My_PRP$ core_NN thesis_NN in_IN this_DT paper_NN is_VBZ that_IN counterfactual_JJ arguments_NNS contribute_VBP much_JJ to_TO the_DT question_NN of_IN when_WRB to_TO apply_VB Hill_NNP 's_POS considerations_NNS to_TO a_DT specific_JJ causal_JJ question_NN ._. 
This_DT is_VBZ not_RB to_TO say_VB that_IN other_JJ conceptualisations_NNS of_IN causality_NN would_MD not_RB contribute_VB to_TO clarifying_VBG Hill_NNP 's_POS considerations_NNS ,_, but_CC the_DT counterfactual_JJ model_NN is_VBZ the_DT one_NN that_WDT directly_RB relates_VBZ to_TO many_JJ statistical_JJ methods_NNS ,_, and_CC it_PRP links_VBZ the_DT ``_`` metaphysical_JJ ''_'' side_NN of_IN causality_NN to_TO epidemiological_JJ practice_NN ._. 
Moreover_RB ,_, I_PRP shall_MD argue_VB that_IN some_DT of_IN Hill_NNP 's_POS considerations_NNS involve_VBP many_JJ counterfactuals_NNS in_IN a_DT broader_JJR causal_JJ system_NN ,_, and_CC that_IN the_DT heuristic_JJ value_NN of_IN these_DT considerations_NNS can_MD be_VB low_JJ ._. 
As_IN Fisher_NNP and_CC Hill_NNP were_VBD friends_NNS for_IN at_IN least_JJS some_DT years_NNS 
To_TO define_VB a_DT counterfactual_JJ effect_NN ,_, imagine_VBP an_DT individual_JJ i_FW at_IN a_DT fixed_JJ time_NN ._. 
Today_NN ,_, the_DT counterfactual_JJ ,_, or_CC potential_JJ outcome_NN ,_, model_NN of_IN causality_NN has_VBZ become_VBN more_RBR or_CC less_RBR standard_JJ in_IN epidemiology_NN ,_, and_CC it_PRP has_VBZ been_VBN argued_VBN that_IN counterfactual_JJ causality_NN captures_VBZ most_JJS aspects_NNS of_IN causality_NN in_IN health_NN sciences_NNS ._. 
Principally_RB we_PRP assume_VBP that_IN -LRB-_-LRB- a_DT -RRB-_-RRB- this_DT individual_NN could_MD be_VB assigned_VBN to_TO both_DT exposure_NN levels_NNS we_PRP aim_VBP to_TO compare_VB -LRB-_-LRB- X_NNP =_SYM 0_CD and_CC X_NNP =_SYM 1_CD respectively_RB -RRB-_-RRB- and_CC -LRB-_-LRB- b_NN -RRB-_-RRB- that_IN the_DT outcome_NN Yi_NNP exists_VBZ under_IN both_DT exposure_NN levels_NNS -LRB-_-LRB- denoted_VBN by_IN Yi0_NNP and_CC Yi1_NNP respectively_RB -RRB-_-RRB- 
Asimilar_JJ idea_NN can_MD be_VB found_VBN in_IN an_DT earlier_JJR paper_NN by_IN Lewis_NNP 
the_DT decisive_JJ question_NN is_VBZ whether_IN the_DT frequency_NN of_IN the_DT undesirable_JJ event_NN B_NN would_MD be_VB influenced_VBN by_IN a_DT change_NN in_IN the_DT environmental_JJ feature_NN A_NN ._. 
``_`` Counterfactual_JJ causality_NN dates_NNS back_RB at_IN least_JJS to_TO the_DT 18th_JJ century_NN Scottish_JJ philosopher_NN David_NNP Hume_NNP 
Hill_NNP 
My_PRP$ core_NN thesis_NN in_IN this_DT paper_NN is_VBZ that_IN counterfactual_JJ arguments_NNS contribute_VBP much_JJ to_TO the_DT question_NN of_IN when_WRB to_TO apply_VB Hill_NNP 's_POS considerations_NNS to_TO a_DT specific_JJ causal_JJ question_NN ._. 
This_DT is_VBZ not_RB to_TO say_VB that_IN other_JJ conceptualisations_NNS of_IN causality_NN would_MD not_RB contribute_VB to_TO clarifying_VBG Hill_NNP 's_POS considerations_NNS ,_, but_CC the_DT counterfactual_JJ model_NN is_VBZ the_DT one_NN that_WDT directly_RB relates_VBZ to_TO many_JJ statistical_JJ methods_NNS ,_, and_CC it_PRP links_VBZ the_DT ``_`` metaphysical_JJ ''_'' side_NN of_IN causality_NN to_TO epidemiological_JJ practice_NN ._. 
Moreover_RB ,_, I_PRP shall_MD argue_VB that_IN some_DT of_IN Hill_NNP 's_POS considerations_NNS involve_VBP many_JJ counterfactuals_NNS in_IN a_DT broader_JJR causal_JJ system_NN ,_, and_CC that_IN the_DT heuristic_JJ value_NN of_IN these_DT considerations_NNS can_MD be_VB low_JJ ._. 
As_IN Fisher_NNP and_CC Hill_NNP were_VBD friends_NNS for_IN at_IN least_JJS some_DT years_NNS 
Principally_RB we_PRP assume_VBP that_IN -LRB-_-LRB- a_DT -RRB-_-RRB- this_DT individual_NN could_MD be_VB assigned_VBN to_TO both_DT exposure_NN levels_NNS we_PRP aim_VBP to_TO compare_VB -LRB-_-LRB- X_NNP =_SYM 0_CD and_CC X_NNP =_SYM 1_CD respectively_RB -RRB-_-RRB- and_CC -LRB-_-LRB- b_NN -RRB-_-RRB- that_IN the_DT outcome_NN Y_NNP i_FW exists_VBZ under_IN both_DT exposure_NN levels_NNS -LRB-_-LRB- denoted_VBN by_IN Y_NNP i0_NNP and_CC Y_NNP i1_CD respectively_RB -RRB-_-RRB- 
g._NNP Ironically_NNP ,_, this_DT paper_NN became_VBD famous_JJ for_IN something_NN it_PRP was_VBD by_IN no_DT means_NNS intended_VBN to_TO be_VB 
Hill_NNP 
25_CD -RRB-_-RRB- have_VBP drawn_VBN attention_NN to_TO the_DT possibility_NN that_IN such_JJ conflicting_JJ knowledge_NN might_MD itself_PRP be_VB wrong_JJ ._. 
Susser_NNP 
Human_JJ experiments_NNS were_VBD hardly_RB available_JJ in_IN epidemiology_NN ,_, and_CC results_NNS from_IN animal_JJ experiments_NNS could_MD not_RB easily_RB be_VB applied_VBN to_TO human_JJ beings_NNS ._. 
To_TO Susser_NNP 
To_TO Susser_NNP 
He_PRP gives_VBZ the_DT following_JJ example_NN :_: ``_`` With_IN the_DT effects_NNS of_IN thalamoide_NN and_CC rubella_NN before_IN us_PRP we_PRP would_MD surely_RB be_VB ready_JJ to_TO accept_VB slighter_NN but_CC similar_JJ evidence_NN with_IN another_DT drug_NN or_CC another_DT viral_JJ disease_NN in_IN pregnancy_NN ._. 
``_`` Susser_NNP 
Hill_NNP acknowledged_VBD that_IN the_DT impression_NN of_IN strength_NN of_IN association_NN depended_VBN on_IN the_DT index_NN used_VBN for_IN the_DT magnitude_NN of_IN association_NN 
.._NN 
The_DT fundamental_JJ problem_NN with_IN the_DT choice_NN of_IN an_DT effect_NN measure_NN is_VBZ that_IN ``_`` neither_DT relative_JJ risk_NN nor_CC any_DT other_JJ measure_NN of_IN association_NN is_VBZ a_DT biologically_RB consistent_JJ feature_NN of_IN an_DT association_NN ._. 
it_PRP is_VBZ a_DT characteristic_NN of_IN a_DT study_NN population_NN that_WDT depends_VBZ on_IN the_DT relative_JJ prevalence_NN of_IN other_JJ causes_NNS ''_'' 
Rothman_NNP and_CC Poole_NNP 
Likewise_RB ,_, differing_VBG results_NNS in_IN different_JJ investigations_NNS might_MD indicate_VB that_IN some_DT studies_NNS correctly_RB showed_VBD a_DT causal_JJ relationship_NN ,_, whereas_IN others_NNS failed_VBD to_TO identify_VB it_PRP ._. 
This_DT point_NN is_VBZ explained_VBN by_IN Rothman_NNP and_CC Greenland_NNP 
25_CD -RRB-_-RRB- :_: causal_JJ agents_NNS might_MD require_VB that_IN another_DT condition_NN was_VBD present_JJ ;_: for_IN instance_NN ,_, transfusion_NN could_MD lead_VB to_TO infection_NN with_IN the_DT human_JJ immunodeficiency_NN virus_NN only_RB if_IN the_DT virus_NN was_VBD present_JJ ._. 
Now_RB ,_, according_VBG to_TO the_DT sufficient-component_JJ cause_NN model_NN 
Hill_NNP 's_POS consideration_NN on_IN specificity_NN for_IN persons_NNS apparently_RB contradicts_VBZ his_PRP$ consideration_NN on_IN consistency_NN ,_, where_WRB repeatedly_RB observing_VBG an_DT association_NN in_IN different_JJ populations_NNS would_MD increase_VB the_DT evidence_NN for_IN a_DT causal_JJ effect_NN ._. 
Rothman_NNP and_CC Greenland_NNP 
225_CD -RRB-_-RRB- ._. 
Others_NNS have_VBP been_VBN less_RBR demanding_VBG and_CC more_RBR specific_JJ in_IN their_PRP$ definition_NN of_IN a_DT dose-response_JJ relation_NN ,_, requiring_VBG only_RB a_DT particular_JJ shape_NN of_IN relationship_NN -LRB-_-LRB- not_RB necessarily_RB linear_JJ or_CC monotonic_JJ -RRB-_-RRB- ,_, which_WDT is_VBZ predicted_VBN from_IN a_DT substantive_JJ theory_NN 
226_CD -RRB-_-RRB- have_VBP added_VBN the_DT extremely_RB important_JJ point_NN that_IN a_DT relationship_NN that_WDT is_VBZ predicted_VBN prospectively_RB is_VBZ much_RB more_RBR convincing_JJ than_IN one_CD that_WDT is_VBZ provided_VBN retrospectively_RB ;_: after_IN observing_VBG an_DT association_NN ,_, it_PRP is_VBZ often_RB easy_JJ to_TO give_VB a_DT plausible_JJ explanation_NN ._. 
According_VBG to_TO Rothman_NNP and_CC Greenland_NNP 
''_'' Susser_NNP 
He_PRP provided_VBD similar_JJ arguments_NNS for_IN specificity_NN of_IN exposure_NN and_CC specificity_NN with_IN regard_NN to_TO individuals_NNS in_IN whom_WP a_DT theory_NN predicts_VBZ an_DT effect_NN ._. 
Counterfactual_JJ causality_NN ,_, and_CC the_DT logically_RB equivalent_JJ causal_JJ graphs_NNS 
To_TO demand_VB a_DT dose-response_JJ relationship_NN could_MD be_VB misleading_JJ if_IN such_JJ an_DT assumption_NN contradicted_VBD substantive_JJ knowledge_NN ._. 
No_DT dose-response_JJ relationship_NN in_IN presumably_RB causal_JJ effects_NNS has_VBZ been_VBN found_VBN ,_, for_IN example_NN ,_, between_IN the_DT intake_NN of_IN inhaled_JJ corticosteroids_NNS and_CC lung_NN function_NN among_IN asthma_NN patients_NNS 
No_DT dose-response_JJ relationship_NN in_IN presumably_RB causal_JJ effects_NNS has_VBZ been_VBN found_VBN ,_, for_IN example_NN ,_, between_IN the_DT intake_NN of_IN inhaled_JJ corticosteroids_NNS and_CC lung_NN function_NN among_IN asthma_NN patients_NNS 
.._CD ''_'' 
-RRB-_-RRB- pointed_VBD out_RP that_IN this_DT rule_NN applies_VBZ to_TO systems_NNS where_WRB quite_RB specific_JJ processes_NNS act_NN ,_, rather_RB than_IN to_TO systems_NNS where_WRB the_DT variables_NNS involved_VBN represent_VBP aggregates_NNS of_IN many_JJ characteristics_NNS ._. 
Weiss_NNP 
He_PRP provided_VBD similar_JJ arguments_NNS for_IN specificity_NN of_IN exposure_NN and_CC specificity_NN with_IN regard_NN to_TO individuals_NNS in_IN whom_WP a_DT theory_NN predicts_VBZ an_DT effect_NN ._. 
Counterfactual_JJ causality_NN ,_, and_CC the_DT logically_RB equivalent_JJ causal_JJ graphs_NNS 
He_PRP provided_VBD similar_JJ arguments_NNS for_IN specificity_NN of_IN exposure_NN and_CC specificity_NN with_IN regard_NN to_TO individuals_NNS in_IN whom_WP a_DT theory_NN predicts_VBZ an_DT effect_NN ._. 
Counterfactual_JJ causality_NN ,_, and_CC the_DT logically_RB equivalent_JJ causal_JJ graphs_NNS 
If_IN the_DT presence_NN of_IN a_DT certain_JJ disease_NN -LRB-_-LRB- X_NNP -RRB-_-RRB- is_VBZ associated_VBN with_IN a_DT higher_JJR subsequent_JJ incidence_NN rate_NN of_IN another_DT disease_NN -LRB-_-LRB- Y_NNP -RRB-_-RRB- ,_, and_CC if_IN prior_JJ Y_NNP also_RB predicts_VBZ an_DT elevated_JJ probability_NN of_IN subsequent_JJ onset_NN of_IN X_NNP ,_, it_PRP is_VBZ sometimes_RB assumed_VBN that_IN a_DT shared_JJ vulnerability_NN was_VBD the_DT common_JJ cause_NN of_IN both_DT associations_NNS ._. 
This_DT possibility_NN has_VBZ ,_, for_IN instance_NN ,_, been_VBN discussed_VBN for_IN the_DT role_NN of_IN anxiety_NN in_IN the_DT development_NN of_IN depression_NN 
To_TO demand_VB a_DT dose-response_JJ relationship_NN could_MD be_VB misleading_JJ if_IN such_JJ an_DT assumption_NN contradicted_VBD substantive_JJ knowledge_NN ._. 
No_DT dose-response_JJ relationship_NN in_IN presumably_RB causal_JJ effects_NNS has_VBZ been_VBN found_VBN ,_, for_IN example_NN ,_, between_IN the_DT intake_NN of_IN inhaled_JJ corticosteroids_NNS and_CC lung_NN function_NN among_IN asthma_NN patients_NNS 
One_CD should_MD be_VB careful_JJ when_WRB applying_VBG this_DT guideline_NN ;_: effect_NN heterogeneity_NN depends_VBZ on_IN the_DT choice_NN of_IN the_DT effect_NN measure_NN ._. 
This_DT choice_NN should_MD be_VB based_VBN on_IN a_DT relevant_JJ substantive_JJ theory_NN and_CC on_IN correspondence_NN with_IN the_DT counterfactual_JJ and_CC sufficient-component_JJ cause_NN model_NN -LRB-_-LRB- the_DT latter_JJ two_CD indicating_VBG that_IN differences_NNS rather_RB than_IN ratios_NNS should_MD be_VB used_VBN -RRB-_-RRB- ;_: both_DT may_MD ,_, however_RB ,_, contradict_VB ._. 
From_IN the_DT counterfactual_JJ perspective_NN ,_, the_DT following_JJ questions_NNS arise_VBP when_WRB asking_VBG whether_IN to_TO apply_VB the_DT consideration_NN on_IN consistency_NN :_: a_DT -RRB-_-RRB- If_IN the_DT causal_JJ effect_NN was_VBD truly_RB the_DT same_JJ in_IN all_DT studies_NNS ,_, would_MD one_CD expect_VBP to_TO observe_VB different_JJ associations_NNS in_IN different_JJ studies_NNS -LRB-_-LRB- possibly_RB involving_VBG different_JJ persons_NNS ,_, places_NNS ,_, circumstances_NNS and_CC time_NN -RRB-_-RRB- ._. 
25_CD -RRB-_-RRB- ,_, whether_IN and_CC to_TO what_WP extent_NN there_EX is_VBZ a_DT causal_JJ effect_NN on_IN average_NN depends_VBZ on_IN the_DT prevalences_NNS of_IN complementary_JJ causal_JJ factors_NNS ._. 
Cox_NNP and_CC Wermuth_NNP 
They_PRP considered_VBD the_DT demanding_VBG of_IN specificity_NN ``_`` useless_JJ and_CC misleading_JJ ''_'' ._. 
This_DT assumption_NN is_VBZ often_RB meaningless_JJ ;_: for_IN instance_NN ,_, smoking_NN has_VBZ effects_NNS on_IN several_JJ diseases_NNS ._. 
Cox_NNP and_CC Wermuth_NNP 
If_IN the_DT shape_NN of_IN the_DT dose-response_JJ relationship_NN were_VBD a_DT more_RBR complex_JJ ,_, especially_RB a_DT non-monotonic_JJ ,_, function_NN ,_, this_DT would_MD require_VB a_DT more_RBR complex_JJ substantive_JJ explanation_NN ._. 
Others_NNS have_VBP been_VBN less_RBR demanding_VBG and_CC more_RBR specific_JJ in_IN their_PRP$ definition_NN of_IN a_DT dose-response_JJ relation_NN ,_, requiring_VBG only_RB a_DT particular_JJ shape_NN of_IN relationship_NN -LRB-_-LRB- not_RB necessarily_RB linear_JJ or_CC monotonic_JJ -RRB-_-RRB- ,_, which_WDT is_VBZ predicted_VBN from_IN a_DT substantive_JJ theory_NN 
On_IN the_DT other_JJ hand_NN ,_, in_IN the_DT absence_NN of_IN such_PDT a_DT theory_NN ``_`` the_DT association_NN we_PRP observe_VBP may_MD be_VB one_CD new_JJ to_TO science_NN or_CC medicine_NN and_CC we_PRP must_MD not_RB dismiss_VB it_PRP too_RB light-heartedly_RB as_RB just_RB too_RB odd_JJ ''_'' 
27_CD -RRB-_-RRB- stated_VBD that_IN results_NNS from_IN randomised_JJ experiments_NNS provided_VBD stronger_JJR evidence_NN than_IN results_NNS based_VBN on_IN other_JJ study_NN designs_NNS ,_, but_CC always_RB had_VBD several_JJ possible_JJ explanations_NNS ._. 
Cox_NNP and_CC Wermuth_NNP 
-RRB-_-RRB- Bias_NNP can_MD be_VB addressed_VBN with_IN multiple_JJ bias_NN modelling_NN ._. 
-LRB-_-LRB- A_DT desired_VBN conclusion_NN might_MD be_VB the_DT simple_JJ existence_NN of_IN a_DT causal_JJ effect_NN or_CC a_DT causal_JJ effect_NN of_IN at_IN least_JJS a_DT certain_JJ magnitude_NN ,_, for_IN instance_NN a_DT two-fold_JJ increase_NN in_IN risk_NN ._. 
Contemporary_NNP methods_NNS for_IN multiple_JJ bias_NN modelling_NN include_VBP Bayesian_JJ methods_NNS and_CC Monte_NNP Carlo_NNP sensitivity_NN analysis_NN -LRB-_-LRB- MCSA_NNP ,_, which_WDT can_MD be_VB modified_VBN to_TO be_VB approximatively_RB interpretable_JJ in_IN a_DT Bayesian_JJ manner_NN under_IN certain_JJ conditions_NNS -RRB-_-RRB- ._. 
These_DT methods_NNS address_VBP the_DT uncertainties_NNS about_IN bias_NN parameters_NNS by_IN assigning_VBG prior_JJ distributions_NNS to_TO them_PRP ._. 
24_CD -RRB-_-RRB- ._. 
it_PRP is_VBZ a_DT characteristic_NN of_IN a_DT study_NN population_NN that_WDT depends_VBZ on_IN the_DT relative_JJ prevalence_NN of_IN other_JJ causes_NNS ''_'' 
24_CD -RRB-_-RRB- provided_VBD counter-examples_NNS for_IN strong_JJ but_CC non-causal_JJ relationships_NNS ._. 
Rothman_NNP and_CC Greenland_NNP 
The_DT population_NN average_JJ effect_NN is_VBZ defined_VBN as_IN the_DT average_NN of_IN individual_JJ causal_JJ effects_NNS over_IN all_DT individuals_NNS in_IN the_DT target_NN population_NN on_IN whom_WP inference_NN is_VBZ to_TO be_VB made_VBN ._. 
The_DT estimation_NN of_IN average_JJ causal_JJ effects_NNS in_IN epidemiology_NN is_VBZ subject_JJ to_TO various_JJ biases_NNS ._. 
These_DT biases_NNS are_VBP determined_VBN both_DT by_IN the_DT study_NN design_NN and_CC the_DT mechanism_NN that_WDT generates_VBZ the_DT data_NNS ._. 
In_IN a_DT randomised_JJ controlled_JJ trial_NN -LRB-_-LRB- RCT_NNP -RRB-_-RRB- ,_, bias_NN due_JJ to_TO confounding_VBG can_MD not_RB occur_VB ,_, but_CC confounders_NNS might_MD be_VB distributed_VBN unequally_RB across_IN treatment_NN levels_NNS by_IN chance_NN ,_, especially_RB in_IN small_JJ samples_NNS ._. 
Rothman_NNP 
However_RB ,_, bias_NN due_JJ to_TO measurement_NN error_NN could_MD still_RB occur_VB in_IN the_DT outcome_NN ,_, and_CC there_EX may_MD be_VB bias_NN due_JJ to_TO selection_NN ,_, missing_VBG data_NNS ,_, etc._FW ._. 
Thus_RB ,_, the_DT outcome_NN has_VBZ to_TO be_VB estimated_VBN under_IN the_DT unobserved_JJ or_CC counterfactual_JJ condition_NN ,_, known_VBN as_IN the_DT counterfactual_JJ or_CC potential_JJ outcome_NN ._. 
According_VBG to_TO Rothman_NNP 
According_VBG to_TO Rothman_NNP 
25_CD -RRB-_-RRB- :_: causal_JJ agents_NNS might_MD require_VB that_IN another_DT condition_NN was_VBD present_JJ ;_: for_IN instance_NN ,_, transfusion_NN could_MD lead_VB to_TO infection_NN with_IN the_DT human_JJ immunodeficiency_NN virus_NN only_RB if_IN the_DT virus_NN was_VBD present_JJ ._. 
Now_RB ,_, according_VBG to_TO the_DT sufficient-component_JJ cause_NN model_NN 
Principally_RB we_PRP assume_VBP that_IN -LRB-_-LRB- a_DT -RRB-_-RRB- this_DT individual_NN could_MD be_VB assigned_VBN to_TO both_DT exposure_NN levels_NNS we_PRP aim_VBP to_TO compare_VB -LRB-_-LRB- X_NNP =_SYM 0_CD and_CC X_NNP =_SYM 1_CD respectively_RB -RRB-_-RRB- and_CC -LRB-_-LRB- b_NN -RRB-_-RRB- that_IN the_DT outcome_NN Y_NNP i_FW exists_VBZ under_IN both_DT exposure_NN levels_NNS -LRB-_-LRB- denoted_VBN by_IN Y_NNP i0_NNP and_CC Y_NNP i1_CD respectively_RB -RRB-_-RRB- 
25_CD -RRB-_-RRB- :_: causal_JJ agents_NNS might_MD require_VB that_IN another_DT condition_NN was_VBD present_JJ ;_: for_IN instance_NN ,_, transfusion_NN could_MD lead_VB to_TO infection_NN with_IN the_DT human_JJ immunodeficiency_NN virus_NN only_RB if_IN the_DT virus_NN was_VBD present_JJ ._. 
Now_RB ,_, according_VBG to_TO the_DT sufficient-component_JJ cause_NN model_NN 
The_DT key_JJ analysis_NN tool_NN to_TO assess_VB the_DT applicability_NN of_IN Hill_NNP 's_POS considerations_NNS is_VBZ multiple_JJ bias_NN modelling_NN -LRB-_-LRB- Bayesian_JJ methods_NNS and_CC Monte_NNP Carlo_NNP sensitivity_NN analysis_NN -RRB-_-RRB- ;_: these_DT methods_NNS should_MD be_VB used_VBN much_RB more_RBR frequently_RB ._. 
IntroductionSir_NNP Austin_NNP Bradford_NNP Hill_NNP -LRB-_-LRB- 1897_CD 
''_'' Counterfactual_JJ causality_NN dates_NNS back_RB at_IN least_JJS to_TO the_DT 18_CD th_JJ century_NN Scottish_JJ philosopher_NN David_NNP Hume_NNP 
Introduction_NNP Sir_NNP Austin_NNP Bradford_NNP Hill_NNP -LRB-_-LRB- 1897_CD 
-RRB-_-RRB- ._. 
g._NNP Ironically_NNP ,_, this_DT paper_NN became_VBD famous_JJ for_IN something_NN it_PRP was_VBD by_IN no_DT means_NNS intended_VBN to_TO be_VB 
Moreover_RB ,_, I_PRP shall_MD argue_VB that_IN some_DT of_IN Hill_NNP 's_POS considerations_NNS involve_VBP many_JJ counterfactuals_NNS in_IN a_DT broader_JJR causal_JJ system_NN ,_, and_CC that_IN the_DT heuristic_JJ value_NN of_IN these_DT considerations_NNS can_MD be_VB low_JJ ._. 
AnalysisCounterfactual_NNP causalityHill_NNP avoided_VBD defining_VBG exactly_RB what_WP he_PRP meant_VBD with_IN a_DT causal_JJ effect_NN :_: ``_`` I_PRP have_VBP no_DT wish_NN ,_, nor_CC the_DT skill_NN to_TO embark_VB upon_IN a_DT philosophical_JJ discussion_NN of_IN the_DT meaning_NN of_IN `_`` causation_NN '_'' ._. ''_'' 
However_RB ,_, it_PRP seems_VBZ that_IN he_PRP applied_VBD the_DT counterfactual_JJ model_NN because_IN he_PRP then_RB writes_VBZ :_: ''_'' ..._: the_DT decisive_JJ question_NN is_VBZ whether_IN the_DT frequency_NN of_IN the_DT undesirable_JJ event_NN B_NN would_MD be_VB influenced_VBN by_IN a_DT change_NN in_IN the_DT environmental_JJ feature_NN A_NN ._. 
1._CD 
Some_DT of_IN my_PRP$ arguments_NNS apply_VBP to_TO several_JJ of_IN Hill_NNP 's_POS considerations_NNS and_CC I_PRP will_MD occasionally_RB not_RB repeat_VB them_PRP to_TO avoid_VB redundancy_NN ._. 
Strength_NN of_IN associationA_NNP strong_JJ association_NN is_VBZ more_RBR likely_JJ to_TO have_VB a_DT causal_JJ component_NN than_IN is_VBZ a_DT modest_JJ associationHill_NNP illustrated_VBD this_DT point_NN with_IN the_DT high_JJ risk_NN ratios_NNS for_IN the_DT association_NN between_IN exposure_NN levels_NNS of_IN smoking_NN and_CC incidence_NN of_IN lung_NN cancer_NN ._. 
However_RB ,_, he_PRP demonstrated_VBD with_IN two_CD counter-examples_NNS that_IN the_DT absence_NN of_IN a_DT strong_JJ association_NN does_VBZ not_RB rule_VB out_RP a_DT causal_JJ effect_NN ._. 
However_RB ,_, he_PRP demonstrated_VBD with_IN two_CD counter-examples_NNS that_IN the_DT absence_NN of_IN a_DT strong_JJ association_NN does_VBZ not_RB rule_VB out_RP a_DT causal_JJ effect_NN ._. 
Hill_NNP acknowledged_VBD that_IN the_DT impression_NN of_IN strength_NN of_IN association_NN depended_VBN on_IN the_DT index_NN used_VBN for_IN the_DT magnitude_NN of_IN association_NN 
2._CD 
Despite_IN this_DT ,_, there_EX seems_VBZ to_TO be_VB no_DT alternative_NN to_TO multiple_JJ bias_NN modelling_NN when_WRB assessing_VBG which_WDT magnitude_NN of_IN association_NN is_VBZ necessary_JJ for_IN the_DT desired_VBN conclusion_NN ._. 
ConsistencyA_NNP relationship_NN is_VBZ observed_JJ repeatedlyFor_NNP Hill_NNP ,_, the_DT repeated_JJ observation_NN of_IN an_DT association_NN included_VBD ``_`` different_JJ persons_NNS ,_, places_NNS ,_, circumstances_NNS and_CC time_NN ''_'' ._. 
The_DT benefit_NN of_IN this_DT rule_NN was_VBD that_IN consistently_RB finding_VBG an_DT association_NN with_IN different_JJ study_NN designs_NNS -LRB-_-LRB- e._SYM 
3._CD 
Here_RB ,_, the_DT uncertainty_NN regarding_VBG whether_IN or_CC not_RB to_TO demand_VB an_DT association_NN -LRB-_-LRB- or_CC which_WDT magnitude_NN of_IN association_NN -RRB-_-RRB- could_MD be_VB high_JJ ,_, and_CC so_RB the_DT consistency_NN consideration_NN might_MD bring_VB more_JJR harm_NN than_IN benefit_NN ._. 
SpecificityA_NN factor_NN influences_VBZ specifically_RB a_DT particular_JJ outcome_NN or_CC populationFor_NNP Hill_NNP ,_, if_IN one_CD observed_VBD an_DT association_NN that_WDT was_VBD specific_JJ for_IN an_DT outcome_NN or_CC group_NN of_IN individuals_NNS ,_, this_DT was_VBD a_DT strong_JJ argument_NN for_IN a_DT causal_JJ effect_NN ._. 
In_IN the_DT absence_NN of_IN specificity_NN ,_, Hill_NNP alludes_VBZ to_TO fallacies_NNS in_IN applying_VBG this_DT rule_NN to_TO conclude_VB the_DT absence_NN of_IN a_DT causal_JJ effect_NN :_: Diseases_NNS may_MD have_VB more_JJR than_IN one_CD cause_NN -LRB-_-LRB- which_WDT Hill_NNP considered_VBD to_TO be_VB the_DT predominant_JJ case_NN -RRB-_-RRB- ._. 
4._CD 
To_TO conclude_VB ,_, the_DT consideration_NN of_IN specificity_NN appears_VBZ to_TO be_VB useful_JJ only_RB when_WRB a_DT causal_JJ system_NN is_VBZ simple_JJ and_CC the_DT knowledge_NN about_IN it_PRP is_VBZ largely_RB certain_JJ ._. 
TemporalityThe_JJ factor_NN must_MD precede_VB the_DT outcome_NN it_PRP is_VBZ assumed_VBN to_TO affectHill_NNP introduced_VBD this_DT reflection_NN with_IN the_DT proverb_NN ``_`` Which_WDT is_VBZ the_DT cart_NN and_CC which_WDT is_VBZ the_DT horse_NN ._. ''_'' 
For_IN instance_NN ,_, he_PRP asked_VBD whether_IN a_DT particular_JJ diet_NN triggered_VBD a_DT certain_JJ disease_NN or_CC whether_IN the_DT disease_NN led_VBD to_TO subsequently_RB altered_JJ dietary_JJ habits_NNS ._. 
5._CD 
In_IN RCTs_NNP ,_, temporal_JJ direction_NN can_MD be_VB established_VBN without_IN error_NN ._. 
To_TO assess_VB temporal_JJ order_NN between_IN X_NNP and_CC Y_NNP ,_, a_DT longitudinal_JJ design_NN is_VBZ preferable_JJ to_TO a_DT design_NN in_IN which_WDT the_DT temporal_JJ direction_NN between_IN X_NNP and_CC Y_NNP has_VBZ to_TO be_VB assessed_VBN retrospectively_RB ._. 
Biological_JJ gradientThe_NNP outcome_NN increases_NNS monotonically_RB with_IN increasing_VBG dose_NN of_IN exposure_NN or_CC according_VBG to_TO a_DT function_NN predicted_VBN by_IN a_DT substantive_JJ theoryHill_NNP favored_VBD linear_JJ relationships_NNS between_IN exposure_NN level_NN and_CC outcome_NN ,_, for_IN instance_NN ,_, between_IN the_DT number_NN of_IN cigarettes_NNS smoked_VBN per_IN day_NN and_CC the_DT death_NN rate_NN from_IN cancer_NN ._. 
If_IN the_DT shape_NN of_IN the_DT dose-response_JJ relationship_NN were_VBD a_DT more_RBR complex_JJ ,_, especially_RB a_DT non-monotonic_JJ ,_, function_NN ,_, this_DT would_MD require_VB a_DT more_RBR complex_JJ substantive_JJ explanation_NN ._. 
g._NNP Plausibility_NNP The_DT observed_JJ association_NN can_MD be_VB plausibly_RB explained_VBN by_IN substantive_JJ matter_NN -LRB-_-LRB- e._NN 6_CD ._. 
RCTs_NNS are_VBP particularly_RB useful_JJ for_IN assessing_VBG dose-response_JJ relationships_NNS ,_, because_IN they_PRP avoid_VBP some_DT biases_NNS that_WDT are_VBP sometimes_RB difficult_JJ to_TO correct_VB for_IN using_VBG other_JJ study_NN designs_NNS ._. 
biological_JJ -RRB-_-RRB- explanationsFor_NNP Hill_NNP 
biological_JJ -RRB-_-RRB- explanations_NNS For_IN Hill_NNP 
7._CD 
This_DT involves_VBZ many_JJ design_NN issues_NNS ,_, such_JJ as_IN the_DT sample_NN sizes_NNS in_IN the_DT present_JJ data_NNS and_CC in_IN other_JJ data_NNS ,_, and_CC the_DT questions_NNS of_IN how_WRB bias_NN acted_VBD and_CC was_VBD addressed_VBN in_IN different_JJ studies_NNS ._. 
CoherenceA_NNP causal_JJ conclusion_NN should_MD not_RB fundamentally_RB contradict_VB present_JJ substantive_JJ knowledgeHill_NNP used_VBD the_DT term_NN ``_`` generally_RB known_VBN facts_NNS ''_'' to_TO indicate_VB that_IN the_DT knowledge_NN against_IN which_WDT an_DT association_NN is_VBZ evaluated_VBN has_VBZ to_TO be_VB undisputable_JJ ._. 
Laboratory_NN evidence_NN that_WDT is_VBZ in_IN line_NN with_IN an_DT association_NN would_MD underline_VB a_DT causal_JJ conclusion_NN and_CC help_NN to_TO identify_VB the_DT causal_JJ agent_NN ._. 
8._CD ''_'' 
Whereas_IN the_DT consideration_NN of_IN coherence_NN would_MD reject_VB the_DT observed_JJ result_NN to_TO be_VB non-causal_JJ if_IN it_PRP contradicted_VBD a_DT predominant_JJ theory_NN ,_, plausibility_NN leaves_VBZ the_DT researcher_NN more_JJR room_NN regarding_VBG which_WDT particular_JJ piece_NN of_IN substantive_JJ knowledge_NN to_TO evaluate_VB the_DT results_NNS against_IN ._. 
ExperimentCausation_NN is_VBZ more_RBR likely_JJ if_IN evidence_NN is_VBZ based_VBN on_IN randomised_JJ experimentsHill_NNP argued_VBD that_IN a_DT causal_JJ interpretation_NN of_IN an_DT association_NN from_IN a_DT non-experimental_JJ study_NN was_VBD supported_VBN if_IN a_DT randomised_JJ prevention_NN derived_VBN from_IN the_DT association_NN confirmed_VBD the_DT finding_NN ._. 
For_IN instance_NN ,_, after_IN finding_VBG that_IN certain_JJ events_NNS were_VBD related_VBN to_TO the_DT number_NN of_IN people_NNS smoking_NN ,_, one_PRP might_MD forbid_VB smoking_NN to_TO see_VB whether_IN the_DT frequency_NN of_IN the_DT events_NNS decrease_VBP consecutively_RB ._. 
9._CD 
As_IN a_DT consequence_NN ,_, one_PRP can_MD hardly_RB ever_RB demonstrate_VB a_DT causal_JJ effect_NN if_IN biases_NNS are_VBP poorly_RB understood_VBN 
His_PRP$ aim_NN was_VBD to_TO unravel_VB the_DT question_NN :_: ``_`` What_WP aspects_NNS of_IN this_DT association_NN should_MD we_PRP especially_RB consider_VBP before_IN deciding_VBG that_IN the_DT most_RBS likely_JJ interpretation_NN of_IN it_PRP is_VBZ causation_NN ._. ''_'' 
Thus_RB ,_, with_IN increasing_VBG complexity_NN ,_, the_DT heuristic_JJ value_NN of_IN Hill_NNP 's_POS considerations_NNS diminishes_VBZ ._. 
If_IN complexity_NN becomes_VBZ very_RB large_JJ ,_, the_DT uncertainty_NN regarding_VBG whether_IN or_CC not_RB to_TO apply_VB a_DT given_VBN consideration_NN can_MD be_VB expected_VBN to_TO approach_VB a_DT decision_NN made_VBN by_IN coin_NN toss_VB ._. 
Here_RB ,_, an_DT original_JJ argument_NN of_IN Hill_NNP becomes_VBZ of_IN particularly_RB important_JJ :_: the_DT required_JJ amount_NN of_IN evidence_NN for_IN a_DT causal_JJ effect_NN should_MD depend_VB on_IN the_DT possible_JJ consequences_NNS of_IN interventions_NNS derived_VBN from_IN causal_JJ conclusions_NNS ._. 
If_IN a_DT causal_JJ conclusion_NN needed_VBD an_DT action_NN that_WDT brought_VBD about_IN more_JJR harm_NN if_IN wrongly_RB taken_VBN than_IN benefit_NN if_IN rightly_RB taken_VBN ,_, a_DT correspondingly_RB high_JJ amount_NN of_IN evidence_NN would_MD be_VB required_VBN ._. 
More_RBR pessimistically_RB ,_, the_DT question_NN of_IN which_WDT guidance_NN is_VBZ followed_VBN depends_VBZ on_IN which_WDT guidelines_NNS are_VBP in_IN line_NN with_IN the_DT desired_VBN answer_NN ._. 
Therefore_RB ,_, it_PRP seems_VBZ likely_JJ that_IN ,_, even_RB if_IN Hill_NNP 's_POS paper_NN had_VBD not_RB been_VBN published_VBN ,_, scientists_NNS '_POS desire_NN for_IN simple_JJ answers_NNS would_MD have_VB caused_VBN another_DT paper_NN to_TO be_VB written_VBN or_CC to_TO be_VB misinterpreted_VBN in_IN the_DT same_JJ way_NN as_IN happened_VBN with_IN Hill_NNP 's_POS article_NN ._. 
List_NN of_IN abbreviations_NNS MCSA_NNP :_: Monte_NNP Carlo_NNP sensitivity_NN analyses_VBZ RCT_NNP :_: randomised_VBN and_CC controlled_VBN trial_NN Competing_VBG interests_NNS The_DT author_NN -LRB-_-LRB- s_PRP -RRB-_-RRB- declare_VBP that_IN they_PRP have_VBP no_DT competing_VBG interests_NNS ._. 
His_PRP$ summary_NN of_IN a_DT lecture_NN entitled_VBN ``_`` The_DT environment_NN and_CC disease_NN :_: Association_NN or_CC causation_NN ''_'' 
Iam_NNP far_RB from_IN claiming_VBG to_TO be_VB able_JJ to_TO answer_VB this_DT question_NN ,_, but_CC I_PRP consider_VBP my_PRP$ speculation_NN being_VBG worth_JJ mentioning_VBG ._. 
In_IN their_PRP$ paper_NN entitled_VBN ``_`` The_DT missed_VBN lessons_NNS of_IN Sir_NNP Austin_NNP Bradford_NNP Hill_NNP ''_'' 
In_IN their_PRP$ paper_NN entitled_VBN ``_`` The_DT missed_VBN lessons_NNS of_IN Sir_NNP Austin_NNP Bradford_NNP Hill_NNP ''_'' 
His_PRP$ summary_NN of_IN a_DT lecture_NN entitled_VBN ``_`` The_DT environment_NN and_CC disease_NN :_: Association_NN or_CC causation_NN ''_'' 
Thus_RB ,_, Y_NNP can_MD not_RB have_VB caused_VBN X_NNP in_IN these_DT individuals_NNS ._. 
Considering_VBG individuals_NNS in_IN whom_WP X_NNP has_VBZ occurred_VBN before_IN Y_NNP ,_, it_PRP is_VBZ logically_RB not_RB possible_JJ that_IN X_NNP would_MD have_VB changed_VBN if_IN Y_NNP had_VBD changed_VBN ,_, because_IN X_NNP is_VBZ fixed_VBN at_IN the_DT time_NN when_WRB Y_NNP occurs_VBZ -LRB-_-LRB- or_CC not_RB -RRB-_-RRB- ._. 
This_DT is_VBZ ,_, indeed_RB ,_, the_DT only_JJ sine_NN qua_FW non_FW criterion_NN for_IN a_DT counterfactual_JJ effect_NN in_IN a_DT single_JJ individual_NN 
Note_VB that_IN there_EX is_VBZ no_DT logical_JJ link_NN to_TO individuals_NNS in_IN whom_WP Y_NNP has_VBZ occurred_VBN before_IN X_NNP ._. 
27_CD ,_, 11_CD -RRB-_-RRB- 
Again_RB ,_, the_DT absence_NN of_IN such_JJ knowledge_NN would_MD not_RB be_VB indicative_JJ of_IN a_DT non-causal_JJ explanation_NN ._. 
Laboratory_NN evidence_NN that_WDT is_VBZ in_IN line_NN with_IN an_DT association_NN would_MD underline_VB a_DT causal_JJ conclusion_NN and_CC help_NN to_TO identify_VB the_DT causal_JJ agent_NN ._. 
The_DT difference_NN in_IN Hill_NNP 's_POS definitions_NNS of_IN plausibility_NN and_CC coherence_NN appears_VBZ to_TO be_VB subtle_JJ 
Whereas_IN plausibility_NN is_VBZ worded_VBN positively_RB -LRB-_-LRB- an_DT association_NN that_WDT should_MD be_VB in_IN line_NN with_IN substantive_JJ knowledge_NN -RRB-_-RRB- ,_, coherence_NN is_VBZ verbalised_VBN negatively_RB -LRB-_-LRB- an_DT association_NN that_WDT should_MD not_RB conflict_VB with_IN substantive_JJ knowledge_NN -RRB-_-RRB- ._. 
Rothman_NNP and_CC Greenland_NNP 
For_IN instance_NN ,_, after_IN finding_VBG that_IN certain_JJ events_NNS were_VBD related_VBN to_TO the_DT number_NN of_IN people_NNS smoking_NN ,_, one_PRP might_MD forbid_VB smoking_NN to_TO see_VB whether_IN the_DT frequency_NN of_IN the_DT events_NNS decrease_VBP consecutively_RB ._. 
To_TO Rothman_NNP and_CC Greenland_NNP 
To_TO Susser_NNP 
The_DT key_JJ analysis_NN tool_NN to_TO assess_VB the_DT applicability_NN of_IN Hill_NNP 's_POS considerations_NNS is_VBZ multiple_JJ bias_NN modelling_NN -LRB-_-LRB- Bayesian_JJ methods_NNS and_CC Monte_NNP Carlo_NNP sensitivity_NN analysis_NN -RRB-_-RRB- ;_: these_DT methods_NNS should_MD be_VB used_VBN much_RB more_RBR frequently_RB ._. 
IntroductionSir_NNP Austin_NNP Bradford_NNP Hill_NNP -LRB-_-LRB- 1897_CD 
''_'' Counterfactual_JJ causality_NN dates_NNS back_RB at_IN least_JJS to_TO the_DT 18_CD th_JJ century_NN Scottish_JJ philosopher_NN David_NNP Hume_NNP 
A._NNP The_NNP idea_NN of_IN randomisation_NN ,_, invented_VBN by_IN R._NNP Being_VBG the_DT inventor_NN of_IN randomised_JJ clinical_JJ trials_NNS 
Fisher_NNP 's_VBZ in_IN the_DT 1920s_NNS and_CC 1930s_NNS was_VBD ,_, in_IN turn_NN ,_, stimulated_VBN by_IN Hume_NNP 
g._NNP Ironically_NNP ,_, this_DT paper_NN became_VBD famous_JJ for_IN something_NN it_PRP was_VBD by_IN no_DT means_NNS intended_VBN to_TO be_VB 
The_DT assertion_NN that_IN rigorous_JJ data_NNS collection_NN is_VBZ not_RB possible_JJ during_IN the_DT acute_JJ phase_NN of_IN a_DT crisis_NN or_CC immediately_RB post-conflict_JJ is_VBZ incorrect_JJ ,_, as_IN shown_VBN by_IN several_JJ surveys_NNS implemented_VBN in_IN such_JJ situations_NNS :_: DRC_NNP 
More_RBR rigorous_JJ HIV_NNP biological_JJ and_CC behavioural_JJ surveillance_NN surveys_NNS must_MD occur_VB in_IN situations_NNS of_IN conflict_NN and_CC displacement_NN as_IN this_DT will_MD provide_VB data_NNS for_IN decision_NN makers_NNS and_CC help_NN to_TO reduce_VB the_DT likelihood_NN of_IN incorrect_JJ ,_, incomplete_JJ or_CC misleading_JJ statements_NNS ._. 
The_DT assertion_NN that_IN rigorous_JJ data_NNS collection_NN is_VBZ not_RB possible_JJ during_IN the_DT acute_JJ phase_NN of_IN a_DT crisis_NN or_CC immediately_RB post-conflict_JJ is_VBZ incorrect_JJ ,_, as_IN shown_VBN by_IN several_JJ surveys_NNS implemented_VBN in_IN such_JJ situations_NNS :_: DRC_NNP 
Particular_JJ attention_NN was_VBD expressed_VBN regarding_VBG high_JJ infection_NN rates_NNS among_IN Sudanese_JJ IDPs_NNS and_CC refugees_NNS ,_, and_CC the_DT fear_NN that_IN refugees_NNS living_VBG in_IN host_NN countries_NNS with_IN high_JJ prevalence_NN rates_NNS will_MD return_VB and_CC exacerbate_VB the_DT epidemic_NN in_IN South_NNP Sudan_NNP 
``_`` Infection_NN rates_NNS are_VBP particularly_RB high_JJ among_IN vulnerable_JJ groups_NNS ,_, such_JJ as_IN internally_RB displaced_VBN persons_NNS -LRB-_-LRB- IDPs_NNP -RRB-_-RRB- and_CC refugees_NNS ''_'' ._. 
Concern_NN regarding_VBG stigmatizing_VBG statements_NNS against_IN refugees_NNS living_VBG in_IN Sudan_NNP and_CC Sudanese_JJ refugees_NNS living_VBG in_IN surrounding_VBG host_NN countries_NNS began_VBD after_IN the_DT Integrated_NNP Regional_NNP Information_NNP Network_NNP -LRB-_-LRB- IRIN_NNP -RRB-_-RRB- 
The_DT situation_NN was_VBD described_VBN as_IN ``_`` severe_JJ ''_'' ,_, ``_`` on_IN the_DT verge_NN of_IN an_DT HIV\/AIDS_NN epidemic_NN ''_'' and_CC a_DT ``_`` disaster_NN ''_'' that_WDT was_VBD going_VBG to_TO ``_`` doubtless_JJ increase_NN the_DT likelihood_NN of_IN a_DT further_JJ spread_NN of_IN the_DT epidemic_NN ''_'' 
These_DT reports_NNS particularly_RB highlighted_VBD the_DT high_JJ HIV_NNP prevalence_NN among_IN IDPs_NNP in_IN the_DT camps_NNS and_CC the_DT highest_JJS prevalence_NN among_IN victims_NNS of_IN the_DT LRA_NNP 
Following_VBG progress_NN in_IN the_DT negotiations_NNS between_IN the_DT Government_NN of_IN Sudan_NNP and_CC the_DT Sudan_NNP People_NNP Liberation_NNP Movement\/Army_NNP ,_, future_JJ peace_NN in_IN South_NNP Sudan_NNP and_CC the_DT consequent_JJ return_NN home_NN of_IN refugees_NNS and_CC IDPs_NNS was_VBD reported_VBN widely_RB in_IN the_DT media_NNS ._. 
Particular_JJ attention_NN was_VBD expressed_VBN regarding_VBG high_JJ infection_NN rates_NNS among_IN Sudanese_JJ IDPs_NNS and_CC refugees_NNS ,_, and_CC the_DT fear_NN that_IN refugees_NNS living_VBG in_IN host_NN countries_NNS with_IN high_JJ prevalence_NN rates_NNS will_MD return_VB and_CC exacerbate_VB the_DT epidemic_NN in_IN South_NNP Sudan_NNP 
Following_VBG progress_NN in_IN the_DT negotiations_NNS between_IN the_DT Government_NN of_IN Sudan_NNP and_CC the_DT Sudan_NNP People_NNP Liberation_NNP Movement\/Army_NNP ,_, future_JJ peace_NN in_IN South_NNP Sudan_NNP and_CC the_DT consequent_JJ return_NN home_NN of_IN refugees_NNS and_CC IDPs_NNS was_VBD reported_VBN widely_RB in_IN the_DT media_NNS ._. 
Particular_JJ attention_NN was_VBD expressed_VBN regarding_VBG high_JJ infection_NN rates_NNS among_IN Sudanese_JJ IDPs_NNS and_CC refugees_NNS ,_, and_CC the_DT fear_NN that_IN refugees_NNS living_VBG in_IN host_NN countries_NNS with_IN high_JJ prevalence_NN rates_NNS will_MD return_VB and_CC exacerbate_VB the_DT epidemic_NN in_IN South_NNP Sudan_NNP 
Particular_JJ attention_NN was_VBD expressed_VBN regarding_VBG high_JJ infection_NN rates_NNS among_IN Sudanese_JJ IDPs_NNS and_CC refugees_NNS ,_, and_CC the_DT fear_NN that_IN refugees_NNS living_VBG in_IN host_NN countries_NNS with_IN high_JJ prevalence_NN rates_NNS will_MD return_VB and_CC exacerbate_VB the_DT epidemic_NN in_IN South_NNP Sudan_NNP 
After_IN discussion_NN with_IN IRIN_NNP ,_, the_DT news_NN organization_NN acted_VBD in_IN a_DT rapid_JJ and_CC professional_JJ manner_NN ._. 
These_DT and_CC other_JJ statements_NNS in_IN the_DT UN_NNP report_NN and_CC IRIN_NNP article_NN were_VBD published_VBN without_IN checking_NN with_IN other_JJ sources_NNS ,_, such_JJ as_IN the_DT United_NNP Nations_NNP High_NNP Commissioner_NNP for_IN Refugees_NNPS ,_, NGOs_NNS working_VBG with_IN the_DT refugees_NNS ,_, or_CC the_DT refugees_NNS themselves_PRP ._. 
They_PRP removed_VBD the_DT original_JJ article_NN from_IN their_PRP$ website_NN ,_, interviewed_VBD different_JJ experts_NNS in_IN the_DT field_NN to_TO provide_VB a_DT more_RBR balanced_JJ view_NN ,_, and_CC changed_VBD the_DT first_JJ statement_NN listed_VBN above_IN to_TO ``_`` The_DT fact_NN that_IN many_JJ Sudanese_NNP will_MD return_VB to_TO their_PRP$ homes_NNS from_IN countries_NNS where_WRB the_DT HIV\/AIDS_NNP rate_NN are_VBP high_JJ might_MD increase_VB the_DT likelihood_NN of_IN a_DT further_JJ spread_NN of_IN the_DT epidemic_NN ''_'' 
7to_CD 7_CD ._. 
3%_CD -LRB-_-LRB- 95_CD %_NN confidence_NN interval_NN -LRB-_-LRB- CI_NNP -RRB-_-RRB- 0_CD ._. 
By_IN the_DT end_NN of_IN 2003_CD ,_, the_DT overall_JJ HIV_NNP prevalence_NN among_IN adults_NNS in_IN Sudan_NNP was_VBD estimated_VBN at_IN 2_CD ._. 
2-RRB-_CD ._. 
In_IN 2002_CD ,_, the_DT Sudanese_JJ government_NN undertook_VBD an_DT HIV_NNP survey_NN in_IN 14_CD of_IN 26_CD states_NNS with_IN the_DT following_JJ results_NNS :_: pregnant_JJ women_NNS at_IN antenatal_JJ clinics_NNS -LRB-_-LRB- 1_CD ._. 
8to_CD 6_CD ._. 
1%_CD -LRB-_-LRB- 95_CD %_NN CI_NNP 2_CD ._. 
National_JJ prevalence_NN estimated_VBN by_IN antenatal_JJ sentinel_NN surveillance_NN peaked_VBD in_IN the_DT early_JJ 1990s_NNS and_CC has_VBZ fallen_VBN to_TO 4_CD ._. 
6-RRB-_CD by_IN the_DT end_NN of_IN 2003_CD ._. 
Sentinel_NNP surveillance_NN shows_VBZ that_IN median_JJ HIV_NNP prevalence_NN in_IN the_DT capital_NN Kampala_NNP declined_VBD from_IN a_DT high_JJ of_IN 29_CD ._. 
Due_JJ to_TO recent_JJ conflict_NN in_IN Cote_NNP d'Ivoire_NNP ,_, which_WDT has_VBZ the_DT highest_JJS HIV_NNP prevalence_NN in_IN the_DT West_NNP Africa_NNP -LRB-_-LRB- 7_CD ._. 
0%_CD -RRB-_-RRB- 
By_IN the_DT end_NN of_IN 2003_CD ,_, HIV_NNP prevalence_NN was_VBD estimated_VBN at_IN 3_CD ._. 
0%_CD was_VBD reported_VBN in_IN two_CD towns_NNS in_IN the_DT Forest_NNP Region_NNP ,_, the_DT area_NN where_WRB the_DT refugees_NNS were_VBD located_VBN ._. 
2%_CD ._. 
Before_IN the_DT national_JJ survey_NN ,_, it_PRP was_VBD assumed_VBN that_IN the_DT overall_JJ HIV_NNP prevalence_NN in_IN Guinea_NNP was_VBD lower_JJR than_IN 2_CD ._. 
Avoid_VB accurate_JJ but_CC misleading_JJ statements_NNS ``_`` The_DT HIV-infection_JJ rate_NN in_IN Sudan_NNP ,_, according_VBG to_TO UNFPA_NNP ,_, is_VBZ already_RB considered_VBN an_DT epidemic_NN ,_, making_VBG Sudan_NNP the_DT country_NN with_IN the_DT highest_JJS infection_NN rate_NN in_IN North_NNP Africa_NNP and_CC the_DT Middle_NNP East_NNP region_NN ''_'' 
0%_CD -RRB-_-RRB- and_CC Eritrean_JJ refugees_NNS -LRB-_-LRB- 4_CD ._. 
5%_CD -RRB-_-RRB- ,_, IDPs_NNP -LRB-_-LRB- 1_CD ._. 
4%_CD -RRB-_-RRB- ,_, tea_NN sellers_NNS -LRB-_-LRB- 2_CD ._. 
1%_CD -RRB-_-RRB- ,_, sex_NN workers_NNS -LRB-_-LRB- 4_CD ._. 
6%_CD -RRB-_-RRB- ,_, sexually_RB transmitted_VBN infections_NNS -LRB-_-LRB- STI_NNP -RRB-_-RRB- patients_NNS -LRB-_-LRB- 1_CD ._. 
0%_CD -RRB-_-RRB- ._. 
Following_VBG progress_NN in_IN the_DT negotiations_NNS between_IN the_DT Government_NN 
However_RB ,_, this_DT is_VBZ also_RB incorrect_JJ ;_: the_DT HIV_NNP prevalence_NN among_IN IDPs_NNP was_VBD estimated_VBN to_TO be_VB 1_CD ._. 
Finally_RB ,_, the_DT same_JJ IRIN_NNP article_NN also_RB claims_VBZ that_IN HIV_NNP infection_NN rates_NNS are_VBP particularly_RB high_JJ among_IN vulnerable_JJ groups_NNS ,_, such_JJ as_IN IDPs_NNS and_CC refugees_NNS ._. 
0%_CD 
This_DT article_NN is_VBZ meant_VBN to_TO stimulate_VB awareness_NN and_CC debate_NN among_IN persons_NNS and_CC organizations_NNS working_VBG on_IN HIV\/AIDS_NNP as_RB well_RB as_IN the_DT media_NNS in_IN order_NN to_TO improve_VB dialogue_NN and_CC ultimately_RB to_TO reduce_VB stigma_NN and_CC discrimination_NN against_IN an_DT already_RB vulnerable_JJ group_NN 
Particular_JJ attention_NN was_VBD expressed_VBN regarding_VBG high_JJ infection_NN rates_NNS among_IN Sudanese_JJ IDPs_NNS and_CC refugees_NNS ,_, and_CC the_DT fear_NN that_IN refugees_NNS living_VBG in_IN host_NN countries_NNS with_IN high_JJ prevalence_NN rates_NNS will_MD return_VB and_CC exacerbate_VB the_DT epidemic_NN in_IN South_NNP Sudan_NNP 
We_PRP discuss_VBP below_IN the_DT critical_JJ aspects_NNS of_IN the_DT coverage_NN of_IN these_DT three_CD case_NN studies_NNS by_IN media_NNS reports_NNS following_VBG four_CD main_JJ arguments_NNS :_: 1_CD ._. 
Avoid_VB stigmatising_VBG statements_NNS and_CC ensure_VB a_DT balanced_JJ view_NN ``_`` The_DT fact_NN that_IN many_JJ Sudanese_NNP will_MD return_VB to_TO their_PRP$ homes_NNS from_IN countries_NNS where_WRB the_DT HIV\/AIDS_NNP prevalence_NN is_VBZ very_RB high_JJ will_MD doubtless_RB increase_VB the_DT likelihood_NN of_IN a_DT further_JJ spread_NN of_IN the_DT epidemic_NN ''_'' ._. 
``_`` Infection_NN rates_NNS are_VBP particularly_RB high_JJ among_IN vulnerable_JJ groups_NNS ,_, such_JJ as_IN internally_RB displaced_VBN persons_NNS -LRB-_-LRB- IDPs_NNP -RRB-_-RRB- and_CC refugees_NNS ''_'' 
Avoid_VB stigmatising_VBG statements_NNS and_CC ensure_VB a_DT balanced_JJ view_NN ``_`` The_DT fact_NN that_IN many_JJ Sudanese_NNP will_MD return_VB to_TO their_PRP$ homes_NNS from_IN countries_NNS where_WRB the_DT HIV\/AIDS_NNP prevalence_NN is_VBZ very_RB high_JJ will_MD doubtless_RB increase_VB the_DT likelihood_NN of_IN a_DT further_JJ spread_NN of_IN the_DT epidemic_NN ''_'' ._. 
``_`` Infection_NN rates_NNS are_VBP particularly_RB high_JJ among_IN vulnerable_JJ groups_NNS ,_, such_JJ as_IN internally_RB displaced_VBN persons_NNS -LRB-_-LRB- IDPs_NNP -RRB-_-RRB- and_CC refugees_NNS ''_'' 
``_`` Infection_NN rates_NNS are_VBP particularly_RB high_JJ among_IN vulnerable_JJ groups_NNS ,_, such_JJ as_IN internally_RB displaced_VBN persons_NNS -LRB-_-LRB- IDPs_NNP -RRB-_-RRB- and_CC refugees_NNS ''_'' ._. 
Concern_NN regarding_VBG stigmatizing_VBG statements_NNS against_IN refugees_NNS living_VBG in_IN Sudan_NNP and_CC Sudanese_JJ refugees_NNS living_VBG in_IN surrounding_VBG host_NN countries_NNS began_VBD after_IN the_DT Integrated_NNP Regional_NNP Information_NNP Network_NNP -LRB-_-LRB- IRIN_NNP -RRB-_-RRB- 
2._CD 
Only_RB near_IN the_DT end_NN of_IN the_DT article_NN does_VBZ it_PRP state_VB that_DT condom_NN use_NN and_CC knowledge_NN of_IN HIV\/AIDS_NNP were_VBD much_RB lower_JJR among_IN Guinean_JJ youth_NN than_IN Liberian_JJ refugees_NNS ._. 
Avoid_VB accurate_JJ but_CC misleading_JJ statements_NNS ``_`` The_DT HIV-infection_JJ rate_NN in_IN Sudan_NNP ,_, according_VBG to_TO UNFPA_NNP ,_, is_VBZ already_RB considered_VBN an_DT epidemic_NN ,_, making_VBG Sudan_NNP the_DT country_NN with_IN the_DT highest_JJS infection_NN rate_NN in_IN North_NNP Africa_NNP and_CC the_DT Middle_NNP East_NNP region_NN ''_'' 
Avoid_VB inaccurate_JJ statements_NNS by_IN clearly_RB stating_VBG sources_NNS and_CC verifying_VBG their_PRP$ credibility_NN ``_`` Data_NNS from_IN the_DT mid-1990s_NNS onwards_NNS suggested_VBD the_DT infection_NN rates_NNS had_VBD risen_VBN rapidly_RB in_IN the_DT conflict-affected_JJ areas_NNS of_IN southern_JJ and_CC western_JJ Sudan_NNP ._. 
According_VBG to_TO a_DT national_JJ prevalence_NN and_CC behavior_NN survey_NN conducted_VBN in_IN 2002_CD ,_, HIV_NNP prevalence_NN was_VBD already_RB four_CD percent_NN among_IN pregnant_JJ women_NNS attending_VBG clinics_NNS in_IN the_DT refugee_NN camps_NNS ''_'' ._. 
There_EX are_VBP no_DT data_NNS at_IN present_RB suggesting_VBG that_IN the_DT HIV_NNP prevalence_NN in_IN South_NNP and_CC West_NNP Sudan_NNP is_VBZ rising_VBG rapidly_RB ._. 
No_DT source_NN is_VBZ provided_VBN for_IN the_DT statement_NN in_IN the_DT above_JJ text_NN box_NN ._. 
There_EX are_VBP no_DT data_NNS at_IN present_RB suggesting_VBG that_IN the_DT HIV_NNP prevalence_NN in_IN South_NNP and_CC West_NNP Sudan_NNP is_VBZ rising_VBG rapidly_RB ._. 
In_IN South_NNP Sudan_NNP ,_, IRIN_NNP reported_VBD that_IN the_DT Sudan_NNP Evangelical_NNP Mission_NNP found_VBD HIV_NNP prevalence_NN to_TO be_VB 4_CD 
5million_NN displaced_VBD as_IN a_DT consequence_NN of_IN the_DT more_RBR recent_JJ conflict_NN in_IN Darfur_NNP must_MD be_VB added_VBN ._. 
In_IN the_DT south_NN of_IN the_DT country_NN ,_, the_DT 21-year_JJ old_JJ war_NN between_IN the_DT Government_NN of_IN Sudan_NNP and_CC the_DT Sudan_NNP People_NNP Liberation_NNP Movement\/Army_NNP has_VBZ caused_VBN the_DT internal_JJ displacement_NN of_IN approximately_RB 4_CD million_CD people_NNS ,_, to_TO which_WDT the_DT more_JJR than_IN 1_CD ._. 
As_IN of_IN the_DT end_NN of_IN 2003_CD ,_, more_JJR than_IN 500,000_CD Sudanese_JJ refugees_NNS were_VBD residing_VBG mainly_RB in_IN Uganda_NNP ,_, Ethiopia_NNP ,_, Kenya_NNP and_CC Chad_NNP ._. 
By_IN the_DT end_NN of_IN 2003_CD ,_, the_DT overall_JJ HIV_NNP prevalence_NN among_IN adults_NNS in_IN Sudan_NNP was_VBD estimated_VBN at_IN 2_CD ._. 
3%_CD -LRB-_-LRB- 95_CD %_NN confidence_NN interval_NN -LRB-_-LRB- CI_NNP -RRB-_-RRB- 0_CD ._. 
At_IN the_DT end_NN of_IN September_NNP 2004_CD ,_, there_EX were_VBD 1_CD ._. 
Northern_NNP Uganda_NNP is_VBZ currently_RB devastated_VBN by_IN a_DT 19-year_JJ old_JJ conflict_NN between_IN the_DT Ugandan_NNP Government_NNP and_CC the_DT Lord_NNP 's_POS Resistance_NNP Army_NNP -LRB-_-LRB- LRA_NNP -RRB-_-RRB- ,_, which_WDT escalated_VBD in_IN 1996_CD causing_VBG massive_JJ population_NN displacement_NN ,_, further_RB aggravated_VBN since_IN the_DT increase_NN of_IN violence_NN in_IN mid-2002_NN ._. 
4million_NNP IDPs_NNP in_IN some_DT 200_CD camps_NNS ,_, living_VBG in_IN extremely_RB difficult_JJ hygienic_JJ and_CC environmental_JJ conditions_NNS and_CC depending_VBG on_IN relief_NN food_NN distribution_NN ._. 
Uganda_NNP experienced_VBD declines_NNS in_IN HIV_NNP prevalence_NN during_IN the_DT 1990s_CD ._. 
National_JJ prevalence_NN estimated_VBN by_IN antenatal_JJ sentinel_NN surveillance_NN peaked_VBD in_IN the_DT early_JJ 1990s_NNS and_CC has_VBZ fallen_VBN to_TO 4_CD ._. 
0%_CD to_TO 4_CD ._. 
3%_CD in_IN 2002_CD ,_, while_IN in_IN areas_NNS outside_IN major_JJ urban_JJ centres_NNS it_PRP decreased_VBD from_IN 12_CD ._. 
4%_CD in_IN 1992_CD down_IN to_TO 8_CD ._. 
6%_CD 
9%_CD in_IN 2002_CD -LRB-_-LRB- p_NN 
9%_CD in_IN 2002_CD -LRB-_-LRB- p_NN 
9%_CD in_IN Kitgum_NNP and_CC 4_CD ._. 
9%_CD 
4%_CD in_IN urban_JJ areas_NNS and_CC 2_CD ._. 
8%_CD among_IN pregnant_JJ women_NNS with_IN 4_CD ._. 
Anational_NNP HIV_NNP seroprevalence_NN survey_NN ,_, undertaken_VBN in_IN Guinea_NNP in_IN December_NNP 2001_CD ,_, showed_VBD an_DT overall_JJ HIV_NNP prevalence_NN of_IN 2_CD ._. 
2%_CD in_IN rural_JJ areas_NNS ._. 
An_DT HIV_NNP prevalence_NN of_IN 7_CD ._. 
0%_CD was_VBD reported_VBN in_IN two_CD towns_NNS in_IN the_DT Forest_NNP Region_NNP ,_, the_DT area_NN where_WRB the_DT refugees_NNS were_VBD located_VBN ._. 
The_DT media_NNS reported_VBD that_IN the_DT higher_JJR HIV_NNP prevalence_NN in_IN the_DT Forest_NNP Region_NNP was_VBD likely_RB due_JJ to_TO the_DT influx_NN of_IN refugees_NNS ,_, blaming_VBG their_PRP$ ``_`` loose_JJ morals_NNS ''_'' that_WDT resulted_VBD in_IN ``_`` flourishing_VBG promiscuity_NN and_CC prostitution_NN ''_'' 
Concern_NN regarding_VBG stigmatizing_VBG statements_NNS against_IN refugees_NNS living_VBG in_IN Sudan_NNP and_CC Sudanese_JJ refugees_NNS living_VBG in_IN surrounding_VBG host_NN countries_NNS began_VBD after_IN the_DT Integrated_NNP Regional_NNP Information_NNP Network_NNP -LRB-_-LRB- IRIN_NNP -RRB-_-RRB- 
The_DT degree_NN of_IN interaction_NN among_IN refugees_NNS and_CC host_NN communities_NNS as_RB well_RB as_IN their_PRP$ HIV_NNP knowledge_NN and_CC behavior_NN all_DT contribute_VBP to_TO the_DT HIV_NNP prevalence_NN in_IN both_DT populations_NNS ._. 
Sudanese_JJ refugees_NNS living_VBG in_IN Kenya_NNP and_CC Uganda_NNP still_RB have_VBP much_RB lower_JJR HIV_NNP prevalence_NN than_IN their_PRP$ surrounding_JJ host_NN communities_NNS despite_IN living_VBG among_IN them_PRP for_IN over_IN a_DT decade_NN 
However_RB ,_, this_DT is_VBZ also_RB incorrect_JJ ;_: the_DT HIV_NNP prevalence_NN among_IN IDPs_NNP was_VBD estimated_VBN to_TO be_VB 1_CD ._. 
Finally_RB ,_, the_DT same_JJ IRIN_NNP article_NN also_RB claims_VBZ that_IN HIV_NNP infection_NN rates_NNS are_VBP particularly_RB high_JJ among_IN vulnerable_JJ groups_NNS ,_, such_JJ as_IN IDPs_NNS and_CC refugees_NNS ._. 
0%_CD 
To_TO further_JJ support_NN this_DT point_NN ,_, several_JJ months_NNS after_IN the_DT initial_JJ and_CC incorrect_JJ statements_NNS were_VBD reported_VBN ,_, all_DT three_CD re-emerged_VBD in_IN the_DT media_NNS 
Sudanese_JJ refugees_NNS living_VBG in_IN Kenya_NNP and_CC Uganda_NNP still_RB have_VBP much_RB lower_JJR HIV_NNP prevalence_NN than_IN their_PRP$ surrounding_JJ host_NN communities_NNS despite_IN living_VBG among_IN them_PRP for_IN over_IN a_DT decade_NN 
However_RB ,_, in_IN 1998_CD ,_, Sudan_NNP reported_VBD the_DT HIV_NNP prevalence_NN in_IN the_DT ANC_NNP sentinel_NN surveillance_NN in_IN El_NNP Gedarif_NNP as_IN 4_CD ._. 
0%_CD 
Children_NNP ,_, particularly_RB girls_NNS ,_, captured_VBN by_IN the_DT LRA_NNP have_VBP been_VBN reported_VBN to_TO have_VB an_DT HIV_NNP prevalence_NN of_IN approximately_RB 50_CD %_NN 
In_IN the_DT past_NN ,_, this_DT vulnerable_JJ group_NN had_VBD already_RB been_VBN suggested_VBN to_TO be_VB infected_VBN with_IN extremely_RB high_JJ rates_NNS of_IN STIs_NNS ,_, including_VBG HIV_NNP ._. 
Furthermore_RB ,_, direct_JJ reference_NN to_TO ``_`` immorality_NN ''_'' among_IN IDPs_NNS as_IN explanation_NN for_IN the_DT higher_JJR rates_NNS of_IN HIV_NNP prevalence_NN was_VBD attributed_VBN to_TO unspecified_JJ ``_`` NGO_NNP -LRB-_-LRB- non-governmental_JJ organization_NN -RRB-_-RRB- workers_NNS ''_'' 
AIDS_NNP comes_VBZ with_IN them_PRP ._. 
Guinea_NNP ``_`` It_PRP 's_VBZ the_DT refugees_NNS '_POS fault_NN ._. 
Furthermore_RB ,_, direct_JJ reference_NN to_TO ``_`` immorality_NN ''_'' among_IN IDPs_NNS as_IN explanation_NN for_IN the_DT higher_JJR rates_NNS of_IN HIV_NNP prevalence_NN was_VBD attributed_VBN to_TO unspecified_JJ ``_`` NGO_NNP -LRB-_-LRB- non-governmental_JJ organization_NN -RRB-_-RRB- workers_NNS ''_'' 
Until_IN late_JJ 2000_CD ,_, the_DT refugees_NNS lived_VBD in_IN small_JJ villages_NNS scattered_VBN throughout_IN the_DT rural_JJ south-eastern_JJ Forest_NN region_NN ._. 
During_IN September_NNP to_TO December_NNP 2000_CD ,_, attacks_NNS by_IN armed_JJ factions_NNS in_IN Guinea_NNP led_VBD to_TO the_DT displacement_NN and_CC consequent_JJ transfer_NN of_IN the_DT refugees_NNS to_TO safer_JJR camps_NNS in_IN the_DT north-west_NN of_IN the_DT country_NN 
Due_JJ to_TO recent_JJ conflict_NN in_IN Cote_NNP d'Ivoire_NNP ,_, which_WDT has_VBZ the_DT highest_JJS HIV_NNP prevalence_NN in_IN the_DT West_NNP Africa_NNP -LRB-_-LRB- 7_CD ._. 
0%_CD -RRB-_-RRB- 
8%_CD ._. 
Before_IN the_DT national_JJ survey_NN ,_, it_PRP was_VBD assumed_VBN that_IN the_DT overall_JJ HIV_NNP prevalence_NN in_IN Guinea_NNP was_VBD lower_JJR than_IN 2_CD ._. 
The_DT media_NNS reported_VBD that_IN the_DT higher_JJR HIV_NNP prevalence_NN in_IN the_DT Forest_NNP Region_NNP was_VBD likely_RB due_JJ to_TO the_DT influx_NN of_IN refugees_NNS ,_, blaming_VBG their_PRP$ ``_`` loose_JJ morals_NNS ''_'' that_WDT resulted_VBD in_IN ``_`` flourishing_VBG promiscuity_NN and_CC prostitution_NN ''_'' 
They_PRP removed_VBD the_DT original_JJ article_NN from_IN their_PRP$ website_NN ,_, interviewed_VBD different_JJ experts_NNS in_IN the_DT field_NN to_TO provide_VB a_DT more_RBR balanced_JJ view_NN ,_, and_CC changed_VBD the_DT first_JJ statement_NN listed_VBN above_IN to_TO ``_`` The_DT fact_NN that_IN many_JJ Sudanese_NNP will_MD return_VB to_TO their_PRP$ homes_NNS from_IN countries_NNS where_WRB the_DT HIV\/AIDS_NNP rate_NN are_VBP high_JJ might_MD increase_VB the_DT likelihood_NN of_IN a_DT further_JJ spread_NN of_IN the_DT epidemic_NN ''_'' 
4%_CD in_IN urban_JJ areas_NNS and_CC 2_CD ._. 
8%_CD among_IN pregnant_JJ women_NNS with_IN 4_CD ._. 
Anational_NNP HIV_NNP seroprevalence_NN survey_NN ,_, undertaken_VBN in_IN Guinea_NNP in_IN December_NNP 2001_CD ,_, showed_VBD an_DT overall_JJ HIV_NNP prevalence_NN of_IN 2_CD ._. 
2%_CD in_IN rural_JJ areas_NNS ._. 
An_DT HIV_NNP prevalence_NN of_IN 7_CD ._. 
0%_CD was_VBD reported_VBN in_IN two_CD towns_NNS in_IN the_DT Forest_NNP Region_NNP ,_, the_DT area_NN where_WRB the_DT refugees_NNS were_VBD located_VBN ._. 
More_RBR rigorous_JJ HIV_NNP biological_JJ and_CC behavioural_JJ surveillance_NN surveys_NNS must_MD occur_VB in_IN situations_NNS of_IN conflict_NN and_CC displacement_NN as_IN this_DT will_MD provide_VB data_NNS for_IN decision_NN makers_NNS and_CC help_NN to_TO reduce_VB the_DT likelihood_NN of_IN incorrect_JJ ,_, incomplete_JJ or_CC misleading_JJ statements_NNS ._. 
The_DT assertion_NN that_IN rigorous_JJ data_NNS collection_NN is_VBZ not_RB possible_JJ during_IN the_DT acute_JJ phase_NN of_IN a_DT crisis_NN or_CC immediately_RB post-conflict_JJ is_VBZ incorrect_JJ ,_, as_IN shown_VBN by_IN several_JJ surveys_NNS implemented_VBN in_IN such_JJ situations_NNS :_: DRC_NNP 
4\/10_CD ,000_CD \/_NN day_NN -RRB-_-RRB- ._. 
8\/10_CD ,000_CD \/_NN day_NN and_CC under_IN five_CD mortality_NN rate_NN of_IN 5_CD ._. 
Conversely_RB ,_, M_NNP 
More_RBR rigorous_JJ HIV_NNP biological_JJ and_CC behavioural_JJ surveillance_NN surveys_NNS must_MD occur_VB in_IN situations_NNS of_IN conflict_NN and_CC displacement_NN as_IN this_DT will_MD provide_VB data_NNS for_IN decision_NN makers_NNS and_CC help_NN to_TO reduce_VB the_DT likelihood_NN of_IN incorrect_JJ ,_, incomplete_JJ or_CC misleading_JJ statements_NNS ._. 
The_DT assertion_NN that_IN rigorous_JJ data_NNS collection_NN is_VBZ not_RB possible_JJ during_IN the_DT acute_JJ phase_NN of_IN a_DT crisis_NN or_CC immediately_RB post-conflict_JJ is_VBZ incorrect_JJ ,_, as_IN shown_VBN by_IN several_JJ surveys_NNS implemented_VBN in_IN such_JJ situations_NNS :_: DRC_NNP 
As_IN in_IN the_DT Democratic_JJ Republic_NNP of_IN Congo_NNP ,_, the_DT main_JJ causes_NNS of_IN death_NN were_VBD indigenous_JJ communicable_JJ diseases_NNS that_WDT have_VBP been_VBN exacerbated_VBN due_JJ to_TO the_DT conflict_NN ,_, such_JJ as_IN malaria_NN -LRB-_-LRB- 47_CD %_NN of_IN all_DT deaths_NNS -RRB-_-RRB- ,_, respiratory_JJ disease_NN -LRB-_-LRB- 28_CD %_NN -RRB-_-RRB- and_CC diarrhoeal_JJ disease_NN -LRB-_-LRB- 21_CD %_NN -RRB-_-RRB- ;_: however_RB ,_, AIDS_NNP could_MD be_VB an_DT underlying_JJ factor_NN that_WDT was_VBD not_RB reported_VBN ._. 
To_TO further_JJ support_NN this_DT point_NN ,_, several_JJ months_NNS after_IN the_DT initial_JJ and_CC incorrect_JJ statements_NNS were_VBD reported_VBN ,_, all_DT three_CD re-emerged_VBD in_IN the_DT media_NNS 
As_IN in_IN the_DT Democratic_JJ Republic_NNP of_IN Congo_NNP ,_, the_DT main_JJ causes_NNS of_IN death_NN were_VBD indigenous_JJ communicable_JJ diseases_NNS that_WDT have_VBP been_VBN exacerbated_VBN due_JJ to_TO the_DT conflict_NN ,_, such_JJ as_IN malaria_NN -LRB-_-LRB- 47_CD %_NN of_IN all_DT deaths_NNS -RRB-_-RRB- ,_, respiratory_JJ disease_NN -LRB-_-LRB- 28_CD %_NN -RRB-_-RRB- and_CC diarrhoeal_JJ disease_NN -LRB-_-LRB- 21_CD %_NN -RRB-_-RRB- ;_: however_RB ,_, AIDS_NNP could_MD be_VB an_DT underlying_JJ factor_NN that_WDT was_VBD not_RB reported_VBN ._. 
To_TO further_JJ support_NN this_DT point_NN ,_, several_JJ months_NNS after_IN the_DT initial_JJ and_CC incorrect_JJ statements_NNS were_VBD reported_VBN ,_, all_DT three_CD re-emerged_VBD in_IN the_DT media_NNS 
To_TO further_JJ support_NN this_DT point_NN ,_, several_JJ months_NNS after_IN the_DT initial_JJ and_CC incorrect_JJ statements_NNS were_VBD reported_VBN ,_, all_DT three_CD re-emerged_VBD in_IN the_DT media_NNS 
To_TO further_JJ support_NN this_DT point_NN ,_, several_JJ months_NNS after_IN the_DT initial_JJ and_CC incorrect_JJ statements_NNS were_VBD reported_VBN ,_, all_DT three_CD re-emerged_VBD in_IN the_DT media_NNS 
The_DT assertion_NN that_IN rigorous_JJ data_NNS collection_NN is_VBZ not_RB possible_JJ during_IN the_DT acute_JJ phase_NN of_IN a_DT crisis_NN or_CC immediately_RB post-conflict_JJ is_VBZ incorrect_JJ ,_, as_IN shown_VBN by_IN several_JJ surveys_NNS implemented_VBN in_IN such_JJ situations_NNS :_: DRC_NNP 
1%_CD reported_VBD among_IN the_DT refugees_NNS ._. 
0%_CD 
However_RB ,_, in_IN 1998_CD ,_, Sudan_NNP reported_VBD the_DT HIV_NNP prevalence_NN in_IN the_DT ANC_NNP sentinel_NN surveillance_NN in_IN El_NNP Gedarif_NNP as_IN 4_CD ._. 
0%_CD 
These_DT reports_NNS particularly_RB highlighted_VBD the_DT high_JJ HIV_NNP prevalence_NN among_IN IDPs_NNP in_IN the_DT camps_NNS and_CC the_DT highest_JJS prevalence_NN among_IN victims_NNS of_IN the_DT LRA_NNP 
.._NN 
``_`` The_DT rate_NN of_IN HIV\/AIDS_NN infection_NN in_IN northern_JJ Uganda_NNP is_VBZ nearly_RB double_JJ that_IN in_IN the_DT rest_NN of_IN the_DT country_NN ._. ''_'' ._. 
HIV_NNP prevalence_NN in_IN the_DT Northern_NNP Uganda_NNP ,_, represented_VBN by_IN the_DT surveillance_NN site_NN located_VBN in_IN Lacor_NNP hospital_NN in_IN Gulu_NNP ,_, is_VBZ often_RB correctly_RB reported_VBN as_IN nearly_RB double_JJ the_DT national_JJ average_NN ._. 
8\/10_CD ,000_CD \/_NN day_NN and_CC under_IN five_CD mortality_NN rate_NN of_IN 5_CD ._. 
Conversely_RB ,_, M_NNP 
More_RBR rigorous_JJ HIV_NNP biological_JJ and_CC behavioural_JJ surveillance_NN surveys_NNS must_MD occur_VB in_IN situations_NNS of_IN conflict_NN and_CC displacement_NN as_IN this_DT will_MD provide_VB data_NNS for_IN decision_NN makers_NNS and_CC help_NN to_TO reduce_VB the_DT likelihood_NN of_IN incorrect_JJ ,_, incomplete_JJ or_CC misleading_JJ statements_NNS ._. 
The_DT assertion_NN that_IN rigorous_JJ data_NNS collection_NN is_VBZ not_RB possible_JJ during_IN the_DT acute_JJ phase_NN of_IN a_DT crisis_NN or_CC immediately_RB post-conflict_JJ is_VBZ incorrect_JJ ,_, as_IN shown_VBN by_IN several_JJ surveys_NNS implemented_VBN in_IN such_JJ situations_NNS :_: DRC_NNP 
These_DT reports_NNS particularly_RB highlighted_VBD the_DT high_JJ HIV_NNP prevalence_NN among_IN IDPs_NNP in_IN the_DT camps_NNS and_CC the_DT highest_JJS prevalence_NN among_IN victims_NNS of_IN the_DT LRA_NNP 
Claims_NNS of_IN extremely_RB high_JJ HIV_NNP prevalence_NN among_IN children_NNS abducted_NN by_IN the_DT LRA_NNP are_VBP not_RB supported_VBN by_IN data_NNS ;_: no_DT systematic_JJ HIV_NNP testing_NN has_VBZ ever_RB been_VBN undertaken_VBN among_IN this_DT group_NN ._. 
The_DT statement_NN reported_VBD above_IN ,_, originally_RB made_VBN by_IN a_DT Government_NNP official_NN and_CC then_RB reported_VBN by_IN numerous_JJ NGOs_NNS and_CC news_NN agencies_NNS ,_, was_VBD subsequently_RB dismissed_VBN by_IN organizations_NNS responsible_JJ for_IN the_DT major_JJ reception_NN centres_NNS for_IN these_DT children_NNS in_IN the_DT region_NN -LRB-_-LRB- personal_JJ communications_NNS and_CC email_NN exchanges_NNS between_IN members_NNS of_IN the_DT Psychosocial_NNP Working_NNP Group_NNP and_CC Child_NNP Care_NNP Centres_NNP in_IN North_NNP Uganda_NNP ,_, August_NNP 2004_CD -RRB-_-RRB- ._. 
4._CD 
Do_VBP not_RB continuously_RB repeat_VB data_NNS and_CC conclusions_NNS from_IN other_JJ news_NN sources_NNS without_IN checking_NN for_IN accuracy_NN 
2%_CD in_IN 2002_CD -RRB-_-RRB- and_CC growing_VBG due_JJ to_TO conflict_NN ._. 
9%_CD in_IN 2002_CD -RRB-_-RRB- is_VBZ nearly_RB twice_RB as_RB high_JJ as_IN the_DT national_JJ rate_NN -LRB-_-LRB- 6_CD ._. 
These_DT reports_NNS particularly_RB highlighted_VBD the_DT high_JJ HIV_NNP prevalence_NN among_IN IDPs_NNP in_IN the_DT camps_NNS and_CC the_DT highest_JJS prevalence_NN among_IN victims_NNS of_IN the_DT LRA_NNP 
4._CD 
The_DT statement_NN reported_VBD above_IN ,_, originally_RB made_VBN by_IN a_DT Government_NNP official_NN and_CC then_RB reported_VBN by_IN numerous_JJ NGOs_NNS and_CC news_NN agencies_NNS ,_, was_VBD subsequently_RB dismissed_VBN by_IN organizations_NNS responsible_JJ for_IN the_DT major_JJ reception_NN centres_NNS for_IN these_DT children_NNS in_IN the_DT region_NN -LRB-_-LRB- personal_JJ communications_NNS and_CC email_NN exchanges_NNS between_IN members_NNS of_IN the_DT Psychosocial_NNP Working_NNP Group_NNP and_CC Child_NNP Care_NNP Centres_NNP in_IN North_NNP Uganda_NNP ,_, August_NNP 2004_CD -RRB-_-RRB- ._. 
Do_VBP not_RB continuously_RB repeat_VB data_NNS and_CC conclusions_NNS from_IN other_JJ news_NN sources_NNS without_IN checking_NN for_IN accuracy_NN 
The_DT first_JJ two_CD issues_NNS were_VBD discussed_VBN previously_RB and_CC have_VBP been_VBN shown_VBN to_TO be_VB incorrect_JJ ._. 
Figure_NNP 1_CD Sequence_NN of_IN reporting_NN of_IN three_CD main_JJ incorrect_JJ statements_NNS on_IN HIV_NNP and_CC North-Uganda_NNP ._. 
The_DT third_JJ issue_NN relates_VBZ to_TO a_DT recent_JJ report_NN on_IN the_DT humanitarian_JJ situation_NN of_IN Northern_NNP Uganda_NNP which_WDT claimed_VBD AIDS_NNP to_TO be_VB the_DT leading_VBG cause_NN of_IN death_NN -LRB-_-LRB- 69_CD %_NN -RRB-_-RRB- in_IN the_DT Gulu_NNP area_NN ,_, three_CD times_NNS higher_JJR than_IN direct_JJ killings_NNS during_IN military_JJ confrontation_NN 
0%_CD 
These_DT reports_NNS particularly_RB highlighted_VBD the_DT high_JJ HIV_NNP prevalence_NN among_IN IDPs_NNP in_IN the_DT camps_NNS and_CC the_DT highest_JJS prevalence_NN among_IN victims_NNS of_IN the_DT LRA_NNP 
More_RBR rigorous_JJ HIV_NNP biological_JJ and_CC behavioural_JJ surveillance_NN surveys_NNS must_MD occur_VB in_IN situations_NNS of_IN conflict_NN and_CC displacement_NN as_IN this_DT will_MD provide_VB data_NNS for_IN decision_NN makers_NNS and_CC help_NN to_TO reduce_VB the_DT likelihood_NN of_IN incorrect_JJ ,_, incomplete_JJ or_CC misleading_JJ statements_NNS ._. 
The_DT assertion_NN that_IN rigorous_JJ data_NNS collection_NN is_VBZ not_RB possible_JJ during_IN the_DT acute_JJ phase_NN of_IN a_DT crisis_NN or_CC immediately_RB post-conflict_JJ is_VBZ incorrect_JJ ,_, as_IN shown_VBN by_IN several_JJ surveys_NNS implemented_VBN in_IN such_JJ situations_NNS :_: DRC_NNP 
2%_CD in_IN 2002_CD -RRB-_-RRB- and_CC growing_VBG due_JJ to_TO conflict_NN ._. 
9%_CD in_IN 2002_CD -RRB-_-RRB- is_VBZ nearly_RB twice_RB as_RB high_JJ as_IN the_DT national_JJ rate_NN -LRB-_-LRB- 6_CD ._. 
These_DT reports_NNS particularly_RB highlighted_VBD the_DT high_JJ HIV_NNP prevalence_NN among_IN IDPs_NNP in_IN the_DT camps_NNS and_CC the_DT highest_JJS prevalence_NN among_IN victims_NNS of_IN the_DT LRA_NNP 
9%_CD in_IN 2002_CD -RRB-_-RRB- is_VBZ nearly_RB twice_RB as_RB high_JJ as_IN the_DT national_JJ rate_NN -LRB-_-LRB- 6_CD ._. 
Several_JJ reports_NNS in_IN the_DT national_JJ and_CC international_JJ press_NN and_CC information_NN disseminated_VBN by_IN international_JJ organizations_NNS have_VBP emphasized_VBN that_IN the_DT HIV_NNP prevalence_NN in_IN northern_JJ Uganda_NNP -LRB-_-LRB- 11_CD ._. 
2%_CD in_IN 2002_CD -RRB-_-RRB- and_CC growing_VBG due_JJ to_TO conflict_VB 
Arecent_JJ example_NN is_VBZ the_DT measures_NNS proposed_VBN by_IN the_DT United_NNP Kingdom_NNP 's_POS Conservative_NNP Party_NNP ,_, after_IN intense_JJ public_JJ and_CC political_JJ debate_NN about_IN the_DT scale_NN and_CC nature_NN of_IN asylum_NN and_CC migration_NN ,_, to_TO affirm_VB that_IN ``_`` the_DT 
K,_NNP either_CC as_IN an_DT asylum_NN seeker_NN or_CC through_IN the_DT immigration_NN service_NN ''_'' 
K,_NNP either_CC as_IN an_DT asylum_NN seeker_NN or_CC through_IN the_DT immigration_NN service_NN ''_'' 
The_DT media_NNS has_VBZ a_DT huge_JJ influence_NN on_IN how_WRB the_DT world_NN observes_VBZ and_CC reacts_VBZ to_TO the_DT HIV_NNP epidemic_NN among_IN conflict-affected_JJ and_CC displaced_VBN populations_NNS ._. 
Therefore_RB ,_, as_IN already_RB argued_VBN for_IN health_NN and_CC medical_JJ reporting_NN in_IN general_JJ 
Background_NN Conflict_NN ,_, poverty_NN and_CC HIV_NNP disproportionately_RB affect_VBP people_NNS in_IN sub-Saharan_NNP Africa_NNP ._. 
Improved_JJ communication_NN with_IN the_DT media_NNS will_MD help_VB to_TO ensure_VB more_RBR accurate_JJ reporting_NN and_CC interpretation_NN ._. 
In_IN 2004_CD ,_, 25_CD active_JJ armed_JJ conflicts_NNS occurred_VBD worldwide_NN ,_, 69_CD countries_NNS were_VBD affected_VBN by_IN refugee_NN movements_NNS and_CC 48_CD countries_NNS by_IN internal_JJ displacement_NN of_IN their_PRP$ populations_NNS ._. 
Africa_NNP was_VBD the_DT most_RBS affected_JJ continent_NN ._. 
The_DT current_JJ estimated_VBN number_NN of_IN refugees_NNS and_CC internally_RB displaced_VBN persons_NNS -LRB-_-LRB- IDPs_NNP -RRB-_-RRB- worldwide_NN are_VBP 12_CD and_CC 25_CD million_CD ,_, respectively_RB 
Africa_NNP was_VBD the_DT most_RBS affected_JJ continent_NN ._. 
In_IN 2004_CD ,_, 25_CD active_JJ armed_JJ conflicts_NNS occurred_VBD worldwide_NN ,_, 69_CD countries_NNS were_VBD affected_VBN by_IN refugee_NN movements_NNS and_CC 48_CD countries_NNS by_IN internal_JJ displacement_NN of_IN their_PRP$ populations_NNS ._. 
The_DT current_JJ estimated_VBN number_NN of_IN refugees_NNS and_CC internally_RB displaced_VBN persons_NNS -LRB-_-LRB- IDPs_NNP -RRB-_-RRB- worldwide_NN are_VBP 12_CD and_CC 25_CD million_CD ,_, respectively_RB 
During_IN September_NNP to_TO December_NNP 2000_CD ,_, attacks_NNS by_IN armed_JJ factions_NNS in_IN Guinea_NNP led_VBD to_TO the_DT displacement_NN and_CC consequent_JJ transfer_NN of_IN the_DT refugees_NNS to_TO safer_JJR camps_NNS in_IN the_DT north-west_NN of_IN the_DT country_NN 
Africa_NNP was_VBD the_DT most_RBS affected_JJ continent_NN ._. 
In_IN 2004_CD ,_, 25_CD active_JJ armed_JJ conflicts_NNS occurred_VBD worldwide_NN ,_, 69_CD countries_NNS were_VBD affected_VBN by_IN refugee_NN movements_NNS and_CC 48_CD countries_NNS by_IN internal_JJ displacement_NN of_IN their_PRP$ populations_NNS ._. 
The_DT current_JJ estimated_VBN number_NN of_IN refugees_NNS and_CC internally_RB displaced_VBN persons_NNS -LRB-_-LRB- IDPs_NNP -RRB-_-RRB- worldwide_NN are_VBP 12_CD and_CC 25_CD million_CD ,_, respectively_RB 
The_DT media_NNS has_VBZ a_DT huge_JJ influence_NN on_IN how_WRB the_DT world_NN observes_VBZ and_CC reacts_VBZ to_TO the_DT HIV_NNP epidemic_NN among_IN conflict-affected_JJ and_CC displaced_VBN populations_NNS ._. 
Therefore_RB ,_, as_IN already_RB argued_VBN for_IN health_NN and_CC medical_JJ reporting_NN in_IN general_JJ 
The_DT media_NNS has_VBZ a_DT huge_JJ influence_NN on_IN how_WRB the_DT world_NN observes_VBZ and_CC reacts_VBZ to_TO the_DT HIV_NNP epidemic_NN among_IN conflict-affected_JJ and_CC displaced_VBN populations_NNS ._. 
Therefore_RB ,_, as_IN already_RB argued_VBN for_IN health_NN and_CC medical_JJ reporting_NN in_IN general_JJ 
The_DT relative_JJ rank_NN of_IN households_NNS using_VBG the_DT score_NN generated_VBD from_IN the_DT first_JJ principal_JJ component_NN is_VBZ then_RB used_VBN as_IN a_DT measure_NN of_IN relative_JJ SEP_NNP ,_, enabling_VBG calculation_NN of_IN a_DT single_JJ estimate_NN of_IN the_DT effect_NN of_IN wealth_NN ._. 
The_DT use_NN of_IN a_DT single_JJ principal_JJ component_NN in_IN this_DT way_NN could_MD be_VB questioned_VBN ,_, since_IN the_DT first_JJ principal_JJ component_NN from_IN PCA_NNP of_IN a_DT set_NN of_IN assets_NNS frequently_RB explains_VBZ a_DT low_JJ proportion_NN of_IN the_DT total_JJ variation_NN in_IN those_DT assets_NNS -LRB-_-LRB- often_RB less_JJR than_IN 20_CD %_NN -RRB-_-RRB- 
Furthermore_RB ,_, there_EX is_VBZ some_DT evidence_NN that_IN utilising_VBG higher_JJR order_NN principal_JJ components_NNS is_VBZ unnecessary_JJ ._. 
McKenzie_NNP demonstrated_VBD that_IN the_DT standard_JJ deviation_NN of_IN higher_JJR order_NN components_NNS was_VBD not_RB associated_VBN with_IN consumption_NN expenditure_NN ,_, whereas_IN that_DT of_IN the_DT first_JJ principal_JJ component_NN was_VBD ._. 
Filmer_NNP and_CC Pritchett_NNP noted_VBD that_IN multivariate_JJ analyses_NNS of_IN 
After_IN the_DT paper_NN by_IN Filmer_NNP and_CC Pritchett_NNP ,_, the_DT use_NN of_IN PCA_NNP for_IN wealth_NN index_NN construction_NN was_VBD quickly_RB adopted_VBN by_IN the_DT World_NNP Bank_NNP and_CC Macro_NNP International_NNP Inc._NNP ._. 
for_IN analysis_NN of_IN inequalities_NNS within_IN DHS_NNP datasets_NNS ._. 
The_DT approach_NN is_VBZ now_RB also_RB more_RBR widely_RB used_VBN ._. 
Nevertheless_RB ,_, this_DT application_NN of_IN PCA_NNP is_VBZ not_RB fully_RB justified_JJ and_CC requires_VBZ further_JJ investigation_NN ._. 
If_IN the_DT first_JJ few_JJ principal_JJ components_NNS explain_VBP a_DT substantial_JJ proportion_NN of_IN the_DT total_JJ variance_NN ,_, they_PRP can_MD be_VB used_VBN to_TO represent_VB the_DT original_JJ items_NNS ,_, thus_RB reducing_VBG the_DT number_NN of_IN variables_NNS required_VBN in_IN models_NNS 
Assets_NNS that_WDT are_VBP more_RBR unequally_RB distributed_VBN across_IN the_DT sample_NN will_MD have_VB a_DT higher_JJR weight_NN in_IN the_DT first_JJ principal_JJ component_NN 
Principal_NN Components_NNP Analysis_NNP -LRB-_-LRB- PCA_NNP -RRB-_-RRB- was_VBD recommended_VBN as_IN a_DT method_NN for_IN determining_VBG weights_NNS for_IN components_NNS of_IN a_DT wealth_NN index_NN by_IN Filmer_NNP and_CC Pritchett_NNP 
The_DT weights_NNS for_IN each_DT indicator_NN from_IN this_DT first_JJ principal_JJ component_NN are_VBP used_VBN to_TO generate_VB a_DT household_NN score_NN ._. 
Assets_NNS that_WDT are_VBP more_RBR unequally_RB distributed_VBN across_IN the_DT sample_NN will_MD have_VB a_DT higher_JJR weight_NN in_IN the_DT first_JJ principal_JJ component_NN 
The_DT relative_JJ rank_NN of_IN households_NNS using_VBG the_DT score_NN generated_VBD from_IN the_DT first_JJ principal_JJ component_NN is_VBZ then_RB used_VBN as_IN a_DT measure_NN of_IN relative_JJ SEP_NNP ,_, enabling_VBG calculation_NN of_IN a_DT single_JJ estimate_NN of_IN the_DT effect_NN of_IN wealth_NN ._. 
The_DT use_NN of_IN a_DT single_JJ principal_JJ component_NN in_IN this_DT way_NN could_MD be_VB questioned_VBN ,_, since_IN the_DT first_JJ principal_JJ component_NN from_IN PCA_NNP of_IN a_DT set_NN of_IN assets_NNS frequently_RB explains_VBZ a_DT low_JJ proportion_NN of_IN the_DT total_JJ variation_NN in_IN those_DT assets_NNS -LRB-_-LRB- often_RB less_JJR than_IN 20_CD %_NN -RRB-_-RRB- 
Weighting_VBG binary_JJ variables_NNS by_IN the_DT inverse_NN of_IN the_DT proportion_NN of_IN the_DT population_NN which_WDT owns_VBZ that_IN item_NN 5_CD ._. 
Using_VBG MCA_NNP including_VBG all_DT categories_NNS of_IN categorical_JJ variablesFollowing_JJ recommended_JJ practice_NN ,_, for_IN index_NN 1_CD dummy_NN binary_JJ variables_NNS were_VBD created_VBN for_IN each_DT category_NN of_IN categorical_JJ variable_NN for_IN inclusion_NN in_IN the_DT PCA_NNP ;_: for_IN example_NN a_DT four-category_JJ variable_NN would_MD have_VB been_VBN converted_VBN into_IN four_CD separate_JJ yes\/no_JJ variables_NNS ;_: for_IN each_DT household_NN one_CD of_IN these_DT would_MD be_VB coded_VBN `_`` yes_RB '_'' the_DT other_JJ three_CD `_`` no_DT '_'' ._. 
Alternative_NNP ways_NNS of_IN using_VBG categorical_JJ variables_NNS in_IN PCA_NNP were_VBD not_RB used_VBN because_IN they_PRP require_VBP imposing_VBG an_DT ordinal_JJ structure_NN on_IN the_DT categories_NNS ._. 
The_DT first_JJ principal_JJ component_NN explains_VBZ the_DT largest_JJS proportion_NN of_IN the_DT total_JJ variance_NN ._. 
The_DT principal_JJ components_NNS are_VBP linear_JJ combinations_NNS of_IN the_DT original_JJ variables_NNS ;_: the_DT weights_NNS are_VBP derived_VBN from_IN the_DT correlation_NN matrix_NN of_IN the_DT data_NNS or_CC the_DT covariance_NN matrix_NN if_IN the_DT data_NNS have_VBP been_VBN standardised_VBN prior_RB to_TO PCA_NNP ._. 
If_IN the_DT first_JJ few_JJ principal_JJ components_NNS explain_VBP a_DT substantial_JJ proportion_NN of_IN the_DT total_JJ variance_NN ,_, they_PRP can_MD be_VB used_VBN to_TO represent_VB the_DT original_JJ items_NNS ,_, thus_RB reducing_VBG the_DT number_NN of_IN variables_NNS required_VBN in_IN models_NNS 
23_CD 
39_CD 
Weighting_VBG the_DT items_NNS in_IN a_DT wealth_NN index_NN When_WRB constructing_VBG a_DT wealth_NN index_NN from_IN a_DT set_NN of_IN variables_NNS ,_, a_DT decision_NN must_MD be_VB made_VBN about_IN the_DT weights_NNS to_TO assign_VB to_TO each_DT indicator_NN ._. 
Principal_NN Components_NNP Analysis_NNP -LRB-_-LRB- PCA_NNP -RRB-_-RRB- was_VBD recommended_VBN as_IN a_DT method_NN for_IN determining_VBG weights_NNS for_IN components_NNS of_IN a_DT wealth_NN index_NN by_IN Filmer_NNP and_CC Pritchett_NNP 
The_DT relative_JJ rank_NN of_IN households_NNS using_VBG the_DT score_NN generated_VBD from_IN the_DT first_JJ principal_JJ component_NN is_VBZ then_RB used_VBN as_IN a_DT measure_NN of_IN relative_JJ SEP_NNP ,_, enabling_VBG calculation_NN of_IN a_DT single_JJ estimate_NN of_IN the_DT effect_NN of_IN wealth_NN ._. 
The_DT use_NN of_IN a_DT single_JJ principal_JJ component_NN in_IN this_DT way_NN could_MD be_VB questioned_VBN ,_, since_IN the_DT first_JJ principal_JJ component_NN from_IN PCA_NNP of_IN a_DT set_NN of_IN assets_NNS frequently_RB explains_VBZ a_DT low_JJ proportion_NN of_IN the_DT total_JJ variation_NN in_IN those_DT assets_NNS -LRB-_-LRB- often_RB less_JJR than_IN 20_CD %_NN -RRB-_-RRB- 
McKenzie_NNP demonstrated_VBD that_IN the_DT standard_JJ deviation_NN of_IN higher_JJR order_NN components_NNS was_VBD not_RB associated_VBN with_IN consumption_NN expenditure_NN ,_, whereas_IN that_DT of_IN the_DT first_JJ principal_JJ component_NN was_VBD 
Its_PRP$ application_NN to_TO the_DT predominantly_RB discrete_JJ data_NNS in_IN a_DT wealth_NN index_NN is_VBZ therefore_RB inappropriate_JJ ._. 
PCA_NNP is_VBZ designed_VBN for_IN use_NN with_IN continuous_JJ ,_, normally-distributed_JJ data_NNS ._. 
The_DT use_NN of_IN binary_JJ dummy_NN variables_NNS for_IN each_DT category_NN of_IN categorical_JJ variables_NNS -LRB-_-LRB- as_IN recommended_VBN by_IN Filmer_NNP and_CC Pritchett_NNP -RRB-_-RRB- is_VBZ particularly_RB problematic_JJ ._. 
The_DT linear_JJ dependence_NN between_IN the_DT dummy_NN variables_NNS may_MD lead_VB to_TO incorrect_JJ estimates_NNS of_IN the_DT wealth_NN index_NN ;_: the_DT PCA_NNP method_NN is_VBZ affected_VBN by_IN collinearity_NN ,_, with_IN variation_NN in_IN the_DT data_NNS arising_VBG both_DT from_IN the_DT underlying_VBG concept_NN of_IN wealth_NN and_CC from_IN the_DT linear_JJ dependence_NN between_IN dummy_JJ variables_NNS of_IN categorical_JJ variables_NNS ._. 
The_DT wealth_NN index_NN may_MD therefore_RB be_VB measuring_VBG a_DT different_JJ aspect_NN of_IN this_DT underlying_VBG socio-economic_JJ concept_NN than_IN consumption_NN expenditure_NN ,_, or_CC it_PRP may_MD be_VB measuring_VBG something_NN else_RB entirely_RB ._. 
Some_DT have_VBP claimed_VBN that_IN a_DT wealth_NN index_NN measures_VBZ a_DT longer-term_JJ economic_JJ status_NN than_IN consumption_NN expenditure_NN ,_, since_IN households_NNS are_VBP more_RBR likely_JJ to_TO alter_VB consumption_NN in_IN response_NN to_TO an_DT economic_JJ shock_NN than_IN they_PRP are_VBP to_TO sell_VB assets_NNS or_CC alter_VB housing_NN characteristics_NNS or_CC access_NN to_TO public_JJ services_NNS ._. 
In_IN this_DT context_NN ,_, the_DT agreement_NN of_IN the_DT wealth_NN index_NN with_IN consumption_NN expenditure_NN did_VBD not_RB differ_VB between_IN total_NN ,_, per_IN adult_NN and_CC per_IN capita_NN consumption_NN expenditure_NN ,_, meaning_VBG that_IN this_DT study_NN was_VBD unable_JJ to_TO shed_VB further_JJ light_NN on_IN which_WDT aspect_NN of_IN long-term_JJ SEP_NNP a_DT wealth_NN index_NN may_MD be_VB measuring_VBG ._. 
After_IN the_DT paper_NN by_IN Filmer_NNP and_CC Pritchett_NNP ,_, the_DT use_NN of_IN PCA_NNP for_IN wealth_NN index_NN construction_NN was_VBD quickly_RB adopted_VBN by_IN the_DT World_NNP Bank_NNP and_CC Macro_NNP International_NNP Inc._NNP ._. 
for_IN analysis_NN of_IN inequalities_NNS within_IN DHS_NNP datasets_NNS ._. 
The_DT approach_NN is_VBZ now_RB also_RB more_RBR widely_RB used_VBN ._. 
Nevertheless_RB ,_, this_DT application_NN of_IN PCA_NNP is_VBZ not_RB fully_RB justified_JJ and_CC requires_VBZ further_JJ investigation_NN ._. 
total_JJ household_NN consumption_NN expenditure_NN was_VBD divided_VBN by_IN the_DT number_NN of_IN household_NN members_NNS ._. 
e._VB For_IN these_DT analyses_NNS ,_, a_DT per_IN capita_NN equivalence_NN scale_NN was_VBD used_VBN ,_, i._VB The_DT assets_NNS used_VBD to_TO construct_VB the_DT wealth_NN indices_NNS were_VBD those_DT used_VBN in_IN analyses_NNS by_IN the_DT World_NNP Bank_NNP of_IN the_DT 2000_CD Malawi_NNP DHS_NNP -LRB-_-LRB- toilet_NN facility_NN ,_, main_JJ cooking_NN fuel_NN ,_, main_JJ drinking_NN water_NN source_NN ,_, floor_NN material_NN of_IN main_JJ dwelling_NN ,_, whether_IN there_EX is_VBZ electricity_NN in_IN the_DT home_NN ,_, owns_VBZ radio_NN ,_, owns_VBZ television\/VCR_NNP ,_, owns_VBZ bicycle_NN ,_, owns_VBZ car_NN ,_, owns_VBZ motorbike\/scooter_NN ,_, owns_VBZ agricultural_JJ land_NN ,_, and_CC presence_NN of_IN a_DT domestic_JJ servant_NN -RRB-_-RRB- 
Survey_NN analysis_NN was_VBD used_VBN for_IN descriptive_JJ analyses_NNS to_TO adjust_VB for_IN the_DT complex_JJ sampling_NN used_VBN in_IN IHS2_NNP ._. 
Sampling_VBG weights_NNS can_MD not_RB be_VB applied_VBN during_IN MCA_NNP and_CC PCA_NNP ;_: therefore_RB ,_, in_IN order_NN to_TO facilitate_VB comparisons_NNS ,_, sampling_VBG weights_NNS were_VBD not_RB used_VBN when_WRB calculating_VBG the_DT weights_NNS for_IN any_DT index_NN ,_, but_CC they_PRP were_VBD used_VBN for_IN generating_NN quintiles_NNS ,_, as_IN in_IN previous_JJ studies_NNS ._. 
The_DT PCA-based_JJ indices_NNS utilised_VBD the_DT weights_NNS from_IN the_DT first_JJ principal_JJ component_NN to_TO ascertain_VB the_DT weights_NNS ._. 
items_NNS expected_VBN to_TO be_VB associated_VBN with_IN higher_JJR SEP_NNP have_VBP a_DT positive_JJ weight_NN and_CC vice_NN versa_RB -RRB-_-RRB- apart_RB from_IN agricultural_JJ land_NN ,_, which_WDT has_VBZ a_DT negative_JJ weight_NN in_IN the_DT PCA_NNP and_CC MCA_NNP indices_NNS ._. 
The_DT negative_JJ weight_NN assigned_VBN to_TO agricultural_JJ land_NN is_VBZ consistent_JJ with_IN the_DT index_NN used_VBN in_IN World_NNP Bank_NNP analysis_NN of_IN the_DT Malawi_NNP DHS_NNP ._. 
The_DT weights_NNS are_VBP not_RB directly_RB comparable_JJ between_IN indices_NNS ,_, as_IN they_PRP are_VBP on_IN different_JJ scales_NNS ._. 
However_RB ,_, the_DT relative_JJ magnitude_NN of_IN weights_NNS across_IN indices_NNS can_MD be_VB compared_VBN ,_, and_CC this_DT illustrates_VBZ some_DT striking_JJ differences_NNS between_IN the_DT indices_NNS ._. 
Survey_NN analysis_NN was_VBD used_VBN for_IN descriptive_JJ analyses_NNS to_TO adjust_VB for_IN the_DT complex_JJ sampling_NN used_VBN in_IN IHS2_NNP ._. 
Sampling_VBG weights_NNS can_MD not_RB be_VB applied_VBN during_IN MCA_NNP and_CC PCA_NNP ;_: therefore_RB ,_, in_IN order_NN to_TO facilitate_VB comparisons_NNS ,_, sampling_VBG weights_NNS were_VBD not_RB used_VBN when_WRB calculating_VBG the_DT weights_NNS for_IN any_DT index_NN ,_, but_CC they_PRP were_VBD used_VBN for_IN generating_NN quintiles_NNS ,_, as_IN in_IN previous_JJ studies_NNS 
Houweling_VBG et_FW al_FW ._. 
It_PRP may_MD be_VB the_DT case_NN ,_, therefore_RB ,_, that_IN variables_NNS are_VBP `_`` double_RB counted_VBN '_'' if_IN included_VBN both_DT in_IN a_DT wealth_NN index_NN and_CC as_IN separate_JJ indicators_NNS in_IN a_DT model_NN ,_, making_VBG interpretation_NN of_IN coefficients_NNS unclear_JJ ._. 
demonstrated_VBD that_IN excluding_VBG from_IN the_DT wealth_NN index_NN variables_NNS thought_VBD to_TO have_VB the_DT strongest_JJS direct_JJ effects_NNS on_IN child_NN health_NN did_VBD affect_VB the_DT magnitude_NN and_CC even_RB direction_NN of_IN inequalities_NNS in_IN child_NN health_NN ,_, but_CC the_DT effect_NN was_VBD not_RB consistent_JJ across_IN countries_NNS 
The_DT PCA-based_JJ indices_NNS utilised_VBD the_DT weights_NNS from_IN the_DT first_JJ principal_JJ component_NN to_TO ascertain_VB the_DT weights_NNS ._. 
AStata_JJ macro_NN for_IN MCA_NNP was_VBD downloaded_VBN from_IN the_DT EconPapers_NNP website_NN ._. 
In_IN a_DT similar_JJ manner_NN to_TO PCA_NNP ,_, the_DT weights_NNS used_VBN are_VBP those_DT identified_VBN from_IN the_DT first_JJ dimension_NN of_IN the_DT MCA_NNP ._. 
It_PRP has_VBZ also_RB been_VBN argued_VBN that_IN while_IN consumption_NN needs_NNS and_CC patterns_NNS will_MD obviously_RB be_VB strongly_RB affected_VBN by_IN household_NN size_NN and_CC composition_NN ,_, the_DT benefits_NNS of_IN most_JJS items_NNS included_VBN in_IN a_DT wealth_NN index_NN are_VBP at_IN the_DT household_NN level_NN 
Furthermore_RB ,_, the_DT agreement_NN of_IN a_DT wealth_NN index_NN with_IN consumption_NN expenditure_NN measures_NNS adjusted_VBN for_IN household_NN size_NN and_CC composition_NN in_IN different_JJ ways_NNS will_MD be_VB examined_VBN to_TO identify_VB which_WDT aspect_NN of_IN long-term_JJ SEP_NNP a_DT wealth_NN index_NN best_RB represents_VBZ ._. 
MethodsTo_NNS illustrate_VBP our_PRP$ exploration_NN of_IN wealth_NN indices_NNS ,_, we_PRP analyzed_VBD data_NNS from_IN the_DT Malawi_NNP Integrated_NNP Household_NNP Survey_NNP 2004_CD 
Aprice_JJ index_NN was_VBD used_VBN to_TO adjust_VB for_IN differences_NNS in_IN prices_NNS across_IN areas_NNS and_CC times_NNS ._. 
The_DT measure_NN of_IN consumption_NN expenditure_NN was_VBD calculated_VBN using_VBG annualised_JJ figures_NNS for_IN consumption_NN expenditure_NN across_IN categories_NNS of_IN food_NN -_: and_CC non-food_JJ consumption_NN according_VBG to_TO the_DT UN_NNP classification_NN system_NN `_`` Classification_NN of_IN Individual_NNP Consumption_NNP According_VBG to_TO Purpose_NNP '_POS ._. 
The_DT Malawi_NNP National_NNP Statistical_NNP Office_NNP evaluated_VBD equivalence_NN scales_NNS for_IN the_DT consumption_NN expenditure_NN aggregate_NN ,_, and_CC found_VBD the_DT poverty_NN profile_NN to_TO be_VB remarkably_RB similar_JJ when_WRB a_DT per_IN capita_NN or_CC a_DT per_IN adult_NN equivalent_NN scale_NN was_VBD used_VBN ._. 
For_IN these_DT analyses_NNS ,_, a_DT per_IN capita_NN equivalence_NN scale_NN was_VBD used_VBN ,_, i._FW e._FW total_JJ household_NN consumption_NN expenditure_NN was_VBD divided_VBN by_IN the_DT number_NN of_IN household_NN members_NNS ._. 
The_DT assets_NNS used_VBD to_TO construct_VB the_DT wealth_NN indices_NNS were_VBD those_DT used_VBN in_IN analyses_NNS by_IN the_DT World_NNP Bank_NNP of_IN the_DT 2000_CD Malawi_NNP DHS_NNP -LRB-_-LRB- toilet_NN facility_NN ,_, main_JJ cooking_NN fuel_NN ,_, main_JJ drinking_NN water_NN source_NN ,_, floor_NN material_NN of_IN main_JJ dwelling_NN ,_, whether_IN there_EX is_VBZ electricity_NN in_IN the_DT home_NN ,_, owns_VBZ radio_NN ,_, owns_VBZ television\/VCR_NNP ,_, owns_VBZ bicycle_NN ,_, owns_VBZ car_NN ,_, owns_VBZ motorbike\/scooter_NN ,_, owns_VBZ agricultural_JJ land_NN ,_, and_CC presence_NN of_IN a_DT domestic_JJ servant_NN -RRB-_-RRB- 
Multiple_NNP Correspondence_NNP Analysis_NNP -LRB-_-LRB- MCA_NNP -RRB-_-RRB- is_VBZ analogous_JJ to_TO PCA_NNP ,_, but_CC is_VBZ for_IN discrete_JJ data_NNS 
They_PRP found_VBD that_IN the_DT index_NN was_VBD very_RB highly_RB correlated_JJ with_IN one_CD constructed_VBN using_VBG PCA_NNP ,_, and_CC that_IN although_IN households_NNS were_VBD not_RB always_RB in_IN the_DT same_JJ quintile_NN by_IN the_DT two_CD indices_NNS ,_, movement_NN was_VBD in_IN most_JJS cases_NNS limited_VBN to_TO one_CD quintile_NN in_IN either_DT direction_NN ._. 
They_PRP also_RB showed_VBD that_IN the_DT weights_NNS assigned_VBN to_TO index_NN items_NNS were_VBD generally_RB similar_JJ by_IN the_DT two_CD methods_NNS ._. 
Other_JJ methods_NNS for_IN weighting_NN items_NNS in_IN a_DT wealth_NN index_NN do_VBP exist_VB ,_, but_CC in_IN general_JJ offer_NN neither_DT more_JJR simplicity_NN than_IN PCA_NNP ,_, nor_CC more_JJR suitability_NN for_IN discrete_JJ data_NNS ._. 
Other_JJ methods_NNS for_IN weighting_NN items_NNS in_IN a_DT wealth_NN index_NN do_VBP exist_VB ,_, but_CC in_IN general_JJ offer_NN neither_DT more_JJR simplicity_NN than_IN PCA_NNP ,_, nor_CC more_JJR suitability_NN for_IN discrete_JJ data_NNS ._. 
For_IN instance_NN ,_, latent_NN variable_JJ approaches_NNS have_VBP been_VBN proposed_VBN ._. 
In_IN his_PRP$ 2005_CD paper_NN ,_, Montgomery_NNP constructs_VBZ a_DT wealth_NN index_NN using_VBG a_DT latent_NN variable_JJ approach_NN called_VBN MIMIC_NNP ;_: this_DT model_NN specifies_VBZ which_WDT variables_NNS are_VBP determinants_NNS of_IN living_NN standards_NNS -LRB-_-LRB- e._SYM 
In_IN other_JJ methods_NNS of_IN wealth_NN index_NN construction_NN ,_, both_DT determinants_NNS and_CC indicators_NNS of_IN the_DT underlying_VBG socio-economic_JJ construct_VBP may_MD be_VB included_VBN without_IN distinction_NN ._. 
For_IN instance_NN ,_, producer_NN durables_NNS such_JJ as_IN farm_NN equipment_NN are_VBP sometimes_RB included_VBN in_IN a_DT wealth_NN index_NN in_IN the_DT same_JJ way_NN as_IN consumer_NN durables_NNS ,_, whereas_IN these_DT should_MD in_IN fact_NN be_VB considered_VBN as_IN determinants_NNS of_IN the_DT socio-economic_NNS construct_VBP and_CC not_RB treated_VBN in_IN the_DT same_JJ way_NN as_IN indicator_NN variables_NNS 
demonstrated_VBD that_IN excluding_VBG from_IN the_DT wealth_NN index_NN variables_NNS thought_VBD to_TO have_VB the_DT strongest_JJS direct_JJ effects_NNS on_IN child_NN health_NN did_VBD affect_VB the_DT magnitude_NN and_CC even_RB direction_NN of_IN inequalities_NNS in_IN child_NN health_NN ,_, but_CC the_DT effect_NN was_VBD not_RB consistent_JJ across_IN countries_NNS 
Other_JJ methods_NNS for_IN weighting_NN items_NNS in_IN a_DT wealth_NN index_NN do_VBP exist_VB ,_, but_CC in_IN general_JJ offer_NN neither_DT more_JJR simplicity_NN than_IN PCA_NNP ,_, nor_CC more_JJR suitability_NN for_IN discrete_JJ data_NNS ._. 
For_IN instance_NN ,_, latent_NN variable_JJ approaches_NNS have_VBP been_VBN proposed_VBN ._. 
In_IN his_PRP$ 2005_CD paper_NN ,_, Montgomery_NNP constructs_VBZ a_DT wealth_NN index_NN using_VBG a_DT latent_NN variable_JJ approach_NN called_VBN MIMIC_NNP ;_: this_DT model_NN specifies_VBZ which_WDT variables_NNS are_VBP determinants_NNS of_IN living_NN standards_NNS -LRB-_-LRB- e._SYM 
Afurther_NNP option_NN could_MD be_VB to_TO assign_VB weights_NNS based_VBN on_IN the_DT price_NN of_IN an_DT item_NN ,_, but_CC this_DT requires_VBZ detailed_JJ information_NN allowing_VBG for_IN date_NN of_IN purchase_NN ,_, area_NN of_IN purchase_NN ,_, and_CC current_JJ condition_NN of_IN the_DT item_NN ._. 
There_EX is_VBZ also_RB some_DT evidence_NN that_IN price-based_JJ indices_NNS are_VBP less_RBR reliable_JJ than_IN alternatives_NNS ;_: one_CD study_NN showed_VBD a_DT price-based_JJ index_NN to_TO have_VB implausible_JJ relationships_NNS with_IN health_NN outcomes_NNS 
The_DT difficulties_NNS of_IN collecting_VBG income_NN and_CC consumption_NN expenditure_NN data_NNS for_IN health_NN research_NN in_IN low-income_JJ countries_NNS remain_VBP ,_, and_CC further_JJ alternatives_NNS to_TO the_DT wealth_NN index_NN approach_NN are_VBP limited_JJ ._. 
Qualitative_JJ methods_NNS such_JJ as_IN Participatory_NNP Wealth_NNP Ranking_NNP -LRB-_-LRB- PWR_NNP -RRB-_-RRB- have_VBP also_RB been_VBN suggested_VBN as_IN an_DT alternative_JJ way_NN of_IN collecting_VBG SEP_NNP data_NNS ,_, but_CC such_JJ methods_NNS are_VBP probably_RB only_RB practical_JJ in_IN small_JJ geographical_JJ areas_NNS ._. 
This_DT work_NN has_VBZ reviewed_VBN some_DT of_IN the_DT issues_NNS with_IN the_DT wealth_NN index_NN approach_NN to_TO SEP_NNP measurement_NN and_CC has_VBZ provided_VBN evidence_NN that_IN the_DT data_NNS included_VBN in_IN the_DT index_NN are_VBP more_RBR important_JJ than_IN the_DT method_NN of_IN index_NN construction_NN ._. 
The_DT difficulties_NNS of_IN collecting_VBG income_NN and_CC consumption_NN expenditure_NN data_NNS for_IN health_NN research_NN in_IN low-income_JJ countries_NNS remain_VBP ,_, and_CC further_JJ alternatives_NNS to_TO the_DT wealth_NN index_NN approach_NN are_VBP limited_JJ ._. 
Qualitative_JJ methods_NNS such_JJ as_IN Participatory_NNP Wealth_NNP Ranking_NNP -LRB-_-LRB- PWR_NNP -RRB-_-RRB- have_VBP also_RB been_VBN suggested_VBN as_IN an_DT alternative_JJ way_NN of_IN collecting_VBG SEP_NNP data_NNS ,_, but_CC such_JJ methods_NNS are_VBP probably_RB only_RB practical_JJ in_IN small_JJ geographical_JJ areas_NNS ._. 
This_DT work_NN has_VBZ reviewed_VBN some_DT of_IN the_DT issues_NNS with_IN the_DT wealth_NN index_NN approach_NN to_TO SEP_NNP measurement_NN and_CC has_VBZ provided_VBN evidence_NN that_IN the_DT data_NNS included_VBN in_IN the_DT index_NN are_VBP more_RBR important_JJ than_IN the_DT method_NN of_IN index_NN construction_NN ._. 
Formative_JJ research_NN may_MD help_VB to_TO identify_VB assets_NNS that_WDT are_VBP strong_JJ predictors_NNS of_IN SEP_NNP in_IN a_DT particular_JJ context_NN ,_, increasing_VBG the_DT appropriateness_NN of_IN the_DT wealth_NN index_NN as_IN a_DT measure_NN of_IN SEP._NNP ._. 
Afurther_NN possibility_NN for_IN selecting_VBG assets_NNS for_IN data_NN collection_NN is_VBZ to_TO identify_VB assets_NNS which_WDT are_VBP highly_RB correlated_VBN with_IN consumption_NN expenditure_NN ._. 
This_DT approach_NN requires_VBZ full_JJ data_NNS on_IN consumption_NN expenditure_NN and_CC assets_NNS from_IN a_DT recent_JJ existing_VBG study_NN in_IN the_DT same_JJ setting_NN ._. 
Both_DT the_DT equal_JJ weights_NNS and_CC the_DT inverse_JJ proportion_NN weighting_NN methods_NNS can_MD only_RB be_VB applied_VBN to_TO binary_JJ data_NNS ._. 
Multiple_NNP Correspondence_NNP Analysis_NNP -LRB-_-LRB- MCA_NNP -RRB-_-RRB- is_VBZ analogous_JJ to_TO PCA_NNP ,_, but_CC is_VBZ for_IN discrete_JJ data_NNS 
Asimilar_JJ method_NN was_VBD applied_VBN by_IN Morris_NNP et_FW al_FW ._. 
ownership_NN of_IN a_DT motorbike_NN may_MD tend_VB to_TO increase_VB up_RP to_TO a_DT certain_JJ income_NN and_CC subsequently_RB decrease_VB in_IN richer_JJR households_NNS 
In_IN contrast_NN ,_, however_RB ,_, Morris_NNP et_NNP al_NNP ._. 
There_EX is_VBZ also_RB some_DT evidence_NN that_IN price-based_JJ indices_NNS are_VBP less_RBR reliable_JJ than_IN alternatives_NNS ;_: one_CD study_NN showed_VBD a_DT price-based_JJ index_NN to_TO have_VB implausible_JJ relationships_NNS with_IN health_NN outcomes_NNS 
This_DT is_VBZ based_VBN on_IN a_DT method_NN originally_RB suggested_VBN by_IN Townsend_NNP 
Another_DT potentially_RB simpler_JJR and_CC more_RBR easily_RB understood_VBN alternative_NN to_TO PCA_NNP is_VBZ to_TO use_VB the_DT inverse_NN of_IN the_DT proportion_NN of_IN households_NNS that_WDT own_VBP an_DT asset_NN as_IN its_PRP$ weight_NN ._. 
This_DT is_VBZ based_VBN on_IN a_DT method_NN originally_RB suggested_VBN by_IN Townsend_NNP 
In_IN contrast_NN ,_, Bollen_NNP et_FW al_FW ._. 
There_EX is_VBZ some_DT evidence_NN that_IN PCA_NNP performs_VBZ no_RB better_RB as_IN a_DT proxy_NN for_IN consumption_NN expenditure_NN than_IN an_DT equal_JJ weights_NNS approach_NN 
Afurther_NNP option_NN could_MD be_VB to_TO assign_VB weights_NNS based_VBN on_IN the_DT price_NN of_IN an_DT item_NN ,_, but_CC this_DT requires_VBZ detailed_JJ information_NN allowing_VBG for_IN date_NN of_IN purchase_NN ,_, area_NN of_IN purchase_NN ,_, and_CC current_JJ condition_NN of_IN the_DT item_NN ._. 
There_EX is_VBZ also_RB some_DT evidence_NN that_IN price-based_JJ indices_NNS are_VBP less_RBR reliable_JJ than_IN alternatives_NNS ;_: one_CD study_NN showed_VBD a_DT price-based_JJ index_NN to_TO have_VB implausible_JJ relationships_NNS with_IN health_NN outcomes_NNS 
Bollen_NNP et_FW al_FW ._. 
Whilst_VB these_DT analyses_NNS have_VBP used_VBN only_RB the_DT assets_NNS collected_VBN by_IN DHS_NNP ,_, further_JJ work_NN investigating_VBG the_DT effects_NNS of_IN using_VBG a_DT wider\/different_JJ set_NN of_IN assets_NNS is_VBZ recommended_VBN ._. 
showed_VBD that_IN within_IN the_DT Ghana_NNP 1998\/9_CD Living_VBG Standards_NNP Measurement_NNP Study_NNP -LRB-_-LRB- LSMS_NNP -RRB-_-RRB- ,_, a_DT wealth_NN index_NN constructed_VBD using_VBG a_DT wider_JJR set_NN of_IN indicators_NNS had_VBD a_DT stronger_JJR relationship_NN with_IN a_DT permanent_JJ income_NN latent_NN variable_JJ than_IN a_DT wealth_NN index_NN constructed_VBD using_VBG only_RB the_DT core_NN set_NN of_IN assets_NNS included_VBN in_IN the_DT DHS_NNP ;_: in_IN the_DT Peru_NNP 1985_CD LSMS_NNP ,_, however_RB ,_, the_DT difference_NN was_VBD small_JJ ._. 
Researchers_NNS are_VBP urged_VBN to_TO remember_VB that_IN this_DT set_NN of_IN core_NN assets_NNS was_VBD not_RB originally_RB included_VBN in_IN the_DT DHS_NNP for_IN SEP_NNP measurement_NN ;_: the_DT assets_NNS predictive_JJ of_IN wealth_NN may_MD vary_VB substantially_RB between_IN settings_NNS and_CC over_IN time_NN and_CC if_IN the_DT wealth_NN index_NN approach_NN to_TO SEP_NNP measurement_NN is_VBZ used_VBN in_IN new_JJ data_NNS collection_NN ,_, it_PRP would_MD seem_VB unwise_JJ to_TO rely_VB on_IN this_DT set_NN of_IN assets_NNS without_IN further_JJ exploration_NN of_IN the_DT important_JJ indicators_NNS of_IN SEP_NNP in_IN a_DT particular_JJ context_NN ._. 
In_IN contrast_NN ,_, Bollen_NNP et_FW al_FW ._. 
There_EX is_VBZ some_DT evidence_NN that_IN PCA_NNP performs_VBZ no_RB better_RB as_IN a_DT proxy_NN for_IN consumption_NN expenditure_NN than_IN an_DT equal_JJ weights_NNS approach_NN 
The_DT literature_NN comparing_VBG indices_NNS constructed_VBD using_VBG PCA_NNP and_CC using_VBG an_DT equal_JJ weights_NNS approach_NN is_VBZ not_RB consistent_JJ ._. 
There_EX is_VBZ some_DT evidence_NN that_IN PCA_NNP performs_VBZ no_RB better_RB as_IN a_DT proxy_NN for_IN consumption_NN expenditure_NN than_IN an_DT equal_JJ weights_NNS approach_NN 
It_PRP could_MD therefore_RB be_VB argued_VBN that_IN simpler_JJR ,_, more_RBR familiar_JJ and_CC easily_RB understood_VBN methods_NNS for_IN weighting_NN the_DT items_NNS in_IN a_DT wealth_NN index_NN would_MD be_VB preferable_JJ ._. 
Using_VBG an_DT equal_JJ weights_NNS approach_NN -LRB-_-LRB- simple_JJ sum_NN -RRB-_-RRB- was_VBD used_VBN in_IN several_JJ early_JJ studies_NNS using_VBG wealth_NN indices_NNS ._. 
Although_IN simple_JJ ,_, this_DT approach_NN could_MD be_VB criticised_VBN for_IN being_VBG arbitrary_JJ and_CC simplistic_JJ ,_, since_IN different_JJ assets_NNS are_VBP unlikely_JJ to_TO have_VB equal_JJ meaning_NN in_IN terms_NNS of_IN SEP._NNP 
It_PRP could_MD therefore_RB be_VB argued_VBN that_IN simpler_JJR ,_, more_RBR familiar_JJ and_CC easily_RB understood_VBN methods_NNS for_IN weighting_NN the_DT items_NNS in_IN a_DT wealth_NN index_NN would_MD be_VB preferable_JJ ._. 
Using_VBG an_DT equal_JJ weights_NNS approach_NN -LRB-_-LRB- simple_JJ sum_NN -RRB-_-RRB- was_VBD used_VBN in_IN several_JJ early_JJ studies_NNS using_VBG wealth_NN indices_NNS ._. 
Although_IN simple_JJ ,_, this_DT approach_NN could_MD be_VB criticised_VBN for_IN being_VBG arbitrary_JJ and_CC simplistic_JJ ,_, since_IN different_JJ assets_NNS are_VBP unlikely_JJ to_TO have_VB equal_JJ meaning_NN in_IN terms_NNS of_IN SEP._NNP 
The_DT linear_JJ dependence_NN between_IN the_DT dummy_NN variables_NNS may_MD lead_VB to_TO incorrect_JJ estimates_NNS of_IN the_DT wealth_NN index_NN ;_: the_DT PCA_NNP method_NN is_VBZ affected_VBN by_IN collinearity_NN ,_, with_IN variation_NN in_IN the_DT data_NNS arising_VBG both_DT from_IN the_DT underlying_VBG concept_NN of_IN wealth_NN and_CC from_IN the_DT linear_JJ dependence_NN between_IN dummy_JJ variables_NNS of_IN categorical_JJ variables_NNS ._. 
This_DT approach_NN has_VBZ been_VBN shown_VBN to_TO be_VB inferior_JJ to_TO several_JJ alternative_JJ methods_NNS of_IN dealing_VBG with_IN categorical_JJ data_NNS ._. 
The_DT alternative_JJ methods_NNS explored_VBN were_VBD using_VBG ordinal_JJ variables_NNS ,_, using_VBG group_NN means_VBZ ,_, and_CC using_VBG polychoric_JJ correlations_NNS ._. 
There_EX are_VBP problems_NNS with_IN recall_NN and_CC reluctance_NN to_TO divulge_VB information_NN ._. 
In_IN low-income_JJ countries_NNS ,_, measurement_NN of_IN consumption_NN expenditure_NN is_VBZ fraught_JJ with_IN difficulties_NNS ._. 
Additionally_RB ,_, prices_NNS are_VBP likely_JJ to_TO differ_VB substantially_RB across_IN times_NNS and_CC areas_NNS ,_, necessitating_VBG complex_JJ adjustment_NN of_IN expenditure_NN figures_NNS to_TO reflect_VB these_DT price_NN differences_NNS ._. 
Furthermore_RB ,_, collecting_VBG consumption_NN expenditure_NN data_NNS requires_VBZ lengthy_JJ questionnaires_NNS that_WDT must_MD be_VB completed_VBN by_IN skilled_JJ and_CC trained_JJ interviewers_NNS ._. 
These_DT items_NNS were_VBD all_RB originally_RB included_VBN in_IN the_DT surveys_NNS for_IN their_PRP$ direct_JJ influences_NNS on_IN health_NN ;_: for_IN instance_NN ,_, television_NN and_CC radio_NN ownership_NN was_VBD of_IN interest_NN to_TO identify_VB households_NNS receiving_VBG public_JJ health_NN messages_NNS ._. 
Researchers_NNS began_VBD to_TO see_VB that_IN these_DT assets_NNS could_MD be_VB used_VBN as_IN indicators_NNS of_IN living_NN standards_NNS and_CC have_VBP sought_VBN to_TO construct_VB wealth_NN indices_NNS for_IN that_DT purpose_NN ._. 
Wealth_NN indices_NNS measure_VBP SEP_NNP at_IN the_DT household_NN level_NN and_CC can_MD only_RB be_VB used_VBN to_TO assess_VB relative_JJ SEP_NNP within_IN a_DT population_NN ._. 
After_IN the_DT paper_NN by_IN Filmer_NNP and_CC Pritchett_NNP ,_, the_DT use_NN of_IN PCA_NNP for_IN wealth_NN index_NN construction_NN was_VBD quickly_RB adopted_VBN by_IN the_DT World_NNP Bank_NNP and_CC Macro_NNP International_NNP Inc._NNP ._. 
for_IN analysis_NN of_IN inequalities_NNS within_IN DHS_NNP datasets_NNS ._. 
The_DT approach_NN is_VBZ now_RB also_RB more_RBR widely_RB used_VBN ._. 
Nevertheless_RB ,_, this_DT application_NN of_IN PCA_NNP is_VBZ not_RB fully_RB justified_JJ and_CC requires_VBZ further_JJ investigation_NN ._. 
g._VB A_DT problem_NN with_IN methods_NNS using_VBG inverse_JJ proportion_NN weights_NNS is_VBZ that_IN not_RB all_DT assets_NNS show_VBP a_DT linear_JJ relationship_NN with_IN living_NN standards_NNS ,_, e._JJ ownership_NN of_IN a_DT motorbike_NN may_MD tend_VB to_TO increase_VB up_RP to_TO a_DT certain_JJ income_NN and_CC subsequently_RB decrease_VB in_IN richer_JJR households_NNS 
Wealth_NN indices_NNS ,_, however_RB ,_, are_VBP not_RB generally_RB adjusted_VBN for_IN household_NN size_NN or_CC composition_NN ._. 
divided_VBN by_IN the_DT total_JJ number_NN of_IN household_NN members_NNS -RRB-_-RRB- ,_, per_IN adult_NN or_CC per_IN adult_NN equivalent_NN -LRB-_-LRB- where_WRB each_DT child_NN is_VBZ considered_VBN to_TO require_VB a_DT pre-determined_JJ proportion_NN of_IN the_DT consumption_NN of_IN one_CD adult_NN -RRB-_-RRB- ._. 
There_EX is_VBZ some_DT evidence_NN that_IN adjusting_VBG a_DT wealth_NN index_NN for_IN household_NN size_NN results_NNS in_IN implausible_JJ relationships_NNS with_IN health_NN outcomes_NNS 
There_EX is_VBZ some_DT evidence_NN that_IN adjusting_VBG a_DT wealth_NN index_NN for_IN household_NN size_NN results_NNS in_IN implausible_JJ relationships_NNS with_IN health_NN outcomes_NNS 
Wealth_NN indices_NNS measure_VBP SEP_NNP at_IN the_DT household_NN level_NN and_CC can_MD only_RB be_VB used_VBN to_TO assess_VB relative_JJ SEP_NNP within_IN a_DT population_NN ._. 
Collection_NN of_IN asset_NN data_NNS has_VBZ been_VBN claimed_VBN to_TO be_VB more_RBR reliable_JJ than_IN income_NN or_CC consumption_NN expenditure_NN ,_, since_IN it_PRP uses_VBZ simple_JJ questions_NNS or_CC direct_JJ observation_NN by_IN the_DT interviewer_NN and_CC should_MD therefore_RB suffer_VB from_IN less_JJR recall_NN or_CC social_JJ desirability_NN bias_NN 
39_CD 
In_IN considering_VBG the_DT appropriateness_NN of_IN a_DT wealth_NN index_NN as_IN a_DT proxy_NN for_IN consumption_NN expenditure_NN ,_, it_PRP has_VBZ been_VBN suggested_VBN that_IN the_DT choice_NN of_IN equivalence_NN scale_NN may_MD have_VB a_DT substantial_JJ impact_NN on_IN the_DT observed_JJ relationship_NN ._. 
Sahn_NNP and_CC Stifel_NNP suggested_VBD that_IN the_DT correlation_NN of_IN a_DT wealth_NN index_NN would_MD be_VB highest_JJS when_WRB total_JJ household_NN expenditures_NNS were_VBD considered_VBN ,_, intermediate_JJ when_WRB a_DT per_IN adult_NN equivalence_NN scale_NN is_VBZ used_VBN ,_, and_CC lowest_JJS when_WRB per_IN capita_NN consumption_NN expenditure_NN is_VBZ used_VBN ._. 
There_EX is_VBZ ,_, however_RB ,_, no_DT evidence_NN of_IN this_DT presented_VBN in_IN the_DT current_JJ body_NN of_IN literature_NN ._. 
Aim_NNP The_DT aim_NN of_IN these_DT analyses_NNS is_VBZ to_TO compare_VB wealth_NN indices_NNS constructed_VBD using_VBG different_JJ weighting_NN methods_NNS to_TO identify_VB whether_IN PCA_NNP offers_VBZ an_DT advantage_NN over_IN either_DT simpler_JJR ,_, more_RBR transparent_JJ methods_NNS -LRB-_-LRB- equal_JJ weights_NNS and_CC inverse_NN of_IN the_DT proportion_NN of_IN the_DT population_NN owning_VBG the_DT asset_NN -RRB-_-RRB- or_CC methods_NNS more_RBR appropriate_JJ for_IN discrete_JJ data_NNS -LRB-_-LRB- MCA_NNP -RRB-_-RRB- ._. 
Collection_NN of_IN asset_NN data_NNS has_VBZ been_VBN claimed_VBN to_TO be_VB more_RBR reliable_JJ than_IN income_NN or_CC consumption_NN expenditure_NN ,_, since_IN it_PRP uses_VBZ simple_JJ questions_NNS or_CC direct_JJ observation_NN by_IN the_DT interviewer_NN and_CC should_MD therefore_RB suffer_VB from_IN less_JJR recall_NN or_CC social_JJ desirability_NN bias_NN 
Introduction_NN Defining_VBG and_CC measuring_VBG socio-economic_JJ position_NN Socio-economic_JJ position_NN -LRB-_-LRB- SEP_NNP -RRB-_-RRB- is_VBZ a_DT concept_NN widely_RB used_VBN in_IN epidemiological_JJ research_NN ._. 
Definitions_NNS vary_VBP ,_, but_CC commonly_RB incorporate_VB physical_JJ resources_NNS ,_, social_JJ resources_NNS ,_, and_CC status_NN within_IN a_DT social_JJ hierarchy_NN ._. 
Measurement_NNP of_IN SEP_NNP is_VBZ crucial_JJ not_RB only_RB for_IN studies_NNS focusing_VBG on_IN the_DT social_JJ determinants_NNS of_IN health_NN ,_, but_CC also_RB for_IN the_DT vast_JJ majority_NN of_IN observational_JJ health_NN research_NN ,_, since_IN SEP_NNP is_VBZ likely_JJ to_TO confound_VB many_JJ relationships_NNS ._. 
Measurement_NNP of_IN SEP_NNP is_VBZ crucial_JJ not_RB only_RB for_IN studies_NNS focusing_VBG on_IN the_DT social_JJ determinants_NNS of_IN health_NN ,_, but_CC also_RB for_IN the_DT vast_JJ majority_NN of_IN observational_JJ health_NN research_NN ,_, since_IN SEP_NNP is_VBZ likely_JJ to_TO confound_VB many_JJ relationships_NNS ._. 
Traditionally_RB ,_, indicators_NNS of_IN SEP_NNP have_VBP tended_VBN to_TO be_VB monetary_JJ measures_NNS such_JJ as_IN income_NN or_CC consumption_NN expenditure_NN ,_, based_VBN on_IN the_DT assumption_NN that_IN material_NN living_NN standards_NNS largely_RB determine_VBP well-being_NN ._. 
Whilst_IN it_PRP is_VBZ now_RB widely_RB recognized_VBN that_IN monetary_JJ measures_NNS of_IN SEP_NNP fail_VBP to_TO capture_VB all_DT of_IN the_DT diverse_JJ aspects_NNS of_IN well-being_NN ,_, their_PRP$ use_NN remains_VBZ widespread_JJ ,_, partially_RB due_JJ to_TO difficulties_NNS in_IN measuring_VBG more_RBR complex_JJ conceptualisations_NNS of_IN SEP_NNP ,_, and_CC because_IN monetary_JJ measures_NNS may_MD have_VB clearer_JJR policy_NN implications_NNS ._. 
These_DT items_NNS were_VBD all_RB originally_RB included_VBN in_IN the_DT surveys_NNS for_IN their_PRP$ direct_JJ influences_NNS on_IN health_NN ;_: for_IN instance_NN ,_, television_NN and_CC radio_NN ownership_NN was_VBD of_IN interest_NN to_TO identify_VB households_NNS receiving_VBG public_JJ health_NN messages_NNS ._. 
Researchers_NNS began_VBD to_TO see_VB that_IN these_DT assets_NNS could_MD be_VB used_VBN as_IN indicators_NNS of_IN living_NN standards_NNS and_CC have_VBP sought_VBN to_TO construct_VB wealth_NN indices_NNS for_IN that_DT purpose_NN ._. 
Wealth_NN indices_NNS measure_VBP SEP_NNP at_IN the_DT household_NN level_NN and_CC can_MD o_VB 
There_EX is_VBZ longstanding_JJ debate_NN about_IN whether_IN income_NN or_CC consumption_NN expenditure_NN is_VBZ a_DT better_JJR measure_NN of_IN SEP._NNP ._. 
Income_NNP is_VBZ generally_RB more_RBR variable_JJ than_IN consumption_NN ;_: Friedman_NNP 's_POS permanent_JJ income_NN hypothesis_NN states_NNS that_IN households_NNS are_VBP likely_JJ to_TO base_VB their_PRP$ consumption_NN decisions_NNS on_IN more_JJR than_IN just_RB their_PRP$ current_JJ income_NN 
Furthermore_RB ,_, the_DT adjustments_NNS required_VBN for_IN price_NN differences_NNS across_IN regions_NNS and_CC imputations_NNS for_IN rental_JJ value_NN of_IN housing_NN and_CC use-value_NN of_IN durable_JJ goods_NNS require_VBP considerable_JJ assumptions_NNS and_CC therefore_RB introduce_VB the_DT possibility_NN of_IN bias_NN ._. 
Consumption_NN expenditure_NN itself_PRP could_MD be_VB viewed_VBN as_IN a_DT proxy_NN for_IN some_DT underlying_JJ socio-economic_JJ concept_NN ,_, such_JJ as_IN Friedman_NNP 's_POS notion_NN of_IN permanent_JJ income_NN 
Two_CD separate_JJ studies_NNS have_VBP demonstrated_VBN weak_JJ correlation_NN between_IN consumption_NN expenditure_NN and_CC wealth_NN indices_NNS :_: a_DT study_NN in_IN Mozambique_NNP showed_VBD a_DT Spearman_NNP 's_POS rank_JJ correlation_NN coefficient_NN of_IN 0_CD ._. 
37_CD ,_, and_CC a_DT study_NN using_VBG multiple_JJ datasets_NNS producing_VBG R2_CD values_NNS from_IN regressions_NNS of_IN consumption_NN expenditure_NN on_IN a_DT wealth_NN index_NN of_IN 
37_CD ,_, and_CC a_DT study_NN using_VBG multiple_JJ datasets_NNS producing_VBG R_NNP 2_CD values_NNS from_IN regressions_NNS of_IN consumption_NN expenditure_NN on_IN a_DT wealth_NN index_NN of_IN 
''_'' This_DT ``_`` risk_NN ''_'' can_MD then_RB be_VB considered_VBN in_IN the_DT context_NN of_IN other_JJ aggravating_JJ and_CC protective_JJ factors_NNS to_TO make_VB informed_JJ programmatic_JJ decisions_NNS ._. 
While_IN ,_, as_IN discussed_VBN in_IN this_DT paper_NN ,_, the_DT LQAS_NNP hypothesis_NN test_NN may_MD not_RB be_VB an_DT optimal_JJ option_NN for_IN interpreting_VBG the_DT results_NNS of_IN nutrition_NN cluster_NN surveys_NNS in_IN emergencies_NNS ,_, it_PRP remains_VBZ a_DT valuable_JJ technique_NN of_IN choice_NN for_IN many_JJ other_JJ public_JJ health_NN applications_NNS ,_, especially_RB where_WRB quick_JJ and_CC inexpensive_JJ screening_NN method_NN for_IN a_DT single_JJ indicator_NN of_IN interest_NN is_VBZ needed_VBN ._. 
Competing_VBG interests_NNS The_DT authors_NNS declare_VBP that_IN they_PRP have_VBP no_DT competing_VBG interests_NNS ._. 
Authors_NNS '_POS contributions_NNS OOB_NNP designed_VBD the_DT study_NN ,_, OOB_NNP and_CC CB_NNP performed_VBD analysis_NN ,_, wrote_VBD and_CC revised_VBD the_DT manuscript_NN ._. 
Several_JJ international_JJ organizations_NNS have_VBP published_VBN guidelines_NNS for_IN implementing_VBG food_NN and_CC nutrition_NN interventions_NNS in_IN emergencies_NNS ,_, where_WRB the_DT need_NN for_IN such_JJ interventions_NNS is_VBZ determined_VBN on_IN the_DT basis_NN of_IN the_DT prevalence_NN of_IN GAM_NNP relative_JJ to_TO pre-determined_JJ thresholds_NNS -LRB-_-LRB- 5_CD %_NN ,_, 10_CD %_NN ,_, 15_CD %_NN -RRB-_-RRB- and_CC the_DT presence_NN of_IN aggravating_VBG factors_NNS ,_, such_JJ as_IN high_JJ mortality_NN rates_NNS ,_, epidemics_NNS of_IN certain_JJ infectious_JJ diseases_NNS ,_, or_CC poor_JJ food_NN security_NN 
Aconventional_JJ way_NN of_IN analyzing_VBG GAM_NNP in_IN a_DT population_NN is_VBZ to_TO estimate_VB the_DT prevalence_NN from_IN a_DT cluster_NN survey_NN and_CC then_RB compute_VB a_DT 95_CD %_NN confidence_NN interval_NN around_IN the_DT estimate_NN 
Discussion_NN The_DT LQAS_NNP hypothesis_NN test_NN used_VBN by_IN Deitchler_NNP and_CC colleagues_NNS is_VBZ formulated_VBN as_IN :_: H_NNP o_NNP :_: p_NN 
For_IN example_NN ,_, Deitchler_NNP and_CC colleagues_NNS ,_, using_VBG 
Aconventional_JJ way_NN of_IN analyzing_VBG GAM_NNP in_IN a_DT population_NN is_VBZ to_TO estimate_VB the_DT prevalence_NN from_IN a_DT cluster_NN survey_NN and_CC then_RB compute_VB a_DT 95_CD %_NN confidence_NN interval_NN around_IN the_DT estimate_NN 
Discussion_NN The_DT LQAS_NNP hypothesis_NN test_NN used_VBN by_IN Deitchler_NNP and_CC colleagues_NNS is_VBZ formulated_VBN as_IN :_: H_NNP o_NNP :_: p_NN 
The_DT authors_NNS also_RB proposed_VBD using_VBG cluster_NN designs_NNS with_IN a_DT reduced_VBN number_NN of_IN individuals_NNS per_IN cluster_NN and_CC a_DT reduced_JJ overall_JJ sample_NN size_NN of_IN about_IN 200_CD ,_, compared_VBN with_IN 900_CD individuals_NNS in_IN a_DT ``_`` conventional_JJ ''_'' 30_CD 
Important_JJ decisions_NNS about_IN implementing_VBG large-scale_JJ interventions_NNS ,_, such_JJ as_IN general_JJ food_NN distribution_NN and\/or_CC feeding_NN programs_NNS ,_, are_VBP often_RB based_VBN principally_RB or_CC in_IN part_NN on_IN the_DT prevalence_NN of_IN GAM_NNP ._. 
Several_JJ international_JJ organizations_NNS have_VBP published_VBN guidelines_NNS for_IN implementing_VBG food_NN and_CC nutrition_NN interventions_NNS in_IN emergencies_NNS ,_, where_WRB the_DT need_NN for_IN such_JJ interventions_NNS is_VBZ determined_VBN on_IN the_DT basis_NN of_IN the_DT prevalence_NN of_IN GAM_NNP relative_JJ to_TO pre-determined_JJ thresholds_NNS -LRB-_-LRB- 5_CD %_NN ,_, 10_CD %_NN ,_, 15_CD %_NN -RRB-_-RRB- and_CC the_DT presence_NN of_IN aggravating_VBG factors_NNS ,_, such_JJ as_IN high_JJ mortality_NN rates_NNS ,_, epidemics_NNS of_IN certain_JJ infectious_JJ diseases_NNS ,_, or_CC poor_JJ food_NN security_NN 
Important_JJ decisions_NNS about_IN implementing_VBG large-scale_JJ interventions_NNS ,_, such_JJ as_IN general_JJ food_NN distribution_NN and\/or_CC feeding_NN programs_NNS ,_, are_VBP often_RB based_VBN principally_RB or_CC in_IN part_NN on_IN the_DT prevalence_NN of_IN GAM_NNP ._. 
Several_JJ international_JJ organizations_NNS have_VBP published_VBN guidelines_NNS for_IN implementing_VBG food_NN and_CC nutrition_NN interventions_NNS in_IN emergencies_NNS ,_, where_WRB the_DT need_NN for_IN such_JJ interventions_NNS is_VBZ determined_VBN on_IN the_DT basis_NN of_IN the_DT prevalence_NN of_IN GAM_NNP relative_JJ to_TO pre-determined_JJ thresholds_NNS -LRB-_-LRB- 5_CD %_NN ,_, 10_CD %_NN ,_, 15_CD %_NN -RRB-_-RRB- and_CC the_DT presence_NN of_IN aggravating_VBG factors_NNS ,_, such_JJ as_IN high_JJ mortality_NN rates_NNS ,_, epidemics_NNS of_IN certain_JJ infectious_JJ diseases_NNS ,_, or_CC poor_JJ food_NN security_NN 
Several_JJ international_JJ organizations_NNS have_VBP published_VBN guidelines_NNS for_IN implementing_VBG food_NN and_CC nutrition_NN interventions_NNS in_IN emergencies_NNS ,_, where_WRB the_DT need_NN for_IN such_JJ interventions_NNS is_VBZ determined_VBN on_IN the_DT basis_NN of_IN the_DT prevalence_NN of_IN GAM_NNP relative_JJ to_TO pre-determined_JJ thresholds_NNS -LRB-_-LRB- 5_CD %_NN ,_, 10_CD %_NN ,_, 15_CD %_NN -RRB-_-RRB- and_CC the_DT presence_NN of_IN aggravating_VBG factors_NNS ,_, such_JJ as_IN high_JJ mortality_NN rates_NNS ,_, epidemics_NNS of_IN certain_JJ infectious_JJ diseases_NNS ,_, or_CC poor_JJ food_NN security_NN 
This_DT can_MD be_VB illustrated_VBN with_IN a_DT simple_JJ example_NN ._. 
provides_VBZ no_DT information_NN concerning_VBG the_DT probability_NN of_IN the_DT true_JJ value_NN being_VBG higher_JJR than_IN the_DT threshold_NN ._. 
The_DT LQAS_NNP hypothesis_NN test_NN is_VBZ performed_VBN by_IN counting_VBG the_DT number_NN of_IN GAM_NNP cases_NNS in_IN the_DT survey_NN sample_NN and_CC comparing_VBG this_DT count_NN to_TO a_DT pre-established_JJ decision_NN rule_NN number_NN 
1,_CD classify_VBP the_DT true_JJ population_NN value_NN of_IN GAM_NNP as_IN 
We_PRP show_VBP how_WRB to_TO approach_VB the_DT classification_NN problem_NN from_IN a_DT Bayesian_JJ perspective_NN ,_, show_VBP some_DT of_IN the_DT advantages_NNS of_IN this_DT approach_NN ,_, and_CC discuss_VB the_DT parallels_NNS between_IN the_DT classical_JJ and_CC Bayesian_JJ approach_NN ._. 
DiscussionA_NNP Brief_NN Review_NNP of_IN LQAS_NNP and_CC B-LQASLQASClassical_NNP LQAS_NNP is_VBZ primarily_RB a_DT classification_NN procedure_NN ._. 
In_IN its_PRP$ simplest_JJS form_NN ,_, the_DT goal_NN is_VBZ to_TO classify_VB the_DT unknown_JJ prevalence_NN of_IN a_DT binary_JJ indicator_NN as_IN greater_JJR than_IN or_CC equal_JJ to_TO some_DT critical_JJ threshold_NN ,_, p_NN \*_NN ,_, or_CC less_JJR than_IN this_DT threshold_NN ._. 
In_IN the_DT industrial_JJ literature_NN ,_, these_DT errors_NNS are_VBP referred_VBN to_TO as_IN the_DT consumer_NN and_CC producer_NN risks_NNS ._. 
Likewise_RB ,_, the_DT probability_NN of_IN a_DT false_JJ positive_NN when_WRB the_DT true_JJ prevalence_NN is_VBZ less_JJR than_IN or_CC equal_JJ to_TO p_VB L_NNP is_VBZ less_JJR than_IN or_CC equal_JJ to_TO 
g._NN However_RB ,_, it_PRP is_VBZ not_RB uncommon_JJ to_TO use_VB much_RB smaller_JJR sample_NN sizes_NNS when_WRB performing_VBG LQAS_NNP -LRB-_-LRB- n_SYM =_SYM 19_CD ,_, e._VB In_IN the_DT example_NN we_PRP present_VBP ,_, the_DT sample_NN size_NN for_IN the_DT survey_NN is_VBZ relatively_RB large_JJ ._. -RRB-_-RRB- ._. 
In_IN this_DT case_NN ,_, the_DT prior_JJ distribution_NN will_MD impact_VB the_DT choice_NN of_IN design_NN more_RBR heavily_RB ._. 
Most_RBS importantly_RB ,_, the_DT prior_JJ should_MD accurately_RB reflect_VB prior_JJ beliefs_NNS and_CC should_MD not_RB be_VB chosen_VBN to_TO subvert_VB the_DT classification_NN procedure_NN ._. 
Brush_NNP ,_, and_CC Sharma_NNP and_CC Bhutani_NNP 
where_WRB a_DT ,_, b_NN 
In_IN health_NN applications_NNS ,_, generally_RB p_VBP U_NNP is_VBZ chosen_VBN to_TO be_VB equal_JJ to_TO the_DT critical_JJ threshold_NN p_NN \*_NN and_CC p_NN L_NNP is_VBZ chosen_VBN to_TO reflect_VB the_DT desired_VBN detectable_JJ deviation_NN from_IN that_DT threshold_NN 
It_PRP is_VBZ interesting_JJ to_TO note_VB that_IN when_WRB a_DT =_SYM 1_CD and_CC b_NN =_SYM 1_CD ,_, the_DT in_IN difference_NN prior_RB ,_, the_DT optimal_JJ decision_NN rule_NN is_VBZ equal_JJ to_TO 20_CD ,_, or_CC np_JJ \*_NN ._. 
Both_DT Bilukha_NNP and_CC Blanton_NNP 
Fan_NN 
For_IN example_NN ,_, in_IN 1996_CD Lattimore_NNP et_NNP al_RB used_VBD B-LQAS_NNP to_TO monitor_VB drug_NN use_NN in_IN Illinois_NNP ._. 
Now_RB ,_, B-LQAS_NNP has_VBZ made_VBN a_DT transition_NN into_IN the_DT economics_NNS and_CC operations_NNS research_NN literature_NN ._. 
In_IN that_DT application_NN ,_, the_DT sampling_NN plan_NN was_VBD determined_VBN by_IN minimizing_VBG expected_VBN cost_NN ,_, as_IN advocated_VBN by_IN Moskowitz_NNP et_FW al_FW 
Clearly_RB ,_, the_DT choice_NN of_IN prior_JJ distribution_NN is_VBZ an_DT important_JJ element_NN of_IN B_NNP -_: LQAS_NNP ._. 
For_IN use_NN with_IN panel_NN data_NNS ,_, or_CC repeated_VBN cross-sectional_JJ surveys_NNS over_IN regular_JJ intervals_NNS ,_, the_DT extension_NN of_IN the_DT above_JJ method_NN needs_VBZ investigating_VBG ._. 
One_CD alternative_NN to_TO complete_VB specification_NN of_IN the_DT prior_JJ is_VBZ to_TO let_VB the_DT data_NNS influence_VBP its_PRP$ shape_NN via_IN empirical_JJ Bayes_NNP procedures_NNS -LRB-_-LRB- see_VB ,_, pg_VB ._. 
122-126_CD for_IN further_JJ discussion_NN -RRB-_-RRB- ._. 
Regardless_RB ,_, the_DT prior_JJ can_NN have_VBP minor_JJ or_CC major_JJ influence_NN on_IN the_DT chosen_JJ design_NN ,_, depending_VBG on_IN the_DT situation_NN ._. 
However_RB ,_, it_PRP is_VBZ also_RB possible_JJ to_TO choose_VB p_NNP L_NNP =_SYM p_NNP U_NNP =_SYM p_JJ \*_NN ,_, which_WDT might_MD be_VB more_RBR appealing_JJ to_TO some_DT practitioners_NNS ._. 
This_DT latter_JJ case_NN is_VBZ discussed_VBN at_IN length_NN in_IN the_DT context_NN of_IN Phase_NN II_NNP clinical_JJ trials_NNS by_IN Wang_NNP et_FW al_FW ._. 
Ultimately_RB ,_, the_DT choice_NN depend_VBP on_IN the_DT application_NN and_CC the_DT priorities_NNS of_IN the_DT investigators_NNS ._. 
We_PRP discuss_VBP this_DT issue_NN further_RBR in_IN the_DT next_JJ section_NN ._. 
The_DT LQAS_NNP procedure_NN is_VBZ discussed_VBN in_IN depth_NN in_IN the_DT next_JJ section_NN ._. 
The_DT choice_NN of_IN sample_NN size_NN and_CC decision_NN rule_NN determine_VB the_DT degree_NN to_TO which_WDT one_PRP can_MD rely_VB on_IN this_DT classification_NN ._. 
Recently_RB ,_, Bilukha_NNP 
The_DT LQAS_NNP procedure_NN is_VBZ discussed_VBN in_IN depth_NN in_IN the_DT next_JJ section_NN ._. 
The_DT choice_NN of_IN sample_NN size_NN and_CC decision_NN rule_NN determine_VB the_DT degree_NN to_TO which_WDT one_PRP can_MD rely_VB on_IN this_DT classification_NN ._. 
Recently_RB ,_, Bilukha_NNP 
Recently_RB ,_, Bilukha_NNP 
We_PRP continue_VBP with_IN this_DT notation_NN to_TO provide_VB a_DT unified_JJ framework_NN ._. 
However_RB ,_, we_PRP might_MD think_VB of_IN Pass_NNP as_IN ``_`` qualifying_VBG for_IN humanitarian_JJ aid_NN ''_'' to_TO facilitate_VB the_DT interpretation_NN ._. 
The_DT interpretation_NN of_IN each_DT of_IN these_DT curves_NNS allows_VBZ us_PRP to_TO make_VB probabilistic_JJ statements_NNS about_IN the_DT parameter_NN of_IN interest_NN ,_, given_VBN the_DT results_NNS of_IN our_PRP$ diagnostic_JJ procedure_NN ;_: such_JJ as_IN statements_NNS like_IN those_DT made_VBN by_IN Bilukha_NNP and_CC Blanton_NNP ,_, which_WDT in_IN their_PRP$ context_NN are_VBP incorrect_JJ ._. 
Intuitively_RB ,_, it_PRP would_MD be_VB desireable_JJ to_TO control_VB for_IN the_DT probability_NN that_IN the_DT prevalence_NN is_VBZ low_JJ when_WRB we_PRP say_VBP it_PRP is_VBZ high_JJ -LRB-_-LRB- or_CC declare_VB a_DT Pass_NN -RRB-_-RRB- ,_, for_IN example_NN ,_, and_CC vice-versa_NN ._. 
It_PRP is_VBZ interesting_JJ to_TO note_VB that_IN when_WRB a_DT =_SYM 1_CD and_CC b_NN =_SYM 1_CD ,_, the_DT in_IN difference_NN prior_RB ,_, the_DT optimal_JJ decision_NN rule_NN is_VBZ equal_JJ to_TO 20_CD ,_, or_CC np_JJ \*_NN ._. 
Both_DT Bilukha_NNP and_CC Blanton_NNP 
The_DT Deitchler_NNP et_NNP al_IN LQAS_NNP designs_NNS serve_VBP as_IN a_DT natural_JJ place_NN to_TO begin_VB this_DT investigation_NN ._. 
It_PRP is_VBZ attractive_JJ to_TO have_VB the_DT ability_NN to_TO make_VB a_DT probability_NN statement_NN about_IN the_DT prevalence_NN of_IN malnutrition_NN ,_, even_RB though_IN it_PRP does_VBZ require_VB that_IN more_JJR structure_NN be_VB imposed_VBN on_IN the_DT model_NN ._. 
Classical_JJ LQAS_NNP has_VBZ generally_RB relied_VBN on_IN frequentist_JJ statistical_JJ principles_NNS ,_, particularly_RB in_IN its_PRP$ application_NN in_IN health_NN -LRB-_-LRB- see_VB for_IN over_IN 800_CD examples_NNS ,_, all_DT of_IN which_WDT take_VBP a_DT frequentist_JJ approach_NN -RRB-_-RRB- ._. 
Further_RB ,_, nowhere_RB in_IN the_DT health_NN literature_NN have_VBP Bayesian_JJ considerations_NNS been_VBN incorporated_VBN into_IN the_DT LQAS_NNP procedure_NN ,_, to_TO the_DT best_JJS of_IN our_PRP$ knowledge_NN ._. 
Further_RB ,_, nowhere_RB in_IN the_DT health_NN literature_NN have_VBP Bayesian_JJ considerations_NNS been_VBN incorporated_VBN into_IN the_DT LQAS_NNP procedure_NN ,_, to_TO the_DT best_JJS of_IN our_PRP$ knowledge_NN ._. 
Yet_RB ,_, Bayes-LQAS_NNP -LRB-_-LRB- B-LQAS_NNP -RRB-_-RRB- is_VBZ well-established_JJ in_IN the_DT industrial_JJ literature_NN ,_, where_WRB it_PRP is_VBZ known_VBN as_IN Bayesian_NNP Acceptance_NNP Sampling_NNP -LRB-_-LRB- see_VB ,_, and_CC references_NNS therein_RB -RRB-_-RRB- ._. 
As_RB early_RB as_IN the_DT 1960_CD 's_POS ,_, Brush_NNP examined_VBD classical_JJ and_CC Bayesian_JJ risks_NNS for_IN a_DT variety_NN of_IN sampling_NN plans_NNS 
Yet_RB ,_, Bayes_NNP -_: LQAS_NNP -LRB-_-LRB- B_NNP -_: LQAS_NNP -RRB-_-RRB- is_VBZ well-established_JJ in_IN the_DT industrial_JJ literature_NN ,_, where_WRB it_PRP is_VBZ known_VBN as_IN Bayesian_NNP Acceptance_NNP Sampling_NNP -LRB-_-LRB- see_VB ,_, and_CC references_NNS therein_RB -RRB-_-RRB- ._. 
As_RB early_RB as_IN the_DT 1960_CD 's_POS ,_, Brush_NNP examined_VBD classical_JJ and_CC Bayesian_JJ risks_NNS for_IN a_DT variety_NN of_IN sampling_NN plans_NNS 
More_RBR recently_RB ,_, Moskowitz_NNP considers_VBZ B-LQAS_NNP under_IN quadratic_JJ and_CC step-loss_JJ functions_NNS 
Indeed_RB ,_, such_JJ statements_NNS would_MD be_VB attractive_JJ and_CC desirable_JJ ,_, if_IN only_RB they_PRP were_VBD correct_JJ ._. 
It_PRP is_VBZ common_JJ for_IN novice_NN statisticians_NNS to_TO make_VB such_JJ statements_NNS as_IN ``_`` the_DT probability_NN that_IN the_DT prevalence_NN lies_VBZ within_IN the_DT confidence_NN interval_NN is_VBZ 95_CD %_NN ''_'' ,_, which_WDT is_VBZ ,_, of_IN course_NN ,_, incorrect_JJ in_IN the_DT frequentist_NN framework_NN ._. 
There_EX is_VBZ a_DT vehicle_NN for_IN making_VBG probability_NN statements_NNS about_IN distributions_NNS of_IN unknown_JJ parameters_NNS :_: Bayesian_JJ inference_NN ._. 
In_IN the_DT Bayesian_JJ framework_NN ,_, the_DT unknown_JJ parameter_NN is_VBZ treated_VBN not_RB as_IN a_DT constant_JJ ,_, but_CC as_IN a_DT random_JJ quantity_NN ,_, which_WDT varies_VBZ according_VBG to_TO some_DT probability_NN distribution_NN ._. 
and_CC for_IN a_DT given_VBN sample_NN size_NN ,_, one_PRP might_MD choose_VB the_DT decision_NN rule_NN to_TO maximize_VB this_DT quantity_NN ._. 
Amore_JJ automated_JJ design_NN selection_NN is_VBZ achieved_VBN by_IN using_VBG the_DT following_JJ Figure_NN of_IN Merit_NNP -LRB-_-LRB- FOM_NNP -RRB-_-RRB- ,_, -LRB-_-LRB- 6_CD -RRB-_-RRB- 
Thus_RB ,_, it_PRP may_MD be_VB more_RBR realistic_JJ to_TO model_VB the_DT prevalence_NN of_IN malnutrition_NN as_IN a_DT random_JJ quantity_NN over_IN time_NN rather_RB than_IN a_DT fixed_VBN quantity_NN ._. 
Deitchler_NNP et_NNP al_NNP found_VBD Lot_NN Quality_NNP Assurance_NNP Sampling_NNP -LRB-_-LRB- LQAS_NNP -RRB-_-RRB- to_TO be_VB a_DT useful_JJ tool_NN to_TO monitor_VB the_DT prevalence_NN of_IN Global_NNP Acute_NNP Malnutrition_NNP ,_, defined_VBN as_IN Weight-for-Height-Z-score_NNP 
In_IN this_DT paper_NN ,_, we_PRP discuss_VBP the_DT potential_JJ benefits_NNS of_IN using_VBG B-LQAS_NNP in_IN health_NN applications_NNS ._. 
In_IN that_DT application_NN ,_, the_DT sampling_NN plan_NN was_VBD determined_VBN by_IN minimizing_VBG expected_VBN cost_NN ,_, as_IN advocated_VBN by_IN Moskowitz_NNP et_FW al_FW 
Asatisfactory_NNP LQAS_NNP design_NN will_MD have_VB the_DT following_JJ properties_NNS :_: For_IN example_NN ,_, in_IN Figure_NNP 1_CD ,_, we_PRP see_VBP an_DT OC_NNP curve_NN with_IN n_NN =_SYM 200_CD and_CC d_SYM =_SYM 14_CD ,_, which_WDT corresponds_VBZ to_TO the_DT LQAS_NNP design_NN used_VBN by_IN Deitchler_NNP et_FW al_FW to_TO classify_VB the_DT prevalence_NN of_IN malnutrition_NN with_IN a_DT critical_JJ threshold_NN p_NN \*_NN =_SYM 0_CD ._. 
10_CD and_CC with_IN p_NNP U_NNP =_SYM 0_CD ._. 
10_CD and_CC p_VB L_NNP =_SYM 0_CD ._. 
05_CD ._. 
In_IN that_DT application_NN ,_, 
Thus_RB ,_, it_PRP may_MD be_VB more_RBR realistic_JJ to_TO model_VB the_DT prevalence_NN of_IN malnutrition_NN as_IN a_DT random_JJ quantity_NN over_IN time_NN rather_RB than_IN a_DT fixed_VBN quantity_NN ._. 
Deitchler_NNP et_NNP al_NNP found_VBD Lot_NN Quality_NNP Assurance_NNP Sampling_NNP -LRB-_-LRB- LQAS_NNP -RRB-_-RRB- to_TO be_VB a_DT useful_JJ tool_NN to_TO monitor_VB the_DT prevalence_NN of_IN Global_NNP Acute_NNP Malnutrition_NNP ,_, defined_VBN as_IN Weight-for-Height-Z-score_NNP 
In_IN this_DT paper_NN ,_, we_PRP discuss_VBP the_DT potential_JJ benefits_NNS of_IN using_VBG B-LQAS_NNP in_IN health_NN applications_NNS ._. 
In_IN that_DT application_NN ,_, the_DT sampling_NN plan_NN was_VBD determined_VBN by_IN minimizing_VBG expected_VBN cost_NN ,_, as_IN advocated_VBN by_IN Moskowitz_NNP et_FW al_FW 
Asatisfactory_NNP LQAS_NNP design_NN will_MD have_VB the_DT following_JJ properties_NNS :_: For_IN example_NN ,_, in_IN Figure_NNP 1_CD ,_, we_PRP see_VBP an_DT OC_NNP curve_NN with_IN n_NN =_SYM 200_CD and_CC d_SYM =_SYM 14_CD ,_, which_WDT corresponds_VBZ to_TO the_DT LQAS_NNP design_NN used_VBN by_IN Deitchler_NNP et_FW al_FW to_TO classify_VB the_DT prevalence_NN of_IN malnutrition_NN with_IN a_DT critical_JJ threshold_NN p_NN \*_NN =_SYM 0_CD ._. 
10_CD and_CC with_IN p_NNP U_NNP =_SYM 0_CD ._. 
10_CD and_CC p_VB L_NNP =_SYM 0_CD ._. 
05_CD ._. 
In_IN that_DT application_NN ,_, 
For_IN example_NN ,_, in_IN 1996_CD Lattimore_NNP et_NNP al_RB used_VBD B-LQAS_NNP to_TO monitor_VB drug_NN use_NN in_IN Illinois_NNP ._. 
Now_RB ,_, B-LQAS_NNP has_VBZ made_VBN a_DT transition_NN into_IN the_DT economics_NNS and_CC operations_NNS research_NN literature_NN ._. 
In_IN that_DT application_NN ,_, the_DT sampling_NN plan_NN was_VBD determined_VBN by_IN minimizing_VBG expected_VBN cost_NN ,_, as_IN advocated_VBN by_IN Moskowitz_NNP et_FW al_FW 
When_WRB a_DT =_SYM 2_CD and_CC b_NN =_SYM 10_CD ,_, this_DT corresponds_VBZ to_TO a_DT prior_JJ density_NN with_IN most_JJS of_IN its_PRP$ mass_NN below_IN 30_CD %_NN ,_, which_WDT is_VBZ a_DT realistic_JJ assumption_NN as_IN malnutrition_NN prevalence_NN is_VBZ rarely_RB as_RB high_JJ as_IN 30_CD %_NN ._. 
For_IN example_NN ,_, in_IN the_DT CE-DAT_NNP global_JJ database_NN of_IN over_IN 1400_CD malnutrition_NN surveys_NNS conducted_VBN in_IN emergency_NN situations_NNS ,_, only_RB 59_CD reported_VBD a_DT prevalence_NN as_RB high_JJ as_IN 30_CD %_NN in_IN children_NNS 6-59_CD months_NNS ._. 
However_RB ,_, we_PRP also_RB look_VBP at_IN the_DT case_NN where_WRB a_DT =_SYM 4_CD and_CC b_NN =_SYM 2_CD and_CC where_WRB a_DT =_SYM b_NN =_SYM 5_CD ,_, reflecting_VBG a_DT prior_JJ belief_NN that_IN the_DT prevalence_NN is_VBZ in_IN fact_NN quite_RB high_JJ ,_, even_RB though_IN this_DT condition_NN is_VBZ probably_RB quite_RB unlikely_JJ in_IN the_DT present_JJ context_NN ._. 
Both_DT Bilukha_NNP and_CC Blanton_NNP 
As_RB early_RB as_IN the_DT 1960_CD 's_POS ,_, Brush_NNP examined_VBD classical_JJ and_CC Bayesian_JJ risks_NNS for_IN a_DT variety_NN of_IN sampling_NN plans_NNS 
Brush_NNP ,_, and_CC Sharma_NNP and_CC Bhutani_NNP 
That_DT is_VBZ ,_, we_PRP let_VBP the_DT prior_JJ distribution_NN ,_, 
Fitzgerald_NNP looks_VBZ at_IN B-LQAS_JJ plans_NNS under_IN an_DT assumed_JJ mixture_NN prior_RB 
However_RB ,_, PWR_NNP may_MD provide_VB invalid_JJ results_NNS ,_, but_CC high_JJ levels_NNS of_IN internal_JJ consistency_NN ,_, if_IN participants_NNS ,_, who_WP were_VBD mostly_RB poor_JJ women_NNS ,_, ascribe_VBP a_DT greater_JJR weight_NN to_TO certain_JJ dimensions_NNS of_IN poverty_NN -LRB-_-LRB- for_IN example_NN ,_, being_VBG widowed_VBN -RRB-_-RRB- than_IN would_MD other_JJ groups_NNS in_IN society_NN ._. 
Survey_NN data_NNS included_VBD information_NN on_IN employment_NN ,_, educational_JJ status_NN and_CC asset-ownership_NN of_IN migrants_NNS ,_, since_IN temporary_JJ migrants_NNS are_VBP important_JJ contributors_NNS to_TO the_DT rural_JJ economy_NN in_IN South_NNP Africa_NNP ._. 
However_RB ,_, no_DT information_NN was_VBD available_JJ on_IN levels_NNS of_IN income_NN remittance_NN ._. 
PWR_NN participants_NNS may_MD be_VB poorly_RB informed_VBN about_IN the_DT wealth_NN of_IN migrants_NNS or_CC their_PRP$ levels_NNS of_IN remittance_NN ._. 
However_RB ,_, there_EX is_VBZ no_DT consensus_NN on_IN what_WP variables_NNS should_MD be_VB included_VBN in_IN such_JJ analyses_NNS ._. 
The_DT aggregation_NN of_IN such_JJ data_NNS can_MD be_VB achieved_VBN through_IN a_DT simple_JJ count_NN ,_, weighting_NN of_IN variables_NNS based_VBN on_IN local_JJ consultation_NN ,_, or_CC throu_NN 
PCA_NNP transforms_VBZ a_DT set_NN of_IN correlated_JJ variables_NNS into_IN a_DT set_NN of_IN uncorrelated_JJ `_`` components_NNS '_POS ._. 
The_DT remaining_VBG factors_NNS were_VBD included_VBN ._. 
When_WRB variables_NNS hold_VBP information_NN about_IN some_DT underlying_VBG concept_NN ,_, PCA_NNP can_MD produce_VB the_DT best_JJS single_JJ composite_JJ variable_NN among_IN all_DT possible_JJ linear_JJ functions_NNS of_IN the_DT original_JJ variables_NNS ._. 
The_DT component_NN explaining_VBG the_DT greatest_JJS proportion_NN of_IN the_DT total_JJ variance_NN is_VBZ called_VBN the_DT first_JJ principal_JJ component_NN ._. 
Analysis_NN Methods_NNS Setting_VBG The_DT study_NN was_VBD conducted_VBN in_IN eight_CD rural_JJ villages_NNS of_IN Limpopo_NNP Province_NNP ,_, South_NNP Africa_NNP ._. 
The_DT province_NN is_VBZ among_IN the_DT most_RBS deprived_VBN in_IN the_DT country_NN ,_, with_IN nearly_RB 50_CD %_NN of_IN the_DT population_NN under_IN 15_CD years_NNS old_JJ ,_, unemployment_NN in_IN excess_NN of_IN 40_CD %_NN ,_, and_CC high_JJ levels_NNS of_IN labor_NN migration_NN 
However_RB ,_, the_DT high_JJ level_NN of_IN internal_JJ consistency_NN for_IN the_DT household_NN wealth_NN ranks_NNS obtained_VBN from_IN three_CD separate_JJ groups_NNS of_IN PWR_NNP participants_NNS provided_VBD some_DT evidence_NN against_IN this_DT ._. 
This_DT finding_NN differs_VBZ from_IN a_DT previous_JJ report_NN of_IN low_JJ reliability_NN for_IN group-informant_JJ food-security_JJ ratings_NNS ._. 
However_RB ,_, reasons_NNS for_IN the_DT low_JJ reliability_NN reported_VBN by_IN those_DT authors_NNS were_VBD addressed_VBN in_IN this_DT study_NN since_IN trained_JJ facilitators_NNS worked_VBD with_IN a_DT homogenous_JJ group_NN of_IN PWR_NNP participants_NNS at_IN all_DT rankings_NNS and_CC emphasised_VBD local_JJ definitions_NNS of_IN poverty_NN ,_, participation_NN and_CC consensus_NN ._. 
The_DT survey_NN attempted_VBD to_TO maximize_VB accurate_JJ reporting_NN through_IN collecting_VBG data_NNS on_IN objective_JJ indicators_NNS ,_, fieldworker_NN training_NN and_CC stressing_VBG the_DT importance_NN of_IN honesty_NN to_TO participants_NNS ._. 
Nevertheless_RB ,_, reporting_VBG biases_NNS may_MD have_VB occurred_VBN ._. 
PWR_NNP partially_RB accounts_VBZ for_IN this_DT ,_, since_IN information_NN is_VBZ acquired_VBN from_IN neighbors_NNS and_CC is_VBZ triangulated_VBN ._. 
This_DT component_NN was_VBD normally_RB distributed_VBN and_CC had_VBD a_DT mean_NN of_IN 0_CD and_CC a_DT standard_JJ deviation_NN of_IN 1_CD ._. 
Awealth_JJ index_NN was_VBD calculated_VBN for_IN households_NNS where_WRB data_NNS were_VBD available_JJ on_IN all_DT variables_NNS ._. 
Statistical_NNP analysis_NN of_IN consistency_NN and_CC agreementFor_NNP the_DT PWR_NNP method_NN only_RB ,_, the_DT intra-cluster_JJ correlation_NN coefficient_NN ,_, a_DT measure_NN of_IN internal_JJ consistency_NN ,_, was_VBD first_RB calculated_VBN from_IN a_DT random-effects_JJ ANOVA_NNP to_TO describe_VB the_DT level_NN of_IN agreement_NN in_IN rankings_NNS of_IN wealth_NN between_IN each_DT of_IN the_DT three_CD rankings_NNS made_VBN for_IN each_DT household_NN ._. 
Secondly_RB ,_, the_DT association_NN of_IN each_DT index_NN with_IN the_DT individual_JJ survey_NN indicators_NNS was_VBD estimated_VBN ._. 
Households_NNS were_VBD divided_VBN into_IN wealth-rank_JJ tertiles_NNS on_IN the_DT basis_NN of_IN each_DT of_IN the_DT methods_NNS ._. 
The_DT first_JJ used_JJ data_NNS only_RB from_IN the_DT participatory_JJ wealth_NN ranking_NN ;_: the_DT second_JJ used_JJ data_NNS from_IN the_DT household_NN survey_NN ,_, but_CC with_IN their_PRP$ selection_NN and_CC weighting_NN informed_VBN by_IN PWR_NNP ;_: the_DT third_JJ used_JJ only_JJ data_NNS from_IN the_DT survey_NN ,_, employing_VBG principal_JJ components_NNS analysis_NN -LRB-_-LRB- PCA_NNP -RRB-_-RRB- to_TO determine_VB the_DT weights_NNS ._. 
Method_NN 1_CD :_: an_DT index_NN of_IN household_NN wealth_NN from_IN PWRDetails_NNS of_IN the_DT scoring_VBG method_NN used_VBN are_VBP provided_VBN in_IN detail_NN elsewhere_RB ._. 
Briefly_RB ,_, within_IN each_DT of_IN the_DT three_CD ranking_JJ processes_NNS ,_, piles_NNS of_IN households_NNS were_VBD assigned_VBN a_DT score_NN such_JJ that_IN the_DT wealthiest_JJS pile_NN received_VBD a_DT score_NN of_IN 100_CD and_CC the_DT poorest_JJS pile_NN a_DT score_NN of_IN 0_CD ._. 
Data_NNP collection_NN Participatory_NNP Wealth_NNP Ranking_NNP -LRB-_-LRB- PWR_NNP -RRB-_-RRB- PWR_NNP was_VBD conducted_VBN in_IN the_DT local_JJ language_NN by_IN specialised_JJ facilitators_NNS from_IN a_DT local_JJ development_NN NGO_NNP -LRB-_-LRB- Small_NNP Enterprise_NNP Foundation_NNP ,_, Tzaneen_NNP -RRB-_-RRB- ._. 
Data_NNS were_VBD recorded_VBN on_IN pre-designed_JJ data_NNS collection_NN forms_NNS ._. 
Community_NNP members_NNS residing_VBG in_IN the_DT same_JJ village_NN section_NN ,_, most_RBS often_RB women_NNS from_IN poor_JJ households_NNS ,_, drew_VBD a_DT map_NN of_IN their_PRP$ residential_JJ area_NN and_CC listed_VBD the_DT households_NNS on_IN cards_NNS ._. 
Data_NNP collection_NN Participatory_NNP Wealth_NNP Ranking_NNP -LRB-_-LRB- PWR_NNP -RRB-_-RRB- PWR_NNP was_VBD conducted_VBN in_IN the_DT local_JJ language_NN by_IN specialised_JJ facilitators_NNS from_IN a_DT local_JJ development_NN NGO_NNP -LRB-_-LRB- Small_NNP Enterprise_NNP Foundation_NNP ,_, Tzaneen_NNP -RRB-_-RRB- ._. 
Data_NNS were_VBD recorded_VBN on_IN pre-designed_JJ data_NNS collection_NN forms_NNS ._. 
Community_NNP members_NNS residing_VBG in_IN the_DT same_JJ village_NN section_NN ,_, most_RBS often_RB women_NNS from_IN poor_JJ households_NNS ,_, drew_VBD a_DT map_NN of_IN their_PRP$ residential_JJ area_NN and_CC listed_VBD the_DT households_NNS on_IN cards_NNS ._. 
The_DT province_NN is_VBZ among_IN the_DT most_RBS deprived_VBN in_IN the_DT country_NN ,_, with_IN nearly_RB 50_CD %_NN of_IN the_DT population_NN under_IN 15_CD years_NNS old_JJ ,_, unemployment_NN in_IN excess_NN of_IN 40_CD %_NN ,_, and_CC high_JJ levels_NNS of_IN labor_NN migration_NN 
Analysis_NN Methods_NNS Setting_VBG The_DT study_NN was_VBD conducted_VBN in_IN eight_CD rural_JJ villages_NNS of_IN Limpopo_NNP Province_NNP ,_, South_NNP Africa_NNP ._. 
The_DT province_NN is_VBZ among_IN the_DT most_RBS deprived_VBN in_IN the_DT country_NN ,_, with_IN nearly_RB 50_CD %_NN of_IN the_DT population_NN under_IN 15_CD years_NNS old_JJ ,_, unemployment_NN in_IN excess_NN of_IN 40_CD %_NN ,_, and_CC high_JJ levels_NNS of_IN labor_NN migration_NN 
This_DT approach_NN is_VBZ widely_RB used_VBN in_IN development_NN practice_NN ,_, but_CC rarely_RB used_VBN in_IN health_NN studies_NNS ._. 
An_DT alternative_JJ technique_NN is_VBZ to_TO use_VB participatory_JJ wealth_NN ranking_NN -LRB-_-LRB- PWR_NNP -RRB-_-RRB- ,_, in_IN which_WDT community_NN members_NNS rank_VBP the_DT wealth_NN of_IN households_NNS in_IN their_PRP$ community_NN ._. 
PWR_NNP can_MD generate_VB useful_JJ statistics_NNS and_CC provide_VB valid_JJ information_NN on_IN relative_JJ wealth_NN 
^This_NN statements_NNS is_VBZ not_RB listed_VBN in_IN Table_NNP 1_CD because_IN it_PRP was_VBD made_VBN less_JJR than_IN 15_CD times_NNS in_IN one_CD stage_NN ,_, but_CC was_VBD the_DT second_JJ most_RBS common_JJ single_JJ statement_NN about_IN family_NN and_CC household_NN made_VBN during_IN the_DT PWR_NNP process_NN Method_NNP 3_CD :_: an_DT index_NN of_IN household_NN wealth_NN from_IN household_NN survey_NN data_NNS with_IN weightings_NNS assigned_VBN by_IN PCA_NNP Fourteen_CD variables_NNS capturing_VBG salient_JJ aspects_NNS of_IN household_NN wealth_NN ,_, decided_VBD upon_IN a_DT priori_FW following_VBG literature_NN review_NN and_CC piloting_VBG in_IN the_DT local_JJ area_NN ,_, were_VBD made_VBN available_JJ for_IN entry_NN into_IN the_DT PCA_NNP ._. 
Items_NNS included_VBD were_VBD not_RB limited_VBN to_TO durable_JJ assets_NNS -LRB-_-LRB- Table_NNP 3_CD -RRB-_-RRB- ._. 
Asset_NNP values_NNS were_VBD derived_VBN from_IN the_DT survey_NN data_NNS by_IN multiplying_VBG the_DT number_NN of_IN owned_JJ assets_NNS that_WDT were_VBD new_JJ -LRB-_-LRB- less_JJR than_IN 2_CD years_NNS -RRB-_-RRB- ,_, relatively_RB new_JJ -LRB-_-LRB- 2_CD 
PCA_NNP assigns_VBZ weights_NNS to_TO variables_NNS according_VBG to_TO mathematical_JJ rules_NNS ,_, while_IN wealth_NN ranking_NN participants_NNS assess_VBP households_NNS in_IN ways_NNS that_WDT are_VBP complex_JJ and_CC non-transparent_JJ ._. 
Our_PRP$ approach_NN to_TO PCA_NNP incorporated_JJ different_JJ facets_NNS of_IN wealth_NN ,_, as_IN in_IN previous_JJ applications_NNS ,_, and_CC drew_VBD out_RP the_DT common_JJ underlying_JJ correlation_NN between_IN them_PRP ._. 
However_RB ,_, the_DT first_JJ principal_JJ component_NN explained_VBD only_RB 22_CD ._. 
7%_CD of_IN the_DT total_JJ variance_NN ,_, suggesting_VBG that_IN factors_NNS included_VBN were_VBD not_RB well_RB correlated_JJ ._. 
These_DT have_VBP included_VBN shortened_JJ income_NN or_CC expenditure_NN questionnaires_NNS ,_, and_CC measures_NNS of_IN housing_NN quality_NN ,_, education_NN or_CC nutritional_JJ status_NN Recently_RB ,_, researchers_NNS have_VBP used_VBN statistical_JJ techniques_NNS to_TO combine_VB multiple_JJ socioeconomic_JJ variables_NNS ,_, usually_RB including_VBG at_IN least_JJS data_NNS on_IN housing_NN and_CC ownership_NN of_IN fixed_VBN assets_NNS ,_, into_IN a_DT measure_NN of_IN household_NN wealth_NN ._. 
The_DT aggregation_NN of_IN such_JJ data_NNS can_MD be_VB achieved_VBN through_IN a_DT simple_JJ count_NN ,_, weighting_NN of_IN variables_NNS based_VBN on_IN local_JJ consultation_NN ,_, or_CC through_IN the_DT application_NN of_IN statistical_JJ procedures_NNS such_JJ as_IN principal_JJ components_NNS analysis_NN -LRB-_-LRB- PCA_NNP -RRB-_-RRB- 
This_DT approach_NN is_VBZ widely_RB used_VBN in_IN development_NN practice_NN ,_, but_CC rarely_RB used_VBN in_IN health_NN studies_NNS ._. 
An_DT alternative_JJ technique_NN is_VBZ to_TO use_VB participatory_JJ wealth_NN ranking_NN -LRB-_-LRB- PWR_NNP -RRB-_-RRB- ,_, in_IN which_WDT community_NN members_NNS rank_VBP the_DT wealth_NN of_IN households_NNS in_IN their_PRP$ community_NN ._. 
PWR_NNP can_MD generate_VB useful_JJ statistics_NNS and_CC provide_VB valid_JJ information_NN on_IN relative_JJ wealth_NN 
Background_NN Research_NN into_IN the_DT socioeconomic_JJ determinants_NNS of_IN health_NN requires_VBZ accurate_JJ tools_NNS for_IN assessing_VBG socioeconomic_JJ position_NN ._. 
While_IN in_IN developed_JJ countries_NNS pre-existing_JJ data_NNS are_VBP often_RB available_JJ ,_, these_DT resources_NNS rarely_RB exist_VBP in_IN developing_VBG countries_NNS and_CC original_JJ data_NNS must_MD be_VB collected_VBN ._. 
Economists_NNS generally_RB regard_VBP detailed_JJ data_NNS on_IN household_NN income_NN and\/or_CC expenditure_NN as_IN the_DT gold-standard_JJ measure_NN of_IN current_JJ socioeconomic_JJ position_NN ._. 
Avariety_NNP of_IN proxy_JJ measures_NNS of_IN socioeconomic_JJ position_NN have_VBP been_VBN developed_VBN ._. 
Consequently_RB ,_, rapid_JJ techniques_NNS for_IN assessing_VBG household_NN wealth_NN are_VBP needed_VBN ._. 
These_DT have_VBP included_VBN shortened_JJ income_NN or_CC expenditure_NN questionnaires_NNS ,_, and_CC measures_NNS of_IN housing_NN quality_NN ,_, education_NN or_CC nutritional_JJ status_NN Recently_RB ,_, researchers_NNS have_VBP used_VBN statistical_JJ techniques_NNS to_TO combine_VB multiple_JJ socioeconomic_JJ variables_NNS ,_, usually_RB including_VBG at_IN least_JJS data_NNS on_IN housing_NN and_CC ownership_NN of_IN fixed_VBN assets_NNS ,_, into_IN a_DT measure_NN of_IN household_NN wealth_NN ._. 
The_DT aggregation_NN of_IN such_JJ data_NNS can_MD be_VB achieved_VBN through_IN a_DT simple_JJ count_NN ,_, weighting_NN of_IN variables_NNS based_VBN on_IN local_JJ consultation_NN ,_, or_CC through_IN the_DT application_NN of_IN statistical_JJ procedures_NNS such_JJ as_IN principal_JJ components_NNS analysis_NN -LRB-_-LRB- PCA_NNP -RRB-_-RRB- 
These_DT have_VBP included_VBN shortened_JJ income_NN or_CC expenditure_NN questionnaires_NNS ,_, and_CC measures_NNS of_IN housing_NN quality_NN ,_, education_NN or_CC nutritional_JJ status_NN Recently_RB ,_, researchers_NNS have_VBP used_VBN statistical_JJ techniques_NNS to_TO combine_VB multiple_JJ socioeconomic_JJ variables_NNS ,_, usually_RB including_VBG at_IN least_JJS data_NNS on_IN housing_NN and_CC ownership_NN of_IN fixed_VBN assets_NNS ,_, into_IN a_DT measure_NN of_IN household_NN wealth_NN ._. 
The_DT aggregation_NN of_IN such_JJ data_NNS can_MD be_VB achieved_VBN through_IN a_DT simple_JJ count_NN ,_, weighting_NN of_IN variables_NNS based_VBN on_IN local_JJ consultation_NN ,_, or_CC through_IN the_DT application_NN of_IN statistical_JJ procedures_NNS such_JJ as_IN principal_JJ components_NNS analysis_NN -LRB-_-LRB- PCA_NNP -RRB-_-RRB- 
An_DT alternative_JJ technique_NN is_VBZ to_TO use_VB participatory_JJ wealth_NN ranking_NN -LRB-_-LRB- PWR_NNP -RRB-_-RRB- ,_, in_IN which_WDT community_NN members_NNS rank_VBP the_DT wealth_NN of_IN households_NNS in_IN their_PRP$ community_NN ._. 
This_DT approach_NN is_VBZ widely_RB used_VBN in_IN development_NN practice_NN 
However_RB ,_, PWR_NNP may_MD provide_VB invalid_JJ results_NNS ,_, but_CC high_JJ levels_NNS of_IN internal_JJ consistency_NN ,_, if_IN participants_NNS ,_, who_WP were_VBD mostly_RB poor_JJ women_NNS ,_, ascribe_VBP a_DT greater_JJR weight_NN to_TO certain_JJ dimensions_NNS of_IN poverty_NN -LRB-_-LRB- for_IN example_NN ,_, being_VBG widowed_VBN -RRB-_-RRB- than_IN would_MD other_JJ groups_NNS in_IN society_NN ._. 
Survey_NN data_NNS included_VBD information_NN on_IN employment_NN ,_, educational_JJ status_NN and_CC asset-ownership_NN of_IN migrants_NNS ,_, since_IN temporary_JJ migrants_NNS are_VBP important_JJ contributors_NNS to_TO the_DT rural_JJ economy_NN in_IN South_NNP Africa_NNP ._. 
However_RB ,_, no_DT information_NN was_VBD available_JJ on_IN levels_NNS of_IN income_NN remittance_NN ._. 
PWR_NN participants_NNS may_MD be_VB poorly_RB informed_VBN about_IN the_DT wealth_NN of_IN migrants_NNS or_CC their_PRP$ levels_NNS of_IN remittance_NN ._. 
The_DT aggregation_NN of_IN such_JJ data_NNS can_MD be_VB achieved_VBN through_IN a_DT simple_JJ count_NN ,_, weighting_NN of_IN variables_NNS based_VBN on_IN local_JJ consultation_NN ,_, or_CC through_IN the_DT application_NN of_IN statistical_JJ procedures_NNS such_JJ as_IN principal_JJ components_NNS analysis_NN -LRB-_-LRB- PCA_NNP -RRB-_-RRB- 
However_RB ,_, there_EX is_VBZ no_DT consensus_NN on_IN what_WP variables_NNS should_MD be_VB included_VBN in_IN such_JJ analyses_NNS ._. 
The_DT aggregation_NN of_IN such_JJ data_NNS can_MD be_VB achieved_VBN through_IN a_DT simp_NN 
The_DT effect_NN of_IN measurement_NN error_NN and_CC misclassification_NN on_IN LRs_NNP could_MD not_RB be_VB found_VBN in_IN the_DT currently_RB available_JJ peer-reviewed_JJ literature_NN ._. 
The_DT direction_NN of_IN bias_NN in_IN estimates_NNS of_IN ORs_NNS and_CC risk_NN ratios_NNS with_IN differential_JJ misclassification_NN can_MD not_RB be_VB predicted_VBN ,_, however_RB ,_, non-differential_JJ misclassification_NN of_IN an_DT exposure_NN has_VBZ been_VBN shown_VBN to_TO result_VB in_IN measures_NNS of_IN association_NN to_TO be_VB consistently_RB biased_VBN towards_IN the_DT null_NN when_WRB evaluated_VBN in_IN a_DT 2_CD 
The_DT effect_NN of_IN measurement_NN error_NN and_CC misclassification_NN on_IN LRs_NNP could_MD not_RB be_VB found_VBN in_IN the_DT currently_RB available_JJ peer-reviewed_JJ literature_NN ._. 
The_DT direction_NN of_IN bias_NN in_IN estimates_NNS of_IN ORs_NNS and_CC risk_NN ratios_NNS with_IN differential_JJ misclassification_NN can_MD not_RB be_VB predicted_VBN ,_, however_RB ,_, non-differential_JJ misclassification_NN of_IN an_DT exposure_NN has_VBZ been_VBN shown_VBN to_TO result_VB in_IN measures_NNS of_IN association_NN to_TO be_VB consistently_RB biased_VBN towards_IN the_DT null_NN when_WRB evaluated_VBN in_IN a_DT 2_CD 
The_DT direction_NN of_IN bias_NN in_IN estimates_NNS of_IN ORs_NNS and_CC risk_NN ratios_NNS with_IN differential_JJ misclassification_NN can_MD not_RB be_VB predicted_VBN ,_, however_RB ,_, non-differential_JJ misclassification_NN of_IN an_DT exposure_NN has_VBZ been_VBN shown_VBN to_TO result_VB in_IN measures_NNS of_IN association_NN to_TO be_VB consistently_RB biased_VBN towards_IN the_DT null_NN when_WRB evaluated_VBN in_IN a_DT 2_CD 
The_DT effect_NN of_IN measurement_NN error_NN and_CC misclassification_NN on_IN LRs_NNP could_MD not_RB be_VB found_VBN in_IN the_DT currently_RB available_JJ peer-reviewed_JJ literature_NN ._. 
The_DT direction_NN of_IN bias_NN in_IN estimates_NNS of_IN ORs_NNS and_CC risk_NN ratios_NNS with_IN differential_JJ misclassification_NN can_MD not_RB be_VB predicted_VBN ,_, however_RB ,_, non-differential_JJ misclassification_NN of_IN an_DT exposure_NN has_VBZ been_VBN shown_VBN to_TO result_VB in_IN measures_NNS of_IN association_NN to_TO be_VB consistently_RB biased_VBN towards_IN the_DT null_NN when_WRB evaluated_VBN in_IN a_DT 2_CD 
The_DT effect_NN of_IN measurement_NN error_NN and_CC misclassification_NN on_IN LRs_NNP could_MD not_RB be_VB found_VBN in_IN the_DT currently_RB available_JJ peer-reviewed_JJ literature_NN ._. 
The_DT direction_NN of_IN bias_NN in_IN estimates_NNS of_IN ORs_NNS and_CC risk_NN ratios_NNS with_IN differential_JJ misclassification_NN can_MD not_RB be_VB predicted_VBN ,_, however_RB ,_, non-differential_JJ misclassification_NN of_IN an_DT exposure_NN has_VBZ been_VBN shown_VBN to_TO result_VB in_IN measures_NNS of_IN association_NN to_TO be_VB consistently_RB biased_VBN towards_IN the_DT null_NN when_WRB evaluated_VBN in_IN a_DT 2_CD 
The_DT effect_NN of_IN measurement_NN error_NN and_CC misclassification_NN on_IN LRs_NNP could_MD not_RB be_VB found_VBN in_IN the_DT currently_RB available_JJ peer-reviewed_JJ literature_NN ._. 
The_DT direction_NN of_IN bias_NN in_IN estimates_NNS of_IN ORs_NNS and_CC risk_NN ratios_NNS with_IN differential_JJ misclassification_NN can_MD not_RB be_VB predicted_VBN ,_, however_RB ,_, non-differential_JJ misclassification_NN of_IN an_DT exposure_NN has_VBZ been_VBN shown_VBN to_TO result_VB in_IN measures_NNS of_IN association_NN to_TO be_VB consistently_RB biased_VBN towards_IN the_DT null_NN when_WRB evaluated_VBN in_IN a_DT 2_CD 
The_DT effect_NN of_IN measurement_NN error_NN and_CC misclassification_NN on_IN LRs_NNP could_MD not_RB be_VB found_VBN in_IN the_DT currently_RB available_JJ peer-reviewed_JJ literature_NN ._. 
The_DT direction_NN of_IN bias_NN in_IN estimates_NNS of_IN ORs_NNS and_CC risk_NN ratios_NNS with_IN differential_JJ misclassification_NN can_MD not_RB be_VB predicted_VBN ,_, however_RB ,_, non-differential_JJ misclassification_NN of_IN an_DT exposure_NN has_VBZ been_VBN shown_VBN to_TO result_VB in_IN measures_NNS of_IN association_NN to_TO be_VB consistently_RB biased_VBN towards_IN the_DT null_NN when_WRB evaluated_VBN in_IN a_DT 2_CD 
The_DT direction_NN of_IN bias_NN in_IN estimates_NNS of_IN ORs_NNS and_CC risk_NN ratios_NNS with_IN differential_JJ misclassification_NN can_MD not_RB be_VB predicted_VBN ,_, however_RB ,_, non-differential_JJ misclassification_NN of_IN an_DT exposure_NN has_VBZ been_VBN shown_VBN to_TO result_VB in_IN measures_NNS of_IN association_NN to_TO be_VB consistently_RB biased_VBN towards_IN the_DT null_NN when_WRB evaluated_VBN in_IN a_DT 2_CD 
The_DT direction_NN of_IN bias_NN in_IN estimates_NNS of_IN ORs_NNS and_CC risk_NN ratios_NNS with_IN differential_JJ misclassification_NN can_MD not_RB be_VB predicted_VBN ,_, however_RB ,_, non-differential_JJ misclassification_NN of_IN an_DT exposure_NN has_VBZ been_VBN shown_VBN to_TO result_VB in_IN measures_NNS of_IN association_NN to_TO be_VB consistently_RB biased_VBN towards_IN the_DT null_NN when_WRB evaluated_VBN in_IN a_DT 2_CD 
When_WRB the_DT exposure_NN is_VBZ classified_VBN into_IN more_JJR than_IN two_CD categories_NNS -LRB-_-LRB- higher-order_JJ tables_NNS -RRB-_-RRB- the_DT direction_NN of_IN deviation_NN is_VBZ no_DT longer_RBR consistently_RB towards_IN the_DT null_JJ value_NN with_IN non-differential_JJ misclassification_NN 
If_IN non-differential_JJ misclassification_NN occurs_VBZ only_RB between_IN exposure_NN levels_NNS 2_CD and_CC 3_CD ,_, for_IN instance_NN ,_, then_RB the_DT usual_JJ ORs_NNP could_MD be_VB biased_VBN towards_IN or_CC away_RB from_IN the_DT null_JJ value_NN ,_, however_RB ,_, the_DT OR_NNP calculated_VBD between_IN level_NN 2_CD and_CC level_NN 3_CD -LRB-_-LRB- not_RB usually_RB reported_VBN -RRB-_-RRB- would_MD consistently_RB be_VB biased_VBN towards_IN the_DT null_NN ._. 
The_DT exception_NN to_TO this_DT rule_NN is_VBZ when_WRB misclassification_NN is_VBZ so_RB extreme_JJ that_IN the_DT probability_NN of_IN incorrect_JJ classification_NN is_VBZ more_RBR likely_JJ than_IN correct_JJ classification_NN 
NA_NNP =_SYM not_RB applicable_JJ ._. 
The_DT null_JJ value_NN of_IN a_DT LR_NNP is_VBZ one_CD ,_, which_WDT would_MD correspond_VB to_TO a_DT particular_JJ test_NN result_NN being_VBG equally_RB likely_JJ in_IN infected_JJ and_CC uninfected_JJ individuals_NNS -LRB-_-LRB- would_MD not_RB affect_VB prior_JJ probabilities_NNS -RRB-_-RRB- ._. 
Aprevious_JJ study_NN demonstrated_VBD that_IN non-differential_JJ ,_, random_JJ measurement_NN error_NN in_IN exposure_NN determination_NN without_IN a_DT systematic_JJ component_NN ,_, consistently_RB led_VBN to_TO attenuation_NN in_IN effect_NN measures_NNS such_JJ as_IN the_DT OR_NNP ._. 
Results_NNS for_IN diagnostic_JJ ORs_NNS agreed_VBD with_IN this_DT previous_JJ finding_NN ;_: however_RB ,_, LRs_NNP estimated_VBD in_IN the_DT present_JJ study_NN were_VBD not_RB consistently_RB biased_VBN towards_IN the_DT null_JJ value_NN ._. 
The_DT proportion_NN of_IN individuals_NNS misclassified_VBN in_IN the_DT four_CD test_NN result_NN categories_NNS does_VBZ not_RB appear_VB to_TO be_VB equal_JJ between_IN infected_JJ and_CC uninfected_JJ individuals_NNS ._. 
Asimilar_JJ finding_NN has_VBZ been_VBN reported_VBN for_IN non-differential_JJ measurement_NN error_NN of_IN exposure_NN ._. 
In_IN this_DT study_NN ,_, however_RB ,_, it_PRP is_VBZ impossible_JJ to_TO know_VB which_WDT particular_JJ individuals_NNS were_VBD misclassified_VBN because_IN only_JJ total_JJ counts_NNS could_MD be_VB calculated_VBN and_CC an_DT accurate_JJ assessment_NN of_IN the_DT magnitude_NN of_IN misclassification_NN could_MD not_RB be_VB determined_VBN ._. 
NA_NNP =_SYM not_RB applicable_JJ ._. 
The_DT proportion_NN of_IN individuals_NNS misclassified_VBN in_IN the_DT four_CD test_NN result_NN categories_NNS does_VBZ not_RB appear_VB to_TO be_VB equal_JJ between_IN infected_JJ and_CC uninfected_JJ individuals_NNS ._. 
Asimilar_JJ finding_NN has_VBZ been_VBN reported_VBN for_IN non-differential_JJ measurement_NN error_NN of_IN exposure_NN 
Larger_JJR test_NN result_NN categories_NNS are_VBP more_RBR positive_JJ -LRB-_-LRB- 0_CD ._. 
The_DT observed_JJ bias_NN towards_IN one_CD causes_VBZ a_DT test_NN result_NN falling_VBG within_IN this_DT category_NN to_TO be_VB less_RBR useful_JJ for_IN that_DT purpose_NN ._. 
30_CD is_VBZ the_DT usual_JJ positive_JJ cutoff_NN for_IN the_DT brucellosis_NN c-ELISA_NN -RRB-_-RRB- and_CC therefore_RB a_DT higher_JJR post-test_JJ probability_NN of_IN infection_NN -LRB-_-LRB- compared_VBN to_TO pre-test_JJ probability_NN -RRB-_-RRB- would_MD be_VB the_DT desired_VBN effect_NN ._. 
All_DT error_NN structures_NNS resulted_VBD in_IN LRs_NNP for_IN these_DT categories_NNS to_TO be_VB biased_VBN towards_IN zero_NN ,_, which_WDT means_VBZ that_IN the_DT test_NN is_VBZ less_RBR useful_JJ for_IN this_DT purpose_NN -LRB-_-LRB- calculated_JJ post-test_JJ probability_NN of_IN infection_NN lower_JJR than_IN the_DT true_JJ value_NN -RRB-_-RRB- ._. 
01_CD intervals_NNS ._. 
99_CD PI_NNP at_IN 0_CD ._. 
01_CD to_TO 0_CD ._. 
Sensitivity_NN and_CC specificity_NN were_VBD calculated_VBN for_IN the_DT c-ELISA_NN at_IN all_DT possible_JJ cutoff_NN values_NNS from_IN 0_CD ._. 
Area_NN under_IN the_DT ROC_NNP curve_NN was_VBD calculated_VBN as_IN an_DT overall_JJ measure_NN of_IN diagnostic_JJ accuracy_NN using_VBG the_DT trapezoid_NN method_NN ._. 
The_DT average_JJ sensitivity_NN between_IN adjacent_JJ cutoffs_NNS was_VBD the_DT mean_JJ height_NN of_IN the_DT trapezoid_NN and_CC base_NN width_NN was_VBD the_DT difference_NN in_IN adjacent_JJ specificities_NNS ._. 
50_CD PI_NNP ._. 
499_CD ,_, and_CC 
These_DT observations_NNS did_VBD not_RB unduly_RB influence_VB the_DT analysis_NN because_IN they_PRP were_VBD considered_VBN equivalent_JJ to_TO the_DT boundary_NN categories_NNS ._. 
Likelihood_NN ratios_NNS are_VBP derived_VBN from_IN the_DT odds_NNS version_NN of_IN Bayes_NNP '_POS theorem_NN ,_, correspond_VBP to_TO the_DT added_VBN information_NN provided_VBN by_IN a_DT test_NN ,_, and_CC are_VBP used_VBN to_TO update_VB the_DT prior_JJ odds_NNS of_IN infection_NN ._. 
The_DT null_JJ value_NN of_IN a_DT LR_NNP is_VBZ one_CD ,_, which_WDT would_MD correspond_VB to_TO a_DT particular_JJ test_NN result_NN being_VBG equally_RB likely_JJ in_IN infected_JJ and_CC uninfected_JJ individuals_NNS -LRB-_-LRB- would_MD not_RB affect_VB prior_JJ probabilities_NNS -RRB-_-RRB- ._. 
The_DT observed_JJ mean_JJ OD_NNP values_NNS for_IN test_NN sera_NN and_CC conjugate-only_JJ controls_NNS from_IN each_DT ELISA_NNP plate_NN were_VBD assumed_VBN to_TO represent_VB the_DT true_JJ biologic_JJ value_NN for_IN purpose_NN of_IN these_DT simulations_NNS ._. 
Commercially_RB available_JJ software_NN was_VBD used_VBN to_TO incorporate_VB error_NN distributions_NNS to_TO both_DT sample_NN and_CC control_NN mean_NN values_NNS independently_RB ._. 
After_IN addition_NN of_IN error_NN to_TO original_JJ mean_JJ OD_NNP values_NNS ,_, the_DT PI_NNP was_VBD re-calculated_JJ for_IN each_DT sample_NN ._. 
Conjugate-only_JJ control_NN samples_NNS contain_VBP no_DT competing_VBG antibodies_NNS and_CC therefore_RB the_DT color_NN change_NN -LRB-_-LRB- i._SYM 
abortus_NN and_CC the_DT data_NNS used_VBN for_IN this_DT simulation_NN study_NN are_VBP results_NNS from_IN a_DT brucellosis_NN competitive_JJ ELISA_NNP -LRB-_-LRB- c-ELISA_NNP -RRB-_-RRB- in_IN 391_CD cattle_NNS and_CC 381_CD domestic_JJ water_NN buffalo_NN -LRB-_-LRB- Bubalus_FW bubalis_FW -RRB-_-RRB- of_IN Trinidad_NNP ._. 
Evaluation_NN of_IN this_DT assay_NN has_VBZ been_VBN reported_VBN elsewhere_RB 
Cattle_NNP and_CC domestic_JJ water_NN buffalo_NN in_IN Trinidad_NNP have_VBP been_VBN found_VBN to_TO be_VB infected_VBN with_IN B._NNP suis_NNS -LRB-_-LRB- swine_NNS -RRB-_-RRB- 
melitensis_NNS -LRB-_-LRB- sheep_NN and_CC goats_NNS -RRB-_-RRB- ,_, and_CC B._NNP abortus_NNP -LRB-_-LRB- primary_JJ reservoir_NN is_VBZ cattle_NNS and_CC water_NN buffalo_NN -RRB-_-RRB- ,_, B._NNP Brucella_NNP species_NNS that_WDT cause_VBP disease_NN in_IN people_NNS include_VBP B._NNP suis_NNP -LRB-_-LRB- swine_NNS -RRB-_-RRB- 
The_DT objective_NN of_IN this_DT study_NN was_VBD to_TO investigate_VB the_DT effects_NNS of_IN non-differential_JJ measurement_NN error_NN on_IN AUC_NNP ,_, LRs_NNP ,_, and_CC diagnostic_JJ ORs_NNS calculated_VBN for_IN a_DT test_NN categorized_VBN into_IN four_CD levels_NNS using_VBG real_JJ data_NNS and_CC simulated_JJ error_NN structures_NNS ._. 
AnalysisData_NNP sourceBrucellosis_NNP is_VBZ a_DT major_JJ disease_NN problem_NN worldwide_NN associated_VBN with_IN chronic_JJ debilitating_JJ infections_NNS in_IN people_NNS and_CC reproductive_JJ failure_NN in_IN domestic_JJ animals_NNS ._. 
Brucella_NNP species_NNS that_WDT cause_VBP disease_NN in_IN people_NNS include_VBP B._NNP abortus_NNP -LRB-_-LRB- primary_JJ reservoir_NN is_VBZ cattle_NNS and_CC water_NN buffalo_NN -RRB-_-RRB- ,_, B._NNP 
The_DT exception_NN to_TO this_DT rule_NN is_VBZ when_WRB misclassification_NN is_VBZ so_RB extreme_JJ that_IN the_DT probability_NN of_IN incorrect_JJ classification_NN is_VBZ more_RBR likely_JJ than_IN correct_JJ classification_NN 
The_DT exception_NN to_TO this_DT rule_NN is_VBZ when_WRB misclassification_NN is_VBZ so_RB extreme_JJ that_IN the_DT probability_NN of_IN incorrect_JJ classification_NN is_VBZ more_RBR likely_JJ than_IN correct_JJ classification_NN 
NA_NNP =_SYM not_RB applicable_JJ ._. 
The_DT proportion_NN of_IN individuals_NNS misclassified_VBN in_IN the_DT four_CD test_NN result_NN categories_NNS does_VBZ not_RB appear_VB to_TO be_VB equal_JJ between_IN infected_JJ and_CC uninfected_JJ individuals_NNS ._. 
Asimilar_JJ finding_NN has_VBZ been_VBN reported_VBN for_IN non-differential_JJ measurement_NN error_NN of_IN exposure_NN ._. 
In_IN this_DT study_NN ,_, however_RB ,_, it_PRP is_VBZ impossible_JJ to_TO know_VB which_WDT particular_JJ individuals_NNS were_VBD misclassified_VBN because_IN only_JJ total_JJ counts_NNS could_MD be_VB calculated_VBN and_CC an_DT accurate_JJ assessment_NN of_IN the_DT magnitude_NN of_IN misclassification_NN could_MD not_RB be_VB determined_VBN ._. 
When_WRB the_DT exposure_NN is_VBZ classified_VBN into_IN more_JJR than_IN two_CD categories_NNS -LRB-_-LRB- higher-order_JJ tables_NNS -RRB-_-RRB- the_DT direction_NN of_IN deviation_NN is_VBZ no_DT longer_RBR consistently_RB towards_IN the_DT null_JJ value_NN with_IN non-differential_JJ misclassification_NN 
If_IN non-differential_JJ misclassification_NN occurs_VBZ only_RB between_IN exposure_NN levels_NNS 2_CD and_CC 3_CD ,_, for_IN instance_NN ,_, then_RB the_DT usual_JJ ORs_NNP could_MD be_VB biased_VBN towards_IN or_CC away_RB from_IN the_DT null_JJ value_NN ,_, however_RB ,_, the_DT OR_NNP calculated_VBD between_IN level_NN 2_CD and_CC level_NN 3_CD -LRB-_-LRB- not_RB usually_RB reported_VBN -RRB-_-RRB- would_MD consistently_RB be_VB biased_VBN towards_IN the_DT null_NN ._. 
The_DT exception_NN to_TO this_DT rule_NN is_VBZ when_WRB misclassification_NN is_VBZ so_RB extreme_JJ that_IN the_DT probability_NN of_IN incorrect_JJ classification_NN is_VBZ more_RBR likely_JJ than_IN correct_JJ classification_NN 
Astudy_JJ or_CC process_NN is_VBZ considered_VBN biased_VBN if_IN a_DT systematic_JJ error_NN is_VBZ present_JJ in_IN study_NN design_NN ,_, data_NNS collection_NN ,_, or_CC data_NN analysis_NN 
The_DT odds_NNS ratio_NN -LRB-_-LRB- OR_NNP -RRB-_-RRB- is_VBZ frequently_RB the_DT measure_NN of_IN association_NN estimated_VBN in_IN studies_NNS concerning_VBG etiology_NN and_CC the_DT likelihood_NN ratio_NN -LRB-_-LRB- LR_NNP -RRB-_-RRB- is_VBZ commonly_RB estimated_VBN for_IN evaluation_NN of_IN diagnostic_JJ tests_NNS ._. 
Odds_NNS ratios_NNS for_IN diagnostic_JJ purposes_NNS can_MD also_RB be_VB estimated_VBN that_WDT quantify_VBP the_DT change_NN in_IN the_DT odds_NNS of_IN infection_NN -LRB-_-LRB- or_CC disease_NN -RRB-_-RRB- resulting_VBG from_IN a_DT positive_JJ test_NN result_NN ._. 
Estimates_NNS of_IN LRs_NNP and_CC diagnostic_JJ ORs_NNS can_MD be_VB affected_VBN by_IN random_JJ and_CC systematic_JJ errors_NNS similar_JJ to_TO other_JJ epidemiologic_JJ measures_NNS of_IN association_NN ._. 
The_DT LR_NNP is_VBZ a_DT measure_NN of_IN association_NN that_WDT quantifies_VBZ how_WRB many_JJ more_JJR times_NNS likely_RB a_DT test_NN result_NN is_VBZ from_IN an_DT infected_JJ individual_NN compared_VBN to_TO one_CD that_WDT is_VBZ uninfected_JJ ._. 
It_PRP is_VBZ calculated_VBN as_IN the_DT ratio_NN of_IN the_DT probability_NN that_IN an_DT infected_JJ individual_NN will_MD have_VB that_DT test_NN result_NN to_TO the_DT probability_NN that_IN an_DT uninfected_JJ individual_NN would_MD have_VB that_DT same_JJ result_NN ._. 
Calculation_NN of_IN LRs_NNP for_IN tests_NNS with_IN quantitative_JJ outcomes_NNS -LRB-_-LRB- e._FW g._FW titers_NNS ,_, optical_JJ densities_NNS -RRB-_-RRB- necessitates_VBZ dividing_VBG up_RP the_DT possible_JJ range_NN of_IN test_NN results_NNS into_IN categories_NNS ._. 
titers_NNS ,_, optical_JJ densities_NNS -RRB-_-RRB- necessitates_VBZ dividing_VBG up_RP the_DT possible_JJ range_NN of_IN test_NN results_NNS into_IN categories_NNS ._. 
Likelihood_NN ratios_NNS are_VBP also_RB mathematically_RB related_VBN to_TO ROC_NNP curves_NNS as_IN the_DT slope_NN between_IN adjacent_JJ test_NN result_NN categories_NNS ._. 
Receiver-operating_JJ characteristic_NN -LRB-_-LRB- ROC_NNP -RRB-_-RRB- curves_NNS are_VBP formed_VBN by_IN plotting_VBG 1_CD 
These_DT categories_NNS were_VBD based_VBN on_IN an_DT evaluation_NN of_IN this_DT assay_NN 
measure_NN of_IN association_NN -RRB-_-RRB- ._. 
g._NNP Background_NNP The_DT goal_NN of_IN epidemiologic_JJ investigations_NNS is_VBZ the_DT collection_NN of_IN valid_JJ data_NNS leading_VBG to_TO a_DT precise_JJ estimate_NN of_IN a_DT population_NN parameter_NN -LRB-_-LRB- e._NN For_IN the_DT purpose_NN of_IN this_DT discussion_NN ,_, an_DT estimate_NN of_IN a_DT parameter_NN will_MD be_VB considered_VBN biased_VBN if_IN the_DT expected_VBN value_NN -LRB-_-LRB- over_IN indefinite_JJ replications_NNS -RRB-_-RRB- is_VBZ not_RB the_DT true_JJ value_NN 
The_DT effect_NN of_IN measurement_NN error_NN and_CC misclassification_NN on_IN LRs_NNP could_MD not_RB be_VB found_VBN in_IN the_DT currently_RB available_JJ peer-reviewed_JJ literature_NN ._. 
The_DT direction_NN of_IN bias_NN in_IN estimates_NNS of_IN ORs_NNS and_CC risk_NN ratios_NNS with_IN differential_JJ misclassification_NN can_MD not_RB be_VB predicted_VBN ,_, however_RB ,_, non-differential_JJ misclassification_NN of_IN an_DT exposure_NN has_VBZ been_VBN shown_VBN to_TO result_VB in_IN measures_NNS of_IN association_NN to_TO be_VB consistently_RB biased_VBN towards_IN the_DT null_NN when_WRB evaluated_VBN in_IN a_DT 2_CD 
The_DT effect_NN of_IN measurement_NN error_NN and_CC misclassification_NN on_IN LRs_NNP could_MD not_RB be_VB found_VBN in_IN the_DT currently_RB available_JJ peer-reviewed_JJ literature_NN ._. 
The_DT direction_NN of_IN bias_NN in_IN estimates_NNS of_IN ORs_NNS and_CC risk_NN ratios_NNS with_IN differential_JJ misclassification_NN can_MD not_RB be_VB predicted_VBN ,_, however_RB ,_, non-differential_JJ misclassification_NN of_IN an_DT exposure_NN has_VBZ been_VBN shown_VBN to_TO result_VB in_IN measures_NNS of_IN association_NN to_TO be_VB consistently_RB biased_VBN towards_IN the_DT null_NN when_WRB evaluated_VBN in_IN a_DT 2_CD 
measure_NN of_IN association_NN -RRB-_-RRB- ._. 
g._NNP Background_NNP The_DT goal_NN of_IN epidemiologic_JJ investigations_NNS is_VBZ the_DT collection_NN of_IN valid_JJ data_NNS leading_VBG to_TO a_DT precise_JJ estimate_NN of_IN a_DT population_NN parameter_NN -LRB-_-LRB- e._NN For_IN the_DT purpose_NN of_IN this_DT discussion_NN ,_, an_DT estimate_NN of_IN a_DT parameter_NN will_MD be_VB considered_VBN biased_VBN if_IN the_DT expected_VBN value_NN -LRB-_-LRB- over_IN indefinite_JJ replications_NNS -RRB-_-RRB- is_VBZ not_RB the_DT true_JJ value_NN 
For_IN the_DT purpose_NN of_IN this_DT discussion_NN ,_, an_DT estimate_NN of_IN a_DT parameter_NN will_MD be_VB considered_VBN biased_VBN if_IN the_DT expected_VBN value_NN -LRB-_-LRB- over_IN indefinite_JJ replications_NNS -RRB-_-RRB- is_VBZ not_RB the_DT true_JJ value_NN 
For_IN the_DT purpose_NN of_IN this_DT discussion_NN ,_, an_DT estimate_NN of_IN a_DT parameter_NN will_MD be_VB considered_VBN biased_VBN if_IN the_DT expected_VBN value_NN -LRB-_-LRB- over_IN indefinite_JJ replications_NNS -RRB-_-RRB- is_VBZ not_RB the_DT true_JJ value_NN 
Likelihood_NN ratios_NNS are_VBP also_RB mathematically_RB related_VBN to_TO ROC_NNP curves_NNS as_IN the_DT slope_NN between_IN adjacent_JJ test_NN result_NN categories_NNS ._. 
Receiver-operating_JJ characteristic_NN -LRB-_-LRB- ROC_NNP -RRB-_-RRB- curves_NNS are_VBP formed_VBN by_IN plotting_VBG 1_CD 
Receiver-operating_JJ characteristic_NN -LRB-_-LRB- ROC_NNP -RRB-_-RRB- curves_NNS are_VBP formed_VBN by_IN plotting_VBG 1_CD 
For_IN every_DT dollar_NN spent_VBN on_IN food_NN in_IN the_DT US_NNP ,_, an_DT average_NN of_IN 20_CD cents_NNS returns_NNS to_TO the_DT grower_NN ;_: for_IN fruit_NN and_CC vegetable_NN farmers_NNS ,_, the_DT gross_JJ return_NN can_MD be_VB as_RB little_JJ as_IN five_CD cents_NNS to_TO the_DT dollar_NN 
Farmers_NNS thus_RB have_VBP limited_VBN power_NN to_TO attract_VB local_JJ labor_NN by_IN increasing_VBG wages_NNS ,_, and_CC many_JJ of_IN these_DT commodities_NNS have_VBP limited_VBN potential_JJ for_IN efficiency_NN gains_NNS through_IN mechanization_NN ,_, leading_VBG instead_RB to_TO what_WP has_VBZ been_VBN referred_VBN to_TO as_IN the_DT ``_`` Mexicanization_NN ''_'' of_IN agriculture_NN 
The_DT low_JJ returns_NNS from_IN agriculture_NN encourage_VBP over-production_NN of_IN food_NN ,_, keeping_VBG prices_NNS artificially_RB low_JJ for_IN consumers_NNS and_CC encouraging_JJ increased_VBN consumption_NN ._. 
The_DT US_NNP produces_VBZ approximately_RB 3500_CD calories_NNS per_IN person_NN per_IN day_NN ,_, a_DT quarter_NN of_IN which_WDT is_VBZ lost_VBN to_TO spoilage_NN and_CC waste_NN 
Although_IN current_JJ regulations_NNS require_VBP employers_NNS to_TO verify_VB the_DT legality_NN of_IN their_PRP$ employees_NNS ,_, the_DT current_JJ structure_NN of_IN the_DT food_NN industry_NN provides_VBZ little_JJ incentive_NN to_TO do_VB so_RB ._. 
For_IN every_DT dollar_NN spent_VBN on_IN food_NN in_IN the_DT US_NNP ,_, an_DT average_NN of_IN 20_CD cents_NNS returns_NNS to_TO the_DT grower_NN ;_: for_IN fruit_NN and_CC vegetable_NN farmers_NNS ,_, the_DT gross_JJ return_NN can_MD be_VB as_RB little_JJ as_IN five_CD cents_NNS to_TO the_DT dollar_NN 
The_DT low_JJ returns_NNS from_IN agriculture_NN encourage_VBP over-production_NN of_IN food_NN ,_, keeping_VBG prices_NNS artificially_RB low_JJ for_IN consumers_NNS and_CC encouraging_JJ increased_VBN consumption_NN ._. 
The_DT US_NNP produces_VBZ approximately_RB 3500_CD calories_NNS per_IN person_NN per_IN day_NN ,_, a_DT quarter_NN of_IN which_WDT is_VBZ lost_VBN to_TO spoilage_NN and_CC waste_NN 
The_DT US_NNP produces_VBZ approximately_RB 3500_CD calories_NNS per_IN person_NN per_IN day_NN ,_, a_DT quarter_NN of_IN which_WDT is_VBZ lost_VBN to_TO spoilage_NN and_CC waste_NN 
The_DT heavy_JJ reliance_NN on_IN temporary_JJ foreign_JJ labor_NN ,_, primarily_RB in_IN food_NN production_NN ,_, building_NN and_CC the_DT service_NN industry_NN ,_, has_VBZ resulted_VBN in_IN a_DT chronic_JJ dependency_NN on_IN immigrants_NNS workers_NNS ,_, many_JJ of_IN them_PRP unauthorized_JJ ,_, to_TO support_VB these_DT sectors_NNS ._. 
Over_IN 70_CD %_NN of_IN farm_NN crop_NN workers_NNS in_IN the_DT US_NNP are_VBP foreign-born_JJ ,_, primarily_RB from_IN Mexico_NNP ;_: more_JJR than_IN 50_CD %_NN of_IN these_DT are_VBP unauthorized_JJ to_TO work_VB in_IN the_DT US_NNP 
Over_IN 70_CD %_NN of_IN farm_NN crop_NN workers_NNS in_IN the_DT US_NNP are_VBP foreign-born_JJ ,_, primarily_RB from_IN Mexico_NNP ;_: more_JJR than_IN 50_CD %_NN of_IN these_DT are_VBP unauthorized_JJ to_TO work_VB in_IN the_DT US_NNP 
Thirty_CD percent_NN of_IN farmworker_NN households_NNS earn_VBP below_IN the_DT poverty_NN line_NN ,_, and_CC over_IN 75_CD %_NN of_IN workers_NNS have_VBP no_DT medical_JJ cover_NN ._. 
Despite_IN this_DT ,_, approximately_RB one_CD quarter_NN have_VBP worked_VBN in_IN the_DT US_NNP under_IN their_PRP$ current_JJ employer_NN for_IN at_IN least_JJS five_CD years_NNS ._. 
The_DT commonly-heard_JJ assertion_NN that_IN foreign_JJ labor_NN fills_VBZ jobs_NNS that_IN Americans_NNPS are_VBP unwilling_JJ to_TO do_VB is_VBZ simply_RB untrue_JJ ;_: these_DT are_VBP jobs_NNS that_IN Americans_NNPS simply_RB can_MD not_RB afford_VB to_TO take_VB ._. 
Over_IN 70_CD %_NN of_IN farm_NN crop_NN workers_NNS in_IN the_DT US_NNP are_VBP foreign-born_JJ ,_, primarily_RB from_IN Mexico_NNP ;_: more_JJR than_IN 50_CD %_NN of_IN these_DT are_VBP unauthorized_JJ to_TO work_VB in_IN the_DT US_NNP 
By_IN contrast_NN ,_, perishable_JJ fruits_NNS and_CC vegetables_NNS are_VBP highly_RB sensitive_JJ to_TO price_NN variations_NNS ,_, yet_RB receive_VBP limited_JJ federal_JJ support_NN ._. 
Farmers_NNS thus_RB have_VBP limited_VBN power_NN to_TO attract_VB local_JJ labor_NN by_IN increasing_VBG wages_NNS ,_, and_CC many_JJ of_IN these_DT commodities_NNS have_VBP limited_VBN potential_JJ for_IN efficiency_NN gains_NNS through_IN mechanization_NN ,_, leading_VBG instead_RB to_TO what_WP has_VBZ been_VBN referred_VBN to_TO as_IN the_DT ``_`` Mexicanization_NN ''_'' of_IN agriculture_NN 
That_IN the_DT US_NNP should_MD find_VB itself_PRP in_IN such_PDT an_DT unenviable_JJ position_NN is_VBZ unsurprising_JJ ._. 
With_IN the_DT prospect_NN of_IN legislative_JJ changes_NNS that_WDT could_MD offer_VB routes_NNS to_TO legal_JJ employment_NN and_CC eventual_JJ citizenship_NN ,_, the_DT Mexican_JJ border_NN has_VBZ already_RB begun_VBN to_TO see_VB a_DT rush_NN of_IN hopefuls_NNS planning_VBG to_TO cross_VB into_IN the_DT US_NNP in_IN time_NN to_TO qualify_VB for_IN any_DT guest-worker_JJ program_NN and_CC before_IN the_DT tightening_NN of_IN border_NN controls_NNS 
For_IN decades_NNS ,_, successive_JJ administrations_NNS have_VBP implemented_VBN inconsistent_JJ and_CC haphazardly-enforced_JJ immigration_NN policies_NNS that_WDT have_VBP nevertheless_RB parallelled_VBN a_DT continual_JJ increase_NN in_IN the_DT influx_NN of_IN migrant_JJ labor_NN 
The_DT US_NNP produces_VBZ approximately_RB 3500_CD calories_NNS per_IN person_NN per_IN day_NN ,_, a_DT quarter_NN of_IN which_WDT is_VBZ lost_VBN to_TO spoilage_NN and_CC waste_NN 
So_RB how_WRB does_VBZ this_DT impact_NN on_IN the_DT public_JJ health_NN community_NN ._. 
Meanwhile_RB ,_, euphemisms_NNS such_JJ as_IN ``_`` guest-worker_NN ''_'' programs_NNS are_VBP merely_RB veiled_VBN admissions_NNS of_IN a_DT society_NN 's_POS unwillingness_NN to_TO bite_VB the_DT hand_NN that_WDT quite_RB literally_RB feeds_VBZ its_PRP$ gluttony_NN ,_, instead_RB maintaining_VBG an_DT underclass_NN of_IN individuals_NNS ``_`` living_VBG under_IN the_DT radar_NN of_IN formal_JJ business_NN ''_'' who_WP bolster_VBP its_PRP$ bloated_JJ economy_NN ,_, but_CC whose_WP$ rights_NNS and_CC contributions_NNS to_TO society_NN are_VBP largely_RB ignored_VBN ._. 
An_DT oft-heard_JJ assertion_NN has_VBZ it_PRP that_IN population_NN movement_NN is_VBZ a_DT natural_JJ consequence_NN of_IN current_JJ ``_`` globalizing_VBG ''_'' trends_NNS 
For_IN public_JJ health_NN to_TO be_VB a_DT successful_JJ endeavor_NN ,_, it_PRP too_RB must_MD be_VB an_DT idea_NN that_WDT transcends_VBZ borders_NNS ,_, a_DT global_JJ enterprise_NN guided_VBN not_RB by_IN the_DT interests_NNS of_IN states_NNS and_CC corporations_NNS ,_, but_CC by_IN the_DT needs_NNS of_IN those_DT most_RBS disenfranchised_JJ in_IN society_NN ._. 
The_DT health_NN of_IN migrant_JJ populations_NNS is_VBZ important_JJ not_RB because_IN migrants_NNS represent_VBP groups_NNS with_IN different_JJ health_NN outcomes_NNS ,_, not_RB because_IN they_PRP are_VBP difficult_JJ populations_NNS to_TO access_NN ,_, not_RB because_IN special_JJ methodologies_NNS are_VBP required_VBN to_TO study_VB their_PRP$ health_NN needs_NNS or_CC deliver_VB interventions_NNS ,_, but_CC because_IN they_PRP ,_, like_IN everyone_NN else_RB ,_, have_VBP basic_JJ entitlements_NNS codified_VBN under_IN the_DT Universal_NNP Declaration_NNP of_IN Human_NNP Rights_NNP ._. 
Viewed_VBN from_IN this_DT perspective_NN ,_, adverse_JJ outcomes_NNS in_IN migrant_JJ populations_NNS become_VBP the_DT physical_JJ and_CC psychological_JJ embodiments_NNS of_IN a_DT long_JJ and_CC complex_JJ combination_NN of_IN structural_JJ factors_NNS so_RB acutely_RB captured_VBN by_IN Upton_NNP Sinclair_NNP a_DT century_NN ago_RB ;_: disease_NN profiles_NNS and_CC methodological_JJ issues_NNS are_VBP mere_JJ details_NNS ,_, albeit_IN very_RB important_JJ details_NNS ,_, in_IN such_JJ a_DT system_NN ._. 
Meanwhile_RB ,_, the_DT forces_NNS of_IN healing_NN ,_, which_WDT deal_VBP in_IN the_DT priceless_JJ and_CC universal_JJ value_NN of_IN health_NN ,_, are_VBP trammeled_VBN by_IN parochialisms_NNS of_IN place_NN and_CC creed_NN ._. ''_'' 
If_IN current_JJ trends_NNS persist_VBP ,_, our_PRP$ adherence_NN and_CC high_JJ dependence_NN on_IN the_DT nation_NN state_NN will_MD make_VB it_PRP increasingly_RB difficult_JJ for_IN us_PRP to_TO meet_VB the_DT health_NN needs_NNS of_IN mobile_JJ populations_NNS ,_, particularly_RB those_DT whose_WP$ health_NN interests_NNS are_VBP not_RB recognized_VBN by_IN any_DT nation_NN ._. 
For_IN public_JJ health_NN to_TO be_VB a_DT successful_JJ endeavor_NN ,_, it_PRP too_RB must_MD be_VB an_DT idea_NN that_WDT transcends_VBZ borders_NNS ,_, a_DT global_JJ enterprise_NN guided_VBN not_RB by_IN the_DT interests_NNS of_IN states_NNS and_CC corporations_NNS ,_, but_CC by_IN the_DT needs_NNS of_IN those_DT most_RBS disenfranchised_JJ in_IN society_NN ._. 
-RRB-_-RRB- it_PRP is_VBZ time_NN to_TO take_VB health_NN rights_NNS as_RB seriously_RB as_IN other_JJ human_JJ rights_NNS ,_, and_CC that_IN intellectual_JJ recognition_NN is_VBZ only_RB a_DT necessary_JJ first_JJ step_NN toward_IN pragmatic_JJ solidarity_NN ,_, that_DT is_VBZ ,_, toward_IN taking_VBG a_DT stand_NN by_IN the_DT side_NN of_IN those_DT who_WP suffer_VBP most_JJS from_IN an_DT increasingly_RB harsh_JJ ``_`` new_JJ world_NN order_NN ._. ''_'' 
Ido_NNP not_RB intend_VBP to_TO provide_VB an_DT immediate_JJ solution_NN to_TO the_DT current_JJ structure_NN of_IN the_DT food_NN supply_NN here_RB ;_: I_PRP wish_VBP instead_RB to_TO argue_VB that_IN even_RB a_DT brief_JJ analysis_NN reveals_VBZ that_IN the_DT health_NN issues_NNS of_IN migrant_JJ farm_NN workers_NNS are_VBP inextricably_RB linked_VBN to_TO the_DT politics_NNS ,_, economics_NNS and_CC culture_NN of_IN food_NN ._. 
Such_JJ analyses_NNS can_MD and_CC should_MD be_VB done_VBN not_RB only_RB in_IN the_DT context_NN of_IN worker_NN migration_NN ,_, but_CC also_RB for_IN other_JJ forms_NNS of_IN migration_NN 
Such_JJ analyses_NNS can_MD and_CC should_MD be_VB done_VBN not_RB only_RB in_IN the_DT context_NN of_IN worker_NN migration_NN ,_, but_CC also_RB for_IN other_JJ forms_NNS of_IN migration_NN 
Ido_NNP not_RB intend_VBP to_TO provide_VB an_DT immediate_JJ solution_NN to_TO the_DT current_JJ structure_NN of_IN the_DT food_NN supply_NN here_RB ;_: I_PRP wish_VBP instead_RB to_TO argue_VB that_IN even_RB a_DT brief_JJ analysis_NN reveals_VBZ that_IN the_DT health_NN issues_NNS of_IN migrant_JJ farm_NN workers_NNS are_VBP inextricably_RB linked_VBN to_TO the_DT politics_NNS ,_, economics_NNS and_CC culture_NN of_IN food_NN ._. 
Such_JJ analyses_NNS can_MD and_CC should_MD be_VB done_VBN not_RB only_RB in_IN the_DT context_NN of_IN worker_NN migration_NN ,_, but_CC also_RB for_IN other_JJ forms_NNS of_IN migration_NN 
So_RB how_WRB does_VBZ this_DT impact_NN on_IN the_DT public_JJ health_NN community_NN ._. 
Meanwhile_RB ,_, euphemisms_NNS such_JJ as_IN ``_`` guest-worker_NN ''_'' programs_NNS are_VBP merely_RB veiled_VBN admissions_NNS of_IN a_DT society_NN 's_POS unwillingness_NN to_TO bite_VB the_DT hand_NN that_WDT quite_RB literally_RB feeds_VBZ its_PRP$ gluttony_NN ,_, instead_RB maintaining_VBG an_DT underclass_NN of_IN individuals_NNS ``_`` living_VBG under_IN the_DT radar_NN of_IN formal_JJ business_NN ''_'' who_WP bolster_VBP its_PRP$ bloated_JJ economy_NN ,_, but_CC whose_WP$ rights_NNS and_CC contributions_NNS to_TO society_NN are_VBP largely_RB ignored_VBN ._. 
An_DT oft-heard_JJ assertion_NN has_VBZ it_PRP that_IN population_NN movement_NN is_VBZ a_DT natural_JJ consequence_NN of_IN current_JJ ``_`` globalizing_VBG ''_'' trends_NNS ._. 
However_RB ,_, uncritical_JJ acceptance_NN of_IN such_JJ apparently_RB benign_JJ statements_NNS merely_RB serves_VBZ to_TO support_VB some_DT particularly_RB pernicious_JJ realities_NNS ._. 
Mark_NNP Bradford_NNP 's_POS work_NN warns_VBZ us_PRP of_IN the_DT pitfalls_NNS of_IN vivid_JJ colors_NNS and_CC bright_JJ lights_NNS ,_, drawing_VBG us_PRP instead_RB towards_IN the_DT darkness_NN and_CC inviting_VBG us_PRP to_TO focus_VB more_RBR closely_RB on_IN those_DT ``_`` living_VBG under_IN the_DT radar_NN of_IN formal_JJ business_NN ''_'' 
They_PRP put_VBD him_PRP in_IN a_DT place_NN where_WRB the_DT snow_NN could_MD not_RB beat_VB in_IN ,_, where_WRB the_DT cold_NN could_MD not_RB eat_VB through_IN his_PRP$ bones_NNS ;_: they_PRP brought_VBD him_PRP food_NN and_CC drink_NN 
192_CD -RRB-_-RRB- And_CC while_IN the_DT protagonist_NN might_MD bemoan_VB and_CC wonder_VB at_IN his_PRP$ misfortunes_NNS ,_, the_DT author_NN is_VBZ in_IN no_DT doubt_NN as_IN to_TO their_PRP$ causal_JJ structure_NN :_: ``_`` He_PRP had_VBD no_DT wit_NN to_TO trace_VB back_RP the_DT social_JJ crime_NN to_TO its_PRP$ far_JJ sources_NNS 
In_IN its_PRP$ original_JJ form_NN ,_, passed_VBN by_IN the_DT House_NNP of_IN Representatives_NNPS last_JJ December_NNP ,_, the_DT bill_NN included_VBD provisions_NNS for_IN erecting_VBG several_JJ hundred_CD miles_NNS of_IN fencing_NN along_IN the_DT US-Mexico_JJ border_NN and_CC classifying_VBG illegal_JJ immigrants_NNS as_IN felons_NNS ._. 
These_DT two_CD factors_NNS proved_VBD to_TO be_VB major_JJ points_NNS of_IN contention_NN in_IN the_DT Senate_NNP debate_NN ,_, as_IN did_VBD the_DT possibility_NN of_IN amendments_NNS incorporating_VBG a_DT so-called_JJ ``_`` guest-worker_JJ ''_'' program_NN 
In_IN its_PRP$ original_JJ form_NN ,_, passed_VBN by_IN the_DT House_NNP of_IN Representatives_NNPS last_JJ December_NNP ,_, the_DT bill_NN included_VBD provisions_NNS for_IN erecting_VBG several_JJ hundred_CD miles_NNS of_IN fencing_NN along_IN the_DT US-Mexico_JJ border_NN and_CC classifying_VBG illegal_JJ immigrants_NNS as_IN felons_NNS ._. 
These_DT two_CD factors_NNS proved_VBD to_TO be_VB major_JJ points_NNS of_IN contention_NN in_IN the_DT Senate_NNP debate_NN ,_, as_IN did_VBD the_DT possibility_NN of_IN amendments_NNS incorporating_VBG a_DT so-called_JJ ``_`` guest-worker_JJ ''_'' program_NN 
These_DT two_CD factors_NNS proved_VBD to_TO be_VB major_JJ points_NNS of_IN contention_NN in_IN the_DT Senate_NNP debate_NN ,_, as_IN did_VBD the_DT possibility_NN of_IN amendments_NNS incorporating_VBG a_DT so-called_JJ ``_`` guest-worker_JJ ''_'' program_NN 
''_'' Genesis_NNP 11_NNP :_: 9_CD ._. 
``_`` Therefore_RB is_VBZ the_DT name_NN of_IN it_PRP called_VBD Babel_NNP ;_: because_IN the_DT Lord_NNP did_VBD there_RB confound_VB the_DT language_NN of_IN all_PDT the_DT earth_NN :_: and_CC from_IN thence_NN did_VBD the_DT Lord_NNP scatter_NN them_PRP abroad_RB upon_IN the_DT face_NN of_IN all_PDT the_DT earth_NN ._. 
The_DT Whitney_NNP Museum_NNP of_IN American_NNP Art_NNP in_IN New_NNP York_NNP recently_RB held_VBD its_PRP$ Biennial_NNP 2006_CD exhibition_NN ._. 
Entitled_NNP Day_NNP for_IN Night_NNP ,_, after_IN the_DT Truffaut_NNP film_NN in_IN which_WDT scenes_NNS shot_VBN in_IN daylight_NN are_VBP made_VBN to_TO imply_VB night-time_JJ ,_, the_DT exhibition_NN was_VBD guided_VBN by_IN themes_NNS of_IN ambiguity_NN ,_, in_IN the_DT literal_JJ -LRB-_-LRB- works_NNS that_WDT are_VBP not_RB quite_RB what_WP they_PRP appear_VBP to_TO be_VB -RRB-_-RRB- ,_, conceptual_JJ -LRB-_-LRB- in_IN deconstructing_VBG the_DT role_NN of_IN the_DT artist_NN in_IN the_DT current_JJ socio-political_JJ climate_NN -RRB-_-RRB- and_CC practical_JJ senses_NNS -LRB-_-LRB- in_IN trying_VBG to_TO define_VB what_WP actually_RB constitutes_VBZ ``_`` American_JJ ''_'' art_NN -RRB-_-RRB- ._. 
Although_IN I_PRP focus_VBP on_IN the_DT United_NNP States_NNP -LRB-_-LRB- US_NNP -RRB-_-RRB- context_NN 
It_PRP is_VBZ precisely_RB in_IN such_JJ an_DT environment_NN 
Intense_JJ opposition_NN to_TO the_DT criminalization_NN of_IN immigrants_NNS led_VBN to_TO large-scale_JJ demonstrations_NNS among_IN the_DT Hispanic_JJ communities_NNS most_RBS likely_JJ to_TO be_VB affected_VBN ,_, and_CC to_TO calls_NNS for_IN legalizing_VBG the_DT considerable_JJ number_NN of_IN illegal_JJ immigrants_NNS already_RB in_IN the_DT country_NN 
That_IN the_DT US_NNP should_MD find_VB itself_PRP in_IN such_PDT an_DT unenviable_JJ position_NN is_VBZ unsurprising_JJ ._. 
With_IN the_DT prospect_NN of_IN legislative_JJ changes_NNS that_WDT could_MD offer_VB routes_NNS to_TO legal_JJ employment_NN and_CC eventual_JJ citizenship_NN ,_, the_DT Mexican_JJ border_NN has_VBZ already_RB begun_VBN to_TO see_VB a_DT rush_NN of_IN hopefuls_NNS planning_VBG to_TO cross_VB into_IN the_DT US_NNP in_IN time_NN to_TO qualify_VB for_IN any_DT guest-worker_JJ program_NN and_CC before_IN the_DT tightening_NN of_IN border_NN controls_NNS 
Many_JJ researchers_NNS have_VBP proposed_VBN epidemiologic_JJ theories_NNS that_WDT move_VBP beyond_IN the_DT risk_NN factor_NN paradigm_NN ._. 
While_IN population_NN disease_NN patterns_NNS are_VBP transitioning_VBG from_IN infectious_JJ diseases_NNS to_TO chronic_JJ diseases_NNS ,_, research_NN models_NNS and_CC intervention_NN strategies_NNS have_VBP not_RB undergone_VBN a_DT similarly_RB dramatic_JJ transition_NN ._. 
Ecologic_JJ approaches_NNS ,_, including_VBG the_DT ecosocial_NN 
Ecologic_JJ approaches_NNS ,_, including_VBG the_DT ecosocial_NN 
However_RB ,_, a_DT public_JJ health_NN research_NN model_NN rooted_VBN in_IN the_DT pre-epidemiologic_JJ transition_NN era_NN is_VBZ unnecessarily_RB limited_JJ ._. 
Currently_RB ,_, many_JJ poor_JJ countries_NNS are_VBP facing_VBG dramatic_JJ increases_NNS in_IN chronic_JJ diseases_NNS ,_, sustained_JJ population_NN growth_NN ,_, and_CC an_DT unprecedented_JJ aging_NN boom_NN ._. 
While_IN population_NN disease_NN patterns_NNS are_VBP transitioning_VBG from_IN infectious_JJ diseases_NNS to_TO chronic_JJ diseases_NNS ,_, research_NN models_NNS and_CC intervention_NN strategies_NNS have_VBP not_RB undergone_VBN a_DT similarly_RB dramatic_JJ transition_NN ._. 
Many_JJ researchers_NNS have_VBP proposed_VBN epidemiologic_JJ theories_NNS that_WDT move_VBP beyond_IN the_DT risk_NN factor_NN paradigm_NN ._. 
While_IN population_NN disease_NN patterns_NNS are_VBP transitioning_VBG from_IN infectious_JJ diseases_NNS to_TO chronic_JJ diseases_NNS ,_, research_NN models_NNS and_CC intervention_NN strategies_NNS have_VBP not_RB undergone_VBN a_DT similarly_RB dramatic_JJ transition_NN ._. 
Ecologic_JJ approaches_NNS ,_, including_VBG the_DT ecosocial_NN 
Lester_NNP Breslow_NNP observed_VBD that_IN people_NNS are_VBP extraordinarily_RB good_JJ predictors_NNS of_IN their_PRP$ own_JJ subsequent_JJ health_NN ._. 
In_IN the_DT 40_CD years_NNS since_IN th_NN 
As_IN noted_VBN above_RB ,_, Breslow_NNP 's_POS work_NN suggests_VBZ that_IN people_NNS understand_VBP their_PRP$ health_NN in_IN a_DT way_NN that_WDT can_MD not_RB be_VB explained_VBN by_IN a_DT purely_RB biomedical_JJ model_NN ._. 
Individuals_NNS likely_RB take_VBP into_IN consideration_NN multiple_JJ factors_NNS concurrently_RB -LRB-_-LRB- including_VBG age_NN ,_, physical_JJ disability_NN ,_, current_JJ disease_NN status_NN ,_, access_NN to_TO healthcare_NN ,_, social_JJ support_NN ,_, etc_FW -RRB-_-RRB- ,_, from_IN all_DT levels_NNS of_IN their_PRP$ life_NN ,_, weighing_VBG what_WP does_VBZ and_CC does_VBZ not_RB make_VB them_PRP healthy_JJ 
However_RB ,_, a_DT public_JJ health_NN research_NN model_NN rooted_VBN in_IN the_DT pre-epidemiologic_JJ transition_NN era_NN is_VBZ unnecessarily_RB limited_JJ ._. 
Currently_RB ,_, many_JJ poor_JJ countries_NNS are_VBP facing_VBG dramatic_JJ increases_NNS in_IN chronic_JJ diseases_NNS ,_, sustained_JJ population_NN growth_NN ,_, and_CC an_DT unprecedented_JJ aging_NN boom_NN ._. 
While_IN population_NN disease_NN patterns_NNS are_VBP transitioning_VBG from_IN infectious_JJ diseases_NNS to_TO chronic_JJ diseases_NNS ,_, research_NN models_NNS and_CC intervention_NN strategies_NNS have_VBP not_RB undergone_VBN a_DT similarly_RB dramatic_JJ transition_NN ._. 
We_PRP could_MD ask_VB ,_, for_IN example_NN ,_, what_WP permits_VBZ 90_CD 
In_IN 1963_CD Dr._NNP Or_CC finally_RB ,_, where_WRB should_MD we_PRP focus_VB our_PRP$ efforts_NNS with_IN the_DT increasing_VBG prevalence_NN of_IN obesity_NN ,_, when_WRB most_RBS obese_JJ people_NNS live_VBP fully_RB functional_JJ lives_NNS ._. 
Lester_NNP Breslow_NNP observed_VBD that_IN people_NNS are_VBP extraordinarily_RB good_JJ predictors_NNS of_IN their_PRP$ own_JJ subsequent_JJ health_NN 
Despite_IN these_DT advances_NNS that_WDT collectively_RB begin_VBP to_TO account_VB for_IN the_DT complexities_NNS of_IN health_NN ,_, most_JJS health_NN researchers_NNS continue_VBP to_TO focus_VB on_IN specific_JJ diseases_NNS ._. 
As_IN noted_VBN above_RB ,_, Breslow_NNP 's_POS work_NN suggests_VBZ that_IN people_NNS understand_VBP their_PRP$ health_NN in_IN a_DT way_NN that_WDT can_MD not_RB be_VB explained_VBN by_IN a_DT purely_RB biomedical_JJ model_NN ._. 
Individuals_NNS likely_RB take_VBP into_IN consideration_NN multiple_JJ factors_NNS concurrently_RB -LRB-_-LRB- including_VBG age_NN ,_, physical_JJ disability_NN ,_, current_JJ disease_NN status_NN ,_, access_NN to_TO healthcare_NN ,_, social_JJ support_NN ,_, etc_FW -RRB-_-RRB- ,_, from_IN all_DT levels_NNS of_IN their_PRP$ life_NN ,_, weighing_VBG what_WP does_VBZ and_CC does_VBZ not_RB make_VB them_PRP healthy_JJ 
Others_NNS have_VBP emphasized_VBN the_DT need_NN for_IN looking_VBG beyond_IN contemporaneous_JJ ,_, individual-level_JJ risk_NN factors_NNS while_IN incorporating_VBG social_JJ and_CC environmental_JJ changes_NNS from_IN a_DT life-course_JJ perspective_NN 
Some_DT epidemiologists_NNS are_VBP focusing_VBG on_IN group-level_JJ effects_NNS ,_, including_VBG neighborhood_NN characteristics_NNS and_CC social_JJ capital_NN ,_, rather_RB than_IN only_RB on_IN individuals_NNS and_CC their_PRP$ risk_NN factors_NNS 
It_PRP is_VBZ unlikely_JJ that_IN a_DT group_NN of_IN public_JJ health_NN professionals_NNS could_MD know_VB in_IN advance_NN what_WP would_MD make_VB the_DT most_JJS difference_NN to_TO the_DT health_NN of_IN people_NNS with_IN economic_JJ and_CC cultural_JJ backgrounds_NNS very_RB different_JJ from_IN their_PRP$ own_JJ ._. 
However_RB ,_, relying_VBG on_IN the_DT collective_JJ community_NN to_TO inform_VB the_DT research_NN and_CC define_VB its_PRP$ own_JJ health-related_JJ goals_NNS could_MD instead_RB lead_VB to_TO more_RBR meaningful_JJ research_NN and_CC more_RBR effective_JJ interventions_NNS ._. 
We_PRP expect_VBP that_IN employing_VBG the_DT framework_NN diagram_NN and_CC definitions_NNS presented_VBN above_RB can_MD be_VB used_VBN as_IN a_DT tool_NN to_TO stimulate_VB discussion_NN and_CC generate_VB questions_NNS at_IN the_DT individual_JJ level_NN ._. 
Though_IN not_RB yet_RB established_VBN ,_, it_PRP is_VBZ likely_JJ that_IN when_WRB individuals_NNS and_CC communities_NNS think_VBP about_IN ,_, discuss_VB ,_, and_CC identify_VB their_PRP$ own_JJ pathways_NNS and_CC barriers_NNS to_TO health_NN ,_, they_PRP are_VBP more_RBR likely_JJ to_TO become_VB advocates_NNS for_IN pursuing_VBG these_DT pathways_NNS and_CC overcoming_VBG the_DT barriers_NNS ._. 
Yet_CC there_EX is_VBZ an_DT essential_JJ second_JJ step_NN :_: developing_VBG and_CC implementing_VBG creative_JJ ,_, thoughtful_JJ ,_, and_CC well-grounded_JJ interventions_NNS ._. 
The_DT framework_NN we_PRP present_VBP is_VBZ intended_VBN 
Implementing_VBG a_DT circumcision_NN program_NN to_TO reduce_VB HIV_NNP transmission_NN may_MD backfire_VB ,_, for_IN example_NN ,_, if_IN the_DT extent_NN of_IN protection_NN that_IN the_DT intervention_NN provides_VBZ is_VBZ misinterpreted_VBN and_CC circumcised_VBN men_NNS begin_VBP to_TO engage_VB in_IN risky_JJ sexual_JJ behavior_NN ._. 
Likewise_RB ,_, such_JJ a_DT program_NN may_MD fail_VB in_IN traditionally_RB non-circumcising_JJ communities_NNS if_IN issues_NNS of_IN cultural_JJ acceptability_NN are_VBP not_RB fully_RB understood_VBN and_CC taken_VBN into_IN account_NN ._. 
The_DT proposed_VBN framework_NN enhances_VBZ the_DT ability_NN of_IN public_JJ health_NN practitioners_NNS to_TO anticipate_VB indirect_JJ consequences_NNS ._. 
Implementing_VBG a_DT circumcision_NN program_NN to_TO reduce_VB HIV_NNP transmission_NN may_MD backfire_VB ,_, for_IN example_NN ,_, if_IN the_DT extent_NN of_IN protection_NN that_IN the_DT intervention_NN provides_VBZ is_VBZ misinterpreted_VBN and_CC circumcised_VBN men_NNS begin_VBP to_TO engage_VB in_IN risky_JJ sexual_JJ behavior_NN ._. 
Likewise_RB ,_, such_JJ a_DT program_NN may_MD fail_VB in_IN traditionally_RB non-circumcising_JJ communities_NNS if_IN issues_NNS of_IN cultural_JJ acceptability_NN are_VBP not_RB fully_RB understood_VBN and_CC taken_VBN into_IN account_NN ._. 
The_DT proposed_VBN framework_NN enhances_VBZ the_DT ability_NN of_IN public_JJ health_NN practitioners_NNS to_TO anticipate_VB indirect_JJ consequences_NNS ._. 
Conducting_VBG health-focused_JJ research_NN Currently_RB ,_, public_JJ health_NN research_NN is_VBZ often_RB conducted_VBN in_IN a_DT community_NN with_IN a_DT predetermined_VBN ,_, disease-specific_JJ agenda_NN ._. 
This_DT research_NN model_NN ,_, which_WDT is_VBZ related_VBN to_TO funding_NN mechanisms_NNS and_CC the_DT need_NN for_IN clearly_RB identified_VBN research_NN plans_NNS ,_, unfortunately_RB may_MD not_RB match_VB what_WP is_VBZ most_RBS important_JJ to_TO ,_, or_CC has_VBZ the_DT largest_JJS impact_NN on_IN ,_, the_DT community_NN ._. 
It_PRP is_VBZ unlikely_JJ that_IN a_DT group_NN of_IN public_JJ health_NN professionals_NNS could_MD know_VB in_IN advance_NN what_WP would_MD make_VB the_DT most_JJS difference_NN to_TO the_DT health_NN of_IN people_NNS with_IN economic_JJ and_CC cultural_JJ backgrounds_NNS very_RB different_JJ from_IN their_PRP$ own_JJ ._. 
It_PRP is_VBZ unlikely_JJ that_IN a_DT group_NN of_IN public_JJ health_NN professionals_NNS could_MD know_VB in_IN advance_NN what_WP would_MD make_VB the_DT most_JJS difference_NN to_TO the_DT health_NN of_IN people_NNS with_IN economic_JJ and_CC cultural_JJ backgrounds_NNS very_RB different_JJ from_IN their_PRP$ own_JJ ._. 
However_RB ,_, relying_VBG on_IN the_DT collective_JJ community_NN to_TO inform_VB the_DT research_NN and_CC define_VB its_PRP$ own_JJ health-related_JJ goals_NNS could_MD instead_RB lead_VB to_TO more_RBR meaningful_JJ research_NN and_CC more_RBR effective_JJ interventions_NNS ._. 
We_PRP expect_VBP that_IN employing_VBG the_DT framework_NN diagram_NN and_CC definitions_NNS presented_VBN above_RB can_MD be_VB used_VBN as_IN a_DT tool_NN to_TO stimulate_VB discussion_NN and_CC generate_VB questions_NNS at_IN the_DT individual_JJ level_NN ._. 
The_DT framework_NN we_PRP present_VBP is_VBZ intended_VBN to_TO guide_VB this_DT process_NN by_IN encouraging_VBG the_DT development_NN of_IN locally_RB relevant_JJ interventions_NNS designed_VBN in_IN concert_NN with_IN the_DT community_NN they_PRP are_VBP intended_VBN to_TO support_VB 
Community_NNP members_NNS may_MD offer_VB insights_NNS on_IN the_DT pathways_NNS to_TO health_NN that_WDT surpass_VBP the_DT collective_JJ capacity_NN of_IN the_DT scientific_JJ community_NN 
Based_VBN on_IN this_DT line_NN of_IN evidence_NN ,_, we_PRP suggest_VBP that_IN individuals_NNS and_CC their_PRP$ communities_NNS hold_VBP the_DT key_NN to_TO uncovering_VBG pathways_NNS to_TO health_NN ._. 
Community_NNP members_NNS may_MD offer_VB insights_NNS on_IN the_DT pathways_NNS to_TO health_NN that_WDT surpass_VBP the_DT collective_JJ capacity_NN of_IN the_DT scientific_JJ community_NN 
Community_NNP members_NNS may_MD offer_VB insights_NNS on_IN the_DT pathways_NNS to_TO health_NN that_WDT surpass_VBP the_DT collective_JJ capacity_NN of_IN the_DT scientific_JJ community_NN 
Though_IN not_RB yet_RB established_VBN ,_, it_PRP is_VBZ likely_JJ that_IN when_WRB individuals_NNS and_CC communities_NNS think_VBP about_IN ,_, discuss_VB ,_, and_CC identify_VB their_PRP$ own_JJ pathways_NNS and_CC barriers_NNS to_TO health_NN ,_, they_PRP are_VBP more_RBR likely_JJ to_TO become_VB advocates_NNS for_IN pursuing_VBG these_DT pathways_NNS and_CC overcoming_VBG the_DT barriers_NNS ._. 
Yet_CC there_EX is_VBZ an_DT essential_JJ second_JJ step_NN :_: developing_VBG and_CC implementing_VBG creative_JJ ,_, thoughtful_JJ ,_, and_CC well-grounded_JJ interventions_NNS 
Yet_CC there_EX is_VBZ an_DT essential_JJ second_JJ step_NN :_: developing_VBG and_CC implementing_VBG creative_JJ ,_, thoughtful_JJ ,_, and_CC well-grounded_JJ interventions_NNS 
Still_RB another_DT approach_NN ,_, salutogenesis_NN ,_, studies_NNS factors_NNS that_WDT contribute_VBP to_TO health_NN instead_RB of_IN disease_NN 
Still_RB another_DT approach_NN ,_, salutogenesis_NN ,_, studies_NNS factors_NNS that_WDT contribute_VBP to_TO health_NN instead_RB of_IN disease_NN 
Arelated_JJ systems_NNS methodology_NN suggests_VBZ a_DT ``_`` population_NN system_NN epidemiology_NN ,_, ''_'' where_WRB the_DT population_NN is_VBZ more_JJR than_IN just_RB a_DT group_NN of_IN independent_JJ individuals_NNS 
Arelated_JJ systems_NNS methodology_NN suggests_VBZ a_DT ``_`` population_NN system_NN epidemiology_NN ,_, ''_'' where_WRB the_DT population_NN is_VBZ more_JJR than_IN just_RB a_DT group_NN of_IN independent_JJ individuals_NNS 
The_DT social_JJ and_CC environmental_JJ contexts_NNS that_WDT likely_RB produced_VBD these_DT diseases_NNS will_MD continue_VB to_TO give_VB rise_NN to_TO new_JJ cases_NNS and_CC new_JJ diseases_NNS ._. 
Our_PRP$ efforts_NNS to_TO improve_VB global_JJ health_NN will_MD continue_VB to_TO fall_VB short_RB of_IN our_PRP$ goal_NN ._. 
One_CD approach_NN to_TO solving_VBG this_DT problem_NN may_MD be_VB to_TO focus_VB on_IN health_NN instead_RB of_IN disease_NN ,_, and_CC to_TO develop_VB comprehensive_JJ ,_, multilevel_JJ ,_, health-promoting_JJ policies_NNS and_CC programs_NNS that_WDT are_VBP meaningful_JJ to_TO people_NNS in_IN their_PRP$ communities_NNS ._. 
Based_VBN on_IN this_DT model_NN ,_, we_PRP have_VBP learned_VBN a_DT great_JJ deal_NN about_IN disease-specific_JJ risk_NN factors_NNS ,_, but_CC little_JJ about_IN common_JJ underlying_JJ causes_NNS of_IN multiple_JJ diseases_NNS or_CC overall_JJ health_NN in_IN populations_NNS 
Participants_NNS can_MD be_VB prompted_VBN to_TO think_VB about_IN diverse_JJ aspects_NNS of_IN their_PRP$ lives_NNS that_WDT impact_VBP how_WRB well_RB they_PRP feel_VBP 
Background_NN The_DT global_JJ healthcare_NN system_NN ,_, which_WDT is_VBZ often_RB a_DT ``_`` disease-care_JJ ''_'' system_NN ,_, is_VBZ at_IN a_DT breaking_NN point_NN ._. 
Healthcare_NNP costs_NNS are_VBP escalating_VBG ,_, and_CC disease-prevention_NN strategies_NNS focused_VBD on_IN changing_VBG behaviors_NNS among_IN individuals_NNS ,_, one_CD at_IN a_DT time_NN ,_, have_VBP had_VBD limited_VBN success_NN ._. 
Even_RB if_IN we_PRP were_VBD able_JJ to_TO reduce_VB all_DT risk_NN factors_NNS and_CC cure_VB every_DT individual_JJ suffering_NN from_IN any_DT one_CD given_VBN disease_NN ,_, the_DT occurrence_NN of_IN risk_NN factors_NNS and_CC diseases_NNS would_MD remain_VB nearly_RB unchanged_JJ in_IN the_DT population_NN as_IN a_DT whole_NN ._. 
Based_VBN on_IN this_DT model_NN ,_, we_PRP have_VBP learned_VBN a_DT great_JJ deal_NN about_IN disease-specific_JJ risk_NN factors_NNS ,_, but_CC little_JJ about_IN common_JJ underlying_JJ causes_NNS of_IN multiple_JJ diseases_NNS or_CC overall_JJ health_NN in_IN populations_NNS 
Background_NN The_DT global_JJ healthcare_NN system_NN ,_, which_WDT is_VBZ often_RB a_DT ``_`` disease-care_JJ ''_'' system_NN ,_, is_VBZ at_IN a_DT breaking_NN point_NN ._. 
Healthcare_NNP costs_NNS are_VBP escalating_VBG ,_, and_CC disease-prevention_NN strategies_NNS focused_VBD on_IN changing_VBG behaviors_NNS among_IN individuals_NNS ,_, one_CD at_IN a_DT time_NN ,_, have_VBP had_VBD limited_VBN success_NN ._. 
Even_RB if_IN we_PRP were_VBD able_JJ to_TO reduce_VB all_DT risk_NN factors_NNS and_CC cure_VB every_DT individual_JJ suffering_NN from_IN any_DT one_CD given_VBN disease_NN ,_, the_DT occurrence_NN of_IN risk_NN factors_NNS and_CC diseases_NNS would_MD remain_VB nearly_RB unchanged_JJ in_IN the_DT population_NN as_IN a_DT whole_NN ._. 
Most_RBS public_JJ health_NN research_NN currently_RB focuses_VBZ on_IN identifying_VBG risk_NN factors_NNS for_IN diseases_NNS one_CD at_IN a_DT time_NN at_IN the_DT individual_JJ level_NN ._. 
Based_VBN on_IN this_DT model_NN ,_, we_PRP have_VBP learned_VBN a_DT great_JJ deal_NN about_IN disease-specific_JJ risk_NN factors_NNS ,_, but_CC little_JJ about_IN common_JJ underlying_JJ causes_NNS of_IN multiple_JJ diseases_NNS or_CC overall_JJ health_NN in_IN populations_NNS 
The_DT social_JJ and_CC environmental_JJ contexts_NNS that_WDT likely_RB produced_VBD these_DT diseases_NNS will_MD continue_VB to_TO give_VB rise_NN to_TO new_JJ cases_NNS and_CC new_JJ diseases_NNS ._. 
Our_PRP$ efforts_NNS to_TO improve_VB global_JJ health_NN will_MD continue_VB to_TO fall_VB short_RB of_IN our_PRP$ goal_NN ._. 
One_CD approach_NN to_TO solving_VBG this_DT problem_NN may_MD be_VB to_TO focus_VB on_IN health_NN instead_RB of_IN disease_NN ,_, and_CC to_TO develop_VB comprehensive_JJ ,_, multilevel_JJ ,_, health-promoting_JJ policies_NNS and_CC programs_NNS that_WDT are_VBP meaningful_JJ to_TO people_NNS in_IN their_PRP$ communities_NNS ._. 
Based_VBN on_IN this_DT model_NN ,_, we_PRP have_VBP learned_VBN a_DT great_JJ deal_NN about_IN disease-specific_JJ risk_NN factors_NNS ,_, but_CC little_JJ about_IN common_JJ underlying_JJ causes_NNS of_IN multiple_JJ diseases_NNS or_CC overall_JJ health_NN in_IN populations_NNS 
Understanding_NN health_NN more_RBR broadly_RB will_MD require_VB a_DT commitment_NN to_TO multidisciplinary_JJ collaboration_NN ._. 
This_DT approach_NN to_TO public_JJ health_NN has_VBZ the_DT potential_NN to_TO bridge_VB the_DT gap_NN between_IN research_NN and_CC practice_NN by_IN aligning_VBG public_JJ health_NN professionals_NNS '_POS goals_NNS with_IN community_NN goals_NNS for_IN the_DT health_NN of_IN its_PRP$ members_NNS ._. 
The_DT broad_JJ impact_NN of_IN innovations_NNS from_IN disciplines_NNS not_RB traditionally_RB associated_VBN with_IN health_NN is_VBZ often_RB overlooked_VBN by_IN researchers_NNS working_VBG in_IN disciplinary_JJ silos_NNS defined_VBN by_IN disease_NN category_NN ._. 
Ideally_RB ,_, communities_NNS would_MD be_VB able_JJ to_TO identify_VB and_CC communicate_VB with_IN researchers_NNS the_DT approaches_NNS that_WDT are_VBP aligned_VBN with_IN their_PRP$ goals_NNS for_IN population_NN health_NN ._. 
Understanding_NN how_WRB and_CC why_WRB some_DT people_NNS remain_VBP healthy_JJ is_VBZ an_DT important_JJ complementary_JJ strategy_NN and_CC may_MD help_VB advance_VB public_JJ health_NN research_NN and_CC practice_NN ._. 
We_PRP could_MD ask_VB ,_, for_IN example_NN ,_, what_WP permits_VBZ 90_CD 
956_CD Combined_NNP -LRB-_-LRB- Nature_NNP Vols_NNPS 409_CD 
042_CD and_CC p_VB =_SYM 0_CD ._. 
Even_RB aside_RB from_IN the_DT fact_NN that_WDT p_VBP =_SYM 0_CD ._. 
086_CD would_MD seem_VB pointless_JJ ._. 
042_CD or_CC 0_CD ._. 
Therefore_RB ,_, quarrelling_VBG over_IN whether_IN the_DT correct_JJ p-value_NN is_VBZ 0_CD ._. 
086_CD have_VBP virtually_RB identical_JJ interpretations_NNS in_IN terms_NNS of_IN relative_JJ likelihoods_NNS for_IN the_DT hypotheses_NNS being_VBG considered_VBN ,_, it_PRP is_VBZ clear_JJ from_IN the_DT above_JJ discussion_NN that_IN when_WRB the_DT null_NN is_VBZ almost_RB certainly_RB false_JJ ,_, that_IN to_TO attain_VB the_DT coveted_JJ p_NN 
e._JJ But_CC given_VBN how_WRB often_RB a_DT particular_JJ study_NN fails_VBZ to_TO generate_VB the_DT expected_VBN result_NN to_TO a_DT strong_JJ degree_NN ,_, publication_NN bias_NN on_IN the_DT part_NN of_IN the_DT journal_NN and_CC selective_JJ reporting_NN by_IN the_DT authors_NNS -LRB-_-LRB- i._NN ,_, in_IN choosing_NN which_WDT test_NN results_NNS to_TO display_VB and_CC how_WRB many_JJ digits_NNS to_TO display_VB -RRB-_-RRB- seem_VBP likely_JJ to_TO be_VB major_JJ contributors_NNS to_TO the_DT observed_JJ patterns_NNS ._. 
It_PRP is_VBZ important_JJ to_TO bear_VB in_IN mind_NN that_IN while_IN Jeng_NNP 's_POS model_NN may_MD be_VB a_DT substantial_JJ improvement_NN over_IN the_DT original_JJ continuous-value_JJ model_NN ,_, it_PRP is_VBZ still_RB a_DT model_NN with_IN strong_JJ assumptions_NNS ._. 
Clearly_RB ,_, more_JJR needs_NNS to_TO be_VB done_VBN to_TO allow_VB critical_JJ readers_NNS the_DT chance_NN to_TO continue_VB the_DT peer_VB review_NN after_IN a_DT paper_NN is_VBZ published_VBN 
In_IN response_NN to_TO these_DT concerns_NNS ,_, we_PRP offer_VBP the_DT following_JJ critique_NN of_IN a_DT critique_NN of_IN a_DT critique_NN ,_, or_CC in_IN keeping_VBG with_IN the_DT title_NN of_IN this_DT analysis_NN ,_, a_DT critique_NN 3_CD ._. 
DiscussionOne_NNP of_IN the_DT best_JJS established_JJ tenets_NNS of_IN modern_JJ biomedical_JJ statistics_NNS is_VBZ that_IN results_NNS should_MD not_RB be_VB reported_VBN as_RB merely_RB statistically_RB significant_JJ or_CC not_RB ,_, as_IN was_VBD the_DT common_JJ practice_NN decades_NNS ago_RB and_CC is_VBZ still_RB woefully_RB too_RB common_JJ in_IN some_DT allied_VBN sciences_NNS ._. 
Although_IN the_DT journal_NN that_WDT produced_VBD the_DT data_NNS used_VBN in_IN these_DT critiques_NNS ,_, Nature_NNP ,_, is_VBZ not_RB primarily_RB a_DT health_NN science_NN journal_NN ,_, the_DT critiques_NNS appeared_VBD in_IN a_DT journal_NN devoted_VBN to_TO research_NN methods_NNS in_IN the_DT health_NN sciences_NNS ,_, and_CC so_IN it_PRP is_VBZ reasonable_JJ to_TO hold_VB those_DT analyses_NNS to_TO the_DT standards_NNS of_IN modern_JJ epidemiology_NN and_CC biostatistics_NNS ._. 
In_IN response_NN to_TO these_DT concerns_NNS ,_, we_PRP offer_VBP the_DT following_JJ critique_NN of_IN a_DT critique_NN of_IN a_DT critique_NN ,_, or_CC in_IN keeping_VBG with_IN the_DT title_NN of_IN this_DT analysis_NN ,_, a_DT critique_NN 3_CD ._. 
DiscussionOne_NNP of_IN the_DT best_JJS established_JJ tenets_NNS of_IN modern_JJ biomedical_JJ statistics_NNS is_VBZ that_IN results_NNS should_MD not_RB be_VB reported_VBN as_RB merely_RB statistically_RB significant_JJ or_CC not_RB ,_, as_IN was_VBD the_DT common_JJ practice_NN decades_NNS ago_RB and_CC is_VBZ still_RB woefully_RB too_RB common_JJ in_IN some_DT allied_VBN sciences_NNS ._. 
Although_IN the_DT journal_NN that_WDT produced_VBD the_DT data_NNS used_VBN in_IN these_DT critiques_NNS ,_, Nature_NNP ,_, is_VBZ not_RB primarily_RB a_DT health_NN science_NN journal_NN ,_, the_DT critiques_NNS appeared_VBD in_IN a_DT journal_NN devoted_VBN to_TO research_NN methods_NNS in_IN the_DT health_NN sciences_NNS ,_, and_CC so_IN it_PRP is_VBZ reasonable_JJ to_TO hold_VB those_DT analyses_NNS to_TO the_DT standards_NNS of_IN modern_JJ epidemiology_NN and_CC biostatistics_NNS ._. 
,effect_NN estimates_NNS in_IN risk-factor_JJ studies_NNS -RRB-_-RRB- ,_, confidence_NN intervals_NNS are_VBP easy_JJ to_TO calculate_VB and_CC report_VB ,_, and_CC are_VBP the_DT preferred_JJ statistics_NNS ,_, as_IN noted_VBN by_IN GBA_NNP in_IN their_PRP$ article_NN ._. 
For_IN some_DT analyses_NNS ,_, such_JJ as_IN tests_NNS of_IN trend_NN and_CC tests_NNS of_IN homogeneity_NN ,_, there_EX is_VBZ no_DT confidence_NN interval_NN to_TO be_VB calculated_VBN and_CC a_DT p-value_NN may_MD be_VB a_DT convenient_JJ summary_NN ._. 
But_CC even_RB in_IN these_DT situations_NNS it_PRP is_VBZ clearly_RB deficient_JJ to_TO revert_VB to_TO a_DT na_TO 
Suggesting_VBG otherwise_RB reinforces_VBZ a_DT much_RB more_RBR common_JJ statistical_JJ error_NN in_IN the_DT health_NN sciences_NNS 
Jeng_NNP managed_VBD to_TO diagnose_VB exactly_RB what_WDT statistic_NN GBA_NNP used_VBD -LRB-_-LRB- to_TO confirm_VB their_PRP$ calculation_NN was_VBD based_VBN on_IN the_DT null_JJ hypothesis_NN of_IN a_DT continuous_JJ distribution_NN -RRB-_-RRB- ,_, but_CC this_DT is_VBZ only_RB because_IN they_PRP published_VBD their_PRP$ data_NNS -LRB-_-LRB- to_TO the_DT credit_NN of_IN these_DT authors_NNS and_CC the_DT journal_NN -RRB-_-RRB- and_CC were_VBD doing_VBG a_DT fairly_RB simple_JJ analysis_NN ._. 
This_DT is_VBZ a_DT rare_JJ circumstance_NN ,_, although_IN published_JJ re-analyses_NNS do_VBP appear_VB occasionally_RB ._. 
Furthermore_RB ,_, even_RB with_IN full_JJ access_NN to_TO data_NNS and_CC models_NNS ,_, many_JJ errors_NNS will_MD escape_VB the_DT scrutiny_NN of_IN whatever_WDT reviewers_NNS and_CC editors_NNS vet_NN a_DT publication_NN ._. 
The_DT explanation_NN for_IN this_DT divergence_NN seems_VBZ unlikely_JJ to_TO be_VB that_IN suggested_VBN by_IN the_DT previous_JJ authors_NNS :_: errors_NNS in_IN calculations_NNS and_CC transcription_NN ._. 
BackgroundIn_NN 2004_CD ,_, Garcia-Berthou_NNP and_CC Alcaraz_NNP 
''_'' This_DT article_NN reported_VBD that_IN last_JJ digits_NNS of_IN published_JJ test_NN statistics_NNS and_CC p-values_NNS in_IN a_DT sample_NN of_IN consecutive_JJ articles_NNS from_IN Nature_NN deviated_VBN from_IN a_DT uniform_JJ distribution_NN more_JJR than_IN would_MD be_VB expected_VBN by_IN chance_NN ._. 
The_DT article_NN ,_, which_WDT also_RB examined_VBD incongruence_NN between_IN reported_VBN statistics_NNS and_CC p-values_NNS ,_, attracted_VBD a_DT great_JJ deal_NN of_IN attention_NN among_IN journal_NN editors_NNS ,_, the_DT popular_JJ press_NN ,_, and_CC a_DT large_JJ number_NN of_IN readers_NNS 
The_DT article_NN ,_, which_WDT also_RB examined_VBD incongruence_NN between_IN reported_VBN statistics_NNS and_CC p-values_NNS ,_, attracted_VBD a_DT great_JJ deal_NN of_IN attention_NN among_IN journal_NN editors_NNS ,_, the_DT popular_JJ press_NN ,_, and_CC a_DT large_JJ number_NN of_IN readers_NNS 
05_CD criterion_NN as_IN if_IN that_DT were_VBD definitive_JJ ,_, without_IN any_DT discussion_NN of_IN power_NN or_CC study_NN biases_NNS ._. 
But_CC even_RB in_IN these_DT situations_NNS it_PRP is_VBZ clearly_RB deficient_JJ to_TO revert_VB to_TO a_DT na_TO 
In_IN their_PRP$ conclusions_NNS ,_, GBA_NNP argue_VBP that_IN ,_, ''_'' 
Null-hypothesis_JJ significance_NN testing_NN may_MD be_VB considered_VBN appropriate_JJ in_IN situations_NNS when_WRB we_PRP are_VBP primarily_RB interested_JJ in_IN assessing_VBG whether_IN a_DT certain_JJ phenomenon_NN exists_VBZ ,_, regardless_RB of_IN the_DT magnitude_NN 
But_CC the_DT null_NN in_IN this_DT scenario_NN might_MD actually_RB be_VB rejected_VBN without_IN even_RB having_VBG to_TO observe_VB any_DT data_NNS at_IN all_DT ._. 
In_IN a_DT subsequently_RB published_VBN note_NN ,_, Senn_NNP observed_VBD that_IN even_RB without_IN any_DT improprieties_NNS in_IN study_NN conduct_NN ,_, the_DT distribution_NN of_IN terminal_NN digits_NNS can_MD not_RB be_VB expected_VBN to_TO be_VB uniform_JJ when_WRB the_DT null_NN is_VBZ not_RB true_JJ ._. 
Furthermore_RB ,_, digit_NN frequencies_NNS will_MD additionally_RB be_VB distorted_VBN by_IN a_DT deficit_NN of_IN zeros_NNS resulting_VBG from_IN the_DT common_JJ but_CC inappropriate_JJ practice_NN of_IN dropping_VBG the_DT zero_NN as_IN a_DT final_JJ digit_NN when_WRB it_PRP would_MD have_VB been_VBN printed_VBN if_IN it_PRP were_VBD non-zero_JJ ._. 
It_PRP is_VBZ important_JJ to_TO bear_VB in_IN mind_NN that_IN while_IN Jeng_NNP 's_POS model_NN may_MD be_VB a_DT substantial_JJ improvement_NN over_IN the_DT original_JJ continuous-value_JJ model_NN ,_, it_PRP is_VBZ still_RB a_DT model_NN with_IN strong_JJ assumptions_NNS ._. 
For_IN example_NN ,_, it_PRP assumes_VBZ that_IN the_DT terminal_JJ digits_NNS should_MD follow_VB a_DT uniform_JJ distribution_NN in_IN the_DT absence_NN of_IN errors_NNS ,_, a_DT premise_NN refuted_VBN by_IN Senn_NNP ._. 
Even_RB if_IN Jeng_NNP 's_POS model_NN were_VBD considered_VBN reasonable_JJ enough_RB to_TO produce_VB an_DT informative_JJ analysis_NN ,_, the_DT implication_NN of_IN the_DT dialog_NN -LRB-_-LRB- and_CC almost_RB all_DT such_JJ dialogs_NNS in_IN biostatistics_NNS and_CC epidemiology_NN -RRB-_-RRB- is_VBZ that_IN the_DT initial_JJ analysis_NN was_VBD right_JJ ,_, until_IN it_PRP was_VBD proven_VBN to_TO be_VB wrong_JJ ,_, at_IN which_WDT point_NN the_DT second_JJ analysis_NN was_VBD assumed_VBN to_TO be_VB right_JJ ._. 
Furthermore_RB ,_, even_RB with_IN full_JJ access_NN to_TO data_NNS and_CC models_NNS ,_, many_JJ errors_NNS will_MD escape_VB the_DT scrutiny_NN of_IN whatever_WDT reviewers_NNS and_CC editors_NNS vet_NN a_DT publication_NN ._. 
In_IN the_DT present_JJ case_NN ,_, for_IN example_NN ,_, the_DT original_JJ reviewers_NNS missed_VBD the_DT opportunity_NN to_TO catch_VB the_DT same_JJ error_NN that_IN Jeng_NNP did_VBD ,_, and_CC all_DT parties_NNS involved_VBN -LRB-_-LRB- including_VBG ourselves_PRP -RRB-_-RRB- missed_VBD the_DT point_NN made_VBN later_RB by_IN Senn_NNP that_IN the_DT distribution_NN on_IN final_JJ digits_NNS would_MD not_RB be_VB uniform_JJ even_RB in_IN the_DT absence_NN of_IN errors_NNS ._. 
As_IN journal_NN reviewers_NNS 
Thus_RB ,_, we_PRP do_VBP not_RB intend_VB a_DT critique_NN of_IN individuals_NNS ,_, but_CC an_DT observation_NN that_IN the_DT finite_JJ capacities_NNS of_IN a_DT few_JJ busy_JJ people_NNS will_MD inevitably_RB let_VB important_JJ errors_NNS escape_VBP notice_NN ._. 
Clearly_RB ,_, more_JJR needs_NNS to_TO be_VB done_VBN to_TO allow_VB critical_JJ readers_NNS the_DT chance_NN to_TO continue_VB the_DT peer_VB review_NN after_IN a_DT paper_NN is_VBZ published_VBN 
Not_RB all_DT empirical_JJ findings_NNS are_VBP perfectly_RB in_IN line_NN with_IN the_DT model_NN of_IN migration_NN as_IN a_DT health_NN transition_NN ._. 
An_DT example_NN is_VBZ the_DT increased_VBN risk_NN -LRB-_-LRB- measured_VBN by_IN mortality_NN or_CC health_NN care_NN utilization_NN -RRB-_-RRB- for_IN CVD_NNP among_IN migrants_NNS from_IN South_NNP Asia_NNP in_IN the_DT UK_NNP 
Other_JJ important_JJ factors_NNS such_JJ as_IN family_NN history_NN ,_, socioeconomic_JJ status_NN ,_, education_NN and_CC living_NN conditions_NNS ,_, as_RB well_RB as_IN health_NN behavior_NN like_IN nutrition_NN ,_, physical_JJ activity_NN ,_, and_CC alcohol_NN and_CC tobacco_NN consumption_NN can_MD act_VB during_IN different_JJ periods_NNS of_IN the_DT migrants_NNS '_POS life_NN ._. 
Accumulations_NNS and_CC interactions_NNS of_IN exposures_NNS in_IN migrants_NNS can_MD occur_VB in_IN several_JJ ways_NNS ,_, including_VBG the_DT accumulation_NN of_IN ``_`` pack_NN years_NNS ''_'' ,_, changed_VBN by_IN migration_NN due_JJ to_TO availability_NN of_IN cigarettes_NNS 
Not_RB all_DT empirical_JJ findings_NNS are_VBP perfectly_RB in_IN line_NN with_IN the_DT model_NN of_IN migration_NN as_IN a_DT health_NN transition_NN ._. 
An_DT example_NN is_VBZ the_DT increased_VBN risk_NN -LRB-_-LRB- measured_VBN by_IN mortality_NN or_CC health_NN care_NN utilization_NN -RRB-_-RRB- for_IN CVD_NNP among_IN migrants_NNS from_IN South_NNP Asia_NNP in_IN the_DT UK_NNP 
Singh_NNP 
Contributing_VBG causes_NNS of_IN these_DT increased_VBN risks_NNS could_MD be_VB that_IN infections_NNS with_IN Helicobacter_NNP pylori_NNP and_CC hepatitis_NNP virus_NN ,_, respectively_RB ,_, are_VBP common_JJ in_IN childhood_NN in_IN economically_RB less-developed_JJ countries_NNS ._. 
Also_RB ,_, the_DT risk_NN for_IN hemorrhagic_JJ stroke_NN is_VBZ increased_VBN among_IN migrants_NNS from_IN these_DT countries_NNS ,_, again_RB associated_VBN with_IN deprived_VBN living_NN conditions_NNS before_IN migration_NN ._. 
Empirical_JJ findings_NNS such_JJ as_IN these_DT demonstrate_VBP that_IN migrants_NNS might_MD face_VB specific_JJ exposures_NNS during_IN childhood_NN -_: a_DT critical_JJ period_NN -_: which_WDT contribute_VBP to_TO health_NN differentials_NNS in_IN later_JJ life_NN in_IN the_DT host_NN country_NN ._. 
Such_JJ polymorphisms_NNS can_MD result_VB in_IN different_JJ disease_NN risks_NNS ._. 
Additionally_RB ,_, differences_NNS in_IN the_DT genetic_JJ background_NN -LRB-_-LRB- ``_`` nature_NN ''_'' -RRB-_-RRB- might_MD exist_VB ,_, due_JJ to_TO geographic_JJ and_CC ethnic_JJ variation_NN in_IN the_DT genetic_JJ make-up_NN of_IN humans_NNS ._. 
An_DT example_NN is_VBZ differences_NNS in_IN blood_NN concentrations_NNS of_IN high-density_JJ lipoprotein_NN cholesterols_NNS -LRB-_-LRB- HDL-C_NNP -RRB-_-RRB- between_IN people_NNS from_IN North-West_NNP Europe_NNP and_CC East_NNP Turkey_NNP due_JJ to_TO genetic_JJ polymorphisms_NNS ._. 
Studying_VBG the_DT explanatory_JJ variables_NNS of_IN migrant_JJ health_NN is_VBZ thus_RB complex_JJ ._. 
The_DT different_JJ factors_NNS of_IN nature_NN and_CC nurture_VB act_NN on_IN their_PRP$ own_JJ and_CC in_IN combination_NN -LRB-_-LRB- interaction_NN -RRB-_-RRB- ,_, i._SYM 
This_DT mortality_NN advantage_NN can_MD be_VB substantial_JJ ._. 
Migration_NN as_IN health_NN transition_NN Some_DT migrant_JJ populations_NNS experience_VBP a_DT lower_JJR mortality_NN than_IN the_DT indigenous_JJ populations_NNS ,_, despite_IN their_PRP$ ,_, on_IN average_NN ,_, lower_JJR socio-economic_JJ status_NN ._. 
Singh_NNP 
Another_DT consequence_NN of_IN the_DT health_NN transition_NN is_VBZ that_IN migrant_JJ populations_NNS may_MD experience_VB an_DT increased_VBN mortality_NN for_IN specific_JJ diseases_NNS ._. 
In_IN the_DT study_NN of_IN Singh_NNP 
Other_JJ forms_NNS of_IN migrant_JJ studies_NNS ,_, such_JJ as_IN qualitative_JJ studies_NNS ,_, are_VBP not_RB explicitly_RB considered_VBN ._. 
Our_PRP$ focus_NN is_VBZ on_IN developing_VBG a_DT framework_NN for_IN epidemiological_JJ migrant_JJ studies_NNS ._. 
Life_NNP course_NN epidemiologyLife_NNP course_NN epidemiology_NN can_MD be_VB defined_VBN as_IN the_DT study_NN of_IN physical_JJ or_CC social_JJ exposures_NNS during_IN gestation_NN ,_, childhood_NN ,_, adolescence_NN ,_, young_JJ adulthood_NN and_CC also_RB adult_JJ life_NN ,_, with_IN the_DT aim_NN ofexamining_VBG their_PRP$ long-term_JJ effects_NNS on_IN health_NN or_CC disease_NN risk_NN in_IN later_JJ life_NN ._. 
Life_NNP course_NN epidemiology_NN can_MD help_VB to_TO construct_VB models_NNS of_IN disease_NN aetiology_NN with_IN an_DT emphasis_NN on_IN timing_NN -LRB-_-LRB- critical\/sensitive_JJ periods_NNS -RRB-_-RRB- ,_, duration_NN -LRB-_-LRB- accumulation_NN -RRB-_-RRB- ,_, and_CC temporal_JJ sequence_NN -LRB-_-LRB- triggers\/interactions_NNS -RRB-_-RRB- of_IN exposures_NNS 
Life_NNP course_NN epidemiology_NN Life_NN course_NN epidemiology_NN can_MD be_VB defined_VBN as_IN the_DT study_NN of_IN physical_JJ or_CC social_JJ exposures_NNS during_IN gestation_NN ,_, childhood_NN ,_, adolescence_NN ,_, young_JJ adulthood_NN and_CC also_RB adult_JJ life_NN ,_, with_IN the_DT aim_NN ofexamining_VBG their_PRP$ long-term_JJ effects_NNS on_IN health_NN or_CC disease_NN risk_NN in_IN later_JJ life_NN ._. 
Life_NNP course_NN epidemiology_NN can_MD help_VB to_TO construct_VB models_NNS of_IN disease_NN aetiology_NN with_IN an_DT emphasis_NN on_IN timing_NN -LRB-_-LRB- critical\/sensitive_JJ periods_NNS -RRB-_-RRB- ,_, duration_NN -LRB-_-LRB- accumulation_NN -RRB-_-RRB- ,_, and_CC temporal_JJ sequence_NN -LRB-_-LRB- triggers\/interactions_NNS -RRB-_-RRB- of_IN exposures_NNS 
-RRB-_-RRB- ._. 
Migrants_NNS often_RB face_VBP different_JJ exposures_NNS in_IN their_PRP$ life_NN course_NN compared_VBN with_IN the_DT autochthonous_JJ populations_NNS of_IN the_DT host_NN countries_NNS due_JJ to_TO the_DT different_JJ situation_NN in_IN their_PRP$ home_NN countries_NNS -LRB-_-LRB- nutrition_NN ,_, hygiene_NN ,_, prevalence_NN of_IN infectious_JJ diseases_NNS ,_, etc._FW ._. 
The_DT inclusive_JJ consideration_NN of_IN these_DT different_JJ influences_NNS and_CC their_PRP$ time_NN scale_NN in_IN a_DT life_NN course_NN perspective_NN ,_, currently_RB an_DT important_JJ theme_NN in_IN Public_NNP Health\/Epidemiology_NNP ,_, is_VBZ still_RB missing_VBG in_IN the_DT research_NN on_IN migrant_JJ health_NN ._. 
Alife_JJ course_NN approach_NN Figure_NN 1_CD shows_VBZ a_DT conceptual_JJ framework_NN for_IN migration_NN and_CC health_NN integrating_VBG the_DT influence_NN of_IN exposures_NNS that_IN migrants_NNS face_VBP during_IN their_PRP$ life_NN course_NN ._. 
Such_JJ polymorphisms_NNS can_MD result_VB in_IN different_JJ disease_NN risks_NNS ._. 
Additionally_RB ,_, differences_NNS in_IN the_DT genetic_JJ background_NN -LRB-_-LRB- ``_`` nature_NN ''_'' -RRB-_-RRB- might_MD exist_VB ,_, due_JJ to_TO geographic_JJ and_CC ethnic_JJ variation_NN in_IN the_DT genetic_JJ make-up_NN of_IN humans_NNS ._. 
An_DT example_NN is_VBZ differences_NNS in_IN blood_NN concentrations_NNS of_IN high-density_JJ lipoprotein_NN cholesterols_NNS -LRB-_-LRB- HDL-C_NNP -RRB-_-RRB- between_IN people_NNS from_IN North-West_NNP Europe_NNP and_CC East_NNP Turkey_NNP due_JJ to_TO genetic_JJ polymorphisms_NNS ._. 
Studying_VBG the_DT explanatory_JJ variables_NNS of_IN migrant_JJ health_NN is_VBZ thus_RB complex_JJ ._. 
The_DT different_JJ factors_NNS of_IN nature_NN and_CC nurture_VB act_NN on_IN their_PRP$ own_JJ and_CC in_IN combination_NN -LRB-_-LRB- interaction_NN -RRB-_-RRB- ,_, i._SYM 
This_DT increase_NN occurs_VBZ rapidly_RB after_IN migration_NN ._. 
An_DT example_NN is_VBZ the_DT increased_VBN risk_NN -LRB-_-LRB- measured_VBN by_IN mortality_NN or_CC health_NN care_NN utilization_NN -RRB-_-RRB- for_IN CVD_NNP among_IN migrants_NNS from_IN South_NNP Asia_NNP in_IN the_DT UK_NNP 
Other_JJ important_JJ factors_NNS such_JJ as_IN family_NN history_NN ,_, socioeconomic_JJ status_NN ,_, education_NN and_CC living_NN conditions_NNS ,_, as_RB well_RB as_IN health_NN behavior_NN like_IN nutrition_NN ,_, physical_JJ activity_NN ,_, and_CC alcohol_NN and_CC tobacco_NN consumption_NN can_MD act_VB during_IN different_JJ periods_NNS of_IN the_DT migrants_NNS '_POS life_NN ._. 
Accumulations_NNS and_CC interactions_NNS of_IN exposures_NNS in_IN migrants_NNS can_MD occur_VB in_IN several_JJ ways_NNS ,_, including_VBG the_DT accumulation_NN of_IN ``_`` pack_NN years_NNS ''_'' ,_, changed_VBN by_IN migration_NN due_JJ to_TO availability_NN of_IN cigarettes_NNS 
Here_RB ,_, a_DT health_NN transition_NN does_VBZ occur_VB ,_, but_CC its_PRP$ effects_NNS are_VBP enhanced_VBN by_IN a_DT gene-environment_JJ interaction_NN ._. 
In_IN contrast_NN to_TO South_JJ Asian_JJ migrants_NNS ,_, ethnic_JJ German_JJ re-settlers_NNS from_IN Eastern_NNP Europe_NNP -LRB-_-LRB- Aussiedler_NNP -RRB-_-RRB- have_VBP a_DT lower_JJR CVD_NNP mortality_NN compared_VBN with_IN the_DT indigenous_JJ German_JJ population_NN ._. 
No_DT marked_JJ increase_NN over_IN time_NN is_VBZ visible_JJ at_IN present_NN ;_: however_RB ,_, the_DT post-migration_JJ observation_NN period_NN is_VBZ still_RB somewhat_RB short_JJ ._. 
In_IN a_DT ``_`` nutrition_NN transition_NN ''_'' ,_, dietary_JJ changes_NNS can_MD be_VB accompanied_VBN by_IN changes_NNS in_IN physical_JJ activity_NN and_CC obesity_NN trends_NNS 
Studies_NNS including_VBG all_PDT these_DT factors_NNS require_VBP a_DT longitudinal_JJ follow-up_JJ not_RB only_RB of_IN a_DT migrant_JJ population_NN ,_, but_CC also_RB of_IN the_DT population_NN in_IN the_DT country_NN of_IN origin_NN and_CC in_IN the_DT host_NN country_NN ._. 
Such_JJ studies_NNS pose_VBP enormous_JJ methodological_JJ challenges_NNS :_: An_DT appropriate_JJ instrument_NN to_TO examine_VB life_NN course_NN aspects_NNS is_VBZ a_DT prospective_JJ birth_NN cohort_NN ;_: however_RB ,_, such_JJ studies_NNS are_VBP very_RB difficult_JJ to_TO implement_VB with_IN first_JJ generation_NN migrants_NNS ,_, because_IN these_DT persons_NNS would_MD have_VB to_TO be_VB included_VBN before_IN migration_NN while_IN still_RB in_IN their_PRP$ countries_NNS of_IN origin_NN ,_, and_CC even_RB before_IN they_PRP even_RB know_VBP that_IN they_PRP might_MD migrate_VB in_IN future_NN ._. 
Given_VBN these_DT obvious_JJ obstacles_NNS ,_, a_DT retrospective_JJ exposure_NN assessment_NN has_VBZ been_VBN the_DT way_NN of_IN choice_NN in_IN migrant_JJ studies_NNS so_RB far_RB ._. 
However_RB ,_, in_IN some_DT countries_NNS of_IN origin_NN ,_, such_JJ as_IN Turkey_NNP ,_, the_DT quality_NN and_CC quantity_NN of_IN health_NN data_NNS is_VBZ improving_VBG ._. 
New_JJ mortality_NN and_CC disease_NN registries_NNS are_VBP being_VBG set_VBN up_RP ,_, thus_RB providing_VBG new_JJ opportunities_NNS for_IN transnational_JJ migrant_JJ health_NN research_NN ._. 
In_IN other_JJ countries_NNS of_IN origin_NN ,_, there_EX are_VBP still_RB far_RB too_RB little_JJ data_NNS available_JJ for_IN such_JJ studies_NNS ._. 
The_DT challenge_NN of_IN selecting_VBG suitable_JJ comparison_NN groups_NNS Researchers_NNS need_VBP to_TO consider_VB against_IN which_WDT population_NN -LRB-_-LRB- s_PRP -RRB-_-RRB- the_DT health_NN status_NN of_IN a_DT migrant_JJ population_NN should_MD be_VB compared_VBN ,_, in_IN particular_JJ when_WRB transnational_JJ epidemiological_JJ studies_NNS are_VBP possible_JJ ._. 
Moreover_RB ,_, they_PRP may_MD to_TO some_DT extent_NN be_VB more_RBR acculturated_VBN or_CC segregated_VBN than_IN their_PRP$ parents_NNS ._. 
The_DT health_NN situation_NN of_IN the_DT second_JJ generation_NN is_VBZ different_JJ to_TO the_DT health_NN situation_NN of_IN first_JJ generation_NN migrants_NNS ,_, because_IN the_DT former_NN did_VBD not_RB face_VB the_DT exposures_NNS in_IN the_DT country_NN of_IN origin_NN and_CC during_IN the_DT migration_NN process_NN ._. 
The_DT higher_JJR disease_NN risks_NNS of_IN migrants_NNS might_MD converge_VB with_IN the_DT risks_NNS of_IN the_DT autochthonous_JJ population_NN in_IN the_DT second_JJ generation_NN or_CC in_IN younger_JJR birth_NN cohorts_NNS ,_, as_IN shown_VBN by_IN studies_NNS about_IN cancer_NN risks_NNS among_IN migrants_NNS in_IN the_DT Netherlands_NNP 
Acculturation_NNP could_MD be_VB a_DT crucial_JJ factor_NN for_IN changes_NNS in_IN health-related_JJ behavior_NN after_IN migration_NN or_CC between_IN generations_NNS ._. 
In_IN the_DT so_RB called_VBN ``_`` dietary_JJ acculturation_NN ''_'' ,_, for_IN example_NN ,_, dietary_JJ habits_NNS of_IN ethnic_JJ minorities_NNS are_VBP becoming_VBG less_RBR healthy_JJ due_JJ to_TO increased_VBN intake_NN of_IN fat_NN ,_, sugar_NN ,_, salt_NN and_CC processed_JJ food_NN 
In_IN a_DT ``_`` nutrition_NN transition_NN ''_'' ,_, dietary_JJ changes_NNS can_MD be_VB accompanied_VBN by_IN changes_NNS in_IN physical_JJ activity_NN and_CC obesity_NN trends_NNS 
In_IN the_DT so_RB called_VBN ``_`` dietary_JJ acculturation_NN ''_'' ,_, for_IN example_NN ,_, dietary_JJ habits_NNS of_IN ethnic_JJ minorities_NNS are_VBP becoming_VBG less_RBR healthy_JJ due_JJ to_TO increased_VBN intake_NN of_IN fat_NN ,_, sugar_NN ,_, salt_NN and_CC processed_JJ food_NN 
In_IN a_DT ``_`` nutrition_NN transition_NN ''_'' ,_, dietary_JJ changes_NNS can_MD be_VB accompanied_VBN by_IN changes_NNS in_IN physical_JJ activity_NN and_CC obesity_NN trends_NNS 
For_IN example_NN ,_, the_DT increased_VBN risks_NNS for_IN lymphatic_JJ leukemia_NN among_IN Turkish_JJ migrants_NNS in_IN Hamburg_NNP ,_, Germany_NNP ,_, might_MD be_VB the_DT result_NN of_IN a_DT higher_JJR prevalence_NN of_IN exposure_NN to_TO Epstein-Barr_NNP virus_NN in_IN Turkey_NNP before_IN migration_NN 
For_IN example_NN ,_, the_DT increased_VBN risks_NNS for_IN lymphatic_JJ leukemia_NN among_IN Turkish_JJ migrants_NNS in_IN Hamburg_NNP ,_, Germany_NNP ,_, might_MD be_VB the_DT result_NN of_IN a_DT higher_JJR prevalence_NN of_IN exposure_NN to_TO Epstein-Barr_NNP virus_NN in_IN Turkey_NNP before_IN migration_NN 
Specific_JJ cultural_JJ beliefs_NNS and_CC behaviors_NNS of_IN ethnic_JJ minorities_NNS may_MD persist_VB over_IN generations_NNS ._. 
For_IN example_NN ,_, cultural_JJ beliefs_NNS ,_, health_NN behaviors_NNS -LRB-_-LRB- nutrition_NN ,_, smoking_NN and_CC alcohol_NN consumption_NN -RRB-_-RRB- ,_, reproductive_JJ factors_NNS and_CC physical_JJ activity_NN are_VBP influenced_VBN by_IN the_DT parents_NNS '_POS lifestyle_NN and_CC behavior_NN ._. 
Socio-economic_JJ conditions_NNS of_IN the_DT parents_NNS determine_VBP the_DT socio-economic_JJ situation_NN of_IN the_DT offspring_NN during_IN childhood_NN and_CC can_MD have_VB a_DT persisting_VBG influence_NN in_IN later_JJ life_NN ._. 
For_IN these_DT reasons_NNS ,_, and_CC due_JJ to_TO their_PRP$ acculturation_NN ,_, the_DT health_NN situation_NN of_IN members_NNS of_IN the_DT second_JJ generation_NN and_CC of_IN ethnic_JJ minorities_NNS differs_VBZ from_IN that_DT of_IN the_DT autochthonous_JJ population_NN ._. 
Moreover_RB ,_, they_PRP may_MD to_TO some_DT extent_NN be_VB more_RBR acculturated_VBN or_CC segregated_VBN than_IN their_PRP$ parents_NNS ._. 
The_DT health_NN situation_NN of_IN the_DT second_JJ generation_NN is_VBZ different_JJ to_TO the_DT health_NN situation_NN of_IN first_JJ generation_NN migrants_NNS ,_, because_IN the_DT former_NN did_VBD not_RB face_VB the_DT exposures_NNS in_IN the_DT country_NN of_IN origin_NN and_CC during_IN the_DT migration_NN process_NN ._. 
The_DT higher_JJR disease_NN risks_NNS of_IN migrants_NNS might_MD converge_VB with_IN the_DT risks_NNS of_IN the_DT autochthonous_JJ population_NN in_IN the_DT second_JJ generation_NN or_CC in_IN younger_JJR birth_NN cohorts_NNS ,_, as_IN shown_VBN by_IN studies_NNS about_IN cancer_NN risks_NNS among_IN migrants_NNS in_IN the_DT Netherlands_NNP 
Studies_NNS taking_VBG this_DT life_NN course_NN framework_NN into_IN account_NN will_MD provide_VB new_JJ insights_NNS in_IN the_DT development_NN of_IN disease_NN and_CC the_DT health_NN situation_NN of_IN migrants_NNS ._. 
For_IN example_NN ,_, analyses_NNS of_IN the_DT change_NN of_IN cancer_NN risks_NNS over_IN time_NN since_IN migration_NN or_CC between_IN migrant_JJ generations_NNS can_MD provide_VB new_JJ insights_NNS into_IN the_DT causes_NNS of_IN cancer_NN ,_, as_RB well_RB as_IN critical_JJ periods_NNS ,_, promoting_VBG factors_NNS ,_, the_DT influence_NN of_IN genes_NNS and_CC environment_NN ,_, and_CC latency_NN periods_NNS of_IN the_DT different_JJ processes_NNS ._. 
We_PRP believe_VBP that_IN further_JJ discussion_NN is_VBZ essential_JJ for_IN developing_VBG the_DT theoretical_JJ framework_NN of_IN migrant_JJ health_NN and_CC for_IN improving_VBG future_JJ empirical_JJ studies_NNS ._. 
For_IN example_NN ,_, the_DT increased_VBN risks_NNS for_IN lymphatic_JJ leukemia_NN among_IN Turkish_JJ migrants_NNS in_IN Hamburg_NNP ,_, Germany_NNP ,_, might_MD be_VB the_DT result_NN of_IN a_DT higher_JJR prevalence_NN of_IN exposure_NN to_TO Epstein-Barr_NNP virus_NN in_IN Turkey_NNP before_IN migration_NN 
Another_DT example_NN is_VBZ the_DT possible_JJ role_NN of_IN infections_NNS during_IN childhood_NN on_IN the_DT risks_NNS for_IN specific_JJ cancers_NNS ._. 
For_IN example_NN ,_, the_DT increased_VBN risks_NNS for_IN lymphatic_JJ leukemia_NN among_IN Turkish_JJ migrants_NNS in_IN Hamburg_NNP ,_, Germany_NNP ,_, might_MD be_VB the_DT result_NN of_IN a_DT higher_JJR prevalence_NN of_IN exposure_NN to_TO Epstein-Barr_NNP virus_NN in_IN Turkey_NNP before_IN migration_NN 
For_IN example_NN ,_, the_DT increased_VBN risks_NNS for_IN lymphatic_JJ leukemia_NN among_IN Turkish_JJ migrants_NNS in_IN Hamburg_NNP ,_, Germany_NNP ,_, might_MD be_VB the_DT result_NN of_IN a_DT higher_JJR prevalence_NN of_IN exposure_NN to_TO Epstein-Barr_NNP virus_NN in_IN Turkey_NNP before_IN migration_NN 
Moreover_RB ,_, they_PRP may_MD to_TO some_DT extent_NN be_VB more_RBR acculturated_VBN or_CC segregated_VBN than_IN their_PRP$ parents_NNS ._. 
The_DT health_NN situation_NN of_IN the_DT second_JJ generation_NN is_VBZ different_JJ to_TO the_DT health_NN situation_NN of_IN first_JJ generation_NN migrants_NNS ,_, because_IN the_DT former_NN did_VBD not_RB face_VB the_DT exposures_NNS in_IN the_DT country_NN of_IN origin_NN and_CC during_IN the_DT migration_NN process_NN ._. 
The_DT higher_JJR disease_NN risks_NNS of_IN migrants_NNS might_MD converge_VB with_IN the_DT risks_NNS of_IN the_DT autochthonous_JJ population_NN in_IN the_DT second_JJ generation_NN or_CC in_IN younger_JJR birth_NN cohorts_NNS ,_, as_IN shown_VBN by_IN studies_NNS about_IN cancer_NN risks_NNS among_IN migrants_NNS in_IN the_DT Netherlands_NNP 
The_DT higher_JJR disease_NN risks_NNS of_IN migrants_NNS might_MD converge_VB with_IN the_DT risks_NNS of_IN the_DT autochthonous_JJ population_NN in_IN the_DT second_JJ generation_NN or_CC in_IN younger_JJR birth_NN cohorts_NNS ,_, as_IN shown_VBN by_IN studies_NNS about_IN cancer_NN risks_NNS among_IN migrants_NNS in_IN the_DT Netherlands_NNP 
In_IN particular_JJ ,_, exposures_NNS in_IN -LRB-_-LRB- early_JJ -RRB-_-RRB- childhood_NN in_IN the_DT country_NN of_IN origin_NN are_VBP included_VBN in_IN the_DT model_NN ._. 
The_DT model_NN helps_VBZ to_TO understand_VB why_WRB ,_, for_IN example_NN ,_, chronic_JJ diseases_NNS arise_VBP at_IN different_JJ times_NNS and_CC with_IN different_JJ probability_NN compared_VBN with_IN the_DT indigenous_JJ population_NN of_IN the_DT host_NN country_NN ._. 
One_CD example_NN is_VBZ the_DT risk_NN of_IN obesity_NN in_IN adulthood_NN ,_, which_WDT is_VBZ influenced_VBN by_IN exposures_NNS in_IN the_DT prenatal_JJ phase_NN :_: a_DT restricted_JJ foetal_JJ growth_NN and_CC low_JJ birth_NN weight_NN ,_, both_DT common_JJ problems_NNS in_IN many_JJ low-income_JJ countries_NNS from_IN which_WDT migrants_NNS originate_VBP ,_, increase_VBP the_DT risk_NN for_IN obesity_NN in_IN adulthood_NN ._. 
The_DT obesity_NN risk_NN of_IN adult_NN migrants_NNS is_VBZ thus_RB not_RB only_RB determined_VBN by_IN their_PRP$ nutritional_JJ behavior_NN and_CC physical_JJ activity_NN in_IN the_DT host_NN country_NN ._. 
-RRB-_-RRB- ._. 
Migrants_NNS often_RB face_VBP different_JJ exposures_NNS in_IN their_PRP$ life_NN course_NN compared_VBN with_IN the_DT autochthonous_JJ populations_NNS of_IN the_DT host_NN countries_NNS due_JJ to_TO the_DT different_JJ situation_NN in_IN their_PRP$ home_NN countries_NNS -LRB-_-LRB- nutrition_NN ,_, hygiene_NN ,_, prevalence_NN of_IN infectious_JJ diseases_NNS ,_, etc._FW ._. 
The_DT inclusive_JJ consideration_NN of_IN these_DT different_JJ influences_NNS and_CC their_PRP$ time_NN scale_NN in_IN a_DT life_NN course_NN perspective_NN ,_, currently_RB an_DT important_JJ theme_NN in_IN Public_NNP Health\/Epidemiology_NNP ,_, is_VBZ still_RB missing_VBG in_IN the_DT research_NN on_IN migrant_JJ health_NN ._. 
Alife_JJ course_NN approach_NN Figure_NN 1_CD shows_VBZ a_DT conceptual_JJ framework_NN for_IN migration_NN and_CC health_NN integrating_VBG the_DT influence_NN of_IN exposures_NNS that_IN migrants_NNS face_VBP during_IN their_PRP$ life_NN course_NN ._. 
2009_CD -RRB-_-RRB- and_CC alcohol_NN consumption_NN ,_, which_WDT interact_VBP with_IN the_DT other_JJ risk_NN factors_NNS and_CC can_MD result_VB in_IN lower_JJR risks_NNS for_IN some_DT diseases_NNS ._. 
There_EX is_VBZ evidence_NN that_IN the_DT risk_NN of_IN several_JJ chronic_JJ diseases_NNS ,_, including_VBG stroke_NN ,_, allergic_JJ disease_NN and_CC cancer_NN ,_, is_VBZ influenced_VBN by_IN early_JJ childhood_NN exposures_NNS ._. 
Migrants_NNS often_RB face_VBP different_JJ exposures_NNS in_IN their_PRP$ life_NN course_NN compared_VBN with_IN the_DT autochthonous_JJ populations_NNS of_IN the_DT host_NN countries_NNS due_JJ to_TO the_DT different_JJ situation_NN in_IN their_PRP$ home_NN countries_NNS -LRB-_-LRB- nutrition_NN ,_, hygiene_NN ,_, prevalence_NN of_IN infectious_JJ diseases_NNS ,_, etc._FW 
Other_JJ important_JJ factors_NNS such_JJ as_IN family_NN history_NN ,_, socioeconomic_JJ status_NN ,_, education_NN and_CC living_NN conditions_NNS ,_, as_RB well_RB as_IN health_NN behavior_NN like_IN nutrition_NN ,_, physical_JJ activity_NN ,_, and_CC alcohol_NN and_CC tobacco_NN consumption_NN can_MD act_VB during_IN different_JJ periods_NNS of_IN the_DT migrants_NNS '_POS life_NN ._. 
Accumulations_NNS and_CC interactions_NNS of_IN exposures_NNS in_IN migrants_NNS can_MD occur_VB in_IN several_JJ ways_NNS ,_, including_VBG the_DT accumulation_NN of_IN ``_`` pack_NN years_NNS ''_'' ,_, changed_VBN by_IN migration_NN due_JJ to_TO availability_NN of_IN cigarettes_NNS 
2009_CD -RRB-_-RRB- and_CC alcohol_NN consumption_NN ,_, which_WDT interact_VBP with_IN the_DT other_JJ risk_NN factors_NNS and_CC can_MD result_VB in_IN lower_JJR risks_NNS for_IN some_DT diseases_NNS ._. 
There_EX is_VBZ evidence_NN that_IN the_DT risk_NN of_IN several_JJ chronic_JJ diseases_NNS ,_, including_VBG stroke_NN ,_, allergic_JJ disease_NN and_CC cancer_NN ,_, is_VBZ influenced_VBN by_IN early_JJ childhood_NN exposures_NNS ._. 
Migrants_NNS often_RB face_VBP different_JJ exposures_NNS in_IN their_PRP$ life_NN course_NN compared_VBN with_IN the_DT autochthonous_JJ populations_NNS of_IN the_DT host_NN countries_NNS due_JJ to_TO the_DT different_JJ situation_NN in_IN their_PRP$ home_NN countries_NNS -LRB-_-LRB- nutrition_NN ,_, hygiene_NN ,_, prevalence_NN of_IN infectious_JJ diseases_NNS ,_, etc._FW 
Other_JJ important_JJ factors_NNS such_JJ as_IN family_NN history_NN ,_, socioeconomic_JJ status_NN ,_, education_NN and_CC living_NN conditions_NNS ,_, as_RB well_RB as_IN health_NN behavior_NN like_IN nutrition_NN ,_, physical_JJ activity_NN ,_, and_CC alcohol_NN and_CC tobacco_NN consumption_NN can_MD act_VB during_IN different_JJ periods_NNS of_IN the_DT migrants_NNS '_POS life_NN ._. 
Accumulations_NNS and_CC interactions_NNS of_IN exposures_NNS in_IN migrants_NNS can_MD occur_VB in_IN several_JJ ways_NNS ,_, including_VBG the_DT accumulation_NN of_IN ``_`` pack_NN years_NNS ''_'' ,_, changed_VBN by_IN migration_NN due_JJ to_TO availability_NN of_IN cigarettes_NNS 
In_IN addition_NN ,_, in_IN the_DT period_NN after_IN the_DT immigration_NN process_NN -_: period_NN -LRB-_-LRB- iii_FW -RRB-_-RRB- -_: migrants_NNS often_RB live_VBP in_IN poorer_JJR socioeconomic_JJ conditions_NNS than_IN the_DT indigenous_JJ population_NN of_IN the_DT host_NN country_NN ,_, which_WDT may_MD increase_VB disease_NN risks_NNS by_IN a_DT process_NN of_IN accumulation_NN ._. 
However_RB ,_, it_PRP should_MD not_RB be_VB ignored_VBN that_IN migrants_NNS might_MD either_RB have_VB specific_JJ health_NN benefits_NNS and_CC resources_NNS 
Examples_NNS are_VBP higher_JJR risks_NNS for_IN stomach_NN cancer_NN due_JJ to_TO infection_NN with_IN Helicobacter_NNP pylori_NNS ,_, or_CC liver_NN cancer_NN due_JJ to_TO hepatitis_NNP B_NNP or_CC C._NNP Another_DT example_NN may_MD be_VB the_DT higher_JJR incidence_NN of_IN childhood_NN leukemia_NN observed_VBD among_IN Turkish_JJ children_NNS in_IN Germany_NNP :_: There_EX is_VBZ evidence_NN showing_VBG that_IN infectious_JJ exposures_NNS due_JJ to_TO unusual_JJ population_NN mixing_NN -LRB-_-LRB- populations_NNS usually_RB separated_VBD coming_VBG in_IN contact_NN with_IN each_DT other_JJ -RRB-_-RRB- modify_VBP the_DT risk_NN of_IN acute_JJ lymphoid_NN leukemia_NN 
Examples_NNS are_VBP higher_JJR risks_NNS for_IN stomach_NN cancer_NN due_JJ to_TO infection_NN with_IN Helicobacter_NNP pylori_NNS ,_, or_CC liver_NN cancer_NN due_JJ to_TO hepatitis_NNP B_NNP or_CC C._NNP Another_DT example_NN may_MD be_VB the_DT higher_JJR incidence_NN of_IN childhood_NN leukemia_NN observed_VBD among_IN Turkish_JJ children_NNS in_IN Germany_NNP :_: There_EX is_VBZ evidence_NN showing_VBG that_IN infectious_JJ exposures_NNS due_JJ to_TO unusual_JJ population_NN mixing_NN -LRB-_-LRB- populations_NNS usually_RB separated_VBD coming_VBG in_IN contact_NN with_IN each_DT other_JJ -RRB-_-RRB- modify_VBP the_DT risk_NN of_IN acute_JJ lymphoid_NN leukemia_NN 
However_RB ,_, studies_NNS about_IN health_NN differences_NNS between_IN migrants_NNS and_CC majority_NN populations_NNS face_VBP a_DT fundamental_JJ problem_NN :_: a_DT broadly_RB accepted_VBN comprehensive_JJ and_CC conclusive_JJ model_NN on_IN migrants_NNS and_CC their_PRP$ health_NN is_VBZ lacking_VBG 
However_RB ,_, studies_NNS about_IN health_NN differences_NNS between_IN migrants_NNS and_CC majority_NN populations_NNS face_VBP a_DT fundamental_JJ problem_NN :_: a_DT broadly_RB accepted_VBN comprehensive_JJ and_CC conclusive_JJ model_NN on_IN migrants_NNS and_CC their_PRP$ health_NN is_VBZ lacking_VBG 
In_IN Germany_NNP ,_, studies_NNS of_IN labor_NN migrants_NNS from_IN southern_JJ Europe_NNP showed_VBD a_DT lower_JJR overall_JJ mortality_NN compared_VBN to_TO the_DT indigenous_JJ population_NN 
However_RB ,_, studies_NNS about_IN health_NN differences_NNS between_IN migrants_NNS and_CC majority_NN populations_NNS face_VBP a_DT fundamental_JJ problem_NN :_: a_DT broadly_RB accepted_VBN comprehensive_JJ and_CC conclusive_JJ model_NN on_IN migrants_NNS and_CC their_PRP$ health_NN is_VBZ lacking_VBG 
Also_RB ,_, we_PRP are_VBP aware_JJ that_IN differences_NNS between_IN migrants_NNS and_CC the_DT autochthonous_JJ populations_NNS of_IN host_NN countries_NNS have_VBP numerous_JJ reasons_NNS ,_, ranging_VBG from_IN genetic_JJ background_NN to_TO lifestyle_NN and_CC nutrition_NN ._. 
Thus_RB not_RB all_DT health_NN differentials_NNS experienced_VBN by_IN migrants_NNS can_MD be_VB attributed_VBN to_TO a_DT single_JJ factor_NN -LRB-_-LRB- such_JJ as_IN low_JJ income_NN -RRB-_-RRB- ,_, and_CC not_RB all_DT differences_NNS are_VBP the_DT expression_NN of_IN social_JJ deprivation_NN or_CC exclusion_NN ._. 
The_DT main_JJ emphasis_NN of_IN this_DT article_NN is_VBZ on_IN migrants_NNS who_WP migrated_VBD from_IN lower-income_JJ to_TO higher-income_JJ countries_NNS ._. 
In_IN summary_NN ,_, the_DT health_NN situation_NN of_IN migrants_NNS is_VBZ influenced_VBN by_IN factors_NNS operating_VBG both_DT in_IN the_DT country_NN of_IN origin_NN as_RB well_RB as_IN in_IN the_DT host_NN country_NN ,_, and_CC acting_VBG at_IN various_JJ phases_NNS in_IN the_DT lives_NNS of_IN migrants_NNS ._. 
The_DT nature_NN and_CC importance_NN of_IN these_DT factors_NNS has_VBZ been_VBN difficult_JJ to_TO determine_VB and_CC to_TO quantify_VB empirically_RB ,_, as_IN previous_JJ models_NNS of_IN migrant_JJ health_NN have_VBP lacked_VBN a_DT crucial_JJ element_NN ,_, namely_RB an_DT explicit_JJ time_NN axis_NNS ._. 
For_IN this_DT reason_NN ,_, we_PRP propose_VBP a_DT new_JJ conceptual_JJ framework_NN based_VBN on_IN life_NN course_NN epidemiology_NN ._. 
Such_JJ a_DT concept_NN should_MD not_RB only_RB include_VBP the_DT main_JJ factors_NNS acting_VBG on_IN the_DT health_NN of_IN migrant_JJ populations_NNS ,_, but_CC also_RB make_VBP their_PRP$ temporal_JJ sequence_NN explicit_JJ ._. 
However_RB ,_, studies_NNS about_IN health_NN differences_NNS between_IN migrants_NNS and_CC majority_NN populations_NNS face_VBP a_DT fundamental_JJ problem_NN :_: a_DT broadly_RB accepted_VBN comprehensive_JJ and_CC conclusive_JJ model_NN on_IN migrants_NNS and_CC their_PRP$ health_NN is_VBZ lacking_VBG 
In_IN addition_NN ,_, in_IN the_DT period_NN after_IN the_DT immigration_NN process_NN -_: period_NN -LRB-_-LRB- iii_FW -RRB-_-RRB- -_: migrants_NNS often_RB live_VBP in_IN poorer_JJR socioeconomic_JJ conditions_NNS than_IN the_DT indigenous_JJ population_NN of_IN the_DT host_NN country_NN ,_, which_WDT may_MD increase_VB disease_NN risks_NNS by_IN a_DT process_NN of_IN accumulation_NN ._. 
However_RB ,_, it_PRP should_MD not_RB be_VB ignored_VBN that_IN migrants_NNS might_MD either_RB have_VB specific_JJ health_NN benefits_NNS and_CC resources_NNS 
Migrants_NNPS migrant_JJ health_NN life_NN course_NN epidemiology_NN Background_NN Both_CC the_DT absolute_JJ numbers_NNS of_IN migrants_NNS as_RB well_RB as_IN their_PRP$ proportion_NN of_IN the_DT total_JJ population_NN are_VBP increasing_VBG in_IN western_JJ European_JJ countries_NNS and_CC the_DT USA_NNP ._. 
In_IN 2005_CD ,_, western_JJ and_CC central_JJ European_JJ countries_NNS hosted_VBD more_JJR than_IN 44_CD million_CD foreign-born_JJ persons_NNS 
The_DT health_NN of_IN migrants_NNS has_VBZ been_VBN extensively_RB studied_VBN ._. 
In_IN 2005_CD ,_, western_JJ and_CC central_JJ European_JJ countries_NNS hosted_VBD more_JJR than_IN 44_CD million_CD foreign-born_JJ persons_NNS ._. 
However_RB ,_, studies_NNS about_IN health_NN differences_NNS between_IN migran_NN 
In_IN summary_NN ,_, the_DT health_NN situation_NN of_IN migrants_NNS is_VBZ influenced_VBN by_IN factors_NNS operating_VBG both_DT in_IN the_DT country_NN of_IN origin_NN as_RB well_RB as_IN in_IN the_DT host_NN country_NN ,_, and_CC acting_VBG at_IN various_JJ phases_NNS in_IN the_DT lives_NNS of_IN migrants_NNS ._. 
The_DT nature_NN and_CC importance_NN of_IN these_DT factors_NNS has_VBZ been_VBN difficult_JJ to_TO determine_VB and_CC to_TO quantify_VB empirically_RB ,_, as_IN previous_JJ models_NNS of_IN migrant_JJ health_NN have_VBP lacked_VBN a_DT crucial_JJ element_NN ,_, namely_RB an_DT explicit_JJ time_NN axis_NNS ._. 
For_IN this_DT reason_NN ,_, we_PRP propose_VBP a_DT new_JJ conceptual_JJ framework_NN based_VBN on_IN life_NN course_NN epidemiology_NN ._. 
Such_JJ a_DT concept_NN should_MD not_RB only_RB include_VBP the_DT main_JJ factors_NNS acting_VBG on_IN the_DT health_NN of_IN migrant_JJ populations_NNS ,_, but_CC also_RB make_VBP their_PRP$ temporal_JJ sequence_NN explicit_JJ ._. 
However_RB ,_, studies_NNS about_IN health_NN differences_NNS between_IN migrants_NNS and_CC majority_NN populations_NNS face_VBP a_DT fundamental_JJ problem_NN :_: a_DT broadly_RB accepted_VBN comprehensive_JJ and_CC conclusive_JJ model_NN on_IN migrants_NNS and_CC their_PRP$ health_NN is_VBZ lacking_VBG 
Also_RB ,_, we_PRP are_VBP aware_JJ that_IN differences_NNS between_IN migrants_NNS and_CC the_DT autochthonous_JJ populations_NNS of_IN host_NN countries_NNS have_VBP numerous_JJ reasons_NNS ,_, ranging_VBG from_IN genetic_JJ background_NN to_TO lifestyle_NN and_CC nutrition_NN ._. 
Thus_RB not_RB all_DT health_NN differentials_NNS experienced_VBN by_IN migrants_NNS can_MD be_VB attributed_VBN to_TO a_DT single_JJ factor_NN -LRB-_-LRB- such_JJ as_IN low_JJ income_NN -RRB-_-RRB- ,_, and_CC not_RB all_DT differences_NNS are_VBP the_DT expression_NN of_IN social_JJ deprivation_NN or_CC exclusion_NN ._. 
The_DT main_JJ emphasis_NN of_IN this_DT article_NN is_VBZ on_IN migrants_NNS who_WP migrated_VBD from_IN lower-income_JJ to_TO higher-income_JJ countries_NNS ._. 
Other_JJ forms_NNS of_IN migrant_JJ studies_NNS ,_, such_JJ as_IN qualitative_JJ studies_NNS ,_, are_VBP not_RB explicitly_RB considered_VBN ._. 
Our_PRP$ focus_NN is_VBZ on_IN developing_VBG a_DT framework_NN for_IN epidemiological_JJ migrant_JJ studies_NNS ._. 
Life_NNP course_NN epidemiologyLife_NNP course_NN epidemiology_NN can_MD be_VB defined_VBN as_IN the_DT study_NN of_IN physical_JJ or_CC social_JJ exposures_NNS during_IN gestation_NN ,_, childhood_NN ,_, adolescence_NN ,_, young_JJ adulthood_NN and_CC also_RB adult_JJ life_NN ,_, with_IN the_DT aim_NN ofexamining_VBG their_PRP$ long-term_JJ effects_NNS on_IN health_NN or_CC disease_NN risk_NN in_IN later_JJ life_NN ._. 
Life_NNP course_NN epidemiology_NN can_MD help_VB to_TO construct_VB models_NNS of_IN disease_NN aetiology_NN with_IN an_DT emphasis_NN on_IN timing_NN -LRB-_-LRB- critical\/sensitive_JJ periods_NNS -RRB-_-RRB- ,_, duration_NN -LRB-_-LRB- accumulation_NN -RRB-_-RRB- ,_, and_CC temporal_JJ sequence_NN -LRB-_-LRB- triggers\/interactions_NNS -RRB-_-RRB- of_IN exposures_NNS 
Other_JJ concepts_NNS of_IN life_NN course_NN epidemiology_NN focus_NN on_IN analyzing_VBG the_DT effects_NNS of_IN accumulated_VBN exposures_NNS over_IN a_DT lifetime_NN on_IN health_NN risks_NNS ,_, including_VBG the_DT temporal_JJ sequence_NN of_IN exposures_NNS during_IN the_DT life_NN course_NN ._. 
These_DT different_JJ concepts_NNS are_VBP not_RB mutually_RB exclusive_JJ but_CC can_MD operate_VB together_RB ._. 
The_DT health_NN of_IN migrants_NNS is_VBZ determined_VBN by_IN additional_JJ exposures_NNS during_IN the_DT life_NN course_NN -LRB-_-LRB- before_IN ,_, during_IN and_CC after_IN migration_NN -RRB-_-RRB- ,_, which_WDT are_VBP not_RB experienced_VBN by_IN the_DT majority_NN population_NN ._. 
-RRB-_-RRB- ._. 
Migrants_NNS often_RB face_VBP different_JJ exposures_NNS in_IN their_PRP$ life_NN course_NN compared_VBN with_IN the_DT autochthonous_JJ populations_NNS of_IN the_DT host_NN countries_NNS due_JJ to_TO the_DT different_JJ situation_NN in_IN their_PRP$ home_NN countries_NNS -LRB-_-LRB- nutrition_NN ,_, hygiene_NN ,_, prevalence_NN of_IN infectious_JJ diseases_NNS ,_, etc._FW ._. 
The_DT inclusive_JJ consideration_NN of_IN these_DT different_JJ influences_NNS and_CC their_PRP$ time_NN scale_NN in_IN a_DT life_NN course_NN perspective_NN ,_, currently_RB an_DT important_JJ theme_NN in_IN Public_NNP Health\/Epidemiology_NNP ,_, is_VBZ still_RB missing_VBG in_IN the_DT research_NN on_IN migrant_JJ health_NN ._. 
Alife_JJ course_NN approach_NN Figure_NN 1_CD shows_VBZ a_DT conceptual_JJ framework_NN for_IN migration_NN and_CC health_NN integrating_VBG the_DT influence_NN of_IN exposures_NNS that_IN migrants_NNS face_VBP during_IN their_PRP$ life_NN course_NN ._. 
Shirima_FW et_FW al._FW ._. 
Instead_RB ,_, they_PRP propose_VBP a_DT purposeful_JJ selection_NN of_IN clusters_NNS guided_VBN by_IN knowledge_NN of_IN the_DT spatial_JJ arrangement_NN of_IN key_JJ population_NN characteristics_NNS ._. 
describe_VB their_PRP$ experience_NN with_IN personal_JJ digital_JJ assistants_NNS in_IN a_DT large_JJ ,_, multi-indicator_JJ baseline_NN survey_NN in_IN rural_JJ Tanzania_NNP and_CC show_VBP that_IN the_DT use_NN of_IN advanced_JJ technologies_NNS can_MD greatly_RB simplify_VB and_CC facilitate_VB the_DT work_NN of_IN survey_NN teams_NNS ._. 
Unfortunately_RB ,_, these_DT devices_NNS still_RB remain_VBP beyond_IN the_DT reach_NN of_IN many_JJ organizations_NNS ,_, and_CC require_VB advanced_JJ expertise_NN not_RB often_RB available_JJ on_IN the_DT ground_NN ._. 
The_DT Working_NNP Group_NNP for_IN Mortality_NNP Estimation_NNP in_IN Emergencies_NNPS 
Finally_RB ,_, Hargreaves_NNPS et_FW al._FW ._. 
Nonetheless_RB ,_, they_PRP are_VBP a_DT promising_JJ tool_NN for_IN data_NNS management_NN in_IN the_DT future_NN ._. 
report_NN on_IN a_DT study_NN from_IN rural_JJ South_NNP Africa_NNP that_WDT compared_VBD standard_JJ survey_NN approaches_VBZ to_TO a_DT participatory_JJ ranking_JJ exercise_NN as_IN methods_NNS for_IN rapidly_RB estimating_VBG household_NN wealth_NN ,_, a_DT key_JJ determinant_NN of_IN health_NN status_NN ._. 
Although_IN their_PRP$ results_NNS are_VBP not_RB definitive_JJ ,_, this_DT study_NN is_VBZ a_DT fitting_JJ conclusion_NN to_TO our_PRP$ issue_NN ,_, as_IN it_PRP suggests_VBZ that_IN traditional_JJ survey_NN methods_NNS need_VBP not_RB always_RB be_VB put_VBN forward_RB as_IN a_DT default_NN solution_NN ._. 
Individuals_NNS or_CC households_NNS around_IN these_DT points_NNS are_VBP then_RB included_VBN using_VBG a_DT variety_NN of_IN sampling_NN methods_NNS ._. 
The_DT standard_JJ 30_CD 
Bostoen_FW et_FW al._FW 's_POS report_NN from_IN Niger_NNP 
In_IN his_PRP$ opinion_NN piece_NN ,_, Spiegel_NNP considers_VBZ the_DT role_NN of_IN various_JJ humanitarian_JJ stakeholders_NNS -LRB-_-LRB- NGOs_NNP ,_, United_NNP Nations_NNP agencies_NNS ,_, and_CC academic_JJ centres_NNS -RRB-_-RRB- in_IN the_DT implementation_NN of_IN surveys_NNS in_IN such_JJ conditions_NNS ,_, and_CC offers_VBZ recommendations_NNS for_IN how_WRB to_TO improve_VB existing_VBG practices_NNS through_IN standardisation_NN of_IN methodologies_NNS ,_, better_JJR training_NN for_IN field_NN staff_NN ,_, timely_JJ deployment_NN of_IN skilled_JJ epidemiologists_NNS ,_, and_CC inter-agency_NN peer_VBP review_NN ._. 
Degomme_NNP and_CC Guha-Sapir_NNP 
Degomme_NNP and_CC Guha-Sapir_NNP 
Prudhon_NNP and_CC Spiegel_NNP 
No_DT health_NN topic_NN is_VBZ as_RB fundamental_JJ as_IN mortality_NN and_CC ,_, in_IN crises_NNS ,_, its_PRP$ measurement_NN is_VBZ of_IN crucial_JJ importance_NN for_IN both_DT operational_JJ planning_NN and_CC advocacy_NN ._. 
Moreover_RB ,_, as_IN shown_VBN by_IN recent_JJ work_NN in_IN Darfur_NNP 
the_DT design_NN effect_NN -RRB-_-RRB- and_CC account_VBP for_IN this_DT in_IN the_DT analysis_NN ._. 
e._NN considering_VBG the_DT optimal_JJ number_NN of_IN clusters_NNS and_CC households_NNS -RRB-_-RRB- and_CC insufficient_JJ recognition_NN of_IN the_DT need_NN to_TO plan_VB for_IN the_DT effect_NN of_IN clustering_VBG -LRB-_-LRB- i._NN Despite_IN its_PRP$ popularity_NN ,_, the_DT EPI_NNP method_NN is_VBZ fraught_JJ with_IN potential_JJ selection_NN biases_NNS -LRB-_-LRB- such_JJ as_IN favoring_VBG denser_JJR areas_NNS and_CC households_NNS around_IN the_DT starting_VBG point_NN -RRB-_-RRB- and_CC can_MD be_VB particularly_RB difficult_JJ to_TO conduct_VB in_IN urban_JJ and_CC peri-urban_JJ settings_NNS ._. 
This_DT is_VBZ clearly_RB a_DT major_JJ area_NN where_WRB alternative_JJ approaches_NNS need_VBP to_TO be_VB developed_VBN urgently_RB ._. 
Grais_NNP et_FW al._FW 
Health_NNP surveys_NNS are_VBP the_DT stethoscope_NN ,_, thermometer_NN and_CC pressure_NN gauge_NN of_IN global_JJ health_NN ._. 
Greater_NNP investment_NN in_IN research_NN on_IN health_NN survey_NN methods_NNS is_VBZ needed_VBN and_CC will_MD have_VB beneficial_JJ effects_NNS for_IN populations_NNS in_IN need_NN ._. 
Measurement_NNP of_IN the_DT health-based_JJ Millennium_NNP Development_NNP Goals_NNP depends_VBZ on_IN large-scale_JJ surveys_NNS such_JJ as_IN the_DT Demographic_NNP and_CC Health_NNP Surveys_NNS ,_, Multiple_NNP Indicator_NNP Cluster_NNP Surveys_NNS ,_, and_CC Living_VBG Standard_NNP Measurement_NNP Surveys_NNS ._. 
For_IN most_JJS international_JJ health_NN interventions_NNS ,_, including_VBG preventive_JJ disease_NN control_NN ,_, curative_JJ care_NN ,_, health_NN system_NN strengthening_NN ,_, and_CC emergency_NN relief_NN ,_, population_NN surveys_NNS are_VBP necessary_JJ to_TO monitor_VB implementation_NN ._. 
Paradoxically_RB ,_, it_PRP is_VBZ precisely_RB in_IN these_DT settings_NNS that_IN surveillance_NN data_NNS are_VBP most_JJS lacking_VBG ,_, and_CC surveys_NNS most_RBS badly_RB needed_VBN to_TO generate_VB information_NN about_IN population_NN health_NN ._. 
On_IN 15_CD February_NNP 2006_CD ,_, the_DT London_NNP School_NNP of_IN Hygiene_NNP and_CC Tropical_NNP Medicine_NNP -LRB-_-LRB- LSHTM_NNP -RRB-_-RRB- hosted_VBD its_PRP$ first_JJ international_JJ conference_NN on_IN health_NN survey_NN methodology_NN in_IN difficult_JJ settings_NNS ._. 
The_DT conference_NN was_VBD attended_VBN by_IN 125_CD participants_NNS from_IN 31_CD institutions_NNS ,_, including_VBG academic_JJ centres_NNS from_IN Europe_NNP ,_, United_NNP States_NNPS of_IN America_NNP and_CC Australia_NNP ,_, international_JJ non-governmental_JJ organizations_NNS -LRB-_-LRB- NGOs_NNP -RRB-_-RRB- ,_, United_NNP Nations_NNP agencies_NNS ,_, and_CC major_JJ public_JJ health_NN institutions_NNS ._. 
In_IN these_DT settings_NNS ,_, uncertain_JJ and_CC rapidly-changing_JJ sampling_NN frames_NNS are_VBP common_JJ ,_, working_JJ conditions_NNS are_VBP challenging_JJ ,_, data_NN collection_NN is_VBZ not_RB considered_VBN a_DT priority_NN ,_, and_CC political_JJ sensitivities_NNS abound_VBP ._. 
In_IN his_PRP$ opinion_NN piece_NN ,_, Spiegel_NNP considers_VBZ the_DT role_NN of_IN various_JJ humanitarian_JJ stakeholders_NNS -LRB-_-LRB- NGOs_NNP ,_, United_NNP Nations_NNP agencies_NNS ,_, and_CC academic_JJ centres_NNS -RRB-_-RRB- in_IN the_DT implementation_NN of_IN surveys_NNS in_IN such_JJ conditions_NNS ,_, and_CC offers_VBZ recommendations_NNS for_IN how_WRB to_TO improve_VB existing_VBG practices_NNS through_IN standardisation_NN of_IN methodologies_NNS ,_, better_JJR training_NN for_IN field_NN staff_NN ,_, timely_JJ deployment_NN of_IN skilled_JJ epidemiologists_NNS ,_, and_CC inter-agency_NN peer_VBP review_NN ._. 
Degomme_NNP and_CC Guha-Sapir_NNP 
Vall_NNP 
No_DT health_NN topic_NN is_VBZ as_RB fundamental_JJ as_IN mortality_NN and_CC ,_, in_IN crises_NNS ,_, its_PRP$ measurement_NN is_VBZ of_IN crucial_JJ importance_NN for_IN both_DT operational_JJ planning_NN and_CC advocacy_NN ._. 
Moreover_RB ,_, as_IN shown_VBN by_IN recent_JJ work_NN in_IN Darfur_NNP 
Although_IN manuals_NNS and_CC guidance_NN exist_VBP ,_, survey_NN methods_NNS used_VBN to_TO estimate_VB mortality_NN retrospectively_RB are_VBP only_RB partially_RB validated_VBN ,_, and_CC a_DT number_NN of_IN methodological_JJ questions_NNS remain_VBP outstanding_JJ ._. 
The_DT Working_NNP Group_NNP for_IN Mortality_NNP Estimation_NNP in_IN Emergencies_NNPS 
Taken_VBN together_RB ,_, this_DT collection_NN of_IN papers_NNS is_VBZ a_DT small_JJ but_CC important_JJ leap_NN towards_IN greater_JJR investment_NN in_IN health_NN survey_NN methodology_NN in_IN settings_NNS where_WRB it_PRP is_VBZ most_RBS needed_VBN ._. 
Following_VBG the_DT success_NN of_IN the_DT first_JJ conference_NN in_IN 2006_CD ,_, CRED_NNP and_CC LSHTM_NNP will_MD be_VB co-hosting_VBG a_DT second_JJ conference_NN ,_, to_TO be_VB held_VBN in_IN Brussels_NNP on_IN 4_CD 
Grais_NNP et_FW al._FW ._. 
This_DT is_VBZ clearly_RB a_DT major_JJ area_NN where_WRB alternative_JJ approaches_NNS need_VBP to_TO be_VB developed_VBN urgently_RB ._. 
's_POS report_NN from_IN Niger_NNP 
All_DT authors_NNS read_VBD and_CC approved_VBD the_DT final_JJ manuscript_NN ._. 
KD_NNP participated_VBD in_IN the_DT analysis_NN of_IN the_DT simulation_NN data_NNS and_CC helped_VBD to_TO draft_VB the_DT manuscript_NN ._. 
Supplementary_NNP MaterialAdditional_NNP file_NN 1Results_NNS of_IN completed_VBN effectiveness_NN trials_NNS of_IN candidate_NN vaginal_JJ microbicides_NNS for_IN the_DT prevention_NN of_IN HIV_NNP acquisition_NN ._. 
Table_NNP showing_VBG the_DT results_NNS of_IN completed_VBN effectiveness_NN trials_NNS of_IN candidate_NN vaginal_JJ microbicides_NNS for_IN the_DT prevention_NN of_IN HIV_NNP acquisition_NN ._. 
Due_JJ to_TO the_DT sensitive_JJ nature_NN of_IN this_DT practice_NN ,_, the_DT prevalence_NN of_IN unprotected_JJ AI_NNP has_VBZ been_VBN notoriously_RB hard_JJ to_TO estimate_VB and_CC is_VBZ believed_VBN to_TO be_VB greatly_RB under-estimated_VBN both_DT in_IN trials_NNS and_CC in_IN behavioral_JJ surveys_NNS ._. 
ANSFG_NNP 2002_CD survey_NN has_VBZ estimated_VBN that_IN 34_CD %_NN of_IN US_NNP women_NNS reported_VBD having_VBG AI_NNP with_IN an_DT opposite_JJ sex_NN partner_NN in_IN their_PRP$ lifetime_NN 
In_IN contrast_NN ,_, among_IN sexually_RB experienced_JJ South_JJ African_JJ youth_NN ,_, 5_CD ._. 
ANSFG_NNP 2002_CD survey_NN has_VBZ estimated_VBN that_IN 34_CD %_NN of_IN US_NNP women_NNS reported_VBD having_VBG AI_NNP with_IN an_DT opposite_JJ sex_NN partner_NN in_IN their_PRP$ lifetime_NN 
Scenario_NN 1_CD represents_VBZ the_DT somewhat_RB ideal_JJ microbicide_NN trial_NN with_IN very_RB high_JJ adherence_NN ,_, low_JJ pregnancy_NN ,_, small_JJ proportion_NN of_IN HIV_NNP infections_NNS from_IN AI_NNP ,_, and_CC no_DT placebo_NN efficacy_NN ._. 
Scenarios_NNS 2_CD and_CC 3_CD reflect_VBP data_NNS from_IN completed_VBN microbicide_NN trials_NNS -LRB-_-LRB- Table_NNP S1_NNP -RRB-_-RRB- and_CC from_IN field_NN studies_NNS -LRB-_-LRB- frequency_NN of_IN AI_NNP -RRB-_-RRB- ,_, although_IN estimates_NNS for_IN adherence_NN and_CC AI_NNP obtained_VBD from_IN trials_NNS are_VBP likely_JJ over_IN -_: and_CC underestimated_VBD ,_, respectively_RB ._. 
We_PRP have_VBP set_VBN the_DT placebo_NN efficacy_NN at_IN 0_CD %_NN and_CC 5_CD %_NN for_IN these_DT scenarios_NNS since_IN there_EX are_VBP no_DT data_NNS available_JJ for_IN many_JJ of_IN the_DT different_JJ placebo_NN gels_NNS that_IN we_PRP used_VBD in_IN the_DT completed_VBN trials_NNS ._. 
Only_RB anecdotal_JJ evidence_NN has_VBZ been_VBN reported_VBN so_RB far_RB ,_, and_CC data_NNS on_IN product_NN sharing_NN remains_VBZ scarce_JJ or_CC even_RB inexistent_JJ ._. 
In_IN addition_NN ,_, further_JJ dilution_NN of_IN efficacy_NN can_MD result_VB from_IN a_DT strong_JJ association_NN between_IN condom_NN use_NN and_CC microbicide_NN use_NN as_IN described_VBN in_IN Trussell_NNP and_CC Dominik_NNP ._. 
Given_VBN the_DT high_JJ efficacy_NN of_IN condoms_NNS ,_, most_JJS of_IN the_DT HIV_NNP infections_NNS that_WDT are_VBP observed_VBN in_IN a_DT trial_NN are_VBP from_IN vaginal_JJ -LRB-_-LRB- or_CC anal_JJ -RRB-_-RRB- intercourse_NN unprotected_VBN by_IN condoms_NNS ._. 
Click_VB here_RB for_IN fileAdditional_JJ file_NN 2Description_JJ and_CC computational_JJ details_NNS of_IN the_DT different_JJ dilution_NN factors_NNS ,_, expected_VBN effectiveness_NN and_CC total_JJ dilution_NN effect_NN ._. 
Table_NNP showing_VBG the_DT description_NN and_CC computational_JJ details_NNS of_IN the_DT different_JJ dilution_NN factors_NNS ,_, expected_VBN effectiveness_NN and_CC total_JJ dilution_NN effect_NN ._. 
All_DT authors_NNS read_VBD and_CC approved_VBD the_DT final_JJ manuscript_NN ._. 
KD_NNP participated_VBD in_IN the_DT analysis_NN of_IN the_DT simulation_NN data_NNS and_CC helped_VBD to_TO draft_VB the_DT manuscript_NN ._. 
Supplementary_NNP MaterialAdditional_NNP file_NN 1Results_NNS of_IN completed_VBN effectiveness_NN trials_NNS of_IN candidate_NN vaginal_JJ microbicides_NNS for_IN the_DT prevention_NN of_IN HIV_NNP acquisition_NN ._. 
Table_NNP showing_VBG the_DT results_NNS of_IN completed_VBN effectiveness_NN trials_NNS of_IN candidate_NN vaginal_JJ microbicides_NNS for_IN the_DT prevention_NN of_IN HIV_NNP acquisition_NN ._. 
Results_NNS of_IN the_DT MDP-301_NNP study_NN ,_, a_DT second_JJ phase_NN 3_CD trial_NN of_IN 0_CD ._. 
10_CD -RRB-_-RRB- ,_, was_VBD welcomed_VBN with_IN optimism_NN ._. 
5%_CD PRO2000_NNP gel_NNP -LRB-_-LRB- Endo_NNP Pharmaceuticals_NNP ,_, Chadds_NNP Ford_NNP ,_, PA_NNP ,_, USA_NNP -RRB-_-RRB- ,_, a_DT viral_JJ entry_NN inhibitor_NN ,_, reported_VBD an_DT estimated_VBN effectiveness_NN of_IN 30_CD %_NN -LRB-_-LRB- 95_CD %_NN CI_NN 
Time_NNP Off-Product_NNP Due_NNP to_TO Pregnancy_NNP and_CC Adverse_JJ Reactions_NNS All_DT candidate_NN vaginal_JJ gel_NN microbicides_NNS under_IN development_NN are_VBP investigational_JJ products_NNS without_IN human_JJ data_NNS on_IN their_PRP$ safety_NN in_IN pregnancy_NN and_CC to_TO the_DT fetus\/embryo_NN ._. 
Although_IN ,_, the_DT product_NN 's_POS active_JJ ingredients_NNS of_IN most_JJS candidates_NNS are_VBP not_RB absorbed_VBN by_IN the_DT genital_JJ mucosa_NN ,_, the_DT fetus\/embryo_NN may_MD still_RB be_VB exposed_VBN due_JJ to_TO the_DT passage_NN of_IN the_DT product_NN through_IN the_DT uterus_NN and_CC the_DT cervical_JJ canal_NN ._. 
Given_VBN that_DT harm_NN from_IN the_DT product_NN can_MD not_RB be_VB entirely_RB ruled_VBN out_RP ,_, microbicide_NN protocols_NNS have_VBP cautiously_RB address_VB the_DT issue_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- by_IN excluding_VBG women_NNS who_WP have_VBP the_DT intention_NN of_IN becoming_VBG pregnant_JJ during_IN the_DT trial_NN or_CC requiring_VBG women_NNS to_TO use_VB at_IN least_JJS one_CD or_CC two_CD contraceptive_JJ methods_NNS and_CC -LRB-_-LRB- 2_CD -RRB-_-RRB- by_IN temporarily_RB withdrawing_VBG the_DT product_NN from_IN women_NNS becoming_VBG pregnant_JJ during_IN the_DT trial_NN with_IN product_NN use_NN resuming_VBG after_IN pregnancy_NN 
Therefore_RB ,_, these_DT trial_NN estimates_NNS of_IN AI_NNP are_VBP most_RBS likely_JJ under-estimating_NN the_DT true_JJ frequency_NN of_IN AI_NNP ._. 
Such_JJ large_JJ differences_NNS are_VBP due_JJ partly_RB to_TO variation_NN across_IN clinical_JJ sites_NNS and_CC to_TO the_DT data_NN collection_NN methods_NNS used_VBN to_TO capture_VB sensitive_JJ behavior_NN ._. 
Placebo_NNP Physical_NNP Barrier\/Lubrication_NNP EffectUp_NNP to_TO five_CD different_JJ placebo_NN gels_NNS have_VBP been_VBN used_VBN in_IN microbicide_NN trials_NNS ,_, many_JJ of_IN which_WDT may_MD not_RB be_VB completely_RB inert_JJ 
The_DT objective_NN of_IN this_DT paper_NN is_VBZ to_TO assess_VB the_DT expected_VBN magnitude_NN of_IN the_DT efficacy_NN dilution_NN in_IN microbicide_NN trials_NNS resulting_VBG from_IN the_DT most_RBS frequent_JJ sources_NNS of_IN dilution_NN ,_, namely_RB product_NN adherence_NN ,_, time_NN off-product_NN due_JJ to_TO pregnancy_NN ,_, HIV_NNP infections_NNS from_IN anal_JJ intercourse_NN and_CC the_DT inertness_NN of_IN placebo_NN gel_NN ._. 
This_DT paper_NN extends_VBZ the_DT works_NNS of_IN Desai_NNP 
The_DT high_JJ variability_NN across_IN trials_NNS can_MD be_VB partly_RB attributed_VBN to_TO different_JJ methods_NNS of_IN assessment_NN ._. 
Product_NN adherence_NN estimates_NNS from_IN completed_VBN microbicide_NN trials_NNS vary_VBP greatly_RB -LRB-_-LRB- see_VB Table_NNP S1_NNP -RRB-_-RRB- ._. 
Self-reported_JJ adherence_NN from_IN face-to-face_JJ interviews_NNS tends_VBZ to_TO over-estimate_VB product_NN adherence_NN because_IN of_IN social_JJ desirability_NN bias_NN ._. 
Therefore_RB ,_, most_JJS estimates_NNS of_IN adherence_NN in_IN Table_NNP S1_NNP over-estimate_VBD the_DT true_JJ proportion_NN of_IN adherent_JJ women_NNS ._. 
The_DT objective_NN of_IN this_DT paper_NN is_VBZ to_TO assess_VB the_DT expected_VBN magnitude_NN of_IN the_DT efficacy_NN dilution_NN in_IN microbicide_NN trials_NNS resulting_VBG from_IN the_DT most_RBS frequent_JJ sources_NNS of_IN dilution_NN ,_, namely_RB product_NN adherence_NN ,_, time_NN off-product_NN due_JJ to_TO pregnancy_NN ,_, HIV_NNP infections_NNS from_IN anal_JJ intercourse_NN and_CC the_DT inertness_NN of_IN placebo_NN gel_NN ._. 
This_DT paper_NN extends_VBZ the_DT works_NNS of_IN Desai_NNP 
The_DT objective_NN of_IN this_DT paper_NN is_VBZ to_TO assess_VB the_DT expected_VBN magnitude_NN of_IN the_DT efficacy_NN dilution_NN in_IN microbicide_NN trials_NNS resulting_VBG from_IN the_DT most_RBS frequent_JJ sources_NNS of_IN dilution_NN ,_, namely_RB product_NN adherence_NN ,_, time_NN off-product_NN due_JJ to_TO pregnancy_NN ,_, HIV_NNP infections_NNS from_IN anal_JJ intercourse_NN and_CC the_DT inertness_NN of_IN placebo_NN gel_NN ._. 
This_DT paper_NN extends_VBZ the_DT works_NNS of_IN Desai_NNP 
This_DT definition_NN implies_VBZ that_IN non-adherent_JJ women_NNS never_RB use_VBP the_DT gel_NN during_IN the_DT trial_NN therefore_RB ;_: they_PRP do_VBP not_RB get_VB any_DT benefit_NN from_IN the_DT gel_NN as_IN gel_NN is_VBZ never_RB used_VBN ._. 
Amore_JJ realistic_JJ alternative_NN model_NN might_MD be_VB preferable_JJ where_WRB women_NNS may_MD use_VB the_DT gel_NN for_IN some_DT acts_NNS of_IN vaginal_JJ intercourse_NN and_CC may_MD not_RB for_IN others_NNS ._. 
Under_IN this_DT alternative_NN model_NN ,_, women_NNS using_VBG the_DT gel_NN for_IN some_DT but_CC not_RB all_DT of_IN the_DT vaginal_JJ acts_NNS would_MD potentially_RB benefit_VB less_JJR than_IN those_DT that_WDT are_VBP always_RB using_VBG the_DT gel_NN ._. 
Scenario_NN 1_CD represents_VBZ the_DT somewhat_RB ideal_JJ microbicide_NN trial_NN with_IN very_RB high_JJ adherence_NN ,_, low_JJ pregnancy_NN ,_, small_JJ proportion_NN of_IN HIV_NNP infections_NNS from_IN AI_NNP ,_, and_CC no_DT placebo_NN efficacy_NN ._. 
Scenarios_NNS 2_CD and_CC 3_CD reflect_VBP data_NNS from_IN completed_VBN microbicide_NN trials_NNS -LRB-_-LRB- Table_NNP S1_NNP -RRB-_-RRB- and_CC from_IN field_NN studies_NNS -LRB-_-LRB- frequency_NN of_IN AI_NNP -RRB-_-RRB- ,_, although_IN estimates_NNS for_IN adherence_NN and_CC AI_NNP obtained_VBD from_IN trials_NNS are_VBP likely_JJ over_IN -_: and_CC underestimated_VBD ,_, respectively_RB ._. 
We_PRP have_VBP set_VBN the_DT placebo_NN efficacy_NN at_IN 0_CD %_NN and_CC 5_CD %_NN for_IN these_DT scenarios_NNS since_IN there_EX are_VBP no_DT data_NNS available_JJ for_IN many_JJ of_IN the_DT different_JJ placebo_NN gels_NNS that_IN we_PRP used_VBD in_IN the_DT completed_VBN trials_NNS ._. 
Those_DT additional_JJ assumptions_NNS could_MD be_VB justified_VBN on_IN the_DT basis_NN of_IN the_DT associations_NNS observed_VBD in_IN microbicide_NN trials_NNS ._. 
Nevertheless_RB ,_, our_PRP$ findings_NNS on_IN the_DT dilution_NN effect_NN due_JJ to_TO adherence_NN alone_RB replicate_VB those_DT by_IN Weiss_NNP et_NNP al_RB obtained_VBD using_VBG a_DT different_JJ model_NN ._. 
For_IN 80_CD %_NN adherence_NN and_CC true_JJ efficacies_NNS of_IN 25_CD %_NN ,_, 50_CD %_NN ,_, and_CC 75_CD %_NN ,_, they_PRP have_VBP obtained_VBN expected_JJ effectiveness_NN of_IN 18_CD %_NN ,_, 37_CD %_NN ,_, and_CC 57_CD %_NN ,_, respectively_RB ,_, compared_VBN to_TO 20_CD %_NN ,_, 40_CD %_NN ,_, and_CC 60_CD %_NN under_IN our_PRP$ model_NN ._. 
Placebo_NNP Physical_NNP Barrier\/Lubrication_NNP Effect_NN Up_IN to_TO five_CD different_JJ placebo_NN gels_NNS have_VBP been_VBN used_VBN in_IN microbicide_NN trials_NNS ,_, many_JJ of_IN which_WDT may_MD not_RB be_VB completely_RB inert_JJ 
Table_NNP S1_NNP reviews_VBZ the_DT findings_NNS of_IN phase_NN 2b\/3_CD microbicide_NN trials_NNS completed_VBN to_TO date_NN -LRB-_-LRB- see_VB Table_NNP S1_NNP in_IN additional_JJ file_NN 1_CD -RRB-_-RRB- ._. 
For_IN instance_NN ,_, the_DT cellulose_NN sulfate_NN gel_NN -LRB-_-LRB- Ushercell_NNP ,_, Polydex_NNP Pharmaceuticals_NNP ,_, Toronto_NNP ,_, ON_NNP ,_, Canada_NNP and_CC Topical_NNP Prevention_NNP of_IN Conception_NNP and_CC Disease_NNP ,_, Chicago_NNP ,_, IL_NNP ,_, USA_NNP -RRB-_-RRB- was_VBD found_VBN to_TO be_VB ineffective_JJ in_IN preventing_VBG HIV_NNP infection_NN and_CC may_MD also_RB have_VB potentially_RB increased_VBN the_DT risk_NN of_IN HIV_NNP acquisition_NN in_IN women_NNS 
All_DT authors_NNS read_VBD and_CC approved_VBD the_DT final_JJ manuscript_NN ._. 
KD_NNP participated_VBD in_IN the_DT analysis_NN of_IN the_DT simulation_NN data_NNS and_CC helped_VBD to_TO draft_VB the_DT manuscript_NN ._. 
Supplementary_NNP MaterialAdditional_NNP file_NN 1Results_NNS of_IN completed_VBN effectiveness_NN trials_NNS of_IN candidate_NN vaginal_JJ microbicides_NNS for_IN the_DT prevention_NN of_IN HIV_NNP acquisition_NN ._. 
Table_NNP showing_VBG the_DT results_NNS of_IN completed_VBN effectiveness_NN trials_NNS of_IN candidate_NN vaginal_JJ microbicides_NNS for_IN the_DT prevention_NN of_IN HIV_NNP acquisition_NN ._. 
For_IN instance_NN ,_, the_DT cellulose_NN sulfate_NN gel_NN -LRB-_-LRB- Ushercell_NNP ,_, Polydex_NNP Pharmaceuticals_NNP ,_, Toronto_NNP ,_, ON_NNP ,_, Canada_NNP and_CC Topical_NNP Prevention_NNP of_IN Conception_NNP and_CC Disease_NNP ,_, Chicago_NNP ,_, IL_NNP ,_, USA_NNP -RRB-_-RRB- was_VBD found_VBN to_TO be_VB ineffective_JJ in_IN preventing_VBG HIV_NNP infection_NN and_CC may_MD also_RB have_VB potentially_RB increased_VBN the_DT risk_NN of_IN HIV_NNP acquisition_NN in_IN women_NNS 
Thus_RB ,_, some_DT of_IN the_DT candidate_NN microbicides_NNS which_WDT have_VBP been_VBN show_NN to_TO increase_VB the_DT risk_NN of_IN HIV_NNP acquisition_NN may_MD have_VB been_VBN more_RBR harmful_JJ than_IN what_WP was_VBD observed_VBN in_IN these_DT trials_NNS ._. 
Acase_NNP in_IN point_NN is_VBZ the_DT Carraguard_NNP trial_NN which_WDT specifically_RB discussed_VBD and_CC attributed_VBD the_DT lack_NN of_IN effectiveness_NN to_TO low_JJ adherence_NN ,_, HIV_NNP infections_NNS from_IN AI_NNP ,_, and_CC the_DT potential_JJ efficacy_NN of_IN the_DT placebo_NN gel_NN used_VBN in_IN the_DT trial_NN 
5%_CD PRO2000_NNP gel_NNP -LRB-_-LRB- Endo_NNP Pharmaceuticals_NNP ,_, Chadds_NNP Ford_NNP ,_, PA_NNP ,_, USA_NNP -RRB-_-RRB- ,_, a_DT viral_JJ entry_NN inhibitor_NN ,_, reported_VBD an_DT estimated_VBN effectiveness_NN of_IN 30_CD %_NN -LRB-_-LRB- 95_CD %_NN CI_NNP -RRB-_-RRB- which_WDT ,_, although_IN of_IN borderline_JJ significance_NN -LRB-_-LRB- p_VB =_SYM 0_CD ._. 
10_CD -RRB-_-RRB- ,_, was_VBD welcomed_VBN with_IN optimism_NN 
All_DT authors_NNS read_VBD and_CC approved_VBD the_DT final_JJ manuscript_NN ._. 
KD_NNP participated_VBD in_IN the_DT analysis_NN of_IN the_DT simulation_NN data_NNS and_CC helped_VBD to_TO draft_VB the_DT manuscript_NN ._. 
Supplementary_NNP MaterialAdditional_NNP file_NN 1Results_NNS of_IN completed_VBN effectiveness_NN trials_NNS of_IN candidate_NN vaginal_JJ microbicides_NNS for_IN the_DT prevention_NN of_IN HIV_NNP acquisition_NN ._. 
Table_NNP showing_VBG the_DT results_NNS of_IN completed_VBN effectiveness_NN trials_NNS of_IN candidate_NN vaginal_JJ microbicides_NNS for_IN the_DT prevention_NN of_IN HIV_NNP acquisition_NN ._. 
Acase_NNP in_IN point_NN is_VBZ the_DT Carraguard_NNP trial_NN which_WDT specifically_RB discussed_VBD and_CC attributed_VBD the_DT lack_NN of_IN effectiveness_NN to_TO low_JJ adherence_NN ,_, HIV_NNP infections_NNS from_IN AI_NNP ,_, and_CC the_DT potential_JJ efficacy_NN of_IN the_DT placebo_NN gel_NN used_VBN in_IN the_DT trial_NN 
This_DT definition_NN implies_VBZ that_IN non-adherent_JJ women_NNS never_RB use_VBP the_DT gel_NN during_IN the_DT trial_NN therefore_RB ;_: they_PRP do_VBP not_RB get_VB any_DT benefit_NN from_IN the_DT gel_NN as_IN gel_NN is_VBZ never_RB used_VBN ._. 
Amore_JJ realistic_JJ alternative_NN model_NN might_MD be_VB preferable_JJ where_WRB women_NNS may_MD use_VB the_DT gel_NN for_IN some_DT acts_NNS of_IN vaginal_JJ intercourse_NN and_CC may_MD not_RB for_IN others_NNS ._. 
Under_IN this_DT alternative_NN model_NN ,_, women_NNS using_VBG the_DT gel_NN for_IN some_DT but_CC not_RB all_DT of_IN the_DT vaginal_JJ acts_NNS would_MD potentially_RB benefit_VB less_JJR than_IN those_DT that_WDT are_VBP always_RB using_VBG the_DT gel_NN ._. 
Although_IN ,_, the_DT product_NN 's_POS active_JJ ingredients_NNS of_IN most_JJS candidates_NNS are_VBP not_RB absorbed_VBN by_IN the_DT genital_JJ mucosa_NN ,_, the_DT fetus\/embryo_NN may_MD still_RB be_VB exposed_VBN due_JJ to_TO the_DT passage_NN of_IN the_DT product_NN through_IN the_DT uterus_NN and_CC the_DT cervical_JJ canal_NN ._. 
Given_VBN that_DT harm_NN from_IN the_DT product_NN can_MD not_RB be_VB entirely_RB ruled_VBN out_RP ,_, microbicide_NN protocols_NNS have_VBP cautiously_RB address_VB the_DT issue_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- by_IN excluding_VBG women_NNS who_WP have_VBP the_DT intention_NN of_IN becoming_VBG pregnant_JJ during_IN the_DT trial_NN or_CC requiring_VBG women_NNS to_TO use_VB at_IN least_JJS one_CD or_CC two_CD contraceptive_JJ methods_NNS and_CC -LRB-_-LRB- 2_CD -RRB-_-RRB- by_IN temporarily_RB withdrawing_VBG the_DT product_NN from_IN women_NNS becoming_VBG pregnant_JJ during_IN the_DT trial_NN with_IN product_NN use_NN resuming_VBG after_IN pregnancy_NN 
Despite_IN these_DT precautions_NNS ,_, pregnancies_NNS occurring_VBG during_IN follow-up_JJ have_JJ lead_NN to_TO high_JJ proportion_NN of_IN follow-up_JJ without_IN product_NN use_NN in_IN many_JJ trials_NNS ._. 
Pregnancy_NN rates_NNS between_IN 16_CD and_CC 64_CD per_IN 100_CD woman-years_NNS have_VBP been_VBN observed_VBN in_IN microbicide_NN trials_NNS which_WDT can_MD lead_VB to_TO a_DT proportion_NN of_IN follow-up_JJ time_NN off-product_NN between_IN 5_CD %_NN and_CC 20_CD %_NN ._. 
Although_IN a_DT product_NN can_MD also_RB be_VB withdrawn_VBN from_IN women_NNS for_IN other_JJ reasons_NNS such_JJ as_IN the_DT occurrence_NN of_IN adverse_JJ reactions_NNS ,_, the_DT dilution_NN effect_NN is_VBZ negligible_JJ because_IN the_DT time_NN off-product_NN due_JJ to_TO other_JJ emerging_VBG conditions_NNS is_VBZ substantially_RB smaller_JJR than_IN the_DT one_CD due_JJ to_TO pregnancy_NN ._. 
Scenario_NN 1_CD represents_VBZ the_DT somewhat_RB ideal_JJ microbicide_NN trial_NN with_IN very_RB high_JJ adherence_NN ,_, low_JJ pregnancy_NN ,_, small_JJ proportion_NN of_IN HIV_NNP infections_NNS from_IN AI_NNP ,_, and_CC no_DT placebo_NN efficacy_NN ._. 
Scenarios_NNS 2_CD and_CC 3_CD reflect_VBP data_NNS from_IN completed_VBN microbicide_NN trials_NNS -LRB-_-LRB- Table_NNP S1_NNP -RRB-_-RRB- and_CC from_IN field_NN studies_NNS -LRB-_-LRB- frequency_NN of_IN AI_NNP -RRB-_-RRB- ,_, although_IN estimates_NNS for_IN adherence_NN and_CC AI_NNP obtained_VBD from_IN trials_NNS are_VBP likely_JJ over_IN -_: and_CC underestimated_VBD ,_, respectively_RB ._. 
We_PRP have_VBP set_VBN the_DT placebo_NN efficacy_NN at_IN 0_CD %_NN and_CC 5_CD %_NN for_IN these_DT scenarios_NNS since_IN there_EX are_VBP no_DT data_NNS available_JJ for_IN many_JJ of_IN the_DT different_JJ placebo_NN gels_NNS that_IN we_PRP used_VBD in_IN the_DT completed_VBN trials_NNS ._. 
Click_VB here_RB for_IN fileAdditional_JJ file_NN 2Description_JJ and_CC computational_JJ details_NNS of_IN the_DT different_JJ dilution_NN factors_NNS ,_, expected_VBN effectiveness_NN and_CC total_JJ dilution_NN effect_NN ._. 
Table_NNP showing_VBG the_DT description_NN and_CC computational_JJ details_NNS of_IN the_DT different_JJ dilution_NN factors_NNS ,_, expected_VBN effectiveness_NN and_CC total_JJ dilution_NN effect_NN ._. 
Placebo_NNP Physical_NNP Barrier\/Lubrication_NNP Effect_NN Up_IN to_TO five_CD different_JJ placebo_NN gels_NNS have_VBP been_VBN used_VBN in_IN microbicide_NN trials_NNS ,_, many_JJ of_IN which_WDT may_MD not_RB be_VB completely_RB inert_JJ 
In_IN general_JJ ,_, choosing_VBG a_DT standard_JJ population_NN with_IN higher_JJR proportions_NNS in_IN the_DT younger_JJR age_NN groups_NNS gives_VBZ greater_JJR weight_NN to_TO events_NNS more_RBR likely_JJ to_TO occur_VB in_IN these_DT age_NN groups_NNS such_JJ as_IN motor_NN vehicle_NN accidents_NNS ,_, infant_NN deaths_NNS and_CC youth_NN suicide_NN ._. 
Conversely_RB the_DT choice_NN of_IN an_DT older_JJR standard_NN gives_VBZ more_JJR prominence_NN to_TO events_NNS that_WDT are_VBP more_RBR frequent_JJ at_IN older_JJR ages_NNS ,_, such_JJ as_IN deaths_NNS from_IN cancer_NN or_CC cardiovascular_JJ disease_NN ._. 
This_DT could_MD potentially_RB affect_VB perceptions_NNS of_IN disparities_NNS ,_, prioritising_VBG decisions_NNS or_CC have_VBP other_JJ flow-on_JJ effects_NNS in_IN policy_NN ._. 
This_DT could_MD potentially_RB affect_VB perceptions_NNS of_IN disparities_NNS ,_, prioritising_VBG decisions_NNS or_CC have_VBP other_JJ flow-on_JJ effects_NNS in_IN policy_NN ._. 
Segi_NNP 's_POS World_NNP and_CC the_DT WHO_WP World_NNP PopulationsIn_NNP New_NNP Zealand_NNP ,_, the_DT most_RBS common_JJ standard_JJ populations_NNS used_VBN to_TO compare_VB M_NNP 
It_PRP was_VBD proposed_VBN as_IN an_DT intermediate_JJ ``_`` world_NN ''_'' standard_NN ,_, with_IN an_DT age_NN structure_NN between_IN that_DT of_IN the_DT younger_JJR ``_`` African_JJ ''_'' standard_NN and_CC the_DT older_JJR ``_`` European_JJ ''_'' standard_NN 
The_DT new_JJ WHO_WP world_NN standard_NN is_VBZ based_VBN on_IN estimates_NNS of_IN the_DT average_JJ age_NN structure_NN of_IN the_DT world_NN 's_POS population_NN -LRB-_-LRB- countries_NNS not_RB defined_VBN -RRB-_-RRB- expected_VBN from_IN the_DT year_NN 2000_CD to_TO 2025_CD ._. 
Although_IN younger_JJR than_IN the_DT ``_`` European_JJ ''_'' standard_NN ,_, it_PRP has_VBZ fewer_JJR children_NNS than_IN Segi_NNP 's_POS standard_NN and_CC a_DT higher_JJR proportion_NN aged_VBN 70_CD years_NNS and_CC over_IN ._. 
The_DT substantial_JJ variation_NN in_IN age_NN structure_NN between_IN indigenous_JJ and_CC non-indigenous_JJ populations_NNS of_IN Aotearoa\/New_NNP Zealand_NNP and_CC the_DT recent_JJ introduction_NN of_IN the_DT WHO_WP world_NN standard_NN has_VBZ stimulated_VBN interest_NN in_IN the_DT effect_NN of_IN different_JJ age_NN standards_NNS on_IN M_NNP 
This_DT could_MD potentially_RB affect_VB perceptions_NNS of_IN disparities_NNS ,_, prioritising_VBG decisions_NNS or_CC have_VBP other_JJ flow-on_JJ effects_NNS in_IN policy_NN ._. 
Segi_NNP 's_POS World_NNP and_CC the_DT WHO_WP World_NNP PopulationsIn_NNP New_NNP Zealand_NNP ,_, the_DT most_RBS common_JJ standard_JJ populations_NNS used_VBN to_TO compare_VB M_NNP 
4using_VBG the_DT 2000_CD standard_NN ._. 
6using_VBG the_DT 1940_CD standard_NN to_TO 1_CD ._. 
For_IN example_NN ,_, 1995_CD mortality_NN ratios_NNS for_IN African_JJ Americans_NNS compared_VBN to_TO White_NNP Americans_NNPS reduced_VBD from_IN 1_CD ._. 
The_DT 2000_CD standard_NN ,_, driven_VBN primarily_RB by_IN the_DT age_NN distribution_NN of_IN the_DT White_JJ non-Hispanic_JJ population_NN ,_, gives_VBZ greater_JJR weight_NN to_TO older_JJR age_NN groups_NNS where_WRB the_DT age-specific_JJ rates_NNS for_IN the_DT two_CD populations_NNS differ_VBP least_JJS 
Nevertheless_RB ,_, the_DT monitoring_NN of_IN trends_NNS and_CC disparities_NNS has_VBZ a_DT vital_JJ role_NN in_IN stimulating_VBG public_JJ and_CC political_JJ determination_NN to_TO address_VB the_DT root_NN and_CC surface_NN causes_NNS of_IN health_NN disparities_NNS ._. 
Krieger_NNP and_CC Williams_NNP reported_VBD an_DT effect_NN of_IN choice_NN of_IN population_NN standard_NN on_IN socioeconomic_JJ disparities_NNS ,_, with_IN the_DT older_JJR age_NN standard_NN having_VBG a_DT net_JJ effect_NN of_IN reducing_VBG the_DT income_NN gradient_NN in_IN mortality_NN ._. 
Thus_RB exploration_NN of_IN the_DT impact_NN of_IN population_NN standards_NNS on_IN indigenous_JJ health_NN data_NNS stratified_VBN by_IN socioeconomic_JJ measures_NNS is_VBZ also_RB necessary_JJ ._. 
The_DT 2000_CD standard_NN ,_, driven_VBN primarily_RB by_IN the_DT age_NN distribution_NN of_IN the_DT White_JJ non-Hispanic_JJ population_NN ,_, gives_VBZ greater_JJR weight_NN to_TO older_JJR age_NN groups_NNS where_WRB the_DT age-specific_JJ rates_NNS for_IN the_DT two_CD populations_NNS differ_VBP least_JJS 
In_IN this_DT method_NN age-specific_JJ rates_NNS from_IN study_NN population_NN -LRB-_-LRB- s_PRP -RRB-_-RRB- are_VBP applied_VBN to_TO a_DT standard_JJ population_NN structure_NN ._. 
The_DT expected_JJ number_NN of_IN cases_NNS is_VBZ then_RB summed_VBN and_CC divided_VBN by_IN the_DT total_JJ standard_JJ population_NN to_TO obtain_VB the_DT overall_JJ standardised_JJ rate_NN ._. 
The_DT weights_NNS provided_VBN by_IN the_DT standard_JJ population_NN are_VBP the_DT same_JJ in_IN all_DT comparison_NN groups_NNS ,_, thus_RB allowing_VBG comparison_NN of_IN rates_NNS for_IN several_JJ study_NN populations_NNS and_CC between_IN time_NN periods_NNS ._. 
Effects_NNPS of_IN different_JJ standard_JJ populations_NNS The_DT choice_NN of_IN standard_JJ population_NN is_VBZ generally_RB thought_VBN to_TO be_VB arbitrary_JJ but_CC can_MD nevertheless_RB affect_VB the_DT results_NNS obtained_VBD ._. 
In_IN general_JJ the_DT use_NN of_IN a_DT young_JJ standard_NN leads_VBZ to_TO a_DT low_JJ standardised_JJ mortality_NN rate_NN ,_, and_CC an_DT old_JJ standard_NN to_TO a_DT high_JJ overall_JJ rate_NN ,_, due_JJ to_TO the_DT strong_JJ association_NN between_IN age_NN and_CC mortality_NN ._. 
This_DT was_VBD demonstrated_VBN recently_RB when_WRB the_DT United_NNP States_NNP -LRB-_-LRB- US_NNP -RRB-_-RRB- changed_VBD its_PRP$ population_NN standard_NN from_IN one_CD based_VBN on_IN the_DT 1940_CD US_NNP population_NN to_TO the_DT significantly_RB older_JJR 2000_CD US_NNP population_NN ._. 
US_NNP coronary_JJ heart_NN disease_NN mortality_NN rates_NNS for_IN 1994_CD adjusted_VBN using_VBG the_DT 1940_CD age_NN structure_NN gave_VBD a_DT rate_NN of_IN 87_CD per_IN 100,000_CD ._. 
However_RB when_WRB the_DT rate_NN was_VBD calculated_VBN two_CD years_NNS later_RB in_IN 1996_CD ,_, but_CC standardised_VBN to_TO the_DT 2000_CD age_NN structure_NN ,_, the_DT result_NN was_VBD more_JJR than_IN twice_RB as_RB high_JJ at_IN 187_CD per_IN 100,000_CD ._. 
An_DT effect_NN was_VBD also_RB observed_VBN in_IN trends_NNS over_IN time_NN ._. 
Between_IN 1979_CD and_CC 1995_CD the_DT crude_JJ US_NNP death_NN rate_NN increased_VBN by_IN 3_CD ._. 
6%_CD while_IN that_DT based_VBN on_IN the_DT 2000_CD standard_NN decreased_VBN by_IN only_RB 9_CD ._. 
Standardised_VBN to_TO the_DT 1940_CD population_NN the_DT rate_NN decreased_VBN by_IN 12_CD ._. 
2%_CD ._. 
Because_IN the_DT decreases_VBZ in_IN age-specific_JJ mortality_NN rates_NNS were_VBD smaller_JJR in_IN the_DT older_JJR age_NN groups_NNS ,_, the_DT decline_NN appears_VBZ attenuated_VBN in_IN the_DT 2000_CD standardised_JJ rates_NNS ._. 
Because_IN the_DT decreases_VBZ in_IN age-specific_JJ mortality_NN rates_NNS were_VBD smaller_JJR in_IN the_DT older_JJR age_NN groups_NNS ,_, the_DT decline_NN appears_VBZ attenuated_VBN in_IN the_DT 2000_CD standardised_JJ rates_NNS ._. 
Importantly_RB ,_, racial\/ethnic_JJ disparities_NNS in_IN health_NN were_VBD also_RB affected_VBN by_IN the_DT change_NN to_TO the_DT 2000_CD standard_NN ,_, appearing_VBG substantially_RB smaller_JJR than_IN those_DT standardised_VBN to_TO the_DT younger_JJR standard_NN ._. 
For_IN example_NN ,_, 1995_CD mortality_NN ratios_NNS for_IN African_JJ Americans_NNS compared_VBN to_TO White_NNP Americans_NNPS reduced_VBD from_IN 1_CD ._. 
The_DT development_NN of_IN an_DT international_JJ indigenous_JJ population_NN standard_NN could_MD contribute_VB to_TO an_DT epidemiology_NN centred_VBD more_JJR within_IN the_DT indigenous_JJ world_NN ._. 
While_IN it_PRP may_MD be_VB controversial_JJ to_TO introduce_VB another_DT population_NN standard_NN ,_, there_EX is_VBZ currently_RB no_DT consistent_JJ standard_NN used_VBN throughout_IN the_DT international_JJ literature_NN ._. 
Several_JJ issues_NNS require_VBP further_JJ consideration_NN for_IN the_DT development_NN of_IN an_DT indigenous_JJ standard_JJ population_NN ._. 
64_CD Age-standardisation_NN There_EX are_VBP a_DT number_NN of_IN methods_NNS that_WDT can_MD take_VB account_NN of_IN age_NN differences_NNS when_WRB comparing_VBG health_NN outcomes_NNS between_IN different_JJ populations_NNS ,_, and_CC it_PRP is_VBZ important_JJ to_TO understand_VB which_WDT tool_NN to_TO use_VB when_WRB 
This_DT could_MD potentially_RB affect_VB perceptions_NNS of_IN disparities_NNS ,_, prioritising_VBG decisions_NNS or_CC have_VBP other_JJ flow-on_JJ effects_NNS in_IN policy_NN ._. 
Segi_NNP 's_POS World_NNP and_CC the_DT WHO_WP World_NNP PopulationsIn_NNP New_NNP Zealand_NNP ,_, the_DT most_RBS common_JJ standard_JJ populations_NNS used_VBN to_TO compare_VB M_NNP 
Segi_NNP 's_POS ``_`` world_NN ''_'' population_NN ,_, devised_VBN in_IN the_DT late_JJ 1950s_NNS by_IN cancer_NN epidemiologist_NN Dr_NNP Mitsuo_NNP Segi_NNP ,_, was_VBD based_VBN on_IN the_DT sum_NN total_NN of_IN male_JJ and_CC female_JJ populations_NNS of_IN the_DT 46_CD countries_NNS in_IN the_DT 1950_CD publications_NNS of_IN the_DT WHO_WP 
Segi_NNP 's_POS World_NNP and_CC the_DT WHO_WP World_NNP Populations_NNPS In_IN New_NNP Zealand_NNP ,_, the_DT most_RBS common_JJ standard_JJ populations_NNS used_VBN to_TO compare_VB M_NNP 
3._CD 
The_DT study_NN of_IN inequities_NNS in_IN health_NN is_VBZ a_DT critical_JJ component_NN of_IN monitoring_VBG government_NN obligations_NNS in_IN respect_NN of_IN indigenous_JJ rights_NNS and_CC ensuring_VBG M_NNP 
Thirdly_RB ,_, the_DT relationship_NN with_IN age_NN is_VBZ different_JJ for_IN health_NN service_NN utilisation_NN than_IN for_IN mortality_NN ._. 
In_IN Aotearoa\/New_NNP Zealand_NNP ,_, measures_NNS of_IN health_NN service_NN performance_NN and_CC funding_NN incentives_NNS include_VBP age-standardised_JJ measures_NNS such_JJ as_IN rates_NNS of_IN visits_NNS to_TO primary_JJ care_NN services_NNS ._. 
The_DT effect_NN of_IN different_JJ age_NN standards_NNS on_IN health_NN utilisation_NN data_NNS requires_VBZ further_JJ investigation_NN ._. 
Finally_RB ,_, the_DT usefulness_NN of_IN age-standardised_JJ data_NNS is_VBZ underpinned_VBN by_IN the_DT quality_NN of_IN the_DT data_NNS sources_NNS ._. 
Accurate_JJ and_CC complete_JJ enumeration_NN of_IN indigenous_JJ peoples_NNS and_CC of_IN our_PRP$ vital_JJ statistics_NNS and_CC health_NN events_NNS must_MD be_VB of_IN primary_JJ concern_NN to_TO users_NNS of_IN health_NN data_NNS ._. 
Associated_NNP with_IN the_DT right_NN to_TO self-identification_NN is_VBZ the_DT right_NN to_TO be_VB counted_VBN as_IN M_NNP 
Associated_NNP with_IN the_DT right_NN to_TO self-identification_NN is_VBZ the_DT right_NN to_TO be_VB counted_VBN as_IN M_NNP 
They_PRP form_VBP at_IN present_JJ non-dominant_JJ sectors_NNS of_IN society_NN and_CC are_VBP determined_VBN to_TO preserve_VB ,_, develop_VB and_CC transmit_VB to_TO future_JJ generations_NNS their_PRP$ ancestral_JJ territories_NNS ,_, and_CC their_PRP$ ethnic_JJ identity_NN ,_, as_IN the_DT basis_NN of_IN their_PRP$ continued_JJ existence_NN as_IN peoples_NNS in_IN accordance_NN with_IN their_PRP$ own_JJ cultural_JJ patterns_NNS ,_, social_JJ institutions_NNS and_CC legal_JJ systems_NNS ._. 
``_`` 2_CD ._. 
The_DT United_NNP Nations_NNPS Draft_NNP Declaration_NNP of_IN the_DT Rights_NNS of_IN Indigenous_NNP Peoples_NNPS affirms_VBZ the_DT right_NN of_IN indigenous_JJ peoples_NNS to_TO self-determination_NN -LRB-_-LRB- Article_NNP 3_CD -RRB-_-RRB- ,_, to_TO freedom_NN from_IN adverse_JJ discrimination_NN based_VBN on_IN indigenous_JJ origin_NN or_CC identity_NN -LRB-_-LRB- Article_NNP 2_CD -RRB-_-RRB- ,_, and_CC to_TO access_NN to_TO health_NN services_NNS without_IN discrimination_NN -LRB-_-LRB- Article_NNP 24_CD -RRB-_-RRB- ._. 
Secondly_RB ,_, further_JJ work_NN needs_VBZ to_TO be_VB done_VBN to_TO examine_VB the_DT effect_NN of_IN age_NN standards_NNS on_IN time_NN trends_NNS in_IN inequalities_NNS 
Several_JJ issues_NNS require_VBP further_JJ consideration_NN for_IN the_DT development_NN of_IN an_DT indigenous_JJ standard_JJ population_NN ._. 
Firstly_RB ,_, although_IN age-standardised_JJ rates_NNS are_VBP artificial_JJ constructs_NNS ,_, they_PRP reflect_VBP underlying_VBG patterns_NNS of_IN health_NN disparities_NNS resulting_VBG from_IN differential_JJ access_NN to_TO the_DT political_JJ ,_, social_JJ ,_, economic_JJ and_CC environmental_JJ determinants_NNS of_IN health_NN ,_, and_CC health_NN care_NN resources_NNS ._. 
It_PRP is_VBZ these_DT factors_NNS ,_, rather_RB than_IN age_NN distribution_NN per_IN se_FW ,_, that_WDT require_VBP attention_NN and_CC intervention_NN ._. 
The_DT development_NN of_IN an_DT international_JJ indigenous_JJ population_NN standard_NN could_MD contribute_VB to_TO an_DT epidemiology_NN centred_VBD more_JJR within_IN the_DT indigenous_JJ world_NN ._. 
While_IN it_PRP may_MD be_VB controversial_JJ to_TO introduce_VB another_DT population_NN standard_NN ,_, there_EX is_VBZ currently_RB no_DT consistent_JJ standard_NN used_VBN throughout_IN the_DT international_JJ literature_NN ._. 
Several_JJ issues_NNS require_VBP further_JJ consideration_NN for_IN the_DT development_NN of_IN an_DT indigenous_JJ standard_JJ population_NN ._. 
New_NNP Zealand_NNP health_NN data_NNS are_VBP known_VBN to_TO have_VB undercounted_VBN M_NNP 
The_DT development_NN of_IN an_DT international_JJ indigenous_JJ population_NN standard_NN could_MD contribute_VB to_TO an_DT epidemiology_NN centred_VBD more_JJR within_IN the_DT indigenous_JJ world_NN ._. 
While_IN it_PRP may_MD be_VB controversial_JJ to_TO introduce_VB another_DT population_NN standard_NN ,_, there_EX is_VBZ currently_RB no_DT consistent_JJ standard_NN used_VBN throughout_IN the_DT international_JJ literature_NN ._. 
Several_JJ issues_NNS require_VBP further_JJ consideration_NN for_IN the_DT development_NN of_IN an_DT indigenous_JJ standard_JJ population_NN ._. 
31_CD -RRB-_-RRB- using_VBG the_DT WHO_WP standard_NN ._. 
87_CD 
Figure_NN 3_CD Percent_NN difference_NN in_IN population_NN weights_NNS :_: comparison_NN of_IN Maori_NNP and_CC non-Maori_JJ populations_NNS with_IN Segi_NNP 's_POS world_NN population_NN and_CC WHO_WP world_NN population_NN ._. 
Projections_NNS for_IN the_DT M_NNP 
Large_JJ variability_NN in_IN weights_NNS between_IN the_DT standard_JJ population_NN and_CC the_DT study_NN populations_NNS can_MD affect_VB the_DT performance_NN of_IN confidence_NN intervals_NNS on_IN rates_NNS ._. 
The_DT greater_JJR the_DT variance_NN ,_, the_DT less_RBR adequate_JJ the_DT coverage_NN probability_NN of_IN the_DT confidence_NN limits_NNS ._. 
Figure_NNP 3_NNP shows_VBZ the_DT percentage_NN difference_NN between_IN the_DT age_NN structures_NNS of_IN Segi_NNP 's_POS or_CC the_DT WHO_WP standard_JJ populations_NNS and_CC the_DT M_NNP 
Confidence_NN intervals_NNS The_DT M_NNP 
Each_DT age-sex-specific_JJ rate_NN was_VBD then_RB multiplied_VBN by_IN the_DT standard_JJ population_NN weight_NN for_IN that_DT age_NN group_NN and_CC summed_VBD to_TO produce_VB the_DT age-sex-standardised_JJ rate_NN ._. 
Ninety-five_JJ percent_NN confidence_NN intervals_NNS were_VBD calculated_VBN for_IN age-sex-standardised_JJ mortality_NN rates_NNS and_CC ratios_NNS using_VBG the_DT log-transformation_NN method_NN ._. 
Results_NNS Comparing_VBG Segi_NNP 's_POS ,_, WHO_WP ,_, M_NNP 
This_DT was_VBD used_VBN for_IN denominators_NNS in_IN rates_NNS and_CC as_IN the_DT M_NNP 
The_DT two_CD world_NN standards_NNS ,_, along_IN with_IN a_DT M_NNP 
Associated_NNP with_IN the_DT right_NN to_TO self-identification_NN is_VBZ the_DT right_NN to_TO be_VB counted_VBN as_IN M_NNP 
Accurate_JJ monitoring_NN and_CC evaluation_NN of_IN the_DT impact_NN of_IN government_NN policy_NN on_IN M_NNP 
However_RB ,_, the_DT tools_NNS used_VBN in_IN epidemiology_NN need_VBP careful_JJ scrutiny_NN to_TO ensure_VB they_PRP are_VBP as_RB responsive_JJ to_TO the_DT interests_NNS of_IN indigenous_JJ peoples_NNS and_CC minority_NN ethnic_JJ groups_NNS as_IN they_PRP are_VBP to_TO those_DT of_IN numerically_RB dominant_JJ populations_NNS ._. 
Kaupapa_NNP M_NNP 
38_CD Total_JJ -LRB-_-LRB- crude_NN -RRB-_-RRB- 13515_CD 490 123891_CD 762_CD 0_CD ._. 
83_CD 65_CD and_CC over_IN 5455 6424 98791_CD 4649_CD 1_CD ._. 
26_CD 45_CD 
In_IN Aotearoa\/New_NNP Zealand_NNP ,_, this_DT information_NN is_VBZ also_RB used_VBN to_TO monitor_VB the_DT impact_NN of_IN government_NN policy_NN and_CC actions_NNS on_IN the_DT health_NN of_IN M_NNP 
In_IN Aotearoa\/New_NNP Zealand_NNP ,_, this_DT information_NN is_VBZ also_RB used_VBN to_TO monitor_VB the_DT impact_NN of_IN government_NN policy_NN and_CC actions_NNS on_IN the_DT health_NN of_IN M_NNP 
Accurate_JJ monitoring_NN and_CC evaluation_NN of_IN the_DT impact_NN of_IN government_NN policy_NN on_IN M_NNP 
64_CD Age-standardisation_NN There_EX are_VBP a_DT number_NN of_IN methods_NNS that_WDT can_MD take_VB account_NN of_IN age_NN differences_NNS when_WRB comparing_VBG health_NN outcomes_NNS between_IN different_JJ populations_NNS ,_, and_CC it_PRP is_VBZ important_JJ to_TO understand_VB which_WDT tool_NN to_TO use_VB when_WRB 
The_DT complexity_NN is_VBZ measured_VBN by_IN the_DT effective_JJ number_NN of_IN parameters_NNS ._. 
DIC_NNP penalizes_VBZ the_DT model_NN goodness-of-fit_NN for_IN additional_JJ complexity_NN ._. 
In_IN order_NN to_TO quantify_VB the_DT variance_NN explained_VBN by_IN the_DT fitted_VBN models_NNS ,_, we_PRP used_VBD a_DT Bayesian_JJ version_NN of_IN the_DT classical_JJ R-squared_NNP ._. 
i._FW e._FW -LRB-_-LRB- 9_CD -RRB-_-RRB- B_NNP R_NNP S_NNP Q_NNP =_SYM 1_CD 
Clearly_RB ,_, the_DT burden_NN of_IN disease_NN would_MD be_VB much_RB lighter_JJR in_IN that_DT case_NN than_IN if_IN most_JJS people_NNS were_VBD to_TO die_VB from_IN influenza_NN prematurely_RB by_IN many_JJ years_NNS ._. 
Amore_JJ adequate_JJ measure_NN of_IN disease_NN burden_NN therefore_RB may_MD be_VB disability-adjusted_JJ life_NN years_NNS -LRB-_-LRB- DALYs_NNP -RRB-_-RRB- ._. 
By_IN estimating_VBG a_DT more_RBR refined_JJ age_NN distribution_NN of_IN those_DT who_WP died_VBD from_IN influenza_NN ,_, calculations_NNS of_IN DALYs_NNP ,_, or_CC at_IN least_JJS of_IN potential_JJ years_NNS of_IN life_NN lost_VBN -LRB-_-LRB- PYLL_NNP -RRB-_-RRB- ,_, should_MD be_VB relatively_RB straightforward_JJ ._. 
To_TO estimate_VB excess_JJ mortality_NN due_JJ to_TO influenza_NN ,_, two_CD fundamental_JJ approaches_NNS have_VBP previously_RB been_VBN used_VBN ._. 
The_DT most_RBS popular_JJ one_NN is_VBZ based_VBN on_IN Serfling_NNP 's_POS seasonal_JJ regression_NN method_NN 
However_RB ,_, to_TO allow_VB for_IN direct_JJ comparison_NN of_IN the_DT model_NN fit_NN we_PRP used_VBD the_DT same_JJ estimation_NN procedure_NN as_IN for_IN the_DT current_JJ model_NN ._. 
The_DT fit_NN of_IN the_DT two_CD age-specific_JJ models_NNS was_VBD compared_VBN using_VBG the_DT deviance_NN information_NN criterion_NN -LRB-_-LRB- DIC_NNP -RRB-_-RRB- ._. 
DIC_NNP penalizes_VBZ the_DT model_NN goodness-of-fit_NN for_IN additional_JJ complexity_NN ._. 
The_DT complexity_NN is_VBZ measured_VBN by_IN the_DT effective_JJ number_NN of_IN parameters_NNS ._. 
4._CD 
To_TO calculate_VB estimated_VBN excess_JJ mortality_NN due_JJ to_TO influenza_NN ,_, all_DT parameters_NNS in_IN 8_CD are_VBP replaced_VBN by_IN their_PRP$ posterior_NN estimates_VBZ Statistical_NNP analysis_NN The_DT parameters_NNS for_IN this_DT hierarchical_JJ model_NN were_VBD estimated_VBN using_VBG a_DT Markov_NNP chain_NN Monte_NNP Carlo_NNP -LRB-_-LRB- MCMC_NNP -RRB-_-RRB- algorithm_NN implemented_VBN in_IN WinBUGS_NNP ,_, version_NN 1_CD ._. 
1-LRB-_NNP Imperial_NNP College_NNP and_CC Medical_NNP Research_NNP Council_NNP ,_, UK_NNP -RRB-_-RRB- ._. 
Uninformative_JJ prior_JJ distributions_NNS were_VBD used_VBN -LRB-_-LRB- additional_JJ file_NN 1_CD -RRB-_-RRB- ._. 
To_TO ensure_VB positivity_NN of_IN all_DT 
Alternatively_RB ,_, one_PRP could_MD postulate_VB that_DT mortality_NN directly_RB attributed_VBN to_TO influenza_NN -LRB-_-LRB- influenza-certified_JJ mortality_NN -RRB-_-RRB- represents_VBZ a_DT certain_JJ proportion_NN of_IN all_DT mortality_NN attributable_JJ to_TO influenza_NN ._. 
This_DT assumption_NN implies_VBZ that_IN the_DT coefficient_NN associated_VBN with_IN influenza-certified_JJ mortality_NN represents_VBZ the_DT ratio_NN of_IN total_JJ influenza_NN mortality_NN to_TO influenza_VB certified_JJ mortality_NN 
This_DT appears_VBZ to_TO be_VB an_DT unrealistic_JJ assumption_NN ._. 
The_DT model_NN ,_, however_RB ,_, implies_VBZ that_IN five_CD hundred_CD influenza_NN positives_NNS ,_, obtained_VBN from_IN a_DT thousand_CD tests_NNS ,_, are_VBP associated_VBN with_IN less_JJR excess_JJ mortality_NN than_IN two_CD influenza_NN positives_NNS ,_, obtained_VBN from_IN three_CD tests_NNS ._. 
The_DT seasonally_RB changing_JJ frequency_NN of_IN influenza_NN testing_NN is_VBZ ,_, at_IN least_JJS partly_RB ,_, due_JJ to_TO the_DT seasonally_RB changing_VBG incidence_NN of_IN other_JJ agents_NNS causing_VBG influenza-like_JJ illness_NN -LRB-_-LRB- ILL_NNP -RRB-_-RRB- ._. 
Alternatively_RB ,_, one_PRP could_MD postulate_VB that_DT mortality_NN directly_RB attributed_VBN to_TO influenza_NN -LRB-_-LRB- influenza-certified_JJ mortality_NN -RRB-_-RRB- represents_VBZ a_DT certain_JJ proportion_NN of_IN all_DT mortality_NN attributable_JJ to_TO influenza_NN ._. 
Incidence_NN of_IN these_DT infections_NNS is_VBZ difficult_JJ to_TO quantify_VB because_IN of_IN their_PRP$ clinical_JJ similarity_NN with_IN other_JJ upper_JJ respiratory_JJ infections_NNS and_CC because_IN laboratory_NN confirmation_NN is_VBZ rarely_RB done_VBN ._. 
Mortality_NN due_JJ to_TO seasonal_JJ influenza_NN ,_, which_WDT may_MD result_VB from_IN exacerbation_NN of_IN underlying_VBG pulmonary_JJ ,_, cardiac_JJ or_CC other_JJ systemic_JJ conditions_NNS is_VBZ ,_, nevertheless_RB ,_, thought_VBD to_TO be_VB substantial_JJ 
Alternatively_RB ,_, one_PRP could_MD postulate_VB that_DT mortality_NN directly_RB attributed_VBN to_TO influenza_NN -LRB-_-LRB- influenza-certified_JJ mortality_NN -RRB-_-RRB- represents_VBZ a_DT certain_JJ proportion_NN of_IN all_DT mortality_NN attributable_JJ to_TO influenza_NN ._. 
This_DT assumption_NN implies_VBZ that_IN the_DT coefficient_NN associated_VBN with_IN influenza-certified_JJ mortality_NN represents_VBZ the_DT ratio_NN of_IN total_JJ influenza_NN mortality_NN to_TO influenza_VB certified_JJ mortality_NN 
This_DT assumption_NN implies_VBZ that_IN the_DT coefficient_NN associated_VBN with_IN influenza-certified_JJ mortality_NN represents_VBZ the_DT ratio_NN of_IN total_JJ influenza_NN mortality_NN to_TO influenza_VB certified_JJ mortality_NN 
The_DT Thompson_NNP model_NN 
Schanzer_NNP et_FW al._FW ._. 
They_PRP may_MD rather_RB be_VB due_JJ to_TO the_DT use_NN of_IN proportion_NN of_IN specimens_NNS testing_VBG positive_JJ to_TO control_VB for_IN influenza_NN mortality_NN ._. 
,like_VB us_PRP ,_, used_VBD a_DT Poisson_NNP model_NN with_IN linear_JJ -LRB-_-LRB- rather_RB than_IN logarithmic_JJ -RRB-_-RRB- link_NN function_NN ,_, to_TO analyze_VB weekly_JJ mortality_NN data_NNS from_IN Canada_NNP ._. 
Modeling_VBG weekly_JJ mortality_NN has_VBZ the_DT advantage_NN of_IN giving_VBG higher_JJR temporal_JJ resolution_NN to_TO the_DT analysis_NN ._. 
On_IN the_DT other_JJ hand_NN ,_, deaths_NNS associated_VBN with_IN ,_, but_CC not_RB attributed_VBN to_TO influenza_NN may_MD occur_VB with_IN some_DT delay_NN and_CC may_MD thus_RB be_VB partially_RB decoupled_VBN from_IN influenza-certified_JJ mortality_NN ._. 
To_TO take_VB into_IN account_NN random_JJ variability_NN in_IN influenza-certified_JJ mortality_NN ,_, we_PRP used_VBD a_DT hierarchical_JJ model_NN ._. 
While_IN the_DT point_NN estimates_NNS for_IN 
S._NNP Recent_JJ U._NNP Mortality_NN due_JJ to_TO seasonal_JJ influenza_NN ,_, which_WDT may_MD result_VB from_IN exacerbation_NN of_IN underlying_VBG pulmonary_JJ ,_, cardiac_JJ or_CC other_JJ systemic_JJ conditions_NNS is_VBZ ,_, nevertheless_RB ,_, thought_VBD to_TO be_VB substantial_JJ 
To_TO estimate_VB excess_JJ mortality_NN due_JJ to_TO influenza_NN ,_, two_CD fundamental_JJ approaches_NNS have_VBP previously_RB been_VBN used_VBN ._. 
The_DT most_RBS popular_JJ one_NN is_VBZ based_VBN on_IN Serfling_NNP 's_POS seasonal_JJ regression_NN method_NN 
For_IN the_DT same_JJ period_NN ,_, Simonsen_NNP et_FW al._FW ._. 
For_IN the_DT year_NN 1995\/96_CD ,_, for_IN example_NN ,_, we_PRP attributed_VBD 12,067_CD excess_JJ deaths_NNS to_TO influenza_NN ._. 
As_IN pointed_VBN out_RP above_RB ,_, the_DT method_NN of_IN Simonsen_NNP et_FW al._FW ._. 
The_DT obvious_JJ question_NN arises_VBZ ,_, which_WDT of_IN these_DT estimates_NNS are_VBP closest_JJS to_TO the_DT true_JJ excess_JJ mortality_NN ._. 
is_VBZ problematic_JJ for_IN two_CD reasons_NNS ._. 
First_RB ,_, it_PRP does_VBZ not_RB account_VB for_IN temporal_JJ correlation_NN between_IN baseline_JJ mortality_NN and_CC influenza_NN excess_JJ mortality_NN ._. 
To_TO estimate_VB excess_JJ mortality_NN due_JJ to_TO influenza_NN ,_, two_CD fundamental_JJ approaches_NNS have_VBP previously_RB been_VBN used_VBN ._. 
The_DT most_RBS popular_JJ one_NN is_VBZ based_VBN on_IN Serfling_NNP 's_POS seasonal_JJ regression_NN method_NN 
To_TO estimate_VB excess_JJ mortality_NN due_JJ to_TO influenza_NN ,_, two_CD fundamental_JJ approaches_NNS have_VBP previously_RB been_VBN used_VBN ._. 
The_DT most_RBS popular_JJ one_NN is_VBZ based_VBN on_IN Serfling_NNP 's_POS seasonal_JJ regression_NN method_NN 
The_DT excellent_JJ fit_NN of_IN our_PRP$ model_NN with_IN the_DT data_NNS suggest_VBP validity_NN of_IN our_PRP$ estimates_NNS ._. 
Conclusion_NN Annual_JJ estimates_NNS for_IN influenza_NN mortality_NN were_VBD highly_RB variable_JJ from_IN year_NN to_TO year_NN ,_, but_CC they_PRP were_VBD systematically_RB lower_JJR than_IN previously_RB published_VBN estimates_NNS ._. 
BackgroundInfluenza_NN viruses_NNS ,_, due_JJ to_TO their_PRP$ genotypic_JJ plasticity_NN ,_, cause_VB yearly_JJ epidemics_NNS that_WDT generally_RB coincide_VBP with_IN peaks_NNS in_IN all-cause_JJ mortality_NN -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ._. 
Incidence_NN of_IN these_DT infections_NNS is_VBZ difficult_JJ to_TO quantify_VB because_IN of_IN their_PRP$ clinical_JJ similarity_NN with_IN other_JJ upper_JJ respiratory_JJ infections_NNS and_CC because_IN laboratory_NN confirmation_NN is_VBZ rarely_RB done_VBN ._. 
Incidence_NN of_IN these_DT infections_NNS is_VBZ difficult_JJ to_TO quantify_VB because_IN of_IN their_PRP$ clinical_JJ similarity_NN with_IN other_JJ upper_JJ respiratory_JJ infections_NNS and_CC because_IN laboratory_NN confirmation_NN is_VBZ rarely_RB done_VBN ._. 
Mortality_NN due_JJ to_TO seasonal_JJ influenza_NN ,_, which_WDT may_MD result_VB from_IN exacerbation_NN of_IN underlying_VBG pulmonary_JJ ,_, cardiac_JJ or_CC other_JJ systemic_JJ conditions_NNS is_VBZ ,_, nevertheless_RB ,_, thought_VBD to_TO be_VB substantial_JJ 
S._NNP Recent_JJ U._NNP Mortality_NN due_JJ to_TO seasonal_JJ influenza_NN ,_, which_WDT may_MD result_VB from_IN exacerbation_NN of_IN underlying_VBG pulmonary_JJ ,_, cardiac_JJ or_CC other_JJ systemic_JJ conditions_NNS is_VBZ ,_, nevertheless_RB ,_, thought_VBD to_TO be_VB substantial_JJ 
Following_VBG this_DT rationale_NN ,_, Thompson_NNP et_NNP al._NNP ._. 
To_TO avoid_VB this_DT difficulty_NN ,_, one_CD could_MD gauge_VB all-cause_JJ mortality_NN with_IN some_DT independent_JJ measure_NN of_IN influenza_NN transmission_NN -LRB-_-LRB- or_CC mortality_NN -RRB-_-RRB- ._. 
estimated_VBN excess_JJ mortality_NN due_JJ to_TO both_DT influenza_NN and_CC respiratory_JJ syncytial_JJ virus_NN -LRB-_-LRB- RSV_NNP -RRB-_-RRB- ._. 
They_PRP used_VBD a_DT generalized_JJ linear_JJ model_NN -LRB-_-LRB- GLM_NNP -RRB-_-RRB- with_IN a_DT Poisson_NNP distribution_NN and_CC a_DT logarithmic_JJ link_NN function_NN to_TO model_VB the_DT weekly_JJ number_NN of_IN deaths_NNS ._. 
excess_JJ mortality_NN due_JJ to_TO influenza_NN for_IN the_DT years_NNS 1995_CD to_TO 2005_CD ._. 
S._NNP We_PRP present_VBP the_DT resulting_VBG estimates_NNS of_IN U._NNP We_PRP compare_VBP these_DT to_TO estimates_NNS obtained_VBN from_IN a_DT Thompson-like_JJ model_NN ,_, as_RB well_RB as_IN to_TO previously_RB published_VBN estimates_NNS of_IN influenza-associated_JJ excess_JJ mortality_NN ._. 
Methods_NNP Data_NNP We_PRP used_VBD Multiple_NNP Cause-of-Death_NNP Data_NNP for_IN the_DT years_NNS 1995_CD to_TO 2005_CD -LRB-_-LRB- Multiple_NNP Cause-of-Death_NNP Microdata_NNP ,_, 1995_CD 
To_TO assess_VB the_DT performance_NN of_IN the_DT current_JJ model_NN ,_, we_PRP also_RB analyzed_VBD the_DT data_NNS with_IN a_DT modified_VBN form_NN of_IN the_DT model_NN proposed_VBN by_IN Thompson_NNP et_FW al._FW ._. ._. 
The_DT modified_VBN model_NN has_VBZ the_DT following_JJ form_NN :_: -LRB-_-LRB- 6_CD -RRB-_-RRB- Y_FW i_FW |_FW 
Thompson_NNP et_FW al._FW ._. 
They_PRP should_MD ,_, in_IN any_DT event_NN ,_, be_VB validated_VBN ._. 
Second_JJ ,_, their_PRP$ model_NN makes_VBZ a_DT priori_FW assumptions_NNS about_IN the_DT parametric_JJ shape_NN of_IN the_DT baseline_JJ function_NN ;_: these_DT assumptions_NNS may_MD or_CC may_MD not_RB be_VB true_JJ ._. 
The_DT Thompson_NNP model_NN ,_, which_WDT superficially_RB resembles_VBZ a_DT hybrid_NN between_IN the_DT Simonsen_NNP model_NN and_CC the_DT model_NN pro_NN 
This_DT consistency_NN implies_VBZ relative_JJ robustness_NN of_IN excess_JJ deaths_NNS estimates_NNS to_TO the_DT choice_NN of_IN a_DT specific_JJ baseline_NN function_NN ._. 
The_DT vast_JJ difference_NN between_IN our_PRP$ and_CC Thompson_NNP 's_POS estimates_NNS can_MD therefore_RB not_RB be_VB explained_VBN by_IN differences_NNS in_IN model_NN structure_NN ,_, nor_CC in_IN the_DT way_NN the_DT baseline_NN function_NN is_VBZ modeled_VBN ._. 
They_PRP may_MD rather_RB be_VB due_JJ to_TO the_DT use_NN of_IN proportion_NN of_IN specimens_NNS testing_VBG positive_JJ to_TO control_VB for_IN influenza_NN mortality_NN ._. 
To_TO estimate_VB excess_JJ mortality_NN due_JJ to_TO influenza_NN ,_, two_CD fundamental_JJ approaches_NNS have_VBP previously_RB been_VBN used_VBN ._. 
The_DT most_RBS popular_JJ one_NN is_VBZ based_VBN on_IN Serfling_NNP 's_POS seasonal_JJ regression_NN method_NN 
To_TO estimate_VB excess_JJ mortality_NN due_JJ to_TO influenza_NN ,_, two_CD fundamental_JJ approaches_NNS have_VBP previously_RB been_VBN used_VBN ._. 
The_DT most_RBS popular_JJ one_NN is_VBZ based_VBN on_IN Serfling_NNP 's_POS seasonal_JJ regression_NN method_NN 
The_DT difference_NN between_IN the_DT baseline_NN function_NN and_CC the_DT observed_JJ numbers_NNS of_IN deaths_NNS is_VBZ then_RB interpreted_VBN as_IN the_DT number_NN of_IN excess_JJ deaths_NNS due_JJ to_TO influenza_NN ._. 
Typically_RB ,_, the_DT baseline_JJ mortality_NN function_NN is_VBZ fitted_VBN to_TO weekly_JJ or_CC monthly_JJ mortality_NN rates_NNS or_CC numbers_NNS during_IN non-influenza_JJ months_NNS ,_, using_VBG two_CD or_CC more_JJR Fourier_NNP terms_NNS ._. 
This_DT approach_NN is_VBZ intuitively_RB appealing_JJ as_IN it_PRP captures_VBZ the_DT strong_JJ seasonal_JJ periodicity_NN of_IN mortality_NN ._. 
To_TO estimate_VB excess_JJ mortality_NN due_JJ to_TO influenza_NN ,_, two_CD fundamental_JJ approaches_NNS have_VBP previously_RB been_VBN used_VBN ._. 
The_DT most_RBS popular_JJ one_NN is_VBZ based_VBN on_IN Serfling_NNP 's_POS seasonal_JJ regression_NN method_NN 
The_DT role_NN of_IN male_JJ circumcision_NN as_IN a_DT HIV_NNP prevention_NN tool_NN is_VBZ now_RB supported_VBN by_IN a_DT landmark_JJ randomised_JJ trial_NN that_WDT showed_VBD a_DT large_JJ and_CC significant_JJ effectiveness_NN against_IN HIV_NNP -LRB-_-LRB- 61_CD %_NN ;_: 95_CD %_NN CI_NNP :_: 34_CD %_NN 
The_DT efficacy_NN estimates_NNS are_VBP valid_JJ when_WRB they_PRP agree_VBP with_IN the_DT true_JJ values_NNS embedded_VBN in_IN the_DT simulation_NN ._. 
The_DT model_NN generates_VBZ simulated_JJ trial_NN data_NNS which_WDT are_VBP then_RB analyzed_VBN to_TO estimate_VB efficacy_NN against_IN HIV_NNP ,_, STI_NNP and_CC overall_JJ effectiveness_NN against_IN HIV_NNP ._. 
Model_NNP parameters_NNS and_CC description_NN of_IN Kisumu_NNP circumcision_NN studyThe_NNP base-case_JJ model_NN parameter_NN values_NNS were_VBD selected_VBN according_VBG to_TO trial_NN design_NN parameters_NNS from_IN the_DT UNIM_NNP circumcision_NN trial_NN in_IN Kisumu_NNP District_NNP of_IN Kenya_NNP ,_, were_VBD estimated_VBN from_IN the_DT trial_NN 's_POS baseline_NN and_CC follow-up_JJ data_NNS ,_, or_CC were_VBD based_VBN on_IN relevant_JJ published_JJ literature_NN ._. 
Parameter_NN values_NNS and_CC references_NNS are_VBP given_VBN in_IN Table_NNP 1_CD ._. 
Table_NNP 1_CD Model_NNP Parameters_NNPS ._. 
Base-case_JJ parameter_NN values_NNS used_VBN in_IN model_NN simulations_NNS and_CC base-case_JJ outputs_NNS for_IN HIV_NNP and_CC STI_NNP prevalence_NN and_CC incidence_NN are_VBP given_VBN ._. 
The_DT role_NN of_IN male_JJ circumcision_NN as_IN a_DT HIV_NNP prevention_NN tool_NN is_VBZ now_RB supported_VBN by_IN a_DT landmark_JJ randomised_JJ trial_NN that_WDT showed_VBD a_DT large_JJ and_CC significant_JJ effectiveness_NN against_IN HIV_NNP -LRB-_-LRB- 61_CD %_NN ;_: 95_CD %_NN CI_NNP :_: 34_CD %_NN 
Because_IN these_DT STIs_NNS are_VBP co-factors_NNS of_IN HIV_NNP transmission_NN ,_, indirect_JJ protection_NN against_IN HIV_NNP ,_, mediated_VBN by_IN the_DT benefit_NN of_IN MC_NNP against_IN STIs_NNP ,_, is_VBZ also_RB possible_JJ ._. 
The_DT role_NN of_IN male_JJ circumcision_NN as_IN a_DT HIV_NNP prevention_NN tool_NN is_VBZ now_RB supported_VBN by_IN a_DT landmark_JJ randomised_JJ trial_NN that_WDT showed_VBD a_DT large_JJ and_CC significant_JJ effectiveness_NN against_IN HIV_NNP -LRB-_-LRB- 61_CD %_NN ;_: 95_CD %_NN CI_NNP :_: 34_CD %_NN 
The_DT role_NN of_IN male_JJ circumcision_NN as_IN a_DT HIV_NNP prevention_NN tool_NN is_VBZ now_RB supported_VBN by_IN a_DT landmark_JJ randomised_JJ trial_NN that_WDT showed_VBD a_DT large_JJ and_CC significant_JJ effectiveness_NN against_IN HIV_NNP -LRB-_-LRB- 61_CD %_NN ;_: 95_CD %_NN CI_NNP :_: 34_CD %_NN 
The_DT efficacy_NN estimates_NNS are_VBP valid_JJ when_WRB they_PRP agree_VBP with_IN the_DT true_JJ values_NNS embedded_VBN in_IN the_DT simulation_NN ._. 
The_DT model_NN generates_VBZ simulated_JJ trial_NN data_NNS which_WDT are_VBP then_RB analyzed_VBN to_TO estimate_VB efficacy_NN against_IN HIV_NNP ,_, STI_NNP and_CC overall_JJ effectiveness_NN against_IN HIV_NNP ._. 
Model_NNP parameters_NNS and_CC description_NN of_IN Kisumu_NNP circumcision_NN studyThe_NNP base-case_JJ model_NN parameter_NN values_NNS were_VBD selected_VBN according_VBG to_TO trial_NN design_NN parameters_NNS from_IN the_DT UNIM_NNP circumcision_NN trial_NN in_IN Kisumu_NNP District_NNP of_IN Kenya_NNP ,_, were_VBD estimated_VBN from_IN the_DT trial_NN 's_POS baseline_NN and_CC follow-up_JJ data_NNS ,_, or_CC were_VBD based_VBN on_IN relevant_JJ published_JJ literature_NN ._. 
Parameter_NN values_NNS and_CC references_NNS are_VBP given_VBN in_IN Table_NNP 1_CD ._. 
Table_NNP 1_CD Model_NNP Parameters_NNPS ._. 
Base-case_JJ parameter_NN values_NNS used_VBN in_IN model_NN simulations_NNS and_CC base-case_JJ outputs_NNS for_IN HIV_NNP and_CC STI_NNP prevalence_NN and_CC incidence_NN are_VBP given_VBN ._. 
Risk_NN due_JJ to_TO abrasions_NNS suffered_VBN by_IN foreskin_NN in_IN uncircumcised_JJ men_NNS ,_, inflammatory_JJ conditions_NNS under_IN the_DT foreskin_NN and_CC high_JJ concentrations_NNS of_IN Langerhans_NNP cells_NNS which_WDT are_VBP targets_NNS for_IN HIV_NNP infection_NN can_MD be_VB directly_RB minimized_VBN by_IN MC_NNP ._. 
Evidence_NN also_RB exists_VBZ for_IN an_DT association_NN between_IN MC_NNP and_CC reduced_JJ risk_NN of_IN infection_NN with_IN certain_JJ sexually_RB transmitted_VBN infections_NNS -LRB-_-LRB- STI_NNP -RRB-_-RRB- such_JJ as_IN chancroid_NN ,_, syphilis_NN ,_, gonorrhoea_NN and_CC HSV_NNP 
Evidence_NN also_RB exists_VBZ for_IN an_DT association_NN between_IN MC_NNP and_CC reduced_JJ risk_NN of_IN infection_NN with_IN certain_JJ sexually_RB transmitted_VBN infections_NNS -LRB-_-LRB- STI_NNP -RRB-_-RRB- such_JJ as_IN chancroid_NN ,_, syphilis_NN ,_, gonorrhoea_NN and_CC HSV_NNP 
In_IN particular_JJ ,_, the_DT strength_NN of_IN interaction_NN modelled_VBN between_IN HIV_NNP and_CC STI_NNP under_IN base-case_JJ assumptions_NNS is_VBZ assumed_VBN to_TO be_VB medium_JJ ;_: presence_NN of_IN STI_NNP in_IN the_DT HIV-infected_JJ sexual_JJ partner_NN increases_VBZ the_DT per_IN partnership_NN probability_NN of_IN HIV_NNP transmission_NN by_IN a_DT factor_NN of_IN 4_CD -LRB-_-LRB- 
This_DT is_VBZ because_IN evidence_NN derived_VBN from_IN observational_JJ studies_NNS is_VBZ prone_JJ to_TO bias_NN due_JJ to_TO confounding_JJ risk_NN factors_NNS and_CC because_IN MC_NNP as_IN a_DT HIV_NNP prevention_NN strategy_NN can_MD be_VB seen_VBN as_IN unethical_JJ ._. 
There_EX is_VBZ mounting_VBG epidemiological_JJ evidence_NN and_CC plausible_JJ biological_JJ explanation_NN to_TO indicate_VB that_IN MC_NNP can_MD protect_VB against_IN HIV_NNP both_DT directly_RB and_CC in_IN 
The_DT role_NN of_IN male_JJ circumcision_NN as_IN a_DT HIV_NNP prevention_NN tool_NN is_VBZ now_RB supported_VBN by_IN a_DT landmark_JJ randomised_JJ trial_NN that_WDT showed_VBD a_DT large_JJ and_CC significant_JJ effectiveness_NN against_IN HIV_NNP -LRB-_-LRB- 61_CD %_NN ;_: 95_CD %_NN CI_NNP :_: 34_CD %_NN 
Recently_RB ,_, two_CD additional_JJ independent_JJ randomised_JJ MC_NNP trials_NNS in_IN Kisumu_NNP ,_, Kenya_NNP 
5%_CD ._. 
4%_CD and_CC HIV_NNP incidence_NN is_VBZ estimated_VBN at_IN 2_CD ._. 
HIV_NNP prevalence_NN in_IN Luo_NNP men_NNS at_IN screening_NN was_VBD 7_CD ._. 
This_DT implies_VBZ a_DT 70_CD %_NN probability_NN -LRB-_-LRB- power_NN -RRB-_-RRB- of_IN declaring_VBG an_DT efficacy_NN better_JJR than_IN zero_CD when_WRB the_DT true_JJ effectiveness_NN is_VBZ 40_CD %_NN ,_, or_CC 90_CD %_NN power_NN when_WRB true_JJ effectiveness_NN is_VBZ 50_CD %_NN ._. 
The_DT Kenya_NNP Demographic_NNP and_CC Health_NNP Survey_NNP -LRB-_-LRB- DHS_NNP -RRB-_-RRB- also_RB reports_VBZ HIV_NNP prevalence_NN :_: Luo_NNP men_NNS aged_VBD 15_CD 
The_DT Kenya_NNP DHS_NNP also_RB indicates_VBZ 7_CD ._. 
0%_CD antibody_NN positive_JJ for_IN HSV_NNP ._. 
0%_CD urine_NN positive_JJ for_IN Chlamydia_NNP trachomatis_NNS and_CC 25_CD ._. 
6%_CD of_IN males_NNS in_IN Nyanza_NNP self-reported_JJ STI_NNP infection_NN ,_, abnormal_JJ genital_NN discharge_VB or_CC ulcerative_JJ sores_NNS in_IN the_DT last_JJ year_NN ._. 
Model_NNP parameters_NNS for_IN sample_NN size_NN ,_, follow-up_JJ duration_NN and_CC randomisation_NN ratio_NN were_VBD chosen_VBN according_VBG to_TO the_DT trial_NN 's_POS design_NN characteristics_NNS ._. 
Estimation_NN of_IN E_NNP H_NNP is_VBZ based_VBN on_IN comparison_NN of_IN HIV_NNP infection_NN times_NNS between_IN trial_NN arms_NNS where_WRB individuals_NNS '_POS follow-up_JJ times_NNS are_VBP stratified_VBN into_IN STI-positive_JJ and_CC STI-negative_JJ intervals_NNS using_VBG exact_JJ STI_NNP infection_NN and_CC recovery_NN times_NNS ._. 
Given_VBN the_DT main_JJ endpoint_NN is_VBZ time_NN to_TO HIV_NNP infection_NN where_WRB STI_NNP status_NN is_VBZ changing_VBG during_IN the_DT follow-up_JJ period_NN and_CC that_IN multiple_JJ STI_NNP events_NNS are_VBP possible_JJ per_IN individual_NN ,_, the_DT Anderson-Gill_NNP counting_NN process_NN -LRB-_-LRB- a_DT generalization_NN of_IN Cox_NNP proportional_JJ hazard_NN models_NNS -RRB-_-RRB- with_IN robust_JJ variance_NN estimates_NNS is_VBZ the_DT most_RBS suitable_JJ method_NN for_IN estimation_NN of_IN EH_NNP ._. 
The_DT Anderson-Gill_NNP counting_NN process_NN is_VBZ also_RB the_DT appropriate_JJ analysis_NN for_IN estimating_VBG E_NNP S_NNP ._. 
Estimation_NN of_IN F_NN is_VBZ based_VBN on_IN comparison_NN of_IN HIV_NNP infection_NN times_NNS between_IN control_NN and_CC treated_VBD arms_NNS without_IN stratification_NN for_IN STI_NNP infection_NN ._. 
Estimation_NN of_IN E_NNP H_NNP is_VBZ based_VBN on_IN comparison_NN of_IN HIV_NNP infection_NN times_NNS between_IN trial_NN arms_NNS where_WRB individuals_NNS '_POS follow-up_JJ times_NNS are_VBP stratified_VBN into_IN STI-positive_JJ and_CC STI-negative_JJ intervals_NNS using_VBG exact_JJ STI_NNP infection_NN and_CC recovery_NN times_NNS ._. 
Given_VBN the_DT main_JJ endpoint_NN is_VBZ time_NN to_TO HIV_NNP infection_NN where_WRB STI_NNP status_NN is_VBZ changing_VBG during_IN the_DT follow-up_JJ period_NN and_CC that_IN multiple_JJ STI_NNP events_NNS are_VBP possible_JJ per_IN individual_NN ,_, the_DT Anderson-Gill_NNP counting_NN process_NN -LRB-_-LRB- a_DT generalization_NN of_IN Cox_NNP proportional_JJ hazard_NN models_NNS -RRB-_-RRB- with_IN robust_JJ variance_NN estimates_NNS is_VBZ the_DT most_RBS suitable_JJ method_NN for_IN estimation_NN of_IN EH_NNP ._. 
The_DT Anderson-Gill_NNP counting_NN process_NN is_VBZ also_RB the_DT appropriate_JJ analysis_NN for_IN estimating_VBG E_NNP S_NNP ._. 
Estimation_NN of_IN F_NN is_VBZ based_VBN on_IN comparison_NN of_IN HIV_NNP infection_NN times_NNS between_IN control_NN and_CC treated_VBD arms_NNS without_IN stratification_NN for_IN STI_NNP infection_NN ._. 
Analyses_NNS were_VBD implemented_VBN with_IN SAS_NNP version_NN 8_CD ._. 
This_DT approximation_NN is_VBZ valid_JJ under_IN low_JJ incidence_NN of_IN HIV_NNP infection_NN and_CC low_JJ STI_NNP prevalence_NN ,_, as_IN under_IN the_DT Kisumu_NNP base-case_JJ assumptions_NNS ._. 
1._CD 
Simulations_NNS and_CC sensitivity_NN analysis_NN Values_NNS for_IN E_NNP H_NNP ,_, modelled_VBN as_IN a_DT reduction_NN in_IN susceptibility_NN upon_IN exposure_NN varied_VBD between_IN 0_CD %_NN and_CC 70_CD %_NN ._. 
The_DT AF_NNP can_MD be_VB approximated_VBN using_VBG estimates_NNS of_IN F_NN and_CC E_NNP H_NNP -LRB-_-LRB- see_VB later_RB -RRB-_-RRB- ._. 
This_DT quantity_NN describes_VBZ how_WRB much_JJ of_IN the_DT overall_JJ effectiveness_NN of_IN MC_NNP against_IN HIV_NNP is_VBZ due_JJ to_TO the_DT indirect_JJ effect_NN mediated_VBN by_IN MC_NNP efficacy_NN against_IN STI_NNP ._. 
Clinical_JJ trial_NN simulatorDynamic_JJ stochastic_JJ models_NNS simulating_VBG trial_NN designs_NNS are_VBP well_RB suited_VBN to_TO study_VB this_DT type_NN of_IN question_NN and_CC have_VBP been_VBN used_VBN successfully_RB in_IN the_DT past_NN to_TO evaluate_VB the_DT quality_NN of_IN epidemiological_JJ studies_NNS on_IN the_DT STI_NNP and_CC HIV_NNP interaction_NN and_CC to_TO validate_VB statistical_JJ analyses_NNS for_IN HIV_NNP vaccine_NN trials_NNS 
Clinical_JJ trial_NN simulator_NN Dynamic_NNP stochastic_JJ models_NNS simulating_VBG trial_NN designs_NNS are_VBP well_RB suited_VBN to_TO study_VB this_DT type_NN of_IN question_NN and_CC have_VBP been_VBN used_VBN successfully_RB in_IN the_DT past_NN to_TO evaluate_VB the_DT quality_NN of_IN epidemiological_JJ studies_NNS on_IN the_DT STI_NNP and_CC HIV_NNP interaction_NN and_CC to_TO validate_VB statistical_JJ analyses_NNS for_IN HIV_NNP vaccine_NN trials_NNS ._. 
Our_PRP$ stochastic_JJ compartmental_JJ model_NN -LRB-_-LRB- see_VB Endnote_NNP -RRB-_-RRB- simulates_VBZ transmission_NN of_IN HIV_NNP and_CC one_CD STI_NNP in_IN a_DT heterosexual_JJ population_NN in_IN which_WDT a_DT clinical_JJ trial_NN is_VBZ embedded_VBN and_CC is_VBZ based_VBN on_IN previous_JJ models_NNS that_IN we_PRP have_VBP used_VBN 
Clinical_JJ trial_NN simulator_NN Dynamic_NNP stochastic_JJ models_NNS simulating_VBG trial_NN designs_NNS are_VBP well_RB suited_VBN to_TO study_VB this_DT type_NN of_IN question_NN and_CC have_VBP been_VBN used_VBN successfully_RB in_IN the_DT past_NN to_TO evaluate_VB the_DT quality_NN of_IN epidemiological_JJ studies_NNS on_IN the_DT STI_NNP and_CC HIV_NNP interaction_NN and_CC to_TO validate_VB statistical_JJ analyses_NNS for_IN HIV_NNP vaccine_NN trials_NNS ._. 
Our_PRP$ stochastic_JJ compartmental_JJ model_NN -LRB-_-LRB- see_VB Endnote_NNP -RRB-_-RRB- simulates_VBZ transmission_NN of_IN HIV_NNP and_CC one_CD STI_NNP in_IN a_DT heterosexual_JJ population_NN in_IN which_WDT a_DT clinical_JJ trial_NN is_VBZ embedded_VBN and_CC is_VBZ based_VBN on_IN previous_JJ models_NNS that_IN we_PRP have_VBP used_VBN 
The_DT term_NN 
The_DT AF_NNP can_MD be_VB approximated_VBN using_VBG estimates_NNS of_IN F_NN and_CC E_NNP H_NNP -LRB-_-LRB- see_VB later_RB -RRB-_-RRB- ._. 
This_DT quantity_NN describes_VBZ how_WRB much_JJ of_IN the_DT overall_JJ effectiveness_NN of_IN MC_NNP against_IN HIV_NNP is_VBZ due_JJ to_TO the_DT indirect_JJ effect_NN mediated_VBN by_IN MC_NNP efficacy_NN against_IN STI_NNP ._. 
Clinical_JJ trial_NN simulatorDynamic_JJ stochastic_JJ models_NNS simulating_VBG trial_NN designs_NNS are_VBP well_RB suited_VBN to_TO study_VB this_DT type_NN of_IN question_NN and_CC have_VBP been_VBN used_VBN successfully_RB in_IN the_DT past_NN to_TO evaluate_VB the_DT quality_NN of_IN epidemiological_JJ studies_NNS on_IN the_DT STI_NNP and_CC HIV_NNP interaction_NN and_CC to_TO validate_VB statistical_JJ analyses_NNS for_IN HIV_NNP vaccine_NN trials_NNS ._. 
Our_PRP$ stochastic_JJ compartmental_JJ model_NN -LRB-_-LRB- see_VB Endnote_NNP -RRB-_-RRB- simulates_VBZ transmission_NN of_IN HIV_NNP and_CC one_CD STI_NNP in_IN a_DT heterosexual_JJ population_NN in_IN which_WDT a_DT clinical_JJ trial_NN is_VBZ embedded_VBN and_CC is_VBZ based_VBN on_IN previous_JJ models_NNS that_IN we_PRP have_VBP used_VBN 
The_DT magnitude_NN of_IN these_DT estimates_NNS is_VBZ in_IN line_NN with_IN meta-analyses_NNS of_IN observational_JJ studies_NNS 
The_DT magnitude_NN of_IN these_DT estimates_NNS is_VBZ in_IN line_NN with_IN meta-analyses_NNS of_IN observational_JJ studies_NNS 
Recently_RB ,_, two_CD additional_JJ independent_JJ randomised_JJ MC_NNP trials_NNS in_IN Kisumu_NNP ,_, Kenya_NNP and_CC Rakai_NNP ,_, Uganda_NNP -LRB-_-LRB- 17_CD 
This_DT is_VBZ because_IN evidence_NN derived_VBN from_IN observational_JJ studies_NNS is_VBZ prone_JJ to_TO bias_NN due_JJ to_TO confounding_JJ risk_NN factors_NNS and_CC because_IN MC_NNP as_IN a_DT HIV_NNP prevention_NN strategy_NN can_MD be_VB seen_VBN as_IN unethical_JJ 
There_EX is_VBZ mounting_VBG epidemiological_JJ evidence_NN and_CC plausible_JJ biological_JJ explanation_NN to_TO indicate_VB that_IN MC_NNP can_MD protect_VB against_IN HIV_NNP both_DT directly_RB and_CC indirectly_RB 
There_EX is_VBZ mounting_VBG epidemiological_JJ evidence_NN and_CC plausible_JJ biological_JJ explanation_NN to_TO indicate_VB that_IN MC_NNP can_MD protect_VB against_IN HIV_NNP both_DT directly_RB and_CC indirectly_RB 
Risk_NN due_JJ to_TO abrasions_NNS suffered_VBN by_IN foreskin_NN in_IN uncircumcised_JJ men_NNS ,_, inflammatory_JJ conditions_NNS under_IN the_DT foreskin_NN and_CC high_JJ concentrations_NNS of_IN Langerhans_NNP cells_NNS which_WDT are_VBP targets_NNS for_IN HIV_NNP infection_NN can_MD be_VB directly_RB minimized_VBN by_IN MC_NNP ._. 
Evidence_NN also_RB exists_VBZ for_IN an_DT association_NN between_IN MC_NNP and_CC reduced_JJ risk_NN of_IN infection_NN with_IN certain_JJ sexually_RB transmitted_VBN infections_NNS -LRB-_-LRB- STI_NNP -RRB-_-RRB- such_JJ as_IN chancroid_NN ,_, syphilis_NN ,_, gonorrhoea_NN and_CC HSV_NNP 
Background_NN The_DT role_NN of_IN male_JJ circumcision_NN -LRB-_-LRB- MC_NNP -RRB-_-RRB- in_IN protecting_VBG against_IN HIV_NNP infection_NN in_IN sub-Saharan_NNP Africa_NNP has_VBZ been_VBN controversial_JJ since_IN the_DT beginning_NN of_IN the_DT HIV_NNP epidemic_NN ._. 
This_DT is_VBZ because_IN evidence_NN derived_VBN from_IN observational_JJ studies_NNS is_VBZ prone_JJ to_TO bias_NN due_JJ to_TO confounding_JJ risk_NN factors_NNS and_CC because_IN MC_NNP as_IN a_DT HIV_NNP prevention_NN strategy_NN can_MD be_VB seen_VBN as_IN unethical_JJ 
Background_NN The_DT role_NN of_IN male_JJ circumcision_NN -LRB-_-LRB- MC_NNP -RRB-_-RRB- in_IN protecting_VBG against_IN HIV_NNP infection_NN in_IN sub-Saharan_NNP Africa_NNP has_VBZ been_VBN controversial_JJ since_IN the_DT beginning_NN of_IN the_DT HIV_NNP epidemic_NN ._. 
This_DT is_VBZ because_IN evidence_NN derived_VBN from_IN observational_JJ studies_NNS is_VBZ prone_JJ to_TO bias_NN due_JJ to_TO confounding_JJ risk_NN factors_NNS and_CC because_IN MC_NNP as_IN a_DT HIV_NNP prevention_NN strategy_NN can_MD be_VB seen_VBN as_IN unethical_JJ 
Recently_RB ,_, two_CD additional_JJ independent_JJ randomised_JJ MC_NNP trials_NNS in_IN Kisumu_NNP ,_, Kenya_NNP 
Similarly_RB ,_, values_NNS for_IN E_NNP S_NNP between_IN 0_CD %_NN to_TO 80_CD %_NN were_VBD explored_VBN ._. 
Simulations_NNS and_CC sensitivity_NN analysis_NN Values_NNS for_IN E_NNP H_NNP ,_, modelled_VBN as_IN a_DT reduction_NN in_IN susceptibility_NN upon_IN exposure_NN varied_VBD between_IN 0_CD %_NN and_CC 70_CD %_NN ._. 
Low_NNP ES_NNP -LRB-_-LRB- ~_CD 0_CD 
Highlighted_VBN is_VBZ a_DT variety_NN of_IN literature_NN and_CC the_DT bibliographic_JJ databases_NNS through_IN which_WDT it_PRP can_MD be_VB accessed_VBN ._. 
The_DT wealth_NN of_IN the_DT Chinese_JJ scientific_JJ literature_NN is_VBZ further_RBR illustrated_VBN by_IN Liu_NNP and_CC colleagues_NNS 
The_DT wealth_NN of_IN the_DT Chinese_JJ scientific_JJ literature_NN is_VBZ further_RBR illustrated_VBN by_IN Liu_NNP and_CC colleagues_NNS 
What_WP are_VBP their_PRP$ prospects_NNS in_IN the_DT 21_CD st_NN century_NN ._. 
Global_JJ epidemiological_JJ literature_NN in_IN non-English_JJ languages_NNS and_CC its_PRP$ retrieval_NN What_WP is_VBZ the_DT current_JJ state_NN of_IN non-English_JJ epidemiological_JJ and_CC public_JJ health_NN journals_NNS ._. 
Has_VBZ the_DT growth_NN of_IN the_DT internet_NN and_CC the_DT movement_NN towards_IN `_`` Open_NNP Access_NNP '_POS made_VBD any_DT difference_NN to_TO their_PRP$ survival_NN ._. 
Are_VBP there_RB any_DT bibliographic_JJ databases_NNS that_WDT make_VBP these_DT journals_NNS more_RBR readily_RB accessible_JJ ._. 
What_WP sort_NN of_IN epidemiological_JJ resources_NNS are_VBP available_JJ in_IN these_DT languages_NNS ._. 
To_TO address_VB these_DT questions_NNS ,_, authors_NNS from_IN diverse_JJ linguistic_JJ and_CC geographical_JJ backgrounds_NNS have_VBP been_VBN invited_VBN to_TO contribute_VB to_TO this_DT thematic_JJ series_NN on_IN `_`` Beyond_NNP English_NNP :_: Accessing_VBG the_DT global_JJ epidemiological_JJ literature_NN '_'' ._. 
This_DT series_NN begins_VBZ with_IN Fung_NNP providing_VBG a_DT guide_NN to_TO Chinese-language_JJ biomedical_JJ journals_NNS ,_, with_IN an_DT emphasis_NN on_IN those_DT of_IN most_JJS interest_NN to_TO epidemiologists_NNS ._. 
Highlighted_VBN is_VBZ a_DT variety_NN of_IN literature_NN and_CC the_DT bibliographic_JJ databases_NNS through_IN which_WDT it_PRP can_MD be_VB accessed_VBN ._. 
As_IN highlighted_VBN in_IN a_DT recent_JJ comment_NN in_IN New_NNP Scientist_NNP ,_, many_JJ local_JJ journals_NNS in_IN the_DT developing_VBG world_NN are_VBP failing_VBG and_CC yet_RB their_PRP$ very_JJ existence_NN is_VBZ vital_JJ as_IN a_DT channel_NN through_IN which_WDT local_JJ research_NN is_VBZ publicised_VBN 
What_WP are_VBP their_PRP$ prospects_NNS in_IN the_DT 21_CD st_NN century_NN ._. 
Global_JJ epidemiological_JJ literature_NN in_IN non-English_JJ languages_NNS and_CC its_PRP$ retrieval_NN What_WP is_VBZ the_DT current_JJ state_NN of_IN non-English_JJ epidemiological_JJ and_CC public_JJ health_NN journals_NNS ._. 
Has_VBZ the_DT growth_NN of_IN the_DT internet_NN and_CC the_DT movement_NN towards_IN `_`` Open_NNP Access_NNP '_POS made_VBD any_DT difference_NN to_TO their_PRP$ survival_NN ._. 
Are_VBP there_RB any_DT bibliographic_JJ databases_NNS that_WDT make_VBP these_DT journals_NNS more_RBR readily_RB accessible_JJ ._. 
What_WP sort_NN of_IN epidemiological_JJ resources_NNS are_VBP available_JJ in_IN these_DT languages_NNS ._. 
By_IN the_DT late_JJ 1980s_NNS ,_, Garfield_NNP noted_VBD that_IN the_DT `_`` French_JJ scientists_NNS seem_VBP to_TO have_VB implicitly_RB acknowledged_VBN that_IN English_NNP is_VBZ ,_, in_IN fact_NN ,_, now_RB the_DT international_JJ language_NN of_IN science_NN ,_, if_IN not_RB in_IN other_JJ areas_NNS of_IN international_JJ activity_NN '_'' 
As_IN highlighted_VBN in_IN a_DT recent_JJ comment_NN in_IN New_NNP Scientist_NNP ,_, many_JJ local_JJ journals_NNS in_IN the_DT developing_VBG world_NN are_VBP failing_VBG and_CC yet_RB their_PRP$ very_JJ existence_NN is_VBZ vital_JJ as_IN a_DT channel_NN through_IN which_WDT local_JJ research_NN is_VBZ publicised_VBN 
Given_VBN that_IN English_NNP has_VBZ become_VBN the_DT global_JJ language_NN of_IN science_NN ,_, non-English-speaking_JJ countries_NNS are_VBP at_IN a_DT disadvantage_NN with_IN respect_NN to_TO global_JJ scientific_JJ communication_NN ,_, and_CC much_RB is_VBZ needed_VBN to_TO remedy_VB this_DT situation_NN ._. 
As_IN highlighted_VBN in_IN a_DT recent_JJ comment_NN in_IN New_NNP Scientist_NNP ,_, many_JJ local_JJ journals_NNS in_IN the_DT developing_VBG world_NN are_VBP failing_VBG and_CC yet_RB their_PRP$ very_JJ existence_NN is_VBZ vital_JJ as_IN a_DT channel_NN through_IN which_WDT local_JJ research_NN is_VBZ publicised_VBN 
Barreto_NNP and_CC Barata_NNP 
Williams_NNP and_CC colleagues_NNS 
Systematic_JJ reviews_NNS should_MD include_VB literature_NN published_VBN in_IN the_DT major_JJ languages_NNS of_IN the_DT world_NN It_PRP is_VBZ crucial_JJ that_IN all_DT systematic_JJ reviews_NNS in_IN epidemiology_NN and_CC public_JJ health_NN aim_NN to_TO include_VB literature_NN published_VBN in_IN the_DT major_JJ languages_NNS of_IN the_DT world_NN ._. 
While_IN such_PDT a_DT list_NN is_VBZ difficult_JJ to_TO define_VB ,_, an_DT example_NN is_VBZ the_DT six_CD official_JJ languages_NNS of_IN the_DT United_NNP Nations_NNPS :_: Arabic_NNP ,_, Chinese_NNP ,_, English_NNP ,_, French_NNP ,_, Spanish_NNP and_CC Russian_NNP ._. 
However_RB ,_, selecting_VBG a_DT canon_NN of_IN scientific_JJ languages_NNS ,_, depends_VBZ on_IN the_DT criteria_NNS on_IN which_WDT it_PRP is_VBZ based_VBN :_: one_CD based_VBN on_IN population_NN size_NN would_MD promote_VB those_DT languages_NNS with_IN a_DT large_JJ number_NN of_IN native_JJ speakers_NNS ,_, while_IN one_CD based_VBN on_IN the_DT volume_NN of_IN scientific_JJ literature_NN published_VBN in_IN the_DT given_VBN language_NN would_MD reflect_VB both_DT traditional_JJ publishing_NN practices_NNS and_CC scientific_JJ outputs_NNS ._. 
It_PRP is_VBZ worth_JJ noting_VBG that_IN EMBASE_NNP is_VBZ rich_JJ in_IN bibliographic_JJ records_NNS published_VBN in_IN non-English_JJ languages_NNS that_WDT are_VBP not_RB as_RB readily_RB available_JJ as_IN those_DT found_VBN in_IN other_JJ popular_JJ sources_NNS such_JJ as_IN PubMed_NNP ._. 
Lastly_RB ,_, Fung_JJ comments_NNS on_IN the_DT current_JJ practice_NN for_IN citing_VBG non-English_JJ peer_VB review_NN publications_NNS among_IN journals_NNS of_IN relevance_NN to_TO epidemiologists_NNS ._. 
Systematic_JJ reviews_NNS should_MD include_VB literature_NN published_VBN in_IN the_DT major_JJ languages_NNS of_IN the_DT world_NN It_PRP is_VBZ crucial_JJ that_IN all_DT systematic_JJ reviews_NNS in_IN epidemi_NN 
Al-Shorbaji_NNP 
Vlassov_NNP and_CC Danishevskii_NNP 
Baussano_NNP and_CC colleagues_NNS 
'published_VBN in_IN the_DT leading_VBG French_JJ journal_NN La_NNP Recherche_NNP 
By_IN suggesting_VBG that_IN `_`` French_JJ scientists_NNS must_MD recognize_VB that_IN French_NNP is_VBZ no_RB longer_RB the_DT international_JJ language_NN ,_, and_CC the_DT adoption_NN of_IN English_NNP as_IN the_DT world_NN language_NN of_IN science_NN should_MD be_VB encouraged_VBN '_'' -LRB-_-LRB- italics_NNS original_JJ -RRB-_-RRB- 
By_IN suggesting_VBG that_IN `_`` French_JJ scientists_NNS must_MD recognize_VB that_IN French_NNP is_VBZ no_RB longer_RB the_DT international_JJ language_NN ,_, and_CC the_DT adoption_NN of_IN English_NNP as_IN the_DT world_NN language_NN of_IN science_NN should_MD be_VB encouraged_VBN '_'' -LRB-_-LRB- italics_NNS original_JJ -RRB-_-RRB- 
By_IN suggesting_VBG that_IN `_`` French_JJ scientists_NNS must_MD recognize_VB that_IN French_NNP is_VBZ no_RB longer_RB the_DT international_JJ language_NN ,_, and_CC the_DT adoption_NN of_IN English_NNP as_IN the_DT world_NN language_NN of_IN science_NN should_MD be_VB encouraged_VBN '_'' -LRB-_-LRB- italics_NNS original_JJ -RRB-_-RRB- 
This_DT editorial_NN suggests_VBZ that_IN all_DT systematic_JJ reviews_NNS in_IN epidemiology_NN and_CC public_JJ health_NN should_MD include_VB literature_NN published_VBN in_IN the_DT major_JJ languages_NNS of_IN the_DT world_NN and_CC that_IN the_DT use_NN of_IN regional_JJ and_CC non-English_JJ bibliographic_JJ databases_NNS should_MD become_VB routine_JJ ._. 
BackgroundIn_NN 1976_CD ,_, Eugene_NNP Garfield_NNP ,_, the_DT founder-president_NN of_IN the_DT Institute_NNP for_IN Scientific_NNP Information_NNP -LRB-_-LRB- now_RB Thomson_NNP Scientific_NNP -RRB-_-RRB- sparked_VBD controversy_NN in_IN France_NNP with_IN his_PRP$ article_NN `_`` Is_VBZ French_JJ Science_NN too_RB Provincial_JJ ._. '_'' 
published_VBN in_IN the_DT leading_VBG French_JJ journal_NN La_NNP Recherche_NNP 
Background_NN In_IN 1976_CD ,_, Eugene_NNP Garfield_NNP ,_, the_DT founder-president_NN of_IN the_DT Institute_NNP for_IN Scientific_NNP Information_NNP -LRB-_-LRB- now_RB Thomson_NNP Scientific_NNP -RRB-_-RRB- sparked_VBD controversy_NN in_IN France_NNP with_IN his_PRP$ article_NN `_`` Is_VBZ French_JJ Science_NN too_RB Provincial_JJ ._. '_'' 
published_VBN in_IN the_DT leading_VBG French_JJ journal_NN La_NNP Recherche_NNP 
'published_VBN in_IN the_DT leading_VBG French_JJ journal_NN La_NNP Recherche_NNP 
In_IN the_DT ensuing_VBG years_NNS ,_, the_DT proportion_NN of_IN scientific_JJ articles_NNS indexed_VBN in_IN international_JJ databases_NNS such_JJ as_IN Medline_NNP 
Medical_JJ journals_NNS published_VBN in_IN French_NNP or_CC German_NNP have_VBP declined_VBN in_IN ranking_NN based_VBN on_IN impact_NN factors_NNS 
-RRB-_-RRB- with_IN emphasis_NN on_IN dynamic_JJ change_NN over_IN time_NN ._. 
Asocial_JJ ecology_NN approach_NN argues_VBZ for_IN models_NNS of_IN explanation_NN that_WDT explore_VBP the_DT interactions_NNS of_IN multiple_JJ causes_NNS -LRB-_-LRB- environmental_JJ ,_, social_JJ ,_, and_CC biological_JJ -RRB-_-RRB- working_VBG through_IN different_JJ mechanisms_NNS and_CC at_IN differing_VBG levels_NNS of_IN scale_NN -LRB-_-LRB- individual_JJ ,_, household_NN ,_, community_NN etc._NN ._. 
The_DT social_JJ ecology_NN of_IN the_DT epidemic_NN is_VBZ defined_VBN in_IN terms_NNS of_IN sociodemographic_JJ ,_, socioeconomic_JJ ,_, structural_JJ ,_, contextual_JJ ,_, biologic_JJ and_CC behavioral_JJ variables_NNS that_WDT facilitate_VBP or_CC inhibit_VBP progression_NN of_IN the_DT epidemic_NN ._. 
The_DT ecological_JJ perspective_NN explains_VBZ how_WRB conflict_NN might_MD impede_VB the_DT progress_NN of_IN the_DT epidemic_NN and_CC it_PRP provides_VBZ clues_NNS as_IN to_TO regional_JJ strategic_JJ factors_NNS that_WDT may_MD exacerbate_VB risk_NN in_IN the_DT post-conflict_JJ setting_NN ._. 
One_CD factor_NN that_WDT may_MD be_VB driving_VBG the_DT epidemic_NN is_VBZ the_DT interaction_NN between_IN poor_JJ women_NNS and_CC rich_JJ men_NNS -LRB-_-LRB- or_CC men_NNS with_IN some_DT income_NN ,_, such_JJ as_IN the_DT military_NN and_CC truck_NN drivers_NNS -RRB-_-RRB- as_IN exemplified_VBN by_IN Drain_NNP et_FW al._FW ._. 
who_WP found_VBD that_IN income_NN inequality_NN was_VBD independently_RB associated_VBN with_IN HIV_NNP seroprevalence_NN ._. 
The_DT ecology_NN of_IN HIV_NNP and_CC conflict_NN also_RB results_VBZ in_IN greater_JJR micro-level_NN variation_NN in_IN the_DT determinants_NNS of_IN HIV_NNP risk_NN ._. 
In_IN addition_NN ,_, migration_NN patterns_NNS may_MD be_VB quite_RB fluid_JJ ,_, enabling_VBG dislocated_JJ populations_NNS to_TO move_VB back_RB and_CC forth_RB between_IN higher_JJR and_CC lower_JJR risk_NN areas_NNS ,_, thus_RB increasing_VBG disassortive_JJ mixing_NN ._. 
Research_NNP suggests_VBZ that_IN urban_JJ rates_NNS of_IN casual\/commercial_JJ sexual_JJ activity_NN tend_VBP to_TO exceed_VB rural_JJ rates_NNS and_CC that_DT exchange_NN of_IN rural\/urban_JJ populations_NNS tends_VBZ to_TO undermine_VB traditional_JJ norms_NNS governing_VBG sexual_JJ activity_NN in_IN rural_JJ areas_NNS 
In_IN Liberia_NNP ,_, 49_CD %_NN of_IN women_NNS surveyed_VBN reported_VBD at_IN least_JJS one_CD act_NN of_IN sexual_JJ or_CC physical_JJ abuse_NN by_IN either_CC a_DT soldier_NN or_CC a_DT fighter_NN during_IN the_DT civil_JJ war_NN 
Such_JJ deficiencies_NNS are_VBP associated_VBN with_IN accelerated_JJ disease_NN progression_NN in_IN HIV_NNP patients_NNS 
Similarly_RB ,_, displaced_VBN populations_NNS are_VBP believed_VBN to_TO be_VB at_IN greater_JJR risk_NN of_IN sexual_JJ violence_NN or_CC sexual_JJ activity_NN as_IN a_DT way_NN to_TO negotiate_VB access_NN to_TO key_JJ resources_NNS for_IN survival_NN ._. 
Arecent_JJ finding_NN regarding_VBG the_DT behavior_NN of_IN humanitarian_JJ aid_NN workers_NNS in_IN western_JJ Africa_NNP tragically_RB supports_VBZ this_DT assertion_NN ._. 
Longer-duration_NN conflicts_NNS generally_RB lead_VBP to_TO greater_JJR cumulative_JJ effects_NNS of_IN conflict_NN on_IN social_JJ infrastructure_NN ._. 
Equally_RB ,_, the_DT point_NN of_IN conflict_NN onset_NN relative_JJ to_TO the_DT progression_NN of_IN the_DT epidemic_NN may_MD determine_VB the_DT degree_NN to_TO which_WDT conflict_NN may_MD result_VB in_IN sustained_JJ low_JJ seroprevalence_NN levels_NNS for_IN the_DT duration_NN of_IN the_DT war_NN ._. 
In_IN Rwanda_NNP ,_, for_IN example_NN ,_, sentinel_JJ surveys_NNS among_IN pregnant_JJ women_NNS and_CC STI_NNP patients_NNS demonstrated_VBD prevalence_NN rates_NNS exceeding_VBG 30_CD %_NN before_IN the_DT 1994_CD genocide_NN ._. 
Because_IN HIV_NNP was_VBD already_RB so_RB prevalent_JJ ,_, community_NN isolation_NN did_VBD not_RB likely_RB curtail_VB the_DT local_JJ spread_NN of_IN the_DT disease_NN ._. 
Because_IN HIV_NNP was_VBD already_RB so_RB prevalent_JJ ,_, community_NN isolation_NN did_VBD not_RB likely_RB curtail_VB the_DT local_JJ spread_NN of_IN the_DT disease_NN ._. 
In_IN contrast_NN ,_, prevalence_NN rates_NNS in_IN Mozambique_NNP in_IN sentinel_NN surveys_NNS of_IN high-risk_JJ populations_NNS appear_VBP to_TO have_VB remained_VBN relatively_RB low_JJ until_IN the_DT war_NN ended_VBD ,_, at_IN which_WDT point_NN the_DT resumption_NN of_IN normal_JJ patterns_NNS of_IN social_JJ mixing_NN occurred_VBD alongside_IN a_DT marked_JJ rise_NN in_IN prevalence_NN rates_NNS ._. 
Thus_RB ,_, when_WRB initial_JJ low_JJ prevalence_NN rates_NNS are_VBP combined_VBN with_IN isolation_NN for_IN long_JJ periods_NNS of_IN time_NN ,_, HIV_NNP progression_NN at_IN the_DT population_NN level_NN may_MD be_VB considerably_RB attenuated_VBN ._. 
Typologies_NNS that_WDT focus_VBP on_IN the_DT determinants_NNS of_IN conflict_NN categorize_NN conflicts_NNS primarily_RB based_VBN upon_IN characteristics_NNS of_IN the_DT political_JJ ,_, legal_JJ ,_, economic_JJ ,_, social_JJ ,_, or_CC cultural_JJ environments_NNS that_WDT are_VBP associated_VBN with_IN greater_JJR risk_NN of_IN conflict_NN ._. 
Examples_NNS of_IN such_JJ factors_NNS include_VBP :_: 
For_IN example_NN ,_, other_JJ categories_NNS of_IN war-related_JJ mortality_NN ,_, such_JJ as_IN civilian_JJ deaths_NNS ,_, deaths_NNS following_VBG famine_NN or_CC disease_NN and_CC deaths_NNS that_WDT are_VBP allowed_VBN to_TO occur_VB for_IN political_JJ reasons_NNS ,_, are_VBP often_RB omitted_VBN ._. 
Similarly_RB ,_, morbidity_NN ,_, malnutrition_NN and_CC displacement_NN among_IN civilians_NNS ,_, highly_RB characteristic_JJ of_IN post-Cold_JJ War_NNP conflicts_NNS in_IN SSA_NNP ,_, have_VBP been_VBN largely_RB overlooked_VBN ._. 
These_DT population-level_JJ results_NNS of_IN conflict_NN appear_VBP ,_, in_IN many_JJ cases_NNS ,_, to_TO help_VB explain_VB the_DT links_NNS between_IN conflict_NN and_CC HIV\/AIDS_NN progression_NN ._. 
e._VB A_DT determinant-based_JJ typology_NN has_VBZ more_RBR direct_JJ application_NN to_TO the_DT critical_JJ areas_NNS of_IN conflict_NN early_JJ warning_NN and_CC prevention_NN ,_, despite_IN the_DT analytical_JJ complexities_NNS derived_VBN from_IN the_DT high_JJ degree_NN of_IN interdependence_NN -LRB-_-LRB- i._JJ interaction_NN -RRB-_-RRB- among_IN these_DT determinants_NNS 
The_DT juxtaposition_NN of_IN high_JJ vulnerability_NN and_CC increased_VBN exposure_NN opportunities_NNS post-conflict_NN can_MD lead_VB to_TO explosive_JJ growth_NN in_IN the_DT epidemic_NN ._. 
This_DT already_RB has_VBZ occurred_VBN to_TO some_DT extent_NN in_IN Mozambique_NNP ._. 
Figure_NN 2_CD HIV_NNP Vulnerability_NNP and_CC Exposure_NNP Opportunity_NNP in_IN Relation_NNP to_TO Conflict_NNP Phase_NN This_DT finding_NN is_VBZ critical_JJ in_IN that_IN it_PRP explains_VBZ in_IN part_NN why_WRB ,_, in_IN some_DT chronic_JJ conflict_NN settings_NNS ,_, apathy_NN has_VBZ developed_VBN towards_IN HIV_NNP because_IN seroprevalence_NN levels_NNS may_MD be_VB low_JJ ._. 
In_IN Cambodia_NNP ,_, for_IN example_NN ,_, household_NN surveys_NNS estimate_VBP prevalence_NN rates_NNS of_IN police_NN and_CC military_JJ personnel_NNS at_IN 8_CD %_NN ,_, while_IN the_DT rate_NN among_IN the_DT civilian_JJ population_NN is_VBZ 2_CD ._. 
7%_CD 
Conflict_NN as_IN an_DT Analytical_NNP Factor_NNP Considerable_NNP research_NN has_VBZ been_VBN conducted_VBN to_TO date_NN to_TO construct_VB comprehensive_JJ typologies_NNS of_IN conflict_NN ._. 
Several_JJ well-established_JJ research_NN initiatives_NNS ,_, such_JJ as_IN the_DT Correlates_NNP of_IN War_NNP Project_NNP ,_, have_VBP developed_VBN typologies_NNS of_IN conflict_NN for_IN application_NN to_TO conflict_VB early_JJ warning_NN and_CC prevention_NN efforts_NNS ._. 
These_DT typologies_NNS categorize_VBP conflicts_NNS based_VBN upon_IN variables_NNS associated_VBN with_IN either_CC the_DT determinants_NNS of_IN conflict_NN or_CC the_DT manifestations_NNS of_IN conflict_NN ._. 
Alternatively_RB ,_, when_WRB conflict_NN subsides_NNS ,_, exposure_NN opportunity_NN may_MD increase_VB ,_, leading_VBG to_TO the_DT potentially_RB explosive_JJ spread_NN of_IN HIV_NNP ._. 
At_IN the_DT end_NN of_IN the_DT Angola_NNP conflict_NN in_IN 2002_CD ,_, the_DT country_NN HIV_NNP prevalence_NN was_VBD relatively_RB lower_JJR than_IN the_DT rates_NNS in_IN other_JJ Southern_JJ African_JJ countries_NNS ,_, which_WDT suggests_VBZ that_DT conflict_NN may_MD have_VB slowed_VBN HIV_NNP spread_NN in_IN this_DT case_NN ._. 
Figure_NNP 3_NNP Maps_NNP of_IN Africa_NNP The_DT present_JJ paper_NN evolved_VBD out_IN of_IN the_DT observation_NN that_IN available_JJ evidence_NN for_IN conflict-affected_JJ countries_NNS in_IN SSA_NNP suggests_VBZ a_DT complex_JJ set_NN of_IN possible_JJ net_JJ effects_NNS of_IN conflict_NN on_IN the_DT HIV_NNP epidemic_NN ,_, with_IN multiple_JJ and_CC quite_RB variable_JJ outcomes_NNS ._. 
To_TO articulate_VB a_DT framework_NN for_IN understanding_VBG the_DT interface_NN between_IN the_DT two_CD crises_NNS ,_, the_DT concepts_NNS of_IN vulnerability_NN ,_, hazard_NN exposure_NN opportunity_NN and_CC risk_NN are_VBP useful_JJ ._. 
These_DT are_VBP borrowed_VBN from_IN the_DT disaster_NN literature_NN but_CC are_VBP germane_JJ for_IN understanding_VBG the_DT evolution_NN of_IN HIV\/AIDS_NNP as_IN a_DT crisis_NN ._. 
Vulnerability_NN is_VBZ the_DT ability_NN of_IN a_DT population_NN to_TO withstand_VB hazards_NNS or_CC shocks_NNS to_TO the_DT system_NN when_WRB they_PRP are_VBP present_JJ ._. 
Popular_NNP wisdom_NN suggests_VBZ that_IN post-conflict_JJ populations_NNS may_MD want_VB to_TO repopulate_VB and_CC ,_, to_TO an_DT extent_NN ,_, that_DT tendency_NN is_VBZ supported_VBN by_IN examination_NN of_IN Demographic_NNP and_CC Health_NNP Survey_NNP -LRB-_-LRB- DHS_NNP -RRB-_-RRB- data_NNS collected_VBN before_IN and_CC after_IN the_DT genocide_NN of_IN 1994_CD ._. 
In_IN 1992_CD and_CC 2000_CD ,_, the_DT DHS_NNP documented_VBD rates_NNS of_IN awareness_NN of_IN HIV_NNP exceeding_VBG 80_CD %_NN and_CC awareness_NN of_IN modern_JJ methods_NNS of_IN contraception_NN exceeding_VBG 90_CD %_NN ._. 
Despite_IN the_DT relatively_RB high_JJ levels_NNS of_IN exposure_NN to_TO information_NN ,_, condom_NN use_NN remained_VBD low_JJ in_IN 2000_CD ,_, though_IN use_NN is_VBZ significant_JJ in_IN higher_JJR risk_NN groups_NNS ._. 
9%_CD to_TO 28_CD ._. 
During_IN the_DT same_JJ period_NN ,_, the_DT percentage_NN of_IN women_NNS reporting_VBG a_DT desire_NN to_TO have_VB six_CD or_CC more_JJR children_NNS increased_VBD from_IN 14_CD ._. 
6%_CD ._. 
These_DT data_NNS highlight_VBP the_DT fact_NN that_IN the_DT constraints_NNS to_TO adoption_NN of_IN condom_NN use_NN remain_VBP significant_JJ on_IN the_DT population_NN level_NN and_CC may_MD in_IN part_NN represent_VBP a_DT desire_NN to_TO repopulate_VB ._. 
In_IN terms_NNS of_IN political\/legal_JJ status_NN ,_, combatant_NN groups_NNS may_MD comprise_VB government_NN military_JJ forces_NNS ,_, paramilitary_JJ forces_NNS ,_, organized_VBN rebel_NN groups_NNS ,_, or_CC highly_RB fragmented_JJ rebel_NN groups_NNS ._. 
Available_JJ data_NNS suggest_VBP but_CC do_VBP not_RB conclusively_RB confirm_VB the_DT oft_NN cited_VBD axiom_NN that_IN significant_JJ differentials_NNS in_IN seroprevalence_NN can_MD exist_VB between_IN government_NN military_JJ and_CC civilian_JJ populations_NNS in_IN Africa_NNP 
It_PRP has_VBZ been_VBN documented_VBN that_IN in_IN the_DT African_JJ context_NN ,_, some_DT military_JJ groups_NNS have_VBP higher_JJR HIV_NNP risk_NN than_IN the_DT general_JJ population_NN 
Available_JJ data_NNS suggest_VBP but_CC do_VBP not_RB conclusively_RB confirm_VB the_DT oft_NN cited_VBD axiom_NN that_IN significant_JJ differentials_NNS in_IN seroprevalence_NN can_MD exist_VB between_IN government_NN military_JJ and_CC civilian_JJ populations_NNS in_IN Africa_NNP 
-RRB-_-RRB- with_IN emphasis_NN on_IN dynamic_JJ change_NN over_IN time_NN ._. 
Asocial_JJ ecology_NN approach_NN argues_VBZ for_IN models_NNS of_IN explanation_NN that_WDT explore_VBP the_DT interactions_NNS of_IN multiple_JJ causes_NNS -LRB-_-LRB- environmental_JJ ,_, social_JJ ,_, and_CC biological_JJ -RRB-_-RRB- working_VBG through_IN different_JJ mechanisms_NNS and_CC at_IN differing_VBG levels_NNS of_IN scale_NN -LRB-_-LRB- individual_JJ ,_, household_NN ,_, community_NN etc._NN ._. 
The_DT social_JJ ecology_NN of_IN the_DT epidemic_NN is_VBZ defined_VBN in_IN terms_NNS of_IN sociodemographic_JJ ,_, socioeconomic_JJ ,_, structural_JJ ,_, contextual_JJ ,_, biologic_JJ and_CC behavioral_JJ variables_NNS that_WDT facilitate_VBP or_CC inhibit_VBP progression_NN of_IN the_DT epidemic_NN ._. 
The_DT ecological_JJ perspective_NN explains_VBZ how_WRB conflict_NN might_MD impede_VB the_DT progress_NN of_IN the_DT epidemic_NN and_CC it_PRP provides_VBZ clues_NNS as_IN to_TO regional_JJ strategic_JJ factors_NNS that_WDT may_MD exacerbate_VB risk_NN in_IN the_DT post-conflict_JJ setting_NN ._. 
Sadly_RB ,_, the_DT international_JJ community_NN has_VBZ compartmentalized_VBN its_PRP$ responses_NNS to_TO HIV_NNP and_CC conflict_NN 
Research_NNP suggests_VBZ that_IN urban_JJ rates_NNS of_IN casual\/commercial_JJ sexual_JJ activity_NN tend_VBP to_TO exceed_VB rural_JJ rates_NNS and_CC that_DT exchange_NN of_IN rural\/urban_JJ populations_NNS tends_VBZ to_TO undermine_VB traditional_JJ norms_NNS governing_VBG sexual_JJ activity_NN in_IN rural_JJ areas_NNS 
It_PRP has_VBZ been_VBN shown_VBN that_DT war_NN can_MD increase_VB partner_NN exchange_NN ,_, as_IN relationships_NNS generally_RB tend_VBP to_TO be_VB shorter-term_JJ ,_, thereby_RB increasing_VBG the_DT reproductive_JJ rate_NN of_IN the_DT disease_NN 
Malnutrition_NN and_CC micronutrient_NN deficiencies_NNS impair_VBP immune_JJ function_NN ,_, thereby_RB increasing_VBG vulnerability_NN to_TO infections_NNS in_IN general_JJ ._. 
Vitamin_NNP A_NNP ,_, for_IN example_NN ,_, has_VBZ been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN immune_JJ function_NN ,_, including_VBG the_DT maintenance_NN of_IN mucosal_JJ epithelia_NN ,_, the_DT growth_NN of_IN immunogenic_JJ cells_NNS and_CC antibody_NN response_NN 
Similarly_RB ,_, vitamin_NN E_NN is_VBZ associated_VBN with_IN neutrophil_NN phagocytosis_NNS and_CC lymphocyte_NN proliferation_NN 
Vitamin_NNP A_NNP ,_, for_IN example_NN ,_, has_VBZ been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN immune_JJ function_NN ,_, including_VBG the_DT maintenance_NN of_IN mucosal_JJ epithelia_NN ,_, the_DT growth_NN of_IN immunogenic_JJ cells_NNS and_CC antibody_NN response_NN 
Such_JJ deficiencies_NNS are_VBP associated_VBN with_IN accelerated_JJ disease_NN progression_NN in_IN HIV_NNP patients_NNS 
Massive_JJ loss_NN of_IN health_NN infrastructure_NN 
Mozambique_NNP lost_VBD the_DT majority_NN of_IN its_PRP$ clinics_NNS during_IN the_DT civil_JJ war_NN ._. 
Massive_JJ loss_NN of_IN health_NN infrastructure_NN 
They_PRP may_MD also_RB be_VB reluctant_JJ to_TO use_VB services_NNS because_IN they_PRP distrust_VBP providers_NNS ._. 
People_NNS may_MD not_RB be_VB able_JJ to_TO get_VB to_TO health_NN care_NN services_NNS because_IN of_IN ambient_JJ danger_NN ._. 
This_DT may_MD have_VB been_VBN a_DT factor_NN in_IN Rwanda_NNP ,_, for_IN example_NN ,_, where_WRB providers_NNS were_VBD particularly_RB implicated_VBN in_IN genocide_NN activities_NNS during_IN the_DT war_NN 
This_DT may_MD have_VB been_VBN a_DT factor_NN in_IN Rwanda_NNP ,_, for_IN example_NN ,_, where_WRB providers_NNS were_VBD particularly_RB implicated_VBN in_IN genocide_NN activities_NNS during_IN the_DT war_NN 
The_DT ecology_NN of_IN HIV_NNP and_CC conflict_NN also_RB results_VBZ in_IN greater_JJR micro-level_NN variation_NN in_IN the_DT determinants_NNS of_IN HIV_NNP risk_NN ._. 
Mock_NNP and_CC Drapcho_NNP showed_VBD that_IN regional_JJ variability_NN and_CC the_DT design_NN effects_NNS -LRB-_-LRB- sample_NN variation_NN across_IN clusters\/villages_NNS -RRB-_-RRB- associated_VBN with_IN measures_NNS of_IN nutrition_NN and_CC mortality_NN were_VBD far_RB greater_JJR among_IN post-conflict_JJ countries_NNS surveyed_VBN by_IN DHS_NNP than_IN are_VBP typically_RB found_VBN in_IN more_RBR stable_JJ settings_NNS ._. 
This_DT is_VBZ plausible_JJ given_VBN that_DT conflict_NN does_VBZ not_RB have_VB a_DT consistent_JJ effect_NN in_IN all_DT areas_NNS of_IN countries_NNS ._. 
g._VB Semi-permanent_JJ refugee_NN populations_NNS that_WDT relocate_VBP near_IN population_NN centers_NNS may_MD be_VB forced_VBN to_TO participate_VB in_IN commercial_JJ sex_NN in_IN order_NN to_TO ensure_VB household_NN livelihoods_NNS or_CC ,_, in_IN extreme_JJ cases_NNS -LRB-_-LRB- e._VB poor_JJ female-headed_JJ households_NNS -RRB-_-RRB- ,_, to_TO exchange_VB sex_NN for_IN food_NN and_CC other_JJ assets_NNS ._. 
In_IN addition_NN ,_, high_JJ levels_NNS of_IN female_JJ illiteracy_NN affect_VBP the_DT ability_NN of_IN women_NNS to_TO seek_VB alternative_JJ forms_NNS of_IN livelihood_NN ._. 
Research_NNP suggests_VBZ that_IN urban_JJ rates_NNS of_IN casual\/commercial_JJ sexual_JJ activity_NN tend_VBP to_TO exceed_VB rural_JJ rates_NNS and_CC that_DT exchange_NN of_IN rural\/urban_JJ populations_NNS tends_VBZ to_TO undermine_VB traditional_JJ norms_NNS governing_VBG sexual_JJ activity_NN in_IN rural_JJ areas_NNS ._. 
It_PRP has_VBZ been_VBN shown_VBN that_DT war_NN can_MD increase_VB partner_NN exchange_NN ,_, as_IN relationships_NNS generally_RB tend_VBP to_TO be_VB shorter-term_JJ ,_, there_EX 
g._VB Semi-permanent_JJ refugee_NN populations_NNS that_WDT relocate_VBP near_IN population_NN centers_NNS may_MD be_VB forced_VBN to_TO participate_VB in_IN commercial_JJ sex_NN in_IN order_NN to_TO ensure_VB household_NN livelihoods_NNS or_CC ,_, in_IN extreme_JJ cases_NNS -LRB-_-LRB- e._VB poor_JJ female-headed_JJ households_NNS -RRB-_-RRB- ,_, to_TO exchange_VB sex_NN for_IN food_NN and_CC other_JJ assets_NNS ._. 
In_IN addition_NN ,_, high_JJ levels_NNS of_IN female_JJ illiteracy_NN affect_VBP the_DT ability_NN of_IN women_NNS to_TO seek_VB alternative_JJ forms_NNS of_IN livelihood_NN ._. 
In_IN northern_JJ Uganda_NNP ,_, many_JJ separated_VBD and_CC widowed_VBD female_JJ Sudanese_JJ refugees_NNS began_VBD brewing_VBG and_CC selling_VBG beer_NN to_TO sustain_VB themselves_PRP and_CC their_PRP$ children_NNS ._. 
This_DT unfortunately_RB led_VBN to_TO an_DT ``_`` increase_NN in_IN unprotected_JJ sex_NN with_IN multiple_JJ partners_NNS while_IN under_IN the_DT influence_NN of_IN alcohol_NN ''_'' ._. 
These_DT vulnerabilities_NNS characterize_VBP populations_NNS in_IN both_DT conflict_NN and_CC post-conflict_JJ phases_NNS ._. 
Factor_NN 3_CD :_: Decreased_JJ availability_NN of_IN reproductive_JJ health_NN and_CC other_JJ health_NN services_NNS Destruction_NNP of_IN the_DT health_NN sector_NN is_VBZ a_DT common_JJ feature_NN of_IN conflicts_NNS and_CC its_PRP$ reconstruction_NN has_VBZ not_RB been_VBN rapid_JJ in_IN most_JJS SSA_NNP countries_NNS ._. 
It_PRP should_MD be_VB noted_VBN that_IN in_IN some_DT conflict-affected_JJ populations_NNS ,_, research_NN suggests_VBZ discriminatory_JJ cultural_JJ attitudes_NNS and_CC practices_NNS ._. 
In_IN Rwanda_NNP ,_, research_NN in_IN 1990_CD found_VBD that_IN men_NNS control_VBP sexual_JJ decision-making_NN ,_, and_CC that_IN HIV_NNP positive_JJ women_NNS were_VBD more_RBR likely_JJ to_TO report_VB coercive_JJ sex_NN and_CC violence_NN with_IN their_PRP$ sexual_JJ partner_NN than_IN HIV_NNP negative_JJ women_NNS 
While_IN exact_JJ figures_NNS are_VBP unavailable_JJ ,_, it_PRP is_VBZ estimated_VBN that_IN between_IN 250,000_CD and_CC 500,000_CD cases_NNS of_IN rape_NN occurred_VBD during_IN the_DT conflict_NN 
First_RB ,_, a_DT more_RBR deliberate_JJ attempt_NN should_MD be_VB made_VBN to_TO support_VB surveillance_NN in_IN countries_NNS and_CC areas_NNS affected_VBN by_IN conflict_NN so_IN that_IN a_DT better_JJR evidence_NN base_NN is_VBZ developed_VBN ._. 
Unfortunately_RB ,_, a_DT review_NN of_IN the_DT UNAIDS_NNP surveillance_NN database_NN revealed_VBD that_IN conflict-affected_JJ countries_NNS have_VBP little_JJ or_CC no_DT systematic_JJ surveillance_NN ,_, despite_IN the_DT existence_NN of_IN relatively_RB stable_JJ areas_NNS ._. 
This_DT may_MD be_VB due_JJ to_TO the_DT fact_NN that_IN lab_NN testing_NN and_CC quality_NN control_NN for_IN HIV_NNP surveillance_NN is_VBZ generally_RB centralized_VBN ._. 
It_PRP is_VBZ known_VBN that_IN poor_JJ nutritional_JJ status_NN is_VBZ associated_VBN with_IN vulnerability_NN to_TO progression_NN from_IN tuberculosis_NN infection_NN to_TO disease_NN ._. 
The_DT immunosuppression_NN associated_VBN with_IN HIV_NNP infection_NN is_VBZ a_DT major_JJ risk_NN factor_NN for_IN the_DT progression_NN of_IN latent_NN tuberculosis_NN infection_NN to_TO active_JJ disease_NN and_CC death_NN ._. 
The_DT increased_VBN level_NN of_IN HIV_NNP in_IN a_DT community_NN will_MD certainly_RB contribute_VB to_TO a_DT high_JJ dual_JJ HIV-TB_JJ burden_NN ._. 
Factor_NN 6_CD :_: Decreased_JJ use_NN of_IN means_NNS to_TO prevent_VB HIV_NNP transmission_NN The_DT isolation_NN and_CC poverty_NN caused_VBN by_IN war_NN often_RB results_VBZ in_IN decreased_VBN knowledge_NN of_IN ,_, and_CC access_NN to_TO ,_, means_VBZ to_TO prevent_VB HIV_NNP transmission_NN ._. 
The_DT widespread_JJ infliction_NN of_IN sexual_JJ violence_NN upon_IN women_NNS during_IN the_DT Rwandan_JJ genocide_NN and_CC its_PRP$ aftermath_NN illustrates_VBZ the_DT extent_NN to_TO which_WDT sexual_JJ violence_NN may_MD be_VB utilized_VBN as_IN an_DT instrument_NN of_IN war_NN ._. 
While_IN exact_JJ figures_NNS are_VBP unavailable_JJ ,_, it_PRP is_VBZ estimated_VBN that_IN between_IN 250,000_CD and_CC 500,000_CD cases_NNS of_IN rape_NN occurred_VBD during_IN the_DT conflict_NN 
The_DT widespread_JJ infliction_NN of_IN sexual_JJ violence_NN upon_IN women_NNS during_IN the_DT Rwandan_JJ genocide_NN and_CC its_PRP$ aftermath_NN illustrates_VBZ the_DT extent_NN to_TO which_WDT sexual_JJ violence_NN may_MD be_VB utilized_VBN as_IN an_DT instrument_NN of_IN war_NN ._. 
While_IN exact_JJ figures_NNS are_VBP unavailable_JJ ,_, it_PRP is_VBZ estimated_VBN that_IN between_IN 250,000_CD and_CC 500,000_CD cases_NNS of_IN rape_NN occurred_VBD during_IN the_DT conflict_NN 
It_PRP calls_VBZ for_IN the_DT development_NN and_CC implementation_NN of_IN national_JJ strategies_NNS that_WDT incorporate_VBP HIV\/AIDS_NNP awareness_NN ,_, prevention_NN ,_, care_NN ,_, and_CC treatment_NN elements_NNS into_IN programs_NNS or_CC actions_NNS that_WDT respond_VBP to_TO emergency_NN situations_NNS ._. 
The_DT declaration_NN recognizes_VBZ that_IN populations_NNS destabilized_VBN by_IN armed_JJ conflict_NN ,_, humanitarian_JJ emergencies_NNS ,_, and_CC natural_JJ disasters_NNS 
Fluid_JJ population_NN movements_NNS are_VBP particularly_RB common_JJ during_IN prolonged_JJ conflicts_NNS in_IN border_NN areas_NNS that_WDT might_MD give_VB rise_NN to_TO population_NN mixing_NN and_CC then_RB repatriation_NN ._. 
In_IN the_DT case_NN of_IN Rwanda_NNP ,_, research_NN illustrates_VBZ that_IN the_DT post-war_JJ period_NN has_VBZ seen_VBN a_DT sharp_JJ decrease_NN in_IN the_DT HIV_NNP prevalence_NN differential_NN between_IN rural_JJ and_CC urban_JJ women_NNS attending_VBG antenatal_JJ clinic_NN services_NNS in_IN Kigali_NNP ._. 
The_DT trend_NN may_MD be_VB due_JJ in_IN large_JJ part_NN to_TO migration_NN between_IN rural_JJ and_CC urban_JJ communities_NNS ,_, combined_VBN with_IN the_DT high_JJ level_NN of_IN sexual_JJ violence_NN inflicted_VBD on_IN rural_JJ women_NNS during_IN the_DT genocide_NN ._. 
Similarly_RB ,_, vitamin_NN E_NN is_VBZ associated_VBN with_IN neutrophil_NN phagocytosis_NNS and_CC lymphocyte_NN proliferation_NN 
Additionally_RB ,_, knowledge_NN levels_NNS tend_VBP to_TO exhibit_VB marked_JJ intra-national_JJ variability_NN ,_, particularly_RB among_IN socially_RB and_CC economically_RB marginalized_VBN groups_NNS ._. 
This_DT variability_NN may_MD be_VB enhanced_VBN in_IN conflict-affected_JJ countries_NNS through_IN regional_JJ isolation_NN ._. 
The_DT case_NN of_IN Rwanda_NNP suggests_VBZ that_DT conflict_NN may_MD affect_VB contraceptive_JJ use_NN and_CC desired_VBN family_NN size_NN ._. 
Popular_NNP wisdom_NN suggests_VBZ that_IN post-conflict_JJ populations_NNS may_MD want_VB to_TO repopulate_VB and_CC ,_, to_TO an_DT extent_NN ,_, that_DT tendency_NN is_VBZ supported_VBN by_IN examination_NN of_IN Demographic_NNP and_CC Health_NNP Survey_NNP -LRB-_-LRB- DHS_NNP -RRB-_-RRB- data_NNS collected_VBN before_IN and_CC after_IN the_DT genocide_NN of_IN 1994_CD ._. 
In_IN Rwanda_NNP ,_, research_NN in_IN 1990_CD found_VBD that_IN men_NNS control_VBP sexual_JJ decision-making_NN ,_, and_CC that_IN HIV_NNP positive_JJ women_NNS were_VBD more_RBR likely_JJ to_TO report_VB coercive_JJ sex_NN and_CC violence_NN with_IN their_PRP$ sexual_JJ partner_NN than_IN HIV_NNP negative_JJ women_NNS 
Similarly_RB ,_, vitamin_NN E_NN is_VBZ associated_VBN with_IN neutrophil_NN phagocytosis_NNS and_CC lymphocyte_NN proliferation_NN 
Similarly_RB ,_, vitamin_NN E_NN is_VBZ associated_VBN with_IN neutrophil_NN phagocytosis_NNS and_CC lymphocyte_NN proliferation_NN 
Supplementation_NN with_IN vitamin_NN A_NN increases_VBZ levels_NNS of_IN natural_JJ killer_NN cells_NNS in_IN HIV_NNP infected_JJ children_NNS 
Similarly_RB ,_, vitamin_NN E_NN is_VBZ associated_VBN with_IN neutrophil_NN phagocytosis_NNS and_CC lymphocyte_NN proliferation_NN 
Vitamin_NNP A_NNP ,_, for_IN example_NN ,_, has_VBZ been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN immune_JJ function_NN ,_, including_VBG the_DT maintenance_NN of_IN mucosal_JJ epithelia_NN ,_, the_DT growth_NN of_IN immunogenic_JJ cells_NNS and_CC antibody_NN response_NN 
Vitamin_NNP A_NNP ,_, for_IN example_NN ,_, has_VBZ been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN immune_JJ function_NN ,_, including_VBG the_DT maintenance_NN of_IN mucosal_JJ epithelia_NN ,_, the_DT growth_NN of_IN immunogenic_JJ cells_NNS and_CC antibody_NN response_NN 
What_WP is_VBZ clear_JJ is_VBZ that_IN African_JJ countries_NNS that_WDT have_VBP experienced_VBN war_NN have_VBP lasting_JJ socioeconomic_JJ effects_NNS ._. 
For_IN example_NN ,_, Mozambique_NNP and_CC Angola_NNP are_VBP among_IN the_DT three_CD lowest_JJS ranking_JJ countries_NNS on_IN all_DT components_NNS of_IN the_DT Human_NNP Development_NNP Index_NNP among_IN Southern_JJ African_JJ countries_NNS ._. 
Infant_NN mortality_NN in_IN these_DT two_CD countries_NNS rank_VBP among_IN the_DT highest_JJS in_IN the_DT world_NN ._. 
Among_IN refugee_NN and_CC displaced_VBN populations_NNS poverty_NN results_NNS from_IN the_DT severing_VBG of_IN livelihood_NN strategies_NNS and_CC catastrophic_JJ asset_NN loss_NN ._. 
4%_CD ._. 
2%_CD ,_, while_IN among_IN urban_JJ civilians_NNS the_DT level_NN was_VBD 6_CD ._. 
In_IN a_DT large_JJ HIV_NNP prevalence_NN study_NN in_IN Ethiopia_NNP ,_, prevalence_NN among_IN urban_JJ military_NN was_VBD 7_CD ._. 
Rural_JJ military_NN registered_VBD a_DT lower_JJR rate_NN than_IN the_DT general_JJ rural_JJ population_NN ._. 
Factor_NN 2_CD :_: Increased_VBN levels_NNS of_IN commercial_JJ or_CC casual_JJ sex_NN Impoverishment_NN coupled_VBN with_IN discrimination_NN against_IN women_NNS and_CC the_DT erosion_NN of_IN traditional_JJ behavioral_JJ norms_NNS may_MD give_VB rise_NN to_TO high_JJ levels_NNS of_IN sex_NN driven_VBN by_IN economic_JJ motives_NNS in_IN conflict_NN and_CC transitional_JJ societies_NNS ._. 
In_IN Cambodia_NNP ,_, for_IN example_NN ,_, household_NN surveys_NNS estimate_VBP prevalence_NN rates_NNS of_IN police_NN and_CC military_JJ personnel_NNS at_IN 8_CD %_NN ,_, while_IN the_DT rate_NN among_IN the_DT civilian_JJ population_NN is_VBZ 2_CD ._. 
7%_CD 
7%_CD 
In_IN post-conflict_JJ settings_NNS ,_, demobilization_NN of_IN combatants_NNS may_MD also_RB result_VB in_IN disassortive_JJ mixing_NN ._. 
Factor_NN 1_CD :_: Increased_VBN interaction_NN among_IN military_JJ and_CC civilians_NNS Conflict_NNP has_VBZ been_VBN demonstrated_VBN to_TO result_VB in_IN the_DT increased_JJ sexual_JJ mixing_NN of_IN military_JJ with_IN civilian_JJ groups_NNS ,_, especially_RB in_IN areas_NNS of_IN high_JJ military_JJ concentration_NN for_IN extended_JJ periods_NNS of_IN time_NN 
Factors_NNS that_WDT May_MD Increase_VB Risk_NNP Accelerating_NNP factors_NNS in_IN this_DT model_NN constitute_VB factors_NNS that_WDT tend_VBP to_TO enhance_VB the_DT spread_NN of_IN HIV_NNP by_IN worsening_VBG dimensions_NNS of_IN population_NN vulnerability_NN or_CC increasing_VBG HIV_NNP exposure_NN opportunity_NN ._. 
Factor_NN 1_CD :_: Increased_VBN interaction_NN among_IN military_JJ and_CC civiliansConflict_NNP has_VBZ been_VBN demonstrated_VBN to_TO result_VB in_IN the_DT increased_JJ sexual_JJ mixing_NN of_IN military_JJ with_IN civilian_JJ groups_NNS ,_, especially_RB in_IN areas_NNS of_IN high_JJ military_JJ concentration_NN for_IN extended_JJ periods_NNS of_IN time_NN 
In_IN those_DT patients_NNS with_IN general_JJ depression_NN ,_, reduced_VBN libido_NN is_VBZ present_JJ in_IN up_IN to_TO three_CD quarters_NNS of_IN patients_NNS 
9%_CD -RRB-_-RRB- of_IN adults_NNS had_VBD depression_NN and_CC almost_RB half_NN -LRB-_-LRB- 41_CD ._. 
In_IN the_DT commune_NN that_WDT experienced_VBD widespread_JJ violent_JJ conflict_NN during_IN the_DT genocide_NN ,_, almost_RB one-fifth_NN -LRB-_-LRB- 17_CD ._. 
8%_CD -RRB-_-RRB- of_IN adults_NNS had_VBD agahinda_JJ gakabije_NN ._. 
The_DT results_NNS ,_, though_IN inconclusive_JJ ,_, suggest_VBP that_IN depression-like_JJ syndromes_NNS may_MD be_VB highly_RB prevalent_JJ in_IN some_DT settings_NNS ._. 
It_PRP has_VBZ been_VBN shown_VBN that_IN absent_JJ or_CC low_JJ libido_NN in_IN those_DT with_IN post-traumatic_JJ stress_NN disorder_NN can_MD be_VB as_RB high_JJ as_IN 69_CD %_NN 
Factor_NN 3_CD :_: Decreased_JJ casual_JJ sex_NN associated_VBN with_IN trauma_NN and_CC depression_NN Available_JJ evidence_NN points_NNS to_TO the_DT unexplored_JJ possibility_NN that_DT conflict_NN may_MD result_VB in_IN decreased_VBN sexual_JJ activity_NN ,_, most_RBS commonly_RB as_IN a_DT result_NN of_IN psychological_JJ sequelae_NN of_IN trauma_NN such_JJ as_IN post-traumatic_JJ stress_NN disorder_NN -LRB-_-LRB- PTSD_NNP -RRB-_-RRB- ._. 
It_PRP has_VBZ been_VBN shown_VBN that_IN absent_JJ or_CC low_JJ libido_NN in_IN those_DT with_IN post-traumatic_JJ stress_NN disorder_NN can_MD be_VB as_RB high_JJ as_IN 69_CD %_NN 
In_IN addition_NN ,_, poor_JJ nutrition_NN and_CC the_DT lack_NN of_IN access_NN to_TO health_NN services_NNS probably_RB decreases_VBZ the_DT survival_NN time_NN of_IN HIV-infected_JJ individuals_NNS ._. 
Arecent_JJ study_NN in_IN Guinea_NNP Bissau_NNP demonstrated_VBD a_DT strong_JJ differential_NN in_IN mortality_NN between_IN war-affected_JJ cohorts_NNS of_IN a_DT tuberculosis_NN treatment_NN program_NN according_VBG to_TO HIV_NNP status_NN ._. 
Factor_NN 3_CD :_: Decreased_JJ casual_JJ sex_NN associated_VBN with_IN trauma_NN and_CC depression_NN Available_JJ evidence_NN points_NNS to_TO the_DT unexplored_JJ possibility_NN that_DT conflict_NN may_MD result_VB in_IN decreased_VBN sexual_JJ activity_NN ,_, most_RBS commonly_RB as_IN a_DT result_NN of_IN psychological_JJ sequelae_NN of_IN trauma_NN such_JJ as_IN post-traumatic_JJ stress_NN disorder_NN -LRB-_-LRB- PTSD_NNP -RRB-_-RRB- ._. 
In_IN Guinea-Bissau_NNP ,_, for_IN example_NN ,_, interruption_NN of_IN TB_NN treatment_NN for_IN HIV_NNP patients_NNS due_JJ to_TO the_DT civil_JJ conflict_NN was_VBD directly_RB responsible_JJ for_IN the_DT significantly_RB higher_JJR mortality_NN rate_NN experienced_VBN by_IN HIV_NNP patients_NNS ._. 
Those_DT who_WP had_VBD completed_VBN TB_NN treatment_NN before_IN the_DT outbreak_NN of_IN the_DT war_NN ,_, showed_VBD no_DT differential_JJ increase_NN in_IN mortality_NN 
It_PRP is_VBZ well_RB established_VBN that_DT mortality_NN among_IN adult_NN males_NNS is_VBZ elevated_VBN in_IN conflict-affected_JJ settings_NNS ._. 
Post-genocide_JJ Rwanda_NNP has_VBZ shown_VBN a_DT demographic_JJ shift_NN such_JJ that_IN among_IN adults_NNS between_IN the_DT ages_NNS of_IN 15_CD and_CC 54_CD years_NNS ,_, women_NNS far_RB outnumber_VB men_NNS ._. 
In_IN addition_NN ,_, poor_JJ nutrition_NN and_CC the_DT lack_NN of_IN access_NN to_TO health_NN services_NNS probably_RB decreases_VBZ the_DT survival_NN time_NN of_IN HIV-infected_JJ individuals_NNS ._. 
Popular_NNP wisdom_NN suggests_VBZ that_IN post-conflict_JJ populations_NNS may_MD want_VB to_TO repopulate_VB and_CC ,_, to_TO an_DT extent_NN ,_, that_DT tendency_NN is_VBZ supported_VBN by_IN examination_NN of_IN Demographic_NNP and_CC Health_NNP Survey_NNP -LRB-_-LRB- DHS_NNP -RRB-_-RRB- data_NNS collected_VBN before_IN and_CC after_IN the_DT genocide_NN of_IN 1994_CD ._. 
In_IN 1992_CD and_CC 2000_CD ,_, the_DT DHS_NNP documented_VBD rates_NNS of_IN awareness_NN of_IN HIV_NNP exceeding_VBG 80_CD %_NN and_CC awareness_NN of_IN modern_JJ methods_NNS of_IN contraception_NN exceeding_VBG 90_CD %_NN ._. 
Despite_IN the_DT relatively_RB high_JJ levels_NNS of_IN exposure_NN to_TO information_NN ,_, condom_NN use_NN remained_VBD low_JJ in_IN 2000_CD ,_, though_IN use_NN is_VBZ significant_JJ in_IN higher_JJR risk_NN groups_NNS ._. 
9%_CD to_TO 28_CD ._. 
During_IN the_DT same_JJ period_NN ,_, the_DT percentage_NN of_IN women_NNS reporting_VBG a_DT desire_NN to_TO have_VB six_CD or_CC more_JJR children_NNS increased_VBD from_IN 14_CD ._. 
6%_CD ._. 
These_DT data_NNS highlight_VBP the_DT fact_NN that_IN the_DT constraints_NNS to_TO adoption_NN of_IN condom_NN use_NN remain_VBP significant_JJ on_IN the_DT population_NN level_NN and_CC may_MD in_IN part_NN represent_VBP a_DT desire_NN to_TO repopulate_VB ._. 
In_IN fact_NN ,_, an_DT extensive_JJ keyword_NN search_NN of_IN the_DT internet_NN and_CC peer-reviewed_JJ journal_NN databases_NNS turned_VBD up_RP fewer_JJR than_IN 100_CD references_NNS to_TO the_DT intersection_NN of_IN HIV_NNP and_CC conflict_NN ._. 
Virtually_RB all_DT studies_NNS are_VBP descriptive_JJ and_CC only_RB one_CD utilized_VBN hypothesis-testing_JJ analytical_JJ strategies_NNS ._. 
Although_IN constraints_NNS on_IN conducting_VBG such_JJ research_NN are_VBP considerable_JJ ,_, research_NN on_IN the_DT interface_NN between_IN the_DT two_CD crises_NNS is_VBZ of_IN critical_JJ importance_NN ._. 
Apolicy_NN forum_NN held_VBN at_IN the_DT United_NNP States_NNPS Institute_NNP for_IN Peace_NNP concluded_VBD that_IN the_DT pandemic_NN will_MD emerge_VB as_IN a_DT deeply_RB destabilizing_JJ force_NN across_IN the_DT social_JJ ,_, political_JJ ,_, and_CC economic_JJ landscapes_NNS of_IN Afri_NNP 
Apolicy_NN forum_NN held_VBN at_IN the_DT United_NNP States_NNPS Institute_NNP for_IN Peace_NNP 
risks_NNS for_IN anti-social_JJ and_CC criminal_JJ behavior_NN later_RB in_IN life_NN 
Almost_RB all_DT SSA_NNP countries_NNS have_VBP directly_RB experienced_VBN ,_, or_CC border_NN a_DT country_NN that_WDT has_VBZ directly_RB experienced_JJ ,_, violent_JJ conflict_NN ._. 
The_DT number_NN of_IN states_NNS engaged_VBN in_IN significant_JJ violent_JJ conflicts_NNS doubled_VBD between_IN 1989_CD and_CC 2000_CD ,_, from_IN 11_CD to_TO 22_CD ._. 
A``_NN conflict_NN belt_NN ''_'' stretches_NNS from_IN Angola_NNP to_TO the_DT Horn_NNP of_IN Africa_NNP ,_, while_IN peace_NN in_IN western_JJ Africa_NNP remains_VBZ elusive_JJ ._. 
This_DT ceremony_NN ,_, which_WDT may_MD occur_VB more_RBR frequently_RB during_IN periods_NNS of_IN elevated_JJ mortality_NN in_IN conflict_NN situations_NNS ,_, places_VBZ the_DT economically_RB vulnerable_JJ widow_NN at_IN an_DT elevated_JJ risk_NN of_IN HIV_NNP transmission_NN ._. 
Factor_NN 9_CD :_: Fragmentation_NN of_IN families_NNS and_CC resultant_JJ vulnerable_JJ household_NN structuresLike_NNP HIV_NNP ,_, conflict_NN decimates_VBZ family_NN structures_NNS through_IN mortality_NN and_CC dislocation_NN ,_, and_CC results_NNS in_IN lasting_JJ effects_NNS on_IN society_NN ._. 
Conflict-affected_JJ populations_NNS typically_RB have_VBP higher_JJR rates_NNS of_IN child-headed_JJ households_NNS -LRB-_-LRB- e._FW g._FW orphans_NNS -RRB-_-RRB- ._. 
Almost_RB all_DT SSA_NNP countries_NNS have_VBP directly_RB experienced_VBN ,_, or_CC border_NN a_DT country_NN that_WDT has_VBZ directly_RB experienced_JJ ,_, violent_JJ conflict_NN ._. 
The_DT number_NN of_IN states_NNS engaged_VBN in_IN significant_JJ violent_JJ conflicts_NNS doubled_VBD between_IN 1989_CD and_CC 2000_CD ,_, from_IN 11_CD to_TO 22_CD ._. 
A``_NN conflict_NN belt_NN ''_'' stretches_NNS from_IN Angola_NNP to_TO the_DT Horn_NNP of_IN Africa_NNP ,_, while_IN peace_NN in_IN western_JJ Africa_NNP remains_VBZ elusive_JJ ._. 
HIV\/AIDS_NNP has_VBZ been_VBN recognized_VBN to_TO play_VB a_DT potential_JJ role_NN in_IN creating_VBG conditions_NNS conducive_JJ to_TO violent_JJ conflict_NN on_IN the_DT continent_NN ,_, although_IN there_EX is_VBZ as_RB yet_RB no_DT good_JJ empirical_JJ evidence_NN to_TO that_DT effect_NN ._. 
Apolicy_NN forum_NN held_VBN at_IN the_DT United_NNP States_NNPS Institute_NNP for_IN Peace_NNP 
The_DT same_JJ quarter_NN century_NN has_VBZ seen_VBN the_DT development_NN of_IN an_DT even_RB more_RBR pervasive_JJ crisis_NN 
e._NN Widows_NNS may_MD be_VB forced_VBN to_TO have_VB intercourse_NN with_IN a_DT close_JJ male_JJ relative_NN -LRB-_-LRB- i._VB It_PRP should_MD also_RB be_VB noted_VBN that_IN in_IN some_DT African_JJ cultures_NNS including_VBG Rwanda_NNP ,_, mourning_VBG rituals_NNS involve_VBP intercourse_NN between_IN the_DT widow_NN or_CC widower_NN and_CC another_DT individual_NN ._. 
brother_NN or_CC cousin_NN -RRB-_-RRB- of_IN her_PRP$ deceased_JJ husband_NN to_TO achieve_VB the_DT purification_NN intended_VBN from_IN the_DT ceremony_NN ._. 
This_DT ceremony_NN ,_, which_WDT may_MD occur_VB more_RBR frequently_RB during_IN periods_NNS of_IN elevated_JJ mortality_NN in_IN conflict_NN situations_NNS ,_, places_VBZ the_DT economically_RB vulnerable_JJ widow_NN at_IN an_DT elevated_JJ risk_NN of_IN HIV_NNP transmission_NN ._. 
g._IN The_DT migration_NN and_CC poverty_NN created_VBN or_CC exacerbated_VBN by_IN conflict_NN may_MD result_VB in_IN increased_VBN exposure_NN opportunity_NN through_IN :_: -LRB-_-LRB- 1_CD -RRB-_-RRB- increased_VBN prevalence_NN of_IN casual_JJ or_CC commercial_JJ sexual_JJ activity_NN ;_: -LRB-_-LRB- 2_CD -RRB-_-RRB- increased_VBN interactions_NNS among_IN civilians_NNS and_CC combatants\/military_JJ personnel_NNS ,_, known_VBN for_IN their_PRP$ high_JJ risk_NN behaviors_NNS ;_: -LRB-_-LRB- 3_CD -RRB-_-RRB- the_DT development_NN of_IN cultures_NNS of_IN violence_NN that_WDT promote_VBP sexual_JJ violence_NN and_CC predation_NN ;_: -LRB-_-LRB- 4_CD -RRB-_-RRB- mass_NN migration_NN ,_, which_WDT increases_VBZ sexual_JJ mixing_NN among_IN populations_NNS ;_: and_CC -LRB-_-LRB- 5_CD -RRB-_-RRB- the_DT destruction_NN of_IN public_JJ health_NN education_NN mechanisms_NNS -LRB-_-LRB- e._NN mass_NN media_NNS ,_, health_NN facilities_NNS ,_, and_CC formal_JJ education_NN -RRB-_-RRB- ,_, which_WDT negatively_RB affects_VBZ public_JJ health-related_JJ knowledge_NN ,_, attitudes_NNS ,_, and_CC practices_NNS 
g._IN The_DT migration_NN and_CC poverty_NN created_VBN or_CC exacerbated_VBN by_IN conflict_NN may_MD result_VB in_IN increased_VBN exposure_NN opportunity_NN through_IN :_: -LRB-_-LRB- 1_CD -RRB-_-RRB- increased_VBN prevalence_NN of_IN casual_JJ or_CC commercial_JJ sexual_JJ activity_NN ;_: -LRB-_-LRB- 2_CD -RRB-_-RRB- increased_VBN interactions_NNS among_IN civilians_NNS and_CC combatants\/military_JJ personnel_NNS ,_, known_VBN for_IN their_PRP$ high_JJ risk_NN behaviors_NNS ;_: -LRB-_-LRB- 3_CD -RRB-_-RRB- the_DT development_NN of_IN cultures_NNS of_IN violence_NN that_WDT promote_VBP sexual_JJ violence_NN and_CC predation_NN ;_: -LRB-_-LRB- 4_CD -RRB-_-RRB- mass_NN migration_NN ,_, which_WDT increases_VBZ sexual_JJ mixing_NN among_IN populations_NNS ;_: and_CC -LRB-_-LRB- 5_CD -RRB-_-RRB- the_DT destruction_NN of_IN public_JJ health_NN education_NN mechanisms_NNS -LRB-_-LRB- e._NN mass_NN media_NNS ,_, health_NN facilities_NNS ,_, and_CC formal_JJ education_NN -RRB-_-RRB- ,_, which_WDT negatively_RB affects_VBZ public_JJ health-related_JJ knowledge_NN ,_, attitudes_NNS ,_, and_CC practices_NNS ._. 
However_RB ,_, the_DT epidemiologic_JJ data_NNS despite_IN their_PRP$ limitations_NNS 2_CD ,_, suggest_VBP that_IN the_DT relationship_NN between_IN conflict_NN and_CC HIV_NNP levels_NNS may_MD be_VB more_RBR complex_JJ than_IN this_DT general_JJ picture_NN of_IN joint_JJ potentiation_NN implies_VBZ ._. 
Those_DT who_WP had_VBD completed_VBN TB_NN treatment_NN before_IN the_DT outbreak_NN of_IN the_DT war_NN ,_, showed_VBD no_DT differential_JJ increase_NN in_IN mortality_NN 
Factor_NN 6_CD :_: Decreased_JJ use_NN of_IN means_NNS to_TO prevent_VB HIV_NNP transmission_NN The_DT isolation_NN and_CC poverty_NN caused_VBN by_IN war_NN often_RB results_VBZ in_IN decreased_VBN knowledge_NN of_IN ,_, and_CC access_NN to_TO ,_, means_VBZ to_TO prevent_VB HIV_NNP transmission_NN ._. 
Population_NNP probability_NN surveys_NNS available_JJ through_IN the_DT Demographic_NNP and_CC Health_NNP Surveys_NNS ,_, UNICEF_NNP 's_POS Multiple_NNP Indicator_NNP Surveys_NNS ,_, and_CC specialized_VBD HIV_NNP behavioral_JJ surveys_NNS show_VBP that_IN knowledge_NN levels_NNS and_CC condom_NN use_NN are_VBP quite_RB low_JJ in_IN conflict-affected_JJ countries_NNS and_CC that_IN they_PRP contrast_VBP with_IN regional_JJ and_CC sub-regional_JJ norms_NNS ,_, especially_RB in_IN cases_NNS of_IN protracted_JJ and_CC widespread_JJ conflict_NN ._. 
Depressed_JJ knowledge_NN levels_NNS reflect_VBP the_DT failure_NN of_IN mass_NN media_NNS campaigns_NNS ,_, formal_JJ education_NN ,_, and_CC literacy_NN and_CC clinic-based_JJ education_NN activities_NNS during_IN and_CC following_VBG conflict_NN ._. 
Another_DT trend_NN estimator_NN applies_VBZ the_DT median_JJ values_NNS of_IN the_DT quintile_NN groups_NNS ._. 
Usually_RB an_DT analysis_NN comparing_VBG each_DT quintile_JJ group_NN to_TO the_DT lowest_JJS -LRB-_-LRB- reference_NN -RRB-_-RRB- group_NN is_VBZ supplemented_VBN with_IN a_DT test_NN for_IN trend_NN for_IN the_DT quintile_JJ numbers_NNS ._. 
The_DT reason_NN for_IN categorizing_VBG the_DT exposure_NN could_MD be_VB to_TO obtain_VB analyses_NNS that_WDT require_VBP less_RBR stringent_JJ assumptions_NNS and_CC that_WDT are_VBP more_RBR robust_JJ to_TO outlying_JJ values_NNS 
We_PRP can_MD not_RB achieve_VB a_DT -RRB-_-RRB- using_VBG just_RB replicate_VB measures_NNS -LRB-_-LRB- without_IN further_JJ assumptions_NNS on_IN the_DT distribution_NN of_IN X_NNP -RRB-_-RRB- but_CC could_MD if_IN we_PRP had_VBD validation_NN data_NNS ._. 
For_IN example_NN ,_, Rosner_NNP 
This_DT implies_VBZ that_IN W_NNP contributes_VBZ no_DT new_JJ information_NN about_IN Y_NNP apart_RB from_IN what_WP is_VBZ already_RB in_IN X_NNP ._. 
,F_NNP -LRB-_-LRB- W_NNP |_NNP X_NNP ,_, Y_NNP -RRB-_-RRB- =_SYM F_NN -LRB-_-LRB- W_NNP |_NNP X_NNP -RRB-_-RRB- ._. 
The_DT idea_NN of_IN regression_NN calibration_NN is_VBZ to_TO predict_VB the_DT unobservable_JJ variable_JJ X_NNP by_IN means_NNS of_IN regression_NN ,_, and_CC then_RB to_TO include_VB this_DT predicted_VBD variable_JJ in_IN the_DT main_JJ analysis_NN ._. 
As_IN such_JJ ,_, it_PRP is_VBZ applicable_JJ to_TO any_DT regression_NN modelling_NN setting_NN ._. 
Extra_JJ information_NN needs_VBZ to_TO be_VB supplied_VBN in_IN order_NN to_TO relate_VB the_DT true_JJ variable_NN to_TO the_DT observed_JJ error-prone_JJ variable_NN ._. 
Usually_RB an_DT analysis_NN comparing_VBG each_DT quintile_JJ group_NN to_TO the_DT lowest_JJS -LRB-_-LRB- reference_NN -RRB-_-RRB- group_NN is_VBZ supplemented_VBN with_IN a_DT test_NN for_IN trend_NN for_IN the_DT quintile_JJ numbers_NNS ._. 
Another_DT trend_NN estimator_NN applies_VBZ the_DT median_JJ values_NNS of_IN the_DT quintile_JJ groups_NNS 
Usually_RB an_DT analysis_NN comparing_VBG each_DT quintile_JJ group_NN to_TO the_DT lowest_JJS -LRB-_-LRB- reference_NN -RRB-_-RRB- group_NN is_VBZ supplemented_VBN with_IN a_DT test_NN for_IN trend_NN for_IN the_DT quintile_JJ numbers_NNS ._. 
Another_DT trend_NN estimator_NN applies_VBZ the_DT median_JJ values_NNS of_IN the_DT quintile_JJ groups_NNS 
The_DT most_RBS well-known_JJ version_NN of_IN regression_NN calibration_NN is_VBZ the_DT one_NN developed_VBN for_IN continuous_JJ explanatory_JJ variables_NNS ._. 
However_RB ,_, in_IN epidemiological_JJ studies_NNS it_PRP is_VBZ also_RB common_JJ to_TO categorize_VB the_DT exposure_NN variables_NNS according_VBG to_TO rank_VB such_JJ as_IN quintiles_NNS ;_: a_DT selection_NN of_IN newer_JJR examples_NNS of_IN studies_NNS using_VBG this_DT approach_NN is_VBZ ._. 
Usually_RB an_DT analysis_NN comparing_VBG each_DT quintile_JJ group_NN to_TO the_DT lowest_JJS -LRB-_-LRB- reference_NN -RRB-_-RRB- group_NN is_VBZ supplemented_VBN with_IN a_DT test_NN for_IN trend_NN for_IN the_DT quintile_JJ numbers_NNS ._. 
This_DT implies_VBZ that_IN W_NNP contributes_VBZ no_DT new_JJ information_NN about_IN Y_NNP apart_RB from_IN what_WP is_VBZ already_RB in_IN X_NNP ._. 
,F_NNP -LRB-_-LRB- W_NNP |_NNP X_NNP ,_, Y_NNP -RRB-_-RRB- =_SYM F_NN -LRB-_-LRB- W_NNP |_NNP X_NNP -RRB-_-RRB- ._. 
The_DT idea_NN of_IN regression_NN calibration_NN is_VBZ to_TO predict_VB the_DT unobservable_JJ variable_JJ X_NNP by_IN means_NNS of_IN regression_NN ,_, and_CC then_RB to_TO include_VB this_DT predicted_VBD variable_JJ in_IN the_DT main_JJ analysis_NN ._. 
As_IN such_JJ ,_, it_PRP is_VBZ applicable_JJ to_TO any_DT regression_NN modelling_NN setting_NN ._. 
Extra_JJ information_NN needs_VBZ to_TO be_VB supplied_VBN in_IN order_NN to_TO relate_VB the_DT true_JJ variable_NN to_TO the_DT observed_JJ error-prone_JJ variable_NN ._. 
There_EX has_VBZ been_VBN extensive_JJ work_NN on_IN estimating_VBG the_DT distribution_NN of_IN X_NNP -LRB-_-LRB- see_VB 
To_TO achieve_VB b_NN -RRB-_-RRB- one_PRP can_MD try_VB to_TO estimate_VB the_DT underlying_VBG distribution_NN of_IN X_NNP ,_, and_CC its_PRP$ percentiles_NNS in_IN a_DT nonparametric_JJ way_NN using_VBG the_DT replicate_VB measures_NNS ._. 
There_EX has_VBZ been_VBN extensive_JJ work_NN on_IN estimating_VBG the_DT distribution_NN of_IN X_NNP -LRB-_-LRB- see_VB 
Recently_RB ,_, K_NNP 
For_IN example_NN ,_, Rosner_NNP suggested_VBD to_TO simply_RB treat_VB these_DT situations_NNS as_IN misclassification_NN problems_NNS ,_, using_VBG ordinal_JJ regression_NN procedures_NNS with_IN validation_NN data_NNS ._. 
Asimilar_JJ appr_NN 
We_PRP also_RB see_VBP that_IN the_DT tendency_NN of_IN the_DT naive_JJ approach_NN to_TO overestimate_VB the_DT effects_NNS of_IN Z_NN ,_, as_IN observed_VBN in_IN Table_NNP 3_CD ,_, is_VBZ continued_VBN here_RB ,_, and_CC now_RB the_DT RC_NNP estimates_NNS are_VBP also_RB affected_VBN ._. 
ExampleTo_NNS illustrate_VBP our_PRP$ results_NNS ,_, we_PRP use_VBP data_NNS on_IN non_JJ supplemental_JJ folate_NN intake_NN ,_, total_JJ energy_NN intake_NN and_CC self-reported_JJ depression_NN from_IN the_DT Norwegian_NNP Women_NNP and_CC Cancer_NNP -LRB-_-LRB- NOWAC_NNP -RRB-_-RRB- cohort_NN study_NN started_VBD in_IN 1991_CD ._. 
The_DT data_NNS were_VBD collected_VBN by_IN food_NN frequency_NN questionnaires_NNS -LRB-_-LRB- FFQs_NNS -RRB-_-RRB- ,_, and_CC we_PRP analyze_VBP a_DT sub_NN replication_NN study_NN in_IN which_WDT a_DT sample_NN of_IN the_DT cohort_NN were_VBD measured_VBN a_DT second_JJ time_NN ._. 
2._CD 
These_DT simulations_NNS were_VBD conducted_VBN using_VBG the_DT software_NN program_NN R_NNP version_NN 2_CD ._. 
Illustration_NN with_IN simulated_JJ data_NNS We_PRP simulated_JJ a_DT variety_NN of_IN situations_NNS to_TO obtain_VB numerical_JJ results_NNS regarding_VBG the_DT biases_NNS of_IN the_DT naive_JJ and_CC the_DT corrected_VBN effect_NN estimates_NNS ._. 
1,_CD in_IN which_WDT the_DT base_NN integrated_VBD routine_JJ for_IN general_JJ linear_JJ models_NNS was_VBD applied_VBN to_TO generated_VBN datasets_NNS of_IN size_NN n_NN =_SYM 100000_CD ._. 
The_DT true_JJ exposure_NN X_NNP and_CC the_DT response_NN Y_NNP were_VBD both_DT generated_VBN from_IN standard_JJ normal_JJ distributions_NNS ._. 
The_DT error_NN U_NNP was_VBD normally_RB distributed_VBN with_IN mean_JJ zero_NN and_CC variance_NN 
With_IN respect_NN to_TO standard_JJ errors_NNS for_IN the_DT RC_NNP corrected_VBD estimates_NNS ,_, these_DT will_MD be_VB underestimated_VBN by_IN ordinary_JJ methods_NNS as_IN they_PRP do_VBP not_RB take_VB into_IN account_NN the_DT variance_NN in_IN the_DT estimation_NN of_IN X_NNP ._. 
Since_IN the_DT computation_NN of_IN explicit_JJ formulas_NNS for_IN the_DT standard_JJ error_NN is_VBZ quite_RB tedious_JJ 
8-LRB-_CD modest_JJ measurement_NN error_NN situation_NN -RRB-_-RRB- ._. 
5,_CD and_CC 0_CD ._. 
2-LRB-_NN which_WDT corresponds_VBZ to_TO a_DT rather_RB large_JJ measurement_NN error_NN -RRB-_-RRB- ,_, 0_CD ._. 
Standard_JJ errors_NNS for_IN the_DT corrected_VBN effect_NN estimates_NNS are_VBP obtained_VBN via_IN resampling_VBG pairs_NNS bootstrapping_VBG with_IN 200_CD bootstrap_NN samples_NNS ._. 
Two_CD replication_NN patterns_NNS were_VBD studied_VBN ._. 
First_RB ,_, we_PRP simulated_JJ situations_NNS where_WRB all_DT individuals_NNS were_VBD measured_VBN twice_RB ,_, that_WDT is_VBZ k_NN i_FW =_SYM k_NN =_SYM 2_CD ._. 
Regression_NN calibration_NN was_VBD introduced_VBN to_TO the_DT epidemiologic_JJ community_NN by_IN Rosner_NNP et_FW al._FW ._. 
It_PRP has_VBZ also_RB been_VBN shown_VBN to_TO have_VB good_JJ properties_NNS in_IN many_JJ situations_NNS ._. 
This_DT implies_VBZ that_IN W_NNP contributes_VBZ no_DT new_JJ information_NN about_IN Y_NNP apart_RB from_IN what_WP is_VBZ already_RB in_IN X_NNP ._. 
,F_NNP -LRB-_-LRB- W_NNP |_NNP X_NNP ,_, Y_NNP -RRB-_-RRB- =_SYM F_NN -LRB-_-LRB- W_NNP |_NNP X_NNP -RRB-_-RRB- ._. 
The_DT idea_NN of_IN regression_NN calibration_NN is_VBZ to_TO predict_VB the_DT unobservable_JJ variable_JJ X_NNP by_IN means_NNS of_IN regression_NN ,_, and_CC then_RB to_TO include_VB this_DT predicted_VBD variable_JJ in_IN the_DT main_JJ analysis_NN ._. 
As_IN such_JJ ,_, it_PRP is_VBZ applicable_JJ to_TO any_DT regression_NN modelling_NN setting_NN ._. 
Extra_JJ information_NN needs_VBZ to_TO be_VB supplied_VBN in_IN order_NN to_TO relate_VB the_DT true_JJ variable_NN to_TO the_DT observed_JJ error-prone_JJ variable_NN ._. 
With_IN respect_NN to_TO standard_JJ errors_NNS for_IN the_DT RC_NNP corrected_VBD estimates_NNS ,_, these_DT will_MD be_VB underestimated_VBN by_IN ordinary_JJ methods_NNS as_IN they_PRP do_VBP not_RB take_VB into_IN account_NN the_DT variance_NN in_IN the_DT estimation_NN of_IN X_NNP ._. 
Since_IN the_DT computation_NN of_IN explicit_JJ formulas_NNS for_IN the_DT standard_JJ error_NN is_VBZ quite_RB tedious_JJ 
It_PRP is_VBZ also_RB possible_JJ to_TO apply_VB information_NN from_IN external_JJ sources_NNS ._. 
The_DT approach_NN involves_VBZ efforts_NNS to_TO somehow_RB relate_VB the_DT observed_JJ variable_NN to_TO the_DT underlying_VBG ``_`` true_JJ ''_'' variable_NN ,_, either_CC through_IN a_DT sub_NN validation_NN study_NN where_WRB the_DT true_JJ value_NN is_VBZ observed_VBN directly_RB for_IN some_DT of_IN the_DT individuals_NNS ,_, through_IN repeated_VBN measurements_NNS for_IN some_DT or_CC all_DT of_IN the_DT individuals_NNS ,_, or_CC by_IN use_NN of_IN so-called_JJ instrumental_JJ variables_NNS that_WDT supply_VBP information_NN about_IN the_DT true_JJ values_NNS relative_JJ to_TO the_DT measured_JJ values_NNS ._. 
Software_NNP for_IN performing_VBG regression_NN calibration_NN is_VBZ available_JJ in_IN STATA_NNP 
g._VB The_DT parameters_NNS in_IN -LRB-_-LRB- 1_CD -RRB-_-RRB- must_MD be_VB estimated_VBN from_IN the_DT data_NNS ,_, e._NN Equation_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- defines_VBZ the_DT RC_NNP predictor_NN for_IN the_DT error-prone_JJ exposure_NN X_NNP ._. 
as_IN described_VBN in_IN ,_, pages_NNS 47_CD 
It_PRP is_VBZ also_RB possible_JJ to_TO apply_VB information_NN from_IN external_JJ sources_NNS ._. 
The_DT approach_NN involves_VBZ efforts_NNS to_TO somehow_RB relate_VB the_DT observed_JJ variable_NN to_TO the_DT underlying_VBG ``_`` true_JJ ''_'' variable_NN ,_, either_CC through_IN a_DT sub_NN validation_NN study_NN where_WRB the_DT true_JJ value_NN is_VBZ observed_VBN directly_RB for_IN some_DT of_IN the_DT individuals_NNS ,_, through_IN repeated_VBN measurements_NNS for_IN some_DT or_CC all_DT of_IN the_DT individuals_NNS ,_, or_CC by_IN use_NN of_IN so-called_JJ instrumental_JJ variables_NNS that_WDT supply_VBP information_NN about_IN the_DT true_JJ values_NNS relative_JJ to_TO the_DT measured_JJ values_NNS ._. 
Software_NNP for_IN performing_VBG regression_NN calibration_NN is_VBZ available_JJ in_IN STATA_NNP 
For_IN this_DT reason_NN ,_, measurement_NN error_NN has_VBZ been_VBN the_DT subject_NN of_IN extensive_JJ research_NN over_IN the_DT recent_JJ decades_NNS ,_, and_CC several_JJ methods_NNS have_VBP been_VBN proposed_VBN for_IN handling_VBG the_DT problem_NN ._. 
In_IN linear_JJ models_NNS the_DT standard_JJ reference_NN is_VBZ 
In_IN linear_JJ models_NNS the_DT standard_JJ reference_NN is_VBZ 
i._NN 
Their_PRP$ mean_NN is_VBZ 
g._VB The_DT parameters_NNS in_IN -LRB-_-LRB- 1_CD -RRB-_-RRB- must_MD be_VB estimated_VBN from_IN the_DT data_NNS ,_, e._NN Equation_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- defines_VBZ the_DT RC_NNP predictor_NN for_IN the_DT error-prone_JJ exposure_NN X_NNP ._. 
as_IN described_VBN in_IN ,_, pages_NNS 47_CD 
With_IN respect_NN to_TO standard_JJ errors_NNS for_IN the_DT RC_NNP corrected_VBD estimates_NNS ,_, these_DT will_MD be_VB underestimated_VBN by_IN ordinary_JJ methods_NNS as_IN they_PRP do_VBP not_RB take_VB into_IN account_NN the_DT variance_NN in_IN the_DT estimation_NN of_IN X_NNP ._. 
Since_IN the_DT computation_NN of_IN explicit_JJ formulas_NNS for_IN the_DT standard_JJ error_NN is_VBZ quite_RB tedious_JJ 
-RRB-_-RRB- underestimates_NNS 
Regression_NN calibration_NN was_VBD introduced_VBN to_TO the_DT epidemiologic_JJ community_NN by_IN Rosner_NNP et_FW al._FW ._. 
It_PRP has_VBZ also_RB been_VBN shown_VBN to_TO have_VB good_JJ properties_NNS in_IN many_JJ situations_NNS ._. 
This_DT implies_VBZ that_IN W_NNP contributes_VBZ no_DT new_JJ information_NN about_IN Y_NNP apart_RB from_IN what_WP is_VBZ already_RB in_IN X_NNP ._. 
,F_NNP -LRB-_-LRB- W_NNP |_NNP X_NNP ,_, Y_NNP -RRB-_-RRB- =_SYM F_NN -LRB-_-LRB- W_NNP |_NNP X_NNP -RRB-_-RRB- ._. 
The_DT idea_NN of_IN regression_NN calibration_NN is_VBZ to_TO predict_VB the_DT unobservable_JJ variable_JJ X_NNP by_IN means_NNS of_IN regression_NN ,_, and_CC then_RB to_TO include_VB this_DT predicted_VBD variable_JJ in_IN the_DT main_JJ analysis_NN ._. 
As_IN such_JJ ,_, it_PRP is_VBZ applicable_JJ to_TO any_DT regression_NN modelling_NN setting_NN ._. 
Extra_JJ information_NN needs_VBZ to_TO be_VB supplied_VBN in_IN order_NN to_TO relate_VB the_DT true_JJ variable_NN to_TO the_DT observed_JJ error-prone_JJ variable_NN ._. 
It_PRP is_VBZ also_RB possible_JJ to_TO apply_VB information_NN from_IN external_JJ sources_NNS ._. 
The_DT approach_NN involves_VBZ efforts_NNS to_TO somehow_RB relate_VB the_DT observed_JJ variable_NN to_TO the_DT underlying_VBG ``_`` true_JJ ''_'' variable_NN ,_, either_CC through_IN a_DT sub_NN validation_NN study_NN where_WRB the_DT true_JJ value_NN is_VBZ observed_VBN directly_RB for_IN some_DT of_IN the_DT individuals_NNS ,_, through_IN repeated_VBN measurements_NNS for_IN some_DT or_CC all_DT of_IN the_DT individuals_NNS ,_, or_CC by_IN use_NN of_IN so-called_JJ instrumental_JJ variables_NNS that_WDT supply_VBP information_NN about_IN the_DT true_JJ values_NNS relative_JJ to_TO the_DT measured_JJ values_NNS ._. 
Software_NNP for_IN performing_VBG regression_NN calibration_NN is_VBZ available_JJ in_IN STATA_NNP 
The_DT most_RBS well-known_JJ version_NN of_IN regression_NN calibration_NN is_VBZ the_DT one_NN developed_VBN for_IN continuous_JJ explanatory_JJ variables_NNS ._. 
However_RB ,_, in_IN epidemiological_JJ studies_NNS it_PRP is_VBZ also_RB common_JJ to_TO categorize_VB the_DT exposure_NN variables_NNS according_VBG to_TO rank_VB such_JJ as_IN quintiles_NNS ;_: a_DT selection_NN of_IN newer_JJR examples_NNS of_IN studies_NNS using_VBG this_DT approach_NN is_VBZ ._. 
Usually_RB an_DT analysis_NN comparing_VBG each_DT quintile_JJ group_NN to_TO the_DT lowest_JJS -LRB-_-LRB- reference_NN -RRB-_-RRB- group_NN is_VBZ supplemented_VBN with_IN a_DT test_NN for_IN trend_NN for_IN the_DT quintile_JJ numbers_NNS ._. 
In_IN a_DT globalised_JJ world_NN in_IN which_WDT travel_NN and_CC migration_NN represent_VBP the_DT experience_NN of_IN a_DT large_JJ and_CC growing_VBG population_NN cohort_NN ,_, they_PRP can_MD be_VB expected_VBN to_TO assume_VB a_DT standard_JJ role_NN as_IN a_DT determination_NN factor_NN influencing_VBG many_JJ health_NN outcomes_NNS 
In_IN a_DT manner_NN similar_JJ to_TO age_NN ,_, sex_NN ,_, genetics_NNS ,_, biology_NN ,_, behavior_NN ,_, and_CC educational_JJ and_CC wealth_NN attainment_NN ,_, the_DT mobility_NN history_NN at_IN both_DT the_DT individual_NN and_CC population_NN levels_NNS will_MD need_VB to_TO become_VB a_DT routine_JJ consideration_NN in_IN healthcare_NN policy_NN ,_, planning_NN ,_, education_NN ,_, training_NN and_CC service_NN delivery_NN ._. 
Table_NNP 4Health_NNP policy_NN issues_NNS resulting_VBG from_IN international_JJ population_NN mobility_NN 
Table_NNP 4_CD Health_NNP policy_NN issues_NNS resulting_VBG from_IN international_JJ population_NN mobility_NN 
The_DT growing_VBG number_NN of_IN migrants_NNS of_IN diverse_JJ nature_NN is_VBZ bridging_VBG existing_VBG and_CC developing_VBG gaps_NNS in_IN health_NN outcome_NN indicators_NNS ._. 
The_DT dynamics_NNS of_IN migration_NN and_CC population_NN mobility_NN are_VBP evolving_VBG at_IN a_DT rate_NN that_WDT creates_VBZ health_NN challenges_NNS for_IN existing_VBG policy_NN and_CC program_NN frameworks_NNS that_WDT differ_VBP from_IN those_DT observed_VBN in_IN historic_JJ migratory_JJ movements_NNS ._. 
The_DT net_JJ result_NN is_VBZ an_DT ongoing_JJ globalisation_NN of_IN health_NN influences_NNS and_CC indicators_NNS currently_RB relevant_JJ at_IN both_DT national_JJ and_CC global_JJ level_NN ._. 
The_DT net_JJ result_NN is_VBZ an_DT ongoing_JJ globalisation_NN of_IN health_NN influences_NNS and_CC indicators_NNS currently_RB relevant_JJ at_IN both_DT national_JJ and_CC global_JJ level_NN ._. 
The_DT epidemiological_JJ impact_NN of_IN population_NN mobility_NN is_VBZ now_RB evident_JJ in_IN a_DT considerable_JJ amount_NN of_IN infectious_JJ disease_NN surveillance_NN information_NN 
The_DT net_JJ result_NN is_VBZ an_DT ongoing_JJ globalisation_NN of_IN health_NN influences_NNS and_CC indicators_NNS currently_RB relevant_JJ at_IN both_DT national_JJ and_CC global_JJ level_NN ._. 
The_DT epidemiological_JJ impact_NN of_IN population_NN mobility_NN is_VBZ now_RB evident_JJ in_IN a_DT considerable_JJ amount_NN of_IN infectious_JJ disease_NN surveillance_NN information_NN 
National_JJ control_NN and_CC regulatory_JJ systems_NNS alone_RB will_MD be_VB unable_JJ to_TO extend_VB their_PRP$ immediate_JJ mandate_NN or_CC authority_NN to_TO the_DT source_NN of_IN the_DT problem_NN ._. 
To_TO be_VB effective_JJ ,_, the_DT management_NN of_IN health_NN issues_NNS resulting_VBG from_IN population_NN mobility_NN will_MD require_VB an_DT integration_NN of_IN national_JJ and_CC global_JJ health_NN initiatives_NNS for_IN both_DT infectious_JJ 
National_JJ control_NN and_CC regulatory_JJ systems_NNS alone_RB will_MD be_VB unable_JJ to_TO extend_VB their_PRP$ immediate_JJ mandate_NN or_CC authority_NN to_TO the_DT source_NN of_IN the_DT problem_NN ._. 
To_TO be_VB effective_JJ ,_, the_DT management_NN of_IN health_NN issues_NNS resulting_VBG from_IN population_NN mobility_NN will_MD require_VB an_DT integration_NN of_IN national_JJ and_CC global_JJ health_NN initiatives_NNS for_IN both_DT infectious_JJ 
International_JJ organizations_NNS such_JJ as_IN the_DT United_NNP Nations_NNP High_NNP Commission_NNP for_IN Refugees_NNPS 
In_IN 1960_CD ,_, there_EX were_VBD approximately_RB 70_CD million_CD international_JJ journeys_NNS globally_RB ._. 
Growth_NN in_IN air_NN travel_NN has_VBZ functionally_RB reduced_VBN previous_JJ limits_NNS on_IN the_DT rapid_JJ international_JJ movement_NN of_IN large_JJ numbers_NNS of_IN individuals_NNS ._. 
The_DT number_NN of_IN similar_JJ international_JJ journeys_NNS in_IN 2004_CD was_VBD in_IN excess_NN of_IN 760_CD million_CD ._. 
The_DT high_JJ volume_NN of_IN international_JJ travel_NN supports_VBZ greater_JJR population_NN exchange_NN and_CC return_NN flows_NNS between_IN migrant_JJ origin_NN and_CC destination_NN locations_NNS ._. 
1to_CD 5_CD ._. 
1\/100_CD ,000_CD -RRB-_-RRB- and_CC 84_CD %_NN for_IN women_NNS -LRB-_-LRB- from_IN 34_CD ._. 
6to_CD 4_CD ._. 
During_IN the_DT interval_NN between_IN 1984_CD and_CC 1999_CD ,_, the_DT age-adjusted_JJ mortality_NN for_IN hypertensive_JJ cardiac_JJ disease_NN in_IN Korean_JJ men_NNS decreased_VBN by_IN 92_CD %_NN -LRB-_-LRB- from_IN 51_CD ._. 
3\/100_CD ,000_CD -RRB-_-RRB- 
3\/100_CD ,000_CD -RRB-_-RRB- ._. 
1to_CD 5_CD ._. 
1\/100_CD ,000_CD -RRB-_-RRB- and_CC 84_CD %_NN for_IN women_NNS -LRB-_-LRB- from_IN 34_CD ._. 
6to_CD 4_CD ._. 
During_IN the_DT interval_NN between_IN 1984_CD and_CC 1999_CD ,_, the_DT age-adjusted_JJ mortality_NN for_IN hypertensive_JJ cardiac_JJ disease_NN in_IN Korean_JJ men_NNS decreased_VBN by_IN 92_CD %_NN -LRB-_-LRB- from_IN 51_CD ._. 
By_IN contrast_NN ,_, examples_NNS of_IN diminishing_VBG levels_NNS of_IN good_JJ health_NN indicators_NNS can_MD be_VB observed_VBN in_IN some_DT Central_JJ and_CC Eastern_JJ European_JJ nations_NNS in_IN the_DT period_NN following_VBG the_DT dissolution_NN of_IN the_DT Soviet_NNP Union_NNP 
1years_NNS -RRB-_-RRB- 
Basic_JJ public_JJ health_NN improvements_NNS such_JJ as_IN the_DT provision_NN of_IN adequate_JJ ,_, safe_JJ drinking_NN water_NN ,_, improved_VBN sewerage_NN and_CC housing_NN can_MD significantly_RB reduce_VB the_DT incidence_NN and_CC prevalence_NN of_IN diseases_NNS of_IN major_JJ public_JJ health_NN importance_NN in_IN the_DT space_NN of_IN less_JJR than_IN a_DT generation_NN 
Unlike_IN refugee_NN movements_NNS before_IN the_DT Second_NNP World_NNP War_NNP that_WDT were_VBD often_RB passive_JJ ,_, modern_JJ international_JJ attention_NN and_CC efforts_NNS are_VBP frequently_RB directed_VBN at_IN assisting_VBG the_DT international_JJ relocation_NN of_IN vulnerable_JJ migrant_JJ populations_NNS ._. 
International_JJ organizations_NNS such_JJ as_IN the_DT United_NNP Nations_NNP High_NNP Commission_NNP for_IN Refugees_NNPS 
Unlike_IN refugee_NN movements_NNS before_IN the_DT Second_NNP World_NNP War_NNP that_WDT were_VBD often_RB passive_JJ ,_, modern_JJ international_JJ attention_NN and_CC efforts_NNS are_VBP frequently_RB directed_VBN at_IN assisting_VBG the_DT international_JJ relocation_NN of_IN vulnerable_JJ migrant_JJ populations_NNS ._. 
International_JJ organizations_NNS such_JJ as_IN the_DT United_NNP Nations_NNP High_NNP Commission_NNP for_IN Refugees_NNPS 
As_IN a_DT result_NN of_IN these_DT events_NNS ,_, between_IN 1960_CD and_CC 2000_CD the_DT legal_JJ and_CC administrative_JJ restrictions_NNS on_IN the_DT ability_NN to_TO travel_VB ,_, work_VB and_CC move_VB internationally_RB have_VBP changed_VBN for_IN hundreds_NNS of_IN millions_NNS of_IN individuals_NNS ._. 
This_DT has_VBZ been_VBN associated_VBN with_IN a_DT profound_JJ shift_NN in_IN the_DT demography_NN of_IN people_NNS on_IN the_DT move_NN and_CC the_DT nature_NN of_IN migration_NN itself_PRP 
This_DT has_VBZ been_VBN associated_VBN with_IN a_DT profound_JJ shift_NN in_IN the_DT demography_NN of_IN people_NNS on_IN the_DT move_NN and_CC the_DT nature_NN of_IN migration_NN itself_PRP 
Addressing_VBG these_DT challenges_NNS at_IN the_DT national_JJ level_NN will_MD require_VB some_DT changes_NNS in_IN the_DT epidemiological_JJ context_NN that_WDT is_VBZ applied_VBN to_TO prospective_JJ policy_NN development_NN and_CC program_NN management_NN -LRB-_-LRB- see_VB table_NN 4_CD -RRB-_-RRB- ._. 
In_IN a_DT globalised_JJ world_NN in_IN which_WDT travel_NN and_CC migration_NN represent_VBP the_DT experience_NN of_IN a_DT large_JJ and_CC growing_VBG population_NN cohort_NN ,_, they_PRP can_MD be_VB expected_VBN to_TO assume_VB a_DT standard_JJ role_NN as_IN a_DT determination_NN factor_NN influencing_VBG many_JJ health_NN outcomes_NNS 
The_DT influence_NN of_IN genetic_JJ and_CC biological_JJ factors_NNS in_IN health_NN and_CC disease_NN will_MD increase_VB in_IN parallel_NN with_IN the_DT size_NN of_IN diverse_JJ migrant_JJ populations_NNS ._. 
At_IN the_DT same_JJ time_NN ,_, the_DT impact_NN and_CC influence_NN of_IN the_DT health_NN environment_NN and_CC epidemiology_NN of_IN disease_NN at_IN the_DT migrants_NNS '_POS place_NN of_IN origin_NN will_MD continue_VB to_TO be_VB reflected_VBN in_IN both_DT migrants_NNS and_CC the_DT children_NNS of_IN migrant_JJ parents_NNS long_RB after_IN the_DT period_NN of_IN immigration_NN ._. 
Addressing_VBG these_DT challenges_NNS at_IN the_DT national_JJ level_NN will_MD require_VB some_DT changes_NNS in_IN the_DT epidemiological_JJ context_NN that_WDT is_VBZ applied_VBN to_TO prospective_JJ policy_NN development_NN and_CC program_NN management_NN -LRB-_-LRB- see_VB table_NN 4_CD -RRB-_-RRB- ._. 
Some_DT nations_NNS with_IN large_JJ immigration_NN medical_JJ programs_NNS maintain_VBP specific_JJ screening_NN or_CC intervention_NN programs_NNS for_IN targeted_JJ diseases_NNS such_JJ as_IN tuberculosis_NN ,_, syphilis_NN and_CC HIV\/AIDS_NN ._. 
Accumulating_VBG evidence_NN suggests_VBZ that_IN more_JJR effective_JJ outcomes_NNS could_MD be_VB obtained_VBN through_IN interventions_NNS focused_VBN on_IN disease_NN control_NN efforts_NNS in_IN source_NN nations_NNS rather_RB than_IN reliance_NN on_IN arrival_NN screening_VBG alone_RB ._. 
The_DT globalisation_NN of_IN risks_NNS 
Demand_NN for_IN these_DT services_NNS will_MD remain_VB in_IN some_DT locations_NNS due_JJ to_TO specific_JJ situational_JJ issues_NNS or_CC particular_JJ migratory_JJ movements_NNS ._. 
Nationally_RB mandated_VBN immigration_NN health_NN screening_NN 
Demand_NN for_IN these_DT services_NNS will_MD remain_VB in_IN some_DT locations_NNS due_JJ to_TO specific_JJ situational_JJ issues_NNS or_CC particular_JJ migratory_JJ movements_NNS ._. 
Nationally_RB mandated_VBN immigration_NN health_NN screening_NN 
At_IN the_DT same_JJ time_NN ,_, current_JJ regional_JJ and_CC global_JJ health_NN disparities_NNS are_VBP anticipated_VBN to_TO remain_VB or_CC increase_VB ,_, despite_IN the_DT international_JJ desire_NN and_CC efforts_NNS to_TO reduce_VB them_PRP ._. 
Global_JJ efforts_NNS aimed_VBN at_IN reducing_VBG global_JJ disparities_NNS and_CC impacts_NNS of_IN disease_NN and_CC ill_JJ health_NN ,_, such_JJ as_IN attempts_NNS to_TO achieve_VB the_DT Millennium_NNP Development_NNP Goals_NNP ,_, are_VBP currently_RB underway_JJ ._. 
These_DT are_VBP long-term_JJ initiatives_NNS that_WDT will_MD take_VB time_NN ,_, resources_NNS and_CC extensive_JJ effort_NN to_TO achieve_VB and_CC maintain_VB ._. 
In_IN several_JJ western_JJ nations_NNS ,_, migrants_NNS and_CC other_JJ mobile_JJ populations_NNS represent_VBP sizeable_JJ and_CC growing_VBG population_NN sectors_NNS ._. 
Over_IN time_NN ,_, the_DT specific_JJ health_NN needs_NNS and_CC characteristics_NNS of_IN these_DT mobile_JJ population_NN cohorts_NNS will_MD exert_VB greater_JJR influence_NN on_IN the_DT health_NN sector_NN in_IN the_DT receiving_VBG host_NN nations_NNS ._. 
The_DT influence_NN of_IN genetic_JJ and_CC biological_JJ factors_NNS in_IN health_NN and_CC disease_NN will_MD increase_VB in_IN parallel_NN with_IN the_DT size_NN of_IN diverse_JJ migrant_JJ populations_NNS ._. 
Some_DT of_IN these_DT activities_NNS are_VBP represented_VBN by_IN the_DT internationalisation_NN of_IN epidemiological_JJ surveillance_NN ,_, reporting_NN and_CC response_NN reflected_VBN in_IN the_DT recent_JJ revisions_NNS to_TO the_DT International_NNP Health_NNP Regulations_NNPS 
International_JJ collaboration_NN is_VBZ underway_JJ to_TO track_VB and_CC monitor_VB disease_NN in_IN the_DT global_JJ context_NN ._. 
Global_JJ response_NN initiatives_NNS have_VBP been_VBN designed_VBN ,_, and_CC in_IN some_DT cases_NNS implemented_VBD ,_, primarily_RB as_IN a_DT result_NN of_IN concerns_NNS regarding_VBG the_DT potential_JJ adverse_JJ population_NN health_NN outcomes_NNS posed_VBN by_IN certain_JJ infectious_JJ disease_NN threats_NNS ._. 
Some_DT of_IN these_DT activities_NNS are_VBP represented_VBN by_IN the_DT internationalisation_NN of_IN epidemiological_JJ surveillance_NN ,_, reporting_NN and_CC response_NN reflected_VBN in_IN the_DT recent_JJ revisions_NNS to_TO the_DT International_NNP Health_NNP Regulations_NNPS 
The_DT globalisation_NN of_IN risks_NNS 
Social_NNP and_CC economic_JJ influences_NNS can_MD be_VB significant_JJ factors_NNS in_IN the_DT creation_NN and_CC maintenance_NN of_IN differences_NNS in_IN health_NN and_CC disease_NN outcomes_NNS between_IN populations_NNS ._. 
Poverty_NN ,_, education_NN ,_, housing_NN and_CC nutrition_NN are_VBP directly_RB related_VBN to_TO disease_NN prevalence_NN and_CC illness_NN outcomes_NNS 
Examples_NNS of_IN environmentally-limited_JJ diseases_NNS include_VBP vector-borne_JJ conditions_NNS ,_, for_IN which_WDT environmental_JJ factors_NNS determine_VBP the_DT distribution_NN of_IN disease_NN transmission_NN ,_, as_IN observed_VBN in_IN the_DT global_JJ epidemiology_NN of_IN malaria_NN ,_, Chagas_NNP '_POS disease_NN ,_, yellow_JJ fever_NN and_CC West_NNP Nile_NNP Virus_NNP ._. 
Environmentally-related_JJ non-communicable_JJ disease_NN epidemiological_JJ disparities_NNS include_VBP micronutrient_NN deficiencies_NNS 
Examples_NNS of_IN environmentally-limited_JJ diseases_NNS include_VBP vector-borne_JJ conditions_NNS ,_, for_IN which_WDT environmental_JJ factors_NNS determine_VBP the_DT distribution_NN of_IN disease_NN transmission_NN ,_, as_IN observed_VBN in_IN the_DT global_JJ epidemiology_NN of_IN malaria_NN ,_, Chagas_NNP '_POS disease_NN ,_, yellow_JJ fever_NN and_CC West_NNP Nile_NNP Virus_NNP ._. 
Environmentally-related_JJ non-communicable_JJ disease_NN epidemiological_JJ disparities_NNS include_VBP micronutrient_NN deficiencies_NNS 
In_IN other_JJ situations_NNS ,_, differences_NNS in_IN health_NN outcomes_NNS ,_, and_CC the_DT factors_NNS that_WDT determine_VBP or_CC influence_VBP health_NN outcomes_NNS ,_, result_NN from_IN more_JJR complex_JJ interactions_NNS ._. 
The_DT environment_NN ,_, socio-economics_NNS ,_, genetics_NNS and_CC biology_NN ,_, and_CC behavioural_JJ factors_NNS influence_NN population_NN measurements_NNS of_IN disease_NN prevalence_NN individually_RB and_CC in_IN combination_NN ._. 
Examples_NNS of_IN environmentally-limited_JJ diseases_NNS include_VBP vector-borne_JJ conditions_NNS ,_, for_IN which_WDT environmental_JJ factors_NNS determine_VBP the_DT distribution_NN of_IN disease_NN transmission_NN ,_, as_IN observed_VBN in_IN the_DT global_JJ epidemiology_NN of_IN malaria_NN ,_, Chagas_NNP '_POS disease_NN ,_, yellow_JJ fever_NN and_CC West_NNP Nile_NNP Virus_NNP ._. 
This_DT context_NN is_VBZ important_JJ in_IN the_DT consideration_NN of_IN illnesses_NNS and_CC diseases_NNS with_IN long_JJ latency_NN or_CC delayed_VBN diagnostic_JJ time_NN 
Evaluating_VBG the_DT migration_NN and_CC mobility_NN history_NN of_IN populations_NNS has_VBZ the_DT additional_JJ advantage_NN of_IN supporting_VBG longitudinal_JJ analysis_NN of_IN health_NN characteristics_NNS ._. 
This_DT context_NN is_VBZ important_JJ in_IN the_DT consideration_NN of_IN illnesses_NNS and_CC diseases_NNS with_IN long_JJ latency_NN or_CC delayed_VBN diagnostic_JJ time_NN 
Such_JJ methodologies_NNS are_VBP already_RB in_IN use_NN in_IN the_DT health_NN sector_NN ._. 
Use_NN of_IN this_DT approach_NN supports_VBZ the_DT examination_NN of_IN the_DT issues_NNS from_IN a_DT global_JJ perspective_NN ._. 
The_DT Global_NNP Fund_NNP approach_NN to_TO tuberculosis_NN ,_, malaria_NN and_CC HIV_NNP similarly_RB represents_VBZ an_DT integrated_JJ ,_, inter-regional_JJ action_NN plan_NN in_IN the_DT face_NN of_IN persistent_JJ global_JJ health_NN challenges_NNS ._. 
As_IN presented_VBN below_IN ,_, considering_VBG migration-relevant_JJ diseases_NNS in_IN terms_NNS of_IN population-based_JJ risk_NN may_MD be_VB more_RBR relevant_JJ to_TO disease_NN control_NN programs_NNS than_IN time-of-entry_JJ screening_NN for_IN individual_JJ conditions_NNS ._. 
Apopulation_NNP health-based_JJ approach_NN considers_VBZ the_DT relationship_NN between_IN migration_NN and_CC health_NN as_IN a_DT progressive_JJ ,_, interactive_JJ process_NN influenced_VBN by_IN temporal_JJ and_CC local_JJ variables_NNS ._. 
The_DT observations_NNS are_VBP less_RBR related_JJ to_TO the_DT administrative_JJ mechanics_NNS of_IN migration_NN and_CC more_RBR sensitive_JJ to_TO the_DT driving_NN forces_NNS that_WDT cause_VBP people_NNS to_TO migrate_VB ._. 
Apopulation-based_JJ approach_NN also_RB facilitates_VBZ the_DT consideration_NN and_CC study_NN of_IN the_DT long-term_JJ consequences_NNS of_IN movement_NN between_IN locations_NNS with_IN different_JJ health_NN determinants_NNS and_CC health_NN outcomes_NNS ._. 
As_IN a_DT consequence_NN of_IN this_DT more_RBR diverse_JJ demographic_JJ and_CC fluid_JJ environment_NN ,_, the_DT perspectives_NNS derived_VBD solely_RB from_IN traditional_JJ immigrant_JJ medical_JJ screening_NN practices_NNS may_MD be_VB limited_VBN ._. 
These_DT limitations_NNS may_MD be_VB overcome_VBN by_IN applying_VBG population_NN health_NN principles_NNS to_TO the_DT study_NN of_IN migration_NN ,_, a_DT process_NN that_WDT may_MD result_VB in_IN observations_NNS that_WDT are_VBP more_RBR applicable_JJ to_TO immigration_NN health_NN policy_NN and_CC program_NN development_NN ._. 
Apopulation_NNP health-based_JJ approach_NN considers_VBZ the_DT relationship_NN between_IN migration_NN and_CC health_NN as_IN a_DT progressive_JJ ,_, interactive_JJ process_NN influenced_VBN by_IN temporal_JJ and_CC local_JJ variables_NNS ._. 
As_IN migrant_JJ demographics_NNS often_RB vary_VBP between_IN receiving_VBG nations_NNS ,_, international_JJ comparisons_NNS involving_VBG the_DT pooled_VBN analysis_NN of_IN several_JJ host_NN nations_NNS would_MD be_VB challenging_JJ in_IN interpretation_NN and_CC of_IN questionable_JJ utility_NN ._. 
However_RB ,_, interest_NN in_IN the_DT global_JJ implications_NNS of_IN the_DT epidemiological_JJ aspects_NNS of_IN migration_NN is_VBZ growing_VBG ._. 
The_DT increasing_VBG desire_NN for_IN improved_VBN information_NN is_VBZ ,_, however_RB ,_, complicated_VBN by_IN the_DT greater_JJR diversity_NN now_RB manifest_JJ in_IN modern_JJ migrant_JJ populations_NNS ._. 
The_DT epidemiological_JJ analysis_NN of_IN illnesses_NNS and_CC disease_NN in_IN migrants_NNS is_VBZ most_RBS commonly_RB approached_VBN in_IN one_CD of_IN two_CD ways_NNS in_IN receiving_VBG countries_NNS ._. 
The_DT first_JJ is_VBZ to_TO consider_VB the_DT health_NN issue_NN of_IN concern_NN in_IN terms_NNS of_IN the_DT status_NN at_IN the_DT time_NN of_IN migration_NN ,_, while_IN the_DT second_NN is_VBZ to_TO study_VB the_DT evolution_NN of_IN the_DT health_NN characteristic_NN over_IN time_NN ._. 
The_DT reference_NN population_NN for_IN the_DT first_JJ analytical_JJ approach_NN is_VBZ normally_RB the_DT host_NN or_CC receiving_VBG population_NN ,_, while_IN the_DT reference_NN group_NN for_IN the_DT second_JJ approach_NN can_MD be_VB either_CC the_DT host_NN population_NN or_CC a_DT comparison_NN cohort_NN at_IN the_DT migrants_NNS '_POS place_NN of_IN origin_NN -LRB-_-LRB- see_VB table_NN 1_CD -RRB-_-RRB- ._. 
The_DT reference_NN population_NN for_IN the_DT first_JJ analytical_JJ approach_NN is_VBZ normally_RB the_DT host_NN or_CC receiving_VBG population_NN ,_, while_IN the_DT reference_NN group_NN for_IN the_DT second_JJ approach_NN can_MD be_VB either_CC the_DT host_NN population_NN or_CC a_DT comparison_NN cohort_NN at_IN the_DT migrants_NNS '_POS place_NN of_IN origin_NN -LRB-_-LRB- see_VB table_NN 1_CD -RRB-_-RRB- ._. 
Table_NNP 1Epidemiological_NNP approaches_VBZ to_TO health_NN and_CC migrationTime_NNP PeriodEpidemiological_NNP CharacteristicReference_NNP PopulationArrival_NNP Phase_NN -LRB-_-LRB- Point_NNP Prevalence_NNP -RRB-_-RRB- PrevalenceHost\/Receiving_NNP populationPost_NNP Arrival_NNP Phase_NN -LRB-_-LRB- Point_NNP Prevalence_NNP or_CC Longitudinal_NNP Studies_NNP -RRB-_-RRB- Incidence\/PrevalenceSimilar_NNP non-migrating_JJ cohort_NN at_IN migrants_NNS '_POS place_NN of_IN originHost\/Receiving_VBG populationThe_JJ quarantine-associated_JJ historical_JJ basis_NN of_IN migration_NN health_NN practices_NNS has_VBZ ensured_VBN that_IN much_JJ of_IN the_DT interest_NN in_IN health_NN and_CC migration_NN has_VBZ been_VBN directed_VBN towards_IN communicable_JJ diseases_NNS 
Table_NNP 1_CD Epidemiological_NNP approaches_NNS to_TO health_NN and_CC migration_NN Time_NNP Period_NNP Epidemiological_NNP Characteristic_NNP Reference_NNP Population_NNP Arrival_NNP Phase_NN -LRB-_-LRB- Point_NNP Prevalence_NNP -RRB-_-RRB- Prevalence_NNP Host\/Receiving_NNP population_NN Post_NNP Arrival_NNP Phase_NN -LRB-_-LRB- Point_NNP Prevalence_NNP or_CC Longitudinal_NNP Studies_NNP -RRB-_-RRB- Incidence\/Prevalence_NNP Similar_JJ non-migrating_JJ cohort_NN at_IN migrants_NNS '_POS place_NN of_IN origin_NN Host\/Receiving_VBG population_NN The_DT quarantine-associated_JJ historical_JJ basis_NN of_IN migration_NN health_NN practices_NNS has_VBZ ensured_VBN that_IN much_JJ of_IN the_DT interest_NN in_IN health_NN and_CC migration_NN has_VBZ been_VBN directed_VBN towards_IN communicable_JJ diseases_NNS 
Table_NNP 1_CD Epidemiological_NNP approaches_NNS to_TO health_NN and_CC migration_NN Time_NNP Period_NNP Epidemiological_NNP Characteristic_NNP Reference_NNP Population_NNP Arrival_NNP Phase_NN -LRB-_-LRB- Point_NNP Prevalence_NNP -RRB-_-RRB- Prevalence_NNP Host\/Receiving_NNP population_NN Post_NNP Arrival_NNP Phase_NN -LRB-_-LRB- Point_NNP Prevalence_NNP or_CC Longitudinal_NNP Studies_NNP -RRB-_-RRB- Incidence\/Prevalence_NNP Similar_JJ non-migrating_JJ cohort_NN at_IN migrants_NNS '_POS place_NN of_IN origin_NN Host\/Receiving_VBG population_NN The_DT quarantine-associated_JJ historical_JJ basis_NN of_IN migration_NN health_NN practices_NNS has_VBZ ensured_VBN that_IN much_JJ of_IN the_DT interest_NN in_IN health_NN and_CC migration_NN has_VBZ been_VBN directed_VBN towards_IN communicable_JJ diseases_NNS 
The_DT implications_NNS for_IN national_JJ and_CC international_JJ health_NN policy_NN and_CC program_NN planning_NN are_VBP presented_VBN ._. 
This_DT paper_NN reviews_VBZ the_DT epidemiological_JJ relationships_NNS resulting_VBG from_IN health_NN disparities_NNS bridged_VBN by_IN migration_NN and_CC describes_VBZ the_DT growing_VBG role_NN of_IN migration_NN and_CC population_NN mobility_NN in_IN global_JJ disease_NN epidemiology_NN ._. 
IntroductionThe_JJ relationships_NNS between_IN disease_NN ,_, travel_NN and_CC migration_NN have_VBP historical_JJ roots_NNS that_WDT continue_VBP to_TO influence_VB modern_JJ medical_JJ activities_NNS 
Introduction_NN The_DT relationships_NNS between_IN disease_NN ,_, travel_NN and_CC migration_NN have_VBP historical_JJ roots_NNS that_WDT continue_VBP to_TO influence_VB modern_JJ medical_JJ activities_NNS 
These_DT activities_NNS have_VBP often_RB been_VBN based_VBN on_IN the_DT principles_NNS of_IN protecting_VBG the_DT recipient_JJ population_NN through_IN policies_NNS of_IN exclusion_NN directed_VBN at_IN the_DT migrant_NN or_CC arriving_VBG traveller_NN ._. 
Derived_VBN from_IN the_DT historical_JJ practices_NNS of_IN quarantine_NN ,_, similar_JJ processes_NNS continue_VBP in_IN a_DT modern_JJ context_NN through_IN immigration_NN medical_JJ screening_NN and_CC border_NN control_NN practices_NNS intended_VBN to_TO reduce_VB threats_NNS to_TO public_JJ health_NN or_CC to_TO mitigate_VB potential_JJ impacts_NNS on_IN healthcare_NN services_NNS ._. 
The_DT epidemiological_JJ analysis_NN of_IN illnesses_NNS and_CC disease_NN in_IN migrants_NNS is_VBZ most_RBS commonly_RB approached_VBN in_IN one_CD of_IN two_CD ways_NNS in_IN receiving_VBG countries_NNS ._. 
Table_NNP 1_CD Epidemiological_NNP approaches_NNS to_TO health_NN and_CC migration_NN Time_NNP Period_NNP Epidemiological_NNP Characteristic_NNP Reference_NNP Population_NNP Arrival_NNP Phase_NN -LRB-_-LRB- Point_NNP Prevalence_NNP -RRB-_-RRB- Prevalence_NNP Host\/Receiving_NNP population_NN Post_NNP Arrival_NNP Phase_NN -LRB-_-LRB- Point_NNP Prevalence_NNP or_CC Longitudinal_NNP Studies_NNP -RRB-_-RRB- Incidence\/Prevalence_NNP Similar_JJ non-migrating_JJ cohort_NN at_IN migrants_NNS '_POS place_NN of_IN origin_NN Host\/Receiving_VBG population_NN The_DT quarantine-associated_JJ historical_JJ basis_NN of_IN migration_NN health_NN practices_NNS has_VBZ ensured_VBN that_IN much_JJ of_IN the_DT interest_NN in_IN health_NN and_CC migration_NN has_VBZ been_VBN directed_VBN towards_IN communicable_JJ diseases_NNS 
Recently_RB ,_, the_DT growing_VBG international_JJ importance_NN of_IN migration_NN has_VBZ stimulated_VBN new_JJ interest_NN in_IN other_JJ aspects_NNS of_IN migrant_JJ health_NN ._. 
In_IN addition_NN to_TO communicable_JJ diseases_NNS ,_, attention_NN is_VBZ now_RB focused_VBN on_IN pre-existing_JJ non-infectious_JJ diseases_NNS 
Additional_JJ factors_NNS that_WDT influence_VBP health_NN risks_NNS and_CC outcomes_NNS include_VBP language_NN skills_NNS 
These_DT factors_NNS result_VBP from_IN the_DT process_NN of_IN migration_NN itself_PRP ,_, for_IN example_NN ,_, during_IN the_DT travel_NN phase_NN between_IN origin_NN and_CC destination_NN ._. 
This_DT is_VBZ frequently_RB observed_VBN in_IN refugees_NNS ,_, displaced_VBN persons_NNS and_CC disadvantaged_JJ migrant_JJ populations_NNS such_JJ as_IN trafficked_JJ or_CC smuggled_JJ persons_NNS 
The_DT capacities_NNS and_CC capabilities_NNS of_IN medical_JJ and_CC health_NN sectors_NNS can_MD affect_VB health_NN through_IN the_DT availability_NN ,_, accessibility_NN 
The_DT capacities_NNS and_CC capabilities_NNS of_IN medical_JJ and_CC health_NN sectors_NNS can_MD affect_VB health_NN through_IN the_DT availability_NN ,_, accessibility_NN 
The_DT capacities_NNS and_CC capabilities_NNS of_IN medical_JJ and_CC health_NN sectors_NNS can_MD affect_VB health_NN through_IN the_DT availability_NN ,_, accessibility_NN 
Additional_JJ factors_NNS that_WDT influence_VBP health_NN risks_NNS and_CC outcomes_NNS include_VBP language_NN skills_NNS 
Poverty_NN ,_, education_NN ,_, housing_NN and_CC nutrition_NN are_VBP directly_RB related_VBN to_TO disease_NN prevalence_NN and_CC illness_NN outcomes_NNS 
Poverty_NN ,_, education_NN ,_, housing_NN and_CC nutrition_NN are_VBP directly_RB related_VBN to_TO disease_NN prevalence_NN and_CC illness_NN outcomes_NNS 
Poverty_NN ,_, education_NN ,_, housing_NN and_CC nutrition_NN are_VBP directly_RB related_VBN to_TO disease_NN prevalence_NN and_CC illness_NN outcomes_NNS 
The_DT capacities_NNS and_CC capabilities_NNS of_IN medical_JJ and_CC health_NN sectors_NNS can_MD affect_VB health_NN through_IN the_DT availability_NN ,_, accessibility_NN 
This_DT can_MD result_VB in_IN a_DT heightened_JJ perception_NN of_IN threat_NN to_TO the_DT public_JJ health_NN of_IN the_DT local_JJ population_NN and_CC increase_NN concerns_NNS regarding_VBG capacity_NN and_CC response_NN of_IN healthcare_NN service_NN delivery_NN ._. 
Recent_JJ examples_NNS of_IN this_DT include_VBP the_DT global_JJ public_JJ health_NN control_NN efforts_NNS resulting_VBG from_IN the_DT 2003_CD SARS_NNP events_NNS 
This_DT can_MD result_VB in_IN a_DT heightened_JJ perception_NN of_IN threat_NN to_TO the_DT public_JJ health_NN of_IN the_DT local_JJ population_NN and_CC increase_NN concerns_NNS regarding_VBG capacity_NN and_CC response_NN of_IN healthcare_NN service_NN delivery_NN ._. 
Recent_JJ examples_NNS of_IN this_DT include_VBP the_DT global_JJ public_JJ health_NN control_NN efforts_NNS resulting_VBG from_IN the_DT 2003_CD SARS_NNP events_NNS 
In_IN considering_VBG migration_NN in_IN a_DT population_NN health_NN context_NN ,_, it_PRP is_VBZ important_JJ to_TO note_VB that_IN not_RB all_DT of_IN the_DT migration-associated_JJ epidemiological_JJ changes_NNS relate_VBP to_TO situations_NNS where_WRB the_DT migrants_NNS are_VBP less_RBR advantaged_JJ than_IN the_DT host_NN population_NN ._. 
In_IN terms_NNS of_IN lifestyle-related_JJ non-infectious_JJ illnesses_NNS ,_, many_JJ migrants_NNS and_CC new_JJ arrivals_NNS display_VBP health_NN parameters_NNS that_WDT are_VBP better_JJR than_IN those_DT of_IN the_DT receiving_NN population_NN 
Similar_JJ differences_NNS in_IN availability_NN can_MD be_VB observed_VBN for_IN smoking_NN and_CC substance_NN abuse_NN prevention_NN programs_NNS ,_, programs_NNS to_TO detect_VB and_CC manage_VB vitamin_NN or_CC micronutrient_NN deficiencies_NNS ,_, promotion_NN of_IN dental_JJ health_NN and_CC programs_NNS to_TO manage_VB genetic_JJ or_CC biological_JJ conditions_NNS 
Temporal_JJ effects_NNS of_IN migration_NN on_IN local_JJ health_NN and_CC disease_NN epidemiology_NN Migration-associated_JJ influences_NNS on_IN the_DT epidemiology_NN of_IN disease_NN have_VBP both_DT immediate_JJ and_CC long-term_JJ effects_NNS on_IN host_NN country_NN health_NN indicators_NNS due_JJ to_TO differentials_NNS in_IN disease_NN prevalence_NN ,_, as_RB well_RB as_IN magnitude_NN factors_NNS associated_VBN with_IN population_NN census_NN shifts_NNS -LRB-_-LRB- because_IN of_IN the_DT number_NN of_IN migrants_NNS and_CC births_NNS to_TO the_DT foreign-born_JJ cohort_NN -RRB-_-RRB- ._. 
For_IN diseases_NNS of_IN rare_JJ or_CC limited_JJ occurrence_NN ,_, particularly_RB where_WRB national_JJ incidence_NN has_VBZ been_VBN reduced_VBN to_TO very_RB low_JJ levels_NNS ,_, the_DT presentation_NN of_IN even_RB a_DT single_JJ case_NN can_MD have_VB important_JJ implications_NNS locally_RB and_CC internationally_RB ._. 
This_DT can_MD result_VB in_IN a_DT heightened_JJ perception_NN of_IN threat_NN to_TO the_DT public_JJ health_NN of_IN the_DT local_JJ population_NN and_CC increase_NN concerns_NNS regarding_VBG capacity_NN and_CC response_NN of_IN healthcare_NN service_NN delivery_NN ._. 
In_IN terms_NNS of_IN lifestyle-related_JJ non-infectious_JJ illnesses_NNS ,_, many_JJ migrants_NNS and_CC new_JJ arrivals_NNS display_VBP health_NN parameters_NNS that_WDT are_VBP better_JJR than_IN those_DT of_IN the_DT receiving_NN population_NN 
This_DT can_MD result_VB in_IN a_DT heightened_JJ perception_NN of_IN threat_NN to_TO the_DT public_JJ health_NN of_IN the_DT local_JJ population_NN and_CC increase_NN concerns_NNS regarding_VBG capacity_NN and_CC response_NN of_IN healthcare_NN service_NN delivery_NN ._. 
Recent_JJ examples_NNS of_IN this_DT include_VBP the_DT global_JJ public_JJ health_NN control_NN efforts_NNS resulting_VBG from_IN the_DT 2003_CD SARS_NNP events_NNS 
This_DT can_MD result_VB in_IN a_DT heightened_JJ perception_NN of_IN threat_NN to_TO the_DT public_JJ health_NN of_IN the_DT local_JJ population_NN and_CC increase_NN concerns_NNS regarding_VBG capacity_NN and_CC response_NN of_IN healthcare_NN service_NN delivery_NN ._. 
Recent_JJ examples_NNS of_IN this_DT include_VBP the_DT global_JJ public_JJ health_NN control_NN efforts_NNS resulting_VBG from_IN the_DT 2003_CD SARS_NNP events_NNS 
This_DT can_MD result_VB in_IN a_DT heightened_JJ perception_NN of_IN threat_NN to_TO the_DT public_JJ health_NN of_IN the_DT local_JJ population_NN and_CC increase_NN concerns_NNS regarding_VBG capacity_NN and_CC response_NN of_IN healthcare_NN service_NN delivery_NN ._. 
Recent_JJ examples_NNS of_IN this_DT include_VBP the_DT global_JJ public_JJ health_NN control_NN efforts_NNS resulting_VBG from_IN the_DT 2003_CD SARS_NNP events_NNS 
This_DT can_MD result_VB in_IN a_DT heightened_JJ perception_NN of_IN threat_NN to_TO the_DT public_JJ health_NN of_IN the_DT local_JJ population_NN and_CC increase_NN concerns_NNS regarding_VBG capacity_NN and_CC response_NN of_IN healthcare_NN service_NN delivery_NN ._. 
Recent_JJ examples_NNS of_IN this_DT include_VBP the_DT global_JJ public_JJ health_NN control_NN efforts_NNS resulting_VBG from_IN the_DT 2003_CD SARS_NNP events_NNS 
Maintaining_VBG sufficient_JJ degrees_NNS of_IN clinical_JJ suspicion_NN as_RB well_RB as_IN laboratory_NN diagnostic_JJ expertise_NN ,_, capacity_NN and_CC access_NN can_MD be_VB costly_JJ and_CC complicated_JJ ._. 
Growing_VBG needs_NNS for_IN cultural_JJ and_CC linguistic_JJ competencies_NNS in_IN the_DT health_NN sector_NN increases_NNS this_DT complexity_NN 
Growing_VBG needs_NNS for_IN cultural_JJ and_CC linguistic_JJ competencies_NNS in_IN the_DT health_NN sector_NN increases_NNS this_DT complexity_NN 
While_IN uncomplicated_JJ in_IN principle_NN ,_, the_DT provision_NN of_IN health_NN promotion_NN or_CC prevention_NN advice_NN ,_, such_JJ as_IN that_DT recently_RB recommended_VBN for_IN asthma_NN and_CC atopy_NN in_IN migrant_JJ populations_NNS 
In_IN some_DT situations_NNS ,_, delayed_JJ treatment_NN can_MD have_VB important_JJ consequences_NNS ._. 
The_DT reintroduction_NN of_IN diseases_NNS into_IN low_JJ incidence_NN locations_NNS through_IN migration_NN coupled_VBN with_IN the_DT growth_NN of_IN new_JJ populations_NNS with_IN wide_JJ linguistic_JJ and_CC cultural_JJ diversity_NN can_MD create_VB difficulties_NNS in_IN recognition_NN ,_, diagnosis_NN and_CC treatment_NN 
In_IN terms_NNS of_IN non-infectious_JJ diseases_NNS ,_, migration-associated_JJ pressures_NNS result_VBP from_IN the_DT need_NN to_TO provide_VB service_NN delivery_NN in_IN culturally_RB or_CC linguistically_RB sensitive_JJ programs_NNS for_IN the_DT prevention_NN or_CC treatment_NN of_IN illness_NN in_IN migrant_JJ communities_NNS ._. 
While_IN uncomplicated_JJ in_IN principle_NN ,_, the_DT provision_NN of_IN health_NN promotion_NN or_CC prevention_NN advice_NN ,_, such_JJ as_IN that_DT recently_RB recommended_VBN for_IN asthma_NN and_CC atopy_NN in_IN migrant_JJ populations_NNS 
In_IN terms_NNS of_IN non-infectious_JJ diseases_NNS ,_, migration-associated_JJ pressures_NNS result_VBP from_IN the_DT need_NN to_TO provide_VB service_NN delivery_NN in_IN culturally_RB or_CC linguistically_RB sensitive_JJ programs_NNS for_IN the_DT prevention_NN or_CC treatment_NN of_IN illness_NN in_IN migrant_JJ communities_NNS ._. 
While_IN uncomplicated_JJ in_IN principle_NN ,_, the_DT provision_NN of_IN health_NN promotion_NN or_CC prevention_NN advice_NN ,_, such_JJ as_IN that_DT recently_RB recommended_VBN for_IN asthma_NN and_CC atopy_NN in_IN migrant_JJ populations_NNS 
Long-term_JJ healthcare_NN policy_NN and_CC planning_NN in_IN migrant-receiving_JJ nations_NNS will_MD have_VB to_TO encompass_VB an_DT international_JJ and_CC more_RBR global_JJ focus_NN to_TO be_VB effective_JJ ._. 
Reliance_NNP on_IN historical_JJ ,_, domestic_JJ epidemiology_NN for_IN policy_NN implementation_NN in_IN these_DT nations_NNS will_MD have_VB limited_VBN relevance_NN when_WRB disease_NN volumes_NNS and_CC case-burdens_NNS originate_VBP beyond_IN the_DT mandate_NN and_CC jurisdiction_NN of_IN national_JJ prevention_NN and_CC control_NN efforts_NNS 
Reliance_NNP on_IN historical_JJ ,_, domestic_JJ epidemiology_NN for_IN policy_NN implementation_NN in_IN these_DT nations_NNS will_MD have_VB limited_VBN relevance_NN when_WRB disease_NN volumes_NNS and_CC case-burdens_NNS originate_VBP beyond_IN the_DT mandate_NN and_CC jurisdiction_NN of_IN national_JJ prevention_NN and_CC control_NN efforts_NNS 
This_DT can_MD result_VB in_IN a_DT heightened_JJ perception_NN of_IN threat_NN to_TO the_DT public_JJ health_NN of_IN the_DT local_JJ population_NN and_CC increase_NN concerns_NNS regarding_VBG capacity_NN and_CC response_NN of_IN healthcare_NN service_NN delivery_NN ._. 
Recent_JJ examples_NNS of_IN this_DT include_VBP the_DT global_JJ public_JJ health_NN control_NN efforts_NNS resulting_VBG from_IN the_DT 2003_CD SARS_NNP events_NNS 
The_DT continued_JJ arrival_NN of_IN new_JJ residents_NNS from_IN high_JJ prevalence_NN areas_NNS will_MD contribute_VB to_TO the_DT existing_VBG disease_NN base_NN of_IN low_JJ incidence_NN migrant-receiving_JJ locations_NNS ._. 
Over_IN time_NN ,_, as_IN observed_VBN with_IN regard_NN to_TO globally_RB prevalent_JJ but_CC non-uniformly_JJ distributed_VBN diseases_NNS such_JJ as_IN tuberculosis_NN ,_, imported_VBN cases_NNS among_IN migrants_NNS and_CC other_JJ mobile_JJ populations_NNS can_MD come_VB to_TO represent_VB the_DT majority_NN of_IN the_DT case_NN load_NN in_IN the_DT recipient_JJ nation_NN ._. 
In_IN these_DT situations_NNS ,_, where_WRB domestic_JJ epidemiology_NN comes_VBZ to_TO reflect_VB global_JJ disease_NN distribution_NN through_IN the_DT process_NN of_IN migration_NN ,_, health_NN policy_NN implications_NNS become_VBP apparent_JJ ._. 
In_IN addition_NN to_TO communicable_JJ diseases_NNS ,_, attention_NN is_VBZ now_RB focused_VBN on_IN pre-existing_JJ non-infectious_JJ diseases_NNS 
In_IN addition_NN to_TO communicable_JJ diseases_NNS ,_, attention_NN is_VBZ now_RB focused_VBN on_IN pre-existing_JJ non-infectious_JJ diseases_NNS 
In_IN addition_NN to_TO communicable_JJ diseases_NNS ,_, attention_NN is_VBZ now_RB focused_VBN on_IN pre-existing_JJ non-infectious_JJ diseases_NNS 
In_IN addition_NN to_TO communicable_JJ diseases_NNS ,_, attention_NN is_VBZ now_RB focused_VBN on_IN pre-existing_JJ non-infectious_JJ diseases_NNS 
Recently_RB ,_, the_DT growing_VBG international_JJ importance_NN of_IN migration_NN has_VBZ stimulated_VBN new_JJ interest_NN in_IN other_JJ aspects_NNS of_IN migrant_JJ health_NN ._. 
In_IN addition_NN to_TO communicable_JJ diseases_NNS ,_, attention_NN is_VBZ now_RB focused_VBN on_IN pre-existing_JJ non-infectious_JJ diseases_NNS 
In_IN addition_NN to_TO communicable_JJ diseases_NNS ,_, attention_NN is_VBZ now_RB focused_VBN on_IN pre-existing_JJ non-infectious_JJ diseases_NNS 
Recently_RB ,_, the_DT growing_VBG international_JJ importance_NN of_IN migration_NN has_VBZ stimulated_VBN new_JJ interest_NN in_IN other_JJ aspects_NNS of_IN migrant_JJ health_NN ._. 
In_IN addition_NN to_TO communicable_JJ diseases_NNS ,_, attention_NN is_VBZ now_RB focused_VBN on_IN pre-existing_JJ non-infectious_JJ diseases_NNS 
Recently_RB ,_, the_DT growing_VBG international_JJ importance_NN of_IN migration_NN has_VBZ stimulated_VBN new_JJ interest_NN in_IN other_JJ aspects_NNS of_IN migrant_JJ health_NN ._. 
In_IN addition_NN to_TO communicable_JJ diseases_NNS ,_, attention_NN is_VBZ now_RB focused_VBN on_IN pre-existing_JJ non-infectious_JJ diseases_NNS 
In_IN addition_NN to_TO communicable_JJ diseases_NNS ,_, attention_NN is_VBZ now_RB focused_VBN on_IN pre-existing_JJ non-infectious_JJ diseases_NNS 
Epidemiological_JJ studies_NNS now_RB involve_VBP chronic_JJ illnesses_NNS 
Another_DT recent_JJ series_NN of_IN factors_NNS affecting_VBG population_NN mobility_NN and_CC migration_NN has_VBZ resulted_VBN from_IN geo-political_JJ changes_NNS such_JJ as_IN the_DT collapse_NN of_IN the_DT former_JJ Soviet_NNP Union_NNP 
However_RB ,_, modern_JJ population_NN pressures_NNS and_CC economic_JJ push-pull_JJ factors_NNS related_VBN to_TO marked_JJ global_JJ differences_NNS in_IN opportunity_NN are_VBP increasingly_RB associated_VBN with_IN irregular_JJ population_NN flows_NNS facilitated_VBN by_IN either_DT smuggling_NN or_CC trafficking_NN of_IN those_DT seeking_VBG a_DT better_JJR life_NN 
Some_DT of_IN these_DT movements_NNS are_VBP regular_JJ and_CC organised_JJ ._. 
In_IN several_JJ locations_NNS ,_, there_EX is_VBZ a_DT repetitive_JJ flow_NN of_IN workers_NNS between_IN regions_NNS of_IN origin_NN and_CC regions_NNS of_IN employment_NN ._. 
However_RB ,_, modern_JJ population_NN pressures_NNS and_CC economic_JJ push-pull_JJ factors_NNS related_VBN to_TO marked_JJ global_JJ differences_NNS in_IN opportunity_NN are_VBP increasingly_RB associated_VBN with_IN irregular_JJ population_NN flows_NNS facilitated_VBN by_IN either_DT smuggling_NN or_CC trafficking_NN of_IN those_DT seeking_VBG a_DT better_JJR life_NN 
The_DT progressive_JJ integration_NN of_IN global_JJ economic_JJ and_CC communications_NNS sectors_NNS has_VBZ been_VBN accompanied_VBN ,_, if_IN not_RB preceded_VBN by_IN ,_, a_DT corresponding_JJ growth_NN in_IN the_DT international_JJ demand_NN and_CC flow_NN of_IN labor_NN and_CC manpower_NN ._. 
The_DT International_NNP Labor_NNP Organization_NNP estimates_VBZ the_DT foreign-born_JJ migrant_JJ labor_NN force_NN to_TO be_VB nearly_RB 90_CD million_CD persons_NNS worldwide_NN 
By_IN the_DT end_NN of_IN the_DT last_JJ millennium_NN ,_, several_JJ globally_RB important_JJ infections_NNS had_VBD reached_VBN the_DT point_NN where_WRB they_PRP were_VBD no_RB longer_RBR of_IN public_JJ health_NN significance_NN in_IN economically_RB advantaged_JJ areas_NNS of_IN the_DT world_NN ._. 
In_IN some_DT areas_NNS of_IN the_DT developed_JJ world_NN ,_, domestic_JJ transmission_NN of_IN serious_JJ infectious_JJ diseases_NNS ,_, such_JJ as_IN measles_NNS 
By_IN the_DT end_NN of_IN the_DT last_JJ millennium_NN ,_, several_JJ globally_RB important_JJ infections_NNS had_VBD reached_VBN the_DT point_NN where_WRB they_PRP were_VBD no_RB longer_RBR of_IN public_JJ health_NN significance_NN in_IN economically_RB advantaged_JJ areas_NNS of_IN the_DT world_NN ._. 
In_IN some_DT areas_NNS of_IN the_DT developed_JJ world_NN ,_, domestic_JJ transmission_NN of_IN serious_JJ infectious_JJ diseases_NNS ,_, such_JJ as_IN measles_NNS 
Current_JJ immigration_NN ,_, family_NN reunification_NN and_CC return_NN dynamics_NNS in_IN Europe_NNP and_CC Central_NNP Asia_NNP are_VBP profoundly_RB different_JJ from_IN those_DT of_IN only_RB two_CD decades_NNS previously_RB ._. 
These_DT changes_NNS have_VBP been_VBN manifested_VBN in_IN both_DT voluntary_JJ migration_NN ,_, such_JJ as_IN that_DT observed_VBD in_IN migrants_NNS from_IN the_DT former_JJ Soviet_NNP Union_NNP to_TO Israel_NNP 
Current_JJ immigration_NN ,_, family_NN reunification_NN and_CC return_NN dynamics_NNS in_IN Europe_NNP and_CC Central_NNP Asia_NNP are_VBP profoundly_RB different_JJ from_IN those_DT of_IN only_RB two_CD decades_NNS previously_RB ._. 
These_DT changes_NNS have_VBP been_VBN manifested_VBN in_IN both_DT voluntary_JJ migration_NN ,_, such_JJ as_IN that_DT observed_VBD in_IN migrants_NNS from_IN the_DT former_JJ Soviet_NNP Union_NNP to_TO Israel_NNP 
Access_NN to_TO and_CC use_NN of_IN complex_JJ and_CC costly_JJ interventions_NNS ,_, such_JJ as_IN cancer_NN treatment_NN ,_, organ_NN system_NN support_NN ,_, transplantation_NN and_CC extensive_JJ pharmacotherapy_NN vary_VBP according_VBG to_TO levels_NNS of_IN national_JJ economic_JJ development_NN ._. 
These_DT disparities_NNS in_IN social_JJ investments_NNS in_IN health_NN services_NNS availability_NN and_CC population_NN access_NN to_TO healthcare_NN are_VBP associated_VBN with_IN several_JJ differential_JJ inter-regional_JJ health_NN outcomes_NNS ,_, including_VBG premature_JJ death_NN and_CC increased_VBN morbidity_NN in_IN the_DT developing_VBG world_NN ._. 
In_IN the_DT absence_NN of_IN extensive_JJ international_JJ travel_NN ,_, population_NN mobility_NN and_CC migration_NN ,_, the_DT effects_NNS of_IN differences_NNS in_IN disease_NN prevalence_NN would_MD have_VB limited_VBN global_JJ significance_NN ._. 
This_DT can_MD create_VB enormous_JJ differences_NNS in_IN the_DT prevalence_NN of_IN certain_JJ conditions_NNS between_IN locations_NNS ._. 
This_DT is_VBZ far_RB in_IN advance_NN of_IN what_WP was_VBD observed_JJ or_CC possible_JJ in_IN the_DT developing_VBG world_NN ._. 
In_IN a_DT mobile_JJ world_NN ,_, travellers_NNS and_CC migrants_NNS crossing_VBG these_DT prevalence_NN gaps_NNS can_MD become_VB the_DT source_NN for_IN outbreaks_NNS of_IN these_DT diseases_NNS ._. 
The_DT creation_NN of_IN such_JJ prevalence_NN differences_NNS is_VBZ not_RB limited_VBN to_TO communicable_JJ diseases_NNS ._. 
The_DT ability_NN to_TO treat_VB and_CC manage_VB non-infectious_JJ diseases_NNS in_IN highly_RB developed_VBN regions_NNS of_IN the_DT world_NN likewise_RB differs_VBZ from_IN the_DT situation_NN in_IN many_JJ developing_VBG regions_NNS ._. 
The_DT global_JJ extension_NN of_IN regional_JJ epidemiological_JJ differences_NNS can_MD have_VB marked_VBN impact_NN on_IN the_DT local_JJ epidemiology_NN of_IN disease_NN ._. 
Examples_NNS include_VBP tuberculosis_NN ,_, sexually-acquired_JJ infections_NNS ,_, Chagas_NNP '_POS disease_NN and_CC strongyloidiasis_NN ,_, for_IN which_WDT foreign-born_JJ migrants_NNS from_IN hyper-endemic_JJ areas_NNS represent_VBP the_DT majority_NN of_IN national_JJ case_NN burden_NN in_IN low_JJ incidence_NN or_CC non-endemic_JJ nations_NNS 
The_DT global_JJ extension_NN of_IN regional_JJ epidemiological_JJ differences_NNS can_MD have_VB marked_VBN impact_NN on_IN the_DT local_JJ epidemiology_NN of_IN disease_NN ._. 
Examples_NNS include_VBP tuberculosis_NN ,_, sexually-acquired_JJ infections_NNS ,_, Chagas_NNP '_POS disease_NN and_CC strongyloidiasis_NN ,_, for_IN which_WDT foreign-born_JJ migrants_NNS from_IN hyper-endemic_JJ areas_NNS represent_VBP the_DT majority_NN of_IN national_JJ case_NN burden_NN in_IN low_JJ incidence_NN or_CC non-endemic_JJ nations_NNS 
Examples_NNS include_VBP tuberculosis_NN ,_, sexually-acquired_JJ infections_NNS ,_, Chagas_NNP '_POS disease_NN and_CC strongyloidiasis_NN ,_, for_IN which_WDT foreign-born_JJ migrants_NNS from_IN hyper-endemic_JJ areas_NNS represent_VBP the_DT majority_NN of_IN national_JJ case_NN burden_NN in_IN low_JJ incidence_NN or_CC non-endemic_JJ nations_NNS 
Examples_NNS include_VBP tuberculosis_NN ,_, sexually-acquired_JJ infections_NNS ,_, Chagas_NNP '_POS disease_NN and_CC strongyloidiasis_NN ,_, for_IN which_WDT foreign-born_JJ migrants_NNS from_IN hyper-endemic_JJ areas_NNS represent_VBP the_DT majority_NN of_IN national_JJ case_NN burden_NN in_IN low_JJ incidence_NN or_CC non-endemic_JJ nations_NNS 
Similar_JJ patterns_NNS of_IN epidemiological_JJ evolution_NN exist_VBP for_IN other_JJ long-term_JJ infections_NNS such_JJ as_IN hepatitis_NNP B_NNP and_CC C_NNP ,_, as_RB well_RB as_IN HIV\/AIDS_NNP in_IN some_DT European_JJ nations_NNS ,_, where_WRB these_DT diseases_NNS are_VBP reported_VBN to_TO be_VB more_RBR common_JJ in_IN foreign-born_JJ migrants_NNS than_IN in_IN native-born_JJ residents_NNS 
Migrants_NNS arriving_VBG from_IN less_JJR developed_JJ regions_NNS of_IN the_DT world_NN may_MD have_VB had_VBD less_JJR access_NN to_TO preventive_JJ care_NN ,_, health_NN promotion_NN programs_NNS ,_, and_CC diagnostic_JJ or_CC therapeutic_JJ interventions_NNS for_IN illness_NN and_CC disease_NN ._. 
Cancer_NN detection_NN programs_NNS and_CC periodic_JJ health_NN examinations_NNS may_MD not_RB be_VB commonly_RB accessible_JJ in_IN many_JJ populations_NNS ._. 
Access_NN to_TO healthcare_NN providers_NNS and_CC basic_JJ services_NNS are_VBP unequally_RB distributed_VBN or_CC subject_JJ to_TO limited_JJ availability_NN in_IN many_JJ places_NNS ._. 
Access_NN to_TO healthcare_NN providers_NNS and_CC basic_JJ services_NNS are_VBP unequally_RB distributed_VBN or_CC subject_JJ to_TO limited_JJ availability_NN in_IN many_JJ places_NNS ._. 
Similar_JJ differences_NNS in_IN availability_NN can_MD be_VB observed_VBN for_IN smoking_NN and_CC substance_NN abuse_NN prevention_NN programs_NNS ,_, programs_NNS to_TO detect_VB and_CC manage_VB vitamin_NN or_CC micronutrient_NN deficiencies_NNS ,_, promotion_NN of_IN dental_JJ health_NN and_CC programs_NNS to_TO manage_VB genetic_JJ or_CC biological_JJ conditions_NNS 
This_DT is_VBZ frequently_RB observed_VBN in_IN refugees_NNS ,_, displaced_VBN persons_NNS and_CC disadvantaged_JJ migrant_JJ populations_NNS such_JJ as_IN trafficked_JJ or_CC smuggled_JJ persons_NNS 
This_DT is_VBZ frequently_RB observed_VBN in_IN refugees_NNS ,_, displaced_VBN persons_NNS and_CC disadvantaged_JJ migrant_JJ populations_NNS such_JJ as_IN trafficked_JJ or_CC smuggled_JJ persons_NNS 
This_DT is_VBZ frequently_RB observed_VBN in_IN refugees_NNS ,_, displaced_VBN persons_NNS and_CC disadvantaged_JJ migrant_JJ populations_NNS such_JJ as_IN trafficked_JJ or_CC smuggled_JJ persons_NNS 
This_DT is_VBZ frequently_RB observed_VBN in_IN refugees_NNS ,_, displaced_VBN persons_NNS and_CC disadvantaged_JJ migrant_JJ populations_NNS such_JJ as_IN trafficked_JJ or_CC smuggled_JJ persons_NNS 
These_DT factors_NNS result_VBP from_IN the_DT process_NN of_IN migration_NN itself_PRP ,_, for_IN example_NN ,_, during_IN the_DT travel_NN phase_NN between_IN origin_NN and_CC destination_NN ._. 
This_DT is_VBZ frequently_RB observed_VBN in_IN refugees_NNS ,_, displaced_VBN persons_NNS and_CC disadvantaged_JJ migrant_JJ populations_NNS such_JJ as_IN trafficked_JJ or_CC smuggled_JJ persons_NNS 
These_DT factors_NNS result_VBP from_IN the_DT process_NN of_IN migration_NN itself_PRP ,_, for_IN example_NN ,_, during_IN the_DT travel_NN phase_NN between_IN origin_NN and_CC destination_NN ._. 
This_DT is_VBZ frequently_RB observed_VBN in_IN refugees_NNS ,_, displaced_VBN persons_NNS and_CC disadvantaged_JJ migrant_JJ populations_NNS such_JJ as_IN trafficked_JJ or_CC smuggled_JJ persons_NNS 
These_DT factors_NNS result_VBP from_IN the_DT process_NN of_IN migration_NN itself_PRP ,_, for_IN example_NN ,_, during_IN the_DT travel_NN phase_NN between_IN origin_NN and_CC destination_NN ._. 
This_DT is_VBZ frequently_RB observed_VBN in_IN refugees_NNS ,_, displaced_VBN persons_NNS and_CC disadvantaged_JJ migrant_JJ populations_NNS such_JJ as_IN trafficked_JJ or_CC smuggled_JJ persons_NNS 
6to_CD 15_CD ._. 
For_IN example_NN ,_, in_IN the_DT thirty_CD years_NNS following_VBG 1965_CD ,_, the_DT difference_NN between_IN life_NN expectancy_NN for_IN males_NNS in_IN the_DT United_NNP Kingdom_NNP and_CC Russia_NNP increased_VBN by_IN more_JJR than_IN ten_CD years_NNS -LRB-_-LRB- range_NN from_IN 3_CD ._. 
1years_NNS -RRB-_-RRB- 
Table_NNP 2_CD The_DT impact_NN of_IN different_JJ health_NN environments_NNS and_CC the_DT phases_NNS of_IN population_NN mobility_NN Occurrence_NN Examples_NNS Consequence_NN at_IN Destination_NN Pre-departure_NN existing_VBG medical_JJ condition_NN -_: prevalence_NN of_IN endemic_JJ disease_NN -_: level_NN of_IN development_NN -_: access_NN to_TO care_VB -_: availability_NN of_IN care_NN Arriving_VBG population_NN displays_NNS health_NN indicators_NNS of_IN origin_NN :_: 
As_IN Tu_FW et_FW al_FW algebraically_RB admit_VB ,_, R_NN 2_CD is_VBZ only_RB an_DT indication_NN of_IN the_DT proportion_NN of_IN the_DT variance_NN in_IN BP_NNP or_CC outcome_NN that_WDT is_VBZ attributable_JJ to_TO the_DT variation_NN in_IN the_DT fitted_JJ mean_NN of_IN BP_NNP 
This_DT is_VBZ ,_, of_IN course_NN ,_, beyond_IN the_DT scope_NN of_IN their_PRP$ paper_NN and_CC ,_, therefore_RB ,_, my_PRP$ commentary_NN ._. 
Furthermore_RB ,_, Tu_FW et_FW al_FW make_VB a_DT passing_NN mention_NN of_IN direct_JJ effect_NN versus_CC indirect_JJ effect_NN -LRB-_-LRB- as_IN might_MD be_VB the_DT case_NN in_IN the_DT consideration_NN of_IN adjustment_NN in_IN Figure_NNP 1_CD -RRB-_-RRB- ._. 
Irefer_VB the_DT curious_JJ reader_NN to_TO the_DT important_JJ work_NN on_IN the_DT complex_JJ issues_NNS involved_VBN in_IN the_DT estimation_NN of_IN direct_JJ effect_NN ._. 
Suffice_VB it_PRP to_TO say_VB that_IN ,_, in_IN common_JJ situations_NNS where_WRB total_JJ effect_NN estimation_NN is_VBZ possible_JJ ,_, direct_JJ effect_NN may_MD be_VB unidentifiable_JJ ._. 
This_DT is_VBZ ,_, of_IN course_NN ,_, beyond_IN the_DT scope_NN of_IN their_PRP$ paper_NN and_CC ,_, therefore_RB ,_, my_PRP$ commentary_NN ._. 
Furthermore_RB ,_, Tu_FW et_FW al_FW make_VB a_DT passing_NN mention_NN of_IN direct_JJ effect_NN versus_CC indirect_JJ effect_NN -LRB-_-LRB- as_IN might_MD be_VB the_DT case_NN in_IN the_DT consideration_NN of_IN adjustment_NN in_IN Figure_NNP 1_CD -RRB-_-RRB- ._. 
Irefer_VB the_DT curious_JJ reader_NN to_TO the_DT important_JJ work_NN on_IN the_DT complex_JJ issues_NNS involved_VBN in_IN the_DT estimation_NN of_IN direct_JJ effect_NN ._. 
Suffice_VB it_PRP to_TO say_VB that_IN ,_, in_IN common_JJ situations_NNS where_WRB total_JJ effect_NN estimation_NN is_VBZ possible_JJ ,_, direct_JJ effect_NN may_MD be_VB unidentifiable_JJ ._. 
In_IN each_DT case_NN ,_, the_DT researcher_NN is_VBZ looking_VBG at_IN statistics_NNS to_TO tell_VB her_PRP what_WP she_PRP may_MD not_RB admit_VB to_TO :_: which_WDT estimate_NN must_MD she_PRP accord_VB causal_JJ interpretation_NN in_IN what_WP causal_JJ world_NN ._. 
In_IN other_JJ words_NNS ,_, these_DT paradoxes_NNS arise_VBP in_IN the_DT context_NN of_IN covariate_NN selection_NN ,_, especially_RB when_WRB looking_VBG to_TO select_VB variables_NNS for_IN adequate_JJ control_NN of_IN confounding_VBG in_IN causal_JJ analysis_NN 
The_DT knowledge_NN needed_VBN to_TO draw_VB these_DT DAGs_NNS and_CC to_TO guide_VB subsequent_JJ analysis_NN resides_VBZ outside_IN the_DT study_NN data_NNS ._. 
Hence_RB ,_, there_EX can_MD be_VB no_DT causal_JJ inference_NN without_IN background_NN knowledge_NN 
Based_VBN on_IN background_NN knowledge_NN and_CC common_JJ sense_NN ,_, Figure_NN 3_CD is_VBZ more_RBR plausible_JJ than_IN 2_CD ._. 
Both_DT BW_NNP and_CC CW_NNP are_VBP more_RBR likely_JJ to_TO be_VB the_DT result_NN of_IN a_DT common_JJ cause_NN -LRB-_-LRB- U_NNP -RRB-_-RRB- ,_, possibly_RB genetic_JJ ._. 
Therefore_RB ,_, temporality_NN can_MD not_RB be_VB used_VBN to_TO judge_VB whether_IN a_DT variable_NN is_VBZ a_DT confounder_NN ,_, part_NN of_IN a_DT sufficient_JJ subset_NN of_IN covariates_NNS needed_VBN to_TO block_VB a_DT backdoor_NN ,_, or_CC not_RB ._. 
Figure_NN 4_CD presents_NNS a_DT scenario_NN where_WRB the_DT unadjusted_JJ effect_NN of_IN BW_NNP on_IN BP_NNP is_VBZ the_DT correct_JJ estimate_NN since_IN CW_NNP is_VBZ a_DT collider_NN -LRB-_-LRB- that_DT is_VBZ ,_, without_IN conditioning_NN ,_, it_PRP already_RB acts_VBZ as_IN a_DT blocker_NN -RRB-_-RRB- in_IN the_DT DAG_NNP depicting_VBG two_CD unobserved_JJ common_JJ causes_NNS of_IN BW_NNP and_CC CW_NNP and_CC of_IN CW_NNP and_CC BP_NNP ._. 
Put_VB this_DT way_NN ,_, Simpson_NNP 's_POS paradox_NN becomes_VBZ a_DT problem_NN of_IN covariate_JJ adjustment_NN -LRB-_-LRB- when_WRB to_TO adjust_VB or_CC not_RB -RRB-_-RRB- in_IN the_DT causal_JJ analysis_NN of_IN non-experimental_JJ or_CC observational_JJ data_NNS ._. 
The_DT paradox_NN arises_VBZ due_JJ to_TO the_DT causal_JJ interpretation_NN of_IN the_DT observation_NN that_IN the_DT proportion_NN of_IN a_DT given_VBN level_NN of_IN BW_NNP is_VBZ evidence_NN for_IN making_VBG an_DT educated_VBN guess_NN of_IN the_DT proportion_NN of_IN a_DT given_VBN BP_NNP level_NN in_IN an_DT observed_JJ sample_NN if_IN the_DT status_NN of_IN the_DT third_JJ related_JJ covariate_NN CW_NNP is_VBZ unknown_JJ ._. 
What_WP we_PRP really_RB want_VBP to_TO answer_VB is_VBZ ``_`` Does_NNP BW_NNP cause_NN BP_NNP ._. ''_'' 
,not_NN ``_`` Does_VBZ observing_VBG BW_NNP allow_VB us_PRP to_TO predict_VB BP_NNP ._. 
''_'' ._. ''_'' 
,not_NN ``_`` Does_VBZ observing_VBG BW_NNP allow_VB us_PRP to_TO predict_VB BP_NNP ._. 
What_WP we_PRP really_RB want_VBP to_TO answer_VB is_VBZ ``_`` Does_NNP BW_NNP cause_NN BP_NNP ._. 
As_IN Pearl_NNP has_VBZ noted_VBN ,_, people_NNS think_VBP ``_`` causes_NNS ''_'' ,_, not_RB proportions_NNS -LRB-_-LRB- the_DT thing_NN that_WDT drives_VBZ the_DT paradox_NN in_IN Simpson_NNP 's_POS paradox_NN -RRB-_-RRB- ;_: ``_`` reversal_NN ''_'' is_VBZ possible_JJ in_IN the_DT calculus_NN of_IN proportions_NNS but_CC impossible_JJ in_IN the_DT calculus_NN of_IN causes_NNS ._. 
Put_VB in_IN Pearl_NNP 's_POS causal_JJ language_NN ,_, the_DT invariance_NN of_IN causal_JJ interpretation_NN that_WDT is_VBZ wrongly_RB used_VBN to_TO interpret_VB evidence_NN of_IN reversal_NN in_IN proportions_NNS in_IN Simpson_NNP 's_POS paradox_NN is_VBZ as_RB follows_VBZ :_: Pr_NN -LRB-_-LRB- BP_NNP =_SYM high_JJ |_NNS do_VBP -LCB-_-LRB- BW_VB =_SYM high_JJ -RCB-_-RRB- ,_, high_JJ CW_NNP -RRB-_-RRB- 
Put_VB in_IN Pearl_NNP 's_POS causal_JJ language_NN ,_, the_DT invariance_NN of_IN causal_JJ interpretation_NN that_WDT is_VBZ wrongly_RB used_VBN to_TO interpret_VB evidence_NN of_IN reversal_NN in_IN proportions_NNS in_IN Simpson_NNP 's_POS paradox_NN is_VBZ as_RB follows_VBZ :_: Pr_NN -LRB-_-LRB- BP_NNP =_SYM high_JJ |_NNS do_VBP -LCB-_-LRB- BW_VB =_SYM high_JJ -RCB-_-RRB- ,_, high_JJ CW_NNP -RRB-_-RRB- 
If_IN the_DT DAG_NNP represented_VBD in_IN Figure_NN 3_CD 
This_DT is_VBZ ,_, of_IN course_NN ,_, beyond_IN the_DT scope_NN of_IN their_PRP$ paper_NN and_CC ,_, therefore_RB ,_, my_PRP$ commentary_NN ._. 
Furthermore_RB ,_, Tu_FW et_FW al_FW make_VB a_DT passing_NN mention_NN of_IN direct_JJ effect_NN versus_CC indirect_JJ effect_NN -LRB-_-LRB- as_IN might_MD be_VB the_DT case_NN in_IN the_DT consideration_NN of_IN adjustment_NN in_IN Figure_NNP 1_CD -RRB-_-RRB- ._. 
Irefer_VB the_DT curious_JJ reader_NN to_TO the_DT important_JJ work_NN on_IN the_DT complex_JJ issues_NNS involved_VBN in_IN the_DT estimation_NN of_IN direct_JJ effect_NN ._. 
Suffice_VB it_PRP to_TO say_VB that_IN ,_, in_IN common_JJ situations_NNS where_WRB total_JJ effect_NN estimation_NN is_VBZ possible_JJ ,_, direct_JJ effect_NN may_MD be_VB unidentifiable_JJ ._. 
For_IN instance_NN ,_, although_IN all_DT effects_NNS of_IN BW_NNP on_IN BP_NNP can_MD still_RB be_VB consistently_RB estimated_VBN even_RB in_IN a_DT scenario_NN where_WRB there_EX is_VBZ an_DT additional_JJ unobserved_JJ common_JJ cause_NN -LRB-_-LRB- U_NNP -RRB-_-RRB- of_IN CW_NNP and_CC BP_NNP as_IN in_IN Figure_NN 6_CD -LRB-_-LRB- modified_VBN from_IN Figure_NN 2_CD -RRB-_-RRB- ,_, the_DT direct_JJ effect_NN of_IN BW_NNP on_IN BP_NNP can_MD not_RB be_VB identified_VBN without_IN measuring_VBG U_NNP in_IN Figure_NNP 7_CD which_WDT is_VBZ a_DT similar_JJ modification_NN of_IN Figure_NN 1_CD ._. 
Like_IN Pearl_NNP 
So_RB ,_, why_WRB bother_VBP with_IN the_DT statistics_NNS of_IN these_DT paradoxes_NNS ,_, much_RB less_JJR their_PRP$ equivalence_NN ,_, in_IN the_DT first_JJ instance_NN if_IN both_DT the_DT correct_JJ language_NN and_CC resolution_NN lie_NN elsewhere_RB ._. 
Although_IN we_PRP are_VBP given_VBN a_DT glimpse_NN of_IN the_DT appropriate_JJ tools_NNS -LRB-_-LRB- such_JJ as_IN the_DT implied_JJ causal_JJ calculus_NN of_IN directed_VBN acyclic_NN graphs_NNS -RRB-_-RRB- ,_, we_PRP must_MD look_VB beyond_IN the_DT authors_NNS '_POS paper_NN for_IN satisfactory_JJ answers_NNS ._. 
At_IN the_DT heart_NN of_IN the_DT phenomenon_NN of_IN change_NN in_IN magnitude_NN ,_, with_IN or_CC without_IN reversal_NN of_IN effect_NN estimate_NN ,_, is_VBZ the_DT question_NN of_IN which_WDT to_TO use_VB :_: the_DT unadjusted_JJ -LRB-_-LRB- combined_VBN table_NN -RRB-_-RRB- or_CC adjusted_VBN -LRB-_-LRB- sub-table_JJ -RRB-_-RRB- estimate_NN ._. 
In_IN other_JJ words_NNS ,_, these_DT paradoxes_NNS arise_VBP in_IN the_DT context_NN of_IN covariate_NN selection_NN ,_, especially_RB when_WRB looking_VBG to_TO select_VB variables_NNS for_IN adequate_JJ control_NN of_IN confounding_VBG in_IN causal_JJ analysis_NN 
The_DT knowledge_NN needed_VBN to_TO draw_VB these_DT DAGs_NNS and_CC to_TO guide_VB subsequent_JJ analysis_NN resides_VBZ outside_IN the_DT study_NN data_NNS ._. 
Hence_RB ,_, there_EX can_MD be_VB no_DT causal_JJ inference_NN without_IN background_NN knowledge_NN ._. 
To_TO appreciate_VB the_DT causal_JJ approach_NN to_TO the_DT paradoxes_NNS ,_, consider_VB the_DT three-variable_JJ model_NN of_IN birth_NN weight_NN -LRB-_-LRB- BW_NNP -RRB-_-RRB- ,_, current_JJ weight_NN -LRB-_-LRB- CW_NNP -RRB-_-RRB- ,_, and_CC blood_NN pressure_NN -LRB-_-LRB- BP_NNP -RRB-_-RRB- used_VBN by_IN the_DT authors_NNS and_CC seen_VBN in_IN the_DT life_NN course_NN epidemiology_NN literature_NN ._. 
Those_DT who_WP believe_VBP in_IN letting_VBG the_DT data_NNS speak_VBP for_IN themselves_PRP are_VBP in_IN for_IN a_DT disappointment_NN ._. 
By_IN rearing_VBG their_PRP$ heads_NNS intermittently_RB in_IN the_DT literature_NN they_PRP remind_VBP us_PRP about_IN the_DT inadequacy_NN of_IN statistical_JJ criteria_NNS for_IN causal_JJ analysis_NN ._. 
Tu_NNP et_NNP al_JJ present_NN an_DT analysis_NN of_IN the_DT equivalence_NN of_IN three_CD paradoxes_NNS ,_, concluding_VBG that_IN all_DT three_CD simply_RB reiterate_VB the_DT unsurprising_JJ change_NN in_IN the_DT association_NN of_IN any_DT two_CD variables_NNS when_WRB a_DT third_JJ variable_NN is_VBZ statistically_RB controlled_VBN for_IN ._. 
Icall_NNP this_DT unsurprising_JJ because_IN reversal_NN or_CC change_NN in_IN magnitude_NN is_VBZ common_JJ in_IN conditional_JJ analysis_NN ._. 
.._NN 
assessed_VBN by_IN R_NN 2_CD ..._: A_DT further_JJ illustration_NN of_IN the_DT futility_NN of_IN the_DT continued_VBN statistical_JJ discussion_NN of_IN the_DT paradoxes_NNS is_VBZ captured_VBN in_IN the_DT discussion_NN of_IN the_DT suppression_NN effect_NN :_: how_WRB an_DT unrelated_JJ covariate_NN -LRB-_-LRB- CW_NNP -RRB-_-RRB- ``_`` increases_VBZ the_DT overall_JJ model_NN fit_NN ._. ''_'' ._. 
Tu_FW et_FW al_FW should_MD not_RB be_VB surprised_VBN that_DT suppression_NN is_VBZ little_RB known_VBN in_IN epidemiology_NN because_IN epidemiologists_NNS do_VBP not_RB and_CC should_MD not_RB use_VB the_DT squared_VBN multiple-correlation-coefficient_JJ R_NNP 2_CD as_IN a_DT measure_NN of_IN goodness-of-fit_NN ._. 
Why_WRB are_VBP they_PRP paradoxes_NNS ._. 
What_WP is_VBZ it_PRP about_IN Simpson_NNP 's_POS and_CC Lord_NNP 's_POS paradoxes_NNS or_CC the_DT suppression_NN effect_NN ,_, beyond_IN their_PRP$ pointing_VBG out_RP the_DT obvious_JJ ,_, that_WDT attracts_VBZ the_DT intermittent_JJ and_CC sometimes_RB alarmist_JJ interests_NNS seen_VBN in_IN the_DT literature_NN ._. 
Aparadox_NNP is_VBZ a_DT seemingly_RB absurd_JJ or_CC self-contradictory_JJ statement_NN or_CC proposition_NN that_WDT may_MD in_IN fact_NN be_VB true_JJ ._. 
What_WP is_VBZ so_RB self-contradictory_JJ about_IN the_DT Simpson_NNP 's_POS ,_, Lord_NNP 's_POS ,_, and_CC suppression_NN phenomena_NNS that_WDT may_MD turn_VB out_RP to_TO be_VB true_JJ ._. 
So_RB ,_, why_WRB bother_VBP with_IN the_DT statistics_NNS of_IN these_DT paradoxes_NNS ,_, much_RB less_JJR their_PRP$ equivalence_NN ,_, in_IN the_DT first_JJ instance_NN if_IN both_DT the_DT correct_JJ language_NN and_CC resolution_NN lie_NN elsewhere_RB ._. 
Although_IN we_PRP are_VBP given_VBN a_DT glimpse_NN of_IN the_DT appropriate_JJ tools_NNS -LRB-_-LRB- such_JJ as_IN the_DT implied_JJ causal_JJ calculus_NN of_IN directed_VBN acyclic_NN graphs_NNS -RRB-_-RRB- ,_, we_PRP must_MD look_VB beyond_IN the_DT authors_NNS '_POS paper_NN for_IN satisfactory_JJ answers_NNS ._. 
At_IN the_DT heart_NN of_IN the_DT phenomenon_NN of_IN change_NN in_IN magnitude_NN ,_, with_IN or_CC without_IN reversal_NN of_IN effect_NN estimate_NN ,_, is_VBZ the_DT question_NN of_IN which_WDT to_TO use_VB :_: the_DT unadjusted_JJ -LRB-_-LRB- combined_VBN table_NN -RRB-_-RRB- or_CC adjusted_VBN -LRB-_-LRB- sub-table_JJ -RRB-_-RRB- estimate_NN ._. 
In_IN other_JJ words_NNS ,_, these_DT paradoxes_NNS arise_VBP in_IN the_DT context_NN of_IN covariate_NN selection_NN ,_, especially_RB when_WRB looking_VBG to_TO select_VB variables_NNS for_IN adequate_JJ control_NN of_IN confounding_VBG in_IN causal_JJ analysis_NN 
This_DT is_VBZ ,_, of_IN course_NN ,_, beyond_IN the_DT scope_NN of_IN their_PRP$ paper_NN and_CC ,_, therefore_RB ,_, my_PRP$ commentary_NN ._. 
Furthermore_RB ,_, Tu_FW et_FW al_FW make_VB a_DT passing_NN mention_NN of_IN direct_JJ effect_NN versus_CC indirect_JJ effect_NN -LRB-_-LRB- as_IN might_MD be_VB the_DT case_NN in_IN the_DT consideration_NN of_IN adjustment_NN in_IN Figure_NNP 1_CD -RRB-_-RRB- ._. 
Irefer_VB the_DT curious_JJ reader_NN to_TO the_DT important_JJ work_NN on_IN the_DT complex_JJ issues_NNS involved_VBN in_IN the_DT estimation_NN of_IN direct_JJ effect_NN ._. 
Suffice_VB it_PRP to_TO say_VB that_IN ,_, in_IN common_JJ situations_NNS where_WRB total_JJ effect_NN estimation_NN is_VBZ possible_JJ ,_, direct_JJ effect_NN may_MD be_VB unidentifiable_JJ ._. 
For_IN instance_NN ,_, although_IN all_DT effects_NNS of_IN BW_NNP on_IN BP_NNP can_MD still_RB be_VB consistently_RB estimated_VBN even_RB in_IN a_DT scenario_NN where_WRB there_EX is_VBZ an_DT additional_JJ unobserved_JJ common_JJ cause_NN -LRB-_-LRB- U_NNP -RRB-_-RRB- of_IN CW_NNP and_CC BP_NNP as_IN in_IN Figure_NN 6_CD -LRB-_-LRB- modified_VBN from_IN Figure_NN 2_CD -RRB-_-RRB- ,_, the_DT direct_JJ effect_NN of_IN BW_NNP on_IN BP_NNP can_MD not_RB be_VB identified_VBN without_IN measuring_VBG U_NNP in_IN Figure_NNP 7_CD which_WDT is_VBZ a_DT similar_JJ modification_NN of_IN Figure_NN 1_CD ._. 
Like_IN Pearl_NNP 
The_DT reader_NN could_MD by_IN now_RB have_VBP doubts_NNS about_IN the_DT correctness_NN of_IN Figure_NN 2_CD where_WRB a_DT later_JJ observation_NN CW_NNP is_VBZ a_DT confounder_NN of_IN the_DT effect_NN of_IN BW_NNP on_IN BP_NNP since_IN one_CD could_MD argue_VB that_IN ,_, by_IN occurring_VBG after_IN BW_NNP ,_, CW_NNP could_MD not_RB be_VB seen_VBN as_IN a_DT common_JJ cause_NN of_IN both_DT BW_NNP and_CC BP_NNP ._. 
-LRB-_-LRB- See_NNP Hern_NNP 
Tu_FW et_FW al_FW should_MD not_RB be_VB surprised_VBN that_DT suppression_NN is_VBZ little_RB known_VBN in_IN epidemiology_NN because_IN epidemiologists_NNS do_VBP not_RB and_CC should_MD not_RB use_VB the_DT squared_VBN multiple-correlation-coefficient_JJ R_NNP 2_CD as_IN a_DT measure_NN of_IN goodness-of-fit_NN ._. 
As_IN Tu_FW et_FW al_FW algebraically_RB admit_VBP ,_, R2_NNP is_VBZ only_RB an_DT indication_NN of_IN the_DT proportion_NN of_IN the_DT variance_NN in_IN BP_NNP or_CC outcome_NN that_WDT is_VBZ attributable_JJ to_TO the_DT variation_NN in_IN the_DT fitted_JJ mean_NN of_IN BP_NNP 
In_IN these_DT situations_NNS ,_, sample_NN sizes_NNS to_TO achieve_VB acceptable_JJ levels_NNS of_IN precision_NN need_VBP to_TO be_VB calculated_VBN for_IN each_DT of_IN the_DT key_JJ indicators_NNS 
The_DT field_NN applications_NNS of_IN this_DT method_NN expanded_VBD rapidly_RB to_TO include_VB measuring_VBG such_JJ key_JJ emergency_NN indicators_NNS as_IN acute_JJ malnutrition_NN ,_, crude_JJ and_CC under-5_JJ mortality_NN ,_, cumulative_JJ incidence_NN of_IN diarrhea_NN and_CC respiratory_NN disease_NN ,_, access_NN to_TO safe_JJ water_NN ,_, prevalence_NN of_IN physical_JJ signs_NNS of_IN micronutrient_JJ deficiencies_NNS ,_, and_CC several_JJ others_NNS ._. 
The_DT challenges_NNS of_IN measuring_VBG these_DT indicators_NNS with_IN sufficient_JJ precision_NN triggered_VBD modifications_NNS to_TO the_DT initially_RB proposed_VBN standard_NN 30_CD 
The_DT challenges_NNS of_IN measuring_VBG these_DT indicators_NNS with_IN sufficient_JJ precision_NN triggered_VBD modifications_NNS to_TO the_DT initially_RB proposed_VBN standard_NN 30_CD 
,may_JJ result_NN in_IN the_DT least_JJS loss_NN of_IN precision_NN compared_VBN to_TO a_DT 30_CD 
Avoiding_VBG threats_NNS to_TO validity_NN One_CD important_JJ question_NN is_VBZ whether_IN designs_NNS in_IN which_WDT the_DT number_NN of_IN survey_NN subjects_NNS per_IN cluster_NN is_VBZ low_JJ -LRB-_-LRB- 3_CD in_IN 67_CD 
Many_JJ surveys_NNS in_IN emergencies_NNS strive_VBP to_TO measure_VB multiple_JJ outcomes_NNS ,_, including_VBG nutritional_JJ status_NN ,_, mortality_NN ,_, water_NN and_CC sanitation_NN indicators_NNS ,_, access_NN to_TO feeding_VBG programs_NNS and_CC food_NN aid_NN ,_, among_IN others_NNS ._. 
In_IN these_DT situations_NNS ,_, sample_NN sizes_NNS to_TO achieve_VB acceptable_JJ levels_NNS of_IN precision_NN need_VBP to_TO be_VB calculated_VBN for_IN each_DT of_IN the_DT key_JJ indicators_NNS 
It_PRP is_VBZ important_JJ to_TO continue_VB building_VBG technical_JJ capacity_NN in_IN cluster_NN survey_NN design_NN within_IN organizations_NNS conducting_VBG cluster_NN surveys_NNS in_IN humanitarian_JJ emergencies_NNS ._. 
Several_JJ important_JJ initiatives_NNS -LRB-_-LRB- Standardized_JJ Monitoring_NN and_CC Assessment_NNP of_IN Relief_NNP and_CC Transitions_NNP -LRB-_-LRB- SMART_NNP -RRB-_-RRB- ,_, Health_NNP and_CC Nutrition_NNP Tracking_NNP Service_NNP -RRB-_-RRB- and_CC recently_RB published_VBN survey_NN manuals_NNS 
By_IN changing_VBG the_DT cluster_NN design_NN ,_, we_PRP can_MD modify_VB both_DT the_DT design_NN effect_NN -LRB-_-LRB- DEFF_NNP -RRB-_-RRB- and_CC the_DT sample_NN size_NN -LRB-_-LRB- n_NN -RRB-_-RRB- ,_, while_IN Z_NN and_CC p_NN will_MD not_RB be_VB affected_VBN ._. 
The_DT design_NN effect_NN can_MD be_VB presented_VBN as_IN a_DT function_NN of_IN the_DT average_JJ cluster_NN size_NN -LRB-_-LRB- m_NN -RRB-_-RRB- and_CC the_DT intracluster_NN correlation_NN coefficient_NN -LRB-_-LRB- Rho_NNP -RRB-_-RRB- ,_, which_WDT describes_VBZ the_DT relatedness_NN of_IN cluster_NN data_NNS by_IN comparing_VBG the_DT variance_NN within_IN clusters_NNS with_IN the_DT variance_NN between_IN clusters_NNS :_: DEFF_NNP =_SYM 1_CD +_CD Rho_NNP -LRB-_-LRB- m-1_JJ -RRB-_-RRB- Therefore_RB ,_, the_DT smaller_JJR the_DT cluster_NN size_NN ,_, the_DT smaller_JJR the_DT design_NN effect_NN ._. 
Decreasing_VBG the_DT design_NN effect_NN through_IN decreasing_VBG the_DT cluster_NN size_NN may_MD ,_, to_TO a_DT certain_JJ degree_NN ,_, offset_VBD the_DT loss_NN of_IN precision_NN resulting_VBG from_IN decreasing_VBG the_DT overall_JJ sample_NN size_NN 
The_DT search_NN ,_, therefore_RB ,_, continues_VBZ for_IN the_DT ``_`` standard_JJ ''_'' designs_NNS that_WDT would_MD enable_VB measurement_NN of_IN most_JJS of_IN the_DT key_JJ emergency_NN indicators_NNS with_IN acceptable_JJ precision_NN while_IN requiring_VBG less_JJR time_NN and_CC fewer_JJR resources_NNS than_IN a_DT 30_CD 
Unfortunately_RB ,_, the_DT body_NN of_IN literature_NN that_WDT provides_VBZ guidance_NN on_IN design_NN effects_NNS for_IN different_JJ outcomes_NNS measured_VBN in_IN cluster_NN surveys_NNS in_IN emergencies_NNS is_VBZ very_RB limited_JJ ,_, and_CC design_NN effects_NNS are_VBP not_RB routinely_RB included_VBN in_IN survey_NN reports_NNS ._. 
Two_CD recent_JJ papers_NNS provide_VBP ,_, however_RB ,_, some_DT insight_NN into_IN commonly_RB seen_VBN magnitudes_NNS of_IN design_NN effects_NNS for_IN indicators_NNS frequently_RB measured_VBN in_IN emergencies_NNS ._. 
From_IN these_DT papers_NNS ,_, it_PRP seems_VBZ that_IN the_DT prevalence_NN of_IN global_JJ acute_JJ malnutrition_NN and_CC anemia_NN tend_VBP to_TO have_VB the_DT lowest_JJS design_NN effects_NNS -LRB-_-LRB- on_IN the_DT magnitude_NN of_IN 1_CD ._. 
0and_CD higher_JJR -RRB-_-RRB- are_VBP observed_VBN for_IN vitamin_NN A_DT distribution_NN and_CC vaccination_NN coverage_NN ._. 
0-RRB-_CD are_VBP observed_VBN for_IN a_DT cumulative_JJ 2-week_JJ incidence_NN of_IN diarrhea_NN and_CC acute_JJ respiratory_JJ infection_NN -LRB-_-LRB- ARI_NNP -RRB-_-RRB- ,_, and_CC yet_RB higher_JJR design_NN effects_NNS -LRB-_-LRB- 5_CD ._. 
The_DT highest_JJS design_NN effects_NNS -LRB-_-LRB- 10_CD and_CC higher_JJR -RRB-_-RRB- are_VBP likely_JJ to_TO be_VB observed_VBN for_IN some_DT household-level_JJ indicators_NNS ,_, such_JJ as_IN access_NN to_TO potable_JJ water_NN or_CC to_TO latrines_NNS ._. 
Therefore_RB ,_, 67_CD 
Organizations_NNPS conducting_VBG cluster_NN surveys_NNS in_IN emergency_NN settings_NNS need_VBP to_TO build_VB their_PRP$ technical_JJ capacity_NN in_IN survey_NN design_NN to_TO be_VB able_JJ to_TO calculate_VB context-specific_JJ sample_NN sizes_NNS individually_RB for_IN each_DT planned_VBN survey_NN ._. 
IntroductionOver_IN the_DT past_JJ three_CD decades_NNS ,_, field_NN surveys_NNS using_VBG a_DT cluster_NN sample_NN design_NN have_VBP become_VBN a_DT standard_JJ ,_, popular_JJ ,_, and_CC widely_RB used_VBN method_NN of_IN measuring_VBG key_JJ nutrition_NN and_CC health_NN indicators_NNS in_IN humanitarian_JJ emergencies_NNS ._. 
This_DT method_NN was_VBD first_RB widely_RB popularized_VBN by_IN the_DT Expanded_NNP Program_NNP on_IN Immunization_NNP -LRB-_-LRB- EPI_NNP -RRB-_-RRB- of_IN the_DT World_NNP Health_NNP Organization_NNP ,_, which_WDT since_IN 1978_CD has_VBZ promoted_VBN using_VBG a_DT 30_CD cluster_NN design_NN ,_, with_IN 7_CD children_NNS per_IN cluster_NN -LRB-_-LRB- popularly_RB known_VBN as_IN ``_`` 30_CD 
Introduction_NN Over_IN the_DT past_JJ three_CD decades_NNS ,_, field_NN surveys_NNS using_VBG a_DT cluster_NN sample_NN design_NN have_VBP become_VBN a_DT standard_JJ ,_, popular_JJ ,_, and_CC widely_RB used_VBN method_NN of_IN measuring_VBG key_JJ nutrition_NN and_CC health_NN indicators_NNS in_IN humanitarian_JJ emergencies_NNS ._. 
This_DT method_NN was_VBD first_RB widely_RB popularized_VBN by_IN the_DT Expanded_NNP Program_NNP on_IN Immunization_NNP -LRB-_-LRB- EPI_NNP -RRB-_-RRB- of_IN the_DT World_NNP Health_NNP Organization_NNP ,_, which_WDT since_IN 1978_CD has_VBZ promoted_VBN using_VBG a_DT 30_CD cluster_NN design_NN ,_, with_IN 7_CD children_NNS per_IN cluster_NN -LRB-_-LRB- popularly_RB known_VBN as_IN ``_`` 30_CD 
Introduction_NN Over_IN the_DT past_JJ three_CD decades_NNS ,_, field_NN surveys_NNS using_VBG a_DT cluster_NN sample_NN design_NN have_VBP become_VBN a_DT standard_JJ ,_, popular_JJ ,_, and_CC widely_RB used_VBN method_NN of_IN measuring_VBG key_JJ nutrition_NN and_CC health_NN indicators_NNS in_IN humanitarian_JJ emergencies_NNS ._. 
This_DT method_NN was_VBD first_RB widely_RB popularized_VBN by_IN the_DT Expanded_NNP Program_NNP on_IN Immunization_NNP -LRB-_-LRB- EPI_NNP -RRB-_-RRB- of_IN the_DT World_NNP Health_NNP Organization_NNP ,_, which_WDT since_IN 1978_CD has_VBZ promoted_VBN using_VBG a_DT 30_CD cluster_NN design_NN ,_, with_IN 7_CD children_NNS per_IN cluster_NN -LRB-_-LRB- popularly_RB known_VBN as_IN ``_`` 30_CD 
This_DT method_NN was_VBD first_RB widely_RB popularized_VBN by_IN the_DT Expanded_NNP Program_NNP on_IN Immunization_NNP -LRB-_-LRB- EPI_NNP -RRB-_-RRB- of_IN the_DT World_NNP Health_NNP Organization_NNP ,_, which_WDT since_IN 1978_CD has_VBZ promoted_VBN using_VBG a_DT 30_CD cluster_NN design_NN ,_, with_IN 7_CD children_NNS per_IN cluster_NN -LRB-_-LRB- popularly_RB known_VBN as_IN ``_`` 30_CD 
The_DT field_NN applications_NNS of_IN this_DT method_NN expanded_VBD rapidly_RB to_TO include_VB measuring_VBG such_JJ key_JJ emergency_NN indicators_NNS as_IN acute_JJ malnutrition_NN ,_, crude_JJ and_CC under-5_JJ mortality_NN ,_, cumulative_JJ incidence_NN of_IN diarrhea_NN and_CC respiratory_NN disease_NN ,_, access_NN to_TO safe_JJ water_NN ,_, prevalence_NN of_IN physical_JJ signs_NNS of_IN micronutrient_JJ deficiencies_NNS ,_, and_CC several_JJ others_NNS ._. 
The_DT challenges_NNS of_IN measuring_VBG these_DT indicators_NNS with_IN sufficient_JJ precision_NN triggered_VBD modifications_NNS to_TO the_DT initially_RB proposed_VBN standard_NN 30_CD 
Organizations_NNPS conducting_VBG cluster_NN surveys_NNS in_IN emergency_NN settings_NNS need_VBP to_TO build_VB their_PRP$ technical_JJ capacity_NN in_IN survey_NN design_NN to_TO be_VB able_JJ to_TO calculate_VB context-specific_JJ sample_NN sizes_NNS individually_RB for_IN each_DT planned_VBN survey_NN ._. 
IntroductionOver_IN the_DT past_JJ three_CD decades_NNS ,_, field_NN surveys_NNS using_VBG a_DT cluster_NN sample_NN design_NN have_VBP become_VBN a_DT standard_JJ ,_, popular_JJ ,_, and_CC widely_RB used_VBN method_NN of_IN measuring_VBG key_JJ nutrition_NN and_CC health_NN indicators_NNS in_IN humanitarian_JJ emergencies_NNS ._. 
This_DT method_NN was_VBD first_RB widely_RB popularized_VBN by_IN the_DT Expanded_NNP Program_NNP on_IN Immunization_NNP -LRB-_-LRB- EPI_NNP -RRB-_-RRB- of_IN the_DT World_NNP Health_NNP Organization_NNP ,_, which_WDT since_IN 1978_CD has_VBZ promoted_VBN using_VBG a_DT 30_CD cluster_NN design_NN ,_, with_IN 7_CD children_NNS per_IN cluster_NN -LRB-_-LRB- popularly_RB known_VBN as_IN ``_`` 30_CD 
This_DT method_NN was_VBD first_RB widely_RB popularized_VBN by_IN the_DT Expanded_NNP Program_NNP on_IN Immunization_NNP -LRB-_-LRB- EPI_NNP -RRB-_-RRB- of_IN the_DT World_NNP Health_NNP Organization_NNP ,_, which_WDT since_IN 1978_CD has_VBZ promoted_VBN using_VBG a_DT 30_CD cluster_NN design_NN ,_, with_IN 7_CD children_NNS per_IN cluster_NN -LRB-_-LRB- popularly_RB known_VBN as_IN ``_`` 30_CD 
Analysis_NN Achieving_VBG acceptable_JJ precision_NN A_DT simplified_VBN formula_NN used_VBN for_IN calculating_VBG the_DT width_NN of_IN the_DT one_CD side_NN of_IN the_DT two-sided_JJ 95_CD %_NN confidence_NN interval_NN in_IN cluster_NN surveys_NNS is_VBZ :_: d_SYM =_SYM Z_NN \*_NN sqrt_NN -LRB-_-LRB- p_NN -LRB-_-LRB- 1-p_JJ -RRB-_-RRB- \*_SYM DEFF\/n_NNP -RRB-_-RRB- where_WRB d_SYM =_SYM the_DT width_NN of_IN one_CD side_NN of_IN the_DT two-sided_JJ 95_CD %_NN confidence_NN interval_FW n_FW =_SYM sample_NN size_NN p_VBD =_SYM the_DT prevalence_NN of_IN the_DT outcome_NN being_VBG measured_VBN DEFF_NNP =_SYM design_NN effect_NN Z_NN =_SYM z_SYM value_NN -LRB-_-LRB- generally_RB 1_CD ._. 
96_CD -RRB-_-RRB- The_DT design_NN effect_NN is_VBZ the_DT ratio_NN of_IN the_DT variance_NN of_IN the_DT estimate_NN under_IN the_DT actual_JJ -LRB-_-LRB- for_IN example_NN ,_, cluster_NN -RRB-_-RRB- design_NN to_TO the_DT variance_NN of_IN the_DT estimate_NN assuming_VBG that_IN the_DT same_JJ data_NNS have_VBP been_VBN collected_VBN by_IN simple_JJ random_JJ sampling_NN 
Analysis_NN Achieving_VBG acceptable_JJ precision_NN A_DT simplified_VBN formula_NN used_VBN for_IN calculating_VBG the_DT width_NN of_IN the_DT one_CD side_NN of_IN the_DT two-sided_JJ 95_CD %_NN confidence_NN interval_NN in_IN cluster_NN surveys_NNS is_VBZ :_: d_SYM =_SYM Z_NN \*_NN sqrt_NN -LRB-_-LRB- p_NN -LRB-_-LRB- 1-p_JJ -RRB-_-RRB- \*_SYM DEFF\/n_NNP -RRB-_-RRB- where_WRB d_SYM =_SYM the_DT width_NN of_IN one_CD side_NN of_IN the_DT two-sided_JJ 95_CD %_NN confidence_NN interval_FW n_FW =_SYM sample_NN size_NN p_VBD =_SYM the_DT prevalence_NN of_IN the_DT outcome_NN being_VBG measured_VBN DEFF_NNP =_SYM design_NN effect_NN Z_NN =_SYM z_SYM value_NN -LRB-_-LRB- generally_RB 1_CD ._. 
96_CD -RRB-_-RRB- The_DT design_NN effect_NN is_VBZ the_DT ratio_NN of_IN the_DT variance_NN of_IN the_DT estimate_NN under_IN the_DT actual_JJ 
The_DT design_NN effect_NN can_MD be_VB presented_VBN as_IN a_DT function_NN of_IN the_DT average_JJ cluster_NN size_NN -LRB-_-LRB- m_NN -RRB-_-RRB- and_CC the_DT intracluster_NN correlation_NN coefficient_NN -LRB-_-LRB- Rho_NNP -RRB-_-RRB- ,_, which_WDT describes_VBZ the_DT relatedness_NN of_IN cluster_NN data_NNS by_IN comparing_VBG the_DT variance_NN within_IN clusters_NNS with_IN the_DT variance_NN between_IN clusters_NNS :_: DEFF_NNP =_SYM 1_CD +_CD Rho_NNP -LRB-_-LRB- m-1_JJ -RRB-_-RRB- Therefore_RB ,_, the_DT smaller_JJR the_DT cluster_NN size_NN ,_, the_DT smaller_JJR the_DT design_NN effect_NN ._. 
Decreasing_VBG the_DT design_NN effect_NN through_IN decreasing_VBG the_DT cluster_NN size_NN may_MD ,_, to_TO a_DT certain_JJ degree_NN ,_, offset_VBD the_DT loss_NN of_IN precision_NN resulting_VBG from_IN decreasing_VBG the_DT overall_JJ sample_NN size_NN 
Unfortunately_RB ,_, the_DT body_NN of_IN literature_NN that_WDT provides_VBZ guidance_NN on_IN design_NN effects_NNS for_IN different_JJ outcomes_NNS measured_VBN in_IN cluster_NN surveys_NNS in_IN emergencies_NNS is_VBZ very_RB limited_JJ ,_, and_CC design_NN effects_NNS are_VBP not_RB routinely_RB included_VBN in_IN survey_NN reports_NNS ._. 
Two_CD recent_JJ papers_NNS provide_VBP ,_, however_RB ,_, some_DT insight_NN into_IN commonly_RB seen_VBN magnitudes_NNS of_IN design_NN effects_NNS for_IN indicators_NNS frequently_RB measured_VBN in_IN emergencies_NNS ._. 
From_IN these_DT papers_NNS ,_, it_PRP seems_VBZ that_IN the_DT prevalence_NN of_IN global_JJ acute_JJ malnutrition_NN and_CC anemia_NN tend_VBP to_TO have_VB the_DT lowest_JJS design_NN effects_NNS -LRB-_-LRB- on_IN the_DT magnitude_NN of_IN 1_CD ._. 
Such_JJ calculations_NNS take_VBP into_IN account_NN not_RB only_RB statistical_JJ variables_NNS ,_, such_JJ as_IN the_DT expected_VBN prevalence_NN of_IN the_DT indicators_NNS being_VBG measured_VBN and_CC the_DT expected_VBN level_NN of_IN clustering_NN of_IN these_DT indicators_NNS ,_, but_CC also_RB logistics_NNS and_CC the_DT time_NN required_VBN to_TO survey_VB households_NNS or_CC individuals_NNS and_CC to_TO move_VB from_IN cluster_NN to_TO cluster_NN ._. 
These_DT calculations_NNS require_VBP substantial_JJ specialized_JJ expertise_NN ,_, which_WDT often_RB is_VBZ not_RB available_JJ to_TO organizations_NNS conducting_VBG surveys_NNS in_IN emergencies_NNS ._. 
The_DT search_NN ,_, therefore_RB ,_, continues_VBZ for_IN the_DT ``_`` standard_JJ ''_'' designs_NNS that_WDT would_MD enable_VB measurement_NN of_IN most_JJS of_IN the_DT key_JJ emergency_NN indicators_NNS with_IN acceptable_JJ precision_NN while_IN requiring_VBG less_JJR time_NN and_CC fewer_JJR resources_NNS than_IN a_DT 30_CD 
In_IN these_DT situations_NNS ,_, sample_NN sizes_NNS to_TO achieve_VB acceptable_JJ levels_NNS of_IN precision_NN need_VBP to_TO be_VB calculated_VBN for_IN each_DT of_IN the_DT key_JJ indicators_NNS 
The_DT search_NN ,_, therefore_RB ,_, continues_VBZ for_IN the_DT ``_`` standard_JJ ''_'' designs_NNS that_WDT would_MD enable_VB measurement_NN of_IN most_JJS of_IN the_DT key_JJ emergency_NN indicators_NNS with_IN acceptable_JJ precision_NN while_IN requiring_VBG less_JJR time_NN and_CC fewer_JJR resources_NNS than_IN a_DT 30_CD 
One_CD way_NN to_TO assess_VB the_DT seriousness_NN of_IN this_DT problem_NN is_VBZ to_TO compare_VB the_DT prevalence_NN estimates_NNS obtained_VBN from_IN a_DT 67_CD 
By_IN changing_VBG the_DT cluster_NN design_NN ,_, we_PRP can_MD modify_VB both_DT the_DT design_NN effect_NN -LRB-_-LRB- DEFF_NNP -RRB-_-RRB- and_CC the_DT sample_NN size_NN -LRB-_-LRB- n_NN -RRB-_-RRB- ,_, while_IN Z_NN and_CC p_NN will_MD not_RB be_VB affected_VBN ._. 
The_DT design_NN effect_NN can_MD be_VB presented_VBN as_IN a_DT function_NN of_IN the_DT average_JJ cluster_NN size_NN -LRB-_-LRB- m_NN -RRB-_-RRB- and_CC the_DT intracluster_NN correlation_NN coefficient_NN -LRB-_-LRB- Rho_NNP -RRB-_-RRB- ,_, which_WDT describes_VBZ the_DT relatedness_NN of_IN cluster_NN data_NNS by_IN comparing_VBG the_DT variance_NN within_IN clusters_NNS with_IN the_DT variance_NN between_IN clusters_NNS :_: DEFF_NNP =_SYM 1_CD +_CD Rho_NNP -LRB-_-LRB- m-1_JJ -RRB-_-RRB- Therefore_RB ,_, the_DT smaller_JJR the_DT cluster_NN size_NN ,_, the_DT smaller_JJR the_DT design_NN effect_NN ._. 
Decreasing_VBG the_DT design_NN effect_NN through_IN decreasing_VBG the_DT cluster_NN size_NN may_MD ,_, to_TO a_DT certain_JJ degree_NN ,_, offset_VBD the_DT loss_NN of_IN precision_NN resulting_VBG from_IN decreasing_VBG the_DT overall_JJ sample_NN size_NN 
Such_JJ calculations_NNS take_VBP into_IN account_NN not_RB only_RB statistical_JJ variables_NNS ,_, such_JJ as_IN the_DT expected_VBN prevalence_NN of_IN the_DT indicators_NNS being_VBG measured_VBN and_CC the_DT expected_VBN level_NN of_IN clustering_NN of_IN these_DT indicators_NNS ,_, but_CC also_RB logistics_NNS and_CC the_DT time_NN required_VBN to_TO survey_VB households_NNS or_CC individuals_NNS and_CC to_TO move_VB from_IN cluster_NN to_TO cluster_NN ._. 
These_DT calculations_NNS require_VBP substantial_JJ specialized_JJ expertise_NN ,_, which_WDT often_RB is_VBZ not_RB available_JJ to_TO organizations_NNS conducting_VBG surveys_NNS in_IN emergencies_NNS 
The_DT challenges_NNS of_IN measuring_VBG these_DT indicators_NNS with_IN sufficient_JJ precision_NN triggered_VBD modifications_NNS to_TO the_DT initially_RB proposed_VBN standard_NN 30_CD 
It_PRP is_VBZ important_JJ to_TO continue_VB building_VBG technical_JJ capacity_NN in_IN cluster_NN survey_NN design_NN within_IN organizations_NNS conducting_VBG cluster_NN surveys_NNS in_IN humanitarian_JJ emergencies_NNS ._. 
Several_JJ important_JJ initiatives_NNS -LRB-_-LRB- Standardized_JJ Monitoring_NN and_CC Assessment_NNP of_IN Relief_NNP and_CC Transitions_NNP -LRB-_-LRB- SMART_NNP -RRB-_-RRB- ,_, Health_NNP and_CC Nutrition_NNP Tracking_NNP Service_NNP -RRB-_-RRB- and_CC recently_RB published_VBN survey_NN manuals_NNS 
This_DT result_NN was_VBD unexpected_JJ because_IN most_JJS sample_NN groups_NNS tend_VBP to_TO become_VB more_JJR like_IN the_DT general_JJ population_NN over_IN time_NN -LRB-_-LRB- or_CC ,_, even_RB if_IN they_PRP differ_VBP at_IN baseline_NN ,_, the_DT effect_NN of_IN that_DT initial_JJ difference_NN becomes_VBZ less_RBR important_JJ -RRB-_-RRB- ._. 
Other_JJ longitudinal_JJ studies_NNS have_VBP found_VBN the_DT mortality_NN of_IN sampled_VBN respondents_NNS and_CC non-respondents_NNS converging_VBG over_IN time_NN ._. 
That_IN the_DT ALSWH_NNP 1921-26_CD cohort_NN had_VBD significantly_RB better_JJR survival_NN was_VBD expected_VBN ,_, as_IN participants_NNS were_VBD self_NN selected_VBN from_IN an_DT initial_JJ sample_NN of_IN randomly_RB selected_VBN Australian_JJ women_NNS ._. 
It_PRP would_MD be_VB expected_VBN that_IN older_JJR women_NNS -_: in_IN particular_JJ those_DT with_IN better_JJR health_NN -LRB-_-LRB- `_`` the_DT healthy_JJ volunteer_NN '_'' -RRB-_-RRB- or_CC who_WP were_VBD more_RBR interested_JJ in_IN their_PRP$ health_NN -_: would_MD be_VB more_RBR likely_JJ to_TO participate_VB in_IN such_PDT a_DT survey_NN ._. 
Similar_JJ effects_NNS have_VBP been_VBN observed_VBN in_IN other_JJ longitudinal_JJ studies_NNS 
Finally_RB the_DT interval-specific_JJ and_CC cumulative_JJ relative_JJ survival_NN ratios_NNS -LRB-_-LRB- R_NNP and_CC CR_NNP -RRB-_-RRB- were_VBD calculated_VBN as_IN the_DT ratios_NNS of_IN the_DT observed_VBN and_CC expected_VBN interval-specific_JJ and_CC cumulative_JJ survivals_NNS :_: R_NNP =_SYM P_FW \/_FW P_FW \*_SYM 
That_IN the_DT ALSWH_NNP 1921-26_CD cohort_NN had_VBD significantly_RB better_JJR survival_NN was_VBD expected_VBN ,_, as_IN participants_NNS were_VBD self_NN selected_VBN from_IN an_DT initial_JJ sample_NN of_IN randomly_RB selected_VBN Australian_JJ women_NNS ._. 
From_IN an_DT initial_JJ sample_NN of_IN 39_CD 000_CD women_NNS selected_VBN from_IN the_DT Medicare_NNP database_NN ,_, 12_CD 432_CD responded_VBD ._. 
It_PRP would_MD be_VB expected_VBN that_IN older_JJR women_NNS -_: in_IN particular_JJ those_DT with_IN better_JJR health_NN -LRB-_-LRB- `_`` the_DT healthy_JJ volunteer_NN '_'' -RRB-_-RRB- or_CC who_WP were_VBD more_RBR interested_JJ in_IN their_PRP$ health_NN -_: would_MD be_VB more_RBR likely_JJ to_TO participate_VB in_IN such_PDT a_DT survey_NN ._. 
Aprevious_JJ paper_NN examining_VBG linkage_NN of_IN the_DT study_NN population_NN to_TO the_DT NDI_NNP in_IN 1998_CD showed_VBD that_IN such_PDT a_DT linkage_NN identified_VBN 95_CD %_NN of_IN the_DT deaths_NNS ,_, however_RB this_DT has_VBZ not_RB been_VBN reassessed_VBN since_IN that_DT time_NN and_CC it_PRP is_VBZ possible_JJ that_IN this_DT capture_NN method_NN has_VBZ worsened_VBN over_IN the_DT last_JJ decade_NN ._. 
Other_JJ studies_NNS of_IN the_DT accuracy_NN of_IN the_DT NDI_NNP found_VBD the_DT false_JJ negative_JJ rate_NN ranging_VBG from_IN 3_CD %_NN to_TO 11_CD %_NN -LRB-_-LRB- compared_VBN to_TO 5_CD %_NN in_IN the_DT ALSWH_NNP study_NN -RRB-_-RRB- 
ARIA_NN categorises_VBZ areas_NNS as_IN `_`` highly_RB accessible_JJ '_'' ,_, `_`` accessible_JJ '_'' ,_, `_`` moderately_RB accessible_JJ '_'' ,_, `_`` remote_JJ '_'' and_CC `_`` very_RB remote_JJ '_'' based_VBN on_IN the_DT road_NN distance_NN from_IN the_DT closest_JJS service_NN center_NN ._. 
Relative_JJ survival_NN was_VBD calculated_VBN using_VBG SAS_NNP macros_NNS created_VBN by_IN Paul_NNP Dickman_NNP ._. 
Comparison_NN to_TO NHS_NNP Selected_NNP demographic_JJ ,_, health_NN behavior_NN ,_, and_CC health_NN status_NN characteristics_NNS of_IN the_DT ALSWH_NNP sample_NN were_VBD compared_VBN to_TO those_DT of_IN participants_NNS of_IN the_DT 1995_CD NHS_NNP of_IN the_DT same_JJ age_NN in_IN order_NN to_TO explore_VB possible_JJ reasons_NNS for_IN observed_JJ differences_NNS in_IN survival_NN ._. 
All_DT analyses_NNS were_VBD performed_VBN using_VBG SAS_NNP version_NN 9_CD ._. 
The_DT proportional_JJ hazards_NNS model_NN was_VBD conducted_VBN using_VBG the_DT SAS_NNP PHREG_NNP procedure_NN ;_: a_DT hazard_NN ratio_NN of_IN less_JJR than_IN one_CD indicates_VBZ better_RBR relative_JJ survival_NN ._. 
1._CD 
Results_NNS Relative_JJ survival_NN There_EX were_VBD 3661_CD deaths_NNS -LRB-_-LRB- 29_CD ._. 
4%_CD -RRB-_-RRB- amongst_IN the_DT 12_CD 432_CD women_NNS born_VBN in_IN 1921-26_CD who_WP participated_VBD in_IN the_DT baseline_JJ survey_NN of_IN the_DT ALSWH_NNP ._. 
Aprevious_JJ paper_NN examining_VBG linkage_NN of_IN the_DT study_NN population_NN to_TO the_DT NDI_NNP in_IN 1998_CD showed_VBD that_IN such_PDT a_DT linkage_NN identified_VBN 95_CD %_NN of_IN the_DT deaths_NNS ,_, however_RB this_DT has_VBZ not_RB been_VBN reassessed_VBN since_IN that_DT time_NN and_CC it_PRP is_VBZ possible_JJ that_IN this_DT capture_NN method_NN has_VBZ worsened_VBN over_IN the_DT last_JJ decade_NN ._. 
Other_JJ studies_NNS of_IN the_DT accuracy_NN of_IN the_DT NDI_NNP found_VBD the_DT false_JJ negative_JJ rate_NN ranging_VBG from_IN 3_CD %_NN to_TO 11_CD %_NN -LRB-_-LRB- compared_VBN to_TO 5_CD %_NN in_IN the_DT ALSWH_NNP study_NN -RRB-_-RRB- 
The_DT women_NNS were_VBD selected_VBN randomly_RB from_IN the_DT national_JJ Medicare_NNP health_NN insurance_NN database_NN -LRB-_-LRB- which_WDT includes_VBZ all_DT citizens_NNS and_CC permanent_JJ residents_NNS of_IN Australia_NNP -RRB-_-RRB- ,_, with_IN intentional_JJ over-sampling_NN of_IN women_NNS living_VBG in_IN rural_JJ and_CC remote_JJ areas_NNS ._. 
In_IN 1996_CD ,_, more_JJR than_IN 40_CD 000_CD women_NNS responded_VBD to_TO the_DT initial_JJ survey_NN ;_: they_PRP were_VBD reasonably_RB representative_JJ of_IN the_DT general_JJ population_NN of_IN Australian_JJ women_NNS in_IN each_DT age_NN group_NN ,_, although_IN compared_VBN with_IN data_NNS from_IN the_DT 1996_CD Australian_NNP Census_NNP there_RB was_VBD over-representation_NN of_IN women_NNS who_WP were_VBD born_VBN in_IN Australia_NNP ,_, employed_VBD and_CC had_VBD a_DT university_NN education_NN ._. 
More_JJR details_NNS about_IN the_DT study_NN can_MD be_VB found_VBN at_IN 
Due_JJ to_TO the_DT small_JJ number_NN of_IN participants_NNS from_IN the_DT Northern_NNP Territory_NNP this_DT jurisdiction_NN is_VBZ not_RB included_VBN in_IN the_DT State\/Territory_NNP comparisons_NNS ._. 
Mortality_NN dataUsing_VBG personal_JJ identifying_VBG information_NN provided_VBN by_IN the_DT participants_NNS ,_, vital_JJ status_NN was_VBD ascertained_VBN by_IN probabilistic_JJ linkage_NN to_TO the_DT National_NNP Death_NNP Index_NNP -LRB-_-LRB- NDI_NNP -RRB-_-RRB- for_IN all_DT participants_NNS from_IN baseline_NN -LRB-_-LRB- 1996_CD -RRB-_-RRB- to_TO 31_CD October_NNP 2008_CD ._. 
The_DT expected_JJ mortality_NN of_IN the_DT study_NN population_NN was_VBD ascertained_VBN using_VBG annual_JJ life_NN tables_NNS produced_VBN by_IN the_DT Australian_NNP Bureau_NNP of_IN Statistics_NNP -LRB-_-LRB- ABS_NNP -RRB-_-RRB- for_IN each_DT State_NNP and_CC Territory_NNP of_IN Australia_NNP 
Death_NNP information_NN was_VBD obtained_VBN from_IN both_DT linkage_NN to_TO the_DT NDI_NNP as_RB well_RB as_IN notification_NN by_IN family_NN or_CC carers_NNS of_IN participants_NNS ._. 
Aprevious_JJ paper_NN examining_VBG linkage_NN of_IN the_DT study_NN population_NN to_TO the_DT NDI_NNP in_IN 1998_CD showed_VBD that_IN such_PDT a_DT linkage_NN identified_VBN 95_CD %_NN of_IN the_DT deaths_NNS ,_, however_RB this_DT has_VBZ not_RB been_VBN reassessed_VBN since_IN that_DT time_NN and_CC it_PRP is_VBZ possible_JJ that_IN this_DT capture_NN method_NN has_VBZ worsened_VBN over_IN the_DT last_JJ decade_NN ._. 
Other_JJ studies_NNS of_IN the_DT accuracy_NN of_IN the_DT NDI_NNP found_VBD the_DT false_JJ negative_JJ rate_NN ranging_VBG from_IN 3_CD %_NN to_TO 11_CD %_NN -LRB-_-LRB- compared_VBN to_TO 5_CD %_NN in_IN the_DT ALSWH_NNP study_NN -RRB-_-RRB- 
Mortality_NN data_NNS Using_VBG personal_JJ identifying_VBG information_NN provided_VBN by_IN the_DT participants_NNS ,_, vital_JJ status_NN was_VBD ascertained_VBN by_IN probabilistic_JJ linkage_NN to_TO the_DT National_NNP Death_NNP Index_NNP -LRB-_-LRB- NDI_NNP -RRB-_-RRB- for_IN all_DT participants_NNS from_IN baseline_NN -LRB-_-LRB- 1996_CD -RRB-_-RRB- to_TO 31_CD October_NNP 2008_CD ._. 
The_DT expected_JJ mortality_NN of_IN the_DT study_NN population_NN was_VBD ascertained_VBN using_VBG annual_JJ life_NN tables_NNS produced_VBN by_IN the_DT Australian_NNP Bureau_NNP of_IN Statistics_NNP -LRB-_-LRB- ABS_NNP -RRB-_-RRB- for_IN each_DT State_NNP and_CC Territory_NNP of_IN Australia_NNP 
The_DT model_NN was_VBD of_IN the_DT form_NN :_: 
The_DT 1995_CD NHS_NNP was_VBD conducted_VBN during_IN the_DT 12-month_JJ period_NN of_IN January_NNP 1995_CD to_TO January_NNP 1996_CD ._. 
It_PRP consists_VBZ of_IN a_DT representative_JJ sample_NN of_IN residents_NNS of_IN private_JJ and_CC non-private_JJ dwellings_NNS in_IN all_DT States_NNPS and_CC Territories_NNPS ,_, but_CC excludes_VBZ special_JJ dwellings_NNS such_JJ as_IN hospitals_NNS ,_, institutions_NNS ,_, and_CC nursing_NN homes_NNS ._. 
It_PRP comprised_VBD about_IN 23_CD 800_CD households_NNS ,_, representing_VBG approximately_RB 57_CD 600_CD persons_NNS 
These_DT comparisons_NNS were_VBD presented_VBN as_IN percentages_NNS and_CC analyzed_VBD using_VBG the_DT 
The_DT many_JJ threats_NNS to_TO the_DT external_JJ validity_NN of_IN a_DT study_NN 's_POS results_NNS include_VBP choice_NN of_IN sampling_VBG frame_NN ,_, representativeness_NN of_IN the_DT initial_JJ sample_NN ,_, and_CC attrition_NN ._. 
These_DT issues_NNS were_VBD discussed_VBN in_IN a_DT previous_JJ paper_NN ,_, and_CC reporting_NN methods_NNS were_VBD proposed_VBN that_WDT would_MD enable_VB the_DT reader_NN to_TO assess_VB -_: at_IN least_JJS qualitatively_RB -_: the_DT generalisability_NN of_IN results_NNS from_IN a_DT cohort_NN or_CC longitudinal_JJ study_NN ._. 
These_DT reporting_NN methods_NNS have_VBP since_IN been_VBN taken_VBN further_RBR with_IN the_DT publication_NN of_IN the_DT Strengthening_VBG the_DT Reporting_NNP of_IN Observational_NNP Studies_NNP in_IN Epidemiology_NNP -LRB-_-LRB- STROBE_NNP -RRB-_-RRB- initiative_NN 
These_DT issues_NNS were_VBD discussed_VBN in_IN a_DT previous_JJ paper_NN ,_, and_CC reporting_NN methods_NNS were_VBD proposed_VBN that_WDT would_MD enable_VB the_DT reader_NN to_TO assess_VB -_: at_IN least_JJS qualitatively_RB -_: the_DT generalisability_NN of_IN results_NNS from_IN a_DT cohort_NN or_CC longitudinal_JJ study_NN ._. 
These_DT reporting_NN methods_NNS have_VBP since_IN been_VBN taken_VBN further_RBR with_IN the_DT publication_NN of_IN the_DT Strengthening_VBG the_DT Reporting_NNP of_IN Observational_NNP Studies_NNP in_IN Epidemiology_NNP -LRB-_-LRB- STROBE_NNP -RRB-_-RRB- initiative_NN 
The_DT advantage_NN of_IN this_DT method_NN is_VBZ that_IN ,_, through_IN a_DT single_JJ measure_NN ,_, it_PRP can_MD indicate_VB the_DT degree_NN to_TO which_WDT a_DT study_NN sample_NN corresponds_NNS to_TO the_DT general_JJ population_NN with_IN respect_NN to_TO health_NN status_NN ._. 
Along_IN with_IN the_DT other_JJ comparisons_NNS of_IN the_DT study_NN population_NN to_TO census_NN and_CC survey_NN data_NNS ,_, this_DT measure_NN provides_VBZ information_NN relevant_JJ to_TO the_DT reporting_NN requirements_NNS of_IN the_DT STROBE_NNP statement_NN ._. 
In_IN the_DT case_NN of_IN the_DT ALSWH_NNP cohort_NN studied_VBD here_RB ,_, it_PRP seems_VBZ likely_JJ that_IN most_JJS of_IN the_DT difference_NN in_IN their_PRP$ survival_NN over_IN that_DT of_IN the_DT general_JJ population_NN is_VBZ attributable_JJ to_TO the_DT better_JJR health_NN of_IN the_DT sample_NN at_IN baseline_NN ._. 
This_DT potential_JJ source_NN of_IN bias_NN is_VBZ different_JJ from_IN biases_NNS that_WDT lead_VBP to_TO other_JJ types_NNS of_IN attrition_NN among_IN participants_NNS who_WP are_VBP still_RB alive_JJ ._. 
Relative_JJ survival_NN is_VBZ the_DT ratio_NN of_IN survival_NN that_WDT is_VBZ observed_VBN in_IN the_DT study_NN sample_NN in_IN comparison_NN to_TO that_DT of_IN the_DT population_NN from_IN which_WDT it_PRP was_VBD drawn_VBN ._. 
This_DT method_NN ,_, which_WDT was_VBD originally_RB developed_VBN to_TO measure_VB survival_NN of_IN cancer_NN patients_NNS ,_, has_VBZ not_RB been_VBN used_VBN previously_RB to_TO assess_VB bias_NN due_JJ to_TO deaths_NNS in_IN cohort_NN studies_NNS ._. 
Using_VBG unit_NN record_NN data_NNS supplied_VBN by_IN the_DT ABS_NNP ,_, these_DT women_NNS were_VBD compared_VBN against_IN the_DT ALSWH_NNP cohort_NN participants_NNS at_IN the_DT first_JJ survey_NN for_IN selected_VBN characteristics_NNS 
This_DT result_NN was_VBD unexpected_JJ because_IN most_JJS sample_NN groups_NNS tend_VBP to_TO become_VB more_JJR like_IN the_DT general_JJ population_NN over_IN time_NN -LRB-_-LRB- or_CC ,_, even_RB if_IN they_PRP differ_VBP at_IN baseline_NN ,_, the_DT effect_NN of_IN that_DT initial_JJ difference_NN becomes_VBZ less_RBR important_JJ -RRB-_-RRB- ._. 
Other_JJ longitudinal_JJ studies_NNS have_VBP found_VBN the_DT mortality_NN of_IN sampled_VBN respondents_NNS and_CC non-respondents_NNS converging_VBG over_IN time_NN ._. 
That_IN the_DT ALSWH_NNP 1921-26_CD cohort_NN had_VBD significantly_RB bette_NN 
It_PRP would_MD be_VB expected_VBN that_IN older_JJR women_NNS -_: in_IN particular_JJ those_DT with_IN better_JJR health_NN -LRB-_-LRB- `_`` the_DT healthy_JJ volunteer_NN '_'' -RRB-_-RRB- or_CC who_WP were_VBD more_RBR interested_JJ in_IN their_PRP$ health_NN -_: would_MD be_VB more_RBR likely_JJ to_TO participate_VB in_IN such_PDT a_DT survey_NN ._. 
Similar_JJ effects_NNS have_VBP been_VBN observed_VBN in_IN other_JJ longitudinal_JJ studies_NNS 
Similar_JJ effects_NNS have_VBP been_VBN observed_VBN in_IN other_JJ longitudinal_JJ studies_NNS ._. 
It_PRP would_MD be_VB expected_VBN that_IN older_JJR women_NNS -_: in_IN particular_JJ those_DT with_IN better_JJR health_NN -LRB-_-LRB- `_`` the_DT healthy_JJ volunteer_NN '_'' -RRB-_-RRB- or_CC who_WP were_VBD more_RBR interested_JJ in_IN their_PRP$ health_NN -_: would_MD be_VB more_RBR likely_JJ to_TO participate_VB in_IN such_PDT a_DT survey_NN ._. 
Consistent_JJ with_IN previous_JJ analysis_NN comparing_VBG the_DT ALSWH_NNP cohort_NN to_TO census_NN data_NNS 
,women_NNS born_VBN in_IN 1921-25_CD -RRB-_-RRB- participated_VBD in_IN the_DT 1995_CD NHS_NNP ._. 
e._VB A_DT total_NN of_IN 894_CD women_NNS aged_VBD 70_CD to_TO 74_CD years_NNS -LRB-_-LRB- i._VB Using_VBG unit_NN record_NN data_NNS supplied_VBN by_IN the_DT ABS_NNP ,_, these_DT women_NNS were_VBD compared_VBN against_IN the_DT ALSWH_NNP cohort_NN participants_NNS at_IN the_DT first_JJ survey_NN for_IN selected_VBN characteristics_NNS 
It_PRP was_VBD assumed_VBN that_IN the_DT expected_VBN mortality_NN experienced_VBN by_IN the_DT study_NN sample_NN during_IN a_DT particular_JJ period_NN would_MD be_VB the_DT same_JJ as_IN mortality_NN in_IN the_DT general_JJ population_NN of_IN the_DT same_JJ sex_NN ,_, age_NN ,_, and_CC State_NNP or_CC Territory_NNP of_IN residence_NN from_IN which_WDT they_PRP are_VBP drawn_VBN ._. 
The_DT Ederer_NNP II_NNP method_NN was_VBD used_VBN to_TO calculate_VB interval-specific_JJ relative_JJ survival_NN ._. 
Firstly_RB the_DT population_NN -LRB-_-LRB- L_NNP -RRB-_-RRB- at_IN the_DT start_NN of_IN each_DT interval_NN in_IN each_DT birth_NN cohort_NN and_CC the_DT number_NN of_IN deaths_NNS -LRB-_-LRB- D_NNP -RRB-_-RRB- and_CC those_DT lost_VBN to_TO follow-up_JJ -LRB-_-LRB- W_NNP -RRB-_-RRB- during_IN the_DT interval_NN were_VBD determined_VBN ._. 
It_PRP would_MD be_VB expected_VBN that_IN older_JJR women_NNS -_: in_IN particular_JJ those_DT with_IN better_JJR health_NN -LRB-_-LRB- `_`` the_DT healthy_JJ volunteer_NN '_'' -RRB-_-RRB- or_CC who_WP were_VBD more_RBR interested_JJ in_IN their_PRP$ health_NN -_: would_MD be_VB more_RBR likely_JJ to_TO participate_VB in_IN such_PDT a_DT survey_NN ._. 
Similar_JJ effects_NNS have_VBP been_VBN observed_VBN in_IN other_JJ longitudinal_JJ studies_NNS 
The_DT effect_NN of_IN oversampling_VBG in_IN rural_JJ areas_NNS was_VBD accounted_VBN for_IN by_IN including_VBG place_NN of_IN residence_NN as_IN it_PRP was_VBD defined_VBN in_IN the_DT original_JJ sample_NN -LRB-_-LRB- urban_JJ ,_, rural_JJ and_CC remote_JJ -RRB-_-RRB- as_IN a_DT covariate_NN in_IN the_DT model_NN ._. 
Factors_NNS considered_VBN in_IN this_DT analysis_NN were_VBD based_VBN on_IN the_DT results_NNS of_IN a_DT previous_JJ study_NN of_IN the_DT survival_NN of_IN this_DT cohort_NN ._. 
These_DT factors_NNS included_VBD were_VBD :_: age_NN ,_, marital_JJ status_NN ,_, country_NN of_IN birth_NN ,_, State_NNP or_CC Territory_NNP of_IN residence_NN ,_, Accessibility\/Remoteness_NNP Index_NNP -LRB-_-LRB- ARIA_NNP -RRB-_-RRB- ,_, education_NN ,_, smoking_NN status_NN ,_, physical_JJ activity_NN ,_, body_NN mass_NN index_NN and_CC self_NN rated_VBN health_NN ._. 
Consistent_JJ with_IN previous_JJ analysis_NN comparing_VBG the_DT ALSWH_NNP cohort_NN to_TO census_NN data_NNS 
Within_IN the_DT source_NN population_NN ,_, we_PRP contrasted_VBD patients_NNS with_IN both_DT blood_NN tests_NNS requested_VBD and_CC with_IN both_DT blood_NN tests_VBZ non-requested_JJ ,_, one_CD at_IN time_NN of_IN admission_NN and_CC one_CD at_IN the_DT end_NN of_IN hospitalization_NN ._. 
For_IN all_DT participants_NNS the_DT discharge_VBP diagnosis_NN was_VBD defined_VBN according_VBG to_TO the_DT ICD-9-CM_NNP code_NN ._. 
Data_NNP analysis_NN Student_NN t-tests_NNS ,_, Mann-Whitney_NNP tests_NNS ,_, and_CC chi-square_JJ tests_NNS were_VBD used_VBN to_TO test_VB for_IN differences_NNS between_IN groups_NNS ,_, as_IN appropriate_JJ ._. 
Of_IN these_DT potential_JJ confounders_NNS ,_, only_RB diagnosis_NN had_VBD a_DT substantial_JJ effect_NN on_IN the_DT comparison_NN between_IN scenarios_NNS ._. 
Glucocorticoid_JJ use_NN was_VBD studied_VBN because_RB of_IN the_DT ongoing_JJ discussion_NN about_IN the_DT effect_NN of_IN glucocorticoids_NNS on_IN the_DT neutrophil_NN count_NN 
One_CD example_NN where_WRB testing_NN bias_NN might_MD occur_VB is_VBZ in_IN physicians_NNS '_POS requests_NNS of_IN blood_NN tests_NNS ._. 
There_EX are_VBP several_JJ strategies_NNS to_TO minimize_VB testing_NN bias_NN ,_, including_VBG selection_NN of_IN proper_JJ patient_NN populations_NNS ,_, measuring_VBG outcomes_NNS for_IN all_DT study_NN participants_NNS ,_, blind_JJ testing_NN ,_, or_CC using_VBG imputation_NN techniques_NNS to_TO deal_VB with_IN missing_JJ data_NNS 
UPOD_NNP data_NNS acquisition_NN and_CC data_NN management_NN is_VBZ in_IN accordance_NN with_IN current_JJ Dutch_JJ privacy_NN and_CC ethical_JJ regulations_NNS ._. 
Amore_JJ complete_JJ description_NN of_IN UPOD_NNP has_VBZ been_VBN published_VBN elsewhere_RB ._. 
UPOD_NNP is_VBZ a_DT unique_JJ clinical_JJ database_NN as_IN it_PRP contains_VBZ results_NNS of_IN hematological_JJ blood_NN tests_NNS measured_VBN with_IN Cell-Dyn_NNP Sapphire_NNP automated_JJ blood_NN cell_NN analyzers_NNS -LRB-_-LRB- Abbott_NNP Diagnostics_NNPS ,_, St._NNP 
UPOD_NNP is_VBZ a_DT unique_JJ clinical_JJ database_NN as_IN it_PRP contains_VBZ results_NNS of_IN hematological_JJ blood_NN tests_NNS measured_VBN with_IN Cell-Dyn_NNP Sapphire_NNP automated_JJ blood_NN cell_NN analyzers_NNS -LRB-_-LRB- Abbott_NNP Diagnostics_NNPS ,_, St._NNP Clara_NNP ,_, California_NNP ,_, USA_NNP -RRB-_-RRB- 
Clara_NNP ,_, California_NNP ,_, USA_NNP -RRB-_-RRB- 
Of_IN these_DT potential_JJ confounders_NNS ,_, only_RB diagnosis_NN had_VBD a_DT substantial_JJ effect_NN on_IN the_DT comparison_NN between_IN scenarios_NNS ._. 
Glucocorticoid_JJ use_NN was_VBD studied_VBN because_RB of_IN the_DT ongoing_JJ discussion_NN about_IN the_DT effect_NN of_IN glucocorticoids_NNS on_IN the_DT neutrophil_NN count_NN ._. 
Subsequently_RB ,_, linear_JJ regression_NN analysis_NN was_VBD used_VBN to_TO estimate_VB the_DT proportion_NN of_IN bias_NN associated_VBN with_IN diagnostic_JJ subgroups_NNS and_CC glucocorticoid_JJ use_NN ._. 
2%_CD by_IN cardiovascular_JJ disease_NN ._. 
The_DT bias_NN in_IN absolute_JJ neutrophil_NN count_NN in_IN the_DT first_JJ blood_NN test_NN could_MD be_VB explained_VBN for_IN 83_CD ._. 
This_DT finding_NN could_MD reflect_VB the_DT role_NN of_IN neutrophils_NNS in_IN cardiovascular_JJ disease_NN ._. 
After_IN excluding_VBG cardiovascular_JJ disease_NN from_IN analysis_NN ,_, there_EX were_VBD no_DT differences_NNS in_IN absolute_JJ neutrophil_NN count_NN or_CC change_NN in_IN neutrophil_NN count_NN for_IN each_DT patient_NN ._. 
Such_JJ selective_JJ processes_NNS might_MD induce_VB testing_NN bias_NN in_IN clinical_JJ database_NN studies_NNS ._. 
Physicians_NNP selectively_RB request_NN tests_NNS for_IN patients_NNS with_IN a_DT high_JJ probability_NN of_IN abnormalities_NNS and_CC less_RBR frequently_RB for_IN patients_NNS with_IN a_DT low_JJ probability_NN ,_, because_IN of_IN patient_JJ burden_NN and_CC costs_NNS 
One_CD example_NN where_WRB testing_NN bias_NN might_MD occur_VB is_VBZ in_IN physicians_NNS '_POS requests_NNS of_IN blood_NN tests_NNS ._. 
There_EX are_VBP several_JJ strategies_NNS to_TO minimize_VB testing_NN bias_NN ,_, including_VBG selection_NN of_IN proper_JJ patient_NN populations_NNS ,_, measuring_VBG outcomes_NNS for_IN all_DT study_NN participants_NNS ,_, blind_JJ testing_NN ,_, or_CC using_VBG imputation_NN techniques_NNS to_TO deal_VB with_IN missing_JJ data_NNS 
Of_IN these_DT potential_JJ confounders_NNS ,_, only_RB diagnosis_NN had_VBD a_DT substantial_JJ effect_NN on_IN the_DT comparison_NN between_IN scenarios_NNS ._. 
Glucocorticoid_JJ use_NN was_VBD studied_VBN because_RB of_IN the_DT ongoing_JJ discussion_NN about_IN the_DT effect_NN of_IN glucocorticoids_NNS on_IN the_DT neutrophil_NN count_NN ._. 
Subsequently_RB ,_, linear_JJ regression_NN analysis_NN was_VBD used_VBN to_TO estimate_VB the_DT proportion_NN of_IN bias_NN associated_VBN with_IN diagnostic_JJ subgroups_NNS and_CC glucocorticoid_JJ use_NN ._. 
2%_CD by_IN cardiovascular_JJ disease_NN ._. 
The_DT bias_NN in_IN absolute_JJ neutrophil_NN count_NN in_IN the_DT first_JJ blood_NN test_NN could_MD be_VB explained_VBN for_IN 83_CD ._. 
This_DT finding_NN could_MD reflect_VB the_DT role_NN of_IN neutrophils_NNS in_IN cardiovascular_JJ disease_NN ._. 
After_IN excluding_VBG cardiovascular_JJ disease_NN from_IN analysis_NN ,_, there_EX were_VBD no_DT differences_NNS in_IN absolute_JJ neutrophil_NN count_NN or_CC change_NN in_IN neutrophil_NN count_NN for_IN each_DT patient_NN ._. 
Aclassic_JJ example_NN of_IN testing_NN bias_NN is_VBZ the_DT association_NN between_IN thrombosis_NN and_CC use_NN of_IN oral_JJ contraceptives_NNS ._. 
Many_JJ studies_NNS state_VBP traditionally_RB that_IN the_DT size_NN of_IN this_DT association_NN is_VBZ overestimated_VBN because_IN of_IN diagnostic_JJ suspicion_NN bias_NN and_CC referral_NN bias_NN ,_, both_DT types_NNS of_IN testing_NN bias_NN 
Aclassic_JJ example_NN of_IN testing_NN bias_NN is_VBZ the_DT association_NN between_IN thrombosis_NN and_CC use_NN of_IN oral_JJ contraceptives_NNS ._. 
Many_JJ studies_NNS state_VBP traditionally_RB that_IN the_DT size_NN of_IN this_DT association_NN is_VBZ overestimated_VBN because_IN of_IN diagnostic_JJ suspicion_NN bias_NN and_CC referral_NN bias_NN ,_, both_DT types_NNS of_IN testing_NN bias_NN 
At_IN time_NN of_IN the_DT second_JJ blood_NN test_NN the_DT difference_NN in_IN absolute_JJ neutrophil_NN count_NN has_VBZ evened_VBN out_RP ,_, as_IN patients_NNS are_VBP healthier_RBR at_IN the_DT end_NN of_IN hospitalization_NN ._. 
The_DT results_NNS of_IN this_DT study_NN are_VBP in_IN accordance_NN with_IN other_JJ studies_NNS finding_VBG that_IN data_NNS are_VBP not_RB missing_VBG at_IN random_JJ 
At_IN time_NN of_IN the_DT second_JJ blood_NN test_NN the_DT difference_NN in_IN absolute_JJ neutrophil_NN count_NN has_VBZ evened_VBN out_RP ,_, as_IN patients_NNS are_VBP healthier_RBR at_IN the_DT end_NN of_IN hospitalization_NN ._. 
The_DT results_NNS of_IN this_DT study_NN are_VBP in_IN accordance_NN with_IN other_JJ studies_NNS finding_VBG that_IN data_NNS are_VBP not_RB missing_VBG at_IN random_JJ ._. 
Further_JJ research_NN is_VBZ needed_VBN to_TO study_VB the_DT clinical_JJ relevance_NN of_IN the_DT bias_NN found_VBN in_IN this_DT study_NN ._. 
Distributions_NNS of_IN diagnostic_JJ subgroups_NNS and_CC testing_NN guidelines_NNS might_MD vary_VB between_IN health_NN care_NN institutions_NNS ._. 
Using_VBG laboratory_NN tests_NNS ,_, a_DT random_JJ tested_VBN parameter_NN ,_, like_IN hemoglobin_NN testing_NN in_IN this_DT study_NN ,_, could_MD serve_VB as_IN comparator_NN group_NN to_TO study_VB testing_NN bias_NN ._. 
With_IN knowledge_NN about_IN the_DT size_NN and_CC direction_NN of_IN testing_NN bias_NN ,_, strategies_NNS such_JJ as_IN imputation_NN techniques_NNS could_MD adjust_VB for_IN this_DT bias_NN in_IN order_NN to_TO obtain_VB an_DT unbiased_JJ risk_NN estimate_NN in_IN epidemiological_JJ studies_NNS ._. 
With_IN development_NN of_IN automated_JJ machines_NNS for_IN routine_JJ analysis_NN ,_, more_JJR parameters_NNS are_VBP measured_VBN than_IN requested_VBN ._. 
2%_CD by_IN cardiovascular_JJ disease_NN ._. 
The_DT bias_NN in_IN absolute_JJ neutrophil_NN count_NN in_IN the_DT first_JJ blood_NN test_NN could_MD be_VB explained_VBN for_IN 83_CD ._. 
This_DT finding_NN could_MD reflect_VB the_DT role_NN of_IN neutrophils_NNS in_IN cardiovascular_JJ disease_NN ._. 
After_IN excluding_VBG cardiovascular_JJ disease_NN from_IN analysis_NN ,_, there_EX were_VBD no_DT differences_NNS in_IN absolute_JJ neutrophil_NN count_NN or_CC change_NN in_IN neutrophil_NN count_NN for_IN each_DT patient_NN ._. 
Background_NN In_IN recent_JJ years_NNS ,_, large_JJ health_NN care_NN databases_NNS are_VBP increasingly_RB used_VBN and_CC provide_VB important_JJ tools_NNS in_IN epidemiological_JJ research_NN 
Advantages_NNS are_VBP that_IN large_JJ amounts_NNS of_IN clinical_JJ data_NNS are_VBP available_JJ at_IN relatively_RB low_JJ cost_NN ,_, and_CC that_IN these_DT databases_NNS usually_RB reflect_VBP daily_JJ practice_NN 
Advantages_NNS are_VBP that_IN large_JJ amounts_NNS of_IN clinical_JJ data_NNS are_VBP available_JJ at_IN relatively_RB low_JJ cost_NN ,_, and_CC that_IN these_DT databases_NNS usually_RB reflect_VBP daily_JJ practice_NN 
The_DT results_NNS from_IN our_PRP$ study_NN show_VB the_DT importance_NN of_IN evaluating_VBG testing_NN bias_NN in_IN epidemiological_JJ studies_NNS obtaining_VBG data_NNS from_IN clinical_JJ databases_NNS ._. 
BackgroundIn_JJ recent_JJ years_NNS ,_, large_JJ health_NN care_NN databases_NNS are_VBP increasingly_RB used_VBN and_CC provide_VB important_JJ tools_NNS in_IN epidemiological_JJ research_NN 
The_DT results_NNS from_IN our_PRP$ study_NN show_VB the_DT importance_NN of_IN evaluating_VBG testing_NN bias_NN in_IN epidemiological_JJ studies_NNS obtaining_VBG data_NNS from_IN clinical_JJ databases_NNS ._. 
BackgroundIn_JJ recent_JJ years_NNS ,_, large_JJ health_NN care_NN databases_NNS are_VBP increasingly_RB used_VBN and_CC provide_VB important_JJ tools_NNS in_IN epidemiological_JJ research_NN 
Background_NN In_IN recent_JJ years_NNS ,_, large_JJ health_NN care_NN databases_NNS are_VBP increasingly_RB used_VBN and_CC provide_VB important_JJ tools_NNS in_IN epidemiological_JJ research_NN 
Advantages_NNS are_VBP that_IN large_JJ amounts_NNS of_IN clinical_JJ data_NNS are_VBP available_JJ at_IN relatively_RB low_JJ cost_NN ,_, and_CC that_IN these_DT databases_NNS usually_RB reflect_VBP daily_JJ practice_NN 
Laboratory_NN testing_NN in_IN clinical_JJ practice_NN is_VBZ never_RB a_DT random_JJ process_NN ,_, as_IN the_DT physician_NN has_VBZ reasons_NNS to_TO perform_VB a_DT test_NN ._. 
Physicians_NNP selectively_RB request_NN tests_NNS for_IN patients_NNS with_IN a_DT high_JJ probability_NN of_IN abnormalities_NNS and_CC less_RBR frequently_RB for_IN patients_NNS with_IN a_DT low_JJ probability_NN ,_, because_IN of_IN patient_JJ burden_NN and_CC costs_NNS 
Such_JJ selective_JJ processes_NNS might_MD induce_VB testing_NN bias_NN in_IN clinical_JJ database_NN studies_NNS ._. 
Physicians_NNP selectively_RB request_NN tests_NNS for_IN patients_NNS with_IN a_DT high_JJ probability_NN of_IN abnormalities_NNS and_CC less_RBR frequently_RB for_IN patients_NNS with_IN a_DT low_JJ probability_NN ,_, because_IN of_IN patient_JJ burden_NN and_CC costs_NNS 
Using_VBG laboratory_NN tests_NNS ,_, a_DT random_JJ tested_VBN parameter_NN ,_, like_IN hemoglobin_NN testing_NN in_IN this_DT study_NN ,_, could_MD serve_VB as_IN comparator_NN group_NN to_TO study_VB testing_NN bias_NN ._. 
With_IN knowledge_NN about_IN the_DT size_NN and_CC direction_NN of_IN testing_NN bias_NN ,_, strategies_NNS such_JJ as_IN imputation_NN techniques_NNS could_MD adjust_VB for_IN this_DT bias_NN in_IN order_NN to_TO obtain_VB an_DT unbiased_JJ risk_NN estimate_NN in_IN epidemiological_JJ studies_NNS ._. 
With_IN development_NN of_IN automated_JJ machines_NNS for_IN routine_JJ analysis_NN ,_, more_JJR parameters_NNS are_VBP measured_VBN than_IN requested_VBN ._. 
Many_JJ studies_NNS state_VBP traditionally_RB that_IN the_DT size_NN of_IN this_DT association_NN is_VBZ overestimated_VBN because_IN of_IN diagnostic_JJ suspicion_NN bias_NN and_CC referral_NN bias_NN ,_, both_DT types_NNS of_IN testing_NN bias_NN 
These_DT discussions_NNS include_VBP alternative_JJ definitions_NNS as_RB well_RB as_IN arguments_NNS that_IN the_DT word_NN actually_RB has_VBZ no_DT definitional_JJ teeth_NNS ._. 
But_CC in_IN the_DT everyday_JJ practical_JJ world_NN of_IN epidemiology_NN -LRB-_-LRB- a_DT field_NN we_PRP define_VBP broadly_RB to_TO include_VB empirical_JJ and_CC experimental_JJ research_NN on_IN diseases_NNS and_CC health-related_JJ exposures_NNS with_IN people_NNS as_IN the_DT unit_NN of_IN analysis_NN -RRB-_-RRB- ,_, we_PRP would_MD venture_VB to_TO say_VB that_IN most_JJS everyone_NN who_WP uses_VBZ causal_JJ language_NN is_VBZ implicitly_RB invoking_VBG the_DT counterfactual_JJ definition_NN ,_, ``_`` but_CC for_IN E_NNP ,_, D_NNP will_MD not_RB occur_VB or_CC would_MD not_RB have_VB occurred_VBN ,_, but_CC given_VBN E_NNP it_PRP will\/would_RB have_VBP ''_'' -LRB-_-LRB- described_VBN in_IN more_JJR detail_NN and_CC with_IN more_RBR symbolic_JJ logic_NN by_IN H_NNP 
''_'' That_DT is_VBZ ,_, whether_IN or_CC not_RB an_DT association_NN is_VBZ strong_JJ is_VBZ a_DT matter_NN of_IN context_NN ._. ''_'' 
adding_VBG ,_, ``_`` high_JJ uncertainty_NN about_IN bias_NN parameters_NNS requires_VBZ larger_JJR associations_NNS than_IN modest_JJ uncertainty_NN does_VBZ ._. 
There_EX are_VBP analytic_JJ methods_NNS being_VBG developed_VBN to_TO put_VB some_DT numbers_NNS to_TO that_DT context_NN ,_, and_CC we_PRP appreciate_VBP and_CC encourage_VBP the_DT attention_NN to_TO quantification_NN of_IN epidemiologic_JJ uncertainty_NN from_IN errors_NNS other_JJ than_IN random_JJ sampling_NN ,_, a_DT line_NN of_IN thinking_VBG in_IN epidemiology_NN that_IN one_CD of_IN us_PRP helped_VBD to_TO launch_VB -LRB-_-LRB- see_VB endnote_NN 1_CD -RRB-_-RRB- ._. 
But_CC despite_IN the_DT fact_NN that_IN this_DT line_NN of_IN thinking_NN sprang_VBN from_IN Maldonado_NNP 's_POS work_NN on_IN causal_NN contrasts_VBZ -LRB-_-LRB- a_DT line_NN of_IN thinking_VBG he_PRP traces_NNS proximately_RB to_TO Greenland_NNP and_CC Robins_NNP 
g._NNP This_NNP conforms_VBZ to_TO what_WP we_PRP have_VBP argued_VBN previously_RB :_: uncertainty_NN about_IN input_NN assumptions_NNS -LRB-_-LRB- e._VB It_PRP primarily_RB supports_VBZ his_PRP$ thesis_NN that_IN complicated_JJ systems_NNS defy_VBP the_DT simple_JJ rules_NNS of_IN thumb_NN ._. 
,the_NN assumptions_NNS that_IN measurement_NN is_VBZ accurate_JJ and_CC confounding_JJ is_VBZ controlled_VBN for_IN -RRB-_-RRB- is_VBZ almost_RB always_RB ignored_VBN in_IN epidemiologic_JJ results_NNS ,_, and_CC people_NNS -LRB-_-LRB- including_VBG experts_NNS -RRB-_-RRB- have_VBP been_VBN shown_VBN to_TO be_VB quite_RB bad_JJ at_IN quantifying_VBG the_DT possible_JJ magnitude_NN of_IN error_NN without_IN mathematical_JJ aids_NNS ._. 
H_NNP 
Values_NNS are_VBP bases_NNS for_IN making_VBG worldly_JJ conclusions_NNS ,_, but_CC tend_VBP to_TO lack_VB scoring_VBG systems_NNS and_CC other_JJ elements_NNS of_IN algorithms_NNS ,_, and_CC any_DT claims_NNS based_VBN on_IN them_PRP are_VBP subject_JJ to_TO interpretation_NN and_CC scrutiny_NN ._. 
Indeed_RB ,_, the_DT empirical_JJ and_CC experimental_JJ evidence_NN Poole_NNP cites_VBZ makes_VBZ clear_JJ that_IN epidemiologists_NNS '_POS interpretations_NNS of_IN the_DT considerations_NNS vary_VBP substantially_RB ._. 
But_CC debates_NNS among_IN scientists_NNS about_IN which_WDT values_NNS are_VBP legitimate_JJ suggest_VBP a_DT feeling_NN that_IN there_EX should_MD be_VB some_DT shared_JJ scientific_JJ common_JJ sense_NN ,_, rather_RB than_IN persistent_JJ heterogeneity_NN of_IN values_NNS ._. 
In_IN that_DT spirit_NN ,_, what_WP many_JJ authors_NNS ,_, including_VBG H_NNP 
g._NNP This_NNP conforms_VBZ to_TO what_WP we_PRP have_VBP argued_VBN previously_RB :_: uncertainty_NN about_IN input_NN assumptions_NNS -LRB-_-LRB- e._VB It_PRP primarily_RB supports_VBZ his_PRP$ thesis_NN that_IN complicated_JJ systems_NNS defy_VBP the_DT simple_JJ rules_NNS of_IN thumb_NN ._. 
,the_NN assumptions_NNS that_IN measurement_NN is_VBZ accurate_JJ and_CC confounding_JJ is_VBZ controlled_VBN for_IN -RRB-_-RRB- is_VBZ almost_RB always_RB ignored_VBN in_IN epidemiologic_JJ results_NNS ,_, and_CC people_NNS -LRB-_-LRB- including_VBG experts_NNS -RRB-_-RRB- have_VBP been_VBN shown_VBN to_TO be_VB quite_RB bad_JJ at_IN quantifying_VBG the_DT possible_JJ magnitude_NN of_IN error_NN without_IN mathematical_JJ aids_NNS ._. 
H_NNP 
Endnote_NNP 1_CD We_PRP find_VBP it_PRP unfortunate_JJ that_IN H_NNP 
There_EX are_VBP analytic_JJ methods_NNS being_VBG developed_VBN to_TO put_VB some_DT numbers_NNS to_TO that_DT context_NN ,_, and_CC we_PRP appreciate_VBP and_CC encourage_VBP the_DT attention_NN to_TO quantification_NN of_IN epidemiologic_JJ uncertainty_NN from_IN errors_NNS other_JJ than_IN random_JJ sampling_NN ,_, a_DT line_NN of_IN thinking_VBG in_IN epidemiology_NN that_IN one_CD of_IN us_PRP helped_VBD to_TO launch_VB -LRB-_-LRB- see_VB endnote_NN 1_CD -RRB-_-RRB- ._. 
But_CC despite_IN the_DT fact_NN that_IN this_DT line_NN of_IN thinking_NN sprang_VBN from_IN Maldonado_NNP 's_POS work_NN on_IN causal_NN contrasts_VBZ -LRB-_-LRB- a_DT line_NN of_IN thinking_VBG he_PRP traces_NNS proximately_RB to_TO Greenland_NNP and_CC Robins_NNP 
''_'' In_IN retrospect_NN ,_, the_DT question_NN clearly_RB missed_VBD the_DT point_NN :_: Like_IN Hill_NNP 's_POS contemplations_NNS ,_, the_DT formalization_NN of_IN counterfactuals_NNS is_VBZ not_RB a_DT new_JJ discovery_NN or_CC even_RB a_DT new_JJ lesson_NN ,_, but_CC rather_RB an_DT articulation_NN of_IN a_DT concept_NN that_WDT deserves_VBZ more_JJR attention_NN -LRB-_-LRB- or_CC basic_JJ awareness_NN -RRB-_-RRB- than_IN it_PRP gets_VBZ in_IN health_NN research_NN ._. 
Indeed_RB ,_, we_PRP emphasized_VBD the_DT need_NN for_IN further_JJ analysis_NN of_IN what_WP is_VBZ ``_`` known_VBN ''_'' in_IN the_DT field_NN -LRB-_-LRB- in_IN the_DT sense_NN of_IN having_VBG been_VBN said_VBD some_DT time_NN ,_, in_IN some_DT way_NN -RRB-_-RRB- ,_, but_CC seem_VBP to_TO be_VB remembered_VBN far_RB too_RB infrequently_RB ,_, as_IN a_DT major_JJ reason_NN for_IN starting_VBG a_DT new_JJ journal_NN ._. 
As_IN every_DT teacher_NN knows_VBZ ,_, spending_NN time_NN contemplating_VBG previous_JJ lessons_NNS is_VBZ usually_RB a_DT lot_NN more_RBR valuable_JJ than_IN introducing_VBG a_DT novel_NN idea_NN every_DT minute_NN of_IN every_DT lecture_NN ._. 
''_'' In_IN retrospect_NN ,_, the_DT question_NN clearly_RB missed_VBD the_DT point_NN :_: Like_IN Hill_NNP 's_POS contemplations_NNS ,_, the_DT formalization_NN of_IN counterfactuals_NNS is_VBZ not_RB a_DT new_JJ discovery_NN or_CC even_RB a_DT new_JJ lesson_NN ,_, but_CC rather_RB an_DT articulation_NN of_IN a_DT concept_NN that_WDT deserves_VBZ more_JJR attention_NN -LRB-_-LRB- or_CC basic_JJ awareness_NN -RRB-_-RRB- than_IN it_PRP gets_VBZ in_IN health_NN research_NN ._. 
Indeed_RB ,_, we_PRP emphasized_VBD the_DT need_NN for_IN further_JJ analysis_NN of_IN what_WP is_VBZ ``_`` known_VBN ''_'' in_IN the_DT field_NN -LRB-_-LRB- in_IN the_DT sense_NN of_IN having_VBG been_VBN said_VBD some_DT time_NN ,_, in_IN some_DT way_NN -RRB-_-RRB- ,_, but_CC seem_VBP to_TO be_VB remembered_VBN far_RB too_RB infrequently_RB ,_, as_IN a_DT major_JJ reason_NN for_IN starting_VBG a_DT new_JJ journal_NN ._. 
As_IN every_DT teacher_NN knows_VBZ ,_, spending_NN time_NN contemplating_VBG previous_JJ lessons_NNS is_VBZ usually_RB a_DT lot_NN more_RBR valuable_JJ than_IN introducing_VBG a_DT novel_NN idea_NN every_DT minute_NN of_IN every_DT lecture_NN ._. 
e._VB Not_RB only_RB is_VBZ there_RB no_DT attempt_NN to_TO conduct_VB and_CC report_VB alternate_JJ analyses_NNS that_WDT test_VBP the_DT robustness_NN of_IN a_DT statistical_JJ model_NN and_CC use_VB the_DT findings_NNS of_IN such_JJ tests_NNS to_TO address_VB uncertainty_NN ,_, but_CC in_IN many_JJ cases_NNS ,_, many_JJ statistical_JJ calculations_NNS are_VBP performed_VBN and_CC the_DT one_CD reported_VBN is_VBZ chosen_VBN because_IN it_PRP is_VBZ an_DT outlier_NN -LRB-_-LRB- i._NN ,_, because_IN it_PRP shows_VBZ a_DT dramatic_JJ result_NN -RRB-_-RRB- ,_, making_VBG it_PRP most_RBS likely_JJ to_TO be_VB an_DT artifact_NN of_IN false_JJ ancillary_JJ hypotheses_NNS about_IN the_DT model_NN ._. 
Thus_RB ,_, not_RB only_RB do_VBP researchers_NNS fail_VB to_TO further_JJ test_NN the_DT causal_JJ conclusions_NNS they_PRP draw_VBP based_VBN on_IN their_PRP$ data_NNS ,_, but_CC their_PRP$ causal_JJ conclusions_NNS are_VBP often_RB not_RB even_RB supported_VBN by_IN their_PRP$ data_NNS -LRB-_-LRB- since_IN most_JJS calculations_NNS using_VBG the_DT data_NNS would_MD produce_VB less_RBR extreme_JJ results_NNS than_IN the_DT ones_NNS reported_VBD -RRB-_-RRB- ._. 
The_DT need_NN for_IN lessons_NNS in_IN common_JJ sense_NN Why_WRB do_VBP health_NN researchers_NNS ,_, seemingly_RB much_RB more_JJR than_IN those_DT in_IN other_JJ fields_NNS ,_, cling_VBP to_TO rules_NNS for_IN assessing_VBG causation_NN to_TO the_DT point_NN that_IN we_PRP have_VBP several_JJ such_JJ lists_NNS as_RB well_RB as_IN a_DT secondary_JJ literature_NN that_WDT tries_VBZ to_TO assess_VB and_CC improve_VB the_DT rules_NNS ._. 
Why_WRB ,_, as_IN suggested_VBN by_IN Kaufman_NNP and_CC Poole_NNP 
Problems_NNS result_VBP when_WRB people_NNS mistakenly_RB treat_VBP Hill_NNP 's_POS lessons_NNS as_IN being_VBG from_IN the_DT wrong_JJ branch_NN of_IN philosophy_NN ,_, interpreting_VBG them_PRP as_IN rules_NNS of_IN logical_JJ rather_RB than_IN worldly_JJ philosophy_NN of_IN science_NN and_CC the_DT ethics_NNS of_IN decision_NN making_NN ._. 
H_NNP 
Our_PRP$ example_NN ,_, that_IN different_JJ disease_NN definitions_NNS should_MD result_VB in_IN inconsistent_JJ associations_NNS -LRB-_-LRB- in_IN a_DT predictable_JJ way_NN -RRB-_-RRB- ,_, introduces_VBZ a_DT testable_JJ hypothesis_NN ._. 
H_NNP 
g._NNP This_NNP conforms_VBZ to_TO what_WP we_PRP have_VBP argued_VBN previously_RB :_: uncertainty_NN about_IN input_NN assumptions_NNS -LRB-_-LRB- e._VB It_PRP primarily_RB supports_VBZ his_PRP$ thesis_NN that_IN complicated_JJ systems_NNS defy_VBP the_DT simple_JJ rules_NNS of_IN thumb_NN ._. 
,the_NN assumptions_NNS that_IN measurement_NN is_VBZ accurate_JJ and_CC confounding_JJ is_VBZ controlled_VBN for_IN -RRB-_-RRB- is_VBZ almost_RB always_RB ignored_VBN in_IN epidemiologic_JJ results_NNS ,_, and_CC people_NNS -LRB-_-LRB- including_VBG experts_NNS -RRB-_-RRB- have_VBP been_VBN shown_VBN to_TO be_VB quite_RB bad_JJ at_IN quantifying_VBG the_DT possible_JJ magnitude_NN of_IN error_NN without_IN mathematical_JJ aids_NNS ._. 
H_NNP 
g._NNP This_NNP conforms_VBZ to_TO what_WP we_PRP have_VBP argued_VBN previously_RB :_: uncertainty_NN about_IN input_NN assumptions_NNS -LRB-_-LRB- e._VB It_PRP primarily_RB supports_VBZ his_PRP$ thesis_NN that_IN complicated_JJ systems_NNS defy_VBP the_DT simple_JJ rules_NNS of_IN thumb_NN ._. 
,the_NN assumptions_NNS that_IN measurement_NN is_VBZ accurate_JJ and_CC confounding_JJ is_VBZ controlled_VBN for_IN -RRB-_-RRB- is_VBZ almost_RB always_RB ignored_VBN in_IN epidemiologic_JJ results_NNS ,_, and_CC people_NNS -LRB-_-LRB- including_VBG experts_NNS -RRB-_-RRB- have_VBP been_VBN shown_VBN to_TO be_VB quite_RB bad_JJ at_IN quantifying_VBG the_DT possible_JJ magnitude_NN of_IN error_NN without_IN mathematical_JJ aids_NNS ._. 
H_NNP 
This_DT suggests_VBZ a_DT presumption_NN of_IN shared_JJ common_JJ sense_NN ._. 
The_DT latter_JJ assessment_NN must_MD be_VB independent_JJ of_IN the_DT criteria_NNS -LRB-_-LRB- since_IN it_PRP is_VBZ meant_VBN to_TO validate_VB the_DT usefulness_NN of_IN the_DT criteria_NNS -RRB-_-RRB- and_CC ,_, most_RBS importantly_RB ,_, is_VBZ presumably_RB meant_VBN to_TO be_VB something_NN most_JJS readers_NNS would_MD agree_VB upon_IN ._. 
Poole_NNP 
This_DT suggests_VBZ a_DT presumption_NN of_IN shared_JJ common_JJ sense_NN ._. 
The_DT latter_JJ assessment_NN must_MD be_VB independent_JJ of_IN the_DT criteria_NNS -LRB-_-LRB- since_IN it_PRP is_VBZ meant_VBN to_TO validate_VB the_DT usefulness_NN of_IN the_DT criteria_NNS -RRB-_-RRB- and_CC ,_, most_RBS importantly_RB ,_, is_VBZ presumably_RB meant_VBN to_TO be_VB something_NN most_JJS readers_NNS would_MD agree_VB upon_IN ._. 
Poole_NNP 
The_DT need_NN for_IN lessons_NNS in_IN common_JJ sense_NN Why_WRB do_VBP health_NN researchers_NNS ,_, seemingly_RB much_RB more_JJR than_IN those_DT in_IN other_JJ fields_NNS ,_, cling_VBP to_TO rules_NNS for_IN assessing_VBG causation_NN to_TO the_DT point_NN that_IN we_PRP have_VBP several_JJ such_JJ lists_NNS as_RB well_RB as_IN a_DT secondary_JJ literature_NN that_WDT tries_VBZ to_TO assess_VB and_CC improve_VB the_DT rules_NNS ._. 
Why_WRB ,_, as_IN suggested_VBN by_IN Kaufman_NNP and_CC Poole_NNP 
This_DT suggests_VBZ a_DT presumption_NN of_IN shared_JJ common_JJ sense_NN ._. 
The_DT latter_JJ assessment_NN must_MD be_VB independent_JJ of_IN the_DT criteria_NNS -LRB-_-LRB- since_IN it_PRP is_VBZ meant_VBN to_TO validate_VB the_DT usefulness_NN of_IN the_DT criteria_NNS -RRB-_-RRB- and_CC ,_, most_RBS importantly_RB ,_, is_VBZ presumably_RB meant_VBN to_TO be_VB something_NN most_JJS readers_NNS would_MD agree_VB upon_IN ._. 
Poole_NNP 
This_DT suggests_VBZ a_DT presumption_NN of_IN shared_JJ common_JJ sense_NN ._. 
The_DT latter_JJ assessment_NN must_MD be_VB independent_JJ of_IN the_DT criteria_NNS -LRB-_-LRB- since_IN it_PRP is_VBZ meant_VBN to_TO validate_VB the_DT usefulness_NN of_IN the_DT criteria_NNS -RRB-_-RRB- and_CC ,_, most_RBS importantly_RB ,_, is_VBZ presumably_RB meant_VBN to_TO be_VB something_NN most_JJS readers_NNS would_MD agree_VB upon_IN ._. 
Poole_NNP 
This_DT notion_NN is_VBZ remarkably_RB robust_JJ given_VBN that_IN these_DT lists_NNS clearly_RB do_VBP not_RB meet_VB usual_JJ definitions_NNS of_IN criteria_NNS ,_, which_WDT imply_VBP some_DT sort_NN of_IN rule_NN or_CC test_NN ._. 
Even_RB when_WRB authors_NNS who_WP invoke_VBP the_DT ``_`` Bradford_NNP Hill_NNP criteria_NNS ''_'' yield_NN to_TO the_DT scolding_NN of_IN various_JJ authors_NNS -LRB-_-LRB- including_VBG us_PRP -RRB-_-RRB- ,_, and_CC dutifully_RB use_VB Hill_NNP 's_POS word_NN 
But_CC ,_, again_RB ,_, since_IN common_JJ sense_NN may_MD be_VB woefully_RB uncommon_JJ ,_, the_DT formalizations_NNS by_IN Maldonado_NNP and_CC others_NNS are_VBP valuable_JJ ._. 
Invoking_VBG counterfactuals_NNS in_IN pursuit_NN of_IN better_JJR causal_JJ criteriaWe_NN thus_RB agree_VBP with_IN H_NNP 
Indeed_RB ,_, there_EX is_VBZ every_DT reason_NN to_TO believe_VB that_IN this_DT was_VBD what_WP Hill_NNP was_VBD trying_VBG to_TO do_VB when_WRB he_PRP gave_VBD his_PRP$ talk_NN ._. 
Problems_NNS result_VBP when_WRB people_NNS mistakenly_RB treat_VBP Hill_NNP 's_POS lessons_NNS as_IN being_VBG from_IN the_DT wrong_JJ branch_NN of_IN philosophy_NN ,_, interpreting_VBG them_PRP as_IN rules_NNS of_IN logical_JJ rather_RB than_IN worldly_JJ philosophy_NN of_IN science_NN and_CC the_DT ethics_NNS of_IN decision_NN making_NN ._. 
H_NNP 
Just_RB as_IN causal_JJ criteria_NNS are_VBP not_RB criteria_NNS ,_, formal_JJ presentation_NN of_IN counterfactuals_NNS does_VBZ not_RB meet_VB the_DT definition_NN of_IN model_NN ,_, which_WDT can_MD be_VB thought_VBN of_IN as_IN a_DT schematic_JJ or_CC representation_NN that_WDT captures_VBZ part_NN of_IN the_DT essence_NN of_IN a_DT more_RBR complicated_JJ system_NN in_IN a_DT way_NN that_WDT leads_VBZ to_TO emergent_VB properties_NNS ._. 
In_IN these_DT pages_NNS ,_, H_NNP 
,drawing_VBG diagrams_NNS of_IN causal_JJ pathways_NNS -RRB-_-RRB- becomes_VBZ more_RBR critical_JJ as_IN a_DT system_NN becomes_VBZ more_RBR complex_JJ ._. 
g._NN ''_'' Of_IN course_NN ,_, common_JJ sense_NN is_VBZ most_RBS useful_JJ in_IN simple_JJ cases_NNS ,_, while_IN modeling_NN -LRB-_-LRB- e._FW H_NNP 
.._NN 
Though_NNP H_NNP 
Just_RB as_IN causal_JJ criteria_NNS are_VBP not_RB criteria_NNS ,_, formal_JJ presentation_NN of_IN counterfactuals_NNS does_VBZ not_RB meet_VB the_DT definition_NN of_IN model_NN ,_, which_WDT can_MD be_VB thought_VBN of_IN as_IN a_DT schematic_JJ or_CC representation_NN that_WDT captures_VBZ part_NN of_IN the_DT essence_NN of_IN a_DT more_RBR complicated_JJ system_NN in_IN a_DT way_NN that_WDT leads_VBZ to_TO emergent_VB properties_NNS ._. 
In_IN these_DT pages_NNS ,_, H_NNP 
But_CC ,_, again_RB ,_, since_IN common_JJ sense_NN may_MD be_VB woefully_RB uncommon_JJ ,_, the_DT formalizations_NNS by_IN Maldonado_NNP and_CC others_NNS are_VBP valuable_JJ ._. 
Invoking_VBG counterfactuals_NNS in_IN pursuit_NN of_IN better_JJR causal_JJ criteriaWe_NN thus_RB agree_VBP with_IN H_NNP 
Values_NNS are_VBP bases_NNS for_IN making_VBG worldly_JJ conclusions_NNS ,_, but_CC tend_VBP to_TO lack_VB scoring_VBG systems_NNS and_CC other_JJ elements_NNS of_IN algorithms_NNS ,_, and_CC any_DT claims_NNS based_VBN on_IN them_PRP are_VBP subject_JJ to_TO interpretation_NN and_CC scrutiny_NN ._. 
Indeed_RB ,_, the_DT empirical_JJ and_CC experimental_JJ evidence_NN Poole_NNP cites_VBZ makes_VBZ clear_JJ that_IN epidemiologists_NNS '_POS interpretations_NNS of_IN the_DT considerations_NNS vary_VBP substantially_RB ._. 
But_CC debates_NNS among_IN scientists_NNS about_IN which_WDT values_NNS are_VBP legitimate_JJ suggest_VBP a_DT feeling_NN that_IN there_EX should_MD be_VB some_DT shared_JJ scientific_JJ common_JJ sense_NN ,_, rather_RB than_IN persistent_JJ heterogeneity_NN of_IN values_NNS ._. 
It_PRP may_MD happen_VB that_IN some_DT particular_JJ groups_NNS do_VBP not_RB receive_VB relief_NN ,_, due_JJ to_TO problems_NNS with_IN access_NN or_CC lack_NN of_IN resources_NNS ,_, but_CC ,_, as_IN Hallam_NNP warns_VBZ ,_, comparisons_NNS between_IN people_NNS who_WP received_VBD assistance_NN and_CC those_DT who_WP did_VBD not_RB need_VB to_TO be_VB used_VBN very_RB carefully_RB ._. 
As_IN a_DT result_NN ,_, 
-RRB-_-RRB- can_MD be_VB significant_JJ ._. 
For_IN example_NN ,_, it_PRP is_VBZ very_RB difficult_JJ to_TO attribute_VB a_DT reduction_NN of_IN conflict-related_JJ excess_JJ mortality_NN to_TO humanitarian_JJ aid_NN only_RB :_: variations_NNS in_IN the_DT baseline_NN mortality_NN -LRB-_-LRB- due_JJ to_TO seasonal_JJ trends_NNS ,_, disease_NN epidemics_NNS ,_, HIV\/AIDS_NN etc._NN ._. 
There_EX is_VBZ an_DT increasing_VBG recognition_NN of_IN the_DT importance_NN of_IN these_DT other_JJ factors_NNS ,_, and_CC that_IN humanitarian_JJ aid_NN ,_, however_RB vital_JJ ,_, is_VBZ only_RB one_CD element_NN of_IN the_DT picture_NN ._. 
Atheoretical_JJ model_NN for_IN measuring_VBG impact_NN There_EX are_VBP three_CD main_JJ considerations_NNS that_WDT are_VBP necessary_JJ for_IN measuring_VBG the_DT impact_NN of_IN health_NN programs_NNS :_: the_DT strength_NN of_IN the_DT evidence_NN suggesting_VBG causation_NN between_IN the_DT intervention_NN and_CC the_DT change_NN in_IN health_NN status_NN ,_, the_DT validity_NN of_IN a_DT baseline_NN of_IN comparison_NN ,_, and_CC the_DT validity_NN of_IN the_DT indicator_NN employed_VBN ._. 
The_DT ``_`` with\/without_NN ''_'' comparison_NN with_IN the_DT use_NN of_IN control_NN groups_NNS creates_VBZ ethical_JJ problems_NNS :_: it_PRP is_VBZ difficult_JJ to_TO deliberately_RB exclude_VB a_DT group_NN from_IN access_NN to_TO potentially_RB life-saving_JJ relief_NN ._. 
It_PRP may_MD happen_VB that_IN some_DT particular_JJ groups_NNS do_VBP not_RB receive_VB relief_NN ,_, due_JJ to_TO problems_NNS with_IN access_NN or_CC lack_NN of_IN resources_NNS ,_, but_CC ,_, as_IN Hallam_NNP warns_VBZ ,_, comparisons_NNS between_IN people_NNS who_WP received_VBD assistance_NN and_CC those_DT who_WP did_VBD not_RB need_VB to_TO be_VB used_VBN very_RB carefully_RB 
It_PRP may_MD happen_VB that_IN some_DT particular_JJ groups_NNS do_VBP not_RB receive_VB relief_NN ,_, due_JJ to_TO problems_NNS with_IN access_NN or_CC lack_NN of_IN resources_NNS ,_, but_CC ,_, as_IN Hallam_NNP warns_VBZ ,_, comparisons_NNS between_IN people_NNS who_WP received_VBD assistance_NN and_CC those_DT who_WP did_VBD not_RB need_VB to_TO be_VB used_VBN very_RB carefully_RB 
There_EX is_VBZ no_DT definition_NN of_IN impact_NN in_IN humanitarian_JJ assistance_NN ._. 
5billion_CD by_IN 2000_CD 
Acentral_JJ question_NN in_IN an_DT impact_NN assessment_NN is_VBZ `_`` what_WP would_MD have_VB happened_VBN in_IN the_DT absence_NN of_IN the_DT aid_NN program_NN ._. '_'' 
In_IN theory_NN ,_, there_EX are_VBP two_CD approaches_NNS to_TO answering_VBG this_DT question_NN :1_CD ._. 
To_TO compare_VB the_DT impact_NN with_IN a_DT control_NN group_NN that_WDT did_VBD not_RB receive_VB aid_NN 
-RRB-_-RRB- can_MD be_VB significant_JJ ._. 
For_IN example_NN ,_, it_PRP is_VBZ very_RB difficult_JJ to_TO attribute_VB a_DT reduction_NN of_IN conflict-related_JJ excess_JJ mortality_NN to_TO humanitarian_JJ aid_NN only_RB :_: variations_NNS in_IN the_DT baseline_NN mortality_NN -LRB-_-LRB- due_JJ to_TO seasonal_JJ trends_NNS ,_, disease_NN epidemics_NNS ,_, HIV\/AIDS_NN etc._NN ._. 
There_EX is_VBZ an_DT increasing_VBG recognition_NN of_IN the_DT importance_NN of_IN these_DT other_JJ factors_NNS ,_, and_CC that_IN humanitarian_JJ aid_NN ,_, however_RB vital_JJ ,_, is_VBZ only_RB one_CD element_NN of_IN the_DT picture_NN ._. 
Atheoretical_JJ model_NN for_IN measuring_VBG impact_NN There_EX are_VBP three_CD main_JJ considerations_NNS that_WDT are_VBP necessary_JJ for_IN measuring_VBG the_DT impact_NN of_IN health_NN programs_NNS :_: the_DT strength_NN of_IN the_DT evidence_NN suggesting_VBG causation_NN between_IN the_DT intervention_NN and_CC the_DT change_NN in_IN health_NN status_NN ,_, the_DT validity_NN of_IN a_DT baseline_NN of_IN comparison_NN ,_, and_CC the_DT validity_NN of_IN the_DT indicator_NN employed_VBN ._. 
This_DT distinction_NN can_MD be_VB more_JJR than_IN academic_JJ ,_, as_IN was_VBD seen_VBN over_IN three_CD decades_NNS of_IN debate_NN regarding_VBG the_DT effects_NNS of_IN smoking_NN on_IN health_NN ._. 
Bradford-Hill_NNP put_VBD forward_JJ criteria_NNS for_IN attempting_VBG to_TO ascribe_VB causation_NN between_IN an_DT exposure_NN and_CC a_DT health_NN outcome_NN 
For_IN example_NN ,_, one_CD of_IN the_DT objectives_NNS of_IN the_DT SMART_JJ initiative_NN is_VBZ to_TO enable_VB judgements_NNS about_IN the_DT overall_JJ impact_NN of_IN the_DT humanitarian_JJ effort_NN ._. 
Another_DT example_NN is_VBZ the_DT Inter-agency_NNP Health_NNP Evaluations_NNPS in_IN Humanitarian_NNP Crises_NNS Initiative_NNP that_WDT proposes_VBZ to_TO establish_VB inter-agency_JJ health_NN program_NN reviews_NNS in_IN order_NN to_TO find_VB new_JJ ways_NNS of_IN looking_VBG at_IN health_NN program_NN performance_NN and_CC its_PRP$ impact_NN on_IN the_DT health_NN of_IN affected_JJ populations_NNS 
Problems_NNS with_IN the_DT lack_NN of_IN skills_NNS A_DT recurrent_JJ problem_NN with_IN the_DT use_NN of_IN epidemiological_JJ methods_NNS such_JJ as_IN surveys_NNS and_CC monitoring_NN is_VBZ the_DT lack_NN of_IN appropriate_JJ skills_NNS for_IN conducting_VBG good_JJ quality_NN assessments_NNS ._. 
Reviewers_NNS from_IN the_DT Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Prevention_NNP -LRB-_-LRB- CDC_NNP -RRB-_-RRB- evaluated_VBD the_DT monitoring_NN of_IN projects_NNS and_CC the_DT measurement_NN of_IN nutritional_JJ status_NN and_CC mortality_NN in_IN Somalia_NNP from_IN the_DT period_NN 1991_CD 
Spiegel_NNP et_FW al._FW ._. 
They_PRP found_VBD that_IN the_DT range_NN of_IN methodologies_NNS employed_VBN and_CC outcomes_NNS measured_VBN were_VBD so_RB variable_JJ and_CC of_IN such_JJ poor_JJ quality_NN that_IN they_PRP prevented_VBD widespread_JJ comparisons_NNS ,_, and_CC that_IN ,_, regardless_RB of_IN consistency_NN ,_, much_JJ of_IN the_DT data_NNS were_VBD simply_RB not_RB credible_JJ due_JJ to_TO poor_JJ collection_NN methods_NNS ._. 
from_IN CDC_NNP reviewed_VBD 125_CD nutritional_JJ surveys_NNS conducted_VBN in_IN Ethiopia_NNP in_IN 1999_CD and_CC 2000_CD during_IN a_DT time_NN of_IN famine_NN but_CC relative_JJ peace_NN and_CC stability_NN ._. 
The_DT surveys_NNS were_VBD carried_VBN out_RP by_IN 14_CD organizations_NNS with_IN a_DT wide_JJ range_NN of_IN survey_NN expertise_NN ._. 
Only_RB 67_CD of_IN the_DT 125_CD surveys_NNS attempted_VBN to_TO conduct_VB a_DT sample_NN that_WDT represented_VBD the_DT population_NN served_VBD ._. 
Only_RB 9_CD of_IN those_DT 67_CD surveys_NNS assigned_VBD clusters_NNS to_TO the_DT population_NN in_IN a_DT manner_NN that_WDT was_VBD proportional_JJ to_TO the_DT sub-units_NNS of_IN the_DT population_NN and_CC only_RB 6_CD of_IN those_DT possessed_VBN the_DT minimum_JJ number_NN of_IN clusters_NNS -LRB-_-LRB- 30_CD -RRB-_-RRB- and_CC children_NNS -LRB-_-LRB- 900_CD -RRB-_-RRB- suggested_VBN by_IN most_JJS nutritional_JJ manuals_NNS ._. 
Spiegel_NNP concluded_VBD that_IN non-governmental_JJ organization_NN -LRB-_-LRB- NGO_NNP -RRB-_-RRB- workers_NNS were_VBD woefully_RB unprepared_JJ to_TO conduct_VB quantitative_JJ assessments_NNS of_IN this_DT kind_NN ,_, and_CC that_IN most_JJS of_IN the_DT surveys_NNS were_VBD of_IN such_JJ poor_JJ quality_NN as_IN to_TO be_VB unhelpful_JJ toward_IN making_VBG sound_JJ relief_NN policy_NN decisions_NNS ._. 
The_DT measurement_NN of_IN anthropometry_NN is_VBZ relatively_RB standardised_JJ compared_VBN to_TO many_JJ other_JJ health_NN outcomes_NNS such_JJ as_IN mortality_NN and_CC mental_JJ health_NN status_NN ._. 
9per_CD 1000_CD per_IN month_NN -RRB-_-RRB- was_VBD far_RB lower_JJR than_IN in_IN a_DT later_JJ repeat_NN survey_NN -LRB-_-LRB- finding_VBG 2_CD ._. 
The_DT resulting_VBG estimate_NN of_IN crude_NN mortality_NN -LRB-_-LRB- 1_CD ._. 
7per_CD 1000_CD per_IN month_NN -RRB-_-RRB- and_CC ,_, in_IN fact_NN ,_, the_DT initial_JJ survey_NN missed_VBD most_JJS of_IN the_DT excess_JJ mortality_NN ._. 
For_IN some_DT project_NN objectives_NNS ,_, such_JJ as_IN the_DT prevention_NN of_IN HIV_NNP transmission_NN ,_, there_EX is_VBZ not_RB even_RB a_DT widely_RB agreed_VBN upon_IN outcome_NN to_TO be_VB measured_VBN that_DT serves_VBZ as_IN a_DT proxy_NN for_IN HIV_NNP incidence_NN ._. 
Foreign_JJ Disaster_NN Assistance_NNP -LRB-_-LRB- OFDA_NNP -RRB-_-RRB- or_CC European_NNP Commission_NNP 's_POS Humanitarian_NNP Aid_NNP Office_NNP ._. 
S._NNP Over_NNP 20_NNP NGOs_NNPS were_VBD providing_VBG general_JJ health_NN services_NNS in_IN the_DT eastern_JJ DRC_NNP in_IN 2000_CD and_CC 2001_CD with_IN funding_NN from_IN either_DT Office_NNP of_IN U._NNP According_VBG to_TO OFDA_NNP ,_, only_RB two_CD of_IN those_DT agencies_NNS could_MD show_VB health_NN benefits_NNS associated_VBN with_IN their_PRP$ programs_NNS ._. 
This_DT seemed_VBD plausible_JJ at_IN the_DT time_NN given_VBN the_DT violent_JJ and_CC chaotic_JJ circumstances_NNS within_IN which_WDT the_DT NGOs_NNS operated_VBD ._. 
Although_IN cluster_NN surveys_NNS are_VBP a_DT compromise_NN measure_NN ,_, in_IN many_JJ situations_NNS -LRB-_-LRB- especially_RB in_IN conflict_NN situations_NNS or_CC where_WRB terrain_NN is_VBZ very_RB difficult_JJ -RRB-_-RRB- it_PRP may_MD prove_VB difficult_JJ to_TO gain_VB access_NN to_TO the_DT 30_CD clusters_NNS proscribed_VBN ._. 
Nomadic_JJ groups_NNS may_MD also_RB prove_VB difficult_JJ to_TO sample_NN 
Although_IN cluster_NN surveys_NNS are_VBP a_DT compromise_NN measure_NN ,_, in_IN many_JJ situations_NNS -LRB-_-LRB- especially_RB in_IN conflict_NN situations_NNS or_CC where_WRB terrain_NN is_VBZ very_RB difficult_JJ -RRB-_-RRB- it_PRP may_MD prove_VB difficult_JJ to_TO gain_VB access_NN to_TO the_DT 30_CD clusters_NNS proscribed_VBN ._. 
Nomadic_JJ groups_NNS may_MD also_RB prove_VB difficult_JJ to_TO sample_NN 
Nomadic_JJ groups_NNS may_MD also_RB prove_VB difficult_JJ to_TO sample_NN ._. 
Although_IN cluster_NN surveys_NNS are_VBP a_DT compromise_NN measure_NN ,_, in_IN many_JJ situations_NNS -LRB-_-LRB- especially_RB in_IN conflict_NN situations_NNS or_CC where_WRB terrain_NN is_VBZ very_RB difficult_JJ -RRB-_-RRB- it_PRP may_MD prove_VB difficult_JJ to_TO gain_VB access_NN to_TO the_DT 30_CD clusters_NNS proscribed_VBN ._. 
Despite_IN these_DT difficulties_NNS ,_, recent_JJ experiences_NNS have_VBP sh_NN 
However_RB ,_, when_WRB the_DT validity_NN of_IN the_DT proxy_NN measure_NN is_VBZ unclear_JJ ,_, there_EX are_VBP risks_NNS in_IN using_VBG performance_NN indicators_NNS as_IN a_DT measure_NN of_IN success_NN ._. 
For_IN example_NN ,_, there_EX is_VBZ strong_JJ evidence_NN that_IN immunising_VBG children_NNS against_IN measles_NNS has_VBZ a_DT direct_JJ effect_NN on_IN reducing_VBG mortality_NN from_IN measles_NNS ;_: therefore_RB ,_, immunisation_NN coverage_NN can_MD be_VB used_VBN as_IN a_DT proxy_NN for_IN impact_NN on_IN mortality_NN 
However_RB ,_, when_WRB the_DT validity_NN of_IN the_DT proxy_NN measure_NN is_VBZ unclear_JJ ,_, there_EX are_VBP risks_NNS in_IN using_VBG performance_NN indicators_NNS as_IN a_DT measure_NN of_IN success_NN ._. 
For_IN example_NN ,_, there_EX is_VBZ strong_JJ evidence_NN that_IN immunising_VBG children_NNS against_IN measles_NNS has_VBZ a_DT direct_JJ effect_NN on_IN reducing_VBG mortality_NN from_IN measles_NNS ;_: therefore_RB ,_, immunisation_NN coverage_NN can_MD be_VB used_VBN as_IN a_DT proxy_NN for_IN impact_NN on_IN mortality_NN 
For_IN example_NN ,_, there_EX is_VBZ strong_JJ evidence_NN that_IN immunising_VBG children_NNS against_IN measles_NNS has_VBZ a_DT direct_JJ effect_NN on_IN reducing_VBG mortality_NN from_IN measles_NNS ;_: therefore_RB ,_, immunisation_NN coverage_NN can_MD be_VB used_VBN as_IN a_DT proxy_NN for_IN impact_NN on_IN mortality_NN 
Abetter_JJ understanding_NN of_IN needs_NNS based_VBN on_IN nutrition_NN and_CC mortality_NN might_MD also_RB enable_VB better_JJR analysis_NN of_IN impact_NN ._. 
Of_IN course_NN ,_, malnutrition_NN and_CC mortality_NN rates_NNS will_MD not_RB necessarily_RB enable_VB impact_NN to_TO be_VB attributed_VBN to_TO particular_JJ projects_NNS or_CC agencies_NNS and_CC may_MD only_RB be_VB able_JJ to_TO demonstrate_VB the_DT extent_NN to_TO which_WDT a_DT relief_NN system_NN as_IN a_DT whole_NN is_VBZ meeting_VBG the_DT needs_NNS of_IN a_DT population_NN ._. 
There_EX is_VBZ a_DT tendency_NN for_IN humanitarian_JJ agencies_NNS to_TO collect_VB performance_NN rather_RB than_IN impact_NN indicators_NNS ._. 
Although_IN cluster_NN surveys_NNS are_VBP a_DT compromise_NN measure_NN ,_, in_IN many_JJ situations_NNS -LRB-_-LRB- especially_RB in_IN conflict_NN situations_NNS or_CC where_WRB terrain_NN is_VBZ very_RB difficult_JJ -RRB-_-RRB- it_PRP may_MD prove_VB difficult_JJ to_TO gain_VB access_NN to_TO the_DT 30_CD clusters_NNS proscribed_VBN ._. 
Nomadic_JJ groups_NNS may_MD also_RB prove_VB difficult_JJ to_TO sample_NN 
Countrywide_NNP figures_NNS are_VBP either_RB unreliable_JJ ,_, out_IN of_IN date_NN ,_, or_CC not_RB appropriate_JJ as_IN they_PRP do_VBP not_RB capture_VB the_DT regions_NNS where_WRB the_DT conflict_NN is_VBZ occurring_VBG ._. 
Arelated_JJ problem_NN that_WDT is_VBZ continuously_RB faced_VBN by_IN humanitarian_JJ agencies_NNS is_VBZ the_DT lack_NN of_IN reliable_JJ population_NN statistics_NNS ._. 
Figure_NNP 1_CD Mortality_NNP in_IN Katana_NNP ,_, 1998_CD 
Existing_VBG approaches_NNS such_JJ as_IN survey_NN methods_NNS or_CC surveillance_NN systems_NNS ,_, although_IN seldom_RB used_VBN by_IN humanitarian_JJ agencies_NNS ,_, can_MD provide_VB significant_JJ insight_NN about_IN the_DT impact_NN of_IN humanitarian_JJ aid_NN ._. 
So_RB far_RB ,_, these_DT tools_NNS remain_VBP mainly_RB used_VBN in_IN early_JJ warning_NN systems_NNS or_CC needs_NNS assessment_NN ._. 
The_DT two_CD most_RBS common_JJ approaches_NNS are_VBP survey_NN methods_NNS and_CC surveillance_NN systems_NNS ._. 
Survey_NN methods_NNS Most_JJS surveys_NNS are_VBP an_DT attempt_NN to_TO actively_RB go_VB out_RB and_CC survey_VB a_DT representative_JJ sample_NN of_IN the_DT population_NN ,_, although_IN they_PRP may_MD take_VB different_JJ forms_NNS ._. 
Bradford-Hill_NNP put_VBD forward_JJ criteria_NNS for_IN attempting_VBG to_TO ascribe_VB causation_NN between_IN an_DT exposure_NN and_CC a_DT health_NN outcome_NN 
Initiatives_NNS as_RB distinct_JJ as_IN the_DT Code_NNP of_IN Conduct_NNP ,_, Sphere_NNP ,_, Active_NNP Learning_NNP Network_NNP for_IN Accountability_NNP and_CC Performance_NNP in_IN Humanitarian_NNP Action_NNP ,_, the_DT Humanitarian_NNP Accountability_NNP Partnership_NNP International_NNP ,_, the_DT Quality_NNP Project_NNP from_IN the_DT French_JJ group_NN Urgence_NNP ,_, r_SYM 
In_IN particular_JJ ,_, a_DT substantial_JJ body_NN of_IN knowledge_NN has_VBZ been_VBN accumulated_VBN regarding_VBG public_JJ health_NN interventions_NNS in_IN emergencies_NNS ,_, in_IN response_NN to_TO calls_NNS for_IN developing_VBG the_DT evidence_NN base_NN of_IN humanitarian_JJ health_NN interventions_NNS 
In_IN particular_JJ ,_, a_DT substantial_JJ body_NN of_IN knowledge_NN has_VBZ been_VBN accumulated_VBN regarding_VBG public_JJ health_NN interventions_NNS in_IN emergencies_NNS ,_, in_IN response_NN to_TO calls_NNS for_IN developing_VBG the_DT evidence_NN base_NN of_IN humanitarian_JJ health_NN interventions_NNS 
Despite_IN the_DT technical_JJ progress_NN in_IN the_DT last_JJ decade_NN ,_, knowledge_NN of_IN the_DT impact_NN of_IN humanitarian_JJ interventions_NNS in_IN alleviating_VBG suffering_NN and_CC ultimately_RB reducing_VBG mortality_NN in_IN the_DT health_NN and_CC other_JJ sectors_NNS remains_VBZ limited_JJ ._. 
There_EX is_VBZ a_DT real_JJ question_NN whether_IN all_PDT the_DT developments_NNS in_IN accountability_NN and_CC implementation_NN actually_RB improve_VB the_DT overall_JJ performance_NN of_IN humanitarian_JJ assistance_NN ._. 
Whereas_IN there_EX is_VBZ a_DT significant_JJ evidence_NN base_NN on_IN the_DT effectiveness_NN of_IN interventions_NNS in_IN acute_JJ emergencies_NNS ,_, especially_RB in_IN refugee_NN settings_NNS ,_, the_DT evidence_NN base_NN is_VBZ much_RB weaker_JJR for_IN situations_NNS of_IN protracted_JJ conflict_NN with_IN longer_JJR term_NN programs_NNS in_IN less_JJR controlled_JJ settings_NNS ._. 
The_DT short_JJ funding_NN cycles_NNS and_CC volatile_JJ nature_NN of_IN emergencies_NNS often_RB prohibit_VBP a_DT systematic_JJ and_CC rigorous_JJ evaluation_NN of_IN either_CC the_DT impact_NN or_CC the_DT monitoring_NN of_IN multiple_JJ agencies_NNS in_IN the_DT same_JJ setting_NN ._. 
Wider_JJR level_NN of_IN impact_NN analysisThere_NNP is_VBZ an_DT increasing_VBG interest_NN in_IN impact_NN analysis_NN at_IN higher_JJR levels_NNS and_CC a_DT `_`` system-wide_JJ approach_NN to_TO performance_NN '_'' ._. 
Several_JJ initiatives_NNS and_CC mechanisms_NNS ,_, from_IN donors_NNS and_CC humanitarian_JJ agencies_NNS ,_, are_VBP attempting_VBG to_TO move_VB beyond_IN the_DT project_NN level_NN and_CC consider_VB sectoral_JJ ,_, multi-sectoral_JJ ,_, or_CC system-wide_JJ impacts_NNS ._. 
Introduction_NN In_IN the_DT last_JJ decade_NN ,_, humanitarian_JJ aid_NN agencies_NNS have_VBP put_VBN a_DT great_JJ deal_NN of_IN effort_NN into_IN improving_VBG the_DT design_NN and_CC management_NN of_IN humanitarian_JJ responses_NNS in_IN conflict_NN situations_NNS :_: humanitarian_JJ agencies_NNS have_VBP agreed_VBN on_IN international_JJ standards_NNS ,_, numerous_JJ technical_JJ guidelines_NNS have_VBP been_VBN produced_VBN ,_, training_NN programs_NNS are_VBP offered_VBN on_IN different_JJ aspects_NNS of_IN humanitarian_JJ programming_NN ,_, and_CC aid_NN programs_NNS are_VBP evaluated_VBN more_RBR systematically_RB ._. 
Initiatives_NNS as_RB distinct_JJ as_IN the_DT Code_NNP of_IN Conduct_NNP ,_, Sphere_NNP ,_, Active_NNP Learning_NNP Network_NNP for_IN Accountability_NNP and_CC Performance_NNP in_IN Humanitarian_NNP Action_NNP ,_, the_DT Humanitarian_NNP Accountability_NNP Partnership_NNP International_NNP ,_, the_DT Quality_NNP Project_NNP from_IN the_DT French_JJ group_NN Urgence_NNP ,_, r_SYM 
Initiatives_NNS as_RB distinct_JJ as_IN the_DT Code_NNP of_IN Conduct_NNP ,_, Sphere_NNP ,_, Active_NNP Learning_NNP Network_NNP for_IN Accountability_NNP and_CC Performance_NNP in_IN Humanitarian_NNP Action_NNP ,_, the_DT Humanitarian_NNP Accountability_NNP Partnership_NNP International_NNP ,_, the_DT Quality_NNP Project_NNP from_IN the_DT French_JJ group_NN Urgence_NNP ,_, r_SYM 
Despite_IN the_DT technical_JJ progress_NN in_IN the_DT last_JJ decade_NN ,_, knowledge_NN of_IN the_DT impact_NN of_IN humanitarian_JJ interventions_NNS in_IN alleviating_VBG suffering_NN and_CC ultimately_RB reducing_VBG mortality_NN in_IN the_DT health_NN and_CC other_JJ sectors_NNS remains_VBZ limited_JJ ._. 
There_EX is_VBZ a_DT real_JJ question_NN whether_IN all_PDT the_DT developments_NNS in_IN accountability_NN and_CC implementation_NN actually_RB improve_VB the_DT overall_JJ performance_NN of_IN humanitarian_JJ assistance_NN ._. 
Whereas_IN there_EX is_VBZ a_DT significant_JJ evidence_NN base_NN on_IN the_DT effectiveness_NN of_IN interventions_NNS in_IN acute_JJ emergencies_NNS ,_, especially_RB in_IN refugee_NN settings_NNS ,_, the_DT evidence_NN base_NN is_VBZ much_RB weaker_JJR for_IN situations_NNS of_IN protracted_JJ conflict_NN with_IN longer_JJR term_NN programs_NNS in_IN less_JJR controlled_JJ settings_NNS ._. 
The_DT increasing_VBG interest_NN in_IN impact_NN analysis_NN arises_VBZ from_IN a_DT number_NN of_IN interlinked_JJ developments_NNS :_: the_DT rapid_JJ increase_NN in_IN the_DT overall_JJ volume_NN of_IN humanitarian_JJ assistance_NN in_IN the_DT last_JJ decade_NN -_: from_IN 2_CD billion_CD in_IN 1990_CD to_TO $_$ 5_CD ._. 
5billion_CD by_IN 2000_CD 
Harms_NNS from_IN physical_JJ inactivity_NN are_VBP not_RB equally_RB distributed_VBN ._. 
The_DT reduction_NN in_IN active_JJ travel_NN is_VBZ fuelling_VBG the_DT obesity_NN epidemic_NN 
The_DT car_NN and_CC place_NN Studies_NNS often_RB use_VBP multilevel_JJ modelling_NN to_TO investigate_VB if_IN ``_`` area_NN effects_NNS ''_'' explain_VBP geographical_JJ differences_NNS in_IN health_NN over_IN and_CC above_IN the_DT composition_NN of_IN people_NNS living_VBG there_RB ._. 
From_IN this_DT it_PRP is_VBZ argued_VBN that_IN ``_`` if_IN variations_NNS in_IN health_NN between_IN areas_NNS can_MD be_VB entirely_RB explained_VBN by_IN characteristics_NNS of_IN the_DT inhabitants_NNS of_IN those_DT areas_NNS ,_, policymakers_NNS need_VBP only_JJ act_NN on_IN improving_VBG the_DT circumstances_NNS of_IN individuals_NNS 
As_IN the_DT most_RBS expensive_JJ commodity_NN purchased_VBN by_IN most_JJS households_NNS -LRB-_-LRB- housing_NN costs_NNS primarily_RB represent_VBP interest_NN and_CC rent_NN not_RB construction_NN costs_NNS -RRB-_-RRB- the_DT car_NN has_VBZ helped_VBN to_TO ensure_VB the_DT growing_VBG consumer_NN demand_NN required_VBN for_IN capital_NN accumulation_NN ._. 
Gorz_NNP and_CC Illich_NNP have_VBP described_VBN car_NN economies_NNS as_IN locked_VBN into_IN radical_JJ dependency_NN ,_, where_WRB massive_JJ resources_NNS are_VBP required_VBN for_IN tasks_NNS -LRB-_-LRB- e._FW g._FW household_NN shopping_NN -RRB-_-RRB- that_WDT could_MD be_VB completed_VBN using_VBG far_RB fewer_JJR resources_NNS ,_, on_IN foot_NN or_CC by_IN bike_NN ._. 
This_DT creates_VBZ a_DT huge_JJ opportunity_NN cost_NN both_DT to_TO the_DT individual_NN and_CC society_NN ._. 
These_DT are_VBP socially_RB shaped_VBN ,_, just_RB as_IN their_PRP$ resolution_NN shapes_VBZ societies_NNS and_CC environments_NNS ._. 
Use_NN value_NN :_: car_NN consumption_NN While_IN the_DT concept_NN of_IN exchange_NN value_NN directs_VBZ attention_NN to_TO production_NN processes_NNS ,_, use_NN value_NN refers_VBZ to_TO consumption_NN or_CC how_WRB cars_NNS are_VBP used_VBN by_IN individuals_NNS to_TO fulfil_VB needs_NNS and_CC desires_NNS ._. 
We_PRP do_VBP not_RB only_RB consume_VB ``_`` things_NNS ''_'' ,_, but_CC ``_`` things_NNS which_WDT are_VBP part_NN of_IN a_DT definite_JJ social_JJ environment_NN ._. ''_'' 
This_DT matters_NNS for_IN epidemiology_NN ,_, as_IN it_PRP directs_VBZ our_PRP$ attention_NN to_TO the_DT health_NN effects_NNS resulting_VBG from_IN this_DT interplay_NN between_IN social_JJ structures_NNS ,_, individual_JJ decisions_NNS ,_, and_CC commodities_NNS ._. 
A2007_CD survey_NN estimated_VBD 1_CD ._. 
The_DT war_NN may_MD not_RB be_VB reduced_VBN to_TO oil_NN but_CC they_PRP can_MD not_RB be_VB divorced_VBN ,_, as_IN many_JJ commentators_NNS have_VBP noted_VBN ,_, including_VBG former_JJ head_NN of_IN the_DT US_NNP federal_JJ reserve_NN Alan_NNP Greenspan_NNP 
As_IN the_DT most_RBS expensive_JJ commodity_NN purchased_VBN by_IN most_JJS households_NNS -LRB-_-LRB- housing_NN costs_NNS primarily_RB represent_VBP interest_NN and_CC rent_NN not_RB construction_NN costs_NNS -RRB-_-RRB- the_DT car_NN has_VBZ helped_VBN to_TO ensure_VB the_DT growing_VBG consumer_NN demand_NN required_VBN for_IN capital_NN accumulation_NN ._. 
Gorz_NNP and_CC Illich_NNP have_VBP described_VBN car_NN economies_NNS as_IN locked_VBN into_IN radical_JJ dependency_NN ,_, where_WRB massive_JJ resources_NNS are_VBP required_VBN for_IN tasks_NNS -LRB-_-LRB- e._FW g._FW household_NN shopping_NN -RRB-_-RRB- that_WDT could_MD be_VB completed_VBN using_VBG far_RB fewer_JJR resources_NNS ,_, on_IN foot_NN or_CC by_IN bike_NN ._. 
This_DT creates_VBZ a_DT huge_JJ opportunity_NN cost_NN both_DT to_TO the_DT individual_NN and_CC society_NN ._. 
If_IN motorised_VBN violence_NN is_VBZ embodied_VBN in_IN road_NN injuries_NNS and_CC deaths_NNS ,_, the_DT threat_NN of_IN violence_NN is_VBZ embodied_VBN through_IN obesity_NN ,_, diabetes_NN ,_, and_CC cardiovascular_JJ disease_NN ._. 
The_DT reduction_NN in_IN active_JJ travel_NN is_VBZ fuelling_VBG the_DT obesity_NN epidemic_NN 
Furthermore_RB ,_, ubiquitous_JJ advertising_NN helps_VBZ to_TO normalise_VB sloth_NN ._. 
Car_NN advertising_NN could_MD have_VB psycho-social_JJ effects_NNS upon_IN health_NN both_DT directly_RB -LRB-_-LRB- through_IN encouraging_VBG the_DT purchase_NN of_IN larger_JJR and_CC more_JJR dangerous_JJ cars_NNS -RRB-_-RRB- and_CC indirectly_RB -LRB-_-LRB- through_IN the_DT validation_NN of_IN `_`` macho_JJ '_'' behavior_NN when_WRB driving_VBG and_CC more_RBR generally_RB -RRB-_-RRB- ._. 
Driving_NNP has_VBZ become_VBN such_JJ a_DT normal_JJ part_NN of_IN everyday_JJ life_NN 
If_IN motorised_VBN violence_NN is_VBZ embodied_VBN in_IN road_NN injuries_NNS and_CC deaths_NNS ,_, the_DT threat_NN of_IN violence_NN is_VBZ embodied_VBN through_IN obesity_NN ,_, diabetes_NN ,_, and_CC cardiovascular_JJ disease_NN ._. 
The_DT reduction_NN in_IN active_JJ travel_NN is_VBZ fuelling_VBG the_DT obesity_NN epidemic_NN 
Thirdly_RB ,_, amenities_NNS literally_RB move_VBP away_RB from_IN people_NNS ,_, through_IN a_DT chain_NN of_IN events_NNS that_WDT leads_VBZ to_TO a_DT lack_NN of_IN local_JJ shops_NNS ,_, services_NNS ,_, and_CC jobs_NNS -LRB-_-LRB- ``_`` the_DT death_NN of_IN the_DT high_JJ street_NN ''_'' :_: Simms_NNP ._. -RRB-_-RRB- 
Together_RB ,_, the_DT threat_NN of_IN violence_NN and_CC the_DT restructuring_NN of_IN place_NN raise_VBP the_DT bar_NN for_IN social_JJ participation_NN ,_, essentially_RB disabling_VBG large_JJ segments_NNS of_IN the_DT population_NN 
Arecent_JJ study_NN found_VBD that_IN only_RB a_DT car-free_JJ London_NNP could_MD achieve_VB target_NN greenhouse_NN gas_NN emission_NN reductions_NNS -LRB-_-LRB- 60_CD %_NN by_IN 2030_CD -RRB-_-RRB- 
Terms_NNS in_IN the_DT critical_JJ transport_NN literature_NN such_JJ as_IN car_NN dependency_NN 
Socially_RB produced_VBN ,_, individually_RB purchased_VBN ,_, and_CC consumed_VBN in_IN a_DT social_JJ context_NN ,_, use_NN values_NNS affect_VBP people_NNS other_JJ than_IN the_DT purchaser_NN ._. 
In_IN neo-classical_JJ economics_NNS these_DT consequences_NNS are_VBP conceptualised_VBN as_IN -LRB-_-LRB- positive_JJ or_CC negative_JJ -RRB-_-RRB- externalities_NNS ,_, a_DT useful_JJ concept_NN ,_, although_IN one_CD too_RB narrowly_RB conceived_VBN by_IN such_JJ economists_NNS ,_, who_WP see_VBP the_DT externality_NN as_IN the_DT exception_NN and_CC believe_VB that_DT monetisation_NN can_MD solve_VB problems_NNS of_IN health_NN and_CC social_JJ justice_NN ._. 
Use_NN values_NNS and_CC accompanying_JJ externalities_NNS incorporate_VBP health_NN effects_NNS ,_, and_CC the_DT concept_NN of_IN use_NN value_NN directs_VBZ our_PRP$ attention_NN to_TO the_DT social_JJ context_NN of_IN consumption_NN ._. 
This_DT evasion_NN is_VBZ reflected_VBN in_IN some_DT health_NN inequalities_NNS literature_NN ._. 
``_`` Car_NN crime_NN ''_'' invokes_VBZ crimes_NNS against_IN cars_NNS ,_, while_IN the_DT softer_JJR term_NN ``_`` driving_JJ offence_NN ''_'' covers_VBZ the_DT exercise_NN of_IN lethal_JJ force_NN ._. 
Wilkinson_NNP extensively_RB discusses_VBZ poor-on-poor_JJ violence_NN ignoring_VBG motorised_JJ violence_NN -LRB-_-LRB- more_RBR typically_RB rich-on-poor_JJ violence_NN -RRB-_-RRB- ._. 
Yet_CC his_PRP$ stress_NN on_IN the_DT real_JJ lack_NN of_IN respect_NN shown_VBN to_TO the_DT poor_JJ is_VBZ exemplified_VBN in_IN the_DT treatment_NN of_IN different_JJ road_NN users_NNS ._. 
Marmot_NNP et_FW al_FW 
After_IN scandals_NNS ,_, corporations_NNS were_VBD banned_VBN in_IN England_NNP in_IN 1720_CD ;_: in_IN 1776_CD the_DT economist_NN Adam_NNP Smith_NNP called_VBD them_PRP a_DT recipe_NN for_IN negligence_NN and_CC profusion_NN ._. 
Yet_RB soon_RB afterwards_RB ,_, the_DT growing_VBG rail_NN industry_NN 's_POS need_NN for_IN large_JJ amounts_NNS of_IN investment_NN resuscitated_VBD the_DT corporate_JJ form_NN ,_, and_CC it_PRP became_VBD widespread_JJ ._. 
Corporations_NNS now_RB rival_VBP governments_NNS as_IN the_DT key_JJ social_JJ form_NN through_IN which_WDT society_NN allocates_VBZ productive_JJ resources_NNS ._. 
Firstly_RB ,_, it_PRP suggests_VBZ the_DT existence_NN of_IN key_JJ `_`` anti-health_JJ forces_NNS '_POS ,_, corporations_NNS which_WDT depend_VBP for_IN their_PRP$ survival_NN on_IN the_DT maintenance_NN and_CC growth_NN of_IN car-based_JJ transportation_NN systems_NNS ._. 
Secondly_RB ,_, transport_NN consumes_VBZ around_IN half_NN of_IN world_NN oil_NN production_NN ,_, and_CC oil-producing_JJ countries_NNS often_RB suffer_VBP from_IN the_DT `_`` curse_NN of_IN natural_JJ resources_NNS '_POS ._. 
Thirdly_RB ,_, the_DT huge_JJ levels_NNS of_IN investment_NN allocated_VBN to_TO car_NN production_NN and_CC associated_JJ activities_NNS imply_VBP huge_JJ opportunity_NN costs_NNS -LRB-_-LRB- including_VBG health_NN costs_NNS -RRB-_-RRB- stemming_VBG from_IN missed_VBN alternative_NN resource_NN uses_VBZ ._. 
Our_PRP$ theoretical_JJ approach_NN responds_VBZ to_TO this_DT interlinked_JJ complexity_NN by_IN foregrounding_VBG epidemiological_JJ implications_NNS of_IN the_DT car_NN 's_POS economic_JJ and_CC social_JJ importance_NN to_TO contemporary_JJ capitalist_NN societies_NNS ._. 
It_PRP draws_VBZ upon_IN Marx_NNP 's_POS distinction_NN between_IN exchange_NN value_NN and_CC use_NN value_NN 
Our_PRP$ theoretical_JJ approach_NN responds_VBZ to_TO this_DT interlinked_JJ complexity_NN by_IN foregrounding_VBG epidemiological_JJ implications_NNS of_IN the_DT car_NN 's_POS economic_JJ and_CC social_JJ importance_NN to_TO contemporary_JJ capitalist_NN societies_NNS ._. 
It_PRP draws_VBZ upon_IN Marx_NNP 's_POS distinction_NN between_IN exchange_NN value_NN and_CC use_NN value_NN 
These_DT harms_NNS and_CC benefits_NNS are_VBP unequally_RB distributed_VBN ._. 
Major_JJ roads_NNS can_MD sever_VB communities_NNS by_IN barring_VBG local_JJ access_NN ,_, communication_NN and_CC social_JJ integration_NN ,_, with_IN implications_NNS for_IN social_JJ capital_NN ._. 
Researchers_NNS have_VBP identified_VBN socio-economic_JJ inequalities_NNS in_IN road_NN traffic_NN injuries_NNS 
These_DT harms_NNS and_CC benefits_NNS are_VBP unequally_RB distributed_VBN ._. 
Major_JJ roads_NNS can_MD sever_VB communities_NNS by_IN barring_VBG local_JJ access_NN ,_, communication_NN and_CC social_JJ integration_NN ,_, with_IN implications_NNS for_IN social_JJ capital_NN ._. 
Researchers_NNS have_VBP identified_VBN socio-economic_JJ inequalities_NNS in_IN road_NN traffic_NN injuries_NNS 
Although_IN lower_JJR income_NN groups_NNS typically_RB have_VBP higher_JJR levels_NNS of_IN transport_NN physical_NN activity_NN for_IN work_NN and_CC shopping_NN ,_, they_PRP have_VBP less_JJR opportunity_NN to_TO participate_VB in_IN leisure_NN related_VBN physical_JJ activity_NN 
The_DT effects_NNS of_IN car_NN dependency_NN clearly_RB illustrate_VBP this_DT ._. 
As_IN Whitehead_NNP 
These_DT harms_NNS and_CC benefits_NNS are_VBP unequally_RB distributed_VBN ._. 
Major_JJ roads_NNS can_MD sever_VB communities_NNS by_IN barring_VBG local_JJ access_NN ,_, communication_NN and_CC social_JJ integration_NN ,_, with_IN implications_NNS for_IN social_JJ capital_NN ._. 
Researchers_NNS have_VBP identified_VBN socio-economic_JJ inequalities_NNS in_IN road_NN traffic_NN injuries_NNS 
2million_CD people_NNS and_CC injures_NNS 50_CD million_CD on_IN the_DT roads_NNS each_DT year_NN 
2million_CD people_NNS and_CC injures_NNS 50_CD million_CD on_IN the_DT roads_NNS each_DT year_NN 
The_DT burning_NN of_IN the_DT fossil_NN fuel_NN ,_, oil_NN ,_, produces_VBZ the_DT kinetic_JJ energy_NN that_WDT kills_VBZ 1_CD ._. 
Amyriad_NNP of_IN pathways_NNS link_VBP car-based_JJ ,_, energy_NN intensive_JJ transport_NN systems_NNS to_TO public_JJ health_NN 
While_IN the_DT psycho-social_JJ literature_NN has_VBZ focused_VBN on_IN important_JJ inequalities_NNS in_IN work_NN related_VBN stress_NN ,_, the_DT daily_JJ life_NN and_CC death_NN decisions_NNS needed_VBN to_TO navigate_VB traffic_NN and_CC the_DT chronic_JJ stress_NN from_IN noise_NN pollution_NN are_VBP less_RBR frequently_RB considered_VBN ._. 
Road_NNP traffic_NN crashes_NNS remain_VBP a_DT neglected_VBN epidemic_NN ,_, despite_IN being_VBG the_DT most_RBS common_JJ cause_NN of_IN violent_JJ injury_NN in_IN almost_RB all_DT countries_NNS 
Developments_NNS include_VBP using_VBG the_DT concept_NN of_IN embodiment_NN to_TO understand_VB health_NN outcomes_NNS as_IN the_DT manifestation_NN of_IN social_JJ inequalities_NNS 
It_PRP shows_VBZ how_WRB attempts_NNS to_TO overcome_VB distributional_JJ inequalities_NNS by_IN encouraging_VBG the_DT poor_JJ to_TO emulate_VB the_DT motor_NN vehicle_NN use_NN levels_NNS of_IN the_DT rich_JJ would_MD prove_VB catastrophic_JJ in_IN the_DT context_NN of_IN climate_NN change_NN ._. 
Eco-social_JJ epidemiologyMost_JJ social_JJ epidemiological_JJ theories_NNS incorporate_VBP ecological_JJ thinking_NN ._. 
Akey_NNP ecological_JJ concept_NN is_VBZ metabolism_NN ._. 
Transport_NNP is_VBZ central_JJ to_TO our_PRP$ individual_JJ and_CC social_JJ metabolism_NN ,_, shaping_VBG our_PRP$ relations_NNS with_IN each_DT other_JJ and_CC our_PRP$ relation_NN with_IN nature_NN and_CC transformed_VBD nature_NN ,_, including_VBG our_PRP$ extractive_JJ relationship_NN with_IN the_DT environment_NN ._. 
Developments_NNS include_VBP using_VBG the_DT concept_NN of_IN embodiment_NN to_TO understand_VB health_NN outcomes_NNS as_IN the_DT manifestation_NN of_IN social_JJ inequalities_NNS 
We_PRP suggest_VBP how_WRB this_DT approach_NN can_MD progress_VB key_JJ debates_NNS on_IN the_DT causes_NNS of_IN health_NN inequalities_NNS and_CC refocus_VB attention_NN from_IN those_DT at_IN the_DT bottom_NN to_TO the_DT social_JJ processes_NNS underlying_VBG the_DT distribution_NN ._. 
Traditional_JJ epidemiological_JJ tools_NNS have_VBP limitations_NNS for_IN understanding_VBG social_JJ and_CC economic_JJ determinants_NNS of_IN health_NN ._. 
Social_NNP processes_NNS are_VBP not_RB fully_RB explained_VBN through_IN the_DT search_NN for_IN discrete_JJ effects_NNS after_IN adjustment_NN for_IN confounding_VBG variables_NNS ._. 
It_PRP shows_VBZ how_WRB attempts_NNS to_TO overcome_VB distributional_JJ inequalities_NNS by_IN encouraging_VBG the_DT poor_JJ to_TO emulate_VB the_DT motor_NN vehicle_NN use_NN levels_NNS of_IN the_DT rich_JJ would_MD prove_VB catastrophic_JJ in_IN the_DT context_NN of_IN climate_NN change_NN ._. 
Eco-social_JJ epidemiologyMost_JJ social_JJ epidemiological_JJ theories_NNS incorporate_VBP ecological_JJ thinking_NN 
Integrated_NNP assessment_NN of_IN the_DT health_NN impact_NN of_IN alternative_JJ transport_NN scenarios_NNS would_MD link_VB these_DT pathways_NNS 
Theoretical_JJ schemas_NNS combine_VBP ecological_JJ and_CC social_JJ perspectives_NNS ,_, including_VBG the_DT eco-social_JJ model_NN of_IN Krieger_NNP 
We_PRP suggest_VBP how_WRB this_DT approach_NN can_MD progress_VB key_JJ debates_NNS on_IN the_DT causes_NNS of_IN health_NN inequalities_NNS and_CC refocus_VB attention_NN from_IN those_DT at_IN the_DT bottom_NN to_TO the_DT social_JJ processes_NNS underlying_VBG the_DT distribution_NN ._. 
Traditional_JJ epidemiological_JJ tools_NNS have_VBP limitations_NNS for_IN understanding_VBG social_JJ and_CC economic_JJ determinants_NNS of_IN health_NN ._. 
Social_NNP processes_NNS are_VBP not_RB fully_RB explained_VBN through_IN the_DT search_NN for_IN discrete_JJ effects_NNS after_IN adjustment_NN for_IN confounding_VBG variables_NNS ._. 
Excluded_VBN from_IN the_DT analysis_NN ,_, social_JJ factors_NNS are_VBP often_RB relegated_VBN to_TO the_DT outer_JJ boxes_NNS of_IN diagrams_NNS used_VBN to_TO illustrate_VB social_JJ determinants_NNS of_IN health_NN ._. 
Typically_RB such_JJ diagrams_NNS are_VBP focused_VBN on_IN the_DT individual_NN not_RB the_DT population_NN ,_, while_IN catch-all_JJ terms_NNS such_JJ as_IN ``_`` economic_JJ context_NN ''_'' leave_VBP social_JJ processes_NNS unexplained_JJ and_CC do_VBP not_RB tell_VB us_PRP how_WRB to_TO operationalise_VB them_PRP ._. 
Transport_NN :_: a_DT broader_JJR view_NN Starting_VBG with_IN social_JJ processes_NNS In_IN this_DT article_NN we_PRP put_VBD forward_RB an_DT approach_NN that_WDT starts_VBZ from_IN social_JJ processes_NNS and_CC social_JJ forms_NNS -LRB-_-LRB- rather_RB than_IN inequality_NN in_IN an_DT outcome_NN or_CC exposure_NN -RRB-_-RRB- and_CC moves_VBZ on_RP to_TO analyze_VB effects_NNS within_IN specified_VBN social_JJ relationships_NNS ._. 
From_IN this_DT it_PRP is_VBZ argued_VBN that_IN ``_`` if_IN variations_NNS in_IN health_NN between_IN areas_NNS can_MD be_VB entirely_RB explained_VBN by_IN characteristics_NNS of_IN the_DT inhabitants_NNS of_IN those_DT areas_NNS ,_, policymakers_NNS need_VBP only_JJ act_NN on_IN improving_VBG the_DT circumstances_NNS of_IN individuals_NNS 
Analysis_NN Challenges_VBZ facing_VBG social_JJ epidemiology_NN Health_NNP inequalities_NNS and_CC the_DT social_JJ determinants_NNS of_IN health_NN have_VBP become_VBN part_NN of_IN mainstream_JJ health_NN discourse_NN ._. 
In_IN March_NNP 2005_CD ,_, the_DT World_NNP Health_NNP Organization_NNP -LRB-_-LRB- WHO_WP -RRB-_-RRB- set_VBN up_RP a_DT Commission_NN on_IN Social_NNP Determinants_NNP of_IN Health_NNP involving_VBG some_DT leading_VBG global_JJ social_JJ epidemiologists_NNS ._. 
Social_NNP epidemiologists_NNS have_VBP drawn_VBN attention_NN to_TO health_NN inequalities_NNS as_IN avoidable_JJ ,_, unfair_JJ and_CC inequitable_JJ ,_, challenging_VBG the_DT individual_JJ risk_NN factor_NN approach_NN and_CC medical_JJ solutions_NNS dominating_VBG much_JJ of_IN 20_CD th_JJ century_NN research_NN ._. 
Social_NNP epidemiologists_NNS have_VBP drawn_VBN attention_NN to_TO health_NN inequalities_NNS as_IN avoidable_JJ ,_, unfair_JJ and_CC inequitable_JJ ,_, challenging_VBG the_DT individual_JJ risk_NN factor_NN approach_NN and_CC medical_JJ solutions_NNS dominating_VBG much_JJ of_IN 20_CD th_JJ century_NN research_NN ._. 
Developments_NNS include_VBP using_VBG the_DT concept_NN of_IN embodiment_NN to_TO understand_VB health_NN outcomes_NNS as_IN the_DT manifestation_NN of_IN social_JJ inequalities_NNS 
Developments_NNS include_VBP using_VBG the_DT concept_NN of_IN embodiment_NN to_TO understand_VB health_NN outcomes_NNS as_IN the_DT manifestation_NN of_IN social_JJ inequalities_NNS 
Social_NNP epidemiologists_NNS have_VBP drawn_VBN attention_NN to_TO health_NN inequalities_NNS as_IN avoidable_JJ ,_, unfair_JJ and_CC inequitable_JJ ,_, challenging_VBG the_DT individual_JJ risk_NN factor_NN approach_NN and_CC medical_JJ solutions_NNS dominating_VBG much_JJ of_IN 20_CD th_JJ century_NN research_NN ._. 
Developments_NNS include_VBP using_VBG the_DT concept_NN of_IN embodiment_NN to_TO understand_VB health_NN outcomes_NNS as_IN the_DT manifestation_NN of_IN social_JJ inequalities_NNS 
Social_NNP processes_NNS are_VBP not_RB fully_RB explained_VBN through_IN the_DT search_NN for_IN discrete_JJ effects_NNS after_IN adjustment_NN for_IN confounding_VBG variables_NNS ._. 
While_IN Rose_NNP 's_POS dictum_NN that_IN the_DT determinants_NNS of_IN health_NN at_IN a_DT population_NN level_NN may_MD be_VB different_JJ from_IN those_DT at_IN individual_JJ level_NN has_VBZ been_VBN influential_JJ in_IN social_JJ epidemiology_NN ,_, reliance_NN on_IN analysis_NN of_IN variation_NN within_IN a_DT population_NN continues_VBZ ._. 
Focusing_VBG on_IN the_DT existing_VBG distribution_NN misses_VBZ those_DT etiological_JJ factors_NNS that_WDT vary_VBP little_RB within_IN a_DT population_NN ,_, such_JJ as_IN car-based_JJ transport_NN systems_NNS ,_, and_CC the_DT interests_NNS ,_, often_RB economic_JJ ,_, driving_VBG the_DT development_NN of_IN these_DT systems_NNS ._. 
Comparative_JJ risk_NN assessment_NN -LRB-_-LRB- CRA_NNP -RRB-_-RRB- has_VBZ compared_VBN radically_RB different_JJ alternative_NN scenarios_NNS for_IN the_DT Global_NNP Burden_NNP of_IN Disease_NNP report_NN 
Excluded_VBN from_IN the_DT analysis_NN ,_, social_JJ factors_NNS are_VBP often_RB relegated_VBN to_TO the_DT outer_JJ boxes_NNS of_IN diagrams_NNS used_VBN to_TO illustrate_VB social_JJ determinants_NNS of_IN health_NN ._. 
Typically_RB such_JJ diagrams_NNS are_VBP focused_VBN on_IN the_DT individual_NN not_RB the_DT population_NN ,_, while_IN catch-all_JJ terms_NNS such_JJ as_IN ``_`` economic_JJ context_NN ''_'' leave_VBP social_JJ processes_NNS unexplained_JJ and_CC do_VBP not_RB tell_VB us_PRP how_WRB to_TO operationalise_VB them_PRP ._. 
Transport_NN :_: a_DT broader_JJR view_NN Starting_VBG with_IN social_JJ processes_NNS In_IN this_DT article_NN we_PRP put_VBD forward_RB an_DT approach_NN that_WDT starts_VBZ from_IN social_JJ processes_NNS and_CC social_JJ forms_NNS -LRB-_-LRB- rather_RB than_IN inequality_NN in_IN an_DT outcome_NN or_CC exposure_NN -RRB-_-RRB- and_CC moves_VBZ on_RP to_TO analyze_VB effects_NNS within_IN specified_VBN social_JJ relationships_NNS ._. 
In_IN a_DT recent_JJ Friends_NNS of_IN the_DT Earth_NNP study_NN ,_, 96_CD %_NN of_IN ads_NNS in_IN UK_NNP newspapers_NNS were_VBD for_IN cars_NNS breaking_VBG the_DT current_JJ voluntary_JJ emissions_NNS limit_NN 
Meanwhile_RB ,_, the_DT US_NNP Alliance_NNP of_IN Automobile_NNP Manufacturers_NNP set_VBD up_RP the_DT well-funded_JJ DriveCongress_NNP campaign_NN to_TO oppose_VB a_DT bill_NN agreed_VBN by_IN the_DT US_NNP Senate_NNP to_TO increase_VB fuel_NN economy_NN standards_NNS on_IN new_JJ vehicles_NNS to_TO 35_CD miles_NNS per_IN gallon_NN by_IN 2020_CD ._. 
Corporations_NNS and_CC related_JJ groups_NNS tied_VBN to_TO the_DT car_NN also_RB try_VB and_CC shape_VB approaches_NNS to_TO road_NN safety_NN through_IN organizations_NNS such_JJ as_IN the_DT Global_NNP Road_NNP Safety_NNP Partnership_NNP ,_, the_DT F_NN 
In_IN 1989_CD ,_, major_JJ car_NN firms_NNS were_VBD founding_JJ members_NNS of_IN the_DT Global_JJ Climate_NN Coalition_NNP ,_, a_DT group_NN of_IN powerful_JJ United_NNP States_NNPS businesses_NNS opposing_VBG environmental_JJ regulations_NNS ,_, which_WDT achieved_VBD its_PRP$ aim_NN of_IN pulling_VBG the_DT US_NNP out_IN of_IN the_DT Kyoto_NNP treaty_NN ._. 
The_DT UK_NNP 's_POS Royal_NNP Society_NNP -LRB-_-LRB- national_JJ academy_NN of_IN science_NN -RRB-_-RRB- recently_RB wrote_VBD to_TO oil_NN giant_NN Exxon_NN expressing_VBG ``_`` concerns_NNS about_IN the_DT support_NN that_IN ExxonMobil_NNP has_VBZ been_VBN giving_VBG to_TO organizations_NNS that_WDT have_VBP been_VBN misinforming_VBG the_DT public_NN about_IN the_DT science_NN of_IN climate_NN change_NN 
The_DT UK_NNP 's_POS Royal_NNP Society_NNP -LRB-_-LRB- national_JJ academy_NN of_IN science_NN -RRB-_-RRB- recently_RB wrote_VBD to_TO oil_NN giant_NN Exxon_NN expressing_VBG ``_`` concerns_NNS about_IN the_DT support_NN that_IN ExxonMobil_NNP has_VBZ been_VBN giving_VBG to_TO organizations_NNS that_WDT have_VBP been_VBN misinforming_VBG the_DT public_NN about_IN the_DT science_NN of_IN climate_NN change_NN 
''_'' Other_JJ oil_NN and_CC car_NN firms_NNS now_RB adopt_VBP publicity_NN strategies_NNS which_WDT claim_VBP to_TO support_VB the_DT environmental_JJ agenda_NN ,_, yet_RB Shell_NNP 's_POS investment_NN in_IN renewables_NNS in_IN 2005_CD was_VBD 1_CD %_NN of_IN total_JJ capital_NN investment_NN ,_, compared_VBN with_IN 69_CD %_NN spent_VBN on_IN searching_VBG for_IN fossil_JJ fuel_NN fields_NNS 
Recently_RB ,_, car_NN lobbyists_NNS helped_VBD persuade_VB the_DT European_NNP Commission_NNP to_TO relax_VB proposed_VBN emissions_NNS regulations_NNS 
Manufacturing_NNP car_NN industry_NN products_NNS ``_`` uses_VBZ up_RP nearly_RB half_PDT the_DT world_NN 's_POS annual_JJ output_NN of_IN rubber_NN ,_, 25_CD %_NN of_IN its_PRP$ glass_NN and_CC 15_CD %_NN of_IN its_PRP$ steel_NN ._. 
No_DT wonder_NN the_DT car_NN industry_NN accounts_VBZ for_IN about_RB 10_CD %_NN of_IN GDP_NNP in_IN rich_JJ countries_NNS ._. ''_'' 
The_DT car_NN economy_NN supports_VBZ associated_JJ industries_NNS -LRB-_-LRB- e._FW g._FW advertising_NN ,_, glass_NN ,_, production_NN ,_, finance_NN ,_, and_CC insurance_NN -RRB-_-RRB- and_CC enabling_VBG industries_NNS -LRB-_-LRB- e._SYM 
Its_PRP$ model_NN is_VBZ based_VBN upon_IN economies_NNS of_IN scale_NN that_WDT only_RB exist_VBP with_IN subsidised_VBN road_NN transport_NN ,_, sprawled_JJ developments_NNS ,_, and_CC heavy_JJ levels_NNS of_IN private_JJ car_NN use_NN ._. 
``_`` Typical_JJ Wal-Mart_NNP stores_NNS generate_VBP several_JJ thousand_CD average_JJ daily_JJ car_NN trips_NNS ''_'' with_IN supercentres_NNS generating_VBG far_RB more_JJR ._. 
Truck-based_JJ freight_NN systems_NNS and_CC car_NN based_VBN passenger_NN transport_NN have_VBP grown_VBN together_RB and_CC reinforced_VBN each_DT other_JJ ._. 
They_PRP have_VBP massive_JJ fixed_VBN capital_NN invested_VBN in_IN refineries_NNS ,_, wells_NNS and_CC factories_NNS and_CC an_DT established_JJ position_NN within_IN the_DT global_JJ economy_NN ,_, with_IN the_DT economic_JJ and_CC political_JJ benefits_NNS this_DT offers_NNS ._. 
Car_NN firms_NNS act_VBP to_TO maintain_VB this_DT through_IN advertising_NN ,_, lobbying_NN ,_, and_CC the_DT promotion_NN of_IN technical_JJ fixes_NNS and_CC individualised_JJ solutions_NNS ._. 
Budgets_NNS for_IN car_NN advertising_NN tower_NN over_IN budgets_NNS promoting_VBG walking_NN and_CC cycling_NN ._. 
Transport_NNP for_IN London_NNP ,_, an_DT authority_NN with_IN a_DT notable_JJ pro-cycling_JJ stance_NN ,_, expects_VBZ to_TO spend_VB only_RB 
Budgets_NNS for_IN car_NN advertising_NN tower_NN over_IN budgets_NNS promoting_VBG walking_NN and_CC cycling_NN ._. 
Car_NN firms_NNS act_VBP to_TO maintain_VB this_DT through_IN advertising_NN ,_, lobbying_NN ,_, and_CC the_DT promotion_NN of_IN technical_JJ fixes_NNS and_CC individualised_JJ solutions_NNS ._. 
Transport_NNP for_IN London_NNP ,_, an_DT authority_NN with_IN a_DT notable_JJ pro-cycling_JJ stance_NN ,_, expects_VBZ to_TO spend_VB only_RB 
Aphysical_JJ impairment_NN may_MD not_RB be_VB experienced_VBN as_IN a_DT disability_NN in_IN an_DT accommodating_VBG society_NN ,_, while_IN in_IN a_DT car-dependent_JJ society_NN the_DT mere_JJ lack_NN of_IN a_DT car_NN can_MD be_VB considered_VBN a_DT disability_NN ._. 
Recently-developed_JJ epidemiological_JJ techniques_NNS could_MD fit_VB within_IN our_PRP$ general_JJ approach_NN ;_: for_IN example_NN Health_NNP Impact_NNP Assessment_NNP -LRB-_-LRB- HIA_NNP -RRB-_-RRB- allows_VBZ an_DT integrated_JJ approach_NN to_TO the_DT effects_NNS of_IN policy_NN changes_NNS ,_, and_CC requires_VBZ explicit_JJ description_NN of_IN the_DT proposed_VBN pathways_NNS ._. 
While_IN typically_RB HIA_NNP has_VBZ been_VBN constrained_VBN by_IN policy_NN debates_NNS ,_, it_PRP can_MD be_VB used_VBN for_IN public_JJ health_NN activism_NN ._. 
More_RBR broadly_RB ,_, we_PRP call_VBP for_IN an_DT approach_NN centring_VBG the_DT role_NN of_IN the_DT car_NN in_IN socio-spatial_JJ processes_NNS leading_VBG to_TO socioeconomic_JJ and_CC geographic_JJ health_NN inequalities_NNS ._. 
Terms_NNS in_IN the_DT critical_JJ transport_NN literature_NN such_JJ as_IN car_NN dependency_NN 
Psychosocial_JJ theorists_NNS have_VBP provided_VBN genuinely_RB social_JJ theories_NNS in_IN attempting_VBG to_TO explain_VB the_DT distribution_NN of_IN health_NN outcomes_NNS by_IN reference_NN to_TO socio-economic_JJ structures_NNS ,_, and_CC innovatively_RB combine_VB sociological_JJ and_CC epidemiological_JJ approaches_NNS ._. 
Marmot_NNP et_FW al_FW 
Transport_NNP is_VBZ central_JJ to_TO our_PRP$ individual_JJ and_CC social_JJ metabolism_NN ,_, shaping_VBG our_PRP$ relations_NNS with_IN each_DT other_JJ and_CC our_PRP$ relation_NN with_IN nature_NN and_CC transformed_VBD nature_NN ,_, including_VBG our_PRP$ extractive_JJ relationship_NN with_IN the_DT environment_NN ._. 
Our_PRP$ maladjusted_JJ metabolism_NN can_MD be_VB seen_VBN acting_VBG on_IN individual_JJ energy_NN imbalance_NN -LRB-_-LRB- through_IN too_RB much_JJ food_NN and_CC fossil_JJ fuel-powered_JJ transport_NN -RRB-_-RRB- leading_VBG to_TO obesity_NN ,_, and_CC on_IN climatic_JJ destabilisation_NN through_IN increased_VBN atmospheric_JJ carbon_NN concentrations_NNS ._. 
We_PRP need_VBP new_JJ epidemiological_JJ thinking_NN about_IN these_DT linkages_NNS and_CC the_DT economic_JJ system_NN that_WDT produces_VBZ them_PRP ._. 
Wilkinson_NNP 
Marmot_NNP et_FW al_FW 
Yet_RB focusing_VBG on_IN material_NN disadvantage_NN can_MD be_VB as_RB restrictive_JJ as_IN focusing_VBG on_IN its_PRP$ psychological_JJ effects_NNS ._. 
As_IN Whitehead_NNP 
Neo-materialist_JJ critics_NNS claim_VBP that_IN psycho-social_JJ theories_NNS introduce_VBP unnecessary_JJ and_CC ahistorical_JJ meta-explanations_NNS to_TO explain_VB diverse_JJ and_CC contingent_JJ pathways_NNS 
They_PRP focus_VBP upon_IN cause_NN specific_NN ,_, material_NN explanations_NNS ,_, arguing_VBG that_IN instead_RB of_IN psychological_JJ states_NNS influencing_VBG health_NN directly_RB ,_, ``_`` misery_NN is_VBZ now_RB a_DT marker_NN for_IN material_NN disadvantage_NN 
More_RBR broadly_RB ,_, we_PRP call_VBP for_IN an_DT approach_NN centring_VBG the_DT role_NN of_IN the_DT car_NN in_IN socio-spatial_JJ processes_NNS leading_VBG to_TO socioeconomic_JJ and_CC geographic_JJ health_NN inequalities_NNS ._. 
Terms_NNS in_IN the_DT critical_JJ transport_NN literature_NN such_JJ as_IN car_NN dependency_NN 
We_PRP believe_VBP it_PRP would_MD be_VB one_CD where_WRB physical_JJ activity_NN is_VBZ part_NN of_IN everyday_JJ life_NN ,_, with_IN safe_JJ and_CC attractive_JJ environments_NNS for_IN socialising_VBG and_CC playing_VBG ,_, clean_JJ air_NN ,_, and_CC equity_NN in_IN accessibility_NN by_IN age_NN ,_, ethnicity_NN and_CC sex_NN ._. 
We_PRP think_VBP that_IN this_DT would_MD mean_VB car-free_JJ cities_NNS ;_: urban_JJ transport_NN based_VBN around_IN walking_NN and_CC cycling_NN would_MD be_VB the_DT best_JJS modes_NNS for_IN most_JJS people_NNS for_IN most_JJS journeys_NNS ,_, public_JJ transport_NN would_MD be_VB used_VBN for_IN longer_JJR journeys_NNS ,_, with_IN small_JJ ,_, light_JJ electric_JJ vehicles_NNS for_IN carrying_VBG heavier_JJR loads_NNS and_CC when_WRB people_NNS are_VBP unable_JJ to_TO walk_VB or_CC cycle_NN 
We_PRP argue_VBP elsewhere_RB that_IN active_JJ travel_NN ,_, in_IN particular_JJ cycling_NN ,_, can_MD be_VB more_RBR inclusive_JJ than_IN is_VBZ commonly_RB recognized_VBN 
Moreover_RB ,_, it_PRP requires_VBZ us_PRP to_TO reconsider_VB the_DT main_JJ barriers_NNS to_TO achieving_VBG environmental_JJ sustainability_NN and_CC improving_VBG population_NN health_NN ._. 
As_IN Rose_NNP argued_VBD ``_`` A_DT radical_JJ approach_NN aims_VBZ to_TO remove_VB the_DT underlying_VBG impediments_NNS to_TO healthier_RBR behavior_NN ,_, or_CC to_TO control_VB the_DT adverse_JJ pressures_NNS ._. 
The_DT first_JJ or_CC medical_JJ approach_NN is_VBZ important_JJ ,_, but_CC only_RB the_DT social_JJ and_CC political_JJ approach_NN confronts_VBZ the_DT root_NN causes_NNS ._. 
Yet_RB initially_RB the_DT tobacco_NN industry_NN had_VBD been_VBN consulted_VBN as_IN a_DT major_JJ employer_NN and_CC industry_NN ._. 
There_EX is_VBZ recognition_NN that_IN the_DT tobacco_NN companies_NNS are_VBP anti-health_JJ forces_NNS and_CC cigarettes_NNS are_VBP a_DT commodity_NN to_TO be_VB challenged_VBN ._. 
Corporations_NNS have_VBP become_VBN the_DT subject_NN of_IN revived_VBN political_JJ critique_NN and_CC climate_NN change_NN campaigners_NNS have_VBP calculated_VBN the_DT greenhouse_NN gas_NN emissions_NNS of_IN corporations_NNS ._. 
Similar_JJ calculations_NNS could_MD be_VB made_VBN for_IN deaths_NNS from_IN road_NN crashes_NNS or_CC oil-related_JJ air_NN pollution_NN ._. 
As_IN Lynch_NNP et_FW al._FW 
As_IN Lynch_NNP et_FW al._FW ._. 
Similar_JJ calculations_NNS could_MD be_VB made_VBN for_IN deaths_NNS from_IN road_NN crashes_NNS or_CC oil-related_JJ air_NN pollution_NN ._. 
point_NN out_IN ,_, reducing_VBG population-wide_JJ risk_NN factors_NNS is_VBZ required_VBN and_CC ''_'' 
Integrated_NNP assessment_NN of_IN the_DT health_NN impact_NN of_IN alternative_JJ transport_NN scenarios_NNS would_MD link_VB these_DT pathways_NNS 
From_IN here_RB ,_, it_PRP is_VBZ important_JJ to_TO take_VB the_DT next_JJ step_NN and_CC investigate_VB structures_NNS and_CC organizations_NNS that_WDT act_VBP as_IN barriers_NNS to_TO achievement_NN of_IN better_JJR population_NN health_NN ._. 
Identifying_VBG anti-health_JJ forcesThe_NNP UK_NNP Public_NNP Health_NNP Association_NNP calls_VBZ for_IN a_DT focus_NN on_IN challenging_JJ anti_JJ health_NN forces_NNS ._. 
Although_IN the_DT relation_NN to_TO health_NN is_VBZ simpler_JJR ,_, we_PRP think_VBP much_RB can_MD be_VB learned_VBN from_IN how_WRB health_NN professionals_NNS have_VBP approached_VBN tobacco_NN ._. 
While_IN typically_RB HIA_NNP has_VBZ been_VBN constrained_VBN by_IN policy_NN debates_NNS ,_, it_PRP can_MD be_VB used_VBN for_IN public_JJ health_NN activism_NN ._. 
Comparative_JJ risk_NN assessment_NN -LRB-_-LRB- CRA_NNP -RRB-_-RRB- has_VBZ compared_VBN radically_RB different_JJ alternative_NN scenarios_NNS for_IN the_DT Global_NNP Burden_NNP of_IN Disease_NNP report_NN 
Road_NNP traffic_NN injuries_NNS were_VBD considered_VBN as_IN a_DT burden_NN of_IN disease_NN by_IN cause_NN ,_, while_IN physical_JJ inactivity_NN ,_, overweight_JJ and_CC obesity_NN and_CC urban_JJ air_NN pollution_NN were_VBD all_RB separately_RB presented_VBN in_IN the_DT risk_NN factor_NN assessment_NN ._. 
Integrated_NNP assessment_NN of_IN the_DT health_NN impact_NN of_IN alternative_JJ transport_NN scenarios_NNS would_MD link_VB these_DT pathways_NNS 
Public_JJ health_NN researchers_NNS recognize_VBP the_DT importance_NN of_IN walking_NN and_CC cycling_NN ,_, but_CC these_DT are_VBP often_RB seen_VBN as_IN leisure_NN activities_NNS ._. 
While_IN the_DT recent_JJ European_JJ WHO_WP report_VBP on_IN the_DT socioeconomic_JJ determinants_NNS of_IN diet_NN and_CC physical_JJ activity_NN for_IN adolescents_NNS discusses_VBZ walking_NN and_CC cycling_NN ,_, it_PRP makes_VBZ no_DT reference_NN to_TO the_DT car_NN and_CC how_WRB motorisation_NN inhibits_VBZ active_JJ travel_NN ._. 
In_IN the_DT UK_NNP literature_NN ,_, the_DT car_NN predominantly_RB appears_VBZ as_IN a_DT proxy_NN for_IN income_NN within_IN regression_NN modelling_NN ._. 
In_IN the_DT UK_NNP literature_NN ,_, the_DT car_NN predominantly_RB appears_VBZ as_IN a_DT proxy_NN for_IN income_NN within_IN regression_NN modelling_NN ._. 
In_IN one_CD major_JJ health_NN inequalities_NNS collection_NN transport_NN is_VBZ absent_JJ from_IN the_DT index_NN ,_, while_IN ``_`` car_NN ownership_NN ''_'' is_VBZ cited_VBN 35_CD times_NNS as_IN an_DT indicator_NN of_IN material_NN well-being_NN or_CC small_JJ area_NN deprivation_NN ._. 
This_DT reduces_VBZ transport_NN to_TO the_DT possession_NN or_CC absence_NN of_IN a_DT car_NN ._. 
By_IN contrast_NN ,_, our_PRP$ social_JJ process_NN approach_NN considers_VBZ health_NN implications_NNS of_IN the_DT car_NN not_RB just_RB as_IN an_DT object_NN in_IN itself_PRP or_CC a_DT marker_NN for_IN material_NN -LRB-_-LRB- dis_NN -RRB-_-RRB- advantage_NN ,_, but_CC within_IN the_DT growing_VBG global_JJ system_NN of_IN corporate_JJ commodity_NN production_NN ._. 
The_DT globalisation_NN literature_NN has_VBZ linked_VBN social_JJ processes_NNS to_TO health_NN outcomes_NNS -LRB-_-LRB- including_VBG the_DT globalisation_NN of_IN the_DT cigarette_NN industry_NN and_CC its_PRP$ targeting_VBG of_IN low_JJ income_NN countries_NNS ,_, producing_VBG a_DT growing_NN and_CC unequal_JJ disease_NN burden_NN -RRB-_-RRB- ._. 
Responding_VBG to_TO the_DT obesity_NN epidemic_NN ,_, the_DT health_NN community_NN is_VBZ drawing_VBG attention_NN to_TO the_DT increasingly_RB concentrated_JJ power_NN of_IN agribusiness_NN and_CC supermarkets_NNS 
These_DT harms_NNS and_CC benefits_NNS are_VBP unequally_RB distributed_VBN ._. 
Major_JJ roads_NNS can_MD sever_VB communities_NNS by_IN barring_VBG local_JJ access_NN ,_, communication_NN and_CC social_JJ integration_NN ,_, with_IN implications_NNS for_IN social_JJ capital_NN ._. 
Researchers_NNS have_VBP identified_VBN socio-economic_JJ inequalities_NNS in_IN road_NN traffic_NN injuries_NNS 
Harms_NNS from_IN physical_JJ inactivity_NN are_VBP not_RB equally_RB distributed_VBN ._. 
The_DT reduction_NN in_IN active_JJ travel_NN is_VBZ fuelling_VBG the_DT obesity_NN epidemic_NN 
However_RB ,_, these_DT approaches_NNS remain_VBP unusual_JJ within_IN epidemiology_NN as_IN a_DT whole_NN ._. 
Responding_VBG to_TO the_DT obesity_NN epidemic_NN ,_, the_DT health_NN community_NN is_VBZ drawing_VBG attention_NN to_TO the_DT increasingly_RB concentrated_JJ power_NN of_IN agribusiness_NN and_CC supermarkets_NNS 
The_DT globalisation_NN literature_NN has_VBZ linked_VBN social_JJ processes_NNS to_TO health_NN outcomes_NNS -LRB-_-LRB- including_VBG the_DT globalisation_NN of_IN the_DT cigarette_NN industry_NN and_CC its_PRP$ targeting_VBG of_IN low_JJ income_NN countries_NNS ,_, producing_VBG a_DT growing_NN and_CC unequal_JJ disease_NN burden_NN -RRB-_-RRB- ._. 
Responding_VBG to_TO the_DT obesity_NN epidemic_NN ,_, the_DT health_NN community_NN is_VBZ drawing_VBG attention_NN to_TO the_DT increasingly_RB concentrated_JJ power_NN of_IN agribusiness_NN and_CC supermarkets_NNS 
The_DT health_NN community_NN has_VBZ targeted_VBN tobacco_NN as_IN a_DT commodity_NN and_CC the_DT industry_NN profiting_VBG from_IN it_PRP ,_, rejecting_VBG technical_JJ fixes_NNS such_JJ as_IN extractor_NN fans_NNS and_CC ``_`` mild_JJ ''_'' cigarettes_NNS ._. 
Some_DT authors_NNS have_VBP highlighted_VBN how_WRB changes_NNS in_IN tobacco_NN consumption_NN were_VBD rooted_VBN in_IN changes_NNS in_IN tobacco_NN production_NN and_CC the_DT changing_VBG needs_NNS of_IN the_DT tobacco_NN industry_NN ._. 
The_DT tobacco_NN industry_NN has_VBZ cast_VBN smoking_NN as_IN an_DT individual_JJ choice_NN by_IN informed_JJ consumers_NNS ,_, but_CC researchers_NNS recognize_VBP the_DT role_NN advertising_NN plays_VBZ in_IN creating_VBG addiction_NN and_CC socially_RB legitimising_VBG smoking_NN -LRB-_-LRB- e._SYM 
g._IN The_DT tobacco_NN industry_NN has_VBZ cast_VBN smoking_NN as_IN an_DT individual_JJ choice_NN by_IN informed_JJ consumers_NNS ,_, but_CC researchers_NNS recognize_VBP the_DT role_NN advertising_NN plays_VBZ in_IN creating_VBG addiction_NN and_CC socially_RB legitimising_VBG smoking_NN 
By_IN contrast_NN ,_, our_PRP$ social_JJ process_NN approach_NN considers_VBZ health_NN implications_NNS of_IN the_DT car_NN not_RB just_RB as_IN an_DT object_NN in_IN itself_PRP or_CC a_DT marker_NN for_IN material_NN -LRB-_-LRB- dis_NN -RRB-_-RRB- advantage_NN ,_, but_CC within_IN the_DT growing_VBG global_JJ system_NN of_IN corporate_JJ commodity_NN production_NN ._. 
The_DT global_JJ passenger_NN motor_NN vehicle_NN fleet_NN could_MD soon_RB reach_VB one_CD billion_CD and_CC road_NN transport_NN already_RB produces_VBZ 17_CD %_NN of_IN energy_NN related_VBN carbon_NN emissions_NNS ._. 
If_IN global_JJ ownership_NN reached_VBD the_DT US_NNP average_NN -LRB-_-LRB- which_WDT is_VBZ still_RB increasing_VBG -RRB-_-RRB- there_EX would_MD be_VB over_IN five_CD billion_CD motor_NN vehicles_NNS ,_, an_DT environmentally_RB terrifying_JJ prospect_NN ._. 
If_IN global_JJ ownership_NN reached_VBD the_DT US_NNP average_NN -LRB-_-LRB- which_WDT is_VBZ still_RB increasing_VBG -RRB-_-RRB- there_EX would_MD be_VB over_IN five_CD billion_CD motor_NN vehicles_NNS ,_, an_DT environmentally_RB terrifying_JJ prospect_NN ._. 
Amyriad_NNP of_IN pathways_NNS link_VBP car-based_JJ ,_, energy_NN intensive_JJ transport_NN systems_NNS to_TO public_JJ health_NN 
Connections_NNP between_IN these_DT deaths_NNS ,_, oil_NN dependent_JJ states_NNS '_POS underdevelopment_NN ,_, and_CC the_DT world_NN 's_POS largest_JJS corporations_NNS are_VBP of_IN major_JJ epidemiological_JJ significance_NN ._. 
Opportunity_NNP costsCar_NNP dependent_JJ transport_NN systems_NNS are_VBP resource_NN intensive_JJ ,_, in_IN particular_JJ energy_NN intensive_JJ ,_, and_CC facilitate_VB other_JJ resource_NN intensive_JJ patterns_NNS of_IN development_NN ,_, including_VBG deforestation_NN ._. 
As_IN the_DT most_RBS expensive_JJ commodity_NN purchased_VBN by_IN most_JJS households_NNS -LRB-_-LRB- housing_NN costs_NNS primarily_RB represent_VBP interest_NN and_CC rent_NN not_RB construction_NN costs_NNS -RRB-_-RRB- the_DT car_NN has_VBZ helped_VBN to_TO ensure_VB the_DT growing_VBG consumer_NN demand_NN required_VBN for_IN capital_NN accumulation_NN ._. 
Road_NNP traffic_NN crashes_NNS remain_VBP a_DT neglected_VBN epidemic_NN ,_, despite_IN being_VBG the_DT most_RBS common_JJ cause_NN of_IN violent_JJ injury_NN in_IN almost_RB all_DT countries_NNS 
We_PRP think_VBP that_IN this_DT would_MD mean_VB car-free_JJ cities_NNS ;_: urban_JJ transport_NN based_VBN around_IN walking_NN and_CC cycling_NN would_MD be_VB the_DT best_JJS modes_NNS for_IN most_JJS people_NNS for_IN most_JJS journeys_NNS ,_, public_JJ transport_NN would_MD be_VB used_VBN for_IN longer_JJR journeys_NNS ,_, with_IN small_JJ ,_, light_JJ electric_JJ vehicles_NNS for_IN carrying_VBG heavier_JJR loads_NNS and_CC when_WRB people_NNS are_VBP unable_JJ to_TO walk_VB or_CC cycle_NN ._. 
Arecent_JJ study_NN found_VBD that_IN only_RB a_DT car-free_JJ London_NNP could_MD achieve_VB target_NN greenhouse_NN gas_NN emission_NN reductions_NNS -LRB-_-LRB- 60_CD %_NN by_IN 2030_CD -RRB-_-RRB- 
Car_NN manufacturers_NNS benefit_VBP from_IN the_DT creation_NN of_IN such_JJ distances_NNS ,_, because_IN mobility_NN becomes_VBZ more_RBR useful_JJ as_IN distances_NNS grow_VBP ._. 
In_IN this_DT way_NN ,_, mass_NN car_NN ownership_NN ,_, backed_VBN by_IN corporate_JJ lobbying_NN for_IN pro-car_JJ policies_NNS ,_, builds_VBZ car-dependency_NN into_IN the_DT urban_JJ fabric_NN ._. 
Firstly_RB ,_, accommodating_VBG environments_NNS to_TO the_DT car_NN encourages_VBZ social_JJ segregation_NN ._. 
Cars_NNS require_VBP copious_JJ space_NN for_IN parking_NN and_CC driving_NN ;_: these_DT needs_NNS can_MD be_VB met_VBN through_IN zoning_VBG and\/or_CC geographical_JJ social_JJ segregation_NN ,_, often_RB around_IN ethnicity_NN or_CC class_NN ._. 
Aneighborhood_NN or_CC community_NN is_VBZ not_RB a_DT fixed_JJ area_NN but_CC relative_JJ to_TO an_DT inhabitant_NN 's_POS mobility_NN ._. 
The_DT same_JJ house_NN may_MD have_VB different_JJ properties_NNS and_CC health_NN effects_NNS for_IN the_DT car_NN driver_NN and_CC for_IN the_DT child_NN who_WP can_MD not_RB cross_VB the_DT congested_JJ street_NN ,_, while_IN a_DT frequent_JJ flyer_NN 's_POS neighborhood_NN may_MD include_VB global_JJ airports_NNS but_CC not_RB the_DT nearby_JJ council_NN estate_NN ._. 
As_IN Freund_NNP and_CC Martin_NNP argue_VBP ,_, ``_`` Sociomaterial_JJ space_NN is_VBZ not_RB simply_RB inert_JJ material_NN --_: an_DT infrastructure_NN of_IN asphalt_NN and_CC concrete_NN --_: but_CC expresses_VBZ and_CC structures_NNS social_JJ life_NN ._. 
Social_NNP space_NN is_VBZ space_NN that_WDT is_VBZ used_VBN ..._: we_PRP need_VBP to_TO replace_VB a_DT static_JJ conception_NN of_IN space_NN with_IN a_DT `_`` movement_NN based_VBN '_'' one_CD ._. 
From_IN this_DT it_PRP is_VBZ argued_VBN that_IN ``_`` if_IN variations_NNS in_IN health_NN between_IN areas_NNS can_MD be_VB entirely_RB explained_VBN by_IN characteristics_NNS of_IN the_DT inhabitants_NNS of_IN those_DT areas_NNS ,_, policymakers_NNS need_VBP only_JJ act_NN on_IN improving_VBG the_DT circumstances_NNS of_IN individuals_NNS 
From_IN this_DT it_PRP is_VBZ argued_VBN that_IN ``_`` if_IN variations_NNS in_IN health_NN between_IN areas_NNS can_MD be_VB entirely_RB explained_VBN by_IN characteristics_NNS of_IN the_DT inhabitants_NNS of_IN those_DT areas_NNS ,_, policymakers_NNS need_VBP only_JJ act_NN on_IN improving_VBG the_DT circumstances_NNS of_IN individuals_NNS 
In_IN particular_JJ ,_, the_DT independent_JJ movement_NN of_IN children_NNS has_VBZ been_VBN curtailed_VBN ._. -RRB-_-RRB- 
Together_RB ,_, the_DT threat_NN of_IN violence_NN and_CC the_DT restructuring_NN of_IN place_NN raise_VBP the_DT bar_NN for_IN social_JJ participation_NN ,_, essentially_RB disabling_VBG large_JJ segments_NNS of_IN the_DT population_NN 
-RRB-_-RRB- Together_RB ,_, the_DT threat_NN of_IN violence_NN and_CC the_DT restructuring_NN of_IN place_NN raise_VBP the_DT bar_NN for_IN social_JJ participation_NN ,_, essentially_RB disabling_VBG large_JJ segments_NNS of_IN the_DT population_NN 
The_DT main_JJ road_NN that_WDT destroys_VBZ distance_NN for_IN the_DT driver_NN can_MD simultaneously_RB block_VB access_NN to_TO local_JJ amenities_NNS for_IN the_DT pedestrian_NN and_CC cyclist_NN ._. 
Thirdly_RB ,_, amenities_NNS literally_RB move_VBP away_RB from_IN people_NNS ,_, through_IN a_DT chain_NN of_IN events_NNS that_WDT leads_VBZ to_TO a_DT lack_NN of_IN local_JJ shops_NNS ,_, services_NNS ,_, and_CC jobs_NNS -LRB-_-LRB- ``_`` the_DT death_NN of_IN the_DT high_JJ street_NN ''_'' :_: Simms_NNP ._. -RRB-_-RRB- 
Together_RB ,_, the_DT threat_NN of_IN violence_NN and_CC the_DT restructuring_NN of_IN place_NN raise_VBP the_DT bar_NN for_IN social_JJ participation_NN ,_, essentially_RB disabling_VBG large_JJ segments_NNS of_IN the_DT population_NN 
Social_NNP segregation_NN physically_RB embeds_VBZ unequal_JJ social_JJ relations_NNS into_IN the_DT built_VBN environment_NN ,_, strengthening_VBG these_DT divisions_NNS ._. 
In_IN the_DT UK_NNP ''_'' 
''_'' Motorisation_NNP creates_VBZ distance_NN only_RB the_DT car_NN can_MD overcome_VB ,_, with_IN cross-sectional_JJ analysis_NN finding_VBG a_DT strongly_RB inverse_JJ relationship_NN between_IN accessibility_NN and_CC motorisation_NN 
Sprawl_NN and_CC its_PRP$ impact_NN on_IN communities_NNS has_VBZ been_VBN linked_VBN with_IN ill-health_NN ,_, through_IN both_DT material_NN and_CC psychosocial_JJ pathways_NNS 
Sprawl_NN is_VBZ seen_VBN as_IN weakening_VBG neighborhood_NN ties_NNS reducing_VBG social_JJ capital_NN ._. 
Land_NNP used_VBD for_IN roads_NNS or_CC driveways_NNS can_MD not_RB be_VB used_VBN for_IN agriculture_NN or_CC forests_NNS and_CC increasing_VBG the_DT built_VBN up_RP surfaces_NNS harms_NNS drainage_NN and_CC water_NN quality_NN 
Economic_JJ capital_NN on_IN balance_NN sheets_NNS represents_VBZ social_JJ relations_NNS ,_, both_DT between_IN competing_VBG owners_NNS of_IN capital_NN and_CC those_DT without_IN capital_NN ._. 
Effects_NNPS of_IN these_DT power_NN asymmetries_NNS can_MD be_VB subtle_JJ or_CC overt_JJ ,_, as_IN when_WRB Barcelona_NNP city_NN authorities_NNS re-started_VBD major_JJ road_NN building_NN programs_NNS in_IN the_DT 1980s_CD ,_, after_IN car_NN firms_NNS threatened_VBD to_TO leave_VB the_DT city_NN and_CC so_RB destroy_VB thousands_NNS of_IN jobs_NNS ._. 
These_DT processes_NNS have_VBP been_VBN contested_VBN ._. 
Cities_NNPS like_IN Bogot_NNP 
Cities_NNPS like_IN Bogot_NNP 
Sign_NN value_NN and_CC car_NN cultures_NNS Finally_RB ,_, sign_NN value_NN directs_VBZ our_PRP$ attention_NN to_TO the_DT car_NN 's_POS cultural_JJ and_CC psycho-social_JJ role_NN ,_, in_IN particular_JJ to_TO advertising_NN ._. 
The_DT car_NN is_VBZ the_DT most_RBS advertised_JJ commodity_NN 
Sign_NN value_NN and_CC car_NN cultures_NNS Finally_RB ,_, sign_NN value_NN directs_VBZ our_PRP$ attention_NN to_TO the_DT car_NN 's_POS cultural_JJ and_CC psycho-social_JJ role_NN ,_, in_IN particular_JJ to_TO advertising_NN ._. 
The_DT car_NN is_VBZ the_DT most_RBS advertised_JJ commodity_NN 
This_DT advertising_NN genre_NN creates_VBZ and_CC builds_VBZ upon_IN hierarchy_NN and_CC anxiety_NN ,_, feeding_VBG an_DT ``_`` ecology_NN of_IN fear_NN ''_'' 
The_DT car_NN is_VBZ the_DT most_RBS advertised_JJ commodity_NN 
Furthermore_RB ,_, ubiquitous_JJ advertising_NN helps_VBZ to_TO normalise_VB sloth_NN ._. 
Car_NN advertising_NN could_MD have_VB psycho-social_JJ effects_NNS upon_IN health_NN both_DT directly_RB -LRB-_-LRB- through_IN encouraging_VBG the_DT purchase_NN of_IN larger_JJR and_CC more_JJR dangerous_JJ cars_NNS -RRB-_-RRB- and_CC indirectly_RB -LRB-_-LRB- through_IN the_DT validation_NN of_IN `_`` macho_JJ '_'' behavior_NN when_WRB driving_VBG and_CC more_RBR generally_RB -RRB-_-RRB- ._. 
Driving_NNP has_VBZ become_VBN such_JJ a_DT normal_JJ part_NN of_IN everyday_JJ life_NN 
We_PRP would_MD argue_VB that_DT car_NN ownership_NN is_VBZ connected_VBN to_TO an_DT increasingly_RB toxic_JJ system_NN of_IN sign_NN values_NNS ,_, which_WDT feeds_VBZ off_RP and_CC encourages_VBZ the_DT threat_NN of_IN violence_NN described_VBN above_IN ._. 
Firms_NNS promote_VBP vehicles_NNS as_IN aggressively_RB conquering_VBG Nature_NN or_CC urban_JJ space_NN ,_, with_IN the_DT recent_JJ Lexus_NNP LX470_NNP campaign_NN even_RB stating_VBG ``_`` Now_RB with_IN added_JJ intimidation_NN ''_'' ._. 
Environments_NNS are_VBP depicted_VBN as_IN hostile_JJ places_NNS from_IN which_WDT cars_NNS provide_VBP protection_NN ._. 
Vehicles_NNPS are_VBP sold_VBN within_IN a_DT militarised_JJ context_NN as_IN ``_`` urban_JJ proof_NN ''_'' and_CC ``_`` rock_VB hard_RB ''_'' -LRB-_-LRB- the_DT Nissan_NNP Navara_NNP ,_, promoted_VBN in_IN conjunction_NN with_IN the_DT film_NN Die_VB Hard_JJ 4_CD ._. 
0-RRB-_NN ._. 
Vehicles_NNPS are_VBP sold_VBN within_IN a_DT militarised_JJ context_NN as_IN ``_`` urban_JJ proof_NN ''_'' and_CC ``_`` rock_VB hard_RB ''_'' -LRB-_-LRB- the_DT Nissan_NNP Navara_NNP ,_, promoted_VBN in_IN conjunction_NN with_IN the_DT film_NN Die_VB Hard_JJ 4_CD ._. 
As_IN ``_`` urban_JJ ''_'' carries_VBZ racialised_JJ connotations_NNS 
As_IN ``_`` urban_JJ ''_'' carries_VBZ racialised_JJ connotations_NNS 
Some_DT authors_NNS have_VBP called_VBN the_DT car_NN a_DT positional_JJ good_NN ,_, one_CD that_WDT provides_VBZ benefits_NNS where_WRB others_NNS have_VBP less_JJR of_IN them_PRP ._. 
This_DT aspect_NN of_IN the_DT car_NN 's_POS -LRB-_-LRB- dys_NNS -RRB-_-RRB- functionality_NN adds_VBZ to_TO the_DT discord_NN between_IN individual_JJ rational_JJ choices_NNS and_CC societal_JJ ones_NNS ._. 
Car_NN advertising_NN could_MD have_VB psycho-social_JJ effects_NNS upon_IN health_NN both_DT directly_RB -LRB-_-LRB- through_IN encouraging_VBG the_DT purchase_NN of_IN larger_JJR and_CC more_JJR dangerous_JJ cars_NNS -RRB-_-RRB- and_CC indirectly_RB -LRB-_-LRB- through_IN the_DT validation_NN of_IN `_`` macho_JJ '_'' behavior_NN when_WRB driving_VBG and_CC more_RBR generally_RB -RRB-_-RRB- ._. 
The_DT curse_NN of_IN black_JJ gold_NN The_DT car_NN economy_NN creates_VBZ oil_NN dependency_NN in_IN both_DT producing_NN and_CC consuming_NN countries_NNS ._. 
In_IN 1912_CD ,_, Churchill_NNP switched_VBD the_DT British_NNP Navy_NNP from_IN Welsh_NNP coal_NN to_TO Persian_NNP Oil_NNP ,_, since_IN when_WRB it_PRP has_VBZ been_VBN a_DT military_JJ imperative_NN to_TO ensure_VB continued_JJ oil_NN supplies_NNS even_RB during_IN war_NN ._. 
The_DT expansion_NN of_IN oil-based_JJ road_NN transport_NN has_VBZ further_RB locked_VBN rich_JJ Western_JJ economies_NNS into_IN oil_NN dependence_NN ._. 
Promoting_VBG education_NN over_IN regulation_NN has_VBZ been_VBN a_DT favored_JJ industry_NN strategy_NN for_IN alcohol_NN ,_, tobacco_NN ,_, and_CC road_NN safety_NN 
One_CD study_NN found_VBD that_IN each_DT 5_CD %_NN rise_NN in_IN oil_NN exports_NNS to_TO Gross_NNP Domestic_NNP Product_NNP -LRB-_-LRB- GDP_NNP -RRB-_-RRB- reduced_VBN life_NN expectancy_NN by_IN four_CD months_NNS and_CC increased_VBN malnutrition_NN by_IN 1_CD %_NN ._. 
The_DT expansion_NN of_IN oil-based_JJ road_NN transport_NN has_VBZ further_RB locked_VBN rich_JJ Western_JJ economies_NNS into_IN oil_NN dependence_NN ._. 
Impacts_NNS on_IN producers_NNS have_VBP been_VBN principally_RB negative_JJ ;_: they_PRP tend_VBP to_TO have_VB poor_JJ health_NN and_CC development_NN with_IN oil_NN export_NN dependence_NN linked_VBN to_TO child_NN malnutrition_NN ,_, low_JJ healthcare_NN spending_NN ,_, low_JJ school_NN enrolment_NN ,_, and_CC poor_JJ adult_NN literacy_NN ._. 
One_CD study_NN found_VBD that_IN each_DT 5_CD %_NN rise_NN in_IN oil_NN exports_NNS to_TO Gross_NNP Domestic_NNP Product_NNP -LRB-_-LRB- GDP_NNP -RRB-_-RRB- reduced_VBN life_NN expectancy_NN by_IN four_CD months_NNS and_CC increased_VBN malnutrition_NN by_IN 1_CD %_NN ._. 
Corporations_NNS and_CC related_JJ groups_NNS tied_VBN to_TO the_DT car_NN also_RB try_VB and_CC shape_VB approaches_NNS to_TO road_NN safety_NN through_IN organizations_NNS such_JJ as_IN the_DT Global_NNP Road_NNP Safety_NNP Partnership_NNP ,_, the_DT F_NN 
.._NN 
According_VBG to_TO Roberts_NNP ''_'' 
Promoting_VBG education_NN over_IN regulation_NN has_VBZ been_VBN a_DT favored_JJ industry_NN strategy_NN for_IN alcohol_NN ,_, tobacco_NN ,_, and_CC road_NN safety_NN 
Corporations_NNS and_CC related_JJ groups_NNS tied_VBN to_TO the_DT car_NN also_RB try_VB and_CC shape_VB approaches_NNS to_TO road_NN safety_NN through_IN organizations_NNS such_JJ as_IN the_DT Global_NNP Road_NNP Safety_NNP Partnership_NNP ,_, the_DT F_NN 
This_DT is_VBZ exemplified_VBN by_IN the_DT catastrophe_NN in_IN Iraq_NNP ,_, one_CD of_IN the_DT few_JJ countries_NNS where_WRB road_NN traffic_NN crashes_NNS are_VBP not_RB the_DT most_RBS common_JJ cause_NN of_IN violent_JJ death_NN ._. 
The_DT war_NN may_MD not_RB be_VB reduced_VBN to_TO oil_NN but_CC they_PRP can_MD not_RB be_VB divorced_VBN ,_, as_IN many_JJ commentators_NNS have_VBP noted_VBN ,_, including_VBG former_JJ head_NN of_IN the_DT US_NNP federal_JJ reserve_NN Alan_NNP Greenspan_NNP 
One_CD study_NN found_VBD that_IN each_DT 5_CD %_NN rise_NN in_IN oil_NN exports_NNS to_TO Gross_NNP Domestic_NNP Product_NNP -LRB-_-LRB- GDP_NNP -RRB-_-RRB- reduced_VBN life_NN expectancy_NN by_IN four_CD months_NNS and_CC increased_VBN malnutrition_NN by_IN 1_CD %_NN ._. 
Recent_JJ controversy_NN surrounding_VBG association_NN between_IN the_DT MMR_NNP vaccine_NN and_CC autism_NN exemplify_NN situations_NNS where_WRB some_DT individuals_NNS perceive_VBP the_DT individual_JJ risks_NNS of_IN vaccination_NN to_TO outweigh_VB the_DT benefits_NNS ._. 
Despite_IN carefully_RB designed_VBN epidemiological_JJ studies_NNS 
Many_JJ countries_NNS have_VBP compulsory_JJ immunization_NN requirements_NNS ._. 
Due_JJ to_TO the_DT preventive_JJ nature_NN of_IN vaccines_NNS ,_, in_IN contrast_NN to_TO therapeutic_JJ treatment_NN of_IN existing_VBG disease_NN ,_, it_PRP is_VBZ difficult_JJ to_TO determine_VB with_IN confidence_NN if_IN an_DT unvaccinated_JJ person_NN will_NN in_IN fact_NN contract_NN disease_NN ._. 
These_DT laws_NNS curtail_VBP individual_JJ autonomy_NN in_IN order_NN to_TO protect_VB the_DT community_NN from_IN infectious_JJ diseases_NNS because_IN unvaccinated_JJ individuals_NNS pose_VBP risk_NN to_TO the_DT community_NN 
In_IN the_DT United_NNP States_NNP -LRB-_-LRB- US_NNP -RRB-_-RRB- ,_, this_DT reasoning_NN is_VBZ supported_VBN by_IN several_JJ Supreme_NNP Court_NNP decisions_NNS including_VBG the_DT landmark_NN Jacobsen_NNP v._CC Massachusetts_NNP ._. 
However_RB ,_, despite_IN their_PRP$ overall_JJ societal_JJ benefit_NN ,_, vaccines_NNS cause_VBP severe_JJ adverse_JJ reactions_NNS in_IN a_DT small_JJ proportion_NN of_IN vaccinees_NNS ._. 
However_RB ,_, despite_IN their_PRP$ overall_JJ societal_JJ benefit_NN ,_, vaccines_NNS cause_VBP severe_JJ adverse_JJ reactions_NNS in_IN a_DT small_JJ proportion_NN of_IN vaccinees_NNS ._. 
To_TO further_VB the_DT societal_JJ benefits_NNS of_IN high_JJ vaccine_NN coverage_NN while_IN attempting_VBG to_TO offset_VB the_DT harm_NN for_IN the_DT small_JJ proportion_NN of_IN individuals_NNS injured_VBN by_IN vaccines_NNS ,_, the_DT US_NNP established_VBD the_DT National_NNP Vaccine_NNP Injury_NNP Compensation_NNP Program_NNP to_TO provide_VB no-fault_JJ compensation_NN for_IN vaccine_NN injured_JJ persons_NNS ._. 
There_EX are_VBP situations_NNS where_WRB there_EX can_MD be_VB a_DT real_JJ or_CC perceived_VBN divergence_NN between_IN individual_NN and_CC community_NN benefits_NNS of_IN vaccination_NN ._. 
Assuming_VBG the_DT individual_NN does_VBZ not_RB travel_VB to_TO a_DT region_NN where_WRB polio_NN is_VBZ still_RB endemic_JJ ,_, a_DT roughly_RB one_CD in_IN a_DT million_CD risk_NN of_IN VAPP_NNP is_VBZ highly_RB unlikely_JJ ,_, but_CC still_RB greater_JJR than_IN the_DT risk_NN of_IN wild_JJ polio_NN ._. 
Yet_RB ,_, if_IN a_DT substantial_JJ number_NN of_IN individuals_NNS were_VBD not_RB vaccinated_VBN because_IN of_IN this_DT individual_JJ risk\/benefit_NN analysis_NN ,_, polio_NN would_MD likely_RB have_VB been_VBN reintroduced_VBN into_IN the_DT US_NNP ,_, as_IN the_DT disease_NN is_VBZ only_RB a_DT plane_NN ride_NN away_RB ,_, leading_VBG to_TO a_DT tragedy_NN of_IN the_DT commons_NNS ._. 
While_IN this_DT divergence_NN in_IN individual_NN versus_CC community_NN benefits_NNS was_VBD short-lived_JJ -LRB-_-LRB- the_DT US_NNP switched_VBD to_TO the_DT inactivated_JJ polio_NN vaccine_NN that_WDT can_MD not_RB cause_VB VAPP_NNP -RRB-_-RRB- ,_, such_PDT a_DT situation_NN can_MD cause_VB a_DT dilemma_NN for_IN parents_NNS ,_, health_NN care_NN providers_NNS and_CC policy_NN makers_NNS ._. 
Recent_JJ controversy_NN surrounding_VBG association_NN between_IN the_DT MMR_NNP vaccine_NN and_CC autism_NN exemplify_NN situations_NNS where_WRB some_DT individuals_NNS perceive_VBP the_DT individual_JJ risks_NNS of_IN vaccination_NN to_TO outweigh_VB the_DT benefits_NNS ._. 
Despite_IN carefully_RB designed_VBN epidemiological_JJ studies_NNS 
Modern_NNP public_JJ health_NN evolved_VBD in_IN 19_CD th_JJ century_NN Europe_NNP under_IN the_DT shadow_NN of_IN utilitarian_JJ ideas_NNS of_IN Jeremy_NNP Bentham_NNP and_CC John_NNP Stuart_NNP Mill_NNP and_CC retains_VBZ its_PRP$ utilitarian_JJ leanings_NNS ._. 
However_RB ,_, the_DT impulse_NN to_TO maximize_VB benefit_NN for_IN the_DT highest_JJS number_NN of_IN people_NNS is_VBZ counterbalanced_VBN by_IN the_DT Kantian_JJ threshold_NN of_IN a_DT categorical_JJ imperative_NN :_: ``_`` Act_NNP only_RB according_VBG to_TO that_DT maxim_NN by_IN which_WDT you_PRP can_MD at_IN the_DT same_JJ time_NN will_MD that_VB it_PRP should_MD become_VB a_DT universal_JJ law_NN ''_'' that_WDT preserves_VBZ individual_JJ autonomy_NN and_CC emphasizes_VBZ ideas_NNS such_JJ as_IN informed_JJ consent_NN ._. 
Restrictions_NNS on_IN individual_JJ rights_NNS are_VBP justified_VBN for_IN two_CD reasons_NNS 
Due_JJ to_TO the_DT preventive_JJ nature_NN of_IN vaccines_NNS ,_, in_IN contrast_NN to_TO therapeutic_JJ treatment_NN of_IN existing_VBG disease_NN ,_, it_PRP is_VBZ difficult_JJ to_TO determine_VB with_IN confidence_NN if_IN an_DT unvaccinated_JJ person_NN will_NN in_IN fact_NN contract_NN disease_NN ._. 
Many_JJ countries_NNS have_VBP compulsory_JJ immunization_NN requirements_NNS ._. 
These_DT laws_NNS curtail_VBP individual_JJ autonomy_NN in_IN order_NN to_TO protect_VB the_DT community_NN from_IN infectious_JJ diseases_NNS because_IN unvaccinated_JJ individuals_NNS pose_VBP risk_NN to_TO the_DT community_NN 
Many_JJ countries_NNS have_VBP compulsory_JJ immunization_NN requirements_NNS ._. 
Due_JJ to_TO the_DT preventive_JJ nature_NN of_IN vaccines_NNS ,_, in_IN contrast_NN to_TO therapeutic_JJ treatment_NN of_IN existing_VBG disease_NN ,_, it_PRP is_VBZ difficult_JJ to_TO determine_VB with_IN confidence_NN if_IN an_DT unvaccinated_JJ person_NN will_NN in_IN fact_NN contract_NN disease_NN ._. 
These_DT laws_NNS curtail_VBP individual_JJ autonomy_NN in_IN order_NN to_TO protect_VB the_DT community_NN from_IN infectious_JJ diseases_NNS because_IN unvaccinated_JJ individuals_NNS pose_VBP risk_NN to_TO the_DT community_NN 
From_IN the_DT perspective_NN of_IN these_DT parents_NNS ,_, the_DT benefits_NNS of_IN MMR_NNP vaccination_NN may_MD not_RB outweigh_VB the_DT -LRB-_-LRB- perceived_VBN -RRB-_-RRB- autism_NN risk_NN ._. 
The_DT community_NN risk\/benefit_NN analysis_NN is_VBZ likewise_RB dependent_JJ on_IN one_NN 's_POS knowledge_NN base_NN and_CC perception_NN of_IN the_DT science_NN 
Recent_JJ controversy_NN surrounding_VBG association_NN between_IN the_DT MMR_NNP vaccine_NN and_CC autism_NN exemplify_NN situations_NNS where_WRB some_DT individuals_NNS perceive_VBP the_DT individual_JJ risks_NNS of_IN vaccination_NN to_TO outweigh_VB the_DT benefits_NNS ._. 
Despite_IN carefully_RB designed_VBN epidemiological_JJ studies_NNS 
From_IN the_DT perspective_NN of_IN these_DT parents_NNS ,_, the_DT benefits_NNS of_IN MMR_NNP vaccination_NN may_MD not_RB outweigh_VB the_DT -LRB-_-LRB- perceived_VBN -RRB-_-RRB- autism_NN risk_NN ._. 
The_DT community_NN risk\/benefit_NN analysis_NN is_VBZ likewise_RB dependent_JJ on_IN one_NN 's_POS knowledge_NN base_NN and_CC perception_NN of_IN the_DT science_NN 
Recent_JJ controversy_NN surrounding_VBG association_NN between_IN the_DT MMR_NNP vaccine_NN and_CC autism_NN exemplify_NN situations_NNS where_WRB some_DT individuals_NNS perceive_VBP the_DT individual_JJ risks_NNS of_IN vaccination_NN to_TO outweigh_VB the_DT benefits_NNS ._. 
Despite_IN carefully_RB designed_VBN epidemiological_JJ studies_NNS 
Appendix_NN 3_CD summaries_NNS the_DT key_JJ evidences_NNS to_TO date_NN on_IN environmental_JJ and_CC genetic_JJ risk_NN factors_NNS for_IN Parkinson_NNP 's_POS disease_NN 
-LRB-_-LRB- a_DT -RRB-_-RRB- Strength_NN of_IN association_NN ._. 
Hill_NNP 's_POS guidelines_NNS are_VBP discussed_VBN in_IN a_DT slightly_RB different_JJ order_NN than_IN in_IN the_DT original_JJ version_NN and_CC statistical_JJ significance_NN is_VBZ omitted_VBN because_IN it_PRP refers_VBZ to_TO the_DT contingent_JJ evaluation_NN of_IN each_DT study_NN and_CC does_VBZ not_RB require_VB a_DT specific_JJ discussion_NN in_IN relation_NN to_TO genomics_NNS ._. 
DJ-1_NN has_VBZ been_VBN seen_VBN to_TO be_VB lacking_VBG in_IN Dutch_JJ families_NNS with_IN Parkinson_NNP 's_POS disease_NN ,_, and_CC to_TO be_VB functionally_RB inactive_JJ because_IN of_IN a_DT point_NN mutation_NN in_IN the_DT Italian_JJ families_NNS studied_VBN by_IN Bonifati_NNP and_CC cols_NNS 
DJ-1_NN has_VBZ been_VBN seen_VBN to_TO be_VB lacking_VBG in_IN Dutch_JJ families_NNS with_IN Parkinson_NNP 's_POS disease_NN ,_, and_CC to_TO be_VB functionally_RB inactive_JJ because_IN of_IN a_DT point_NN mutation_NN in_IN the_DT Italian_JJ families_NNS studied_VBN by_IN Bonifati_NNP and_CC cols_NNS 
To_TO do_VB this_DT we_PRP use_VBP simplified_VBN versions_NNS of_IN models_NNS proposed_VBN by_IN Khoury_NNP et_FW al._FW ._. 
We_PRP consider_VBP first_RB the_DT case_NN study_NN of_IN gene-environment_JJ interactions_NNS -LRB-_-LRB- GEI_NNP -RRB-_-RRB- involving_VBG risk_NN of_IN Parkinson_NNP 's_POS disease_NN ,_, the_DT DJ-1_NNP gene_NN and_CC exposure_NN to_TO paraquat_NN described_VBN above_IN ._. 
The_DT approach_NN we_PRP propose_VBP uses_VBZ the_DT statistically_RB formal_JJ representation_NN of_IN DAG_NNP models_NNS ._. 
,the_JJ detailed_JJ biological_JJ mechanisms_NNS in_IN animal_NN models_NNS -RRB-_-RRB- of_IN the_DT interaction_NN are_VBP not_RB completely_RB known_VBN ._. 
This_DT is_VBZ in_IN contrast_NN to_TO Weinberg_NNP 's_POS paper_NN 
The_DT approach_NN we_PRP propose_VBP uses_VBZ the_DT statistically_RB formal_JJ representation_NN of_IN DAG_NNP models_NNS ._. 
,the_JJ detailed_JJ biological_JJ mechanisms_NNS in_IN animal_NN models_NNS -RRB-_-RRB- of_IN the_DT interaction_NN are_VBP not_RB completely_RB known_VBN ._. 
This_DT is_VBZ in_IN contrast_NN to_TO Weinberg_NNP 's_POS paper_NN which_WDT ,_, although_IN invaluable_JJ in_IN highlighting_VBG the_DT pros_NNS and_CC cons_NNS of_IN DAG_NNP models_NNS ,_, does_VBZ not_RB actually_RB use_VB DAGs_NNP ,_, but_CC heur_NN 
The_DT approach_NN we_PRP propose_VBP uses_VBZ the_DT statistically_RB formal_JJ representation_NN of_IN DAG_NNP models_NNS ._. 
,the_JJ detailed_JJ biological_JJ mechanisms_NNS in_IN animal_NN models_NNS -RRB-_-RRB- of_IN the_DT interaction_NN are_VBP not_RB completely_RB known_VBN ._. 
This_DT is_VBZ in_IN contrast_NN to_TO Weinberg_NNP 's_POS paper_NN 
-LRB-_-LRB- b_NN -RRB-_-RRB- Consistency_NN of_IN the_DT association_NN ._. 
,they_NN are_VBP often_RB related_VBN to_TO each_DT other_JJ ,_, as_IN in_IN this_DT paragraph_NN the_DT strength_NN of_IN association_NN is_VBZ related_VBN to_TO the_DT biological_JJ plausibility_NN -RRB-_-RRB- ._. 
After_IN the_DT first_JJ variants_NNS described_VBN ,_, different_JJ variants_NNS of_IN the_DT DJ-1_NNP gene_NN associated_VBN with_IN the_DT same_JJ Parkinson_NNP 's_POS disease_NN phenotype_NN have_VBP been_VBN found_VBN in_IN patients_NNS of_IN Ashkenazi_NNP Jewish_NNP and_CC Afro-Caribbean_JJ origins_NNS 
In_IN environmental_JJ epidemiological_JJ studies_NNS in_IN humans_NNS ,_, the_DT association_NN has_VBZ been_VBN found_VBN substantially_RB consistent_JJ across_IN studies_NNS ,_, although_IN some_DT associations_NNS did_VBD not_RB reach_VB statistical_JJ significance_NN ,_, mainly_RB due_JJ to_TO limited_JJ sample_NN size_NN ._. 
In_IN a_DT study_NN in_IN Taiwan_NNP ,_, where_WRB paraquat_NN is_VBZ routinely_RB used_VBN in_IN rice_NN fields_NNS ,_, a_DT strong_JJ association_NN between_IN paraquat_NN exposure_NN and_CC Parkinson_NNP 's_POS disease_NN was_VBD found_VBN ;_: the_DT hazard_NN increased_VBN by_IN more_JJR than_IN six_CD times_NNS in_IN subjects_NNS exposed_VBN for_IN more_JJR than_IN 20_CD years_NNS 
-LRB-_-LRB- g_NN -RRB-_-RRB- Coherence_NN with_IN previous_JJ knowledge_NN ._. 
It_PRP is_VBZ ,_, therefore_RB ,_, plausible_JJ that_IN these_DT two_CD factors_NNS may_MD interact_VB during_IN the_DT course_NN of_IN life_NN producing_VBG Parkinson_NNP 's_POS symptoms_NNS in_IN genetically_RB susceptible_JJ individuals_NNS 
The_DT protein_NN encoded_VBN by_IN PINK-1_NN gene_NN is_VBZ a_DT mitochondrial_JJ kinase_NN that_WDT seems_VBZ to_TO be_VB involved_VBN in_IN protecting_VBG the_DT cell_NN from_IN mitochondrial_JJ dysfunction_NN and_CC stress-induced_JJ apoptosis_NN 
g._NN However_RB ,_, temporality_NN is_VBZ crucial_JJ if_IN we_PRP go_VBP beyond_IN genetic_JJ effects_NNS and_CC consider_VB epigenetic_JJ mechanisms_NNS ;_: e._NN ,_, gene_NN regulation_NN by_IN environmental_JJ factors_NNS 
An_DT example_NN of_IN the_DT influence_NN of_IN study_NN design_NN is_VBZ the_DT investigation_NN of_IN gene-disease_JJ associations_NNS in_IN founder_NN populations_NNS ,_, in_IN which_WDT the_DT effect_NN of_IN a_DT genetic_JJ variant_NN is_VBZ likely_JJ to_TO be_VB higher_JJR than_IN the_DT average_NN across_IN all_DT populations_NNS 
Acollection_NNP of_IN archived_JJ specimens_NNS may_MD help_VB ,_, as_IN can_NN knowledge_NN on_IN the_DT usual_JJ course_NN of_IN events_NNS gained_VBN from_IN molecular_JJ pathology_NN studies_NNS ._. 
For_IN epigenetic_JJ mechanisms_NNS temporality_NN is_VBZ even_RB more_RBR crucial_JJ ,_, but_CC it_PRP is_VBZ beyond_IN the_DT purpose_NN of_IN this_DT article_NN ._. 
In_IN genomics_NNS ,_, the_DT possibility_NN of_IN observing_VBG a_DT dose-response_JJ gradient_NN depends_VBZ on_IN the_DT model_NN of_IN genotype-phenotype_JJ relationships_NNS ._. 
Chronic_JJ systemic_JJ exposure_NN to_TO rotenone_NN has_VBZ been_VBN demonstrated_VBN to_TO cause_VB highly_RB selective_JJ nigrostriatal_JJ dopaminergic_JJ degeneration_NN associated_VBN with_IN characteristic_JJ movement_NN disorders_NNS in_IN rats_NNS 
g._NN However_RB ,_, temporality_NN is_VBZ crucial_JJ if_IN we_PRP go_VBP beyond_IN genetic_JJ effects_NNS and_CC consider_VB epigenetic_JJ mechanisms_NNS ;_: e._NN ,_, gene_NN regulation_NN by_IN environmental_JJ factors_NNS 
g._NN In_IN addition_NN ,_, the_DT expression_NN of_IN genes_NNS is_VBZ so_RB dependent_JJ on_IN the_DT surrounding_JJ circumstances_NNS -LRB-_-LRB- other_JJ genes_NNS ,_, internal_JJ environment_NN -_: e._NN ,_, immunological_JJ and_CC nutritional_JJ status_NN -_: ,_, external_JJ physical_JJ environment_NN ,_, gene_NN expression_NN -RRB-_-RRB- ,_, that_IN the_DT same_JJ main_JJ clinical_JJ effect_NN of_IN a_DT gene_NN variant_NN is_VBZ difficult_JJ to_TO capture_VB in_IN different_JJ studies_NNS conducted_VBN under_IN different_JJ conditions_NNS ._. 
In_IN fact_NN ,_, such_JJ main_JJ effects_NNS may_MD not_RB be_VB identical_JJ in_IN different_JJ studies_NNS that_WDT are_VBP conducted_VBN in_IN actual_JJ -_: sometimes_RB ,_, very_RB different_JJ -_: human_JJ contexts_NNS ;_: a_DT genuine_JJ heterogeneity_NN of_IN human_JJ genetic_JJ effects_NNS across_IN population_NN groups_NNS -_: and_CC individuals_NNS -_: is_VBZ to_TO be_VB expected_VBN on_IN the_DT basis_NN of_IN knowledge_NN on_IN how_WRB biological_JJ ,_, clinical_JJ and_CC environmental_JJ processes_NNS jointly_RB cause_VBP disease_NN in_IN humans_NNS ._. 
Acollection_NNP of_IN archived_JJ specimens_NNS may_MD help_VB ,_, as_IN can_NN knowledge_NN on_IN the_DT usual_JJ course_NN of_IN events_NNS gained_VBN from_IN molecular_JJ pathology_NN studies_NNS ._. 
For_IN epigenetic_JJ mechanisms_NNS temporality_NN is_VBZ even_RB more_RBR crucial_JJ ,_, but_CC it_PRP is_VBZ beyond_IN the_DT purpose_NN of_IN this_DT article_NN ._. 
In_IN genomics_NNS ,_, the_DT possibility_NN of_IN observing_VBG a_DT dose-response_JJ gradient_NN depends_VBZ on_IN the_DT model_NN of_IN genotype-phenotype_JJ relationships_NNS ._. 
However_RB ,_, genetic_JJ research_NN has_VBZ fundamental_JJ differences_NNS from_IN clinical_JJ and_CC epidemiological_JJ research_NN ._. 
In_IN summary_NN ,_, Hill_NNP 's_POS causal_JJ criteria_NNS and_CC related_JJ logical_JJ tools_NNS that_WDT have_VBP long_RB been_VBN applied_VBN fruitfully_RB to_TO clinical_JJ and_CC epidemiological_JJ research_NN may_MD also_RB be_VB applied_VBN productively_RB to_TO research_NN in_IN genetics_NNS ._. 
For_IN example_NN ,_, in_IN genetics_NNS confounding_VBG can_MD be_VB the_DT consequence_NN of_IN events_NNS that_WDT may_MD not_RB be_VB directly_RB addressed_VBN at_IN the_DT other_JJ levels_NNS ,_, including_VBG haplotype_NN blocks_NNS ,_, allelic_JJ heterogeneity_NN ,_, overdominance_NN ,_, and_CC epistasis_NN ._. 
Selection_NN bias_NN is_VBZ more_RBR easily_RB measurable_JJ in_IN genomic_JJ studies_NNS ,_, because_IN we_PRP have_VBP the_DT null_JJ hypothesis_NN represented_VBN by_IN Hardy-Weinberg_NNP equilibrium_NN -LRB-_-LRB- HWE_NNP -RRB-_-RRB- ;_: i._SYM 
However_RB ,_, genetic_JJ guidelines_NNS on_IN causality_NN do_VBP exist_VB and_CC ,_, in_IN fact_NN ,_, have_VBP interesting_JJ similarities_NNS with_IN Hill_NNP 's_POS criteria_NNS :_: -LRB-_-LRB- a_DT -RRB-_-RRB- linkage_NN to_TO a_DT particular_JJ region_NN of_IN the_DT human_JJ genome_NN -LRB-_-LRB- LOD_NNP 
Criteria_NNP -LRB-_-LRB- a_DT -RRB-_-RRB- ,_, -LRB-_-LRB- b_NN -RRB-_-RRB- and_CC -LRB-_-LRB- c_NN -RRB-_-RRB- refer_VBP to_TO background_NN knowledge_NN ._. -RRB-_-RRB- ._. 
However_RB ,_, genetic_JJ guidelines_NNS on_IN causality_NN do_VBP exist_VB and_CC ,_, in_IN fact_NN ,_, have_VBP interesting_JJ similarities_NNS with_IN Hill_NNP 's_POS criteria_NNS :_: -LRB-_-LRB- a_DT -RRB-_-RRB- linkage_NN to_TO a_DT particular_JJ region_NN of_IN the_DT human_JJ genome_NN -LRB-_-LRB- LOD_NNP 
In_IN fact_NN ,_, such_JJ main_JJ effects_NNS may_MD not_RB be_VB identical_JJ in_IN different_JJ studies_NNS that_WDT are_VBP conducted_VBN in_IN actual_JJ -_: sometimes_RB ,_, very_RB different_JJ -_: human_JJ contexts_NNS ;_: a_DT genuine_JJ heterogeneity_NN of_IN human_JJ genetic_JJ effects_NNS across_IN population_NN groups_NNS -_: and_CC individuals_NNS -_: is_VBZ to_TO be_VB expected_VBN on_IN the_DT basis_NN of_IN knowledge_NN on_IN how_WRB biological_JJ ,_, clinical_JJ and_CC environmental_JJ processes_NNS jointly_RB cause_VBP disease_NN in_IN humans_NNS ._. 
An_DT example_NN of_IN the_DT influence_NN of_IN study_NN design_NN is_VBZ the_DT investigation_NN of_IN gene-disease_JJ associations_NNS in_IN founder_NN populations_NNS ,_, in_IN which_WDT the_DT effect_NN of_IN a_DT genetic_JJ variant_NN is_VBZ likely_JJ to_TO be_VB higher_JJR than_IN the_DT average_NN across_IN all_DT populations_NNS 
However_RB ,_, in_IN genetics_NNS the_DT penetrance_NN of_IN an_DT individual_JJ genetic_JJ variant_NN associated_VBN with_IN a_DT disease_NN depends_VBZ on_IN the_DT interactions_NNS of_IN the_DT variant_NN with_IN external_JJ exposures_NNS ,_, the_DT internal_JJ environment_NN ,_, or_CC other_JJ genetic_JJ variants_NNS ._. 
In_IN spite_NN of_IN the_DT etiologic_JJ complexity_NN of_IN common_JJ diseases_NNS and_CC the_DT resulting_JJ weak_JJ effects_NNS of_IN individual_JJ genetic_JJ variants_NNS ,_, theoretical_JJ work_NN suggests_VBZ that_IN the_DT combination_NN of_IN as_RB few_JJ as_IN 20_CD common_JJ variants_NNS with_IN weak_JJ to_TO moderate_JJ effect_NN sizes_NNS ,_, when_WRB put_VBN together_RB as_IN a_DT system_NN of_IN variants_NNS -LRB-_-LRB- or_CC genomic_JJ profiles_NNS -RRB-_-RRB- ,_, can_MD account_VB for_IN a_DT substantial_JJ attributable_JJ fraction_NN of_IN the_DT disease_NN in_IN the_DT population_NN ._. 
On_IN the_DT other_JJ hand_NN ,_, a_DT large_JJ number_NN of_IN rare_JJ variants_NNS each_DT 
,in_NN mice_NNS -RRB-_-RRB- that_WDT are_VBP only_RB a_DT partial_JJ approximation_NN of_IN the_DT complex_JJ human_JJ disease_NN ;_: an_DT example_NN is_VBZ the_DT Super_NNP Oxide_NNP Dismutase-1_NNP -LRB-_-LRB- SOD1_NNP -RRB-_-RRB- mutated_VBN mouse_NN model_NN for_IN Amyotrophic_NNP Lateral_NNP Sclerosis_NNP -LRB-_-LRB- ALS_NNP -RRB-_-RRB- ,_, which_WDT has_VBZ different_JJ motor_NN characteristics_NNS than_IN the_DT human_JJ disease_NN ._. 
Appendix_NN 2_CD The_DT calculus_NN of_IN the_DT Decision_NNP Theoretic_NNP Framework_NNP -LRB-_-LRB- DTF_NNP -RRB-_-RRB- The_DT calculus_NN of_IN DTFConditional_JJ independence_NN 
This_DT may_MD be_VB more_RBR convincing_JJ evidence_NN of_IN the_DT truly_RB causal_JJ nature_NN of_IN the_DT association_NN ,_, given_VBN the_DT available_JJ biological_JJ knowledge_NN on_IN environmental_JJ influences_NNS on_IN gene_NN expression_NN ._. 
Consistency_NN in_IN genetic_JJ studies_NNS was_VBD traditionally_RB poor_JJ in_IN the_DT ``_`` candidate_NN gene_NN ''_'' era_NN ,_, with_IN few_JJ associations_NNS confirmed_VBD in_IN more_JJR than_IN one_CD study_NN ,_, but_CC this_DT has_VBZ changed_VBN rapidly_RB with_IN genome-wide_JJ association_NN studies_NNS -LRB-_-LRB- GWAs_NNP -RRB-_-RRB- ._. 
More_JJR than_IN 600_CD stable_JJ replicated_VBN hits_NNS have_VBP been_VBN reported_VBN in_IN 2007_CD and_CC 2008_CD from_IN GWAs_NNP ,_, due_JJ to_TO an_DT in-built_JJ ,_, strong_JJ process_NN of_IN replication_NN of_IN findings_NNS ._. 
g._NNP This_NNP led_VBD to_TO synopses_NNS on_IN various_JJ topics_NNS in_IN genetic_JJ epidemiology_NN ;_: e._VB In_IN 2006_CD ,_, a_DT Human_NNP Genome_NNP Epidemiology_NNP Network_NNP -LRB-_-LRB- HuGENet_NNP -RRB-_-RRB- workshop_NN in_IN Venice_NNP was_VBD devoted_VBN to_TO the_DT development_NN of_IN standardized_JJ criteria_NNS for_IN the_DT assessment_NN of_IN the_DT credibility_NN of_IN cumulative_JJ evidence_NN on_IN gene-disease_JJ associations_NNS ._. 
,on_NNP DNA_NNP repair_NN 
These_DT guidelines_NNS contributed_VBD to_TO modifying_VBG the_DT approach_NN to_TO genetic_JJ inferences_NNS using_VBG Hill_NNP 's_POS criteria_NNS that_IN we_PRP adopt_VBP here_RB ._. 
Main_NNP theoretical_JJ issues_NNS underlying_VBG the_DT application_NN of_IN Hill_NNP 's_POS criteria_NNS in_IN genetics_NNS and_CC genomics_NNS are_VBP shown_VBN in_IN Appendix_NNP 1_CD 
2and_CD 1_CD ._. 
,relative_JJ risks_NNS are_VBP usually_RB under_IN 2_CD ,_, and_CC often_RB between_IN 1_CD ._. 
e._NNP Empirical_NNP findings_NNS show_VBP that_IN even_RB for_IN fairly_RB well_RB established_VBN associations_NNS ,_, the_DT effect_NN sizes_NNS are_VBP weak_JJ to_TO modest_JJ ;_: i._NN 6_CD -RRB-_-RRB- ._. 
Generally_RB speaking_NN ,_, the_DT stronger_JJR the_DT association_NN between_IN a_DT risk_NN factor_NN and_CC a_DT disease_NN ,_, the_DT more_RBR likely_JJ it_PRP is_VBZ that_IN the_DT association_NN is_VBZ causal_JJ ,_, because_IN confounding_JJ and_CC other_JJ biases_NNS are_VBP unlikely_JJ to_TO explain_VB it_PRP away_RB ._. 
This_DT shows_VBZ where_WRB the_DT ``_`` familial_JJ ''_'' terminology_NN used_VBN in_IN DAGs_NNP comes_VBZ from_IN ._. 
If_IN however_RB ,_, we_PRP can_MD see_VB their_PRP$ parents_NNS Barry_NNP and_CC Barbara_NNP -LRB-_-LRB- B_NNP -RRB-_-RRB- ,_, then_RB knowing_VBG about_IN Colin_NNP gives_VBZ us_PRP no_DT further_JJ information_NN on_IN Alfred_NNP ._. 
Conditional_JJ independence_NN is_VBZ a_DT non-graphical_JJ -LRB-_-LRB- and_CC non-causal_JJ -RRB-_-RRB- equivalent_NN of_IN the_DT d-separation_NN criteria_NNS used_VBN in_IN the_DT causal_JJ DAG_NNP approach_NN 
To_TO do_VB this_DT we_PRP use_VBP simplified_VBN versions_NNS of_IN models_NNS proposed_VBN by_IN Khoury_NNP et_FW al._FW ._. 
We_PRP consider_VBP first_RB the_DT case_NN study_NN of_IN gene-environment_JJ interactions_NNS -LRB-_-LRB- GEI_NNP -RRB-_-RRB- involving_VBG risk_NN of_IN Parkinson_NNP 's_POS disease_NN ,_, the_DT DJ-1_NNP gene_NN and_CC exposure_NN to_TO paraquat_NN described_VBN above_IN ._. 
As_IN mentioned_VBN above_IN ,_, these_DT are_VBP loosely_RB based_VBN on_IN Khoury_NNP et_FW al._FW ._. 
Now_RB we_PRP turn_VBP our_PRP$ attention_NN to_TO looking_VBG at_IN the_DT case_NN by_IN evaluating_VBG the_DT plausibility_NN of_IN a_DT few_JJ different_JJ GEI_NNP scenarios_NNS ._. 
g._NN However_RB ,_, temporality_NN is_VBZ crucial_JJ if_IN we_PRP go_VBP beyond_IN genetic_JJ effects_NNS and_CC consider_VB epigenetic_JJ mechanisms_NNS ;_: e._NN ,_, gene_NN regulation_NN by_IN environmental_JJ factors_NNS 
An_DT example_NN of_IN the_DT influence_NN of_IN study_NN design_NN is_VBZ the_DT investigation_NN of_IN gene-disease_JJ associations_NNS in_IN founder_NN populations_NNS ,_, in_IN which_WDT the_DT effect_NN of_IN a_DT genetic_JJ variant_NN is_VBZ likely_JJ to_TO be_VB higher_JJR than_IN the_DT average_NN across_IN all_DT populations_NNS 
Acollection_NNP of_IN archived_JJ specimens_NNS may_MD help_VB ,_, as_IN can_NN knowledge_NN on_IN the_DT usual_JJ course_NN of_IN events_NNS gained_VBN from_IN molecular_JJ pathology_NN studies_NNS ._. 
For_IN epigenetic_JJ mechanisms_NNS temporality_NN is_VBZ even_RB more_RBR crucial_JJ ,_, but_CC it_PRP is_VBZ beyond_IN the_DT purpose_NN of_IN this_DT article_NN ._. 
In_IN genomics_NNS ,_, the_DT possibility_NN of_IN observing_VBG a_DT dose-response_JJ gradient_NN depends_VBZ on_IN the_DT model_NN of_IN genotype-phenotype_JJ relationships_NNS ._. 
To_TO some_DT extent_NN it_PRP is_VBZ reasonable_JJ to_TO hope_VB that_IN genetic_JJ associations_NNS are_VBP specific_JJ ,_, thus_RB facilitating_VBG causal_JJ inference_NN ._. 
For_IN example_NN ,_, 5-HTT_JJ variants_NNS have_VBP been_VBN associated_VBN specifically_RB with_IN bipolar_JJ disorder_NN ,_, probably_RB because_IN of_IN the_DT role_NN of_IN the_DT gene_NN in_IN serotonin_NN metabolism_NN ._. 
But_CC expectations_NNS of_IN specificity_NN may_MD disregard_VB biological_JJ knowledge_NN -LRB-_-LRB- e._FW g._FW ,_, on_IN cofactors_NNS ,_, multiple_JJ causes_NNS and_CC effects_NNS -RRB-_-RRB- that_WDT makes_VBZ unspecificity_NN more_RBR plausible_JJ ._. 
This_DT problem_NN goes_VBZ beyond_IN the_DT present_JJ contribution_NN ,_, but_CC is_VBZ worth_JJ mentioning_VBG ._. 
,gene_JJ regulation_NN by_IN environmental_JJ factors_NNS 
This_DT problem_NN goes_VBZ beyond_IN the_DT present_JJ contribution_NN ,_, but_CC is_VBZ worth_JJ mentioning_VBG ._. 
,gene_JJ regulation_NN by_IN environmental_JJ factors_NNS 
e._VB For_IN example_NN ,_, the_DT association_NN of_IN some_DT lifestyle_NN factors_NNS with_IN genotypes_NNS predisposing_VBG -LRB-_-LRB- or_CC causing_VBG -RRB-_-RRB- Parkinson_NNP 's_POS disease_NN is_VBZ possible_JJ as_IN the_DT dopaminergic_JJ system_NN is_VBZ involved_VBN in_IN rewarding_JJ mechanisms_NNS and_CC it_PRP is_VBZ hypothesized_VBN to_TO influence_VB some_DT seeking_VBG behaviors_NNS and_CC addiction_NN -LRB-_-LRB- i._NN ,_, smoking_NN or_CC alcohol_NN drinking_NN -RRB-_-RRB- ._. 
The_DT idea_NN of_IN I_PRP as_IN a_DT variable_NN to_TO represent_VB interaction_NN is_VBZ similar_JJ to_TO the_DT sufficient_JJ component_NN cause_NN -LRB-_-LRB- SCC_NNP -RRB-_-RRB- variables_NNS in_IN VanderWeele_NNP and_CC Robins_NNP 
Confounding_VBG between_IN both_DT exposure_NN to_TO paraquat_NN and_CC the_DT disease_NN might_MD be_VB due_JJ ,_, for_IN example_NN ,_, to_TO the_DT fact_NN that_IN people_NNS exposed_VBN to_TO paraquat_NN may_MD also_RB be_VB more_RBR likely_JJ to_TO smoke_VB ,_, a_DT factor_NN that_WDT is_VBZ negatively_RB associated_VBN with_IN the_DT risk_NN of_IN Parkinson_NNP 's_POS disease_NN 
,smoking_NN or_CC alcohol_NN drinking_NN -RRB-_-RRB- ._. 
e._VB For_IN example_NN ,_, the_DT association_NN of_IN some_DT lifestyle_NN factors_NNS with_IN genotypes_NNS predisposing_VBG -LRB-_-LRB- or_CC causing_VBG -RRB-_-RRB- Parkinson_NNP 's_POS disease_NN is_VBZ possible_JJ as_IN the_DT dopaminergic_JJ system_NN is_VBZ involved_VBN in_IN rewarding_JJ mechanisms_NNS and_CC it_PRP is_VBZ hypothesized_VBN to_TO influence_VB some_DT seeking_VBG behaviors_NNS and_CC addiction_NN -LRB-_-LRB- i._VB The_DT idea_NN of_IN I_PRP as_IN a_DT variable_NN to_TO represent_VB interaction_NN is_VBZ similar_JJ to_TO the_DT sufficient_JJ component_NN cause_NN -LRB-_-LRB- SCC_NNP -RRB-_-RRB- variables_NNS in_IN VanderWeele_NNP and_CC Robins_NNP 
Whilst_IN the_DT causal_JJ DAG_NNP framework_NN is_VBZ appealing_JJ and_CC intuitive_JJ ,_, we_PRP wish_VBP to_TO draw_VB attention_NN to_TO an_DT alternative_JJ approach_NN to_TO causal_JJ inference_NN ,_, the_DT Decision_NNP Theoretic_NNP Framework_NNP -LRB-_-LRB- DTF_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ based_VBN on_IN a_DT formal_JJ treatment_NN of_IN conditional_JJ independences_NNS -LRB-_-LRB- a_DT non-graphical_JJ version_NN of_IN the_DT 'd_NNP -_: separation_NN criteria_NNS '_POS -RRB-_-RRB- 
As_IN in_IN this_DT case_NN both_DT the_DT genetic_JJ make-up_NN and_CC the_DT exposure_NN status_NN of_IN the_DT flies_VBZ have_VB been_VBN intervened_VBN upon_IN under_IN controlled_JJ conditions_NNS ,_, we_PRP can_MD make_VB causal_JJ inference_NN based_VBN on_IN this_DT data_NN by_IN introducing_VBG randomisation_NN variables_NNS into_IN our_PRP$ DAG_NNP ._. 
The_DT DAG_NNP in_IN Figure_NNP 9_CD is_VBZ an_DT augmented_JJ DAG_NNP that_WDT includes_VBZ randomisation_NN variables_NNS Rp_NNP and_CC Rd._NNP ._. 
These_DT tell_VBP us_PRP whether_IN P_NNP or_CC DJ-1_NNP are_VBP being_VBG randomised_VBN or_CC not_RB and_CC allow_VB us_PRP to_TO make_VB inferences_NNS about_IN interventions_NNS and_CC ,_, hence_RB ,_, causality_NN using_VBG DAGs_NNP ._. 
If_IN U_NNP depends_VBZ on_IN X_NNP then_RB we_PRP have_VBP that_IN U_NNP is_VBZ a_DT mediator_NN as_IN in_IN Figure_NNP 3B_NNP ._. 
This_DT corresponds_VBZ precisely_RB to_TO the_DT situation_NN described_VBN by_IN the_DT DAG_NNP in_IN Figure_NNP 3A_NNP ._. 
As_IN also_RB shown_VBN in_IN Figure_NNP 3B_NNP ,_, interventions_NNS are_VBP represented_VBN by_IN decision_NN nodes_NNS -LRB-_-LRB- square_JJ boxes_NNS -RRB-_-RRB- in_IN augmented_JJ DAGs_NNS ,_, and_CC these_DT can_MD be_VB used_VBN to_TO make_VB some_DT causal_JJ inferences_NNS ,_, as_IN DAGs_NNS explicitly_RB represent_VBP interventions_NNS ._. 
By_IN introducing_VBG the_DT randomisation\/intervention_NN variables_NNS explicitly_RB into_IN the_DT DAG_NNP ,_, we_PRP can_MD use_VB conditional_JJ independences_NNS to_TO determine_VB when_WRB it_PRP is_VBZ possible_JJ to_TO estimate_VB the_DT causal_JJ effect_NN -LRB-_-LRB- based_VBN R_NNP =_SYM a_DT ,_, b_NN -RRB-_-RRB- from_IN data_NNS that_WDT are_VBP observational_JJ -LRB-_-LRB- based_VBN on_IN R_NNP =_SYM 
Appendix_NN 2_CD provides_VBZ additional_JJ details_NNS on_IN statistics_NNS and_CC assumptions_NNS underlying_VBG the_DT DTF_NNP 
This_DT is_VBZ also_RB true_JJ for_IN a_DT substantial_JJ part_NN of_IN basic_JJ biomedical_JJ research_NN ._. 
Amain_JJ problem_NN when_WRB making_VBG causal_JJ inferences_NNS in_IN clinical_JJ and_CC epidemiological_JJ research_NN is_VBZ that_IN most_JJS data_NNS are_VBP observational_JJ ._. 
It_PRP is_VBZ certainly_RB an_DT issue_NN in_IN human_JJ genetics_NNS ,_, where_WRB there_EX is_VBZ usually_RB no_DT randomization_NN -LRB-_-LRB- except_IN in_IN circumstances_NNS where_WRB Mendelian_JJ randomization_NN can_MD be_VB applied_VBN -RRB-_-RRB- ,_, and_CC knowledge_NN of_IN the_DT genetic_JJ pathways_NNS is_VBZ tenuous_JJ or_CC incomplete_JJ ._. 
In_IN such_JJ circumstances_NNS we_PRP must_MD be_VB careful_JJ to_TO distinguish_VB causal_JJ relationships_NNS from_IN associations_NNS resulting_VBG from_IN unobserved_JJ biases_NNS or_CC chance_NN ._. 
This_DT is_VBZ in_IN contrast_NN to_TO Weinberg_NNP 's_POS paper_NN 
This_DT is_VBZ because_IN controlled_JJ interventions_NNS usually_RB -LRB-_-LRB- and_CC more_RBR easily_RB -RRB-_-RRB- guarantee_NN that_IN the_DT association_NN investigated_VBN is_VBZ not_RB confounded_VBN -LRB-_-LRB- but_CC this_DT is_VBZ not_RB an_DT absolute_JJ rule_NN -RRB-_-RRB- ._. 
VanderWeele_NNP and_CC Robins_NNP assume_VBP that_IN genes_NNS can_MD be_VB considered_VBN causes_NNS of_IN diseases_NNS ,_, without_IN discussing_VBG the_DT implications_NNS or_CC bringing_VBG additional_JJ information_NN such_JJ as_IN Hill_NNP 's_POS criteria_NNS into_IN play_NN ;_: we_PRP believe_VBP that_IN this_DT is_VBZ a_DT strong_JJ assumption_NN :_: knowledge_NN on_IN the_DT mechanisms_NNS that_WDT govern_VBP the_DT subclinical_JJ development_NN and_CC clinical_JJ course_NN of_IN complex_JJ diseases_NNS is_VBZ rather_RB limited_JJ ._. 
In_IN summary_NN ,_, we_PRP believe_VBP that_IN the_DT DAG_NNP and_CC causal_JJ criteria-based_JJ approaches_NNS can_MD complement_VB one_CD another_DT ,_, as_IN one_CD helps_VBZ to_TO assess_VB the_DT strength_NN of_IN evidence_NN ,_, while_IN the_DT other_JJ disentangles_NNS -_: in_IN a_DT visual_JJ but_CC also_RB formal_JJ way_NN -_: the_DT role_NN played_VBN by_IN genes_NNS ,_, environmental_JJ exposures_NNS ,_, and_CC their_PRP$ interactions_NNS ._. 
There_EX has_VBZ been_VBN much_JJ debate_NN on_IN the_DT exact_JJ nature_NN and_CC roles_NNS of_IN DAGs_NNS in_IN the_DT biomedical_JJ literature_NN ._. 
They_PRP are_VBP a_DT rigorous_JJ way_NN of_IN visualising_VBG complex_JJ systems_NNS ,_, clarifying_VBG ideas_NNS ,_, complementing_VBG the_DT formulation_NN of_IN hypotheses_NNS ,_, and_CC guiding_VBG quantitative_JJ analyses_NNS ._. 
The_DT most_RBS widespread_JJ approach_NN in_IN the_DT health_NN sciences_NNS is_VBZ the_DT causal_JJ DAG_NNP approach_NN promoted_VBN by_IN Greenland_NNP ,_, Robins_NNP ,_, Hern_NNP 
In_IN causal_JJ DAG_NNP approaches_NNS ,_, the_DT directed_VBN edges_NNS in_IN a_DT DAG_NNP represent_VBP causal_JJ relationships_NNS ._. 
The_DT most_RBS widespread_JJ approach_NN in_IN the_DT health_NN sciences_NNS is_VBZ the_DT causal_JJ DAG_NNP approach_NN promoted_VBN by_IN Greenland_NNP ,_, Robins_NNP ,_, Hern_NNP 
Conditional_JJ independence_NN is_VBZ a_DT non-graphical_JJ -LRB-_-LRB- and_CC non-causal_JJ -RRB-_-RRB- equivalent_NN of_IN the_DT d-separation_NN criteria_NNS used_VBN in_IN the_DT causal_JJ DAG_NNP approach_NN 
Whilst_IN the_DT causal_JJ DAG_NNP framework_NN is_VBZ appealing_JJ and_CC intuitive_JJ ,_, we_PRP wish_VBP to_TO draw_VB attention_NN to_TO an_DT alternative_JJ approach_NN to_TO causal_JJ inference_NN ,_, the_DT Decision_NNP Theoretic_NNP Framework_NNP -LRB-_-LRB- DTF_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ based_VBN on_IN a_DT formal_JJ treatment_NN of_IN conditional_JJ independences_NNS -LRB-_-LRB- a_DT non-graphical_JJ version_NN of_IN the_DT 'd_NNP -_: separation_NN criteria_NNS '_POS -RRB-_-RRB- 
It_PRP is_VBZ generally_RB accepted_VBN that_IN the_DT ideal_NN for_IN causal_JJ inference_NN is_VBZ the_DT randomised_JJ controlled_JJ trial_NN because_IN confounding_VBG is_VBZ eliminated_VBN or_CC attenuated_VBN ._. 
It_PRP is_VBZ generally_RB also_RB accepted_VBN that_IN when_WRB we_PRP perform_VBP an_DT external_JJ intervention_NN ,_, such_JJ as_IN randomisation_NN on_IN a_DT system_NN in_IN equilibrium_NN ,_, we_PRP can_MD view_VB the_DT consequences_NNS as_IN causal_NN ._. 
Thus_RB ,_, intervention_NN is_VBZ a_DT formal_JJ way_NN of_IN asserting_VBG cause-effect_JJ relationships_NNS ._. 
In_IN DTF_NNP we_PRP introduce_VBP randomisation_NN as_IN a_DT variable_JJ R_NNP -LRB-_-LRB- Figure_NNP 3_CD -RRB-_-RRB- ._. 
One_CD assumption_NN that_WDT is_VBZ often_RB made_VBN is_VBZ that_IN all_DT observed_JJ confounders_NNS U_NNP are_NNP observed_VBD ._. 
The_DT question_NN is_VBZ ,_, therefore_RB ,_, how_WRB to_TO make_VB an_DT inference_NN about_IN the_DT former_JJ using_VBG the_DT latter_JJ ._. 
However_RB ,_, this_DT is_VBZ often_RB not_RB possible_JJ and_CC other_JJ approaches_NNS that_WDT simulate_VBP randomisation_NN ,_, such_JJ as_IN the_DT instrumental_JJ variable_JJ approach_NN known_VBN as_IN Mendelian_JJ randomisation_NN 
Hardy-Weinberg_JJ equilibrium_NN is_VBZ based_VBN on_IN assumptions_NNS of_IN population_NN genetics_NNS related_VBN to_TO the_DT lack_NN of_IN selection_NN ,_, inbreeding_NN ,_, migration_NN ;_: departure_NN from_IN HWE_NNP can_MD thus_RB point_VB towards_IN the_DT possibility_NN of_IN gross_JJ bias_NN -LRB-_-LRB- such_JJ as_IN genotyping_VBG errors_NNS or_CC selection_NN bias_NN -RRB-_-RRB- ._. 
Explicit_JJ guidelines_NNS for_IN causal_JJ assessment_NN are_VBP more_RBR popular_JJ in_IN clinical_JJ and_CC epidemiological_JJ research_NN than_IN in_IN genetics_NNS ._. 
The_DT reasons_NNS for_IN that_DT have_VBP seldom_RB been_VBN addressed_VBN ._. 
They_PRP are_VBP probably_RB related_VBN to_TO the_DT different_JJ nature_NN of_IN the_DT objects_NNS ,_, factors_NNS ,_, mechanisms_NNS and_CC processes_NNS that_WDT we_VBP study_NN at_IN each_DT level_NN ._. 
Thus_RB ,_, we_PRP propose_VBP a_DT more_RBR conservative_JJ approach_NN that_WDT involves_VBZ assessing_VBG the_DT causal_JJ properties_NNS of_IN each_DT individual_JJ relationship_NN ._. 
Afinal_JJ caveat_NN to_TO interpreting_VBG DAGs_NNS involving_VBG genes_NNS as_IN causal_NN is_VBZ whether_IN genetic_JJ variants_NNS can_MD be_VB considered_VBN causes_NNS of_IN diseases_NNS ;_: in_IN a_DT strict_JJ sense_NN this_DT issue_NN is_VBZ unresolved_JJ ._. 
It_PRP is_VBZ generally_RB accepted_VBN that_IN the_DT causal_JJ nature_NN of_IN a_DT relationship_NN can_MD be_VB assured_VBN when_WRB interventions_NNS -LRB-_-LRB- such_JJ as_IN those_DT performed_VBN in_IN experiments_NNS -RRB-_-RRB- take_VBP place_NN ._. 
There_EX has_VBZ been_VBN much_JJ debate_NN on_IN the_DT exact_JJ nature_NN and_CC roles_NNS of_IN DAGs_NNS in_IN the_DT biomedical_JJ literature_NN ._. 
They_PRP are_VBP a_DT rigorous_JJ way_NN of_IN visualising_VBG complex_JJ systems_NNS ,_, clarifying_VBG ideas_NNS ,_, complementing_VBG the_DT formulation_NN of_IN hypotheses_NNS ,_, and_CC guiding_VBG quantitative_JJ analyses_NNS ._. 
The_DT most_RBS widespread_JJ approach_NN in_IN the_DT health_NN sciences_NNS is_VBZ the_DT causal_JJ DAG_NNP approach_NN promoted_VBN by_IN Greenland_NNP ,_, Robins_NNP ,_, Hern_NNP 
Toxicological_JJ evidence_NN suggests_VBZ that_IN both_DT paraquat_NN and_CC rotenone_NN exert_VBP a_DT neurotoxic_JJ action_NN that_WDT might_MD play_VB a_DT role_NN in_IN the_DT etiopathogenic_JJ process_NN of_IN Parkinson_NNP 's_POS disease_NN ._. 
Moreover_RB ,_, clinical_JJ symptoms_NNS of_IN Parkinson_NNP 's_POS disease_NN have_VBP been_VBN reproduced_VBN in_IN rats_NNS by_IN chronic_JJ administration_NN of_IN paraquat_NN ._. 
Evidence_NN from_IN animal_NN experiments_NNS shows_VBZ that_IN knockout_NN models_NNS of_IN Drosophila_NNP Melanogaster_NNP -LRB-_-LRB- fruit_NN fly_NN -RRB-_-RRB- lacking_VBG DJ-1_NN function_NN ,_, display_VBP a_DT marked_JJ and_CC selective_JJ sensitivity_NN to_TO the_DT environmental_JJ oxidative_JJ insults_NNS exerted_VBN by_IN both_DT paraquat_NN and_CC rotenone_NN 
Moreover_RB ,_, clinical_JJ symptoms_NNS of_IN Parkinson_NNP 's_POS disease_NN have_VBP been_VBN reproduced_VBN in_IN rats_NNS by_IN chronic_JJ administration_NN of_IN paraquat_NN ._. 
Evidence_NN from_IN animal_NN experiments_NNS shows_VBZ that_IN knockout_NN models_NNS of_IN Drosophila_NNP Melanogaster_NNP -LRB-_-LRB- fruit_NN fly_NN -RRB-_-RRB- lacking_VBG DJ-1_NN function_NN ,_, display_VBP a_DT marked_JJ and_CC selective_JJ sensitivity_NN to_TO the_DT environmental_JJ oxidative_JJ insults_NNS exerted_VBN by_IN both_DT paraquat_NN and_CC rotenone_NN 
After_IN the_DT first_JJ variants_NNS described_VBN ,_, different_JJ variants_NNS of_IN the_DT DJ-1_NNP gene_NN associated_VBN with_IN the_DT same_JJ Parkinson_NNP 's_POS disease_NN phenotype_NN have_VBP been_VBN found_VBN in_IN patients_NNS of_IN Ashkenazi_NNP Jewish_NNP and_CC Afro-Caribbean_JJ origins_NNS 
The_DT specificity_NN of_IN the_DT association_NN between_IN DJ-1_CD gene_NN mutations_NNS and_CC Parkinson_NNP 's_POS disease_NN will_MD be_VB clearer_JJR once_IN the_DT data_NNS on_IN the_DT pathological_JJ features_NNS of_IN the_DT DJ-1_NNP patients_NNS will_MD be_VB available_JJ -LRB-_-LRB- see_VB Appendix_NNP 3_CD -RRB-_-RRB- ._. 
Chronic_JJ systemic_JJ exposure_NN to_TO rotenone_NN has_VBZ been_VBN demonstrated_VBN to_TO cause_VB highly_RB selective_JJ nigrostriatal_JJ dopaminergic_JJ degeneration_NN associated_VBN with_IN characteristic_JJ movement_NN disorders_NNS in_IN rats_NNS 
-LRB-_-LRB- f_LS -RRB-_-RRB- Biological_JJ plausibility_NN ._. 
In_IN addition_NN ,_, several_JJ studies_NNS observed_VBD a_DT positive_JJ correlation_NN with_IN duration_NN of_IN exposure_NN to_TO ,_, and_CC high_JJ dose_NN of_IN ,_, herbicides_NNS and_CC insecticides_NNS in_IN humans_NNS 
There_EX has_VBZ been_VBN much_JJ debate_NN on_IN the_DT exact_JJ nature_NN and_CC roles_NNS of_IN DAGs_NNS in_IN the_DT biomedical_JJ literature_NN ._. 
They_PRP are_VBP a_DT rigorous_JJ way_NN of_IN visualising_VBG complex_JJ systems_NNS ,_, clarifying_VBG ideas_NNS ,_, complementing_VBG the_DT formulation_NN of_IN hypotheses_NNS ,_, and_CC guiding_VBG quantitative_JJ analyses_NNS ._. 
The_DT most_RBS widespread_JJ approach_NN in_IN the_DT health_NN sciences_NNS is_VBZ the_DT causal_JJ DAG_NNP approach_NN promoted_VBN by_IN Greenland_NNP ,_, Robins_NNP ,_, Hern_NNP 
In_IN a_DT study_NN in_IN Taiwan_NNP ,_, where_WRB paraquat_NN is_VBZ routinely_RB used_VBN in_IN rice_NN fields_NNS ,_, a_DT strong_JJ association_NN between_IN paraquat_NN exposure_NN and_CC Parkinson_NNP 's_POS disease_NN was_VBD found_VBN ;_: the_DT hazard_NN increased_VBN by_IN more_JJR than_IN six_CD times_NNS in_IN subjects_NNS exposed_VBN for_IN more_JJR than_IN 20_CD years_NNS 
There_EX is_VBZ no_DT a_FW priori_FW association_NN between_IN the_DT gene_NN and_CC the_DT external_JJ exposure_NN ;_: this_DT is_VBZ represented_VBN by_IN the_DT absence_NN of_IN a_DT directed_VBN edge_NN between_IN DJ-1_NNP and_CC P_NNP in_IN the_DT DAGs_NNP below_IN ._. 
Generally_RB ,_, this_DT is_VBZ a_DT plausible_JJ assumption_NN provided_VBD that_IN the_DT exposure_NN does_VBZ not_RB modify_VB the_DT genetic_JJ structure_NN ._. 
In_IN this_DT specific_JJ example_NN ,_, this_DT assumption_NN is_VBZ likely_JJ to_TO be_VB true_JJ ._. 
However_RB ,_, with_IN other_JJ environmental_JJ exposures_NNS this_DT assumption_NN does_VBZ not_RB hold_VB ._. 
Acore_JJ issue_NN with_IN these_DT models_NNS is_VBZ that_IN I_PRP is_VBZ essentially_RB unobservable_JJ in_IN humans_NNS living_VBG under_IN normal_JJ conditions_NNS ;_: these_DT biological_JJ interactions_NNS can_MD only_RB be_VB tested_VBN in_IN animal_NN experiments_NNS ._. 
Thus_RB ,_, in_IN humans_NNS we_PRP can_MD not_RB disentangle_VB the_DT two_CD DAGs_NNS above_IN apart_RB without_IN further_JJ information_NN -LRB-_-LRB- VanderWeele_NNP and_CC Robins_NNP provide_VBP some_DT tests_NNS to_TO determine_VB which_WDT individuals_NNS present_VBP Y_NNP only_RB when_WRB the_DT interaction_NN I_PRP is_VBZ ``_`` on_IN ''_'' provided_VBN there_EX is_VBZ no_DT unmeasured_JJ confounding_NN -RRB-_-RRB- ._. 
In_IN order_NN to_TO be_VB able_JJ to_TO fully_RB tell_VB them_PRP apart_RB ,_, an_DT experiment_NN can_MD be_VB conducted_VBN or_CC the_DT relative_JJ risks_NNS can_MD be_VB compared_VBN -LRB-_-LRB- see_VB Appendix_NNP 1_CD -RRB-_-RRB- ._. 
This_DT is_VBZ because_IN controlled_JJ interventions_NNS usually_RB -LRB-_-LRB- and_CC more_RBR easily_RB -RRB-_-RRB- guarantee_NN that_IN the_DT association_NN investigated_VBN is_VBZ not_RB confounded_VBN -LRB-_-LRB- but_CC this_DT is_VBZ not_RB an_DT absolute_JJ rule_NN -RRB-_-RRB- ._. 
VanderWeele_NNP and_CC Robins_NNP assume_VBP that_IN genes_NNS can_MD be_VB considered_VBN causes_NNS of_IN diseases_NNS ,_, without_IN discussing_VBG the_DT implications_NNS or_CC bringing_VBG additional_JJ information_NN such_JJ as_IN Hill_NNP 's_POS criteria_NNS into_IN play_NN ;_: we_PRP believe_VBP that_IN this_DT is_VBZ a_DT strong_JJ assumption_NN :_: knowledge_NN on_IN the_DT mechanisms_NNS that_WDT govern_VBP the_DT subclinical_JJ development_NN and_CC clinical_JJ course_NN of_IN complex_JJ diseases_NNS is_VBZ rather_RB limited_JJ ._. 
In_IN summary_NN ,_, we_PRP believe_VBP that_IN the_DT DAG_NNP and_CC causal_JJ criteria-based_JJ approaches_NNS can_MD complement_VB one_CD another_DT ,_, as_IN one_CD helps_VBZ to_TO assess_VB the_DT strength_NN of_IN evidence_NN ,_, while_IN the_DT other_JJ disentangles_NNS -_: in_IN a_DT visual_JJ but_CC also_RB formal_JJ way_NN -_: the_DT role_NN played_VBN by_IN genes_NNS ,_, environmental_JJ exposures_NNS ,_, and_CC their_PRP$ interactions_NNS ._. 
-LRB-_-LRB- b_NN -RRB-_-RRB- Consistency_NN of_IN the_DT association_NN ._. 
,they_NN are_VBP often_RB related_VBN to_TO each_DT other_JJ ,_, as_IN in_IN this_DT paragraph_NN the_DT strength_NN of_IN association_NN is_VBZ related_VBN to_TO the_DT biological_JJ plausibility_NN -RRB-_-RRB- ._. 
After_IN the_DT first_JJ variants_NNS described_VBN ,_, different_JJ variants_NNS of_IN the_DT DJ-1_NNP gene_NN associated_VBN with_IN the_DT same_JJ Parkinson_NNP 's_POS disease_NN phenotype_NN have_VBP been_VBN found_VBN in_IN patients_NNS of_IN Ashkenazi_NNP Jewish_NNP and_CC Afro-Caribbean_JJ origins_NNS 
-LRB-_-LRB- g_NN -RRB-_-RRB- Coherence_NN with_IN previous_JJ knowledge_NN ._. 
It_PRP is_VBZ ,_, therefore_RB ,_, plausible_JJ that_IN these_DT two_CD factors_NNS may_MD interact_VB during_IN the_DT course_NN of_IN life_NN producing_VBG Parkinson_NNP 's_POS symptoms_NNS in_IN genetically_RB susceptible_JJ individuals_NNS 
However_RB ,_, like_IN epidemiologic_JJ studies_NNS ,_, genetic_JJ studies_NNS are_VBP also_RB commonly_RB based_VBN on_IN observational_JJ studies_NNS ,_, and_CC may_MD thus_RB be_VB affected_VBN by_IN similar_JJ weaknesses_NNS ._. 
As_IN the_DT contribution_NN of_IN genetics_NNS to_TO the_DT understanding_NN of_IN disease_NN etiology_NN becomes_VBZ more_RBR important_JJ ,_, causal_JJ assessment_NN of_IN genetic_JJ and_CC genomic_JJ evidence_NN will_MD become_VB a_DT key_JJ issue_NN ._. 
We_PRP have_VBP explored_VBN two_CD complementary_JJ ways_NNS to_TO tackle_VB causality_NN in_IN gene-environment_NN interactions_NNS ._. 
The_DT application_NN of_IN causal_JJ guidelines_NNS to_TO genetics_NNS is_VBZ not_RB straightforward_JJ ,_, and_CC it_PRP becomes_VBZ very_RB complex_JJ ,_, in_IN particular_JJ ,_, if_IN one_CD wants_VBZ to_TO study_VB gene-environment_JJ interactions_NNS ,_, as_IN we_PRP have_VBP illustrated_VBN with_IN Parkinson_NNP 's_POS disease_NN ._. 
DJ-1_NN is_VBZ involved_VBN in_IN many_JJ cell_NN processes_NNS including_VBG oncogenic_JJ transformation_NN ,_, gene_NN expression_NN and_CC chaperon_NN activity_NN ,_, and_CC it_PRP mediates_VBZ oxidative_JJ stress_NN responses_NNS 
41_CD to_TO 4_CD ._. 
:2_CD ._. 
I._NN 22_CD -LRB-_-LRB- 95_CD %_NN C._NNP 36_CD -RRB-_-RRB- to_TO 3_CD ._. 
34_CD -_: 4_CD ._. 
:0_CD ._. 
I._NNP 25_CD -LRB-_-LRB- 95_CD %_NN C._NNP A_NNP meta-analysis_NN of_IN the_DT association_NN of_IN pesticides_NNS and_CC Parkinson_NNP 's_POS disease_NN points_VBZ out_RP that_IN both_DT pesticide_NN exposure_NN in_IN general_JJ and_CC selective_JJ exposure_NN to_TO paraquat_NN seem_VBP to_TO be_VB associated_VBN with_IN Parkinson_NNP 's_POS disease_NN ,_, with_IN odds_NNS ratios_NNS ranging_VBG from_IN 1_CD ._. 
31_CD -RRB-_-RRB- 
In_IN this_DT case_NN ,_, while_IN it_PRP is_VBZ unlikely_JJ that_IN suffering_VBG from_IN Parkinson_NNP 's_POS disease_NN would_MD have_VB influenced_VBN past_JJ exposure_NN to_TO pesticides_NNS or_CC their_PRP$ metabolism_NN ,_, it_PRP could_MD have_VB influenced_VBN recall_NN ._. 
The_DT observed_JJ dose-response_JJ relationship_NN ,_, with_IN 20_CD years_NNS of_IN exposure_NN required_VBN ,_, favors_VBZ the_DT existence_NN of_IN a_DT true_JJ association_NN ,_, and_CC is_VBZ compatible_JJ with_IN disease_NN characteristics_NNS of_IN neurodegeneration_NN ,_, 
Adose-response_JJ relationship_NN between_IN toxicant_JJ exposure_NN and_CC neural_JJ loss_NN in_IN animal_NN experiments_NNS has_VBZ been_VBN observed_VBN 
DJ-1_NN has_VBZ been_VBN seen_VBN to_TO be_VB lacking_VBG in_IN Dutch_JJ families_NNS with_IN Parkinson_NNP 's_POS disease_NN ,_, and_CC to_TO be_VB functionally_RB inactive_JJ because_IN of_IN a_DT point_NN mutation_NN in_IN the_DT Italian_JJ families_NNS studied_VBN by_IN Bonifati_NNP and_CC cols_NNS 
Nonetheless_RB ,_, a_DT co-dominant_JJ model_NN should_MD not_RB be_VB completely_RB ruled_VBN out_RP as_IN a_DT careful_JJ neurological_JJ evaluation_NN of_IN heterozygote_JJ subjects_NNS might_MD point_VB out_RP some_DT sub-clinical_JJ changes_NNS 
22-12_CD ._. 
67_CD did_VBD not_RB reach_VB statistical_JJ significance_NN -LRB-_-LRB- 95_CD %_NN CI_NNP :_: 0_CD ._. 
However_RB ,_, in_IN another_DT population-based_JJ case-control_JJ study_NN in_IN Washington_NNP ,_, the_DT odds_NNS ratio_NN of_IN 1_CD ._. 
76_CD -RRB-_-RRB- 
On_IN the_DT other_JJ hand_NN ,_, tea_NN and_CC coffee_NN drinking_NN ,_, use_NN of_IN non-steroidal_JJ anti-inflammatory_JJ drugs_NNS ,_, and_CC high_JJ blood_NN levels_NNS of_IN uric_JJ acid_NN have_VBP been_VBN suggested_VBN to_TO be_VB protective_JJ for_IN Parkinson_NNP 's_POS disease_NN ._. 
Parkinson_NNP 's_POS disease_NN :_: single_JJ gene_NN disordersTo_NN date_NN ,_, eleven_CD monogenic_JJ forms_NNS have_VBP been_VBN identified_VBN -LRB-_-LRB- with_IN PARK1_CD to_TO 11_CD gene_NN acronyms_NNS -RRB-_-RRB- ;_: they_PRP will_MD be_VB selectively_RB discussed_VBN below_IN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- 
Three_CD known_JJ dominant_JJ mutations_NNS on_IN the_DT SNCA_NNP gene_NN have_VBP been_VBN identified_VBN in_IN families_NNS affected_VBN by_IN Parkinsonism_NNP with_IN dementia_NN characterised_VBN pathologically_RB by_IN diffuse_JJ Lewy_NNP bodies_NNS ,_, mainly_RB composed_VBN of_IN 
However_RB ,_, some_DT cases_NNS with_IN tau-positive_JJ pathology_NN without_IN Lewy_NNP bodies_NNS have_VBP been_VBN observed_VBN even_RB within_IN the_DT same_JJ family_NN ._. 
The_DT pathway_NN leading_VBG to_TO one_CD or_CC the_DT other_JJ condition_NN is_VBZ likely_JJ to_TO be_VB influenced_VBN by_IN genetic_JJ and\/or_CC environmental_JJ factors_NNS that_WDT remain_VBP to_TO be_VB identified_VBN ._. 
There_EX are_VBP more_JJR than_IN 50_CD known_VBN variants_NNS in_IN the_DT parkin_NN gene_NN and_CC their_PRP$ effect_NN on_IN the_DT disease_NN appears_VBZ to_TO be_VB recessive_JJ ._. 
This_DT behavior_NN can_MD be_VB due_JJ to_TO the_DT fact_NN that_IN the_DT outcome_NN is_VBZ mutation-specific_JJ :_: some_DT mutations_NNS can_MD reduce_VB rather_RB than_IN abolish_VB the_DT protein_NN activity_NN affecting_VBG substrate_NN specificity_NN ._. 
Otherwise_RB ,_, these_DT two_CD different_JJ outcomes_NNS can_MD share_VB the_DT primary_JJ cause_NN -LRB-_-LRB- as_IN for_IN the_DT LRRK_NNP case_NN -RRB-_-RRB- ,_, which_WDT is_VBZ subsequently_RB influenced_VBN by_IN gene-gene_NN and\/or_CC gene-environment_NN interactions_NNS ._. 
For_IN the_DT last_JJ two_CD recessive_JJ mutations_NNS ,_, PINK-1_NNP and_CC DJ-1_NNP there_EX is_VBZ no_DT pathological_JJ information_NN available_JJ ._. 
For_IN the_DT last_JJ two_CD recessive_JJ mutations_NNS ,_, PINK-1_NNP and_CC DJ-1_NNP there_EX is_VBZ no_DT pathological_JJ information_NN available_JJ ._. 
The_DT protein_NN encoded_VBN by_IN PINK-1_NN gene_NN is_VBZ a_DT mitochondrial_JJ kinase_NN that_WDT seems_VBZ to_TO be_VB involved_VBN in_IN protecting_VBG the_DT cell_NN from_IN mitochondrial_JJ dysfunction_NN and_CC stress-induced_JJ apoptosis_NN 
Appendix_NN 3_CD summaries_NNS the_DT key_JJ evidences_NNS to_TO date_NN on_IN environmental_JJ and_CC genetic_JJ risk_NN factors_NNS for_IN Parkinson_NNP 's_POS disease_NN 
The_DT DAG_NNP in_IN Figure_NNP 4_CD shows_VBZ a_DT complex_JJ situation_NN we_PRP can_MD imagine_VB ,_, given_VBN assumptions_NNS 1_CD and_CC 2_CD ,_, in_IN which_WDT there_EX is_VBZ confounding_VBG between_IN both_DT the_DT exposure_NN to_TO paraquat_NN and_CC the_DT disease_NN outcome_NN -LRB-_-LRB- Cp_NNP -RRB-_-RRB- as_RB well_RB as_IN confounding_VBG between_IN DJ-1_NNP and_CC the_DT disease_NN -LRB-_-LRB- Cd_NN -RRB-_-RRB- ,_, and_CC no_DT other_JJ variables_NNS are_VBP postulated_VBN ._. 
Confounding_VBG between_IN both_DT exposure_NN to_TO paraquat_NN and_CC the_DT disease_NN might_MD be_VB due_JJ ,_, for_IN example_NN ,_, to_TO the_DT fact_NN that_IN people_NNS exposed_VBN to_TO paraquat_NN may_MD also_RB be_VB more_RBR likely_JJ to_TO smoke_VB ,_, a_DT factor_NN that_WDT is_VBZ negatively_RB associated_VBN with_IN the_DT risk_NN of_IN Parkinson_NNP 's_POS disease_NN 
Amore_JJ detailed_JJ description_NN of_IN such_JJ variables_NNS is_VBZ given_VBN in_IN Appendix_NNP 2_CD ._. 
Another_DT way_NN of_IN introducing_VBG causality_NN is_VBZ by_IN adding_VBG so_RB called_VBN intervention_NN or_CC randomisation_NN variables_NNS to_TO a_DT DAG_NNP and_CC to_TO the_DT corresponding_JJ probability_NN statements_NNS ._. 
As_IN a_DT thorough_JJ explanation_NN is_VBZ beyond_IN the_DT scope_NN of_IN this_DT paper_NN we_PRP refer_VBP the_DT interested_JJ reader_NN to_TO Dawid_NNP 
However_RB ,_, this_DT is_VBZ often_RB not_RB possible_JJ and_CC other_JJ approaches_NNS that_WDT simulate_VBP randomisation_NN ,_, such_JJ as_IN the_DT instrumental_JJ variable_JJ approach_NN known_VBN as_IN Mendelian_JJ randomisation_NN 
In_IN a_DT study_NN in_IN Taiwan_NNP ,_, where_WRB paraquat_NN is_VBZ routinely_RB used_VBN in_IN rice_NN fields_NNS ,_, a_DT strong_JJ association_NN between_IN paraquat_NN exposure_NN and_CC Parkinson_NNP 's_POS disease_NN was_VBD found_VBN ;_: the_DT hazard_NN increased_VBN by_IN more_JJR than_IN six_CD times_NNS in_IN subjects_NNS exposed_VBN for_IN more_JJR than_IN 20_CD years_NNS 
Third_JJ ,_, we_PRP apply_VBP Hill_NNP 's_POS criteria_NNS to_TO each_DT of_IN the_DT hypothesised_JJ associations_NNS to_TO assess_VB causality_NN in_IN light_NN of_IN the_DT available_JJ evidence_NN ._. 
Parkinson_NNP 's_POS disease_NN is_VBZ the_DT most_RBS common_JJ neurodegenerative_JJ disorder_NN after_IN Alzheimer_NNP 's_POS disease_NN ,_, affecting_VBG 16-19_CD new_JJ individuals_NNS per_IN 100,000_CD persons_NNS each_DT year_NN in_IN developed_JJ countries_NNS ._. 
Characterized_VBN by_IN bradykinesia_NN ,_, resting_VBG tremor_NN ,_, rigidity_NN and_CC postural_JJ instability_NN ,_, it_PRP is_VBZ also_RB one_CD of_IN the_DT most_RBS common_JJ late-life_JJ movement_NN disorders_NNS ._. 
Characterized_VBN by_IN bradykinesia_NN ,_, resting_VBG tremor_NN ,_, rigidity_NN and_CC postural_JJ instability_NN ,_, it_PRP is_VBZ also_RB one_CD of_IN the_DT most_RBS common_JJ late-life_JJ movement_NN disorders_NNS ._. 
The_DT pathological_JJ characteristic_NN of_IN the_DT disease_NN is_VBZ a_DT selective_JJ loss_NN of_IN pigmented_JJ neurons_NNS ,_, most_RBS prominently_RB in_IN the_DT substantia_NN nigra_NN -LRB-_-LRB- one_CD of_IN the_DT brain_NN basal_NN ganglia_NN -RRB-_-RRB- accompanied_VBN by_IN a_DT characteristic_NN 
Amore_JJ detailed_JJ description_NN of_IN such_JJ variables_NNS is_VBZ given_VBN in_IN Appendix_NNP 2_CD ._. 
Another_DT way_NN of_IN introducing_VBG causality_NN is_VBZ by_IN adding_VBG so_RB called_VBN intervention_NN or_CC randomisation_NN variables_NNS to_TO a_DT DAG_NNP and_CC to_TO the_DT corresponding_JJ probability_NN statements_NNS ._. 
As_IN a_DT thorough_JJ explanation_NN is_VBZ beyond_IN the_DT scope_NN of_IN this_DT paper_NN we_PRP refer_VBP the_DT interested_JJ reader_NN to_TO Dawid_NNP 
Conditional_JJ independence_NN is_VBZ a_DT non-graphical_JJ -LRB-_-LRB- and_CC non-causal_JJ -RRB-_-RRB- equivalent_NN of_IN the_DT d-separation_NN criteria_NNS used_VBN in_IN the_DT causal_JJ DAG_NNP approach_NN 
By_IN introducing_VBG the_DT randomisation\/intervention_NN variables_NNS explicitly_RB into_IN the_DT DAG_NNP ,_, we_PRP can_MD use_VB conditional_JJ independences_NNS to_TO determine_VB when_WRB it_PRP is_VBZ possible_JJ to_TO estimate_VB the_DT causal_JJ effect_NN -LRB-_-LRB- based_VBN R_NNP =_SYM a_DT ,_, b_NN -RRB-_-RRB- from_IN data_NNS that_WDT are_VBP observational_JJ -LRB-_-LRB- based_VBN on_IN R_NNP =_SYM 
Amore_JJ detailed_JJ description_NN of_IN such_JJ variables_NNS is_VBZ given_VBN in_IN Appendix_NNP 2_CD ._. 
Another_DT way_NN of_IN introducing_VBG causality_NN is_VBZ by_IN adding_VBG so_RB called_VBN intervention_NN or_CC randomisation_NN variables_NNS to_TO a_DT DAG_NNP and_CC to_TO the_DT corresponding_JJ probability_NN statements_NNS ._. 
As_IN a_DT thorough_JJ explanation_NN is_VBZ beyond_IN the_DT scope_NN of_IN this_DT paper_NN we_PRP refer_VBP the_DT interested_JJ reader_NN to_TO Dawid_NNP 
However_RB ,_, this_DT is_VBZ often_RB not_RB possible_JJ and_CC other_JJ approaches_NNS that_WDT simulate_VBP randomisation_NN ,_, such_JJ as_IN the_DT instrumental_JJ variable_JJ approach_NN known_VBN as_IN Mendelian_JJ randomisation_NN 
While_IN the_DT causes_NNS of_IN Parkinson_NNP 's_POS disease_NN remain_VBP unknown_JJ ,_, significant_JJ progress_NN is_VBZ being_VBG made_VBN in_IN elucidating_VBG genetic_JJ and_CC environmental_JJ risk_NN factors_NNS and_CC the_DT neurodegenerative_JJ process_NN underlying_VBG the_DT disease_NN ._. 
Appendix_NN 3_CD summaries_NNS the_DT key_JJ evidences_NNS to_TO date_NN on_IN environmental_JJ and_CC genetic_JJ risk_NN factors_NNS for_IN Parkinson_NNP 's_POS disease_NN 
Again_RB ,_, as_IN a_DT detailed_JJ description_NN of_IN the_DT formal_JJ DTF_NNP is_VBZ beyond_IN the_DT scope_NN of_IN this_DT paper_NN ,_, we_PRP refer_VBP the_DT interested_JJ reader_NN to_TO previous_JJ work_NN ._. 
42_CD 43Appendix_NNP 3_NNP Parkinson_NNP 's_POS disease_NN :_: environmental_JJ and_CC genetic_JJ risk_NN factorsParkinson_NNP 's_POS disease_NN :_: environmental_JJ factorsLarge_JJ epidemiological_JJ studies_NNS aimed_VBN at_IN identifying_VBG risk_NN factors_NNS for_IN Parkinson_NNP 's_POS disease_NN have_VBP suggested_VBN a_DT role_NN of_IN 1-methyl-4-phenyl-1_JJ ,2,3,6_CD -_: tetrahydropyridine_NN -LRB-_-LRB- MPTP_NNP -RRB-_-RRB- -LRB-_-LRB- a_DT compound_NN accidentally_RB produced_VBN in_IN the_DT manufacture_NN of_IN illegal_JJ drugs_NNS -RRB-_-RRB- ,_, of_IN some_DT pesticides_NNS ,_, of_IN certain_JJ metals_NNS and_CC of_IN polychlorinated_JJ biphenyls_NNS 
42_CD 43_CD Appendix_NNP 3_NNP Parkinson_NNP 's_POS disease_NN :_: environmental_JJ and_CC genetic_JJ risk_NN factors_NNS Parkinson_NNP 's_POS disease_NN :_: environmental_JJ factors_NNS Large_JJ epidemiological_JJ studies_NNS aimed_VBN at_IN identifying_VBG risk_NN factors_NNS for_IN Parkinson_NNP 's_POS disease_NN have_VBP suggested_VBN a_DT role_NN of_IN 1-methyl-4-phenyl-1_JJ ,2,3,6_CD -_: tetrahydropyridine_NN -LRB-_-LRB- MPTP_NNP -RRB-_-RRB- -LRB-_-LRB- a_DT compound_NN accidentally_RB produced_VBN in_IN the_DT manufacture_NN of_IN illegal_JJ drugs_NNS -RRB-_-RRB- ,_, of_IN some_DT pesticides_NNS ,_, of_IN certain_JJ metals_NNS and_CC of_IN polychlorinated_JJ biphenyls_NNS 
Amore_JJ detailed_JJ description_NN of_IN such_JJ variables_NNS is_VBZ given_VBN in_IN Appendix_NNP 2_CD ._. 
Another_DT way_NN of_IN introducing_VBG causality_NN is_VBZ by_IN adding_VBG so_RB called_VBN intervention_NN or_CC randomisation_NN variables_NNS to_TO a_DT DAG_NNP and_CC to_TO the_DT corresponding_JJ probability_NN statements_NNS ._. 
As_IN a_DT thorough_JJ explanation_NN is_VBZ beyond_IN the_DT scope_NN of_IN this_DT paper_NN we_PRP refer_VBP the_DT interested_JJ reader_NN to_TO Dawid_NNP 
However_RB ,_, this_DT is_VBZ often_RB not_RB possible_JJ and_CC other_JJ approaches_NNS that_WDT simulate_VBP randomisation_NN ,_, such_JJ as_IN the_DT instrumental_JJ variable_JJ approach_NN known_VBN as_IN Mendelian_JJ randomisation_NN 
By_IN introducing_VBG the_DT randomisation\/intervention_NN variables_NNS explicitly_RB into_IN the_DT DAG_NNP ,_, we_PRP can_MD use_VB conditional_JJ independences_NNS to_TO determine_VB when_WRB it_PRP is_VBZ possible_JJ to_TO estimate_VB the_DT causal_JJ effect_NN -LRB-_-LRB- based_VBN R_NNP =_SYM a_DT ,_, b_NN -RRB-_-RRB- from_IN data_NNS that_WDT are_VBP observational_JJ -LRB-_-LRB- based_VBN on_IN R_NNP =_SYM 
This_DT is_VBZ also_RB true_JJ for_IN a_DT substantial_JJ part_NN of_IN basic_JJ biomedical_JJ research_NN ._. 
Amain_JJ problem_NN when_WRB making_VBG causal_JJ inferences_NNS in_IN clinical_JJ and_CC epidemiological_JJ research_NN is_VBZ that_IN most_JJS data_NNS are_VBP observational_JJ ._. 
It_PRP is_VBZ certainly_RB an_DT issue_NN in_IN human_JJ genetics_NNS ,_, where_WRB there_EX is_VBZ usually_RB no_DT randomization_NN -LRB-_-LRB- except_IN in_IN circumstances_NNS where_WRB Mendelian_JJ randomization_NN can_MD be_VB applied_VBN -RRB-_-RRB- ,_, and_CC knowledge_NN of_IN the_DT genetic_JJ pathways_NNS is_VBZ tenuous_JJ or_CC incomplete_JJ ._. 
In_IN such_JJ circumstances_NNS we_PRP must_MD be_VB careful_JJ to_TO distinguish_VB causal_JJ relationships_NNS from_IN associations_NNS resulting_VBG from_IN unobserved_JJ biases_NNS or_CC chance_NN ._. 
These_DT guidelines_NNS contributed_VBD to_TO modifying_VBG the_DT approach_NN to_TO genetic_JJ inferences_NNS using_VBG Hill_NNP 's_POS criteria_NNS that_IN we_PRP adopt_VBP here_RB ._. 
Main_NNP theoretical_JJ issues_NNS underlying_VBG the_DT application_NN of_IN Hill_NNP 's_POS criteria_NNS in_IN genetics_NNS and_CC genomics_NNS are_VBP shown_VBN in_IN Appendix_NNP 1_CD 
g._NNP Genetic_NNP experimental_JJ studies_NNS have_VBP also_RB long_RB been_VBN known_VBN to_TO reproduce_VB disease_NN phenotypes_NNS -LRB-_-LRB- e._JJ Extrapolation_NN of_IN the_DT results_NNS of_IN these_DT experiments_NNS to_TO humans_NNS is_VBZ challenging_VBG due_JJ to_TO differences_NNS between_IN humans_NNS and_CC the_DT knock-out_JJ organisms_NNS in_IN both_DT the_DT genetic_JJ make-up_NN and_CC the_DT potential_JJ types_NNS of_IN gene-gene_NN and_CC gene-environment_NN interactions_NNS ._. 
,in_NN mice_NNS -RRB-_-RRB- that_WDT are_VBP only_RB a_DT partial_JJ approximation_NN of_IN the_DT complex_JJ human_JJ disease_NN ;_: an_DT example_NN is_VBZ the_DT Super_NNP Oxide_NNP Dismutase-1_NNP -LRB-_-LRB- SOD1_NNP -RRB-_-RRB- mutated_VBN mouse_NN model_NN for_IN Amyotrophic_NNP Lateral_NNP Sclerosis_NNP -LRB-_-LRB- ALS_NNP -RRB-_-RRB- ,_, which_WDT has_VBZ different_JJ motor_NN characteristics_NNS than_IN the_DT human_JJ disease_NN ._. 
Appendix_NN 2_CD The_DT calculus_NN of_IN the_DT Decision_NNP Theoretic_NNP Framework_NNP -LRB-_-LRB- DTF_NNP -RRB-_-RRB- The_DT calculus_NN of_IN DTF_NNP Conditional_JJ independence_NN 
However_RB ,_, a_DT different_JJ kind_NN of_IN dose-response_NN is_VBZ observable_JJ if_IN we_PRP consider_VBP the_DT cumulative_JJ effect_NN of_IN multiple_JJ genes_NNS or_CC SNPs_NNS ._. 
Both_DT the_DT risk_NN of_IN lung_NN cancer_NN and_CC the_DT levels_NNS of_IN DNA_NN damage_NN can_MD increase_VB approximately_RB linearly_RB with_IN an_DT increasing_VBG number_NN of_IN ``_`` at_IN risk_NN ''_'' gene_NN variants_NNS ._. 
Gene_NNP copy_NN number_NN variation_NN can_MD lead_VB to_TO more_RBR complex_JJ dose-response_JJ relationships_NNS ._. 
Quantitative_JJ continuous_JJ markers_NNS used_VBN in_IN epigenetics_NNS -LRB-_-LRB- promoter_NN methylation_NN -RRB-_-RRB- and_CC transcriptomics_NNS -LRB-_-LRB- gene_NN expression_NN -RRB-_-RRB- may_MD be_VB analyzed_VBN in_IN search_NN of_IN dose-response_JJ effects_NNS -LRB-_-LRB- linear_JJ or_CC non-linear_JJ -RRB-_-RRB- ._. 
This_DT unexpected_JJ non-specificity_NN may_MD be_VB true_JJ and_CC due_JJ ,_, for_IN instance_NN ,_, to_TO a_DT pleiotropic_JJ effect_NN of_IN the_DT exposure_NN ;_: or_CC the_DT apparent_JJ association_NN with_IN the_DT outcome_NN -LRB-_-LRB- in_IN this_DT case_NN ,_, other_JJ than_IN bladder_NN cancer_NN -RRB-_-RRB- may_MD be_VB confounded_VBN by_IN yet_RB unknown_JJ factors_NNS ._. 
Similar_JJ situations_NNS are_VBP encountered_VBN in_IN clinical_JJ medicine_NN and_CC non_JJ genetic_JJ epidemiology_NN ;_: for_IN example_NN ,_, the_DT early_JJ observation_NN of_IN an_DT inverse_JJ association_NN between_IN hormone_NN replacement_NN therapy_NN -LRB-_-LRB- HRT_NNP -RRB-_-RRB- and_CC mortality_NN due_JJ to_TO accidents_NNS and_CC violence_NN ,_, which_WDT was_VBD of_IN the_DT same_JJ magnitude_NN as_IN that_DT originally_RB found_VBN for_IN cardiovascular_JJ mortality_NN ._. 
This_DT prompted_VBD a_DT debate_NN on_IN the_DT causal_JJ nature_NN of_IN the_DT association_NN between_IN HRT_NNP and_CC cardiovascular_JJ mortality_NN ,_, as_IN no_DT plausible_JJ biological_JJ reason_NN for_IN the_DT protective_JJ effect_NN of_IN HRT_NNP on_IN violent_JJ death_NN could_MD be_VB argued_VBN ._. 
Such_JJ postulated_JJ associations_NNS are_VBP biologically_RB plausible_JJ because_IN there_EX is_VBZ evidence_NN that_IN aromatic_JJ amines_NNS or_CC heterocyclic_JJ aromatic_JJ amines_NNS ,_, which_WDT are_VBP metabolised_VBN by_IN NAT2_NNP ,_, are_VBP involved_VBN in_IN bladder_NN or_CC colon_NN carcinogenesis_NN ._. 
Nevertheless_RB ,_, NAT2_JJ associations_NNS are_VBP also_RB observed_VBN with_IN breast_NN and_CC lung_NN cancer_NN and_CC mesothelioma_NN ,_, without_IN evidence_NN of_IN biological_JJ plausibility_NN ._. 
This_DT unexpected_JJ non-specificity_NN may_MD be_VB true_JJ and_CC due_JJ ,_, for_IN instance_NN ,_, to_TO a_DT pleiotropic_JJ effect_NN of_IN the_DT exposure_NN ;_: or_CC the_DT apparent_JJ association_NN with_IN the_DT outcome_NN -LRB-_-LRB- in_IN this_DT case_NN ,_, other_JJ than_IN bladder_NN cancer_NN -RRB-_-RRB- may_MD be_VB confounded_VBN by_IN yet_RB unknown_JJ factors_NNS ._. 
Such_JJ postulated_JJ associations_NNS are_VBP biologically_RB plausible_JJ because_IN there_EX is_VBZ evidence_NN that_IN aromatic_JJ amines_NNS or_CC heterocyclic_JJ aromatic_JJ amines_NNS ,_, which_WDT are_VBP metabolised_VBN by_IN NAT2_NNP ,_, are_VBP involved_VBN in_IN bladder_NN or_CC colon_NN carcinogenesis_NN ._. 
Nevertheless_RB ,_, NAT2_JJ associations_NNS are_VBP also_RB observed_VBN with_IN breast_NN and_CC lung_NN cancer_NN and_CC mesothelioma_NN ,_, without_IN evidence_NN of_IN biological_JJ plausibility_NN ._. 
This_DT unexpected_JJ non-specificity_NN may_MD be_VB true_JJ and_CC due_JJ ,_, for_IN instance_NN ,_, to_TO a_DT pleiotropic_JJ effect_NN of_IN the_DT exposure_NN ;_: or_CC the_DT apparent_JJ association_NN with_IN the_DT outcome_NN -LRB-_-LRB- in_IN this_DT case_NN ,_, other_JJ than_IN bladder_NN cancer_NN -RRB-_-RRB- may_MD be_VB confounded_VBN by_IN yet_RB unknown_JJ factors_NNS ._. 
,PAHs_NNS and_CC other_JJ carcinogens_NNS for_IN cigarette_NN smoking_NN -RRB-_-RRB- ,_, and_CC of_IN its_PRP$ biological_JJ or_CC environmental_JJ effects_NNS ._. 
For_IN example_NN ,_, on_IN the_DT basis_NN of_IN functional_JJ knowledge_NN ,_, only_RB bladder_NN cancer_NN ,_, and_CC perhaps_RB colon_NN cancer_NN ,_, may_MD be_VB expected_VBN to_TO be_VB associated_VBN with_IN NAT2_CD variants_NNS ._. 
Such_JJ postulated_JJ associations_NNS are_VBP biologically_RB plausible_JJ because_IN there_EX is_VBZ evidence_NN that_IN aromatic_JJ amines_NNS or_CC heterocyclic_JJ aromatic_JJ amines_NNS ,_, which_WDT are_VBP metabolised_VBN by_IN NAT2_NNP ,_, are_VBP involved_VBN in_IN bladder_NN or_CC colon_NN carcinogenesis_NN ._. 
While_IN the_DT causes_NNS of_IN Parkinson_NNP 's_POS disease_NN remain_VBP unknown_JJ ,_, significant_JJ progress_NN is_VBZ being_VBG made_VBN in_IN elucidating_VBG genetic_JJ and_CC environmental_JJ risk_NN factors_NNS and_CC the_DT neurodegenerative_JJ process_NN underlying_VBG the_DT disease_NN ._. 
Appendix_NN 3_CD summaries_NNS the_DT key_JJ evidences_NNS to_TO date_NN on_IN environmental_JJ and_CC genetic_JJ risk_NN factors_NNS for_IN Parkinson_NNP 's_POS disease_NN 
Meulener_FW et_FW al._FW ._. 
In_IN the_DT case_NN of_IN Drosophila_NNP the_DT situation_NN is_VBZ simpler_JJR ._. 
The_DT method_NN we_PRP have_VBP proposed_VBN can_MD however_RB be_VB extended_VBN to_TO include_VB confounders_NNS and_CC intermediate_JJ variables_NNS ._. 
show_NN that_IN both_DT exposure_NN to_TO pesticides_NNS and_CC the_DT mutation_NN of_IN DJ-1_NN may_MD be_VB associated_VBN with_IN increased_VBN risk_NN of_IN neural_JJ degeneration_NN ._. 
Further_RB ,_, the_DT combination_NN of_IN the_DT two_CD has_VBZ also_RB been_VBN demonstrated_VBN to_TO aggravate_VB the_DT condition_NN ,_, as_IN the_DT flies_VBZ which_WDT had_VBD the_DT DJ-1_NNP gene_NN knocked_VBD out_RP exhibited_VBD a_DT ten-fold_JJ increase_NN in_IN sensitivity_NN to_TO paraquat_NN -LRB-_-LRB- which_WDT would_MD indicate_VB a_DT supra-multiplicative_JJ interaction_NN -RRB-_-RRB- ._. 
With_IN respect_NN to_TO the_DT interaction_NN parameter_NN ,_, there_EX is_VBZ as_RB yet_RB no_DT epidemiological_JJ study_NN that_WDT has_VBZ tested_VBN whether_IN there_EX is_VBZ an_DT interaction_NN between_IN DJ-1_NNP and_CC pesticides_NNS ;_: thus_RB neither_CC the_DT existence_NN nor_CC the_DT strength_NN of_IN such_PDT an_DT association_NN are_VBP known_VBN ._. 
However_RB ,_, knockout_NN models_NNS of_IN Drosophila_NNP Melanogaster_NNP -LRB-_-LRB- fruit_NN fly_NN -RRB-_-RRB- lacking_VBG DJ-1_NN function_NN ,_, display_VBP a_DT marked_JJ and_CC selective_JJ sensitivity_NN to_TO the_DT environmental_JJ oxidative_JJ insults_NNS exerted_VBN by_IN both_DT paraquat_NN and_CC rotenone_NN 
This_DT protein_NN has_VBZ been_VBN demonstrated_VBN to_TO be_VB involved_VBN in_IN cell_NN protection_NN during_IN oxidative_JJ stress_NN ._. 
The_DT protein_NN encoded_VBN by_IN DJ-1_NN gene_NN also_RB is_VBZ localized_VBN on_IN mitochondria_NNS ,_, but_CC it_PRP seems_VBZ to_TO belong_VB to_TO the_DT chaperones_NNS family_NN ,_, induced_VBN by_IN oxidative_JJ stress_NN 
,PAHs_NNS and_CC other_JJ carcinogens_NNS for_IN cigarette_NN smoking_NN -RRB-_-RRB- ,_, and_CC of_IN its_PRP$ biological_JJ or_CC environmental_JJ effects_NNS ._. 
For_IN example_NN ,_, on_IN the_DT basis_NN of_IN functional_JJ knowledge_NN ,_, only_RB bladder_NN cancer_NN ,_, and_CC perhaps_RB colon_NN cancer_NN ,_, may_MD be_VB expected_VBN to_TO be_VB associated_VBN with_IN NAT2_CD variants_NNS ._. 
Such_JJ postulated_JJ associations_NNS are_VBP biologically_RB plausible_JJ because_IN there_EX is_VBZ evidence_NN that_IN aromatic_JJ amines_NNS or_CC heterocyclic_JJ aromatic_JJ amines_NNS ,_, which_WDT are_VBP metabolised_VBN by_IN NAT2_NNP ,_, are_VBP involved_VBN in_IN bladder_NN or_CC colon_NN carcinogenesis_NN ._. 
For_IN example_NN ,_, MTHFR_NNP variation_NN involves_VBZ folic_JJ acid_NN and_CC methylation_NN pathways_NNS that_WDT may_MD have_VB potential_JJ relevance_NN to_TO the_DT genesis_NN of_IN many_JJ disease_NN outcomes_NNS ,_, as_IN birth_NN defects_NNS ,_, cardiovascular_JJ disease_NN and_CC cancer_NN 
However_RB ,_, a_DT different_JJ kind_NN of_IN dose-response_NN is_VBZ observable_JJ if_IN we_PRP consider_VBP the_DT cumulative_JJ effect_NN of_IN multiple_JJ genes_NNS or_CC SNPs_NNS ._. 
Both_DT the_DT risk_NN of_IN lung_NN cancer_NN and_CC the_DT levels_NNS of_IN DNA_NN damage_NN can_MD increase_VB approximately_RB linearly_RB with_IN an_DT increasing_VBG number_NN of_IN ``_`` at_IN risk_NN ''_'' gene_NN variants_NNS ._. 
Gene_NNP copy_NN number_NN variation_NN can_MD lead_VB to_TO more_RBR complex_JJ dose-response_JJ relationships_NNS ._. 
Quantitative_JJ continuous_JJ markers_NNS used_VBN in_IN epigenetics_NNS -LRB-_-LRB- promoter_NN methylation_NN -RRB-_-RRB- and_CC transcriptomics_NNS -LRB-_-LRB- gene_NN expression_NN -RRB-_-RRB- may_MD be_VB analyzed_VBN in_IN search_NN of_IN dose-response_JJ effects_NNS -LRB-_-LRB- linear_JJ or_CC non-linear_JJ -RRB-_-RRB- ._. 
This_DT is_VBZ an_DT extension_NN of_IN the_DT concept_NN of_IN pleiotropy_NN that_IN we_PRP see_VBP in_IN single_JJ gene_NN disorders_NNS ._. 
Apotential_JJ problem_NN in_IN the_DT use_NN of_IN specificity_NN as_IN a_DT criterion_NN for_IN causality_NN is_VBZ that_IN many_JJ genetic_JJ variants_NNS belong_VBP to_TO metabolic_JJ ,_, inflammatory_JJ ,_, homeostatic_JJ and_CC other_JJ pathways_NNS that_WDT could_MD influence_VB multiple_JJ disease_NN processes_NNS ._. 
For_IN example_NN ,_, MTHFR_NNP variation_NN involves_VBZ folic_JJ acid_NN and_CC methylation_NN pathways_NNS that_WDT may_MD have_VB potential_JJ relevance_NN to_TO the_DT genesis_NN of_IN many_JJ disease_NN outcomes_NNS ,_, as_IN birth_NN defects_NNS ,_, cardiovascular_JJ disease_NN and_CC cancer_NN 
,research_NN that_WDT integrates_VBZ knowledge_NN ,_, data_NNS ,_, methods_NNS ,_, techniques_NNS ,_, and_CC reasoning_NN from_IN multiple_JJ disciplines_NNS ,_, approaches_NNS and_CC levels_NNS of_IN analysis_NN to_TO generate_VB knowledge_NN that_IN no_DT discipline_NN alone_RB may_MD achieve_VB 
Adeletion_NNP of_IN the_DT DJ-1_NNP gene_NN in_IN a_DT Dutch_JJ family_NN and_CC a_DT mutation_NN conferring_VBG a_DT functionally_RB inactive_JJ form_NN in_IN an_DT Italian_JJ family_NN associated_VBN with_IN early_JJ onset_NN PD_NNP were_VBD first_RB observed_VBN in_IN 2001_CD 
,research_NN that_WDT integrates_VBZ knowledge_NN ,_, data_NNS ,_, methods_NNS ,_, techniques_NNS ,_, and_CC reasoning_NN from_IN multiple_JJ disciplines_NNS ,_, approaches_NNS and_CC levels_NNS of_IN analysis_NN to_TO generate_VB knowledge_NN that_IN no_DT discipline_NN alone_RB may_MD achieve_VB 
g._NN There_EX is_VBZ in_IN fact_NN some_DT empirical_JJ evidence_NN suggesting_VBG that_IN gene-disease_JJ associations_NNS are_VBP less_RBR prone_JJ to_TO confounding_VBG -LRB-_-LRB- e._FW ,_, by_IN socio-economic_JJ status_NN -RRB-_-RRB- than_IN associations_NNS between_IN genes_NNS and_CC environmental_JJ and_CC lifestyle_NN variables_NNS ._. 
There_EX are_VBP some_DT well_RB known_VBN methodological_JJ challenges_NNS in_IN interpreting_VBG the_DT causal_JJ significance_NN of_IN gene-disease_JJ associations_NNS ;_: they_PRP include_VBP epistasis_NN ,_, linkage_NN disequilibrium_NN ,_, and_CC gene-environment_NN interactions_NNS -LRB-_-LRB- GEI_NNP -RRB-_-RRB- 
This_DT is_VBZ also_RB true_JJ for_IN a_DT substantial_JJ part_NN of_IN basic_JJ biomedical_JJ research_NN ._. 
Amain_JJ problem_NN when_WRB making_VBG causal_JJ inferences_NNS in_IN clinical_JJ and_CC epidemiological_JJ research_NN is_VBZ that_IN most_JJS data_NNS are_VBP observational_JJ ._. 
It_PRP is_VBZ certainly_RB an_DT issue_NN in_IN human_JJ genetics_NNS ,_, where_WRB there_EX is_VBZ usually_RB no_DT randomization_NN -LRB-_-LRB- except_IN in_IN circumstances_NNS where_WRB Mendelian_JJ randomization_NN can_MD be_VB applied_VBN -RRB-_-RRB- ,_, and_CC knowledge_NN of_IN the_DT genetic_JJ pathways_NNS is_VBZ tenuous_JJ or_CC incomplete_JJ ._. 
In_IN such_JJ circumstances_NNS we_PRP must_MD be_VB careful_JJ to_TO distinguish_VB causal_JJ relationships_NNS from_IN associations_NNS resulting_VBG from_IN unobserved_JJ biases_NNS or_CC chance_NN ._. 
,by_JJ socio-economic_JJ status_NN -RRB-_-RRB- than_IN associations_NNS between_IN genes_NNS and_CC environmental_JJ and_CC lifestyle_NN variables_NNS ._. 
There_EX are_VBP some_DT well_RB known_VBN methodological_JJ challenges_NNS in_IN interpreting_VBG the_DT causal_JJ significance_NN of_IN gene-disease_JJ associations_NNS ;_: they_PRP include_VBP epistasis_NN ,_, linkage_NN disequilibrium_NN ,_, and_CC gene-environment_NN interactions_NNS -LRB-_-LRB- GEI_NNP -RRB-_-RRB- 
,on_NNP DNA_NNP repair_NN 
Main_NNP theoretical_JJ issues_NNS underlying_VBG the_DT application_NN of_IN Hill_NNP 's_POS criteria_NNS in_IN genetics_NNS and_CC genomics_NNS are_VBP shown_VBN in_IN Appendix_NNP 1_CD 
e._FW More_RBR generally_RB ,_, the_DT present_JJ paper_NN is_VBZ an_DT example_NN of_IN integrative_JJ research_NN ,_, i._VBD Once_RB these_DT relationships_NNS have_VBP been_VBN specified_VBN ,_, they_PRP are_VBP analyzed_VBN using_VBG criteria_NNS to_TO assess_VB causality_NN that_WDT have_VBP long_RB been_VBN used_VBN in_IN clinical_JJ and_CC epidemiological_JJ research_NN ._. 
,research_NN that_WDT integrates_VBZ knowledge_NN ,_, data_NNS ,_, methods_NNS ,_, techniques_NNS ,_, and_CC reasoning_NN from_IN multiple_JJ disciplines_NNS ,_, approaches_NNS and_CC levels_NNS of_IN analysis_NN to_TO generate_VB knowledge_NN that_IN no_DT discipline_NN alone_RB may_MD achieve_VB 
Hardy-Weinberg_JJ equilibrium_NN is_VBZ based_VBN on_IN assumptions_NNS of_IN population_NN genetics_NNS related_VBN to_TO the_DT lack_NN of_IN selection_NN ,_, inbreeding_NN ,_, migration_NN ;_: departure_NN from_IN HWE_NNP can_MD thus_RB point_VB towards_IN the_DT possibility_NN of_IN gross_JJ bias_NN -LRB-_-LRB- such_JJ as_IN genotyping_VBG errors_NNS or_CC selection_NN bias_NN -RRB-_-RRB- ._. 
Explicit_JJ guidelines_NNS for_IN causal_JJ assessment_NN are_VBP more_RBR popular_JJ in_IN clinical_JJ and_CC epidemiological_JJ research_NN than_IN in_IN genetics_NNS ._. 
The_DT reasons_NNS for_IN that_DT have_VBP seldom_RB been_VBN addressed_VBN ._. 
They_PRP are_VBP probably_RB related_VBN to_TO the_DT different_JJ nature_NN of_IN the_DT objects_NNS ,_, factors_NNS ,_, mechanisms_NNS and_CC processes_NNS that_WDT we_VBP study_NN at_IN each_DT level_NN ._. 
Criteria_NNP -LRB-_-LRB- a_DT -RRB-_-RRB- ,_, -LRB-_-LRB- b_NN -RRB-_-RRB- and_CC -LRB-_-LRB- c_NN -RRB-_-RRB- refer_VBP to_TO background_NN knowledge_NN ._. -RRB-_-RRB- ._. 
However_RB ,_, genetic_JJ guidelines_NNS on_IN causality_NN do_VBP exist_VB and_CC ,_, in_IN fact_NN ,_, have_VBP interesting_JJ similarities_NNS with_IN Hill_NNP 's_POS criteria_NNS :_: -LRB-_-LRB- a_DT -RRB-_-RRB- linkage_NN to_TO a_DT particular_JJ region_NN of_IN the_DT human_JJ genome_NN -LRB-_-LRB- LOD_NNP 
This_DT is_VBZ also_RB true_JJ for_IN a_DT substantial_JJ part_NN of_IN basic_JJ biomedical_JJ research_NN ._. 
Amain_JJ problem_NN when_WRB making_VBG causal_JJ inferences_NNS in_IN clinical_JJ and_CC epidemiological_JJ research_NN is_VBZ that_IN most_JJS data_NNS are_VBP observational_JJ ._. 
It_PRP is_VBZ certainly_RB an_DT issue_NN in_IN human_JJ genetics_NNS ,_, where_WRB there_EX is_VBZ usually_RB no_DT randomization_NN -LRB-_-LRB- except_IN in_IN circumstances_NNS where_WRB Mendelian_JJ randomization_NN can_MD be_VB applied_VBN -RRB-_-RRB- ,_, and_CC knowledge_NN of_IN the_DT genetic_JJ pathways_NNS is_VBZ tenuous_JJ or_CC incomplete_JJ ._. 
In_IN such_JJ circumstances_NNS we_PRP must_MD be_VB careful_JJ to_TO distinguish_VB causal_JJ relationships_NNS from_IN associations_NNS resulting_VBG from_IN unobserved_JJ biases_NNS or_CC chance_NN ._. 
Moreover_RB ,_, clinical_JJ symptoms_NNS of_IN Parkinson_NNP 's_POS disease_NN have_VBP been_VBN reproduced_VBN in_IN rats_NNS by_IN chronic_JJ administration_NN of_IN paraquat_NN ._. 
Evidence_NN from_IN animal_NN experiments_NNS shows_VBZ that_IN knockout_NN models_NNS of_IN Drosophila_NNP Melanogaster_NNP -LRB-_-LRB- fruit_NN fly_NN -RRB-_-RRB- lacking_VBG DJ-1_NN function_NN ,_, display_VBP a_DT marked_JJ and_CC selective_JJ sensitivity_NN to_TO the_DT environmental_JJ oxidative_JJ insults_NNS exerted_VBN by_IN both_DT paraquat_NN and_CC rotenone_NN 
This_DT problem_NN goes_VBZ beyond_IN the_DT present_JJ contribution_NN ,_, but_CC is_VBZ worth_JJ mentioning_VBG ._. 
,gene_JJ regulation_NN by_IN environmental_JJ factors_NNS 
Adose-response_JJ curve_NN with_IN length_NN of_IN exposure_NN was_VBD also_RB observed_VBN in_IN plantation_NN workers_NNS in_IN Hawaii_NNP 
Causal_JJ guidelines_NNS usually_RB include_VBP a_DT series_NN of_IN criteria_NNS that_WDT help_VBP assess_VB which_WDT observed_JJ associations_NNS are_VBP potentially_RB causal_JJ ._. 
They_PRP were_VBD introduced_VBN initially_RB by_IN Bradford-Hill_NNP in_IN the_DT debate_NN about_IN the_DT role_NN of_IN smoking_NN in_IN the_DT aetiology_NN of_IN lung_NN cancer_NN ;_: given_VBN the_DT issue_NN ,_, they_PRP were_VBD meant_VBN for_IN observational_JJ studies_NNS only_RB ,_, but_CC many_JJ of_IN the_DT criteria_NNS can_MD be_VB applied_VBN to_TO clinical_JJ trials_NNS and_CC other_JJ experimental_JJ studies_NNS as_RB well_RB ._. 
Although_IN Hill_NNP did_VBD not_RB have_VB genetic_JJ epidemiology_NN in_IN mind_NN at_IN the_DT time_NN ,_, today_NN his_PRP$ criteria_NNS remain_VBP relevant_JJ to_TO causal_JJ assessment_NN in_IN this_DT field_NN and_CC ,_, as_IN we_PRP will_MD show_VB ,_, to_TO many_JJ areas_NNS of_IN human_JJ genetics_NNS as_RB well_RB ._. 
reproducibility_NN in_IN animal_NN models_NNS -RRB-_-RRB- ;_: and_CC 9_CD -RRB-_-RRB- Analogy_NNP ._. 
g._NNP Hill_NNP 's_POS approach_NN is_VBZ based_VBN on_IN nine_CD criteria_NNS :_: 1_LS -RRB-_-RRB- Strength_NN of_IN association_NN ;_: 2_LS -RRB-_-RRB- Consistency_NN ;_: 3_LS -RRB-_-RRB- Specificity_NN of_IN association_NN ;_: 4_CD -RRB-_-RRB- Temporality_NN ;_: 5_LS -RRB-_-RRB- Biological_JJ gradient_NN -LRB-_-LRB- dose-response_JJ relationship_NN -RRB-_-RRB- ;_: 6_CD -RRB-_-RRB- Biological_JJ plausibility_NN ;_: 7_CD -RRB-_-RRB- Coherence_NN ;_: 8_CD -RRB-_-RRB- Experimental_JJ evidence_NN -LRB-_-LRB- e._FW Statistical_NNP significance_NN was_VBD not_RB listed_VBN but_CC discussed_VBN separately_RB by_IN Hill_NNP ._. 
One_CD major_JJ criticism_NN leveled_VBD at_IN Hill_NNP 's_POS approach_NN is_VBZ that_IN it_PRP considers_VBZ one_CD causal_JJ factor_NN at_IN a_DT time_NN and_CC is_VBZ not_RB intended_VBN to_TO tackle_VB complex_JJ relationships_NNS and_CC interactions_NNS ,_, such_JJ as_IN those_DT encountered_VBN in_IN modern_JJ molecular_JJ medicine_NN and_CC genomics_NNS ,_, which_WDT deal_VBP with_IN chains_NNS of_IN mediators_NNS and_CC not_RB only_RB directly_RB acting_JJ exposures_NNS ._. 
g._NNP This_NNP led_VBD to_TO synopses_NNS on_IN various_JJ topics_NNS in_IN genetic_JJ epidemiology_NN ;_: e._VB In_IN 2006_CD ,_, a_DT Human_NNP Genome_NNP Epidemiology_NNP Network_NNP -LRB-_-LRB- HuGENet_NNP -RRB-_-RRB- workshop_NN in_IN Venice_NNP was_VBD devoted_VBN to_TO the_DT development_NN of_IN standardized_JJ criteria_NNS for_IN the_DT assessment_NN of_IN the_DT credibility_NN of_IN cumulative_JJ evidence_NN on_IN gene-disease_JJ associations_NNS ._. 
,on_NNP DNA_NNP repair_NN 
They_PRP urged_VBD that_IN the_DT evidence_NN of_IN harm_NN was_VBD sufficient_JJ to_TO require_VB government_NN intervention_NN 
On_IN June_NNP 1_CD ,_, 1961_CD ,_, the_DT American_NNP Cancer_NNP Society_NNP ,_, the_DT American_NNP Heart_NNP Association_NNP ,_, the_DT American_NNP Public_NNP Health_NNP Association_NNP ,_, and_CC the_DT National_NNP Tuberculosis_NNP Association_NNP sent_VBD a_DT joint_JJ letter_NN to_TO President_NNP Kennedy_NNP asking_VBG for_IN the_DT appointment_NN of_IN a_DT special_JJ commission_NN to_TO address_VB the_DT need_NN for_IN government_NN action_NN on_IN smoking_NN and_CC health_NN ._. 
They_PRP urged_VBD that_IN the_DT evidence_NN of_IN harm_NN was_VBD sufficient_JJ to_TO require_VB government_NN intervention_NN 
On_IN June_NNP 1_CD ,_, 1961_CD ,_, the_DT American_NNP Cancer_NNP Society_NNP ,_, the_DT American_NNP Heart_NNP Association_NNP ,_, the_DT American_NNP Public_NNP Health_NNP Association_NNP ,_, and_CC the_DT National_NNP Tuberculosis_NNP Association_NNP sent_VBD a_DT joint_JJ letter_NN to_TO President_NNP Kennedy_NNP asking_VBG for_IN the_DT appointment_NN of_IN a_DT special_JJ commission_NN to_TO address_VB the_DT need_NN for_IN government_NN action_NN on_IN smoking_NN and_CC health_NN ._. 
They_PRP urged_VBD that_IN the_DT evidence_NN of_IN harm_NN was_VBD sufficient_JJ to_TO require_VB government_NN intervention_NN 
''_'' The_DT fact_NN that_IN more_JJR could_MD be_VB learned_VBN did_VBD not_RB preclude_VB making_VBG judgments_NNS ,_, and_CC if_IN it_PRP were_VBD not_RB for_IN the_DT power_NN of_IN tobacco_NN and_CC the_DT tobacco_NN industry_NN ,_, the_DT evidence_NN ``_`` would_MD be_VB generally_RB be_VB regarded_VBN as_IN beyond_IN dispute_NN ._. ''_'' 
Robert_NNP Koch_NNP 's_POS postulates_NNS had_VBD previously_RB provided_VBN a_DT framework_NN for_IN identifying_VBG causes_NNS of_IN infectious_JJ diseases_NNS ,_, but_CC those_DT postulates_NNS ,_, which_WDT required_VBD isolation_NN of_IN a_DT parasite_NN and_CC inducing_VBG the_DT disease_NN in_IN the_DT laboratory_NN ,_, had_VBD limited_VBN application_NN for_IN environmental_JJ causes_NNS of_IN chronic_JJ diseases_NNS ._. 
Thus_RB ,_, as_IN the_DT evidence_NN linking_VBG smoking_NN and_CC lung_NN cancer_NN developed_VBN during_IN the_DT 1950s_NNS ,_, public_JJ health_NN scientists_NNS debated_VBD the_DT requirements_NNS for_IN demonstrating_VBG causation_NN ,_, and_CC criteria_NNS proposed_VBN during_IN these_DT debates_NNS were_VBD later_RB used_VBN in_IN the_DT 1964_CD report_NN ._. 
On_IN June_NNP 1_CD ,_, 1961_CD ,_, the_DT American_NNP Cancer_NNP Society_NNP ,_, the_DT American_NNP Heart_NNP Association_NNP ,_, the_DT American_NNP Public_NNP Health_NNP Association_NNP ,_, and_CC the_DT National_NNP Tuberculosis_NNP Association_NNP sent_VBD a_DT joint_JJ letter_NN to_TO President_NNP Kennedy_NNP asking_VBG for_IN the_DT appointment_NN of_IN a_DT special_JJ commission_NN to_TO address_VB the_DT need_NN for_IN government_NN action_NN on_IN smoking_NN and_CC health_NN ._. 
In_IN addition_NN to_TO their_PRP$ historical_JJ interest_NN ,_, these_DT reports_NNS allow_VBP us_PRP to_TO observe_VB how_WRB two_CD expert_JJ panels_NNS with_IN a_DT common_JJ mandate_NN apply_VB identical_JJ ,_, pre-stated_JJ inferential_JJ criteria_NNS to_TO the_DT same_JJ questions_NNS as_IN the_DT evidence_NN accumulates_VBZ over_IN time_NN ._. 
Additionally_RB ,_, this_DT particular_JJ example_NN allows_VBZ us_PRP to_TO focus_VB on_IN the_DT process_NN of_IN causal_JJ inference_NN because_IN ,_, while_IN judgments_NNS about_IN the_DT relationship_NN between_IN smoking_NN and_CC these_DT four_CD cancers_NNS changed_VBN over_IN time_NN ,_, each_DT of_IN these_DT cancers_NNS has_VBZ since_IN been_VBN clearly_RB linked_VBN to_TO smoking_NN 
In_IN 1957_CD ,_, the_DT Study_NNP Group_NNP on_IN Smoking_NNP and_CC Health_NNP ,_, including_VBG members_NNS of_IN the_DT American_NNP Cancer_NNP Society_NNP ,_, the_DT American_NNP Heart_NNP Association_NNP ,_, the_DT National_NNP Cancer_NNP Institute_NNP -LRB-_-LRB- NCI_NNP -RRB-_-RRB- and_CC the_DT National_NNP Heart_NNP Institute_NNP concluded_VBD that_IN ``_`` The_DT sum_NN total_NN of_IN scientific_JJ evidence_NN establishes_VBZ beyond_IN a_DT reasonable_JJ doubt_NN that_IN cigarette_NN smoking_NN is_VBZ a_DT causative_JJ factor_NN in_IN the_DT rapidly_RB increasing_VBG incidence_NN of_IN human_JJ epidermoid_JJ carcinoma_NN of_IN the_DT lung_NN ._. ''_'' 
Two_CD years_NNS later_RB ,_, a_DT follow_VBP up_RP review_NN prepared_VBN by_IN a_DT group_NN of_IN leading_VBG epidemiologists_NNS and_CC biostatisticians_NNS -LRB-_-LRB- including_VBG Jerome_NNP Cornfield_NNP ,_, William_NNP Haenszel_NNP ,_, Michael_NNP Shimkin_NNP ,_, E._NNP Cuyler_NNP Hammond_NNP ,_, Abraham_NNP Lilienfeld_NNP and_CC Ernst_NNP Wynder_NNP -RRB-_-RRB- took_VBD account_NN of_IN the_DT growing_VBG pool_NN of_IN cohort_NN data_NNS and_CC responded_VBD in_IN substantial_JJ detail_NN to_TO various_JJ critiques_NNS that_WDT had_VBD been_VBN offered_VBN of_IN the_DT evidence_NN ._. 
They_PRP urged_VBD that_IN the_DT evidence_NN of_IN harm_NN was_VBD sufficient_JJ to_TO require_VB government_NN intervention_NN 
Thus_RB ,_, Surgeon_NNP General_NNP Luther_NNP Terry_NNP decided_VBD that_IN what_WP was_VBD needed_VBN first_RB was_VBD a_DT comprehensive_JJ review_NN of_IN all_PDT the_DT data_NNS on_IN smoking_NN and_CC health_NN by_IN an_DT expert_JJ advisory_JJ committee_NN ._. 
While_IN public_JJ health_NN activists_NNS saw_VBD this_DT move_NN as_IN another_DT delaying_NN tactic_NN 
0._CD 
In_IN the_DT cases_NNS we_PRP studied_VBD ,_, for_IN example_NN ,_, no_DT causal_JJ inferences_NNS were_VBD made_VBN where_WRB the_DT strength_NN of_IN association_NN was_VBD less_JJR than_IN 3_CD ._. 
At_IN the_DT same_JJ time_NN ,_, ecologic_JJ studies_NNS showing_VBG population_NN level_NN trends_NNS in_IN cigarette_NN use_NN and_CC cancer_NN mortality_NN played_VBD an_DT important_JJ role_NN in_IN supporting_VBG the_DT criterion_NN of_IN coherence_NN ,_, while_IN such_JJ studies_NNS appear_VBP to_TO be_VB given_VBN less_JJR weight_NN by_IN epidemiologists_NNS since_IN then_RB 
The_DT amount_NN and_CC type_NN of_IN evidence_NN expected_VBN to_TO support_VB a_DT causal_JJ inference_NN can_MD change_VB over_IN time_NN ,_, as_IN new_JJ scientific_JJ methods_NNS become_VBP available_JJ and_CC new_JJ disciplines_NNS develop_VBP ._. 
Historians_NNS have_VBP suggested_VBN that_IN the_DT level_NN of_IN proof_NN required_VBN to_TO demonstrate_VB a_DT causal_JJ link_NN between_IN smoking_NN and_CC lung_NN cancer_NN was_VBD especially_RB high_JJ in_IN 1964_CD ,_, because_IN the_DT methods_NNS of_IN chronic_JJ disease_NN epidemiology_NN in_IN use_NN were_VBD new_JJ and_CC not_RB well_RB understood_VBN by_IN scientists_NNS in_IN other_JJ disciplines_NNS ._. 
By_IN 1982_CD ,_, epidemiologic_JJ methods_NNS had_VBD become_VBN more_RBR widely_RB used_VBN and_CC the_DT health_NN effects_NNS of_IN smoking_NN were_VBD more_RBR widely_RB accepted_VBN by_IN scientists_NNS and_CC clinicians_NNS ._. 
Additionally_RB ,_, extra-scientific_JJ values_NNS have_VBP been_VBN acknowledged_VBN to_TO play_VB a_DT role_NN in_IN evidence-based_JJ public_JJ health_NN ,_, accounting_VBG in_IN part_NN for_IN why_WRB different_JJ expert_NN groups_NNS sometimes_RB reach_VBP divergent_JJ conclusions_NNS based_VBN on_IN identical_JJ evidence_NN 
Luther_NNP Terry_NNP attempted_VBD to_TO minimize_VB such_JJ influences_NNS by_IN limiting_VBG the_DT committee_NN 's_POS purview_NN to_TO reviewing_VBG the_DT science_NN ,_, excluding_VBG policy_NN recommendations_NNS ,_, and_CC by_IN carefully_RB selecting_VBG committee_NN members_NNS who_WP would_MD not_RB be_VB perceived_VBN to_TO be_VB in_IN conflict_NN ._. 
Nevertheless_RB ,_, it_PRP is_VBZ reasonable_JJ to_TO ask_VB whether_IN the_DT tobacco_NN industry_NN ,_, which_WDT was_VBD challenging_VBG the_DT science_NN and_CC vigorously_RB opposing_JJ tobacco_NN regulation_NN at_IN the_DT time_NN ,_, could_MD have_VB influenced_VBN the_DT committee_NN 's_POS actions_NNS ._. 
However_RB ,_, in_IN the_DT end_NN the_DT committee_NN took_VBD a_DT strong_JJ position_NN on_IN the_DT evidence_NN linking_VBG smoking_NN with_IN lung_NN and_CC laryngeal_NN cancer_NN ._. 
The_DT Royal_NNP College_NNP of_IN Physicians_NNP -LRB-_-LRB- RCP_NNP -RRB-_-RRB- had_VBD released_VBN its_PRP$ own_JJ expert_NN committee_NN review_NN on_IN smoking_NN and_CC health_NN in_IN 1962_CD ,_, which_WDT concluded_VBD that_IN cigarette_NN smoking_NN is_VBZ a_DT cause_NN of_IN lung_NN cancer_NN but_CC did_VBD not_RB claim_VB causation_NN for_IN any_DT other_JJ type_NN of_IN cancer_NN ._. 
However_RB ,_, the_DT RCP_NNP did_VBD not_RB cite_VB any_DT explicit_JJ guidelines_NNS for_IN causal_JJ inference_NN or_CC provide_VB a_DT detailed_JJ analysis_NN of_IN the_DT evidence_NN for_IN cancers_NNS other_JJ than_IN lung_NN cancer_NN ,_, making_VBG it_PRP difficult_JJ to_TO assess_VB why_WRB they_PRP reached_VBD a_DT different_JJ conclusion_NN for_IN laryngeal_NN cancer_NN from_IN the_DT 1964_CD Surgeon_NNP General_NNP 's_POS committee_NN ._. 
While_IN this_DT study_NN suggests_VBZ that_IN use_NN of_IN the_DT causal_JJ criteria_NNS does_VBZ not_RB make_VB inferences_NNS entirely_RB transparent_JJ ,_, application_NN of_IN the_DT criteria_NNS is_VBZ certainly_RB a_DT major_JJ advance_NN over_IN not_RB employing_VBG any_DT explicit_JJ inferential_JJ criteria_NNS ._. 
The_DT process_NN of_IN synthesizing_VBG evidence_NN and_CC drawing_VBG causal_JJ conclusions_NNS does_VBZ not_RB occur_VB in_IN isolation_NN ,_, of_IN course_NN ,_, but_CC within_IN a_DT social_JJ and_CC political_JJ context_NN ,_, and_CC sometimes_RB that_DT context_NN ,_, particularly_RB in_IN the_DT case_NN of_IN smoking_NN and_CC lung_NN cancer_NN in_IN 1964_CD ,_, is_VBZ highly_RB charged_VBN ._. 
Historians_NNS and_CC sociologists_NNS of_IN science_NN have_VBP presented_VBN evidence_NN that_IN extra-scientific_JJ values_NNS ,_, such_JJ as_IN ideology_NN or_CC personal_JJ gain_NN ,_, can_MD influence_VB how_WRB scientists_NNS interpret_VBP evidence_NN 
The_DT process_NN of_IN synthesizing_VBG evidence_NN and_CC drawing_VBG causal_JJ conclusions_NNS does_VBZ not_RB occur_VB in_IN isolation_NN ,_, of_IN course_NN ,_, but_CC within_IN a_DT social_JJ and_CC political_JJ context_NN ,_, and_CC sometimes_RB that_DT context_NN ,_, particularly_RB in_IN the_DT case_NN of_IN smoking_NN and_CC lung_NN cancer_NN in_IN 1964_CD ,_, is_VBZ highly_RB charged_VBN ._. 
Historians_NNS and_CC sociologists_NNS of_IN science_NN have_VBP presented_VBN evidence_NN that_IN extra-scientific_JJ values_NNS ,_, such_JJ as_IN ideology_NN or_CC personal_JJ gain_NN ,_, can_MD influence_VB how_WRB scientists_NNS interpret_VBP evidence_NN 
Historians_NNS and_CC sociologists_NNS of_IN science_NN have_VBP presented_VBN evidence_NN that_IN extra-scientific_JJ values_NNS ,_, such_JJ as_IN ideology_NN or_CC personal_JJ gain_NN ,_, can_MD influence_VB how_WRB scientists_NNS interpret_VBP evidence_NN 
Additionally_RB ,_, extra-scientific_JJ values_NNS have_VBP been_VBN acknowledged_VBN to_TO play_VB a_DT role_NN in_IN evidence-based_JJ public_JJ health_NN ,_, accounting_VBG in_IN part_NN for_IN why_WRB different_JJ expert_NN groups_NNS sometimes_RB reach_VBP divergent_JJ conclusions_NNS based_VBN on_IN identical_JJ evidence_NN 
We_PRP maintain_VBP that_IN further_JJ case_NN studies_NNS like_IN this_DT one_CD ,_, both_DT contemporary_JJ and_CC historical_JJ ,_, can_MD raise_VB new_JJ research_NN questions_NNS and_CC provide_VB essential_JJ information_NN to_TO allow_VB epidemiologists_NNS and_CC other_JJ public_JJ health_NN scientists_NNS to_TO critically_RB examine_VB application_NN of_IN causal_JJ criteria_NNS today_NN ._. 
Our_PRP$ findings_NNS suggest_VBP that_IN the_DT method_NN of_IN causal_JJ inference_NN that_WDT has_VBZ been_VBN articulated_VBN in_IN textbooks_NNS and_CC in_IN the_DT Surgeon_NNP General_NNP reports_NNS is_VBZ incomplete_JJ ,_, in_IN that_DT individual_JJ criteria_NNS and_CC their_PRP$ joint_JJ application_NN can_MD be_VB open_JJ to_TO multiple_JJ interpretations_NNS ._. 
Thus_RB ,_, there_EX are_VBP elements_NNS of_IN practice_NN that_WDT can_MD only_RB be_VB understood_VBN by_IN observing_VBG how_WRB causal_JJ criteria_NNS are_VBP applied_VBN in_IN real_JJ situations_NNS ._. 
The_DT 1964_CD committee_NN explicitly_RB excluded_VBD two_CD epidemiologic_JJ studies_NNS conducted_VBN and_CC funded_VBN by_IN a_DT tobacco_NN company_NN 
But_CC in_IN spite_NN of_IN this_DT twenty_CD year_NN gap_NN ,_, the_DT 1982_CD report_NN still_RB did_VBD not_RB declare_VB a_DT causal_JJ link_NN between_IN cigarette_NN smoking_NN and_CC bladder_NN cancer_NN ,_, demonstrating_VBG that_IN the_DT causal_JJ criteria_NNS continued_VBD to_TO play_VB an_DT essential_JJ role_NN ._. 
Additionally_RB ,_, attitudes_NNS about_IN the_DT role_NN of_IN potential_JJ conflicts_NNS of_IN interest_NN have_VBP changed_VBN over_IN time_NN 
The_DT amount_NN and_CC type_NN of_IN evidence_NN expected_VBN to_TO support_VB a_DT causal_JJ inference_NN can_MD change_VB over_IN time_NN ,_, as_IN new_JJ scientific_JJ methods_NNS become_VBP available_JJ and_CC new_JJ disciplines_NNS develop_VBP ._. 
Historians_NNS have_VBP suggested_VBN that_IN the_DT level_NN of_IN proof_NN required_VBN to_TO demonstrate_VB a_DT causal_JJ link_NN between_IN smoking_NN and_CC lung_NN cancer_NN was_VBD especially_RB high_JJ in_IN 1964_CD ,_, because_IN the_DT methods_NNS of_IN chronic_JJ disease_NN epidemiology_NN in_IN use_NN were_VBD new_JJ and_CC not_RB well_RB understood_VBN by_IN scientists_NNS in_IN other_JJ disciplines_NNS ._. 
By_IN 1982_CD ,_, epidemiologic_JJ methods_NNS had_VBD become_VBN more_RBR widely_RB used_VBN and_CC the_DT health_NN effects_NNS of_IN smoking_NN were_VBD more_RBR widely_RB accepted_VBN by_IN scientists_NNS and_CC clinicians_NNS ._. 
In_IN particular_JJ ,_, although_IN temporality_NN and_CC specificity_NN were_VBD included_VBN as_IN criteria_NNS ,_, they_PRP were_VBD not_RB referred_VBN to_TO at_IN all_DT in_IN the_DT 1964_CD report_NN with_IN the_DT exception_NN of_IN lung_NN cancer_NN ._. 
These_DT results_NNS add_VBP to_TO previous_JJ findings_NNS that_IN authors_NNS of_IN review_NN papers_NNS apply_VBP causal_JJ criteria_NNS inconsistently_RB ,_, often_RB excluding_VBG or_CC even_RB altering_VBG criteria_NNS without_IN giving_VBG reasons_NNS for_IN these_DT changes_NNS ._. 
It_PRP is_VBZ possible_JJ that_IN some_DT criteria_NNS were_VBD used_VBN implicitly_RB in_IN the_DT process_NN of_IN causal_JJ inference_NN in_IN the_DT reports_NNS of_IN the_DT Surgeon_NNP General_NNP ,_, but_CC that_DT their_PRP$ application_NN was_VBD not_RB adequately_RB described_VBN ._. 
Two_CD prospective_JJ studies_NNS of_IN tobacco_NN workers_NNS that_WDT had_VBD not_RB found_VBN any_DT increased_VBN mortality_NN among_IN smokers_NNS were_VBD dismissed_VBN by_IN the_DT Surgeon_NNP General_NNP 's_POS committee_NN because_IN of_IN ``_`` major_JJ defects_NNS ''_'' ._. 
These_DT studies_NNS ,_, conducted_VBN by_IN the_DT American_NNP Tobacco_NNP Company_NNP ,_, compared_VBN disease_NN rates_NNS in_IN a_DT heavy_JJ smoking_NN population_NN of_IN tobacco_NN workers_NNS with_IN those_DT of_IN the_DT general_JJ population_NN ,_, thus_RB being_VBG vulnerable_JJ to_TO the_DT ``_`` healthy_JJ worker_NN ''_'' effect_NN ,_, and_CC did_VBD not_RB have_VB individual_JJ level_NN information_NN on_IN smoking_NN status_NN ._. 
While_IN the_DT cohort_NN studies_NNS linked_VBD cigarette_NN smoking_NN to_TO numerous_JJ diseases_NNS ,_, the_DT committee_NN concluded_VBD that_IN the_DT specificity_NN criterion_NN was_VBD met_VBN for_IN lung_NN cancer_NN because_IN the_DT strength_NN of_IN association_NN was_VBD so_RB much_RB greater_JJR than_IN for_IN other_JJ diseases_NNS ,_, and_CC because_IN they_PRP reasoned_VBD that_IN the_DT majority_NN of_IN lung_NN cancers_NNS were_VBD attributable_JJ to_TO smoking_NN -LRB-_-LRB- based_VBN on_IN the_DT magnitude_NN of_IN the_DT relative_JJ risk_NN -RRB-_-RRB- 
Additionally_RB ,_, attitudes_NNS about_IN the_DT role_NN of_IN potential_JJ conflicts_NNS of_IN interest_NN have_VBP changed_VBN over_IN time_NN ._. 
The_DT 1964_CD committee_NN explicitly_RB excluded_VBD two_CD epidemiologic_JJ stud_NN 
Two_CD prospective_JJ studies_NNS of_IN tobacco_NN workers_NNS that_WDT had_VBD not_RB found_VBN any_DT increased_VBN mortality_NN among_IN smokers_NNS were_VBD dismissed_VBN by_IN the_DT Surgeon_NNP General_NNP 's_POS committee_NN because_IN of_IN ``_`` major_JJ defects_NNS ''_'' ._. 
These_DT studies_NNS ,_, conducted_VBN by_IN the_DT American_NNP Tobacco_NNP Company_NNP ,_, compared_VBN disease_NN rates_NNS in_IN a_DT heavy_JJ smoking_NN population_NN of_IN tobacco_NN workers_NNS with_IN those_DT of_IN the_DT general_JJ population_NN ,_, thus_RB being_VBG vulnerable_JJ to_TO the_DT ``_`` healthy_JJ worker_NN ''_'' effect_NN ,_, and_CC did_VBD not_RB have_VB individual_JJ level_NN information_NN on_IN smoking_NN status_NN ._. 
While_IN the_DT cohort_NN studies_NNS linked_VBD cigarette_NN smoking_NN to_TO numerous_JJ diseases_NNS ,_, the_DT committee_NN concluded_VBD that_IN the_DT specificity_NN criterion_NN was_VBD met_VBN for_IN lung_NN cancer_NN because_IN the_DT strength_NN of_IN association_NN was_VBD so_RB much_RB greater_JJR than_IN for_IN other_JJ diseases_NNS ,_, and_CC because_IN they_PRP reasoned_VBD that_IN the_DT majority_NN of_IN lung_NN cancers_NNS were_VBD attributable_JJ to_TO smoking_NN -LRB-_-LRB- based_VBN on_IN the_DT magnitude_NN of_IN the_DT relative_JJ risk_NN -RRB-_-RRB- 
Additionally_RB ,_, attitudes_NNS about_IN the_DT role_NN of_IN potential_JJ conflicts_NNS of_IN interest_NN have_VBP changed_VBN over_IN time_NN 
We_PRP obtained_VBD all_DT original_JJ research_NN papers_NNS for_IN the_DT case-control_JJ studies_NNS cited_VBN in_IN the_DT reports_NNS as_IN studies_NNS of_IN cigarette_NN smoking_NN and_CC the_DT four_CD cancers_NNS ._. 
We_PRP conducted_VBD meta-analyses_NNS on_IN the_DT published_VBN data_NNS from_IN the_DT case-control_JJ studies_NNS using_VBG the_DT DerSimonian-Laird_NNP method_NN ._. 
We_PRP excluded_VBD the_DT case-control_JJ studies_NNS that_WDT included_VBD only_JJ women_NNS ,_, since_IN the_DT smoking_NN habits_NNS for_IN men_NNS and_CC women_NNS were_VBD quite_RB different_JJ at_IN the_DT time_NN ,_, and_CC we_PRP excluded_VBD studies_NNS that_WDT did_VBD not_RB report_VB numbers_NNS of_IN cases_NNS and_CC controls_NNS and_CC numbers_NNS of_IN smokers_NNS and_CC nonsmokers_NNS within_IN these_DT groups_NNS ,_, as_IN these_DT did_VBD not_RB allow_VB calculation_NN of_IN an_DT odds_NNS ratio_NN ;_: for_IN example_NN ,_, some_DT papers_NNS only_RB reported_VBD percentages_NNS or_CC ratios_NNS without_IN providing_VBG the_DT actual_JJ numbers_NNS used_VBN to_TO calculate_VB them_PRP ._. 
Official_JJ records_NNS in_IN the_DT National_NNP Archives_NNPS from_IN the_DT Surgeon_NNP General_NNP 's_POS Advisory_NNP Committee_NNP on_IN Smoking_NNP and_CC Health_NNP ,_, which_WDT authored_VBD the_DT 1964_CD report_NN ,_, did_VBD not_RB yield_VB additional_JJ details_NNS about_IN the_DT committee_NN 's_POS causal_JJ reasoning_NN ._. 
In_IN both_DT reports_NNS ,_, cohort_NN mortality_NN and_CC case-control_JJ study_NN data_NNS were_VBD available_JJ for_IN all_DT cancers_NNS ._. 
In_IN order_NN to_TO clearly_RB summarize_VB the_DT case-control_JJ evidence_NN available_JJ to_TO the_DT 1964_CD and_CC 1982_CD committees_NNS ,_, we_PRP conducted_VBD our_PRP$ own_JJ pooled_VBN analysis_NN of_IN the_DT case-control_JJ data_NNS ._. 
The_DT 1982_CD report_NN ,_, The_DT Health_NNP Consequences_NNPS of_IN Smoking_NNP :_: Cancer_NNP ,_, was_VBD assembled_VBN by_IN an_DT editorial_NN committee_NN of_IN scientists_NNS ,_, and_CC individual_JJ chapters_NNS were_VBD authored_VBN by_IN small_JJ groups_NNS of_IN a_DT few_JJ experts_NNS with_IN multiple_JJ layers_NNS of_IN review_NN ._. 
The_DT largest_JJS chapter_NN ,_, Biomedical_JJ Evidence_NN for_IN Determining_VBG Causality_NNP ,_, was_VBD written_VBN by_IN respiratory_JJ medicine_NN specialist_NN Richard_NNP Bordow_NNP and_CC epidemiologist_NN Abraham_NNP Lilienfeld_NNP ._. 
Many_JJ of_IN the_DT authors_NNS and_CC reviewers_NNS were_VBD actively_RB working_VBG on_IN research_NN related_VBN to_TO smoking_NN and_CC health_NN at_IN the_DT time_NN ._. 
Nevertheless_RB ,_, the_DT criteria_NNS for_IN causality_NN that_WDT were_VBD applied_VBN were_VBD the_DT same_JJ as_IN those_DT applied_VBN in_IN the_DT 1964_CD report_NN ._. 
MethodsTwo_NN reports_NNS of_IN the_DT Surgeon_NNP General_NNP on_IN smoking_NN and_CC health_NN that_WDT applied_VBD causal_JJ criteria_NNS to_TO the_DT four_CD cancers_NNS at_IN different_JJ points_NNS in_IN time_NN -LRB-_-LRB- 1964_CD and_CC 1982_CD -RRB-_-RRB- form_VBP the_DT basis_NN of_IN our_PRP$ investigation_NN ._. 
We_PRP chose_VBD these_DT two_CD reports_NNS because_IN they_PRP applied_VBD the_DT same_JJ causal_JJ criteria_NNS yet_RB also_RB represent_VB a_DT time_NN period_NN during_IN which_WDT evidence_NN linking_VBG smoking_NN and_CC some_DT cancers_NNS was_VBD growing_VBG substantially_RB ._. 
Records_NNP of_IN the_DT Committee_NN at_IN the_DT National_NNP Archives_NNPS do_VBP not_RB include_VB formal_JJ meeting_NN minutes_NNS that_WDT might_MD characterize_VB the_DT group_NN 's_POS discussions_NNS 
Unfortunately_RB ,_, there_EX is_VBZ little_JJ remaining_VBG documentation_NN of_IN the_DT committee_NN 's_POS process_NN and_CC deliberations_NNS ._. 
Records_NNP of_IN the_DT Committee_NN at_IN the_DT National_NNP Archives_NNPS do_VBP not_RB include_VB formal_JJ meeting_NN minutes_NNS that_WDT might_MD characterize_VB the_DT group_NN 's_POS discussions_NNS 
D._NNP ,_, Ph._NNP ._. 
D._NNP Seevers_NNP ,_, M._NNP ,_, Epidemiology_NNP Maurice_NNP H._NNP D._NNP Schuman_NNP ,_, M._NNP ,_, Internal_NNP Medicine_NNP -LRB-_-LRB- pulmonary_JJ diseases_NNS -RRB-_-RRB- Leonard_NNP M._NNP ,_, PharmacologyThe_NNP committee_NN members_NNS held_VBD their_PRP$ first_JJ meeting_NN at_IN the_DT National_NNP Library_NNP of_IN Medicine_NNP in_IN Bethesda_NNP ,_, Maryland_NNP ,_, on_IN November_NNP 9_CD ,_, 1962_CD ,_, with_IN their_PRP$ deliberations_NNS under_IN strict_JJ secrecy_NN ._. 
Outside_JJ communication_NN with_IN the_DT committee_NN members_NNS was_VBD controlled_VBN ._. 
Unfortunately_RB ,_, there_EX is_VBZ little_JJ remaining_VBG documentation_NN of_IN the_DT committee_NN 's_POS process_NN and_CC deliberations_NNS ._. 
Major_JJ medical_JJ associations_NNS ,_, volunteer_VBP public_JJ health_NN organizations_NNS ,_, the_DT Tobacco_NNP Institute_NNP ,_, the_DT Food_NNP and_CC Drug_NNP Administration_NNP ,_, the_DT Federal_NNP Trade_NNP Commission_NNP and_CC the_DT President_NNP 's_POS Office_NNP of_IN Science_NNP and_CC Technology_NNP were_VBD all_DT given_VBN the_DT opportunity_NN to_TO delete_VB anyone_NN from_IN the_DT list_NN for_IN any_DT reason_NN ._. 
President_NNP Kennedy_NNP himself_PRP promised_VBD that_IN there_EX would_MD be_VB no_DT political_JJ interference_NN with_IN the_DT committee_NN 's_POS work_NN 
S._NNP There_RB had_VBD been_VBN earlier_JJR statements_NNS by_IN the_DT U._NNP Forty_CD years_NNS ago_RB ,_, the_DT release_NN of_IN the_DT Surgeon_NNP General_NNP 's_POS report_NN on_IN Smoking_NNP and_CC Health_NNP marked_VBD a_DT turning_NN point_NN in_IN scientific_JJ and_CC public_JJ health_NN efforts_NNS to_TO address_VB the_DT consequences_NNS of_IN tobacco_NN use_NN for_IN human_JJ health_NN 
S._NNP There_RB had_VBD been_VBN earlier_JJR statements_NNS by_IN the_DT U._NNP Forty_CD years_NNS ago_RB ,_, the_DT release_NN of_IN the_DT Surgeon_NNP General_NNP 's_POS report_NN on_IN Smoking_NNP and_CC Health_NNP marked_VBD a_DT turning_NN point_NN in_IN scientific_JJ and_CC public_JJ health_NN efforts_NNS to_TO address_VB the_DT consequences_NNS of_IN tobacco_NN use_NN for_IN human_JJ health_NN 
The_DT 1964_CD Surgeon_NNP General_NNP 's_POS report_NN discussed_VBD lung_NN cancer_NN first_RB and_CC devoted_VBD more_JJR than_IN five_CD times_NNS as_IN much_JJ space_NN to_TO it_PRP than_IN for_IN any_DT of_IN the_DT other_JJ cancers_NNS ._. 
Much_JJ of_IN the_DT discussion_NN responded_VBD to_TO specific_JJ criticisms_NNS that_WDT had_VBD been_VBN raised_VBN in_IN prior_JJ scientific_JJ debates_NNS about_IN the_DT growing_VBG evidence_NN on_IN smoking_NN and_CC health_NN ._. 
The_DT summary_NN odds_NNS ratio_NN from_IN 25_CD case-control_JJ studies_NNS was_VBD 5_CD ._. 
43_CD -LRB-_-LRB- 95_CD %_NN CI_NNP :_: 4_CD ._. 
82_CD 
Nevertheless_RB ,_, the_DT 1964_CD report_NN became_VBD a_DT landmark_NN in_IN the_DT history_NN of_IN evidence-based_JJ public_JJ health_NN because_IN of_IN its_PRP$ explicit_JJ use_NN of_IN pre-stated_JJ criteria_NNS for_IN causal_JJ inference_NN 
Nevertheless_RB ,_, the_DT 1964_CD report_NN became_VBD a_DT landmark_NN in_IN the_DT history_NN of_IN evidence-based_JJ public_JJ health_NN because_IN of_IN its_PRP$ explicit_JJ use_NN of_IN pre-stated_JJ criteria_NNS for_IN causal_JJ inference_NN 
Robert_NNP Koch_NNP 's_POS postulates_NNS had_VBD previously_RB provided_VBN a_DT framework_NN for_IN identifying_VBG causes_NNS of_IN infectious_JJ diseases_NNS ,_, but_CC those_DT postulates_NNS ,_, which_WDT required_VBD isolation_NN of_IN a_DT parasite_NN and_CC inducing_VBG the_DT disease_NN in_IN the_DT laboratory_NN ,_, had_VBD limited_VBN application_NN for_IN environmental_JJ causes_NNS of_IN chronic_JJ diseases_NNS ._. 
Thus_RB ,_, as_IN the_DT evidence_NN linking_VBG smoking_NN and_CC lung_NN cancer_NN developed_VBN during_IN the_DT 1950s_NNS ,_, public_JJ health_NN scientists_NNS debated_VBD the_DT requirements_NNS for_IN demonstrating_VBG causation_NN ,_, and_CC criteria_NNS proposed_VBN during_IN these_DT debates_NNS were_VBD later_RB used_VBN in_IN the_DT 1964_CD report_NN ._. 
On_IN June_NNP 1_CD ,_, 1961_CD ,_, the_DT American_NNP Cancer_NNP Society_NNP ,_, the_DT American_NNP Heart_NNP Association_NNP ,_, the_DT American_NNP Public_NNP Health_NNP Association_NNP ,_, and_CC the_DT National_NNP Tuberculosis_NNP Association_NNP sent_VBD a_DT joint_JJ letter_NN to_TO President_NNP Kennedy_NNP asking_VBG for_IN the_DT appointment_NN of_IN a_DT special_JJ commission_NN to_TO address_VB the_DT need_NN for_IN government_NN action_NN on_IN smoking_NN and_CC health_NN ._. 
Further_JJ empirical_JJ study_NN and_CC critical_JJ examination_NN of_IN the_DT process_NN by_IN which_WDT causal_JJ conclusions_NNS are_VBP reached_VBN can_MD play_VB an_DT important_JJ role_NN in_IN advancing_VBG the_DT practice_NN of_IN epidemiology_NN by_IN helping_VBG public_JJ health_NN scientists_NNS to_TO better_RBR understand_VB the_DT practice_NN of_IN causal_JJ inference_NN ._. 
Forty_CD years_NNS ago_RB ,_, the_DT release_NN of_IN the_DT Surgeon_NNP General_NNP 's_POS report_NN on_IN Smoking_NNP and_CC Health_NNP marked_VBD a_DT turning_NN point_NN in_IN scientific_JJ and_CC public_JJ health_NN efforts_NNS to_TO address_VB the_DT consequences_NNS of_IN tobacco_NN use_NN for_IN human_JJ health_NN 
While_IN public_JJ health_NN activists_NNS saw_VBD this_DT move_NN as_IN another_DT delaying_NN tactic_NN 
Their_PRP$ expertise_NN included_VBD pathology_NN ,_, surgery_NN ,_, chemistry_NN ,_, cancer_NN biology_NN ,_, internal_JJ medicine_NN ,_, pharmacology_NN ,_, statistics_NNS ,_, and_CC epidemiology_NN ._. 
Given_VBN the_DT importance_NN that_IN the_DT epidemiologic_JJ evidence_NN took_VBD on_RP in_IN the_DT inquiry_NN ,_, it_PRP is_VBZ important_JJ to_TO note_VB that_IN the_DT committee_NN included_VBD only_RB one_CD epidemiologist_NN and_CC one_CD biostatistician_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
Table_NNP 1_CD 1964_CD Report_NNP :_: Members_NNS of_IN the_DT Advisory_NNP Committee_NNP to_TO the_DT U._NNP S._NNP Surgeon_NNP General_NNP Name_NN and_CC Degrees_NNP Discipline_NNP Stanhope_NNP Bayne-Jones_NNP ,_, M._NNP 
Nevertheless_RB ,_, the_DT criteria_NNS for_IN causality_NN that_WDT were_VBD applied_VBN were_VBD the_DT same_JJ as_IN those_DT applied_VBN in_IN the_DT 1964_CD report_NN ._. 
MethodsTwo_NN reports_NNS of_IN the_DT Surgeon_NNP General_NNP on_IN smoking_NN and_CC health_NN that_WDT applied_VBD causal_JJ criteria_NNS to_TO the_DT four_CD cancers_NNS at_IN different_JJ points_NNS in_IN time_NN -LRB-_-LRB- 1964_CD and_CC 1982_CD -RRB-_-RRB- form_VBP the_DT basis_NN of_IN our_PRP$ investigation_NN ._. 
We_PRP chose_VBD these_DT two_CD reports_NNS because_IN they_PRP applied_VBD the_DT same_JJ causal_JJ criteria_NNS yet_RB also_RB represent_VB a_DT time_NN period_NN during_IN which_WDT evidence_NN linking_VBG smoking_NN and_CC some_DT cancers_NNS was_VBD growing_VBG substantially_RB ._. 
These_DT studies_NNS ,_, conducted_VBN by_IN the_DT American_NNP Tobacco_NNP Company_NNP ,_, compared_VBN disease_NN rates_NNS in_IN a_DT heavy_JJ smoking_NN population_NN of_IN tobacco_NN workers_NNS with_IN those_DT of_IN the_DT general_JJ population_NN ,_, thus_RB being_VBG vulnerable_JJ to_TO the_DT ``_`` healthy_JJ worker_NN ''_'' effect_NN ,_, and_CC did_VBD not_RB have_VB individual_JJ level_NN information_NN on_IN smoking_NN status_NN ._. 
While_IN the_DT cohort_NN studies_NNS linked_VBD cigarette_NN smoking_NN to_TO numerous_JJ diseases_NNS ,_, the_DT committee_NN concluded_VBD that_IN the_DT specificity_NN criterion_NN was_VBD met_VBN for_IN lung_NN cancer_NN because_IN the_DT strength_NN of_IN association_NN was_VBD so_RB much_RB greater_JJR than_IN for_IN other_JJ diseases_NNS ,_, and_CC because_IN they_PRP reasoned_VBD that_IN the_DT majority_NN of_IN lung_NN cancers_NNS were_VBD attributable_JJ to_TO smoking_NN -LRB-_-LRB- based_VBN on_IN the_DT magnitude_NN of_IN the_DT relative_JJ risk_NN -RRB-_-RRB- 
S._NNP There_RB had_VBD been_VBN earlier_JJR statements_NNS by_IN the_DT U._NNP Forty_CD years_NNS ago_RB ,_, the_DT release_NN of_IN the_DT Surgeon_NNP General_NNP 's_POS report_NN on_IN Smoking_NNP and_CC Health_NNP marked_VBD a_DT turning_NN point_NN in_IN scientific_JJ and_CC public_JJ health_NN efforts_NNS to_TO address_VB the_DT consequences_NNS of_IN tobacco_NN use_NN for_IN human_JJ health_NN 
Additionally_RB ,_, this_DT particular_JJ example_NN allows_VBZ us_PRP to_TO focus_VB on_IN the_DT process_NN of_IN causal_JJ inference_NN because_IN ,_, while_IN judgments_NNS about_IN the_DT relationship_NN between_IN smoking_NN and_CC these_DT four_CD cancers_NNS changed_VBN over_IN time_NN ,_, each_DT of_IN these_DT cancers_NNS has_VBZ since_IN been_VBN clearly_RB linked_VBN to_TO smoking_NN 
''_'' The_DT fact_NN that_IN more_JJR could_MD be_VB learned_VBN did_VBD not_RB preclude_VB making_VBG judgments_NNS ,_, and_CC if_IN it_PRP were_VBD not_RB for_IN the_DT power_NN of_IN tobacco_NN and_CC the_DT tobacco_NN industry_NN ,_, the_DT evidence_NN ``_`` would_MD be_VB generally_RB be_VB regarded_VBN as_IN beyond_IN dispute_NN ._. ''_'' 
S._NNP There_RB had_VBD been_VBN earlier_JJR statements_NNS by_IN the_DT U._NNP Forty_CD years_NNS ago_RB ,_, the_DT release_NN of_IN the_DT Surgeon_NNP General_NNP 's_POS report_NN on_IN Smoking_NNP and_CC Health_NNP marked_VBD a_DT turning_NN point_NN in_IN scientific_JJ and_CC public_JJ health_NN efforts_NNS to_TO address_VB the_DT consequences_NNS of_IN tobacco_NN use_NN for_IN human_JJ health_NN 
Additionally_RB ,_, this_DT particular_JJ example_NN allows_VBZ us_PRP to_TO focus_VB on_IN the_DT process_NN of_IN causal_JJ inference_NN because_IN ,_, while_IN judgments_NNS about_IN the_DT relationship_NN between_IN smoking_NN and_CC these_DT four_CD cancers_NNS changed_VBN over_IN time_NN ,_, each_DT of_IN these_DT cancers_NNS has_VBZ since_IN been_VBN clearly_RB linked_VBN to_TO smoking_NN 
''_'' 
While_IN the_DT discipline_NN of_IN epidemiology_NN has_VBZ developed_VBN new_JJ quantitative_JJ methods_NNS and_CC research_NN tools_NNS in_IN recent_JJ decades_NNS ,_, the_DT application_NN of_IN the_DT causal_JJ criteria_NNS today_NN has_VBZ been_VBN shaped_VBN substantially_RB by_IN their_PRP$ early_JJ use_NN in_IN evaluating_VBG the_DT evidence_NN on_IN smoking_NN and_CC health_NN ._. 
However_RB ,_, while_IN there_EX has_VBZ been_VBN considerable_JJ theoretical_JJ discussion_NN of_IN causal_JJ inference_NN among_IN epidemiologists_NNS over_IN the_DT years_NNS ,_, there_EX has_VBZ been_VBN little_JJ effort_NN to_TO study_VB how_WRB these_DT criteria_NNS have_VBP been_VBN actually_RB applied_VBN in_IN practice_NN ._. 
The_DT most_RBS recent_JJ Surgeon_NNP General_NNP 's_POS report_NN on_IN the_DT health_NN consequences_NNS of_IN smoking_NN devotes_VBZ an_DT entire_JJ chapter_NN to_TO the_DT changing_VBG causal_JJ language_NN and_CC conclusions_NNS across_IN the_DT reports_NNS ,_, but_CC the_DT chapter_NN does_VBZ not_RB include_VB empirical_JJ analysis_NN of_IN why_WRB those_DT conclusions_NNS changed_VBD -LRB-_-LRB- i._SYM 
what_WP were_VBD the_DT key_JJ factors_NNS in_IN the_DT evidence_NN that_WDT supported_VBD new_JJ ,_, stronger_JJR causal_JJ conclusions_NNS ._. 
e._IN The_DT most_RBS recent_JJ Surgeon_NNP General_NNP 's_POS report_NN on_IN the_DT health_NN consequences_NNS of_IN smoking_NN devotes_VBZ an_DT entire_JJ chapter_NN to_TO the_DT changing_VBG causal_JJ language_NN and_CC conclusions_NNS across_IN the_DT reports_NNS ,_, but_CC the_DT chapter_NN does_VBZ not_RB include_VB empirical_JJ analysis_NN of_IN why_WRB those_DT conclusions_NNS changed_VBD -LRB-_-LRB- i._NN -RRB-_-RRB- ._. 
In_IN order_NN to_TO observe_VB and_CC understand_VB how_WRB the_DT causal_JJ criteria_NNS were_VBD applied_VBN to_TO diverse_JJ bodies_NNS of_IN evidence_NN over_IN time_NN ,_, we_PRP conducted_VBD a_DT case_NN study_NN of_IN the_DT use_NN of_IN causal_JJ criteria_NNS in_IN two_CD reports_NNS of_IN the_DT Surgeon_NNP General_NNP on_IN smoking_NN and_CC health_NN ,_, from_IN 1964_CD and_CC 1982_CD ._. 
Verbal_JJ autopsy_NN The_DT VA_NNP methodology_NN has_VBZ been_VBN used_VBN for_IN demographic_JJ surveillance_NN and_CC in_IN research_NN settings_NNS to_TO estimate_VB cause-of-death_JJ -LRB-_-LRB- COD_NNP -RRB-_-RRB- structures_NNS for_IN decades_NNS ._. 
The_DT components_NNS of_IN the_DT tool_NN and_CC its_PRP$ application_NN are_VBP discussed_VBN in_IN detail_NN in_IN other_JJ papers_NNS ._. 
Experience_NN with_IN VA_NNP in_IN emergencies_NNS is_VBZ scarce_JJ ,_, and_CC there_EX are_VBP insufficient_JJ data_NNS to_TO inform_VB about_IN its_PRP$ usefulness_NN in_IN natural_JJ or_CC man-made_JJ catastrophes_NNS ._. 
In_IN crisis_NN situations_NNS ,_, families_NNS often_RB experience_VBP sudden_JJ ,_, unexpected_JJ and_CC very_RB recent_JJ losses_NNS ;_: these_DT require_VBP interviewers_NNS trained_VBN in_IN bereavement_NN techniques_NNS and_CC in_IN psychological_JJ counselling_NN ._. 
Well-trained_JJ lay_VBN interviewers_NNS could_MD return_VB to_TO the_DT household_NN in_IN which_WDT a_DT death_NN was_VBD noted_VBN during_IN the_DT survey_NN ;_: a_DT similar_JJ procedure_NN is_VBZ currently_RB used_VBN at_IN many_JJ demographic_JJ surveillance_NN sites_NNS in_IN low-income_JJ countries_NNS ._. 
Another_DT possibility_NN is_VBZ to_TO set_VB up_RP a_DT focus_NN group_NN at_IN the_DT survey_NN site_NN ,_, using_VBG a_DT VA-type_JJ process_NN to_TO elucidate_VB the_DT major_JJ causes_NNS of_IN death_NN in_IN advance_NN of_IN the_DT survey_NN ._. 
The_DT VA_NNP can_MD be_VB a_DT painful_JJ process_NN for_IN bereaved_JJ relatives_NNS ._. 
Additionally_RB ,_, it_PRP is_VBZ a_DT cost_NN -_: and_CC time-intensive_JJ process_NN to_TO derive_VB the_DT COD_NNP from_IN the_DT questionnaires_NNS because_IN medical_JJ doctors_NNS or_CC medically_RB trained_JJ personnel_NNS need_VBP to_TO review_VB each_DT form_NN in_IN order_NN to_TO assign_VB diagnoses_NNS ._. 
For_IN psychological_JJ and_CC ethical_JJ reasons_NNS ,_, it_PRP may_MD not_RB be_VB possible_JJ to_TO perform_VB the_DT interview_NN in_IN a_DT few_JJ minutes_NNS ,_, even_RB if_IN the_DT tool_NN would_MD permit_VB this_DT ._. 
In_IN crisis_NN situations_NNS ,_, families_NNS often_RB experience_VBP sudden_JJ ,_, unexpected_JJ and_CC very_RB recent_JJ losses_NNS ;_: these_DT require_VBP interviewers_NNS trained_VBN in_IN bereavement_NN techniques_NNS and_CC in_IN psychological_JJ counselling_NN ._. 
For_IN non-VC_JJ surveys_NNS ,_, a_DT sample_NN size_NN of_IN 900_CD tends_VBZ to_TO be_VB used_VBN -LRB-_-LRB- 30_CD clusters_NNS of_IN 30_CD households_NNS or_CC children_NNS ,_, depending_VBG on_IN the_DT variable_JJ being_VBG measured_VBN -RRB-_-RRB- ._. 
Despite_IN recommendations_NNS to_TO improve_VB and_CC adapt_VB second_JJ stage_NN sampling_NN for_IN non-EPI_JJ purposes_NNS ,_, over_IN time_NN it_PRP has_VBZ become_VBN common_JJ practice_NN to_TO apply_VB this_DT survey_NN method_NN without_IN questioning_VBG its_PRP$ appropriateness_NN for_IN the_DT outcome_NN being_VBG measured_VBN ._. 
The_DT main_JJ problem_NN with_IN the_DT random_JJ walk_NN approach_NN followed_VBN by_IN proximity_NN sampling_NN is_VBZ that_IN the_DT probability_NN of_IN a_DT household_NN being_VBG selected_VBN is_VBZ unknown_JJ ,_, since_IN the_DT total_JJ number_NN of_IN households_NNS in_IN the_DT community_NN is_VBZ unknown_JJ ._. 
The_DT defined_VBN area_NN to_TO which_WDT the_DT cluster_NN has_VBZ been_VBN allocated_VBN is_VBZ further_RBR divided_VBN into_IN segments_NNS of_IN approximately_RB equal_JJ size_NN ,_, at_IN a_DT level_NN at_IN which_WDT a_DT complete_JJ listing_NN of_IN households_NNS in_IN the_DT segment_NN can_MD be_VB made_VBN ._. 
One_CD segment_NN is_VBZ then_RB selected_VBN randomly_RB ,_, and_CC all_DT households_NNS within_IN it_PRP may_MD then_RB be_VB selected_VBN or_CC ,_, alternatively_RB ,_, the_DT desired_VBN number_NN of_IN households_NNS to_TO make_VB up_RP a_DT cluster_NN may_MD be_VB selected_VBN using_VBG simple_JJ or_CC systematic_JJ sampling_NN ._. 
However_RB ,_, segmentation_NN is_VBZ not_RB always_RB possible_JJ due_JJ to_TO time_NN ,_, security_NN and_CC human_JJ resource_NN constraints_NNS ._. 
In_IN 1978_CD ,_, the_DT World_NNP Health_NNP Organization_NNP 's_POS Expanded_NNP Programme_NNP on_IN Immunization_NNP -LRB-_-LRB- WHO_WP EPI_NNP -RRB-_-RRB- adopted_VBD the_DT ``_`` 30_CD by_IN 7_CD ''_'' two-stage_JJ cluster_NN sample_NN survey_NN design_NN for_IN rapidly_RB estimating_VBG vaccine_NN coverage_NN -LRB-_-LRB- VC_NNP -RRB-_-RRB- in_IN children_NNS aged_VBN 12_CD to_TO 23_CD months_NNS ._. 
Manuals_NNS an_DT 
Briefly_RB ,_, the_DT WHO_WP EPI_NNP ``_`` random_JJ walk_NN ''_'' approach_NN for_IN household_NN selection_NN involves_VBZ choosing_VBG a_DT random_JJ direction_NN from_IN the_DT center_NN of_IN the_DT community_NN and_CC then_RB selection_NN of_IN one_CD household_NN at_IN random_JJ along_IN an_DT imaginary_JJ line_NN connecting_VBG the_DT center_NN to_TO the_DT periphery_NN ._. 
Subsequent_JJ households_NNS are_VBP then_RB selected_VBN by_IN proximity_NN -LRB-_-LRB- the_DT next_JJ nearest_JJS household_NN -RRB-_-RRB- or_CC visiting_VBG every_DT Nth_NNP closest_JJS household_NN until_IN the_DT sample_NN size_NN for_IN the_DT cluster_NN is_VBZ achieved_VBN 
In_IN 1978_CD ,_, the_DT World_NNP Health_NNP Organization_NNP 's_POS Expanded_NNP Programme_NNP on_IN Immunization_NNP -LRB-_-LRB- WHO_WP EPI_NNP -RRB-_-RRB- adopted_VBD the_DT ``_`` 30_CD by_IN 7_CD ''_'' two-stage_JJ cluster_NN sample_NN survey_NN design_NN for_IN rapidly_RB estimating_VBG vaccine_NN coverage_NN -LRB-_-LRB- VC_NNP -RRB-_-RRB- in_IN children_NNS aged_VBN 12_CD to_TO 23_CD months_NNS 
We_PRP focus_VBP here_RB on_IN one_CD approach_NN for_IN household_NN selection_NN that_WDT has_VBZ led_VBN to_TO much_JJ discussion_NN ._. 
The_DT final_JJ stage_NN of_IN sampling_NN consists_VBZ of_IN selecting_VBG a_DT given_VBN number_NN of_IN basic_JJ sampling_NN units_NNS -LRB-_-LRB- in_IN mortality_NN surveys_NNS ,_, these_DT are_VBP usually_RB households_NNS -RRB-_-RRB- within_IN a_DT cluster_NN ._. 
In_IN 1978_CD ,_, the_DT World_NNP Health_NNP Organization_NNP 's_POS Expanded_NNP Programme_NNP on_IN Immunization_NNP -LRB-_-LRB- WHO_WP EPI_NNP -RRB-_-RRB- adopted_VBD the_DT ``_`` 30_CD by_IN 7_CD ''_'' two-stage_JJ cluster_NN sample_NN survey_NN design_NN for_IN rapidly_RB estimating_VBG vaccine_NN coverage_NN -LRB-_-LRB- VC_NNP -RRB-_-RRB- in_IN children_NNS aged_VBN 12_CD to_TO 23_CD months_NNS 
In_IN 1978_CD ,_, the_DT World_NNP Health_NNP Organization_NNP 's_POS Expanded_NNP Programme_NNP on_IN Immunization_NNP -LRB-_-LRB- WHO_WP EPI_NNP -RRB-_-RRB- adopted_VBD the_DT ``_`` 30_CD by_IN 7_CD ''_'' two-stage_JJ cluster_NN sample_NN survey_NN design_NN for_IN rapidly_RB estimating_VBG vaccine_NN coverage_NN -LRB-_-LRB- VC_NNP -RRB-_-RRB- in_IN children_NNS aged_VBN 12_CD to_TO 23_CD months_NNS 
In_IN 1978_CD ,_, the_DT World_NNP Health_NNP Organization_NNP 's_POS Expanded_NNP Programme_NNP on_IN Immunization_NNP -LRB-_-LRB- WHO_WP EPI_NNP -RRB-_-RRB- adopted_VBD the_DT ``_`` 30_CD by_IN 7_CD ''_'' two-stage_JJ cluster_NN sample_NN survey_NN design_NN for_IN rapidly_RB estimating_VBG vaccine_NN coverage_NN -LRB-_-LRB- VC_NNP -RRB-_-RRB- in_IN children_NNS aged_VBN 12_CD to_TO 23_CD months_NNS 
Different_JJ methods_NNS of_IN eliciting_VBG this_DT information_NN have_VBP been_VBN applied_VBN ,_, and_CC are_VBP reviewed_VBN below_IN as_RB well_RB as_IN by_IN Woodruff_NNP ._. 
The_DT recall_NN period_NN is_VBZ discussed_VBN in_IN further_JJ detail_NN in_IN the_DT World_NNP Food_NNP Programme_NNP -LRB-_-LRB- WFP_NNP -RRB-_-RRB- 's_POS latest_JJS manual_NN 
The_DT hybrid_JJ method_NN is_VBZ a_DT combination_NN of_IN these_DT methods_NNS attempting_VBG to_TO account_VB for_IN both_DT in_IN -_: and_CC out-migration_NN ._. 
It_PRP is_VBZ described_VBN in_IN the_DT Standardised_JJ Monitoring_NN and_CC Assessment_NNP of_IN Relief_NNP and_CC Transitions_NNP -LRB-_-LRB- SMART_NNP -RRB-_-RRB- and_CC WFP_NNP manuals_NNS 
The_DT method_NN includes_VBZ questions_NNS about_IN those_DT who_WP have_VBP been_VBN born_VBN since_IN the_DT start_NN of_IN the_DT recall_NN period_NN and_CC those_DT who_WP have_VBP out-migrated_VBN during_IN the_DT recall_NN period_NN ._. 
In-migrants_NNS are_VBP not_RB usually_RB included_VBN ._. 
The_DT denominator_NN is_VBZ calculated_VBN as_IN the_DT total_JJ number_NN in_IN the_DT household_NN at_IN the_DT start_NN of_IN the_DT recall_NN period_NN ,_, plus_CC half_NN of_IN the_DT newborns_NNS ,_, minus_NN half_NN of_IN the_DT deaths_NNS and_CC out-migrants_NNS ,_, multiplied_VBN by_IN the_DT recall_NN period_NN ._. 
The_DT hybrid_JJ method_NN is_VBZ a_DT combination_NN of_IN these_DT methods_NNS attempting_VBG to_TO account_VB for_IN both_DT in_IN -_: and_CC out-migration_NN ._. 
It_PRP is_VBZ described_VBN in_IN the_DT Standardised_JJ Monitoring_NN and_CC Assessment_NNP of_IN Relief_NNP and_CC Transitions_NNP -LRB-_-LRB- SMART_NNP -RRB-_-RRB- and_CC WFP_NNP manuals_NNS 
The_DT validity_NN of_IN such_JJ household_NN reports_NNS is_VBZ unknown_JJ ._. 
Generally_RB ,_, investigators_NNS ask_VBP decedents_NNS '_POS next-of-kin_NN about_IN the_DT most_RBS likely_JJ cause_NN of_IN death_NN and_CC record_VB the_DT answer_NN openly_RB or_CC assign_VB it_PRP to_TO a_DT pre-defined_JJ list_NN of_IN diseases_NNS or_CC signs_NNS and_CC symptoms_NNS ,_, which_WDT are_VBP sometimes_RB based_VBN on_IN local_JJ disease_NN terms_NNS or_CC informal_JJ qualitative_JJ investigation_NN ._. 
Recognising_VBG this_DT ,_, the_DT SMART_NNP protocol_NN recommends_VBZ classifying_VBG causes_NNS of_IN death_NN more_RBR conservatively_RB ,_, into_IN ``_`` violent_JJ ''_'' and_CC ``_`` other_JJ ''_'' 
Conclusion_NN Mortality_NN surveys_NNS have_VBP an_DT increasing_VBG impact_NN on_IN the_DT allocation_NN of_IN humanitarian_JJ relief_NN and_CC on_IN shaping_VBG international_JJ public_JJ opinion_NN and_CC government_NN response_NN to_TO major_JJ humanitarian_JJ crises_NNS ._. 
Recent_JJ years_NNS have_VBP seen_VBN more_RBR region-wide_JJ and_CC complex_JJ survey_NN efforts_NNS ,_, sometimes_RB resulting_VBG in_IN controversial_JJ and_CC disputed_JJ estimates_NNS ._. 
We_PRP examined_VBD several_JJ methodological_JJ problems_NNS and_CC outstanding_JJ issues_NNS with_IN retrospective_JJ mortality_NN estimation_NN in_IN humanitarian_JJ crises_NNS ._. 
The_DT ICC_NNP depends_VBZ on_IN the_DT variance_NN within_IN and_CC between_IN clusters_NNS ,_, the_DT actual_JJ frequency_NN of_IN the_DT outcome_NN being_VBG measured_VBN ,_, the_DT cluster_NN size_NN 
With_IN implicit_JJ stratification_NN the_DT sampling_VBG frame_NN of_IN PSUs_NNP is_VBZ ranked_VBN according_VBG to_TO this_DT continuous_JJ stratification_NN variable_JJ ._. 
The_DT data_NNS are_VBP analyzed_VBN after_IN applying_VBG Kish_NNP 's_POS method_NN of_IN paired_VBN clusters_NNS to_TO define_VB the_DT `_`` implicit_JJ '_'' strata_NN ._. 
By_IN pairing_VBG the_DT clusters_NNS the_DT maximum_JJ number_NN of_IN strata_NN of_IN minimum_JJ size_NN is_VBZ created_VBN ._. 
Each_DT cluster_NN in_IN the_DT pair_NN will_MD therefore_RB be_VB very_RB similar_JJ with_IN regard_NN to_TO the_DT variable_NN selected_VBN ._. 
Note_NN :_: The_DT ICC_NNP can_MD be_VB used_VBN to_TO calculate_VB Deff_NNP for_IN different_JJ numbers_NNS of_IN individuals_NNS per_IN cluster_NN -LRB-_-LRB- m_NN -RRB-_-RRB- using_VBG the_DT following_JJ formula_NN :_: ICC_NNP =_SYM -LRB-_-LRB- Deff_NNP -1_CD -RRB-_-RRB- \/_NN -LRB-_-LRB- m_SYM -_: 1_CD -RRB-_-RRB- ._. 
There_EX is_VBZ little_RB published_VBN research_NN from_IN mortality_NN studies_NNS on_IN observed_JJ Deff_NNP and_CC ICC_NNP to_TO provide_VB accessible_JJ guidance_NN for_IN non-statisticians_NNS in_IN the_DT context_NN of_IN humanitarian_JJ emergencies_NNS ._. 
We_PRP recommend_VBP that_IN ,_, before_IN any_DT cluster_NN survey_NN ,_, investigators_NNS perform_VBP a_DT literature_NN search_NN for_IN past_JJ reports_NNS providing_VBG Deff_NNP or_CC ICC_NNP within_IN the_DT population_NN to_TO be_VB studied_VBN ,_, so_RB as_IN to_TO inform_VB sample_NN size_NN calculations_NNS ._. 
For_IN a_DT given_VBN number_NN of_IN clusters_NNS ,_, increasing_VBG the_DT number_NN of_IN households_NNS sampled_VBN per_IN cluster_NN will_MD improve_VB precision_NN ,_, although_IN this_DT may_MD be_VB counteracted_VBN by_IN an_DT increase_NN in_IN Deff_NNP ._. 
An_DT alternative_JJ approach_NN for_IN improving_VBG precision_NN is_VBZ to_TO increase_VB the_DT number_NN of_IN clusters_NNS ,_, as_IN demonstrated_VBN in_IN a_DT recent_JJ review_NN of_IN earlier_JJR cluster_NN surveys_NNS ._. 
However_RB ,_, the_DT extra_JJ resources_NNS needed_VBN for_IN this_DT approach_NN -LRB-_-LRB- time_NN ,_, more_JJR survey_NN teams_NNS and_CC so_RB on_IN -RRB-_-RRB- should_MD be_VB considered_VBN when_WRB making_VBG the_DT decision_NN between_IN increasing_VBG cluster_NN size_NN and_CC selecting_VBG more_JJR clusters_NNS ._. 
This_DT causes_VBZ some_DT loss_NN in_IN precision_NN ._. 
In_IN the_DT latter_JJ two_CD cases_NNS ,_, weighting_NN is_VBZ needed_VBN in_IN order_NN to_TO obtain_VB an_DT arithmetically_RB correct_JJ pooled_VBN estimate_NN ._. 
Implicit_JJ stratification_NN can_MD also_RB be_VB used_VBN to_TO increase_VB precision_NN ,_, and_CC is_VBZ a_DT preferable_JJ alternative_NN to_TO explicit_JJ stratification_NN when_WRB a_DT continuous_JJ variable_NN is_VBZ known_VBN or_CC thought_VBN to_TO be_VB associated_VBN with_IN the_DT outcome_NN ._. 
With_IN implicit_JJ stratification_NN the_DT sampling_VBG frame_NN of_IN PSUs_NNP is_VBZ ranked_VBN according_VBG to_TO this_DT continuous_JJ stratification_NN variable_JJ ._. 
Ascertainment_NN of_IN events_NNS and_CC person-time_JJ denominator_NN The_DT number_NN of_IN people_NNS living_VBG in_IN all_DT surveyed_VBN households_NNS and_CC the_DT amount_NN of_IN time_NN each_DT of_IN them_PRP spent_VBD in_IN the_DT sampling_NN universe_NN during_IN the_DT recall_NN period_NN comprise_VBP the_DT basic_JJ denominator_NN for_IN computing_NN mortality_NN rates_NNS ._. 
Different_JJ methods_NNS of_IN eliciting_VBG this_DT information_NN have_VBP been_VBN applied_VBN ,_, and_CC are_VBP reviewed_VBN below_IN as_RB well_RB as_IN by_IN Woodruff_NNP ._. 
The_DT recall_NN period_NN is_VBZ discussed_VBN in_IN further_JJ detail_NN in_IN the_DT World_NNP Food_NNP Programme_NNP -LRB-_-LRB- WFP_NNP -RRB-_-RRB- 's_POS latest_JJS manual_NN 
For_IN example_NN ,_, for_IN sites_NNS with_IN an_DT existing_VBG map_NN ,_, a_DT ``_`` sampling_NN grid_NN ''_'' can_MD be_VB superimposed_VBN and_CC co-ordinates_NNS selected_VBN at_IN random_JJ 
1._CD 
2._CD 
Clustering_VBG of_IN risk_NN of_IN death_NN 1_CD ._. 
2._CD 
1._CD 
This_DT would_MD result_VB in_IN greater_JJR geographical_JJ spread_NN ,_, thus_RB decreasing_VBG clustering_NN -LRB-_-LRB- see_VB below_IN -RRB-_-RRB- and_CC favoring_VBG randomness_NN ._. 
Why_WRB clustering_VBG occursRisk_NNP of_IN death_NN may_MD be_VB clustered_VBN ,_, a_DT phenomenon_NN that_WDT is_VBZ probably_RB more_RBR pronounced_JJ in_IN emergencies_NNS ;_: particular_JJ villages_NNS may_MD suffer_VB disproportionate_JJ violent_JJ attacks_NNS ,_, be_VB different_JJ in_IN terms_NNS of_IN access_NN to_TO healthcare_NN ,_, or_CC differ_VBP in_IN certain_JJ epidemic-prone_JJ diseases_NNS like_IN measles_NNS ,_, which_WDT may_MD spread_VB from_IN index_NN cases_NNS to_TO neighbors_NNS and_CC close_JJ contacts_NNS ._. 
Thus_RB ,_, there_EX is_VBZ an_DT increased_VBN probability_NN that_IN individuals_NNS within_IN clusters_NNS will_MD resemble_VB each_DT other_JJ -LRB-_-LRB- i._SYM 
1._CD 
2._CD 
Clustering_VBG of_IN risk_NN of_IN death_NN 1_CD ._. 
2._CD 
1._CD 
This_DT would_MD result_VB in_IN greater_JJR geographical_JJ spread_NN ,_, thus_RB decreasing_VBG clustering_NN -LRB-_-LRB- see_VB below_IN -RRB-_-RRB- and_CC favoring_VBG randomness_NN ._. 
Why_WRB clustering_VBG occursRisk_NNP of_IN death_NN may_MD be_VB clustered_VBN ,_, a_DT phenomenon_NN that_WDT is_VBZ probably_RB more_RBR pronounced_JJ in_IN emergencies_NNS ;_: particular_JJ villages_NNS may_MD suffer_VB disproportionate_JJ violent_JJ attacks_NNS ,_, be_VB different_JJ in_IN terms_NNS of_IN access_NN to_TO healthcare_NN ,_, or_CC differ_VBP in_IN certain_JJ epidemic-prone_JJ diseases_NNS like_IN measles_NNS ,_, which_WDT may_MD spread_VB from_IN index_NN cases_NNS to_TO neighbors_NNS and_CC close_JJ contacts_NNS ._. 
Thus_RB ,_, there_EX is_VBZ an_DT increased_VBN probability_NN that_IN individuals_NNS within_IN clusters_NNS will_MD resemble_VB each_DT other_JJ -LRB-_-LRB- i._SYM 
The_DT ICC_NNP indicates_VBZ the_DT likelihood_NN of_IN individuals_NNS within_IN the_DT same_JJ cluster_NN sharing_VBG the_DT same_JJ outcome_NN -LRB-_-LRB- an_DT ICC_NNP of_IN 1_CD means_VBZ total_JJ clustering_NN ,_, and_CC an_DT ICC_NNP of_IN zero_CD means_NNS no_DT clustering_NN -RRB-_-RRB- ._. 
The_DT ICC_NNP depends_VBZ on_IN the_DT variance_NN within_IN and_CC between_IN clusters_NNS ,_, the_DT actual_JJ frequency_NN of_IN the_DT outcome_NN being_VBG measured_VBN ,_, the_DT cluster_NN size_NN 
Conclusion_NN Mortality_NN surveys_NNS have_VBP an_DT increasing_VBG impact_NN on_IN the_DT allocation_NN of_IN humanitarian_JJ relief_NN and_CC on_IN shaping_VBG international_JJ public_JJ opinion_NN and_CC government_NN response_NN to_TO major_JJ humanitarian_JJ crises_NNS ._. 
Recent_JJ years_NNS have_VBP seen_VBN more_RBR region-wide_JJ and_CC complex_JJ survey_NN efforts_NNS ,_, sometimes_RB resulting_VBG in_IN controversial_JJ and_CC disputed_JJ estimates_NNS ._. 
We_PRP examined_VBD several_JJ methodological_JJ problems_NNS and_CC outstanding_JJ issues_NNS with_IN retrospective_JJ mortality_NN estimation_NN in_IN humanitarian_JJ crises_NNS ._. 
Recognising_VBG this_DT ,_, the_DT SMART_NNP protocol_NN recommends_VBZ classifying_VBG causes_NNS of_IN death_NN more_RBR conservatively_RB ,_, into_IN ``_`` violent_JJ ''_'' and_CC ``_`` other_JJ ''_'' ._. 
The_DT verbal_JJ autopsy_NN -LRB-_-LRB- VA_NNP -RRB-_-RRB- literature_NN shows_VBZ that_IN the_DT sensitivity_NN and_CC specificity_NN of_IN the_DT tool_NN for_IN broad_JJ categories_NNS are_VBP much_RB higher_JJR than_IN for_IN the_DT more_RBR detailed_JJ level_NN 
Verbal_JJ autopsy_NN The_DT VA_NNP methodology_NN has_VBZ been_VBN used_VBN for_IN demographic_JJ surveillance_NN and_CC in_IN research_NN settings_NNS to_TO estimate_VB cause-of-death_JJ -LRB-_-LRB- COD_NNP -RRB-_-RRB- structures_NNS for_IN decades_NNS ._. 
The_DT components_NNS of_IN the_DT tool_NN and_CC its_PRP$ application_NN are_VBP discussed_VBN in_IN detail_NN in_IN other_JJ papers_NNS ._. 
Experience_NN with_IN VA_NNP in_IN emergencies_NNS is_VBZ scarce_JJ ,_, and_CC there_EX are_VBP insufficient_JJ data_NNS to_TO inform_VB about_IN its_PRP$ usefulness_NN in_IN natural_JJ or_CC man-made_JJ catastrophes_NNS ._. 
Calculation_NN of_IN person-time_NN at_IN risk_NN If_IN the_DT approximate_JJ dates_NNS can_MD reliably_RB be_VB established_VBN ,_, each_DT individual_NN 's_POS person-time_NN may_MD be_VB computed_VBN ._. 
This_DT provides_VBZ a_DT more_RBR accurate_JJ denominator_NN ,_, especially_RB when_WRB populations_NNS vary_VBP non-linearly_JJ during_IN the_DT recall_NN period_NN ._. 
The_DT related_JJ indicator_NN of_IN mortality_NN would_MD then_RB be_VB a_DT real_JJ rate_NN showing_VBG death_NN occurrence_NN per_IN unit_NN of_IN person-time_NN for_IN a_DT specific_JJ population_NN size_NN -LRB-_-LRB- e._SYM 
The_DT random_JJ walk_NN method_NN -LRB-_-LRB- as_RB well_RB as_IN alternative_JJ final_JJ stage_NN sampling_NN methods_NNS such_JJ as_IN use_NN of_IN a_DT sampling_NN grid_NN and_CC random_JJ GPS_NNP point_NN selection_NN -RRB-_-RRB- needs_VBZ to_TO be_VB compared_VBN with_IN the_DT gold_JJ standard_NN of_IN listing_VBG all_DT basic_JJ sampling_VBG units_NNS and_CC then_RB selecting_VBG the_DT required_JJ number_NN using_VBG simple_JJ random_JJ sampling_NN ._. 
Other_JJ alternative_JJ methods_NNS such_JJ as_IN the_DT exhaustive_JJ case-finding_JJ approach_NN should_MD also_RB be_VB fully_RB investigated_VBN ._. 
Studies_NNS are_VBP needed_VBN which_WDT will_MD compare_VB ,_, using_VBG the_DT same_JJ survey_NN method_NN on_IN the_DT same_JJ population_NN ,_, estimates_NNS of_IN mortality_NN obtained_VBD using_VBG past_JJ ,_, current_JJ and_CC hybrid_JJ household_NN census_NN methods_NNS with_IN prior_JJ birth_NN history_NN methods_NNS ._. 
number_NN of_IN deaths_NNS per_IN 10_CD 000_CD person-days_NNS -RRB-_-RRB- ._. 
g._IN The_DT related_JJ indicator_NN of_IN mortality_NN would_MD then_RB be_VB a_DT real_JJ rate_NN showing_VBG death_NN occurrence_NN per_IN unit_NN of_IN person-time_NN for_IN a_DT specific_JJ population_NN size_NN -LRB-_-LRB- e._FW Whilst_FW most_JJS populations_NNS are_VBP more_RBR or_CC less_RBR static_JJ cohorts_NNS without_IN much_RB in_IN -_: or_CC out-migration_NN ,_, others_NNS undergo_VBP massive_JJ fragmentation_NN and_CC displacement_NN during_IN the_DT recall_NN period_NN 
number_NN of_IN deaths_NNS per_IN 10_CD 000_CD person-days_NNS -RRB-_-RRB- ._. 
g._IN The_DT related_JJ indicator_NN of_IN mortality_NN would_MD then_RB be_VB a_DT real_JJ rate_NN showing_VBG death_NN occurrence_NN per_IN unit_NN of_IN person-time_NN for_IN a_DT specific_JJ population_NN size_NN -LRB-_-LRB- e._FW Whilst_FW most_JJS populations_NNS are_VBP more_RBR or_CC less_RBR static_JJ cohorts_NNS without_IN much_RB in_IN -_: or_CC out-migration_NN ,_, others_NNS undergo_VBP massive_JJ fragmentation_NN and_CC displacement_NN during_IN the_DT recall_NN period_NN 
Adisadvantage_NNP of_IN this_DT method_NN is_VBZ that_IN orphans_NNS are_VBP missed_VBN ,_, and_CC mortality_NN may_MD thereby_RB be_VB underestimated_VBN ._. 
Underestimation_NNP may_MD also_RB be_VB a_DT problem_NN in_IN situations_NNS of_IN very_RB high_JJ maternal_NN and_CC child_NN mortality_NN ._. 
An_DT advantage_NN ,_, however_RB ,_, is_VBZ that_IN both_DT under_IN 5_CD mortality_NN during_IN the_DT recall_NN period_NN and_CC that_IN over_IN a_DT 5-year_JJ period_NN can_MD be_VB computed_VBN ._. 
2._CD 
2._CD 
2._CD 
Alocal_JJ events_NNS calendar_NN is_VBZ needed_VBN if_IN accurate_JJ dates_NNS are_VBP either_DT unknown_NN or_CC can_MD not_RB be_VB approximated_VBN by_IN household_NN respondents_NNS ._. 
Age_NNP standardisation_NN and_CC presentation_NN of_IN age_NN pyramidsAge-standardised_JJ rates_NNS are_VBP more_RBR informative_JJ than_IN crude_JJ mortality_NN rates_NNS ,_, and_CC can_MD be_VB computed_VBN using_VBG the_DT WHO_WP standard_NN ._. 
Whether_NNP or_CC not_RB mortality_NN rates_NNS are_VBP age-standardised_JJ ,_, it_PRP is_VBZ important_JJ to_TO illustrate_VB the_DT sampled_VBN population_NN 's_POS age_NN structure_NN using_VBG age_NN pyramids_NNS ._. 
Adisadvantage_NNP of_IN this_DT method_NN is_VBZ that_IN orphans_NNS are_VBP missed_VBN ,_, and_CC mortality_NN may_MD thereby_RB be_VB underestimated_VBN ._. 
Underestimation_NNP may_MD also_RB be_VB a_DT problem_NN in_IN situations_NNS of_IN very_RB high_JJ maternal_NN and_CC child_NN mortality_NN ._. 
An_DT advantage_NN ,_, however_RB ,_, is_VBZ that_IN both_DT under_IN 5_CD mortality_NN during_IN the_DT recall_NN period_NN and_CC that_IN over_IN a_DT 5-year_JJ period_NN can_MD be_VB computed_VBN ._. 
4._CD 
1._CD 
2._CD 
It_PRP is_VBZ described_VBN in_IN the_DT Standardised_JJ Monitoring_NN and_CC Assessment_NNP of_IN Relief_NNP and_CC Transitions_NNP -LRB-_-LRB- SMART_NNP -RRB-_-RRB- and_CC WFP_NNP manuals_NNS 
For_IN example_NN ,_, for_IN sites_NNS with_IN an_DT existing_VBG map_NN ,_, a_DT ``_`` sampling_NN grid_NN ''_'' can_MD be_VB superimposed_VBN and_CC co-ordinates_NNS selected_VBN at_IN random_JJ ._. 
Similarly_RB ,_, GPS_NNP units_NNS can_MD be_VB used_VBN to_TO establish_VB the_DT boundary_NN of_IN the_DT cluste_NN 
Other_JJ methods_NNS exist_VBP for_IN selection_NN of_IN the_DT first_JJ household_NN in_IN the_DT cluster_NN ._. 
However_RB ,_, segmentation_NN is_VBZ not_RB always_RB possible_JJ due_JJ to_TO time_NN ,_, security_NN and_CC human_JJ resource_NN constraints_NNS ._. 
For_IN example_NN ,_, for_IN sites_NNS with_IN an_DT existing_VBG map_NN ,_, a_DT ``_`` sampling_NN grid_NN ''_'' can_MD be_VB superimposed_VBN and_CC co-ordinates_NNS selected_VBN at_IN random_JJ 
For_IN non-VC_JJ surveys_NNS ,_, a_DT sample_NN size_NN of_IN 900_CD tends_VBZ to_TO be_VB used_VBN -LRB-_-LRB- 30_CD clusters_NNS of_IN 30_CD households_NNS or_CC children_NNS ,_, depending_VBG on_IN the_DT variable_JJ being_VBG measured_VBN -RRB-_-RRB- ._. 
Despite_IN recommendations_NNS to_TO improve_VB and_CC adapt_VB second_JJ stage_NN sampling_NN for_IN non-EPI_JJ purposes_NNS ,_, over_IN time_NN it_PRP has_VBZ become_VBN common_JJ practice_NN to_TO apply_VB this_DT survey_NN method_NN without_IN questioning_VBG its_PRP$ appropriateness_NN for_IN the_DT outcome_NN being_VBG measured_VBN ._. 
The_DT main_JJ problem_NN with_IN the_DT random_JJ walk_NN approach_NN followed_VBN by_IN proximity_NN sampling_NN is_VBZ that_IN the_DT probability_NN of_IN a_DT household_NN being_VBG selected_VBN is_VBZ unknown_JJ ,_, since_IN the_DT total_JJ number_NN of_IN households_NNS in_IN the_DT community_NN is_VBZ unknown_JJ ._. 
For_IN non-VC_JJ surveys_NNS ,_, a_DT sample_NN size_NN of_IN 900_CD tends_VBZ to_TO be_VB used_VBN -LRB-_-LRB- 30_CD clusters_NNS of_IN 30_CD households_NNS or_CC children_NNS ,_, depending_VBG on_IN the_DT variable_JJ being_VBG measured_VBN -RRB-_-RRB- ._. 
Despite_IN recommendations_NNS to_TO improve_VB and_CC adapt_VB second_JJ stage_NN sampling_NN for_IN non-EPI_JJ purposes_NNS ,_, over_IN time_NN it_PRP has_VBZ become_VBN common_JJ practice_NN to_TO apply_VB this_DT survey_NN method_NN without_IN questioning_VBG its_PRP$ appropriateness_NN for_IN the_DT outcome_NN being_VBG measured_VBN ._. 
The_DT main_JJ problem_NN with_IN the_DT random_JJ walk_NN approach_NN followed_VBN by_IN proximity_NN sampling_NN is_VBZ that_IN the_DT probability_NN of_IN a_DT household_NN being_VBG selected_VBN is_VBZ unknown_JJ ,_, since_IN the_DT total_JJ number_NN of_IN households_NNS in_IN the_DT community_NN is_VBZ unknown_JJ ._. 
Subsequent_JJ households_NNS are_VBP then_RB selected_VBN by_IN proximity_NN -LRB-_-LRB- the_DT next_JJ nearest_JJS household_NN -RRB-_-RRB- or_CC visiting_VBG every_DT N_NNP th_NN closest_JJS household_NN until_IN the_DT sample_NN size_NN for_IN the_DT cluster_NN is_VBZ achieved_VBN 
Subsequent_JJ households_NNS are_VBP then_RB selected_VBN by_IN proximity_NN -LRB-_-LRB- the_DT next_JJ nearest_JJS household_NN -RRB-_-RRB- or_CC visiting_VBG every_DT N_NNP th_NN closest_JJS household_NN until_IN the_DT sample_NN size_NN for_IN the_DT cluster_NN is_VBZ achieved_VBN 
Subsequent_JJ households_NNS are_VBP then_RB selected_VBN by_IN proximity_NN -LRB-_-LRB- the_DT next_JJ nearest_JJS household_NN -RRB-_-RRB- or_CC visiting_VBG every_DT N_NNP th_NN closest_JJS household_NN until_IN the_DT sample_NN size_NN for_IN the_DT cluster_NN is_VBZ achieved_VBN 
Asex_NN or_CC age_NN group_NN with_IN a_DT clear_JJ deficit_NN could_MD indicate_VB recent_JJ high_JJ mortality_NN ,_, high_JJ out-migration_NN ,_, over-representation_NN of_IN other_JJ age-groups_NNS and\/or_CC sex_NN ,_, high_JJ mortality_NN several_JJ years_NNS before_IN the_DT survey_NN ,_, or_CC changes_NNS in_IN birth_NN rate_NN ._. 
Age_NNP pyramids_NNS are_VBP best_RB constructed_VBN using_VBG 5-year_JJ age-groups_NNS ._. 
Those_DT under_IN 5_CD can_MD be_VB shown_VBN on_IN a_DT separate_JJ age-pyramid_NN by_IN one-year_JJ categories_NNS to_TO highlight_VB recent_JJ trends_NNS among_IN newborns_NNS ._. 
Subsequent_JJ households_NNS are_VBP then_RB selected_VBN by_IN proximity_NN -LRB-_-LRB- the_DT next_JJ nearest_JJS household_NN -RRB-_-RRB- or_CC visiting_VBG every_DT N_NNP th_NN closest_JJS household_NN until_IN the_DT sample_NN size_NN for_IN the_DT cluster_NN is_VBZ achieved_VBN 
Subsequent_JJ households_NNS are_VBP then_RB selected_VBN by_IN proximity_NN -LRB-_-LRB- the_DT next_JJ nearest_JJS household_NN -RRB-_-RRB- or_CC visiting_VBG every_DT N_NNP th_NN closest_JJS household_NN until_IN the_DT sample_NN size_NN for_IN the_DT cluster_NN is_VBZ achieved_VBN 
Subsequent_JJ households_NNS are_VBP then_RB selected_VBN by_IN proximity_NN -LRB-_-LRB- the_DT next_JJ nearest_JJS household_NN -RRB-_-RRB- or_CC visiting_VBG every_DT N_NNP th_NN closest_JJS household_NN until_IN the_DT sample_NN size_NN for_IN the_DT cluster_NN is_VBZ achieved_VBN 
Prospective_JJ vital_JJ event_NN registration_NN is_VBZ absent_JJ or_CC deteriorates_VBZ in_IN nearly_RB all_DT crisis-affected_JJ populations_NNS and_CC as_IN a_DT result_NN ,_, retrospective_JJ household_NN surveys_NNS are_VBP often_RB used_VBN to_TO estimate_VB and_CC describe_VB patterns_NNS of_IN mortality_NN ._. 
Despite_IN their_PRP$ widespread_JJ use_NN and_CC policy_NN implications_NNS ,_, methods_NNS behind_IN retrospective_JJ mortality_NN surveys_NNS have_VBP been_VBN validated_VBN only_RB in_IN specific_JJ contexts_NNS through_IN comparison_NN with_IN other_JJ concurrent_JJ surveys_NNS or_CC with_IN alternative_JJ data_NNS sources_NNS that_WDT happen_VBP to_TO be_VB available_JJ ._. 
Research_NN to_TO optimise_VB mortality_NN survey_NN methods_NNS has_VBZ been_VBN scant_JJ ._. 
Survey_NN estimates_NNS have_VBP rarely_RB been_VBN compared_VBN with_IN a_DT proven_JJ `_`` gold_NN standard_NN '_'' mortality_NN rate_NN measurement_NN system_NN ._. 
Conclusion_NN Mortality_NN surveys_NNS have_VBP an_DT increasing_VBG impact_NN on_IN the_DT allocation_NN of_IN humanitarian_JJ relief_NN and_CC on_IN shaping_VBG international_JJ public_JJ opinion_NN and_CC government_NN response_NN to_TO major_JJ humanitarian_JJ crises_NNS ._. 
Recent_JJ years_NNS have_VBP seen_VBN more_RBR region-wide_JJ and_CC complex_JJ survey_NN efforts_NNS ,_, sometimes_RB resulting_VBG in_IN controversial_JJ and_CC disputed_JJ estimates_NNS ._. 
We_PRP examined_VBD several_JJ methodological_JJ problems_NNS and_CC outstanding_JJ issues_NNS with_IN retrospective_JJ mortality_NN estimation_NN in_IN humanitarian_JJ crises_NNS ._. 
Different_JJ types_NNS of_IN questionnaires_NNS have_VBP been_VBN proposed_VBN ,_, but_CC their_PRP$ performance_NN in_IN various_JJ cultural_JJ and_CC crisis_NN settings_NNS has_VBZ been_VBN insufficiently_RB evaluated_VBN ._. 
Furthermore_RB ,_, even_RB when_WRB the_DT methodology_NN is_VBZ uncontroversial_JJ ,_, reviews_NNS of_IN field_NN surveys_NNS of_IN nutritional_JJ status_NN ,_, immunisation_NN ,_, and_CC HIV-related_JJ behaviors_NNS have_VBP highlighted_VBN frequent_JJ problems_NNS of_IN imprecision_NN and_CC bias_NN due_JJ to_TO non-adherence_JJ to_TO best_JJS practices_NNS ._. 
Current_JJ mortality_NN survey_NN approaches_NNS essentially_RB feature_VBP three_CD methodological_JJ components_NNS :_: -LRB-_-LRB- i_FW -RRB-_-RRB- selection_NN of_IN a_DT representative_JJ sample_NN of_IN households_NNS in_IN the_DT population_NN ,_, using_VBG a_DT given_VBN design_NN -LRB-_-LRB- usually_RB cluster_NN sampling_NN -RRB-_-RRB- ;_: -LRB-_-LRB- ii_FW -RRB-_-RRB- a_DT questionnaire_NN administered_VBN to_TO household_NN respondents_NNS enquiring_VBG about_IN deaths_NNS and_CC other_JJ demographic_JJ indicators_NNS during_IN a_DT given_VBN recall_NN period_NN ;_: and_CC -LRB-_-LRB- iii_FW -RRB-_-RRB- an_DT attempt_NN ,_, however_RB crude_JJ ,_, to_TO determine_VB the_DT cause_NN of_IN any_DT reported_VBN deaths_NNS ._. 
Subsequent_JJ households_NNS are_VBP then_RB selected_VBN by_IN proximity_NN -LRB-_-LRB- the_DT next_JJ nearest_JJS household_NN -RRB-_-RRB- or_CC visiting_VBG every_DT N_NNP th_NN closest_JJS household_NN until_IN the_DT sample_NN size_NN for_IN the_DT cluster_NN is_VBZ achieved_VBN 
Background_NN Measuring_VBG rates_NNS and_CC circumstances_NNS of_IN population_NN mortality_NN is_VBZ an_DT essential_JJ component_NN of_IN evidence-based_JJ humanitarian_JJ relief_NN interventions_NNS ._. 
Crude_JJ and_CC under-5_JJ mortality_NN rates_NNS are_VBP used_VBN internationally_RB to_TO benchmark_NN the_DT severity_NN of_IN crises_NNS and_CC evaluate_VB the_DT effectiveness_NN of_IN humanitarian_JJ assistance_NN ._. 
Prospective_JJ vital_JJ event_NN registration_NN is_VBZ absent_JJ or_CC deteriorates_VBZ in_IN nearly_RB all_DT crisis-affected_JJ populations_NNS and_CC as_IN a_DT result_NN ,_, retrospective_JJ household_NN surveys_NNS are_VBP often_RB used_VBN to_TO estimate_VB and_CC describe_VB patterns_NNS of_IN mortality_NN ._. 
Prospective_JJ vital_JJ event_NN registration_NN is_VBZ absent_JJ or_CC deteriorates_VBZ in_IN nearly_RB all_DT crisis-affected_JJ populations_NNS and_CC as_IN a_DT result_NN ,_, retrospective_JJ household_NN surveys_NNS are_VBP often_RB used_VBN to_TO estimate_VB and_CC describe_VB patterns_NNS of_IN mortality_NN ._. 
Despite_IN their_PRP$ widespread_JJ use_NN and_CC policy_NN implications_NNS ,_, methods_NNS behind_IN retrospective_JJ mortality_NN surveys_NNS have_VBP been_VBN validated_VBN only_RB in_IN specific_JJ contexts_NNS through_IN comparison_NN with_IN other_JJ concurrent_JJ surveys_NNS or_CC with_IN alternative_JJ data_NNS sources_NNS that_WDT happen_VBP to_TO be_VB available_JJ ._. 
Research_NN to_TO optimise_VB mortality_NN survey_NN methods_NNS has_VBZ been_VBN scant_JJ ._. 
Survey_NN estimates_NNS have_VBP rarely_RB been_VBN compared_VBN with_IN a_DT proven_JJ `_`` gold_NN standard_NN '_'' mortality_NN rate_NN measurement_NN system_NN ._. 
Conclusion_NN Mortality_NN surveys_NNS have_VBP an_DT increasing_VBG impact_NN on_IN the_DT allocation_NN of_IN humanitarian_JJ relief_NN and_CC on_IN shaping_VBG international_JJ public_JJ opinion_NN and_CC government_NN response_NN to_TO major_JJ humanitarian_JJ crises_NNS ._. 
Recent_JJ years_NNS have_VBP seen_VBN more_RBR region-wide_JJ and_CC complex_JJ survey_NN efforts_NNS ,_, sometimes_RB resulting_VBG in_IN controversial_JJ and_CC disputed_JJ estimates_NNS ._. 
We_PRP examined_VBD several_JJ methodological_JJ problems_NNS and_CC outstanding_JJ issues_NNS with_IN retrospective_JJ mortality_NN estimation_NN in_IN humanitarian_JJ crises_NNS ._. 
g._VB In_IN some_DT countries_NNS -LRB-_-LRB- e._VB Another_DT possibility_NN is_VBZ to_TO set_VB up_RP a_DT focus_NN group_NN at_IN the_DT survey_NN site_NN ,_, using_VBG a_DT VA-type_JJ process_NN to_TO elucidate_VB the_DT major_JJ causes_NNS of_IN death_NN in_IN advance_NN of_IN the_DT survey_NN ._. 
Iraq_NNP -RRB-_-RRB- death_NN certificates_NNS are_VBP available_JJ ;_: these_DT aid_NN greatly_RB in_IN identifying_VBG causes_NNS of_IN death_NN ._. 
Conclusion_NN Mortality_NN surveys_NNS have_VBP an_DT increasing_VBG impact_NN on_IN the_DT allocation_NN of_IN humanitarian_JJ relief_NN and_CC on_IN shaping_VBG international_JJ public_JJ opinion_NN and_CC government_NN response_NN to_TO major_JJ humanitarian_JJ crises_NNS ._. 
Different_JJ types_NNS of_IN questionnaires_NNS have_VBP been_VBN proposed_VBN ,_, but_CC their_PRP$ performance_NN in_IN various_JJ cultural_JJ and_CC crisis_NN settings_NNS has_VBZ been_VBN insufficiently_RB evaluated_VBN ._. 
Furthermore_RB ,_, even_RB when_WRB the_DT methodology_NN is_VBZ uncontroversial_JJ ,_, reviews_NNS of_IN field_NN surveys_NNS of_IN nutritional_JJ status_NN ,_, immunisation_NN ,_, and_CC HIV-related_JJ behaviors_NNS have_VBP highlighted_VBN frequent_JJ problems_NNS of_IN imprecision_NN and_CC bias_NN due_JJ to_TO non-adherence_JJ to_TO best_JJS practices_NNS ._. 
Current_JJ mortality_NN survey_NN approaches_NNS essentially_RB feature_VBP three_CD methodological_JJ components_NNS :_: -LRB-_-LRB- i_FW -RRB-_-RRB- selection_NN of_IN a_DT representative_JJ sample_NN of_IN households_NNS in_IN the_DT population_NN ,_, using_VBG a_DT given_VBN design_NN -LRB-_-LRB- usually_RB cluster_NN sampling_NN -RRB-_-RRB- ;_: -LRB-_-LRB- ii_FW -RRB-_-RRB- a_DT questionnaire_NN administered_VBN to_TO household_NN respondents_NNS enquiring_VBG about_IN deaths_NNS and_CC other_JJ demographic_JJ indicators_NNS during_IN a_DT given_VBN recall_NN period_NN ;_: and_CC -LRB-_-LRB- iii_FW -RRB-_-RRB- an_DT attempt_NN ,_, however_RB crude_JJ ,_, to_TO determine_VB the_DT cause_NN of_IN any_DT reported_VBN deaths_NNS ._. 
Systematic_JJ sampling_NN ,_, whereby_WRB each_DT n_FW th_FW household_NN is_VBZ sampled_VBN ,_, is_VBZ the_DT second_JJ best_JJS choice_NN :_: it_PRP requires_VBZ only_RB knowledge_NN of_IN the_DT total_JJ number_NN of_IN households_NNS ,_, but_CC is_VBZ mainly_RB feasible_JJ if_IN households_NNS are_VBP laid_VBN out_RP along_RB clearly_RB defined_VBN streets_NNS or_CC in_IN a_DT clear_JJ pattern_NN ._. 
Simple_NN and_CC systematic_JJ random_JJ sampling_NN designs_NNS are_VBP explained_VBN fully_RB elsewhere_RB and_CC ,_, as_IN their_PRP$ application_NN for_IN mortality_NN estimation_NN does_VBZ not_RB present_VB specific_JJ challenges_NNS ,_, they_PRP are_VBP not_RB explored_VBN further_RB here_RB ._. 
Although_IN they_PRP may_MD be_VB practicable_JJ only_RB in_IN some_DT situations_NNS ,_, investigators_NNS should_MD always_RB consider_VB these_DT two_CD options_NNS first_RB ,_, especially_RB if_IN a_DT sampling_VBG frame_NN of_IN households_NNS can_MD readily_RB be_VB constructed_VBN ._. 
For_IN the_DT results_NNS reported_VBD here_RB ,_, the_DT lower_JJR bound_VBN of_IN the_DT CI_NNP results_NNS is_VBZ truncated_VBN at_IN 0_CD ._. 
Due_JJ to_TO the_DT low_JJ mortality_NN rate_NN and_CC wide_JJ confidence_NN intervals_NNS ,_, the_DT lower_JJR bound_VBN of_IN the_DT CIs_NNP for_IN the_DT 33_CD 
20_CD ._. 
10_CD and_CC beta_JJ error_NN of_IN 0_CD ._. 
This_DT sample_NN size_NN allows_VBZ for_IN assessment_NN of_IN GAM_NNP against_IN the_DT 10_CD %_NN and_CC 15_CD %_NN upper_JJ thresholds_NNS -LRB-_-LRB- with_IN lower_JJR thresholds_NNS of_IN 5_CD %_NN and_CC 10_CD %_NN ,_, respectively_RB -RRB-_-RRB- ,_, while_IN maintaining_VBG a_DT maximum_JJ alpha_NN error_NN of_IN 0_CD ._. 
In_IN emergencies_NNS ,_, the_DT 10_CD %_NN and_CC 15_CD %_NN GAM_NNP threshold_NN levels_NNS are_VBP often_RB used_VBN to_TO determine_VB the_DT scale_NN of_IN humanitarian_JJ response_NN warranted_VBD and_CC the_DT most_RBS appropriate_JJ type_NN of_IN nutrition_NN intervention_NN to_TO implement_VB 
The_DT sampled_VBN clusters_NNS -LRB-_-LRB- villages_NNS -RRB-_-RRB- were_VBD selected_VBN independently_RB for_IN each_DT design_NN using_VBG Probability_NNP Proportionate_NNP to_TO Size_NN -LRB-_-LRB- PPS_NNP -RRB-_-RRB- ._. 
The_DT spin-the-bottle_JJ method_NN was_VBD used_VBN to_TO randomly_RB select_VB the_DT first_JJ household_NN to_TO be_VB sampled_VBN within_IN each_DT cluster_NN ._. 
Subsequent_JJ households_NNS in_IN each_DT cluster_NN were_VBD selected_VBN by_IN sampling_VBG the_DT nearest_JJS household_NN to_TO the_DT right_NN ._. 
The_DT utility_NN of_IN a_DT 30_CD 
04_CD ._. 
Anthropometric_JJ data_NNS were_VBD processed_VBN against_IN the_DT NCHS\/WHO_NNP 1978_CD child_NN growth_NN references_NNS using_VBG Epi-Info_NNP 6_CD ._. 
Children_NNS with_IN anthropometric_JJ data_NNS flagged_VBN by_IN Epi-Info_NNP were_VBD removed_VBN from_IN analysis_NN of_IN anthropometric_JJ indicators_NNS unless_IN bipedal_JJ edema_NN was_VBD indicated_VBN ,_, in_IN which_WDT case_NN the_DT child_NN was_VBD retained_VBN for_IN analysis_NN of_IN GAM_NNP ._. 
Although_IN the_DT sampling_NN protocol_NN was_VBD well_RB implemented_VBN ,_, some_DT clusters_NNS in_IN the_DT datasets_NNS were_VBD either_CC over_IN -_: or_CC undersized_JJ ._. 
The_DT utility_NN of_IN a_DT 30_CD 
The_DT assessment_NN method_NN commonly_RB used_VBN in_IN emergency_NN settings_NNS is_VBZ a_DT 30_CD 
1._CD 
1._CD 
Asecondary_JJ objective_NN of_IN the_DT study_NN was_VBD to_TO use_VB data_NNS from_IN the_DT 33_CD 
The_DT use_NN of_IN LQAS_NNP in_IN international_JJ health_NN requires_VBZ familiarity_NN with_IN terms_NNS such_JJ as_IN `_`` upper_JJ and_CC lower_JJR thresholds_NNS '_POS ,_, `_`` alpha_NN and_CC beta_NN errors_NNS '_POS ,_, and_CC `_`` decision_NN rules_NNS '_POS ._. 
These_DT terms_NNS are_VBP well_RB described_VBN throughout_IN the_DT LQAS_NNP literature_NN 
LQAS_NNP hypothesis_VBZ test_NN of_IN GAM_NNP prevalence_NN with_IN the_DT 33_CD 
2Background_JJ on_IN LQAS_NNP LQAS_NNP is_VBZ a_DT quality_NN assurance_NN method_NN frequently_RB applied_VBD in_IN international_JJ health_NN 
The_DT use_NN of_IN LQAS_NNP in_IN international_JJ health_NN requires_VBZ familiarity_NN with_IN terms_NNS such_JJ as_IN `_`` upper_JJ and_CC lower_JJR thresholds_NNS '_POS ,_, `_`` alpha_NN and_CC beta_NN errors_NNS '_POS ,_, and_CC `_`` decision_NN rules_NNS '_POS ._. 
These_DT terms_NNS are_VBP well_RB described_VBN throughout_IN the_DT LQAS_NNP literature_NN ._. 
In_IN a_DT typical_JJ application_NN ,_, the_DT investigator_NN determines_VBZ a_DT priori_FW the_DT indicator_NN of_IN interest_NN -LRB-_-LRB- e._FW g._FW GAM_NNP -RRB-_-RRB- ,_, the_DT upper_JJ threshold_NN level_NN -LRB-_-LRB- p_FW o_FW -RRB-_-RRB- against_IN which_WDT the_DT data_NNS will_MD be_VB tested_VBN -LRB-_-LRB- e._SYM 
where_WRB the_DT true_JJ GAM_NNP prevalence_NN is_VBZ 
Ha_NN :_: p_NN 
Subsequent_JJ households_NNS in_IN each_DT cluster_NN were_VBD selected_VBN by_IN sampling_VBG the_DT nearest_JJS household_NN to_TO the_DT right_NN ._. 
Data_NNS collected_VBN at_IN each_DT household_NN followed_VBD the_DT conventional_JJ sampling_NN protocol_NN used_VBN in_IN emergencies_NNS ._. 
In_IN households_NNS that_WDT had_VBD no_DT children_NNS 6_CD 
2._CD 
92_CD ._. 
6-RRB-_FW +_FW \/_FW -_: 12_CD ._. 
8,_CD 74_CD ._. 
7-LRB-_CD 48_CD ._. 
161_CD ._. 
5-RRB-_FW +_FW \/_FW -_: 10_CD ._. 
4,_CD 72_CD ._. 
4-LRB-_CD 52_CD ._. 
062_CD ._. 
6-RRB-_FW +_FW \/_FW -_: 13_CD ._. 
7,_CD 79_CD ._. 
7-LRB-_CD 53_CD ._. 
5month_JJ recall_NN -RRB-_-RRB- 66_CD ._. 
4Estimation_NN and_CC precision_NN of_IN mortality_NN ratesIn_NNP addition_NN to_TO the_DT above_JJ indicators_NNS ,_, two_CD indicators_NNS of_IN retrospective_JJ mortality_NN were_VBD tabulated_VBN using_VBG the_DT household_NN sample_NN of_IN each_DT design_NN and_CC methods_NNS recommended_VBN by_IN Standardized_JJ Monitoring_NN and_CC Assessment_NNP of_IN Relief_NNP and_CC Transitions_NNP -LRB-_-LRB- SMART_NNP -RRB-_-RRB- ._. 
Fairly_RB similar_JJ point_NN estimate_NN results_NNS are_VBP shown_VBN among_IN the_DT designs_NNS in_IN each_DT AU_NNP ;_: however_RB ,_, in_IN comparison_NN to_TO the_DT 30_CD 
For_IN the_DT results_NNS reported_VBD here_RB ,_, the_DT lower_JJR bound_VBN of_IN the_DT CI_NNP results_NNS is_VBZ truncated_VBN at_IN 0_CD ._. 
Due_JJ to_TO the_DT low_JJ mortality_NN rate_NN and_CC wide_JJ confidence_NN intervals_NNS ,_, the_DT lower_JJR bound_VBN of_IN the_DT CIs_NNP for_IN the_DT 33_CD 
Data_NNP collection_NN in_IN emergency_NN settings_NNS Appropriate_JJ response_NN to_TO a_DT nutritional_JJ emergency_NN requires_VBZ reliable_JJ and_CC timely_JJ data_NNS about_IN the_DT health_NN ,_, nutrition_NN ,_, and_CC food_NN security_NN status_NN of_IN the_DT affected_JJ population_NN ._. 
The_DT assessment_NN method_NN commonly_RB used_VBN in_IN emergency_NN settings_NNS is_VBZ a_DT 30_CD 
The_DT assessment_NN method_NN commonly_RB used_VBN in_IN emergency_NN settings_NNS is_VBZ a_DT 30_CD 
,30_CD 
The_DT utility_NN of_IN a_DT 30_CD 
Some_DT studies_NNS have_VBP shown_VBN 30_CD 
Studies_NNS have_VBP been_VBN conducted_VBN or_CC are_VBP currently_RB underway_JJ to_TO investigate_VB alternative_JJ methods_NNS to_TO collect_VB reliable_JJ data_NNS in_IN emergency_NN settings_NNS 
However_RB ,_, that_DT study_NN did_VBD not_RB sample_NN for_IN each_DT design_NN independently_RB ;_: rather_RB ,_, data_NNS were_VBD shared_VBN among_IN the_DT designs_NNS when_WRB the_DT same_JJ primary_JJ sampling_NN unit_NN -LRB-_-LRB- PSU_NNP -RRB-_-RRB- was_VBD selected_VBN for_IN sampling_NN by_IN multiple_JJ designs_NNS ._. 
The_DT investigators_NNS recommended_VBD that_IN a_DT second_JJ study_NN ,_, using_VBG independent_JJ samples_NNS for_IN each_DT design_NN ,_, be_VB carried_VBN out_RP to_TO validate_VB the_DT 33_CD 
The_DT use_NN of_IN LQAS_NNP in_IN international_JJ health_NN requires_VBZ familiarity_NN with_IN terms_NNS such_JJ as_IN `_`` upper_JJ and_CC lower_JJR thresholds_NNS '_POS ,_, `_`` alpha_NN and_CC beta_NN errors_NNS '_POS ,_, and_CC `_`` decision_NN rules_NNS '_POS ._. 
These_DT terms_NNS are_VBP well_RB described_VBN throughout_IN the_DT LQAS_NNP literature_NN ._. 
In_IN a_DT typical_JJ application_NN ,_, the_DT investigator_NN determines_VBZ a_DT priori_FW the_DT indicator_NN of_IN interest_NN -LRB-_-LRB- e._FW g._FW GAM_NNP -RRB-_-RRB- ,_, the_DT upper_JJ threshold_NN level_NN -LRB-_-LRB- p_FW o_FW -RRB-_-RRB- against_IN which_WDT the_DT data_NNS will_MD be_VB tested_VBN -LRB-_-LRB- e._SYM 
Collection_NN of_IN a_DT sample_NN of_IN 200_CD observations_NNS by_IN the_DT SRS_NNP method_NN used_VBN in_IN standard_JJ LQAS_NNP applications_NNS would_MD ,_, however_RB ,_, be_VB onerous_JJ and_CC time_NN consuming_NN ;_: and_CC thus_RB impractical_JJ in_IN an_DT emergency_NN setting_NN ._. 
To_TO investigate_VB the_DT validity_NN of_IN using_VBG a_DT cluster_NN sampling_NN approach_NN ,_, as_IN opposed_VBN to_TO a_DT SRS_NNP for_IN LQAS_NNP assessment_NN of_IN GAM_NNP prevalence_NN ,_, the_DT FANTA\/CRS\/OSU_NNP team_NN conducted_VBD a_DT series_NN of_IN computer_NN simulations_NNS which_WDT showed_VBD that_IN the_DT binomial_JJ probabilities_NNS for_IN the_DT LQAS_NNP decision_NN rules_NNS were_VBD accurate_JJ when_WRB assessing_VBG a_DT prevalence_NN of_IN 10_CD %_NN ,_, 15_CD %_NN ,_, and_CC 20_CD %_NN -LRB-_-LRB- using_VBG lower_JJR thresholds_NNS of_IN 5_CD %_NN ,_, 10_CD %_NN and_CC 15_CD %_NN ,_, respectively_RB -RRB-_-RRB- ,_, with_IN a_DT sample_NN size_NN of_IN n_FW ~_FW 200_CD and_CC data_NNS collected_VBN in_IN clusters_NNS of_IN size_NN 2_CD 
2._CD 
2._CD 
2._CD 
4percentage_CD points_NNS ._. 
0percentage_CD points_NNS -LRB-_-LRB- underweight_JJ -RRB-_-RRB- with_IN a_DT median_JJ difference_NN of_IN +_FW \/_FW -_: 1_CD ._. 
LQAS_NNP hypothesis_VBZ test_NN of_IN GAM_NNP prevalenceAlthough_NNP a_DT SRS_NNP is_VBZ usually_RB required_VBN for_IN LQAS_NNP hypothesis_NN testing_NN ,_, earlier_JJR simulation_NN studies_NNS have_VBP shown_VBN the_DT 33_CD 
Discussion_NNP This_NNP study_NN advances_NNS what_WP is_VBZ known_VBN about_IN the_DT performance_NN of_IN the_DT 33_CD 
Data_NNP analysis_NN Point_NNP estimates_NNS ,_, 95_CD %_NN CIs_NNS ,_, design_NN effects_NNS ,_, and_CC intra-cluster_JJ correlation_NN results_NNS for_IN all_DT designs_NNS were_VBD derived_VBN using_VBG Intercooled_NNP Stata_NNP v_VBD 9_CD ._. 
2._CD 
For_IN point_NN estimate_NN and_CC design_NN effect_NN -LRB-_-LRB- deff_NN -RRB-_-RRB- calculations_NNS ,_, data_NNS were_VBD weighted_VBN inversely_RB proportional_JJ to_TO the_DT achieved_VBN cluster_NN sample_NN size_NN ._. 
The_DT results_NNS of_IN this_DT study_NN therefore_RB provide_VBP a_DT unique_JJ opportunity_NN to_TO evaluate_VB the_DT empirical_JJ trade-offs_NNS of_IN each_DT of_IN the_DT sampling_VBG designs_NNS with_IN respect_NN to_TO the_DT precision_NN of_IN estimates_NNS ,_, and_CC the_DT time_NN and_CC cost_NN required_VBN for_IN data_NNS collection_NN ._. 
The_DT design_NN effect_NN for_IN an_DT indicator_NN can_MD often_RB be_VB approximated_VBN using_VBG the_DT below_IN formula_NN :_: Deff_NNP =_SYM 1_CD +_CD p_NN -LRB-_-LRB- b-1_JJ -RRB-_-RRB- ,_, where_WRB p_NN is_VBZ the_DT intra-cluster_JJ correlation_NN -LRB-_-LRB- rho_NN -RRB-_-RRB- and_CC b_NN is_VBZ the_DT number_NN of_IN observations_NNS per_IN cluster_NN 
Use_NN of_IN the_DT binomial_JJ distribution_NN for_IN hypothesis_NN testing_NN usually_RB requires_VBZ that_IN observations_NNS in_IN a_DT sample_NN be_VB randomly_RB and_CC independently_RB selected_VBN ._. 
For_IN population-based_JJ surveys_NNS in_IN the_DT international_JJ health_NN setting_NN ,_, a_DT Simple_NN Random_NNP Sample_NNP -LRB-_-LRB- SRS_NNP -RRB-_-RRB- is_VBZ therefore_RB most_RBS often_RB used_VBN for_IN selection_NN of_IN the_DT sample_NN to_TO be_VB analyzed_VBN by_IN LQAS_NNP 
Until_IN that_DT time_NN ,_, LQAS_NNP had_VBD been_VBN less_RBR frequently_RB used_VBN to_TO assess_VB nutritional_JJ status_NN indicators_NNS 
3._CD 
1._CD 
1._CD 
The_DT beta_JJ error_NN is_VBZ the_DT type_NN II_NNP error_NN ,_, or_CC the_DT probability_NN of_IN failing_VBG to_TO reject_VB the_DT null_JJ hypothesis_NN when_WRB it_PRP is_VBZ false_JJ ,_, also_RB referred_VBD to_TO as_IN the_DT ``_`` provider_NN risk_NN ''_'' in_IN LQAS_NNP ._. 
LQAS_NNP hypothesis_VBZ test_NN of_IN GAM_NNP prevalence_NN with_IN the_DT 33_CD 
10_CD and_CC beta_JJ error_NN of_IN 0_CD ._. 
This_DT sample_NN size_NN allows_VBZ for_IN assessment_NN of_IN GAM_NNP against_IN the_DT 10_CD %_NN and_CC 15_CD %_NN upper_JJ thresholds_NNS -LRB-_-LRB- with_IN lower_JJR thresholds_NNS of_IN 5_CD %_NN and_CC 10_CD %_NN ,_, respectively_RB -RRB-_-RRB- ,_, while_IN maintaining_VBG a_DT maximum_JJ alpha_NN error_NN of_IN 0_CD ._. 
20_NNP 
Collection_NN of_IN a_DT sample_NN of_IN 200_CD observations_NNS by_IN the_DT SRS_NNP method_NN used_VBN in_IN standard_JJ LQAS_NNP applications_NNS would_MD ,_, however_RB ,_, be_VB onerous_JJ and_CC time_NN consuming_NN ;_: and_CC thus_RB impractical_JJ in_IN an_DT emergency_NN setting_NN ._. 
To_TO investigate_VB the_DT validity_NN of_IN using_VBG a_DT cluster_NN sampling_NN approach_NN ,_, as_IN opposed_VBN to_TO a_DT SRS_NNP for_IN LQAS_NNP assessment_NN of_IN GAM_NNP prevalence_NN ,_, the_DT FANTA\/CRS\/OSU_NNP team_NN conducted_VBD a_DT series_NN of_IN computer_NN simulations_NNS which_WDT showed_VBD that_IN the_DT binomial_JJ probabilities_NNS for_IN the_DT LQAS_NNP decision_NN rules_NNS were_VBD accurate_JJ when_WRB assessing_VBG a_DT prevalence_NN of_IN 10_CD %_NN ,_, 15_CD %_NN ,_, and_CC 20_CD %_NN -LRB-_-LRB- using_VBG lower_JJR thresholds_NNS of_IN 5_CD %_NN ,_, 10_CD %_NN and_CC 15_CD %_NN ,_, respectively_RB -RRB-_-RRB- ,_, with_IN a_DT sample_NN size_NN of_IN n_FW ~_FW 200_CD and_CC data_NNS collected_VBN in_IN clusters_NNS of_IN size_NN 2_CD 
2._CD 
2._CD 
2._CD 
4percentage_CD points_NNS ._. 
0percentage_CD points_NNS -LRB-_-LRB- underweight_JJ -RRB-_-RRB- with_IN a_DT median_JJ difference_NN of_IN +_FW \/_FW -_: 1_CD ._. 
LQAS_NNP hypothesis_VBZ test_NN of_IN GAM_NNP prevalenceAlthough_NNP a_DT SRS_NNP is_VBZ usually_RB required_VBN for_IN LQAS_NNP hypothesis_NN testing_NN ,_, earlier_JJR simulation_NN studies_NNS have_VBP shown_VBN the_DT 33_CD 
For_IN the_DT results_NNS reported_VBD here_RB ,_, the_DT lower_JJR bound_VBN of_IN the_DT CI_NNP results_NNS is_VBZ truncated_VBN at_IN 0_CD ._. 
Due_JJ to_TO the_DT low_JJ mortality_NN rate_NN and_CC wide_JJ confidence_NN intervals_NNS ,_, the_DT lower_JJR bound_VBN of_IN the_DT CIs_NNP for_IN the_DT 33_CD 
Subsequent_JJ households_NNS in_IN each_DT cluster_NN were_VBD selected_VBN by_IN sampling_VBG the_DT nearest_JJS household_NN to_TO the_DT right_NN ._. 
Data_NNS collected_VBN at_IN each_DT household_NN followed_VBD the_DT conventional_JJ sampling_NN protocol_NN used_VBN in_IN emergencies_NNS ._. 
In_IN households_NNS that_WDT had_VBD no_DT children_NNS 6_CD 
,30_CD 
In_IN philosophy_NN of_IN science_NN there_EX is_VBZ a_DT long_JJ tradition_NN of_IN discussing_VBG both_DT the_DT content_NN of_IN the_DT term_NN and_CC how_WRB to_TO achieve_VB knowledge_NN about_IN the_DT association_NN of_IN events_NNS 
There_EX are_VBP several_JJ examples_NNS from_IN recent_JJ history_NN in_IN Norway_NNP where_WRB the_DT accused_VBN was_VBD found_VBN not_RB guilty_JJ in_IN the_DT criminal_JJ court_NN case_NN but_CC was_VBD convicted_VBN to_TO pay_VB economic_JJ compensation_NN in_IN a_DT following_JJ civil_JJ lawsuit_NN ._. 
Causal_JJ connection_NN in_IN law_NN is_VBZ usually_RB divided_VBN into_IN two_CD parts_NNS ,_, ``_`` cause-in-fact_NN ''_'' and_CC ``_`` proximate_JJ cause_NN ''_'' ._. 
``_`` Cause-in-fact_NN ''_'' comes_VBZ closest_JJS to_TO what_WP is_VBZ regarded_VBN as_IN causality_NN in_IN science_NN ._. 
However_RB ,_, while_IN science_NN mostly_RB deals_VBZ with_IN causal_JJ generalisation_NN ,_, law_NN focuses_VBZ more_RBR on_IN causes_NNS of_IN specific_JJ events_NNS ._. 
The_DT outbreak_NN strain_NN was_VBD detected_VBN in_IN swabs_NNS from_IN 12_CD batches_NNS produced_VBN in_IN 2001_CD and_CC 2002_CD 
Some_DT years_NNS prior_RB to_TO the_DT outbreak_NN ,_, customers_NNS had_VBD periodically_RB complained_VBN about_IN discolored_VBN swabs_NNS ._. 
Having_VBG QA_NNP systems_NNS is_VBZ one_CD of_IN several_JJ requirements_NNS by_IN Norwegian_NNP and_CC EU_NNP law_NN to_TO be_VB able_JJ to_TO mark_VB the_DT product_NN ``_`` CE_NNP ''_'' -LRB-_-LRB- Communaut_NNP 
In_IN 1999_CD ,_, the_DT producer_NN commissioned_VBD an_DT external_JJ evaluation_NN and_CC implemented_VBD some_DT ,_, but_CC not_RB all_PDT the_DT advice_NN given_VBN ;_: among_IN the_DT latter_NN was_VBD the_DT advice_NN to_TO establish_VB microbiological_JJ quality_NN control_NN of_IN the_DT final_JJ product_NN 
2007_CD -RRB-_-RRB- to_TO the_DT European_NNP Council_NNP Directive_NNP on_IN Medical_JJ devices_NNS has_VBZ defined_VBN a_DT ``_`` single_JJ use_NN device_NN ''_'' as_IN ``_`` a_DT device_NN intended_VBN to_TO be_VB used_VBN once_RB only_RB for_IN a_DT single_JJ patient_NN ''_'' ._. 
The_DT claim_NN of_IN antiseptic_JJ properties_NNS of_IN the_DT swab_NN -LRB-_-LRB- which_WDT was_VBD never_RB documented_VBN by_IN the_DT producers_NNS -RRB-_-RRB- may_MD have_VB led_VBN some_DT health_NN care_NN workers_NNS to_TO underestimate_VB the_DT risk_NN this_DT practice_NN posed_VBD ._. 
Placing_VBG a_DT swab_NN coated_VBN with_IN an_DT oral_JJ cavity_NN bacterial_JJ flora_NNS in_IN a_DT glass_NN of_IN water_NN with_IN saliva_NN and_CC mucus_NN as_IN nutrition_NN ,_, may_MD lead_VB to_TO extensive_JJ bacterial_JJ growth_NN up_IN to_TO a_DT concentration_NN which_WDT makes_VBZ it_PRP potentially_RB harmful_JJ ._. 
In_IN epidemiology_NN causality_NN has_VBZ been_VBN hotly_RB debated_VBN 
In_IN philosophy_NN of_IN science_NN there_EX is_VBZ a_DT long_JJ tradition_NN of_IN discussing_VBG both_DT the_DT content_NN of_IN the_DT term_NN and_CC how_WRB to_TO achieve_VB knowledge_NN about_IN the_DT association_NN of_IN events_NNS 
This_DT list_NN of_IN ``_`` Guidelines_NNS for_IN causation_NN ''_'' is_VBZ more_JJR in_IN tune_NN with_IN modern_JJ epidemiological_JJ science_NN as_IN they_PRP emphasize_VBP the_DT strength_NN of_IN association_NN rather_RB than_IN pure_JJ mechanical_JJ determinism_NN ._. 
However_RB ,_, many_JJ have_VBP criticised_VBN Hill_NNP 's_POS list_NN and_CC in_IN recent_JJ years_NNS there_EX has_VBZ been_VBN a_DT resurge_NN in_IN the_DT debate_NN about_IN causality_NN ._. 
Moreover_RB ,_, probabilistic_JJ graphical_JJ methods_NNS ,_, such_JJ as_IN Bayesian_JJ networks_NNS ,_, may_MD also_RB be_VB used_VBN in_IN order_NN to_TO represent_VB the_DT probabilistic_JJ independencies_NNS between_IN variables_NNS ._. 
The_DT concept_NN of_IN causality_NN is_VBZ intuitively_RB simple_JJ and_CC yet_RB so_RB intricately_RB complex_JJ ._. 
Two_CD examples_NNS are_VBP the_DT debate_NN on_IN where_WRB the_DT Spanish_JJ flu_NN came_VBD from_IN and_CC who_WP was_VBD responsible_JJ for_IN starting_VBG the_DT Aids_NNP epidemic_NN ._. 
In_IN epidemiology_NN causality_NN has_VBZ been_VBN hotly_RB debated_VBN ._. 
In_IN philosophy_NN of_IN science_NN 
Causation_NN in_IN epidemiology_JJ Classic_JJ epidemiology_NN has_VBZ been_VBN mainly_RB backward_RB looking_VBG ,_, seeking_VBG an_DT explanation_NN to_TO an_DT event_NN ._. 
In_IN much_JJ of_IN the_DT 19th_JJ century_NN there_EX was_VBD a_DT profound_JJ debate_NN on_IN what_WP caused_VBD many_JJ of_IN the_DT major_JJ diseases_NNS of_IN the_DT time_NN ,_, being_VBG it_PRP miasmata_JJ -LRB-_-LRB- stench_JJ or_CC bad_JJ air_NN -RRB-_-RRB- or_CC contagions_NNS 
In_IN much_JJ of_IN the_DT 19_CD th_JJ century_NN there_EX was_VBD a_DT profound_JJ debate_NN on_IN what_WP caused_VBD many_JJ of_IN the_DT major_JJ diseases_NNS of_IN the_DT time_NN ,_, being_VBG it_PRP miasmata_JJ -LRB-_-LRB- stench_JJ or_CC bad_JJ air_NN -RRB-_-RRB- or_CC contagions_NNS 
aeruginosa_NN bacterium_NN into_IN the_DT production_NN facilities_NNS through_IN the_DT municipal_JJ water_NN pipe_NN 
Hence_RB ,_, the_DT actions_NNS of_IN the_DT producer_NN -LRB-_-LRB- as_RB well_RB as_IN the_DT health_NN care_NN professionals_NNS -RRB-_-RRB- appear_VBP to_TO breach_VB with_IN basic_JJ deontological_JJ bearings_NNS in_IN health_NN care_NN ._. 
Moreover_RB ,_, if_IN the_DT moral_JJ norms_NNS of_IN the_DT producer_NN 's_POS responsibilities_NNS are_VBP adequately_RB regulated_VBN by_IN law_NN ,_, breaking_VBG these_DT legal_JJ regulations_NNS ,_, such_JJ as_IN the_DT Act_NN on_IN medical_JJ devices_NNS 
In_IN a_DT probabilistic_NN or_CC risk_NN assessment_NN approach_NN ,_, low_JJ threshold_NN reporting_NN systems_NNS with_IN appropriate_JJ follow-up_JJ routines_NNS and_CC adequate_JJ surveillance_NN systems_NNS ,_, make_VB it_PRP more_RBR likely_JJ that_IN the_DT contaminated_VBN swabs_NNS and_CC the_DT outbreak_NN would_MD have_VB been_VBN detected_VBN earlier_RBR -LRB-_-LRB- counterfactual_JJ -RRB-_-RRB- ._. 
Surveillance_NN systems_NNS are_VBP in_IN place_NN for_IN many_JJ infectious_JJ diseases_NNS ,_, but_CC not_RB for_IN Pseudomonas_NNP infections_NNS ._. 
Only_RB the_DT most_RBS prevalent_JJ or_CC serious_JJ diseases_NNS are_VBP included_VBN into_IN the_DT surveillance_NN systems_NNS after_IN weighing_VBG factors_NNS such_JJ as_IN costs_NNS and_CC preventability_NN ._. 
Traditionally_RB ,_, medical_JJ errors_NNS have_VBP been_VBN divided_VBN into_IN three_CD :_: Unintentional_JJ error_NN ,_, intentional_JJ error_NN and_CC random_JJ mishaps_NNS ._. 
In_IN addition_NN ,_, bad_JJ outcomes_NNS may_MD happen_VB without_IN error_NN ._. 
For_IN our_PRP$ discussion_NN we_PRP will_MD only_RB focus_VB on_IN unintentional_JJ error_NN as_IN no_DT one_NN in_IN this_DT outbreak_NN ever_RB was_VBD suspected_VBN of_IN intentionally_RB wanting_VBG to_TO cause_VB harm_NN ._. 
However_RB ,_, the_DT non-adherence_NN to_TO norms_NNS and_CC regulations_NNS and_CC the_DT non-application_JJ or_CC non-acquisition_JJ of_IN knowledge_NN can_MD be_VB conceived_VBN of_IN as_IN malpractice_NN ._. 
It_PRP is_VBZ not_RB the_DT case_NN that_DT science_NN has_VBZ not_RB yet_RB progressed_VBN enough_RB ,_, or_CC that_IN there_EX are_VBP limitations_NNS in_IN the_DT predictive_JJ nature_NN of_IN knowledge_NN with_IN regards_VBZ to_TO the_DT particular_JJ case_NN ._. 
The_DT health_NN care_NN workers_NNS aim_VBP at_IN saving_VBG lives_NNS and_CC alleviate_VB pain_NN and_CC suffering_NN ._. 
Their_PRP$ work_NN is_VBZ legally_RB regulated_VBN by_IN laws_NNS and_CC regulations_NNS ,_, and_CC professionally_RB by_IN guidelines_NNS ,_, instructions_NNS and_CC training_NN ._. 
In_IN all_DT their_PRP$ appearances_NNS the_DT producer_NN gave_VBD no_DT impression_NN of_IN intending_VBG to_TO harm_VB anyone_NN ,_, and_CC from_IN a_DT virtue-ethical_JJ standpoint_NN ,_, the_DT company_NN appeared_VBD favourably_RB -LRB-_-LRB- see_VB endnote_NN 1_CD -RRB-_-RRB- ._. 
When_WRB the_DT connection_NN between_IN the_DT swab_NN and_CC the_DT outbreak_NN was_VBD detected_VBN ,_, the_DT director_NN of_IN Sn_NN 
In_IN all_DT their_PRP$ appearances_NNS the_DT producer_NN gave_VBD no_DT impression_NN of_IN intending_VBG to_TO harm_VB anyone_NN ,_, and_CC from_IN a_DT virtue-ethical_JJ standpoint_NN ,_, the_DT company_NN appeared_VBD favourably_RB -LRB-_-LRB- see_VB endnote_NN 1_CD -RRB-_-RRB- ._. 
When_WRB the_DT connection_NN between_IN the_DT swab_NN and_CC the_DT outbreak_NN was_VBD detected_VBN ,_, the_DT director_NN of_IN Sn_NN 
aeruginosa_NN bacterium_NN was_VBD also_RB detected_VBN in_IN a_DT rubber_NN hose_NN leading_VBG from_IN a_DT water_NN tap_VB supplied_VBN with_IN municipal_JJ water_NN to_TO a_DT large_JJ steel_NN tank_NN used_VBN in_IN the_DT production_NN 
One_CD of_IN their_PRP$ new_JJ initiatives_NNS was_VBD to_TO partly_RB blame_VB the_DT outbreak_NN on_IN the_DT introduction_NN of_IN the_DT P._NNP Some_DT months_NNS later_RB the_DT company_NN started_VBD to_TO focus_VB more_RBR on_IN other_JJ factors_NNS influencing_VBG the_DT outbreak_NN ._. 
aeruginosa_NN bacterium_NN into_IN the_DT production_NN facilities_NNS through_IN the_DT municipal_JJ water_NN pipe_NN 
On_IN the_DT contrary_NN ,_, it_PRP is_VBZ common_JJ microbiological_JJ knowledge_NN that_IN P._NNP However_RB ,_, there_EX are_VBP no_DT requirements_NNS for_IN tap_VBP water_NN to_TO be_VB Pseudomonas_NNPS or_CC bacteria_NNS free_JJ ._. 
aeruginosa_NN at_IN times_NNS can_MD be_VB detected_VBN in_IN water_NN and_CC soil_NN ._. 
The_DT bacteria_NNS could_MD have_VB originated_VBN from_IN other_JJ sources_NNS and_CC contaminated_VBD the_DT rubber_NN hose_NN ._. 
Using_VBG the_DT ``_`` but-for_JJ ''_'' test_NN on_IN the_DT water_NN supply_NN fails_VBZ to_TO show_VB it_PRP to_TO be_VB a_DT cause-in-fact_NN due_JJ to_TO the_DT uncertainty_NN of_IN the_DT origin_NN of_IN the_DT first_JJ bacteria_NNS ._. 
On_IN the_DT contrary_NN ,_, it_PRP is_VBZ common_JJ microbiological_JJ knowledge_NN that_IN P._NNP However_RB ,_, there_EX are_VBP no_DT requirements_NNS for_IN tap_VBP water_NN to_TO be_VB Pseudomonas_NNPS or_CC bacteria_NNS free_JJ ._. 
aeruginosa_NN at_IN times_NNS can_MD be_VB detected_VBN in_IN water_NN and_CC soil_NN ._. 
The_DT bacteria_NNS could_MD have_VB originated_VBN from_IN other_JJ sources_NNS and_CC contaminated_VBD the_DT rubber_NN hose_NN ._. 
Using_VBG the_DT ``_`` but-for_JJ ''_'' test_NN on_IN the_DT water_NN supply_NN fails_VBZ to_TO show_VB it_PRP to_TO be_VB a_DT cause-in-fact_NN due_JJ to_TO the_DT uncertainty_NN of_IN the_DT origin_NN of_IN the_DT first_JJ bacteria_NNS ._. 
Hence_RB ,_, bacteria_NNS in_IN the_DT tap_VBP water_NN can_MD not_RB be_VB seen_VBN as_IN a_DT legal_JJ cause_NN of_IN the_DT outbreak_NN ._. 
Likewise_RB ,_, due_JJ to_TO the_DT uncertainty_NN of_IN the_DT origin_NN it_PRP fails_VBZ a_DT counterfactual_JJ NESS_NNP test_NN ._. 
Many_JJ of_IN the_DT hospitals_NNS had_VBD several_JJ deficiencies_NNS in_IN their_PRP$ QA_NNP systems_NNS ,_, for_IN instance_NN concerning_VBG the_DT selection_NN of_IN which_WDT products_NNS to_TO purchase_VB ;_: the_DT actual_JJ procurement_NN of_IN the_DT product_NN ;_: the_DT logistic_JJ system_NN for_IN reception_NN ,_, distribution_NN ,_, storage_NN ,_, and_CC use_NN of_IN the_DT product_NN ._. 
Many_JJ of_IN these_DT deficiencies_NNS are_VBP in_IN breach_NN of_IN national_JJ guidelines_NNS and_CC legal_JJ regulations_NNS but_CC did_VBD probably_RB not_RB have_VB any_DT influence_NN on_IN this_DT particular_JJ outbreak_NN ._. 
One_CD large_JJ hospital_NN reached_VBD a_DT court_NN settlement_NN on_IN 19_CD June_NNP 2006_CD with_IN the_DT producer_NN and_CC received_VBD compensation_NN amounting_VBG to_TO 3_CD ._. 
3million_NNP NOK_NNP -LRB-_-LRB- 
The_DT police_NN started_VBD an_DT investigation_NN of_IN the_DT producer_NN but_CC decided_VBD not_RB to_TO press_NN charges_NNS ._. ''_'' 
No_DT one_NN was_VBD made_VBN criminally_RB liable_JJ after_IN this_DT outbreak_NN ._. 
The_DT Norwegian_NNP Directorate_NNP for_IN Health_NNP and_CC Social_NNP Affairs_NNP appealed_VBD the_DT decision_NN several_JJ months_NNS after_IN the_DT time_NN limit_NN for_IN appeal_NN had_VBD expired_VBN ;_: hence_RB the_DT Attorney-General_NNP could_MD not_RB reopen_VB the_DT case_NN ._. 
Norsk_NN pasientskadeerstatning_NN -LRB-_-LRB- NPE_NNP ,_, the_DT Norwegian_NNP System_NNP of_IN Compensation_NNP to_TO Patients_NNPS -RRB-_-RRB- grants_VBZ monetary_JJ compensation_NN mainly_RB for_IN economical_JJ loss_NN and_CC to_TO some_DT degree_NN for_IN permanent_JJ disablement_NN due_JJ to_TO injury_NN inflicted_VBN as_IN a_DT result_NN of_IN treatment_NN in_IN public_JJ health_NN services_NNS in_IN Norway_NNP 
The_DT Norwegian_NNP Directorate_NNP for_IN Health_NNP and_CC Social_NNP Affairs_NNP appealed_VBD the_DT decision_NN several_JJ months_NNS after_IN the_DT time_NN limit_NN for_IN appeal_NN had_VBD expired_VBN ;_: hence_RB the_DT Attorney-General_NNP could_MD not_RB reopen_VB the_DT case_NN ._. 
Norsk_NN pasientskadeerstatning_NN -LRB-_-LRB- NPE_NNP ,_, the_DT Norwegian_NNP System_NNP of_IN Compensation_NNP to_TO Patients_NNPS -RRB-_-RRB- grants_VBZ monetary_JJ compensation_NN mainly_RB for_IN economical_JJ loss_NN and_CC to_TO some_DT degree_NN for_IN permanent_JJ disablement_NN due_JJ to_TO injury_NN inflicted_VBN as_IN a_DT result_NN of_IN treatment_NN in_IN public_JJ health_NN services_NNS in_IN Norway_NNP 
The_DT Norwegian_NNP Directorate_NNP for_IN Health_NNP and_CC Social_NNP Affairs_NNP appealed_VBD the_DT decision_NN several_JJ months_NNS after_IN the_DT time_NN limit_NN for_IN appeal_NN had_VBD expired_VBN ;_: hence_RB the_DT Attorney-General_NNP could_MD not_RB reopen_VB the_DT case_NN 
The_DT police_NN started_VBD an_DT investigation_NN of_IN the_DT producer_NN but_CC decided_VBD not_RB to_TO press_NN charges_NNS ._. ''_'' 
No_DT one_NN was_VBD made_VBN criminally_RB liable_JJ after_IN this_DT outbreak_NN ._. 
The_DT Norwegian_NNP Directorate_NNP for_IN Health_NNP and_CC Social_NNP Affairs_NNP appealed_VBD the_DT decision_NN several_JJ months_NNS after_IN the_DT time_NN limit_NN for_IN appeal_NN had_VBD expired_VBN ;_: hence_RB the_DT Attorney-General_NNP could_MD not_RB reopen_VB the_DT case_NN ._. 
Norsk_NN pasientskadeerstatning_NN -LRB-_-LRB- NPE_NNP ,_, the_DT Norwegian_NNP System_NNP of_IN Compensation_NNP to_TO Patients_NNPS -RRB-_-RRB- grants_VBZ monetary_JJ compensation_NN mainly_RB for_IN economical_JJ loss_NN and_CC to_TO some_DT degree_NN for_IN permanent_JJ disablement_NN due_JJ to_TO injury_NN inflicted_VBN as_IN a_DT result_NN of_IN treatment_NN in_IN public_JJ health_NN services_NNS in_IN Norway_NNP 
Of_IN 256_CD claims_NNS processed_VBD 48_CD were_VBD accepted_VBN for_IN compensation_NN and_CC 2_CD ._. 
By_IN 18_CD February_NNP 2004_CD ,_, NPE_NNP had_VBD received_VBN a_DT total_NN of_IN 287_CD claims_NNS ._. 
3million_NNP NOK_NNP -LRB-_-LRB- 
When_WRB human_JJ error_NN repetitively_RB occurs_VBZ within_IN a_DT system_NN it_PRP is_VBZ of_IN interest_NN to_TO discuss_VB whether_IN to_TO have_VB a_DT person_NN approach_NN or_CC a_DT system_NN approach_NN ._. 
If_IN preventing_VBG future_JJ errors_NNS is_VBZ the_DT aim_NN ,_, a_DT system_NN approach_NN appears_VBZ to_TO be_VB more_RBR rewarding_JJ ._. 
However_RB ,_, even_RB though_IN responsibility_NN of_IN the_DT management_NN does_VBZ not_RB free_VB the_DT individual_JJ employees_NNS from_IN responsibility_NN ,_, it_PRP would_MD be_VB fruitless_JJ to_TO try_VB to_TO identify_VB individual_JJ health_NN care_NN workers_NNS reusing_VBG the_DT swab_NN and_CC place_VB them_PRP under_IN moral_JJ and_CC legal_JJ scrutiny_NN ._. 
It_PRP can_MD be_VB argued_VBN that_IN the_DT reuse_NN of_IN the_DT swabs_NNS in_IN the_DT hospitals_NNS is_VBZ also_RB proximate_JJ ,_, at_IN least_JJS for_IN some_DT of_IN the_DT patients_NNS becoming_VBG infected_JJ during_IN the_DT outbreak_NN ._. 
Whether_IN the_DT individual_JJ HCW_NNP or_CC the_DT hospital_NN system_NN is_VBZ responsible_JJ is_VBZ open_JJ for_IN debate_NN ._. 
Why_WRB was_VBD no_DT one_NN criminally_RB charged_VBN in_IN this_DT outbreak_NN ._. 
We_PRP have_VBP argued_VBN for_IN a_DT causal_JJ association_NN between_IN the_DT contaminated_VBN swabs_NNS and_CC Pseudomonas_NNP infection_NN and_CC death_NN ,_, and_CC a_DT breech_NN of_IN regulations_NNS during_IN production_NN has_VBZ been_VBN established_VBN ._. 
It_PRP can_MD partly_RB be_VB ascribed_VBN to_TO the_DT nation_NN 's_POS economic_JJ poverty_NN up_RP until_IN a_DT few_JJ decades_NNS ago_RB and_CC to_TO our_PRP$ Lutheran_NNP tradition_NN of_IN modesty_NN -LRB-_-LRB- ``_`` In_IN the_DT sweat_NN of_IN thy_NN face_NN shalt_NN thou_NNS eat_VBP bread_NN ''_'' ,_, Genesis_NNP 3:19_CD -RRB-_-RRB- ._. 
This_DT demand_NN of_IN being_VBG economical_JJ is_VBZ also_RB reflected_VBN in_IN the_DT Act_NN on_IN health_NN personnel_NNS and_CC in_IN instructions_NNS from_IN the_DT hospital_NN management_NN ._. 
Single_JJ use_NN products_NNS are_VBP in_IN conflict_NN with_IN being_VBG economical_JJ ._. 
In_IN several_JJ hospitals_NNS it_PRP was_VBD accepted_VBN or_CC even_RB encouraged_VBD to_TO reuse_VB the_DT swabs_NNS ,_, possibly_RB considering_VBG them_PRP to_TO be_VB a_DT variant_NN of_IN the_DT tooth-brush_NN ._. 
The_DT producer_NN ,_, Sn_NN 
Consequently_RB ,_, the_DT deficient_JJ logistics_NNS systems_NNS in_IN the_DT hospitals_NNS appear_VBP not_RB to_TO be_VB a_DT cause-in-fact_NN of_IN this_DT outbreak_NN ._. 
However_RB ,_, competent_JJ procurers_NNS in_IN hospitals_NNS might_MD have_VB detected_VBN inferior_JJ products_NNS or_CC the_DT lack_NN of_IN documentation_NN ,_, such_JJ as_IN the_DT declaration_NN of_IN conformity_NN which_WDT is_VBZ required_VBN for_IN all_DT CE_NNP marked_VBD medical_JJ devices_NNS with_IN the_DT EU_NNP directive_NN ._. 
Health_NNP care_NN workers_NNS -LRB-_-LRB- HCWs_NNS -RRB-_-RRB- are_VBP constantly_RB told_VBN to_TO be_VB economical_JJ and_CC prudent_JJ in_IN the_DT use_NN of_IN medical_JJ equipment_NN ._. 
Moreover_RB ,_, if_IN the_DT moral_JJ norms_NNS of_IN the_DT producer_NN 's_POS responsibilities_NNS are_VBP adequately_RB regulated_VBN by_IN law_NN ,_, breaking_VBG these_DT legal_JJ regulations_NNS ,_, such_JJ as_IN the_DT Act_NN on_IN medical_JJ devices_NNS 
This_DT list_NN of_IN ``_`` Guidelines_NNS for_IN causation_NN ''_'' is_VBZ more_JJR in_IN tune_NN with_IN modern_JJ epidemiological_JJ science_NN as_IN they_PRP emphasize_VBP the_DT strength_NN of_IN association_NN rather_RB than_IN pure_JJ mechanical_JJ determinism_NN ._. 
However_RB ,_, many_JJ have_VBP criticised_VBN Hill_NNP 's_POS list_NN and_CC in_IN recent_JJ years_NNS there_EX has_VBZ been_VBN a_DT resurge_NN in_IN the_DT debate_NN about_IN causality_NN ._. 
Moreover_RB ,_, probabilistic_JJ graphical_JJ methods_NNS ,_, such_JJ as_IN Bayesian_JJ networks_NNS ,_, may_MD also_RB be_VB used_VBN in_IN order_NN to_TO represent_VB the_DT probabilistic_JJ independencies_NNS between_IN variables_NNS ._. 
The_DT NESS_NNP test_NN described_VBN above_IN is_VBZ a_DT clarification_NN or_CC specific_JJ instance_NN of_IN an_DT INUS_NNP condition_NN 
To_TO overcome_VB this_DT ,_, Mackie_NNP introduced_VBD the_DT so-called_JJ INUS_NNP condition_NN of_IN causation_NN ._. 
In_IN complex_JJ situations_NNS many_JJ factors_NNS contribute_VBP to_TO an_DT effect_NN ,_, and_CC there_EX are_VBP logistic_JJ problems_NNS in_IN that_IN an_DT event_NN occurs_VBZ some_DT but_CC not_RB all_DT times_NNS a_DT constellation_NN of_IN factors_NNS occurs_VBZ ._. 
An_DT INUS_NNP condition_NN for_IN some_DT effect_NN is_VBZ an_DT Insufficient_JJ but_CC Non-redundant_JJ part_NN of_IN an_DT Unnecessary_JJ but_CC Sufficient_JJ condition_NN 
There_EX will_MD not_RB be_VB an_DT outbreak_NN every_DT time_NN these_DT conditions_NNS occur_VBP ._. 
aeruginosa_NN in_IN the_DT mouth_NN swabs_NNS and_CC the_DT patients_NNS '_POS susceptibility_NN ,_, are_VBP not_RB sufficient_JJ for_IN the_DT outbreak_NN ._. 
Applying_VBG the_DT concept_NN of_IN the_DT INUS_NNP condition_NN is_VBZ helpful_JJ ._. 
Using_VBG contaminated_VBN swabs_NNS was_VBD in_IN itself_PRP insufficient_JJ but_CC non-redundant_JJ ,_, but_CC together_RB with_IN other_JJ factors_NNS like_IN the_DT susceptibility_NN of_IN the_DT patients_NNS ,_, the_DT infectious_JJ dose_NN ,_, and_CC underlying_VBG illnesses_NNS ,_, became_VBD sufficient_JJ to_TO infect_VB or_CC colonise_VB the_DT patient_NN ._. 
Counterfactual_JJ theories_NNS of_IN causation_NN in_IN sciences_NNS The_DT central_JJ question_NN in_IN counterfactual_JJ theories_NNS of_IN causation_NN is_VBZ ``_`` What_WP would_MD have_VB happened_VBN if_IN not_RB event_NN c_NN had_VBD happened_VBN ._. ''_'' 
And_CC the_DT answer_NN is_VBZ :_: ``_`` If_IN not_RB event_NN c_NN had_VBD occurred_VBN ,_, then_RB the_DT event_NN e_SYM would_MD not_RB have_VB occurred_VBN ''_'' ._. 
Counterfactual_JJ reasoning_NN can_MD be_VB used_VBN both_DT in_IN deterministic_JJ and_CC probabilistic_JJ models_NNS ._. 
In_IN daily_JJ life_NN and_CC in_IN medicine_NN counterfactual_JJ reasoning_NN is_VBZ extensively_RB used_VBN ._. 
e._VB Another_DT influential_JJ test_NN for_IN causation_NN is_VBZ the_DT NESS-test_JJ ,_, i._JJ One_CD standard_JJ method_NN of_IN establishing_VBG factual_JJ causation_NN is_VBZ the_DT ``_`` but-for_JJ ''_'' test_NN ,_, aiming_VBG at_IN excluding_VBG those_DT factors_NNS that_WDT had_VBD no_DT impact_NN on_IN the_DT course_NN of_IN events_NNS ._. 
Necessary_JJ Element_NN of_IN a_DT Sufficient_NNP Set_NNP test_NN ._. 
``_`` Proximate_JJ cause_NN ''_'' ,_, also_RB called_VBN ``_`` adequate_JJ cause_NN ''_'' ,_, embodies_VBZ reasons_NNS for_IN limiting_VBG the_DT extent_NN of_IN legal_JJ responsibility_NN and_CC liability_NN ._. 
The_DT ``_`` but-for_JJ ''_'' test_NN asks_VBZ :_: Would_MD the_DT consequences_NNS have_VBP occurred_VBN in_IN these_DT circumstances_NNS had_VBD the_DT condition_NN not_RB been_VBN present_JJ ._. 
The_DT NESS_NNP test_NN asks_VBZ :_: In_IN these_DT circumstances_NNS ,_, is_VBZ the_DT condition_NN a_DT necessary_JJ member_NN of_IN a_DT set_NN of_IN conditions_NNS that_WDT are_VBP together_RB sufficient_JJ to_TO produce_VB the_DT consequence_NN 
An_DT audit_NN of_IN the_DT producer_NN revealed_VBD serious_JJ breaches_NNS of_IN production_NN regulations_NNS 
There_EX are_VBP several_JJ examples_NNS from_IN recent_JJ history_NN in_IN Norway_NNP where_WRB the_DT accused_VBN was_VBD found_VBN not_RB guilty_JJ in_IN the_DT criminal_JJ court_NN case_NN but_CC was_VBD convicted_VBN to_TO pay_VB economic_JJ compensation_NN in_IN a_DT following_JJ civil_JJ lawsuit_NN ._. 
Causal_JJ connection_NN in_IN law_NN is_VBZ usually_RB divided_VBN into_IN two_CD parts_NNS ,_, ``_`` cause-in-fact_NN ''_'' and_CC ``_`` proximate_JJ cause_NN ''_'' ._. 
``_`` Cause-in-fact_NN ''_'' comes_VBZ closest_JJS to_TO what_WP is_VBZ regarded_VBN as_IN causality_NN in_IN science_NN ._. 
However_RB ,_, while_IN science_NN mostly_RB deals_VBZ with_IN causal_JJ generalisation_NN ,_, law_NN focuses_VBZ more_RBR on_IN causes_NNS of_IN specific_JJ events_NNS ._. 
e._VB Another_DT influential_JJ test_NN for_IN causation_NN is_VBZ the_DT NESS-test_JJ ,_, i._JJ One_CD standard_JJ method_NN of_IN establishing_VBG factual_JJ causation_NN is_VBZ the_DT ``_`` but-for_JJ ''_'' test_NN ,_, aiming_VBG at_IN excluding_VBG those_DT factors_NNS that_WDT had_VBD no_DT impact_NN on_IN the_DT course_NN of_IN events_NNS ._. 
Necessary_JJ Element_NN of_IN a_DT Sufficient_NNP Set_NNP test_NN ._. 
``_`` Proximate_JJ cause_NN ''_'' ,_, also_RB called_VBN ``_`` adequate_JJ cause_NN ''_'' ,_, embodies_VBZ reasons_NNS for_IN limiting_VBG the_DT extent_NN of_IN legal_JJ responsibility_NN and_CC liability_NN ._. 
An_DT INUS_NNP condition_NN for_IN some_DT effect_NN is_VBZ an_DT Insufficient_JJ but_CC Non-redundant_JJ part_NN of_IN an_DT Unnecessary_JJ but_CC Sufficient_JJ condition_NN 
g._JJ common_JJ cold_NN ,_, schizophrenia_NN or_CC meningitis_NNS -RRB-_-RRB- or_CC by_IN causal_JJ criteria_NNS -LRB-_-LRB- grouping_VBG ill_JJ persons_NNS with_IN respect_NN to_TO a_DT specified_JJ experience_NN believed_VBN to_TO be_VB a_DT cause_NN of_IN their_PRP$ illness_NN ,_, e._JJ lead_NN poisoning_NN or_CC meningococcal_JJ disease_NN -RRB-_-RRB- ._. 
To_TO have_VB a_DT Pseudomonas_NNP aeruginosa_NN infection_NN implies_VBZ by_IN name_NN and_CC definition_NN causality_NN of_IN the_DT bacterium_NN ._. 
The_DT NESS_NNP test_NN asks_VBZ :_: In_IN these_DT circumstances_NNS ,_, is_VBZ the_DT condition_NN a_DT necessary_JJ member_NN of_IN a_DT set_NN of_IN conditions_NNS that_WDT are_VBP together_RB sufficient_JJ to_TO produce_VB the_DT consequence_NN 
For_IN a_DT disease_NN like_IN cholera_NN John_NNP Snow_NNP ,_, the_DT father_NN of_IN epidemiology_NN ,_, was_VBD in_IN favor_NN of_IN the_DT theory_NN of_IN a_DT contagion_NN which_WDT he_PRP called_VBD ``_`` morbid_JJ matter_NN ''_'' 
For_IN a_DT disease_NN like_IN cholera_NN John_NNP Snow_NNP ,_, the_DT father_NN of_IN epidemiology_NN ,_, was_VBD in_IN favor_NN of_IN the_DT theory_NN of_IN a_DT contagion_NN which_WDT he_PRP called_VBD ``_`` morbid_JJ matter_NN ''_'' 
''_'' ``_`` If_IN you_PRP had_VBD n't_RB been_VBN exposed_VBN to_TO asbestos_NN ,_, you_PRP would_MD not_RB have_VB contracted_VBN mesothelioma_NN ._. 
``_`` If_IN the_DT needle_NN had_VBD n't_RB been_VBN contaminated_VBN ,_, the_DT patient_NN would_MD not_RB have_VB acquired_VBN hepatitis_NN ._. ''_'' 
Many_JJ of_IN the_DT epidemiological_JJ study_NN designs_NNS have_VBP counterfactual_JJ thinking_NN embodied_VBD ._. 
In_IN cohort_NN studies_NNS we_PRP compare_VBP exposed_JJ and_CC unexposed_JJ individuals_NNS for_IN a_DT certain_JJ risk_NN factor_NN ._. 
The_DT unexposed_JJ group_NN can_MD be_VB viewed_VBN as_IN ``_`` what_WP if_IN this_DT exposure_NN did_VBD not_RB occur_VB ''_'' ._. 
This_DT list_NN of_IN ``_`` Guidelines_NNS for_IN causation_NN ''_'' is_VBZ more_JJR in_IN tune_NN with_IN modern_JJ epidemiological_JJ science_NN as_IN they_PRP emphasize_VBP the_DT strength_NN of_IN association_NN rather_RB than_IN pure_JJ mechanical_JJ determinism_NN ._. 
However_RB ,_, many_JJ have_VBP criticised_VBN Hill_NNP 's_POS list_NN and_CC in_IN recent_JJ years_NNS there_EX has_VBZ been_VBN a_DT resurge_NN in_IN the_DT debate_NN about_IN causality_NN ._. 
Moreover_RB ,_, probabilistic_JJ graphical_JJ methods_NNS ,_, such_JJ as_IN Bayesian_JJ networks_NNS ,_, may_MD also_RB be_VB used_VBN in_IN order_NN to_TO represent_VB the_DT probabilistic_JJ independencies_NNS between_IN variables_NNS ._. 
Due_JJ to_TO criminal_JJ procedure_NN laws_NNS and_CC other_JJ factors_NNS outside_IN the_DT discourse_NN of_IN causality_NN ,_, no_DT one_NN was_VBD criminally_RB charged_VBN for_IN the_DT outbreak_NN which_WDT caused_VBD much_JJ suffering_NN and_CC shortening_VBG the_DT life_NN of_IN at_IN least_JJS 34_CD people_NNS ._. 
IntroductionIn_NNP 2002_CD ,_, we_PRP traced_VBD the_DT source_NN of_IN a_DT large_JJ outbreak_NN of_IN Pseudomonas_NNP aeruginosa_NN infections_NNS to_TO contaminated_VBN mouth_NN swabs_NNS extensively_RB used_VBN in_IN Norwegian_JJ health_NN care_NN 
Then_RB we_PRP will_MD discuss_VB the_DT responsibility_NN and_CC fallibility_NN for_IN two_CD of_IN the_DT main_JJ actors_NNS in_IN the_DT outbreak_NN ._. 
Setting_VBG the_DT sceneLate_NNP February_NNP 2002_CD ,_, the_DT Norwegian_NNP Institute_NNP of_IN Public_NNP Health_NNP -LRB-_-LRB- NIPH_NNP -RRB-_-RRB- was_VBD alerted_VBN of_IN a_DT possible_JJ increase_NN in_IN the_DT number_NN of_IN Pseudomonas_NNP infections_NNS in_IN clinical_JJ wards_NNS of_IN Norwegian_JJ hospitals_NNS ._. 
After_IN a_DT strenuous_JJ outbreak_NN investigation_NN ,_, on_IN 8_CD April_NNP 2002_CD ,_, the_DT outbreak_NN strain_NN was_VBD isolated_VBN from_IN a_DT domestically_RB produced_VBN mouth_NN swab_NN for_IN use_NN in_IN health_NN care_NN ,_, called_VBN ``_`` Dent-O-Sept_NNP ''_'' -LRB-_-LRB- figure_NN 1_CD -RRB-_-RRB- ._. 
For_IN at_IN least_JJS 34_CD patients_NNS the_DT investigators_NNS concluded_VBD that_IN the_DT P._NNP The_DT strain_NN was_VBD detected_VBN in_IN 231_CD patients_NNS from_IN 24_CD hospitals_NNS ,_, of_IN whom_WP 71_CD -LRB-_-LRB- 31_CD %_NN -RRB-_-RRB- died_VBD while_IN hospitalised_VBN ;_: all_DT had_VBD severe_JJ underlying_JJ disease_NN ._. 
aeruginosa_NN infection_NN probably_RB contributed_VBD to_TO the_DT patient_NN 's_POS death_NN ._. 
No_DT one_NN was_VBD found_VBN criminally_RB liable_JJ for_IN the_DT outbreak_NN ._. 
Two_CD of_IN the_DT authors_NNS -LRB-_-LRB- BGI_NNP and_CC PA_NNP -RRB-_-RRB- were_VBD responsible_JJ for_IN the_DT outbreak_NN investigation_NN at_IN the_DT Norwegian_NNP Institute_NNP of_IN Public_NNP Health_NNP 
No_DT one_NN was_VBD found_VBN criminally_RB liable_JJ for_IN the_DT outbreak_NN ._. 
aeruginosa_NN infection_NN probably_RB contributed_VBD to_TO the_DT patient_NN 's_POS death_NN ._. 
Two_CD of_IN the_DT authors_NNS -LRB-_-LRB- BGI_NNP and_CC PA_NNP -RRB-_-RRB- were_VBD responsible_JJ for_IN the_DT outbreak_NN investigation_NN at_IN the_DT Norwegian_NNP Institute_NNP of_IN Public_NNP Health_NNP 
Although_IN the_DT attention_NN was_VBD brought_VBN to_TO the_DT individual_JJ cases_NNS by_IN clinical_JJ manifestations_NNS -LRB-_-LRB- infections_NNS -RRB-_-RRB- ,_, we_PRP included_VBD in_IN the_DT outbreak_NN all_DT patients_NNS with_IN genotypically_RB identical_JJ strains_NNS of_IN P._NNP aeruginosa_NN ,_, irrespective_RB of_IN survival_NN or_CC severity_NN of_IN disease_NN ._. 
For_IN this_DT analysis_NN we_PRP will_MD make_VB it_PRP clear_JJ which_WDT of_IN the_DT four_CD different_JJ outcomes_NNS we_PRP have_VBP in_IN mind_NN ;_: 1_CD ._. 
being_VBG a_DT case_NN as_IN defined_VBN in_IN the_DT outbreak_NN investigation_NN ,_, 2_CD ._. 
Moreover_RB ,_, probabilistic_JJ graphical_JJ methods_NNS ,_, such_JJ as_IN Bayesian_JJ networks_NNS ,_, may_MD also_RB be_VB used_VBN in_IN order_NN to_TO represent_VB the_DT probabilistic_JJ independencies_NNS between_IN variables_NNS ._. 
Causation_NN in_IN the_DT Dent-O-Sept_NNP caseWe_NNP have_VBP now_RB presented_VBN theories_NNS for_IN causation_NN ,_, which_WDT can_MD now_RB be_VB applied_VBN in_IN a_DT specific_JJ case_NN ,_, the_DT Dent-O-Sept_NNP outbreak_NN in_IN Norway_NNP in_IN 2002_CD ._. 
Necessary_JJ and_CC sufficient_JJ conditions_NNS The_DT P._NNP aeruginosa_NN bacterium_NN is_VBZ not_RB a_DT necessary_JJ and_CC sufficient_JJ condition_NN for_IN the_DT death_NN of_IN people_NNS ._. 
3._CD 
aeruginosa_JJ ,_, adjusted_JJ odds_NNS ratio_NN 5_CD ._. 
Association_NNP for_IN having_VBG used_VBN the_DT swab_NN during_IN hospitalisation_NN and_CC having_VBG the_DT outbreak_NN strain_NN of_IN P._NNP Detecting_VBG genotypically_RB identical_JJ strains_NNS of_IN the_DT bacterium_NN in_IN patients_NNS ,_, the_DT product_NN and_CC in_IN the_DT production_NN facility_NN 2_CD ._. 
Consistency_NN of_IN as_IN 
There_EX are_VBP many_JJ other_JJ outbreaks_NNS caused_VBN by_IN medical_JJ devices_NNS ._. 
Analogy_NNP Yes_NNP ._. 
9._CD 
When_WRB the_DT source_NN was_VBD removed_VBN the_DT number_NN of_IN cases_NNS gradually_RB diminished_VBD to_TO zero_CD ._. 
-LRB-_-LRB- References_NNPS in_IN -RRB-_-RRB- Key_NNP actorsWe_NNP will_MD now_RB in_IN some_DT more_JJR detail_NN analyze_VB key_JJ actors_NNS -LRB-_-LRB- table_NN 2_CD -RRB-_-RRB- and_CC events_NNS in_IN the_DT light_NN of_IN causation_NN and_CC prepare_VB for_IN the_DT next_JJ section_NN on_IN moral_JJ responsibility_NN ._. 
Table_NNP 2_CD The_DT main_JJ participants_NNS in_IN the_DT Dent-O-Sept_NNP outbreak_NN and_CC some_DT of_IN their_PRP$ roles_NNS ,_, responsibilities_NNS and_CC actions_NNS ._. 
Arushed_JJ investigation_NN might_MD have_VB resulted_VBN in_IN not_RB detecting_VBG the_DT cause_NN or_CC getting_VBG the_DT results_NNS wrong_JJ ,_, whereas_IN a_DT broad_JJ ,_, systematic_JJ investigation_NN might_MD have_VB taken_VBN too_RB long_RB causing_VBG unnecessary_JJ sufferings_NNS and_CC deaths_NNS ._. 
As_IN two_CD of_IN the_DT authors_NNS of_IN this_DT article_NN -LRB-_-LRB- BGI_NNP and_CC PA_NNP -RRB-_-RRB- were_VBD responsible_JJ for_IN the_DT outbreak_NN investigation_NN we_PRP are_VBP not_RB competent_JJ to_TO appraise_VB the_DT investigation_NN ._. 
In_IN conclusion_NN ,_, many_JJ factors_NNS contributed_VBD to_TO the_DT outbreak_NN and_CC its_PRP$ eventual_JJ dimension_NN ._. 
The_DT main_JJ necessary_JJ condition_NN for_IN the_DT outbreak_NN was_VBD the_DT contamination_NN of_IN the_DT swabs_NNS in_IN the_DT production_NN facility_NN ._. 
Introduction_NN In_IN 2002_CD ,_, we_PRP traced_VBD the_DT source_NN of_IN a_DT large_JJ outbreak_NN of_IN Pseudomonas_NNP aeruginosa_NN infections_NNS to_TO contaminated_VBN mouth_NN swabs_NNS extensively_RB used_VBN in_IN Norwegian_JJ health_NN care_NN 
Figure_NNP 1_CD The_DT Dent-O-Sept_NNP mouth_NN swab_NN ._. 
The_DT finding_NN was_VBD publicised_VBN ,_, the_DT product_NN was_VBD recalled_VBN ,_, and_CC the_DT production_NN ceased_VBD permanently_RB ._. 
The_DT outbreak_NN strain_NN was_VBD detected_VBN in_IN swabs_NNS from_IN 12_CD batches_NNS produced_VBN in_IN 2001_CD and_CC 2002_CD 
No_DT one_NN was_VBD found_VBN criminally_RB liable_JJ for_IN the_DT outbreak_NN ._. 
aeruginosa_NN infection_NN probably_RB contributed_VBD to_TO the_DT patient_NN 's_POS death_NN ._. 
Two_CD of_IN the_DT authors_NNS -LRB-_-LRB- BGI_NNP and_CC PA_NNP -RRB-_-RRB- were_VBD responsible_JJ for_IN the_DT outbreak_NN investigation_NN at_IN the_DT Norwegian_NNP Institute_NNP of_IN Public_NNP Health_NNP 
Moreover_RB ,_, probabilistic_JJ graphical_JJ methods_NNS ,_, such_JJ as_IN Bayesian_JJ networks_NNS ,_, may_MD also_RB be_VB used_VBN in_IN order_NN to_TO represent_VB the_DT probabilistic_JJ independencies_NNS between_IN variables_NNS ._. 
Causation_NN in_IN the_DT Dent-O-Sept_NNP caseWe_NNP have_VBP now_RB presented_VBN theories_NNS for_IN causation_NN ,_, which_WDT can_MD now_RB be_VB applied_VBN in_IN a_DT specific_JJ case_NN ,_, the_DT Dent-O-Sept_NNP outbreak_NN in_IN Norway_NNP in_IN 2002_CD ._. 
Necessary_JJ and_CC sufficient_JJ conditions_NNS The_DT P._NNP aeruginosa_NN bacterium_NN is_VBZ not_RB a_DT necessary_JJ and_CC sufficient_JJ condition_NN for_IN the_DT death_NN of_IN people_NNS ._. 
Temporal_JJ sequence_NN of_IN association_NN Yes_RB ._. 
4._CD 
aeruginosa_NN infection_NN varied_VBD widely_RB ._. 
The_DT clinical_JJ manifestations_NNS of_IN the_DT P._NNP However_RB ,_, the_DT outbreak_NN strain_NN of_IN the_DT bacteria_NNS was_VBD found_VBN in_IN six_CD patients_NNS before_IN the_DT production_NN of_IN the_DT first_JJ contaminated_VBN batch_NN of_IN swabs_NNS was_VBD detected_VBN ._. 
When_WRB the_DT swabs_NNS were_VBD withdrawn_VBN from_IN the_DT marked_VBN the_DT number_NN of_IN cases_NNS gradually_RB diminished_VBN and_CC disappeared_VBN ._. 
This_DT differed_VBD even_RB in_IN swabs_NNS produced_VBN at_IN the_DT same_JJ time_NN of_IN day_NN on_IN the_DT same_JJ date_NN ._. 
The_DT presence_NN of_IN the_DT outbreak_NN strain_NN in_IN the_DT production_NN facility_NN was_VBD necessary_JJ for_IN contamination_NN to_TO occur_VB ,_, but_CC not_RB sufficient_JJ as_IN not_RB all_DT swabs_NNS were_VBD contaminated_VBN ._. 
The_DT main_JJ hypothesis_NN of_IN the_DT outbreak_NN investigation_NN team_NN was_VBD that_IN bacteria-containing_JJ biofilm_NN was_VBD randomly_RB shed_VBN from_IN the_DT production_NN equipment_NN into_IN the_DT swab_NN wraps_VBZ ._. 
Using_VBG the_DT judicial_JJ ,_, counterfactual_JJ ``_`` but-for_JJ ''_'' test_NN :_: ``_`` But-for_JJ the_DT absence_NN of_IN a_DT microbiological_JJ quality_NN control_NN of_IN the_DT production_NN equipment_NN and_CC the_DT final_JJ product_NN ,_, would_MD the_DT contamination_NN have_VBP been_VBN detected_VBN earlier_RBR and_CC the_DT outbreak_NN avoided_VBD ._. 
Atotal_NNP of_IN 76_CD of_IN 1565_CD swabs_NNS examined_VBN during_IN the_DT outbreak_NN investigation_NN contained_VBD the_DT outbreak_NN strain_NN of_IN P._NNP aeruginosa_NN ,_, and_CC more_JJR than_IN 250_CD swabs_NNS -LRB-_-LRB- 16_CD %_NN -RRB-_-RRB- contained_VBD one_CD or_CC more_JJR microbes_NNS -LRB-_-LRB- including_VBG the_DT outbreak_NN strain_NN -RRB-_-RRB- ,_, also_RB in_IN swabs_NNS produced_VBD years_NNS before_IN the_DT Dent-O-Sept_NNP outbreak_NN started_VBD ._. 
Consequently_RB ,_, not_RB abiding_VBG by_IN the_DT requirement_NN to_TO have_VB QA_NNP systems_NNS including_VBG an_DT effective_JJ microbiological_JJ control_NN system_NN can_MD be_VB seen_VBN as_IN a_DT cause_NN in_IN the_DT legal_JJ sense_NN for_IN this_DT outbreak_NN to_TO occur_VB ._. 
The_DT P._NNP The_DT same_JJ goes_VBZ if_IN we_PRP apply_VBP a_DT counterfactual_JJ NESS_NNP test_NN ._. 
Consequently_RB ,_, not_RB abiding_VBG by_IN the_DT requirement_NN to_TO have_VB QA_NNP systems_NNS including_VBG an_DT effective_JJ microbiological_JJ control_NN system_NN can_MD be_VB seen_VBN as_IN a_DT cause_NN in_IN the_DT legal_JJ sense_NN for_IN this_DT outbreak_NN to_TO occur_VB ._. 
aeruginosa_NN bacterium_NN was_VBD also_RB detected_VBN in_IN a_DT rubber_NN hose_NN leading_VBG from_IN a_DT water_NN tap_VB supplied_VBN with_IN municipal_JJ water_NN to_TO a_DT large_JJ steel_NN tank_NN used_VBN in_IN the_DT production_NN 
Arushed_JJ investigation_NN might_MD have_VB resulted_VBN in_IN not_RB detecting_VBG the_DT cause_NN or_CC getting_VBG the_DT results_NNS wrong_JJ ,_, whereas_IN a_DT broad_JJ ,_, systematic_JJ investigation_NN might_MD have_VB taken_VBN too_RB long_RB causing_VBG unnecessary_JJ sufferings_NNS and_CC deaths_NNS ._. 
As_IN two_CD of_IN the_DT authors_NNS of_IN this_DT article_NN -LRB-_-LRB- BGI_NNP and_CC PA_NNP -RRB-_-RRB- were_VBD responsible_JJ for_IN the_DT outbreak_NN investigation_NN we_PRP are_VBP not_RB competent_JJ to_TO appraise_VB the_DT investigation_NN ._. 
In_IN conclusion_NN ,_, many_JJ factors_NNS contributed_VBD to_TO the_DT outbreak_NN and_CC its_PRP$ eventual_JJ dimension_NN ._. 
The_DT main_JJ necessary_JJ condition_NN for_IN the_DT outbreak_NN was_VBD the_DT contamination_NN of_IN the_DT swabs_NNS in_IN the_DT production_NN facility_NN ._. 
The_DT concept_NN of_IN causality_NN is_VBZ intuitively_RB simple_JJ and_CC yet_RB so_RB intricately_RB complex_JJ ._. 
Two_CD examples_NNS are_VBP the_DT debate_NN on_IN where_WRB the_DT Spanish_JJ flu_NN came_VBD from_IN and_CC who_WP was_VBD responsible_JJ for_IN starting_VBG the_DT Aids_NNP epidemic_NN ._. 
In_IN epidemiology_NN causality_NN has_VBZ been_VBN hotly_RB debated_VBN 
Consequently_RB one_PRP can_MD never_RB prove_VB causality_NN between_IN factors_NNS and_CC an_DT outcome_NN ,_, only_RB strengthen_VB or_CC weaken_VB a_DT proposed_VBN association_NN ._. 
In_IN this_DT tradition_NN Sir_NNP Austin_NNP Bradford_NNP Hill_NNP listed_VBD nine_CD viewpoints_NNS from_IN which_WDT to_TO study_VB the_DT association_NN of_IN two_CD variables_NNS in_IN order_NN to_TO claim_VB causation_NN ._. 
Causation_NN in_IN epidemiology_JJ Classic_JJ epidemiology_NN has_VBZ been_VBN mai_FW 
In_IN epidemiology_NN ,_, probabilistic_JJ approaches_NNS are_VBP most_RBS often_RB used_VBN in_IN the_DT conceptual_JJ thinking_NN of_IN a_DT relationship_NN and_CC in_IN the_DT statistical_JJ testing_NN of_IN the_DT strength_NN of_IN association_NN 
This_DT list_NN of_IN ``_`` Guidelines_NNS for_IN causation_NN ''_'' is_VBZ more_JJR in_IN tune_NN with_IN modern_JJ epidemiological_JJ science_NN as_IN they_PRP emphasize_VBP the_DT strength_NN of_IN association_NN rather_RB than_IN pure_JJ mechanical_JJ determinism_NN ._. 
However_RB ,_, many_JJ have_VBP criticised_VBN Hill_NNP 's_POS list_NN and_CC in_IN recent_JJ years_NNS there_EX has_VBZ been_VBN a_DT resurge_NN in_IN the_DT debate_NN about_IN causality_NN ._. 
Moreover_RB ,_, probabilistic_JJ graphical_JJ methods_NNS ,_, such_JJ as_IN Bayesian_JJ networks_NNS ,_, may_MD also_RB be_VB used_VBN in_IN order_NN to_TO represent_VB the_DT probabilistic_JJ independencies_NNS between_IN variables_NNS ._. 
That_DT is_VBZ ,_, the_DT outcome_NN -LRB-_-LRB- effect_NN -RRB-_-RRB- may_MD vary_VB according_VBG to_TO probability_NN distribution_NN ._. 
Probabilistic_JJ causality_NN on_IN the_DT other_JJ hand_NN claims_NNS that_IN the_DT causal_JJ relationship_NN is_VBZ probabilistic_JJ ,_, and_CC not_RB invariant_JJ ._. 
Probabilistic_JJ theories_NNS of_IN causation_NN state_NN that_WDT causes_VBZ raise_VB the_DT probabilities_NNS of_IN their_PRP$ effects_NNS 
Probabilistic_JJ theories_NNS of_IN causation_NN state_NN that_WDT causes_VBZ raise_VB the_DT probabilities_NNS of_IN their_PRP$ effects_NNS 
In_IN the_DT field_NN of_IN psychology_NN ,_, Shadish_FW et_FW al._FW ._. 
In_IN an_DT early_JJ contribution_NN to_TO counterfactual_JJ reasoning_NN about_IN causation_NN ,_, the_DT philosopher_NN Mackie_NNP argued_VBD that_IN we_PRP must_MD consider_VB conditions_NNS as_RB well_RB as_IN actions_NNS to_TO be_VB potential_JJ causes_NNS -LRB-_-LRB- chapter_NN 2_CD -RRB-_-RRB- ._. 
From_IN epidemiology_NN ,_, we_PRP quote_VBP Rothman_NNP and_CC Greenland_NNP :_: ``_`` We_PRP can_MD define_VB a_DT cause_NN of_IN a_DT specific_JJ disease_NN as_IN an_DT antecedent_JJ event_NN ,_, condition_NN ,_, or_CC characteristic_NN that_WDT was_VBD necessary_JJ for_IN the_DT occurrence_NN of_IN the_DT disease_NN at_IN the_DT moment_NN it_PRP occurred_VBD ,_, given_VBN that_IN other_JJ conditions_NNS are_VBP fixed_VBN ._. ''_'' 
-LRB-_-LRB- p._NN 8_CD ,_, our_PRP$ italics_NNS -RRB-_-RRB- ._. 
Note_VB As_IN Greenland_NNP describes_VBZ ,_, when_WRB we_PRP study_VBP an_DT exposure_NN as_IN a_DT cause_NN ,_, our_PRP$ goal_NN is_VBZ to_TO compare_VB the_DT outcomes_NNS of_IN the_DT same_JJ people_NNS in_IN the_DT exposed_JJ and_CC the_DT unexposed_JJ state_NN ._. 
Sander_NNP Greenland_NNP 's_POS elegant_JJ paper_NN raises_VBZ deep_JJ questions_NNS about_IN the_DT way_NN in_IN which_WDT we_PRP choose_VBP and_CC evaluate_VBP public_JJ health_NN actions_NNS ._. 
We_PRP agree_VBP with_IN the_DT main_JJ thrust_NN of_IN his_PRP$ argument_NN with_IN respect_NN to_TO public_JJ health_NN policy_NN ._. 
We_PRP have_VBP some_DT concerns_NNS ,_, however_RB ,_, about_IN his_PRP$ treatment_NN of_IN social_JJ causes_NNS ,_, and_CC on_IN this_DT point_NN we_PRP focus_VBP our_PRP$ critique_NN ._. 
But_CC it_PRP has_VBZ turned_VBN out_RP to_TO be_VB extremely_RB difficult_JJ to_TO reduce_VB the_DT smoking_NN epidemic_JJ worldwide_NN over_IN the_DT past_JJ half_JJ century_NN ._. 
While_IN cigarette_NN consumption_NN per_IN person_NN has_VBZ declined_VBN in_IN some_DT high_JJ income_NN countries_NNS over_IN the_DT past_JJ few_JJ decades_NNS ,_, the_DT global_JJ impact_NN on_IN health_NN continues_VBZ to_TO accumulate_VB ,_, with_IN a_DT predicted_VBN rise_NN in_IN smoking-related_JJ illness_NN and_CC death_NN in_IN low_JJ and_CC middle_JJ income_NN countries_NNS ,_, where_WRB the_DT vast_JJ majority_NN of_IN the_DT world_NN 's_POS more_JJR than_IN one_CD billion_CD smokers_NNS now_RB live_VBP ._. 
On_IN the_DT other_JJ hand_NN ,_, raising_VBG levels_NNS of_IN education_NN ,_, which_WDT may_MD at_IN first_RB seem_VBP a_DT more_RBR difficult_JJ task_NN ,_, has_VBZ actually_RB been_VBN achieved_VBN throughout_IN much_JJ of_IN the_DT globe_NN over_IN the_DT same_JJ period_NN ._. 
But_CC it_PRP has_VBZ turned_VBN out_RP to_TO be_VB extremely_RB difficult_JJ to_TO reduce_VB the_DT smoking_NN epidemic_JJ worldwide_NN over_IN the_DT past_JJ half_JJ century_NN ._. 
While_IN cigarette_NN consumption_NN per_IN person_NN has_VBZ declined_VBN in_IN some_DT high_JJ income_NN countries_NNS over_IN the_DT past_JJ few_JJ decades_NNS ,_, the_DT global_JJ impact_NN on_IN health_NN continues_VBZ to_TO accumulate_VB ,_, with_IN a_DT predicted_VBN rise_NN in_IN smoking-related_JJ illness_NN and_CC death_NN in_IN low_JJ and_CC middle_JJ income_NN countries_NNS ,_, where_WRB the_DT vast_JJ majority_NN of_IN the_DT world_NN 's_POS more_JJR than_IN one_CD billion_CD smokers_NNS now_RB live_VBP 
The_DT inclusion_NN of_IN conditions_NNS as_IN causes_NNS has_VBZ a_DT long_JJ tradition_NN under_IN counterfactual_JJ reasoning_NN ._. 
Finally_RB ,_, we_PRP suggest_VBP that_IN although_IN epidemiologists_NNS most_RBS often_RB study_NN conditions_NNS rather_RB than_IN actions_NNS ,_, counterfactual_JJ reasoning_NN is_VBZ applicable_JJ to_TO our_PRP$ discipline_NN ._. 
In_IN an_DT early_JJ contribution_NN to_TO counterfactual_JJ reasoning_NN about_IN causation_NN ,_, the_DT philosopher_NN Mackie_NNP argued_VBD that_IN we_PRP must_MD consider_VB conditions_NNS as_RB well_RB as_IN actions_NNS to_TO be_VB potential_JJ causes_NNS -LRB-_-LRB- chapter_NN 2_CD -RRB-_-RRB- ._. 
In_IN the_DT field_NN of_IN psychology_NN ,_, Shadish_FW et_FW al._FW ._. 
According_VBG to_TO evolution_NN theory_NN ,_, selection_NN does_VBZ not_RB operate_VB with_IN any_DT particular_JJ goal_NN in_IN mind_NN ;_: it_PRP simply_RB optimizes_VBZ the_DT perpetuation_NN of_IN DNA_NN across_IN time_NN by_IN constructing_VBG bodies_NNS capable_JJ of_IN carrying_VBG the_DT DNA_NN and_CC passing_VBG it_PRP successfully_RB from_IN one_CD generation_NN to_TO the_DT next_JJ ._. 
This_DT idea_NN has_VBZ since_IN appeared_VBN several_JJ times_NNS in_IN the_DT published_VBN literature_NN in_IN the_DT 20th_JJ century_NN ,_, including_VBG the_DT first_JJ detailed_JJ presentation_NN of_IN morphology_NN and_CC body_NN design_NN 
Biochemical_JJ constraints_NNS involve_VBP the_DT inevitable_JJ accumulation_NN of_IN damage_NN that_WDT occurs_VBZ at_IN all_DT levels_NNS of_IN biological_JJ organization_NN ,_, including_VBG the_DT maintenance_NN and_CC repair_NN processes_VBZ themselves_PRP 
An_DT important_JJ message_NN in_IN this_DT paper_NN is_VBZ that_DT biology_NN reminds_VBZ us_PRP that_IN evolutionary_JJ success_NN does_VBZ not_RB require_VB living_NN to_TO old_JJ age_NN ,_, it_PRP only_RB requires_VBZ living_VBG long_RB enough_RB to_TO reproduce_VB ._. 
Our_PRP$ bodies_NNS fail_VBP over_IN time_NN not_RB because_IN they_PRP were_VBD designed_VBN to_TO fall_VB victim_NN to_TO aging_NN and_CC disease_NN at_IN a_DT predetermined_VBN age_NN ,_, or_CC even_RB because_IN of_IN the_DT acquisition_NN of_IN risk_NN factors_NNS and_CC decadent_JJ lifestyles_NNS ,_, but_CC because_IN they_PRP were_VBD not_RB designed_VBN for_IN extended_JJ operation_NN ._. 
The_DT diseases_NNS and_CC disorders_NNS we_PRP experience_VBP in_IN the_DT post-reproductive_JJ period_NN of_IN the_DT lifespan_NN are_VBP ,_, therefore_RB ,_, not_RB flaws_NNS from_IN an_DT evolutionary_JJ perspective_NN ,_, and_CC unless_IN proven_VBN otherwise_RB ,_, should_MD not_RB be_VB attributed_VBN to_TO personal_JJ failure_NN or_CC exclusive_JJ by-products_NNS of_IN environmental_JJ risk_NN factors_NNS ._. 
Rapid_NNP declines_NNS in_IN death_NN rates_NNS at_IN younger_JJR ages_NNS led_VBD to_TO a_DT redistribution_NN of_IN death_NN from_IN the_DT young_JJ to_TO the_DT old_JJ ,_, contributing_VBG to_TO the_DT accompanying_JJ 30-year_JJ rise_NN in_IN life_NN expectancy_NN that_WDT occurred_VBD over_IN the_DT century_NN ._. 
Although_IN the_DT rise_NN in_IN life_NN expectancy_NN in_IN the_DT 20th_JJ century_NN is_VBZ a_DT triumph_NN of_IN public_JJ health_NN and_CC modern_JJ medicine_NN ,_, the_DT price_NN paid_VBN for_IN this_DT great_JJ success_NN is_VBZ a_DT developed_JJ world_NN dominated_VBN by_IN the_DT dual_JJ demographic_JJ landmarks_NNS of_IN population_NN growth_NN and_CC population_NN aging_NN 
,smoking_JJ ,_, fatty_JJ foods_NNS ,_, obesity_NN ,_, stress_NN ,_, etc._FW g._FW Although_IN scientific_JJ studies_NNS based_VBN on_IN theoretical_JJ and_CC methodological_JJ principles_NNS of_IN epidemiology_NN have_VBP been_VBN instrumental_JJ in_IN identifying_VBG risk_NN factors_NNS for_IN chronic_JJ degenerative_JJ diseases_NNS -LRB-_-LRB- e._NN ,_, and_CC their_PRP$ effects_NNS on_IN heart_NN disease_NN ,_, stroke_NN ,_, and_CC many_JJ cancers_NNS -RRB-_-RRB- 
The_DT necessity_NN for_IN more_JJR and_CC better_JJR data_NNS led_VBD epidemiologists_NNS to_TO forge_VB collaborative_JJ ties_NNS with_IN policy_NN makers_NNS and_CC biostatisticians_NNS in_IN order_NN to_TO develop_VB reliable_JJ reporting_NN systems_NNS for_IN vital_JJ events_NNS ,_, such_JJ as_IN births_NNS ,_, deaths_NNS ,_, and_CC the_DT identification_NN and_CC distribution_NN of_IN specific_JJ diseases_NNS ._. 
These_DT collaborations_NNS with_IN scientists_NNS from_IN other_JJ disciplines_NNS exemplify_VBP the_DT important_JJ interdisciplinary_JJ background_NN of_IN the_DT field_NN ._. 
The_DT biology_NN of_IN association_NN -LRB-_-LRB- with_IN the_DT exception_NN of_IN genetic_JJ heterogeneity_NN -RRB-_-RRB- is_VBZ neither_RB the_DT main_JJ focus_NN of_IN 
Rapid_NNP declines_NNS in_IN death_NN rates_NNS at_IN younger_JJR ages_NNS led_VBD to_TO a_DT redistribution_NN of_IN death_NN from_IN the_DT young_JJ to_TO the_DT old_JJ ,_, contributing_VBG to_TO the_DT accompanying_JJ 30-year_JJ rise_NN in_IN life_NN expectancy_NN that_WDT occurred_VBD over_IN the_DT century_NN ._. 
Although_IN the_DT rise_NN in_IN life_NN expectancy_NN in_IN the_DT 20th_JJ century_NN is_VBZ a_DT triumph_NN of_IN public_JJ health_NN and_CC modern_JJ medicine_NN ,_, the_DT price_NN paid_VBN for_IN this_DT great_JJ success_NN is_VBZ a_DT developed_JJ world_NN dominated_VBN by_IN the_DT dual_JJ demographic_JJ landmarks_NNS of_IN population_NN growth_NN and_CC population_NN aging_NN 
British_JJ actuary_NN Benjamin_NNP Gompertz_NNP provided_VBD the_DT first_JJ mathematical_JJ support_NN for_IN this_DT view_NN by_IN demonstrating_VBG that_IN for_IN a_DT significant_JJ portion_NN of_IN the_DT human_JJ lifespan_NN ,_, the_DT risk_NN of_IN death_NN rises_NNS exponentially_RB with_IN age_NN 
The_DT modern_JJ notion_NN of_IN the_DT biodemography_NN of_IN aging_NN arose_VBN in_IN the_DT early_JJ 1990s_NNS ,_, as_IN scientists_NNS from_IN a_DT broad_JJ range_NN of_IN scientific_JJ backgrounds_NNS began_VBD speculating_VBG about_IN the_DT biological_JJ forces_NNS responsible_JJ for_IN the_DT similar_JJ age_NN patterns_NNS of_IN death_NN that_IN they_PRP observed_VBD among_IN sexually-reproducing_JJ species_NNS ._. 
The_DT theoretical_JJ basis_NN for_IN the_DT biodemography_NN of_IN aging_NN is_VBZ derived_VBN principally_RB from_IN evolutionary_JJ biology_NN 
The_DT theoretical_JJ basis_NN for_IN the_DT biodemography_NN of_IN aging_NN is_VBZ derived_VBN principally_RB from_IN evolutionary_JJ biology_NN 
Evolution_NN is_VBZ blind_JJ to_TO the_DT health_NN consequences_NNS of_IN genes_NNS expressed_VBN in_IN older_JJR regions_NNS of_IN the_DT lifespan_NN because_IN there_EX is_VBZ no_DT selection_NN to_TO act_VB upon_IN them_PRP once_RB they_PRP have_VBP been_VBN propagated_VBN ._. 
Empirical_JJ tests_NNS of_IN this_DT hypothesis_NN have_VBP shown_VBN that_IN the_DT age_NN trajectory_NN of_IN death_NN is_VBZ ,_, in_IN fact_NN ,_, a_DT species-specific_JJ phenomenon_NN that_IN ,_, as_IN predicted_VBN from_IN evolution_NN theory_NN ,_, is_VBZ calibrated_VBN to_TO the_DT onset_NN and_CC length_NN of_IN a_DT species_NNS '_POS reproductive_JJ window_NN ._. 
The_DT reproductive_JJ window_NN ,_, in_IN turn_NN ,_, is_VBZ a_DT genetically_RB determined_VBN attribute_NN that_WDT is_VBZ established_VBN as_IN part_NN of_IN a_DT life_NN history_NN strategy_NN that_WDT has_VBZ been_VBN molded_VBN by_IN the_DT environment_NN within_IN which_WDT each_DT species_NNS evolved_VBD ._. 
An_DT epidemiological_JJ view_NN of_IN disease_NN and_CC death_NN Epidemiology_NNP developed_VBD from_IN the_DT long_JJ history_NN of_IN human_JJ experience_NN with_IN infectious_JJ disease_NN epidemics_NNS ._. 
An_DT empirically-based_JJ science_NN arising_VBG during_IN the_DT 18th_JJ and_CC 19th_JJ centuries_NNS ,_, the_DT driving_VBG force_NN of_IN the_DT discipline_NN is_VBZ an_DT effort_NN to_TO explain_VB and_CC understand_VB in_IN humans_NNS ,_, non-random_JJ health-related_JJ attributes_NNS of_IN small_JJ and_CC large_JJ populations_NNS ,_, ranging_VBG from_IN the_DT clustering_NN of_IN fevers_NNS to_TO age_NN shifts_NNS in_IN populations_NNS across_IN time_NN ._. 
The_DT necessity_NN for_IN more_JJR and_CC better_JJR data_NNS led_VBD epidemiologists_NNS to_TO forge_VB collaborative_JJ ties_NNS with_IN policy_NN makers_NNS and_CC biostatisticians_NNS in_IN order_NN to_TO develop_VB reliable_JJ reporting_NN systems_NNS for_IN vital_JJ events_NNS ,_, such_JJ as_IN births_NNS ,_, deaths_NNS ,_, and_CC the_DT identification_NN and_CC distribution_NN of_IN specific_JJ diseases_NNS ._. 
,demographers_NNS and_CC epidemiologists_NNS -RRB-_-RRB- in_IN order_NN to_TO provide_VB a_DT biological_JJ rationale_NN for_IN the_DT timing_NN and_CC causes_NNS of_IN death_NN in_IN humans_NNS and_CC other_JJ sexually_RB reproducing_VBG species_NNS ._. 
The_DT earliest_JJS antecedents_NNS to_TO the_DT modern_JJ biodemography_NN of_IN aging_VBG date_NN back_RB to_TO the_DT French_JJ zoologist_NN Georges_NNP Buffon_NNP ,_, who_WP demonstrated_VBD that_IN ``_`` physical_JJ laws_NNS ''_'' regulate_VB the_DT duration_NN of_IN life_NN in_IN humans_NNS and_CC other_JJ species_NNS ._. 
These_DT physical_JJ laws_NNS ,_, according_VBG to_TO Buffon_NNP ,_, link_VBP the_DT biological_JJ clocks_NNS that_WDT govern_VBP growth_NN and_CC development_NN to_TO similar_JJ clocks_NNS that_IN he_PRP thought_VBD influenced_VBN duration_NN of_IN life_NN ._. 
What_WP this_DT biodemographic_JJ perspective_NN has_VBZ taught_VBN us_PRP thus_RB far_RB is_VBZ that_IN for_IN each_DT species_NNS there_EX is_VBZ a_DT fundamental_JJ link_NN between_IN the_DT timing_NN of_IN sexual_JJ maturation_NN ,_, the_DT length_NN of_IN the_DT reproductive_JJ window_NN ,_, and_CC the_DT rate_NN of_IN increase_NN in_IN the_DT death_NN rate_NN from_IN biological_JJ causes_NNS of_IN death_NN ._. 
Thus_RB ,_, there_EX is_VBZ biology_NN in_IN the_DT life_NN table_NN as_RB originally_RB anticipated_VBN by_IN Benjamin_NNP Gompertz_NNP 
These_DT physical_JJ laws_NNS ,_, according_VBG to_TO Buffon_NNP ,_, link_VBP the_DT biological_JJ clocks_NNS that_WDT govern_VBP growth_NN and_CC development_NN to_TO similar_JJ clocks_NNS that_IN he_PRP thought_VBD influenced_VBN duration_NN of_IN life_NN ._. 
British_JJ actuary_NN Benjamin_NNP Gompertz_NNP provided_VBD the_DT first_JJ mathematical_JJ support_NN for_IN this_DT view_NN by_IN demonstrating_VBG that_IN for_IN a_DT significant_JJ portion_NN of_IN the_DT human_JJ lifespan_NN ,_, the_DT risk_NN of_IN death_NN rises_NNS exponentially_RB with_IN age_NN 
The_DT modern_JJ notion_NN of_IN the_DT biodemography_NN of_IN aging_NN arose_VBN in_IN the_DT early_JJ 1990s_NNS ,_, as_IN scientists_NNS from_IN a_DT broad_JJ range_NN of_IN scientific_JJ backgrounds_NNS began_VBD speculating_VBG about_IN the_DT biological_JJ forces_NNS responsible_JJ for_IN the_DT similar_JJ age_NN patterns_NNS of_IN death_NN that_IN they_PRP observed_VBD among_IN sexually-reproducing_JJ species_NNS ._. 
The_DT theoretical_JJ basis_NN for_IN the_DT biodemography_NN of_IN aging_NN is_VBZ derived_VBN principally_RB from_IN evolutionary_JJ biology_NN 
Although_IN one_CD role_NN of_IN the_DT epidemiologist_NN is_VBZ to_TO improve_VB quality_NN of_IN life_NN ,_, often_RB at_IN best_JJS what_WP can_MD be_VB accomplished_VBN is_VBZ slowing_VBG the_DT progression_NN of_IN diseases_NNS and_CC conditions_NNS expressed_VBN in_IN older_JJR regions_NNS of_IN the_DT lifespan_NN by_IN suppressing_VBG their_PRP$ symptoms_NNS ._. 
These_DT include_VBP Alzheimer_NNP 's_POS disease_NN and_CC related_JJ dementias_NNS ,_, vision_NN and_CC hearing_NN loss_NN ,_, hip_NN fracture_NN ,_, osteoporosis_NN and_CC osteoarthritis_NN ,_, incontinence_NN ,_, depression_NN ,_, social_JJ isolation_NN ,_, widowhood_NN ,_, and_CC institutionalization_NN ._. 
In_IN an_DT aging_NN world_NN where_WRB the_DT envelope_NN of_IN human_JJ survival_NN is_VBZ continuing_VBG to_TO be_VB extended_VBN ,_, a_DT biodemographic_JJ perspective_NN leads_VBZ to_TO the_DT realization_NN that_IN the_DT expression_NN of_IN disease_NN becomes_VBZ more_RBR a_DT by-product_NN of_IN extended_JJ survival_NN rather_RB than_IN the_DT end_NN product_NN of_IN identifiable_JJ and_CC modifiable_JJ risk_NN factors_NNS ._. 
,smoking_JJ ,_, fatty_JJ foods_NNS ,_, obesity_NN ,_, stress_NN ,_, etc._FW g._FW Although_IN scientific_JJ studies_NNS based_VBN on_IN theoretical_JJ and_CC methodological_JJ principles_NNS of_IN epidemiology_NN have_VBP been_VBN instrumental_JJ in_IN identifying_VBG risk_NN factors_NNS for_IN chronic_JJ degenerative_JJ diseases_NNS -LRB-_-LRB- e._NN ,_, and_CC their_PRP$ effects_NNS on_IN heart_NN disease_NN ,_, stroke_NN ,_, and_CC many_JJ cancers_NNS -RRB-_-RRB- 
,smoking_JJ ,_, fatty_JJ foods_NNS ,_, obesity_NN ,_, stress_NN ,_, etc._FW g._FW Although_IN scientific_JJ studies_NNS based_VBN on_IN theoretical_JJ and_CC methodological_JJ principles_NNS of_IN epidemiology_NN have_VBP been_VBN instrumental_JJ in_IN identifying_VBG risk_NN factors_NNS for_IN chronic_JJ degenerative_JJ diseases_NNS -LRB-_-LRB- e._NN ,_, and_CC their_PRP$ effects_NNS on_IN heart_NN disease_NN ,_, stroke_NN ,_, and_CC many_JJ cancers_NNS -RRB-_-RRB- 
Finally_RB ,_, the_DT implications_NNS that_IN the_DT biodemography_NN of_IN aging_NN has_VBZ for_IN the_DT degree_NN to_TO which_WDT chronic_JJ degenerative_JJ diseases_NNS can_MD be_VB influenced_VBN by_IN risk_NN factor_NN modification_NN may_MD be_VB of_IN even_RB greater_JJR relevance_NN to_TO epidemiologists_NNS 
The_DT most_RBS common_JJ historical_JJ explanation_NN for_IN the_DT loss_NN of_IN immortality_NN ,_, the_DT lack_NN of_IN perfect_JJ health_NN ,_, and_CC the_DT steady_JJ decline_NN in_IN human_JJ longevity_NN has_VBZ been_VBN that_IN each_DT new_JJ generation_NN has_VBZ adopted_VBN increasingly_RB more_RBR decadent_JJ lifestyles_NNS ._. 
Roger_NNP Bacon_NNP ,_, an_DT influential_JJ English_JJ philosopher_NN and_CC scientist_NN of_IN the_DT 13th_JJ century_NN ,_, was_VBD the_DT first_JJ to_TO popularize_VB this_DT view_NN ._. 
However_RB ,_, he_PRP also_RB believed_VBD that_IN the_DT trend_NN toward_IN shorter_JJR lifespans_NNS could_MD be_VB reversed_VBN by_IN invoking_VBG the_DT ``_`` secret_JJ arts_NNS ''_'' of_IN the_DT past_NN 
Thus_RB ,_, smoking_NN was_VBD shown_VBN to_TO increase_VB the_DT risk_NN of_IN heart_NN disease_NN and_CC cancers_NNS ._. 
The_DT concept_NN of_IN risk_NN factors_NNS was_VBD introduced_VBN to_TO facilitate_VB understanding_NN and_CC prevention_NN ._. 
Fatty_JJ foods_NNS ,_, obesity_NN ,_, and_CC lack_NN of_IN exercise_NN clearly_RB predisposed_VBD people_NNS to_TO these_DT conditions_NNS ._. 
However_RB ,_, frustration_NN arose_VBD over_IN the_DT years_NNS ,_, as_IN it_PRP was_VBD shown_VBN that_IN these_DT risk_NN factors_NNS accounted_VBD at_IN best_JJS for_IN only_JJ half_NN of_IN the_DT deaths_NNS from_IN these_DT three_CD causes_NNS ._. 
The_DT modern_JJ notion_NN of_IN the_DT biodemography_NN of_IN aging_NN arose_VBN in_IN the_DT early_JJ 1990s_NNS ,_, as_IN scientists_NNS from_IN a_DT broad_JJ range_NN of_IN scientific_JJ backgrounds_NNS began_VBD speculating_VBG about_IN the_DT biological_JJ forces_NNS responsible_JJ for_IN the_DT similar_JJ age_NN patterns_NNS of_IN death_NN that_IN they_PRP observed_VBD among_IN sexually-reproducing_JJ species_NNS ._. 
The_DT theoretical_JJ basis_NN for_IN the_DT biodemography_NN of_IN aging_NN is_VBZ derived_VBN principally_RB from_IN evolutionary_JJ biology_NN 
e._VB The_DT link_NN between_IN death_NN and_CC reproduction_NN is_VBZ based_VBN on_IN the_DT evolutionary_JJ principle_NN that_IN the_DT force_NN of_IN natural_JJ selection_NN begins_VBZ to_TO decline_VB rapidly_RB once_RB reproduction_NN commences_NNS ,_, approaching_VBG negligible_JJ levels_NNS at_IN the_DT end_NN of_IN the_DT reproductive_JJ window_NN -LRB-_-LRB- i._NN ,_, at_IN menopause_NN -RRB-_-RRB- ._. 
The_DT force_NN of_IN natural_JJ selection_NN refers_VBZ to_TO the_DT ability_NN of_IN selection_NN to_TO influence_VB the_DT distribution_NN and_CC frequency_NN of_IN alleles_NNS in_IN the_DT population_NN 
The_DT force_NN of_IN natural_JJ selection_NN refers_VBZ to_TO the_DT ability_NN of_IN selection_NN to_TO influence_VB the_DT distribution_NN and_CC frequency_NN of_IN alleles_NNS in_IN the_DT population_NN 
However_RB ,_, neither_DT Darwin_NNP nor_CC those_DT who_WP followed_VBD in_IN his_PRP$ footsteps_NNS ever_RB examined_VBD the_DT morphology_NN of_IN living_NN things_NNS from_IN the_DT perspective_NN of_IN an_DT aging_NN animal_NN ._. 
Epidemiology_NNP of_IN degenerative_JJ diseases_NNS in_IN an_DT aging_NN worldThe_NN theoretical_JJ and_CC methodological_JJ basis_NN for_IN epidemiology_NN arose_VBD out_IN of_IN a_DT communicable_JJ disease_NN model_NN where_WRB a_DT notion_NN of_IN avoiding_VBG and_CC curing_VBG the_DT common_JJ fatal_JJ diseases_NNS of_IN the_DT time_NN was_VBD prevalent_JJ and_CC enormously_RB successful_JJ ._. 
As_IN a_DT measure_NN of_IN that_DT success_NN ,_, half_NN of_IN the_DT gain_NN in_IN life_NN expectancy_NN at_IN birth_NN in_IN the_DT 20_CD th_JJ century_NN was_VBD achieved_VBN by_IN 1920_CD 
The_DT force_NN of_IN natural_JJ selection_NN refers_VBZ to_TO the_DT ability_NN of_IN selection_NN to_TO influence_VB the_DT distribution_NN and_CC frequency_NN of_IN alleles_NNS in_IN the_DT population_NN 
Darwin_NNP 's_POS observations_NNS about_IN imperfections_NNS in_IN the_DT morphological_JJ characteristics_NNS of_IN living_NN things_NNS were_VBD inconsistent_JJ with_IN the_DT works_NNS of_IN an_DT intelligent_JJ designer_NN ,_, which_WDT led_VBD him_PRP to_TO the_DT idea_NN that_IN all_DT forms_NNS of_IN life_NN have_VBP an_DT evolutionary_JJ history_NN based_VBN on_IN change_NN over_IN time_NN ._. 
The_DT life_NN history_NN details_NNS such_JJ as_IN growth_NN ,_, development_NN ,_, and_CC maturation_NN that_WDT emerge_VBP from_IN this_DT unique_JJ evolutionary_JJ history_NN of_IN every_DT species_NNS are_VBP central_JJ to_TO understanding_VBG the_DT variations_NNS that_WDT exist_VBP between_IN individuals_NNS and_CC species_NNS -LRB-_-LRB- including_VBG humans_NNS -RRB-_-RRB- in_IN the_DT temporal_JJ distribution_NN of_IN age-determined_JJ diseases_NNS and_CC the_DT timing_NN of_IN death_NN ._. 
Finally_RB ,_, the_DT implications_NNS that_IN the_DT biodemography_NN of_IN aging_NN has_VBZ for_IN the_DT degree_NN to_TO which_WDT chronic_JJ degenerative_JJ diseases_NNS can_MD be_VB influenced_VBN by_IN risk_NN factor_NN modification_NN may_MD be_VB of_IN even_RB greater_JJR relevance_NN to_TO epidemiologists_NNS 
The_DT modern_JJ notion_NN of_IN the_DT biodemography_NN of_IN aging_NN arose_VBN in_IN the_DT early_JJ 1990s_NNS ,_, as_IN scientists_NNS from_IN a_DT broad_JJ range_NN of_IN scientific_JJ backgrounds_NNS began_VBD speculating_VBG about_IN the_DT biological_JJ forces_NNS responsible_JJ for_IN the_DT similar_JJ age_NN patterns_NNS of_IN death_NN that_IN they_PRP observed_VBD among_IN sexually-reproducing_JJ species_NNS ._. 
The_DT theoretical_JJ basis_NN for_IN the_DT biodemography_NN of_IN aging_NN is_VBZ derived_VBN principally_RB from_IN evolutionary_JJ biology_NN 
The_DT modern_JJ notion_NN of_IN the_DT biodemography_NN of_IN aging_NN arose_VBN in_IN the_DT early_JJ 1990s_NNS ,_, as_IN scientists_NNS from_IN a_DT broad_JJ range_NN of_IN scientific_JJ backgrounds_NNS began_VBD speculating_VBG about_IN the_DT biological_JJ forces_NNS responsible_JJ for_IN the_DT similar_JJ age_NN patterns_NNS of_IN death_NN that_IN they_PRP observed_VBD among_IN sexually-reproducing_JJ species_NNS ._. 
The_DT theoretical_JJ basis_NN for_IN the_DT biodemography_NN of_IN aging_NN is_VBZ derived_VBN principally_RB from_IN evolutionary_JJ biology_NN 
In_IN developed_JJ countries_NNS ,_, where_WRB life_NN expectancy_NN is_VBZ about_RB 75_CD years_NNS for_IN males_NNS and_CC 80_CD years_NNS for_IN females_NNS ,_, the_DT classic_JJ indicators_NNS of_IN health_NN are_VBP becoming_VBG less_RBR useful_JJ ._. 
Infant_NN mortality_NN has_VBZ been_VBN very_RB low_JJ for_IN more_JJR than_IN 20_CD years_NNS and_CC the_DT concept_NN of_IN ``_`` premature_JJ death_NN ''_'' is_VBZ no_RB longer_RB a_DT sensitive_JJ health_NN indicator_NN ._. 
Instead_RB ,_, with_IN each_DT succeeding_VBG year_NN lived_VBD at_IN the_DT tip_NN of_IN the_DT exponential_JJ curve_NN of_IN mortality_NN ,_, numerous_JJ detrimental_JJ physiologic_JJ mechanisms_NNS and_CC morbidities_NNS are_VBP activated_VBN ._. 
According_VBG to_TO evolution_NN theory_NN ,_, selection_NN does_VBZ not_RB operate_VB with_IN any_DT particular_JJ goal_NN in_IN mind_NN ;_: it_PRP simply_RB optimizes_VBZ the_DT perpetuation_NN of_IN DNA_NN across_IN time_NN by_IN constructing_VBG bodies_NNS capable_JJ of_IN carrying_VBG the_DT DNA_NN and_CC passing_VBG it_PRP successfully_RB from_IN one_CD generation_NN to_TO the_DT next_JJ ._. 
This_DT idea_NN has_VBZ since_IN appeared_VBN several_JJ times_NNS in_IN the_DT published_VBN literature_NN in_IN the_DT 20th_JJ century_NN ,_, including_VBG the_DT first_JJ detailed_JJ presentation_NN of_IN morphology_NN and_CC body_NN design_NN 
Biochemical_JJ constraints_NNS involve_VBP the_DT inevitable_JJ accumulation_NN of_IN damage_NN that_WDT occurs_VBZ at_IN all_DT levels_NNS of_IN biological_JJ organization_NN ,_, including_VBG the_DT maintenance_NN and_CC repair_NN processes_VBZ themselves_PRP 
13_CD -RRB-_-RRB- ._. 
revealed_VBN and_CC made_VBN manifest_JJ only_RB by_IN the_DT most_RBS unnatural_JJ experiment_NN of_IN prolonging_VBG an_DT animal_NN 's_POS life_NN by_IN sheltering_VBG it_PRP from_IN the_DT hazards_NNS of_IN its_PRP$ ordinary_JJ existence_NN ''_'' -LRB-_-LRB- p._VB The_DT dramatic_JJ increase_NN in_IN the_DT last_JJ century_NN in_IN the_DT number_NN of_IN people_NNS living_VBG for_IN seven_CD decades_NNS or_CC more_JJR 
13_CD -RRB-_-RRB- ._. 
revealed_VBN and_CC made_VBN manifest_JJ only_RB by_IN the_DT most_RBS unnatural_JJ experiment_NN of_IN prolonging_VBG an_DT animal_NN 's_POS life_NN by_IN sheltering_VBG it_PRP from_IN the_DT hazards_NNS of_IN its_PRP$ ordinary_JJ existence_NN ''_'' -LRB-_-LRB- p._VB The_DT dramatic_JJ increase_NN in_IN the_DT last_JJ century_NN in_IN the_DT number_NN of_IN people_NNS living_VBG for_IN seven_CD decades_NNS or_CC more_JJR 
Now_RB that_IN human_JJ survival_NN has_VBZ been_VBN progressively_RB extended_VBN deeper_JJR into_IN the_DT post-reproductive_JJ period_NN of_IN the_DT lifespan_NN ,_, a_DT biodemographic_JJ perspective_NN reveals_VBZ biochemical_JJ and_CC biomechanical_JJ forces_NNS that_WDT have_VBP a_DT profound_JJ influence_NN on_IN population_NN frailty_NN ,_, disease_NN expression_NN ,_, and_CC duration_NN of_IN life_NN ._. 
Biochemical_JJ constraints_NNS involve_VBP the_DT inevitable_JJ accumulation_NN of_IN damage_NN that_WDT occurs_VBZ at_IN all_DT levels_NNS of_IN biological_JJ organization_NN ,_, including_VBG the_DT maintenance_NN and_CC repair_NN processes_VBZ themselves_PRP 
According_VBG to_TO evolution_NN theory_NN ,_, selection_NN does_VBZ not_RB operate_VB with_IN any_DT particular_JJ goal_NN in_IN mind_NN ;_: it_PRP simply_RB optimizes_VBZ the_DT perpetuation_NN of_IN DNA_NN across_IN time_NN by_IN constructing_VBG bodies_NNS capable_JJ of_IN carrying_VBG the_DT DNA_NN and_CC passing_VBG it_PRP successfully_RB from_IN one_CD generation_NN to_TO the_DT next_JJ ._. 
This_DT idea_NN has_VBZ since_IN appeared_VBN several_JJ times_NNS in_IN the_DT published_VBN literature_NN in_IN the_DT 20th_JJ century_NN ,_, including_VBG the_DT first_JJ detailed_JJ presentation_NN of_IN morphology_NN and_CC body_NN design_NN 
13_CD -RRB-_-RRB- ._. 
revealed_VBN and_CC made_VBN manifest_JJ only_RB by_IN the_DT most_RBS unnatural_JJ experiment_NN of_IN prolonging_VBG an_DT animal_NN 's_POS life_NN by_IN sheltering_VBG it_PRP from_IN the_DT hazards_NNS of_IN its_PRP$ ordinary_JJ existence_NN ''_'' -LRB-_-LRB- p._VB The_DT dramatic_JJ increase_NN in_IN the_DT last_JJ century_NN in_IN the_DT number_NN of_IN people_NNS living_VBG for_IN seven_CD decades_NNS or_CC more_JJR 
Biochemical_JJ constraints_NNS involve_VBP the_DT inevitable_JJ accumulation_NN of_IN damage_NN that_WDT occurs_VBZ at_IN all_DT levels_NNS of_IN biological_JJ organization_NN ,_, including_VBG the_DT maintenance_NN and_CC repair_NN processes_VBZ themselves_PRP 
The_DT diseases_NNS and_CC disorders_NNS that_WDT arise_VBP from_IN the_DT negative_JJ side_NN of_IN this_DT legacy_NN are_VBP unfortunate_JJ and_CC unanticipated_JJ by-products_NNS of_IN the_DT human_JJ ingenuity_NN that_WDT has_VBZ allowed_VBN our_PRP$ bodies_NNS to_TO be_VB operated_VBN far_RB longer_RBR than_IN nature_NN has_VBZ historically_RB permitted_VBN ._. 
Had_VBD natural_JJ selection_NN operated_VBN with_IN a_DT particular_JJ goal_NN in_IN mind_NN ,_, such_JJ as_IN a_DT healthy_JJ old_JJ age_NN ,_, there_EX is_VBZ reason_NN to_TO believe_VB that_IN the_DT morphological_JJ structures_NNS and_CC biochemical_JJ makeup_NN of_IN sexually-reproducing_JJ species_NNS would_MD probably_RB be_VB far_RB different_JJ from_IN what_WP is_VBZ currently_RB the_DT case_NN ._. 
It_PRP is_VBZ important_JJ to_TO remember_VB that_IN in_IN an_DT aging_VBG world_NN the_DT expression_NN of_IN disease_NN and_CC how_WRB long_RB we_PRP live_VBP as_IN both_DT individuals_NNS and_CC populations_NNS is_VBZ more_RBR a_DT product_NN of_IN evolutionary_JJ neglect_NN ,_, not_RB evolutionary_JJ intent_NN ._. 
These_DT beliefs_NNS ,_, and_CC the_DT quest_NN for_IN longer_JJR lives_NNS that_WDT arises_VBZ from_IN them_PRP ,_, have_VBP been_VBN obsessions_NNS throughout_IN human_JJ history_NN ,_, having_VBG become_VBN a_DT central_JJ part_NN of_IN the_DT paradigm_NN of_IN modern_JJ medicine_NN and_CC the_DT effort_NN of_IN epidemiologists_NNS to_TO understand_VB how_WRB risk_NN factors_NNS alter_VBP death_NN rates_NNS ._. 
In_IN modern_JJ times_NNS ,_, aging_NN is_VBZ described_VBN by_IN some_DT as_IN a_DT disease_NN that_WDT can_MD be_VB reversed_VBN ,_, slowed_VBD ,_, or_CC even_RB eliminated_VBN by_IN changes_NNS in_IN lifestyles_NNS or_CC by_IN ingesting_VBG vitamins_NNS ,_, minerals_NNS ,_, anti-oxidants_NNS ,_, and_CC hormones_NNS 
Elements_NNS of_IN this_DT latter_JJ idea_NN contribute_VBP to_TO modern_JJ epidemiologic_JJ thought_NN ._. 
The_DT second_JJ is_VBZ the_DT notion_NN that_IN the_DT health_NN and_CC longevity_NN consequences_NNS associated_VBN with_IN perfection_NN can_MD be_VB reclaimed_VBN through_IN human_JJ actions_NNS ._. 
These_DT beliefs_NNS ,_, and_CC the_DT quest_NN for_IN longer_JJR lives_NNS that_WDT arises_VBZ from_IN them_PRP ,_, have_VBP been_VBN obsessions_NNS throughout_IN human_JJ history_NN ,_, having_VBG become_VBN a_DT central_JJ part_NN of_IN the_DT paradigm_NN of_IN modern_JJ medicine_NN and_CC the_DT effort_NN of_IN epidemiologists_NNS to_TO understand_VB how_WRB risk_NN factors_NNS alter_VBP death_NN rates_NNS ._. 
In_IN modern_JJ times_NNS ,_, aging_NN is_VBZ described_VBN by_IN some_DT as_IN a_DT disease_NN that_WDT can_MD be_VB reversed_VBN ,_, slowed_VBD ,_, or_CC even_RB eliminated_VBN by_IN changes_NNS in_IN lifestyles_NNS or_CC by_IN ingesting_VBG vitamins_NNS ,_, minerals_NNS ,_, anti-oxidants_NNS ,_, and_CC hormones_NNS 
Biochemical_JJ constraints_NNS involve_VBP the_DT inevitable_JJ accumulation_NN of_IN damage_NN that_WDT occurs_VBZ at_IN all_DT levels_NNS of_IN biological_JJ organization_NN ,_, including_VBG the_DT maintenance_NN and_CC repair_NN processes_VBZ themselves_PRP 
For_IN example_NN ,_, from_IN a_DT biodemographic_JJ perspective_NN it_PRP is_VBZ suggested_VBN that_IN aging_NN and_CC many_JJ of_IN the_DT diseases_NNS that_WDT accompany_VBP it_PRP are_VBP not_RB deviant_JJ departures_NNS from_IN perfection_NN ,_, or_CC even_RB the_DT sole_JJ consequence_NN of_IN moderately_RB decadent_JJ lifestyles_NNS ._. 
Instead_RB ,_, they_PRP are_VBP primarily_RB the_DT consequence_NN of_IN operating_VBG our_PRP$ bodies_NNS beyond_IN their_PRP$ biological_JJ warranty_NN period_NN -LRB-_-LRB- i._FW e._FW ,_, beyond_IN the_DT time_NN when_WRB parents_NNS can_MD contribute_VB to_TO the_DT reproductive_JJ fitness_NN of_IN their_PRP$ own_JJ offspring_NN -RRB-_-RRB- ._. 
These_DT beliefs_NNS ,_, and_CC the_DT quest_NN for_IN longer_JJR lives_NNS that_WDT arises_VBZ from_IN them_PRP ,_, have_VBP been_VBN obsessions_NNS throughout_IN human_JJ history_NN ,_, having_VBG become_VBN a_DT central_JJ part_NN of_IN the_DT paradigm_NN of_IN modern_JJ medicine_NN and_CC the_DT effort_NN of_IN epidemiologists_NNS to_TO understand_VB how_WRB risk_NN factors_NNS alter_VBP death_NN rates_NNS ._. 
In_IN modern_JJ times_NNS ,_, aging_NN is_VBZ described_VBN by_IN some_DT as_IN a_DT disease_NN that_WDT can_MD be_VB reversed_VBN ,_, slowed_VBD ,_, or_CC even_RB eliminated_VBN by_IN changes_NNS in_IN lifestyles_NNS or_CC by_IN ingesting_VBG vitamins_NNS ,_, minerals_NNS ,_, anti-oxidants_NNS ,_, and_CC hormones_NNS 
The_DT modern_JJ notion_NN of_IN the_DT biodemography_NN of_IN aging_NN arose_VBN in_IN the_DT early_JJ 1990s_NNS ,_, as_IN scientists_NNS from_IN a_DT broad_JJ range_NN of_IN scientific_JJ backgrounds_NNS began_VBD speculating_VBG about_IN the_DT biological_JJ forces_NNS responsible_JJ for_IN the_DT similar_JJ age_NN patterns_NNS of_IN death_NN that_IN they_PRP observed_VBD among_IN sexually-reproducing_JJ species_NNS ._. 
The_DT theoretical_JJ basis_NN for_IN the_DT biodemography_NN of_IN aging_NN is_VBZ derived_VBN principally_RB from_IN evolutionary_JJ biology_NN 
The_DT modern_JJ notion_NN of_IN the_DT biodemography_NN of_IN aging_NN arose_VBN in_IN the_DT early_JJ 1990s_NNS ,_, as_IN scientists_NNS from_IN a_DT broad_JJ range_NN of_IN scientific_JJ backgrounds_NNS began_VBD speculating_VBG about_IN the_DT biological_JJ forces_NNS responsible_JJ for_IN the_DT similar_JJ age_NN patterns_NNS of_IN death_NN that_IN they_PRP observed_VBD among_IN sexually-reproducing_JJ species_NNS ._. 
The_DT theoretical_JJ basis_NN for_IN the_DT biodemography_NN of_IN aging_NN is_VBZ derived_VBN principally_RB from_IN evolutionary_JJ biology_NN 
The_DT force_NN of_IN natural_JJ selection_NN refers_VBZ to_TO the_DT ability_NN of_IN selection_NN to_TO influence_VB the_DT distribution_NN and_CC frequency_NN of_IN alleles_NNS in_IN the_DT population_NN 
Instead_RB ,_, what_WP occurred_VBD was_VBD a_DT steady_JJ decline_NN in_IN death_NN rates_NNS accompanied_VBN by_IN a_DT diminishing_VBG rise_NN in_IN life_NN expectancy_NN at_IN birth_NN and_CC at_IN older_JJR ages_NNS ._. 
The_DT phenomenon_NN of_IN diminishing_VBG longevity_NN gains_NNS from_IN lifestyle_NN modification_NN is_VBZ referred_VBN to_TO here_RB as_IN the_DT Medawarian_NNP Paradox_NNP ,_, named_VBN after_IN Sir_NNP Peter_NNP Medawar_NNP who_WP suggested_VBD that_DT aging_NN is_VBZ ''_'' ..._: revealed_VBN and_CC made_VBN manifest_JJ only_RB by_IN the_DT most_RBS unnatural_JJ experiment_NN of_IN prolonging_VBG an_DT animal_NN 's_POS life_NN by_IN sheltering_VBG it_PRP from_IN the_DT hazards_NNS of_IN its_PRP$ ordinary_JJ existence_NN ''_'' -LRB-_-LRB- p._SYM 
According_VBG to_TO evolution_NN theory_NN ,_, selection_NN does_VBZ not_RB operate_VB with_IN any_DT particular_JJ goal_NN in_IN mind_NN ;_: it_PRP simply_RB optimizes_VBZ the_DT perpetuation_NN of_IN DNA_NN across_IN time_NN by_IN constructing_VBG bodies_NNS capable_JJ of_IN carrying_VBG the_DT DNA_NN and_CC passing_VBG it_PRP successfully_RB from_IN one_CD generation_NN to_TO the_DT next_JJ ._. 
This_DT idea_NN has_VBZ since_IN appeared_VBN several_JJ times_NNS in_IN the_DT published_VBN literature_NN in_IN the_DT 20th_JJ century_NN ,_, including_VBG the_DT first_JJ detailed_JJ presentation_NN of_IN morphology_NN and_CC body_NN design_NN 
The_DT modern_JJ notion_NN of_IN the_DT biodemography_NN of_IN aging_NN arose_VBN in_IN the_DT early_JJ 1990s_NNS ,_, as_IN scientists_NNS from_IN a_DT broad_JJ range_NN of_IN scientific_JJ backgrounds_NNS began_VBD speculating_VBG about_IN the_DT biological_JJ forces_NNS responsible_JJ for_IN the_DT similar_JJ age_NN patterns_NNS of_IN death_NN that_IN they_PRP observed_VBD among_IN sexually-reproducing_JJ species_NNS ._. 
The_DT theoretical_JJ basis_NN for_IN the_DT biodemography_NN of_IN aging_NN is_VBZ derived_VBN principally_RB from_IN evolutionary_JJ biology_NN 
The_DT force_NN of_IN natural_JJ selection_NN refers_VBZ to_TO the_DT ability_NN of_IN selection_NN to_TO influence_VB the_DT distribution_NN and_CC frequency_NN of_IN alleles_NNS in_IN the_DT population_NN 
This_DT occurs_VBZ ,_, in_IN part_NN ,_, because_IN the_DT number_NN of_IN person-years-of-life_JJ -LRB-_-LRB- PYL_NNP -RRB-_-RRB- added_VBD to_TO the_DT life_NN table_NN when_WRB a_DT child_NN is_VBZ saved_VBN from_IN death_NN is_VBZ almost_RB always_RB considerably_RB greater_JJR than_IN the_DT PYL_NNP added_VBD when_WRB an_DT older_JJR person_NN has_VBZ their_PRP$ life_NN extended_VBN ._. 
In_IN addition_NN ,_, while_IN preventive_JJ measures_NNS have_VBP been_VBN shown_VBN to_TO reduce_VB death_NN rates_NNS at_IN middle_NN and_CC older_JJR ages_NNS among_IN population_NN subgroups_NNS that_WDT adhere_VBP to_TO healthy_JJ behavioral_JJ practices_NNS ,_, most_JJS of_IN the_DT population_NN has_VBZ not_RB adopted_VBN these_DT practices_NNS ._. 
Diminishing_VBG increases_NNS in_IN life_NN expectancy_NN at_IN birth_NN in_IN developed_JJ nations_NNS today_NN ,_, despite_IN the_DT intensive_JJ efforts_NNS by_IN epidemiologists_NNS and_CC other_JJ public_JJ health_NN experts_NNS to_TO modulate_VB lifestyles_NNS ,_, present_VBP a_DT paradox_NN that_WDT can_MD also_RB benefit_VB from_IN a_DT biodemographic_JJ examination_NN of_IN aging_NN and_CC disease_NN ._. 
Introduction_NN The_DT timing_NN with_IN which_WDT death_NN occurs_VBZ and_CC the_DT underlying_VBG causes_NNS that_WDT contribute_VBP to_TO it_PRP in_IN humans_NNS and_CC other_JJ sexually_RB reproducing_VBG species_NNS have_VBP been_VBN the_DT subject_NN of_IN scientific_JJ inquiry_NN for_IN hundreds_NNS of_IN years_NNS ,_, occupying_VBG the_DT minds_NNS of_IN scientists_NNS from_IN widely_RB ranging_VBG scientific_JJ disciplines_NNS ._. 
For_IN example_NN ,_, actuaries_NNS -LRB-_-LRB- who_WP study_VBP humans_NNS exclusively_RB -RRB-_-RRB- focus_NN on_IN the_DT practical_JJ use_NN of_IN death_NN statistics_NNS ,_, as_IN in_IN calculating_VBG premiums_NNS for_IN insurance_NN companies_NNS or_CC forecasting_NN survival_NN in_IN order_NN to_TO assess_VB the_DT solvency_NN of_IN age-entitlement_JJ programs_NNS 
Demographers_NNS have_VBP historically_RB worked_VBN in_IN much_RB the_DT same_JJ way_NN as_IN actuaries_NNS ,_, also_RB on_IN a_DT single_JJ species_NNS ,_, by_IN explaining_VBG and_CC understanding_VBG the_DT trends_NNS ,_, causes_NNS ,_, and_CC consequences_NNS of_IN mortality_NN within_IN and_CC between_IN subgroups_NNS of_IN the_DT population_NN and_CC across_IN time_NN ._. 
In_IN modern_JJ times_NNS ,_, population_NN biologists_NNS and_CC entomologists_NNS have_VBP begun_VBN to_TO study_VB the_DT demography_NN of_IN death_NN among_IN species_NNS other_JJ than_IN humans_NNS ._. 
Unlike_IN demographers_NNS ,_, epidemiologists_NNS invoke_VBP a_DT disease-specific_JJ approach_NN that_WDT has_VBZ its_PRP$ historical_JJ roots_NNS in_IN the_DT study_NN of_IN infectious_JJ disease_NN epidemics_NNS ,_, with_IN a_DT subsequent_JJ focus_NN on_IN chronic_JJ diseases_NNS and_CC conditions_NNS ._. 
Demographers_NNS have_VBP historically_RB worked_VBN in_IN much_RB the_DT same_JJ way_NN as_IN actuaries_NNS ,_, also_RB on_IN a_DT single_JJ species_NNS ,_, by_IN explaining_VBG and_CC understanding_VBG the_DT trends_NNS ,_, causes_NNS ,_, and_CC consequences_NNS of_IN mortality_NN within_IN and_CC between_IN subgroups_NNS of_IN the_DT population_NN and_CC across_IN time_NN ._. 
In_IN modern_JJ times_NNS ,_, population_NN biologists_NNS and_CC entomologists_NNS have_VBP begun_VBN to_TO study_VB the_DT demography_NN of_IN death_NN among_IN species_NNS other_JJ than_IN humans_NNS ._. 
Unlike_IN demographers_NNS ,_, epidemiologists_NNS invoke_VBP a_DT disease-specific_JJ approach_NN that_WDT has_VBZ its_PRP$ historical_JJ roots_NNS in_IN the_DT study_NN of_IN infectious_JJ disease_NN epidemics_NNS ,_, with_IN a_DT subsequent_JJ focus_NN on_IN chronic_JJ diseases_NNS and_CC conditions_NNS ._. 
In_IN contrast_NN to_TO the_DT scientists_NNS who_WP work_VBP at_IN the_DT level_NN of_IN populations_NNS ,_, biogerontologists_NNS examine_VBP death_NN for_IN humans_NNS and_CC other_JJ species_NNS from_IN a_DT micro_NN perspective_NN as_IN they_PRP endeavor_VBP to_TO explain_VB and_CC understand_VB changes_NNS that_WDT occur_VBP across_IN time_NN in_IN molecules_NNS ,_, cells_NNS ,_, tissues_NNS ,_, and_CC organs_NNS that_WDT eventually_RB contribute_VBP to_TO disease_NN and_CC death_NN ._. 
The_DT biodemography_NN of_IN aging_NN is_VBZ a_DT ``_`` new_JJ ''_'' scientific_JJ discipline_NN ,_, arising_VBG in_IN the_DT late_JJ 20th_JJ century_NN as_IN a_DT product_NN of_IN efforts_NNS to_TO merge_VB the_DT micro_NN analysis_NN of_IN mortality_NN explored_VBN by_IN biologists_NNS with_IN the_DT macro_NN analysis_NN of_IN scientists_NNS who_WP do_VBP research_NN at_IN the_DT population_NN level_NN -LRB-_-LRB- e._FW g._FW ,_, demographers_NNS and_CC epidemiologists_NNS -RRB-_-RRB- in_IN order_NN to_TO provide_VB a_DT biological_JJ rationale_NN for_IN the_DT timing_NN and_CC causes_NNS of_IN death_NN in_IN humans_NNS and_CC other_JJ sexually_RB reproducing_VBG species_NNS ._. 
In_IN this_DT paper_NN ,_, the_DT biodemography_NN of_IN aging_NN is_VBZ introduced_VBN in_IN light_NN of_IN traditional_JJ epidemiologic_JJ models_NNS of_IN disease_NN causation_NN and_CC death_NN ._. 
IntroductionThe_JJ timing_NN with_IN which_WDT death_NN occurs_VBZ and_CC the_DT underlying_VBG causes_NNS that_WDT contribute_VBP to_TO it_PRP in_IN humans_NNS and_CC other_JJ sexually_RB reproducing_VBG species_NNS have_VBP been_VBN the_DT subject_NN of_IN scientific_JJ inquiry_NN for_IN hundreds_NNS of_IN years_NNS ,_, occupying_VBG the_DT minds_NNS of_IN scientists_NNS from_IN widely_RB ranging_VBG scientific_JJ disciplines_NNS ._. 
For_IN example_NN ,_, actuaries_NNS -LRB-_-LRB- who_WP study_VBP humans_NNS exclusively_RB -RRB-_-RRB- focus_NN on_IN the_DT practical_JJ use_NN of_IN death_NN statistics_NNS ,_, as_IN in_IN calculating_VBG premiums_NNS for_IN insurance_NN companies_NNS or_CC forecasting_NN survival_NN in_IN order_NN to_TO assess_VB the_DT solvency_NN of_IN age-entitlement_JJ programs_NNS 
Introduction_NN The_DT timing_NN with_IN which_WDT death_NN occurs_VBZ and_CC the_DT underlying_VBG causes_NNS that_WDT contribute_VBP to_TO it_PRP in_IN humans_NNS and_CC other_JJ sexually_RB reproducing_VBG species_NNS have_VBP been_VBN the_DT subject_NN of_IN scientific_JJ inquiry_NN for_IN hundreds_NNS of_IN years_NNS ,_, occupying_VBG the_DT minds_NNS of_IN scientists_NNS from_IN widely_RB ranging_VBG scientific_JJ disciplines_NNS ._. 
For_IN example_NN ,_, actuaries_NNS -LRB-_-LRB- who_WP study_VBP humans_NNS exclusively_RB -RRB-_-RRB- focus_NN on_IN the_DT practical_JJ use_NN of_IN death_NN statistics_NNS ,_, as_IN in_IN calculating_VBG premiums_NNS for_IN insurance_NN companies_NNS or_CC forecasting_NN survival_NN in_IN order_NN to_TO assess_VB the_DT solvency_NN of_IN age-entitlement_JJ programs_NNS 
However_RB ,_, frustration_NN arose_VBD over_IN the_DT years_NNS ,_, as_IN it_PRP was_VBD shown_VBN that_IN these_DT risk_NN factors_NNS accounted_VBD at_IN best_JJS for_IN only_JJ half_NN of_IN the_DT deaths_NNS from_IN these_DT three_CD causes_NNS ._. 
It_PRP is_VBZ now_RB realized_VBN that_IN such_JJ phenomena_NNS as_IN environment_NN ,_, psychosocial_JJ factors_NNS ,_, and_CC genetics_NNS also_RB play_VBP important_JJ roles_NNS ._. 
In_IN general_JJ ,_, control_NN of_IN chronic_JJ diseases_NNS has_VBZ been_VBN effective_JJ enough_RB to_TO produce_VB a_DT gradual_JJ increase_NN in_IN life_NN expectancy_NN ,_, albeit_IN at_IN a_DT diminishing_VBG rate_NN ._. 
Now_RB that_IN human_JJ survival_NN has_VBZ been_VBN progressively_RB extended_VBN deeper_JJR into_IN the_DT post-reproductive_JJ period_NN of_IN the_DT lifespan_NN ,_, a_DT biodemographic_JJ perspective_NN reveals_VBZ biochemical_JJ and_CC biomechanical_JJ forces_NNS that_WDT have_VBP a_DT profound_JJ influence_NN on_IN population_NN frailty_NN ,_, disease_NN expression_NN ,_, and_CC duration_NN of_IN life_NN ._. 
Biochemical_JJ constraints_NNS involve_VBP the_DT inevitable_JJ accumulation_NN of_IN damage_NN that_WDT occurs_VBZ at_IN all_DT levels_NNS of_IN biological_JJ organization_NN ,_, including_VBG the_DT maintenance_NN and_CC repair_NN processes_VBZ themselves_PRP 
The_DT theoretical_JJ basis_NN for_IN the_DT biodemography_NN of_IN aging_NN is_VBZ derived_VBN principally_RB from_IN evolutionary_JJ biology_NN 
In_IN contrast_NN to_TO the_DT scientists_NNS who_WP work_VBP at_IN the_DT level_NN of_IN populations_NNS ,_, biogerontologists_NNS examine_VBP death_NN for_IN humans_NNS and_CC other_JJ species_NNS from_IN a_DT micro_NN perspective_NN as_IN they_PRP endeavor_VBP to_TO explain_VB and_CC understand_VB changes_NNS that_WDT occur_VBP across_IN time_NN in_IN molecules_NNS ,_, cells_NNS ,_, tissues_NNS ,_, and_CC organs_NNS that_WDT eventually_RB contribute_VBP to_TO disease_NN and_CC death_NN ._. 
The_DT biodemography_NN of_IN aging_NN is_VBZ a_DT ``_`` new_JJ ''_'' scientific_JJ discipline_NN ,_, arising_VBG in_IN the_DT late_JJ 20th_JJ century_NN as_IN a_DT product_NN of_IN efforts_NNS to_TO merge_VB the_DT micro_NN analysis_NN of_IN mortality_NN explored_VBN by_IN biologists_NNS with_IN the_DT macro_NN analysis_NN of_IN scientists_NNS who_WP do_VBP research_NN at_IN the_DT population_NN level_NN -LRB-_-LRB- e._FW g._FW ,_, demographers_NNS and_CC epidemiologists_NNS -RRB-_-RRB- in_IN order_NN to_TO provide_VB a_DT biological_JJ rationale_NN for_IN the_DT timing_NN and_CC causes_NNS of_IN death_NN in_IN humans_NNS and_CC other_JJ sexually_RB reproducing_VBG species_NNS ._. 
Ethical_JJ issues_NNS in_IN health_NN communication_NN include_VBP the_DT need_NN to_TO avoid_VB conflicts_NNS of_IN interest_NN ,_, to_TO present_JJ facts_NNS about_IN health_NN hazards_NNS or_CC health_NN opportunities_NNS in_IN a_DT truthful_JJ ,_, balanced_JJ ,_, and_CC timely_JJ fashion_NN ,_, and_CC to_TO avoid_VB distorting_VBG the_DT facts_NNS or_CC concealing_VBG ambiguities_NNS in_IN the_DT scientific_JJ evidence_NN 
In_IN 1968_CD ,_, Wilson_NNP and_CC Jungner_NNP 
Screening_NN raises_VBZ a_DT number_NN of_IN important_JJ ethical_JJ issues_NNS around_IN informed_JJ consent_NN ,_, privacy_NN and_CC confidentiality_NN ,_, risks_NNS and_CC potential_JJ benefits_NNS ,_, and_CC the_DT allocation_NN of_IN finite_JJ public_JJ resources_NNS for_IN screening_NN ._. 
The_DT principle_NN of_IN respect_NN for_IN individuals_NNS '_POS freedom_NN supports_VBZ the_DT right_NN of_IN participants_NNS to_TO informed_JJ consent_NN prior_RB to_TO screening_NN ._. 
Provisions_NNS for_IN informed_JJ consent_NN ensure_VB that_IN people_NNS undergoing_VBG screening_NN make_VBP free_JJ choices_NNS ,_, and_CC encourage_VB providers_NNS to_TO act_VB responsibly_RB in_IN their_PRP$ interactions_NNS with_IN patients_NNS ._. 
Provisions_NNS for_IN informed_JJ consent_NN ensure_VB that_IN people_NNS undergoing_VBG screening_NN make_VBP free_JJ choices_NNS ,_, and_CC encourage_VB providers_NNS to_TO act_VB responsibly_RB in_IN their_PRP$ interactions_NNS with_IN patients_NNS ._. 
Subjects_NNS should_MD be_VB given_VBN information_NN about_IN the_DT procedure_NN ,_, the_DT meaning_NN of_IN a_DT positive_JJ or_CC negative_JJ test_NN result_NN ,_, and_CC any_DT appreciable_JJ risks_NNS or_CC potential_JJ harms_NNS and_CC benefits_NNS before_IN undergoing_VBG screening_NN 
For_IN example_NN ,_, most_JJS states_NNS require_VBP that_IN infants_NNS be_VB screened_VBN for_IN certain_JJ genetic_JJ disorders_NNS ,_, such_JJ as_IN phenylketonuria_NN -LRB-_-LRB- PKU_NNP -RRB-_-RRB- ._. 
Infants_NNS are_VBP subject_JJ to_TO the_DT screening_VBG program_NN unless_IN their_PRP$ parents_NNS refuse_VBP for_IN religious_JJ or_CC philosophical_JJ reasons_NNS 
Infants_NNS are_VBP subject_JJ to_TO the_DT screening_VBG program_NN unless_IN their_PRP$ parents_NNS refuse_VBP for_IN religious_JJ or_CC philosophical_JJ reasons_NNS 
These_DT principles_NNS are_VBP often_RB cited_VBN in_IN planning_VBG and_CC evaluating_VBG population_NN screening_NN programs_NNS ;_: they_PRP relate_VBP to_TO the_DT adequacy_NN of_IN the_DT scientific_JJ evidence_NN ,_, the_DT balance_NN of_IN risks_NNS and_CC benefits_NNS ,_, the_DT availability_NN of_IN an_DT effective_JJ treatment_NN ,_, the_DT acceptability_NN of_IN the_DT screening_VBG test_NN to_TO the_DT population_NN ,_, and_CC the_DT costs_NNS and_CC resources_NNS required_VBN 
The_DT potential_JJ harms_NNS of_IN screening_NN may_MD also_RB include_VB ``_`` labeling_VBG ''_'' effects_NNS and_CC the_DT psychologic_JJ impact_NN of_IN test_NN results_NNS or_CC a_DT diagnosis_NN ._. 
If_IN prognosis_NN is_VBZ not_RB improved_VBN by_IN presymptomatic_JJ detection_NN ,_, screening_VBG for_IN a_DT disease_NN can_MD cause_VB anxiety_NN without_IN providing_VBG any_DT benefit_NN ._. 
Medical_JJ information_NN collected_VBN as_IN part_NN of_IN screening_NN should_MD be_VB rigorously_RB safeguarded_VBN to_TO protect_VB patient_JJ privacy_NN and_CC confidentiality_NN and_CC to_TO minimize_VB risks_NNS or_CC potential_JJ harms_NNS such_JJ as_IN stigma_NN or_CC discrimination_NN ._. 
Medical_JJ information_NN collected_VBN as_IN part_NN of_IN screening_NN should_MD be_VB rigorously_RB safeguarded_VBN to_TO protect_VB patient_JJ privacy_NN and_CC confidentiality_NN and_CC to_TO minimize_VB risks_NNS or_CC potential_JJ harms_NNS such_JJ as_IN stigma_NN or_CC discrimination_NN ._. 
Only_RB a_DT few_JJ specific_JJ exceptions_NNS exist_VBP ,_, such_JJ as_IN mandatory_JJ partner_NN notification_NN laws_NNS for_IN HIV_NNP infection_NN that_IN physicians_NNS are_VBP legally_RB required_VBN to_TO follow_VB in_IN some_DT states_NNS ._. 
Summary_NN and_CC conclusion_NN The_DT burgeoning_VBG interest_NN in_IN ethical_JJ issues_NNS in_IN epidemiologic_JJ research_NN and_CC public_JJ health_NN practice_NN reflects_VBZ both_DT the_DT important_JJ societal_JJ role_NN of_IN public_JJ health_NN and_CC the_DT growing_VBG public_JJ interest_NN in_IN the_DT scientific_JJ integrity_NN of_IN health_NN information_NN and_CC the_DT equitable_JJ distribution_NN of_IN health_NN care_NN resources_NNS ._. 
There_EX is_VBZ a_DT need_NN to_TO balance_VB health_NN as_IN a_DT value_NN with_IN values_NNS of_IN privacy_NN and_CC autonomy_NN -LRB-_-LRB- for_IN example_NN ,_, in_IN relation_NN to_TO immunization_NN policies_NNS -RRB-_-RRB- ._. 
Several_JJ authors_NNS have_VBP considered_VBN the_DT circumstances_NNS under_IN which_WDT personal_JJ autonomy_NN can_MD be_VB abridged_JJ to_TO promote_VB the_DT health_NN of_IN the_DT whole_JJ community_NN and_CC the_DT moral_JJ justification_NN for_IN coercive_JJ public_JJ health_NN interventions_NNS and_CC lifestyle_NN strategies_NNS 
The_DT risks_NNS and_CC potential_JJ harms_NNS of_IN public_JJ health_NN interventions_NNS include_VBP ineffective_JJ ,_, counterproductive_JJ ,_, or_CC harmful_JJ interventions_NNS ;_: unanticipated_JJ consequences_NNS ;_: and_CC labeling_VBG or_CC stigmatizing_VBG of_IN individuals_NNS 
Principle-based_JJ approaches_NNS Principle-based_JJ approaches_NNS to_TO moral_JJ reasoning_NN were_VBD developed_VBN to_TO address_VB ethical_JJ issues_NNS in_IN clinical_JJ medicine_NN and_CC are_VBP not_RB necessarily_RB the_DT optimal_JJ approach_NN for_IN analyzing_VBG ethical_JJ issues_NNS in_IN public_JJ health_NN ._. 
The_DT four_CD principles_NNS of_IN beneficence_NN ,_, nonmaleficence_NN ,_, justice_NN ,_, and_CC respect_NN for_IN autonomy_NN are_VBP mentioned_VBN in_IN ethics_NNS guidelines_NNS drafted_VBN for_IN public_JJ health_NN professionals_NNS ,_, although_IN the_DT guidelines_NNS do_VBP not_RB provide_VB an_DT exhaustive_JJ account_NN of_IN how_WRB the_DT principles_NNS can_MD be_VB used_VBN as_IN a_DT framework_NN for_IN ethical_JJ decision_NN making_NN 
Many_JJ of_IN these_DT issues_NNS have_VBP been_VBN addressed_VBN in_IN the_DT literature_NN on_IN ethics_NNS in_IN epidemiology_NN and_CC public_JJ health_NN practice_NN including_VBG ethics_NNS guidelines_NNS ._. 
Issues_NNS dealt_VBD with_IN in_IN ethics_NNS guidelines_NNS for_IN epidemiologists_NNS and_CC the_DT published_VBN literatureEthical_JJ and_CC professional_JJ norms_NNS in_IN epidemiology_NN have_VBP been_VBN clarified_VBN in_IN ethics_NNS guidelines_NNS for_IN epidemiologists_NNS and_CC other_JJ public_JJ health_NN professionals_NNS ._. 
Ethics_NNS guidelines_NNS such_JJ as_IN those_DT developed_VBN for_IN the_DT Industrial_NNP Epidemiology_NNP Forum_NNP ,_, the_DT International_NNP Society_NNP for_IN Environmental_NNP Epidemiology_NNP ,_, and_CC the_DT A_NNP 
Ethics_NNS guidelines_NNS for_IN environmental_JJ epidemiologists_NNS drafted_VBN by_IN Colin_NNP Soskolne_NNP and_CC Andrew_NNP Light_NNP ,_, which_WDT were_VBD adopted_VBN by_IN the_DT International_NNP Society_NNP for_IN Environmental_NNP Epidemiology_NNP in_IN 1999_CD ,_, highlight_VBP the_DT important_JJ obligations_NNS that_IN epidemiologists_NNS have_VBP to_TO communities_NNS that_WDT are_VBP affected_VBN by_IN environmental_JJ hazards_NNS 
It_PRP may_MD also_RB be_VB important_JJ to_TO disclose_VB information_NN about_IN potential_JJ or_CC actual_JJ financial_JJ conflicts_NNS of_IN interest_NN when_WRB obtaining_VBG informed_JJ consent_NN from_IN research_NN participants_NNS ._. 
Arelated_JJ issue_NN is_VBZ that_IN health_NN researchers_NNS should_MD avoid_VB entering_VBG into_IN contractual_JJ agreements_NNS that_WDT prevent_VBP them_PRP from_IN publishing_VBG results_NNS in_IN a_DT timely_JJ manner_NN 
Communicating_VBG research_NN results_NNS in_IN a_DT timely_JJ manner_NN ,_, without_IN censorship_NN or_CC interference_NN from_IN the_DT funder_NN ,_, is_VBZ essential_JJ for_IN maintaining_VBG public_JJ trust_NN 
Principles_NNS such_JJ as_IN justice_NN also_RB figure_NN prominently_RB in_IN still-evolving_JJ ethics_NNS frameworks_NNS that_WDT have_VBP been_VBN proposed_VBN for_IN public_JJ health_NN 
Ongoing_JJ progressive_JJ specification_NN is_VBZ needed_VBN as_IN new_JJ issues_NNS and_CC concerns_NNS arise_VBP ._. 
Practical_NNP problems_NNS in_IN public_JJ health_NN ethics_NNS require_VBP that_IN these_DT principles_NNS be_VB made_VBN more_RBR applicable_JJ through_IN a_DT process_NN of_IN specification_NN and_CC reform_NN 
In_IN such_JJ deliberations_NNS ,_, particular_JJ decisions_NNS and_CC actions_NNS may_MD be_VB justified_VBN by_IN ethical_JJ theory_NN or_CC an_DT integrated_JJ body_NN of_IN rules_NNS and_CC principles_NNS ._. 
Two_CD theories_NNS have_VBP commonly_RB been_VBN cited_VBN in_IN public_JJ health_NN research_NN and_CC practice_NN :_: deontological_JJ and_CC utilitarian_JJ ._. 
Deontological_JJ theories_NNS -LRB-_-LRB- sometimes_RB referred_VBD to_TO as_IN Kantian_JJ theories_NNS -RRB-_-RRB- hold_VBP that_IN people_NNS should_MD not_RB be_VB treated_VBN as_IN means_NNS to_TO an_DT end_NN and_CC that_IN some_DT actions_NNS are_VBP right_JJ or_CC wrong_JJ regardless_RB of_IN the_DT consequences_NNS ._. 
The_DT principle_NN of_IN utility_NN requires_VBZ aggregate_JJ or_CC collective_JJ benefits_NNS to_TO be_VB maximized_VBN ._. 
Utilitarian_JJ theories_NNS ,_, on_IN the_DT other_JJ hand_NN ,_, strive_VBP to_TO maximize_VB beneficial_JJ consequences_NNS ._. 
From_IN a_DT utilitarian_JJ perspective_NN ,_, the_DT principle_NN of_IN utility_NN is_VBZ the_DT ultimate_JJ ethical_JJ principle_NN from_IN which_WDT all_DT other_JJ principles_NNS are_VBP derived_VBN ._. 
Utilitarian_JJ theories_NNS provide_VBP strong_JJ justification_NN for_IN public_JJ health_NN programs_NNS such_JJ as_IN mandatory_JJ vaccination_NN programs_NNS for_IN children_NNS and_CC the_DT fluoridation_NN of_IN public_JJ water_NN supplies_NNS ._. 
In_IN situations_NNS where_WRB there_EX is_VBZ conflict_NN between_IN principles_NNS ,_, it_PRP may_MD be_VB necessary_JJ to_TO choose_VB between_IN them_PRP or_CC to_TO assign_VB greater_JJR weight_NN to_TO one_CD ._. 
Practical_NNP problems_NNS in_IN public_JJ health_NN ethics_NNS require_VBP that_IN these_DT principles_NNS be_VB made_VBN more_RBR applicable_JJ through_IN a_DT process_NN of_IN specification_NN and_CC reform_NN 
The_DT principle_NN of_IN nonmaleficence_NN requires_VBZ that_IN harmful_JJ acts_NNS be_VB avoided_VBN ._. 
This_DT principle_NN underlies_VBZ ethical_JJ rules_NNS and_CC norms_NNS that_WDT require_VBP that_IN public_JJ health_NN institutions_NNS act_VBP in_IN a_DT timely_JJ manner_NN on_IN the_DT information_NN they_PRP have_VBP and_CC that_IN they_PRP expeditiously_RB make_VBP the_DT information_NN available_JJ to_TO the_DT public_NN 
Respect_NN for_IN the_DT individual_NN is_VBZ a_DT principle_NN rooted_VBN in_IN the_DT Western_JJ tradition_NN ,_, which_WDT grants_VBZ importance_NN to_TO individual_JJ freedom_NN in_IN political_JJ life_NN ,_, and_CC to_TO personal_JJ development_NN ._. 
Principles_NNS of_IN justice_NN are_VBP also_RB important_JJ ._. 
Utilitarian_JJ theories_NNS of_IN justice_NN emphasize_VB a_DT mixture_NN of_IN criteria_NNS so_IN that_DT public_JJ utility_NN is_VBZ maximized_VBN ._. 
Such_JJ decisions_NNS are_VBP often_RB made_VBN by_IN focusing_VBG on_IN the_DT circumstances_NNS of_IN the_DT case_NN at_IN hand_NN and_CC the_DT moral_JJ context_NN in_IN which_WDT the_DT case_NN rests_VBZ ._. 
Case-based_JJ methods_NNS such_JJ as_IN casuistry_NN are_VBP grounded_VBN in_IN analogical_JJ reasoning_NN ,_, appeal_NN to_TO paradigmatic_JJ cases_NNS ,_, and_CC practical_JJ judgment_NN 
The_DT claim_NN is_VBZ backed_VBN by_IN a_DT form_NN of_IN logical_JJ reasoning_NN described_VBN in_IN terms_NNS of_IN grounds_NNS or_CC relevant_JJ circumstances_NNS ,_, maxims_NNS ,_, and_CC the_DT backings_NNS or_CC more_JJR general_JJ notions_NNS that_WDT support_VBP the_DT maxims_NNS ._. 
The_DT descriptions_NNS of_IN the_DT case_NN ,_, including_VBG the_DT circumstances_NNS ,_, maxims_NNS ,_, and_CC logical_JJ thought_NN ,_, constitute_VBP its_PRP$ basic_JJ structure_NN or_CC morphology_NN ._. 
Placing_VBG a_DT particular_JJ case_NN alongside_IN other_JJ similar_JJ cases_NNS has_VBZ been_VBN referred_VBN to_TO as_IN taxonomy_NN ._. 
Casuistic_JJ reasoning_NN begins_VBZ with_IN relatively_RB clear_JJ ,_, paradigmatic_JJ cases_NNS in_IN which_WDT some_DT ethical_JJ norm_NN indicates_VBZ the_DT right_JJ course_NN of_IN action_NN ._. 
Virtue_NNP ethics_NNS and_CC the_DT moral_JJ rule-based_JJ system_NN of_IN Gert_NNP and_CC Clouser_NNP ,_, however_RB ,_, have_VBP been_VBN discussed_VBN as_IN potential_JJ alternatives_NNS to_TO other_JJ leading_VBG approaches_NNS to_TO moral_JJ reasoning_NN in_IN public_JJ health_NN ethics_NNS 
Other_JJ steps_NNS that_WDT can_MD be_VB taken_VBN to_TO resolve_VB moral_JJ controversies_NNS include_VBP using_VBG examples_NNS and_CC counter-examples_NNS and_CC analyzing_VBG arguments_NNS to_TO expose_VB their_PRP$ inadequacies_NNS ,_, gaps_NNS ,_, and_CC fallacies_NNS ._. 
In_IN addition_NN ,_, moral_JJ problems_NNS can_MD sometimes_RB be_VB resolved_VBN by_IN getting_VBG the_DT disputing_VBG parties_NNS to_TO adopt_VB a_DT new_JJ policy_NN or_CC code_NN ,_, such_JJ as_IN ethics_NNS guidelines_NNS for_IN epidemiologists_NNS 
Different_JJ methods_NNS of_IN moral_JJ reasoning_NN have_VBP been_VBN applied_VBN to_TO ethical_JJ decision_NN making_VBG in_IN public_JJ health_NN research_NN and_CC practice_NN 
Case-based_JJ methods_NNS such_JJ as_IN casuistry_NN are_VBP grounded_VBN in_IN analogical_JJ reasoning_NN ,_, appeal_NN to_TO paradigmatic_JJ cases_NNS ,_, and_CC practical_JJ judgment_NN 
Recent_JJ articles_NNS have_VBP included_VBN conceptual_JJ frameworks_NNS of_IN public_JJ health_NN ethics_NNS and_CC overviews_NNS of_IN historical_JJ developments_NNS in_IN the_DT field_NN 
Ethics_NNS in_IN public_JJ health_NN involves_VBZ an_DT interplay_NN between_IN protecting_VBG the_DT welfare_NN of_IN the_DT individual_NN ,_, as_IN in_IN medicine_NN ,_, and_CC the_DT public_JJ health_NN goal_NN of_IN protecting_VBG the_DT public_JJ welfare_NN 
The_DT four_CD principles_NNS of_IN beneficence_NN ,_, nonmaleficence_NN ,_, justice_NN ,_, and_CC respect_NN for_IN autonomy_NN are_VBP mentioned_VBN in_IN ethics_NNS guidelines_NNS drafted_VBN for_IN public_JJ health_NN professionals_NNS ,_, although_IN the_DT guidelines_NNS do_VBP not_RB provide_VB an_DT exhaustive_JJ account_NN of_IN how_WRB the_DT principles_NNS can_MD be_VB used_VBN as_IN a_DT framework_NN for_IN ethical_JJ decision_NN making_NN 
Respect_NN for_IN the_DT individual_NN is_VBZ a_DT principle_NN rooted_VBN in_IN the_DT Western_JJ tradition_NN ,_, which_WDT grants_VBZ importance_NN to_TO individual_JJ freedom_NN in_IN political_JJ life_NN ,_, and_CC to_TO personal_JJ development_NN ._. 
Principles_NNS of_IN justice_NN are_VBP also_RB important_JJ ._. 
Utilitarian_JJ theories_NNS of_IN justice_NN emphasize_VB a_DT mixture_NN of_IN criteria_NNS so_IN that_DT public_JJ utility_NN is_VBZ maximized_VBN ._. 
Other_JJ theories_NNS of_IN justice_NN hold_VBP that_DT society_NN has_VBZ an_DT obligation_NN to_TO correct_VB inequalities_NNS in_IN the_DT distribution_NN of_IN resources_NNS ,_, and_CC that_IN those_DT who_WP are_VBP least_JJS well_RB off_RB should_MD benefit_VB most_JJS from_IN resources_NNS such_JJ as_IN screening_NN services_NNS ._. 
Such_JJ theories_NNS of_IN justice_NN provide_VBP considerable_JJ support_NN for_IN maximizing_VBG benefits_NNS to_TO medically_RB underserved_JJ people_NNS ._. 
Case-based_JJ approaches_NNS to_TO moral_JJ reasoning_NN While_IN many_JJ general_JJ ethical_JJ questions_NNS have_VBP been_VBN answered_VBN on_IN the_DT basis_NN of_IN general_JJ principles_NNS and_CC theories_NNS ,_, the_DT specific_JJ decisions_NNS that_WDT emerge_VBP in_IN particular_JJ cases_NNS may_MD remain_VB unaddressed_JJ by_IN the_DT principles_NNS ._. 
Ethical_JJ concerns_NNS can_MD be_VB anticipated_VBN or_CC identified_VBN early_RB and_CC effectively_RB addressed_VBN through_IN careful_JJ analysis_NN and_CC consultation_NN ._. 
IntroductionA_NNP rich_JJ and_CC growing_VBG body_NN of_IN literature_NN has_VBZ emerged_VBN on_IN ethics_NNS in_IN epidemiologic_JJ research_NN and_CC public_JJ health_NN practice_NN 
Introduction_NN A_DT rich_JJ and_CC growing_VBG body_NN of_IN literature_NN has_VBZ emerged_VBN on_IN ethics_NNS in_IN epidemiologic_JJ research_NN and_CC public_JJ health_NN practice_NN 
Recent_JJ articles_NNS have_VBP included_VBN conceptual_JJ frameworks_NNS of_IN public_JJ health_NN ethics_NNS and_CC overviews_NNS of_IN historical_JJ developments_NNS in_IN the_DT field_NN 
The_DT four_CD principles_NNS of_IN beneficence_NN ,_, nonmaleficence_NN ,_, justice_NN ,_, and_CC respect_NN for_IN autonomy_NN are_VBP mentioned_VBN in_IN ethics_NNS guidelines_NNS drafted_VBN for_IN public_JJ health_NN professionals_NNS ,_, although_IN the_DT guidelines_NNS do_VBP not_RB provide_VB an_DT exhaustive_JJ account_NN of_IN how_WRB the_DT principles_NNS can_MD be_VB used_VBN as_IN a_DT framework_NN for_IN ethical_JJ decision_NN making_NN 
Respect_NN for_IN the_DT individual_NN is_VBZ a_DT principle_NN rooted_VBN in_IN the_DT Western_JJ tradition_NN ,_, which_WDT grants_VBZ importance_NN to_TO individual_JJ freedom_NN in_IN political_JJ life_NN ,_, and_CC to_TO personal_JJ development_NN ._. 
Principles_NNS of_IN justice_NN are_VBP also_RB important_JJ ._. 
Utilitarian_JJ theories_NNS of_IN justice_NN emphasize_VB a_DT mixture_NN of_IN criteria_NNS so_IN that_DT public_JJ utility_NN is_VBZ maximized_VBN ._. 
Other_JJ theories_NNS of_IN justice_NN hold_VBP that_DT society_NN has_VBZ an_DT obligation_NN to_TO correct_VB inequalities_NNS in_IN the_DT distribution_NN of_IN resources_NNS ,_, and_CC that_IN those_DT who_WP are_VBP least_JJS well_RB off_RB should_MD benefit_VB most_JJS from_IN resources_NNS such_JJ as_IN screening_NN services_NNS ._. 
Such_JJ theories_NNS of_IN justice_NN provide_VBP considerable_JJ support_NN for_IN maximizing_VBG benefits_NNS to_TO medically_RB underserved_JJ people_NNS ._. 
Case-based_JJ approaches_NNS to_TO moral_JJ reasoning_NN While_IN many_JJ general_JJ ethical_JJ questions_NNS have_VBP been_VBN answered_VBN on_IN the_DT basis_NN of_IN general_JJ principles_NNS and_CC theories_NNS ,_, the_DT specific_JJ decisions_NNS that_WDT emerge_VBP in_IN particular_JJ cases_NNS may_MD remain_VB unaddressed_JJ by_IN the_DT principles_NNS ._. 
Case-based_JJ methods_NNS such_JJ as_IN casuistry_NN are_VBP grounded_VBN in_IN analogical_JJ reasoning_NN ,_, appeal_NN to_TO paradigmatic_JJ cases_NNS ,_, and_CC practical_JJ judgment_NN 
S._NNP Criteria_NNP for_IN the_DT effectiveness_NN of_IN clinical_JJ preventive_JJ services_NNS have_VBP been_VBN developed_VBN by_IN the_DT Canadian_NNP Task_NNP Force_NNP on_IN the_DT Periodic_NNP Health_NNP Examination_NNP 
The_DT potential_JJ benefits_NNS of_IN screening_NN include_VBP the_DT early_JJ detection_NN of_IN disease_NN and_CC the_DT prevention_NN of_IN serious_JJ illness_NN or_CC disability_NN and_CC improved_VBN survival_NN ._. 
The_DT societal_JJ benefits_NNS of_IN screening_NN include_VBP substantial_JJ reductions_NNS in_IN morbidity_NN and_CC mortality_NN ._. 
Screening_NN is_VBZ undertaken_VBN for_IN conditions_NNS that_WDT are_VBP important_JJ public_JJ health_NN problems_NNS and_CC those_DT for_IN which_WDT early_JJ detection_NN and_CC treatment_NN are_VBP effective_JJ ._. 
The_DT potential_JJ harms_NNS and_CC risks_NNS associated_VBN with_IN screening_VBG also_RB have_VBP to_TO be_VB taken_VBN into_IN account_NN ,_, especially_RB since_IN screening_NN programs_NNS are_VBP aimed_VBN at_IN large_JJ numbers_NNS of_IN apparently_RB healthy_JJ people_NNS ._. 
Minor_NNP complications_NNS or_CC infrequent_JJ adverse_JJ effects_NNS that_WDT would_MD be_VB acceptable_JJ in_IN the_DT treatment_NN of_IN a_DT severe_JJ illness_NN take_VB on_RP greater_JJR importance_NN when_WRB screening_VBG asymptomatic_JJ people_NNS and_CC require_VB careful_JJ evaluation_NN to_TO determine_VB whether_IN the_DT potential_JJ benefits_NNS exceed_VBP risks_NNS ._. 
There_EX may_MD be_VB risks_NNS associated_VBN with_IN false-positive_JJ or_CC false-negative_JJ test_NN results_NNS ._. 
The_DT potential_JJ harms_NNS of_IN screening_NN may_MD also_RB include_VB ``_`` labeling_VBG ''_'' effects_NNS and_CC the_DT psychologic_JJ impact_NN of_IN test_NN results_NNS or_CC a_DT diagnosis_NN ._. 
Subjects_NNS should_MD be_VB given_VBN information_NN about_IN the_DT procedure_NN ,_, the_DT meaning_NN of_IN a_DT positive_JJ or_CC negative_JJ test_NN result_NN ,_, and_CC any_DT appreciable_JJ risks_NNS or_CC potential_JJ harms_NNS and_CC benefits_NNS before_IN undergoing_VBG screening_NN 
Screening_NN is_VBZ undertaken_VBN for_IN conditions_NNS that_WDT are_VBP important_JJ public_JJ health_NN problems_NNS and_CC those_DT for_IN which_WDT early_JJ detection_NN and_CC treatment_NN are_VBP effective_JJ ._. 
If_IN early_JJ treatment_NN is_VBZ not_RB effective_JJ ,_, then_RB early_JJ detection_NN alone_RB merely_RB extends_VBZ the_DT length_NN of_IN time_NN the_DT disease_NN is_VBZ known_VBN to_TO exist_VB ,_, without_IN extending_VBG survival_NN ._. 
Public_JJ health_NN policy_NN makers_NNS rely_VBP on_IN information_NN from_IN randomized_VBN controlled_JJ trials_NNS and_CC other_JJ sources_NNS to_TO evaluate_VB the_DT effectiveness_NN ,_, potential_JJ benefits_NNS ,_, and_CC risks_NNS or_CC potential_JJ harms_NNS of_IN screening_NN ._. 
Afundamental_JJ public_JJ health_NN activity_NN is_VBZ to_TO measure_VB and_CC monitor_VB changes_NNS in_IN health_NN status_NN ,_, risk_NN factors_NNS ,_, and_CC health_NN service_NN access_NN and_CC utilization_NN ._. 
The_DT effective_JJ dissemination_NN of_IN information_NN is_VBZ as_RB important_JJ as_IN data_NNS collection_NN and_CC analysis_NN ;_: the_DT collected_VBN information_NN must_MD have_VB a_DT demonstrated_VBN utility_NN 
The_DT effective_JJ dissemination_NN of_IN information_NN is_VBZ as_RB important_JJ as_IN data_NNS collection_NN and_CC analysis_NN ;_: the_DT collected_VBN information_NN must_MD have_VB a_DT demonstrated_VBN utility_NN 
Sometimes_RB this_DT is_VBZ because_IN the_DT public_NN or_CC government_NN authorities_NNS perceive_VBP an_DT imminent_JJ threat_NN that_WDT demands_VBZ immediate_JJ action_NN ._. 
The_DT primary_JJ purpose_NN of_IN the_DT activity_NN is_VBZ to_TO determine_VB the_DT nature_NN and_CC magnitude_NN of_IN a_DT public_JJ health_NN problem_NN in_IN the_DT community_NN and_CC to_TO implement_VB appropriate_JJ measures_NNS to_TO address_VB the_DT problem_NN 
Several_JJ frameworks_NNS for_IN analyzing_VBG and_CC addressing_VBG ethical_JJ and_CC policy_NN issues_NNS in_IN public_JJ health_NN screening_NN programs_NNS have_VBP been_VBN proposed_VBN ._. 
In_IN 1968_CD ,_, Wilson_NNP and_CC Jungner_NNP 
Other_JJ issues_NNS addressed_VBN in_IN the_DT guidelines_NNS include_VBP those_DT pertaining_VBG to_TO scientific_JJ misconduct_NN ,_, intellectual_JJ property_NN and_CC data_NN sharing_NN ,_, publication_NN of_IN research_NN findings_NNS ,_, and_CC cross-cultural_JJ or_CC international_JJ health_NN research_NN ._. 
Ethical_JJ issues_NNS in_IN public_JJ health_NN practiceAn_NN expanding_VBG body_NN of_IN literature_NN has_VBZ considered_VBN the_DT important_JJ ethical_JJ issues_NNS that_WDT arise_VBP in_IN such_JJ areas_NNS of_IN public_JJ health_NN practice_NN as_IN surveillance_NN ,_, emergency_NN responses_NNS ,_, and_CC program_NN evaluation_NN ._. 
In_IN further_RB specifying_VBG ethical_JJ norms_NNS in_IN particular_JJ contexts_NNS ,_, it_PRP is_VBZ important_JJ to_TO draw_VB distinctions_NNS between_IN epidemiologic_JJ research_NN and_CC public_JJ health_NN practice_NN activities_NNS ._. 
Investigators_NNS should_MD carefully_RB consider_VB ethical_JJ issues_NNS in_IN each_DT project_NN ,_, regardless_RB of_IN whether_IN it_PRP is_VBZ research_NN or_CC public_JJ health_NN practice_NN ._. 
Ethical_JJ issues_NNS in_IN public_JJ health_NN surveillanceEthics_NNS guidelines_NNS for_IN public_JJ health_NN surveillance_NN have_VBP been_VBN developed_VBN for_IN disease_NN registry_NN personnel_NNS ,_, and_CC a_DT growing_VBG body_NN of_IN literature_NN has_VBZ evolved_VBN in_IN this_DT area_NN ,_, indicating_VBG increasing_VBG interest_NN ._. 
These_DT developments_NNS are_VBP partly_RB a_DT response_NN to_TO public_JJ concern_NN over_IN the_DT privacy_NN and_CC confidentiality_NN of_IN health_NN information_NN and_CC technological_JJ advances_NNS such_JJ as_IN the_DT use_NN of_IN the_DT Internet_NNP to_TO disseminate_VB data_NNS from_IN surveillance_NN systems_NNS and_CC disease_NN registries_NNS ._. 
In_IN further_RB specifying_VBG ethical_JJ norms_NNS in_IN particular_JJ contexts_NNS ,_, it_PRP is_VBZ important_JJ to_TO draw_VB distinctions_NNS between_IN epidemiologic_JJ research_NN and_CC public_JJ health_NN practice_NN activities_NNS ._. 
For_IN example_NN ,_, requirements_NNS for_IN submitting_VBG research_NN protocols_NNS to_TO an_DT IRB_NNP do_VBP not_RB necessarily_RB apply_VB to_TO outbreak_NN investigations_NNS and_CC other_JJ emergency_NN responses_NNS 
The_DT guidelines_NNS and_CC approaches_NNS for_IN conducting_VBG epidemiologic_JJ field_NN investigations_NNS reflect_VBP the_DT urgency_NN of_IN discovering_VBG causative_JJ factors_NNS and_CC the_DT need_NN to_TO make_VB practical_JJ recommendations_NNS ,_, such_JJ as_IN during_IN the_DT SARS_NNP epidemic_NN 
Program_NN evaluation_NN ,_, on_IN the_DT other_JJ hand_NN ,_, refers_VBZ to_TO the_DT systematic_JJ application_NN of_IN scientific_JJ and_CC statistical_JJ procedures_NNS for_IN measuring_VBG program_NN conceptualization_NN ,_, design_NN ,_, implementation_NN ,_, and_CC utility_NN ;_: the_DT comparison_NN of_IN these_DT measurements_NNS ;_: and_CC the_DT use_NN of_IN the_DT resulting_VBG information_NN to_TO optimize_VB program_NN outcomes_NNS ._. 
Federal_JJ regulations_NNS -LRB-_-LRB- Title_NNP 45_CD CFR_NNP Part_NNP 46_CD -RRB-_-RRB- ,_, which_WDT deal_VBP with_IN issues_NNS such_JJ as_IN IRB_NNP review_NN and_CC informed_JJ consent_NN requirements_NNS ,_, mostly_RB address_VB biomedical_JJ research_NN 
Although_IN some_DT public_JJ health_NN activities_NNS can_MD clearly_RB be_VB classified_VBN as_IN either_DT research_NN or_CC non-research_JJ activities_NNS for_IN regulatory_JJ purposes_NNS ,_, for_IN other_JJ activities_NNS the_DT classification_NN is_VBZ more_RBR difficult_JJ ._. 
For_IN example_NN ,_, scientific_JJ knowledge_NN generated_VBN in_IN controlling_VBG a_DT disease_NN outbreak_NN may_MD turn_VB out_RP to_TO be_VB useful_JJ in_IN other_JJ settings_NNS ,_, even_RB though_IN generating_VBG generalizable_JJ knowledge_NN was_VBD not_RB the_DT primary_JJ intent_NN of_IN the_DT investigation_NN ._. 
In_IN applying_VBG the_DT federal_JJ regulations_NNS for_IN protecting_VBG participants_NNS in_IN public_JJ health_NN research_NN ,_, U._NNP S._NNP agencies_NNS have_VBP distinguished_VBN health_NN research_NN and_CC non-research_JJ public_JJ health_NN practice_NN activities_NNS ._. 
Surveillance_NN projects_NNS may_MD have_VB a_DT research_NN component_NN when_WRB they_PRP involve_VBP the_DT collection_NN and_CC analysis_NN of_IN health-related_JJ data_NNS conducted_VBN either_RB to_TO generate_VB knowledge_NN that_WDT is_VBZ applicable_JJ to_TO other_JJ populations_NNS and_CC settings_NNS or_CC to_TO contribute_VB to_TO general_JJ knowledge_NN about_IN the_DT health_NN condition_NN ._. 
Most_JJS emergency_NN responses_NNS and_CC outbreak_NN investigations_NNS tend_VBP to_TO be_VB non-research_JJ because_IN these_DT projects_NNS are_VBP undertaken_VBN to_TO solve_VB an_DT immediate_JJ health_NN problem_NN and_CC any_DT knowledge_NN gained_VBN will_MD likely_RB benefit_VB only_RB the_DT study_NN participants_NNS or_CC target_NN population_NN ._. 
Although_IN some_DT ethical_JJ requirements_NNS ,_, such_JJ as_IN IRB_NNP review_NN ,_, do_VBP not_RB apply_VB equally_RB to_TO epidemiologic_JJ research_NN and_CC non-research_JJ public_JJ health_NN practice_NN activities_NNS ,_, there_EX are_VBP many_JJ important_JJ similarities_NNS between_IN the_DT ethics_NNS of_IN epidemiologic_JJ research_NN and_CC non-research_JJ -LRB-_-LRB- for_IN example_NN ,_, requirements_NNS for_IN confidentiality_NN protection_NN in_IN research_NN and_CC non-research_JJ disease_NN surveillance_NN systems_NNS -RRB-_-RRB- ._. 
For_IN example_NN ,_, requirements_NNS for_IN submitting_VBG research_NN protocols_NNS to_TO an_DT IRB_NNP do_VBP not_RB necessarily_RB apply_VB to_TO outbreak_NN investigations_NNS and_CC other_JJ emergency_NN responses_NNS 
Specific_JJ measures_NNS taken_VBN by_IN researchers_NNS to_TO protect_VB the_DT confidentiality_NN of_IN health_NN information_NN include_VBP keeping_VBG records_NNS under_IN lock_NN and_CC key_NN ,_, limiting_VBG access_NN to_TO confidential_JJ records_NNS ,_, discarding_VBG personal_JJ identifiers_NNS from_IN data_NN collection_NN forms_NNS and_CC computer_NN files_NNS whenever_WRB feasible_JJ ,_, and_CC training_NN staff_NN in_IN the_DT importance_NN of_IN privacy_NN and_CC confidentiality_NN protection_NN 
Other_JJ measures_NNS that_WDT have_VBP been_VBN employed_VBN to_TO safeguard_VB health_NN information_NN include_VBP encrypting_VBG computer_NN databases_NNS ,_, limiting_VBG geographic_JJ detail_NN ,_, and_CC suppressing_VBG cells_NNS in_IN tabulated_JJ data_NNS where_WRB the_DT number_NN of_IN cases_NNS in_IN the_DT cell_NN is_VBZ small_JJ ._. 
In_IN the_DT United_NNP States_NNPS ,_, the_DT Health_NNP Insurance_NNP Portability_NNP and_CC Accountability_NNP Act_NNP -LRB-_-LRB- HIPAA_NNP -RRB-_-RRB- of_IN 1996_CD took_VBD effect_NN early_RB in_IN 2004_CD after_IN extensive_JJ planning_NN and_CC discussion_NN 
Despite_IN the_DT important_JJ role_NN played_VBN by_IN research_NN ethics_NNS committees_NNS and_CC IRBs_NNS ,_, researchers_NNS have_VBP sometimes_RB expressed_VBN concern_NN about_IN the_DT obstacles_NNS that_IN human-subjects_JJ review_NN can_MD create_VB ._. 
In_IN some_DT countries_NNS ,_, human-subjects_JJ review_NN has_VBZ been_VBN streamlined_JJ with_IN the_DT use_NN of_IN standardized_JJ forms_NNS and_CC review_NN processes_NNS or_CC by_IN centralizing_VBG review_NN by_IN research_NN ethics_NNS committees_NNS ._. 
As_IN previously_RB mentioned_VBN ,_, one_CD of_IN the_DT important_JJ issues_NNS considered_VBN by_IN research_NN ethics_NNS committees_NNS and_CC by_IN individual_JJ researchers_NNS is_VBZ the_DT adequacy_NN of_IN provisions_NNS for_IN obtaining_VBG the_DT informed_JJ consent_NN of_IN study_NN participants_NNS ._. 
Other_JJ issues_NNS addressed_VBN in_IN the_DT guidelines_NNS include_VBP those_DT pertaining_VBG to_TO scientific_JJ misconduct_NN ,_, intellectual_JJ property_NN and_CC data_NN sharing_NN ,_, publication_NN of_IN research_NN findings_NNS ,_, and_CC cross-cultural_JJ or_CC international_JJ health_NN research_NN ._. 
Ethical_JJ issues_NNS in_IN public_JJ health_NN practiceAn_NN expanding_VBG body_NN of_IN literature_NN has_VBZ considered_VBN the_DT important_JJ ethical_JJ issues_NNS that_WDT arise_VBP in_IN such_JJ areas_NNS of_IN public_JJ health_NN practice_NN as_IN surveillance_NN ,_, emergency_NN responses_NNS ,_, and_CC program_NN evaluation_NN ._. 
In_IN further_RB specifying_VBG ethical_JJ norms_NNS in_IN particular_JJ contexts_NNS ,_, it_PRP is_VBZ important_JJ to_TO draw_VB distinctions_NNS between_IN epidemiologic_JJ research_NN and_CC public_JJ health_NN practice_NN activities_NNS ._. 
Investigators_NNS should_MD carefully_RB consider_VB ethical_JJ issues_NNS in_IN each_DT project_NN ,_, regardless_RB of_IN whether_IN it_PRP is_VBZ research_NN or_CC public_JJ health_NN practice_NN ._. 
Ethical_JJ issues_NNS in_IN public_JJ health_NN surveillanceEthics_NNS guidelines_NNS for_IN public_JJ health_NN surveillance_NN have_VBP been_VBN developed_VBN for_IN disease_NN registry_NN personnel_NNS ,_, and_CC a_DT growing_VBG body_NN of_IN literature_NN has_VBZ evolved_VBN in_IN this_DT area_NN ,_, indicating_VBG increasing_VBG interest_NN ._. 
These_DT developments_NNS are_VBP partly_RB a_DT response_NN to_TO public_JJ concern_NN over_IN the_DT privacy_NN and_CC confidentiality_NN of_IN health_NN information_NN and_CC technological_JJ advances_NNS such_JJ as_IN the_DT use_NN of_IN the_DT Internet_NNP to_TO disseminate_VB data_NNS from_IN surveillance_NN systems_NNS and_CC disease_NN registries_NNS ._. 
Refinements_NNS have_VBP been_VBN proposed_VBN over_IN the_DT years_NNS ,_, with_IN further_JJ specification_NN of_IN the_DT principles_NNS of_IN screening_NN 
Principles_NNS of_IN informed_JJ consent_NN for_IN screening_NN have_VBP some_DT features_NNS in_IN common_JJ with_IN emerging_VBG models_NNS of_IN informed_JJ decision_NN making_NN and_CC shared_JJ decision_NN making_VBG for_IN screening_NN and_CC other_JJ health_NN care_NN services_NNS 
Principles_NNS of_IN informed_JJ consent_NN for_IN screening_NN have_VBP some_DT features_NNS in_IN common_JJ with_IN emerging_VBG models_NNS of_IN informed_JJ decision_NN making_NN and_CC shared_JJ decision_NN making_VBG for_IN screening_NN and_CC other_JJ health_NN care_NN services_NNS 
These_DT principles_NNS are_VBP often_RB cited_VBN in_IN planning_VBG and_CC evaluating_VBG population_NN screening_NN programs_NNS ;_: they_PRP relate_VBP to_TO the_DT adequacy_NN of_IN the_DT scientific_JJ evidence_NN ,_, the_DT balance_NN of_IN risks_NNS and_CC benefits_NNS ,_, the_DT availability_NN of_IN an_DT effective_JJ treatment_NN ,_, the_DT acceptability_NN of_IN the_DT screening_VBG test_NN to_TO the_DT population_NN ,_, and_CC the_DT costs_NNS and_CC resources_NNS required_VBN 
As_IN discussed_VBN by_IN Briss_NNP et_FW al._FW ._. 
Such_JJ models_NNS emphasize_VBP that_IN people_NNS should_MD be_VB provided_VBN with_IN balanced_JJ and_CC relevant_JJ information_NN so_IN they_PRP can_MD make_VB informed_JJ decisions_NNS about_IN screening_VBG options_NNS 
There_EX is_VBZ a_DT need_NN to_TO balance_VB health_NN as_IN a_DT value_NN with_IN values_NNS of_IN privacy_NN and_CC autonomy_NN -LRB-_-LRB- for_IN example_NN ,_, in_IN relation_NN to_TO immunization_NN policies_NNS -RRB-_-RRB- ._. 
Several_JJ authors_NNS have_VBP considered_VBN the_DT circumstances_NNS under_IN which_WDT personal_JJ autonomy_NN can_MD be_VB abridged_JJ to_TO promote_VB the_DT health_NN of_IN the_DT whole_JJ community_NN and_CC the_DT moral_JJ justification_NN for_IN coercive_JJ public_JJ health_NN interventions_NNS and_CC lifestyle_NN strategies_NNS 
There_EX is_VBZ a_DT need_NN for_IN sensitivity_NN to_TO ethnic_JJ and_CC cultural_JJ habits_NNS and_CC norms_NNS and_CC to_TO avoid_VB ``_`` top-down_JJ ''_'' planning_NN ,_, in_IN which_WDT the_DT health_NN concerns_NNS and_CC self-defined_JJ information_NN needs_NNS of_IN the_DT target_NN population_NN are_VBP ignored_VBN in_IN favor_NN of_IN professional_JJ preoccupations_NNS and_CC concerns_NNS ._. 
Such_JJ concerns_NNS have_VBP been_VBN successfully_RB addressed_VBN through_IN community-based_JJ participatory_JJ research_NN ,_, which_WDT is_VBZ a_DT collaborative_JJ ,_, empowering_VBG process_NN that_WDT helps_VBZ develop_VB competencies_NNS in_IN communities_NNS 
To_TO give_VB informed_JJ consent_NN for_IN screening_NN ,_, participants_NNS need_VBP to_TO understand_VB the_DT risk_NN of_IN a_DT false-positive_JJ test_NN result_NN and_CC the_DT procedures_NNS that_WDT may_MD follow_VB it_PRP 
The_DT guidelines_NNS and_CC approaches_NNS for_IN conducting_VBG epidemiologic_JJ field_NN investigations_NNS reflect_VBP the_DT urgency_NN of_IN discovering_VBG causative_JJ factors_NNS and_CC the_DT need_NN to_TO make_VB practical_JJ recommendations_NNS ,_, such_JJ as_IN during_IN the_DT SARS_NNP epidemic_NN 
Program_NN evaluation_NN ,_, on_IN the_DT other_JJ hand_NN ,_, refers_VBZ to_TO the_DT systematic_JJ application_NN of_IN scientific_JJ and_CC statistical_JJ procedures_NNS for_IN measuring_VBG program_NN conceptualization_NN ,_, design_NN ,_, implementation_NN ,_, and_CC utility_NN ;_: the_DT comparison_NN of_IN these_DT measurements_NNS ;_: and_CC the_DT use_NN of_IN the_DT resulting_VBG information_NN to_TO optimize_VB program_NN outcomes_NNS ._. 
Federal_JJ regulations_NNS -LRB-_-LRB- Title_NNP 45_CD CFR_NNP Part_NNP 46_CD -RRB-_-RRB- ,_, which_WDT deal_VBP with_IN issues_NNS such_JJ as_IN IRB_NNP review_NN and_CC informed_JJ consent_NN requirements_NNS ,_, mostly_RB address_VB biomedical_JJ research_NN 
These_DT developments_NNS are_VBP partly_RB a_DT response_NN to_TO public_JJ concern_NN over_IN the_DT privacy_NN and_CC confidentiality_NN of_IN health_NN information_NN and_CC technological_JJ advances_NNS such_JJ as_IN the_DT use_NN of_IN the_DT Internet_NNP to_TO disseminate_VB data_NNS from_IN surveillance_NN systems_NNS and_CC disease_NN registries_NNS ._. 
Data_NNS collected_VBN through_IN surveillance_NN systems_NNS provide_VBP for_IN the_DT ongoing_JJ evaluation_NN of_IN disease_NN risk_NN factors_NNS ,_, incidence_NN ,_, and_CC mortality_NN ,_, and_CC allow_VB for_IN the_DT evaluation_NN of_IN health_NN care_NN utilization_NN ,_, treatment_NN ,_, and_CC disease_NN prevention_NN and_CC control_NN activities_NNS ._. 
These_DT and_CC other_JJ benefits_NNS of_IN public_JJ health_NN surveillance_NN must_MD be_VB balanced_VBN against_IN possible_JJ risks_NNS and_CC harms_NNS ,_, such_JJ as_IN infringements_NNS on_IN personal_JJ privacy_NN ._. 
Investigators_NNS should_MD carefully_RB consider_VB ethical_JJ issues_NNS in_IN each_DT project_NN ,_, regardless_RB of_IN whether_IN it_PRP is_VBZ research_NN or_CC public_JJ health_NN practice_NN ._. 
Ethical_JJ issues_NNS in_IN public_JJ health_NN surveillanceEthics_NNS guidelines_NNS for_IN public_JJ health_NN surveillance_NN have_VBP been_VBN developed_VBN for_IN disease_NN registry_NN personnel_NNS ,_, and_CC a_DT growing_VBG body_NN of_IN literature_NN has_VBZ evolved_VBN in_IN this_DT area_NN ,_, indicating_VBG increasing_VBG interest_NN ._. 
These_DT developments_NNS are_VBP partly_RB a_DT response_NN to_TO public_JJ concern_NN over_IN the_DT privacy_NN and_CC confidentiality_NN of_IN health_NN information_NN and_CC technological_JJ advances_NNS such_JJ as_IN the_DT use_NN of_IN the_DT Internet_NNP to_TO disseminate_VB data_NNS from_IN surveillance_NN systems_NNS and_CC disease_NN registries_NNS ._. 
These_DT and_CC other_JJ benefits_NNS of_IN public_JJ health_NN surveillance_NN must_MD be_VB balanced_VBN against_IN possible_JJ risks_NNS and_CC harms_NNS ,_, such_JJ as_IN infringements_NNS on_IN personal_JJ privacy_NN ._. 
The_DT need_NN to_TO balance_VB potential_JJ benefits_NNS against_IN risks_NNS underlines_VBZ the_DT rule_NN that_IN surveillance_NN data_NNS should_MD not_RB be_VB collected_VBN if_IN they_PRP will_MD not_RB be_VB used_VBN ._. 
Thus_RB ,_, public_JJ health_NN professionals_NNS have_VBP ethical_JJ obligations_NNS to_TO both_DT maximize_VB the_DT potential_JJ benefits_NNS of_IN routinely_RB collected_VBN surveillance_NN and_CC disease_NN registry_NN data_NNS and_CC minimize_VB risks_NNS and_CC potential_JJ harms_NNS ._. 
The_DT guidelines_NNS and_CC approaches_NNS for_IN conducting_VBG epidemiologic_JJ field_NN investigations_NNS reflect_VBP the_DT urgency_NN of_IN discovering_VBG causative_JJ factors_NNS and_CC the_DT need_NN to_TO make_VB practical_JJ recommendations_NNS ,_, such_JJ as_IN during_IN the_DT SARS_NNP epidemic_NN 
Program_NN evaluation_NN ,_, on_IN the_DT other_JJ hand_NN ,_, refers_VBZ to_TO the_DT systematic_JJ application_NN of_IN scientific_JJ and_CC statistical_JJ procedures_NNS for_IN measuring_VBG program_NN conceptualization_NN ,_, design_NN ,_, implementation_NN ,_, and_CC utility_NN ;_: the_DT comparison_NN of_IN these_DT measurements_NNS ;_: and_CC the_DT use_NN of_IN the_DT resulting_VBG information_NN to_TO optimize_VB program_NN outcomes_NNS ._. 
Federal_JJ regulations_NNS -LRB-_-LRB- Title_NNP 45_CD CFR_NNP Part_NNP 46_CD -RRB-_-RRB- ,_, which_WDT deal_VBP with_IN issues_NNS such_JJ as_IN IRB_NNP review_NN and_CC informed_JJ consent_NN requirements_NNS ,_, mostly_RB address_VB biomedical_JJ research_NN 
This_DT includes_VBZ public_JJ health_NN practice_NN activities_NNS such_JJ as_IN surveillance_NN ._. 
The_DT privacy_NN rules_NNS included_VBN in_IN HIPAA_NNP permit_NN disclosures_NNS without_IN individual_JJ authorization_NN to_TO public_JJ health_NN authorities_NNS who_WP can_MD legally_RB collect_VB or_CC receive_VB the_DT information_NN for_IN the_DT purpose_NN of_IN preventing_VBG or_CC controlling_VBG disease_NN ,_, injury_NN ,_, or_CC disability_NN ._. 
Health_NNP promotion_NN and_CC disease_NN preventionThe_JJ potential_JJ benefits_NNS of_IN disease_NN prevention_NN and_CC health_NN promotion_NN efforts_NNS include_VBP a_DT healthier_RBR society_NN and_CC reduced_JJ fiscal_JJ expenditure_NN and_CC increased_VBN productivity_NN and_CC efficiency_NN ._. 
Individual_JJ members_NNS of_IN society_NN can_MD also_RB benefit_VB ._. 
There_EX is_VBZ a_DT need_NN to_TO balance_VB health_NN as_IN a_DT value_NN with_IN values_NNS of_IN privacy_NN and_CC autonomy_NN -LRB-_-LRB- for_IN example_NN ,_, in_IN relation_NN to_TO immunization_NN policies_NNS -RRB-_-RRB- ._. 
Field_NN epidemiology_NN and_CC investigations_NNS of_IN disease_NN outbreaks_NNS require_VBP us_PRP to_TO consider_VB when_WRB the_DT data_NNS are_VBP sufficient_JJ to_TO take_VB action_NN rather_RB than_IN to_TO ask_VB what_WP additional_JJ questions_NNS might_MD be_VB answered_VBN by_IN the_DT data_NNS 
The_DT primary_JJ purpose_NN of_IN the_DT activity_NN is_VBZ to_TO determine_VB the_DT nature_NN and_CC magnitude_NN of_IN a_DT public_JJ health_NN problem_NN in_IN the_DT community_NN and_CC to_TO implement_VB appropriate_JJ measures_NNS to_TO address_VB the_DT problem_NN 
Afurther_JJ issue_NN is_VBZ that_IN there_EX is_VBZ often_RB a_DT need_NN to_TO translate_VB informed_JJ consent_NN statements_NNS into_IN a_DT language_NN other_JJ than_IN English_NNP ._. 
The_DT important_JJ issues_NNS that_WDT arise_VBP in_IN international_JJ research_NN conducted_VBN by_IN researchers_NNS from_IN countries_NNS such_JJ as_IN the_DT United_NNP States_NNPS and_CC Great_NNP Britain_NNP in_IN developing_VBG countries_NNS have_VBP also_RB received_VBN considerable_JJ attention_NN ._. 
Privacy_NN and_CC confidentiality_NN One_CD important_JJ way_NN in_IN which_WDT public_JJ health_NN researchers_NNS reduce_VBP potential_JJ harms_NNS and_CC risks_NNS to_TO participants_NNS in_IN epidemiologic_JJ studies_NNS is_VBZ by_IN rigorously_RB protecting_VBG the_DT confidentiality_NN of_IN their_PRP$ health_NN information_NN ._. 
Other_JJ obligations_NNS to_TO community_NN members_NNS and_CC to_TO research_NN participants_NNS have_VBP been_VBN highlighted_VBN in_IN ethics_NNS guidelines_NNS for_IN epidemiologists_NNS and_CC public_JJ health_NN institutions_NNS 
To_TO address_VB such_JJ concerns_NNS ,_, funding_NN agencies_NNS and_CC research_NN institutions_NNS have_VBP taken_VBN steps_NNS such_JJ as_IN adopting_VBG new_JJ training_NN programs_NNS that_WDT encourage_VBP researchers_NNS to_TO avoid_VB or_CC disclose_VB conflicts_NNS of_IN interest_NN ,_, and_CC revising_VBG or_CC strengthening_VBG institutional_JJ rules_NNS and_CC guidelines_NNS ._. 
Professional_JJ societies_NNS and_CC medical_JJ associations_NNS have_VBP also_RB issued_VBN policy_NN statements_NNS and_CC recommendations_NNS about_IN how_WRB best_JJS to_TO address_VB conflicts_NNS of_IN interest_NN in_IN clinical_JJ research_NN ._. 
Researchers_NNS should_MD disclose_VB financial_JJ interests_NNS and_CC sources_NNS of_IN funding_NN when_WRB publishing_VBG research_NN results_NNS ._. 
Conflicts_NNS of_IN interest_NN can_MD affect_VB scientific_JJ judgment_NN and_CC harm_VB scientific_JJ objectivity_NN ._. 
Recent_JJ media_NNS reports_NNS about_IN previously_RB undisclosed_JJ conflicts_NNS of_IN interest_NN in_IN the_DT United_NNP States_NNPS and_CC other_JJ countries_NNS have_VBP raised_VBN public_JJ awareness_NN of_IN the_DT potential_NN for_IN conflicts_NNS of_IN interest_NN in_IN clinical_JJ research_NN and_CC epidemiology_NN ,_, and_CC about_IN the_DT need_NN for_IN institutions_NNS and_CC individual_JJ researchers_NNS to_TO address_VB such_JJ conflicts_NNS ._. 
Studies_NNS have_VBP suggested_VBN that_IN financial_JJ interests_NNS and_CC researchers_NNS '_POS commitment_NN to_TO a_DT hypothesis_NN can_NN influence_NN reported_VBD research_NN results_NNS 
The_DT risks_NNS of_IN epidemiologic_JJ studies_NNS and_CC practice_NN activities_NNS can_MD be_VB minimized_VBN by_IN rigorously_RB protecting_VBG the_DT confidentiality_NN of_IN health_NN information_NN ,_, as_IN discussed_VBN below_IN ._. 
Although_IN the_DT risks_NNS posed_VBN by_IN epidemiologic_JJ studies_NNS are_VBP often_RB minor_JJ compared_VBN with_IN those_DT that_WDT may_MD be_VB associated_VBN with_IN clinical_JJ trials_NNS and_CC other_JJ experimental_JJ studies_NNS ,_, participants_NNS in_IN epidemiologic_JJ studies_NNS may_MD be_VB burdened_VBN by_IN a_DT loss_NN of_IN privacy_NN ,_, by_IN time_NN spent_VBD completing_VBG interviews_NNS and_CC examinations_NNS ,_, and_CC by_IN possible_JJ adverse_JJ psychological_JJ effects_NNS such_JJ as_IN enhanced_JJ grief_NN or_CC anxiety_NN ._. 
Such_JJ risks_NNS and_CC potential_JJ harms_NNS can_MD be_VB minimized_VBN by_IN careful_JJ attention_NN to_TO study_VB procedures_NNS and_CC questionnaire_NN design_NN ,_, for_IN example_NN ,_, by_IN limiting_VBG the_DT length_NN of_IN interviews_NNS or_CC by_IN scheduling_VBG them_PRP on_IN a_DT date_NN that_WDT is_VBZ less_RBR likely_JJ to_TO result_VB in_IN adverse_JJ psychological_JJ effects_NNS ._. 
Afurther_JJ obligation_NN is_VBZ the_DT need_NN to_TO ensure_VB that_IN the_DT burdens_NNS and_CC potential_JJ benefits_NNS of_IN epidemiologic_JJ studies_NNS are_VBP distributed_VBN equitably_RB ._. 
The_DT potential_JJ benefits_NNS of_IN epidemiologic_JJ research_NN are_VBP often_RB societal_JJ in_IN nature_NN ,_, such_JJ as_IN obtaining_VBG new_JJ information_NN about_IN the_DT causes_NNS of_IN diseases_NNS ,_, or_CC identifying_VBG health_NN disparities_NNS across_IN groups_NNS defined_VBN by_IN race_NN ,_, ethnicity_NN ,_, socioeconomic_JJ status_NN ,_, or_CC other_JJ factors_NNS ._. 
Research_NN participants_NNS may_MD receive_VB direct_JJ benefits_NNS from_IN participation_NN in_IN some_DT studies_NNS ,_, such_JJ as_IN when_WRB a_DT previously_RB unrecognized_JJ disease_NN or_CC risk_NN factor_NN is_VBZ detected_VBN during_IN examinations_NNS ._. 
Privacy_NN and_CC confidentiality_NN One_CD important_JJ way_NN in_IN which_WDT public_JJ health_NN researchers_NNS reduce_VBP potential_JJ harms_NNS and_CC risks_NNS to_TO participants_NNS in_IN epidemiologic_JJ studies_NNS is_VBZ by_IN rigorously_RB protecting_VBG the_DT confidentiality_NN of_IN their_PRP$ health_NN information_NN ._. 
Specific_JJ measures_NNS taken_VBN by_IN researchers_NNS to_TO protect_VB the_DT confidentiality_NN of_IN health_NN information_NN include_VBP keeping_VBG records_NNS under_IN lock_NN and_CC key_NN ,_, limiting_VBG access_NN to_TO confidential_JJ records_NNS ,_, discarding_VBG personal_JJ identifiers_NNS from_IN data_NN collection_NN forms_NNS and_CC computer_NN files_NNS whenever_WRB feasible_JJ ,_, and_CC training_NN staff_NN in_IN the_DT importance_NN of_IN privacy_NN and_CC confidentiality_NN protection_NN 
Many_JJ of_IN these_DT issues_NNS have_VBP been_VBN addressed_VBN in_IN the_DT literature_NN on_IN ethics_NNS in_IN epidemiology_NN and_CC public_JJ health_NN practice_NN including_VBG ethics_NNS guidelines_NNS ._. 
Issues_NNS dealt_VBD with_IN in_IN ethics_NNS guidelines_NNS for_IN epidemiologists_NNS and_CC the_DT published_VBN literatureEthical_JJ and_CC professional_JJ norms_NNS in_IN epidemiology_NN have_VBP been_VBN clarified_VBN in_IN ethics_NNS guidelines_NNS for_IN epidemiologists_NNS and_CC other_JJ public_JJ health_NN professionals_NNS ._. 
Ethics_NNS guidelines_NNS such_JJ as_IN those_DT developed_VBN for_IN the_DT Industrial_NNP Epidemiology_NNP Forum_NNP ,_, the_DT International_NNP Society_NNP for_IN Environmental_NNP Epidemiology_NNP ,_, and_CC the_DT American_NNP College_NNP of_IN Epidemiology_NNP provide_VBP useful_JJ accounts_NNS of_IN epidemiologists_NNS '_POS obligations_NNS to_TO research_NN participants_NNS ,_, society_NN ,_, employers_NNS ,_, and_CC colleagues_NNS ._. 
The_DT ethics_NNS guidelines_NNS adopted_VBN by_IN the_DT American_NNP College_NNP of_IN Epidemiology_NNP discuss_VBP core_NN values_NNS ,_, duties_NNS ,_, and_CC virtues_NNS in_IN epidemiology_NN ;_: the_DT professional_JJ role_NN of_IN epidemiologists_NNS ;_: minimizing_VBG risks_NNS and_CC protecting_VBG the_DT welfare_NN of_IN research_NN participants_NNS ;_: providing_VBG benefits_NNS ;_: ensuring_VBG an_DT equitable_JJ distribution_NN of_IN risks_NNS and_CC benefits_NNS ;_: protecting_VBG confidentiality_NN and_CC privacy_NN ;_: obtaining_VBG informed_JJ consent_NN ;_: submitting_VBG proposed_VBN studies_NNS for_IN ethical_JJ review_NN ;_: maintaining_VBG public_JJ trust_NN ;_: avoiding_VBG conflicts_NNS of_IN interest_NN and_CC partiality_NN ;_: communicating_VBG ethical_JJ requirements_NNS ;_: confronting_VBG unacceptable_JJ conduct_NN ;_: and_CC obligations_NNS to_TO communities_NNS 
Afurther_JJ issue_NN is_VBZ that_IN there_EX is_VBZ often_RB a_DT need_NN to_TO translate_VB informed_JJ consent_NN statements_NNS into_IN a_DT language_NN other_JJ than_IN English_NNP ._. 
The_DT important_JJ issues_NNS that_WDT arise_VBP in_IN international_JJ research_NN conducted_VBN by_IN researchers_NNS from_IN countries_NNS such_JJ as_IN the_DT United_NNP States_NNPS and_CC Great_NNP Britain_NNP in_IN developing_VBG countries_NNS have_VBP also_RB received_VBN considerable_JJ attention_NN ._. 
Privacy_NN and_CC confidentiality_NN One_CD important_JJ way_NN in_IN which_WDT public_JJ health_NN researchers_NNS reduce_VBP potential_JJ harms_NNS and_CC risks_NNS to_TO participants_NNS in_IN epidemiologic_JJ studies_NNS is_VBZ by_IN rigorously_RB protecting_VBG the_DT confidentiality_NN of_IN their_PRP$ health_NN information_NN ._. 
''_'' In_IN general_JJ ,_, there_EX is_VBZ a_DT need_NN for_IN voluntariness_NN in_IN health_NN education_NN ,_, health_NN promotion_NN ,_, and_CC public_JJ health_NN communication_NN programs_NNS ._. 
The_DT risks_NNS and_CC potential_JJ harms_NNS of_IN public_JJ health_NN interventions_NNS include_VBP ineffective_JJ ,_, counterproductive_JJ ,_, or_CC harmful_JJ interventions_NNS ;_: unanticipated_JJ consequences_NNS ;_: and_CC labeling_VBG or_CC stigmatizing_VBG of_IN individuals_NNS 
Undue_JJ stress_NN upon_IN the_DT individual_NN 's_POS role_NN in_IN the_DT cause_NN of_IN illness_NN could_MD lead_VB to_TO a_DT ``_`` blame_NN the_DT victim_NN ''_'' mentality_NN 
Such_JJ concerns_NNS have_VBP been_VBN successfully_RB addressed_VBN through_IN community-based_JJ participatory_JJ research_NN ,_, which_WDT is_VBZ a_DT collaborative_JJ ,_, empowering_VBG process_NN that_WDT helps_VBZ develop_VB competencies_NNS in_IN communities_NNS ._. 
Ethical_JJ issues_NNS in_IN health_NN communication_NN include_VBP the_DT need_NN to_TO avoid_VB conflicts_NNS of_IN interest_NN ,_, to_TO present_JJ facts_NNS about_IN health_NN hazards_NNS or_CC health_NN opportunities_NNS in_IN a_DT truthful_JJ ,_, balanced_JJ ,_, 
Many_JJ of_IN these_DT issues_NNS have_VBP been_VBN addressed_VBN in_IN the_DT literature_NN on_IN ethics_NNS in_IN epidemiology_NN and_CC public_JJ health_NN practice_NN including_VBG ethics_NNS guidelines_NNS ._. 
Issues_NNS dealt_VBD with_IN in_IN ethics_NNS guidelines_NNS for_IN epidemiologists_NNS and_CC the_DT published_VBN literatureEthical_JJ and_CC professional_JJ norms_NNS in_IN epidemiology_NN have_VBP been_VBN clarified_VBN in_IN ethics_NNS guidelines_NNS for_IN epidemiologists_NNS and_CC other_JJ public_JJ health_NN professionals_NNS ._. 
Ethics_NNS guidelines_NNS such_JJ as_IN those_DT developed_VBN for_IN the_DT Industrial_NNP Epidemiology_NNP Forum_NNP ,_, the_DT International_NNP Society_NNP for_IN Environmental_NNP Epidemiology_NNP ,_, and_CC the_DT American_NNP College_NNP of_IN Epidemiology_NNP provide_VBP useful_JJ accounts_NNS of_IN epidemiologists_NNS '_POS obligations_NNS to_TO research_NN participants_NNS ,_, society_NN ,_, employers_NNS ,_, and_CC colleagues_NNS ._. 
Ethics_NNS guidelines_NNS such_JJ as_IN those_DT developed_VBN for_IN the_DT Industrial_NNP Epidemiology_NNP Forum_NNP ,_, the_DT International_NNP Society_NNP for_IN Environmental_NNP Epidemiology_NNP ,_, and_CC the_DT American_NNP College_NNP of_IN Epidemiology_NNP provide_VBP useful_JJ accounts_NNS of_IN epidemiologists_NNS '_POS obligations_NNS to_TO research_NN participants_NNS ,_, society_NN ,_, employers_NNS ,_, and_CC colleagues_NNS ._. 
Ethics_NNS guidelines_NNS for_IN environmental_JJ epidemiologists_NNS drafted_VBN by_IN Colin_NNP Soskolne_NNP and_CC Andrew_NNP Light_NNP ,_, which_WDT were_VBD adopted_VBN by_IN the_DT International_NNP Society_NNP for_IN Environmental_NNP Epidemiology_NNP in_IN 1999_CD ,_, highlight_VBP the_DT important_JJ obligations_NNS that_IN epidemiologists_NNS have_VBP to_TO communities_NNS that_WDT are_VBP affected_VBN by_IN environmental_JJ hazards_NNS 
Communicating_VBG research_NN results_NNS in_IN a_DT timely_JJ manner_NN ,_, without_IN censorship_NN or_CC interference_NN from_IN the_DT funder_NN ,_, is_VBZ essential_JJ for_IN maintaining_VBG public_JJ trust_NN 
In_IN addition_NN ,_, moral_JJ problems_NNS can_MD sometimes_RB be_VB resolved_VBN by_IN getting_VBG the_DT disputing_VBG parties_NNS to_TO adopt_VB a_DT new_JJ policy_NN or_CC code_NN ,_, such_JJ as_IN ethics_NNS guidelines_NNS for_IN epidemiologists_NNS 
Other_JJ approaches_NNS to_TO moral_JJ reasoning_NN Other_JJ approaches_NNS to_TO moral_JJ reasoning_NN ,_, such_JJ as_IN rights-based_JJ theories_NNS ,_, duty-based_JJ theories_NNS ,_, contractarianism_NN ,_, the_DT ethics_NNS of_IN care_NN ,_, narrative_NN ethics_NNS ,_, and_CC communitarianism_NN have_VBP not_RB been_VBN widely_RB applied_VBN in_IN public_JJ health_NN ._. 
Virtue_NNP ethics_NNS and_CC the_DT moral_JJ rule-based_JJ system_NN of_IN Gert_NNP and_CC Clouser_NNP ,_, however_RB ,_, have_VBP been_VBN discussed_VBN as_IN potential_JJ alternatives_NNS to_TO other_JJ leading_VBG approaches_NNS to_TO moral_JJ reasoning_NN in_IN public_JJ health_NN ethics_NNS 
Other_JJ issues_NNS addressed_VBN in_IN the_DT guidelines_NNS include_VBP those_DT pertaining_VBG to_TO scientific_JJ misconduct_NN ,_, intellectual_JJ property_NN and_CC data_NN sharing_NN ,_, publication_NN of_IN research_NN findings_NNS ,_, and_CC cross-cultural_JJ or_CC international_JJ health_NN research_NN ._. 
Ethical_JJ issues_NNS in_IN public_JJ health_NN practiceAn_NN expanding_VBG body_NN of_IN literature_NN has_VBZ considered_VBN the_DT important_JJ ethical_JJ issues_NNS that_WDT arise_VBP in_IN such_JJ areas_NNS of_IN public_JJ health_NN practice_NN as_IN surveillance_NN ,_, emergency_NN responses_NNS ,_, and_CC program_NN evaluation_NN ._. 
In_IN further_RB specifying_VBG ethical_JJ norms_NNS in_IN particular_JJ contexts_NNS ,_, it_PRP is_VBZ important_JJ to_TO draw_VB distinctions_NNS between_IN epidemiologic_JJ research_NN and_CC public_JJ health_NN practice_NN activities_NNS ._. 
Investigators_NNS should_MD carefully_RB consider_VB ethical_JJ issues_NNS in_IN each_DT project_NN ,_, regardless_RB of_IN whether_IN it_PRP is_VBZ research_NN or_CC public_JJ health_NN practice_NN ._. 
Ethical_JJ issues_NNS in_IN public_JJ health_NN surveillanceEthics_NNS guidelines_NNS for_IN public_JJ health_NN surveillance_NN have_VBP been_VBN developed_VBN for_IN disease_NN registry_NN personnel_NNS ,_, and_CC a_DT growing_VBG body_NN of_IN literature_NN has_VBZ evolved_VBN in_IN this_DT area_NN ,_, indicating_VBG increasing_VBG interest_NN ._. 
These_DT developments_NNS are_VBP partly_RB a_DT response_NN to_TO public_JJ concern_NN over_IN the_DT privacy_NN and_CC confidentiality_NN of_IN health_NN information_NN and_CC technological_JJ advances_NNS such_JJ as_IN the_DT use_NN of_IN the_DT Internet_NNP to_TO disseminate_VB data_NNS from_IN surveillance_NN systems_NNS and_CC disease_NN registries_NNS ._. 
''_'' Public_JJ health_NN activities_NNS also_RB include_VBP community_NN collaborations_NNS and_CC partnerships_NNS for_IN health_NN and_CC the_DT identification_NN of_IN priorities_NNS for_IN public_JJ health_NN action_NN ._. 
Previous_JJ authors_NNS have_VBP identified_VBN ethical_JJ issues_NNS and_CC core_NN values_NNS in_IN public_JJ health_NN ,_, and_CC highlighted_VBN differences_NNS and_CC similarities_NNS between_IN public_JJ health_NN ethics_NNS and_CC other_JJ areas_NNS of_IN bioethics_NNS ._. 
Public_JJ health_NN ethics_NNS ,_, which_WDT can_MD be_VB defined_VBN as_IN the_DT identification_NN ,_, analysis_NN ,_, and_CC resolution_NN of_IN ethical_JJ problems_NNS arising_VBG in_IN public_JJ health_NN practice_NN and_CC research_NN ,_, has_VBZ different_JJ domains_NNS from_IN those_DT of_IN medical_JJ ethics_NNS ._. 
Other_JJ ethical_JJ concerns_NNS in_IN public_JJ health_NN relate_VBP to_TO the_DT need_NN to_TO ensure_VB a_DT just_JJ distribution_NN of_IN public_JJ health_NN resources_NNS 
Utilitarian_JJ theories_NNS provide_VBP strong_JJ justification_NN for_IN public_JJ health_NN programs_NNS such_JJ as_IN mandatory_JJ vaccination_NN programs_NNS for_IN children_NNS and_CC the_DT fluoridation_NN of_IN public_JJ water_NN supplies_NNS ._. 
Different_JJ methods_NNS of_IN moral_JJ reasoning_NN have_VBP been_VBN applied_VBN to_TO ethical_JJ decision_NN making_VBG in_IN public_JJ health_NN research_NN and_CC practice_NN 
Such_JJ decisions_NNS are_VBP often_RB made_VBN by_IN focusing_VBG on_IN the_DT circumstances_NNS of_IN the_DT case_NN at_IN hand_NN and_CC the_DT moral_JJ context_NN in_IN which_WDT the_DT case_NN rests_VBZ ._. 
Case-based_JJ methods_NNS such_JJ as_IN casuistry_NN are_VBP grounded_VBN in_IN analogical_JJ reasoning_NN ,_, appeal_NN to_TO paradigmatic_JJ cases_NNS ,_, and_CC practical_JJ judgment_NN 
Other_JJ approaches_NNS to_TO moral_JJ reasoning_NN Other_JJ approaches_NNS to_TO moral_JJ reasoning_NN ,_, such_JJ as_IN rights-based_JJ theories_NNS ,_, duty-based_JJ theories_NNS ,_, contractarianism_NN ,_, the_DT ethics_NNS of_IN care_NN ,_, narrative_NN ethics_NNS ,_, and_CC communitarianism_NN have_VBP not_RB been_VBN widely_RB applied_VBN in_IN public_JJ health_NN ._. 
Virtue_NNP ethics_NNS and_CC the_DT moral_JJ rule-based_JJ system_NN of_IN Gert_NNP and_CC Clouser_NNP ,_, however_RB ,_, have_VBP been_VBN discussed_VBN as_IN potential_JJ alternatives_NNS to_TO other_JJ leading_VBG approaches_NNS to_TO moral_JJ reasoning_NN in_IN public_JJ health_NN ethics_NNS 
Introduction_NN A_DT rich_JJ and_CC growing_VBG body_NN of_IN literature_NN has_VBZ emerged_VBN on_IN ethics_NNS in_IN epidemiologic_JJ research_NN and_CC public_JJ health_NN practice_NN 
Recent_JJ articles_NNS have_VBP included_VBN conceptual_JJ frameworks_NNS of_IN public_JJ health_NN ethics_NNS and_CC overviews_NNS of_IN historical_JJ developments_NNS in_IN the_DT field_NN 
''_'' Public_JJ health_NN activities_NNS also_RB include_VBP community_NN collaborations_NNS and_CC partnerships_NNS for_IN health_NN and_CC the_DT identification_NN of_IN priorities_NNS for_IN public_JJ health_NN action_NN ._. 
Previous_JJ authors_NNS have_VBP identified_VBN ethical_JJ issues_NNS and_CC core_NN values_NNS in_IN public_JJ health_NN ,_, and_CC highlighted_VBN differences_NNS and_CC similarities_NNS between_IN public_JJ health_NN ethics_NNS and_CC other_JJ areas_NNS of_IN bioethics_NNS ._. 
Public_JJ health_NN ethics_NNS ,_, which_WDT can_MD be_VB defined_VBN as_IN the_DT identification_NN ,_, analysis_NN ,_, and_CC resolution_NN of_IN ethical_JJ problems_NNS arising_VBG in_IN public_JJ health_NN practice_NN and_CC research_NN ,_, has_VBZ different_JJ domains_NNS from_IN those_DT of_IN medical_JJ ethics_NNS ._. 
Other_JJ ethical_JJ concerns_NNS in_IN public_JJ health_NN relate_VBP to_TO the_DT need_NN to_TO ensure_VB a_DT just_JJ distribution_NN of_IN public_JJ health_NN resources_NNS 
In_IN many_JJ public_JJ health_NN activities_NNS there_EX is_VBZ a_DT tension_NN between_IN concerns_NNS over_IN personal_JJ liberties_NNS and_CC individual_JJ autonomy_NN and_CC public_JJ health_NN perspectives_NNS ,_, which_WDT may_MD be_VB utilitarian_JJ ,_, paternalistic_JJ ,_, or_CC communitarian_NN ._. 
Communitarian_JJ perspectives_NNS may_MD favor_VB limiting_VBG individual_JJ autonomy_NN for_IN the_DT sake_NN of_IN the_DT common_JJ good_JJ or_CC public_JJ interest_NN ._. 
Despite_IN the_DT importance_NN of_IN mandatory_JJ public_JJ health_NN activities_NNS required_VBN by_IN law_NN ,_, many_JJ examples_NNS of_IN voluntary_JJ public_JJ health_NN activities_NNS can_MD be_VB cited_VBN ._. 
Ethical_JJ concerns_NNS can_MD be_VB anticipated_VBN or_CC identified_VBN early_RB and_CC effectively_RB addressed_VBN through_IN careful_JJ analysis_NN and_CC consultation_NN ._. 
IntroductionA_NNP rich_JJ and_CC growing_VBG body_NN of_IN literature_NN has_VBZ emerged_VBN on_IN ethics_NNS in_IN epidemiologic_JJ research_NN and_CC public_JJ health_NN practice_NN 
Public_JJ health_NN ethics_NNS ,_, which_WDT can_MD be_VB defined_VBN as_IN the_DT identification_NN ,_, analysis_NN ,_, and_CC resolution_NN of_IN ethical_JJ problems_NNS arising_VBG in_IN public_JJ health_NN practice_NN and_CC research_NN ,_, has_VBZ different_JJ domains_NNS from_IN those_DT of_IN medical_JJ ethics_NNS ._. 
Ethical_JJ concerns_NNS in_IN public_JJ health_NN often_RB relate_VBP to_TO the_DT dual_JJ obligations_NNS of_IN public_JJ health_NN professionals_NNS to_TO acquire_VB and_CC apply_VB scientific_JJ knowledge_NN aimed_VBN at_IN restoring_VBG and_CC protecting_VBG the_DT public_NN 's_POS health_NN while_IN respecting_VBG individual_JJ autonomy_NN 
Ethical_JJ concerns_NNS in_IN public_JJ health_NN often_RB relate_VBP to_TO the_DT dual_JJ obligations_NNS of_IN public_JJ health_NN professionals_NNS to_TO acquire_VB and_CC apply_VB scientific_JJ knowledge_NN aimed_VBN at_IN restoring_VBG and_CC protecting_VBG the_DT public_NN 's_POS health_NN while_IN respecting_VBG individual_JJ autonomy_NN 
Other_JJ issues_NNS addressed_VBN in_IN the_DT guidelines_NNS include_VBP those_DT pertaining_VBG to_TO scientific_JJ misconduct_NN ,_, intellectual_JJ property_NN and_CC data_NN sharing_NN ,_, publication_NN of_IN research_NN findings_NNS ,_, and_CC cross-cultural_JJ or_CC international_JJ health_NN research_NN ._. 
Ethical_JJ issues_NNS in_IN public_JJ health_NN practiceAn_NN expanding_VBG body_NN of_IN literature_NN has_VBZ considered_VBN the_DT important_JJ ethical_JJ issues_NNS that_WDT arise_VBP in_IN such_JJ areas_NNS of_IN public_JJ health_NN practice_NN as_IN surveillance_NN ,_, emergency_NN responses_NNS ,_, and_CC program_NN evaluation_NN ._. 
In_IN further_RB specifying_VBG ethical_JJ norms_NNS in_IN particular_JJ contexts_NNS ,_, it_PRP is_VBZ important_JJ to_TO draw_VB distinctions_NNS between_IN epidemiologic_JJ research_NN and_CC public_JJ health_NN practice_NN activities_NNS ._. 
Several_JJ authors_NNS have_VBP considered_VBN the_DT circumstances_NNS under_IN which_WDT personal_JJ autonomy_NN can_MD be_VB abridged_JJ to_TO promote_VB the_DT health_NN of_IN the_DT whole_JJ community_NN and_CC the_DT moral_JJ justification_NN for_IN coercive_JJ public_JJ health_NN interventions_NNS and_CC lifestyle_NN strategies_NNS 
Public_JJ health_NN ethics_NNS ,_, which_WDT can_MD be_VB defined_VBN as_IN the_DT identification_NN ,_, analysis_NN ,_, and_CC resolution_NN of_IN ethical_JJ problems_NNS arising_VBG in_IN public_JJ health_NN practice_NN and_CC research_NN ,_, has_VBZ different_JJ domains_NNS from_IN those_DT of_IN medical_JJ ethics_NNS ._. 
Ethical_JJ concerns_NNS in_IN public_JJ health_NN often_RB relate_VBP to_TO the_DT dual_JJ obligations_NNS of_IN public_JJ health_NN professionals_NNS to_TO acquire_VB and_CC apply_VB scientific_JJ knowledge_NN aimed_VBN at_IN restoring_VBG and_CC protecting_VBG the_DT public_NN 's_POS health_NN while_IN respecting_VBG individual_JJ autonomy_NN 
Introduction_NN A_DT rich_JJ and_CC growing_VBG body_NN of_IN literature_NN has_VBZ emerged_VBN on_IN ethics_NNS in_IN epidemiologic_JJ research_NN and_CC public_JJ health_NN practice_NN 
''_'' As_IN noted_VBN by_IN Childress_NNP et_FW al._FW ._. 
Definitions_NNS and_CC conceptualizations_NNS of_IN public_JJ health_NN ethics_NNS The_DT starting_VBG point_NN for_IN conceptualizations_NNS of_IN public_JJ health_NN ethics_NNS has_VBZ often_RB been_VBN general_JJ definitions_NNS of_IN public_JJ health_NN ,_, such_JJ as_IN the_DT definition_NN provided_VBN by_IN the_DT Institute_NNP of_IN Medicine_NNP in_IN 1988_CD :_: ``_`` Public_JJ health_NN is_VBZ what_WP we_PRP ,_, as_IN a_DT society_NN ,_, do_VBP collectively_RB to_TO assure_VB the_DT conditions_NNS in_IN which_WDT people_NNS can_MD be_VB healthy_JJ ._. 
,``_NNP Public_NNP health_NN is_VBZ primarily_RB concerned_VBN with_IN the_DT health_NN of_IN the_DT entire_JJ population_NN ,_, rather_RB than_IN the_DT health_NN of_IN individuals_NNS ._. 
Its_PRP$ features_NNS include_VBP an_DT emphasis_NN on_IN the_DT promotion_NN of_IN health_NN and_CC the_DT prevention_NN of_IN disease_NN and_CC disability_NN ;_: the_DT collection_NN and_CC use_NN of_IN epidemiological_JJ data_NNS ,_, population_NN surveillance_NN ,_, and_CC other_JJ forms_NNS of_IN empirical_JJ quantitative_JJ assessment_NN ;_: a_DT recognition_NN of_IN the_DT multidimensional_JJ nature_NN of_IN the_DT determinants_NNS of_IN health_NN ;_: and_CC a_DT focus_NN on_IN the_DT complex_JJ interactions_NNS of_IN many_JJ factors_NNS 
The_DT four_CD principles_NNS of_IN beneficence_NN ,_, nonmaleficence_NN ,_, justice_NN ,_, and_CC respect_NN for_IN autonomy_NN are_VBP mentioned_VBN in_IN ethics_NNS guidelines_NNS drafted_VBN for_IN public_JJ health_NN professionals_NNS ,_, although_IN the_DT guidelines_NNS do_VBP not_RB provide_VB an_DT exhaustive_JJ account_NN of_IN how_WRB the_DT principles_NNS can_MD be_VB used_VBN as_IN a_DT framework_NN for_IN ethical_JJ decision_NN making_NN 
As_IN noted_VBN by_IN Childress_NNP et_FW al._FW ._. 
From_IN this_DT perspective_NN ,_, a_DT just_JJ distribution_NN of_IN benefits_NNS from_IN public_JJ health_NN programs_NNS or_CC research_NN is_VBZ determined_VBN by_IN the_DT utility_NN to_TO all_DT affected_VBN ._. 
,public_JJ health_NN activities_NNS are_VBP generally_RB understood_VBN to_TO be_VB consequentialist_JJ in_IN that_IN the_DT primary_JJ end_NN that_WDT is_VBZ sought_VBN is_VBZ the_DT health_NN of_IN the_DT public_NN ._. 
An_DT egalitarian_JJ theory_NN of_IN justice_NN holds_VBZ that_IN each_DT person_NN should_MD share_VB equally_RB in_IN the_DT distribution_NN of_IN the_DT potential_JJ benefits_NNS of_IN health_NN care_NN resources_NNS such_JJ as_IN screening_NN services_NNS ._. 
Principle-based_JJ approaches_NNS Principle-based_JJ approaches_NNS to_TO moral_JJ reasoning_NN were_VBD developed_VBN to_TO address_VB ethical_JJ issues_NNS in_IN clinical_JJ medicine_NN and_CC are_VBP not_RB necessarily_RB the_DT optimal_JJ approach_NN for_IN analyzing_VBG ethical_JJ issues_NNS in_IN public_JJ health_NN ._. 
The_DT four_CD principles_NNS of_IN beneficence_NN ,_, nonmaleficence_NN ,_, justice_NN ,_, and_CC respect_NN for_IN autonomy_NN are_VBP mentioned_VBN in_IN ethics_NNS guidelines_NNS drafted_VBN for_IN public_JJ health_NN professionals_NNS ,_, although_IN the_DT guidelines_NNS do_VBP not_RB provide_VB an_DT exhaustive_JJ account_NN of_IN how_WRB the_DT principles_NNS can_MD be_VB used_VBN as_IN a_DT framework_NN for_IN ethical_JJ decision_NN making_NN 
Beneficence_NNP involves_VBZ both_DT the_DT protection_NN of_IN individual_JJ welfare_NN and_CC the_DT promotion_NN of_IN the_DT common_JJ welfare_NN ._. 
This_DT principle_NN underlies_VBZ ethical_JJ rules_NNS and_CC norms_NNS that_WDT require_VBP that_IN public_JJ health_NN institutions_NNS act_VBP in_IN a_DT timely_JJ manner_NN on_IN the_DT information_NN they_PRP have_VBP and_CC that_IN they_PRP expeditiously_RB make_VBP the_DT information_NN available_JJ to_TO the_DT public_NN 
Arelated_JJ issue_NN is_VBZ that_IN health_NN researchers_NNS should_MD avoid_VB entering_VBG into_IN contractual_JJ agreements_NNS that_WDT prevent_VBP them_PRP from_IN publishing_VBG results_NNS in_IN a_DT timely_JJ manner_NN 
In_IN addition_NN ,_, epidemiologists_NNS should_MD respect_VB cultural_JJ diversity_NN in_IN carrying_VBG out_RP studies_NNS and_CC in_IN communicating_VBG with_IN members_NNS of_IN affected_JJ communities_NNS ._. 
Other_JJ obligations_NNS to_TO community_NN members_NNS and_CC to_TO research_NN participants_NNS have_VBP been_VBN highlighted_VBN in_IN ethics_NNS guidelines_NNS for_IN epidemiologists_NNS and_CC public_JJ health_NN institutions_NNS 
Glucose_NN intolerance_NN ,_, obesity_NN ,_, dyslipidemia_NN and_CC hypertension_NN are_VBP part_NN of_IN a_DT common_JJ pathological_JJ syndrome_NN of_IN insulin_NN resistance_NN 
Glucose_NN intolerance_NN ,_, obesity_NN ,_, dyslipidemia_NN and_CC hypertension_NN are_VBP part_NN of_IN a_DT common_JJ pathological_JJ syndrome_NN of_IN insulin_NN resistance_NN 
This_DT suggests_VBZ that_IN some_DT of_IN the_DT effect_NN of_IN urbanisation_NN may_MD be_VB mediated_VBN through_IN biological_JJ factors_NNS that_WDT result_VBP in_IN increased_VBN secretion_NN of_IN insulin_NN due_JJ to_TO tissue_NN resistance_NN to_TO its_PRP$ actions_NNS ._. 
Although_IN none_NN of_IN the_DT Indian_JJ studies_NNS specifically_RB studied_VBD migrants_NNS ,_, similarly_RB high_JJ levels_NNS of_IN serum_NN insulin_NN have_VBP been_VBN reported_VBN in_IN Asian_NNP Indians_NNPS living_VBG abroad_RB 
0mmol\/l_CD -RRB-_-RRB- and_CC old_JJ -LRB-_-LRB- fasting_JJ plasma_NN glucose_NN greater_JJR than_IN 7_CD ._. 
Diagnosis_NN of_IN diabetes_NN was_VBD made_VBN using_VBG both_DT the_DT new_JJ -LRB-_-LRB- fasting_JJ plasma_NN glucose_NN greater_JJR than_IN 7_CD ._. 
8mmol\/l_CD -RRB-_-RRB- WHO_WP criteria_NNS ,_, in_IN which_WDT a_DT glucose_NN tolerance_NN test_NN is_VBZ not_RB required_VBN 
8mmol\/l_CD -RRB-_-RRB- WHO_WP criteria_NNS ,_, in_IN which_WDT a_DT glucose_NN tolerance_NN test_NN is_VBZ not_RB required_VBN ._. 
0mmol\/l_CD -RRB-_-RRB- and_CC old_JJ -LRB-_-LRB- fasting_JJ plasma_NN glucose_NN greater_JJR than_IN 7_CD ._. 
Assessment_NNP of_IN dietary_JJ intake_NN and_CC physical_JJ activityDiet_NNP was_VBD assessed_VBN by_IN interviewer-administered_JJ semi-quantitative_JJ food_NN frequency_NN questionnaire_NN using_VBG validated_VBN and_CC reproducible_JJ food_NN frequency_NN methodology_NN 
Main_NNP outcome_NN measures_VBZ The_DT main_JJ outcomes_NNS under_IN study_NN are_VBP obesity_NN and_CC diabetes_NN ._. 
Figure_NNP 1_CD Sampling_NNP strategy_NN for_IN each_DT factory_NN ._. 
Overweight_JJ and_CC obesity_NN were_VBD defined_VBN using_VBG Indian_JJ reference_NN ranges_NNS as_IN a_DT body_NN mass_NN index_NN -LRB-_-LRB- BMI_NNP -RRB-_-RRB- greater_JJR than_IN 23_CD kg\/m2_NN and_CC obesity_NN 25_CD kg\/m2_CD ._. 
Measures_NNS of_IN central_JJ adiposity_NN -LRB-_-LRB- 
Overweight_JJ and_CC obesity_NN were_VBD defined_VBN using_VBG Indian_JJ reference_NN ranges_NNS as_IN a_DT body_NN mass_NN index_NN -LRB-_-LRB- BMI_NNP -RRB-_-RRB- greater_JJR than_IN 23_CD kg\/m_NN 2_CD and_CC obesity_NN 25_CD kg\/m_NN 2_CD ._. 
Measures_NNS of_IN central_JJ adiposity_NN -LRB-_-LRB- waist-hip_JJ ratio_NN -RRB-_-RRB- were_VBD made_VBN and_CC is_VBZ planned_VBN in_IN the_DT main_JJ study_NN to_TO assess_VB body_NN fat_JJ composition_NN using_VBG skin-fold_JJ measures_NNS at_IN sub-scapular_JJ ,_, triceps_NNS ,_, and_CC medial_JJ calf_NN sites_NNS and_CC use_VB predictive_JJ equations_NNS derived_VBN from_IN Indian_JJ populations_NNS validated_VBD using_VBG hydrodensitometry_NN 
The_DT effects_NNS of_IN the_DT migration_NN process_NN itself_PRP have_VBP been_VBN explored_VBN in_IN only_RB a_DT very_RB limited_JJ way_NN so_RB far_RB 
Participants_NNS in_IN the_DT CVDRFS_NNP baseline_NN survey_NN ,_, together_RB with_IN their_PRP$ co-resident_JJ spouses_NNS ,_, were_VBD asked_VBN about_IN rural-to-urban_JJ migration_NN and_CC those_DT responding_VBG positively_RB ,_, together_RB with_IN a_DT 25_CD %_NN random_JJ sample_NN of_IN non-migrants_NNS ,_, were_VBD invited_VBN to_TO participate_VB in_IN the_DT study_NN ._. 
Indian_NNP Census_NNP 2001_CD definitions_NNS were_VBD used_VBN to_TO classify_VB areas_NNS as_IN urban_JJ or_CC rural_JJ based_VBN on_IN population_NN size_NN and_CC density_NN and_CC non-agricultural_JJ employment_NN ._. 
Migration_NN status_NN was_VBD attributed_VBN only_RB to_TO intra-generation_JJ migrants_NNS -LRB-_-LRB- i._FW e._FW `_`` first-generation_NN '_'' -RRB-_-RRB- and_CC of_IN at_IN least_JJS one_CD year_NN 's_POS duration_NN ._. 
Arise_VB in_IN obesity_NN does_VBZ not_RB appear_VB to_TO be_VB an_DT inevitable_JJ consequence_NN of_IN migration_NN ;_: studies_NNS have_VBP found_VBN declines_NNS in_IN obesity_NN with_IN increased_VBN acculturation_NN following_VBG migration_NN 
The_DT effects_NNS of_IN the_DT migration_NN process_NN itself_PRP have_VBP been_VBN explored_VBN in_IN only_RB a_DT very_RB limited_JJ way_NN so_RB far_RB 
The_DT importance_NN of_IN insulin_NN resistance_NN lies_VBZ in_IN accumulating_VBG evidence_NN that_IN it_PRP is_VBZ causally_RB associated_VBN with_IN type_NN 2_CD diabetes_NN and_CC CHD_NNP 
8mmol\/l_CD -RRB-_-RRB- WHO_WP criteria_NNS ,_, in_IN which_WDT a_DT glucose_NN tolerance_NN test_NN is_VBZ not_RB required_VBN ._. 
0mmol\/l_CD -RRB-_-RRB- and_CC old_JJ -LRB-_-LRB- fasting_JJ plasma_NN glucose_NN greater_JJR than_IN 7_CD ._. 
Assessment_NNP of_IN dietary_JJ intake_NN and_CC physical_JJ activityDiet_NNP was_VBD assessed_VBN by_IN interviewer-administered_JJ semi-quantitative_JJ food_NN frequency_NN questionnaire_NN using_VBG validated_VBN and_CC reproducible_JJ food_NN frequency_NN methodology_NN 
8mmol\/l_CD -RRB-_-RRB- WHO_WP criteria_NNS ,_, in_IN which_WDT a_DT glucose_NN tolerance_NN test_NN is_VBZ not_RB required_VBN ._. 
0mmol\/l_CD -RRB-_-RRB- and_CC old_JJ -LRB-_-LRB- fasting_JJ plasma_NN glucose_NN greater_JJR than_IN 7_CD ._. 
Assessment_NNP of_IN dietary_JJ intake_NN and_CC physical_JJ activityDiet_NNP was_VBD assessed_VBN by_IN interviewer-administered_JJ semi-quantitative_JJ food_NN frequency_NN questionnaire_NN using_VBG validated_VBN and_CC reproducible_JJ food_NN frequency_NN methodology_NN 
Implications_NNS Several_JJ lessons_NNS have_VBP been_VBN learned_VBN in_IN the_DT process_NN of_IN conducting_VBG this_DT extended_JJ pilot_NN study_NN ._. 
Although_IN nutritional_JJ surveillance_NN is_VBZ used_VBN throughout_IN India_NNP ,_, and_CC reports_NNS of_IN validated_VBN questionnaires_NNS were_VBD found_VBN ,_, the_DT existing_VBG food_NN frequency_NN questionnaires_NNS available_JJ were_VBD not_RB adequate_JJ for_IN making_VBG comparisons_NNS between_IN rural_JJ and_CC urban_JJ areas_NNS ,_, or_CC for_IN comparisons_NNS between_IN different_JJ regions_NNS of_IN India_NNP ._. 
This_DT is_VBZ because_IN of_IN marked_JJ regional_JJ differences_NNS in_IN staple_JJ foods_NNS consumed_VBN ,_, seasonal_JJ variability_NN in_IN food_NN availability_NN ,_, cooking_NN oils_NNS used_VBD and_CC recipes_NNS used_VBN ._. 
Implications_NNS Several_JJ lessons_NNS have_VBP been_VBN learned_VBN in_IN the_DT process_NN of_IN conducting_VBG this_DT extended_JJ pilot_NN study_NN ._. 
Although_IN nutritional_JJ surveillance_NN is_VBZ used_VBN throughout_IN India_NNP ,_, and_CC reports_NNS of_IN validated_VBN questionnaires_NNS were_VBD found_VBN ,_, the_DT existing_VBG food_NN frequency_NN questionnaires_NNS available_JJ were_VBD not_RB adequate_JJ for_IN making_VBG comparisons_NNS between_IN rural_JJ and_CC urban_JJ areas_NNS ,_, or_CC for_IN comparisons_NNS between_IN different_JJ regions_NNS of_IN India_NNP ._. 
This_DT is_VBZ because_IN of_IN marked_JJ regional_JJ differences_NNS in_IN staple_JJ foods_NNS consumed_VBN ,_, seasonal_JJ variability_NN in_IN food_NN availability_NN ,_, cooking_NN oils_NNS used_VBD and_CC recipes_NNS used_VBN ._. 
9%_CD -RRB-_-RRB- and_CC obesity_NN -LRB-_-LRB- 12_CD ._. 
Peri-urban_JJ areas_NNS are_VBP reported_VBN to_TO have_VB an_DT intermediate_JJ prevalence_NN of_IN diabetes_NN -LRB-_-LRB- 5_CD ._. 
5%_CD -RRB-_-RRB- ._. 
Although_IN these_DT studies_NNS used_VBD different_JJ criteria_NNS from_IN ours_PRP to_TO define_VB obesity_NN and_CC diabetes_NN ,_, this_DT is_VBZ unlikely_JJ to_TO explain_VB the_DT marked_JJ increase_NN in_IN both_DT conditions_NNS over_IN time_NN and_CC the_DT widening_NN gradient_NN between_IN urban_JJ ,_, peri-urban_JJ and_CC rural_JJ prevalence_NN ._. 
Although_IN these_DT studies_NNS used_VBD different_JJ criteria_NNS from_IN ours_PRP to_TO define_VB obesity_NN and_CC diabetes_NN ,_, this_DT is_VBZ unlikely_JJ to_TO explain_VB the_DT marked_JJ increase_NN in_IN both_DT conditions_NNS over_IN time_NN and_CC the_DT widening_NN gradient_NN between_IN urban_JJ ,_, peri-urban_JJ and_CC rural_JJ prevalence_NN ._. 
In_IN a_DT large_JJ survey_NN of_IN six_CD cities_NNS ,_, an_DT age-adjusted_JJ diabetes_NN prevalence_NN of_IN 12_CD %_NN was_VBD recently_RB reported_VBN ,_, demonstrating_VBG that_IN rates_NNS are_VBP continuing_VBG to_TO rise_VB ._. 
Table_NNP 3_CD Indian_JJ studies_NNS of_IN urban-rural_JJ comparisons_NNS of_IN obesity_NN and_CC diabetes_NN prevalence_NN Study_NNP Obesity_NNP prevalence_NN -LRB-_-LRB- %_NN -RRB-_-RRB- Urban\/Rural_NNP Ratio_NNP Diabetes_NNP prevalence_NN -LRB-_-LRB- %_NN -RRB-_-RRB- Urban\/Rural_NNP Ratio_NNP Urban_NNP Rural_NNP Urban_NNP Rural_NNP ICMR_NNP ,_, 1975_CD 
e._VB Recently_RB ,_, it_PRP has_VBZ become_VBN apparent_JJ that_IN phenotypic_JJ differences_NNS in_IN identical_JJ twins_NNS may_MD be_VB caused_VBN not_RB only_RB by_IN environmental_JJ factors_NNS but_CC also_RB by_IN epigenetic_JJ factors_NNS -LRB-_-LRB- i._JJ cellular_JJ information_NN ,_, other_JJ than_IN the_DT DNA_NNP sequence_NN ,_, that_WDT is_VBZ heritable_JJ 
Cohort_NN studies_NNS can_MD be_VB used_VBN to_TO examine_VB migration_NN effects_NNS but_CC require_VBP substantial_JJ numbers_NNS of_IN people_NNS to_TO migrate_VB if_IN effects_NNS on_IN disease_NN events_NNS are_VBP to_TO be_VB studied_VBN with_IN sufficient_JJ power_NN ._. 
For_IN example_NN ,_, in_IN the_DT British_NNP Regional_NNP Heart_NNP Study_NNP blood_NN pressure_NN and_CC coronary_JJ heart_NN disease_NN were_VBD more_RBR strongly_RB correlated_VBN with_IN place_NN of_IN adult_NN residence_NN than_IN place_NN of_IN birth_NN ,_, suggesting_VBG that_IN exposures_NNS during_IN adult_NN life_NN were_VBD more_JJR important_JJ determinants_NNS than_IN genetic_JJ or_CC early_JJ life_NN factors_NNS 
Previous_JJ studies_NNS in_IN India_NNP No_NNP previous_JJ study_NN has_VBZ examined_VBN the_DT effects_NNS of_IN rural_JJ to_TO urban_JJ migration_NN on_IN obesity_NN and_CC diabetes_NN in_IN India_NNP ._. 
Comparisons_NNS of_IN the_DT prevalence_NN of_IN obesity_NN and_CC diabetes_NN mellitus_NN in_IN rural_JJ and_CC urban_JJ areas_NNS of_IN India_NNP have_VBP been_VBN reported_VBN in_IN a_DT large_JJ ,_, but_CC out-dated_JJ study_NN 
-RRB-_-RRB- ._. -RRB-_-RRB- ._. 
Smaller_JJR surveys_NNS from_IN other_JJ urban_JJ and_CC rural_JJ regions_NNS of_IN India_NNP report_NN comparable_JJ prevalences_NNS of_IN obesity_NN and_CC diabetes_NN ,_, but_CC have_VBP not_RB attempted_VBN to_TO make_VB direct_JJ comparisons_NNS using_VBG standardised_JJ methodology_NN ._. 
Urban-rural_JJ gradients_NNS in_IN diabetes_NN may_MD be_VB higher_JJR in_IN south_RB than_IN north_JJ India_NNP 
Previous_JJ studies_NNS in_IN India_NNP No_NNP previous_JJ study_NN has_VBZ examined_VBN the_DT effects_NNS of_IN rural_JJ to_TO urban_JJ migration_NN on_IN obesity_NN and_CC diabetes_NN in_IN India_NNP ._. 
Comparisons_NNS of_IN the_DT prevalence_NN of_IN obesity_NN and_CC diabetes_NN mellitus_NN in_IN rural_JJ and_CC urban_JJ areas_NNS of_IN India_NNP have_VBP been_VBN reported_VBN in_IN a_DT large_JJ ,_, but_CC out-dated_JJ study_NN 
Briefly_RB ,_, the_DT excess_JJ mortality_NN among_IN Irish-born_JJ migrants_NNS to_TO the_DT USA_NNP ,_, apparent_JJ in_IN the_DT 1950s_CD ,_, prompted_VBD a_DT study_NN of_IN Boston-dwelling_JJ Irish_JJ and_CC their_PRP$ sibs_NNS still_RB living_VBG in_IN Ireland_NNP compared_VBN with_IN Boston-dwelling_JJ Americans_NNPS ._. 
No_DT differences_NNS in_IN cardiovascular_JJ risk_NN was_VBD found_VBN between_IN the_DT groups_NNS and_CC this_DT was_VBD probably_RB an_DT effect_NN of_IN divergent_JJ and_CC marked_JJ secular_JJ trends_NNS in_IN risk_NN in_IN Ireland_NNP -LRB-_-LRB- rising_VBG risk_NN -RRB-_-RRB- and_CC USA_NNP -LRB-_-LRB- falling_VBG risk_NN -RRB-_-RRB- at_IN the_DT time_NN of_IN study_NN 
Although_IN sib-comparisons_NNS appear_VBP to_TO be_VB like_IN twin_JJ studies_NNS ,_, it_PRP is_VBZ important_JJ to_TO recognize_VB that_IN the_DT main_JJ purpose_NN of_IN twin_NN studies_NNS is_VBZ to_TO determine_VB the_DT genetic_JJ contribution_NN of_IN diseases_NNS by_IN examining_VBG discordance_NN in_IN traits_NNS between_IN monozygotic_JJ -LRB-_-LRB- identical_JJ genes_NNS -RRB-_-RRB- and_CC dizygotic_JJ twins_NNS -LRB-_-LRB- no_DT more_RBR genetically_RB similar_JJ than_IN sibs_NNS -RRB-_-RRB- ._. 
In_IN obesity_NN and_CC diabetes_NN that_WDT clearly_RB have_VBP a_DT genetic_JJ contribution_NN demonstrated_VBN by_IN heritability_NN indicators_NNS 
In_IN obesity_NN and_CC diabetes_NN that_WDT clearly_RB have_VBP a_DT genetic_JJ contribution_NN demonstrated_VBN by_IN heritability_NN indicators_NNS 
e._VB Recently_RB ,_, it_PRP has_VBZ become_VBN apparent_JJ that_IN phenotypic_JJ differences_NNS in_IN identical_JJ twins_NNS may_MD be_VB caused_VBN not_RB only_RB by_IN environmental_JJ factors_NNS but_CC also_RB by_IN epigenetic_JJ factors_NNS -LRB-_-LRB- i._JJ cellular_JJ information_NN ,_, other_JJ than_IN the_DT DNA_NNP sequence_NN ,_, that_WDT is_VBZ heritable_JJ 
Prospective_JJ studies_NNS in_IN high-risk_JJ individuals_NNS have_VBP found_VBN that_IN insulin_NN resistance_NN is_VBZ the_DT most_RBS prominent_JJ and_CC earliest_JJS metabolic_JJ defect_NN that_WDT can_MD be_VB detected_VBN in_IN the_DT pre-diabetic_JJ state_NN ,_, conferring_VBG high_JJ risk_NN of_IN subsequent_JJ development_NN of_IN diabetes_NN 
Glucose_NN intolerance_NN ,_, obesity_NN ,_, dyslipidemia_NN and_CC hypertension_NN are_VBP part_NN of_IN a_DT common_JJ pathological_JJ syndrome_NN of_IN insulin_NN resistance_NN 
In_IN the_DT main_JJ study_NN fasting_VBG insulin_NN levels_NNS are_VBP being_VBG measured_VBN to_TO provide_VB relevant_JJ data_NNS ._. 
Little_NNP is_VBZ known_VBN about_IN the_DT ways_NNS in_IN which_WDT migration_NN and_CC social_JJ patterning_NN interact_NN to_TO increase_VB this_DT fundamental_JJ biological_JJ step_NN in_IN the_DT path_NN to_TO development_NN of_IN diabetes_NN ._. 
Glucose_NN intolerance_NN ,_, obesity_NN ,_, dyslipidemia_NN and_CC hypertension_NN are_VBP part_NN of_IN a_DT common_JJ pathological_JJ syndrome_NN of_IN insulin_NN resistance_NN 
-RRB-_-RRB- ._. 
Smaller_JJR surveys_NNS from_IN other_JJ urban_JJ and_CC rural_JJ regions_NNS of_IN India_NNP report_NN comparable_JJ prevalences_NNS of_IN obesity_NN and_CC diabetes_NN ,_, but_CC have_VBP not_RB attempted_VBN to_TO make_VB direct_JJ comparisons_NNS using_VBG standardised_JJ methodology_NN ._. -RRB-_-RRB- 
The_DT importance_NN of_IN insulin_NN resistance_NN lies_VBZ in_IN accumulating_VBG evidence_NN that_IN it_PRP is_VBZ causally_RB associated_VBN with_IN type_NN 2_CD diabetes_NN and_CC CHD_NNP 
Indian_JJ migrants_NNS abroad_RB appear_VBP to_TO be_VB at_IN particularly_RB high_JJ risk_NN compared_VBN with_IN the_DT host_NN populations_NNS they_PRP join_VBP ._. 
Indians_NNPS living_VBG in_IN Mauritius_NNP ,_, Fiji_NNP ,_, Singapore_NNP ,_, Tanzania_NNP ,_, Netherlands_NNP and_CC Britain_NNP have_VBP very_RB high_JJ diabetes_NN prevalences_NNS -LRB-_-LRB- 15_CD 
This_DT suggests_VBZ that_IN some_DT of_IN the_DT effect_NN of_IN urbanisation_NN may_MD be_VB mediated_VBN through_IN biological_JJ factors_NNS that_WDT result_VBP in_IN increased_VBN secretion_NN of_IN insulin_NN due_JJ to_TO tissue_NN resistance_NN to_TO its_PRP$ actions_NNS ._. 
Although_IN none_NN of_IN the_DT Indian_JJ studies_NNS specifically_RB studied_VBD migrants_NNS ,_, similarly_RB high_JJ levels_NNS of_IN serum_NN insulin_NN have_VBP been_VBN reported_VBN in_IN Asian_NNP Indians_NNPS living_VBG abroad_RB 
Indians_NNPS living_VBG in_IN Mauritius_NNP ,_, Fiji_NNP ,_, Singapore_NNP ,_, Tanzania_NNP ,_, Netherlands_NNP and_CC Britain_NNP have_VBP very_RB high_JJ diabetes_NN prevalences_NNS -LRB-_-LRB- 15_CD 
This_DT suggests_VBZ that_IN some_DT of_IN the_DT effect_NN of_IN urbanisation_NN may_MD be_VB mediated_VBN through_IN biological_JJ factors_NNS that_WDT result_VBP in_IN increased_VBN secretion_NN of_IN insulin_NN due_JJ to_TO tissue_NN resistance_NN to_TO its_PRP$ actions_NNS ._. 
Although_IN none_NN of_IN the_DT Indian_JJ studies_NNS specifically_RB studied_VBD migrants_NNS ,_, similarly_RB high_JJ levels_NNS of_IN serum_NN insulin_NN have_VBP been_VBN reported_VBN in_IN Asian_NNP Indians_NNPS living_VBG abroad_RB 
Indian_JJ migrants_NNS abroad_RB appear_VBP to_TO be_VB at_IN particularly_RB high_JJ risk_NN compared_VBN with_IN the_DT host_NN populations_NNS they_PRP join_VBP ._. 
Indians_NNPS living_VBG in_IN Mauritius_NNP ,_, Fiji_NNP ,_, Singapore_NNP ,_, Tanzania_NNP ,_, Netherlands_NNP and_CC Britain_NNP have_VBP very_RB high_JJ diabetes_NN prevalences_NNS -LRB-_-LRB- 15_CD 
This_DT suggests_VBZ that_IN some_DT of_IN the_DT effect_NN of_IN urbanisation_NN may_MD be_VB mediated_VBN through_IN biological_JJ factors_NNS that_WDT result_VBP in_IN increased_VBN secretion_NN of_IN insulin_NN due_JJ to_TO tissue_NN resistance_NN to_TO its_PRP$ actions_NNS ._. 
Although_IN none_NN of_IN the_DT Indian_JJ studies_NNS specifically_RB studied_VBD migrants_NNS ,_, similarly_RB high_JJ levels_NNS of_IN serum_NN insulin_NN have_VBP been_VBN reported_VBN in_IN Asian_NNP Indians_NNPS living_VBG abroad_RB 
-RRB-_-RRB- ._. 
Smaller_JJR surveys_NNS from_IN other_JJ urban_JJ and_CC rural_JJ regions_NNS of_IN India_NNP report_NN comparable_JJ prevalences_NNS of_IN obesity_NN and_CC diabetes_NN ,_, but_CC have_VBP not_RB attempted_VBN to_TO make_VB direct_JJ comparisons_NNS using_VBG standardised_JJ methodology_NN ._. -RRB-_-RRB- 
43_CD ._. 
32_CD ._. 
9~_CD 2_CD South_NNP India_NNP ,_, 1992_CD 22_CD 2_CD 11_CD 8_CD ._. 
6_CD 
Sib_NNP comparison_NN ,_, twin_NN and_CC cohort_NN designs_NNS The_DT sib-comparison_JJ design_NN was_VBD first_RB used_VBN in_IN a_DT study_NN of_IN the_DT effects_NNS of_IN Irish_JJ migration_NN to_TO the_DT USA_NNP in_IN the_DT Boston-Irish_NNP Diet_NNP Heart_NNP study_NN ._. 
Briefly_RB ,_, the_DT excess_JJ mortality_NN among_IN Irish-born_JJ migrants_NNS to_TO the_DT USA_NNP ,_, apparent_JJ in_IN the_DT 1950s_CD ,_, prompted_VBD a_DT study_NN of_IN Boston-dwelling_JJ Irish_JJ and_CC their_PRP$ sibs_NNS still_RB living_VBG in_IN Ireland_NNP compared_VBN with_IN Boston-dwelling_JJ Americans_NNPS ._. 
No_DT di_FW 
Serum_NNP HDL-cholesterol_NNP was_VBD estimated_VBN directly_RB by_IN an_DT elimination_NN method_NN 
Laboratory_NNP assays_VBZ Blood_NNP samples_NNS were_VBD transported_VBN weekly_JJ to_TO All_NNP India_NNP Institute_NNP of_IN Medical_NNP Sciences_NNP -LRB-_-LRB- AIIMS_NNP -RRB-_-RRB- ,_, Delhi_NNP ,_, having_VBG been_VBN separated_VBN and_CC stored_VBN at_IN -20_CD 
Laboratory_NNP assays_VBZ Blood_NNP samples_NNS were_VBD transported_VBN weekly_JJ to_TO All_NNP India_NNP Institute_NNP of_IN Medical_NNP Sciences_NNP -LRB-_-LRB- AIIMS_NNP -RRB-_-RRB- ,_, Delhi_NNP ,_, having_VBG been_VBN separated_VBN and_CC stored_VBN at_IN -20_CD 
Previous_JJ studies_NNS have_VBP used_VBN simple_JJ short_JJ questions_NNS about_IN occupation_NN ,_, leisure_NN time_NN activity_NN and_CC household_NN work_NN ,_, and_CC related_VBN those_DT to_TO outcomes_NNS of_IN interest_NN such_JJ as_IN obesity_NN and_CC related_JJ disorders_NNS 
No_DT validated_VBN Indian_JJ physical_JJ activity_NN questionnaire_NN exists_VBZ ,_, but_CC the_DT energy_NN cost_NN of_IN a_DT range_NN of_IN activities_NNS has_VBZ been_VBN assessed_VBN ,_, enabling_VBG METS_NNS enabling_VBG metabolic_JJ equivalents_NNS of_IN task_NN -LRB-_-LRB- METs_NNPS ,_, 1_CD MET_NNP is_VBZ equivalent_JJ to_TO a_DT metabolic_JJ rate_NN consuming_NN 1_CD kilocalorie_NN per_IN kilogram_NN of_IN body_NN weight_NN per_IN hour_NN -RRB-_-RRB- to_TO be_VB derived_VBN from_IN a_DT 24-hour_JJ activity_NN record_NN 
No_DT validated_VBN Indian_JJ physical_JJ activity_NN questionnaire_NN exists_VBZ ,_, but_CC the_DT energy_NN cost_NN of_IN a_DT range_NN of_IN activities_NNS has_VBZ been_VBN assessed_VBN ,_, enabling_VBG METS_NNS enabling_VBG metabolic_JJ equivalents_NNS of_IN task_NN -LRB-_-LRB- METs_NNPS ,_, 1_CD MET_NNP is_VBZ equivalent_JJ to_TO a_DT metabolic_JJ rate_NN consuming_NN 1_CD kilocalorie_NN per_IN kilogram_NN of_IN body_NN weight_NN per_IN hour_NN -RRB-_-RRB- to_TO be_VB derived_VBN from_IN a_DT 24-hour_JJ activity_NN record_NN 
Physical_JJ activity_NN status_NN was_VBD assessed_VBN by_IN interviewer-administered_JJ questionnaire_NN ._. 
Detailed_JJ nutrient_NN values_NNS for_IN Indian_JJ foods_NNS were_VBD used_VBN to_TO calculate_VB macro_NN and_CC micro_NN nutrients_NNS ._. 
No_DT validated_VBN Indian_JJ physical_JJ activity_NN questionnaire_NN exists_VBZ ,_, but_CC the_DT energy_NN cost_NN of_IN a_DT range_NN of_IN activities_NNS has_VBZ been_VBN assessed_VBN ,_, enabling_VBG METS_NNS enabling_VBG metabolic_JJ equivalents_NNS of_IN task_NN -LRB-_-LRB- METs_NNPS ,_, 1_CD MET_NNP is_VBZ equivalent_JJ to_TO a_DT metabolic_JJ rate_NN consuming_NN 1_CD 
Physical_JJ activity_NN status_NN was_VBD assessed_VBN by_IN interviewer-administered_JJ questionnaire_NN ._. 
Detailed_JJ nutrient_NN values_NNS for_IN Indian_JJ foods_NNS were_VBD used_VBN to_TO calculate_VB macro_NN and_CC micro_NN nutrients_NNS ._. 
No_DT validated_VBN Indian_JJ physical_JJ activity_NN questionnaire_NN exists_VBZ ,_, but_CC the_DT energy_NN cost_NN of_IN a_DT range_NN of_IN activities_NNS has_VBZ been_VBN assessed_VBN ,_, enabling_VBG METS_NNS enabling_VBG metabolic_JJ equivalents_NNS of_IN task_NN -LRB-_-LRB- METs_NNPS ,_, 1_CD MET_NNP is_VBZ equivalent_JJ to_TO a_DT metabolic_JJ rate_NN consuming_NN 1_CD kilocalorie_NN per_IN kilogram_NN of_IN body_NN weight_NN per_IN hour_NN -RRB-_-RRB- to_TO be_VB derived_VBN from_IN a_DT 24-hour_JJ activity_NN record_NN 
Assessment_NNP of_IN dietary_JJ intake_NN and_CC physical_JJ activity_NN Diet_NNP was_VBD assessed_VBN by_IN interviewer-administered_JJ semi-quantitative_JJ food_NN frequency_NN questionnaire_NN using_VBG validated_VBN and_CC reproducible_JJ food_NN frequency_NN methodology_NN 
Migrating_VBG populations_NNS can_MD provide_VB stronger_JJR evidence_NN as_IN people_NNS migrating_VBG from_IN low_JJ to_TO high_JJ risk_NN populations_NNS would_MD be_VB expected_VBN to_TO acquire_VB the_DT high_JJ risk_NN of_IN the_DT host_NN population_NN if_IN the_DT disease_NN is_VBZ largely_RB environmentally_RB determined_VBN ._. 
In_IN a_DT classic_JJ migrant_JJ study_NN of_IN Tokelau_NNP islanders_NNS following_VBG a_DT hurricane_NN in_IN 1966_CD ,_, migrants_NNS to_TO New_NNP Zealand_NNP had_VBD a_DT higher_JJR risk_NN of_IN diabetes_NN and_CC were_VBD more_RBR obese_JJ compared_VBN to_TO non-migrants_NNS ,_, which_WDT was_VBD related_VBN to_TO their_PRP$ duration_NN of_IN stay_NN and_CC family_NN size_NN ,_, but_CC not_RB age_NN at_IN migration_NN ._. 
These_DT findings_NNS suggest_VBP a_DT rapid_JJ acquisition_NN of_IN health_NN behaviors_NNS increasing_VBG the_DT risk_NN of_IN diabetes_NN ._. 
By_IN contrast_NN ,_, the_DT migration_NN experience_NN of_IN Japanese_JJ migrating_NN to_TO the_DT USA_NNP has_VBZ been_VBN more_RBR gradual_JJ ,_, they_PRP have_VBP joined_VBN kith_NN and_CC kin_NN ,_, and_CC the_DT opportunity_NN to_TO maintain_VB a_DT Japanese_JJ lifestyle_NN has_VBZ existed_VBN ._. 
Migrating_VBG populations_NNS can_MD provide_VB stronger_JJR evidence_NN as_IN people_NNS migrating_VBG from_IN low_JJ to_TO high_JJ risk_NN populations_NNS would_MD be_VB expected_VBN to_TO acquire_VB the_DT high_JJ risk_NN of_IN the_DT host_NN population_NN if_IN the_DT disease_NN is_VBZ largely_RB environmentally_RB determined_VBN ._. 
In_IN a_DT classic_JJ migrant_JJ study_NN of_IN Tokelau_NNP islanders_NNS following_VBG a_DT hurricane_NN in_IN 1966_CD ,_, migrants_NNS to_TO New_NNP Zealand_NNP had_VBD a_DT higher_JJR risk_NN of_IN diabetes_NN and_CC were_VBD more_RBR obese_JJ compared_VBN to_TO non-migrants_NNS ,_, which_WDT was_VBD related_VBN to_TO their_PRP$ duration_NN of_IN stay_NN and_CC family_NN size_NN ,_, but_CC not_RB age_NN at_IN migration_NN ._. 
These_DT findings_NNS suggest_VBP a_DT rapid_JJ acquisition_NN of_IN health_NN behaviors_NNS increasing_VBG the_DT risk_NN of_IN diabetes_NN ._. 
By_IN contrast_NN ,_, the_DT migration_NN experience_NN of_IN Japanese_JJ migrating_NN to_TO the_DT USA_NNP has_VBZ been_VBN more_RBR gradual_JJ ,_, they_PRP have_VBP joined_VBN kith_NN and_CC kin_NN ,_, and_CC the_DT opportunity_NN to_TO maintain_VB a_DT Japanese_JJ lifestyle_NN has_VBZ existed_VBN ._. 
By_IN contrast_NN ,_, the_DT migration_NN experience_NN of_IN Japanese_JJ migrating_NN to_TO the_DT USA_NNP has_VBZ been_VBN more_RBR gradual_JJ ,_, they_PRP have_VBP joined_VBN kith_NN and_CC kin_NN ,_, and_CC the_DT opportunity_NN to_TO maintain_VB a_DT Japanese_JJ lifestyle_NN has_VBZ existed_VBN ._. 
Despite_IN this_DT lack_NN of_IN apparent_JJ acculturation_NN ,_, the_DT risk_NN of_IN diabetes_NN amongst_IN Japanese_JJ living_NN in_IN Hawaii_NNP and_CC Los_NNP Angeles_NNP is_VBZ 2_CD 
Insulin_NN levels_NNS are_VBP higher_JJR in_IN those_DT living_VBG in_IN the_DT USA_NNP than_IN Japan_NNP for_IN the_DT same_JJ degree_NN of_IN obesity_NN and_CC glucose_NN intolerance_NN ,_, suggestive_JJ of_IN acquired_VBN insulin_NN resistance_NN ._. 
Importantly_RB ,_, those_DT who_WP retain_VBP a_DT traditional_JJ lifestyle_NN and_CC are_VBP not_RB obese_JJ are_VBP less_RBR likely_JJ to_TO be_VB diabetic_JJ ,_, although_IN the_DT risk_NN is_VBZ still_RB higher_JJR than_IN in_IN Japan_NNP 
It_PRP is_VBZ possible_JJ that_IN simple_JJ urban-rural_JJ study_NN designs_NNS under-estimate_VBP the_DT true_JJ differences_NNS in_IN diabetes_NN risk_NN between_IN migrants_NNS and_CC non-migrants_NNS ._. 
BackgroundThe_JJ health_NN consequences_NNS of_IN migration_NN are_VBP classically_RB conceptualised_VBN in_IN terms_NNS of_IN exposures_NNS experienced_VBN in_IN the_DT home_NN country_NN ;_: exposures_NNS acquired_VBN in_IN the_DT new_JJ country_NN ;_: health_NN or_CC disease_NN selection_NN of_IN those_DT who_WP migrate_VBP ;_: and_CC ,_, exposures_NNS due_JJ to_TO the_DT process_NN of_IN migration_NN itself_PRP ._. 
The_DT usual_JJ typologies_NNS of_IN migrant_NN 
The_DT usual_JJ typologies_NNS of_IN migrant_NN 
Age_NNP at_IN migration_NN and_CC gender_NN are_VBP likely_JJ to_TO be_VB key_JJ factors_NNS 
Prospective_JJ studies_NNS in_IN high-risk_JJ individuals_NNS have_VBP found_VBN that_IN insulin_NN resistance_NN is_VBZ the_DT most_RBS prominent_JJ and_CC earliest_JJS metabolic_JJ defect_NN that_WDT can_MD be_VB detected_VBN in_IN the_DT pre-diabetic_JJ state_NN ,_, conferring_VBG high_JJ risk_NN of_IN subsequent_JJ development_NN of_IN diabetes_NN 
Importantly_RB ,_, those_DT who_WP retain_VBP a_DT traditional_JJ lifestyle_NN and_CC are_VBP not_RB obese_JJ are_VBP less_RBR likely_JJ to_TO be_VB diabetic_JJ ,_, although_IN the_DT risk_NN is_VBZ still_RB higher_JJR than_IN in_IN Japan_NNP 
Importantly_RB ,_, those_DT who_WP retain_VBP a_DT traditional_JJ lifestyle_NN and_CC are_VBP not_RB obese_JJ are_VBP less_RBR likely_JJ to_TO be_VB diabetic_JJ ,_, although_IN the_DT risk_NN is_VBZ still_RB higher_JJR than_IN in_IN Japan_NNP 
International_JJ law_NN may_MD be_VB useful_JJ for_IN setting_VBG standards_NNS and_CC goals_NNS that_WDT frame_VBP a_DT mission_NN 's_POS rules_NNS of_IN engagement_NN and_CC entry_NN agreements_NNS ._. 
Sustainable_JJ behavior_NN change_NN requires_VBZ national_JJ support_NN for_IN humanitarian_JJ ethics_NNS and_CC its_PRP$ duties_NNS ,_, including_VBG the_DT adoption_NN and_CC rati_NNS 
Poor_NNP survey_NN methods_NNS ,_, studies_NNS restricted_VBN to_TO urban_JJ centres_NNS with_IN elevated_JJ prevalence_NN ,_, and_CC biased_VBD analyses_NNS of_IN findings_NNS have_VBP contributed_VBN to_TO the_DT assumption_NN that_IN HIV_NNP transmission_NN dramatically_RB increases_VBZ in_IN conflict_NN settings_NNS 
The_DT presence_NN of_IN international_JJ expatriate_NN staff_NN has_VBZ some_DT protective_JJ impact_NN on_IN civilians_NNS by_IN deterring_VBG belligerents_NNS ,_, creating_VBG confidence_NN in_IN communities_NNS and_CC attracting_VBG global_JJ attention_NN to_TO crises_NNS 
The_DT use_NN of_IN sexual_JJ violence_NN as_IN a_DT weapon_NN of_IN war_NN has_VBZ been_VBN particularly_RB associated_VBN with_IN concerns_NNS about_IN heightened_JJ HIV_NNP incidence_NN among_IN women_NNS and_CC girls_NNS 
Widespread_JJ rape_NN by_IN armed_JJ combatants_NNS has_VBZ been_VBN documented_VBN in_IN Burundi_NNP 
The_DT use_NN of_IN sexual_JJ violence_NN as_IN a_DT weapon_NN of_IN war_NN has_VBZ been_VBN particularly_RB associated_VBN with_IN concerns_NNS about_IN heightened_JJ HIV_NNP incidence_NN among_IN women_NNS and_CC girls_NNS 
The_DT use_NN of_IN sexual_JJ violence_NN as_IN a_DT weapon_NN of_IN war_NN has_VBZ been_VBN particularly_RB associated_VBN with_IN concerns_NNS about_IN heightened_JJ HIV_NNP incidence_NN among_IN women_NNS and_CC girls_NNS 
The_DT use_NN of_IN sexual_JJ violence_NN as_IN a_DT weapon_NN of_IN war_NN has_VBZ been_VBN particularly_RB associated_VBN with_IN concerns_NNS about_IN heightened_JJ HIV_NNP incidence_NN among_IN women_NNS and_CC girls_NNS 
The_DT use_NN of_IN sexual_JJ violence_NN as_IN a_DT weapon_NN of_IN war_NN has_VBZ been_VBN particularly_RB associated_VBN with_IN concerns_NNS about_IN heightened_JJ HIV_NNP incidence_NN among_IN women_NNS and_CC girls_NNS 
Our_PRP$ findings_NNS also_RB draw_VBP attention_NN to_TO the_DT need_NN for_IN improved_VBN surveillance_NN of_IN sexual_JJ violence_NN and_CC its_PRP$ impact_NN on_IN HIV_NNP epidemiology_NN ._. 
Humanitarian_JJ organizations_NNS ,_, including_VBG UN_NNP organizations_NNS ,_, as_RB well_RB as_IN the_DT media_NNS have_VBP sometimes_RB published_VBN inaccurate_JJ or_CC misleading_JJ HIV_NNP information_NN about_IN conflict-affected_JJ populations_NNS 
Widespread_JJ rape_NN by_IN armed_JJ combatants_NNS has_VBZ been_VBN documented_VBN in_IN Burundi_NNP 
However_RB ,_, empirical_JJ research_NN suggests_VBZ that_IN HIV_NNP incidence_NN in_IN armed_JJ conflicts_NNS may_MD in_IN fact_NN diminish_VBP ,_, remain_VBP constant_JJ or_CC not_RB increase_VB to_TO the_DT same_JJ magnitude_NN compared_VBN with_IN those_DT countries_NNS not_RB in_IN conflict_NN ._. 
This_DT may_MD be_VB due_JJ to_TO reductions_NNS in_IN population_NN mobility_NN ,_, access_NN ,_, and_CC urbanisation_NN 
These_DT include_VBP the_DT reduction_NN in_IN social_JJ mobility_NN that_WDT occurs_VBZ during_IN times_NNS of_IN conflict_NN ,_, reduced_VBN number_NN of_IN sexual_JJ partners_NNS outside_IN of_IN the_DT rape_NN scenarios_NNS ,_, and_CC possibly_RB lower_JJR HIV_NNP rates_NNS amongst_IN the_DT assailants_NNS than_IN previously_RB believed_VBN ._. 
Many_JJ of_IN the_DT men_NNS who_WP rape_NN are_VBP young_JJ ,_, live_VBP in_IN rural_JJ settings_NNS ,_, and_CC may_MD have_VB a_DT low_JJ prevalence_NN of_IN HIV_NNP ._. 
However_RB ,_, perhaps_RB the_DT most_RBS important_JJ factor_NN for_IN the_DT low_JJ change_NN in_IN HIV_NNP prevalence_NN rates_NNS at_IN the_DT population_NN level_NN may_MD be_VB the_DT relatively_RB low_JJ transmission_NN rates_NNS of_IN HIV_NNP infection_NN through_IN sexual_JJ intercourse_NN ._. 
However_RB ,_, perhaps_RB the_DT most_RBS important_JJ factor_NN for_IN the_DT low_JJ change_NN in_IN HIV_NNP prevalence_NN rates_NNS at_IN the_DT population_NN level_NN may_MD be_VB the_DT relatively_RB low_JJ transmission_NN rates_NNS of_IN HIV_NNP infection_NN through_IN sexual_JJ intercourse_NN ._. 
This_DT is_VBZ in_IN stark_JJ contrast_NN to_TO repeated_JJ and_CC long-term_JJ exposure_NN that_WDT often_RB occurs_VBZ in_IN concurrent_JJ sexual_JJ relationships_NNS ;_: the_DT latter_NN has_VBZ shown_VBN to_TO increase_VB the_DT likelihood_NN of_IN transmission_NN at_IN an_DT individual_NN and_CC population_NN level_NN given_VBN the_DT multiple_JJ exposures_NNS and_CC interconnecting_VBG networks_NNS ._. 
The_DT conclusions_NNS of_IN this_DT article_NN do_VBP not_RB have_VB a_DT significant_JJ impact_NN on_IN current_JJ practices_NNS in_IN the_DT field_NN from_IN an_DT operational_JJ perspective_NN ._. 
There_EX is_VBZ a_DT need_NN for_IN the_DT international_JJ community_NN to_TO better_RB understand_VB the_DT drivers_NNS of_IN sexual_JJ violence_NN against_IN women_NNS in_IN armed_JJ conflicts_NNS ._. 
This_DT is_VBZ critical_JJ in_IN countries_NNS such_JJ as_IN the_DT DRC_NNP ,_, where_WRB rape_NN at_IN the_DT hands_NNS of_IN government_NN and_CC guerrilla_NN armed_JJ combatants_NNS is_VBZ reportedly_RB increasing_VBG in_IN numbers_NNS and_CC magnitude_NN of_IN violence_NN 
The_DT consequences_NNS of_IN conflict_NN and_CC rape_NN are_VBP long_RB lasting_JJ ._. 
Zero_JJ tolerance_NN of_IN sexual_JJ violence_NN must_MD be_VB an_DT international_JJ priority_NN ._. 
One_CD long_JJ term_NN sequela_NN of_IN rape_NN is_VBZ its_PRP$ association_NN with_IN sexual_JJ risk_NN behavior_NN and_CC with_IN HIV_NNP and_CC other_JJ sexually_RB transmitted_JJ infections_NNS 
There_EX is_VBZ a_DT need_NN for_IN the_DT international_JJ community_NN to_TO better_RB understand_VB the_DT drivers_NNS of_IN sexual_JJ violence_NN against_IN women_NNS in_IN armed_JJ conflicts_NNS ._. 
This_DT is_VBZ critical_JJ in_IN countries_NNS such_JJ as_IN the_DT DRC_NNP ,_, where_WRB rape_NN at_IN the_DT hands_NNS of_IN government_NN and_CC guerrilla_NN armed_JJ combatants_NNS is_VBZ reportedly_RB increasing_VBG in_IN numbers_NNS and_CC magnitude_NN of_IN violence_NN 
The_DT consequences_NNS of_IN conflict_NN and_CC rape_NN are_VBP long_RB lasting_JJ ._. 
Zero_JJ tolerance_NN of_IN sexual_JJ violence_NN must_MD be_VB an_DT international_JJ priority_NN ._. 
One_CD long_JJ term_NN sequela_NN of_IN rape_NN is_VBZ its_PRP$ association_NN with_IN sexual_JJ risk_NN behavior_NN and_CC with_IN HIV_NNP and_CC other_JJ sexually_RB transmitted_JJ infections_NNS ._. 
Although_IN difficult_JJ to_TO study_VB and_CC quantify_VB ,_, it_PRP has_VBZ been_VBN hypothesised_VBN that_IN the_DT indirect_JJ effects_NNS of_IN conflict_NN and_CC rape_NN may_MD ultimately_RB cause_VB women_NNS and_CC children_NNS to_TO increase_VB their_PRP$ vulnerability_NN and_CC risk_NN behavior_NN that_WDT could_MD ultimately_RB end_VB in_IN their_PRP$ becoming_VBG HIV_NNP positive_JJ ._. 
Although_IN difficult_JJ to_TO study_VB and_CC quantify_VB ,_, it_PRP has_VBZ been_VBN hypothesised_VBN that_IN the_DT indirect_JJ effects_NNS of_IN conflict_NN and_CC rape_NN may_MD ultimately_RB cause_VB women_NNS and_CC children_NNS to_TO increase_VB their_PRP$ vulnerability_NN and_CC risk_NN behavior_NN that_WDT could_MD ultimately_RB end_VB in_IN their_PRP$ becoming_VBG HIV_NNP positive_JJ ._. 
Various_JJ forms_NNS of_IN exposure_NN to_TO trauma_NN in_IN childhood_NN might_MD result_VB in_IN increased_VBN use_NN of_IN violence_NN ,_, including_VBG sexual_JJ violence_NN ,_, in_IN later_JJ years_NNS as_RB well_RB as_IN sexual_JJ risk-taking_NN ._. 
However_RB ,_, it_PRP is_VBZ unclear_JJ how_WRB these_DT indirect_JJ affects_VBZ of_IN rape_NN would_MD affect_VB the_DT HIV_NNP prevalence_NN at_IN the_DT population_NN level_NN ._. 
However_RB ,_, a_DT recent_JJ study_NN now_RB suggests_VBZ that_IN only_JJ long-serving_JJ soldiers_NNS and_CC soldiers_NNS belonging_VBG to_TO less_RBR disciplined_JJ forces_NNS may_MD be_VB at_IN increased_VBN risk_NN of_IN infection_NN 
So_RB now_RB what_WP ._. 
HIV_NNP prevalence_NN in_IN militaries_NNS may_MD be_VB lower_JJR than_IN previously_RB assumed_VBN due_JJ to_TO the_DT common_JJ military_JJ practice_NN of_IN recruiting_VBG young_JJ men_NNS from_IN low-prevalence_JJ rural_JJ areas_NNS ,_, to_TO screening_VBG out_RP HIV-positive_JJ individuals_NNS through_IN routine_JJ testing_NN ,_, and_CC to_TO stationing_VBG soldiers_NNS in_IN remote_JJ areas_NNS with_IN limited_JJ mobility_NN and_CC remuneration_NN 
So_RB now_RB what_WP ._. 
HIV_NNP prevalence_NN in_IN militaries_NNS may_MD be_VB lower_JJR than_IN previously_RB assumed_VBN due_JJ to_TO the_DT common_JJ military_JJ practice_NN of_IN recruiting_VBG young_JJ men_NNS from_IN low-prevalence_JJ rural_JJ areas_NNS ,_, to_TO screening_VBG out_RP HIV-positive_JJ individuals_NNS through_IN routine_JJ testing_NN ,_, and_CC to_TO stationing_VBG soldiers_NNS in_IN remote_JJ areas_NNS with_IN limited_JJ mobility_NN and_CC remuneration_NN 
Elevated_JJ feelings_NNS of_IN dread_NN combined_VBN with_IN unknown_JJ risk_NN tend_VBP to_TO increase_VB people_NNS 's_POS perception_NN of_IN risk_NN ._. 
This_DT has_VBZ been_VBN demonstrated_VBN in_IN the_DT context_NN of_IN blood_NN transfusions_NNS ,_, where_WRB perceived_VBN risk_NN of_IN HIV_NNP transmission_NN is_VBZ high_JJ ,_, in_IN spite_NN of_IN the_DT actual_JJ risk_NN being_VBG quite_RB low_JJ when_WRB blood_NN is_VBZ properly_RB screened_VBN ._. 
The_DT growing_VBG body_NN of_IN empirical_JJ evidence_NN suggests_VBZ the_DT international_JJ community_NN 's_POS perceived_VBN risk_NN about_IN the_DT impact_NN of_IN widespread_JJ rape_NN on_IN HIV_NNP prevalence_NN overestimated_VBD the_DT actual_JJ risk_NN ._. 
Although_IN there_EX is_VBZ a_DT growing_VBG acknowledgement_NN among_IN international_JJ organizations_NNS about_IN the_DT collective_JJ responsibility_NN to_TO protect_VB civilians_NNS in_IN conflict_NN settings_NNS 
The_DT presence_NN of_IN international_JJ expatriate_NN staff_NN has_VBZ some_DT protective_JJ impact_NN on_IN civilians_NNS by_IN deterring_VBG belligerents_NNS ,_, creating_VBG confidence_NN in_IN communities_NNS and_CC attracting_VBG global_JJ attention_NN to_TO crises_NNS 
The_DT conclusions_NNS of_IN this_DT article_NN do_VBP not_RB have_VB a_DT significant_JJ impact_NN on_IN current_JJ practices_NNS in_IN the_DT field_NN from_IN an_DT operational_JJ perspective_NN ._. 
Proper_JJ care_NN and_CC treatment_NN must_MD be_VB provided_VBN to_TO every_DT survivor_NN of_IN rape_NN regardless_RB of_IN the_DT epidemiological_JJ effects_NNS of_IN HIV_NNP transmission_NN at_IN the_DT population_NN level_NN 
Increased_VBN attention_NN should_MD be_VB undertaken_VBN to_TO promote_VB HIV_NNP prevention_NN practices_NNS among_IN armed_JJ combatants_NNS ._. 
In_IN response_NN to_TO the_DT problem_NN of_IN troops_NNS being_VBG both_DT victims_NNS and_CC transmitters_NNS of_IN the_DT virus_NN ,_, the_DT UN_NNP Security_NNP Council_NNP adopted_VBD Resolution_NNP 1308_CD that_IN calls_NNS for_IN national_JJ strategies_NNS to_TO address_VB the_DT spread_NN of_IN AIDS_NNP among_IN uniformed_JJ services_NNS ,_, including_VBG through_IN awareness_NN raising_NN and_CC training_NN among_IN their_PRP$ ranks_NNS ._. 
UNAIDS_NNS and_CC the_DT UN_NNP Department_NNP of_IN Peacekeeping_NNP Operations_NNP are_VBP working_VBG with_IN national_JJ authorities_NNS to_TO mainstream_JJ HIV\/AIDS_NNP programs_NNS in_IN all_DT UN_NNP peacekeeping_NN missions_NNS ._. 
UNAIDS_NNS and_CC the_DT UN_NNP Department_NNP of_IN Peacekeeping_NNP Operations_NNP are_VBP working_VBG with_IN national_JJ authorities_NNS to_TO mainstream_JJ HIV\/AIDS_NNP programs_NNS in_IN all_DT UN_NNP peacekeeping_NN missions_NNS ._. 
AIDS_NNP advisors_NNS have_VBP been_VBN placed_VBN in_IN 29_CD SSA_NNP countries_NNS ,_, including_VBG those_DT with_IN current_JJ or_CC recent_JJ conflict_NN such_JJ as_IN Burundi_NNP ,_, C_NNP 
This_DT is_VBZ regardless_RB if_IN the_DT rape_NN occurs_VBZ in_IN conflict_NN or_CC from_IN a_DT domestic_JJ partner_NN ._. 
Sexual_JJ violence_NN must_MD be_VB treated_VBN as_IN a_DT protection_NN issue_NN and_CC not_RB solely_RB a_DT reproductive_JJ health_NN and_CC psychosocial_JJ issue_NN 
Proper_JJ care_NN and_CC treatment_NN must_MD be_VB provided_VBN to_TO every_DT survivor_NN of_IN rape_NN regardless_RB of_IN the_DT epidemiological_JJ effects_NNS of_IN HIV_NNP transmission_NN at_IN the_DT population_NN level_NN 
HIV_NNP post-exposure_JJ prophylaxis_NN ,_, treatment_NN of_IN sexually_RB transmitted_JJ infections_NNS ,_, and_CC psychosocial_JJ support_NN -RRB-_-RRB- ._. 
International_JJ law_NN may_MD be_VB useful_JJ for_IN setting_VBG standards_NNS and_CC goals_NNS that_WDT frame_VBP a_DT mission_NN 's_POS rules_NNS of_IN engagement_NN and_CC entry_NN agreements_NNS 
In_IN fact_NN ,_, rape_NN perpetrated_VBN by_IN a_DT stranger_NN reflects_VBZ only_RB a_DT small_JJ proportion_NN of_IN women_NNS 's_POS experiences_NNS of_IN coerced_VBN sex_NN which_WDT is_VBZ more_RBR commonly_RB perpetrated_VBN by_IN known_JJ persons_NNS such_JJ as_IN within_IN marriages_NNS ,_, dating_VBG relationships_NNS and_CC families_NNS 
Proper_JJ care_NN and_CC treatment_NN must_MD be_VB provided_VBN to_TO every_DT survivor_NN of_IN rape_NN regardless_RB of_IN the_DT epidemiological_JJ effects_NNS of_IN HIV_NNP transmission_NN at_IN the_DT population_NN level_NN 
The_DT presence_NN of_IN international_JJ expatriate_NN staff_NN has_VBZ some_DT protective_JJ impact_NN on_IN civilians_NNS by_IN deterring_VBG belligerents_NNS ,_, creating_VBG confidence_NN in_IN communities_NNS and_CC attracting_VBG global_JJ attention_NN to_TO crises_NNS 
The_DT conclusions_NNS of_IN this_DT article_NN do_VBP not_RB have_VB a_DT significant_JJ impact_NN on_IN current_JJ practices_NNS in_IN the_DT field_NN from_IN an_DT operational_JJ perspective_NN ._. 
Proper_JJ care_NN and_CC treatment_NN must_MD be_VB provided_VBN to_TO every_DT survivor_NN of_IN rape_NN regardless_RB of_IN the_DT epidemiological_JJ effects_NNS of_IN HIV_NNP transmission_NN at_IN the_DT population_NN level_NN 
Proper_JJ care_NN and_CC treatment_NN must_MD be_VB provided_VBN to_TO every_DT survivor_NN of_IN rape_NN regardless_RB of_IN the_DT epidemiological_JJ effects_NNS of_IN HIV_NNP transmission_NN at_IN the_DT population_NN level_NN 
The_DT presence_NN of_IN international_JJ expatriate_NN staff_NN has_VBZ some_DT protective_JJ impact_NN on_IN civilians_NNS by_IN deterring_VBG belligerents_NNS ,_, creating_VBG confidence_NN in_IN communities_NNS and_CC attracting_VBG global_JJ attention_NN to_TO crises_NNS 
UNAIDS_NNP has_VBZ previously_RB assumed_VBN that_IN rates_NNS of_IN HIV_NNP among_IN armed_JJ combatants_NNS is_VBZ 2_CD to_TO 5_CD times_NNS higher_JJR than_IN among_IN civilian_JJ populations_NNS 
Little_JJ information_NN exists_VBZ about_IN HIV_NNP prevalence_NN among_IN armed_JJ combatants_NNS in_IN conflict_NN affected_VBD SSA_NNP countries_NNS ._. 
UNAIDS_NNP has_VBZ previously_RB assumed_VBN that_IN rates_NNS of_IN HIV_NNP among_IN armed_JJ combatants_NNS is_VBZ 2_CD to_TO 5_CD times_NNS higher_JJR than_IN among_IN civilian_JJ populations_NNS 
008_CD ,_, the_DT rate_NN of_IN heterosexual_JJ transmission_NN among_IN individuals_NNS with_IN acute_JJ and_CC recent_JJ primary_JJ HIV_NN infection_NN 
On_IN the_DT upper_JJ end_NN ,_, we_PRP assumed_VBD a_DT rate_NN of_IN 0_CD ._. 
These_DT population_NN estimates_NNS are_VBP based_VBN on_IN all_DT residents_NNS of_IN nations_NNS within_IN SSA_NNP regardless_RB of_IN legal_JJ status_NN or_CC citizenship_NN ,_, and_CC represent_VBP a_DT compendium_NN of_IN data_NNS on_IN population_NN ,_, fertility_NN ,_, mortality_NN ,_, contraceptive_JJ use_NN ,_, and_CC related_JJ demographic_JJ topics_NNS provided_VBN by_IN the_DT US_NNP Census_NNP Bureau_NNP ._. 
High_JJ ,_, low_JJ and_CC mid-range_JJ estimates_NNS of_IN national_JJ HIV_NNP prevalence_NN estimates_NNS for_IN women_NNS aged_VBN 5_CD 
37_CD We_PRP obtained_VBD annual_JJ population_NN estimates_NNS for_IN the_DT countries_NNS under_IN study_NN from_IN United_NNP States_NNPS Census_NNP Bureau_NNP 's_POS International_NNP Data_NNP Base_NNP 
023_CD 1_CD ._. 
238,074_CD 0_CD ._. 
43_CD 3_CD ._. 
23_CD 15_CD 8,858,471_CD 13_CD ._. 
004_CD 0_CD ._. 
66,346_CD 0_CD ._. 
72_CD 1_CD ._. 
03_CD 10_CD 5,905,647_CD 6_CD ._. 
000_CD 0_CD ._. 
8793_CD 0_CD ._. 
37We_NNP obtained_VBD annual_JJ population_NN estimates_NNS for_IN the_DT countries_NNS under_IN study_NN from_IN United_NNP States_NNPS Census_NNP Bureau_NNP 's_POS International_NNP Data_NNP Base_NNP 
Arecent_JJ systematic_JJ review_NN of_IN the_DT seven_CD conflict_NN affected_JJ countries_NNS found_VBD that_IN existing_VBG data_NNS do_VBP not_RB support_VB a_DT link_NN between_IN widespread_JJ rape_NN and_CC increased_VBD HIV_NNP prevalence_NN at_IN the_DT population_NN level_NN 
This_DT may_MD be_VB due_JJ to_TO reductions_NNS in_IN population_NN mobility_NN ,_, access_NN ,_, and_CC urbanisation_NN 
046_CD %_NN -RRB-_-RRB- ._. 
007_CD 
Humanitarian_JJ organizations_NNS ,_, including_VBG UN_NNP organizations_NNS ,_, as_RB well_RB as_IN the_DT media_NNS have_VBP sometimes_RB published_VBN inaccurate_JJ or_CC misleading_JJ HIV_NNP information_NN about_IN conflict-affected_JJ populations_NNS 
However_RB ,_, empirical_JJ research_NN suggests_VBZ that_IN HIV_NNP incidence_NN in_IN armed_JJ conflicts_NNS may_MD in_IN fact_NN diminish_VBP ,_, remain_VBP constant_JJ or_CC not_RB increase_VB to_TO the_DT same_JJ magnitude_NN compared_VBN with_IN those_DT countries_NNS not_RB in_IN conflict_NN ._. 
This_DT may_MD be_VB due_JJ to_TO reductions_NNS in_IN population_NN mobility_NN ,_, access_NN ,_, and_CC urbanisation_NN 
5million_CD people_NNS 
5million_CD people_NNS 
Armed_VBN conflicts_NNS have_VBP traditionally_RB been_VBN considered_VBN catalysts_NNS for_IN HIV_NNP transmission_NN due_JJ to_TO associated_JJ sexual_JJ violence_NN against_IN women_NNS ,_, lack_NN of_IN access_NN to_TO preventive_JJ and_CC curative_JJ heath_NN services_NNS ,_, and_CC increased_VBN vulnerability_NN and_CC risks_NNS incurred_VBN by_IN population_NN displacement_NN and_CC food_NN insecurity_NN 
Armed_VBN conflicts_NNS have_VBP traditionally_RB been_VBN considered_VBN catalysts_NNS for_IN HIV_NNP transmission_NN due_JJ to_TO associated_JJ sexual_JJ violence_NN against_IN women_NNS ,_, lack_NN of_IN access_NN to_TO preventive_JJ and_CC curative_JJ heath_NN services_NNS ,_, and_CC increased_VBN vulnerability_NN and_CC risks_NNS incurred_VBN by_IN population_NN displacement_NN and_CC food_NN insecurity_NN 
It_PRP also_RB helps_VBZ decision-makers_NNS prioritise_VB their_PRP$ funding_NN and_CC interventions_NNS ._. 
Even_RB if_IN programs_NNS in_IN the_DT field_NN do_VBP not_RB significantly_RB change_VB ,_, our_PRP$ understanding_NN of_IN what_WP the_DT outcomes_NNS of_IN such_JJ interventions_NNS can_MD achieve_VB will_MD be_VB more_RBR realistic_JJ ._. 
Sub-Saharan_NNP Africa_NNP -LRB-_-LRB- SSA_NNP -RRB-_-RRB- is_VBZ overwhelmingly_RB affected_VBN by_IN HIV\/AIDS_NNP 
It_PRP is_VBZ also_RB the_DT region_NN with_IN the_DT highest_JJS number_NN of_IN armed_JJ conflicts_NNS worldwide_NN ._. 
Sub-Saharan_NNP Africa_NNP -LRB-_-LRB- SSA_NNP -RRB-_-RRB- is_VBZ overwhelmingly_RB affected_VBN by_IN HIV\/AIDS_NNP 
In_IN 2005_CD ,_, armed_JJ conflicts_NNS were_VBD active_JJ in_IN 15_CD of_IN SSA_NNP 's_POS 47_CD countries_NNS 
The_DT use_NN of_IN sexual_JJ violence_NN as_IN a_DT weapon_NN of_IN war_NN has_VBZ been_VBN particularly_RB associated_VBN with_IN concerns_NNS about_IN heightened_JJ HIV_NNP incidence_NN among_IN women_NNS and_CC girls_NNS 
The_DT use_NN of_IN sexual_JJ violence_NN as_IN a_DT weapon_NN of_IN war_NN has_VBZ been_VBN particularly_RB associated_VBN with_IN concerns_NNS about_IN heightened_JJ HIV_NNP incidence_NN among_IN women_NNS and_CC girls_NNS 
Bibliographic_JJ databases_NNS in_IN German_NNP As_RB is_VBZ the_DT case_NN for_IN Italian_JJ and_CC French_JJ ,_, there_EX are_VBP also_RB various_JJ web-based_JJ bibliographic_JJ databases_NNS in_IN German_JJ speaking_NN countries_NNS that_WDT also_RB cover_VBP literature_NN relevant_JJ to_TO public_JJ health_NN and_CC epidemiology_NN ._. 
Aside_RB from_IN general_JJ catalogues_NNS offered_VBN by_IN national_JJ and_CC university_NN libraries_NNS in_IN Austria_NNP ,_, Switzerland_NNP ,_, and_CC Germany_NNP ,_, some_DT examples_NNS that_WDT focus_VBP on_IN medicine_NN ,_, social_JJ and_CC health_NN sciences_NNS in_IN particular_JJ include_VBP -LRB-_-LRB- topics_NNS covered_VBN are_VBP given_VBN in_IN brackets_NNS -RRB-_-RRB- :_: SOMED_VBN -LRB-_-LRB- social_JJ medicine_NN -RRB-_-RRB- ,_, Archido_NNP -LRB-_-LRB- publications_NNS and_CC information_NN related_VBN to_TO drugs_NNS and_CC addiction_NN -RRB-_-RRB- 
Bibliographic_JJ databases_NNS in_IN German_NNP As_RB is_VBZ the_DT case_NN for_IN Italian_JJ and_CC French_JJ ,_, there_EX are_VBP also_RB various_JJ web-based_JJ bibliographic_JJ databases_NNS in_IN German_JJ speaking_NN countries_NNS that_WDT also_RB cover_VBP literature_NN relevant_JJ to_TO public_JJ health_NN and_CC epidemiology_NN ._. 
Aside_RB from_IN general_JJ catalogues_NNS offered_VBN by_IN national_JJ and_CC university_NN libraries_NNS in_IN Austria_NNP ,_, Switzerland_NNP ,_, and_CC Germany_NNP ,_, some_DT examples_NNS that_WDT focus_VBP on_IN medicine_NN ,_, social_JJ and_CC health_NN sciences_NNS in_IN particular_JJ include_VBP -LRB-_-LRB- topics_NNS covered_VBN are_VBP given_VBN in_IN brackets_NNS -RRB-_-RRB- :_: SOMED_VBN -LRB-_-LRB- social_JJ medicine_NN -RRB-_-RRB- ,_, Archido_NNP -LRB-_-LRB- publications_NNS and_CC information_NN related_VBN to_TO drugs_NNS and_CC addiction_NN -RRB-_-RRB- 
in_IN the_DT field_NN of_IN eugenics_NNS -RRB-_-RRB- 
As_IN will_MD be_VB seen_VBN in_IN the_DT following_NN ,_, the_DT historical_JJ development_NN of_IN epidemiology_NN also_RB finds_VBZ expression_NN in_IN the_DT publication_NN behavior_NN of_IN epidemiologists_NNS and_CC the_DT current_JJ role_NN of_IN German-language_JJ epidemiology_NN and_CC public_JJ health_NN publications_NNS ._. 
Journals_NNPS in_IN epidemiology_NN and_CC public_JJ health_NN :_: GermanIn_NNP Germany_NNP ,_, epidemiology_NN is_VBZ considered_VBN to_TO be_VB one_CD of_IN the_DT constitutional_JJ or_CC core_JJ sciences_NNS of_IN public_JJ health_NN ._. 
Hence_RB ,_, the_DT findings_NNS of_IN non-clinical_JJ epidemiological_JJ studies_NNS are_VBP published_VBN in_IN public_JJ health_NN journals_NNS as_RB well_RB as_IN in_IN epidemiological_JJ journals_NNS ._. 
German-language_JJ medical_JJ and_CC medical_JJ research_NN journals_NNS started_VBD to_TO recover_VB earlier_RBR ,_, but_CC initially_RB followed_VBD a_DT ``_`` German_JJ ''_'' ,_, rather_RB than_IN international_JJ approach_NN :_: a_DT tendency_NN to_TO focus_VB on_IN experience_NN ,_, rather_RB than_IN evidence_NN ,_, persisted_VBD much_RB longer_RBR in_IN the_DT German_JJ literature_NN than_IN in_IN that_DT of_IN the_DT United_NNP Kingdom_NNP and_CC the_DT United_NNP States_NNPS ._. 
For_IN example_NN ,_, evidence_NN from_IN randomised_JJ ,_, controlled_JJ trials_NNS was_VBD introduced_VBN in_IN a_DT systematic_JJ way_NN only_RB much_RB later_RBR in_IN German-language_JJ journals_NNS ._. 
As_IN will_MD be_VB seen_VBN in_IN the_DT following_NN ,_, the_DT historical_JJ development_NN of_IN epidemiology_NN also_RB finds_VBZ expression_NN in_IN the_DT publication_NN behavior_NN of_IN epidemiologists_NNS and_CC the_DT current_JJ role_NN of_IN German-language_JJ epidemiology_NN and_CC public_JJ health_NN publications_NNS ._. 
Thus_RB ,_, German_JJ scientists_NNS used_VBN to_TO communicate_VB in_IN German_NNP in_IN the_DT past_NN ._. 
For_IN example_NN ,_, Robert_NNP Koch_NNP published_VBD almost_RB exclusively_RB in_IN German_NNP 
Nevertheless_RB ,_, as_IN Ofori-Adjei_NNP et_FW al._FW ._. 
the_DT paper_NN by_IN Vlassov_NNP and_CC Danishevskii_NNP in_IN this_DT thematic_JJ series_NN -RRB-_-RRB- ._. 
argue_VB ,_, local_JJ journals_NNS in_IN native_JJ languages_NNS are_VBP a_DT health_NN resource_NN and_CC are_VBP important_JJ for_IN the_DT contextualisation_NN of_IN evidence_NN on_IN which_WDT public_JJ health_NN practices_NNS are_VBP based_VBN 
g._NN After_IN World_NNP War_NNP II_NNP ,_, social_JJ medicine_NN was_VBD discredited_VBN in_IN Germany_NNP because_IN of_IN its_PRP$ misuse_NN by_IN the_DT Nazis_NNPS -LRB-_-LRB- e._NN in_IN the_DT field_NN of_IN eugenics_NNS -RRB-_-RRB- 
Bibliographic_JJ databases_NNS in_IN German_NNP As_RB is_VBZ the_DT case_NN for_IN Italian_JJ and_CC French_JJ ,_, there_EX are_VBP also_RB various_JJ web-based_JJ bibliographic_JJ databases_NNS in_IN German_JJ speaking_NN countries_NNS that_WDT also_RB cover_VBP literature_NN relevant_JJ to_TO public_JJ health_NN and_CC epidemiology_NN ._. 
Aside_RB from_IN general_JJ catalogues_NNS offered_VBN by_IN national_JJ and_CC university_NN libraries_NNS in_IN Austria_NNP ,_, Switzerland_NNP ,_, and_CC Germany_NNP ,_, some_DT examples_NNS that_WDT focus_VBP on_IN medicine_NN ,_, social_JJ and_CC health_NN sciences_NNS in_IN particular_JJ include_VBP -LRB-_-LRB- topics_NNS covered_VBN are_VBP given_VBN in_IN brackets_NNS -RRB-_-RRB- :_: SOMED_VBN -LRB-_-LRB- social_JJ medicine_NN -RRB-_-RRB- ,_, Archido_NNP -LRB-_-LRB- publications_NNS and_CC information_NN related_VBN to_TO drugs_NNS and_CC addiction_NN -RRB-_-RRB- 
Bibliographic_JJ databases_NNS in_IN German_NNP As_RB is_VBZ the_DT case_NN for_IN Italian_JJ and_CC French_JJ ,_, there_EX are_VBP also_RB various_JJ web-based_JJ bibliographic_JJ databases_NNS in_IN German_JJ speaking_NN countries_NNS that_WDT also_RB cover_VBP literature_NN relevant_JJ to_TO public_JJ health_NN and_CC epidemiology_NN ._. 
Aside_RB from_IN general_JJ catalogues_NNS offered_VBN by_IN national_JJ and_CC university_NN libraries_NNS in_IN Austria_NNP ,_, Switzerland_NNP ,_, and_CC Germany_NNP ,_, some_DT examples_NNS that_WDT focus_VBP on_IN medicine_NN ,_, social_JJ and_CC health_NN sciences_NNS in_IN particular_JJ include_VBP -LRB-_-LRB- topics_NNS covered_VBN are_VBP given_VBN in_IN brackets_NNS -RRB-_-RRB- :_: SOMED_VBN -LRB-_-LRB- social_JJ medicine_NN -RRB-_-RRB- 
This_DT could_MD be_VB due_JJ to_TO the_DT higher_JJR impact_NN factors_NNS of_IN English_JJ language_NN journals_NNS and_CC the_DT higher_JJR ``_`` international_JJ visibility_NN ''_'' of_IN English-language_JJ publications_NNS ._. 
This_DT phenomenon_NN can_MD be_VB evidenced_VBN in_IN the_DT so-called_JJ ``_`` Exzellenzinitiative_NNP ''_'' in_IN which_WDT German_JJ universities_NNS competed_VBD for_IN government_NN funding_NN 
Bibliographic_JJ databases_NNS in_IN German_NNP As_RB is_VBZ the_DT case_NN for_IN Italian_JJ and_CC French_JJ ,_, there_EX are_VBP also_RB various_JJ web-based_JJ bibliographic_JJ databases_NNS in_IN German_JJ speaking_NN countries_NNS that_WDT also_RB cover_VBP literature_NN relevant_JJ to_TO public_JJ health_NN and_CC epidemiology_NN ._. 
Aside_RB from_IN general_JJ catalogues_NNS offered_VBN by_IN national_JJ and_CC university_NN libraries_NNS in_IN Austria_NNP ,_, Switzerland_NNP ,_, and_CC Germany_NNP ,_, some_DT examples_NNS that_WDT focus_VBP on_IN medicine_NN ,_, social_JJ and_CC health_NN sciences_NNS in_IN particular_JJ include_VBP -LRB-_-LRB- topics_NNS covered_VBN are_VBP given_VBN in_IN brackets_NNS -RRB-_-RRB- :_: SOMED_VBN -LRB-_-LRB- social_JJ medicine_NN -RRB-_-RRB- ,_, Archido_NNP -LRB-_-LRB- publications_NNS and_CC information_NN related_VBN to_TO drugs_NNS and_CC addiction_NN -RRB-_-RRB- 
Other_JJ relevant_JJ databases_NNS include_VBP Base_NNP de_FW donn_FW 
Other_JJ relevant_JJ databases_NNS include_VBP Base_NNP de_FW donn_FW 
INIST_NNP combines_VBZ documents_NNS from_IN The_DT Institute_NNP for_IN Scientific_NNP and_CC Technical_NNP Information_NNP -LRB-_-LRB- INIST_NNP -RRB-_-RRB- 
INIST_NNP combines_VBZ documents_NNS from_IN The_DT Institute_NNP for_IN Scientific_NNP and_CC Technical_NNP Information_NNP -LRB-_-LRB- INIST_NNP -RRB-_-RRB- 
INIST_NNP combines_VBZ documents_NNS from_IN The_DT Institute_NNP for_IN Scientific_NNP and_CC Technical_NNP Information_NNP -LRB-_-LRB- INIST_NNP -RRB-_-RRB- 
CAT_NNP ._. 
This_DT database_NN contains_VBZ documents_NNS covering_VBG research_NN in_IN Sciences_NNP ,_, Technology_NNP ,_, Medicine_NNP ,_, Humanity_NNP and_CC Social_NNP Sciences_NNPS across_IN the_DT world_NN from_IN 1973_CD to_TO today_NN ._. 
INIST_NNP combines_VBZ documents_NNS from_IN The_DT Institute_NNP for_IN Scientific_NNP and_CC Technical_NNP Information_NNP -LRB-_-LRB- INIST_NNP -RRB-_-RRB- 
CAT_NNP ._. 
This_DT database_NN contains_VBZ documents_NNS covering_VBG research_NN in_IN Sciences_NNP ,_, Technology_NNP ,_, Medicine_NNP ,_, Humanity_NNP and_CC Social_NNP Sciences_NNPS across_IN the_DT world_NN from_IN 1973_CD to_TO today_NN ._. 
INIST_NNP combines_VBZ documents_NNS from_IN The_DT Institute_NNP for_IN Scientific_NNP and_CC Technical_NNP Information_NNP -LRB-_-LRB- INIST_NNP -RRB-_-RRB- 
CAT_NNP ._. 
This_DT database_NN contains_VBZ documents_NNS covering_VBG research_NN in_IN Sciences_NNP ,_, Technology_NNP ,_, Medicine_NNP ,_, Humanity_NNP and_CC Social_NNP Sciences_NNPS across_IN the_DT world_NN from_IN 1973_CD to_TO today_NN ._. 
INIST_NNP combines_VBZ documents_NNS from_IN The_DT Institute_NNP for_IN Scientific_NNP and_CC Technical_NNP Information_NNP -LRB-_-LRB- INIST_NNP -RRB-_-RRB- 
CAT_NNP ._. 
This_DT database_NN contains_VBZ documents_NNS covering_VBG research_NN in_IN Sciences_NNP ,_, Technology_NNP ,_, Medicine_NNP ,_, Humanity_NNP and_CC Social_NNP Sciences_NNPS across_IN the_DT world_NN from_IN 1973_CD to_TO today_NN ._. 
INIST_NNP combines_VBZ documents_NNS from_IN The_DT Institute_NNP for_IN Scientific_NNP and_CC Technical_NNP Information_NNP -LRB-_-LRB- INIST_NNP -RRB-_-RRB- 
Bibliographic_JJ databases_NNS in_IN French_NNP One_CD of_IN the_DT most_RBS extensive_JJ bibliographic_JJ databases_NNS in_IN French_NNP is_VBZ CAT_NNP ._. 
INIST_NNP ,_, which_WDT provides_VBZ access_NN to_TO 15_CD million_CD references_NNS ._. 
This_DT database_NN contains_VBZ documents_NNS covering_VBG research_NN in_IN Sciences_NNP ,_, Technology_NNP ,_, Medicine_NNP ,_, Humanity_NNP and_CC Social_NNP Sciences_NNPS across_IN the_DT world_NN from_IN 1973_CD to_TO today_NN ._. 
Spatial_JJ and_CC temporal_JJ differences_NNS of_IN these_DT developments_NNS across_IN Western_NNP Europe_NNP due_JJ to_TO different_JJ national_JJ contexts_NNS are_VBP observed_JJ ._. 
While_IN epidemiology_NN had_VBD made_VBN much_JJ progress_NN since_IN the_DT 19th_JJ century_NN in_IN countries_NNS such_JJ as_IN Great_JJ Britain_NNP 
Spatial_JJ and_CC temporal_JJ differences_NNS of_IN these_DT developments_NNS across_IN Western_NNP Europe_NNP due_JJ to_TO different_JJ national_JJ contexts_NNS are_VBP observed_JJ ._. 
While_IN epidemiology_NN had_VBD made_VBN much_JJ progress_NN since_IN the_DT 19th_JJ century_NN in_IN countries_NNS such_JJ as_IN Great_JJ Britain_NNP 
The_DT first_JJ journal_NN of_IN public_JJ health_NN in_IN any_DT language_NN was_VBD founded_VBN by_IN French_JJ physicians_NNS in_IN 1829_CD and_CC was_VBD published_VBN in_IN French_NNP ._. 
The_DT Annales_NNP d'hygi_NN 
The_DT Annales_NNP d'hygi_NN 
Fifty_CD years_NNS later_RB ,_, with_IN the_DT creation_NN of_IN the_DT first_JJ two_CD national_JJ public_JJ health_NN organizations_NNS in_IN 1877_CD ,_, three_CD new_JJ journals_NNS focusing_VBG on_IN public_JJ health_NN and_CC hygiene_NN were_VBD created_VBN ,_, namely_RB the_DT Journal_NNP d'hygi_NNS 
Spatial_JJ and_CC temporal_JJ differences_NNS of_IN these_DT developments_NNS across_IN Western_NNP Europe_NNP due_JJ to_TO different_JJ national_JJ contexts_NNS are_VBP observed_JJ ._. 
While_IN epidemiology_NN had_VBD made_VBN much_JJ progress_NN since_IN the_DT 19th_JJ century_NN in_IN countries_NNS such_JJ as_IN Great_JJ Britain_NNP 
Spatial_JJ and_CC temporal_JJ differences_NNS of_IN these_DT developments_NNS across_IN Western_NNP Europe_NNP due_JJ to_TO different_JJ national_JJ contexts_NNS are_VBP observed_JJ ._. 
While_IN epidemiology_NN had_VBD made_VBN much_JJ progress_NN since_IN the_DT 19th_JJ century_NN in_IN countries_NNS such_JJ as_IN Great_JJ Britain_NNP 
Moreover_RB ,_, basic_JJ epidemiological_JJ training_NN is_VBZ often_RB required_VBN to_TO write_VB and_CC defend_VB the_DT thesis_NN concluding_VBG health-related_JJ academic_JJ courses_NNS ._. 
It_PRP is_VBZ worth_JJ noting_VBG that_IN the_DT intensive_JJ summer_NN school_NN ``_`` European_NNP Educational_NNP Programme_NNP in_IN Epidemiology_NNP ''_'' -LRB-_-LRB- EEPE_NNP -RRB-_-RRB- 
This_DT paper_NN discusses_VBZ the_DT historical_JJ development_NN of_IN epidemiology_NN and_CC the_DT current_JJ scene_NN of_IN epidemiological_JJ and_CC public_JJ health_NN journals_NNS ,_, databases_NNS and_CC professional_JJ education_NN in_IN three_CD Western_JJ European_JJ languages_NNS :_: French_JJ ,_, German_JJ and_CC Italian_JJ ,_, and_CC examines_VBZ the_DT dynamics_NNS and_CC struggles_NNS they_PRP have_VBP today_NN ._. 
IntroductionEpidemiology_JJ and_CC public_JJ health_NN have_VBP followed_VBN multiple_JJ lines_NNS of_IN development_NN in_IN Western_NNP Europe_NNP in_IN the_DT past_JJ several_JJ centuries_NNS 
Academic_NNP journals_NNS of_IN non-English-speaking_JJ countries_NNS struggle_NN for_IN survival_NN and_CC are_VBP under_IN increasing_VBG pressure_NN to_TO switch_VB to_TO English_NNP 
Introduction_NNP Epidemiology_NNP and_CC public_JJ health_NN have_VBP followed_VBN multiple_JJ lines_NNS of_IN development_NN in_IN Western_NNP Europe_NNP in_IN the_DT past_JJ several_JJ centuries_NNS 
From_IN the_DT quarantine_NN of_IN ships_NNS introduced_VBN by_IN powerful_JJ Italian_JJ city-states_NNS to_TO the_DT improvement_NN in_IN water_NN supply_NN and_CC the_DT sewage_NN system_NN in_IN Victorian_JJ England_NNP ,_, many_JJ schools_NNS of_IN thought_NN from_IN diverse_JJ social_JJ and_CC national_JJ contexts_NNS contributed_VBD to_TO the_DT development_NN of_IN various_JJ public_JJ health_NN practices_NNS and_CC the_DT science_NN of_IN epidemiology_NN 
Fifty_CD years_NNS later_RB ,_, with_IN the_DT creation_NN of_IN the_DT first_JJ two_CD national_JJ public_JJ health_NN organizations_NNS in_IN 1877_CD ,_, three_CD new_JJ journals_NNS focusing_VBG on_IN public_JJ health_NN and_CC hygiene_NN were_VBD created_VBN ,_, namely_RB the_DT Journal_NNP d'hygi_NNS 
Even_RB though_IN health_NN has_VBZ been_VBN proclaimed_VBN as_IN a_DT right_NN for_IN every_DT citizen_NN in_IN a_DT modern_JJ democracy_NN after_IN the_DT French_JJ Revolution_NN -LRB-_-LRB- 1789_CD 
From_IN the_DT quarantine_NN of_IN ships_NNS introduced_VBN by_IN powerful_JJ Italian_JJ city-states_NNS to_TO the_DT improvement_NN in_IN water_NN supply_NN and_CC the_DT sewage_NN system_NN in_IN Victorian_JJ England_NNP ,_, many_JJ schools_NNS of_IN thought_NN from_IN diverse_JJ social_JJ and_CC national_JJ contexts_NNS contributed_VBD to_TO the_DT development_NN of_IN various_JJ public_JJ health_NN practices_NNS and_CC the_DT science_NN of_IN epidemiology_NN 
While_IN epidemiology_NN had_VBD made_VBN much_JJ progress_NN since_IN the_DT 19_CD th_JJ century_NN in_IN countries_NNS such_JJ as_IN Great_JJ Britain_NNP 
Since_IN the_DT end_NN of_IN the_DT Second_NNP World_NNP War_NNP ,_, English_NNP has_VBZ become_VBN the_DT international_JJ language_NN of_IN scientific_JJ communication_NN 
Swiss_NNP School_NNP of_IN Public_NNP Health_NNP plus_NN ,_, a_DT foundation_NN jointly_RB founded_VBN by_IN the_DT Universities_NNS of_IN Basel_NNP ,_, Bern_NNP ,_, Geneva_NNP ,_, Lausanne_NNP ,_, Lugano_NNP and_CC Zurich_NNP -RRB-_-RRB- as_RB well_RB as_IN in_IN francophone_NN Africa_NNP -LRB-_-LRB- cf._SYM 
Institut_NNP National_NNP de_NNP la_NNP Sant_NNP 
Swiss_NNP School_NNP of_IN Public_NNP Health_NNP plus_NN ,_, a_DT foundation_NN jointly_RB founded_VBN by_IN the_DT Universities_NNS of_IN Basel_NNP ,_, Bern_NNP ,_, Geneva_NNP ,_, Lausanne_NNP ,_, Lugano_NNP and_CC Zurich_NNP -RRB-_-RRB- as_RB well_RB as_IN in_IN francophone_NN Africa_NNP -LRB-_-LRB- cf._SYM 
In_IN Qu_NNP 
Basic_JJ epidemiology_NN and_CC public_JJ health_NN training_NN is_VBZ also_RB offered_VBN in_IN other_JJ universities_NNS such_JJ as_IN the_DT University_NNP of_IN Sherbrooke_NNP and_CC University_NNP of_IN Qu_NNP 
g._NN Through_IN universities_NNS and_CC specialist_NN institutes_NN ,_, postgraduate_NN epidemiology_NN and_CC public_JJ health_NN courses_NNS are_VBP also_RB offered_VBN in_IN French_NNP in_IN Belgium_NNP -LRB-_-LRB- e._NNP Prince_NNP Leopold_NNP Institute_NNP of_IN Tropical_NNP Medicine_NNP ,_, Antwerp_NNP -RRB-_-RRB- and_CC Switzerland_NNP -LRB-_-LRB- cf._NNP Swiss_NNP School_NNP of_IN Public_NNP Health_NNP plus_CC 
Prince_NNP Leopold_NNP Institute_NNP of_IN Tropical_NNP Medicine_NNP ,_, Antwerp_NNP -RRB-_-RRB- and_CC Switzerland_NNP -LRB-_-LRB- cf._JJ g._NN Through_IN universities_NNS and_CC specialist_NN institutes_NN ,_, postgraduate_NN epidemiology_NN and_CC public_JJ health_NN courses_NNS are_VBP also_RB offered_VBN in_IN French_NNP in_IN Belgium_NNP -LRB-_-LRB- e._NNP Swiss_NNP School_NNP of_IN Public_NNP Health_NNP plus_CC 
Professional_JJ education_NN in_IN epidemiology_NN and_CC public_JJ health_NN in_IN French_JJ Today_NN ,_, France_NNP offers_VBZ post-graduate_JJ training_NN through_IN the_DT 
Professional_JJ education_NN in_IN epidemiology_NN and_CC public_JJ health_NN in_IN French_JJ Today_NN ,_, France_NNP offers_VBZ post-graduate_JJ training_NN through_IN the_DT 
Professional_JJ education_NN in_IN epidemiology_NN and_CC public_JJ health_NN in_IN French_JJ Today_NN ,_, France_NNP offers_VBZ post-graduate_JJ training_NN through_IN the_DT 
In_IN Qu_NNP 
Bibliographic_JJ databases_NNS are_VBP gateways_NNS to_TO the_DT vast_JJ quantity_NN of_IN medical_JJ literature_NN ._. 
The_DT historical_JJ development_NN of_IN the_DT profession_NN of_IN epidemiology_NN and_CC public_JJ health_NN and_CC their_PRP$ respective_JJ journals_NNS ,_, databases_NNS and_CC professional_JJ education_NN in_IN these_DT linguistic_JJ communities_NNS followed_VBD different_JJ paths_NNS due_JJ to_TO differences_NNS in_IN historical_JJ ,_, social_JJ and_CC political_JJ circumstances_NNS ._. 
There_EX is_VBZ evidence_NN that_IN many_JJ non-English_JJ medical_JJ journals_NNS are_VBP not_RB indexed_VBN by_IN major_JJ English-based_JJ bibliographic_JJ databases_NNS like_IN PubMed_NNP and_CC Web_NNP of_IN Science_NNP ,_, and_CC that_IN alternative_JJ databases_NNS like_IN EMBASE_NNP provide_VBP more_RBR comprehensive_JJ coverage_NN of_IN non-English_JJ literature_NN -LRB-_-LRB- please_VB refer_VBP to_TO the_DT following_JJ papers_NNS ,_, all_DT available_JJ in_IN this_DT thematic_JJ series_NN :_: papers_NNS on_IN Chinese_JJ bibliographic_JJ databases_NNS 
Bibliographic_JJ databases_NNS are_VBP gateways_NNS to_TO the_DT vast_JJ quantity_NN of_IN medical_JJ literature_NN ._. 
The_DT historical_JJ development_NN of_IN the_DT profession_NN of_IN epidemiology_NN and_CC public_JJ health_NN and_CC their_PRP$ respective_JJ journals_NNS ,_, databases_NNS and_CC professional_JJ education_NN in_IN these_DT linguistic_JJ communities_NNS followed_VBD different_JJ paths_NNS due_JJ to_TO differences_NNS in_IN historical_JJ ,_, social_JJ and_CC political_JJ circumstances_NNS ._. 
There_EX is_VBZ evidence_NN that_IN many_JJ non-English_JJ medical_JJ journals_NNS are_VBP not_RB indexed_VBN by_IN major_JJ English-based_JJ bibliographic_JJ databases_NNS like_IN PubMed_NNP and_CC Web_NNP of_IN Science_NNP ,_, and_CC that_IN alternative_JJ databases_NNS like_IN EMBASE_NNP provide_VBP more_RBR comprehensive_JJ coverage_NN of_IN non-English_JJ literature_NN -LRB-_-LRB- please_VB refer_VBP to_TO the_DT following_JJ papers_NNS ,_, all_DT available_JJ in_IN this_DT thematic_JJ series_NN :_: papers_NNS on_IN Chinese_JJ bibliographic_JJ databases_NNS 
Databases_NNS and_CC online_JJ resources_NNS :_: Italian_JJ Although_IN no_DT comprehensive_JJ bibliographic_JJ database_NN is_VBZ available_JJ in_IN Italian_JJ ,_, many_JJ databases_NNS relevant_JJ to_TO epidemiology_NN and_CC public_JJ health_NN are_VBP accessible_JJ on_IN the_DT web_NN ._. 
Without_IN claiming_VBG any_DT completeness_NN ,_, the_DT following_JJ websites_NNS can_MD be_VB cited_VBN :_: a_DT registry_NN of_IN clinical_JJ -LRB-_-LRB- drug_NN -RRB-_-RRB- trials_NNS conducted_VBN in_IN Italy_NNP ;_: an_DT overview_NN of_IN epidemiological_JJ activities_NNS -LRB-_-LRB- studies_NNS ,_, meeting_NN ,_, resources_NNS -RRB-_-RRB- throughout_IN the_DT country_NN 
Databases_NNS and_CC online_JJ resources_NNS :_: Italian_JJ Although_IN no_DT comprehensive_JJ bibliographic_JJ database_NN is_VBZ available_JJ in_IN Italian_JJ ,_, many_JJ databases_NNS relevant_JJ to_TO epidemiology_NN and_CC public_JJ health_NN are_VBP accessible_JJ on_IN the_DT web_NN ._. 
Without_IN claiming_VBG any_DT completeness_NN ,_, the_DT following_JJ websites_NNS can_MD be_VB cited_VBN :_: a_DT registry_NN of_IN clinical_JJ -LRB-_-LRB- drug_NN -RRB-_-RRB- trials_NNS conducted_VBN in_IN Italy_NNP ;_: an_DT overview_NN of_IN epidemiological_JJ activities_NNS -LRB-_-LRB- studies_NNS ,_, meeting_NN ,_, resources_NNS -RRB-_-RRB- throughout_IN the_DT country_NN 
Sc_NN ._. 
Currently_RB ,_, four_CD additional_JJ M._NNP -RRB-_-RRB- in_IN Epidemiology_NNP ,_, was_VBD started_VBN in_IN 1997_CD by_IN the_DT Italian_NNP Association_NNP of_IN Epidemiology_NNP -LRB-_-LRB- AIE_NNP -RRB-_-RRB- ,_, is_VBZ now_RB run_VBN by_IN the_DT University_NNP of_IN Turin_NNP on_IN a_DT biennial_JJ basis_NN ,_, and_CC is_VBZ part_NN of_IN the_DT network_NN ``_`` European_NNP Master_NNP of_IN Science_NNP in_IN Epidemiology_NNP ''_'' -LRB-_-LRB- EU-MSE_NNP -RRB-_-RRB- 
Without_IN claiming_VBG any_DT completeness_NN ,_, the_DT following_JJ websites_NNS can_MD be_VB cited_VBN :_: a_DT registry_NN of_IN clinical_JJ -LRB-_-LRB- drug_NN -RRB-_-RRB- trials_NNS conducted_VBN in_IN Italy_NNP ;_: an_DT overview_NN of_IN epidemiological_JJ activities_NNS -LRB-_-LRB- studies_NNS ,_, meeting_NN ,_, resources_NNS -RRB-_-RRB- throughout_IN the_DT country_NN 
Databases_NNS and_CC online_JJ resources_NNS :_: Italian_JJ Although_IN no_DT comprehensive_JJ bibliographic_JJ database_NN is_VBZ available_JJ in_IN Italian_JJ ,_, many_JJ databases_NNS relevant_JJ to_TO epidemiology_NN and_CC public_JJ health_NN are_VBP accessible_JJ on_IN the_DT web_NN ._. 
Without_IN claiming_VBG any_DT completeness_NN ,_, the_DT following_JJ websites_NNS can_MD be_VB cited_VBN :_: a_DT registry_NN of_IN clinical_JJ -LRB-_-LRB- drug_NN -RRB-_-RRB- trials_NNS conducted_VBN in_IN Italy_NNP ;_: an_DT overview_NN of_IN epidemiological_JJ activities_NNS -LRB-_-LRB- studies_NNS ,_, meeting_NN ,_, resources_NNS -RRB-_-RRB- throughout_IN the_DT country_NN 
Sc_NN ._. 
The_DT first_JJ post-graduate_JJ course_NN in_IN Epidemiology_NNP ,_, a_DT Masters_NNP of_IN Science_NNP -LRB-_-LRB- M._NNP It_PRP is_VBZ worth_JJ noting_VBG that_IN the_DT intensive_JJ summer_NN school_NN ``_`` European_NNP Educational_NNP Programme_NNP in_IN Epidemiology_NNP ''_'' -LRB-_-LRB- EEPE_NNP -RRB-_-RRB- 
Sc_NN ._. 
Currently_RB ,_, four_CD additional_JJ M._NNP -RRB-_-RRB- in_IN Epidemiology_NNP ,_, was_VBD started_VBN in_IN 1997_CD by_IN the_DT Italian_NNP Association_NNP of_IN Epidemiology_NNP -LRB-_-LRB- AIE_NNP -RRB-_-RRB- ,_, is_VBZ now_RB run_VBN by_IN the_DT University_NNP of_IN Turin_NNP on_IN a_DT biennial_JJ basis_NN ,_, and_CC is_VBZ part_NN of_IN the_DT network_NN ``_`` European_NNP Master_NNP of_IN Science_NNP in_IN Epidemiology_NNP ''_'' -LRB-_-LRB- EU-MSE_NNP -RRB-_-RRB- 
Moreover_RB ,_, basic_JJ epidemiological_JJ training_NN is_VBZ often_RB required_VBN to_TO write_VB and_CC defend_VB the_DT thesis_NN concluding_VBG health-related_JJ academic_JJ courses_NNS ._. 
It_PRP is_VBZ worth_JJ noting_VBG that_IN the_DT intensive_JJ summer_NN school_NN ``_`` European_NNP Educational_NNP Programme_NNP in_IN Epidemiology_NNP ''_'' -LRB-_-LRB- EEPE_NNP -RRB-_-RRB- 
Bibliographic_JJ databases_NNS are_VBP gateways_NNS to_TO the_DT vast_JJ quantity_NN of_IN medical_JJ literature_NN ._. 
The_DT historical_JJ development_NN of_IN the_DT profession_NN of_IN epidemiology_NN and_CC public_JJ health_NN and_CC their_PRP$ respective_JJ journals_NNS ,_, databases_NNS and_CC professional_JJ education_NN in_IN these_DT linguistic_JJ communities_NNS followed_VBD different_JJ paths_NNS due_JJ to_TO differences_NNS in_IN historical_JJ ,_, social_JJ and_CC political_JJ circumstances_NNS ._. 
There_EX is_VBZ evidence_NN that_IN many_JJ non-English_JJ medical_JJ journals_NNS are_VBP not_RB indexed_VBN by_IN major_JJ English-based_JJ bibliographic_JJ databases_NNS like_IN PubMed_NNP and_CC Web_NNP of_IN Science_NNP ,_, and_CC that_IN alternative_JJ databases_NNS like_IN EMBASE_NNP provide_VBP more_RBR comprehensive_JJ coverage_NN of_IN non-English_JJ literature_NN -LRB-_-LRB- please_VB refer_VBP to_TO the_DT following_JJ papers_NNS ,_, all_DT available_JJ in_IN this_DT thematic_JJ series_NN :_: papers_NNS on_IN Chinese_JJ bibliographic_JJ databases_NNS 
Sc_NN ._. 
The_DT first_JJ post-graduate_JJ course_NN in_IN Epidemiology_NNP ,_, a_DT Masters_NNP of_IN Science_NNP -LRB-_-LRB- M._NNP It_PRP is_VBZ worth_JJ noting_VBG that_IN the_DT intensive_JJ summer_NN school_NN ``_`` European_NNP Educational_NNP Programme_NNP in_IN Epidemiology_NNP ''_'' -LRB-_-LRB- EEPE_NNP -RRB-_-RRB- 
Click_VB here_RB for_IN file_NN Acknowledgements_NNP ICHF_NNP thanks_NNS Mr._NNP Tze-Wan_NNP Kwan_NNP 's_POS article_NN on_IN the_DT `_`` overdominance_NN '_'' of_IN the_DT English_JJ language_NN ._. 
The_DT authors_NNS thank_VBP the_DT anonymous_JJ reviewers_NNS ,_, Ms._NNP Anita_NNP Ramesh_NNP ,_, and_CC Dr._NNP Gambhir_NNP Manoj_NNP for_IN their_PRP$ helpful_JJ comments_NNS on_IN this_DT paper_NN ._. 
As_IN a_DT legacy_NN of_IN the_DT French_JJ and_CC Belgian_JJ colonial_NN empires_NNS ,_, French_NNP is_VBZ an_DT official_JJ language_NN in_IN 30_CD countries_NNS 
Incidentally_RB ,_, this_DT phenomenon_NN of_IN two_CD tiers_NNS of_IN journals_NNS is_VBZ observed_VBN in_IN Russia_NNP as_RB well_RB -LRB-_-LRB- cf._NN -RRB-_-RRB- to_TO access_VB the_DT latest_JJS research_NN outputs_NNS ._. 
the_DT paper_NN by_IN Vlassov_NNP and_CC Danishevskii_NNP in_IN this_DT thematic_JJ series_NN -RRB-_-RRB- ._. 
Nevertheless_RB ,_, as_IN Ofori-Adjei_NNP et_FW al._FW ._. 
argue_VB ,_, local_JJ journals_NNS in_IN native_JJ languages_NNS are_VBP a_DT health_NN resource_NN and_CC are_VBP important_JJ for_IN the_DT contextualisation_NN of_IN evidence_NN on_IN which_WDT public_JJ health_NN practices_NNS are_VBP based_VBN 
The_DT larger_JJR the_DT size_NN and_CC the_DT more_RBR international_JJ the_DT potential_JJ readerships_NNS are_VBP ,_, the_DT more_RBR likely_JJ a_DT journal_NN is_VBZ to_TO survive_VB ._. 
As_IN a_DT legacy_NN of_IN the_DT French_JJ and_CC Belgian_JJ colonial_NN empires_NNS ,_, French_NNP is_VBZ an_DT official_JJ language_NN in_IN 30_CD countries_NNS 
The_DT larger_JJR the_DT size_NN and_CC the_DT more_RBR international_JJ the_DT potential_JJ readerships_NNS are_VBP ,_, the_DT more_RBR likely_JJ a_DT journal_NN is_VBZ to_TO survive_VB ._. 
As_IN a_DT legacy_NN of_IN the_DT French_JJ and_CC Belgian_JJ colonial_NN empires_NNS ,_, French_NNP is_VBZ an_DT official_JJ language_NN in_IN 30_CD countries_NNS 
However_RB ,_, it_PRP would_MD be_VB biased_VBN to_TO ignore_VB the_DT fact_NN that_IN a_DT globalising_VBG world_NN ,_, not_RB least_JJS the_DT scientific_JJ community_NN at_IN large_JJ ,_, demands_VBZ a_DT global_JJ language_NN so_RB as_IN to_TO break_VB down_RP linguistic_JJ barriers_NNS and_CC foster_JJ international_JJ communication_NN in_IN a_DT more_RBR effective_JJ and_CC efficient_JJ way_NN ._. 
As_IN a_DT legacy_NN of_IN the_DT British_NNP Empire_NNP and_CC the_DT current_JJ status_NN of_IN the_DT USA_NNP as_IN the_DT leading_VBG superpower_NN ,_, English_NNP has_VBZ overtaken_VBN French_JJ and_CC German_JJ as_IN the_DT global_JJ language_NN 
As_IN a_DT legacy_NN of_IN the_DT British_NNP Empire_NNP and_CC the_DT current_JJ status_NN of_IN the_DT USA_NNP as_IN the_DT leading_VBG superpower_NN ,_, English_NNP has_VBZ overtaken_VBN French_JJ and_CC German_JJ as_IN the_DT global_JJ language_NN 
The_DT first_JJ recorded_JJ specialised_JJ journal_NN on_IN public_JJ health_NN ,_, Public_NNP Health_NNP Journal_NNP ,_, began_VBD in_IN 1910_CD and_CC was_VBD published_VBN in_IN both_DT languages_NNS ._. 
Between_IN 1880_CD and_CC 1910_CD ,_, a_DT group_NN of_IN Qu_NNP 
In_IN addition_NN ,_, constant_JJ tensions_NNS between_IN French_JJ and_CC English-speaking_JJ Canadians_NNPS within_IN medical_JJ and_CC public_JJ health_NN communities_NNS also_RB enabled_VBD Qu_NNP 
The_DT creation_NN of_IN the_DT first_JJ French-speaking_JJ hygiene_NN school_NN -LRB-_-LRB- University_NNP of_IN Montr_NNP 
In_IN 1888_CD ,_, the_DT ``_`` Institut_NNP Pasteur_NNP ''_'' opened_VBD its_PRP$ doors_NNS in_IN Paris_NNP ._. 
He_PRP also_RB created_VBD the_DT first_JJ vaccine_NN against_IN rabies_NNS ,_, and_CC on_IN the_DT whole_JJ his_PRP$ work_NN served_VBD to_TO improve_VB epidemiology_NN and_CC public_JJ health_NN ._. 
Background_NN :_: Qu_NN 
g._NN After_IN the_DT establishment_NN of_IN the_DT Confederation_NNP ,_, England_NNP continued_VBD to_TO have_VB a_DT strong_JJ influence_NN on_IN Canada_NNP 's_POS decisions_NNS 
It_PRP is_VBZ well_RB known_VBN that_IN Canada_NNP is_VBZ divided_VBN linguistically_RB into_IN two_CD communities_NNS with_IN two_CD official_JJ languages_NNS :_: English_NNP and_CC French_NNP ._. 
The_DT first_JJ recorded_JJ specialised_JJ journal_NN on_IN public_JJ health_NN ,_, Public_NNP Health_NNP Journal_NNP ,_, began_VBD in_IN 1910_CD and_CC was_VBD published_VBN in_IN both_DT languages_NNS ._. 
Between_IN 1880_CD and_CC 1910_CD ,_, a_DT group_NN of_IN Qu_NNP 
The_DT particular_JJ linguistic_JJ profile_NN of_IN Canada_NNP probably_RB encouraged_VBD and_CC influenced_VBD Qu_NNP 
As_IN a_DT chemist_NN ,_, Pasteur_NNP discovered_VBD that_IN organisms_NNS such_JJ as_IN bacteria_NNS were_VBD responsible_JJ of_IN the_DT change_NN of_IN taste_NN in_IN beer_NN and_CC wine_NN as_RB well_RB as_IN milk_NN ._. 
He_PRP demonstrated_VBD that_IN bacteria_NNS could_MD be_VB removed_VBN by_IN heating_VBG the_DT liquid_NN -LRB-_-LRB- pasteurisation_NN -RRB-_-RRB- of_IN each_DT beverage_NN ._. 
He_PRP also_RB created_VBD the_DT first_JJ vaccine_NN against_IN rabies_NNS ,_, and_CC on_IN the_DT whole_JJ his_PRP$ work_NN served_VBD to_TO improve_VB epidemiology_NN and_CC public_JJ health_NN ._. 
He_PRP also_RB created_VBD the_DT first_JJ vaccine_NN against_IN rabies_NNS ,_, and_CC on_IN the_DT whole_JJ his_PRP$ work_NN served_VBD to_TO improve_VB epidemiology_NN and_CC public_JJ health_NN ._. 
In_IN 1888_CD ,_, the_DT ``_`` Institut_NNP Pasteur_NNP ''_'' opened_VBD its_PRP$ doors_NNS in_IN Paris_NNP ._. 
Background_NN :_: Qu_NN 
Other_JJ relevant_JJ databases_NNS include_VBP Base_NNP de_FW donn_FW 
In_IN this_DT article_NN ,_, French_NNP ,_, German_NNP and_CC Italian_NNP have_VBP been_VBN chosen_VBN as_IN representatives_NNS of_IN non-English_JJ Western_JJ European_JJ languages_NNS ._. 
-LRB-_-LRB- For_IN Portuguese_JJ and_CC Spanish_JJ scenarios_NNS ,_, please_VB refer_VBP to_TO articles_NNS by_IN Barreto_NNP and_CC Barata_NNP 
Bibliographic_JJ databases_NNS are_VBP gateways_NNS to_TO the_DT vast_JJ quantity_NN of_IN medical_JJ literature_NN ._. 
The_DT historical_JJ development_NN of_IN the_DT profession_NN of_IN epidemiology_NN and_CC public_JJ health_NN and_CC their_PRP$ respective_JJ journals_NNS ,_, databases_NNS and_CC professional_JJ education_NN in_IN these_DT linguistic_JJ communities_NNS followed_VBD different_JJ paths_NNS due_JJ to_TO differences_NNS in_IN historical_JJ ,_, social_JJ and_CC political_JJ circumstances_NNS ._. 
There_EX is_VBZ evidence_NN that_IN many_JJ non-English_JJ medical_JJ journals_NNS are_VBP not_RB indexed_VBN by_IN major_JJ English-based_JJ bibliographic_JJ databases_NNS like_IN PubMed_NNP and_CC Web_NNP of_IN Science_NNP ,_, and_CC that_IN alternative_JJ databases_NNS like_IN EMBASE_NNP provide_VBP more_RBR comprehensive_JJ coverage_NN of_IN non-English_JJ literature_NN -LRB-_-LRB- please_VB refer_VBP to_TO the_DT following_JJ papers_NNS ,_, all_DT available_JJ in_IN this_DT thematic_JJ series_NN :_: papers_NNS on_IN Chinese_JJ bibliographic_JJ databases_NNS 
-LRB-_-LRB- For_IN Portuguese_JJ and_CC Spanish_JJ scenarios_NNS ,_, please_VB refer_VBP to_TO articles_NNS by_IN Barreto_NNP and_CC Barata_NNP 
Bibliographic_JJ databases_NNS are_VBP gateways_NNS to_TO the_DT vast_JJ quantity_NN of_IN medical_JJ literature_NN ._. 
The_DT historical_JJ development_NN of_IN the_DT profession_NN of_IN epidemiology_NN and_CC public_JJ health_NN and_CC their_PRP$ respective_JJ journals_NNS ,_, databases_NNS and_CC professional_JJ education_NN in_IN these_DT linguistic_JJ communities_NNS followed_VBD different_JJ paths_NNS due_JJ to_TO differences_NNS in_IN historical_JJ ,_, social_JJ and_CC political_JJ circumstances_NNS ._. 
There_EX is_VBZ evidence_NN that_IN many_JJ non-English_JJ medical_JJ journals_NNS are_VBP not_RB indexed_VBN by_IN major_JJ English-based_JJ bibliographic_JJ databases_NNS like_IN PubMed_NNP and_CC Web_NNP of_IN Science_NNP ,_, and_CC that_IN alternative_JJ databases_NNS like_IN EMBASE_NNP provide_VBP more_RBR comprehensive_JJ coverage_NN of_IN non-English_JJ literature_NN -LRB-_-LRB- please_VB refer_VBP to_TO the_DT following_JJ papers_NNS ,_, all_DT available_JJ in_IN this_DT thematic_JJ series_NN :_: papers_NNS on_IN Chinese_JJ bibliographic_JJ databases_NNS 
France_NNP obviously_RB has_VBZ more_JJR publications_NNS than_IN either_DT Canada_NNP or_CC Africa_NNP ,_, but_CC unlike_IN Canada_NNP ,_, journals_NNS published_VBN in_IN France_NNP are_VBP unilingual_JJ -LRB-_-LRB- except_IN for_IN the_DT Revue_NNP d'_NN 
One_CD of_IN the_DT consequences_NNS of_IN the_DT current_JJ situation_NN is_VBZ the_DT transformation_NN of_IN French_JJ journals_NNS into_IN bilingual_JJ publications_NNS ._. 
This_DT is_VBZ the_DT case_NN for_IN the_DT journal_NN Ruptures_NNS ,_, previously_RB published_VBN by_IN the_DT Department_NNP of_IN Public_NNP Health_NNP of_IN the_DT University_NNP of_IN Montr_NNP 
Additionally_RB ,_, some_DT services_NNS offer_VBP meta-search_JJ in_IN different_JJ databases_NNS ._. 
Aside_RB from_IN general_JJ catalogues_NNS offered_VBN by_IN national_JJ and_CC university_NN libraries_NNS in_IN Austria_NNP ,_, Switzerland_NNP ,_, and_CC Germany_NNP ,_, some_DT examples_NNS that_WDT focus_VBP on_IN medicine_NN ,_, social_JJ and_CC health_NN sciences_NNS in_IN particular_JJ include_VBP -LRB-_-LRB- topics_NNS covered_VBN are_VBP given_VBN in_IN brackets_NNS -RRB-_-RRB- :_: SOMED_VBN -LRB-_-LRB- social_JJ medicine_NN -RRB-_-RRB- ,_, Archido_NNP -LRB-_-LRB- publications_NNS and_CC information_NN related_VBN to_TO drugs_NNS and_CC addiction_NN -RRB-_-RRB- 
Additionally_RB ,_, some_DT services_NNS offer_VBP meta-search_JJ in_IN different_JJ databases_NNS ._. 
Aside_RB from_IN general_JJ catalogues_NNS offered_VBN by_IN national_JJ and_CC university_NN libraries_NNS in_IN Austria_NNP ,_, Switzerland_NNP ,_, and_CC Germany_NNP ,_, some_DT examples_NNS that_WDT focus_VBP on_IN medicine_NN ,_, social_JJ and_CC health_NN sciences_NNS in_IN particular_JJ include_VBP -LRB-_-LRB- topics_NNS covered_VBN are_VBP given_VBN in_IN brackets_NNS -RRB-_-RRB- :_: SOMED_VBN -LRB-_-LRB- social_JJ medicine_NN -RRB-_-RRB- ,_, Archido_NNP -LRB-_-LRB- publications_NNS and_CC information_NN related_VBN to_TO drugs_NNS and_CC addiction_NN -RRB-_-RRB- 
Bibliographic_JJ databases_NNS in_IN German_NNP As_RB is_VBZ the_DT case_NN for_IN Italian_JJ and_CC French_JJ ,_, there_EX are_VBP also_RB various_JJ web-based_JJ bibliographic_JJ databases_NNS in_IN German_JJ speaking_NN countries_NNS that_WDT also_RB cover_VBP literature_NN relevant_JJ to_TO public_JJ health_NN and_CC epidemiology_NN ._. 
Aside_RB from_IN general_JJ catalogues_NNS offered_VBN by_IN national_JJ and_CC university_NN libraries_NNS in_IN Austria_NNP ,_, Switzerland_NNP ,_, and_CC Germany_NNP ,_, some_DT examples_NNS that_WDT focus_VBP on_IN medicine_NN ,_, social_JJ and_CC health_NN sciences_NNS in_IN particular_JJ include_VBP -LRB-_-LRB- topics_NNS covered_VBN are_VBP given_VBN in_IN brackets_NNS -RRB-_-RRB- :_: SOMED_VBN -LRB-_-LRB- social_JJ medicine_NN -RRB-_-RRB- ,_, Archido_NNP -LRB-_-LRB- publications_NNS and_CC information_NN related_VBN to_TO drugs_NNS and_CC addiction_NN -RRB-_-RRB- 
Bibliographic_JJ databases_NNS in_IN German_NNP As_RB is_VBZ the_DT case_NN for_IN Italian_JJ and_CC French_JJ ,_, there_EX are_VBP also_RB various_JJ web-based_JJ bibliographic_JJ databases_NNS in_IN German_JJ speaking_NN countries_NNS that_WDT also_RB cover_VBP literature_NN relevant_JJ to_TO public_JJ health_NN and_CC epidemiology_NN ._. 
Aside_RB from_IN general_JJ catalogues_NNS offered_VBN by_IN national_JJ and_CC university_NN libraries_NNS in_IN Austria_NNP ,_, Switzerland_NNP ,_, and_CC Germany_NNP ,_, some_DT examples_NNS that_WDT focus_VBP on_IN medicine_NN ,_, social_JJ and_CC health_NN sciences_NNS in_IN particular_JJ include_VBP -LRB-_-LRB- topics_NNS covered_VBN are_VBP given_VBN in_IN brackets_NNS -RRB-_-RRB- :_: SOMED_VBN -LRB-_-LRB- social_JJ medicine_NN -RRB-_-RRB- ,_, Archido_NNP -LRB-_-LRB- publications_NNS and_CC information_NN related_VBN to_TO drugs_NNS and_CC addiction_NN -RRB-_-RRB- 
Scenario_NN 3_CD :_: Italian_NNP Background_NNP :_: Italy_NNP In_IN Italy_NNP ,_, before_IN the_DT unification_NN in_IN 1861_CD ,_, epidemiology_NN developed_VBD within_IN the_DT context_NN of_IN public_JJ health_NN 
Public_JJ health_NN courses_NNS have_VBP been_VBN available_JJ in_IN Switzerland_NNP since_IN 1990_CD 
Later_RB ,_, further_JJ education_NN in_IN public_JJ health_NN was_VBD financed_VBN through_IN scholarships_NNS via_IN a_DT national_JJ fund_NN ._. 
In_IN the_DT 1950s_NNS and_CC 1960s_NNS ,_, some_DT Swiss_JJ physicians_NNS took_VBD epidemiology_NN and_CC public_JJ health_NN courses_NNS in_IN the_DT United_NNP States_NNPS and_CC the_DT United_NNP Kingdom_NNP ,_, mostly_RB at_IN their_PRP$ own_JJ expense_NN ._. 
Public_JJ health_NN courses_NNS have_VBP been_VBN available_JJ in_IN Switzerland_NNP since_IN 1990_CD 
Before_IN the_DT establishment_NN of_IN public_JJ health_NN courses_NNS in_IN recent_JJ years_NNS ,_, public_JJ health_NN education_NN took_VBD place_NN abroad_RB and_CC was_VBD supported_VBN by_IN scholarship_NN programs_NNS ._. 
The_DT oldest_JJS German-language_JJ School_NN of_IN Public_NNP Health_NNP is_VBZ located_VBN in_IN Austria_NNP and_CC was_VBD founded_VBN in_IN 1986_CD ._. 
In_IN Switzerland_NNP ,_, however_RB ,_, the_DT development_NN of_IN public_JJ health_NN started_VBD a_DT bit_NN earlier_RBR ._. 
In_IN the_DT 1950s_NNS and_CC 1960s_NNS ,_, some_DT Swiss_JJ physicians_NNS took_VBD epidemiology_NN and_CC public_JJ health_NN courses_NNS in_IN the_DT United_NNP States_NNPS and_CC the_DT United_NNP Kingdom_NNP ,_, mostly_RB at_IN their_PRP$ own_JJ expense_NN ._. 
Scenario_NN 3_CD :_: Italian_NNP Background_NNP :_: Italy_NNP In_IN Italy_NNP ,_, before_IN the_DT unification_NN in_IN 1861_CD ,_, epidemiology_NN developed_VBD within_IN the_DT context_NN of_IN public_JJ health_NN 
In_IN particular_JJ ,_, based_VBN on_IN either_CC the_DT miasmatic_NN or_CC the_DT epidemiological-materialistic_JJ paradigm_NN of_IN epidemics_NNS ,_, scientists_NNS developed_VBD theories_NNS to_TO interpret_VB the_DT cholera_NN outbreaks_NNS periodically_RB striking_VBG the_DT Italian_JJ peninsula_NN 
Within_IN this_DT context_NN descriptive_JJ and_CC analytical_JJ epidemiological_JJ methods_NNS were_VBD adopted_VBN to_TO assess_VB the_DT local_JJ burden_NN of_IN malaria_NN ,_, to_TO design_VB and_CC test_VB the_DT efficacy_NN and_CC impact_NN of_IN both_DT preventive_JJ and_CC curative_JJ measures_NNS ,_, and_CC finally_RB to_TO evaluate_VB the_DT results_NNS of_IN extensive_JJ campaigns_NNS against_IN malaria_NN in_IN rural_JJ settings_NNS ._. 
Eventually_RB ,_, Italy_NNP was_VBD declared_VBN malaria-free_JJ in_IN 1962_CD ._. 
After_IN the_DT Second_NNP World_NNP War_NNP ,_, the_DT focus_NN progressively_RB shifted_VBD towards_IN non-communicable_JJ diseases_NNS ;_: in_IN particular_JJ ,_, major_JJ efforts_NNS were_VBD devoted_VBN to_TO occupational_JJ ,_, environmental_JJ and_CC cancer_NN epidemiology_NN ._. 
The_DT contribution_NN of_IN Italian_JJ epidemiology_NN at_IN an_DT international_JJ level_NN has_VBZ become_VBN increasingly_RB relevant_JJ ._. 
As_IN an_DT example_NN we_PRP would_MD like_VB to_TO recall_VB the_DT key_JJ role_NN played_VBN by_IN Lorenzo_NNP Tomatis_NNP -LRB-_-LRB- 1929_CD 
During_IN the_DT last_JJ few_JJ decades_NNS ,_, epidemiology_NN has_VBZ become_VBN increasingly_RB relevant_JJ in_IN Italy_NNP as_IN a_DT driving_VBG force_NN of_IN the_DT National_NNP Health_NNP Service_NNP ._. 
Epidemiological_JJ resources_NNS and_CC activities_NNS are_VBP currently_RB present_JJ both_DT at_IN the_DT central_JJ level_NN ,_, in_IN particular_JJ within_IN the_DT National_NNP Health_NNP Institute_NNP -LRB-_-LRB- Istituto_NNP Superiore_NNP di_NNP Sanit_NNP 
Epidemiological_JJ resources_NNS and_CC activities_NNS are_VBP currently_RB present_JJ both_DT at_IN the_DT central_JJ level_NN ,_, in_IN particular_JJ within_IN the_DT National_NNP Health_NNP Institute_NNP -LRB-_-LRB- Istituto_NNP Superiore_NNP di_NNP Sanit_NNP 
Local_NNP Health_NNP Unit_NNP 
Databases_NNS and_CC online_JJ resources_NNS :_: Italian_JJ Although_IN no_DT comprehensive_JJ bibliographic_JJ database_NN is_VBZ available_JJ in_IN Italian_JJ ,_, many_JJ databases_NNS relevant_JJ to_TO epidemiology_NN and_CC public_JJ health_NN are_VBP accessible_JJ on_IN the_DT web_NN ._. 
Without_IN claiming_VBG any_DT completeness_NN ,_, the_DT following_JJ websites_NNS can_MD be_VB cited_VBN :_: a_DT registry_NN of_IN clinical_JJ -LRB-_-LRB- drug_NN -RRB-_-RRB- trials_NNS conducted_VBN in_IN Italy_NNP ;_: an_DT overview_NN of_IN epidemiological_JJ activities_NNS -LRB-_-LRB- studies_NNS ,_, meeting_NN ,_, resources_NNS -RRB-_-RRB- throughout_IN the_DT country_NN 
Local_NNP Health_NNP Unit_NNP 
Atypical_JJ example_NN is_VBZ given_VBN by_IN the_DT 21_CD population-based_JJ cancer_NN registries_NNS active_JJ mainly_RB in_IN Northern_NNP and_CC Central_NNP Italy_NNP 
Atypical_JJ example_NN is_VBZ given_VBN by_IN the_DT 21_CD population-based_JJ cancer_NN registries_NNS active_JJ mainly_RB in_IN Northern_NNP and_CC Central_NNP Italy_NNP 
Databases_NNS and_CC online_JJ resources_NNS :_: Italian_JJ Although_IN no_DT comprehensive_JJ bibliographic_JJ database_NN is_VBZ available_JJ in_IN Italian_JJ ,_, many_JJ databases_NNS relevant_JJ to_TO epidemiology_NN and_CC public_JJ health_NN are_VBP accessible_JJ on_IN the_DT web_NN ._. 
Without_IN claiming_VBG any_DT completeness_NN ,_, the_DT following_JJ websites_NNS can_MD be_VB cited_VBN :_: a_DT registry_NN of_IN clinical_JJ -LRB-_-LRB- drug_NN -RRB-_-RRB- trials_NNS conducted_VBN in_IN Italy_NNP 
Scenario_NN 2_CD :_: German_JJ Background_NN :_: Germany_NNP Today_NNP ,_, German_JJ epidemiologists_NNS tend_VBP to_TO publish_VB major_JJ results_NNS and_CC methodological_JJ aspects_NNS of_IN their_PRP$ studies_NNS in_IN English_JJ language_NN journals_NNS -LRB-_-LRB- European_JJ or_CC American_JJ -RRB-_-RRB- ,_, followed_VBN by_IN papers_NNS on_IN selective_JJ aspects_NNS of_IN the_DT study_NN or_CC overviews_NNS in_IN German_JJ in_IN German_JJ journals_NNS ._. 
For_IN example_NN ,_, a_DT team_NN who_WP conducted_VBD a_DT retrospective_JJ cohort_NN study_NN of_IN ethnic_JJ German_JJ migrants_NNS in_IN Germany_NNP published_VBD innovative_JJ aspects_NNS of_IN the_DT methodology_NN and_CC major_JJ findings_NNS in_IN English_NNP in_IN the_DT European_NNP Journal_NNP of_IN Epidemiology_NNP 
Scenario_NN 2_CD :_: German_JJ Background_NN :_: Germany_NNP Today_NNP ,_, German_JJ epidemiologists_NNS tend_VBP to_TO publish_VB major_JJ results_NNS and_CC methodological_JJ aspects_NNS of_IN their_PRP$ studies_NNS in_IN English_JJ language_NN journals_NNS -LRB-_-LRB- European_JJ or_CC American_JJ -RRB-_-RRB- ,_, followed_VBN by_IN papers_NNS on_IN selective_JJ aspects_NNS of_IN the_DT study_NN or_CC overviews_NNS in_IN German_JJ in_IN German_JJ journals_NNS ._. 
For_IN example_NN ,_, a_DT team_NN who_WP conducted_VBD a_DT retrospective_JJ cohort_NN study_NN of_IN ethnic_JJ German_JJ migrants_NNS in_IN Germany_NNP published_VBD innovative_JJ aspects_NNS of_IN the_DT methodology_NN and_CC major_JJ findings_NNS in_IN English_NNP in_IN the_DT European_NNP Journal_NNP of_IN Epidemiology_NNP 
For_IN example_NN ,_, a_DT team_NN who_WP conducted_VBD a_DT retrospective_JJ cohort_NN study_NN of_IN ethnic_JJ German_JJ migrants_NNS in_IN Germany_NNP published_VBD innovative_JJ aspects_NNS of_IN the_DT methodology_NN and_CC major_JJ findings_NNS in_IN English_NNP in_IN the_DT European_NNP Journal_NNP of_IN Epidemiology_NNP 
Scenario_NN 2_CD :_: German_JJ Background_NN :_: Germany_NNP Today_NNP ,_, German_JJ epidemiologists_NNS tend_VBP to_TO publish_VB major_JJ results_NNS and_CC methodological_JJ aspects_NNS of_IN their_PRP$ studies_NNS in_IN English_JJ language_NN journals_NNS -LRB-_-LRB- European_JJ or_CC American_JJ -RRB-_-RRB- ,_, followed_VBN by_IN papers_NNS on_IN selective_JJ aspects_NNS of_IN the_DT study_NN or_CC overviews_NNS in_IN German_JJ in_IN German_JJ journals_NNS ._. 
For_IN example_NN ,_, a_DT team_NN who_WP conducted_VBD a_DT retrospective_JJ cohort_NN study_NN of_IN ethnic_JJ German_JJ migrants_NNS in_IN Germany_NNP published_VBD innovative_JJ aspects_NNS of_IN the_DT methodology_NN and_CC major_JJ findings_NNS in_IN English_NNP in_IN the_DT European_NNP Journal_NNP of_IN Epidemiology_NNP 
g._NN 
g._NN 
Employment_NNP opportunities_NNS for_IN French_JJ researchers_NNS and_CC practitioners_NNS are_VBP flourishing_VBG within_IN health_NN care_NN ,_, administration_NN ,_, and_CC academia_NN due_JJ to_TO the_DT increase_NN of_IN chronic_JJ and_CC infectious_JJ diseases_NNS ._. 
It_PRP is_VBZ possible_JJ that_IN partnerships_NNS between_IN French-speaking_JJ countries_NNS and_CC Qu_NN 
g._NN 
This_DT also_RB applied_VBN to_TO social_JJ medicine_NN -LRB-_-LRB- the_DT precursor_NN of_IN epidemiology_NN and_CC public_JJ health_NN -RRB-_-RRB- 
German_NNP used_VBD to_TO be_VB a_DT major_JJ language_NN of_IN science_NN in_IN the_DT 19th_JJ and_CC early_JJ 20th_JJ century_NN ._. 
What_WP is_VBZ the_DT history_NN behind_IN this_DT situation_NN ._. 
This_DT also_RB applied_VBN to_TO social_JJ medicine_NN -LRB-_-LRB- the_DT precursor_NN of_IN epidemiology_NN and_CC public_JJ health_NN -RRB-_-RRB- 
However_RB ,_, after_IN World_NNP War_NNP I_NNP and_CC II_NNP ,_, the_DT German_JJ language_NN lost_VBD some_DT of_IN its_PRP$ dominance_NN in_IN many_JJ core_JJ areas_NNS of_IN science_NN ._. 
The_DT reason_NN for_IN this_DT was_VBD ,_, among_IN other_JJ things_NNS ,_, anti-German_JJ sentiment_NN related_VBN to_TO the_DT atrocities_NNS committed_VBN during_IN the_DT Nazi_NNP regime_NN ,_, as_RB well_RB as_IN the_DT economic_JJ and_CC cultural_JJ influence_NN of_IN the_DT United_NNP States_NNPS combined_VBN with_IN the_DT prestige_NN associated_VBN with_IN the_DT English_JJ language_NN ._. 
After_IN World_NNP War_NNP II_NNP ,_, social_JJ medicine_NN was_VBD discredited_VBN in_IN Germany_NNP because_IN of_IN its_PRP$ misuse_NN by_IN the_DT Nazis_NNPS -LRB-_-LRB- e._SYM 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS ._. 
Table_NNP 1Randomised_NNP controlled_VBD trials_NNS of_IN HIV_NNP prevention_NN 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
One_CD plausible_JJ reason_NN for_IN the_DT strong_JJ ,_, consistent_JJ impact_NN of_IN male_JJ circumcision_NN on_IN HIV_NNP acquisition_NN is_VBZ the_DT in-built_JJ 100_CD %_NN `_`` adherence_NN '_'' of_IN foreskin_NN removal_NN ._. 
Other_JJ biomedical_JJ interventions_NNS ,_, such_JJ as_IN treatment_NN of_IN bacterial_JJ STDs_NNS ,_, also_RB have_VBP the_DT potential_NN for_IN substantial_JJ efficacy_NN based_VBN on_IN observational_JJ studies_NNS but_CC only_RB one_CD of_IN these_DT RCTs_NNS afforded_VBD significant_JJ protection_NN against_IN HIV_NNP acquisition_NN 
Other_JJ biomedical_JJ interventions_NNS ,_, such_JJ as_IN treatment_NN of_IN bacterial_JJ STDs_NNS ,_, also_RB have_VBP the_DT potential_NN for_IN substantial_JJ efficacy_NN based_VBN on_IN observational_JJ studies_NNS but_CC only_RB one_CD of_IN these_DT RCTs_NNS afforded_VBD significant_JJ protection_NN against_IN HIV_NNP acquisition_NN 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
One_CD plausible_JJ reason_NN for_IN the_DT strong_JJ ,_, consistent_JJ impact_NN of_IN male_JJ circumcision_NN on_IN HIV_NNP acquisition_NN is_VBZ the_DT in-built_JJ 100_CD %_NN `_`` adherence_NN '_'' of_IN foreskin_NN removal_NN ._. 
Other_JJ biomedical_JJ interventions_NNS ,_, such_JJ as_IN treatment_NN of_IN bacterial_JJ STDs_NNS ,_, also_RB have_VBP the_DT potential_NN for_IN substantial_JJ efficacy_NN based_VBN on_IN observational_JJ studies_NNS but_CC only_RB one_CD of_IN these_DT RCTs_NNS afforded_VBD significant_JJ protection_NN against_IN HIV_NNP acquisition_NN 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
0015_CD is_VBZ the_DT average_JJ HIV_NNP transmission_NN probability_NN per_IN coital_JJ act_NN over_IN all_DT HIV_NNP stages_NNS for_IN vaginal_JJ intercourse_NN 
The_DT only_JJ one_CD of_IN these_DT for_IN which_WDT there_EX has_VBZ been_VBN consistent_JJ efficacy_NN in_IN multiple_JJ trials_NNS is_VBZ male_JJ circumcision_NN in_IN heterosexual_JJ men_NNS ._. 
These_DT trial_NN results_NNS were_VBD striking_JJ both_DT in_IN the_DT magnitude_NN of_IN effect_NN -LRB-_-LRB- summary_NN efficacy_NN 58_CD %_NN ,_, 95_CD %_NN CI_NNP 43_CD %_NN 
Analysis_NN Methods_NNS The_DT impact_NN of_IN adherence_NN in_IN an_DT RCT_NNP for_IN an_DT intervention_NN with_IN different_JJ levels_NNS of_IN efficacy_NN was_VBD calculated_VBN by_IN linking_VBG the_DT risk_NN per_IN sexual_JJ exposure_NN to_TO the_DT cumulative_JJ risk_NN calculated_VBN in_IN longitudinal_JJ trials_NNS using_VBG simplifying_VBG assumptions_NNS 
zIntervention_NNP =_SYM 1_CD 
0015_CD is_VBZ the_DT average_JJ HIV_NNP transmission_NN probability_NN per_IN coital_JJ act_NN over_IN all_DT HIV_NNP stages_NNS for_IN vaginal_JJ intercourse_NN 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
All_DT of_IN these_DT interventions_NNS ,_, except_IN an_DT HIV_NNP vaccine_NN ,_, require_VBP ongoing_JJ user-adherence_NN ._. 
To_TO our_PRP$ knowledge_NN ,_, there_EX are_VBP currently_RB 12_CD ongoing_JJ HIV_NNP prevention_NN trials_NNS ,_, examining_VBG a_DT range_NN of_IN interventions_NNS including_VBG community-based_JJ HIV_NNP voluntary_JJ counseling_NN and_CC testing_NN ,_, vaginal_JJ microbicides_NNS ,_, oral_JJ PrEP_NNP ,_, herpes_VBZ therapy_NN ,_, and_CC an_DT HIV_NNP vaccine_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
Consistent_JJ use_NN of_IN pharmaceutical_JJ interventions_NNS such_JJ as_IN ,_, oral_JJ PrEP_NN or_CC vaginal_JJ microbicides_NNS may_MD be_VB easier_JJR to_TO achieve_VB than_IN maintenance_NN of_IN behavioural_JJ interventions_NNS ,_, as_IN suggested_VBN by_IN experience_NN with_IN anti-retroviral_JJ therapy_NN ,_, for_IN which_WDT adherence_NN in_IN sub-Saharan_JJ African_JJ populations_NNS is_VBZ high_RB compared_VBN with_IN that_DT for_IN condoms_NNS 
7%_CD in_IN Zimbabwe_NNP in_IN 2005_CD 
In_IN the_DT MIRA_NNP trial_NN ,_, there_EX was_VBD some_DT evidence_NN of_IN impact_NN among_IN those_DT women_NNS reporting_VBG high_JJ levels_NNS of_IN adherence_NN ,_, and_CC suboptimal_JJ adherence_NN is_VBZ suggested_VBN by_IN the_DT annual_JJ incidence_NN of_IN first_JJ pregnancy_NN being_VBG similar_JJ in_IN both_DT intervention_NN and_CC control_NN groups_NNS -LRB-_-LRB- 13_CD %_NN -RRB-_-RRB- ,_, and_CC consistent_JJ with_IN the_DT reported_VBN rates_NNS of_IN pregnancy_NN in_IN these_DT populations_NNS -LRB-_-LRB- 13_CD ._. 
7%_CD in_IN Zimbabwe_NNP in_IN 2005_CD 
Other_JJ biomedical_JJ interventions_NNS ,_, such_JJ as_IN treatment_NN of_IN bacterial_JJ STDs_NNS ,_, also_RB have_VBP the_DT potential_NN for_IN substantial_JJ efficacy_NN based_VBN on_IN observational_JJ studies_NNS but_CC only_RB one_CD of_IN these_DT RCTs_NNS afforded_VBD significant_JJ protection_NN against_IN HIV_NNP acquisition_NN 
Attention_NN must_MD be_VB given_VBN to_TO methods_NNS of_IN maximizing_VBG adherence_NN when_WRB piloting_VBG and_CC designing_VBG RCTs_NNP and_CC HIV_NNP prevention_NN programs_NNS ._. 
BackgroundRecent_NNP randomized_VBD controlled_JJ trials_NNS -LRB-_-LRB- RCT_NNP -RRB-_-RRB- of_IN herpes_NNS suppressive_JJ therapy_NN ,_, female_JJ diaphragms_NNS and_CC gel_NN in_IN addition_NN to_TO male_JJ condoms_NNS -LRB-_-LRB- the_DT Methods_NNS for_IN Improving_NN Reproductive_NNP Health_NNP in_IN Africa_NNP ,_, or_CC MIRA_NNP trial_NN -RRB-_-RRB- 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
Background_NN Recent_JJ randomized_JJ controlled_JJ trials_NNS -LRB-_-LRB- RCT_NNP -RRB-_-RRB- of_IN herpes_NNS suppressive_JJ therapy_NN ,_, female_JJ diaphragms_NNS and_CC gel_NN in_IN addition_NN to_TO male_JJ condoms_NNS -LRB-_-LRB- the_DT Methods_NNS for_IN Improving_NN Reproductive_NNP Health_NNP in_IN Africa_NNP ,_, or_CC MIRA_NNP trial_NN -RRB-_-RRB- 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
Table_NNP 1_CD Randomised_NNP controlled_VBD trials_NNS of_IN HIV_NNP prevention_NN with_IN HIV_NNP incidence_NN as_IN an_DT outcome_NN for_IN sexual_JJ transmission_NN Intervention_NN Individual_NN or_CC cluster_NN randomization_NN RCTs_NNS completed_VBN or_CC stopped_VBN RCTs_NNS showing_VBG efficacy_NN RCTs_NNS ongoing_JJ Individual_NNP 2_CD 0_CD 0_CD Behavior_NN change_NN -LRB-_-LRB- abstinence\/delay_NN ,_, sex_NN partner_NN reduction_NN ,_, counseling_NN and_CC testing_NN ,_, condoms_NNS ,_, diaphragms_NNS ,_, microfinance_NN -RRB-_-RRB- Cluster_NN 5_CD 0_CD 2_CD 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
Table_NNP 1_CD Randomised_NNP controlled_VBD trials_NNS of_IN HIV_NNP prevention_NN with_IN HIV_NNP incidence_NN as_IN an_DT outcome_NN for_IN sexual_JJ transmission_NN Intervention_NN Individual_NN or_CC cluster_NN randomization_NN RCTs_NNS completed_VBN or_CC stopped_VBN RCTs_NNS showing_VBG efficacy_NN RCTs_NNS ongoing_JJ Individual_NNP 2_CD 0_CD 0_CD Behavior_NN change_NN -LRB-_-LRB- abstinence\/delay_NN ,_, sex_NN partner_NN reduction_NN ,_, counseling_NN and_CC testing_NN ,_, condoms_NNS ,_, diaphragms_NNS ,_, microfinance_NN -RRB-_-RRB- Cluster_NN 5_CD 0_CD 2_CD 
Attention_NN must_MD be_VB given_VBN to_TO methods_NNS of_IN maximizing_VBG adherence_NN when_WRB piloting_VBG and_CC designing_VBG RCTs_NNP and_CC HIV_NNP prevention_NN programs_NNS ._. 
BackgroundRecent_NNP randomized_VBD controlled_JJ trials_NNS -LRB-_-LRB- RCT_NNP -RRB-_-RRB- of_IN herpes_NNS suppressive_JJ therapy_NN ,_, female_JJ diaphragms_NNS and_CC gel_NN in_IN addition_NN to_TO male_JJ condoms_NNS -LRB-_-LRB- the_DT Methods_NNS for_IN Improving_NN Reproductive_NNP Health_NNP in_IN Africa_NNP ,_, or_CC MIRA_NNP trial_NN -RRB-_-RRB- 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
It_PRP is_VBZ striking_JJ that_IN the_DT only_JJ intervention_NN for_IN which_WDT multiple_JJ trials_NNS have_VBP shown_VBN efficacy_NN in_IN preventing_VBG HIV_NNP is_VBZ male_JJ circumcision_NN 
Reasons_NNS for_IN the_DT inconsistent_JJ results_NNS of_IN the_DT bacterial_JJ STD_NNP treatment_NN trials_NNS have_VBP been_VBN widely_RB discussed_VBN 
It_PRP is_VBZ possible_JJ that_IN adherence_NN was_VBD not_RB the_DT main_JJ problem_NN in_IN these_DT trials_NNS ,_, but_CC rather_RB that_IN the_DT drug_NN or_CC dosage_NN used_VBN was_VBD insufficient_JJ to_TO switch_VB off_RP the_DT frequent_JJ subclinical_JJ HSV_NNP reactivations_NNS ._. 
In_IN the_DT Mwanza_NNP trial_NN 
Attention_NN must_MD be_VB given_VBN to_TO methods_NNS of_IN maximizing_VBG adherence_NN when_WRB piloting_VBG and_CC designing_VBG RCTs_NNP and_CC HIV_NNP prevention_NN programs_NNS ._. 
BackgroundRecent_NNP randomized_VBD controlled_JJ trials_NNS -LRB-_-LRB- RCT_NNP -RRB-_-RRB- of_IN herpes_NNS suppressive_JJ therapy_NN ,_, female_JJ diaphragms_NNS and_CC gel_NN in_IN addition_NN to_TO male_JJ condoms_NNS -LRB-_-LRB- the_DT Methods_NNS for_IN Improving_NN Reproductive_NNP Health_NNP in_IN Africa_NNP ,_, or_CC MIRA_NNP trial_NN -RRB-_-RRB- 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
Attention_NN must_MD be_VB given_VBN to_TO methods_NNS of_IN maximizing_VBG adherence_NN when_WRB piloting_VBG and_CC designing_VBG RCTs_NNP and_CC HIV_NNP prevention_NN programs_NNS ._. 
BackgroundRecent_NNP randomized_VBD controlled_JJ trials_NNS -LRB-_-LRB- RCT_NNP -RRB-_-RRB- of_IN herpes_NNS suppressive_JJ therapy_NN ,_, female_JJ diaphragms_NNS and_CC gel_NN in_IN addition_NN to_TO male_JJ condoms_NNS -LRB-_-LRB- the_DT Methods_NNS for_IN Improving_NN Reproductive_NNP Health_NNP in_IN Africa_NNP ,_, or_CC MIRA_NNP trial_NN -RRB-_-RRB- 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
It_PRP is_VBZ striking_JJ that_IN the_DT only_JJ intervention_NN for_IN which_WDT multiple_JJ trials_NNS have_VBP shown_VBN efficacy_NN in_IN preventing_VBG HIV_NNP is_VBZ male_JJ circumcision_NN 
Reasons_NNS for_IN the_DT inconsistent_JJ results_NNS of_IN the_DT bacterial_JJ STD_NNP treatment_NN trials_NNS have_VBP been_VBN widely_RB discussed_VBN 
In_IN the_DT Mwanza_NNP trial_NN 
Background_NN Recent_JJ randomized_JJ controlled_JJ trials_NNS -LRB-_-LRB- RCT_NNP -RRB-_-RRB- of_IN herpes_NNS suppressive_JJ therapy_NN ,_, female_JJ diaphragms_NNS and_CC gel_NN in_IN addition_NN to_TO male_JJ condoms_NNS -LRB-_-LRB- the_DT Methods_NNS for_IN Improving_NN Reproductive_NNP Health_NNP in_IN Africa_NNP ,_, or_CC MIRA_NNP trial_NN -RRB-_-RRB- 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS ._. 
Table_NNP 1Randomised_NNP controlled_VBD trials_NNS of_IN HIV_NNP prevention_NN with_IN HIV_NNP incidence_NN as_IN an_DT outcome_NN for_IN sexual_JJ transmissionInterventionIndividual_NN or_CC cluster_NN randomizationRCTs_NNS completed_VBN o_SYM 
These_DT disappointing_JJ findings_NNS contribute_VBP to_TO a_DT total_NN of_IN 31_CD completed_VBN RCTs_NNS with_IN HIV_NNP incidence_NN as_IN a_DT primary_JJ outcome_NN for_IN sexual_JJ transmission_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, of_IN which_WDT only_RB four_CD have_VBP shown_VBN a_DT statistically_RB significant_JJ reduction_NN in_IN new_JJ HIV_NNP infections_NNS 
One_CD plausible_JJ reason_NN for_IN the_DT strong_JJ ,_, consistent_JJ impact_NN of_IN male_JJ circumcision_NN on_IN HIV_NNP acquisition_NN is_VBZ the_DT in-built_JJ 100_CD %_NN `_`` adherence_NN '_'' of_IN foreskin_NN removal_NN ._. 
Other_JJ biomedical_JJ interventions_NNS ,_, such_JJ as_IN treatment_NN of_IN bacterial_JJ STDs_NNS ,_, also_RB have_VBP the_DT potential_NN for_IN substantial_JJ efficacy_NN based_VBN on_IN observational_JJ studies_NNS but_CC only_RB one_CD of_IN these_DT RCTs_NNS afforded_VBD significant_JJ protection_NN against_IN HIV_NNP acquisition_NN 
In_IN this_DT paper_NN ,_, we_PRP use_VBP simple_JJ quantitative_JJ methods_NNS to_TO explore_VB the_DT impact_NN of_IN various_JJ levels_NNS of_IN adherence_NN on_IN observed_JJ efficacy_NN in_IN randomized_JJ controlled_JJ trials_NNS ,_, and_CC discuss_VB the_DT implications_NNS for_IN designing_VBG future_JJ HIV_NNP intervention_NN trials_NNS ._. 
AnalysisMethodsThe_JJ impact_NN of_IN adherence_NN in_IN an_DT RCT_NNP for_IN an_DT intervention_NN with_IN different_JJ levels_NNS of_IN efficacy_NN was_VBD calculated_VBN by_IN linking_VBG the_DT risk_NN per_IN sexual_JJ exposure_NN to_TO the_DT cumulative_JJ risk_NN calculated_VBN in_IN longitudinal_JJ trials_NNS using_VBG simplifying_VBG assumptions_NNS 
These_DT did_VBD not_RB entail_VB significant_JJ methodological_JJ deviations_NNS from_IN the_DT survey_NN protocol_NN ,_, required_VBN little_JJ training_NN ,_, and_CC we_PRP believed_VBD that_IN they_PRP could_MD be_VB conducted_VBN quickly_RB ._. 
Variations_NNS on_IN both_DT of_IN these_DT alternative_JJ methods_NNS have_VBP been_VBN used_VBN in_IN previous_JJ retrospective_JJ cluster_NN surveys_NNS 
These_DT did_VBD not_RB entail_VB significant_JJ methodological_JJ deviations_NNS from_IN the_DT survey_NN protocol_NN ,_, required_VBN little_JJ training_NN ,_, and_CC we_PRP believed_VBD that_IN they_PRP could_MD be_VB conducted_VBN quickly_RB ._. 
Variations_NNS on_IN both_DT of_IN these_DT alternative_JJ methods_NNS have_VBP been_VBN used_VBN in_IN previous_JJ retrospective_JJ cluster_NN surveys_NNS 
As_IN described_VBN by_IN Brogan_NNP et_FW al_FW ,_, 
According_VBG to_TO the_DT manufacturer_NN 's_POS specifications_NNS ,_, the_DT handheld_JJ GPS_NNP is_VBZ accurate_JJ to_TO 15_CD meters_NNS ._. 
Aseries_NNS of_IN GPS_NNP points_NNS was_VBD taken_VBN for_IN each_DT change_NN in_IN direction_NN along_IN the_DT perimeter_NN of_IN the_DT quartier_NN using_VBG a_DT hand-held_JJ Garmin_NNP 12_CD XL_NNP GPS_NNP device_NN -LRB-_-LRB- Olathe_NNP ,_, KS_NNP ,_, USA_NNP -RRB-_-RRB- ._. 
These_DT coordinates_VBZ were_VBD then_RB entered_VBN into_IN E-Pop_JJ software_NN ,_, which_WDT both_DT produces_VBZ a_DT map_NN of_IN the_DT area_NN and_CC allows_VBZ for_IN random_JJ selection_NN of_IN the_DT starting_VBG GPS_NNP point_NN ._. 
Figure_NN 1_CD shows_VBZ an_DT example_NN of_IN the_DT quartier_NN boundary_NN drawn_VBD using_VBG GPS_NNP coordinates_VBZ ._. 
The_DT time_NN taken_VBN to_TO complete_VB these_DT steps_NNS was_VBD considered_VBN as_IN the_DT advance_NN preparation_NN time_NN for_IN this_DT method_NN ._. 
One_CD randomly-selected_JJ household_NN within_IN each_DT compound_NN was_VBD surveyed_VBN ._. 
For_IN all_DT three_CD methods_NNS ,_, we_PRP used_VBD a_DT sampling_VBG interval_NN of_IN every_DT fifth_JJ compound_NN instead_RB of_IN proximity_NN sampling_VBG to_TO minimize_VB the_DT cluster_NN effect_NN ._. 
Description_NN of_IN methodsSpin-the-pen_NNP methodWe_NNP followed_VBD the_DT spin-the-pen_JJ -LRB-_-LRB- random_JJ walk_NN -RRB-_-RRB- method_NN ,_, which_WDT has_VBZ been_VBN described_VBN in_IN several_JJ manuals_NNS ._. 
Little_JJ additional_JJ advance_NN preparation_NN time_NN was_VBD required_VBN to_TO conduct_VB this_DT method_NN in_IN the_DT field_NN once_IN clusters_NNS were_VBD identified_VBN ._. 
One_CD randomly-selected_JJ household_NN within_IN each_DT compound_NN was_VBD surveyed_VBN ._. 
For_IN all_DT three_CD methods_NNS ,_, we_PRP used_VBD a_DT sampling_VBG interval_NN of_IN every_DT fifth_JJ compound_NN instead_RB of_IN proximity_NN sampling_VBG to_TO minimize_VB the_DT cluster_NN effect_NN ._. 
Description_NN of_IN methodsSpin-the-pen_NNP methodWe_NNP followed_VBD the_DT spin-the-pen_JJ -LRB-_-LRB- random_JJ walk_NN -RRB-_-RRB- method_NN ,_, which_WDT has_VBZ been_VBN described_VBN in_IN several_JJ manuals_NNS ._. 
Little_JJ additional_JJ advance_NN preparation_NN time_NN was_VBD required_VBN to_TO conduct_VB this_DT method_NN in_IN the_DT field_NN once_IN clusters_NNS were_VBD identified_VBN ._. 
One_CD randomly-selected_JJ household_NN within_IN each_DT compound_NN was_VBD surveyed_VBN ._. 
For_IN all_DT three_CD methods_NNS ,_, we_PRP used_VBD a_DT sampling_VBG interval_NN of_IN every_DT fifth_JJ compound_NN instead_RB of_IN proximity_NN sampling_VBG to_TO minimize_VB the_DT cluster_NN effect_NN ._. 
Description_NN of_IN methodsSpin-the-pen_NNP methodWe_NNP followed_VBD the_DT spin-the-pen_JJ -LRB-_-LRB- random_JJ walk_NN -RRB-_-RRB- method_NN ,_, which_WDT has_VBZ been_VBN described_VBN in_IN several_JJ manuals_NNS ._. 
Little_JJ additional_JJ advance_NN preparation_NN time_NN was_VBD required_VBN to_TO conduct_VB this_DT method_NN in_IN the_DT field_NN once_IN clusters_NNS were_VBD identified_VBN ._. 
``_`` Spinning_VBG the_DT pen_NN ''_'' is_VBZ often_RB justified_JJ as_IN a_DT way_NN to_TO avoid_VB costly_JJ and_CC time-consuming_JJ listing_NN of_IN all_DT households_NNS in_IN the_DT selected_JJ cluster_NN in_IN the_DT absence_NN of_IN a_DT sampling_NN frame_NN ._. 
As_RB long_RB as_IN the_DT starting_JJ point_NN is_VBZ selected_VBN randomly_RB and_CC probabilities_NNS of_IN selection_NN can_MD be_VB calculated_VBN -LRB-_-LRB- the_DT number_NN of_IN households_NNS selected_VBN divided_VBN by_IN the_DT total_JJ number_NN eligible_NN for_IN selection_NN from_IN the_DT sampling_VBG frame_NN -RRB-_-RRB- ,_, thus_RB obtaining_VBG a_DT probability_NN sample_NN ,_, supporters_NNS claim_VBP the_DT method_NN can_MD be_VB considered_VBN unbiased_JJ ._. 
However_RB ,_, these_DT two_CD conditions_NNS are_VBP rarely_RB met_VBN ._. 
Firstly_RB ,_, by_IN starting_VBG household_NN selection_NN from_IN the_DT center_NN of_IN the_DT cluster_NN ,_, households_NNS near_IN the_DT center_NN are_VBP more_RBR likely_JJ to_TO be_VB selected_VBN than_IN outlying_JJ households_NNS ._. 
As_IN described_VBN by_IN Brogan_NNP et_FW al_FW ,_, 
As_IN described_VBN by_IN Brogan_NNP et_FW al_FW ,_, if_IN we_PRP assu_VBP 
Background_NN Over_IN time_NN ,_, the_DT World_NNP Health_NNP Organization_NNP Expanded_NNP Program_NNP on_IN Immunization_NNP -LRB-_-LRB- EPI_NNP -RRB-_-RRB- cluster_NN survey_NN design_NN has_VBZ become_VBN the_DT default_NN choice_NN in_IN the_DT field_NN to_TO measure_VB vaccination_NN coverage_NN and_CC other_JJ indicators_NNS ,_, even_RB when_WRB a_DT sampling_NN frame_NN is_VBZ available_JJ ._. 
The_DT cluster_NN method_NN was_VBD developed_VBN in_IN the_DT 1970s_NNS for_IN immunization_NN coverage_NN in_IN the_DT USA_NNP and_CC expanded_VBN for_IN the_DT smallpox_NN eradication_NN campaign_NN later_RB that_DT decade_NN ._. 
In_IN a_DT two-stage_JJ cluster_NN design_NN ,_, the_DT first_JJ stage_NN involves_VBZ selection_NN of_IN clusters_NNS throughout_IN the_DT survey_NN area_NN ;_: this_DT is_VBZ usually_RB done_VBN proportionally_RB to_TO estimated_VBN population_NN size_NN ._. 
Background_NN Over_IN time_NN ,_, the_DT World_NNP Health_NNP Organization_NNP Expanded_NNP Program_NNP on_IN Immunization_NNP -LRB-_-LRB- EPI_NNP -RRB-_-RRB- cluster_NN survey_NN design_NN has_VBZ become_VBN the_DT default_NN choice_NN in_IN the_DT field_NN to_TO measure_VB vaccination_NN coverage_NN and_CC other_JJ indicators_NNS ,_, even_RB when_WRB a_DT sampling_NN frame_NN is_VBZ available_JJ ._. 
The_DT cluster_NN method_NN was_VBD developed_VBN in_IN the_DT 1970s_NNS for_IN immunization_NN coverage_NN in_IN the_DT USA_NNP and_CC expanded_VBN for_IN the_DT smallpox_NN eradication_NN campaign_NN later_RB that_DT decade_NN ._. 
In_IN a_DT two-stage_JJ cluster_NN design_NN ,_, the_DT first_JJ stage_NN involves_VBZ selection_NN of_IN clusters_NNS throughout_IN the_DT survey_NN area_NN ;_: this_DT is_VBZ usually_RB done_VBN proportionally_RB to_TO estimated_VBN population_NN size_NN ._. 
The_DT next_JJ stage_NN concerns_NNS selection_NN of_IN the_DT first_JJ sample_NN household_NN within_IN the_DT cluster_NN ._. 
In_IN a_DT two-stage_JJ cluster_NN design_NN ,_, the_DT first_JJ stage_NN involves_VBZ selection_NN of_IN clusters_NNS throughout_IN the_DT survey_NN area_NN ;_: this_DT is_VBZ usually_RB done_VBN proportionally_RB to_TO estimated_VBN population_NN size_NN ._. 
The_DT method_NN has_VBZ been_VBN described_VBN in_IN detail_NN in_IN previous_JJ publications_NNS and_CC manuals_NNS 
For_IN estimation_NN of_IN the_DT time_NN taken_VBN to_TO select_VB the_DT first_JJ household_NN ,_, we_PRP considered_VBD both_DT the_DT advance_NN preparation_NN time_NN -LRB-_-LRB- time_NN before_IN field_NN implementation_NN -RRB-_-RRB- and_CC the_DT time_NN needed_VBN for_IN survey_NN teams_NNS in_IN the_DT field_NN ._. 
For_IN illustrative_JJ purposes_NNS only_RB ,_, we_PRP also_RB compared_VBD the_DT vaccination_NN coverage_NN estimate_NN obtained_VBD using_VBG the_DT three_CD methods_NNS ._. 
Vaccination_NN coverage_NN estimates_NNS were_VBD obtained_VBN by_IN interviewing_VBG the_DT head_NN of_IN household_NN on_IN vaccination_NN status_NN of_IN all_DT members_NNS of_IN the_DT household_NN ._. 
The_DT next_JJ stage_NN concerns_NNS selection_NN of_IN the_DT first_JJ sample_NN household_NN within_IN the_DT cluster_NN ._. 
In_IN a_DT two-stage_JJ cluster_NN design_NN ,_, the_DT first_JJ stage_NN involves_VBZ selection_NN of_IN clusters_NNS throughout_IN the_DT survey_NN area_NN ;_: this_DT is_VBZ usually_RB done_VBN proportionally_RB to_TO estimated_VBN population_NN size_NN ._. 
The_DT method_NN has_VBZ been_VBN described_VBN in_IN detail_NN in_IN previous_JJ publications_NNS and_CC manuals_NNS 
The_DT method_NN has_VBZ been_VBN described_VBN in_IN detail_NN in_IN previous_JJ publications_NNS and_CC manuals_NNS 
Firstly_RB ,_, by_IN starting_VBG household_NN selection_NN from_IN the_DT center_NN of_IN the_DT cluster_NN ,_, households_NNS near_IN the_DT center_NN are_VBP more_RBR likely_JJ to_TO be_VB selected_VBN than_IN outlying_JJ households_NNS ._. 
As_IN described_VBN by_IN Brogan_NNP et_FW al_FW ,_, 
These_DT did_VBD not_RB entail_VB significant_JJ methodological_JJ deviations_NNS from_IN the_DT survey_NN protocol_NN ,_, required_VBN little_JJ training_NN ,_, and_CC we_PRP believed_VBD that_IN they_PRP could_MD be_VB conducted_VBN quickly_RB ._. 
Variations_NNS on_IN both_DT of_IN these_DT alternative_JJ methods_NNS have_VBP been_VBN used_VBN in_IN previous_JJ retrospective_JJ cluster_NN surveys_NNS 
The_DT method_NN has_VBZ been_VBN described_VBN in_IN detail_NN in_IN previous_JJ publications_NNS and_CC manuals_NNS 
Examples_NNS include_VBP Qiji_NNP ._. 
The_DT former_JJ provides_VBZ an_DT online_JJ interface_NN for_IN authors_NNS to_TO publish_VB their_PRP$ papers_NNS directly_RB online_VBP ,_, without_IN peer-review_JJ or_CC other_JJ form_NN of_IN quality_NN control_NN ._. 
cn_NN 
The_DT latter_NN transfers_VBZ paper-based_JJ peer-reviewed_JJ journals_NNS onto_IN the_DT web_NN for_IN free_JJ access_NN -LRB-_-LRB- usually_RB in_IN PDF_NNP format_NN -RRB-_-RRB- ._. 
The_DT Alliance_NNP of_IN open_JJ access_NN journals_NNS -LRB-_-LRB- OAJs_NNP -RRB-_-RRB- ,_, sponsored_VBN by_IN the_DT Society_NNP of_IN China_NNP University_NNP Journals_NNPS in_IN Natural_NNP Sciences_NNPS ,_, provides_VBZ access_NN to_TO a_DT number_NN of_IN OA_NNP journals_NNS ,_, predominantly_RB Chinese_JJ university_NN journals_NNS ._. 
The_DT international_JJ Directory_NNP of_IN Open_NNP Access_NNP Journals_NNPS -LRB-_-LRB- DOAJ_NNP -RRB-_-RRB- 
The_DT increasing_VBG trend_NN of_IN using_VBG impact_NN factors_NNS published_VBN by_IN Thomson_NNP Scientific_NNP as_IN an_DT indicator_NN in_IN academic_JJ evaluation_NN in_IN universities_NNS and_CC research_NN institutes_NN has_VBZ received_VBN much_JJ criticism_NN from_IN non-English-speakers_NNS of_IN the_DT developing_VBG world_NN 
One_CD of_IN the_DT criticisms_NNS against_IN it_PRP is_VBZ the_DT alleged_JJ language_NN bias_NN of_IN the_DT Thomson_NNP Scientific_NNP database_NN coverage_NN towards_IN journals_NNS published_VBN in_IN English_NNP and_CC in_IN the_DT industrialised_JJ world_NN ._. 
The_DT `_`` what-if_NN '_'' scenarios_NNS of_IN inclusion_NN of_IN non-Science_JJ Citation_NNP Index_NNP -LRB-_-LRB- SCI_NNP -RRB-_-RRB- -_: indexed_VBN journals_NNS upon_IN the_DT impact_NN factors_NNS of_IN SCI-indexed_JJ journals_NNS have_VBP been_VBN studied_VBN and_CC the_DT `_`` hypothetical_JJ '_'' impact_NN factors_NNS of_IN the_DT non-SCI-indexed_JJ journals_NNS calculated_VBN 
One_CD of_IN the_DT criticisms_NNS against_IN it_PRP is_VBZ the_DT alleged_JJ language_NN bias_NN of_IN the_DT Thomson_NNP Scientific_NNP database_NN coverage_NN towards_IN journals_NNS published_VBN in_IN English_NNP and_CC in_IN the_DT industrialised_JJ world_NN ._. 
The_DT `_`` what-if_NN '_'' scenarios_NNS of_IN inclusion_NN of_IN non-Science_JJ Citation_NNP Index_NNP -LRB-_-LRB- SCI_NNP -RRB-_-RRB- -_: indexed_VBN journals_NNS upon_IN the_DT impact_NN factors_NNS of_IN SCI-indexed_JJ journals_NNS have_VBP been_VBN studied_VBN and_CC the_DT `_`` hypothetical_JJ '_'' impact_NN factors_NNS of_IN the_DT non-SCI-indexed_JJ journals_NNS calculated_VBN 
The_DT `_`` what-if_NN '_'' scenarios_NNS of_IN inclusion_NN of_IN non-Science_JJ Citation_NNP Index_NNP -LRB-_-LRB- SCI_NNP -RRB-_-RRB- -_: indexed_VBN journals_NNS upon_IN the_DT impact_NN factors_NNS of_IN SCI-indexed_JJ journals_NNS have_VBP been_VBN studied_VBN and_CC the_DT `_`` hypothetical_JJ '_'' impact_NN factors_NNS of_IN the_DT non-SCI-indexed_JJ journals_NNS calculated_VBN 
Towards_IN a_DT truly_RB global_JJ impact_NN factor_NN ._. 
For_IN further_JJ discussion_NN ,_, please_VB refer_VBP to_TO Appendix_NNP 3_CD ._. 
As_IN the_DT Chinese_JJ share_NN of_IN the_DT world_NN 's_POS scientific_JJ output_NN increases_NNS and_CC as_IN Chinese_JJ scientists_NNS become_VBP more_RBR fluent_JJ in_IN English_NNP ,_, more_RBR English_JJ language_NN biomedical_JJ journals_NNS published_VBN in_IN China_NNP will_MD receive_VB their_PRP$ limelight_NN in_IN the_DT international_JJ arena_NN ._. 
The_DT increasing_VBG trend_NN of_IN using_VBG impact_NN factors_NNS published_VBN by_IN Thomson_NNP Scientific_NNP as_IN an_DT indicator_NN in_IN academic_JJ evaluation_NN in_IN universities_NNS and_CC research_NN institutes_NN has_VBZ received_VBN much_JJ criticism_NN from_IN non-English-speakers_NNS of_IN the_DT developing_VBG world_NN 
The_DT increasing_VBG trend_NN of_IN using_VBG impact_NN factors_NNS published_VBN by_IN Thomson_NNP Scientific_NNP as_IN an_DT indicator_NN in_IN academic_JJ evaluation_NN in_IN universities_NNS and_CC research_NN institutes_NN has_VBZ received_VBN much_JJ criticism_NN from_IN non-English-speakers_NNS of_IN the_DT developing_VBG world_NN 
Examples_NNS include_VBP Qiji_NNP ._. 
The_DT former_JJ provides_VBZ an_DT online_JJ interface_NN for_IN authors_NNS to_TO publish_VB their_PRP$ papers_NNS directly_RB online_VBP ,_, without_IN peer-review_JJ or_CC other_JJ form_NN of_IN quality_NN control_NN ._. 
cn_NN 
Examples_NNS include_VBP Qiji_NNP ._. 
The_DT former_JJ provides_VBZ an_DT online_JJ interface_NN for_IN authors_NNS to_TO publish_VB their_PRP$ papers_NNS directly_RB online_VBP ,_, without_IN peer-review_JJ or_CC other_JJ form_NN of_IN quality_NN control_NN ._. 
cn_NN 
In_IN order_NN to_TO better_RB evaluate_VB the_DT performances_NNS of_IN Latin_JJ American_JJ journals_NNS ,_, SciELO_NNP publishes_VBZ bibliometric_JJ indices_NNS of_IN its_PRP$ own_JJ ,_, similar_JJ to_TO that_DT of_IN Thomson_NNP Scientific_NNP ,_, using_VBG data_NNS from_IN its_PRP$ database_NN which_WDT reflect_VBP more_JJR the_DT regional_JJ context_NN 
In_IN the_DT long_JJ run_NN ,_, I_PRP envision_VBP an_DT international_JJ collaboration_NN between_IN Thomson_NNP Scientific_NNP ,_, SciELO_NNP ,_, the_DT Chinese_JJ databases_NNS and_CC other_JJ bibliographic_JJ databases_NNS to_TO provide_VB authors_NNS and_CC editors_NNS alike_RB with_IN a_DT more_RBR accurate_JJ and_CC comprehensive_JJ bibliometric_JJ data_NNS of_IN journal_NN performance_NN by_IN collating_VBG data_NNS across_IN the_DT various_JJ databases_NNS ._. 
Open_NNP AccessOpen_NNP Access_NNP -LRB-_-LRB- OA_NNP -RRB-_-RRB- online_JJ publishing_NN in_IN China_NNP falls_VBZ into_IN two_CD categories_NNS :_: non-peer-reviewed_JJ and_CC peer-reviewed_JJ ._. 
The_DT former_JJ provides_VBZ an_DT online_JJ interface_NN for_IN authors_NNS to_TO publish_VB their_PRP$ papers_NNS directly_RB online_VBP ,_, without_IN peer-review_JJ or_CC other_JJ form_NN of_IN quality_NN control_NN ._. 
Appendix_NNP 3_NNP A_NNP survey_NN of_IN English_JJ language_NN biomedical_JJ journals_NNS of_IN China_NNP A_DT survey_NN of_IN English_JJ language_NN biomedical_JJ journals_NNS published_VBN in_IN China_NNP was_VBD conducted_VBN by_IN Yu_NNP et_FW al._FW ._. 
in_IN 2006_CD via_IN self-administered_JJ questionnaires_NNS and_CC interviews_NNS of_IN their_PRP$ editorial_NN boards_NNS ._. 
The_DT survey_NN covered_VBD 31_CD journals_NNS and_CC gave_VBD a_DT good_JJ summary_NN of_IN their_PRP$ basic_JJ information_NN ,_, bibliometrics_NNS ,_, and_CC details_NNS of_IN their_PRP$ management_NN ,_, editorial_NN board_NN ,_, publication_NN and_CC distribution_NN ._. 
The_DT majority_NN of_IN these_DT submissions_NNS came_VBD from_IN other_JJ developing_VBG countries_NNS ._. 
Eighteen_CD journals_NNS received_VBD manuscripts_NNS from_IN outside_JJ China_NNP ,_, ranging_VBG from_IN a_DT few_JJ manuscripts_NNS per_IN year_NN to_TO 30_CD %_NN of_IN its_PRP$ total_JJ number_NN of_IN manuscripts_NNS received_VBN ._. 
One_CD of_IN the_DT consequences_NNS of_IN low_JJ supply_NN of_IN high-quality_JJ manuscripts_NNS is_VBZ that_IN the_DT frequency_NN of_IN publication_NN of_IN journals_NNS in_IN China_NNP is_VBZ low_JJ :_: 19_CD of_IN the_DT 31_CD English_JJ language_NN journals_NNS are_VBP quarterly_JJ or_CC semi-annual_JJ -LRB-_-LRB- Table_NNP 8_CD -RRB-_-RRB- 
One_CD of_IN the_DT consequences_NNS of_IN low_JJ supply_NN of_IN high-quality_JJ manuscripts_NNS is_VBZ that_IN the_DT frequency_NN of_IN publication_NN of_IN journals_NNS in_IN China_NNP is_VBZ low_JJ :_: 19_CD of_IN the_DT 31_CD English_JJ language_NN journals_NNS are_VBP quarterly_JJ or_CC semi-annual_JJ -LRB-_-LRB- Table_NNP 8_CD -RRB-_-RRB- 
One_CD of_IN the_DT consequences_NNS of_IN low_JJ supply_NN of_IN high-quality_JJ manuscripts_NNS is_VBZ that_IN the_DT frequency_NN of_IN publication_NN of_IN journals_NNS in_IN China_NNP is_VBZ low_JJ :_: 19_CD of_IN the_DT 31_CD English_JJ language_NN journals_NNS are_VBP quarterly_JJ or_CC semi-annual_JJ -LRB-_-LRB- Table_NNP 8_CD -RRB-_-RRB- 
Table_NNP 7_CD Annual_JJ number_NN of_IN manuscripts_NNS received_VBN by_IN 31_CD English_JJ language_NN biomedical_JJ journals_NNS of_IN China_NNP -LRB-_-LRB- data_NNS adapted_VBN from_IN -RRB-_-RRB- Annual_JJ number_NN of_IN manuscripts_NNS received_VBD 
Yu_FW et_FW al._FW ._. 
All_PDT the_DT others_NNS work_VBP part-time_JJ for_IN the_DT journals_NNS ._. 
Among_IN these_DT 31_CD journals_NNS ,_, the_DT only_JJ full-time_JJ Editor-in-Chief_NN is_VBZ that_IN of_IN the_DT World_NNP Journal_NNP of_IN Gastroenterology_NNP :_: WJG_NNP ._. 
argued_VBD that_IN this_DT was_VBD very_RB disadvantageous_JJ to_TO the_DT development_NN of_IN these_DT journals_NNS ._. 
The_DT number_NN of_IN full-time_JJ editors_NNS varied_VBN across_IN the_DT 31_CD journals_NNS -LRB-_-LRB- Table_NNP 8_CD -RRB-_-RRB- ,_, while_IN 13_CD journals_NNS had_VBD additional_JJ part-time_JJ editors_NNS varying_VBG from_IN one_CD to_TO six_CD ._. 
Yu_FW et_FW al._FW ._. 
The_DT number_NN of_IN full-time_JJ editors_NNS varied_VBN across_IN the_DT 31_CD journals_NNS -LRB-_-LRB- Table_NNP 8_CD -RRB-_-RRB- ,_, while_IN 13_CD journals_NNS had_VBD additional_JJ part-time_JJ editors_NNS varying_VBG from_IN one_CD to_TO six_CD ._. 
In_IN order_NN to_TO attract_VB talent_NN and_CC prevent_VB further_JJ brain-drain_NN ,_, Yu_FW et_FW al._FW ._. 
More_JJR training_NN is_VBZ needed_VBN ._. 
Given_VBN these_DT disturbing_JJ facts_NNS ,_, Yu_FW et_FW al._FW ._. 
Seven_CD journals_NNS ran_VBD a_DT deficit_NN balance_NN ;_: 14_CD achieved_VBN breakeven_NNS and_CC two_CD made_VBN profits_NNS -LRB-_-LRB- no_DT reply_NN from_IN eight_CD journals_NNS -RRB-_-RRB- ._. 
suggested_VBD that_IN while_IN the_DT Chinese_JJ government_NN should_MD increase_VB its_PRP$ financial_JJ investment_NN in_IN these_DT journals_NNS ,_, the_DT editorial_NN boards_NNS should_MD also_RB learn_VB how_WRB to_TO manage_VB the_DT journals_NNS more_RBR efficiently_RB ._. 
International_JJ peer-review_NN has_VBZ been_VBN archived_VBN by_IN thirteen_CD of_IN the_DT 31_CD journals_NNS ._. 
Peer_JJR reviewers_NNS were_VBD drawn_VBN mainly_RB from_IN the_DT West_NNP and_CC Japan_NNP ._. 
All_DT 31_CD journals_NNS studied_VBN are_VBP now_RB online_JJ ,_, of_IN which_WDT eleven_NNS have_VBP their_PRP$ own_JJ websites_NNS ._. 
Apart_RB from_IN two_CD Germans_NNS ,_, they_PRP all_DT come_VBP from_IN English-speaking_JJ countries_NNS ,_, and_CC their_PRP$ number_NN is_VBZ limited_VBN to_TO one_CD per_IN journal_NN ,_, with_IN one_CD exception_NN which_WDT has_VBZ three_CD non-Chinese_JJ editors_NNS ._. 
To_TO different_JJ extents_NNS ,_, they_PRP all_DT manage_VBP their_PRP$ editorial_NN process_NN of_IN submission_NN ,_, peer-review_NN and_CC re-submission_NN electronically_RB 
According_VBG to_TO Yu_NNP et_NNP al_NNP ._. 
To_TO different_JJ extents_NNS ,_, they_PRP all_DT manage_VBP their_PRP$ editorial_NN process_NN of_IN submission_NN ,_, peer-review_NN and_CC re-submission_NN electronically_RB 
Using_VBG data_NNS of_IN 2003_CD ,_, Yu_FW et_FW al._FW ._. 
Publishing_NNP in_IN English_NNP is_VBZ correlated_VBN to_TO higher_JJR international_JJ visibility_NN 
The_DT analysis_NN of_IN Yu_NNP et_FW al._FW ._. 
Interestingly_RB ,_, by_IN moving_VBG towards_IN an_DT international_JJ readership_NN ,_, these_DT English_JJ language_NN journals_NNS of_IN China_NNP fared_VBD not_RB so_RB well_RB in_IN China_NNP either_CC -LRB-_-LRB- Table_NNP 10_CD -RRB-_-RRB- ._. 
further_RBR supported_VBN claims_NNS made_VBN in_IN the_DT main_JJ text_NN that_IN journals_NNS published_VBN in_IN China_NNP are_VBP caught_VBN in_IN a_DT dilemma_NN :_: publ_NN 
71_CD -RRB-_-RRB- 9_CD -LRB-_-LRB- 29_CD ._. 
03_CD -RRB-_-RRB- 12_CD -LRB-_-LRB- 38_CD ._. 
76_CD -RRB-_-RRB- English_JJ language_NN biomedical_JJ journals_NNS 31_CD 9_CD -LRB-_-LRB- 29_CD ._. 
53_CD -RRB-_-RRB- 32_CD -LRB-_-LRB- 3_CD ._. 
29_CD -RRB-_-RRB- 64_CD -LRB-_-LRB- 7_CD ._. 
72_CD -RRB-_-RRB- Biomedical_NNP journals_NNS 850_CD 11_CD -LRB-_-LRB- 1_CD ._. 
03_CD -RRB-_-RRB- Table_NNP 10Chinese_JJ bibliometric_JJ data_NNS of_IN journals_NNS published_VBN in_IN China_NNP -LRB-_-LRB- data_NNS adapted_VBN from_IN -RRB-_-RRB- CategoriesImpact_NNP factorOverall_NNP cited_VBD frequencyMean_JJ immediacy_NN indexMean_JJ international_JJ article_NN ratioHighestLowestMeanHighestLowestMeanEnglish_JJ language_NN biomedical_JJ journals_NNS of_IN China_NNP -LRB-_-LRB- 2002_CD -RRB-_-RRB- 2_CD ._. 
920_CD 0_CD 0_CD ._. 
236_CD 1844_CD 0_CD 140_CD 0_CD ._. 
064_CD 0_CD ._. 
18_CD English_JJ language_NN journals_NNS of_IN China_NNP -LRB-_-LRB- 2002_CD -RRB-_-RRB- 2_CD ._. 
920_CD 0_CD 0_CD ._. 
117_CD 1844_CD 0_CD 28_CD 0_CD ._. 
As_IN the_DT HKCMA_NNP was_VBD renamed_VBN as_IN HKMA_NNP in_IN 1970_CD ,_, the_DT Bulletin_NNP was_VBD renamed_VBN the_DT Bulletin_NNP of_IN the_DT Hong_NNP Kong_NNP Medical_NNP Association_NNP -LRB-_-LRB- -RRB-_-RRB- -LRB-_-LRB- volume_NN 22_CD continues_VBZ -RRB-_-RRB- ,_, which_WDT was_VBD later_RB continued_VBN by_IN the_DT Journal_NNP of_IN the_DT Hong_NNP Kong_NNP Medical_NNP Association_NNP -LRB-_-LRB- Chinese_JJ title_NN unchanged_JJ -RRB-_-RRB- in_IN 1985_CD -LRB-_-LRB- volume_NN 37_CD continues_VBZ -RRB-_-RRB- 
Table_NNP 3_NNP lists_VBZ 24_CD English_JJ language_NN journals_NNS on_IN health_NN and_CC medical_JJ science_NN available_JJ in_IN Wan_NNP Fang_NNP ._. 
According_VBG to_TO Wan_NNP Fang_NNP categories_NNS ,_, eight_CD are_VBP on_IN agriculture_NN ,_, 58_CD on_IN fundamental_JJ science_NN ,_, 24_CD on_IN health_NN and_CC medical_JJ science_NN ,_, 48_CD on_IN science_NN 
English_JJ language_NN journals_NNS in_IN the_DT Wan_NNP Fang_NNP database_NN There_EX are_VBP 141_CD titles_NNS under_IN the_DT category_NN of_IN English_NNP China_NNP Online_NNP Journals_NNPS ._. 
According_VBG to_TO Wan_NNP Fang_NNP categories_NNS ,_, eight_CD are_VBP on_IN agriculture_NN ,_, 58_CD on_IN fundamental_JJ science_NN ,_, 24_CD on_IN health_NN and_CC medical_JJ science_NN ,_, 48_CD on_IN science_NN 
Afull_JJ list_NN in_IN alphabetical_JJ order_NN is_VBZ available_JJ in_IN ._. 
Table_NNP 3_NNP lists_VBZ 24_CD English_JJ language_NN journals_NNS on_IN health_NN and_CC medical_JJ science_NN available_JJ in_IN Wan_NNP Fang_NNP ._. 
Table_NNP 3English_NNP language_NN journals_NNS -LRB-_-LRB- Health_NNP and_CC Medical_NNP Science_NNP -RRB-_-RRB- available_JJ via_IN Wan_NNP Fang_NNP English_NNP China_NNP Online_NNP Journals_NNPS 
Wan_NNP Fang_NNP and_CC iLib_NNP Both_CC Wan_NNP Fang_NNP database_NN and_CC iLib_NNP are_VBP run_VBN by_IN Wanfang_NNP Data_NNP ,_, an_DT affiliate_NN of_IN the_DT Chinese_NNP Ministry_NNP of_IN Science_NNP 
From_IN there_RB a_DT link_NN is_VBZ provided_VBN to_TO the_DT full_JJ text_NN PDF_NNP file_NN which_WDT requires_VBZ payment_NN or_CC subscription_NN ._. 
Chinese_JJ links_NNS in_IN Google_NNP Scholar_NNP provided_VBN by_IN the_DT Wan_NNP Fang_NNP database_NN and_CC iLib_NNP will_MD directly_RB lead_VB to_TO the_DT Chinese_JJ abstract_JJ page_NN ._. 
Although_IN a_DT previous_JJ study_NN performed_VBN in_IN 2005_CD found_VBD an_DT English_JJ language_NN bias_NN in_IN Google_NNP Scholar_NNP ,_, the_DT search_NN engine_NN has_VBZ evolved_VBN so_RB quickly_RB that_IN a_DT new_JJ study_NN of_IN its_PRP$ article_NN coverage_NN is_VBZ definitely_RB worthwhile_JJ ._. 
Wan_NNP Fang_NNP and_CC iLib_NNP Both_CC Wan_NNP Fang_NNP database_NN and_CC iLib_NNP are_VBP run_VBN by_IN Wanfang_NNP Data_NNP ,_, an_DT affiliate_NN of_IN the_DT Chinese_NNP Ministry_NNP of_IN Science_NNP 
The_DT other_JJ two_CD `_`` core_NN journal_NN '_'' databases_NNS are_VBP the_DT Chinese_NNP Science_NNP Citation_NNP Database_NNP 
In_IN additional_JJ to_TO these_DT functions_NNS ,_, Google_NNP Scholar_NNP also_RB provides_VBZ links_NNS to_TO institutional_JJ libraries_NNS and_CC the_DT British_NNP Library_NNP ,_, citation_NN records_NNS ,_, links_NNS to_TO related_JJ articles_NNS ,_, and_CC it_PRP groups_NNS different_JJ entries_NNS of_IN the_DT same_JJ article_NN together_RB ._. 
For_IN a_DT more_RBR structured_JJ search_NN ,_, the_DT Advanced_NNP Scholar_NNP Search_NNP is_VBZ needed_VBN ,_, of_IN which_WDT a_DT Chinese_JJ interface_NN is_VBZ also_RB available_JJ ._. 
As_IN of_IN 13_CD th_NN February_NNP 2008_CD ,_, the_DT Chinese_JJ links_NNS in_IN Google_NNP Scholar_NNP provided_VBN by_IN VIP_NNP information_NN are_VBP linked_VBN to_TO the_DT PDF_NNP full_JJ text_NN which_WDT requires_VBZ subscription_NN to_TO VIP_NNP information_NN ._. 
e._NNP Firstly_NNP ,_, Google_NNP Scholar_NNP -LRB-_-LRB- Chinese_JJ interface_NN -RRB-_-RRB- provides_VBZ `_`` pinyin_NN search_NN '_'' ,_, i._FW There_EX are_VBP two_CD apparent_JJ advantages_NNS -LRB-_-LRB- especially_RB for_IN non-Chinese_JJ speakers_NNS -RRB-_-RRB- of_IN searching_VBG for_IN Chinese_JJ articles_NNS in_IN Google_NNP Scholar_NNP ._. 
using_VBG a_DT standardised_JJ Romanised_JJ form_NN of_IN Chinese_NNP ,_, known_VBN as_IN pinyin_NN in_IN Chinese_NNP ._. 
For_IN example_NN ,_, if_IN I_PRP type_NN `_`` bing_NNP du_NNP '_'' in_IN the_DT Google_NNP Scholar_NNP English_NNP interface_NN ,_, I_PRP will_MD obtain_VB journal_NN articles_NNS with_IN authors_NNS of_IN the_DT family_NN name_NN Bing_NNP Du_NNP ._. 
Taiwan_NNP Academia_NNP Search_NNP 
IMICAMS_NNP :_: Institute_NNP of_IN Medical_NNP Informatics_NNP ,_, Chinese_NNP Academy_NNP of_IN Medical_NNP Sciences_NNPS ._. 
IMICAMS_NNP :_: Institute_NNP of_IN Medical_NNP Informatics_NNP ,_, Chinese_NNP Academy_NNP of_IN Medical_NNP Sciences_NNPS ._. 
Click_VB here_RB for_IN file_NN Acknowledgements_NNP ICHF_NNP thanks_NNS Prof._NNP Adams_NNP for_IN providing_VBG him_PRP with_IN his_PRP$ manuscript_NN on_IN Chinese_JJ bibliographic_JJ databases_NNS and_CC alerting_VBG him_PRP to_TO the_DT existence_NN of_IN three_CD of_IN the_DT five_CD databases_NNS that_WDT are_VBP covered_VBN in_IN his_PRP$ article_NN ._. 
He_PRP is_VBZ grateful_JJ to_TO Mr._NNP David_NNP Aanensen_NNP ,_, Dr._NNP Yan_NNP Che_NNP ,_, Dr._NNP Manoj_NNP Gambhir_NNP ,_, Dr._NNP James_NNP Lewis_NNP ,_, Dr._NNP Dabing_NNP Lu_NNP ,_, Dr._NNP 
Taiwan_NNP Academia_NNP Search_NNP 
-Chinese_JJ interface_NN 
Google_NNP scholar_NN Google_NNP Scholar_NNP provides_VBZ a_DT convenient_JJ starting_NN point_NN for_IN searching_VBG Chinese_JJ articles_NNS ,_, of_IN which_WDT the_DT bibliographic_JJ data_NN is_VBZ mainly_RB provided_VBN by_IN VIP_NNP information_NN ,_, Wan_NNP Fang_NNP database_NN and_CC iLib_NNP -LRB-_-LRB- all_DT accessed_VBN on_IN 21_CD st_NN February_NNP ,_, 2007_CD -RRB-_-RRB- ._. 
For_IN Chinese_JJ speakers_NNS ,_, Google_NNP Scholar_NNP also_RB provides_VBZ a_DT Chinese_JJ interface_NN ._. 
There_EX are_VBP two_CD apparent_JJ advantages_NNS -LRB-_-LRB- especially_RB for_IN non-Chinese_JJ speakers_NNS -RRB-_-RRB- of_IN searching_VBG for_IN Chinese_JJ articles_NNS in_IN Google_NNP Scholar_NNP ._. 
Taiwan_NNP Academia_NNP Search_NNP 
-Chinese_JJ interface_NN 
Users_NNS of_IN traditional_JJ Chinese_JJ characters_NNS can_MD use_VB Yahoo_NNP ._. 
There_EX are_VBP six_CD mainland_JJ Chinese_JJ bibliographic_JJ databases_NNS through_IN which_WDT Chinese_JJ language_NN biomedical_JJ journal_NN articles_NNS can_MD be_VB searched_VBN and_CC located_VBN and_CC of_IN which_WDT two_CD provide_VBP English_JJ interfaces_NNS :_: -LRB-_-LRB- a_DT -RRB-_-RRB- Chinese_NNP Biomedical_NNP Literature_NNP Database_NNP -LRB-_-LRB- CBM_NNP -RRB-_-RRB- ,_, -LRB-_-LRB- b_NN -RRB-_-RRB- Chinese_NNP Medical_NNP Current_NNP Content_NNP -LRB-_-LRB- CMCC_NNP -RRB-_-RRB- 
Since_IN the_DT introduction_NN of_IN modern_JJ medicine_NN by_IN missionary_JJ doctors_NNS in_IN the_DT 19_CD th_NN century_NN 
Epidemiologists_NNS from_IN the_DT non-Chinese_JJ world_NN may_MD wonder_VB what_WP resources_NNS of_IN scientific_JJ knowledge_NN and_CC epidemiological_JJ information_NN China_NNP -LRB-_-LRB- whose_WP$ health_NN research_NN serves_VBZ a_DT fifth_NN of_IN the_DT world_NN 's_POS population_NN -RRB-_-RRB- may_MD offer_VB us_PRP ._. 
In_IN 1994_CD ,_, the_DT British_NNP Medical_NNP Journal_NNP published_VBD an_DT editorial_NN recommending_VBG to_TO its_PRP$ readers_NNS the_DT Chinese_JJ medical_JJ journals_NNS 
In_IN another_DT study_NN ,_, Wang_NNP and_CC Zhang_NNP found_VBD that_IN by_IN 1995_CD ,_, the_DT ``_`` frequency_NN of_IN using_VBG statistical_JJ tests_NNS in_IN Chinese_JJ medical_JJ journals_NNS appears_VBZ comparable_JJ to_TO that_DT in_IN other_JJ parts_NNS of_IN the_DT world_NN ''_'' ,_, but_CC ``_`` the_DT lack_NN or_CC inappropriate_JJ use_NN of_IN statistics_NNS remains_VBZ a_DT problem_NN ''_'' 
Appendix_NNP 1_CD Chinese_JJ biomedical_JJ journals_NNS indexed_VBN in_IN bibliographic_JJ databases_NNS In_IN 1990_CD ,_, Gastel_NNP and_CC Weng_NNP 
In_IN 1994_CD ,_, the_DT British_NNP Medical_NNP Journal_NNP published_VBD an_DT editorial_NN recommending_VBG to_TO its_PRP$ readers_NNS the_DT Chinese_JJ medical_JJ journals_NNS 
The_DT other_JJ two_CD `_`` core_NN journal_NN '_'' databases_NNS are_VBP the_DT Chinese_NNP Science_NNP Citation_NNP Database_NNP 
This_DT reflects_VBZ the_DT difficulty_NN of_IN breaking_VBG through_IN into_IN the_DT international_JJ market_NN ._. 
However_RB ,_, only_RB seven_CD of_IN these_DT 18_CD journals_NNS achieved_VBD an_DT international_JJ circulation_NN of_IN more_JJR than_IN 100_CD copies_NNS ._. 
Publishing_NNP in_IN English_NNP is_VBZ correlated_VBN to_TO higher_JJR international_JJ visibility_NN 
However_RB ,_, 13_CD years_NNS have_VBP gone_VBN by_IN ,_, and_CC the_DT Chinese_JJ medical_JJ and_CC scientific_JJ literature_NN is_VBZ still_RB largely_RB terra_NN incognita_NN outside_IN China_NNP 
Epidemiologists_NNS are_VBP encouraged_VBN to_TO search_VB the_DT Chinese_JJ bibliographic_JJ databases_NNS for_IN Chinese_JJ journal_NN articles_NNS ._. 
IntroductionThe_NNP Chinese_NNP have_VBP had_VBN a_DT long_JJ history_NN in_IN infectious_JJ disease_NN control_NN ,_, and_CC records_NNS of_IN epidemics_NNS can_MD be_VB traced_VBN back_RB two_CD millennia_NNS 
Since_IN the_DT introduction_NN of_IN modern_JJ medicine_NN by_IN missionary_JJ doctors_NNS in_IN the_DT 19_CD th_NN century_NN 
However_RB ,_, rapid_JJ industrialization_NN and_CC urbanization_NN are_VBP accompanied_VBN by_IN many_JJ social_JJ problems_NNS ,_, from_IN the_DT increasing_VBG rich-poor_JJ ,_, urban-rural_JJ ,_, coastal-interior_JJ disparity_NN to_TO heavy_JJ environmental_JJ pollution_NN ._. 
Changes_NNS in_IN disease_NN profile_NN with_IN the_DT increasing_VBG burden_NN of_IN non-communicable_JJ diseases_NNS as_IN a_DT result_NN of_IN an_DT aging_VBG population_NN with_IN a_DT successful_JJ one-child_JJ policy_NN posed_VBD new_JJ challenges_NNS in_IN the_DT 21st_JJ century_NN 
Introduction_NNP The_NNP Chinese_NNP have_VBP had_VBN a_DT long_JJ history_NN in_IN infectious_JJ disease_NN control_NN ,_, and_CC records_NNS of_IN epidemics_NNS can_MD be_VB traced_VBN back_RB two_CD millennia_NNS 
Introduction_NNP The_NNP Chinese_NNP have_VBP had_VBN a_DT long_JJ history_NN in_IN infectious_JJ disease_NN control_NN ,_, and_CC records_NNS of_IN epidemics_NNS can_MD be_VB traced_VBN back_RB two_CD millennia_NNS ._. 
Since_IN the_DT introduction_NN of_IN modern_JJ medicine_NN by_IN missionary_JJ doctors_NNS in_IN the_DT 19th_JJ 
Changes_NNS in_IN disease_NN profile_NN with_IN the_DT increasing_VBG burden_NN of_IN non-communicable_JJ diseases_NNS as_IN a_DT result_NN of_IN an_DT aging_VBG population_NN with_IN a_DT successful_JJ one-child_JJ policy_NN posed_VBD new_JJ challenges_NNS in_IN the_DT 21_CD st_NN century_NN 
However_RB ,_, 13_CD years_NNS have_VBP gone_VBN by_IN ,_, and_CC the_DT Chinese_JJ medical_JJ and_CC scientific_JJ literature_NN is_VBZ still_RB largely_RB terra_NN incognita_NN outside_IN China_NNP 
For_IN a_DT more_RBR in-depth_JJ study_NN of_IN the_DT research_NN potential_NN of_IN Chinese_JJ biomedical_JJ bibliographic_JJ databases_NNS ,_, illustrated_VBN by_IN the_DT example_NN of_IN schistosomiasis_NN research_NN ,_, please_VB refer_VBP to_TO the_DT paper_NN in_IN this_DT thematic_JJ issue_NN by_IN Liu_NNP et_FW al._FW ._. ._. 
Chinese_JJ biomedical_JJ journals_NNS :_: an_DT overview_NN Today_NN there_EX are_VBP more_JJR than_IN 5000_CD academic_JJ periodicals_NNS published_VBN in_IN mainland_NN China_NNP ,_, and_CC around_IN a_DT thousand_CD of_IN these_DT are_VBP related_VBN to_TO biomedicine_NN and_CC health_NN ._. 
The_DT first_JJ one_CD is_VBZ Comprehensive_NNP Lists_NNP of_IN Titles_NNP of_IN Chinese_NNP Core_NNP Journals_NNPS -LRB-_-LRB- zhongwen_FW hexin_FW qikan_FW yaomu_FW zonglan_FW -RRB-_-RRB- published_VBN by_IN The_DT National_NNP Library_NNP of_IN China_NNP every_DT four_CD years_NNS ._. 
The_DT latest_JJS one_NN was_VBD published_VBN in_IN 2004_CD which_WDT is_VBZ available_JJ at_IN 
In_IN Tables_NNP 4_CD ,_, 5_CD and_CC 6_CD ,_, those_DT journals_NNS that_WDT were_VBD indexed_VBN in_IN the_DT Comprehensive_NNP Lists_VBZ 2004_CD are_VBP indicated_VBN as_IN `_`` Chinese_JJ core_NN journals_NNS 2004_CD '_'' accordingly_RB ._. 
The_DT other_JJ two_CD `_`` core_NN journal_NN '_'' databases_NNS are_VBP the_DT Chinese_NNP Science_NNP Citation_NNP Database_NNP 
615_CD -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- -LRB-_-LRB- For_IN the_DT history_NN of_IN CMJ_NNP ,_, please_VBP refer_VB to_TO Appendix_NNP 2_CD ._. 
The_DT CMJ_NNP has_VBZ an_DT impact_NN factor_NN -LRB-_-LRB- 2006_CD -RRB-_-RRB- of_IN 0_CD ._. -RRB-_-RRB- 
There_EX are_VBP 105_CD journals_NNS under_IN the_DT category_NN of_IN ``_`` Preventive_JJ medicine_NN and_CC hygienics_NNS ''_'' in_IN the_DT Chinese_JJ portal_NN of_IN the_DT Wan_NNP Fang_NNP database_NN and_CC in_IN iLib_NNP as_IN of_IN 21_CD February_NNP 2007_CD ,_, which_WDT covers_VBZ journals_NNS in_IN epidemiology_NN ,_, preventive_JJ medicine_NN ,_, occupational_JJ health_NN ,_, toxicology_NN ,_, health_NN economics_NNS and_CC hospital_NN management_NN ._. 
Chinese_JJ core_NN journals_NNS and_CC VIP_NNP impact_NN factor_NN A_DT few_JJ pieces_NNS of_IN data_NNS can_MD help_VB us_PRP evaluate_VB the_DT quality_NN of_IN these_DT journals_NNS ._. 
615_CD -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- -LRB-_-LRB- For_IN the_DT history_NN of_IN CMJ_NNP ,_, please_VBP refer_VB to_TO Appendix_NNP 2_CD ._. 
The_DT CMJ_NNP has_VBZ an_DT impact_NN factor_NN -LRB-_-LRB- 2006_CD -RRB-_-RRB- of_IN 0_CD ._. -RRB-_-RRB- 
There_EX are_VBP 105_CD journals_NNS under_IN the_DT category_NN of_IN ``_`` Preventive_JJ medicine_NN and_CC hygienics_NNS ''_'' in_IN the_DT Chinese_JJ portal_NN of_IN the_DT Wan_NNP Fang_NNP database_NN and_CC in_IN iLib_NNP as_IN of_IN 21_CD February_NNP 2007_CD ,_, which_WDT covers_VBZ journals_NNS in_IN epidemiology_NN ,_, preventive_JJ medicine_NN ,_, occupational_JJ health_NN ,_, toxicology_NN ,_, health_NN economics_NNS and_CC hospital_NN management_NN ._. 
Chinese_JJ core_NN journals_NNS and_CC VIP_NNP impact_NN factor_NN A_DT few_JJ pieces_NNS of_IN data_NNS can_MD help_VB us_PRP evaluate_VB the_DT quality_NN of_IN these_DT journals_NNS ._. 
Among_IN the_DT 5000_CD +_CD Chinese_JJ journals_NNS ,_, some_DT are_VBP classified_VBN as_IN `_`` core_NN journals_NNS '_POS ._. 
However_RB ,_, as_IN language_NN bias_NN is_VBZ suspected_VBN among_IN these_DT English-language_JJ indexing_NN services_NNS ,_, it_PRP is_VBZ important_JJ to_TO look_VB at_IN the_DT data_NNS produced_VBN by_IN the_DT Chinese_NNPS themselves_PRP ._. 
According_VBG to_TO Sun_NNP ,_, these_DT are_VBP indexed_VBN by_IN at_IN least_JJS one_CD of_IN the_DT following_JJ three_CD indexing_NN systems_NNS ._. 
The_DT first_JJ one_CD is_VBZ Comprehensive_NNP Lists_NNP of_IN Titles_NNP of_IN Chinese_NNP Core_NNP Journals_NNPS -LRB-_-LRB- zhongwen_FW hexin_FW qikan_FW yaomu_FW zonglan_FW -RRB-_-RRB- published_VBN by_IN The_DT National_NNP Library_NNP of_IN China_NNP every_DT four_CD years_NNS ._. 
Table_NNP 1_CD -RRB-_-RRB- ._. 
Some_DT are_VBP indexed_VBN in_IN MEDLINE_NNP ,_, like_IN the_DT Journal_NNP of_IN Peking_NNP University_NNP -LRB-_-LRB- Health_NNP Sciences_NNPS -RRB-_-RRB- -LRB-_-LRB- cf._VB The_DT performances_NNS of_IN 41_CD of_IN these_DT medical_JJ university_NN journals_NNS have_VBP been_VBN analyzed_VBN recently_RB 
The_DT first_JJ one_CD is_VBZ Comprehensive_NNP Lists_NNP of_IN Titles_NNP of_IN Chinese_NNP Core_NNP Journals_NNPS -LRB-_-LRB- zhongwen_FW hexin_FW qikan_FW yaomu_FW zonglan_FW -RRB-_-RRB- published_VBN by_IN The_DT National_NNP Library_NNP of_IN China_NNP every_DT four_CD years_NNS ._. 
The_DT latest_JJS one_NN was_VBD published_VBN in_IN 2004_CD which_WDT is_VBZ available_JJ at_IN 
48 1007-9327_CD Taiyuan_NNP Research_NNP 
g._NNP Currently_NNP ,_, it_PRP is_VBZ the_DT Chinese_JJ national_JJ standard_NN that_IN scientific_JJ periodicals_NNS published_VBN in_IN mainland_NN China_NNP in_IN the_DT Chinese_JJ language_NN should_MD contain_VB English_JJ abstracts_NNS for_IN every_DT original_JJ research_NN article_NN and_CC English_JJ titles_NNS for_IN selected_JJ important_JJ articles_NNS -LRB-_-LRB- e._NN editorials_NNS ,_, reviews_NNS ,_, forums_NNS and_CC short_JJ research_NN articles_NNS ,_, depending_VBG on_IN the_DT judgement_NN of_IN the_DT editorial_NN board_NN -RRB-_-RRB- ._. 
The_DT English_JJ table_NN of_IN contents_NNS is_VBZ available_JJ online_NN ,_, free_JJ of_IN charge_NN ,_, through_IN the_DT Wan_NNP Fang_NNP database_NN ._. 
However_RB ,_, the_DT English_JJ abstracts_NNS are_VBP only_RB available_JJ in_IN the_DT full_JJ text_NN PDF_NNP file_NN from_IN the_DT Wan_NNP Fang_NNP database_NN that_WDT requires_VBZ subscription_NN ._. 
Other_JJ national_JJ journals_NNS include_VBP CPMA_NNP journals_NNS ,_, like_IN the_DT China_NNP Preventive_NNP Medicine_NNP and_CC the_DT Chinese_NNP Journal_NNP of_IN Public_NNP Health_NNP ,_, and_CC the_DT International_NNP Journal_NNP of_IN Epidemiology_NNP and_CC Infectious_NNP Disease_NNP -LRB-_-LRB- formerly_RB entitled_VBN ,_, Foreign_NNP Medical_NNP Sciences_NNP -LRB-_-LRB- Epidemiology_NNP and_CC Infectious_NNP Disease_NNP -RRB-_-RRB- -RRB-_-RRB- of_IN CMA_NNP ._. 
Of_IN 31_CD provinces_NNS ,_, autonomous_JJ regions_NNS and_CC municipalities_NNS of_IN the_DT People_NNP 's_POS Republic_NNP -LRB-_-LRB- excluding_VBG the_DT Special_JJ Administrative_JJ Regions_NNS of_IN Hong_NNP Kong_NNP and_CC Macao_NNP -RRB-_-RRB- ,_, only_RB 12_CD publish_VBP their_PRP$ own_JJ journals_NNS of_IN preventive_JJ medicine_NN -LRB-_-LRB- Table_NNP 4_CD -RRB-_-RRB- 
The_DT others_NNS are_VBP trying_VBG hard_RB to_TO `_`` catch_VB up_RP '_'' ._. 
Three_CD provincial_JJ preventive_JJ medicine_NN journals_NNS received_VBD a_DT VIP_NNP impact_NN factor_NN :_: that_IN of_IN Henan_NNP and_CC Jiangsu_NNP as_RB well_RB as_IN Gonggong_NNP Weisheng_NNP Yu_NNP Yufang_NNP Yixue_NNP of_IN Hubei_NNP -LRB-_-LRB- Table_NNP 4_CD -RRB-_-RRB- ._. 
For_IN example_NN ,_, the_DT Journal_NNP of_IN Applied_NNP Preventive_NNP Medicine_NNP -LRB-_-LRB- new_JJ title_NN since_IN 2006_CD ,_, Volume_NN 12_CD issue_NN 3_CD ;_: formerly_RB entitled_VBN ,_, Guangxi_NNP Journal_NNP of_IN Preventive_NNP Medicine_NNP -RRB-_-RRB- from_IN Guangxi_NNP Zhuang_NNP Autonomous_NNP Region_NNP in_IN southern_JJ China_NNP now_RB has_VBZ an_DT international_JJ board_NN of_IN editors_NNS ._. 
The_DT development_NN of_IN the_DT internet_NN has_VBZ prompted_VBN a_DT drastic_JJ change_NN in_IN the_DT ecology_NN of_IN academic_JJ publication_NN worldwide_NN and_CC Chinese_JJ journals_NNS are_VBP no_DT exception_NN ._. 
Anew_JJ approach_NN must_MD be_VB adopted_VBN if_IN Chinese_JJ scientific_JJ journals_NNS aspire_VBP to_TO secure_VB a_DT wider_JJR readership_NN and_CC a_DT higher_JJR citation_NN rate_NN ._. 
Since_IN the_DT Scientific_NNP Electronic_NNP Library_NNP Online_NNP can_MD provide_VB free_JJ online_JJ access_NN to_TO English_JJ abstracts_NNS of_IN Spanish_JJ and_CC Portuguese_JJ journal_NN articles_NNS ,_, it_PRP would_MD seem_VB appropriate_JJ for_IN the_DT Wan_NNP Fang_NNP database_NN to_TO move_VB towards_IN a_DT similar_JJ standard_NN ._. 
Of_IN course_NN ,_, English_JJ abstracts_NNS are_VBP available_JJ for_IN journals_NNS indexed_VBN by_IN PubMed_NNP or_CC ISI_NNP Web_NNP of_IN Science_NNP ._. 
Chinese_JJ journals_NNS in_IN epidemiology_NN and_CC preventive_JJ medicine_NN Here_RB ,_, I_PRP introduce_VBP journals_NNS that_WDT are_VBP of_IN particular_JJ interest_NN to_TO epidemiologists_NNS ._. 
Chinese_NNP Journal_NNP of_IN Traumatology_NNP 6_CD 1008-1275_CD n\/a_IN 100886162_CD 1998_CD E_NNP 3_NNP 11_NNP Chin_NNP Med_NNP J_NNP -LRB-_-LRB- Engl_NNP -RRB-_-RRB- 
Chinese_JJ journals_NNS in_IN epidemiology_NN and_CC preventive_JJ medicine_NN Here_RB ,_, I_PRP introduce_VBP journals_NNS that_WDT are_VBP of_IN particular_JJ interest_NN to_TO epidemiologists_NNS ._. 
The_DT top_JJ general_JJ medical_JJ journal_NN in_IN mainland_NN China_NNP is_VBZ the_DT Open_NNP Access_NNP English_NNP semi-monthly_JJ Chinese_NNP Medical_NNP Journal_NNP ,_, abbreviated_JJ as_IN Chin_NNP Med_NNP J_NNP -LRB-_-LRB- Engl_NNP -RRB-_-RRB- or_CC the_DT CMJ_NNP ,_, and_CC its_PRP$ sister_JJ periodical_NN in_IN Chinese_NNP ,_, Zhonghua_NNP Yi_NNP Xue_NNP Za_NNP Zhi_NNP ,_, the_DT National_NNP Medical_NNP Journal_NNP of_IN China_NNP ._. 
Both_DT are_VBP MEDLINE-indexed_JJ ._. 
The_DT CMJ_NNP has_VBZ an_DT impact_NN factor_NN -LRB-_-LRB- 2006_CD -RRB-_-RRB- of_IN 0_CD ._. 
615_CD -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- -LRB-_-LRB- For_IN the_DT history_NN of_IN CMJ_NNP ,_, please_VBP refer_VB to_TO Appendix_NNP 2_CD ._. 
The_DT Alliance_NNP of_IN open_JJ access_NN journals_NNS -LRB-_-LRB- OAJs_NNP -RRB-_-RRB- ,_, sponsored_VBN by_IN the_DT Society_NNP of_IN China_NNP University_NNP Journals_NNPS in_IN Natural_NNP Sciences_NNPS ,_, provides_VBZ access_NN to_TO a_DT number_NN of_IN OA_NNP journals_NNS ,_, predominantly_RB Chinese_JJ university_NN journals_NNS ._. 
The_DT international_JJ Directory_NNP of_IN Open_NNP Access_NNP Journals_NNPS -LRB-_-LRB- DOAJ_NNP -RRB-_-RRB- 
-LRB-_-LRB- A_DT brief_JJ history_NN of_IN the_DT Chinese_NNP Medical_NNP Journal_NNP ,_, written_VBN in_IN Chinese_NNP ,_, can_MD be_VB found_VBN on_IN the_DT CMJ_NNP website_NN ._. -RRB-_-RRB- 
Note_NN :_: The_DT year_NN 1975_CD ,_, as_IN the_DT date_NN of_IN resumed_VBN publication_NN of_IN the_DT CMJ_NNP ,_, is_VBZ correct_JJ according_VBG to_TO the_DT CMJ_NNP website_NN 
-RRB-_-RRB- Note_NN :_: The_DT year_NN 1975_CD ,_, as_IN the_DT date_NN of_IN resumed_VBN publication_NN of_IN the_DT CMJ_NNP ,_, is_VBZ correct_JJ according_VBG to_TO the_DT CMJ_NNP website_NN 
However_RB ,_, one_PRP can_MD find_VB evidence_NN among_IN American_JJ medical_JJ literature_NN that_IN the_DT CMJ_NNP resumed_VBD publication_NN in_IN January_NNP 1973_CD as_IN volume_NN 1_CD number_NN 1_CD 
-LRB-_-LRB- A_DT brief_JJ history_NN of_IN the_DT Chinese_NNP Medical_NNP Journal_NNP ,_, written_VBN in_IN Chinese_NNP ,_, can_MD be_VB found_VBN on_IN the_DT CMJ_NNP website_NN ._. -RRB-_-RRB- 
Note_NN :_: The_DT year_NN 1975_CD ,_, as_IN the_DT date_NN of_IN resumed_VBN publication_NN of_IN the_DT CMJ_NNP ,_, is_VBZ correct_JJ according_VBG to_TO the_DT CMJ_NNP website_NN 
-LRB-_-LRB- Note_VB :_: Acta_NNP Pharmacologica_NNP Sinica_NNP publishes_VBZ in_IN English_NNP according_VBG to_TO MEDLINE_NNP but_CC JCR_NNP 2006_CD records_NNS it_PRP as_RB multi-lingual_JJ ._. -RRB-_-RRB- 
As_IN of_IN 30th_JJ September_NNP 2006_CD ,_, 20,800_CD serial_JJ titles_NNS were_VBD received_VBN by_IN the_DT National_NNP Library_NNP of_IN Medicine_NNP ,_, the_DT largest_JJS medical_JJ library_NN in_IN the_DT world_NN 
Perhaps_RB it_PRP is_VBZ time_NN to_TO add_VB to_TO our_PRP$ list_NN the_DT Chinese_JJ databases_NNS and_CC also_RB include_VBP Chinese_JJ papers_NNS ._. 
It_PRP has_VBZ been_VBN suggested_VBN that_IN in_IN order_NN to_TO be_VB comprehensive_JJ ,_, we_PRP should_MD apply_VB LILACS_NNP in_IN our_PRP$ literature_NN search_NN to_TO cover_VB Spanish_JJ and_CC Portuguese_JJ articles_NNS in_IN our_PRP$ systematic_JJ reviews_NNS 
There_EX were_VBD a_DT few_JJ records_NNS whose_WP$ country_NN of_IN publication_NN data_NNS were_VBD missing_JJ or_CC mistaken_JJ and_CC were_VBD corrected_VBN for_IN in_IN the_DT analysis_NN ._. 
Chemical_NNP AbstractsAccording_NNP to_TO a_DT recent_JJ study_NN ,_, from_IN 1932_CD to_TO 2005_CD ,_, there_EX were_VBD 1093_CD journals_NNS -LRB-_-LRB- 537_CD titles_NNS current_JJ in_IN 2005_CD -RRB-_-RRB- from_IN greater_JJR China_NNP ,_, including_VBG Hong_NNP Kong_NNP -LRB-_-LRB- n_SYM =_SYM 7_CD ,_, 0_CD ._. 
6%_CD -RRB-_-RRB- and_CC Taiwan_NNP -LRB-_-LRB- n_SYM =_SYM 58_CD ,_, 5_CD ._. 
3%_CD -RRB-_-RRB- indexed_VBD in_IN Chemical_NN Abstracts_NNS ,_, among_IN which_WDT 51_CD -LRB-_-LRB- 4_CD ._. 
7%_CD -RRB-_-RRB- belonged_VBD to_TO biological_JJ sciences_NNS and_CC 216_CD were_VBD health-related_JJ -LRB-_-LRB- yiyaoweisheng_NN -RRB-_-RRB- ,_, i._SYM 
If_IN we_PRP relax_VBP our_PRP$ criterion_NN and_CC include_VBP non-MEDLINE-indexed_JJ journals_NNS in_IN our_PRP$ analysis_NN ,_, there_EX are_VBP 146_CD mainland_JJ Chinese_JJ journals_NNS -LRB-_-LRB- of_IN general_JJ science_NN ,_, biology_NN ,_, medicine_NN ,_, veterinary_JJ science_NN ,_, agriculture_NN and_CC forestry_NN -RRB-_-RRB- indexed_VBD in_IN the_DT PubMed_NNP journal_NN database_NN -LRB-_-LRB- for_IN details_NNS of_IN data_NNS analysis_NN ,_, see_VBP below_IN -RRB-_-RRB- ,_, of_IN which_WDT 110_CD publish_VBP articles_NNS in_IN Chinese_NNP ,_, 24_CD in_IN English_NNP and_CC seven_CD in_IN either_DT Chinese_NNP or_CC English_NNP -LRB-_-LRB- with_IN one_CD in_IN Chinese_NNP or_CC Latin_NNP and_CC one_CD with_IN missing_VBG language_NN data_NNS -RRB-_-RRB- ._. 
Wan_NNP Fang_NNP databaseAs_NNP of_IN June_NNP 2007_CD ,_, there_EX are_VBP 1056_CD Chinese_JJ journals_NNS in_IN the_DT field_NN of_IN health_NN ,_, medicine_NN and_CC biology_NN according_VBG to_TO the_DT English_JJ portal_NN of_IN Wan_NNP Fang_NNP database_NN ._. 
985_CD titles_NNS fall_VBP in_IN the_DT category_NN of_IN yiyaoweisheng_NN -LRB-_-LRB- 
Up_IN to_TO 14_CD th_NN October_NNP 2005_CD ,_, a_DT total_NN of_IN 693610_CD articles_NNS had_VBD been_VBN indexed_VBN ._. 
The_DT first_JJ journal_NN being_VBG indexed_VBN was_VBD Chinese_NNP Medical_NNP Journal_NNP -LRB-_-LRB- see_VB Appendix_NNP 2_CD -RRB-_-RRB- ._. 
Afull_JJ list_NN of_IN the_DT indexed_VBN journals_NNS with_IN their_PRP$ ISSN_NNP ,_, indexed_VBD years_NNS and_CC number_NN of_IN indexed_VBN articles_NNS can_MD be_VB found_VBN at_IN ._. 
Scopus_NNP Up_RB to_TO 16_CD th_NN January_NNP 2006_CD ,_, a_DT total_NN of_IN 340_CD journals_NNS ,_, with_IN 333621_CD articles_NNS ,_, published_VBN in_IN China_NNP have_VBP been_VBN indexed_VBN in_IN Scopus_NNP ,_, among_IN which_WDT 73_CD -LRB-_-LRB- 21_CD ._. 
e._IN 7_CD %_NN -RRB-_-RRB- belonged_VBD to_TO biological_JJ sciences_NNS and_CC 216_CD were_VBD health-related_JJ -LRB-_-LRB- yiyaoweisheng_NN -RRB-_-RRB- ,_, i._VBD 3_CD %_NN -RRB-_-RRB- indexed_VBN in_IN Chemical_NN Abstracts_NNS ,_, among_IN which_WDT 51_CD -LRB-_-LRB- 4_CD ._. 
category_NN Q_NNP and_CC R_NNP according_VBG to_TO the_DT Chinese_NNP Library_NNP Classification_NNP ._. 
English_JJ language_NN journals_NNS made_VBD up_RP of_IN 9_CD ._. 
7%_CD -LRB-_-LRB- n_SYM =_SYM 106_CD -RRB-_-RRB- of_IN the_DT total_NN ._. 
The_DT majority_NN of_IN the_DT journals_NNS indexed_VBN were_VBD established_VBN in_IN or_CC after_IN 1980_CD -LRB-_-LRB- 69_CD ._. 
Henceforth_NNP ,_, the_DT use_NN of_IN English_NNP by_IN the_DT CMJ_NNP ,_, should_MD be_VB interpreted_VBN as_IN a_DT deliberate_JJ act_NN on_IN the_DT part_NN of_IN the_DT Chinese_NNPS to_TO communicate_VB cross-culturally_RB to_TO the_DT rest_NN of_IN the_DT world_NN ._. 
-LRB-_-LRB- A_DT brief_JJ history_NN of_IN the_DT Chinese_NNP Medical_NNP Journal_NNP ,_, written_VBN in_IN Chinese_NNP ,_, can_MD be_VB found_VBN on_IN the_DT CMJ_NNP website_NN ._. -RRB-_-RRB- 
Note_NN :_: The_DT year_NN 1975_CD ,_, as_IN the_DT date_NN of_IN resumed_VBN publication_NN of_IN the_DT CMJ_NNP ,_, is_VBZ correct_JJ according_VBG to_TO the_DT CMJ_NNP website_NN 
Comparing_VBG this_DT to_TO other_JJ bibliographic_JJ databases_NNS ,_, 58_CD of_IN these_DT 340_CD journals_NNS were_VBD also_RB indexed_VBN by_IN Thomson_NNP Scientific_NNP ,_, 264_CD by_IN Wan_NNP Fang_NNP database_NN and_CC 280_CD by_IN VIP_NNP Information_NNP ._. 
Afull_JJ list_NN of_IN the_DT journals_NNS indexed_VBD in_IN Scopus_NNP with_IN a_DT detailed_JJ analysis_NN can_MD be_VB found_VBN at_IN Bao_NNP ._. 
Appendix_NNP 2_CD History_NN and_CC Language_NN :_: A_DT case_NN study_NN of_IN three_CD flagship_NN general_JJ medical_JJ journals_NNS in_IN greater_JJR China_NNP Introduction_NNP The_DT purpose_NN of_IN this_DT appendix_NN is_VBZ to_TO illustrate_VB how_WRB the_DT historical_JJ background_NN of_IN a_DT geopolitical_JJ region_NN influences_VBZ the_DT choice_NN of_IN language_NN of_IN publication_NN of_IN a_DT biomedical_JJ journal_NN ._. 
The_DT society_NN journal_NN ,_, the_DT Bulletin_NNP of_IN the_DT Hong_NNP Kong_NNP Chinese_NNP Medical_NNP Association_NNP -LRB-_-LRB- -RRB-_-RRB- was_VBD established_VBN in_IN 1948_CD -LRB-_-LRB- Note_NN -RRB-_-RRB- ._. 
As_IN the_DT HKCMA_NNP was_VBD renamed_VBN as_IN HKMA_NNP in_IN 1970_CD ,_, the_DT Bulletin_NNP was_VBD renamed_VBN the_DT Bulletin_NNP of_IN the_DT Hong_NNP Kong_NNP Medical_NNP Association_NNP -LRB-_-LRB- 
It_PRP skipped_VBD publishing_NN in_IN 1950_CD and_CC continued_VBD in_IN 1951_CD as_IN volume_NN 3_CD ._. 
Note_NN :_: Volume_NN numbering_VBG of_IN the_DT Bulletin_NNP of_IN the_DT Hong_NNP Kong_NNP Chinese_NNP Medical_NNP Association_NNP started_VBD in_IN 1948_CD as_IN volume_NN 1_CD ._. 
Again_RB in_IN 1959_CD ,_, it_PRP skipped_VBD publishing_NN and_CC it_PRP continued_VBD in_IN 1960_CD as_IN volume_NN 11_CD ._. 
Discussion_NN The_DT above_JJ section_NN illustrated_VBD how_WRB Chinese_JJ doctors_NNS adapt_VBP to_TO changes_NNS in_IN the_DT socio-political_JJ arena_NN by_IN their_PRP$ choices_NNS of_IN language_NN of_IN publication_NN of_IN their_PRP$ flagship_NN general_JJ medicine_NN journals_NNS ._. 
As_IN the_DT HKCMA_NNP was_VBD renamed_VBN as_IN HKMA_NNP in_IN 1970_CD ,_, the_DT Bulletin_NNP was_VBD renamed_VBN the_DT Bulletin_NNP of_IN the_DT Hong_NNP Kong_NNP Medical_NNP Association_NNP -LRB-_-LRB- -RRB-_-RRB- -LRB-_-LRB- volume_NN 22_CD continues_VBZ -RRB-_-RRB- ,_, which_WDT was_VBD later_RB continued_VBN by_IN the_DT Journal_NNP of_IN the_DT Hong_NNP Kong_NNP Medical_NNP Association_NNP -LRB-_-LRB- Chinese_JJ title_NN unchanged_JJ -RRB-_-RRB- in_IN 1985_CD -LRB-_-LRB- volume_NN 37_CD continues_VBZ -RRB-_-RRB- 
-RRB-_-RRB- Hong_NNP Kong_NNP Medical_NNP Journal_NNP The_NNP Hong_NNP Kong_NNP Medical_NNP Journal_NNP -LRB-_-LRB- -RRB-_-RRB- is_VBZ the_DT official_JJ journal_NN of_IN the_DT Hong_NNP Kong_NNP Academy_NNP of_IN Medicine_NNP and_CC the_DT Hong_NNP Kong_NNP Medical_NNP Association_NNP -LRB-_-LRB- HKMA_NNP -RRB-_-RRB- 
-RRB-_-RRB- is_VBZ the_DT official_JJ journal_NN of_IN the_DT Hong_NNP Kong_NNP Academy_NNP of_IN Medicine_NNP and_CC the_DT Hong_NNP Kong_NNP Medical_NNP Association_NNP -LRB-_-LRB- HKMA_NNP -RRB-_-RRB- 
-RRB-_-RRB- in_IN 1991_CD and_CC Formosan_NNP Journal_NNP of_IN Medicine_NNP -LRB-_-LRB- 
The_DT decision_NN to_TO split_VB the_DT journal_NN into_IN two_CD ,_, one_CD in_IN English_NNP for_IN the_DT publication_NN of_IN research_NN output_NN and_CC one_CD in_IN Chinese_NNP for_IN the_DT continuing_VBG medical_JJ education_NN at_IN the_DT grass-roots_JJ level_NN ,_, is_VBZ a_DT classic_JJ example_NN of_IN the_DT dilemma_NN between_IN serving_VBG local_JJ needs_NNS and_CC communicating_VBG research_NN outputs_NNS to_TO the_DT world_NN ._. 
-LRB-_-LRB- A_DT Power-Point_JJ presentation_NN of_IN the_DT History_NN of_IN the_DT Formosan_NNP Medical_NNP Association_NNP and_CC its_PRP$ Journal_NNP ,_, written_VBN in_IN Chinese_NNP ,_, can_MD be_VB found_VBN at_IN ._. -RRB-_-RRB- 
Hong_NNP Kong_NNP Medical_NNP Journal_NNP The_NNP Hong_NNP Kong_NNP Medical_NNP Journal_NNP -LRB-_-LRB- 
-RRB-_-RRB- Hong_NNP Kong_NNP Medical_NNP Journal_NNP The_NNP Hong_NNP Kong_NNP Medical_NNP Journal_NNP -LRB-_-LRB- -RRB-_-RRB- is_VBZ the_DT official_JJ journal_NN of_IN the_DT Hong_NNP Kong_NNP Academy_NNP of_IN Medicine_NNP and_CC the_DT Hong_NNP Kong_NNP Medical_NNP Association_NNP -LRB-_-LRB- HKMA_NNP -RRB-_-RRB- 
However_RB ,_, one_PRP can_MD find_VB evidence_NN among_IN American_JJ medical_JJ literature_NN that_IN the_DT CMJ_NNP resumed_VBD publication_NN in_IN January_NNP 1973_CD as_IN volume_NN 1_CD number_NN 1_CD 
Searching_VBG for_IN Chinese_JJ articles_NNS :_: the_DT bibliographic_NN databases_VBZ Full_JJ texts_NNS of_IN more_JJR than_IN five_CD thousand_CD Chinese_JJ journals_NNS are_VBP now_RB available_JJ online_NN ._. 
There_EX are_VBP six_CD mainland_JJ Chinese_JJ bibliographic_JJ databases_NNS through_IN which_WDT Chinese_JJ language_NN biomedical_JJ journal_NN articles_NNS can_MD be_VB searched_VBN and_CC located_VBN and_CC of_IN which_WDT two_CD provide_VBP English_JJ interfaces_NNS :_: -LRB-_-LRB- a_DT -RRB-_-RRB- Chinese_NNP Biomedical_NNP Literature_NNP Database_NNP -LRB-_-LRB- CBM_NNP -RRB-_-RRB- ,_, -LRB-_-LRB- b_NN -RRB-_-RRB- Chinese_NNP Medical_NNP Current_NNP Content_NNP -LRB-_-LRB- CMCC_NNP -RRB-_-RRB- 
-Chinese_JJ interface_NN 
Searching_VBG for_IN Chinese_JJ articles_NNS :_: the_DT bibliographic_NN databases_VBZ Full_JJ texts_NNS of_IN more_JJR than_IN five_CD thousand_CD Chinese_JJ journals_NNS are_VBP now_RB available_JJ online_NN ._. 
There_EX are_VBP six_CD mainland_JJ Chinese_JJ bibliographic_JJ databases_NNS through_IN which_WDT Chinese_JJ language_NN biomedical_JJ journal_NN articles_NNS can_MD be_VB searched_VBN and_CC located_VBN and_CC of_IN which_WDT two_CD provide_VBP English_JJ interfaces_NNS :_: -LRB-_-LRB- a_DT -RRB-_-RRB- Chinese_NNP Biomedical_NNP Literature_NNP Database_NNP -LRB-_-LRB- CBM_NNP -RRB-_-RRB- ,_, -LRB-_-LRB- b_NN -RRB-_-RRB- Chinese_NNP Medical_NNP Current_NNP Content_NNP -LRB-_-LRB- CMCC_NNP -RRB-_-RRB- 
-Chinese_JJ interface_NN 
While_IN Wan_NNP Fang_NNP provides_VBZ access_NN to_TO databases_NNS of_IN journal_NN articles_NNS ,_, conference_NN proceedings_NNS ,_, degree_NN theses_NNS ,_, patents_NNS ,_, national_JJ and_CC industrial_JJ standards_NNS and_CC even_RB listed_VBN companies_NNS in_IN China_NNP ,_, iLib_NNP is_VBZ essentially_RB a_DT subset_NN of_IN Wan_NNP Fang_NNP and_CC is_VBZ restricted_VBN to_TO journal_NN articles_NNS only_RB ._. 
The_DT Wan_NNP Fang_NNP database_NN maintains_VBZ two_CD portals_NNS ,_, one_CD in_IN Chinese_NNP 
985_CD titles_NNS fall_VBP in_IN the_DT category_NN of_IN yiyaoweisheng_NN -LRB-_-LRB- :_: Medical_NNP ,_, pharmaceutical_NN and_CC hygiene\/health_NN -RRB-_-RRB- as_IN of_IN 7th_JJ August_NNP 2007_CD ,_, according_VBG to_TO the_DT Chinese_JJ portal_NN of_IN Wan_NNP Fang_NNP database_NN ._. 
PubMed_VBN On_IN 21_CD st_NN November_NNP 2006_CD ,_, the_DT PubMed_NNP journal_NN database_NN was_VBD searched_VBN with_IN the_DT following_JJ search_NN terms_NNS :_: China_NNP OR_NNP Chinese_NNP OR_NNP Zhongguo_NNP OR_NNP Sinica_NNP OR_NNP Taiwan_NNP OR_NNP Taiwanese_NNPS OR_NNP Taiwanica_NNP OR_NNP Formosa_NNP OR_NNP Formosan_NNP OR_NNP Hong_NNP Kong_NNP ._. 
Searching_VBG for_IN Chinese_JJ articles_NNS :_: the_DT bibliographic_NN databases_VBZ Full_JJ texts_NNS of_IN more_JJR than_IN five_CD thousand_CD Chinese_JJ journals_NNS are_VBP now_RB available_JJ online_NN ._. 
There_EX are_VBP six_CD mainland_JJ Chinese_JJ bibliographic_JJ databases_NNS through_IN which_WDT Chinese_JJ language_NN biomedical_JJ journal_NN articles_NNS can_MD be_VB searched_VBN and_CC located_VBN and_CC of_IN which_WDT two_CD provide_VBP English_JJ interfaces_NNS :_: -LRB-_-LRB- a_DT -RRB-_-RRB- Chinese_NNP Biomedical_NNP Literature_NNP Database_NNP -LRB-_-LRB- CBM_NNP -RRB-_-RRB- ,_, -LRB-_-LRB- b_NN -RRB-_-RRB- Chinese_NNP Medical_NNP Current_NNP Content_NNP -LRB-_-LRB- CMCC_NNP -RRB-_-RRB- 
-Chinese_JJ interface_NN 
Searching_VBG for_IN Chinese_JJ articles_NNS :_: the_DT bibliographic_NN databases_VBZ Full_JJ texts_NNS of_IN more_JJR than_IN five_CD thousand_CD Chinese_JJ journals_NNS are_VBP now_RB available_JJ online_NN ._. 
There_EX are_VBP six_CD mainland_JJ Chinese_JJ bibliographic_JJ databases_NNS through_IN which_WDT Chinese_JJ language_NN biomedical_JJ journal_NN articles_NNS can_MD be_VB searched_VBN and_CC located_VBN and_CC of_IN which_WDT two_CD provide_VBP English_JJ interfaces_NNS :_: -LRB-_-LRB- a_DT -RRB-_-RRB- Chinese_NNP Biomedical_NNP Literature_NNP Database_NNP -LRB-_-LRB- CBM_NNP -RRB-_-RRB- ,_, -LRB-_-LRB- b_NN -RRB-_-RRB- Chinese_NNP Medical_NNP Current_NNP Content_NNP -LRB-_-LRB- CMCC_NNP -RRB-_-RRB- 
-Chinese_JJ interface_NN 
Searching_VBG for_IN Chinese_JJ articles_NNS :_: the_DT bibliographic_NN databases_VBZ Full_JJ texts_NNS of_IN more_JJR than_IN five_CD thousand_CD Chinese_JJ journals_NNS are_VBP now_RB available_JJ online_NN ._. 
There_EX are_VBP six_CD mainland_JJ Chinese_JJ bibliographic_JJ databases_NNS through_IN which_WDT Chinese_JJ language_NN biomedical_JJ journal_NN articles_NNS can_MD be_VB searched_VBN and_CC located_VBN and_CC of_IN which_WDT two_CD provide_VBP English_JJ interfaces_NNS :_: -LRB-_-LRB- a_DT -RRB-_-RRB- Chinese_NNP Biomedical_NNP Literature_NNP Database_NNP -LRB-_-LRB- CBM_NNP -RRB-_-RRB- ,_, -LRB-_-LRB- b_NN -RRB-_-RRB- Chinese_NNP Medical_NNP Current_NNP Content_NNP -LRB-_-LRB- CMCC_NNP -RRB-_-RRB- 
-Chinese_JJ interface_NN 
Searching_VBG for_IN Chinese_JJ articles_NNS :_: the_DT bibliographic_NN databases_VBZ Full_JJ texts_NNS of_IN more_JJR than_IN five_CD thousand_CD Chinese_JJ journals_NNS are_VBP now_RB available_JJ online_NN ._. 
There_EX are_VBP six_CD mainland_JJ Chinese_JJ bibliographic_JJ databases_NNS through_IN which_WDT Chinese_JJ language_NN biomedical_JJ journal_NN articles_NNS can_MD be_VB searched_VBN and_CC located_VBN and_CC of_IN which_WDT two_CD provide_VBP English_JJ interfaces_NNS :_: -LRB-_-LRB- a_DT -RRB-_-RRB- Chinese_NNP Biomedical_NNP Literature_NNP Database_NNP -LRB-_-LRB- CBM_NNP -RRB-_-RRB- ,_, -LRB-_-LRB- b_NN -RRB-_-RRB- Chinese_NNP Medical_NNP Current_NNP Content_NNP -LRB-_-LRB- CMCC_NNP -RRB-_-RRB- 
-Chinese_JJ interface_NN 
Of_IN these_DT 14_CD journals_NNS ,_, only_RB one_CD was_VBD published_VBN in_IN Chinese_NNP ,_, while_IN the_DT rest_NN were_VBD in_IN English_NNP ._. 
Seventy-four_JJ journals_NNS from_IN mainland_JJ China_NNP were_VBD indexed_VBN in_IN 2006_CD Journal_NNP Citation_NNP Reports_NNP 
-RRB-_-RRB- As_IN of_IN 30_CD th_NN September_NNP 2006_CD ,_, 20,800_CD serial_JJ titles_NNS were_VBD received_VBN by_IN the_DT National_NNP Library_NNP of_IN Medicine_NNP ,_, the_DT largest_JJS medical_JJ library_NN in_IN the_DT world_NN 
Of_IN these_DT 14_CD journals_NNS ,_, only_RB one_CD was_VBD published_VBN in_IN Chinese_NNP ,_, while_IN the_DT rest_NN were_VBD in_IN English_NNP ._. 
Seventy-four_JJ journals_NNS from_IN mainland_JJ China_NNP were_VBD indexed_VBN in_IN 2006_CD Journal_NNP Citation_NNP Reports_NNP 
-RRB-_-RRB- As_IN of_IN 30_CD th_NN September_NNP 2006_CD ,_, 20,800_CD serial_JJ titles_NNS were_VBD received_VBN by_IN the_DT National_NNP Library_NNP of_IN Medicine_NNP ,_, the_DT largest_JJS medical_JJ library_NN in_IN the_DT world_NN 
Searching_VBG for_IN Chinese_JJ articles_NNS :_: the_DT bibliographic_NN databases_VBZ Full_JJ texts_NNS of_IN more_JJR than_IN five_CD thousand_CD Chinese_JJ journals_NNS are_VBP now_RB available_JJ online_NN ._. 
There_EX are_VBP six_CD mainland_JJ Chinese_JJ bibliographic_JJ databases_NNS through_IN which_WDT Chinese_JJ language_NN biomedical_JJ journal_NN articles_NNS can_MD be_VB searched_VBN and_CC located_VBN and_CC of_IN which_WDT two_CD provide_VBP English_JJ interfaces_NNS :_: -LRB-_-LRB- a_DT -RRB-_-RRB- Chinese_NNP Biomedical_NNP Literature_NNP Database_NNP -LRB-_-LRB- CBM_NNP -RRB-_-RRB- ,_, -LRB-_-LRB- b_NN -RRB-_-RRB- Chinese_NNP Medical_NNP Current_NNP Content_NNP -LRB-_-LRB- CMCC_NNP -RRB-_-RRB- 
-Chinese_JJ interface_NN 
While_IN Wan_NNP Fang_NNP provides_VBZ access_NN to_TO databases_NNS of_IN journal_NN articles_NNS ,_, conference_NN proceedings_NNS ,_, degree_NN theses_NNS ,_, patents_NNS ,_, national_JJ and_CC industrial_JJ standards_NNS and_CC even_RB listed_VBN companies_NNS in_IN China_NNP ,_, iLib_NNP is_VBZ essentially_RB a_DT subset_NN of_IN Wan_NNP Fang_NNP and_CC is_VBZ restricted_VBN to_TO journal_NN articles_NNS only_RB ._. 
The_DT Wan_NNP Fang_NNP database_NN maintains_VBZ two_CD portals_NNS ,_, one_CD in_IN Chinese_NNP 
Searching_VBG for_IN Chinese_JJ articles_NNS :_: the_DT bibliographic_NN databases_VBZ Full_JJ texts_NNS of_IN more_JJR than_IN five_CD thousand_CD Chinese_JJ journals_NNS are_VBP now_RB available_JJ online_NN ._. 
There_EX are_VBP six_CD mainland_JJ Chinese_JJ bibliographic_JJ databases_NNS through_IN which_WDT Chinese_JJ language_NN biomedical_JJ journal_NN articles_NNS can_MD be_VB searched_VBN and_CC located_VBN and_CC of_IN which_WDT two_CD provide_VBP English_JJ interfaces_NNS :_: -LRB-_-LRB- a_DT -RRB-_-RRB- Chinese_NNP Biomedical_NNP Literature_NNP Database_NNP -LRB-_-LRB- CBM_NNP -RRB-_-RRB- ,_, -LRB-_-LRB- b_NN -RRB-_-RRB- Chinese_NNP Medical_NNP Current_NNP Content_NNP -LRB-_-LRB- CMCC_NNP -RRB-_-RRB- 
-Chinese_JJ interface_NN 
Thus_RB ,_, the_DT cost_NN of_IN setting_VBG up_RP and_CC maintaining_VBG an_DT individual_JJ website_NN for_IN a_DT journal_NN may_MD seem_VB to_TO be_VB a_DT potential_JJ financial_JJ disincentive_NN ._. 
Furthermore_RB ,_, most_JJS OA_NNP journals_NNS ,_, like_IN that_DT of_IN BioMed_NNP Central_NNP 
Thus_RB ,_, the_DT cost_NN of_IN setting_VBG up_RP and_CC maintaining_VBG an_DT individual_JJ website_NN for_IN a_DT journal_NN may_MD seem_VB to_TO be_VB a_DT potential_JJ financial_JJ disincentive_NN ._. 
Furthermore_RB ,_, most_JJS OA_NNP journals_NNS ,_, like_IN that_DT of_IN BioMed_NNP Central_NNP 
However_RB ,_, to_TO date_VB the_DT proportion_NN of_IN mainland_JJ Chinese_JJ journals_NNS adopting_VBG the_DT OA_NNP publishing_NN model_NN is_VBZ small_JJ ._. 
One_CD possible_JJ reason_NN is_VBZ that_IN Chinese_JJ bibliographic_JJ databases_NNS ,_, unlike_IN their_PRP$ Western_JJ counterparts_NNS ,_, provide_VB subscribed_VBD readers_NNS with_IN PDF_NNP full_JJ text_NN on_IN behalf_NN of_IN the_DT journals_NNS at_IN an_DT affordable_JJ rate_NN 
The_DT Alliance_NNP of_IN open_JJ access_NN journals_NNS -LRB-_-LRB- OAJs_NNP -RRB-_-RRB- ,_, sponsored_VBN by_IN the_DT Society_NNP of_IN China_NNP University_NNP Journals_NNPS in_IN Natural_NNP Sciences_NNPS ,_, provides_VBZ access_NN to_TO a_DT number_NN of_IN OA_NNP journals_NNS ,_, predominantly_RB Chinese_JJ university_NN journals_NNS ._. 
The_DT international_JJ Directory_NNP of_IN Open_NNP Access_NNP Journals_NNPS -LRB-_-LRB- DOAJ_NNP -RRB-_-RRB- 
Comparing_VBG English_JJ and_CC German_JJ journals_NNS ,_, Egger_NNP et_FW al._FW ._. 
Back_RB in_IN 1995_CD ,_, Gr_NN 
Apart_RB from_IN those_DT who_WP do_VBP field_NN work_NN in_IN China_NNP ,_, what_WP important_JJ epidemiological_JJ information_NN does_VBZ the_DT Chinese_JJ literature_NN offer_NN us_PRP ._. 
Avoid_JJ language_NN biasPerhaps_VBZ one_CD important_JJ application_NN is_VBZ to_TO avoid_VB language_NN bias_NN in_IN our_PRP$ literature_NN reviews_NNS ._. 
Back_RB in_IN 1995_CD ,_, Gr_NN 
While_IN OA_NNP journals_NNS in_IN the_DT West_NNP can_MD grant_VB waivers_NNS to_TO authors_NNS from_IN low_JJ income_NN countries_NNS because_IN their_PRP$ overhead_NN costs_NNS are_VBP met_VBN by_IN membership_NN fees_NNS and_CC article_NN processing_NN charges_NNS paid_VBN by_IN universities_NNS and_CC authors_NNS from_IN the_DT West_NNP ,_, for_IN most_JJS Chinese_JJ journals_NNS this_DT will_MD be_VB difficult_JJ as_IN most_JJS of_IN their_PRP$ authors_NNS come_VBP from_IN mainland_JJ China_NNP ._. 
However_RB ,_, there_EX are_VBP reasons_NNS to_TO believe_VB that_IN many_JJ mainland_JJ Chinese_JJ authors_NNS welcome_VBP the_DT development_NN of_IN OA_NNP publishing_NN ._. 
Given_VBN the_DT current_JJ limited_JJ accessibility_NN of_IN full_JJ text_NN Chinese_JJ journal_NN articles_NNS from_IN outside_JJ China_NNP ,_, OA_NNP journals_NNS may_MD prove_VB to_TO be_VB an_DT option_NN for_IN rapid_JJ scientific_JJ communication_NN between_IN authors_NNS and_CC readers_NNS from_IN within_IN China_NNP and_CC without_IN ._. 
This_DT led_VBD to_TO the_DT worry_NN that_IN language_NN bias_NN could_MD be_VB introduced_VBN to_TO reviews_NNS and_CC meta-analyses_NNS restricted_VBN to_TO data_NNS published_VBN in_IN English_NNP ,_, leading_VBG to_TO distorted_JJ results_NNS ._. 
However_RB ,_, subsequent_JJ studies_NNS found_VBD little_JJ evidence_NN supporting_VBG this_DT assertion_NN ._. 
Pham_FW et_FW al._FW ._. 
found_VBD that_IN language_NN bias_NN led_VBD to_TO an_DT under-estimation_NN of_IN the_DT protective_JJ effect_NN of_IN intervention_NN in_IN RCTs_NNP in_IN complementary_JJ and_CC alternative_JJ medicine_NN -LRB-_-LRB- CAM_NNP -RRB-_-RRB- systematic_JJ reviews_NNS but_CC not_RB in_IN that_DT of_IN conventional_JJ medicine_NN 
This_DT led_VBD to_TO the_DT worry_NN that_IN language_NN bias_NN could_MD be_VB introduced_VBN to_TO reviews_NNS and_CC meta-analyses_NNS restricted_VBN to_TO data_NNS published_VBN in_IN English_NNP ,_, leading_VBG to_TO distorted_JJ results_NNS ._. 
However_RB ,_, subsequent_JJ studies_NNS found_VBD little_JJ evidence_NN supporting_VBG this_DT assertion_NN ._. 
Pham_FW et_FW al._FW ._. 
found_VBD that_IN language_NN bias_NN led_VBD to_TO an_DT under-estimation_NN of_IN the_DT protective_JJ effect_NN of_IN intervention_NN in_IN RCTs_NNP in_IN complementary_JJ and_CC alternative_JJ medicine_NN -LRB-_-LRB- CAM_NNP -RRB-_-RRB- systematic_JJ reviews_NNS but_CC not_RB in_IN that_DT of_IN conventional_JJ medicine_NN 
Pham_FW et_FW al._FW ._. 
However_RB ,_, subsequent_JJ studies_NNS found_VBD little_JJ evidence_NN supporting_VBG this_DT assertion_NN ._. 
found_VBD that_IN language_NN bias_NN led_VBD to_TO an_DT under-estimation_NN of_IN the_DT protective_JJ effect_NN of_IN intervention_NN in_IN RCTs_NNP in_IN complementary_JJ and_CC alternative_JJ medicine_NN -LRB-_-LRB- CAM_NNP -RRB-_-RRB- systematic_JJ reviews_NNS but_CC not_RB in_IN that_DT of_IN conventional_JJ medicine_NN 
Regarding_VBG the_DT quality_NN of_IN reports_NNS ,_, trials_NNS and_CC systematic_JJ reviews_NNS published_VBN in_IN English_NNP and_CC those_DT in_IN languages_NNS other_JJ than_IN English_NNP -LRB-_-LRB- LOE_NNP -RRB-_-RRB- ,_, are_VBP similar_JJ 
found_VBD that_IN language_NN bias_NN led_VBD to_TO an_DT under-estimation_NN of_IN the_DT protective_JJ effect_NN of_IN intervention_NN in_IN RCTs_NNP in_IN complementary_JJ and_CC alternative_JJ medicine_NN -LRB-_-LRB- CAM_NNP -RRB-_-RRB- systematic_JJ reviews_NNS but_CC not_RB in_IN that_DT of_IN conventional_JJ medicine_NN 
Regarding_VBG the_DT quality_NN of_IN reports_NNS ,_, trials_NNS and_CC systematic_JJ reviews_NNS published_VBN in_IN English_NNP and_CC those_DT in_IN languages_NNS other_JJ than_IN English_NNP -LRB-_-LRB- LOE_NNP -RRB-_-RRB- ,_, are_VBP similar_JJ 
found_VBD that_IN language_NN bias_NN led_VBD to_TO an_DT under-estimation_NN of_IN the_DT protective_JJ effect_NN of_IN intervention_NN in_IN RCTs_NNP in_IN complementary_JJ and_CC alternative_JJ medicine_NN -LRB-_-LRB- CAM_NNP -RRB-_-RRB- systematic_JJ reviews_NNS but_CC not_RB in_IN that_DT of_IN conventional_JJ medicine_NN ._. 
Regarding_VBG the_DT quality_NN of_IN reports_NNS ,_, trials_NNS and_CC systematic_JJ reviews_NNS published_VBN in_IN English_NNP and_CC those_DT in_IN languages_NNS other_JJ than_IN English_NNP -LRB-_-LRB- LOE_NNP -RRB-_-RRB- ,_, are_VBP similar_JJ 
Quality_NNP of_IN articles_NNS The_DT quality_NN of_IN articles_NNS published_VBN in_IN Chinese_JJ medical_JJ journals_NNS has_VBZ led_VBN to_TO debates_NNS in_IN Western_JJ academia_NN ._. 
The_DT conclusion_NN of_IN a_DT recent_JJ systematic_JJ review_NN on_IN the_DT clinical_JJ effectiveness_NN of_IN treatment_NN with_IN hyperbaric_JJ oxygen_NN for_IN neonatal_JJ hypoxic-ischaemic_JJ encephalophathy_NN that_IN the_DT ``_`` Chinese_JJ medical_JJ literature_NN may_MD be_VB a_DT rich_JJ source_NN of_IN evidence_NN to_TO inform_VB clinical_JJ practice_NN and_CC other_JJ systematic_JJ reviews_NNS ''_'' was_VBD disputed_VBN ._. 
In_IN an_DT online_JJ rapid_JJ response_NN ,_, Peter_NNP C._NNP Gotzsche_NNP -LRB-_-LRB- ``_`` No_RB double_JJ standards_NNS in_IN research_NN ,_, please_VB ''_'' dated_VBD 26_CD th_NN August_NNP 2006_CD -RRB-_-RRB- argued_VBD that_IN Liu_NNP et_FW al._FW 
had_VBD provided_VBN no_DT evidence_NN for_IN their_PRP$ statement_NN ._. 
Gotzsche_NNP -LRB-_-LRB- ``_`` No_RB double_JJ standards_NNS in_IN research_NN ,_, please_VB ''_'' dated_VBD 26_CD th_NN August_NNP 2006_CD -RRB-_-RRB- argued_VBD that_IN Liu_NNP et_FW al._FW ._. 
The_DT standard_NN adopted_VBN by_IN Cochrane_NNP and_CC CONSORT_NNP by_IN which_WDT the_DT Chinese_JJ trials_NNS identified_VBN in_IN 
since_IN they_PRP are_VBP adopted_VBN internationally_RB ,_, including_VBG by_IN the_DT Chinese_NNP Cochrane_NNP Centre_NNP ._. 
The_DT standard_NN adopted_VBN by_IN Cochrane_NNP and_CC CONSORT_NNP by_IN which_WDT the_DT Chinese_JJ trials_NNS identified_VBN in_IN 
since_IN they_PRP are_VBP adopted_VBN internationally_RB ,_, including_VBG by_IN the_DT Chinese_NNP Cochrane_NNP Centre_NNP ._. 
The_DT standard_NN adopted_VBN by_IN Cochrane_NNP and_CC CONSORT_NNP by_IN which_WDT the_DT Chinese_JJ trials_NNS identified_VBN in_IN 
Gotzsche_NNP also_RB cited_VBD two_CD reviews_NNS to_TO argue_VB that_IN ``_`` Chinese_JJ trials_NNS are_VBP far_RB more_RBR positive_JJ ,_, on_IN average_NN ,_, than_IN trials_NNS performed_VBN in_IN other_JJ countries_NNS ''_'' ._. 
In_IN another_DT study_NN ,_, Wang_NNP and_CC Zhang_NNP found_VBD that_IN by_IN 1995_CD ,_, the_DT ``_`` fr_NN 
g._FW There_EX are_VBP examples_NNS of_IN reviews_NNS that_WDT cover_VBP Chinese_JJ journals_NNS and_CC evaluate_VB the_DT evidence_NN available_JJ ,_, e._JJ in_IN a_DT recent_JJ review_NN on_IN the_DT effectiveness_NN of_IN hand-washing_NN in_IN preventing_VBG SARS_NNP ,_, among_IN the_DT ten_CD case-control_JJ studies_NNS identified_VBN ,_, four_CD were_VBD published_VBN in_IN Chinese_JJ journals_NNS ._. 
Conclusion_NN Chinese_JJ journals_NNS are_VBP a_DT mine_NN of_IN epidemiological_JJ information_NN that_WDT is_VBZ yet_RB to_TO be_VB explored_VBN by_IN the_DT outside_JJ world_NN ._. 
Thanks_NNS to_TO the_DT development_NN of_IN the_DT internet_NN and_CC bibliographic_JJ databases_NNS ,_, they_PRP can_MD now_RB be_VB explored_VBN with_IN relative_JJ ease_NN ._. 
It_PRP has_VBZ been_VBN suggested_VBN that_IN in_IN order_NN to_TO be_VB comprehensive_JJ ,_, we_PRP should_MD apply_VB LILACS_NNP in_IN our_PRP$ literature_NN search_NN to_TO cover_VB Spanish_JJ and_CC Portuguese_JJ articles_NNS in_IN our_PRP$ systematic_JJ reviews_NNS 
Thanks_NNS to_TO the_DT development_NN of_IN the_DT internet_NN and_CC bibliographic_JJ databases_NNS ,_, they_PRP can_MD now_RB be_VB explored_VBN with_IN relative_JJ ease_NN ._. 
It_PRP has_VBZ been_VBN suggested_VBN that_IN in_IN order_NN to_TO be_VB comprehensive_JJ ,_, we_PRP should_MD apply_VB LILACS_NNP in_IN our_PRP$ literature_NN search_NN to_TO cover_VB Spanish_JJ and_CC Portuguese_JJ articles_NNS in_IN our_PRP$ systematic_JJ reviews_NNS 
-LRB-_-LRB- Chinese_NNP Journal_NNP of_IN Trauma_NNP -RRB-_-RRB- ;_: 4_CD ._. 
There_EX is_VBZ a_DT Chinese_JJ language_NN journal_NN of_IN a_DT similar_JJ title_NN :_: 
g._IN Some_DT are_VBP even_RB considering_VBG switching_VBG to_TO English_NNP completely_RB ,_, e._VB Switching_VBG to_TO English_NNP :_: Opportunities_NNPS and_CC pitfalls_NNS More_RBR and_CC more_RBR Chinese_JJ language_NN biomedical_JJ journals_NNS now_RB accept_VBP submission_NN of_IN English_JJ articles_NNS -LRB-_-LRB- with_IN Chinese_JJ abstracts_NNS -RRB-_-RRB- ._. 
the_DT Journal_NNP of_IN Molecular_NNP Biology_NNP 
It_PRP is_VBZ common_JJ among_IN mainland_JJ Chinese_JJ universities_NNS to_TO publish_VB university_NN journals_NNS that_WDT contain_VBP predominantly_RB their_PRP$ own_JJ research_NN outputs_NNS ._. 
These_DT journals_NNS number_NN around_IN 2000_CD in_IN total_NN ,_, of_IN which_WDT nearly_RB half_RB belong_VB to_TO natural_JJ sciences_NNS ._. 
University_NNP journals_NNS published_VBN by_IN medical_JJ universities_NNS or_CC medical_JJ faculties_NNS of_IN comprehensive_JJ universities_NNS cover_VBP the_DT whole_JJ spectrum_NN of_IN medical_JJ specialities_NNS ._. 
The_DT performances_NNS of_IN 41_CD of_IN these_DT medical_JJ university_NN journals_NNS have_VBP been_VBN analyzed_VBN recently_RB 
Nearly_RB half_NN of_IN the_DT 31_CD English_JJ language_NN journals_NNS surveyed_VBN are_VBP general_JJ medical_JJ journals_NNS ,_, while_IN there_EX are_VBP no_DT English_JJ language_NN journals_NNS from_IN China_NNP that_WDT are_VBP specialised_VBN in_IN fields_NNS like_IN epidemiology_NN and_CC preventive_JJ medicine_NN ._. 
As_IN it_PRP has_VBZ been_VBN suggested_VBN ,_, general_JJ journals_NNS should_MD merge_VB to_TO raise_VB their_PRP$ profile_NN while_IN others_NNS should_MD specialise_VB to_TO avoid_VB overlap_VB in_IN disciplines_NNS ._. 
Among_IN these_DT 31_CD journals_NNS ,_, the_DT only_JJ full-time_JJ Editor-in-Chief_NN is_VBZ that_IN of_IN the_DT World_NNP Journal_NNP of_IN Gastroenterology_NNP :_: WJG_NNP ._. 
According_VBG to_TO Zhang_NNP et_FW al._FW ._. 
the_DT Journal_NNP of_IN Molecular_NNP Biology_NNP 
They_PRP are_VBP indexed_VBN by_IN Medline_NNP and_CC Chemical_NNP Abstracts_NNPS ._. 
The_DT Chinese_NNP Journal_NNP of_IN Epidemiology_NNP and_CC the_DT Chinese_NNP Journal_NNP of_IN Preventive_NNP Medicine_NNP -LRB-_-LRB- both_DT published_VBN by_IN the_DT Chinese_NNP Medical_NNP Association_NNP -LRB-_-LRB- CMA_NNP -RRB-_-RRB- -RRB-_-RRB- ,_, and_CC Journal_NNP of_IN Hygiene_NNP Research_NNP -LRB-_-LRB- published_VBN by_IN the_DT Chinese_NNP Center_NNP for_IN Disease_NNP Control_NNP and_CC Prevention_NNP -LRB-_-LRB- China_NNP CDC_NNP -RRB-_-RRB- -RRB-_-RRB- ,_, represent_VBP the_DT best_JJS research_NN outputs_NNS of_IN the_DT disciplines_NNS in_IN mainland_NN China_NNP ._. 
Other_JJ national_JJ journals_NNS include_VBP CPMA_NNP journals_NNS ,_, like_IN the_DT China_NNP Preventive_NNP Medicine_NNP and_CC the_DT Chinese_NNP Journal_NNP of_IN Public_NNP Health_NNP ,_, and_CC the_DT International_NNP Journal_NNP of_IN Epidemiology_NNP and_CC Infectious_NNP Disease_NNP -LRB-_-LRB- formerly_RB entitled_VBN ,_, Foreign_NNP Medical_NNP Sciences_NNP -LRB-_-LRB- Epidemiology_NNP and_CC Infectious_NNP Disease_NNP -RRB-_-RRB- -RRB-_-RRB- of_IN CMA_NNP ._. 
Of_IN 31_CD provinces_NNS ,_, autonomous_JJ regions_NNS and_CC municipalities_NNS of_IN the_DT People_NNP 's_POS Republic_NNP -LRB-_-LRB- excluding_VBG the_DT Special_JJ Administrative_JJ Regions_NNS of_IN Hong_NNP Kong_NNP and_CC Macao_NNP -RRB-_-RRB- ,_, only_RB 12_CD publish_VBP their_PRP$ own_JJ journals_NNS of_IN preventive_JJ medicine_NN -LRB-_-LRB- Table_NNP 4_CD -RRB-_-RRB- 
CAST_NN :_: China_NNP Association_NNP for_IN Science_NNP and_CC Technology_NNP ;_: CDC_NNP :_: Center_NNP for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ;_: CHIS_NNP :_: China_NNP Health_NNP Informatics_NNPS Society_NNP ;_: CIEHM_NNP :_: Committee_NNP of_IN Industrial_NNP Enterprise_NNP Hospital_NNP Management_NNP ;_: CIQ_NNP Tianjin_NNP :_: Tianjin_NNP Entry-Exit_NNP Inspection_NNP and_CC Quarantine_NNP Bureau_NNP ;_: CIQT_NNP :_: China_NNP Inspection_NNP and_CC Quarantine_NNP Times_NNP ;_: CMA_NNP :_: Chinese_NNP Medical_NNP Association_NNP ;_: CMU_NNP :_: Chinese_NNP Medical_NNP Universtiy_NNP ;_: CPMA_NNP :_: Chinese_NNP Preventive_NNP Medicine_NNP Association_NNP ;_: GAQSIQPRC_NNP :_: General_NNP Administration_NNP of_IN Quality_NNP Supervision_NNP ,_, Inspection_NNP and_CC Quarantine_NNP of_IN the_DT People_NNS 's_POS Republic_NNP of_IN China_NNP ;_: GDEBMRC_NNP :_: Guangdong_NNP Evidence-based_JJ Medicine_NNP Research_NNP Center_NNP ;_: GPPH_NNP :_: Guangdong_NNP Provinicial_NNP People_NNP 's_POS Hospital_NN ;_: HB_NNP :_: Health_NNP Bureau_NNP -LRB-_-LRB- of_IN a_DT Province_NNP or_CC an_DT -LRB-_-LRB- Ethnic_NNP Minority_NNP -RRB-_-RRB- Autonomous_NNP Region_NNP or_CC a_DT Municipality_NN -RRB-_-RRB- ;_: IOHM_NNP :_: Institute_NNP of_IN Occupational_NNP Health_NNP and_CC Medicine_NNP ;_: ITHA_NNP :_: International_NNP Travel_NNP Healthcare_NNP Association_NNP ;_: MoH_NNP :_: Ministry_NNP of_IN Health_NNP ;_: NIPD_NNP :_: National_NNP Institute_NNP of_IN Parasitic_NNP Diseases_NNP ,_, Chinese_NNP Center_NNP for_IN Disease_NNP Control_NNP and_CC Prevention_NNP ;_: NPFPC_NNP :_: National_NNP Population_NNP and_CC Family_NNP Planning_NNP Commission_NNP of_IN China_NNP ;_: NRIFP_NNP :_: National_NNP Research_NNP Institute_NNP for_IN Family_NNP Planning_NNP ,_, NPFPC_NNP ;_: PLA_NNP :_: People_NNP 's_POS Liberation_NNP Army_NNP ;_: PMA_NNP :_: Preventive_NNP Medicine_NNP Association_NNP ;_: SCRIOHDPC_NNP :_: South_NNP China_NNP Regional_NNP Institute_NNP for_IN Occupational_NNP Health_NNP ,_, Disease_NNP Prevention_NNP and_CC Control_NNP ;_: SIPPR_NNP :_: Shanghai_NNP Institute_NNP of_IN Planned_NNP Parenthood_NNP Research_NNP ;_: SMWSB_NNP :_: Shanghai_NNP Municipal_NNP Work_NNP Safety_NNP Bureau_NNP ;_: SODPCICI_NNP :_: Shanghai_NNP Occupational_NNP Diseases_NNPS Prevention_NNP and_CC Cure_NNP Institute_NNP of_IN Chemical_NNP Industry_NNP ;_: TAHSYSU_NNP :_: The_NNP Third_NNP Affiliated_NNP Hospital_NNP of_IN the_DT Sun_NNP Yat-Sen_NNP University_NNP ._. 
Apart_RB from_IN impact_NN factors_NNS published_VBN by_IN Thomson_NNP Scientific_NNP in_IN JCR_NNP ,_, VIP_NNP Information_NNP also_RB publishes_VBZ bibliometric_JJ data_NNS of_IN some_DT of_IN the_DT journals_NNS indexed_VBD in_IN its_PRP$ database_NN ._. 
Ahandful_NNP of_IN journals_NNS listed_VBN in_IN Table_NNP 4_CD have_VBP their_PRP$ VIP_NNP impact_NN factor_NN and_CC immediacy_NN index_NN available_JJ ,_, which_WDT can_MD contribute_VB towards_IN evaluation_NN of_IN their_PRP$ quality_NN ._. 
Should_MD the_DT Chinese_NNPS do_VBP the_DT same_JJ ._. 
Brazilians_NNS can_MD now_RB evaluate_VB their_PRP$ journals_NNS using_VBG the_DT SciELO_NNP impact_NN factor_NN ,_, rather_RB than_IN relying_VBG solely_RB on_IN that_DT published_VBN in_IN JCR_NNP 
Some_DT of_IN these_DT journals_NNS have_VBP been_VBN listed_VBN as_IN Chinese_JJ core_NN journals_NNS in_IN 2004_CD :_: three_CD in_IN parasitology_NN -LRB-_-LRB- Table_NNP 5_CD -RRB-_-RRB- ,_, one_CD in_IN medical_JJ statistics_NNS ,_, one_CD in_IN school_NN health_NN ,_, five_CD in_IN occupational_JJ health_NN and_CC two_CD in_IN reproductive_JJ health_NN and_CC family_NN planning_NN -LRB-_-LRB- Table_NNP 6_CD -RRB-_-RRB- ._. 
Specialist_NN national_JJ journals_NNS like_IN the_DT Chinese_NNP Journal_NNP of_IN Parasitology_NNP and_CC Parasitic_NNP Diseases_NNPS ,_, of_IN the_DT Chinese_NNP Preventive_NNP Medicine_NNP Association_NNP -LRB-_-LRB- CPMA_NNP -RRB-_-RRB- series_NN ,_, publish_VB papers_NNS of_IN high_JJ academic_JJ standard_NN in_IN their_PRP$ respective_JJ specialties_NNS ._. 
University_NNP journals_NNS Articles_NNPS of_IN epidemiological_JJ relevance_NN may_MD also_RB be_VB found_VBN in_IN medical_JJ university_NN journals_NNS ._. 
Guangdong_NNP Provincial_NNP HB_NNP GDEBMRC_NNP ;_: GPPH_NNP ;_: TAHSYSU_NNP 6_CD 1671-5144_CD 44-1548_CD \/_NN R_NNP C_NNP Reproductive_NNP Health_NNP and_CC Family_NNP Planning_NNP Chinese_NNP Journal_NNP of_IN Family_NNP Planning_NNP NPFPCNRIFP121004-818911-4550_NNP \/_NNP RYCJournal_NNP of_IN Reproduction_NNP and_CC Contraception_NNP NPFPC_NNP SIPPR_VBD 4_CD 1001-7844_CD 31-1555_CD \/_NN R_NNP E_NNP Journal_NNP of_IN Reproductive_NNP Medicine_NNP 
NPFPC_FW SIPPR_FW 4_CD 1001-7844_CD 31-1555_CD \/_NN R_NNP E_NNP Journal_NNP of_IN Reproductive_NNP Medicine_NNP NPFPCPeking_NNP Union_NNP Hospital_NNP ;_: NRIFP61004-384511-4645_NNP \/_NNP RCReproduction_NNP and_CC Contraception_NNP NPFPC_NNP SIPPR_NNP 12 0253-357_CD X_NNP 31-1344_CD \/_NNP R_NNP Y_NNP C_NNP None_NN of_IN the_DT journals_NNS listed_VBN above_RB receive_VBP bibliometric_JJ data_NNS ,_, like_IN impact_NN factor_NN and_CC immediacy_NN index_NN ,_, from_IN Thomson_NNP Scientific_NNP 's_POS Journal_NNP Citation_NNP Reports_NNP or_CC from_IN VIP_NNP Information_NNP Qikan_NNP Pingjia_NNP -LRB-_-LRB- Journal_NNP evaluation_NN -RRB-_-RRB- 2005_CD ._. 
All_DT but_CC one_CD are_VBP published_VBN in_IN Chinese_NNP ._. 
Table_NNP 6_CD lists_NNS 23_CD journals_NNS on_IN non-communicable_JJ diseases_NNS ,_, medical_JJ statistics_NNS ,_, school_NN health_NN ,_, occupational_JJ health_NN ,_, port\/frontier_NN health_NN and_CC quarantine_NN ,_, evidence-based_JJ medicine_NN and_CC reproductive_JJ health_NN and_CC family_NN planning_NN ._. 
The_DT exception_NN ,_, the_DT Journal_NNP of_IN Reproduction_NNP and_CC Contraception_NNP is_VBZ published_VBN in_IN English_NNP with_IN a_DT sister_NN publication_NN ,_, Reproduction_NNP and_CC Contraception_NNP ,_, published_VBN in_IN Chinese_NNP ._. 
Some_DT of_IN these_DT journals_NNS have_VBP been_VBN listed_VBN as_IN Chinese_JJ core_NN journals_NNS in_IN 2004_CD :_: three_CD in_IN parasitology_NN -LRB-_-LRB- Table_NNP 5_CD -RRB-_-RRB- ,_, one_CD in_IN medical_JJ statistics_NNS ,_, one_CD in_IN school_NN health_NN ,_, five_CD in_IN occupational_JJ health_NN and_CC two_CD in_IN reproductive_JJ health_NN and_CC family_NN planning_NN -LRB-_-LRB- Table_NNP 6_CD -RRB-_-RRB- ._. 
by_IN dropping_VBG the_DT word_NN `_`` Chinese_JJ '_'' from_IN their_PRP$ titles_NNS -RRB-_-RRB- ,_, they_PRP face_VBP severe_JJ competition_NN from_IN their_PRP$ counterparts_NNS in_IN North_NNP America_NNP and_CC Europe_NNP ._. 
Nevertheless_RB ,_, there_EX are_VBP a_DT few_JJ successes_NNS so_RB far_RB ,_, like_IN Cell_NNP Research_NNP and_CC the_DT World_NNP Journal_NNP of_IN Gastroenterology_NNP :_: WJG_NNP that_WDT are_VBP now_RB indexed_VBN in_IN Science_NNP Citation_NNP Index_NNP Expanded_NNP and_CC MEDLINE_NNP ._. 
As_IN the_DT Chinese_JJ share_NN of_IN the_DT world_NN 's_POS scientific_JJ output_NN increases_NNS and_CC as_IN Chinese_JJ scientists_NNS become_VBP more_RBR fluent_JJ in_IN English_NNP ,_, more_RBR English_JJ language_NN biomedical_JJ journals_NNS published_VBN in_IN China_NNP will_MD recei_VB 
The_DT Journal_NNP of_IN the_DT Formosan_NNP Medical_NNP Society_NNP ,_, see_VBP Appendix_NNP 2_CD -RRB-_-RRB- ._. 
Given_VBN that_IN mainland_JJ Chinese_NNP and_CC Hong_NNP Kong_NNP readers_NNS are_VBP unlikely_JJ to_TO read_VB Taiwanese_JJ journals_NNS ,_, these_DT journals_NNS switch_VBP to_TO English_NNP to_TO gain_VB a_DT wider_JJR readership_NN -LRB-_-LRB- cf._VB Their_PRP$ situation_NN is_VBZ not_RB unlike_IN that_DT of_IN journals_NNS published_VBN in_IN some_DT small_JJ European_JJ countries_NNS ._. 
On_IN the_DT contrary_NN ,_, in_IN mainland_NN China_NNP ,_, with_IN its_PRP$ huge_JJ population_NN and_CC considerable_JJ number_NN of_IN scientists_NNS and_CC medical_JJ professionals_NNS ,_, the_DT internal_JJ market_NN for_IN biomedical_JJ journals_NNS is_VBZ substantial_JJ enough_RB to_TO sustain_VB a_DT sizable_JJ number_NN of_IN Chinese_JJ language_NN journals_NNS ._. 
In_IN some_DT special_JJ cases_NNS ,_, the_DT two_CD approaches_NNS could_MD be_VB used_VBN complementarily_RB :_: for_IN instance_NN ,_, the_DT effect_NN of_IN vitamin_NN A_DT deficiency_NN on_IN child_NN morbidity_NN -LRB-_-LRB- diarrhea_NN and_CC acute_JJ lower_JJR respiratory_NN infections_NNS -RRB-_-RRB- was_VBD verified_VBN using_VBG observational_JJ studies_NNS and_CC later_RB ,_, the_DT effect_NN of_IN vitamin_NN A_DT supplementation_NN of_IN deficient_JJ children_NNS on_IN morbidity_NN was_VBD tested_VBN experimentally_RB ._. 
The_DT questions_NNS put_VBD forward_RB by_IN Greenland_NNP in_IN the_DT paper_NN published_VBN here_RB 
It_PRP is_VBZ not_RB by_IN chance_NN that_IN the_DT classical_JJ study_NN designs_NNS used_VBN in_IN epidemiology_NN are_VBP well_RB suited_VBN for_IN this_DT task_NN ._. 
During_IN the_DT 1990s_CD several_JJ leading_VBG epidemiologists_NNS intensified_VBN alerts_VBZ about_IN the_DT insufficiency_NN and_CC limits_NNS of_IN such_JJ strategies_NNS used_VBN in_IN epidemiology_NN ._. 
While_IN the_DT focus_NN of_IN their_PRP$ criticisms_NNS varied_VBN from_IN theoretical_JJ or_CC paradigmatic_JJ questions_NNS to_TO more_RBR applied_JJ ones_NNS ,_, together_RB they_PRP raised_VBD serious_JJ concerns_NNS about_IN the_DT role_NN of_IN epidemiology_NN to_TO fulfill_VB its_PRP$ mission_NN of_IN producing_VBG sound_JJ knowledge_NN and_CC informing_VBG effective_JJ actions_NNS compatible_JJ with_IN present_JJ and_CC future_JJ population_NN health_NN needs_NNS ._. 
In_IN some_DT special_JJ cases_NNS ,_, the_DT two_CD approaches_NNS could_MD be_VB used_VBN complementarily_RB :_: for_IN instance_NN ,_, the_DT effect_NN of_IN vitamin_NN A_DT deficiency_NN on_IN child_NN morbidity_NN -LRB-_-LRB- diarrhea_NN and_CC acute_JJ lower_JJR respiratory_NN infections_NNS -RRB-_-RRB- was_VBD verified_VBN using_VBG observational_JJ studies_NNS and_CC later_RB ,_, the_DT effect_NN of_IN vitamin_NN A_DT supplementation_NN of_IN deficient_JJ children_NNS on_IN morbidity_NN was_VBD tested_VBN experimentally_RB ._. 
The_DT questions_NNS put_VBD forward_RB by_IN Greenland_NNP in_IN the_DT paper_NN published_VBN here_RB 
Stuart_NNP Mill_NNP in_IN the_DT mid-19_JJ th_JJ century_NN ._. 
However_RB ,_, the_DT first_JJ to_TO transform_VB philosophical_JJ causal_JJ concerns_NNS in_IN an_DT organized_JJ logical_JJ system_NN from_IN which_WDT causal_JJ relationships_NNS could_MD be_VB inferred_VBN was_VBD the_DT philosopher_NN J._NNP He_PRP formulated_VBD the_DT so_RB called_VBN Mill_NNP 's_POS Canons_NNS ._. 
At_IN the_DT same_JJ time_NN ,_, bacteriologists_NNS excited_VBN with_IN their_PRP$ newly-emerging_JJ discipline_NN were_VBD looking_VBG for_IN more_JJR specific_JJ systems_NNS to_TO help_VB them_PRP to_TO check_VB etiological_JJ associations_NNS between_IN infectious_JJ agents_NNS and_CC specific_JJ diseases_NNS ,_, and_CC to_TO attend_VB this_DT need_NN the_DT Henl_NNP 
After_IN that_DT ,_, it_PRP would_MD take_VB nearly_RB a_DT century_NN for_IN new_JJ causal_JJ formulations_NNS related_VBN to_TO health-related_JJ events_NNS to_TO be_VB developed_VBN ._. 
The_DT rise_NN of_IN the_DT chronic_JJ diseases_NNS as_IN the_DT main_JJ component_NN of_IN the_DT morbidity_NN and_CC the_DT mortality_NN in_IN rich_JJ countries_NNS and_CC the_DT consequent_JJ changes_NNS that_IN this_DT had_VBD upon_IN the_DT causal_JJ thinking_NN in_IN epidemiology_NN -LRB-_-LRB- until_IN then_RB dominated_VBN by_IN infectious_JJ disease_NN -RRB-_-RRB- was_VBD the_DT stimulus_NN for_IN the_DT development_NN of_IN the_DT widely_RB known_VBN Hill_NNP criteria_NNS of_IN causality_NN ._. 
In_IN order_NN to_TO address_VB problems_NNS raised_VBN by_IN newly_RB discovered_VBN infectious_JJ agents_NNS that_WDT did_VBD not_RB behave_VB according_VBG to_TO the_DT Henl_NNP 
The_DT rise_NN of_IN the_DT chronic_JJ diseases_NNS as_IN the_DT main_JJ component_NN of_IN the_DT morbidity_NN and_CC the_DT mortality_NN in_IN rich_JJ countries_NNS and_CC the_DT consequent_JJ changes_NNS that_IN this_DT had_VBD upon_IN the_DT causal_JJ thinking_NN in_IN epidemiology_NN -LRB-_-LRB- until_IN then_RB dominated_VBN by_IN infectious_JJ disease_NN -RRB-_-RRB- was_VBD the_DT stimulus_NN for_IN the_DT development_NN of_IN the_DT widely_RB known_VBN Hill_NNP criteria_NNS of_IN causality_NN ._. 
In_IN order_NN to_TO address_VB problems_NNS raised_VBN by_IN newly_RB discovered_VBN infectious_JJ agents_NNS that_WDT did_VBD not_RB behave_VB according_VBG to_TO the_DT Henl_NNP 
It_PRP is_VBZ not_RB by_IN chance_NN that_IN the_DT classical_JJ study_NN designs_NNS used_VBN in_IN epidemiology_NN are_VBP well_RB suited_VBN for_IN this_DT task_NN ._. 
During_IN the_DT 1990s_CD several_JJ leading_VBG epidemiologists_NNS intensified_VBN alerts_VBZ about_IN the_DT insufficiency_NN and_CC limits_NNS of_IN such_JJ strategies_NNS used_VBN in_IN epidemiology_NN ._. 
While_IN the_DT focus_NN of_IN their_PRP$ criticisms_NNS varied_VBN from_IN theoretical_JJ or_CC paradigmatic_JJ questions_NNS to_TO more_RBR applied_JJ ones_NNS ,_, together_RB they_PRP raised_VBD serious_JJ concerns_NNS about_IN the_DT role_NN of_IN epidemiology_NN to_TO fulfill_VB its_PRP$ mission_NN of_IN producing_VBG sound_JJ knowledge_NN and_CC informing_VBG effective_JJ actions_NNS compatible_JJ with_IN present_JJ and_CC future_JJ population_NN health_NN needs_NNS ._. 
In_IN some_DT special_JJ cases_NNS ,_, the_DT two_CD approaches_NNS could_MD be_VB used_VBN complementarily_RB :_: for_IN instance_NN ,_, the_DT effect_NN of_IN vitamin_NN A_DT deficiency_NN on_IN child_NN morbidity_NN -LRB-_-LRB- diarrhea_NN and_CC acute_JJ lower_JJR respiratory_NN infections_NNS -RRB-_-RRB- was_VBD verified_VBN using_VBG observational_JJ studies_NNS and_CC later_RB ,_, the_DT effect_NN of_IN vitamin_NN A_DT supplementation_NN of_IN deficient_JJ children_NNS on_IN morbidity_NN was_VBD tested_VBN experimentally_RB ._. 
The_DT questions_NNS put_VBD forward_RB by_IN Greenland_NNP in_IN the_DT paper_NN published_VBN here_RB 
g._NN Micro-simulation_NN ,_, or_CC agent-based_JJ models_NNS -LRB-_-LRB- e._VB These_DT models_NNS tend_VBP to_TO assume_VB that_IN individuals_NNS form_VBP relatively_RB stable_JJ partnerships_NNS -LRB-_-LRB- some_DT ,_, indeed_RB ,_, assume_VB a_DT static_JJ network_NN -RRB-_-RRB- ._. -RRB-_-RRB- 
in_IN which_WDT individuals_NNS are_VBP often_RB assumed_JJ to_TO reside_VB in_IN households_NNS travel_VBP to_TO schools_NNS or_CC workplaces_NNS daily_RB and_CC so_RB on_IN ,_, fall_NN into_IN the_DT latter_JJ category_NN of_IN models_NNS in_IN which_WDT individuals_NNS are_VBP -LRB-_-LRB- often_RB implicitly_RB -RRB-_-RRB- assumed_VBD to_TO form_VB relatively_RB stable_JJ contact_NN networks_NNS ._. 
Which_WDT of_IN these_DT classes_NNS of_IN model_NN best_RB fits_VBZ reality_NN :_: one_CD in_IN which_WDT at_IN least_JJS some_DT of_IN the_DT contacts_NNS are_VBP stable_JJ -LRB-_-LRB- such_JJ as_IN network_NN models_NNS -RRB-_-RRB- ,_, or_CC one_CD in_IN which_WDT contacts_NNS are_VBP transient_JJ and_CC constantly_RB changing_VBG -LRB-_-LRB- as_IN in_IN mass_JJ action_NN variants_NNS -RRB-_-RRB- ._. 
g._JJ Other_JJ methods_NNS of_IN estimating_VBG contact_NN patterns_NNS have_VBP been_VBN proposed_VBN ,_, such_JJ as_IN using_VBG travel-to-work_NN data_NNS -LRB-_-LRB- e._FW -RRB-_-RRB- or_CC mobile_JJ telephones_NNS or_CC other_JJ devices_NNS to_TO track_VB individuals_NNS ._. 
These_DT techniques_NNS do_VBP not_RB ,_, however_RB ,_, provide_VB information_NN on_IN contacts_NNS and_CC their_PRP$ intimacy_NN ._. 
They_PRP merely_RB provide_VBP data_NNS on_IN the_DT location_NN of_IN individuals_NNS ._. 
Thus_RB the_DT dynamic_JJ patterns_NNS of_IN contacts_NNS and_CC the_DT number_NN of_IN contacts_NNS that_IN individuals_NNS make_VBP reported_VBN here_RB appears_VBZ to_TO be_VB broadly_RB consistent_JJ with_IN the_DT few_JJ other_JJ studies_NNS available_JJ in_IN the_DT literature_NN ._. 
The_DT accuracy_NN of_IN diary-based_JJ reporting_NN of_IN contacts_NNS has_VBZ been_VBN questioned_VBN 
The_DT difference_NN in_IN age_NN between_IN primary_JJ and_CC secondary_JJ cases_NNS -LRB-_-LRB- defined_VBN by_IN date_NN of_IN onset_NN -RRB-_-RRB- was_VBD compared_VBN for_IN clusters_NNS of_IN measles_NNS and_CC meningococcal_JJ disease_NN occurring_VBG over_IN the_DT period_NN 1995_CD 
Thus_RB the_DT dynamic_JJ patterns_NNS of_IN contacts_NNS and_CC the_DT number_NN of_IN contacts_NNS that_IN individuals_NNS make_VBP reported_VBN here_RB appears_VBZ to_TO be_VB broadly_RB consistent_JJ with_IN the_DT few_JJ other_JJ studies_NNS available_JJ in_IN the_DT literature_NN ._. 
The_DT accuracy_NN of_IN diary-based_JJ reporting_NN of_IN contacts_NNS has_VBZ been_VBN questioned_VBN 
The_DT accuracy_NN of_IN diary-based_JJ reporting_NN of_IN contacts_NNS has_VBZ been_VBN questioned_VBN 
Second_JJ ,_, although_IN the_DT survey_NN was_VBD well_RB accepted_VBN ,_, the_DT quality_NN of_IN the_DT resulting_VBG data_NNS is_VBZ difficult_JJ to_TO judge_VB ,_, as_IN there_EX are_VBP so_RB few_JJ similar_JJ studies_NNS ._. 
The_DT number_NN of_IN individuals_NNS contacted_VBN per_IN day_NN is_VBZ similar_JJ to_TO that_DT reported_VBN in_IN our_PRP$ previous_JJ study_NN -LRB-_-LRB- 17_CD contacts_NNS -RRB-_-RRB- and_CC by_IN de_NNP Sola_NNP Pool_NNP and_CC Kochen_NNP 
Thus_RB ,_, it_PRP seems_VBZ that_IN under-recording_NN is_VBZ more_RBR likely_JJ to_TO have_VB occurred_VBN at_IN the_DT lower_JJR intensity_NN of_IN contact_NN ._. 
From_IN our_PRP$ experience_NN accuracy_NN of_IN reporting_NN is_VBZ greatly_RB improved_VBN by_IN ensuring_VBG that_IN individuals_NNS know_VBP in_IN advance_NN when_WRB they_PRP are_VBP to_TO report_VB their_PRP$ contacts_NNS ,_, rather_RB than_IN relying_VBG on_IN them_PRP to_TO remember_VB them_PRP afterwards_RB ,_, although_IN this_DT was_VBD not_RB the_DT case_NN in_IN the_DT Belgian_JJ study_NN ._. 
Other_JJ methods_NNS of_IN estimating_VBG contact_NN patterns_NNS have_VBP been_VBN proposed_VBN ,_, such_JJ as_IN using_VBG travel-to-work_NN data_NNS -LRB-_-LRB- e._SYM 
Such_JJ information_NN will_MD aid_VB the_DT development_NN and_CC parameterisation_NN of_IN models_NNS of_IN close_JJ contact_NN diseases_NNS ,_, and_CC may_MD have_VB direct_JJ use_NN in_IN outbreak_NN investigations_NNS ._. 
BackgroundMathematical_JJ models_NNS have_VBP long_RB been_VBN used_VBN to_TO further_VB our_PRP$ understanding_NN of_IN the_DT spread_NN of_IN close-contact_JJ infections_NNS ,_, such_JJ as_IN measles_NNS and_CC tuberculosis_NNS ,_, and_CC make_VB quantitative_JJ predictions_NNS regarding_VBG the_DT possible_JJ impact_NN of_IN control_NN policies_NNS 
Background_NNP Mathematical_NNP models_NNS have_VBP long_RB been_VBN used_VBN to_TO further_VB our_PRP$ understanding_NN of_IN the_DT spread_NN of_IN close-contact_JJ infections_NNS ,_, such_JJ as_IN measles_NNS and_CC tuberculosis_NNS ,_, and_CC make_VB quantitative_JJ predictions_NNS regarding_VBG the_DT possible_JJ impact_NN of_IN control_NN policies_NNS 
g._NNP This_NNP stimulated_VBD a_DT large_JJ number_NN of_IN detailed_JJ surveys_NNS of_IN patterns_NNS of_IN sexual_JJ mixing_NN in_IN many_JJ different_JJ countries_NNS -LRB-_-LRB- e._NN -RRB-_-RRB- that_WDT has_VBZ lead_NN to_TO a_DT deeper_JJR understanding_NN of_IN the_DT spread_NN of_IN sexually-transmitted_JJ infections_NNS and_CC improved_VBN model-based_JJ predictions_NNS ._. 
No_DT comparable_JJ research_NN effort_NN has_VBZ been_VBN initiated_VBN for_IN close-contact_JJ infections_NNS ,_, even_RB though_IN many_JJ of_IN the_DT major_JJ health_NN threats_NNS that_WDT face_VBP us_PRP today_NN -LRB-_-LRB- such_JJ as_IN pandemic_JJ influenza_NN or_CC severe_JJ acute_JJ respiratory_JJ syndrome_NN -RRB-_-RRB- ,_, and_CC the_DT endemic_JJ diseases_NNS that_WDT cause_VBP such_JJ morbidity_NN worldwide_NN -LRB-_-LRB- such_JJ as_IN pneumococcal_JJ disease_NN ,_, influenza_NN and_CC measles_NNS -RRB-_-RRB- are_VBP spread_VBN via_IN this_DT route_NN ._. 
Largely_RB through_IN the_DT development_NN and_CC exploration_NN of_IN these_DT models_NNS the_DT pivotal_JJ role_NN of_IN the_DT patterns_NNS of_IN host_NN mixing_VBG to_TO the_DT spread_NN of_IN such_JJ pathogens_NNS has_VBZ been_VBN acknowledged_VBN 
Background_NNP Mathematical_NNP models_NNS have_VBP long_RB been_VBN used_VBN to_TO further_VB our_PRP$ understanding_NN of_IN the_DT spread_NN of_IN close-contact_JJ infections_NNS ,_, such_JJ as_IN measles_NNS and_CC tuberculosis_NNS ,_, and_CC make_VB quantitative_JJ predictions_NNS regarding_VBG the_DT possible_JJ impact_NN of_IN control_NN policies_NNS 
Since_IN the_DT patterns_NNS of_IN mixing_NN are_VBP crucial_JJ to_TO determining_VBG the_DT spread_NN of_IN these_DT infections_NNS -LRB-_-LRB- they_PRP can_MD only_RB be_VB spread_VBN via_IN contact_NN -RRB-_-RRB- ,_, the_DT lack_NN of_IN an_DT empirical_JJ base_NN on_IN which_WDT the_DT models_NNS are_VBP based_VBN is_VBZ problematic_JJ ._. 
This_DT study_NN aims_VBZ to_TO explore_VB these_DT issues_NNS of_IN both_DT appropriate_JJ model_NN structure_NN and_CC parameterisation_NN by_IN asking_VBG individuals_NNS to_TO record_VB details_NNS of_IN those_DT that_IN they_PRP contacted_VBD in_IN diaries_NNS ._. 
The_DT results_NNS should_MD allow_VB a_DT deeper_JJR understanding_NN of_IN the_DT routes_NNS of_IN transmission_NN ,_, improve_VB the_DT parameterisation_NN of_IN models_NNS ,_, and_CC aid_VB the_DT investigation_NN of_IN outbreaks_NNS of_IN close-contact_JJ pathogens_NNS ._. 
The_DT contacts_NNS were_VBD recoded_VBN during_IN a_DT two-week_JJ period_NN during_IN the_DT spring_NN term_NN ._. 
Analysis_NN Methods_NNS A_DT convenience_NN sample_NN of_IN undergraduate_JJ students_NNS at_IN the_DT University_NNP of_IN Warwick_NNP were_VBD asked_VBN to_TO record_VB details_NNS of_IN the_DT persons_NNS they_PRP had_VBD contact_NN with_IN for_IN three_CD days_NNS ._. 
As_IN individuals_NNS tend_VBP to_TO make_VB similar_JJ numbers_NNS of_IN contacts_NNS during_IN weekdays_NNS ,_, but_CC fewer_JJR during_IN the_DT weekend_NN ,_, individuals_NNS were_VBD over-sampled_JJ during_IN the_DT weekend_NN ._. 
Hence_RB ,_, participants_NNS were_VBD randomly_RB assigned_VBN one_CD weekday_NN and_CC both_DT weekend_NN days_NNS or_CC alternatively_RB ,_, two_CD randomly_RB assigned_VBN weekdays_NNS and_CC one_CD randomly_RB assigned_VBN weekend_NN day_NN ._. 
Second_JJ ,_, although_IN the_DT survey_NN was_VBD well_RB accepted_VBN ,_, the_DT quality_NN of_IN the_DT resulting_VBG data_NNS is_VBZ difficult_JJ to_TO judge_VB ,_, as_IN there_EX are_VBP so_RB few_JJ similar_JJ studies_NNS ._. 
The_DT number_NN of_IN individuals_NNS contacted_VBN per_IN day_NN is_VBZ similar_JJ to_TO that_DT reported_VBN in_IN our_PRP$ previous_JJ study_NN -LRB-_-LRB- 17_CD contacts_NNS -RRB-_-RRB- and_CC by_IN de_NNP Sola_NNP Pool_NNP and_CC Kochen_NNP 
Such_JJ information_NN will_MD aid_VB the_DT development_NN and_CC parameterisation_NN of_IN models_NNS of_IN close_JJ contact_NN diseases_NNS ,_, and_CC may_MD have_VB direct_JJ use_NN in_IN outbreak_NN investigations_NNS ._. 
BackgroundMathematical_JJ models_NNS have_VBP long_RB been_VBN used_VBN to_TO further_VB our_PRP$ understanding_NN of_IN the_DT spread_NN of_IN close-contact_JJ infections_NNS ,_, such_JJ as_IN measles_NNS and_CC tuberculosis_NNS ,_, and_CC make_VB quantitative_JJ predictions_NNS regarding_VBG the_DT possible_JJ impact_NN of_IN control_NN policies_NNS 
Largely_RB through_IN the_DT development_NN and_CC exploration_NN of_IN these_DT models_NNS the_DT pivotal_JJ role_NN of_IN the_DT patterns_NNS of_IN host_NN mixing_VBG to_TO the_DT spread_NN of_IN such_JJ pathogens_NNS has_VBZ been_VBN acknowledged_VBN 
Background_NNP Mathematical_NNP models_NNS have_VBP long_RB been_VBN used_VBN to_TO further_VB our_PRP$ understanding_NN of_IN the_DT spread_NN of_IN close-contact_JJ infections_NNS ,_, such_JJ as_IN measles_NNS and_CC tuberculosis_NNS ,_, and_CC make_VB quantitative_JJ predictions_NNS regarding_VBG the_DT possible_JJ impact_NN of_IN control_NN policies_NNS 
e._NNP Broadly_NNP ,_, the_DT models_NNS employed_VBN by_IN epidemiologists_NNS can_MD be_VB subdivided_VBN into_IN two_CD 
g._NNP This_NNP stimulated_VBD a_DT large_JJ number_NN of_IN detailed_JJ surveys_NNS of_IN patterns_NNS of_IN sexual_JJ mixing_NN in_IN many_JJ different_JJ countries_NNS -LRB-_-LRB- e._NN -RRB-_-RRB- that_WDT has_VBZ lead_NN to_TO a_DT deeper_JJR understanding_NN of_IN the_DT spread_NN of_IN sexually-transmitted_JJ infections_NNS and_CC improved_VBN model-based_JJ predictions_NNS ._. 
No_DT comparable_JJ research_NN effort_NN has_VBZ been_VBN initiated_VBN for_IN close-contact_JJ infections_NNS ,_, even_RB though_IN many_JJ of_IN the_DT major_JJ health_NN threats_NNS that_WDT face_VBP us_PRP today_NN -LRB-_-LRB- such_JJ as_IN pandemic_JJ influenza_NN or_CC severe_JJ acute_JJ res_NNS 
Second_JJ ,_, although_IN the_DT survey_NN was_VBD well_RB accepted_VBN ,_, the_DT quality_NN of_IN the_DT resulting_VBG data_NNS is_VBZ difficult_JJ to_TO judge_VB ,_, as_IN there_EX are_VBP so_RB few_JJ similar_JJ studies_NNS ._. 
The_DT number_NN of_IN individuals_NNS contacted_VBN per_IN day_NN is_VBZ similar_JJ to_TO that_DT reported_VBN in_IN our_PRP$ previous_JJ study_NN -LRB-_-LRB- 17_CD contacts_NNS -RRB-_-RRB- and_CC by_IN de_NNP Sola_NNP Pool_NNP and_CC Kochen_NNP 
Largely_RB through_IN the_DT development_NN and_CC exploration_NN of_IN these_DT models_NNS the_DT pivotal_JJ role_NN of_IN the_DT patterns_NNS of_IN host_NN mixing_VBG to_TO the_DT spread_NN of_IN such_JJ pathogens_NNS has_VBZ been_VBN acknowledged_VBN 
e._NNP Broadly_NNP ,_, the_DT models_NNS employed_VBN by_IN epidemiologists_NNS can_MD be_VB subdivided_VBN into_IN two_CD 
That_DT is_VBZ ,_, those_DT that_WDT were_VBD contacted_VBN are_VBP a_DT -LRB-_-LRB- random_JJ -RRB-_-RRB- sample_NN of_IN those_DT available_JJ to_TO contact_VB at_IN this_DT level_NN ._. 
In_IN addition_NN ,_, although_IN recorded_JJ contacts_NNS are_VBP presumably_RB only_JJ proxies_NNS of_IN real_JJ at-risk_JJ events_NNS ,_, a_DT recent_JJ paper_NN has_VBZ suggested_VBN that_IN they_PRP offer_VBP a_DT better_JJR explanation_NN of_IN observed_JJ incidence_NN of_IN mumps_NNS and_CC influenza_NN than_IN common_JJ mass-action_NN assumptions_NNS ._. 
In_IN addition_NN ,_, the_DT definitions_NNS used_VBD take_VB no_DT account_NN of_IN repeat_NN contacts_NNS with_IN the_DT same_JJ individual_NN in_IN a_DT day_NN ,_, or_CC the_DT length_NN of_IN time_NN over_IN which_WDT the_DT contact_NN took_VBD place_NN ._. 
The_DT Health_NNP Protection_NNP Agency_NNP investigates_VBZ and_CC records_VBZ outbreaks_NNS of_IN selected_JJ infectious_JJ diseases_NNS in_IN England_NNP and_CC Wales_NNP ._. 
The_DT difference_NN in_IN age_NN between_IN primary_JJ and_CC secondary_JJ cases_NNS -LRB-_-LRB- defined_VBN by_IN date_NN of_IN onset_NN -RRB-_-RRB- was_VBD compared_VBN for_IN clusters_NNS of_IN measles_NNS and_CC meningococcal_JJ disease_NN occurring_VBG over_IN the_DT period_NN 1995_CD 
The_DT exclusion_NN of_IN the_DT literature_NN in_IN Portuguese_NNP ,_, Spanish_NNP and_CC other_JJ languages_NNS may_MD lead_VB to_TO significant_JJ biases_NNS in_IN systematic_JJ reviews_NNS ._. 
Asystematic_JJ review_NN about_IN maternal_JJ morbidity_NN and_CC mortality_NN searched_VBD scientific_JJ papers_NNS in_IN eleven_CD different_JJ databases_NNS ,_, and_CC about_RB 20_CD %_NN of_IN the_DT papers_NNS included_VBD were_VBD published_VBN in_IN languages_NNS other_JJ than_IN English_NNP ._. 
The_DT authors_NNS concluded_VBD that_IN for_IN this_DT type_NN of_IN systematic_JJ review_NN ,_, based_VBN on_IN observational_JJ studie_NN 
It_PRP started_VBD in_IN 1991_CD ._. 
Epidemiology_NNP themes_NNS are_VBP not_RB frequently_RB published_VBN in_IN this_DT journal_NN ._. 
Physis_NNP is_VBZ a_DT publication_NN dedicated_VBN to_TO production_NN in_IN the_DT field_NN of_IN Collective_NNP Health_NNP ,_, with_IN emphasis_NN on_IN Human_NNP and_CC Social_NNP Sciences_NNPS ,_, Health_NNP Policies_NNS ,_, Planning_NNP and_CC Management_NNP ._. 
Revista_NNP Brasileira_NNP de_FW Sa_FW 
Considering_VBG that_IN the_DT indexation_NN criteria_NNS for_IN journals_NNS in_IN LILACS_NNP database_NN follow_VBP the_DT same_JJ standards_NNS required_VBN by_IN Medline_NNP ,_, it_PRP is_VBZ possible_JJ to_TO conclude_VB that_IN 90_CD %_NN of_IN the_DT Latin_NNP American_NNP and_CC Caribbean_NNP scientific_JJ production_NN does_VBZ not_RB circulate_VB in_IN the_DT international_JJ scientific_JJ community_NN ,_, probably_RB due_JJ to_TO the_DT language_NN barrier_NN ._. 
Clark_NNP and_CC Castro_NNP verified_VBD the_DT impact_NN that_IN a_DT search_NN in_IN LILACS_NNP database_NN could_MD have_VB on_IN the_DT choice_NN of_IN papers_NNS for_IN systematic_JJ reviews_NNS published_VBN in_IN five_CD medical_JJ journals_NNS with_IN the_DT highest_JJS impact_NN factor_NN ._. 
In_IN 70_CD %_NN of_IN the_DT cases_NNS analyzed_VBD -LRB-_-LRB- 62_CD systematic_JJ reviews_NNS -RRB-_-RRB- ,_, the_DT search_NN in_IN LILACS_NNP identified_VBD new_JJ papers_NNS that_WDT could_MD have_VB been_VBN included_VBN and_CC which_WDT had_VBD not_RB been_VBN identified_VBN by_IN authors_NNS ._. 
In_IN 70_CD %_NN of_IN the_DT cases_NNS analyzed_VBD -LRB-_-LRB- 62_CD systematic_JJ reviews_NNS -RRB-_-RRB- ,_, the_DT search_NN in_IN LILACS_NNP identified_VBD new_JJ papers_NNS that_WDT could_MD have_VB been_VBN included_VBN and_CC which_WDT had_VBD not_RB been_VBN identified_VBN by_IN authors_NNS ._. 
Another_DT important_JJ aspect_NN that_IN results_NNS in_IN the_DT exclusion_NN of_IN the_DT literature_NN published_VBN in_IN languages_NNS other_JJ than_IN English_NNP is_VBZ emphasized_VBN by_IN Freitas_NNP and_CC collaborators_NNS ._. 
The_DT authors_NNS show_VBP that_IN most_JJS of_IN the_DT clinical_JJ essays_NNS published_VBN in_IN English_JJ show_NN statistically_RB significant_JJ results_NNS ,_, while_IN less_JJR than_IN half_NN of_IN the_DT studies_NNS published_VBN in_IN other_JJ languages_NNS present_VBP positive_JJ results_NNS ._. 
Discussion_NN Although_IN English_NNP has_VBZ been_VBN increasingly_RB regarded_VBN as_IN the_DT lingua_NN franca_NN to_TO communicate_VB in_IN sciences_NNS ,_, Brazilian_JJ researchers_NNS ,_, as_IN it_PRP usually_RB happens_VBZ with_IN researchers_NNS of_IN other_JJ nationalities_NNS whose_WP$ mother_NN tongue_NN is_VBZ not_RB English_JJ ,_, normally_RB face_VBP the_DT dilemma_NN between_IN publishing_VBG their_PRP$ work_NN in_IN English_NNP ,_, trying_VBG to_TO increase_VB their_PRP$ visibility_NN in_IN the_DT international_JJ scientific_JJ community_NN or_CC publish_VB in_IN the_DT native_JJ language_NN seeking_VBG to_TO have_VB greater_JJR social_JJ impact_NN ,_, that_DT is_VBZ ,_, using_VBG the_DT results_NNS of_IN their_PRP$ research_NN to_TO solve_VB real_JJ local_JJ problems_NNS ._. 
This_DT dilemma_NN is_VBZ very_RB present_JJ in_IN professional_JJ and_CC applied_JJ areas_NNS such_JJ as_IN Public_NNP Health_NNP 
Previous_JJ studies_NNS have_VBP documented_VBN that_IN papers_NNS published_VBN in_IN languages_NNS other_JJ than_IN English_NNP have_VBP a_DT great_JJ risk_NN of_IN being_VBG ignored_VBN ,_, simply_RB because_IN they_PRP were_VBD written_VBN in_IN languages_NNS that_WDT are_VBP not_RB accessible_JJ to_TO the_DT international_JJ scientific_JJ community_NN ._. 
However_RB ,_, ``_`` authors_NNS usually_RB want_VBP to_TO attract_VB interest_NN to_TO their_PRP$ work_NN both_DT domestically_RB and_CC internationally_RB ''_'' as_IN Meneghini_NNP and_CC Packer_NNP said_VBD ._. 
According_VBG to_TO these_DT authors_NNS ,_, Brazilian_JJ researchers_NNS publish_VBP about_IN 50,000_CD papers_NNS every_DT year_NN ,_, 60_CD %_NN of_IN which_WDT are_VBP in_IN Portuguese_NNP and_CC 40_CD %_NN in_IN other_JJ languages_NNS ,_, mainly_RB English_NNP ._. 
This_DT dilemma_NN is_VBZ very_RB present_JJ in_IN professional_JJ and_CC applied_JJ areas_NNS such_JJ as_IN Public_NNP Health_NNP 
Between_IN 5_CD %_NN and_CC 9_CD %_NN of_IN the_DT papers_NNS have_VBP foreign_JJ researchers_NNS as_IN co-authors_NNS ._. 
of_IN papers_NNS downloaded_VBD Cadernos_NNP de_FW Sa_FW 
Limiting_VBG the_DT analysis_NN to_TO the_DT papers_NNS that_WDT received_VBD 250_CD citations_NNS or_CC more_JJR ,_, collaboration_NN with_IN foreign_JJ authors_NNS was_VBD observed_VBN in_IN 89_CD ._. 
2%_CD of_IN the_DT papers_NNS ._. 
The_DT Internet_NNP and_CC Open_NNP Access_NNP Teachers_NNPS ,_, researchers_NNS ,_, students_NNS and_CC employees_NNS of_IN 188_CD higher_JJR education_NN and_CC research_NN institutions_NNS throughout_IN Brazil_NNP have_VBP immediate_JJ access_NN to_TO a_DT considerable_JJ part_NN of_IN global_JJ scientific_JJ production_NN updated_VBN through_IN CAPES_NNP '_POS journal_NN portal_NN ,_, maintained_VBN by_IN the_DT government_NN of_IN Brazil_NNP at_IN the_DT annual_JJ cost_NN of_IN US$_$ 20_CD million_CD ._. 
It_PRP prints_VBZ unpublished_JJ papers_NNS that_WDT are_VBP considered_VBN relevant_JJ to_TO the_DT area_NN of_IN public_JJ health_NN ._. 
Cadernos_NNP de_NNP Sa_NNP 
Its_PRP$ objective_NN is_VBZ to_TO disseminate_VB the_DT scientific_JJ knowledge_NN on_IN health_NN promotion_NN to_TO professionals_NNS from_IN the_DT areas_NNS of_IN nutrition_NN ,_, nursing_NN ,_, pharmacy_NN ,_, physical_JJ therapy_NN ,_, speech_NN therapy_NN ,_, occupational_JJ therapy_NN ,_, dentistry_NN ,_, physical_JJ education_NN ,_, medicine_NN and_CC other_JJ related_JJ areas_NNS ._. 
Papers_NNP can_MD be_VB freely_RB accessed_VBN in_IN the_DT journal_NN 's_POS website_NN ._. 
Revista_NNP de_NNP Aten_NNP 
Appendix_NN 2_CD :_: Summary_NN of_IN characterisitics_NNS of_IN Epidemiology_NNP and_CC public_JJ health_NN journals_NNS published_VBN in_IN Portugal_NNP During_IN the_DT period_NN spanning_VBG from_IN 1996_CD to_TO 2002_CD ,_, six_CD issues_NNS of_IN the_DT Revista_NNP de_NNP Epidemiologia_NNP were_VBD published_VBN ,_, which_WDT were_VBD in_IN fact_NN supplements_NNS of_IN Arquivos_NNP of_IN Medicina_NNP ,_, recently_RB included_VBD into_IN SciELO_NNP Portugal_NNP ._. 
These_DT six_CD issues_NNS are_VBP available_JJ for_IN free_JJ access_NN at_IN the_DT website_NN of_IN the_DT Portuguese_NNP Association_NNP of_IN Epidemiology_NNP ._. 
Revista_NNP Portuguesa_NNP de_FW Sa_FW 
It_PRP is_VBZ a_DT regional_JJ journal_NN and_CC mainly_RB publishes_VBZ the_DT results_NNS of_IN studies_NNS and_CC research_NN in_IN the_DT field_NN of_IN public_JJ health_NN produced_VBN in_IN the_DT Department_NNP of_IN Health_NNP of_IN the_DT State_NNP of_IN Bahia_NNP ._. 
The_DT last_JJ volumes_NNS can_MD be_VB freely_RB accessed_VBN at_IN the_DT website_NN Sa_NN 
They_PRP value_VBP especially_RB the_DT papers_NNS that_WDT make_VBP an_DT interface_NN between_IN health_NN and_CC human_JJ sciences_NNS ._. 
It_PRP also_RB publishes_VBZ experience_NN reports_NNS ,_, biographies_NNS ,_, interviews_NNS and_CC testimonies_NNS ._. 
Papers_NNP can_MD be_VB freely_RB accessed_VBN directly_RB at_IN the_DT website_NN ._. 
Revista_NNP Baiana_NNP de_FW Sa_FW 
It_PRP is_VBZ published_VBN by_IN the_DT School_NN of_IN Public_NNP Health_NNP of_IN Minas_NNP Gerais_NNP '_POS State_NNP Health_NNP Department_NNP ._. 
Revista_NNP da_NNP Escola_NNP Mineira_NNP de_FW Sa_FW 
Among_IN the_DT journal_NN 's_POS objectives_NNS ,_, we_PRP may_MD highlight_VB building_VBG awareness_NN among_IN healthcare_NN workers_NNS and_CC authorities_NNS to_TO foster_VB and_CC disseminate_VB themes_NNS and_CC research_NN in_IN primary_JJ healthcare_NN ._. 
The_DT journal_NN has_VBZ been_VBN published_VBN since_IN 1997_CD and_CC issues_NNS after_IN 2003_CD are_VBP available_JJ for_IN download_NN at_IN the_DT website_NN ._. 
Revista_NNP da_NNP Escola_NNP Mineira_NNP de_FW Sa_FW 
Latin-American_NNP and_CC Caribbean_NNP System_NNP of_IN Information_NNP in_IN Health_NNP Sciences_NNPS ..._: Bibliographic_JJ databases_NNS and_CC Open_NNP Access_NNP LILACS-Latin_NNP American_NNP and_CC Caribbean_NNP Literature_NNP in_IN Health_NNP Sciences_NNPS LILACS_NNP database_NN is_VBZ produced_VBN in_IN a_DT cooperative_JJ manner_NN by_IN the_DT institutions_NNS that_WDT integrate_VBP the_DT ._. 
LILACS_NNP registers_VBZ scientific-technical_JJ literature_NN in_IN health_NN produced_VBN by_IN Latin_JJ American_JJ and_CC Caribbean_JJ authors_NNS as_IN of_IN 1982_CD 
The_DT main_JJ objectives_NNS of_IN this_DT database_NN are_VBP bibliographic_JJ control_NN and_CC dissemination_NN of_IN Latin_NNP American_NNP and_CC Caribbean_NNP technical_JJ and_CC scientific_JJ literature_NN in_IN Health_NNP ,_, not_RB included_VBN in_IN international_JJ databases_NNS ._. 
LILACS_NNP describes_VBZ and_CC indexes_NNS theses_NNS ,_, books_NNS ,_, book_NN chapters_NNS ,_, annals_NN of_IN congresses_NNS or_CC conferences_NNS ,_, technical-scientific_JJ reports_NNS ,_, journal_NN papers_NNS ,_, and_CC other_JJ publications_NNS related_VBN to_TO Health_NNP 
2%_CD -RRB-_-RRB- ,_, and_CC Chile_NNP -LRB-_-LRB- 1_CD ._. 
4%_CD -RRB-_-RRB- ,_, Mexico_NNP -LRB-_-LRB- 2_CD ._. 
The_DT remainder_NN Brazilian_JJ production_NN is_VBZ distributed_VBN across_IN different_JJ Latin_JJ American_JJ countries_NNS ,_, particularly_RB Argentina_NNP -LRB-_-LRB- 4_CD ._. 
9%_CD -RRB-_-RRB- ._. 
SciELO_NN 
LILACS_NNP describes_VBZ and_CC indexes_NNS theses_NNS ,_, books_NNS ,_, book_NN chapters_NNS ,_, annals_NN of_IN congresses_NNS or_CC conferences_NNS ,_, technical-scientific_JJ reports_NNS ,_, journal_NN papers_NNS ,_, and_CC other_JJ publications_NNS related_VBN to_TO Health_NNP 
9%_CD -RRB-_-RRB- ._. 
2%_CD -RRB-_-RRB- ,_, and_CC Chile_NNP -LRB-_-LRB- 1_CD ._. 
4%_CD -RRB-_-RRB- ,_, Mexico_NNP -LRB-_-LRB- 2_CD ._. 
The_DT remainder_NN Brazilian_JJ production_NN is_VBZ distributed_VBN across_IN different_JJ Latin_JJ American_JJ countries_NNS ,_, particularly_RB Argentina_NNP -LRB-_-LRB- 4_CD ._. 
SciELO_NN 
These_DT collections_NNS total_VBP 450_CD titles_NNS in_IN several_JJ areas_NNS of_IN knowledge_NN ._. 
SciELO_NN 
The_DT first_JJ four_CD are_VBP journals_NNS published_VBN in_IN Brazil_NNP ,_, SciELO_NNP ,_, created_VBN in_IN 1997_CD as_IN the_DT result_NN of_IN the_DT cooperation_NN between_IN the_DT Latin_NNP American_NNP and_CC Caribbean_NNP Center_NNP of_IN Information_NNP in_IN Health_NNP Sciences_NNPS and_CC the_DT S_NNP 
The_DT number_NN of_IN downloads_NNS of_IN the_DT most_RBS accessed_VBN paper_NN in_IN each_DT of_IN them_PRP ranged_VBD between_IN 300_CD and_CC 27,900_CD ._. 
Even_RB though_IN each_DT of_IN them_PRP was_VBD included_VBN in_IN the_DT database_NN at_IN different_JJ times_NNS ,_, it_PRP is_VBZ possible_JJ to_TO see_VB that_IN all_DT of_IN them_PRP are_VBP very_RB frequently_RB accessed_VBN with_IN downloads_NNS of_IN full_JJ papers_NNS ._. 
Alarge_JJ number_NN of_IN papers_NNS received_VBD more_JJR than_IN 500_CD downloads_NNS in_IN each_DT journal_NN and_CC the_DT number_NN of_IN papers_NNS downloaded_VBN in_IN full_JJ version_NN was_VBD expressive_JJ in_IN all_DT journals_NNS ,_, varying_VBG mainly_RB due_JJ to_TO the_DT time_NN of_IN inclusion_NN of_IN the_DT Journal_NNP in_IN the_DT database_NN ._. 
Table_NNP 6_CD Statistics_NNS of_IN downloads_NNS of_IN full_JJ paper_NN in_IN journals_NNS of_IN Public_NNP Health_NNP and_CC Epidemiology_NNP in_IN SciELO_NNP database_NN ,_, 1999_CD to_TO 2007_CD ._. 
SciELO_NNP is_VBZ among_IN the_DT 10_CD most_RBS visited_VBN databases_NNS through_IN Google_NNP Scholar_NNP and_CC accounts_VBZ for_IN 14_CD %_NN of_IN accesses_NNS to_TO journals_NNS of_IN the_DT Directory_NNP of_IN Open_NNP Access_NNP Journals_NNPS -LRB-_-LRB- DOAJ_NNP -RRB-_-RRB- ._. 
Collection_NN papers_NNS can_MD be_VB accessed_VBN directly_RB on_IN the_DT website_NN or_CC through_IN LILACS_NNP -LRB-_-LRB- Latin_NNP American_NNP Literature_NNP in_IN Health_NNP Sciences_NNPS -RRB-_-RRB- ,_, DOAJ_NNP ,_, PubMed\/MedLine_NNP ,_, World_NNP Cat_NNP ,_, WoS_NNP ,_, Lattes_VBZ platform_NN CAPES_NNS '_POS journal_NN portal_NN ,_, and_CC Google_NNP Scholar_NNP ._. 
The_DT average_JJ cost_NN of_IN SciELO_NNP operation_NN is_VBZ US$_$ 5,800_CD per_IN journal_NN year_NN ,_, approximately_RB US$_$ 114_CD per_IN new_JJ paper_NN included_VBD ,_, US$_$ 14_CD ._. 
Abrief_JJ summary_NN of_IN the_DT characteristics_NNS of_IN some_DT of_IN these_DT journals_NNS is_VBZ provided_VBN in_IN Appendix_NNP 2_CD ._. 
Epidemiology_NNP and_CC public_JJ health_NN journals_NNS in_IN Portugal_NNP In_IN Portugal_NNP SciELO_NNP database_NN makes_VBZ available_JJ for_IN free_JJ access_NN papers_NNS published_VBN by_IN six_CD journals_NNS on_IN health_NN sciences_NNS ,_, none_NN of_IN them_PRP exclusively_RB dedicated_VBD to_TO the_DT field_NN of_IN Public_NNP Health_NNP or_CC specifically_RB to_TO epidemiology_NN -LRB-_-LRB- Table_NNP 3_CD -RRB-_-RRB- ._. 
Table_NNP 3Portuguese_NNP Health_NNP Science_NNP Journals_NNPS in_IN SciELO_NNP databaseJournalsDatabaseLanguageArquivos_NNP de_IN MedicinaSciELOPortugueseJornal_NNP Portugu_NNP 
Table_NNP 5_CD presents_VBZ the_DT local_JJ and_CC foreign_JJ journals_NNS most_RBS often_RB cited_VBN in_IN the_DT papers_NNS published_VBN by_IN Brazilian_JJ Public_NNP Health_NNP and_CC Epidemiology_NNP journals_NNS in_IN SciELO_NNP database_NN ._. 
The_DT journals_NNS most_RBS often_RB cited_VBN are_VBP those_DT with_IN the_DT most_JJS visibility_NN in_IN their_PRP$ respective_JJ areas_NNS ,_, showing_VBG the_DT familiarity_NN of_IN Brazilian_JJ authors_NNS with_IN global_JJ scientific_JJ production_NN ._. 
Table_NNP 5_CD National_JJ and_CC foreign_JJ journals_NNS most_RBS cited_VBN in_IN papers_NNS published_VBN in_IN national_JJ journals_NNS of_IN Public_NNP Health_NNP and_CC Epidemiology_NNP ,_, SciELO_NNP database_NN ,_, 1999_CD 
The_DT average_JJ cost_NN of_IN SciELO_NNP operation_NN is_VBZ US$_$ 5,800_CD per_IN journal_NN year_NN ,_, approximately_RB US$_$ 114_CD per_IN new_JJ paper_NN included_VBD ,_, US$_$ 14_CD ._. 
55_CD per_IN paper_NN maintained_VBN on_IN the_DT database_NN and_CC 2_CD cents_NNS per_IN full_JJ text_NN download_NN ._. 
SciELO_NNP portal_JJ search_NN system_NN provides_VBZ queries_NNS per_IN journal_NN ,_, author_NN ,_, title_NN ,_, issue_NN ,_, type_NN of_IN research_NN ,_, and_CC access_NN to_TO full_JJ text_NN in_IN html_NN or_CC pdf_NN ._. 
These_DT facts_NNS had_VBD an_DT impact_NN on_IN scientific_JJ production_NN and_CC ,_, in_IN the_DT period_NN from_IN 1973_CD to_TO 1992_CD ,_, Brazil_NNP already_RB accounted_VBD for_IN 60_CD ._. 
7%_CD of_IN the_DT papers_NNS on_IN public_JJ health_NN produced_VBN by_IN researchers_NNS from_IN Latin_NNP America_NNP ,_, and_CC published_VBN in_IN indexed_VBN journals_NNS of_IN the_DT database_NN ISI\/Thomson_NNP Scientific_NNP ._. 
This_DT fact_NN becomes_VBZ more_RBR relevant_JJ when_WRB we_PRP note_VBP that_IN with_IN regard_NN to_TO clinical_JJ and_CC biomedical_JJ research_NN ,_, the_DT percentage_NN of_IN Brazilian_JJ production_NN was_VBD 26_CD ._. 
3%_CD of_IN them_PRP published_VBN in_IN English_NNP ._. 
About_IN 18,000_CD papers_NNS are_VBP published_VBN in_IN journals_NNS indexed_VBN by_IN the_DT Thomson_NNP Scientific_NNP Web_NNP of_IN Science_NNP database_NN ,_, 97_CD ._. 
Barreto_NNP analyzed_VBD the_DT Brazilian_JJ production_NN in_IN epidemiology_NN indexed_VBN in_IN MedLine_NNP between_IN 1984_CD and_CC 2004_CD ._. 
Using_VBG a_DT Boolean_JJ combination_NN of_IN many_JJ terms_NNS to_TO select_VB papers_NNS in_IN epidemiology_NN ,_, in_IN the_DT early_JJ phase_NN of_IN the_DT period_NN ,_, 1984_CD 
The_DT average_JJ composition_NN of_IN each_DT group_NN is_VBZ 6_CD ._. 
The_DT directory_NN of_IN research_NN groups_NNS of_IN the_DT Brazilian_JJ National_NNP Research_NNP Council_NNP includes_VBZ ,_, as_IN per_IN the_DT 2004_CD census_NN ,_, 506_CD groups_NNS with_IN at_IN least_JJS one_CD line_NN of_IN research_NN in_IN epidemiology_NN ._. 
1researchers_NNS ._. 
Research_NN funding_NN in_IN epidemiology_NN is_VBZ fundamentally_RB raised_VBN from_IN national_JJ agencies_NNS :_: National_NNP Research_NNP Council_NNP -LRB-_-LRB- CNPq_NNP -RRB-_-RRB- ,_, Agency_NNP for_IN the_DT Financing_NN of_IN Studies_NNP and_CC Projects_NNP -LRB-_-LRB- FINEP_NNP -RRB-_-RRB- ,_, Department_NNP of_IN Science_NNP and_CC Technology_NNP of_IN the_DT Ministry_NNP of_IN Health_NNP -LRB-_-LRB- DECIT\/MS_NNP -RRB-_-RRB- ,_, and_CC state-based_JJ research_NN funding_NN agencies_NNS in_IN most_JJS of_IN the_DT country_NN 's_POS 27_CD States_NNS ._. 
Asmall_JJ share_NN of_IN projects_NNS receives_VBZ foreign_JJ funds_NNS from_IN international_JJ funding_NN agencies_NNS and_CC bodies_NNS of_IN the_DT United_NNP Nations_NNPS system_NN ._. 
The_DT past_JJ years_NNS recorded_VBD substantial_JJ increase_NN of_IN financial_JJ resources_NNS directed_VBN to_TO health_NN research_NN ._. 
Bibliographic_JJ databases_NNS and_CC Open_NNP Access_NNP LILACS-Latin_NNP American_NNP and_CC Caribbean_NNP Literature_NNP in_IN Health_NNP Sciences_NNPS LILACS_NNP database_NN is_VBZ produced_VBN in_IN a_DT cooperative_JJ manner_NN by_IN the_DT institutions_NNS that_WDT integrate_VBP the_DT ._. 
As_IN of_IN August_NNP 2007_CD ,_, the_DT Managing_VBG Committee_NNP changed_VBD the_DT rule_NN ,_, defining_VBG that_IN Public_NNP Health_NNP journals_NNS entitled_VBN to_TO be_VB included_VBN in_IN the_DT collection_NN should_MD publish_VB chiefly_RB papers_NNS related_VBN to_TO disciplines_NNS in_IN the_DT field_NN of_IN Public_NNP Health_NNP ,_, including_VBG health_NN politics_NNS ,_, management_NN ,_, and_CC planning_NN ,_, social_JJ sciences_NNS and_CC public_JJ health_NN ,_, health_NN promotion_NN and_CC interventions_NNS ,_, and_CC epidemiology_NN ._. 
Epidemiology_NNP and_CC public_JJ health_NN Brazilian_JJ journalsIn_NNP Brazil_NNP ,_, there_EX are_VBP approximately_RB 839_CD scientific_JJ journals_NNS that_WDT can_MD be_VB classified_VBN in_IN the_DT different_JJ fields_NNS of_IN Health_NNP Sciences_NNPS ._. 
In_IN the_DT SciELO_NNP database_NN ,_, there_EX are_VBP 57_CD Brazilian_JJ journals_NNS on_IN Health_NNP Sciences_NNPS ,_, being_VBG three_CD in_IN Tropical_NNP Medicine_NNP and_CC eight_CD in_IN Public_NNP Health_NNP and_CC Epidemiology_NNP ._. 
5million_JJ for_IN all_DT Brazilian_JJ journals_NNS in_IN the_DT SciELO_NNP collection_NN ._. 
0The_JJ monthly_JJ average_NN downloads_NNS to_TO full_JJ texts_NNS is_VBZ around_IN 7_CD ._. 
Over_IN the_DT past_JJ 5_CD years_NNS ,_, three_CD Public_NNP Health_NNP journals_NNS were_VBD among_IN the_DT most_RBS frequently_RB visited_VBN :_: Cadernos_NNP de_NNP Sa_NNP 
Over_IN the_DT past_JJ 5_CD years_NNS ,_, three_CD Public_NNP Health_NNP journals_NNS were_VBD among_IN the_DT most_RBS frequently_RB visited_VBN :_: Cadernos_NNP de_NNP Sa_NNP 
The_DT Internet_NNP and_CC Open_NNP Access_NNP Teachers_NNPS ,_, researchers_NNS ,_, students_NNS and_CC employees_NNS of_IN 188_CD higher_JJR education_NN and_CC research_NN institutions_NNS throughout_IN Brazil_NNP have_VBP immediate_JJ access_NN to_TO a_DT considerable_JJ part_NN of_IN global_JJ scientific_JJ production_NN updated_VBN through_IN CAPES_NNP '_POS journal_NN portal_NN ,_, maintained_VBN by_IN the_DT government_NN of_IN Brazil_NNP at_IN the_DT annual_JJ cost_NN of_IN US$_$ 20_CD million_CD ._. 
CAPES_NNS '_POS journal_NN portal_NN provides_VBZ free_JJ access_NN to_TO full_JJ versions_NNS of_IN papers_NNS of_IN more_JJR than_IN 11,419_CD international_JJ ,_, national_JJ and_CC foreign_JJ journals_NNS ,_, and_CC to_TO more_JJR than_IN 90_CD databases_NNS with_IN abstracts_NNS of_IN documents_NNS in_IN all_DT areas_NNS of_IN knowledge_NN ._. 
It_PRP also_RB includes_VBZ a_DT selection_NN of_IN important_JJ sources_NNS of_IN academic_JJ info_NN 
The_DT use_NN of_IN the_DT portal_NN is_VBZ free_JJ for_IN the_DT users_NNS from_IN participating_VBG institutions_NNS ,_, that_DT is_VBZ ,_, all_DT public_JJ ,_, philanthropic_JJ or_CC for-profit_JJ universities_NNS whose_WP$ graduate_JJ programs_NNS are_VBP credentialed_VBN through_IN the_DT three-yearly_JJ evaluation_NN of_IN their_PRP$ post-graduation_JJ courses_NNS ._. 
Access_NN is_VBZ provided_VBN through_IN any_DT terminal_NN connected_VBN to_TO the_DT Internet_NNP located_VBN in_IN the_DT institutions_NNS or_CC authorized_VBN by_IN them_PRP ._. 
All_DT graduate_NN ,_, research_NN and_CC undergraduate_JJ programs_NNS of_IN the_DT Country_NN gain_NN in_IN quality_NN ,_, productivity_NN and_CC competitiveness_NN by_IN using_VBG the_DT Portal_NNP that_WDT is_VBZ in_IN constant_JJ development_NN ._. 
Incorporating_VBG effect_NN modification_NN however_RB removes_VBZ the_DT direct_JJ interpretability_NN of_IN the_DT main_JJ treatment_NN effect_NN one_NN wishes_VBZ to_TO estimate_VB ,_, thereby_RB limiting_VBG one_CD benefit_NN of_IN using_VBG a_DT propensity_NN score_NN ._. 
Still_RB ,_, Sturmer_NNP and_CC colleagues_NNS suggest_VBP that_IN the_DT propensity_NN score-adjustment_JJ approach_NN may_MD yet_RB have_VB an_DT advantage_NN over_IN traditional_JJ methods_NNS when_WRB effect_NN modification_NN is_VBZ present_JJ ,_, because_IN it_PRP allows_VBZ for_IN a_DT summary_NN effect_NN size_NN across_IN all_DT strata_NN of_IN the_DT effect_NN modifiers_NNS ._. 
This_DT can_MD be_VB relevant_JJ in_IN pharmacoepidemiology_NN ,_, to_TO estimate_VB how_WRB a_DT total_JJ population_NN might_MD benefit_VB from_IN a_DT particular_JJ drug_NN ._. 
Alternative_NNP techniques_NNS to_TO adjust_VB for_IN the_DT propensity_NN score_NN include_VBP matching_NN or_CC regression_NN ._. 
01_CD of_IN the_DT propensity_NN score_NN ._. 
However_RB ,_, regression_NN is_VBZ affected_VBN by_IN measurement_NN errors_NNS in_IN the_DT propensity_NN score_NN ._. 
Furthermore_RB ,_, it_PRP assumes_VBZ a_DT linear_JJ relationship_NN between_IN the_DT propensity_NN score_NN and_CC the_DT natural_JJ logarithm_NN of_IN the_DT hazard_NN ._. 
When_WRB the_DT outcome_NN is_VBZ rare_JJ ,_, propensity_NN score-adjustment_NN yields_NNS effect_VBP size_NN estimates_NNS with_IN a_DT higher_JJR precision_NN ._. 
Reviews_NNS of_IN studies_NNS applying_VBG propensity_NN score-adjustment_NN methods_NNS have_VBP shown_VBN however_RB ,_, that_DT propensity_NN score-stratified_JJ modeling_NN was_VBD often_RB not_RB implemented_VBN or_CC reported_VBN appropriately_RB ._. 
Researchers_NNS should_MD carefully_RB assess_VB whether_IN propensity_NN score-adjustment_NN methods_NNS are_VBP appropriate_JJ for_IN their_PRP$ specific_JJ situation_NN ._. 
Choosing_VBG which_WDT method_NN may_MD depend_VB on_IN the_DT quantity_NN of_IN data_NNS ._. 
Similar_JJ to_TO our_PRP$ findings_NNS ,_, both_DT studies_NNS concluded_VBD that_IN propensity_NN score-stratified_JJ modeling_NN rarely_RB led_VBD to_TO a_DT different_JJ result_NN compared_VBN with_IN multivariable-adjusted_JJ modeling_NN ._. 
Cepeda_NNP and_CC colleagues_NNS report_VBP from_IN their_PRP$ simulation_NN study_NN that_IN with_IN eight_CD or_CC more_JJR outcomes_NNS per_IN confounder_NN ,_, the_DT multivariable-adjusted_JJ logistic_JJ regression_NN model_NN showed_VBD better_JJR precision_NN ._. 
However_RB ,_, with_IN fewer_JJR than_IN eight_CD events_NNS per_IN confounder_NN ,_, propensity_NN score-stratified_JJ modeling_NN performed_VBD better_RBR ._. 
Since_IN the_DT proportionality_NN assumption_NN was_VBD not_RB satisfied_JJ ,_, time-stratified_JJ analyses_NNS are_VBP presented_VBN ._. 
They_PRP show_VBP a_DT relative_JJ survival_NN benefit_NN of_IN PD_NNP compared_VBN with_IN HD_NNP that_WDT diminishes_VBZ with_IN increasing_VBG age_NN and_CC in_IN the_DT presence_NN of_IN diabetes_NN ._. 
The_DT clinical_JJ issues_NNS associated_VBN with_IN these_DT findings_NNS are_VBP discussed_VBN more_RBR in_IN depth_NN elsewhere_RB ._. 
Table_NNP 4_CD Multivariable-adjusted_JJ and_CC propensity_NN score-stratified_JJ models_NNS with_IN interaction_NN variables_NNS Multivariable-adjusted_JJ model_NN Propensity_NNP score-stratified_JJ model_NN HR_NNP -LRB-_-LRB- 95_CD %_NN CI_NNP -RRB-_-RRB- HR_NNP -LRB-_-LRB- 95_CD %_NN CI_NNP -RRB-_-RRB- Age_NNP -LRB-_-LRB- per_IN yr_NN -RRB-_-RRB- 1_CD ._. 
Failure_NN to_TO include_VB important_JJ confounders_NNS can_MD lead_VB to_TO biased_VBN estimates_NNS of_IN the_DT treatment_NN effect_NN 
However_RB ,_, Weitzen_NNP and_CC colleagues_NNS in_IN their_PRP$ simulation_NN study_NN showed_VBD that_IN neither_CC the_DT c-statistic_JJ nor_CC the_DT Hosmer-Lemeshow_NNP goodness-of-fit_NN test_NN was_VBD sensitive_JJ to_TO omission_NN of_IN an_DT important_JJ confounder_NN from_IN the_DT propensity_NN score_NN model_NN ._. 
Failure_NN to_TO include_VB important_JJ confounders_NNS can_MD lead_VB to_TO bia_NN 
Several_JJ advantages_NNS of_IN propensity_NN score-stratified_JJ versus_CC traditional_JJ multivariable-adjusted_JJ modeling_NN have_VBP been_VBN suggested_VBN ._. 
The_DT propensity_NN model_NN does_VBZ not_RB need_VB to_TO be_VB parsimonious_JJ and_CC easy_JJ to_TO understand_VB because_IN it_PRP is_VBZ not_RB the_DT focus_NN of_IN the_DT study_NN ._. 
Furthermore_RB ,_, the_DT propensity_NN score_NN enables_VBZ a_DT direct_JJ estimation_NN of_IN comparability_NN of_IN the_DT treatment_NN groups_NNS by_IN assessing_VBG the_DT covariate_JJ balance_NN between_IN groups_NNS ._. 
Furthermore_RB ,_, the_DT propensity_NN score_NN enables_VBZ a_DT direct_JJ estimation_NN of_IN comparability_NN of_IN the_DT treatment_NN groups_NNS by_IN assessing_VBG the_DT covariate_JJ balance_NN between_IN groups_NNS ._. 
Inability_NN to_TO balance_VB confounders_NNS alerts_VBZ investigators_NNS that_IN the_DT treatment_NN groups_NNS are_VBP not_RB sufficiently_RB overlapping_VBG with_IN respect_NN to_TO these_DT confounders_NNS and_CC that_DT selection_NN bias_NN may_MD not_RB be_VB resolvable_JJ ._. 
Traditional_JJ multivariable_JJ regression_NN modeling_NN will_MD not_RB detect_VB this_DT directly_RB ._. 
Patients_NNS with_IN end_NN stage_NN renal_JJ disease_NN -LRB-_-LRB- ESRD_NNP -RRB-_-RRB- require_VBP renal_JJ replacement_NN therapy_NN -LRB-_-LRB- RRT_NNP -RRB-_-RRB- ._. 
However_RB in_IN the_DT setting_NN of_IN end-stage_JJ renal_JJ disease_NN ,_, the_DT assignment_NN of_IN a_DT patient_NN to_TO a_DT specific_JJ dialysis_NN modality_NN should_MD be_VB tailored_VBN to_TO a_DT patient_NN 's_POS specific_JJ pretreatment_NN characteristics_NNS and_CC should_MD not_RB be_VB determined_VBN by_IN the_DT summary_NN effect_NN size_NN across_IN all_DT strata_NN of_IN the_DT effect_NN modifiers_NNS ._. 
Other_JJ studies_NNS that_WDT compared_VBD propensity_NN score-stratified_JJ versus_CC multivariable-adjusted_JJ modeling_NN have_VBP been_VBN reviewed_VBN by_IN Shah_NNP and_CC colleagues_NNS 
They_PRP showed_VBD that_IN when_WRB there_EX is_VBZ a_DT non-uniform_JJ treatment_NN effect_NN ,_, different_JJ adjustment_NN methods_NNS can_MD result_VB in_IN divergent_JJ results_NNS ,_, which_WDT may_MD all_DT be_VB correct_JJ but_CC depend_VBP on_IN the_DT research_NN question_NN implied_VBN by_IN the_DT adjustment_NN method_NN ._. 
Propensity_NN score_NN ,_, as_IN opposed_VBN to_TO traditional_JJ multivariate_JJ modeling_NN ,_, enables_VBZ a_DT direct_JJ estimation_NN of_IN comparability_NN of_IN the_DT treatment_NN groups_NNS by_IN assessing_VBG the_DT covariate_JJ balance_NN between_IN groups_NNS ._. 
For_IN the_DT propensity_NN score-adjustment_JJ approach_NN ,_, there_EX are_VBP no_DT accepted_JJ rules_NNS for_IN construction_NN and_CC evaluation_NN of_IN the_DT propensity_NN score_NN model_NN ._. 
When_WRB the_DT outcome_NN is_VBZ rare_JJ ,_, propensity_NN score-adjustment_NN yields_NNS effect_VBP size_NN estimates_NNS with_IN a_DT higher_JJR precision_NN ._. 
Reviews_NNS of_IN studies_NNS applying_VBG propensity_NN score-adjustment_NN methods_NNS have_VBP shown_VBN however_RB ,_, that_DT propensity_NN score-stratified_JJ modeling_NN was_VBD often_RB not_RB implemented_VBN or_CC reported_VBN appropriately_RB ._. 
Researchers_NNS should_MD carefully_RB assess_VB whether_IN propensity_NN score-adjustment_NN methods_NNS are_VBP appropriate_JJ for_IN their_PRP$ specific_JJ situation_NN ._. 
Therefore_RB ,_, comparison_NN of_IN patient_JJ survival_NN on_IN HD_NNP and_CC PD_NNP is_VBZ complicated_VBN ._. 
Many_JJ factors_NNS influence_VBP dialysis_NN treatment_NN assignment_NN :_: not_RB only_RB the_DT clinical_JJ characteristics_NNS of_IN a_DT patient_NN ,_, but_CC also_RB patient_NN and_CC physician_NN preference_NN ,_, cultural_JJ factors_NNS and_CC reimbursement_NN policy_NN decisions_NNS may_MD play_VB a_DT role_NN ._. 
Because_IN the_DT one_CD randomized_VBN controlled_JJ trial_NN that_WDT has_VBZ been_VBN undertaken_VBN to_TO assess_VB survival_NN differences_NNS had_VBD to_TO be_VB stopped_VBN prematurely_RB because_IN of_IN low_JJ inclusion_NN rates_NNS ,_, observational_JJ studies_NNS have_VBP to_TO be_VB relied_VBN upon_IN to_TO compare_VB survival_NN on_IN HD_NNP versus_CC PD_NNP ._. 
Our_PRP$ aim_NN was_VBD to_TO compare_VB a_DT propensity_NN score-stratified_JJ model_NN with_IN a_DT traditional_JJ multivariable-adjusted_JJ model_NN ,_, specifically_RB in_IN estimating_VBG survival_NN of_IN hemodialysis_NNS -LRB-_-LRB- HD_NNP -RRB-_-RRB- versus_CC peritoneal_JJ dialysis_NN -LRB-_-LRB- PD_NNP -RRB-_-RRB- patients_NNS to_TO assess_VB the_DT possible_JJ advantages_NNS of_IN using_VBG a_DT propensity_NN score_NN ._. 
The_DT outcome_NN of_IN interest_NN was_VBD all-cause_JJ mortality_NN ,_, as_IN registered_VBN by_IN RENINE_NNP ._. 
We_PRP excluded_VBD patients_NNS younger_JJR than_IN 18_CD years_NNS ,_, patients_NNS who_WP underwent_VBD RRT_NNP for_IN less_JJR than_IN 30_CD days_NNS ,_, patients_NNS who_WP had_VBD more_JJR than_IN one_CD episode_NN of_IN recovery_NN of_IN renal_JJ function_NN ,_, or_CC who_WP died_VBD directly_RB following_VBG a_DT period_NN of_IN renal_JJ recovery_NN ,_, patients_NNS who_WP received_VBD a_DT pre-emptive_JJ transplantation_NN ,_, patients_NNS who_WP died_VBD during_IN the_DT first_JJ 90_CD days_NNS of_IN renal_JJ replacement_NN therapy_NN and_CC patients_NNS from_IN centers_NNS treating_VBG fewer_JJR than_IN 20_CD dialysis_NN patients_NNS or_CC fewer_JJR than_IN 5_CD PD_NNP patients_NNS ._. 
The_DT registry_NN collects_VBZ information_NN on_IN date_NN and_CC cause_NN of_IN death_NN and_CC verifies_VBZ its_PRP$ information_NN yearly_JJ with_IN all_DT centers_NNS ._. 
From_IN registry_JJ data_NNS we_PRP also_RB determined_VBD age_NN and_CC gender_NN of_IN patients_NNS ,_, baseline_JJ dialysis_NN modality_NN ,_, year_NN of_IN first_JJ dialysis_NN ,_, and_CC the_DT center_NN at_IN which_WDT dialysis_NN was_VBD started_VBN ._. 
The_DT outcome_NN of_IN interest_NN was_VBD all-cause_JJ mortality_NN ,_, as_IN registered_VBN by_IN RENINE_NNP ._. 
We_PRP excluded_VBD patients_NNS younger_JJR than_IN 18_CD years_NNS ,_, patients_NNS who_WP underwent_VBD RRT_NNP for_IN less_JJR than_IN 30_CD days_NNS ,_, patients_NNS who_WP had_VBD more_JJR than_IN one_CD episode_NN of_IN recovery_NN of_IN renal_JJ function_NN ,_, or_CC who_WP died_VBD directly_RB following_VBG a_DT period_NN of_IN renal_JJ recovery_NN ,_, patients_NNS who_WP received_VBD a_DT pre-emptive_JJ transplantation_NN ,_, patients_NNS who_WP died_VBD during_IN the_DT first_JJ 90_CD days_NNS of_IN renal_JJ replacement_NN therapy_NN and_CC patients_NNS from_IN centers_NNS treating_VBG fewer_JJR than_IN 20_CD dialysis_NN patients_NNS or_CC fewer_JJR than_IN 5_CD PD_NNP patients_NNS ._. 
The_DT registry_NN collects_VBZ information_NN on_IN date_NN and_CC cause_NN of_IN death_NN and_CC verifies_VBZ its_PRP$ information_NN yearly_JJ with_IN all_DT centers_NNS 
When_WRB the_DT models_NNS included_VBD interaction_NN variables_NNS ,_, all_DT covariates_NNS remained_VBD independent_JJ predictors_NNS ,_, but_CC now_RB dialysis_NN modality_NN besides_IN its_PRP$ interaction_NN variables_NNS became_VBD statistically_RB significant_JJ ._. 
Supporting_VBG our_PRP$ findings_NNS ,_, the_DT identified_VBN effect_NN modifiers_NNS ,_, age_NN and_CC diabetes_NN as_IN primary_JJ renal_JJ disease_NN ,_, correspond_VBP to_TO those_DT found_VBN in_IN previous_JJ studies_NNS ._. 
Our_PRP$ study_NN informs_VBZ the_DT discussion_NN of_IN the_DT utility_NN of_IN propensity_NN score_NN in_IN outcomes_NNS research_NN ._. 
In_IN theory_NN ,_, the_DT use_NN of_IN propensity_NN score-stratified_JJ modeling_NN may_MD allow_VB for_IN a_DT more_RBR straightforward_JJ estimation_NN of_IN the_DT relative_JJ mortality_NN risk_NN in_IN comparison_NN with_IN multivariable-adjusted_JJ modeling_NN ._. 
Introduction_NN Using_VBG observational_JJ data_NNS to_TO compare_VB outcomes_NNS associated_VBN with_IN different_JJ treatments_NNS may_MD result_VB in_IN biased_VBN estimates_NNS because_IN of_IN non-random_JJ treatment_NN assignment_NN ._. 
To_TO correct_VB for_IN variables_NNS that_WDT may_MD confound_VB an_DT association_NN ,_, the_DT traditional_JJ approach_NN is_VBZ to_TO apply_VB multivariable-adjusted_JJ modeling_NN ,_, but_CC in_IN recent_JJ years_NNS ,_, use_NN of_IN propensity_NN scores_NNS has_VBZ become_VBN increasingly_RB popular_JJ 
However_RB in_IN the_DT setting_NN of_IN end-stage_JJ renal_JJ disease_NN ,_, the_DT assignment_NN of_IN a_DT patient_NN to_TO a_DT specific_JJ dialysis_NN modality_NN should_MD be_VB tailored_VBN to_TO a_DT patient_NN 's_POS specific_JJ pretreatment_NN characteristics_NNS and_CC should_MD not_RB be_VB determined_VBN by_IN the_DT summary_NN effect_NN size_NN across_IN all_DT strata_NN of_IN the_DT effect_NN modifiers_NNS ._. 
Other_JJ studies_NNS that_WDT compared_VBD propensity_NN score-stratified_JJ versus_CC multivariable-adjusted_JJ modeling_NN have_VBP been_VBN reviewed_VBN by_IN Shah_NNP and_CC colleagues_NNS 
When_WRB the_DT outcome_NN is_VBZ rare_JJ ,_, propensity_NN score-adjustment_NN yields_NNS effect_VBP size_NN estimates_NNS with_IN a_DT higher_JJR precision_NN ._. 
Reviews_NNS of_IN studies_NNS applying_VBG propensity_NN score-adjustment_NN methods_NNS have_VBP shown_VBN however_RB ,_, that_DT propensity_NN score-stratified_JJ modeling_NN was_VBD often_RB not_RB implemented_VBN or_CC reported_VBN appropriately_RB ._. 
Researchers_NNS should_MD carefully_RB assess_VB whether_IN propensity_NN score-adjustment_NN methods_NNS are_VBP appropriate_JJ for_IN their_PRP$ specific_JJ situation_NN ._. 
To_TO correct_VB for_IN variables_NNS that_WDT may_MD confound_VB an_DT association_NN ,_, the_DT traditional_JJ approach_NN is_VBZ to_TO apply_VB multivariable-adjusted_JJ modeling_NN ,_, but_CC in_IN recent_JJ years_NNS ,_, use_NN of_IN propensity_NN scores_NNS has_VBZ become_VBN increasingly_RB popular_JJ 
To_TO correct_VB for_IN variables_NNS that_WDT may_MD confound_VB an_DT association_NN ,_, the_DT traditional_JJ approach_NN is_VBZ to_TO apply_VB multivariable-adjusted_JJ modeling_NN ,_, but_CC in_IN recent_JJ years_NNS ,_, use_NN of_IN propensity_NN scores_NNS has_VBZ become_VBN increasingly_RB popular_JJ 
Further_RB ,_, Weitzen_NNP and_CC colleagues_NNS 
When_WRB the_DT models_NNS included_VBD interaction_NN variables_NNS ,_, all_DT covariates_NNS remained_VBD independent_JJ predictors_NNS ,_, but_CC now_RB dialysis_NN modality_NN besides_IN its_PRP$ interaction_NN variables_NNS became_VBD statistically_RB significant_JJ ._. 
Supporting_VBG our_PRP$ findings_NNS ,_, the_DT identified_VBN effect_NN modifiers_NNS ,_, age_NN and_CC diabetes_NN as_IN primary_JJ renal_JJ disease_NN ,_, correspond_VBP to_TO those_DT found_VBN in_IN previous_JJ studies_NNS ._. 
Our_PRP$ study_NN informs_VBZ the_DT discussion_NN of_IN the_DT utility_NN of_IN propensity_NN score_NN in_IN outcomes_NNS research_NN ._. 
In_IN theory_NN ,_, the_DT use_NN of_IN 
65_CD and_CC 0_CD ._. 
The_DT propensity_NN score_NN was_VBD then_RB evaluated_VBN for_IN the_DT following_JJ criteria_NNS :_: 1_LS -RRB-_-RRB- a_DT reasonable_JJ Nagelkerke_NNP 's_POS r_NN 2_CD -_: statistic_NN as_IN a_DT measure_NN of_IN fit_NN and_CC a_DT c_NN -_: statistic_NN between_IN 0_CD ._. 
85_CD as_IN a_DT measure_NN of_IN discriminative_JJ power_NN ,_, 2_CD -RRB-_-RRB- good_JJ calibration_NN as_IN measured_VBN by_IN the_DT PS-predicted_JJ and_CC observed_JJ proportion_NN of_IN PD_NNP patients_NNS within_IN quintiles_NNS of_IN the_DT propensity_NN score_NN ,_, and_CC 3_CD -RRB-_-RRB- balanced_JJ covariates_NNS within_IN quintiles_NNS of_IN the_DT propensity_NN score_NN 
85_CD as_IN a_DT measure_NN of_IN discriminative_JJ power_NN ,_, 2_CD -RRB-_-RRB- good_JJ calibration_NN as_IN measured_VBN by_IN the_DT PS-predicted_JJ and_CC observed_JJ proportion_NN of_IN PD_NNP patients_NNS within_IN quintiles_NNS of_IN the_DT propensity_NN score_NN ,_, and_CC 3_CD -RRB-_-RRB- balanced_JJ covariates_NNS within_IN quintiles_NNS of_IN the_DT propensity_NN score_NN 
However_RB ,_, with_IN fewer_JJR than_IN eight_CD events_NNS per_IN confounder_NN ,_, propensity_NN score-stratified_JJ modeling_NN performed_VBD better_RBR ._. 
Furthermore_RB ,_, the_DT choice_NN also_RB depends_VBZ on_IN the_DT research_NN question_NN ,_, as_IN suggested_VBN by_IN Kurth_NNP and_CC colleagues_NNS ._. 
They_PRP showed_VBD that_IN when_WRB there_EX is_VBZ a_DT non-uniform_JJ treatment_NN effect_NN ,_, different_JJ adjustment_NN methods_NNS can_MD result_VB in_IN divergent_JJ results_NNS ,_, which_WDT may_MD all_DT be_VB correct_JJ but_CC depend_VBP on_IN the_DT research_NN question_NN implied_VBN by_IN the_DT adjustment_NN method_NN ._. 
Evaluation_NN of_IN a_DT propensity_NN score_NN model_NN often_RB consists_VBZ of_IN assessing_VBG discrimination_NN with_IN the_DT c-statistic_JJ and_CC calibration_NN with_IN goodness-of-fit_JJ tests_NNS ._. 
However_RB ,_, Weitzen_NNP and_CC colleagues_NNS in_IN their_PRP$ simulation_NN study_NN showed_VBD that_IN neither_CC the_DT c-statistic_JJ nor_CC the_DT Hosmer-Lemeshow_NNP goodness-of-fit_NN test_NN was_VBD sensitive_JJ to_TO omission_NN of_IN an_DT important_JJ confounder_NN from_IN the_DT propensity_NN score_NN model_NN 
Information_NN on_IN primary_JJ renal_JJ diagnosis_NN however_RB is_VBZ available_JJ with_IN the_DT most_RBS important_JJ co-morbid_JJ condition_NN ,_, diabetes_NN ,_, likely_RB well-represented_JJ because_IN of_IN the_DT strong_JJ correlation_NN between_IN diabetes_NN and_CC diabetes_NN as_IN primary_JJ renal_JJ disease_NN -LRB-_-LRB- PRD-DM_NNP -RRB-_-RRB- ._. 
Further_RB ,_, Weitzen_NNP and_CC colleagues_NNS 
Researchers_NNS in_IN the_DT emerging_VBG field_NN of_IN `_`` economic_JJ epidemiology_NN '_'' depart_VBP from_IN existing_VBG epidemiological_JJ studies_NNS by_IN modelling_VBG aggregate_JJ behavior_NN on_IN the_DT premise_NN that_IN a_DT rational_JJ individual_NN 's_POS decision_NN ,_, with_IN respect_NN to_TO vaccinations_NNS ,_, is_VBZ influenced_VBN by_IN both_DT economic_JJ and_CC epidemiological_JJ incentives_NNS ._. 
Geoffard_NNP and_CC Philipson_NNP 
Partial_JJ mandatory_JJ programs_NNS crowd_VBP out_RP the_DT private_JJ demand_NN for_IN vaccination_NN outside_IN the_DT program_NN ,_, in_IN the_DT sense_NN that_IN some_DT individuals_NNS would_MD vaccinate_VB in_IN the_DT absence_NN of_IN the_DT program_NN ,_, but_CC will_MD not_RB vaccinate_VB in_IN its_PRP$ presence_NN -LRB-_-LRB- as_IN prevalence_NN is_VBZ lowered_VBN by_IN the_DT compulsory_JJ program_NN and_CC therefore_RB the_DT incentive_NN diminishes_VBZ -RRB-_-RRB- ._. 
This_DT crowding_VBG out_RP effect_NN is_VBZ one_CD of_IN the_DT possible_JJ interpretations_NNS of_IN why_WRB pre-school_JJ vaccination_NN rates_NNS are_VBP relatively_RB low_JJ in_IN the_DT US_NNP ,_, given_VBN the_DT mandatory_JJ vaccination_NN required_VBN in_IN public_JJ schools_NNS ._. 
The_DT crowding_VBG out_RP effect_NN can_MD also_RB be_VB observed_VBN in_IN 
It_PRP needs_VBZ to_TO be_VB mentioned_VBN here_RB that_IN the_DT analysis_NN of_IN Geoffard_NNP and_CC Philipson_NNP 
The_DT transmission_NN and_CC control_NN of_IN infectious_JJ diseases_NNS are_VBP strongly_RB influenced_VBN by_IN both_DT the_DT individual_JJ and_CC collective_JJ choices_NNS people_NNS make_VBP ._. 
The_DT choice_NN of_IN vaccination_NN is_VBZ guided_VBN by_IN the_DT incentives_NNS and_CC constraints_NNS regarding_VBG vaccination_NN ,_, and_CC individual_JJ free_JJ choices_NNS do_VBP not_RB converge_VB to_TO the_DT social_JJ optimum_JJ for_IN a_DT variety_NN of_IN other_JJ reasons_NNS such_JJ as_IN imperfect_JJ information_NN and_CC differences_NNS in_IN the_DT rate_NN of_IN time_NN preference_NN between_IN individuals_NNS and_CC society_NN ._. 
If_IN individual_JJ behavior_NN does_VBZ not_RB match_VB with_IN the_DT social_JJ optimum_JJ ,_, society_NN as_IN a_DT whole_NN faces_VBZ the_DT costs_NNS of_IN morbidity_NN and_CC mortality_NN associated_VBN with_IN the_DT spread_NN of_IN infectious_JJ diseases_NNS ._. 
The_DT transmission_NN and_CC control_NN of_IN infectious_JJ diseases_NNS are_VBP strongly_RB influenced_VBN by_IN both_DT the_DT individual_JJ and_CC collective_JJ choices_NNS people_NNS make_VBP ._. 
The_DT choice_NN of_IN vaccination_NN is_VBZ guided_VBN by_IN the_DT incentives_NNS and_CC constraints_NNS regarding_VBG vaccination_NN ,_, and_CC individual_JJ free_JJ choices_NNS do_VBP not_RB converge_VB to_TO the_DT social_JJ optimum_JJ for_IN a_DT variety_NN of_IN other_JJ reasons_NNS such_JJ as_IN imperfect_JJ information_NN and_CC differences_NNS in_IN the_DT rate_NN of_IN time_NN preference_NN between_IN individuals_NNS and_CC society_NN ._. 
If_IN individual_JJ behavior_NN does_VBZ not_RB match_VB with_IN the_DT social_JJ optimum_JJ ,_, society_NN as_IN a_DT whole_NN faces_VBZ the_DT costs_NNS of_IN morbidity_NN and_CC mortality_NN associated_VBN with_IN the_DT spread_NN of_IN infectious_JJ diseases_NNS ._. 
Immunisation_NNP represents_VBZ a_DT classic_JJ case_NN of_IN social_JJ dilemma_NN :_: a_DT conflict_NN of_IN interest_NN between_IN the_DT private_JJ gains_NNS of_IN individuals_NNS and_CC the_DT collective_JJ gains_NNS of_IN a_DT society_NN ._. 
An_DT individual_NN 's_POS self-interest_NN and_CC choice_NN often_RB leads_VBZ to_TO a_DT vaccination_NN uptake_NN rate_NN less_JJR than_IN the_DT social_JJ optimum_JJ as_IN individuals_NNS do_VBP not_RB take_VB into_IN account_NN the_DT benefit_NN to_TO others_NNS ._. 
Conventional_JJ wisdom_NN generally_RB favors_VBZ public_JJ intervention_NN in_IN order_NN to_TO produce_VB a_DT socially_RB warranted_JJ level_NN of_IN vaccination_NN ._. 
Individuals_NNS with_IN religious_JJ ,_, medical_JJ or_CC social_JJ reasons_NNS are_VBP often_RB exempted_VBN ._. 
As_IN the_DT benefits_NNS to_TO society_NN are_VBP larger_JJR than_IN the_DT sum_NN of_IN those_DT to_TO individuals_NNS ,_, public_JJ policy_NN measures_NNS aim_VBP to_TO increase_VB demand_NN closer_RBR to_TO the_DT social_JJ optimum_JJ by_IN subsidising_VBG the_DT vaccine_NN -LRB-_-LRB- many_JJ countries_NNS provide_VBP vaccines_NNS free_JJ of_IN charge_NN -RRB-_-RRB- or_CC through_IN compulsory_JJ vaccination_NN ,_, although_IN such_JJ a_DT policy_NN is_VBZ almost_RB always_RB partial_JJ ._. 
There_EX is_VBZ ,_, however_RB ,_, controversy_NN over_IN the_DT effectiveness_NN of_IN public_JJ intervention_NN compared_VBN to_TO the_DT free_JJ choice_NN outcome_NN ,_, and_CC it_PRP is_VBZ the_DT intention_NN of_IN this_DT article_NN to_TO address_VB this_DT issue_NN ._. 
Vaccination_NN decisions_NNS are_VBP made_VBN under_IN imperfect_JJ information_NN ,_, which_WDT means_VBZ an_DT individual_NN 's_POS assessment_NN of_IN the_DT risks_NNS and_CC benefits_NNS of_IN vaccination_NN is_VBZ often_RB inaccurate_JJ ._. 
,vaccination_NN -RRB-_-RRB- and_CC thus_RB suggest_VBP that_IN the_DT likelihood_NN of_IN infection_NN and_CC disease_NN incidence_NN will_MD eventually_RB fall_VB with_IN rising_VBG prevalence_NN ,_, and_CC vice_NN versa_RB when_WRB prevalence_NN is_VBZ low_JJ ._. 
This_DT type_NN of_IN analysis_NN along_IN with_IN other_JJ research_NN essentially_RB challenges_VBZ the_DT effectiveness_NN of_IN public_JJ intervention_NN of_IN any_DT kind_NN that_WDT is_VBZ aimed_VBN to_TO stimulate_VB demand_NN ,_, due_JJ to_TO the_DT fact_NN that_IN private_JJ incentives_NNS to_TO vaccinate_VB counteract_VB the_DT expected_VBN outcome_NN of_IN such_JJ interventions_NNS ._. 
Price_NN subsidy_NN does_VBZ not_RB achieve_VB the_DT expected_VBN outcome_NN because_IN prevalence_NN of_IN disease_NN -LRB-_-LRB- which_WDT is_VBZ related_VBN to_TO risk_NN of_IN disease_NN -RRB-_-RRB- counteracts_VBZ the_DT price_NN sensitiveness_NN of_IN demand_NN ._. 
Researchers_NNS in_IN the_DT emerging_VBG field_NN of_IN `_`` economic_JJ epidemiology_NN '_'' depart_VBP from_IN existing_VBG epidemiological_JJ studies_NNS by_IN modelling_VBG aggregate_JJ behavior_NN on_IN the_DT premise_NN that_IN a_DT rational_JJ individual_NN 's_POS decision_NN ,_, with_IN respect_NN to_TO vaccinations_NNS ,_, is_VBZ influenced_VBN by_IN both_DT economic_JJ and_CC epidemiological_JJ incentives_NNS ._. 
Geoffard_NNP and_CC Philipson_NNP 
The_DT crowding_VBG out_RP effect_NN can_MD also_RB be_VB observed_VBN in_IN the_DT time_NN delay_NN of_IN vaccination_NN where_WRB vaccination_NN of_IN certain_JJ cohorts_NNS of_IN children_NNS is_VBZ delayed_VBN when_WRB the_DT prevalence_NN of_IN disease_NN is_VBZ lowered_VBN by_IN vaccination_NN of_IN earlier_JJR age_NN groups_NNS of_IN children_NNS ._. 
It_PRP needs_VBZ to_TO be_VB mentioned_VBN here_RB that_IN the_DT analysis_NN of_IN Geoffard_NNP and_CC Philipson_NNP 
Individuals_NNS with_IN religious_JJ ,_, medical_JJ or_CC social_JJ reasons_NNS are_VBP often_RB exempted_VBN ._. 
As_IN the_DT benefits_NNS to_TO society_NN are_VBP larger_JJR than_IN the_DT sum_NN of_IN those_DT to_TO individuals_NNS ,_, public_JJ policy_NN measures_NNS aim_VBP to_TO increase_VB demand_NN closer_RBR to_TO the_DT social_JJ optimum_JJ by_IN subsidising_VBG the_DT vaccine_NN -LRB-_-LRB- many_JJ countries_NNS provide_VBP vaccines_NNS free_JJ of_IN charge_NN -RRB-_-RRB- or_CC through_IN compulsory_JJ vaccination_NN ,_, although_IN such_JJ a_DT policy_NN is_VBZ almost_RB always_RB partial_JJ ._. 
There_EX is_VBZ ,_, however_RB ,_, controversy_NN over_IN the_DT effectiveness_NN of_IN public_JJ intervention_NN compared_VBN to_TO the_DT free_JJ choice_NN outcome_NN 
Researchers_NNS in_IN the_DT emerging_VBG field_NN of_IN `_`` economic_JJ epidemiology_NN '_'' depart_VBP from_IN existing_VBG epidemiological_JJ studies_NNS by_IN modelling_VBG aggregate_JJ behavior_NN on_IN the_DT premise_NN that_IN a_DT rational_JJ individual_NN 's_POS decision_NN ,_, with_IN respect_NN to_TO vaccinations_NNS ,_, is_VBZ influenced_VBN by_IN both_DT economic_JJ and_CC epidemiological_JJ incentives_NNS ._. 
Geoffard_NNP and_CC Philipson_NNP 
However_RB ,_, there_EX is_VBZ an_DT emerging_VBG consensus_NN among_IN experts_NNS in_IN genetic_JJ epidemiology_NN that_IN DNA_NNP is_VBZ not_RB the_DT sole_JJ unit_NN of_IN heredity_NN and_CC that_DT genotype_NN and_CC environment_NN are_VBP not_RB the_DT only_JJ determinants_NNS of_IN phenotype_NN 
MicroRNAs_NNS -LRB-_-LRB- miRNAs_NNP -RRB-_-RRB- are_VBP small_JJ -LRB-_-LRB- approximately_RB 22_CD nucleotides_NNS long_RB -RRB-_-RRB- RNA_NNP molecules_NNS that_WDT may_MD be_VB involved_VBN in_IN post-transcriptional_JJ control_NN of_IN gene_NN expression_NN 
The_DT cells_NNS of_IN eukaryotic_JJ organisms_NNS contain_VBP an_DT additional_JJ level_NN of_IN information_NN superimposed_VBN on_IN the_DT DNA_NNP double_JJ helix_NN ,_, a_DT nucleoprotein_JJ entity_NN known_VBN as_IN ``_`` chromatin_NN ''_'' ._. 
This_DT ``_`` DNA_NN packaging_NN ''_'' -LRB-_-LRB- or_CC ``_`` epigenome_NN ''_'' -RRB-_-RRB- has_VBZ recently_RB been_VBN implicated_VBN in_IN the_DT regulation_NN of_IN the_DT complex_JJ interactions_NNS of_IN the_DT enzymatic_JJ processes_NNS of_IN replication_NN ,_, transcription_NN ,_, recombination_NN ,_, and_CC DNA_NN repair_NN 
Inherited_VBN changes_NNS in_IN the_DT ``_`` epigenome_NN ''_'' have_VBP been_VBN postulated_VBN as_IN a_DT possible_JJ pathway_NN explaining_VBG the_DT differences_NNS in_IN gene_NN expression_NN seen_VBN in_IN individuals_NNS with_IN identical_JJ ``_`` genomes_NNS ''_'' 
Agrowing_VBG body_NN of_IN evidence_NN suggests_VBZ that_IN the_DT impact_NN of_IN environmental_JJ influences_NNS may_MD extend_VB beyond_IN the_DT DNA_NN sequence_NN 
Mendelian_JJ randomization_NN studies_NNS may_MD also_RB counteract_VB some_DT key_JJ shortcomings_NNS of_IN randomized_JJ controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNP -RRB-_-RRB- ,_, such_JJ as_IN high_JJ cost_NN ,_, unfeasibility_JJ with_IN some_DT exposures_NNS ,_, and_CC problems_NNS with_IN generalizeability_NN 
The_DT emerging_VBG field_NN of_IN epigenetics_NNS studies_VBZ heritable_JJ changes_NNS in_IN gene_NN expression_NN that_WDT occur_VBP without_IN directly_RB altering_VBG the_DT DNA_NNP sequence_NN ._. 
Thus_RB ,_, epigenetics_NNS is_VBZ dedicated_VBN to_TO the_DT study_NN of_IN non-Mendelian_JJ -LRB-_-LRB- meiotically_RB and_CC mitotically_RB -RRB-_-RRB- ,_, heritable_JJ changes_NNS in_IN gene_NN expression_NN not_RB accompanied_VBN by_IN a_DT change_NN in_IN genotype\/DNA_NNP sequences_NNS 
Amajor_JJ difference_NN between_IN genetic_JJ and_CC epigenetic_JJ outcomes_NNS is_VBZ that_IN ,_, while_IN DNA_NNP sequence_NN is_VBZ static_JJ ,_, the_DT epigenome_NN is_VBZ dynamic_JJ and_CC changes_NNS with_IN cell_NN type_NN ,_, during_IN the_DT cell_NN cycle_NN ,_, in_IN response_NN to_TO biologic_JJ signals_NNS ,_, and_CC with_IN the_DT environment_NN 
Classical_JJ Mendelian_JJ inheritance_NN of_IN traits_NNS from_IN parents_NNS to_TO offspring_NN follows_VBZ the_DT DNA_NNP pairing_NN and_CC transmission_NN patterns_NNS as_IN illustrated_VBN by_IN the_DT Watson-Crick_NNP model_NN of_IN DNA_NNP ._. 
However_RB ,_, there_EX is_VBZ an_DT emerging_VBG consensus_NN among_IN experts_NNS in_IN genetic_JJ epidemiology_NN that_IN DNA_NNP is_VBZ not_RB the_DT sole_JJ unit_NN of_IN heredity_NN and_CC that_DT genotype_NN and_CC environment_NN are_VBP not_RB the_DT only_JJ determinants_NNS of_IN phenotype_NN 
Mendelian_JJ randomization_NN studies_NNS may_MD also_RB counteract_VB some_DT key_JJ shortcomings_NNS of_IN randomized_JJ controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNP -RRB-_-RRB- ,_, such_JJ as_IN high_JJ cost_NN ,_, unfeasibility_JJ with_IN some_DT exposures_NNS ,_, and_CC problems_NNS with_IN generalizeability_NN 
The_DT emerging_VBG field_NN of_IN epigenetics_NNS studies_VBZ heritable_JJ changes_NNS in_IN gene_NN expression_NN that_WDT occur_VBP without_IN directly_RB altering_VBG the_DT DNA_NNP sequence_NN ._. 
Thus_RB ,_, epigenetics_NNS is_VBZ dedicated_VBN to_TO the_DT study_NN of_IN non-Mendelian_JJ -LRB-_-LRB- meiotically_RB and_CC mitotically_RB -RRB-_-RRB- ,_, heritable_JJ changes_NNS in_IN gene_NN expression_NN not_RB accompanied_VBN by_IN a_DT change_NN in_IN genotype\/DNA_NNP sequences_NNS 
The_DT molecular_JJ mechanisms_NNS of_IN epigenetic_JJ modifications_NNS include_VBP DNA_NNP methylation_NN and_CC chromatin_NN structure_NN and_CC histone_NN modifications_NNS 
Acetylation_NNP ,_, methylation_NN ,_, phosphorylation_NN ,_, and_CC ubiquitylation_NN are_VBP implicated_VBN in_IN activation_NN ;_: while_IN methylation_NN ,_, ubiquitylation_NN ,_, sumoylation_NN ,_, deimination_NN and_CC proline_NN isomerization_NN are_VBP involved_VBN in_IN gene_NN repression_NN 
Certain_JJ gene-environment_NN interactions_NNS -LRB-_-LRB- in_IN ancestral_JJ parents_NNS -RRB-_-RRB- are_VBP thought_VBN to_TO be_VB mediated_VBN through_IN molecular_JJ changes_NNS in_IN the_DT epigenome_NN ._. 
The_DT non-random_JJ nature_NN of_IN such_JJ alterations_NNS may_MD necessitate_VB caution_NN in_IN the_DT interpretation_NN of_IN the_DT estimates_NNS from_IN the_DT Mendelian_NNP randomization_NN -LRB-_-LRB- instrumental_JJ variable_NN -RRB-_-RRB- analyses_NNS ._. 
In_IN recognition_NN of_IN the_DT presence_NN of_IN this_DT ``_`` epigenetic_JJ bias_NN ,_, ''_'' Bjornsson_NNP et_FW al._FW ._. 
have_VBP suggested_VBN that_IN including_VBG epigenotypes_NNS in_IN models_NNS of_IN disease_NN causation_NN might_MD act_VB as_IN a_DT surrogate_NN of_IN parental_JJ environmental_JJ exposure_NN and_CC thus_RB increase_VB the_DT power_NN of_IN epidemiological_JJ studies_NNS 
This_DT ``_`` DNA_NN packaging_NN ''_'' -LRB-_-LRB- or_CC ``_`` epigenome_NN ''_'' -RRB-_-RRB- has_VBZ recently_RB been_VBN implicated_VBN in_IN the_DT regulation_NN of_IN the_DT complex_JJ interactions_NNS of_IN the_DT enzymatic_JJ processes_NNS of_IN replication_NN ,_, transcription_NN ,_, recombination_NN ,_, and_CC DNA_NN repair_NN 
However_RB ,_, depending_VBG on_IN the_DT location_NN ,_, any_DT given_VBN modification_NN is_VBZ capable_JJ of_IN either_DT activation_NN or_CC repression_NN 
This_DT results_NNS in_IN an_DT interaction_NN between_IN the_DT allocated_VBN treatment_NN and_CC extraneous_JJ variables_NNS -LRB-_-LRB- see_VB Figure_NNP 4_CD -RRB-_-RRB- and_CC violates_VBZ the_DT assumptions_NNS of_IN ITT_NNP ._. 
In_IN non-blinded_JJ randomized_JJ trials_NNS ,_, opportunities_NNS for_IN extraneous_JJ variables_NNS to_TO interact_VB with_IN ITT_NNP increase_NN with_IN the_DT length_NN of_IN the_DT trial_NN ._. 
Similar_JJ to_TO this_DT finding_NN in_IN RCTs_NNP ,_, in_IN Mendelian_JJ randomization_NN studies_NNS specific_JJ genotypes_NNS may_MD interact_VB with_IN a_DT range_NN of_IN extraneous_JJ factors_NNS and_CC establish_VB epigenetic_JJ changes_NNS that_WDT are_VBP inherited_VBN by_IN subsequent_JJ generations_NNS ._. 
In_IN a_DT related_JJ finding_NN ,_, Sadeghnejad_NNP ,_, et_FW al._FW ._. 
This_DT risk_NN was_VBD further_RB heightened_VBN when_WRB both_DT the_DT grandmother_NN and_CC the_DT mother_NN smoked_VBN during_IN pregnancy_NN 
These_DT two_CD steps_NNS add_VBP up_IN to_TO the_DT -LRB-_-LRB- overall_JJ -RRB-_-RRB- effect_NN of_IN G_NNP on_IN Y_NNP -LRB-_-LRB- Figure_NNP 3_CD -RRB-_-RRB- ._. 
between_IN allocated_VBN genotype_NN and_CC intermediate_JJ phenotype_NN -RRB-_-RRB- ,_, 
Further_JJ strengthening_NN this_DT evidence_NN in_IN humans_NNS ,_, Li_NNP et_FW al._FW ._. 
In_IN agreement_NN with_IN a_DT possible_JJ epigenetic_JJ inheritance_NN pattern_NN ,_, a_DT recent_JJ study_NN in_IN mice_NNS showed_VBD that_IN experimentally-induced_JJ contact_NN dermatitis_NNS in_IN the_DT mother_NN prior_RB to_TO conception_NN resulted_VBD in_IN an_DT increased_VBN asthma_NN incidence_NN in_IN the_DT offspring_NN 
As_IN we_PRP alluded_VBD to_TO earlier_RBR ,_, findings_NNS in_IN support_NN of_IN this_DT concept_NN have_VBP recently_RB been_VBN reported_VBN by_IN Li_NNP et_FW al._FW ._. 
Their_PRP$ results_NNS showed_VBD grandmaternal_JJ smoking_NN during_IN the_DT mother_NN 's_POS fetal_JJ period_NN to_TO be_VB associated_VBN with_IN a_DT greater_JJR risk_NN of_IN asthma_NN in_IN the_DT grandchildren_NNS ,_, independent_JJ of_IN maternal_JJ smoking_NN status_NN ._. 
This_DT risk_NN was_VBD further_RB heightened_VBN when_WRB both_DT the_DT grandmother_NN and_CC the_DT mother_NN smoked_VBN during_IN pregnancy_NN 
recently_RB proposed_VBN that_IN maternally-mediated_JJ changes_NNS in_IN gene_NN expression_NN may_MD be_VB more_RBR relevant_JJ in_IN elucidating_VBG the_DT etiology_NN of_IN disease_NN in_IN the_DT offspring_NN than_IN the_DT inheritance_NN pattern_NN of_IN the_DT genetic_JJ code_NN 
Gluckman_NNP et_FW al._FW ._. 
Certain_JJ features_NNS of_IN complex_JJ diseases_NNS that_WDT have_VBP defied_VBN classical_JJ Mendelian_JJ genetics_NNS may_MD be_VB explained_VBN ,_, at_IN least_JJS in_IN part_NN ,_, by_IN the_DT inheritability_NN ,_, partial_JJ stability_NN and_CC reversibility_NN of_IN epigenetic_JJ regulation_NN ._. 
recently_RB proposed_VBN that_IN maternally-mediated_JJ changes_NNS in_IN gene_NN expression_NN may_MD be_VB more_RBR relevant_JJ in_IN elucidating_VBG the_DT etiology_NN of_IN disease_NN in_IN the_DT offspring_NN than_IN the_DT inheritance_NN pattern_NN of_IN the_DT genetic_JJ code_NN ._. 
In_IN agreement_NN with_IN a_DT possible_JJ epigenetic_JJ inheritance_NN pattern_NN ,_, a_DT recent_JJ study_NN in_IN mice_NNS showed_VBD that_IN experimentally-induced_JJ contact_NN dermatitis_NNS in_IN the_DT mother_NN prior_RB to_TO conception_NN resulted_VBD in_IN 
While_IN acetylation_NN and_CC phosphorylation_NN are_VBP thought_VBN to_TO be_VB responsible_JJ for_IN short-term_JJ reversible_JJ changes_NNS in_IN gene_NN expression_NN ,_, methylation_NN is_VBZ generally_RB more_RBR stable_JJ and_CC involved_VBN in_IN the_DT long_JJ term_NN maintenance_NN of_IN expression_NN status_NN 
These_DT changes_NNS generally_RB involve_VBP DNA_NN modification_NN -LRB-_-LRB- without_IN change_NN in_IN nucleotide_NN sequence_NN -RRB-_-RRB- ,_, histone_JJ protein_NN modifications_NNS ,_, and_CC regulation_NN of_IN gene_NN expression_NN by_IN microRNAs_NNS ._. 
MicroRNAs_NNS -LRB-_-LRB- miRNAs_NNP -RRB-_-RRB- are_VBP small_JJ -LRB-_-LRB- approximately_RB 22_CD nucleotides_NNS long_RB -RRB-_-RRB- RNA_NNP molecules_NNS that_WDT may_MD be_VB involved_VBN in_IN post-transcriptional_JJ control_NN of_IN gene_NN expression_NN 
The_DT emerging_VBG field_NN of_IN epigenetics_NNS studies_VBZ heritable_JJ changes_NNS in_IN gene_NN expression_NN that_WDT occur_VBP without_IN directly_RB altering_VBG the_DT DNA_NNP sequence_NN ._. 
Thus_RB ,_, epigenetics_NNS is_VBZ dedicated_VBN to_TO the_DT study_NN of_IN non-Mendelian_JJ -LRB-_-LRB- meiotically_RB and_CC mitotically_RB -RRB-_-RRB- ,_, heritable_JJ changes_NNS in_IN gene_NN expression_NN not_RB accompanied_VBN by_IN a_DT change_NN in_IN genotype\/DNA_NNP sequences_NNS 
MicroRNAs_NNS -LRB-_-LRB- miRNAs_NNP -RRB-_-RRB- are_VBP small_JJ -LRB-_-LRB- approximately_RB 22_CD nucleotides_NNS long_RB -RRB-_-RRB- RNA_NNP molecules_NNS that_WDT may_MD be_VB involved_VBN in_IN post-transcriptional_JJ control_NN of_IN gene_NN expression_NN 
In_IN recognition_NN of_IN the_DT presence_NN of_IN this_DT ``_`` epigenetic_JJ bias_NN ,_, ''_'' Bjornsson_NNP et_FW al._FW ._. 
The_DT non-random_JJ nature_NN of_IN such_JJ alterations_NNS may_MD necessitate_VB caution_NN in_IN the_DT interpretation_NN of_IN the_DT estimates_NNS from_IN the_DT Mendelian_NNP randomization_NN -LRB-_-LRB- instrumental_JJ variable_NN -RRB-_-RRB- analyses_NNS ._. 
have_VBP suggested_VBN that_IN including_VBG epigenotypes_NNS in_IN models_NNS of_IN disease_NN causation_NN might_MD act_VB as_IN a_DT surrogate_NN of_IN parental_JJ environmental_JJ exposure_NN and_CC thus_RB increase_VB the_DT power_NN of_IN epidemiological_JJ studies_NNS 
These_DT additional_JJ data_NNS would_MD enable_VB adjustment_NN for_IN ``_`` epigenetic_JJ bias_NN ''_'' as_IN described_VBN in_IN this_DT paper_NN ._. 
gene_NN expression_NN -RRB-_-RRB- of_IN the_DT various_JJ genes_NNS tested_VBN ._. 
Such_JJ tools_NNS may_MD make_VB it_PRP possible_JJ to_TO apply_VB certain_JJ ``_`` correction_NN factors_NNS ''_'' or_CC to_TO stratify_VB future_JJ analyses_NNS by_IN ``_`` methylation_NN status_NN ''_'' -LRB-_-LRB- or_CC ``_`` expression_NN status_NN ''_'' -RRB-_-RRB- ,_, in_IN the_DT assessment_NN of_IN gene_NN effect_NN ._. 
Until_IN such_PDT a_DT time_NN ,_, caution_NN is_VBZ needed_VBN in_IN the_DT interpretation_NN of_IN Mendelian_JJ randomization_NN studies_NNS ._. 
Abbreviations_NNP LD_NNP :_: Linkage_NNP Disequilibrium_NNP ;_: DNA_NNP :_: deoxyribonucleic_JJ acid_NN ;_: MR_NNP :_: Mendelian_NNP Randomization_NNP ;_: RCT_NNP :_: randomized_VBN controlled_JJ trial_NN ;_: ITT_NNP :_: Intention_NN to_TO treat_VB analysis_NN ;_: IV_NNP :_: instrumental_JJ variable_NN ._. 
Instrumental_JJ variable_JJ -LRB-_-LRB- IV_NNP -RRB-_-RRB- methods_NNS 
Mendelian_JJ randomization_NN refers_VBZ to_TO the_DT random_JJ assortment_NN of_IN alleles_NNS inherited_VBN by_IN offspring_NN from_IN their_PRP$ parents_NNS at_IN conception_NN ._. 
This_DT random_JJ assortment_NN of_IN inherited_VBN alleles_NNS has_VBZ been_VBN likened_VBN to_TO a_DT randomized_VBN clinical_JJ trial_NN -LRB-_-LRB- RCT_NNP -RRB-_-RRB- ,_, in_IN which_WDT the_DT research_NN subjects_NNS are_VBP randomly_RB allocated_VBN to_TO different_JJ genotypes_NNS rather_RB than_IN to_TO medical_JJ interventions_NNS 
RCTs_NNS use_VBP intention-to-treat_NN -LRB-_-LRB- ITT_NNP -RRB-_-RRB- analysis_NN to_TO assess_VB therapeutic_JJ effects_NNS ._. 
Randomized_VBN controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNS -RRB-_-RRB- currently_RB provide_VBP the_DT best_JJS evidence_NN for_IN potentially_RB therapeutic_JJ or_CC prophylactic_JJ interventions_NNS ._. 
ITT_NNP analyses_NNS assess_VBP allocated_VBN treatment_NN as_IN the_DT predictor_NN of_IN outcome_NN ,_, and_CC are_VBP assumed_VBN to_TO be_VB unconfounded_JJ because_IN of_IN randomization_NN ,_, irrespective_RB of_IN compliance_NN ,_, adherence_NN and_CC contamination_NN 
ITT_NNP analyses_NNS assess_VBP allocated_VBN treatment_NN as_IN the_DT predictor_NN of_IN outcome_NN ,_, and_CC are_VBP assumed_VBN to_TO be_VB unconfounded_JJ because_IN of_IN randomization_NN ,_, irrespective_RB of_IN compliance_NN ,_, adherence_NN and_CC contamination_NN ._. 
Thus_RB ,_, the_DT ITT_NNP effect_NN is_VBZ the_DT effect_NN of_IN allocating_VBG a_DT treatment_NN rather_RB than_IN the_DT biologic_JJ effect_NN of_IN received_JJ tr_NN 
Adapted_VBN from_IN Nitsch_NNP D_NNP ,_, et_FW al._FW ._. 
Figure_NNP 1_CD Conceptual_JJ analogies_NNS between_IN a_DT randomized_VBN controlled_JJ trial_NN -LRB-_-LRB- left_JJ graph_NN -RRB-_-RRB- and_CC Mendelian_JJ randomization_NN approach_NN -LRB-_-LRB- right_JJ graph_NN -RRB-_-RRB- ._. ._. 
Core_NNP Assumptions_NNPS Implied_NNP in_IN Mendelian_NNP Randomization_NNP Studies_NNP In_IN order_NN to_TO understand_VB the_DT bias_NN introduced_VBN by_IN epigenetic_JJ modifications_NNS of_IN gene_NN expression_NN ,_, the_DT underlying_VBG statistical_JJ assumptions_NNS in_IN MR_NNP studies_NNS are_VBP outlined_VBN next_JJ ._. 
Secondly_RB ,_, ``_`` randomization_NN ''_'' in_IN MR_NNP studies_NNS occurs_VBZ at_IN conception_NN while_IN RCT_NNP studies_NNS randomize_VBP patients_NNS in_IN adulthood_NN ._. 
This_DT minimizes_VBZ biases_NNS due_JJ to_TO canalization_NN and_CC developmental_JJ adaptation_NN ._. 
Mendelian_JJ randomization_NN studies_NNS may_MD also_RB counteract_VB some_DT key_JJ shortcomings_NNS of_IN randomized_JJ controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNP -RRB-_-RRB- ,_, such_JJ as_IN high_JJ cost_NN ,_, unfeasibility_JJ with_IN some_DT exposures_NNS ,_, and_CC problems_NNS with_IN generalizeability_NN 
This_DT minimizes_VBZ biases_NNS due_JJ to_TO canalization_NN and_CC developmental_JJ adaptation_NN ._. 
Secondly_RB ,_, ``_`` randomization_NN ''_'' in_IN MR_NNP studies_NNS occurs_VBZ at_IN conception_NN while_IN RCT_NNP studies_NNS randomize_VBP patients_NNS in_IN adulthood_NN ._. 
Mendelian_JJ randomization_NN studies_NNS may_MD also_RB counteract_VB some_DT key_JJ shortcomings_NNS of_IN randomized_JJ controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNP -RRB-_-RRB- ,_, such_JJ as_IN high_JJ cost_NN ,_, unfeasibility_JJ with_IN some_DT exposures_NNS ,_, and_CC problems_NNS with_IN generalizeability_NN 
Mendelian_JJ randomization_NN studies_NNS may_MD also_RB counteract_VB some_DT key_JJ shortcomings_NNS of_IN randomized_JJ controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNP -RRB-_-RRB- ,_, such_JJ as_IN high_JJ cost_NN ,_, unfeasibility_JJ with_IN some_DT exposures_NNS ,_, and_CC problems_NNS with_IN generalizeability_NN 
-LRB-_-LRB- Adapted_VBN from_IN Nitsch_NNP D_NNP ,_, et_FW al._FW ._. 
e._NN Although_IN a_DT more_RBR complicated_JJ model_NN is_VBZ possible_JJ ,_, to_TO illustrate_VB the_DT IV_NNP approach_NN we_PRP assume_VBP linear_JJ relationships_NNS among_IN G_NNP ,_, X_NNP ,_, and_CC Y_NNP -LRB-_-LRB- i._FW ``_`` a_DT one-unit_JJ change_NN in_IN G_NNP is_VBZ estimated_VBN to_TO result_VB in_IN a_DT 
e._VB blinding_VBG to_TO allocation_NN -LRB-_-LRB- G_NNP associated_VBN with_IN X_NNP and_CC independent_JJ of_IN U_NNP -RRB-_-RRB- and_CC the_DT absence_NN of_IN any_DT other_JJ pathway_NN from_IN G_NNP to_TO Y_NNP -LRB-_-LRB- i._NNP G_NNP being_VBG independent_JJ of_IN Y_NNP given_VBN X_NNP and_CC U_NNP -RRB-_-RRB- ._. 
An_DT intuitive_JJ motivation_NN for_IN equation_NN -LRB-_-LRB- 5_CD -RRB-_-RRB- is_VBZ that_IN the_DT change_NN in_IN outcome_NN for_IN a_DT unit_NN change_NN in_IN the_DT instrument_NN ,_, 
Based_VBN on_IN our_PRP$ derivation_NN ,_, we_PRP can_MD see_VB that_IN this_DT estimate_NN avoids_VBZ the_DT contaminating_VBG effect_NN of_IN the_DT variation_NN in_IN Y_NNP due_JJ to_TO the_DT confounders_NNS of_IN the_DT X-Y_NNP association_NN ._. 
In_IN Mendelian_JJ randomization_NN studies_NNS ,_, 
From_IN Figure_NN 3_CD and_CC equations_NNS -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC -LRB-_-LRB- 3_CD -RRB-_-RRB- ,_, the_DT less_RBR precisely_RB the_DT genotype_NN predicts_VBZ the_DT gene_NN expression_NN -LRB-_-LRB- gene_NN product_NN -RRB-_-RRB- ,_, the_DT less_RBR accurate_JJ the_DT derived_VBN effect_NN estimate_NN for_IN the_DT causal_JJ association_NN between_IN the_DT level_NN of_IN gene_NN expression_NN and_CC the_DT outcome_NN -LRB-_-LRB- disease_NN -RRB-_-RRB- ._. 
This_DT necessity_NN for_IN a_DT strong_JJ gene_NN 
Instrumental_JJ variable_JJ -LRB-_-LRB- IV_NNP -RRB-_-RRB- methods_NNS 
We_PRP will_MD illustrate_VB the_DT occurrence_NN of_IN the_DT epigenetic_JJ bias_NN both_DT algebraically_RB and_CC with_IN a_DT data_NN simulation_NN ._. 
What_WP is_VBZ currently_RB knownMendelian_JJ randomization_NN and_CC its_PRP$ shortfallsMendelian_JJ randomization_NN studies_NNS exploit_VBP the_DT idea_NN that_IN the_DT genotype_NN only_RB affects_VBZ the_DT disease_NN status_NN indirectly_RB and_CC is_VBZ assigned_VBN randomly_RB at_IN meiosis_NN ,_, independent_JJ of_IN measured_JJ and_CC unmeasured_JJ -LRB-_-LRB- or_CC measured-with-error_JJ -RRB-_-RRB- confounders_NNS ._. 
These_DT properties_NNS define_VBP an_DT instrumental_JJ variable_JJ -LRB-_-LRB- IV_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ a_DT variable_NN associated_VBN with_IN the_DT outcome_NN only_RB through_IN its_PRP$ robust_JJ association_NN with_IN an_DT intermediary_NN variable_NN 
Unfortunately_RB ,_, for_IN many_JJ types_NNS of_IN exposure_NN in_IN epidemiology_NN ,_, it_PRP is_VBZ both_DT impractical_JJ and_CC unethical_JJ to_TO randomize_VB study_NN participants_NNS to_TO different_JJ ``_`` treatment_NN ''_'' arms_NNS ._. 
Confounder_JJR control_NN in_IN observational_JJ studies_NNS may_MD also_RB be_VB problematic_JJ due_JJ to_TO incomplete_JJ understanding_NN of_IN the_DT relevant_JJ confounders_NNS in_IN a_DT given_VBN situation_NN ,_, or_CC due_JJ to_TO inherent_JJ measurement_NN errors_NNS that_WDT arise_VBP in_IN the_DT assessment_NN of_IN such_JJ confounders_NNS 
Also_RB ,_, let_VB U_NNP be_VB an_DT unobservable_JJ variable_NN that_WDT confounds_VBZ the_DT effect_NN of_IN X_NNP on_IN Y._NNP For_IN this_DT and_CC subsequent_JJ sections_NNS ,_, let_VBD the_DT causal_JJ effect_NN of_IN X_NNP -LRB-_-LRB- intermediate_JJ phenotype_NN -RRB-_-RRB- on_IN Y_NNP be_VB the_DT relationship_NN of_IN primary_JJ interest_NN ,_, and_CC let_VB G_NNP -LRB-_-LRB- genotype_NN -RRB-_-RRB- be_VB the_DT variable_JJ we_PRP want_VBP to_TO use_VB as_IN the_DT instrumental_JJ variable_JJ -LRB-_-LRB- IV_NNP -RRB-_-RRB- ._. 
Three_CD core_NN assumptions_NNS characterize_VBP an_DT instrumental_JJ variable_JJ -LRB-_-LRB- IV_NNP -RRB-_-RRB- ._. 
A._NNP G_NNP is_VBZ independent_JJ of_IN the_DT confounding_NN factors_VBZ U_NNP that_WDT confound_VBP the_DT association_NN of_IN X_NNP and_CC the_DT outcome_NN Y._NNP 
must_MD not_RB be_VB -LRB-_-LRB- marginally_RB -RRB-_-RRB- independent_JJ of_IN X_NNP -RRB-_-RRB- ._. 
e._VB The_DT instrumental_JJ variable_JJ G_NNP is_VBZ associated_VBN with_IN the_DT exposure_NN of_IN interest_NN X_NNP -LRB-_-LRB- i._IN The_DT stronger_JJR this_DT association_NN ,_, the_DT ``_`` better_JJR ''_'' an_DT instrument_NN G_NNP is_VBZ ,_, providing_VBG more_JJR information_NN on_IN the_DT causal_JJ association_NN between_IN X_NNP and_CC Y_NNP -LRB-_-LRB- small_JJ standard_JJ errors_NNS and_CC narrow_JJ confidence_NN intervals_NNS -RRB-_-RRB- 
to_TO be_VB useful_JJ as_IN an_DT IV_NNP ,_, G_NNP does_VBZ not_RB have_VB to_TO be_VB the_DT ``_`` right_JJ ''_'' gene_NN ._. 
e._VB It_PRP is_VBZ important_JJ to_TO state_NN at_IN this_DT point_NN that_IN G_NNP does_VBZ not_RB need_VB to_TO be_VB causal_JJ for_IN X_NNP ,_, i._VBP The_DT association_NN could_MD instead_RB be_VB due_JJ to_TO a_DT mediator_NN variable_JJ or_CC through_IN another_DT unobserved_JJ variable_NN that_WDT affects_VBZ both_DT G_NNP and_CC X_NNP ._. 
This_DT may_MD occur_VB in_IN situations_NNS where_WRB there_EX is_VBZ linkage_NN disequilibrium_NN -LRB-_-LRB- LD_NNP -RRB-_-RRB- between_IN G_NNP -LRB-_-LRB- G1_NNP -RRB-_-RRB- and_CC another_DT genotype_NN -LRB-_-LRB- G2_NNP -RRB-_-RRB- -LRB-_-LRB- Figure_NNP 2B_NNP -RRB-_-RRB- ._. 
If_IN the_DT levels_NNS but_CC not_RB the_DT function_NN of_IN a_DT potential_JJ disease_NN risk_NN factor_NN is_VBZ determined_VBN by_IN a_DT genetic_JJ polymorphism_NN ,_, then_RB the_DT levels_NNS of_IN the_DT risk_NN factor_NN will_MD effectively_RB be_VB assumed_VBN to_TO have_VB been_VBN randomly_RB assigned_VBN at_IN conception_NN ._. 
This_DT `_`` randomization_NN '_'' will_MD potentially_RB obviate_VB the_DT effect_NN of_IN confounding_VBG in_IN the_DT test_NN of_IN genotype-disease_JJ associations_NNS ._. 
In_IN order_NN to_TO illustrate_VB the_DT principles_NNS of_IN Mendelian_JJ randomization_NN ,_, we_PRP will_MD use_VB a_DT familiar_JJ methodological_JJ concept_NN that_WDT is_VBZ well-recognized_JJ in_IN randomized_JJ controlled_JJ trials_NNS 
Randomized_VBN controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNS -RRB-_-RRB- currently_RB provide_VBP the_DT best_JJS evidence_NN for_IN potentially_RB therapeutic_JJ or_CC prophylactic_JJ interventions_NNS ._. 
RCTs_NNS use_VBP intention-to-treat_NN -LRB-_-LRB- ITT_NNP -RRB-_-RRB- analysis_NN to_TO assess_VB therapeutic_JJ effects_NNS 
ITT_NNP analyses_NNS assess_VBP allocated_VBN treatment_NN as_IN the_DT predictor_NN of_IN outcome_NN ,_, and_CC are_VBP assumed_VBN to_TO be_VB unconfounded_JJ because_IN of_IN randomization_NN ,_, irrespective_RB of_IN compliance_NN ,_, adherence_NN and_CC contamination_NN ._. 
Thus_RB ,_, the_DT ITT_NNP effect_NN is_VBZ the_DT effect_NN of_IN allocating_VBG a_DT treatment_NN rather_RB than_IN the_DT biologic_JJ effect_NN of_IN received_JJ treatment_NN -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- 
As_IN an_DT increasing_VBG number_NN of_IN epidemiologists_NNS employ_VBP Mendelian_JJ randomization_NN methods_NNS in_IN their_PRP$ research_NN ,_, caution_NN is_VBZ therefore_RB needed_VBN in_IN drawing_VBG conclusions_NNS from_IN these_DT studies_NNS if_IN these_DT assumptions_NNS are_VBP not_RB met_VBN ._. 
IntroductionThe_JJ use_NN of_IN genotypes_NNS that_WDT affect_VBP modifiable_JJ risk_NN factors_NNS to_TO make_VB causal_JJ inferences_NNS falls_VBZ under_IN the_DT umbrella_NN of_IN Mendelian_NNP Randomization_NNP -LRB-_-LRB- MR_NNP -RRB-_-RRB- studies_NNS ._. 
Instrumental_JJ variable_JJ -LRB-_-LRB- IV_NNP -RRB-_-RRB- methods_NNS 
Introduction_NN The_DT use_NN of_IN genotypes_NNS that_WDT affect_VBP modifiable_JJ risk_NN factors_NNS to_TO make_VB causal_JJ inferences_NNS falls_VBZ under_IN the_DT umbrella_NN of_IN Mendelian_NNP Randomization_NNP -LRB-_-LRB- MR_NNP -RRB-_-RRB- studies_NNS ._. 
Instrumental_JJ variable_JJ -LRB-_-LRB- IV_NNP -RRB-_-RRB- methods_NNS 
This_DT random_JJ assortment_NN of_IN inherited_VBN alleles_NNS has_VBZ been_VBN likened_VBN to_TO a_DT randomized_VBN clinical_JJ trial_NN -LRB-_-LRB- RCT_NNP -RRB-_-RRB- ,_, in_IN which_WDT the_DT research_NN subjects_NNS are_VBP randomly_RB allocated_VBN to_TO different_JJ genotypes_NNS rather_RB than_IN to_TO medical_JJ interventions_NNS ._. 
Mendelian_JJ randomization_NN studies_NNS include_VBP any_DT study_NN that_WDT uses_VBZ genetic_JJ variation_NN as_IN a_DT robust_JJ proxy_NN for_IN a_DT potential_JJ disease_NN risk_NN -LRB-_-LRB- which_WDT can_MD not_RB be_VB assessed_VBN without_IN biases_NNS -RRB-_-RRB- for_IN the_DT purpose_NN of_IN making_VBG causal_JJ inferences_NNS about_IN the_DT outcomes_NNS of_IN the_DT modifiable_JJ exposure_NN 
We_PRP will_MD illustrate_VB the_DT occurrence_NN of_IN the_DT epigenetic_JJ bias_NN both_DT algebraically_RB and_CC with_IN a_DT data_NN simulation_NN ._. 
What_WP is_VBZ currently_RB knownMendelian_JJ randomization_NN and_CC its_PRP$ shortfallsMendelian_JJ randomization_NN studies_NNS exploit_VBP the_DT idea_NN that_IN the_DT genotype_NN only_RB affects_VBZ the_DT disease_NN status_NN indirectly_RB and_CC is_VBZ assigned_VBN randomly_RB at_IN meiosis_NN ,_, independent_JJ of_IN measured_JJ and_CC unmeasured_JJ -LRB-_-LRB- or_CC measured-with-error_JJ -RRB-_-RRB- confounders_NNS ._. 
These_DT properties_NNS define_VBP an_DT instrumental_JJ variable_JJ -LRB-_-LRB- IV_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ a_DT variable_NN associated_VBN with_IN the_DT outcome_NN only_RB through_IN its_PRP$ robust_JJ association_NN with_IN an_DT intermediary_NN variable_NN 
What_WP is_VBZ currently_RB known_VBN Mendelian_JJ randomization_NN and_CC its_PRP$ shortfalls_NNS Mendelian_JJ randomization_NN studies_NNS exploit_VBP the_DT idea_NN that_IN the_DT genotype_NN only_RB affects_VBZ the_DT disease_NN status_NN indirectly_RB and_CC is_VBZ assigned_VBN randomly_RB at_IN meiosis_NN ,_, independent_JJ of_IN measured_JJ and_CC unmeasured_JJ -LRB-_-LRB- or_CC measured-with-error_JJ -RRB-_-RRB- confounders_NNS ._. 
These_DT properties_NNS define_VBP an_DT instrumental_JJ variable_JJ -LRB-_-LRB- IV_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ a_DT variable_NN associated_VBN with_IN the_DT outcome_NN only_RB through_IN its_PRP$ robust_JJ association_NN with_IN an_DT intermediary_NN variable_NN 
Also_RB ,_, let_VB U_NNP be_VB an_DT unobservable_JJ variable_NN that_WDT confounds_VBZ the_DT effect_NN of_IN X_NNP on_IN Y._NNP For_IN this_DT and_CC subsequent_JJ sections_NNS ,_, let_VBD the_DT causal_JJ effect_NN of_IN X_NNP -LRB-_-LRB- intermediate_JJ phenotype_NN -RRB-_-RRB- on_IN Y_NNP be_VB the_DT relationship_NN of_IN primary_JJ interest_NN ,_, and_CC let_VB G_NNP -LRB-_-LRB- genotype_NN -RRB-_-RRB- be_VB the_DT variable_JJ we_PRP want_VBP to_TO use_VB as_IN the_DT instrumental_JJ variable_JJ -LRB-_-LRB- IV_NNP -RRB-_-RRB- ._. 
Three_CD core_NN assumptions_NNS characterize_VBP an_DT instrumental_JJ variable_JJ -LRB-_-LRB- IV_NNP -RRB-_-RRB- 
There_EX are_VBP several_JJ methodological_JJ advantages_NNS of_IN MR_NNP studies_NNS ._. 
Conditional_JJ on_IN X_NNP and_CC U_NNP ,_, the_DT instrument_NN and_CC the_DT response_NN are_VBP independent_JJ ._. 
Unlike_IN conventional_JJ RCTs_NNS ,_, MR_NNP studies_NNS can_MD be_VB conducted_VBN in_IN a_DT representative_JJ sample_NN without_IN imposing_VBG any_DT exclusion_NN criteria_NNS or_CC requiring_VBG volunteers_NNS to_TO be_VB amenable_JJ to_TO random_JJ treatment_NN allocation_NN ._. 
Secondly_RB ,_, ``_`` randomization_NN ''_'' in_IN MR_NNP studies_NNS occurs_VBZ at_IN conception_NN while_IN RCT_NNP studies_NNS randomize_VBP patients_NNS in_IN adulthood_NN ._. 
This_DT minimizes_VBZ biases_NNS due_JJ to_TO canalization_NN and_CC developmental_JJ adaptation_NN ._. 
Secondly_RB ,_, ``_`` randomization_NN ''_'' in_IN MR_NNP studies_NNS occurs_VBZ at_IN conception_NN while_IN RCT_NNP studies_NNS randomize_VBP patients_NNS in_IN adulthood_NN ._. 
Mendelian_JJ randomization_NN studies_NNS may_MD also_RB counteract_VB some_DT key_JJ shortcomings_NNS of_IN randomized_JJ controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNP -RRB-_-RRB- ,_, such_JJ as_IN high_JJ cost_NN ,_, unfeasibility_JJ with_IN some_DT exposures_NNS ,_, and_CC problems_NNS with_IN generalizeability_NN 
Previous_JJ studies_NNS have_VBP addressed_VBN some_DT of_IN the_DT key_JJ potential_JJ shortfalls_NNS of_IN MR_NNP studies_NNS ._. 
These_DT include_VBP the_DT paucity_NN of_IN suitable_JJ genetic_JJ variants_NNS ,_, unreliable_JJ -LRB-_-LRB- genetic_JJ -RRB-_-RRB- associations_NNS ,_, genetic_JJ confounding_NN by_IN population_NN stratification_NN ,_, linkage_NN disequilibrium_NN -LRB-_-LRB- LD_NNP -RRB-_-RRB- ,_, pleiotropy_JJ ,_, functional_JJ genomic_JJ confounding_NN due_JJ to_TO developmental_JJ canalization_NN and_CC gene_NN imprinting_NN ,_, the_DT need_NN for_IN large_JJ sample_NN sizes_NNS and_CC some_DT potential_JJ problems_NNS with_IN binary_JJ outcomes_NNS 
Gbeing_VBG independent_JJ of_IN Y_NNP given_VBN X_NNP and_CC U_NNP -RRB-_-RRB- ._. 
e._VB blinding_VBG to_TO allocation_NN -LRB-_-LRB- G_NNP associated_VBN with_IN X_NNP and_CC independent_JJ of_IN U_NNP -RRB-_-RRB- and_CC the_DT absence_NN of_IN any_DT other_JJ pathway_NN from_IN G_NNP to_TO Y_NNP -LRB-_-LRB- i._VB An_DT intuitive_JJ motivation_NN for_IN equation_NN -LRB-_-LRB- 5_CD -RRB-_-RRB- is_VBZ that_IN the_DT change_NN in_IN outcome_NN for_IN a_DT unit_NN change_NN in_IN the_DT instrument_NN ,_, 
Estimation_NN of_IN the_DT causal_JJ effect_NN 
As_IN an_DT increasing_VBG number_NN of_IN epidemiologists_NNS employ_VBP Mendelian_JJ randomization_NN methods_NNS in_IN their_PRP$ research_NN ,_, caution_NN is_VBZ therefore_RB needed_VBN in_IN drawing_VBG conclusions_NNS from_IN these_DT studies_NNS if_IN these_DT assumptions_NNS are_VBP not_RB met_VBN ._. 
IntroductionThe_JJ use_NN of_IN genotypes_NNS that_WDT affect_VBP modifiable_JJ risk_NN factors_NNS to_TO make_VB causal_JJ inferences_NNS falls_VBZ under_IN the_DT umbrella_NN of_IN Mendelian_NNP Randomization_NNP -LRB-_-LRB- MR_NNP -RRB-_-RRB- studies_NNS ._. 
Instrumental_JJ variable_JJ -LRB-_-LRB- IV_NNP -RRB-_-RRB- methods_NNS 
Secondly_RB ,_, ``_`` randomization_NN ''_'' in_IN MR_NNP studies_NNS occurs_VBZ at_IN conception_NN while_IN RCT_NNP studies_NNS randomize_VBP patients_NNS in_IN adulthood_NN ._. 
This_DT minimizes_VBZ biases_NNS due_JJ to_TO canalization_NN and_CC developmental_JJ adaptation_NN ._. 
Mendelian_JJ randomization_NN studies_NNS may_MD also_RB counteract_VB some_DT key_JJ shortcomings_NNS of_IN randomized_JJ controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNP -RRB-_-RRB- ,_, such_JJ as_IN high_JJ cost_NN ,_, unfeasibility_JJ with_IN some_DT exposures_NNS ,_, and_CC problems_NNS with_IN generalizeability_NN 
Mendelian_JJ randomization_NN studies_NNS may_MD also_RB counteract_VB some_DT key_JJ shortcomings_NNS of_IN randomized_JJ controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNP -RRB-_-RRB- ,_, such_JJ as_IN high_JJ cost_NN ,_, unfeasibility_JJ with_IN some_DT exposures_NNS ,_, and_CC problems_NNS with_IN generalizeability_NN 
Introduction_NN The_DT use_NN of_IN genotypes_NNS that_WDT affect_VBP modifiable_JJ risk_NN factors_NNS to_TO make_VB causal_JJ inferences_NNS falls_VBZ under_IN the_DT umbrella_NN of_IN Mendelian_NNP Randomization_NNP -LRB-_-LRB- MR_NNP -RRB-_-RRB- studies_NNS ._. 
Instrumental_JJ variable_JJ -LRB-_-LRB- IV_NNP -RRB-_-RRB- methods_NNS 
These_DT two_CD steps_NNS add_VBP up_IN to_TO the_DT -LRB-_-LRB- overall_JJ -RRB-_-RRB- effect_NN of_IN G_NNP on_IN Y_NNP -LRB-_-LRB- Figure_NNP 3_CD -RRB-_-RRB- ._. 
between_IN allocated_VBN genotype_NN and_CC intermediate_JJ phenotype_NN -RRB-_-RRB- ,_, 
RCTs_NNS use_VBP intention-to-treat_NN -LRB-_-LRB- ITT_NNP -RRB-_-RRB- analysis_NN to_TO assess_VB therapeutic_JJ effects_NNS ._. 
Randomized_VBN controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNS -RRB-_-RRB- currently_RB provide_VBP the_DT best_JJS evidence_NN for_IN potentially_RB therapeutic_JJ or_CC prophylactic_JJ interventions_NNS ._. 
ITT_NNP analyses_NNS assess_VBP allocated_VBN treatment_NN as_IN the_DT predictor_NN of_IN outcome_NN ,_, and_CC are_VBP assumed_VBN to_TO be_VB unconfounded_JJ because_IN of_IN randomization_NN ,_, irrespective_RB of_IN compliance_NN ,_, adhere_NN 
Unfortunately_RB ,_, for_IN many_JJ types_NNS of_IN exposure_NN in_IN epidemiology_NN ,_, it_PRP is_VBZ both_DT impractical_JJ and_CC unethical_JJ to_TO randomize_VB study_NN participants_NNS to_TO different_JJ ``_`` treatment_NN ''_'' arms_NNS ._. 
Confounder_JJR control_NN in_IN observational_JJ studies_NNS may_MD also_RB be_VB problematic_JJ due_JJ to_TO incomplete_JJ understanding_NN of_IN the_DT relevant_JJ confounders_NNS in_IN a_DT given_VBN situation_NN ,_, or_CC due_JJ to_TO inherent_JJ measurement_NN errors_NNS that_WDT arise_VBP in_IN the_DT assessment_NN of_IN such_JJ confounders_NNS 
Confounder_JJR control_NN in_IN observational_JJ studies_NNS may_MD also_RB be_VB problematic_JJ due_JJ to_TO incomplete_JJ understanding_NN of_IN the_DT relevant_JJ confounders_NNS in_IN a_DT given_VBN situation_NN ,_, or_CC due_JJ to_TO inherent_JJ measurement_NN errors_NNS that_WDT arise_VBP in_IN the_DT assessment_NN of_IN such_JJ confounders_NNS 
McDonnell_NNP et_NNP al_NNP ._. 
The_DT authors_NNS examine_VBP the_DT complexities_NNS of_IN this_DT issue_NN and_CC analyze_VB how_WRB conflict_NN can_MD both_DT exacerbate_VB and_CC retard_VB the_DT spread_NN of_IN HIV_NNP ._. 
evaluate_VB the_DT role_NN of_IN epidemiologists_NNS in_IN conflict_NN settings_NNS ._. 
Present_JJ barriers_NNS to_TO effective_JJ engagement_NN stem_NN from_IN the_DT fact_NN that_IN epidemiologists_NNS do_VBP not_RB receive_VB training_NN on_IN issues_NNS pertinent_JJ to_TO their_PRP$ operating_NN in_IN conflict-affected_JJ areas_NNS ._. 
Specifically_RB ,_, the_DT opportunistic_JJ use_NN of_IN military_JJ language_NN in_IN public_JJ health_NN issues_NNS has_VBZ not_RB been_VBN particularly_RB welcome_JJ ._. 
Political_JJ calls_NNS for_IN war_NN on_IN the_DT societal_JJ problems_NNS of_IN drugs_NNS and_CC cancer_NN have_VBP been_VBN accused_VBN of_IN victimizing_VBG individuals_NNS and_CC setting_VBG implausible_JJ goals_NNS for_IN their_PRP$ prevention_NN and_CC control_NN 
Ironically_RB ,_, we_PRP have_VBP yet_RB to_TO publicly_RB declare_VB war_NN on_IN the_DT greatest_JJS of_IN societal_JJ ills_NNS ,_, war_NN itself_PRP ._. 
Political_JJ calls_NNS for_IN war_NN on_IN the_DT societal_JJ problems_NNS of_IN drugs_NNS and_CC cancer_NN have_VBP been_VBN accused_VBN of_IN victimizing_VBG individuals_NNS and_CC setting_VBG implausible_JJ goals_NNS for_IN their_PRP$ prevention_NN and_CC control_NN 
``_`` And_CC there_EX went_VBD out_RP another_DT horse_NN that_WDT was_VBD red_JJ :_: and_CC power_NN was_VBD given_VBN to_TO him_PRP that_WDT sat_VBD thereon_NN to_TO take_VB peace_NN from_IN the_DT earth_NN ,_, and_CC that_IN they_PRP should_MD kill_VB one_CD another_DT :_: and_CC there_EX was_VBD given_VBN unto_JJ him_PRP a_DT great_JJ sword_NN ._. ''_'' 
Specifically_RB ,_, the_DT opportunistic_JJ use_NN of_IN military_JJ language_NN in_IN public_JJ health_NN issues_NNS has_VBZ not_RB been_VBN particularly_RB welcome_JJ ._. 
Political_JJ calls_NNS for_IN war_NN on_IN the_DT societal_JJ problems_NNS of_IN drugs_NNS and_CC cancer_NN have_VBP been_VBN accused_VBN of_IN victimizing_VBG individuals_NNS and_CC setting_VBG implausible_JJ goals_NNS for_IN their_PRP$ prevention_NN and_CC control_NN 
Perhaps_RB most_RBS important_JJ are_VBP appropriate_JJ communication_NN skills_NNS to_TO enable_VB epidemiologists_NNS to_TO present_VB their_PRP$ message_NN clearly_RB as_IN health_NN related_VBN rather_RB than_IN political_JJ ._. 
Roberts_NNP and_CC Hofmann_NNP place_VBP the_DT work_NN of_IN humanitarian_JJ agencies_NNS under_IN the_DT epidemiologist_NN 's_POS gaze_VB ._. 
All_DT too_RB often_RB such_JJ agencies_NNS ,_, with_IN the_DT best_JJS intentions_NNS ,_, measure_NN success_NN in_IN terms_NNS of_IN process_NN 
Here_RB ,_, we_PRP draw_VBP a_DT parallel_NN with_IN the_DT early_JJ efforts_NNS to_TO communicate_VB the_DT link_NN between_IN smoking_NN and_CC lung_NN cancer_NN ._. 
In_IN his_PRP$ reflections_NNS on_IN the_DT subject_NN ,_, Ernst_NNP Wynder_NNP describes_VBZ the_DT opposition_NN he_PRP encountered_VBD when_WRB trying_VBG to_TO relay_VB the_DT findings_NNS from_IN the_DT first_JJ studies_NNS establishing_VBG the_DT epidemiologic_JJ link_NN ._. 
Opposition_NN came_VBD not_RB just_RB from_IN the_DT conflicted_JJ interests_NNS of_IN governments_NNS ,_, the_DT media_NNS and_CC tobacco_NN companies_NNS ,_, but_CC also_RB from_IN within_IN the_DT public_JJ health_NN profession_NN ,_, which_WDT was_VBD at_IN the_DT time_NN dominated_VBN by_IN physicians_NNS ,_, many_DT of_IN whom_WP were_VBD smokers_NNS ,_, were_VBD unused_JJ to_TO the_DT interpretation_NN of_IN epidemiologic_JJ data_NNS or_CC simply_RB thought_VBD the_DT association_NN to_TO be_VB implausible_JJ ._. 
Scientists_NNS and_CC physicians_NNS can_MD not_RB be_VB content_JJ with_IN discoveries_NNS until_IN their_PRP$ beneficial_JJ or_CC protective_JJ outcome_NN for_IN the_DT population_NN has_VBZ been_VBN fully_RB realized_VBN ._. 
This_DT means_VBZ that_IN the_DT members_NNS of_IN the_DT scientific_JJ and_CC medical_JJ community_NN must_MD become_VB more_RBR proactive_JJ in_IN public_JJ health_NN matters_NNS ._. ''_'' 
The_DT issue_NN of_IN consensus_NN is_VBZ important_JJ ,_, but_CC difficult_JJ ._. 
Some_DT will_MD argue_VB that_DT war_NN is_VBZ inherently_RB bad_JJ for_IN public_JJ health_NN and_CC should_MD always_RB be_VB opposed_VBN ._. 
Mock_FW et_FW al_FW ._. 
In_IN the_DT face_NN of_IN such_JJ challenges_NNS ,_, the_DT authors_NNS of_IN the_DT articles_NNS in_IN this_DT special_JJ issue_NN deal_NN with_IN a_DT broad_JJ range_NN of_IN issues_NNS of_IN great_JJ relevance_NN to_TO epidemiologists_NNS ._. 
argue_VBP that_IN the_DT interface_NN of_IN HIV\/AIDS_NN and_CC conflict_NN is_VBZ more_RBR complex_JJ than_IN is_VBZ usually_RB assumed_JJ ._. 
It_PRP is_VBZ often_RB said_VBD that_DT war_NN exacerbates_VBZ the_DT HIV_NNP epidemic_NN ,_, but_CC the_DT ecologic_JJ evidence_NN suggests_VBZ that_IN this_DT is_VBZ not_RB always_RB the_DT case_NN ._. 
In_IN effect_NN ,_, there_EX are_VBP other_JJ brain_NN regions_NNS ,_, which_WDT have_VBP been_VBN shown_VBN to_TO play_VB significant_JJ roles_NNS in_IN the_DT stress-induced_JJ suppression_NN of_IN reproduction_NN ._. 
We_PRP have_VBP previously_RB shown_VBN that_IN CRF_NNP administration_NN into_IN the_DT bed_NN nucleus_NN of_IN stria_NN terminalis_NNS -LRB-_-LRB- BNST_NNP -RRB-_-RRB- -LRB-_-LRB- 50_CD -RRB-_-RRB- or_CC locus_FW coeruleus_FW -LRB-_-LRB- LC_NNP -RRB-_-RRB- -LRB-_-LRB- 51_CD -RRB-_-RRB- also_RB results_NNS in_IN the_DT concomitant_JJ suppression_NN of_IN pulsatile_JJ LH_NNP secretion_NN with_IN activation_NN of_IN GABAergic_JJ neurons_NNS within_IN the_DT mPOA_NNP ._. 
Moreover_RB ,_, microinfusion_NN of_IN CRF_NNP antagonist_NN into_IN either_CC the_DT BNST_NNP -LRB-_-LRB- 50_CD -RRB-_-RRB- or_CC the_DT LC_NNP -LRB-_-LRB- 51_CD -RRB-_-RRB- blocked_VBD the_DT psychogenic_JJ but_CC not_RB metabolic_JJ stress_NN 
We_PRP have_VBP previously_RB shown_VBN that_IN CRF_NNP administration_NN into_IN the_DT bed_NN nucleus_NN of_IN stria_NN terminalis_NNS -LRB-_-LRB- BNST_NNP -RRB-_-RRB- -LRB-_-LRB- 50_CD -RRB-_-RRB- or_CC locus_FW coeruleus_FW -LRB-_-LRB- LC_NNP -RRB-_-RRB- -LRB-_-LRB- 51_CD -RRB-_-RRB- also_RB results_NNS in_IN the_DT concomitant_JJ suppression_NN of_IN pulsatile_JJ LH_NNP secretion_NN with_IN activation_NN of_IN GABAergic_JJ neurons_NNS within_IN the_DT mPOA_NNP ._. 
Moreover_RB ,_, microinfusion_NN of_IN CRF_NNP antagonist_NN into_IN either_CC the_DT BNST_NNP -LRB-_-LRB- 50_CD -RRB-_-RRB- or_CC the_DT LC_NNP -LRB-_-LRB- 51_CD -RRB-_-RRB- blocked_VBD the_DT psychogenic_JJ but_CC not_RB metabolic_JJ stress_NN 
Interestingly_RB ,_, both_DT MeA_NNP and_CC CeA_NNP lesions_NNS did_VBD not_RB affect_VB the_DT inhibitory_JJ response_NN to_TO hypoglycemic_JJ stress_NN ._. 
Further_RB ,_, the_DT BNST_NNP -LRB-_-LRB- 50_CD -RRB-_-RRB- and_CC LC_NNP -LRB-_-LRB- 51_CD -RRB-_-RRB- appear_VBP not_RB to_TO be_VB involved_VBN in_IN mediating_VBG the_DT inhibitory_JJ effect_NN of_IN this_DT metabolic_JJ stressor_NN on_IN GnRH_NNP pulse_NN generator_NN activity_NN ,_, and_CC the_DT neural_JJ circuitry_NN underlying_VBG this_DT response_NN remains_VBZ to_TO be_VB established_VBN ._. 
Although_IN we_PRP have_VBP postulated_VBN that_IN projections_NNS from_IN the_DT amygdala_NN that_WDT mediate_VBP stress_NN effects_NNS on_IN the_DT GnRH_NNP pulse_NN generator_NN terminate_VBP on_IN targets_NNS in_IN the_DT mPOA_NNP ,_, a_DT caveat_NN to_TO consider_VB is_VBZ the_DT overwhelming_JJ evidence_NN that_IN the_DT neural_NN construct_VBP comprising_VBG this_DT hypothalamic_JJ oscillator_NN resides_VBZ in_IN the_DT arcuate_JJ nucleus_NN of_IN the_DT mediobasal_JJ hypothalamus_NN in_IN rats_NNS -LRB-_-LRB- 59_CD -RRB-_-RRB- in_IN common_NN with_IN other_JJ species_NNS including_VBG primates_NNS -LRB-_-LRB- 60_CD -RRB-_-RRB- ._. 
Additionally_RB ,_, anatomical_JJ studies_NNS indicate_VBP that_IN the_DT MeA_NNP has_VBZ extensive_JJ direct_JJ projections_NNS to_TO the_DT GnRH-rich_NNP mPOA_NNP -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- ._. 
Because_IN extrinsic_JJ projections_NNS of_IN the_DT MeA_NNP are_VBP predominantly_RB GABAergic_JJ -LRB-_-LRB- 49_CD -RRB-_-RRB- ,_, this_DT raises_VBZ the_DT possibility_NN that_IN the_DT attenuation_NN of_IN the_DT restraint_NN stress-induced_JJ suppression_NN of_IN pulsatile_JJ LH_NNP secretion_NN ,_, observed_VBN in_IN MeA_NNP lesioned_VBD rats_NNS ,_, may_MD result_VB from_IN removal_NN of_IN inhibitory_JJ GABAergic_JJ inputs_NNS to_TO the_DT mPOA_NNP ._. 
However_RB ,_, the_DT neurochemical_JJ phenotype_NN of_IN the_DT direct_JJ projections_NNS from_IN the_DT MeA_NNP to_TO the_DT mPOA_NNP is_VBZ unknown_JJ ._. 
However_RB ,_, the_DT robust_JJ connections_NNS between_IN the_DT amygdala_NN and_CC the_DT BNST_NNP -LRB-_-LRB- 52_CD ,_, 56_CD -RRB-_-RRB- ,_, which_WDT in_IN turn_NN projects_NNS heavily_RB to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 62_CD -RRB-_-RRB- ,_, may_MD provide_VB an_DT indirect_JJ functional_JJ route_NN for_IN amygdaloid_JJ influence_NN on_IN GnRH_NNP pulse_NN generator_NN activity_NN ;_: this_DT is_VBZ a_DT postulate_NN that_WDT remains_VBZ to_TO be_VB explored_VBN ._. 
Nevertheless_RB ,_, the_DT observation_NN that_IN microinfusion_NN of_IN a_DT wide_JJ range_NN of_IN neuropeptides_NNS ,_, including_VBG calcitonin_NN gene-related_JJ peptide_NN ,_, CRF_NNP ,_, or_CC GABA_NNP ,_, directly_RB into_IN the_DT mPOA_NNP suppresses_VBZ pulsatile_JJ LH_NNP secretion_NN -LRB-_-LRB- 30_CD ,_, 63_CD ,_, 64_CD -RRB-_-RRB- is_VBZ not_RB inconsistent_JJ with_IN the_DT notion_NN of_IN a_DT neurocircuit_JJ relay_NN via_IN the_DT mPOA_NNP to_TO the_DT mediobasal_JJ hypothalamus_NN to_TO modulate_VB GnRH_NNP pulse_NN generator_NN activity_NN ._. 
In_IN the_DT present_JJ study_NN an_DT ovariectomized_VBN rat_NN model_NN without_IN gonadal_JJ steroid_NN replacement_NN was_VBD used_VBN ._. 
Because_IN there_EX is_VBZ substantial_JJ evidence_NN that_IN gonadal_JJ steroids_NNS ,_, in_IN particular_JJ estradiol_NN ,_, sensitize_VB the_DT GnRH_NNP pulse_NN generator_NN to_TO the_DT inhibitory_JJ effects_NNS of_IN stress_NN -LRB-_-LRB- 65_CD 
MeA-mediated_JJ activation_NN of_IN GABAergic_JJ neurons_NNS after_IN restraint_NN stress_NN ,_, as_IN shown_VBN by_IN a_DT greater_JJR percentage_NN of_IN GAD_NNP 67_CD neurons_NNS expressing_VBG Fos_NNP immunoreactivity_NN in_IN the_DT mPOA_NNP of_IN intact_JJ compared_VBN with_IN MeA_NNP lesioned_VBD animals_NNS ,_, is_VBZ consistent_JJ with_IN the_DT suggestion_NN of_IN a_DT functional_JJ relationship_NN between_IN these_DT two_CD areas_NNS of_IN the_DT brain_NN and_CC the_DT possibility_NN that_IN preoptic_JJ GABAergic_JJ neurons_NNS may_MD underlie_VB the_DT reduction_NN in_IN GnRH_NNP pulse_NN generator_NN activity_NN ._. 
Numerous_JJ studies_NNS indicate_VBP that_IN GABA_NNP plays_VBZ an_DT important_JJ inhibitory_JJ role_NN in_IN the_DT regulation_NN of_IN GnRH\/LH_NNP secretion_NN ,_, because_IN endogenous_JJ GABA_NNP release_NN has_VBZ been_VBN shown_VBN to_TO exert_VB a_DT powerful_JJ inhibitory_JJ effect_NN on_IN the_DT activation_NN of_IN GnRH_NNP neurons_NNS in_IN vitro_NN -LRB-_-LRB- 29_CD -RRB-_-RRB- and_CC local_JJ infusion_NN of_IN GABA_NNP into_IN the_DT mPOA_NNP to_TO suppress_VB GnRH_NNP expression_NN -LRB-_-LRB- 48_CD -RRB-_-RRB- and_CC pulsatile_JJ LH_NNP release_NN -LRB-_-LRB- 30_CD -RRB-_-RRB- ._. 
More_RBR importantly_RB ,_, intra-mPOA_JJ administration_NN of_IN GABA_NNP receptor_NN antagonist_NN blocks_VBZ stress-induced_JJ suppression_NN of_IN LH_NNP pulses_NNS -LRB-_-LRB- Lin_NNP ,_, Li_NNP ,_, 
The_DT amygdala_NN with_IN its_PRP$ medial_JJ subdivision_NN has_VBZ been_VBN strongly_RB implicated_VBN in_IN regulating_VBG reproductive_JJ processes_NNS ,_, such_JJ as_IN ovulation_NN ,_, estrous_JJ cyclicity_NN ,_, pituitary_JJ LH_NNP and_CC FSH_NNP production_NN ,_, as_RB well_RB as_IN sexual_JJ behavior_NN -LRB-_-LRB- 12_CD 
Arecent_JJ report_NN indicating_VBG that_IN lowering_VBG stress_NN levels_NNS with_IN cognitive_JJ behavioral_JJ therapy_NN restored_VBD ovulation_NN in_IN more_JJR than_IN 80_CD %_NN of_IN women_NNS with_IN functional_JJ hypothalamic_JJ amenorrhoea_NN -LRB-_-LRB- 16_CD -RRB-_-RRB- may_MD also_RB underlie_VB the_DT clinical_JJ importance_NN of_IN the_DT limbic_JJ system_NN in_IN the_DT suppression_NN of_IN the_DT HPG_NNP axis_NNS ._. 
More_RBR specifically_RB ,_, it_PRP has_VBZ been_VBN shown_VBN that_IN plasma_NN LH_NNP levels_NNS increase_NN after_IN MeA_NNP lesioning_VBG -LRB-_-LRB- 17_CD -RRB-_-RRB- while_IN electrical_JJ stimulation_NN of_IN the_DT MeA_NNP results_NNS in_IN delayed_JJ puberty_NN in_IN female_JJ rats_NNS -LRB-_-LRB- 18_CD -RRB-_-RRB- ,_, suggesting_VBG this_DT nucleus_NN exerts_VBZ an_DT inhibitory_JJ influence_NN on_IN reproductive_JJ function_NN ._. 
Such_PDT an_DT influence_NN of_IN the_DT MeA_NNP on_IN the_DT HPG_NNP axis_NN is_VBZ further_RBR supported_VBN by_IN neuroanatomical_JJ studies_NNS demonstrating_VBG the_DT existence_NN of_IN extensive_JJ direct_JJ projections_NNS from_IN the_DT MeA_NNP to_TO the_DT hypothalamic_JJ GnRH-rich_NNP medial_JJ preoptic_JJ area_NN -LRB-_-LRB- mPOA_NNP -RRB-_-RRB- -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- although_IN the_DT neurochemical_JJ phenotype_NN of_IN these_DT efferents_NNS is_VBZ unknown_JJ ._. 
Conversely_RB ,_, MeA_NNP lesioning_NN has_VBZ also_RB been_VBN shown_VBN to_TO reduce_VB ovulation_NN -LRB-_-LRB- 12_CD -RRB-_-RRB- and_CC the_DT mating-induced_JJ enhancement_NN of_IN lordosis_NNS in_IN female_JJ rats_NNS -LRB-_-LRB- 41_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, the_DT precise_JJ role_NN of_IN the_DT MeA_NNP in_IN the_DT control_NN of_IN LH_NNP secretion_NN is_VBZ also_RB controversial_JJ with_IN reports_NNS of_IN increases_NNS in_IN LH_NNP secretion_NN after_IN both_DT MeA_NNP lesioning_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- and_CC MeA_NNP stimulation_NN in_IN rats_NNS -LRB-_-LRB- 13_CD ,_, 42_CD ,_, 43_CD -RRB-_-RRB- and_CC reports_NNS indicating_VBG that_IN MeA_NNP lesioning_NN has_VBZ no_DT effect_NN on_IN LH_NNP secretion_NN in_IN the_DT rhesus_JJ monkey_NN -LRB-_-LRB- 44_CD -RRB-_-RRB- ,_, immature_JJ rat_NN -LRB-_-LRB- 45_CD -RRB-_-RRB- ,_, and_CC deer-mice_JJ -LRB-_-LRB- 46_CD -RRB-_-RRB- ._. 
Nonetheless_RB the_DT studies_NNS presented_VBN above_IN ,_, regardless_RB of_IN whether_IN they_PRP demonstrate_VBP an_DT inhibitory_JJ or_CC stimulatory_JJ role_NN for_IN the_DT MeA_NNP on_IN LH_NNP secretion_NN ,_, focus_NN on_IN either_DT changes_NNS in_IN mean_JJ circulating_VBG levels_NNS of_IN LH_NNP or_CC the_DT LH_NNP surge_NN ._. 
There_EX is_VBZ accumulating_VBG evidence_NN describing_VBG a_DT role_NN for_IN limbic_JJ brain_NN structures_NNS as_IN modulators_NNS of_IN the_DT hypothalamo-pituitary-gonadal_JJ -LRB-_-LRB- HPG_NNP -RRB-_-RRB- axis_NNS ._. 
The_DT amygdala_NN with_IN its_PRP$ medial_JJ subdivision_NN has_VBZ been_VBN strongly_RB implicated_VBN in_IN regulating_VBG reproductive_JJ processes_NNS ,_, such_JJ as_IN ovulation_NN ,_, estrous_JJ cyclicity_NN ,_, pituitary_JJ LH_NNP and_CC FSH_NNP production_NN ,_, as_RB well_RB as_IN sexual_JJ behavior_NN -LRB-_-LRB- 12_CD 
There_EX is_VBZ accumulating_VBG evidence_NN describing_VBG a_DT role_NN for_IN limbic_JJ brain_NN structures_NNS as_IN modulators_NNS of_IN the_DT hypothalamo-pituitary-gonadal_JJ -LRB-_-LRB- HPG_NNP -RRB-_-RRB- axis_NNS ._. 
The_DT amygdala_NN with_IN its_PRP$ medial_JJ subdivision_NN has_VBZ been_VBN strongly_RB implicated_VBN in_IN regulating_VBG reproductive_JJ processes_NNS ,_, such_JJ as_IN ovulation_NN ,_, estrous_JJ cyclicity_NN ,_, pituitary_JJ LH_NNP and_CC FSH_NNP production_NN ,_, as_RB well_RB as_IN sexual_JJ behavior_NN -LRB-_-LRB- 12_CD 
Electrical_JJ stimulation_NN of_IN the_DT MeA_NNP delays_NNS puberty_NN in_IN female_JJ rats_NNS -LRB-_-LRB- 18_CD -RRB-_-RRB- ,_, suggesting_VBG an_DT inhibitory_JJ influence_NN on_IN gonadotropin_NN secretion_NN ._. 
Conversely_RB ,_, MeA_NNP lesioning_NN has_VBZ also_RB been_VBN shown_VBN to_TO reduce_VB ovulation_NN -LRB-_-LRB- 12_CD -RRB-_-RRB- and_CC the_DT mating-induced_JJ enhancement_NN of_IN lordosis_NNS in_IN female_JJ rats_NNS -LRB-_-LRB- 41_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, the_DT precise_JJ role_NN of_IN the_DT MeA_NNP in_IN the_DT control_NN of_IN LH_NNP secretion_NN is_VBZ also_RB controversial_JJ with_IN reports_NNS of_IN increases_NNS in_IN LH_NNP secretion_NN after_IN both_DT MeA_NNP lesioning_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- and_CC MeA_NNP stimulation_NN in_IN rats_NNS -LRB-_-LRB- 13_CD ,_, 42_CD ,_, 43_CD -RRB-_-RRB- and_CC reports_NNS indicating_VBG that_IN MeA_NNP lesioning_NN has_VBZ no_DT effect_NN on_IN LH_NNP secretion_NN in_IN the_DT rhesus_JJ monkey_NN -LRB-_-LRB- 44_CD -RRB-_-RRB- ,_, immature_JJ rat_NN -LRB-_-LRB- 45_CD -RRB-_-RRB- ,_, and_CC deer-mice_JJ -LRB-_-LRB- 46_CD -RRB-_-RRB- ._. 
Conversely_RB ,_, MeA_NNP lesioning_NN has_VBZ also_RB been_VBN shown_VBN to_TO reduce_VB ovulation_NN -LRB-_-LRB- 12_CD -RRB-_-RRB- and_CC the_DT mating-induced_JJ enhancement_NN of_IN lordosis_NNS in_IN female_JJ rats_NNS -LRB-_-LRB- 41_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, the_DT precise_JJ role_NN of_IN the_DT MeA_NNP in_IN the_DT control_NN of_IN LH_NNP secretion_NN is_VBZ also_RB controversial_JJ with_IN reports_NNS of_IN increases_NNS in_IN LH_NNP secretion_NN after_IN both_DT MeA_NNP lesioning_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- and_CC MeA_NNP stimulation_NN in_IN rats_NNS -LRB-_-LRB- 13_CD ,_, 42_CD ,_, 43_CD -RRB-_-RRB- and_CC reports_NNS indicating_VBG that_IN MeA_NNP lesioning_NN has_VBZ no_DT effect_NN on_IN LH_NNP secretion_NN in_IN the_DT rhesus_JJ monkey_NN -LRB-_-LRB- 44_CD -RRB-_-RRB- ,_, immature_JJ rat_NN -LRB-_-LRB- 45_CD -RRB-_-RRB- ,_, and_CC deer-mice_JJ -LRB-_-LRB- 46_CD -RRB-_-RRB- ._. 
Nonetheless_RB the_DT studies_NNS presented_VBN above_IN ,_, regardless_RB of_IN whether_IN they_PRP demonstrate_VBP an_DT inhibitory_JJ or_CC stimulatory_JJ role_NN for_IN the_DT MeA_NNP on_IN LH_NNP secretion_NN ,_, focus_NN on_IN either_DT changes_NNS in_IN mean_JJ circulating_VBG levels_NNS of_IN LH_NNP or_CC the_DT LH_NNP surge_NN ._. 
Nonetheless_RB the_DT studies_NNS presented_VBN above_IN ,_, regardless_RB of_IN whether_IN they_PRP demonstrate_VBP an_DT inhibitory_JJ or_CC stimulatory_JJ role_NN for_IN the_DT MeA_NNP on_IN LH_NNP secretion_NN ,_, focus_NN on_IN either_DT changes_NNS in_IN mean_JJ circulating_VBG levels_NNS of_IN LH_NNP or_CC the_DT LH_NNP surge_NN ._. 
Although_IN electrochemical_JJ stimulation_NN of_IN the_DT CeA_NNP has_VBZ no_DT effect_NN on_IN mean_NN circulating_VBG levels_NNS of_IN LH_NNP -LRB-_-LRB- 13_CD -RRB-_-RRB- ,_, the_DT CeA_NNP has_VBZ been_VBN shown_VBN to_TO be_VB involved_VBN in_IN maternal_JJ -LRB-_-LRB- 47_CD -RRB-_-RRB- and_CC sexual_JJ behavior_NN -LRB-_-LRB- 23_CD -RRB-_-RRB- ._. 
In_IN the_DT present_JJ study_NN ,_, we_PRP found_VBD that_IN MeA_NNP or_CC CeA_NNP lesions_NNS do_VBP not_RB affect_VB LH_NNP pulse_NN frequency_NN under_IN stress-free_JJ conditions_NNS ._. 
Of_IN a_DT number_NN of_IN subdivisions_NNS of_IN the_DT amygdala_NN ,_, the_DT medial_JJ nucleus_NN -LRB-_-LRB- MeA_NNP -RRB-_-RRB- which_WDT projects_NNS to_TO basal_JJ forebrain_NN ,_, hypothalamic_JJ ,_, and_CC brain_NN stem_NN structures_NNS demonstrates_VBZ the_DT most_RBS neuronal_JJ activation_NN in_IN response_NN to_TO psychogenic_JJ stressors_NNS such_JJ as_IN restraint_NN ,_, forced_VBD swim_VB ,_, noise_NN ,_, or_CC predator_NN exposure_NN -LRB-_-LRB- 4_CD 
The_DT HPG-inhibitory_JJ role_NN for_IN the_DT MeA_NNP and_CC CeA_NNP is_VBZ consistent_JJ with_IN their_PRP$ well-known_JJ function_NN in_IN regulating_VBG the_DT stress_NN response_NN following_VBG stress_NN exposure_NN -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
Indeed_RB damage_NN to_TO the_DT MeA_NNP has_VBZ been_VBN shown_VBN to_TO decrease_VB anxiety-related_JJ behavior_NN and_CC corticosterone_NN responses_NNS to_TO stressors_NNS -LRB-_-LRB- 9_CD ,_, 10_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ,_, while_IN MeA_NNP stimulation_NN has_VBZ been_VBN shown_VBN to_TO increase_VB HPA_NNP axis_NN output_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC facilitate_VB its_PRP$ stress-induced_JJ activation_NN -LRB-_-LRB- 38_CD -RRB-_-RRB- ._. 
Electrical_JJ stimulation_NN of_IN the_DT CeA_NNP results_NNS in_IN the_DT activation_NN of_IN the_DT autonomic_JJ nervous_JJ system_NN -LRB-_-LRB- 39_CD -RRB-_-RRB- ,_, while_IN lesions_NNS of_IN the_DT CeA_NNP attenuate_VB corticosterone_JJ release_NN evoked_VBN by_IN interleukin-1_NN 
Moreover_RB ,_, consistent_JJ with_IN its_PRP$ stressor-specific_JJ role_NN ,_, selective_JJ MeA_NNP lesioning_NN has_VBZ been_VBN found_VBN to_TO block_VB the_DT activation_NN of_IN hypothalamic_JJ paraventricular_JJ neuroendocrine_NN cell_NN responses_NNS to_TO acute_JJ restraint_NN -LRB-_-LRB- 9_CD -RRB-_-RRB- and_CC the_DT increase_NN in_IN corticosterone_NN in_IN response_NN to_TO predator_NN odor_NN in_IN rats_NNS -LRB-_-LRB- 10_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, the_DT central_JJ nucleus_NN -LRB-_-LRB- CeA_NNP -RRB-_-RRB- of_IN the_DT amygdala_NN has_VBZ been_VBN shown_VBN to_TO be_VB highly_RB responsive_JJ to_TO systemic_JJ stressors_NNS like_IN inflammation_NN or_CC hemorrhage_NN -LRB-_-LRB- 7_CD ,_, 8_CD -RRB-_-RRB- ,_, with_IN specific_JJ lesions_NNS of_IN this_DT subnucleus_NN resulting_VBG in_IN an_DT attenuation_NN of_IN the_DT HPA_NNP response_NN after_IN interleukin-1_NN 
Indeed_RB damage_NN to_TO the_DT MeA_NNP has_VBZ been_VBN shown_VBN to_TO decrease_VB anxiety-related_JJ behavior_NN and_CC corticosterone_NN responses_NNS to_TO stressors_NNS -LRB-_-LRB- 9_CD ,_, 10_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ,_, while_IN MeA_NNP stimulation_NN has_VBZ been_VBN shown_VBN to_TO increase_VB HPA_NNP axis_NN output_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC facilitate_VB its_PRP$ stress-induced_JJ activation_NN -LRB-_-LRB- 38_CD -RRB-_-RRB- ._. 
Electrical_JJ stimulation_NN of_IN the_DT CeA_NNP results_NNS in_IN the_DT activation_NN of_IN the_DT autonomic_JJ nervous_JJ system_NN -LRB-_-LRB- 39_CD -RRB-_-RRB- ,_, while_IN lesions_NNS of_IN the_DT CeA_NNP attenuate_VB corticosterone_JJ release_NN evoked_VBN by_IN interleukin-1_NN 
Bilateral_JJ lesions_NNS of_IN the_DT MeA_NNP markedly_RB attenuated_VBD the_DT psychogenic_JJ -LRB-_-LRB- restraint_NN -RRB-_-RRB- stress-induced_JJ suppression_NN of_IN pulsatile_JJ LH_NNP release_NN without_IN affecting_VBG the_DT inhibitory_JJ response_NN induced_VBN by_IN immunological_JJ -LRB-_-LRB- LPS_NNP -RRB-_-RRB- or_CC metabolic_JJ -LRB-_-LRB- IIH_NNP -RRB-_-RRB- stressors_NNS ,_, suggesting_VBG that_IN the_DT MeA_NNP suppresses_VBZ reproductive_JJ function_NN only_RB when_WRB specifically_RB activated_VBN by_IN psychogenic_JJ stressors_NNS ._. 
With_IN regards_VBZ to_TO systemic_JJ stressors_NNS ,_, the_DT CeA_NNP has_VBZ been_VBN shown_VBN to_TO be_VB highly_RB responsive_JJ to_TO stressors_NNS like_IN inflammation_NN or_CC hemorrhage_NN -LRB-_-LRB- 7_CD ,_, 8_CD -RRB-_-RRB- ,_, with_IN specific_JJ lesions_NNS of_IN this_DT sub-nucleus_NN resulting_VBG in_IN an_DT attenuation_NN of_IN the_DT HPA_NNP response_NN after_IN interleukin-1_NN 
Similar_JJ to_TO the_DT partial_JJ effect_NN of_IN MeA_NNP lesioning_VBG on_IN restraint_NN stress-induced_JJ suppression_NN of_IN LH_NNP pulses_NNS ,_, the_DT inhibitory_JJ effect_NN of_IN LPS_NNP stress_NN on_IN pulsatile_JJ LH_NNP secretion_NN was_VBD not_RB completely_RB blocked_VBN by_IN bilateral_JJ CeA_NNP lesions_NNS ._. 
It_PRP has_VBZ been_VBN reported_VBN that_IN there_EX are_VBP very_RB few_JJ -LRB-_-LRB- 55_CD -RRB-_-RRB- or_CC no_DT -LRB-_-LRB- 20_CD ,_, 52_CD -RRB-_-RRB- neural_JJ projections_NNS from_IN the_DT CeA_NNP to_TO the_DT GnRH-rich_NNP mPOA_NNP ._. 
Nevertheless_RB ,_, the_DT CeA_NNP is_VBZ known_VBN to_TO densely_RB innervate_VB the_DT BNST_NNP ,_, primarily_RB with_IN CRF_NNP containing_VBG neurons_NNS -LRB-_-LRB- 21_CD ,_, 56_CD -RRB-_-RRB- ._. 
Arecent_JJ report_NN indicating_VBG that_IN lowering_VBG stress_NN levels_NNS with_IN cognitive_JJ behavioral_JJ therapy_NN restored_VBD ovulation_NN in_IN more_JJR than_IN 80_CD %_NN of_IN women_NNS with_IN functional_JJ hypothalamic_JJ amenorrhoea_NN -LRB-_-LRB- 16_CD -RRB-_-RRB- may_MD also_RB underlie_VB the_DT clinical_JJ importance_NN of_IN the_DT limbic_JJ system_NN in_IN the_DT suppression_NN of_IN the_DT HPG_NNP axis_NNS ._. 
More_RBR specifically_RB ,_, it_PRP has_VBZ been_VBN shown_VBN that_IN plasma_NN LH_NNP levels_NNS increase_NN after_IN MeA_NNP lesioning_VBG -LRB-_-LRB- 17_CD -RRB-_-RRB- while_IN electrical_JJ stimulation_NN of_IN the_DT MeA_NNP results_NNS in_IN delayed_JJ puberty_NN in_IN female_JJ rats_NNS -LRB-_-LRB- 18_CD -RRB-_-RRB- ,_, suggesting_VBG this_DT nucleus_NN exerts_VBZ an_DT inhibitory_JJ influence_NN on_IN reproductive_JJ function_NN ._. 
Such_PDT an_DT influence_NN of_IN the_DT MeA_NNP on_IN the_DT HPG_NNP axis_NN is_VBZ further_RBR supported_VBN by_IN neuroanatomical_JJ studies_NNS demonstrating_VBG the_DT existence_NN of_IN extensive_JJ direct_JJ projections_NNS from_IN the_DT MeA_NNP to_TO the_DT hypothalamic_JJ GnRH-rich_NNP medial_JJ preoptic_JJ area_NN -LRB-_-LRB- mPOA_NNP -RRB-_-RRB- -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- although_IN the_DT neurochemical_JJ phenotype_NN of_IN these_DT efferents_NNS is_VBZ unknown_JJ ._. 
The_DT MeA_NNP has_VBZ also_RB been_VBN implicated_VBN in_IN regulating_VBG reproduction_NN and_CC therefore_RB the_DT HPG_NNP axis_NNS ,_, however_RB its_PRP$ precise_JJ role_NN in_IN modulating_VBG this_DT neuroendocrine_NN axis_NN is_VBZ controversial_JJ ._. 
Electrical_JJ stimulation_NN of_IN the_DT MeA_NNP delays_NNS puberty_NN in_IN female_JJ rats_NNS -LRB-_-LRB- 18_CD -RRB-_-RRB- ,_, suggesting_VBG an_DT inhibitory_JJ influence_NN on_IN gonadotropin_NN secretion_NN ._. 
Conversely_RB ,_, MeA_NNP lesioning_NN has_VBZ also_RB been_VBN shown_VBN to_TO reduce_VB ovulation_NN -LRB-_-LRB- 12_CD -RRB-_-RRB- and_CC the_DT mating-induced_JJ enhancement_NN of_IN lordosis_NNS in_IN female_JJ rats_NNS -LRB-_-LRB- 41_CD -RRB-_-RRB- ._. 
More_RBR specifically_RB ,_, it_PRP has_VBZ been_VBN shown_VBN that_IN plasma_NN LH_NNP levels_NNS increase_NN after_IN MeA_NNP lesioning_VBG -LRB-_-LRB- 17_CD -RRB-_-RRB- while_IN electrical_JJ stimulation_NN of_IN the_DT MeA_NNP results_NNS in_IN delayed_JJ puberty_NN in_IN female_JJ rats_NNS -LRB-_-LRB- 18_CD -RRB-_-RRB- ,_, suggesting_VBG this_DT nucleus_NN exerts_VBZ an_DT inhibitory_JJ influence_NN on_IN reproductive_JJ function_NN ._. 
Such_PDT an_DT influence_NN of_IN the_DT MeA_NNP on_IN the_DT HPG_NNP axis_NN is_VBZ further_RBR supported_VBN by_IN neuroanatomical_JJ studies_NNS demonstrating_VBG the_DT existence_NN of_IN extensive_JJ direct_JJ projections_NNS from_IN the_DT MeA_NNP to_TO the_DT hypothalamic_JJ GnRH-rich_NNP medial_JJ preoptic_JJ area_NN -LRB-_-LRB- mPOA_NNP -RRB-_-RRB- -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- although_IN the_DT neurochemical_JJ phenotype_NN of_IN these_DT efferents_NNS is_VBZ unknown_JJ ._. 
The_DT CeA_NNP contains_VBZ a_DT major_JJ corticotropin-releasing_NN factor_NN -LRB-_-LRB- CRF_NNP -RRB-_-RRB- neuronal_JJ population_NN -LRB-_-LRB- 21_CD -RRB-_-RRB- ,_, which_WDT is_VBZ a_DT key_JJ inhibitory_JJ neuropeptide_NN of_IN the_DT GnRH_NNP pulse_NN generator_NN -LRB-_-LRB- 22_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, the_DT levels_NNS of_IN Fos_NNS and_CC percentage_NN of_IN GAD_NNP 67_CD neurons_NNS expressing_VBG Fos_NNP within_IN the_DT mPOA_NNP were_VBD very_RB low_JJ and_CC indifferent_JJ between_IN the_DT MeA_NNP lesioned_JJ and_CC intact_JJ animals_NNS in_IN the_DT absence_NN of_IN restraint_NN stress_NN ,_, which_WDT further_RB emphasizes_VBZ a_DT role_NN for_IN the_DT MeA_NNP in_IN regulation_NN of_IN the_DT reproductive_JJ neuroendocrine_NN system_NN during_IN stress_NN but_CC not_RB under_IN nonstress_JJ conditions_NNS ._. 
Additionally_RB ,_, anatomical_JJ studies_NNS indicate_VBP that_IN the_DT MeA_NNP has_VBZ extensive_JJ direct_JJ projections_NNS to_TO the_DT GnRH-rich_NNP mPOA_NNP -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- ._. 
Because_IN extrinsic_JJ projections_NNS of_IN the_DT MeA_NNP are_VBP predominantly_RB GABAergic_JJ -LRB-_-LRB- 49_CD -RRB-_-RRB- ,_, this_DT raises_VBZ the_DT possibility_NN that_IN the_DT attenuation_NN of_IN the_DT restraint_NN stress-induced_JJ suppression_NN of_IN pulsatile_JJ LH_NNP secretion_NN ,_, observed_VBN in_IN MeA_NNP lesioned_VBD rats_NNS ,_, may_MD result_VB from_IN removal_NN of_IN inhibitory_JJ GABAergic_JJ inputs_NNS to_TO the_DT mPOA_NNP ._. 
Nevertheless_RB ,_, the_DT CeA_NNP is_VBZ known_VBN to_TO densely_RB innervate_VB the_DT BNST_NNP ,_, primarily_RB with_IN CRF_NNP containing_VBG neurons_NNS -LRB-_-LRB- 21_CD ,_, 56_CD -RRB-_-RRB- ._. 
Further_RB ,_, LPS_NNP stress_NN induces_VBZ strong_JJ Fos_NNP expression_NN in_IN both_CC the_DT BNST_NNP -LRB-_-LRB- 57_CD -RRB-_-RRB- and_CC LC_NNP -LRB-_-LRB- 58_CD -RRB-_-RRB- ._. 
Thus_RB ,_, the_DT CeA_NNP may_MD similarly_RB provide_VB input_NN to_TO the_DT postulated_JJ multi-synaptic_JJ pathway_NN to_TO the_DT mPOA_NNP described_VBD above_IN ._. 
Further_RB ,_, the_DT BNST_NNP -LRB-_-LRB- 50_CD -RRB-_-RRB- and_CC LC_NNP -LRB-_-LRB- 51_CD -RRB-_-RRB- appear_VBP not_RB to_TO be_VB involved_VBN in_IN mediating_VBG the_DT inhibitory_JJ effect_NN of_IN this_DT metabolic_JJ stressor_NN on_IN GnRH_NNP pulse_NN generator_NN activity_NN ,_, and_CC the_DT neural_JJ circuitry_NN underlying_VBG this_DT response_NN remains_VBZ to_TO be_VB established_VBN ._. 
Although_IN we_PRP have_VBP postulated_VBN that_IN projections_NNS from_IN the_DT amygdala_NN that_WDT mediate_VBP stress_NN effects_NNS on_IN the_DT GnRH_NNP pulse_NN generator_NN terminate_VBP on_IN targets_NNS in_IN the_DT mPOA_NNP ,_, a_DT caveat_NN to_TO consider_VB is_VBZ the_DT overwhelming_JJ evidence_NN that_IN the_DT neural_NN construct_VBP comprising_VBG this_DT hypothalamic_JJ oscillator_NN resides_VBZ in_IN the_DT arcuate_JJ nucleus_NN of_IN the_DT mediobasal_JJ hypothalamus_NN in_IN rats_NNS -LRB-_-LRB- 59_CD -RRB-_-RRB- in_IN common_NN with_IN other_JJ species_NNS including_VBG primates_NNS -LRB-_-LRB- 60_CD -RRB-_-RRB- ._. 
The_DT very_RB sparse_JJ direct_JJ projections_NNS from_IN the_DT MeA\/CeA_NNP to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 52_CD ,_, 61_CD -RRB-_-RRB- might_MD suggest_VB a_DT rather_RB limited_JJ level_NN of_IN interaction_NN between_IN these_DT brain_NN regions_NNS ._. 
The_DT HPG-inhibitory_JJ role_NN for_IN the_DT MeA_NNP and_CC CeA_NNP is_VBZ consistent_JJ with_IN their_PRP$ well-known_JJ function_NN in_IN regulating_VBG the_DT stress_NN response_NN following_VBG stress_NN exposure_NN -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
Indeed_RB damage_NN to_TO the_DT MeA_NNP has_VBZ been_VBN shown_VBN to_TO decrease_VB anxiety-related_JJ behavior_NN and_CC corticosterone_NN responses_NNS to_TO stressors_NNS -LRB-_-LRB- 9_CD ,_, 10_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ,_, while_IN MeA_NNP stimulation_NN has_VBZ been_VBN shown_VBN to_TO increase_VB HPA_NNP axis_NN output_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC facilitate_VB its_PRP$ stress-induced_JJ activation_NN -LRB-_-LRB- 38_CD -RRB-_-RRB- ._. 
Electrical_JJ stimulation_NN of_IN the_DT CeA_NNP results_NNS in_IN the_DT activation_NN of_IN the_DT autonomic_JJ nervous_JJ system_NN -LRB-_-LRB- 39_CD -RRB-_-RRB- ,_, while_IN lesions_NNS of_IN the_DT CeA_NNP attenuate_VB corticosterone_JJ release_NN evoked_VBN by_IN interleukin-1_NN 
Indeed_RB damage_NN to_TO the_DT MeA_NNP has_VBZ been_VBN shown_VBN to_TO decrease_VB anxiety-related_JJ behavior_NN and_CC corticosterone_NN responses_NNS to_TO stressors_NNS -LRB-_-LRB- 9_CD ,_, 10_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ,_, while_IN MeA_NNP stimulation_NN has_VBZ been_VBN shown_VBN to_TO increase_VB HPA_NNP axis_NN output_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC facilitate_VB its_PRP$ stress-induced_JJ activation_NN -LRB-_-LRB- 38_CD -RRB-_-RRB- ._. 
Electrical_JJ stimulation_NN of_IN the_DT CeA_NNP results_NNS in_IN the_DT activation_NN of_IN the_DT autonomic_JJ nervous_JJ system_NN -LRB-_-LRB- 39_CD -RRB-_-RRB- ,_, while_IN lesions_NNS of_IN the_DT CeA_NNP attenuate_VB corticosterone_JJ release_NN evoked_VBN by_IN interleukin-1_NN 
Fine_NNP focusing_VBG was_VBD performed_VBN to_TO ensure_VB counting_NN of_IN all_DT immunostained_JJ cells_NNS throughout_IN the_DT thickness_NN of_IN the_DT sections_NNS ._. 
Statistical_NNP analysisThe_NNP algorithm_NN ULTRA_NNP was_VBD used_VBN to_TO establish_VB the_DT detection_NN of_IN LH_NNP pulses_NNS -LRB-_-LRB- 34_CD -RRB-_-RRB- ._. 
Two_CD intraassay_JJ coefficients_NNS of_IN variation_NN of_IN the_DT assay_NN were_VBD used_VBN as_IN the_DT reference_NN threshold_NN for_IN the_DT pulse_NN detection_NN ._. 
These_DT data_NNS suggest_VBP that_DT restraint_NN stress-induced_VBD MeA_NNP activity_NN and_CC immunological_JJ stress-induced_JJ CeA_NNP activity_NN can_MD impact_VB the_DT HPG_NNP axis_NN by_IN exerting_VBG an_DT inhibitory_JJ effect_NN on_IN the_DT GnRH_NNP pulse_NN generator_NN ._. 
The_DT HPG-inhibitory_JJ role_NN for_IN the_DT MeA_NNP and_CC CeA_NNP is_VBZ consistent_JJ with_IN their_PRP$ well-known_JJ function_NN in_IN regulating_VBG the_DT stress_NN response_NN following_VBG stress_NN exposure_NN -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
Indeed_RB damage_NN to_TO the_DT MeA_NNP has_VBZ been_VBN shown_VBN to_TO decrease_VB anxiety-related_JJ behavior_NN and_CC corticosterone_NN responses_NNS to_TO stressors_NNS -LRB-_-LRB- 9_CD ,_, 10_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ,_, while_IN MeA_NNP stimulation_NN has_VBZ been_VBN shown_VBN to_TO increase_VB HPA_NNP axis_NN output_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC facilitate_VB its_PRP$ stress-induced_JJ activation_NN -LRB-_-LRB- 38_CD -RRB-_-RRB- ._. 
The_DT HPG-inhibitory_JJ role_NN for_IN the_DT MeA_NNP and_CC CeA_NNP is_VBZ consistent_JJ with_IN their_PRP$ well-known_JJ function_NN in_IN regulating_VBG the_DT stress_NN response_NN following_VBG stress_NN exposure_NN -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
Indeed_RB damage_NN to_TO the_DT MeA_NNP has_VBZ been_VBN shown_VBN to_TO decrease_VB anxiety-related_JJ behavior_NN and_CC corticosterone_NN responses_NNS to_TO stressors_NNS -LRB-_-LRB- 9_CD ,_, 10_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ,_, while_IN MeA_NNP stimulation_NN has_VBZ been_VBN shown_VBN to_TO increase_VB HPA_NNP axis_NN output_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC facilitate_VB its_PRP$ stress-induced_JJ activation_NN -LRB-_-LRB- 38_CD -RRB-_-RRB- ._. 
Electrical_JJ stimulation_NN of_IN the_DT CeA_NNP results_NNS in_IN the_DT activation_NN of_IN the_DT autonomic_JJ nervous_JJ system_NN -LRB-_-LRB- 39_CD -RRB-_-RRB- ,_, while_IN lesions_NNS of_IN the_DT CeA_NNP attenuate_VB corticosterone_JJ release_NN evoked_VBN by_IN interleukin-1_NN 
The_DT HPG-inhibitory_JJ role_NN for_IN the_DT MeA_NNP and_CC CeA_NNP is_VBZ consistent_JJ with_IN their_PRP$ well-known_JJ function_NN in_IN regulating_VBG the_DT stress_NN response_NN following_VBG stress_NN exposure_NN -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
Indeed_RB damage_NN to_TO the_DT MeA_NNP has_VBZ been_VBN shown_VBN to_TO decrease_VB anxiety-related_JJ behavior_NN and_CC corticosterone_NN responses_NNS to_TO stressors_NNS -LRB-_-LRB- 9_CD ,_, 10_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ,_, while_IN MeA_NNP stimulation_NN has_VBZ been_VBN shown_VBN to_TO increase_VB HPA_NNP axis_NN output_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC facilitate_VB its_PRP$ stress-induced_JJ activation_NN -LRB-_-LRB- 38_CD -RRB-_-RRB- ._. 
Electrical_JJ stimulation_NN of_IN the_DT CeA_NNP results_NNS in_IN the_DT activation_NN of_IN the_DT autonomic_JJ nervous_JJ system_NN -LRB-_-LRB- 39_CD -RRB-_-RRB- ,_, while_IN lesions_NNS of_IN the_DT CeA_NNP attenuate_VB corticosterone_JJ release_NN evoked_VBN by_IN interleukin-1_NN 
In_IN addition_NN ,_, immunostaining_VBG for_IN Fos_NNP protein_NN ,_, a_DT marker_NN of_IN neuronal_JJ activation_NN ,_, was_VBD used_VBN to_TO establish_VB whether_IN MeA_NNP lesions_NNS affected_VBD activation_NN of_IN the_DT mPOA_NNP in_IN response_NN to_TO restraint_NN stress_NN ._. 
Because_IN of_IN the_DT ubiquity_NN of_IN 
MeA-mediated_JJ activation_NN of_IN GABAergic_JJ neurons_NNS after_IN restraint_NN stress_NN ,_, as_IN shown_VBN by_IN a_DT greater_JJR percentage_NN of_IN GAD_NNP 67_CD neurons_NNS expressing_VBG Fos_NNP immunoreactivity_NN in_IN the_DT mPOA_NNP of_IN intact_JJ compared_VBN with_IN MeA_NNP lesioned_VBD animals_NNS ,_, is_VBZ consistent_JJ with_IN the_DT suggestion_NN of_IN a_DT functional_JJ relationship_NN between_IN these_DT two_CD areas_NNS of_IN the_DT brain_NN and_CC the_DT possibility_NN that_IN preoptic_JJ GABAergic_JJ neurons_NNS may_MD underlie_VB the_DT reduction_NN in_IN GnRH_NNP pulse_NN generator_NN activity_NN ._. 
Numerous_JJ studies_NNS indicate_VBP that_IN GABA_NNP plays_VBZ an_DT important_JJ inhibitory_JJ role_NN in_IN the_DT regulation_NN of_IN GnRH\/LH_NNP secretion_NN ,_, because_IN endogenous_JJ GABA_NNP release_NN has_VBZ been_VBN shown_VBN to_TO exert_VB a_DT powerful_JJ inhibitory_JJ effect_NN on_IN the_DT activation_NN of_IN GnRH_NNP neurons_NNS in_IN vitro_NN -LRB-_-LRB- 29_CD -RRB-_-RRB- and_CC local_JJ infusion_NN of_IN GABA_NNP into_IN the_DT mPOA_NNP to_TO suppress_VB GnRH_NNP expression_NN -LRB-_-LRB- 48_CD -RRB-_-RRB- and_CC pulsatile_JJ LH_NNP release_NN -LRB-_-LRB- 30_CD -RRB-_-RRB- ._. 
More_RBR importantly_RB ,_, intra-mPOA_JJ administration_NN of_IN GABA_NNP receptor_NN antagonist_NN blocks_VBZ stress-induced_JJ suppression_NN of_IN LH_NNP pulses_NNS -LRB-_-LRB- Lin_NNP ,_, Li_NNP ,_, 
However_RB ,_, the_DT robust_JJ connections_NNS between_IN the_DT amygdala_NN and_CC the_DT BNST_NNP -LRB-_-LRB- 52_CD ,_, 56_CD -RRB-_-RRB- ,_, which_WDT in_IN turn_NN projects_NNS heavily_RB to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 62_CD -RRB-_-RRB- ,_, may_MD provide_VB an_DT indirect_JJ functional_JJ route_NN for_IN amygdaloid_JJ influence_NN on_IN GnRH_NNP pulse_NN generator_NN activity_NN ;_: this_DT is_VBZ a_DT postulate_NN that_WDT remains_VBZ to_TO be_VB explored_VBN ._. 
Nevertheless_RB ,_, the_DT observation_NN that_IN microinfusion_NN of_IN a_DT wide_JJ range_NN of_IN neuropeptides_NNS ,_, including_VBG calcitonin_NN gene-related_JJ peptide_NN ,_, CRF_NNP ,_, or_CC GABA_NNP ,_, directly_RB into_IN the_DT mPOA_NNP suppresses_VBZ pulsatile_JJ LH_NNP secretion_NN -LRB-_-LRB- 30_CD ,_, 63_CD ,_, 64_CD -RRB-_-RRB- is_VBZ not_RB inconsistent_JJ with_IN the_DT notion_NN of_IN a_DT neurocircuit_JJ relay_NN via_IN the_DT mPOA_NNP to_TO the_DT mediobasal_JJ hypothalamus_NN to_TO modulate_VB GnRH_NNP pulse_NN generator_NN activity_NN ._. 
In_IN the_DT present_JJ study_NN an_DT ovariectomized_VBN rat_NN model_NN without_IN gonadal_JJ steroid_NN replacement_NN was_VBD used_VBN ._. 
Because_IN there_EX is_VBZ substantial_JJ evidence_NN that_IN gonadal_JJ steroids_NNS ,_, in_IN particular_JJ estradiol_NN ,_, sensitize_VB the_DT GnRH_NNP pulse_NN generator_NN to_TO the_DT inhibitory_JJ effects_NNS of_IN stress_NN -LRB-_-LRB- 65_CD 
In_IN addition_NN ,_, immunostaining_VBG for_IN Fos_NNP protein_NN ,_, a_DT marker_NN of_IN neuronal_JJ activation_NN ,_, was_VBD used_VBN to_TO establish_VB whether_IN MeA_NNP lesions_NNS affected_VBD activation_NN of_IN the_DT mPOA_NNP in_IN response_NN to_TO restraint_NN stress_NN ._. 
Because_IN of_IN the_DT ubiquity_NN of_IN 
5mm_JJ posterior_NN to_TO Bregma_NNP ,_, and_CC 7_CD ._. 
1mm_JJ lateral_NN ,_, 2_CD ._. 
7mm_CD below_IN the_DT surface_NN of_IN the_DT dura_NN for_IN the_DT MeA_NNP ;_: 4_CD ._. 
7mm_CD below_IN the_DT surface_NN of_IN the_DT dura_NN for_IN the_DT CeA_NNP -LRB-_-LRB- 32_CD -RRB-_-RRB- ._. 
Sham_NN lesions_NNS were_VBD carried_VBN out_IN using_VBG the_DT same_JJ procedure_NN but_CC with_IN sterile_JJ artificial_JJ cerebrospinal_JJ fluid_NN ._. 
All_DT analysis_NN was_VBD performed_VBN on_IN coded_VBN slides_NNS by_IN two_CD individual_JJ investigators_NNS without_IN knowledge_NN of_IN experimental_JJ treatment_NN conditions_NNS ._. 
The_DT boundaries_NNS of_IN the_DT mPOA_NNP counted_VBN were_VBD determined_VBN by_IN comparing_VBG the_DT Paxinos_NNP and_CC Watson_NNP 's_POS rat_NN brain_NN atlas_NNS -LRB-_-LRB- 32_CD -RRB-_-RRB- with_IN neuroanatomical_JJ and_CC cytoarchitectural_JJ landmarks_NNS ._. 
Sections_NNS used_VBN for_IN mPOA_NNP analysis_NN were_VBD taken_VBN from_IN the_DT region_NN corresponding_JJ to_TO bregma_NN +0_CD ._. 
20_CD to_TO 
Sham_NN lesions_NNS were_VBD carried_VBN out_IN using_VBG the_DT same_JJ procedure_NN but_CC with_IN sterile_JJ artificial_JJ cerebrospinal_JJ fluid_NN ._. 
After_IN a_DT 10-d_JJ recovery_NN period_NN ,_, the_DT rats_NNS were_VBD fitted_VBN with_IN two_CD indwelling_VBG cardiac_JJ catheters_NNS via_IN the_DT jugular_JJ veins_NNS ,_, as_RB previously_RB described_VBN -LRB-_-LRB- 33_CD -RRB-_-RRB- ._. 
The_DT catheters_NNS were_VBD exteriorized_VBN at_IN the_DT back_NN of_IN the_DT head_NN and_CC secured_VBN to_TO a_DT cranial_JJ attachment_NN ;_: the_DT rats_NNS were_VBD fitted_VBN with_IN a_DT 30-cm-long_JJ metal_NN spring_NN tether_NN -LRB-_-LRB- Instec_NNP Laboratories_NNP Inc_NNP ,_, Boulder_NNP ,_, CO_NNP -RRB-_-RRB- ._. 
Control_NN treatment_NN matching_VBG a_DT specific_JJ stressor_NN was_VBD also_RB given_VBN to_TO separate_JJ groups_NNS of_IN animals_NNS with_IN bilateral_JJ MeA_NNP or_CC CeA_NNP lesions_NNS ._. 
For_IN restraint_NN stress_NN ,_, the_DT MeA_NNP lesioned_VBD -LRB-_-LRB- n_SYM =_SYM 12_CD -RRB-_-RRB- or_CC intact_JJ -LRB-_-LRB- n_SYM =_SYM 8_CD -RRB-_-RRB- rats_NNS and_CC CeA_NNP lesioned_VBD -LRB-_-LRB- n_SYM =_SYM 12_CD -RRB-_-RRB- or_CC corresponding_JJ intact_JJ -LRB-_-LRB- n_SYM =_SYM 8_CD -RRB-_-RRB- animals_NNS were_VBD placed_VBN in_IN restraint_NN devices_NNS for_IN 60_CD min_NN -LRB-_-LRB- 33_CD -RRB-_-RRB- ,_, and_CC automated_JJ blood_NN sampling_NN continued_VBD uninterrupted_JJ during_IN restraint_NN and_CC the_DT 3-h_JJ postrestraint_NN period_NN ._. 
Control_NNP MeA_NNP lesioned_VBD -LRB-_-LRB- n_SYM =_SYM 10_CD -RRB-_-RRB- or_CC CeA_NNP lesioned_VBD -LRB-_-LRB- n_SYM =_SYM 10_CD -RRB-_-RRB- animals_NNS underwent_VBD the_DT same_JJ procedures_NNS but_CC were_VBD not_RB restrained_VBN ._. 
In_IN the_DT present_JJ study_NN an_DT ovariectomized_VBN rat_NN model_NN without_IN gonadal_JJ steroid_NN replacement_NN was_VBD used_VBN ._. 
Nevertheless_RB ,_, the_DT observation_NN that_IN microinfusion_NN of_IN a_DT wide_JJ range_NN of_IN neuropeptides_NNS ,_, including_VBG calcitonin_NN gene-related_JJ peptide_NN ,_, CRF_NNP ,_, or_CC GABA_NNP ,_, directly_RB into_IN the_DT mPOA_NNP suppresses_VBZ pulsatile_JJ LH_NNP secretion_NN -LRB-_-LRB- 30_CD ,_, 63_CD ,_, 64_CD -RRB-_-RRB- is_VBZ not_RB inconsistent_JJ with_IN the_DT notion_NN of_IN a_DT neurocircuit_JJ relay_NN via_IN the_DT mPOA_NNP to_TO the_DT mediobasal_JJ hypothalamus_NN to_TO modulate_VB GnRH_NNP pulse_NN generator_NN activity_NN ._. 
Because_IN there_EX is_VBZ substantial_JJ evidence_NN that_IN gonadal_JJ steroids_NNS ,_, in_IN particular_JJ estradiol_NN ,_, sensitize_VB the_DT GnRH_NNP pulse_NN generator_NN to_TO the_DT inhibitory_JJ effects_NNS of_IN stress_NN -LRB-_-LRB- 65_CD 
Nevertheless_RB ,_, the_DT CeA_NNP is_VBZ known_VBN to_TO densely_RB innervate_VB the_DT BNST_NNP ,_, primarily_RB with_IN CRF_NNP containing_VBG neurons_NNS -LRB-_-LRB- 21_CD ,_, 56_CD -RRB-_-RRB- ._. 
Further_RB ,_, LPS_NNP stress_NN induces_VBZ strong_JJ Fos_NNP expression_NN in_IN both_CC the_DT BNST_NNP -LRB-_-LRB- 57_CD -RRB-_-RRB- and_CC LC_NNP -LRB-_-LRB- 58_CD -RRB-_-RRB- ._. 
Thus_RB ,_, the_DT CeA_NNP may_MD similarly_RB provide_VB input_NN to_TO the_DT postulated_JJ multi-synaptic_JJ pathway_NN to_TO the_DT mPOA_NNP described_VBD above_IN ._. 
Although_IN we_PRP have_VBP postulated_VBN that_IN projections_NNS from_IN the_DT amygdala_NN that_WDT mediate_VBP stress_NN effects_NNS on_IN the_DT GnRH_NNP pulse_NN generator_NN terminate_VBP on_IN targets_NNS in_IN the_DT mPOA_NNP ,_, a_DT caveat_NN to_TO consider_VB is_VBZ the_DT overwhelming_JJ evidence_NN that_IN the_DT neural_NN construct_VBP comprising_VBG this_DT hypothalamic_JJ oscillator_NN resides_VBZ in_IN the_DT arcuate_JJ nucleus_NN of_IN the_DT mediobasal_JJ hypothalamus_NN in_IN rats_NNS -LRB-_-LRB- 59_CD -RRB-_-RRB- in_IN common_NN with_IN other_JJ species_NNS including_VBG primates_NNS -LRB-_-LRB- 60_CD -RRB-_-RRB- ._. 
The_DT very_RB sparse_JJ direct_JJ projections_NNS from_IN the_DT MeA\/CeA_NNP to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 52_CD ,_, 61_CD -RRB-_-RRB- might_MD suggest_VB a_DT rather_RB limited_JJ level_NN of_IN interaction_NN between_IN these_DT brain_NN regions_NNS ._. 
However_RB ,_, the_DT robust_JJ connections_NNS between_IN the_DT amygdala_NN and_CC the_DT BNST_NNP -LRB-_-LRB- 52_CD ,_, 56_CD -RRB-_-RRB- ,_, which_WDT in_IN turn_NN projects_NNS heavily_RB to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 62_CD -RRB-_-RRB- ,_, may_MD provide_VB an_DT indirect_JJ functional_JJ route_NN for_IN amygdaloid_JJ influence_NN on_IN GnRH_NNP pulse_NN generator_NN activity_NN ;_: this_DT is_VBZ a_DT postulate_NN that_WDT remains_VBZ to_TO be_VB explored_VBN ._. 
However_RB ,_, the_DT robust_JJ connections_NNS between_IN the_DT amygdala_NN and_CC the_DT BNST_NNP -LRB-_-LRB- 52_CD ,_, 56_CD -RRB-_-RRB- ,_, which_WDT in_IN turn_NN projects_NNS heavily_RB to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 62_CD -RRB-_-RRB- ,_, may_MD provide_VB an_DT indirect_JJ functional_JJ route_NN for_IN amygdaloid_JJ influence_NN on_IN GnRH_NNP pulse_NN generator_NN activity_NN ;_: this_DT is_VBZ a_DT postulate_NN that_WDT remains_VBZ to_TO be_VB explored_VBN ._. 
Nevertheless_RB ,_, the_DT observation_NN that_IN microinfusion_NN of_IN a_DT wide_JJ range_NN of_IN neuropeptides_NNS ,_, including_VBG calcitonin_NN gene-related_JJ peptide_NN ,_, CRF_NNP ,_, or_CC GABA_NNP ,_, directly_RB into_IN the_DT mPOA_NNP suppresses_VBZ pulsatile_JJ LH_NNP secretion_NN -LRB-_-LRB- 30_CD ,_, 63_CD ,_, 64_CD -RRB-_-RRB- is_VBZ not_RB inconsistent_JJ with_IN the_DT notion_NN of_IN a_DT neurocircuit_JJ relay_NN via_IN the_DT mPOA_NNP to_TO the_DT mediobasal_JJ hypothalamus_NN to_TO modulate_VB GnRH_NNP pulse_NN generator_NN activity_NN ._. 
In_IN the_DT present_JJ study_NN an_DT ovariectomized_VBN rat_NN model_NN without_IN gonadal_JJ steroid_NN replacement_NN was_VBD used_VBN ._. 
Because_IN there_EX is_VBZ substantial_JJ evidence_NN that_IN gonadal_JJ steroids_NNS ,_, in_IN particular_JJ estradiol_NN ,_, sensitize_VB the_DT GnRH_NNP pulse_NN generator_NN to_TO the_DT inhibitory_JJ effects_NNS of_IN stress_NN -LRB-_-LRB- 65_CD 
Moreover_RB ,_, microinfusion_NN of_IN CRF_NNP antagonist_NN into_IN either_CC the_DT BNST_NNP -LRB-_-LRB- 50_CD -RRB-_-RRB- or_CC the_DT LC_NNP -LRB-_-LRB- 51_CD -RRB-_-RRB- blocked_VBD the_DT psychogenic_JJ but_CC not_RB metabolic_JJ stress_NN 
The_DT very_RB sparse_JJ direct_JJ projections_NNS from_IN the_DT MeA\/CeA_NNP to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 52_CD ,_, 61_CD -RRB-_-RRB- might_MD suggest_VB a_DT rather_RB limited_JJ level_NN of_IN interaction_NN between_IN these_DT brain_NN regions_NNS ._. 
However_RB ,_, the_DT robust_JJ connections_NNS between_IN the_DT amygdala_NN and_CC the_DT BNST_NNP -LRB-_-LRB- 52_CD ,_, 56_CD -RRB-_-RRB- ,_, which_WDT in_IN turn_NN projects_NNS heavily_RB to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 62_CD -RRB-_-RRB- ,_, may_MD provide_VB an_DT indirect_JJ functional_JJ route_NN for_IN amygdaloid_JJ influence_NN on_IN GnRH_NNP pulse_NN generator_NN activity_NN ;_: this_DT is_VBZ a_DT postulate_NN that_WDT remains_VBZ to_TO be_VB explored_VBN ._. 
Nevertheless_RB ,_, the_DT observation_NN that_IN microinfusion_NN of_IN a_DT wide_JJ range_NN of_IN neuropeptides_NNS ,_, including_VBG calcitonin_NN gene-related_JJ peptide_NN ,_, CRF_NNP ,_, or_CC GABA_NNP ,_, directly_RB into_IN the_DT mPOA_NNP suppresses_VBZ pulsatile_JJ LH_NNP secretion_NN -LRB-_-LRB- 30_CD ,_, 63_CD ,_, 64_CD -RRB-_-RRB- is_VBZ not_RB inconsistent_JJ with_IN the_DT notion_NN of_IN a_DT neurocircuit_JJ relay_NN via_IN the_DT mPOA_NNP to_TO the_DT mediobasal_JJ hypothalamus_NN to_TO modulate_VB GnRH_NNP pulse_NN generator_NN activity_NN ._. 
In_IN the_DT present_JJ study_NN an_DT ovariectomized_VBN rat_NN model_NN without_IN gonadal_JJ steroid_NN replacement_NN was_VBD used_VBN ._. 
Nevertheless_RB ,_, the_DT observation_NN that_IN microinfusion_NN of_IN a_DT wide_JJ range_NN of_IN neuropeptides_NNS ,_, including_VBG calcitonin_NN gene-related_JJ peptide_NN ,_, CRF_NNP ,_, or_CC GABA_NNP ,_, directly_RB into_IN the_DT mPOA_NNP suppresses_VBZ pulsatile_JJ LH_NNP secretion_NN -LRB-_-LRB- 30_CD ,_, 63_CD ,_, 64_CD -RRB-_-RRB- is_VBZ not_RB inconsistent_JJ with_IN the_DT notion_NN of_IN a_DT neurocircuit_JJ relay_NN via_IN the_DT mPOA_NNP to_TO the_DT mediobasal_JJ hypothalamus_NN to_TO modulate_VB GnRH_NNP pulse_NN generator_NN activity_NN ._. 
Because_IN there_EX is_VBZ substantial_JJ evidence_NN that_IN gonadal_JJ steroids_NNS ,_, in_IN particular_JJ estradiol_NN ,_, sensitize_VB the_DT GnRH_NNP pulse_NN generator_NN to_TO the_DT inhibitory_JJ effects_NNS of_IN stress_NN -LRB-_-LRB- 65_CD 
Nonetheless_RB the_DT studies_NNS presented_VBN above_IN ,_, regardless_RB of_IN whether_IN they_PRP demonstrate_VBP an_DT inhibitory_JJ or_CC stimulatory_JJ role_NN for_IN the_DT MeA_NNP on_IN LH_NNP secretion_NN ,_, focus_NN on_IN either_DT changes_NNS in_IN mean_JJ circulating_VBG levels_NNS of_IN LH_NNP or_CC the_DT LH_NNP surge_NN ._. 
Although_IN electrochemical_JJ stimulation_NN of_IN the_DT CeA_NNP has_VBZ no_DT effect_NN on_IN mean_NN circulating_VBG levels_NNS of_IN LH_NNP -LRB-_-LRB- 13_CD -RRB-_-RRB- ,_, the_DT CeA_NNP has_VBZ been_VBN shown_VBN to_TO be_VB involved_VBN in_IN maternal_JJ -LRB-_-LRB- 47_CD -RRB-_-RRB- and_CC sexual_JJ behavior_NN -LRB-_-LRB- 23_CD -RRB-_-RRB- ._. 
In_IN the_DT present_JJ study_NN ,_, we_PRP found_VBD that_IN MeA_NNP or_CC CeA_NNP lesions_NNS do_VBP not_RB affect_VB LH_NNP pulse_NN frequency_NN under_IN stress-free_JJ conditions_NNS ._. 
In_IN effect_NN ,_, there_EX are_VBP other_JJ brain_NN regions_NNS ,_, which_WDT have_VBP been_VBN shown_VBN to_TO play_VB significant_JJ roles_NNS in_IN the_DT stress-induced_JJ suppression_NN of_IN reproduction_NN ._. 
We_PRP have_VBP previously_RB shown_VBN that_IN CRF_NNP administration_NN into_IN the_DT bed_NN nucleus_NN of_IN stria_NN terminalis_NNS -LRB-_-LRB- BNST_NNP -RRB-_-RRB- -LRB-_-LRB- 50_CD -RRB-_-RRB- or_CC locus_FW coeruleus_FW -LRB-_-LRB- LC_NNP -RRB-_-RRB- -LRB-_-LRB- 51_CD -RRB-_-RRB- also_RB results_NNS in_IN the_DT concomitant_JJ suppression_NN of_IN pulsatile_JJ LH_NNP secretion_NN with_IN activation_NN of_IN GABAergic_JJ neurons_NNS within_IN the_DT mPOA_NNP ._. 
Moreover_RB ,_, microinfusion_NN of_IN CRF_NNP antagonist_NN into_IN either_CC the_DT BNST_NNP -LRB-_-LRB- 50_CD -RRB-_-RRB- or_CC the_DT LC_NNP -LRB-_-LRB- 51_CD -RRB-_-RRB- blocked_VBD the_DT psychogenic_JJ but_CC not_RB metabolic_JJ stress_NN 
We_PRP have_VBP previously_RB shown_VBN that_IN CRF_NNP administration_NN into_IN the_DT bed_NN nucleus_NN of_IN stria_NN terminalis_NNS -LRB-_-LRB- BNST_NNP -RRB-_-RRB- -LRB-_-LRB- 50_CD -RRB-_-RRB- or_CC locus_FW coeruleus_FW -LRB-_-LRB- LC_NNP -RRB-_-RRB- -LRB-_-LRB- 51_CD -RRB-_-RRB- also_RB results_NNS in_IN the_DT concomitant_JJ suppression_NN of_IN pulsatile_JJ LH_NNP secretion_NN with_IN activation_NN of_IN GABAergic_JJ neurons_NNS within_IN the_DT mPOA_NNP ._. 
Moreover_RB ,_, microinfusion_NN of_IN CRF_NNP antagonist_NN into_IN either_CC the_DT BNST_NNP -LRB-_-LRB- 50_CD -RRB-_-RRB- or_CC the_DT LC_NNP -LRB-_-LRB- 51_CD -RRB-_-RRB- blocked_VBD the_DT psychogenic_JJ but_CC not_RB metabolic_JJ stress_NN 
Interestingly_RB ,_, both_DT MeA_NNP and_CC CeA_NNP lesions_NNS did_VBD not_RB affect_VB the_DT inhibitory_JJ response_NN to_TO hypoglycemic_JJ stress_NN ._. 
Further_RB ,_, the_DT BNST_NNP -LRB-_-LRB- 50_CD -RRB-_-RRB- and_CC LC_NNP -LRB-_-LRB- 51_CD -RRB-_-RRB- appear_VBP not_RB to_TO be_VB involved_VBN in_IN mediating_VBG the_DT inhibitory_JJ effect_NN of_IN this_DT metabolic_JJ stressor_NN on_IN GnRH_NNP pulse_NN generator_NN activity_NN ,_, and_CC the_DT neural_JJ circuitry_NN underlying_VBG this_DT response_NN remains_VBZ to_TO be_VB established_VBN ._. 
Although_IN we_PRP have_VBP postulated_VBN that_IN projections_NNS from_IN the_DT amygdala_NN that_WDT mediate_VBP stress_NN effects_NNS on_IN the_DT GnRH_NNP pulse_NN generator_NN terminate_VBP on_IN targets_NNS in_IN the_DT mPOA_NNP ,_, a_DT caveat_NN to_TO consider_VB is_VBZ the_DT overwhelming_JJ evidence_NN that_IN the_DT neural_NN construct_VBP comprising_VBG this_DT hypothalamic_JJ oscillator_NN resides_VBZ in_IN the_DT arcuate_JJ nucleus_NN of_IN the_DT mediobasal_JJ hypothalamus_NN in_IN rats_NNS -LRB-_-LRB- 59_CD -RRB-_-RRB- in_IN common_NN with_IN other_JJ species_NNS including_VBG primates_NNS -LRB-_-LRB- 60_CD -RRB-_-RRB- ._. 
Further_RB ,_, the_DT BNST_NNP -LRB-_-LRB- 50_CD -RRB-_-RRB- and_CC LC_NNP -LRB-_-LRB- 51_CD -RRB-_-RRB- appear_VBP not_RB to_TO be_VB involved_VBN in_IN mediating_VBG the_DT inhibitory_JJ effect_NN of_IN this_DT metabolic_JJ stressor_NN on_IN GnRH_NNP pulse_NN generator_NN activity_NN ,_, and_CC the_DT neural_JJ circuitry_NN underlying_VBG this_DT response_NN remains_VBZ to_TO be_VB established_VBN ._. 
Although_IN we_PRP have_VBP postulated_VBN that_IN projections_NNS from_IN the_DT amygdala_NN that_WDT mediate_VBP stress_NN effects_NNS on_IN the_DT GnRH_NNP pulse_NN generator_NN terminate_VBP on_IN targets_NNS in_IN the_DT mPOA_NNP ,_, a_DT caveat_NN to_TO consider_VB is_VBZ the_DT overwhelming_JJ evidence_NN that_IN the_DT neural_NN construct_VBP comprising_VBG this_DT hypothalamic_JJ oscillator_NN resides_VBZ in_IN the_DT arcuate_JJ nucleus_NN of_IN the_DT mediobasal_JJ hypothalamus_NN in_IN rats_NNS -LRB-_-LRB- 59_CD -RRB-_-RRB- in_IN common_NN with_IN other_JJ species_NNS including_VBG primates_NNS -LRB-_-LRB- 60_CD -RRB-_-RRB- ._. 
The_DT very_RB sparse_JJ direct_JJ projections_NNS from_IN the_DT MeA\/CeA_NNP to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 52_CD ,_, 61_CD -RRB-_-RRB- might_MD suggest_VB a_DT rather_RB limited_JJ level_NN of_IN interaction_NN between_IN these_DT brain_NN regions_NNS ._. 
In_IN the_DT present_JJ study_NN an_DT ovariectomized_VBN rat_NN model_NN without_IN gonadal_JJ steroid_NN replacement_NN was_VBD used_VBN ._. 
Nevertheless_RB ,_, the_DT observation_NN that_IN microinfusion_NN of_IN a_DT wide_JJ range_NN of_IN neuropeptides_NNS ,_, including_VBG calcitonin_NN gene-related_JJ peptide_NN ,_, CRF_NNP ,_, or_CC GABA_NNP ,_, directly_RB into_IN the_DT mPOA_NNP suppresses_VBZ pulsatile_JJ LH_NNP secretion_NN -LRB-_-LRB- 30_CD ,_, 63_CD ,_, 64_CD -RRB-_-RRB- is_VBZ not_RB inconsistent_JJ with_IN the_DT notion_NN of_IN a_DT neurocircuit_JJ relay_NN via_IN the_DT mPOA_NNP to_TO the_DT mediobasal_JJ hypothalamus_NN to_TO modulate_VB GnRH_NNP pulse_NN generator_NN activity_NN ._. 
Because_IN there_EX is_VBZ substantial_JJ evidence_NN that_IN gonadal_JJ steroids_NNS ,_, in_IN particular_JJ estradiol_NN ,_, sensitize_VB the_DT GnRH_NNP pulse_NN generator_NN to_TO the_DT inhibitory_JJ effects_NNS of_IN stress_NN -LRB-_-LRB- 65_CD 
Conversely_RB ,_, MeA_NNP lesioning_NN has_VBZ also_RB been_VBN shown_VBN to_TO reduce_VB ovulation_NN -LRB-_-LRB- 12_CD -RRB-_-RRB- and_CC the_DT mating-induced_JJ enhancement_NN of_IN lordosis_NNS in_IN female_JJ rats_NNS -LRB-_-LRB- 41_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, the_DT precise_JJ role_NN of_IN the_DT MeA_NNP in_IN the_DT control_NN of_IN LH_NNP secretion_NN is_VBZ also_RB controversial_JJ with_IN reports_NNS of_IN increases_NNS in_IN LH_NNP secretion_NN after_IN both_DT MeA_NNP lesioning_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- and_CC MeA_NNP stimulation_NN in_IN rats_NNS -LRB-_-LRB- 13_CD ,_, 42_CD ,_, 43_CD -RRB-_-RRB- and_CC reports_NNS indicating_VBG that_IN MeA_NNP lesioning_NN has_VBZ no_DT effect_NN on_IN LH_NNP secretion_NN in_IN the_DT rhesus_JJ monkey_NN -LRB-_-LRB- 44_CD -RRB-_-RRB- ,_, immature_JJ rat_NN -LRB-_-LRB- 45_CD -RRB-_-RRB- ,_, and_CC deer-mice_JJ -LRB-_-LRB- 46_CD -RRB-_-RRB- ._. 
Nonetheless_RB the_DT studies_NNS presented_VBN above_IN ,_, regardless_RB of_IN whether_IN they_PRP demonstrate_VBP an_DT inhibitory_JJ or_CC stimulatory_JJ role_NN for_IN the_DT MeA_NNP on_IN LH_NNP secretion_NN ,_, focus_NN on_IN either_DT changes_NNS in_IN mean_JJ circulating_VBG levels_NNS of_IN LH_NNP or_CC the_DT LH_NNP surge_NN ._. 
Moreover_RB ,_, microinfusion_NN of_IN CRF_NNP antagonist_NN into_IN either_CC the_DT BNST_NNP -LRB-_-LRB- 50_CD -RRB-_-RRB- or_CC the_DT LC_NNP -LRB-_-LRB- 51_CD -RRB-_-RRB- blocked_VBD the_DT psychogenic_JJ but_CC not_RB metabolic_JJ stress_NN 
Conversely_RB ,_, MeA_NNP lesioning_NN has_VBZ also_RB been_VBN shown_VBN to_TO reduce_VB ovulation_NN -LRB-_-LRB- 12_CD -RRB-_-RRB- and_CC the_DT mating-induced_JJ enhancement_NN of_IN lordosis_NNS in_IN female_JJ rats_NNS -LRB-_-LRB- 41_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, the_DT precise_JJ role_NN of_IN the_DT MeA_NNP in_IN the_DT control_NN of_IN LH_NNP secretion_NN is_VBZ also_RB controversial_JJ with_IN reports_NNS of_IN increases_NNS in_IN LH_NNP secretion_NN after_IN both_DT MeA_NNP lesioning_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- and_CC MeA_NNP stimulation_NN in_IN rats_NNS -LRB-_-LRB- 13_CD ,_, 42_CD ,_, 43_CD -RRB-_-RRB- and_CC reports_NNS indicating_VBG that_IN MeA_NNP lesioning_NN has_VBZ no_DT effect_NN on_IN LH_NNP secretion_NN in_IN the_DT rhesus_JJ monkey_NN -LRB-_-LRB- 44_CD -RRB-_-RRB- ,_, immature_JJ rat_NN -LRB-_-LRB- 45_CD -RRB-_-RRB- ,_, and_CC deer-mice_JJ -LRB-_-LRB- 46_CD -RRB-_-RRB- ._. 
Nonetheless_RB the_DT studies_NNS presented_VBN above_IN ,_, regardless_RB of_IN whether_IN they_PRP demonstrate_VBP an_DT inhibitory_JJ or_CC stimulatory_JJ role_NN for_IN the_DT MeA_NNP on_IN LH_NNP secretion_NN ,_, focus_NN on_IN either_DT changes_NNS in_IN mean_JJ circulating_VBG levels_NNS of_IN LH_NNP or_CC the_DT LH_NNP surge_NN ._. 
Conversely_RB ,_, MeA_NNP lesioning_NN has_VBZ also_RB been_VBN shown_VBN to_TO reduce_VB ovulation_NN -LRB-_-LRB- 12_CD -RRB-_-RRB- and_CC the_DT mating-induced_JJ enhancement_NN of_IN lordosis_NNS in_IN female_JJ rats_NNS -LRB-_-LRB- 41_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, the_DT precise_JJ role_NN of_IN the_DT MeA_NNP in_IN the_DT control_NN of_IN LH_NNP secretion_NN is_VBZ also_RB controversial_JJ with_IN reports_NNS of_IN increases_NNS in_IN LH_NNP secretion_NN after_IN both_DT MeA_NNP lesioning_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- and_CC MeA_NNP stimulation_NN in_IN rats_NNS -LRB-_-LRB- 13_CD ,_, 42_CD ,_, 43_CD -RRB-_-RRB- and_CC reports_NNS indicating_VBG that_IN MeA_NNP lesioning_NN has_VBZ no_DT effect_NN on_IN LH_NNP secretion_NN in_IN the_DT rhesus_JJ monkey_NN -LRB-_-LRB- 44_CD -RRB-_-RRB- ,_, immature_JJ rat_NN -LRB-_-LRB- 45_CD -RRB-_-RRB- ,_, and_CC deer-mice_JJ -LRB-_-LRB- 46_CD -RRB-_-RRB- ._. 
Nonetheless_RB the_DT studies_NNS presented_VBN above_IN ,_, regardless_RB of_IN whether_IN they_PRP demonstrate_VBP an_DT inhibitory_JJ or_CC stimulatory_JJ role_NN for_IN the_DT MeA_NNP on_IN LH_NNP secretion_NN ,_, focus_NN on_IN either_DT changes_NNS in_IN mean_JJ circulating_VBG levels_NNS of_IN LH_NNP or_CC the_DT LH_NNP surge_NN ._. 
Conversely_RB ,_, MeA_NNP lesioning_NN has_VBZ also_RB been_VBN shown_VBN to_TO reduce_VB ovulation_NN -LRB-_-LRB- 12_CD -RRB-_-RRB- and_CC the_DT mating-induced_JJ enhancement_NN of_IN lordosis_NNS in_IN female_JJ rats_NNS -LRB-_-LRB- 41_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, the_DT precise_JJ role_NN of_IN the_DT MeA_NNP in_IN the_DT control_NN of_IN LH_NNP secretion_NN is_VBZ also_RB controversial_JJ with_IN reports_NNS of_IN increases_NNS in_IN LH_NNP secretion_NN after_IN both_DT MeA_NNP lesioning_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- and_CC MeA_NNP stimulation_NN in_IN rats_NNS -LRB-_-LRB- 13_CD ,_, 42_CD ,_, 43_CD -RRB-_-RRB- and_CC reports_NNS indicating_VBG that_IN MeA_NNP lesioning_NN has_VBZ no_DT effect_NN on_IN LH_NNP secretion_NN in_IN the_DT rhesus_JJ monkey_NN -LRB-_-LRB- 44_CD -RRB-_-RRB- ,_, immature_JJ rat_NN -LRB-_-LRB- 45_CD -RRB-_-RRB- ,_, and_CC deer-mice_JJ -LRB-_-LRB- 46_CD -RRB-_-RRB- ._. 
Nonetheless_RB the_DT studies_NNS presented_VBN above_IN ,_, regardless_RB of_IN whether_IN they_PRP demonstrate_VBP an_DT inhibitory_JJ or_CC stimulatory_JJ role_NN for_IN the_DT MeA_NNP on_IN LH_NNP secretion_NN ,_, focus_NN on_IN either_DT changes_NNS in_IN mean_JJ circulating_VBG levels_NNS of_IN LH_NNP or_CC the_DT LH_NNP surge_NN ._. 
Conversely_RB ,_, MeA_NNP lesioning_NN has_VBZ also_RB been_VBN shown_VBN to_TO reduce_VB ovulation_NN -LRB-_-LRB- 12_CD -RRB-_-RRB- and_CC the_DT mating-induced_JJ enhancement_NN of_IN lordosis_NNS in_IN female_JJ rats_NNS -LRB-_-LRB- 41_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, the_DT precise_JJ role_NN of_IN the_DT MeA_NNP in_IN the_DT control_NN of_IN LH_NNP secretion_NN is_VBZ also_RB controversial_JJ with_IN reports_NNS of_IN increases_NNS in_IN LH_NNP secretion_NN after_IN both_DT MeA_NNP lesioning_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- and_CC MeA_NNP stimulation_NN in_IN rats_NNS -LRB-_-LRB- 13_CD ,_, 42_CD ,_, 43_CD -RRB-_-RRB- and_CC reports_NNS indicating_VBG that_IN MeA_NNP lesioning_NN has_VBZ no_DT effect_NN on_IN LH_NNP secretion_NN in_IN the_DT rhesus_JJ monkey_NN -LRB-_-LRB- 44_CD -RRB-_-RRB- ,_, immature_JJ rat_NN -LRB-_-LRB- 45_CD -RRB-_-RRB- ,_, and_CC deer-mice_JJ -LRB-_-LRB- 46_CD -RRB-_-RRB- ._. 
Nonetheless_RB the_DT studies_NNS presented_VBN above_IN ,_, regardless_RB of_IN whether_IN they_PRP demonstrate_VBP an_DT inhibitory_JJ or_CC stimulatory_JJ role_NN for_IN the_DT MeA_NNP on_IN LH_NNP secretion_NN ,_, focus_NN on_IN either_DT changes_NNS in_IN mean_JJ circulating_VBG levels_NNS of_IN LH_NNP or_CC the_DT LH_NNP surge_NN ._. 
Electrical_JJ stimulation_NN of_IN the_DT MeA_NNP delays_NNS puberty_NN in_IN female_JJ rats_NNS -LRB-_-LRB- 18_CD -RRB-_-RRB- ,_, suggesting_VBG an_DT inhibitory_JJ influence_NN on_IN gonadotropin_NN secretion_NN ._. 
Conversely_RB ,_, MeA_NNP lesioning_NN has_VBZ also_RB been_VBN shown_VBN to_TO reduce_VB ovulation_NN -LRB-_-LRB- 12_CD -RRB-_-RRB- and_CC the_DT mating-induced_JJ enhancement_NN of_IN lordosis_NNS in_IN female_JJ rats_NNS -LRB-_-LRB- 41_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, the_DT precise_JJ role_NN of_IN the_DT MeA_NNP in_IN the_DT control_NN of_IN LH_NNP secretion_NN is_VBZ also_RB controversial_JJ with_IN reports_NNS of_IN increases_NNS in_IN LH_NNP secretion_NN after_IN both_DT MeA_NNP lesioning_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- and_CC MeA_NNP stimulation_NN in_IN rats_NNS -LRB-_-LRB- 13_CD ,_, 42_CD ,_, 43_CD -RRB-_-RRB- and_CC reports_NNS indicating_VBG that_IN MeA_NNP lesioning_NN has_VBZ no_DT effect_NN on_IN LH_NNP secretion_NN in_IN the_DT rhesus_JJ monkey_NN -LRB-_-LRB- 44_CD -RRB-_-RRB- ,_, immature_JJ rat_NN -LRB-_-LRB- 45_CD -RRB-_-RRB- ,_, and_CC deer-mice_JJ -LRB-_-LRB- 46_CD -RRB-_-RRB- ._. 
Indeed_RB damage_NN to_TO the_DT MeA_NNP has_VBZ been_VBN shown_VBN to_TO decrease_VB anxiety-related_JJ behavior_NN and_CC corticosterone_NN responses_NNS to_TO stressors_NNS -LRB-_-LRB- 9_CD ,_, 10_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ,_, while_IN MeA_NNP stimulation_NN has_VBZ been_VBN shown_VBN to_TO increase_VB HPA_NNP axis_NN output_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC facilitate_VB its_PRP$ stress-induced_JJ activation_NN -LRB-_-LRB- 38_CD -RRB-_-RRB- ._. 
Electrical_JJ stimulation_NN of_IN the_DT CeA_NNP results_NNS in_IN the_DT activation_NN of_IN the_DT autonomic_JJ nervous_JJ system_NN -LRB-_-LRB- 39_CD -RRB-_-RRB- ,_, while_IN lesions_NNS of_IN the_DT CeA_NNP attenuate_VB corticosterone_JJ release_NN evoked_VBN by_IN interleukin-1_NN 
In_IN addition_NN ,_, immunostaining_VBG for_IN Fos_NNP protein_NN ,_, a_DT marker_NN of_IN neuronal_JJ activation_NN ,_, was_VBD used_VBN to_TO establish_VB whether_IN MeA_NNP lesions_NNS affected_VBD activation_NN of_IN the_DT mPOA_NNP in_IN response_NN to_TO restraint_NN stress_NN ._. 
Because_IN of_IN the_DT ubiquity_NN of_IN 
MeA-mediated_JJ activation_NN of_IN GABAergic_JJ neurons_NNS after_IN restraint_NN stress_NN ,_, as_IN shown_VBN by_IN a_DT greater_JJR percentage_NN of_IN GAD_NNP 67_CD neurons_NNS expressing_VBG Fos_NNP immunoreactivity_NN in_IN the_DT mPOA_NNP of_IN intact_JJ compared_VBN with_IN MeA_NNP lesioned_VBD animals_NNS ,_, is_VBZ consistent_JJ with_IN the_DT suggestion_NN of_IN a_DT functional_JJ relationship_NN between_IN these_DT two_CD areas_NNS of_IN the_DT brain_NN and_CC the_DT possibility_NN that_IN preoptic_JJ GABAergic_JJ neurons_NNS may_MD underlie_VB the_DT reduction_NN in_IN GnRH_NNP pulse_NN generator_NN activity_NN ._. 
Numerous_JJ studies_NNS indicate_VBP that_IN GABA_NNP plays_VBZ an_DT important_JJ inhibitory_JJ role_NN in_IN the_DT regulation_NN of_IN GnRH\/LH_NNP secretion_NN ,_, because_IN endogenous_JJ GABA_NNP release_NN has_VBZ been_VBN shown_VBN to_TO exert_VB a_DT powerful_JJ inhibitory_JJ effect_NN on_IN the_DT activation_NN of_IN GnRH_NNP neurons_NNS in_IN vitro_NN -LRB-_-LRB- 29_CD -RRB-_-RRB- and_CC local_JJ infusion_NN of_IN GABA_NNP into_IN the_DT mPOA_NNP to_TO suppress_VB GnRH_NNP expression_NN -LRB-_-LRB- 48_CD -RRB-_-RRB- and_CC pulsatile_JJ LH_NNP release_NN -LRB-_-LRB- 30_CD -RRB-_-RRB- ._. 
More_RBR importantly_RB ,_, intra-mPOA_JJ administration_NN of_IN GABA_NNP receptor_NN antagonist_NN blocks_VBZ stress-induced_JJ suppression_NN of_IN LH_NNP pulses_NNS -LRB-_-LRB- Lin_NNP ,_, Li_NNP ,_, 
In_IN addition_NN ,_, immunostaining_VBG for_IN Fos_NNP protein_NN ,_, a_DT marker_NN of_IN neuronal_JJ activation_NN ,_, was_VBD used_VBN to_TO establish_VB whether_IN MeA_NNP lesions_NNS affected_VBD activation_NN of_IN the_DT mPOA_NNP in_IN response_NN to_TO restraint_NN stress_NN ._. 
Because_IN of_IN the_DT ubiquity_NN of_IN 
In_IN addition_NN ,_, immunostaining_VBG for_IN Fos_NNP protein_NN ,_, a_DT marker_NN of_IN neuronal_JJ activation_NN ,_, was_VBD used_VBN to_TO establish_VB whether_IN MeA_NNP lesions_NNS affected_VBD activation_NN of_IN the_DT mPOA_NNP in_IN response_NN to_TO restraint_NN stress_NN ._. 
Because_IN of_IN the_DT ubiquity_NN of_IN 
Moreover_RB ,_, recent_JJ studies_NNS indicate_VBP that_IN CRF_NNP within_IN the_DT CeA_NNP negatively_RB impacts_VBZ reproductive_JJ physiology_NN in_IN female_JJ rats_NNS by_IN disrupting_VBG the_DT estrus_NN cycle_NN and_CC decreasing_VBG GnRH_NNP expression_NN in_IN the_DT mPOA_NNP -LRB-_-LRB- 23_CD -RRB-_-RRB- ._. 
The_DT present_JJ study_NN was_VBD designed_VBN to_TO investigate_VB whether_IN neurotoxic_JJ lesions_NNS specific_JJ to_TO the_DT MeA_NNP block_NN psychological_JJ -LRB-_-LRB- restraint_NN -RRB-_-RRB- stress-induced_JJ suppression_NN of_IN pulsatile_JJ LH_NNP release_NN in_IN the_DT rat_NN and_CC compare_VB the_DT response_NN with_IN commonly_RB used_VBN systemic_JJ stressors_NNS such_JJ as_IN insulin-induced_JJ hypoglycemia_NN -LRB-_-LRB- IIH_NNP -RRB-_-RRB- or_CC lipopolysaccharide_NN -LRB-_-LRB- LPS_NNP -RRB-_-RRB- ,_, which_WDT readily_RB suppress_VBP LH_NNP pulses_NNS in_IN a_DT variety_NN of_IN species_NNS -LRB-_-LRB- 24_CD 
Experimentation_NN commenced_VBD 3_CD d_SYM later_RB ._. 
The_DT distal_JJ end_NN of_IN the_DT tether_NN was_VBD attached_VBN to_TO a_DT fluid_JJ swivel_NN -LRB-_-LRB- Instec_NNP Laboratories_NNP -RRB-_-RRB- ,_, which_WDT allowed_VBD the_DT rat_NN freedom_NN to_TO move_VB around_IN the_DT enclosure_NN ._. 
The_DT role_NN of_IN the_DT MeA_NNP and_CC CeA_NNP in_IN the_DT restraint_NN ,_, LPS_NNP ,_, hypoglycemic_JJ stress-induced_JJ suppression_NN of_IN pulsatile_JJ LH_NNP secretionOn_NNP the_DT morning_NN of_IN experimentation_NN ,_, the_DT rats_NNS were_VBD attached_VBN via_IN one_CD of_IN the_DT two_CD cardiac_JJ catheters_NNS to_TO a_DT computer-controlled_JJ automated_JJ blood_NN sampling_NN system_NN ,_, which_WDT allows_VBZ for_IN the_DT intermittent_JJ withdrawal_NN of_IN small_JJ blood_NN samples_NNS -LRB-_-LRB- 25_CD 
For_IN the_DT immunological_JJ stressor_NN ,_, 2_CD h_NN into_IN the_DT 6_CD h_NN blood_NN sampling_VBG procedure_NN ,_, LPS_NNP -LRB-_-LRB- 25_CD 
3IU\/kg_CD in_IN 0_CD ._. 
After_IN 2_CD h_NN of_IN controlled_JJ blood_NN sampling_NN insulin_NN -LRB-_-LRB- 0_CD ._. 
For_IN insulin-induced_JJ hypoglycemic_JJ stress_NN ,_, the_DT rats_NNS were_VBD fasted_VBN overnight_JJ but_CC were_VBD provided_VBN with_IN water_NN ad_NN libitum_NN throughout_IN ._. 
3ml_CD of_IN saline_NN -RRB-_-RRB- was_VBD administered_VBN through_IN the_DT second_JJ iv_NN catheter_NN -LRB-_-LRB- 25_CD -RRB-_-RRB- in_IN MeA_NNP lesioned_VBD -LRB-_-LRB- n_SYM =_SYM 12_CD -RRB-_-RRB- ,_, MeA_NNP intact_JJ -LRB-_-LRB- n_SYM =_SYM 8_CD -RRB-_-RRB- ,_, CeA_NNP lesioned_VBD -LRB-_-LRB- n_SYM =_SYM 12_CD -RRB-_-RRB- ,_, and_CC CeA_NNP intact_JJ -LRB-_-LRB- n_SYM =_SYM 8_CD -RRB-_-RRB- rats_NNS ._. 
Control_NNP MeA_NNP lesioned_VBD -LRB-_-LRB- n_SYM =_SYM 10_CD -RRB-_-RRB- or_CC CeA_NNP lesioned_VBD -LRB-_-LRB- n_SYM =_SYM 10_CD -RRB-_-RRB- animals_NNS were_VBD also_RB fasted_VBD overnight_JJ but_CC given_VBN 0_CD ._. 
Moreover_RB ,_, recent_JJ studies_NNS indicate_VBP that_IN CRF_NNP within_IN the_DT CeA_NNP negatively_RB impacts_VBZ reproductive_JJ physiology_NN in_IN female_JJ rats_NNS by_IN disrupting_VBG the_DT estrus_NN cycle_NN and_CC decreasing_VBG GnRH_NNP expression_NN in_IN the_DT mPOA_NNP -LRB-_-LRB- 23_CD -RRB-_-RRB- ._. 
The_DT present_JJ study_NN was_VBD designed_VBN to_TO investigate_VB whether_IN neurotoxic_JJ lesions_NNS specific_JJ to_TO the_DT MeA_NNP block_NN psychological_JJ -LRB-_-LRB- restraint_NN -RRB-_-RRB- stress-induced_JJ suppression_NN of_IN pulsatile_JJ LH_NNP release_NN in_IN the_DT rat_NN and_CC compare_VB the_DT response_NN with_IN commonly_RB used_VBN systemic_JJ stressors_NNS such_JJ as_IN insulin-induced_JJ hypoglycemia_NN -LRB-_-LRB- IIH_NNP -RRB-_-RRB- or_CC lipopolysaccharide_NN -LRB-_-LRB- LPS_NNP -RRB-_-RRB- ,_, which_WDT readily_RB suppress_VBP LH_NNP pulses_NNS in_IN a_DT variety_NN of_IN species_NNS -LRB-_-LRB- 24_CD 
The_DT CeA_NNP contains_VBZ a_DT major_JJ corticotropin-releasing_NN factor_NN -LRB-_-LRB- CRF_NNP -RRB-_-RRB- neuronal_JJ population_NN -LRB-_-LRB- 21_CD -RRB-_-RRB- ,_, which_WDT is_VBZ a_DT key_JJ inhibitory_JJ neuropeptide_NN of_IN the_DT GnRH_NNP pulse_NN generator_NN -LRB-_-LRB- 22_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, recent_JJ studies_NNS indicate_VBP that_IN CRF_NNP within_IN the_DT CeA_NNP negatively_RB impacts_VBZ reproductive_JJ physiology_NN in_IN female_JJ rats_NNS by_IN disrupting_VBG the_DT estrus_NN cycle_NN and_CC decreasing_VBG GnRH_NNP expression_NN in_IN the_DT mPOA_NNP -LRB-_-LRB- 23_CD -RRB-_-RRB- ._. 
The_DT present_JJ study_NN was_VBD designed_VBN to_TO investigate_VB whether_IN neurotoxic_JJ lesions_NNS specific_JJ to_TO the_DT MeA_NNP block_NN psychological_JJ -LRB-_-LRB- restraint_NN -RRB-_-RRB- stress-induced_JJ suppression_NN of_IN pulsatile_JJ LH_NNP release_NN in_IN the_DT rat_NN and_CC compare_VB the_DT response_NN with_IN commonly_RB used_VBN systemic_JJ stressors_NNS such_JJ as_IN insulin-induced_JJ hypoglycemia_NN -LRB-_-LRB- IIH_NNP -RRB-_-RRB- or_CC lipopolysaccharide_NN -LRB-_-LRB- LPS_NNP -RRB-_-RRB- ,_, which_WDT readily_RB suppress_VBP LH_NNP pulses_NNS in_IN a_DT variety_NN of_IN species_NNS -LRB-_-LRB- 24_CD 
Nonetheless_RB the_DT studies_NNS presented_VBN above_IN ,_, regardless_RB of_IN whether_IN they_PRP demonstrate_VBP an_DT inhibitory_JJ or_CC stimulatory_JJ role_NN for_IN the_DT MeA_NNP on_IN LH_NNP secretion_NN ,_, focus_NN on_IN either_DT changes_NNS in_IN mean_JJ circulating_VBG levels_NNS of_IN LH_NNP or_CC the_DT LH_NNP surge_NN ._. 
Although_IN electrochemical_JJ stimulation_NN of_IN the_DT CeA_NNP has_VBZ no_DT effect_NN on_IN mean_NN circulating_VBG levels_NNS of_IN LH_NNP -LRB-_-LRB- 13_CD -RRB-_-RRB- ,_, the_DT CeA_NNP has_VBZ been_VBN shown_VBN to_TO be_VB involved_VBN in_IN maternal_JJ -LRB-_-LRB- 47_CD -RRB-_-RRB- and_CC sexual_JJ behavior_NN -LRB-_-LRB- 23_CD -RRB-_-RRB- ._. 
In_IN the_DT present_JJ study_NN ,_, we_PRP found_VBD that_IN MeA_NNP or_CC CeA_NNP lesions_NNS do_VBP not_RB affect_VB LH_NNP pulse_NN frequency_NN under_IN stress-free_JJ conditions_NNS ._. 
With_IN regards_VBZ to_TO systemic_JJ stressors_NNS ,_, the_DT CeA_NNP has_VBZ been_VBN shown_VBN to_TO be_VB highly_RB responsive_JJ to_TO stressors_NNS like_IN inflammation_NN or_CC hemorrhage_NN -LRB-_-LRB- 7_CD ,_, 8_CD -RRB-_-RRB- ,_, with_IN specific_JJ lesions_NNS of_IN this_DT sub-nucleus_NN resulting_VBG in_IN an_DT attenuation_NN of_IN the_DT HPA_NNP response_NN after_IN interleukin-1_NN 
Such_PDT an_DT influence_NN of_IN the_DT MeA_NNP on_IN the_DT HPG_NNP axis_NN is_VBZ further_RBR supported_VBN by_IN neuroanatomical_JJ studies_NNS demonstrating_VBG the_DT existence_NN of_IN extensive_JJ direct_JJ projections_NNS from_IN the_DT MeA_NNP to_TO the_DT hypothalamic_JJ GnRH-rich_NNP medial_JJ preoptic_JJ area_NN -LRB-_-LRB- mPOA_NNP -RRB-_-RRB- -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- although_IN the_DT neurochemical_JJ phenotype_NN of_IN these_DT efferents_NNS is_VBZ unknown_JJ ._. 
The_DT CeA_NNP contains_VBZ a_DT major_JJ corticotropin-releasing_NN factor_NN -LRB-_-LRB- CRF_NNP -RRB-_-RRB- neuronal_JJ population_NN -LRB-_-LRB- 21_CD -RRB-_-RRB- ,_, which_WDT is_VBZ a_DT key_JJ inhibitory_JJ neuropeptide_NN of_IN the_DT GnRH_NNP pulse_NN generator_NN -LRB-_-LRB- 22_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, recent_JJ studies_NNS indicate_VBP that_IN CRF_NNP within_IN the_DT CeA_NNP negatively_RB impacts_VBZ reproductive_JJ physiology_NN in_IN female_JJ rats_NNS by_IN disrupting_VBG the_DT estrus_NN cycle_NN and_CC decreasing_VBG GnRH_NNP expression_NN in_IN the_DT mPOA_NNP -LRB-_-LRB- 23_CD -RRB-_-RRB- ._. 
Such_PDT an_DT influence_NN of_IN the_DT MeA_NNP on_IN the_DT HPG_NNP axis_NN is_VBZ further_RBR supported_VBN by_IN neuroanatomical_JJ studies_NNS demonstrating_VBG the_DT existence_NN of_IN extensive_JJ direct_JJ projections_NNS from_IN the_DT MeA_NNP to_TO the_DT hypothalamic_JJ GnRH-rich_NNP medial_JJ preoptic_JJ area_NN -LRB-_-LRB- mPOA_NNP -RRB-_-RRB- -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- although_IN the_DT neurochemical_JJ phenotype_NN of_IN these_DT efferents_NNS is_VBZ unknown_JJ ._. 
The_DT CeA_NNP contains_VBZ a_DT major_JJ corticotropin-releasing_NN factor_NN -LRB-_-LRB- CRF_NNP -RRB-_-RRB- neuronal_JJ population_NN -LRB-_-LRB- 21_CD -RRB-_-RRB- ,_, which_WDT is_VBZ a_DT key_JJ inhibitory_JJ neuropeptide_NN of_IN the_DT GnRH_NNP pulse_NN generator_NN -LRB-_-LRB- 22_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, recent_JJ studies_NNS indicate_VBP that_IN CRF_NNP within_IN the_DT CeA_NNP negatively_RB impacts_VBZ reproductive_JJ physiology_NN in_IN female_JJ rats_NNS by_IN disrupting_VBG the_DT estrus_NN cycle_NN and_CC decreasing_VBG GnRH_NNP expression_NN in_IN the_DT mPOA_NNP -LRB-_-LRB- 23_CD -RRB-_-RRB- ._. 
It_PRP has_VBZ been_VBN reported_VBN that_IN there_EX are_VBP very_RB few_JJ -LRB-_-LRB- 55_CD -RRB-_-RRB- or_CC no_DT -LRB-_-LRB- 20_CD ,_, 52_CD -RRB-_-RRB- neural_JJ projections_NNS from_IN the_DT CeA_NNP to_TO the_DT GnRH-rich_NNP mPOA_NNP ._. 
Nevertheless_RB ,_, the_DT CeA_NNP is_VBZ known_VBN to_TO densely_RB innervate_VB the_DT BNST_NNP ,_, primarily_RB with_IN CRF_NNP containing_VBG neurons_NNS -LRB-_-LRB- 21_CD ,_, 56_CD -RRB-_-RRB- ._. 
Further_RB ,_, LPS_NNP stress_NN induces_VBZ strong_JJ Fos_NNP expression_NN in_IN both_CC the_DT BNST_NNP -LRB-_-LRB- 57_CD -RRB-_-RRB- and_CC LC_NNP -LRB-_-LRB- 58_CD -RRB-_-RRB- ._. 
Thus_RB ,_, the_DT CeA_NNP may_MD similarly_RB provide_VB input_NN to_TO the_DT postulated_JJ multi-synaptic_JJ pathway_NN to_TO the_DT mPOA_NNP described_VBD above_IN ._. 
More_RBR specifically_RB ,_, it_PRP has_VBZ been_VBN shown_VBN that_IN plasma_NN LH_NNP levels_NNS increase_NN after_IN MeA_NNP lesioning_VBG -LRB-_-LRB- 17_CD -RRB-_-RRB- while_IN electrical_JJ stimulation_NN of_IN the_DT MeA_NNP results_NNS in_IN delayed_JJ puberty_NN in_IN female_JJ rats_NNS -LRB-_-LRB- 18_CD -RRB-_-RRB- ,_, suggesting_VBG this_DT nucleus_NN exerts_VBZ an_DT inhibitory_JJ influence_NN on_IN reproductive_JJ function_NN ._. 
Such_PDT an_DT influence_NN of_IN the_DT MeA_NNP on_IN the_DT HPG_NNP axis_NN is_VBZ further_RBR supported_VBN by_IN neuroanatomical_JJ studies_NNS demonstrating_VBG the_DT existence_NN of_IN extensive_JJ direct_JJ projections_NNS from_IN the_DT MeA_NNP to_TO the_DT hypothalamic_JJ GnRH-rich_NNP medial_JJ preoptic_JJ area_NN -LRB-_-LRB- mPOA_NNP -RRB-_-RRB- -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- although_IN the_DT neurochemical_JJ phenotype_NN of_IN these_DT efferents_NNS is_VBZ unknown_JJ ._. 
The_DT CeA_NNP contains_VBZ a_DT major_JJ corticotropin-releasing_NN factor_NN -LRB-_-LRB- CRF_NNP -RRB-_-RRB- neuronal_JJ population_NN -LRB-_-LRB- 21_CD -RRB-_-RRB- ,_, which_WDT is_VBZ a_DT key_JJ inhibitory_JJ neuropeptide_NN of_IN the_DT GnRH_NNP pulse_NN generator_NN -LRB-_-LRB- 22_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, the_DT levels_NNS of_IN Fos_NNS and_CC percentage_NN of_IN GAD_NNP 67_CD neurons_NNS expressing_VBG Fos_NNP within_IN the_DT mPOA_NNP were_VBD very_RB low_JJ and_CC indifferent_JJ between_IN the_DT MeA_NNP lesioned_JJ and_CC intact_JJ animals_NNS in_IN the_DT absence_NN of_IN restraint_NN stress_NN ,_, which_WDT further_RB emphasizes_VBZ a_DT role_NN for_IN the_DT MeA_NNP in_IN regulation_NN of_IN the_DT reproductive_JJ neuroendocrine_NN system_NN during_IN stress_NN but_CC not_RB under_IN nonstress_JJ conditions_NNS ._. 
Additionally_RB ,_, anatomical_JJ studies_NNS indicate_VBP that_IN the_DT MeA_NNP has_VBZ extensive_JJ direct_JJ projections_NNS to_TO the_DT GnRH-rich_NNP mPOA_NNP -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- ._. 
Because_IN extrinsic_JJ projections_NNS of_IN the_DT MeA_NNP are_VBP predominantly_RB GABAergic_JJ -LRB-_-LRB- 49_CD -RRB-_-RRB- ,_, this_DT raises_VBZ the_DT possibility_NN that_IN the_DT attenuation_NN of_IN the_DT restraint_NN stress-induced_JJ suppression_NN of_IN pulsatile_JJ LH_NNP secretion_NN ,_, observed_VBN in_IN MeA_NNP lesioned_VBD rats_NNS ,_, may_MD result_VB from_IN removal_NN of_IN inhibitory_JJ GABAergic_JJ inputs_NNS to_TO the_DT mPOA_NNP ._. 
Similar_JJ to_TO the_DT partial_JJ effect_NN of_IN MeA_NNP lesioning_VBG on_IN restraint_NN stress-induced_JJ suppression_NN of_IN LH_NNP pulses_NNS ,_, the_DT inhibitory_JJ effect_NN of_IN LPS_NNP stress_NN on_IN pulsatile_JJ LH_NNP secretion_NN was_VBD not_RB completely_RB blocked_VBN by_IN bilateral_JJ CeA_NNP lesions_NNS ._. 
It_PRP has_VBZ been_VBN reported_VBN that_IN there_EX are_VBP very_RB few_JJ -LRB-_-LRB- 55_CD -RRB-_-RRB- or_CC no_DT -LRB-_-LRB- 20_CD ,_, 52_CD -RRB-_-RRB- neural_JJ projections_NNS from_IN the_DT CeA_NNP to_TO the_DT GnRH-rich_NNP mPOA_NNP ._. 
Nevertheless_RB ,_, the_DT CeA_NNP is_VBZ known_VBN to_TO densely_RB innervate_VB the_DT BNST_NNP ,_, primarily_RB with_IN CRF_NNP containing_VBG neurons_NNS -LRB-_-LRB- 21_CD ,_, 56_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, in_IN accordance_NN with_IN the_DT notion_NN that_IN psychogenic_JJ and_CC systemic_JJ stressors_NNS activate_VBP distinct_JJ neuronal_JJ pathways_NNS ,_, it_PRP is_VBZ now_RB the_DT understanding_NN that_IN like_IN other_JJ limbic_JJ structures_NNS ,_, the_DT effect_NN of_IN the_DT amygdala_NN on_IN the_DT HPA_NNP axis_NN is_VBZ also_RB stressor_NN -_: and_CC region-specific_JJ -LRB-_-LRB- 3_CD -RRB-_-RRB- ._. 
Of_IN a_DT number_NN of_IN subdivisions_NNS of_IN the_DT amygdala_NN ,_, the_DT medial_JJ nucleus_NN -LRB-_-LRB- MeA_NNP -RRB-_-RRB- which_WDT projects_NNS to_TO basal_JJ forebrain_NN ,_, hypothalamic_JJ ,_, and_CC brain_NN stem_NN structures_NNS demonstrates_VBZ the_DT most_RBS neuronal_JJ activation_NN in_IN response_NN to_TO psychogenic_JJ stressors_NNS such_JJ as_IN restraint_NN ,_, forced_VBD swim_VB ,_, noise_NN ,_, or_CC predator_NN exposure_NN -LRB-_-LRB- 4_CD 
Thus_RB ,_, based_VBN on_IN the_DT results_NNS from_IN this_DT study_NN ,_, it_PRP appears_VBZ that_IN the_DT MeA_NNP and_CC CeA_NNP per_FW se_FW are_VBP not_RB involved_VBN in_IN the_DT normal_JJ regulation_NN of_IN LH_NNP pulses_NNS under_IN nonstressed_JJ conditions_NNS ,_, but_CC nonetheless_RB their_PRP$ activation_NN under_IN stressful_JJ conditions_NNS consequently_RB inhibits_VBZ GnRH_NNP pulse_NN generator_NN activity_NN ._. 
In_IN accordance_NN with_IN studies_NNS demonstrating_VBG the_DT specific_JJ role_NN of_IN the_DT MeA_NNP in_IN regulating_VBG the_DT stress_NN response_NN to_TO psychogenic_JJ but_CC not_RB systemic_JJ stressors_NNS evidenced_VBN by_IN intense_JJ c-fos_JJ expression_NN within_IN the_DT MeA_NNP in_IN response_NN to_TO restraint_NN ,_, swim_VB ,_, noise_NN ,_, or_CC predator_NN exposure_NN -LRB-_-LRB- 4_CD 
Moreover_RB ,_, microinfusion_NN of_IN CRF_NNP antagonist_NN into_IN either_CC the_DT BNST_NNP -LRB-_-LRB- 50_CD -RRB-_-RRB- or_CC the_DT LC_NNP -LRB-_-LRB- 51_CD -RRB-_-RRB- blocked_VBD the_DT psychogenic_JJ but_CC not_RB metabolic_JJ stress_NN 
Similar_JJ to_TO the_DT partial_JJ effect_NN of_IN MeA_NNP lesioning_VBG on_IN restraint_NN stress-induced_JJ suppression_NN of_IN LH_NNP pulses_NNS ,_, the_DT inhibitory_JJ effect_NN of_IN LPS_NNP stress_NN on_IN pulsatile_JJ LH_NNP secretion_NN was_VBD not_RB completely_RB blocked_VBN by_IN bilateral_JJ CeA_NNP lesions_NNS ._. 
It_PRP has_VBZ been_VBN reported_VBN that_IN there_EX are_VBP very_RB few_JJ -LRB-_-LRB- 55_CD -RRB-_-RRB- or_CC no_DT -LRB-_-LRB- 20_CD ,_, 52_CD -RRB-_-RRB- neural_JJ projections_NNS from_IN the_DT CeA_NNP to_TO the_DT GnRH-rich_NNP mPOA_NNP ._. 
Nevertheless_RB ,_, the_DT CeA_NNP is_VBZ known_VBN to_TO densely_RB innervate_VB the_DT BNST_NNP ,_, primarily_RB with_IN CRF_NNP containing_VBG neurons_NNS -LRB-_-LRB- 21_CD ,_, 56_CD -RRB-_-RRB- ._. 
Although_IN we_PRP have_VBP postulated_VBN that_IN projections_NNS from_IN the_DT amygdala_NN that_WDT mediate_VBP stress_NN effects_NNS on_IN the_DT GnRH_NNP pulse_NN generator_NN terminate_VBP on_IN targets_NNS in_IN the_DT mPOA_NNP ,_, a_DT caveat_NN to_TO consider_VB is_VBZ the_DT overwhelming_JJ evidence_NN that_IN the_DT neural_NN construct_VBP comprising_VBG this_DT hypothalamic_JJ oscillator_NN resides_VBZ in_IN the_DT arcuate_JJ nucleus_NN of_IN the_DT mediobasal_JJ hypothalamus_NN in_IN rats_NNS -LRB-_-LRB- 59_CD -RRB-_-RRB- in_IN common_NN with_IN other_JJ species_NNS including_VBG primates_NNS -LRB-_-LRB- 60_CD -RRB-_-RRB- ._. 
The_DT very_RB sparse_JJ direct_JJ projections_NNS from_IN the_DT MeA\/CeA_NNP to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 52_CD ,_, 61_CD -RRB-_-RRB- might_MD suggest_VB a_DT rather_RB limited_JJ level_NN of_IN interaction_NN between_IN these_DT brain_NN regions_NNS ._. 
However_RB ,_, the_DT robust_JJ connections_NNS between_IN the_DT amygdala_NN and_CC the_DT BNST_NNP -LRB-_-LRB- 52_CD ,_, 56_CD -RRB-_-RRB- ,_, which_WDT in_IN turn_NN projects_NNS heavily_RB to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 62_CD -RRB-_-RRB- ,_, may_MD provide_VB an_DT indirect_JJ functional_JJ route_NN for_IN amygdaloid_JJ influence_NN on_IN GnRH_NNP pulse_NN generator_NN activity_NN ;_: this_DT is_VBZ a_DT postulate_NN that_WDT remains_VBZ to_TO be_VB explored_VBN ._. 
The_DT very_RB sparse_JJ direct_JJ projections_NNS from_IN the_DT MeA\/CeA_NNP to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 52_CD ,_, 61_CD -RRB-_-RRB- might_MD suggest_VB a_DT rather_RB limited_JJ level_NN of_IN interaction_NN between_IN these_DT brain_NN regions_NNS ._. 
However_RB ,_, the_DT robust_JJ connections_NNS between_IN the_DT amygdala_NN and_CC the_DT BNST_NNP -LRB-_-LRB- 52_CD ,_, 56_CD -RRB-_-RRB- ,_, which_WDT in_IN turn_NN projects_NNS heavily_RB to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 62_CD -RRB-_-RRB- ,_, may_MD provide_VB an_DT indirect_JJ functional_JJ route_NN for_IN amygdaloid_JJ influence_NN on_IN GnRH_NNP pulse_NN generator_NN activity_NN ;_: this_DT is_VBZ a_DT postulate_NN that_WDT remains_VBZ to_TO be_VB explored_VBN ._. 
Nevertheless_RB ,_, the_DT observation_NN that_IN microinfusion_NN of_IN a_DT wide_JJ range_NN of_IN neuropeptides_NNS ,_, including_VBG calcitonin_NN gene-related_JJ peptide_NN ,_, CRF_NNP ,_, or_CC GABA_NNP ,_, directly_RB into_IN the_DT mPOA_NNP suppresses_VBZ pulsatile_JJ LH_NNP secretion_NN -LRB-_-LRB- 30_CD ,_, 63_CD ,_, 64_CD -RRB-_-RRB- is_VBZ not_RB inconsistent_JJ with_IN the_DT notion_NN of_IN a_DT neurocircuit_JJ relay_NN via_IN the_DT mPOA_NNP to_TO the_DT mediobasal_JJ hypothalamus_NN to_TO modulate_VB GnRH_NNP pulse_NN generator_NN activity_NN ._. 
Furthermore_RB ,_, in_IN accordance_NN with_IN the_DT notion_NN that_IN psychogenic_JJ and_CC systemic_JJ stressors_NNS activate_VBP distinct_JJ neuronal_JJ pathways_NNS ,_, it_PRP is_VBZ now_RB the_DT understanding_NN that_IN like_IN other_JJ limbic_JJ structures_NNS ,_, the_DT effect_NN of_IN the_DT amygdala_NN on_IN the_DT HPA_NNP axis_NN is_VBZ also_RB stressor_NN -_: and_CC region-specific_JJ -LRB-_-LRB- 3_CD -RRB-_-RRB- ._. 
Of_IN a_DT number_NN of_IN subdivisions_NNS of_IN the_DT amygdala_NN ,_, the_DT medial_JJ nucleus_NN -LRB-_-LRB- MeA_NNP -RRB-_-RRB- which_WDT projects_NNS to_TO basal_JJ forebrain_NN ,_, hypothalamic_JJ ,_, and_CC brain_NN stem_NN structures_NNS demonstrates_VBZ the_DT most_RBS neuronal_JJ activation_NN in_IN response_NN to_TO psychogenic_JJ stressors_NNS such_JJ as_IN restraint_NN ,_, forced_VBD swim_VB ,_, noise_NN ,_, or_CC predator_NN exposure_NN -LRB-_-LRB- 4_CD 
Furthermore_RB ,_, in_IN accordance_NN with_IN the_DT notion_NN that_IN psychogenic_JJ and_CC systemic_JJ stressors_NNS activate_VBP distinct_JJ neuronal_JJ pathways_NNS ,_, it_PRP is_VBZ now_RB the_DT understanding_NN that_IN like_IN other_JJ limbic_JJ structures_NNS ,_, the_DT effect_NN of_IN the_DT amygdala_NN on_IN the_DT HPA_NNP axis_NN is_VBZ also_RB stressor_NN -_: and_CC region-specific_JJ -LRB-_-LRB- 3_CD -RRB-_-RRB- ._. 
Of_IN a_DT number_NN of_IN subdivisions_NNS of_IN the_DT amygdala_NN ,_, the_DT medial_JJ nucleus_NN -LRB-_-LRB- MeA_NNP -RRB-_-RRB- which_WDT projects_NNS to_TO basal_JJ forebrain_NN ,_, hypothalamic_JJ ,_, and_CC brain_NN stem_NN structures_NNS demonstrates_VBZ the_DT most_RBS neuronal_JJ activation_NN in_IN response_NN to_TO psychogenic_JJ stressors_NNS such_JJ as_IN restraint_NN ,_, forced_VBD swim_VB ,_, noise_NN ,_, or_CC predator_NN exposure_NN -LRB-_-LRB- 4_CD 
Thus_RB ,_, based_VBN on_IN the_DT results_NNS from_IN this_DT study_NN ,_, it_PRP appears_VBZ that_IN the_DT MeA_NNP and_CC CeA_NNP per_FW se_FW are_VBP not_RB involved_VBN in_IN the_DT normal_JJ regulation_NN of_IN LH_NNP pulses_NNS under_IN nonstressed_JJ conditions_NNS ,_, but_CC nonetheless_RB their_PRP$ activation_NN under_IN stressful_JJ conditions_NNS consequently_RB inhibits_VBZ GnRH_NNP pulse_NN generator_NN activity_NN ._. 
In_IN accordance_NN with_IN studies_NNS demonstrating_VBG the_DT specific_JJ role_NN of_IN the_DT MeA_NNP in_IN regulating_VBG the_DT stress_NN response_NN to_TO psychogenic_JJ but_CC not_RB systemic_JJ stressors_NNS evidenced_VBN by_IN intense_JJ c-fos_JJ expression_NN within_IN the_DT MeA_NNP in_IN response_NN to_TO restraint_NN ,_, swim_VB ,_, noise_NN ,_, or_CC predator_NN exposure_NN -LRB-_-LRB- 4_CD 
Thus_RB ,_, based_VBN on_IN the_DT results_NNS from_IN this_DT study_NN ,_, it_PRP appears_VBZ that_IN the_DT MeA_NNP and_CC CeA_NNP per_FW se_FW are_VBP not_RB involved_VBN in_IN the_DT normal_JJ regulation_NN of_IN LH_NNP pulses_NNS under_IN nonstressed_JJ conditions_NNS ,_, but_CC nonetheless_RB their_PRP$ activation_NN under_IN stressful_JJ conditions_NNS consequently_RB inhibits_VBZ GnRH_NNP pulse_NN generator_NN activity_NN ._. 
In_IN accordance_NN with_IN studies_NNS demonstrating_VBG the_DT specific_JJ role_NN of_IN the_DT MeA_NNP in_IN regulating_VBG the_DT stress_NN response_NN to_TO psychogenic_JJ but_CC not_RB systemic_JJ stressors_NNS evidenced_VBN by_IN intense_JJ c-fos_JJ expression_NN within_IN the_DT MeA_NNP in_IN response_NN to_TO restraint_NN ,_, swim_VB ,_, noise_NN ,_, or_CC predator_NN exposure_NN -LRB-_-LRB- 4_CD 
Moreover_RB ,_, consistent_JJ with_IN its_PRP$ stressor-specific_JJ role_NN ,_, selective_JJ MeA_NNP lesioning_NN has_VBZ been_VBN found_VBN to_TO block_VB the_DT activation_NN of_IN hypothalamic_JJ paraventricular_JJ neuroendocrine_NN cell_NN responses_NNS to_TO acute_JJ restraint_NN -LRB-_-LRB- 9_CD -RRB-_-RRB- and_CC the_DT increase_NN in_IN corticosterone_NN in_IN response_NN to_TO predator_NN odor_NN in_IN rats_NNS -LRB-_-LRB- 10_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, the_DT central_JJ nucleus_NN -LRB-_-LRB- CeA_NNP -RRB-_-RRB- of_IN the_DT amygdala_NN has_VBZ been_VBN shown_VBN to_TO be_VB highly_RB responsive_JJ to_TO systemic_JJ stressors_NNS like_IN inflammation_NN or_CC hemorrhage_NN -LRB-_-LRB- 7_CD ,_, 8_CD -RRB-_-RRB- ,_, with_IN specific_JJ lesions_NNS of_IN this_DT subnucleus_NN resulting_VBG in_IN an_DT attenuation_NN of_IN the_DT HPA_NNP response_NN after_IN interleukin-1_NN 
Bilateral_JJ lesions_NNS of_IN the_DT MeA_NNP markedly_RB attenuated_VBD the_DT psychogenic_JJ -LRB-_-LRB- restraint_NN -RRB-_-RRB- stress-induced_JJ suppression_NN of_IN pulsatile_JJ LH_NNP release_NN without_IN affecting_VBG the_DT inhibitory_JJ response_NN induced_VBN by_IN immunological_JJ -LRB-_-LRB- LPS_NNP -RRB-_-RRB- or_CC metabolic_JJ -LRB-_-LRB- IIH_NNP -RRB-_-RRB- stressors_NNS ,_, suggesting_VBG that_IN the_DT MeA_NNP suppresses_VBZ reproductive_JJ function_NN only_RB when_WRB specifically_RB activated_VBN by_IN psychogenic_JJ stressors_NNS ._. 
With_IN regards_VBZ to_TO systemic_JJ stressors_NNS ,_, the_DT CeA_NNP has_VBZ been_VBN shown_VBN to_TO be_VB highly_RB responsive_JJ to_TO stressors_NNS like_IN inflammation_NN or_CC hemorrhage_NN -LRB-_-LRB- 7_CD ,_, 8_CD -RRB-_-RRB- ,_, with_IN specific_JJ lesions_NNS of_IN this_DT sub-nucleus_NN resulting_VBG in_IN an_DT attenuation_NN of_IN the_DT HPA_NNP response_NN after_IN interleukin-1_NN 
Stress_NN exerts_VBZ profound_JJ inhibitory_JJ effects_NNS on_IN reproductive_JJ function_NN by_IN suppressing_VBG the_DT pulsatile_JJ release_NN of_IN gonadotrophin-releasing_JJ hormone_NN and_CC therefore_RB LH_NNP ,_, however_RB the_DT mechanisms_NNS by_IN which_WDT stressors_NNS disrupt_VBP the_DT hypothalamic_JJ GnRH_NNP pulse_NN generator_NN remain_VBP to_TO be_VB fully_RB elucidated_VBN ._. 
The_DT amygdaloid_JJ complex_NN ,_, a_DT prominent_JJ limbic_JJ brain_NN structure_NN ,_, has_VBZ been_VBN implicated_VBN in_IN many_JJ aspects_NNS of_IN the_DT neuroendocrine_JJ responses_NNS during_IN stress_NN ,_, including_VBG activation_NN of_IN the_DT hypothalamo-pituitary-adrenal_JJ -LRB-_-LRB- HPA_NNP -RRB-_-RRB- axis_NNS ;_: with_IN numerous_JJ studies_NNS demonstrating_VBG that_IN while_IN its_PRP$ lesioning_NN leads_VBZ to_TO decreases_VBZ in_IN the_DT stress-induced_JJ release_NN of_IN corticosterone_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- ,_, its_PRP$ stimulation_NN has_VBZ the_DT opposite_JJ effect_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, in_IN accordance_NN with_IN the_DT notion_NN that_IN psychogenic_JJ and_CC systemic_JJ stressors_NNS activate_VBP distinct_JJ neuronal_JJ pathways_NNS ,_, it_PRP is_VBZ now_RB the_DT understanding_NN that_IN like_IN other_JJ limbic_JJ structures_NNS ,_, the_DT effect_NN of_IN the_DT amygdala_NN on_IN the_DT HPA_NNP axis_NN is_VBZ also_RB stressor_NN -_: and_CC region-specific_JJ -LRB-_-LRB- 3_CD -RRB-_-RRB- ._. 
Stress_NN exerts_VBZ profound_JJ inhibitory_JJ effects_NNS on_IN reproductive_JJ function_NN by_IN suppressing_VBG the_DT pulsatile_JJ release_NN of_IN gonadotrophin-releasing_JJ hormone_NN and_CC therefore_RB LH_NNP ,_, however_RB the_DT mechanisms_NNS by_IN which_WDT stressors_NNS disrupt_VBP the_DT hypothalamic_JJ GnRH_NNP pulse_NN generator_NN remain_VBP to_TO be_VB fully_RB elucidated_VBN ._. 
The_DT amygdaloid_JJ complex_NN ,_, a_DT prominent_JJ limbic_JJ brain_NN structure_NN ,_, has_VBZ been_VBN implicated_VBN in_IN many_JJ aspects_NNS of_IN the_DT neuroendocrine_JJ responses_NNS during_IN stress_NN ,_, including_VBG activation_NN of_IN the_DT hypothalamo-pituitary-adrenal_JJ -LRB-_-LRB- HPA_NNP -RRB-_-RRB- axis_NNS ;_: with_IN numerous_JJ studies_NNS demonstrating_VBG that_IN while_IN its_PRP$ lesioning_NN leads_VBZ to_TO decreases_VBZ in_IN the_DT stress-induced_JJ release_NN of_IN corticosterone_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- ,_, its_PRP$ stimulation_NN has_VBZ the_DT opposite_JJ effect_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, in_IN accordance_NN with_IN the_DT notion_NN that_IN psychogenic_JJ and_CC systemic_JJ stressors_NNS activate_VBP distinct_JJ neuronal_JJ pathways_NNS ,_, it_PRP is_VBZ now_RB the_DT understanding_NN that_IN like_IN other_JJ limbic_JJ structures_NNS ,_, the_DT effect_NN of_IN the_DT amygdala_NN on_IN the_DT HPA_NNP axis_NN is_VBZ also_RB stressor_NN -_: and_CC region-specific_JJ -LRB-_-LRB- 3_CD -RRB-_-RRB- ._. 
The_DT HPG-inhibitory_JJ role_NN for_IN the_DT MeA_NNP and_CC CeA_NNP is_VBZ consistent_JJ with_IN their_PRP$ well-known_JJ function_NN in_IN regulating_VBG the_DT stress_NN response_NN following_VBG stress_NN exposure_NN -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
Indeed_RB damage_NN to_TO the_DT MeA_NNP has_VBZ been_VBN shown_VBN to_TO decrease_VB anxiety-related_JJ behavior_NN and_CC corticosterone_NN responses_NNS to_TO stressors_NNS -LRB-_-LRB- 9_CD ,_, 10_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ,_, while_IN MeA_NNP stimulation_NN has_VBZ been_VBN shown_VBN to_TO increase_VB HPA_NNP axis_NN output_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC facilitate_VB its_PRP$ stress-induced_JJ activation_NN -LRB-_-LRB- 38_CD -RRB-_-RRB- ._. 
Electrical_JJ stimulation_NN of_IN the_DT CeA_NNP results_NNS in_IN the_DT activation_NN of_IN the_DT autonomic_JJ nervous_JJ system_NN -LRB-_-LRB- 39_CD -RRB-_-RRB- ,_, while_IN lesions_NNS of_IN the_DT CeA_NNP attenuate_VB corticosterone_JJ release_NN evoked_VBN by_IN interleukin-1_NN 
The_DT amygdaloid_JJ complex_NN ,_, a_DT prominent_JJ limbic_JJ brain_NN structure_NN ,_, has_VBZ been_VBN implicated_VBN in_IN many_JJ aspects_NNS of_IN the_DT neuroendocrine_JJ responses_NNS during_IN stress_NN ,_, including_VBG activation_NN of_IN the_DT hypothalamo-pituitary-adrenal_JJ -LRB-_-LRB- HPA_NNP -RRB-_-RRB- axis_NNS ;_: with_IN numerous_JJ studies_NNS demonstrating_VBG that_IN while_IN its_PRP$ lesioning_NN leads_VBZ to_TO decreases_VBZ in_IN the_DT stress-induced_JJ release_NN of_IN corticosterone_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- ,_, its_PRP$ stimulation_NN has_VBZ the_DT opposite_JJ effect_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, in_IN accordance_NN with_IN the_DT notion_NN that_IN psychogenic_JJ and_CC systemic_JJ stressors_NNS activate_VBP distinct_JJ neuronal_JJ pathways_NNS ,_, it_PRP is_VBZ now_RB the_DT understanding_NN that_IN like_IN other_JJ limbic_JJ structures_NNS ,_, the_DT effect_NN of_IN the_DT amygdala_NN on_IN the_DT HPA_NNP axis_NN is_VBZ also_RB stressor_NN -_: and_CC region-specific_JJ -LRB-_-LRB- 3_CD -RRB-_-RRB- ._. 
Of_IN a_DT number_NN of_IN subdivisions_NNS of_IN the_DT amygdala_NN ,_, the_DT medial_JJ nucleus_NN -LRB-_-LRB- MeA_NNP -RRB-_-RRB- which_WDT projects_NNS to_TO basal_JJ forebrain_NN ,_, hypothalamic_JJ ,_, and_CC brain_NN stem_NN structures_NNS demonstrates_VBZ the_DT most_RBS neuronal_JJ activation_NN in_IN response_NN to_TO psychogenic_JJ stressors_NNS such_JJ as_IN restraint_NN ,_, forced_VBD swim_VB ,_, noise_NN ,_, or_CC predator_NN exposure_NN -LRB-_-LRB- 4_CD 
In_IN the_DT present_JJ study_NN an_DT ovariectomized_VBN rat_NN model_NN without_IN gonadal_JJ steroid_NN replacement_NN was_VBD used_VBN ._. 
Nevertheless_RB ,_, the_DT observation_NN that_IN microinfusion_NN of_IN a_DT wide_JJ range_NN of_IN neuropeptides_NNS ,_, including_VBG calcitonin_NN gene-related_JJ peptide_NN ,_, CRF_NNP ,_, or_CC GABA_NNP ,_, directly_RB into_IN the_DT mPOA_NNP suppresses_VBZ pulsatile_JJ LH_NNP secretion_NN -LRB-_-LRB- 30_CD ,_, 63_CD ,_, 64_CD -RRB-_-RRB- is_VBZ not_RB inconsistent_JJ with_IN the_DT notion_NN of_IN a_DT neurocircuit_JJ relay_NN via_IN the_DT mPOA_NNP to_TO the_DT mediobasal_JJ hypothalamus_NN to_TO modulate_VB GnRH_NNP pulse_NN generator_NN activity_NN ._. 
Because_IN there_EX is_VBZ substantial_JJ evidence_NN that_IN gonadal_JJ steroids_NNS ,_, in_IN particular_JJ estradiol_NN ,_, sensitize_VB the_DT GnRH_NNP pulse_NN generator_NN to_TO the_DT inhibitory_JJ effects_NNS of_IN stress_NN -LRB-_-LRB- 65_CD 
It_PRP has_VBZ been_VBN reported_VBN that_IN there_EX are_VBP very_RB few_JJ -LRB-_-LRB- 55_CD -RRB-_-RRB- or_CC no_DT -LRB-_-LRB- 20_CD ,_, 52_CD -RRB-_-RRB- neural_JJ projections_NNS from_IN the_DT CeA_NNP to_TO the_DT GnRH-rich_NNP mPOA_NNP ._. 
Nevertheless_RB ,_, the_DT CeA_NNP is_VBZ known_VBN to_TO densely_RB innervate_VB the_DT BNST_NNP ,_, primarily_RB with_IN CRF_NNP containing_VBG neurons_NNS -LRB-_-LRB- 21_CD ,_, 56_CD -RRB-_-RRB- ._. 
Further_RB ,_, LPS_NNP stress_NN induces_VBZ strong_JJ Fos_NNP expression_NN in_IN both_CC the_DT BNST_NNP -LRB-_-LRB- 57_CD -RRB-_-RRB- and_CC LC_NNP -LRB-_-LRB- 58_CD -RRB-_-RRB- ._. 
Thus_RB ,_, the_DT CeA_NNP may_MD similarly_RB provide_VB input_NN to_TO the_DT postulated_JJ multi-synaptic_JJ pathway_NN to_TO the_DT mPOA_NNP described_VBD above_IN ._. 
The_DT very_RB sparse_JJ direct_JJ projections_NNS from_IN the_DT MeA\/CeA_NNP to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 52_CD ,_, 61_CD -RRB-_-RRB- might_MD suggest_VB a_DT rather_RB limited_JJ level_NN of_IN interaction_NN between_IN these_DT brain_NN regions_NNS ._. 
However_RB ,_, the_DT robust_JJ connections_NNS between_IN the_DT amygdala_NN and_CC the_DT BNST_NNP -LRB-_-LRB- 52_CD ,_, 56_CD -RRB-_-RRB- ,_, which_WDT in_IN turn_NN projects_NNS heavily_RB to_TO the_DT arcuate_NN nucleus_NN -LRB-_-LRB- 62_CD -RRB-_-RRB- ,_, may_MD provide_VB an_DT indirect_JJ functional_JJ route_NN for_IN amygdaloid_JJ influence_NN on_IN GnRH_NNP pulse_NN generator_NN activity_NN ;_: this_DT is_VBZ a_DT postulate_NN that_WDT remains_VBZ to_TO be_VB explored_VBN ._. 
Nevertheless_RB ,_, the_DT observation_NN that_IN microinfusion_NN of_IN a_DT wide_JJ range_NN of_IN neuropeptides_NNS ,_, including_VBG calcitonin_NN gene-related_JJ peptide_NN ,_, CRF_NNP ,_, or_CC GABA_NNP ,_, directly_RB into_IN the_DT mPOA_NNP suppresses_VBZ pulsatile_JJ LH_NNP secretion_NN -LRB-_-LRB- 30_CD ,_, 63_CD ,_, 64_CD -RRB-_-RRB- is_VBZ not_RB inconsistent_JJ with_IN the_DT notion_NN of_IN a_DT neurocircuit_JJ relay_NN via_IN the_DT mPOA_NNP to_TO the_DT mediobasal_JJ hypothalamus_NN to_TO modulate_VB GnRH_NNP pulse_NN generator_NN activity_NN ._. 
Furthermore_RB ,_, in_IN accordance_NN with_IN the_DT notion_NN that_IN psychogenic_JJ and_CC systemic_JJ stressors_NNS activate_VBP distinct_JJ neuronal_JJ pathways_NNS ,_, it_PRP is_VBZ now_RB the_DT understanding_NN that_IN like_IN other_JJ limbic_JJ structures_NNS ,_, the_DT effect_NN of_IN the_DT amygdala_NN on_IN the_DT HPA_NNP axis_NN is_VBZ also_RB stressor_NN -_: and_CC region-specific_JJ -LRB-_-LRB- 3_CD -RRB-_-RRB- ._. 
Of_IN a_DT number_NN of_IN subdivisions_NNS of_IN the_DT amygdala_NN ,_, the_DT medial_JJ nucleus_NN -LRB-_-LRB- MeA_NNP -RRB-_-RRB- which_WDT projects_NNS to_TO basal_JJ forebrain_NN ,_, hypothalamic_JJ ,_, and_CC brain_NN stem_NN structures_NNS demonstrates_VBZ the_DT most_RBS neuronal_JJ activation_NN in_IN response_NN to_TO psychogenic_JJ stressors_NNS such_JJ as_IN restraint_NN ,_, forced_VBD swim_VB ,_, noise_NN ,_, or_CC predator_NN exposure_NN -LRB-_-LRB- 4_CD 
Moreover_RB ,_, consistent_JJ with_IN its_PRP$ stressor-specific_JJ role_NN ,_, selective_JJ MeA_NNP lesioning_NN has_VBZ been_VBN found_VBN to_TO block_VB the_DT activation_NN of_IN hypothalamic_JJ paraventricular_JJ neuroendocrine_NN cell_NN responses_NNS to_TO acute_JJ restraint_NN -LRB-_-LRB- 9_CD -RRB-_-RRB- and_CC the_DT increase_NN in_IN corticosterone_NN in_IN response_NN to_TO predator_NN odor_NN in_IN rats_NNS -LRB-_-LRB- 10_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, the_DT central_JJ nucleus_NN -LRB-_-LRB- CeA_NNP -RRB-_-RRB- of_IN the_DT amygdala_NN has_VBZ been_VBN shown_VBN to_TO be_VB highly_RB responsive_JJ to_TO systemic_JJ stressors_NNS like_IN inflammation_NN or_CC hemorrhage_NN -LRB-_-LRB- 7_CD ,_, 8_CD -RRB-_-RRB- ,_, with_IN specific_JJ lesions_NNS of_IN this_DT subnucleus_NN resulting_VBG in_IN an_DT attenuation_NN of_IN the_DT HPA_NNP response_NN after_IN interleukin-1_NN 
Thus_RB ,_, based_VBN on_IN the_DT results_NNS from_IN this_DT study_NN ,_, it_PRP appears_VBZ that_IN the_DT MeA_NNP and_CC CeA_NNP per_FW se_FW are_VBP not_RB involved_VBN in_IN the_DT normal_JJ regulation_NN of_IN LH_NNP pulses_NNS under_IN nonstressed_JJ conditions_NNS ,_, but_CC nonetheless_RB their_PRP$ activation_NN under_IN stressful_JJ conditions_NNS consequently_RB inhibits_VBZ GnRH_NNP pulse_NN generator_NN activity_NN ._. 
In_IN accordance_NN with_IN studies_NNS demonstrating_VBG the_DT specific_JJ role_NN of_IN the_DT MeA_NNP in_IN regulating_VBG the_DT stress_NN response_NN to_TO psychogenic_JJ but_CC not_RB systemic_JJ stressors_NNS evidenced_VBN by_IN intense_JJ c-fos_JJ expression_NN within_IN the_DT MeA_NNP in_IN response_NN to_TO restraint_NN ,_, swim_VB ,_, noise_NN ,_, or_CC predator_NN exposure_NN -LRB-_-LRB- 4_CD 
Bilateral_JJ lesions_NNS of_IN the_DT MeA_NNP markedly_RB attenuated_VBD the_DT psychogenic_JJ -LRB-_-LRB- restraint_NN -RRB-_-RRB- stress-induced_JJ suppression_NN of_IN pulsatile_JJ LH_NNP release_NN without_IN affecting_VBG the_DT inhibitory_JJ response_NN induced_VBN by_IN immunological_JJ -LRB-_-LRB- LPS_NNP -RRB-_-RRB- or_CC metabolic_JJ -LRB-_-LRB- IIH_NNP -RRB-_-RRB- stressors_NNS ,_, suggesting_VBG that_IN the_DT MeA_NNP suppresses_VBZ reproductive_JJ function_NN only_RB when_WRB specifically_RB activated_VBN by_IN psychogenic_JJ stressors_NNS ._. 
With_IN regards_VBZ to_TO systemic_JJ stressors_NNS ,_, the_DT CeA_NNP has_VBZ been_VBN shown_VBN to_TO be_VB highly_RB responsive_JJ to_TO stressors_NNS like_IN inflammation_NN or_CC hemorrhage_NN -LRB-_-LRB- 7_CD ,_, 8_CD -RRB-_-RRB- ,_, with_IN specific_JJ lesions_NNS of_IN this_DT sub-nucleus_NN resulting_VBG in_IN an_DT attenuation_NN of_IN the_DT HPA_NNP response_NN after_IN interleukin-1_NN 
Of_IN a_DT number_NN of_IN subdivisions_NNS of_IN the_DT amygdala_NN ,_, the_DT medial_JJ nucleus_NN -LRB-_-LRB- MeA_NNP -RRB-_-RRB- which_WDT projects_NNS to_TO basal_JJ forebrain_NN ,_, hypothalamic_JJ ,_, and_CC brain_NN stem_NN structures_NNS demonstrates_VBZ the_DT most_RBS neuronal_JJ activation_NN in_IN response_NN to_TO psychogenic_JJ stressors_NNS such_JJ as_IN restraint_NN ,_, forced_VBD swim_VB ,_, noise_NN ,_, or_CC predator_NN exposure_NN -LRB-_-LRB- 4_CD 
Moreover_RB ,_, consistent_JJ with_IN its_PRP$ stressor-specific_JJ role_NN ,_, selective_JJ MeA_NNP lesioning_NN has_VBZ been_VBN found_VBN to_TO block_VB the_DT activation_NN of_IN hypothalamic_JJ paraventricular_JJ neuroendocrine_NN cell_NN responses_NNS to_TO acute_JJ restraint_NN -LRB-_-LRB- 9_CD -RRB-_-RRB- and_CC the_DT increase_NN in_IN corticosterone_NN in_IN response_NN to_TO predator_NN odor_NN in_IN rats_NNS -LRB-_-LRB- 10_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, the_DT central_JJ nucleus_NN -LRB-_-LRB- CeA_NNP -RRB-_-RRB- of_IN the_DT amygdala_NN has_VBZ been_VBN shown_VBN to_TO be_VB highly_RB responsive_JJ to_TO systemic_JJ stressors_NNS like_IN inflammation_NN or_CC hemorrhage_NN -LRB-_-LRB- 7_CD ,_, 8_CD -RRB-_-RRB- ,_, with_IN specific_JJ lesions_NNS of_IN this_DT subnucleus_NN resulting_VBG in_IN an_DT attenuation_NN of_IN the_DT HPA_NNP response_NN after_IN interleukin-1_NN 
The_DT HPG-inhibitory_JJ role_NN for_IN the_DT MeA_NNP and_CC CeA_NNP is_VBZ consistent_JJ with_IN their_PRP$ well-known_JJ function_NN in_IN regulating_VBG the_DT stress_NN response_NN following_VBG stress_NN exposure_NN -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
Indeed_RB damage_NN to_TO the_DT MeA_NNP has_VBZ been_VBN shown_VBN to_TO decrease_VB anxiety-related_JJ behavior_NN and_CC corticosterone_NN responses_NNS to_TO stressors_NNS -LRB-_-LRB- 9_CD ,_, 10_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ,_, while_IN MeA_NNP stimulation_NN has_VBZ been_VBN shown_VBN to_TO increase_VB HPA_NNP axis_NN output_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC facilitate_VB its_PRP$ stress-induced_JJ activation_NN -LRB-_-LRB- 38_CD -RRB-_-RRB- ._. 
Electrical_JJ stimulation_NN of_IN the_DT CeA_NNP results_NNS in_IN the_DT activation_NN of_IN the_DT autonomic_JJ nervous_JJ system_NN -LRB-_-LRB- 39_CD -RRB-_-RRB- ,_, while_IN lesions_NNS of_IN the_DT CeA_NNP attenuate_VB corticosterone_JJ release_NN evoked_VBN by_IN interleukin-1_NN 
Bilateral_JJ lesions_NNS of_IN the_DT MeA_NNP markedly_RB attenuated_VBD the_DT psychogenic_JJ -LRB-_-LRB- restraint_NN -RRB-_-RRB- stress-induced_JJ suppression_NN of_IN pulsatile_JJ LH_NNP release_NN without_IN affecting_VBG the_DT inhibitory_JJ response_NN induced_VBN by_IN immunological_JJ -LRB-_-LRB- LPS_NNP -RRB-_-RRB- or_CC metabolic_JJ -LRB-_-LRB- IIH_NNP -RRB-_-RRB- stressors_NNS ,_, suggesting_VBG that_IN the_DT MeA_NNP suppresses_VBZ reproductive_JJ function_NN only_RB when_WRB specifically_RB activated_VBN by_IN psychogenic_JJ stressors_NNS ._. 
With_IN regards_VBZ to_TO systemic_JJ stressors_NNS ,_, the_DT CeA_NNP has_VBZ been_VBN shown_VBN to_TO be_VB highly_RB responsive_JJ to_TO stressors_NNS like_IN inflammation_NN or_CC hemorrhage_NN -LRB-_-LRB- 7_CD ,_, 8_CD -RRB-_-RRB- ,_, with_IN specific_JJ lesions_NNS of_IN this_DT sub-nucleus_NN resulting_VBG in_IN an_DT attenuation_NN of_IN the_DT HPA_NNP response_NN after_IN interleukin-1_NN 
However_RB ,_, earlier_JJR studies_NNS on_IN EDL_NNP and_CC OE_NNP ,_, with_IN and_CC without_IN testosterone_NN supplementation_NN ,_, have_VBP emphasized_VBN the_DT importance_NN of_IN exocrine_JJ testicular_JJ luminal_JJ factors_NNS in_IN regulation_NN of_IN the_DT proximal_JJ portion_NN of_IN epididymis_NNS ,_, and_CC particularly_RB of_IN the_DT IS_VBZ ._. 
In_IN rats_NNS and_CC mice_NNS ,_, interruption_NN of_IN the_DT flow_NN of_IN testicular_JJ fluids_NNS by_IN EDL_NNP results_NNS in_IN striking_JJ involution_NN of_IN the_DT IS_VBZ ,_, with_IN less_RBR dramatic_JJ ,_, yet_RB clear_JJ regressive_JJ changes_NNS more_RBR distally_RB -LRB-_-LRB- 14_CD 
This_DT similarity_NN does_VBZ not_RB rule_VB out_RP the_DT role_NN of_IN testicular_JJ factors_NNS other_JJ than_IN testosterone_NN in_IN the_DT regulation_NN of_IN the_DT proximal_JJ epididymis_NNS ;_: rather_RB it_PRP suggests_VBZ a_DT permissive_JJ role_NN for_IN androgens_NNS ._. 
Experiments_NNS in_IN rats_NNS have_VBP indicated_VBN that_IN the_DT main_JJ mode_NN of_IN action_NN of_IN testosterone_NN in_IN caput_FW epididymis_FW is_VBZ through_IN its_PRP$ conversion_NN into_IN DHT_NNP via_IN the_DT amplification_NN pathway_NN operated_VBN by_IN type_NN I_PRP steroid_VBD 5_CD 
However_RB ,_, earlier_JJR studies_NNS on_IN EDL_NNP and_CC OE_NNP ,_, with_IN and_CC without_IN testosterone_NN supplementation_NN ,_, have_VBP emphasized_VBN the_DT importance_NN of_IN exocrine_JJ testicular_JJ luminal_JJ factors_NNS in_IN regulation_NN of_IN the_DT proximal_JJ portion_NN of_IN epididymis_NNS ,_, and_CC particularly_RB of_IN the_DT IS_VBZ ._. 
In_IN rats_NNS and_CC mice_NNS ,_, interruption_NN of_IN the_DT flow_NN of_IN testicular_JJ fluids_NNS by_IN EDL_NNP results_NNS in_IN striking_JJ involution_NN of_IN the_DT IS_VBZ ,_, with_IN less_RBR dramatic_JJ ,_, yet_RB clear_JJ regressive_JJ changes_NNS more_RBR distally_RB -LRB-_-LRB- 14_CD 
Ros1_NNP ,_, a_DT protooncogene_JJ tyrosine_NN kinase_NN receptor_NN ,_, is_VBZ expressed_VBN in_IN the_DT proximal_JJ epididymis_NNS ,_, and_CC its_PRP$ knockout_NN mice_NNS present_JJ with_IN agenesis_NN of_IN the_DT IS_VBZ -LRB-_-LRB- 11_CD -RRB-_-RRB- ._. 
Another_DT protooncogene_NN ,_, Araf_NNP ,_, encodes_VBZ a_DT serine\/threonine_JJ kinase_NN and_CC is_VBZ expressed_VBN mainly_RB in_IN the_DT principal_JJ epithelial_JJ cells_NNS of_IN the_DT murine_FW caput_FW epididymidis_FW -LRB-_-LRB- 12_CD -RRB-_-RRB- ._. 
Bcl2l15_NNP ,_, also_RB termed_VBD Bfk_NNP ,_, is_VBZ a_DT novel_JJ member_NN of_IN the_DT Bcl2_NNP gene_NN family_NN ,_, and_CC its_PRP$ expression_NN has_VBZ been_VBN found_VBN to_TO be_VB confined_VBN to_TO principal_JJ cells_NNS of_IN IS_VBZ -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
Another_DT protooncogene_NN ,_, Araf_NNP ,_, encodes_VBZ a_DT serine\/threonine_JJ kinase_NN and_CC is_VBZ expressed_VBN mainly_RB in_IN the_DT principal_JJ epithelial_JJ cells_NNS of_IN the_DT murine_FW caput_FW epididymidis_FW -LRB-_-LRB- 12_CD -RRB-_-RRB- ._. 
Bcl2l15_NNP ,_, also_RB termed_VBD Bfk_NNP ,_, is_VBZ a_DT novel_JJ member_NN of_IN the_DT Bcl2_NNP gene_NN family_NN ,_, and_CC its_PRP$ expression_NN has_VBZ been_VBN found_VBN to_TO be_VB confined_VBN to_TO principal_JJ cells_NNS of_IN IS_VBZ -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
Rnase10_JJ and_CC Etv4_JJ expression_NN were_VBD similarly_RB ,_, and_CC nearly_RB totally_RB ,_, lost_VBN in_IN all_DT experimental_JJ groups_NNS ,_, indicating_VBG that_IN the_DT proper_JJ expression_NN of_IN this_DT gene_NN requires_VBZ both_DT endocrine_JJ androgen_NN action_NN and_CC lumicrine_NN factors_NNS ._. 
Rnase10_NNP is_VBZ a_DT ribonuclease-like_JJ protein_NN with_IN unknown_JJ function_NN ,_, being_VBG expressed_VBN mainly_RB in_IN the_DT IS_VBZ -LRB-_-LRB- 6_CD -RRB-_-RRB- ,_, and_CC Etv4_NNP is_VBZ a_DT member_NN of_IN the_DT polyoma_NN virus_NN enhancer_NN activator_NN 3_CD family_NN ,_, shown_VBN to_TO be_VB expressed_VBN in_IN the_DT rat_NN epididymis_VBZ with_IN highest_JJS level_NN in_IN IS_VBZ -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
Srd5a1_NNP encodes_VBZ the_DT enzyme_NN steroid_VBD 5_CD 
This_DT similarity_NN does_VBZ not_RB rule_VB out_RP the_DT role_NN of_IN testicular_JJ factors_NNS other_JJ than_IN testosterone_NN in_IN the_DT regulation_NN of_IN the_DT proximal_JJ epididymis_NNS ;_: rather_RB it_PRP suggests_VBZ a_DT permissive_JJ role_NN for_IN androgens_NNS ._. 
Experiments_NNS in_IN rats_NNS have_VBP indicated_VBN that_IN the_DT main_JJ mode_NN of_IN action_NN of_IN testosterone_NN in_IN caput_FW epididymis_FW is_VBZ through_IN its_PRP$ conversion_NN into_IN DHT_NNP via_IN the_DT amplification_NN pathway_NN operated_VBN by_IN type_NN I_PRP steroid_VBD 5_CD 
Srd5a1_NNP encodes_VBZ the_DT enzyme_NN steroid_VBD 5_CD 
The_DT phenotypic_JJ mismatch_NN between_IN steroid_NN 5_CD 
Experiments_NNS in_IN rats_NNS have_VBP indicated_VBN that_IN the_DT main_JJ mode_NN of_IN action_NN of_IN testosterone_NN in_IN caput_FW epididymis_FW is_VBZ through_IN its_PRP$ conversion_NN into_IN DHT_NNP via_IN the_DT amplification_NN pathway_NN operated_VBN by_IN type_NN I_PRP steroid_VBD 5_CD 
Experiments_NNS in_IN rats_NNS have_VBP indicated_VBN that_IN the_DT main_JJ mode_NN of_IN action_NN of_IN testosterone_NN in_IN caput_FW epididymis_FW is_VBZ through_IN its_PRP$ conversion_NN into_IN DHT_NNP via_IN the_DT amplification_NN pathway_NN operated_VBN by_IN type_NN I_PRP steroid_VBD 5_CD 
In_IN the_DT Ros1_NNP knockout_NN ,_, the_DT length_NN of_IN the_DT tubule_NN lined_VBN with_IN underdeveloped_JJ epithelium_NN is_VBZ considerably_RB shorter_JJR than_IN that_DT in_IN the_DT ProxE-ARKO_NNP mice_NNS ,_, in_IN which_WDT gene_NN inactivation_NN extends_VBZ down_RB to_TO zone_NN 3_CD and_CC occurs_VBZ at_IN a_DT later_RB postnatal_JJ stage_NN in_IN a_DT partly_RB differentiated_VBN and_CC therefore_RB longer_JJR tubule_NN ._. 
Although_IN clogging_VBG of_IN spermatozoa_NN in_IN this_DT dead_JJ space_NN may_MD also_RB be_VB promoted_VBN by_IN the_DT altered_JJ luminal_JJ fluid_NN affecting_VBG the_DT physicochemical_JJ properties_NNS of_IN the_DT sperm_NN cell_NN surface_NN ,_, epididymal_JJ obstruction_NN also_RB ensues_VBZ in_IN a_DT proximal_JJ epididymis_NN with_IN less_RBR complete_JJ ,_, mosaic_JJ inactivation_NN of_IN the_DT Ar_NNP in_IN principal_JJ cells_NNS ,_, as_IN demonstrated_VBN in_IN a_DT study_NN using_VBG a_DT FoxG1-Cre_JJ mouse_NN to_TO inactivate_VB Ar_NNP in_IN the_DT epididymis_NNS -LRB-_-LRB- 27_CD -RRB-_-RRB- ._. 
The_DT differential_JJ response_NN patterns_NNS of_IN the_DT epididymal_JJ genes_NNS to_TO the_DT experimental_JJ manipulations_NNS allowed_VBD us_PRP to_TO conclude_VB that_IN the_DT proximal_JJ epididymis_NN expresses_VBZ genes_NNS that_WDT are_VBP predominately_RB under_IN direct_JJ androgen_NN regulation_NN ,_, requiring_VBG functional_JJ Ar_NNP expression_NN ;_: such_JJ genes_NNS were_VBD Araf_NNP and_CC Bcl2l15_NNP ._. 
Although_IN the_DT disruption_NN of_IN Ar_NNP in_IN the_DT proximal_JJ epididymis_NNS resulted_VBD in_IN the_DT current_JJ study_NN in_IN severe_JJ hypoplasia_NN of_IN the_DT epithelium_NN and_CC obstruction_NN ,_, it_PRP is_VBZ curious_JJ that_IN the_DT latter_NN does_VBZ not_RB occur_VB in_IN the_DT Ros1_NNP knockout_NN males_NNS with_IN complete_JJ IS_VBZ agenesis_NNS -LRB-_-LRB- 11_CD -RRB-_-RRB- ._. 
Instead_RB ,_, these_DT males_NNS are_VBP infertile_JJ because_IN of_IN impaired_JJ sperm_NN volume_NN regulation_NN during_IN their_PRP$ epididymal_JJ transit_NN ,_, resulting_VBG in_IN swollen_JJ spermatozoa_NN displaying_VBG angulated_JJ tails_NNS and_CC inability_NN to_TO pass_VB through_IN the_DT uterotubal_JJ junction_NN -LRB-_-LRB- 25_CD ,_, 26_CD -RRB-_-RRB- ._. 
The_DT reason_NN for_IN this_DT phenotype_NN mismatch_NN may_MD be_VB simply_RB mechanical_JJ ._. 
In_IN the_DT Ros1_NNP knockout_NN ,_, the_DT length_NN of_IN the_DT tubule_NN lined_VBN with_IN underdeveloped_JJ epithelium_NN is_VBZ considerably_RB shorter_JJR than_IN that_DT in_IN the_DT ProxE-ARKO_NNP mice_NNS ,_, in_IN which_WDT gene_NN inactivation_NN extends_VBZ down_RB to_TO zone_NN 3_CD and_CC occurs_VBZ at_IN a_DT later_RB postnatal_JJ stage_NN in_IN a_DT partly_RB differentiated_VBN and_CC therefore_RB longer_JJR tubule_NN ._. 
There_EX were_VBD also_RB genes_NNS regulated_VBN by_IN both_DT androgen_NN and_CC lumicrine_NN factors_NNS -LRB-_-LRB- Rnase10_NNP ,_, Etv4_NNP ,_, and_CC Srd5a1_NNP -RRB-_-RRB- ._. 
In_IN this_DT group_NN ,_, the_DT lumicrine_JJ action_NN of_IN androgen_JJ present_NN in_IN testicular_JJ efferent_JJ fluid_NN at_IN concentrations_NNS up_IN to_TO 60-fold_CD of_IN those_DT in_IN blood_NN plasma_NN -LRB-_-LRB- 26_CD -RRB-_-RRB- remains_VBZ a_DT possibility_NN ._. 
On_IN the_DT other_JJ hand_NN ,_, existence_NN of_IN hitherto_JJ unidentified_JJ lumicrine_NN regulators_NNS distinct_JJ from_IN androgen_NN is_VBZ indicated_VBN by_IN the_DT profile_NN of_IN Ros1_JJ expression_NN ._. 
Although_IN the_DT disruption_NN of_IN Ar_NNP in_IN the_DT proximal_JJ epididymis_NNS resulted_VBD in_IN the_DT current_JJ study_NN in_IN severe_JJ hypoplasia_NN of_IN the_DT epithelium_NN and_CC obstruction_NN ,_, it_PRP is_VBZ curious_JJ that_IN the_DT latter_NN does_VBZ not_RB occur_VB in_IN the_DT Ros1_NNP knockout_NN males_NNS with_IN complete_JJ IS_VBZ agenesis_NNS -LRB-_-LRB- 11_CD -RRB-_-RRB- ._. 
Instead_RB ,_, these_DT males_NNS are_VBP infertile_JJ because_IN of_IN impaired_JJ sperm_NN volume_NN regulation_NN during_IN their_PRP$ epididymal_JJ transit_NN ,_, resulting_VBG in_IN swollen_JJ spermatozoa_NN displaying_VBG angulated_JJ tails_NNS and_CC inability_NN to_TO pass_VB through_IN the_DT uterotubal_JJ junction_NN -LRB-_-LRB- 25_CD ,_, 26_CD -RRB-_-RRB- ._. 
The_DT reason_NN for_IN this_DT phenotype_NN mismatch_NN may_MD be_VB simply_RB mechanical_JJ ._. 
In_IN the_DT Ros1_NNP knockout_NN ,_, the_DT length_NN of_IN the_DT tubule_NN lined_VBN with_IN underdeveloped_JJ epithelium_NN is_VBZ considerably_RB shorter_JJR than_IN that_DT in_IN the_DT ProxE-ARKO_NNP mice_NNS ,_, in_IN which_WDT gene_NN inactivation_NN extends_VBZ down_RB to_TO zone_NN 3_CD and_CC occurs_VBZ at_IN a_DT later_RB postnatal_JJ stage_NN in_IN a_DT partly_RB differentiated_VBN and_CC therefore_RB longer_JJR tubule_NN ._. 
Whereas_IN this_DT model_NN may_MD apply_VB to_TO the_DT rat_NN ,_, the_DT situation_NN in_IN the_DT mouse_NN appears_VBZ to_TO be_VB somewhat_RB different_JJ ._. 
Although_IN the_DT administration_NN of_IN DHT_NNP after_IN orchidectomy_NN can_MD restore_VB the_DT morphology_NN of_IN murine_NN IS_VBZ to_TO some_DT extent_NN -LRB-_-LRB- 22_CD -RRB-_-RRB- ,_, the_DT genital_JJ structures_NNS and_CC fertility_NN of_IN males_NNS with_IN 5_CD 
Although_IN the_DT administration_NN of_IN DHT_NNP after_IN orchidectomy_NN can_MD restore_VB the_DT morphology_NN of_IN murine_NN IS_VBZ to_TO some_DT extent_NN -LRB-_-LRB- 22_CD -RRB-_-RRB- ,_, the_DT genital_JJ structures_NNS and_CC fertility_NN of_IN males_NNS with_IN 5_CD 
Whereas_IN this_DT model_NN may_MD apply_VB to_TO the_DT rat_NN ,_, the_DT situation_NN in_IN the_DT mouse_NN appears_VBZ to_TO be_VB somewhat_RB different_JJ ._. 
Although_IN the_DT administration_NN of_IN DHT_NNP after_IN orchidectomy_NN can_MD restore_VB the_DT morphology_NN of_IN murine_NN IS_VBZ to_TO some_DT extent_NN -LRB-_-LRB- 22_CD -RRB-_-RRB- ,_, the_DT genital_JJ structures_NNS and_CC fertility_NN of_IN males_NNS with_IN 5_CD 
Whereas_IN this_DT model_NN may_MD apply_VB to_TO the_DT rat_NN ,_, the_DT situation_NN in_IN the_DT mouse_NN appears_VBZ to_TO be_VB somewhat_RB different_JJ ._. 
Although_IN the_DT administration_NN of_IN DHT_NNP after_IN orchidectomy_NN can_MD restore_VB the_DT morphology_NN of_IN murine_NN IS_VBZ to_TO some_DT extent_NN -LRB-_-LRB- 22_CD -RRB-_-RRB- ,_, the_DT genital_JJ structures_NNS and_CC fertility_NN of_IN males_NNS with_IN 5_CD 
e._VB A_DT hypothetical_JJ model_NN was_VBD therefore_RB proposed_VBN that_IN the_DT proximal_JJ epididymis_NN is_VBZ regulated_VBN by_IN DHT_NNP whose_WP$ local_JJ formation_NN from_IN testosterone_NN ,_, i._VBN by_IN steroid_NN 5_CD 
Experiments_NNS in_IN rats_NNS have_VBP indicated_VBN that_IN the_DT main_JJ mode_NN of_IN action_NN of_IN testosterone_NN in_IN caput_FW epididymis_FW is_VBZ through_IN its_PRP$ conversion_NN into_IN DHT_NNP via_IN the_DT amplification_NN pathway_NN operated_VBN by_IN type_NN I_PRP steroid_VBD 5_CD 
However_RB ,_, this_DT type_NN of_IN experiment_NN can_MD not_RB exclude_VB the_DT possibility_NN that_WDT combined_VBD action_NN of_IN androgen_NN and_CC lumicrine_NN factors_NNS is_VBZ required_VBN for_IN the_DT maintenance_NN of_IN IS_VBZ ._. 
Of_IN note_NN ,_, the_DT androgen_NN receptor_NN -LRB-_-LRB- Ar_NNP -RRB-_-RRB- gene_NN is_VBZ strongly_RB expressed_VBN in_IN the_DT IS_VBZ -LRB-_-LRB- 4_CD -RRB-_-RRB- ,_, but_CC as_IN stated_VBN above_IN ,_, its_PRP$ function_NN still_RB remains_VBZ unclear_JJ ._. 
As_IN a_DT novel_JJ approach_NN to_TO elucidate_VB the_DT role_NN of_IN androgen_NN action_NN in_IN epididymal_JJ function_NN and_CC in_IN particular_JJ in_IN the_DT IS_VBZ ,_, we_PRP used_VBD the_DT targeted_JJ gene_NN ablation_NN technique_NN ,_, crossing_VBG the_DT Ar_NNP loxP_NNP mice_NNS -LRB-_-LRB- 5_CD -RRB-_-RRB- with_IN a_DT novel_JJ Cre_NNP deletor_NN mouse_NN expressing_VBG Cre_NNP recombinase_NN under_IN the_DT promoter_NN of_IN Rnase10_NNP ,_, a_DT gene_NN with_IN specific_JJ expression_NN in_IN the_DT proximal_JJ epididymis_NNS -LRB-_-LRB- 6_CD -RRB-_-RRB- ._. 
Of_IN note_NN ,_, the_DT androgen_NN receptor_NN -LRB-_-LRB- Ar_NNP -RRB-_-RRB- gene_NN is_VBZ strongly_RB expressed_VBN in_IN the_DT IS_VBZ -LRB-_-LRB- 4_CD -RRB-_-RRB- ,_, but_CC as_IN stated_VBN above_IN ,_, its_PRP$ function_NN still_RB remains_VBZ unclear_JJ ._. 
As_IN a_DT novel_JJ approach_NN to_TO elucidate_VB the_DT role_NN of_IN androgen_NN action_NN in_IN epididymal_JJ function_NN and_CC in_IN particular_JJ in_IN the_DT IS_VBZ ,_, we_PRP used_VBD the_DT targeted_JJ gene_NN ablation_NN technique_NN ,_, crossing_VBG the_DT ArloxP_NNP mice_NNS -LRB-_-LRB- 5_CD -RRB-_-RRB- with_IN a_DT novel_JJ Cre_NNP deletor_NN mouse_NN expressing_VBG Cre_NNP recombinase_NN under_IN the_DT promoter_NN of_IN Rnase10_NNP ,_, a_DT gene_NN with_IN specific_JJ expression_NN in_IN the_DT proximal_JJ epididymis_NNS -LRB-_-LRB- 6_CD -RRB-_-RRB- ._. 
The_DT results_NNS obtained_VBD clearly_RB demonstrate_VB a_DT role_NN for_IN direct_JJ androgen_NN action_NN in_IN the_DT proximal_JJ epididymis_NNS ._. 
1,_CD and_CC used_VBN for_IN the_DT production_NN of_IN proximal_JJ epididymis-specific_JJ Ar_NN knockout_NN mice_NNS by_IN crossing_VBG to_TO congenic_JJ B6_NNP ._. 
ArloxP_JJ homozygous_JJ females_NNS -LRB-_-LRB- 5_CD -RRB-_-RRB- ._. 
Genotypes_NNS of_IN transgenic_JJ mice_NNS were_VBD determined_VBN by_IN PCR_NNP with_IN allele-specific_JJ primers_NNS ._. 
The_DT iCre_NNP sequence_NN was_VBD identified_VBN with_IN the_DT following_JJ pair_NN of_IN primers_NNS :_: 5_CD 
The_DT intact_JJ Rnase10_NNP allele_NN was_VBD identified_VBN with_IN 5_CD 
Of_IN note_NN ,_, the_DT androgen_NN receptor_NN -LRB-_-LRB- Ar_NNP -RRB-_-RRB- gene_NN is_VBZ strongly_RB expressed_VBN in_IN the_DT IS_VBZ -LRB-_-LRB- 4_CD -RRB-_-RRB- ,_, but_CC as_IN stated_VBN above_IN ,_, its_PRP$ function_NN still_RB remains_VBZ unclear_JJ ._. 
As_IN a_DT novel_JJ approach_NN to_TO elucidate_VB the_DT role_NN of_IN androgen_NN action_NN in_IN epididymal_JJ function_NN and_CC in_IN particular_JJ in_IN the_DT IS_VBZ ,_, we_PRP used_VBD the_DT targeted_JJ gene_NN ablation_NN technique_NN ,_, crossing_VBG the_DT ArloxP_NNP mice_NNS -LRB-_-LRB- 5_CD -RRB-_-RRB- with_IN a_DT novel_JJ Cre_NNP deletor_NN mouse_NN expressing_VBG Cre_NNP recombinase_NN under_IN the_DT promoter_NN of_IN Rnase10_NNP ,_, a_DT gene_NN with_IN specific_JJ expression_NN in_IN the_DT proximal_JJ epididymis_NNS -LRB-_-LRB- 6_CD -RRB-_-RRB- ._. 
The_DT results_NNS obtained_VBD clearly_RB demonstrate_VB a_DT role_NN for_IN direct_JJ androgen_NN action_NN in_IN the_DT proximal_JJ epididymis_NNS ._. 
Bar_NNP ,_, 50_CD 
The_DT expression_NN of_IN Rnase10_JJ starts_NNS at_IN around_IN 17_CD d_SYM postpartum_NN -LRB-_-LRB- dpp_NN -RRB-_-RRB- -LRB-_-LRB- 6_CD -RRB-_-RRB- coincidentally_RB with_IN the_DT differentiation_NN of_IN IS_VBZ ._. 
Although_IN Rnase10_NNP has_VBZ previously_RB been_VBN described_VBN to_TO be_VB expressed_VBN exclusively_RB in_IN the_DT epididymal_NN IS_VBZ -LRB-_-LRB- 6_CD -RRB-_-RRB- ,_, the_DT zone_NN of_IN Ar_JJ inactivation_NN in_IN the_DT ProxE-ARKO_NNP mice_NNS appeared_VBD also_RB to_TO include_VB the_DT whole_NN of_IN segment_NN II_NNP ,_, continuing_VBG into_IN segment_NN III_NNP -LRB-_-LRB- Fig_NNP ._. 
2B_CD and_CC Supplemental_NNP Fig_NNP ._. 
1-RRB-_CD ._. 
The_DT spatial_JJ pattern_NN of_IN Ar_JJ inactivation_NN in_IN the_DT ProxE-ARKO_NNP epididymis_NN was_VBD found_VBN to_TO correspond_VB to_TO the_DT area_NN of_IN endogenous_JJ Rnase10_JJ expression_NN as_IN confirmed_VBN by_IN RT-PCR_NNP -LRB-_-LRB- Fig_NNP ._. 
Bar_NNP ,_, 30_CD 
e._NNP The_NNP Cre_NNP -_: loxP_JJ technology_NN used_VBN in_IN this_DT study_NN allows_VBZ spatial_JJ control_NN over_IN inactivation_NN of_IN the_DT Ar_NNP gene_NN ,_, its_PRP$ timing_NN being_VBG determined_VBN by_IN the_DT developmental_JJ onset_NN of_IN Rnase10_JJ expression_NN ,_, i._NN from_IN d_SYM 17_CD postpartum_NN by_IN RT-PCR_NNP -LRB-_-LRB- 6_CD -RRB-_-RRB- ._. 
In_IN our_PRP$ immunohistochemical_JJ characterization_NN of_IN the_DT prepubertal_JJ epididymal_JJ epithelium_NN in_IN ProxE-ARKO_JJ males_NNS ,_, we_PRP found_VBD that_IN the_DT development_NN of_IN the_DT proximal_JJ segment_NN of_IN the_DT epididymis_NN was_VBD aborted_VBN once_RB the_DT epithelial_JJ cells_NNS had_VBD reached_VBN the_DT differentiation_NN stage_NN at_IN which_WDT they_PRP began_VBD to_TO express_VB Rnase10_NNP ._. 
Detection_NN of_IN a_DT single_JJ amplicon_NN was_VBD confirmed_VBN by_IN a_DT dissociation_NN curve_NN at_IN the_DT end_NN of_IN real-time_JJ PCR_NNP cycle_NN ._. 
Cycle_NN threshold_NN values_NNS were_VBD analyzed_VBN as_IN described_VBN -LRB-_-LRB- 7_CD -RRB-_-RRB- using_VBG Gapdh_NNP mRNA_NNP as_IN internal_JJ control_NN ._. 
Statistical_NNP analyses_VBZ The_DT numeric_JJ data_NNS are_VBP presented_VBN as_IN mean_NN 
It_PRP is_VBZ well_RB established_VBN that_IN the_DT normal_JJ development_NN and_CC functional_JJ integrity_NN of_IN the_DT epididymis_NNS are_VBP dependent_JJ on_IN androgen_NN action_NN ._. 
The_DT epididymis_NN does_VBZ not_RB develop_VB in_IN the_DT absence_NN of_IN normal_JJ testicular_JJ testosterone_NN production_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- ,_, and_CC if_IN androgen_JJ action_NN in_IN adult_NN age_NN is_VBZ eliminated_VBN by_IN orchidectomy_NN -LRB-_-LRB- OE_NNP -RRB-_-RRB- or_CC antiandrogen_JJ treatment_NN ,_, the_DT consequence_NN is_VBZ epididymal_JJ weight_NN loss_NN secondary_JJ to_TO disappearance_NN of_IN spermatozoa_NN from_IN the_DT lumen_NNS as_RB well_RB as_IN cytoplasmic_JJ shrinkage_NN and_CC apoptosis_NN of_IN epididymal_JJ cells_NNS -LRB-_-LRB- 1_CD -RRB-_-RRB- ._. 
If_IN testosterone_NN levels_NNS are_VBP restored_VBN after_IN castration_NN ,_, the_DT regressive_JJ changes_NNS in_IN the_DT distal_JJ caput_NN ,_, corpus_NN ,_, and_CC cauda_NN epididymidis_NNS are_VBP reversed_JJ -LRB-_-LRB- 2_CD -RRB-_-RRB- but_CC not_RB in_IN the_DT initial_JJ segment_NN -LRB-_-LRB- IS_VBZ -RRB-_-RRB- ,_, which_WDT has_VBZ cast_VBN doubt_NN on_IN androgen_NN dependence_NN of_IN this_DT epididymal_JJ zone_NN ,_, whose_WP$ normal_JJ function_NN is_VBZ crucial_JJ for_IN the_DT functional_JJ maturation_NN of_IN sperm_NN ._. 
It_PRP is_VBZ well_RB established_VBN that_IN the_DT normal_JJ development_NN and_CC functional_JJ integrity_NN of_IN the_DT epididymis_NNS are_VBP dependent_JJ on_IN androgen_NN action_NN ._. 
The_DT epididymis_NN does_VBZ not_RB develop_VB in_IN the_DT absence_NN of_IN normal_JJ testicular_JJ testosterone_NN production_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- ,_, and_CC if_IN androgen_JJ action_NN in_IN adult_NN age_NN is_VBZ eliminated_VBN by_IN orchidectomy_NN -LRB-_-LRB- OE_NNP -RRB-_-RRB- or_CC antiandrogen_JJ treatment_NN ,_, the_DT consequence_NN is_VBZ epididymal_JJ weight_NN loss_NN secondary_JJ to_TO disappearance_NN of_IN spermatozoa_NN from_IN the_DT lumen_NNS as_RB well_RB as_IN cytoplasmic_JJ shrinkage_NN and_CC apoptosis_NN of_IN epididymal_JJ cells_NNS -LRB-_-LRB- 1_CD -RRB-_-RRB- ._. 
If_IN testosterone_NN levels_NNS are_VBP restored_VBN after_IN castration_NN ,_, the_DT regressive_JJ changes_NNS in_IN the_DT distal_JJ caput_NN ,_, corpus_NN ,_, and_CC cauda_NN epididymidis_NNS are_VBP reversed_JJ -LRB-_-LRB- 2_CD -RRB-_-RRB- but_CC not_RB in_IN the_DT initial_JJ segment_NN -LRB-_-LRB- IS_VBZ -RRB-_-RRB- ,_, which_WDT has_VBZ cast_VBN doubt_NN on_IN androgen_NN dependence_NN of_IN this_DT epididymal_JJ zone_NN ,_, whose_WP$ normal_JJ function_NN is_VBZ crucial_JJ for_IN the_DT functional_JJ maturation_NN of_IN sperm_NN ._. 
The_DT epididymis_NN does_VBZ not_RB develop_VB in_IN the_DT absence_NN of_IN normal_JJ testicular_JJ testosterone_NN production_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- ,_, and_CC if_IN androgen_JJ action_NN in_IN adult_NN age_NN is_VBZ eliminated_VBN by_IN orchidectomy_NN -LRB-_-LRB- OE_NNP -RRB-_-RRB- or_CC antiandrogen_JJ treatment_NN ,_, the_DT consequence_NN is_VBZ epididymal_JJ weight_NN loss_NN secondary_JJ to_TO disappearance_NN of_IN spermatozoa_NN from_IN the_DT lumen_NNS as_RB well_RB as_IN cytoplasmic_JJ shrinkage_NN and_CC apoptosis_NN of_IN epididymal_JJ cells_NNS -LRB-_-LRB- 1_CD -RRB-_-RRB- ._. 
If_IN testosterone_NN levels_NNS are_VBP restored_VBN after_IN castration_NN ,_, the_DT regressive_JJ changes_NNS in_IN the_DT distal_JJ caput_NN ,_, corpus_NN ,_, and_CC cauda_NN epididymidis_NNS are_VBP reversed_JJ -LRB-_-LRB- 2_CD -RRB-_-RRB- but_CC not_RB in_IN the_DT initial_JJ segment_NN -LRB-_-LRB- IS_VBZ -RRB-_-RRB- ,_, which_WDT has_VBZ cast_VBN doubt_NN on_IN androgen_NN dependence_NN of_IN this_DT epididymal_JJ zone_NN ,_, whose_WP$ normal_JJ function_NN is_VBZ crucial_JJ for_IN the_DT functional_JJ maturation_NN of_IN sperm_NN ._. 
Efferent_JJ duct_NN ligation_NN -LRB-_-LRB- EDL_NNP -RRB-_-RRB- experiments_NNS ,_, producing_VBG clear_JJ hypotrophic_JJ changes_NNS in_IN the_DT IS_VBZ ,_, have_VBP emphasized_VBN the_DT importance_NN of_IN factors_NNS present_JJ in_IN the_DT testicular_JJ efferent_JJ fluid_NN -LRB-_-LRB- i._SYM 
e._FW Efferent_FW duct_FW ligation_NN -LRB-_-LRB- EDL_NNP -RRB-_-RRB- experiments_NNS ,_, producing_VBG clear_JJ hypotrophic_JJ changes_NNS in_IN the_DT IS_VBZ ,_, have_VBP emphasized_VBN the_DT importance_NN of_IN factors_NNS present_JJ in_IN the_DT testicular_JJ efferent_JJ fluid_NN -LRB-_-LRB- i._FW lumicrine_FW regulation_NN -RRB-_-RRB- in_IN the_DT maintenance_NN of_IN structural_JJ and_CC functional_JJ integrity_NN of_IN the_DT IS_VBZ -LRB-_-LRB- 2_CD -RRB-_-RRB- ._. 
In_IN agreement_NN with_IN this_DT contention_NN ,_, a_DT recent_JJ study_NN on_IN androgen_JJ replacement_NN of_IN regressed_VBN rat_NN epididymis_NNS after_IN OE_NNP showed_VBD that_IN cell_NN proliferation_NN was_VBD increased_VBN in_IN all_DT epididymal_JJ regions_NNS except_IN for_IN the_DT IS_VBZ -LRB-_-LRB- 3_CD -RRB-_-RRB- ._. 
In_IN rats_NNS and_CC mice_NNS ,_, interruption_NN of_IN the_DT flow_NN of_IN testicular_JJ fluids_NNS by_IN EDL_NNP results_NNS in_IN striking_JJ involution_NN of_IN the_DT IS_VBZ ,_, with_IN less_RBR dramatic_JJ ,_, yet_RB clear_JJ regressive_JJ changes_NNS more_RBR distally_RB -LRB-_-LRB- 14_CD 
lumicrine_JJ regulation_NN -RRB-_-RRB- in_IN the_DT maintenance_NN of_IN structural_JJ and_CC functional_JJ integrity_NN of_IN the_DT IS_VBZ -LRB-_-LRB- 2_CD -RRB-_-RRB- ._. 
e._VB In_IN agreement_NN with_IN this_DT contention_NN ,_, a_DT recent_JJ study_NN on_IN androgen_JJ replacement_NN of_IN regressed_VBN rat_NN epididymis_NNS after_IN OE_NNP showed_VBD that_IN cell_NN proliferation_NN was_VBD increased_VBN in_IN all_DT epididymal_JJ regions_NNS except_IN for_IN the_DT IS_VBZ -LRB-_-LRB- 3_CD -RRB-_-RRB- ._. 
However_RB ,_, this_DT type_NN of_IN experiment_NN can_MD not_RB exclude_VB the_DT possibility_NN that_WDT combined_VBD action_NN of_IN androgen_NN and_CC lumicrine_NN factors_NNS is_VBZ required_VBN for_IN the_DT maintenance_NN of_IN IS_VBZ ._. 
Consequent_JJ to_TO the_DT disappearance_NN of_IN the_DT AR_NNP ,_, there_EX was_VBD a_DT loss_NN of_IN epithelial_JJ height_NN ,_, whereas_IN further_JJ development_NN of_IN the_DT IS_VBZ was_VBD aborted_JJ ._. 
Accordingly_RB ,_, the_DT principal_JJ cell-specific_JJ glutamate_JJ transporter_NN excitatory_JJ amino_JJ acid_NN carrier_NN 1_CD -LRB-_-LRB- solute_JJ carrier_NN family_NN 1_CD -RRB-_-RRB- -LRB-_-LRB- 8_CD -RRB-_-RRB- ,_, localized_VBN in_IN stereocilia_NN in_IN IS_VBZ and_CC in_IN microvilli_NNS in_IN the_DT more_RBR distal_JJ parts_NNS of_IN the_DT epididymis_NNS ,_, was_VBD absent_JJ in_IN the_DT knockout_NN IS_VBZ but_CC present_JJ in_IN corpus_NN and_CC cauda_NN -LRB-_-LRB- Supplemental_NNP Fig_NNP ._. 
3-RRB-_CD ._. 
Ar_NN expression_NN remained_VBD intact_JJ in_IN the_DT rest_NN of_IN the_DT Wolffian_JJ duct-derived_JJ structures_NNS ,_, as_RB well_RB as_IN in_IN the_DT testes_NNS and_CC accessory_JJ sex_NN glands_NNS -LRB-_-LRB- Fig_NNP ._. 
Bar_NNP ,_, 30_CD 
AgRP_NNP may_MD also_RB act_VB as_IN an_DT inverse_JJ agonist_NN at_IN MC4R_NNP ._. 
Furthermore_RB ,_, unlike_IN 
Furthermore_RB ,_, they_PRP showed_VBD that_IN treatment_NN of_IN the_DT cells_NNS with_IN AgRP_NNP could_MD dose_NN dependently_RB suppress_VBP adenylate_JJ cyclase_NN activity_NN ,_, consistent_JJ with_IN inverse_JJ agonist_JJ activity_NN at_IN a_DT constitutively_RB active_JJ receptor_NN ._. 
Similarly_RB ,_, Haskell-Luevano_NNP and_CC Monck_NNP -LRB-_-LRB- 16_CD -RRB-_-RRB- demonstrated_VBD that_IN signaling_VBG through_IN a_DT constitutively_RB active_JJ MC4R_NNP mutant_JJ could_MD be_VB dose_NN dependently_RB suppressed_VBN by_IN AgRP_NNP ,_, supporting_VBG the_DT hypothesis_NN that_IN AgRP_NNP has_VBZ inverse_JJ agonist_JJ activity_NN ._. 
More_RBR recently_RB ,_, in_IN vivo_NN evidence_NN indicating_VBG that_IN AgRP_NNP may_MD have_VB inverse_JJ agonist_JJ activity_NN has_VBZ emerged_VBN using_VBG Pomc_NNP 
In_IN vitro_NN studies_NNS indicate_VBP that_IN constitutive_JJ activity_NN of_IN the_DT MC4R_NNP can_MD be_VB dose_NN dependently_RB suppressed_VBN by_IN AgRP_NNP -LRB-_-LRB- 15_CD ,_, 16_CD -RRB-_-RRB- ._. 
Further_JJ support_NN comes_VBZ from_IN in_IN vivo_NN data_NNS showing_VBG that_IN AgRP_NNP administration_NN to_TO a_DT transgenic_JJ mouse_NN model_NN wholly_RB lacking_VBG hypothalamic_JJ POMC-derived_JJ peptides_NNS can_MD still_RB bring_VB about_IN changes_NNS in_IN food_NN intake_NN and_CC energy_NN expenditure_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- ._. 
We_PRP have_VBP previously_RB used_VBN a_DT mouse_NN model_NN of_IN POMC_NNP deficiency_NN -LRB-_-LRB- Pomc_NNP 
Central_JJ administration_NN of_IN a_DT single_JJ dose_NN of_IN 0_CD ._. 
More_RBR recently_RB ,_, in_IN vivo_NN evidence_NN indicating_VBG that_IN AgRP_NNP may_MD have_VB inverse_JJ agonist_JJ activity_NN has_VBZ emerged_VBN using_VBG Pomc_NNP 
However_RB ,_, one_CD potential_JJ modifier_NN may_MD be_VB that_IN the_DT transgenic_JJ model_NN was_VBD largely_RB backcrossed_VBN onto_IN a_DT C57BL\/6_NNP strain_NN ,_, whereas_IN mice_NNS used_VBN in_IN the_DT current_JJ study_NN were_VBD congenic_JJ to_TO a_DT 129SV_NNP background_NN ._. 
Furthermore_RB ,_, the_DT model_NN used_VBN by_IN Tolle_NNP and_CC Low_NNP -LRB-_-LRB- 17_CD -RRB-_-RRB- retains_VBZ the_DT potential_JJ confounding_JJ effect_NN of_IN endogenous_JJ AgRP-derived_JJ ligands_NNS ._. 
Our_PRP$ model_NN lacks_VBZ all_PDT the_DT endogenous_JJ ligands_NNS of_IN the_DT central_JJ melanocortin_NN system_NN ,_, whereas_IN it_PRP is_VBZ conceivable_JJ that_IN in_IN the_DT Pomc_NNP 
There_EX is_VBZ clear_JJ asymmetry_NN in_IN hypothalamic_JJ Agrp_NNP and_CC Pomc_NNP expression_NN ,_, with_IN different_JJ diurnal_JJ variability_NN and_CC response_NN to_TO fasting_NN -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, unlike_IN 
Further_JJ uncertainties_NNS over_IN the_DT role_NN of_IN AgRP_NNP include_VBP the_DT potential_JJ mechanisms_NNS underlying_VBG both_DT the_DT long-lasting_JJ and_CC putative_JJ melanocortin-independent_JJ effects_NNS of_IN AgRP_NNP ._. 
For_IN example_NN ,_, a_DT single_JJ dose_NN of_IN 100_CD pmol_NN has_VBZ been_VBN reported_VBN to_TO produce_VB a_DT robust_JJ increase_NN in_IN food_NN intake_NN that_WDT persists_VBZ for_IN an_DT entire_JJ week_NN -LRB-_-LRB- 14_CD -RRB-_-RRB- ,_, and_CC centrally_RB administered_VBN AgRP_NNP has_VBZ been_VBN shown_VBN to_TO increase_VB food_NN intake_NN in_IN Mc4r_NNP 
AgRP_NNP may_MD also_RB act_VB as_IN an_DT inverse_JJ agonist_NN at_IN MC4R_NNP ._. 
Furthermore_RB ,_, unlike_IN 
Nijenhuis_NNPS et_FW al._FW ._. 
Early_JJ evidence_NN for_IN AgRP_NNP acting_VBG as_IN an_DT inverse_JJ agonist_NN came_VBD from_IN in_IN vitro_NN studies_NNS ._. 
-LRB-_-LRB- 15_CD -RRB-_-RRB- showed_VBD that_IN MCB16\/G4F_NNP cell_NN lines_NNS transfected_VBN with_IN human_JJ MC4R_NNP had_VBD adenylate_JJ cyclase_NN activity_NN that_WDT correlated_VBD with_IN receptor_NN expression_NN level_NN in_IN the_DT clones_NNS ._. 
Furthermore_RB ,_, they_PRP showed_VBD that_IN treatment_NN of_IN the_DT cells_NNS with_IN AgRP_NNP could_MD dose_NN dependently_RB suppress_VBP adenylate_JJ cyclase_NN activity_NN ,_, consistent_JJ with_IN inverse_JJ agonist_JJ activity_NN at_IN a_DT constitutively_RB active_JJ receptor_NN ._. 
In_IN contrast_NN to_TO melanocortins_NNS ,_, central_JJ AgRP_NNP administration_NN potently_RB stimulates_VBZ food_NN intake_NN -LRB-_-LRB- 10_CD -RRB-_-RRB- ._. 
Like_IN POMC_NNP ,_, AgRP_NNP is_VBZ a_DT propeptide_NN that_WDT undergoes_VBZ processing_NN to_TO produce_VB smaller_JJR ,_, active_JJ peptides_NNS -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
These_DT and_CC many_JJ other_JJ studies_NNS unequivocally_RB show_VBP that_IN AgRP_NNP is_VBZ a_DT competitive_JJ antagonist_NN of_IN melanocortins_NNS at_IN both_DT the_DT MC3R_NNP and_CC MC4R_NNP -LRB-_-LRB- 11_CD ,_, 12_CD -RRB-_-RRB- ._. 
Despite_IN this_DT ,_, a_DT full_JJ understanding_NN of_IN the_DT biology_NN of_IN AgRP_NNP remains_VBZ elusive_JJ ,_, and_CC there_EX are_VBP data_NNS to_TO suggest_VB that_IN central_JJ melanocortin_NN signaling_VBG is_VBZ rather_RB more_RBR complex_JJ than_IN a_DT simple_JJ competition_NN for_IN binding_JJ at_IN MC4R_NNP ._. 
Despite_IN this_DT ,_, a_DT full_JJ understanding_NN of_IN the_DT biology_NN of_IN AgRP_NNP remains_VBZ elusive_JJ ,_, and_CC there_EX are_VBP data_NNS to_TO suggest_VB that_IN central_JJ melanocortin_NN signaling_VBG is_VBZ rather_RB more_RBR complex_JJ than_IN a_DT simple_JJ competition_NN for_IN binding_JJ at_IN MC4R_NNP ._. 
There_EX is_VBZ clear_JJ asymmetry_NN in_IN hypothalamic_JJ Agrp_NNP and_CC Pomc_NNP expression_NN ,_, with_IN different_JJ diurnal_JJ variability_NN and_CC response_NN to_TO fasting_NN -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, unlike_IN 
Like_IN POMC_NNP ,_, AgRP_NNP is_VBZ a_DT propeptide_NN that_WDT undergoes_VBZ processing_NN to_TO produce_VB smaller_JJR ,_, active_JJ peptides_NNS -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
In_IN contrast_NN to_TO melanocortins_NNS ,_, central_JJ AgRP_NNP administration_NN potently_RB stimulates_VBZ food_NN intake_NN -LRB-_-LRB- 10_CD -RRB-_-RRB- ._. 
These_DT and_CC many_JJ other_JJ studies_NNS unequivocally_RB show_VBP that_IN AgRP_NNP is_VBZ a_DT competitive_JJ antagonist_NN of_IN melanocortins_NNS at_IN both_DT the_DT MC3R_NNP and_CC MC4R_NNP -LRB-_-LRB- 11_CD ,_, 12_CD -RRB-_-RRB- ._. 
In_IN contrast_NN to_TO melanocortins_NNS ,_, central_JJ AgRP_NNP administration_NN potently_RB stimulates_VBZ food_NN intake_NN -LRB-_-LRB- 10_CD -RRB-_-RRB- ._. 
Like_IN POMC_NNP ,_, AgRP_NNP is_VBZ a_DT propeptide_NN that_WDT undergoes_VBZ processing_NN to_TO produce_VB smaller_JJR ,_, active_JJ peptides_NNS -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
These_DT and_CC many_JJ other_JJ studies_NNS unequivocally_RB show_VBP that_IN AgRP_NNP is_VBZ a_DT competitive_JJ antagonist_NN of_IN melanocortins_NNS at_IN both_DT the_DT MC3R_NNP and_CC MC4R_NNP -LRB-_-LRB- 11_CD ,_, 12_CD -RRB-_-RRB- ._. 
Despite_IN this_DT ,_, a_DT full_JJ understanding_NN of_IN the_DT biology_NN of_IN AgRP_NNP remains_VBZ elusive_JJ ,_, and_CC there_EX are_VBP data_NNS to_TO suggest_VB that_IN central_JJ melanocortin_NN signaling_VBG is_VBZ rather_RB more_RBR complex_JJ than_IN a_DT simple_JJ competition_NN for_IN binding_JJ at_IN MC4R_NNP ._. 
AgRP_NNP was_VBD first_RB identified_VBN when_WRB found_VBN to_TO be_VB up-regulated_JJ in_IN ob_FW \/_FW ob_FW and_CC db_FW \/_FW db_FW mice_NNS -LRB-_-LRB- 25_CD -RRB-_-RRB- ._. 
Finally_RB ,_, icv_NN studies_NNS in_IN DKO_NNP mice_NNS have_VBP shown_VBN that_IN whereas_IN NDP_NNP -_: 
Further_JJ support_NN comes_VBZ from_IN in_IN vivo_NN data_NNS showing_VBG that_IN AgRP_NNP administration_NN to_TO a_DT transgenic_JJ mouse_NN model_NN wholly_RB lacking_VBG hypothalamic_JJ POMC-derived_JJ peptides_NNS can_MD still_RB bring_VB about_IN changes_NNS in_IN food_NN intake_NN and_CC energy_NN expenditure_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- ._. 
We_PRP have_VBP previously_RB used_VBN a_DT mouse_NN model_NN of_IN POMC_NNP deficiency_NN -LRB-_-LRB- Pomc_NNP 
Pomc_NN 
Although_IN we_PRP have_VBP not_RB undertaken_VBN such_PDT an_DT exhaustive_JJ study_NN of_IN aged_VBN mice_NNS ,_, our_PRP$ measurements_NNS did_VBD not_RB reveal_VB a_DT late-onset_NN phenotype_NN observed_VBD in_IN DKO_NNP mice_NNS with_IN coexisting_VBG AgRP_NNP deficiency_NN when_WRB compared_VBN with_IN age-matched_JJ Pomc_NNP 
Therefore_RB ,_, we_PRP hypothesized_VBD that_IN the_DT corticosterone-supplemented_JJ phenotype_NN was_VBD due_JJ to_TO a_DT mechanism_NN involving_VBG AgRP_NNP ,_, with_IN suppression_NN of_IN Agrp_NNP by_IN the_DT hypoadrenal_JJ state_NN protecting_VBG Pomc_NNP -_: deficient_JJ mice_NNS from_IN the_DT full_JJ adverse_JJ metabolic_JJ effects_NNS of_IN melanocortin_NN deficiency_NN ._. 
However_RB ,_, in_IN the_DT current_JJ study_NN ,_, there_EX were_VBD no_DT discernible_JJ differences_NNS in_IN Pomc_NNP 
33_CD -RRB-_-RRB- ._. 
Mutations_NNS resulting_VBG in_IN receptor_NN malfunction_NN and_CC constitutive_JJ activity_NN in_IN a_DT range_NN of_IN GPCRs_NNS such_JJ as_IN TSH_NNP ,_, LH_NNP ,_, and_CC PTH_NNP have_VBP also_RB been_VBN reported_VBN -LRB-_-LRB- reviewed_VBN in_IN Ref_NNP ._. 
Although_IN there_EX are_VBP also_RB data_NNS to_TO indicate_VB that_DT histamine_NN H3_NN receptor_NN can_MD have_VB constitutive_JJ activity_NN in_IN vivo_NN -LRB-_-LRB- 34_CD -RRB-_-RRB- ,_, questions_NNS remain_VBP about_IN the_DT physiological_JJ relevance_NN of_IN constitutive_JJ activity_NN within_IN GPCRs_NNP ._. 
Early_JJ evidence_NN for_IN AgRP_NNP acting_VBG as_IN an_DT inverse_JJ agonist_NN came_VBD from_IN in_IN vitro_NN studies_NNS ._. 
Nijenhuis_NNPS et_FW al._FW 
If_IN constitutive_JJ activity_NN of_IN the_DT MCR4_NNP could_MD be_VB suppressed_VBN by_IN AgRP_NNP in_IN vivo_NN ,_, we_PRP would_MD hypothesize_VB an_DT intermediate_JJ phenotype_NN for_IN the_DT DKO_NNP mouse_NN when_WRB compared_VBN with_IN the_DT Pomc_NNP 
One_CD caveat_NN is_VBZ that_IN corticosterone-treated_JJ DKO_NNP mice_NNS already_RB display_VBP hyperphagia_NN ,_, and_CC our_PRP$ model_NN system_NN may_MD not_RB have_VB been_VBN sensitive_JJ enough_RB to_TO detect_VB further_JJ increase_NN in_IN food_NN intake_NN brought_VBD about_RP by_IN inverse_JJ agonist_JJ activity_NN ._. 
Furthermore_RB ,_, because_IN melanocortin_JJ pathways_NNS controlling_VBG energy_NN balance_NN are_VBP known_VBN to_TO have_VB regional_JJ divergence_NN ,_, with_IN MC4Rs_NNS in_IN the_DT paraventricular_JJ hypothalamus_NN and\/or_CC the_DT amygdala_NN controlling_VBG food_NN intake_NN whereas_IN MC4Rs_NNS elsewhere_RB control_VBP energy_NN expenditure_NN -LRB-_-LRB- 36_CD -RRB-_-RRB- ,_, we_PRP can_MD not_RB exclude_VB the_DT hypothesis_NN that_IN this_DT regional_JJ specificity_NN extends_VBZ also_RB to_TO the_DT activity_NN of_IN AgRP_NNP ,_, it_PRP being_VBG an_DT antagonist_NN globally_RB and_CC an_DT inverse_JJ agonist_NN only_RB in_IN a_DT limited_JJ number_NN of_IN sites_NNS ._. 
However_RB ,_, it_PRP is_VBZ noteworthy_JJ that_IN when_WRB judged_VBN by_IN the_DT effects_NNS on_IN BAT_NNP Ucp1_NNP expression_NN ,_, central_JJ administration_NN of_IN AgRP_NNP revealed_VBD antagonist_NN activity_NN only_RB ._. 
To_TO attempt_VB to_TO overcome_VB this_DT issue_NN ,_, a_DT series_NN of_IN studies_NNS undertook_VBD to_TO ablate_VB AgRP_NNP neurons_NNS in_IN adult_NN life_NN ._. 
Such_PDT an_DT approach_NN brought_VBD about_RB more_RBR robust_JJ phenotype_NN -LRB-_-LRB- 37_CD 
For_IN example_NN ,_, a_DT single_JJ dose_NN of_IN 100_CD pmol_NN has_VBZ been_VBN reported_VBN to_TO produce_VB a_DT robust_JJ increase_NN in_IN food_NN intake_NN that_WDT persists_VBZ for_IN an_DT entire_JJ week_NN -LRB-_-LRB- 14_CD -RRB-_-RRB- ,_, and_CC centrally_RB administered_VBN AgRP_NNP has_VBZ been_VBN shown_VBN to_TO increase_VB food_NN intake_NN in_IN Mc4r_NNP 
Amore_JJ contentious_JJ aspect_NN of_IN AgRP_JJ biology_NN relates_VBZ to_TO its_PRP$ potential_JJ action_NN as_IN an_DT inverse_JJ agonist_NN at_IN melanocortin_NN receptors_NNS ._. 
Since_IN the_DT first_JJ report_NN by_IN Costa_NNP and_CC Herz_NNP -LRB-_-LRB- 31_CD -RRB-_-RRB- that_IN 
Amore_JJ contentious_JJ aspect_NN of_IN AgRP_JJ biology_NN relates_VBZ to_TO its_PRP$ potential_JJ action_NN as_IN an_DT inverse_JJ agonist_NN at_IN melanocortin_NN receptors_NNS ._. 
Since_IN the_DT first_JJ report_NN by_IN Costa_NNP and_CC Herz_NNP -LRB-_-LRB- 31_CD -RRB-_-RRB- that_IN 
Mutations_NNS resulting_VBG in_IN receptor_NN malfunction_NN and_CC constitutive_JJ activity_NN in_IN a_DT range_NN of_IN GPCRs_NNS such_JJ as_IN TSH_NNP ,_, LH_NNP ,_, and_CC PTH_NNP have_VBP also_RB been_VBN reported_VBN -LRB-_-LRB- reviewed_VBN in_IN Ref_NNP ._. 
33_CD -RRB-_-RRB- ._. 
Although_IN there_EX are_VBP also_RB data_NNS to_TO indicate_VB that_DT histamine_NN H3_NN receptor_NN can_MD have_VB constitutive_JJ activity_NN in_IN vivo_NN -LRB-_-LRB- 34_CD -RRB-_-RRB- ,_, questions_NNS remain_VBP about_IN the_DT physiological_JJ relevance_NN of_IN constitutive_JJ activity_NN within_IN GPCRs_NNP ._. 
However_RB ,_, because_IN these_DT studies_NNS deleted_VBD the_DT whole_JJ AgRP_NNP neuron_NN ,_, and_CC deletion_NN of_IN the_DT neuron_NN is_VBZ a_DT far_RB greater_JJR insult_NN than_IN deletion_NN of_IN the_DT peptide_NN alone_RB -LRB-_-LRB- 41_CD -RRB-_-RRB- ,_, the_DT possibility_NN of_IN this_DT effect_NN being_VBG due_JJ to_TO neuropeptides_NNS other_JJ than_IN AgRP_NNP remained_VBD ._. 
Indeed_RB ,_, recent_JJ studies_NNS have_VBP shown_VBN that_DT starvation_NN after_IN ablation_NN of_IN AgRP_JJ neurons_NNS is_VBZ independent_JJ of_IN melanocortin_NN signaling_VBG -LRB-_-LRB- 42_CD -RRB-_-RRB- and_CC that_IN it_PRP is_VBZ in_IN fact_NN the_DT loss_NN of_IN secretion_NN of_IN 
Could_MD AgRP_NNP also_RB have_VBP a_DT role_NN outside_NN of_IN the_DT melanocortin_NN system_NN ._. 
Indeed_RB ,_, recent_JJ studies_NNS have_VBP shown_VBN that_DT starvation_NN after_IN ablation_NN of_IN AgRP_JJ neurons_NNS is_VBZ independent_JJ of_IN melanocortin_NN signaling_VBG -LRB-_-LRB- 42_CD -RRB-_-RRB- and_CC that_IN it_PRP is_VBZ in_IN fact_NN the_DT loss_NN of_IN secretion_NN of_IN 
Could_MD AgRP_NNP also_RB have_VBP a_DT role_NN outside_NN of_IN the_DT melanocortin_NN system_NN ._. 
Indeed_RB ,_, recent_JJ studies_NNS have_VBP shown_VBN that_DT starvation_NN after_IN ablation_NN of_IN AgRP_JJ neurons_NNS is_VBZ independent_JJ of_IN melanocortin_NN signaling_VBG -LRB-_-LRB- 42_CD -RRB-_-RRB- and_CC that_IN it_PRP is_VBZ in_IN fact_NN the_DT loss_NN of_IN secretion_NN of_IN 
However_RB ,_, because_IN these_DT studies_NNS deleted_VBD the_DT whole_JJ AgRP_NNP neuron_NN ,_, and_CC deletion_NN of_IN the_DT neuron_NN is_VBZ a_DT far_RB greater_JJR insult_NN than_IN deletion_NN of_IN the_DT peptide_NN alone_RB -LRB-_-LRB- 41_CD -RRB-_-RRB- ,_, the_DT possibility_NN of_IN this_DT effect_NN being_VBG due_JJ to_TO neuropeptides_NNS other_JJ than_IN AgRP_NNP remained_VBD ._. 
Indeed_RB ,_, recent_JJ studies_NNS have_VBP shown_VBN that_DT starvation_NN after_IN ablation_NN of_IN AgRP_JJ neurons_NNS is_VBZ independent_JJ of_IN melanocortin_NN signaling_VBG -LRB-_-LRB- 42_CD -RRB-_-RRB- and_CC that_IN it_PRP is_VBZ in_IN fact_NN the_DT loss_NN of_IN secretion_NN of_IN 
There_EX are_VBP reports_NNS that_IN central_JJ administration_NN of_IN AgRP_JJ increases_NNS ethanol_NN intake_NN in_IN C57BL\/6J_NNP mice_NNS -LRB-_-LRB- 44_CD -RRB-_-RRB- ,_, whereas_IN Agrp_NNP 
Such_PDT an_DT approach_NN brought_VBD about_RB more_RBR robust_JJ phenotype_NN -LRB-_-LRB- 37_CD 
The_DT true_JJ effects_NNS of_IN AgRP_NNP may_MD require_VB more_RBR genetically_RB modified_VBN precision_NN being_VBG brought_VBN to_TO bear_VB ,_, both_DT in_IN terms_NNS of_IN neuroanatomical_JJ regional_JJ loss_NN and_CC in_IN timing_NN of_IN perturbation_NN ._. 
Although_IN technically_RB challenging_JJ ,_, adult-onset_JJ loss_NN of_IN the_DT AgRP_NNP peptide_NN alone_RB through_IN the_DT use_NN of_IN conditional_JJ or_CC inducible_JJ loss_NN may_MD be_VB one_CD possible_JJ approach_NN to_TO bring_VB clarity_NN to_TO our_PRP$ understanding_NN of_IN this_DT enigmatic_JJ peptide_NN -LRB-_-LRB- 41_CD -RRB-_-RRB- ._. ._. ._. 
Supplementary_NNP Material_NNP ._. ._. ._. 
Supplemental_NNP Data_NNP ._. ._. 
To_TO attempt_VB to_TO overcome_VB this_DT issue_NN ,_, a_DT series_NN of_IN studies_NNS undertook_VBD to_TO ablate_VB AgRP_NNP neurons_NNS in_IN adult_NN life_NN ._. 
Such_PDT an_DT approach_NN brought_VBD about_RB more_RBR robust_JJ phenotype_NN -LRB-_-LRB- 37_CD 
Further_JJ uncertainties_NNS over_IN the_DT role_NN of_IN AgRP_NNP include_VBP the_DT potential_JJ mechanisms_NNS underlying_VBG both_DT the_DT long-lasting_JJ and_CC putative_JJ melanocortin-independent_JJ effects_NNS of_IN AgRP_NNP ._. 
For_IN example_NN ,_, a_DT single_JJ dose_NN of_IN 100_CD pmol_NN has_VBZ been_VBN reported_VBN to_TO produce_VB a_DT robust_JJ increase_NN in_IN food_NN intake_NN that_WDT persists_VBZ for_IN an_DT entire_JJ week_NN -LRB-_-LRB- 14_CD -RRB-_-RRB- ,_, and_CC centrally_RB administered_VBN AgRP_NNP has_VBZ been_VBN shown_VBN to_TO increase_VB food_NN intake_NN in_IN Mc4r_NNP 
We_PRP have_VBP previously_RB shown_VBN that_IN corticosterone_JJ supplementation_NN of_IN Pomc_NNP 
Our_NNP reported_VBD phenotype_NN of_IN Pomc_NNP 
AgRP_NNP was_VBD first_RB identified_VBN when_WRB found_VBN to_TO be_VB up-regulated_JJ in_IN ob_FW \/_FW ob_FW and_CC db_FW \/_FW db_FW mice_NNS -LRB-_-LRB- 25_CD -RRB-_-RRB- ._. 
Finally_RB ,_, icv_NN studies_NNS in_IN DKO_NNP mice_NNS have_VBP shown_VBN that_IN whereas_IN NDP_NNP -_: 
Finally_RB ,_, icv_NN studies_NNS in_IN DKO_NNP mice_NNS have_VBP shown_VBN that_IN whereas_IN NDP_NNP -_: 
All_DT animals_NNS received_VBD analgesia_NN -LRB-_-LRB- Rimadyl_NNP ,_, 5_CD mg\/kg_NN ;_: Pfizer_NNP Animal_NNP Health_NNP ,_, Kent_NNP ,_, UK_NNP -RRB-_-RRB- and_CC antibiotic_JJ -LRB-_-LRB- Teramycin_NNP LA_NNP ,_, 60_CD mg\/kg_NN ;_: Pfizer_NNP Animal_NNP Health_NNP -RRB-_-RRB- before_IN being_VBG returned_VBN to_TO their_PRP$ home_NN cage_NN ._. 
All_DT DKO_NNP animals_NNS used_VBN in_IN icv_NN studies_NNS received_VBD corticosterone-supplemented_JJ drinking_NN water_NN for_IN the_DT duration_NN of_IN the_DT study_NN -LRB-_-LRB- 24_CD -RRB-_-RRB- ._. 
After_IN 1_CD wk_NN recovery_NN ,_, daily_JJ food_NN intake_NN and_CC body_NN weight_NN measurements_NNS were_VBD started_VBN 1_CD d_SYM before_IN peptide_NN treatment_NN ._. 
Peptides_NNPS AgRP_NNP 82_CD 
Peptides_NNPS AgRP_NNP 82_CD 
Materials_NNPS and_CC Methods_NNPS Animals_NNPS Agrp_NNP 
Further_JJ pharmacological_JJ studies_NNS -LRB-_-LRB- 11_CD -RRB-_-RRB- and_CC work_NN carried_VBD out_RP using_VBG transgenic_JJ murine_NN models_NNS -LRB-_-LRB- 26_CD -RRB-_-RRB- confirmed_VBD unequivocally_RB that_IN it_PRP is_VBZ able_JJ to_TO bring_VB about_IN robust_JJ changes_NNS in_IN food_NN intake_NN and_CC body_NN weight_NN through_IN antagonism_NN of_IN central_JJ melanocortin_NN receptors_NNS ._. 
In_IN light_NN of_IN these_DT data_NNS ,_, it_PRP was_VBD surprising_JJ that_IN the_DT first_JJ study_NN of_IN an_DT Agrp_NN 
Further_JJ support_NN comes_VBZ from_IN in_IN vivo_NN data_NNS showing_VBG that_IN AgRP_NNP administration_NN to_TO a_DT transgenic_JJ mouse_NN model_NN wholly_RB lacking_VBG hypothalamic_JJ POMC-derived_JJ peptides_NNS can_MD still_RB bring_VB about_IN changes_NNS in_IN food_NN intake_NN and_CC energy_NN expenditure_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- ._. 
We_PRP have_VBP previously_RB used_VBN a_DT mouse_NN model_NN of_IN POMC_NNP deficiency_NN -LRB-_-LRB- Pomc_NNP 
Lyophilized_VBN peptides_NNS were_VBD dissolved_VBN in_IN sterile_JJ water_NN immediately_RB before_IN administration_NN ._. 
-_: 
Central_JJ administration_NN of_IN melanocortin_NN agonists_NNS significantly_RB reduce_VB food_NN intake_NN -LRB-_-LRB- 2_CD ,_, 3_CD -RRB-_-RRB- ._. 
The_DT POMC_NNP propeptide_NN is_VBZ processed_VBN posttranslationally_RB to_TO produce_VB the_DT melanocortin_JJ peptides_NNS 
Central_JJ administration_NN of_IN melanocortin_NN agonists_NNS significantly_RB reduce_VB food_NN intake_NN -LRB-_-LRB- 2_CD ,_, 3_CD -RRB-_-RRB- ._. 
The_DT POMC_NNP propeptide_NN is_VBZ processed_VBN posttranslationally_RB to_TO produce_VB the_DT melanocortin_JJ peptides_NNS 
Further_JJ support_NN comes_VBZ from_IN in_IN vivo_NN data_NNS showing_VBG that_IN AgRP_NNP administration_NN to_TO a_DT transgenic_JJ mouse_NN model_NN wholly_RB lacking_VBG hypothalamic_JJ POMC-derived_JJ peptides_NNS can_MD still_RB bring_VB about_IN changes_NNS in_IN food_NN intake_NN and_CC energy_NN expenditure_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- ._. 
We_PRP have_VBP previously_RB used_VBN a_DT mouse_NN model_NN of_IN POMC_NNP deficiency_NN -LRB-_-LRB- Pomc_NNP 
We_PRP have_VBP previously_RB used_VBN a_DT mouse_NN model_NN of_IN POMC_NNP deficiency_NN -LRB-_-LRB- Pomc_NNP 
Qian_NNP -LRB-_-LRB- Merck_NNP -RRB-_-RRB- -LRB-_-LRB- 21_CD -RRB-_-RRB- -RRB-_-RRB- were_VBD backcrossed_VBN 10_CD +_NN generations_NNS onto_IN the_DT 129S2\/SVH_NNP background_NN -LRB-_-LRB- 
Central_JJ administration_NN of_IN melanocortin_NN agonists_NNS significantly_RB reduce_VB food_NN intake_NN -LRB-_-LRB- 2_CD ,_, 3_CD -RRB-_-RRB- ._. 
The_DT POMC_NNP propeptide_NN is_VBZ processed_VBN posttranslationally_RB to_TO produce_VB the_DT melanocortin_JJ peptides_NNS 
Central_JJ melanocortin_NN 3_CD and_CC 4_CD receptors_NNS -LRB-_-LRB- MC3\/4-R_NN -RRB-_-RRB- are_VBP critical_JJ regulators_NNS of_IN energy_NN homeostasis_NN ._. 
If_IN AgRP_NNP has_VBZ significant_JJ melanocortin-independent_JJ actions_NNS ,_, these_DT are_VBP of_IN insufficient_JJ magnitude_NN in_IN vivo_NN to_TO impact_VB any_DT of_IN the_DT detailed_JJ phenotypes_NNS we_PRP have_VBP measured_VBN under_IN a_DT wide_JJ variety_NN of_IN conditions_NNS ._. 
MC4Rs_NNS have_VBP an_DT established_VBN role_NN in_IN energy_NN intake_NN and_CC energy_NN expenditure_NN ,_, whereas_IN MC3Rs_NNP may_MD have_VB a_DT more_RBR subtle_JJ involvement_NN in_IN nutrient_NN partitioning_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- ._. 
These_DT receptors_NNS receive_VBP inputs_NNS from_IN two_CD anatomically_RB distinct_JJ subsets_NNS of_IN arcuate_JJ neurons_NNS ,_, which_WDT constitute_VBP the_DT hypothalamic_JJ melanocortin_NN system_NN ._. 
The_DT POMC_NNP propeptide_NN is_VBZ processed_VBN posttranslationally_RB to_TO produce_VB the_DT melanocortin_JJ peptides_NNS 
The_DT POMC_NNP propeptide_NN is_VBZ processed_VBN posttranslationally_RB to_TO produce_VB the_DT melanocortin_JJ peptides_NNS 
Central_JJ administration_NN of_IN melanocortin_NN agonists_NNS significantly_RB reduce_VB food_NN intake_NN -LRB-_-LRB- 2_CD ,_, 3_CD -RRB-_-RRB- ._. 
The_DT POMC_NNP propeptide_NN is_VBZ processed_VBN posttranslationally_RB to_TO produce_VB the_DT melanocortin_JJ peptides_NNS 
The_DT second_JJ neuronal_JJ population_NN expresses_VBZ ,_, among_IN other_JJ peptides_NNS ,_, Agouti-related_JJ peptide_NN -LRB-_-LRB- AgRP_NNP -RRB-_-RRB- ._. 
Furthermore_RB ,_, impairment_NN of_IN either_CC the_DT synthesis_NN -LRB-_-LRB- 4_CD ,_, 5_CD -RRB-_-RRB- or_CC processing_NN -LRB-_-LRB- 6_CD 
06_NNS fold_VBP ,_, comparable_JJ to_TO the_DT control_NN Gln-evoked_JJ response_NN -LRB-_-LRB- n_SYM =_SYM 6_CD ,_, Table_NNP 2_CD -RRB-_-RRB- ._. 
11_CD 
This_DT observation_NN suggests_VBZ that_IN the_DT cAMP-dependent_JJ pathway_NN is_VBZ critical_JJ in_IN determining_VBG whether_IN an_DT amino_JJ acid_NN effectively_RB triggers_VBZ and_CC maintains_VBZ GLP-1_JJ secretion_NN over_IN a_DT 2-h_JJ incubation_NN period_NN ._. 
In_IN GLUTag_JJ cells_NNS ,_, cAMP_NNP modulates_VBZ plasma_NN membrane_NN ion_NN channels_NNS resulting_VBG in_IN depolarization_NN and_CC increased_VBN excitability_NN -LRB-_-LRB- 16_CD -RRB-_-RRB- ,_, thereby_RB tending_VBG also_RB to_TO mobilize_VB Cai2_NNP +_NNP -LRB-_-LRB- 7_CD -RRB-_-RRB- ._. 
However_RB ,_, its_PRP$ principal_JJ action_NN is_VBZ probably_RB on_IN downstream_JJ targets_NNS ,_, resulting_VBG in_IN enhanced_JJ vesicle_NN exocytosis_NN by_IN Epac_NNP -_: and_CC PKA-dependent_JJ pathways_NNS ,_, as_IN described_VBN in_IN other_JJ endocrine_NN cells_NNS -LRB-_-LRB- reviewed_VBN in_IN Ref_NNP ._. 
Further_JJ studies_NNS in_IN human_JJ subjects_NNS confirmed_VBD the_DT relevance_NN of_IN this_DT finding_NN ,_, as_IN oral_JJ supplements_NNS of_IN Gln_NNP ,_, given_VBN to_TO lean_VB healthy_JJ human_JJ subjects_NNS ,_, were_VBD found_VBN to_TO elevate_VB plasma_NN GLP-1_NN levels_NNS within_IN 30_CD min_NN of_IN ingestion_NN ._. 
Importantly_RB ,_, this_DT effect_NN was_VBD also_RB observed_VBN in_IN obese_JJ type_NN 2_CD diabetic_JJ subjects_NNS -LRB-_-LRB- 10_CD -RRB-_-RRB- ,_, and_CC therefore_RB the_DT GLP-1_NNP secretory_NN pathway_NN triggered_VBN by_IN Gln_NNP may_MD represent_VB a_DT novel_NN therapeutic_JJ target_NN ._. 
The_DT potential_NN of_IN Gln-based_JJ therapies_NNS to_TO increase_VB GLP-1_JJ secretion_NN in_IN human_JJ subjects_NNS has_VBZ increased_VBN interest_NN in_IN the_DT signaling_VBG pathways_NNS triggered_VBN by_IN this_DT amino_JJ acid_NN in_IN L_NNP cells_NNS ._. 
102_CD Conclusion_NN and_CC physiological_JJ perspective_NN Previously_RB ,_, we_PRP showed_VBD that_IN Gln_NNP triggered_VBD electrical_JJ activity_NN in_IN GLUTag_NNP cells_NNS ,_, but_CC we_PRP were_VBD unable_JJ to_TO explain_VB the_DT amplifying_VBG pathway_NN responsible_JJ for_IN the_DT greater_JJR effect_NN of_IN Gln_NNP compared_VBN with_IN other_JJ amino_JJ acids_NNS ._. 
The_DT findings_NNS did_VBD ,_, however_RB ,_, spark_VBP an_DT interest_NN in_IN the_DT potential_JJ use_NN of_IN Gln_NNP as_IN a_DT GLP-1_JJ secretagogue_NN in_IN human_JJ subjects_NNS ,_, and_CC it_PRP is_VBZ notable_JJ that_IN an_DT effect_NN originally_RB identified_VBN in_IN a_DT cell_NN line_NN was_VBD subsequently_RB reproduced_VBN in_IN type_NN 2_CD diabetic_JJ and_CC obese_JJ subjects_NNS -LRB-_-LRB- 10_CD -RRB-_-RRB- ,_, and_CC has_VBZ now_RB been_VBN further_RB validated_VBN in_IN studies_NNS on_IN primary_JJ L_NNP cells_NNS ._. 
The_DT present_JJ results_NNS suggest_VBP that_IN Gln-triggered_JJ membrane_NN depolarization_NN and_CC elevation_NN of_IN cAMP_JJ act_NN synergistically_RB on_IN L_NNP cells_NNS and_CC account_NN for_IN the_DT particular_JJ effectiveness_NN of_IN this_DT amino_JJ acid_NN on_IN GLP-1_NN secretion_NN ._. 
2m_FW m_FW -RRB-_-RRB- is_VBZ close_JJ to_TO normal_JJ plasma_NN glutamine_NN concentrations_NNS ,_, which_WDT range_VBP from_IN 0_CD ._. 
The_DT EC_NNP 50_CD for_IN glutamine_NN triggered_VBD GLP-1_JJ secretion_NN from_IN primary_JJ L_NNP cells_NNS -LRB-_-LRB- 
Glutamine_NNP elevates_VBZ intracellular_JJ cAMP_NN -LRB-_-LRB- cAMP_FW i_FW -RRB-_-RRB- An_DT alternative_NN signaling_VBG pathway_NN could_MD involve_VB elevation_NN of_IN cAMP_NNP i_FW which_WDT is_VBZ a_DT known_JJ potent_JJ L_NNP cell_NN stimulus_NN -LRB-_-LRB- 16_CD -RRB-_-RRB- -LRB-_-LRB- 7_CD -RRB-_-RRB- ._. 
We_PRP investigated_VBD this_DT using_VBG a_DT cAMP_NNP FRET_NNP sensor_NN based_VBN on_IN Epac2_NNP ,_, which_WDT we_PRP validated_VBD recently_RB for_IN monitoring_VBG cAMP_JJ levels_NNS in_IN single_JJ GLUTag_NNP cells_NNS -LRB-_-LRB- 11_CD ,_, 17_CD -RRB-_-RRB- -LRB-_-LRB- Fig_NNP ._. 
4A_CD -RRB-_-RRB- ._. 
Gln_NNP -LRB-_-LRB- 10_CD m_FW m_FW -RRB-_-RRB- evoked_VBD a_DT significant_JJ rise_NN in_IN the_DT CFP\/YFP_NNP ratio_NN in_IN GLUTag_JJ cells_NNS compared_VBN with_IN vehicle_NN control_NN ,_, indicative_JJ of_IN elevated_JJ cAMP_NNP i_FW -LRB-_-LRB- P_SYM 
Responses_NNS to_TO a_DT test_NN agent_NN were_VBD expressed_VBN as_IN the_DT mean_JJ ratio_NN in_IN test_NN agent_NN divided_VBN by_IN the_DT mean_NN of_IN the_DT ratios_NNS measured_VBN before_IN and_CC after_IN washout_NN ._. 
cAMP-measurements_NNS using_VBG F_NN 
Glutamine_NNP elevates_VBZ intracellular_JJ cAMP_NN -LRB-_-LRB- cAMP_FW i_FW -RRB-_-RRB- An_DT alternative_NN signaling_VBG pathway_NN could_MD involve_VB elevation_NN of_IN cAMP_NNP i_FW which_WDT is_VBZ a_DT known_JJ potent_JJ L_NNP cell_NN stimulus_NN -LRB-_-LRB- 16_CD -RRB-_-RRB- -LRB-_-LRB- 7_CD -RRB-_-RRB- ._. 
We_PRP investigated_VBD this_DT using_VBG a_DT cAMP_NNP FRET_NNP sensor_NN based_VBN on_IN Epac2_NNP ,_, which_WDT we_PRP validated_VBD recently_RB for_IN monitoring_VBG cAMP_JJ levels_NNS in_IN single_JJ GLUTag_NNP cells_NNS -LRB-_-LRB- 11_CD ,_, 17_CD -RRB-_-RRB- -LRB-_-LRB- Fig_NNP ._. 
4A_CD -RRB-_-RRB- ._. 
Gln_NNP -LRB-_-LRB- 10_CD m_FW m_FW -RRB-_-RRB- evoked_VBD a_DT significant_JJ rise_NN in_IN the_DT CFP\/YFP_NNP ratio_NN in_IN GLUTag_JJ cells_NNS compared_VBN with_IN vehicle_NN control_NN ,_, indicative_JJ of_IN elevated_JJ cAMP_NNP i_FW -LRB-_-LRB- P_SYM 
Gln_NNP -LRB-_-LRB- 1_CD m_FW m_FW -RRB-_-RRB- was_VBD also_RB tested_VBN in_IN the_DT presence_NN of_IN 0_CD ._. 
However_RB ,_, direct_JJ application_NN of_IN glucosamine_NN failed_VBD to_TO stimulate_VB secretion_NN of_IN GLP-1_NN release_NN and_CC actually_RB decreased_VBD GLP-1_JJ levels_NNS below_IN basal_NN -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- ._. 
2_CD 
However_RB ,_, its_PRP$ principal_JJ action_NN is_VBZ probably_RB on_IN downstream_JJ targets_NNS ,_, resulting_VBG in_IN enhanced_JJ vesicle_NN exocytosis_NN by_IN Epac_NNP -_: and_CC PKA-dependent_JJ pathways_NNS ,_, as_IN described_VBN in_IN other_JJ endocrine_NN cells_NNS -LRB-_-LRB- reviewed_VBN in_IN Ref_NNP ._. 
21_CD -RRB-_-RRB- ._. 
Finally_RB ,_, Gln_NNP also_RB stimulated_VBD a_DT small_JJ but_CC significant_JJ Ca_JJ 2_CD +_NN response_NN in_IN the_DT absence_NN of_IN extracellular_JJ Ca_JJ 2_CD +_NN ,_, suggesting_VBG that_IN it_PRP may_MD also_RB trigger_VB the_DT release_NN of_IN Ca_JJ 2_CD +_NN from_IN an_DT intracellular_JJ store_NN ._. 
Interestingly_RB ,_, slc6a19_CD -LRB-_-LRB- B_NNP 0_CD AT1_NNP -RRB-_-RRB- ,_, a_DT Na_FW +_FW -_: dependent_JJ electrogenic_JJ transporter_NN ,_, was_VBD the_DT most_RBS highly_RB expressed_VBN of_IN the_DT Gln-carrying_JJ Slc_NNP members_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, and_CC was_VBD highly_RB enriched_VBN in_IN L_NNP cells_NNS compared_VBN with_IN their_PRP$ neighbors_NNS ._. 
B0AT1_NNP is_VBZ reported_VBN to_TO localize_VB to_TO the_DT apical_JJ membrane_NN of_IN intestinal_JJ cells_NNS -LRB-_-LRB- 20_CD -RRB-_-RRB- where_WRB it_PRP would_MD be_VB exposed_VBN to_TO the_DT luminal_JJ contents_NNS ._. 
Although_IN its_PRP$ role_NN in_IN the_DT Gln-evoked_JJ GLP-1_NN response_NN is_VBZ currently_RB unclear_JJ ,_, given_VBN that_IN it_PRP is_VBZ highly_RB enriched_VBN in_IN the_DT L_NNP cell_NN ,_, it_PRP may_MD play_VB a_DT significant_JJ role_NN in_IN the_DT response_NN of_IN the_DT L_NNP cell_NN to_TO luminal_JJ neutral_JJ amino_JJ acids_NNS ._. 
2-RRB-_CD ,_, including_VBG the_DT incretin_NN effect_NN which_WDT enhances_VBZ insulin_NN secretion_NN but_CC which_WDT is_VBZ impaired_VBN in_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- 3_CD -RRB-_-RRB- ._. 
Type_NN 2_CD diabetes_NN treatments_NNS have_VBP recently_RB entered_VBN the_DT market_NN ,_, aimed_VBN at_IN targeting_VBG the_DT GLP-1_JJ axis_NN by_IN either_CC inhibiting_VBG its_PRP$ rapid_JJ clearance_NN by_IN dipeptidyl-peptidase_JJ IV_NNP -LRB-_-LRB- DPP4_NNP -RRB-_-RRB- or_CC using_VBG DPP4-resistant_JJ GLP-1_NN mimetics_NNS -LRB-_-LRB- 4_CD -RRB-_-RRB- ._. 
Current_JJ research_NN is_VBZ now_RB also_RB focusing_VBG on_IN developing_VBG treatments_NNS that_WDT could_MD potentially_RB hijack_VB the_DT endogenous_JJ secretory_JJ mechanisms_NNS in_IN L_NNP cells_NNS and_CC increase_VB intestinal_JJ GLP-1_NN release_NN ._. 
Current_JJ research_NN is_VBZ now_RB also_RB focusing_VBG on_IN developing_VBG treatments_NNS that_WDT could_MD potentially_RB hijack_VB the_DT endogenous_JJ secretory_JJ mechanisms_NNS in_IN L_NNP cells_NNS and_CC increase_VB intestinal_JJ GLP-1_NN release_NN ._. 
This_DT may_MD have_VB the_DT advantage_NN that_IN hormones_NNS levels_NNS would_MD be_VB elevated_VBN in_IN the_DT neighborhood_NN of_IN the_DT intestinal_JJ epithelium_NN ,_, where_WRB GLP-1_NNP is_VBZ also_RB believed_VBN to_TO act_VB on_IN vagal_JJ afferent_JJ neurones_NNS mediating_VBG GLP-1_NN 
Arange_NNP of_IN nutrients_NNS stimulate_VBP the_DT release_NN of_IN GLP-1_NN both_DT in_IN vitro_NN and_CC in_IN vivo_NN -LRB-_-LRB- reviewed_VBN in_IN Ref_NNP ._. 
This_DT may_MD have_VB the_DT advantage_NN that_IN hormones_NNS levels_NNS would_MD be_VB elevated_VBN in_IN the_DT neighborhood_NN of_IN the_DT intestinal_JJ epithelium_NN ,_, where_WRB GLP-1_NNP is_VBZ also_RB believed_VBN to_TO act_VB on_IN vagal_JJ afferent_JJ neurones_NNS mediating_VBG GLP-1_NN 
To_TO date_NN ,_, the_DT cellular_JJ biology_NN of_IN enteroendocrine_JJ cells_NNS ,_, because_IN of_IN their_PRP$ low_JJ density_NN -LRB-_-LRB- 
All_DT reagents_NNS were_VBD supplied_VBN by_IN Sigma_NNP -LRB-_-LRB- Poole_NNP ,_, UK_NNP -RRB-_-RRB- unless_IN otherwise_RB stated_VBN ._. 
Where_WRB possible_JJ all_DT drugs_NNS were_VBD prepared_VBN as_IN a_DT 1000_CD 
Cultures_NNS were_VBD preincubated_VBN for_IN 10_CD min_NN or_CC 30_CD min_NN if_IN being_VBG cotreated_VBN with_IN channel_NN toxins_NNS or_CC antagonists_NNS ,_, respectively_RB ._. 
Secreted_VBN and_CC cellular_JJ GLP-1_NN were_VBD extracted_VBN as_RB previously_RB described_VBN -LRB-_-LRB- 7_CD -RRB-_-RRB- ,_, and_CC active_JJ GLP-1_NN was_VBD quantified_VBN using_VBG an_DT ELISA_NNP -LRB-_-LRB- Millipore_NNP ,_, Watford_NNP ,_, UK_NNP -RRB-_-RRB- ._. 
GLP-1_NN secretion_NN was_VBD expressed_VBN as_IN a_DT fraction_NN of_IN the_DT total_JJ hormone_NN -LRB-_-LRB- secreted_VBN +_RB extracted_VBN -RRB-_-RRB- measured_VBN from_IN a_DT well_NN and_CC was_VBD normalized_VBN to_TO the_DT basal_JJ secretion_NN measured_VBN under_IN control_NN conditions_NNS in_IN parallel_NN in_IN the_DT same_JJ set_NN of_IN experiments_NNS ._. 
Flow_NN cytometry_NN Venus_NNP positive_JJ cells_NNS were_VBD purified_VBN from_IN GLU-Venus_JJ colonic_JJ tissue_NN ,_, digested_VBN as_IN above_IN but_CC with_IN a_DT higher_JJR collagenase_NN concentration_NN of_IN 1_CD mg\/ml_NN in_IN Hanks_NNP '_POS Balanced_NNP Salt_NNP Solution_NN ,_, to_TO obtain_VB single_JJ cells_NNS ._. 
Cell_NN suspensions_NNS were_VBD separated_VBN using_VBG a_DT MoFlo_NNP Beckman_NNP Coulter_NNP Cytomation_NNP sorter_NN -LRB-_-LRB- 488_CD nm_NN excitation_NN -RRB-_-RRB- to_TO obtain_VB populations_NNS of_IN 
Another_DT potential_JJ fate_NN of_IN glutamine_NN is_VBZ metabolism_NN to_TO glucosamine_NN ,_, and_CC so_RB in_IN the_DT absence_NN of_IN a_DT specific_JJ inhibitor_NN of_IN glucosamine_NN synthesis_NN ,_, we_PRP examined_VBD the_DT effect_NN of_IN 10_CD m_FW m_FW glucosamine_FW itself_PRP ._. 
Glucosamine_NNP should_MD be_VB transported_VBN directly_RB into_IN L_NNP cells_NNS via_IN GLUT2_NNP ,_, which_WDT is_VBZ expressed_VBN in_IN the_DT L_NNP cell_NN -LRB-_-LRB- 7_CD -RRB-_-RRB- ._. 
However_RB ,_, direct_JJ application_NN of_IN glucosamine_NN failed_VBD to_TO stimulate_VB secretion_NN of_IN GLP-1_NN release_NN and_CC actually_RB decreased_VBD GLP-1_JJ levels_NNS below_IN basal_NN -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- ._. 
2,_CD B_NNP and_CC E_NNP -RRB-_-RRB- ,_, we_PRP examined_VBD the_DT potential_JJ involvement_NN of_IN Gq-coupled_JJ pathways_NNS ._. 
Given_VBN that_IN small_JJ rises_NNS in_IN Ca_JJ i_FW 2_CD +_NN persisted_VBD in_IN the_DT absence_NN of_IN extracellular_JJ Ca_JJ 2_CD +_CD ,_, consistent_JJ with_IN Ca_JJ 2_CD +_SYM -_: release_NN from_IN intracellular_JJ stores_NNS -LRB-_-LRB- Fig_NNP ._. 
Gq_JJ activation_NN leads_VBZ to_TO the_DT activation_NN of_IN protein_NN kinase_NN C_NNP ,_, a_DT potent_JJ secretory_JJ stimulus_NN in_IN many_JJ cell_NN types_NNS including_VBG enteroendocrine_JJ cells_NNS -LRB-_-LRB- 7_CD -RRB-_-RRB- ._. 
Inhibitors_NNS of_IN phospholipase_JJ C_NNP -LRB-_-LRB- 10_CD 
06_NNS fold_VBP ,_, comparable_JJ to_TO the_DT control_NN Gln-evoked_JJ response_NN -LRB-_-LRB- n_SYM =_SYM 6_CD ,_, Table_NNP 2_CD -RRB-_-RRB- ._. 
11_CD 
However_RB ,_, not_RB all_DT GLUTag_NNP amino_JJ acid_NN responses_NNS were_VBD reproduced_VBN in_IN the_DT primary_JJ cells_NNS :_: Ala_NNP and_CC Gly_NNP for_IN example_NN triggered_VBD GLP-1_JJ secretion_NN from_IN GLUTag_JJ cells_NNS via_IN a_DT pathway_NN involving_VBG ionotropic_JJ Gly_NNP receptors_NNS -LRB-_-LRB- 18_CD -RRB-_-RRB- ,_, but_CC we_PRP found_VBD no_DT evidence_NN for_IN this_DT pathway_NN in_IN primary_JJ colonic_JJ cultures_NNS ._. 
Lcells_NNS in_IN culture_NN display_VBP a_DT basal_JJ tone_NN of_IN electrical_JJ activity_NN ,_, observed_VBD as_RB infrequent_JJ Na_FW +_FW -_: dependent_JJ action_NN potentials_NNS -LRB-_-LRB- 7_CD -RRB-_-RRB- ,_, that_WDT maintains_VBZ a_DT background_NN level_NN of_IN GLP-1_NN secretion_NN ._. 
Clamping_VBG the_DT membrane_NN potential_NN at_IN a_DT more_RBR hyperpolarized_JJ level_NN with_IN diazoxide_NN ,_, or_CC inhibiting_VBG voltage_NN gated_VBN Na_NNP +_CD channels_NNS or_CC L_NNP -_: and_CC Q-type_JJ voltage-gated_JJ Ca_JJ 2_CD +_NN channels_NNS decreased_VBD basal_JJ GLP-1_JJ secretion_NN from_IN primary_JJ cultures_NNS -LRB-_-LRB- Rogers_NNP et_NNP al._NNP ._. 
This_DT observation_NN suggests_VBZ that_IN the_DT cAMP-dependent_JJ pathway_NN is_VBZ critical_JJ in_IN determining_VBG whether_IN an_DT amino_JJ acid_NN effectively_RB triggers_VBZ and_CC maintains_VBZ GLP-1_JJ secretion_NN over_IN a_DT 2-h_JJ incubation_NN period_NN ._. 
In_IN GLUTag_JJ cells_NNS ,_, cAMP_NNP modulates_VBZ plasma_NN membrane_NN ion_NN channels_NNS resulting_VBG in_IN depolarization_NN and_CC increased_VBN excitability_NN -LRB-_-LRB- 16_CD -RRB-_-RRB- ,_, thereby_RB tending_VBG also_RB to_TO mobilize_VB Cai2_NNP +_NNP -LRB-_-LRB- 7_CD -RRB-_-RRB- ._. 
However_RB ,_, its_PRP$ principal_JJ action_NN is_VBZ probably_RB on_IN downstream_JJ targets_NNS ,_, resulting_VBG in_IN enhanced_JJ vesicle_NN exocytosis_NN by_IN Epac_NNP -_: and_CC PKA-dependent_JJ pathways_NNS ,_, as_IN described_VBN in_IN other_JJ endocrine_NN cells_NNS -LRB-_-LRB- reviewed_VBN in_IN Ref_NNP ._. 
01_CD for_IN comparison_NN between_IN control_NN and_CC test_NN extracellular_JJ saline_NN by_IN Student_NNP 's_POS t_NN test_NN ._. 
05_CD ;_: ##_NNP ,_, P_NNP 
Therapeutic_JJ agents_NNS like_IN glutamine_NN that_WDT target_VBP synergistic_JJ pathways_NNS in_IN L_NNP cells_NNS might_MD play_VB a_DT future_JJ role_NN in_IN the_DT treatment_NN of_IN type_NN 2_CD diabetes_NN ._. 
Glucagon-like_JJ peptide_NN 1_CD -LRB-_-LRB- GLP-1_NN -RRB-_-RRB- is_VBZ synthesized_VBN in_IN and_CC secreted_VBN from_IN enteroendocrine_JJ L_NNP cells_NNS ,_, which_WDT are_VBP located_VBN throughout_IN the_DT intestine_NN but_CC predominantly_RB found_VBD more_RBR distally_RB in_IN the_DT ileum_NN and_CC colon_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- ._. 
GLP-1_NN is_VBZ released_VBN after_IN nutrient_NN ingestion_NN and_CC mediates_VBZ a_DT number_NN of_IN effects_NNS that_WDT help_VBP maintain_VB euglycemia_NN -LRB-_-LRB- reviewed_VBN in_IN Ref_NNP ._. 
GLP-1_NN is_VBZ released_VBN after_IN nutrient_NN ingestion_NN and_CC mediates_VBZ a_DT number_NN of_IN effects_NNS that_WDT help_VBP maintain_VB euglycemia_NN -LRB-_-LRB- reviewed_VBN in_IN Ref_NNP ._. 
2-RRB-_CD ,_, including_VBG the_DT incretin_NN effect_NN which_WDT enhances_VBZ insulin_NN secretion_NN but_CC which_WDT is_VBZ impaired_VBN in_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- 3_CD -RRB-_-RRB- ._. 
Type_NN 2_CD diabetes_NN treatments_NNS have_VBP recently_RB entered_VBN the_DT market_NN ,_, aimed_VBN at_IN targeting_VBG the_DT GLP-1_JJ axis_NN by_IN either_CC inhibiting_VBG its_PRP$ rapid_JJ clearance_NN by_IN dipeptidyl-peptidase_JJ IV_NNP -LRB-_-LRB- DPP4_NNP -RRB-_-RRB- or_CC using_VBG DPP4-resistant_JJ GLP-1_NN mimetics_NNS -LRB-_-LRB- 4_CD -RRB-_-RRB- ._. 
GLP-1_NN is_VBZ released_VBN after_IN nutrient_NN ingestion_NN and_CC mediates_VBZ a_DT number_NN of_IN effects_NNS that_WDT help_VBP maintain_VB euglycemia_NN -LRB-_-LRB- reviewed_VBN in_IN Ref_NNP ._. 
2-RRB-_CD ,_, including_VBG the_DT incretin_NN effect_NN which_WDT enhances_VBZ insulin_NN secretion_NN but_CC which_WDT is_VBZ impaired_VBN in_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- 3_CD -RRB-_-RRB- ._. 
Type_NN 2_CD diabetes_NN treatments_NNS have_VBP recently_RB entered_VBN the_DT market_NN ,_, aimed_VBN at_IN targeting_VBG the_DT GLP-1_JJ axis_NN by_IN either_CC inhibiting_VBG its_PRP$ rapid_JJ clearance_NN by_IN dipeptidyl-peptidase_JJ IV_NNP -LRB-_-LRB- DPP4_NNP -RRB-_-RRB- or_CC using_VBG DPP4-resistant_JJ GLP-1_NN mimetics_NNS -LRB-_-LRB- 4_CD -RRB-_-RRB- ._. 
In_IN the_DT past_JJ few_JJ years_NNS a_DT number_NN of_IN G_NNP protein_NN 
Three_CD members_NNS of_IN the_DT Class_NNP C_NNP GPCR_NNP family_NN have_VBP been_VBN shown_VBN to_TO respond_VB to_TO L-amino_JJ acids_NNS ,_, although_IN none_NN reportedly_RB show_VB a_DT preference_NN for_IN glutamine_NN :_: the_DT umami_NN taste_NN receptor_NN ,_, Tas1R1\/Tas1R3_NNP ,_, the_DT calcium-sensing_JJ receptor_NN ,_, CasR_NNP ,_, and_CC the_DT less_RBR well_RB characterized_VBN GPRC6A_NNP receptor_NN -LRB-_-LRB- for_IN review_NN ,_, see_VBP Ref_NNP ._. 
15_CD -RRB-_-RRB- ._. 
Involvement_NN of_IN the_DT former_JJ two_CD is_VBZ unlikely_JJ ,_, as_IN their_PRP$ amino_JJ acid_NN rank_NN potency_NN and_CC known_VBN downstream_JJ pathways_NNS do_VBP not_RB match_VB the_DT pattern_NN described_VBN in_IN this_DT article_NN ._. 
Our_PRP$ data_NNS therefore_RB suggest_VBP there_EX may_MD be_VB another_DT amino_JJ acid_NN receptor\/sensor_NN with_IN a_DT preference_NN for_IN Gln_NNP ,_, perhaps_RB comprising_VBG another_DT family_NN C_NNP GPCR_NNP ,_, yet_RB to_TO be_VB identified_VBN ._. 
The_DT recently_RB observed_VBD heterodimerization_NN of_IN family_NN C_NNP GPCRs_NNP ,_, which_WDT include_VBP the_DT metabotropic_JJ glutamate_JJ receptors_NNS and_CC amino_JJ acid_NN receptors_NNS -LRB-_-LRB- 15_CD -RRB-_-RRB- ,_, raises_VBZ the_DT possibility_NN that_IN a_DT glutamine-selective_JJ receptor_NN might_MD be_VB generated_VBN from_IN a_DT combination_NN of_IN different_JJ members_NNS of_IN this_DT family_NN ._. 
Table_NNP 3_CD ._. 
MicroArray_NN expression_NN of_IN amino_JJ acid_NN 
Amino_JJ acids_NNS such_JJ as_IN glutamine_NN and_CC Ala_NNP ,_, which_WDT are_VBP known_VBN substrates_NNS of_IN system_NN A_NN transporters_NNS including_VBG SNAT2_NNP ,_, increased_VBD Ca_JJ i_FW 2_CD +_NN to_TO a_DT similar_JJ degree_NN in_IN L_NNP cells_NNS ,_, consistent_JJ with_IN the_DT expression_NN of_IN slc38_CD members_NNS by_IN microarray_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
Even_RB though_IN SNAT2_NNP is_VBZ believed_VBN to_TO be_VB located_VBN basolaterally_RB -LRB-_-LRB- 19_CD -RRB-_-RRB- ,_, given_VBN the_DT high_JJ level_NN of_IN expression_NN of_IN slc38a2_CD and_CC the_DT effect_NN of_IN meAIB_NNP on_IN Cai2_NNP +_NNP in_IN L_NNP cells_NNS ,_, it_PRP is_VBZ likely_JJ that_IN this_DT member_NN of_IN the_DT Slc_NNP family_NN is_VBZ involved_VBN in_IN the_DT Gln-mediated_JJ response_NN ._. 
Interestingly_RB ,_, slc6a19_CD -LRB-_-LRB- B_NNP 0_CD AT1_NNP -RRB-_-RRB- ,_, a_DT Na_FW +_FW -_: dependent_JJ electrogenic_JJ transporter_NN ,_, was_VBD the_DT most_RBS highly_RB expressed_VBN of_IN the_DT Gln-carrying_JJ Slc_NNP members_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, and_CC was_VBD highly_RB enriched_VBN in_IN L_NNP cells_NNS compared_VBN with_IN their_PRP$ neighbors_NNS ._. 
To_TO date_NN ,_, the_DT cellular_JJ biology_NN of_IN enteroendocrine_JJ cells_NNS ,_, because_IN of_IN their_PRP$ low_JJ density_NN -LRB-_-LRB- 
Hypotheses_NNS arising_VBG from_IN the_DT study_NN of_IN cell_NN lines_NNS can_MD now_RB therefore_RB be_VB further_RB explored_VBN in_IN primary_JJ tissue_NN ._. 
Previously_RB ,_, we_PRP reported_VBD that_IN L-glutamine_NNP -LRB-_-LRB- Gln_NNP -RRB-_-RRB- stimulated_VBD secretion_NN from_IN the_DT GLP-1_NN producing_VBG cell_NN line_NN ,_, GLUTag_NNP ,_, and_CC interestingly_RB ,_, that_IN it_PRP was_VBD by_IN far_RB the_DT most_RBS effective_JJ of_IN the_DT L-amino_JJ acids_NNS tested_VBN -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
The_DT Gln-mediated_JJ response_NN appeared_VBD to_TO comprise_VB two_CD components_NNS :_: an_DT electrogenic_JJ pathway_NN generating_VBG action_NN potentials_NNS and_CC calcium_NN influx_NN ,_, proposed_VBD to_TO be_VB driven_VBN by_IN Na_FW +_FW -_: dependent_JJ amino_JJ acid_NN uptake_NN by_IN SLC38A2_NNP -LRB-_-LRB- SNAT2_NNP ,_, ATA2_NNP -RRB-_-RRB- ,_, and_CC a_DT second_JJ amplifying_VBG pathway_NN acting_VBG downstream_JJ or_CC independent_JJ of_IN membrane_NN depolarization_NN ,_, the_DT nature_NN of_IN which_WDT remained_VBD unclear_JJ ._. 
19_CD m_NN m_NN -LRB-_-LRB- n_SYM =_SYM 3_CD 
001_CD ._. 
The_DT additional_JJ effect_NN of_IN glutamine_NN was_VBD analyzed_VBN using_VBG Student_NNP 's_POS t_NN test_NN ;_: ###_NNP ,_, P_NNP 
2D_CD -RRB-_-RRB- ._. 
Na_FW +_FW containing_VBG solution_NN ,_, n_VB =_SYM 8_CD ,_, Fig_NNP ._. 
01_CD vs._NN Furthermore_RB ,_, the_DT Gln-mediated_JJ elevation_NN in_IN Ca_JJ i_FW 2_CD +_NN was_VBD dependent_JJ on_IN extracellular_JJ Na_JJ +_NN as_IN the_DT Ca_JJ 2_CD +_NN response_NN was_VBD largely_RB abolished_VBN when_WRB the_DT majority_NN of_IN the_DT Na_NNP +_NN was_VBD removed_VBN -LRB-_-LRB- P_SYM 
aCotransporter_JJ mode_NN dependent_JJ on_IN Na_FW +_FW ._. 
C,_NN cotransporter_NN ;_: E_NNP ,_, exchanger_NN ;_: F_NN ,_, facilitated_VBN transporter_NN ._. 
Glutamine_NNP stimulates_VBZ secretion_NN via_IN an_DT additional_JJ nonelectrogenic_JJ pathwayIn_NNP GLUTag_NNP cells_NNS ,_, Gln_NNP was_VBD previously_RB found_VBN to_TO potentiate_VB GLP-1_JJ secretion_NN by_IN an_DT additional_JJ pathway_NN acting_VBG downstream_JJ or_CC independent_JJ of_IN membrane_NN depolarization_NN and_CC Ca2_JJ +_NN entry_NN -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
This_DT was_VBD further_RB examined_VBN in_IN primary_JJ murine_JJ L_NNP cells_NNS ,_, by_IN performing_VBG static_JJ secretion_NN experiments_NNS in_IN the_DT presence_NN of_IN 75_CD m_FW m_FW KCl_NNP and_CC 340_CD 
This_DT appears_VBZ to_TO be_VB attributable_JJ to_TO its_PRP$ ability_NN to_TO trigger_VB two_CD independent_JJ pathways_NNS 
The_DT finding_NN that_IN the_DT Gln-evoked_JJ Ca_JJ 2_CD +_NN response_NN was_VBD markedly_RB attenuated_VBN by_IN the_DT removal_NN of_IN extracellular_JJ Na_NNP +_NN or_CC Ca_JJ 2_CD +_NN supports_VBZ the_DT involvement_NN of_IN Na_FW +_FW -_: dependent_JJ electrogenic_JJ transporters_NNS and_CC a_DT Ca_JJ 2_CD +_NN influx_NN pathway_NN in_IN mediating_VBG this_DT initial_JJ response_NN to_TO amino_JJ acids_NNS ._. 
In_IN GLUTag_JJ cells_NNS we_PRP showed_VBD previously_RB that_IN amino_JJ acid_NN transport_NN induced_VBD a_DT small_JJ Na_JJ +_NN -_: dependent_JJ inward_JJ current_NN of_IN 
Given_VBN the_DT similarities_NNS between_IN the_DT GLUTag_NNP and_CC primary_JJ L_NNP cell_NN results_NNS ,_, the_DT GLUTag_NNP cell_NN line_NN appears_VBZ a_DT valid_JJ model_NN for_IN investigating_VBG Gln-evoked_JJ signaling_VBG ._. 
However_RB ,_, not_RB all_DT GLUTag_NNP amino_JJ acid_NN responses_NNS were_VBD reproduced_VBN in_IN the_DT primary_JJ cells_NNS :_: Ala_NNP and_CC Gly_NNP for_IN example_NN triggered_VBD GLP-1_JJ secretion_NN from_IN GLUTag_JJ cells_NNS via_IN a_DT pathway_NN involving_VBG ionotropic_JJ Gly_NNP receptors_NNS -LRB-_-LRB- 18_CD -RRB-_-RRB- ,_, but_CC we_PRP found_VBD no_DT evidence_NN for_IN this_DT pathway_NN in_IN primary_JJ colonic_JJ cultures_NNS ._. 
Lcells_NNS in_IN culture_NN display_VBP a_DT basal_JJ tone_NN of_IN electrical_JJ activity_NN ,_, observed_VBD as_RB infrequent_JJ Na_FW +_FW -_: dependent_JJ action_NN potentials_NNS -LRB-_-LRB- 7_CD -RRB-_-RRB- ,_, that_WDT maintains_VBZ a_DT background_NN level_NN of_IN GLP-1_NN secretion_NN ._. 
01_CD compared_VBN with_IN KCl\/diazoxide_NNP control_NN by_IN Student_NNP 's_POS t_NN test_NN ._. 
\*\*_SYM ,_, P_SYM 
Because_IN the_DT physiochemical_JJ properties_NNS of_IN GCs_NNP suggested_VBD that_IN they_PRP could_MD quickly_RB cross_VB cellular_JJ membranes_NNS ,_, it_PRP was_VBD assumed_VBN that_IN they_PRP would_MD also_RB easily_RB enter_VBP the_DT CNS_NNP by_IN passive_JJ diffusion_NN ._. 
It_PRP is_VBZ now_RB known_VBN that_IN GCs_NNP also_RB interact_VBP with_IN glucose_NN transporters_NNS in_IN human_JJ cells_NNS -LRB-_-LRB- 9_CD 
The_DT presence_NN of_IN digoxin_NN was_VBD also_RB able_JJ to_TO reduce_VB the_DT distribution_NN of_IN 
Because_IN the_DT physiochemical_JJ properties_NNS of_IN GCs_NNP suggested_VBD that_IN they_PRP could_MD quickly_RB cross_VB cellular_JJ membranes_NNS ,_, it_PRP was_VBD assumed_VBN that_IN they_PRP would_MD also_RB easily_RB enter_VBP the_DT CNS_NNP by_IN passive_JJ diffusion_NN ._. 
It_PRP is_VBZ now_RB known_VBN that_IN GCs_NNP also_RB interact_VBP with_IN glucose_NN transporters_NNS in_IN human_JJ cells_NNS -LRB-_-LRB- 9_CD 
The_DT contribution_NN of_IN these_DT transporters_NNS to_TO GC_NNP physiology_NN is_VBZ still_RB unclear_JJ ,_, partly_RB because_IN of_IN the_DT different_JJ techniques_NNS used_VBN to_TO examine_VB this_DT issue_NN ,_, as_IN discussed_VBN in_IN detail_NN in_IN our_PRP$ previous_JJ work_NN -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
For_IN example_NN ,_, experiments_NNS using_VBG whole-body_JJ distribution_NN methods_NNS after_IN peripheral_JJ injection_NN of_IN radioactive_JJ GCs_NNS in_IN mice_NNS initially_RB suggested_VBD that_IN the_DT efflux_NN transporter_NN ,_, P-gp_NNP ,_, restricts_VBZ the_DT access_NN of_IN cortisol_NN and_CC corticosterone_NN to_TO the_DT murine_NN brain_NN -LRB-_-LRB- 25_CD ,_, 26_CD -RRB-_-RRB- and_CC is_VBZ also_RB implicated_VBN in_IN the_DT regulation_NN of_IN the_DT HPA_NNP axis_NNS -LRB-_-LRB- 14_CD ,_, 15_CD -RRB-_-RRB- ._. 
However_RB ,_, our_PRP$ recent_JJ results_NNS obtained_VBN from_IN murine_JJ brain_NN distribution_NN studies_NNS using_VBG direct_JJ brain_NN perfusion_NN show_NN that_IN P-gp_NNP restricts_VBZ the_DT accumulation_NN of_IN 
Because_IN the_DT physiochemical_JJ properties_NNS of_IN GCs_NNP suggested_VBD that_IN they_PRP could_MD quickly_RB cross_VB cellular_JJ membranes_NNS ,_, it_PRP was_VBD assumed_VBN that_IN they_PRP would_MD also_RB easily_RB enter_VBP the_DT CNS_NNP by_IN passive_JJ diffusion_NN ._. 
It_PRP is_VBZ now_RB known_VBN that_IN GCs_NNP also_RB interact_VBP with_IN glucose_NN transporters_NNS in_IN human_JJ cells_NNS -LRB-_-LRB- 9_CD 
The_DT contribution_NN of_IN these_DT transporters_NNS to_TO GC_NNP physiology_NN is_VBZ still_RB unclear_JJ ,_, partly_RB because_IN of_IN the_DT different_JJ techniques_NNS used_VBN to_TO examine_VB this_DT issue_NN ,_, as_IN discussed_VBN in_IN detail_NN in_IN our_PRP$ previous_JJ work_NN -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
For_IN example_NN ,_, experiments_NNS using_VBG whole-body_JJ distribution_NN methods_NNS after_IN peripheral_JJ injection_NN of_IN radioactive_JJ GCs_NNS in_IN mice_NNS initially_RB suggested_VBD that_IN the_DT efflux_NN transporter_NN ,_, P-gp_NNP ,_, restricts_VBZ the_DT access_NN of_IN cortisol_NN and_CC corticosterone_NN to_TO the_DT murine_NN brain_NN -LRB-_-LRB- 25_CD ,_, 26_CD -RRB-_-RRB- and_CC is_VBZ also_RB implicated_VBN in_IN the_DT regulation_NN of_IN the_DT HPA_NNP axis_NNS -LRB-_-LRB- 14_CD ,_, 15_CD -RRB-_-RRB- ._. 
However_RB ,_, our_PRP$ recent_JJ results_NNS obtained_VBN from_IN murine_JJ brain_NN distribution_NN studies_NNS using_VBG direct_JJ brain_NN perfusion_NN show_NN that_IN P-gp_NNP restricts_VBZ the_DT accumulation_NN of_IN 
Because_IN the_DT physiochemical_JJ properties_NNS of_IN GCs_NNP suggested_VBD that_IN they_PRP could_MD quickly_RB cross_VB cellular_JJ membranes_NNS ,_, it_PRP was_VBD assumed_VBN that_IN they_PRP would_MD also_RB easily_RB enter_VBP the_DT CNS_NNP by_IN passive_JJ diffusion_NN ._. 
It_PRP is_VBZ now_RB known_VBN that_IN GCs_NNP also_RB interact_VBP with_IN glucose_NN transporters_NNS in_IN human_JJ cells_NNS -LRB-_-LRB- 9_CD 
-LRB-_-LRB- 41_CD -RRB-_-RRB- may_MD have_VB effects_NNS on_IN the_DT oat_NN ,_, oatp_NN ,_, or_CC multidrug_JJ resistance_NN associated_VBN protein_NN transporter_NN families_NNS ,_, also_RB making_VBG these_DT transporters_NNS candidates_NNS for_IN those_DT mechanisms_NNS seen_VBN here_RB ._. 
Furthermore_RB ,_, GRs_NNS have_VBP been_VBN shown_VBN to_TO modulate_VB or_CC inhibit_VB the_DT transport_NN of_IN known_JJ substrates_NNS of_IN glucose_NN transporters_NNS in_IN rodent_NN and_CC human_JJ cells_NNS -LRB-_-LRB- 9_CD 
Because_IN the_DT physiochemical_JJ properties_NNS of_IN GCs_NNP suggested_VBD that_IN they_PRP could_MD quickly_RB cross_VB cellular_JJ membranes_NNS ,_, it_PRP was_VBD assumed_VBN that_IN they_PRP would_MD also_RB easily_RB enter_VBP the_DT CNS_NNP by_IN passive_JJ diffusion_NN ._. 
It_PRP is_VBZ now_RB known_VBN that_IN GCs_NNP also_RB interact_VBP with_IN glucose_NN transporters_NNS in_IN human_JJ cells_NNS -LRB-_-LRB- 9_CD 
These_DT transporters_NNS have_VBP been_VBN identified_VBN at_IN the_DT rodent_NN and_CC human_JJ BBB_NNP and_CC choroid_JJ plexuses_NNS -LRB-_-LRB- 18_CD 
For_IN example_NN ,_, experiments_NNS using_VBG whole-body_JJ distribution_NN methods_NNS after_IN peripheral_JJ injection_NN of_IN radioactive_JJ GCs_NNS in_IN mice_NNS initially_RB suggested_VBD that_IN the_DT efflux_NN transporter_NN ,_, P-gp_NNP ,_, restricts_VBZ the_DT access_NN of_IN cortisol_NN and_CC corticosterone_NN to_TO the_DT murine_NN brain_NN -LRB-_-LRB- 25_CD ,_, 26_CD -RRB-_-RRB- and_CC is_VBZ also_RB implicated_VBN in_IN the_DT regulation_NN of_IN the_DT HPA_NNP axis_NNS -LRB-_-LRB- 14_CD ,_, 15_CD -RRB-_-RRB- ._. 
However_RB ,_, our_PRP$ recent_JJ results_NNS obtained_VBN from_IN murine_JJ brain_NN distribution_NN studies_NNS using_VBG direct_JJ brain_NN perfusion_NN show_NN that_IN P-gp_NNP restricts_VBZ the_DT accumulation_NN of_IN 
However_RB ,_, our_PRP$ recent_JJ results_NNS obtained_VBN from_IN murine_JJ brain_NN distribution_NN studies_NNS using_VBG direct_JJ brain_NN perfusion_NN show_NN that_IN P-gp_NNP restricts_VBZ the_DT accumulation_NN of_IN 
Indeed_RB ,_, after_IN systemic_JJ administration_NN of_IN these_DT GCs_NNS ,_, we_PRP also_RB showed_VBD the_DT presence_NN of_IN radiolabeled_JJ by-products_NNS in_IN the_DT plasma_NN ,_, which_WDT would_MD make_VB accurate_JJ data_NNS interpretation_NN in_IN the_DT initial_JJ 2001_CD and_CC 2003_CD studies_NNS difficult_JJ -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
In_IN this_DT study_NN ,_, we_PRP extend_VBP our_PRP$ investigation_NN of_IN the_DT transport_NN of_IN GCs_NNS across_IN the_DT BBB_NNP -LRB-_-LRB- 13_CD -RRB-_-RRB- to_TO that_DT of_IN GC_NNP transport_NN across_IN the_DT BCSFB_NNP and_CC nonbarrier_JJ regions_NNS in_IN wild-type_JJ controls_NNS and_CC P-gp-deficient_JJ mice_NNS ._. 
This_DT allowed_JJ exploration_NN of_IN the_DT influence_NN of_IN P-gp_NNP on_IN CNS_NNP delivery_NN via_IN routes_NNS other_JJ than_IN the_DT BBB_NNP ._. 
We_PRP then_RB explore_VBP the_DT interaction_NN of_IN GCs_NNS with_IN transporters_NNS other_JJ than_IN P-gp_JJ at_IN the_DT level_NN of_IN both_DT the_DT BBB_NNP and_CC BCSFB_NNP barriers_NNS ._. 
The_DT body_NN cavity_NN was_VBD opened_VBN and_CC the_DT left_JJ ventricle_NN cannulated_VBN with_IN a_DT fine_JJ needle_NN -LRB-_-LRB- 25_CD gauge_NN -RRB-_-RRB- connected_VBN to_TO a_DT perfusion_NN circuit_NN ._. 
AWatson-Marlow_JJ peristaltic_JJ pump_NN -LRB-_-LRB- 323S\/RL_CD ;_: Watson-Marlow_NNP ,_, Falmouth_NNP ,_, UK_NNP -RRB-_-RRB- was_VBD used_VBN to_TO perfuse_VB the_DT heart_NN in_IN situ_NN with_IN a_DT modified_VBN Krebs-Henseleit_NNP mammalian_JJ Ringer_NN solution_NN as_IN detailed_VBN previously_RB -LRB-_-LRB- 13_CD -RRB-_-RRB- ,_, which_WDT was_VBD warmed_VBN -LRB-_-LRB- 37_CD C_NNP -RRB-_-RRB- and_CC oxygenated_VBN -LRB-_-LRB- 95_CD %_NN O2_CD ,_, 5_CD %_NN CO2_CD -RRB-_-RRB- ._. 
With_IN the_DT start_NN of_IN perfusion_NN -LRB-_-LRB- 5_CD ._. 
0ml\/min_CD -RRB-_-RRB- ,_, the_DT right_JJ atrium_NN was_VBD sectioned_VBN to_TO create_VB an_DT open_JJ circuit_NN and_CC allow_VB drainage_NN of_IN the_DT artificial_JJ plasma_NN ._. 
Interactions_NNS of_IN 
Interactions_NNS of_IN 
The_DT presence_NN of_IN 
Interestingly_RB ,_, the_DT distribution_NN of_IN cortisol_NN in_IN the_DT hypothalamus_NN and_CC cerebellum_NN was_VBD actually_RB increased_VBN in_IN the_DT presence_NN of_IN 300_CD 
This_DT increase_NN indicated_VBD the_DT presence_NN of_IN an_DT efflux_NN mechanism_NN and_CC the_DT identification_NN of_IN an_DT efflux_JJ mechanism_NN in_IN the_DT hypothalamus_NN is_VBZ consistent_JJ with_IN the_DT previously_RB published_VBN multiple_JJ time-point_JJ perfusion_NN data_NNS that_IN identified_VBN efflux_NN by_IN P-gp_NNP in_IN this_DT region_NN -LRB-_-LRB- 13_CD -RRB-_-RRB- ,_, although_IN it_PRP can_MD not_RB be_VB confirmed_VBN that_IN the_DT mechanism_NN seen_VBN in_IN these_DT cross-competition_JJ studies_NNS is_VBZ P-gp_JJ ._. 
Our_PRP$ previous_JJ multiple_JJ time-point_JJ perfusion_NN data_NNS obtained_VBN in_IN mice_NNS did_VBD not_RB detect_VB efflux_NN by_IN P-gp_NNP in_IN the_DT cerebellum_NN -LRB-_-LRB- 13_CD -RRB-_-RRB- ,_, which_WDT suggests_VBZ that_IN 1_CD -RRB-_-RRB- another_DT efflux_NN transporter_NN that_WDT can_MD efflux_VB cortisol_NN may_MD be_VB present_JJ in_IN this_DT region_NN ,_, 2_CD -RRB-_-RRB- P-gp_NN is_VBZ present_JJ in_IN 
If_IN corticosterone_NN is_VBZ in_IN fact_NN inhibiting_VBG P-gp_NNP ,_, this_DT could_MD explain_VB why_WRB an_DT increase_NN in_IN 
It_PRP is_VBZ now_RB known_VBN that_IN GCs_NNP also_RB interact_VBP with_IN glucose_NN transporters_NNS in_IN human_JJ cells_NNS -LRB-_-LRB- 9_CD 
Unlabeled_JJ digoxin_NN We_PRP specifically_RB investigated_VBD the_DT contribution_NN of_IN oatp2_CD ,_, using_VBG its_PRP$ inhibitor_NN ,_, digoxin_NN ._. 
Oatp2_NNP has_VBZ been_VBN detected_VBN in_IN choroidal_JJ epithelium_NN ,_, likely_RB localized_VBN to_TO the_DT apical_JJ membrane_NN -LRB-_-LRB- or_CC subapically_RB -RRB-_-RRB- -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- and_CC is_VBZ also_RB found_VBN in_IN murine_JJ brain_NN capilliaries_NNS -LRB-_-LRB- 21_CD ,_, 22_CD -RRB-_-RRB- ,_, where_WRB it_PRP bidirectionally_RB transports_VBZ substrates_NNS -LRB-_-LRB- 32_CD -RRB-_-RRB- ._. 
Also_RB ,_, oatp2_NN has_VBZ been_VBN shown_VBN to_TO efflux_VB the_DT neuroactive_JJ steroid_JJ dehydroepiandrosterone_NN sulfate_NN -LRB-_-LRB- 33_CD -RRB-_-RRB- ,_, thus_RB oatp2_CD was_VBD hypothesized_VBN to_TO be_VB the_DT transporter_NN possibly_RB detected_VBD in_IN these_DT self-inhibition_JJ and_CC cross-competition_JJ studies_NNS in_IN wild-type_JJ mice_NNS ._. 
The_DT brain\/choroid_NN plexus_VBZ perfusion_NN method_NN used_VBN in_IN this_DT present_JJ study_NN is_VBZ designed_VBN to_TO detect_VB transport_NN ,_, thus_RB the_DT likelihood_NN is_VBZ that_IN this_DT decrease_NN that_WDT is_VBZ seen_VBN in_IN the_DT distribution_NN of_IN 
This_DT could_MD be_VB due_JJ to_TO differences_NNS in_IN the_DT affinity_NN of_IN this_DT transporter_NN for_IN cortisol_NN and_CC corticosterone_NN and_CC \/_NN or_CC suggests_VBZ that_IN there_EX is_VBZ inhibition_NN of_IN a_DT bidirectional_JJ transporter_NN or_CC indicates_VBZ the_DT presence_NN of_IN separate_JJ influx_NN and_CC efflux_NN transporters_NNS ._. 
Potentially_RB ,_, this_DT difference_NN could_MD implicate_VB P-gp_NNP ,_, because_IN corticosterone_NN has_VBZ been_VBN identified_VBN as_IN a_DT suspected_JJ inhibitor_NN of_IN P-gp_NNP ,_, rather_RB than_IN a_DT substrate_NN -LRB-_-LRB- 39_CD -RRB-_-RRB- ._. 
If_IN corticosterone_NN is_VBZ in_IN fact_NN inhibiting_VBG P-gp_NNP ,_, this_DT could_MD explain_VB why_WRB an_DT increase_NN in_IN cortisol_NN accumulation_NN could_MD be_VB seen_VBN with_IN the_DT combination_NN of_IN cortisol_NN and_CC corticosterone_NN and_CC not_RB with_IN cortisol_NN alone_RB ._. 
In_IN support_NN of_IN our_PRP$ data_NNS ,_, a_DT recent_JJ article_NN investigating_VBG P-gp_NN at_IN the_DT BCSFB_NNP revealed_VBD a_DT lower_JJR level_NN of_IN P-gp_JJ expression_NN in_IN the_DT rat_NN and_CC human_JJ choroid_NN plexuses_NNS compared_VBN with_IN brain_NN microvessels_NNS using_VBG immunohistochemical_JJ analysis_NN with_IN the_DT P-gp-specific_JJ murine_NN antibody_NN C219_NNP -LRB-_-LRB- 5_CD -RRB-_-RRB- ,_, which_WDT suggests_VBZ a_DT reduced_JJ contribution_NN of_IN P-gp_NNP in_IN the_DT transport_NN of_IN its_PRP$ substrates_NNS across_IN the_DT BCSFB_NNP ._. 
P-gp_NN has_VBZ been_VBN detected_VBN in_IN porcine_NN and_CC rodent_NN choroid_NN plexuses_NNS previously_RB -LRB-_-LRB- 24_CD ,_, 34_CD -RRB-_-RRB- ,_, and_CC evidence_NN of_IN P-gp_JJ activity_NN at_IN the_DT choroid_JJ plexus_NN has_VBZ been_VBN seen_VBN -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
To_TO further_RBR investigate_VB the_DT activity_NN of_IN P-gp_NN at_IN the_DT BCSF_NNP barrier_NN ,_, 99m_FW Tc-sestamibi_FW ,_, a_DT nonmetabolized_JJ pharmaceutical_NN that_WDT is_VBZ known_VBN to_TO be_VB transported_VBN by_IN both_DT human_JJ P-gp_JJ and_CC multidrug_JJ resistance_NN associated_VBN protein_NN 1_CD -LRB-_-LRB- 24_CD -RRB-_-RRB- ,_, was_VBD injected_VBN into_IN the_DT mouse_NN tail_NN vein_NN ._. 
In_IN support_NN of_IN our_PRP$ data_NNS ,_, a_DT recent_JJ article_NN investigating_VBG P-gp_NN at_IN the_DT BCSFB_NNP revealed_VBD a_DT lower_JJR level_NN of_IN P-gp_JJ expression_NN in_IN the_DT rat_NN and_CC human_JJ choroid_NN plexuses_NNS compared_VBN with_IN brain_NN microvessels_NNS using_VBG immunohistochemical_JJ analysis_NN with_IN the_DT P-gp-specific_JJ murine_NN antibody_NN C219_NNP -LRB-_-LRB- 5_CD -RRB-_-RRB- ,_, which_WDT suggests_VBZ a_DT reduced_JJ contribution_NN of_IN P-gp_NNP in_IN the_DT transport_NN of_IN its_PRP$ substrates_NNS across_IN the_DT BCSFB_NNP ._. 
P-gp_NN has_VBZ been_VBN detected_VBN in_IN porcine_NN and_CC rodent_NN choroid_NN plexuses_NNS previously_RB -LRB-_-LRB- 24_CD ,_, 34_CD -RRB-_-RRB- ,_, and_CC evidence_NN of_IN P-gp_JJ activity_NN at_IN the_DT choroid_JJ plexus_NN has_VBZ been_VBN seen_VBN -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
To_TO further_RBR investigate_VB the_DT activity_NN of_IN P-gp_NN at_IN the_DT BCSF_NNP barrier_NN ,_, 99m_FW Tc-sestamibi_FW ,_, a_DT nonmetabolized_JJ pharmaceutical_NN that_WDT is_VBZ known_VBN to_TO be_VB transported_VBN by_IN both_DT human_JJ P-gp_JJ and_CC multidrug_JJ resistance_NN associated_VBN protein_NN 1_CD -LRB-_-LRB- 24_CD -RRB-_-RRB- ,_, was_VBD injected_VBN into_IN the_DT mouse_NN tail_NN vein_NN ._. 
Together_RB ,_, these_DT findings_NNS support_VBP our_PRP$ results_NNS and_CC provide_VB evidence_NN that_IN P-gp_NNP exerts_VBZ a_DT negligible_JJ effect_NN in_IN the_DT distribution_NN of_IN 
Together_RB ,_, these_DT findings_NNS support_VBP our_PRP$ results_NNS and_CC provide_VB evidence_NN that_IN P-gp_NNP exerts_VBZ a_DT negligible_JJ effect_NN in_IN the_DT distribution_NN of_IN 
e._NN 
Self-inhibition_NN studies_NNS Single_VBP time-point_JJ perfusions_NNS -LRB-_-LRB- 20_CD min_NN -RRB-_-RRB- were_VBD conducted_VBN in_IN FVB-abcb1a_JJ \/_NN b_NN -LRB-_-LRB- +_FW \/_FW +_FW -RRB-_-RRB- mice_NNS ,_, i._VBP wild-type_JJ controls_NNS ,_, with_IN cortisol_NN in_IN the_DT presence_NN of_IN an_DT excess_NN of_IN unlabeled_JJ cortisol_NN -LRB-_-LRB- 30_CD or_CC 300_CD 
Because_IN the_DT unlabeled_JJ corticosterone_NN is_VBZ present_JJ in_IN an_DT extremely_RB high_JJ concentration_NN ,_, it_PRP is_VBZ likely_JJ that_IN the_DT overall_JJ concentration_NN of_IN corticosterone_NN that_WDT could_MD be_VB detected_VBN in_IN these_DT regions_NNS would_MD be_VB reduced_VBN ._. 
The_DT 30_CD 
1_CD 
Unlabeled_JJ digoxin_NN We_PRP specifically_RB investigated_VBD the_DT contribution_NN of_IN oatp2_CD ,_, using_VBG its_PRP$ inhibitor_NN ,_, digoxin_NN ._. 
Oatp2_NNP has_VBZ been_VBN detected_VBN in_IN choroidal_JJ epithelium_NN ,_, likely_RB localized_VBN to_TO the_DT apical_JJ membrane_NN -LRB-_-LRB- or_CC subapically_RB -RRB-_-RRB- -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- and_CC is_VBZ also_RB found_VBN in_IN murine_JJ brain_NN capilliaries_NNS -LRB-_-LRB- 21_CD ,_, 22_CD -RRB-_-RRB- ,_, where_WRB it_PRP bidirectionally_RB transports_VBZ substrates_NNS -LRB-_-LRB- 32_CD -RRB-_-RRB- ._. 
Also_RB ,_, oatp2_NN has_VBZ been_VBN shown_VBN to_TO efflux_VB the_DT neuroactive_JJ steroid_JJ dehydroepiandrosterone_NN sulfate_NN -LRB-_-LRB- 33_CD -RRB-_-RRB- ,_, thus_RB oatp2_CD was_VBD hypothesized_VBN to_TO be_VB the_DT transporter_NN possibly_RB detected_VBD in_IN these_DT self-inhibition_JJ and_CC cross-competition_JJ studies_NNS in_IN wild-type_JJ mice_NNS ._. 
Oatp2_NNP has_VBZ been_VBN detected_VBN in_IN choroidal_JJ epithelium_NN ,_, likely_RB localized_VBN to_TO the_DT apical_JJ membrane_NN -LRB-_-LRB- or_CC subapically_RB -RRB-_-RRB- -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- and_CC is_VBZ also_RB found_VBN in_IN murine_JJ brain_NN capilliaries_NNS -LRB-_-LRB- 21_CD ,_, 22_CD -RRB-_-RRB- ,_, where_WRB it_PRP bidirectionally_RB transports_VBZ substrates_NNS -LRB-_-LRB- 32_CD -RRB-_-RRB- ._. 
Also_RB ,_, oatp2_NN has_VBZ been_VBN shown_VBN to_TO efflux_VB the_DT neuroactive_JJ steroid_JJ dehydroepiandrosterone_NN sulfate_NN -LRB-_-LRB- 33_CD -RRB-_-RRB- ,_, thus_RB oatp2_CD was_VBD hypothesized_VBN to_TO be_VB the_DT transporter_NN possibly_RB detected_VBD in_IN these_DT self-inhibition_JJ and_CC cross-competition_JJ studies_NNS in_IN wild-type_JJ mice_NNS ._. 
The_DT presence_NN of_IN digoxin_NN was_VBD also_RB able_JJ to_TO reduce_VB the_DT distribution_NN of_IN 
In_IN an_DT in_IN vivo_NN system_NN ,_, the_DT presence_NN of_IN corticosterone_JJ binding_JJ globulin_NN in_IN the_DT plasma_NN and_CC the_DT action_NN of_IN 11_CD 
However_RB ,_, it_PRP is_VBZ a_DT limitation_NN of_IN this_DT study_NN that_IN all_DT of_IN our_PRP$ perfusion_NN experiments_NNS were_VBD conducted_VBN at_IN a_DT single_JJ concentration_NN ,_, and_CC experiments_NNS investigating_VBG the_DT accumulation_NN of_IN corticosterone_NN ,_, as_RB well_RB as_IN cortisol_NN ,_, at_IN differing_VBG concentrations_NNS would_MD yield_VB valuable_JJ data_NNS ._. 
In_IN an_DT in_IN vivo_NN system_NN ,_, the_DT presence_NN of_IN corticosterone_JJ binding_JJ globulin_NN in_IN the_DT plasma_NN and_CC the_DT action_NN of_IN 11_CD 
-LRB-_-LRB- 41_CD -RRB-_-RRB- may_MD have_VB effects_NNS on_IN the_DT oat_NN ,_, oatp_NN ,_, or_CC multidrug_JJ resistance_NN associated_VBN protein_NN transporter_NN families_NNS ,_, also_RB making_VBG these_DT transporters_NNS candidates_NNS for_IN those_DT mechanisms_NNS seen_VBN here_RB ._. 
Furthermore_RB ,_, GRs_NNS have_VBP been_VBN shown_VBN to_TO modulate_VB or_CC inhibit_VB the_DT transport_NN of_IN known_JJ substrates_NNS of_IN glucose_NN transporters_NNS in_IN rodent_NN and_CC human_JJ cells_NNS -LRB-_-LRB- 9_CD 
Washout_NN studies_NNS would_MD also_RB provide_VB clarification_NN to_TO the_DT question_NN of_IN retention_NN of_IN GCs_NNP in_IN these_DT tissues_NNS ,_, but_CC it_PRP is_VBZ unlikely_JJ that_IN the_DT retention_NN times_NNS of_IN GCs_NNS by_IN those_DT tissues_NNS highly_RB expressing_VBG MR_NNP or_CC GR_NNP would_MD differ_VB from_IN those_DT tissues_NNS that_WDT do_VBP not_RB ._. 
As_IN plasma_NN corticosterone_NN levels_NNS in_IN humans_NNS are_VBP only_RB 5_CD %_NN of_IN the_DT circulating_VBG cortisol_NN concentrations_NNS ,_, but_CC the_DT concentrations_NNS of_IN corticosterone_NN in_IN brain_NN are_VBP 30_CD %_NN of_IN brain_NN cortisol_NN -LRB-_-LRB- 26_CD -RRB-_-RRB- ,_, this_DT would_MD indicate_VB that_IN there_EX is_VBZ differential_JJ entry_NN of_IN these_DT hormones_NNS ,_, possibly_RB by_IN some_DT of_IN the_DT mechanisms_NNS identified_VBN here_RB ,_, and_CC changes_NNS in_IN their_PRP$ accumulation_NN could_MD be_VB an_DT underlying_JJ problem_NN in_IN HPA_NNP axis_NNS regulation_NN in_IN humans_NNS during_IN stress_NN -LRB-_-LRB- 46_CD -RRB-_-RRB- ._. 
In_IN conclusion_NN ,_, P-gp_NN does_VBZ not_RB majorly_RB regulate_VB the_DT access_NN of_IN 
The_DT presence_NN of_IN digoxin_NN was_VBD also_RB able_JJ to_TO reduce_VB the_DT distribution_NN of_IN 
The_DT broadly_RB selective_JJ inhibitor_NN probenecid_NN used_VBN by_IN Steffgen_NNP et_FW al._FW ._. 
However_RB ,_, not_RB all_DT of_IN the_DT transport_NN mechanisms_NNS that_WDT were_VBD detected_VBN in_IN the_DT studies_NNS can_MD be_VB identified_VBN as_IN mediated_VBN by_IN oatp2_CD ._. 
-LRB-_-LRB- 41_CD -RRB-_-RRB- may_MD have_VB effects_NNS on_IN the_DT oat_NN ,_, oatp_NN ,_, or_CC multidrug_JJ resistance_NN associated_VBN protein_NN transporter_NN families_NNS ,_, also_RB making_VBG these_DT transporters_NNS candidates_NNS for_IN those_DT mechanisms_NNS seen_VBN here_RB ._. 
Furthermore_RB ,_, GRs_NNS have_VBP been_VBN shown_VBN to_TO modulate_VB or_CC inhibit_VB the_DT transport_NN of_IN known_JJ substrates_NNS of_IN glucose_NN transporters_NNS in_IN rodent_NN and_CC human_JJ cells_NNS -LRB-_-LRB- 9_CD 
The_DT presence_NN of_IN digoxin_NN was_VBD also_RB able_JJ to_TO reduce_VB the_DT distribution_NN of_IN 
-LRB-_-LRB- 41_CD -RRB-_-RRB- may_MD have_VB effects_NNS on_IN the_DT oat_NN ,_, oatp_NN ,_, or_CC multidrug_JJ resistance_NN associated_VBN protein_NN transporter_NN families_NNS ,_, also_RB making_VBG these_DT transporters_NNS candidates_NNS for_IN those_DT mechanisms_NNS seen_VBN here_RB ._. 
Furthermore_RB ,_, GRs_NNS have_VBP been_VBN shown_VBN to_TO modulate_VB or_CC inhibit_VB the_DT transport_NN of_IN known_JJ substrates_NNS of_IN glucose_NN transporters_NNS in_IN rodent_NN and_CC human_JJ cells_NNS -LRB-_-LRB- 9_CD 
e._NN 
Self-inhibition_NN studies_NNS Single_VBP time-point_JJ perfusions_NNS -LRB-_-LRB- 20_CD min_NN -RRB-_-RRB- were_VBD conducted_VBN in_IN FVB-abcb1a_JJ \/_NN b_NN -LRB-_-LRB- +_FW \/_FW +_FW -RRB-_-RRB- mice_NNS ,_, i._VBP wild-type_JJ controls_NNS ,_, with_IN cortisol_NN in_IN the_DT presence_NN of_IN an_DT excess_NN of_IN unlabeled_JJ cortisol_NN -LRB-_-LRB- 30_CD or_CC 300_CD 
Because_IN the_DT unlabeled_JJ corticosterone_NN is_VBZ present_JJ in_IN an_DT extremely_RB high_JJ concentration_NN ,_, it_PRP is_VBZ likely_JJ that_IN the_DT overall_JJ concentration_NN of_IN corticosterone_NN that_WDT could_MD be_VB detected_VBN in_IN these_DT regions_NNS would_MD be_VB reduced_VBN ._. 
The_DT 30_CD 
We_PRP then_RB explore_VBP the_DT interaction_NN of_IN GCs_NNS with_IN transporters_NNS other_JJ than_IN P-gp_JJ at_IN the_DT level_NN of_IN both_DT the_DT BBB_NNP and_CC BCSFB_NNP barriers_NNS ._. 
The_DT method_NN used_VBN is_VBZ a_DT well-established_JJ brain\/choroid_JJ plexus_NN perfusion_NN technique_NN in_IN anesthetized_JJ mice_NNS that_WDT allows_VBZ perfusion_NN of_IN both_DT cerebral_JJ hemispheres_NNS and_CC consequent_JJ examination_NN of_IN molecule_NN movement_NN across_IN the_DT BBB_NNP and_CC the_DT BCSFB_NNP -LRB-_-LRB- 27_CD -RRB-_-RRB- ._. 
Materials_NNPS and_CC Methods_NNPS Materials_NNPS Radiolabeled_NNP substances_NNS cortisol_NN -LRB-_-LRB- 74_CD ._. 
0Ci\/mmol_NNP -RRB-_-RRB- and_CC 
When_WRB the_DT 
The_DT contribution_NN of_IN these_DT transporters_NNS to_TO GC_NNP physiology_NN is_VBZ still_RB unclear_JJ ,_, partly_RB because_IN of_IN the_DT different_JJ techniques_NNS used_VBN to_TO examine_VB this_DT issue_NN ,_, as_IN discussed_VBN in_IN detail_NN in_IN our_PRP$ previous_JJ work_NN -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
For_IN example_NN ,_, experiments_NNS using_VBG whole-body_JJ distribution_NN methods_NNS after_IN peripheral_JJ injection_NN of_IN radioactive_JJ GCs_NNS in_IN mice_NNS initially_RB suggested_VBD that_IN the_DT efflux_NN transporter_NN ,_, P-gp_NNP ,_, restricts_VBZ the_DT access_NN of_IN cortisol_NN and_CC corticosterone_NN to_TO the_DT murine_NN brain_NN -LRB-_-LRB- 25_CD ,_, 26_CD -RRB-_-RRB- and_CC is_VBZ also_RB implicated_VBN in_IN the_DT regulation_NN of_IN the_DT HPA_NNP axis_NNS -LRB-_-LRB- 14_CD ,_, 15_CD -RRB-_-RRB- ._. 
However_RB ,_, our_PRP$ recent_JJ results_NNS obtained_VBN from_IN murine_JJ brain_NN distribution_NN studies_NNS using_VBG direct_JJ brain_NN perfusion_NN show_NN that_IN P-gp_NNP restricts_VBZ the_DT accumulation_NN of_IN 
Washout_NN studies_NNS would_MD also_RB provide_VB clarification_NN to_TO the_DT question_NN of_IN retention_NN of_IN GCs_NNP in_IN these_DT tissues_NNS ,_, but_CC it_PRP is_VBZ unlikely_JJ that_IN the_DT retention_NN times_NNS of_IN GCs_NNS by_IN those_DT tissues_NNS highly_RB expressing_VBG MR_NNP or_CC GR_NNP would_MD differ_VB from_IN those_DT tissues_NNS that_WDT do_VBP not_RB ._. 
As_IN plasma_NN corticosterone_NN levels_NNS in_IN humans_NNS are_VBP only_RB 5_CD %_NN of_IN the_DT circulating_VBG cortisol_NN concentrations_NNS ,_, but_CC the_DT concentrations_NNS of_IN corticosterone_NN in_IN brain_NN are_VBP 30_CD %_NN of_IN brain_NN cortisol_NN -LRB-_-LRB- 26_CD -RRB-_-RRB- ,_, this_DT would_MD indicate_VB that_IN there_EX is_VBZ differential_JJ entry_NN of_IN these_DT hormones_NNS ,_, possibly_RB by_IN some_DT of_IN the_DT mechanisms_NNS identified_VBN here_RB ,_, and_CC changes_NNS in_IN their_PRP$ accumulation_NN could_MD be_VB an_DT underlying_JJ problem_NN in_IN HPA_NNP axis_NNS regulation_NN in_IN humans_NNS during_IN stress_NN -LRB-_-LRB- 46_CD -RRB-_-RRB- ._. 
In_IN conclusion_NN ,_, P-gp_NN does_VBZ not_RB majorly_RB regulate_VB the_DT access_NN of_IN 
The_DT contribution_NN of_IN these_DT transporters_NNS to_TO GC_NNP physiology_NN is_VBZ still_RB unclear_JJ ,_, partly_RB because_IN of_IN the_DT different_JJ techniques_NNS used_VBN to_TO examine_VB this_DT issue_NN ,_, as_IN discussed_VBN in_IN detail_NN in_IN our_PRP$ previous_JJ work_NN -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
For_IN example_NN ,_, experiments_NNS using_VBG whole-body_JJ distribution_NN methods_NNS after_IN peripheral_JJ injection_NN of_IN radioactive_JJ GCs_NNS in_IN mice_NNS initially_RB suggested_VBD that_IN the_DT efflux_NN transporter_NN ,_, P-gp_NNP ,_, restricts_VBZ the_DT access_NN of_IN cortisol_NN and_CC corticosterone_NN to_TO the_DT murine_NN brain_NN -LRB-_-LRB- 25_CD ,_, 26_CD -RRB-_-RRB- and_CC is_VBZ also_RB implicated_VBN in_IN the_DT regulation_NN of_IN the_DT HPA_NNP axis_NNS -LRB-_-LRB- 14_CD ,_, 15_CD -RRB-_-RRB- ._. 
However_RB ,_, our_PRP$ recent_JJ results_NNS obtained_VBN from_IN murine_JJ brain_NN distribution_NN studies_NNS using_VBG direct_JJ brain_NN perfusion_NN show_NN that_IN P-gp_NNP restricts_VBZ the_DT accumulation_NN of_IN 
It_PRP is_VBZ now_RB known_VBN that_IN GCs_NNP also_RB interact_VBP with_IN glucose_NN transporters_NNS in_IN human_JJ cells_NNS -LRB-_-LRB- 9_CD 
In_IN support_NN of_IN our_PRP$ data_NNS ,_, a_DT recent_JJ article_NN investigating_VBG P-gp_NN at_IN the_DT BCSFB_NNP revealed_VBD a_DT lower_JJR level_NN of_IN P-gp_JJ expression_NN in_IN the_DT rat_NN and_CC human_JJ choroid_NN plexuses_NNS compared_VBN with_IN brain_NN microvessels_NNS using_VBG immunohistochemical_JJ analysis_NN with_IN the_DT P-gp-specific_JJ murine_NN antibody_NN C219_NNP -LRB-_-LRB- 5_CD -RRB-_-RRB- ,_, which_WDT suggests_VBZ a_DT reduced_JJ contribution_NN of_IN P-gp_NNP in_IN the_DT transport_NN of_IN its_PRP$ substrates_NNS across_IN the_DT BCSFB_NNP ._. 
P-gp_NN has_VBZ been_VBN detected_VBN in_IN porcine_NN and_CC rodent_NN choroid_NN plexuses_NNS previously_RB -LRB-_-LRB- 24_CD ,_, 34_CD -RRB-_-RRB- ,_, and_CC evidence_NN of_IN P-gp_JJ activity_NN at_IN the_DT choroid_JJ plexus_NN has_VBZ been_VBN seen_VBN -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
To_TO further_RBR investigate_VB the_DT activity_NN of_IN P-gp_NN at_IN the_DT BCSF_NNP barrier_NN ,_, 99m_FW Tc-sestamibi_FW ,_, a_DT nonmetabolized_JJ pharmaceutical_NN that_WDT is_VBZ known_VBN to_TO be_VB transported_VBN by_IN both_DT human_JJ P-gp_JJ and_CC multidrug_JJ resistance_NN associated_VBN protein_NN 1_CD -LRB-_-LRB- 24_CD -RRB-_-RRB- ,_, was_VBD injected_VBN into_IN the_DT mouse_NN tail_NN vein_NN ._. 
P-gp_NN has_VBZ been_VBN detected_VBN in_IN porcine_NN and_CC rodent_NN choroid_NN plexuses_NNS previously_RB -LRB-_-LRB- 24_CD ,_, 34_CD -RRB-_-RRB- ,_, and_CC evidence_NN of_IN P-gp_JJ activity_NN at_IN the_DT choroid_JJ plexus_NN has_VBZ been_VBN seen_VBN -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
To_TO further_RBR investigate_VB the_DT activity_NN of_IN P-gp_NN at_IN the_DT BCSF_NNP barrier_NN ,_, 99mTc-sestamibi_NNP ,_, a_DT nonmetabolized_JJ pharmaceutical_NN that_WDT is_VBZ known_VBN to_TO be_VB transported_VBN by_IN both_DT human_JJ P-gp_JJ and_CC multidrug_JJ resistance_NN associated_VBN protein_NN 1_CD -LRB-_-LRB- 24_CD -RRB-_-RRB- ,_, was_VBD injected_VBN into_IN the_DT mouse_NN tail_NN vein_NN ._. 
The_DT radioactivity_NN associated_VBN with_IN serum_NN ,_, blood_NN ,_, and_CC CSF_NNP of_IN 99m_NNP Tc-sestamibi_NNP in_IN abcd1a\/1b_CD -LRB-_-LRB- +_FW \/_FW +_FW -RRB-_-RRB- and_CC abcd1a\/b_CD -LRB-_-LRB- 
To_TO further_RBR investigate_VB the_DT activity_NN of_IN P-gp_NN at_IN the_DT BCSF_NNP barrier_NN ,_, 99m_FW Tc-sestamibi_FW ,_, a_DT nonmetabolized_JJ pharmaceutical_NN that_WDT is_VBZ known_VBN to_TO be_VB transported_VBN by_IN both_DT human_JJ P-gp_JJ and_CC multidrug_JJ resistance_NN associated_VBN protein_NN 1_CD -LRB-_-LRB- 24_CD -RRB-_-RRB- ,_, was_VBD injected_VBN into_IN the_DT mouse_NN tail_NN vein_NN ._. 
The_DT radioactivity_NN associated_VBN with_IN serum_NN ,_, blood_NN ,_, and_CC CSF_NNP of_IN 99mTc-sestamibi_NNP in_IN abcd1a\/1b_CD -LRB-_-LRB- +_FW \/_FW +_FW -RRB-_-RRB- and_CC abcd1a\/b_CD -LRB-_-LRB- 
Unlabeled_JJ digoxin_NN We_PRP specifically_RB investigated_VBD the_DT contribution_NN of_IN oatp2_CD ,_, using_VBG its_PRP$ inhibitor_NN ,_, digoxin_NN ._. 
Oatp2_NNP has_VBZ been_VBN detected_VBN in_IN choroidal_JJ epithelium_NN ,_, likely_RB localized_VBN to_TO the_DT apical_JJ membrane_NN -LRB-_-LRB- or_CC subapically_RB -RRB-_-RRB- -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- and_CC is_VBZ also_RB found_VBN in_IN murine_JJ brain_NN capilliaries_NNS -LRB-_-LRB- 21_CD ,_, 22_CD -RRB-_-RRB- ,_, where_WRB it_PRP bidirectionally_RB transports_VBZ substrates_NNS -LRB-_-LRB- 32_CD -RRB-_-RRB- ._. 
Also_RB ,_, oatp2_NN has_VBZ been_VBN shown_VBN to_TO efflux_VB the_DT neuroactive_JJ steroid_JJ dehydroepiandrosterone_NN sulfate_NN -LRB-_-LRB- 33_CD -RRB-_-RRB- ,_, thus_RB oatp2_CD was_VBD hypothesized_VBN to_TO be_VB the_DT transporter_NN possibly_RB detected_VBD in_IN these_DT self-inhibition_JJ and_CC cross-competition_JJ studies_NNS in_IN wild-type_JJ mice_NNS ._. 
The_DT half-saturation_NN constant_JJ -LRB-_-LRB- K_NNP m_NN -RRB-_-RRB- for_IN inhibition_NN of_IN mouse_NN oatp2_NN being_VBG 5_CD ._. 
Transport_NN inhibition_NN studies_NNS Digoxin_NNP -LRB-_-LRB- 25_CD 
Unlabeled_JJ digoxin_NN We_PRP specifically_RB investigated_VBD the_DT contribution_NN of_IN oatp2_CD ,_, using_VBG its_PRP$ inhibitor_NN ,_, digoxin_NN ._. 
Oatp2_NNP has_VBZ been_VBN detected_VBN in_IN choroidal_JJ epithelium_NN ,_, likely_RB localized_VBN to_TO the_DT apical_JJ membrane_NN -LRB-_-LRB- or_CC subapically_RB -RRB-_-RRB- -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- and_CC is_VBZ also_RB found_VBN in_IN murine_JJ brain_NN capilliaries_NNS -LRB-_-LRB- 21_CD ,_, 22_CD -RRB-_-RRB- ,_, where_WRB it_PRP bidirectionally_RB transports_VBZ substrates_NNS -LRB-_-LRB- 32_CD -RRB-_-RRB- ._. 
Also_RB ,_, oatp2_NN has_VBZ been_VBN shown_VBN to_TO efflux_VB the_DT neuroactive_JJ steroid_JJ dehydroepiandrosterone_NN sulfate_NN -LRB-_-LRB- 33_CD -RRB-_-RRB- ,_, thus_RB oatp2_CD was_VBD hypothesized_VBN to_TO be_VB the_DT transporter_NN possibly_RB detected_VBD in_IN these_DT self-inhibition_JJ and_CC cross-competition_JJ studies_NNS in_IN wild-type_JJ mice_NNS ._. 
Unlabeled_JJ digoxin_NN We_PRP specifically_RB investigated_VBD the_DT contribution_NN of_IN oatp2_CD ,_, using_VBG its_PRP$ inhibitor_NN ,_, digoxin_NN ._. 
Oatp2_NNP has_VBZ been_VBN detected_VBN in_IN choroidal_JJ epithelium_NN ,_, likely_RB localized_VBN to_TO the_DT apical_JJ membrane_NN -LRB-_-LRB- or_CC subapically_RB -RRB-_-RRB- -LRB-_-LRB- 19_CD ,_, 20_CD -RRB-_-RRB- and_CC is_VBZ also_RB found_VBN in_IN murine_JJ brain_NN capilliaries_NNS -LRB-_-LRB- 21_CD ,_, 22_CD -RRB-_-RRB- ,_, where_WRB it_PRP bidirectionally_RB transports_VBZ substrates_NNS -LRB-_-LRB- 32_CD -RRB-_-RRB- ._. 
Also_RB ,_, oatp2_NN has_VBZ been_VBN shown_VBN to_TO efflux_VB the_DT neuroactive_JJ steroid_JJ dehydroepiandrosterone_NN sulfate_NN -LRB-_-LRB- 33_CD -RRB-_-RRB- ,_, thus_RB oatp2_CD was_VBD hypothesized_VBN to_TO be_VB the_DT transporter_NN possibly_RB detected_VBD in_IN these_DT self-inhibition_JJ and_CC cross-competition_JJ studies_NNS in_IN wild-type_JJ mice_NNS ._. 
Based_VBN on_IN their_PRP$ highly_RB lipophilic_JJ properties_NNS ,_, GCs_NNS have_VBP been_VBN assumed_VBN to_TO passively_RB diffuse_VB through_IN the_DT cell_NN membrane_NN ,_, because_IN they_PRP must_MD reach_VB their_PRP$ intracellular_JJ receptors_NNS to_TO exert_VB their_PRP$ actions_NNS -LRB-_-LRB- 2_CD -RRB-_-RRB- ._. 
This_DT notion_NN is_VBZ also_RB supported_VBN by_IN the_DT fact_NN that_IN the_DT lipophilicity_NN of_IN these_DT molecules_NNS correlates_VBZ with_IN their_PRP$ cellular_JJ accumulation_NN in_IN artificial_JJ phospolipid\/cholesterol_JJ membranes_NNS -LRB-_-LRB- 3_CD -RRB-_-RRB- and_CC that_IN the_DT n-octanol-water_JJ partition_NN coefficients_NNS correlate_VBP to_TO the_DT membrane_NN permeability_NN of_IN these_DT molecules_NNS in_IN both_DT hamster_NN fibroblasts_NNS and_CC rat_NN hepatoma_NN cells_NNS -LRB-_-LRB- 4_CD -RRB-_-RRB- ._. 
However_RB ,_, the_DT ability_NN of_IN these_DT GCs_NNS to_TO access_VB the_DT brain_NN may_MD be_VB a_DT more_RBR complicated_JJ process_NN ._. 
The_DT free_JJ movement_NN of_IN molecules_NNS into_IN the_DT majority_NN of_IN brain_NN regions_NNS is_VBZ restricted_VBN by_IN the_DT presence_NN of_IN the_DT blood-brain_JJ barrier_NN -LRB-_-LRB- BBB_NNP -RRB-_-RRB- and_CC blood-cerebrospinal_JJ fluid_NN -LRB-_-LRB- CSF_NNP -RRB-_-RRB- barrier_NN -LRB-_-LRB- BCSFB_NNP -RRB-_-RRB- ._. 
The_DT free_JJ movement_NN of_IN molecules_NNS into_IN the_DT majority_NN of_IN brain_NN regions_NNS is_VBZ restricted_VBN by_IN the_DT presence_NN of_IN the_DT blood-brain_JJ barrier_NN -LRB-_-LRB- BBB_NNP -RRB-_-RRB- and_CC blood-cerebrospinal_JJ fluid_NN -LRB-_-LRB- CSF_NNP -RRB-_-RRB- barrier_NN -LRB-_-LRB- BCSFB_NNP -RRB-_-RRB- ._. 
The_DT BBB_NNP is_VBZ found_VBN at_IN the_DT level_NN of_IN the_DT capillary_JJ endothelial_JJ cells_NNS of_IN cerebral_JJ vasculature_NN ,_, whereas_IN the_DT BCSFB_NNP is_VBZ found_VBN at_IN the_DT fluid-secreting_JJ epithelium_NN of_IN the_DT choroid_JJ plexus_NN and_CC at_IN the_DT arachnoid_NN membrane_NN -LRB-_-LRB- 5_CD -RRB-_-RRB- ._. 
The_DT fenestrated_JJ capillaries_NNS of_IN the_DT vessels_NNS that_WDT feed_VBP the_DT choroid_JJ plexus_NNS allow_VBP for_IN relatively_RB free_JJ movement_NN of_IN molecules_NNS into_IN choroid_JJ plexus_NN tissue_NN ,_, and_CC some_DT of_IN these_DT molecules_NNS may_MD then_RB be_VB transported_VBN into_IN CSF_NNP ._. 
In_IN humans_NNS ,_, iv_NN administered_VBD cortisol_NN passed_VBN from_IN blood_NN into_IN CSF_NNP ,_, and_CC intrathecally_RB administered_VBN cortisol_NN was_VBD detected_VBN in_IN blood_NN -LRB-_-LRB- 8_CD -RRB-_-RRB- ,_, suggesting_VBG that_DT cortisol_NN is_VBZ not_RB prevented_VBN from_IN crossing_VBG the_DT BCSFB_NNP ._. 
Of_IN special_JJ note_NN is_VBZ the_DT differential_JJ expression_NN of_IN transporters_NNS in_IN capillary_JJ endothelium_NN -LRB-_-LRB- BBB_NNP -RRB-_-RRB- and_CC choroidal_JJ epithelium_NN -LRB-_-LRB- BCSFB_NNP -RRB-_-RRB- that_WDT may_MD contribute_VB to_TO differential_JJ access_NN of_IN the_DT same_JJ molecules_NNS to_TO each_DT barrier_NN compartment_NN -LRB-_-LRB- 5_CD -RRB-_-RRB- ._. 
Additionally_RB ,_, there_EX are_VBP central_JJ nervous_JJ system_NN -LRB-_-LRB- CNS_NNP -RRB-_-RRB- regions_NNS that_WDT have_VBP nonbarrier_JJ type_NN capillaries_NNS ._. 
pituitary_JJ gland_NN -RRB-_-RRB- using_VBG transporter-deficient_JJ mice_NNS ,_, no_DT functional_JJ P-gp_JJ activity_NN was_VBD detected_VBN ._. 
e._NN 
choroid_FW plexus_FW -RRB-_-RRB- and_CC in_IN an_DT HPA_NNP axis-related_JJ nonbarrier_NN region_NN -LRB-_-LRB- i._NN In_IN support_NN of_IN our_PRP$ data_NNS ,_, a_DT recent_JJ article_NN investigating_VBG P-gp_NN at_IN the_DT BCSFB_NNP revealed_VBD a_DT lower_JJR level_NN of_IN P-gp_JJ expression_NN in_IN the_DT rat_NN and_CC human_JJ choroid_NN plexuses_NNS compared_VBN with_IN brain_NN microvessels_NNS using_VBG immunohistochemical_JJ analysis_NN with_IN the_DT P-gp-specific_JJ murine_NN antibody_NN C219_NNP -LRB-_-LRB- 5_CD -RRB-_-RRB- ,_, which_WDT suggests_VBZ a_DT reduced_JJ contribution_NN of_IN P-gp_NNP in_IN the_DT transport_NN of_IN its_PRP$ substrates_NNS across_IN the_DT BCSFB_NNP ._. 
P-gp_NN has_VBZ been_VBN detected_VBN in_IN porcine_NN and_CC rodent_NN choroid_NN plexuses_NNS previously_RB -LRB-_-LRB- 24_CD ,_, 34_CD -RRB-_-RRB- ,_, and_CC evidence_NN of_IN P-gp_JJ activity_NN at_IN the_DT choroid_JJ plexus_NN has_VBZ been_VBN seen_VBN -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
The_DT fenestrated_JJ capillaries_NNS of_IN the_DT vessels_NNS that_WDT feed_VBP the_DT choroid_JJ plexus_NNS allow_VBP for_IN relatively_RB free_JJ movement_NN of_IN molecules_NNS into_IN choroid_JJ plexus_NN tissue_NN ,_, and_CC some_DT of_IN these_DT molecules_NNS may_MD then_RB be_VB transported_VBN into_IN CSF_NNP ._. 
The_DT ventricular_JJ distribution_NN of_IN CSF-borne_JJ signals_NNS occurs_VBZ by_IN bulk_NN flow_NN ,_, and_CC there_EX is_VBZ no_DT physical_JJ restriction_NN in_IN the_DT movement_NN of_IN molecules_NNS from_IN the_DT CSF_NNP to_TO the_DT brain_NN ;_: however_RB ,_, movement_NN from_IN CSF_NNP to_TO brain_NN is_VBZ limited_JJ -LRB-_-LRB- 6_CD -RRB-_-RRB- ._. 
Nevertheless_RB ,_, passage_NN through_IN the_DT BCSFB_NNP may_MD provide_VB an_DT 
3and_CD 39_CD ._. 
4_CD 
Overall_RB ,_, these_DT data_NNS suggest_VBP that_IN the_DT majority_NN of_IN cortisol_NN and_CC corticosterone_NN present_NN in_IN the_DT plasma_NN diffuse_NN into_IN the_DT CNS_NNP and_CC that_IN transporters_NNS do_VBP not_RB play_VB a_DT major_JJ role_NN in_IN the_DT accumulation_NN of_IN these_DT GCs_NNS in_IN the_DT brain_NN ._. 
Fundamental_JJ processes_NNS of_IN the_DT body_NN ,_, such_JJ as_IN the_DT body_NN 's_POS stress_NN response_NN and_CC energy_NN metabolism_NN ,_, are_VBP regulated_VBN by_IN the_DT hypothalamic-pituitary-adrenal_JJ -LRB-_-LRB- HPA_NNP -RRB-_-RRB- axis_NNS ,_, and_CC hyperactivity_NN of_IN this_DT axis_NN has_VBZ been_VBN seen_VBN in_IN approximately_RB 50_CD %_NN of_IN patients_NNS with_IN depression_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- ._. 
The_DT proper_JJ functioning_NN of_IN this_DT axis_NN is_VBZ dependent_JJ on_IN the_DT ability_NN of_IN glucocorticoids_NNS -LRB-_-LRB- GCs_NNP -RRB-_-RRB- ,_, mainly_RB cortisol_NN in_IN humans_NNS and_CC corticosterone_NN in_IN rodents_NNS ,_, to_TO access_VB brain_NN targets_NNS such_JJ as_IN the_DT hypothalamus_NN and_CC regulate_VB their_PRP$ own_JJ secretion_NN ._. 
The_DT proper_JJ functioning_NN of_IN this_DT axis_NN is_VBZ dependent_JJ on_IN the_DT ability_NN of_IN glucocorticoids_NNS -LRB-_-LRB- GCs_NNP -RRB-_-RRB- ,_, mainly_RB cortisol_NN in_IN humans_NNS and_CC corticosterone_NN in_IN rodents_NNS ,_, to_TO access_VB brain_NN targets_NNS such_JJ as_IN the_DT hypothalamus_NN and_CC regulate_VB their_PRP$ own_JJ secretion_NN ._. 
Based_VBN on_IN their_PRP$ highly_RB lipophilic_JJ properties_NNS ,_, GCs_NNS have_VBP been_VBN assumed_VBN to_TO passively_RB diffuse_VB through_IN the_DT cell_NN membrane_NN ,_, because_IN they_PRP must_MD reach_VB their_PRP$ intracellular_JJ receptors_NNS to_TO exert_VB their_PRP$ actions_NNS -LRB-_-LRB- 2_CD -RRB-_-RRB- ._. 
This_DT notion_NN is_VBZ also_RB supported_VBN by_IN the_DT fact_NN that_IN the_DT lipophilicity_NN of_IN these_DT molecules_NNS correlates_VBZ with_IN their_PRP$ cellular_JJ accumulation_NN in_IN artificial_JJ phospolipid\/cholesterol_JJ membranes_NNS -LRB-_-LRB- 3_CD -RRB-_-RRB- and_CC that_IN the_DT n-octanol-water_JJ partition_NN coefficients_NNS correlate_VBP to_TO the_DT membrane_NN permeability_NN of_IN these_DT molecules_NNS in_IN both_DT hamster_NN fibroblasts_NNS and_CC rat_NN hepatoma_NN cells_NNS -LRB-_-LRB- 4_CD -RRB-_-RRB- ._. 
Based_VBN on_IN their_PRP$ highly_RB lipophilic_JJ properties_NNS ,_, GCs_NNS have_VBP been_VBN assumed_VBN to_TO passively_RB diffuse_VB through_IN the_DT cell_NN membrane_NN ,_, because_IN they_PRP must_MD reach_VB their_PRP$ intracellular_JJ receptors_NNS to_TO exert_VB their_PRP$ actions_NNS -LRB-_-LRB- 2_CD -RRB-_-RRB- ._. 
This_DT notion_NN is_VBZ also_RB supported_VBN by_IN the_DT fact_NN that_IN the_DT lipophilicity_NN of_IN these_DT molecules_NNS correlates_VBZ with_IN their_PRP$ cellular_JJ accumulation_NN in_IN artificial_JJ phospolipid\/cholesterol_JJ membranes_NNS -LRB-_-LRB- 3_CD -RRB-_-RRB- and_CC that_IN the_DT n-octanol-water_JJ partition_NN coefficients_NNS correlate_VBP to_TO the_DT membrane_NN permeability_NN of_IN these_DT molecules_NNS in_IN both_DT hamster_NN fibroblasts_NNS and_CC rat_NN hepatoma_NN cells_NNS -LRB-_-LRB- 4_CD -RRB-_-RRB- ._. 
However_RB ,_, the_DT ability_NN of_IN these_DT GCs_NNS to_TO access_VB the_DT brain_NN may_MD be_VB a_DT more_RBR complicated_JJ process_NN ._. 
The_DT free_JJ movement_NN of_IN molecules_NNS into_IN the_DT majority_NN of_IN brain_NN regions_NNS is_VBZ restricted_VBN by_IN the_DT presence_NN of_IN the_DT blood-brain_JJ barrier_NN -LRB-_-LRB- BBB_NNP -RRB-_-RRB- and_CC blood-cerebrospinal_JJ fluid_NN -LRB-_-LRB- CSF_NNP -RRB-_-RRB- barrier_NN -LRB-_-LRB- BCSFB_NNP -RRB-_-RRB- ._. 
0_CD 
Because_IN the_DT physiochemical_JJ properties_NNS of_IN GCs_NNP suggested_VBD that_IN they_PRP could_MD quickly_RB cross_VB cellular_JJ membranes_NNS ,_, it_PRP was_VBD assumed_VBN that_IN they_PRP would_MD also_RB easily_RB enter_VBP the_DT CNS_NNP by_IN passive_JJ diffusion_NN ._. 
It_PRP is_VBZ now_RB known_VBN that_IN GCs_NNP also_RB interact_VBP with_IN glucose_NN transporters_NNS in_IN human_JJ cells_NNS -LRB-_-LRB- 9_CD 
-LRB-_-LRB- 41_CD -RRB-_-RRB- may_MD have_VB effects_NNS on_IN the_DT oat_NN ,_, oatp_NN ,_, or_CC multidrug_JJ resistance_NN associated_VBN protein_NN transporter_NN families_NNS ,_, also_RB making_VBG these_DT transporters_NNS candidates_NNS for_IN those_DT mechanisms_NNS seen_VBN here_RB ._. 
Furthermore_RB ,_, GRs_NNS have_VBP been_VBN shown_VBN to_TO modulate_VB or_CC inhibit_VB the_DT transport_NN of_IN known_JJ substrates_NNS of_IN glucose_NN transporters_NNS in_IN rodent_NN and_CC human_JJ cells_NNS -LRB-_-LRB- 9_CD 
Discussion_NNP An_NNP emerging_VBG theme_NN in_IN GPCR_NNP biology_NN is_VBZ the_DT requirement_NN of_IN some_DT receptors_NNS for_IN accessory_JJ proteins_NNS that_WDT assist_VBP trafficking_NN and_CC ligand_NN binding_JJ ._. 
The_DT RAMP_NN proteins_NNS ,_, which_WDT classically_RB associate_JJ with_IN the_DT calcitonin_NN receptor_NN and_CC calcitonin-like_JJ receptor_NN ,_, provide_VBP the_DT prototype_NN for_IN this_DT class_NN of_IN proteins_NNS ,_, and_CC features_NNS such_JJ as_IN the_DT association_NN with_IN receptor_NN in_IN the_DT ER_NNP ,_, trafficking_NN to_TO the_DT plasma_NN membrane_NN ,_, and_CC contribution_NN to_TO ligand_VB binding_JJ and_CC signaling_VBG are_VBP also_RB identified_VBN with_IN the_DT receptor_NN transporting_VBG proteins_NNS ,_, receptor_NN expression_NN enhancing_VBG protein_NN and_CC MRAP_NNP proteins_NNS -LRB-_-LRB- 2_CD ,_, 16_CD 
Discussion_NNP An_NNP emerging_VBG theme_NN in_IN GPCR_NNP biology_NN is_VBZ the_DT requirement_NN of_IN some_DT receptors_NNS for_IN accessory_JJ proteins_NNS that_WDT assist_VBP trafficking_NN and_CC ligand_NN binding_JJ ._. 
The_DT RAMP_NN proteins_NNS ,_, which_WDT classically_RB associate_JJ with_IN the_DT calcitonin_NN receptor_NN and_CC calcitonin-like_JJ receptor_NN ,_, provide_VBP the_DT prototype_NN for_IN this_DT class_NN of_IN proteins_NNS ,_, and_CC features_NNS such_JJ as_IN the_DT association_NN with_IN receptor_NN in_IN the_DT ER_NNP ,_, trafficking_NN to_TO the_DT plasma_NN membrane_NN ,_, and_CC contribution_NN to_TO ligand_VB binding_JJ and_CC signaling_VBG are_VBP also_RB identified_VBN with_IN the_DT receptor_NN transporting_VBG proteins_NNS ,_, receptor_NN expression_NN enhancing_VBG protein_NN and_CC MRAP_NNP proteins_NNS -LRB-_-LRB- 2_CD ,_, 16_CD 
The_DT demonstration_NN that_IN MC2R_JJ homodimerizes_NNS is_VBZ based_VBN on_IN coimmunoprecipitation_NN and_CC BRET_NNP data_NNS ._. 
Second_JJ ,_, dimerization_NN of_IN receptor_NN molecules_NNS ,_, each_DT with_IN an_DT associated_JJ MRAP_NNP dimmer_NN ,_, may_MD lead_VB to_TO BRET_NNP generation_NN between_IN MRAP_NNP dimers_NNS in_IN addition_NN to_TO from_IN within_IN a_DT single_JJ MRAP_NNP dimer_NN ._. 
This_DT is_VBZ not_RB especially_RB surprising_JJ because_IN the_DT majority_NN of_IN GPCRs_NNS studied_VBN -LRB-_-LRB- including_VBG some_DT of_IN the_DT melanocortin_NN receptors_NNS -RRB-_-RRB- have_VBP demonstrated_VBN some_DT evidence_NN of_IN homodimer_NN formation_NN -LRB-_-LRB- 13_CD 
The_DT demonstration_NN that_IN MC2R_JJ homodimerizes_NNS is_VBZ based_VBN on_IN coimmunoprecipitation_NN and_CC BRET_NNP data_NNS ._. 
Second_JJ ,_, dimerization_NN of_IN receptor_NN molecules_NNS ,_, each_DT with_IN an_DT associated_JJ MRAP_NNP dimmer_NN ,_, may_MD lead_VB to_TO BRET_NNP generation_NN between_IN MRAP_NNP dimers_NNS in_IN addition_NN to_TO from_IN within_IN a_DT single_JJ MRAP_NNP dimer_NN ._. 
This_DT is_VBZ not_RB especially_RB surprising_JJ because_IN the_DT majority_NN of_IN GPCRs_NNS studied_VBN -LRB-_-LRB- including_VBG some_DT of_IN the_DT melanocortin_NN receptors_NNS -RRB-_-RRB- have_VBP demonstrated_VBN some_DT evidence_NN of_IN homodimer_NN formation_NN -LRB-_-LRB- 13_CD 
Human_NNP MRAPx3Flag_NNP is_VBZ depicted_VBN by_IN the_DT arrowheads_NNS ._. 
Lysates_NNS were_VBD immunoprecipitated_VBN -LRB-_-LRB- IP_NNP -RRB-_-RRB- with_IN the_DT anti-HA_JJ antibody_NN and_CC immunoblotted_VBD using_VBG anti-Flag_JJ antibody_NN ._. 
The_DT ACTH_NNP -LRB-_-LRB- 1_CD 
In_IN support_NN of_IN this_DT latter_JJ view_NN is_VBZ the_DT observation_NN that_IN parallel_JJ homodimer_NN BRET_NNP signals_NNS become_VBP detectable_JJ only_RB in_IN the_DT presence_NN of_IN MC2R_NNP ._. 
Anumber_NNP of_IN studies_NNS have_VBP suggested_VBN that_IN several_JJ melanocortin_NN receptors_NNS can_MD form_VB homo\/heterodimeric_JJ structures_NNS -LRB-_-LRB- 10_CD ,_, 13_CD -RRB-_-RRB- ._. 
We_PRP investigated_VBD the_DT effect_NN of_IN MRAP_NNP and_CC ACTH_NNP on_IN the_DT homodimerization_NN of_IN the_DT MC2R_NNP using_VBG coimmunoprecipitation_NN ._. 
The_DT demonstration_NN that_IN MC2R_JJ homodimerizes_NNS is_VBZ based_VBN on_IN coimmunoprecipitation_NN and_CC BRET_NNP data_NNS ._. 
Second_JJ ,_, dimerization_NN of_IN receptor_NN molecules_NNS ,_, each_DT with_IN an_DT associated_JJ MRAP_NNP dimmer_NN ,_, may_MD lead_VB to_TO BRET_NNP generation_NN between_IN MRAP_NNP dimers_NNS in_IN addition_NN to_TO from_IN within_IN a_DT single_JJ MRAP_NNP dimer_NN ._. 
This_DT is_VBZ not_RB especially_RB surprising_JJ because_IN the_DT majority_NN of_IN GPCRs_NNS studied_VBN -LRB-_-LRB- including_VBG some_DT of_IN the_DT melanocortin_NN receptors_NNS -RRB-_-RRB- have_VBP demonstrated_VBN some_DT evidence_NN of_IN homodimer_NN formation_NN -LRB-_-LRB- 13_CD 
Such_JJ a_DT structure_NN is_VBZ apparently_RB unique_JJ in_IN eukaryotic_JJ biology_NN and_CC raises_VBZ interesting_JJ questions_NNS over_IN the_DT mechanisms_NNS of_IN translation_NN and_CC membrane_NN insertion_NN of_IN these_DT proteins_NNS ._. 
Several_JJ pieces_NNS of_IN data_NNS ,_, including_VBG fluorescent_JJ complementation_NN studies_NNS ,_, indicate_VBP that_IN the_DT MRAP_NNP homodimer_NN forms_NNS in_IN the_DT ER_NNP and_CC that_IN the_DT dimeric_JJ form_NN is_VBZ essential_JJ for_IN the_DT MC2R_NNP to_TO be_VB trafficked_VBN to_TO the_DT cell_NN surface_NN -LRB-_-LRB- 10_CD -RRB-_-RRB- ._. 
However_RB ,_, there_EX is_VBZ no_DT reported_JJ data_NNS on_IN the_DT dynamics_NNS of_IN the_DT ACTH_NNP receptor_NN complex_NN ._. 
We_PRP used_VBD a_DT bioluminescence_NN resonance_NN energy_NN transfer_NN -LRB-_-LRB- BRET_NNP -RRB-_-RRB- approach_NN to_TO study_VB the_DT homo\/heterodimerization_NN of_IN the_DT MC2R_NNP and_CC MRAP_NNP in_IN living_NN cells_NNS and_CC explore_VB the_DT possibility_NN that_IN receptor_NN activation_NN may_MD influence_VB the_DT complex_NN ._. 
In_IN support_NN of_IN this_DT latter_JJ view_NN is_VBZ the_DT observation_NN that_IN parallel_JJ homodimer_NN BRET_NNP signals_NNS become_VBP detectable_JJ only_RB in_IN the_DT presence_NN of_IN MC2R_NNP ._. 
Anumber_NNP of_IN studies_NNS have_VBP suggested_VBN that_IN several_JJ melanocortin_NN receptors_NNS can_MD form_VB homo\/heterodimeric_JJ structures_NNS -LRB-_-LRB- 10_CD ,_, 13_CD -RRB-_-RRB- ._. 
We_PRP investigated_VBD the_DT effect_NN of_IN MRAP_NNP and_CC ACTH_NNP on_IN the_DT homodimerization_NN of_IN the_DT MC2R_NNP using_VBG coimmunoprecipitation_NN ._. 
The_DT RAMP_NN proteins_NNS ,_, which_WDT classically_RB associate_JJ with_IN the_DT calcitonin_NN receptor_NN and_CC calcitonin-like_JJ receptor_NN ,_, provide_VBP the_DT prototype_NN for_IN this_DT class_NN of_IN proteins_NNS ,_, and_CC features_NNS such_JJ as_IN the_DT association_NN with_IN receptor_NN in_IN the_DT ER_NNP ,_, trafficking_NN to_TO the_DT plasma_NN membrane_NN ,_, and_CC contribution_NN to_TO ligand_VB binding_JJ and_CC signaling_VBG are_VBP also_RB identified_VBN with_IN the_DT receptor_NN transporting_VBG proteins_NNS ,_, receptor_NN expression_NN enhancing_VBG protein_NN and_CC MRAP_NNP proteins_NNS -LRB-_-LRB- 2_CD ,_, 16_CD 
The_DT receptor_NN activity_NN modifying_VBG protein_NN -LRB-_-LRB- RAMP_NNP -RRB-_-RRB- 1-EYFP-myc_NNP construct_VB was_VBD a_DT kind_JJ gift_NN from_IN Professor_NNP Michele_NNP Bouvier_NNP -LRB-_-LRB- Department_NNP of_IN Biochemistry_NNP ,_, University_NNP of_IN Montreal_NNP ,_, Montreal_NNP ,_, Quebec_NNP ,_, Canada_NNP -RRB-_-RRB- ._. 
The_DT BRET-based_JJ exchange_NN protein_NN directly_RB activated_VBN by_IN cAMP_NNP -LRB-_-LRB- EPAC_NNP -RRB-_-RRB- cAMP_FW biosensor_FW consisting_VBG of_IN the_DT human_JJ EPAC1_NNP sequence_NN flanked_VBN by_IN citrine_NN -LRB-_-LRB- an_DT EYFP_NNP -RRB-_-RRB- and_CC Renilla_NNP luciferase_NN -LRB-_-LRB- 11_CD -RRB-_-RRB- was_VBD kindly_RB provided_VBN by_IN Professor_NNP Sternweis_NNP -LRB-_-LRB- University_NNP of_IN Texas_NNP Southwestern_NNP Medical_NNP Centre_NNP ,_, Dallas_NNP ,_, TX_NNP -RRB-_-RRB- ._. 
The_DT MC2Rx3_NNP hemagglutinin_NN -LRB-_-LRB- HA_NNP -RRB-_-RRB- construct_VBP was_VBD obtained_VBN from_IN Missouri_NNP University_NNP of_IN Science_NNP and_CC Technology_NNP cDNA_NNP Resource_NNP Centre_NNP -LRB-_-LRB- 
Discussion_NNP An_NNP emerging_VBG theme_NN in_IN GPCR_NNP biology_NN is_VBZ the_DT requirement_NN of_IN some_DT receptors_NNS for_IN accessory_JJ proteins_NNS that_WDT assist_VBP trafficking_NN and_CC ligand_NN binding_JJ ._. 
The_DT RAMP_NN proteins_NNS ,_, which_WDT classically_RB associate_JJ with_IN the_DT calcitonin_NN receptor_NN and_CC calcitonin-like_JJ receptor_NN ,_, provide_VBP the_DT prototype_NN for_IN this_DT class_NN of_IN proteins_NNS ,_, and_CC features_NNS such_JJ as_IN the_DT association_NN with_IN receptor_NN in_IN the_DT ER_NNP ,_, trafficking_NN to_TO the_DT plasma_NN membrane_NN ,_, and_CC contribution_NN to_TO ligand_VB binding_JJ and_CC signaling_VBG are_VBP also_RB identified_VBN with_IN the_DT receptor_NN transporting_VBG proteins_NNS ,_, receptor_NN expression_NN enhancing_VBG protein_NN and_CC MRAP_NNP proteins_NNS -LRB-_-LRB- 2_CD ,_, 16_CD 
The_DT demonstration_NN that_IN MC2R_JJ homodimerizes_NNS is_VBZ based_VBN on_IN coimmunoprecipitation_NN and_CC BRET_NNP data_NNS ._. 
Second_JJ ,_, dimerization_NN of_IN receptor_NN molecules_NNS ,_, each_DT with_IN an_DT associated_JJ MRAP_NNP dimmer_NN ,_, may_MD lead_VB to_TO BRET_NNP generation_NN between_IN MRAP_NNP dimers_NNS in_IN addition_NN to_TO from_IN within_IN a_DT single_JJ MRAP_NNP dimer_NN ._. 
This_DT is_VBZ not_RB especially_RB surprising_JJ because_IN the_DT majority_NN of_IN GPCRs_NNS studied_VBN -LRB-_-LRB- including_VBG some_DT of_IN the_DT melanocortin_NN receptors_NNS -RRB-_-RRB- have_VBP demonstrated_VBN some_DT evidence_NN of_IN homodimer_NN formation_NN -LRB-_-LRB- 13_CD 
The_DT second_JJ phase_NN was_VBD a_DT slower_JJR persistent_JJ BRET_NNP increase_NN that_WDT is_VBZ the_DT signal_NN measured_VBN in_IN the_DT initial_JJ single_JJ time_NN point_NN studies_NNS -LRB-_-LRB- Fig_NNP 4_CD -RRB-_-RRB- ,_, and_CC this_DT signal_NN was_VBD blocked_VBN by_IN the_DT PKA_NNP antagonist_NN ._. 
It_PRP is_VBZ tempting_JJ to_TO speculate_VB that_IN this_DT latter_JJ conformational_JJ change_NN correlates_VBZ with_IN desensitization_NN of_IN the_DT receptor_NN ,_, which_WDT we_PRP have_VBP previously_RB shown_VBN to_TO have_VB a_DT similar_JJ time_NN course_NN and_CC to_TO be_VB PKA_NNP dependent_JJ -LRB-_-LRB- 30_CD -RRB-_-RRB- ._. 
Against_IN this_DT ,_, mutagenesis_NNS of_IN serine_NN 208_CD in_IN the_DT MC2R_NNP ,_, which_WDT was_VBD previously_RB found_VBN to_TO be_VB a_DT target_NN of_IN PKA_NNP in_IN the_DT mouse_NN MC2R_NNP -LRB-_-LRB- 30_CD -RRB-_-RRB- ,_, failed_VBD to_TO influence_VB BRET_NNP signal_NN generation_NN -LRB-_-LRB- data_NNS not_RB shown_VBN -RRB-_-RRB- ._. 
It_PRP is_VBZ tempting_JJ to_TO speculate_VB that_IN this_DT latter_JJ conformational_JJ change_NN correlates_VBZ with_IN desensitization_NN of_IN the_DT receptor_NN ,_, which_WDT we_PRP have_VBP previously_RB shown_VBN to_TO have_VB a_DT similar_JJ time_NN course_NN and_CC to_TO be_VB PKA_NNP dependent_JJ -LRB-_-LRB- 30_CD -RRB-_-RRB- ._. 
Against_IN this_DT ,_, mutagenesis_NNS of_IN serine_NN 208_CD in_IN the_DT MC2R_NNP ,_, which_WDT was_VBD previously_RB found_VBN to_TO be_VB a_DT target_NN of_IN PKA_NNP in_IN the_DT mouse_NN MC2R_NNP -LRB-_-LRB- 30_CD -RRB-_-RRB- ,_, failed_VBD to_TO influence_VB BRET_NNP signal_NN generation_NN -LRB-_-LRB- data_NNS not_RB shown_VBN -RRB-_-RRB- ._. 
This_DT may_MD indicate_VB that_IN the_DT influence_NN of_IN PKA_NNP on_IN the_DT human_JJ MC2R_NN is_VBZ more_RBR complex_JJ than_IN on_IN the_DT mouse_NN receptor_NN ._. 
The_DT 
The_DT 
5min_CD and_CC reached_VBD a_DT plateau_NN at_IN about_RB 15_CD 
The_DT rate_NN of_IN calcium_NN elevation_NN was_VBD found_VBN to_TO correlate_VB with_IN the_DT extent_NN of_IN receptor_NN occupancy_NN ._. 
The_DT rapid_JJ binding_JJ component_NN of_IN neurokinin_NN A_NN to_TO tachykinin_NN receptors_NNS was_VBD associated_VBN with_IN a_DT cellular_JJ calcium_NN response_NN ._. 
The_DT slow_JJ component_NN was_VBD required_VBN for_IN cAMP_NNP accumulation_NN and_CC signaling_VBG -LRB-_-LRB- 33_CD -RRB-_-RRB- and_CC was_VBD detected_VBN after_IN 1_CD ._. 
5min_CD and_CC reached_VBD a_DT plateau_NN at_IN about_RB 15_CD 
This_DT is_VBZ largely_RB based_VBN on_IN the_DT low_JJ BRET_NN or_CC fluorescence_NN resonance_NN energy_NN transfer_NN signals_NNS observed_VBD for_IN these_DT GPCRs_NNS ,_, which_WDT are_VBP greatly_RB enhanced_VBN after_IN exposure_NN to_TO agonist_VB -LRB-_-LRB- 20_CD 
This_DT is_VBZ largely_RB based_VBN on_IN the_DT low_JJ BRET_NN or_CC fluorescence_NN resonance_NN energy_NN transfer_NN signals_NNS observed_VBD for_IN these_DT GPCRs_NNS ,_, which_WDT are_VBP greatly_RB enhanced_VBN after_IN exposure_NN to_TO agonist_VB -LRB-_-LRB- 20_CD 
This_DT is_VBZ largely_RB based_VBN on_IN the_DT low_JJ BRET_NN or_CC fluorescence_NN resonance_NN energy_NN transfer_NN signals_NNS observed_VBD for_IN these_DT GPCRs_NNS ,_, which_WDT are_VBP greatly_RB enhanced_VBN after_IN exposure_NN to_TO agonist_VB -LRB-_-LRB- 20_CD 
This_DT is_VBZ largely_RB based_VBN on_IN the_DT low_JJ BRET_NN or_CC fluorescence_NN resonance_NN energy_NN transfer_NN signals_NNS observed_VBD for_IN these_DT GPCRs_NNS ,_, which_WDT are_VBP greatly_RB enhanced_VBN after_IN exposure_NN to_TO agonist_VB -LRB-_-LRB- 20_CD 
This_DT is_VBZ largely_RB based_VBN on_IN the_DT low_JJ BRET_NN or_CC fluorescence_NN resonance_NN energy_NN transfer_NN signals_NNS observed_VBD for_IN these_DT GPCRs_NNS ,_, which_WDT are_VBP greatly_RB enhanced_VBN after_IN exposure_NN to_TO agonist_VB -LRB-_-LRB- 20_CD 
This_DT is_VBZ largely_RB based_VBN on_IN the_DT low_JJ BRET_NN or_CC fluorescence_NN resonance_NN energy_NN transfer_NN signals_NNS observed_VBD for_IN these_DT GPCRs_NNS ,_, which_WDT are_VBP greatly_RB enhanced_VBN after_IN exposure_NN to_TO agonist_VB -LRB-_-LRB- 20_CD 
This_DT is_VBZ largely_RB based_VBN on_IN the_DT low_JJ BRET_NN or_CC fluorescence_NN resonance_NN energy_NN transfer_NN signals_NNS observed_VBD for_IN these_DT GPCRs_NNS ,_, which_WDT are_VBP greatly_RB enhanced_VBN after_IN exposure_NN to_TO agonist_VB -LRB-_-LRB- 20_CD 
Some_DT authors_NNS have_VBP suggested_VBN that_IN agonist_JJ activation_NN of_IN GPCRs_NNP induces_VBZ the_DT formation_NN of_IN dimers_NNS of_IN GPCRs_NNS that_WDT are_VBP otherwise_RB monomeric_JJ in_IN their_PRP$ inactive_JJ state_NN ._. 
This_DT is_VBZ largely_RB based_VBN on_IN the_DT low_JJ BRET_NN or_CC fluorescence_NN resonance_NN energy_NN transfer_NN signals_NNS observed_VBD for_IN these_DT GPCRs_NNS ,_, which_WDT are_VBP greatly_RB enhanced_VBN after_IN exposure_NN to_TO agonist_VB -LRB-_-LRB- 20_CD 
Some_DT authors_NNS have_VBP suggested_VBN that_IN agonist_JJ activation_NN of_IN GPCRs_NNP induces_VBZ the_DT formation_NN of_IN dimers_NNS of_IN GPCRs_NNS that_WDT are_VBP otherwise_RB monomeric_JJ in_IN their_PRP$ inactive_JJ state_NN ._. 
This_DT is_VBZ largely_RB based_VBN on_IN the_DT low_JJ BRET_NN or_CC fluorescence_NN resonance_NN energy_NN transfer_NN signals_NNS observed_VBD for_IN these_DT GPCRs_NNS ,_, which_WDT are_VBP greatly_RB enhanced_VBN after_IN exposure_NN to_TO agonist_VB -LRB-_-LRB- 20_CD 
Some_DT authors_NNS have_VBP suggested_VBN that_IN agonist_JJ activation_NN of_IN GPCRs_NNP induces_VBZ the_DT formation_NN of_IN dimers_NNS of_IN GPCRs_NNS that_WDT are_VBP otherwise_RB monomeric_JJ in_IN their_PRP$ inactive_JJ state_NN ._. 
This_DT is_VBZ largely_RB based_VBN on_IN the_DT low_JJ BRET_NN or_CC fluorescence_NN resonance_NN energy_NN transfer_NN signals_NNS observed_VBD for_IN these_DT GPCRs_NNS ,_, which_WDT are_VBP greatly_RB enhanced_VBN after_IN exposure_NN to_TO agonist_VB -LRB-_-LRB- 20_CD 
The_DT MC2R_NNP is_VBZ retained_VBN at_IN the_DT endoplasmic_JJ reticulum_NN -LRB-_-LRB- ER_NNP -RRB-_-RRB- when_WRB expressed_VBN in_IN cells_NNS that_WDT are_VBP devoid_JJ of_IN MRAP_NNP ._. 
When_WRB MC2R_NNP is_VBZ coexpressed_VBN with_IN MRAP_NNP ,_, however_RB ,_, as_IN in_IN adrenocortical_JJ cell_NN lines_NNS or_CC in_IN appropriately_RB transfected_VBN cells_NNS ,_, the_DT MC2R_NNP is_VBZ seen_VBN to_TO traffic_NN to_TO the_DT plasma_NN membrane_NN and_CC to_TO generate_VB a_DT signal_NN in_IN response_NN to_TO ACTH_NNP -LRB-_-LRB- 2_CD 
MRAP_NNP therefore_RB acts_VBZ as_IN an_DT accessory_JJ factor_NN by_IN facilitating_VBG trafficking_NN of_IN the_DT MC2R_NNP to_TO the_DT cell_NN surface_NN ._. 
MRAP_NNP appears_VBZ to_TO have_VB an_DT important_JJ additional_JJ function_NN in_IN assisting_VBG ACTH_NNP binding_JJ and_CC consequently_RB signal_VB transduction_NN -LRB-_-LRB- 3_CD ,_, 4_CD -RRB-_-RRB- ._. 
Mutations_NNS in_IN MRAP_NNP result_NN in_IN a_DT syndrome_NN of_IN severe_JJ ACTH_NNP insensitivity_NN -LRB-_-LRB- 6_CD ,_, 7_CD -RRB-_-RRB- ,_, and_CC knockdown_NN of_IN MRAP_NNP in_IN an_DT adrenocortical_JJ cell_NN line_NN reduces_VBZ ACTH_NNP responsiveness_NN -LRB-_-LRB- 8_CD -RRB-_-RRB- ._. 
The_DT MC2R_NNP is_VBZ retained_VBN at_IN the_DT endoplasmic_JJ reticulum_NN -LRB-_-LRB- ER_NNP -RRB-_-RRB- when_WRB expressed_VBN in_IN cells_NNS that_WDT are_VBP devoid_JJ of_IN MRAP_NNP ._. 
When_WRB MC2R_NNP is_VBZ coexpressed_VBN with_IN MRAP_NNP ,_, however_RB ,_, as_IN in_IN adrenocortical_JJ cell_NN lines_NNS or_CC in_IN appropriately_RB transfected_VBN cells_NNS ,_, the_DT MC2R_NNP is_VBZ seen_VBN to_TO traffic_NN to_TO the_DT plasma_NN membrane_NN and_CC to_TO generate_VB a_DT signal_NN in_IN response_NN to_TO ACTH_NNP -LRB-_-LRB- 2_CD 
MRAP_NNP appears_VBZ to_TO have_VB an_DT important_JJ additional_JJ function_NN in_IN assisting_VBG ACTH_NNP binding_JJ and_CC consequently_RB signal_VB transduction_NN -LRB-_-LRB- 3_CD ,_, 4_CD -RRB-_-RRB- ._. 
Mutations_NNS in_IN MRAP_NNP result_NN in_IN a_DT syndrome_NN of_IN severe_JJ ACTH_NNP insensitivity_NN -LRB-_-LRB- 6_CD ,_, 7_CD -RRB-_-RRB- ,_, and_CC knockdown_NN of_IN MRAP_NNP in_IN an_DT adrenocortical_JJ cell_NN line_NN reduces_VBZ ACTH_NNP responsiveness_NN -LRB-_-LRB- 8_CD -RRB-_-RRB- ._. 
MRAP_NNP functions_NNS as_IN a_DT homodimer_NN that_WDT is_VBZ highly_RB resistant_JJ to_TO dissociation_NN by_IN sodium_NN dodecyl_NN sulfate_NN and_CC 
MRAP_NNP appears_VBZ to_TO have_VB an_DT important_JJ additional_JJ function_NN in_IN assisting_VBG ACTH_NNP binding_JJ and_CC consequently_RB signal_VB transduction_NN -LRB-_-LRB- 3_CD ,_, 4_CD -RRB-_-RRB- ._. 
Mutations_NNS in_IN MRAP_NNP result_NN in_IN a_DT syndrome_NN of_IN severe_JJ ACTH_NNP insensitivity_NN -LRB-_-LRB- 6_CD ,_, 7_CD -RRB-_-RRB- ,_, and_CC knockdown_NN of_IN MRAP_NNP in_IN an_DT adrenocortical_JJ cell_NN line_NN reduces_VBZ ACTH_NNP responsiveness_NN -LRB-_-LRB- 8_CD -RRB-_-RRB- ._. 
MRAP_NNP functions_NNS as_IN a_DT homodimer_NN that_WDT is_VBZ highly_RB resistant_JJ to_TO dissociation_NN by_IN sodium_NN dodecyl_NN sulfate_NN and_CC 
The_DT receptor_NN mediating_VBG this_DT action_NN is_VBZ the_DT melanocortin_NN 2_CD receptor_NN -LRB-_-LRB- MC2R_NNP -RRB-_-RRB- ,_, a_DT member_NN of_IN the_DT melanocortin_NN receptor_NN family_NN that_WDT collectively_RB forms_VBZ a_DT subfamily_NN of_IN the_DT rhodopsin_NN \/_NN 
Similar_JJ to_TO the_DT other_JJ four_CD members_NNS of_IN the_DT melanocortin_NN receptor_NN family_NN ,_, the_DT MC2R_NNP signals_VBZ primarily_RB via_IN the_DT G_NNP protein_NN G_NNP 
The_DT MC2R_NNP is_VBZ retained_VBN at_IN the_DT endoplasmic_JJ reticulum_NN -LRB-_-LRB- ER_NNP -RRB-_-RRB- when_WRB expressed_VBN in_IN cells_NNS that_WDT are_VBP devoid_JJ of_IN MRAP_NNP ._. 
When_WRB MC2R_NNP is_VBZ coexpressed_VBN with_IN MRAP_NNP ,_, however_RB ,_, as_IN in_IN adrenocortical_JJ cell_NN lines_NNS or_CC in_IN appropriately_RB transfected_VBN cells_NNS ,_, the_DT MC2R_NNP is_VBZ seen_VBN to_TO traffic_NN to_TO the_DT plasma_NN membrane_NN and_CC to_TO generate_VB a_DT signal_NN in_IN response_NN to_TO ACTH_NNP -LRB-_-LRB- 2_CD 
Discussion_NNP An_NNP emerging_VBG theme_NN in_IN GPCR_NNP biology_NN is_VBZ the_DT requirement_NN of_IN some_DT receptors_NNS for_IN accessory_JJ proteins_NNS that_WDT assist_VBP trafficking_NN and_CC ligand_NN binding_JJ ._. 
The_DT RAMP_NN proteins_NNS ,_, which_WDT classically_RB associate_JJ with_IN the_DT calcitonin_NN receptor_NN and_CC calcitonin-like_JJ receptor_NN ,_, provide_VBP the_DT prototype_NN for_IN this_DT class_NN of_IN proteins_NNS ,_, and_CC features_NNS such_JJ as_IN the_DT association_NN with_IN receptor_NN in_IN the_DT ER_NNP ,_, trafficking_NN to_TO the_DT plasma_NN membrane_NN ,_, and_CC contribution_NN to_TO ligand_VB binding_JJ and_CC signaling_VBG are_VBP also_RB identified_VBN with_IN the_DT receptor_NN transporting_VBG proteins_NNS ,_, receptor_NN expression_NN enhancing_VBG protein_NN and_CC MRAP_NNP proteins_NNS -LRB-_-LRB- 2_CD ,_, 16_CD 
The_DT MC2R_NNP is_VBZ retained_VBN at_IN the_DT endoplasmic_JJ reticulum_NN -LRB-_-LRB- ER_NNP -RRB-_-RRB- when_WRB expressed_VBN in_IN cells_NNS that_WDT are_VBP devoid_JJ of_IN MRAP_NNP ._. 
When_WRB MC2R_NNP is_VBZ coexpressed_VBN with_IN MRAP_NNP ,_, however_RB ,_, as_IN in_IN adrenocortical_JJ cell_NN lines_NNS or_CC in_IN appropriately_RB transfected_VBN cells_NNS ,_, the_DT MC2R_NNP is_VBZ seen_VBN to_TO traffic_NN to_TO the_DT plasma_NN membrane_NN and_CC to_TO generate_VB a_DT signal_NN in_IN response_NN to_TO ACTH_NNP -LRB-_-LRB- 2_CD 
MRAP_NNP therefore_RB acts_VBZ as_IN an_DT accessory_JJ factor_NN by_IN facilitating_VBG trafficking_NN of_IN the_DT MC2R_NNP to_TO the_DT cell_NN surface_NN ._. 
MRAP_NNP appears_VBZ to_TO have_VB an_DT important_JJ additional_JJ function_NN in_IN assisting_VBG ACTH_NNP binding_JJ and_CC consequently_RB signal_VB transduction_NN -LRB-_-LRB- 3_CD ,_, 4_CD -RRB-_-RRB- ._. 
Mutations_NNS in_IN MRAP_NNP result_NN in_IN a_DT syndrome_NN of_IN severe_JJ ACTH_NNP insensitivity_NN -LRB-_-LRB- 6_CD ,_, 7_CD -RRB-_-RRB- ,_, and_CC knockdown_NN of_IN MRAP_NNP in_IN an_DT adrenocortical_JJ cell_NN line_NN reduces_VBZ ACTH_NNP responsiveness_NN -LRB-_-LRB- 8_CD -RRB-_-RRB- ._. 
4B_CD -RRB-_-RRB- ._. 
An_DT alternative_JJ possibility_NN ,_, that_IN agonist_JJ stimulation_NN led_VBD to_TO additional_JJ recruitment_NN of_IN MRAP_NNP into_IN the_DT receptor_NN complex_NN ,_, was_VBD investigated_VBN by_IN coimmunoprecipitation_NN studies_NNS ,_, but_CC no_DT evidence_NN for_IN this_DT occurrence_NN was_VBD found_VBN -LRB-_-LRB- Fig_NNP ._. 
The_DT four_CD bands_NNS that_WDT are_VBP represented_VBN by_IN the_DT arrows_NNS in_IN this_DT figure_NN are_VBP typical_JJ of_IN the_DT appearance_NN of_IN human_JJ MRAP_NNP on_IN immunoblotting_VBG that_IN we_PRP have_VBP reported_VBN previously_RB -LRB-_-LRB- 3_CD -RRB-_-RRB- ._. 
The_DT predicted_VBD molecular_JJ mass_NN of_IN the_DT human_JJ MRAP_NNP Flag_NNP protein_NN is_VBZ 24_CD kDa_NNP ,_, and_CC the_DT multiple_JJ bands_NNS may_MD correspond_VB to_TO posttranslationally_RB modified_VBN MRAP_NNP or_CC cleavage_NN products_NNS ._. 
MRAP_NNP appears_VBZ to_TO have_VB an_DT important_JJ additional_JJ function_NN in_IN assisting_VBG ACTH_NNP binding_JJ and_CC consequently_RB signal_VB transduction_NN -LRB-_-LRB- 3_CD ,_, 4_CD -RRB-_-RRB- ._. 
Mutations_NNS in_IN MRAP_NNP result_NN in_IN a_DT syndrome_NN of_IN severe_JJ ACTH_NNP insensitivity_NN -LRB-_-LRB- 6_CD ,_, 7_CD -RRB-_-RRB- ,_, and_CC knockdown_NN of_IN MRAP_NNP in_IN an_DT adrenocortical_JJ cell_NN line_NN reduces_VBZ ACTH_NNP responsiveness_NN -LRB-_-LRB- 8_CD -RRB-_-RRB- ._. 
MRAP_NNP functions_NNS as_IN a_DT homodimer_NN that_WDT is_VBZ highly_RB resistant_JJ to_TO dissociation_NN by_IN sodium_NN dodecyl_NN sulfate_NN and_CC 
Mutations_NNS in_IN MRAP_NNP result_NN in_IN a_DT syndrome_NN of_IN severe_JJ ACTH_NNP insensitivity_NN -LRB-_-LRB- 6_CD ,_, 7_CD -RRB-_-RRB- ,_, and_CC knockdown_NN of_IN MRAP_NNP in_IN an_DT adrenocortical_JJ cell_NN line_NN reduces_VBZ ACTH_NNP responsiveness_NN -LRB-_-LRB- 8_CD -RRB-_-RRB- ._. 
MRAP_NNP functions_NNS as_IN a_DT homodimer_NN that_WDT is_VBZ highly_RB resistant_JJ to_TO dissociation_NN by_IN sodium_NN dodecyl_NN sulfate_NN and_CC 
MRAP_NNP functions_NNS as_IN a_DT homodimer_NN that_WDT is_VBZ highly_RB resistant_JJ to_TO dissociation_NN by_IN sodium_NN dodecyl_NN sulfate_NN and_CC 
The_DT RAMP_NN proteins_NNS ,_, which_WDT classically_RB associate_JJ with_IN the_DT calcitonin_NN receptor_NN and_CC calcitonin-like_JJ receptor_NN ,_, provide_VBP the_DT prototype_NN for_IN this_DT class_NN of_IN proteins_NNS ,_, and_CC features_NNS such_JJ as_IN the_DT association_NN with_IN receptor_NN in_IN the_DT ER_NNP ,_, trafficking_NN to_TO the_DT plasma_NN membrane_NN ,_, and_CC contribution_NN to_TO ligand_VB binding_JJ and_CC signaling_VBG are_VBP also_RB identified_VBN with_IN the_DT receptor_NN transporting_VBG proteins_NNS ,_, receptor_NN expression_NN enhancing_VBG protein_NN and_CC MRAP_NNP proteins_NNS -LRB-_-LRB- 2_CD ,_, 16_CD 
This_DT discrepancy_NN could_MD stem_VB from_IN the_DT fact_NN that_IN the_DT majority_NN of_IN these_DT reports_NNS are_VBP performed_VBN in_IN vitro_NN -LRB-_-LRB- 49_CD ,_, 50_CD ,_, 52_CD -RRB-_-RRB- ._. 
The_DT few_JJ studies_NNS that_WDT measure_VBP the_DT effect_NN of_IN TNF_NNP 
The_DT few_JJ studies_NNS that_WDT measure_VBP the_DT effect_NN of_IN TNF_NNP 
Notably_RB ,_, higher_JJR expression_NN levels_NNS of_IN ATGL_NNP and_CC HSL_NNP ,_, along_IN with_IN TNF_NNP 
The_DT few_JJ studies_NNS that_WDT measure_VBP the_DT effect_NN of_IN TNF_NNP 
Thus_RB ,_, we_PRP propose_VBP that_WDT elevated_VBD TNF_NNP 
Given_VBN the_DT scarce_JJ information_NN on_IN the_DT effects_NNS of_IN JunB_NNP in_IN AT_NNP ,_, despite_IN that_DT its_PRP$ up-regulation_NN is_VBZ found_VBN among_IN the_DT first_JJ responses_NNS of_IN AT_NNP to_TO nutrient_NN signals_NNS such_JJ as_IN insulin_NN ,_, the_DT present_JJ paper_NN addresses_VBZ the_DT role_NN of_IN JunB_NN deficiency_NN in_IN AT_NNP metabolism_NN ._. 
JunB_NN knockout_NN -LRB-_-LRB- JunB-KO_JJ -RRB-_-RRB- mice_NNS suffer_VBP from_IN chronic_JJ myeloid_JJ leukemia-like_JJ disease_NN -LRB-_-LRB- 15_CD ,_, 16_CD -RRB-_-RRB- ._. 
It_PRP was_VBD reported_VBN that_IN they_PRP are_VBP growth_NN retarded_JJ and_CC show_VB reduced_JJ bone_NN formation_NN and_CC longitudinal_JJ bone_NN growth_NN -LRB-_-LRB- 17_CD ,_, 18_CD -RRB-_-RRB- ._. 
Discussion_NN In_IN this_DT study_NN ,_, we_PRP have_VBP explored_VBN the_DT effects_NNS of_IN JunB_NN deficiency_NN on_IN AT_NNP metabolism_NN in_IN mice_NNS ._. 
Lack_NN of_IN JunB_NN in_IN the_DT embryo_NN is_VBZ lethal_JJ ,_, but_CC strategies_NNS have_VBP been_VBN developed_VBN to_TO obtain_VB viable_JJ JunB-deficient_JJ mice_NNS -LRB-_-LRB- 17_CD ,_, 16_CD -RRB-_-RRB- ._. 
We_PRP found_VBD that_IN these_DT JunB-deficient_JJ animals_NNS have_VBP strongly_RB reduced_VBN weight_NN gain_NN reflected_VBN by_IN massively_RB reduced_VBN AT_NNP mass_NN ,_, leading_VBG to_TO a_DT death_NN rate_NN of_IN approximately_RB 70_CD %_NN within_IN the_DT first_JJ 4_CD months_NNS after_IN birth_NN ._. 
JunB_NN knockout_NN -LRB-_-LRB- JunB-KO_JJ -RRB-_-RRB- mice_NNS suffer_VBP from_IN chronic_JJ myeloid_JJ leukemia-like_JJ disease_NN -LRB-_-LRB- 15_CD ,_, 16_CD -RRB-_-RRB- ._. 
Given_VBN the_DT scarce_JJ information_NN on_IN the_DT effects_NNS of_IN JunB_NNP in_IN AT_NNP ,_, despite_IN that_DT its_PRP$ up-regulation_NN is_VBZ found_VBN among_IN the_DT first_JJ responses_NNS of_IN AT_NNP to_TO nutrient_NN signals_NNS such_JJ as_IN insulin_NN ,_, the_DT present_JJ paper_NN addresses_VBZ the_DT role_NN of_IN JunB_NN deficiency_NN in_IN AT_NNP metabolism_NN ._. 
It_PRP was_VBD reported_VBN that_IN they_PRP are_VBP growth_NN retarded_JJ and_CC show_VB reduced_JJ bone_NN formation_NN and_CC longitudinal_JJ bone_NN growth_NN -LRB-_-LRB- 17_CD ,_, 18_CD -RRB-_-RRB- ._. 
Here_RB we_PRP show_VBP that_IN the_DT growth_NN retardation_NN of_IN JunB-deficient_JJ mice_NNS correlates_VBZ with_IN a_DT strongly_RB reduced_VBN fat_JJ mass_NN -LRB-_-LRB- and_CC is_VBZ also_RB associated_VBN with_IN high_JJ lethality_NN -RRB-_-RRB- ._. 
From_IN these_DT results_NNS ,_, we_PRP conclude_VBP that_IN the_DT reduced_VBN AT_NNP mass_NN seems_VBZ to_TO be_VB a_DT consequence_NN of_IN increased_VBN lipolytic_JJ rate_NN ,_, most_RBS likely_RB mediated_VBN by_IN a_DT combination_NN of_IN ATGL\/HSL_NNP up-regulation_NN and_CC perilipin_NN down-regulation_NN ._. 
Materials_NNPS and_CC MethodsAnimal_NNP experimentsMice_NNP carrying_VBG the_DT floxed_FW JunB_FW allele_FW -LRB-_-LRB- JunBfl\/fl_NNP -RRB-_-RRB- were_VBD crossed_VBN to_TO MORE-Cre_JJ mice_NNS to_TO derive_VB JunB-deficient_JJ mice_NNS -LRB-_-LRB- 17_CD -RRB-_-RRB- ._. 
Only_RB male_JJ mice_NNS were_VBD used_VBN for_IN this_DT study_NN ._. 
Animals_NNS were_VBD kept_VBN on_IN a_DT 12-h_JJ light_NN ,_, 12-h_JJ dark_JJ cycle_NN and_CC on_IN a_DT standard_JJ laboratory_NN chow_NN diet_NN -LRB-_-LRB- 4_CD ._. 
Discussion_NN In_IN this_DT study_NN ,_, we_PRP have_VBP explored_VBN the_DT effects_NNS of_IN JunB_NN deficiency_NN on_IN AT_NNP metabolism_NN in_IN mice_NNS ._. 
Lack_NN of_IN JunB_NN in_IN the_DT embryo_NN is_VBZ lethal_JJ ,_, but_CC strategies_NNS have_VBP been_VBN developed_VBN to_TO obtain_VB viable_JJ JunB-deficient_JJ mice_NNS -LRB-_-LRB- 17_CD ,_, 16_CD -RRB-_-RRB- ._. 
We_PRP found_VBD that_IN these_DT JunB-deficient_JJ animals_NNS have_VBP strongly_RB reduced_VBN weight_NN gain_NN reflected_VBN by_IN massively_RB reduced_VBN AT_NNP mass_NN ,_, leading_VBG to_TO a_DT death_NN rate_NN of_IN approximately_RB 70_CD %_NN within_IN the_DT first_JJ 4_CD months_NNS after_IN birth_NN ._. 
Insulin_NN has_VBZ been_VBN shown_VBN to_TO be_VB an_DT important_JJ hormonal_JJ regulator_NN of_IN HSL_NNP and_CC ATGL_NNP expression_NN and_CC activity_NN -LRB-_-LRB- 32_CD 
It_PRP down-regulates_VBZ expression_NN of_IN adipogenic_JJ marker_NN genes_NNS like_IN PPAR_NNP 
Here_RB we_PRP show_VBP that_IN the_DT growth_NN retardation_NN of_IN JunB-deficient_JJ mice_NNS correlates_VBZ with_IN a_DT strongly_RB reduced_VBN fat_JJ mass_NN -LRB-_-LRB- and_CC is_VBZ also_RB associated_VBN with_IN high_JJ lethality_NN -RRB-_-RRB- ._. 
However_RB ,_, although_IN expression_NN levels_NNS of_IN JunB_NN have_VBP been_VBN shown_VBN to_TO influence_VB adipogenesis_NNS in_IN vitro_NN -LRB-_-LRB- 14_CD -RRB-_-RRB- ,_, we_PRP could_MD not_RB find_VB any_DT changes_NNS in_IN the_DT expression_NN of_IN adipogenic_JJ marker_NN genes_NNS like_IN C\/EBP_NNP 
These_DT data_NNS indicate_VBP that_IN the_DT capacity_NN to_TO gain_VB weight_NN is_VBZ retained_VBN in_IN JunB-KO_JJ mice_NNS ,_, which_WDT strongly_RB reverses_VBZ the_DT early_JJ death_NN of_IN these_DT mice_NNS ._. 
JunB_NN is_VBZ not_RB required_VBN for_IN adipogenic_JJ differentiation_NN of_IN 3T3-L1_NN cells_NNS and_CC MEFRecently_NNP ,_, it_PRP has_VBZ been_VBN published_VBN that_IN overexpression_NN of_IN JunB_NN blocks_NNS adipocytic_JJ differentiation_NN in_IN highly_RB aggressive_JJ sarcomas_NNS and_CC in_IN 3T3-L1_CD cells_NNS through_IN an_DT interaction_NN with_IN C\/EBP_NNP 
To_TO analyze_VB whether_IN JunB_NN is_VBZ involved_VBN in_IN the_DT acquisition_NN of_IN fat_JJ stores_NNS ,_, we_PRP examined_VBD whether_IN JunB_NNP is_VBZ involved_VBN in_IN adipogenesis_NN ._. 
In_IN fact_NN ,_, it_PRP has_VBZ been_VBN previously_RB shown_VBN that_IN JunB_NN overexpression_NN reduces_VBZ adipocytic_JJ differentiation_NN through_IN an_DT interaction_NN with_IN C\/EBP_NNP 
Given_VBN the_DT scarce_JJ information_NN on_IN the_DT effects_NNS of_IN JunB_NNP in_IN AT_NNP ,_, despite_IN that_DT its_PRP$ up-regulation_NN is_VBZ found_VBN among_IN the_DT first_JJ responses_NNS of_IN AT_NNP to_TO nutrient_NN signals_NNS such_JJ as_IN insulin_NN ,_, the_DT present_JJ paper_NN addresses_VBZ the_DT role_NN of_IN JunB_NN deficiency_NN in_IN AT_NNP metabolism_NN ._. 
JunB_NN knockout_NN -LRB-_-LRB- JunB-KO_JJ -RRB-_-RRB- mice_NNS suffer_VBP from_IN chronic_JJ myeloid_JJ leukemia-like_JJ disease_NN -LRB-_-LRB- 15_CD ,_, 16_CD -RRB-_-RRB- ._. 
It_PRP was_VBD reported_VBN that_IN they_PRP are_VBP growth_NN retarded_JJ and_CC show_VB reduced_JJ bone_NN formation_NN and_CC longitudinal_JJ bone_NN growth_NN -LRB-_-LRB- 17_CD ,_, 18_CD -RRB-_-RRB- ._. 
JunB_NN and_CC other_JJ AP-1_NN proteins_NNS are_VBP early_JJ responders_NNS to_TO mitogenic_JJ stimuli_NNS ,_, such_JJ as_IN insulin_NN ,_, which_WDT up-regulates_VBZ JunB_NN in_IN several_JJ model_NN systems_NNS like_IN human_JJ myotubes_NNS -LRB-_-LRB- 8_CD -RRB-_-RRB- and_CC 3T3-L1_CD adipocytes_NNS -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
In_IN vivo_NN ,_, JunB_NN expression_NN responds_VBZ to_TO plasma_NN insulin_NN levels_NNS in_IN human_JJ skeletal_JJ muscle_NN -LRB-_-LRB- SM_NNP -RRB-_-RRB- -LRB-_-LRB- 10_CD -RRB-_-RRB- and_CC murine_JJ liver_NN and_CC adipose_NN tissue_NN -LRB-_-LRB- AT_NNP -RRB-_-RRB- -LRB-_-LRB- 11_CD -RRB-_-RRB- and_CC is_VBZ influenced_VBN by_IN plasma_NN glucose_NN concentrations_NNS in_IN mouse_NN liver_NN and_CC AT_NNP -LRB-_-LRB- 11_CD ,_, 12_CD -RRB-_-RRB- ._. 
All_PDT these_DT facts_NNS highlight_VBP that_DT JunB_NN might_MD have_VB an_DT important_JJ role_NN in_IN insulin-sensitive_JJ tissues_NNS ,_, but_CC its_PRP$ exact_JJ function_NN remains_VBZ unclear_JJ ._. 
Until_IN today_NN ,_, little_RB was_VBD known_VBN about_IN the_DT influence_NN of_IN AP-1_JJ proteins_NNS on_IN adipocyte_JJ differentiation_NN or_CC fat_JJ cell_NN metabolism_NN ._. 
DeltaFosB_NNP ,_, another_DT AP-1_NNP family_NN member_NN ,_, inhibits_VBZ adipogenesis_NNS both_DT in_IN vivo_NN and_CC in_IN vitro_NN -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
It_PRP down-regulates_VBZ expression_NN of_IN adipogenic_JJ marker_NN genes_NNS like_IN PPAR_NNP 
DeltaFosB_NNP ,_, another_DT AP-1_NNP family_NN member_NN ,_, inhibits_VBZ adipogenesis_NNS both_DT in_IN vivo_NN and_CC in_IN vitro_NN -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
Until_IN today_NN ,_, little_RB was_VBD known_VBN about_IN the_DT influence_NN of_IN AP-1_JJ proteins_NNS on_IN adipocyte_JJ differentiation_NN or_CC fat_JJ cell_NN metabolism_NN ._. 
It_PRP down-regulates_VBZ expression_NN of_IN adipogenic_JJ marker_NN genes_NNS like_IN PPAR_NNP 
JunB_NN and_CC other_JJ AP-1_NN proteins_NNS are_VBP early_JJ responders_NNS to_TO mitogenic_JJ stimuli_NNS ,_, such_JJ as_IN insulin_NN ,_, which_WDT up-regulates_VBZ JunB_NN in_IN several_JJ model_NN systems_NNS like_IN human_JJ myotubes_NNS -LRB-_-LRB- 8_CD -RRB-_-RRB- and_CC 3T3-L1_CD adipocytes_NNS -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
In_IN vivo_NN ,_, JunB_NN expression_NN responds_VBZ to_TO plasma_NN insulin_NN levels_NNS in_IN human_JJ skeletal_JJ muscle_NN -LRB-_-LRB- SM_NNP -RRB-_-RRB- -LRB-_-LRB- 10_CD -RRB-_-RRB- and_CC murine_JJ liver_NN and_CC adipose_NN tissue_NN -LRB-_-LRB- AT_NNP -RRB-_-RRB- -LRB-_-LRB- 11_CD -RRB-_-RRB- and_CC is_VBZ influenced_VBN by_IN plasma_NN glucose_NN concentrations_NNS in_IN mouse_NN liver_NN and_CC AT_NNP -LRB-_-LRB- 11_CD ,_, 12_CD -RRB-_-RRB- ._. 
All_PDT these_DT facts_NNS highlight_VBP that_DT JunB_NN might_MD have_VB an_DT important_JJ role_NN in_IN insulin-sensitive_JJ tissues_NNS ,_, but_CC its_PRP$ exact_JJ function_NN remains_VBZ unclear_JJ ._. 
JunB_NN and_CC other_JJ AP-1_NN proteins_NNS are_VBP early_JJ responders_NNS to_TO mitogenic_JJ stimuli_NNS ,_, such_JJ as_IN insulin_NN ,_, which_WDT up-regulates_VBZ JunB_NN in_IN several_JJ model_NN systems_NNS like_IN human_JJ myotubes_NNS -LRB-_-LRB- 8_CD -RRB-_-RRB- and_CC 3T3-L1_CD adipocytes_NNS -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
In_IN vivo_NN ,_, JunB_NN expression_NN responds_VBZ to_TO plasma_NN insulin_NN levels_NNS in_IN human_JJ skeletal_JJ muscle_NN -LRB-_-LRB- SM_NNP -RRB-_-RRB- -LRB-_-LRB- 10_CD -RRB-_-RRB- and_CC murine_JJ liver_NN and_CC adipose_NN tissue_NN -LRB-_-LRB- AT_NNP -RRB-_-RRB- -LRB-_-LRB- 11_CD -RRB-_-RRB- and_CC is_VBZ influenced_VBN by_IN plasma_NN glucose_NN concentrations_NNS in_IN mouse_NN liver_NN and_CC AT_NNP -LRB-_-LRB- 11_CD ,_, 12_CD -RRB-_-RRB- ._. 
All_PDT these_DT facts_NNS highlight_VBP that_DT JunB_NN might_MD have_VB an_DT important_JJ role_NN in_IN insulin-sensitive_JJ tissues_NNS ,_, but_CC its_PRP$ exact_JJ function_NN remains_VBZ unclear_JJ ._. 
JunB_NN and_CC other_JJ AP-1_NN proteins_NNS are_VBP early_JJ responders_NNS to_TO mitogenic_JJ stimuli_NNS ,_, such_JJ as_IN insulin_NN ,_, which_WDT up-regulates_VBZ JunB_NN in_IN several_JJ model_NN systems_NNS like_IN human_JJ myotubes_NNS -LRB-_-LRB- 8_CD -RRB-_-RRB- and_CC 3T3-L1_CD adipocytes_NNS -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
In_IN vivo_NN ,_, JunB_NN expression_NN responds_VBZ to_TO plasma_NN insulin_NN levels_NNS in_IN human_JJ skeletal_JJ muscle_NN -LRB-_-LRB- SM_NNP -RRB-_-RRB- -LRB-_-LRB- 10_CD -RRB-_-RRB- and_CC murine_JJ liver_NN and_CC adipose_NN tissue_NN -LRB-_-LRB- AT_NNP -RRB-_-RRB- -LRB-_-LRB- 11_CD -RRB-_-RRB- and_CC is_VBZ influenced_VBN by_IN plasma_NN glucose_NN concentrations_NNS in_IN mouse_NN liver_NN and_CC AT_NNP -LRB-_-LRB- 11_CD ,_, 12_CD -RRB-_-RRB- ._. 
All_PDT these_DT facts_NNS highlight_VBP that_DT JunB_NN might_MD have_VB an_DT important_JJ role_NN in_IN insulin-sensitive_JJ tissues_NNS ,_, but_CC its_PRP$ exact_JJ function_NN remains_VBZ unclear_JJ ._. 
JunB_NN knockout_NN -LRB-_-LRB- JunB-KO_JJ -RRB-_-RRB- mice_NNS suffer_VBP from_IN chronic_JJ myeloid_JJ leukemia-like_JJ disease_NN -LRB-_-LRB- 15_CD ,_, 16_CD -RRB-_-RRB- ._. 
Given_VBN the_DT scarce_JJ information_NN on_IN the_DT effects_NNS of_IN JunB_NNP in_IN AT_NNP ,_, despite_IN that_DT its_PRP$ up-regulation_NN is_VBZ found_VBN among_IN the_DT first_JJ responses_NNS of_IN AT_NNP to_TO nutrient_NN signals_NNS such_JJ as_IN insulin_NN ,_, the_DT present_JJ paper_NN addresses_VBZ the_DT role_NN of_IN JunB_NN deficiency_NN in_IN AT_NNP metabolism_NN ._. 
It_PRP was_VBD reported_VBN that_IN they_PRP are_VBP growth_NN retarded_JJ and_CC show_VB reduced_JJ bone_NN formation_NN and_CC longitudinal_JJ bone_NN growth_NN -LRB-_-LRB- 17_CD ,_, 18_CD -RRB-_-RRB- ._. 
Here_RB we_PRP show_VBP that_IN the_DT growth_NN retardation_NN of_IN JunB-deficient_JJ mice_NNS correlates_VBZ with_IN a_DT strongly_RB reduced_VBN fat_JJ mass_NN -LRB-_-LRB- and_CC is_VBZ also_RB associated_VBN with_IN high_JJ lethality_NN -RRB-_-RRB- ._. 
Silencing_VBG of_IN JunB_NN using_VBG short_JJ hairpin_NN RNA_NNP -LRB-_-LRB- shRNA_NNP -RRB-_-RRB- lentivirus_NN particles_VBZ One_CD control_NN nontargeting_VBG shRNA_NNP lentivirus_NNS and_CC four_CD shRNA_JJ lentiviruses_NNS directed_VBN against_IN JunB_NNP were_VBD purchased_VBN from_IN Sigma_NNP -LRB-_-LRB- MISSION_NNP shRNA_NNP lentiviral_JJ particles_NNS NM_008416_NNP -RRB-_-RRB- ._. 
Gene_NNP silencing_VBG in_IN 3T3-L1_NN cells_NNS was_VBD performed_VBN as_RB previously_RB described_VBN elsewhere_RB -LRB-_-LRB- 19_CD -RRB-_-RRB- ._. 
Cell_NN culture_NN and_CC differentiation_NN analysis_NN 3T3-L1_NN cells_NNS were_VBD grown_VBN and_CC induced_VBN to_TO differentiate_VB as_RB previously_RB described_VBN elsewhere_RB -LRB-_-LRB- 19_CD -RRB-_-RRB- ._. 
Gene_NNP silencing_VBG in_IN 3T3-L1_NN cells_NNS was_VBD performed_VBN as_RB previously_RB described_VBN elsewhere_RB -LRB-_-LRB- 19_CD -RRB-_-RRB- ._. 
Silencing_VBG of_IN JunB_NN using_VBG short_JJ hairpin_NN RNA_NNP -LRB-_-LRB- shRNA_NNP -RRB-_-RRB- lentivirus_NN particles_VBZ One_CD control_NN nontargeting_VBG shRNA_NNP lentivirus_NNS and_CC four_CD shRNA_JJ lentiviruses_NNS directed_VBN against_IN JunB_NNP were_VBD purchased_VBN from_IN Sigma_NNP -LRB-_-LRB- MISSION_NNP shRNA_NNP lentiviral_JJ particles_NNS NM_008416_NNP -RRB-_-RRB- ._. 
Cell_NN culture_NN and_CC differentiation_NN analysis3T3-L1_NN cells_NNS were_VBD grown_VBN and_CC induced_VBN to_TO differentiate_VB as_RB previously_RB described_VBN elsewhere_RB -LRB-_-LRB- 19_CD -RRB-_-RRB- ._. 
Mouse_NNP embryonic_JJ fibroblasts_NNS -LRB-_-LRB- MEF_NNP -RRB-_-RRB- from_IN WT_NNP and_CC JunB-KO_NNP animals_NNS were_VBD harvested_VBN from_IN intercrosses_NNS between_IN heterozygous_JJ JunB-KO_JJ mice_NNS as_IN described_VBN elsewhere_RB -LRB-_-LRB- 20_CD -RRB-_-RRB- ._. 
Because_IN insulin_NN is_VBZ known_VBN as_IN a_DT pivotal_JJ lipolytic_JJ hormone_NN -LRB-_-LRB- 32_CD 
However_RB ,_, the_DT IST_NNP showed_VBD that_IN there_EX is_VBZ ameliorated_JJ insulin_NN sensitivity_NN in_IN JunB-KO_JJ mice_NNS ,_, which_WDT might_MD in_IN turn_NN lead_NN to_TO the_DT lower_JJR glucose_NN and_CC insulin_NN levels_NNS displayed_VBN by_IN these_DT mice_NNS ._. 
This_DT result_NN is_VBZ somewhat_RB surprising_JJ because_IN most_JJS of_IN the_DT more_RBR severely_RB lipodystrophic_JJ mouse_NN models_NNS are_VBP insulin_NN resistant_NN -LRB-_-LRB- 59_CD 
The_DT topic_NN of_IN nutritional_JJ reversion_NN of_IN cachexia_NN is_VBZ also_RB highly_RB controversial_JJ ._. 
We_PRP also_RB found_VBD that_IN JunB-KO_JJ mice_NNS on_IN a_DT HFD_NNP can_MD normalize_VB their_PRP$ weight_NN to_TO WT_VB levels_NNS within_IN 4_CD 
For_IN cancer_NN cachexia_NN ,_, it_PRP has_VBZ been_VBN shown_VBN that_IN neither_DT oral_JJ nor_CC iv_JJ nutritional_JJ supplementation_NN can_MD reverse_VB the_DT weight_NN loss_NN in_IN cachectic_JJ subjects_NNS -LRB-_-LRB- 38_CD -RRB-_-RRB- ._. 
On_IN the_DT other_JJ hand_NN ,_, HFD_NNP have_VBP previously_RB been_VBN shown_VBN to_TO ameliorate_VB cachexia_NN symptoms_NNS in_IN other_JJ noncancerous_JJ animal_NN models_NNS -LRB-_-LRB- 38_CD ,_, 39_CD -RRB-_-RRB- ._. 
Finally_RB ,_, strongly_RB arguing_VBG in_IN favor_NN of_IN a_DT cachexia-resembling_JJ phenotype_NN of_IN JunB-KO_JJ mice_NNS ,_, their_PRP$ decreased_VBN body_NN -LRB-_-LRB- and_CC fat_JJ -RRB-_-RRB- weight_NN might_MD be_VB caused_VBN by_IN increased_JJ transcriptional_JJ up-regulation_NN of_IN the_DT lipolytic_JJ pathway_NN in_IN WAT_NNP ._. 
For_IN cancer_NN cachexia_NN ,_, it_PRP has_VBZ been_VBN shown_VBN that_IN neither_DT oral_JJ nor_CC iv_JJ nutritional_JJ supplementation_NN can_MD reverse_VB the_DT weight_NN loss_NN in_IN cachectic_JJ subjects_NNS -LRB-_-LRB- 38_CD -RRB-_-RRB- ._. 
On_IN the_DT other_JJ hand_NN ,_, HFD_NNP have_VBP previously_RB been_VBN shown_VBN to_TO ameliorate_VB cachexia_NN symptoms_NNS in_IN other_JJ noncancerous_JJ animal_NN models_NNS -LRB-_-LRB- 38_CD ,_, 39_CD -RRB-_-RRB- ._. 
Finally_RB ,_, strongly_RB arguing_VBG in_IN favor_NN of_IN a_DT cachexia-resembling_JJ phenotype_NN of_IN JunB-KO_JJ mice_NNS ,_, their_PRP$ decreased_VBN body_NN -LRB-_-LRB- and_CC fat_JJ -RRB-_-RRB- weight_NN might_MD be_VB caused_VBN by_IN increased_JJ transcriptional_JJ up-regulation_NN of_IN the_DT lipolytic_JJ pathway_NN in_IN WAT_NNP ._. 
Thus_RB ,_, we_PRP propose_VBP that_WDT elevated_VBD TNF_NNP 
Notably_RB ,_, higher_JJR expression_NN levels_NNS of_IN ATGL_NNP and_CC HSL_NNP ,_, along_IN with_IN TNF_NNP 
Thus_RB ,_, the_DT increase_NN of_IN ATGL_NNP and_CC HSL_NNP might_MD be_VB due_JJ to_TO a_DT systemic_JJ effect\/factor_NN in_IN JunB-KO_JJ mice_NNS ,_, like_IN the_DT significantly_RB decreased_VBN insulin_NN levels_NNS ._. 
Insulin_NN has_VBZ been_VBN shown_VBN to_TO be_VB an_DT important_JJ hormonal_JJ regulator_NN of_IN HSL_NNP and_CC ATGL_NNP expression_NN and_CC activity_NN -LRB-_-LRB- 32_CD 
Finally_RB ,_, we_PRP find_VBP significantly_RB reduced_VBN circulating_VBG insulin_NN in_IN fasted_JJ JunB-KO_JJ mice_NNS ._. 
chronically_RB changed_VBN levels_NNS -RRB-_-RRB- are_VBP of_IN major_JJ importance_NN and_CC define_VB the_DT context_NN of_IN TNF_NNP 
JunB-KO_JJ mice_NNS develop_VBP a_DT chronic_JJ myeloid_JJ leukemia-like_JJ disease_NN later_RB in_IN life_NN -LRB-_-LRB- 17_CD -RRB-_-RRB- ,_, but_CC we_PRP report_VBP here_RB that_IN a_DT phenotype_NN resembling_VBG cachexia_NN develops_VBZ early_RB postnatally_RB in_IN these_DT mice_NNS ,_, before_IN the_DT onset_NN of_IN leukemia_NN ._. 
Cachexia_NNP is_VBZ recognized_VBN as_IN a_DT severe_JJ wasting_NN syndrome_NN associated_VBN with_IN cancer_NN or_CC other_JJ nonmalignant_JJ conditions_NNS -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
However_RB ,_, JunB-KO_JJ mice_NNS reflect_VBP only_RB some_DT hallmarks_NNS of_IN cachexia_NN while_IN lacking_VBG others_NNS ._. 
For_IN instance_NN ,_, cachexia_NN is_VBZ characterized_VBN by_IN loss_NN of_IN muscle_NN mass_NN with_IN or_CC without_IN loss_NN of_IN fat_JJ mass_NN -LRB-_-LRB- 36_CD -RRB-_-RRB- ,_, but_CC lean_JJ body_NN mass_NN of_IN JunB-KO_JJ mice_NNS is_VBZ not_RB different_JJ from_IN WT_NNP mice_NNS ._. 
For_IN instance_NN ,_, cachexia_NN is_VBZ characterized_VBN by_IN loss_NN of_IN muscle_NN mass_NN with_IN or_CC without_IN loss_NN of_IN fat_JJ mass_NN -LRB-_-LRB- 36_CD -RRB-_-RRB- ,_, but_CC lean_JJ body_NN mass_NN of_IN JunB-KO_JJ mice_NNS is_VBZ not_RB different_JJ from_IN WT_NNP mice_NNS ._. 
Furthermore_RB ,_, insulin_NN resistance_NN and_CC anorexia_NN are_VBP often_RB associated_VBN with_IN cachexia_NN -LRB-_-LRB- 35_CD -RRB-_-RRB- ,_, which_WDT can_MD not_RB be_VB recapitulated_VBN in_IN JunB-KO_JJ mice_NNS -LRB-_-LRB- they_PRP are_VBP more_JJR insulin_NN sensitive_JJ than_IN WT_NNP mice_NNS ,_, and_CC their_PRP$ food_NN intake_NN is_VBZ equal_JJ to_TO WT_VB mice_NNS -RRB-_-RRB- ,_, although_IN increased_VBN lipolysis_NN in_IN cancer_NN cachexia_NN has_VBZ also_RB been_VBN shown_VBN to_TO occur_VB independently_RB of_IN malnutrition_NN -LRB-_-LRB- 24_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ._. 
We_PRP also_RB found_VBD that_IN JunB-KO_JJ mice_NNS on_IN a_DT HFD_NNP can_MD normalize_VB their_PRP$ weight_NN to_TO WT_VB levels_NNS within_IN 4_CD 
However_RB ,_, JunB-KO_JJ mice_NNS reflect_VBP only_RB some_DT hallmarks_NNS of_IN cachexia_NN while_IN lacking_VBG others_NNS ._. 
Cachexia_NNP is_VBZ recognized_VBN as_IN a_DT severe_JJ wasting_NN syndrome_NN associated_VBN with_IN cancer_NN or_CC other_JJ nonmalignant_JJ conditions_NNS -LRB-_-LRB- 35_CD -RRB-_-RRB- ._. 
For_IN instance_NN ,_, cachexia_NN is_VBZ characterized_VBN by_IN loss_NN of_IN muscle_NN mass_NN with_IN or_CC without_IN loss_NN of_IN fat_JJ mass_NN -LRB-_-LRB- 36_CD -RRB-_-RRB- ,_, but_CC lean_JJ body_NN mass_NN of_IN JunB-KO_JJ mice_NNS is_VBZ not_RB different_JJ from_IN WT_NNP mice_NNS ._. 
Furthermore_RB ,_, insulin_NN resistance_NN and_CC anorexia_NN are_VBP often_RB associated_VBN with_IN cachexia_NN -LRB-_-LRB- 35_CD -RRB-_-RRB- ,_, which_WDT can_MD not_RB be_VB recapitulated_VBN in_IN JunB-KO_JJ mice_NNS -LRB-_-LRB- they_PRP are_VBP more_JJR insulin_NN sensitive_JJ than_IN WT_NNP mice_NNS ,_, and_CC their_PRP$ food_NN intake_NN is_VBZ equal_JJ to_TO WT_VB mice_NNS -RRB-_-RRB- ,_, although_IN increased_VBN lipolysis_NN in_IN cancer_NN cachexia_NN has_VBZ also_RB been_VBN shown_VBN to_TO occur_VB independently_RB of_IN malnutrition_NN -LRB-_-LRB- 24_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ._. 
For_IN instance_NN ,_, cachexia_NN is_VBZ characterized_VBN by_IN loss_NN of_IN muscle_NN mass_NN with_IN or_CC without_IN loss_NN of_IN fat_JJ mass_NN -LRB-_-LRB- 36_CD -RRB-_-RRB- ,_, but_CC lean_JJ body_NN mass_NN of_IN JunB-KO_JJ mice_NNS is_VBZ not_RB different_JJ from_IN WT_NNP mice_NNS ._. 
Furthermore_RB ,_, insulin_NN resistance_NN and_CC anorexia_NN are_VBP often_RB associated_VBN with_IN cachexia_NN -LRB-_-LRB- 35_CD -RRB-_-RRB- ,_, which_WDT can_MD not_RB be_VB recapitulated_VBN in_IN JunB-KO_JJ mice_NNS -LRB-_-LRB- they_PRP are_VBP more_JJR insulin_NN sensitive_JJ than_IN WT_NNP mice_NNS ,_, and_CC their_PRP$ food_NN intake_NN is_VBZ equal_JJ to_TO WT_VB mice_NNS -RRB-_-RRB- ,_, although_IN increased_VBN lipolysis_NN in_IN cancer_NN cachexia_NN has_VBZ also_RB been_VBN shown_VBN to_TO occur_VB independently_RB of_IN malnutrition_NN -LRB-_-LRB- 24_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ._. 
We_PRP also_RB found_VBD that_IN JunB-KO_JJ mice_NNS on_IN a_DT HFD_NNP can_MD normalize_VB their_PRP$ weight_NN to_TO WT_VB levels_NNS within_IN 4_CD 
For_IN instance_NN ,_, cachexia_NN is_VBZ characterized_VBN by_IN loss_NN of_IN muscle_NN mass_NN with_IN or_CC without_IN loss_NN of_IN fat_JJ mass_NN -LRB-_-LRB- 36_CD -RRB-_-RRB- ,_, but_CC lean_JJ body_NN mass_NN of_IN JunB-KO_JJ mice_NNS is_VBZ not_RB different_JJ from_IN WT_NNP mice_NNS ._. 
Furthermore_RB ,_, insulin_NN resistance_NN and_CC anorexia_NN are_VBP often_RB associated_VBN with_IN cachexia_NN -LRB-_-LRB- 35_CD -RRB-_-RRB- ,_, which_WDT can_MD not_RB be_VB recapitulated_VBN in_IN JunB-KO_JJ mice_NNS -LRB-_-LRB- they_PRP are_VBP more_JJR insulin_NN sensitive_JJ than_IN WT_NNP mice_NNS ,_, and_CC their_PRP$ food_NN intake_NN is_VBZ equal_JJ to_TO WT_VB mice_NNS -RRB-_-RRB- ,_, although_IN increased_VBN lipolysis_NN in_IN cancer_NN cachexia_NN has_VBZ also_RB been_VBN shown_VBN to_TO occur_VB independently_RB of_IN malnutrition_NN -LRB-_-LRB- 24_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ._. 
We_PRP also_RB found_VBD that_IN JunB-KO_JJ mice_NNS on_IN a_DT HFD_NNP can_MD normalize_VB their_PRP$ weight_NN to_TO WT_VB levels_NNS within_IN 4_CD 
TNF_NNP 
Additionally_RB ,_, we_PRP found_VBD the_DT expression_NN of_IN perilipin_NN ,_, a_DT lipid_NN droplet-coating_JJ and_CC lipolysis-restricting_JJ protein_NN ,_, to_TO be_VB strongly_RB reduced_VBN in_IN WAT_NNP of_IN JunB-KO_JJ mice_NNS ._. 
TNF_NNP 
Additionally_RB ,_, the_DT plasma_NN FFA_NNP to_TO WAT_NNP mass_NN ratio_NN of_IN fasted_JJ JunB-KO_JJ mice_NNS is_VBZ elevated_VBN ,_, suggesting_VBG increased_VBN lipolysis_NN in_IN agreement_NN with_IN the_DT increased_VBN expression_NN of_IN lipolytic_JJ genes_NNS ._. 
At_IN least_JJS in_IN human_JJ fat_JJ cells_NNS and_CC for_IN HSL_NNP ,_, a_DT strong_JJ positive_JJ correlation_NN between_IN lipolytic_JJ activity_NN and_CC mRNA_NNP expression_NN has_VBZ been_VBN shown_VBN -LRB-_-LRB- 31_CD -RRB-_-RRB- ._. 
Therefore_RB ,_, AT_NNP reduction_NN in_IN JunB-KO_JJ mice_NNS could_MD be_VB due_JJ to_TO an_DT increased_VBN lipolytic_NN rate_NN leading_VBG to_TO decreased_VBN fat_JJ accretion_NN ._. 
Thus_RB ,_, the_DT increase_NN of_IN ATGL_NNP and_CC HSL_NNP might_MD be_VB due_JJ to_TO a_DT systemic_JJ effect\/factor_NN in_IN JunB-KO_JJ mice_NNS ,_, like_IN the_DT significantly_RB decreased_VBN insulin_NN levels_NNS ._. 
Insulin_NN has_VBZ been_VBN shown_VBN to_TO be_VB an_DT important_JJ hormonal_JJ regulator_NN of_IN HSL_NNP and_CC ATGL_NNP expression_NN and_CC activity_NN -LRB-_-LRB- 32_CD 
Finally_RB ,_, we_PRP find_VBP significantly_RB reduced_VBN circulating_VBG insulin_NN in_IN fasted_JJ JunB-KO_JJ mice_NNS ._. 
chronically_RB changed_VBN levels_NNS -RRB-_-RRB- are_VBP of_IN major_JJ importance_NN and_CC define_VB the_DT context_NN of_IN TNF_NNP 
The_DT few_JJ studies_NNS that_WDT measure_VBP the_DT effect_NN of_IN TNF_NNP 
nuclear_JJ factor_NN -_: 
However_RB ,_, there_EX are_VBP also_RB mouse_NN models_NNS with_IN reduced_JJ AT_NNP mass_NN that_WDT develop_VBP neither_DT a_DT fatty_JJ liver_NN nor_CC insulin_NN resistance_NN -LRB-_-LRB- 62_CD -RRB-_-RRB- ._. 
The_DT increased_VBN insulin_NN sensitivity_NN could_MD be_VB an_DT effect_NN of_IN the_DT low_JJ AT_NNP mass_NN ,_, much_RB like_IN the_DT reduction_NN of_IN AT_NNP mass_NN in_IN obesity_NN has_VBZ been_VBN related_VBN to_TO amelioration_NN of_IN insulin_NN sensitivity_NN in_IN part_NN due_JJ to_TO reduced_JJ FA_NNP levels_NNS -LRB-_-LRB- 63_CD ,_, 64_CD -RRB-_-RRB- ._. 
In_IN agreement_NN ,_, a_DT model_NN with_IN a_DT nonsecretable_JJ TNF_NNP 
The_DT few_JJ studies_NNS that_WDT measure_VBP the_DT effect_NN of_IN TNF_NNP 
This_DT result_NN is_VBZ somewhat_RB surprising_JJ because_IN most_JJS of_IN the_DT more_RBR severely_RB lipodystrophic_JJ mouse_NN models_NNS are_VBP insulin_NN resistant_NN -LRB-_-LRB- 59_CD 
However_RB ,_, the_DT IST_NNP showed_VBD that_IN there_EX is_VBZ ameliorated_JJ insulin_NN sensitivity_NN in_IN JunB-KO_JJ mice_NNS ,_, which_WDT might_MD in_IN turn_NN lead_NN to_TO the_DT lower_JJR glucose_NN and_CC insulin_NN levels_NNS displayed_VBN by_IN these_DT mice_NNS ._. 
This_DT result_NN is_VBZ somewhat_RB surprising_JJ because_IN most_JJS of_IN the_DT more_RBR severely_RB lipodystrophic_JJ mouse_NN models_NNS are_VBP insulin_NN resistant_NN -LRB-_-LRB- 59_CD 
Notably_RB ,_, higher_JJR expression_NN levels_NNS of_IN ATGL_NNP and_CC HSL_NNP ,_, along_IN with_IN TNF_NNP 
The_DT few_JJ studies_NNS that_WDT measure_VBP the_DT effect_NN of_IN TNF_NNP 
Thus_RB ,_, our_PRP$ data_NNS suggest_VBP that_IN also_RB up-regulation_NN of_IN ATGL_NNP ,_, along_IN with_IN HSL_NNP ,_, could_MD be_VB involved_VBN in_IN the_DT formation_NN of_IN a_DT cachectic_JJ phenotype_NN ._. 
TNF_NNP 
Thus_RB ,_, our_PRP$ data_NNS suggest_VBP that_IN also_RB up-regulation_NN of_IN ATGL_NNP ,_, along_IN with_IN HSL_NNP ,_, could_MD be_VB involved_VBN in_IN the_DT formation_NN of_IN a_DT cachectic_JJ phenotype_NN ._. 
TNF_NNP 
Thus_RB ,_, our_PRP$ data_NNS suggest_VBP that_IN also_RB up-regulation_NN of_IN ATGL_NNP ,_, along_IN with_IN HSL_NNP ,_, could_MD be_VB involved_VBN in_IN the_DT formation_NN of_IN a_DT cachectic_JJ phenotype_NN ._. 
TNF_NNP 
Interestingly_RB ,_, perilipin_NN -LRB-_-LRB- also_RB a_DT PPAR_NN 
The_DT increased_VBN insulin_NN sensitivity_NN could_MD be_VB an_DT effect_NN of_IN the_DT low_JJ AT_NNP mass_NN ,_, much_RB like_IN the_DT reduction_NN of_IN AT_NNP mass_NN in_IN obesity_NN has_VBZ been_VBN related_VBN to_TO amelioration_NN of_IN insulin_NN sensitivity_NN in_IN part_NN due_JJ to_TO reduced_JJ FA_NNP levels_NNS -LRB-_-LRB- 63_CD ,_, 64_CD -RRB-_-RRB- ._. 
In_IN agreement_NN ,_, a_DT model_NN with_IN a_DT nonsecretable_JJ TNF_NNP 
Increased_VBN lipolysis_NN in_IN cancer_NN cachexia_NN was_VBD previously_RB attributed_VBN to_TO up-regulation_NN of_IN HSL_NNP expression_NN -LRB-_-LRB- 23_CD ,_, 24_CD -RRB-_-RRB- ,_, whereas_IN ATGL_NNP expression_NN was_VBD not_RB changed_VBN -LRB-_-LRB- 23_CD -RRB-_-RRB- ._. 
AT_NNP loss_NN and_CC increased_VBN lipolysis_NNS have_VBP also_RB been_VBN shown_VBN to_TO be_VB associated_VBN with_IN noncancer_JJ cachexia_NN -LRB-_-LRB- 40_CD 
Increased_VBN lipolysis_NN in_IN cancer_NN cachexia_NN was_VBD previously_RB attributed_VBN to_TO up-regulation_NN of_IN HSL_NNP expression_NN -LRB-_-LRB- 23_CD ,_, 24_CD -RRB-_-RRB- ,_, whereas_IN ATGL_NNP expression_NN was_VBD not_RB changed_VBN -LRB-_-LRB- 23_CD -RRB-_-RRB- ._. 
AT_NNP loss_NN and_CC increased_VBN lipolysis_NNS have_VBP also_RB been_VBN shown_VBN to_TO be_VB associated_VBN with_IN noncancer_JJ cachexia_NN -LRB-_-LRB- 40_CD 
However_RB ,_, there_EX are_VBP also_RB mouse_NN models_NNS with_IN reduced_JJ AT_NNP mass_NN that_WDT develop_VBP neither_DT a_DT fatty_JJ liver_NN nor_CC insulin_NN resistance_NN -LRB-_-LRB- 62_CD -RRB-_-RRB- ._. 
The_DT increased_VBN insulin_NN sensitivity_NN could_MD be_VB an_DT effect_NN of_IN the_DT low_JJ AT_NNP mass_NN ,_, much_RB like_IN the_DT reduction_NN of_IN AT_NNP mass_NN in_IN obesity_NN has_VBZ been_VBN related_VBN to_TO amelioration_NN of_IN insulin_NN sensitivity_NN in_IN part_NN due_JJ to_TO reduced_JJ FA_NNP levels_NNS -LRB-_-LRB- 63_CD ,_, 64_CD -RRB-_-RRB- ._. 
In_IN agreement_NN ,_, a_DT model_NN with_IN a_DT nonsecretable_JJ TNF_NNP 
Thus_RB ,_, our_PRP$ data_NNS suggest_VBP that_IN also_RB up-regulation_NN of_IN ATGL_NNP ,_, along_IN with_IN HSL_NNP ,_, could_MD be_VB involved_VBN in_IN the_DT formation_NN of_IN a_DT cachectic_JJ phenotype_NN ._. 
TNF_NNP 
TNF_NNP 
Thus_RB ,_, our_PRP$ data_NNS suggest_VBP that_IN also_RB up-regulation_NN of_IN ATGL_NNP ,_, along_IN with_IN HSL_NNP ,_, could_MD be_VB involved_VBN in_IN the_DT formation_NN of_IN a_DT cachectic_JJ phenotype_NN ._. 
TNF_NNP 
Additionally_RB ,_, we_PRP found_VBD the_DT expression_NN of_IN perilipin_NN ,_, a_DT lipid_NN droplet-coating_JJ and_CC lipolysis-restricting_JJ protein_NN ,_, to_TO be_VB strongly_RB reduced_VBN in_IN WAT_NNP of_IN JunB-KO_JJ mice_NNS ._. 
TNF_NNP 
TNF_NNP 
5A_CD -RRB-_-RRB- ._. 
In_IN addition_NN ,_, HSL_NNP mRNA_NNP expression_NN was_VBD significantly_RB increased_VBN -LRB-_-LRB- Fig_NNP ._. 
5A_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, comparative_JJ gene_NN identification-58_JJ -LRB-_-LRB- CGI-58_NNP -RRB-_-RRB- ,_, an_DT important_JJ activator_NN of_IN ATGL_FW lipolysis_FW ,_, is_VBZ significantly_RB increased_VBN in_IN WAT_NNP of_IN JunB-KO_JJ mice_NNS -LRB-_-LRB- Fig_NNP ._. 
Finally_RB ,_, the_DT plasma_NN FFA_NNP levels_NNS in_IN relation_NN to_TO total_JJ adipose_NN mass_NN -LRB-_-LRB- 23_CD ,_, 24_CD -RRB-_-RRB- of_IN fasted_VBN JunB-deficient_NNP mice_NNS are_VBP 1_CD ._. 
5-fold_JJ elevated_VBD compared_VBN with_IN WT_NNP animals_NNS -LRB-_-LRB- 0_CD ._. 
216_CD 
For_IN instance_NN ,_, cachexia_NN is_VBZ characterized_VBN by_IN loss_NN of_IN muscle_NN mass_NN with_IN or_CC without_IN loss_NN of_IN fat_JJ mass_NN -LRB-_-LRB- 36_CD -RRB-_-RRB- ,_, but_CC lean_JJ body_NN mass_NN of_IN JunB-KO_JJ mice_NNS is_VBZ not_RB different_JJ from_IN WT_NNP mice_NNS ._. 
Furthermore_RB ,_, insulin_NN resistance_NN and_CC anorexia_NN are_VBP often_RB associated_VBN with_IN cachexia_NN -LRB-_-LRB- 35_CD -RRB-_-RRB- ,_, which_WDT can_MD not_RB be_VB recapitulated_VBN in_IN JunB-KO_JJ mice_NNS -LRB-_-LRB- they_PRP are_VBP more_JJR insulin_NN sensitive_JJ than_IN WT_NNP mice_NNS ,_, and_CC their_PRP$ food_NN intake_NN is_VBZ equal_JJ to_TO WT_VB mice_NNS -RRB-_-RRB- ,_, although_IN increased_VBN lipolysis_NN in_IN cancer_NN cachexia_NN has_VBZ also_RB been_VBN shown_VBN to_TO occur_VB independently_RB of_IN malnutrition_NN -LRB-_-LRB- 24_CD ,_, 36_CD ,_, 37_CD -RRB-_-RRB- ._. 
We_PRP also_RB found_VBD that_IN JunB-KO_JJ mice_NNS on_IN a_DT HFD_NNP can_MD normalize_VB their_PRP$ weight_NN to_TO WT_VB levels_NNS within_IN 4_CD 
Finally_RB ,_, strongly_RB arguing_VBG in_IN favor_NN of_IN a_DT cachexia-resembling_JJ phenotype_NN of_IN JunB-KO_JJ mice_NNS ,_, their_PRP$ decreased_VBN body_NN -LRB-_-LRB- and_CC fat_JJ -RRB-_-RRB- weight_NN might_MD be_VB caused_VBN by_IN increased_JJ transcriptional_JJ up-regulation_NN of_IN the_DT lipolytic_JJ pathway_NN in_IN WAT_NNP ._. 
Increased_VBN lipolysis_NN in_IN cancer_NN cachexia_NN was_VBD previously_RB attributed_VBN to_TO up-regulation_NN of_IN HSL_NNP expression_NN -LRB-_-LRB- 23_CD ,_, 24_CD -RRB-_-RRB- ,_, whereas_IN ATGL_NNP expression_NN was_VBD not_RB changed_VBN -LRB-_-LRB- 23_CD -RRB-_-RRB- ._. 
AT_NNP loss_NN and_CC increased_VBN lipolysis_NNS have_VBP also_RB been_VBN shown_VBN to_TO be_VB associated_VBN with_IN noncancer_JJ cachexia_NN -LRB-_-LRB- 40_CD 
5A_CD -RRB-_-RRB- ._. 
In_IN addition_NN ,_, HSL_NNP mRNA_NNP expression_NN was_VBD significantly_RB increased_VBN -LRB-_-LRB- Fig_NNP ._. 
5A_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, comparative_JJ gene_NN identification-58_JJ -LRB-_-LRB- CGI-58_NNP -RRB-_-RRB- ,_, an_DT important_JJ activator_NN of_IN ATGL_FW lipolysis_FW ,_, is_VBZ significantly_RB increased_VBN in_IN WAT_NNP of_IN JunB-KO_JJ mice_NNS -LRB-_-LRB- Fig_NNP ._. 
Finally_RB ,_, the_DT plasma_NN FFA_NNP levels_NNS in_IN relation_NN to_TO total_JJ adipose_NN mass_NN -LRB-_-LRB- 23_CD ,_, 24_CD -RRB-_-RRB- of_IN fasted_VBN JunB-deficient_NNP mice_NNS are_VBP 1_CD ._. 
5-fold_JJ elevated_VBD compared_VBN with_IN WT_NNP animals_NNS -LRB-_-LRB- 0_CD ._. 
216_CD 
Finally_RB ,_, strongly_RB arguing_VBG in_IN favor_NN of_IN a_DT cachexia-resembling_JJ phenotype_NN of_IN JunB-KO_JJ mice_NNS ,_, their_PRP$ decreased_VBN body_NN -LRB-_-LRB- and_CC fat_JJ -RRB-_-RRB- weight_NN might_MD be_VB caused_VBN by_IN increased_JJ transcriptional_JJ up-regulation_NN of_IN the_DT lipolytic_JJ pathway_NN in_IN WAT_NNP ._. 
Increased_VBN lipolysis_NN in_IN cancer_NN cachexia_NN was_VBD previously_RB attributed_VBN to_TO up-regulation_NN of_IN HSL_NNP expression_NN -LRB-_-LRB- 23_CD ,_, 24_CD -RRB-_-RRB- ,_, whereas_IN ATGL_NNP expression_NN was_VBD not_RB changed_VBN -LRB-_-LRB- 23_CD -RRB-_-RRB- ._. 
AT_NNP loss_NN and_CC increased_VBN lipolysis_NNS have_VBP also_RB been_VBN shown_VBN to_TO be_VB associated_VBN with_IN noncancer_JJ cachexia_NN -LRB-_-LRB- 40_CD 
Finally_RB ,_, strongly_RB arguing_VBG in_IN favor_NN of_IN a_DT cachexia-resembling_JJ phenotype_NN of_IN JunB-KO_JJ mice_NNS ,_, their_PRP$ decreased_VBN body_NN -LRB-_-LRB- and_CC fat_JJ -RRB-_-RRB- weight_NN might_MD be_VB caused_VBN by_IN increased_JJ transcriptional_JJ up-regulation_NN of_IN the_DT lipolytic_JJ pathway_NN in_IN WAT_NNP ._. 
Increased_VBN lipolysis_NN in_IN cancer_NN cachexia_NN was_VBD previously_RB attributed_VBN to_TO up-regulation_NN of_IN HSL_NNP expression_NN -LRB-_-LRB- 23_CD ,_, 24_CD -RRB-_-RRB- ,_, whereas_IN ATGL_NNP expression_NN was_VBD not_RB changed_VBN -LRB-_-LRB- 23_CD -RRB-_-RRB- ._. 
AT_NNP loss_NN and_CC increased_VBN lipolysis_NNS have_VBP also_RB been_VBN shown_VBN to_TO be_VB associated_VBN with_IN noncancer_JJ cachexia_NN -LRB-_-LRB- 40_CD 
Relative_JJ mRNA_NNP expression_NN levels_NNS were_VBD calculated_VBN using_VBG averaged_VBD 
After_IN 3_CD d_SYM ,_, medium_NN was_VBD replaced_VBN by_IN growth_NN medium_NN supplemented_VBN with_IN 1_CD 
Cell_NN culture_NN and_CC differentiation_NN analysis_NN 3T3-L1_NN cells_NNS were_VBD grown_VBN and_CC induced_VBN to_TO differentiate_VB as_RB previously_RB described_VBN elsewhere_RB -LRB-_-LRB- 19_CD -RRB-_-RRB- ._. 
Mouse_NNP embryonic_JJ fibroblasts_NNS -LRB-_-LRB- MEF_NNP -RRB-_-RRB- from_IN WT_NNP and_CC JunB-KO_NNP animals_NNS were_VBD harvested_VBN from_IN intercrosses_NNS between_IN heterozygous_JJ JunB-KO_JJ mice_NNS as_IN described_VBN elsewhere_RB -LRB-_-LRB- 20_CD -RRB-_-RRB- ._. 
MEF_NNP were_VBD grown_VBN in_IN culture_NN medium_NN -LRB-_-LRB- 
It_PRP has_VBZ been_VBN described_VBN as_IN a_DT growth-inhibiting_JJ protein_NN that_WDT antagonizes_VBZ the_DT proliferative_JJ effects_NNS of_IN c-Jun_NN ._. 
It_PRP suppresses_VBZ cell_NN proliferation_NN by_IN direct_JJ transcriptional_JJ activation_NN of_IN the_DT cell_NN cycle_NN suppressor_NN p16INK4A_NNP -LRB-_-LRB- 3_NNP -RRB-_-RRB- and_CC by_IN negatively_RB regulating_VBG cyclin_FW D1_FW -LRB-_-LRB- 4_CD -RRB-_-RRB- ._. 
On_IN the_DT other_JJ hand_NN ,_, JunB_NNP has_VBZ also_RB a_DT cell_NN cycle-promoting_JJ role_NN through_IN activating_VBG the_DT transcription_NN of_IN the_DT cell_NN cycle_NN regulator_NN cyclin_NN A_NN -LRB-_-LRB- 5_CD -RRB-_-RRB- ._. 
It_PRP suppresses_VBZ cell_NN proliferation_NN by_IN direct_JJ transcriptional_JJ activation_NN of_IN the_DT cell_NN cycle_NN suppressor_NN p16INK4A_NNP -LRB-_-LRB- 3_NNP -RRB-_-RRB- and_CC by_IN negatively_RB regulating_VBG cyclin_FW D1_FW -LRB-_-LRB- 4_CD -RRB-_-RRB- ._. 
On_IN the_DT other_JJ hand_NN ,_, JunB_NNP has_VBZ also_RB a_DT cell_NN cycle-promoting_JJ role_NN through_IN activating_VBG the_DT transcription_NN of_IN the_DT cell_NN cycle_NN regulator_NN cyclin_NN A_NN -LRB-_-LRB- 5_CD -RRB-_-RRB- ._. 
However_RB ,_, AP-1_JJ proteins_NNS not_RB only_RB act_VB as_IN oncogenes_NNS or_CC tumor_NN suppressors_NNS ,_, but_CC they_PRP are_VBP also_RB involved_VBN in_IN a_DT broader_JJR spectrum_NN of_IN cellular_JJ events_NNS ,_, such_JJ as_IN apoptosis_NN ,_, differentiation_NN ,_, and_CC inflammation_NN -LRB-_-LRB- 1_CD ,_, 6_CD ,_, 7_CD -RRB-_-RRB- ._. 
On_IN the_DT other_JJ hand_NN ,_, JunB_NNP has_VBZ also_RB a_DT cell_NN cycle-promoting_JJ role_NN through_IN activating_VBG the_DT transcription_NN of_IN the_DT cell_NN cycle_NN regulator_NN cyclin_NN A_NN -LRB-_-LRB- 5_CD -RRB-_-RRB- ._. 
However_RB ,_, AP-1_JJ proteins_NNS not_RB only_RB act_VB as_IN oncogenes_NNS or_CC tumor_NN suppressors_NNS ,_, but_CC they_PRP are_VBP also_RB involved_VBN in_IN a_DT broader_JJR spectrum_NN of_IN cellular_JJ events_NNS ,_, such_JJ as_IN apoptosis_NN ,_, differentiation_NN ,_, and_CC inflammation_NN -LRB-_-LRB- 1_CD ,_, 6_CD ,_, 7_CD -RRB-_-RRB- ._. 
JunB_NN and_CC other_JJ AP-1_NN proteins_NNS are_VBP early_JJ responders_NNS to_TO mitogenic_JJ stimuli_NNS ,_, such_JJ as_IN insulin_NN ,_, which_WDT up-regulates_VBZ JunB_NN in_IN several_JJ model_NN systems_NNS like_IN human_JJ myotubes_NNS -LRB-_-LRB- 8_CD -RRB-_-RRB- and_CC 3T3-L1_CD adipocytes_NNS -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
TNF_NNP 
Recently_RB ,_, Guinea-Viniegra_NNP et_FW al._FW ._. 
TNF_NNP 
-LRB-_-LRB- 6_CD -RRB-_-RRB- reported_VBD that_IN Jun_NNP proteins_NNS control_VBP TNF_NNP 
On_IN the_DT other_JJ hand_NN ,_, JunB_NNP has_VBZ also_RB a_DT cell_NN cycle-promoting_JJ role_NN through_IN activating_VBG the_DT transcription_NN of_IN the_DT cell_NN cycle_NN regulator_NN cyclin_NN A_NN -LRB-_-LRB- 5_CD -RRB-_-RRB- ._. 
However_RB ,_, AP-1_JJ proteins_NNS not_RB only_RB act_VB as_IN oncogenes_NNS or_CC tumor_NN suppressors_NNS ,_, but_CC they_PRP are_VBP also_RB involved_VBN in_IN a_DT broader_JJR spectrum_NN of_IN cellular_JJ events_NNS ,_, such_JJ as_IN apoptosis_NN ,_, differentiation_NN ,_, and_CC inflammation_NN -LRB-_-LRB- 1_CD ,_, 6_CD ,_, 7_CD -RRB-_-RRB- ._. 
JunB_NN and_CC other_JJ AP-1_NN proteins_NNS are_VBP early_JJ responders_NNS to_TO mitogenic_JJ stimuli_NNS ,_, such_JJ as_IN insulin_NN ,_, which_WDT up-regulates_VBZ JunB_NN in_IN several_JJ model_NN systems_NNS like_IN human_JJ myotubes_NNS -LRB-_-LRB- 8_CD -RRB-_-RRB- and_CC 3T3-L1_CD adipocytes_NNS -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
JunB_NN is_VBZ a_DT member_NN of_IN the_DT activator_NN protein-1_NN -LRB-_-LRB- AP-1_NN -RRB-_-RRB- transcription_NN factor_NN family_NN ._. 
In_IN summary_NN ,_, this_DT study_NN provides_VBZ valuable_JJ insights_NNS into_IN the_DT impact_NN of_IN JunB_NN deficiency_NN on_IN the_DT metabolic_JJ state_NN of_IN mice_NNS ._. 
Several_JJ AP-1_NN proteins_NNS ,_, including_VBG Jun_NNP ,_, Fos_NNP ,_, and_CC activating_VBG transcription_NN factor_NN family_NN members_NNS dimerize_VBP to_TO exert_VB their_PRP$ actions_NNS -LRB-_-LRB- 1_CD -RRB-_-RRB- ._. 
Among_IN their_PRP$ effects_NNS ,_, the_DT most_RBS investigated_VBN is_VBZ their_PRP$ capacity_NN to_TO modulate_VB proliferation_NN -LRB-_-LRB- for_IN review_NN see_VBP Refs_NNPS ._. 
Among_IN their_PRP$ effects_NNS ,_, the_DT most_RBS investigated_VBN is_VBZ their_PRP$ capacity_NN to_TO modulate_VB proliferation_NN -LRB-_-LRB- for_IN review_NN see_VBP Refs_NNPS ._. 
1and_CD 2_CD -RRB-_-RRB- ._. 
In_IN this_DT regard_NN ,_, JunB_NNP has_VBZ a_DT dual_JJ role_NN ._. 
It_PRP has_VBZ been_VBN described_VBN as_IN a_DT growth-inhibiting_JJ protein_NN that_WDT antagonizes_VBZ the_DT proliferative_JJ effects_NNS of_IN c-Jun_NN ._. 
On_IN the_DT other_JJ hand_NN ,_, JunB_NNP has_VBZ also_RB a_DT cell_NN cycle-promoting_JJ role_NN through_IN activating_VBG the_DT transcription_NN of_IN the_DT cell_NN cycle_NN regulator_NN cyclin_NN A_NN -LRB-_-LRB- 5_CD -RRB-_-RRB- ._. 
However_RB ,_, AP-1_JJ proteins_NNS not_RB only_RB act_VB as_IN oncogenes_NNS or_CC tumor_NN suppressors_NNS ,_, but_CC they_PRP are_VBP also_RB involved_VBN in_IN a_DT broader_JJR spectrum_NN of_IN cellular_JJ events_NNS ,_, such_JJ as_IN apoptosis_NN ,_, differentiation_NN ,_, and_CC inflammation_NN -LRB-_-LRB- 1_CD ,_, 6_CD ,_, 7_CD -RRB-_-RRB- ._. 
JunB_NN and_CC other_JJ AP-1_NN proteins_NNS are_VBP early_JJ responders_NNS to_TO mitogenic_JJ stimuli_NNS ,_, such_JJ as_IN insulin_NN ,_, which_WDT up-regulates_VBZ JunB_NN in_IN several_JJ model_NN systems_NNS like_IN human_JJ myotubes_NNS -LRB-_-LRB- 8_CD -RRB-_-RRB- and_CC 3T3-L1_CD adipocytes_NNS -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
Among_IN their_PRP$ effects_NNS ,_, the_DT most_RBS investigated_VBN is_VBZ their_PRP$ capacity_NN to_TO modulate_VB proliferation_NN -LRB-_-LRB- for_IN review_NN see_VBP Refs_NNPS ._. 
1and_CD 2_CD -RRB-_-RRB- ._. 
In_IN this_DT regard_NN ,_, JunB_NNP has_VBZ a_DT dual_JJ role_NN ._. 
It_PRP has_VBZ been_VBN described_VBN as_IN a_DT growth-inhibiting_JJ protein_NN that_WDT antagonizes_VBZ the_DT proliferative_JJ effects_NNS of_IN c-Jun_NN ._. 
It_PRP has_VBZ been_VBN described_VBN as_IN a_DT growth-inhibiting_JJ protein_NN that_WDT antagonizes_VBZ the_DT proliferative_JJ effects_NNS of_IN c-Jun_NN ._. 
It_PRP suppresses_VBZ cell_NN proliferation_NN by_IN direct_JJ transcriptional_JJ activation_NN of_IN the_DT cell_NN cycle_NN suppressor_NN p16INK4A_NNP -LRB-_-LRB- 3_NNP -RRB-_-RRB- and_CC by_IN negatively_RB regulating_VBG cyclin_FW D1_FW -LRB-_-LRB- 4_CD -RRB-_-RRB- ._. 
On_IN the_DT other_JJ hand_NN ,_, JunB_NNP has_VBZ also_RB a_DT cell_NN cycle-promoting_JJ role_NN through_IN activating_VBG the_DT transcription_NN of_IN the_DT cell_NN cycle_NN regulator_NN cyclin_NN A_NN -LRB-_-LRB- 5_CD -RRB-_-RRB- ._. 
In_IN AT_NNP of_IN JunB-KO_JJ mice_NNS ,_, however_RB ,_, PPAR_NNP 
However_RB ,_, AP-1_JJ proteins_NNS not_RB only_RB act_VB as_IN oncogenes_NNS or_CC tumor_NN suppressors_NNS ,_, but_CC they_PRP are_VBP also_RB involved_VBN in_IN a_DT broader_JJR spectrum_NN of_IN cellular_JJ events_NNS ,_, such_JJ as_IN apoptosis_NN ,_, differentiation_NN ,_, and_CC inflammation_NN -LRB-_-LRB- 1_CD ,_, 6_CD ,_, 7_CD -RRB-_-RRB- ._. 
JunB_NN and_CC other_JJ AP-1_NN proteins_NNS are_VBP early_JJ responders_NNS to_TO mitogenic_JJ stimuli_NNS ,_, such_JJ as_IN insulin_NN ,_, which_WDT up-regulates_VBZ JunB_NN in_IN several_JJ model_NN systems_NNS like_IN human_JJ myotubes_NNS -LRB-_-LRB- 8_CD -RRB-_-RRB- and_CC 3T3-L1_CD adipocytes_NNS -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
In_IN vivo_NN ,_, JunB_NN expression_NN responds_VBZ to_TO plasma_NN insulin_NN levels_NNS in_IN human_JJ skeletal_JJ muscle_NN -LRB-_-LRB- SM_NNP -RRB-_-RRB- -LRB-_-LRB- 10_CD -RRB-_-RRB- and_CC murine_JJ liver_NN and_CC adipose_NN tissue_NN -LRB-_-LRB- AT_NNP -RRB-_-RRB- -LRB-_-LRB- 11_CD -RRB-_-RRB- and_CC is_VBZ influenced_VBN by_IN plasma_NN glucose_NN concentrations_NNS in_IN mouse_NN liver_NN and_CC AT_NNP -LRB-_-LRB- 11_CD ,_, 12_CD -RRB-_-RRB- ._. 
However_RB ,_, AP-1_JJ proteins_NNS not_RB only_RB act_VB as_IN oncogenes_NNS or_CC tumor_NN suppressors_NNS ,_, but_CC they_PRP are_VBP also_RB involved_VBN in_IN a_DT broader_JJR spectrum_NN of_IN cellular_JJ events_NNS ,_, such_JJ as_IN apoptosis_NN ,_, differentiation_NN ,_, and_CC inflammation_NN -LRB-_-LRB- 1_CD ,_, 6_CD ,_, 7_CD -RRB-_-RRB- ._. 
JunB_NN and_CC other_JJ AP-1_NN proteins_NNS are_VBP early_JJ responders_NNS to_TO mitogenic_JJ stimuli_NNS ,_, such_JJ as_IN insulin_NN ,_, which_WDT up-regulates_VBZ JunB_NN in_IN several_JJ model_NN systems_NNS like_IN human_JJ myotubes_NNS -LRB-_-LRB- 8_CD -RRB-_-RRB- and_CC 3T3-L1_CD adipocytes_NNS -LRB-_-LRB- 9_CD -RRB-_-RRB- ._. 
In_IN vivo_NN ,_, JunB_NN expression_NN responds_VBZ to_TO plasma_NN insulin_NN levels_NNS in_IN human_JJ skeletal_JJ muscle_NN -LRB-_-LRB- SM_NNP -RRB-_-RRB- -LRB-_-LRB- 10_CD -RRB-_-RRB- and_CC murine_JJ liver_NN and_CC adipose_NN tissue_NN -LRB-_-LRB- AT_NNP -RRB-_-RRB- -LRB-_-LRB- 11_CD -RRB-_-RRB- and_CC is_VBZ influenced_VBN by_IN plasma_NN glucose_NN concentrations_NNS in_IN mouse_NN liver_NN and_CC AT_NNP -LRB-_-LRB- 11_CD ,_, 12_CD -RRB-_-RRB- ._. 
Taken_VBN together_RB ,_, these_DT data_NNS indicate_VBP that_IN the_DT enhanced_JJ expression_NN of_IN Shh_NNP mRNA_NNP in_IN the_DT cortex_NN is_VBZ accompanied_VBN by_IN significant_JJ increases_NNS in_IN histone_NN acetylation_NN levels_NNS within_IN Shh_NNP ,_, but_CC not_RB Ptc_NNP or_CC Smo_NNP ,_, transcriptional_JJ regulatory_JJ sequences_NNS ._. 
DiscussionThyroid_JJ hormone_NN is_VBZ known_VBN to_TO exert_VB profound_JJ effects_NNS on_IN neurodevelopment_NN and_CC retains_VBZ a_DT powerful_JJ influence_NN on_IN plasticity_NN within_IN the_DT mature_JJ brain_NN ,_, including_VBG key_JJ effects_NNS on_IN adult_JJ hippocampal_JJ neurogenesis_NN -LRB-_-LRB- 13_CD ,_, 15_CD ,_, 50_CD ,_, 51_CD -RRB-_-RRB- ._. 
Although_IN several_JJ thyroid_JJ hormone-responsive_JJ genes_NNS ,_, such_JJ as_IN reelin_NN ,_, Dab-1_NNP ,_, and_CC Neurogenic_NNP differentiation_NN ,_, have_VBP been_VBN hypothesized_VBN to_TO mediate_VB the_DT neurodevelopmental_JJ influences_NNS of_IN thyroid_JJ hormone_NN ,_, most_JJS of_IN these_DT genes_NNS are_VBP transcriptionally_RB responsive_JJ to_TO thyroid_JJ hormone_NN only_RB during_IN select_JJ developmental_JJ time_NN windows_NNS -LRB-_-LRB- 22_CD ,_, 52_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, we_PRP find_VBP that_IN in_IN the_DT embryonic_JJ and_CC adult_JJ mammalian_JJ brain_NN ,_, thyroid_JJ hormone_NN perturbations_NNS induce_VBP a_DT bidirectional_JJ regulation_NN of_IN the_DT Shh_NNP signaling_VBG cascade_NN in_IN a_DT region-specific_JJ manner_NN ._. 
Although_IN TRs_NNP are_VBP known_VBN to_TO be_VB expressed_VBN in_IN the_DT fetal_JJ brain_NN well_RB before_IN the_DT initiation_NN of_IN embryonic_JJ thyroid_JJ hormone_NN synthesis_NN -LRB-_-LRB- 7_CD ,_, 9_CD -RRB-_-RRB- ,_, and_CC epidemiological_JJ evidence_NN indicates_VBZ that_IN thyroid_JJ hormone_NN perturbations_NNS in_IN the_DT first_JJ trimester_NN influence_NN fetal_JJ brain_NN development_NN -LRB-_-LRB- 1_CD ,_, 54_CD -RRB-_-RRB- ,_, so_RB far_RB ,_, only_RB few_JJ thyroid_JJ hormone-responsive_JJ genes_NNS within_IN the_DT fetus_NN have_VBP been_VBN identified_VBN -LRB-_-LRB- 55_CD ,_, 56_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS indicate_VBP that_IN maternal_JJ hyperthyroidism_NN significantly_RB up-regulates_VBZ embryonic_JJ Shh_NNP expression_NN in_IN ventral_JJ forebrain_NN signaling_VBG areas_NNS and_CC the_DT diencephalic_JJ signaling_VBG center_NN of_IN the_DT Zli_NNP ,_, and_CC maternal_JJ hypothyroidism_NN results_NNS in_IN a_DT region-specific_JJ decline_NN of_IN Shh_NNP within_IN the_DT embryonic_JJ Zli_NNP ._. 
Recent_JJ elegant_JJ studies_NNS have_VBP demonstrated_VBN an_DT opposite_JJ regulation_NN ,_, showing_VBG that_IN Shh_NNP signaling_VBG can_MD modulate_VB thyroid_JJ hormone_NN activity_NN in_IN neuronal_JJ cells_NNS through_IN the_DT regulation_NN of_IN deiodinases_NNS 2_CD and_CC 3_CD ._. 
Shh_NNP has_VBZ been_VBN reported_VBN to_TO reduce_VB thyroid_JJ hormone_NN signaling_VBG through_IN decreased_VBN deiodinase_NN 2_CD and_CC enhanced_JJ deiodinase_NN 3_CD activity_NN in_IN astrocytes_NNS and_CC neurons_NNS ,_, respectively_RB -LRB-_-LRB- 74_CD -RRB-_-RRB- ._. 
This_DT then_RB evokes_VBZ the_DT tantalizing_JJ but_CC speculative_JJ possibility_NN of_IN a_DT negative_JJ feedback_NN loop_NN wherein_NN thyroid_NN hormone_NN enhances_VBZ neuronal_JJ Shh_NNP signaling_VBG and_CC Shh_NNP serves_VBZ to_TO restrict_VB thyroid_JJ hormone-mediated_JJ effects_NNS via_IN deiodinase_NN activity_NN modulation_NN ._. 
It_PRP is_VBZ possible_JJ that_IN the_DT relative_JJ extent_NN of_IN unliganded_JJ TR_NNP repressor_NN effects_NNS on_IN Shh_NNP mRNA_NNP expression_NN may_MD still_RB be_VB minimal_JJ in_IN the_DT adult-onset_JJ hypothyroid_JJ brain_NN ._. 
However_RB ,_, a_DT single_JJ previous_JJ study_NN indicates_VBZ that_IN postnatal_JJ hypothyroidism_NN reduces_VBZ Shh_NNP expression_NN in_IN the_DT cerebellum_NN ,_, an_DT effect_NN suggested_VBD to_TO contribute_VB to_TO the_DT cerebellar_JJ morphological_JJ defects_NNS observed_VBN with_IN postnatal_JJ hypothyroidism_NN -LRB-_-LRB- 64_CD -RRB-_-RRB- ._. 
In_IN contrast_NN to_TO the_DT extensive_JJ effects_NNS of_IN adult-onset_JJ hyperthyroidism_NN on_IN expression_NN of_IN the_DT Shh_NNP cascade_NN ,_, hypothyroidism_NN in_IN adulthood_NN resulted_VBD in_IN a_DT spatially_RB restricted_JJ and_CC selective_JJ down-regulation_NN of_IN Smo_NNP expression_NN within_IN the_DT DG_NNP ._. 
Results_NNS Maternal_JJ hypothyroidism_NN decreases_VBZ Shh_NNP signaling_VBG cascade_NN expression_NN in_IN the_DT embryonic_JJ rat_NN brain_NN Shh_NNP is_VBZ expressed_VBN in_IN ventral_JJ signaling_VBG areas_NNS within_IN the_DT Hyp_NNP and_CC ventral_JJ telencephalon_NN ,_, where_WRB it_PRP is_VBZ critical_JJ for_IN the_DT development_NN of_IN the_DT ventral_JJ forebrain_NN ,_, specifying_VBG cell_NN fate_NN choice_NN ,_, proliferation_NN ,_, and_CC survival_NN -LRB-_-LRB- 42_CD 
We_PRP show_VBP that_IN Shh_JJ expression_NN is_VBZ rapidly_RB regulated_VBN both_DT in_IN vivo_NN and_CC in_IN vitro_NN in_IN response_NN to_TO thyroid_JJ hormone_NN ,_, accompanied_VBN by_IN significant_JJ epigenetic_JJ histone_NN modifications_NNS within_IN upstream_JJ regions_NNS of_IN the_DT Shh_NNP gene_NN ._. 
Both_DT thyroid_JJ hormone_NN and_CC Shh_NNP have_VBP been_VBN independently_RB demonstrated_VBN to_TO regulate_VB diverse_JJ aspects_NNS of_IN central_JJ nervous_JJ system_NN development_NN ,_, including_VBG effects_NNS on_IN proliferation_NN and_CC maturation_NN ,_, and_CC to_TO retain_VB a_DT profound_JJ influence_NN on_IN the_DT adult_NN brain_NN ,_, modulating_VBG recruitment_NN ,_, survival_NN ,_, and_CC differentiation_NN of_IN neuronal_JJ and_CC oligodendrocytic_JJ progenitors_NNS -LRB-_-LRB- 13_CD ,_, 14_CD ,_, 29_CD ,_, 31_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS suggest_VBP that_IN specific_JJ developmental_NN and_CC plasticity_NN associated_JJ actions_NNS of_IN thyroid_JJ hormone_NN may_MD be_VB mediated_VBN by_IN its_PRP$ control_NN of_IN the_DT Shh_NNP pathway_NN and_CC motivate_VB future_JJ experiments_NNS to_TO determine_VB the_DT mechanistic_JJ contribution_NN of_IN Shh_NNP to_TO the_DT effects_NNS of_IN thyroid_JJ hormone_NN in_IN both_CC the_DT developing_JJ and_CC mature_JJ nervous_JJ system_NN ._. 
Taken_VBN together_RB ,_, these_DT data_NNS indicate_VBP that_IN the_DT enhanced_JJ expression_NN of_IN Shh_NNP mRNA_NNP in_IN the_DT cortex_NN is_VBZ accompanied_VBN by_IN significant_JJ increases_NNS in_IN histone_NN acetylation_NN levels_NNS within_IN Shh_NNP ,_, but_CC not_RB Ptc_NNP or_CC Smo_NNP ,_, transcriptional_JJ regulatory_JJ sequences_NNS ._. 
DiscussionThyroid_JJ hormone_NN is_VBZ known_VBN to_TO exert_VB profound_JJ effects_NNS on_IN neurodevelopment_NN and_CC retains_VBZ a_DT powerful_JJ influence_NN on_IN plasticity_NN within_IN the_DT mature_JJ brain_NN ,_, including_VBG key_JJ effects_NNS on_IN adult_JJ hippocampal_JJ neurogenesis_NN -LRB-_-LRB- 13_CD ,_, 15_CD ,_, 50_CD ,_, 51_CD -RRB-_-RRB- ._. 
Although_IN several_JJ thyroid_JJ hormone-responsive_JJ genes_NNS ,_, such_JJ as_IN reelin_NN ,_, Dab-1_NNP ,_, and_CC Neurogenic_NNP differentiation_NN ,_, have_VBP been_VBN hypothesized_VBN to_TO mediate_VB the_DT neurodevelopmental_JJ influences_NNS of_IN thyroid_JJ hormone_NN ,_, most_JJS of_IN these_DT genes_NNS are_VBP transcriptionally_RB responsive_JJ to_TO thyroid_JJ hormone_NN only_RB during_IN select_JJ developmental_JJ time_NN windows_NNS -LRB-_-LRB- 22_CD ,_, 52_CD -RRB-_-RRB- ._. 
In_IN contrast_NN to_TO the_DT extensive_JJ effects_NNS of_IN adult-onset_JJ hyperthyroidism_NN on_IN expression_NN of_IN the_DT Shh_NNP cascade_NN ,_, hypothyroidism_NN in_IN adulthood_NN resulted_VBD in_IN a_DT spatially_RB restricted_JJ and_CC selective_JJ down-regulation_NN of_IN Smo_NNP expression_NN within_IN the_DT DG_NNP ._. 
Adult-onset_JJ hypothyroidism_NN is_VBZ known_VBN to_TO result_VB in_IN a_DT neurogenic_JJ decline_NN ,_, through_IN a_DT reduced_VBN proliferation_NN ,_, survival_NN ,_, and_CC neuronal_JJ differentiation_NN of_IN hippocampal_JJ progenitors_NNS -LRB-_-LRB- 12_CD ,_, 13_CD ,_, 15_CD -RRB-_-RRB- ._. 
Shh_NNP is_VBZ essential_JJ to_TO the_DT maintenance_NN of_IN the_DT adult_JJ hippocampal_JJ stem_NN cell_NN niche_NN and_CC is_VBZ known_VBN to_TO modulate_VB the_DT proliferation_NN ,_, survival_NN ,_, and_CC maintenance_NN of_IN adult_NN progenitors_NNS -LRB-_-LRB- 29_CD ,_, 31_CD -RRB-_-RRB- ._. 
However_RB ,_, maternally_RB derived_VBN thyroid_NN hormone_NN ,_, transported_VBN via_IN the_DT placenta_NN ,_, is_VBZ known_VBN to_TO alter_VB neural_JJ progenitor_NN proliferation_NN ,_, differentiation_NN ,_, and_CC migration_NN within_IN the_DT developing_VBG embryo_NN ,_, which_WDT expresses_VBZ thyroid_JJ hormone_NN receptor_NN -LRB-_-LRB- TR_NNP -RRB-_-RRB- isoforms_NNS before_IN the_DT onset_NN of_IN fetal_JJ thyroid_JJ hormone_NN synthesis_NN -LRB-_-LRB- 5_CD 
In_IN contrast_NN to_TO the_DT extensive_JJ effects_NNS of_IN adult-onset_JJ hyperthyroidism_NN on_IN expression_NN of_IN the_DT Shh_NNP cascade_NN ,_, hypothyroidism_NN in_IN adulthood_NN resulted_VBD in_IN a_DT spatially_RB restricted_JJ and_CC selective_JJ down-regulation_NN of_IN Smo_NNP expression_NN within_IN the_DT DG_NNP ._. 
Adult-onset_JJ hypothyroidism_NN is_VBZ known_VBN to_TO result_VB in_IN a_DT neurogenic_JJ decline_NN ,_, through_IN a_DT reduced_VBN proliferation_NN ,_, survival_NN ,_, and_CC neuronal_JJ differentiation_NN of_IN hippocampal_JJ progenitors_NNS -LRB-_-LRB- 12_CD ,_, 13_CD ,_, 15_CD -RRB-_-RRB- ._. 
Shh_NNP is_VBZ essential_JJ to_TO the_DT maintenance_NN of_IN the_DT adult_JJ hippocampal_JJ stem_NN cell_NN niche_NN and_CC is_VBZ known_VBN to_TO modulate_VB the_DT proliferation_NN ,_, survival_NN ,_, and_CC maintenance_NN of_IN adult_NN progenitors_NNS -LRB-_-LRB- 29_CD ,_, 31_CD -RRB-_-RRB- ._. 
Taken_VBN together_RB ,_, these_DT data_NNS indicate_VBP that_IN the_DT enhanced_JJ expression_NN of_IN Shh_NNP mRNA_NNP in_IN the_DT cortex_NN is_VBZ accompanied_VBN by_IN significant_JJ increases_NNS in_IN histone_NN acetylation_NN levels_NNS within_IN Shh_NNP ,_, but_CC not_RB Ptc_NNP or_CC Smo_NNP ,_, transcriptional_JJ regulatory_JJ sequences_NNS ._. 
DiscussionThyroid_JJ hormone_NN is_VBZ known_VBN to_TO exert_VB profound_JJ effects_NNS on_IN neurodevelopment_NN and_CC retains_VBZ a_DT powerful_JJ influence_NN on_IN plasticity_NN within_IN the_DT mature_JJ brain_NN ,_, including_VBG key_JJ effects_NNS on_IN adult_JJ hippocampal_JJ neurogenesis_NN -LRB-_-LRB- 13_CD ,_, 15_CD ,_, 50_CD ,_, 51_CD -RRB-_-RRB- ._. 
Although_IN several_JJ thyroid_JJ hormone-responsive_JJ genes_NNS ,_, such_JJ as_IN reelin_NN ,_, Dab-1_NNP ,_, and_CC Neurogenic_NNP differentiation_NN ,_, have_VBP been_VBN hypothesized_VBN to_TO mediate_VB the_DT neurodevelopmental_JJ influences_NNS of_IN thyroid_JJ hormone_NN ,_, most_JJS of_IN these_DT genes_NNS are_VBP transcriptionally_RB responsive_JJ to_TO thyroid_JJ hormone_NN only_RB during_IN select_JJ developmental_JJ time_NN windows_NNS -LRB-_-LRB- 22_CD ,_, 52_CD -RRB-_-RRB- ._. 
In_IN contrast_NN to_TO the_DT extensive_JJ effects_NNS of_IN adult-onset_JJ hyperthyroidism_NN on_IN expression_NN of_IN the_DT Shh_NNP cascade_NN ,_, hypothyroidism_NN in_IN adulthood_NN resulted_VBD in_IN a_DT spatially_RB restricted_JJ and_CC selective_JJ down-regulation_NN of_IN Smo_NNP expression_NN within_IN the_DT DG_NNP ._. 
Adult-onset_JJ hypothyroidism_NN is_VBZ known_VBN to_TO result_VB in_IN a_DT neurogenic_JJ decline_NN ,_, through_IN a_DT reduced_VBN proliferation_NN ,_, survival_NN ,_, and_CC neuronal_JJ differentiation_NN of_IN hippocampal_JJ progenitors_NNS -LRB-_-LRB- 12_CD ,_, 13_CD ,_, 15_CD -RRB-_-RRB- ._. 
Shh_NNP is_VBZ essential_JJ to_TO the_DT maintenance_NN of_IN the_DT adult_JJ hippocampal_JJ stem_NN cell_NN niche_NN and_CC is_VBZ known_VBN to_TO modulate_VB the_DT proliferation_NN ,_, survival_NN ,_, and_CC maintenance_NN of_IN adult_NN progenitors_NNS -LRB-_-LRB- 29_CD ,_, 31_CD -RRB-_-RRB- ._. 
Shh_NNP is_VBZ essential_JJ to_TO the_DT maintenance_NN of_IN the_DT adult_JJ hippocampal_JJ stem_NN cell_NN niche_NN and_CC is_VBZ known_VBN to_TO modulate_VB the_DT proliferation_NN ,_, survival_NN ,_, and_CC maintenance_NN of_IN adult_NN progenitors_NNS -LRB-_-LRB- 29_CD ,_, 31_CD -RRB-_-RRB- ._. 
We_PRP have_VBP previously_RB demonstrated_VBN an_DT effect_NN of_IN adult-onset_JJ hypothyroidism_NN on_IN hippocampal_JJ progenitors_NNS -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
Hypothyroidism_NNP resulted_VBD in_IN a_DT significant_JJ decrease_NN in_IN Smo_NNP mRNA_NNP levels_NNS selectively_RB in_IN the_DT DG_NNP ,_, raising_VBG the_DT intriguing_JJ possibility_NN that_IN the_DT neurogenic_JJ decline_NN observed_VBN in_IN hypothyroid_JJ animals_NNS may_MD be_VB mediated_VBN through_IN a_DT reduced_VBN responsivity_NN to_TO Shh_VB signaling_VBG ._. 
We_PRP show_VBP that_IN Shh_JJ expression_NN is_VBZ rapidly_RB regulated_VBN both_DT in_IN vivo_NN and_CC in_IN vitro_NN in_IN response_NN to_TO thyroid_JJ hormone_NN ,_, accompanied_VBN by_IN significant_JJ epigenetic_JJ histone_NN modifications_NNS within_IN upstream_JJ regions_NNS of_IN the_DT Shh_NNP gene_NN ._. 
Both_DT thyroid_JJ hormone_NN and_CC Shh_NNP have_VBP been_VBN independently_RB demonstrated_VBN to_TO regulate_VB diverse_JJ aspects_NNS of_IN central_JJ nervous_JJ system_NN development_NN ,_, including_VBG effects_NNS on_IN proliferation_NN and_CC maturation_NN ,_, and_CC to_TO retain_VB a_DT profound_JJ influence_NN on_IN the_DT adult_NN brain_NN ,_, modulating_VBG recruitment_NN ,_, survival_NN ,_, and_CC differentiation_NN of_IN neuronal_JJ and_CC oligodendrocytic_JJ progenitors_NNS -LRB-_-LRB- 13_CD ,_, 14_CD ,_, 29_CD ,_, 31_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS suggest_VBP that_IN specific_JJ developmental_NN and_CC plasticity_NN associated_JJ actions_NNS of_IN thyroid_JJ hormone_NN may_MD be_VB mediated_VBN by_IN its_PRP$ control_NN of_IN the_DT Shh_NNP pathway_NN and_CC motivate_VB future_JJ experiments_NNS to_TO determine_VB the_DT mechanistic_JJ contribution_NN of_IN Shh_NNP to_TO the_DT effects_NNS of_IN thyroid_JJ hormone_NN in_IN both_CC the_DT developing_JJ and_CC mature_JJ nervous_JJ system_NN ._. 
Our_PRP$ results_NNS raise_VBP the_DT possibility_NN that_IN specific_JJ neurodevelopmental_JJ actions_NNS of_IN thyroid_JJ hormone_NN may_MD be_VB mediated_VBN by_IN its_PRP$ control_NN of_IN the_DT Shh_NNP pathway_NN ,_, providing_VBG a_DT mechanistic_JJ link_NN between_IN thyroid_JJ hormone_NN perturbations_NNS and_CC early_JJ developmental_JJ effects_NNS ._. 
For_IN example_NN ,_, maternal_JJ thyroid_JJ hormone_NN deficiency_NN is_VBZ associated_VBN with_IN impaired_JJ cortical_JJ interneuron_NN development_NN ,_, in_IN particular_JJ of_IN parvalbumin_NN and_CC calretinin_NN immunoreactive_JJ neocortical_JJ interneurons_NNS -LRB-_-LRB- 10_CD ,_, 11_CD ,_, 57_CD -RRB-_-RRB- ._. 
It_PRP is_VBZ particularly_RB intriguing_JJ in_IN this_DT regard_NN to_TO note_NN that_WDT reduced_VBD Shh_NNP signaling_VBG in_IN the_DT embryonic_JJ ventral_JJ forebrain_NN alters_VBZ cortical_JJ interneuron_NN composition_NN ,_, reducing_VBG parvalbumin_JJ positive_JJ interneuron_NN number_NN -LRB-_-LRB- 58_CD -RRB-_-RRB- ._. 
Several_JJ studies_NNS suggest_VBP that_IN the_DT critical_JJ period_NN in_IN which_WDT thyroid_JJ hormone_NN exerts_VBZ dramatic_JJ effects_NNS on_IN neuronal_JJ structure_NN appears_VBZ to_TO be_VB predominantly_RB during_IN early_JJ postnatal_JJ life_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- ._. 
However_RB ,_, maternally_RB derived_VBN thyroid_NN hormone_NN ,_, transported_VBN via_IN the_DT placenta_NN ,_, is_VBZ known_VBN to_TO alter_VB neural_JJ progenitor_NN proliferation_NN ,_, differentiation_NN ,_, and_CC migration_NN within_IN the_DT developing_VBG embryo_NN ,_, which_WDT expresses_VBZ thyroid_JJ hormone_NN receptor_NN -LRB-_-LRB- TR_NNP -RRB-_-RRB- isoforms_NNS before_IN the_DT onset_NN of_IN fetal_JJ thyroid_JJ hormone_NN synthesis_NN -LRB-_-LRB- 5_CD 
Our_PRP$ results_NNS raise_VBP the_DT possibility_NN that_IN specific_JJ neurodevelopmental_JJ actions_NNS of_IN thyroid_JJ hormone_NN may_MD be_VB mediated_VBN by_IN its_PRP$ control_NN of_IN the_DT Shh_NNP pathway_NN ,_, providing_VBG a_DT mechanistic_JJ link_NN between_IN thyroid_JJ hormone_NN perturbations_NNS and_CC early_JJ developmental_JJ effects_NNS ._. 
For_IN example_NN ,_, maternal_JJ thyroid_JJ hormone_NN deficiency_NN is_VBZ associated_VBN with_IN impaired_JJ cortical_JJ interneuron_NN development_NN ,_, in_IN particular_JJ of_IN parvalbumin_NN and_CC calretinin_NN immunoreactive_JJ neocortical_JJ interneurons_NNS -LRB-_-LRB- 10_CD ,_, 11_CD ,_, 57_CD -RRB-_-RRB- ._. 
It_PRP is_VBZ particularly_RB intriguing_JJ in_IN this_DT regard_NN to_TO note_NN that_WDT reduced_VBD Shh_NNP signaling_VBG in_IN the_DT embryonic_JJ ventral_JJ forebrain_NN alters_VBZ cortical_JJ interneuron_NN composition_NN ,_, reducing_VBG parvalbumin_JJ positive_JJ interneuron_NN number_NN -LRB-_-LRB- 58_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, we_PRP find_VBP that_IN in_IN the_DT embryonic_JJ and_CC adult_JJ mammalian_JJ brain_NN ,_, thyroid_JJ hormone_NN perturbations_NNS induce_VBP a_DT bidirectional_JJ regulation_NN of_IN the_DT Shh_NNP signaling_VBG cascade_NN in_IN a_DT region-specific_JJ manner_NN ._. 
Although_IN TRs_NNP are_VBP known_VBN to_TO be_VB expressed_VBN in_IN the_DT fetal_JJ brain_NN well_RB before_IN the_DT initiation_NN of_IN embryonic_JJ thyroid_JJ hormone_NN synthesis_NN -LRB-_-LRB- 7_CD ,_, 9_CD -RRB-_-RRB- ,_, and_CC epidemiological_JJ evidence_NN indicates_VBZ that_IN thyroid_JJ hormone_NN perturbations_NNS in_IN the_DT first_JJ trimester_NN influence_NN fetal_JJ brain_NN development_NN -LRB-_-LRB- 1_CD ,_, 54_CD -RRB-_-RRB- ,_, so_RB far_RB ,_, only_RB few_JJ thyroid_JJ hormone-responsive_JJ genes_NNS within_IN the_DT fetus_NN have_VBP been_VBN identified_VBN -LRB-_-LRB- 55_CD ,_, 56_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS indicate_VBP that_IN maternal_JJ hyperthyroidism_NN significantly_RB up-regulates_VBZ embryonic_JJ Shh_NNP expression_NN in_IN ventral_JJ forebrain_NN signaling_VBG areas_NNS and_CC the_DT diencephalic_JJ signaling_VBG center_NN of_IN the_DT Zli_NNP ,_, and_CC maternal_JJ hypothyroidism_NN results_NNS in_IN a_DT region-specific_JJ decline_NN of_IN Shh_NNP within_IN the_DT embryonic_JJ Zli_NNP ._. 
However_RB ,_, maternally_RB derived_VBN thyroid_NN hormone_NN ,_, transported_VBN via_IN the_DT placenta_NN ,_, is_VBZ known_VBN to_TO alter_VB neural_JJ progenitor_NN proliferation_NN ,_, differentiation_NN ,_, and_CC migration_NN within_IN the_DT developing_VBG embryo_NN ,_, which_WDT expresses_VBZ thyroid_JJ hormone_NN receptor_NN -LRB-_-LRB- TR_NNP -RRB-_-RRB- isoforms_NNS before_IN the_DT onset_NN of_IN fetal_JJ thyroid_JJ hormone_NN synthesis_NN -LRB-_-LRB- 5_CD 
Furthermore_RB ,_, thyroid_JJ hormone_NN is_VBZ known_VBN to_TO exert_VB effects_NNS on_IN neuronal_JJ and_CC glial_JJ progenitor_NN proliferation_NN ,_, survival_NN ,_, and_CC maturation_NN within_IN the_DT adult_NN brain_NN -LRB-_-LRB- 12_CD 
In_IN silico_NN analysis_NN indicated_VBD the_DT presence_NN of_IN putative_JJ TREs_NNS within_IN upstream_JJ regulatory_JJ sequences_NNS of_IN the_DT Shh_NNP gene_NN ._. 
Thyroid_JJ hormone_NN mediated_VBD transcriptional_JJ regulation_NN is_VBZ associated_VBN with_IN recruitment_NN of_IN coactivators_NNS and_CC targeted_JJ histone_NN acetylation_NN changes_NNS in_IN upstream_JJ regions_NNS of_IN thyroid_JJ hormone-responsive_JJ genes_NNS -LRB-_-LRB- 70_CD -RRB-_-RRB- ._. 
Previous_JJ studies_NNS from_IN Xenopus_NNP demonstrate_VBP that_IN T_NNP 3_NNP bound_VBD to_TO TRs_NNP can_MD recruit_VB histone_JJ acetyl_NN transferases_NNS to_TO its_PRP$ target_NN genes_NNS -LRB-_-LRB- 71_CD ,_, 72_CD -RRB-_-RRB- ,_, and_CC the_DT expression_NN of_IN thyroid_JJ hormone-responsive_JJ genes_NNS in_IN Xenopus_NNP has_VBZ also_RB been_VBN shown_VBN to_TO correlate_VB with_IN the_DT acetylation_NN status_NN of_IN their_PRP$ promoters_NNS -LRB-_-LRB- 73_CD -RRB-_-RRB- ._. 
Thyroid_JJ hormone_NN mediated_VBD transcriptional_JJ regulation_NN is_VBZ associated_VBN with_IN recruitment_NN of_IN coactivators_NNS and_CC targeted_JJ histone_NN acetylation_NN changes_NNS in_IN upstream_JJ regions_NNS of_IN thyroid_JJ hormone-responsive_JJ genes_NNS -LRB-_-LRB- 70_CD -RRB-_-RRB- ._. 
Previous_JJ studies_NNS from_IN Xenopus_NNP demonstrate_VBP that_IN T3_NNP bound_VBD to_TO TRs_NNP can_MD recruit_VB histone_JJ acetyl_NN transferases_NNS to_TO its_PRP$ target_NN genes_NNS -LRB-_-LRB- 71_CD ,_, 72_CD -RRB-_-RRB- ,_, and_CC the_DT expression_NN of_IN thyroid_JJ hormone-responsive_JJ genes_NNS in_IN Xenopus_NNP has_VBZ also_RB been_VBN shown_VBN to_TO correlate_VB with_IN the_DT acetylation_NN status_NN of_IN their_PRP$ promoters_NNS -LRB-_-LRB- 73_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS demonstrate_VBP significant_JJ and_CC rapid_JJ in_IN vivo_NN increases_NNS in_IN global_JJ histone_NN H3_CD and_CC H4_CD acetylation_NN both_DT at_IN the_DT putative_JJ TRE_NNP sites_NNS within_IN upstream_JJ regions_NNS of_IN the_DT Shh_NNP gene_NN ,_, as_RB well_RB as_IN close_RB to_TO the_DT transcriptional_JJ start_NN site_NN ._. 
For_IN example_NN ,_, maternal_JJ thyroid_JJ hormone_NN deficiency_NN is_VBZ associated_VBN with_IN impaired_JJ cortical_JJ interneuron_NN development_NN ,_, in_IN particular_JJ of_IN parvalbumin_NN and_CC calretinin_NN immunoreactive_JJ neocortical_JJ interneurons_NNS -LRB-_-LRB- 10_CD ,_, 11_CD ,_, 57_CD -RRB-_-RRB- ._. 
It_PRP is_VBZ particularly_RB intriguing_JJ in_IN this_DT regard_NN to_TO note_NN that_WDT reduced_VBD Shh_NNP signaling_VBG in_IN the_DT embryonic_JJ ventral_JJ forebrain_NN alters_VBZ cortical_JJ interneuron_NN composition_NN ,_, reducing_VBG parvalbumin_JJ positive_JJ interneuron_NN number_NN -LRB-_-LRB- 58_CD -RRB-_-RRB- ._. 
Adult-onset_JJ perturbations_NNS in_IN thyroid_JJ hormone_NN status_NN also_RB significantly_RB regulated_VBN the_DT expression_NN of_IN Shh_NNP signaling_VBG components_NNS in_IN a_DT bidirectional_JJ fashion_NN ,_, suggesting_VBG a_DT continued_JJ sensitivity_NN of_IN Shh_JJ expression_NN to_TO thyroid_JJ hormone_NN into_IN adulthood_NN ._. 
Excess_JJ thyroid_JJ hormone_NN levels_NNS also_RB appear_VBP to_TO unmask_VB Smo_NNP expression_NN within_IN the_DT neocortex_NN ,_, a_DT brain_NN region_NN that_WDT normally_RB has_VBZ very_RB low_JJ levels_NNS of_IN Smo_NNP mRNA_NNP in_IN euthyroid_JJ controls_NNS ,_, and_CC this_DT could_MD serve_VB to_TO potentiate_VB the_DT thyroid_JJ hormone-mediated_JJ effects_NNS on_IN the_DT Shh_NNP signaling_VBG pathway_NN through_IN increased_VBN expression_NN of_IN both_DT the_DT ligand_NN as_RB well_RB as_IN the_DT signaling_VBG receptor_NN ._. 
The_DT enhanced_JJ Ptc_NNP expression_NN observed_VBD in_IN T3-treated_JJ adult_NN animals_NNS could_MD be_VB interpreted_VBN as_IN reflective_JJ of_IN such_JJ increases_NNS in_IN Shh_NNP signaling_VBG ,_, because_IN Ptc_NNP is_VBZ a_DT transcriptional_JJ target_NN of_IN Shh_NNP -LRB-_-LRB- 59_CD ,_, 60_CD -RRB-_-RRB- ._. 
T3_CD administration_NN also_RB significantly_RB enhanced_VBN Smo_NNP mRNA_NNP within_IN the_DT hippocampal_JJ neurogenic_JJ niche_NN ._. 
It_PRP is_VBZ possible_JJ that_IN enhanced_JJ Shh_NNP ligand_NN from_IN the_DT VDB_NNP may_MD be_VB transported_VBN via_IN the_DT septo-hippocampal_JJ pathway_NN resulting_VBG in_IN increased_VBN Shh_NNP signaling_VBG within_IN the_DT hippocampus_NN -LRB-_-LRB- 61_CD -RRB-_-RRB- ,_, which_WDT is_VBZ supported_VBN by_IN the_DT evidence_NN of_IN enhanced_JJ Ptc_NNP expression_NN in_IN the_DT DG_NNP ._. 
Hypoxanthine_JJ phosphoribosyl_NN transferase_NN -LRB-_-LRB- Hprt_NNP -RRB-_-RRB- was_VBD used_VBN as_IN an_DT endogenous_JJ housekeeping_NN gene_NN control_NN ._. 
To_TO compare_VB the_DT expression_NN of_IN Hprt_NNP and_CC target_NN genes_NNS ,_, the_DT comparative_JJ threshold_NN cycle_NN -LRB-_-LRB- CT_NNP -RRB-_-RRB- method_NN was_VBD used_VBN as_IN described_VBN previously_RB -LRB-_-LRB- 38_CD -RRB-_-RRB- ._. 
Primer_NN sequences_NNS used_VBN are_VBP described_VBN in_IN Supplemental_NNP Table_NNP 2_CD ._. 
Data_NNS are_VBP fold_VB change_NN 
Discussion_NNP Thyroid_NNP hormone_NN is_VBZ known_VBN to_TO exert_VB profound_JJ effects_NNS on_IN neurodevelopment_NN and_CC retains_VBZ a_DT powerful_JJ influence_NN on_IN plasticity_NN within_IN the_DT mature_JJ brain_NN ,_, including_VBG key_JJ effects_NNS on_IN adult_JJ hippocampal_JJ neurogenesis_NN -LRB-_-LRB- 13_CD ,_, 15_CD ,_, 50_CD ,_, 51_CD -RRB-_-RRB- ._. 
Although_IN several_JJ thyroid_JJ hormone-responsive_JJ genes_NNS ,_, such_JJ as_IN reelin_NN ,_, Dab-1_NNP ,_, and_CC Neurogenic_NNP differentiation_NN ,_, have_VBP been_VBN hypothesized_VBN to_TO mediate_VB the_DT neurodevelopmental_JJ influences_NNS of_IN thyroid_JJ hormone_NN ,_, most_JJS of_IN these_DT genes_NNS are_VBP transcriptionally_RB responsive_JJ to_TO thyroid_JJ hormone_NN only_RB during_IN select_JJ developmental_JJ time_NN windows_NNS -LRB-_-LRB- 22_CD ,_, 52_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, there_EX are_VBP relatively_RB few_JJ genes_NNS that_WDT retain_VBP thyroid_JJ hormone_NN responsivity_NN across_IN the_DT life_NN span_NN ,_, for_IN example_NN neuroendocrine_NN specific_JJ protein_NN and_CC octamer_NN transcription_NN factor-1_NN ,_, which_WDT are_VBP reported_VBN to_TO be_VB regulated_VBN in_IN both_DT the_DT embryonic_JJ and_CC adult_JJ brain_NN -LRB-_-LRB- 24_CD -RRB-_-RRB- ._. 
Shh_FW +_FW \/_FW LacZ_NNP mice_NNS were_VBD generated_VBN by_IN A._NNP All_NNP animal_NN procedures_NNS were_VBD carried_VBN out_RP in_IN accordance_NN with_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP Guide_NNP for_IN the_DT Care_NNP and_CC Use_NNP of_IN Laboratory_NNP Animals_NNPS and_CC approved_VBN by_IN the_DT Tata_NNP Institute_NNP of_IN Fundamental_JJ Research_NNP and_CC Columbia_NNP University_NNP Institutional_NNP Animal_NNP Ethics_NNP Committees_NNS ._. 
Kottmann_NNP through_IN the_DT targeting_VBG of_IN an_DT internal_JJ ribosome_NN entry_NN site_NN LacZ_NNP construct_VBP into_IN the_DT 3_CD 
Shh_FW +_FW \/_FW LacZ_NNP mice_NNS were_VBD generated_VBN by_IN A._NNP All_NNP animal_NN procedures_NNS were_VBD carried_VBN out_RP in_IN accordance_NN with_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP Guide_NNP for_IN the_DT Care_NNP and_CC Use_NNP of_IN Laboratory_NNP Animals_NNPS and_CC approved_VBN by_IN the_DT Tata_NNP Institute_NNP of_IN Fundamental_JJ Research_NNP and_CC Columbia_NNP University_NNP Institutional_NNP Animal_NNP Ethics_NNP Committees_NNS ._. 
Kottmann_NNP through_IN the_DT targeting_VBG of_IN an_DT internal_JJ ribosome_NN entry_NN site_NN LacZ_NNP construct_VBP into_IN the_DT 3_CD 
Quantitative_JJ analysis_NN for_IN 
Louis_NNP ,_, MO_NNP -RRB-_-RRB- ._. 
The_DT brains_NNS were_VBD postfixed_VBN in_IN 4_CD %_NN paraformaldehyde_NN and_CC free-floating_JJ sections_NNS -LRB-_-LRB- 30_CD 
Cells_NNS were_VBD harvested_VBN 3_CD h_NN after_IN T_NNP 3_CD treatment_NN and_CC processed_VBN for_IN RNA_NNP extraction_NN ,_, with_IN all_DT assays_NNS performed_VBN in_IN triplicate_NN ._. 
Quantitative_JJ PCR_NNP -LRB-_-LRB- qPCR_NNP -RRB-_-RRB- RNA_NNP purification_NN ,_, cDNA_NNP synthesis_NN ,_, and_CC qPCR_NNP were_VBD performed_VBN as_IN described_VBN previously_RB -LRB-_-LRB- 37_CD -RRB-_-RRB- ._. 
In_IN brief_JJ ,_, total_JJ RNA_NNP was_VBD isolated_VBN using_VBG Tri_NNP Reagent_NNP -LRB-_-LRB- Sigma_NNP -RRB-_-RRB- ,_, according_VBG to_TO the_DT manufacturer_NN 's_POS protocol_NN ._. 
Further_RB ,_, under_IN conditions_NNS of_IN damage_NN ,_, reactive_JJ astrocytes_NNS within_IN the_DT cortex_NN are_VBP reported_VBN to_TO express_VB Shh_NNP and_CC induce_VB oligodendrocytic_JJ progenitor_NN proliferation_NN -LRB-_-LRB- 68_CD -RRB-_-RRB- ._. 
Shh_JJ administration_NN into_IN the_DT neocortex_NN of_IN normal_JJ animals_NNS is_VBZ also_RB capable_JJ of_IN recruiting_VBG premyelinating_JJ oligodendrocytic_JJ progenitors_NNS -LRB-_-LRB- 30_CD ,_, 69_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS indicate_VBP that_IN T_NNP 3_NNP administration_NN in_IN normal_JJ animals_NNS induces_VBZ neuronal_JJ Shh_NNP expression_NN ,_, and_CC this_DT may_MD serve_VB to_TO recruit_VB premyelinating_VBG oligodendrocytic_JJ progenitors_NNS even_RB in_IN the_DT absence_NN of_IN overt_JJ damage_NN ._. 
Given_VBN that_IN thyroid_JJ hormone_NN influences_VBZ neural_JJ and_CC glial_JJ progenitors_NNS in_IN both_DT the_DT developing_VBG as_RB well_RB as_IN mature_JJ nervous_JJ system_NN ,_, we_PRP hypothesized_VBD that_IN the_DT expression_NN of_IN developmental_JJ morphogens_NNS ,_, which_WDT retain_VBP a_DT powerful_JJ influence_NN on_IN these_DT progenitors_NNS across_IN the_DT lifespan_NN ,_, may_MD be_VB regulated_VBN by_IN thyroid_JJ hormone_NN ._. 
Sonic_JJ hedgehog_NN -LRB-_-LRB- Shh_NNP -RRB-_-RRB- ,_, a_DT major_JJ developmental_JJ morphogen_NN ,_, is_VBZ thought_VBN to_TO be_VB a_DT key_JJ regulator_NN of_IN neural_JJ and_CC oligodendroglial_JJ progenitors_NNS across_IN development_NN and_CC into_IN adulthood_NN -LRB-_-LRB- 28_CD 
Adult-onset_JJ hypothyroidism_NN is_VBZ known_VBN to_TO result_VB in_IN a_DT neurogenic_JJ decline_NN ,_, through_IN a_DT reduced_VBN proliferation_NN ,_, survival_NN ,_, and_CC neuronal_JJ differentiation_NN of_IN hippocampal_JJ progenitors_NNS -LRB-_-LRB- 12_CD ,_, 13_CD ,_, 15_CD -RRB-_-RRB- ._. 
Shh_NNP is_VBZ essential_JJ to_TO the_DT maintenance_NN of_IN the_DT adult_JJ hippocampal_JJ stem_NN cell_NN niche_NN and_CC is_VBZ known_VBN to_TO modulate_VB the_DT proliferation_NN ,_, survival_NN ,_, and_CC maintenance_NN of_IN adult_NN progenitors_NNS -LRB-_-LRB- 29_CD ,_, 31_CD -RRB-_-RRB- ._. 
We_PRP have_VBP previously_RB demonstrated_VBN an_DT effect_NN of_IN adult-onset_JJ hypothyroidism_NN on_IN hippocampal_JJ progenitors_NNS -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
We_PRP show_VBP that_IN Shh_JJ expression_NN is_VBZ rapidly_RB regulated_VBN both_DT in_IN vivo_NN and_CC in_IN vitro_NN in_IN response_NN to_TO thyroid_JJ hormone_NN ,_, accompanied_VBN by_IN significant_JJ epigenetic_JJ histone_NN modifications_NNS within_IN upstream_JJ regions_NNS of_IN the_DT Shh_NNP gene_NN ._. 
Both_DT thyroid_JJ hormone_NN and_CC Shh_NNP have_VBP been_VBN independently_RB demonstrated_VBN to_TO regulate_VB diverse_JJ aspects_NNS of_IN central_JJ nervous_JJ system_NN development_NN ,_, including_VBG effects_NNS on_IN proliferation_NN and_CC maturation_NN ,_, and_CC to_TO retain_VB a_DT profound_JJ influence_NN on_IN the_DT adult_NN brain_NN ,_, modulating_VBG recruitment_NN ,_, survival_NN ,_, and_CC differentiation_NN of_IN neuronal_JJ and_CC oligodendrocytic_JJ progenitors_NNS -LRB-_-LRB- 13_CD ,_, 14_CD ,_, 29_CD ,_, 31_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS suggest_VBP that_IN specific_JJ developmental_NN and_CC plasticity_NN associated_JJ actions_NNS of_IN thyroid_JJ hormone_NN may_MD be_VB mediated_VBN by_IN its_PRP$ control_NN of_IN the_DT Shh_NNP pathway_NN and_CC motivate_VB future_JJ experiments_NNS to_TO determine_VB the_DT mechanistic_JJ contribution_NN of_IN Shh_NNP to_TO the_DT effects_NNS of_IN thyroid_JJ hormone_NN in_IN both_CC the_DT developing_JJ and_CC mature_JJ nervous_JJ system_NN ._. 
Sonic_JJ hedgehog_NN -LRB-_-LRB- Shh_NNP -RRB-_-RRB- ,_, a_DT major_JJ developmental_JJ morphogen_NN ,_, is_VBZ thought_VBN to_TO be_VB a_DT key_JJ regulator_NN of_IN neural_JJ and_CC oligodendroglial_JJ progenitors_NNS across_IN development_NN and_CC into_IN adulthood_NN -LRB-_-LRB- 28_CD 
Shh_NNP mediates_VBZ its_PRP$ biological_JJ effects_NNS via_IN its_PRP$ membrane-associated_JJ receptors_NNS smoothened_VBD -LRB-_-LRB- Smo_NNP -RRB-_-RRB- and_CC patched_VBN -LRB-_-LRB- Ptc_NNP ,_, Ptch1_NNP -RRB-_-RRB- ,_, such_JJ that_IN Shh_NNP binding_JJ to_TO Ptc_NNP relieves_VBZ the_DT inhibitory_JJ influence_NN of_IN Ptc_NNP on_IN Smo_NNP ,_, thus_RB activating_VBG the_DT downstream_JJ cascade_NN -LRB-_-LRB- 32_CD -RRB-_-RRB- ._. 
Strikingly_RB ,_, during_IN amphibian_JJ metamorphosis_NNS ,_, thyroid_JJ hormone_NN is_VBZ reported_VBN to_TO exert_VB its_PRP$ metamorphic_JJ effects_NNS within_IN the_DT gastrointestinal_JJ system_NN via_IN influencing_VBG Xenopus_NNP hedgehog_NN -LRB-_-LRB- Xhh_NNP -RRB-_-RRB- expression_NN ,_, indicating_VBG that_IN this_DT developmental_JJ signaling_VBG pathway_NN can_MD be_VB targeted_VBN by_IN thyroid_JJ hormone_NN in_IN vertebrates_NNS -LRB-_-LRB- 33_CD -RRB-_-RRB- ._. 
We_PRP hypothesized_VBD that_IN perturbations_NNS of_IN thyroid_JJ hormone_NN status_NN may_MD influence_VB expression_NN of_IN Shh_NNP ,_, or_CC its_PRP$ receptors_NNS Ptc_NNP and_CC Smo_NNP ,_, both_DT in_IN the_DT embryonic_JJ and_CC adult_JJ mammalian_JJ brain_NN ._. 
Perhaps_RB the_DT most_RBS dramatic_JJ example_NN of_IN the_DT tissue_NN morphoregulatory_JJ effects_NNS of_IN thyroid_JJ hormone_NN are_VBP those_DT observed_VBN during_IN amphibian_NN metamorphosis_NN ,_, a_DT process_NN entirely_RB dependent_JJ on_IN the_DT induction_NN of_IN a_DT genetic_JJ program_NN by_IN thyroid_JJ hormone_NN -LRB-_-LRB- 53_CD -RRB-_-RRB- ._. 
Previous_JJ evidence_NN indicates_VBZ that_IN Xhh_NNP is_VBZ an_DT early_JJ ,_, direct_JJ target_NN gene_NN of_IN thyroid_JJ hormone_NN and_CC is_VBZ required_VBN to_TO mediate_VB the_DT metamorphic_JJ effects_NNS of_IN thyroid_JJ hormone_NN in_IN the_DT gastrointestinal_JJ system_NN -LRB-_-LRB- 33_CD -RRB-_-RRB- ._. 
It_PRP is_VBZ interesting_JJ to_TO note_VB that_IN thyroid_JJ hormone-mediated_JJ induction_NN of_IN Xhh_NNP in_IN tadpoles_NNS is_VBZ tissue-specific_JJ with_IN no_DT effects_NNS observed_VBD in_IN the_DT brain_NN -LRB-_-LRB- 33_CD -RRB-_-RRB- ._. 
Previous_JJ evidence_NN indicates_VBZ that_IN Xhh_NNP is_VBZ an_DT early_JJ ,_, direct_JJ target_NN gene_NN of_IN thyroid_JJ hormone_NN and_CC is_VBZ required_VBN to_TO mediate_VB the_DT metamorphic_JJ effects_NNS of_IN thyroid_JJ hormone_NN in_IN the_DT gastrointestinal_JJ system_NN -LRB-_-LRB- 33_CD -RRB-_-RRB- ._. 
It_PRP is_VBZ interesting_JJ to_TO note_VB that_IN thyroid_JJ hormone-mediated_JJ induction_NN of_IN Xhh_NNP in_IN tadpoles_NNS is_VBZ tissue-specific_JJ with_IN no_DT effects_NNS observed_VBD in_IN the_DT brain_NN -LRB-_-LRB- 33_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, we_PRP find_VBP that_IN in_IN the_DT embryonic_JJ and_CC adult_JJ mammalian_JJ brain_NN ,_, thyroid_JJ hormone_NN perturbations_NNS induce_VBP a_DT bidirectional_JJ regulation_NN of_IN the_DT Shh_NNP signaling_VBG cascade_NN in_IN a_DT region-specific_JJ manner_NN ._. 
We_PRP did_VBD not_RB observe_VB 
We_PRP did_VBD not_RB observe_VB 
Our_PRP$ results_NNS raise_VBP the_DT possibility_NN that_IN specific_JJ neurodevelopmental_JJ actions_NNS of_IN thyroid_JJ hormone_NN may_MD be_VB mediated_VBN by_IN its_PRP$ control_NN of_IN the_DT Shh_NNP pathway_NN ,_, providing_VBG a_DT mechanistic_JJ link_NN between_IN thyroid_JJ hormone_NN perturbations_NNS and_CC early_JJ developmental_JJ effects_NNS ._. 
For_IN example_NN ,_, maternal_JJ thyroid_JJ hormone_NN deficiency_NN is_VBZ associated_VBN with_IN impaired_JJ cortical_JJ interneuron_NN development_NN ,_, in_IN particular_JJ of_IN parvalbumin_NN and_CC calretinin_NN immunoreactive_JJ neocortical_JJ interneurons_NNS -LRB-_-LRB- 10_CD ,_, 11_CD ,_, 57_CD -RRB-_-RRB- ._. 
It_PRP is_VBZ particularly_RB intriguing_JJ in_IN this_DT regard_NN to_TO note_NN that_WDT reduced_VBD Shh_NNP signaling_VBG in_IN the_DT embryonic_JJ ventral_JJ forebrain_NN alters_VBZ cortical_JJ interneuron_NN composition_NN ,_, reducing_VBG parvalbumin_JJ positive_JJ interneuron_NN number_NN -LRB-_-LRB- 58_CD -RRB-_-RRB- ._. 
It_PRP is_VBZ possible_JJ that_IN enhanced_JJ Shh_NNP ligand_NN from_IN the_DT VDB_NNP may_MD be_VB transported_VBN via_IN the_DT septo-hippocampal_JJ pathway_NN resulting_VBG in_IN increased_VBN Shh_NNP signaling_VBG within_IN the_DT hippocampus_NN -LRB-_-LRB- 61_CD -RRB-_-RRB- ,_, which_WDT is_VBZ supported_VBN by_IN the_DT evidence_NN of_IN enhanced_JJ Ptc_NNP expression_NN in_IN the_DT DG_NNP ._. 
In_IN this_DT context_NN ,_, it_PRP is_VBZ noteworthy_JJ that_IN T3_NNP administration_NN is_VBZ capable_JJ of_IN increasing_VBG the_DT postmitotic_JJ survival_NN and_CC neuronal_JJ differentiation_NN of_IN hippocampal_JJ progenitors_NNS -LRB-_-LRB- 62_CD -RRB-_-RRB- ,_, an_DT effect_NN that_WDT overlaps_VBZ with_IN the_DT enhanced_JJ survival_NN observed_VBD after_IN treatment_NN with_IN Smo_NNP agonists_NNS -LRB-_-LRB- 63_CD -RRB-_-RRB- ._. 
Although_IN adult_JJ hyperthyroidism_NN significantly_RB enhanced_VBN Shh_NNP ligand_NN expression_NN ,_, we_PRP did_VBD not_RB observe_VB any_DT change_NN in_IN the_DT ligand_NN in_IN adult-onset_JJ hypothyroid_JJ animals_NNS within_IN the_DT brain_NN regions_NNS examined_VBD ._. 
We_PRP provide_VBP novel_JJ evidence_NN that_IN the_DT major_JJ developmental_JJ morphogen_NN Shh_NNP is_VBZ a_DT thyroid_JJ hormone-responsive_JJ gene_NN from_IN the_DT very_RB earliest_JJS stages_NNS of_IN embryonic_JJ forebrain_NN development_NN into_IN adulthood_NN ._. 
Perhaps_RB the_DT most_RBS dramatic_JJ example_NN of_IN the_DT tissue_NN morphoregulatory_JJ effects_NNS of_IN thyroid_JJ hormone_NN are_VBP those_DT observed_VBN during_IN amphibian_NN metamorphosis_NN ,_, a_DT process_NN entirely_RB dependent_JJ on_IN the_DT induction_NN of_IN a_DT genetic_JJ program_NN by_IN thyroid_JJ hormone_NN -LRB-_-LRB- 53_CD -RRB-_-RRB- ._. 
Previous_JJ evidence_NN indicates_VBZ that_IN Xhh_NNP is_VBZ an_DT early_JJ ,_, direct_JJ target_NN gene_NN of_IN thyroid_JJ hormone_NN and_CC is_VBZ required_VBN to_TO mediate_VB the_DT metamorphic_JJ effects_NNS of_IN thyroid_JJ hormone_NN in_IN the_DT gastrointestinal_JJ system_NN -LRB-_-LRB- 33_CD -RRB-_-RRB- ._. 
It_PRP is_VBZ possible_JJ that_IN enhanced_JJ Shh_NNP ligand_NN from_IN the_DT VDB_NNP may_MD be_VB transported_VBN via_IN the_DT septo-hippocampal_JJ pathway_NN resulting_VBG in_IN increased_VBN Shh_NNP signaling_VBG within_IN the_DT hippocampus_NN -LRB-_-LRB- 61_CD -RRB-_-RRB- ,_, which_WDT is_VBZ supported_VBN by_IN the_DT evidence_NN of_IN enhanced_JJ Ptc_NNP expression_NN in_IN the_DT DG_NNP ._. 
In_IN this_DT context_NN ,_, it_PRP is_VBZ noteworthy_JJ that_IN T3_NNP administration_NN is_VBZ capable_JJ of_IN increasing_VBG the_DT postmitotic_JJ survival_NN and_CC neuronal_JJ differentiation_NN of_IN hippocampal_JJ progenitors_NNS -LRB-_-LRB- 62_CD -RRB-_-RRB- ,_, an_DT effect_NN that_WDT overlaps_VBZ with_IN the_DT enhanced_JJ survival_NN observed_VBD after_IN treatment_NN with_IN Smo_NNP agonists_NNS -LRB-_-LRB- 63_CD -RRB-_-RRB- ._. 
Although_IN adult_JJ hyperthyroidism_NN significantly_RB enhanced_VBN Shh_NNP ligand_NN expression_NN ,_, we_PRP did_VBD not_RB observe_VB any_DT change_NN in_IN the_DT ligand_NN in_IN adult-onset_JJ hypothyroid_JJ animals_NNS within_IN the_DT brain_NN regions_NNS examined_VBD ._. 
Thyroid_JJ hormone_NN mediated_VBD transcriptional_JJ regulation_NN is_VBZ associated_VBN with_IN recruitment_NN of_IN coactivators_NNS and_CC targeted_JJ histone_NN acetylation_NN changes_NNS in_IN upstream_JJ regions_NNS of_IN thyroid_JJ hormone-responsive_JJ genes_NNS -LRB-_-LRB- 70_CD -RRB-_-RRB- ._. 
Previous_JJ studies_NNS from_IN Xenopus_NNP demonstrate_VBP that_IN T3_NNP bound_VBD to_TO TRs_NNP can_MD recruit_VB histone_JJ acetyl_NN transferases_NNS to_TO its_PRP$ target_NN genes_NNS -LRB-_-LRB- 71_CD ,_, 72_CD -RRB-_-RRB- ,_, and_CC the_DT expression_NN of_IN thyroid_JJ hormone-responsive_JJ genes_NNS in_IN Xenopus_NNP has_VBZ also_RB been_VBN shown_VBN to_TO correlate_VB with_IN the_DT acetylation_NN status_NN of_IN their_PRP$ promoters_NNS -LRB-_-LRB- 73_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS demonstrate_VBP significant_JJ and_CC rapid_JJ in_IN vivo_NN increases_NNS in_IN global_JJ histone_NN H3_CD and_CC H4_CD acetylation_NN both_DT at_IN the_DT putative_JJ TRE_NNP sites_NNS within_IN upstream_JJ regions_NNS of_IN the_DT Shh_NNP gene_NN ,_, as_RB well_RB as_IN close_RB to_TO the_DT transcriptional_JJ start_NN site_NN ._. 
Recent_JJ studies_NNS suggest_VBP that_IN thyroid_JJ hormone_NN enhances_VBZ oligodendrocytic_JJ progenitor_NN recruitment_NN and_CC maturation_NN to_TO promote_VB recovery_NN in_IN animal_NN models_NNS of_IN demyelination_NN -LRB-_-LRB- 65_CD 
T3_CD administration_NN also_RB significantly_RB enhanced_VBN Smo_NNP mRNA_NNP within_IN the_DT hippocampal_JJ neurogenic_JJ niche_NN ._. 
The_DT enhanced_JJ Ptc_NNP expression_NN observed_VBD in_IN T_NNP 3_CD -_: treated_VBN adult_NN animals_NNS could_MD be_VB interpreted_VBN as_IN reflective_JJ of_IN such_JJ increases_NNS in_IN Shh_NNP signaling_VBG ,_, because_IN Ptc_NNP is_VBZ a_DT transcriptional_JJ target_NN of_IN Shh_NNP -LRB-_-LRB- 59_CD ,_, 60_CD -RRB-_-RRB- ._. 
It_PRP is_VBZ possible_JJ that_IN enhanced_JJ Shh_NNP ligand_NN from_IN the_DT VDB_NNP may_MD be_VB transported_VBN via_IN the_DT septo-hippocampal_JJ pathway_NN resulting_VBG in_IN increased_VBN Shh_NNP signaling_VBG within_IN the_DT hippocampus_NN -LRB-_-LRB- 61_CD -RRB-_-RRB- ,_, which_WDT is_VBZ supported_VBN by_IN the_DT evidence_NN of_IN enhanced_JJ Ptc_NNP expression_NN in_IN the_DT DG_NNP ._. 
In_IN this_DT context_NN ,_, it_PRP is_VBZ noteworthy_JJ that_IN T_NNP 3_NNP administration_NN is_VBZ capable_JJ of_IN increasing_VBG the_DT postmitotic_JJ survival_NN and_CC neuronal_JJ differentiation_NN of_IN hippocampal_JJ progenitors_NNS -LRB-_-LRB- 62_CD -RRB-_-RRB- ,_, an_DT effect_NN that_WDT overlaps_VBZ with_IN the_DT enhanced_JJ survival_NN observed_VBD after_IN treatment_NN with_IN Smo_NNP agonists_NNS -LRB-_-LRB- 63_CD -RRB-_-RRB- ._. 
Further_RB ,_, under_IN conditions_NNS of_IN damage_NN ,_, reactive_JJ astrocytes_NNS within_IN the_DT cortex_NN are_VBP reported_VBN to_TO express_VB Shh_NNP and_CC induce_VB oligodendrocytic_JJ progenitor_NN proliferation_NN -LRB-_-LRB- 68_CD -RRB-_-RRB- ._. 
Shh_JJ administration_NN into_IN the_DT neocortex_NN of_IN normal_JJ animals_NNS is_VBZ also_RB capable_JJ of_IN recruiting_VBG premyelinating_JJ oligodendrocytic_JJ progenitors_NNS -LRB-_-LRB- 30_CD ,_, 69_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS indicate_VBP that_IN T_NNP 3_NNP administration_NN in_IN normal_JJ animals_NNS induces_VBZ neuronal_JJ Shh_NNP expression_NN ,_, and_CC this_DT may_MD serve_VB to_TO recruit_VB premyelinating_VBG oligodendrocytic_JJ progenitors_NNS even_RB in_IN the_DT absence_NN of_IN overt_JJ damage_NN ._. 
Excess_JJ thyroid_JJ hormone_NN levels_NNS also_RB appear_VBP to_TO unmask_VB Smo_NNP expression_NN within_IN the_DT neocortex_NN ,_, a_DT brain_NN region_NN that_WDT normally_RB has_VBZ very_RB low_JJ levels_NNS of_IN Smo_NNP mRNA_NNP in_IN euthyroid_JJ controls_NNS ,_, and_CC this_DT could_MD serve_VB to_TO potentiate_VB the_DT thyroid_JJ hormone-mediated_JJ effects_NNS on_IN the_DT Shh_NNP signaling_VBG pathway_NN through_IN increased_VBN expression_NN of_IN both_DT the_DT ligand_NN as_RB well_RB as_IN the_DT signaling_VBG receptor_NN ._. 
The_DT enhanced_JJ Ptc_NNP expression_NN observed_VBD in_IN T3-treated_JJ adult_NN animals_NNS could_MD be_VB interpreted_VBN as_IN reflective_JJ of_IN such_JJ increases_NNS in_IN Shh_NNP signaling_VBG ,_, because_IN Ptc_NNP is_VBZ a_DT transcriptional_JJ target_NN of_IN Shh_NNP -LRB-_-LRB- 59_CD ,_, 60_CD -RRB-_-RRB- ._. 
T3_CD administration_NN also_RB significantly_RB enhanced_VBN Smo_NNP mRNA_NNP within_IN the_DT hippocampal_JJ neurogenic_JJ niche_NN ._. 
It_PRP is_VBZ possible_JJ that_IN enhanced_JJ Shh_NNP ligand_NN from_IN the_DT VDB_NNP may_MD be_VB transported_VBN via_IN the_DT septo-hippocampal_JJ pathway_NN resulting_VBG in_IN increased_VBN Shh_NNP signaling_VBG within_IN the_DT hippocampus_NN -LRB-_-LRB- 61_CD -RRB-_-RRB- ,_, which_WDT is_VBZ supported_VBN by_IN the_DT evidence_NN of_IN enhanced_JJ Ptc_NNP expression_NN in_IN the_DT DG_NNP ._. 
We_PRP did_VBD not_RB observe_VB 
In_IN contrast_NN ,_, we_PRP find_VBP that_IN in_IN the_DT embryonic_JJ and_CC adult_JJ mammalian_JJ brain_NN ,_, thyroid_JJ hormone_NN perturbations_NNS induce_VBP a_DT bidirectional_JJ regulation_NN of_IN the_DT Shh_NNP signaling_VBG cascade_NN in_IN a_DT region-specific_JJ manner_NN ._. 
Although_IN TRs_NNP are_VBP known_VBN to_TO be_VB expressed_VBN in_IN the_DT fetal_JJ brain_NN well_RB before_IN the_DT initiation_NN of_IN embryonic_JJ thyroid_JJ hormone_NN synthesis_NN -LRB-_-LRB- 7_CD ,_, 9_CD -RRB-_-RRB- ,_, and_CC epidemiological_JJ evidence_NN indicates_VBZ that_IN thyroid_JJ hormone_NN perturbations_NNS in_IN the_DT first_JJ trimester_NN influence_NN fetal_JJ brain_NN development_NN -LRB-_-LRB- 1_CD ,_, 54_CD -RRB-_-RRB- ,_, so_RB far_RB ,_, only_RB few_JJ thyroid_JJ hormone-responsive_JJ genes_NNS within_IN the_DT fetus_NN have_VBP been_VBN identified_VBN -LRB-_-LRB- 55_CD ,_, 56_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS indicate_VBP that_IN maternal_JJ hyperthyroidism_NN significantly_RB up-regulates_VBZ embryonic_JJ Shh_NNP expression_NN in_IN ventral_JJ forebrain_NN signaling_VBG areas_NNS and_CC the_DT diencephalic_JJ signaling_VBG center_NN of_IN the_DT Zli_NNP ,_, and_CC maternal_JJ hypothyroidism_NN results_NNS in_IN a_DT region-specific_JJ decline_NN of_IN Shh_NNP within_IN the_DT embryonic_JJ Zli_NNP ._. 
Results_NNS Maternal_JJ hypothyroidism_NN decreases_VBZ Shh_NNP signaling_VBG cascade_NN expression_NN in_IN the_DT embryonic_JJ rat_NN brain_NN Shh_NNP is_VBZ expressed_VBN in_IN ventral_JJ signaling_VBG areas_NNS within_IN the_DT Hyp_NNP and_CC ventral_JJ telencephalon_NN ,_, where_WRB it_PRP is_VBZ critical_JJ for_IN the_DT development_NN of_IN the_DT ventral_JJ forebrain_NN ,_, specifying_VBG cell_NN fate_NN choice_NN ,_, proliferation_NN ,_, and_CC survival_NN -LRB-_-LRB- 42_CD 
05_CD ._. 
Differences_NNS were_VBD considered_VBN to_TO be_VB statistically_RB significant_JJ at_IN P_NNP 
05_CD ._. 
Differences_NNS were_VBD considered_VBN to_TO be_VB statistically_RB significant_JJ at_IN P_NNP 
Taken_VBN together_RB ,_, these_DT data_NNS indicate_VBP that_IN the_DT enhanced_JJ expression_NN of_IN Shh_NNP mRNA_NNP in_IN the_DT cortex_NN is_VBZ accompanied_VBN by_IN significant_JJ increases_NNS in_IN histone_NN acetylation_NN levels_NNS within_IN Shh_NNP ,_, but_CC not_RB Ptc_NNP or_CC Smo_NNP ,_, transcriptional_JJ regulatory_JJ sequences_NNS ._. 
DiscussionThyroid_JJ hormone_NN is_VBZ known_VBN to_TO exert_VB profound_JJ effects_NNS on_IN neurodevelopment_NN and_CC retains_VBZ a_DT powerful_JJ influence_NN on_IN plasticity_NN within_IN the_DT mature_JJ brain_NN ,_, including_VBG key_JJ effects_NNS on_IN adult_JJ hippocampal_JJ neurogenesis_NN -LRB-_-LRB- 13_CD ,_, 15_CD ,_, 50_CD ,_, 51_CD -RRB-_-RRB- ._. 
Although_IN several_JJ thyroid_JJ hormone-responsive_JJ genes_NNS ,_, such_JJ as_IN reelin_NN ,_, Dab-1_NNP ,_, and_CC Neurogenic_NNP differentiation_NN ,_, have_VBP been_VBN hypothesized_VBN to_TO mediate_VB the_DT neurodevelopmental_JJ influences_NNS of_IN thyroid_JJ hormone_NN ,_, most_JJS of_IN these_DT genes_NNS are_VBP transcriptionally_RB responsive_JJ to_TO thyroid_JJ hormone_NN only_RB during_IN select_JJ developmental_JJ time_NN windows_NNS -LRB-_-LRB- 22_CD ,_, 52_CD -RRB-_-RRB- ._. 
Nuclei_NNP were_VBD counterstained_VBN using_VBG Hoechst_NNP 33342_CD -LRB-_-LRB- Invitrogen_NNP -RRB-_-RRB- ._. 
Secondary_JJ antibodies_NNS used_VBN were_VBD Alexa_NNP Fluor_NNP 488-conjugated_JJ antigoat_NN -LRB-_-LRB- 1:400_CD -RRB-_-RRB- and_CC rhodamine-conjugated_JJ antimouse_NN IgG_NNP -LRB-_-LRB- 1:500_CD -RRB-_-RRB- ._. 
ChIP_NNP assayChIP_NNP was_VBD carried_VBN out_RP as_RB described_VBN previously_RB -LRB-_-LRB- 41_CD -RRB-_-RRB- ._. 
Briefly_RB ,_, bilateral_JJ cortices_NNS were_VBD dissected_VBN ,_, fixed_VBN to_TO cross-link_VB the_DT DNA_NN and_CC the_DT bound_VBN proteins_NNS ._. 
The_DT tissue_NN was_VBD dounce_NN homogenized_VBN ,_, sonicated_VBN ,_, and_CC immunoprecipitated_VBD using_VBG a_DT pan-acetylation_NN histone_NN 3_CD -LRB-_-LRB- H3_CD -RRB-_-RRB- or_CC pan-acetylation_NN histone_NN 4_CD -LRB-_-LRB- H4_CD -RRB-_-RRB- antibody_NN -LRB-_-LRB- 1_CD 
Primer_NN sequences_NNS used_VBN are_VBP described_VBN in_IN Supplemental_NNP Table_NNP 2_CD ._. 
Data_NNS are_VBP fold_VB change_NN 
Adult-onset_JJ hypothyroidism_NN is_VBZ known_VBN to_TO result_VB in_IN a_DT neurogenic_JJ decline_NN ,_, through_IN a_DT reduced_VBN proliferation_NN ,_, survival_NN ,_, and_CC neuronal_JJ differentiation_NN of_IN hippocampal_JJ progenitors_NNS -LRB-_-LRB- 12_CD ,_, 13_CD ,_, 15_CD -RRB-_-RRB- ._. 
Shh_NNP is_VBZ essential_JJ to_TO the_DT maintenance_NN of_IN the_DT adult_JJ hippocampal_JJ stem_NN cell_NN niche_NN and_CC is_VBZ known_VBN to_TO modulate_VB the_DT proliferation_NN ,_, survival_NN ,_, and_CC maintenance_NN of_IN adult_NN progenitors_NNS -LRB-_-LRB- 29_CD ,_, 31_CD -RRB-_-RRB- ._. 
We_PRP have_VBP previously_RB demonstrated_VBN an_DT effect_NN of_IN adult-onset_JJ hypothyroidism_NN on_IN hippocampal_JJ progenitors_NNS -LRB-_-LRB- 13_CD -RRB-_-RRB- ._. 
We_PRP show_VBP that_IN Shh_JJ expression_NN is_VBZ rapidly_RB regulated_VBN both_DT in_IN vivo_NN and_CC in_IN vitro_NN in_IN response_NN to_TO thyroid_JJ hormone_NN ,_, accompanied_VBN by_IN significant_JJ epigenetic_JJ histone_NN modifications_NNS within_IN upstream_JJ regions_NNS of_IN the_DT Shh_NNP gene_NN ._. 
Both_DT thyroid_JJ hormone_NN and_CC Shh_NNP have_VBP been_VBN independently_RB demonstrated_VBN to_TO regulate_VB diverse_JJ aspects_NNS of_IN central_JJ nervous_JJ system_NN development_NN ,_, including_VBG effects_NNS on_IN proliferation_NN and_CC maturation_NN ,_, and_CC to_TO retain_VB a_DT profound_JJ influence_NN on_IN the_DT adult_NN brain_NN ,_, modulating_VBG recruitment_NN ,_, survival_NN ,_, and_CC differentiation_NN of_IN neuronal_JJ and_CC oligodendrocytic_JJ progenitors_NNS -LRB-_-LRB- 13_CD ,_, 14_CD ,_, 29_CD ,_, 31_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS suggest_VBP that_IN specific_JJ developmental_NN and_CC plasticity_NN associated_JJ actions_NNS of_IN thyroid_JJ hormone_NN may_MD be_VB mediated_VBN by_IN its_PRP$ control_NN of_IN the_DT Shh_NNP pathway_NN and_CC motivate_VB future_JJ experiments_NNS to_TO determine_VB the_DT mechanistic_JJ contribution_NN of_IN Shh_NNP to_TO the_DT effects_NNS of_IN thyroid_JJ hormone_NN in_IN both_CC the_DT developing_JJ and_CC mature_JJ nervous_JJ system_NN ._. 
Given_VBN that_IN thyroid_JJ hormone_NN influences_VBZ neural_JJ and_CC glial_JJ progenitors_NNS in_IN both_DT the_DT developing_VBG as_RB well_RB as_IN mature_JJ nervous_JJ system_NN ,_, we_PRP hypothesized_VBD that_IN the_DT expression_NN of_IN developmental_JJ morphogens_NNS ,_, which_WDT retain_VBP a_DT powerful_JJ influence_NN on_IN these_DT progenitors_NNS across_IN the_DT lifespan_NN ,_, may_MD be_VB regulated_VBN by_IN thyroid_JJ hormone_NN ._. 
Sonic_JJ hedgehog_NN -LRB-_-LRB- Shh_NNP -RRB-_-RRB- ,_, a_DT major_JJ developmental_JJ morphogen_NN ,_, is_VBZ thought_VBN to_TO be_VB a_DT key_JJ regulator_NN of_IN neural_JJ and_CC oligodendroglial_JJ progenitors_NNS across_IN development_NN and_CC into_IN adulthood_NN -LRB-_-LRB- 28_CD 
Several_JJ thyroid_JJ hormone-responsive_JJ genes_NNS ,_, including_VBG laminin_NN ,_, transient_JJ axonal_JJ glycoprotein-1_JJ ,_, reelin_JJ ,_, neurogenic_JJ differentiation_NN ,_, rabconnectin_NN 3\/neurogranin_CD ,_, and_CC Dab-1_NNP ,_, have_VBP been_VBN implicated_VBN in_IN mediating_VBG thyroid_JJ hormone_NN effects_NNS on_IN neurodevelopment_NN -LRB-_-LRB- 21_CD 
Thyroid_JJ hormone_NN mediated_VBD transcriptional_JJ regulation_NN is_VBZ associated_VBN with_IN recruitment_NN of_IN coactivators_NNS and_CC targeted_JJ histone_NN acetylation_NN changes_NNS in_IN upstream_JJ regions_NNS of_IN thyroid_JJ hormone-responsive_JJ genes_NNS -LRB-_-LRB- 70_CD -RRB-_-RRB- ._. 
Previous_JJ studies_NNS from_IN Xenopus_NNP demonstrate_VBP that_IN T3_NNP bound_VBD to_TO TRs_NNP can_MD recruit_VB histone_JJ acetyl_NN transferases_NNS to_TO its_PRP$ target_NN genes_NNS -LRB-_-LRB- 71_CD ,_, 72_CD -RRB-_-RRB- ,_, and_CC the_DT expression_NN of_IN thyroid_JJ hormone-responsive_JJ genes_NNS in_IN Xenopus_NNP has_VBZ also_RB been_VBN shown_VBN to_TO correlate_VB with_IN the_DT acetylation_NN status_NN of_IN their_PRP$ promoters_NNS -LRB-_-LRB- 73_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS demonstrate_VBP significant_JJ and_CC rapid_JJ in_IN vivo_NN increases_NNS in_IN global_JJ histone_NN H3_CD and_CC H4_CD acetylation_NN both_DT at_IN the_DT putative_JJ TRE_NNP sites_NNS within_IN upstream_JJ regions_NNS of_IN the_DT Shh_NNP gene_NN ,_, as_RB well_RB as_IN close_RB to_TO the_DT transcriptional_JJ start_NN site_NN ._. 
Several_JJ thyroid_JJ hormone-responsive_JJ genes_NNS ,_, including_VBG laminin_NN ,_, transient_JJ axonal_JJ glycoprotein-1_JJ ,_, reelin_JJ ,_, neurogenic_JJ differentiation_NN ,_, rabconnectin_NN 3\/neurogranin_CD ,_, and_CC Dab-1_NNP ,_, have_VBP been_VBN implicated_VBN in_IN mediating_VBG thyroid_JJ hormone_NN effects_NNS on_IN neurodevelopment_NN -LRB-_-LRB- 21_CD 
Thyroid_JJ hormone_NN effects_NNS are_VBP mediated_VBN through_IN the_DT transcriptional_JJ regulation_NN of_IN target_NN genes_NNS via_IN distinct_JJ TR_NNP isoforms_NNS ,_, encoded_VBN by_IN the_DT TR_NNP 
Although_IN several_JJ thyroid_JJ hormone-responsive_JJ genes_NNS ,_, such_JJ as_IN reelin_NN ,_, Dab-1_NNP ,_, and_CC Neurogenic_NNP differentiation_NN ,_, have_VBP been_VBN hypothesized_VBN to_TO mediate_VB the_DT neurodevelopmental_JJ influences_NNS of_IN thyroid_JJ hormone_NN ,_, most_JJS of_IN these_DT genes_NNS are_VBP transcriptionally_RB responsive_JJ to_TO thyroid_JJ hormone_NN only_RB during_IN select_JJ developmental_JJ time_NN windows_NNS -LRB-_-LRB- 22_CD ,_, 52_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, there_EX are_VBP relatively_RB few_JJ genes_NNS that_WDT retain_VBP thyroid_JJ hormone_NN responsivity_NN across_IN the_DT life_NN span_NN ,_, for_IN example_NN neuroendocrine_NN specific_JJ protein_NN and_CC octamer_NN transcription_NN factor-1_NN ,_, which_WDT are_VBP reported_VBN to_TO be_VB regulated_VBN in_IN both_DT the_DT embryonic_JJ and_CC adult_JJ brain_NN -LRB-_-LRB- 24_CD -RRB-_-RRB- ._. 
Such_JJ thyroid_JJ hormone-responsive_JJ genes_NNS are_VBP particularly_RB interesting_JJ ,_, because_IN they_PRP are_VBP candidates_NNS to_TO mediate_VB the_DT effects_NNS of_IN thyroid_JJ hormone_NN in_IN both_CC the_DT developing_JJ and_CC mature_JJ brain_NN ._. 
White_JJ bars_NNS ,_, embryos_NNS derived_VBN from_IN vehicle-treated_JJ dams_NNS ;_: black_JJ bars_NNS ,_, embryos_NNS derived_VBN from_IN chronic_JJ T_NNP 3_CD -_: treated_VBN dams_NNS ._. 
Adult-onset_JJ hypothyroid_JJ status_NN selectively_RB decreases_VBZ Smo_NNP mRNA_NNP in_IN the_DT DG_NNP subfield_NN of_IN the_DT hippocampusShh_NNP continues_VBZ to_TO be_VB expressed_VBN within_IN specific_JJ regions_NNS in_IN the_DT adult_JJ mammalian_JJ brain_NN ,_, including_VBG the_DT neocortex_NN ,_, striatum_NN ,_, and_CC the_DT VDB_NNP -LRB-_-LRB- 49_CD -RRB-_-RRB- ._. 
Although_IN Ptc_NNP expression_NN is_VBZ widespread_JJ in_IN the_DT adult_NN brain_NN ,_, the_DT signaling_VBG coreceptor_NN Smo_NNP is_VBZ predominantly_RB expressed_VBN in_IN the_DT adult_JJ neurogenic_JJ niches_NNS ,_, namely_RB the_DT SVZ_NNP lining_VBG the_DT lateral_JJ ventricles_NNS and_CC in_IN the_DT DG_NNP subfield_NN of_IN the_DT hippocampus_NN -LRB-_-LRB- 49_CD -RRB-_-RRB- ._. 
Adult-onset_JJ hypothyroid_JJ status_NN selectively_RB decreases_VBZ Smo_NNP mRNA_NNP in_IN the_DT DG_NNP subfield_NN of_IN the_DT hippocampus_NN Shh_NNP continues_VBZ to_TO be_VB expressed_VBN within_IN specific_JJ regions_NNS in_IN the_DT adult_JJ mammalian_JJ brain_NN ,_, including_VBG the_DT neocortex_NN ,_, striatum_NN ,_, and_CC the_DT VDB_NNP -LRB-_-LRB- 49_CD -RRB-_-RRB- ._. 
Although_IN Ptc_NNP expression_NN is_VBZ widespread_JJ in_IN the_DT adult_NN brain_NN ,_, the_DT signaling_VBG coreceptor_NN Smo_NNP is_VBZ predominantly_RB expressed_VBN in_IN the_DT adult_JJ neurogenic_JJ niches_NNS ,_, namely_RB the_DT SVZ_NNP lining_VBG the_DT lateral_JJ ventricles_NNS and_CC in_IN the_DT DG_NNP subfield_NN of_IN the_DT hippocampus_NN -LRB-_-LRB- 49_CD -RRB-_-RRB- ._. 
Adult_NN hypothyroid_NN status_NN resulted_VBD in_IN no_DT change_NN in_IN the_DT expression_NN of_IN Shh_NNP mRNA_NNP -LRB-_-LRB- Supplemental_NNP Fig_NNP ._. 
1-RRB-_CD ._. 
Discussion_NNP Thyroid_NNP hormone_NN is_VBZ known_VBN to_TO exert_VB profound_JJ effects_NNS on_IN neurodevelopment_NN and_CC retains_VBZ a_DT powerful_JJ influence_NN on_IN plasticity_NN within_IN the_DT mature_JJ brain_NN ,_, including_VBG key_JJ effects_NNS on_IN adult_JJ hippocampal_JJ neurogenesis_NN -LRB-_-LRB- 13_CD ,_, 15_CD ,_, 50_CD ,_, 51_CD -RRB-_-RRB- ._. 
Although_IN several_JJ thyroid_JJ hormone-responsive_JJ genes_NNS ,_, such_JJ as_IN reelin_NN ,_, Dab-1_NNP ,_, and_CC Neurogenic_NNP differentiation_NN ,_, have_VBP been_VBN hypothesized_VBN to_TO mediate_VB the_DT neurodevelopmental_JJ influences_NNS of_IN thyroid_JJ hormone_NN ,_, most_JJS of_IN these_DT genes_NNS are_VBP transcriptionally_RB responsive_JJ to_TO thyroid_JJ hormone_NN only_RB during_IN select_JJ developmental_JJ time_NN windows_NNS -LRB-_-LRB- 22_CD ,_, 52_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, there_EX are_VBP relatively_RB few_JJ genes_NNS that_WDT retain_VBP thyroid_JJ hormone_NN responsivity_NN across_IN the_DT life_NN span_NN ,_, for_IN example_NN neuroendocrine_NN specific_JJ protein_NN and_CC octamer_NN transcription_NN factor-1_NN ,_, which_WDT are_VBP reported_VBN to_TO be_VB regulated_VBN in_IN both_DT the_DT embryonic_JJ and_CC adult_JJ brain_NN -LRB-_-LRB- 24_CD -RRB-_-RRB- ._. 
Thyroid_JJ hormone_NN effects_NNS are_VBP mediated_VBN through_IN the_DT transcriptional_JJ regulation_NN of_IN target_NN genes_NNS via_IN distinct_JJ TR_NNP isoforms_NNS ,_, encoded_VBN by_IN the_DT TR_NNP 
Taken_VBN together_RB ,_, these_DT studies_NNS provide_VBP evidence_NN of_IN a_DT role_NN for_IN thyroid_JJ hormone_NN in_IN modulating_VBG structure_NN and_CC function_NN in_IN the_DT mammalian_JJ brain_NN throughout_IN life_NN ._. 
Thyroid_JJ hormone_NN effects_NNS are_VBP mediated_VBN through_IN the_DT transcriptional_JJ regulation_NN of_IN target_NN genes_NNS via_IN distinct_JJ TR_NNP isoforms_NNS ,_, encoded_VBN by_IN the_DT TR_NNP 
Our_PRP$ results_NNS indicate_VBP that_IN maternal_JJ and_CC adult-onset_JJ perturbations_NNS of_IN euthyroid_JJ status_NN cause_NN robust_JJ and_CC region-specific_JJ changes_NNS in_IN the_DT Shh_NNP pathway_NN in_IN the_DT embryonic_JJ and_CC adult_JJ forebrain_NN ,_, implicating_VBG Shh_NNP as_IN a_DT possible_JJ mechanistic_JJ link_NN for_IN specific_JJ neurodevelopmental_JJ effects_NNS of_IN thyroid_JJ hormone_NN ._. 
Thyroid_JJ hormone_NN deficiencies_NNS during_IN critical_JJ periods_NNS of_IN brain_NN development_NN result_NN in_IN profound_JJ structural_JJ as_RB well_RB as_IN functional_JJ abnormalities_NNS -LRB-_-LRB- 1_CD 
Several_JJ studies_NNS suggest_VBP that_IN the_DT critical_JJ period_NN in_IN which_WDT thyroid_JJ hormone_NN exerts_VBZ dramatic_JJ effects_NNS on_IN neuronal_JJ structure_NN appears_VBZ to_TO be_VB predominantly_RB during_IN early_JJ postnatal_JJ life_NN -LRB-_-LRB- 1_CD -RRB-_-RRB- ._. 
However_RB ,_, maternally_RB derived_VBN thyroid_NN hormone_NN ,_, transported_VBN via_IN the_DT placenta_NN ,_, is_VBZ known_VBN to_TO alter_VB neural_JJ progenitor_NN proliferation_NN ,_, differentiation_NN ,_, and_CC migration_NN within_IN the_DT developing_VBG embryo_NN ,_, which_WDT expresses_VBZ thyroid_JJ hormone_NN receptor_NN -LRB-_-LRB- TR_NNP -RRB-_-RRB- isoforms_NNS before_IN the_DT onset_NN of_IN fetal_JJ thyroid_JJ hormone_NN synthesis_NN -LRB-_-LRB- 5_CD 
To_TO correct_VB for_IN nonlinearity_NN ,_, 14_CD C_NNP standards_NNS were_VBD used_VBN for_IN calibration_NN ._. 
Levels_NNS of_IN Shh_NNP ,_, Ptc_NNP ,_, and_CC Smo_NNP transcripts_NNS were_VBD analyzed_VBN using_VBG the_DT Macintosh-based_JJ Scion_NNP Image_NN software_NN -LRB-_-LRB- Scion_NNP ,_, Frederick_NNP ,_, MD_NNP -RRB-_-RRB- ._. 
An_DT equivalent_JJ area_NN was_VBD outlined_VBN for_IN each_DT sample_NN ,_, and_CC optical_JJ density_NN measurements_NNS -LRB-_-LRB- 6_CD 
In_IN contrast_NN ,_, we_PRP find_VBP that_IN in_IN the_DT embryonic_JJ and_CC adult_JJ mammalian_JJ brain_NN ,_, thyroid_JJ hormone_NN perturbations_NNS induce_VBP a_DT bidirectional_JJ regulation_NN of_IN the_DT Shh_NNP signaling_VBG cascade_NN in_IN a_DT region-specific_JJ manner_NN ._. 
Although_IN TRs_NNP are_VBP known_VBN to_TO be_VB expressed_VBN in_IN the_DT fetal_JJ brain_NN well_RB before_IN the_DT initiation_NN of_IN embryonic_JJ thyroid_JJ hormone_NN synthesis_NN -LRB-_-LRB- 7_CD ,_, 9_CD -RRB-_-RRB- ,_, and_CC epidemiological_JJ evidence_NN indicates_VBZ that_IN thyroid_JJ hormone_NN perturbations_NNS in_IN the_DT first_JJ trimester_NN influence_NN fetal_JJ brain_NN development_NN -LRB-_-LRB- 1_CD ,_, 54_CD -RRB-_-RRB- ,_, so_RB far_RB ,_, only_RB few_JJ thyroid_JJ hormone-responsive_JJ genes_NNS within_IN the_DT fetus_NN have_VBP been_VBN identified_VBN -LRB-_-LRB- 55_CD ,_, 56_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS indicate_VBP that_IN maternal_JJ hyperthyroidism_NN significantly_RB up-regulates_VBZ embryonic_JJ Shh_NNP expression_NN in_IN ventral_JJ forebrain_NN signaling_VBG areas_NNS and_CC the_DT diencephalic_JJ signaling_VBG center_NN of_IN the_DT Zli_NNP ,_, and_CC maternal_JJ hypothyroidism_NN results_NNS in_IN a_DT region-specific_JJ decline_NN of_IN Shh_NNP within_IN the_DT embryonic_JJ Zli_NNP ._. 
Our_PRP$ results_NNS indicate_VBP that_IN maternal_JJ and_CC adult-onset_JJ perturbations_NNS of_IN euthyroid_JJ status_NN cause_NN robust_JJ and_CC region-specific_JJ changes_NNS in_IN the_DT Shh_NNP pathway_NN in_IN the_DT embryonic_JJ and_CC adult_JJ forebrain_NN ,_, implicating_VBG Shh_NNP as_IN a_DT possible_JJ mechanistic_JJ link_NN for_IN specific_JJ neurodevelopmental_JJ effects_NNS of_IN thyroid_JJ hormone_NN ._. 
Thyroid_JJ hormone_NN deficiencies_NNS during_IN critical_JJ periods_NNS of_IN brain_NN development_NN result_NN in_IN profound_JJ structural_JJ as_RB well_RB as_IN functional_JJ abnormalities_NNS -LRB-_-LRB- 1_CD 
Thyroid_JJ hormone_NN deficiencies_NNS during_IN critical_JJ periods_NNS of_IN brain_NN development_NN result_NN in_IN profound_JJ structural_JJ as_RB well_RB as_IN functional_JJ abnormalities_NNS -LRB-_-LRB- 1_CD 
Furthermore_RB ,_, thyroid_JJ hormone_NN is_VBZ known_VBN to_TO exert_VB effects_NNS on_IN neuronal_JJ and_CC glial_JJ progenitor_NN proliferation_NN ,_, survival_NN ,_, and_CC maturation_NN within_IN the_DT adult_NN brain_NN -LRB-_-LRB- 12_CD 
In_IN contrast_NN ,_, we_PRP find_VBP that_IN in_IN the_DT embryonic_JJ and_CC adult_JJ mammalian_JJ brain_NN ,_, thyroid_JJ hormone_NN perturbations_NNS induce_VBP a_DT bidirectional_JJ regulation_NN of_IN the_DT Shh_NNP signaling_VBG cascade_NN in_IN a_DT region-specific_JJ manner_NN ._. 
Although_IN TRs_NNP are_VBP known_VBN to_TO be_VB expressed_VBN in_IN the_DT fetal_JJ brain_NN well_RB before_IN the_DT initiation_NN of_IN embryonic_JJ thyroid_JJ hormone_NN synthesis_NN -LRB-_-LRB- 7_CD ,_, 9_CD -RRB-_-RRB- ,_, and_CC epidemiological_JJ evidence_NN indicates_VBZ that_IN thyroid_JJ hormone_NN perturbations_NNS in_IN the_DT first_JJ trimester_NN influence_NN fetal_JJ brain_NN development_NN -LRB-_-LRB- 1_CD ,_, 54_CD -RRB-_-RRB- ,_, so_RB far_RB ,_, only_RB few_JJ thyroid_JJ hormone-responsive_JJ genes_NNS within_IN the_DT fetus_NN have_VBP been_VBN identified_VBN -LRB-_-LRB- 55_CD ,_, 56_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS indicate_VBP that_IN maternal_JJ hyperthyroidism_NN significantly_RB up-regulates_VBZ embryonic_JJ Shh_NNP expression_NN in_IN ventral_JJ forebrain_NN signaling_VBG areas_NNS and_CC the_DT diencephalic_JJ signaling_VBG center_NN of_IN the_DT Zli_NNP ,_, and_CC maternal_JJ hypothyroidism_NN results_NNS in_IN a_DT region-specific_JJ decline_NN of_IN Shh_NNP within_IN the_DT embryonic_JJ Zli_NNP ._. 
Furthermore_RB ,_, thyroid_JJ hormone_NN is_VBZ known_VBN to_TO exert_VB effects_NNS on_IN neuronal_JJ and_CC glial_JJ progenitor_NN proliferation_NN ,_, survival_NN ,_, and_CC maturation_NN within_IN the_DT adult_NN brain_NN -LRB-_-LRB- 12_CD 
To_TO correct_VB for_IN nonlinearity_NN ,_, 14_CD C_NNP standards_NNS were_VBD used_VBN for_IN calibration_NN ._. 
Levels_NNS of_IN Shh_NNP ,_, Ptc_NNP ,_, and_CC Smo_NNP transcripts_NNS were_VBD analyzed_VBN using_VBG the_DT Macintosh-based_JJ Scion_NNP Image_NN software_NN -LRB-_-LRB- Scion_NNP ,_, Frederick_NNP ,_, MD_NNP -RRB-_-RRB- ._. 
An_DT equivalent_JJ area_NN was_VBD outlined_VBN for_IN each_DT sample_NN ,_, and_CC optical_JJ density_NN measurements_NNS -LRB-_-LRB- 6_CD 
In_IN contrast_NN ,_, we_PRP find_VBP that_IN in_IN the_DT embryonic_JJ and_CC adult_JJ mammalian_JJ brain_NN ,_, thyroid_JJ hormone_NN perturbations_NNS induce_VBP a_DT bidirectional_JJ regulation_NN of_IN the_DT Shh_NNP signaling_VBG cascade_NN in_IN a_DT region-specific_JJ manner_NN ._. 
Although_IN TRs_NNP are_VBP known_VBN to_TO be_VB expressed_VBN in_IN the_DT fetal_JJ brain_NN well_RB before_IN the_DT initiation_NN of_IN embryonic_JJ thyroid_JJ hormone_NN synthesis_NN -LRB-_-LRB- 7_CD ,_, 9_CD -RRB-_-RRB- ,_, and_CC epidemiological_JJ evidence_NN indicates_VBZ that_IN thyroid_JJ hormone_NN perturbations_NNS in_IN the_DT first_JJ trimester_NN influence_NN fetal_JJ brain_NN development_NN -LRB-_-LRB- 1_CD ,_, 54_CD -RRB-_-RRB- ,_, so_RB far_RB ,_, only_RB few_JJ thyroid_JJ hormone-responsive_JJ genes_NNS within_IN the_DT fetus_NN have_VBP been_VBN identified_VBN -LRB-_-LRB- 55_CD ,_, 56_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS indicate_VBP that_IN maternal_JJ hyperthyroidism_NN significantly_RB up-regulates_VBZ embryonic_JJ Shh_NNP expression_NN in_IN ventral_JJ forebrain_NN signaling_VBG areas_NNS and_CC the_DT diencephalic_JJ signaling_VBG center_NN of_IN the_DT Zli_NNP ,_, and_CC maternal_JJ hypothyroidism_NN results_NNS in_IN a_DT region-specific_JJ decline_NN of_IN Shh_NNP within_IN the_DT embryonic_JJ Zli_NNP ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_NNP et_NNP al._IN 59_CD Barden_NNP et_FW al._FW 20_CD 1_CD ._. 
50_CD 1_CD ._. 
02_CD 1_CD ._. 
52_CD 6_CD ._. 
06_CD Participates_NNPS in_IN cell_NN 
The_DT initial_JJ conclusion_NN from_IN these_DT data_NNS is_VBZ that_IN any_DT combination_NN of_IN more_JJR than_IN five_CD to_TO ten_CD genes_NNS increases_VBZ the_DT reliability_NN of_IN distinguishing_VBG between_IN malignant_JJ and_CC benign_JJ tissue_NN samples_NNS ._. 
This_DT result_NN is_VBZ similar_JJ to_TO that_DT obtained_VBN by_IN Hua_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ,_, who_WP demonstrated_VBD on_IN simulated_JJ and_CC real_JJ breast_NN cancer_NN data_NNS that_IN for_IN different_JJ classifiers_NNS the_DT number_NN of_IN features_NNS lower_JJR than_IN five_CD was_VBD usually_RB much_RB less_RBR effective_JJ than_IN larger_JJR classifiers_NNS ._. 
2003_CD -RRB-_-RRB- ._. 
However_RB ,_, this_DT method_NN does_VBZ not_RB allow_VB proper_JJ classification_NN of_IN all_DT thyroid_JJ tumors_NNS -LRB-_-LRB- Baloch_NNP 
2001_CD ,_, 2004_CD ,_, Jarzab_FW et_FW al._FW ._. 
This_DT large_JJ 180-array_JJ dataset_NN is_VBZ derived_VBN respectively_RB from_IN de_JJ novo_NN studies_NNS -LRB-_-LRB- n_SYM =_SYM 40_CD -RRB-_-RRB- ,_, previously_RB published_VBN own_JJ microarray_NN data_NNS -LRB-_-LRB- n_SYM =_SYM 124_CD ;_: Eszlinger_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, and_CC accessible_JJ datasets_NNS published_VBN by_IN other_JJ authors_NNS -LRB-_-LRB- n_SYM =_SYM 16_CD ;_: Huang_NNP et_FW al._FW ._. 
2001_CD -RRB-_-RRB- ._. 
We_PRP set_VBD the_DT following_JJ goals_NNS for_IN the_DT study_NN :_: To_TO assess_VB accuracy_NN of_IN benign\/malignant_JJ classification_NN of_IN thyroid_JJ specimens_NNS in_IN relation_NN to_TO gene_NN set_NN size_NN ,_, in_IN the_DT context_NN of_IN PTC_NNP and_CC To_TO optimize_VB the_DT list_NN of_IN diagnostically_RB relevant_JJ genes_NNS in_IN PTC_NNP ._. 
The_DT specimens_NNS were_VBD derived_VBN from_IN eight_CD patients_NNS and_CC included_VBD both_DT PTC_NNP tumors_NNS and_CC their_PRP$ surrounding_JJ thyroid_NN tissues_NNS ._. 
The_DT dataset_NN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2001_CD -RRB-_-RRB- is_VBZ publicly_RB available_JJ at_IN 
Within_IN the_DT list_NN of_IN the_DT well-known_JJ genes_NNS which_WDT received_VBD high_JJ scores_NNS by_IN BBFR_NNP ,_, one_CD should_MD mention_VB gene_NN encoding_VBG FN1_NNP ,_, met_VBD proto-oncogene_JJ -LRB-_-LRB- MET_NNP ;_: both_DT scored_VBD 4_CD ._. 
4_CD 
Similarly_RB ,_, thyroid-specific_JJ -LRB-_-LRB- down-regulated_JJ -RRB-_-RRB- genes_NNS ,_, deiodinase_NN ,_, iodothyronine_NN ,_, type_NN I_NN and_CC thyroid_NN peroxidase_NN ,_, were_VBD widely_RB recognized_VBN previously_RB for_IN their_PRP$ diagnostic_JJ significance_NN both_DT in_IN microarray-based_JJ -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2001_CD ,_, Huang_NNP et_FW al._FW ._. 
2001_CD ,_, Baris_NNP et_FW al._FW ._. 
2004_CD ,_, Cerutti_NNP et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- and_CC single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
Its_PRP$ function_NN is_VBZ unknown_JJ ._. 
It_PRP is_VBZ an_DT ancient_JJ gene_NN highly_RB conserved_VBN from_IN Caenorhabditis_NNP elegans_NNS to_TO mammals_NNS and_CC expressed_VBN in_IN fetal_JJ brain_NN ._. 
Already_RB the_DT first_JJ microarray-based_JJ analysis_NN of_IN a_DT PTC_NNP gene_NN expression_NN profile_NN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2001_CD -RRB-_-RRB- indicated_VBD the_DT dominant_JJ position_NN of_IN genes_NNS controlling_VBG cell_NN 
Besides_IN ,_, FN1_NNP mentioned_VBD earlier_RBR ,_, and_CC intercellular_JJ adhesion_NN molecule_NN 1_CD -LRB-_-LRB- ICAM-1_NN ;_: Kawai_NNP et_FW al._FW ._. 
2001_CD -RRB-_-RRB- indicated_VBD the_DT dominant_JJ position_NN of_IN genes_NNS controlling_VBG cell_NN 
It_PRP converts_VBZ adenine_JJ nucleotides_NNS to_TO adenosine_VB ,_, thus_RB participating_VBG in_IN the_DT control_NN of_IN signal_NN transduction_NN ._. 
DPP4_NNP ,_, another_DT membrane-bound_JJ enzyme_NN which_WDT hydrolyzes_VBZ peptides_NNS engaged_VBN in_IN paracrine_NN and_CC autocrine_NN regulation_NN ,_, is_VBZ up-regulated_JJ in_IN PTCs_NNP both_DT on_IN RNA_NNP and_CC protein_NN level_NN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2001_CD ,_, Kholova_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
The_DT contribution_NN of_IN various_JJ enzymes_NNS to_TO our_PRP$ list_NN is_VBZ striking_JJ :_: others_NNS ,_, not_RB described_VBN previously_RB in_IN the_DT context_NN of_IN thyroid_JJ gland_NN ,_, comprise_VBP UDP-galactose_JJ epimerase_NN -LRB-_-LRB- GALE_NNP -RRB-_-RRB- and_CC glutaminyl-peptide_JJ cyclotransferase_NN -LRB-_-LRB- QPCT_NNP -RRB-_-RRB- ,_, both_DT with_IN virtually_RB unknown_JJ expression_NN patterns_NNS ._. 
Bootstrap-based_JJ multi-gene_JJ classification_NN of_IN PTC_NNP microarray_NN data_NNS Selection_NN of_IN genes_NNS is_VBZ an_DT important_JJ goal_NN of_IN microarray_NN studies_NNS contributing_VBG to_TO broader_JJR understanding_NN of_IN the_DT cancer_NN transcriptome_NN as_RB well_RB as_IN yielding_VBG novel_JJ molecular_JJ cancer_NN markers_NNS ._. 
Such_JJ studies_NNS have_VBP been_VBN successfully_RB performed_VBN in_IN PTC_NNP and_CC large_JJ numbers_NNS of_IN discriminating_VBG physiologically_RB relevant_JJ genes_NNS were_VBD proposed_VBN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2001_CD ,_, Wasenius_FW et_FW al._FW ._. 
2003_CD ,_, Aldred_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, b_NN ,_, Wreesmann_FW et_FW al._FW ._. 
21_CD 3_CD ._. 
11_CD 3_CD ._. 
77_CD 4_CD ._. 
87_CD 3_CD ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- -RRB-_-RRB- DPP4_NNP Dipeptidylpeptidase_NNP 4_CD -LRB-_-LRB- CD26_NNP ,_, adenosine_JJ deaminase_NN complexing_VBG protein_NN 2_CD -RRB-_-RRB- 203717_at_CD 9_CD 42_CD 
33_CD Eszlinger_NNP et_NNP al._IN 79_CD 
17_CD 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- Epithelial_JJ adhesion_NN molecule_NN plays_VBZ a_DT key_JJ role_NN in_IN lymphocyte_NN infiltration_NN into_IN the_DT thyroid_NN a_DT The_DT original_JJ papers_NNS -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2001_CD ,_, 2004_CD ,_, Huang_NNP et_FW al._FW ._. 
2001_CD ,_, Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- containing_VBG datasets_NNS included_VBN in_IN the_DT present_JJ study_NN were_VBD not_RB cited_VBN here_RB ._. 
Although_IN the_DT estimation_NN of_IN CIs_NNP by_IN Monte_NNP Carlo_NNP analysis_NN has_VBZ not_RB gained_VBN a_DT general_JJ acceptance_NN still_RB ,_, it_PRP is_VBZ necessary_JJ to_TO stress_VB the_DT very_RB good_JJ accuracy_NN of_IN PTC_NNP diagnosis_NN in_IN our_PRP$ study_NN with_IN the_DT lower_JJR range_NN of_IN the_DT CI_NNP at_IN 95_CD %_NN ,_, obtained_VBD using_VBG a_DT sufficiently_RB large_JJ study_NN group_NN ,_, mimicking_VBG the_DT real_JJ clinical_JJ setting_NN ._. 
From_IN a_DT clinical_JJ point_NN of_IN view_NN ,_, for_IN a_DT PTC_NNP classifier_NN ,_, an_DT even_RB higher_JJR accuracy_NN is_VBZ required_VBN ,_, as_IN the_DT risk_NN of_IN diagnosing_VBG PTC_NNP in_IN a_DT thyroid_JJ nodule_NN is_VBZ only_RB about_RB 5_CD %_NN -LRB-_-LRB- Hegedus_NNP 2004_CD -RRB-_-RRB- ._. 
Our_PRP$ results_NNS stress_VBP the_DT importance_NN of_IN multi-gene_JJ approaches_NNS for_IN the_DT molecular_JJ diagnosis_NN of_IN cancer_NN ._. 
We_PRP observed_VBD that_IN lower_JJR limits_NNS of_IN accuracy_NN CIs_NNS were_VBD decreased_VBN in_IN case_NN of_IN classification_NN by_IN gene_NN sets_NNS with_IN less_JJR than_IN ten_CD genes_NNS ._. 
74_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ,_, Hamada_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Takano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- ,_, 1999_CD and_CC c_NN Prasad_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Ghinea_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Wreesmann_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_NNP al._IN 83_CD Barden_NNP et_FW al._FW 06_FW 
80_CD 2_CD ._. 
66_CD 2_CD ._. 
69_CD 2_CD ._. 
35_CD 4_CD ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Fe_NNP -LRB-_-LRB- II_NNP -RRB-_-RRB- -_: dependent_JJ enzyme_NN responsible_JJ for_IN aromatic_JJ ring_NN cleavage_NN RXRG_NNP Retinoid_NNP X_NNP receptor_NN ,_, 
All_PDT these_DT genes_NNS except_IN ADORA1_NNP were_VBD previously_RB found_VBN by_IN single_JJ gene_NN studies_NNS -LRB-_-LRB- see_VB Table_NNP 1_CD -RRB-_-RRB- and_CC later_RB confirmed_VBN by_IN microarray_NN approaches_NNS ._. 
Moreover_RB ,_, in_IN the_DT recent_JJ meta-analysis_NN of_IN thyroid_NN cancer_NN gene_NN expression_NN profile_NN ,_, MET_NNP and_CC FN1_NNP were_VBD included_VBN into_IN top_JJ 12_CD candidates_NNS for_IN consistent_JJ gene_NN expression_NN markers_NNS -LRB-_-LRB- Griffith_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Similarly_RB ,_, thyroid-specific_JJ -LRB-_-LRB- down-regulated_JJ -RRB-_-RRB- genes_NNS ,_, deiodinase_NN ,_, iodothyronine_NN ,_, type_NN I_NN and_CC thyroid_NN peroxidase_NN ,_, were_VBD widely_RB recognized_VBN previously_RB for_IN their_PRP$ diagnostic_JJ significance_NN both_DT in_IN microarray-based_JJ -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD ,_, 2004_CD -RRB-_-RRB- ,_, Mazzanti_NNP et_NNP al._VBD 26_CD Aldred_NNP et_NNP al._IN 46_CD 
28_CD 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ,_, Hamada_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Takano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- ,_, 1999_CD and_CC c_NN Prasad_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Ghinea_FW et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC Liu_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Chevillard_NNP et_NNP al._IN 56_CD Barden_NNP et_FW al._FW 14_CD 2_CD ._. 
61_CD 3_CD ._. 
99_CD 2_CD ._. 
60_CD 4_CD ._. 
50_CD Converts_VBZ glucose_NN to_TO galactose_VB and_CC N_NNP -_: acetylglucosamine_NN to_TO its_PRP$ UDP-derivatives_NNP QPCT_NNP Glutaminyl-peptide_JJ cyclotransferase_NN -LRB-_-LRB- glutaminyl_JJ cyclase_NN -RRB-_-RRB- 205174_s_at_CD 6_CD 43_CD 
-LRB-_-LRB- 2002_CD ,_, 2004_CD -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Takano_NNP et_NNP al._IN 81_CD Huang_NNP et_FW al._FW 21_CD 3_CD ._. 
11_CD 3_CD ._. 
77_CD 4_CD ._. 
87_CD 3_CD ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- -RRB-_-RRB- DPP4_NNP Dipeptidylpeptidase_NNP 4_CD -LRB-_-LRB- CD26_NNP ,_, adenosine_JJ deaminase_NN complexing_VBG protein_NN 2_CD -RRB-_-RRB- 203717_at_CD 9_CD 42_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Wreesmann_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- c_NN De_NNP Micco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- ,_, c_NN Czarnocka_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, c_NN Le_NNP Fourn_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, c_NN Ambroziak_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Chevillard_NNP et_NNP al._IN 41_CD Barden_NNP et_NNP al._VBD 86_CD 2_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Transmembrane_NNP heparan_JJ sulfate_NN proteoglycan_NN involved_VBN in_IN the_DT organization_NN of_IN the_DT actin_NN cytoskeleton_NN and_CC in_IN cell_NN 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Cerutti_NNP et_NNP al._IN 75_CD Barden_NNP et_NNP al._IN 93_CD 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Chevillard_NNP et_FW al._FW 07_FW Barden_FW et_FW al._FW 55_CD 3_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Schelfhout_FW et_FW al._FW ._. 
-LRB-_-LRB- 1989_CD -RRB-_-RRB- The_DT smallest_JJS known_JJ keratin_NN expressed_VBN in_IN some_DT types_NNS of_IN cancer_NN ID3_NNP Inhibitor_NNP of_IN DNA_NNP binding_JJ 3_CD ,_, dominant_JJ negative_JJ helix-loop-helix_JJ protein_NN 207826_s_at_CD 35_CD 26_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Jacques_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD ,_, 2005_CD -RRB-_-RRB- ,_, Prasad_NNP et_NNP al._IN 00_CD Baris_NNP et_NNP al._IN 97_CD 
The_DT obtained_VBN data_NNS were_VBD log2_RB transformed_VBN ._. 
affx_NN -RRB-_-RRB- which_WDT yielded_VBD an_DT intersection_NN of_IN 9530_CD probe_NN sets_NNS ._. 
com\/support\/technical_JJ \/_NN comparison_spreadsheets_NNS ._. 
Neighborhood_NN analysis_NN and_CC recursive_JJ elimination_NN in_IN gene_NN selectionFor_NN selection_NN of_IN gene_NN sets_NNS with_IN diagnostic_JJ potential_NN ,_, we_PRP applied_VBD here_RB the_DT recursive_JJ feature_NN elimination_NN -LRB-_-LRB- RFE_NNP -RRB-_-RRB- algorithm_NN -LRB-_-LRB- Guyon_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- which_WDT is_VBZ computationally_RB less_JJR demanding_VBG than_IN recursive_JJ feature_NN replacement_NN used_VBN in_IN our_PRP$ previous_JJ studies_NNS -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
At_IN several_JJ institutions_NNS ,_, genomic_JJ studies_NNS have_VBP been_VBN undertaken_VBN which_WDT besides_IN focusing_VBG on_IN basic_JJ biological_JJ issues_NNS -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2001_CD ,_, Giordano_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, also_RB explore_VBP potential_JJ diagnostic_JJ applications_NNS -LRB-_-LRB- Aldred_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2003_CD ,_, Baris_NNP et_FW al._FW ._. 
2001_CD ,_, Wasenius_FW et_FW al._FW ._. 
2004_CD ,_, Giordano_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, all_DT up-regulated_JJ with_IN the_DT exception_NN of_IN BCL2_NNP ._. 
Their_PRP$ inclusion_NN in_IN our_PRP$ classifier_NN positively_RB validates_VBZ the_DT applied_JJ criteria_NNS ._. 
2005_CD ,_, Detours_NNPS et_FW al._FW ._. 
2004_CD ,_, Baris_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, b_NN ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2005_CD ,_, Giordano_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
However_RB ,_, in_IN the_DT majority_NN of_IN these_DT studies_NNS ,_, the_DT selection_NN of_IN important_JJ genes_NNS was_VBD based_VBN on_IN either_DT fold-change_NN or_CC significance_NN criteria_NNS obtained_VBD using_VBG classical_JJ statistical_JJ tests_NNS ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Zou_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- c_NN Belfiore_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 1997_CD -RRB-_-RRB- and_CC c_NN Ippolito_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- Ramirez_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2000_CD -RRB-_-RRB- ,_, Ruco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_FW et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ,_, Hamada_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Takano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- ,_, 1999_CD and_CC c_NN Prasad_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Zou_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- See_VB the_DT information_NN given_VBN above_IN for_IN another_DT probeset_NN of_IN the_DT same_JJ gene_NN DTX4_NNP Deltex_NNP 4_CD homolog_NN -LRB-_-LRB- Drosophila_NNP -RRB-_-RRB- 212611_at_CD 18_CD 39_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Wreesmann_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD ,_, 2005_CD -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- ,_, Baris_NNP et_NNP al._IN 39_CD Hoos_NNP et_NNP al._IN 74_CD 
02_CD 4_CD ._. 
13_CD 4_CD ._. 
29_CD 4_CD ._. 
42_CD 6_CD ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- Anti-apoptotic_JJ protein_NN TACSTD2_CD Tumor-associated_JJ calcium_NN signal_NN transducer_NN 2_CD 202286_s_at_CD 22_CD 36_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Wreesmann_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- c_NN De_NNP Micco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- ,_, c_NN Czarnocka_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, c_NN Le_NNP Fourn_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Aldred_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Fe_NNP -LRB-_-LRB- II_NNP -RRB-_-RRB- -_: dependent_JJ enzyme_NN responsible_JJ for_IN aromatic_JJ ring_NN cleavage_NN RXRG_NNP Retinoid_NNP X_NNP receptor_NN ,_, 
2006_CD -RRB-_-RRB- ._. 
2005_CD ,_, Eszlinger_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- which_WDT is_VBZ computationally_RB less_JJR demanding_VBG than_IN recursive_JJ feature_NN replacement_NN used_VBN in_IN our_PRP$ previous_JJ studies_NNS -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
The_DT introductory_JJ gene_NN selection_NN was_VBD performed_VBN using_VBG neighborhood_NN analysis_NN -LRB-_-LRB- 200_CD genes_NNS ;_: Golub_NNP et_FW al._FW ._. 
1999_CD ,_, Slonim_FW et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ,_, further_JJ selection_NN of_IN the_DT 100_CD best_JJS genes_NNS set_VBN was_VBD carried_VBN out_RP by_IN RFE_NNP ._. 
SVMs_NNS and_CC classification_NN The_DT linear_JJ SVM_NNP -LRB-_-LRB- Boser_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC Musholt_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Berlingieri_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Fedele_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD ,_, 2005_CD -RRB-_-RRB- and_CC Jacques_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Architectural_JJ transcription_NN factor_NN -LRB-_-LRB- Noro_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- -RRB-_-RRB- RYR1_NNP Ryanodine_NNP receptor_NN 1_CD -LRB-_-LRB- skeletal_JJ -RRB-_-RRB- 205485_at_CD 12_CD 40_CD 
SVMs_NNS have_VBP been_VBN confirmed_VBN as_IN an_DT effective_JJ method_NN of_IN multi-gene_JJ set_NN selection_NN and_CC this_DT is_VBZ supported_VBN by_IN our_PRP$ comparison_NN to_TO other_JJ class_NN prediction_NN methods_NNS ._. 
Our_PRP$ procedure_NN helps_VBZ us_PRP to_TO optimize_VB the_DT list_NN of_IN markers_NNS which_WDT are_VBP to_TO be_VB implemented_VBN to_TO real-time_JJ quantitative_JJ PCR-supported_JJ fine_JJ needle_NN biopsy_NN -LRB-_-LRB- Lubitz_NNP 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Ghinea_FW et_FW al._FW ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- ,_, 1999_CD and_CC c_NN Prasad_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Takano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC Liu_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Extracellular_JJ matrix_NN glycoprotein_NN participates_VBZ in_IN cell_NN adhesion_NN ,_, regulates_VBZ proliferation_NN and_CC survival_NN of_IN thyroid_JJ cells_NNS via_IN integrin_NN receptors_NNS -LRB-_-LRB- Illario_FW et_FW al._FW ._. 
01_CD Kim_NNP et_NNP al._IN 50_CD 2_CD ._. 
58_CD 3_CD ._. 
80_CD 2_CD ._. 
37_CD 4_CD ._. 
29_CD Downstream_NNP target_NN of_IN pituitary_JJ tumor_NN transforming_VBG gene_NN -LRB-_-LRB- PTTG_NNP -RRB-_-RRB- RUNX1_CD Runt-related_JJ transcription_NN factor_NN 1_CD -LRB-_-LRB- acute_JJ myeloid_JJ leukemia_NN 1_CD ;_: aml1_CD oncogene_NN -RRB-_-RRB- 209360_s_at_CD 36_CD 26_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Chevillard_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Transmembrane_NNP heparan_JJ sulfate_NN proteoglycan_NN involved_VBN in_IN the_DT organization_NN of_IN the_DT actin_NN cytoskeleton_NN and_CC in_IN cell_NN 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, c_NN Aksoy_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Mitselou_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Jacques_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC cLetsas_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Stassi_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Basolo_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- Anti-apoptotic_JJ protein_NN TACSTD2_CD Tumor-associated_JJ calcium_NN signal_NN transducer_NN 2_CD 202286_s_at_CD 22_CD 36_CD 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Berlingieri_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Fedele_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD ,_, 2005_CD -RRB-_-RRB- and_CC Jacques_NNP et_NNP al._IN 62_CD Baris_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC Musholt_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Architectural_JJ transcription_NN factor_NN -LRB-_-LRB- Noro_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- -RRB-_-RRB- RYR1_NNP Ryanodine_NNP receptor_NN 1_CD -LRB-_-LRB- skeletal_JJ -RRB-_-RRB- 205485_at_CD 12_CD 40_CD 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Weber_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW 24_CD Barden_NNP et_FW al._FW 60_CD 1_CD ._. 
00_CD 1_CD ._. 
62_CD 3_CD ._. 
62_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Participates_VBZ in_IN protein_NN ubiquination_NN RAB27A_NNP RAB27A_NNP ,_, member_NN RAS_NNP oncogene_NN family_NN 210951_x_at_VBD 19_CD 38_CD 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Jacques_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Wreesmann_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD ,_, 2005_CD -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Mitselou_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, c_NN Aksoy_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC c_NN Letsas_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Stassi_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Basolo_NNP et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- and_CC single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
2004_CD a_DT ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
1999_CD ,_, De_NNP Micco_NNP et_FW al._FW ._. 
1999_CD ,_, Czarnocka_FW et_FW al._FW ._. 
2001_CD ,_, Le_NNP Fourn_NNP et_FW al._FW ._. 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2005_CD ,_, Arnaldi_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Wreesmann_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- cDe_FW Micco_FW et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- ,_, c_NN Czarnocka_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, c_NN Le_NNP Fourn_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, c_NN Ambroziak_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC c_NN Arnaldi_NNP et_NNP al._NNP ._. 
26_CD Aldred_NNP et_NNP al._IN 46_CD 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC c_NN Letsas_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, c_NN Aksoy_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Mitselou_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Jacques_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Stassi_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Basolo_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- Anti-apoptotic_JJ protein_NN TACSTD2_CD Tumor-associated_JJ calcium_NN signal_NN transducer_NN 2_CD 202286_s_at_CD 22_CD 36_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Cerutti_NNP et_NNP al._IN 76_CD Barden_NNP et_FW al._FW 09_FW 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Klopper_NNP et_NNP al._VBD 62_CD Haugen_NNP et_FW al._FW 80_CD 2_CD ._. 
66_CD 2_CD ._. 
69_CD 2_CD ._. 
35_CD 4_CD ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Fe_NNP -LRB-_-LRB- II_NNP -RRB-_-RRB- -_: dependent_JJ enzyme_NN responsible_JJ for_IN aromatic_JJ ring_NN cleavage_NN RXRG_NNP Retinoid_NNP X_NNP receptor_NN ,_, 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Chevillard_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Schelfhout_FW et_FW al._FW ._. 
-LRB-_-LRB- 1989_CD -RRB-_-RRB- The_DT smallest_JJS known_JJ keratin_NN expressed_VBN in_IN some_DT types_NNS of_IN cancer_NN ID3_NNP Inhibitor_NNP of_IN DNA_NNP binding_JJ 3_CD ,_, dominant_JJ negative_JJ helix-loop-helix_JJ protein_NN 207826_s_at_CD 35_CD 26_CD 
1999_CD ,_, Shimura_NNP et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
Nevertheless_RB ,_, neither_CC our_PRP$ approach_NN nor_CC the_DT meta-analysis_NN mentioned_VBD earlier_RB indicated_VBN other_JJ thyroid-specific_JJ genes_NNS ,_, confirming_VBG the_DT lesser_JJR diagnostic_JJ potency_NN of_IN sodium_NN iodide_NN symporter_NN ,_, thyroglobulin_NN ,_, thyrotrophin_NN receptor_NN ,_, or_CC thyroid-specific_JJ transcription_NN factors_NNS ,_, shown_VBN to_TO be_VB down-regulated_JJ in_IN previous_JJ single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
2001_CD ,_, Scouten_NNP et_FW al._FW ._. 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2005_CD ,_, Wagner_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT top_JJ gene_NN identified_VBN by_IN our_PRP$ effort_NN ,_, MPPED2_NNP ,_, which_WDT is_VBZ lost_VBN in_IN PTC_NNP ,_, was_VBD not_RB previously_RB considered_VBN for_IN its_PRP$ role_NN in_IN PTC_NNP ,_, although_IN it_PRP was_VBD previously_RB listed_VBN by_IN Aldred_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- ,_, Woodhouse_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Lelievre_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD ,_, 2004_CD -RRB-_-RRB- and_CC Prasad_NNP et_NNP al._VBD 81_CD Aldred_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- and_CC Schnurr_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Membrane_NN receptor_NN ,_, stimulates_VBZ motility_NN and_CC modulates_VBZ proliferation_NN HMGA2_NNP High-mobility_NNP group_NN AT-hook_NNP 2_CD 208025_s_at_CD 11_CD 40_CD 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
Nevertheless_RB ,_, neither_CC our_PRP$ approach_NN nor_CC the_DT meta-analysis_NN mentioned_VBD earlier_RB indicated_VBN other_JJ thyroid-specific_JJ genes_NNS ,_, confirming_VBG the_DT lesser_JJR diagnostic_JJ potency_NN of_IN sodium_NN iodide_NN symporter_NN ,_, thyroglobulin_NN ,_, thyrotrophin_NN receptor_NN ,_, or_CC thyroid-specific_JJ transcription_NN factors_NNS ,_, shown_VBN to_TO be_VB down-regulated_JJ in_IN previous_JJ single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
1999_CD ,_, Shimura_NNP et_FW al._FW ._. 
2001_CD ,_, Scouten_NNP et_FW al._FW ._. 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2005_CD ,_, Wagner_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT top_JJ gene_NN identified_VBN by_IN our_PRP$ effort_NN ,_, MPPED2_NNP ,_, which_WDT is_VBZ lost_VBN in_IN PTC_NNP ,_, was_VBD not_RB previously_RB considered_VBN for_IN its_PRP$ role_NN in_IN PTC_NNP ,_, although_IN it_PRP was_VBD previously_RB listed_VBN by_IN Aldred_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Hamada_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Wreesmann_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Signal_NNP transducer_NN coupled_VBN with_IN calcium_NN channels_NNS ,_, participates_VBZ in_IN apoptosis_NN -LRB-_-LRB- Sedlak_NNP 
The_DT introductory_JJ gene_NN selection_NN was_VBD performed_VBN using_VBG neighborhood_NN analysis_NN -LRB-_-LRB- 200_CD genes_NNS ;_: Golub_NNP et_FW al._FW ._. 
1999_CD ,_, Slonim_FW et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ,_, further_JJ selection_NN of_IN the_DT 100_CD best_JJS genes_NNS set_VBN was_VBD carried_VBN out_RP by_IN RFE_NNP ._. 
SVMs_NNS and_CC classification_NN The_DT linear_JJ SVM_NNP -LRB-_-LRB- Boser_NNP et_FW al._FW ._. 
e._JJ Iterations_NNS of_IN all_DT stages_NNS of_IN the_DT classifier_NN construction_NN -LRB-_-LRB- i._FW Bootstrap_NNP for_IN estimation_NN of_IN classifier_NN accuracy_NN and_CC its_PRP$ CI_NN In_IN order_NN to_TO determine_VB the_DT accuracy_NN of_IN the_DT developed_JJ classifier_NN ,_, we_PRP performed_VBD classical_JJ bootstrap_NN procedure_NN in_IN 500_CD resampling_JJ iterations_NNS -LRB-_-LRB- selection_NN with_IN equal_JJ probability_NN and_CC return_NN of_IN samples_NNS ;_: Efron_NNP 1979_CD -RRB-_-RRB- ._. 
gene_NN preselection_NN ,_, gene_NN selection_NN ,_, and_CC classifier_NN learning_NN -RRB-_-RRB- were_VBD performed_VBN in_IN each_DT bootstrap_NN ,_, as_IN suggested_VBN previously_RB -LRB-_-LRB- Simon_NNP et_NNP al._NNP ._. 
2003_CD -RRB-_-RRB- ._. 
The_DT accuracy_NN of_IN the_DT classifier_NN was_VBD calculated_VBN using_VBG the_DT 0_CD ._. 
632_CD bootstrap_NN estimator_NN -LRB-_-LRB- Efron_NNP 1983_CD -RRB-_-RRB- ._. 
Originally_RB ,_, in_IN a_DT bootstrap_JJ iteration_NN one_NN counts_VBZ only_RB the_DT number_NN of_IN misclassifications_NNS ._. 
2005_CD -RRB-_-RRB- ._. 
submitted_VBN -RRB-_-RRB- than_IN data_NNS created_VBN by_IN leave-one-out_JJ cross-validation_NN of_IN the_DT whole_JJ dataset_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
Since_IN in_IN all_DT bootstrap_JJ iterations_NNS every_DT step_NN of_IN data_NN processing_NN -LRB-_-LRB- gene_NN selection_NN and_CC classifier_NN training_NN -RRB-_-RRB- has_VBZ to_TO be_VB repeated_VBN -LRB-_-LRB- Simon_NNP et_NNP al._NNP ._. 
2003_CD -RRB-_-RRB- ,_, some_DT additional_JJ knowledge_NN can_MD be_VB gained_VBN ._. 
The_DT procedure_NN used_VBN by_IN us_PRP enables_VBZ ranking_NN of_IN genes_NNS which_WDT are_VBP most_RBS often_RB present_JJ in_IN the_DT classifiers_NNS obtained_VBN from_IN the_DT different_JJ subsets_NNS of_IN the_DT training_NN set_NN -LRB-_-LRB- BBFR_NNP -RRB-_-RRB- ._. 
Although_IN the_DT selected_VBN genes_NNS were_VBD obtained_VBN by_IN analysis_NN of_IN PTC_NNP ,_, many_JJ of_IN them_PRP may_MD be_VB found_VBN also_RB in_IN other_JJ types_NNS of_IN thyroid_JJ tumors_NNS -LRB-_-LRB- M_NNP Oczko-Wojciechowska_NNP ,_, J_NNP Starzy_NNP 
When_WRB we_PRP included_VBD both_DT benign_JJ and_CC malignant_JJ samples_NNS from_IN both_DT platforms_NNS ,_, the_DT vast_JJ majority_NN of_IN these_DT samples_NNS were_VBD properly_RB classified_VBN ._. 
Using_VBG Affymetrix_NNP GeneChips_NNP ,_, Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- had_VBD previously_RB reported_VBN 20_CD of_IN 43_CD genes_NNS now_RB confirmed_VBN by_IN us_PRP as_RB diagnostically_RB relevant_JJ for_IN PTC_NNP ._. 
73_CD 2_CD ._. 
93_CD 1_CD ._. 
22_CD 2_CD ._. 
15_CD 5_CD ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Oxygen_NN transport_NN MET_NNP Met_NNP proto-oncogene_NN -LRB-_-LRB- hepatocyte_JJ growth_NN factor_NN receptor_NN -RRB-_-RRB- 213807_x_at_CD 3_CD 45_CD 
91_CD Chen_NNP et_NNP al._VBD 75_CD 3_CD ._. 
52_CD 2_CD ._. 
72_CD 3_CD ._. 
24_CD 8_CD ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- -RRB-_-RRB- FN1_NNP Fibronectin_NNP 1_CD 210495_x_at_CD 4_CD 44_CD 
14_CD 2_CD ._. 
61_CD 3_CD ._. 
99_CD 2_CD ._. 
60_CD 4_CD ._. 
50_CD Converts_VBZ glucose_NN to_TO galactose_VB and_CC N_NNP -_: acetylglucosamine_NN to_TO its_PRP$ UDP-derivatives_NNP QPCT_NNP Glutaminyl-peptide_JJ cyclotransferase_NN -LRB-_-LRB- glutaminyl_JJ cyclase_NN -RRB-_-RRB- 205174_s_at_CD 6_CD 43_CD 
02_CD 2_CD ._. 
12_CD 2_CD ._. 
56_CD 2_CD ._. 
68_CD 7_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Converts_VBZ glutaminyl_JJ peptides_NNS to_TO cyclic_JJ pyroglutamyl_NN ones_NNS NELL2_VBP NEL-like_JJ 2_CD -LRB-_-LRB- chicken_NN -RRB-_-RRB- 203413_at_CD 7_CD 42_CD 
33_CD Aldred_NNP et_FW al._FW 05_FW 
53_CD 1_CD ._. 
27_CD 2_CD ._. 
70_CD 2_CD ._. 
96_CD 4_CD ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- -RRB-_-RRB- RYR1_NNP Ryanodine_NNP receptor_NN 1_CD -LRB-_-LRB- skeletal_JJ -RRB-_-RRB- 205485_at_CD 12_CD 40_CD 
09_CD 
36_CD 2_CD ._. 
98_CD 1_CD ._. 
33_CD 1_CD ._. 
31_CD 6_CD ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- -RRB-_-RRB- NRIP1_NNP Nuclear_NNP receptor-interacting_JJ protein_NN 1_CD 202599_s_at_CD 16_CD 39_CD 
53_CD 2_CD ._. 
76_CD 1_CD ._. 
68_CD 2_CD ._. 
44_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- Interacts_VBZ with_IN nuclear_JJ receptors_NNS MET_NNP Met_NNP proto-oncogene_NN -LRB-_-LRB- hepatocyte_JJ growth_NN factor_NN receptor_NN -RRB-_-RRB- 211599_x_at_CD 17_CD 39_CD 
60_NNP 1_CD ._. 
00_CD 1_CD ._. 
62_CD 3_CD ._. 
62_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Participates_VBZ in_IN protein_NN ubiquination_NN RAB27A_NNP RAB27A_NNP ,_, member_NN RAS_NNP oncogene_NN family_NN 210951_x_at_VBD 19_CD 38_CD 
-LRB-_-LRB- 2001_CD ,_, 2004_CD -RRB-_-RRB- ,_, Huang_NNP et_NNP al._IN 33_CD Eszlinger_NNP et_NNP al._IN 79_CD 
06_CD 
20_CD 1_CD ._. 
50_CD 1_CD ._. 
02_CD 1_CD ._. 
52_CD 6_CD ._. 
06_CD Participates_NNPS in_IN cell_NN 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Aldred_NNP et_NNP al._IN 92_CD Huang_NNP et_NNP al._IN 17_CD 
62_CD 
86_CD 2_CD ._. 
45_CD 1_CD ._. 
31_CD 2_CD ._. 
76_CD 8_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- An_DT ancient_JJ isozyme_NN SDC4_NNP Syndecan_NNP 4_CD -LRB-_-LRB- amphiglycan_JJ ,_, ryudocan_JJ -RRB-_-RRB- 202071_at_CD 31_CD 28_CD 
93_CD 
55_CD 3_CD ._. 
22_CD 3_CD ._. 
71_CD 3_CD ._. 
92_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Thyroid-specific_JJ enzyme_NN crucial_JJ for_IN organification_NN of_IN iodine_NN and_CC synthesis_NN of_IN thyroid_JJ hormones_NNS KRT19_NNP Keratin_NNP 19 201650_CD __NN at_IN 34_CD 27_CD 
43_CD 1_CD ._. 
28_CD 1_CD ._. 
29_CD 2_CD ._. 
57_CD 6_CD ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- -RRB-_-RRB- 64_CD 
Wellcome_NNP Trust_NNP Introduction_NNP Discrimination_NNP between_IN benign_JJ thyroid_JJ nodules_NNS and_CC cancer_NN is_VBZ an_DT important_JJ aspect_NN of_IN determining_VBG the_DT optimal_JJ extent_NN of_IN thyroid_JJ surgery_NN ._. 
However_RB ,_, this_DT method_NN does_VBZ not_RB allow_VB proper_JJ classification_NN of_IN all_DT thyroid_JJ tumors_NNS -LRB-_-LRB- Baloch_NNP 
We_PRP noted_VBD only_RB one_CD gene_NN clearly_RB related_VBN to_TO apoptosis_NN -LRB-_-LRB- and_CC lost_VBN in_IN PTC_NNP -RRB-_-RRB- ,_, the_DT well-known_JJ BCL2_NNP ._. 
Both_DT of_IN these_DT functional_JJ classes_NNS are_VBP typical_JJ for_IN cancer_NN genes_NNS ._. 
Interestingly_RB enough_RB ,_, some_DT immunohistochemical_JJ studies_NNS report_VBP its_PRP$ up-regulation_NN in_IN PTC_NNP -LRB-_-LRB- Aksoy_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Although_IN the_DT selected_VBN genes_NNS were_VBD obtained_VBN by_IN analysis_NN of_IN PTC_NNP ,_, many_JJ of_IN them_PRP may_MD be_VB found_VBN also_RB in_IN other_JJ types_NNS of_IN thyroid_JJ tumors_NNS -LRB-_-LRB- M_NNP Oczko-Wojciechowska_NNP ,_, J_NNP Starzy_NNP 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Mitselou_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Jacques_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Wreesmann_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, cAksoy_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC c_NN Letsas_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Stassi_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Basolo_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- Anti-apoptotic_JJ protein_NN TACSTD2_CD Tumor-associated_JJ calcium_NN signal_NN transducer_NN 2_CD 202286_s_at_CD 22_CD 36_CD 
2001_CD ,_, Giordano_NNP et_FW al._FW ._. 
At_IN several_JJ institutions_NNS ,_, genomic_JJ studies_NNS have_VBP been_VBN undertaken_VBN which_WDT besides_IN focusing_VBG on_IN basic_JJ biological_JJ issues_NNS -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, also_RB explore_VBP potential_JJ diagnostic_JJ applications_NNS -LRB-_-LRB- Aldred_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, b_NN -RRB-_-RRB- ._. 
Our_PRP$ recent_JJ microarray-based_JJ analysis_NN brought_VBD a_DT 20-gene_JJ classifier_NN to_TO differentiate_VB between_IN papillary_JJ thyroid_NN cancer_NN -LRB-_-LRB- PTC_NNP -RRB-_-RRB- and_CC normal_JJ thyroid_NN tissue_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW 
2001_CD ,_, Wasenius_FW et_FW al._FW ._. 
Such_JJ studies_NNS have_VBP been_VBN successfully_RB performed_VBN in_IN PTC_NNP and_CC large_JJ numbers_NNS of_IN discriminating_VBG physiologically_RB relevant_JJ genes_NNS were_VBD proposed_VBN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2003_CD ,_, Aldred_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, b_NN ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD ,_, Baris_NNP et_FW al._FW ._. 
26_CD Aldred_NNP et_NNP al._IN 46_CD 
33_CD Aldred_NNP et_FW al._FW 05_FW 
81_CD Aldred_NNP et_FW al._FW 00_CD 2_CD ._. 
30_CD 2_CD ._. 
85_CD 2_CD ._. 
16_CD 4_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Membrane_FW enzyme_FW ,_, participates_VBZ in_IN breakdown_NN of_IN secreted_JJ peptides_NNS ADORA1_NNP Adenosine_NNP A1_NNP receptor_NN 205481_at_VBD 10_CD 41_CD 
24_CD Aldred_NNP et_NNP al._IN 48_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Aldred_NNP et_NNP al._IN 92_CD Huang_NNP et_NNP al._IN 17_CD 
46_CD 
05_CD 
00_CD 2_CD ._. 
30_CD 2_CD ._. 
85_CD 2_CD ._. 
16_CD 4_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Membrane_FW enzyme_FW ,_, participates_VBZ in_IN breakdown_NN of_IN secreted_JJ peptides_NNS ADORA1_NNP Adenosine_NNP A1_NNP receptor_NN 205481_at_VBD 10_CD 41_CD 
48_CD 
92_CD Huang_NNP et_NNP al._IN 17_CD 
-LRB-_-LRB- 2003_CD a_DT ,_, b_NN -RRB-_-RRB- and_CC Ozog_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, c_NN Kholova_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Kehlen_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Aratake_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- and_CC Schagdarsurengin_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Membrane_FW enzyme_FW ,_, participates_VBZ in_IN breakdown_NN of_IN secreted_JJ peptides_NNS ADORA1_NNP Adenosine_NNP A1_NNP receptor_NN 205481_at_VBD 10_CD 41_CD 
2001_CD ,_, Le_NNP Fourn_NNP et_FW al._FW ._. 
1999_CD ,_, Czarnocka_FW et_FW al._FW ._. 
1999_CD ,_, De_NNP Micco_NNP et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- and_CC single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2005_CD ,_, Arnaldi_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Nevertheless_RB ,_, neither_CC our_PRP$ approach_NN nor_CC the_DT meta-analysis_NN mentioned_VBD earlier_RB indicated_VBN other_JJ thyroid-specific_JJ genes_NNS ,_, confirming_VBG the_DT lesser_JJR diagnostic_JJ potency_NN of_IN sodium_NN iodide_NN symporter_NN ,_, thyroglobulin_NN ,_, thyrotrophin_NN receptor_NN ,_, or_CC thyroid-specific_JJ transcription_NN factors_NNS ,_, shown_VBN to_TO be_VB down-regulated_JJ in_IN previous_JJ single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
2001_CD ,_, Scouten_NNP et_FW al._FW ._. 
1999_CD ,_, Shimura_NNP et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
Nevertheless_RB ,_, neither_CC our_PRP$ approach_NN nor_CC the_DT meta-analysis_NN mentioned_VBD earlier_RB indicated_VBN other_JJ thyroid-specific_JJ genes_NNS ,_, confirming_VBG the_DT lesser_JJR diagnostic_JJ potency_NN of_IN sodium_NN iodide_NN symporter_NN ,_, thyroglobulin_NN ,_, thyrotrophin_NN receptor_NN ,_, or_CC thyroid-specific_JJ transcription_NN factors_NNS ,_, shown_VBN to_TO be_VB down-regulated_JJ in_IN previous_JJ single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2005_CD ,_, Wagner_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT top_JJ gene_NN identified_VBN by_IN our_PRP$ effort_NN ,_, MPPED2_NNP ,_, which_WDT is_VBZ lost_VBN in_IN PTC_NNP ,_, was_VBD not_RB previously_RB considered_VBN for_IN its_PRP$ role_NN in_IN PTC_NNP ,_, although_IN it_PRP was_VBD previously_RB listed_VBN by_IN Aldred_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, c_NN Le_NNP Fourn_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- ,_, c_NN Czarnocka_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- c_NN De_NNP Micco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, cAmbroziak_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC c_NN Arnaldi_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Kohrle_NNP -LRB-_-LRB- 1999_CD -RRB-_-RRB- 5_CD 
2004_CD a_DT ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD ,_, Cerutti_NNP et_FW al._FW ._. 
2001_CD ,_, Baris_NNP et_FW al._FW ._. 
2001_CD ,_, Huang_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- and_CC single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
1999_CD ,_, De_NNP Micco_NNP et_FW al._FW ._. 
1999_CD ,_, Czarnocka_FW et_FW al._FW ._. 
2001_CD ,_, Le_NNP Fourn_NNP et_FW al._FW ._. 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
2005_CD ,_, Arnaldi_FW et_FW al._FW ._. 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2001_CD ,_, Le_NNP Fourn_NNP et_FW al._FW ._. 
1999_CD ,_, Czarnocka_FW et_FW al._FW ._. 
Nevertheless_RB ,_, neither_CC our_PRP$ approach_NN nor_CC the_DT meta-analysis_NN mentioned_VBD earlier_RB indicated_VBN other_JJ thyroid-specific_JJ genes_NNS ,_, confirming_VBG the_DT lesser_JJR diagnostic_JJ potency_NN of_IN sodium_NN iodide_NN symporter_NN ,_, thyroglobulin_NN ,_, thyrotrophin_NN receptor_NN ,_, or_CC thyroid-specific_JJ transcription_NN factors_NNS ,_, shown_VBN to_TO be_VB down-regulated_JJ in_IN previous_JJ single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
1999_CD ,_, Shimura_NNP et_FW al._FW ._. 
2001_CD ,_, Scouten_NNP et_FW al._FW ._. 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2005_CD ,_, Wagner_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Cerutti_NNP et_NNP al._IN 75_CD Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Arturi_FW et_FW al._FW ._. 
-LRB-_-LRB- 1997_CD -RRB-_-RRB- ,_, Lazar_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- and_CC Furuya_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Thyroid-specific_JJ enzyme_NN crucial_JJ for_IN organification_NN of_IN iodine_NN and_CC synthesis_NN of_IN thyroid_JJ hormones_NNS KRT19_NNP Keratin_NNP 19 201650_CD __NN at_IN 34_CD 27_CD 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2001_CD ,_, Le_NNP Fourn_NNP et_FW al._FW ._. 
1999_CD ,_, Czarnocka_FW et_FW al._FW ._. 
1999_CD ,_, De_NNP Micco_NNP et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
2005_CD ,_, Arnaldi_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Nevertheless_RB ,_, neither_CC our_PRP$ approach_NN nor_CC the_DT meta-analysis_NN mentioned_VBD earlier_RB indicated_VBN other_JJ thyroid-specific_JJ genes_NNS ,_, confirming_VBG the_DT lesser_JJR diagnostic_JJ potency_NN of_IN sodium_NN iodide_NN symporter_NN ,_, thyroglobulin_NN ,_, thyrotrophin_NN receptor_NN ,_, or_CC thyroid-specific_JJ transcription_NN factors_NNS ,_, shown_VBN to_TO be_VB down-regulated_JJ in_IN previous_JJ single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, c_NN Ambroziak_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, c_NN Le_NNP Fourn_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- ,_, c_NN Czarnocka_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- c_NN De_NNP Micco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC cArnaldi_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Kohrle_NNP -LRB-_-LRB- 1999_CD -RRB-_-RRB- 5_CD 
62_CD Haugen_NNP et_FW al._FW 80_CD 2_CD ._. 
66_CD 2_CD ._. 
69_CD 2_CD ._. 
35_CD 4_CD ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Fe_NNP -LRB-_-LRB- II_NNP -RRB-_-RRB- -_: dependent_JJ enzyme_NN responsible_JJ for_IN aromatic_JJ ring_NN cleavage_NN RXRG_NNP Retinoid_NNP X_NNP receptor_NN ,_, 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC c_NN Arnaldi_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, c_NN Ambroziak_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, c_NN Le_NNP Fourn_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- ,_, c_NN Czarnocka_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Kohrle_NNP -LRB-_-LRB- 1999_CD -RRB-_-RRB- 5_CD 
77_CD 
2004_CD -RRB-_-RRB- and_CC single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
2004_CD a_DT ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD ,_, Cerutti_NNP et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
1999_CD ,_, De_NNP Micco_NNP et_FW al._FW ._. 
1999_CD ,_, Czarnocka_FW et_FW al._FW ._. 
2001_CD ,_, Le_NNP Fourn_NNP et_FW al._FW ._. 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2005_CD ,_, Arnaldi_FW et_FW al._FW ._. 
Nevertheless_RB ,_, neither_CC our_PRP$ approach_NN nor_CC the_DT meta-analysis_NN mentioned_VBD earlier_RB indicated_VBN other_JJ thyroid-specific_JJ genes_NNS ,_, confirming_VBG the_DT lesser_JJR diagnostic_JJ potency_NN of_IN sodium_NN iodide_NN symporter_NN ,_, thyroglobulin_NN ,_, thyrotrophin_NN receptor_NN ,_, or_CC thyroid-specific_JJ transcription_NN factors_NNS ,_, shown_VBN to_TO be_VB down-regulated_JJ in_IN previous_JJ single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
1999_CD ,_, Shimura_NNP et_FW al._FW ._. 
2001_CD ,_, Scouten_NNP et_FW al._FW ._. 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2005_CD ,_, Wagner_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Arturi_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Cerutti_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1997_CD -RRB-_-RRB- ,_, Lazar_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- and_CC Furuya_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Thyroid-specific_JJ enzyme_NN crucial_JJ for_IN organification_NN of_IN iodine_NN and_CC synthesis_NN of_IN thyroid_JJ hormones_NNS KRT19_NNP Keratin_NNP 19 201650_CD __NN at_IN 34_CD 27_CD 
DPP4_NNP ,_, another_DT membrane-bound_JJ enzyme_NN which_WDT hydrolyzes_VBZ peptides_NNS engaged_VBN in_IN paracrine_NN and_CC autocrine_NN regulation_NN ,_, is_VBZ up-regulated_JJ in_IN PTCs_NNP both_DT on_IN RNA_NNP and_CC protein_NN level_NN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2001_CD ,_, Kholova_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
The_DT contribution_NN of_IN various_JJ enzymes_NNS to_TO our_PRP$ list_NN is_VBZ striking_JJ :_: others_NNS ,_, not_RB described_VBN previously_RB in_IN the_DT context_NN of_IN thyroid_JJ gland_NN ,_, comprise_VBP UDP-galactose_JJ epimerase_NN -LRB-_-LRB- GALE_NNP -RRB-_-RRB- and_CC glutaminyl-peptide_JJ cyclotransferase_NN -LRB-_-LRB- QPCT_NNP -RRB-_-RRB- ,_, both_DT with_IN virtually_RB unknown_JJ expression_NN patterns_NNS ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, c_NN Kholova_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Kehlen_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD ,_, 2004_CD -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003a_CD ,_, b_NN -RRB-_-RRB- and_CC Ozog_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Aratake_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- and_CC Schagdarsurengin_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Membrane_FW enzyme_FW ,_, participates_VBZ in_IN breakdown_NN of_IN secreted_JJ peptides_NNS ADORA1_NNP Adenosine_NNP A1_NNP receptor_NN 205481_at_VBD 10_CD 41_CD 
50_CD 2_CD ._. 
58_CD 3_CD ._. 
80_CD 2_CD ._. 
37_CD 4_CD ._. 
29_CD Downstream_NNP target_NN of_IN pituitary_JJ tumor_NN transforming_VBG gene_NN -LRB-_-LRB- PTTG_NNP -RRB-_-RRB- RUNX1_CD Runt-related_JJ transcription_NN factor_NN 1_CD -LRB-_-LRB- acute_JJ myeloid_JJ leukemia_NN 1_CD ;_: aml1_CD oncogene_NN -RRB-_-RRB- 209360_s_at_CD 36_CD 26_CD 
1998_CD -RRB-_-RRB- ._. 
ICAM1_NNP was_VBD shown_VBN to_TO be_VB present_JJ in_IN thyroid_NN cancer_NN cells_NNS -LRB-_-LRB- Kawai_FW et_FW al._FW ._. 
DPP4_NNP -LRB-_-LRB- CD26_NNP -RRB-_-RRB- ,_, ICAM1_CD ,_, and_CC ENTPD1_NNP -LRB-_-LRB- CD39_NNP -RRB-_-RRB- may_MD be_VB considered_VBN as_IN immune-related_JJ genes_NNS ,_, although_IN their_PRP$ expression_NN is_VBZ not_RB confined_VBN to_TO immune_JJ or_CC endothelial_JJ cells_NNS ._. 
ENTPD1_CD -LRB-_-LRB- ecto-ATPase_JJ -RRB-_-RRB- ,_, in_IN turn_NN ,_, has_VBZ not_RB been_VBN described_VBN before_IN for_IN the_DT thyroid_JJ gland_NN ;_: its_PRP$ expression_NN was_VBD shown_VBN in_IN some_DT other_JJ organs_NNS like_IN salivary_JJ glands_NNS or_CC exocrine_NN pancreas_NNS -LRB-_-LRB- Kittel_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
It_PRP converts_VBZ adenine_JJ nucleotides_NNS to_TO adenosine_VB ,_, thus_RB participating_VBG in_IN the_DT control_NN of_IN signal_NN transduction_NN ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Sarquis_NNP et_NNP al._VBD 48_CD Weber_NNP et_FW al._FW 49_CD 1_CD ._. 
97_CD 1_CD ._. 
75_CD 1_CD ._. 
71_CD 6_CD ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- -RRB-_-RRB- ENTPD1_FW Ectonucleoside_FW triphosphate_FW diphosphohydrolase_FW 1_CD 209473_at_CD 32_CD 27_CD 
1999_CD ,_, Czarnocka_FW et_FW al._FW ._. 
1999_CD ,_, De_NNP Micco_NNP et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- and_CC single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
2001_CD ,_, Le_NNP Fourn_NNP et_FW al._FW ._. 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2005_CD ,_, Arnaldi_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Nevertheless_RB ,_, neither_CC our_PRP$ approach_NN nor_CC the_DT meta-analysis_NN mentioned_VBD earlier_RB indicated_VBN other_JJ thyroid-specific_JJ genes_NNS ,_, confirming_VBG the_DT lesser_JJR diagnostic_JJ potency_NN of_IN sodium_NN iodide_NN symporter_NN ,_, thyroglobulin_NN ,_, thyrotrophin_NN receptor_NN ,_, or_CC thyroid-specific_JJ transcription_NN factors_NNS ,_, shown_VBN to_TO be_VB down-regulated_JJ in_IN previous_JJ single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- ,_, c_NN Czarnocka_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- c_NN De_NNP Micco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, cLe_FW Fourn_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, c_NN Ambroziak_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC c_NN Arnaldi_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Kohrle_NNP -LRB-_-LRB- 1999_CD -RRB-_-RRB- 5_CD 
-LRB-_-LRB- 2003_CD ,_, 2004_CD -RRB-_-RRB- and_CC Prasad_NNP et_NNP al._VBD 81_CD Aldred_NNP et_FW al._FW 00_CD 2_CD ._. 
30_CD 2_CD ._. 
85_CD 2_CD ._. 
16_CD 4_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Membrane_FW enzyme_FW ,_, participates_VBZ in_IN breakdown_NN of_IN secreted_JJ peptides_NNS ADORA1_NNP Adenosine_NNP A1_NNP receptor_NN 205481_at_VBD 10_CD 41_CD 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Weber_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD ,_, 2004_CD -RRB-_-RRB- ,_, Barden_NNP et_NNP al._IN 33_CD Aldred_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Sarquis_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Breakdown_NN of_IN secreted_JJ peptides_NNS ,_, homologous_RB to_TO prostate_NN membrane-specific_JJ antigen_NN -LRB-_-LRB- Gingras_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ,_, Musholt_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Weber_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW 24_CD Barden_NNP et_FW al._FW 60_CD 1_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- and_CC Sarquis_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Prenylated_NNP membrane_NN bound_VBD protein_NN with_IN GTP-ase_JJ function_NN 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Weber_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_NNP al._IN 41_CD Barden_NNP et_NNP al._IN 62_CD 
48_CD Weber_NNP et_FW al._FW 49_CD 1_CD ._. 
97_CD 1_CD ._. 
75_CD 1_CD ._. 
71_CD 6_CD ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- -RRB-_-RRB- ENTPD1_FW Ectonucleoside_FW triphosphate_FW diphosphohydrolase_FW 1_CD 209473_at_CD 32_CD 27_CD 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Weber_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_NNP al._IN 53_CD Barden_NNP et_NNP al._VBD 43_CD 1_CD ._. 
28_CD 1_CD ._. 
29_CD 2_CD ._. 
57_CD 6_CD ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- -RRB-_-RRB- 64_CD 
-LRB-_-LRB- 2000_CD -RRB-_-RRB- ,_, Ruco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- Ramirez_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 1997_CD -RRB-_-RRB- and_CC c_NN Ippolito_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- c_NN Belfiore_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- and_CC Scarpino_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Membrane_NNP tyrosine_NN kinase_NN receptor_NN enhances_VBZ cell_NN motility_NN ,_, invasiveness_NN ,_, and_CC chemokine_NN production_NN -LRB-_-LRB- Ruco_FW et_FW al._FW ._. 
62_CD Does_NNP not_RB normally_RB appear_VB in_IN thyroid_NN ,_, in_IN adult_NN mouse_NN becomes_VBZ restricted_VBN to_TO epidermis_NNS ,_, testis_NNS and_CC placenta_NN -LRB-_-LRB- Tonoli_FW et_FW al._FW ._. 
-LRB-_-LRB- 2000_CD -RRB-_-RRB- ,_, Plum_FW et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC Green_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Forms_VBZ incompatible_JJ hemichannels_NNS with_IN thyroidal_JJ connexin_NN 43_CD -LRB-_-LRB- Dahl_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_FW et_FW al._FW 60_NNP Barden_NNP et_FW al._FW 73_CD 2_CD ._. 
93_CD 1_CD ._. 
22_CD 2_CD ._. 
15_CD 5_CD ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Oxygen_NN transport_NN MET_NNP Met_NNP proto-oncogene_NN -LRB-_-LRB- hepatocyte_JJ growth_NN factor_NN receptor_NN -RRB-_-RRB- 213807_x_at_CD 3_CD 45_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_FW et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Barden_NNP et_NNP al._IN 91_CD Chen_NNP et_NNP al._VBD 75_CD 3_CD ._. 
52_CD 2_CD ._. 
72_CD 3_CD ._. 
-LRB-_-LRB- 2004a_CD ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ,_, Hamada_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Takano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Takano_NNP et_NNP al._IN 81_CD Huang_NNP et_FW al._FW 21_CD 3_CD ._. 
11_CD 3_CD ._. 
77_CD 4_CD ._. 
87_CD 3_CD ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- -RRB-_-RRB- DPP4_NNP Dipeptidylpeptidase_NNP 4_CD -LRB-_-LRB- CD26_NNP ,_, adenosine_JJ deaminase_NN complexing_VBG protein_NN 2_CD -RRB-_-RRB- 203717_at_CD 9_CD 42_CD 
81_CD Aldred_NNP et_FW al._FW 00_CD 2_CD ._. 
30_CD 2_CD ._. 
85_CD 2_CD ._. 
16_CD 4_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Membrane_FW enzyme_FW ,_, participates_VBZ in_IN breakdown_NN of_IN secreted_JJ peptides_NNS ADORA1_NNP Adenosine_NNP A1_NNP receptor_NN 205481_at_VBD 10_CD 41_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_NNP et_NNP al._IN 54_CD Barden_NNP et_NNP al._VBD 53_CD 2_CD ._. 
76_CD 1_CD ._. 
68_CD 2_CD ._. 
44_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- Interacts_VBZ with_IN nuclear_JJ receptors_NNS MET_NNP Met_NNP proto-oncogene_NN -LRB-_-LRB- hepatocyte_JJ growth_NN factor_NN receptor_NN -RRB-_-RRB- 211599_x_at_CD 17_CD 39_CD 
07_CD 1_CD ._. 
00_CD 2_CD ._. 
24_CD 2_CD ._. 
24_CD 8_CD ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- See_VB the_DT information_NN given_VBN above_IN for_IN another_DT probeset_NN of_IN the_DT same_JJ gene_NN DTX4_NNP Deltex_NNP 4_CD homolog_NN -LRB-_-LRB- Drosophila_NNP -RRB-_-RRB- 212611_at_CD 18_CD 39_CD 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- ,_, Baris_NNP et_NNP al._IN 39_CD Hoos_NNP et_NNP al._IN 74_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD ,_, 2004_CD -RRB-_-RRB- ,_, Huang_NNP et_NNP al._IN 33_CD Eszlinger_NNP et_NNP al._IN 79_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_NNP al._IN 83_CD Barden_NNP et_FW al._FW 06_FW 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Aldred_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Aldred_NNP et_NNP al._IN 92_CD Huang_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004a_CD ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Fe_NNP -LRB-_-LRB- II_NNP -RRB-_-RRB- -_: dependent_JJ enzyme_NN responsible_JJ for_IN aromatic_JJ ring_NN cleavage_NN RXRG_NNP Retinoid_NNP X_NNP receptor_NN ,_, 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Chevillard_NNP et_NNP al._IN 41_CD Barden_NNP et_NNP al._VBD 86_CD 2_CD ._. 
45_CD 1_CD ._. 
31_CD 2_CD ._. 
76_CD 8_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- An_DT ancient_JJ isozyme_NN SDC4_NNP Syndecan_NNP 4_CD -LRB-_-LRB- amphiglycan_JJ ,_, ryudocan_JJ -RRB-_-RRB- 202071_at_CD 31_CD 28_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Chevillard_NNP et_FW al._FW 07_FW Barden_FW et_FW al._FW 55_CD 3_CD ._. 
22_CD 3_CD ._. 
71_CD 3_CD ._. 
92_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Thyroid-specific_JJ enzyme_NN crucial_JJ for_IN organification_NN of_IN iodine_NN and_CC synthesis_NN of_IN thyroid_JJ hormones_NNS KRT19_NNP Keratin_NNP 19 201650_CD __NN at_IN 34_CD 27_CD 
00_CD Baris_NNP et_NNP al._IN 97_CD 
2005_CD -RRB-_-RRB- ._. 
Underexpression_NNP of_IN hemoglobin_NN transcripts_NNS -LRB-_-LRB- HBA1\/A2_NNP and_CC HBB_NNP scored_VBD at_IN positions_NNS 2_CD and_CC 25_CD respectively_RB -RRB-_-RRB- was_VBD already_RB discussed_VBN in_IN our_PRP$ papers_NNS as_IN a_DT very_RB characteristic_JJ feature_NN of_IN PTC_NNP gene_NN expression_NN profile_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
We_PRP believe_VBP that_IN the_DT down-regulation_NN of_IN hemoglobin_NN gene_NN could_MD be_VB associated_VBN with_IN tumor_NN hypoxia_NN ;_: HBA_NNP has_VBZ also_RB been_VBN considered_VBN a_DT tumor_NN suppressor_NN since_IN transduction_NN of_IN this_DT gene_NN in_IN an_DT anaplastic_JJ thyroid_NN cancer_NN cell_NN line_NN induces_VBZ an_DT anti-proliferative_JJ effect_NN -LRB-_-LRB- Onda_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Many_JJ of_IN the_DT genes_NNS listed_VBN in_IN Table_NNP 1_CD participate_VB in_IN signal_NN transduction_NN ;_: among_IN them_PRP are_VBP MET_NNP ,_, ADORA1_NNP ,_, RAB27A_NNP as_RB well_RB as_IN tumor-associated_JJ calcium_NN signal_NN transducer_NN 2_CD ,_, inositol_JJ 1,4,5-triphosphate_JJ receptor_NN ,_, type_NN 1_CD -LRB-_-LRB- ITPR1_NNP -RRB-_-RRB- ,_, ryanodine_NN receptor_NN 1_CD ,_, all_DT up-regulated_JJ in_IN PTC_NNP except_IN for_IN ITPR1_NNP ._. 
87_CD Griffith_NNP et_NNP al._IN 28_CD 
24_CD Aldred_NNP et_NNP al._IN 48_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, c_NN Kholova_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Kehlen_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD ,_, 2004_CD -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003a_CD ,_, b_NN -RRB-_-RRB- and_CC Ozog_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Aratake_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- and_CC Schagdarsurengin_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Membrane_FW enzyme_FW ,_, participates_VBZ in_IN breakdown_NN of_IN secreted_JJ peptides_NNS ADORA1_NNP Adenosine_NNP A1_NNP receptor_NN 205481_at_VBD 10_CD 41_CD 
Loss_NN of_IN CDH16_NNP -LRB-_-LRB- kidney-specific_JJ cadherin_NN ;_: Thomson_NNP et_FW al._FW ._. 
2004_CD a_DT -RRB-_-RRB- ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2001_CD ,_, Chevillard_NNP et_FW al._FW ._. 
1998_CD -RRB-_-RRB- was_VBD indicated_VBN for_IN the_DT first_JJ time_NN in_IN our_PRP$ study_NN ,_, a_DT gene_NN closely_RB related_VBN to_TO cadherin_NN E_NNP -LRB-_-LRB- CDH1_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ well_RB known_VBN to_TO be_VB lost_VBN in_IN a_DT subgroup_NN of_IN PTCs_NNS with_IN negative_JJ prognostic_JJ significance_NN -LRB-_-LRB- Rocha_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ,_, while_IN cadherin_NN P_NNP -LRB-_-LRB- CDH3_NNP -RRB-_-RRB- is_VBZ up-regulated_JJ in_IN PTC_NNP -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Other_JJ genes_NNS involved_VBN in_IN cell_NN adhesion_NN and_CC present_NN in_IN our_PRP$ list_NN comprise_VBP ectonucleoside_FW triphosphate_FW diphosphohydrolase_FW 1_CD -LRB-_-LRB- ENTPD1_CD -RRB-_-RRB- -LRB-_-LRB- up-regulated_JJ -RRB-_-RRB- and_CC less_RBR known_JJ genes_NNS such_JJ as_IN NEL-like_JJ 2_CD -LRB-_-LRB- up-regulated_JJ -RRB-_-RRB- and_CC sushi_NN ,_, nidogen_NN ,_, and_CC EGF-like_JJ domains_NNS 1_CD -LRB-_-LRB- down-regulated_JJ -RRB-_-RRB- ,_, both_DT exhibiting_VBG EGF-like_JJ repeats_NNS -LRB-_-LRB- Watanabe_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- Ramirez_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 1997_CD -RRB-_-RRB- and_CC c_NN Ippolito_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- c_NN Belfiore_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2000_CD -RRB-_-RRB- ,_, Ruco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- and_CC Scarpino_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Membrane_NNP tyrosine_NN kinase_NN receptor_NN enhances_VBZ cell_NN motility_NN ,_, invasiveness_NN ,_, and_CC chemokine_NN production_NN -LRB-_-LRB- Ruco_FW et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- and_CC Scarpino_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2000_CD -RRB-_-RRB- ,_, Ruco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- Ramirez_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 1997_CD -RRB-_-RRB- and_CC c_NN Ippolito_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Membrane_NNP tyrosine_NN kinase_NN receptor_NN enhances_VBZ cell_NN motility_NN ,_, invasiveness_NN ,_, and_CC chemokine_NN production_NN -LRB-_-LRB- Ruco_FW et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- -RRB-_-RRB- FN1_NNP Fibronectin_NNP 1_CD 210495_x_at_CD 4_CD 44_CD 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Takano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ,_, Hamada_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- ,_, 1999_CD and_CC cPrasad_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Ghinea_FW et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC Liu_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Extracellular_JJ matrix_NN glycoprotein_NN participates_VBZ in_IN cell_NN adhesion_NN ,_, regulates_VBZ proliferation_NN and_CC survival_NN of_IN thyroid_JJ cells_NNS via_IN integrin_NN receptors_NNS -LRB-_-LRB- Illario_FW et_FW al._FW ._. 
-LRB-_-LRB- 1997_CD -RRB-_-RRB- and_CC c_NN Ippolito_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- c_NN Belfiore_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Zou_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- Ramirez_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2000_CD -RRB-_-RRB- ,_, Ruco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- and_CC Scarpino_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Membrane_NNP tyrosine_NN kinase_NN receptor_NN enhances_VBZ cell_NN motility_NN ,_, invasiveness_NN ,_, and_CC chemokine_NN production_NN -LRB-_-LRB- Ruco_FW et_FW al._FW ._. 
2004_CD a_DT ,_, b_NN ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2003_CD ,_, Aldred_NNP et_FW al._FW ._. 
2004_CD ,_, Baris_NNP et_FW al._FW ._. 
2005_CD ,_, Detours_NNPS et_FW al._FW ._. 
2005_CD ,_, Giordano_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
However_RB ,_, in_IN the_DT majority_NN of_IN these_DT studies_NNS ,_, the_DT selection_NN of_IN important_JJ genes_NNS was_VBD based_VBN on_IN either_DT fold-change_NN or_CC significance_NN criteria_NNS obtained_VBD using_VBG classical_JJ statistical_JJ tests_NNS ._. 
62_CD Baris_NNP et_NNP al._IN 58_CD 2_CD ._. 
24_CD 3_CD ._. 
66_CD 3_CD ._. 
90_CD 4_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Membrane_NN receptor_NN ,_, stimulates_VBZ motility_NN and_CC modulates_VBZ proliferation_NN HMGA2_NNP High-mobility_NNP group_NN AT-hook_NNP 2_CD 208025_s_at_CD 11_CD 40_CD 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- ,_, Baris_NNP et_NNP al._IN 39_CD Hoos_NNP et_NNP al._IN 74_CD 
00_CD Baris_NNP et_NNP al._IN 97_CD 
2001_CD ,_, Wasenius_FW et_FW al._FW 4_CD 
2001_CD ,_, Huang_NNP et_FW al._FW ._. 
Similarly_RB ,_, thyroid-specific_JJ -LRB-_-LRB- down-regulated_JJ -RRB-_-RRB- genes_NNS ,_, deiodinase_NN ,_, iodothyronine_NN ,_, type_NN I_NN and_CC thyroid_NN peroxidase_NN ,_, were_VBD widely_RB recognized_VBN previously_RB for_IN their_PRP$ diagnostic_JJ significance_NN both_DT in_IN microarray-based_JJ -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2001_CD ,_, Baris_NNP et_FW al._FW ._. 
2004_CD ,_, Cerutti_NNP et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- and_CC single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
58_CD 2_CD ._. 
24_CD 3_CD ._. 
66_CD 3_CD ._. 
90_CD 4_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Membrane_NN receptor_NN ,_, stimulates_VBZ motility_NN and_CC modulates_VBZ proliferation_NN HMGA2_NNP High-mobility_NNP group_NN AT-hook_NNP 2_CD 208025_s_at_CD 11_CD 40_CD 
39_CD Hoos_NNP et_NNP al._IN 74_CD 
97_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Zou_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- cBelfiore_FW et_FW al._FW ._. 
-LRB-_-LRB- 1997_CD -RRB-_-RRB- and_CC c_NN Ippolito_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- Ramirez_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2000_CD -RRB-_-RRB- ,_, Ruco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- and_CC Scarpino_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Stassi_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC c_NN Letsas_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, c_NN Aksoy_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Mitselou_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Jacques_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Basolo_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- Anti-apoptotic_JJ protein_NN TACSTD2_CD Tumor-associated_JJ calcium_NN signal_NN transducer_NN 2_CD 202286_s_at_CD 22_CD 36_CD 
2000_CD -RRB-_-RRB- ,_, further_JJ selection_NN of_IN the_DT 100_CD best_JJS genes_NNS set_VBN was_VBD carried_VBN out_RP by_IN RFE_NNP ._. 
1999_CD ,_, Slonim_FW et_FW al._FW ._. 
The_DT introductory_JJ gene_NN selection_NN was_VBD performed_VBN using_VBG neighborhood_NN analysis_NN -LRB-_-LRB- 200_CD genes_NNS ;_: Golub_NNP et_FW al._FW ._. 
SVMs_NNP and_CC classificationThe_NNP linear_JJ SVM_NNP -LRB-_-LRB- Boser_NNP et_FW al._FW ._. 
1992_CD ,_, Vapnik_NNP 1995_CD -RRB-_-RRB- was_VBD used_VBN for_IN developing_VBG the_DT classification_NN rule_NN ._. 
As_IN mentioned_VBN earlier_RBR ,_, the_DT classifier_NN was_VBD independently_RB trained_VBN for_IN different_JJ numbers_NNS of_IN selected_VBN genes_NNS -LRB-_-LRB- from_IN 1_CD to_TO 100_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Fedele_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD ,_, 2005_CD -RRB-_-RRB- and_CC Jacques_NNP et_FW al._FW 62_CD Baris_NNP et_NNP al._IN 58_CD 2_CD ._. 
24_CD 3_CD ._. 
66_CD 3_CD ._. 
90_CD 4_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Membrane_NN receptor_NN ,_, stimulates_VBZ motility_NN and_CC modulates_VBZ proliferation_NN HMGA2_NNP High-mobility_NNP group_NN AT-hook_NNP 2_CD 208025_s_at_CD 11_CD 40_CD 
The_DT final_JJ decision_NN is_VBZ based_VBN on_IN decisions_NNS of_IN all_DT base_NN classifiers_NNS ._. 
Each_DT base_NN classifier_NN is_VBZ trained_VBN on_IN different_JJ bootstrap_NN subsamples_NNS ._. 
The_DT simplest_JJS approach_NN is_VBZ bagging_VBG -LRB-_-LRB- bootstrap_JJ aggregating_NN -RRB-_-RRB- originally_RB proposed_VBN by_IN Breiman_NNP -LRB-_-LRB- 1996_CD -RRB-_-RRB- ._. 
In_IN bagging_NN ,_, the_DT subsamples_NNS are_VBP randomly_RB drawn_VBN as_IN in_IN classical_JJ bootstrapping_NN where_WRB each_DT observation_NN is_VBZ picked_VBN with_IN the_DT same_JJ probability_NN 1_CD \/_FW m_FW ,_, where_WRB m_NN is_VBZ the_DT number_NN of_IN all_DT observations_NNS ._. 
From_IN the_DT diagnostic_JJ point_NN of_IN view_NN ,_, the_DT major_JJ drawback_NN of_IN the_DT SVM-based_JJ methods_NNS are_VBP the_DT fluctuations_NNS of_IN gene_NN content_NN between_IN classifiers_NNS of_IN different_JJ size_NN or_CC based_VBN on_IN slightly_RB different_JJ training_NN sets_NNS ._. 
To_TO overcome_VB this_DT problem_NN ,_, we_PRP extended_VBD the_DT original_JJ algorithm_NN with_IN bootstrap_JJ iterations_NNS ,_, as_IN recommended_VBN -LRB-_-LRB- Braga-Neto_NNP 
75_CD 3_CD ._. 
52_CD 2_CD ._. 
72_CD 3_CD ._. 
24_CD 8_CD ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- -RRB-_-RRB- FN1_NNP Fibronectin_NNP 1_CD 210495_x_at_CD 4_CD 44_CD 
2001_CD ,_, Baris_NNP et_FW al._FW ._. 
2001_CD ,_, Huang_NNP et_FW al._FW ._. 
Similarly_RB ,_, thyroid-specific_JJ -LRB-_-LRB- down-regulated_JJ -RRB-_-RRB- genes_NNS ,_, deiodinase_NN ,_, iodothyronine_NN ,_, type_NN I_NN and_CC thyroid_NN peroxidase_NN ,_, were_VBD widely_RB recognized_VBN previously_RB for_IN their_PRP$ diagnostic_JJ significance_NN both_DT in_IN microarray-based_JJ -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2004_CD ,_, Cerutti_NNP et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- and_CC single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
76_CD Barden_NNP et_FW al._FW 09_FW 
75_CD Barden_NNP et_NNP al._IN 93_CD 
The_DT latter_NN was_VBD also_RB indicated_VBN by_IN the_DT meta-analysis_NN of_IN Griffith_NNP et_FW al._FW ._. 
The_DT contribution_NN of_IN various_JJ enzymes_NNS to_TO our_PRP$ list_NN is_VBZ striking_JJ :_: others_NNS ,_, not_RB described_VBN previously_RB in_IN the_DT context_NN of_IN thyroid_JJ gland_NN ,_, comprise_VBP UDP-galactose_JJ epimerase_NN -LRB-_-LRB- GALE_NNP -RRB-_-RRB- and_CC glutaminyl-peptide_JJ cyclotransferase_NN -LRB-_-LRB- QPCT_NNP -RRB-_-RRB- ,_, both_DT with_IN virtually_RB unknown_JJ expression_NN patterns_NNS ._. 
Among_IN gene_NN encoding_VBG enzymes_NNS lost_VBN in_IN PTC_NNP are_VBP plasma_NN glutamate_JJ carboxypeptidase_NN ,_, plasma_NN glutamate_NN carboxypeptidase_NN -LRB-_-LRB- Gingras_FW et_FW al._FW ._. 
1999_CD -RRB-_-RRB- ,_, not_RB mentioned_VBN in_IN any_DT thyroid-related_JJ study_NN before_IN ;_: carbonic_JJ anhydrase_NN 4_CD -LRB-_-LRB- CA4_NNP -RRB-_-RRB- ,_, and_CC even_RB the_DT well-known_JJ homogentisate_NN oxidase_NN -LRB-_-LRB- encoding_VBG HGD_NNP -RRB-_-RRB- ,_, not_RB previously_RB related_VBN to_TO the_DT thyroid_NN in_IN any_DT context_NN ,_, although_IN listed_VBN in_IN many_JJ microarray-based_JJ reports_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Sarquis_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Weber_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD ,_, 2004_CD -RRB-_-RRB- ,_, Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Breakdown_NN of_IN secreted_JJ peptides_NNS ,_, homologous_RB to_TO prostate_NN membrane-specific_JJ antigen_NN -LRB-_-LRB- Gingras_FW et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- -RRB-_-RRB- DPP4_NNP Dipeptidylpeptidase_NNP 4_CD -LRB-_-LRB- CD26_NNP ,_, adenosine_JJ deaminase_NN complexing_VBG protein_NN 2_CD -RRB-_-RRB- 203717_at_CD 9_CD 42_CD 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- ,_, 1999_CD and_CC c_NN Prasad_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Takano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ,_, Hamada_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Ghinea_FW et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC Liu_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Extracellular_JJ matrix_NN glycoprotein_NN participates_VBZ in_IN cell_NN adhesion_NN ,_, regulates_VBZ proliferation_NN and_CC survival_NN of_IN thyroid_JJ cells_NNS via_IN integrin_NN receptors_NNS -LRB-_-LRB- Illario_FW et_FW al._FW ._. 
-LRB-_-LRB- 1997_CD -RRB-_-RRB- ,_, Lazar_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Arturi_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- andFuruya_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Thyroid-specific_JJ enzyme_NN crucial_JJ for_IN organification_NN of_IN iodine_NN and_CC synthesis_NN of_IN thyroid_JJ hormones_NNS KRT19_NNP Keratin_NNP 19 201650_CD __NN at_IN 34_CD 27_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Schmutzler_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Klopper_NNP et_NNP al._VBD 62_CD Haugen_NNP et_FW al._FW 80_CD 2_CD ._. 
66_CD 2_CD ._. 
69_CD 2_CD ._. 
35_CD 4_CD ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Fe_NNP -LRB-_-LRB- II_NNP -RRB-_-RRB- -_: dependent_JJ enzyme_NN responsible_JJ for_IN aromatic_JJ ring_NN cleavage_NN RXRG_NNP Retinoid_NNP X_NNP receptor_NN ,_, 
In_IN boosting_VBG ,_, different_JJ observations_NNS may_MD be_VB picked_VBN with_IN different_JJ probability_NN and_CC the_DT final_JJ decision_NN is_VBZ weighted_JJ sum_NN of_IN decisions_NNS of_IN base_NN classifiers_NNS ._. 
The_DT well-known_JJ boosting_VBG algorithm_NN is_VBZ AdaBoost_NNP -LRB-_-LRB- Freund_NNP 
Wellcome_NNP Trust_NNP Introduction_NNP Discrimination_NNP between_IN benign_JJ thyroid_JJ nodules_NNS and_CC cancer_NN is_VBZ an_DT important_JJ aspect_NN of_IN determining_VBG the_DT optimal_JJ extent_NN of_IN thyroid_JJ surgery_NN ._. 
However_RB ,_, this_DT method_NN does_VBZ not_RB allow_VB proper_JJ classification_NN of_IN all_DT thyroid_JJ tumors_NNS -LRB-_-LRB- Baloch_NNP 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, also_RB explore_VBP potential_JJ diagnostic_JJ applications_NNS -LRB-_-LRB- Aldred_NNP et_FW al._FW ._. 
2004a_JJ ,_, b_NN -RRB-_-RRB- ._. 
Our_PRP$ recent_JJ microarray-based_JJ analysis_NN brought_VBD a_DT 20-gene_JJ classifier_NN to_TO differentiate_VB between_IN papillary_JJ thyroid_NN cancer_NN -LRB-_-LRB- PTC_NNP -RRB-_-RRB- and_CC normal_JJ thyroid_NN tissue_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2003_CD ,_, Aldred_NNP et_FW al._FW ._. 
2001_CD ,_, Wasenius_FW et_FW al._FW ._. 
Such_JJ studies_NNS have_VBP been_VBN successfully_RB performed_VBN in_IN PTC_NNP and_CC large_JJ numbers_NNS of_IN discriminating_VBG physiologically_RB relevant_JJ genes_NNS were_VBD proposed_VBN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2004a_JJ ,_, b_NN ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD ,_, Baris_NNP et_FW al._FW ._. 
2005_CD ,_, Detours_NNPS et_FW al._FW ._. 
2005_CD ,_, Giordano_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
However_RB ,_, in_IN the_DT majority_NN of_IN these_DT studies_NNS ,_, the_DT selection_NN of_IN important_JJ genes_NNS was_VBD based_VBN on_IN either_DT fold-change_NN or_CC significance_NN criteria_NNS obtained_VBD using_VBG classical_JJ statistical_JJ tests_NNS ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Finley_NNP et_FW al._FW ._. 
Using_VBG Affymetrix_NNP GeneChips_NNP ,_, Barden_NNP et_FW al._FW ._. 
When_WRB we_PRP included_VBD both_DT benign_JJ and_CC malignant_JJ samples_NNS from_IN both_DT platforms_NNS ,_, the_DT vast_JJ majority_NN of_IN these_DT samples_NNS were_VBD properly_RB classified_VBN ._. 
-LRB-_-LRB- 2004a_CD ,_, b_NN -RRB-_-RRB- had_VBD previously_RB reported_VBN 20_CD of_IN 43_CD genes_NNS now_RB confirmed_VBN by_IN us_PRP as_RB diagnostically_RB relevant_JJ for_IN PTC_NNP ._. 
This_DT is_VBZ a_DT level_NN of_IN agreement_NN rarely_RB noted_VBD for_IN inter-group_JJ comparisons_NNS of_IN microarray_NN results_NNS ._. 
Our_PRP$ analysis_NN has_VBZ been_VBN performed_VBN on_IN microarray_NN data_NNS pre-processed_JJ by_IN the_DT standard_JJ MAS5_NNP algorithm_NN ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_FW et_FW al._FW 60_NNP Barden_NNP et_FW al._FW 73_CD 2_CD ._. 
93_CD 1_CD ._. 
22_CD 2_CD ._. 
15_CD 5_CD ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Oxygen_NN transport_NN MET_NNP Met_NNP proto-oncogene_NN -LRB-_-LRB- hepatocyte_JJ growth_NN factor_NN receptor_NN -RRB-_-RRB- 213807_x_at_CD 3_CD 45_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_FW et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Barden_NNP et_NNP al._IN 91_CD Chen_NNP et_NNP al._VBD 75_CD 3_CD ._. 
52_CD 2_CD ._. 
72_CD 3_CD ._. 
-LRB-_-LRB- 2004a_CD ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ,_, Hamada_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Takano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Chevillard_NNP et_NNP al._IN 56_CD Barden_NNP et_FW al._FW 14_CD 2_CD ._. 
61_CD 3_CD ._. 
99_CD 2_CD ._. 
60_CD 4_CD ._. 
50_CD Converts_VBZ glucose_NN to_TO galactose_VB and_CC N_NNP -_: acetylglucosamine_NN to_TO its_PRP$ UDP-derivatives_NNP QPCT_NNP Glutaminyl-peptide_JJ cyclotransferase_NN -LRB-_-LRB- glutaminyl_JJ cyclase_NN -RRB-_-RRB- 205174_s_at_CD 6_CD 43_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Finley_NNP et_NNP al._IN 53_CD Barden_NNP et_FW al._FW 02_CD 2_CD ._. 
12_CD 2_CD ._. 
56_CD 2_CD ._. 
68_CD 7_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Converts_VBZ glutaminyl_JJ peptides_NNS to_TO cyclic_JJ pyroglutamyl_NN ones_NNS NELL2_VBP NEL-like_JJ 2_CD -LRB-_-LRB- chicken_NN -RRB-_-RRB- 203413_at_CD 7_CD 42_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD ,_, 2004_CD -RRB-_-RRB- ,_, Barden_NNP et_NNP al._IN 33_CD Aldred_NNP et_FW al._FW 05_FW 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Finley_NNP et_NNP al._IN 92_CD Barden_NNP et_NNP al._VBD 53_CD 1_CD ._. 
27_CD 2_CD ._. 
70_CD 2_CD ._. 
96_CD 4_CD ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- -RRB-_-RRB- RYR1_NNP Ryanodine_NNP receptor_NN 1_CD -LRB-_-LRB- skeletal_JJ -RRB-_-RRB- 205485_at_CD 12_CD 40_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Cerutti_NNP et_NNP al._IN 76_CD Barden_NNP et_FW al._FW 09_FW 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Finley_NNP et_FW al._FW 06_FW Barden_FW et_FW al._FW 36_CD 2_CD ._. 
98_CD 1_CD ._. 
33_CD 1_CD ._. 
31_CD 6_CD ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- -RRB-_-RRB- NRIP1_NNP Nuclear_NNP receptor-interacting_JJ protein_NN 1_CD 202599_s_at_CD 16_CD 39_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_NNP et_NNP al._IN 54_CD Barden_NNP et_NNP al._VBD 53_CD 2_CD ._. 
76_CD 1_CD ._. 
68_CD 2_CD ._. 
44_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- Interacts_VBZ with_IN nuclear_JJ receptors_NNS MET_NNP Met_NNP proto-oncogene_NN -LRB-_-LRB- hepatocyte_JJ growth_NN factor_NN receptor_NN -RRB-_-RRB- 211599_x_at_CD 17_CD 39_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW 24_CD Barden_NNP et_FW al._FW 60_CD 1_CD ._. 
00_CD 1_CD ._. 
62_CD 3_CD ._. 
62_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Participates_VBZ in_IN protein_NN ubiquination_NN RAB27A_NNP RAB27A_NNP ,_, member_NN RAS_NNP oncogene_NN family_NN 210951_x_at_VBD 19_CD 38_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD ,_, 2004_CD -RRB-_-RRB- ,_, Huang_NNP et_NNP al._IN 33_CD Eszlinger_NNP et_NNP al._IN 79_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_NNP al._IN 83_CD Barden_NNP et_FW al._FW 06_FW 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_NNP et_NNP al._IN 59_CD Barden_NNP et_FW al._FW 20_CD 1_CD ._. 
50_CD 1_CD ._. 
02_CD 1_CD ._. 
52_CD 6_CD ._. 
06_CD Participates_NNPS in_IN cell_NN 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Aldred_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Aldred_NNP et_NNP al._IN 92_CD Huang_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004a_CD ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Fe_NNP -LRB-_-LRB- II_NNP -RRB-_-RRB- -_: dependent_JJ enzyme_NN responsible_JJ for_IN aromatic_JJ ring_NN cleavage_NN RXRG_NNP Retinoid_NNP X_NNP receptor_NN ,_, 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_NNP al._IN 41_CD Barden_NNP et_NNP al._IN 62_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Chevillard_NNP et_NNP al._IN 41_CD Barden_NNP et_NNP al._VBD 86_CD 2_CD ._. 
45_CD 1_CD ._. 
31_CD 2_CD ._. 
76_CD 8_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- An_DT ancient_JJ isozyme_NN SDC4_NNP Syndecan_NNP 4_CD -LRB-_-LRB- amphiglycan_JJ ,_, ryudocan_JJ -RRB-_-RRB- 202071_at_CD 31_CD 28_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Cerutti_NNP et_NNP al._IN 75_CD Barden_NNP et_NNP al._IN 93_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Chevillard_NNP et_FW al._FW 07_FW Barden_FW et_FW al._FW 55_CD 3_CD ._. 
22_CD 3_CD ._. 
71_CD 3_CD ._. 
92_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Thyroid-specific_JJ enzyme_NN crucial_JJ for_IN organification_NN of_IN iodine_NN and_CC synthesis_NN of_IN thyroid_JJ hormones_NNS KRT19_NNP Keratin_NNP 19 201650_CD __NN at_IN 34_CD 27_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_NNP al._IN 53_CD Barden_NNP et_NNP al._VBD 43_CD 1_CD ._. 
28_CD 1_CD ._. 
29_CD 2_CD ._. 
57_CD 6_CD ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- -RRB-_-RRB- 64_CD 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, also_RB explore_VBP potential_JJ diagnostic_JJ applications_NNS -LRB-_-LRB- Aldred_NNP et_FW al._FW ._. 
2001_CD ,_, Giordano_NNP et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, b_NN -RRB-_-RRB- ._. 
Our_PRP$ recent_JJ microarray-based_JJ analysis_NN brought_VBD a_DT 20-gene_JJ classifier_NN to_TO differentiate_VB between_IN papillary_JJ thyroid_NN cancer_NN -LRB-_-LRB- PTC_NNP -RRB-_-RRB- and_CC normal_JJ thyroid_NN tissue_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2003_CD ,_, Baris_NNP et_FW al._FW ._. 
2001_CD ,_, Wasenius_FW et_FW al._FW 4_CD 
2004_CD ,_, Cerutti_NNP et_FW al._FW ._. 
2001_CD ,_, Baris_NNP et_FW al._FW ._. 
2001_CD ,_, Huang_NNP et_FW al._FW ._. 
Similarly_RB ,_, thyroid-specific_JJ -LRB-_-LRB- down-regulated_JJ -RRB-_-RRB- genes_NNS ,_, deiodinase_NN ,_, iodothyronine_NN ,_, type_NN I_NN and_CC thyroid_NN peroxidase_NN ,_, were_VBD widely_RB recognized_VBN previously_RB for_IN their_PRP$ diagnostic_JJ significance_NN both_DT in_IN microarray-based_JJ -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- and_CC single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
1999_CD ,_, De_NNP Micco_NNP et_FW al._FW ._. 
2001_CD ,_, Chevillard_NNP et_FW al._FW ._. 
1998_CD -RRB-_-RRB- ,_, it_PRP seems_VBZ important_JJ to_TO mention_VB syndecan_NN 4_CD -LRB-_-LRB- SDC4_NNP -RRB-_-RRB- ,_, a_DT transmembrane_NN heparan_NN sulfate_NN proteoglycan_NN known_VBN to_TO bind_NN FN1_NN and_CC functioning_NN also_RB as_IN CXCL12_NN receptor_NN in_IN signal_NN transduction_NN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT -RRB-_-RRB- ._. 
Loss_NN of_IN CDH16_NNP -LRB-_-LRB- kidney-specific_JJ cadherin_NN ;_: Thomson_NNP et_FW al._FW ._. 
1998_CD -RRB-_-RRB- was_VBD indicated_VBN for_IN the_DT first_JJ time_NN in_IN our_PRP$ study_NN ,_, a_DT gene_NN closely_RB related_VBN to_TO cadherin_NN E_NNP -LRB-_-LRB- CDH1_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ well_RB known_VBN to_TO be_VB lost_VBN in_IN a_DT subgroup_NN of_IN PTCs_NNS with_IN negative_JJ prognostic_JJ significance_NN -LRB-_-LRB- Rocha_FW et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2003_CD ,_, Aldred_NNP et_FW al._FW ._. 
2001_CD ,_, Wasenius_FW et_FW al._FW ._. 
Such_JJ studies_NNS have_VBP been_VBN successfully_RB performed_VBN in_IN PTC_NNP and_CC large_JJ numbers_NNS of_IN discriminating_VBG physiologically_RB relevant_JJ genes_NNS were_VBD proposed_VBN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, b_NN ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD ,_, Baris_NNP et_FW al._FW ._. 
2005_CD ,_, Detours_NNPS et_FW al._FW ._. 
2005_CD ,_, Giordano_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Using_VBG Affymetrix_NNP GeneChips_NNP ,_, Barden_NNP et_FW al._FW ._. 
When_WRB we_PRP included_VBD both_DT benign_JJ and_CC malignant_JJ samples_NNS from_IN both_DT platforms_NNS ,_, the_DT vast_JJ majority_NN of_IN these_DT samples_NNS were_VBD properly_RB classified_VBN ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- had_VBD previously_RB reported_VBN 20_CD of_IN 43_CD genes_NNS now_RB confirmed_VBN by_IN us_PRP as_RB diagnostically_RB relevant_JJ for_IN PTC_NNP ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_FW et_FW al._FW 60_NNP Barden_NNP et_FW al._FW 73_CD 2_CD ._. 
93_CD 1_CD ._. 
22_CD 2_CD ._. 
15_CD 5_CD ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Oxygen_NN transport_NN MET_NNP Met_NNP proto-oncogene_NN -LRB-_-LRB- hepatocyte_JJ growth_NN factor_NN receptor_NN -RRB-_-RRB- 213807_x_at_CD 3_CD 45_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_FW et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Barden_NNP et_NNP al._IN 91_CD Chen_NNP et_NNP al._VBD 75_CD 3_CD ._. 
52_CD 2_CD ._. 
72_CD 3_CD ._. 
24_CD 8_CD ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- -RRB-_-RRB- FN1_NNP Fibronectin_NNP 1_CD 210495_x_at_CD 4_CD 44_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Chevillard_NNP et_NNP al._IN 56_CD Barden_NNP et_FW al._FW 14_CD 2_CD ._. 
61_CD 3_CD ._. 
99_CD 2_CD ._. 
60_CD 4_CD ._. 
50_CD Converts_VBZ glucose_NN to_TO galactose_VB and_CC N_NNP -_: acetylglucosamine_NN to_TO its_PRP$ UDP-derivatives_NNP QPCT_NNP Glutaminyl-peptide_JJ cyclotransferase_NN -LRB-_-LRB- glutaminyl_JJ cyclase_NN -RRB-_-RRB- 205174_s_at_CD 6_CD 43_CD 
53_CD Barden_NNP et_FW al._FW 02_CD 2_CD ._. 
12_CD 2_CD ._. 
56_CD 2_CD ._. 
68_CD 7_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Converts_VBZ glutaminyl_JJ peptides_NNS to_TO cyclic_JJ pyroglutamyl_NN ones_NNS NELL2_VBP NEL-like_JJ 2_CD -LRB-_-LRB- chicken_NN -RRB-_-RRB- 203413_at_CD 7_CD 42_CD 
-LRB-_-LRB- 2003_CD ,_, 2004_CD -RRB-_-RRB- ,_, Barden_NNP et_NNP al._IN 33_CD Aldred_NNP et_FW al._FW 05_FW 
92_CD Barden_NNP et_NNP al._VBD 53_CD 1_CD ._. 
27_CD 2_CD ._. 
70_CD 2_CD ._. 
96_CD 4_CD ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- -RRB-_-RRB- RYR1_NNP Ryanodine_NNP receptor_NN 1_CD -LRB-_-LRB- skeletal_JJ -RRB-_-RRB- 205485_at_CD 12_CD 40_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Cerutti_NNP et_NNP al._IN 76_CD Barden_NNP et_FW al._FW 09_FW 
06_CD Barden_NNP et_FW al._FW 36_CD 2_CD ._. 
98_CD 1_CD ._. 
33_CD 1_CD ._. 
31_CD 6_CD ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- -RRB-_-RRB- NRIP1_NNP Nuclear_NNP receptor-interacting_JJ protein_NN 1_CD 202599_s_at_CD 16_CD 39_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_NNP et_NNP al._IN 54_CD Barden_NNP et_NNP al._VBD 53_CD 2_CD ._. 
76_CD 1_CD ._. 
68_CD 2_CD ._. 
44_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- Interacts_VBZ with_IN nuclear_JJ receptors_NNS MET_NNP Met_NNP proto-oncogene_NN -LRB-_-LRB- hepatocyte_JJ growth_NN factor_NN receptor_NN -RRB-_-RRB- 211599_x_at_CD 17_CD 39_CD 
24_CD Barden_NNP et_FW al._FW 60_CD 1_CD ._. 
00_CD 1_CD ._. 
62_CD 3_CD ._. 
62_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Participates_VBZ in_IN protein_NN ubiquination_NN RAB27A_NNP RAB27A_NNP ,_, member_NN RAS_NNP oncogene_NN family_NN 210951_x_at_VBD 19_CD 38_CD 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD ,_, 2004_CD -RRB-_-RRB- ,_, Huang_NNP et_NNP al._IN 33_CD Eszlinger_NNP et_NNP al._IN 79_CD 
83_CD Barden_NNP et_FW al._FW 06_FW 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_NNP et_NNP al._IN 59_CD Barden_NNP et_FW al._FW 20_CD 1_CD ._. 
50_CD 1_CD ._. 
02_CD 1_CD ._. 
52_CD 6_CD ._. 
06_CD Participates_NNPS in_IN cell_NN 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Aldred_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Aldred_NNP et_NNP al._IN 92_CD Huang_NNP et_NNP al._IN 17_CD 
41_CD Barden_NNP et_NNP al._IN 62_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Chevillard_NNP et_NNP al._IN 41_CD Barden_NNP et_NNP al._VBD 86_CD 2_CD ._. 
45_CD 1_CD ._. 
31_CD 2_CD ._. 
76_CD 8_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- An_DT ancient_JJ isozyme_NN SDC4_NNP Syndecan_NNP 4_CD -LRB-_-LRB- amphiglycan_JJ ,_, ryudocan_JJ -RRB-_-RRB- 202071_at_CD 31_CD 28_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Cerutti_NNP et_NNP al._IN 75_CD Barden_NNP et_NNP al._IN 93_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Chevillard_NNP et_FW al._FW 07_FW Barden_FW et_FW al._FW 55_CD 3_CD ._. 
22_CD 3_CD ._. 
71_CD 3_CD ._. 
92_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Thyroid-specific_JJ enzyme_NN crucial_JJ for_IN organification_NN of_IN iodine_NN and_CC synthesis_NN of_IN thyroid_JJ hormones_NNS KRT19_NNP Keratin_NNP 19 201650_CD __NN at_IN 34_CD 27_CD 
53_CD Barden_NNP et_NNP al._VBD 43_CD 1_CD ._. 
28_CD 1_CD ._. 
29_CD 2_CD ._. 
57_CD 6_CD ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- -RRB-_-RRB- 64_CD 
-LRB-_-LRB- 2004_CD ,_, 2005_CD -RRB-_-RRB- and_CC Jacques_NNP et_FW al._FW 62_CD Baris_NNP et_NNP al._IN 58_CD 2_CD ._. 
24_CD 3_CD ._. 
66_CD 3_CD ._. 
90_CD 4_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Membrane_NN receptor_NN ,_, stimulates_VBZ motility_NN and_CC modulates_VBZ proliferation_NN HMGA2_NNP High-mobility_NNP group_NN AT-hook_NNP 2_CD 208025_s_at_CD 11_CD 40_CD 
Our_PRP$ recent_JJ microarray-based_JJ analysis_NN brought_VBD a_DT 20-gene_JJ classifier_NN to_TO differentiate_VB between_IN papillary_JJ thyroid_NN cancer_NN -LRB-_-LRB- PTC_NNP -RRB-_-RRB- and_CC normal_JJ thyroid_NN tissue_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, further_RB verified_VBD using_VBG three_CD independent_JJ datasets_NNS -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Very_RB large_JJ and_CC easily_RB distinguishable_JJ differences_NNS between_IN the_DT molecular_JJ profiles_NNS of_IN PTC_NNP and_CC normal_JJ thyroid_NN have_VBP clearly_RB demonstrated_VBN the_DT applicability_NN of_IN gene_NN expression_NN findings_NNS to_TO diagnostic_JJ purposes_NNS ._. 
2002_CD -RRB-_-RRB- which_WDT is_VBZ computationally_RB less_JJR demanding_VBG than_IN recursive_JJ feature_NN replacement_NN used_VBN in_IN our_PRP$ previous_JJ studies_NNS -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
2005_CD ,_, Eszlinger_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
The_DT introductory_JJ gene_NN selection_NN was_VBD performed_VBN using_VBG neighborhood_NN analysis_NN -LRB-_-LRB- 200_CD genes_NNS ;_: Golub_NNP et_FW al._FW ._. 
Nevertheless_RB ,_, our_PRP$ bootstrap-based_JJ method_NN allows_VBZ detecting_VBG outlier_NN samples_NNS and_CC provides_VBZ the_DT estimation_NN of_IN CIs_NNP for_IN the_DT classification_NN accuracy_NN ,_, which_WDT is_VBZ much_RB more_RBR informative_JJ than_IN the_DT accuracy_NN estimator_NN alone_RB ._. 
PTC_NNP and_CC normal\/benign_JJ difference_NN versus_IN inter-platform_JJ differenceTo_NNP assure_VB a_DT sufficient_JJ number_NN of_IN tissue_NN samples_NNS ,_, it_PRP was_VBD necessary_JJ to_TO combine_VB data_NNS obtained_VBD using_VBG different_JJ generations_NNS of_IN GeneChips_NNP ,_, which_WDT can_MD not_RB be_VB compared_VBN by_IN a_DT direct_JJ approach_NN -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
The_DT use_NN of_IN multi-gene_JJ classifiers_NNS allows_VBZ ,_, however_RB ,_, overcoming_VBG this_DT difficulty_NN ._. 
We_PRP showed_VBD earlier_RBR that_IN the_DT classifier_NN selected_VBD using_VBG the_DT U133_NNP platform_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
We_PRP showed_VBD earlier_RBR that_IN the_DT classifier_NN selected_VBD using_VBG the_DT U133_NNP platform_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
The_DT use_NN of_IN multi-gene_JJ classifiers_NNS allows_VBZ ,_, however_RB ,_, overcoming_VBG this_DT difficulty_NN ._. 
2005_CD -RRB-_-RRB- performs_VBZ well_RB on_IN U95-obtained_JJ data_NNS and_CC has_VBZ high_JJ classification_NN accuracy_NN -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
In_IN the_DT present_JJ paper_NN ,_, we_PRP demonstrate_VBP that_IN it_PRP is_VBZ possible_JJ ,_, after_IN correctly_RB matching_VBG genes_NNS from_IN two_CD different_JJ generation_NN microarrays_NNS ,_, to_TO derive_VB an_DT efficient_JJ multi-gene_JJ classifier_NN ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- in_IN breast_NN cancer_NN ._. 
This_DT was_VBD indicated_VBN for_IN the_DT first_JJ time_NN by_IN Ein-Dor_NNP et_FW al._FW ._. 
Redundancy_NN of_IN multi-gene_JJ cancer_NN classifiers_NNS This_DT is_VBZ inherently_RB linked_VBN to_TO the_DT huge_JJ differences_NNS in_IN gene_NN expression_NN profiles_NNS of_IN several_JJ tumors_NNS ,_, originating_VBG from_IN the_DT same_JJ tissue_NN ._. 
These_DT authors_NNS re-analyzed_VBD the_DT data_NNS of_IN va_NN n't_RB Veer_VB et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC showed_VBD that_IN multiple_JJ similar_JJ classifiers_NNS may_MD be_VB obtained_VBN ;_: they_PRP have_VBP comparable_JJ classification_NN potency_NN as_IN van_NN 
SVMs_NNS and_CC classification_NN The_DT linear_JJ SVM_NNP -LRB-_-LRB- Boser_NNP et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ,_, further_JJ selection_NN of_IN the_DT 100_CD best_JJS genes_NNS set_VBN was_VBD carried_VBN out_RP by_IN RFE_NNP ._. 
1992_CD ,_, Vapnik_NNP 1995_CD -RRB-_-RRB- was_VBD used_VBN for_IN developing_VBG the_DT classification_NN rule_NN ._. 
As_IN mentioned_VBN earlier_RBR ,_, the_DT classifier_NN was_VBD independently_RB trained_VBN for_IN different_JJ numbers_NNS of_IN selected_VBN genes_NNS -LRB-_-LRB- from_IN 1_CD to_TO 100_CD -RRB-_-RRB- ._. 
81_CD Huang_NNP et_FW al._FW 21_CD 3_CD ._. 
11_CD 3_CD ._. 
77_CD 4_CD ._. 
87_CD 3_CD ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- -RRB-_-RRB- DPP4_NNP Dipeptidylpeptidase_NNP 4_CD -LRB-_-LRB- CD26_NNP ,_, adenosine_JJ deaminase_NN complexing_VBG protein_NN 2_CD -RRB-_-RRB- 203717_at_CD 9_CD 42_CD 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Takano_NNP et_NNP al._IN 81_CD Huang_NNP et_FW al._FW 21_CD 3_CD ._. 
11_CD 3_CD ._. 
77_CD 4_CD ._. 
87_CD 3_CD ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- -RRB-_-RRB- DPP4_NNP Dipeptidylpeptidase_NNP 4_CD -LRB-_-LRB- CD26_NNP ,_, adenosine_JJ deaminase_NN complexing_VBG protein_NN 2_CD -RRB-_-RRB- 203717_at_CD 9_CD 42_CD 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ,_, Hamada_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Takano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- ,_, 1999_CD and_CC c_NN Prasad_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Ghinea_FW et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC Liu_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Extracellular_JJ matrix_NN glycoprotein_NN participates_VBZ in_IN cell_NN adhesion_NN ,_, regulates_VBZ proliferation_NN and_CC survival_NN of_IN thyroid_JJ cells_NNS via_IN integrin_NN receptors_NNS -LRB-_-LRB- Illario_FW et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Takano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ,_, Hamada_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- ,_, 1999_CD and_CC cPrasad_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Ghinea_FW et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC Liu_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Extracellular_JJ matrix_NN glycoprotein_NN participates_VBZ in_IN cell_NN adhesion_NN ,_, regulates_VBZ proliferation_NN and_CC survival_NN of_IN thyroid_JJ cells_NNS via_IN integrin_NN receptors_NNS -LRB-_-LRB- Illario_FW et_FW al._FW ._. 
2004_CD a_DT -RRB-_-RRB- ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2001_CD ,_, Chevillard_NNP et_FW al._FW ._. 
1998_CD -RRB-_-RRB- ,_, it_PRP seems_VBZ important_JJ to_TO mention_VB syndecan_NN 4_CD -LRB-_-LRB- SDC4_NNP -RRB-_-RRB- ,_, a_DT transmembrane_NN heparan_NN sulfate_NN proteoglycan_NN known_VBN to_TO bind_NN FN1_NN and_CC functioning_NN also_RB as_IN CXCL12_NN receptor_NN in_IN signal_NN transduction_NN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
Loss_NN of_IN CDH16_NNP -LRB-_-LRB- kidney-specific_JJ cadherin_NN ;_: Thomson_NNP et_FW al._FW ._. 
1998_CD -RRB-_-RRB- was_VBD indicated_VBN for_IN the_DT first_JJ time_NN in_IN our_PRP$ study_NN ,_, a_DT gene_NN closely_RB related_VBN to_TO cadherin_NN E_NNP -LRB-_-LRB- CDH1_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ well_RB known_VBN to_TO be_VB lost_VBN in_IN a_DT subgroup_NN of_IN PTCs_NNS with_IN negative_JJ prognostic_JJ significance_NN -LRB-_-LRB- Rocha_FW et_FW al._FW ._. 
71_CD 0_CD ._. 
44_CD 2_CD ._. 
04_CD 2_CD ._. 
49_CD 4_CD ._. 
-LRB-_-LRB- 1995_CD -RRB-_-RRB- -RRB-_-RRB- Calcium-dependent_JJ ,_, membrane-associated_JJ glycoprotein_NN ,_, participates_VBZ in_IN cell_NN adhesion_NN GJB3_NNP Gap_NNP junction_NN protein_NN 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- Low_NNP molecular_JJ weight_NN ,_, cysteine-rich_JJ ,_, zinc-donating_JJ protein_NN ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Cherian_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
Associated_NNP with_IN protection_NN against_IN DNA_NNP damage_NN ,_, stress_NN ,_, and_CC apoptosis_NN -LRB-_-LRB- Theocharis_NNPS et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- -RRB-_-RRB- ICAM1_NNP Intercellular_NNP adhesion_NN molecule_NN 1_CD -LRB-_-LRB- CD54_NNP -RRB-_-RRB- ,_, human_JJ rhinovirus_NN receptor_NN 202638_s_at_VBD 43_CD 24_CD 
68_CD 
Therefore_RB ,_, we_PRP decided_VBD to_TO use_VB a_DT balanced_JJ mixture_NN of_IN samples_NNS from_IN malignant_JJ and_CC benign_JJ tumors_NNS and_CC normal_JJ thyroid_JJ tissue_NN to_TO mimic_VB the_DT clinical_JJ situation_NN ,_, where_WRB the_DT material_NN from_IN any_DT of_IN these_DT may_MD be_VB obtained_VBN and_CC shall_MD be_VB properly_RB classified_VBN ._. 
This_DT large_JJ 180-array_JJ dataset_NN is_VBZ derived_VBN respectively_RB from_IN de_JJ novo_NN studies_NNS -LRB-_-LRB- n_SYM =_SYM 40_CD -RRB-_-RRB- ,_, previously_RB published_VBN own_JJ microarray_NN data_NNS -LRB-_-LRB- n_SYM =_SYM 124_CD ;_: Eszlinger_NNP et_FW al._FW ._. 
2001_CD ,_, 2004_CD ,_, Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, and_CC accessible_JJ datasets_NNS published_VBN by_IN other_JJ authors_NNS -LRB-_-LRB- n_SYM =_SYM 16_CD ;_: Huang_NNP et_FW al._FW ._. 
The_DT specimens_NNS included_VBD 15_CD autonomously_RB functioning_VBG thyroid_JJ nodules_NNS ,_, 22_CD cold_JJ thyroid_NN nodules_NNS ,_, and_CC 37_CD samples_NNS of_IN their_PRP$ respective_JJ surrounding_VBG thyroid_NN tissues_NNS ._. 
The_DT analysis_NN of_IN these_DT datasets_NNS was_VBD published_VBN previously_RB -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2001_CD ,_, 2004_CD -RRB-_-RRB- and_CC the_DT datasets_NNS are_VBP available_JJ at_IN 
2006_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, in_IN the_DT recent_JJ meta-analysis_NN of_IN thyroid_NN cancer_NN gene_NN expression_NN profile_NN ,_, MET_NNP and_CC FN1_NNP were_VBD included_VBN into_IN top_JJ 12_CD candidates_NNS for_IN consistent_JJ gene_NN expression_NN markers_NNS -LRB-_-LRB- Griffith_NNP et_FW al._FW ._. 
Similarly_RB ,_, thyroid-specific_JJ -LRB-_-LRB- down-regulated_JJ -RRB-_-RRB- genes_NNS ,_, deiodinase_NN ,_, iodothyronine_NN ,_, type_NN I_NN and_CC thyroid_NN peroxidase_NN ,_, were_VBD widely_RB recognized_VBN previously_RB for_IN their_PRP$ diagnostic_JJ significance_NN both_DT in_IN microarray-based_JJ -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2001_CD ,_, Huang_NNP et_FW al._FW ._. 
2001_CD ,_, Baris_NNP et_FW al._FW ._. 
2004_CD ,_, Cerutti_NNP et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, Wreesmann_FW et_FW al._FW ._. 
79_CD 
40_CD Kawai_NNP et_FW al._FW 70_CD 2_CD ._. 
57_CD 1_CD ._. 
61_CD 2_CD ._. 
18_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- -RRB-_-RRB- ICAM1_NNP Intercellular_NNP adhesion_NN molecule_NN 1_CD -LRB-_-LRB- CD54_NNP -RRB-_-RRB- ,_, human_JJ rhinovirus_NN receptor_NN 202638_s_at_VBD 43_CD 24_CD 
This_DT large_JJ 180-array_JJ dataset_NN is_VBZ derived_VBN respectively_RB from_IN de_JJ novo_NN studies_NNS -LRB-_-LRB- n_SYM =_SYM 40_CD -RRB-_-RRB- ,_, previously_RB published_VBN own_JJ microarray_NN data_NNS -LRB-_-LRB- n_SYM =_SYM 124_CD ;_: Eszlinger_NNP et_FW al._FW ._. 
2001_CD ,_, 2004_CD ,_, Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, and_CC accessible_JJ datasets_NNS published_VBN by_IN other_JJ authors_NNS -LRB-_-LRB- n_SYM =_SYM 16_CD ;_: Huang_NNP et_FW al._FW ._. 
2001_CD -RRB-_-RRB- ._. 
We_PRP set_VBD the_DT following_JJ goals_NNS for_IN the_DT study_NN :_: To_TO assess_VB accuracy_NN of_IN benign\/malignant_JJ classification_NN of_IN thyroid_JJ specimens_NNS in_IN relation_NN to_TO gene_NN set_NN size_NN ,_, in_IN the_DT context_NN of_IN PTC_NNP and_CC To_TO optimize_VB the_DT list_NN of_IN diagnostically_RB relevant_JJ genes_NNS in_IN PTC_NNP ._. 
The_DT analysis_NN of_IN these_DT datasets_NNS was_VBD published_VBN previously_RB -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
The_DT specimens_NNS included_VBD 15_CD autonomously_RB functioning_VBG thyroid_JJ nodules_NNS ,_, 22_CD cold_JJ thyroid_NN nodules_NNS ,_, and_CC 37_CD samples_NNS of_IN their_PRP$ respective_JJ surrounding_VBG thyroid_NN tissues_NNS ._. 
2001_CD ,_, 2004_CD -RRB-_-RRB- and_CC the_DT datasets_NNS are_VBP available_JJ at_IN http:\/\/www_NN ._. 
uni-leipzig_JJ ._. 
de\/innere_FW \/_FW __FW forschung\/schwerpunkte\/etiology_FW ._. 
33_CD Eszlinger_NNP et_NNP al._IN 79_CD 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- Epithelial_JJ adhesion_NN molecule_NN plays_VBZ a_DT key_JJ role_NN in_IN lymphocyte_NN infiltration_NN into_IN the_DT thyroid_NN a_DT The_DT original_JJ papers_NNS -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2001_CD ,_, 2004_CD ,_, Huang_NNP et_FW al._FW ._. 
2001_CD ,_, Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- containing_VBG datasets_NNS included_VBN in_IN the_DT present_JJ study_NN were_VBD not_RB cited_VBN here_RB ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Jacques_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD ,_, 2005_CD -RRB-_-RRB- ,_, Prasad_NNP et_FW al._FW 00_FW Baris_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Cherian_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- Low_NNP molecular_JJ weight_NN ,_, cysteine-rich_JJ ,_, zinc-donating_JJ protein_NN ._. 
Associated_NNP with_IN protection_NN against_IN DNA_NNP damage_NN ,_, stress_NN ,_, and_CC apoptosis_NN -LRB-_-LRB- Theocharis_NNPS et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, also_RB explore_VBP potential_JJ diagnostic_JJ applications_NNS -LRB-_-LRB- Aldred_NNP et_FW al._FW ._. 
2001_CD ,_, Giordano_NNP et_FW al._FW ._. 
At_IN several_JJ institutions_NNS ,_, genomic_JJ studies_NNS have_VBP been_VBN undertaken_VBN which_WDT besides_IN focusing_VBG on_IN basic_JJ biological_JJ issues_NNS -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, b_NN -RRB-_-RRB- ._. 
Our_PRP$ recent_JJ microarray-based_JJ analysis_NN brought_VBD a_DT 20-gene_JJ classifier_NN to_TO differentiate_VB between_IN papillary_JJ thyroid_NN cancer_NN -LRB-_-LRB- PTC_NNP -RRB-_-RRB- and_CC normal_JJ thyroid_NN tissue_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW 
2003_CD ,_, Baris_NNP et_FW al._FW ._. 
2001_CD ,_, Wasenius_FW et_FW al._FW 4_CD 
1998_CD -RRB-_-RRB- ,_, it_PRP seems_VBZ important_JJ to_TO mention_VB syndecan_NN 4_CD -LRB-_-LRB- SDC4_NNP -RRB-_-RRB- ,_, a_DT transmembrane_NN heparan_NN sulfate_NN proteoglycan_NN known_VBN to_TO bind_NN FN1_NN and_CC functioning_NN also_RB as_IN CXCL12_NN receptor_NN in_IN signal_NN transduction_NN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2001_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT -RRB-_-RRB- ._. 
Loss_NN of_IN CDH16_NNP -LRB-_-LRB- kidney-specific_JJ cadherin_NN ;_: Thomson_NNP et_FW al._FW ._. 
1998_CD -RRB-_-RRB- was_VBD indicated_VBN for_IN the_DT first_JJ time_NN in_IN our_PRP$ study_NN ,_, a_DT gene_NN closely_RB related_VBN to_TO cadherin_NN E_NNP -LRB-_-LRB- CDH1_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ well_RB known_VBN to_TO be_VB lost_VBN in_IN a_DT subgroup_NN of_IN PTCs_NNS with_IN negative_JJ prognostic_JJ significance_NN -LRB-_-LRB- Rocha_FW et_FW al._FW ._. 
2003_CD ,_, Aldred_NNP et_FW al._FW ._. 
2001_CD ,_, Wasenius_FW et_FW al._FW ._. 
Such_JJ studies_NNS have_VBP been_VBN successfully_RB performed_VBN in_IN PTC_NNP and_CC large_JJ numbers_NNS of_IN discriminating_VBG physiologically_RB relevant_JJ genes_NNS were_VBD proposed_VBN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, b_NN ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD ,_, Baris_NNP et_FW al._FW ._. 
2005_CD ,_, Detours_NNPS et_FW al._FW ._. 
2005_CD ,_, Giordano_NNP et_FW al._FW ._. 
56_CD Barden_NNP et_FW al._FW 14_CD 2_CD ._. 
61_CD 3_CD ._. 
99_CD 2_CD ._. 
60_CD 4_CD ._. 
50_CD Converts_VBZ glucose_NN to_TO galactose_VB and_CC N_NNP -_: acetylglucosamine_NN to_TO its_PRP$ UDP-derivatives_NNP QPCT_NNP Glutaminyl-peptide_JJ cyclotransferase_NN -LRB-_-LRB- glutaminyl_JJ cyclase_NN -RRB-_-RRB- 205174_s_at_CD 6_CD 43_CD 
41_CD Barden_NNP et_NNP al._VBD 86_CD 2_CD ._. 
45_CD 1_CD ._. 
31_CD 2_CD ._. 
76_CD 8_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- An_DT ancient_JJ isozyme_NN SDC4_NNP Syndecan_NNP 4_CD -LRB-_-LRB- amphiglycan_JJ ,_, ryudocan_JJ -RRB-_-RRB- 202071_at_CD 31_CD 28_CD 
07_CD Barden_NNP et_FW al._FW 55_CD 3_CD ._. 
22_CD 3_CD ._. 
71_CD 3_CD ._. 
92_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Thyroid-specific_JJ enzyme_NN crucial_JJ for_IN organification_NN of_IN iodine_NN and_CC synthesis_NN of_IN thyroid_JJ hormones_NNS KRT19_NNP Keratin_NNP 19 201650_CD __NN at_IN 34_CD 27_CD 
1999_CD ,_, De_NNP Micco_NNP et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- and_CC single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
2004_CD a_DT ,_, Wreesmann_FW et_FW al._FW ._. 
1999_CD ,_, Czarnocka_FW et_FW al._FW ._. 
2001_CD ,_, Le_NNP Fourn_NNP et_FW al._FW ._. 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2005_CD ,_, Arnaldi_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Nevertheless_RB ,_, neither_CC our_PRP$ approach_NN nor_CC the_DT meta-analysis_NN mentioned_VBD earlier_RB indicated_VBN other_JJ thyroid-specific_JJ genes_NNS ,_, confirming_VBG the_DT lesser_JJR diagnostic_JJ potency_NN of_IN sodium_NN iodide_NN symporter_NN ,_, thyroglobulin_NN ,_, thyrotrophin_NN receptor_NN ,_, or_CC thyroid-specific_JJ transcription_NN factors_NNS ,_, shown_VBN to_TO be_VB down-regulated_JJ in_IN previous_JJ single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- c_NN De_NNP Micco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Wreesmann_FW et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- ,_, cCzarnocka_FW et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, c_NN Le_NNP Fourn_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, c_NN Ambroziak_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC c_NN Arnaldi_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Kohrle_NNP -LRB-_-LRB- 1999_CD -RRB-_-RRB- 5_CD 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC Green_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2000_CD -RRB-_-RRB- ,_, Plum_NNP et_NNP al._IN 62_CD Does_VBZ not_RB normally_RB appear_VB in_IN thyroid_NN ,_, in_IN adult_NN mouse_NN becomes_VBZ restricted_VBN to_TO epidermis_NNS ,_, testis_NNS and_CC placenta_NN -LRB-_-LRB- Tonoli_FW et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Forms_VBZ incompatible_JJ hemichannels_NNS with_IN thyroidal_JJ connexin_NN 43_CD -LRB-_-LRB- Dahl_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1996_CD -RRB-_-RRB- -RRB-_-RRB- EMID1_NNP EMI_NNP domain_NN containing_VBG 1_CD 213779_at_CD 15_CD 39_CD 
2004_CD ,_, Baris_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, b_NN ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2005_CD ,_, Detours_NNPS et_FW al._FW ._. 
2005_CD ,_, Giordano_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
However_RB ,_, in_IN the_DT majority_NN of_IN these_DT studies_NNS ,_, the_DT selection_NN of_IN important_JJ genes_NNS was_VBD based_VBN on_IN either_DT fold-change_NN or_CC significance_NN criteria_NNS obtained_VBD using_VBG classical_JJ statistical_JJ tests_NNS ._. 
As_IN mentioned_VBN earlier_RBR ,_, the_DT classifier_NN was_VBD independently_RB trained_VBN for_IN different_JJ numbers_NNS of_IN selected_VBN genes_NNS -LRB-_-LRB- from_IN 1_CD to_TO 100_CD -RRB-_-RRB- ._. 
Bootstrap_NNP for_IN estimation_NN of_IN classifier_NN accuracy_NN and_CC its_PRP$ CIIn_NNP order_NN to_TO determine_VB the_DT accuracy_NN of_IN the_DT developed_JJ classifier_NN ,_, we_PRP performed_VBD classical_JJ bootstrap_NN procedure_NN in_IN 500_CD resampling_JJ iterations_NNS -LRB-_-LRB- selection_NN with_IN equal_JJ probability_NN and_CC return_NN of_IN samples_NNS ;_: Efron_NNP 1979_CD -RRB-_-RRB- ._. 
Iterations_NNS of_IN all_DT stages_NNS of_IN the_DT classifier_NN construction_NN -LRB-_-LRB- i._FW e._FW gene_NN preselection_NN ,_, gene_NN selection_NN ,_, and_CC classifier_NN learning_NN -RRB-_-RRB- were_VBD performed_VBN in_IN each_DT bootstrap_NN ,_, as_IN suggested_VBN previously_RB -LRB-_-LRB- Simon_NNP et_NNP al._NN 
The_DT accuracy_NN of_IN the_DT classifier_NN was_VBD calculated_VBN using_VBG the_DT 0_CD ._. 
2003_CD -RRB-_-RRB- ._. 
gene_NN preselection_NN ,_, gene_NN selection_NN ,_, and_CC classifier_NN learning_NN -RRB-_-RRB- were_VBD performed_VBN in_IN each_DT bootstrap_NN ,_, as_IN suggested_VBN previously_RB -LRB-_-LRB- Simon_NNP et_NNP al._VBD 632_CD bootstrap_NN estimator_NN -LRB-_-LRB- Efron_NNP 1983_CD -RRB-_-RRB- ._. 
The_DT distribution_NN of_IN the_DT misclassification_NN rate_NN obtained_VBN during_IN all_DT bootstrap_JJ runs_NNS was_VBD used_VBN to_TO estimate_VB the_DT 95_CD %_NN CI_NNP ._. 
Redundancy_NN of_IN multi-gene_JJ cancer_NN classifiers_NNS This_DT is_VBZ inherently_RB linked_VBN to_TO the_DT huge_JJ differences_NNS in_IN gene_NN expression_NN profiles_NNS of_IN several_JJ tumors_NNS ,_, originating_VBG from_IN the_DT same_JJ tissue_NN ._. 
This_DT was_VBD indicated_VBN for_IN the_DT first_JJ time_NN by_IN Ein-Dor_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- in_IN breast_NN cancer_NN ._. 
These_DT authors_NNS re-analyzed_VBD the_DT data_NNS of_IN va_NN n't_RB Veer_VB et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC showed_VBD that_IN multiple_JJ similar_JJ classifiers_NNS may_MD be_VB obtained_VBN ;_: they_PRP have_VBP comparable_JJ classification_NN potency_NN as_IN van_NN 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Aratake_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD a_DT ,_, b_NN -RRB-_-RRB- and_CC Ozog_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, c_NN Kholova_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Kehlen_FW et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- and_CC Schagdarsurengin_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Membrane_FW enzyme_FW ,_, participates_VBZ in_IN breakdown_NN of_IN secreted_JJ peptides_NNS ADORA1_NNP Adenosine_NNP A1_NNP receptor_NN 205481_at_VBD 10_CD 41_CD 
-LRB-_-LRB- 2000_CD -RRB-_-RRB- ,_, Plum_NNP et_NNP al._IN 62_CD Does_VBZ not_RB normally_RB appear_VB in_IN thyroid_NN ,_, in_IN adult_NN mouse_NN becomes_VBZ restricted_VBN to_TO epidermis_NNS ,_, testis_NNS and_CC placenta_NN -LRB-_-LRB- Tonoli_FW et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC Green_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Forms_VBZ incompatible_JJ hemichannels_NNS with_IN thyroidal_JJ connexin_NN 43_CD -LRB-_-LRB- Dahl_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1996_CD -RRB-_-RRB- -RRB-_-RRB- EMID1_NNP EMI_NNP domain_NN containing_VBG 1_CD 213779_at_CD 15_CD 39_CD 
4_CD 
Such_JJ studies_NNS have_VBP been_VBN successfully_RB performed_VBN in_IN PTC_NNP and_CC large_JJ numbers_NNS of_IN discriminating_VBG physiologically_RB relevant_JJ genes_NNS were_VBD proposed_VBN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2001_CD ,_, Wasenius_FW et_FW al._FW ._. 
2003_CD ,_, Aldred_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD a_DT ,_, b_NN ,_, Wreesmann_FW et_FW al._FW ._. 
60_NNP Barden_NNP et_FW al._FW 73_CD 2_CD ._. 
93_CD 1_CD ._. 
22_CD 2_CD ._. 
15_CD 5_CD ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Oxygen_NN transport_NN MET_NNP Met_NNP proto-oncogene_NN -LRB-_-LRB- hepatocyte_JJ growth_NN factor_NN receptor_NN -RRB-_-RRB- 213807_x_at_CD 3_CD 45_CD 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Barden_NNP et_NNP al._IN 91_CD Chen_NNP et_NNP al._VBD 75_CD 3_CD ._. 
52_CD 2_CD ._. 
72_CD 3_CD ._. 
24_CD 8_CD ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- -RRB-_-RRB- FN1_NNP Fibronectin_NNP 1_CD 210495_x_at_CD 4_CD 44_CD 
54_CD Barden_NNP et_NNP al._VBD 53_CD 2_CD ._. 
76_CD 1_CD ._. 
68_CD 2_CD ._. 
44_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- Interacts_VBZ with_IN nuclear_JJ receptors_NNS MET_NNP Met_NNP proto-oncogene_NN -LRB-_-LRB- hepatocyte_JJ growth_NN factor_NN receptor_NN -RRB-_-RRB- 211599_x_at_CD 17_CD 39_CD 
59_CD Barden_NNP et_FW al._FW 20_CD 1_CD ._. 
50_CD 1_CD ._. 
02_CD 1_CD ._. 
52_CD 6_CD ._. 
06_CD Participates_NNPS in_IN cell_NN 
2004_CD ,_, Ambroziak_NNP et_FW al._FW ._. 
2001_CD ,_, Scouten_NNP et_FW al._FW ._. 
1999_CD ,_, Shimura_NNP et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
Nevertheless_RB ,_, neither_CC our_PRP$ approach_NN nor_CC the_DT meta-analysis_NN mentioned_VBD earlier_RB indicated_VBN other_JJ thyroid-specific_JJ genes_NNS ,_, confirming_VBG the_DT lesser_JJR diagnostic_JJ potency_NN of_IN sodium_NN iodide_NN symporter_NN ,_, thyroglobulin_NN ,_, thyrotrophin_NN receptor_NN ,_, or_CC thyroid-specific_JJ transcription_NN factors_NNS ,_, shown_VBN to_TO be_VB down-regulated_JJ in_IN previous_JJ single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
2005_CD ,_, Wagner_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT top_JJ gene_NN identified_VBN by_IN our_PRP$ effort_NN ,_, MPPED2_NNP ,_, which_WDT is_VBZ lost_VBN in_IN PTC_NNP ,_, was_VBD not_RB previously_RB considered_VBN for_IN its_PRP$ role_NN in_IN PTC_NNP ,_, although_IN it_PRP was_VBD previously_RB listed_VBN by_IN Aldred_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD ,_, 2004_CD -RRB-_-RRB- ,_, Barden_NNP et_NNP al._IN 33_CD Aldred_NNP et_FW al._FW 05_FW 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW 24_CD Barden_NNP et_FW al._FW 60_CD 1_CD ._. 
00_CD 1_CD ._. 
62_CD 3_CD ._. 
62_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Participates_VBZ in_IN protein_NN ubiquination_NN RAB27A_NNP RAB27A_NNP ,_, member_NN RAS_NNP oncogene_NN family_NN 210951_x_at_VBD 19_CD 38_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_NNP al._IN 41_CD Barden_NNP et_NNP al._IN 62_CD 
49_CD 1_CD ._. 
97_CD 1_CD ._. 
75_CD 1_CD ._. 
71_CD 6_CD ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- -RRB-_-RRB- ENTPD1_FW Ectonucleoside_FW triphosphate_FW diphosphohydrolase_FW 1_CD 209473_at_CD 32_CD 27_CD 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_NNP al._IN 53_CD Barden_NNP et_NNP al._VBD 43_CD 1_CD ._. 
28_CD 1_CD ._. 
29_CD 2_CD ._. 
57_CD 6_CD ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- -RRB-_-RRB- 64_CD 
2005_CD -RRB-_-RRB- ._. 
2003_CD -RRB-_-RRB- ,_, while_IN cadherin_NN P_NNP -LRB-_-LRB- CDH3_NNP -RRB-_-RRB- is_VBZ up-regulated_JJ in_IN PTC_NNP -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
1998_CD -RRB-_-RRB- was_VBD indicated_VBN for_IN the_DT first_JJ time_NN in_IN our_PRP$ study_NN ,_, a_DT gene_NN closely_RB related_VBN to_TO cadherin_NN E_NNP -LRB-_-LRB- CDH1_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ well_RB known_VBN to_TO be_VB lost_VBN in_IN a_DT subgroup_NN of_IN PTCs_NNS with_IN negative_JJ prognostic_JJ significance_NN -LRB-_-LRB- Rocha_FW et_FW al._FW ._. 
Other_JJ genes_NNS involved_VBN in_IN cell_NN adhesion_NN and_CC present_NN in_IN our_PRP$ list_NN comprise_VBP ectonucleoside_FW triphosphate_FW diphosphohydrolase_FW 1_CD -LRB-_-LRB- ENTPD1_CD -RRB-_-RRB- -LRB-_-LRB- up-regulated_JJ -RRB-_-RRB- and_CC less_RBR known_JJ genes_NNS such_JJ as_IN NEL-like_JJ 2_CD -LRB-_-LRB- up-regulated_JJ -RRB-_-RRB- and_CC sushi_NN ,_, nidogen_NN ,_, and_CC EGF-like_JJ domains_NNS 1_CD -LRB-_-LRB- down-regulated_JJ -RRB-_-RRB- ,_, both_DT exhibiting_VBG EGF-like_JJ repeats_NNS -LRB-_-LRB- Watanabe_NNP et_FW al._FW ._. 
1996_CD -RRB-_-RRB- ._. 
The_DT GJB3_NNP gene_NN -LRB-_-LRB- connexin_NN 31_CD -RRB-_-RRB- encodes_VBZ the_DT protein_NN subunit_NN of_IN gap_NN junctions_NNS ,_, essential_JJ for_IN cell_NN 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2003_CD ,_, Baris_NNP et_FW al._FW ._. 
2001_CD ,_, Wasenius_FW et_FW al._FW 4_CD 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD ,_, Cerutti_NNP et_FW al._FW ._. 
2001_CD ,_, Baris_NNP et_FW al._FW ._. 
2001_CD ,_, Huang_NNP et_FW al._FW ._. 
Similarly_RB ,_, thyroid-specific_JJ -LRB-_-LRB- down-regulated_JJ -RRB-_-RRB- genes_NNS ,_, deiodinase_NN ,_, iodothyronine_NN ,_, type_NN I_NN and_CC thyroid_NN peroxidase_NN ,_, were_VBD widely_RB recognized_VBN previously_RB for_IN their_PRP$ diagnostic_JJ significance_NN both_DT in_IN microarray-based_JJ -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2004a_NNP ,_, Wreesmann_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- and_CC single_JJ gene_NN studies_NNS -LRB-_-LRB- Arturi_FW et_FW al._FW ._. 
1997_CD ,_, Lazar_NNP et_FW al._FW ._. 
1999_CD ,_, De_NNP Micco_NNP et_FW al._FW ._. 
1999_CD ,_, Czarnocka_FW et_FW al._FW ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2003_CD ,_, Aldred_NNP et_FW al._FW ._. 
2001_CD ,_, Wasenius_FW et_FW al._FW ._. 
Such_JJ studies_NNS have_VBP been_VBN successfully_RB performed_VBN in_IN PTC_NNP and_CC large_JJ numbers_NNS of_IN discriminating_VBG physiologically_RB relevant_JJ genes_NNS were_VBD proposed_VBN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2004a_JJ ,_, b_NN ,_, Wreesmann_FW et_FW al._FW ._. 
2004_CD ,_, Baris_NNP et_FW al._FW ._. 
2005_CD ,_, Detours_NNPS et_FW al._FW ._. 
2005_CD ,_, Giordano_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
However_RB ,_, in_IN the_DT majority_NN of_IN these_DT studies_NNS ,_, the_DT selection_NN of_IN important_JJ genes_NNS was_VBD based_VBN on_IN either_DT fold-change_NN or_CC significance_NN criteria_NNS obtained_VBD using_VBG classical_JJ statistical_JJ tests_NNS ._. 
-LRB-_-LRB- 2004_CD ,_, 2005_CD -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- ,_, Baris_NNP et_NNP al._IN 39_CD Hoos_NNP et_NNP al._IN 74_CD 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Barden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD ,_, 2004_CD -RRB-_-RRB- ,_, Huang_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Wreesmann_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- c_NN De_NNP Micco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- ,_, c_NN Czarnocka_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_NNP al._IN 83_CD Barden_NNP et_FW al._FW 06_FW 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Lelievre_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD ,_, 2004_CD -RRB-_-RRB- and_CC Prasad_NNP et_NNP al._VBD 81_CD Aldred_NNP et_FW al._FW 00_CD 2_CD ._. 
30_CD 2_CD ._. 
85_CD 2_CD ._. 
16_CD 4_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Membrane_FW enzyme_FW ,_, participates_VBZ in_IN breakdown_NN of_IN secreted_JJ peptides_NNS ADORA1_NNP Adenosine_NNP A1_NNP receptor_NN 205481_at_VBD 10_CD 41_CD 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_FW et_FW al._FW 60_NNP Barden_NNP et_FW al._FW 73_CD 2_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Zou_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- c_NN Belfiore_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 1997_CD -RRB-_-RRB- and_CC c_NN Ippolito_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- Ramirez_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Finley_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, Wasenius_NNP et_NNP al._IN 54_CD Barden_NNP et_NNP al._VBD 53_CD 2_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Zou_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- See_VB the_DT information_NN given_VBN above_IN for_IN another_DT probeset_NN of_IN the_DT same_JJ gene_NN DTX4_NNP Deltex_NNP 4_CD homolog_NN -LRB-_-LRB- Drosophila_NNP -RRB-_-RRB- 212611_at_CD 18_CD 39_CD 
For_IN the_DT remaining_VBG samples_NNS ,_, in_IN 175_CD out_IN of_IN 180_CD cases_NNS -LRB-_-LRB- 
DPP4_NNP ,_, another_DT membrane-bound_JJ enzyme_NN which_WDT hydrolyzes_VBZ peptides_NNS engaged_VBN in_IN paracrine_NN and_CC autocrine_NN regulation_NN ,_, is_VBZ up-regulated_JJ in_IN PTCs_NNP both_DT on_IN RNA_NNP and_CC protein_NN level_NN -LRB-_-LRB- Huang_FW et_FW al._FW ._. 
2001_CD ,_, Kholova_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
The_DT contribution_NN of_IN various_JJ enzymes_NNS to_TO our_PRP$ list_NN is_VBZ striking_JJ :_: others_NNS ,_, not_RB described_VBN previously_RB in_IN the_DT context_NN of_IN thyroid_JJ gland_NN ,_, comprise_VBP UDP-galactose_JJ epimerase_NN -LRB-_-LRB- GALE_NNP -RRB-_-RRB- and_CC glutaminyl-peptide_JJ cyclotransferase_NN -LRB-_-LRB- QPCT_NNP -RRB-_-RRB- ,_, both_DT with_IN virtually_RB unknown_JJ expression_NN patterns_NNS ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Kehlen_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD ,_, 2004_CD -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Takano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, cKholova_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD a_DT ,_, b_NN -RRB-_-RRB- and_CC Ozog_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Aratake_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- and_CC Schagdarsurengin_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Membrane_FW enzyme_FW ,_, participates_VBZ in_IN breakdown_NN of_IN secreted_JJ peptides_NNS ADORA1_NNP Adenosine_NNP A1_NNP receptor_NN 205481_at_VBD 10_CD 41_CD 
2003_CD -RRB-_-RRB- ._. 
This_DT is_VBZ convincingly_RB illustrated_VBN by_IN the_DT overlapping_VBG results_NNS of_IN our_PRP$ analysis_NN and_CC one_CD of_IN the_DT studies_NNS which_WDT dealt_VBD with_IN follicular_JJ thyroid_NN tumors_NNS only_RB -LRB-_-LRB- Barden_NNP et_FW al._FW ._. 
Accuracy_NN of_IN discriminating_VBG PTC_NNP from_IN benign\/normal_JJ thyroid_NN tissueOur_NNP study_NN is_VBZ the_DT first_JJ to_TO define_VB the_DT classification_NN accuracy_NN for_IN thyroid_NN cancer_NN by_IN 95_CD %_NN CIs_NNS and_CC one_CD of_IN the_DT few_JJ dealing_VBG with_IN the_DT problem_NN of_IN diagnostic_JJ accuracy_NN of_IN microarray-derived_JJ classifiers_NNS -LRB-_-LRB- Kerr_NNP 
2001_CD -RRB-_-RRB- indicated_VBD the_DT dominant_JJ position_NN of_IN genes_NNS controlling_VBG cell_NN 
DPP4_NNP -LRB-_-LRB- CD26_NNP -RRB-_-RRB- ,_, ICAM1_CD ,_, and_CC ENTPD1_NNP -LRB-_-LRB- CD39_NNP -RRB-_-RRB- may_MD be_VB considered_VBN as_IN immune-related_JJ genes_NNS ,_, although_IN their_PRP$ expression_NN is_VBZ not_RB confined_VBN to_TO immune_JJ or_CC endothelial_JJ cells_NNS ._. 
ICAM1_NNP was_VBD shown_VBN to_TO be_VB present_JJ in_IN thyroid_NN cancer_NN cells_NNS -LRB-_-LRB- Kawai_FW et_FW al._FW ._. 
1998_CD -RRB-_-RRB- ._. 
ENTPD1_CD -LRB-_-LRB- ecto-ATPase_JJ -RRB-_-RRB- ,_, in_IN turn_NN ,_, has_VBZ not_RB been_VBN described_VBN before_IN for_IN the_DT thyroid_JJ gland_NN ;_: its_PRP$ expression_NN was_VBD shown_VBN in_IN some_DT other_JJ organs_NNS like_IN salivary_JJ glands_NNS or_CC exocrine_NN pancreas_NNS -LRB-_-LRB- Kittel_NNP et_FW al._FW ._. 
70_CD 2_CD ._. 
57_CD 1_CD ._. 
61_CD 2_CD ._. 
18_CD 5_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- -RRB-_-RRB- ICAM1_NNP Intercellular_NNP adhesion_NN molecule_NN 1_CD -LRB-_-LRB- CD54_NNP -RRB-_-RRB- ,_, human_JJ rhinovirus_NN receptor_NN 202638_s_at_VBD 43_CD 24_CD 
2004_CD a_DT ,_, b_NN -RRB-_-RRB- ._. 
2004_CD ,_, Finley_NNP et_FW al._FW ._. 
2004_CD ,_, Chevillard_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, also_RB explore_VBP potential_JJ diagnostic_JJ applications_NNS -LRB-_-LRB- Aldred_NNP et_FW al._FW ._. 
Our_PRP$ recent_JJ microarray-based_JJ analysis_NN brought_VBD a_DT 20-gene_JJ classifier_NN to_TO differentiate_VB between_IN papillary_JJ thyroid_NN cancer_NN -LRB-_-LRB- PTC_NNP -RRB-_-RRB- and_CC normal_JJ thyroid_NN tissue_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, further_RB verified_VBD using_VBG three_CD independent_JJ datasets_NNS -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Very_RB large_JJ and_CC easily_RB distinguishable_JJ differences_NNS between_IN the_DT molecular_JJ profiles_NNS of_IN PTC_NNP and_CC normal_JJ thyroid_NN have_VBP clearly_RB demonstrated_VBN the_DT applicability_NN of_IN gene_NN expression_NN findings_NNS to_TO diagnostic_JJ purposes_NNS ._. 
This_DT large_JJ 180-array_JJ dataset_NN is_VBZ derived_VBN respectively_RB from_IN de_JJ novo_NN studies_NNS -LRB-_-LRB- n_SYM =_SYM 40_CD -RRB-_-RRB- ,_, previously_RB published_VBN own_JJ microarray_NN data_NNS -LRB-_-LRB- n_SYM =_SYM 124_CD ;_: Eszlinger_NNP et_FW al._FW ._. 
2001_CD ,_, 2004_CD ,_, Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, and_CC accessible_JJ datasets_NNS published_VBN by_IN other_JJ authors_NNS -LRB-_-LRB- n_SYM =_SYM 16_CD ;_: Huang_NNP et_FW al._FW ._. 
2001_CD -RRB-_-RRB- ._. 
We_PRP set_VBD the_DT following_JJ goals_NNS for_IN the_DT study_NN :_: To_TO assess_VB accuracy_NN of_IN benign\/malignant_JJ classification_NN of_IN thyroid_JJ specimens_NNS in_IN relation_NN to_TO gene_NN set_NN size_NN ,_, in_IN the_DT context_NN of_IN PTC_NNP and_CC To_TO optimize_VB the_DT list_NN of_IN diagnostically_RB relevant_JJ genes_NNS in_IN PTC_NNP ._. 
www_NN ._. 
genomika_NN ._. 
Fifty_CD microarrays_NNS were_VBD included_VBN in_IN our_PRP$ previously_RB published_VBN study_NN and_CC publicly_RB available_JJ at_IN 
Neighborhood_NN analysis_NN and_CC recursive_JJ elimination_NN in_IN gene_NN selection_NN For_IN selection_NN of_IN gene_NN sets_NNS with_IN diagnostic_JJ potential_NN ,_, we_PRP applied_VBD here_RB the_DT recursive_JJ feature_NN elimination_NN -LRB-_-LRB- RFE_NNP -RRB-_-RRB- algorithm_NN -LRB-_-LRB- Guyon_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- which_WDT is_VBZ computationally_RB less_JJR demanding_VBG than_IN recursive_JJ feature_NN replacement_NN used_VBN in_IN our_PRP$ previous_JJ studies_NNS -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
2005_CD ,_, Eszlinger_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
The_DT introductory_JJ gene_NN selection_NN was_VBD performed_VBN using_VBG neighborhood_NN analysis_NN -LRB-_-LRB- 200_CD genes_NNS ;_: Golub_NNP et_FW al._FW ._. 
1998_CD -RRB-_-RRB- was_VBD indicated_VBN for_IN the_DT first_JJ time_NN in_IN our_PRP$ study_NN ,_, a_DT gene_NN closely_RB related_VBN to_TO cadherin_NN E_NNP -LRB-_-LRB- CDH1_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ well_RB known_VBN to_TO be_VB lost_VBN in_IN a_DT subgroup_NN of_IN PTCs_NNS with_IN negative_JJ prognostic_JJ significance_NN -LRB-_-LRB- Rocha_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ,_, while_IN cadherin_NN P_NNP -LRB-_-LRB- CDH3_NNP -RRB-_-RRB- is_VBZ up-regulated_JJ in_IN PTC_NNP -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Other_JJ genes_NNS involved_VBN in_IN cell_NN adhesion_NN and_CC present_NN in_IN our_PRP$ list_NN comprise_VBP ectonucleoside_FW triphosphate_FW diphosphohydrolase_FW 1_CD -LRB-_-LRB- ENTPD1_CD -RRB-_-RRB- -LRB-_-LRB- up-regulated_JJ -RRB-_-RRB- and_CC less_RBR known_JJ genes_NNS such_JJ as_IN NEL-like_JJ 2_CD -LRB-_-LRB- up-regulated_JJ -RRB-_-RRB- and_CC sushi_NN ,_, nidogen_NN ,_, and_CC EGF-like_JJ domains_NNS 1_CD -LRB-_-LRB- down-regulated_JJ -RRB-_-RRB- ,_, both_DT exhibiting_VBG EGF-like_JJ repeats_NNS -LRB-_-LRB- Watanabe_NNP et_FW al._FW ._. 
1999_CD -RRB-_-RRB- ,_, not_RB mentioned_VBN in_IN any_DT thyroid-related_JJ study_NN before_IN ;_: carbonic_JJ anhydrase_NN 4_CD -LRB-_-LRB- CA4_NNP -RRB-_-RRB- ,_, and_CC even_RB the_DT well-known_JJ homogentisate_NN oxidase_NN -LRB-_-LRB- encoding_VBG HGD_NNP -RRB-_-RRB- ,_, not_RB previously_RB related_VBN to_TO the_DT thyroid_NN in_IN any_DT context_NN ,_, although_IN listed_VBN in_IN many_JJ microarray-based_JJ reports_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
Underexpression_NNP of_IN hemoglobin_NN transcripts_NNS -LRB-_-LRB- HBA1\/A2_NNP and_CC HBB_NNP scored_VBD at_IN positions_NNS 2_CD and_CC 25_CD respectively_RB -RRB-_-RRB- was_VBD already_RB discussed_VBN in_IN our_PRP$ papers_NNS as_IN a_DT very_RB characteristic_JJ feature_NN of_IN PTC_NNP gene_NN expression_NN profile_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
We_PRP believe_VBP that_IN the_DT down-regulation_NN of_IN hemoglobin_NN gene_NN could_MD be_VB associated_VBN with_IN tumor_NN hypoxia_NN ;_: HBA_NNP has_VBZ also_RB been_VBN considered_VBN a_DT tumor_NN suppressor_NN since_IN transduction_NN of_IN this_DT gene_NN in_IN an_DT anaplastic_JJ thyroid_NN cancer_NN cell_NN line_NN induces_VBZ an_DT anti-proliferative_JJ effect_NN -LRB-_-LRB- Onda_FW et_FW al._FW ._. 
Indeed_RB ,_, our_PRP$ current_JJ data_NNS generated_VBD using_VBG the_DT bootstrap_JJ technique_NN show_NN much_RB better_JJR agreement_NN with_IN the_DT results_NNS of_IN other_JJ thyroid_JJ cancer_NN studies_NNS -LRB-_-LRB- Oczko-Wojciechowska_FW et_FW al._FW ._. 
submitted_VBN -RRB-_-RRB- than_IN data_NNS created_VBN by_IN leave-one-out_JJ cross-validation_NN of_IN the_DT whole_JJ dataset_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Originally_RB ,_, in_IN a_DT bootstrap_JJ iteration_NN one_NN counts_VBZ only_RB the_DT number_NN of_IN misclassifications_NNS ._. 
Since_IN in_IN all_DT bootstrap_JJ iterations_NNS every_DT step_NN of_IN data_NN processing_NN -LRB-_-LRB- gene_NN selection_NN and_CC classifier_NN training_NN -RRB-_-RRB- has_VBZ to_TO be_VB repeated_VBN -LRB-_-LRB- Simon_NNP et_NNP al._NNP ._. 
The_DT use_NN of_IN multi-gene_JJ classifiers_NNS allows_VBZ ,_, however_RB ,_, overcoming_VBG this_DT difficulty_NN ._. 
2006_CD -RRB-_-RRB- ._. 
PTC_NNP and_CC normal\/benign_JJ difference_NN versus_IN inter-platform_JJ difference_NN To_TO assure_VB a_DT sufficient_JJ number_NN of_IN tissue_NN samples_NNS ,_, it_PRP was_VBD necessary_JJ to_TO combine_VB data_NNS obtained_VBD using_VBG different_JJ generations_NNS of_IN GeneChips_NNP ,_, which_WDT can_MD not_RB be_VB compared_VBN by_IN a_DT direct_JJ approach_NN -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
We_PRP showed_VBD earlier_RBR that_IN the_DT classifier_NN selected_VBD using_VBG the_DT U133_NNP platform_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- performs_VBZ well_RB on_IN U95-obtained_JJ data_NNS and_CC has_VBZ high_JJ classification_NN accuracy_NN -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
2001_CD ,_, 2004_CD ,_, Huang_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- Epithelial_JJ adhesion_NN molecule_NN plays_VBZ a_DT key_JJ role_NN in_IN lymphocyte_NN infiltration_NN into_IN the_DT thyroid_NN a_DT The_DT original_JJ papers_NNS -LRB-_-LRB- Eszlinger_FW et_FW al._FW ._. 
2001_CD ,_, Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- containing_VBG datasets_NNS included_VBN in_IN the_DT present_JJ study_NN were_VBD not_RB cited_VBN here_RB ._. 
RXRG_NNP was_VBD listed_VBN in_IN our_PRP$ previous_JJ microarray-based_JJ analysis_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW 
2005_CD -RRB-_-RRB- containing_VBG datasets_NNS included_VBN in_IN the_DT present_JJ study_NN were_VBD not_RB cited_VBN here_RB ._. 
2001_CD ,_, Jarzab_FW et_FW al._FW ._. 
RXRG_NNP was_VBD listed_VBN in_IN our_PRP$ previous_JJ microarray-based_JJ analysis_NN -LRB-_-LRB- Jarzab_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, together_RB with_IN FN1_NNP ,_, MET_NNP ,_, KRT19_NNP ,_, DPP4_NNP ,_, HBB_NNP ,_, QPCT_NNP ,_, GJB3_NNP ,_, and_CC DTX4_NNP ,_, also_RB occurring_VBG in_IN this_DT table_NN ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Griffith_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD ,_, 2004_CD -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ,_, Takano_NNP et_NNP al._IN 81_CD Huang_NNP et_FW al._FW 21_CD 3_CD ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Kehlen_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- ,_, c_NN Kholova_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2003_CD a_DT ,_, b_NN -RRB-_-RRB- and_CC Ozog_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Aratake_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- and_CC Schagdarsurengin_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ,_, who_WP demonstrated_VBD on_IN simulated_JJ and_CC real_JJ breast_NN cancer_NN data_NNS that_IN for_IN different_JJ classifiers_NNS the_DT number_NN of_IN features_NNS lower_JJR than_IN five_CD was_VBD usually_RB much_RB less_RBR effective_JJ than_IN larger_JJR classifiers_NNS ._. 
Recent_JJ paper_NN reports_VBZ a_DT six-gene_JJ molecular_JJ classifier_NN ,_, efficient_JJ for_IN molecular_JJ diagnosis_NN of_IN thyroid_NN cancer_NN -LRB-_-LRB- Kebebew_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Bootstrap-based_JJ multi-gene_JJ classification_NN of_IN PTC_NNP microarray_NN data_NNS Selection_NN of_IN genes_NNS is_VBZ an_DT important_JJ goal_NN of_IN microarray_NN studies_NNS contributing_VBG to_TO broader_JJR understanding_NN of_IN the_DT cancer_NN transcriptome_NN as_RB well_RB as_IN yielding_VBG novel_JJ molecular_JJ cancer_NN markers_NNS ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- c_NN Belfiore_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- and_CC Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Zou_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD a_DT ,_, b_NN -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 1997_CD -RRB-_-RRB- and_CC cIppolito_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- Ramirez_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2000_CD -RRB-_-RRB- ,_, Ruco_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- and_CC Scarpino_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Membrane_NNP tyrosine_NN kinase_NN receptor_NN enhances_VBZ cell_NN motility_NN ,_, invasiveness_NN ,_, and_CC chemokine_NN production_NN -LRB-_-LRB- Ruco_FW et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- and_CC Liu_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Ghinea_FW et_FW al._FW ._. 
-LRB-_-LRB- 1998_CD -RRB-_-RRB- ,_, 1999_CD and_CC c_NN Prasad_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2006_CD -RRB-_-RRB- Takano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Extracellular_JJ matrix_NN glycoprotein_NN participates_VBZ in_IN cell_NN adhesion_NN ,_, regulates_VBZ proliferation_NN and_CC survival_NN of_IN thyroid_JJ cells_NNS via_IN integrin_NN receptors_NNS -LRB-_-LRB- Illario_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- -RRB-_-RRB- GALE_NNP UDP-galactose-4-epimerase_NNP 202528_at_VBD 5_CD 43_CD 
62_CD Baris_NNP et_NNP al._IN 58_CD 2_CD ._. 
24_CD 3_CD ._. 
66_CD 3_CD ._. 
90_CD 4_CD ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- Membrane_NN receptor_NN ,_, stimulates_VBZ motility_NN and_CC modulates_VBZ proliferation_NN HMGA2_NNP High-mobility_NNP group_NN AT-hook_NNP 2_CD 208025_s_at_CD 11_CD 40_CD 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Giordano_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, Wreesmann_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD ,_, 2005_CD -RRB-_-RRB- ,_, Prasad_FW et_FW al._FW ._. 
-LRB-_-LRB- 2002_CD -RRB-_-RRB- ,_, Baris_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC Jacques_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Mitselou_FW et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- ,_, c_NN Aksoy_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- and_CC c_NN Letsas_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- Stassi_FW et_FW al._FW ._. 
-LRB-_-LRB- 2003_CD -RRB-_-RRB- and_CC Basolo_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD ,_, 2005_CD -RRB-_-RRB- ,_, Prasad_NNP et_NNP al._IN 00_CD Baris_NNP et_NNP al._IN 97_CD 
g._NN Although_IN many_JJ authors_NNS demonstrate_VBP the_DT superiority_NN of_IN other_JJ pre-processing_JJ methods_NNS -LRB-_-LRB- e._VB Our_PRP$ analysis_NN has_VBZ been_VBN performed_VBN on_IN microarray_NN data_NNS pre-processed_JJ by_IN the_DT standard_JJ MAS5_NNP algorithm_NN ._. 
RMA_NNP or_CC GC-RMA_NNP ;_: Irizarry_NNP et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ,_, for_IN inter-platform_JJ comparisons_NNS ,_, the_DT MAS5_NNP method_NN still_RB seems_VBZ to_TO be_VB a_DT reasonable_JJ approach_NN ._. 
In_IN the_DT MAS5_NNP algorithm_NN ,_, each_DT array_NN is_VBZ processed_VBN independently_RB and_CC the_DT bootstrap_JJ procedure_NN does_VBZ not_RB have_VB to_TO involve_VB this_DT step_NN ._. 
2007_CD -RRB-_-RRB- ._. 
The_DT human_JJ GR_NNP is_VBZ a_DT transcription_NN factor_NN that_WDT is_VBZ expressed_VBN in_IN virtually_RB all_DT cells_NNS and_CC displays_NNS genome-wide_JJ action_NN ,_, influencing_VBG around_IN 20_CD %_NN of_IN the_DT expressed_VBN genome_NN -LRB-_-LRB- Donn_FW et_FW al_FW ._. 
Activation_NN by_IN Gc_NNP ligand_VBD results_NNS in_IN transcriptional_JJ induction_NN or_CC repression_NN -LRB-_-LRB- Lu_SYM 
2A_CD -RRB-_-RRB- ._. 
PBS_NNP injection_NN had_VBD no_DT effect_NN on_IN apoptosis_NN ,_, and_CC as_RB expected_VBN ,_, the_DT resulting_JJ tumors_NNS were_VBD negative_JJ for_IN eYFP_NNP expression_NN -LRB-_-LRB- Fig_NNP ._. 
As_IN adenoviral_JJ delivery_NN of_IN transgenes_NNS is_VBZ a_DT relatively_RB inefficient_JJ process_NN -LRB-_-LRB- Krasnykh_NNP et_FW al._FW ._. 
2000_CD -RRB-_-RRB- which_WDT depends_VBZ upon_IN viral_JJ diffusion_NN from_IN the_DT injection_NN site_NN ,_, we_PRP estimated_VBD the_DT number_NN of_IN successfully_RB infected_VBN cells\/tumor_NN by_IN enumerating_VBG the_DT number_NN of_IN eYFP_NNP transcripts\/tumor_NNP ._. 
The_DT Bcl-2_JJ family_NN of_IN proteins_NNS tightly_RB regulates_VBZ apoptosis_NN ,_, with_IN damage_NN signals_NNS being_VBG transduced_VBN by_IN the_DT BH3-only_JJ proteins_NNS -LRB-_-LRB- tBid_NNP ,_, Bad_NNP ,_, Bim_NNP ,_, Noxa_NNP ,_, and_CC Puma_NNP -RRB-_-RRB- which_WDT interact_VBP with_IN pro-survival_JJ family_NN members_NNS -LRB-_-LRB- Bcl-2_NNP ,_, Bcl-xL_NNP ,_, Bcl-w_NNP ,_, A1_CD ,_, and_CC Mcl-1_NNP -RRB-_-RRB- to_TO ablate_VB their_PRP$ pro-survival_JJ function_NN ._. 
This_DT ablation_NN allows_VBZ activation_NN of_IN Bax_NNP and_CC Bak_NNP which_WDT commit_VBP the_DT cell_NN to_TO apoptosis_NN -LRB-_-LRB- Adams_NNP 
Mitochondrial_JJ apoptosis_NN is_VBZ regulated_VBN via_IN a_DT balance_NN between_IN the_DT BH3-only_JJ pro-apoptotic_JJ proteins_NNS -LRB-_-LRB- such_JJ as_IN Bad_NNP ,_, Bim_NNP ,_, Bid_NNP ,_, Noxa_NNP ,_, and_CC Puma_NNP -RRB-_-RRB- and_CC the_DT pro-survival_JJ proteins_NNS -LRB-_-LRB- such_JJ as_IN Bcl-2_NNP and_CC Bcl-xL_NNP -RRB-_-RRB- ._. 
Cell_NN survival_NN is_VBZ promoted_VBN by_IN elevated_JJ levels_NNS of_IN pro-survival_JJ proteins_NNS such_JJ as_IN Bcl-2_NNP and_CC Bcl-xL_NNP ,_, which_WDT prevent_VBP Bax-mediated_JJ perturbation_NN of_IN the_DT mitochondrial_JJ membrane_NN -LRB-_-LRB- Adams_NNP 
1995_CD -RRB-_-RRB- have_VBP shown_VBN that_IN SCLC_NNP cells_NNS contain_VBP negligible_JJ amounts_NNS of_IN functional_JJ GR_NNP ,_, and_CC hypothesized_VBD this_DT to_TO be_VB the_DT cause_NN of_IN Gc_JJ resistance_NN ._. 
The_DT human_JJ GR_NNP is_VBZ a_DT transcription_NN factor_NN that_WDT is_VBZ expressed_VBN in_IN virtually_RB all_DT cells_NNS and_CC displays_NNS genome-wide_JJ action_NN ,_, influencing_VBG around_IN 20_CD %_NN of_IN the_DT expressed_VBN genome_NN -LRB-_-LRB- Donn_FW et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
Activation_NN by_IN Gc_NNP ligand_VBD results_NNS in_IN transcriptional_JJ induction_NN or_CC repression_NN -LRB-_-LRB- Lu_SYM 
1988_CD -RRB-_-RRB- ._. 
All_DT procedures_NNS were_VBD carried_VBN out_RP using_VBG approved_VBN protocols_NNS -LRB-_-LRB- Home_NNP Office_NNP Project_NNP License_NNP 4002328_CD -RRB-_-RRB- in_IN accordance_NN with_IN the_DT Scientific_NNP Procedures_NNPS Act_NNP 1986_CD and_CC in_IN line_NN with_IN the_DT United_NNP Kingdom_NNP Co-ordinating_NNP Committee_NNP on_IN Cancer_NNP Research_NNP Guidelines_NNS on_IN the_DT welfare_NN of_IN animals_NNS in_IN experimental_JJ neoplasia_NN -LRB-_-LRB- Workman_NNP et_FW al_FW ._. 
ACTH_NNP precursor_NN and_CC corticosterone_JJ assaysACTH_NNP precursors_NNS were_VBD measured_VBN using_VBG a_DT specific_JJ two-site_JJ ELISA_NNP based_VBN on_IN an_DT IRMA_NNP format_NN described_VBD previously_RB -LRB-_-LRB- Crosby_NNP et_FW al._FW ._. 
1988_CD -RRB-_-RRB- ._. 
Corticosterone_NNP was_VBD measured_VBN using_VBG an_DT ELISA_NNP with_IN a_DT sensitivity_NN of_IN 0_CD ._. 
17_CD 
1996_CD ,_, Sommer_NNP et_FW al_FW ._. 
We_PRP -LRB-_-LRB- Ray_NNP et_NNP al_NNP ._. 
The_DT inability_NN of_IN Gcs_NNP to_TO inhibit_VB ACTH_NNP precursor_NN expression_NN in_IN SCLCs_NNP prompted_VBD investigation_NN of_IN GR_NNP expression_NN in_IN SCLCs_NNP ._. 
2007_CD -RRB-_-RRB- and_CC others_NNS -LRB-_-LRB- Hofmann_NNP et_FW al._FW ._. 
1995_CD -RRB-_-RRB- have_VBP shown_VBN that_IN SCLC_NNP cells_NNS contain_VBP negligible_JJ amounts_NNS of_IN functional_JJ GR_NNP ,_, and_CC hypothesized_VBD this_DT to_TO be_VB the_DT cause_NN of_IN Gc_JJ resistance_NN ._. 
Pertinent_JJ to_TO this_DT study_NN ,_, Gcs_NNS induce_VBP massive_JJ apoptosis_NN in_IN lymphoid_JJ cells_NNS ,_, and_CC thus_RB are_VBP used_VBN as_IN for_IN the_DT treatment_NN of_IN hematological_JJ malignancies_NNS ._. 
Despite_IN being_VBG the_DT subject_NN of_IN much_JJ study_NN ,_, a_DT canonical_JJ pathway_NN for_IN GR-induced_JJ apoptosis_NN has_VBZ not_RB been_VBN described_VBN and_CC the_DT mechanisms_NNS may_MD vary_VB between_IN cell_NN types_NNS -LRB-_-LRB- Herr_FW et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
The_DT requirement_NN for_IN sufficient_JJ levels_NNS of_IN functional_JJ GR_NNP to_TO induce_VB apoptosis_NN has_VBZ been_VBN demonstrated_VBN in_IN transgenic_JJ mice_NNS with_IN increased_VBN or_CC decreased_VBN GR_NNP expression_NN in_IN human_JJ acute_JJ lymphoblastic_JJ leukemia_NN -LRB-_-LRB- T-ALL_JJ -RRB-_-RRB- cells_NNS expressing_VBG differing_VBG GR_NNP levels_NNS and_CC in_IN Gc-resistant_JJ and_CC Gc-sensitive_JJ multiple_JJ myeloma_NN cells_NNS -LRB-_-LRB- Schmidt_NNP et_FW al_FW ._. 
1998_CD -RRB-_-RRB- ._. 
In_IN GR_NNP dim\/dim_NN mice_NNS ,_, in_IN which_WDT the_DT GR_NNP is_VBZ unable_JJ to_TO dimerize_VB and_CC therefore_RB unable_JJ to_TO bind_NN to_TO DNA_NNP ,_, normal_JJ Gc-induced_JJ thymocyte_NN apoptosis_NN does_VBZ not_RB occur_VB ,_, suggesting_VBG that_IN Gc-induced_JJ apoptosis_NN involves_VBZ de_FW novo_FW gene_NN expression_NN -LRB-_-LRB- Reichardt_NNP et_FW al_FW ._. 
However_RB ,_, gene_NN expression_NN analysis_NN has_VBZ revealed_VBN that_IN some_DT of_IN the_DT events_NNS leading_VBG to_TO apoptosis_NN may_MD be_VB activated_VBN by_IN the_DT non-genomic_JJ actions_NNS of_IN the_DT GR_NNP -LRB-_-LRB- Herr_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
We_PRP have_VBP recently_RB discovered_VBN that_DT restoration_NN of_IN GR_NNP expression_NN in_IN human_JJ SCLC_NNP cells_NNS in_IN vitro_NN powerfully_RB induces_VBZ apoptosis_NNS -LRB-_-LRB- Sommer_NNP et_FW al_FW ._. 
It_PRP is_VBZ the_DT most_RBS aggressive_JJ of_IN the_DT lung_NN cancer_NN subtypes_NNS and_CC is_VBZ generally_RB disseminated_VBN at_IN the_DT time_NN of_IN diagnosis_NN ._. 
While_IN it_PRP is_VBZ initially_RB responsive_JJ to_TO chemotherapy_NN ,_, the_DT 5-year_JJ survival_NN rate_NN is_VBZ 
As_IN the_DT number_NN of_IN dying_VBG cells_NNS seen_VBN in_IN GR-eYFP-infected_JJ cell_NN cultures_NNS is_VBZ greater_JJR than_IN the_DT number_NN of_IN cells_NNS estimated_VBN to_TO be_VB infected_JJ -LRB-_-LRB- eYFP_JJ positive_NN after_IN eYFP_NNP adenoviral_JJ infection_NN -RRB-_-RRB- ,_, this_DT supports_VBZ a_DT bystander_NN cell_NN kill_NN effect_NN ._. 
Bystander_NN killing_NN plays_VBZ a_DT crucial_JJ role_NN in_IN cancer_NN therapy_NN as_IN it_PRP significantly_RB amplifies_VBZ the_DT anti-tumor_JJ effect_NN of_IN cytotoxic_JJ therapy_NN -LRB-_-LRB- Hyer_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
This_DT has_VBZ been_VBN observed_VBN in_IN response_NN to_TO u._VB v._IN radiation_NN ,_, photodynamic_JJ therapy_NN ,_, and_CC chemotherapeutic_JJ agents_NNS in_IN diverse_JJ cell_NN types_NNS such_JJ as_IN lymphocytes_NNS ,_, fibroblasts_NNS ,_, endothelial_JJ cells_NNS ,_, and_CC tumor_NN cells_NNS ._. 
SCLCs_NNS are_VBP neuroendocrine_JJ carcinomas_NNS able_JJ to_TO secrete_VB a_DT variety_NN of_IN ectopic_JJ neuropeptides_NNS including_VBG the_DT ACTH_NNP precursor_NN ,_, proopiomelanocortin_NN ._. 
The_DT ectopic_JJ secretion_NN of_IN ACTH_NNP precursors_NNS by_IN SCLCs_NNP has_VBZ been_VBN shown_VBN to_TO be_VB resistant_JJ to_TO normal_JJ negative_JJ feedback_NN inhibition_NN by_IN circulating_VBG glucocorticoids_NNS -LRB-_-LRB- Gcs_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ evidence_NN of_IN Gc_JJ resistance_NN -LRB-_-LRB- White_NNP et_NNP al._NN ._. 
1990_CD ,_, White_NNP 
Analyses_NNS were_VBD run_VBN using_VBG SPSS_NNP ._. 
ACTH_NN precursors_NNS and_CC qRT-PCR_NNP were_VBD compared_VBN using_VBG an_DT unpaired_JJ Student_NN 's_POS t_NN -_: test_NN ._. 
ResultsSCLC_NNP xenograftsDMS_NNP 79_CD cells_NNS were_VBD used_VBN for_IN xenograft_NN generation_NN because_IN they_PRP secrete_VBP ACTH_NNP precursor_NN peptides_NNS -LRB-_-LRB- a_DT frequent_JJ clinical_JJ feature_NN of_IN human_JJ SCLCs_NNS -RRB-_-RRB- ,_, providing_VBG a_DT potential_JJ biomarker_NN for_IN tumor_NN presence_NN or_CC mass_NN -LRB-_-LRB- White_NNP et_NNP al._NN ._. 
1990_CD -RRB-_-RRB- ._. 
DMS_NNP 79_CD cell_NN xenografts_NNS exhibited_VBD typical_JJ SCLC_NNP pathology_NN ,_, and_CC the_DT mice_NNS had_VBD marked_VBN increases_NNS in_IN circulating_VBG ACTH_NNP precursor_NN concentrations_NNS -LRB-_-LRB- Fig_NNP ._. 
The_DT time_NN taken_VBN for_IN each_DT tumor_NN to_TO reach_VB RTV4_NNP was_VBD calculated_VBN ,_, and_CC the_DT data_NNS were_VBD log_VB transformed_VBN to_TO overcome_VB the_DT non-parametric_JJ data_NNS and_CC subjected_VBN to_TO a_DT two-tailed_JJ t_NN -_: test_NN ._. 
All_DT procedures_NNS were_VBD carried_VBN out_RP using_VBG approved_VBN protocols_NNS -LRB-_-LRB- Home_NNP Office_NNP Project_NNP License_NNP 4002328_CD -RRB-_-RRB- in_IN accordance_NN with_IN the_DT Scientific_NNP Procedures_NNPS Act_NNP 1986_CD and_CC in_IN line_NN with_IN the_DT United_NNP Kingdom_NNP Co-ordinating_NNP Committee_NNP on_IN Cancer_NNP Research_NNP Guidelines_NNS on_IN the_DT welfare_NN of_IN animals_NNS in_IN experimental_JJ neoplasia_NN -LRB-_-LRB- Workman_NNP et_FW al._FW ._. 
1988_CD -RRB-_-RRB- ._. 
ACTH_NNP precursor_NN and_CC corticosterone_NN assays_NNS ACTH_NNP precursors_NNS were_VBD measured_VBN using_VBG a_DT specific_JJ two-site_JJ ELISA_NNP based_VBN on_IN an_DT IRMA_NNP format_NN described_VBD previously_RB -LRB-_-LRB- Crosby_NNP et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ._. 
Activation_NN by_IN Gc_NNP ligand_VBD results_NNS in_IN transcriptional_JJ induction_NN or_CC repression_NN -LRB-_-LRB- Lu_SYM 
2004_CD -RRB-_-RRB- ._. 
The_DT requirement_NN for_IN sufficient_JJ levels_NNS of_IN functional_JJ GR_NNP to_TO induce_VB apoptosis_NN has_VBZ been_VBN demonstrated_VBN in_IN transgenic_JJ mice_NNS with_IN increased_VBN or_CC decreased_VBN GR_NNP expression_NN in_IN human_JJ acute_JJ lymphoblastic_JJ leukemia_NN -LRB-_-LRB- T-ALL_JJ -RRB-_-RRB- cells_NNS expressing_VBG differing_VBG GR_NNP levels_NNS and_CC in_IN Gc-resistant_JJ and_CC Gc-sensitive_JJ multiple_JJ myeloma_NN cells_NNS -LRB-_-LRB- Schmidt_NNP et_FW al_FW ._. 
In_IN GRdim\/dim_NNP mice_NNS ,_, in_IN which_WDT the_DT GR_NNP is_VBZ unable_JJ to_TO dimerize_VB and_CC therefore_RB unable_JJ to_TO bind_NN to_TO DNA_NNP ,_, normal_JJ Gc-induced_JJ thymocyte_NN apoptosis_NN does_VBZ not_RB occur_VB ,_, suggesting_VBG that_IN Gc-induced_JJ apoptosis_NN involves_VBZ de_FW novo_FW gene_NN expression_NN -LRB-_-LRB- Reichardt_NNP et_FW al._FW ._. 
1998_CD -RRB-_-RRB- ._. 
However_RB ,_, gene_NN expression_NN analysis_NN has_VBZ revealed_VBN that_IN some_DT of_IN the_DT events_NNS leading_VBG to_TO apoptosis_NN may_MD be_VB activated_VBN by_IN the_DT non-genomic_JJ actions_NNS of_IN the_DT GR_NNP -LRB-_-LRB- Herr_NNP et_FW al_FW ._. 
Most_RBS notably_RB ,_, over-expression_NN of_IN GR_NNP by_IN adenoviral_JJ infection_NN in_IN these_DT tumors_NNS significantly_RB inhibited_VBD Bcl-2_JJ and_CC Bcl-xL_JJ transcript_NN abundance_NN ._. 
These_DT results_NNS are_VBP similar_JJ to_TO those_DT in_IN the_DT juvenile_JJ rat_NN hippocampus_NN ,_, where_WRB dexamethasone_NN has_VBZ been_VBN shown_VBN to_TO downregulate_VB Bcl-2_JJ and_CC Bcl-xL_JJ and_CC upregulate_JJ Bax_NNP -LRB-_-LRB- Sandau_NNP 
Most_RBS notably_RB ,_, over-expression_NN of_IN GR_NNP by_IN adenoviral_JJ infection_NN in_IN these_DT tumors_NNS significantly_RB inhibited_VBD Bcl-2_JJ and_CC Bcl-xL_JJ transcript_NN abundance_NN ._. 
These_DT results_NNS are_VBP similar_JJ to_TO those_DT in_IN the_DT juvenile_JJ rat_NN hippocampus_NN ,_, where_WRB dexamethasone_NN has_VBZ been_VBN shown_VBN to_TO downregulate_VB Bcl-2_JJ and_CC Bcl-xL_JJ and_CC upregulate_JJ Bax_NNP -LRB-_-LRB- Sandau_NNP 
2007_CD -RRB-_-RRB- ._. 
Despite_IN being_VBG the_DT subject_NN of_IN much_JJ study_NN ,_, a_DT canonical_JJ pathway_NN for_IN GR-induced_JJ apoptosis_NN has_VBZ not_RB been_VBN described_VBN and_CC the_DT mechanisms_NNS may_MD vary_VB between_IN cell_NN types_NNS -LRB-_-LRB- Herr_FW et_FW al_FW ._. 
The_DT requirement_NN for_IN sufficient_JJ levels_NNS of_IN functional_JJ GR_NNP to_TO induce_VB apoptosis_NN has_VBZ been_VBN demonstrated_VBN in_IN transgenic_JJ mice_NNS with_IN increased_VBN or_CC decreased_VBN GR_NNP expression_NN in_IN human_JJ acute_JJ lymphoblastic_JJ leukemia_NN -LRB-_-LRB- T-ALL_JJ -RRB-_-RRB- cells_NNS expressing_VBG differing_VBG GR_NNP levels_NNS and_CC in_IN Gc-resistant_JJ and_CC Gc-sensitive_JJ multiple_JJ myeloma_NN cells_NNS -LRB-_-LRB- Schmidt_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
In_IN GR_NNP dim\/dim_NN mice_NNS ,_, in_IN which_WDT the_DT GR_NNP is_VBZ unable_JJ to_TO dimerize_VB and_CC therefore_RB unable_JJ to_TO bind_NN to_TO DNA_NNP ,_, normal_JJ Gc-induced_JJ thymocyte_NN apoptosis_NN does_VBZ not_RB occur_VB ,_, suggesting_VBG that_IN Gc-induced_JJ apoptosis_NN involves_VBZ de_FW novo_FW gene_NN expression_NN -LRB-_-LRB- Reichardt_NNP et_FW al_FW ._. 
Resistance_NN to_TO therapy_NN in_IN multiple_JJ cancers_NNS is_VBZ associated_VBN with_IN over-expression_NN of_IN Bcl-2_NNP and_CC Bcl-xL_NNP -LRB-_-LRB- Olejniczak_NNP et_FW al_FW ._. 
2007_CD ,_, Schwartz_NNP et_NNP al._NNP ._. 
2007_CD -RRB-_-RRB- ._. 
Bcl-2_NN is_VBZ over-expressed_JJ in_IN 75_CD %_NN of_IN the_DT SCLCs_NNS -LRB-_-LRB- Pisick_FW et_FW al_FW ._. 
2003_CD -RRB-_-RRB- ,_, and_CC its_PRP$ locus_NN is_VBZ amplified_VBN in_IN 48_CD %_NN of_IN the_DT patients_NNS -LRB-_-LRB- Olejniczak_NNP et_FW al_FW ._. 
We_PRP -LRB-_-LRB- Ray_NNP et_NNP al_NNP ._. 
The_DT inability_NN of_IN Gcs_NNP to_TO inhibit_VB ACTH_NNP precursor_NN expression_NN in_IN SCLCs_NNP prompted_VBD investigation_NN of_IN GR_NNP expression_NN in_IN SCLCs_NNP ._. 
1996_CD ,_, Sommer_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- and_CC others_NNS -LRB-_-LRB- Hofmann_NNP et_FW al_FW ._. 
1995_CD -RRB-_-RRB- have_VBP shown_VBN that_IN SCLC_NNP cells_NNS contain_VBP negligible_JJ amounts_NNS of_IN functional_JJ GR_NNP ,_, and_CC hypothesized_VBD this_DT to_TO be_VB the_DT cause_NN of_IN Gc_JJ resistance_NN ._. 
2007_CD -RRB-_-RRB- ._. 
However_RB ,_, gene_NN expression_NN analysis_NN has_VBZ revealed_VBN that_IN some_DT of_IN the_DT events_NNS leading_VBG to_TO apoptosis_NN may_MD be_VB activated_VBN by_IN the_DT non-genomic_JJ actions_NNS of_IN the_DT GR_NNP -LRB-_-LRB- Herr_NNP et_FW al_FW ._. 
We_PRP have_VBP recently_RB discovered_VBN that_DT restoration_NN of_IN GR_NNP expression_NN in_IN human_JJ SCLC_NNP cells_NNS in_IN vitro_NN powerfully_RB induces_VBZ apoptosis_NNS -LRB-_-LRB- Sommer_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ,_, suggesting_VBG that_DT loss_NN of_IN GR_NNP expression_NN in_IN SCLC_NNP cells_NNS promotes_VBZ their_PRP$ survival_NN ._. 
Transgenic_NNP GR_NNP expression_NN ,_, which_WDT induced_VBD apoptotic_JJ cell_NN death_NN in_IN SCLC_NNP cells_NNS ,_, also_RB upregulated_VBD pro-apoptotic_JJ genes_NNS of_IN the_DT Bcl-2_NNP family_NN -LRB-_-LRB- Sommer_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ,_, suggesting_VBG that_DT loss_NN of_IN GR_NNP expression_NN in_IN SCLC_NNP cells_NNS promotes_VBZ their_PRP$ survival_NN ._. 
We_PRP have_VBP recently_RB discovered_VBN that_DT restoration_NN of_IN GR_NNP expression_NN in_IN human_JJ SCLC_NNP cells_NNS in_IN vitro_NN powerfully_RB induces_VBZ apoptosis_NNS -LRB-_-LRB- Sommer_NNP et_FW al_FW ._. 
Transgenic_NNP GR_NNP expression_NN ,_, which_WDT induced_VBD apoptotic_JJ cell_NN death_NN in_IN SCLC_NNP cells_NNS ,_, also_RB upregulated_VBD pro-apoptotic_JJ genes_NNS of_IN the_DT Bcl-2_NNP family_NN -LRB-_-LRB- Sommer_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
The_DT Bcl-2_JJ family_NN of_IN proteins_NNS tightly_RB regulates_VBZ apoptosis_NN ,_, with_IN damage_NN signals_NNS being_VBG transduced_VBN by_IN the_DT BH3-only_JJ proteins_NNS -LRB-_-LRB- tBid_NNP ,_, Bad_NNP ,_, Bim_NNP ,_, Noxa_NNP ,_, and_CC Puma_NNP -RRB-_-RRB- which_WDT interact_VBP with_IN pro-survival_JJ family_NN members_NNS -LRB-_-LRB- Bcl-2_NNP ,_, Bcl-xL_NNP ,_, Bcl-w_NNP ,_, A1_CD ,_, and_CC Mcl-1_NNP -RRB-_-RRB- to_TO ablate_VB their_PRP$ pro-survival_JJ function_NN ._. 
Importantly_RB ,_, we_PRP found_VBD that_IN GR_NNP over-expression_NN caused_VBD a_DT significant_JJ slowing_NN in_IN tumor_NN growth_NN ,_, together_RB with_IN a_DT possible_JJ bystander_NN effect_NN ._. 
In_IN contrast_NN to_TO in_IN vitro_NN findings_NNS that_IN GR_NNP over-expression_NN upregulated_VBD the_DT pro-apoptotic_JJ genes_NNS ,_, Bad_NNP and_CC Bax_NNP -LRB-_-LRB- Sommer_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ,_, in_IN the_DT in_IN vivo_NN environment_NN ,_, GR_NNP over-expression_NN downregulated_VBD the_DT pro-survival_JJ genes_NNS ,_, Bcl-2_NNP and_CC Bcl-xL_NNP ._. 
Viral_JJ vector_NN construction_NN and_CC propagation_NN The_DT AdEasy_NNP Adenoviral_NNP Vector_NNP System_NNP -LRB-_-LRB- Stratagene_NNP ,_, La_NNP Jolla_NNP ,_, CA_NNP ,_, USA_NNP -RRB-_-RRB- was_VBD used_VBN to_TO produce_VB adenoviral_JJ vectors_NNS carrying_VBG GR-eYFP_NNP and_CC eYFP_NNP ._. 
Briefly_RB ,_, GR-eYFP_NNP and_CC eYFP_NNP were_VBD excised_VBN from_IN pFUNC1_NNP GR-eYFP_NNP and_CC pFUNC1_NNP eYFP_NNP -LRB-_-LRB- Sommer_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- using_VBG Not1_NNP and_CC were_VBD subcloned_VBN into_IN pShuttle-CMV_NNP ._. 
Successfully_RB ligated_VBN pShuttle-CMV_NNP was_VBD linearized_VBN with_IN Pme1_JJ and_CC co-transformed_JJ with_IN pAdEasy-1_JJ supercoiled_JJ vector_NN into_IN BJ5183_CD competent_JJ cells_NNS ._. 
5in_JJ non-engrafted_JJ animals_NNS -RRB-_-RRB- ,_, as_IN predicted_VBN from_IN the_DT raised_VBN ACTH_NNP peptide_NN concentrations_NNS ,_, providing_VBG an_DT accurate_JJ model_NN of_IN the_DT ectopic_JJ ACTH_NNP syndrome_NN ._. 
Development_NNP of_IN adenoviral_JJ vectors_NNS for_IN GR-eYFP_NNP and_CC eYFPPreviously_NNP ,_, we_PRP had_VBD shown_VBN that_IN retrovirally_RB mediated_VBN over-expression_NN of_IN GR-eYFP_NNP in_IN SCLC_NNP cell_NN lines_NNS in_IN vitro_NN resulted_VBD in_IN apoptotic_JJ cell_NN death_NN when_WRB compared_VBN with_IN the_DT effects_NNS of_IN a_DT control_NN virus_NN expressing_VBG eYFP_NNP alone_RB -LRB-_-LRB- Sommer_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
However_RB ,_, effects_NNS on_IN pure_JJ cell_NN populations_NNS in_IN vitro_NN may_MD not_RB translate_VB into_IN the_DT complex_JJ environment_NN of_IN a_DT solid_JJ tumor_NN ,_, with_IN vascular_NN and_CC cell_NN matrix_NN components_NNS influencing_VBG the_DT tumor_NN cells_NNS ._. 
Over-expression_NN of_IN GR_NNP by_IN adenoviral_JJ infection_NN caused_VBD the_DT death_NN of_IN infected_JJ SCLC_NNP cells_NNS -LRB-_-LRB- yellow_JJ arrow_NN -RRB-_-RRB- when_WRB compared_VBN with_IN cells_NNS infected_VBN with_IN control_NN virus_NN -LRB-_-LRB- Fig_NNP ._. 
4A_NNP and_CC B_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ an_DT effect_NN similar_JJ to_TO that_DT seen_VBN with_IN retroviral_JJ gene_NN delivery_NN -LRB-_-LRB- Sommer_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
Interestingly_RB ,_, there_EX is_VBZ also_RB a_DT clear_JJ shift_NN in_IN the_DT population_NN of_IN non-GR-eYFP-positive_JJ SCLC_NNP cells_NNS toward_IN cell_NN death_NN -LRB-_-LRB- black_JJ arrow_NN ;_: Fig_NNP ._. 
We_PRP have_VBP shown_VBN that_DT over-expression_NN of_IN GR_NNP in_IN these_DT SCLC_NNP xenografts_NNS leads_VBZ to_TO apoptotic_JJ cell_NN death_NN associated_VBN with_IN downregulation_NN of_IN the_DT pro-survival_JJ genes_NNS ,_, Bcl-2_NNP and_CC Bcl-xL_NNP ,_, and_CC results_NNS in_IN delayed_JJ tumor_NN growth_NN in_IN vivo_NN ._. 
Previously_RB ,_, we_PRP had_VBD shown_VBN that_IN the_DT SCLC_NNP cell_NN line_NN -LRB-_-LRB- DMS_NNP 79_CD -RRB-_-RRB- used_VBN to_TO create_VB the_DT xenograft_NN model_NN expressed_VBD very_RB low_JJ levels_NNS of_IN the_DT GR_NNP ,_, and_CC that_DT restoration_NN of_IN GR_NNP expression_NN in_IN the_DT cells_NNS by_IN transfection_NN inhibited_VBD the_DT secretion_NN of_IN ACTH_NNP precursors_NNS from_IN the_DT cells_NNS in_IN culture_NN -LRB-_-LRB- Sommer_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
In_IN this_DT study_NN ,_, we_PRP found_VBD that_IN tumors_NNS formed_VBN from_IN DMS_NNP 79_CD cells_NNS also_RB secreted_VBD ACTH_NNP precursor_NN peptides_NNS ._. 
However_RB ,_, the_DT frequency_NN of_IN apoptotic_JJ cells_NNS in_IN Ad-GR-eYFP-injected_JJ tumors_NNS is_VBZ greater_JJR than_IN the_DT predicted_VBN frequency_NN of_IN transgene-expressing_JJ cells_NNS ,_, based_VBN on_IN the_DT experiments_NNS with_IN the_DT Ad-eYFP-injected_NNP tumors_NNS ._. 
Indeed_RB ,_, both_DT retroviral_JJ delivery_NN of_IN GR_NNP -LRB-_-LRB- Sommer_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- and_CC adenoviral_JJ delivery_NN to_TO SCLC_NNP cells_NNS in_IN vitro_NN resulted_VBD in_IN a_DT striking_JJ excess_NN of_IN apoptotic_JJ cells_NNS compared_VBN with_IN the_DT number_NN found_VBD to_TO be_VB expressing_VBG the_DT transgene_NN ._. 
This_DT effect_NN has_VBZ been_VBN shown_VBN previously_RB where_WRB small_JJ molecule_NN inhibitors_NNS of_IN pro-survival_JJ proteins_NNS such_JJ as_IN ABT-737_NNP improved_VBD survival_NN and_CC caused_VBD tumor_NN regression_NN in_IN mice_NNS -LRB-_-LRB- Oltersdorf_NNP et_FW al_FW ._. 
2005_CD ,_, Tahir_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
Amajor_JJ limitation_NN of_IN gene_NN delivery_NN using_VBG adenoviral_JJ vectors_NNS is_VBZ the_DT inability_NN to_TO transduce_VB all_PDT the_DT tumor_NN cells_NNS in_IN vivo_NN ._. 
The_DT ectopic_JJ secretion_NN of_IN ACTH_NNP precursors_NNS by_IN SCLCs_NNP has_VBZ been_VBN shown_VBN to_TO be_VB resistant_JJ to_TO normal_JJ negative_JJ feedback_NN inhibition_NN by_IN circulating_VBG glucocorticoids_NNS -LRB-_-LRB- Gcs_NNP -RRB-_-RRB- ,_, which_WDT is_VBZ evidence_NN of_IN Gc_JJ resistance_NN -LRB-_-LRB- White_NNP et_NNP al_NN ._. 
1990_CD ,_, White_NNP 
2007_CD -RRB-_-RRB- ._. 
The_DT human_JJ GR_NNP is_VBZ a_DT transcription_NN factor_NN that_WDT is_VBZ expressed_VBN in_IN virtually_RB all_DT cells_NNS and_CC displays_NNS genome-wide_JJ action_NN ,_, influencing_VBG around_IN 20_CD %_NN of_IN the_DT expressed_VBN genome_NN -LRB-_-LRB- Donn_FW et_FW al_FW ._. 
Activation_NN by_IN Gc_NNP ligand_VBD results_NNS in_IN transcriptional_JJ induction_NN or_CC repression_NN -LRB-_-LRB- Lu_SYM 
Quantitative_NNP PCR_NNP was_VBD performed_VBN using_VBG SYBR_NNP Green_NNP JumpStart_NNP Taq_NNP ready_JJ mix_NN -LRB-_-LRB- Sigma_NNP -RRB-_-RRB- as_IN per_IN the_DT manufacturer_NN 's_POS instructions_NNS ._. 
Results_NNS were_VBD analyzed_VBN using_VBG the_DT 2_CD 
2007_CD -RRB-_-RRB- ._. 
The_DT human_JJ GR_NNP is_VBZ a_DT transcription_NN factor_NN that_WDT is_VBZ expressed_VBN in_IN virtually_RB all_DT cells_NNS and_CC displays_NNS genome-wide_JJ action_NN ,_, influencing_VBG around_IN 20_CD %_NN of_IN the_DT expressed_VBN genome_NN -LRB-_-LRB- Donn_FW et_FW al_FW ._. 
Activation_NN by_IN Gc_NNP ligand_VBD results_NNS in_IN transcriptional_JJ induction_NN or_CC repression_NN -LRB-_-LRB- Lu_SYM 
These_DT results_NNS are_VBP similar_JJ to_TO those_DT in_IN the_DT juvenile_JJ rat_NN hippocampus_NN ,_, where_WRB dexamethasone_NN has_VBZ been_VBN shown_VBN to_TO downregulate_VB Bcl-2_JJ and_CC Bcl-xL_JJ and_CC upregulate_JJ Bax_NNP -LRB-_-LRB- Sandau_NNP 
Here_RB ,_, we_PRP suggest_VBP that_IN GR-mediated_JJ inhibition_NN of_IN Bcl-2_NNP and_CC Bcl-xL_NNP would_MD relieve_VB repression_NN of_IN Bax_NNP activity_NN and_CC thus_RB trigger_VB the_DT apoptotic_JJ cascade_NN ,_, thereby_RB slowing_VBG tumor_NN growth_NN ._. 
This_DT effect_NN has_VBZ been_VBN shown_VBN previously_RB where_WRB small_JJ molecule_NN inhibitors_NNS of_IN pro-survival_JJ proteins_NNS such_JJ as_IN ABT-737_NNP improved_VBD survival_NN and_CC caused_VBD tumor_NN regression_NN in_IN mice_NNS -LRB-_-LRB- Oltersdorf_NNP et_FW al._FW ._. 
2005_CD ,_, Tahir_NNP et_NNP al_NNP ._. 
2007_CD -RRB-_-RRB- ._. 
Amajor_JJ limitation_NN of_IN gene_NN delivery_NN using_VBG adenoviral_JJ vectors_NNS is_VBZ the_DT inability_NN to_TO transduce_VB all_PDT the_DT tumor_NN cells_NNS in_IN vivo_NN ._. 
Cell_NN survival_NN is_VBZ promoted_VBN by_IN elevated_JJ levels_NNS of_IN pro-survival_JJ proteins_NNS such_JJ as_IN Bcl-2_NNP and_CC Bcl-xL_NNP ,_, which_WDT prevent_VBP Bax-mediated_JJ perturbation_NN of_IN the_DT mitochondrial_JJ membrane_NN -LRB-_-LRB- Adams_NNP 
Bcl-2_NN is_VBZ over-expressed_JJ in_IN 75_CD %_NN of_IN the_DT SCLCs_NNS -LRB-_-LRB- Pisick_FW et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
2007_CD ,_, Schwartz_NNP et_NNP al_NNP ._. 
Resistance_NN to_TO therapy_NN in_IN multiple_JJ cancers_NNS is_VBZ associated_VBN with_IN over-expression_NN of_IN Bcl-2_NNP and_CC Bcl-xL_NNP -LRB-_-LRB- Olejniczak_NNP et_FW al_FW ._. 
2003_CD -RRB-_-RRB- ,_, and_CC its_PRP$ locus_NN is_VBZ amplified_VBN in_IN 48_CD %_NN of_IN the_DT patients_NNS -LRB-_-LRB- Olejniczak_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
While_IN the_DT Bcl-2_JJ locus_NN in_IN the_DT DMS_NNP 79_CD cells_NNS used_VBN to_TO create_VB the_DT xenografts_NNS is_VBZ not_RB amplified_VBN -LRB-_-LRB- Olejniczak_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
2003_CD -RRB-_-RRB- ,_, and_CC its_PRP$ locus_NN is_VBZ amplified_VBN in_IN 48_CD %_NN of_IN the_DT patients_NNS -LRB-_-LRB- Olejniczak_NNP et_FW al_FW ._. 
Bcl-2_NN is_VBZ over-expressed_JJ in_IN 75_CD %_NN of_IN the_DT SCLCs_NNS -LRB-_-LRB- Pisick_FW et_FW al_FW ._. 
While_IN the_DT Bcl-2_JJ locus_NN in_IN the_DT DMS_NNP 79_CD cells_NNS used_VBN to_TO create_VB the_DT xenografts_NNS is_VBZ not_RB amplified_VBN -LRB-_-LRB- Olejniczak_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ,_, we_PRP found_VBD that_IN the_DT tumors_NNS over-expressed_JJ Bcl-2_NN as_RB well_RB as_IN Bcl-xL_JJ ,_, Bad_JJ ,_, and_CC Bim_NNP in_IN comparison_NN to_TO transcript_NN levels_NNS in_IN vitro_NN ,_, while_IN Bax_NNP levels_NNS remained_VBD unchanged_JJ ._. 
2007_CD -RRB-_-RRB- ._. 
2007_CD ,_, Schwartz_NNP et_NNP al_NNP ._. 
Resistance_NN to_TO therapy_NN in_IN multiple_JJ cancers_NNS is_VBZ associated_VBN with_IN over-expression_NN of_IN Bcl-2_NNP and_CC Bcl-xL_NNP -LRB-_-LRB- Olejniczak_NNP et_FW al_FW ._. 
Bcl-2_NN is_VBZ over-expressed_JJ in_IN 75_CD %_NN of_IN the_DT SCLCs_NNS -LRB-_-LRB- Pisick_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ,_, and_CC its_PRP$ locus_NN is_VBZ amplified_VBN in_IN 48_CD %_NN of_IN the_DT patients_NNS -LRB-_-LRB- Olejniczak_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
While_IN the_DT Bcl-2_JJ locus_NN in_IN the_DT DMS_NNP 79_CD cells_NNS used_VBN to_TO create_VB the_DT xenografts_NNS is_VBZ not_RB amplified_VBN -LRB-_-LRB- Olejniczak_NNP et_FW al_FW ._. 
The_DT latter_JJ mechanism_NN is_VBZ well_RB documented_VBN in_IN response_NN to_TO radiation_NN ,_, but_CC the_DT nature_NN of_IN the_DT signal_NN -LRB-_-LRB- s_PRP -RRB-_-RRB- remains_VBZ unknown_JJ -LRB-_-LRB- Prise_NN 
The_DT inability_NN of_IN Gcs_NNP to_TO inhibit_VB ACTH_NNP precursor_NN expression_NN in_IN SCLCs_NNP prompted_VBD investigation_NN of_IN GR_NNP expression_NN in_IN SCLCs_NNP ._. 
We_PRP -LRB-_-LRB- Ray_NNP et_NNP al._NNP ._. 
1996_CD ,_, Sommer_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- and_CC others_NNS -LRB-_-LRB- Hofmann_NNP et_FW al_FW ._. 
1995_CD -RRB-_-RRB- have_VBP shown_VBN that_IN SCLC_NNP cells_NNS contain_VBP negligible_JJ amounts_NNS of_IN functional_JJ GR_NNP ,_, and_CC hypothesized_VBD this_DT to_TO be_VB the_DT cause_NN of_IN Gc_JJ resistance_NN ._. 
radiation_NN ,_, photodynamic_JJ therapy_NN ,_, and_CC chemotherapeutic_JJ agents_NNS in_IN diverse_JJ cell_NN types_NNS such_JJ as_IN lymphocytes_NNS ,_, fibroblasts_NNS ,_, endothelial_JJ cells_NNS ,_, and_CC tumor_NN cells_NNS ._. 
Despite_IN the_DT importance_NN of_IN this_DT phenomenon_NN ,_, the_DT mechanisms_NNS that_WDT are_VBP responsible_JJ are_VBP poorly_RB defined_VBN -LRB-_-LRB- Prise_NN 
Alternatively_RB ,_, the_DT release_NN of_IN 
Thus_RB ,_, it_PRP is_VBZ possible_JJ that_IN the_DT bystander_NN apoptosis_NN seen_VBN in_IN this_DT study_NN is_VBZ mediated_VBN by_IN transmission_NN of_IN apoptotic_JJ signals_NNS through_IN gap_NN junctions_NNS ._. 
However_RB ,_, it_PRP is_VBZ clear_JJ that_IN bystander_NN responses_NNS are_VBP more_RBR complex_JJ ,_, and_CC harder_JJR to_TO define_VB in_IN tumors_NNS grown_VBN in_IN vivo_NN -LRB-_-LRB- Prise_NN 
In_IN fact_NN ,_, the_DT overexpression_NN of_IN Aurora-A_NNP in_IN different_JJ human_JJ cell_NN lines_NNS has_VBZ been_VBN shown_VBN to_TO induce_VB centrosome_JJ amplification_NN and_CC to_TO potentiate_VB the_DT oncogenic_JJ action_NN of_IN Ras_NNP ._. 
In_IN human_JJ thyrocytes_NNS ,_, Ras_NNP participates_VBZ in_IN transformation_NN and_CC chromosome_NN instability_NN -LRB-_-LRB- Bischoff_NNP 
All_DT secondary_JJ antibodies_NNS horseradish_NN peroxidase_NN conjugated_VBN were_VBD purchased_VBN from_IN Jackson_NNP Immuno_NNP Research_NNP Laboratories_NNP -LRB-_-LRB- Baltimore_NNP ,_, MD_NNP ,_, USA_NNP -RRB-_-RRB- ._. 
Cell_NN cultures_NNS and_CC human_JJ thyroid_NN tissuesThe_NNP normal_JJ strain_NN of_IN human_JJ thyrocytes_NNS -LRB-_-LRB- HTU5_NNP -RRB-_-RRB- has_VBZ been_VBN cultured_VBN as_RB previously_RB described_VBN -LRB-_-LRB- Curcio_NNP et_FW al._FW ._. 
1994_CD ,_, Perrella_NNP et_FW al._FW ._. 
1997_CD -RRB-_-RRB- ._. 
These_DT diploid_JJ and_CC non-tumorigenic_JJ cells_NNS retain_VBP in_IN culture_NN the_DT functional_JJ feature_NN of_IN normal_JJ human_JJ thyrocytes_NNS ,_, such_JJ as_IN the_DT ability_NN to_TO express_VB the_DT major_JJ thyroid_JJ specific_JJ genes_NNS -LRB-_-LRB- i._SYM 
In_IN contrast_NN ,_, a_DT high_JJ proportion_NN of_IN human_JJ breast_NN and_CC ovarian_NN cancer_NN tissues_NNS shows_VBZ a_DT downregulation_NN of_IN TACC1_NNP and_CC TACC3_NNP expression_NN -LRB-_-LRB- Conte_NNP et_FW al._FW ._. 
2002_CD ,_, 2003_CD ,_, Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN this_DT work_NN ,_, we_PRP show_VBP that_IN TACC3_NNP expression_NN was_VBD significantly_RB downregulated_VBN in_IN different_JJ thyroid_JJ carcinoma-derived_JJ cell_NN lines_NNS ,_, but_CC not_RB in_IN a_DT cell_NN line_NN derived_VBN from_IN a_DT benign_JJ follicular_JJ thyroid_NN tumor_NN ._. 
Interestingly_RB ,_, we_PRP found_VBD that_IN the_DT expression_NN of_IN TACC3_NNP and_CC Aurora-A_NNP in_IN thyroid_NN cancer_NN varied_VBD together_RB ._. 
This_DT observation_NN corroborates_VBZ similar_JJ findings_NNS reported_VBN in_IN breast_NN cancer_NN tissues_NNS -LRB-_-LRB- Conte_NNP et_FW al._FW ._. 
2003_CD -RRB-_-RRB- and_CC suggests_VBZ common_JJ molecular_JJ mechanism_NN -LRB-_-LRB- s_PRP -RRB-_-RRB- regulating_VBG their_PRP$ expression_NN ._. 
In_IN breast_NN cancers_NNS ,_, increased_VBD expressions_NNS of_IN TACC3_NNP and_CC Aurora-A_NNP mRNAs_NNP have_VBP been_VBN linked_VBN with_IN cancer_NN progression_NN and_CC high-grade_JJ tumors_NNS -LRB-_-LRB- Ma_NNP et_FW al._FW ._. 
The_DT latter_NN belongs_VBZ to_TO the_DT Aurora_NNP kinase_NN family_NN which_WDT includes_VBZ three_CD members_NNS ,_, namely_RB Aurora-A_NNP ,_, Aurora-B_NNP ,_, and_CC Aurora-C_NNP -LRB-_-LRB- Bischoff_NNP 
2005_CD -RRB-_-RRB- ._. 
2000_CD ,_, Gergely_NNP 2002_CD ,_, Pascreau_NNP et_FW al._FW ._. 
TACC3_CD protein_NN is_VBZ localized_VBN around_IN the_DT centrosomes_NNS during_IN mitosis_NN where_WRB it_PRP forms_VBZ complexes_NNS with_IN the_DT microtubule-associated_JJ protein_NN ch-TOG_NN following_VBG TACC3_NNP phosphorylation_NN by_IN Aurora-A_JJ kinase_NN -LRB-_-LRB- Gergely_NNP et_FW al._FW ._. 
The_DT latter_NN belongs_VBZ to_TO the_DT Aurora_NNP kinase_NN family_NN which_WDT includes_VBZ three_CD members_NNS ,_, namely_RB Aurora-A_NNP ,_, Aurora-B_NNP ,_, and_CC Aurora-C_NNP -LRB-_-LRB- Bischoff_NNP 
2005_CD -RRB-_-RRB- ._. 
2000_CD ,_, Gergely_NNP 2002_CD ,_, Pascreau_NNP et_FW al._FW ._. 
TACC3_CD protein_NN is_VBZ localized_VBN around_IN the_DT centrosomes_NNS during_IN mitosis_NN where_WRB it_PRP forms_VBZ complexes_NNS with_IN the_DT microtubule-associated_JJ protein_NN ch-TOG_NN following_VBG TACC3_NNP phosphorylation_NN by_IN Aurora-A_JJ kinase_NN -LRB-_-LRB- Gergely_NNP et_FW al._FW ._. 
The_DT latter_NN belongs_VBZ to_TO the_DT Aurora_NNP kinase_NN family_NN which_WDT includes_VBZ three_CD members_NNS ,_, namely_RB Aurora-A_NNP ,_, Aurora-B_NNP ,_, and_CC Aurora-C_NNP -LRB-_-LRB- Bischoff_NNP 
The_DT latter_NN belongs_VBZ to_TO the_DT Aurora_NNP kinase_NN family_NN which_WDT includes_VBZ three_CD members_NNS ,_, namely_RB Aurora-A_NNP ,_, Aurora-B_NNP ,_, and_CC Aurora-C_NNP -LRB-_-LRB- Bischoff_NNP 
Aurora-A_NNP is_VBZ mainly_RB associated_VBN with_IN centrosome_NN in_IN mitotic_JJ cells_NNS where_WRB it_PRP interacts_VBZ with_IN and_CC phosphorylates_VBZ several_JJ substrates_NNS including_VBG Eg5_NNP ,_, TPX2_CD ,_, and_CC the_DT above-described_JJ TACC3_CD involved_VBN in_IN spindle_NN formation_NN and_CC stability_NN -LRB-_-LRB- Bischoff_NNP 
Aurora-A_NNP has_VBZ been_VBN shown_VBN to_TO be_VB overexpressed_VBN in_IN solid_JJ tumor_NN and_CC its_PRP$ increase_NN correlates_VBZ with_IN centrosome_JJ amplification_NN -LRB-_-LRB- Bischoff_NNP 
In_IN fact_NN ,_, the_DT overexpression_NN of_IN Aurora-A_NNP in_IN different_JJ human_JJ cell_NN lines_NNS has_VBZ been_VBN shown_VBN to_TO induce_VB centrosome_JJ amplification_NN and_CC to_TO potentiate_VB the_DT oncogenic_JJ action_NN of_IN Ras_NNP ._. 
In_IN human_JJ thyrocytes_NNS ,_, Ras_NNP participates_VBZ in_IN transformation_NN and_CC chromosome_NN instability_NN -LRB-_-LRB- Bischoff_NNP 
Thus_RB ,_, we_PRP may_MD speculate_VB that_IN ,_, as_IN hypothesized_VBN for_IN TACC3_NNP ,_, either_CC up_RB -_: or_CC downregulation_NN of_IN Aurora-A_NNP may_MD lead_VB to_TO a_DT proliferative_JJ advantage_NN for_IN thyroid_NN cancer_NN cells_NNS ._. 
This_DT is_VBZ not_RB surprising_JJ since_IN both_DT the_DT up_RB -_: and_CC downregulation_NN of_IN its_PRP$ expression_NN have_VBP been_VBN reported_VBN to_TO cause_VB abnormal_JJ mitosis_NN with_IN defects_NNS in_IN chromosome_NN segregation_NN and_CC cytokinesis_NNS -LRB-_-LRB- Bischoff_NNP 
2005_CD -RRB-_-RRB- ._. 
2002_CD ,_, Lauffart_FW et_FW al._FW ._. 
However_RB ,_, a_DT reduction_NN in_IN its_PRP$ expression_NN has_VBZ been_VBN documented_VBN in_IN ovarian_NN and_CC breast_NN cancer_NN tissues_NNS -LRB-_-LRB- Conte_NNP et_FW al._FW ._. 
Similarly_RB ,_, TACC2_NNP and_CC TACC3_NNP expression_NN has_VBZ been_VBN shown_VBN to_TO be_VB reduced_VBN in_IN several_JJ cancers_NNS -LRB-_-LRB- Chen_FW et_FW al._FW ._. 
2000_CD ,_, Lauffart_FW et_FW al._FW ._. 
2003_CD ,_, Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, a_DT number_NN of_IN malignant_JJ tumors_NNS exhibit_VBP deletions_NNS or_CC rearrangements_NNS of_IN 4p16_CD and_CC 8p11_CD ,_, the_DT loci_NN of_IN TACC3_CD and_CC TACC1_CD genes_NNS respectively_RB -LRB-_-LRB- Sato_FW et_FW al._FW ._. 
Fifty-six_JJ percent_NN of_IN DTC_NNP showed_VBD a_DT significant_JJ reduction_NN in_IN TACC3_CD gene_NN expression_NN while_IN TACC3_NNP expression_NN was_VBD found_VBN to_TO be_VB significantly_RB upregulated_VBN in_IN 44_CD %_NN ._. 
Taken_VBN all_RB together_RB ,_, the_DT findings_NNS reported_VBN here_RB may_MD suggest_VB that_IN ,_, in_IN thyroid_JJ cells_NNS ,_, TACC3_JJ protein_NN may_MD function_VB as_IN both_DT transforming_VBG and_CC tumor-suppressor_JJ factor_NN ,_, as_IN demonstrated_VBN in_IN other_JJ cell_NN types_NNS -LRB-_-LRB- Chen_FW et_FW al._FW ._. 
2000_CD ,_, Raff_NNP 2002_CD -RRB-_-RRB- ._. 
Since_IN TACC3_NNP and_CC Aurora-A_NNP are_VBP partners_NNS in_IN thyroid_JJ cells_NNS ,_, the_DT expression_NN of_IN Aurora-A_NNP was_VBD analyzed_VBN in_IN the_DT same_JJ tissues_NNS ._. 
The_DT cells_NNS were_VBD then_RB rinsed_VBN with_IN PBS_NNP and_CC collected_VBN by_IN scraping_VBG with_IN a_DT rubber_NN policeman_NN in_IN PBS_NNP ._. 
Cell_NN cycle_NN analysis_NN The_DT FTC-133_NN cells_NNS were_VBD cultured_VBN up_IN to_TO 70_CD 
1999_CD b_NN -RRB-_-RRB- ._. 
In_IN fact_NN ,_, TACC1_CD gene_NN was_VBD first_RB discovered_VBN as_IN a_DT gene_NN amplified_VBN in_IN breast_NN cancer_NN and_CC its_PRP$ overexpression_NN causes_VBZ fibroblast_JJ transformation_NN ,_, suggesting_VBG that_IN its_PRP$ amplification_NN contributes_VBZ to_TO cancer_NN progression_NN -LRB-_-LRB- Still_RB et_FW al._FW ._. 
However_RB ,_, a_DT reduction_NN in_IN its_PRP$ expression_NN has_VBZ been_VBN documented_VBN in_IN ovarian_NN and_CC breast_NN cancer_NN tissues_NNS -LRB-_-LRB- Conte_NNP et_FW al._FW ._. 
2002_CD ,_, Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Similarly_RB ,_, TACC2_NNP and_CC TACC3_NNP expression_NN has_VBZ been_VBN shown_VBN to_TO be_VB reduced_VBN in_IN several_JJ cancers_NNS -LRB-_-LRB- Chen_FW et_FW al._FW ._. 
Aberrations_NNS of_IN TACC_NNP genes_NNS have_VBP been_VBN associated_VBN with_IN various_JJ cancers_NNS -LRB-_-LRB- Still_RB et_FW al._FW ._. 
The_DT three_CD human_JJ TACC_NNP proteins_NNS are_VBP also_RB suspected_VBN to_TO play_VB a_DT role_NN in_IN oncogenesis_NN ._. 
1999a_NNP ,_, Conte_NNP et_FW al._FW ._. 
2002_CD ,_, Line_NNP et_NNP al._NNP ._. 
2002_CD ,_, Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, TACC3_CD have_VBP been_VBN found_VBN overexpressed_VBN in_IN various_JJ cancer_NN cell_NN lines_NNS -LRB-_-LRB- Still_RB et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
1999_CD a_DT ,_, Ma_NNP et_FW al._FW ._. 
Upregulation_NNP of_IN TACC3_NNP expression_NN has_VBZ been_VBN observed_VBN during_IN the_DT transition_NN of_IN breast_NN cancer_NN from_IN in_IN situ_JJ preinvasive_JJ ductal_JJ carcinoma_NN to_TO invasive_JJ ductal_JJ carcinoma_NN ,_, and_CC in_IN multiple_JJ myeloma_NN -LRB-_-LRB- Still_RB et_FW al._FW ._. 
In_IN contrast_NN ,_, a_DT high_JJ proportion_NN of_IN human_JJ breast_NN and_CC ovarian_NN cancer_NN tissues_NNS shows_VBZ a_DT downregulation_NN of_IN TACC1_NNP and_CC TACC3_NNP expression_NN -LRB-_-LRB- Conte_NNP et_FW al._FW ._. 
2002_CD ,_, 2003_CD ,_, Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN this_DT work_NN ,_, we_PRP show_VBP that_IN TACC3_NNP expression_NN was_VBD significantly_RB downregulated_VBN in_IN different_JJ thyroid_JJ carcinoma-derived_JJ cell_NN lines_NNS ,_, but_CC not_RB in_IN a_DT cell_NN line_NN derived_VBN from_IN a_DT benign_JJ follicular_JJ thyroid_NN tumor_NN ._. 
Tissue_NN samples_NNS were_VBD immediately_RB frozen_VBN in_IN liquid_JJ nitrogen_NN ,_, stored_VBN at_IN 
TACC_NNP proteins_NNS are_VBP likely_RB important_JJ in_IN M-phase_JJ entry_NN since_IN they_PRP regulate_VBP both_DT spindle_NN assembly_NN and_CC mRNA_NNP translation_NN -LRB-_-LRB- Pascreau_FW et_FW al._FW ._. 
2005_CD ,_, Peset_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT three_CD human_JJ TACC_NNP proteins_NNS are_VBP also_RB suspected_VBN to_TO play_VB a_DT role_NN in_IN oncogenesis_NN ._. 
Aberrations_NNS of_IN TACC_NNP genes_NNS have_VBP been_VBN associated_VBN with_IN various_JJ cancers_NNS -LRB-_-LRB- Still_RB et_FW al._FW ._. 
2000_CD ,_, Gergely_NNP 2002_CD -RRB-_-RRB- ._. 
In_IN human_JJ ,_, three_CD members_NNS TACC1_CD ,_, TACC2_CD ,_, and_CC TACC3_NNP have_VBP been_VBN identified_VBN and_CC they_PRP are_VBP involved_VBN in_IN the_DT progression_NN of_IN mitosis_NN -LRB-_-LRB- Sadek_FW et_FW al._FW ._. 
The_DT relevance_NN of_IN TACC3_CD physiological_JJ function_NN has_VBZ been_VBN assessed_VBN by_IN TACC3_CD knockout_NN mice_NNS ,_, which_WDT die_VBP during_IN embryogenesis_NN due_JJ to_TO a_DT massive_JJ increase_NN in_IN apoptosis_NN and_CC overexpression_NN of_IN the_DT p53_NN target_NN gene_NN -LRB-_-LRB- Piekorz_FW et_FW al._FW ._. 
2002_CD ,_, Sadek_NNP et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
TACC3_CD protein_NN is_VBZ localized_VBN around_IN the_DT centrosomes_NNS during_IN mitosis_NN where_WRB it_PRP forms_VBZ complexes_NNS with_IN the_DT microtubule-associated_JJ protein_NN ch-TOG_NN following_VBG TACC3_NNP phosphorylation_NN by_IN Aurora-A_JJ kinase_NN -LRB-_-LRB- Gergely_NNP et_FW al._FW ._. 
There_EX is_VBZ also_RB evidence_NN that_IN TACC_NNP genes_NNS expression_NN is_VBZ deregulated_VBN in_IN different_JJ cancer_NN tissues_NNS ._. 
Indeed_RB ,_, regulation_NN of_IN Aurora-A_JJ gene_NN expression_NN is_VBZ critical_JJ for_IN centrosome_JJ functions_NNS and_CC its_PRP$ up_RP -_: or_CC downregulation_NN leads_VBZ to_TO abnormal_JJ mitosis_NN as_RB well_RB as_IN to_TO chromosome_NN segregation_NN and_CC cytokinesis_NN defects_NNS -LRB-_-LRB- Bischoff_NNP 
2005_CD -RRB-_-RRB- ._. 
In_IN human_JJ thyrocytes_NNS ,_, Ras_NNP participates_VBZ in_IN transformation_NN and_CC chromosome_NN instability_NN -LRB-_-LRB- Bischoff_NNP 
Upregulation_NNP of_IN TACC3_NNP expression_NN has_VBZ been_VBN observed_VBN during_IN the_DT transition_NN of_IN breast_NN cancer_NN from_IN in_IN situ_JJ preinvasive_JJ ductal_JJ carcinoma_NN to_TO invasive_JJ ductal_JJ carcinoma_NN ,_, and_CC in_IN multiple_JJ myeloma_NN -LRB-_-LRB- Still_RB et_FW al._FW ._. 
1999a_NNP ,_, Ma_NNP et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, a_DT high_JJ proportion_NN of_IN human_JJ breast_NN and_CC ovarian_NN cancer_NN tissues_NNS shows_VBZ a_DT downregulation_NN of_IN TACC1_NNP and_CC TACC3_NNP expression_NN -LRB-_-LRB- Conte_NNP et_FW al._FW 
2003_CD -RRB-_-RRB- and_CC suggests_VBZ common_JJ molecular_JJ mechanism_NN -LRB-_-LRB- s_PRP -RRB-_-RRB- regulating_VBG their_PRP$ expression_NN ._. 
This_DT observation_NN corroborates_VBZ similar_JJ findings_NNS reported_VBN in_IN breast_NN cancer_NN tissues_NNS -LRB-_-LRB- Conte_NNP et_FW al._FW ._. 
In_IN breast_NN cancers_NNS ,_, increased_VBD expressions_NNS of_IN TACC3_NNP and_CC Aurora-A_NNP mRNAs_NNP have_VBP been_VBN linked_VBN with_IN cancer_NN progression_NN and_CC high-grade_JJ tumors_NNS -LRB-_-LRB- Ma_NNP et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, in_IN the_DT series_NN of_IN thyroid_JJ cancers_NNS analyzed_VBD here_RB ,_, no_DT correlation_NN was_VBD found_VBN between_IN the_DT expression_NN of_IN either_DT Aurora-A_NNP or_CC TACC3_NNP ,_, and_CC clinical_JJ or_CC histological_JJ parameters_NNS -LRB-_-LRB- including_VBG patient_NN 's_POS age_NN ,_, tumor_NN stage_NN ,_, size_NN ,_, or_CC histology_NN -RRB-_-RRB- ._. 
2001_CD ,_, Ouyang_NNP et_FW al._FW ._. 
Although_IN derived_VBN from_IN the_DT same_JJ cell_NN type_NN ,_, different_JJ thyroid_NN neoplasms_NNS show_VBP specific_JJ histological_JJ features_NNS ,_, biological_JJ behavior_NN ,_, and_CC degree_NN of_IN differentiation_NN ,_, as_IN a_DT consequence_NN of_IN different_JJ genetic_JJ alterations_NNS -LRB-_-LRB- Shahedian_FW et_FW al._FW ._. 
2002_CD ,_, Nikiforova_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
The_DT large_JJ majority_NN of_IN follicular_JJ thyroid_NN cancers_NNS are_VBP represented_VBN by_IN the_DT differentiated_VBN papillary_NN -LRB-_-LRB- B-CPAP_NNP -RRB-_-RRB- and_CC follicular_JJ thyroid_NN carcinomas_NNS -LRB-_-LRB- FTCs_NNS -RRB-_-RRB- which_WDT ,_, following_VBG dedifferentiation_NN ,_, are_VBP thought_VBN to_TO give_VB rise_NN to_TO the_DT aggressive_JJ anaplastic_JJ thyroid_NN carcinomas_NNS -LRB-_-LRB- Kinder_NNP 2003_CD ,_, Pasieka_NNP 2003_CD -RRB-_-RRB- ._. 
Thyroid_JJ follicular_JJ cell-derived_JJ cancers_NNS are_VBP often_RB characterized_VBN by_IN chromosomal_JJ instability_NN and_CC aneuploidy_NN -LRB-_-LRB- Shahedian_FW et_FW al._FW ._. 
2001_CD ,_, Ouyang_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
They_PRP represent_VBP the_DT most_RBS common_JJ endocrine_NN malignancy_NN accounting_NN for_IN 1_CD %_NN of_IN all_DT new_JJ malignant_JJ diseases_NNS -LRB-_-LRB- Sherman_NNP 2003_CD -RRB-_-RRB- ._. 
Although_IN derived_VBN from_IN the_DT same_JJ cell_NN type_NN ,_, different_JJ thyroid_NN neoplasms_NNS show_VBP specific_JJ histological_JJ features_NNS ,_, biological_JJ behavior_NN ,_, and_CC degree_NN of_IN differentiation_NN ,_, as_IN a_DT consequence_NN of_IN different_JJ genetic_JJ alterations_NNS -LRB-_-LRB- Shahedian_FW et_FW al._FW ._. 
2001_CD ,_, Ouyang_NNP et_FW al._FW ._. 
2002_CD ,_, Nikiforova_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
The_DT large_JJ majority_NN of_IN follicular_JJ thyroid_NN cancers_NNS are_VBP represented_VBN by_IN the_DT differentiated_VBN papillary_NN -LRB-_-LRB- B-CPAP_NNP -RRB-_-RRB- and_CC follicular_JJ thyroid_NN carcinomas_NNS -LRB-_-LRB- FTCs_NNS -RRB-_-RRB- which_WDT ,_, following_VBG dedifferentiation_NN ,_, are_VBP thought_VBN to_TO give_VB rise_NN to_TO the_DT aggressive_JJ anaplastic_JJ thyroid_NN carcinomas_NNS -LRB-_-LRB- Kinder_NNP 2003_CD ,_, Pasieka_NNP 2003_CD -RRB-_-RRB- ._. 
Thyroid_JJ follicular_JJ neoplasms_NNS are_VBP often_RB characterized_VBN by_IN aneuploidy_NN -LRB-_-LRB- Shahedian_FW et_FW al._FW ._. 
Discussion_NN As_IN our_PRP$ knowledge_NN about_IN the_DT molecular_JJ process_NN controlling_VBG cell_NN division_NN is_VBZ growing_VBG ,_, an_DT increasing_VBG number_NN of_IN proteins_NNS are_VBP now_RB suspected_VBN to_TO play_VB a_DT relevant_JJ role_NN in_IN the_DT genetic_JJ instability_NN ,_, an_DT hallmark_NN of_IN solid_JJ cancers_NNS progression_NN ._. 
2001_CD ,_, Ouyang_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
In_IN this_DT context_NN ,_, we_PRP recently_RB demonstrated_VBD that_IN the_DT three_CD members_NNS of_IN the_DT Aurora_NNP kinase_NN family_NN ,_, Aurora-A_NNP ,_, Aurora-B_NNP ,_, and_CC Aurora-C_NNP ,_, involved_VBN in_IN the_DT regulation_NN of_IN multiple_JJ aspects_NNS of_IN chromosome_NN segregation_NN and_CC cytokinesis_NN ,_, are_VBP overexpressed_VBN in_IN malignant_JJ thyroid_JJ tumor-derived_JJ cell_NN lines_NNS and_CC tissues_NNS -LRB-_-LRB- Ulisse_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, it_PRP has_VBZ been_VBN documented_VBN that_DT p53_NN is_VBZ a_DT substrate_NN of_IN Aurora-A_NNP and_CC its_PRP$ phosphorylation_NN on_IN Ser215_NNP leads_VBZ to_TO the_DT inhibition_NN of_IN the_DT p53_NN transactivating_VBG action_NN on_IN several_JJ genes_NNS -LRB-_-LRB- Liu_NNP et_FW al._FW ._. 
Thus_RB ,_, alterations_NNS in_IN the_DT crosstalk_NN between_IN Aurora_NNP kinase_NN A_NN and_CC p53_NN could_MD be_VB relevant_JJ in_IN thyroid_JJ tumor_NN progression_NN by_IN compromising_VBG the_DT fidelity_NN of_IN chromosome_NN segregation_NN -LRB-_-LRB- Parry_NNP et_FW al._FW ._. 
1998_CD ,_, Shahedian_FW et_FW al._FW ._. 
2001_CD -RRB-_-RRB- ._. 
In_IN order_NN to_TO get_VB more_JJR insight_NN about_IN the_DT molecular_JJ mechanism_NN of_IN thyroid_NN cancer_NN progression_NN ,_, we_PRP have_VBP here_RB characterized_VBN ,_, in_IN normal_JJ and_CC tumoral_JJ human_JJ thyrocytes_NNS and_CC tissues_NNS ,_, the_DT expression_NN of_IN TACC3_NNP gene_NN which_WDT encodes_VBZ for_IN a_DT protein_NN substrate_NN of_IN Aurora-A_NNP ._. 
TACC3_CD protein_NN is_VBZ localized_VBN around_IN the_DT centrosomes_NNS during_IN mitosis_NN where_WRB it_PRP forms_VBZ complexes_NNS with_IN the_DT microtubule-associated_JJ protein_NN ch-TOG_NN following_VBG TACC3_NNP phosphorylation_NN by_IN Aurora-A_JJ kinase_NN -LRB-_-LRB- Gergely_NNP et_FW al._FW ._. 
2000_CD ,_, Gergely_NNP 2002_CD ,_, Pascreau_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT latter_NN belongs_VBZ to_TO the_DT Aurora_NNP kinase_NN family_NN which_WDT includes_VBZ three_CD members_NNS ,_, namely_RB Aurora-A_NNP ,_, Aurora-B_NNP ,_, and_CC Aurora-C_NNP -LRB-_-LRB- Bischoff_NNP 
Clues_NNS about_IN their_PRP$ functions_NNS have_VBP come_VBN from_IN Drosophila_NNP and_CC Xenopus_NNP ._. 
Nevertheless_RB ,_, it_PRP is_VBZ well_RB established_VBN that_IN these_DT proteins_NNS are_VBP all_DT involved_VBN in_IN the_DT regulation_NN of_IN the_DT mitotic_JJ phase_NN of_IN the_DT cell_NN cycle_NN -LRB-_-LRB- Gergely_NNP 2002_CD -RRB-_-RRB- ._. 
TACC_NNP proteins_NNS are_VBP likely_RB important_JJ in_IN M-phase_JJ entry_NN since_IN they_PRP regulate_VBP both_DT spindle_NN assembly_NN and_CC mRNA_NNP translation_NN -LRB-_-LRB- Pascreau_FW et_FW al._FW ._. 
2005_CD ,_, Peset_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT three_CD human_JJ TACC_NNP proteins_NNS are_VBP also_RB suspected_VBN to_TO play_VB a_DT role_NN in_IN oncogenesis_NN ._. 
In_IN Xenopus_NNP and_CC Drosophila_NNP ,_, Aurora-A_NNP has_VBZ been_VBN shown_VBN to_TO interact_VB with_IN the_DT human_JJ TACC3_CD orthologues_NNS ,_, maskin_NN ,_, and_CC D-TACC_NNP respectively_RB -LRB-_-LRB- Giet_FW et_FW al._FW ._. 
2002_CD ,_, Pascreau_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN human_JJ thyroid_NN cells_NNS ,_, Aurora-A_NNP and_CC TACC3_NNP co-localized_VBD at_IN the_DT spindle_NN pole_NN ,_, where_WRB they_PRP may_MD have_VB a_DT role_NN in_IN microtubules_NNS growth_NN and_CC stability_NN ,_, as_IN suggested_VBN in_IN Drosophila_NNP -LRB-_-LRB- Raff_NNP 2002_CD -RRB-_-RRB- ._. 
2003_CD -RRB-_-RRB- ._. 
2002_CD ,_, Nikiforova_FW et_FW al._FW ._. 
2001_CD ,_, Ouyang_NNP et_FW al._FW ._. 
Although_IN derived_VBN from_IN the_DT same_JJ cell_NN type_NN ,_, different_JJ thyroid_NN neoplasms_NNS show_VBP specific_JJ histological_JJ features_NNS ,_, biological_JJ behavior_NN ,_, and_CC degree_NN of_IN differentiation_NN ,_, as_IN a_DT consequence_NN of_IN different_JJ genetic_JJ alterations_NNS -LRB-_-LRB- Shahedian_FW et_FW al._FW ._. 
The_DT large_JJ majority_NN of_IN follicular_JJ thyroid_NN cancers_NNS are_VBP represented_VBN by_IN the_DT differentiated_VBN papillary_NN -LRB-_-LRB- B-CPAP_NNP -RRB-_-RRB- and_CC follicular_JJ thyroid_NN carcinomas_NNS -LRB-_-LRB- FTCs_NNS -RRB-_-RRB- which_WDT ,_, following_VBG dedifferentiation_NN ,_, are_VBP thought_VBN to_TO give_VB rise_NN to_TO the_DT aggressive_JJ anaplastic_JJ thyroid_NN carcinomas_NNS -LRB-_-LRB- Kinder_NNP 2003_CD ,_, Pasieka_NNP 2003_CD -RRB-_-RRB- ._. 
We_PRP recently_RB demonstrated_VBD an_DT altered_JJ expression_NN of_IN the_DT Aurora-A_JJ gene_NN in_IN cell_NN lines_NNS derived_VBN from_IN different_JJ histotypes_NNS of_IN human_JJ thyroid_NN tumors_NNS and_CC in_IN papillary_JJ carcinoma_NN tissues_NNS -LRB-_-LRB- Ulisse_FW et_FW al._FW ._. 
Cell_NN cultures_NNS and_CC human_JJ thyroid_NN tissues_NNS The_DT normal_JJ strain_NN of_IN human_JJ thyrocytes_NNS -LRB-_-LRB- HTU5_NNP -RRB-_-RRB- has_VBZ been_VBN cultured_VBN as_RB previously_RB described_VBN -LRB-_-LRB- Curcio_NNP et_FW al._FW ._. 
1994_CD ,_, Perrella_NNP et_FW al._FW ._. 
1997_CD -RRB-_-RRB- ._. 
These_DT diploid_JJ and_CC non-tumorigenic_JJ cells_NNS retain_VBP in_IN culture_NN the_DT functional_JJ feature_NN of_IN normal_JJ human_JJ thyrocytes_NNS ,_, such_JJ as_IN the_DT ability_NN to_TO express_VB the_DT major_JJ thyroid_JJ specific_JJ genes_NNS -LRB-_-LRB- i._SYM 
The_DT large_JJ majority_NN of_IN follicular_JJ thyroid_NN cancers_NNS are_VBP represented_VBN by_IN the_DT differentiated_VBN papillary_NN -LRB-_-LRB- B-CPAP_NNP -RRB-_-RRB- and_CC follicular_JJ thyroid_NN carcinomas_NNS -LRB-_-LRB- FTCs_NNS -RRB-_-RRB- which_WDT ,_, following_VBG dedifferentiation_NN ,_, are_VBP thought_VBN to_TO give_VB rise_NN to_TO the_DT aggressive_JJ anaplastic_JJ thyroid_NN carcinomas_NNS -LRB-_-LRB- Kinder_NNP 2003_CD ,_, Pasieka_NNP 2003_CD -RRB-_-RRB- ._. 
We_PRP recently_RB demonstrated_VBD an_DT altered_JJ expression_NN of_IN the_DT Aurora-A_JJ gene_NN in_IN cell_NN lines_NNS derived_VBN from_IN different_JJ histotypes_NNS of_IN human_JJ thyroid_NN tumors_NNS and_CC in_IN papillary_JJ carcinoma_NN tissues_NNS -LRB-_-LRB- Ulisse_FW et_FW al._FW ._. 
2006_CD a_DT -RRB-_-RRB- ._. 
Since_IN the_DT TACC3_NNP protein_NN represents_VBZ a_DT substrate_NN of_IN Aurora-A_JJ kinase_NN and_CC ,_, to_TO the_DT best_JJS of_IN our_PRP$ knowledge_NN ,_, the_DT expression_NN of_IN the_DT three_CD TACC_NNP genes_NNS has_VBZ never_RB been_VBN characterized_VBN in_IN human_JJ thyroid_NN tissues_NNS ,_, we_PRP here_RB investigated_VBD the_DT TACC3_NNP expression_NN ,_, the_DT cellular_JJ localization_NN in_IN normal_JJ and_CC transformed_VBD human_JJ thyrocytes_NNS ,_, and_CC its_PRP$ interaction_NN with_IN Aurora-A_NNP ._. 
thyroglobulin_NN and_CC thyrotrophin_NN -LRB-_-LRB- TSH_NNP -RRB-_-RRB- receptor_NN -RRB-_-RRB- and_CC to_TO increase_VB cAMP_JJ level_NN following_VBG TSH_NNP stimulation_NN ._. 
All_PDT the_DT other_JJ tumor-derived_JJ cell_NN lines_NNS have_VBP been_VBN cultured_VBN as_RB previously_RB described_VBN -LRB-_-LRB- Ulisse_FW et_FW al._FW ._. 
2006_CD a_DT -RRB-_-RRB- ._. 
The_DT cells_NNS were_VBD maintained_VBN in_IN continuous_JJ monolayer_NN cultures_NNS at_IN 37_CD 
Expression_NN of_IN the_DT target_NN genes_NNS in_IN the_DT tumoral_JJ thyroid_NN tissues_NNS or_CC tumor-derived_JJ cell_NN lines_NNS was_VBD normalized_VBN respectively_RB ,_, against_IN the_DT expression_NN found_VBN in_IN the_DT matched_VBN normal_JJ tissues_NNS or_CC the_DT HTU5_NNP cells_NNS ,_, and_CC reported_VBD as_RB fold_VB of_IN variation_NN ._. 
Western_JJ blot_NN analysisCells_VBZ protein_NN extracts_NNS were_VBD obtained_VBN as_RB previously_RB described_VBN -LRB-_-LRB- Ulisse_FW et_FW al._FW ._. 
2006_CD a_DT -RRB-_-RRB- ._. 
Aliquots_NNS of_IN 50_CD 
The_DT western_JJ blots_NNS were_VBD revealed_VBN by_IN chemiluminescence_NN using_VBG the_DT Super_NNP Signal_NNP kit_NN from_IN Pierce_NNP -LRB-_-LRB- Rockford_NNP ,_, IL_NNP ,_, USA_NNP -RRB-_-RRB- ._. 
ImmunofluorescenceThe_JJ different_JJ cells_NNS lines_NNS were_VBD growth_NN on_IN glass_NN cover_NN slips_VBZ and_CC treated_VBD as_RB described_VBN -LRB-_-LRB- Ulisse_FW et_FW al._FW ._. 
2006_CD a_DT -RRB-_-RRB- ._. 
The_DT cells_NNS were_VBD incubated_VBN for_IN 1_CD 
Some_DT of_IN the_DT latter_NN were_VBD then_RB exposed_VBN to_TO fresh_JJ medium_NN containing_VBG 5_CD %_NN FBS_NNP for_IN 24_CD 
Interaction_NNP of_IN TACC3_NNP with_IN Aurora-A_NNP in_IN thyroid_JJ cells_NNS Since_IN Aurora-A_NNP has_VBZ been_VBN reported_VBN to_TO interact_VB with_IN TACC3_NNP in_IN other_JJ cellular_JJ systems_NNS ,_, we_PRP analyzed_VBD their_PRP$ interaction_NN in_IN thyroid_JJ cells_NNS ._. 
To_TO this_DT end_NN ,_, the_DT FTC-derived_JJ cell_NN line_NN ,_, the_DT FTC-133_NN was_VBD employed_VBN ,_, since_IN these_DT cells_NNS express_VBP a_DT high_JJ level_NN of_IN Aurora-A_NNP -LRB-_-LRB- Ulisse_NNP et_FW al._FW ._. 
2006_CD a_DT -RRB-_-RRB- and_CC ,_, as_IN described_VBN above_IN ,_, a_DT relative_JJ high_JJ amount_NN of_IN TACC3_NNP ._. 
As_IN in_IN HTU5_CD cells_NNS ,_, TACC3_NNP co-localized_VBD with_IN 
2002_CD -RRB-_-RRB- ._. 
2001_CD ,_, Ouyang_NNP et_FW al._FW ._. 
Thyroid_JJ follicular_JJ neoplasms_NNS are_VBP often_RB characterized_VBN by_IN aneuploidy_NN -LRB-_-LRB- Shahedian_FW et_FW al._FW ._. 
In_IN this_DT context_NN ,_, we_PRP recently_RB demonstrated_VBD that_IN the_DT three_CD members_NNS of_IN the_DT Aurora_NNP kinase_NN family_NN ,_, Aurora-A_NNP ,_, Aurora-B_NNP ,_, and_CC Aurora-C_NNP ,_, involved_VBN in_IN the_DT regulation_NN of_IN multiple_JJ aspects_NNS of_IN chromosome_NN segregation_NN and_CC cytokinesis_NN ,_, are_VBP overexpressed_VBN in_IN malignant_JJ thyroid_JJ tumor-derived_JJ cell_NN lines_NNS and_CC tissues_NNS -LRB-_-LRB- Ulisse_FW et_FW al._FW ._. 
2006_CD a_DT -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, the_DT alteration_NN in_IN Aurora-A_JJ gene_NN expression_NN may_MD help_VB to_TO shed_VB some_DT light_NN on_IN the_DT molecular_JJ mechanisms_NNS involved_VBN in_IN the_DT genetic_JJ instability_NN of_IN thyroid_JJ cancers_NNS ._. 
As_IN for_IN TACC3_NNP ,_, both_DT up_RB -_: and_CC downregulation_NN of_IN Aurora-A_NNP was_VBD observed_VBN ._. 
Since_IN TACC3_NNP and_CC Aurora-A_NNP are_VBP partners_NNS in_IN thyroid_JJ cells_NNS ,_, the_DT expression_NN of_IN Aurora-A_NNP was_VBD analyzed_VBN in_IN the_DT same_JJ tissues_NNS ._. 
In_IN a_DT recent_JJ study_NN ,_, performed_VBN on_IN seven_CD normal_RB matched_VBN PTC_NNP tissues_NNS ,_, we_PRP reported_VBD an_DT upregulation_NN of_IN Aurora-A_NNP in_IN five_CD over_IN seven_CD normal_RB matched_VBN PTC_NNP tissues_NNS -LRB-_-LRB- Ulisse_FW et_FW al._FW ._. 
2006_CD a_DT -RRB-_-RRB- ._. 
In_IN the_DT new_JJ series_NN of_IN thyroid_JJ cancer_NN tissues_NNS analyzed_VBD here_RB ,_, we_PRP found_VBD that_IN Aurora-A_JJ expression_NN was_VBD upregulated_VBN in_IN 5_CD out_IN of_IN 13_CD PTC_NNP tissues_NNS ,_, unchanged_JJ in_IN three_CD and_CC downregulated_VBD in_IN five_CD PTC_NNP as_RB well_RB as_IN in_IN three_CD FTC_NNP tissues_NNS ._. 
Controls_NNP for_IN DNA_NNP contamination_NN were_VBD performed_VBN omitting_VBG the_DT reverse_JJ transcriptase_NN ._. 
Five_CD micrograms_NNS of_IN total_JJ RNA_NNP samples_NNS were_VBD reverse_RB transcribed_VBN and_CC the_DT obtained_VBN cDNAs_NNS used_VBN as_IN a_DT template_NN for_IN the_DT quantitative_JJ PCR_NNP amplifications_NNS of_IN TACC3_NNP ,_, Aurora-A_NNP ,_, and_CC 
2003_CD -RRB-_-RRB- ._. 
2002_CD ,_, Sadek_NNP et_FW al._FW ._. 
The_DT relevance_NN of_IN TACC3_CD physiological_JJ function_NN has_VBZ been_VBN assessed_VBN by_IN TACC3_CD knockout_NN mice_NNS ,_, which_WDT die_VBP during_IN embryogenesis_NN due_JJ to_TO a_DT massive_JJ increase_NN in_IN apoptosis_NN and_CC overexpression_NN of_IN the_DT p53_NN target_NN gene_NN -LRB-_-LRB- Piekorz_FW et_FW al._FW ._. 
TACC3_CD protein_NN is_VBZ localized_VBN around_IN the_DT centrosomes_NNS during_IN mitosis_NN where_WRB it_PRP forms_VBZ complexes_NNS with_IN the_DT microtubule-associated_JJ protein_NN ch-TOG_NN following_VBG TACC3_NNP phosphorylation_NN by_IN Aurora-A_JJ kinase_NN -LRB-_-LRB- Gergely_NNP et_FW al._FW ._. 
2000_CD ,_, Gergely_NNP 2002_CD ,_, Pascreau_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT latter_NN belongs_VBZ to_TO the_DT Aurora_NNP kinase_NN family_NN which_WDT includes_VBZ three_CD members_NNS ,_, namely_RB Aurora-A_NNP ,_, Aurora-B_NNP ,_, and_CC Aurora-C_NNP -LRB-_-LRB- Bischoff_NNP 
ac_NN ._. 
wellcome_NN ._. 
Wellcome_NNP TrustIntroductionThe_NNP transforming_VBG acidic_JJ coiled-coil_NN -LRB-_-LRB- TACC_NNP -RRB-_-RRB- proteins_NNS form_VBP an_DT evolutionarily_RB conserved_VBN family_NN characterized_VBN by_IN the_DT presence_NN at_IN their_PRP$ C-terminal_JJ end_NN of_IN a_DT common_JJ coiled-coil_JJ motif_NN of_IN 
In_IN human_JJ ,_, three_CD members_NNS TACC1_CD ,_, TACC2_CD ,_, and_CC TACC3_NNP have_VBP been_VBN identified_VBN and_CC they_PRP are_VBP involved_VBN in_IN the_DT progression_NN of_IN mitosis_NN -LRB-_-LRB- Sadek_FW et_FW al._FW ._. 
2000_CD ,_, Gergely_NNP 2002_CD -RRB-_-RRB- ._. 
The_DT relevance_NN of_IN TACC3_CD physiological_JJ function_NN has_VBZ been_VBN assessed_VBN by_IN TACC3_CD knockout_NN mice_NNS ,_, which_WDT die_VBP during_IN embryogenesis_NN due_JJ to_TO a_DT massive_JJ increase_NN in_IN apoptosis_NN and_CC overexpression_NN of_IN the_DT p53_NN target_NN gene_NN -LRB-_-LRB- Piekorz_FW et_FW al._FW ._. 
TACC3_CD protein_NN is_VBZ localized_VBN around_IN the_DT centrosomes_NNS during_IN mitosis_NN where_WRB it_PRP forms_VBZ complexes_NNS with_IN the_DT microtubule-associated_JJ protein_NN ch-TOG_NN following_VBG TACC3_NNP phosphorylation_NN by_IN Aurora-A_JJ kinase_NN -LRB-_-LRB- Gergely_NNP et_FW al._FW ._. 
2000_CD ,_, Gergely_NNP 2002_CD ,_, Pascreau_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT latter_NN belongs_VBZ to_TO the_DT Aurora_NNP kinase_NN family_NN which_WDT includes_VBZ three_CD members_NNS ,_, namely_RB Aurora-A_NNP ,_, Aurora-B_NNP ,_, and_CC Aurora-C_NNP -LRB-_-LRB- Bischoff_NNP 
TACC_NNP proteins_NNS belong_VBP to_TO a_DT conserved_VBN family_NN of_IN centrosome_JJ and_CC microtubule-associated_JJ proteins_NNS whose_WP$ functions_NNS are_VBP not_RB clearly_RB understood_VBN ._. 
Nevertheless_RB ,_, it_PRP is_VBZ well_RB established_VBN that_IN these_DT proteins_NNS are_VBP all_DT involved_VBN in_IN the_DT regulation_NN of_IN the_DT mitotic_JJ phase_NN of_IN the_DT cell_NN cycle_NN -LRB-_-LRB- Gergely_NNP 2002_CD -RRB-_-RRB- ._. 
Clues_NNS about_IN their_PRP$ functions_NNS have_VBP come_VBN from_IN Drosophila_NNP and_CC Xenopus_NNP ._. 
TACC_NNP proteins_NNS are_VBP likely_RB important_JJ in_IN M-phase_JJ entry_NN since_IN they_PRP regulate_VBP both_DT spindle_NN assembly_NN and_CC mRNA_NNP translation_NN -LRB-_-LRB- Pascreau_FW et_FW al._FW ._. 
Effects_NNPS of_IN VX-680_NNP on_IN FTC-133_NNP cell_NN ploidy_NN ,_, centrosome_JJ maturation_NN ,_, and_CC TACC3_NNP localization_NN In_IN the_DT attempt_NN to_TO elucidate_VB the_DT functional_JJ role_NN of_IN Aurora-A_NNP and_CC TACC3_NNP interaction_NN ,_, the_DT effects_NNS of_IN FTC-133_JJ treatment_NN with_IN the_DT Aurora_NNP kinase_NN inhibitor_NN VX-680_NN were_VBD studied_VBN ._. 
In_IN particular_JJ ,_, FTC-133_JJ cells_NNS were_VBD treated_VBN with_IN VX-680_NN at_IN 500_CD 
Our_PRP$ immunofluorescence_NN results_NNS showing_VBG that_IN TACC3_NNP is_VBZ localized_VBN along_IN the_DT spindle_NN microtubules_NNS in_IN mitotic_JJ cells_NNS are_VBP in_IN favor_NN of_IN a_DT cell_NN cycle-regulated_JJ expression_NN of_IN the_DT TACC3_NNP protein_NN in_IN thyrocytes_NNS ._. 
In_IN Xenopus_NNP and_CC Drosophila_NNP ,_, Aurora-A_NNP has_VBZ been_VBN shown_VBN to_TO interact_VB with_IN the_DT human_JJ TACC3_CD orthologues_NNS ,_, maskin_NN ,_, and_CC D-TACC_NNP respectively_RB -LRB-_-LRB- Giet_FW et_FW al._FW ._. 
2002_CD ,_, Pascreau_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN human_JJ thyroid_NN cells_NNS ,_, Aurora-A_NNP and_CC TACC3_NNP co-localized_VBD at_IN the_DT spindle_NN pole_NN ,_, where_WRB they_PRP may_MD have_VB a_DT role_NN in_IN microtubules_NNS growth_NN and_CC stability_NN ,_, as_IN suggested_VBN in_IN Drosophila_NNP -LRB-_-LRB- Raff_NNP 2002_CD -RRB-_-RRB- ._. 
Nevertheless_RB ,_, these_DT observations_NNS suggest_VBP that_IN Aurora-A_JJ activity_NN is_VBZ ,_, directly_RB or_CC indirectly_RB ,_, required_VBN for_IN TACC3_NNP localization_NN on_IN the_DT spindle_NN microtubule_NN ._. 
This_DT is_VBZ in_IN agreement_NN with_IN recent_JJ observations_NNS in_IN Xenopus_NNP laevis_VBZ egg_NN extracts_NNS showing_VBG that_IN Aurora-A_JJ phosphorylation_NN of_IN TACC3\/maskin_NNP is_VBZ required_VBN for_IN centrosome-dependent_JJ microtubule_NN assembly_NN in_IN mitosis_NN -LRB-_-LRB- Kinoshita_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Opposite_JJ variations_NNS of_IN TACC_NNP expression_NN have_VBP been_VBN reported_VBN in_IN various_JJ cancers_NNS ._. 
Upregulation_NNP of_IN TACC3_NNP expression_NN has_VBZ been_VBN observed_VBN during_IN the_DT transition_NN of_IN breast_NN cancer_NN from_IN in_IN situ_JJ preinvasive_JJ ductal_JJ carcinoma_NN to_TO invasive_JJ ductal_JJ carcinoma_NN ,_, and_CC in_IN multiple_JJ myeloma_NN -LRB-_-LRB- Still_RB et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
2002_CD ,_, Nikiforova_FW et_FW al._FW ._. 
2001_CD ,_, Ouyang_NNP et_FW al._FW ._. 
Although_IN derived_VBN from_IN the_DT same_JJ cell_NN type_NN ,_, different_JJ thyroid_NN neoplasms_NNS show_VBP specific_JJ histological_JJ features_NNS ,_, biological_JJ behavior_NN ,_, and_CC degree_NN of_IN differentiation_NN ,_, as_IN a_DT consequence_NN of_IN different_JJ genetic_JJ alterations_NNS -LRB-_-LRB- Shahedian_FW et_FW al._FW ._. 
The_DT large_JJ majority_NN of_IN follicular_JJ thyroid_NN cancers_NNS are_VBP represented_VBN by_IN the_DT differentiated_VBN papillary_NN -LRB-_-LRB- B-CPAP_NNP -RRB-_-RRB- and_CC follicular_JJ thyroid_NN carcinomas_NNS -LRB-_-LRB- FTCs_NNS -RRB-_-RRB- which_WDT ,_, following_VBG dedifferentiation_NN ,_, are_VBP thought_VBN to_TO give_VB rise_NN to_TO the_DT aggressive_JJ anaplastic_JJ thyroid_NN carcinomas_NNS -LRB-_-LRB- Kinder_NNP 2003_CD ,_, Pasieka_NNP 2003_CD -RRB-_-RRB- ._. 
We_PRP recently_RB demonstrated_VBD an_DT altered_JJ expression_NN of_IN the_DT Aurora-A_JJ gene_NN in_IN cell_NN lines_NNS derived_VBN from_IN different_JJ histotypes_NNS of_IN human_JJ thyroid_NN tumors_NNS and_CC in_IN papillary_JJ carcinoma_NN tissues_NNS -LRB-_-LRB- Ulisse_FW et_FW al._FW ._. 
However_RB ,_, a_DT reduction_NN in_IN its_PRP$ expression_NN has_VBZ been_VBN documented_VBN in_IN ovarian_NN and_CC breast_NN cancer_NN tissues_NNS -LRB-_-LRB- Conte_NNP et_FW al._FW ._. 
2002_CD ,_, Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Similarly_RB ,_, TACC2_NNP and_CC TACC3_NNP expression_NN has_VBZ been_VBN shown_VBN to_TO be_VB reduced_VBN in_IN several_JJ cancers_NNS -LRB-_-LRB- Chen_FW et_FW al._FW ._. 
2000_CD ,_, Lauffart_FW et_FW al._FW ._. 
Similarly_RB ,_, TACC2_NNP and_CC TACC3_NNP expression_NN has_VBZ been_VBN shown_VBN to_TO be_VB reduced_VBN in_IN several_JJ cancers_NNS -LRB-_-LRB- Chen_FW et_FW al._FW ._. 
2003_CD ,_, Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, a_DT number_NN of_IN malignant_JJ tumors_NNS exhibit_VBP deletions_NNS or_CC rearrangements_NNS of_IN 4p16_CD and_CC 8p11_CD ,_, the_DT loci_NN of_IN TACC3_CD and_CC TACC1_CD genes_NNS respectively_RB -LRB-_-LRB- Sato_FW et_FW al._FW ._. 
2002_CD ,_, Line_NNP et_NNP al._NNP ._. 
1999_CD a_DT ,_, Conte_NNP et_FW al._FW ._. 
Aberrations_NNS of_IN TACC_NNP genes_NNS have_VBP been_VBN associated_VBN with_IN various_JJ cancers_NNS -LRB-_-LRB- Still_RB et_FW al._FW ._. 
2002_CD ,_, Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, TACC3_CD have_VBP been_VBN found_VBN overexpressed_VBN in_IN various_JJ cancer_NN cell_NN lines_NNS -LRB-_-LRB- Still_RB et_FW al._FW ._. 
In_IN particular_JJ ,_, TACC3_CD have_VBP been_VBN found_VBN overexpressed_VBN in_IN various_JJ cancer_NN cell_NN lines_NNS -LRB-_-LRB- Still_RB et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
1999a_CD -RRB-_-RRB- but_CC ,_, in_IN contrast_NN ,_, lost_VBN in_IN 67_CD %_NN ovarian_NN tumors_NNS -LRB-_-LRB- Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Up_IN to_TO now_RB ,_, the_DT expression_NN and_CC functions_NNS of_IN TACC3_NNP in_IN human_JJ thyrocytes_NNS have_VBP not_RB been_VBN documented_VBN ._. 
In_IN contrast_NN ,_, a_DT high_JJ proportion_NN of_IN human_JJ breast_NN and_CC ovarian_NN cancer_NN tissues_NNS shows_VBZ a_DT downregulation_NN of_IN TACC1_NNP and_CC TACC3_NNP expression_NN -LRB-_-LRB- Conte_NNP et_FW al._FW ._. 
2002_CD ,_, 2003_CD ,_, Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN this_DT work_NN ,_, we_PRP show_VBP that_IN TACC3_NNP expression_NN was_VBD significantly_RB downregulated_VBN in_IN different_JJ thyroid_JJ carcinoma-derived_JJ cell_NN lines_NNS ,_, but_CC not_RB in_IN a_DT cell_NN line_NN derived_VBN from_IN a_DT benign_JJ follicular_JJ thyroid_NN tumor_NN ._. 
Similarly_RB ,_, TACC2_NNP and_CC TACC3_NNP expression_NN has_VBZ been_VBN shown_VBN to_TO be_VB reduced_VBN in_IN several_JJ cancers_NNS -LRB-_-LRB- Chen_FW et_FW al._FW ._. 
2000_CD ,_, Lauffart_FW et_FW al._FW ._. 
2003_CD ,_, Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, a_DT number_NN of_IN malignant_JJ tumors_NNS exhibit_VBP deletions_NNS or_CC rearrangements_NNS of_IN 4p16_CD and_CC 8p11_CD ,_, the_DT loci_NN of_IN TACC3_CD and_CC TACC1_CD genes_NNS respectively_RB -LRB-_-LRB- Sato_FW et_FW al._FW ._. 
1999_CD a_DT ,_, Conte_NNP et_FW al._FW ._. 
Aberrations_NNS of_IN TACC_NNP genes_NNS have_VBP been_VBN associated_VBN with_IN various_JJ cancers_NNS -LRB-_-LRB- Still_RB et_FW al._FW ._. 
2002_CD ,_, Line_NNP et_NNP al._NNP ._. 
2002_CD ,_, Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, TACC3_CD have_VBP been_VBN found_VBN overexpressed_VBN in_IN various_JJ cancer_NN cell_NN lines_NNS -LRB-_-LRB- Still_RB et_FW al._FW ._. 
Moreover_RB ,_, a_DT number_NN of_IN malignant_JJ tumors_NNS exhibit_VBP deletions_NNS or_CC rearrangements_NNS of_IN 4p16_CD and_CC 8p11_CD ,_, the_DT loci_NN of_IN TACC3_CD and_CC TACC1_CD genes_NNS respectively_RB -LRB-_-LRB- Sato_FW et_FW al._FW ._. 
1991_CD ,_, Still_RB et_FW al._FW ._. 
1999_CD a_DT -RRB-_-RRB- ._. 
Thyroid_JJ follicular_JJ cell-derived_JJ cancers_NNS are_VBP often_RB characterized_VBN by_IN chromosomal_JJ instability_NN and_CC aneuploidy_NN -LRB-_-LRB- Shahedian_FW et_FW al._FW ._. 
The_DT three_CD human_JJ TACC_NNP proteins_NNS are_VBP also_RB suspected_VBN to_TO play_VB a_DT role_NN in_IN oncogenesis_NN ._. 
2005_CD -RRB-_-RRB- ._. 
2005_CD ,_, Peset_FW et_FW al._FW ._. 
Aberrations_NNS of_IN TACC_NNP genes_NNS have_VBP been_VBN associated_VBN with_IN various_JJ cancers_NNS -LRB-_-LRB- Still_RB et_FW al._FW ._. 
1999_CD a_DT ,_, Conte_NNP et_FW al._FW ._. 
2002_CD ,_, Line_NNP et_NNP al._NNP ._. 
2002_CD ,_, Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, TACC3_CD have_VBP been_VBN found_VBN overexpressed_VBN in_IN various_JJ cancer_NN cell_NN lines_NNS -LRB-_-LRB- Still_RB et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
2002_CD ,_, Lauffart_FW et_FW al._FW ._. 
2002_CD ,_, Line_NNP et_NNP al._NNP ._. 
1999_CD a_DT ,_, Conte_NNP et_FW al._FW ._. 
Aberrations_NNS of_IN TACC_NNP genes_NNS have_VBP been_VBN associated_VBN with_IN various_JJ cancers_NNS -LRB-_-LRB- Still_RB et_FW al._FW ._. 
In_IN particular_JJ ,_, TACC3_CD have_VBP been_VBN found_VBN overexpressed_VBN in_IN various_JJ cancer_NN cell_NN lines_NNS -LRB-_-LRB- Still_RB et_FW al._FW ._. 
1999_CD a_DT -RRB-_-RRB- but_CC ,_, in_IN contrast_NN ,_, lost_VBN in_IN 67_CD %_NN ovarian_NN tumors_NNS -LRB-_-LRB- Lauffart_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Up_IN to_TO now_RB ,_, the_DT expression_NN and_CC functions_NNS of_IN TACC3_NNP in_IN human_JJ thyrocytes_NNS have_VBP not_RB been_VBN documented_VBN ._. 
Opposite_JJ variations_NNS of_IN TACC_NNP expression_NN have_VBP been_VBN reported_VBN in_IN various_JJ cancers_NNS ._. 
2005_CD -RRB-_-RRB- ._. 
This_DT is_VBZ in_IN agreement_NN with_IN recent_JJ observations_NNS in_IN Xenopus_NNP laevis_VBZ egg_NN extracts_NNS showing_VBG that_IN Aurora-A_JJ phosphorylation_NN of_IN TACC3\/maskin_NNP is_VBZ required_VBN for_IN centrosome-dependent_JJ microtubule_NN assembly_NN in_IN mitosis_NN -LRB-_-LRB- Kinoshita_NNP et_FW al._FW ._. 
Upregulation_NNP of_IN TACC3_NNP expression_NN has_VBZ been_VBN observed_VBN during_IN the_DT transition_NN of_IN breast_NN cancer_NN from_IN in_IN situ_JJ preinvasive_JJ ductal_JJ carcinoma_NN to_TO invasive_JJ ductal_JJ carcinoma_NN ,_, and_CC in_IN multiple_JJ myeloma_NN -LRB-_-LRB- Still_RB et_FW al._FW ._. 
1999_CD a_DT ,_, Ma_NNP et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, a_DT high_JJ proportion_NN of_IN human_JJ breast_NN and_CC ovarian_NN cancer_NN tissues_NNS shows_VBZ a_DT downregulation_NN of_IN TACC1_NNP and_CC TACC3_NNP expression_NN -LRB-_-LRB- Conte_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
2001_CD ,_, Ouyang_NNP et_FW al._FW ._. 
Thyroid_JJ follicular_JJ cell-derived_JJ cancers_NNS are_VBP often_RB characterized_VBN by_IN chromosomal_JJ instability_NN and_CC aneuploidy_NN -LRB-_-LRB- Shahedian_FW et_FW al._FW ._. 
They_PRP represent_VBP the_DT most_RBS common_JJ endocrine_NN malignancy_NN accounting_NN for_IN 1_CD %_NN of_IN all_DT new_JJ malignant_JJ diseases_NNS -LRB-_-LRB- Sherman_NNP 2003_CD -RRB-_-RRB- ._. 
Although_IN derived_VBN from_IN the_DT same_JJ cell_NN type_NN ,_, different_JJ thyroid_NN neoplasms_NNS show_VBP specific_JJ histological_JJ features_NNS ,_, biological_JJ behavior_NN ,_, and_CC degree_NN of_IN differentiation_NN ,_, as_IN a_DT consequence_NN of_IN different_JJ genetic_JJ alterations_NNS -LRB-_-LRB- Shahedian_FW et_FW al._FW ._. 
1999_CD a_DT -RRB-_-RRB- ._. 
1991_CD ,_, Still_RB et_FW al._FW ._. 
Moreover_RB ,_, a_DT number_NN of_IN malignant_JJ tumors_NNS exhibit_VBP deletions_NNS or_CC rearrangements_NNS of_IN 4p16_CD and_CC 8p11_CD ,_, the_DT loci_NN of_IN TACC3_CD and_CC TACC1_CD genes_NNS respectively_RB -LRB-_-LRB- Sato_FW et_FW al._FW ._. 
Thyroid_JJ follicular_JJ cell-derived_JJ cancers_NNS are_VBP often_RB characterized_VBN by_IN chromosomal_JJ instability_NN and_CC aneuploidy_NN -LRB-_-LRB- Shahedian_FW et_FW al._FW ._. 
2001_CD ,_, Ouyang_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
They_PRP represent_VBP the_DT most_RBS common_JJ endocrine_NN malignancy_NN accounting_NN for_IN 1_CD %_NN of_IN all_DT new_JJ malignant_JJ diseases_NNS -LRB-_-LRB- Sherman_NNP 2003_CD -RRB-_-RRB- ._. 
They_PRP represent_VBP the_DT most_RBS common_JJ endocrine_NN malignancy_NN accounting_NN for_IN 1_CD %_NN of_IN all_DT new_JJ malignant_JJ diseases_NNS -LRB-_-LRB- Sherman_NNP 2003_CD -RRB-_-RRB- ._. 
Although_IN derived_VBN from_IN the_DT same_JJ cell_NN type_NN ,_, different_JJ thyroid_NN neoplasms_NNS show_VBP specific_JJ histological_JJ features_NNS ,_, biological_JJ behavior_NN ,_, and_CC degree_NN of_IN differentiation_NN ,_, as_IN a_DT consequence_NN of_IN different_JJ genetic_JJ alterations_NNS -LRB-_-LRB- Shahedian_FW et_FW al._FW ._. 
2001_CD ,_, Ouyang_NNP et_FW al._FW ._. 
2002_CD ,_, Nikiforova_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
The_DT large_JJ majority_NN of_IN follicular_JJ thyroid_NN cancers_NNS are_VBP represented_VBN by_IN the_DT differentiated_VBN papillary_NN -LRB-_-LRB- B-CPAP_NNP -RRB-_-RRB- and_CC follicular_JJ thyroid_NN carcinomas_NNS -LRB-_-LRB- FTCs_NNS -RRB-_-RRB- which_WDT ,_, following_VBG dedifferentiation_NN ,_, are_VBP thought_VBN to_TO give_VB rise_NN to_TO the_DT aggressive_JJ anaplastic_JJ thyroid_NN carcinomas_NNS -LRB-_-LRB- Kinder_NNP 2003_CD ,_, Pasieka_NNP 2003_CD -RRB-_-RRB- ._. 
Discussion_NN As_IN our_PRP$ knowledge_NN about_IN the_DT molecular_JJ process_NN controlling_VBG cell_NN division_NN is_VBZ growing_VBG ,_, an_DT increasing_VBG number_NN of_IN proteins_NNS are_VBP now_RB suspected_VBN to_TO play_VB a_DT relevant_JJ role_NN in_IN the_DT genetic_JJ instability_NN ,_, an_DT hallmark_NN of_IN solid_JJ cancers_NNS progression_NN ._. 
Thyroid_JJ follicular_JJ neoplasms_NNS are_VBP often_RB characterized_VBN by_IN aneuploidy_NN -LRB-_-LRB- Shahedian_FW et_FW al._FW ._. 
2001_CD ,_, Ouyang_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
In_IN this_DT context_NN ,_, we_PRP recently_RB demonstrated_VBD that_IN the_DT three_CD members_NNS of_IN the_DT Aurora_NNP kinase_NN family_NN ,_, Aurora-A_NNP ,_, Aurora-B_NNP ,_, and_CC Aurora-C_NNP ,_, involved_VBN in_IN the_DT regulation_NN of_IN multiple_JJ aspects_NNS of_IN chromosome_NN segregation_NN and_CC cytokinesis_NN ,_, are_VBP overexpressed_VBN in_IN malignant_JJ thyroid_JJ tumor-derived_JJ cell_NN lines_NNS and_CC tissues_NNS -LRB-_-LRB- Ulisse_FW et_FW al._FW ._. 
Thus_RB ,_, alterations_NNS in_IN the_DT crosstalk_NN between_IN Aurora_NNP kinase_NN A_NN and_CC p53_NN could_MD be_VB relevant_JJ in_IN thyroid_JJ tumor_NN progression_NN by_IN compromising_VBG the_DT fidelity_NN of_IN chromosome_NN segregation_NN -LRB-_-LRB- Parry_NNP et_FW al._FW ._. 
1998_CD ,_, Shahedian_FW et_FW al._FW ._. 
2001_CD -RRB-_-RRB- ._. 
In_IN order_NN to_TO get_VB more_JJR insight_NN about_IN the_DT molecular_JJ mechanism_NN of_IN thyroid_NN cancer_NN progression_NN ,_, we_PRP have_VBP here_RB characterized_VBN ,_, in_IN normal_JJ and_CC tumoral_JJ human_JJ thyrocytes_NNS and_CC tissues_NNS ,_, the_DT expression_NN of_IN TACC3_NNP gene_NN which_WDT encodes_VBZ for_IN a_DT protein_NN substrate_NN of_IN Aurora-A_NNP ._. 
2005_CD -RRB-_-RRB- ._. 
2003_CD ,_, Lauffart_FW et_FW al._FW ._. 
2000_CD ,_, Lauffart_FW et_FW al._FW ._. 
Similarly_RB ,_, TACC2_NNP and_CC TACC3_NNP expression_NN has_VBZ been_VBN shown_VBN to_TO be_VB reduced_VBN in_IN several_JJ cancers_NNS -LRB-_-LRB- Chen_FW et_FW al._FW ._. 
Moreover_RB ,_, a_DT number_NN of_IN malignant_JJ tumors_NNS exhibit_VBP deletions_NNS or_CC rearrangements_NNS of_IN 4p16_CD and_CC 8p11_CD ,_, the_DT loci_NN of_IN TACC3_CD and_CC TACC1_CD genes_NNS respectively_RB -LRB-_-LRB- Sato_FW et_FW al._FW ._. 
1991_CD ,_, Still_RB et_FW al._FW ._. 
1999_CD a_DT -RRB-_-RRB- ._. 
Thyroid_JJ follicular_JJ cell-derived_JJ cancers_NNS are_VBP often_RB characterized_VBN by_IN chromosomal_JJ instability_NN and_CC aneuploidy_NN -LRB-_-LRB- Shahedian_FW et_FW al._FW 
Wellcome_NNP Trust_NNP Introduction_NNP The_DT transforming_VBG acidic_JJ coiled-coil_NN -LRB-_-LRB- TACC_NNP -RRB-_-RRB- proteins_NNS form_VBP an_DT evolutionarily_RB conserved_VBN family_NN characterized_VBN by_IN the_DT presence_NN at_IN their_PRP$ C-terminal_JJ end_NN of_IN a_DT common_JJ coiled-coil_JJ motif_NN of_IN 
The_DT relevance_NN of_IN TACC3_CD physiological_JJ function_NN has_VBZ been_VBN assessed_VBN by_IN TACC3_CD knockout_NN mice_NNS ,_, which_WDT die_VBP during_IN embryogenesis_NN due_JJ to_TO a_DT massive_JJ increase_NN in_IN apoptosis_NN and_CC overexpression_NN of_IN the_DT p53_NN target_NN gene_NN -LRB-_-LRB- Piekorz_FW et_FW al._FW ._. 
2002_CD ,_, Sadek_NNP et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
TACC3_CD protein_NN is_VBZ localized_VBN around_IN the_DT centrosomes_NNS during_IN mitosis_NN where_WRB it_PRP forms_VBZ complexes_NNS with_IN the_DT microtubule-associated_JJ protein_NN ch-TOG_NN following_VBG TACC3_NNP phosphorylation_NN by_IN Aurora-A_JJ kinase_NN -LRB-_-LRB- Gergely_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
2002_CD ,_, Pascreau_NNP et_FW al._FW ._. 
In_IN Xenopus_NNP and_CC Drosophila_NNP ,_, Aurora-A_NNP has_VBZ been_VBN shown_VBN to_TO interact_VB with_IN the_DT human_JJ TACC3_CD orthologues_NNS ,_, maskin_NN ,_, and_CC D-TACC_NNP respectively_RB -LRB-_-LRB- Giet_FW et_FW al._FW ._. 
In_IN human_JJ thyroid_NN cells_NNS ,_, Aurora-A_NNP and_CC TACC3_NNP co-localized_VBD at_IN the_DT spindle_NN pole_NN ,_, where_WRB they_PRP may_MD have_VB a_DT role_NN in_IN microtubules_NNS growth_NN and_CC stability_NN ,_, as_IN suggested_VBN in_IN Drosophila_NNP -LRB-_-LRB- Raff_NNP 2002_CD -RRB-_-RRB- ._. 
Inhibition_NN of_IN Aurora-A_JJ by_IN VX-680_NN in_IN FTC-133_NN cells_NNS which_WDT lead_VBP to_TO abnormal_JJ spindle_NN formation_NN characterized_VBN by_IN shorter_JJR microtubules_NNS ,_, delocalized_VBD TACC3_CD from_IN the_DT spindle_NN microtubules_NNS ._. 
Taken_VBN all_RB together_RB ,_, the_DT findings_NNS reported_VBN here_RB may_MD suggest_VB that_IN ,_, in_IN thyroid_JJ cells_NNS ,_, TACC3_JJ protein_NN may_MD function_VB as_IN both_DT transforming_VBG and_CC tumor-suppressor_JJ factor_NN ,_, as_IN demonstrated_VBN in_IN other_JJ cell_NN types_NNS -LRB-_-LRB- Chen_FW et_FW al._FW ._. 
2000_CD ,_, Raff_NNP 2002_CD -RRB-_-RRB- ._. 
Since_IN TACC3_NNP and_CC Aurora-A_NNP are_VBP partners_NNS in_IN thyroid_JJ cells_NNS ,_, the_DT expression_NN of_IN Aurora-A_NNP was_VBD analyzed_VBN in_IN the_DT same_JJ tissues_NNS ._. 
ac_NN ._. 
wellcome_NN ._. 
Wellcome_NNP TrustIntroductionThe_NNP transforming_VBG acidic_JJ coiled-coil_NN -LRB-_-LRB- TACC_NNP -RRB-_-RRB- proteins_NNS form_VBP an_DT evolutionarily_RB conserved_VBN family_NN characterized_VBN by_IN the_DT presence_NN at_IN their_PRP$ C-terminal_JJ end_NN of_IN a_DT common_JJ coiled-coil_JJ motif_NN of_IN 
Animal_NNP models_NNS support_VBP a_DT high_JJ proliferation_NN rate_NN of_IN B-RAF-mutated_JJ versus_CC non-B-RAF-mutated_JJ thyroid_JJ carcinoma_NN cells_NNS ._. 
BRAF_NN mutations_NNS leading_VBG to_TO activation_NN of_IN the_DT MAPK\/ERK_NNP signalling_NN pathway_NN are_VBP the_DT most_RBS important_JJ mutational_JJ event_NN in_IN thyroid_JJ carcinomas_NNS ,_, especially_RB in_IN PTC_NNP progression_NN -LRB-_-LRB- Durante_FW et_FW al._FW ._. 
2007_CD ,_, Lee_NNP et_NNP al_NNP ._. 
2007_CD ,_, Elisei_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ._. 
To_TO study_VB the_DT impact_NN of_IN oncogenic_JJ signalling_NN on_IN HIF-1_NN 
Immunofluorescence_NN images_NNS were_VBD acquired_VBN with_IN an_DT Olympus_NNP BX71_NNP microscope_NN ._. 
Finally_RB ,_, cells_NNS were_VBD embedded_VBN in_IN ProLong_NNP Gold_NNP Antifade_NNP Reagent_NNP with_IN DAPI_NNP -LRB-_-LRB- Invitrogen_NNP -RRB-_-RRB- and_CC viewed_VBN by_IN fluorescent_JJ microscopy_NN -LRB-_-LRB- DeltaVision_NNP ,_, Washington_NNP ,_, DC_NNP ,_, USA_NNP -RRB-_-RRB- ._. 
Assessment_NNP of_IN HIF-1_NNP proficiencyCells_NNPS were_VBD infected_VBN with_IN an_DT adenovirus_NN containing_VBG a_DT firefly_JJ luciferase_NN reporter_NN construct_VBP linked_VBN to_TO trimers_NNS of_IN the_DT lactate_NN dehydrogenase_NN -LRB-_-LRB- LDH_NNP -RRB-_-RRB- hypoxia-responsive_JJ element_NN -LRB-_-LRB- HRE_NNP -RRB-_-RRB- sequence_NN -LRB-_-LRB- Cowen_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- 5_CD h_NN prior_RB to_TO exposure_NN to_TO the_DT respective_JJ condition_NN ._. 
The_DT multiplicity_NN of_IN infection_NN -LRB-_-LRB- MOI_NNP ;_: number_NN of_IN viral_JJ particles_NNS per_IN cell_NN -RRB-_-RRB- used_VBN was_VBD 20_CD ._. 
Atrimer_NNP of_IN the_DT HRE_NNP from_IN the_DT LDH_NNP gene_NN was_VBD linked_VBN to_TO the_DT firefly_RB luciferase_JJ gene_NN and_CC cloned_VBD into_IN an_DT E1\/E3-deleted_JJ adenoviral_JJ backbone_NN ._. 
We_PRP have_VBP previously_RB shown_VBN that_IN luciferase_NN expression_NN driven_VBN by_IN this_DT construct_VBP is_VBZ robustly_RB upregulated_VBN in_IN response_NN to_TO hypoxia_NN in_IN a_DT range_NN of_IN cell_NN lines_NNS -LRB-_-LRB- Cowen_FW et_FW al._FW ._. 
2004_CD ,_, Chadderton_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT MOI_NNP used_VBD was_VBD 20_CD viral_JJ particles_NNS per_IN cell_NN ,_, which_WDT was_VBD sufficient_JJ for_IN infection_NN of_IN 
In_IN addition_NN ,_, we_PRP evaluated_VBD the_DT expression_NN of_IN the_DT HIF_NNP target_NN genes_NNS ,_, CA-9_NNP and_CC GLUT1_NNP -LRB-_-LRB- Fig_NNP ._. 
No_DT clear_JJ relationship_NN between_IN both_DT markers_NNS was_VBD detectable_JJ ._. 
1C_CD -RRB-_-RRB- ,_, which_WDT can_MD reflect_VB tissue_NN hypoxia_NN in_IN other_JJ epithelial_JJ tumors_NNS -LRB-_-LRB- Airley_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
GLUT1_NNP was_VBD expressed_VBN to_TO equivalent_JJ levels_NNS in_IN all_DT analyzed_VBN tumors_NNS -LRB-_-LRB- Fig_NNP ._. 
1C_NNP and_CC D_NNP -RRB-_-RRB- ._. 
CA-9_NN was_VBD expressed_VBN in_IN all_DT dedifferentiated_VBN ATC_NNP tumors_NNS compared_VBN with_IN 77_CD %_NN of_IN FTCs_NNS and_CC 80_CD %_NN of_IN PTCs_NNP ._. 
g._VB It_PRP is_VBZ important_JJ to_TO note_VB that_DT HIF-1_NN 
The_DT highest_JJS levels_NNS of_IN HIF-1_NN 
Recent_JJ literature_NN supports_VBZ an_DT impact_NN of_IN small_JJ therapeutic_JJ molecules_NNS that_WDT modulate_VBP HIF-1_NN 
Control_NN sections_NNS were_VBD incubated_VBN with_IN rabbit_NN or_CC mouse_NN IgG_NN as_IN the_DT primary_JJ antibody_NN ._. 
Sections_NNS were_VBD counterstained_VBN with_IN hematoxylin_NN ._. 
The_DT extent_NN of_IN immunostaining_VBG was_VBD evaluated_VBN by_IN the_DT method_NN described_VBN by_IN Allred_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1993_CD -RRB-_-RRB- ._. 
The_DT mean_JJ scores_NNS of_IN three_CD independent_JJ reviewers_NNS are_VBP shown_VBN ._. 
Immunofluoresence_NN and_CC cell_NN imaging_NN Cells_NNS were_VBD seeded_VBN at_IN a_DT density_NN of_IN 5_CD 
Five_CD examples_NNS of_IN normal_JJ thyroid_NN ,_, papillary_JJ -LRB-_-LRB- PTC_NNP -RRB-_-RRB- ,_, follicular_JJ -LRB-_-LRB- FTC_NNP -RRB-_-RRB- ,_, and_CC anaplastic_JJ -LRB-_-LRB- ATC_NNP -RRB-_-RRB- carcinomas_NNS are_VBP displayed_VBN ,_, which_WDT show_VBP the_DT variation_NN of_IN HIF-1_NN 
2003_CD ,_, Williams_NNP et_NNP al_NNP ._. 
In_IN addition_NN ,_, HIF-1_NN 
44_CD 
Figure_NN 2_CD HIF-1_NN 
2005_CD ,_, Brown_NNP et_NNP al_NN ._. 
2003_CD ,_, Williams_NNP et_NNP al_NNP ._. 
In_IN addition_NN ,_, HIF-1_NN 
Our_PRP$ data_NNS showed_VBD that_IN the_DT PI3K_NNP inhibitor_NN ,_, LY294002_CD ,_, very_RB distinctly_RB decreased_VBN both_DT HIF-1_NN 
We_PRP have_VBP previously_RB shown_VBN that_IN luciferase_NN expression_NN driven_VBN by_IN this_DT construct_VBP is_VBZ robustly_RB upregulated_VBN in_IN response_NN to_TO hypoxia_NN in_IN a_DT range_NN of_IN cell_NN lines_NNS -LRB-_-LRB- Cowen_FW et_FW al_FW ._. 
2004_CD ,_, Chadderton_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT MOI_NNP used_VBD was_VBD 20_CD viral_JJ particles_NNS per_IN cell_NN ,_, which_WDT was_VBD sufficient_JJ for_IN infection_NN of_IN 
However_RB ,_, expression_NN of_IN HIF-1_JJ target_NN genes_NNS like_IN GLUT1_NNP -LRB-_-LRB- Yasuda_NNP et_FW al_FW ._. 
2004_CD -RRB-_-RRB- ._. 
In_IN a_DT clinical_JJ study_NN ,_, low_JJ levels_NNS of_IN HIF-1_NN 
HIF-1_NN 
This_DT fits_VBZ well_RB into_IN the_DT concept_NN of_IN the_DT PI3K_NNP pathway_NN being_VBG involved_VBN in_IN the_DT aggressive_JJ behavior_NN of_IN these_DT cells_NNS -LRB-_-LRB- Paes_NNS 
2007_CD -RRB-_-RRB- ._. 
2003_CD ,_, Hou_FW et_FW al_FW ._. 
Available_JJ data_NNS suggest_VBP that_IN the_DT most_RBS frequent_JJ mutational_JJ events_NNS in_IN these_DT carcinomas_NNS are_VBP mutations_NNS in_IN B-RAF_NNP ,_, leading_VBG to_TO activation_NN of_IN the_DT RAF\/MEK_NNP -LRB-_-LRB- mitogen-activated_JJ protein\/extracellular_JJ signal-regulated_JJ kinase_NN -LRB-_-LRB- ERK_NNP -RRB-_-RRB- kinase_NN -RRB-_-RRB- \/_CD ERK_NNP pathway_NN and_CC in_IN phosphoinositide_NN 3-kinase_JJ -LRB-_-LRB- PI3K_NNP -RRB-_-RRB- \/_FW AKT_FW signalling_VBG -LRB-_-LRB- Kimura_FW et_FW al_FW ._. 
Arecent_JJ summary_NN suggests_VBZ that_IN whilst_JJ B-RAF_NNP mutations_NNS represent_VBP an_DT early_JJ stage_NN event_NN ,_, particularly_RB in_IN the_DT development_NN of_IN papillary_JJ thyroid_JJ carcinomas_NNS ,_, changes_NNS in_IN the_DT PI3K_NNP pathway_NN occur_VBP later_RB and_CC are_VBP associated_VBN with_IN aggressive_JJ transition_NN -LRB-_-LRB- Paes_NNS 
Arecent_JJ systematic_JJ analysis_NN suggests_VBZ that_IN 15_CD %_NN of_IN PTC_NNP and_CC 
This_DT close_JJ link_NN between_IN one_CD of_IN the_DT most_RBS frequently_RB altered_JJ signalling_VBG cascades_NNS in_IN thyroid_JJ carcinomas_NNS ,_, PI3K_NNP ,_, and_CC HIF-1_NN 
Previous_JJ data_NNS characterizing_VBG the_DT potential_JJ role_NN of_IN HIF-1_NN 
This_DT promotes_VBZ tumor_NN cell_NN survival_NN and_CC disease_NN progression_NN ._. 
Hypoxia_NNP triggers_VBZ a_DT coordinated_VBN transcriptional_NN response_NN ,_, which_WDT impacts_VBZ on_IN the_DT activation_NN of_IN many_JJ genes_NNS involved_VBN in_IN the_DT physiological_JJ adaptation_NN of_IN tumor_NN cells_NNS ._. 
Examples_NNS of_IN such_JJ target_NN genes_NNS include_VBP the_DT glucose_NN transporter_NN 1_CD -LRB-_-LRB- GLUT1_NNP -RRB-_-RRB- ,_, which_WDT increases_VBZ glucose_NN uptake_NN into_IN cells_NNS for_IN anaerobic_JJ respiration_NN -LRB-_-LRB- glycolysis_NNS -RRB-_-RRB- ,_, genes_NNS involved_VBN in_IN the_DT maintenance_NN of_IN the_DT intracellular_JJ milieu_NN ,_, for_IN example_NN ,_, carbonic_JJ anhydrase-9_JJ -LRB-_-LRB- CA-9_NNP -RRB-_-RRB- ,_, MCT-4_NNP and_CC NHE-1_NNP \/_FW -6_FW ,_, and_CC genes_NNS that_WDT increase_VBP or_CC restore_VBP vascular_JJ supply_NN to_TO the_DT cells_NNS such_JJ as_IN vascular_JJ endothelial_JJ growth_NN factor_NN -LRB-_-LRB- VEGF_NNP ;_: Pouyssegur_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
These_DT adaptive_JJ processes_NNS are_VBP controlled_VBN by_IN hypoxia-inducible_JJ factor_NN 1_CD -LRB-_-LRB- HIF-1_NN -RRB-_-RRB- ,_, which_WDT is_VBZ composed_VBN of_IN two_CD subunits_NNS ,_, the_DT oxygen-sensitive_JJ HIF-1_NN 
Under_IN normoxic_JJ conditions_NNS ,_, HIF-1_NN 
The_DT thyroid_JJ carcinoma_NN cells_NNS also_RB showed_VBD a_DT functional_JJ HIF-1_NN response_NN as_IN a_DT consequence_NN of_IN hypoxia_NN ,_, identified_VBD both_DT from_IN protein_NN expression_NN and_CC HIF_NNP reporter_NN activation_NN studies_NNS ._. 
These_DT observations_NNS are_VBP consistent_JJ with_IN data_NNS from_IN other_JJ epithelial_JJ tumors_NNS -LRB-_-LRB- Pouyssegur_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Interestingly_RB ,_, of_IN the_DT two_CD downstream_JJ targets_NNS analyzed_VBD ,_, CA-9_NNP appeared_VBD more_RBR responsive_JJ than_IN GLUT1_CD to_TO stimulation_NN via_IN HIF-1_NNP and_CC was_VBD markedly_RB induced_VBN in_IN all_DT cell_NN lines_NNS ._. 
This_DT is_VBZ because_IN overexpression_NN of_IN GLUT1_NNP has_VBZ been_VBN described_VBN in_IN thyroid_JJ cancers_NNS and_CC is_VBZ linked_VBN to_TO tumor_NN aggressiveness_NN ._. 
However_RB ,_, the_DT underlying_JJ mechanism_NN is_VBZ not_RB clearly_RB understood_VBN -LRB-_-LRB- Schonberger_NNP et_FW al._FW ._. 
2002_CD ,_, Kim_NNP et_NNP al_NNP ._. 
2006_CD -RRB-_-RRB- ._. 
Recent_JJ data_NNS -LRB-_-LRB- Yasuda_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- suggest_VBP almost_RB 50_CD %_NN of_IN differentiated_JJ thyroid_NN tumors_NNS express_VBP GLUT1_NNP with_IN expression_NN not_RB always_RB being_VBG restricted_VBN to_TO the_DT membrane_NN ._. 
Snap_VB frozen_JJ tissue_NN was_VBD paraffin_NN embedded_VBN and_CC stained_VBN by_IN standard_JJ immunohistochemistry_JJ techniques_NNS ._. 
All_DT patients_NNS involved_VBN in_IN this_DT study_NN gave_VBD informed_JJ consent_NN ,_, and_CC the_DT use_NN of_IN the_DT material_NN was_VBD approved_VBN by_IN the_DT respective_JJ Ethical_JJ Committees_NNS ._. 
For_IN functional_JJ studies_NNS ,_, we_PRP used_VBD thyroid_JJ carcinoma_NN cell_NN lines_NNS derived_VBN from_IN papillary_JJ -LRB-_-LRB- BcPAP_NNP -RRB-_-RRB- ,_, follicular_JJ -LRB-_-LRB- WRO_NNP and_CC FTC-133_NNP -RRB-_-RRB- and_CC anaplastic_JJ thyroid_JJ carcinomas_NNS -LRB-_-LRB- 8505c_CD -RRB-_-RRB- -LRB-_-LRB- Schweppe_NNP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
WRO_NNP ,_, BcPAP_NNP and_CC 8505c_CD were_VBD cultured_VBN in_IN RPMI_NNP supplemented_VBD with_IN 2_CD 
In_IN contrast_NN ,_, previous_JJ studies_NNS undertaken_VBN with_IN the_DT B-RAF-mutated_JJ putative_JJ thyroid_NN line_NN NPA_NNP demonstrated_VBD a_DT clear_JJ correlation_NN between_IN the_DT inhibition_NN of_IN reporter_NN activity_NN and_CC expression_NN of_IN HIF-1_NN 
g._VB It_PRP is_VBZ important_JJ to_TO note_VB that_DT HIF-1_NN 
The_DT relative_JJ weak_JJ inhibition_NN seen_VBN may_MD be_VB explained_VBN by_IN the_DT reported_VBN long_JJ half-live_NN of_IN CA-9_NN -LRB-_-LRB- 48_CD 
2009_CD -RRB-_-RRB- ._. 
phosphatase_NN and_CC tensin_NN homolog_NN deleted_VBD on_IN chromosome_NN ten_CD -LRB-_-LRB- PTEN_NNP -RRB-_-RRB- ,_, and_CC studies_NNS have_VBP implicated_VBN both_DT the_DT MEK\/ERK_NNP and_CC PI3K_NNP pathways_NNS in_IN HIF-1_NN regulation_NN -LRB-_-LRB- Bardos_NNPS 
They_PRP reflected_VBD the_DT common_JJ genotype_JJ aberrations_NNS associated_VBN with_IN these_DT subtypes_NNS with_IN the_DT highly_RB prevalent_JJ B-RAF_NNP V600E_NNP mutation_NN present_NN in_IN the_DT BCPAP_NNP and_CC 8505c_JJ cell_NN lines_NNS -LRB-_-LRB- Xu_FW et_FW al_FW ._. 
2003_CD ,_, Elisei_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ,_, and_CC the_DT FTC-133_NN harbouring_VBG a_DT PTEN_NNP mutation_NN -LRB-_-LRB- Weng_FW et_FW al_FW ._. 
2001_CD -RRB-_-RRB- ._. 
To_TO elucidate_VB functional_JJ HIF-1_NN 
2007_CD ,_, Lee_NNP et_NNP al_NNP ._. 
BRAF_NN mutations_NNS leading_VBG to_TO activation_NN of_IN the_DT MAPK\/ERK_NNP signalling_NN pathway_NN are_VBP the_DT most_RBS important_JJ mutational_JJ event_NN in_IN thyroid_JJ carcinomas_NNS ,_, especially_RB in_IN PTC_NNP progression_NN -LRB-_-LRB- Durante_FW et_FW al_FW ._. 
2007_CD ,_, Elisei_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
To_TO study_VB the_DT impact_NN of_IN oncogenic_JJ signalling_NN on_IN HIF-1_NN 
Available_JJ data_NNS suggest_VBP that_IN the_DT most_RBS frequent_JJ mutational_JJ events_NNS in_IN these_DT carcinomas_NNS are_VBP mutations_NNS in_IN B-RAF_NNP ,_, leading_VBG to_TO activation_NN of_IN the_DT RAF\/MEK_NNP -LRB-_-LRB- mitogen-activated_JJ protein\/extracellular_JJ signal-regulated_JJ kinase_NN -LRB-_-LRB- ERK_NNP -RRB-_-RRB- kinase_NN -RRB-_-RRB- \/_CD ERK_NNP pathway_NN and_CC in_IN phosphoinositide_NN 3-kinase_JJ -LRB-_-LRB- PI3K_NNP -RRB-_-RRB- \/_FW AKT_FW signalling_VBG -LRB-_-LRB- Kimura_FW et_FW al_FW ._. 
2003_CD ,_, Hou_FW et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
Arecent_JJ summary_NN suggests_VBZ that_IN whilst_JJ B-RAF_NNP mutations_NNS represent_VBP an_DT early_JJ stage_NN event_NN ,_, particularly_RB in_IN the_DT development_NN of_IN papillary_JJ thyroid_JJ carcinomas_NNS ,_, changes_NNS in_IN the_DT PI3K_NNP pathway_NN occur_VBP later_RB and_CC are_VBP associated_VBN with_IN aggressive_JJ transition_NN -LRB-_-LRB- Paes_NNS 
Our_PRP$ data_NNS suggests_VBZ that_DT HIF-1_NN 
Here_RB we_PRP have_VBP shown_VBN that_DT HIF-1_NN 
However_RB ,_, the_DT underlying_JJ mechanism_NN is_VBZ not_RB clearly_RB understood_VBN -LRB-_-LRB- Schonberger_NNP et_FW al_FW ._. 
This_DT is_VBZ because_IN overexpression_NN of_IN GLUT1_NNP has_VBZ been_VBN described_VBN in_IN thyroid_JJ cancers_NNS and_CC is_VBZ linked_VBN to_TO tumor_NN aggressiveness_NN ._. 
2002_CD ,_, Kim_NNP et_NNP al._NNP ._. 
2006_CD -RRB-_-RRB- ._. 
Recent_JJ data_NNS -LRB-_-LRB- Yasuda_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- suggest_VBP almost_RB 50_CD %_NN of_IN differentiated_JJ thyroid_NN tumors_NNS express_VBP GLUT1_NNP with_IN expression_NN not_RB always_RB being_VBG restricted_VBN to_TO the_DT membrane_NN ._. 
2003_CD -RRB-_-RRB- ._. 
In_IN vitro_NN studies_NNS have_VBP shown_VBN that_DT stimulation_NN of_IN VEGF_NNP production_NN in_IN SW579_CD thyroid_JJ tumor_NN cells_NNS is_VBZ dependent_JJ on_IN HIF-1_NN 
Our_PRP$ data_NNS raises_VBZ the_DT question_NN of_IN whether_IN HIF-1_NN 
Given_VBN the_DT strong_JJ association_NN of_IN HIF-1_NN 
The_DT precise_JJ molecular_JJ mechanisms_NNS promoting_VBG the_DT development_NN and_CC progression_NN of_IN the_DT disease_NN are_VBP only_RB partially_RB known_VBN ._. 
Available_JJ data_NNS suggest_VBP that_IN the_DT most_RBS frequent_JJ mutational_JJ events_NNS in_IN these_DT carcinomas_NNS are_VBP mutations_NNS in_IN B-RAF_NNP ,_, leading_VBG to_TO activation_NN of_IN the_DT RAF\/MEK_NNP -LRB-_-LRB- mitogen-activated_JJ protein\/extracellular_JJ signal-regulated_JJ kinase_NN -LRB-_-LRB- ERK_NNP -RRB-_-RRB- kinase_NN -RRB-_-RRB- \/_CD ERK_NNP pathway_NN and_CC in_IN phosphoinositide_NN 3-kinase_JJ -LRB-_-LRB- PI3K_NNP -RRB-_-RRB- \/_FW AKT_FW signalling_VBG -LRB-_-LRB- Kimura_FW et_FW al._FW ._. 
2003_CD ,_, Hou_FW et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
Arecent_JJ summary_NN suggests_VBZ that_IN whilst_JJ B-RAF_NNP mutations_NNS represent_VBP an_DT early_JJ stage_NN event_NN ,_, particularly_RB in_IN the_DT development_NN of_IN papillary_JJ thyroid_JJ carcinomas_NNS ,_, changes_NNS in_IN the_DT PI3K_NNP pathway_NN occur_VBP later_RB and_CC are_VBP associated_VBN with_IN aggressive_JJ transition_NN -LRB-_-LRB- Paes_NNS 
BRAF_NN mutations_NNS leading_VBG to_TO activation_NN of_IN the_DT MAPK\/ERK_NNP signalling_NN pathway_NN are_VBP the_DT most_RBS important_JJ mutational_JJ event_NN in_IN thyroid_JJ carcinomas_NNS ,_, especially_RB in_IN PTC_NNP progression_NN -LRB-_-LRB- Durante_FW et_FW al_FW ._. 
2007_CD ,_, Lee_NNP et_NNP al._NNP ._. 
2007_CD ,_, Elisei_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ._. 
To_TO study_VB the_DT impact_NN of_IN oncogenic_JJ signalling_NN on_IN HIF-1_NN 
These_DT cells_NNS have_VBP now_RB been_VBN identified_VBN as_IN originating_VBG from_IN melanoma_NN -LRB-_-LRB- Schweppe_NNP et_FW al_FW ._. 
In_IN contrast_NN ,_, previous_JJ studies_NNS undertaken_VBN with_IN the_DT B-RAF-mutated_JJ putative_JJ thyroid_NN line_NN NPA_NNP demonstrated_VBD a_DT clear_JJ correlation_NN between_IN the_DT inhibition_NN of_IN reporter_NN activity_NN and_CC expression_NN of_IN HIF-1_NN 
2004_CD -RRB-_-RRB- ._. 
In_IN a_DT clinical_JJ study_NN ,_, low_JJ levels_NNS of_IN HIF-1_NN 
2006_CD -RRB-_-RRB- ._. 
2002_CD ,_, Kim_NNP et_NNP al_NNP ._. 
However_RB ,_, the_DT underlying_JJ mechanism_NN is_VBZ not_RB clearly_RB understood_VBN -LRB-_-LRB- Schonberger_NNP et_FW al_FW ._. 
Recent_JJ data_NNS -LRB-_-LRB- Yasuda_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- suggest_VBP almost_RB 50_CD %_NN of_IN differentiated_JJ thyroid_NN tumors_NNS express_VBP GLUT1_NNP with_IN expression_NN not_RB always_RB being_VBG restricted_VBN to_TO the_DT membrane_NN ._. 
The_DT cell_NN line_NN panel_NN included_VBD those_DT derived_VBN from_IN papillary_JJ -LRB-_-LRB- BcPAP_NNP -RRB-_-RRB- ,_, follicular_JJ -LRB-_-LRB- WRO_NNP and_CC FTC-133_NNP -RRB-_-RRB- and_CC anaplastic_JJ -LRB-_-LRB- 8505c_JJ -RRB-_-RRB- thyroid_JJ tumors_NNS ._. 
They_PRP reflected_VBD the_DT common_JJ genotype_JJ aberrations_NNS associated_VBN with_IN these_DT subtypes_NNS with_IN the_DT highly_RB prevalent_JJ B-RAF_NNP V600E_NNP mutation_NN present_NN in_IN the_DT BCPAP_NNP and_CC 8505c_JJ cell_NN lines_NNS -LRB-_-LRB- Xu_FW et_FW al._FW ._. 
2003_CD ,_, Elisei_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ,_, and_CC the_DT FTC-133_NN harbouring_VBG a_DT PTEN_NNP mutation_NN -LRB-_-LRB- Weng_FW et_FW al_FW ._. 
2001_CD -RRB-_-RRB- ._. 
To_TO elucidate_VB functional_JJ HIF-1_NN 
In_IN addition_NN ,_, HIF-1_NN 
Vascular_JJ endothelial_JJ growth_NN factor_NN ELISA_NNP Cells_NNPS were_VBD incubated_VBN in_IN normoxia_NN or_CC anoxia_NN for_IN 18_CD 
2003_CD ,_, Elisei_FW et_FW al_FW ._. 
They_PRP reflected_VBD the_DT common_JJ genotype_JJ aberrations_NNS associated_VBN with_IN these_DT subtypes_NNS with_IN the_DT highly_RB prevalent_JJ B-RAF_NNP V600E_NNP mutation_NN present_NN in_IN the_DT BCPAP_NNP and_CC 8505c_JJ cell_NN lines_NNS -LRB-_-LRB- Xu_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ,_, and_CC the_DT FTC-133_NN harbouring_VBG a_DT PTEN_NNP mutation_NN -LRB-_-LRB- Weng_FW et_FW al._FW ._. 
2001_CD -RRB-_-RRB- ._. 
To_TO elucidate_VB functional_JJ HIF-1_NN 
2003_CD ,_, Sobhanifar_NNP et_NNP al_NNP ._. 
The_DT relative_JJ weak_JJ inhibition_NN seen_VBN may_MD be_VB explained_VBN by_IN the_DT reported_VBN long_JJ half-live_NN of_IN CA-9_NN -LRB-_-LRB- 48_CD 
2003_CD ,_, Mitsuyama_NNP et_FW al_FW ._. 
Preclinical_JJ data_NNS suggest_VBP the_DT possibility_NN to_TO improve_VB current_JJ therapies_NNS by_IN specifically_RB inhibiting_VBG the_DT sIL-6R_NNP -LRB-_-LRB- Nowell_NNP et_FW al_FW ._. 
2006a_JJ ,_, Rose-John_JJ et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
Whether_IN classical_JJ and_CC IL-6TS_JJ pathways_NNS may_MD be_VB able_JJ to_TO transduce_VB specific_JJ events_NNS in_IN PC_NN is_VBZ not_RB known_VBN yet_RB ._. 
LNCaP_NNP ,_, PC3_NNP ,_, Du145_NNP -LRB-_-LRB- PC_NNP cells_NNS derived_VBD respectively_RB from_IN lymph_FW node_FW ,_, bone_NN and_CC brain_NN metastases_NNS -RRB-_-RRB- ,_, 22Rv1_JJ -LRB-_-LRB- Sramkoski_FW et_FW al_FW ._. 
1999_CD -RRB-_-RRB- and_CC BPH-1_NNP -LRB-_-LRB- Hayward_NNP et_FW al._FW ._. 
1995_CD -RRB-_-RRB- were_VBD grown_VBN in_IN RPMI_NNP 1640_CD -LRB-_-LRB- PAA_NNP Laboratories_NNP -RRB-_-RRB- supplemented_VBN with_IN 10_CD %_NN FCS_NNP ,_, penicillin\/streptomycin_CD and_CC 2_CD 
-LRB-_-LRB- 2007_CD -RRB-_-RRB- ;_: they_PRP demonstrated_VBD that_IN maspin-negative_JJ PC_NN cells_NNS from_IN TRAMP_NN mice_NNS give_VBP rise_NN to_TO numerous_JJ liver_NN metastases_NNS in_IN nude_JJ male_NN mice_NNS ,_, whereas_IN forced_VBN maspin_NN expression_NN in_IN the_DT same_JJ cells_NNS dramatically_RB reduced_VBD their_PRP$ metastatic_JJ activity_NN ._. 
Yet_RB ,_, athymic_JJ nude_JJ mice_NNS inoculated_VBN with_IN PC3-overexpressing_JJ maspin_NN developed_VBD significantly_RB fewer_JJR and_CC less_RBR destructive_JJ bone_NN metastases_NNS than_IN parental_JJ PC3_NNP -LRB-_-LRB- Hall_NNP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
We_PRP demonstrate_VBP that_DT IL-6_NN decreases_VBZ the_DT expression_NN of_IN maspin_NN in_IN Du145_NNP ,_, LAPC4_NNP and_CC LNCaP_NNP PC_NN cells_NNS but_CC not_RB in_IN the_DT non-cancerous_JJ prostate_NN cells_NNS ._. 
IL-6TS_NN decreases_VBZ maspin_NN expression_NN in_IN PC_NN cell_NN lines_NNS In_IN order_NN to_TO investigate_VB the_DT mechanism_NN by_IN which_WDT IL-6TS_NNP may_MD promote_VB the_DT spread_NN of_IN PC_NN cells_NNS ,_, we_PRP looked_VBD at_IN the_DT expression_NN of_IN maspin_NN ,_, a_DT tumor_NN suppressor_NN recently_RB shown_VBN to_TO be_VB involved_VBN in_IN regulation_NN of_IN cell_NN adhesion_NN and_CC motility_NN in_IN PC_NN -LRB-_-LRB- Sheng_FW et_FW al_FW ._. 
1996_CD ,_, Abraham_NNP et_FW al._FW ._. 
2003_CD ,_, Ngamkitidechakul_NNP et_FW al_FW ._. 
2003_CD -RRB-_-RRB- ._. 
We_PRP found_VBD that_IN the_DT non-cancerous_JJ epithelial_JJ prostate_NN cells_NNS BPH-1_NNP and_CC EP156T_NNP express_VBP higher_JJR basal_JJ levels_NNS of_IN the_DT protein_NN compared_VBN to_TO the_DT PC_NN cell_NN lines_NNS tested_VBN -LRB-_-LRB- Fig_NNP ._. 
1996_CD ,_, Zhang_NNP et_NNP al_NNP ._. 
1994_CD ,_, Sheng_FW et_FW al_FW ._. 
In_IN order_NN to_TO clarify_VB through_IN which_WDT mechanism_NN IL-6_NN could_MD facilitate_VB the_DT spread_NN of_IN PC_NN cells_NNS ,_, we_PRP considered_VBD the_DT tumor_NN suppressor_NN gene_NN maspin_NN ,_, a_DT 42_CD 
The_DT role_NN of_IN IL-6TS_NN on_IN maspin_NN regulation_NN is_VBZ further_RBR supported_VBN by_IN experiments_NNS showing_VBG that_IN the_DT levels_NNS of_IN maspin_NN decrease_NN in_IN LAPC4_CD cells_NNS after_IN exposure_NN to_TO sIL-6R_NNP and_CC IL-6_NNP ._. 
Interestingly_RB ,_, an_DT increased_VBN attachment_NN on_IN fibronectin-coated_JJ plates_NNS by_IN Du145_JJ cells_NNS overexpressing_VBG maspin_NN was_VBD also_RB reported_VBN -LRB-_-LRB- Abraham_NNP et_FW al._FW ._. 
2003_CD ,_, Tahmatzopoulos_NNPS et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
Maspin_NNP expression_NN is_VBZ reduced_VBN in_IN prostate_NN tumors_NNS and_CC cancer_NN cell_NN lines_NNS compared_VBN to_TO normal_JJ prostate_NN epithelial_JJ cells_NNS -LRB-_-LRB- Sheng_FW et_FW al_FW ._. 
2001_CD ,_, Steiner_NNP et_FW al_FW ._. 
In_IN vitro_NN and_CC in_IN vivo_NN studies_NNS suggested_VBD a_DT pathogenic_JJ role_NN of_IN this_DT cytokine_NN in_IN the_DT progression_NN of_IN PC_NNP -LRB-_-LRB- Lin_NNP et_FW al_FW ._. 
2003_CD ,_, 2006_CD ,_, Cavarretta_NNP et_FW al._FW ._. 
2007_CD ,_, Malinowska_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, an_DT anti-IL-6_JJ therapy_NN was_VBD shown_VBN to_TO be_VB effective_JJ in_IN inducing_VBG apoptosis_NN and_CC regression_NN of_IN androgen-dependent_JJ prostate_NN xenografts_NNS in_IN nude_JJ mice_NNS and_CC the_DT following_JJ inhibition_NN of_IN the_DT conversion_NN to_TO an_DT androgen-independent_JJ phenotype_NN -LRB-_-LRB- Wallner_NNP et_FW al_FW ._. 
To_TO avoid_VB artefacts_NNS due_JJ to_TO changes_NNS in_IN cell_NN viability_NN ,_, values_NNS were_VBD normalised_VBN to_TO the_DT values_NNS obtained_VBN from_IN cells_NNS equally_RB treated_VBN but_CC not_RB washed_VBN ._. 
Western_JJ blot_NN analysisCells_NNS were_VBD processed_VBN for_IN western_JJ blot_NN analyses_NNS as_RB previously_RB described_VBN -LRB-_-LRB- Cavarretta_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
Statistical_NNP analysis_NN All_DT experiments_NNS were_VBD repeated_VBN at_IN least_JJS three_CD times_NNS ._. 
RT-PCR_NNP and_CC ELISA_NNP assays_NNS were_VBD repeated_VBN twice_RB ._. 
2009_CD -RRB-_-RRB- ,_, as_RB well_RB as_IN in_IN colon_NN cancer_NN and_CC melanoma_NN -LRB-_-LRB- Jones_NNP et_NNP al_NNP ._. 
However_RB ,_, lately_RB ,_, it_PRP became_VBD evident_JJ that_IN IL-6TS_NNP has_VBZ a_DT major_JJ relevance_NN in_IN the_DT pathogenesis_NN and_CC development_NN of_IN chronic_JJ inflammatory_JJ diseases_NNS -LRB-_-LRB- Scheller_NNP 
2003_CD ,_, Ngamkitidechakul_NNP et_FW al_FW ._. 
2003_CD ,_, Cher_NNP et_FW al_FW ._. 
2000_CD ,_, Abraham_NNP et_FW al_FW ._. 
1996_CD ,_, Zhang_NNP et_NNP al_NNP ._. 
2003_CD ,_, Denk_FW et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, Du145_NNP ,_, LNCaP_NNP and_CC PC3_NNP cells_NNS were_VBD shown_VBN to_TO be_VB inhibited_VBN in_IN terms_NNS of_IN invasion_NN and_CC motility_NN when_WRB treated_VBN with_IN exogenous_JJ recombinant_JJ maspin_NN -LRB-_-LRB- Schaefer_NNP 
2000_CD ,_, Abraham_NNP et_FW al_FW ._. 
1996_CD ,_, Zhang_NNP et_NNP al_NNP ._. 
1994_CD ,_, Sheng_FW et_FW al_FW ._. 
In_IN order_NN to_TO clarify_VB through_IN which_WDT mechanism_NN IL-6_NN could_MD facilitate_VB the_DT spread_NN of_IN PC_NN cells_NNS ,_, we_PRP considered_VBD the_DT tumor_NN suppressor_NN gene_NN maspin_NN ,_, a_DT 42_CD 
1995_CD ,_, Shariat_NNP et_FW al_FW ._. 
In_IN particular_JJ ,_, clinical_JJ observations_NNS have_VBP documented_VBN increased_VBN IL-6_NN levels_NNS in_IN plasma_NN from_IN patients_NNS with_IN therapy-resistant_JJ metastatic_JJ disease_NN compared_VBN to_TO patients_NNS with_IN earlier_JJR stages_NNS of_IN the_DT disease_NN and_CC healthy_JJ individuals_NNS -LRB-_-LRB- Twillie_FW et_FW al_FW ._. 
2001_CD ,_, George_NNP et_NNP al._NNP ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN vitro_NN and_CC in_IN vivo_NN studies_NNS suggested_VBD a_DT pathogenic_JJ role_NN of_IN this_DT cytokine_NN in_IN the_DT progression_NN of_IN PC_NNP -LRB-_-LRB- Lin_NNP et_FW al_FW ._. 
In_IN contrast_NN ,_, advanced_JJ stages_NNS of_IN the_DT tumor_NN ,_, after_IN regression_NN obtained_VBN with_IN androgen_NN ablation_NN therapies_NNS ,_, eventually_RB develop_VB a_DT therapy-refractory_JJ phenotype_NN ._. 
Median_JJ survival_NN of_IN men_NNS with_IN therapy-resistant_JJ metastatic_JJ PC_NN is_VBZ limited_VBN to_TO only_RB 1_CD 
2006_CD -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, an_DT anti-IL-6_JJ therapy_NN was_VBD shown_VBN to_TO be_VB effective_JJ in_IN inducing_VBG apoptosis_NN and_CC regression_NN of_IN androgen-dependent_JJ prostate_NN xenografts_NNS in_IN nude_JJ mice_NNS and_CC the_DT following_JJ inhibition_NN of_IN the_DT conversion_NN to_TO an_DT androgen-independent_JJ phenotype_NN -LRB-_-LRB- Wallner_NNP et_FW al_FW ._. 
Although_IN IL-6_NNP represents_VBZ a_DT promising_JJ potential_JJ therapeutic_JJ target_NN ,_, biological_JJ responses_NNS to_TO IL-6_NNP and\/or_CC anti-IL-6_NNP treatment_NN are_VBP pleiotropic_JJ in_IN various_JJ PC_NN cell_NN lines_NNS and_CC xenografts_NNS confirming_VBG the_DT complexity_NN of_IN the_DT IL-6_NNP action_NN -LRB-_-LRB- Naka_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
IL-6_NN binds_VBZ to_TO its_PRP$ specific_JJ receptor_NN ,_, IL-6_NN receptor_NN 
These_DT data_NNS further_RB underline_VBP the_DT relevance_NN of_IN the_DT relative_JJ content_NN of_IN sIL-6R_NNP and_CC mIL-6R_NNP for_IN a_DT specific_JJ effect_NN of_IN the_DT cytokine_NN ._. 
Consistent_JJ with_IN our_PRP$ finding_NN ,_, a_DT decrease_NN of_IN proliferation_NN by_IN IL-6TS_NNP has_VBZ also_RB been_VBN recently_RB observed_VBN in_IN a_DT pleomorphic_JJ malignant_JJ fibrous_JJ histiocytoma_NN cell_NN line_NN -LRB-_-LRB- Nakanishi_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
Afusion_NN protein_NN consisting_VBG of_IN human_JJ IL-6_NN and_CC human_JJ sIL-6R_NN was_VBD also_RB shown_VBN to_TO reduce_VB proliferation_NN of_IN B16_FW melanoma_FW -LRB-_-LRB- Ozbek_NNP et_FW al_FW ._. 
This_DT kind_NN of_IN signal_NN transduction_NN is_VBZ named_VBN IL-6_NNP trans-signalling_NN -LRB-_-LRB- IL-6TS_NN -RRB-_-RRB- ._. 
The_DT complex_JJ IL-6_NNP \/_FW sIL-6R_FW activates_FW gp130_FW also_RB in_IN the_DT absence_NN of_IN the_DT mIL-6R_NN ._. 
The_DT IL-6_NNP \/_NN sIL-6R_NN complex_NN may_MD therefore_RB potentiate_VB the_DT signal_NN transduced_VBN by_IN the_DT mIL-6R_NN or_CC activate_VB it_PRP in_IN cells_NNS that_WDT do_VBP not_RB express_VB the_DT receptor_NN -LRB-_-LRB- Rose-John_NNP 2003_CD -RRB-_-RRB- ._. 
The_DT gp130_JJ subunit_NN can_MD also_RB exist_VB in_IN a_DT soluble_JJ form_NN named_VBN sgp130_CD ._. 
sgp130_NN has_VBZ been_VBN shown_VBN to_TO exclusively_RB inhibit_VB activation_NN of_IN the_DT complex_JJ IL-6_NNP \/_NN sIL-6R_NN without_IN interfering_VBG with_IN the_DT complex_JJ IL-6_NNP \/_NN mIL-6R_NN -LRB-_-LRB- Jostock_FW et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
2001_CD ,_, George_NNP et_NNP al_NNP ._. 
1995_CD ,_, Shariat_NNP et_FW al_FW ._. 
In_IN particular_JJ ,_, clinical_JJ observations_NNS have_VBP documented_VBN increased_VBN IL-6_NN levels_NNS in_IN plasma_NN from_IN patients_NNS with_IN therapy-resistant_JJ metastatic_JJ disease_NN compared_VBN to_TO patients_NNS with_IN earlier_JJR stages_NNS of_IN the_DT disease_NN and_CC healthy_JJ individuals_NNS -LRB-_-LRB- Twillie_FW et_FW al_FW ._. 
In_IN vitro_NN and_CC in_IN vivo_NN studies_NNS suggested_VBD a_DT pathogenic_JJ role_NN of_IN this_DT cytokine_NN in_IN the_DT progression_NN of_IN PC_NNP -LRB-_-LRB- Lin_NNP et_FW al._FW ._. 
2001_CD ,_, Steiner_NNP et_FW al_FW ._. 
2003_CD ,_, 2006_CD ,_, Cavarretta_NNP et_FW al_FW ._. 
2007_CD ,_, Malinowska_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, an_DT anti-IL-6_JJ therapy_NN was_VBD shown_VBN to_TO be_VB effective_JJ in_IN inducing_VBG apoptosis_NN and_CC regression_NN of_IN androgen-dependent_JJ prostate_NN xenografts_NNS in_IN nude_JJ mice_NNS and_CC the_DT following_JJ inhibition_NN of_IN the_DT conversion_NN to_TO an_DT androgen-independent_JJ phenotype_NN -LRB-_-LRB- Wallner_NNP et_FW al_FW ._. 
In_IN particular_JJ ,_, Du145_NNP ,_, LNCaP_NNP and_CC PC3_NNP cells_NNS were_VBD shown_VBN to_TO be_VB inhibited_VBN in_IN terms_NNS of_IN invasion_NN and_CC motility_NN when_WRB treated_VBN with_IN exogenous_JJ recombinant_JJ maspin_NN -LRB-_-LRB- Schaefer_NNP 
Consistent_JJ with_IN this_DT ,_, we_PRP also_RB measured_VBD dramatically_RB higher_JJR basal_JJ levels_NNS of_IN maspin_NN in_IN the_DT non-cancerous_JJ prostate_NN epithelial_JJ cells_NNS compared_VBN to_TO PC_NN cells_NNS ._. 
Decreased_JJ expression_NN of_IN maspin_NN has_VBZ been_VBN shown_VBN to_TO correlate_VB with_IN breast_NN and_CC PC_NN progression_NN -LRB-_-LRB- Maass_FW et_FW al._FW ._. 
2000_CD ,_, Pierson_NNP et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, in_IN human_JJ primary_JJ PCs_NNS ,_, maspin_NN expression_NN consistently_RB appears_VBZ to_TO be_VB down-regulated_JJ at_IN the_DT critical_JJ transition_NN from_IN non-invasive_JJ ,_, low-grade_JJ disease_NN to_TO highly_RB invasive_JJ ,_, high-grade_JJ PC_NN -LRB-_-LRB- Pierson_NNP et_FW al_FW ._. 
2003_CD ,_, 2006_CD ,_, Cavarretta_NNP et_FW al_FW ._. 
2001_CD ,_, Steiner_NNP et_FW al_FW ._. 
In_IN vitro_NN and_CC in_IN vivo_NN studies_NNS suggested_VBD a_DT pathogenic_JJ role_NN of_IN this_DT cytokine_NN in_IN the_DT progression_NN of_IN PC_NNP -LRB-_-LRB- Lin_NNP et_FW al_FW ._. 
2007_CD ,_, Malinowska_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, an_DT anti-IL-6_JJ therapy_NN was_VBD shown_VBN to_TO be_VB effective_JJ in_IN inducing_VBG apoptosis_NN and_CC regression_NN of_IN androgen-dependent_JJ prostate_NN xenografts_NNS in_IN nude_JJ mice_NNS and_CC the_DT following_JJ inhibition_NN of_IN the_DT conversion_NN to_TO an_DT androgen-independent_JJ phenotype_NN -LRB-_-LRB- Wallner_NNP et_FW al_FW ._. 
Results_NNS were_VBD normalised_VBN to_TO cell_NN number_NN in_IN the_DT respective_JJ well_NN ._. 
After_IN 72_CD 
Du145_NNP ,_, LNCaP_NNP and_CC EP156T_NNP cells_NNS were_VBD treated_VBN with_IN 5_CD 
Preclinical_JJ data_NNS suggest_VBP the_DT possibility_NN to_TO improve_VB current_JJ therapies_NNS by_IN specifically_RB inhibiting_VBG the_DT sIL-6R_NNP -LRB-_-LRB- Nowell_NNP et_FW al_FW ._. 
2003_CD ,_, Mitsuyama_NNP et_FW al._FW ._. 
2006_CD a_DT ,_, Rose-John_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
Whether_IN classical_JJ and_CC IL-6TS_JJ pathways_NNS may_MD be_VB able_JJ to_TO transduce_VB specific_JJ events_NNS in_IN PC_NN is_VBZ not_RB known_VBN yet_RB ._. 
2001_CD ,_, Kallen_NNP 2002_CD ,_, Becker_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, as_RB well_RB as_IN in_IN colon_NN cancer_NN and_CC melanoma_NN -LRB-_-LRB- Jones_NNP et_NNP al_NNP ._. 
2004_CD ,_, Mitsuyama_NNP et_FW al._FW ._. 
2006_CD b_NN ,_, Kang_FW et_FW al_FW ._. 
2007_CD ,_, Wagley_NNP et_FW al_FW ._. 
2007_CD ,_, Nowell_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
Preclinical_JJ data_NNS suggest_VBP the_DT possibility_NN to_TO improve_VB current_JJ therapies_NNS by_IN specifically_RB inhibiting_VBG the_DT sIL-6R_NNP -LRB-_-LRB- Nowell_NNP et_FW al_FW ._. 
Interestingly_RB ,_, inhibition_NN of_IN IL-6TS_NNP antagonised_VBD the_DT effect_NN of_IN the_DT cytokine_NN on_IN maspin_NN levels_NNS suggesting_VBG the_DT main_JJ role_NN for_IN the_DT sIL-6R_NN in_IN mediating_VBG this_DT effect_NN of_IN IL-6_NNP ._. 
The_DT soluble_JJ gp130_NN may_MD regulate_VB maspin_NN expression_NN also_RB in_IN the_DT absence_NN of_IN the_DT IL-6_NNP -LRB-_-LRB- data_NNS not_RB shown_VBN -RRB-_-RRB- confirming_VBG the_DT already_RB proposed_VBN binding_JJ of_IN sgp130_CD to_TO other_JJ ligands\/soluble_JJ receptors_NNS -LRB-_-LRB- Montero-Julian_JJ et_FW al._FW ._. 
1997_CD ,_, Jones_NNP et_NNP al_NNP ._. 
2001_CD -RRB-_-RRB- ._. 
However_RB ,_, in_IN the_DT presence_NN of_IN the_DT cytokine_NN ,_, affinity_NN of_IN sgp130_NN for_IN IL-6TS_NN prevails_VBZ ._. 
Interleukin-6_NNP -LRB-_-LRB- IL-6_NNP -RRB-_-RRB- ,_, a_DT cytokine_NN known_VBN as_IN mediator_NN of_IN immunological_JJ and_CC inflammatory_JJ events_NNS ,_, has_VBZ been_VBN shown_VBN to_TO have_VB a_DT role_NN in_IN the_DT development_NN and_CC progression_NN of_IN several_JJ types_NNS of_IN tumors_NNS -LRB-_-LRB- Trikha_FW et_FW al_FW ._. 
2003_CD ,_, Mumm_NNP 
2001_CD ,_, Steiner_NNP et_FW al_FW ._. 
In_IN vitro_NN and_CC in_IN vivo_NN studies_NNS suggested_VBD a_DT pathogenic_JJ role_NN of_IN this_DT cytokine_NN in_IN the_DT progression_NN of_IN PC_NNP -LRB-_-LRB- Lin_NNP et_FW al_FW ._. 
2003_CD ,_, 2006_CD ,_, Cavarretta_NNP et_FW al._FW ._. 
2007_CD ,_, Malinowska_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, an_DT anti-IL-6_JJ therapy_NN was_VBD shown_VBN to_TO be_VB effective_JJ in_IN inducing_VBG apoptosis_NN and_CC regression_NN of_IN androgen-dependent_JJ prostate_NN xenografts_NNS in_IN nude_JJ mice_NNS and_CC the_DT following_JJ inhibition_NN of_IN the_DT conversion_NN to_TO an_DT androgen-independent_JJ phenotype_NN -LRB-_-LRB- Wallner_NNP et_FW al_FW ._. 
Although_IN high_JJ levels_NNS of_IN IL-6_NN are_VBP considered_VBN indicators_NNS of_IN bad_JJ prognosis_NN and_CC consistently_RB found_VBD associated_VBN with_IN metastases_NNS ,_, very_RB little_JJ data_NNS showing_VBG a_DT direct_JJ link_NN between_IN IL-6_NN and_CC metastatogenesis_NN in_IN different_JJ malignancies_NNS are_VBP known_VBN -LRB-_-LRB- Kanazawa_NNP et_FW al_FW ._. 
2007_CD ,_, Studebaker_NNP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ;_: surprisingly_RB ,_, no_DT reports_NNS are_VBP so_RB far_RB available_JJ in_IN the_DT field_NN of_IN PC_NN ._. 
As_IN previously_RB mentioned_VBN ,_, an_DT association_NN between_IN the_DT levels_NNS of_IN sIL-6R_NN in_IN PC_NN patients_NNS before_IN prostatectomy_NN and_CC higher_JJR probability_NN to_TO develop_VB metastases_NNS has_VBZ been_VBN found_VBN -LRB-_-LRB- Kattan_FW et_FW al_FW ._. 
2006_CD -RRB-_-RRB- were_VBD grown_VBN in_IN modified_VBN MCDB153_NNP -LRB-_-LRB- Biological_NNP Industries_NNPS ,_, Kibbutz_NNP Beit_NNP Haemek_NNP ,_, Israel_NNP -RRB-_-RRB- supplemented_VBN with_IN 5_CD %_NN FCS_NNP -LRB-_-LRB- PAA_NNP Laboratories_NNP ,_, Pasching_NNP ,_, Austria_NNP -RRB-_-RRB- ,_, 50_CD 
In_IN vitro_NN and_CC in_IN vivo_NN studies_NNS suggested_VBD a_DT pathogenic_JJ role_NN of_IN this_DT cytokine_NN in_IN the_DT progression_NN of_IN PC_NNP -LRB-_-LRB- Lin_NNP et_FW al_FW ._. 
2001_CD ,_, Steiner_NNP et_FW al._FW ._. 
2003_CD ,_, 2006_CD ,_, Cavarretta_NNP et_FW al_FW ._. 
2007_CD ,_, Malinowska_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, an_DT anti-IL-6_JJ therapy_NN was_VBD shown_VBN to_TO be_VB effective_JJ in_IN inducing_VBG apoptosis_NN and_CC regression_NN of_IN androgen-dependent_JJ prostate_NN xenografts_NNS in_IN nude_JJ mice_NNS and_CC the_DT following_JJ inhibition_NN of_IN the_DT conversion_NN to_TO an_DT androgen-independent_JJ phenotype_NN -LRB-_-LRB- Wallner_NNP et_FW al_FW ._. 
It_PRP has_VBZ been_VBN reported_VBN that_IN in_IN a_DT large_JJ cohort_NN of_IN patients_NNS with_IN clinically_RB localized_JJ PC_NN ,_, the_DT preoperative_JJ serum_NN levels_NNS of_IN IL-6_NNP and_CC sIL-6R_NNP are_VBP higher_JJR in_IN those_DT who_WP will_MD develop_VB metastases_NNS compared_VBN to_TO individuals_NNS who_WP will_MD not_RB experience_VB recurrence_NN of_IN disease_NN in_IN the_DT following_JJ 5_CD years_NNS -LRB-_-LRB- Kattan_NNP et_FW al_FW ._. 
2003_CD ,_, Shariat_NNP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
Interestingly_RB ,_, sIL-6R_NNP showed_VBD a_DT stronger_JJR association_NN with_IN disease_NN progression_NN than_IN IL-6_NNP ,_, suggesting_VBG a_DT role_NN for_IN sIL-6R_NN in_IN mediating_VBG specific_JJ cytokine_NN effects_NNS and_CC the_DT spread_NN of_IN metastases_NNS ._. 
2003_CD ,_, Shariat_NNP et_FW al_FW ._. 
As_IN previously_RB mentioned_VBN ,_, an_DT association_NN between_IN the_DT levels_NNS of_IN sIL-6R_NN in_IN PC_NN patients_NNS before_IN prostatectomy_NN and_CC higher_JJR probability_NN to_TO develop_VB metastases_NNS has_VBZ been_VBN found_VBN -LRB-_-LRB- Kattan_FW et_FW al_FW ._. 
2004_CD ,_, 2008_CD -RRB-_-RRB- ._. 
We_PRP therefore_RB turned_VBD our_PRP$ attention_NN to_TO the_DT possible_JJ involvement_NN of_IN IL-6_NNP \/_NNP sIL-6R_NNP in_IN mechanisms_NNS responsible_JJ for_IN cancer_NN dissemination_NN to_TO secondary_JJ organs_NNS ._. 
We_PRP concluded_VBD that_IN sIL-6R_NNP has_VBZ a_DT role_NN in_IN decreasing_VBG adhesion_NN and_CC increasing_VBG motility_NN and_CC migration_NN of_IN PC_NN cells_NNS ,_, events_NNS that_WDT represent_VBP crucial_JJ initial_JJ steps_NNS in_IN the_DT formation_NN of_IN metastases_NNS ._. 
IL-6TS_NN decreases_VBZ maspin_NN expression_NN in_IN PC_NN cell_NN linesIn_NN order_NN to_TO investigate_VB the_DT mechanism_NN by_IN which_WDT IL-6TS_NNP may_MD promote_VB the_DT spread_NN of_IN PC_NN cells_NNS ,_, we_PRP looked_VBD at_IN the_DT expression_NN of_IN maspin_NN ,_, a_DT tumor_NN suppressor_NN recently_RB shown_VBN to_TO be_VB involved_VBN in_IN regulation_NN of_IN cell_NN adhesion_NN and_CC motility_NN in_IN PC_NN -LRB-_-LRB- Sheng_FW et_FW al._FW ._. 
1996_CD ,_, Abraham_NNP et_FW al_FW ._. 
2003_CD ,_, Ngamkitidechakul_NNP et_FW al_FW ._. 
2003_CD -RRB-_-RRB- ._. 
We_PRP found_VBD that_IN the_DT non-cancerous_JJ epithelial_JJ prostate_NN cells_NNS BPH-1_NNP and_CC EP156T_NNP express_VBP higher_JJR basal_JJ levels_NNS of_IN the_DT protein_NN compared_VBN to_TO the_DT PC_NN cell_NN lines_NNS tested_VBN -LRB-_-LRB- Fig_NNP ._. 
In_IN order_NN to_TO clarify_VB through_IN which_WDT mechanism_NN IL-6_NN could_MD facilitate_VB the_DT spread_NN of_IN PC_NN cells_NNS ,_, we_PRP considered_VBD the_DT tumor_NN suppressor_NN gene_NN maspin_NN ,_, a_DT 42_CD 
2005_CD -RRB-_-RRB- ._. 
2003_CD ,_, Tahmatzopoulos_NNPS et_FW al_FW ._. 
Interestingly_RB ,_, an_DT increased_VBN attachment_NN on_IN fibronectin-coated_JJ plates_NNS by_IN Du145_JJ cells_NNS overexpressing_VBG maspin_NN was_VBD also_RB reported_VBN -LRB-_-LRB- Abraham_NNP et_FW al_FW ._. 
Maspin_NNP expression_NN is_VBZ reduced_VBN in_IN prostate_NN tumors_NNS and_CC cancer_NN cell_NN lines_NNS compared_VBN to_TO normal_JJ prostate_NN epithelial_JJ cells_NNS -LRB-_-LRB- Sheng_FW et_FW al._FW ._. 
1996_CD -RRB-_-RRB- ._. 
Consistent_JJ with_IN this_DT ,_, we_PRP also_RB measured_VBD dramatically_RB higher_JJR basal_JJ levels_NNS of_IN maspin_NN in_IN the_DT non-cancerous_JJ prostate_NN epithelial_JJ cells_NNS compared_VBN to_TO PC_NN cells_NNS ._. 
In_IN particular_JJ ,_, clinical_JJ observations_NNS have_VBP documented_VBN increased_VBN IL-6_NN levels_NNS in_IN plasma_NN from_IN patients_NNS with_IN therapy-resistant_JJ metastatic_JJ disease_NN compared_VBN to_TO patients_NNS with_IN earlier_JJR stages_NNS of_IN the_DT disease_NN and_CC healthy_JJ individuals_NNS -LRB-_-LRB- Twillie_FW et_FW al_FW ._. 
1995_CD ,_, Shariat_NNP et_FW al._FW ._. 
2001_CD ,_, George_NNP et_NNP al_NNP ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN vitro_NN and_CC in_IN vivo_NN studies_NNS suggested_VBD a_DT pathogenic_JJ role_NN of_IN this_DT cytokine_NN in_IN the_DT progression_NN of_IN PC_NNP -LRB-_-LRB- Lin_NNP et_FW al_FW ._. 
As_IN previously_RB mentioned_VBN ,_, an_DT association_NN between_IN the_DT levels_NNS of_IN sIL-6R_NN in_IN PC_NN patients_NNS before_IN prostatectomy_NN and_CC higher_JJR probability_NN to_TO develop_VB metastases_NNS has_VBZ been_VBN found_VBN -LRB-_-LRB- Kattan_FW et_FW al_FW ._. 
2003_CD ,_, Shariat_NNP et_FW al._FW ._. 
2004_CD ,_, 2008_CD -RRB-_-RRB- ._. 
We_PRP therefore_RB turned_VBD our_PRP$ attention_NN to_TO the_DT possible_JJ involvement_NN of_IN IL-6_NNP \/_NNP sIL-6R_NNP in_IN mechanisms_NNS responsible_JJ for_IN cancer_NN dissemination_NN to_TO secondary_JJ organs_NNS ._. 
2007_CD -RRB-_-RRB- ._. 
2003_CD ,_, Denk_FW et_FW al_FW ._. 
2003_CD ,_, Ngamkitidechakul_NNP et_FW al_FW ._. 
2003_CD ,_, Cher_NNP et_FW al_FW ._. 
2000_CD ,_, Abraham_NNP et_FW al_FW ._. 
In_IN particular_JJ ,_, Du145_NNP ,_, LNCaP_NNP and_CC PC3_NNP cells_NNS were_VBD shown_VBN to_TO be_VB inhibited_VBN in_IN terms_NNS of_IN invasion_NN and_CC motility_NN when_WRB treated_VBN with_IN exogenous_JJ recombinant_JJ maspin_NN -LRB-_-LRB- Schaefer_NNP 
Classical_JJ and_CC IL-6TS_NN are_VBP thought_VBN to_TO act_VB in_IN concert_NN in_IN mediating_VBG the_DT response_NN to_TO IL-6_NNP ._. 
2001_CD -RRB-_-RRB- ._. 
sgp130_NN has_VBZ been_VBN shown_VBN to_TO exclusively_RB inhibit_VB activation_NN of_IN the_DT complex_JJ IL-6_NNP \/_NN sIL-6R_NN without_IN interfering_VBG with_IN the_DT complex_JJ IL-6_NNP \/_NN mIL-6R_NN -LRB-_-LRB- Jostock_FW et_FW al_FW ._. 
However_RB ,_, lately_RB ,_, it_PRP became_VBD evident_JJ that_IN IL-6TS_NNP has_VBZ a_DT major_JJ relevance_NN in_IN the_DT pathogenesis_NN and_CC development_NN of_IN chronic_JJ inflammatory_JJ diseases_NNS -LRB-_-LRB- Scheller_NNP 
However_RB ,_, lately_RB ,_, it_PRP became_VBD evident_JJ that_IN IL-6TS_NNP has_VBZ a_DT major_JJ relevance_NN in_IN the_DT pathogenesis_NN and_CC development_NN of_IN chronic_JJ inflammatory_JJ diseases_NNS -LRB-_-LRB- Scheller_NNP 
The_DT soluble_JJ gp130_NN may_MD regulate_VB maspin_NN expression_NN also_RB in_IN the_DT absence_NN of_IN the_DT IL-6_NNP -LRB-_-LRB- data_NNS not_RB shown_VBN -RRB-_-RRB- confirming_VBG the_DT already_RB proposed_VBN binding_JJ of_IN sgp130_CD to_TO other_JJ ligands\/soluble_JJ receptors_NNS -LRB-_-LRB- Montero-Julian_JJ et_FW al_FW ._. 
1997_CD ,_, Jones_NNP et_NNP al._NNP ._. 
2001_CD -RRB-_-RRB- ._. 
However_RB ,_, in_IN the_DT presence_NN of_IN the_DT cytokine_NN ,_, affinity_NN of_IN sgp130_NN for_IN IL-6TS_NN prevails_VBZ ._. 
The_DT role_NN of_IN IL-6TS_NN on_IN maspin_NN regulation_NN is_VBZ further_RBR supported_VBN by_IN experiments_NNS showing_VBG that_IN the_DT levels_NNS of_IN maspin_NN decrease_NN in_IN LAPC4_CD cells_NNS after_IN exposure_NN to_TO sIL-6R_NNP and_CC IL-6_NNP ._. 
Interestingly_RB ,_, LNCaP-high_JJ passage_NN -LRB-_-LRB- LNCaP-HP_JJ -RRB-_-RRB- cells_NNS released_VBD a_DT much_RB higher_JJR amount_NN of_IN both_DT soluble_JJ receptors_NNS ._. 
We_PRP chose_VBD for_IN our_PRP$ next_JJ experiments_NNS two_CD sIL-6R-positive_JJ cell_NN lines_NNS known_VBN to_TO respond_VB differently_RB to_TO the_DT cytokine_NN :_: LNCaP_JJ cells_NNS that_WDT are_VBP growth-inhibited_JJ -LRB-_-LRB- Hobisch_FW et_FW al._FW ._. 
2001_CD -RRB-_-RRB- and_CC Du145_NNP cells_NNS that_WDT are_VBP growth-stimulated_JJ by_IN the_DT cytokine_NN -LRB-_-LRB- Onuma_FW et_FW al_FW ._. 
2003_CD -RRB-_-RRB- ._. 
sIL-6R_NN mediates_VBZ an_DT anti-proliferative_JJ effect_NN of_IN IL-6_NN in_IN different_JJ PC_NN cells_NNS To_TO unmask_VB a_DT possible_JJ specific_JJ role_NN of_IN the_DT different_JJ IL-6Rs_NNS on_IN cell_NN proliferation_NN ,_, we_PRP applied_VBD four_CD approaches_NNS ,_, illustrated_VBN in_IN Figs_NNP 1_CD 
2009_CD -RRB-_-RRB- ,_, as_RB well_RB as_IN in_IN colon_NN cancer_NN and_CC melanoma_NN -LRB-_-LRB- Jones_NNP et_NNP al_NNP ._. 
However_RB ,_, lately_RB ,_, it_PRP became_VBD evident_JJ that_IN IL-6TS_NNP has_VBZ a_DT major_JJ relevance_NN in_IN the_DT pathogenesis_NN and_CC development_NN of_IN chronic_JJ inflammatory_JJ diseases_NNS -LRB-_-LRB- Scheller_NNP 
The_DT gp130_JJ subunit_NN can_MD also_RB exist_VB in_IN a_DT soluble_JJ form_NN named_VBN sgp130_CD ._. 
The_DT IL-6_NNP \/_NN sIL-6R_NN complex_NN may_MD therefore_RB potentiate_VB the_DT signal_NN transduced_VBN by_IN the_DT mIL-6R_NN or_CC activate_VB it_PRP in_IN cells_NNS that_WDT do_VBP not_RB express_VB the_DT receptor_NN -LRB-_-LRB- Rose-John_NNP 2003_CD -RRB-_-RRB- ._. 
sgp130_NN has_VBZ been_VBN shown_VBN to_TO exclusively_RB inhibit_VB activation_NN of_IN the_DT complex_JJ IL-6_NNP \/_NN sIL-6R_NN without_IN interfering_VBG with_IN the_DT complex_JJ IL-6_NNP \/_NNP mIL-6R_NNP -LRB-_-LRB- Jostock_NNP et_FW al._FW ._. 
2001_CD -RRB-_-RRB- ._. 
Classical_JJ and_CC IL-6TS_NN are_VBP thought_VBN to_TO act_VB in_IN concert_NN in_IN mediating_VBG the_DT response_NN to_TO IL-6_NNP ._. 
However_RB ,_, lately_RB ,_, it_PRP became_VBD evident_JJ that_IN IL-6TS_NNP has_VBZ a_DT major_JJ relevance_NN in_IN the_DT pathogenesis_NN and_CC development_NN of_IN chronic_JJ inflammatory_JJ diseases_NNS -LRB-_-LRB- Scheller_NNP 
2004_CD ,_, Mitsuyama_NNP et_FW al_FW ._. 
2001_CD ,_, Kallen_NNP 2002_CD ,_, Becker_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, as_RB well_RB as_IN in_IN colon_NN cancer_NN and_CC melanoma_NN -LRB-_-LRB- Jones_NNP et_NNP al_NNP ._. 
2006b_NNP ,_, Kang_NNP et_FW al._FW ._. 
2007_CD ,_, Wagley_NNP et_FW al_FW ._. 
2007_CD ,_, Nowell_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
Preclinical_JJ data_NNS suggest_VBP the_DT possibility_NN to_TO improve_VB current_JJ therapies_NNS by_IN specifically_RB inhibiting_VBG the_DT sIL-6R_NNP -LRB-_-LRB- Nowell_NNP et_FW al_FW ._. 
In_IN this_DT regard_NN ,_, we_PRP cross-refer_VBP to_TO Knupfer_NNP 
At_IN this_DT stage_NN ,_, the_DT possibility_NN of_IN interactions_NNS between_IN sIL-6R_NNP and_CC other_JJ not_RB yet_RB identified_VBN factors_NNS can_MD not_RB be_VB excluded_VBN and_CC the_DT situation_NN in_IN vivo_NN seems_VBZ to_TO be_VB more_RBR complex_JJ ._. 
In_IN this_DT regard_NN ,_, we_PRP cross-refer_VBP to_TO Knupfer_NNP 
Whether_IN classical_JJ and_CC IL-6TS_JJ pathways_NNS may_MD be_VB able_JJ to_TO transduce_VB specific_JJ events_NNS in_IN PC_NN is_VBZ not_RB known_VBN yet_RB ._. 
It_PRP has_VBZ been_VBN reported_VBN that_IN in_IN a_DT large_JJ cohort_NN of_IN patients_NNS with_IN clinically_RB localized_JJ PC_NN ,_, the_DT preoperative_JJ serum_NN levels_NNS of_IN IL-6_NNP and_CC sIL-6R_NNP are_VBP higher_JJR in_IN those_DT who_WP will_MD develop_VB metastases_NNS compared_VBN to_TO individuals_NNS who_WP will_MD not_RB experience_VB recurrence_NN of_IN disease_NN in_IN the_DT following_JJ 5_CD years_NNS -LRB-_-LRB- Kattan_NNP et_FW al._FW ._. 
2003_CD ,_, Shariat_NNP et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ._. 
Interestingly_RB ,_, sIL-6R_NNP showed_VBD a_DT stronger_JJR association_NN with_IN disease_NN progression_NN than_IN IL-6_NNP ,_, suggesting_VBG a_DT role_NN for_IN sIL-6R_NN in_IN mediating_VBG specific_JJ cytokine_NN effects_NNS and_CC the_DT spread_NN of_IN metastases_NNS ._. 
2008_CD -RRB-_-RRB- ;_: surprisingly_RB ,_, no_DT reports_NNS are_VBP so_RB far_RB available_JJ in_IN the_DT field_NN of_IN PC_NN ._. 
2007_CD ,_, Studebaker_NNP et_FW al_FW ._. 
As_IN previously_RB mentioned_VBN ,_, an_DT association_NN between_IN the_DT levels_NNS of_IN sIL-6R_NN in_IN PC_NN patients_NNS before_IN prostatectomy_NN and_CC higher_JJR probability_NN to_TO develop_VB metastases_NNS has_VBZ been_VBN found_VBN -LRB-_-LRB- Kattan_NNP et_FW al._FW ._. 
2003_CD ,_, Shariat_NNP et_FW al_FW ._. 
2004_CD ,_, 2008_CD -RRB-_-RRB- ._. 
We_PRP therefore_RB turned_VBD our_PRP$ attention_NN to_TO the_DT possible_JJ involvement_NN of_IN IL-6_NNP \/_NNP sIL-6R_NNP in_IN mechanisms_NNS responsible_JJ for_IN cancer_NN dissemination_NN to_TO secondary_JJ organs_NNS ._. 
Median_JJ survival_NN of_IN men_NNS with_IN therapy-resistant_JJ metastatic_JJ PC_NN is_VBZ limited_VBN to_TO only_RB 1_CD 
In_IN this_DT study_NN ,_, we_PRP asked_VBD whether_IN the_DT effects_NNS of_IN IL-6_NN on_IN PC_NN cell_NN proliferation_NN are_VBP dependent_JJ on_IN the_DT preferential_JJ activation_NN of_IN its_PRP$ membrane_NN or_CC the_DT soluble_JJ receptor_NN and_CC whether_IN IL-6TS_NNP may_MD play_VB a_DT role_NN in_IN processes_NNS that_WDT facilitate_VBP metastasis_NN formation_NN ._. 
Materials_NNPS and_CC methodsCell_NNP lines_NNS and_CC chemicalsEP156T_JJ cells_NNS -LRB-_-LRB- human_JJ normal_JJ prostate_NN epithelium_NN ,_, immortalised_VBN with_IN hTERT_NNP -RRB-_-RRB- -LRB-_-LRB- Kogan_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- were_VBD grown_VBN in_IN modified_VBN MCDB153_NNP -LRB-_-LRB- Biological_NNP Industries_NNPS ,_, Kibbutz_NNP Beit_NNP Haemek_NNP ,_, Israel_NNP -RRB-_-RRB- supplemented_VBN with_IN 5_CD %_NN FCS_NNP -LRB-_-LRB- PAA_NNP Laboratories_NNP ,_, Pasching_NNP ,_, Austria_NNP -RRB-_-RRB- ,_, 50_CD 
In_IN contrast_NN ,_, advanced_JJ stages_NNS of_IN the_DT tumor_NN ,_, after_IN regression_NN obtained_VBN with_IN androgen_NN ablation_NN therapies_NNS ,_, eventually_RB develop_VB a_DT therapy-refractory_JJ phenotype_NN ._. 
Median_JJ survival_NN of_IN men_NNS with_IN therapy-resistant_JJ metastatic_JJ PC_NN is_VBZ limited_VBN to_TO only_RB 1_CD 
2004_CD -RRB-_-RRB- ._. 
Consistent_JJ with_IN our_PRP$ finding_NN ,_, a_DT decrease_NN of_IN proliferation_NN by_IN IL-6TS_NNP has_VBZ also_RB been_VBN recently_RB observed_VBN in_IN a_DT pleomorphic_JJ malignant_JJ fibrous_JJ histiocytoma_NN cell_NN line_NN -LRB-_-LRB- Nakanishi_NNP et_FW al_FW ._. 
Afusion_NN protein_NN consisting_VBG of_IN human_JJ IL-6_NN and_CC human_JJ sIL-6R_NN was_VBD also_RB shown_VBN to_TO reduce_VB proliferation_NN of_IN B16_FW melanoma_FW -LRB-_-LRB- Ozbek_NNP et_FW al._FW ._. 
2001_CD -RRB-_-RRB- and_CC F10_NNP ._. 
9cells_NNS -LRB-_-LRB- Wagley_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
At_IN this_DT stage_NN ,_, the_DT possibility_NN of_IN interactions_NNS between_IN sIL-6R_NNP and_CC other_JJ not_RB yet_RB identified_VBN factors_NNS can_MD not_RB be_VB excluded_VBN and_CC the_DT situation_NN in_IN vivo_NN seems_VBZ to_TO be_VB more_RBR complex_JJ ._. 
We_PRP chose_VBD for_IN our_PRP$ next_JJ experiments_NNS two_CD sIL-6R-positive_JJ cell_NN lines_NNS known_VBN to_TO respond_VB differently_RB to_TO the_DT cytokine_NN :_: LNCaP_JJ cells_NNS that_WDT are_VBP growth-inhibited_JJ -LRB-_-LRB- Hobisch_FW et_FW al_FW ._. 
2001_CD -RRB-_-RRB- and_CC Du145_NNP cells_NNS that_WDT are_VBP growth-stimulated_JJ by_IN the_DT cytokine_NN -LRB-_-LRB- Onuma_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
sIL-6R_NN mediates_VBZ an_DT anti-proliferative_JJ effect_NN of_IN IL-6_NN in_IN different_JJ PC_NN cells_NNS To_TO unmask_VB a_DT possible_JJ specific_JJ role_NN of_IN the_DT different_JJ IL-6Rs_NNS on_IN cell_NN proliferation_NN ,_, we_PRP applied_VBD four_CD approaches_NNS ,_, illustrated_VBN in_IN Figs_NNP 1_CD 
Classical_JJ and_CC IL-6TS_NN are_VBP thought_VBN to_TO act_VB in_IN concert_NN in_IN mediating_VBG the_DT response_NN to_TO IL-6_NNP ._. 
2001_CD -RRB-_-RRB- ._. 
sgp130_NN has_VBZ been_VBN shown_VBN to_TO exclusively_RB inhibit_VB activation_NN of_IN the_DT complex_JJ IL-6_NNP \/_NN sIL-6R_NN without_IN interfering_VBG with_IN the_DT complex_JJ IL-6_NNP \/_NN mIL-6R_NN -LRB-_-LRB- Jostock_FW et_FW al_FW ._. 
However_RB ,_, lately_RB ,_, it_PRP became_VBD evident_JJ that_IN IL-6TS_NNP has_VBZ a_DT major_JJ relevance_NN in_IN the_DT pathogenesis_NN and_CC development_NN of_IN chronic_JJ inflammatory_JJ diseases_NNS -LRB-_-LRB- Scheller_NNP 
2007_CD ,_, Wagley_NNP et_FW al_FW ._. 
2006_CD b_NN ,_, Kang_FW et_FW al_FW ._. 
2004_CD ,_, Mitsuyama_NNP et_FW al_FW ._. 
2001_CD ,_, Kallen_NNP 2002_CD ,_, Becker_NNP et_FW al_FW ._. 
2007_CD ,_, Nowell_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
Preclinical_JJ data_NNS suggest_VBP the_DT possibility_NN to_TO improve_VB current_JJ therapies_NNS by_IN specifically_RB inhibiting_VBG the_DT sIL-6R_NNP -LRB-_-LRB- Nowell_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
2007_CD ,_, Nowell_NNP et_FW al_FW ._. 
2007_CD ,_, Wagley_NNP et_FW al_FW ._. 
2006_CD b_NN ,_, Kang_FW et_FW al_FW ._. 
2004_CD ,_, Mitsuyama_NNP et_FW al_FW ._. 
Preclinical_JJ data_NNS suggest_VBP the_DT possibility_NN to_TO improve_VB current_JJ therapies_NNS by_IN specifically_RB inhibiting_VBG the_DT sIL-6R_NNP -LRB-_-LRB- Nowell_NNP et_FW al._FW ._. 
2003_CD ,_, Mitsuyama_NNP et_FW al_FW ._. 
2006_CD a_DT ,_, Rose-John_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
Whether_IN classical_JJ and_CC IL-6TS_JJ pathways_NNS may_MD be_VB able_JJ to_TO transduce_VB specific_JJ events_NNS in_IN PC_NN is_VBZ not_RB known_VBN yet_RB ._. 
1996_CD ,_, Abraham_NNP et_FW al_FW ._. 
IL-6TS_NN decreases_VBZ maspin_NN expression_NN in_IN PC_NN cell_NN lines_NNS In_IN order_NN to_TO investigate_VB the_DT mechanism_NN by_IN which_WDT IL-6TS_NNP may_MD promote_VB the_DT spread_NN of_IN PC_NN cells_NNS ,_, we_PRP looked_VBD at_IN the_DT expression_NN of_IN maspin_NN ,_, a_DT tumor_NN suppressor_NN recently_RB shown_VBN to_TO be_VB involved_VBN in_IN regulation_NN of_IN cell_NN adhesion_NN and_CC motility_NN in_IN PC_NN -LRB-_-LRB- Sheng_FW et_FW al_FW ._. 
2003_CD ,_, Ngamkitidechakul_NNP et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
We_PRP found_VBD that_IN the_DT non-cancerous_JJ epithelial_JJ prostate_NN cells_NNS BPH-1_NNP and_CC EP156T_NNP express_VBP higher_JJR basal_JJ levels_NNS of_IN the_DT protein_NN compared_VBN to_TO the_DT PC_NN cell_NN lines_NNS tested_VBN -LRB-_-LRB- Fig_NNP ._. 
2003_CD ,_, Cher_NNP et_FW al_FW ._. 
2000_CD ,_, Abraham_NNP et_FW al_FW ._. 
1996_CD ,_, Zhang_NNP et_NNP al_NNP ._. 
1994_CD ,_, Sheng_FW et_FW al_FW ._. 
In_IN order_NN to_TO clarify_VB through_IN which_WDT mechanism_NN IL-6_NN could_MD facilitate_VB the_DT spread_NN of_IN PC_NN cells_NNS ,_, we_PRP considered_VBD the_DT tumor_NN suppressor_NN gene_NN maspin_NN ,_, a_DT 42_CD 
siRNA_NN transfections_NNS Cells_NNS were_VBD seeded_VBN onto_IN 96-well_JJ or_CC 6-well_JJ plates_NNS and_CC transfected_VBN on_IN the_DT next_JJ day_NN with_IN 5_CD or_CC 25_CD 
This_DT is_VBZ the_DT first_JJ evidence_NN that_WDT IL-6TS_VBZ activation_NN may_MD promote_VB PC_NN dissemination_NN ._. 
We_PRP measured_VBD an_DT IL-6_FW \/_FW sIL-6R-dependent_JJ decrease_NN of_IN attachment_NN of_IN Du145_NNP and_CC LAPC4_NNP cells_NNS to_TO one_CD of_IN the_DT major_JJ components_NNS of_IN the_DT prostate_NN ECM_NNP ._. 
In_IN order_NN to_TO clarify_VB through_IN which_WDT mechanism_NN IL-6_NN could_MD facilitate_VB the_DT spread_NN of_IN PC_NN cells_NNS ,_, we_PRP considered_VBD the_DT tumor_NN suppressor_NN gene_NN maspin_NN ,_, a_DT 42_CD 
Decreased_JJ expression_NN of_IN maspin_NN has_VBZ been_VBN shown_VBN to_TO correlate_VB with_IN breast_NN and_CC PC_NN progression_NN -LRB-_-LRB- Maass_FW et_FW al_FW ._. 
2000_CD ,_, Pierson_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
In_IN particular_JJ ,_, in_IN human_JJ primary_JJ PCs_NNS ,_, maspin_NN expression_NN consistently_RB appears_VBZ to_TO be_VB down-regulated_JJ at_IN the_DT critical_JJ transition_NN from_IN non-invasive_JJ ,_, low-grade_JJ disease_NN to_TO highly_RB invasive_JJ ,_, high-grade_JJ PC_NN -LRB-_-LRB- Pierson_NNP et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
2000_CD ,_, Pierson_NNP et_FW al_FW ._. 
Decreased_JJ expression_NN of_IN maspin_NN has_VBZ been_VBN shown_VBN to_TO correlate_VB with_IN breast_NN and_CC PC_NN progression_NN -LRB-_-LRB- Maass_FW et_FW al_FW ._. 
In_IN particular_JJ ,_, in_IN human_JJ primary_JJ PCs_NNS ,_, maspin_NN expression_NN consistently_RB appears_VBZ to_TO be_VB down-regulated_JJ at_IN the_DT critical_JJ transition_NN from_IN non-invasive_JJ ,_, low-grade_JJ disease_NN to_TO highly_RB invasive_JJ ,_, high-grade_JJ PC_NN -LRB-_-LRB- Pierson_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
With_IN respect_NN to_TO possible_JJ signalling_VBG pathways_NNS activated_VBN by_IN IL-6TS_NN ,_, we_PRP have_VBP considered_VBN phosphorylation_NN of_IN STAT3_NNP ,_, ERK1\/2_NNP and_CC STAT1_NNP in_IN cells_NNS in_IN which_WDT IL-6TS_NNP had_VBD been_VBN previously_RB enhanced_VBN or_CC inhibited_VBN ._. 
Interestingly_RB ,_, we_PRP found_VBD that_IN activation_NN of_IN IL-6TS_NNP resulted_VBD in_IN increased_VBN motility_NN and_CC migration_NN of_IN PC_NN cells_NNS ._. 
In_IN accordance_NN with_IN this_DT ,_, a_DT role_NN for_IN IL-6_NNP in_IN promoting_VBG migration_NN and_CC invasion_NN has_VBZ been_VBN very_RB recently_RB reported_VBN also_RB in_IN breast_NN tumor_NN cells_NNS -LRB-_-LRB- Walter_NNP et_NNP al._NNP ._. 
2009_CD -RRB-_-RRB- ._. 
Changes_NNS in_IN adhesive_NN properties_NNS to_TO extracellular_JJ matrix_NN -LRB-_-LRB- ECM_NNP -RRB-_-RRB- components_NNS also_RB play_VBP a_DT critical_JJ role_NN in_IN the_DT process_NN of_IN tumor_NN dissemination_NN being_VBG an_DT essential_JJ prerequisite_NN for_IN increased_VBN acquisition_NN of_IN movement_NN of_IN the_DT cells_NNS ._. 
2009_CD -RRB-_-RRB- ._. 
2007_CD ,_, Malinowska_NNP et_FW al_FW ._. 
2003_CD ,_, 2006_CD ,_, Cavarretta_NNP et_FW al_FW ._. 
2001_CD ,_, Steiner_NNP et_FW al_FW ._. 
In_IN vitro_NN and_CC in_IN vivo_NN studies_NNS suggested_VBD a_DT pathogenic_JJ role_NN of_IN this_DT cytokine_NN in_IN the_DT progression_NN of_IN PC_NNP -LRB-_-LRB- Lin_NNP et_FW al_FW ._. 
In_IN particular_JJ ,_, an_DT anti-IL-6_JJ therapy_NN was_VBD shown_VBN to_TO be_VB effective_JJ in_IN inducing_VBG apoptosis_NN and_CC regression_NN of_IN androgen-dependent_JJ prostate_NN xenografts_NNS in_IN nude_JJ mice_NNS and_CC the_DT following_JJ inhibition_NN of_IN the_DT conversion_NN to_TO an_DT androgen-independent_JJ phenotype_NN -LRB-_-LRB- Wallner_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Although_IN IL-6_NNP represents_VBZ a_DT promising_JJ potential_JJ therapeutic_JJ target_NN ,_, biological_JJ responses_NNS to_TO IL-6_NNP and\/or_CC anti-IL-6_NNP treatment_NN are_VBP pleiotropic_JJ in_IN various_JJ PC_NN cell_NN lines_NNS and_CC xenografts_NNS confirming_VBG the_DT complexity_NN of_IN the_DT IL-6_NNP action_NN -LRB-_-LRB- Naka_FW et_FW al_FW ._. 
1994_CD ,_, Sheng_FW et_FW al_FW ._. 
In_IN order_NN to_TO clarify_VB through_IN which_WDT mechanism_NN IL-6_NN could_MD facilitate_VB the_DT spread_NN of_IN PC_NN cells_NNS ,_, we_PRP considered_VBD the_DT tumor_NN suppressor_NN gene_NN maspin_NN ,_, a_DT 42_CD 
Abetter_JJ understanding_NN of_IN the_DT mechanisms_NNS responsible_JJ for_IN recurrence_NN of_IN the_DT tumor_NN is_VBZ the_DT basis_NN for_IN any_DT possible_JJ therapeutical_JJ improvement_NN ._. 
Interleukin-6_NNP -LRB-_-LRB- IL-6_NNP -RRB-_-RRB- ,_, a_DT cytokine_NN known_VBN as_IN mediator_NN of_IN immunological_JJ and_CC inflammatory_JJ events_NNS ,_, has_VBZ been_VBN shown_VBN to_TO have_VB a_DT role_NN in_IN the_DT development_NN and_CC progression_NN of_IN several_JJ types_NNS of_IN tumors_NNS -LRB-_-LRB- Trikha_FW et_FW al._FW ._. 
2003_CD ,_, Mumm_NNP 
Interestingly_RB ,_, an_DT increased_VBN attachment_NN on_IN fibronectin-coated_JJ plates_NNS by_IN Du145_JJ cells_NNS overexpressing_VBG maspin_NN was_VBD also_RB reported_VBN -LRB-_-LRB- Abraham_NNP et_FW al_FW ._. 
2003_CD ,_, Tahmatzopoulos_NNPS et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Maspin_NNP expression_NN is_VBZ reduced_VBN in_IN prostate_NN tumors_NNS and_CC cancer_NN cell_NN lines_NNS compared_VBN to_TO normal_JJ prostate_NN epithelial_JJ cells_NNS -LRB-_-LRB- Sheng_FW et_FW al_FW ._. 
2006_CD b_NN ,_, Kang_FW et_FW al_FW ._. 
2004_CD ,_, Mitsuyama_NNP et_FW al_FW ._. 
2001_CD ,_, Kallen_NNP 2002_CD ,_, Becker_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, as_RB well_RB as_IN in_IN colon_NN cancer_NN and_CC melanoma_NN -LRB-_-LRB- Jones_NNP et_NNP al_NNP ._. 
2007_CD ,_, Wagley_NNP et_FW al._FW ._. 
2007_CD ,_, Nowell_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
Preclinical_JJ data_NNS suggest_VBP the_DT possibility_NN to_TO improve_VB current_JJ therapies_NNS by_IN specifically_RB inhibiting_VBG the_DT sIL-6R_NNP -LRB-_-LRB- Nowell_NNP et_FW al_FW ._. 
2001_CD -RRB-_-RRB- and_CC F10_NNP ._. 
Afusion_NN protein_NN consisting_VBG of_IN human_JJ IL-6_NN and_CC human_JJ sIL-6R_NN was_VBD also_RB shown_VBN to_TO reduce_VB proliferation_NN of_IN B16_FW melanoma_FW -LRB-_-LRB- Ozbek_NNP et_FW al_FW ._. 
9cells_NNS -LRB-_-LRB- Wagley_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
At_IN this_DT stage_NN ,_, the_DT possibility_NN of_IN interactions_NNS between_IN sIL-6R_NNP and_CC other_JJ not_RB yet_RB identified_VBN factors_NNS can_MD not_RB be_VB excluded_VBN and_CC the_DT situation_NN in_IN vivo_NN seems_VBZ to_TO be_VB more_RBR complex_JJ ._. 
2003_CD ,_, Mumm_NNP 
2000_CD -RRB-_-RRB- ._. 
The_DT administration_NN of_IN anti-PRL_JJ antibodies_NNS ,_, PRL_NNP antisense_JJ oligonucleotides_NNS ,_, or_CC PRL_NNP antagonists_NNS suppresses_VBZ the_DT mitogenic_JJ activity_NN of_IN locally_RB produced_VBN PRL_NNP and_CC inhibits_VBZ growth_NN in_IN breast_NN tumor_NN cell_NN lines_NNS -LRB-_-LRB- Fuh_NNP 
Several_JJ researchers_NNS have_VBP related_VBN endocrine_JJ and\/or_CC autocrine\/paracrine_JJ PRL_NNP production_NN with_IN mammary_JJ disorders_NNS ,_, including_VBG tumorogenesis_NNS -LRB-_-LRB- Vonderhaar_NNP 1999_CD ,_, Wennbo_NNP 
The_DT role_NN of_IN PRL_NNP in_IN inducing_VBG mammary_JJ tumorogenesis_NN has_VBZ been_VBN thoroughly_RB discussed_VBN -LRB-_-LRB- Vonderhaar_NNP 1999_CD ,_, Wennbo_NNP 
2005_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, as_IN in_IN the_DT pituitary_JJ gland_NN ,_, Pit-1_NN regulates_VBZ GH_NNP expression_NN in_IN the_DT MCF-7_NNP human_JJ breast_NN adenocarcinoma_NN cell_NN line_NN -LRB-_-LRB- Gil-Puig_FW et_FW al_FW ._. 
Prolactin_NNP -LRB-_-LRB- PRL_NNP -RRB-_-RRB- and_CC its_PRP$ corresponding_JJ receptor_NN have_VBP also_RB been_VBN found_VBN in_IN extrapituitary_JJ tissues_NNS ,_, including_VBG normal_JJ human_JJ breast_NN ,_, mammary_JJ tumors_NNS ,_, and_CC breast_NN cell_NN lines_NNS -LRB-_-LRB- Clevenger_NNP et_FW al._FW ._. 
1995_CD ,_, Ginsburg_NNP 
While_IN its_PRP$ pituitary_JJ function_NN has_VBZ been_VBN extensively_RB evaluated_VBN ,_, Pit-1_NN is_VBZ also_RB expressed_VBN in_IN several_JJ extrapituitary_JJ tissues_NNS and_CC cell_NN lines_NNS ,_, including_VBG the_DT mammary_JJ gland_NN ,_, where_WRB its_PRP$ role_NN is_VBZ still_RB unclear_JJ -LRB-_-LRB- Delhase_FW et_FW al_FW ._. 
1993_CD ,_, Bamberger_NNP et_FW al._FW ._. 
1995_CD ,_, Gil-Puig_NNP et_FW al_FW ._. 
2002_CD ,_, 2005_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, as_IN in_IN the_DT pituitary_JJ gland_NN ,_, Pit-1_NN regulates_VBZ GH_NNP expression_NN in_IN the_DT MCF-7_NNP human_JJ breast_NN adenocarcinoma_NN cell_NN line_NN -LRB-_-LRB- Gil-Puig_FW et_FW al_FW ._. 
1998_CD -RRB-_-RRB- ,_, but_CC the_DT regulation_NN of_IN extrapituitary_JJ PRL_NNP is_VBZ not_RB yet_RB understood_VBN ._. 
1995_CD ,_, Ginsburg_NNP 
8_CD 
In_IN addition_NN ,_, PRL_NNP provides_VBZ a_DT proliferative_JJ stimulus_NN to_TO rodent_VB mammary_JJ tumorogenesis_NNS -LRB-_-LRB- Welsch_NNP 
2005_CD -RRB-_-RRB- ._. 
This_DT suggests_VBZ that_IN depending_VBG on_IN its_PRP$ level_NN ,_, the_DT expression_NN of_IN Pit-1_NN may_MD be_VB involved_VBN in_IN normal_JJ mammary_JJ development_NN ,_, breast_NN disorders_NNS ,_, or_CC both_DT -LRB-_-LRB- Gil-Puig_FW et_FW al_FW ._. 
The_DT role_NN of_IN PRL_NNP in_IN inducing_VBG mammary_JJ tumorogenesis_NN has_VBZ been_VBN thoroughly_RB discussed_VBN -LRB-_-LRB- Vonderhaar_NNP 1999_CD ,_, Wennbo_NNP 
However_RB ,_, few_JJ studies_NNS have_VBP evaluated_VBN PRL_NNP expression_NN by_IN immunohistochemistry_NN in_IN series_NN of_IN human_JJ mammary_JJ tumors_NNS -LRB-_-LRB- Bhatavdekar_FW et_FW al_FW ._. 
2000a_JJ ,_, b_NN -RRB-_-RRB- ._. 
These_DT authors_NNS have_VBP shown_VBN that_IN PRL_NNP immunoreactivity_NN was_VBD present_JJ in_IN 78_CD %_NN -LRB-_-LRB- 87_CD out_IN of_IN 111_CD -RRB-_-RRB- and_CC 82_CD %_NN -LRB-_-LRB- 76_CD out_IN of_IN 93_CD -RRB-_-RRB- of_IN tumors_NNS ,_, similar_JJ to_TO our_PRP$ own_JJ finding_NN -LRB-_-LRB- 77_CD %_NN ,_, 73\/94_CD -RRB-_-RRB- ,_, and_CC that_IN increased_VBN PRL_NNP positivity_NN was_VBD significantly_RB associated_VBN with_IN increased_VBN tumor_NN size_NN ,_, higher_JJR stage_NN ,_, nodal_JJ involvement_NN ,_, and_CC worse_JJR overall_JJ survival_NN in_IN univariate_JJ analyses_NNS ,_, although_IN the_DT association_NN was_VBD attenuated_VBN after_IN adjustment_NN for_IN stage_NN -LRB-_-LRB- Bhatavdekar_FW et_FW al_FW ._. 
2003_CD -RRB-_-RRB- ._. 
2002_CD ,_, Clevenger_NNP et_FW al_FW ._. 
The_DT role_NN of_IN PRL_NNP in_IN inducing_VBG mammary_JJ tumorogenesis_NN has_VBZ been_VBN thoroughly_RB discussed_VBN -LRB-_-LRB- Vonderhaar_NNP 1999_CD ,_, Wennbo_NNP 
2000_CD a_DT ,_, b_NN -RRB-_-RRB- ._. 
However_RB ,_, few_JJ studies_NNS have_VBP evaluated_VBN PRL_NNP expression_NN by_IN immunohistochemistry_NN in_IN series_NN of_IN human_JJ mammary_JJ tumors_NNS -LRB-_-LRB- Bhatavdekar_FW et_FW al_FW ._. 
These_DT authors_NNS have_VBP shown_VBN that_IN PRL_NNP immunoreactivity_NN was_VBD present_JJ in_IN 78_CD %_NN -LRB-_-LRB- 87_CD out_IN of_IN 111_CD -RRB-_-RRB- and_CC 82_CD %_NN -LRB-_-LRB- 76_CD out_IN of_IN 93_CD -RRB-_-RRB- of_IN tumors_NNS ,_, similar_JJ to_TO our_PRP$ own_JJ finding_NN -LRB-_-LRB- 77_CD %_NN ,_, 73\/94_CD -RRB-_-RRB- ,_, and_CC that_IN increased_VBN PRL_NNP positivity_NN was_VBD significantly_RB associated_VBN with_IN increased_VBN tumor_NN size_NN ,_, higher_JJR stage_NN ,_, nodal_JJ involvement_NN ,_, and_CC worse_JJR overall_JJ survival_NN in_IN univariate_JJ analyses_NNS ,_, although_IN the_DT association_NN was_VBD attenuated_VBN after_IN adjustment_NN for_IN stage_NN -LRB-_-LRB- Bhatavdekar_FW et_FW al._FW ._. 
2000_CD a_DT -RRB-_-RRB- ._. 
No_DT data_NNS about_IN determination_NN of_IN Pit-1_JJ expression_NN by_IN immunohistochemistry_NN in_IN human_JJ breast_NN tumor_NN series_NN is_VBZ currently_RB available_JJ ._. 
These_DT data_NNS seem_VBP to_TO suggest_VB that_DT Pit-1_NN increases_VBZ cell_NN proliferation_NN independently_RB of_IN PRL_NNP probably_RB by_IN inducing_VBG cyclin_NN D1_CD levels_NNS ._. 
With_IN respect_NN to_TO this_DT ,_, it_PRP has_VBZ been_VBN previously_RB demonstrated_VBN that_IN Pit-1_JJ leads_NNS to_TO a_DT significant_JJ increase_NN in_IN cell_NN proliferation_NN in_IN both_DT pituitary_JJ -LRB-_-LRB- Castrillo_NNP et_FW al._FW ._. 
1991_CD -RRB-_-RRB- and_CC extrapituitary_JJ cell_NN lines_NNS -LRB-_-LRB- Gaiddon_FW et_FW al_FW ._. 
1999_CD ,_, Gil-Puig_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
To_TO study_VB the_DT relationships_NNS between_IN Pit-1_NNP and_CC PRL_NNP in_IN human_JJ breast_NN cancer_NN ,_, we_PRP also_RB evaluated_VBD the_DT Pit-1_NNP and_CC PRL_NNP expression_NN in_IN 94_CD invasive_JJ ductal_JJ carcinomas_NNS ._. 
3A._CD Results_NNS are_VBP shown_VBN in_IN Fig_NNP ._. 
After_IN 24_CD 
e._VB In_IN order_NN to_TO evaluate_VB the_DT mechanisms_NNS of_IN action_NN of_IN Pit-1-increased_JJ cell_NN proliferation_NN -LRB-_-LRB- i._NN Figure_NN 3_NNP B_NNP shows_VBZ a_DT representative_JJ panel_NN of_IN DAPI_NNP and_CC BrdU_NNP in_IN control_NN ,_, PRL-treated_JJ and\/or_CC transfected_JJ MCF-7_NN cells_NNS ._. 
independently_RB or_CC PRL-mediated_JJ -RRB-_-RRB- ,_, we_PRP administrated_VBD AG-490_NNP ,_, a_DT potent_JJ inhibitor_NN of_IN the_DT Jak2_JJ tyrosine_NN kinase_NN ,_, which_WDT is_VBZ critical_JJ for_IN transmission_NN of_IN PRL-induced_JJ proliferative_JJ signals_NNS -LRB-_-LRB- Brockman_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
As_IN shown_VBN in_IN Fig_NNP ._. 
3C_CD -LRB-_-LRB- lane_NN 4_CD -RRB-_-RRB- ,_, Pit-1_JJ overexpression_NN induced_VBD an_DT increase_NN in_IN Jak2_JJ phosphorylation_NN ,_, which_WDT was_VBD blocked_VBN -LRB-_-LRB- lane_NN 5_CD -RRB-_-RRB- after_IN AG-490_NNP administration_NN ._. 
It_PRP has_VBZ been_VBN demonstrated_VBN that_IN PRL_NNP transcriptionally_RB increases_VBZ the_DT levels_NNS of_IN cyclin_NN D1_NN that_WDT is_VBZ a_DT key_JJ factor_NN in_IN cell_NN cycle_NN ._. 
This_DT further_RB indicates_VBZ that_IN PRL_NNP directly_RB induces_VBZ cell_NN proliferation_NN -LRB-_-LRB- Brockman_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
In_IN the_DT present_JJ study_NN ,_, we_PRP also_RB found_VBD a_DT significant_JJ increase_NN in_IN BrdU_NNP uptake_NN after_IN PRL_NNP administration_NN ._. 
Xunta_NNP de_NNP Galicia_NNP PGIDIT06PXIB208028PR_NNP Introduction_NNP The_DT transcription_NN factor_NN Pit-1_NNP \/_NNP Pou1f1_NNP was_VBD first_RB described_VBN in_IN the_DT pituitary_JJ gland_NN ,_, where_WRB it_PRP acts_VBZ in_IN cell_NN differentiation_NN during_IN organogenesis_NNS of_IN the_DT anterior_JJ pituitary_NN in_IN mammals_NNS and_CC as_IN a_DT transcriptional_JJ activator_NN for_IN pituitary_JJ gene_NN transcription_NN -LRB-_-LRB- Lefevre_NNP et_FW al_FW ._. 
1987_CD ,_, Nelson_NNP et_NNP al._NNP ._. 
1988_CD -RRB-_-RRB- ._. 
Mice_NNP with_IN inactivating_VBG mutations_NNS or_CC deletions_NNS of_IN the_DT Pit-1_JJ gene_NN fail_VBP to_TO generate_VB somatotrophs_NNS ,_, lactotrophs_NNS ,_, and_CC thyrotrophs_NNS ,_, and_CC consequently_RB exhibit_VB anterior_JJ pituitary_JJ hypoplasia_NN and_CC dwarfism_NN -LRB-_-LRB- Li_NNP et_FW al_FW ._. 
001_CD -RRB-_-RRB- ._. 
2D_CD ,_, cotransfection_NN with_IN the_DT pGL2B-hPRL_NN 
In_IN addition_NN ,_, PRL_NNP provides_VBZ a_DT proliferative_JJ stimulus_NN to_TO rodent_VB mammary_JJ tumorogenesis_NNS -LRB-_-LRB- Welsch_NNP 
2005_CD -RRB-_-RRB- ._. 
This_DT suggests_VBZ that_IN depending_VBG on_IN its_PRP$ level_NN ,_, the_DT expression_NN of_IN Pit-1_NN may_MD be_VB involved_VBN in_IN normal_JJ mammary_JJ development_NN ,_, breast_NN disorders_NNS ,_, or_CC both_DT -LRB-_-LRB- Gil-Puig_FW et_FW al_FW ._. 
The_DT role_NN of_IN PRL_NNP in_IN inducing_VBG mammary_JJ tumorogenesis_NN has_VBZ been_VBN thoroughly_RB discussed_VBN -LRB-_-LRB- Vonderhaar_NNP 1999_CD ,_, Wennbo_NNP 
For_IN instance_NN ,_, adenoviral_JJ delivery_NN of_IN Pit-1_NN in_IN mouse_NN liver_NN induces_VBZ the_DT transient_JJ differentiation_NN of_IN adult_JJ hepatic_JJ stem_NN cells_NNS into_IN PRL-producing_JJ cells_NNS -LRB-_-LRB- Lee_NNP et_NNP al_NNP ._. 
2005_CD -RRB-_-RRB- ,_, and_CC transfection_NN of_IN the_DT corticotropic_JJ AtT-20_NN and_CC the_DT gonadotropic_NN 
Pit-1_JJ induction_NN has_VBZ also_RB been_VBN demonstrated_VBN to_TO lead_VB to_TO PRL_NNP or_CC GH_NNP expression_NN in_IN other_JJ extrapituitary_JJ tissues_NNS ._. 
For_IN instance_NN ,_, adenoviral_JJ delivery_NN of_IN Pit-1_NN in_IN mouse_NN liver_NN induces_VBZ the_DT transient_JJ differentiation_NN of_IN adult_JJ hepatic_JJ stem_NN cells_NNS into_IN PRL-producing_JJ cells_NNS -LRB-_-LRB- Lee_NNP et_NNP al._NNP ._. 
2005_CD -RRB-_-RRB- ,_, and_CC transfection_NN of_IN the_DT corticotropic_JJ AtT-20_NN and_CC the_DT gonadotropic_NN 
Considering_VBG the_DT possible_JJ role_NN of_IN PRL_NNP in_IN breast_NN cancer_NN disorders_NNS ,_, the_DT function_NN of_IN Pit-1_NN in_IN breast_NN should_MD be_VB the_DT focus_NN of_IN further_JJ research_NN ._. 
Xunta_NNP de_NNP GaliciaPGIDIT06PXIB208028PRIntroductionThe_NNP transcription_NN factor_NN Pit-1_NNP \/_NNP Pou1f1_NNP was_VBD first_RB described_VBN in_IN the_DT pituitary_JJ gland_NN ,_, where_WRB it_PRP acts_VBZ in_IN cell_NN differentiation_NN during_IN organogenesis_NNS of_IN the_DT anterior_JJ pituitary_NN in_IN mammals_NNS and_CC as_IN a_DT transcriptional_JJ activator_NN for_IN pituitary_JJ gene_NN transcription_NN -LRB-_-LRB- Lefevre_NNP et_FW al._FW ._. 
1987_CD ,_, Nelson_NNP et_NNP al_NNP ._. 
1988_CD -RRB-_-RRB- ._. 
Mice_NNP with_IN inactivating_VBG mutations_NNS or_CC deletions_NNS of_IN the_DT Pit-1_JJ gene_NN fail_VBP to_TO generate_VB somatotrophs_NNS ,_, lactotrophs_NNS ,_, and_CC thyrotrophs_NNS ,_, and_CC consequently_RB exhibit_VB anterior_JJ pituitary_JJ hypoplasia_NN and_CC dwarfism_NN -LRB-_-LRB- Li_NNP et_FW al_FW ._. 
1988_CD -RRB-_-RRB- ._. 
1987_CD ,_, Nelson_NNP et_NNP al_NNP ._. 
Xunta_NNP de_NNP Galicia_NNP PGIDIT06PXIB208028PR_NNP Introduction_NNP The_DT transcription_NN factor_NN Pit-1_NNP \/_NNP Pou1f1_NNP was_VBD first_RB described_VBN in_IN the_DT pituitary_JJ gland_NN ,_, where_WRB it_PRP acts_VBZ in_IN cell_NN differentiation_NN during_IN organogenesis_NNS of_IN the_DT anterior_JJ pituitary_NN in_IN mammals_NNS and_CC as_IN a_DT transcriptional_JJ activator_NN for_IN pituitary_JJ gene_NN transcription_NN -LRB-_-LRB- Lefevre_NNP et_FW al_FW ._. 
Mice_NNP with_IN inactivating_VBG mutations_NNS or_CC deletions_NNS of_IN the_DT Pit-1_JJ gene_NN fail_VBP to_TO generate_VB somatotrophs_NNS ,_, lactotrophs_NNS ,_, and_CC thyrotrophs_NNS ,_, and_CC consequently_RB exhibit_VB anterior_JJ pituitary_JJ hypoplasia_NN and_CC dwarfism_NN -LRB-_-LRB- Li_NNP et_FW al._FW ._. 
1990_CD -RRB-_-RRB- ,_, thereby_RB demonstrating_VBG the_DT importance_NN of_IN Pit-1_NN in_IN the_DT ontogeny_NN of_IN the_DT pituitary_JJ gland_NN ._. 
While_IN its_PRP$ pituitary_JJ function_NN has_VBZ been_VBN extensively_RB evaluated_VBN ,_, Pit-1_NN is_VBZ also_RB expressed_VBN in_IN several_JJ extrapituitary_JJ tissues_NNS and_CC cell_NN lines_NNS ,_, including_VBG the_DT mammary_JJ gland_NN ,_, where_WRB its_PRP$ role_NN is_VBZ still_RB unclear_JJ -LRB-_-LRB- Delhase_FW et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
For_IN instance_NN ,_, recent_JJ prospective_JJ studies_NNS have_VBP linked_VBN PRL_NNP levels_NNS with_IN breast_NN cancer_NN etiology_NN in_IN women_NNS ,_, particularly_RB in_IN estrogen-positive_JJ tumors_NNS -LRB-_-LRB- Tworoger_FW et_FW al_FW ._. 
The_DT administration_NN of_IN anti-PRL_JJ antibodies_NNS ,_, PRL_NNP antisense_JJ oligonucleotides_NNS ,_, or_CC PRL_NNP antagonists_NNS suppresses_VBZ the_DT mitogenic_JJ activity_NN of_IN locally_RB produced_VBN PRL_NNP and_CC inhibits_VBZ growth_NN in_IN breast_NN tumor_NN cell_NN lines_NNS -LRB-_-LRB- Fuh_NNP 
However_RB ,_, some_DT extrapituitary_JJ tissues_NNS and_CC cell_NN lines_NNS ,_, such_JJ as_IN prostate_NN cancer_NN cells_NNS and_CC the_DT human_JJ breast_NN adenocarcinoma_NN cells_NNS ,_, SK-BR-3_NNP ,_, do_VBP not_RB express_VB Pit-1_NN ,_, yet_CC PRL_NNP transcripts_NNS corresponding_JJ to_TO the_DT proximal_JJ promoter_NN are_VBP present_JJ -LRB-_-LRB- Shaw-Bruha_FW et_FW al_FW ._. 
1997_CD ,_, Manfroid_FW et_FW al._FW ._. 
2005_CD ,_, Dagvadorj_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
This_DT seems_VBZ to_TO support_VB that_IN Pit-1-independent_JJ PRL_NNP regulation_NN in_IN nonpituitary_JJ tissues_NNS can_MD occur_VB ._. 
1995_CD -RRB-_-RRB- ._. 
For_IN example_NN ,_, in_IN a_DT subclone_NN of_IN the_DT SKUT-1B_NNP uterine_NN sarcoma_NN cell_NN line_NN ,_, Pit-1_JJ transfection_NN does_VBZ not_RB modify_VB endogenous_JJ PRL_NNP levels_NNS -LRB-_-LRB- Gellersen_FW et_FW al_FW ._. 
However_RB ,_, in_IN SK-BR-3_JJ cells_NNS that_WDT contain_VBP PRL_NNP but_CC not_RB Pit-1_JJ ,_, overexpression_NN of_IN Pit-1_NN induces_VBZ the_DT activation_NN of_IN transfected_JJ constructs_NNS containing_VBG the_DT proximal_JJ pituitary_JJ PRL_NNP promoter_NN -LRB-_-LRB- Manfroid_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- and_CC the_DT induction_NN of_IN PRL_NNP mRNA_NNP ,_, as_IN observed_VBN in_IN our_PRP$ study_NN ._. 
Pit-1_JJ induction_NN has_VBZ also_RB been_VBN demonstrated_VBN to_TO lead_VB to_TO PRL_NNP or_CC GH_NNP expression_NN in_IN other_JJ extrapituitary_JJ tissues_NNS ._. 
2005_CD -RRB-_-RRB- ._. 
1991_CD ,_, Gil-Puig_NNP et_FW al_FW ._. 
These_DT bands_NNS that_WDT arise_VBP from_IN two_CD alternative_NN translation_NN 
Prolactin_NNP -LRB-_-LRB- PRL_NNP -RRB-_-RRB- and_CC its_PRP$ corresponding_JJ receptor_NN have_VBP also_RB been_VBN found_VBN in_IN extrapituitary_JJ tissues_NNS ,_, including_VBG normal_JJ human_JJ breast_NN ,_, mammary_JJ tumors_NNS ,_, and_CC breast_NN cell_NN lines_NNS -LRB-_-LRB- Clevenger_NNP et_FW al_FW ._. 
1995_CD ,_, Ginsburg_NNP 
1990_CD -RRB-_-RRB- ,_, thereby_RB demonstrating_VBG the_DT importance_NN of_IN Pit-1_NN in_IN the_DT ontogeny_NN of_IN the_DT pituitary_JJ gland_NN ._. 
Mice_NNP with_IN inactivating_VBG mutations_NNS or_CC deletions_NNS of_IN the_DT Pit-1_JJ gene_NN fail_VBP to_TO generate_VB somatotrophs_NNS ,_, lactotrophs_NNS ,_, and_CC thyrotrophs_NNS ,_, and_CC consequently_RB exhibit_VB anterior_JJ pituitary_JJ hypoplasia_NN and_CC dwarfism_NN -LRB-_-LRB- Li_NNP et_FW al_FW ._. 
While_IN its_PRP$ pituitary_JJ function_NN has_VBZ been_VBN extensively_RB evaluated_VBN ,_, Pit-1_NN is_VBZ also_RB expressed_VBN in_IN several_JJ extrapituitary_JJ tissues_NNS and_CC cell_NN lines_NNS ,_, including_VBG the_DT mammary_JJ gland_NN ,_, where_WRB its_PRP$ role_NN is_VBZ still_RB unclear_JJ -LRB-_-LRB- Delhase_FW et_FW al._FW ._. 
1993_CD ,_, Bamberger_NNP et_FW al_FW ._. 
1995_CD ,_, Gil-Puig_NNP et_FW al_FW ._. 
2002_CD ,_, 2005_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, as_IN in_IN the_DT pituitary_JJ gland_NN ,_, Pit-1_NN regulates_VBZ GH_NNP expression_NN in_IN the_DT MCF-7_NNP human_JJ breast_NN adenocarcinoma_NN cell_NN line_NN -LRB-_-LRB- Gil-Puig_FW et_FW al_FW ._. 
1994_CD ,_, Shaw-Bruha_NNP et_FW al_FW ._. 
1994_CD ,_, Gellersen_NNP et_NNP al_NNP ._. 
The_DT distal_JJ promoter_NN is_VBZ present_JJ in_IN PRL_NNP gene_NN at_IN extrapituitary_JJ sites_NNS ,_, such_JJ as_IN placenta_NN ,_, lymphoid_JJ cells_NNS ,_, normal_JJ and_CC neoplastic_JJ human_JJ breast_NN ,_, and_CC human_JJ prostate_NN -LRB-_-LRB- Berwaer_FW et_FW al_FW ._. 
1997_CD ,_, Dagvadorj_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
However_RB ,_, both_DT proximal_JJ pituitary_JJ and_CC distal_JJ extrapituitary_JJ PRL_NNP promoters_NNS are_VBP expressed_VBN in_IN a_DT subset_NN of_IN normal_JJ and_CC tumoral_JJ breast_NN tissues_NNS ,_, breast_NN cell_NN lines_NNS ,_, and_CC in_IN prostate_NN tissue_NN -LRB-_-LRB- Shaw-Bruha_FW et_FW al_FW ._. 
However_RB ,_, both_DT proximal_JJ pituitary_JJ and_CC distal_JJ extrapituitary_JJ PRL_NNP promoters_NNS are_VBP expressed_VBN in_IN a_DT subset_NN of_IN normal_JJ and_CC tumoral_JJ breast_NN tissues_NNS ,_, breast_NN cell_NN lines_NNS ,_, and_CC in_IN prostate_NN tissue_NN -LRB-_-LRB- Shaw-Bruha_FW et_FW al_FW ._. 
1997_CD ,_, Dagvadorj_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
PRL_NNP transcripts_NNS arising_VBG from_IN either_CC the_DT distal_JJ or_CC proximal_JJ promoter_NN encode_VB identical_JJ proteins_NNS ,_, which_WDT gives_VBZ the_DT PRL_NNP gene_NN a_DT tissue-specific_JJ regulation_NN ._. 
1997_CD ,_, Manfroid_FW et_FW al_FW ._. 
However_RB ,_, some_DT extrapituitary_JJ tissues_NNS and_CC cell_NN lines_NNS ,_, such_JJ as_IN prostate_NN cancer_NN cells_NNS and_CC the_DT human_JJ breast_NN adenocarcinoma_NN cells_NNS ,_, SK-BR-3_NNP ,_, do_VBP not_RB express_VB Pit-1_NN ,_, yet_CC PRL_NNP transcripts_NNS corresponding_JJ to_TO the_DT proximal_JJ promoter_NN are_VBP present_JJ -LRB-_-LRB- Shaw-Bruha_FW et_FW al_FW ._. 
2005_CD ,_, Dagvadorj_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
This_DT seems_VBZ to_TO support_VB that_IN Pit-1-independent_JJ PRL_NNP regulation_NN in_IN nonpituitary_JJ tissues_NNS can_MD occur_VB ._. 
2007_CD -RRB-_-RRB- ._. 
For_IN instance_NN ,_, recent_JJ prospective_JJ studies_NNS have_VBP linked_VBN PRL_NNP levels_NNS with_IN breast_NN cancer_NN etiology_NN in_IN women_NNS ,_, particularly_RB in_IN estrogen-positive_JJ tumors_NNS -LRB-_-LRB- Tworoger_FW et_FW al_FW ._. 
The_DT administration_NN of_IN anti-PRL_JJ antibodies_NNS ,_, PRL_NNP antisense_JJ oligonucleotides_NNS ,_, or_CC PRL_NNP antagonists_NNS suppresses_VBZ the_DT mitogenic_JJ activity_NN of_IN locally_RB produced_VBN PRL_NNP and_CC inhibits_VBZ growth_NN in_IN breast_NN tumor_NN cell_NN lines_NNS -LRB-_-LRB- Fuh_NNP 
PRL_NNP transcripts_NNS arising_VBG from_IN either_CC the_DT distal_JJ or_CC proximal_JJ promoter_NN encode_VB identical_JJ proteins_NNS ,_, which_WDT gives_VBZ the_DT PRL_NNP gene_NN a_DT tissue-specific_JJ regulation_NN ._. 
The_DT effects_NNS of_IN PRL_NNP on_IN milk_NN production_NN and_CC on_IN mammary_JJ growth_NN and_CC differentiation_NN are_VBP well_RB known_VBN -LRB-_-LRB- Freeman_NNP et_NNP al._NNP ._. 
2000_CD -RRB-_-RRB- ._. 
In_IN addition_NN ,_, PRL_NNP provides_VBZ a_DT proliferative_JJ stimulus_NN to_TO rodent_VB mammary_JJ tumorogenesis_NNS -LRB-_-LRB- Welsch_NNP 
Human_NNP PRL_NNP gene_NN is_VBZ regulated_VBN at_IN a_DT transcriptional_JJ level_NN by_IN two_CD different_JJ promoters_NNS -LRB-_-LRB- Berwaer_FW et_FW al_FW ._. 
1994_CD ,_, Gellersen_NNP et_FW al._FW ._. 
1994_CD -RRB-_-RRB- ._. 
First_RB ,_, the_DT proximal_JJ pituitary_JJ promoter_NN is_VBZ located_VBN in_IN the_DT exon_FW 1b_FW and_CC contains_VBZ Pit-1_JJ response_NN elements_NNS ;_: the_DT human_JJ pituitary_JJ PRL_NNP gene_NN contains_VBZ only_RB this_DT promoter_NN ._. 
The_DT distal_JJ promoter_NN is_VBZ present_JJ in_IN PRL_NNP gene_NN at_IN extrapituitary_JJ sites_NNS ,_, such_JJ as_IN placenta_NN ,_, lymphoid_JJ cells_NNS ,_, normal_JJ and_CC neoplastic_JJ human_JJ breast_NN ,_, and_CC human_JJ prostate_NN -LRB-_-LRB- Berwaer_FW et_FW al_FW ._. 
1994_CD ,_, Gellersen_NNP et_FW al._FW ._. 
1994_CD ,_, Shaw-Bruha_NNP et_FW al_FW ._. 
1997_CD ,_, Dagvadorj_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
However_RB ,_, both_DT proximal_JJ pituitary_JJ and_CC distal_JJ extrapituitary_JJ PRL_NNP promoters_NNS are_VBP expressed_VBN in_IN a_DT subset_NN of_IN normal_JJ and_CC tumoral_JJ breast_NN tissues_NNS ,_, breast_NN cell_NN lines_NNS ,_, and_CC in_IN prostate_NN tissue_NN -LRB-_-LRB- Shaw-Bruha_FW et_FW al_FW ._. 
With_IN respect_NN to_TO this_DT ,_, it_PRP has_VBZ been_VBN previously_RB demonstrated_VBN that_IN Pit-1_JJ leads_NNS to_TO a_DT significant_JJ increase_NN in_IN cell_NN proliferation_NN in_IN both_DT pituitary_JJ -LRB-_-LRB- Castrillo_NNP et_FW al_FW ._. 
1991_CD -RRB-_-RRB- and_CC extrapituitary_JJ cell_NN lines_NNS -LRB-_-LRB- Gaiddon_FW et_FW al._FW ._. 
1999_CD ,_, Gil-Puig_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
To_TO study_VB the_DT relationships_NNS between_IN Pit-1_NNP and_CC PRL_NNP in_IN human_JJ breast_NN cancer_NN ,_, we_PRP also_RB evaluated_VBD the_DT Pit-1_NNP and_CC PRL_NNP expression_NN in_IN 94_CD invasive_JJ ductal_JJ carcinomas_NNS ._. 
1993_CD ,_, Bamberger_NNP et_FW al_FW ._. 
While_IN its_PRP$ pituitary_JJ function_NN has_VBZ been_VBN extensively_RB evaluated_VBN ,_, Pit-1_NN is_VBZ also_RB expressed_VBN in_IN several_JJ extrapituitary_JJ tissues_NNS and_CC cell_NN lines_NNS ,_, including_VBG the_DT mammary_JJ gland_NN ,_, where_WRB its_PRP$ role_NN is_VBZ still_RB unclear_JJ -LRB-_-LRB- Delhase_FW et_FW al_FW ._. 
1995_CD ,_, Gil-Puig_NNP et_FW al._FW ._. 
2002_CD ,_, 2005_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, as_IN in_IN the_DT pituitary_JJ gland_NN ,_, Pit-1_NN regulates_VBZ GH_NNP expression_NN in_IN the_DT MCF-7_NNP human_JJ breast_NN adenocarcinoma_NN cell_NN line_NN -LRB-_-LRB- Gil-Puig_FW et_FW al_FW ._. 
This_DT seems_VBZ to_TO support_VB that_IN Pit-1-independent_JJ PRL_NNP regulation_NN in_IN nonpituitary_JJ tissues_NNS can_MD occur_VB ._. 
2007_CD -RRB-_-RRB- ._. 
For_IN example_NN ,_, in_IN a_DT subclone_NN of_IN the_DT SKUT-1B_NNP uterine_NN sarcoma_NN cell_NN line_NN ,_, Pit-1_JJ transfection_NN does_VBZ not_RB modify_VB endogenous_JJ PRL_NNP levels_NNS -LRB-_-LRB- Gellersen_FW et_FW al._FW ._. 
1995_CD -RRB-_-RRB- ._. 
However_RB ,_, in_IN SK-BR-3_JJ cells_NNS that_WDT contain_VBP PRL_NNP but_CC not_RB Pit-1_JJ ,_, overexpression_NN of_IN Pit-1_NN induces_VBZ the_DT activation_NN of_IN transfected_JJ constructs_NNS containing_VBG the_DT proximal_JJ pituitary_JJ PRL_NNP promoter_NN -LRB-_-LRB- Manfroid_FW et_FW al_FW ._. 
Prolactin_NNP -LRB-_-LRB- PRL_NNP -RRB-_-RRB- and_CC its_PRP$ corresponding_JJ receptor_NN have_VBP also_RB been_VBN found_VBN in_IN extrapituitary_JJ tissues_NNS ,_, including_VBG normal_JJ human_JJ breast_NN ,_, mammary_JJ tumors_NNS ,_, and_CC breast_NN cell_NN lines_NNS -LRB-_-LRB- Clevenger_NNP et_FW al_FW ._. 
1995_CD ,_, Ginsburg_NNP 
1995_CD ,_, Gil-Puig_NNP et_FW al_FW ._. 
1993_CD ,_, Bamberger_NNP et_FW al_FW ._. 
While_IN its_PRP$ pituitary_JJ function_NN has_VBZ been_VBN extensively_RB evaluated_VBN ,_, Pit-1_NN is_VBZ also_RB expressed_VBN in_IN several_JJ extrapituitary_JJ tissues_NNS and_CC cell_NN lines_NNS ,_, including_VBG the_DT mammary_JJ gland_NN ,_, where_WRB its_PRP$ role_NN is_VBZ still_RB unclear_JJ -LRB-_-LRB- Delhase_FW et_FW al_FW ._. 
2002_CD ,_, 2005_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, as_IN in_IN the_DT pituitary_JJ gland_NN ,_, Pit-1_NN regulates_VBZ GH_NNP expression_NN in_IN the_DT MCF-7_NNP human_JJ breast_NN adenocarcinoma_NN cell_NN line_NN -LRB-_-LRB- Gil-Puig_FW et_FW al_FW ._. 
2002_CD ,_, 2005_CD -RRB-_-RRB- ._. 
1995_CD ,_, Gil-Puig_NNP et_FW al_FW ._. 
1993_CD ,_, Bamberger_NNP et_FW al_FW ._. 
While_IN its_PRP$ pituitary_JJ function_NN has_VBZ been_VBN extensively_RB evaluated_VBN ,_, Pit-1_NN is_VBZ also_RB expressed_VBN in_IN several_JJ extrapituitary_JJ tissues_NNS and_CC cell_NN lines_NNS ,_, including_VBG the_DT mammary_JJ gland_NN ,_, where_WRB its_PRP$ role_NN is_VBZ still_RB unclear_JJ -LRB-_-LRB- Delhase_FW et_FW al_FW ._. 
Moreover_RB ,_, as_IN in_IN the_DT pituitary_JJ gland_NN ,_, Pit-1_NN regulates_VBZ GH_NNP expression_NN in_IN the_DT MCF-7_NNP human_JJ breast_NN adenocarcinoma_NN cell_NN line_NN -LRB-_-LRB- Gil-Puig_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Prolactin_NNP -LRB-_-LRB- PRL_NNP -RRB-_-RRB- and_CC its_PRP$ corresponding_JJ receptor_NN have_VBP also_RB been_VBN found_VBN in_IN extrapituitary_JJ tissues_NNS ,_, including_VBG normal_JJ human_JJ breast_NN ,_, mammary_JJ tumors_NNS ,_, and_CC breast_NN cell_NN lines_NNS -LRB-_-LRB- Clevenger_NNP et_FW al_FW ._. 
RNA_NNP isolation_NN ,_, RT-PCR_NNP ,_, and_CC quantitative_JJ PCR_NNP Isolation_NN of_IN total_JJ RNA_NNP from_IN the_DT cell_NN lines_NNS was_VBD performed_VBN with_IN the_DT TRIzol_NNP reagent_NN -LRB-_-LRB- Invitrogen_NNP -RRB-_-RRB- ,_, according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._. 
cDNA_JJ synthesis_NN was_VBD performed_VBN as_IN described_VBN elsewhere_RB -LRB-_-LRB- Gil-Puig_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Five_CD microliters_NNS of_IN the_DT cDNA_NNP were_VBD amplified_VBN by_IN PCR_NNP using_VBG 2_CD units_NNS of_IN Taq_NNP polymerase_NN -LRB-_-LRB- Gene_NNP Craft_NNP ,_, Koln_NNP ,_, Germany_NNP -RRB-_-RRB- in_IN a_DT buffer_NN containing_VBG 50_CD 
These_DT bands_NNS that_WDT arise_VBP from_IN two_CD alternative_NN translation_NN 
Effect_NN of_IN overexpression_NN and_CC silencing_VBG of_IN Pit-1_NN on_IN the_DT proliferation_NN of_IN MCF-7_JJ cells_NNS To_TO evaluate_VB the_DT effect_NN of_IN Pit-1_JJ overexpression_NN on_IN MCF-7_JJ cell_NN proliferation_NN ,_, these_DT cells_NNS were_VBD transfected_VBN with_IN pRSV-hPit-1_JJ expression_NN vector_NN for_IN 48_CD 
1991_CD -RRB-_-RRB- and_CC extrapituitary_JJ cell_NN lines_NNS -LRB-_-LRB- Gaiddon_FW et_FW al_FW ._. 
With_IN respect_NN to_TO this_DT ,_, it_PRP has_VBZ been_VBN previously_RB demonstrated_VBN that_IN Pit-1_JJ leads_NNS to_TO a_DT significant_JJ increase_NN in_IN cell_NN proliferation_NN in_IN both_DT pituitary_JJ -LRB-_-LRB- Castrillo_NNP et_FW al_FW ._. 
1999_CD ,_, Gil-Puig_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
To_TO study_VB the_DT relationships_NNS between_IN Pit-1_NNP and_CC PRL_NNP in_IN human_JJ breast_NN cancer_NN ,_, we_PRP also_RB evaluated_VBD the_DT Pit-1_NNP and_CC PRL_NNP expression_NN in_IN 94_CD invasive_JJ ductal_JJ carcinomas_NNS ._. 
It_PRP has_VBZ previously_RB been_VBN demonstrated_VBN that_DT Pit-1_NN is_VBZ expressed_VBN in_IN both_DT normal_JJ and_CC tumoral_JJ human_JJ breast_NN ,_, with_IN Pit-1_NNP mRNA_NNP levels_NNS being_VBG higher_JJR in_IN tumors_NNS ._. 
This_DT suggests_VBZ that_IN depending_VBG on_IN its_PRP$ level_NN ,_, the_DT expression_NN of_IN Pit-1_NN may_MD be_VB involved_VBN in_IN normal_JJ mammary_JJ development_NN ,_, breast_NN disorders_NNS ,_, or_CC both_DT -LRB-_-LRB- Gil-Puig_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT role_NN of_IN PRL_NNP in_IN inducing_VBG mammary_JJ tumorogenesis_NN has_VBZ been_VBN thoroughly_RB discussed_VBN -LRB-_-LRB- Vonderhaar_NNP 1999_CD ,_, Wennbo_NNP 
In_IN addition_NN ,_, PRL_NNP provides_VBZ a_DT proliferative_JJ stimulus_NN to_TO rodent_VB mammary_JJ tumorogenesis_NNS -LRB-_-LRB- Welsch_NNP 
2005_CD -RRB-_-RRB- ._. 
This_DT suggests_VBZ that_IN depending_VBG on_IN its_PRP$ level_NN ,_, the_DT expression_NN of_IN Pit-1_NN may_MD be_VB involved_VBN in_IN normal_JJ mammary_JJ development_NN ,_, breast_NN disorders_NNS ,_, or_CC both_DT -LRB-_-LRB- Gil-Puig_FW et_FW al_FW ._. 
The_DT role_NN of_IN PRL_NNP in_IN inducing_VBG mammary_JJ tumorogenesis_NN has_VBZ been_VBN thoroughly_RB discussed_VBN -LRB-_-LRB- Vonderhaar_NNP 1999_CD ,_, Wennbo_NNP 
2003_CD -RRB-_-RRB- ._. 
2002_CD ,_, Clevenger_NNP et_FW al_FW ._. 
Several_JJ researchers_NNS have_VBP related_VBN endocrine_JJ and\/or_CC autocrine\/paracrine_JJ PRL_NNP production_NN with_IN mammary_JJ disorders_NNS ,_, including_VBG tumorogenesis_NNS -LRB-_-LRB- Vonderhaar_NNP 1999_CD ,_, Wennbo_NNP 
2005_CD -RRB-_-RRB- ._. 
1991_CD ,_, Gil-Puig_NNP et_FW al_FW ._. 
These_DT bands_NNS that_WDT arise_VBP from_IN two_CD alternative_NN translation_NN 
1994_CD ,_, Gellersen_NNP et_NNP al_NNP ._. 
The_DT distal_JJ promoter_NN is_VBZ present_JJ in_IN PRL_NNP gene_NN at_IN extrapituitary_JJ sites_NNS ,_, such_JJ as_IN placenta_NN ,_, lymphoid_JJ cells_NNS ,_, normal_JJ and_CC neoplastic_JJ human_JJ breast_NN ,_, and_CC human_JJ prostate_NN -LRB-_-LRB- Berwaer_FW et_FW al_FW ._. 
1994_CD ,_, Shaw-Bruha_NNP et_FW al._FW ._. 
1997_CD ,_, Dagvadorj_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
However_RB ,_, both_DT proximal_JJ pituitary_JJ and_CC distal_JJ extrapituitary_JJ PRL_NNP promoters_NNS are_VBP expressed_VBN in_IN a_DT subset_NN of_IN normal_JJ and_CC tumoral_JJ breast_NN tissues_NNS ,_, breast_NN cell_NN lines_NNS ,_, and_CC in_IN prostate_NN tissue_NN -LRB-_-LRB- Shaw-Bruha_FW et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
1997_CD ,_, Dagvadorj_NNP et_FW al_FW ._. 
1994_CD ,_, Shaw-Bruha_NNP et_FW al_FW ._. 
1994_CD ,_, Gellersen_NNP et_NNP al_NNP ._. 
The_DT distal_JJ promoter_NN is_VBZ present_JJ in_IN PRL_NNP gene_NN at_IN extrapituitary_JJ sites_NNS ,_, such_JJ as_IN placenta_NN ,_, lymphoid_JJ cells_NNS ,_, normal_JJ and_CC neoplastic_JJ human_JJ breast_NN ,_, and_CC human_JJ prostate_NN -LRB-_-LRB- Berwaer_FW et_FW al_FW ._. 
However_RB ,_, both_DT proximal_JJ pituitary_JJ and_CC distal_JJ extrapituitary_JJ PRL_NNP promoters_NNS are_VBP expressed_VBN in_IN a_DT subset_NN of_IN normal_JJ and_CC tumoral_JJ breast_NN tissues_NNS ,_, breast_NN cell_NN lines_NNS ,_, and_CC in_IN prostate_NN tissue_NN -LRB-_-LRB- Shaw-Bruha_NNP et_FW al._FW ._. 
1997_CD ,_, Dagvadorj_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
PRL_NNP transcripts_NNS arising_VBG from_IN either_CC the_DT distal_JJ or_CC proximal_JJ promoter_NN encode_VB identical_JJ proteins_NNS ,_, which_WDT gives_VBZ the_DT PRL_NNP gene_NN a_DT tissue-specific_JJ regulation_NN ._. 
At_IN the_DT pituitary_JJ level_NN ,_, it_PRP is_VBZ well_RB known_VBN that_IN Pit-1_JJ binds_NNS to_TO the_DT proximal_JJ PRL_NNP promoter_NN and_CC induces_VBZ PRL_NNP expression_NN ._. 
However_RB ,_, some_DT extrapituitary_JJ tissues_NNS and_CC cell_NN lines_NNS ,_, such_JJ as_IN prostate_NN cancer_NN cells_NNS and_CC the_DT human_JJ breast_NN adenocarcinoma_NN cells_NNS ,_, SK-BR-3_NNP ,_, do_VBP not_RB express_VB Pit-1_NN ,_, yet_CC PRL_NNP transcripts_NNS corresponding_JJ to_TO the_DT proximal_JJ promoter_NN are_VBP present_JJ -LRB-_-LRB- Shaw-Bruha_NNP et_FW al._FW ._. 
1997_CD ,_, Manfroid_FW et_FW al_FW ._. 
2005_CD ,_, Dagvadorj_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
This_DT seems_VBZ to_TO support_VB that_IN Pit-1-independent_JJ PRL_NNP regulation_NN in_IN nonpituitary_JJ tissues_NNS can_MD occur_VB ._. 
Twelve_CD to_TO 24_CD 
The_DT cell_NN lysate_NN was_VBD then_RB centrifuged_VBN at_IN 14_CD 
To_TO determine_VB the_DT relative_JJ amounts_NNS of_IN Pit-1_JJ ,_, cyclin_JJ D1_NNP ,_, PRL_NNP ,_, and_CC 
2000_CD -RRB-_-RRB- ._. 
The_DT effects_NNS of_IN PRL_NNP on_IN milk_NN production_NN and_CC on_IN mammary_JJ growth_NN and_CC differentiation_NN are_VBP well_RB known_VBN -LRB-_-LRB- Freeman_NNP et_NNP al_NNP ._. 
In_IN addition_NN ,_, PRL_NNP provides_VBZ a_DT proliferative_JJ stimulus_NN to_TO rodent_VB mammary_JJ tumorogenesis_NNS -LRB-_-LRB- Welsch_NNP 
Pit-1_NN has_VBZ two_CD major_JJ immunoreactive_JJ bands_NNS that_WDT are_VBP readily_RB visible_JJ in_IN samples_NNS from_IN human_JJ cell_NN lines_NNS and_CC human_JJ mammary_JJ glands_NNS ._. 
These_DT bands_NNS that_WDT arise_VBP from_IN two_CD alternative_NN translation_NN 
The_DT present_JJ study_NN ,_, however_RB ,_, showed_VBD no_DT association_NN between_IN obesity_NN or_CC circulating_VBG androgen_NN levels_NNS and_CC endometrial_JJ cancer_NN risk_NN in_IN women_NNS who_WP were_VBD premenopausal_JJ at_IN blood_NN donation_NN ,_, and_CC which_WDT is_VBZ consistent_JJ with_IN some_DT ,_, but_CC not_RB all_DT previous_JJ data_NNS -LRB-_-LRB- all_DT from_IN traditional_JJ case_NN 
1997_CD ,_, Rinaldi_NNP et_FW al_FW ._. 
1994_CD ,_, Falk_NNP et_NNP al_NNP ._. 
Although_IN the_DT association_NN between_IN BMI_NNP and_CC endometrial_JJ cancer_NN risk_NN in_IN postmenopausal_JJ women_NNS was_VBD only_RB moderately_RB weakened_VBN after_IN an_DT adjustment_NN for_IN free_JJ estradiol_NN ,_, the_DT corresponding_JJ 
2005_CD -RRB-_-RRB- ._. 
,that_NNS contain_VBP progestagen_NN as_RB well_RB as_IN estrogen_NN throughout_IN the_DT treatment_NN period_NN -RRB-_-RRB- have_VBP a_DT protective_JJ effect_NN -LRB-_-LRB- Cancer_NNP and_CC Steroid_NNP Hormone_NNP Study_NNP 1987_CD ,_, Beral_NNP et_FW al_FW ._. 
Most_JJS of_IN the_DT larger_JJR retrospective_NN case_NN 
2004_CD -RRB-_-RRB- and_CC 57_CD postmenopausal_JJ cases_NNS -LRB-_-LRB- Zeleniuch-Jacquotte_NNP et_FW al_FW ._. 
These_DT findings_NNS are_VBP consistent_JJ with_IN data_NNS from_IN two_CD smaller_JJR prospective_JJ studies_NNS -LRB-_-LRB- that_WDT included_VBD 124_CD -LRB-_-LRB- Lukanova_FW et_FW al_FW ._. 
2001_CD -RRB-_-RRB- respectively_RB -RRB-_-RRB- and_CC most_JJS of_IN the_DT larger_JJR case_NN 
In_IN contrast_NN to_TO previous_JJ prospective_JJ -LRB-_-LRB- Lukanova_FW et_FW al_FW ._. 
Analyses_NNS with_IN mutual_JJ adjustments_NNS between_IN the_DT androgens_NNS -LRB-_-LRB- testosterone_NN and_CC free_JJ testosterone_NN -RRB-_-RRB- and_CC estrogens_NNS -LRB-_-LRB- estrone_NN ,_, estradiol_NN -RRB-_-RRB- suggest_VBP that_IN ,_, in_IN this_DT age_NN group_NN ,_, the_DT association_NN of_IN endometrial_JJ cancer_NN risk_NN with_IN free_JJ testosterone_NN levels_NNS could_MD be_VB a_DT result_NN of_IN peripheral_JJ conversion_NN of_IN these_DT androgens_NNS into_IN estradiol_NN ._. 
2004_CD -RRB-_-RRB- and_CC case_NN 
1982_CD ,_, Key_NNP 
e._IN 2005_CD -RRB-_-RRB- and_CC sequential_JJ oral_JJ contraceptives_NNS -LRB-_-LRB- OCs_NNP ;_: Weiss_NNP 
1993_CD ,_, Potischman_NNP et_FW al_FW ._. 
1991_CD ,_, Nyholm_NNP et_NNP al_NNP ._. 
2001_CD -RRB-_-RRB- respectively_RB -RRB-_-RRB- and_CC most_JJS of_IN the_DT larger_JJR case_NN 
2002_CD -RRB-_-RRB- and_CC is_VBZ the_DT fourth_JJ most_RBS common_JJ cancer_NN in_IN women_NNS in_IN westernized_JJ countries_NNS -LRB-_-LRB- Parkin_FW et_FW al_FW ._. 
Wellcome_NNP Trust_NNP Introduction_NNP Endometrial_NNP cancer_NN comprises_VBZ about_RB 4_CD %_NN of_IN all_DT cancers_NNS in_IN women_NNS worldwide_NN -LRB-_-LRB- Parkin_FW et_FW al_FW ._. 
2002_CD ,_, Bray_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Obesity_NNP is_VBZ an_DT important_JJ risk_NN factor_NN for_IN this_DT disease_NN in_IN both_DT pre_NN -_: and_CC postmenopausal_JJ women_NNS ,_, accounting_VBG for_IN 
2005_CD -RRB-_-RRB- ._. 
2002_CD ,_, Bray_FW et_FW al_FW ._. 
2002_CD -RRB-_-RRB- and_CC is_VBZ the_DT fourth_JJ most_RBS common_JJ cancer_NN in_IN women_NNS in_IN westernized_JJ countries_NNS -LRB-_-LRB- Parkin_FW et_FW al_FW ._. 
Obesity_NNP is_VBZ an_DT important_JJ risk_NN factor_NN for_IN this_DT disease_NN in_IN both_DT pre_NN -_: and_CC postmenopausal_JJ women_NNS ,_, accounting_VBG for_IN 
Although_IN the_DT association_NN between_IN BMI_NNP and_CC endometrial_JJ cancer_NN risk_NN in_IN postmenopausal_JJ women_NNS was_VBD only_RB moderately_RB weakened_VBN after_IN an_DT adjustment_NN for_IN free_JJ estradiol_NN ,_, the_DT corresponding_JJ 
that_WDT are_VBP related_VBN to_TO chronic_JJ hyperinsulinemia_NN and_CC reductions_NNS in_IN endometrial_JJ tissue_NN concentrations_NNS of_IN IGF-binding_JJ protein-1_NN -LRB-_-LRB- Kaaks_FW et_FW al_FW ._. 
2002_CD -RRB-_-RRB- or_CC to_TO low_JJ adiponectin_NN levels_NNS -LRB-_-LRB- Cust_FW et_FW al._FW ._. 
2007_CD -RRB-_-RRB- or_CC inflammatory_JJ factors_NNS -LRB-_-LRB- Modugno_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- -RRB-_-RRB- ._. 
Our_PRP$ study_NN results_NNS also_RB indicate_VBP that_IN increasing_VBG circulating_VBG levels_NNS of_IN free_JJ testosterone_NN and_CC ,_, to_TO a_DT lesser_JJR extent_NN ,_, total_JJ testosterone_NN are_VBP also_RB associated_VBN with_IN increasing_VBG postmenopausal_JJ endometrial_JJ cancer_NN risk_NN ._. 
1994_CD ,_, Falk_NNP et_NNP al_NNP ._. 
Although_IN the_DT association_NN between_IN BMI_NNP and_CC endometrial_JJ cancer_NN risk_NN in_IN postmenopausal_JJ women_NNS was_VBD only_RB moderately_RB weakened_VBN after_IN an_DT adjustment_NN for_IN free_JJ estradiol_NN ,_, the_DT corresponding_JJ 
However_RB ,_, the_DT steroid_JJ hormone_NN assays_NNS used_VBN in_IN the_DT present_JJ study_NN have_VBP been_VBN validated_VBN and_CC showed_VBD very_RB high_JJ correlations_NNS -LRB-_-LRB- 
The_DT laboratory_NN personnel_NNS performing_VBG the_DT hormone_NN assays_NNS were_VBD blinded_VBN as_IN to_TO the_DT case_NN 
1996_CD -RRB-_-RRB- ,_, we_PRP found_VBD no_DT evidence_NN that_WDT elevated_VBD levels_NNS of_IN androgens_NNS of_IN adrenal_JJ origin_NN ,_, such_JJ as_IN A-dione_NNP and_CC DHEAS_NNP ,_, were_VBD associated_VBN with_IN risk_NN ._. 
Free_JJ testosterone_NN levels_NNS used_VBN in_IN the_DT present_JJ analyses_NNS were_VBD calculated_VBN on_IN the_DT basis_NN of_IN mass_NN action_NN law_NN equations_NNS ,_, which_WDT have_VBP been_VBN previously_RB validated_VBN within_IN the_DT range_NN of_IN postmenopausal_JJ hormone_NN concentrations_NNS ,_, by_IN theoretical_JJ simulations_NNS and_CC direct_JJ comparison_NN with_IN free_JJ testosterone_NN measurements_NNS obtained_VBN by_IN an_DT equilibrium_NN dialysis_NN method_NN -LRB-_-LRB- Rinaldi_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
Additional_JJ simulations_NNS in_IN our_PRP$ laboratory_NN have_VBP shown_VBN that_IN these_DT same_JJ calculation_NN methods_NNS will_MD also_RB provide_VB valid_JJ results_NNS for_IN premenopausal_JJ women_NNS ,_, provided_VBN that_IN their_PRP$ blood_NN levels_NNS of_IN testosterone_NN ,_, estradiol_NN ,_, SHBG_NNP ,_, and_CC dihydrotestosterone_NN are_VBP all_DT within_IN the_DT normal_JJ -LRB-_-LRB- non-pathological_JJ -RRB-_-RRB- range_NN ._. 
1996_CD -RRB-_-RRB- ._. 
In_IN premenopausal_JJ women_NNS ,_, data_NNS on_IN the_DT association_NN between_IN circulating_VBG levels_NNS of_IN sex_NN steroid_NN hormones_NNS and_CC endometrial_JJ cancer_NN risk_NN are_VBP sparse_JJ ,_, but_CC suggest_VBP a_DT role_NN for_IN elevated_JJ levels_NNS of_IN estrone_NN and_CC androstenedione_NN -LRB-_-LRB- Potischman_NNP et_FW al_FW ._. 
To_TO date_NN ,_, only_RB two_CD prospective_JJ studies_NNS have_VBP examined_VBN the_DT relationship_NN of_IN endometrial_JJ cancer_NN risk_NN with_IN prediagnostic_JJ circulating_VBG levels_NNS of_IN sex_NN steroids_NNS ,_, and_CC these_DT studies_NNS focused_VBD entirely_RB on_IN women_NNS who_WP were_VBD postmenopausal_JJ at_IN the_DT time_NN of_IN blood_NN donation_NN -LRB-_-LRB- Zeleniuch-Jacquotte_NNP et_FW al._FW ._. 
2001_CD ,_, Lukanova_FW et_FW al_FW ._. 
2004_CD -RRB-_-RRB- ._. 
We_PRP report_VBP here_RB the_DT results_NNS from_IN a_DT case_NN 
These_DT findings_NNS are_VBP consistent_JJ with_IN data_NNS from_IN two_CD smaller_JJR prospective_JJ studies_NNS -LRB-_-LRB- that_WDT included_VBD 124_CD -LRB-_-LRB- Lukanova_FW et_FW al_FW ._. 
2004_CD -RRB-_-RRB- and_CC 57_CD postmenopausal_JJ cases_NNS -LRB-_-LRB- Zeleniuch-Jacquotte_NNP et_FW al._FW ._. 
2001_CD -RRB-_-RRB- respectively_RB -RRB-_-RRB- and_CC most_JJS of_IN the_DT larger_JJR case_NN 
-LRB-_-LRB- The_DT stability_NN of_IN serum_NN sex_NN steroid_NN levels_NNS measured_VBN in_IN blood_NN transported_VBN at_IN ambient_JJ temperatures_NNS or_CC kept_VBD at_IN ambient_JJ temperatures_NNS for_IN 24_CD or_CC 48_CD 
Most_JJS of_IN the_DT larger_JJR retrospective_NN case_NN 
2001_CD -RRB-_-RRB- respectively_RB -RRB-_-RRB- and_CC most_JJS of_IN the_DT larger_JJR case_NN 
In_IN conclusion_NN ,_, relatively_RB high_JJ blood_NN concentrations_NNS of_IN estrogens_NNS and_CC free_JJ testosterone_NN are_VBP associated_VBN with_IN an_DT increased_VBN endometrial_NN cancer_NN risk_NN in_IN postmenopausal_JJ women_NNS ._. 
Wellcome_NNP TrustIntroductionEndometrial_NNP cancer_NN comprises_VBZ about_RB 4_CD %_NN of_IN all_DT cancers_NNS in_IN women_NNS worldwide_NN -LRB-_-LRB- Parkin_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- and_CC is_VBZ the_DT fourth_JJ most_RBS common_JJ cancer_NN in_IN women_NNS in_IN westernized_JJ countries_NNS -LRB-_-LRB- Parkin_FW et_FW al_FW ._. 
2002_CD ,_, Bray_FW et_FW al_FW ._. 
Wellcome_NNP Trust_NNP Introduction_NNP Endometrial_NNP cancer_NN comprises_VBZ about_RB 4_CD %_NN of_IN all_DT cancers_NNS in_IN women_NNS worldwide_NN -LRB-_-LRB- Parkin_FW et_FW al_FW ._. 
2002_CD -RRB-_-RRB- and_CC is_VBZ the_DT fourth_JJ most_RBS common_JJ cancer_NN in_IN women_NNS in_IN westernized_JJ countries_NNS -LRB-_-LRB- Parkin_FW et_FW al._FW ._. 
2002_CD ,_, Bray_FW et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
Obesity_NNP is_VBZ an_DT important_JJ risk_NN factor_NN for_IN this_DT disease_NN in_IN both_DT pre_NN -_: and_CC postmenopausal_JJ women_NNS ,_, accounting_VBG for_IN 
After_IN the_DT menopause_NN ,_, when_WRB ovarian_JJ production_NN of_IN both_DT estrogen_NN and_CC progesterone_NN ceases_VBZ ,_, the_DT major_JJ source_NN of_IN estrogen_NN is_VBZ via_IN peripheral_JJ conversion_NN ,_, mostly_RB within_IN adipose_JJ tissue_NN ,_, of_IN androgens_NNS that_WDT continue_VBP being_VBG produced_VBN by_IN the_DT adrenal_JJ glands_NNS and_CC ovaries_NNS ._. 
In_IN addition_NN ,_, weight-related_JJ increases_NNS in_IN insulin_NN inhibit_VBP the_DT synthesis_NN of_IN SHBG_NNP -LRB-_-LRB- Plymate_FW et_FW al._FW ._. 
1988_CD -RRB-_-RRB- ,_, a_DT protein_NN that_WDT tightly_RB binds_VBZ estradiol_NN and_CC testosterone_NN ._. 
In_IN consequence_NN ,_, increasing_VBG adiposity_NN is_VBZ associated_VBN with_IN increasing_VBG blood_NN concentrations_NNS of_IN estrogen_NN ,_, and_CC with_IN increasing_VBG fractions_NNS of_IN estradiol_NN -LRB-_-LRB- and_CC also_RB testosterone_NN -RRB-_-RRB- unbound_JJ to_TO SHBG_NNP ,_, that_WDT can_MD freely_RB diffuse_VB to_TO target_VB tissues_NNS ._. 
These_DT well-known_JJ relationships_NNS of_IN adiposity_NN with_IN circulating_VBG levels_NNS of_IN total_JJ and_CC bioavailable_JJ estradiol_NN were_VBD clearly_RB seen_VBN in_IN our_PRP$ data_NNS ._. 
Although_IN the_DT association_NN between_IN BMI_NNP and_CC endometrial_JJ cancer_NN risk_NN in_IN postmenopausal_JJ women_NNS was_VBD only_RB moderately_RB weakened_VBN after_IN an_DT adjustment_NN for_IN free_JJ estradiol_NN ,_, the_DT corresponding_JJ 
1991_CD ,_, Nyholm_NNP et_NNP al_NNP ._. 
Most_JJS of_IN the_DT larger_JJR retrospective_NN case_NN 
1996_CD -RRB-_-RRB- ._. 
1993_CD ,_, Potischman_NNP et_FW al_FW ._. 
1991_CD ,_, Nyholm_NNP et_NNP al_NNP ._. 
Most_JJS of_IN the_DT larger_JJR retrospective_NN case_NN 
1991_CD ,_, Nyholm_NNP et_NNP al_NNP ._. 
2001_CD -RRB-_-RRB- respectively_RB -RRB-_-RRB- and_CC most_JJS of_IN the_DT larger_JJR case_NN 
2004_CD -RRB-_-RRB- and_CC case_NN 
2003_CD -RRB-_-RRB- ._. 
Nevertheless_RB ,_, this_DT hypothesis_NN is_VBZ consistent_JJ with_IN the_DT epidemiologic_JJ observations_NNS of_IN a_DT higher_JJR endometrial_JJ cancer_NN risk_NN among_IN women_NNS with_IN polycystic_JJ ovarian_JJ syndrome_NN ,_, a_DT condition_NN characterized_VBN by_IN obesity_NN ,_, ovarian_JJ hyperandrogenism_NN ,_, anovulation_NN ,_, and_CC progesterone_NN deficiency_NN -LRB-_-LRB- Hardiman_NNP et_FW al_FW ._. 
The_DT present_JJ study_NN ,_, however_RB ,_, showed_VBD no_DT association_NN between_IN obesity_NN or_CC circulating_VBG androgen_NN levels_NNS and_CC endometrial_JJ cancer_NN risk_NN in_IN women_NNS who_WP were_VBD premenopausal_JJ at_IN blood_NN donation_NN ,_, and_CC which_WDT is_VBZ consistent_JJ with_IN some_DT ,_, but_CC not_RB all_DT previous_JJ data_NNS -LRB-_-LRB- all_DT from_IN traditional_JJ case_NN 
For_IN all_DT confounding_JJ variables_NNS considered_VBN in_IN our_PRP$ analyses_NNS ,_, the_DT percentage_NN of_IN missing_VBG values_NNS was_VBD below_IN 3_CD %_NN -LRB-_-LRB- except_IN for_IN age_NN at_IN menopause_NN :_: 7_CD %_NN -RRB-_-RRB- ._. 
To_TO avoid_VB exclusion_NN of_IN all_DT of_IN these_DT women_NNS from_IN our_PRP$ logistic_JJ regression_NN analyses_NNS ,_, we_PRP imputed_JJ missing_VBG values_NNS using_VBG a_DT sequence_NN of_IN regression_NN models_NNS as_RB describe_VBP in_IN Raghunathan_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2001_CD -RRB-_-RRB- ._. 
In_IN this_DT approach_NN ,_, normal_JJ linear_JJ regression_NN models_NNS are_VBP used_VBN for_IN continuous_JJ variables_NNS and_CC polytomous_JJ regression_NN models_NNS for_IN categorical_JJ variables_NNS ._. 
With_IN a_DT total_NN of_IN 247_CD incident_NN cases_NNS of_IN endometrial_JJ cancer_NN and_CC 481_CD matched_VBN controls_NNS ,_, this_DT is_VBZ the_DT largest_JJS prospective_JJ study_NN to_TO date_NN on_IN the_DT relationships_NNS between_IN endometrial_JJ cancer_NN risk_NN and_CC serum_NN levels_NNS of_IN estrogens_NNS ,_, androgens_NNS ,_, and_CC sex_NN hormone-binding_NN globulin_NN -LRB-_-LRB- SHBG_NNP -RRB-_-RRB- ._. 
Subjects_NNS and_CC methodsStudy_NNP cohortEPIC_NNP recruitment_NN procedures_NNS and_CC collection_NN of_IN questionnaire_NN data_NNS ,_, anthropometric_JJ measurements_NNS ,_, and_CC blood_NN samples_NNS have_VBP been_VBN described_VBN in_IN detail_NN previously_RB -LRB-_-LRB- Riboli_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
In_IN brief_JJ ,_, extensive_JJ standardized_JJ questionnaire_NN data_NNS on_IN dietary_JJ and_CC non-dietary_JJ variables_NNS were_VBD collected_VBN between_IN 1992_CD and_CC 1998_CD from_IN about_IN 500_CD 
Here_RB ,_, blood_NN samples_NNS were_VBD collected_VBN throughout_IN the_DT United_NNP Kingdom_NNP and_CC transported_VBN to_TO a_DT laboratory_NN in_IN Norfolk_NNP by_IN mail_NN at_IN ambient_JJ temperature_NN ._. 
-LRB-_-LRB- The_DT stability_NN of_IN serum_NN sex_NN steroid_NN levels_NNS measured_VBN in_IN blood_NN transported_VBN at_IN ambient_JJ temperatures_NNS or_CC kept_VBD at_IN ambient_JJ temperatures_NNS for_IN 24_CD or_CC 48_CD 
2002_CD -RRB-_-RRB- ._. 
The_DT physiological_JJ mechanisms_NNS underlying_VBG this_DT relationship_NN are_VBP not_RB completely_RB understood_VBN ,_, but_CC may_MD involve_VB alterations_NNS in_IN endogenous_JJ sex_NN steroid_NN metabolism_NN -LRB-_-LRB- Kaaks_FW et_FW al_FW ._. 
The_DT predominant_JJ hypothesis_NN describing_VBG the_DT relationship_NN between_IN sex_NN steroid_NN hormones_NNS and_CC endometrial_JJ cancer_NN risk_NN is_VBZ known_VBN as_IN the_DT 
1982_CD ,_, Key_NNP 
However_RB ,_, this_DT is_VBZ difficult_JJ to_TO examine_VB directly_RB in_IN large-scale_JJ epidemiologic_JJ studies_NNS because_IN of_IN the_DT marked_JJ cyclical_JJ variation_NN in_IN estradiol_NN and_CC progesterone_NN levels_NNS in_IN premenopausal_JJ women_NNS ._. 
Nevertheless_RB ,_, this_DT hypothesis_NN is_VBZ consistent_JJ with_IN the_DT epidemiologic_JJ observations_NNS of_IN a_DT higher_JJR endometrial_JJ cancer_NN risk_NN among_IN women_NNS with_IN polycystic_JJ ovarian_JJ syndrome_NN ,_, a_DT condition_NN characterized_VBN by_IN obesity_NN ,_, ovarian_JJ hyperandrogenism_NN ,_, anovulation_NN ,_, and_CC progesterone_NN deficiency_NN -LRB-_-LRB- Hardiman_NNP et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
The_DT present_JJ study_NN ,_, however_RB ,_, showed_VBD no_DT association_NN between_IN obesity_NN or_CC circulating_VBG androgen_NN levels_NNS and_CC endometrial_JJ cancer_NN risk_NN in_IN women_NNS who_WP were_VBD premenopausal_JJ at_IN blood_NN donation_NN ,_, and_CC which_WDT is_VBZ consistent_JJ with_IN some_DT ,_, but_CC not_RB all_DT previous_JJ data_NNS -LRB-_-LRB- all_DT from_IN traditional_JJ case_NN 
Women_NNS who_WP had_VBD had_VBN a_DT hysterectomy_NN were_VBD also_RB excluded_VBN from_IN the_DT study_NN ._. 
Women_NNS who_WP were_VBD between_IN 42_CD and_CC 55_CD years_NNS of_IN age_NN -LRB-_-LRB- inclusive_JJ -RRB-_-RRB- and_CC had_VBD equivocal_JJ questionnaire_NN data_NNS for_IN menopausal_JJ status_NN were_VBD classified_VBN as_IN having_VBG an_DT unknown_JJ menopausal_JJ status_NN and_CC were_VBD excluded_VBN from_IN the_DT subsequent_JJ analyses_NNS ._. 
The_DT methods_NNS used_VBD to_TO determine_VB the_DT phase_NN of_IN menstrual_JJ cycle_NN at_IN blood_NN donation_NN from_IN premenopausal_JJ women_NNS have_VBP been_VBN described_VBN in_IN detail_NN previously_RB -LRB-_-LRB- Kaaks_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Follow-up_JJ for_IN cancer_NN incidence_NN and_CC vital_JJ status_NN In_IN Denmark_NNP ,_, Italy_NNP ,_, the_DT Netherlands_NNP ,_, Spain_NNP ,_, and_CC the_DT United_NNP Kingdom_NNP ,_, incident_NN cancer_NN cases_NNS were_VBD identified_VBN through_IN record_NN linkage_NN with_IN regional_JJ cancer_NN registries_NNS ._. 
2001_CD -RRB-_-RRB- ._. 
Obesity_NNP is_VBZ an_DT important_JJ risk_NN factor_NN for_IN this_DT disease_NN in_IN both_DT pre_NN -_: and_CC postmenopausal_JJ women_NNS ,_, accounting_VBG for_IN 
The_DT prospective_JJ design_NN of_IN our_PRP$ study_NN minimizes_VBZ the_DT risk_NN of_IN 
The_DT finding_NN that_IN obesity_NN is_VBZ associated_VBN with_IN increased_JJ endometrial_JJ risk_NN in_IN postmenopausal_JJ women_NNS is_VBZ well_RB established_VBN -LRB-_-LRB- Kaaks_FW et_FW al_FW ._. 
2002_CD ,_, Vainio_NNP 
g._NN However_RB ,_, one_PRP can_MD not_RB exclude_VB the_DT possibility_NN that_DT obesity_NN may_MD ,_, at_IN least_JJS partly_RB ,_, influence_NN endometrial_NN cancer_NN risk_NN via_IN mechanisms_NNS that_WDT are_VBP unrelated_JJ to_TO bioavailable_JJ estrogen_NN levels_NNS -LRB-_-LRB- e._NN that_WDT are_VBP related_VBN to_TO chronic_JJ hyperinsulinemia_NN and_CC reductions_NNS in_IN endometrial_JJ tissue_NN concentrations_NNS of_IN IGF-binding_JJ protein-1_NN -LRB-_-LRB- Kaaks_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- or_CC to_TO low_JJ adiponectin_NN levels_NNS -LRB-_-LRB- Cust_FW et_FW al_FW ._. 
2007_CD -RRB-_-RRB- or_CC inflammatory_JJ factors_NNS -LRB-_-LRB- Modugno_NNP et_FW al_FW ._. 
1996_CD ,_, Furberg_NNP 
2001_CD -RRB-_-RRB- ,_, suggesting_VBG that_IN the_DT relative_JJ ranking_NN of_IN women_NNS according_VBG to_TO their_PRP$ estrogen_NN level_NN is_VBZ not_RB affected_JJ using_VBG these_DT assays_NNS ._. 
Finally_RB ,_, serum_NN levels_NNS of_IN androgens_NNS and_CC estrogens_NNS may_MD be_VB poor_JJ indicators_NNS of_IN total_JJ androgenic_JJ and_CC estrogenic_JJ activities_NNS as_IN they_PRP do_VBP not_RB reflect_VB local_JJ conversion_NN of_IN adrenal_JJ precursors_NNS -LRB-_-LRB- such_JJ as_IN DHEA_NNP and_CC DHEAS_NNP -RRB-_-RRB- into_IN more_RBR active_JJ sex_NN steroids_NNS in_IN target_NN tissue_NN -LRB-_-LRB- Labrie_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
The_DT true_JJ relative_JJ risks_NNS associated_VBN with_IN the_DT elevated_JJ serum_NN and_CC tissue_NN concentrations_NNS of_IN estrogens_NNS and_CC testosterone_NN therefore_RB may_MD have_VB been_VBN underestimated_VBN in_IN our_PRP$ study_NN ._. 
The_DT predominant_JJ hypothesis_NN describing_VBG the_DT relationship_NN between_IN sex_NN steroid_NN hormones_NNS and_CC endometrial_JJ cancer_NN risk_NN is_VBZ known_VBN as_IN the_DT 
The_DT 
This_DT prospective_JJ study_NN is_VBZ the_DT first_JJ to_TO examine_VB the_DT association_NN between_IN endogenous_JJ androgens_NNS and_CC endometrial_JJ cancer_NN risk_NN among_IN women_NNS who_WP were_VBD premenopausal_JJ at_IN blood_NN donation_NN ._. 
It_PRP has_VBZ been_VBN hypothesized_VBN that_IN in_IN premenopausal_JJ women_NNS ,_, whose_WP$ circulating_VBG estradiol_NN levels_NNS generally_RB are_VBP above_IN a_DT threshold_NN of_IN about_IN 50_CD 
2002_CD -RRB-_-RRB- or_CC to_TO low_JJ adiponectin_NN levels_NNS -LRB-_-LRB- Cust_FW et_FW al_FW ._. 
that_WDT are_VBP related_VBN to_TO chronic_JJ hyperinsulinemia_NN and_CC reductions_NNS in_IN endometrial_JJ tissue_NN concentrations_NNS of_IN IGF-binding_JJ protein-1_NN -LRB-_-LRB- Kaaks_FW et_FW al_FW ._. 
2007_CD -RRB-_-RRB- or_CC inflammatory_JJ factors_NNS -LRB-_-LRB- Modugno_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- -RRB-_-RRB- ._. 
Our_PRP$ study_NN results_NNS also_RB indicate_VBP that_IN increasing_VBG circulating_VBG levels_NNS of_IN free_JJ testosterone_NN and_CC ,_, to_TO a_DT lesser_JJR extent_NN ,_, total_JJ testosterone_NN are_VBP also_RB associated_VBN with_IN increasing_VBG postmenopausal_JJ endometrial_JJ cancer_NN risk_NN ._. 
To_TO date_NN ,_, only_RB two_CD prospective_JJ studies_NNS have_VBP examined_VBN the_DT relationship_NN of_IN endometrial_JJ cancer_NN risk_NN with_IN prediagnostic_JJ circulating_VBG levels_NNS of_IN sex_NN steroids_NNS ,_, and_CC these_DT studies_NNS focused_VBD entirely_RB on_IN women_NNS who_WP were_VBD postmenopausal_JJ at_IN the_DT time_NN of_IN blood_NN donation_NN -LRB-_-LRB- Zeleniuch-Jacquotte_NNP et_FW al_FW ._. 
2001_CD ,_, Lukanova_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
We_PRP report_VBP here_RB the_DT results_NNS from_IN a_DT case_NN 
Norway_NNP was_VBD not_RB included_VBN in_IN the_DT present_JJ study_NN because_IN blood_NN samples_NNS have_VBP been_VBN collected_VBN only_RB recently_RB and_CC very_RB few_JJ cases_NNS of_IN endometrial_JJ cancer_NN have_VBP been_VBN diagnosed_VBN ._. 
Sweden_NNP was_VBD not_RB included_VBN because_IN of_IN limited_JJ questionnaire_NN information_NN at_IN the_DT time_NN of_IN blood_NN donation_NN about_IN menopausal_JJ status_NN ,_, past_JJ and_CC current_JJ use_NN of_IN exogenous_JJ hormones_NNS ,_, and_CC phase_NN of_IN menstrual_JJ cycle_NN -LRB-_-LRB- Malm_NNP 
These_DT results_NNS were_VBD statistically_RB significant_JJ ,_, similar_JJ between_IN the_DT eight_CD European_JJ countries_NNS included_VBN in_IN the_DT analysis_NN ,_, and_CC not_RB altered_VBN by_IN smoking_NN ,_, parity_NN ,_, and_CC other_JJ known_VBN risk_NN factors_NNS for_IN endometrial_JJ cancer_NN ._. 
These_DT findings_NNS are_VBP consistent_JJ with_IN data_NNS from_IN two_CD smaller_JJR prospective_JJ studies_NNS -LRB-_-LRB- that_WDT included_VBD 124_CD -LRB-_-LRB- Lukanova_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- and_CC 57_CD postmenopausal_JJ cases_NNS -LRB-_-LRB- Zeleniuch-Jacquotte_NNP et_FW al_FW ._. 
2001_CD -RRB-_-RRB- respectively_RB -RRB-_-RRB- and_CC most_JJS of_IN the_DT larger_JJR case_NN 
Our_PRP$ study_NN results_NNS also_RB indicate_VBP that_IN increasing_VBG circulating_VBG levels_NNS of_IN free_JJ testosterone_NN and_CC ,_, to_TO a_DT lesser_JJR extent_NN ,_, total_JJ testosterone_NN are_VBP also_RB associated_VBN with_IN increasing_VBG postmenopausal_JJ endometrial_JJ cancer_NN risk_NN ._. 
These_DT results_NNS are_VBP in_IN line_NN with_IN those_DT from_IN a_DT previous_JJ prospective_JJ study_NN ,_, which_WDT showed_VBD an_DT association_NN of_IN risk_NN with_IN total_JJ testosterone_NN -LRB-_-LRB- Lukanova_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
Since_IN in_IN this_DT previous_JJ study_NN ,_, risk_NN was_VBD also_RB inversely_RB related_VBN to_TO SHBG_NNP levels_NNS ,_, it_PRP is_VBZ likely_JJ that_IN risk_NN would_MD also_RB be_VB positively_RB related_VBN to_TO free_JJ testosterone_NN levels_NNS ,_, although_IN no_DT direct_JJ estimates_NNS for_IN free_JJ testosterone_NN were_VBD provided_VBN ._. 
Analyses_NNS with_IN mutual_JJ adjustments_NNS between_IN the_DT androgens_NNS -LRB-_-LRB- testosterone_NN and_CC free_JJ testosterone_NN -RRB-_-RRB- and_CC estrogens_NNS -LRB-_-LRB- estrone_NN ,_, estradiol_NN -RRB-_-RRB- suggest_VBP that_IN ,_, in_IN this_DT age_NN group_NN ,_, the_DT association_NN of_IN endometrial_JJ cancer_NN risk_NN with_IN free_JJ testosterone_NN levels_NNS could_MD be_VB a_DT result_NN of_IN peripheral_JJ conversion_NN of_IN these_DT androgens_NNS into_IN estradiol_NN ._. 
In_IN contrast_NN to_TO previous_JJ prospective_JJ -LRB-_-LRB- Lukanova_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- and_CC case_NN 
The_DT finding_NN that_IN obesity_NN is_VBZ associated_VBN with_IN increased_JJ endometrial_JJ risk_NN in_IN postmenopausal_JJ women_NNS is_VBZ well_RB established_VBN -LRB-_-LRB- Kaaks_FW et_FW al_FW ._. 
2002_CD ,_, Vainio_NNP 
The_DT magnitude_NN of_IN risk_NN associated_VBN with_IN free_JJ testosterone_NN was_VBD similar_JJ to_TO that_DT of_IN the_DT estrogens_NNS and_CC because_IN the_DT levels_NNS of_IN sex_NN hormones_NNS are_VBP positively_RB correlated_VBN with_IN each_DT other_JJ ,_, it_PRP is_VBZ difficult_JJ to_TO identify_VB which_WDT single_JJ hormone_NN is_VBZ most_RBS strongly_RB associated_VBN with_IN endometrial_JJ cancer_NN risk_NN ._. 
However_RB ,_, unlike_IN estrogens_NNS ,_, testosterone_NN does_VBZ not_RB seem_VB to_TO have_VB a_DT direct_JJ stimulatory_JJ effect_NN on_IN endometrial_JJ cell_NN proliferation_NN -LRB-_-LRB- Tuckerman_NNP et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ._. 
Analyses_NNS with_IN mutual_JJ adjustments_NNS between_IN the_DT androgens_NNS -LRB-_-LRB- testosterone_NN and_CC free_JJ testosterone_NN -RRB-_-RRB- and_CC estrogens_NNS -LRB-_-LRB- estrone_NN ,_, estradiol_NN -RRB-_-RRB- suggest_VBP that_IN ,_, in_IN this_DT age_NN group_NN ,_, the_DT association_NN of_IN endometrial_JJ cancer_NN risk_NN with_IN free_JJ testosterone_NN levels_NNS could_MD be_VB a_DT result_NN of_IN peripheral_JJ conversion_NN of_IN these_DT androgens_NNS into_IN estradiol_NN ._. 
2003_CD -RRB-_-RRB- ._. 
Nevertheless_RB ,_, this_DT hypothesis_NN is_VBZ consistent_JJ with_IN the_DT epidemiologic_JJ observations_NNS of_IN a_DT higher_JJR endometrial_JJ cancer_NN risk_NN among_IN women_NNS with_IN polycystic_JJ ovarian_JJ syndrome_NN ,_, a_DT condition_NN characterized_VBN by_IN obesity_NN ,_, ovarian_JJ hyperandrogenism_NN ,_, anovulation_NN ,_, and_CC progesterone_NN deficiency_NN -LRB-_-LRB- Hardiman_NNP et_FW al_FW ._. 
The_DT present_JJ study_NN ,_, however_RB ,_, showed_VBD no_DT association_NN between_IN obesity_NN or_CC circulating_VBG androgen_NN levels_NNS and_CC endometrial_JJ cancer_NN risk_NN in_IN women_NNS who_WP were_VBD premenopausal_JJ at_IN blood_NN donation_NN ,_, and_CC which_WDT is_VBZ consistent_JJ with_IN some_DT ,_, but_CC not_RB all_DT previous_JJ data_NNS -LRB-_-LRB- all_DT from_IN traditional_JJ case_NN 
e._IN 2005_CD -RRB-_-RRB- and_CC sequential_JJ oral_JJ contraceptives_NNS -LRB-_-LRB- OCs_NNP ;_: Weiss_NNP 
These_DT included_VBD 54_CD cases_NNS in_IN Denmark_NNP ,_, 52_CD in_IN Italy_NNP ,_, 37_CD in_IN Spain_NNP ,_, 28_CD in_IN the_DT Netherlands_NNP ,_, 32_CD in_IN the_DT UK_NNP ,_, 20_CD in_IN Germany_NNP ,_, 16_CD in_IN France_NNP ,_, and_CC 8_CD in_IN Greece_NNP ._. 
Detailed_JJ tumor_NN morphology_NN was_VBD specified_VBN for_IN 127_CD cases_NNS -LRB-_-LRB- 51_CD %_NN -RRB-_-RRB- ,_, of_IN which_WDT 118_CD cases_NNS -LRB-_-LRB- 94_CD %_NN -RRB-_-RRB- were_VBD classified_VBN as_IN type_NN I_PRP -LRB-_-LRB- endometrioid_JJ adenocarcinomas_NNS -RRB-_-RRB- and_CC 9_CD cases_NNS -LRB-_-LRB- 6_CD %_NN -RRB-_-RRB- as_IN type_NN II_NNP -LRB-_-LRB- serous_JJ papillary_NN ,_, clear_JJ cell_NN or_CC squamous_JJ adenocarcinomas_NNS ;_: Tavassoli_NNP 
Differences_NNS in_IN baseline_JJ characteristics_NNS between_IN case_NN patients_NNS and_CC control_NN subjects_NNS were_VBD compared_VBN using_VBG the_DT paired_VBN t_NN -_: test_NN for_IN continuous_JJ variables_NNS and_CC the_DT 
The_DT unopposed_JJ estrogen_NN hypothesis_NN is_VBZ supported_VBN by_IN the_DT observations_NNS that_IN the_DT use_NN of_IN estrogen-only_JJ hormone-replacement_NN therapy_NN -LRB-_-LRB- HRT_NNP ;_: Beral_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- and_CC sequential_JJ oral_JJ contraceptives_NNS -LRB-_-LRB- OCs_NNP ;_: Weiss_NNP 
Additional_JJ simulations_NNS in_IN our_PRP$ laboratory_NN have_VBP shown_VBN that_IN these_DT same_JJ calculation_NN methods_NNS will_MD also_RB provide_VB valid_JJ results_NNS for_IN premenopausal_JJ women_NNS ,_, provided_VBN that_IN their_PRP$ blood_NN levels_NNS of_IN testosterone_NN ,_, estradiol_NN ,_, SHBG_NNP ,_, and_CC dihydrotestosterone_NN are_VBP all_DT within_IN the_DT normal_JJ -LRB-_-LRB- non-pathological_JJ -RRB-_-RRB- range_NN ._. 
Adirect_JJ validation_NN of_IN calculated_JJ versus_CC directly_RB measured_JJ values_NNS of_IN free_JJ testosterone_NN in_IN premenopausal_JJ women_NNS was_VBD published_VBN by_IN Vermeulen_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- ._. 
This_DT prospective_JJ study_NN is_VBZ the_DT first_JJ to_TO examine_VB the_DT association_NN between_IN endogenous_JJ androgens_NNS and_CC endometrial_JJ cancer_NN risk_NN among_IN women_NNS who_WP were_VBD premenopausal_JJ at_IN blood_NN donation_NN ._. 
2000_CD ,_, Astuti_FW et_FW al_FW ._. 
2000_CD ,_, Gimm_FW et_FW al_FW ._. 
1997_CD ,_, Baysal_FW et_FW al_FW ._. 
1995_CD ,_, Woodward_NNP et_FW al_FW ._. 
1993_CD ,_, Crossey_FW et_FW al_FW ._. 
2001a_JJ ,_, b_NN ,_, Neumann_NNP et_FW al._FW ._. 
2002_CD ,_, Schiavi_NNP et_FW al_FW ._. 
2005_CD ,_, Mannelli_FW et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
In_IN addition_NN ,_, germline_NN mutations_NNS in_IN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP associated_VBN with_IN susceptibility_NN to_TO renal_JJ cell_NN carcinoma_NN -LRB-_-LRB- RCC_NNP -RRB-_-RRB- ,_, though_IN the_DT risk_NN of_IN RCC_NNP is_VBZ about_RB five_CD times_NNS higher_JJR in_IN VHL_NNP disease_NN -LRB-_-LRB- Maher_NNP et_FW al_FW ._. 
2001_CD ,_, Yu_FW et_FW al_FW ._. 
2001_CD ,_, Masson_NNP et_NNP al_NNP ._. 
2001_CD ,_, Jaakkola_FW et_FW al_FW ._. 
The_DT oxygen-dependent_JJ interaction_NN of_IN pVHL_NNP with_IN HIF_NNP -_: 
2002_CD -RRB-_-RRB- ._. 
2001_CD -RRB-_-RRB- :_: non-hydroxylated_JJ HIF_NNP -_: 
Under_IN hypoxic_JJ conditions_NNS ,_, the_DT rate_NN of_IN prolyl_NN hydroxylation_NN ,_, and_CC hence_RB the_DT rate_NN of_IN proteasomal_JJ degradation_NN of_IN HIF_NNP -_: 
To_TO date_NN ,_, germline_NN mutations_NNS in_IN PHD2_NNP have_VBP been_VBN associated_VBN with_IN congenital_JJ polycythemia_NN and_CC ,_, in_IN one_CD case\/family_JJ ,_, recurrent_JJ extra-adrenal_JJ phaeochromocytoma_NN -LRB-_-LRB- Percy_NNP et_FW al_FW ._. 
2006_CD ,_, 2007_CD ,_, Al-Sheikh_NNP et_FW al._FW ._. 
2008_CD ,_, Ladroue_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ._. 
We_PRP hypothesised_VBD that_IN patients_NNS with_IN features_NNS of_IN inherited_VBN susceptibility_NN to_TO phaeochromocytoma_NN and\/or_CC RCC_NNP might_MD harbor_VB germline_NN mutations_NNS in_IN PHD1_NNP ,_, PHD2_NNP or_CC PHD3_NNP ._. 
PHD2_CD mutations_NNS were_VBD initially_RB described_VBN in_IN association_NN with_IN familial_JJ erythrocytosis_NNS -LRB-_-LRB- Percy_NNP et_FW al_FW ._. 
2006_CD ,_, 2007_CD ,_, Al-Sheikh_NNP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- and_CC that_IN the_DT patient_NN reported_VBN by_IN Ladroue_NNP et_FW al_FW ._. 
-LRB-_-LRB- 2008_CD -RRB-_-RRB- had_VBD both_DT recurrent_JJ paraganglioma_NN and_CC congenital_JJ erythrocytosis_NNS ._. 
2000_CD ,_, Gimm_FW et_FW al_FW ._. 
1997_CD ,_, Baysal_FW et_FW al_FW ._. 
1995_CD ,_, Woodward_NNP et_FW al_FW ._. 
1993_CD ,_, Crossey_FW et_FW al_FW ._. 
Introduction_NNP Germline_NNP mutations_NNS in_IN the_DT von_NNP Hippel_NNP 
Germline_JJ mutations_NNS in_IN both_DT VHL_NNP and_CC SDHB\/D_NNP mutations_NNS are_VBP important_JJ causes_NNS of_IN familial_JJ phaeochromocytoma_NN ;_: however_RB ,_, somatic_JJ mutations_NNS of_IN these_DT genes_NNS are_VBP infrequent_JJ in_IN sporadic_JJ tumors_NNS -LRB-_-LRB- Eng_FW et_FW al_FW ._. 
1995_CD ,_, Astuti_FW et_FW al._FW ._. 
2001_CD a_DT ,_, b_NN -RRB-_-RRB- ._. 
Hence_RB ,_, we_PRP concentrated_VBD our_PRP$ efforts_NNS on_IN testing_NN for_IN germline_NN PHD1_CD ,_, PHD2_CD and_CC PHD3_CD mutations_NNS in_IN patients_NNS with_IN features_NNS of_IN inherited_VBN phaeochromocytoma_NN ._. 
Although_IN it_PRP might_MD be_VB hypothesised_VBN that_IN germline_JJ PHD2_NNP mutations_NNS might_MD be_VB restricted_VBN to_TO phaeochromocytoma_NN patients_NNS with_IN congenital_JJ erythrocytosis_NNS ,_, we_PRP did_VBD not_RB identify_VB a_DT PHD2_NNP mutation_NN in_IN a_DT patient_NN with_IN early_JJ onset_NN phaeochromocytoma_NN and_CC erythrocytosis_NN ._. 
All_DT three_CD PHD_NNP isoforms_NNS regulate_VBP both_DT HIF-1_NN 
1994_CD ,_, Gnarra_FW et_FW al_FW ._. 
In_IN contrast_NN to_TO phaeochromocytoma_NN ,_, somatic_JJ VHL_NNP mutations_NNS are_VBP very_RB frequent_JJ in_IN sporadic_JJ RCC_NNP -LRB-_-LRB- Foster_NNP et_NNP al_NNP ._. 
1994_CD ,_, Banks_NNP et_NNP al._NNP ._. 
2006_CD -RRB-_-RRB- -LRB-_-LRB- though_IN somatic_JJ SDHB_NNP inactivation_NN is_VBZ rare_JJ in_IN RCC_NNP -LRB-_-LRB- Morris_NNP et_FW al_FW ._. 
2004_CD -RRB-_-RRB- -RRB-_-RRB- ._. 
However_RB ,_, large-scale_JJ resequencing_NN of_IN RCC_NNP samples_NNS -LRB-_-LRB- n_SYM =_SYM 101_CD -RRB-_-RRB- did_VBD not_RB detect_VB mutations_NNS in_IN PHD1_NNP ,_, PHD2_NNP or_CC PHD3_NNP -LRB-_-LRB- Dalgliesh_NNP et_FW al_FW ._. 
2000_CD ,_, Astuti_FW et_FW al_FW ._. 
2000_CD ,_, Gimm_FW et_FW al_FW ._. 
1997_CD ,_, Baysal_FW et_FW al_FW ._. 
1995_CD ,_, Woodward_NNP et_FW al_FW ._. 
1993_CD ,_, Crossey_FW et_FW al_FW ._. 
2001a_JJ ,_, b_NN ,_, Neumann_NNP et_FW al._FW ._. 
2002_CD ,_, Schiavi_NNP et_FW al_FW ._. 
2005_CD ,_, Mannelli_FW et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
In_IN addition_NN ,_, germline_NN mutations_NNS in_IN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP associated_VBN with_IN susceptibility_NN to_TO renal_JJ cell_NN carcinoma_NN -LRB-_-LRB- RCC_NNP -RRB-_-RRB- ,_, though_IN the_DT risk_NN of_IN RCC_NNP is_VBZ about_RB five_CD times_NNS higher_JJR in_IN VHL_NNP disease_NN -LRB-_-LRB- Maher_NNP et_FW al_FW ._. 
1995_CD ,_, Astuti_FW et_FW al_FW ._. 
Germline_JJ mutations_NNS in_IN both_DT VHL_NNP and_CC SDHB\/D_NNP mutations_NNS are_VBP important_JJ causes_NNS of_IN familial_JJ phaeochromocytoma_NN ;_: however_RB ,_, somatic_JJ mutations_NNS of_IN these_DT genes_NNS are_VBP infrequent_JJ in_IN sporadic_JJ tumors_NNS -LRB-_-LRB- Eng_FW et_FW al_FW ._. 
2001a_JJ ,_, b_NN -RRB-_-RRB- ._. 
Hence_RB ,_, we_PRP concentrated_VBD our_PRP$ efforts_NNS on_IN testing_NN for_IN germline_NN PHD1_CD ,_, PHD2_CD and_CC PHD3_CD mutations_NNS in_IN patients_NNS with_IN features_NNS of_IN inherited_VBN phaeochromocytoma_NN ._. 
2008_CD -RRB-_-RRB- ._. 
Intriguingly_RB ,_, PHD3_NNP -LRB-_-LRB- but_CC not_RB PHD1_CD or_CC PHD2_CD -RRB-_-RRB- is_VBZ a_DT key_JJ mediator_NN of_IN this_DT apoptotic_JJ pathway_NN ,_, and_CC germline_NN mutations_NNS in_IN KIF1BBeta_NNP -LRB-_-LRB- that_DT encodes_VBZ a_DT target_NN of_IN PHD3\/EGLN3_NNP -RRB-_-RRB- have_VBP been_VBN associated_VBN with_IN familial_JJ susceptibility_NN to_TO neural_JJ crest_NN tumors_NNS -LRB-_-LRB- Schlisio_FW et_FW al_FW ._. 
Furthermore_RB ,_, PHD3_JJ knockout_NN mice_NNS demonstrated_VBD increased_JJ numbers_NNS of_IN cells_NNS in_IN the_DT superior_JJ cervical_JJ ganglion_NN ,_, adrenal_JJ medulla_NN and_CC carotid_NN body_NN -LRB-_-LRB- Bishop_NNP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
However_RB ,_, we_PRP identified_VBD only_RB one_CD potential_JJ PHD3_NNP mutation_NN in_IN our_PRP$ cohort_NN of_IN inherited_VBN phaeochromocytoma_NN probands_NNS and_CC ,_, although_IN the_DT missense_NN variant_NN was_VBD not_RB detected_VBN in_IN normal_JJ controls_NNS ,_, we_PRP did_VBD not_RB detect_VB any_DT evidence_NN that_IN the_DT p._NN 
1995_CD ,_, Woodward_NNP et_FW al_FW ._. 
1993_CD ,_, Crossey_FW et_FW al_FW ._. 
Introduction_NNP Germline_NNP mutations_NNS in_IN the_DT von_NNP Hippel_NNP 
g._IN The_DT advent_NN of_IN comprehensive_JJ genomic_JJ analysis_NN techniques_NNS -LRB-_-LRB- e._FW Nevertheless_RB ,_, a_DT significant_JJ fraction_NN of_IN patients_NNS with_IN features_NNS of_IN inherited_VBN phaeochromocytoma_NN or_CC RCC_NNP do_VBP not_RB have_VB a_DT detectable_JJ mutation_NN in_IN a_DT known_VBN susceptibility_NN gene_NN ._. 
whole_JJ exome_NN resequencing_VBG -RRB-_-RRB- -LRB-_-LRB- Kryukov_NNP et_FW al._FW ._. 
2009_CD ,_, Summerer_FW et_FW al_FW ._. 
2010_CD -RRB-_-RRB- should_MD expedite_VB the_DT identification_NN of_IN novel_JJ phaeochromocytoma\/RCC_NNP predisposition_NN genes_NNS and_CC so_RB provide_VB further_JJ insights_NNS into_IN the_DT mechanism_NN of_IN tumourigenesis_NNS in_IN these_DT disorders_NNS ._. 
2006_CD ,_, 2007_CD ,_, Al-Sheikh_NNP et_FW al_FW ._. 
To_TO date_NN ,_, germline_NN mutations_NNS in_IN PHD2_NNP have_VBP been_VBN associated_VBN with_IN congenital_JJ polycythemia_NN and_CC ,_, in_IN one_CD case\/family_JJ ,_, recurrent_JJ extra-adrenal_JJ phaeochromocytoma_NN -LRB-_-LRB- Percy_NNP et_FW al_FW ._. 
2008_CD ,_, Ladroue_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
We_PRP hypothesised_VBD that_IN patients_NNS with_IN features_NNS of_IN inherited_VBN susceptibility_NN to_TO phaeochromocytoma_NN and\/or_CC RCC_NNP might_MD harbor_VB germline_NN mutations_NNS in_IN PHD1_NNP ,_, PHD2_NNP or_CC PHD3_NNP ._. 
Discussion_NN We_PRP did_VBD not_RB find_VB any_DT evidence_NN that_IN germline_JJ mutations_NNS in_IN PHD1_NNP ,_, PHD2_NNP or_CC PHD3_NNP are_VBP frequent_JJ causes_NNS of_IN inherited_VBN susceptibility_NN to_TO phaeochromocytoma_NN or_CC RCC_NNP ._. 
Thus_RB ,_, although_IN Ladroue_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2008_CD -RRB-_-RRB- reported_VBD a_DT patient_NN with_IN recurrent_JJ paraganglioma_NN and_CC a_DT germline_FW PHD2_FW missense_FW mutation_NN -LRB-_-LRB- c._FW 1121A_FW 
2006_CD ,_, 2007_CD ,_, Al-Sheikh_NNP et_FW al_FW ._. 
PHD2_CD mutations_NNS were_VBD initially_RB described_VBN in_IN association_NN with_IN familial_JJ erythrocytosis_NNS -LRB-_-LRB- Percy_NNP et_FW al_FW ._. 
2008_CD -RRB-_-RRB- and_CC that_IN the_DT patient_NN reported_VBN by_IN Ladroue_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2008_CD -RRB-_-RRB- had_VBD both_DT recurrent_JJ paraganglioma_NN and_CC congenital_JJ erythrocytosis_NNS ._. 
Although_IN it_PRP might_MD be_VB hypothesised_VBN that_IN germline_JJ PHD2_NNP mutations_NNS might_MD be_VB restricted_VBN to_TO phaeochromocytoma_NN patients_NNS with_IN congenital_JJ erythrocytosis_NNS ,_, we_PRP did_VBD not_RB identify_VB a_DT PHD2_NNP mutation_NN in_IN a_DT patient_NN with_IN early_JJ onset_NN phaeochromocytoma_NN and_CC erythrocytosis_NN ._. 
However_RB ,_, large-scale_JJ resequencing_NN of_IN RCC_NNP samples_NNS -LRB-_-LRB- n_SYM =_SYM 101_CD -RRB-_-RRB- did_VBD not_RB detect_VB mutations_NNS in_IN PHD1_NNP ,_, PHD2_NNP or_CC PHD3_NNP -LRB-_-LRB- Dalgliesh_NNP et_FW al_FW ._. 
2010_CD -RRB-_-RRB- ,_, and_CC we_PRP have_VBP not_RB detected_VBN frequent_JJ evidence_NN of_IN up-regulation_NN of_IN any_DT of_IN the_DT three_CD prolyl_NN hydroxylase_NN genes_NNS in_IN RCC_NNP cell_NN lines_NNS treated_VBN with_IN 5-azacytidine_JJ -LRB-_-LRB- Morris_NNP et_NNP al._NNP ._. 
2010_CD and_CC unpublished_JJ studies_NNS -RRB-_-RRB- ._. 
The_DT absence_NN of_IN germline_NN PHD1_CD ,_, PHD2_CD or_CC PHD3_CD mutations_NNS in_IN inherited_VBN phaeochromocytoma_NN or_CC RCC_NNP might_MD suggest_VB that_DT inactivation_NN of_IN one_CD of_IN these_DT genes_NNS is_VBZ insufficient_JJ to_TO replicate_VB the_DT range_NN of_IN pro-oncogenic_JJ effects_NNS associated_VBN with_IN pathogenic_JJ germline_NN VHL_NNP or_CC SDHB\/D_NNP mutations_NNS ._. 
2001_CD ,_, Masson_NNP et_NNP al_NNP ._. 
2001_CD ,_, Jaakkola_FW et_FW al_FW ._. 
The_DT oxygen-dependent_JJ interaction_NN of_IN pVHL_NNP with_IN HIF_NNP -_: 
1997_CD ,_, Baysal_FW et_FW al_FW ._. 
1995_CD ,_, Woodward_NNP et_FW al_FW ._. 
1993_CD ,_, Crossey_FW et_FW al_FW ._. 
Introduction_NNP Germline_NNP mutations_NNS in_IN the_DT von_NNP Hippel_NNP 
In_IN contrast_NN to_TO phaeochromocytoma_NN ,_, somatic_JJ VHL_NNP mutations_NNS are_VBP very_RB frequent_JJ in_IN sporadic_JJ RCC_NNP -LRB-_-LRB- Foster_NNP et_NNP al_NNP ._. 
1994_CD ,_, Gnarra_FW et_FW al._FW ._. 
1994_CD ,_, Banks_NNP et_NNP al_NNP ._. 
2006_CD -RRB-_-RRB- -LRB-_-LRB- though_IN somatic_JJ SDHB_NNP inactivation_NN is_VBZ rare_JJ in_IN RCC_NNP -LRB-_-LRB- Morris_NNP et_FW al_FW ._. 
2004_CD -RRB-_-RRB- -RRB-_-RRB- ._. 
1994_CD ,_, Schlingensiepen_NNP et_FW al_FW ._. 
They_PRP suggested_VBD that_IN inherited_VBN phaeochromocytomas_NNS originate_VBP from_IN sympathetic_JJ neuronal_JJ precursor_NN cells_NNS that_WDT usually_RB undergo_VBP c-Jun-dependent_JJ apoptosis_NN during_IN embryogenesis_NN when_WRB growth_NN factors_NNS such_JJ as_IN nerve_NN growth_NN factor_NN -LRB-_-LRB- NGF_NNP -RRB-_-RRB- become_VBP limiting_VBG -LRB-_-LRB- Estus_FW et_FW al_FW ._. 
1994_CD ,_, Ham_NNP et_FW al._FW ._. 
1995_CD ,_, Xia_FW et_FW al_FW ._. 
1995_CD -RRB-_-RRB- ._. 
Germline_NNP VHL_NNP and_CC SDHB_NNP mutations_NNS compromise_VBP this_DT pathway_NN leading_VBG to_TO a_DT failure_NN of_IN normal_JJ developmental_JJ apoptosis_NN and_CC survival_NN of_IN cells_NNS that_WDT would_MD give_VB rise_NN to_TO phaeochromocytoma_NN ._. 
Interestingly_RB ,_, functional_JJ analysis_NN of_IN pVHL_JJ mutants_NNS has_VBZ also_RB suggested_VBN that_IN some_DT VHL_NNP mutations_NNS associated_VBN with_IN a_DT high_JJ risk_NN of_IN phaeochromocytoma_NN do_VBP not_RB compromise_VB pVHL_JJ regulation_NN of_IN HIF_NNP ,_, so_RB implicating_VBG HIF-independent_JJ mechanisms_NNS in_IN the_DT development_NN of_IN VHL-associated_JJ phaeochromocytoma_NN -LRB-_-LRB- Clifford_NNP et_FW al_FW ._. 
2001_CD ,_, Hoffman_NNP et_NNP al._NNP ._. 
2001_CD -RRB-_-RRB- ._. 
Consistent_JJ with_IN this_DT hypothesis_NN ,_, Lee_NNP et_NNP al_NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- described_VBD a_DT HIF-independent_JJ pathway_NN linked_VBN to_TO inherited_VBN causes_NNS of_IN phaeochromocytoma_NN -LRB-_-LRB- including_VBG those_DT associated_VBN with_IN germline_NN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP mutations_NNS -RRB-_-RRB- ._. 
1999_CD -RRB-_-RRB- ._. 
In_IN normoxia_NN ,_, the_DT HIF-1_NN and_CC HIF-2_NN 
The_DT oxygen-dependent_JJ interaction_NN of_IN pVHL_NNP with_IN HIF_NNP -_: 
3%_CD collagenase_NN for_IN 30_CD 
The_DT VHL_NNP tumor_NN suppressor_NN gene_NN product_NN -LRB-_-LRB- pVHL_NNP -RRB-_-RRB- has_VBZ multiple_JJ functions_NNS -LRB-_-LRB- see_VB Frew_NNP 
2007_CD ,_, Ricketts_NNPS et_FW al_FW ._. 
2004_CD ,_, Ong_NNP et_FW al_FW ._. 
1993_CD ,_, Vanharanta_NNP et_FW al_FW ._. 
1990_CD ,_, Latif_NNP et_FW al_FW ._. 
In_IN addition_NN ,_, germline_NN mutations_NNS in_IN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP associated_VBN with_IN susceptibility_NN to_TO renal_JJ cell_NN carcinoma_NN -LRB-_-LRB- RCC_NNP -RRB-_-RRB- ,_, though_IN the_DT risk_NN of_IN RCC_NNP is_VBZ about_RB five_CD times_NNS higher_JJR in_IN VHL_NNP disease_NN -LRB-_-LRB- Maher_NNP et_FW al_FW ._. 
2008_CD ,_, 2010_CD -RRB-_-RRB- ._. 
Several_JJ mechanisms_NNS have_VBP been_VBN implicated_VBN in_IN the_DT development_NN of_IN VHL_NNP -_: related_JJ and_CC SDHB\/D_NNP -_: related_JJ phaeochromocytomas_NNS ._. 
2001_CD a_DT ,_, b_NN ,_, Neumann_NNP et_FW al_FW ._. 
2000_CD ,_, Astuti_FW et_FW al_FW ._. 
2000_CD ,_, Gimm_FW et_FW al_FW ._. 
1997_CD ,_, Baysal_FW et_FW al_FW ._. 
1995_CD ,_, Woodward_NNP et_FW al_FW ._. 
2002_CD ,_, Schiavi_NNP et_FW al._FW ._. 
2005_CD ,_, Mannelli_FW et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
In_IN addition_NN ,_, germline_NN mutations_NNS in_IN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP associated_VBN with_IN susceptibility_NN to_TO renal_JJ cell_NN carcinoma_NN -LRB-_-LRB- RCC_NNP -RRB-_-RRB- ,_, though_IN the_DT risk_NN of_IN RCC_NNP is_VBZ about_RB five_CD times_NNS higher_JJR in_IN VHL_NNP disease_NN -LRB-_-LRB- Maher_NNP et_FW al_FW ._. 
All_DT three_CD PHD_NNP isoforms_NNS regulate_VBP both_DT HIF-1_NN 
2004_CD ,_, Ong_NNP et_FW al_FW ._. 
1993_CD ,_, Vanharanta_NNP et_FW al_FW ._. 
1990_CD ,_, Latif_NNP et_FW al_FW ._. 
In_IN addition_NN ,_, germline_NN mutations_NNS in_IN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP associated_VBN with_IN susceptibility_NN to_TO renal_JJ cell_NN carcinoma_NN -LRB-_-LRB- RCC_NNP -RRB-_-RRB- ,_, though_IN the_DT risk_NN of_IN RCC_NNP is_VBZ about_RB five_CD times_NNS higher_JJR in_IN VHL_NNP disease_NN -LRB-_-LRB- Maher_NNP et_FW al_FW ._. 
2007_CD ,_, Ricketts_NNPS et_FW al._FW ._. 
2008_CD ,_, 2010_CD -RRB-_-RRB- ._. 
Several_JJ mechanisms_NNS have_VBP been_VBN implicated_VBN in_IN the_DT development_NN of_IN VHL_NNP -_: related_JJ and_CC SDHB\/D_NNP -_: related_JJ phaeochromocytomas_NNS ._. 
e._NNP Materials_NNPS and_CC methods_NNS Patients_NNS and_CC samples_NNS We_PRP analyzed_VBD DNA_NNP from_IN a_DT -RRB-_-RRB- 82_CD individuals_NNS with_IN features_NNS of_IN inherited_VBN phaeochromocytoma_NN -LRB-_-LRB- extra-adrenal_JJ tumors_NNS in_IN 23_CD cases_NNS -RRB-_-RRB- susceptibility_NN -LRB-_-LRB- i._FW familial_FW phaeochromocytoma_FW -LRB-_-LRB- n_SYM =_SYM 6_CD -RRB-_-RRB- ,_, multiple_JJ tumors_NNS -LRB-_-LRB- n_SYM =_SYM 30_CD -RRB-_-RRB- or_CC young_JJ age_NN at_IN onset_NN -LRB-_-LRB- diagnosed_VBN age_NN 30_CD years_NNS or_CC less_JJR ,_, range_NN 5_CD 
2005_CD -RRB-_-RRB- ._. 
2004_CD ,_, Raval_NNP et_FW al_FW ._. 
All_DT three_CD PHD_NNP isoforms_NNS regulate_VBP both_DT HIF-1_NN 
To_TO date_NN ,_, germline_NN mutations_NNS in_IN PHD2_NNP have_VBP been_VBN associated_VBN with_IN congenital_JJ polycythemia_NN and_CC ,_, in_IN one_CD case\/family_JJ ,_, recurrent_JJ extra-adrenal_JJ phaeochromocytoma_NN -LRB-_-LRB- Percy_NNP et_FW al_FW ._. 
2006_CD ,_, 2007_CD ,_, Al-Sheikh_NNP et_FW al._FW ._. 
2008_CD ,_, Ladroue_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ._. 
We_PRP hypothesised_VBD that_IN patients_NNS with_IN features_NNS of_IN inherited_VBN susceptibility_NN to_TO phaeochromocytoma_NN and\/or_CC RCC_NNP might_MD harbor_VB germline_NN mutations_NNS in_IN PHD1_NNP ,_, PHD2_NNP or_CC PHD3_NNP ._. 
PHD2_CD mutations_NNS were_VBD initially_RB described_VBN in_IN association_NN with_IN familial_JJ erythrocytosis_NNS -LRB-_-LRB- Percy_NNP et_FW al_FW ._. 
2006_CD ,_, 2007_CD ,_, Al-Sheikh_NNP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- and_CC that_IN the_DT patient_NN reported_VBN by_IN Ladroue_NNP et_FW al_FW ._. 
-LRB-_-LRB- 2008_CD -RRB-_-RRB- had_VBD both_DT recurrent_JJ paraganglioma_NN and_CC congenital_JJ erythrocytosis_NNS ._. 
Inactivation_NN of_IN SDHB\/D_NNP has_VBZ been_VBN linked_VBN to_TO accumulation_NN of_IN succinate_NN that_WDT inhibits_VBZ the_DT prolyl_NN hydroxylase_NN enzymes_VBZ necessary_JJ for_IN proteasomal_JJ degradation_NN of_IN HIF_NNP -_: 
2001_CD -RRB-_-RRB- ._. 
In_IN humans_NNS ,_, three_CD EGLN_NNP homologs_NNS have_VBP been_VBN implicated_VBN in_IN HIF_NNP -_: 
4%_CD -RRB-_-RRB- ._. 
H374R_CD ,_, with_IN loss_NN of_IN the_DT wild-type_JJ allele_NN in_IN paraganglioma_NN tissue_NN -RRB-_-RRB- ,_, our_PRP$ findings_NNS suggest_VBP that_IN PHD2_NNP mutations_NNS are_VBP rare_JJ in_IN patients_NNS with_IN features_NNS of_IN inherited_VBN phaeochromocytoma_NN -LRB-_-LRB- 95_CD %_NN confidence_NN interval_NN 0_CD 
1993_CD ,_, Vanharanta_NNP et_FW al_FW ._. 
1990_CD ,_, Latif_NNP et_FW al_FW ._. 
In_IN addition_NN ,_, germline_NN mutations_NNS in_IN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP associated_VBN with_IN susceptibility_NN to_TO renal_JJ cell_NN carcinoma_NN -LRB-_-LRB- RCC_NNP -RRB-_-RRB- ,_, though_IN the_DT risk_NN of_IN RCC_NNP is_VBZ about_RB five_CD times_NNS higher_JJR in_IN VHL_NNP disease_NN -LRB-_-LRB- Maher_NNP et_FW al_FW ._. 
2004_CD ,_, Ong_NNP et_FW al._FW ._. 
2007_CD ,_, Ricketts_NNPS et_FW al_FW ._. 
2008_CD ,_, 2010_CD -RRB-_-RRB- ._. 
Several_JJ mechanisms_NNS have_VBP been_VBN implicated_VBN in_IN the_DT development_NN of_IN VHL_NNP -_: related_JJ and_CC SDHB\/D_NNP -_: related_JJ phaeochromocytomas_NNS ._. 
Samples_NNS were_VBD blinded_VBN and_CC assays_NNS were_VBD performed_VBN in_IN duplicate_VB ._. 
Approximately_RB ,_, 400_CD cells_NNS were_VBD scored_VBN for_IN each_DT sample_NN ._. 
For_IN the_DT second_JJ apoptosis_NN assay_NN ,_, sympathetic_JJ neurons_NNS were_VBD isolated_VBN from_IN the_DT superior_JJ cervical_JJ ganglia_NN -LRB-_-LRB- SCG_NNP -RRB-_-RRB- as_RB previously_RB described_VBN -LRB-_-LRB- Palmada_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
Briefly_RB ,_, SCG_NNP from_IN Sprague_NNP 
g._NNP Functional_NNP studies_NNS of_IN mutant_JJ pVHL_JJ protein_NN associated_VBN with_IN differing_VBG VHL_NNP disease_NN phenotypes_NNS -LRB-_-LRB- e._FW rerio_FW ,_, bioinformatic_JJ predictions_NNS of_IN likely_JJ pathogenicity_NN -LRB-_-LRB- Polyphen_NNP and_CC SIFT_NNP programs_NNS -RRB-_-RRB- were_VBD equivocal_JJ and_CC the_DT substitution_NN occurs_VBZ outside_JJ of_IN the_DT prolyl_JJ hydroxylation_NN catalytic_JJ domain_NN -LRB-_-LRB- AA_NNP 189_CD 
germline_NN mutations_NNS in_IN PHDs_NNS ,_, HIF-1_JJ or_CC HIF-2_JJ genes_NNS -RRB-_-RRB- might_MD not_RB be_VB sufficient_JJ to_TO cause_VB an_DT inherited_VBN RCC_NNP phenotype_NN ._. 
Interestingly_RB ,_, functional_JJ analysis_NN of_IN pVHL_JJ mutants_NNS has_VBZ also_RB suggested_VBN that_IN some_DT VHL_NNP mutations_NNS associated_VBN with_IN a_DT high_JJ risk_NN of_IN phaeochromocytoma_NN do_VBP not_RB compromise_VB pVHL_JJ regulation_NN of_IN HIF_NNP ,_, so_RB implicating_VBG HIF-independent_JJ mechanisms_NNS in_IN the_DT development_NN of_IN VHL-associated_JJ phaeochromocytoma_NN -LRB-_-LRB- Clifford_NNP et_FW al._FW ._. 
2001_CD ,_, Hoffman_NNP et_NNP al_NNP ._. 
2001_CD -RRB-_-RRB- ._. 
Consistent_JJ with_IN this_DT hypothesis_NN ,_, Lee_NNP et_NNP al_NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- described_VBD a_DT HIF-independent_JJ pathway_NN linked_VBN to_TO inherited_VBN causes_NNS of_IN phaeochromocytoma_NN -LRB-_-LRB- including_VBG those_DT associated_VBN with_IN germline_NN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP mutations_NNS -RRB-_-RRB- ._. 
2006_CD ,_, Flashman_NNP et_FW al_FW ._. 
The_DT substitution_NN was_VBD predicted_VBN to_TO be_VB benign_JJ and_CC tolerated_VBN by_IN bioinformatic_JJ analysis_NN with_IN the_DT Polyphen_NNP and_CC SIFT_NNP programs_NNS ,_, and_CC occurred_VBD in_IN the_DT N-terminal_JJ region_NN of_IN the_DT protein_NN which_WDT ,_, by_IN analogy_NN with_IN structural_JJ and_CC biochemical_JJ work_NN on_IN the_DT catalytic_JJ domain_NN of_IN PHD2_NNP -LRB-_-LRB- residues_NNS 181_CD 
3and_CD Table_NNP 1_CD -RRB-_-RRB- ._. 
Structurally_RB informed_VBN bioinformatic_JJ analysis_NN with_IN the_DT Polyphen_NNP and_CC SIFT_NNP programs_NNS suggested_VBD that_IN this_DT substitution_NN is_VBZ likely_JJ to_TO be_VB a_DT benign_JJ variant_NN ,_, and_CC Ser289_NNP residue_NN is_VBZ not_RB conserved_VBN in_IN rodents_NNS or_CC in_IN human_JJ PHDs_NNS -LRB-_-LRB- see_VB Fig_NNP ._. 
Crystallographic_JJ analyses_NNS -LRB-_-LRB- Chowdhury_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- reveal_VBP that_IN Ser289_NNP is_VBZ not_RB involved_VBN with_IN the_DT active_JJ site_NN -LRB-_-LRB- see_VB Figs_NNS 1_CD and_CC 5_CD -RRB-_-RRB- ._. 
Analysis_NN of_IN PHD1_NNP Mutation_NNP analysis_NN of_IN PHD1_NNP in_IN 82_CD patients_NNS with_IN evidence_NN of_IN inherited_VBN phaeochromocytoma_NN susceptibility_NN revealed_VBD a_DT novel_JJ non-synonymous_JJ p._NN 
S247_NNP is_VBZ located_VBN in_IN the_DT variable_JJ region_NN -LRB-_-LRB- variable_JJ with_IN respect_NN to_TO PHD1_NNP ,_, PHD2_NNP and_CC PHD3_NNP sequences_NNS -RRB-_-RRB- between_IN strands_NNS 
2007_CD ,_, Flashman_NNP et_FW al_FW ._. 
Subsequent_JJ biophysical_JJ analyses_NNS have_VBP shown_VBN that_IN this_DT region_NN is_VBZ flexible_JJ and_CC involved_VBN in_IN determining_VBG the_DT prolyl_JJ hydroxylation_NN site_NN selectivity_NN of_IN the_DT PHDs_NNS -LRB-_-LRB- Villar_FW et_FW al_FW ._. 
2008_CD ,_, Chowdhury_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
However_RB ,_, a_DT point_NN mutation_NN at_IN this_DT position_NN -LRB-_-LRB- Ser289Lys_NNS -RRB-_-RRB- that_WDT could_MD be_VB produced_VBN in_IN the_DT soluble_JJ form_NN was_VBD as_RB active_JJ as_IN wild-type_JJ PHD2_NN -LRB-_-LRB- in_IN studies_NNS using_VBG recombinant_JJ tPHD2_NNP -RRB-_-RRB- with_IN respect_NN to_TO hydroxylation_NN of_IN the_DT peptide_JJ fragments_NNS of_IN the_DT N_NNP -_: and_CC C_NNP -_: terminal_JJ oxygen-dependent_JJ degradation_NN domains_NNS of_IN HIF-1_NN 
Figure_NN 5_CD Ribbon_NNP representation_NN of_IN tPHD2_NNP ._. 
,and_NNP P_NNP values_NNS from_IN Student_NNP 's_POS t_NN -_: tests_NNS are_VBP shown_VBN ._. 
d._NN Error_NN bars_NNS demonstrate_VBP s._NNP CODD_NNP complex_JJ structure_NN showing_VBG the_DT germline_NN mutation_NN sites_NNS -LRB-_-LRB- highlighted_VBN in_IN white_JJ -RRB-_-RRB- in_IN PHD2_NNP -LRB-_-LRB- Chowdhury_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
The_DT tPHD2_NNS fold_VBP comprises_VBZ four_CD 
The_DT tPHD2_NNS fold_VBP comprises_VBZ four_CD 
2004_CD -RRB-_-RRB- -RRB-_-RRB- ._. 
2006_CD -RRB-_-RRB- -LRB-_-LRB- though_IN somatic_JJ SDHB_NNP inactivation_NN is_VBZ rare_JJ in_IN RCC_NNP -LRB-_-LRB- Morris_NNP et_FW al_FW ._. 
1994_CD ,_, Banks_NNP et_NNP al_NNP ._. 
However_RB ,_, large-scale_JJ resequencing_NN of_IN RCC_NNP samples_NNS -LRB-_-LRB- n_SYM =_SYM 101_CD -RRB-_-RRB- did_VBD not_RB detect_VB mutations_NNS in_IN PHD1_NNP ,_, PHD2_NNP or_CC PHD3_NNP -LRB-_-LRB- Dalgliesh_NNP et_FW al._FW ._. 
2010_CD -RRB-_-RRB- ,_, and_CC we_PRP have_VBP not_RB detected_VBN frequent_JJ evidence_NN of_IN up-regulation_NN of_IN any_DT of_IN the_DT three_CD prolyl_NN hydroxylase_NN genes_NNS in_IN RCC_NNP cell_NN lines_NNS treated_VBN with_IN 5-azacytidine_JJ -LRB-_-LRB- Morris_NNP et_NNP al_NNP ._. 
Introduction_NNP Germline_NNP mutations_NNS in_IN the_DT von_NNP Hippel_NNP 
2002_CD -RRB-_-RRB- ._. 
2001_CD -RRB-_-RRB- :_: non-hydroxylated_JJ HIF_NNP -_: 
Under_IN hypoxic_JJ conditions_NNS ,_, the_DT rate_NN of_IN prolyl_NN hydroxylation_NN ,_, and_CC hence_RB the_DT rate_NN of_IN proteasomal_JJ degradation_NN of_IN HIF_NNP -_: 
Arg8Ser_RBR mutant_JJ in_IN the_DT sensitive_JJ rat_NN sympathetic_JJ neuron_NN apoptosis_NN assay_NN suggests_VBZ that_IN the_DT variant_NN might_MD contribute_VB to_TO phaeochromocytoma_NN susceptibility_NN ,_, we_PRP suggest_VBP that_IN germline_JJ PHD3_NNP mutations_NNS are_VBP not_RB a_DT frequent_JJ cause_NN of_IN inherited_VBN phaeochromocytoma_NN ._. 
Germline_JJ mutations_NNS in_IN both_DT VHL_NNP and_CC SDHB\/D_NNP mutations_NNS are_VBP important_JJ causes_NNS of_IN familial_JJ phaeochromocytoma_NN ;_: however_RB ,_, somatic_JJ mutations_NNS of_IN these_DT genes_NNS are_VBP infrequent_JJ in_IN sporadic_JJ tumors_NNS -LRB-_-LRB- Eng_FW et_FW al._FW ._. 
1995_CD ,_, Astuti_FW et_FW al_FW ._. 
2001_CD a_DT ,_, b_NN -RRB-_-RRB- ._. 
Hence_RB ,_, we_PRP concentrated_VBD our_PRP$ efforts_NNS on_IN testing_NN for_IN germline_NN PHD1_CD ,_, PHD2_CD and_CC PHD3_CD mutations_NNS in_IN patients_NNS with_IN features_NNS of_IN inherited_VBN phaeochromocytoma_NN ._. 
The_DT substitution_NN was_VBD predicted_VBN to_TO be_VB benign_JJ and_CC tolerated_VBN by_IN bioinformatic_JJ analysis_NN with_IN the_DT Polyphen_NNP and_CC SIFT_NNP programs_NNS ,_, and_CC occurred_VBD in_IN the_DT N-terminal_JJ region_NN of_IN the_DT protein_NN which_WDT ,_, by_IN analogy_NN with_IN structural_JJ and_CC biochemical_JJ work_NN on_IN the_DT catalytic_JJ domain_NN of_IN PHD2_NNP -LRB-_-LRB- residues_NNS 181_CD 
Subsequent_JJ biophysical_JJ analyses_NNS have_VBP shown_VBN that_IN this_DT region_NN is_VBZ flexible_JJ and_CC involved_VBN in_IN determining_VBG the_DT prolyl_JJ hydroxylation_NN site_NN selectivity_NN of_IN the_DT PHDs_NNS -LRB-_-LRB- Villar_FW et_FW al_FW ._. 
2007_CD ,_, Flashman_NNP et_FW al._FW ._. 
2008_CD ,_, Chowdhury_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
However_RB ,_, a_DT point_NN mutation_NN at_IN this_DT position_NN -LRB-_-LRB- Ser289Lys_NNS -RRB-_-RRB- that_WDT could_MD be_VB produced_VBN in_IN the_DT soluble_JJ form_NN was_VBD as_RB active_JJ as_IN wild-type_JJ PHD2_NN -LRB-_-LRB- in_IN studies_NNS using_VBG recombinant_JJ tPHD2_NNP -RRB-_-RRB- with_IN respect_NN to_TO hydroxylation_NN of_IN the_DT peptide_JJ fragments_NNS of_IN the_DT N_NNP -_: and_CC C_NNP -_: terminal_JJ oxygen-dependent_JJ degradation_NN domains_NNS of_IN HIF-1_NN 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- described_VBD a_DT HIF-independent_JJ pathway_NN linked_VBN to_TO inherited_VBN causes_NNS of_IN phaeochromocytoma_NN -LRB-_-LRB- including_VBG those_DT associated_VBN with_IN germline_NN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP mutations_NNS -RRB-_-RRB- ._. 
They_PRP suggested_VBD that_IN inherited_VBN phaeochromocytomas_NNS originate_VBP from_IN sympathetic_JJ neuronal_JJ precursor_NN cells_NNS that_WDT usually_RB undergo_VBP c-Jun-dependent_JJ apoptosis_NN during_IN embryogenesis_NN when_WRB growth_NN factors_NNS such_JJ as_IN nerve_NN growth_NN factor_NN -LRB-_-LRB- NGF_NNP -RRB-_-RRB- become_VBP limiting_VBG -LRB-_-LRB- Estus_FW et_FW al._FW ._. 
1994_CD ,_, Schlingensiepen_NNP et_FW al_FW ._. 
1994_CD ,_, Ham_NNP et_NNP al_NNP ._. 
1995_CD ,_, Xia_FW et_FW al_FW ._. 
1995_CD -RRB-_-RRB- ._. 
Germline_NNP VHL_NNP and_CC SDHB_NNP mutations_NNS compromise_VBP this_DT pathway_NN leading_VBG to_TO a_DT failure_NN of_IN normal_JJ developmental_JJ apoptosis_NN and_CC survival_NN of_IN cells_NNS that_WDT would_MD give_VB rise_NN to_TO phaeochromocytoma_NN ._. 
Several_JJ mechanisms_NNS have_VBP been_VBN implicated_VBN in_IN the_DT development_NN of_IN VHL_NNP -_: related_JJ and_CC SDHB\/D_NNP -_: related_JJ phaeochromocytomas_NNS ._. 
The_DT VHL_NNP tumor_NN suppressor_NN gene_NN product_NN -LRB-_-LRB- pVHL_NNP -RRB-_-RRB- has_VBZ multiple_JJ functions_NNS -LRB-_-LRB- see_VB Frew_NNP 
The_DT absence_NN of_IN germline_NN PHD1_CD ,_, PHD2_CD or_CC PHD3_CD mutations_NNS in_IN inherited_VBN phaeochromocytoma_NN or_CC RCC_NNP might_MD suggest_VB that_DT inactivation_NN of_IN one_CD of_IN these_DT genes_NNS is_VBZ insufficient_JJ to_TO replicate_VB the_DT range_NN of_IN pro-oncogenic_JJ effects_NNS associated_VBN with_IN pathogenic_JJ germline_NN VHL_NNP or_CC SDHB\/D_NNP mutations_NNS ._. 
pVHL_NNP has_VBZ been_VBN reported_VBN to_TO have_VB multiple_JJ functions_NNS -LRB-_-LRB- Frew_NNP 
In_IN our_PRP$ preliminary_JJ analysis_NN of_IN sporadic_JJ phaeochromocytoma_NN ,_, we_PRP did_VBD not_RB find_VB any_DT frequent_JJ evidence_NN for_IN somatic_JJ inactivation_NN of_IN PHD1_NNP ,_, PHD2_NNP or_CC PHD3_NNP ._. 
In_IN contrast_NN to_TO phaeochromocytoma_NN ,_, somatic_JJ VHL_NNP mutations_NNS are_VBP very_RB frequent_JJ in_IN sporadic_JJ RCC_NNP -LRB-_-LRB- Foster_NNP et_FW al._FW ._. 
1994_CD ,_, Gnarra_FW et_FW al_FW ._. 
1994_CD ,_, Banks_NNP et_NNP al_NNP ._. 
2006_CD -RRB-_-RRB- -LRB-_-LRB- though_IN somatic_JJ SDHB_NNP inactivation_NN is_VBZ rare_JJ in_IN RCC_NNP -LRB-_-LRB- Morris_NNP et_FW al_FW ._. 
Several_JJ mechanisms_NNS have_VBP been_VBN implicated_VBN in_IN the_DT development_NN of_IN VHL_NNP -_: related_JJ and_CC SDHB\/D_NNP -_: related_JJ phaeochromocytomas_NNS ._. 
The_DT VHL_NNP tumor_NN suppressor_NN gene_NN product_NN -LRB-_-LRB- pVHL_NNP -RRB-_-RRB- has_VBZ multiple_JJ functions_NNS -LRB-_-LRB- see_VB Frew_NNP 
2005_CD -RRB-_-RRB- ._. 
This_DT latter_JJ process_NN has_VBZ also_RB been_VBN linked_VBN to_TO other_JJ phaeochromocytoma_NN susceptibility_NN disorders_NNS -LRB-_-LRB- multiple_JJ endocrine_NN neoplasia_NN type_NN 2_CD and_CC neurofibromatosis_NN -RRB-_-RRB- -LRB-_-LRB- Lee_NNP et_NNP al_NNP ._. 
In_IN normoxia_NN ,_, the_DT HIF-1_NN and_CC HIF-2_NN 
2001_CD ,_, Jaakkola_FW et_FW al_FW ._. 
The_DT oxygen-dependent_JJ interaction_NN of_IN pVHL_NNP with_IN HIF_NNP -_: 
2002_CD ,_, Schiavi_NNP et_FW al_FW ._. 
2001_CD a_DT ,_, b_NN ,_, Neumann_NNP et_FW al_FW ._. 
2000_CD ,_, Astuti_FW et_FW al_FW ._. 
2000_CD ,_, Gimm_FW et_FW al_FW ._. 
1997_CD ,_, Baysal_FW et_FW al_FW ._. 
2005_CD ,_, Mannelli_FW et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
In_IN addition_NN ,_, germline_NN mutations_NNS in_IN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP associated_VBN with_IN susceptibility_NN to_TO renal_JJ cell_NN carcinoma_NN -LRB-_-LRB- RCC_NNP -RRB-_-RRB- ,_, though_IN the_DT risk_NN of_IN RCC_NNP is_VBZ about_RB five_CD times_NNS higher_JJR in_IN VHL_NNP disease_NN -LRB-_-LRB- Maher_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
2005_CD ,_, Mannelli_FW et_FW al_FW ._. 
2002_CD ,_, Schiavi_NNP et_FW al_FW ._. 
2001_CD a_DT ,_, b_NN ,_, Neumann_NNP et_FW al_FW ._. 
2000_CD ,_, Astuti_FW et_FW al_FW ._. 
In_IN addition_NN ,_, germline_NN mutations_NNS in_IN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP associated_VBN with_IN susceptibility_NN to_TO renal_JJ cell_NN carcinoma_NN -LRB-_-LRB- RCC_NNP -RRB-_-RRB- ,_, though_IN the_DT risk_NN of_IN RCC_NNP is_VBZ about_RB five_CD times_NNS higher_JJR in_IN VHL_NNP disease_NN -LRB-_-LRB- Maher_NNP et_FW al._FW ._. 
1990_CD ,_, Latif_NNP et_FW al_FW ._. 
1993_CD ,_, Vanharanta_NNP et_FW al_FW ._. 
2004_CD ,_, Ong_NNP et_FW al_FW ._. 
2007_CD ,_, Ricketts_NNPS et_FW al_FW ._. 
2008_CD ,_, 2010_CD -RRB-_-RRB- ._. 
2006_CD -RRB-_-RRB- ._. 
2005_CD -RRB-_-RRB- ;_: phaeochromocytomas_NNS from_IN patients_NNS with_IN germline_JJ VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP mutations_NNS demonstrate_VBP up-regulation_NN of_IN HIF-1_NN 
2005_CD -RRB-_-RRB- ._. 
Although_IN HIF_NNP dysregulation_NN and_CC a_DT pseudohypoxic_JJ state_NN are_VBP features_NNS of_IN both_DT VHL_NNP -_: and_CC SDHB\/D_NNP -_: associated_JJ tumors_NNS ,_, another_DT potential_JJ mechanism_NN for_IN phaeochromocytoma_NN susceptibility_NN in_IN these_DT disorders_NNS is_VBZ a_DT failure_NN of_IN normal_JJ prolyl_NN hydroxylase_NN domain_NN isoform_NN 3_CD -LRB-_-LRB- PHD3_NNP -RRB-_-RRB- -LRB-_-LRB- EGLN3_NNP -RRB-_-RRB- -_: dependent_JJ developmental_JJ apoptosis_NN of_IN sympathetic_JJ neuronal_JJ cells_NNS causing_VBG persistence_NN of_IN 
All_DT amplification_NN was_VBD done_VBN using_VBG HotStarTaq_NNP DNA_NNP polymerase_NN -LRB-_-LRB- Qiagen_NNP -RRB-_-RRB- ._. 
PHD3_NNP CpG_NNP island_NN was_VBD amplified_VBN by_IN nested_JJ PCR_NNP using_VBG primers_NNS :_: PHD3CoF1_CD 5_CD 
PHD3_FW induced_FW apoptosis_FW assays_FW Two_CD different_JJ apoptosis_NN assays_NNS were_VBD performed_VBN ;_: an_DT initial_JJ method_NN to_TO demonstrate_VB differences_NNS and_CC a_DT second_JJ ,_, more_RBR sensitive_JJ method_NN ._. 
The_DT first_JJ apoptosis_NN assay_NN was_VBD performed_VBN essentially_RB as_IN described_VBN by_IN Lee_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ._. 
Undifferentiated_JJ rat_NN PC12_NN cells_NNS were_VBD plated_VBN onto_IN collagen-coated_JJ 6-well_JJ plates_NNS and_CC were_VBD cotransfected_VBN the_DT following_JJ day_NN with_IN 500_CD 
Arg8Ser_JJ mutant_JJ PHD3_NN ,_, empty_JJ vector_NN control_NN or_CC a_DT catalytically_FW inert_FW p._FW Arg8Ser_FW missense_FW substitution_NN might_MD alter_VB pro-apoptotic_JJ activity_NN ,_, PC12_NN cells_NNS and_CC rat_NN sympathetic_JJ neurons_NNS were_VBD transfected_VBN with_IN either_DT wild-type_JJ PHD3_NNP ,_, p._FW His196Arg_FW PHD3_FW mutant_JJ -LRB-_-LRB- Lee_NNP et_NNP al._NNP ._. 
2005_CD ,_, Schlisio_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ._. 
For_IN the_DT PC12_NNP cells_NNS ,_, a_DT baseline_JJ apoptosis_NN rate_NN of_IN 2_CD 
2001_CD -RRB-_-RRB- ._. 
2001_CD ,_, Hoffman_NNP et_NNP al_NNP ._. 
Interestingly_RB ,_, functional_JJ analysis_NN of_IN pVHL_JJ mutants_NNS has_VBZ also_RB suggested_VBN that_IN some_DT VHL_NNP mutations_NNS associated_VBN with_IN a_DT high_JJ risk_NN of_IN phaeochromocytoma_NN do_VBP not_RB compromise_VB pVHL_JJ regulation_NN of_IN HIF_NNP ,_, so_RB implicating_VBG HIF-independent_JJ mechanisms_NNS in_IN the_DT development_NN of_IN VHL-associated_JJ phaeochromocytoma_NN -LRB-_-LRB- Clifford_NNP et_FW al_FW ._. 
Consistent_JJ with_IN this_DT hypothesis_NN ,_, Lee_NNP et_NNP al._NNP ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- described_VBD a_DT HIF-independent_JJ pathway_NN linked_VBN to_TO inherited_VBN causes_NNS of_IN phaeochromocytoma_NN -LRB-_-LRB- including_VBG those_DT associated_VBN with_IN germline_NN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP mutations_NNS -RRB-_-RRB- ._. 
No_DT confirmed_VBN pathogenic_NN mutations_NNS were_VBD detected_VBN suggesting_VBG that_IN mutations_NNS in_IN these_DT genes_NNS are_VBP not_RB a_DT frequent_JJ cause_NN of_IN inherited_VBN phaeochromocytoma_NN or_CC RCC_NNP ._. 
IntroductionGermline_JJ mutations_NNS in_IN the_DT von_NNP Hippel_NNP 
In_IN addition_NN ,_, germline_NN mutations_NNS in_IN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP associated_VBN with_IN susceptibility_NN to_TO renal_JJ cell_NN carcinoma_NN -LRB-_-LRB- RCC_NNP -RRB-_-RRB- ,_, though_IN the_DT risk_NN of_IN RCC_NNP is_VBZ about_RB five_CD times_NNS higher_JJR in_IN VHL_NNP disease_NN -LRB-_-LRB- Maher_NNP et_FW al_FW ._. 
1990_CD ,_, Latif_NNP et_FW al._FW ._. 
1993_CD ,_, Vanharanta_NNP et_FW al_FW ._. 
2004_CD ,_, Ong_NNP et_FW al_FW ._. 
2007_CD ,_, Ricketts_NNPS et_FW al_FW ._. 
2008_CD ,_, 2010_CD -RRB-_-RRB- ._. 
Several_JJ mechanisms_NNS have_VBP been_VBN implicated_VBN in_IN the_DT development_NN of_IN VHL_NNP -_: related_JJ and_CC SDHB\/D_NNP -_: related_JJ phaeochromocytomas_NNS ._. 
1994_CD ,_, Banks_NNP et_NNP al_NNP ._. 
1994_CD ,_, Gnarra_FW et_FW al_FW ._. 
In_IN contrast_NN to_TO phaeochromocytoma_NN ,_, somatic_JJ VHL_NNP mutations_NNS are_VBP very_RB frequent_JJ in_IN sporadic_JJ RCC_NNP -LRB-_-LRB- Foster_NNP et_NNP al_NNP ._. 
2006_CD -RRB-_-RRB- -LRB-_-LRB- though_IN somatic_JJ SDHB_NNP inactivation_NN is_VBZ rare_JJ in_IN RCC_NNP -LRB-_-LRB- Morris_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- -RRB-_-RRB- ._. 
However_RB ,_, large-scale_JJ resequencing_NN of_IN RCC_NNP samples_NNS -LRB-_-LRB- n_SYM =_SYM 101_CD -RRB-_-RRB- did_VBD not_RB detect_VB mutations_NNS in_IN PHD1_NNP ,_, PHD2_NNP or_CC PHD3_NNP -LRB-_-LRB- Dalgliesh_NNP et_FW al_FW ._. 
1994_CD ,_, Ham_NNP et_NNP al_NNP ._. 
1994_CD ,_, Schlingensiepen_NNP et_FW al_FW ._. 
They_PRP suggested_VBD that_IN inherited_VBN phaeochromocytomas_NNS originate_VBP from_IN sympathetic_JJ neuronal_JJ precursor_NN cells_NNS that_WDT usually_RB undergo_VBP c-Jun-dependent_JJ apoptosis_NN during_IN embryogenesis_NN when_WRB growth_NN factors_NNS such_JJ as_IN nerve_NN growth_NN factor_NN -LRB-_-LRB- NGF_NNP -RRB-_-RRB- become_VBP limiting_VBG -LRB-_-LRB- Estus_FW et_FW al_FW ._. 
1995_CD ,_, Xia_FW et_FW al._FW ._. 
1995_CD -RRB-_-RRB- ._. 
Germline_NNP VHL_NNP and_CC SDHB_NNP mutations_NNS compromise_VBP this_DT pathway_NN leading_VBG to_TO a_DT failure_NN of_IN normal_JJ developmental_JJ apoptosis_NN and_CC survival_NN of_IN cells_NNS that_WDT would_MD give_VB rise_NN to_TO phaeochromocytoma_NN ._. 
familial_JJ phaeochromocytoma_NN -LRB-_-LRB- n_SYM =_SYM 6_CD -RRB-_-RRB- ,_, multiple_JJ tumors_NNS -LRB-_-LRB- n_SYM =_SYM 30_CD -RRB-_-RRB- or_CC young_JJ age_NN at_IN onset_NN -LRB-_-LRB- diagnosed_VBN age_NN 30_CD years_NNS or_CC less_JJR ,_, range_NN 5_CD 
PHD2_NNP appears_VBZ to_TO be_VB the_DT major_JJ regulator_NN of_IN HIF_NNP -_: 
2A_CD -RRB-_-RRB- -LRB-_-LRB- but_CC not_RB in_IN 222_CD control_NN chromosomes_NNS -RRB-_-RRB- ._. 
Arg8Ser_NNP -RRB-_-RRB- ,_, was_VBD detected_VBN in_IN 1_CD of_IN 82_CD patients_NNS with_IN features_NNS of_IN non-syndromic_JJ inherited_VBN phaeochromocytoma_NN susceptibility_NN -LRB-_-LRB- see_VB Fig_NNP ._. 
The_DT substitution_NN was_VBD predicted_VBN to_TO be_VB benign_JJ and_CC tolerated_VBN by_IN bioinformatic_JJ analysis_NN with_IN the_DT Polyphen_NNP and_CC SIFT_NNP programs_NNS ,_, and_CC occurred_VBD in_IN the_DT N-terminal_JJ region_NN of_IN the_DT protein_NN which_WDT ,_, by_IN analogy_NN with_IN structural_JJ and_CC biochemical_JJ work_NN on_IN the_DT catalytic_JJ domain_NN of_IN PHD2_NNP -LRB-_-LRB- residues_NNS 181_CD 
rerio_NN -RRB-_-RRB- ,_, we_PRP are_VBP unable_JJ to_TO prove_VB a_DT loss_NN of_IN function_NN effect_NN ._. 
While_IN the_DT absence_NN of_IN the_DT variant_NN in_IN 222_CD chromosomes_NNS from_IN normal_JJ subjects_NNS and_CC bioinformatic_JJ analysis_NN were_VBD suggestive_JJ of_IN pathogenicity_NN -LRB-_-LRB- the_DT S247_NNP residue_NN is_VBZ conserved_VBN in_IN D._NNP S247_NNP is_VBZ located_VBN in_IN the_DT variable_JJ region_NN -LRB-_-LRB- variable_JJ with_IN respect_NN to_TO PHD1_NNP ,_, PHD2_NNP and_CC PHD3_NNP sequences_NNS -RRB-_-RRB- between_IN strands_NNS 
2009_CD -RRB-_-RRB- ._. 
CODD_NNP complex_JJ structure_NN showing_VBG the_DT germline_NN mutation_NN sites_NNS -LRB-_-LRB- highlighted_VBN in_IN white_JJ -RRB-_-RRB- in_IN PHD2_NNP -LRB-_-LRB- Chowdhury_NNP et_FW al_FW ._. 
The_DT tPHD2_NNS fold_VBP comprises_VBZ four_CD 
1990_CD ,_, Latif_NNP et_FW al_FW ._. 
In_IN addition_NN ,_, germline_NN mutations_NNS in_IN VHL_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP associated_VBN with_IN susceptibility_NN to_TO renal_JJ cell_NN carcinoma_NN -LRB-_-LRB- RCC_NNP -RRB-_-RRB- ,_, though_IN the_DT risk_NN of_IN RCC_NNP is_VBZ about_RB five_CD times_NNS higher_JJR in_IN VHL_NNP disease_NN -LRB-_-LRB- Maher_NNP et_FW al_FW ._. 
1993_CD ,_, Vanharanta_NNP et_FW al._FW ._. 
2004_CD ,_, Ong_NNP et_FW al_FW ._. 
2007_CD ,_, Ricketts_NNPS et_FW al_FW ._. 
2008_CD ,_, 2010_CD -RRB-_-RRB- ._. 
Several_JJ mechanisms_NNS have_VBP been_VBN implicated_VBN in_IN the_DT development_NN of_IN VHL_NNP -_: related_JJ and_CC SDHB\/D_NNP -_: related_JJ phaeochromocytomas_NNS ._. 
whole_JJ exome_NN resequencing_VBG -RRB-_-RRB- -LRB-_-LRB- Kryukov_NNP et_FW al_FW ._. 
g._IN The_DT advent_NN of_IN comprehensive_JJ genomic_JJ analysis_NN techniques_NNS -LRB-_-LRB- e._NN 2009_CD ,_, Summerer_FW et_FW al._FW ._. 
2010_CD -RRB-_-RRB- should_MD expedite_VB the_DT identification_NN of_IN novel_JJ phaeochromocytoma\/RCC_NNP predisposition_NN genes_NNS and_CC so_RB provide_VB further_JJ insights_NNS into_IN the_DT mechanism_NN of_IN tumourigenesis_NNS in_IN these_DT disorders_NNS ._. 
1993_CD ,_, Crossey_FW et_FW al_FW ._. 
Introduction_NNP Germline_NNP mutations_NNS in_IN the_DT von_NNP Hippel_NNP 
2009_CD -RRB-_-RRB- ._. 
2006_CD ,_, Chowdhury_NNP et_FW al_FW ._. 
S247_NNP is_VBZ located_VBN in_IN the_DT variable_JJ region_NN -LRB-_-LRB- variable_JJ with_IN respect_NN to_TO PHD1_NNP ,_, PHD2_NNP and_CC PHD3_NNP sequences_NNS -RRB-_-RRB- between_IN strands_NNS 
His196Arg_NNP PHD3_NNP mutant_JJ -LRB-_-LRB- Lee_NNP et_NNP al_NNP ._. 
Arg8Ser_JJ mutant_JJ PHD3_NN ,_, empty_JJ vector_NN control_NN or_CC a_DT catalytically_RB inert_JJ p._NN 2005_CD ,_, Schlisio_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
For_IN the_DT PC12_NNP cells_NNS ,_, a_DT baseline_JJ apoptosis_NN rate_NN of_IN 2_CD 
Germline_NNP VHL_NNP and_CC SDHB_NNP mutations_NNS compromise_VBP this_DT pathway_NN leading_VBG to_TO a_DT failure_NN of_IN normal_JJ developmental_JJ apoptosis_NN and_CC survival_NN of_IN cells_NNS that_WDT would_MD give_VB rise_NN to_TO phaeochromocytoma_NN ._. 
Intriguingly_RB ,_, PHD3_NNP -LRB-_-LRB- but_CC not_RB PHD1_CD or_CC PHD2_CD -RRB-_-RRB- is_VBZ a_DT key_JJ mediator_NN of_IN this_DT apoptotic_JJ pathway_NN ,_, and_CC germline_NN mutations_NNS in_IN KIF1BBeta_NNP -LRB-_-LRB- that_DT encodes_VBZ a_DT target_NN of_IN PHD3\/EGLN3_NNP -RRB-_-RRB- have_VBP been_VBN associated_VBN with_IN familial_JJ susceptibility_NN to_TO neural_JJ crest_NN tumors_NNS -LRB-_-LRB- Schlisio_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, PHD3_JJ knockout_NN mice_NNS demonstrated_VBD increased_JJ numbers_NNS of_IN cells_NNS in_IN the_DT superior_JJ cervical_JJ ganglion_NN ,_, adrenal_JJ medulla_NN and_CC carotid_NN body_NN -LRB-_-LRB- Bishop_NNP et_FW al_FW ._. 
They_PRP suggested_VBD that_IN inherited_VBN phaeochromocytomas_NNS originate_VBP from_IN sympathetic_JJ neuronal_JJ precursor_NN cells_NNS that_WDT usually_RB undergo_VBP c-Jun-dependent_JJ apoptosis_NN during_IN embryogenesis_NN when_WRB growth_NN factors_NNS such_JJ as_IN nerve_NN growth_NN factor_NN -LRB-_-LRB- NGF_NNP -RRB-_-RRB- become_VBP limiting_VBG -LRB-_-LRB- Estus_FW et_FW al_FW ._. 
1994_CD ,_, Schlingensiepen_NNP et_FW al._FW ._. 
1994_CD ,_, Ham_NNP et_NNP al_NNP ._. 
1995_CD ,_, Xia_FW et_FW al_FW ._. 
1995_CD -RRB-_-RRB- ._. 
Germline_NNP VHL_NNP and_CC SDHB_NNP mutations_NNS compromise_VBP this_DT pathway_NN leading_VBG to_TO a_DT failure_NN of_IN normal_JJ developmental_JJ apoptosis_NN and_CC survival_NN of_IN cells_NNS that_WDT would_MD give_VB rise_NN to_TO phaeochromocytoma_NN ._. 
g._IN 2005_CD -RRB-_-RRB- ,_, succinate_JJ accumulation_NN may_MD also_RB inhibit_VB other_JJ 2-oxoglutarate-dependent_JJ enzyme_NN superfamily_NN members_NNS which_WDT may_MD also_RB contribute_VB to_TO the_DT development_NN of_IN SDHB\/D-associated_JJ tumors_NNS -LRB-_-LRB- e._FW histone_FW demethylases_FW ,_, some_DT of_IN which_WDT are_VBP implicated_VBN in_IN the_DT epigenetic_JJ regulation_NN of_IN oncogenes_NNS and_CC tumor_NN suppressor_NN genes_NNS -RRB-_-RRB- -LRB-_-LRB- Smith_NNP et_NNP al._NNP ._. 
2008_CD -RRB-_-RRB- ._. 
Nevertheless_RB ,_, a_DT significant_JJ fraction_NN of_IN patients_NNS with_IN features_NNS of_IN inherited_VBN phaeochromocytoma_NN or_CC RCC_NNP do_VBP not_RB have_VB a_DT detectable_JJ mutation_NN in_IN a_DT known_VBN susceptibility_NN gene_NN ._. 
2003_CD -RRB-_-RRB- ._. 
1999_CD -RRB-_-RRB- ,_, and_CC overexpression_NN of_IN HIF-2_NN 
The_DT absence_NN of_IN germline_NN PHD1_CD ,_, PHD2_CD or_CC PHD3_CD mutations_NNS in_IN inherited_VBN phaeochromocytoma_NN or_CC RCC_NNP might_MD suggest_VB that_DT inactivation_NN of_IN one_CD of_IN these_DT genes_NNS is_VBZ insufficient_JJ to_TO replicate_VB the_DT range_NN of_IN pro-oncogenic_JJ effects_NNS associated_VBN with_IN pathogenic_JJ germline_NN VHL_NNP or_CC SDHB\/D_NNP mutations_NNS ._. 
pVHL_NNP has_VBZ been_VBN reported_VBN to_TO have_VB multiple_JJ functions_NNS -LRB-_-LRB- Frew_NNP 
1996_CD ,_, Schoenmakers_NNPS et_FW al_FW ._. 
Within_IN these_DT ,_, specific_JJ AREs_NNS differ_VBP from_IN the_DT classical_JJ inverted_JJ TGTTCT_NNP ,_, having_VBG a_DT greater_JJR similarity_NN to_TO a_DT direct_JJ repeat_NN of_IN the_DT same_JJ sequence_NN ,_, but_CC with_IN a_DT change_NN of_IN T_NN 
1993_CD ,_, Mostov_NNP 1994_CD ,_, Claessens_NNPS et_FW al_FW ._. 
1983_CD ,_, Rennie_NNP et_FW al_FW ._. 
Two_CD well-studied_JJ examples_NNS are_VBP the_DT rat_NN dorsal_JJ prostate-specific_JJ probasin_NN -LRB-_-LRB- PB_NNP -RRB-_-RRB- promoter_NN and_CC the_DT prostate_NN trans-epithelial_JJ transporter_NN of_IN IgM_NNP -LRB-_-LRB- secretory_JJ component_NN or_CC SC_NNP -RRB-_-RRB- promoter_NN -LRB-_-LRB- Dodd_NNP et_NNP al_NNP ._. 
1996_CD ,_, Verrijdt_FW et_FW al._FW ._. 
1999_CD -RRB-_-RRB- ._. 
Within_IN these_DT ,_, specific_JJ AREs_NNS differ_VBP from_IN the_DT classical_JJ inverted_JJ TGTTCT_NNP ,_, having_VBG a_DT greater_JJR similarity_NN to_TO a_DT direct_JJ repeat_NN of_IN the_DT same_JJ sequence_NN ,_, but_CC with_IN a_DT change_NN of_IN T_NN 
PHB_NNP is_VBZ a_DT highly_RB conserved_VBN 32_CD 
1983_CD ,_, Rennie_NNP et_FW al_FW ._. 
Two_CD well-studied_JJ examples_NNS are_VBP the_DT rat_NN dorsal_JJ prostate-specific_JJ probasin_NN -LRB-_-LRB- PB_NNP -RRB-_-RRB- promoter_NN and_CC the_DT prostate_NN trans-epithelial_JJ transporter_NN of_IN IgM_NNP -LRB-_-LRB- secretory_JJ component_NN or_CC SC_NNP -RRB-_-RRB- promoter_NN -LRB-_-LRB- Dodd_NNP et_NNP al_NNP ._. 
1993_CD ,_, Mostov_NNP 1994_CD ,_, Claessens_NNPS et_FW al._FW ._. 
1996_CD ,_, Verrijdt_FW et_FW al_FW ._. 
1999_CD -RRB-_-RRB- ._. 
Within_IN these_DT ,_, specific_JJ AREs_NNS differ_VBP from_IN the_DT classical_JJ inverted_JJ TGTTCT_NNP ,_, having_VBG a_DT greater_JJR similarity_NN to_TO a_DT direct_JJ repeat_NN of_IN the_DT same_JJ sequence_NN ,_, but_CC with_IN a_DT change_NN of_IN T_NN 
1999_CD -RRB-_-RRB- ._. 
1996_CD ,_, Verrijdt_FW et_FW al_FW ._. 
1993_CD ,_, Mostov_NNP 1994_CD ,_, Claessens_NNPS et_FW al_FW ._. 
1983_CD ,_, Rennie_NNP et_FW al_FW ._. 
Two_CD well-studied_JJ examples_NNS are_VBP the_DT rat_NN dorsal_JJ prostate-specific_JJ probasin_NN -LRB-_-LRB- PB_NNP -RRB-_-RRB- promoter_NN and_CC the_DT prostate_NN trans-epithelial_JJ transporter_NN of_IN IgM_NNP -LRB-_-LRB- secretory_JJ component_NN or_CC SC_NNP -RRB-_-RRB- promoter_NN -LRB-_-LRB- Dodd_NNP et_NNP al_NNP ._. 
Within_IN these_DT ,_, specific_JJ AREs_NNS differ_VBP from_IN the_DT classical_JJ inverted_JJ TGTTCT_NNP ,_, having_VBG a_DT greater_JJR similarity_NN to_TO a_DT direct_JJ repeat_NN of_IN the_DT same_JJ sequence_NN ,_, but_CC with_IN a_DT change_NN of_IN T_NN 
2008_CD -RRB-_-RRB- ._. 
2007_CD ,_, Jemal_NNP et_FW al_FW ._. 
Association_NNP of_IN International_NNP Cancer_NNP Research_NNP Medical_NNP Research_NNP Council_NNP Hammersmith_NNP Hospital_NNP Special_JJ Trustees_NNP Introduction_NNP Prostate_NNP cancer_NN is_VBZ the_DT most_RBS commonly_RB diagnosed_VBN cancer_NN in_IN males_NNS ,_, accounting_VBG for_IN 25_CD %_NN of_IN new_JJ cases_NNS in_IN both_CC the_DT United_NNP States_NNPS and_CC Europe_NNP ,_, where_WRB it_PRP is_VBZ the_DT second_JJ and_CC third_JJ leading_VBG cause_NN of_IN male_JJ cancer_NN deaths_NNS respectively_RB -LRB-_-LRB- Ferlay_FW et_FW al_FW ._. 
The_DT androgen_NN signalling_VBG pathway_NN is_VBZ central_JJ in_IN prostate_NN cancer_NN progression_NN and_CC therapy_NN ,_, as_IN tumors_NNS are_VBP initially_RB dependent_JJ upon_IN androgens_NNS for_IN growth_NN -LRB-_-LRB- Agoulnik_NNP 
Although_IN initially_RB successful_JJ ,_, such_JJ therapies_NNS inevitably_RB fail_VBP and_CC patients_NNS relapse_VBP with_IN 
AR_NNP then_RB recruits_VBZ regulatory_JJ protein_NN complexes_NNS to_TO the_DT promoters_NNS of_IN these_DT genes_NNS -LRB-_-LRB- Tsai_NNP 
2006_CD -RRB-_-RRB- ,_, and_CC PHB_NNP inhibits_VBZ key_JJ proteins_NNS in_IN the_DT G_NNP 1_CD 
g._NN androstenedione_NN have_VBP partial_JJ antagonist_JJ effects_NNS e._FW g._FW Additionally_RB ,_, the_DT growth-stimulating_JJ properties_NNS of_IN knocking_VBG down_IN PHB_NNP in_IN the_DT absence_NN of_IN testosterone_NN ,_, as_IN seen_VBN in_IN this_DT study_NN ,_, may_MD be_VB due_JJ to_TO increased_VBN activity_NN of_IN AR_NNP in_IN a_DT low_JJ testosterone_NN environment_NN or_CC indeed_RB a_DT lack_NN of_IN repressive_JJ activity_NN in_IN the_DT presence_NN of_IN adrenal_JJ androgens_NNS ,_, some_DT of_IN which_WDT e._FW androstenedione_FW -LRB-_-LRB- Chen_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
Certainly_RB ,_, the_DT current_JJ data_NNS suggest_VBP further_JJ studies_NNS will_MD be_VB needed_VBN before_IN pharmacologically_RB increasing_VBG corepressor_JJ protein_NN levels_NNS ,_, or_CC activity_NN could_MD be_VB used_VBN as_IN a_DT therapeutic_JJ strategy_NN for_IN hormone-dependent_JJ cancers_NNS ._. 
Although_IN initially_RB successful_JJ ,_, such_JJ therapies_NNS inevitably_RB fail_VBP and_CC patients_NNS relapse_VBP with_IN 
1992_CD ,_, 1993_CD -RRB-_-RRB- ._. 
However_RB ,_, recent_JJ studies_NNS in_IN breast_NN cancer_NN indicate_VBP that_IN the_DT simple_JJ protein_NN level_NN measurement_NN was_VBD insufficient_JJ ,_, as_IN high_JJ PHB_NNP levels_NNS masked_VBD underlying_JJ inactivating_VBG mutations_NNS in_IN the_DT Rb_NN and_CC E2F-binding_JJ regions_NNS of_IN PHB_NNP -LRB-_-LRB- Sato_NNP et_FW al_FW ._. 
PHB_NNP has_VBZ been_VBN shown_VBN to_TO be_VB downregulated_VBN in_IN gliomas_NNS -LRB-_-LRB- Chumbalkar_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Loss_NN of_IN the_DT PHB_NNP repressor_NN protein_NN may_MD impact_VB on_IN the_DT repressive_JJ effectiveness_NN of_IN hormone_NN antagonists_NNS such_JJ as_IN the_DT partial_JJ anti-oestrogen_JJ tamoxifen_NN -LRB-_-LRB- Wang_NNP et_NNP al_NNP ._. 
E2F_CD transcription_NN factors_NNS regulate_VBP genes_NNS involved_VBN in_IN differentiation_NN ,_, proliferation_NN and_CC apoptosis_NN ;_: and_CC ,_, together_RB with_IN the_DT retinoblastoma_NN -LRB-_-LRB- pRb_NNP -RRB-_-RRB- protein_NN ,_, they_PRP regulate_VBP the_DT G_NNP 1_CD \/_NNP S_NNP transition_NN ._. 
PHB_NNP appears_VBZ to_TO repress_VB E2F_NNP via_IN recruitment_NN of_IN HDAC1_NNP ,_, NCoR_NNP and_CC BRG1\/Brm_NNP -LRB-_-LRB- Choi_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ,_, thus_RB condensing_VBG chromatin_NN and_CC silencing_VBG gene_NN activation_NN ._. 
Overexpression_NNP of_IN PHB_NNP results_NNS in_IN G_NNP 1_CD \/_NNP S_NNP arrest_NN and_CC the_DT inhibition_NN of_IN E2F-mediated_JJ apoptosis_NN -LRB-_-LRB- Fusaro_FW et_FW al_FW ._. 
The_DT exact_JJ mechanisms_NNS of_IN anti-androgen_JJ action_NN are_VBP poorly_RB understood_VBN ,_, but_CC they_PRP appear_VBP to_TO promote_VB the_DT recruitment_NN of_IN repressive_JJ protein_NN complexes_NNS ,_, or_CC corepressors_NNS ,_, to_TO the_DT AR_NNP -LRB-_-LRB- Wang_NNP et_FW al_FW ._. 
2005_CD ,_, Powell_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Which_WDT corepressors_NNS may_MD be_VB required_VBN for_IN in_IN vivo_NN repression_NN of_IN the_DT AR_NN by_IN anti-androgens_NNS is_VBZ not_RB known_VBN ,_, but_CC potentially_RB these_DT will_MD be_VB candidates_NNS involved_VBN in_IN disease_NN progression_NN and_CC in_IN development_NN of_IN 
Histology_NNP and_CC immunohistochemistry_JJ Standard_JJ protocols_NNS were_VBD carried_VBN out_RP as_RB described_VBN -LRB-_-LRB- Powell_NNP et_FW al_FW ._. 
2004_CD ,_, 2006_CD -RRB-_-RRB- ._. 
Antibodies_NNS used_VBN were_VBD :_: mouse_NN anti-human_NN PHB_NNP primary_JJ antibody_NN -LRB-_-LRB- AbCam_NNP Ltd_NNP @_IN 1:500_CD -RRB-_-RRB- ;_: Ki67_NNP -LRB-_-LRB- DAKO_NNP M7249_NNP @_SYM 1:50_CD -RRB-_-RRB- ;_: phospho-histone_JJ H3_NNP -LRB-_-LRB- Millipore_NNP UK_NNP Ltd_NNP ,_, Watford_NNP ,_, UK_NNP 06-570_CD @_SYM 1:250_CD -RRB-_-RRB- ._. 
2002_CD -RRB-_-RRB- or_CC treated_VBN with_IN cytotoxic_JJ agents_NNS such_JJ as_IN camptothecin_NN -LRB-_-LRB- Fusaro_FW et_FW al_FW ._. 
Similar_JJ protective_JJ effects_NNS have_VBP been_VBN shown_VBN for_IN PHB_NNP when_WRB LNCaP_NNP cells_NNS were_VBD deprived_VBN of_IN growth_NN factors_NNS -LRB-_-LRB- Vander_NNP Heiden_NNP et_FW al_FW ._. 
2002_CD ,_, Rastogi_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Reduction_NN of_IN PHB_NNP levels_NNS in_IN LNCaP\/Luc_JJ cells_NNS increased_VBD androgen-stimulated_JJ entry_NN into_IN S-phase_JJ ,_, AR_JJ activation_NN as_IN measured_VBN by_IN the_DT luciferase_NN assay_NN and_CC increased_VBN growth_NN ._. 
Association_NNP of_IN International_NNP Cancer_NNP Research_NNP Medical_NNP Research_NNP Council_NNP Hammersmith_NNP Hospital_NNP Special_JJ Trustees_NNP Introduction_NNP Prostate_NNP cancer_NN is_VBZ the_DT most_RBS commonly_RB diagnosed_VBN cancer_NN in_IN males_NNS ,_, accounting_VBG for_IN 25_CD %_NN of_IN new_JJ cases_NNS in_IN both_CC the_DT United_NNP States_NNPS and_CC Europe_NNP ,_, where_WRB it_PRP is_VBZ the_DT second_JJ and_CC third_JJ leading_VBG cause_NN of_IN male_JJ cancer_NN deaths_NNS respectively_RB -LRB-_-LRB- Ferlay_FW et_FW al_FW ._. 
2007_CD ,_, Jemal_NNP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
The_DT androgen_NN signalling_VBG pathway_NN is_VBZ central_JJ in_IN prostate_NN cancer_NN progression_NN and_CC therapy_NN ,_, as_IN tumors_NNS are_VBP initially_RB dependent_JJ upon_IN androgens_NNS for_IN growth_NN -LRB-_-LRB- Agoulnik_NNP 
The_DT androgen_NN signalling_VBG pathway_NN is_VBZ central_JJ in_IN prostate_NN cancer_NN progression_NN and_CC therapy_NN ,_, as_IN tumors_NNS are_VBP initially_RB dependent_JJ upon_IN androgens_NNS for_IN growth_NN -LRB-_-LRB- Agoulnik_NNP 
The_DT roles_NNS of_IN PHB_NNP and_CC the_DT AR_NNP may_MD also_RB overlap_VB in_IN their_PRP$ control_NN of_IN cell_NN cycle_NN entry_NN ._. 
Removal_NN of_IN PHB_NNP via_IN RNAi_NNP may_MD result_VB in_IN decreased_VBN chromatin_NN condensation_NN ,_, making_VBG DNA_NNP more_RBR accessible_JJ for_IN transcription_NN factor_NN binding_JJ ._. 
The_DT AR_NNP may_MD play_VB a_DT part_NN in_IN DNA_NNP replication_NN initiation_NN and_CC licensing_NN in_IN certain_JJ cell_NN types_NNS -LRB-_-LRB- Litvinov_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ,_, and_CC PHB_NNP inhibits_VBZ key_JJ proteins_NNS in_IN the_DT G_NNP 1_CD 
However_RB ,_, in_IN support_NN of_IN this_DT concept_NN ,_, recently_RB ,_, a_DT potential_JJ mechanism_NN for_IN in_IN vivo_NN reduction_NN in_IN PHB_NNP levels_NNS has_VBZ been_VBN suggested_VBN by_IN Liu_NNP et_FW al_FW ._. 
They_PRP reported_VBD that_IN PHB_NNP is_VBZ a_DT potential_JJ target_NN of_IN the_DT microRNA-27a_NN ,_, which_WDT is_VBZ upregulated_VBN in_IN gastric_JJ adenocarcinoma_NN and_CC may_MD act_VB as_IN an_DT oncogene_NN by_IN reducing_VBG PHB_NNP levels_NNS -LRB-_-LRB- Liu_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
Finally_RB ,_, there_EX are_VBP many_JJ potential_JJ corepressors_NNS and_CC coactivators_NNS of_IN AR_NN within_IN prostate_NN cells_NNS ,_, any_DT of_IN which_WDT either_CC alone_RB or_CC in_IN combination_NN may_MD have_VB powerful_JJ effects_NNS upon_IN AR_NNP signalling_VBG and_CC hence_RB tumor_NN progression_NN ._. 
One_CD such_JJ potential_JJ AR_NN corepressor_NN is_VBZ prohibitin_JJ -LRB-_-LRB- PHB_NNP -RRB-_-RRB- ._. 
Which_WDT corepressors_NNS may_MD be_VB required_VBN for_IN in_IN vivo_NN repression_NN of_IN the_DT AR_NN by_IN anti-androgens_NNS is_VBZ not_RB known_VBN ,_, but_CC potentially_RB these_DT will_MD be_VB candidates_NNS involved_VBN in_IN disease_NN progression_NN and_CC in_IN development_NN of_IN 
1983_CD ,_, Rennie_NNP et_FW al_FW ._. 
Two_CD well-studied_JJ examples_NNS are_VBP the_DT rat_NN dorsal_JJ prostate-specific_JJ probasin_NN -LRB-_-LRB- PB_NNP -RRB-_-RRB- promoter_NN and_CC the_DT prostate_NN trans-epithelial_JJ transporter_NN of_IN IgM_NNP -LRB-_-LRB- secretory_JJ component_NN or_CC SC_NNP -RRB-_-RRB- promoter_NN -LRB-_-LRB- Dodd_NNP et_NNP al_NNP ._. 
1993_CD ,_, Mostov_NNP 1994_CD ,_, Claessens_NNPS et_FW al._FW ._. 
1996_CD ,_, Verrijdt_FW et_FW al_FW ._. 
1999_CD -RRB-_-RRB- ._. 
Within_IN these_DT ,_, specific_JJ AREs_NNS differ_VBP from_IN the_DT classical_JJ inverted_JJ TGTTCT_NNP ,_, having_VBG a_DT greater_JJR similarity_NN to_TO a_DT direct_JJ repeat_NN of_IN the_DT same_JJ sequence_NN ,_, but_CC with_IN a_DT change_NN of_IN T_NN 
1997_CD -RRB-_-RRB- ._. 
1995_CD ,_, Coates_NNP et_NNP al_NNP ._. 
PHB_NNP is_VBZ a_DT highly_RB conserved_VBN 32_CD 
Total_JJ testosterone_NN from_IN mouse_NN serum_NN was_VBD measured_VBN using_VBG ELISA_NNP kits_NNS -LRB-_-LRB- Calbiotech_NNP ,_, CA_NNP ,_, USA_NNP -RRB-_-RRB- ._. 
This_DT was_VBD replaced_VBN by_IN medium_NN containing_VBG increasing_VBG doxycycline_NN -LRB-_-LRB- 0_CD 
Chromatin_NN immunoprecipitation_NN Cells_NNS -LRB-_-LRB- 1_CD 
2008_CD -RRB-_-RRB- ,_, associating_VBG with_IN oestrogen-regulated_JJ promoters_NNS in_IN the_DT absence_NN of_IN hormone_NN and_CC dissociating_VBG after_IN hormone_NN treatment_NN ._. 
Interestingly_RB ,_, PHB_NNP has_VBZ been_VBN implicated_VBN in_IN mediating_VBG the_DT anti-proliferative_JJ actions_NNS of_IN anti-oestrogens_NNS ,_, and_CC reduction_NN in_IN PHB_NNP levels_NNS reduced_VBD the_DT anti-proliferative_JJ actions_NNS of_IN such_JJ ER_NNP antagonists_NNS -LRB-_-LRB- Wang_NNP et_NNP al._NNP ._. 
2004_CD -RRB-_-RRB- ._. 
These_DT studies_NNS ,_, together_RB with_IN the_DT report_NN that_IN PHB_NNP is_VBZ required_VBN for_IN the_DT recruitment_NN of_IN the_DT BRG1-containing_JJ chromatin_NN remodelling_VBG complex_NN to_TO antagonist-bound_JJ AR_NNP -LRB-_-LRB- Dai_FW et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
PHB_NNP has_VBZ been_VBN shown_VBN to_TO be_VB downregulated_VBN in_IN gliomas_NNS -LRB-_-LRB- Chumbalkar_FW et_FW al_FW ._. 
1992_CD ,_, 1993_CD -RRB-_-RRB- ._. 
However_RB ,_, recent_JJ studies_NNS in_IN breast_NN cancer_NN indicate_VBP that_IN the_DT simple_JJ protein_NN level_NN measurement_NN was_VBD insufficient_JJ ,_, as_IN high_JJ PHB_NNP levels_NNS masked_VBD underlying_JJ inactivating_VBG mutations_NNS in_IN the_DT Rb_NN and_CC E2F-binding_JJ regions_NNS of_IN PHB_NNP -LRB-_-LRB- Sato_NNP et_FW al_FW ._. 
Loss_NN of_IN the_DT PHB_NNP repressor_NN protein_NN may_MD impact_VB on_IN the_DT repressive_JJ effectiveness_NN of_IN hormone_NN antagonists_NNS such_JJ as_IN the_DT partial_JJ anti-oestrogen_JJ tamoxifen_NN -LRB-_-LRB- Wang_NNP et_NNP al._NNP ._. 
2004_CD -RRB-_-RRB- and_CC androgen_NN antagonists_NNS -LRB-_-LRB- Dai_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ,_, indicating_VBG that_IN PHB_NNP may_MD have_VB different_JJ tumor_NN supporting_VBG roles_NNS at_IN different_JJ times_NNS in_IN the_DT development_NN of_IN hormone-dependent_JJ cancer_NN ._. 
However_RB ,_, the_DT AR_NNP is_VBZ still_RB required_VBN for_IN tumor_NN growth_NN ,_, and_CC in_IN many_JJ cases_NNS ,_, tumors_NNS circumvent_VBP the_DT requirement_NN for_IN high_JJ levels_NNS of_IN androgens_NNS by_IN receptor_NN amplification_NN ,_, or_CC mutation_NN resulting_VBG in_IN a_DT receptor_NN with_IN broadened_VBN ligand_NN responsiveness_NN -LRB-_-LRB- Brinkmann_NNP 
The_DT AR_NNP may_MD play_VB a_DT part_NN in_IN DNA_NNP replication_NN initiation_NN and_CC licensing_NN in_IN certain_JJ cell_NN types_NNS -LRB-_-LRB- Litvinov_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ,_, and_CC PHB_NNP inhibits_VBZ key_JJ proteins_NNS in_IN the_DT G1_NNP 
2006_CD -RRB-_-RRB- ,_, and_CC PHB_NNP inhibits_VBZ key_JJ proteins_NNS in_IN the_DT G_NNP 1_CD 
The_DT AR_NNP can_NN bind_NN to_TO these_DT canonical_JJ elements_NNS ,_, but_CC promoter_NN analysis_NN of_IN androgen-responsive_JJ genes_NNS revealed_VBD additional_JJ non-consensus_JJ response_NN elements_NNS with_IN apparent_JJ AR_NNP specificity_NN ._. 
Two_CD well-studied_JJ examples_NNS are_VBP the_DT rat_NN dorsal_JJ prostate-specific_JJ probasin_NN -LRB-_-LRB- PB_NNP -RRB-_-RRB- promoter_NN and_CC the_DT prostate_NN trans-epithelial_JJ transporter_NN of_IN IgM_NNP -LRB-_-LRB- secretory_JJ component_NN or_CC SC_NNP -RRB-_-RRB- promoter_NN -LRB-_-LRB- Dodd_NNP et_NNP al._NNP ._. 
1983_CD ,_, Rennie_NNP et_FW al_FW ._. 
1993_CD ,_, Mostov_NNP 1994_CD ,_, Claessens_NNPS et_FW al_FW ._. 
1996_CD ,_, Verrijdt_FW et_FW al_FW ._. 
1999_CD -RRB-_-RRB- ._. 
Within_IN these_DT ,_, specific_JJ AREs_NNS differ_VBP from_IN the_DT classical_JJ inverted_JJ TGTTCT_NNP ,_, having_VBG a_DT greater_JJR similarity_NN to_TO a_DT direct_JJ repeat_NN of_IN the_DT same_JJ sequence_NN ,_, but_CC with_IN a_DT change_NN of_IN T_NN 
2004_CD -RRB-_-RRB- ._. 
Interestingly_RB ,_, PHB_NNP has_VBZ been_VBN implicated_VBN in_IN mediating_VBG the_DT anti-proliferative_JJ actions_NNS of_IN anti-oestrogens_NNS ,_, and_CC reduction_NN in_IN PHB_NNP levels_NNS reduced_VBD the_DT anti-proliferative_JJ actions_NNS of_IN such_JJ ER_NNP antagonists_NNS -LRB-_-LRB- Wang_NNP et_NNP al_NNP ._. 
These_DT studies_NNS ,_, together_RB with_IN the_DT report_NN that_IN PHB_NNP is_VBZ required_VBN for_IN the_DT recruitment_NN of_IN the_DT BRG1-containing_JJ chromatin_NN remodelling_VBG complex_NN to_TO antagonist-bound_JJ AR_NNP -LRB-_-LRB- Dai_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ,_, make_VBP PHB_NNP an_DT excellent_JJ candidate_NN AR_NN corepressor_NN ,_, important_JJ in_IN prostate_NN cancer_NN progression_NN and_CC therapy_NN ._. 
Loss_NN of_IN the_DT PHB_NNP repressor_NN protein_NN may_MD impact_VB on_IN the_DT repressive_JJ effectiveness_NN of_IN hormone_NN antagonists_NNS such_JJ as_IN the_DT partial_JJ anti-oestrogen_JJ tamoxifen_NN -LRB-_-LRB- Wang_NNP et_NNP al_NNP ._. 
2004_CD -RRB-_-RRB- and_CC androgen_NN antagonists_NNS -LRB-_-LRB- Dai_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ,_, indicating_VBG that_IN PHB_NNP may_MD have_VB different_JJ tumor_NN supporting_VBG roles_NNS at_IN different_JJ times_NNS in_IN the_DT development_NN of_IN hormone-dependent_JJ cancer_NN ._. 
2008_CD -RRB-_-RRB- ,_, thus_RB condensing_VBG chromatin_NN and_CC silencing_VBG gene_NN activation_NN ._. 
PHB_NNP appears_VBZ to_TO repress_VB E2F_NNP via_IN recruitment_NN of_IN HDAC1_NNP ,_, NCoR_NNP and_CC BRG1\/Brm_NNP -LRB-_-LRB- Choi_FW et_FW al_FW ._. 
Overexpression_NNP of_IN PHB_NNP results_NNS in_IN G1\/S_NNP arrest_NN and_CC the_DT inhibition_NN of_IN E2F-mediated_JJ apoptosis_NN -LRB-_-LRB- Fusaro_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
We_PRP previously_RB showed_VBD that_IN PHB_NNP represses_VBZ ligand-dependent_JJ AR_NNP activity_NN and_CC also_RB inhibits_VBZ androgen-stimulated_JJ growth_NN of_IN prostate_NN cancer_NN cells_NNS ,_, in_IN vitro_NN -LRB-_-LRB- Gamble_NNP et_NNP al_NNP ._. 
Similar_JJ protective_JJ effects_NNS have_VBP been_VBN shown_VBN for_IN PHB_NNP when_WRB LNCaP_NNP cells_NNS were_VBD deprived_VBN of_IN growth_NN factors_NNS -LRB-_-LRB- Vander_NNP Heiden_NNP et_FW al_FW ._. 
2002_CD -RRB-_-RRB- or_CC treated_VBN with_IN cytotoxic_JJ agents_NNS such_JJ as_IN camptothecin_NN -LRB-_-LRB- Fusaro_FW et_FW al._FW ._. 
2002_CD ,_, Rastogi_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
Reduction_NN of_IN PHB_NNP levels_NNS in_IN LNCaP\/Luc_JJ cells_NNS increased_VBD androgen-stimulated_JJ entry_NN into_IN S-phase_JJ ,_, AR_JJ activation_NN as_IN measured_VBN by_IN the_DT luciferase_NN assay_NN and_CC increased_VBN growth_NN ._. 
This_DT study_NN provides_VBZ proof_NN of_IN principle_NN that_IN i_FW -RRB-_-RRB- reduction_NN in_IN PHB_NNP promotes_VBZ both_DT androgen-dependent_JJ and_CC 
2002_CD -RRB-_-RRB- ._. 
Overexpression_NNP of_IN PHB_NNP results_NNS in_IN G_NNP 1_CD \/_NNP S_NNP arrest_NN and_CC the_DT inhibition_NN of_IN E2F-mediated_JJ apoptosis_NN -LRB-_-LRB- Fusaro_FW et_FW al_FW ._. 
We_PRP previously_RB showed_VBD that_IN PHB_NNP represses_VBZ ligand-dependent_JJ AR_NNP activity_NN and_CC also_RB inhibits_VBZ androgen-stimulated_JJ growth_NN of_IN prostate_NN cancer_NN cells_NNS ,_, in_IN vitro_NN -LRB-_-LRB- Gamble_NNP et_NNP al._NNP ._. 
2007_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, we_PRP found_VBD PHB_NNP protein_NN levels_NNS in_IN prostate_NN cancer_NN cells_NNS to_TO be_VB downregulated_VBN in_IN response_NN to_TO androgens_NNS -LRB-_-LRB- Gamble_NNP et_NNP al_NNP ._. 
MAR._NNP ._. 
Blunted_VBN MAR_NNP fragments_NNS were_VBD ligated_VBN into_IN the_DT Sma1_NNP and_CC BamH1_NNP sites_NNS -LRB-_-LRB- restriction_NN mapping_NN confirmed_VBD directionality_NN -RRB-_-RRB- of_IN p_NN -_: tk_NN -_: Luc-ARE_JJ to_TO create_VB pARE_NNP ._. 
Generating_NNP a_DT tetracycline-inducible_JJ systemLNCaP\/TR2_JJ cells_NNS expressing_VBG the_DT Tet_NNP repressor_NN were_VBD generated_VBN as_IN described_VBN -LRB-_-LRB- Gamble_NNP et_NNP al._NNP ._. 
2007_CD -RRB-_-RRB- and_CC stably_RB transfected_VBN with_IN the_DT following_JJ vectors_NNS ._. 
PHB_NNP cDNA_NNP was_VBD cloned_VBN into_IN pcDNA4\/TO_NNP -LRB-_-LRB- Invitrogen_NNP -RRB-_-RRB- ._. 
The_DT cell_NN line_NN was_VBD named_VBN LNCaP\/Luc_NNP ._. 
After_IN 2_CD 
1A_CD -RRB-_-RRB- ._. 
MAR_NNP vector_NN -LRB-_-LRB- Fig_NNP ._. 
Next_NNP ,_, MAR_NNP were_VBD added_VBN upstream_JJ and_CC downstream_JJ of_IN the_DT reporter_NN cassette_NN to_TO generate_VB the_DT insulated_VBN pARE_NNP ._. 
This_DT was_VBD transfected_VBN into_IN LNCaP\/TR2_JJ cells_NNS -LRB-_-LRB- stably_RB expressing_VBG the_DT tetracycline_NN repressor_NN protein_NN ;_: Gamble_NNP et_NNP al._NNP ._. 
2007_CD -RRB-_-RRB- ._. 
Clones_NNS were_VBD tested_VBN for_IN androgen-inducible_JJ luciferase_NN activity_NN and_CC for_IN cross-reactivity_NN or_CC activation_NN by_IN other_JJ steroid_NN hormones_NNS and_CC their_PRP$ receptors_NNS ._. 
Identical_JJ results_NNS were_VBD found_VBN at_IN the_DT regulatory_JJ region_NN of_IN the_DT endogenous_JJ androgen-responsive_JJ gene_NN ,_, PSA_NNP ._. 
PHB_NNP influences_VBZ AR_NNP activity_NN and_CC cell_NN cycle_NN distribution_NN in_IN vitroPreviously_NNP ,_, we_PRP showed_VBD that_IN PHB_NNP overexpression_NN from_IN stably_RB integrated_VBN tetracycline-inducible_JJ vectors_NNS could_MD repress_VB androgen-dependent_JJ endogenous_JJ gene_NN expression_NN and_CC androgen-stimulated_JJ growth_NN of_IN LNCaP_JJ cells_NNS in_IN vitro_NN -LRB-_-LRB- Gamble_NNP et_NNP al._NNP ._. 
2007_CD -RRB-_-RRB- ._. 
Therefore_RB ,_, the_DT same_JJ doxycycline-inducible_JJ vector_NN -LRB-_-LRB- pcDNA4\/TO\/PHB_NNP -RRB-_-RRB- was_VBD used_VBN to_TO stably_RB transfect_VB the_DT LNCaP\/Luc_NNP cells_NNS to_TO produce_VB a_DT new_JJ stable_JJ cell_NN line_NN ,_, LNCaP\/Luc\/PHB-cDNA_NNP ._. 
2007_CD -RRB-_-RRB- ._. 
We_PRP previously_RB showed_VBD that_IN PHB_NNP represses_VBZ ligand-dependent_JJ AR_NNP activity_NN and_CC also_RB inhibits_VBZ androgen-stimulated_JJ growth_NN of_IN prostate_NN cancer_NN cells_NNS ,_, in_IN vitro_NN -LRB-_-LRB- Gamble_NNP et_NNP al_NNP ._. 
Furthermore_RB ,_, we_PRP found_VBD PHB_NNP protein_NN levels_NNS in_IN prostate_NN cancer_NN cells_NNS to_TO be_VB downregulated_VBN in_IN response_NN to_TO androgens_NNS -LRB-_-LRB- Gamble_NNP et_NNP al._NNP ._. 
2004_CD -RRB-_-RRB- ,_, presumably_RB enabling_VBG androgen-stimulated_JJ cell_NN cycle_NN entry_NN and_CC growth_NN ._. 
More_RBR recently_RB ,_, PHB_NNP has_VBZ been_VBN shown_VBN to_TO be_VB a_DT corepressor_NN of_IN the_DT estrogen_NN receptor_NN -LRB-_-LRB- ER_SYM 
PHB_NNP cDNA_NNP was_VBD cloned_VBN into_IN pcDNA4\/TO_NNP -LRB-_-LRB- Invitrogen_NNP -RRB-_-RRB- ._. 
2007_CD -RRB-_-RRB- and_CC stably_RB transfected_VBN with_IN the_DT following_JJ vectors_NNS ._. 
For_IN siRNA_NNP knock_VB down_RP ,_, a_DT H1_NNP promoter_NN for_IN RNA_NNP pol_NN III_NNP -LRB-_-LRB- containing_VBG two_CD Tet-repressor_JJ binding_JJ sites_NNS -RRB-_-RRB- was_VBD cloned_VBN into_IN a_DT promoter-less_JJ pcDNA3_JJ vector_NN -LRB-_-LRB- Invitrogen_NNP -RRB-_-RRB- ,_, generating_NN pcDNA\/2_NN 
Therefore_RB ,_, the_DT same_JJ doxycycline-inducible_JJ vector_NN -LRB-_-LRB- pcDNA4\/TO\/PHB_NNP -RRB-_-RRB- was_VBD used_VBN to_TO stably_RB transfect_VB the_DT LNCaP\/Luc_NNP cells_NNS to_TO produce_VB a_DT new_JJ stable_JJ cell_NN line_NN ,_, LNCaP\/Luc\/PHB-cDNA_NNP ._. 
Additionally_RB ,_, a_DT doxycycline-inducible_JJ RNAi_NNP hairpin_NN vector_NN -LRB-_-LRB- p2TetR\/PHB_NNP -RRB-_-RRB- ,_, based_VBN on_IN previously_RB validated_VBN RNAi_FW oligos_FW -LRB-_-LRB- Gamble_NNP et_NNP al._NNP ._. 
2004_CD -RRB-_-RRB- ,_, was_VBD used_VBN to_TO generate_VB an_DT inducible_JJ PHB_NNP knockdown_NN cell_NN line_NN LNCaP\/Luc\/PHB-RNAi_NNP ,_, allowing_VBG effects_NNS of_IN manipulating_VBG PHB_NNP levels_NNS to_TO be_VB studied_VBN within_IN a_DT chromatinized_JJ system_NN both_DT in_IN vitro_NN and_CC in_IN vivo_NN ._. 
It_PRP is_VBZ likely_JJ that_IN indirect_JJ interactions_NNS or_CC competition_NN between_IN AR_NNP and_CC PHB_NNP would_MD arise_VB at_IN this_DT G_NNP 1_CD \/_NNP S_NNP boundary_NN ._. 
Direct_JJ interaction_NN between_IN AR_NNP and_CC PHB_NNP remains_VBZ elusive_JJ -LRB-_-LRB- Gamble_NNP et_NNP al._NNP ._. 
2004_CD -RRB-_-RRB- ,_, but_CC recent_JJ evidence_NN for_IN a_DT more_RBR direct_JJ interaction_NN between_IN PHB_NNP and_CC steroid_JJ receptors_NNS exists_VBZ ._. 
2004_CD -RRB-_-RRB- ,_, presumably_RB enabling_VBG androgen-stimulated_JJ cell_NN cycle_NN entry_NN and_CC growth_NN ._. 
Furthermore_RB ,_, we_PRP found_VBD PHB_NNP protein_NN levels_NNS in_IN prostate_NN cancer_NN cells_NNS to_TO be_VB downregulated_VBN in_IN response_NN to_TO androgens_NNS -LRB-_-LRB- Gamble_NNP et_NNP al_NNP ._. 
More_RBR recently_RB ,_, PHB_NNP has_VBZ been_VBN shown_VBN to_TO be_VB a_DT corepressor_NN of_IN the_DT estrogen_NN receptor_NN -LRB-_-LRB- ER_SYM 
2004_CD -RRB-_-RRB- ,_, but_CC recent_JJ evidence_NN for_IN a_DT more_RBR direct_JJ interaction_NN between_IN PHB_NNP and_CC steroid_JJ receptors_NNS exists_VBZ ._. 
PHB_NN associates_NNS with_IN oestrogen-regulated_JJ promoters_NNS directly_RB in_IN the_DT absence_NN of_IN hormone_NN ,_, supporting_VBG its_PRP$ role_NN as_IN a_DT transcriptional_JJ corepressor_NN -LRB-_-LRB- He_PRP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ,_, and_CC may_MD physically_RB interfere_VB with_IN transcription_NN factor_NN binding_JJ to_TO the_DT response_NN element_NN ._. 
From_IN this_DT study_NN ,_, PHB_NNP overexpression_NN inhibits_VBZ cell_NN growth_NN ,_, but_CC may_MD also_RB protect_VB against_IN hormonal_JJ starvation_NN during_IN anti-androgen_JJ therapy_NN ._. 
Prostate_NN development_NN is_VBZ driven_VBN by_IN the_DT potent_JJ androgen_NN dihydrotestosterone_NN -LRB-_-LRB- DHT_NNP -RRB-_-RRB- ,_, produced_VBN within_IN prostate_NN cells_NNS by_IN the_DT action_NN of_IN 5_CD 
Although_IN initially_RB successful_JJ ,_, such_JJ therapies_NNS inevitably_RB fail_VBP and_CC patients_NNS relapse_VBP with_IN 
For_IN PHB_NNP manipulation_NN within_IN the_DT LNCaP\/Luc_NNP cells_NNS ,_, doxycycline_NN was_VBD administered_VBN in_IN drinking_NN water_NN -LRB-_-LRB- 20_CD 
Although_IN initially_RB successful_JJ ,_, such_JJ therapies_NNS inevitably_RB fail_VBP and_CC patients_NNS relapse_VBP with_IN 
The_DT mechanisms_NNS of_IN AR_NNP activation_NN within_IN such_JJ tumors_NNS are_VBP poorly_RB understood_VBN ._. 
The_DT AR_NNP remains_VBZ active_JJ within_IN the_DT majority_NN of_IN these_DT hormone-refractory_JJ tumors_NNS and_CC is_VBZ required_VBN for_IN prostate_NN cell_NN growth_NN ,_, differentiation_NN and_CC gene_NN expression_NN ._. 
AR_NN mutations_NNS and\/or_CC amplification_NN are_VBP frequently_RB found_VBN in_IN advanced_JJ tumors_NNS ,_, and_CC it_PRP has_VBZ been_VBN postulated_VBN that_WDT decreases_VBZ in_IN corepressor_NN proteins_NNS or_CC increases_NNS in_IN coactivator_NN proteins_NNS could_MD also_RB be_VB potential_JJ activation_NN pathways_NNS for_IN the_DT progression_NN of_IN tumors_NNS to_TO this_DT androgen-independent_JJ stage_NN -LRB-_-LRB- Isaacs_NNP 
Light_NN emission_NN from_IN luciferase_NN was_VBD detected_VBN by_IN the_DT IVIS_NNP Imaging_NNP System_NNP 100_CD series_NN -LRB-_-LRB- Xenogen_NNP Corporation_NNP -RRB-_-RRB- ,_, and_CC overlaid_VBD as_IN a_DT pseudocolor_NN image_NN with_IN reference_NN scale_NN ,_, upon_IN a_DT greyscale_JJ optical_JJ image_NN ._. 
Photon_NNP emission_NN was_VBD later_RB normalized_VBN either_RB to_TO cell_NN number_NN ,_, measured_VBN using_VBG the_DT sulphorhodamine_JJ B_NNP assay_NN as_RB previously_RB described_VBN -LRB-_-LRB- Skehan_FW et_FW al._FW ._. 
1990_CD -RRB-_-RRB- ,_, or_CC to_TO tumor_NN volume_NN ._. 
Measurement_NNP of_IN serum_NN doxycycline_NN and_CC testosterone_NN Serum_NN was_VBD collected_VBN from_IN mice_NNS given_VBN doxycycline_NN -LRB-_-LRB- 0_CD 
However_RB ,_, in_IN the_DT absence_NN of_IN androgen_NN ,_, tumors_NNS with_IN PHB_NNP overexpression_NN showed_VBD an_DT apparent_JJ inhibition_NN of_IN tumor_NN involution_NN and_CC apoptosis_NN ,_, suggesting_VBG that_IN PHB_NNP overexpression_NN leads_VBZ to_TO cell_NN cycle_NN arrest_NN regardless_RB of_IN hormone_NN effects_NNS ,_, and_CC may_MD consequently_RB have_VB a_DT protective_JJ role_NN against_IN apoptosis_NNS caused_VBN by_IN hormonal_JJ starvation_NN stress_NN ._. 
Similar_JJ protective_JJ effects_NNS have_VBP been_VBN shown_VBN for_IN PHB_NNP when_WRB LNCaP_NNP cells_NNS were_VBD deprived_VBN of_IN growth_NN factors_NNS -LRB-_-LRB- Vander_NNP Heiden_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- or_CC treated_VBN with_IN cytotoxic_JJ agents_NNS such_JJ as_IN camptothecin_NN -LRB-_-LRB- Fusaro_FW et_FW al_FW ._. 
2002_CD ,_, Rastogi_NNP et_FW al_FW ._. 
Within_IN these_DT ,_, specific_JJ AREs_NNS differ_VBP from_IN the_DT classical_JJ inverted_JJ TGTTCT_NNP ,_, having_VBG a_DT greater_JJR similarity_NN to_TO a_DT direct_JJ repeat_NN of_IN the_DT same_JJ sequence_NN ,_, but_CC with_IN a_DT change_NN of_IN T_NN 
However_RB ,_, recent_JJ studies_NNS in_IN breast_NN cancer_NN indicate_VBP that_IN the_DT simple_JJ protein_NN level_NN measurement_NN was_VBD insufficient_JJ ,_, as_IN high_JJ PHB_NNP levels_NNS masked_VBD underlying_JJ inactivating_VBG mutations_NNS in_IN the_DT Rb_NN and_CC E2F-binding_JJ regions_NNS of_IN PHB_NNP -LRB-_-LRB- Sato_NNP et_FW al_FW ._. 
1992_CD ,_, 1993_CD -RRB-_-RRB- ._. 
PHB_NNP has_VBZ been_VBN shown_VBN to_TO be_VB downregulated_VBN in_IN gliomas_NNS -LRB-_-LRB- Chumbalkar_FW et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
Loss_NN of_IN the_DT PHB_NNP repressor_NN protein_NN may_MD impact_VB on_IN the_DT repressive_JJ effectiveness_NN of_IN hormone_NN antagonists_NNS such_JJ as_IN the_DT partial_JJ anti-oestrogen_JJ tamoxifen_NN -LRB-_-LRB- Wang_NNP et_NNP al_NNP ._. 
2008_CD -RRB-_-RRB- ,_, but_CC any_DT extensive_JJ studies_NNS on_IN the_DT levels_NNS of_IN PHB_NNP protein_NN within_IN prostate_NN cancers_NNS and_CC its_PRP$ effects_NNS on_IN disease_NN progression_NN are_VBP currently_RB lacking_VBG ._. 
However_RB ,_, recent_JJ studies_NNS in_IN breast_NN cancer_NN indicate_VBP that_IN the_DT simple_JJ protein_NN level_NN measurement_NN was_VBD insufficient_JJ ,_, as_IN high_JJ PHB_NNP levels_NNS masked_VBD underlying_JJ inactivating_VBG mutations_NNS in_IN the_DT Rb_NN and_CC E2F-binding_JJ regions_NNS of_IN PHB_NNP -LRB-_-LRB- Sato_NNP et_FW al._FW ._. 
1992_CD ,_, 1993_CD -RRB-_-RRB- ._. 
PHB_NNP has_VBZ been_VBN shown_VBN to_TO be_VB downregulated_VBN in_IN gliomas_NNS -LRB-_-LRB- Chumbalkar_FW et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
Loss_NN of_IN the_DT PHB_NNP repressor_NN protein_NN may_MD impact_VB on_IN the_DT repressive_JJ effectiveness_NN of_IN hormone_NN antagonists_NNS such_JJ as_IN the_DT partial_JJ anti-oestrogen_JJ tamoxifen_NN -LRB-_-LRB- Wang_NNP et_NNP al_NNP ._. 
Two_CD well-studied_JJ examples_NNS are_VBP the_DT rat_NN dorsal_JJ prostate-specific_JJ probasin_NN -LRB-_-LRB- PB_NNP -RRB-_-RRB- promoter_NN and_CC the_DT prostate_NN trans-epithelial_JJ transporter_NN of_IN IgM_NNP -LRB-_-LRB- secretory_JJ component_NN or_CC SC_NNP -RRB-_-RRB- promoter_NN -LRB-_-LRB- Dodd_NNP et_NNP al_NNP ._. 
1983_CD ,_, Rennie_NNP et_FW al._FW ._. 
1993_CD ,_, Mostov_NNP 1994_CD ,_, Claessens_NNPS et_FW al_FW ._. 
1996_CD ,_, Verrijdt_FW et_FW al_FW ._. 
1999_CD -RRB-_-RRB- ._. 
Within_IN these_DT ,_, specific_JJ AREs_NNS differ_VBP from_IN the_DT classical_JJ inverted_JJ TGTTCT_NNP ,_, having_VBG a_DT greater_JJR similarity_NN to_TO a_DT direct_JJ repeat_NN of_IN the_DT same_JJ sequence_NN ,_, but_CC with_IN a_DT change_NN of_IN T_NN 
Conversely_RB ,_, a_DT reduction_NN in_IN PHB_NNP levels_NNS may_MD increase_VB the_DT ability_NN of_IN the_DT AR_NNP to_TO promote_VB cell_NN growth_NN and_CC gene_NN expression_NN ,_, but_CC could_MD cause_VB inappropriate_JJ cell_NN cycle_NN entry_NN and_CC mitochondrial_JJ dysfunction_NN ._. 
PHB_NNP is_VBZ an_DT upregulated_JJ marker_NN for_IN distinguishing_VBG benign_JJ hyperplasia_NN from_IN prostate_NN cancer_NN -LRB-_-LRB- Ummanni_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ,_, but_CC any_DT extensive_JJ studies_NNS on_IN the_DT levels_NNS of_IN PHB_NNP protein_NN within_IN prostate_NN cancers_NNS and_CC its_PRP$ effects_NNS on_IN disease_NN progression_NN are_VBP currently_RB lacking_VBG ._. 
In_IN the_DT absence_NN of_IN ligand_NN ,_, AR_NNP is_VBZ cytoplasmic_JJ ;_: ligand_NN binding_JJ induces_VBZ an_DT active_JJ conformation_NN and_CC translocation_NN into_IN the_DT nucleus_NN where_WRB it_PRP binds_VBZ specific_JJ androgen_JJ response_NN elements_NNS -LRB-_-LRB- AREs_NNPS -RRB-_-RRB- in_IN the_DT regulatory_JJ regions_NNS of_IN target_NN genes_NNS ,_, thus_RB influencing_VBG rates_NNS of_IN gene_NN transactivation_NN ._. 
AR_NNP then_RB recruits_VBZ regulatory_JJ protein_NN complexes_NNS to_TO the_DT promoters_NNS of_IN these_DT genes_NNS -LRB-_-LRB- Tsai_NNP 
Similar_JJ results_NNS have_VBP also_RB been_VBN obtained_VBN for_IN total_JJ PR_NNP protein_NN ,_, and_CC the_DT sharp_JJ decline_NN in_IN PR_NNP was_VBD found_VBN to_TO coincide_VB with_IN the_DT luteal_JJ elevation_NN of_IN serum_NN progesterone_NN concentration_NN in_IN these_DT studies_NNS -LRB-_-LRB- Verhage_NNP et_FW al_FW ._. 
1980_CD ,_, Pino_NNP et_FW al._FW ._. 
1984_CD ,_, Helm_NNP et_FW al_FW ._. 
1987_CD -RRB-_-RRB- ._. 
This_DT is_VBZ consistent_JJ with_IN studies_NNS demonstrating_VBG the_DT polyubiquitination_NN and_CC subsequent_JJ degradation_NN of_IN PR_NNP protein_NN upon_IN exposure_NN to_TO progesterone_NN -LRB-_-LRB- Lange_FW et_FW al_FW ._. 
However_RB ,_, studies_NNS indicate_VBP that_IN the_DT secretory_JJ cell_NN type_NN is_VBZ not_RB overrepresented_VBN during_IN this_DT phase_NN ._. 
One_CD possibility_NN ,_, therefore_RB ,_, for_IN the_DT partitioning_NN of_IN luteal_JJ phase_NN samples_NNS with_IN HGSC_NNP may_MD be_VB an_DT enrichment_NN of_IN secretory_JJ cells_NNS in_IN the_DT FTE_NNP during_IN the_DT luteal_JJ phase_NN ._. 
The_DT relative_JJ proportions_NNS of_IN secretory_NN to_TO ciliated_JJ cells_NNS in_IN different_JJ segments_NNS of_IN the_DT human_JJ fallopian_JJ tube_NN throughout_IN the_DT ovarian_JJ cycle_NN were_VBD previously_RB studied_VBN by_IN Crow_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1994_CD -RRB-_-RRB- ._. 
They_PRP reported_VBD an_DT increase_NN in_IN the_DT proportion_NN of_IN ciliated_JJ cells_NNS -LRB-_-LRB- hence_RB a_DT decrease_NN in_IN the_DT proportion_NN of_IN secretory_JJ cells_NNS -RRB-_-RRB- along_IN the_DT length_NN of_IN the_DT tube_NN ,_, with_IN the_DT highest_JJS proportion_NN of_IN ciliated_JJ cells_NNS observed_VBN in_IN the_DT fimbriae_NN -LRB-_-LRB- the_DT location_NN of_IN the_DT overwhelming_JJ majority_NN of_IN HGSC_NNP precursor_NN lesions_NNS -RRB-_-RRB- ._. 
CIHR_NNP MOP74726_NNP Introduction_NNP Epithelial_NNP ovarian_NN cancers_NNS ,_, which_WDT constitute_VBP the_DT 5th_JJ leading_JJ cause_NN of_IN cancer-related_JJ death_NN in_IN North_JJ American_JJ women_NNS ,_, are_VBP thought_VBN to_TO arise_VB through_IN two_CD basic_JJ pathways_NNS ._. 
While_IN most_JJS histological_JJ subtypes_NNS likely_RB arise_VBP from_IN the_DT ovarian_JJ surface_NN epithelium_NN -LRB-_-LRB- OSE_NNP -RRB-_-RRB- ,_, accumulating_VBG evidence_NN provides_VBZ strong_JJ support_NN that_IN high-grade_JJ serous_JJ adnexal_JJ cancer_NN ,_, commonly_RB attributed_VBN to_TO an_DT ovarian_JJ origin_NN ,_, arises_VBZ from_IN the_DT distal_JJ fallopian_JJ tube_NN epithelium_NN -LRB-_-LRB- FTE_NNP ;_: Colgan_NNP et_FW al._FW ._. 
2001_CD ,_, Piek_NNP et_FW al_FW ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- have_VBP demonstrated_VBN a_DT marked_JJ reduction_NN in_IN PR_NNP mRNA_NNP in_IN ovarian_NN cancer_NN cell_NN lines_NNS compared_VBN with_IN primary_JJ cultures_NNS of_IN normal_JJ OSE_NNP using_VBG semi-quantitative_JJ RT-PCR_NN ,_, and_CC others_NNS have_VBP found_VBN low_JJ PR_NNP protein_NN expression_NN in_IN both_DT BRCA1-associated_JJ and_CC sporadic_JJ serous_JJ ovarian_NN cancers_NNS by_IN immunohistochemistry_JJ -LRB-_-LRB- Aghmesheh_FW et_FW al_FW ._. 
However_RB ,_, recent_JJ studies_NNS have_VBP strongly_RB suggested_VBN that_IN the_DT FTE_NNP is_VBZ the_DT source_NN of_IN HGSC_NNP -LRB-_-LRB- Colgan_NNP et_FW al._FW ._. 
2001_CD ,_, Piek_NNP et_FW al_FW ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
Lau_NNP et_FW al_FW ._. 
This_DT is_VBZ consistent_JJ with_IN several_JJ studies_NNS that_WDT have_VBP reported_VBN decreased_VBN expression_NN of_IN PR_NNP in_IN ovarian_JJ and_CC fallopian_JJ tube_NN cancers_NNS ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- have_VBP demonstrated_VBN a_DT marked_JJ reduction_NN in_IN PR_NNP mRNA_NNP in_IN ovarian_NN cancer_NN cell_NN lines_NNS compared_VBN with_IN primary_JJ cultures_NNS of_IN normal_JJ OSE_NNP using_VBG semi-quantitative_JJ RT-PCR_NN ,_, and_CC others_NNS have_VBP found_VBN low_JJ PR_NNP protein_NN expression_NN in_IN both_DT BRCA1-associated_JJ and_CC sporadic_JJ serous_JJ ovarian_NN cancers_NNS by_IN immunohistochemistry_JJ -LRB-_-LRB- Aghmesheh_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
However_RB ,_, recent_JJ studies_NNS have_VBP strongly_RB suggested_VBN that_IN the_DT FTE_NNP is_VBZ the_DT source_NN of_IN HGSC_NNP -LRB-_-LRB- Colgan_NNP et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ,_, studies_NNS of_IN relative_JJ PR_NNP isoform_NN expression_NN in_IN FTE_NNP exhibiting_VBG focal_JJ accumulation_NN of_IN p53_NN -LRB-_-LRB- p53_NN signatures_NNS -RRB-_-RRB- ,_, tubal_JJ intraepithelial_JJ carcinomas_NNS and_CC their_PRP$ proposed_VBN intermediaries_NNS should_MD be_VB performed_VBN to_TO determine_VB whether_IN differential_JJ isoform_NN expression_NN may_MD play_VB a_DT role_NN at_IN any_DT stage_NN during_IN HGSC_NNP development_NN ._. 
Astudy_JJ comparing_VBG steroid_NN receptor_NN expression_NN in_IN familial_JJ and_CC sporadic_JJ serous_JJ carcinomas_NNS reported_VBD no_DT statistical_JJ difference_NN in_IN either_DT PR-A_NN or_CC PR-B_NN expression_NN -LRB-_-LRB- Aghmesheh_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Initial_JJ studies_NNS investigating_VBG the_DT effect_NN of_IN BRCA_NNP mutation_NN status_NN on_IN PR_NNP expression_NN in_IN non-malignant_JJ cells_NNS did_VBD not_RB distinguish_JJ by_IN isoform_NN ,_, but_CC rather_RB focused_VBN on_IN determining_VBG total_JJ PR_NNP protein_NN levels_NNS ._. 
Decreased_VBN PR-A_JJ and_CC PR-B_JJ immunostaining_NN in_IN luteal_JJ phase_NN FTE_NNP and_CC HGSC_NNP specimens_NNS In_IN light_NN of_IN previous_JJ studies_NNS showing_VBG selective_JJ loss_NN of_IN either_DT PR-A_NNP or_CC PR-B_NNP in_IN ovarian_NN -LRB-_-LRB- Akahira_FW et_FW al_FW ._. 
2000_CD ,_, 2002_CD -RRB-_-RRB- and_CC breast_NN -LRB-_-LRB- Graham_NNP et_NNP al._NNP ._. 
1995_CD ,_, Ariga_NNP et_FW al_FW ._. 
2001_CD ,_, Mote_FW et_FW al_FW ._. 
2002_CD ,_, Jacobsen_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- cancers_NNS ,_, immunohistochemistry_NN was_VBD performed_VBN on_IN tissue_NN microarrays_NNS using_VBG PR-A_NNP -_: or_CC PR-B-specific_JJ antibodies_NNS ._. 
-LRB-_-LRB- 2000_CD -RRB-_-RRB- have_VBP demonstrated_VBN a_DT lower_JJR expression_NN of_IN PR-A_NN compared_VBN with_IN PR-B_NN for_IN all_DT epithelial_JJ ovarian_NN cancer_NN histotypes_NNS using_VBG both_DT RT-PCR_NN and_CC immunohistochemistry_NN ;_: relative_JJ isoform_NN levels_NNS did_VBD not_RB vary_VB with_IN grade_NN or_CC stage_NN of_IN tumor_NN ._. 
In_IN a_DT follow-up_JJ study_NN ,_, this_DT group_NN reported_VBD a_DT progressive_JJ downregulation_NN of_IN PR-A_NNP ,_, but_CC not_RB of_IN PR-B_NN ,_, from_IN normal_JJ OSE_NNP through_IN benign_JJ ,_, borderline_JJ and_CC malignant_JJ serous_JJ ovarian_NN tumors_NNS -LRB-_-LRB- Akahira_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
In_IN normal_JJ OSE_NNP and_CC serous_JJ adenomas_NNS ,_, both_DT isoforms_NNS were_VBD equally_RB expressed_VBN ,_, whereas_IN PR-B_NNP predominated_VBD in_IN borderline_JJ and_CC malignant_JJ tumors_NNS ._. 
01_CD -RRB-_-RRB- ._. 
Importantly_RB ,_, PR_NNP mRNA_NNP was_VBD barely_RB detectable_JJ in_IN HGSC_NNP specimens_NNS ,_, with_IN expression_NN levels_NNS 
Because_IN expression_NN of_IN both_DT isoforms_NNS in_IN HGSC_NNP was_VBD barely_RB detectable_JJ by_IN immunohistochemistry_JJ ,_, consistent_JJ with_IN our_PRP$ RT-qPCR_JJ data_NNS ,_, ratios_NNS of_IN PR-A_NNP to_TO PR-B_NNP were_VBD not_RB calculated_VBN ._. 
Akahira_FW et_FW al._FW ._. 
-LRB-_-LRB- 2000_CD -RRB-_-RRB- have_VBP demonstrated_VBN a_DT lower_JJR expression_NN of_IN PR-A_NN compared_VBN with_IN PR-B_NN for_IN all_DT epithelial_JJ ovarian_NN cancer_NN histotypes_NNS using_VBG both_DT RT-PCR_NN and_CC immunohistochemistry_NN ;_: relative_JJ isoform_NN levels_NNS did_VBD not_RB vary_VB with_IN grade_NN or_CC stage_NN of_IN tumor_NN ._. 
Progesterone_NNP can_MD also_RB lead_VB to_TO rapid_JJ activation_NN of_IN a_DT number_NN of_IN genes_NNS through_IN protein_NN 
2009_CD -RRB-_-RRB- ._. 
2008_CD ,_, Gellersen_FW et_FW al_FW ._. 
2003_CD ,_, Boonyaratanakornkit_NNP et_FW al_FW ._. 
Progesterone_NNP can_MD also_RB lead_VB to_TO rapid_JJ activation_NN of_IN a_DT number_NN of_IN genes_NNS through_IN protein_NN 
2000_CD ,_, 2002_CD -RRB-_-RRB- and_CC breast_NN -LRB-_-LRB- Graham_NNP et_NNP al_NNP ._. 
Decreased_VBN PR-A_JJ and_CC PR-B_JJ immunostaining_NN in_IN luteal_JJ phase_NN FTE_NNP and_CC HGSC_NNP specimens_NNS In_IN light_NN of_IN previous_JJ studies_NNS showing_VBG selective_JJ loss_NN of_IN either_DT PR-A_NNP or_CC PR-B_NNP in_IN ovarian_NN -LRB-_-LRB- Akahira_FW et_FW al_FW ._. 
1995_CD ,_, Ariga_NNP et_FW al._FW ._. 
2001_CD ,_, Mote_FW et_FW al_FW ._. 
2002_CD ,_, Jacobsen_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- cancers_NNS ,_, immunohistochemistry_NN was_VBD performed_VBN on_IN tissue_NN microarrays_NNS using_VBG PR-A_NNP -_: or_CC PR-B-specific_JJ antibodies_NNS ._. 
While_IN PR-A_NNP and_CC PR-B_NNP are_VBP expressed_VBN at_IN roughly_RB equivalent_JJ levels_NNS in_IN normal_JJ human_JJ breast_NN epithelium_NN throughout_IN the_DT cycle_NN ,_, several_JJ studies_NNS have_VBP found_VBN a_DT predominance_NN of_IN PR-A_NNP in_IN a_DT high_JJ proportion_NN of_IN invasive_JJ breast_NN tumors_NNS -LRB-_-LRB- Graham_NNP et_NNP al_NNP ._. 
1995_CD ,_, Ariga_NNP et_FW al._FW ._. 
2001_CD ,_, Mote_FW et_FW al_FW ._. 
2002_CD -RRB-_-RRB- and_CC in_IN ductal_JJ carcinomas_NNS in_IN situ_NN -LRB-_-LRB- Mote_FW et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
Aspecific_JJ lack_NN of_IN expression_NN of_IN the_DT PR-B_NN isoform_NN has_VBZ also_RB been_VBN observed_VBN in_IN normal_JJ breast_NN epithelium_NN obtained_VBN from_IN BRCA_NNP mutation_NN carriers_NNS compared_VBN with_IN control_NN patients_NNS ,_, resulting_VBG in_IN predominant_JJ expression_NN of_IN PR-A_NNP in_IN 40_CD %_NN of_IN cases_NNS -LRB-_-LRB- Mote_FW et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, thus_RB the_DT OSE_NNP may_MD not_RB be_VB the_DT appropriate_JJ comparator_NN ._. 
2008_CD ,_, Shaw_NNP et_NNP al_NNP ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
Asingle_JJ previous_JJ study_NN has_VBZ reported_VBN slightly_RB decreased_VBN PR_NNP protein_NN expression_NN in_IN fallopian_JJ tube_NN carcinomas_NNS relative_JJ to_TO areas_NNS of_IN benign_JJ FTE_NNP in_IN patients_NNS with_IN or_CC without_IN a_DT BRCA_NNP mutation_NN -LRB-_-LRB- Cass_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Our_PRP$ study_NN extends_VBZ these_DT observations_NNS to_TO both_DT tubal_JJ and_CC ovarian_JJ HGSC_NNP samples_NNS and_CC to_TO FTE_VB samples_NNS obtained_VBN from_IN women_NNS without_IN adnexal_JJ cancer_NN ._. 
Unsupervised_JJ clustering_NN and_CC sample_NN prediction_NN analyses_NNS using_VBG genes_NNS reported_VBN as_IN PR-A_NNP -_: and_CC PR-B-specific_JJ targets_NNS further_RB showed_VBD that_IN BRCA_NNP -_: mutated_VBN samples_NNS did_VBD not_RB exhibit_VB an_DT altered_JJ PR_NNP response_NN ._. 
The_DT finding_NN that_IN PR_NNP mRNA_NNP is_VBZ lowest_JJS during_IN the_DT luteal_JJ phase_NN -LRB-_-LRB- in_IN both_DT carriers_NNS and_CC controls_NNS -RRB-_-RRB- is_VBZ consistent_JJ with_IN previous_JJ studies_NNS of_IN normal_JJ human_JJ FTE_NN throughout_IN the_DT ovarian_JJ cycle_NN ,_, which_WDT have_VBP shown_VBN little_JJ or_CC no_DT PR_NNP expression_NN during_IN this_DT phase_NN as_IN determined_VBN by_IN semi-quantitative_JJ RT-PCR_NNP -LRB-_-LRB- Briton-Jones_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Similar_JJ results_NNS have_VBP also_RB been_VBN obtained_VBN for_IN total_JJ PR_NNP protein_NN ,_, and_CC the_DT sharp_JJ decline_NN in_IN PR_NNP was_VBD found_VBN to_TO coincide_VB with_IN the_DT luteal_JJ elevation_NN of_IN serum_NN progesterone_NN concentration_NN in_IN these_DT studies_NNS -LRB-_-LRB- Verhage_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
2006_CD ,_, Gellersen_NNP et_NNP al_NNP ._. 
Progesterone_NNP classically_RB signals_VBZ by_IN binding_JJ to_TO intracellular_JJ progesterone_NN receptors_NNS -LRB-_-LRB- PR_NNP -RRB-_-RRB- ,_, leading_VBG to_TO receptor_NN dimerisation_NN and_CC binding_JJ to_TO specific_JJ hormone_NN response_NN elements_NNS located_VBN in_IN the_DT promoter_NN region_NN of_IN target_NN genes_NNS to_TO regulate_VB transcription_NN through_IN interaction_NN with_IN co-regulatory_JJ proteins_NNS -LRB-_-LRB- Mulac-Jericevic_NNP 
2002_CD -RRB-_-RRB- ._. 
2001_CD ,_, Fan_FW et_FW al_FW ._. 
Interestingly_RB ,_, PR_NNP expression_NN was_VBD higher_JJR in_IN inclusion_NN cyst_NN epithelium_NN from_IN mutation_NN carriers_NNS compared_VBN with_IN controls_NNS ,_, potentially_RB consistent_JJ with_IN the_DT repression_NN of_IN ER_NNP transactivation_NN activity_NN by_IN wild-type_JJ BRCA1_NNP -LRB-_-LRB- Zheng_NNP et_FW al_FW ._. 
BRCA1_NNP has_VBZ also_RB been_VBN reported_VBN to_TO function_VB as_IN a_DT PR_NNP transcriptional_NN repressor_NN -LRB-_-LRB- Ma_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ;_: thus_RB we_PRP had_VBD expected_VBN to_TO see_VB a_DT separation_NN of_IN FTEb_NNP and_CC FTEn_NNP cases_NNS based_VBN on_IN established_JJ PR-responsive_JJ genes_NNS ._. 
Furthermore_RB ,_, if_IN ligand-independent_JJ genes_NNS were_VBD found_VBN to_TO be_VB predictive_JJ of_IN BRCA_NNP mutation_NN status_NN ,_, this_DT could_MD suggest_VB a_DT potential_JJ role_NN for_IN crosstalk_NN between_IN PR_NNP and_CC cytokine_NN signalling_VBG pathways_NNS that_WDT may_MD be_VB locally_RB elevated_VBN following_VBG ovulation_NN -LRB-_-LRB- Denner_NNP et_FW al_FW ._. 
1990_CD ,_, Pierson-Mullany_NNP 
2006_CD -RRB-_-RRB- ._. 
PR-A_NNP and_CC PR-B_NNP are_VBP co-expressed_JJ at_IN roughly_RB equivalent_JJ levels_NNS in_IN most_JJS target_NN tissues_NNS -LRB-_-LRB- Shao_FW et_FW al_FW ._. 
PR-A_NN is_VBZ truncated_VBN at_IN the_DT amino-terminal_JJ domain_NN and_CC has_VBZ been_VBN shown_VBN to_TO exhibit_VB differential_JJ functional_JJ properties_NNS compared_VBN with_IN the_DT full-length_JJ PR-B_NN isoform_NN ,_, including_VBG regulation_NN of_IN distinct_JJ genes_NNS -LRB-_-LRB- Jacobsen_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- and_CC differential_JJ effects_NNS on_IN target_NN tissues_NNS in_IN knockout_NN mice_NNS -LRB-_-LRB- Mulac-Jericevic_NNP 
Phosphorylation_NN of_IN PR_NNP in_IN the_DT absence_NN of_IN ligand_NN ,_, through_IN the_DT activation_NN of_IN cytokine_NN or_CC growth_NN factor_NN signalling_VBG pathways_NNS such_JJ as_IN epidermal_JJ growth_NN factor_NN ,_, can_MD activate_VB PR-dependent_JJ gene_NN expression_NN ._. 
In_IN breast_NN epithelial_NN cells_NNS ,_, ligand-independent_JJ signalling_NN is_VBZ primarily_RB through_IN the_DT PR-A_NNP isoform_NN -LRB-_-LRB- Jacobsen_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT genes_NNS regulated_VBN by_IN ligand-independent_JJ signalling_NN are_VBP largely_RB distinct_JJ from_IN those_DT regulated_VBN by_IN ligand-dependent_JJ PR_NNP activation_NN -LRB-_-LRB- Jacobsen_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN breast_NN epithelial_NN cells_NNS ,_, ligand-independent_JJ signalling_NN is_VBZ primarily_RB through_IN the_DT PR-A_NNP isoform_NN -LRB-_-LRB- Jacobsen_NNP et_FW al_FW ._. 
The_DT genes_NNS regulated_VBN by_IN ligand-independent_JJ signalling_NN are_VBP largely_RB distinct_JJ from_IN those_DT regulated_VBN by_IN ligand-dependent_JJ PR_NNP activation_NN -LRB-_-LRB- Jacobsen_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Differential_JJ expression_NN of_IN PR_NNP isoforms_NNS in_IN FTEb_NNP could_MD thus_RB underlie_VB the_DT altered_JJ gene_NN expression_NN profiles_NNS ,_, particularly_RB during_IN the_DT luteal_JJ phase_NN when_WRB circulating_VBG progesterone_NN levels_NNS are_VBP elevated_VBN ._. 
05_CD ._. 
Comparisons_NNS were_VBD considered_VBN statistically_RB significant_JJ if_IN P_NN 
2001_CD ,_, Mote_FW et_FW al_FW ._. 
1995_CD ,_, Ariga_NNP et_FW al_FW ._. 
2000_CD ,_, 2002_CD -RRB-_-RRB- and_CC breast_NN -LRB-_-LRB- Graham_NNP et_NNP al_NNP ._. 
Decreased_VBN PR-A_JJ and_CC PR-B_JJ immunostaining_NN in_IN luteal_JJ phase_NN FTE_NNP and_CC HGSC_NNP specimens_NNS In_IN light_NN of_IN previous_JJ studies_NNS showing_VBG selective_JJ loss_NN of_IN either_DT PR-A_NNP or_CC PR-B_NNP in_IN ovarian_NN -LRB-_-LRB- Akahira_FW et_FW al_FW ._. 
2002_CD ,_, Jacobsen_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- cancers_NNS ,_, immunohistochemistry_NN was_VBD performed_VBN on_IN tissue_NN microarrays_NNS using_VBG PR-A_NNP -_: or_CC PR-B-specific_JJ antibodies_NNS ._. 
These_DT data_NNS suggest_VBP a_DT subtle_JJ shift_NN in_IN the_DT PR-A_NNP :_: PR-B_NN staining_VBG ratio_NN during_IN the_DT luteal_JJ phase_NN ,_, potentially_RB reflective_JJ of_IN a_DT slightly_RB lower_JJR level_NN of_IN PR-A_NN relative_JJ to_TO PR-B_NNP during_IN this_DT phase_NN ._. 
Gene_NNP expression_NN analysis_NN of_IN profiled_VBN FTE_NNP based_VBN on_IN proposed_VBN PR-A_NN and_CC PR-B_NN target_NN genesTo_NNP determine_VBP whether_IN the_DT expression_NN of_IN PR-dependent_JJ genes_NNS separates_VBZ FTE_NNP samples_NNS into_IN meaningful_JJ subgroups_NNS ,_, unsupervised_JJ clustering_NN of_IN all_DT individual_JJ samples_NNS was_VBD performed_VBN using_VBG genes_NNS previously_RB shown_VBN to_TO be_VB altered_VBN downstream_JJ of_IN PR_NNP activation_NN by_IN Jacobsen_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ._. 
Genes_NNS with_IN altered_JJ expression_NN specifically_RB due_JJ to_TO PR-A_NNP or_CC PR-B_NNP activation_NN ,_, both_DT dependent_JJ and_CC independent_JJ of_IN ligand_NN ,_, were_VBD identified_VBN in_IN estrogen_NN receptor_NN -LRB-_-LRB- ER_NNP -RRB-_-RRB- -_: positive_JJ ,_, PR-negative_JJ T47D_NNP breast_NN cancer_NN cell_NN lines_NNS engineered_VBN to_TO express_VB PR-A_NNP or_CC PR-B_NNP under_IN the_DT control_NN of_IN an_DT inducible_JJ promoter_NN -LRB-_-LRB- Jacobsen_NNP et_FW al_FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ._. 
Gene_NNP expression_NN analysis_NN of_IN profiled_VBN FTE_NNP based_VBN on_IN proposed_VBN PR-A_NNP and_CC PR-B_NNP target_NN genes_NNS To_TO determine_VB whether_IN the_DT expression_NN of_IN PR-dependent_JJ genes_NNS separates_VBZ FTE_NNP samples_NNS into_IN meaningful_JJ subgroups_NNS ,_, unsupervised_JJ clustering_NN of_IN all_DT individual_JJ samples_NNS was_VBD performed_VBN using_VBG genes_NNS previously_RB shown_VBN to_TO be_VB altered_VBN downstream_JJ of_IN PR_NNP activation_NN by_IN Jacobsen_NNP et_FW al_FW ._. 
Genes_NNS with_IN altered_JJ expression_NN specifically_RB due_JJ to_TO PR-A_NNP or_CC PR-B_NNP activation_NN ,_, both_DT dependent_JJ and_CC independent_JJ of_IN ligand_NN ,_, were_VBD identified_VBN in_IN estrogen_NN receptor_NN -LRB-_-LRB- ER_NNP -RRB-_-RRB- -_: positive_JJ ,_, PR-negative_JJ T47D_NNP breast_NN cancer_NN cell_NN lines_NNS engineered_VBN to_TO express_VB PR-A_NNP or_CC PR-B_NNP under_IN the_DT control_NN of_IN an_DT inducible_JJ promoter_NN -LRB-_-LRB- Jacobsen_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Specifically_RB ,_, 37_CD distinct_JJ genes_NNS were_VBD found_VBN to_TO be_VB altered_VBN in_IN PR-A_NNP +_NNP -LRB-_-LRB- relative_JJ to_TO PR_NNP null_NNP -RRB-_-RRB- T47D_CD cells_NNS after_IN 6_CD 
1990_CD ,_, Pierson-Mullany_NNP 
In_IN contrast_NN ,_, none_NN of_IN the_DT PR-dependent_JJ subsets_NNS -LRB-_-LRB- particularly_RB probe_NN sets_VBZ corresponding_JJ to_TO PR-A_VB ligand-independent_JJ genes_NNS -RRB-_-RRB- were_VBD successful_JJ at_IN predicting_VBG whether_IN a_DT particular_JJ non-malignant_JJ sample_NN was_VBD obtained_VBN from_IN a_DT BRCA1\/2_NNP mutation_NN carrier_NN or_CC control_NN patient_NN -LRB-_-LRB- as_IN indicated_VBN by_IN a_DT low_JJ sample_NN prediction_NN accuracy_NN for_IN dataset_NN B_NNP ,_, total_JJ n_NN =_SYM 24_CD samples_NNS -RRB-_-RRB- ,_, indicating_VBG that_IN the_DT overall_JJ PR_NNP response_NN is_VBZ not_RB altered_VBN due_JJ to_TO BRCA_NNP mutation_NN status_NN ._. 
As_IN expected_VBN ,_, all_DT lists_NNS were_VBD predictive_JJ of_IN the_DT stage_NN of_IN the_DT ovarian_JJ cycle_NN of_IN a_DT given_VBN FTE_NNP sample_NN -LRB-_-LRB- dataset_NN C_NNP ,_, total_JJ n_NN =_SYM 24_CD samples_NNS -RRB-_-RRB- ,_, providing_VBG further_JJ support_NN of_IN the_DT PR_NNP dependence_NN of_IN the_DT genes_NNS identified_VBN by_IN Jacobsen_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2005_CD -RRB-_-RRB- ._. 
Finally_RB ,_, certain_JJ subsets_NNS of_IN PR-dependent_JJ genes_NNS -LRB-_-LRB- such_JJ as_IN those_DT activated_VBN by_IN PR-A_NNP overall_NN and_CC PR-B_NN -RRB-_-RRB- were_VBD relatively_RB successful_JJ at_IN predicting_VBG whether_IN a_DT particular_JJ luteal_JJ phase_NN sample_NN belonged_VBD to_TO the_DT FTEb_NNP -LRB-_-LRB- S_NNP -RRB-_-RRB- subgroup_NN -LRB-_-LRB- dataset_NN D_NNP ,_, total_JJ n_NN =_SYM 12_CD samples_NNS -RRB-_-RRB- ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2001_CD ,_, Piek_NNP et_FW al_FW ._. 
While_IN most_JJS histological_JJ subtypes_NNS likely_RB arise_VBP from_IN the_DT ovarian_JJ surface_NN epithelium_NN -LRB-_-LRB- OSE_NNP -RRB-_-RRB- ,_, accumulating_VBG evidence_NN provides_VBZ strong_JJ support_NN that_IN high-grade_JJ serous_JJ adnexal_JJ cancer_NN ,_, commonly_RB attributed_VBN to_TO an_DT ovarian_JJ origin_NN ,_, arises_VBZ from_IN the_DT distal_JJ fallopian_JJ tube_NN epithelium_NN -LRB-_-LRB- FTE_NNP ;_: Colgan_NNP et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al._FW ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
2008_CD ,_, Shaw_NNP et_NNP al_NNP ._. 
2009_CD -RRB-_-RRB- ._. 
We_PRP have_VBP previously_RB demonstrated_VBN that_IN non-malignant_JJ FTE_NNP collected_VBN during_IN the_DT luteal_JJ phase_NN from_IN breast_NN cancer_NN susceptibility_NN gene_NN 1\/2_CD -LRB-_-LRB- BRCA1\/2_NNP -RRB-_-RRB- mutation_NN carriers_NNS exhibits_VBZ gene_NN expression_NN profiles_NNS more_RBR closely_RB resembling_VBG that_IN of_IN ovarian_JJ and_CC fallopian_JJ tube_NN high-grade_JJ serous_JJ carcinoma_NN -LRB-_-LRB- HGSC_NNP -RRB-_-RRB- than_IN FTE_NNP from_IN control_NN patients_NNS -LRB-_-LRB- Tone_FW et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2001_CD ,_, Piek_NNP et_FW al_FW ._. 
However_RB ,_, recent_JJ studies_NNS have_VBP strongly_RB suggested_VBN that_IN the_DT FTE_NNP is_VBZ the_DT source_NN of_IN HGSC_NNP -LRB-_-LRB- Colgan_NNP et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al._FW ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
2008_CD ,_, Shaw_NNP et_NNP al_NNP ._. 
2009_CD -RRB-_-RRB- ,_, thus_RB the_DT OSE_NNP may_MD not_RB be_VB the_DT appropriate_JJ comparator_NN ._. 
We_PRP chose_VBD to_TO include_VB the_DT latter_JJ set_NN of_IN genes_NNS in_IN our_PRP$ analysis_NN -LRB-_-LRB- despite_IN being_VBG altered_VBN in_IN the_DT absence_NN of_IN progesterone_NN -RRB-_-RRB- ,_, since_IN the_DT ligand_NN dependency_NN of_IN a_DT particular_JJ gene_NN may_MD be_VB influenced_VBN by_IN cell_NN or_CC tissue_NN type_NN ._. 
As_IN exposure_NN to_TO progesterone_NN leads_VBZ to_TO downregulation_NN of_IN both_DT PR_NNP isoforms_NNS -LRB-_-LRB- Lange_FW et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ,_, gene_NN expression_NN could_MD also_RB be_VB altered_VBN by_IN decreased_VBN levels_NNS of_IN PR-A_NNP irrespective_RB of_IN the_DT absence_NN or_CC presence_NN of_IN ligand_NN ._. 
1987_CD -RRB-_-RRB- ._. 
1984_CD ,_, Helm_NNP et_FW al_FW ._. 
1980_CD ,_, Pino_NNP et_NNP al_NNP ._. 
Similar_JJ results_NNS have_VBP also_RB been_VBN obtained_VBN for_IN total_JJ PR_NNP protein_NN ,_, and_CC the_DT sharp_JJ decline_NN in_IN PR_NNP was_VBD found_VBN to_TO coincide_VB with_IN the_DT luteal_JJ elevation_NN of_IN serum_NN progesterone_NN concentration_NN in_IN these_DT studies_NNS -LRB-_-LRB- Verhage_NNP et_FW al_FW ._. 
This_DT is_VBZ consistent_JJ with_IN studies_NNS demonstrating_VBG the_DT polyubiquitination_NN and_CC subsequent_JJ degradation_NN of_IN PR_NNP protein_NN upon_IN exposure_NN to_TO progesterone_NN -LRB-_-LRB- Lange_FW et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ._. 
Thus_RB ,_, the_DT decline_NN in_IN PR_NNP expression_NN in_IN the_DT luteal_JJ phase_NN samples_NNS observed_VBN in_IN this_DT study_NN likely_RB represents_VBZ downregulation_NN of_IN PR_NNP ._. 
This_DT is_VBZ consistent_JJ with_IN several_JJ studies_NNS that_WDT have_VBP reported_VBN decreased_VBN expression_NN of_IN PR_NNP in_IN ovarian_JJ and_CC fallopian_JJ tube_NN cancers_NNS ._. 
Lau_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- have_VBP demonstrated_VBN a_DT marked_JJ reduction_NN in_IN PR_NNP mRNA_NNP in_IN ovarian_NN cancer_NN cell_NN lines_NNS compared_VBN with_IN primary_JJ cultures_NNS of_IN normal_JJ OSE_NNP using_VBG semi-quantitative_JJ RT-PCR_NN ,_, and_CC others_NNS have_VBP found_VBN low_JJ PR_NNP protein_NN expression_NN in_IN both_DT BRCA1-associated_JJ and_CC sporadic_JJ serous_JJ ovarian_NN cancers_NNS by_IN immunohistochemistry_JJ -LRB-_-LRB- Aghmesheh_FW et_FW al_FW ._. 
Interestingly_RB ,_, previous_JJ studies_NNS have_VBP demonstrated_VBN loss_NN of_IN heterozygosity_NN -LRB-_-LRB- LOH_NNP -RRB-_-RRB- at_IN the_DT PR_NNP locus_NN -LRB-_-LRB- 11q22_CD -RRB-_-RRB- in_IN up_IN to_TO 50_CD %_NN of_IN analyzed_VBN ovarian_NN carcinomas_NNS of_IN varying_VBG histotypes_NNS -LRB-_-LRB- Gabra_FW et_FW al_FW ._. 
1995_CD ,_, Launonen_FW et_FW al._FW ._. 
1998_CD -RRB-_-RRB- ,_, providing_VBG a_DT potential_JJ explanation_NN for_IN PR_NNP loss_NN in_IN HGSC_NNP specimens_NNS ._. 
In_IN one_CD such_JJ study_NN ,_, 6\/15_CD -LRB-_-LRB- 40_CD %_NN -RRB-_-RRB- of_IN informative_JJ serous_JJ carcinoma_NN specimens_NNS exhibited_VBD LOH_NNP ;_: furthermore_RB ,_, LOH_NNP at_IN 11q22_CD was_VBD significantly_RB associated_VBN with_IN low_JJ tumor_NN PR_NNP content_NN in_IN the_DT full_JJ cohort_NN of_IN 38_CD ovarian_NN carcinomas_NNS studied_VBD -LRB-_-LRB- Gabra_FW et_FW al_FW ._. 
Whether_NNP LOH_NNP occurs_VBZ in_IN HGSC_NNP precursor_NN lesions_NNS in_IN the_DT FTE_NNP remains_VBZ to_TO be_VB determined_VBN ._. 
1995_CD -RRB-_-RRB- ._. 
In_IN one_CD such_JJ study_NN ,_, 6\/15_CD -LRB-_-LRB- 40_CD %_NN -RRB-_-RRB- of_IN informative_JJ serous_JJ carcinoma_NN specimens_NNS exhibited_VBD LOH_NNP ;_: furthermore_RB ,_, LOH_NNP at_IN 11q22_CD was_VBD significantly_RB associated_VBN with_IN low_JJ tumor_NN PR_NNP content_NN in_IN the_DT full_JJ cohort_NN of_IN 38_CD ovarian_NN carcinomas_NNS studied_VBD -LRB-_-LRB- Gabra_FW et_FW al_FW ._. 
Expression_NN of_IN PR_NNP has_VBZ been_VBN reported_VBN to_TO be_VB a_DT favourable_JJ prognostic_JJ indicator_NN in_IN ovarian_NN cancer_NN -LRB-_-LRB- Lee_NNP et_NNP al._NNP ._. 
2005_CD -RRB-_-RRB- ,_, but_CC this_DT finding_NN may_MD be_VB misleading_VBG due_JJ to_TO the_DT inclusion_NN of_IN multiple_JJ histotypes_NNS in_IN the_DT analysis_NN ._. 
In_IN light_NN of_IN recent_JJ studies_NNS outlining_VBG the_DT progression_NN to_TO HGSC_NNP from_IN normal_JJ FTE_NNP -LRB-_-LRB- Crum_NNP et_FW al_FW ._. 
2010_CD -RRB-_-RRB- ,_, this_DT is_VBZ not_RB thought_VBN to_TO be_VB the_DT case_NN for_IN HGSC_NNP ._. 
2007_CD ,_, Lee_NNP et_NNP al._NNP ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ,_, studies_NNS of_IN relative_JJ PR_NNP isoform_NN expression_NN in_IN FTE_NNP exhibiting_VBG focal_JJ accumulation_NN of_IN p53_NN -LRB-_-LRB- p53_NN signatures_NNS -RRB-_-RRB- ,_, tubal_JJ intraepithelial_JJ carcinomas_NNS and_CC their_PRP$ proposed_VBN intermediaries_NNS should_MD be_VB performed_VBN to_TO determine_VB whether_IN differential_JJ isoform_NN expression_NN may_MD play_VB a_DT role_NN at_IN any_DT stage_NN during_IN HGSC_NNP development_NN ._. 
1982_CD ,_, Crum_NNP et_FW al_FW ._. 
Several_JJ studies_NNS suggest_VBP that_IN HGSC_NNP arises_VBZ from_IN the_DT secretory_NN rather_RB than_IN the_DT ciliated_VBN FTE_NNP -LRB-_-LRB- Talamo_FW et_FW al_FW ._. 
2007_CD ,_, Lee_NNP et_NNP al._NNP ._. 
2007_CD -RRB-_-RRB- ._. 
One_CD possibility_NN ,_, therefore_RB ,_, for_IN the_DT partitioning_NN of_IN luteal_JJ phase_NN samples_NNS with_IN HGSC_NNP may_MD be_VB an_DT enrichment_NN of_IN secretory_JJ cells_NNS in_IN the_DT FTE_NNP during_IN the_DT luteal_JJ phase_NN ._. 
The_DT relative_JJ levels_NNS of_IN PR-A_NNP and_CC PR-B_NNP influence_VBP the_DT response_NN of_IN target_NN cells_NNS to_TO progesterone_VB ._. 
Also_RB consistent_JJ was_VBD our_PRP$ finding_NN that_IN none_NN of_IN the_DT clear_JJ cell_NN carcinomas_NNS and_CC only_RB one_CD of_IN six_CD mucinous_JJ carcinomas_NNS examined_VBN showed_VBD positive_JJ PR-A_NN or_CC PR-B_NN staining_NN ,_, suggesting_VBG a_DT potential_JJ role_NN for_IN PR_NNP loss_NN in_IN these_DT histotypes_NNS ._. 
For_IN instance_NN ,_, breast_NN cancer_NN cells_NNS with_IN predominant_JJ expression_NN of_IN PR-A_NNP have_VBP shown_VBN an_DT exaggerated_JJ proliferative_JJ response_NN to_TO luteal_JJ phase_NN levels_NNS of_IN progesterone_NN compared_VBN with_IN cells_NNS with_IN predominant_JJ expression_NN of_IN PR-B_NNP -LRB-_-LRB- Leo_NNP 
2005_CD -RRB-_-RRB- ._. 
The_DT finding_NN that_IN PR_NNP mRNA_NNP is_VBZ lowest_JJS during_IN the_DT luteal_JJ phase_NN -LRB-_-LRB- in_IN both_DT carriers_NNS and_CC controls_NNS -RRB-_-RRB- is_VBZ consistent_JJ with_IN previous_JJ studies_NNS of_IN normal_JJ human_JJ FTE_NN throughout_IN the_DT ovarian_JJ cycle_NN ,_, which_WDT have_VBP shown_VBN little_JJ or_CC no_DT PR_NNP expression_NN during_IN this_DT phase_NN as_IN determined_VBN by_IN semi-quantitative_JJ RT-PCR_NNP -LRB-_-LRB- Briton-Jones_NNP et_FW al_FW ._. 
Similar_JJ results_NNS have_VBP also_RB been_VBN obtained_VBN for_IN total_JJ PR_NNP protein_NN ,_, and_CC the_DT sharp_JJ decline_NN in_IN PR_NNP was_VBD found_VBN to_TO coincide_VB with_IN the_DT luteal_JJ elevation_NN of_IN serum_NN progesterone_NN concentration_NN in_IN these_DT studies_NNS -LRB-_-LRB- Verhage_NNP et_FW al._FW ._. 
1980_CD ,_, Pino_NNP et_NNP al_NNP ._. 
1984_CD ,_, Helm_NNP et_FW al_FW ._. 
1987_CD -RRB-_-RRB- ._. 
This_DT is_VBZ consistent_JJ with_IN studies_NNS demonstrating_VBG the_DT polyubiquitination_NN and_CC subsequent_JJ degradation_NN of_IN PR_NNP protein_NN upon_IN exposure_NN to_TO progesterone_NN -LRB-_-LRB- Lange_FW et_FW al_FW ._. 
2003_CD -RRB-_-RRB- ._. 
In_IN studies_NNS of_IN BRCA_NNP -_: associated_VBN OSE_NNP ,_, the_DT only_JJ difference_NN observed_VBD was_VBD an_DT increased_VBN expression_NN of_IN PR_NNP protein_NN in_IN inclusion_NN cyst_NN epithelium_NN compared_VBN with_IN OSE_NNP ,_, which_WDT the_DT authors_NNS attributed_VBN to_TO an_DT increased_VBN exposure_NN to_TO ovarian_VB stroma-derived_JJ hormones_NNS including_VBG estrogen_NN -LRB-_-LRB- Piek_FW et_FW al_FW ._. 
Interestingly_RB ,_, PR_NNP expression_NN was_VBD higher_JJR in_IN inclusion_NN cyst_NN epithelium_NN from_IN mutation_NN carriers_NNS compared_VBN with_IN controls_NNS ,_, potentially_RB consistent_JJ with_IN the_DT repression_NN of_IN ER_NNP transactivation_NN activity_NN by_IN wild-type_JJ BRCA1_NNP -LRB-_-LRB- Zheng_NNP et_FW al._FW ._. 
2001_CD ,_, Fan_FW et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
BRCA1_NNP has_VBZ also_RB been_VBN reported_VBN to_TO function_VB as_IN a_DT PR_NNP transcriptional_NN repressor_NN -LRB-_-LRB- Ma_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
2008_CD ,_, Shaw_NNP et_NNP al_NNP ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
We_PRP have_VBP previously_RB demonstrated_VBN that_IN non-malignant_JJ FTE_NNP collected_VBN during_IN the_DT luteal_JJ phase_NN from_IN breast_NN cancer_NN susceptibility_NN gene_NN 1\/2_CD -LRB-_-LRB- BRCA1\/2_NNP -RRB-_-RRB- mutation_NN carriers_NNS exhibits_VBZ gene_NN expression_NN profiles_NNS more_RBR closely_RB resembling_VBG that_IN of_IN ovarian_JJ and_CC fallopian_JJ tube_NN high-grade_JJ serous_JJ carcinoma_NN -LRB-_-LRB- HGSC_NNP -RRB-_-RRB- than_IN FTE_NNP from_IN control_NN patients_NNS -LRB-_-LRB- Tone_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
This_DT finding_NN suggests_VBZ that_IN the_DT FTE_NNP of_IN BRCA_NNP mutation_NN carriers_NNS -LRB-_-LRB- FTEb_NNP -RRB-_-RRB- responds_VBZ differently_RB to_TO the_DT luteal_JJ phase_NN milieu_NN ,_, which_WDT may_MD contribute_VB to_TO its_PRP$ predisposition_NN to_TO malignant_JJ transformation_NN ._. 
To_TO our_PRP$ knowledge_NN ,_, this_DT is_VBZ the_DT first_JJ comparative_JJ study_NN of_IN PR_NNP expression_NN in_IN non-malignant_JJ FTE_NNP in_IN the_DT follicular_JJ and_CC luteal_JJ phases_NNS of_IN the_DT ovarian_JJ cycle_NN in_IN BRCA1\/2_CD mutation_NN carriers_NNS and_CC control_NN patients_NNS ._. 
Materials_NNPS and_CC methodsStudy_NNP samplesGene_NNP expression_NN data_NNS derived_VBN from_IN laser_NN capture_NN microdissected_VBD -LRB-_-LRB- LCM_NNP -RRB-_-RRB- snap-frozen_JJ FTE_NNP and_CC HGSC_NNP specimens_NNS as_IN part_NN of_IN our_PRP$ original_JJ profiling_NN study_NN -LRB-_-LRB- Tone_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- were_VBD used_VBN to_TO evaluate_VB expression_NN levels_NNS of_IN PR_NNP and_CC PR-responsive_JJ genes_NNS ._. 
Specific_JJ clinical_JJ characteristics_NNS associated_VBN with_IN these_DT samples_NNS were_VBD previously_RB presented_VBN -LRB-_-LRB- Tone_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- were_VBD used_VBN to_TO evaluate_VB expression_NN levels_NNS of_IN PR_NNP and_CC PR-responsive_JJ genes_NNS ._. 
Materials_NNPS and_CC methods_NNS Study_NN samples_NNS Gene_NNP expression_NN data_NNS derived_VBN from_IN laser_NN capture_NN microdissected_VBD -LRB-_-LRB- LCM_NNP -RRB-_-RRB- snap-frozen_JJ FTE_NNP and_CC HGSC_NNP specimens_NNS as_IN part_NN of_IN our_PRP$ original_JJ profiling_NN study_NN -LRB-_-LRB- Tone_FW et_FW al_FW ._. 
Specific_JJ clinical_JJ characteristics_NNS associated_VBN with_IN these_DT samples_NNS were_VBD previously_RB presented_VBN -LRB-_-LRB- Tone_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
Briefly_RB ,_, these_DT samples_NNS included_VBD histologically_RB normal_JJ fallopian_JJ tubes_NNS from_IN 12_CD confirmed_VBD BRCA1\/2_CD mutation_NN carriers_NNS and_CC 12_CD control_NN patients_NNS undergoing_VBG salpingo-oophorectomy_NN for_IN reasons_NNS other_JJ than_IN family_NN history_NN or_CC adnexal_JJ malignancy_NN ,_, and_CC 13_CD HGSC_NNP diagnosed_VBD as_IN being_VBG of_IN tubal_JJ or_CC ovarian_JJ origin_NN ._. 
RNA_NNP extracted_VBD from_IN the_DT same_JJ representative_JJ LCM_NNP samples_NNS used_VBN in_IN our_PRP$ original_JJ study_NN -LRB-_-LRB- histologically_RB normal_JJ FTE_NNP from_IN six_CD BRCA1_CD mutation_NN carriers_NNS and_CC controls_NNS from_IN both_DT the_DT luteal_JJ and_CC follicular_JJ phases_NNS and_CC six_CD HGSC_NNP samples_NNS -RRB-_-RRB- was_VBD used_VBN to_TO compare_VB PR_NNP expression_NN levels_NNS by_IN RT-qPCR_NNP ._. 
We_PRP constructed_VBD two_CD tissue_NN microarrays_NNS using_VBG formalin-fixed_JJ paraffin-embedded_JJ samples_NNS from_IN the_DT University_NNP Health_NNP Network_NNP Ovarian_NNP Tissue_NNP Bank_NNP ,_, as_IN described_VBN in_IN our_PRP$ previous_JJ publication_NN -LRB-_-LRB- Tone_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
The_DT fallopian_JJ tube_NN array_NN included_VBD one_CD 1_CD ._. 
5_CD 
The_DT use_NN of_IN all_DT tissues_NNS in_IN this_DT study_NN was_VBD approved_VBN by_IN the_DT University_NNP Health_NNP Network_NNP Research_NNP Ethics_NNP Board_NNP ,_, and_CC all_DT patients_NNS provided_VBD informed_JJ consent_NN ._. 
RT-qPCR_NNP for_IN PR_NNP mRNAReal_NNP time_NN RT-qPCR_NNP was_VBD performed_VBN as_IN described_VBN previously_RB -LRB-_-LRB- Tone_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- with_IN the_DT following_JJ modifications_NNS ._. 
Primer_NN sequences_NNS used_VBD included_VBN PR_NNP :_: forward_RB 5_CD 
05_CD ._. 
Statistical_NNP significance_NN was_VBD determined_VBN as_IN P_NN 
0,_CD R_NNP Foundation_NNP for_IN Statistical_NNP Computing_NNP ,_, Vienna_NNP ,_, Austria_NNP -RRB-_-RRB- ._. 
10_CD ._. 
44_CD -RRB-_-RRB- package_NN of_IN R_NNP -LRB-_-LRB- v2_JJ ._. 
2002_CD -RRB-_-RRB- found_VBN in_IN the_DT pamr_NN -LRB-_-LRB- v1_CD ._. 
Each_DT gene_NN set_NN was_VBD tested_VBN against_IN a_DT predefined_JJ categorical_JJ binary_JJ variable_NN relevant_JJ to_TO a_DT subset_NN of_IN patient_JJ expression_NN data_NNS from_IN Tone_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2008_CD -RRB-_-RRB- ._. 
Expression_NN data_NNS for_IN each_DT set_NN of_IN patients_NNS under_IN consideration_NN were_VBD normalised_VBN in_IN GeneSpringGX_NNP independently_RB using_VBG the_DT RMA_NNP algorithm_NN as_RB well_RB as_IN to_TO the_DT median_JJ expression_NN value_NN of_IN each_DT gene_NN across_IN all_DT samples_NNS ._. 
Model_NNP building_NN and_CC prediction_NN was_VBD done_VBN using_VBG a_DT leave-one-out_JJ cross-validation_NN ,_, with_IN the_DT number_NN of_IN cross_JJ validation_NN folds_VBZ equal_JJ to_TO the_DT smallest_JJS number_NN of_IN samples_NNS in_IN one_CD of_IN the_DT classes_NNS under_IN consideration_NN ._. 
ResultsDecreased_JJ expression_NN of_IN PR_NNP mRNA_NNP in_IN luteal_JJ phase_NN FTE_NNP and_CC HGSC_NNP specimensAnalysis_NNP of_IN previously_RB obtained_VBN gene_NN expression_NN profiles_NNS of_IN microdissected_VBN non-malignant_JJ FTE_NNP and_CC HGSC_NNP specimens_NNS -LRB-_-LRB- Tone_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- revealed_VBD a_DT decreased_VBN expression_NN of_IN PR_NNP mRNA_NNP in_IN FTE_NNP samples_NNS obtained_VBN during_IN the_DT luteal_JJ phase_NN relative_JJ to_TO follicular_JJ phase_NN in_IN both_DT BRCA_NNP mutation_NN carriers_NNS -LRB-_-LRB- P_SYM 
No_DT differences_NNS in_IN PR_NNP mRNA_NNP expression_NN were_VBD observed_VBN in_IN samples_NNS obtained_VBN from_IN mutation_NN carriers_NNS versus_CC normal_JJ controls_NNS during_IN either_DT phase_NN of_IN the_DT ovarian_JJ cycle_NN ._. 
Asubset_NNP of_IN four_CD BRCA1-mutated_JJ luteal_JJ specimens_NNS ,_, which_WDT we_PRP have_VBP previously_RB highlighted_VBN because_IN they_PRP grouped_VBD closely_RB with_IN HGSC_NNP based_VBN on_IN global_JJ gene_NN expression_NN -LRB-_-LRB- denoted_VBN as_IN FTEb_NNP -LRB-_-LRB- S_NNP -RRB-_-RRB- ;_: Tone_NNP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ,_, showed_VBD similar_JJ expression_NN of_IN PR_NNP compared_VBN with_IN other_JJ samples_NNS obtained_VBN during_IN the_DT luteal_JJ phase_NN ._. 
FTE_NNP from_IN BRCA_NNP mutation_NN carriers_NNS collected_VBN during_IN the_DT luteal_JJ phase_NN molecularly_RB resembled_VBD HGSC_NNP ,_, rather_RB than_IN FTE_NNP collected_VBD during_IN the_DT follicular_JJ phase_NN or_CC from_IN normal_JJ control_NN patients_NNS ._. 
This_DT was_VBD particularly_RB apparent_JJ for_IN four_CD FTEb_NNP luteal_NN samples_NNS ,_, referred_VBD to_TO as_IN FTEb_NNP -LRB-_-LRB- S_NNP -RRB-_-RRB- ,_, which_WDT grouped_VBD with_IN HGSC_NNP at_IN the_DT global_JJ gene_NN expression_NN level_NN -LRB-_-LRB- Tone_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
In_IN this_DT study_NN ,_, we_PRP investigated_VBD the_DT potential_NN for_IN altered_JJ PR_NNP expression_NN and_CC signalling_VBG to_TO contribute_VB to_TO this_DT differential_JJ gene_NN expression_NN pattern_NN ._. 
2006_CD -RRB-_-RRB- ._. 
2005_CD -RRB-_-RRB- and_CC differential_JJ effects_NNS on_IN target_NN tissues_NNS in_IN knockout_NN mice_NNS -LRB-_-LRB- Mulac-Jericevic_NNP 
Amore_JJ definitive_JJ analysis_NN therefore_RB awaits_VBZ the_DT identification_NN of_IN PR_NNP target_NN genes_NNS more_RBR specific_JJ to_TO FTE_NNP cells_NNS ._. 
Several_JJ studies_NNS suggest_VBP that_IN HGSC_NNP arises_VBZ from_IN the_DT secretory_NN rather_RB than_IN the_DT ciliated_VBN FTE_NNP -LRB-_-LRB- Talamo_FW et_FW al._FW ._. 
1982_CD ,_, Crum_NNP et_FW al_FW ._. 
2007_CD ,_, Lee_NNP et_NNP al_NNP ._. 
2007_CD -RRB-_-RRB- ._. 
One_CD possibility_NN ,_, therefore_RB ,_, for_IN the_DT partitioning_NN of_IN luteal_JJ phase_NN samples_NNS with_IN HGSC_NNP may_MD be_VB an_DT enrichment_NN of_IN secretory_JJ cells_NNS in_IN the_DT FTE_NNP during_IN the_DT luteal_JJ phase_NN ._. 
Atwo-way_JJ hierarchical_JJ cluster_NN analysis_NN with_IN average_JJ linkage_NN using_VBG a_DT Pearson_NNP centered_VBN similarity_NN distance_NN metric_NN was_VBD then_RB performed_VBN ._. 
Classification_NN accuracy_NN of_IN subsets_NNS of_IN PR_NNP isoform-specific_JJ genes_NNS was_VBD assessed_VBN using_VBG the_DT supervised_JJ ,_, shrunken_JJ centroid_JJ class_NN prediction_NN method_NN -LRB-_-LRB- prediction_NN analysis_NN of_IN microarrays_NNS -LRB-_-LRB- PAM_NNP -RRB-_-RRB- ;_: Tibshirani_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- found_VBN in_IN the_DT pamr_NN -LRB-_-LRB- v1_CD ._. 
44_CD -RRB-_-RRB- package_NN of_IN R_NNP -LRB-_-LRB- v2_JJ ._. 
10_CD ._. 
0,_CD R_NNP Foundation_NNP for_IN Statistical_NNP Computing_NNP ,_, Vienna_NNP ,_, Austria_NNP -RRB-_-RRB- ._. 
FTEb_NNP -LRB-_-LRB- S_NNP -RRB-_-RRB- samples_NNS partitioned_VBN together_RB within_IN group_NN Ib_NN separate_JJ from_IN the_DT majority_NN of_IN HGSC_NNP in_IN group_NN II_NNP ._. 
To_TO extend_VB our_PRP$ analysis_NN of_IN PR-dependent_JJ gene_NN expression_NN in_IN FTE_NNP and_CC HGSC_NNP ,_, we_PRP tested_VBD the_DT ability_NN of_IN these_DT probe_NN sets_VBZ to_TO predict_VB a_DT given_VBN sample_NN category_NN using_VBG a_DT shrunken_JJ centroid_JJ classification_NN methodology_NN -LRB-_-LRB- Tibshirani_FW et_FW al._FW ._. 
2002_CD ;_: results_NNS shown_VBN in_IN Table_NNP 1_CD -RRB-_-RRB- ._. 
Athreshold_NNP of_IN 0_CD for_IN the_DT shrinkage_NN factor_NN was_VBD used_VBN in_IN order_NN to_TO include_VB all_DT probe_NN sets_NNS in_IN the_DT prediction_NN ,_, and_CC all_DT results_NNS are_VBP based_VBN on_IN a_DT leave-one-out_JJ cross-validation_NN analysis_NN ._. 
However_RB ,_, the_DT grade_NN of_IN the_DT serous_JJ carcinomas_NNS was_VBD not_RB indicated_VBN ,_, and_CC while_IN low-grade_JJ serous_JJ carcinomas_NNS are_VBP thought_VBN to_TO be_VB derived_VBN from_IN borderline_JJ tumors_NNS -LRB-_-LRB- Singer_NNP et_NNP al_NNP ._. 
2002_CD ,_, Shih_NNP 
In_IN normal_JJ OSE_NNP and_CC serous_JJ adenomas_NNS ,_, both_DT isoforms_NNS were_VBD equally_RB expressed_VBN ,_, whereas_IN PR-B_NNP predominated_VBD in_IN borderline_JJ and_CC malignant_JJ tumors_NNS ._. 
However_RB ,_, the_DT grade_NN of_IN the_DT serous_JJ carcinomas_NNS was_VBD not_RB indicated_VBN ,_, and_CC while_IN low-grade_JJ serous_JJ carcinomas_NNS are_VBP thought_VBN to_TO be_VB derived_VBN from_IN borderline_JJ tumors_NNS -LRB-_-LRB- Singer_NNP et_NNP al._NNP ._. 
2002_CD ,_, Shih_NNP 
Since_IN elevated_JJ progesterone_NN secretion_NN is_VBZ a_DT hallmark_NN of_IN the_DT luteal_JJ phase_NN ,_, the_DT altered_JJ gene_NN expression_NN in_IN these_DT samples_NNS may_MD reflect_VB a_DT differential_JJ response_NN to_TO progesterone_NN ._. 
Progesterone_NNP classically_RB signals_VBZ by_IN binding_JJ to_TO intracellular_JJ progesterone_NN receptors_NNS -LRB-_-LRB- PR_NNP -RRB-_-RRB- ,_, leading_VBG to_TO receptor_NN dimerisation_NN and_CC binding_JJ to_TO specific_JJ hormone_NN response_NN elements_NNS located_VBN in_IN the_DT promoter_NN region_NN of_IN target_NN genes_NNS to_TO regulate_VB transcription_NN through_IN interaction_NN with_IN co-regulatory_JJ proteins_NNS -LRB-_-LRB- Mulac-Jericevic_NNP 
2008_CD -RRB-_-RRB- ._. 
The_DT canonical_JJ PR_NNP is_VBZ expressed_VBN as_IN two_CD isoforms_NNS ,_, PR-A_NNP and_CC PR-B_NNP ,_, which_WDT are_VBP encoded_VBN by_IN a_DT single_JJ gene_NN but_CC arise_VB through_IN alternative_JJ use_NN of_IN two_CD promoters_NNS -LRB-_-LRB- Boonyaratanakornkit_FW et_FW al_FW ._. 
PR-A_NNP and_CC PR-B_NNP are_VBP co-expressed_JJ at_IN roughly_RB equivalent_JJ levels_NNS in_IN most_JJS target_NN tissues_NNS -LRB-_-LRB- Shao_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
PR-A_NN is_VBZ truncated_VBN at_IN the_DT amino-terminal_JJ domain_NN and_CC has_VBZ been_VBN shown_VBN to_TO exhibit_VB differential_JJ functional_JJ properties_NNS compared_VBN with_IN the_DT full-length_JJ PR-B_NN isoform_NN ,_, including_VBG regulation_NN of_IN distinct_JJ genes_NNS -LRB-_-LRB- Jacobsen_NNP et_FW al_FW ._. 
PR-A_NN is_VBZ truncated_VBN at_IN the_DT amino-terminal_JJ domain_NN and_CC has_VBZ been_VBN shown_VBN to_TO exhibit_VB differential_JJ functional_JJ properties_NNS compared_VBN with_IN the_DT full-length_JJ PR-B_NN isoform_NN ,_, including_VBG regulation_NN of_IN distinct_JJ genes_NNS -LRB-_-LRB- Jacobsen_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- and_CC differential_JJ effects_NNS on_IN target_NN tissues_NNS in_IN knockout_NN mice_NNS -LRB-_-LRB- Mulac-Jericevic_NNP 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2008_CD ,_, Shaw_NNP et_NNP al._NNP ._. 
2009_CD -RRB-_-RRB- ._. 
We_PRP have_VBP previously_RB demonstrated_VBN that_IN non-malignant_JJ FTE_NNP collected_VBN during_IN the_DT luteal_JJ phase_NN from_IN breast_NN cancer_NN susceptibility_NN gene_NN 1\/2_CD -LRB-_-LRB- BRCA1\/2_NNP -RRB-_-RRB- mutation_NN carriers_NNS exhibits_VBZ gene_NN expression_NN profiles_NNS more_RBR closely_RB resembling_VBG that_IN of_IN ovarian_JJ and_CC fallopian_JJ tube_NN high-grade_JJ serous_JJ carcinoma_NN -LRB-_-LRB- HGSC_NNP -RRB-_-RRB- than_IN FTE_NNP from_IN control_NN patients_NNS -LRB-_-LRB- Tone_FW et_FW al_FW ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2008_CD ,_, Shaw_NNP et_NNP al._NNP ._. 
2009_CD -RRB-_-RRB- ,_, thus_RB the_DT OSE_NNP may_MD not_RB be_VB the_DT appropriate_JJ comparator_NN ._. 
Asingle_JJ previous_JJ study_NN has_VBZ reported_VBN slightly_RB decreased_VBN PR_NNP protein_NN expression_NN in_IN fallopian_JJ tube_NN carcinomas_NNS relative_JJ to_TO areas_NNS of_IN benign_JJ FTE_NNP in_IN patients_NNS with_IN or_CC without_IN a_DT BRCA_NNP mutation_NN -LRB-_-LRB- Cass_FW et_FW al_FW ._. 
2000_CD -RRB-_-RRB- ,_, gene_NN expression_NN could_MD also_RB be_VB altered_VBN by_IN decreased_VBN levels_NNS of_IN PR-A_NNP irrespective_RB of_IN the_DT absence_NN or_CC presence_NN of_IN ligand_NN ._. 
Furthermore_RB ,_, if_IN ligand-independent_JJ genes_NNS were_VBD found_VBN to_TO be_VB predictive_JJ of_IN BRCA_NNP mutation_NN status_NN ,_, this_DT could_MD suggest_VB a_DT potential_JJ role_NN for_IN crosstalk_NN between_IN PR_NNP and_CC cytokine_NN signalling_VBG pathways_NNS that_WDT may_MD be_VB locally_RB elevated_VBN following_VBG ovulation_NN -LRB-_-LRB- Denner_NNP et_FW al._FW ._. 
1990_CD ,_, Pierson-Mullany_NNP 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2001_CD ,_, Piek_NNP et_FW al_FW ._. 
While_IN most_JJS histological_JJ subtypes_NNS likely_RB arise_VBP from_IN the_DT ovarian_JJ surface_NN epithelium_NN -LRB-_-LRB- OSE_NNP -RRB-_-RRB- ,_, accumulating_VBG evidence_NN provides_VBZ strong_JJ support_NN that_IN high-grade_JJ serous_JJ adnexal_JJ cancer_NN ,_, commonly_RB attributed_VBN to_TO an_DT ovarian_JJ origin_NN ,_, arises_VBZ from_IN the_DT distal_JJ fallopian_JJ tube_NN epithelium_NN -LRB-_-LRB- FTE_NNP ;_: Colgan_NNP et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al._FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
2008_CD ,_, Shaw_NNP et_NNP al_NNP ._. 
2009_CD -RRB-_-RRB- ._. 
We_PRP have_VBP previously_RB demonstrated_VBN that_IN non-malignant_JJ FTE_NNP collected_VBN during_IN the_DT luteal_JJ phase_NN from_IN breast_NN cancer_NN susceptibility_NN gene_NN 1\/2_CD -LRB-_-LRB- BRCA1\/2_NNP -RRB-_-RRB- mutation_NN carriers_NNS exhibits_VBZ gene_NN expression_NN profiles_NNS more_RBR closely_RB resembling_VBG that_IN of_IN ovarian_JJ and_CC fallopian_JJ tube_NN high-grade_JJ serous_JJ carcinoma_NN -LRB-_-LRB- HGSC_NNP -RRB-_-RRB- than_IN FTE_NNP from_IN control_NN patients_NNS -LRB-_-LRB- Tone_FW et_FW al_FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2001_CD ,_, Piek_NNP et_FW al_FW ._. 
However_RB ,_, recent_JJ studies_NNS have_VBP strongly_RB suggested_VBN that_IN the_DT FTE_NNP is_VBZ the_DT source_NN of_IN HGSC_NNP -LRB-_-LRB- Colgan_NNP et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al._FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
2008_CD ,_, Shaw_NNP et_NNP al_NNP ._. 
2009_CD -RRB-_-RRB- ,_, thus_RB the_DT OSE_NNP may_MD not_RB be_VB the_DT appropriate_JJ comparator_NN ._. 
2010_CD -RRB-_-RRB- ,_, this_DT is_VBZ not_RB thought_VBN to_TO be_VB the_DT case_NN for_IN HGSC_NNP ._. 
2002_CD ,_, Shih_NNP 
Several_JJ studies_NNS suggest_VBP that_IN HGSC_NNP arises_VBZ from_IN the_DT secretory_NN rather_RB than_IN the_DT ciliated_VBN FTE_NNP -LRB-_-LRB- Talamo_FW et_FW al_FW ._. 
1982_CD ,_, Crum_NNP et_FW al._FW ._. 
2007_CD ,_, Lee_NNP et_NNP al_NNP ._. 
2007_CD -RRB-_-RRB- ._. 
One_CD possibility_NN ,_, therefore_RB ,_, for_IN the_DT partitioning_NN of_IN luteal_JJ phase_NN samples_NNS with_IN HGSC_NNP may_MD be_VB an_DT enrichment_NN of_IN secretory_JJ cells_NNS in_IN the_DT FTE_NNP during_IN the_DT luteal_JJ phase_NN ._. 
2001_CD ,_, Piek_NNP et_FW al_FW ._. 
While_IN most_JJS histological_JJ subtypes_NNS likely_RB arise_VBP from_IN the_DT ovarian_JJ surface_NN epithelium_NN -LRB-_-LRB- OSE_NNP -RRB-_-RRB- ,_, accumulating_VBG evidence_NN provides_VBZ strong_JJ support_NN that_IN high-grade_JJ serous_JJ adnexal_JJ cancer_NN ,_, commonly_RB attributed_VBN to_TO an_DT ovarian_JJ origin_NN ,_, arises_VBZ from_IN the_DT distal_JJ fallopian_JJ tube_NN epithelium_NN -LRB-_-LRB- FTE_NNP ;_: Colgan_NNP et_FW al_FW ._. 
2001_CD ,_, Finch_NNP et_FW al._FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
2008_CD ,_, Shaw_NNP et_NNP al_NNP ._. 
2001_CD ,_, Piek_NNP et_FW al_FW ._. 
However_RB ,_, recent_JJ studies_NNS have_VBP strongly_RB suggested_VBN that_IN the_DT FTE_NNP is_VBZ the_DT source_NN of_IN HGSC_NNP -LRB-_-LRB- Colgan_NNP et_FW al_FW ._. 
2001_CD ,_, Finch_NNP et_FW al._FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
2008_CD ,_, Shaw_NNP et_NNP al_NNP ._. 
Interestingly_RB ,_, PR_NNP expression_NN was_VBD higher_JJR in_IN inclusion_NN cyst_NN epithelium_NN from_IN mutation_NN carriers_NNS compared_VBN with_IN controls_NNS ,_, potentially_RB consistent_JJ with_IN the_DT repression_NN of_IN ER_NNP transactivation_NN activity_NN by_IN wild-type_JJ BRCA1_NNP -LRB-_-LRB- Zheng_NNP et_FW al_FW ._. 
2001_CD ,_, Fan_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
BRCA1_NNP has_VBZ also_RB been_VBN reported_VBN to_TO function_VB as_IN a_DT PR_NNP transcriptional_NN repressor_NN -LRB-_-LRB- Ma_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ;_: thus_RB we_PRP had_VBD expected_VBN to_TO see_VB a_DT separation_NN of_IN FTEb_NNP and_CC FTEn_NNP cases_NNS based_VBN on_IN established_JJ PR-responsive_JJ genes_NNS ._. 
Our_PRP$ studies_NNS further_RB demonstrate_VBP a_DT strong_JJ downregulation_NN of_IN PR_NNP expression_NN in_IN HGSC_NNP samples_NNS ,_, such_JJ that_IN PR_NNP expression_NN is_VBZ nearly_RB absent_JJ in_IN malignant_JJ cells_NNS ._. 
Interestingly_RB ,_, previous_JJ studies_NNS have_VBP demonstrated_VBN loss_NN of_IN heterozygosity_NN -LRB-_-LRB- LOH_NNP -RRB-_-RRB- at_IN the_DT PR_NNP locus_NN -LRB-_-LRB- 11q22_CD -RRB-_-RRB- in_IN up_IN to_TO 50_CD %_NN of_IN analyzed_VBN ovarian_NN carcinomas_NNS of_IN varying_VBG histotypes_NNS -LRB-_-LRB- Gabra_FW et_FW al._FW ._. 
1995_CD ,_, Launonen_FW et_FW al_FW ._. 
1998_CD -RRB-_-RRB- ,_, providing_VBG a_DT potential_JJ explanation_NN for_IN PR_NNP loss_NN in_IN HGSC_NNP specimens_NNS ._. 
In_IN one_CD such_JJ study_NN ,_, 6\/15_CD -LRB-_-LRB- 40_CD %_NN -RRB-_-RRB- of_IN informative_JJ serous_JJ carcinoma_NN specimens_NNS exhibited_VBD LOH_NNP ;_: furthermore_RB ,_, LOH_NNP at_IN 11q22_CD was_VBD significantly_RB associated_VBN with_IN low_JJ tumor_NN PR_NNP content_NN in_IN the_DT full_JJ cohort_NN of_IN 38_CD ovarian_NN carcinomas_NNS studied_VBD -LRB-_-LRB- Gabra_FW et_FW al_FW ._. 
1998_CD -RRB-_-RRB- ,_, providing_VBG a_DT potential_JJ explanation_NN for_IN PR_NNP loss_NN in_IN HGSC_NNP specimens_NNS ._. 
1995_CD ,_, Launonen_FW et_FW al_FW ._. 
Interestingly_RB ,_, previous_JJ studies_NNS have_VBP demonstrated_VBN loss_NN of_IN heterozygosity_NN -LRB-_-LRB- LOH_NNP -RRB-_-RRB- at_IN the_DT PR_NNP locus_NN -LRB-_-LRB- 11q22_CD -RRB-_-RRB- in_IN up_IN to_TO 50_CD %_NN of_IN analyzed_VBN ovarian_NN carcinomas_NNS of_IN varying_VBG histotypes_NNS -LRB-_-LRB- Gabra_FW et_FW al_FW ._. 
In_IN one_CD such_JJ study_NN ,_, 6\/15_CD -LRB-_-LRB- 40_CD %_NN -RRB-_-RRB- of_IN informative_JJ serous_JJ carcinoma_NN specimens_NNS exhibited_VBD LOH_NNP ;_: furthermore_RB ,_, LOH_NNP at_IN 11q22_CD was_VBD significantly_RB associated_VBN with_IN low_JJ tumor_NN PR_NNP content_NN in_IN the_DT full_JJ cohort_NN of_IN 38_CD ovarian_NN carcinomas_NNS studied_VBD -LRB-_-LRB- Gabra_FW et_FW al._FW ._. 
1995_CD -RRB-_-RRB- ._. 
Whether_NNP LOH_NNP occurs_VBZ in_IN HGSC_NNP precursor_NN lesions_NNS in_IN the_DT FTE_NNP remains_VBZ to_TO be_VB determined_VBN ._. 
Expression_NN of_IN PR_NNP has_VBZ been_VBN reported_VBN to_TO be_VB a_DT favourable_JJ prognostic_JJ indicator_NN in_IN ovarian_NN cancer_NN -LRB-_-LRB- Lee_NNP et_NNP al_NNP ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2001_CD ,_, Piek_NNP et_FW al_FW ._. 
2007_CD ,_, Folkins_FW et_FW al._FW ._. 
2008_CD ,_, Shaw_NNP et_NNP al_NNP ._. 
2009_CD -RRB-_-RRB- ._. 
We_PRP have_VBP previously_RB demonstrated_VBN that_IN non-malignant_JJ FTE_NNP collected_VBN during_IN the_DT luteal_JJ phase_NN from_IN breast_NN cancer_NN susceptibility_NN gene_NN 1\/2_CD -LRB-_-LRB- BRCA1\/2_NNP -RRB-_-RRB- mutation_NN carriers_NNS exhibits_VBZ gene_NN expression_NN profiles_NNS more_RBR closely_RB resembling_VBG that_IN of_IN ovarian_JJ and_CC fallopian_JJ tube_NN high-grade_JJ serous_JJ carcinoma_NN -LRB-_-LRB- HGSC_NNP -RRB-_-RRB- than_IN FTE_NNP from_IN control_NN patients_NNS -LRB-_-LRB- Tone_FW et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2001_CD ,_, Piek_NNP et_FW al_FW ._. 
2007_CD ,_, Folkins_FW et_FW al._FW ._. 
2008_CD ,_, Shaw_NNP et_NNP al_NNP ._. 
2009_CD -RRB-_-RRB- ,_, thus_RB the_DT OSE_NNP may_MD not_RB be_VB the_DT appropriate_JJ comparator_NN ._. 
Asingle_JJ previous_JJ study_NN has_VBZ reported_VBN slightly_RB decreased_VBN PR_NNP protein_NN expression_NN in_IN fallopian_JJ tube_NN carcinomas_NNS relative_JJ to_TO areas_NNS of_IN benign_JJ FTE_NNP in_IN patients_NNS with_IN or_CC without_IN a_DT BRCA_NNP mutation_NN -LRB-_-LRB- Cass_FW et_FW al_FW ._. 
2007_CD ,_, Lee_NNP et_NNP al_NNP ._. 
In_IN light_NN of_IN recent_JJ studies_NNS outlining_VBG the_DT progression_NN to_TO HGSC_NNP from_IN normal_JJ FTE_NNP -LRB-_-LRB- Crum_NNP et_FW al_FW ._. 
2007_CD ,_, Folkins_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ,_, studies_NNS of_IN relative_JJ PR_NNP isoform_NN expression_NN in_IN FTE_NNP exhibiting_VBG focal_JJ accumulation_NN of_IN p53_NN -LRB-_-LRB- p53_NN signatures_NNS -RRB-_-RRB- ,_, tubal_JJ intraepithelial_JJ carcinomas_NNS and_CC their_PRP$ proposed_VBN intermediaries_NNS should_MD be_VB performed_VBN to_TO determine_VB whether_IN differential_JJ isoform_NN expression_NN may_MD play_VB a_DT role_NN at_IN any_DT stage_NN during_IN HGSC_NNP development_NN ._. 
Close_JJ examination_NN of_IN the_DT reported_VBN data_NN indicates_VBZ that_IN 64_CD %_NN of_IN endometrioid_JJ carcinomas_NNS were_VBD considered_VBN positive_JJ for_IN PR_NNP -LRB-_-LRB- 
Progesterone_NNP classically_RB signals_VBZ by_IN binding_JJ to_TO intracellular_JJ progesterone_NN receptors_NNS -LRB-_-LRB- PR_NNP -RRB-_-RRB- ,_, leading_VBG to_TO receptor_NN dimerisation_NN and_CC binding_JJ to_TO specific_JJ hormone_NN response_NN elements_NNS located_VBN in_IN the_DT promoter_NN region_NN of_IN target_NN genes_NNS to_TO regulate_VB transcription_NN through_IN interaction_NN with_IN co-regulatory_JJ proteins_NNS -LRB-_-LRB- Mulac-Jericevic_NNP 
2003_CD ,_, Boonyaratanakornkit_NNP et_FW al_FW ._. 
Progesterone_NNP can_MD also_RB lead_VB to_TO rapid_JJ activation_NN of_IN a_DT number_NN of_IN genes_NNS through_IN protein_NN 
1980_CD ,_, Pino_NNP et_NNP al_NNP ._. 
Similar_JJ results_NNS have_VBP also_RB been_VBN obtained_VBN for_IN total_JJ PR_NNP protein_NN ,_, and_CC the_DT sharp_JJ decline_NN in_IN PR_NNP was_VBD found_VBN to_TO coincide_VB with_IN the_DT luteal_JJ elevation_NN of_IN serum_NN progesterone_NN concentration_NN in_IN these_DT studies_NNS -LRB-_-LRB- Verhage_NNP et_FW al_FW ._. 
1984_CD ,_, Helm_NNP et_FW al._FW ._. 
1987_CD -RRB-_-RRB- ._. 
This_DT is_VBZ consistent_JJ with_IN studies_NNS demonstrating_VBG the_DT polyubiquitination_NN and_CC subsequent_JJ degradation_NN of_IN PR_NNP protein_NN upon_IN exposure_NN to_TO progesterone_NN -LRB-_-LRB- Lange_FW et_FW al_FW ._. 
Decreased_VBN PR-A_JJ and_CC PR-B_JJ immunostaining_NN in_IN luteal_JJ phase_NN FTE_NNP and_CC HGSC_NNP specimens_NNS In_IN light_NN of_IN previous_JJ studies_NNS showing_VBG selective_JJ loss_NN of_IN either_DT PR-A_NNP or_CC PR-B_NNP in_IN ovarian_NN -LRB-_-LRB- Akahira_FW et_FW al_FW ._. 
2000_CD ,_, 2002_CD -RRB-_-RRB- and_CC breast_NN -LRB-_-LRB- Graham_NNP et_NNP al._NNP ._. 
1995_CD ,_, Ariga_NNP et_FW al_FW ._. 
2001_CD ,_, Mote_FW et_FW al_FW ._. 
2002_CD ,_, Jacobsen_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- cancers_NNS ,_, immunohistochemistry_NN was_VBD performed_VBN on_IN tissue_NN microarrays_NNS using_VBG PR-A_NNP -_: or_CC PR-B-specific_JJ antibodies_NNS ._. 
For_IN instance_NN ,_, breast_NN cancer_NN cells_NNS with_IN predominant_JJ expression_NN of_IN PR-A_NNP have_VBP shown_VBN an_DT exaggerated_JJ proliferative_JJ response_NN to_TO luteal_JJ phase_NN levels_NNS of_IN progesterone_NN compared_VBN with_IN cells_NNS with_IN predominant_JJ expression_NN of_IN PR-B_NNP -LRB-_-LRB- Leo_NNP 
Since_IN elevated_JJ progesterone_NN secretion_NN is_VBZ a_DT hallmark_NN of_IN the_DT luteal_JJ phase_NN ,_, the_DT altered_JJ gene_NN expression_NN in_IN these_DT samples_NNS may_MD reflect_VB a_DT differential_JJ response_NN to_TO progesterone_NN ._. 
Progesterone_NNP classically_RB signals_VBZ by_IN binding_JJ to_TO intracellular_JJ progesterone_NN receptors_NNS -LRB-_-LRB- PR_NNP -RRB-_-RRB- ,_, leading_VBG to_TO receptor_NN dimerisation_NN and_CC binding_JJ to_TO specific_JJ hormone_NN response_NN elements_NNS located_VBN in_IN the_DT promoter_NN region_NN of_IN target_NN genes_NNS to_TO regulate_VB transcription_NN through_IN interaction_NN with_IN co-regulatory_JJ proteins_NNS -LRB-_-LRB- Mulac-Jericevic_NNP 
PR-A_NN is_VBZ truncated_VBN at_IN the_DT amino-terminal_JJ domain_NN and_CC has_VBZ been_VBN shown_VBN to_TO exhibit_VB differential_JJ functional_JJ properties_NNS compared_VBN with_IN the_DT full-length_JJ PR-B_NN isoform_NN ,_, including_VBG regulation_NN of_IN distinct_JJ genes_NNS -LRB-_-LRB- Jacobsen_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- and_CC differential_JJ effects_NNS on_IN target_NN tissues_NNS in_IN knockout_NN mice_NNS -LRB-_-LRB- Mulac-Jericevic_NNP 
1993_CD ,_, Mote_FW et_FW al_FW ._. 
Interestingly_RB ,_, PR-A_NNP has_VBZ been_VBN shown_VBN to_TO act_VB as_IN a_DT transdominant_JJ inhibitor_NN of_IN PR-B_NN -LRB-_-LRB- Vegeto_FW et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ,_, and_CC the_DT relative_JJ expression_NN of_IN these_DT two_CD isoforms_NNS has_VBZ been_VBN shown_VBN to_TO vary_VB in_IN reproductive_JJ tissues_NNS as_IN a_DT result_NN of_IN development_NN and_CC hormonal_JJ status_NN and_CC carcinogenesis_NN -LRB-_-LRB- Mulac-Jericevic_NNP 
2002_CD -RRB-_-RRB- ._. 
2002_CD -RRB-_-RRB- and_CC in_IN ductal_JJ carcinomas_NNS in_IN situ_NN -LRB-_-LRB- Mote_FW et_FW al_FW ._. 
2001_CD ,_, Mote_FW et_FW al_FW ._. 
1995_CD ,_, Ariga_NNP et_FW al_FW ._. 
Aspecific_JJ lack_NN of_IN expression_NN of_IN the_DT PR-B_NN isoform_NN has_VBZ also_RB been_VBN observed_VBN in_IN normal_JJ breast_NN epithelium_NN obtained_VBN from_IN BRCA_NNP mutation_NN carriers_NNS compared_VBN with_IN control_NN patients_NNS ,_, resulting_VBG in_IN predominant_JJ expression_NN of_IN PR-A_NNP in_IN 40_CD %_NN of_IN cases_NNS -LRB-_-LRB- Mote_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
In_IN this_DT study_NN ,_, we_PRP found_VBD a_DT decreased_VBN expression_NN of_IN both_DT PR-A_NNP and_CC PR-B_NNP in_IN HGSC_NNP relative_JJ to_TO its_PRP$ probable_JJ cell_NN type_NN of_IN origin_NN ._. 
Interestingly_RB ,_, PR-A_NNP has_VBZ been_VBN shown_VBN to_TO act_VB as_IN a_DT transdominant_JJ inhibitor_NN of_IN PR-B_NN -LRB-_-LRB- Vegeto_FW et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
1993_CD ,_, Mote_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ,_, and_CC the_DT relative_JJ expression_NN of_IN these_DT two_CD isoforms_NNS has_VBZ been_VBN shown_VBN to_TO vary_VB in_IN reproductive_JJ tissues_NNS as_IN a_DT result_NN of_IN development_NN and_CC hormonal_JJ status_NN and_CC carcinogenesis_NN -LRB-_-LRB- Mulac-Jericevic_NNP 
1995_CD ,_, Ariga_NNP et_FW al_FW ._. 
2000_CD ,_, 2002_CD -RRB-_-RRB- and_CC breast_NN -LRB-_-LRB- Graham_NNP et_NNP al_NNP ._. 
Decreased_VBN PR-A_JJ and_CC PR-B_JJ immunostaining_NN in_IN luteal_JJ phase_NN FTE_NNP and_CC HGSC_NNP specimens_NNS In_IN light_NN of_IN previous_JJ studies_NNS showing_VBG selective_JJ loss_NN of_IN either_DT PR-A_NNP or_CC PR-B_NNP in_IN ovarian_NN -LRB-_-LRB- Akahira_FW et_FW al_FW ._. 
2001_CD ,_, Mote_FW et_FW al._FW ._. 
2002_CD ,_, Jacobsen_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- cancers_NNS ,_, immunohistochemistry_NN was_VBD performed_VBN on_IN tissue_NN microarrays_NNS using_VBG PR-A_NNP -_: or_CC PR-B-specific_JJ antibodies_NNS ._. 
1995_CD ,_, Ariga_NNP et_FW al_FW ._. 
While_IN PR-A_NNP and_CC PR-B_NNP are_VBP expressed_VBN at_IN roughly_RB equivalent_JJ levels_NNS in_IN normal_JJ human_JJ breast_NN epithelium_NN throughout_IN the_DT cycle_NN ,_, several_JJ studies_NNS have_VBP found_VBN a_DT predominance_NN of_IN PR-A_NNP in_IN a_DT high_JJ proportion_NN of_IN invasive_JJ breast_NN tumors_NNS -LRB-_-LRB- Graham_NNP et_NNP al_NNP ._. 
2001_CD ,_, Mote_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- and_CC in_IN ductal_JJ carcinomas_NNS in_IN situ_NN -LRB-_-LRB- Mote_FW et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
Aspecific_JJ lack_NN of_IN expression_NN of_IN the_DT PR-B_NN isoform_NN has_VBZ also_RB been_VBN observed_VBN in_IN normal_JJ breast_NN epithelium_NN obtained_VBN from_IN BRCA_NNP mutation_NN carriers_NNS compared_VBN with_IN control_NN patients_NNS ,_, resulting_VBG in_IN predominant_JJ expression_NN of_IN PR-A_NNP in_IN 40_CD %_NN of_IN cases_NNS -LRB-_-LRB- Mote_FW et_FW al_FW ._. 
2001_CD ,_, Mote_FW et_FW al_FW ._. 
1995_CD ,_, Ariga_NNP et_FW al_FW ._. 
While_IN PR-A_NNP and_CC PR-B_NNP are_VBP expressed_VBN at_IN roughly_RB equivalent_JJ levels_NNS in_IN normal_JJ human_JJ breast_NN epithelium_NN throughout_IN the_DT cycle_NN ,_, several_JJ studies_NNS have_VBP found_VBN a_DT predominance_NN of_IN PR-A_NNP in_IN a_DT high_JJ proportion_NN of_IN invasive_JJ breast_NN tumors_NNS -LRB-_-LRB- Graham_NNP et_NNP al_NNP ._. 
2002_CD -RRB-_-RRB- and_CC in_IN ductal_JJ carcinomas_NNS in_IN situ_NN -LRB-_-LRB- Mote_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
Aspecific_JJ lack_NN of_IN expression_NN of_IN the_DT PR-B_NN isoform_NN has_VBZ also_RB been_VBN observed_VBN in_IN normal_JJ breast_NN epithelium_NN obtained_VBN from_IN BRCA_NNP mutation_NN carriers_NNS compared_VBN with_IN control_NN patients_NNS ,_, resulting_VBG in_IN predominant_JJ expression_NN of_IN PR-A_NNP in_IN 40_CD %_NN of_IN cases_NNS -LRB-_-LRB- Mote_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- with_IN the_DT following_JJ modifications_NNS ._. 
PR_NNP isoform-specific_JJ immunohistochemistry_NN Immunohistochemistry_NNP was_VBD performed_VBN using_VBG standard_JJ procedures_NNS as_IN described_VBN previously_RB -LRB-_-LRB- Tone_FW et_FW al_FW ._. 
PR-A_NN protein_NN was_VBD detected_VBN using_VBG mouse_NN monoclonal_JJ anti-PR_JJ antibody_NN -LRB-_-LRB- PGR-312_NN -LRB-_-LRB- 16_CD -RRB-_-RRB- ,_, Novocastra_NNP Laboratories_NNP ,_, Newcastle_NNP ,_, UK_NNP ;_: Mote_NNP et_FW al._FW ._. 
2001_CD -RRB-_-RRB- at_IN a_DT dilution_NN of_IN 1_CD in_IN 200_CD ._. 
PR-B_NN was_VBD detected_VBN using_VBG anti-PR_NNP -LRB-_-LRB- B-form_NNP -RRB-_-RRB- antibody_NN -LRB-_-LRB- PGR-B_NNP -LRB-_-LRB- SAN27_NNP -RRB-_-RRB- ,_, Novocastra_NNP Laboratories_NNP -RRB-_-RRB- at_IN a_DT dilution_NN of_IN 1_CD in_IN 200_CD ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2001_CD ,_, Piek_NNP et_FW al_FW ._. 
While_IN most_JJS histological_JJ subtypes_NNS likely_RB arise_VBP from_IN the_DT ovarian_JJ surface_NN epithelium_NN -LRB-_-LRB- OSE_NNP -RRB-_-RRB- ,_, accumulating_VBG evidence_NN provides_VBZ strong_JJ support_NN that_IN high-grade_JJ serous_JJ adnexal_JJ cancer_NN ,_, commonly_RB attributed_VBN to_TO an_DT ovarian_JJ origin_NN ,_, arises_VBZ from_IN the_DT distal_JJ fallopian_JJ tube_NN epithelium_NN -LRB-_-LRB- FTE_NNP ;_: Colgan_NNP et_FW al_FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al._FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
2008_CD ,_, Shaw_NNP et_NNP al_NNP ._. 
2009_CD -RRB-_-RRB- ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2001_CD ,_, Piek_NNP et_FW al_FW ._. 
However_RB ,_, recent_JJ studies_NNS have_VBP strongly_RB suggested_VBN that_IN the_DT FTE_NNP is_VBZ the_DT source_NN of_IN HGSC_NNP -LRB-_-LRB- Colgan_NNP et_FW al_FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al._FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
2008_CD ,_, Shaw_NNP et_NNP al_NNP ._. 
2009_CD -RRB-_-RRB- ,_, thus_RB the_DT OSE_NNP may_MD not_RB be_VB the_DT appropriate_JJ comparator_NN ._. 
However_RB ,_, the_DT grade_NN of_IN the_DT serous_JJ carcinomas_NNS was_VBD not_RB indicated_VBN ,_, and_CC while_IN low-grade_JJ serous_JJ carcinomas_NNS are_VBP thought_VBN to_TO be_VB derived_VBN from_IN borderline_JJ tumors_NNS -LRB-_-LRB- Singer_NNP et_NNP al_NNP ._. 
2002_CD ,_, Shih_NNP 
In_IN these_DT studies_NNS ,_, no_DT differential_JJ expression_NN was_VBD observed_VBN in_IN non-malignant_JJ FTE_NNP and_CC OSE_NNP from_IN mutation_NN carriers_NNS and_CC controls_NNS -LRB-_-LRB- Piek_FW et_FW al_FW ._. 
2001_CD ,_, 2003_CD -RRB-_-RRB- ._. 
PR_NNP protein_NN was_VBD expressed_VBN abundantly_RB in_IN both_DT ciliated_JJ and_CC secretory_JJ FTE_NNP cells_NNS ,_, and_CC expression_NN in_IN morphologically_RB normal_JJ and_CC dysplastic_JJ areas_NNS from_IN mutation_NN carriers_NNS was_VBD similar_JJ -LRB-_-LRB- Piek_FW et_FW al_FW ._. 
This_DT is_VBZ consistent_JJ with_IN our_PRP$ findings_NNS of_IN no_DT differences_NNS in_IN either_DT PR-A_NN or_CC PR-B_NN expression_NN as_IN a_DT function_NN of_IN BRCA_NNP mutation_NN status_NN ._. 
In_IN studies_NNS of_IN BRCA-associated_NNP OSE_NNP ,_, the_DT only_JJ difference_NN observed_VBD was_VBD an_DT increased_VBN expression_NN of_IN PR_NNP protein_NN in_IN inclusion_NN cyst_NN epithelium_NN compared_VBN with_IN OSE_NNP ,_, which_WDT the_DT authors_NNS attributed_VBN to_TO an_DT increased_VBN exposure_NN to_TO ovarian_VB stroma-derived_JJ hormones_NNS including_VBG estrogen_NN -LRB-_-LRB- Piek_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
Interestingly_RB ,_, PR_NNP expression_NN was_VBD higher_JJR in_IN inclusion_NN cyst_NN epithelium_NN from_IN mutation_NN carriers_NNS compared_VBN with_IN controls_NNS ,_, potentially_RB consistent_JJ with_IN the_DT repression_NN of_IN ER_NNP transactivation_NN activity_NN by_IN wild-type_JJ BRCA1_NNP -LRB-_-LRB- Zheng_NNP et_FW al_FW ._. 
While_IN most_JJS histological_JJ subtypes_NNS likely_RB arise_VBP from_IN the_DT ovarian_JJ surface_NN epithelium_NN -LRB-_-LRB- OSE_NNP -RRB-_-RRB- ,_, accumulating_VBG evidence_NN provides_VBZ strong_JJ support_NN that_IN high-grade_JJ serous_JJ adnexal_JJ cancer_NN ,_, commonly_RB attributed_VBN to_TO an_DT ovarian_JJ origin_NN ,_, arises_VBZ from_IN the_DT distal_JJ fallopian_JJ tube_NN epithelium_NN -LRB-_-LRB- FTE_NNP ;_: Colgan_NNP et_FW al_FW ._. 
2001_CD ,_, Piek_NNP et_FW al._FW ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
However_RB ,_, recent_JJ studies_NNS have_VBP strongly_RB suggested_VBN that_IN the_DT FTE_NNP is_VBZ the_DT source_NN of_IN HGSC_NNP -LRB-_-LRB- Colgan_NNP et_FW al_FW ._. 
2001_CD ,_, Piek_NNP et_FW al._FW ._. 
2001_CD ,_, Finch_NNP et_FW al_FW ._. 
2006_CD ,_, Medeiros_NNPS et_FW al_FW ._. 
2006_CD ,_, Crum_NNP et_FW al_FW ._. 
2007_CD ,_, Kindelberger_NNP et_FW al_FW ._. 
2007_CD ,_, Folkins_FW et_FW al_FW ._. 
Initial_JJ studies_NNS investigating_VBG the_DT effect_NN of_IN BRCA_NNP mutation_NN status_NN on_IN PR_NNP expression_NN in_IN non-malignant_JJ cells_NNS did_VBD not_RB distinguish_JJ by_IN isoform_NN ,_, but_CC rather_RB focused_VBN on_IN determining_VBG total_JJ PR_NNP protein_NN levels_NNS ._. 
In_IN these_DT studies_NNS ,_, no_DT differential_JJ expression_NN was_VBD observed_VBN in_IN non-malignant_JJ FTE_NNP and_CC OSE_NNP from_IN mutation_NN carriers_NNS and_CC controls_NNS -LRB-_-LRB- Piek_FW et_FW al._FW ._. 
2001_CD ,_, 2003_CD -RRB-_-RRB- ._. 
PR_NNP protein_NN was_VBD expressed_VBN abundantly_RB in_IN both_DT ciliated_JJ and_CC secretory_JJ FTE_NNP cells_NNS ,_, and_CC expression_NN in_IN morphologically_RB normal_JJ and_CC dysplastic_JJ areas_NNS from_IN mutation_NN carriers_NNS was_VBD similar_JJ -LRB-_-LRB- Piek_FW et_FW al_FW ._. 
2001_CD ,_, 2003_CD -RRB-_-RRB- ._. 
In_IN these_DT studies_NNS ,_, no_DT differential_JJ expression_NN was_VBD observed_VBN in_IN non-malignant_JJ FTE_NNP and_CC OSE_NNP from_IN mutation_NN carriers_NNS and_CC controls_NNS -LRB-_-LRB- Piek_FW et_FW al_FW ._. 
PR_NNP protein_NN was_VBD expressed_VBN abundantly_RB in_IN both_DT ciliated_JJ and_CC secretory_JJ FTE_NNP cells_NNS ,_, and_CC expression_NN in_IN morphologically_RB normal_JJ and_CC dysplastic_JJ areas_NNS from_IN mutation_NN carriers_NNS was_VBD similar_JJ -LRB-_-LRB- Piek_FW et_FW al._FW ._. 
2001_CD -RRB-_-RRB- ._. 
This_DT is_VBZ consistent_JJ with_IN our_PRP$ findings_NNS of_IN no_DT differences_NNS in_IN either_DT PR-A_NN or_CC PR-B_NN expression_NN as_IN a_DT function_NN of_IN BRCA_NNP mutation_NN status_NN ._. 
Differing_VBG levels_NNS of_IN evidence_NN support_NN roles_NNS for_IN these_DT proposed_VBN biomarkers_NNS in_IN breast_NN cancer_NN ,_, but_CC the_DT greatest_JJS pool_NN of_IN epidemiologic_JJ data_NNS in_IN postmenopausal_JJ women_NNS exists_VBZ for_IN insulin_NN -LRB-_-LRB- Gunter_NNP et_FW al_FW ._. 
2009_CD ,_, Kabat_NNP et_FW al._FW ._. 
2009_CD ,_, Neilson_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- and_CC IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS -LRB-_-LRB- Key_NNP et_FW al_FW ._. 
2010_CD -RRB-_-RRB- ._. 
The_DT link_NN between_IN insulin_NN and_CC breast_NN cancer_NN is_VBZ now_RB sufficiently_RB convincing_JJ that_IN metformin_NN ,_, a_DT pharmacologic_JJ agent_NN that_WDT improves_VBZ insulin_NN sensitivity_NN ,_, is_VBZ being_VBG considered_VBN for_IN breast_NN cancer_NN prevention_NN and_CC treatment_NN -LRB-_-LRB- Gonzalez-Angulo_NNP 
Only_RB a_DT few_JJ studies_NNS have_VBP addressed_VBN the_DT effects_NNS of_IN exercise_NN on_IN leptin_NN in_IN postmenopausal_JJ women_NNS -LRB-_-LRB- Kohrt_NNP et_FW al_FW ._. 
1996_CD ,_, Ryan_NNP et_FW al._FW ._. 
2000_CD ,_, Hayase_FW et_FW al_FW ._. 
2002_CD ,_, Frank_NNP et_NNP al_NNP ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- and_CC only_RB two_CD of_IN them_PRP were_VBD RCTs_NNP -LRB-_-LRB- Frank_NNP et_FW al_FW ._. 
While_IN it_PRP is_VBZ biologically_RB plausible_JJ that_IN leptin_NN increases_NNS postmenopausal_JJ breast_NN cancer_NN risk_NN ,_, epidemiological_JJ findings_NNS have_VBP been_VBN inconsistent_JJ -LRB-_-LRB- Neilson_NNP et_FW al_FW ._. 
2009_CD ,_, Wu_NNP et_FW al._FW ._. 
2009_CD ,_, Maccio_FW et_FW al_FW ._. 
2010_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, most_JJS studies_NNS in_IN postmenopausal_JJ women_NNS have_VBP shown_VBN significant_JJ inverse_JJ associations_NNS between_IN adiponectin_NN and_CC breast_NN cancer_NN risk_NN -LRB-_-LRB- Neilson_NNP et_FW al_FW ._. 
This_DT evidence_NN is_VBZ consistent_JJ with_IN our_PRP$ findings_NNS and_CC other_JJ comparable_JJ RCTs_NNS -LRB-_-LRB- McTiernan_NNP et_FW al_FW ._. 
Early_RB epidemiological_JJ evidence_NN -LRB-_-LRB- Orenstein_NNP 
2010_CD -RRB-_-RRB- ._. 
2009_CD -RRB-_-RRB- and_CC IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS -LRB-_-LRB- Key_NNP et_FW al_FW ._. 
2009_CD ,_, Neilson_NNP et_FW al_FW ._. 
2009_CD ,_, Kabat_FW et_FW al_FW ._. 
The_DT link_NN between_IN insulin_NN and_CC breast_NN cancer_NN is_VBZ now_RB sufficiently_RB convincing_JJ that_IN metformin_NN ,_, a_DT pharmacologic_JJ agent_NN that_WDT improves_VBZ insulin_NN sensitivity_NN ,_, is_VBZ being_VBG considered_VBN for_IN breast_NN cancer_NN prevention_NN and_CC treatment_NN -LRB-_-LRB- Gonzalez-Angulo_NNP 
1976_CD ,_, Chappell_NNP et_FW al_FW ._. 
Insulin_NNP -LRB-_-LRB- Osborne_NNP et_FW al_FW ._. 
2011_CD -RRB-_-RRB- ,_, but_CC the_DT biologic_JJ mechanisms_NNS underlying_VBG this_DT association_NN are_VBP not_RB well_RB understood_VBN ._. 
2001_CD -RRB-_-RRB- insulin-like_JJ growth_NN factor_NN 1_CD -LRB-_-LRB- IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS ;_: Yu_NNP 
1976_CD ,_, Chappell_NNP et_FW al_FW ._. 
Insulin_NNP -LRB-_-LRB- Osborne_NNP et_FW al_FW ._. 
2011_CD -RRB-_-RRB- ,_, but_CC the_DT biologic_JJ mechanisms_NNS underlying_VBG this_DT association_NN are_VBP not_RB well_RB understood_VBN ._. 
2001_CD -RRB-_-RRB- insulin-like_JJ growth_NN factor_NN 1_CD -LRB-_-LRB- IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS ;_: Yu_NNP 
2009_CD -RRB-_-RRB- ._. 
Exercise_NN also_RB lowered_VBD circulating_VBG insulin_NN significantly_RB in_IN the_DT Dose_NN 
2005_CD ,_, Pi-Sunyer_NNP et_FW al_FW ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2004_CD ,_, Frank_NNP et_NNP al_NNP ._. 
Of_IN five_CD previous_JJ noteworthy_JJ RCTs_NNS with_IN similar_JJ study_NN populations_NNS and\/or_CC outcomes_NNS of_IN interest_NN -LRB-_-LRB- Houmard_FW et_FW al_FW ._. 
2007_CD ,_, Arsenault_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ,_, only_RB one_CD trial_NN lead_NN by_IN McTiernan_NNP -LRB-_-LRB- Frank_NNP et_FW al_FW ._. 
2005_CD ,_, McTiernan_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- was_VBD of_IN comparable_JJ size_NN ,_, duration_NN and_CC scope_NN to_TO the_DT ALPHA_NNP Trial_NNP ._. 
2005_CD -RRB-_-RRB- ,_, our_PRP$ study_NN demonstrated_VBD decreased_VBN insulin_NN concentrations_NNS and_CC HOMA-IR_NN in_IN exercisers_NNS that_WDT differed_VBD significantly_RB from_IN changes_NNS in_IN controls_NNS across_IN 12_CD months_NNS of_IN exercise_NN ;_: no_DT significant_JJ change_NN in_IN glucose_NN was_VBD found_VBN in_IN either_DT trial_NN ._. 
Exercise_NN also_RB lowered_VBD circulating_VBG insulin_NN significantly_RB in_IN the_DT Dose_NN 
However_RB ,_, we_PRP and_CC others_NNS found_VBD no_DT changes_NNS in_IN adiponectin_JJ levels_NNS with_IN exercise_NN -LRB-_-LRB- Giannopoulou_NNP et_FW al_FW ._. 
2005_CD ,_, Arsenault_NNP et_FW al._FW ._. 
2009_CD ,_, Coker_NNP et_FW al_FW ._. 
2009_CD ,_, Ligibel_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
Although_IN RCT_NNP evidence_NN relating_VBG chronic_JJ exercise_NN to_TO circulating_VBG adiponectin_NN has_VBZ been_VBN inconclusive_JJ -LRB-_-LRB- Simpson_NNP 
2010_CD b_NN -RRB-_-RRB- and_CC the_DT others_NNS -LRB-_-LRB- Giannopoulou_NNP et_FW al_FW ._. 
3_CD 
2004_CD ,_, Dieudonne_NNP et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ,_, and_CC adiponectin_NN -LRB-_-LRB- Brakenhielm_FW et_FW al_FW ._. 
2007_CD ,_, Cirillo_NNP et_FW al_FW ._. 
2003_CD ,_, Geisler_NNP et_FW al_FW ._. 
2006_CD ,_, Arditi_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- are_VBP metabolic_JJ factors_NNS hypothesized_VBN to_TO mediate_VB the_DT association_NN between_IN physical_JJ activity_NN and_CC postmenopausal_JJ breast_NN cancer_NN risk_NN -LRB-_-LRB- Neilson_NNP et_FW al_FW ._. 
1985_CD ,_, Matthews_NNP et_NNP al_NNP ._. 
5-LRB-_NNP Hosker_NNP et_FW al_FW ._. 
Asurrogate_JJ measure_NN of_IN whole_JJ body_NN insulin_NN sensitivity_NN and_CC 
We_PRP used_VBD insulin_NN and_CC HOMA-IR_NNP as_IN IR_NNP indicators_NNS ,_, which_WDT are_VBP practical_JJ alternatives_NNS to_TO the_DT gold_JJ standard_JJ euglycaemic_JJ hyperinsulinemic_JJ clamp_NN method_NN -LRB-_-LRB- DeFronzo_NNP et_FW al_FW ._. 
1979_CD ,_, Bergman_NNP et_FW al._FW ._. 
1985_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, given_VBN the_DT number_NN of_IN secondary_JJ analyses_NNS of_IN these_DT data_NNS ,_, type_NN I_NN error_NN is_VBZ a_DT possibility_NN ._. 
Adiponectin_JJ levels_NNS have_VBP an_DT inverse_JJ association_NN with_IN adiposity_NN ._. 
06_CD -RRB-_-RRB- ;_: this_DT difference_NN might_MD be_VB attributable_JJ to_TO the_DT higher_JJR volume_NN of_IN exercise_NN undertaken_VBN in_IN our_PRP$ trial_NN or_CC the_DT minimal_JJ fat_JJ loss_NN in_IN the_DT earlier_JJR study_NN ._. 
Exercise_NN may_MD lower_VB the_DT levels_NNS of_IN the_DT obesity-related_JJ inflammatory_JJ markers_NNS ,_, tumor_NN necrosis_NN factor_NN -_: 
2007_CD ,_, Cirillo_NNP et_FW al_FW ._. 
2003_CD ,_, Geisler_NNP et_FW al_FW ._. 
2001_CD -RRB-_-RRB- insulin-like_JJ growth_NN factor_NN 1_CD -LRB-_-LRB- IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS ;_: Yu_NNP 
2004_CD ,_, Frank_NNP et_NNP al_NNP ._. 
Of_IN five_CD previous_JJ noteworthy_JJ RCTs_NNS with_IN similar_JJ study_NN populations_NNS and\/or_CC outcomes_NNS of_IN interest_NN -LRB-_-LRB- Houmard_FW et_FW al_FW ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al._FW ._. 
2005_CD ,_, Pi-Sunyer_NNP et_FW al_FW ._. 
2007_CD ,_, Arsenault_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, only_RB one_CD trial_NN lead_NN by_IN McTiernan_NNP -LRB-_-LRB- Frank_NNP et_FW al_FW ._. 
2002_CD ,_, Frank_NNP et_NNP al_NNP ._. 
2000_CD ,_, Hayase_FW et_FW al_FW ._. 
1996_CD ,_, Ryan_NNP et_FW al_FW ._. 
Only_RB a_DT few_JJ studies_NNS have_VBP addressed_VBN the_DT effects_NNS of_IN exercise_NN on_IN leptin_NN in_IN postmenopausal_JJ women_NNS -LRB-_-LRB- Kohrt_NNP et_FW al_FW ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- and_CC only_RB two_CD of_IN them_PRP were_VBD RCTs_NNP -LRB-_-LRB- Frank_NNP et_FW al_FW ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
One_CD trial_NN -LRB-_-LRB- Frank_NNP et_NNP al_NNP ._. 
2005_CD -RRB-_-RRB- and_CC only_RB two_CD of_IN them_PRP were_VBD RCTs_NNP -LRB-_-LRB- Frank_NNP et_FW al_FW ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2002_CD ,_, Frank_NNP et_NNP al_NNP ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
One_CD trial_NN -LRB-_-LRB- Frank_NNP et_NNP al_NNP ._. 
2005_CD -RRB-_-RRB- showed_VBD decreased_VBN leptin_NN concentrations_NNS with_IN exercise_NN ;_: however_RB ,_, in_IN our_PRP$ most_RBS adherent_JJ subgroup_NN ,_, we_PRP observed_VBD more_JJR than_IN twice_RB the_DT decrease_NN in_IN leptin_NN -LRB-_-LRB- 12_CD %_NN with_IN 
2005_CD -RRB-_-RRB- versus_CC 30_CD %_NN with_IN 
2003_CD -RRB-_-RRB- ._. 
Exercise_NN may_MD lower_VB the_DT levels_NNS of_IN the_DT obesity-related_JJ inflammatory_JJ markers_NNS ,_, tumor_NN necrosis_NN factor_NN -_: 
3_CD 
2000_CD ,_, Ryan_NNP 2000_CD ,_, Wareham_NNP et_FW al_FW ._. 
In_IN general_JJ ,_, exercise_NN with_IN moderate_JJ weight_NN loss_NN has_VBZ been_VBN found_VBN to_TO improve_VB insulin_NN sensitivity_NN -LRB-_-LRB- Albright_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- and_CC prevent_VB type_NN 2_CD diabetes_NN -LRB-_-LRB- Gill_NNP 
1989_CD ,_, Levy_NNP et_NNP al_NNP ._. 
1985_CD ,_, Bonora_NNP et_FW al_FW ._. 
1985_CD ,_, Matthews_NNP et_NNP al_NNP ._. 
5-LRB-_NNP Hosker_NNP et_FW al_FW ._. 
Asurrogate_JJ measure_NN of_IN whole_JJ body_NN insulin_NN sensitivity_NN and_CC 
2009_CD -RRB-_-RRB- ,_, and_CC perhaps_RB also_RB acts_VBZ as_IN an_DT indicator_NN of_IN postmenopausal_JJ breast_NN cancer_NN risk_NN ,_, which_WDT may_MD be_VB more_RBR sensitive_JJ than_IN either_DT marker_NN on_IN its_PRP$ own_JJ -LRB-_-LRB- Cleary_NNP et_FW al_FW ._. 
2009_CD ,_, Jarde_FW et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
Since_IN all_DT of_IN these_DT proposed_VBN biomarkers_NNS are_VBP related_VBN to_TO IR_NNP and_CC obesity_NN ,_, we_PRP hypothesized_VBD that_IN their_PRP$ levels_NNS could_MD be_VB modified_VBN with_IN sustained_JJ physical_JJ activity_NN ._. 
2009_CD -RRB-_-RRB- ,_, it_PRP was_VBD only_RB recently_RB proposed_VBN as_IN a_DT biomarker_NN of_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Cleary_NNP et_FW al_FW ._. 
Since_IN this_DT ratio_NN appears_VBZ to_TO estimate_VB IR_NNP -LRB-_-LRB- Finucane_NNP et_FW al_FW ._. 
2009_CD ,_, Jarde_FW et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
Thus_RB ,_, our_PRP$ study_NN provides_VBZ a_DT new_JJ insight_NN ,_, using_VBG a_DT potentially_RB stronger_JJR indicator_NN of_IN breast_NN cancer_NN risk_NN than_IN leptin_NN or_CC adiponectin_NN on_IN its_PRP$ own_JJ ,_, into_IN how_WRB exercise_NN impacts_VBZ the_DT causal_JJ pathway_NN between_IN exercise_NN and_CC postmenopausal_JJ breast_NN cancer_NN ._. 
1999_CD ,_, Friedenreich_NNP 2001_CD ,_, IARC_NNP Working_NNP Group_NNP 2002_CD ,_, Kushi_FW et_FW al_FW ._. 
Aneed_VBN for_IN additional_JJ tightly_RB controlled_JJ ,_, long-term_JJ intervention_NN trials_NNS to_TO examine_VB the_DT impact_NN of_IN exercise_NN on_IN proposed_VBN biomarkers_NNS for_IN breast_NN cancer_NN risk_NN has_VBZ been_VBN widely_RB recognized_VBN -LRB-_-LRB- McTiernan_NNP et_FW al_FW ._. 
2006_CD ,_, Physical_JJ Activity_NN Guidelines_NNS Advisory_NNP Committee_NNP 2008_CD -RRB-_-RRB- ._. 
In_IN response_NN to_TO this_DT recognized_VBN need_NN for_IN more_JJR research_NN ,_, the_DT Alberta_NNP Physical_NNP Activity_NNP and_CC Breast_NNP Cancer_NNP Prevention_NNP -LRB-_-LRB- ALPHA_NNP -RRB-_-RRB- Trial_NNP was_VBD a_DT 12-month_JJ exercise_NN intervention_NN trial_NN designed_VBN to_TO improve_VB the_DT understanding_NN of_IN the_DT biologic_JJ mechanisms_NNS mediating_VBG the_DT association_NN between_IN physical_JJ activity_NN and_CC postmenopausal_JJ breast_NN cancer_NN risk_NN ._. 
We_PRP classified_VBD exercise_NN adherence_NN into_IN three_CD categories_NNS pre-defined_VBN by_IN public_JJ health_NN guidelines_NNS :_: 
2000_CD ,_, Ryan_NNP 2000_CD ,_, Wareham_NNP et_FW al_FW ._. 
In_IN general_JJ ,_, exercise_NN with_IN moderate_JJ weight_NN loss_NN has_VBZ been_VBN found_VBN to_TO improve_VB insulin_NN sensitivity_NN -LRB-_-LRB- Albright_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- and_CC prevent_VB type_NN 2_CD diabetes_NN -LRB-_-LRB- Gill_NNP 
The_DT benefits_NNS of_IN improved_VBN insulin_NN sensitivity_NN include_VBP not_RB only_JJ cancer_NN risk_NN reduction_NN but_CC also_RB lower_JJR risk_NN of_IN metabolic_JJ syndrome_NN ,_, cardiovascular_JJ disease_NN ,_, and_CC type_NN 2_CD diabetes_NN ._. 
Our_PRP$ finding_NN of_IN improved_VBN hormone_NN levels_NNS with_IN exercise_NN 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2004_CD ,_, Frank_NNP et_NNP al_NNP ._. 
Of_IN five_CD previous_JJ noteworthy_JJ RCTs_NNS with_IN similar_JJ study_NN populations_NNS and\/or_CC outcomes_NNS of_IN interest_NN -LRB-_-LRB- Houmard_FW et_FW al_FW ._. 
2005_CD ,_, Pi-Sunyer_NNP et_FW al._FW ._. 
2007_CD ,_, Arsenault_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, only_RB one_CD trial_NN lead_NN by_IN McTiernan_NNP -LRB-_-LRB- Frank_NNP et_FW al_FW ._. 
2005_CD ,_, McTiernan_NNP et_FW al_FW ._. 
2010_CD -RRB-_-RRB- ._. 
Nevertheless_RB ,_, a_DT recent_JJ pooled_VBN analysis_NN found_VBD a_DT significantly_RB increased_VBN risk_NN of_IN breast_NN cancer_NN with_IN elevated_JJ IGF1_NNP and_CC IGFBP3_NNP in_IN postmenopausal_JJ women_NNS -LRB-_-LRB- Key_NNP et_FW al_FW ._. 
Leptin_NN and_CC adiponectin_NN are_VBP adipokines_NNS that_WDT relate_VBP strongly_RB to_TO obesity_NN and_CC insulin_NN resistance_NN -LRB-_-LRB- IR_NNP ;_: Pittas_NNP et_FW al._FW ._. 
2004_CD ,_, Dyck_FW et_FW al_FW ._. 
2006_CD -RRB-_-RRB- but_CC their_PRP$ roles_NNS in_IN breast_NN cancer_NN are_VBP unclear_JJ ._. 
While_IN it_PRP is_VBZ biologically_RB plausible_JJ that_IN leptin_NN increases_NNS postmenopausal_JJ breast_NN cancer_NN risk_NN ,_, epidemiological_JJ findings_NNS have_VBP been_VBN inconsistent_JJ -LRB-_-LRB- Neilson_NNP et_FW al_FW ._. 
An_DT association_NN between_IN high_JJ circulating_VBG IGF1_NN and_CC breast_NN cancer_NN risk_NN has_VBZ been_VBN demonstrated_VBN fairly_RB consistently_RB among_IN premenopausal_JJ ,_, but_CC not_RB postmenopausal_JJ ,_, women_NNS -LRB-_-LRB- Fletcher_NNP et_NNP al_NNP ._. 
2005_CD -RRB-_-RRB- and_CC associations_NNS with_IN IGF-binding_JJ protein_NN 3_CD -LRB-_-LRB- IGFBP3_NNP -RRB-_-RRB- have_VBP been_VBN inconsistent_JJ -LRB-_-LRB- Renehan_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Nevertheless_RB ,_, a_DT recent_JJ pooled_VBN analysis_NN found_VBD a_DT significantly_RB increased_VBN risk_NN of_IN breast_NN cancer_NN with_IN elevated_JJ IGF1_NNP and_CC IGFBP3_NNP in_IN postmenopausal_JJ women_NNS -LRB-_-LRB- Key_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
2009_CD ,_, Goodwin_NNP et_FW al_FW ._. 
The_DT link_NN between_IN insulin_NN and_CC breast_NN cancer_NN is_VBZ now_RB sufficiently_RB convincing_JJ that_IN metformin_NN ,_, a_DT pharmacologic_JJ agent_NN that_WDT improves_VBZ insulin_NN sensitivity_NN ,_, is_VBZ being_VBG considered_VBN for_IN breast_NN cancer_NN prevention_NN and_CC treatment_NN -LRB-_-LRB- Gonzalez-Angulo_NNP 
Only_RB a_DT few_JJ studies_NNS have_VBP addressed_VBN this_DT question_NN previously_RB via_IN randomized_VBN controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNS -RRB-_-RRB- on_IN postmenopausal_JJ women_NNS -LRB-_-LRB- Neilson_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, including_VBG one_CD RCT_NNP that_WDT focused_VBD on_IN breast_NN cancer_NN -LRB-_-LRB- Frank_NNP et_NNP al._NNP ._. 
2005_CD -RRB-_-RRB- ._. 
Aneed_VBN for_IN additional_JJ tightly_RB controlled_JJ ,_, long-term_JJ intervention_NN trials_NNS to_TO examine_VB the_DT impact_NN of_IN exercise_NN on_IN proposed_VBN biomarkers_NNS for_IN breast_NN cancer_NN risk_NN has_VBZ been_VBN widely_RB recognized_VBN -LRB-_-LRB- McTiernan_NNP et_FW al_FW ._. 
Of_IN five_CD previous_JJ noteworthy_JJ RCTs_NNS with_IN similar_JJ study_NN populations_NNS and\/or_CC outcomes_NNS of_IN interest_NN -LRB-_-LRB- Houmard_FW et_FW al_FW ._. 
2004_CD ,_, Frank_NNP et_NNP al._NNP ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2005_CD ,_, Pi-Sunyer_NNP et_FW al_FW ._. 
2007_CD ,_, Arsenault_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, only_RB one_CD trial_NN lead_NN by_IN McTiernan_NNP -LRB-_-LRB- Frank_NNP et_FW al_FW ._. 
2007_CD ,_, Arsenault_NNP et_FW al_FW ._. 
2005_CD ,_, Pi-Sunyer_NNP et_FW al_FW ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2004_CD ,_, Frank_NNP et_NNP al_NNP ._. 
2009_CD -RRB-_-RRB- ,_, only_RB one_CD trial_NN lead_NN by_IN McTiernan_NNP -LRB-_-LRB- Frank_NNP et_FW al._FW ._. 
2005_CD ,_, McTiernan_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- was_VBD of_IN comparable_JJ size_NN ,_, duration_NN and_CC scope_NN to_TO the_DT ALPHA_NNP Trial_NNP ._. 
In_IN contrast_NN to_TO the_DT other_JJ trials_NNS ,_, the_DT ALPHA_NNP Trial_NNP included_VBD healthy_JJ ,_, postmenopausal_JJ women_NNS with_IN a_DT BMI_NNP ranging_VBG from_IN 22_CD 
Thus_RB ,_, our_PRP$ study_NN provides_VBZ a_DT new_JJ insight_NN ,_, using_VBG a_DT potentially_RB stronger_JJR indicator_NN of_IN breast_NN cancer_NN risk_NN than_IN leptin_NN or_CC adiponectin_NN on_IN its_PRP$ own_JJ ,_, into_IN how_WRB exercise_NN impacts_VBZ the_DT causal_JJ pathway_NN between_IN exercise_NN and_CC postmenopausal_JJ breast_NN cancer_NN ._. 
As_IN with_IN the_DT McTiernan_NNP trial_NN -LRB-_-LRB- Frank_NNP et_NNP al._NNP ._. 
2005_CD -RRB-_-RRB- ,_, our_PRP$ study_NN demonstrated_VBD decreased_VBN insulin_NN concentrations_NNS and_CC HOMA-IR_NN in_IN exercisers_NNS that_WDT differed_VBD significantly_RB from_IN changes_NNS in_IN controls_NNS across_IN 12_CD months_NNS of_IN exercise_NN ;_: no_DT significant_JJ change_NN in_IN glucose_NN was_VBD found_VBN in_IN either_DT trial_NN ._. 
2004_CD -RRB-_-RRB- ._. 
Another_DT RCT_NNP ,_, the_DT Studies_NNP of_IN Targeted_NNP Risk_NNP Reduction_NNP Interventions_NNPS through_IN Defined_NNP Exercise_NNP -LRB-_-LRB- STRRIDE_NNP -RRB-_-RRB- ,_, found_VBD improvements_NNS in_IN insulin_NN sensitivity_NN in_IN 154_CD overweight\/obese_JJ adults_NNS that_WDT were_VBD greater_JJR with_IN 170_CD 
Exercise_NN may_MD lower_VB serum_NN insulin_NN levels_NNS by_IN promoting_VBG fat_JJ loss_NN and_CC preserving_VBG lean_JJ body_NN mass_NN ,_, and_CC independently_RB of_IN fat_JJ loss_NN by_IN increasing_VBG the_DT number_NN and_CC activity_NN of_IN glucose_NN transporters_NNS in_IN muscle_NN and_CC adipose_NN tissue_NN -LRB-_-LRB- Ryan_NNP 2000_CD -RRB-_-RRB- ._. 
Another_DT trial_NN of_IN older_JJR women_NNS -LRB-_-LRB- Frank_NNP et_NNP al._NNP ._. 
2005_CD -RRB-_-RRB- found_VBD decreased_VBN insulin_NN and_CC HOMA-IR_JJ scores_NNS only_RB in_IN women_NNS whose_WP$ total_JJ body_NN fat_NN was_VBD decreased_VBN by_IN the_DT intervention_NN ,_, which_WDT suggests_VBZ these_DT changes_NNS were_VBD driven_VBN by_IN fat_JJ loss_NN ._. 
We_PRP similarly_RB showed_VBD total_NN and_CC percent_NN body_NN fat_JJ loss_NN to_TO be_VB mediators_NNS of_IN exercise-induced_JJ changes_NNS in_IN HOMA-IR_NNP -LRB-_-LRB- Table_NNP 4_CD -RRB-_-RRB- ._. 
The_DT same_JJ trial_NN -LRB-_-LRB- Frank_NNP et_NNP al._NNP ._. 
2005_CD -RRB-_-RRB- showed_VBD no_DT difference_NN across_IN changes_NNS in_IN body_NN weight_NN ,_, percent_NN body_NN fat_JJ or_CC intra-abdominal_JJ adiposity_NN ,_, concordant_NN with_IN our_PRP$ findings_NNS for_IN insulin_NN ._. 
2000_CD ,_, Hayase_FW et_FW al_FW ._. 
1996_CD ,_, Ryan_NNP et_FW al_FW ._. 
Only_RB a_DT few_JJ studies_NNS have_VBP addressed_VBN the_DT effects_NNS of_IN exercise_NN on_IN leptin_NN in_IN postmenopausal_JJ women_NNS -LRB-_-LRB- Kohrt_NNP et_FW al_FW ._. 
2002_CD ,_, Frank_NNP et_NNP al._NNP ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- and_CC only_RB two_CD of_IN them_PRP were_VBD RCTs_NNP -LRB-_-LRB- Frank_NNP et_FW al_FW ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2002_CD ,_, Frank_NNP et_NNP al_NNP ._. 
2000_CD ,_, Hayase_FW et_FW al_FW ._. 
1996_CD ,_, Ryan_NNP et_FW al_FW ._. 
Only_RB a_DT few_JJ studies_NNS have_VBP addressed_VBN the_DT effects_NNS of_IN exercise_NN on_IN leptin_NN in_IN postmenopausal_JJ women_NNS -LRB-_-LRB- Kohrt_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- and_CC only_RB two_CD of_IN them_PRP were_VBD RCTs_NNP -LRB-_-LRB- Frank_NNP et_FW al._FW ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
One_CD trial_NN -LRB-_-LRB- Frank_NNP et_NNP al_NNP ._. 
2005_CD -RRB-_-RRB- showed_VBD decreased_VBN leptin_NN concentrations_NNS with_IN exercise_NN ;_: however_RB ,_, in_IN our_PRP$ most_RBS adherent_JJ subgroup_NN ,_, we_PRP observed_VBD more_JJR than_IN twice_RB the_DT decrease_NN in_IN leptin_NN -LRB-_-LRB- 12_CD %_NN with_IN 
2005_CD -RRB-_-RRB- ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- and_CC only_RB two_CD of_IN them_PRP were_VBD RCTs_NNP -LRB-_-LRB- Frank_NNP et_FW al_FW ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
One_CD trial_NN -LRB-_-LRB- Frank_NNP et_NNP al._NNP ._. 
2005_CD -RRB-_-RRB- showed_VBD decreased_VBN leptin_NN concentrations_NNS with_IN exercise_NN ;_: however_RB ,_, in_IN our_PRP$ most_RBS adherent_JJ subgroup_NN ,_, we_PRP observed_VBD more_JJR than_IN twice_RB the_DT decrease_NN in_IN leptin_NN -LRB-_-LRB- 12_CD %_NN with_IN 
One_CD trial_NN -LRB-_-LRB- Frank_NNP et_NNP al_NNP ._. 
2005_CD -RRB-_-RRB- ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- and_CC only_RB two_CD of_IN them_PRP were_VBD RCTs_NNP -LRB-_-LRB- Frank_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- showed_VBD decreased_VBN leptin_NN concentrations_NNS with_IN exercise_NN ;_: however_RB ,_, in_IN our_PRP$ most_RBS adherent_JJ subgroup_NN ,_, we_PRP observed_VBD more_JJR than_IN twice_RB the_DT decrease_NN in_IN leptin_NN -LRB-_-LRB- 12_CD %_NN with_IN 
Aneed_VBN for_IN additional_JJ tightly_RB controlled_JJ ,_, long-term_JJ intervention_NN trials_NNS to_TO examine_VB the_DT impact_NN of_IN exercise_NN on_IN proposed_VBN biomarkers_NNS for_IN breast_NN cancer_NN risk_NN has_VBZ been_VBN widely_RB recognized_VBN -LRB-_-LRB- McTiernan_NNP et_FW al_FW ._. 
1999_CD ,_, Friedenreich_NNP 2001_CD ,_, IARC_NNP Working_NNP Group_NNP 2002_CD ,_, Kushi_FW et_FW al._FW ._. 
2006_CD ,_, Physical_JJ Activity_NN Guidelines_NNS Advisory_NNP Committee_NNP 2008_CD -RRB-_-RRB- ._. 
In_IN response_NN to_TO this_DT recognized_VBN need_NN for_IN more_JJR research_NN ,_, the_DT Alberta_NNP Physical_NNP Activity_NNP and_CC Breast_NNP Cancer_NNP Prevention_NNP -LRB-_-LRB- ALPHA_NNP -RRB-_-RRB- Trial_NNP was_VBD a_DT 12-month_JJ exercise_NN intervention_NN trial_NN designed_VBN to_TO improve_VB the_DT understanding_NN of_IN the_DT biologic_JJ mechanisms_NNS mediating_VBG the_DT association_NN between_IN physical_JJ activity_NN and_CC postmenopausal_JJ breast_NN cancer_NN risk_NN ._. 
Canadian_NNP Breast_NNP Cancer_NNP Research_NNP Alliance_NNP #_# 017468_CD Alberta_NNP Cancer_NNP Foundation_NNP #_# 22170_CD Introduction_NNP Physical_NNP activity_NN reduces_VBZ the_DT risk_NN of_IN postmenopausal_JJ breast_NN cancer_NN -LRB-_-LRB- Monninkhof_FW et_FW al_FW ._. 
2007_CD ,_, World_NNP Cancer_NNP Research_NNP Fund_NNP and_CC the_DT American_NNP Institute_NNP for_IN Cancer_NNP Research_NNP 2007_CD ,_, Friedenreich_NNP 
Dietary_JJ intake_NN of_IN the_DT previous_JJ year_NN was_VBD assessed_VBN using_VBG the_DT National_NNP Cancer_NNP Institute_NNP 's_POS Diet_NNP History_NN Questionnaire_NNP previously_RB adapted_VBD for_IN use_NN in_IN Canadian_JJ populations_NNS -LRB-_-LRB- Csizmadi_FW et_FW al_FW ._. 
2007_CD -RRB-_-RRB- and_CC physical_JJ activity_NN was_VBD assessed_VBN using_VBG the_DT past_JJ year_NN total_JJ physical_JJ activity_NN questionnaire_NN -LRB-_-LRB- Friedenreich_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Fitness_NNP was_VBD assessed_VBN using_VBG a_DT modified_VBN Balke_NNP treadmill_NN protocol_NN to_TO estimate_VB maximum_JJ oxygen_NN consumption_NN -LRB-_-LRB- VO_FW 2max_FW -RRB-_-RRB- from_IN submaximal_JJ exercise_NN intensities_NNS ._. 
We_PRP previously_RB reported_VBD that_IN the_DT intervention_NN significantly_RB decreased_VBD adiposity_NN -LRB-_-LRB- Friedenreich_FW et_FW al_FW ._. 
2010b_CD -RRB-_-RRB- and_CC circulating_VBG estradiol_NN and_CC increased_VBN sex_NN hormone-binding_NN globulin_NN -LRB-_-LRB- Friedenreich_NNP et_FW al._FW ._. 
2010_CD a_DT -RRB-_-RRB- ,_, which_WDT were_VBD primary_JJ outcomes_NNS of_IN the_DT trial_NN ._. 
Here_RB ,_, we_PRP report_VBP on_IN metabolic_JJ factors_NNS as_IN secondary_JJ outcomes_NNS ,_, namely_RB ,_, insulin_NN ,_, glucose_NN ,_, homeostasis_NN model_NN assessment_NN of_IN IR_NNP -LRB-_-LRB- HOMA-IR_NNP -RRB-_-RRB- ,_, IGF1_NNP ,_, IGFBP3_NNP ,_, IGF1\/IGFBP3_NNP ratio_NN ,_, leptin_NN ,_, adiponectin_NN ,_, and_CC A\/L_NNP ratio_NN ._. 
Here_RB ,_, we_PRP report_VBP on_IN metabolic_JJ factors_NNS as_IN secondary_JJ outcomes_NNS ,_, namely_RB ,_, insulin_NN ,_, glucose_NN ,_, homeostasis_NN model_NN assessment_NN of_IN IR_NNP -LRB-_-LRB- HOMA-IR_NNP -RRB-_-RRB- ,_, IGF1_NNP ,_, IGFBP3_NNP ,_, IGF1\/IGFBP3_NNP ratio_NN ,_, leptin_NN ,_, adiponectin_NN ,_, and_CC A\/L_NNP ratio_NN ._. 
Materials_NNPS and_CC methodsThe_NNP design_NN and_CC methods_NNS for_IN the_DT ALPHA_NNP Trial_NNP have_VBP been_VBN described_VBN -LRB-_-LRB- Friedenreich_NNP et_FW al._FW ._. 
2010_CD a_DT -RRB-_-RRB- ._. 
In_IN brief_NN ,_, this_DT study_NN was_VBD an_DT efficacy_NN trial_NN designed_VBN as_IN a_DT two-centred_JJ ,_, two-armed_JJ RCT_NNP conducted_VBN in_IN postmenopausal_JJ women_NNS living_VBG in_IN Calgary_NNP and_CC Edmonton_NNP ,_, Alberta_NNP ,_, Canada_NNP ._. 
Leptin_NNP and_CC total_JJ adiponectin_NN were_VBD measured_VBN by_IN RIA_NNP -LRB-_-LRB- Millipore_NNP ,_, St_NNP Charles_NNP ,_, MO_NNP ,_, USA_NNP -RRB-_-RRB- ;_: intra-assay_JJ and_CC inter-assay_JJ CV_NNP were_VBD 6_CD and_CC 5_CD %_NN ,_, and_CC 8_CD and_CC 12_CD %_NN respectively_RB ._. 
Sample_NNP sizeSample_NNP size_NN calculations_NNS were_VBD based_VBN on_IN the_DT primary_JJ estrogen_NN and_CC adiposity_NN outcomes_NNS for_IN which_WDT power_NN 
2007_CD -RRB-_-RRB- and_CC 
In_IN response_NN to_TO this_DT recognized_VBN need_NN for_IN more_JJR research_NN ,_, the_DT Alberta_NNP Physical_NNP Activity_NNP and_CC Breast_NNP Cancer_NNP Prevention_NNP -LRB-_-LRB- ALPHA_NNP -RRB-_-RRB- Trial_NNP was_VBD a_DT 12-month_JJ exercise_NN intervention_NN trial_NN designed_VBN to_TO improve_VB the_DT understanding_NN of_IN the_DT biologic_JJ mechanisms_NNS mediating_VBG the_DT association_NN between_IN physical_JJ activity_NN and_CC postmenopausal_JJ breast_NN cancer_NN risk_NN ._. 
We_PRP previously_RB reported_VBD that_IN the_DT intervention_NN significantly_RB decreased_VBD adiposity_NN -LRB-_-LRB- Friedenreich_NNP et_FW al._FW ._. 
2010_CD b_NN -RRB-_-RRB- and_CC circulating_VBG estradiol_NN and_CC increased_VBN sex_NN hormone-binding_NN globulin_NN -LRB-_-LRB- Friedenreich_NNP et_FW al_FW ._. 
Duplicate_VB anthropometric_JJ measurements_NNS were_VBD taken_VBN using_VBG standardized_JJ methods_NNS ._. 
Fitness_NNP was_VBD assessed_VBN using_VBG a_DT modified_VBN Balke_NNP treadmill_NN protocol_NN to_TO estimate_VB maximum_JJ oxygen_NN consumption_NN -LRB-_-LRB- VO_FW 2max_FW -RRB-_-RRB- from_IN submaximal_JJ exercise_NN intensities_NNS ._. 
Total_JJ body_NN fat_NN was_VBD assessed_VBN using_VBG whole_JJ body_NN dual_JJ X-ray_NN absorptiometry_NN scans_VBZ -LRB-_-LRB- Friedenreich_NNP et_FW al._FW ._. 
2010_CD b_NN -RRB-_-RRB- ._. 
Percent_NN body_NN fat_NN was_VBD calculated_VBN as_IN 100_CD %_NN 
Given_VBN that_DT leptin_NN and_CC adiponectin_NN derive_VBP almost_RB exclusively_RB from_IN adipose_JJ tissue_NN ,_, their_PRP$ levels_NNS should_MD change_VB with_IN exercise-induced_JJ body_NN fat_JJ loss_NN and_CC decreased_VBD central_JJ adiposity_NN -LRB-_-LRB- Ritland_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ,_, which_WDT was_VBD experienced_VBN in_IN this_DT trial_NN -LRB-_-LRB- Friedenreich_NNP et_FW al._FW ._. 
2010_CD b_NN -RRB-_-RRB- ._. 
We_PRP observed_VBD reductions_NNS in_IN leptin_NN for_IN exercisers_NNS ,_, which_WDT increased_VBD in_IN a_DT dose-dependent_JJ manner_NN with_IN exercise_NN adherence_NN ._. 
2010_CD -RRB-_-RRB- ,_, perhaps_RB more_JJR than_IN the_DT 2_CD ._. 
Although_IN RCT_NNP evidence_NN relating_VBG chronic_JJ exercise_NN to_TO circulating_VBG adiponectin_NN has_VBZ been_VBN inconclusive_JJ -LRB-_-LRB- Simpson_NNP 
2001_CD -RRB-_-RRB- insulin-like_JJ growth_NN factor_NN 1_CD -LRB-_-LRB- IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS ;_: Yu_NNP 
2009_CD -RRB-_-RRB- ._. 
2009_CD ,_, Ligibel_NNP et_FW al_FW ._. 
2009_CD ,_, Coker_NNP et_FW al_FW ._. 
2005_CD ,_, Arsenault_NNP et_FW al_FW ._. 
However_RB ,_, we_PRP and_CC others_NNS found_VBD no_DT changes_NNS in_IN adiponectin_JJ levels_NNS with_IN exercise_NN -LRB-_-LRB- Giannopoulou_NNP et_FW al_FW ._. 
Although_IN RCT_NNP evidence_NN relating_VBG chronic_JJ exercise_NN to_TO circulating_VBG adiponectin_NN has_VBZ been_VBN inconclusive_JJ -LRB-_-LRB- Simpson_NNP 
2009_CD ,_, Wu_NNP et_FW al_FW ._. 
While_IN it_PRP is_VBZ biologically_RB plausible_JJ that_IN leptin_NN increases_NNS postmenopausal_JJ breast_NN cancer_NN risk_NN ,_, epidemiological_JJ findings_NNS have_VBP been_VBN inconsistent_JJ -LRB-_-LRB- Neilson_NNP et_FW al_FW ._. 
2009_CD ,_, Maccio_FW et_FW al._FW ._. 
2010_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, most_JJS studies_NNS in_IN postmenopausal_JJ women_NNS have_VBP shown_VBN significant_JJ inverse_JJ associations_NNS between_IN adiponectin_NN and_CC breast_NN cancer_NN risk_NN -LRB-_-LRB- Neilson_NNP et_FW al_FW ._. 
Exercisers_NNS and_CC controls_NNS were_VBD similar_JJ at_IN baseline_NN with_IN respect_NN to_TO age_NN ,_, body_NN composition_NN ,_, and_CC proposed_VBN biomarker_NN concentrations_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
Baseline_NN leptin_NN concentrations_NNS were_VBD high_JJ relative_JJ to_TO normal_JJ weight_NN women_NNS -LRB-_-LRB- Mahabir_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- and_CC 
2009_CD ,_, Coker_NNP et_FW al_FW ._. 
2005_CD ,_, Arsenault_NNP et_FW al_FW ._. 
However_RB ,_, we_PRP and_CC others_NNS found_VBD no_DT changes_NNS in_IN adiponectin_JJ levels_NNS with_IN exercise_NN -LRB-_-LRB- Giannopoulou_NNP et_FW al_FW ._. 
2009_CD ,_, Ligibel_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
Although_IN RCT_NNP evidence_NN relating_VBG chronic_JJ exercise_NN to_TO circulating_VBG adiponectin_NN has_VBZ been_VBN inconclusive_JJ -LRB-_-LRB- Simpson_NNP 
Canadian_NNP Breast_NNP Cancer_NNP Research_NNP Alliance_NNP #_# 017468_CD Alberta_NNP Cancer_NNP Foundation_NNP #_# 22170_CD Introduction_NNP Physical_NNP activity_NN reduces_VBZ the_DT risk_NN of_IN postmenopausal_JJ breast_NN cancer_NN -LRB-_-LRB- Monninkhof_FW et_FW al_FW ._. 
2007_CD ,_, World_NNP Cancer_NNP Research_NNP Fund_NNP and_CC the_DT American_NNP Institute_NNP for_IN Cancer_NNP Research_NNP 2007_CD ,_, Friedenreich_NNP 
1976_CD ,_, Chappell_NNP et_FW al_FW ._. 
Insulin_NNP -LRB-_-LRB- Osborne_NNP et_FW al_FW ._. 
2011_CD -RRB-_-RRB- ,_, but_CC the_DT biologic_JJ mechanisms_NNS underlying_VBG this_DT association_NN are_VBP not_RB well_RB understood_VBN ._. 
2001_CD -RRB-_-RRB- insulin-like_JJ growth_NN factor_NN 1_CD -LRB-_-LRB- IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS ;_: Yu_NNP 
1985_CD ,_, Bonora_NNP et_FW al_FW ._. 
1985_CD ,_, Matthews_NNP et_NNP al_NNP ._. 
5-LRB-_NNP Hosker_NNP et_FW al_FW ._. 
Asurrogate_JJ measure_NN of_IN whole_JJ body_NN insulin_NN sensitivity_NN and_CC 
2009_CD -RRB-_-RRB- ._. 
2009_CD ,_, Ligibel_NNP et_FW al_FW ._. 
2009_CD ,_, Coker_NNP et_FW al_FW ._. 
2005_CD ,_, Arsenault_NNP et_FW al_FW ._. 
However_RB ,_, we_PRP and_CC others_NNS found_VBD no_DT changes_NNS in_IN adiponectin_JJ levels_NNS with_IN exercise_NN -LRB-_-LRB- Giannopoulou_NNP et_FW al_FW ._. 
Although_IN RCT_NNP evidence_NN relating_VBG chronic_JJ exercise_NN to_TO circulating_VBG adiponectin_NN has_VBZ been_VBN inconclusive_JJ -LRB-_-LRB- Simpson_NNP 
Aneed_VBN for_IN additional_JJ tightly_RB controlled_JJ ,_, long-term_JJ intervention_NN trials_NNS to_TO examine_VB the_DT impact_NN of_IN exercise_NN on_IN proposed_VBN biomarkers_NNS for_IN breast_NN cancer_NN risk_NN has_VBZ been_VBN widely_RB recognized_VBN -LRB-_-LRB- McTiernan_NNP et_FW al_FW ._. 
1999_CD ,_, Friedenreich_NNP 2001_CD ,_, IARC_NNP Working_NNP Group_NNP 2002_CD ,_, Kushi_FW et_FW al._FW ._. 
2006_CD ,_, Physical_JJ Activity_NN Guidelines_NNS Advisory_NNP Committee_NNP 2008_CD -RRB-_-RRB- ._. 
In_IN response_NN to_TO this_DT recognized_VBN need_NN for_IN more_JJR research_NN ,_, the_DT Alberta_NNP Physical_NNP Activity_NNP and_CC Breast_NNP Cancer_NNP Prevention_NNP -LRB-_-LRB- ALPHA_NNP -RRB-_-RRB- Trial_NNP was_VBD a_DT 12-month_JJ exercise_NN intervention_NN trial_NN designed_VBN to_TO improve_VB the_DT understanding_NN of_IN the_DT biologic_JJ mechanisms_NNS mediating_VBG the_DT association_NN between_IN physical_JJ activity_NN and_CC postmenopausal_JJ breast_NN cancer_NN risk_NN ._. 
2009_CD ,_, Neilson_NNP et_FW al_FW ._. 
2009_CD ,_, Kabat_FW et_FW al_FW ._. 
Differing_VBG levels_NNS of_IN evidence_NN support_NN roles_NNS for_IN these_DT proposed_VBN biomarkers_NNS in_IN breast_NN cancer_NN ,_, but_CC the_DT greatest_JJS pool_NN of_IN epidemiologic_JJ data_NNS in_IN postmenopausal_JJ women_NNS exists_VBZ for_IN insulin_NN -LRB-_-LRB- Gunter_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- and_CC IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS -LRB-_-LRB- Key_NNP et_FW al._FW ._. 
2010_CD -RRB-_-RRB- ._. 
The_DT link_NN between_IN insulin_NN and_CC breast_NN cancer_NN is_VBZ now_RB sufficiently_RB convincing_JJ that_IN metformin_NN ,_, a_DT pharmacologic_JJ agent_NN that_WDT improves_VBZ insulin_NN sensitivity_NN ,_, is_VBZ being_VBG considered_VBN for_IN breast_NN cancer_NN prevention_NN and_CC treatment_NN -LRB-_-LRB- Gonzalez-Angulo_NNP 
2006_CD -RRB-_-RRB- ._. 
2005_CD -RRB-_-RRB- and_CC associations_NNS with_IN IGF-binding_JJ protein_NN 3_CD -LRB-_-LRB- IGFBP3_NNP -RRB-_-RRB- have_VBP been_VBN inconsistent_JJ -LRB-_-LRB- Renehan_NNP et_FW al_FW ._. 
Nevertheless_RB ,_, a_DT recent_JJ pooled_VBN analysis_NN found_VBD a_DT significantly_RB increased_VBN risk_NN of_IN breast_NN cancer_NN with_IN elevated_JJ IGF1_NNP and_CC IGFBP3_NNP in_IN postmenopausal_JJ women_NNS -LRB-_-LRB- Key_NNP et_FW al._FW ._. 
2010_CD -RRB-_-RRB- ._. 
Leptin_NN and_CC adiponectin_NN are_VBP adipokines_NNS that_WDT relate_VBP strongly_RB to_TO obesity_NN and_CC insulin_NN resistance_NN -LRB-_-LRB- IR_NNP ;_: Pittas_NNP et_FW al_FW ._. 
We_PRP observed_VBD reductions_NNS in_IN leptin_NN for_IN exercisers_NNS ,_, which_WDT increased_VBD in_IN a_DT dose-dependent_JJ manner_NN with_IN exercise_NN adherence_NN ._. 
Only_RB a_DT few_JJ studies_NNS have_VBP addressed_VBN the_DT effects_NNS of_IN exercise_NN on_IN leptin_NN in_IN postmenopausal_JJ women_NNS -LRB-_-LRB- Kohrt_NNP et_FW al._FW ._. 
1996_CD ,_, Ryan_NNP et_FW al_FW ._. 
2000_CD ,_, Hayase_FW et_FW al_FW ._. 
2002_CD ,_, Frank_NNP et_NNP al_NNP ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- and_CC only_RB two_CD of_IN them_PRP were_VBD RCTs_NNP -LRB-_-LRB- Frank_NNP et_FW al_FW ._. 
Therefore_RB ,_, the_DT evidence_NN is_VBZ weak_JJ that_IN chronic_JJ exercise_NN lowers_VBZ IGF1_NNP in_IN postmenopausal_JJ women_NNS ._. 
Arecent_JJ review_NN also_RB suggested_VBD that_IN long-term_JJ exercise_NN may_MD actually_RB increase_VB circulating_VBG IGF1_NNP -LRB-_-LRB- Nindl_NNP 
For_IN IR_NNP outcomes_NNS ,_, using_VBG the_DT same_JJ approach_NN for_IN sample_NN size_NN estimation_NN as_IN for_IN the_DT primary_JJ outcomes_NNS ,_, namely_RB the_DT normal_JJ theory_NN formula_NN for_IN comparing_VBG means_NNS of_IN two_CD independent_JJ samples_NNS with_IN 
In_IN general_JJ ,_, exercise_NN with_IN moderate_JJ weight_NN loss_NN has_VBZ been_VBN found_VBN to_TO improve_VB insulin_NN sensitivity_NN -LRB-_-LRB- Albright_NNP et_FW al_FW ._. 
2000_CD ,_, Ryan_NNP 2000_CD ,_, Wareham_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- and_CC prevent_VB type_NN 2_CD diabetes_NN -LRB-_-LRB- Gill_NNP 
In_IN general_JJ ,_, exercise_NN with_IN moderate_JJ weight_NN loss_NN has_VBZ been_VBN found_VBN to_TO improve_VB insulin_NN sensitivity_NN -LRB-_-LRB- Albright_NNP et_FW al_FW ._. 
2000_CD ,_, Ryan_NNP 2000_CD ,_, Wareham_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- and_CC prevent_VB type_NN 2_CD diabetes_NN -LRB-_-LRB- Gill_NNP 
Our_PRP$ findings_NNS for_IN an_DT effect_NN of_IN aerobic_JJ exercise_NN on_IN insulin_NN and_CC HOMA-IR_JJ scores_NNS ,_, which_WDT was_VBD attenuated_VBN but_CC not_RB wholly_RB explained_VBN by_IN changes_NNS in_IN adiposity_NN ,_, are_VBP biologically_RB plausible_JJ ._. 
Exercise_NN may_MD lower_VB serum_NN insulin_NN levels_NNS by_IN promoting_VBG fat_JJ loss_NN and_CC preserving_VBG lean_JJ body_NN mass_NN ,_, and_CC independently_RB of_IN fat_JJ loss_NN by_IN increasing_VBG the_DT number_NN and_CC activity_NN of_IN glucose_NN transporters_NNS in_IN muscle_NN and_CC adipose_NN tissue_NN -LRB-_-LRB- Ryan_NNP 2000_CD -RRB-_-RRB- ._. 
Another_DT trial_NN of_IN older_JJR women_NNS -LRB-_-LRB- Frank_NNP et_NNP al_NNP ._. 
2005_CD -RRB-_-RRB- found_VBD decreased_VBN insulin_NN and_CC HOMA-IR_JJ scores_NNS only_RB in_IN women_NNS whose_WP$ total_JJ body_NN fat_NN was_VBD decreased_VBN by_IN the_DT intervention_NN ,_, which_WDT suggests_VBZ these_DT changes_NNS were_VBD driven_VBN by_IN fat_JJ loss_NN ._. 
Spearman_NNP 's_POS rank_JJ correlation_NN coefficients_NNS were_VBD estimated_VBN to_TO relate_VB changes_NNS in_IN metabolic_JJ factors_NNS to_TO changes_NNS in_IN percent_NN body_NN fat_NN in_IN exercisers_NNS ._. 
We_PRP classified_VBD exercise_NN adherence_NN into_IN three_CD categories_NNS pre-defined_VBN by_IN public_JJ health_NN guidelines_NNS :_: 
1991_CD ,_, Rudenski_FW et_FW al_FW ._. 
1989_CD ,_, Levy_NNP et_NNP al_NNP ._. 
1985_CD ,_, Bonora_NNP et_FW al_FW ._. 
1985_CD ,_, Matthews_NNP et_NNP al_NNP ._. 
5-LRB-_NNP Hosker_NNP et_FW al_FW ._. 
1991_CD ,_, Turner_NNP et_NNP al._NNP ._. 
1993_CD -RRB-_-RRB- ._. 
Leptin_NNP and_CC total_JJ adiponectin_NN were_VBD measured_VBN by_IN RIA_NNP -LRB-_-LRB- Millipore_NNP ,_, St_NNP Charles_NNP ,_, MO_NNP ,_, USA_NNP -RRB-_-RRB- ;_: intra-assay_JJ and_CC inter-assay_JJ CV_NNP were_VBD 6_CD and_CC 5_CD %_NN ,_, and_CC 8_CD and_CC 12_CD %_NN respectively_RB ._. 
2009_CD -RRB-_-RRB- ._. 
2009_CD ,_, Ligibel_NNP et_FW al_FW ._. 
2009_CD ,_, Coker_NNP et_FW al_FW ._. 
2005_CD ,_, Arsenault_NNP et_FW al_FW ._. 
However_RB ,_, we_PRP and_CC others_NNS found_VBD no_DT changes_NNS in_IN adiponectin_JJ levels_NNS with_IN exercise_NN -LRB-_-LRB- Giannopoulou_NNP et_FW al_FW ._. 
Although_IN RCT_NNP evidence_NN relating_VBG chronic_JJ exercise_NN to_TO circulating_VBG adiponectin_NN has_VBZ been_VBN inconclusive_JJ -LRB-_-LRB- Simpson_NNP 
Insulin_NNP -LRB-_-LRB- Osborne_NNP et_FW al_FW ._. 
2011_CD -RRB-_-RRB- ,_, but_CC the_DT biologic_JJ mechanisms_NNS underlying_VBG this_DT association_NN are_VBP not_RB well_RB understood_VBN ._. 
1976_CD ,_, Chappell_NNP et_FW al._FW ._. 
2001_CD -RRB-_-RRB- insulin-like_JJ growth_NN factor_NN 1_CD -LRB-_-LRB- IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS ;_: Yu_NNP 
Emerging_VBG research_NN suggests_VBZ that_IN the_DT ratio_NN of_IN adiponectin_NN :_: leptin_NN -LRB-_-LRB- A\/L_NNP or_CC conversely_RB ,_, L\/A_NNP -RRB-_-RRB- provides_VBZ a_DT surrogate_JJ measure_NN of_IN IR_NNP -LRB-_-LRB- Finucane_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, and_CC perhaps_RB also_RB acts_VBZ as_IN an_DT indicator_NN of_IN postmenopausal_JJ breast_NN cancer_NN risk_NN ,_, which_WDT may_MD be_VB more_RBR sensitive_JJ than_IN either_DT marker_NN on_IN its_PRP$ own_JJ -LRB-_-LRB- Cleary_NNP et_FW al._FW ._. 
2009_CD ,_, Jarde_FW et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
Since_IN all_DT of_IN these_DT proposed_VBN biomarkers_NNS are_VBP related_VBN to_TO IR_NNP and_CC obesity_NN ,_, we_PRP hypothesized_VBD that_IN their_PRP$ levels_NNS could_MD be_VB modified_VBN with_IN sustained_JJ physical_JJ activity_NN ._. 
Since_IN this_DT ratio_NN appears_VBZ to_TO estimate_VB IR_NNP -LRB-_-LRB- Finucane_NNP et_FW al_FW ._. 
In_IN particular_JJ ,_, no_DT previous_JJ RCT_NNP has_VBZ examined_VBN the_DT effect_NN of_IN exercise_NN on_IN the_DT ratio_NN of_IN adiponectin\/leptin_NN ._. 
2009_CD -RRB-_-RRB- ,_, it_PRP was_VBD only_RB recently_RB proposed_VBN as_IN a_DT biomarker_NN of_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Cleary_NNP et_FW al._FW ._. 
2009_CD ,_, Jarde_FW et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
Thus_RB ,_, our_PRP$ study_NN provides_VBZ a_DT new_JJ insight_NN ,_, using_VBG a_DT potentially_RB stronger_JJR indicator_NN of_IN breast_NN cancer_NN risk_NN than_IN leptin_NN or_CC adiponectin_NN on_IN its_PRP$ own_JJ ,_, into_IN how_WRB exercise_NN impacts_VBZ the_DT causal_JJ pathway_NN between_IN exercise_NN and_CC postmenopausal_JJ breast_NN cancer_NN ._. 
2003_CD ,_, Geisler_NNP et_FW al_FW ._. 
2001_CD -RRB-_-RRB- insulin-like_JJ growth_NN factor_NN 1_CD -LRB-_-LRB- IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS ;_: Yu_NNP 
Covariate_JJ information_NN Demographic_JJ characteristics_NNS ,_, medical_JJ and_CC reproductive_JJ history_NN were_VBD obtained_VBN from_IN a_DT self-administered_JJ baseline_NN questionnaire_NN ;_: all_DT other_JJ covariate_JJ measures_NNS were_VBD taken_VBN at_IN baseline_NN and_CC 12_CD months_NNS ._. 
Dietary_JJ intake_NN of_IN the_DT previous_JJ year_NN was_VBD assessed_VBN using_VBG the_DT National_NNP Cancer_NNP Institute_NNP 's_POS Diet_NNP History_NN Questionnaire_NNP previously_RB adapted_VBD for_IN use_NN in_IN Canadian_JJ populations_NNS -LRB-_-LRB- Csizmadi_FW et_FW al._FW ._. 
2007_CD -RRB-_-RRB- and_CC physical_JJ activity_NN was_VBD assessed_VBN using_VBG the_DT past_JJ year_NN total_JJ physical_JJ activity_NN questionnaire_NN -LRB-_-LRB- Friedenreich_FW et_FW al_FW ._. 
2005_CD ,_, Arsenault_NNP et_FW al_FW ._. 
However_RB ,_, we_PRP and_CC others_NNS found_VBD no_DT changes_NNS in_IN adiponectin_JJ levels_NNS with_IN exercise_NN -LRB-_-LRB- Giannopoulou_NNP et_FW al_FW ._. 
2009_CD ,_, Coker_NNP et_FW al._FW ._. 
2009_CD ,_, Ligibel_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
Although_IN RCT_NNP evidence_NN relating_VBG chronic_JJ exercise_NN to_TO circulating_VBG adiponectin_NN has_VBZ been_VBN inconclusive_JJ -LRB-_-LRB- Simpson_NNP 
2008_CD -RRB-_-RRB- ,_, and_CC adiponectin_NN -LRB-_-LRB- Brakenhielm_FW et_FW al_FW ._. 
2007_CD ,_, Cirillo_NNP et_FW al_FW ._. 
2003_CD ,_, Geisler_NNP et_FW al_FW ._. 
2001_CD -RRB-_-RRB- insulin-like_JJ growth_NN factor_NN 1_CD -LRB-_-LRB- IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS ;_: Yu_NNP 
Limitations_NNPS include_VBP some_DT lack_NN of_IN compliance_NN among_IN the_DT control_NN group_NN :_: 10_CD %_NN of_IN controls_NNS increased_VBD recreational_JJ activity_NN by_IN 20_NNP MET-hours\/week_NNP ._. 
We_PRP used_VBD insulin_NN and_CC HOMA-IR_NNP as_IN IR_NNP indicators_NNS ,_, which_WDT are_VBP practical_JJ alternatives_NNS to_TO the_DT gold_JJ standard_JJ euglycaemic_JJ hyperinsulinemic_JJ clamp_NN method_NN -LRB-_-LRB- DeFronzo_NNP et_FW al._FW ._. 
1979_CD ,_, Bergman_NNP et_FW al_FW ._. 
1985_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, given_VBN the_DT number_NN of_IN secondary_JJ analyses_NNS of_IN these_DT data_NNS ,_, type_NN I_NN error_NN is_VBZ a_DT possibility_NN ._. 
2009_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, most_JJS studies_NNS in_IN postmenopausal_JJ women_NNS have_VBP shown_VBN significant_JJ inverse_JJ associations_NNS between_IN adiponectin_NN and_CC breast_NN cancer_NN risk_NN -LRB-_-LRB- Neilson_NNP et_FW al_FW ._. 
Emerging_VBG research_NN suggests_VBZ that_IN the_DT ratio_NN of_IN adiponectin_NN :_: leptin_NN -LRB-_-LRB- A\/L_NNP or_CC conversely_RB ,_, L\/A_NNP -RRB-_-RRB- provides_VBZ a_DT surrogate_JJ measure_NN of_IN IR_NNP -LRB-_-LRB- Finucane_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ,_, and_CC perhaps_RB also_RB acts_VBZ as_IN an_DT indicator_NN of_IN postmenopausal_JJ breast_NN cancer_NN risk_NN ,_, which_WDT may_MD be_VB more_RBR sensitive_JJ than_IN either_DT marker_NN on_IN its_PRP$ own_JJ -LRB-_-LRB- Cleary_NNP et_FW al_FW ._. 
In_IN particular_JJ ,_, no_DT previous_JJ RCT_NNP has_VBZ examined_VBN the_DT effect_NN of_IN exercise_NN on_IN the_DT ratio_NN of_IN adiponectin\/leptin_NN ._. 
Since_IN this_DT ratio_NN appears_VBZ to_TO estimate_VB IR_NNP -LRB-_-LRB- Finucane_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ,_, it_PRP was_VBD only_RB recently_RB proposed_VBN as_IN a_DT biomarker_NN of_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Cleary_NNP et_FW al_FW ._. 
2009_CD ,_, Jarde_FW et_FW al_FW ._. 
We_PRP observed_VBD significantly_RB greater_JJR increases_NNS in_IN the_DT A\/L_NNP ratio_NN in_IN exercisers_NNS than_IN in_IN controls_NNS ,_, driven_VBN mainly_RB by_IN decreased_VBN leptin_NN ._. 
This_DT finding_NN indicates_VBZ improved_VBN insulin_NN sensitivity_NN ,_, as_IN did_VBD the_DT changes_NNS we_PRP observed_VBD for_IN insulin_NN and_CC HOMA-IR_NN ;_: all_DT three_CD indices_NNS have_VBP been_VBN strongly_RB associated_VBN with_IN the_DT insulin_NN sensitivity_NN index_NN from_IN hyperinsulinaemic_NN 
Leptin_NN and_CC adiponectin_NN are_VBP adipokines_NNS that_WDT relate_VBP strongly_RB to_TO obesity_NN and_CC insulin_NN resistance_NN -LRB-_-LRB- IR_NNP ;_: Pittas_NNP et_FW al_FW ._. 
2004_CD ,_, Dyck_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- but_CC their_PRP$ roles_NNS in_IN breast_NN cancer_NN are_VBP unclear_JJ ._. 
While_IN it_PRP is_VBZ biologically_RB plausible_JJ that_IN leptin_NN increases_NNS postmenopausal_JJ breast_NN cancer_NN risk_NN ,_, epidemiological_JJ findings_NNS have_VBP been_VBN inconsistent_JJ -LRB-_-LRB- Neilson_NNP et_FW al_FW ._. 
Only_RB a_DT few_JJ large_JJ RCTs_NNS have_VBP examined_VBN the_DT effects_NNS of_IN a_DT long-term_JJ exercise-only_JJ intervention_NN on_IN these_DT metabolic_JJ factors_NNS in_IN older_JJR women_NNS ._. 
Of_IN five_CD previous_JJ noteworthy_JJ RCTs_NNS with_IN similar_JJ study_NN populations_NNS and\/or_CC outcomes_NNS of_IN interest_NN -LRB-_-LRB- Houmard_FW et_FW al._FW ._. 
2004_CD ,_, Frank_NNP et_NNP al_NNP ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2005_CD ,_, Pi-Sunyer_NNP et_FW al_FW ._. 
2007_CD ,_, Arsenault_NNP et_FW al_FW ._. 
In_IN secondary_JJ analyses_NNS ,_, we_PRP observed_VBD significant_JJ trends_NNS between_IN exercise_NN adherence_NN and_CC insulin_NN and_CC HOMA-IR_NN changes_NNS respectively_RB ._. 
Another_DT RCT_NNP ,_, the_DT Studies_NNP of_IN Targeted_NNP Risk_NNP Reduction_NNP Interventions_NNPS through_IN Defined_NNP Exercise_NNP -LRB-_-LRB- STRRIDE_NNP -RRB-_-RRB- ,_, found_VBD improvements_NNS in_IN insulin_NN sensitivity_NN in_IN 154_CD overweight\/obese_JJ adults_NNS that_WDT were_VBD greater_JJR with_IN 170_CD 
Asurrogate_JJ measure_NN of_IN whole_JJ body_NN insulin_NN sensitivity_NN and_CC 
1996_CD ,_, Ryan_NNP et_FW al_FW ._. 
Only_RB a_DT few_JJ studies_NNS have_VBP addressed_VBN the_DT effects_NNS of_IN exercise_NN on_IN leptin_NN in_IN postmenopausal_JJ women_NNS -LRB-_-LRB- Kohrt_NNP et_FW al_FW ._. 
2000_CD ,_, Hayase_FW et_FW al._FW ._. 
2002_CD ,_, Frank_NNP et_NNP al_NNP ._. 
2005_CD ,_, Giannopoulou_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- and_CC only_RB two_CD of_IN them_PRP were_VBD RCTs_NNP -LRB-_-LRB- Frank_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
2007_CD -RRB-_-RRB- are_VBP metabolic_JJ factors_NNS hypothesized_VBN to_TO mediate_VB the_DT association_NN between_IN physical_JJ activity_NN and_CC postmenopausal_JJ breast_NN cancer_NN risk_NN -LRB-_-LRB- Neilson_NNP et_FW al_FW ._. 
Differing_VBG levels_NNS of_IN evidence_NN support_NN roles_NNS for_IN these_DT proposed_VBN biomarkers_NNS in_IN breast_NN cancer_NN ,_, but_CC the_DT greatest_JJS pool_NN of_IN epidemiologic_JJ data_NNS in_IN postmenopausal_JJ women_NNS exists_VBZ for_IN insulin_NN -LRB-_-LRB- Gunter_NNP et_FW al._FW ._. 
2009_CD ,_, Kabat_FW et_FW al_FW ._. 
2009_CD ,_, Neilson_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- and_CC IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS -LRB-_-LRB- Key_NNP et_FW al_FW ._. 
1vs_CD 5_CD ._. 
However_RB ,_, varying_VBG insulin_NN levels_NNS ,_, comparable_JJ with_IN the_DT 12-month_JJ changes_NNS that_IN we_PRP observed_VBD in_IN exercisers_NNS -LRB-_-LRB- 6_CD ._. 
3_CD 
2009_CD -RRB-_-RRB- ._. 
3_CD 
The_DT link_NN between_IN insulin_NN and_CC breast_NN cancer_NN is_VBZ now_RB sufficiently_RB convincing_JJ that_IN metformin_NN ,_, a_DT pharmacologic_JJ agent_NN that_WDT improves_VBZ insulin_NN sensitivity_NN ,_, is_VBZ being_VBG considered_VBN for_IN breast_NN cancer_NN prevention_NN and_CC treatment_NN -LRB-_-LRB- Gonzalez-Angulo_NNP 
2010_CD -RRB-_-RRB- ._. 
2009_CD -RRB-_-RRB- and_CC IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS -LRB-_-LRB- Key_NNP et_FW al_FW ._. 
2009_CD ,_, Neilson_NNP et_FW al_FW ._. 
2009_CD ,_, Kabat_FW et_FW al_FW ._. 
The_DT link_NN between_IN insulin_NN and_CC breast_NN cancer_NN is_VBZ now_RB sufficiently_RB convincing_JJ that_IN metformin_NN ,_, a_DT pharmacologic_JJ agent_NN that_WDT improves_VBZ insulin_NN sensitivity_NN ,_, is_VBZ being_VBG considered_VBN for_IN breast_NN cancer_NN prevention_NN and_CC treatment_NN -LRB-_-LRB- Gonzalez-Angulo_NNP 
d._NN 
05_CD -LRB-_-LRB- two-sided_JJ ;_: Rosner_NNP 1986_CD -RRB-_-RRB- and_CC s._NN For_IN IR_NNP outcomes_NNS ,_, using_VBG the_DT same_JJ approach_NN for_IN sample_NN size_NN estimation_NN as_IN for_IN the_DT primary_JJ outcomes_NNS ,_, namely_RB the_DT normal_JJ theory_NN formula_NN for_IN comparing_VBG means_NNS of_IN two_CD independent_JJ samples_NNS with_IN 
Canadian_NNP Breast_NNP Cancer_NNP Research_NNP Alliance_NNP #_# 017468_CD Alberta_NNP Cancer_NNP Foundation_NNP #_# 22170_CD Introduction_NNP Physical_NNP activity_NN reduces_VBZ the_DT risk_NN of_IN postmenopausal_JJ breast_NN cancer_NN -LRB-_-LRB- Monninkhof_FW et_FW al_FW ._. 
2007_CD ,_, World_NNP Cancer_NNP Research_NNP Fund_NNP and_CC the_DT American_NNP Institute_NNP for_IN Cancer_NNP Research_NNP 2007_CD ,_, Friedenreich_NNP 
The_DT benefits_NNS of_IN improved_VBN insulin_NN sensitivity_NN include_VBP not_RB only_JJ cancer_NN risk_NN reduction_NN but_CC also_RB lower_JJR risk_NN of_IN metabolic_JJ syndrome_NN ,_, cardiovascular_JJ disease_NN ,_, and_CC type_NN 2_CD diabetes_NN ._. 
Our_PRP$ finding_NN of_IN improved_VBN hormone_NN levels_NNS with_IN exercise_NN 
2011_CD -RRB-_-RRB- ,_, but_CC the_DT biologic_JJ mechanisms_NNS underlying_VBG this_DT association_NN are_VBP not_RB well_RB understood_VBN ._. 
2007_CD ,_, World_NNP Cancer_NNP Research_NNP Fund_NNP and_CC the_DT American_NNP Institute_NNP for_IN Cancer_NNP Research_NNP 2007_CD ,_, Friedenreich_NNP 
2005_CD ,_, Seo_FW et_FW al_FW ._. 
This_DT evidence_NN is_VBZ consistent_JJ with_IN our_PRP$ findings_NNS and_CC other_JJ comparable_JJ RCTs_NNS -LRB-_-LRB- McTiernan_NNP et_FW al_FW ._. 
2010_CD -RRB-_-RRB- with_IN one_CD exception_NN :_: that_IN RCT_NNP -LRB-_-LRB- Orsatti_NNP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- showed_VBD significantly_RB increased_VBN IGF1_NNP with_IN exercise_NN ._. 
Arecent_JJ review_NN also_RB suggested_VBD that_IN long-term_JJ exercise_NN may_MD actually_RB increase_VB circulating_VBG IGF1_NNP -LRB-_-LRB- Nindl_NNP 
Aneed_VBN for_IN additional_JJ tightly_RB controlled_JJ ,_, long-term_JJ intervention_NN trials_NNS to_TO examine_VB the_DT impact_NN of_IN exercise_NN on_IN proposed_VBN biomarkers_NNS for_IN breast_NN cancer_NN risk_NN has_VBZ been_VBN widely_RB recognized_VBN -LRB-_-LRB- McTiernan_NNP et_FW al_FW ._. 
1999_CD ,_, Friedenreich_NNP 2001_CD ,_, IARC_NNP Working_NNP Group_NNP 2002_CD ,_, Kushi_FW et_FW al._FW ._. 
2006_CD ,_, Physical_JJ Activity_NN Guidelines_NNS Advisory_NNP Committee_NNP 2008_CD -RRB-_-RRB- ._. 
In_IN response_NN to_TO this_DT recognized_VBN need_NN for_IN more_JJR research_NN ,_, the_DT Alberta_NNP Physical_NNP Activity_NNP and_CC Breast_NNP Cancer_NNP Prevention_NNP -LRB-_-LRB- ALPHA_NNP -RRB-_-RRB- Trial_NNP was_VBD a_DT 12-month_JJ exercise_NN intervention_NN trial_NN designed_VBN to_TO improve_VB the_DT understanding_NN of_IN the_DT biologic_JJ mechanisms_NNS mediating_VBG the_DT association_NN between_IN physical_JJ activity_NN and_CC postmenopausal_JJ breast_NN cancer_NN risk_NN ._. 
2006_CD ,_, Arditi_FW et_FW al_FW ._. 
2004_CD ,_, Dieudonne_NNP et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ,_, and_CC adiponectin_NN -LRB-_-LRB- Brakenhielm_FW et_FW al_FW ._. 
2007_CD ,_, Cirillo_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- are_VBP metabolic_JJ factors_NNS hypothesized_VBN to_TO mediate_VB the_DT association_NN between_IN physical_JJ activity_NN and_CC postmenopausal_JJ breast_NN cancer_NN risk_NN -LRB-_-LRB- Neilson_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
Differing_VBG levels_NNS of_IN evidence_NN support_NN roles_NNS for_IN these_DT proposed_VBN biomarkers_NNS in_IN breast_NN cancer_NN ,_, but_CC the_DT greatest_JJS pool_NN of_IN epidemiologic_JJ data_NNS in_IN postmenopausal_JJ women_NNS exists_VBZ for_IN insulin_NN -LRB-_-LRB- Gunter_NNP et_FW al_FW ._. 
2009_CD ,_, Kabat_FW et_FW al_FW ._. 
Differing_VBG levels_NNS of_IN evidence_NN support_NN roles_NNS for_IN these_DT proposed_VBN biomarkers_NNS in_IN breast_NN cancer_NN ,_, but_CC the_DT greatest_JJS pool_NN of_IN epidemiologic_JJ data_NNS in_IN postmenopausal_JJ women_NNS exists_VBZ for_IN insulin_NN -LRB-_-LRB- Gunter_NNP et_FW al_FW ._. 
2009_CD ,_, Neilson_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- and_CC IGF1_NNP and_CC its_PRP$ binding_JJ proteins_NNS -LRB-_-LRB- Key_NNP et_FW al_FW ._. 
2010_CD -RRB-_-RRB- ._. 
The_DT link_NN between_IN insulin_NN and_CC breast_NN cancer_NN is_VBZ now_RB sufficiently_RB convincing_JJ that_IN metformin_NN ,_, a_DT pharmacologic_JJ agent_NN that_WDT improves_VBZ insulin_NN sensitivity_NN ,_, is_VBZ being_VBG considered_VBN for_IN breast_NN cancer_NN prevention_NN and_CC treatment_NN -LRB-_-LRB- Gonzalez-Angulo_NNP 
2006_CD -RRB-_-RRB- but_CC their_PRP$ roles_NNS in_IN breast_NN cancer_NN are_VBP unclear_JJ ._. 
2004_CD ,_, Dyck_FW et_FW al_FW ._. 
Leptin_NN and_CC adiponectin_NN are_VBP adipokines_NNS that_WDT relate_VBP strongly_RB to_TO obesity_NN and_CC insulin_NN resistance_NN -LRB-_-LRB- IR_NNP ;_: Pittas_NNP et_FW al_FW ._. 
While_IN it_PRP is_VBZ biologically_RB plausible_JJ that_IN leptin_NN increases_NNS postmenopausal_JJ breast_NN cancer_NN risk_NN ,_, epidemiological_JJ findings_NNS have_VBP been_VBN inconsistent_JJ -LRB-_-LRB- Neilson_NNP et_FW al._FW ._. 
2009_CD ,_, Wu_NNP et_FW al_FW ._. 
2009_CD ,_, Maccio_FW et_FW al_FW ._. 
2010_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, most_JJS studies_NNS in_IN postmenopausal_JJ women_NNS have_VBP shown_VBN significant_JJ inverse_JJ associations_NNS between_IN adiponectin_NN and_CC breast_NN cancer_NN risk_NN -LRB-_-LRB- Neilson_NNP et_FW al_FW ._. 
2010_CD -RRB-_-RRB- ._. 
2009_CD ,_, Maccio_FW et_FW al_FW ._. 
2009_CD ,_, Wu_NNP et_FW al_FW ._. 
While_IN it_PRP is_VBZ biologically_RB plausible_JJ that_IN leptin_NN increases_NNS postmenopausal_JJ breast_NN cancer_NN risk_NN ,_, epidemiological_JJ findings_NNS have_VBP been_VBN inconsistent_JJ -LRB-_-LRB- Neilson_NNP et_FW al_FW ._. 
In_IN contrast_NN ,_, most_JJS studies_NNS in_IN postmenopausal_JJ women_NNS have_VBP shown_VBN significant_JJ inverse_JJ associations_NNS between_IN adiponectin_NN and_CC breast_NN cancer_NN risk_NN -LRB-_-LRB- Neilson_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
Emerging_VBG research_NN suggests_VBZ that_IN the_DT ratio_NN of_IN adiponectin_NN :_: leptin_NN -LRB-_-LRB- A\/L_NNP or_CC conversely_RB ,_, L\/A_NNP -RRB-_-RRB- provides_VBZ a_DT surrogate_JJ measure_NN of_IN IR_NNP -LRB-_-LRB- Finucane_NNP et_FW al_FW ._. 
Since_IN all_DT of_IN these_DT proposed_VBN biomarkers_NNS are_VBP related_VBN to_TO IR_NNP and_CC obesity_NN ,_, we_PRP hypothesized_VBD that_IN their_PRP$ levels_NNS could_MD be_VB modified_VBN with_IN sustained_JJ physical_JJ activity_NN ._. 
Only_RB a_DT few_JJ studies_NNS have_VBP addressed_VBN this_DT question_NN previously_RB via_IN randomized_VBN controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNS -RRB-_-RRB- on_IN postmenopausal_JJ women_NNS -LRB-_-LRB- Neilson_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ,_, including_VBG one_CD RCT_NNP that_WDT focused_VBD on_IN breast_NN cancer_NN -LRB-_-LRB- Frank_NNP et_NNP al_NNP ._. 
2005_CD -RRB-_-RRB- ._. 
Aneed_VBN for_IN additional_JJ tightly_RB controlled_JJ ,_, long-term_JJ intervention_NN trials_NNS to_TO examine_VB the_DT impact_NN of_IN exercise_NN on_IN proposed_VBN biomarkers_NNS for_IN breast_NN cancer_NN risk_NN has_VBZ been_VBN widely_RB recognized_VBN -LRB-_-LRB- McTiernan_NNP et_FW al_FW ._. 
Previously_RB inactive_JJ postmenopausal_JJ women_NNS who_WP engaged_VBD in_IN a_DT moderate-to-vigorous_JJ intensity_NN exercise_NN program_NN experienced_VBD changes_NNS in_IN insulin_NN ,_, HOMA-IR_NNP ,_, leptin_NN ,_, and_CC adiponectin\/leptin_NN that_WDT might_MD decrease_VB the_DT risk_NN for_IN postmenopausal_JJ breast_NN cancer_NN ._. 
Canadian_NNP Breast_NNP Cancer_NNP Research_NNP Alliance_NNP #_# 017468Alberta_NNP Cancer_NNP Foundation_NNP #_# 22170IntroductionPhysical_JJ activity_NN reduces_VBZ the_DT risk_NN of_IN postmenopausal_JJ breast_NN cancer_NN -LRB-_-LRB- Monninkhof_FW et_FW al._FW ._. 
2007_CD ,_, World_NNP Cancer_NNP Research_NNP Fund_NNP and_CC the_DT American_NNP Institute_NNP for_IN Cancer_NNP Research_NNP 2007_CD ,_, Friedenreich_NNP 
2005_CD -RRB-_-RRB- showed_VBD no_DT difference_NN across_IN changes_NNS in_IN body_NN weight_NN ,_, percent_NN body_NN fat_JJ or_CC intra-abdominal_JJ adiposity_NN ,_, concordant_NN with_IN our_PRP$ findings_NNS for_IN insulin_NN ._. 
Early_RB epidemiological_JJ evidence_NN -LRB-_-LRB- Orenstein_NNP 
2008_CD -RRB-_-RRB- showed_VBD significantly_RB increased_VBN IGF1_NNP with_IN exercise_NN ._. 
2010_CD -RRB-_-RRB- with_IN one_CD exception_NN :_: that_IN RCT_NNP -LRB-_-LRB- Orsatti_NNP et_FW al_FW ._. 
Arecent_JJ review_NN also_RB suggested_VBD that_IN long-term_JJ exercise_NN may_MD actually_RB increase_VB circulating_VBG IGF1_NNP -LRB-_-LRB- Nindl_NNP 
2005_CD -RRB-_-RRB- ._. 
2009_CD -RRB-_-RRB- ,_, including_VBG one_CD RCT_NNP that_WDT focused_VBD on_IN breast_NN cancer_NN -LRB-_-LRB- Frank_NNP et_NNP al_NNP ._. 
Only_RB a_DT few_JJ studies_NNS have_VBP addressed_VBN this_DT question_NN previously_RB via_IN randomized_VBN controlled_JJ trials_NNS -LRB-_-LRB- RCTs_NNS -RRB-_-RRB- on_IN postmenopausal_JJ women_NNS -LRB-_-LRB- Neilson_NNP et_FW al_FW ._. 
Aneed_VBN for_IN additional_JJ tightly_RB controlled_JJ ,_, long-term_JJ intervention_NN trials_NNS to_TO examine_VB the_DT impact_NN of_IN exercise_NN on_IN proposed_VBN biomarkers_NNS for_IN breast_NN cancer_NN risk_NN has_VBZ been_VBN widely_RB recognized_VBN -LRB-_-LRB- McTiernan_NNP et_FW al._FW ._. 
1999_CD ,_, Friedenreich_NNP 2001_CD ,_, IARC_NNP Working_NNP Group_NNP 2002_CD ,_, Kushi_FW et_FW al_FW ._. 
2006_CD ,_, Physical_JJ Activity_NN Guidelines_NNS Advisory_NNP Committee_NNP 2008_CD -RRB-_-RRB- ._. 
5-LRB-_NNP Hosker_NNP et_FW al_FW ._. 
Asurrogate_JJ measure_NN of_IN whole_JJ body_NN insulin_NN sensitivity_NN and_CC 
2009_CD -RRB-_-RRB- ,_, only_RB one_CD trial_NN lead_NN by_IN McTiernan_NNP -LRB-_-LRB- Frank_NNP et_FW al_FW ._. 
2007_CD ,_, Arsenault_NNP et_FW al_FW ._. 
2005_CD ,_, Pi-Sunyer_NNP et_FW al_FW ._. 
2005_CD ,_, McTiernan_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- was_VBD of_IN comparable_JJ size_NN ,_, duration_NN and_CC scope_NN to_TO the_DT ALPHA_NNP Trial_NNP ._. 
In_IN contrast_NN to_TO the_DT other_JJ trials_NNS ,_, the_DT ALPHA_NNP Trial_NNP included_VBD healthy_JJ ,_, postmenopausal_JJ women_NNS with_IN a_DT BMI_NNP ranging_VBG from_IN 22_CD 
Early_RB epidemiological_JJ evidence_NN -LRB-_-LRB- Orenstein_NNP 
from_IN the_DT Physical_NNP Activity_NNP for_IN Total_NNP Health_NNP trial_NN ,_, -LRB-_-LRB- Irwin_NNP et_FW al_FW ._. 
d._NN 
05_CD -LRB-_-LRB- two-sided_JJ ;_: Rosner_NNP 1986_CD -RRB-_-RRB- and_CC s._VBD 2003_CD ,_, McTiernan_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- we_PRP had_VBD power_NN 
5if_JJ radiotherapy_NN occurred_VBD before_IN 10_CD years_NNS ,_, and_CC 0_CD ._. 
At_IN 1_CD 
2005_CD -RRB-_-RRB- ._. 
9if_IN it_PRP occurred_VBD later_RB ,_, the_DT risk_NN then_RB decreases_VBZ following_VBG a_DT symmetrical_JJ curve_NN ,_, consistent_JJ with_IN a_DT cell_NN killing_NN effect_NN -LRB-_-LRB- Sigurdson_FW et_FW al_FW ._. 
The_DT relative_JJ risk_NN for_IN doses_NNS of_IN about_IN 40_CD 
It_PRP should_MD be_VB mentioned_VBN that_IN in_IN a_DT cohort_NN of_IN patients_NNS developing_VBG secondary_JJ radiation-induced_JJ thyroid_NN tumors_NNS ,_, 11_CD of_IN 27_CD patients_NNS received_VBD chemotherapy_NN for_IN their_PRP$ primary_JJ tumor_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
Importantly_RB ,_, for_IN the_DT validity_NN of_IN the_DT data_NNS ,_, it_PRP was_VBD shown_VBN that_DT chemotherapy_NN for_IN the_DT first_JJ cancer_NN was_VBD not_RB associated_VBN with_IN thyroid_JJ cancer_NN risk_NN and_CC it_PRP did_VBD not_RB modify_VB the_DT effect_NN of_IN radiotherapy_NN -LRB-_-LRB- Sigurdson_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Our_PRP$ study_NN is_VBZ the_DT first_JJ transcriptome_NN analysis_NN of_IN post-radiotherapy_JJ radiation-induced_JJ thyroid_NN tumors_NNS ._. 
Finally_RB ,_, another_DT feature_NN of_IN exposure_NN of_IN the_DT thyroid_JJ gland_NN to_TO radiation_NN is_VBZ the_DT increased_VBN frequency_NN of_IN autoimmune_JJ dysfunctions_NNS ._. 
In_IN this_DT respect_NN ,_, an_DT immunoglobulin_JJ kappa_NN light_NN chain_NN variable_JJ region_NN -LRB-_-LRB- accession_NN number_NN L12079_NNP -RRB-_-RRB- was_VBD identified_VBN in_IN patients_NNS with_IN Graves_NNP '_POS disease_NN -LRB-_-LRB- Chazenbalk_NNP et_FW al._FW ._. 
1993_CD -RRB-_-RRB- ,_, as_RB well_RB as_IN genes_NNS involved_VBN in_IN T_NNP lymphocyte_NN function_NN -LRB-_-LRB- POU2AF1_CD ,_, CLECL1_CD ,_, IL2RG_CD ,_, CCL22_CD ,_, MADCAM1_CD ,_, LY75_CD ,_, and_CC TRAT1_CD -RRB-_-RRB- were_VBD deregulated_VBN and_CC thus_RB could_MD also_RB be_VB related_VBN to_TO the_DT immune_JJ thyroid_JJ status_NN of_IN radiation-induced_JJ tumors_NNS ._. 
The_DT WNT_NNP \/_NN 
-LRB-_-LRB- 2007_CD -RRB-_-RRB- ,_, we_PRP found_VBD that_IN radiation-induced_JJ tumors_NNS are_VBP imprinted_VBN by_IN an_DT oxidative_JJ stress_NN hallmark_NN since_IN deregulated_VBN genes_NNS such_JJ as_IN CFL1_NNP ,_, CLU_NNP ,_, DHCR24_NNP ,_, FMOD_NNP ,_, GSTM1-2_NNP ,_, and_CC PRNP_NNP are_VBP involved_VBN in_IN sensitivity_NN to_TO H_NNP 2_CD O_NNP 2_CD or_CC ionizing_VBG radiation_NN exposure_NN ._. 
Interestingly_RB ,_, chronic_JJ oxidative_JJ stress_NN is_VBZ known_VBN to_TO provoke_VB increasing_VBG chromosomal_JJ instability_NN -LRB-_-LRB- Abdel-Rahman_NNP 2008_CD -RRB-_-RRB- and_CC we_PRP observed_VBD that_IN genes_NNS regulating_VBG the_DT G2\/M_NNP phase_NN and\/or_CC checkpoints_NNS -LRB-_-LRB- PTTG1_NNP ,_, SPAG5_NNP ,_, DNAH9_NNP ,_, C13orf3_NNP ,_, NUP153_NNP ,_, CENPE_NNP ,_, CDCA8_CD ,_, STK10_CD ,_, or_CC NDC80_CD -RRB-_-RRB- were_VBD differentially_RB expressed_VBN in_IN radiation-induced_JJ tumors_NNS ._. 
One_CD of_IN the_DT central_JJ players_NNS in_IN the_DT cellular_JJ response_NN to_TO DNA_NN damage_NN and_CC in_IN the_DT maintenance_NN of_IN genome_NN integrity_NN following_VBG cell_NN exposure_NN to_TO oxidative_JJ stress_NN is_VBZ the_DT tumor_NN suppressor_NN p53_NN ._. 
Preprocessing_VBG of_IN microarrays_NNS The_DT procedure_NN for_IN array_NN scanning_VBG ,_, calculation_NN of_IN fluorescence_NN intensities_NNS ,_, data_NNS normalization_NN ,_, and_CC statistical_JJ analysis_NN were_VBD performed_VBN as_IN described_VBN previously_RB -LRB-_-LRB- Chevillard_NNP et_FW al_FW ._. 
2004_CD -RRB-_-RRB- with_IN modifications_NNS -LRB-_-LRB- Bastide_FW et_FW al._FW ._. 
2009_CD ,_, Daino_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ._. 
All_DT data_NN is_VBZ deposited_VBN in_IN Array_NNP Express_NNP database_NN -LRB-_-LRB- 
2010_CD -RRB-_-RRB- ,_, but_CC without_IN blind_JJ validation_NN of_IN the_DT signature_NN ._. 
2007_CD ,_, Stein_NNP et_NNP al_NNP ._. 
Others_NNS studies_NNS found_VBD radiation-induced_JJ signatures_NNS in_IN post-Chernobyl_NNP PTC_NNP -LRB-_-LRB- Port_NNP et_FW al_FW ._. 
Arecent_JJ study_NN compared_VBD cell_NN cycle_NN protein_NN expression_NN in_IN sporadic_JJ and_CC post-radiotherapy_JJ PTC_NNP ,_, but_CC none_NN of_IN the_DT tested_VBN markers_NNS could_MD be_VB associated_VBN with_IN the_DT etiology_NN -LRB-_-LRB- Achille_FW et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ,_, while_IN combinations_NNS of_IN protein_NN markers_NNS such_JJ as_IN matrix_NN metalloproteinases_NNS ,_, cathepsins_NNS ,_, and_CC neurotrophic_JJ tyrosine_NN kinase_NN receptor_NN 1_CD allowed_VBN discrimination_NN of_IN post-Chernobyl_NNP PTC_NNP as_IN a_DT function_NN of_IN etiology_NN by_IN immunostaining_VBG -LRB-_-LRB- Boltze_FW et_FW al_FW ._. 
Interestingly_RB ,_, genes_NNS known_VBN to_TO connect_VB the_DT WNT_NNP pathway_NN with_IN cellular_JJ response_NN to_TO hypoxia_NN -LRB-_-LRB- ARD1A_NNP ;_: Lim_NNP et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ,_, to_TO the_DT EGFR_NNP ,_, TGF_NNP ,_, and_CC NOCHT_NNP -LRB-_-LRB- TLE2_NNP -RRB-_-RRB- pathways_NNS -LRB-_-LRB- Buscarlet_NNP 
Arecent_JJ study_NN compared_VBD cell_NN cycle_NN protein_NN expression_NN in_IN sporadic_JJ and_CC post-radiotherapy_JJ PTC_NNP ,_, but_CC none_NN of_IN the_DT tested_VBN markers_NNS could_MD be_VB associated_VBN with_IN the_DT etiology_NN -LRB-_-LRB- Achille_FW et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, while_IN combinations_NNS of_IN protein_NN markers_NNS such_JJ as_IN matrix_NN metalloproteinases_NNS ,_, cathepsins_NNS ,_, and_CC neurotrophic_JJ tyrosine_NN kinase_NN receptor_NN 1_CD allowed_VBN discrimination_NN of_IN post-Chernobyl_NNP PTC_NNP as_IN a_DT function_NN of_IN etiology_NN by_IN immunostaining_VBG -LRB-_-LRB- Boltze_FW et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
Together_RB ,_, these_DT studies_NNS must_MD be_VB considered_VBN as_IN preliminary_JJ and_CC others_NNS should_MD be_VB analyzed_VBN to_TO establish_VB a_DT robust_JJ characterization_NN of_IN the_DT gene_NN expression_NN differences_NNS between_IN sporadic_JJ and_CC radiation-induced_JJ PTC_NNP -LRB-_-LRB- rPTC_NNP -RRB-_-RRB- ._. 
Ahigher_JJ incidence_NN of_IN thyroid_NN cancer_NN has_VBZ been_VBN reported_VBN in_IN epidemiological_JJ studies_NNS after_IN either_DT internal_JJ or_CC external_JJ exposure_NN to_TO radiation_NN -LRB-_-LRB- Ron_NNP et_NNP al_NNP ._. 
1995_CD ,_, Cardis_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Apooled_JJ analysis_NN of_IN seven_CD studies_NNS established_VBN that_IN the_DT excess_JJ relative_JJ risk_NN of_IN thyroid_NN cancer_NN in_IN subjects_NNS irradiated_VBN at_IN a_DT young_JJ age_NN was_VBD very_RB high_JJ 
All_DT patients_NNS were_VBD Caucasian_JJ except_IN one_CD who_WP was_VBD African_JJ black_NN ._. 
Radiation_NNP exposure_NN was_VBD specifically_RB investigated_VBN in_IN each_DT patient_NN by_IN examining_VBG their_PRP$ medical_JJ records_NNS and\/or_CC by_IN postal_JJ contact_NN ._. 
Tumors_NNS from_IN patients_NNS who_WP were_VBD exposed_VBN to_TO external_JJ radiation_NN were_VBD considered_VBN as_IN radiation-induced_JJ according_VBG to_TO Cahan_NNP 's_POS criteria_NNS -LRB-_-LRB- Cahan_NNP et_FW al._FW ._. 
1948_CD -RRB-_-RRB- :_: 1_LS -RRB-_-RRB- after_IN radiotherapy_NN ,_, the_DT second_JJ neoplasm_NN must_MD arise_VB in_IN the_DT irradiated_JJ field_NN and_CC be_VB proved_VBN histologically_RB ;_: 2_LS -RRB-_-RRB- a_DT latent_NN period_NN of_IN several_JJ years_NNS must_MD have_VB elapsed_VBN between_IN radiation_NN exposure_NN and_CC development_NN of_IN the_DT second_JJ neoplasm_NN ;_: and_CC 3_CD -RRB-_-RRB- the_DT second_JJ tumor_NN must_MD be_VB histologically_RB different_JJ from_IN the_DT first_JJ tumor_NN ._. 
2009_CD -RRB-_-RRB- ._. 
2001_CD ,_, Castellone_NNP et_NNP al_NNP ._. 
The_DT WNT_NNP \/_NN 
From_IN the_DT enlarged_JJ set_NN :_: EFNA1_NNP ,_, EIF2AK2_NNP ,_, FAM38A_NNP ,_, MED1_NNP ,_, MGEF8_NNP ,_, PPL_NNP ,_, SCARA3_NNP ,_, SMO_NNP ,_, and_CC ZFHX4_NNP -RRB-_-RRB- ,_, several_JJ of_IN these_DT genes_NNS could_MD be_VB potential_JJ markers_NNS of_IN radiation-induced_JJ thyroid_JJ tumors_NNS ,_, independently_RB of_IN the_DT histology_NN and_CC the_DT internal_JJ 
The_DT MDM2_NNP gene_NN is_VBZ overexpressed_VBN in_IN radiation-induced_JJ tumors_NNS along_IN with_IN genes_NNS regulating_VBG its_PRP$ function_NN or_CC stabilization_NN ,_, such_JJ as_IN KAT5_NNP ,_, TWIST2_CD ,_, TSPYL2_CD ,_, MAPKAPK2_CD ,_, and_CC HSPB1_NNP ._. 
Recent_JJ data_NNS have_VBP pointed_VBN to_TO a_DT link_NN between_IN cancer_NN ,_, DNA_NN damage_NN response_NN ,_, and_CC circadian_JJ clock_NN regulation_NN -LRB-_-LRB- Sahar_NNP 
2-RRB-_CD ._. 
Molecular_JJ specificities_NNS of_IN post-radiotherapy-induced_JJ tumors_NNS Deregulated_VBD genes_NNS in_IN radiation-induced_JJ tumors_NNS are_VBP mostly_RB involved_VBN in_IN molecular_JJ mechanisms_NNS such_JJ as_IN cellular_JJ response_NN to_TO oxidative_JJ stress_NN and_CC irradiation_NN ,_, response_NN to_TO hypoxia_NN ,_, regulation_NN of_IN p53_NN function_NN ,_, immune_JJ response_NN ,_, and_CC signal_NN transduction_NN pathways_NNS including_VBG mitogen-activated_JJ protein_NN kinase_NN -LRB-_-LRB- MAPK_NNP -RRB-_-RRB- ,_, epidermal_JJ growth_NN factor_NN receptor_NN -LRB-_-LRB- EGFR_NNP -RRB-_-RRB- ,_, RAC\/CDC42_NNP ,_, hedgehog_NN ,_, transforming_VBG growth_NN factor_NN -LRB-_-LRB- TGF_NNP -RRB-_-RRB- \/_CD bone_NN morphogenetic_JJ protein_NN -LRB-_-LRB- BMP_NN -RRB-_-RRB- ,_, calcium_NN signaling_VBG ,_, and_CC WNT_NNP canonical_JJ and_CC noncanonical_JJ pathways_NNS -LRB-_-LRB- Fig_NNP ._. 
The_DT WNT_NNP \/_NN 
2007_CD -RRB-_-RRB- ._. 
2004_CD ,_, Colonna_NNP et_FW al_FW ._. 
Some_DT data_NNS suggest_VBP that_IN this_DT increase_NN is_VBZ at_IN least_JJS partly_RB related_VBN to_TO the_DT routine_JJ screening_NN of_IN thyroid_JJ nodules_NNS using_VBG neck_NN ultrasound_NN and_CC fine_JJ needle_NN biopsy_NN ,_, which_WDT permit_VBP the_DT detection_NN of_IN small_JJ papillary_JJ carcinomas_NNS that_WDT would_MD otherwise_RB have_VB gone_VBN undetected_JJ -LRB-_-LRB- Leenhardt_FW et_FW al_FW ._. 
This_DT high_JJ prevalence_NN of_IN such_JJ small_JJ cancers_NNS had_VBD already_RB been_VBN reported_VBN in_IN autopsy_NN studies_NNS -LRB-_-LRB- Harach_FW et_FW al._FW ._. 
1985_CD ,_, Yamamoto_NNP et_NNP al_NNP ._. 
1990_CD -RRB-_-RRB- ._. 
However_RB ,_, it_PRP is_VBZ not_RB possible_JJ to_TO exclude_VB the_DT possibility_NN that_IN some_DT of_IN these_DT thyroid_JJ tumors_NNS could_MD have_VB been_VBN radiation-induced_JJ ._. 
One_CD of_IN the_DT central_JJ players_NNS in_IN the_DT cellular_JJ response_NN to_TO DNA_NN damage_NN and_CC in_IN the_DT maintenance_NN of_IN genome_NN integrity_NN following_VBG cell_NN exposure_NN to_TO oxidative_JJ stress_NN is_VBZ the_DT tumor_NN suppressor_NN p53_NN ._. 
In_IN thyroid_NN cancer_NN ,_, a_DT very_RB low_JJ frequency_NN of_IN TP53_CD mutations_NNS was_VBD observed_VBN in_IN sporadic_JJ and_CC in_IN post-Chernobyl_JJ tumors_NNS -LRB-_-LRB- Hillebrandt_NNP et_FW al._FW ._. 
1996_CD ,_, Nikiforov_NNP et_FW al_FW ._. 
1996_CD -RRB-_-RRB- ._. 
However_RB ,_, p53_NN protein_NN overexpression_NN was_VBD described_VBN ,_, in_IN PTC_NNP and_CC anaplastic_JJ thyroid_JJ carcinomas_NNS ,_, not_RB associated_VBN with_IN gene_NN mutation_NN ,_, suggesting_VBG that_IN other_JJ mechanisms_NNS may_MD regulate_VB p53_NN in_IN thyroid_JJ tumors_NNS -LRB-_-LRB- Soares_FW et_FW al_FW ._. 
2002_CD ,_, Moya_FW et_FW al_FW ._. 
In_IN parallel_NN ,_, genes_NNS associated_VBN with_IN thyroid_JJ dysfunction_NN or_CC susceptibility_NN to_TO thyroid_JJ disease_NN ,_, such_JJ as_IN IGFBP3_NNP ,_, DUOX2_NNP ,_, NKX2_NNP 1\/TTF1_NNP ,_, GNA11_NNP ,_, and_CC SLC26A4\/pendrin_NNP -LRB-_-LRB- Moreno_NNP et_FW al_FW ._. 
2006_CD ,_, Kero_FW et_FW al._FW ._. 
2007_CD ,_, Kopp_NNP et_FW al_FW ._. 
2008_CD ,_, Kursunluoglu_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, or_CC with_IN other_JJ autoimmune_JJ diseases_NNS ,_, such_JJ as_IN IL17B_NNP ,_, IRF4_NNP ,_, LAIR2_NNP ,_, and_CC RC3H1_NNP ,_, were_VBD also_RB deregulated_VBN ._. 
2006_CD ,_, Kero_FW et_FW al_FW ._. 
2002_CD ,_, Moya_FW et_FW al_FW ._. 
In_IN parallel_NN ,_, genes_NNS associated_VBN with_IN thyroid_JJ dysfunction_NN or_CC susceptibility_NN to_TO thyroid_JJ disease_NN ,_, such_JJ as_IN IGFBP3_NNP ,_, DUOX2_NNP ,_, NKX2_NNP 1\/TTF1_NNP ,_, GNA11_NNP ,_, and_CC SLC26A4\/pendrin_NNP -LRB-_-LRB- Moreno_NNP et_FW al_FW ._. 
2007_CD ,_, Kopp_NNP et_FW al._FW ._. 
2008_CD ,_, Kursunluoglu_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, or_CC with_IN other_JJ autoimmune_JJ diseases_NNS ,_, such_JJ as_IN IL17B_NNP ,_, IRF4_NNP ,_, LAIR2_NNP ,_, and_CC RC3H1_NNP ,_, were_VBD also_RB deregulated_VBN ._. 
This_DT included_VBD some_DT highly_RB discriminating_VBG genes_NNS of_IN the_DT signature_NN ,_, such_JJ as_IN MAPKAPK2_NNP ,_, PARP1_NNP ,_, IFI16_NNP ,_, PTTG1_NNP ,_, RAD32B_NNP ,_, and_CC BHLHE40_NNP ,_, which_WDT participate_VBP in_IN cellular_JJ response_NN to_TO stress_NN ,_, DNA_NN damage_NN ,_, DNA_NN repair_NN ,_, and_CC genetic_JJ stability_NN ._. 
DHCR24_NNP ,_, which_WDT protects_VBZ p53_NN against_IN MDM2-dependent_JJ degradation_NN following_VBG oxidative_JJ stress_NN -LRB-_-LRB- Kuehnle_NNP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ,_, has_VBZ already_RB been_VBN found_VBN to_TO be_VB deregulated_VBN in_IN Chernobyl_NNP tumors_NNS -LRB-_-LRB- Detours_NNPS et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
The_DT MDM2_NNP gene_NN is_VBZ overexpressed_VBN in_IN radiation-induced_JJ tumors_NNS along_IN with_IN genes_NNS regulating_VBG its_PRP$ function_NN or_CC stabilization_NN ,_, such_JJ as_IN KAT5_NNP ,_, TWIST2_CD ,_, TSPYL2_CD ,_, MAPKAPK2_CD ,_, and_CC HSPB1_NNP ._. 
2007_CD ,_, Kopp_NNP et_FW al_FW ._. 
2006_CD ,_, Kero_FW et_FW al_FW ._. 
2002_CD ,_, Moya_FW et_FW al_FW ._. 
In_IN parallel_NN ,_, genes_NNS associated_VBN with_IN thyroid_JJ dysfunction_NN or_CC susceptibility_NN to_TO thyroid_JJ disease_NN ,_, such_JJ as_IN IGFBP3_NNP ,_, DUOX2_NNP ,_, NKX2_NNP 1\/TTF1_NNP ,_, GNA11_NNP ,_, and_CC SLC26A4\/pendrin_NNP -LRB-_-LRB- Moreno_NNP et_FW al_FW ._. 
2008_CD ,_, Kursunluoglu_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ,_, or_CC with_IN other_JJ autoimmune_JJ diseases_NNS ,_, such_JJ as_IN IL17B_NNP ,_, IRF4_NNP ,_, LAIR2_NNP ,_, and_CC RC3H1_NNP ,_, were_VBD also_RB deregulated_VBN ._. 
This_DT has_VBZ led_VBN to_TO debate_VB concerning_VBG a_DT potential_JJ link_NN with_IN changes_NNS in_IN environmental_JJ exposure_NN linked_VBN to_TO nuclear_JJ tests_NNS ,_, the_DT nuclear_JJ industry_NN ,_, and_CC ,_, in_IN Western_NNP Europe_NNP ,_, Chernobyl_NNP disaster_NN fallout_NN ._. 
Some_DT data_NNS suggest_VBP that_IN this_DT increase_NN is_VBZ at_IN least_JJS partly_RB related_VBN to_TO the_DT routine_JJ screening_NN of_IN thyroid_JJ nodules_NNS using_VBG neck_NN ultrasound_NN and_CC fine_JJ needle_NN biopsy_NN ,_, which_WDT permit_VBP the_DT detection_NN of_IN small_JJ papillary_JJ carcinomas_NNS that_WDT would_MD otherwise_RB have_VB gone_VBN undetected_JJ -LRB-_-LRB- Leenhardt_FW et_FW al._FW ._. 
2004_CD ,_, Colonna_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
This_DT high_JJ prevalence_NN of_IN such_JJ small_JJ cancers_NNS had_VBD already_RB been_VBN reported_VBN in_IN autopsy_NN studies_NNS -LRB-_-LRB- Harach_FW et_FW al_FW ._. 
Radiation-induced_JJ thyroid_NN tumors_NNS have_VBP no_DT specific_JJ histological_JJ characteristics_NNS -LRB-_-LRB- Rubino_FW et_FW al_FW ._. 
However_RB ,_, it_PRP is_VBZ not_RB possible_JJ to_TO exclude_VB the_DT possibility_NN that_IN some_DT of_IN these_DT thyroid_JJ tumors_NNS could_MD have_VB been_VBN radiation-induced_JJ ._. 
2002_CD ,_, Williams_NNP et_NNP al._NNP ._. 
2008_CD -RRB-_-RRB- ._. 
They_PRP are_VBP either_DT follicular_JJ thyroid_NN adenomas_NNS -LRB-_-LRB- FTA_NNP -RRB-_-RRB- or_CC papillary_JJ thyroid_JJ carcinomas_NNS -LRB-_-LRB- PTC_NNP -RRB-_-RRB- ._. 
These_DT histological_JJ subtypes_NNS are_VBP also_RB the_DT most_RBS frequent_JJ sporadic_JJ thyroid_NN tumors_NNS ._. 
02_CD 
This_DT high_JJ prevalence_NN of_IN such_JJ small_JJ cancers_NNS had_VBD already_RB been_VBN reported_VBN in_IN autopsy_NN studies_NNS -LRB-_-LRB- Harach_FW et_FW al_FW ._. 
1985_CD ,_, Yamamoto_NNP et_NNP al._NNP ._. 
1990_CD -RRB-_-RRB- ._. 
However_RB ,_, it_PRP is_VBZ not_RB possible_JJ to_TO exclude_VB the_DT possibility_NN that_IN some_DT of_IN these_DT thyroid_JJ tumors_NNS could_MD have_VB been_VBN radiation-induced_JJ ._. 
Others_NNS studies_NNS found_VBD radiation-induced_JJ signatures_NNS in_IN post-Chernobyl_NNP PTC_NNP -LRB-_-LRB- Port_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
However_RB ,_, the_DT authors_NNS were_VBD able_JJ to_TO classify_VB their_PRP$ series_NN of_IN tumors_NNS by_IN using_VBG a_DT signature_NN that_WDT was_VBD previously_RB found_VBN to_TO discriminate_JJ between_IN irradiated_JJ -_: and_CC hydrogen-peroxide-treated_JJ lymphocytes_NNS -LRB-_-LRB- Detours_NNPS et_FW al_FW ._. 
2007_CD ,_, Stein_NNP et_NNP al._NNP ._. 
2010_CD -RRB-_-RRB- ,_, but_CC without_IN blind_JJ validation_NN of_IN the_DT signature_NN ._. 
Arecent_JJ study_NN compared_VBD cell_NN cycle_NN protein_NN expression_NN in_IN sporadic_JJ and_CC post-radiotherapy_JJ PTC_NNP ,_, but_CC none_NN of_IN the_DT tested_VBN markers_NNS could_MD be_VB associated_VBN with_IN the_DT etiology_NN -LRB-_-LRB- Achille_FW et_FW al_FW ._. 
Due_JJ to_TO the_DT high_JJ frequency_NN of_IN sporadic_JJ thyroid_JJ tumors_NNS in_IN the_DT general_JJ population_NN ,_, we_PRP followed_VBD very_RB stringent_JJ criteria_NNS to_TO minimize_VB the_DT risk_NN of_IN including_VBG a_DT sporadic_JJ tumor_NN -LRB-_-LRB- S-tumor_JJ -RRB-_-RRB- in_IN the_DT group_NN of_IN R-tumors_NNS :_: we_PRP strictly_RB followed_VBD Cahan_NNP 's_POS criteria_NNS for_IN R-tumor_JJ selection_NN ._. 
Moreover_RB ,_, these_DT tumors_NNS should_MD have_VB developed_VBN in_IN children_NNS who_WP were_VBD exposed_VBN to_TO radiotherapy_NN while_IN younger_JJR than_IN 15_CD ,_, since_IN this_DT corresponds_NNS to_TO the_DT period_NN of_IN highest_JJS thyroid_JJ radiation_NN sensitivity_NN -LRB-_-LRB- Steliarova-Foucher_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Regarding_VBG the_DT risk_NN as_IN a_DT function_NN of_IN the_DT dose_NN received_VBN at_IN the_DT thyroid_JJ gland_NN ,_, it_PRP was_VBD shown_VBN that_IN ,_, in_IN this_DT age_NN range_NN ,_, the_DT relative_JJ risk_NN at_IN 1_CD 
For_IN all_DT patients_NNS who_WP received_VBD radiotherapy_NN for_IN a_DT primary_JJ cancer_NN ,_, the_DT doses_NNS received_VBN by_IN the_DT thyroid_JJ gland_NN were_VBD calculated_VBN and_CC are_VBP presented_VBN in_IN Table_NNP 1_CD ._. 
Mutation_NNP analysisRET\/PTC1_NNP and_CC RET\/PTC3_NNP rearrangements_NNS were_VBD detected_VBN by_IN RT-PCR_NNP as_IN described_VBN in_IN Smida_NNP et_FW al._FW ._. 
-LRB-_-LRB- 1999_CD -RRB-_-RRB- ._. 
Mutations_NNS of_IN BRAF_NNP and_CC HRAS_NNP ,_, KRAS_NNP ,_, and_CC NRAS_NNP genes_NNS were_VBD analyzed_VBN by_IN cDNA_NNP sequencing_VBG -LRB-_-LRB- Beckman_NNP Coulter_NNP Genomics_NNP -LRB-_-LRB- Cogenics_NNP -RRB-_-RRB- ,_, Grenoble_NNP ,_, France_NNP -RRB-_-RRB- after_IN PCR_NNP amplification_NN ._. 
1996_CD -RRB-_-RRB- ._. 
1996_CD ,_, Nikiforov_NNP et_FW al_FW ._. 
In_IN thyroid_NN cancer_NN ,_, a_DT very_RB low_JJ frequency_NN of_IN TP53_CD mutations_NNS was_VBD observed_VBN in_IN sporadic_JJ and_CC in_IN post-Chernobyl_JJ tumors_NNS -LRB-_-LRB- Hillebrandt_FW et_FW al_FW ._. 
However_RB ,_, p53_NN protein_NN overexpression_NN was_VBD described_VBN ,_, in_IN PTC_NNP and_CC anaplastic_JJ thyroid_JJ carcinomas_NNS ,_, not_RB associated_VBN with_IN gene_NN mutation_NN ,_, suggesting_VBG that_IN other_JJ mechanisms_NNS may_MD regulate_VB p53_NN in_IN thyroid_JJ tumors_NNS -LRB-_-LRB- Soares_FW et_FW al._FW ._. 
1994_CD ,_, Malaguarnera_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
In_IN radiation-induced_JJ tumors_NNS ,_, a_DT decrease_NN in_IN TP53_CD gene_NN expression_NN was_VBD observed_VBN ,_, but_CC it_PRP was_VBD not_RB selected_VBN in_IN the_DT highly_RB discriminating_VBG signature_NN -LRB-_-LRB- Fig_NNP ._. 
Some_DT data_NNS suggest_VBP that_IN this_DT increase_NN is_VBZ at_IN least_JJS partly_RB related_VBN to_TO the_DT routine_JJ screening_NN of_IN thyroid_JJ nodules_NNS using_VBG neck_NN ultrasound_NN and_CC fine_JJ needle_NN biopsy_NN ,_, which_WDT permit_VBP the_DT detection_NN of_IN small_JJ papillary_JJ carcinomas_NNS that_WDT would_MD otherwise_RB have_VB gone_VBN undetected_JJ -LRB-_-LRB- Leenhardt_FW et_FW al_FW ._. 
2004_CD ,_, Colonna_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
This_DT high_JJ prevalence_NN of_IN such_JJ small_JJ cancers_NNS had_VBD already_RB been_VBN reported_VBN in_IN autopsy_NN studies_NNS -LRB-_-LRB- Harach_FW et_FW al_FW ._. 
05_CD 
Molecular_JJ differences_NNS between_IN sporadic_JJ and_CC radiation-induced_JJ thyroid_NN tumors_NNS were_VBD sought_VBN using_VBG microarray_NN transcriptome_NN analysis_NN ._. 
The_DT first_JJ study_NN ,_, including_VBG sporadic_JJ and_CC post-Chernobyl_JJ PTC_NNP ,_, did_VBD not_RB show_VB any_DT specific_JJ radiation-induced_JJ gene_NN expression_NN signature_NN -LRB-_-LRB- Detours_NNPS et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
However_RB ,_, the_DT authors_NNS were_VBD able_JJ to_TO classify_VB their_PRP$ series_NN of_IN tumors_NNS by_IN using_VBG a_DT signature_NN that_WDT was_VBD previously_RB found_VBN to_TO discriminate_JJ between_IN irradiated_JJ -_: and_CC hydrogen-peroxide-treated_JJ lymphocytes_NNS -LRB-_-LRB- Detours_NNPS et_FW al_FW ._. 
Supplementary_NNP Table_NNP 1_CD ,_, see_VBP section_NN on_IN supplementary_JJ data_NNS given_VBN at_IN the_DT end_NN of_IN this_DT article_NN ._. 
RNA_NNP extraction_NN ,_, labeling_VBG ,_, and_CC hybridizationThe_NNP protocol_NN for_IN RNA_NNP extraction_NN ,_, RNA_NNP amplification_NN ,_, and_CC labeling_VBG was_VBD as_IN described_VBN in_IN Daino_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2009_CD -RRB-_-RRB- ._. 
Quality_NNP of_IN RNA_NNP was_VBD assessed_VBN using_VBG the_DT RNA_NNP 6000_CD Nano_NNP Lab-On-Chip_NNP as_IN developed_VBN on_IN the_DT Agilent_NNP 2100_CD Bioanalyzer_NNP device_NN -LRB-_-LRB- Agilent_NNP Technologies_NNP ,_, Palo_NNP Alto_NNP ,_, CA_NNP ,_, USA_NNP -RRB-_-RRB- ._. 
2004_CD -RRB-_-RRB- with_IN modifications_NNS -LRB-_-LRB- Bastide_FW et_FW al_FW ._. 
Preprocessing_VBG of_IN microarrays_NNS The_DT procedure_NN for_IN array_NN scanning_VBG ,_, calculation_NN of_IN fluorescence_NN intensities_NNS ,_, data_NNS normalization_NN ,_, and_CC statistical_JJ analysis_NN were_VBD performed_VBN as_IN described_VBN previously_RB -LRB-_-LRB- Chevillard_NNP et_FW al_FW ._. 
2009_CD ,_, Daino_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
All_DT data_NN is_VBZ deposited_VBN in_IN Array_NNP Express_NNP database_NN -LRB-_-LRB- 
At_IN the_DT time_NN of_IN the_DT blind_JJ classification_NN the_DT tumor_NN histology_NN ,_, but_CC no_DT radiation_NN exposure_NN history_NN ,_, was_VBD known_VBN ._. 
Written_VBN informed_JJ consent_NN was_VBD obtained_VBN from_IN all_DT patients_NNS at_IN the_DT Institut_NNP Gustave_NNP Roussy_NNP and_CC the_DT study_NN was_VBD performed_VBN in_IN accordance_NN with_IN protocols_NNS previously_RB approved_VBN by_IN the_DT ethics_NNS committee_NN of_IN Bic_NNP 
Technical_NNP data_NNS concerning_VBG the_DT radiotherapy_NN procedure_NN were_VBD obtained_VBN from_IN radiotherapy_NN records_NNS ._. 
-LRB-_-LRB- 1996_CD ,_, 2009_CD -RRB-_-RRB- ._. 
Direct_JJ individual_JJ radiotherapy_NN dose_NN calculations_NNS were_VBD performed_VBN using_VBG the_DT homemade_JJ Dos_EG_NNP software_NN package_NN -LRB-_-LRB- Diallo_FW et_FW al._FW ._. 
1996_CD -RRB-_-RRB- ._. 
For_IN each_DT patient_NN ,_, a_DT simple_JJ mathematical_JJ phantom_JJ anatomy_NN was_VBD generated_VBN according_VBG to_TO patient_JJ dimensions_NNS ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT first_JJ study_NN ,_, including_VBG sporadic_JJ and_CC post-Chernobyl_JJ PTC_NNP ,_, did_VBD not_RB show_VB any_DT specific_JJ radiation-induced_JJ gene_NN expression_NN signature_NN -LRB-_-LRB- Detours_NNPS et_FW al_FW ._. 
However_RB ,_, the_DT authors_NNS were_VBD able_JJ to_TO classify_VB their_PRP$ series_NN of_IN tumors_NNS by_IN using_VBG a_DT signature_NN that_WDT was_VBD previously_RB found_VBN to_TO discriminate_JJ between_IN irradiated_JJ -_: and_CC hydrogen-peroxide-treated_JJ lymphocytes_NNS -LRB-_-LRB- Detours_NNPS et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
Others_NNS studies_NNS found_VBD radiation-induced_JJ signatures_NNS in_IN post-Chernobyl_NNP PTC_NNP -LRB-_-LRB- Port_NNP et_FW al_FW ._. 
2007_CD ,_, Stein_NNP et_NNP al_NNP ._. 
-LRB-_-LRB- 2007_CD -RRB-_-RRB- ,_, suggesting_VBG common_JJ deregulated_VBN pathways_NNS in_IN post-radiotherapy_JJ and_CC post-Chernobyl_JJ tumors_NNS ._. 
Genes_NNS such_JJ as_IN ABI2_NNP ,_, COL4A5_NNP ,_, FAT3_NNP ,_, IGFBP3_NNP ,_, KRTAP3-2_NNP ,_, and_CC SPOCK1_NNP and_CC several_JJ immunoglobulin_NN chains_NNS were_VBD deregulated_VBN in_IN post-radiotherapy_JJ tumors_NNS ,_, while_IN genes_NNS of_IN the_DT same_JJ family_NN and\/or_CC function_NN ,_, such_JJ as_IN ABI3_NNP ,_, COL4A6_NNP ,_, FAT2_NNP ,_, IGFBP1_NNP ,_, KRTAP2-1_NNP ,_, KRTAP2-4_NNP ,_, SPOCK2_NNP and_CC other_JJ immunoglobulin_NN chains_NNS ,_, were_VBD also_RB deregulated_VBN in_IN the_DT study_NN of_IN Port_NNP et_FW al_FW ._. 
Since_IN we_PRP also_RB observed_VBD genes_NNS in_IN common_JJ with_IN another_DT previously_RB published_VBN post-Chernobyl_JJ series_NN of_IN thyroid_JJ tumors_NNS -LRB-_-LRB- Detours_NNPS et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ,_, -LRB-_-LRB- genes_NNS from_IN the_DT signature_NN :_: C4A_NNP ,_, CLU_NNP ;_: DCI_NNP ,_, DHCR24_NNP ,_, EGFR_NNP ,_, EGR3_CD ,_, GTF2H2_CD ,_, ICAM3_CD ,_, NRIP1_CD ,_, PLA2R1_CD ,_, and_CC RPS19_NNP ._. 
2008_CD -RRB-_-RRB- ,_, to_TO the_DT EGFR_NNP ,_, TGF_NNP ,_, and_CC NOCHT_NNP -LRB-_-LRB- TLE2_NNP -RRB-_-RRB- pathways_NNS -LRB-_-LRB- Buscarlet_NNP 
DHCR24_NNP ,_, which_WDT protects_VBZ p53_NN against_IN MDM2_NNP -_: dependent_JJ degradation_NN following_VBG oxidative_JJ stress_NN -LRB-_-LRB- Kuehnle_NNP et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ,_, has_VBZ already_RB been_VBN found_VBN to_TO be_VB deregulated_VBN in_IN Chernobyl_NNP tumors_NNS -LRB-_-LRB- Detours_NNPS et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
The_DT MDM2_NNP gene_NN is_VBZ overexpressed_VBN in_IN radiation-induced_JJ tumors_NNS along_IN with_IN genes_NNS regulating_VBG its_PRP$ function_NN or_CC stabilization_NN ,_, such_JJ as_IN KAT5_NNP ,_, TWIST2_CD ,_, TSPYL2_CD ,_, MAPKAPK2_CD ,_, and_CC HSPB1_NNP ._. 
Calculation_NN of_IN the_DT dose_NN received_VBN by_IN the_DT thyroid_JJ gland_NN The_DT approach_NN and_CC software_NN used_VBN for_IN retrospective_JJ dose_NN evaluations_NNS has_VBZ been_VBN previously_RB detailed_VBN in_IN Diallo_NNP et_FW al_FW ._. 
-LRB-_-LRB- 1996_CD ,_, 2009_CD -RRB-_-RRB- ._. 
Technical_NNP data_NNS concerning_VBG the_DT radiotherapy_NN procedure_NN were_VBD obtained_VBN from_IN radiotherapy_NN records_NNS ._. 
Direct_JJ individual_JJ radiotherapy_NN dose_NN calculations_NNS were_VBD performed_VBN using_VBG the_DT homemade_JJ Dos_EG_NNP software_NN package_NN -LRB-_-LRB- Diallo_FW et_FW al_FW ._. 
If_IN exposure_NN occurred_VBD in_IN adulthood_NN ,_, the_DT risk_NN is_VBZ much_RB lower_JJR -LRB-_-LRB- Richardson_NNP 2009_CD -RRB-_-RRB- ._. 
1995_CD -RRB-_-RRB- ._. 
The_DT risk_NN of_IN developing_VBG a_DT thyroid_JJ carcinoma_NN is_VBZ the_DT highest_JJS 15_CD 
Our_PRP$ results_NNS help_VBP shed_VB light_NN on_IN radiation-induced_JJ thyroid_JJ carcinogenesis_NN ,_, since_IN specific_JJ molecular_JJ pathways_NNS are_VBP deregulated_VBN in_IN radiation-induced_JJ tumors_NNS ._. 
Electricit_NN 
1995_CD -RRB-_-RRB- ._. 
The_DT risk_NN of_IN developing_VBG a_DT thyroid_JJ carcinoma_NN is_VBZ the_DT highest_JJS 15_CD 
2007_CD -RRB-_-RRB- ._. 
However_RB ,_, the_DT authors_NNS were_VBD able_JJ to_TO classify_VB their_PRP$ series_NN of_IN tumors_NNS by_IN using_VBG a_DT signature_NN that_WDT was_VBD previously_RB found_VBN to_TO discriminate_JJ between_IN irradiated_JJ -_: and_CC hydrogen-peroxide-treated_JJ lymphocytes_NNS -LRB-_-LRB- Detours_NNPS et_FW al_FW ._. 
Others_NNS studies_NNS found_VBD radiation-induced_JJ signatures_NNS in_IN post-Chernobyl_NNP PTC_NNP -LRB-_-LRB- Port_NNP et_FW al._FW ._. 
2007_CD ,_, Stein_NNP et_NNP al_NNP ._. 
2010_CD -RRB-_-RRB- ,_, but_CC without_IN blind_JJ validation_NN of_IN the_DT signature_NN ._. 
Arecent_JJ study_NN compared_VBD cell_NN cycle_NN protein_NN expression_NN in_IN sporadic_JJ and_CC post-radiotherapy_JJ PTC_NNP ,_, but_CC none_NN of_IN the_DT tested_VBN markers_NNS could_MD be_VB associated_VBN with_IN the_DT etiology_NN -LRB-_-LRB- Achille_FW et_FW al_FW ._. 
An_DT overlap_VBP was_VBD found_VBN between_IN post-radiotherapy_JJ deregulated_VBN genes_NNS ,_, identified_VBN in_IN this_DT study_NN ,_, and_CC post-Chernobyl_JJ deregulated_VBN genes_NNS ._. 
EPB41L3_NNP ,_, a_DT tumor_NN suppressor_NN included_VBN in_IN the_DT 322-gene_JJ signature_NN ,_, and_CC RERG_NNP ,_, C13ORF33_NNP ,_, GZMH_NNP ,_, MST150_NNP ,_, RARRES1_NNP ,_, RIPK4_NNP ,_, and_CC SFRP1_NNP ,_, found_VBN in_IN the_DT enlarged_JJ set_NN ,_, were_VBD reported_VBN in_IN a_DT set_NN of_IN deregulated_VBN genes_NNS in_IN post-Chernobyl_NNP PTC_NNP -LRB-_-LRB- Port_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
Genes_NNS such_JJ as_IN ABI2_NNP ,_, COL4A5_NNP ,_, FAT3_NNP ,_, IGFBP3_NNP ,_, KRTAP3-2_NNP ,_, and_CC SPOCK1_NNP and_CC several_JJ immunoglobulin_NN chains_NNS were_VBD deregulated_VBN in_IN post-radiotherapy_JJ tumors_NNS ,_, while_IN genes_NNS of_IN the_DT same_JJ family_NN and\/or_CC function_NN ,_, such_JJ as_IN ABI3_NNP ,_, COL4A6_NNP ,_, FAT2_NNP ,_, IGFBP1_NNP ,_, KRTAP2-1_NNP ,_, KRTAP2-4_NNP ,_, SPOCK2_NNP and_CC other_JJ immunoglobulin_NN chains_NNS ,_, were_VBD also_RB deregulated_VBN in_IN the_DT study_NN of_IN Port_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
EPB41L3_NNP ,_, a_DT tumor_NN suppressor_NN included_VBN in_IN the_DT 322-gene_JJ signature_NN ,_, and_CC RERG_NNP ,_, C13ORF33_NNP ,_, GZMH_NNP ,_, MST150_NNP ,_, RARRES1_NNP ,_, RIPK4_NNP ,_, and_CC SFRP1_NNP ,_, found_VBN in_IN the_DT enlarged_JJ set_NN ,_, were_VBD reported_VBN in_IN a_DT set_NN of_IN deregulated_VBN genes_NNS in_IN post-Chernobyl_NNP PTC_NNP -LRB-_-LRB- Port_NNP et_FW al_FW ._. 
Genes_NNS such_JJ as_IN ABI2_NNP ,_, COL4A5_NNP ,_, FAT3_NNP ,_, IGFBP3_NNP ,_, KRTAP3-2_NNP ,_, and_CC SPOCK1_NNP and_CC several_JJ immunoglobulin_NN chains_NNS were_VBD deregulated_VBN in_IN post-radiotherapy_JJ tumors_NNS ,_, while_IN genes_NNS of_IN the_DT same_JJ family_NN and\/or_CC function_NN ,_, such_JJ as_IN ABI3_NNP ,_, COL4A6_NNP ,_, FAT2_NNP ,_, IGFBP1_NNP ,_, KRTAP2-1_NNP ,_, KRTAP2-4_NNP ,_, SPOCK2_NNP and_CC other_JJ immunoglobulin_NN chains_NNS ,_, were_VBD also_RB deregulated_VBN in_IN the_DT study_NN of_IN Port_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2007_CD -RRB-_-RRB- ,_, suggesting_VBG common_JJ deregulated_VBN pathways_NNS in_IN post-radiotherapy_JJ and_CC post-Chernobyl_JJ tumors_NNS ._. 
Since_IN we_PRP also_RB observed_VBD genes_NNS in_IN common_JJ with_IN another_DT previously_RB published_VBN post-Chernobyl_JJ series_NN of_IN thyroid_JJ tumors_NNS -LRB-_-LRB- Detours_NNPS et_FW al_FW ._. 
In_IN thyroid_NN cancer_NN ,_, a_DT very_RB low_JJ frequency_NN of_IN TP53_CD mutations_NNS was_VBD observed_VBN in_IN sporadic_JJ and_CC in_IN post-Chernobyl_JJ tumors_NNS -LRB-_-LRB- Hillebrandt_FW et_FW al_FW ._. 
1996_CD ,_, Nikiforov_NNP et_FW al._FW ._. 
1996_CD -RRB-_-RRB- ._. 
However_RB ,_, p53_NN protein_NN overexpression_NN was_VBD described_VBN ,_, in_IN PTC_NNP and_CC anaplastic_JJ thyroid_JJ carcinomas_NNS ,_, not_RB associated_VBN with_IN gene_NN mutation_NN ,_, suggesting_VBG that_IN other_JJ mechanisms_NNS may_MD regulate_VB p53_NN in_IN thyroid_JJ tumors_NNS -LRB-_-LRB- Soares_FW et_FW al_FW ._. 
In_IN parallel_NN ,_, genes_NNS associated_VBN with_IN thyroid_JJ dysfunction_NN or_CC susceptibility_NN to_TO thyroid_JJ disease_NN ,_, such_JJ as_IN IGFBP3_NNP ,_, DUOX2_NNP ,_, NKX2_NNP 1\/TTF1_NNP ,_, GNA11_NNP ,_, and_CC SLC26A4\/pendrin_NNP -LRB-_-LRB- Moreno_NNP et_FW al_FW ._. 
2002_CD ,_, Moya_FW et_FW al._FW ._. 
2006_CD ,_, Kero_FW et_FW al_FW ._. 
2007_CD ,_, Kopp_NNP et_FW al_FW ._. 
2008_CD ,_, Kursunluoglu_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, or_CC with_IN other_JJ autoimmune_JJ diseases_NNS ,_, such_JJ as_IN IL17B_NNP ,_, IRF4_NNP ,_, LAIR2_NNP ,_, and_CC RC3H1_NNP ,_, were_VBD also_RB deregulated_VBN ._. 
1993_CD -RRB-_-RRB- ,_, as_RB well_RB as_IN genes_NNS involved_VBN in_IN T_NNP lymphocyte_NN function_NN -LRB-_-LRB- POU2AF1_CD ,_, CLECL1_CD ,_, IL2RG_CD ,_, CCL22_CD ,_, MADCAM1_CD ,_, LY75_CD ,_, and_CC TRAT1_CD -RRB-_-RRB- were_VBD deregulated_VBN and_CC thus_RB could_MD also_RB be_VB related_VBN to_TO the_DT immune_JJ thyroid_JJ status_NN of_IN radiation-induced_JJ tumors_NNS ._. 
In_IN parallel_NN ,_, genes_NNS associated_VBN with_IN thyroid_JJ dysfunction_NN or_CC susceptibility_NN to_TO thyroid_JJ disease_NN ,_, such_JJ as_IN IGFBP3_NNP ,_, DUOX2_NNP ,_, NKX2_NNP 1\/TTF1_NNP ,_, GNA11_NNP ,_, and_CC SLC26A4\/pendrin_NNP -LRB-_-LRB- Moreno_NNP et_FW al._FW ._. 
2002_CD ,_, Moya_FW et_FW al_FW ._. 
2006_CD ,_, Kero_FW et_FW al_FW ._. 
2007_CD ,_, Kopp_NNP et_FW al_FW ._. 
2008_CD ,_, Kursunluoglu_NNP et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, or_CC with_IN other_JJ autoimmune_JJ diseases_NNS ,_, such_JJ as_IN IL17B_NNP ,_, IRF4_NNP ,_, LAIR2_NNP ,_, and_CC RC3H1_NNP ,_, were_VBD also_RB deregulated_VBN ._. 
However_RB ,_, p53_NN protein_NN overexpression_NN was_VBD described_VBN ,_, in_IN PTC_NNP and_CC anaplastic_JJ thyroid_JJ carcinomas_NNS ,_, not_RB associated_VBN with_IN gene_NN mutation_NN ,_, suggesting_VBG that_IN other_JJ mechanisms_NNS may_MD regulate_VB p53_NN in_IN thyroid_JJ tumors_NNS -LRB-_-LRB- Soares_FW et_FW al_FW ._. 
1994_CD ,_, Malaguarnera_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
In_IN radiation-induced_JJ tumors_NNS ,_, a_DT decrease_NN in_IN TP53_CD gene_NN expression_NN was_VBD observed_VBN ,_, but_CC it_PRP was_VBD not_RB selected_VBN in_IN the_DT highly_RB discriminating_VBG signature_NN -LRB-_-LRB- Fig_NNP ._. 
However_RB ,_, it_PRP is_VBZ not_RB possible_JJ to_TO exclude_VB the_DT possibility_NN that_IN some_DT of_IN these_DT thyroid_JJ tumors_NNS could_MD have_VB been_VBN radiation-induced_JJ ._. 
Radiation-induced_JJ thyroid_NN tumors_NNS have_VBP no_DT specific_JJ histological_JJ characteristics_NNS -LRB-_-LRB- Rubino_FW et_FW al._FW ._. 
2002_CD ,_, Williams_NNP et_NNP al_NNP ._. 
2008_CD -RRB-_-RRB- ._. 
They_PRP are_VBP either_DT follicular_JJ thyroid_NN adenomas_NNS -LRB-_-LRB- FTA_NNP -RRB-_-RRB- or_CC papillary_JJ thyroid_JJ carcinomas_NNS -LRB-_-LRB- PTC_NNP -RRB-_-RRB- ._. 
Our_PRP$ results_NNS help_VBP shed_VB light_NN on_IN radiation-induced_JJ thyroid_JJ carcinogenesis_NN ,_, since_IN specific_JJ molecular_JJ pathways_NNS are_VBP deregulated_VBN in_IN radiation-induced_JJ tumors_NNS ._. 
Electricit_NN 
1995_CD -RRB-_-RRB- ._. 
Electricit_NN 
7per_NNP Gray_NNP -LRB-_-LRB- Gy_NNP -RRB-_-RRB- 
It_PRP has_VBZ been_VBN estimated_VBN that_IN 88_CD %_NN of_IN thyroid_JJ carcinomas_NNS occurring_VBG in_IN subjects_NNS exposed_VBN to_TO radiation_NN doses_NNS equal_JJ to_TO 1_CD 
Regarding_VBG the_DT risk_NN as_IN a_DT function_NN of_IN the_DT dose_NN received_VBN at_IN the_DT thyroid_JJ gland_NN ,_, it_PRP was_VBD shown_VBN that_IN ,_, in_IN this_DT age_NN range_NN ,_, the_DT relative_JJ risk_NN at_IN 1_CD 
Regarding_VBG the_DT thyroid_JJ radiosensitivity_NN in_IN adulthood_NN ,_, it_PRP should_MD be_VB mentioned_VBN that_IN four_CD tumors_NNS of_IN the_DT validation_NN group_NN ,_, which_WDT are_VBP classified_VBN as_IN R-tumors_NNS ,_, developed_VBN in_IN patients_NNS who_WP received_VBD radiotherapy_NN at_IN 30_CD ,_, 35_CD ,_, 36_CD ,_, and_CC 37_CD years_NNS old_JJ ._. 
These_DT data_NNS are_VBP in_IN agreement_NN with_IN the_DT fact_NN that_IN although_IN the_DT risk_NN of_IN radiation-induced_JJ thyroid_NN cancer_NN decreases_VBZ as_IN age_NN increases_NNS ,_, the_DT excess_NN of_IN relative_JJ risk_NN per_IN gray_JJ is_VBZ still_RB positive_JJ up_IN to_TO 40_CD years_NNS old_JJ -LRB-_-LRB- Ron_NNP et_NNP al._NNP ._. 
1995_CD -RRB-_-RRB- ._. 
It_PRP should_MD be_VB mentioned_VBN that_IN in_IN a_DT cohort_NN of_IN patients_NNS developing_VBG secondary_JJ radiation-induced_JJ thyroid_NN tumors_NNS ,_, 11_CD of_IN 27_CD patients_NNS received_VBD chemotherapy_NN for_IN their_PRP$ primary_JJ tumor_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
2004_CD ,_, Eisenhofer_NNP et_FW al_FW ._. 
Gain_NN of_IN chromosomes_NNS 17q_CD and_CC 11q13_CD was_VBD more_RBR frequently_RB identified_VBN in_IN malignant_JJ tumors_NNS -LRB-_-LRB- August_NNP et_FW al_FW ._. 
2004_CD ,_, Casc_NNP 
Both_DT the_DT clinical_JJ and_CC biochemical_JJ features_NNS of_IN pheochromocytomas_NNS are_VBP mostly_RB the_DT result_NN of_IN the_DT overproduction_NN of_IN catecholamines_NNS ._. 
In_IN sporadic_JJ pheochromocytomas_NNS and_CC paragangliomas_NNS ,_, 
2003_CD ,_, August_NNP et_FW al_FW ._. 
2000_CD ,_, Opocher_FW et_FW al_FW ._. 
Loss_NN of_IN chromosome_NN 1p_CD recently_RB detected_VBN in_IN pheochromocytomas_NNS -LRB-_-LRB- Dannenberg_NNP et_FW al_FW ._. 
2004_CD ,_, Aarts_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- was_VBD the_DT most_RBS frequent_JJ chromosomal_JJ deletions_NNS in_IN our_PRP$ study_NN ._. 
The_DT deletion_NN occurred_VBD in_IN all_DT three_CD types_NNS of_IN pheochromocytomas_NNS with_IN similar_JJ frequency_NN ;_: therefore_RB ,_, this_DT may_MD be_VB indicative_JJ of_IN early_JJ events_NNS in_IN the_DT tumorigenesis_NN of_IN sporadic_JJ pheochromocytoma_NN ._. 
2000_CD -RRB-_-RRB- ._. 
1995_CD ,_, Edstrom_NNP et_FW al_FW ._. 
1993_CD ,_, Zeiger_NNP et_FW al_FW ._. 
1992_CD ,_, Shin_NNP et_FW al_FW ._. 
1990_CD ,_, Moley_NNP et_FW al_FW ._. 
Studies_NNS of_IN genomic_JJ alterations_NNS in_IN primary_JJ pheochromocytomas_NNS using_VBG comparative_JJ genomic_JJ hybridization_NN -LRB-_-LRB- CGH_NNP -RRB-_-RRB- have_VBP shown_VBN the_DT loss_NN of_IN chromosomes_NNS 1p_CD ,_, 3p_CD ,_, 3q_CD ,_, 11p_CD ,_, 17p_CD ,_, and_CC 22q_CD at_IN various_JJ frequencies_NNS ,_, suggesting_VBG the_DT existence_NN of_IN tumor_NN suppressor_NN gene_NN loci_NNS in_IN these_DT locations_NNS -LRB-_-LRB- Yokogoshi_FW et_FW al_FW ._. 
Gain_NN of_IN chromosomes_NNS 17q_CD and_CC 11q13_CD was_VBD more_RBR frequently_RB identified_VBN in_IN malignant_JJ tumors_NNS -LRB-_-LRB- August_NNP et_FW al._FW ._. 
2004_CD ,_, Eisenhofer_NNP et_FW al_FW ._. 
2004_CD ,_, Casc_NNP 
2000_CD ,_, Opocher_FW et_FW al_FW ._. 
Loss_NN of_IN chromosome_NN 1p_CD recently_RB detected_VBN in_IN pheochromocytomas_NNS -LRB-_-LRB- Dannenberg_NNP et_FW al_FW ._. 
2003_CD ,_, August_NNP et_FW al._FW ._. 
2004_CD ,_, Aarts_NNP et_NNP al_NNP ._. 
2006_CD -RRB-_-RRB- was_VBD the_DT most_RBS frequent_JJ chromosomal_JJ deletions_NNS in_IN our_PRP$ study_NN ._. 
The_DT deletion_NN occurred_VBD in_IN all_DT three_CD types_NNS of_IN pheochromocytomas_NNS with_IN similar_JJ frequency_NN ;_: therefore_RB ,_, this_DT may_MD be_VB indicative_JJ of_IN early_JJ events_NNS in_IN the_DT tumorigenesis_NN of_IN sporadic_JJ pheochromocytoma_NN ._. 
These_DT results_NNS were_VBD similar_JJ to_TO that_DT detected_VBN by_IN CGH_NNP -LRB-_-LRB- Brinkschmidt_NNP et_FW al_FW ._. 
Our_PRP$ study_NN ,_, revealed_VBD the_DT frequent_JJ gain_NN of_IN chromosome_NN 17q_CD in_IN malignant_JJ tumors_NNS ,_, which_WDT indicated_VBD that_IN this_DT region_NN may_MD be_VB associated_VBN with_IN the_DT malignancy_NN of_IN the_DT disorders_NNS ._. 
2001_CD ,_, August_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
The_DT design_NN of_IN the_DT MLPA_NNP analysis_NN takes_VBZ advantage_NN of_IN changes_NNS not_RB only_RB in_IN chromosome_NN but_CC also_RB in_IN the_DT genes_NNS themselves_PRP to_TO demonstrate_VB the_DT relevant_JJ genetic_JJ changes_NNS in_IN tumors_NNS ._. 
It_PRP encodes_VBZ a_DT tumor_NN antigen_NN ,_, p185_CD ,_, which_WDT is_VBZ related_VBN to_TO the_DT epidermal_JJ growth_NN factor_NN receptor_NN ._. 
ERBB-2_NN oncogene_NN ,_, originally_RB called_VBN NEU_NNP -LRB-_-LRB- neuron\/glioblastoma_NN derived_VBD oncogene_NN homolog_NN -RRB-_-RRB- ,_, was_VBD derived_VBN from_IN the_DT rat_NN neuro\/glioblastoma_NN cell_NN lines_NNS ._. 
Further_JJ studies_NNS proved_VBD that_IN ERBB-2_NN gene_NN product_NN is_VBZ a_DT 185_CD 
This_DT method_NN is_VBZ easy_JJ to_TO perform_VB and_CC could_MD offer_VB an_DT alternative_NN to_TO CGH_NNP studies_NNS -LRB-_-LRB- Hogervorst_FW et_FW al_FW ._. 
This_DT method_NN relies_VBZ on_IN sequence-specific_JJ probe_NN hybridization_NN to_TO genomic_JJ DNA_NN followed_VBN by_IN multiplex-PCR_JJ amplification_NN of_IN the_DT hybridized_VBN probe_NN and_CC semi-quantitative_JJ analysis_NN of_IN the_DT resulting_JJ PCR_NNP products_NNS ._. 
2003_CD ,_, Bremmer_NNP et_FW al._FW ._. 
2005_CD ,_, van_NNP Dijk_NNP et_FW al_FW ._. 
2005_CD ,_, Postma_FW et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
We_PRP investigated_VBD 43_CD pheochromocytoma_NN tissue_NN samples_NNS using_VBG MLPA_NNP analysis_NN and_CC found_VBD that_IN several_JJ genes_NNS may_MD contribute_VB to_TO the_DT tumorigenesis_NN of_IN pheochromocytoma_NN or_CC malignancy_NN of_IN the_DT disease_NN ._. 
1993_CD ,_, Maher_NNP 
1993_CD ,_, Eisenhofer_NNP et_FW al_FW ._. 
As_IN the_DT genes_NNS responsible_JJ for_IN these_DT hereditary_JJ cancer_NN syndromes_NNS were_VBD identified_VBN ,_, attention_NN has_VBZ been_VBN shifted_VBN to_TO the_DT identification_NN of_IN additional_JJ genetic_JJ alterations_NNS in_IN sporadic_JJ pheochromocytomas_NNS ,_, especially_RB malignant_JJ ones_NNS -LRB-_-LRB- Neumann_NNP et_FW al_FW ._. 
2004_CD ,_, Brouwers_NNP et_FW al._FW ._. 
2005_CD ,_, Korpershoek_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
However_RB ,_, somatic_JJ genome_NN alteration_NN researches_VBZ are_VBP very_RB important_JJ to_TO understand_VB the_DT mechanism_NN of_IN pheochromocytomas_NNS ._. 
Our_PRP$ study_NN ,_, revealed_VBD the_DT frequent_JJ gain_NN of_IN chromosome_NN 17q_CD in_IN malignant_JJ tumors_NNS ,_, which_WDT indicated_VBD that_IN this_DT region_NN may_MD be_VB associated_VBN with_IN the_DT malignancy_NN of_IN the_DT disorders_NNS ._. 
These_DT results_NNS were_VBD similar_JJ to_TO that_DT detected_VBN by_IN CGH_NNP -LRB-_-LRB- Brinkschmidt_NNP et_FW al._FW ._. 
2001_CD ,_, August_NNP et_FW al_FW ._. 
2004_CD -RRB-_-RRB- ._. 
The_DT design_NN of_IN the_DT MLPA_NNP analysis_NN takes_VBZ advantage_NN of_IN changes_NNS not_RB only_RB in_IN chromosome_NN but_CC also_RB in_IN the_DT genes_NNS themselves_PRP to_TO demonstrate_VB the_DT relevant_JJ genetic_JJ changes_NNS in_IN tumors_NNS ._. 
To_TO find_VB new_JJ candidate_NN genes_NNS ,_, we_PRP performed_VBD multiplex_JJ ligation-dependent_JJ probe_NN amplification_NN -LRB-_-LRB- MLPA_NNP -RRB-_-RRB- analysis_NN in_IN pheochromocytomas_NNS ._. 
MLPA_NNP is_VBZ a_DT new_JJ technique_NN used_VBN to_TO measure_VB the_DT copy_NN number_NN of_IN up_IN to_TO 45_CD nucleic_JJ acid_NN sequences_NNS in_IN one_CD single_JJ reaction_NN -LRB-_-LRB- Schouten_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
This_DT method_NN relies_VBZ on_IN sequence-specific_JJ probe_NN hybridization_NN to_TO genomic_JJ DNA_NN followed_VBN by_IN multiplex-PCR_JJ amplification_NN of_IN the_DT hybridized_VBN probe_NN and_CC semi-quantitative_JJ analysis_NN of_IN the_DT resulting_JJ PCR_NNP products_NNS ._. 
1990_CD ,_, Moley_NNP et_FW al_FW ._. 
Studies_NNS of_IN genomic_JJ alterations_NNS in_IN primary_JJ pheochromocytomas_NNS using_VBG comparative_JJ genomic_JJ hybridization_NN -LRB-_-LRB- CGH_NNP -RRB-_-RRB- have_VBP shown_VBN the_DT loss_NN of_IN chromosomes_NNS 1p_CD ,_, 3p_CD ,_, 3q_CD ,_, 11p_CD ,_, 17p_CD ,_, and_CC 22q_CD at_IN various_JJ frequencies_NNS ,_, suggesting_VBG the_DT existence_NN of_IN tumor_NN suppressor_NN gene_NN loci_NNS in_IN these_DT locations_NNS -LRB-_-LRB- Yokogoshi_FW et_FW al_FW ._. 
1992_CD ,_, Shin_NNP et_FW al._FW ._. 
1993_CD ,_, Zeiger_NNP et_FW al_FW ._. 
1995_CD ,_, Edstrom_NNP et_FW al_FW ._. 
2000_CD -RRB-_-RRB- ._. 
Gain_NN of_IN chromosomes_NNS 17q_CD and_CC 11q13_CD was_VBD more_RBR frequently_RB identified_VBN in_IN malignant_JJ tumors_NNS -LRB-_-LRB- August_NNP et_FW al_FW ._. 
In_IN sporadic_JJ pheochromocytomas_NNS and_CC paragangliomas_NNS ,_, 
Studies_NNS of_IN genomic_JJ alterations_NNS in_IN primary_JJ pheochromocytomas_NNS using_VBG comparative_JJ genomic_JJ hybridization_NN -LRB-_-LRB- CGH_NNP -RRB-_-RRB- have_VBP shown_VBN the_DT loss_NN of_IN chromosomes_NNS 1p_CD ,_, 3p_CD ,_, 3q_CD ,_, 11p_CD ,_, 17p_CD ,_, and_CC 22q_CD at_IN various_JJ frequencies_NNS ,_, suggesting_VBG the_DT existence_NN of_IN tumor_NN suppressor_NN gene_NN loci_NNS in_IN these_DT locations_NNS -LRB-_-LRB- Yokogoshi_FW et_FW al_FW ._. 
1990_CD ,_, Moley_NNP et_FW al._FW ._. 
1992_CD ,_, Shin_NNP et_FW al_FW ._. 
1993_CD ,_, Zeiger_NNP et_FW al_FW ._. 
1995_CD ,_, Edstrom_NNP et_FW al_FW ._. 
2000_CD -RRB-_-RRB- ._. 
Gain_NN of_IN chromosomes_NNS 17q_CD and_CC 11q13_CD was_VBD more_RBR frequently_RB identified_VBN in_IN malignant_JJ tumors_NNS -LRB-_-LRB- August_NNP et_FW al_FW ._. 
Loss_NN of_IN chromosome_NN 1p_CD recently_RB detected_VBN in_IN pheochromocytomas_NNS -LRB-_-LRB- Dannenberg_NNP et_FW al_FW ._. 
However_RB ,_, somatic_JJ genome_NN alteration_NN researches_VBZ are_VBP very_RB important_JJ to_TO understand_VB the_DT mechanism_NN of_IN pheochromocytomas_NNS ._. 
2000_CD ,_, Opocher_FW et_FW al._FW ._. 
2003_CD ,_, August_NNP et_FW al_FW ._. 
2004_CD ,_, Aarts_NNP et_NNP al_NNP ._. 
2006_CD -RRB-_-RRB- was_VBD the_DT most_RBS frequent_JJ chromosomal_JJ deletions_NNS in_IN our_PRP$ study_NN ._. 
e._IN Some_DT recent_JJ clinical_JJ trials_NNS have_VBP found_VBN trastuzumab_NN reduces_VBZ the_DT risk_NN of_IN relapse_NN in_IN breast_NN cancer_NN patients_NNS by_IN 50_CD %_NN when_WRB given_VBN in_IN the_DT adjuvant_JJ setting_NN -LRB-_-LRB- i._NN ,_, after_IN breast_NN cancer_NN surgery_NN ,_, before_IN the_DT cancer_NN has_VBZ spread_VBN any_DT further_RBR -RRB-_-RRB- for_IN 1_CD year_NN -LRB-_-LRB- Piccart-Gebhart_NNP et_FW al._FW ._. 
2005_CD ,_, Romond_FW et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN our_PRP$ study_NN ,_, further_JJ IHC_NNP analysis_NN confirmed_VBD that_IN there_EX was_VBD significant_JJ difference_NN in_IN malignant_JJ and_CC benign_JJ pheochromocytomas_NNS ,_, which_WDT indicated_VBD that_IN ERBB-2_NN oncogene_NN may_MD be_VB an_DT important_JJ gene_NN in_IN the_DT malignant_JJ development_NN of_IN pheochromocytomas_NNS ._. 
1998_CD -RRB-_-RRB- ._. 
Overexpression_NN of_IN the_DT ERBB-2_NN ,_, a_DT breast_NN cancer_NN marker_NN ,_, is_VBZ associated_VBN with_IN rapid_JJ tumor_NN growth_NN ,_, increased_VBN risk_NN of_IN recurrence_NN after_IN surgery_NN ,_, poor_JJ response_NN to_TO conventional_JJ chemotherapy_NN ,_, and_CC shortened_VBD survival_NN ,_, and_CC this_DT ERBB-2_NN overexpression_NN has_VBZ also_RB been_VBN implicated_VBN in_IN the_DT neoplastic_JJ transformation_NN of_IN prostate_NN cancer_NN -LRB-_-LRB- Ross_NNP 
2005_CD ,_, van_NNP Dijk_NNP et_FW al_FW ._. 
2003_CD ,_, Bremmer_NNP et_FW al_FW ._. 
This_DT method_NN is_VBZ easy_JJ to_TO perform_VB and_CC could_MD offer_VB an_DT alternative_NN to_TO CGH_NNP studies_NNS -LRB-_-LRB- Hogervorst_FW et_FW al_FW ._. 
2005_CD ,_, Postma_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
We_PRP investigated_VBD 43_CD pheochromocytoma_NN tissue_NN samples_NNS using_VBG MLPA_NNP analysis_NN and_CC found_VBD that_IN several_JJ genes_NNS may_MD contribute_VB to_TO the_DT tumorigenesis_NN of_IN pheochromocytoma_NN or_CC malignancy_NN of_IN the_DT disease_NN ._. 
,after_JJR breast_NN cancer_NN surgery_NN ,_, before_IN the_DT cancer_NN has_VBZ spread_VBN any_DT further_RBR -RRB-_-RRB- for_IN 1_CD year_NN -LRB-_-LRB- Piccart-Gebhart_NNP et_FW al_FW ._. 
2005_CD ,_, Romond_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN our_PRP$ study_NN ,_, further_JJ IHC_NNP analysis_NN confirmed_VBD that_IN there_EX was_VBD significant_JJ difference_NN in_IN malignant_JJ and_CC benign_JJ pheochromocytomas_NNS ,_, which_WDT indicated_VBD that_IN ERBB-2_NN oncogene_NN may_MD be_VB an_DT important_JJ gene_NN in_IN the_DT malignant_JJ development_NN of_IN pheochromocytomas_NNS ._. 
1986_CD -RRB-_-RRB- ._. 
Further_JJ studies_NNS proved_VBD that_IN ERBB-2_NN gene_NN product_NN is_VBZ a_DT 185_CD 
2003_CD ,_, Bremmer_NNP et_FW al_FW ._. 
This_DT method_NN is_VBZ easy_JJ to_TO perform_VB and_CC could_MD offer_VB an_DT alternative_NN to_TO CGH_NNP studies_NNS -LRB-_-LRB- Hogervorst_FW et_FW al_FW ._. 
2005_CD ,_, van_NNP Dijk_NNP et_FW al._FW ._. 
2005_CD ,_, Postma_FW et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
We_PRP investigated_VBD 43_CD pheochromocytoma_NN tissue_NN samples_NNS using_VBG MLPA_NNP analysis_NN and_CC found_VBD that_IN several_JJ genes_NNS may_MD contribute_VB to_TO the_DT tumorigenesis_NN of_IN pheochromocytoma_NN or_CC malignancy_NN of_IN the_DT disease_NN ._. 
However_RB ,_, somatic_JJ genome_NN alteration_NN researches_VBZ are_VBP very_RB important_JJ to_TO understand_VB the_DT mechanism_NN of_IN pheochromocytomas_NNS ._. 
Loss_NN of_IN chromosome_NN 1p_CD recently_RB detected_VBN in_IN pheochromocytomas_NNS -LRB-_-LRB- Dannenberg_NNP et_FW al._FW ._. 
2000_CD ,_, Opocher_FW et_FW al_FW ._. 
2003_CD ,_, August_NNP et_FW al_FW ._. 
2004_CD ,_, Aarts_NNP et_NNP al_NNP ._. 
2006_CD -RRB-_-RRB- was_VBD the_DT most_RBS frequent_JJ chromosomal_JJ deletions_NNS in_IN our_PRP$ study_NN ._. 
The_DT diagnosis_NN of_IN pheochromocytoma_NN was_VBD confirmed_VBN on_IN the_DT basis_NN of_IN clinical_JJ manifestations_NNS including_VBG persistent_JJ or_CC paroxysmal_JJ hypertension_NN with_IN the_DT classic_JJ triad_NN of_IN severe_JJ headaches_NNS ,_, palpitations_NNS ,_, and_CC diaphoresis_NN ,_, biochemical_JJ features_NNS including_VBG serum_NN and_CC urinary_JJ metanephrine_NN -LRB-_-LRB- MN_NNP -RRB-_-RRB- ,_, nor-MN_NNP -LRB-_-LRB- NMN_NNP -RRB-_-RRB- ,_, and_CC positive_JJ CT_NNP or_CC 131_CD I-MIBG_NNP scan_VB ._. 
The_DT diagnosis_NN of_IN malignant_JJ pheochromocytoma_NN was_VBD based_VBN on_IN the_DT presence_NN of_IN distant_JJ metastases_NNS or_CC lymph_JJ node_NN infiltrations_NNS ,_, that_DT is_VBZ ,_, the_DT presence_NN of_IN chromaffin_NN tissue_NN at_IN sites_NNS where_WRB this_DT tissue_NN is_VBZ normally_RB absent_JJ -LRB-_-LRB- Eisenhofer_NNP et_FW al._FW ._. 
1999_CD ,_, Weise_FW et_FW al_FW ._. 
2002_CD ,_, Mittendorf_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
Of_IN the_DT 43_CD patients_NNS ,_, 9_CD had_VBD malignant_JJ disease_NN ,_, 7_CD were_VBD paragangliomas_NNS of_IN the_DT abdomen_NN ,_, and_CC the_DT rest_NN of_IN the_DT 27_CD patients_NNS were_VBD with_IN benign_JJ pheochromocytomas_NNS ._. 
1993_CD ,_, Zeiger_NNP et_FW al_FW ._. 
1992_CD ,_, Shin_NNP et_FW al_FW ._. 
1990_CD ,_, Moley_NNP et_FW al_FW ._. 
Studies_NNS of_IN genomic_JJ alterations_NNS in_IN primary_JJ pheochromocytomas_NNS using_VBG comparative_JJ genomic_JJ hybridization_NN -LRB-_-LRB- CGH_NNP -RRB-_-RRB- have_VBP shown_VBN the_DT loss_NN of_IN chromosomes_NNS 1p_CD ,_, 3p_CD ,_, 3q_CD ,_, 11p_CD ,_, 17p_CD ,_, and_CC 22q_CD at_IN various_JJ frequencies_NNS ,_, suggesting_VBG the_DT existence_NN of_IN tumor_NN suppressor_NN gene_NN loci_NNS in_IN these_DT locations_NNS -LRB-_-LRB- Yokogoshi_FW et_FW al_FW ._. 
1995_CD ,_, Edstrom_NNP et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ._. 
Gain_NN of_IN chromosomes_NNS 17q_CD and_CC 11q13_CD was_VBD more_RBR frequently_RB identified_VBN in_IN malignant_JJ tumors_NNS -LRB-_-LRB- August_NNP et_FW al_FW ._. 
This_DT method_NN relies_VBZ on_IN sequence-specific_JJ probe_NN hybridization_NN to_TO genomic_JJ DNA_NN followed_VBN by_IN multiplex-PCR_JJ amplification_NN of_IN the_DT hybridized_VBN probe_NN and_CC semi-quantitative_JJ analysis_NN of_IN the_DT resulting_JJ PCR_NNP products_NNS ._. 
This_DT method_NN is_VBZ easy_JJ to_TO perform_VB and_CC could_MD offer_VB an_DT alternative_NN to_TO CGH_NNP studies_NNS -LRB-_-LRB- Hogervorst_FW et_FW al._FW ._. 
2003_CD ,_, Bremmer_NNP et_FW al_FW ._. 
2005_CD ,_, van_NNP Dijk_NNP et_FW al_FW ._. 
2005_CD ,_, Postma_FW et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
We_PRP investigated_VBD 43_CD pheochromocytoma_NN tissue_NN samples_NNS using_VBG MLPA_NNP analysis_NN and_CC found_VBD that_IN several_JJ genes_NNS may_MD contribute_VB to_TO the_DT tumorigenesis_NN of_IN pheochromocytoma_NN or_CC malignancy_NN of_IN the_DT disease_NN ._. 
Gain_NN of_IN chromosomes_NNS 17q_CD and_CC 11q13_CD was_VBD more_RBR frequently_RB identified_VBN in_IN malignant_JJ tumors_NNS -LRB-_-LRB- August_NNP et_FW al_FW ._. 
2004_CD ,_, Eisenhofer_NNP et_FW al._FW ._. 
2004_CD ,_, Casc_NNP 
As_IN the_DT genes_NNS responsible_JJ for_IN these_DT hereditary_JJ cancer_NN syndromes_NNS were_VBD identified_VBN ,_, attention_NN has_VBZ been_VBN shifted_VBN to_TO the_DT identification_NN of_IN additional_JJ genetic_JJ alterations_NNS in_IN sporadic_JJ pheochromocytomas_NNS ,_, especially_RB malignant_JJ ones_NNS -LRB-_-LRB- Neumann_NNP et_FW al_FW ._. 
1993_CD ,_, Eisenhofer_NNP et_FW al._FW ._. 
2004_CD ,_, Brouwers_NNP et_FW al_FW ._. 
2005_CD ,_, Korpershoek_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
However_RB ,_, somatic_JJ genome_NN alteration_NN researches_VBZ are_VBP very_RB important_JJ to_TO understand_VB the_DT mechanism_NN of_IN pheochromocytomas_NNS ._. 
In_IN sporadic_JJ pheochromocytomas_NNS and_CC paragangliomas_NNS ,_, 
2004_CD ,_, Brouwers_NNP et_FW al_FW ._. 
1993_CD ,_, Eisenhofer_NNP et_FW al_FW ._. 
As_IN the_DT genes_NNS responsible_JJ for_IN these_DT hereditary_JJ cancer_NN syndromes_NNS were_VBD identified_VBN ,_, attention_NN has_VBZ been_VBN shifted_VBN to_TO the_DT identification_NN of_IN additional_JJ genetic_JJ alterations_NNS in_IN sporadic_JJ pheochromocytomas_NNS ,_, especially_RB malignant_JJ ones_NNS -LRB-_-LRB- Neumann_NNP et_FW al_FW ._. 
2005_CD ,_, Korpershoek_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
However_RB ,_, somatic_JJ genome_NN alteration_NN researches_VBZ are_VBP very_RB important_JJ to_TO understand_VB the_DT mechanism_NN of_IN pheochromocytomas_NNS ._. 
The_DT pheochromocytomas_NNS can_MD be_VB a_DT part_NN of_IN some_DT of_IN the_DT hereditary_JJ syndromes_NNS ,_, including_VBG MEN2_NNP ,_, VHL_NNP ,_, NF1_NNP ,_, and_CC paraganglioma_NN syndrome_NN ._. 
As_IN the_DT genes_NNS responsible_JJ for_IN these_DT hereditary_JJ cancer_NN syndromes_NNS were_VBD identified_VBN ,_, attention_NN has_VBZ been_VBN shifted_VBN to_TO the_DT identification_NN of_IN additional_JJ genetic_JJ alterations_NNS in_IN sporadic_JJ pheochromocytomas_NNS ,_, especially_RB malignant_JJ ones_NNS -LRB-_-LRB- Neumann_NNP et_FW al._FW ._. 
1993_CD ,_, Eisenhofer_NNP et_FW al_FW ._. 
2004_CD ,_, Brouwers_NNP et_FW al_FW ._. 
2005_CD ,_, Korpershoek_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
However_RB ,_, somatic_JJ genome_NN alteration_NN researches_VBZ are_VBP very_RB important_JJ to_TO understand_VB the_DT mechanism_NN of_IN pheochromocytomas_NNS ._. 
1999_CD ,_, Weise_FW et_FW al_FW ._. 
The_DT diagnosis_NN of_IN malignant_JJ pheochromocytoma_NN was_VBD based_VBN on_IN the_DT presence_NN of_IN distant_JJ metastases_NNS or_CC lymph_JJ node_NN infiltrations_NNS ,_, that_DT is_VBZ ,_, the_DT presence_NN of_IN chromaffin_NN tissue_NN at_IN sites_NNS where_WRB this_DT tissue_NN is_VBZ normally_RB absent_JJ -LRB-_-LRB- Eisenhofer_NNP et_FW al_FW ._. 
2002_CD ,_, Mittendorf_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
Of_IN the_DT 43_CD patients_NNS ,_, 9_CD had_VBD malignant_JJ disease_NN ,_, 7_CD were_VBD paragangliomas_NNS of_IN the_DT abdomen_NN ,_, and_CC the_DT rest_NN of_IN the_DT 27_CD patients_NNS were_VBD with_IN benign_JJ pheochromocytomas_NNS ._. 
1992_CD ,_, Shin_NNP et_FW al_FW ._. 
1990_CD ,_, Moley_NNP et_FW al_FW ._. 
Studies_NNS of_IN genomic_JJ alterations_NNS in_IN primary_JJ pheochromocytomas_NNS using_VBG comparative_JJ genomic_JJ hybridization_NN -LRB-_-LRB- CGH_NNP -RRB-_-RRB- have_VBP shown_VBN the_DT loss_NN of_IN chromosomes_NNS 1p_CD ,_, 3p_CD ,_, 3q_CD ,_, 11p_CD ,_, 17p_CD ,_, and_CC 22q_CD at_IN various_JJ frequencies_NNS ,_, suggesting_VBG the_DT existence_NN of_IN tumor_NN suppressor_NN gene_NN loci_NNS in_IN these_DT locations_NNS -LRB-_-LRB- Yokogoshi_FW et_FW al_FW ._. 
1993_CD ,_, Zeiger_NNP et_FW al._FW ._. 
1995_CD ,_, Edstrom_NNP et_FW al_FW ._. 
2000_CD -RRB-_-RRB- ._. 
Gain_NN of_IN chromosomes_NNS 17q_CD and_CC 11q13_CD was_VBD more_RBR frequently_RB identified_VBN in_IN malignant_JJ tumors_NNS -LRB-_-LRB- August_NNP et_FW al_FW ._. 
1986_CD -RRB-_-RRB- ._. 
Further_JJ studies_NNS proved_VBD that_IN ERBB-2_NN gene_NN product_NN is_VBZ a_DT 185_CD 
2006_CD -RRB-_-RRB- ._. 
2002_CD ,_, Bausch_NNP et_FW al_FW ._. 
1993_CD ,_, Maher_NNP 
The_DT diagnosis_NN of_IN malignant_JJ pheochromocytoma_NN was_VBD based_VBN on_IN the_DT presence_NN of_IN distant_JJ metastases_NNS or_CC lymph_JJ node_NN infiltrations_NNS ,_, that_DT is_VBZ ,_, the_DT presence_NN of_IN chromaffin_NN tissue_NN at_IN sites_NNS where_WRB this_DT tissue_NN is_VBZ normally_RB absent_JJ -LRB-_-LRB- Eisenhofer_NNP et_FW al_FW ._. 
1999_CD ,_, Weise_FW et_FW al._FW ._. 
2002_CD ,_, Mittendorf_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
Of_IN the_DT 43_CD patients_NNS ,_, 9_CD had_VBD malignant_JJ disease_NN ,_, 7_CD were_VBD paragangliomas_NNS of_IN the_DT abdomen_NN ,_, and_CC the_DT rest_NN of_IN the_DT 27_CD patients_NNS were_VBD with_IN benign_JJ pheochromocytomas_NNS ._. 
Trastuzumab_NNP -LRB-_-LRB- Herceptin_NNP -RRB-_-RRB- is_VBZ a_DT human_JJ monoclonal_NN antibody_NN that_WDT appears_VBZ to_TO block_VB the_DT growth_NN signals_NNS transmitted_VBN by_IN ERBB-2_NN to_TO the_DT nucleus_NN and_CC enhances_VBZ the_DT response_NN to_TO chemotherapeutic_JJ agents_NNS -LRB-_-LRB- Pietras_FW et_FW al_FW ._. 
1998_CD ,_, Slamon_NNP et_FW al._FW ._. 
2001_CD -RRB-_-RRB- ._. 
Antibody_NN against_IN ERBB-2_NNP has_VBZ been_VBN FDA_NNP approved_VBD for_IN clinical_JJ treatment_NN of_IN cancer_NN under_IN the_DT brand_NN name_NN Herceptin_NNP ._. 
1981_CD ,_, Maurer_NNP 1982_CD -RRB-_-RRB- ,_, and_CC the_DT occurrence_NN of_IN lactotroph_JJ adenomas_NNS in_IN transsexual_JJ men_NNS during_IN pharmacological_JJ estrogen_NN treatment_NN -LRB-_-LRB- Mueller_NNP 
2004_CD -RRB-_-RRB- ._. 
In_IN humans_NNS ,_, tissue-specific_JJ overexpression_NN of_IN CCND1_NNP ,_, or_CC decreased_VBD expression_NN of_IN p16_CD ,_, p18_CD ,_, and_CC p27_CD ,_, is_VBZ common_JJ in_IN tumors_NNS of_IN the_DT pituitary_JJ gland_NN -LRB-_-LRB- Peters_NNP 1994_CD ,_, Musat_FW et_FW al_FW ._. 
Recently_RB ,_, overexpression_NN of_IN the_DT high-mobility_JJ group_NN protein_NN A2_NNP -LRB-_-LRB- HMGA2_NNP -RRB-_-RRB- in_IN pituitary_JJ tumors_NNS has_VBZ been_VBN described_VBN in_IN mice_NNS and_CC men_NNS -LRB-_-LRB- Fedele_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
This_DT factor_NN binds_VBZ to_TO the_DT inactive_JJ RB\/E2F1_NNP complex_NN ,_, displacing_VBG histone_JJ deacetylase_NN 1_CD -LRB-_-LRB- HDAC1_NNP -RRB-_-RRB- ,_, leading_VBG to_TO histone_VB acetylation_NN ,_, opening_VBG of_IN the_DT chromatin_NN structure_NN ,_, and_CC stabilizing_VBG E2F1_NNP -LRB-_-LRB- Fedele_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
Recently_RB ,_, overexpression_NN of_IN the_DT high-mobility_JJ group_NN protein_NN A2_NNP -LRB-_-LRB- HMGA2_NNP -RRB-_-RRB- in_IN pituitary_JJ tumors_NNS has_VBZ been_VBN described_VBN in_IN mice_NNS and_CC men_NNS -LRB-_-LRB- Fedele_FW et_FW al_FW ._. 
This_DT factor_NN binds_VBZ to_TO the_DT inactive_JJ RB\/E2F1_NNP complex_NN ,_, displacing_VBG histone_JJ deacetylase_NN 1_CD -LRB-_-LRB- HDAC1_NNP -RRB-_-RRB- ,_, leading_VBG to_TO histone_VB acetylation_NN ,_, opening_VBG of_IN the_DT chromatin_NN structure_NN ,_, and_CC stabilizing_VBG E2F1_NNP -LRB-_-LRB- Fedele_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Besides_IN the_DT role_NN of_IN E_NNP 2_CD in_IN the_DT pathogenesis_NN of_IN pituitary_JJ tumors_NNS -LRB-_-LRB- Heaney_NNP et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ,_, E_NNP 2_CD -_: induced_JJ proliferation_NN in_IN breast_NN cancer_NN cells_NNS activates_VBZ c-fos_JJ ,_, c-jun_JJ ,_, and_CC c-myc_JJ -LRB-_-LRB- Sutherland_NNP et_FW al_FW ._. 
Gx_NNP and_CC all_DT antihormone_JJ treatments_NNS reduced_VBD the_DT expression_NN of_IN Ccnd1_NNP and_CC E2f1_NNP ._. 
4._CD 
Response_NNP of_IN pituitary_JJ gene_NN expression_NN to_TO hormone_NN manipulations_NNS We_PRP then_RB analyzed_VBD the_DT responses_NNS of_IN selected_VBN genes_NNS ,_, with_IN likely_JJ involvement_NN in_IN the_DT tumorigenesis_NN ,_, to_TO Gx_NNP and_CC hormone_NN antagonist_NN treatments_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ;_: the_DT results_NNS are_VBP presented_VBN in_IN Fig_NNP ._. 
The_DT expression_NN of_IN Hmga2_NNP ,_, a_DT stabilizer_NN of_IN E2F1_NNP -LRB-_-LRB- Fedele_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ,_, was_VBD suppressed_VBN by_IN Gx_NN and_CC mifepristone_NN ,_, but_CC not_RB by_IN bromocriptine_NN ._. 
Pgr_NNP expression_NN was_VBD measured_VBN because_RB of_IN the_DT putative_JJ involvement_NN of_IN P_NNP 4_CD in_IN the_DT tumorigenesis_NN ._. 
This_DT finding_NN was_VBD supported_VBN by_IN P_NNP 4_CD effects_NNS in_IN cultured_JJ primary_JJ mouse_NN pituitary_NN cells_NNS and_CC in_IN a_DT rat_NN somatomammotroph_NN cell_NN line_NN ._. 
The_DT mechanism_NN of_IN the_DT tumor_NN promotion_NN in_IN the_DT presence_NN of_IN P4_NNP was_VBD found_VBN to_TO involve_VB in_IN the_DT activation_NN of_IN CCND1_NNP and_CC HMGA2_NNP ,_, which_WDT are_VBP also_RB activated_VBN in_IN human_JJ pituitary_JJ adenomas_NNS -LRB-_-LRB- Peters_NNP 1994_CD ,_, Fedele_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Hence_RB ,_, the_DT molecular_JJ pathogenesis_NN of_IN these_DT murine_JJ tumors_NNS may_MD have_VB similar_JJ features_NNS with_IN that_DT of_IN human_JJ pituitary_JJ adenomas_NNS ._. 
The_DT same_JJ effect_NN of_IN P_NNP 4_CD was_VBD observed_VBN in_IN cultures_NNS of_IN primary_JJ mouse_NN pituitary_NN and_CC rat_NN GH3_CD cells_NNS ._. 
Indeed_RB ,_, we_PRP found_VBD out_RP that_IN P_NNP 4_CD up-regulated_JJ in_IN the_DT TG_NNP mice_NNS ,_, when_WRB exposed_VBN to_TO physiological_JJ levels_NNS of_IN E_NNP 2_CD ,_, the_DT well-established_JJ tumorigenic_JJ CCND1\/CDK4\/RB_NNP \/_NNP E2F1_NNP signaling_VBG cascade_NN ._. 
Concomitant_JJ upregulation_NN of_IN the_DT architectural_JJ transcription_NN factor_NN Hmga2_NNP was_VBD found_VBN in_IN the_DT pituitary_JJ adenoma_NN ,_, in_IN keeping_VBG with_IN its_PRP$ established_JJ involvement_NN in_IN pituitary_JJ tumorigenesis_NNS in_IN mice_NNS and_CC men_NNS -LRB-_-LRB- Fedele_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Hence_RB ,_, CCND1_JJ activation_NN ,_, leading_VBG to_TO stimulation_NN of_IN E2F1_NNP expression_NN ,_, seems_VBZ to_TO occur_VB by_IN several_JJ converging_VBG mechanisms_NNS in_IN our_PRP$ pituitary_JJ adenomas_NN model_NN ._. 
Hence_RB ,_, CCND1_JJ activation_NN ,_, leading_VBG to_TO stimulation_NN of_IN E2F1_NNP expression_NN ,_, seems_VBZ to_TO occur_VB by_IN several_JJ converging_VBG mechanisms_NNS in_IN our_PRP$ pituitary_JJ adenomas_NN model_NN ._. 
One_CD is_VBZ decreased_VBN RB_NN expression_NN ,_, which_WDT results_NNS in_IN E2F1_NNP activation_NN ,_, the_DT other_JJ is_VBZ upregulation_NN of_IN HMGA2_NNP ,_, which_WDT displaces_VBZ HDAC1_CD from_IN the_DT inactive_JJ pRB\/E2F1_NNP complex_NN ,_, resulting_VBG in_IN the_DT acetylation_NN and_CC activation_NN of_IN the_DT latter_JJ -LRB-_-LRB- Fedele_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
In_IN addition_NN ,_, we_PRP found_VBD in_IN GH3_NNP cells_NNS increased_VBD RB_NN phosphorylation_NN ,_, which_WDT results_VBZ in_IN inactivation_NN of_IN this_DT protein_NN and_CC enhanced_JJ cyclin_NN D_NNP stimulation_NN of_IN E2F1_NNP ._. 
Female_JJ sex_NN is_VBZ a_DT risk_NN factor_NN for_IN prolactinomas_NNS in_IN humans_NNS ,_, apparently_RB due_JJ to_TO the_DT effects_NNS of_IN estradiol_NN -LRB-_-LRB- E_NNP 2_CD -RRB-_-RRB- ._. 
This_DT link_NN is_VBZ supported_VBN for_IN example_NN by_IN more_RBR common_JJ occurrence_NN of_IN these_DT tumors_NNS in_IN women_NNS -LRB-_-LRB- Faglia_NNP 1993_CD ,_, Drange_FW et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ,_, the_DT increase_NN of_IN their_PRP$ growth_NN during_IN pregnancy_NN -LRB-_-LRB- Molitch_NNP 1999_CD -RRB-_-RRB- ,_, the_DT stimulating_VBG effect_NN of_IN estrogens_NNS on_IN PRL_NNP secretion_NN -LRB-_-LRB- Lieberman_NNP et_FW al_FW ._. 
Supplementary_NNP Table_NNP 1_CD ,_, see_VBP section_NN on_IN supplementary_JJ data_NNS given_VBN at_IN the_DT end_NN of_IN this_DT article_NN -LRB-_-LRB- including_VBG the_DT primer_NN pairs_NNS ,_, annealing_VBG temperatures_NNS ,_, and_CC gene_NN bank_NN accession_NN numbers_NNS -RRB-_-RRB- ._. 
qRT-PCR_JJ analysis_NN was_VBD carried_VBN out_RP as_RB described_VBN previously_RB -LRB-_-LRB- Ahtiainen_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Further_JJ details_NNS about_IN the_DT methodology_NN and_CC quality_NN control_NN are_VBP presented_VBN in_IN Supplementary_NNP data_NNS ._. 
2001_CD ,_, Rey-Roldan_JJ et_FW al_FW ._. 
While_IN several_JJ previous_JJ studies_NNS demonstrate_VBP the_DT inhibitory_JJ effects_NNS of_IN P_NNP 4_CD on_IN the_DT growth_NN and_CC PRL_NNP production_NN of_IN normal_JJ and_CC tumorous_JJ pituitary_JJ cells_NNS -LRB-_-LRB- Haug_NNP 
Pituitary_JJ glands_NNS were_VBD weighed_VBN ,_, fixed_VBN in_IN 4_CD %_NN paraformaldehyde_NN or_CC snap-frozen_NN in_IN liquid_JJ nitrogen_NN ,_, and_CC stored_VBD at_IN 
If_IN extrapolated_VBN to_TO humans_NNS ,_, and_CC given_VBN the_DT importance_NN of_IN endogenous_JJ P_NNP 4_CD and_CC synthetic_JJ progestins_NNS in_IN female_JJ reproductive_JJ functions_NNS and_CC their_PRP$ pharmacotherapy_NN ,_, it_PRP is_VBZ relevant_JJ to_TO revisit_VB the_DT potential_JJ role_NN of_IN these_DT hormones_NNS in_IN the_DT origin_NN and_CC growth_NN of_IN prolactinomas_NNS ._. 
Wellcome_NNP TrustIntroductionThe_NNP prevalence_NN of_IN pituitary_JJ adenomas_NNS is_VBZ according_VBG to_TO a_DT recent_JJ report_NN 94\/100_CD 
2002_CD -RRB-_-RRB- ,_, E_NNP 2_CD -_: induced_JJ proliferation_NN in_IN breast_NN cancer_NN cells_NNS activates_VBZ c-fos_JJ ,_, c-jun_JJ ,_, and_CC c-myc_JJ -LRB-_-LRB- Sutherland_NNP et_FW al_FW ._. 
1998_CD ,_, Cicatiello_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ,_, and_CC in_IN endometrial_JJ carcinoma_NN extracellular-signal-related_JJ kinase_NN -LRB-_-LRB- ERK_NNP -RRB-_-RRB- 1\/2_CD -LRB-_-LRB- Kashima_NNP et_FW al_FW ._. 
1994_CD ,_, Yen_NNP 
The_DT mitogenic_JJ effect_NN of_IN E_NN 2_CD and_CC P_NNP 4_CD in_IN breast_NN cancer_NN cells_NNS is_VBZ mediated_VBN through_IN increased_VBN CCND1_NNP 
Tamoxifen_NNP ,_, bromocriptine_NN ,_, and_CC mifepristone_NN treatments_NNS also_RB down-regulated_JJ Ccnd1_NNP expression_NN ,_, suggesting_VBG that_IN the_DT upregulation_NN of_IN pituitary_JJ Ccnd1_NNP expression_NN in_IN TG_NNP females_NNS could_MD occur_VB through_IN cross-talk_NN between_IN normal_JJ E_NNP 2_CD and_CC high_JJ P_NN 4_CD levels_NNS ,_, and_CC decreased_VBD dopaminergic_JJ tone_NN ._. 
Similar_JJ responses_NNS were_VBD observed_VBN with_IN the_DT downstream_JJ effector_NN E2f1_NNP ,_, in_IN agreement_NN with_IN a_DT recent_JJ report_NN that_IN CCND1_NNP can_MD recruit_VB its_PRP$ own_JJ promoter_NN through_IN the_DT RB\/E2F_NNP pathway_NN after_IN ESR1\/PGR_NNP activation_NN -LRB-_-LRB- Cicatiello_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
The_DT role_NN of_IN P_NNP 4_CD was_VBD further_RB confirmed_VBN in_IN cultured_JJ primary_JJ pituitary_JJ cells_NNS showing_VBG that_IN only_RB the_DT E_NNP 2_CD \/_FW P_FW 4_CD combination_NN induced_VBD Ccnd1_JJ expression_NN ._. 
Synergism_NNP between_IN E_NNP 2_CD and_CC P_NNP 4_CD action_NN has_VBZ been_VBN observed_VBN in_IN some_DT endocrine_NN tumors_NNS ._. 
2009_CD -RRB-_-RRB- ,_, leading_VBG in_IN both_DT models_NNS to_TO upregulation_NN of_IN cyclins_NNS D1_NNP and_CC E._NNP In_NNP cultured_VBD post-menopausal_JJ ,_, hormonally_RB treated_VBN breast_NN tissue_NN ,_, E2_NNP ,_, the_DT synthetic_JJ progestin_NN medroxyprogesterone_NN acetate_NN and_CC their_PRP$ combination_NN increase_NN the_DT number_NN of_IN Ki-67-positive_JJ cells_NNS -LRB-_-LRB- Eigeliene_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ,_, with_IN concomitant_JJ increase_NN in_IN CCND1_NNP and_CC p21-positive_JJ cells_NNS and_CC reduced_VBN p27_JJ expression_NN ._. 
Whether_IN similar_JJ synergism_NN is_VBZ possible_JJ between_IN E_NNP 2_CD and_CC P_NNP 4_CD in_IN the_DT pathogenesis_NN of_IN pituitary_JJ adenomas_NNS has_VBZ not_RB been_VBN studied_VBN ._. 
Female_JJ sex_NN is_VBZ a_DT risk_NN factor_NN for_IN prolactinomas_NNS in_IN humans_NNS ,_, apparently_RB due_JJ to_TO the_DT effects_NNS of_IN estradiol_NN -LRB-_-LRB- E_NNP 2_CD -RRB-_-RRB- ._. 
This_DT link_NN is_VBZ supported_VBN for_IN example_NN by_IN more_RBR common_JJ occurrence_NN of_IN these_DT tumors_NNS in_IN women_NNS -LRB-_-LRB- Faglia_NNP 1993_CD ,_, Drange_FW et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ,_, the_DT increase_NN of_IN their_PRP$ growth_NN during_IN pregnancy_NN -LRB-_-LRB- Molitch_NNP 1999_CD -RRB-_-RRB- ,_, the_DT stimulating_VBG effect_NN of_IN estrogens_NNS on_IN PRL_NNP secretion_NN -LRB-_-LRB- Lieberman_NNP et_FW al_FW ._. 
1998_CD -RRB-_-RRB- ._. 
1998_CD ,_, Yamasaki_FW et_FW al_FW ._. 
1992_CD ,_, Franklin_NNP et_NNP al_NNP ._. 
Increased_VBN activation_NN of_IN the_DT cyclin_NN D1_NNP -LRB-_-LRB- CCND1_NNP -RRB-_-RRB- \/_FW cyclin-dependent_FW kinase_FW 4_CD -LRB-_-LRB- CDK4_NNP -RRB-_-RRB- \/_CD retinoblastoma_NN protein_NN -LRB-_-LRB- RB_NN -RRB-_-RRB- \/_NN transcription_NN factor_NN E2F1_NNP pathway_NN ,_, or_CC its_PRP$ suppressed_VBN inhibition_NN due_JJ to_TO deficiency_NN of_IN p18_CD and_CC p27_CD ,_, has_VBZ been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN mouse_NN models_NNS of_IN pituitary_JJ tumors_NNS -LRB-_-LRB- Jacks_NNPS et_FW al_FW ._. 
In_IN humans_NNS ,_, tissue-specific_JJ overexpression_NN of_IN CCND1_NNP ,_, or_CC decreased_VBD expression_NN of_IN p16_CD ,_, p18_CD ,_, and_CC p27_CD ,_, is_VBZ common_JJ in_IN tumors_NNS of_IN the_DT pituitary_JJ gland_NN -LRB-_-LRB- Peters_NNP 1994_CD ,_, Musat_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
Recently_RB ,_, overexpression_NN of_IN the_DT high-mobility_JJ group_NN protein_NN A2_NNP -LRB-_-LRB- HMGA2_NNP -RRB-_-RRB- in_IN pituitary_JJ tumors_NNS has_VBZ been_VBN described_VBN in_IN mice_NNS and_CC men_NNS -LRB-_-LRB- Fedele_FW et_FW al_FW ._. 
Because_IN of_IN the_DT only_RB slight_JJ 2_CD ._. 
1991_CD -RRB-_-RRB- ,_, and_CC its_PRP$ expression_NN was_VBD highly_RB up-regulated_JJ in_IN the_DT TG_NNP pituitaries_NNS ,_, and_CC dramatically_RB suppressed_VBN by_IN Gx_NNP ,_, while_IN the_DT other_JJ hormone_NN manipulations_NNS had_VBD smaller_JJR decreasing_VBG effects_NNS ._. 
1-fold_JJ overexpression_NN of_IN bone_NN morphogenic_JJ protein_NN 4_CD -LRB-_-LRB- Bmp4_NNP -RRB-_-RRB- ,_, a_DT known_JJ stimulus_NN of_IN prolactinoma_NN growth_NN -LRB-_-LRB- Paez-Pereda_NNP et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ,_, in_IN the_DT TG_NNP pituitaries_NNS ,_, we_PRP also_RB assessed_VBD the_DT expression_NN level_NN of_IN noggin_NN -LRB-_-LRB- Nog_NNP -RRB-_-RRB- ,_, the_DT inhibitor_NN of_IN BMP4_NNP -LRB-_-LRB- 
Estrogens_NNS are_VBP apparently_RB not_RB the_DT only_JJ cause_NN ,_, and_CC the_DT role_NN of_IN other_JJ possible_JJ ovarian_JJ hormones_NNS and_CC local_JJ growth_NN factors_NNS in_IN this_DT tumorigenesis_NN is_VBZ less_RBR well_RB defined_VBN ._. 
Although_IN progesterone_NN -LRB-_-LRB- P4_CD -RRB-_-RRB- receptors_NNS are_VBP expressed_VBN in_IN mouse_NN pituitary_NN lactotroph_NN cells_NNS -LRB-_-LRB- Turgeon_NNP et_FW al._FW ._. 
2001_CD -RRB-_-RRB- and_CC human_JJ prolactinomas_NNS -LRB-_-LRB- Jaffrain-Rea_FW et_FW al_FW ._. 
1996_CD -RRB-_-RRB- ,_, the_DT role_NN of_IN P_NNP 4_CD in_IN pituitary_JJ tumorigenesis_NN remains_VBZ confusing_JJ with_IN reports_NNS on_IN both_DT stimulatory_JJ and_CC inhibitory_JJ effects_NNS in_IN rodents_NNS -LRB-_-LRB- Poel_NNP 1966_CD ,_, Lamberts_NNPS et_FW al_FW ._. 
This_DT link_NN is_VBZ supported_VBN for_IN example_NN by_IN more_RBR common_JJ occurrence_NN of_IN these_DT tumors_NNS in_IN women_NNS -LRB-_-LRB- Faglia_NNP 1993_CD ,_, Drange_FW et_FW al_FW ._. 
2000_CD -RRB-_-RRB- ,_, the_DT increase_NN of_IN their_PRP$ growth_NN during_IN pregnancy_NN -LRB-_-LRB- Molitch_NNP 1999_CD -RRB-_-RRB- ,_, the_DT stimulating_VBG effect_NN of_IN estrogens_NNS on_IN PRL_NNP secretion_NN -LRB-_-LRB- Lieberman_NNP et_FW al._FW ._. 
1981_CD ,_, Maurer_NNP 1982_CD -RRB-_-RRB- ,_, and_CC the_DT occurrence_NN of_IN lactotroph_JJ adenomas_NNS in_IN transsexual_JJ men_NNS during_IN pharmacological_JJ estrogen_NN treatment_NN -LRB-_-LRB- Mueller_NNP 
1998_CD -RRB-_-RRB- ._. 
Cross-talk_NN between_IN ESR1_NNP and_CC PGR_NNP has_VBZ shown_VBN to_TO be_VB mediated_VBN through_IN the_DT SRC\/P21ras\/ERK_NNP pathway_NN in_IN human_JJ breast_NN cancer_NN cells_NNS -LRB-_-LRB- Migliaccio_NNP et_FW al_FW ._. 
Dopamine_NNP D2_NNP receptors_NNS mediate_VBP their_PRP$ inhibitory_NN signaling_VBG through_IN inactivation_NN of_IN ERK1\/2_NNP -LRB-_-LRB- Liu_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ,_, explaining_VBG why_WRB bromocriptine_NN treatment_NN down-regulated_JJ Ccnd1_NNP ._. 
Tamoxifen_NNP ,_, bromocriptine_NN ,_, and_CC mifepristone_NN treatments_NNS also_RB down-regulated_JJ Ccnd1_NNP expression_NN ,_, suggesting_VBG that_IN the_DT upregulation_NN of_IN pituitary_JJ Ccnd1_NNP expression_NN in_IN TG_NNP females_NNS could_MD occur_VB through_IN cross-talk_NN between_IN normal_JJ E_NNP 2_CD and_CC high_JJ P_NN 4_CD levels_NNS ,_, and_CC decreased_VBD dopaminergic_JJ tone_NN ._. 
1998_CD -RRB-_-RRB- ._. 
In_IN the_DT mammary_JJ gland_NN and_CC uterine_NN epithelium_NN ,_, E_NNP 2_CD clearly_RB stimulates_VBZ cell_NN proliferation_NN ,_, whereas_IN P_NNP 4_CD has_VBZ both_DT stimulatory_JJ and_CC inhibitory_JJ effects_NNS -LRB-_-LRB- Sutherland_NNP et_FW al_FW ._. 
In_IN contrast_NN ,_, in_IN uterine_NN stroma_NN ,_, P4_NNP stimulates_VBZ cell_NN proliferation_NN both_DT in_IN the_DT presence_NN and_CC in_IN the_DT absence_NN of_IN E2_NNP -LRB-_-LRB- Martin_NNP et_FW al._FW ._. 
1973_CD -RRB-_-RRB- ._. 
The_DT mitogenic_JJ effect_NN of_IN E_NN 2_CD and_CC P_NNP 4_CD in_IN breast_NN cancer_NN cells_NNS is_VBZ mediated_VBN through_IN increased_VBN CCND1_NNP 
2000_CD -RRB-_-RRB- ,_, the_DT increase_NN of_IN their_PRP$ growth_NN during_IN pregnancy_NN -LRB-_-LRB- Molitch_NNP 1999_CD -RRB-_-RRB- ,_, the_DT stimulating_VBG effect_NN of_IN estrogens_NNS on_IN PRL_NNP secretion_NN -LRB-_-LRB- Lieberman_NNP et_FW al_FW ._. 
1981_CD ,_, Maurer_NNP 1982_CD -RRB-_-RRB- ,_, and_CC the_DT occurrence_NN of_IN lactotroph_JJ adenomas_NNS in_IN transsexual_JJ men_NNS during_IN pharmacological_JJ estrogen_NN treatment_NN -LRB-_-LRB- Mueller_NNP 
2006_CD -RRB-_-RRB- ,_, and_CC prolactinomas_NNS are_VBP by_IN far_RB the_DT commonest_JJS form_NN of_IN pituitary_JJ tumors_NNS -LRB-_-LRB- 66_CD %_NN -RRB-_-RRB- ._. 
Wellcome_NNP Trust_NNP Introduction_NNP The_DT prevalence_NN of_IN pituitary_JJ adenomas_NNS is_VBZ according_VBG to_TO a_DT recent_JJ report_NN 94\/100_CD 
1996_CD -RRB-_-RRB- ._. 
CCND1_NNP is_VBZ a_DT known_JJ target_NN of_IN the_DT MAPK\/ERK_NNP signaling_VBG pathway_NN ,_, and_CC continued_VBD Ccnd1_NNP expression_NN requires_VBZ sustained_VBN MAPK_NNP activation_NN -LRB-_-LRB- Lavoie_FW et_FW al_FW ._. 
Cross-talk_NN between_IN ESR1_NNP and_CC PGR_NNP has_VBZ shown_VBN to_TO be_VB mediated_VBN through_IN the_DT SRC\/P21ras\/ERK_NNP pathway_NN in_IN human_JJ breast_NN cancer_NN cells_NNS -LRB-_-LRB- Migliaccio_NNP et_FW al._FW ._. 
1998_CD -RRB-_-RRB- ._. 
Dopamine_NNP D2_NNP receptors_NNS mediate_VBP their_PRP$ inhibitory_NN signaling_VBG through_IN inactivation_NN of_IN ERK1\/2_NNP -LRB-_-LRB- Liu_NNP et_FW al_FW ._. 
This_DT link_NN is_VBZ supported_VBN for_IN example_NN by_IN more_RBR common_JJ occurrence_NN of_IN these_DT tumors_NNS in_IN women_NNS -LRB-_-LRB- Faglia_NNP 1993_CD ,_, Drange_FW et_FW al_FW ._. 
2000_CD -RRB-_-RRB- ,_, the_DT increase_NN of_IN their_PRP$ growth_NN during_IN pregnancy_NN -LRB-_-LRB- Molitch_NNP 1999_CD -RRB-_-RRB- ,_, the_DT stimulating_VBG effect_NN of_IN estrogens_NNS on_IN PRL_NNP secretion_NN -LRB-_-LRB- Lieberman_NNP et_FW al._FW ._. 
1981_CD ,_, Maurer_NNP 1982_CD -RRB-_-RRB- ,_, and_CC the_DT occurrence_NN of_IN lactotroph_JJ adenomas_NNS in_IN transsexual_JJ men_NNS during_IN pharmacological_JJ estrogen_NN treatment_NN -LRB-_-LRB- Mueller_NNP 
2000_CD -RRB-_-RRB- ,_, the_DT increase_NN of_IN their_PRP$ growth_NN during_IN pregnancy_NN -LRB-_-LRB- Molitch_NNP 1999_CD -RRB-_-RRB- ,_, the_DT stimulating_VBG effect_NN of_IN estrogens_NNS on_IN PRL_NNP secretion_NN -LRB-_-LRB- Lieberman_NNP et_FW al_FW ._. 
1981_CD ,_, Maurer_NNP 1982_CD -RRB-_-RRB- ,_, and_CC the_DT occurrence_NN of_IN lactotroph_JJ adenomas_NNS in_IN transsexual_JJ men_NNS during_IN pharmacological_JJ estrogen_NN treatment_NN -LRB-_-LRB- Mueller_NNP 
2008_CD -RRB-_-RRB- ,_, there_EX are_VBP also_RB studies_NNS on_IN stimulatory_JJ effects_NNS of_IN this_DT steroid_NN ,_, especially_RB in_IN combination_NN with_IN E_NNP 2_CD -LRB-_-LRB- Poel_NNP 1966_CD ,_, Chen_NNP 
2001_CD ,_, Rey-Roldan_JJ et_FW al_FW ._. 
While_IN several_JJ previous_JJ studies_NNS demonstrate_VBP the_DT inhibitory_JJ effects_NNS of_IN P_NNP 4_CD on_IN the_DT growth_NN and_CC PRL_NNP production_NN of_IN normal_JJ and_CC tumorous_JJ pituitary_JJ cells_NNS -LRB-_-LRB- Haug_NNP 
1992_CD ,_, Franklin_NNP et_NNP al_NNP ._. 
Increased_VBN activation_NN of_IN the_DT cyclin_NN D1_NNP -LRB-_-LRB- CCND1_NNP -RRB-_-RRB- \/_FW cyclin-dependent_FW kinase_FW 4_CD -LRB-_-LRB- CDK4_NNP -RRB-_-RRB- \/_CD retinoblastoma_NN protein_NN -LRB-_-LRB- RB_NN -RRB-_-RRB- \/_NN transcription_NN factor_NN E2F1_NNP pathway_NN ,_, or_CC its_PRP$ suppressed_VBN inhibition_NN due_JJ to_TO deficiency_NN of_IN p18_CD and_CC p27_CD ,_, has_VBZ been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN mouse_NN models_NNS of_IN pituitary_JJ tumors_NNS -LRB-_-LRB- Jacks_NNPS et_FW al_FW ._. 
1998_CD ,_, Yamasaki_FW et_FW al._FW ._. 
1998_CD -RRB-_-RRB- ._. 
In_IN humans_NNS ,_, tissue-specific_JJ overexpression_NN of_IN CCND1_NNP ,_, or_CC decreased_VBD expression_NN of_IN p16_CD ,_, p18_CD ,_, and_CC p27_CD ,_, is_VBZ common_JJ in_IN tumors_NNS of_IN the_DT pituitary_JJ gland_NN -LRB-_-LRB- Peters_NNP 1994_CD ,_, Musat_FW et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ,_, but_CC that_IN of_IN the_DT other_JJ ovarian_JJ sex_NN hormone_NN ,_, P_NNP 4_CD ,_, remains_VBZ controversial_JJ ._. 
The_DT role_NN of_IN E_NNP 2_CD in_IN the_DT induction_NN of_IN pituitary_JJ adenomas_NNS is_VBZ well_RB known_VBN -LRB-_-LRB- Heaney_NNP et_FW al_FW ._. 
While_IN several_JJ previous_JJ studies_NNS demonstrate_VBP the_DT inhibitory_JJ effects_NNS of_IN P4_NN on_IN the_DT growth_NN and_CC PRL_NNP production_NN of_IN normal_JJ and_CC tumorous_JJ pituitary_JJ cells_NNS -LRB-_-LRB- Haug_NNP 
Increased_VBN activation_NN of_IN the_DT cyclin_NN D1_NNP -LRB-_-LRB- CCND1_NNP -RRB-_-RRB- \/_FW cyclin-dependent_FW kinase_FW 4_CD -LRB-_-LRB- CDK4_NNP -RRB-_-RRB- \/_CD retinoblastoma_NN protein_NN -LRB-_-LRB- RB_NN -RRB-_-RRB- \/_NN transcription_NN factor_NN E2F1_NNP pathway_NN ,_, or_CC its_PRP$ suppressed_VBN inhibition_NN due_JJ to_TO deficiency_NN of_IN p18_CD and_CC p27_CD ,_, has_VBZ been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN mouse_NN models_NNS of_IN pituitary_JJ tumors_NNS -LRB-_-LRB- Jacks_NNPS et_FW al_FW ._. 
1992_CD ,_, Franklin_NNP et_NNP al._NNP ._. 
1998_CD ,_, Yamasaki_FW et_FW al_FW ._. 
1998_CD -RRB-_-RRB- ._. 
In_IN humans_NNS ,_, tissue-specific_JJ overexpression_NN of_IN CCND1_NNP ,_, or_CC decreased_VBD expression_NN of_IN p16_CD ,_, p18_CD ,_, and_CC p27_CD ,_, is_VBZ common_JJ in_IN tumors_NNS of_IN the_DT pituitary_JJ gland_NN -LRB-_-LRB- Peters_NNP 1994_CD ,_, Musat_FW et_FW al_FW ._. 
Likewise_RB ,_, several_JJ rodent_NN models_NNS support_VBP the_DT role_NN of_IN estrogens_NNS in_IN the_DT formation_NN of_IN prolactinomas_NNS -LRB-_-LRB- Walker_NNP 
1981_CD ,_, Maurer_NNP 1982_CD -RRB-_-RRB- ,_, and_CC the_DT occurrence_NN of_IN lactotroph_JJ adenomas_NNS in_IN transsexual_JJ men_NNS during_IN pharmacological_JJ estrogen_NN treatment_NN -LRB-_-LRB- Mueller_NNP 
2006_CD -RRB-_-RRB- ._. 
This_DT factor_NN binds_VBZ to_TO the_DT inactive_JJ RB\/E2F1_NNP complex_NN ,_, displacing_VBG histone_JJ deacetylase_NN 1_CD -LRB-_-LRB- HDAC1_NNP -RRB-_-RRB- ,_, leading_VBG to_TO histone_VB acetylation_NN ,_, opening_VBG of_IN the_DT chromatin_NN structure_NN ,_, and_CC stabilizing_VBG E2F1_NNP -LRB-_-LRB- Fedele_NNP et_FW al_FW ._. 
Besides_IN the_DT role_NN of_IN E2_NNP in_IN the_DT pathogenesis_NN of_IN pituitary_JJ tumors_NNS -LRB-_-LRB- Heaney_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ,_, E_NNP 2_CD -_: induced_JJ proliferation_NN in_IN breast_NN cancer_NN cells_NNS activates_VBZ c-fos_JJ ,_, c-jun_JJ ,_, and_CC c-myc_JJ -LRB-_-LRB- Sutherland_NNP et_FW al_FW ._. 
Fourthly_RB ,_, P_NNP 4_CD alone_RB had_VBD no_DT effect_NN on_IN pituitary_JJ growth_NN ,_, and_CC showed_VBD no_DT estrogenic_JJ effects_NNS ,_, such_JJ as_IN stimulation_NN of_IN PRL_NNP secretion_NN or_CC upregulation_NN of_IN pituitary_JJ Pgr_NNP expression_NN ,_, thus_RB excluding_VBG the_DT conversion_NN of_IN P_NNP 4_CD to_TO functionally_RB meaningful_JJ levels_NNS of_IN E_NNP 2_CD ._. 
The_DT role_NN of_IN E2_NNP in_IN the_DT induction_NN of_IN pituitary_JJ adenomas_NNS is_VBZ well_RB known_VBN -LRB-_-LRB- Heaney_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ,_, but_CC that_IN of_IN the_DT other_JJ ovarian_JJ sex_NN hormone_NN ,_, P_NNP 4_CD ,_, remains_VBZ controversial_JJ ._. 
While_IN several_JJ previous_JJ studies_NNS demonstrate_VBP the_DT inhibitory_JJ effects_NNS of_IN P_NNP 4_CD on_IN the_DT growth_NN and_CC PRL_NNP production_NN of_IN normal_JJ and_CC tumorous_JJ pituitary_JJ cells_NNS -LRB-_-LRB- Haug_NNP 
Recent_JJ studies_NNS have_VBP elucidated_VBN the_DT molecular_JJ pathogenesis_NN of_IN pituitary_JJ adenomas_NNS ._. 
1985_CD -RRB-_-RRB- ._. 
1996_CD -RRB-_-RRB- ,_, the_DT role_NN of_IN P_NNP 4_CD in_IN pituitary_JJ tumorigenesis_NN remains_VBZ confusing_JJ with_IN reports_NNS on_IN both_DT stimulatory_JJ and_CC inhibitory_JJ effects_NNS in_IN rodents_NNS -LRB-_-LRB- Poel_NNP 1966_CD ,_, Lamberts_NNPS et_FW al_FW ._. 
Increased_VBN activation_NN of_IN the_DT cyclin_NN D1_NNP -LRB-_-LRB- CCND1_NNP -RRB-_-RRB- \/_FW cyclin-dependent_FW kinase_FW 4_CD -LRB-_-LRB- CDK4_NNP -RRB-_-RRB- \/_CD retinoblastoma_NN protein_NN -LRB-_-LRB- RB_NN -RRB-_-RRB- \/_NN transcription_NN factor_NN E2F1_NNP pathway_NN ,_, or_CC its_PRP$ suppressed_VBN inhibition_NN due_JJ to_TO deficiency_NN of_IN p18_CD and_CC p27_CD ,_, has_VBZ been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN mouse_NN models_NNS of_IN pituitary_JJ tumors_NNS -LRB-_-LRB- Jacks_NNPS et_FW al._FW ._. 
1992_CD ,_, Franklin_NNP et_NNP al_NNP ._. 
1998_CD ,_, Yamasaki_FW et_FW al_FW ._. 
1998_CD -RRB-_-RRB- ._. 
In_IN humans_NNS ,_, tissue-specific_JJ overexpression_NN of_IN CCND1_NNP ,_, or_CC decreased_VBD expression_NN of_IN p16_CD ,_, p18_CD ,_, and_CC p27_CD ,_, is_VBZ common_JJ in_IN tumors_NNS of_IN the_DT pituitary_JJ gland_NN -LRB-_-LRB- Peters_NNP 1994_CD ,_, Musat_FW et_FW al_FW ._. 
Its_PRP$ expression_NN did_VBD not_RB differ_VB between_IN the_DT WT_NNP and_CC TG_NNP females_NNS ,_, but_CC was_VBD decreased_VBN by_IN Gx_NNP and_CC slightly_RB increased_VBN by_IN bromocriptine_NN ._. 
Galanin_NNP is_VBZ a_DT marker_NN of_IN lactotrophs_NNS and_CC their_PRP$ response_NN to_TO estrogens_NNS -LRB-_-LRB- Hyde_NNP et_FW al._FW ._. 
1991_CD -RRB-_-RRB- ,_, and_CC its_PRP$ expression_NN was_VBD highly_RB up-regulated_JJ in_IN the_DT TG_NNP pituitaries_NNS ,_, and_CC dramatically_RB suppressed_VBN by_IN Gx_NNP ,_, while_IN the_DT other_JJ hormone_NN manipulations_NNS had_VBD smaller_JJR decreasing_VBG effects_NNS ._. 
1998_CD ,_, Cicatiello_NNP et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ,_, E_NNP 2_CD -_: induced_JJ proliferation_NN in_IN breast_NN cancer_NN cells_NNS activates_VBZ c-fos_JJ ,_, c-jun_JJ ,_, and_CC c-myc_JJ -LRB-_-LRB- Sutherland_NNP et_FW al_FW ._. 
2004_CD -RRB-_-RRB- ,_, and_CC in_IN endometrial_JJ carcinoma_NN extracellular-signal-related_JJ kinase_NN -LRB-_-LRB- ERK_NNP -RRB-_-RRB- 1\/2_CD -LRB-_-LRB- Kashima_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ,_, leading_VBG in_IN both_DT models_NNS to_TO upregulation_NN of_IN cyclins_NNS D1_NNP and_CC E._NNP Synergism_NNP between_IN E_NNP 2_CD and_CC P_NNP 4_CD action_NN has_VBZ been_VBN observed_VBN in_IN some_DT endocrine_NN tumors_NNS ._. 
Although_IN progesterone_NN -LRB-_-LRB- P_NNP 4_CD -RRB-_-RRB- receptors_NNS are_VBP expressed_VBN in_IN mouse_NN pituitary_NN lactotroph_NN cells_NNS -LRB-_-LRB- Turgeon_NNP et_FW al_FW ._. 
2001_CD -RRB-_-RRB- and_CC human_JJ prolactinomas_NNS -LRB-_-LRB- Jaffrain-Rea_FW et_FW al._FW ._. 
1996_CD -RRB-_-RRB- ,_, the_DT role_NN of_IN P_NNP 4_CD in_IN pituitary_JJ tumorigenesis_NN remains_VBZ confusing_JJ with_IN reports_NNS on_IN both_DT stimulatory_JJ and_CC inhibitory_JJ effects_NNS in_IN rodents_NNS -LRB-_-LRB- Poel_NNP 1966_CD ,_, Lamberts_NNPS et_FW al_FW ._. 
In_IN addition_NN ,_, we_PRP found_VBD in_IN GH3_NNP cells_NNS increased_VBD RB_NN phosphorylation_NN ,_, which_WDT results_VBZ in_IN inactivation_NN of_IN this_DT protein_NN and_CC enhanced_JJ cyclin_NN D_NNP stimulation_NN of_IN E2F1_NNP ._. 
CCND1_NNP is_VBZ a_DT known_JJ target_NN of_IN the_DT MAPK\/ERK_NNP signaling_VBG pathway_NN ,_, and_CC continued_VBD Ccnd1_NNP expression_NN requires_VBZ sustained_VBN MAPK_NNP activation_NN -LRB-_-LRB- Lavoie_FW et_FW al._FW ._. 
1996_CD -RRB-_-RRB- ._. 
Cross-talk_NN between_IN ESR1_NNP and_CC PGR_NNP has_VBZ shown_VBN to_TO be_VB mediated_VBN through_IN the_DT SRC\/P21ras\/ERK_NNP pathway_NN in_IN human_JJ breast_NN cancer_NN cells_NNS -LRB-_-LRB- Migliaccio_NNP et_FW al_FW ._. 
2001_CD -RRB-_-RRB- and_CC human_JJ prolactinomas_NNS -LRB-_-LRB- Jaffrain-Rea_FW et_FW al_FW ._. 
Although_IN progesterone_NN -LRB-_-LRB- P_NNP 4_CD -RRB-_-RRB- receptors_NNS are_VBP expressed_VBN in_IN mouse_NN pituitary_NN lactotroph_NN cells_NNS -LRB-_-LRB- Turgeon_NNP et_FW al_FW ._. 
1996_CD -RRB-_-RRB- ,_, the_DT role_NN of_IN P4_NNP in_IN pituitary_JJ tumorigenesis_NN remains_VBZ confusing_JJ with_IN reports_NNS on_IN both_DT stimulatory_JJ and_CC inhibitory_JJ effects_NNS in_IN rodents_NNS -LRB-_-LRB- Poel_NNP 1966_CD ,_, Lamberts_NNPS et_FW al._FW ._. 
1985_CD -RRB-_-RRB- ._. 
Recent_JJ studies_NNS have_VBP elucidated_VBN the_DT molecular_JJ pathogenesis_NN of_IN pituitary_JJ adenomas_NNS ._. 
Increased_VBN activation_NN of_IN the_DT cyclin_NN D1_NNP -LRB-_-LRB- CCND1_NNP -RRB-_-RRB- \/_FW cyclin-dependent_FW kinase_FW 4_CD -LRB-_-LRB- CDK4_NNP -RRB-_-RRB- \/_CD retinoblastoma_NN protein_NN -LRB-_-LRB- RB_NN -RRB-_-RRB- \/_NN transcription_NN factor_NN E2F1_NNP pathway_NN ,_, or_CC its_PRP$ suppressed_VBN inhibition_NN due_JJ to_TO deficiency_NN of_IN p18_CD and_CC p27_CD ,_, has_VBZ been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN mouse_NN models_NNS of_IN pituitary_JJ tumors_NNS -LRB-_-LRB- Jacks_NNPS et_FW al_FW ._. 
Whether_IN similar_JJ synergism_NN is_VBZ possible_JJ between_IN E_NNP 2_CD and_CC P_NNP 4_CD in_IN the_DT pathogenesis_NN of_IN pituitary_JJ adenomas_NNS has_VBZ not_RB been_VBN studied_VBN ._. 
We_PRP have_VBP reported_VBN previously_RB that_IN transgenic_JJ -LRB-_-LRB- TG_NNP -RRB-_-RRB- female_JJ mice_NNS with_IN elevated_JJ LH\/human_NNP choriongonadotropin_NN -LRB-_-LRB- hCG_NNP -RRB-_-RRB- action_NN through_IN the_DT expression_NN of_IN the_DT hCG_NN 
In_IN the_DT current_JJ study_NN ,_, we_PRP explore_VBP in_IN more_JJR detail_NN the_DT role_NN of_IN the_DT high_JJ circulating_VBG levels_NNS of_IN P_NNP 4_CD in_IN these_DT animals_NNS in_IN the_DT growth_NN of_IN the_DT pituitary_JJ adenomas_NNS and_CC elucidate_VB the_DT molecular_JJ mechanisms_NNS involved_VBN ._. 
Materials_NNPS and_CC methodsThe_NNP transgenic_JJ mouse_NN modelTG_NNP female_JJ mice_NNS of_IN the_DT FVB\/N_NNP strain_NN expressing_VBG heterozygously_RB the_DT hCG_NN 
05_CD was_VBD considered_VBN statistically_RB significant_JJ ._. 
AP_NNP value_NN 
Somewhat_RB weaker_JJR inhibition_NN was_VBD found_VBN with_IN bromocriptine_NN and_CC mifepristone_NN alone_RB ._. 
The_DT inhibitory_JJ effects_NNS of_IN tamoxifen_NN and_CC tamoxifen_NN +_NN mifepristone_NN combination_NN were_VBD equal_JJ ._. 
Short_JJ tamoxifen_NN treatment_NN between_IN 1_CD week_NN and_CC 2_CD months_NNS of_IN age_NN ,_, to_TO block_VB the_DT action_NN of_IN the_DT peripubertal_JJ E2_NNP peak_NN in_IN TG_NNP females_NNS -LRB-_-LRB- Rulli_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ,_, persistently_RB reduced_VBN pituitary_JJ weights_NNS ,_, and_CC subsequent_JJ mifepristone_NN treatment_NN of_IN these_DT mice_NNS -LRB-_-LRB- 2_CD 
Supplementary_NNP Table_NNP 1_CD -RRB-_-RRB- ._. 
endocrinology-journals_NNS ._. 
Ccnd1\/Cdk4_NNP ,_, E2f1_NNP ,_, and_CC Hmga2_NNP are_VBP up-regulated_JJ ,_, and_CC RB1_NNP is_VBZ down-regulated_JJ ,_, in_IN the_DT adenomatous_JJ pituitaries_NNS A_DT number_NN of_IN candidate_NN genes_NNS with_IN putative_JJ involvement_NN in_IN the_DT pituitary_JJ adenoma_NN formation_NN ,_, selected_VBN on_IN the_DT basis_NN of_IN literature_NN ,_, were_VBD studied_VBN by_IN qRT-PCR_NNP for_IN altered_JJ expression_NN in_IN the_DT tumors_NNS -LRB-_-LRB- 
Effect_NN of_IN E_NNP 2_CD ,_, P_NN 4_CD ,_, and_CC their_PRP$ combination_NN on_IN primary_JJ mouse_NN pituitary_NN cells_NNS and_CC GH3_CD cells_NNS Finally_RB ,_, to_TO obtain_VB further_JJ evidence_NN for_IN a_DT direct_JJ P_NNP 4_CD effect_NN on_IN pituitary_JJ cell_NN proliferation_NN ,_, we_PRP stimulated_VBD primary_JJ pituitary_JJ cells_NNS of_IN adult_JJ TG_NNP females_NNS with_IN E_NNP 2_CD ,_, P_NN 4_CD ,_, and_CC their_PRP$ combination_NN ._. 
The_DT concentrations_NNS used_VBD -LRB-_-LRB- E2_CD =_SYM 100_CD 
While_IN several_JJ previous_JJ studies_NNS demonstrate_VBP the_DT inhibitory_JJ effects_NNS of_IN P_NNP 4_CD on_IN the_DT growth_NN and_CC PRL_NNP production_NN of_IN normal_JJ and_CC tumorous_JJ pituitary_JJ cells_NNS -LRB-_-LRB- Haug_NNP 
2001_CD -RRB-_-RRB- and_CC human_JJ prolactinomas_NNS -LRB-_-LRB- Jaffrain-Rea_FW et_FW al_FW ._. 
Although_IN progesterone_NN -LRB-_-LRB- P_NNP 4_CD -RRB-_-RRB- receptors_NNS are_VBP expressed_VBN in_IN mouse_NN pituitary_NN lactotroph_NN cells_NNS -LRB-_-LRB- Turgeon_NNP et_FW al_FW ._. 
1996_CD -RRB-_-RRB- ,_, the_DT role_NN of_IN P4_NNP in_IN pituitary_JJ tumorigenesis_NN remains_VBZ confusing_JJ with_IN reports_NNS on_IN both_DT stimulatory_JJ and_CC inhibitory_JJ effects_NNS in_IN rodents_NNS -LRB-_-LRB- Poel_NNP 1966_CD ,_, Lamberts_NNPS et_FW al._FW ._. 
1985_CD -RRB-_-RRB- ._. 
Recent_JJ studies_NNS have_VBP elucidated_VBN the_DT molecular_JJ pathogenesis_NN of_IN pituitary_JJ adenomas_NNS ._. 
Increased_VBN activation_NN of_IN the_DT cyclin_NN D1_NNP -LRB-_-LRB- CCND1_NNP -RRB-_-RRB- \/_FW cyclin-dependent_FW kinase_FW 4_CD -LRB-_-LRB- CDK4_NNP -RRB-_-RRB- \/_CD retinoblastoma_NN protein_NN -LRB-_-LRB- RB_NN -RRB-_-RRB- \/_NN transcription_NN factor_NN E2F1_NNP pathway_NN ,_, or_CC its_PRP$ suppressed_VBN inhibition_NN due_JJ to_TO deficiency_NN of_IN p18_CD and_CC p27_CD ,_, has_VBZ been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN mouse_NN models_NNS of_IN pituitary_JJ tumors_NNS -LRB-_-LRB- Jacks_NNPS et_FW al_FW ._. 
2001_CD ,_, Rey-Roldan_JJ et_FW al_FW ._. 
While_IN several_JJ previous_JJ studies_NNS demonstrate_VBP the_DT inhibitory_JJ effects_NNS of_IN P_NNP 4_CD on_IN the_DT growth_NN and_CC PRL_NNP production_NN of_IN normal_JJ and_CC tumorous_JJ pituitary_JJ cells_NNS -LRB-_-LRB- Haug_NNP 
2002_CD -RRB-_-RRB- ,_, but_CC that_IN of_IN the_DT other_JJ ovarian_JJ sex_NN hormone_NN ,_, P_NNP 4_CD ,_, remains_VBZ controversial_JJ ._. 
The_DT role_NN of_IN E_NNP 2_CD in_IN the_DT induction_NN of_IN pituitary_JJ adenomas_NNS is_VBZ well_RB known_VBN -LRB-_-LRB- Heaney_NNP et_FW al_FW ._. 
While_IN several_JJ previous_JJ studies_NNS demonstrate_VBP the_DT inhibitory_JJ effects_NNS of_IN P4_NN on_IN the_DT growth_NN and_CC PRL_NNP production_NN of_IN normal_JJ and_CC tumorous_JJ pituitary_JJ cells_NNS -LRB-_-LRB- Haug_NNP 
1998_CD -RRB-_-RRB- ._. 
1998_CD ,_, Yamasaki_FW et_FW al_FW ._. 
1992_CD ,_, Franklin_NNP et_NNP al_NNP ._. 
Increased_VBN activation_NN of_IN the_DT cyclin_NN D1_NNP -LRB-_-LRB- CCND1_NNP -RRB-_-RRB- \/_FW cyclin-dependent_FW kinase_FW 4_CD -LRB-_-LRB- CDK4_NNP -RRB-_-RRB- \/_CD retinoblastoma_NN protein_NN -LRB-_-LRB- RB_NN -RRB-_-RRB- \/_NN transcription_NN factor_NN E2F1_NNP pathway_NN ,_, or_CC its_PRP$ suppressed_VBN inhibition_NN due_JJ to_TO deficiency_NN of_IN p18_CD and_CC p27_CD ,_, has_VBZ been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN mouse_NN models_NNS of_IN pituitary_JJ tumors_NNS -LRB-_-LRB- Jacks_NNPS et_FW al_FW ._. 
In_IN humans_NNS ,_, tissue-specific_JJ overexpression_NN of_IN CCND1_NNP ,_, or_CC decreased_VBD expression_NN of_IN p16_CD ,_, p18_CD ,_, and_CC p27_CD ,_, is_VBZ common_JJ in_IN tumors_NNS of_IN the_DT pituitary_JJ gland_NN -LRB-_-LRB- Peters_NNP 1994_CD ,_, Musat_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
Recently_RB ,_, overexpression_NN of_IN the_DT high-mobility_JJ group_NN protein_NN A2_NNP -LRB-_-LRB- HMGA2_NNP -RRB-_-RRB- in_IN pituitary_JJ tumors_NNS has_VBZ been_VBN described_VBN in_IN mice_NNS and_CC men_NNS -LRB-_-LRB- Fedele_FW et_FW al_FW ._. 
This_DT finding_NN was_VBD supported_VBN by_IN P_NNP 4_CD effects_NNS in_IN cultured_JJ primary_JJ mouse_NN pituitary_NN cells_NNS and_CC in_IN a_DT rat_NN somatomammotroph_NN cell_NN line_NN ._. 
The_DT mechanism_NN of_IN the_DT tumor_NN promotion_NN in_IN the_DT presence_NN of_IN P4_NNP was_VBD found_VBN to_TO involve_VB in_IN the_DT activation_NN of_IN CCND1_NNP and_CC HMGA2_NNP ,_, which_WDT are_VBP also_RB activated_VBN in_IN human_JJ pituitary_JJ adenomas_NNS -LRB-_-LRB- Peters_NNP 1994_CD ,_, Fedele_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Hence_RB ,_, the_DT molecular_JJ pathogenesis_NN of_IN these_DT murine_JJ tumors_NNS may_MD have_VB similar_JJ features_NNS with_IN that_DT of_IN human_JJ pituitary_JJ adenomas_NNS ._. 
Further_JJ details_NNS about_IN the_DT methodology_NN and_CC quality_NN control_NN are_VBP presented_VBN in_IN Supplementary_NNP data_NNS ._. 
2005_CD -RRB-_-RRB- ._. 
Primary_JJ cell_NN culturesPrimary_JJ pituitary_JJ cell_NN cultures_NNS were_VBD performed_VBN as_IN described_VBN earlier_RBR ,_, with_IN minor_JJ modifications_NNS -LRB-_-LRB- Pastorcic_FW et_FW al._FW ._. 
1995_CD -RRB-_-RRB- ._. 
Briefly_RB ,_, 3_CD 
Besides_IN the_DT role_NN of_IN E_NNP 2_CD in_IN the_DT pathogenesis_NN of_IN pituitary_JJ tumors_NNS -LRB-_-LRB- Heaney_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
This_DT factor_NN binds_VBZ to_TO the_DT inactive_JJ RB\/E2F1_NNP complex_NN ,_, displacing_VBG histone_JJ deacetylase_NN 1_CD -LRB-_-LRB- HDAC1_NNP -RRB-_-RRB- ,_, leading_VBG to_TO histone_VB acetylation_NN ,_, opening_VBG of_IN the_DT chromatin_NN structure_NN ,_, and_CC stabilizing_VBG E2F1_NNP -LRB-_-LRB- Fedele_NNP et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ,_, E2-induced_JJ proliferation_NN in_IN breast_NN cancer_NN cells_NNS activates_VBZ c-fos_JJ ,_, c-jun_JJ ,_, and_CC c-myc_JJ -LRB-_-LRB- Sutherland_NNP et_FW al._FW ._. 
1998_CD ,_, Cicatiello_NNP et_FW al_FW ._. 
2004_CD -RRB-_-RRB- ,_, and_CC in_IN endometrial_JJ carcinoma_NN extracellular-signal-related_JJ kinase_NN -LRB-_-LRB- ERK_NNP -RRB-_-RRB- 1\/2_CD -LRB-_-LRB- Kashima_NNP et_FW al_FW ._. 
Additive_JJ and_CC synergistic_JJ effects_NNS of_IN E_NN 2_CD and_CC P_NNP 4_CD are_VBP well_RB known_VBN on_IN the_DT growth_NN of_IN other_JJ hormone-responsive_JJ tumors_NNS ._. 
In_IN the_DT mammary_JJ gland_NN and_CC uterine_NN epithelium_NN ,_, E2_NNP clearly_RB stimulates_VBZ cell_NN proliferation_NN ,_, whereas_IN P4_NNP has_VBZ both_DT stimulatory_JJ and_CC inhibitory_JJ effects_NNS -LRB-_-LRB- Sutherland_NNP et_FW al._FW ._. 
1998_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, in_IN uterine_NN stroma_NN ,_, P_NN 4_CD stimulates_VBZ cell_NN proliferation_NN both_DT in_IN the_DT presence_NN and_CC in_IN the_DT absence_NN of_IN E_NNP 2_CD -LRB-_-LRB- Martin_NNP et_NNP al_NNP ._. 
1973_CD -RRB-_-RRB- ._. 
In_IN contrast_NN ,_, in_IN uterine_NN stroma_NN ,_, P_NN 4_CD stimulates_VBZ cell_NN proliferation_NN both_DT in_IN the_DT presence_NN and_CC in_IN the_DT absence_NN of_IN E_NNP 2_CD -LRB-_-LRB- Martin_NNP et_NNP al_NNP ._. 
The_DT mitogenic_JJ effect_NN of_IN E2_NNP and_CC P4_NNP in_IN breast_NN cancer_NN cells_NNS is_VBZ mediated_VBN through_IN increased_VBN CCND1_NNP 
In_IN contrast_NN ,_, ample_JJ evidence_NN shows_VBZ stimulatory_JJ effect_NN of_IN P_NNP 4_CD ,_, and_CC P_NNP 4_CD \/_NNP E_NNP 2_CD combination_NN ,_, on_IN the_DT growth_NN other_JJ hormone-responsive_JJ tumors_NNS ,_, such_JJ as_IN breast_NN and_CC uterine_NN carcinomas_NNS -LRB-_-LRB- Cicatiello_FW et_FW al_FW ._. 
2004_CD ,_, Saitoh_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
The_DT effect_NN observed_VBD is_VBZ intimately_RB dependent_JJ on_IN the_DT cell_NN type_NN ,_, timing_NN and_CC dose_NN of_IN treatment_NN ,_, and_CC the_DT effect_NN of_IN P_NN 4_CD is_VBZ often_RB biphasic_JJ ,_, with_IN an_DT acute_JJ stimulatory_JJ effect_NN followed_VBN by_IN loss_NN of_IN the_DT effect_NN or_CC inhibition_NN ._. 
1998_CD ,_, Cicatiello_NNP et_FW al_FW ._. 
The_DT mitogenic_JJ effect_NN of_IN E_NN 2_CD and_CC P_NNP 4_CD in_IN breast_NN cancer_NN cells_NNS is_VBZ mediated_VBN through_IN increased_VBN CCND1_NNP 
2000_CD -RRB-_-RRB- ._. 
Primer_NN sequences_NNS are_VBP available_JJ upon_IN request_NN and_CC PCR_NN conditions_NNS for_IN Bsm_NNP I_PRP have_VBP already_RB been_VBN published_VBN -LRB-_-LRB- Giguere_NNP et_FW al_FW ._. 
The_DT absence_NN of_IN the_DT polymorphic_JJ site_NN -LRB-_-LRB- B_NNP -RRB-_-RRB- resulted_VBD in_IN an_DT 850_CD 
2001_CD ,_, Wacholder_NNP et_FW al_FW ._. 
1993_CD ,_, Rothman_NNP 
2001_CD ,_, Hou_FW et_FW al_FW ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
1998_CD ,_, Ingles_FW et_FW al_FW ._. 
Eleven_CD studies_NNS assessed_VBD Bsm_NNP I_NNP association_NN with_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Ruggiero_FW et_FW al_FW ._. 
2002_CD ,_, Buyru_FW et_FW al._FW ._. 
2003_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2003_CD ,_, 2004_CD ,_, Hefler_NNP et_FW al_FW ._. 
2004_CD ,_, Chen_FW et_FW al_FW ._. 
2005_CD ,_, Lowe_NNP et_NNP al_NNP ._. 
2005_CD ,_, McCullough_NNP et_FW al_FW ._. 
1999_CD ,_, Shin_NNP et_FW al_FW ._. 
1996_CD ,_, John_NNP et_NNP al_NNP ._. 
1996_CD ,_, Negri_NNP et_FW al_FW ._. 
1991_CD ,_, Knekt_FW et_FW al_FW ._. 
1991_CD ,_, Zaridze_FW et_FW al_FW ._. 
2002_CD ,_, Abbas_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- although_IN not_RB all_DT -LRB-_-LRB- Graham_NNP et_NNP al_NNP ._. 
1991_CD ,_, Simard_NNP et_FW al_FW ._. 
1991_CD ,_, Levi_NNP et_FW al_FW ._. 
2001_CD -RRB-_-RRB- ._. 
An_DT inverse_JJ relationship_NN between_IN vitamin_NN D\/calcium_NN intakes_NNS and_CC breast_NN density_NN has_VBZ also_RB been_VBN observed_VBN -LRB-_-LRB- Holmes_NNP et_NNP al_NNP ._. 
An_DT inverse_JJ relationship_NN between_IN vitamin_NN D\/calcium_NN intakes_NNS and_CC breast_NN density_NN has_VBZ also_RB been_VBN observed_VBN -LRB-_-LRB- Holmes_NNP et_NNP al_NNP ._. 
2001_CD ,_, Berube_NNP et_FW al._FW ._. 
2004_CD ,_, 2005_CD ,_, Colangelo_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ,_, as_RB well_RB as_IN synchronized_VBN seasonal_JJ variations_NNS of_IN circulating_VBG 25-hydroxyvitamin_JJ D_NNP -LRB-_-LRB- 25_CD -LRB-_-LRB- OH_NNP -RRB-_-RRB- D_NNP -RRB-_-RRB- and_CC breast_NN density_NN -LRB-_-LRB- Brisson_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
Arecent_NNP randomized_VBD controlled_JJ trial_NN involving_VBG vitamin_JJ D_NNP supplementation_NN sufficient_JJ to_TO raise_VB serum_NN 25_CD -LRB-_-LRB- OH_NNP -RRB-_-RRB- D_NNP 
Controls_NNP had_VBD to_TO be_VB free_JJ of_IN breast_NN cancer_NN or_CC any_DT other_JJ cancer_NN -LRB-_-LRB- except_IN cervical_JJ intraepithelial_JJ neoplasm_NN or_CC basocellular_JJ skin_NN cancer_NN -RRB-_-RRB- ._. 
Details_NNS from_IN this_DT cohort_NN studied_VBN for_IN genetic_JJ and_CC environmental_JJ risk_NN factors_NNS affecting_VBG bone_NN mineral_NN density_NN have_VBP already_RB been_VBN described_VBN elsewhere_RB -LRB-_-LRB- Blanchet_NNP et_FW al._FW ._. 
2003_CD ,_, Laflamme_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
Atotal_NNP of_IN 622_CD cases_NNS and_CC 974_CD controls_NNS were_VBD genotyped_VBN in_IN the_DT same_JJ laboratory_NN as_IN in_IN study_NN 1_CD ._. 
2001_CD ,_, Berube_NNP et_FW al_FW ._. 
An_DT inverse_JJ relationship_NN between_IN vitamin_NN D\/calcium_NN intakes_NNS and_CC breast_NN density_NN has_VBZ also_RB been_VBN observed_VBN -LRB-_-LRB- Holmes_NNP et_NNP al_NNP ._. 
2004_CD ,_, 2005_CD ,_, Colangelo_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ,_, as_RB well_RB as_IN synchronized_VBN seasonal_JJ variations_NNS of_IN circulating_VBG 25-hydroxyvitamin_JJ D_NNP -LRB-_-LRB- 25_CD -LRB-_-LRB- OH_NNP -RRB-_-RRB- D_NNP -RRB-_-RRB- and_CC breast_NN density_NN -LRB-_-LRB- Brisson_NNP et_FW al_FW ._. 
2004_CD ,_, 2005_CD ,_, Colangelo_NNP et_FW al_FW ._. 
2001_CD ,_, Berube_NNP et_FW al_FW ._. 
An_DT inverse_JJ relationship_NN between_IN vitamin_NN D\/calcium_NN intakes_NNS and_CC breast_NN density_NN has_VBZ also_RB been_VBN observed_VBN -LRB-_-LRB- Holmes_NNP et_NNP al_NNP ._. 
2006_CD -RRB-_-RRB- ,_, as_RB well_RB as_IN synchronized_VBN seasonal_JJ variations_NNS of_IN circulating_VBG 25-hydroxyvitamin_JJ D_NNP -LRB-_-LRB- 25_CD -LRB-_-LRB- OH_NNP -RRB-_-RRB- D_NNP -RRB-_-RRB- and_CC breast_NN density_NN -LRB-_-LRB- Brisson_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
Arecent_NNP randomized_VBD controlled_JJ trial_NN involving_VBG vitamin_JJ D_NNP supplementation_NN sufficient_JJ to_TO raise_VB serum_NN 25_CD -LRB-_-LRB- OH_NNP -RRB-_-RRB- D_NNP 
1999_CD ,_, Ingles_FW et_FW al_FW ._. 
FokI_NN and_CC breast_NN cancer_NN Seven_CD papers_NNS have_VBP analyzed_VBN the_DT association_NN of_IN Fok_NNP I_PRP with_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Curran_NNP et_FW al_FW ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al._FW ._. 
2001_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2003_CD ,_, 2004_CD ,_, Chen_FW et_FW al_FW ._. 
2005_CD ,_, McCullough_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ,_, three_CD of_IN which_WDT are_VBP apparently_RB emerging_VBG from_IN the_DT same_JJ UK_NNP Caucasian_NNP population_NN sample_NN -LRB-_-LRB- Bretherton-Watt_NNP et_FW al_FW ._. 
2005_CD ,_, McCullough_NNP et_FW al_FW ._. 
2003_CD ,_, 2004_CD ,_, Chen_FW et_FW al_FW ._. 
2001_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ,_, three_CD of_IN which_WDT are_VBP apparently_RB emerging_VBG from_IN the_DT same_JJ UK_NNP Caucasian_NNP population_NN sample_NN -LRB-_-LRB- Bretherton-Watt_NNP et_FW al._FW ._. 
2001_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2003_CD ,_, 2004_CD -RRB-_-RRB- and_CC are_VBP reporting_VBG non-significant_JJ but_CC generally_RB lower_JJR relative_JJ risk_NN of_IN breast_NN cancer_NN for_IN the_DT f_SYM allele_JJ carriers_NNS ._. 
1998_CD ,_, Ingles_FW et_FW al_FW ._. 
Eleven_CD studies_NNS assessed_VBD Bsm_NNP I_NNP association_NN with_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Ruggiero_FW et_FW al_FW ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al._FW ._. 
2001_CD ,_, Hou_FW et_FW al_FW ._. 
2002_CD ,_, Buyru_FW et_FW al_FW ._. 
2003_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2003_CD ,_, 2004_CD ,_, Hefler_NNP et_FW al_FW ._. 
2004_CD ,_, Chen_FW et_FW al_FW ._. 
Studies_NNS among_IN Caucasian_JJ women_NNS are_VBP showing_VBG mixed_JJ results_NNS ._. 
2002_CD -RRB-_-RRB- with_IN allele_JJ frequencies_NNS considerably_RB different_JJ from_IN those_DT seen_VBN in_IN Caucasian_JJ populations_NNS ._. 
Some_DT earlier_JJR and_CC smaller_JJR studies_NNS -LRB-_-LRB- Bretherton-Watt_NNP et_FW al._FW ._. 
2001_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2003_CD ,_, 2004_CD ,_, Lowe_NNP et_NNP al_NNP ._. 
2005_CD -RRB-_-RRB- reported_VBD significant_JJ increased_VBN risk_NN for_IN bb_NN carriers_NNS while_IN larger_JJR and_CC more_JJR recent_JJ ones_NNS -LRB-_-LRB- Hefler_NNP et_FW al_FW ._. 
http:\/\/cgems_NNS ._. 
cancer_NN ._. 
013_CD -RRB-_-RRB- of_IN the_DT same_JJ order_NN of_IN magnitude_NN with_IN Bsm_NNP I_PRP -LRB-_-LRB- rs1544410_CD ;_: see_VB 
FokI_NN and_CC breast_NN cancer_NN Seven_CD papers_NNS have_VBP analyzed_VBN the_DT association_NN of_IN Fok_NNP I_PRP with_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Curran_NNP et_FW al_FW ._. 
1999_CD ,_, Ingles_FW et_FW al._FW ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
2001_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2003_CD ,_, 2004_CD ,_, Chen_FW et_FW al_FW ._. 
2005_CD ,_, McCullough_NNP et_FW al_FW ._. 
Three_CD other_JJ studies_NNS -LRB-_-LRB- Curran_NNP et_FW al_FW ._. 
2003_CD ,_, 2004_CD -RRB-_-RRB- and_CC are_VBP reporting_VBG non-significant_JJ but_CC generally_RB lower_JJR relative_JJ risk_NN of_IN breast_NN cancer_NN for_IN the_DT f_SYM allele_JJ carriers_NNS ._. 
1999_CD ,_, Ingles_FW et_FW al._FW ._. 
2000_CD ,_, McCullough_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- did_VBD not_RB observe_VB any_DT association_NN ._. 
In_IN the_DT Nurses_NNPS '_POS Health_NNP Study_NNP -LRB-_-LRB- Chen_NNP et_FW al_FW ._. 
Eleven_CD studies_NNS assessed_VBD Bsm_NNP I_NNP association_NN with_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Ruggiero_FW et_FW al_FW ._. 
The_DT variable-length_JJ poly_NN -LRB-_-LRB- A_NN -RRB-_-RRB- sequence_NN has_VBZ been_VBN associated_VBN with_IN breast_NN cancer_NN and_CC also_RB with_IN bone_NN mineral_NN density_NN and_CC height_NN ._. 
1998_CD ,_, Ingles_FW et_FW al._FW ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
2001_CD ,_, Hou_FW et_FW al_FW ._. 
2002_CD ,_, Buyru_FW et_FW al_FW ._. 
2003_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2003_CD ,_, 2004_CD ,_, Hefler_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
2005_CD ,_, McCullough_NNP et_FW al_FW ._. 
2005_CD ,_, Lowe_NNP et_NNP al_NNP ._. 
2004_CD ,_, Chen_FW et_FW al_FW ._. 
2003_CD ,_, 2004_CD ,_, Hefler_NNP et_FW al_FW ._. 
Only_RB two_CD studies_NNS reported_VBD a_DT significant_JJ increased_VBN risk_NN for_IN the_DT BB_NNP carriers_NNS and_CC they_PRP were_VBD respectively_RB from_IN a_DT Hispanic_JJ -LRB-_-LRB- Ingles_FW et_FW al._FW ._. 
2000_CD -RRB-_-RRB- and_CC a_DT Taiwanese_JJ population_NN -LRB-_-LRB- Hou_FW et_FW al_FW ._. 
2002_CD -RRB-_-RRB- with_IN allele_JJ frequencies_NNS considerably_RB different_JJ from_IN those_DT seen_VBN in_IN Caucasian_JJ populations_NNS ._. 
2003_CD ,_, 2004_CD ,_, Chen_FW et_FW al_FW ._. 
2001_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
1999_CD ,_, Ingles_FW et_FW al_FW ._. 
2005_CD ,_, McCullough_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ,_, three_CD of_IN which_WDT are_VBP apparently_RB emerging_VBG from_IN the_DT same_JJ UK_NNP Caucasian_NNP population_NN sample_NN -LRB-_-LRB- Bretherton-Watt_NNP et_FW al_FW ._. 
1999_CD ,_, Ingles_FW et_FW al_FW ._. 
Three_CD other_JJ studies_NNS -LRB-_-LRB- Curran_NNP et_FW al_FW ._. 
2003_CD ,_, 2004_CD -RRB-_-RRB- and_CC are_VBP reporting_VBG non-significant_JJ but_CC generally_RB lower_JJR relative_JJ risk_NN of_IN breast_NN cancer_NN for_IN the_DT f_SYM allele_JJ carriers_NNS ._. 
2000_CD ,_, McCullough_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- did_VBD not_RB observe_VB any_DT association_NN ._. 
In_IN the_DT Nurses_NNPS '_POS Health_NNP Study_NNP -LRB-_-LRB- Chen_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- conducted_VBN within_IN US_NNP population_NN ,_, the_DT ff_NN carriers_NNS showed_VBD a_DT statistically_RB significant_JJ increase_NN in_IN relative_JJ risk_NN of_IN breast_NN cancer_NN compared_VBN with_IN women_NNS with_IN the_DT FF_NNP genotype_NN -LRB-_-LRB- OR_NNP =_SYM 1_CD ._. 
2005_CD ,_, Lowe_NNP et_NNP al_NNP ._. 
2004_CD ,_, Chen_FW et_FW al_FW ._. 
2003_CD ,_, 2004_CD ,_, Hefler_NNP et_FW al_FW ._. 
2003_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2002_CD ,_, Buyru_FW et_FW al_FW ._. 
2005_CD ,_, McCullough_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
Only_RB two_CD studies_NNS reported_VBD a_DT significant_JJ increased_VBN risk_NN for_IN the_DT BB_NNP carriers_NNS and_CC they_PRP were_VBD respectively_RB from_IN a_DT Hispanic_JJ -LRB-_-LRB- Ingles_FW et_FW al_FW ._. 
Canadian_NNP Breast_NNP Cancer_NNP Research_NNP Alliance_NNP 4811-82_CD Introduction_NNP Low-vitamin_NNP D_NNP intakes_VBZ or_CC circulating_VBG levels_NNS have_VBP been_VBN associated_VBN with_IN increased_VBN breast_NN cancer_NN risk_NN in_IN several_JJ ecological_JJ -LRB-_-LRB- Garland_NNP et_FW al_FW ._. 
1990_CD ,_, 1999_CD ,_, Grant_NNP 2002_CD ,_, 2003_CD -RRB-_-RRB- ,_, case_NN 
1994_CD -RRB-_-RRB- ._. 
The_DT absence_NN of_IN the_DT polymorphic_JJ site_NN -LRB-_-LRB- B_NNP -RRB-_-RRB- resulted_VBD in_IN an_DT 850_CD 
1996_CD -RRB-_-RRB- except_IN that_DT overnight_JJ digestion_NN with_IN 1U_NNP of_IN Fok_NNP I_PRP was_VBD used_VBN to_TO minimize_VB partial_JJ digests_NNS ._. 
For_IN the_DT Fok_NNP I_PRP polymorphism_VBP ,_, PCR_NNP amplification_NN and_CC digestion_NN were_VBD done_VBN as_IN published_VBN -LRB-_-LRB- Gross_NNP et_NNP al_NNP ._. 
The_DT absence_NN of_IN the_DT FokI_NNP polymorphic_NN site_NN -LRB-_-LRB- F_NN -RRB-_-RRB- resulted_VBD in_IN a_DT 265_CD 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
1999_CD ,_, Ingles_FW et_FW al_FW ._. 
FokI_NN and_CC breast_NN cancer_NN Seven_CD papers_NNS have_VBP analyzed_VBN the_DT association_NN of_IN Fok_NNP I_PRP with_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Curran_NNP et_FW al_FW ._. 
2001_CD ,_, Guy_NNP et_NNP al._NNP ._. 
2003_CD ,_, 2004_CD ,_, Chen_FW et_FW al_FW ._. 
2005_CD ,_, McCullough_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ,_, three_CD of_IN which_WDT are_VBP apparently_RB emerging_VBG from_IN the_DT same_JJ UK_NNP Caucasian_NNP population_NN sample_NN -LRB-_-LRB- Bretherton-Watt_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ,_, three_CD of_IN which_WDT are_VBP apparently_RB emerging_VBG from_IN the_DT same_JJ UK_NNP Caucasian_NNP population_NN sample_NN -LRB-_-LRB- Bretherton-Watt_NNP et_FW al_FW ._. 
2001_CD ,_, Guy_NNP et_NNP al._NNP ._. 
2003_CD ,_, 2004_CD -RRB-_-RRB- and_CC are_VBP reporting_VBG non-significant_JJ but_CC generally_RB lower_JJR relative_JJ risk_NN of_IN breast_NN cancer_NN for_IN the_DT f_SYM allele_JJ carriers_NNS ._. 
2002_CD ,_, Buyru_FW et_FW al_FW ._. 
2001_CD ,_, Hou_FW et_FW al_FW ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
1998_CD ,_, Ingles_FW et_FW al_FW ._. 
Eleven_CD studies_NNS assessed_VBD Bsm_NNP I_NNP association_NN with_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Ruggiero_FW et_FW al_FW ._. 
2003_CD ,_, Guy_NNP et_NNP al._NNP ._. 
2003_CD ,_, 2004_CD ,_, Hefler_NNP et_FW al_FW ._. 
2004_CD ,_, Chen_FW et_FW al_FW ._. 
2005_CD ,_, Lowe_NNP et_NNP al_NNP ._. 
2005_CD ,_, McCullough_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
Some_DT earlier_JJR and_CC smaller_JJR studies_NNS -LRB-_-LRB- Bretherton-Watt_NNP et_FW al_FW ._. 
Studies_NNS among_IN Caucasian_JJ women_NNS are_VBP showing_VBG mixed_JJ results_NNS ._. 
2001_CD ,_, Guy_NNP et_NNP al._NNP ._. 
2003_CD ,_, 2004_CD ,_, Lowe_NNP et_NNP al_NNP ._. 
2005_CD -RRB-_-RRB- reported_VBD significant_JJ increased_VBN risk_NN for_IN bb_NN carriers_NNS while_IN larger_JJR and_CC more_JJR recent_JJ ones_NNS -LRB-_-LRB- Hefler_NNP et_FW al_FW ._. 
2001_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
1999_CD ,_, Ingles_FW et_FW al_FW ._. 
FokI_NN and_CC breast_NN cancer_NN Seven_CD papers_NNS have_VBP analyzed_VBN the_DT association_NN of_IN Fok_NNP I_PRP with_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Curran_NNP et_FW al_FW ._. 
2003_CD ,_, 2004_CD ,_, Chen_FW et_FW al._FW ._. 
2005_CD ,_, McCullough_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ,_, three_CD of_IN which_WDT are_VBP apparently_RB emerging_VBG from_IN the_DT same_JJ UK_NNP Caucasian_NNP population_NN sample_NN -LRB-_-LRB- Bretherton-Watt_NNP et_FW al_FW ._. 
2001_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2007_CD -RRB-_-RRB- ,_, three_CD of_IN which_WDT are_VBP apparently_RB emerging_VBG from_IN the_DT same_JJ UK_NNP Caucasian_NNP population_NN sample_NN -LRB-_-LRB- Bretherton-Watt_NNP et_FW al_FW ._. 
2003_CD ,_, 2004_CD -RRB-_-RRB- and_CC are_VBP reporting_VBG non-significant_JJ but_CC generally_RB lower_JJR relative_JJ risk_NN of_IN breast_NN cancer_NN for_IN the_DT f_SYM allele_JJ carriers_NNS ._. 
Three_CD other_JJ studies_NNS -LRB-_-LRB- Curran_NNP et_FW al_FW ._. 
1999_CD ,_, Ingles_FW et_FW al_FW ._. 
2000_CD ,_, McCullough_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- did_VBD not_RB observe_VB any_DT association_NN ._. 
2003_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2002_CD ,_, Buyru_FW et_FW al_FW ._. 
2001_CD ,_, Hou_FW et_FW al_FW ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
1998_CD ,_, Ingles_FW et_FW al_FW ._. 
2003_CD ,_, 2004_CD ,_, Hefler_NNP et_FW al._FW ._. 
2004_CD ,_, Chen_FW et_FW al_FW ._. 
2005_CD ,_, Lowe_NNP et_NNP al_NNP ._. 
2005_CD ,_, McCullough_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
Only_RB two_CD studies_NNS reported_VBD a_DT significant_JJ increased_VBN risk_NN for_IN the_DT BB_NNP carriers_NNS and_CC they_PRP were_VBD respectively_RB from_IN a_DT Hispanic_JJ -LRB-_-LRB- Ingles_FW et_FW al_FW ._. 
2001_CD ,_, Guy_NNP et_NNP al_NNP ._. 
Some_DT earlier_JJR and_CC smaller_JJR studies_NNS -LRB-_-LRB- Bretherton-Watt_NNP et_FW al_FW ._. 
Studies_NNS among_IN Caucasian_JJ women_NNS are_VBP showing_VBG mixed_JJ results_NNS ._. 
2003_CD ,_, 2004_CD ,_, Lowe_NNP et_NNP al._NNP ._. 
2005_CD -RRB-_-RRB- reported_VBD significant_JJ increased_VBN risk_NN for_IN bb_NN carriers_NNS while_IN larger_JJR and_CC more_JJR recent_JJ ones_NNS -LRB-_-LRB- Hefler_NNP et_FW al_FW ._. 
Associations_NNS of_IN Fok_NNP I_NNP and_CC Bsm_NNP I_PRP with_IN invasive_JJ breast_NN cancer_NN There_EX was_VBD no_DT statistically_RB significant_JJ deviation_NN from_IN the_DT expected_VBN Hardy_NNP 
2003_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2002_CD ,_, Buyru_FW et_FW al_FW ._. 
2001_CD ,_, Hou_FW et_FW al_FW ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
1998_CD ,_, Ingles_FW et_FW al_FW ._. 
2003_CD ,_, 2004_CD ,_, Hefler_NNP et_FW al._FW ._. 
2004_CD ,_, Chen_FW et_FW al_FW ._. 
2005_CD ,_, Lowe_NNP et_NNP al_NNP ._. 
2005_CD ,_, McCullough_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
Only_RB two_CD studies_NNS reported_VBD a_DT significant_JJ increased_VBN risk_NN for_IN the_DT BB_NNP carriers_NNS and_CC they_PRP were_VBD respectively_RB from_IN a_DT Hispanic_JJ -LRB-_-LRB- Ingles_FW et_FW al_FW ._. 
2003_CD ,_, 2004_CD ,_, Lowe_NNP et_NNP al_NNP ._. 
2001_CD ,_, Guy_NNP et_NNP al_NNP ._. 
Some_DT earlier_JJR and_CC smaller_JJR studies_NNS -LRB-_-LRB- Bretherton-Watt_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- reported_VBD significant_JJ increased_VBN risk_NN for_IN bb_NN carriers_NNS while_IN larger_JJR and_CC more_JJR recent_JJ ones_NNS -LRB-_-LRB- Hefler_NNP et_FW al._FW ._. 
2004_CD ,_, Chen_FW et_FW al_FW ._. 
2005_CD -RRB-_-RRB- did_VBD not_RB confirm_VB previous_JJ associations_NNS ._. 
Although_IN our_PRP$ Bsm_NNP I_NN results_NNS from_IN both_DT studies_NNS are_VBP non-significant_JJ ,_, they_PRP are_VBP nevertheless_RB showing_VBG the_DT same_JJ pattern_NN ,_, perhaps_RB suggesting_VBG a_DT lack_NN of_IN statistical_JJ power_NN ._. 
2001_CD -RRB-_-RRB- ._. 
1991_CD ,_, Levi_NNP et_FW al_FW ._. 
1991_CD ,_, Simard_NNP et_FW al_FW ._. 
2008_CD -RRB-_-RRB- although_IN not_RB all_DT -LRB-_-LRB- Graham_NNP et_NNP al_NNP ._. 
2002_CD ,_, Abbas_FW et_FW al_FW ._. 
An_DT inverse_JJ relationship_NN between_IN vitamin_NN D\/calcium_NN intakes_NNS and_CC breast_NN density_NN has_VBZ also_RB been_VBN observed_VBN -LRB-_-LRB- Holmes_NNP et_NNP al._NNP ._. 
2001_CD ,_, Berube_NNP et_FW al_FW ._. 
2004_CD ,_, 2005_CD ,_, Colangelo_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ,_, as_RB well_RB as_IN synchronized_VBN seasonal_JJ variations_NNS of_IN circulating_VBG 25-hydroxyvitamin_JJ D_NNP -LRB-_-LRB- 25_CD -LRB-_-LRB- OH_NNP -RRB-_-RRB- D_NNP -RRB-_-RRB- and_CC breast_NN density_NN -LRB-_-LRB- Brisson_NNP et_FW al_FW ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
1998_CD ,_, Ingles_FW et_FW al_FW ._. 
Eleven_CD studies_NNS assessed_VBD Bsm_NNP I_NNP association_NN with_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Ruggiero_FW et_FW al_FW ._. 
2001_CD ,_, Hou_FW et_FW al._FW ._. 
2002_CD ,_, Buyru_FW et_FW al_FW ._. 
2003_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2003_CD ,_, 2004_CD ,_, Hefler_NNP et_FW al_FW ._. 
2004_CD ,_, Chen_FW et_FW al_FW ._. 
2005_CD ,_, Lowe_NNP et_NNP al_NNP ._. 
Only_RB two_CD studies_NNS reported_VBD a_DT significant_JJ increased_VBN risk_NN for_IN the_DT BB_NNP carriers_NNS and_CC they_PRP were_VBD respectively_RB from_IN a_DT Hispanic_JJ -LRB-_-LRB- Ingles_FW et_FW al_FW ._. 
2000_CD -RRB-_-RRB- and_CC a_DT Taiwanese_JJ population_NN -LRB-_-LRB- Hou_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- with_IN allele_JJ frequencies_NNS considerably_RB different_JJ from_IN those_DT seen_VBN in_IN Caucasian_JJ populations_NNS ._. 
Studies_NNS among_IN Caucasian_JJ women_NNS are_VBP showing_VBG mixed_JJ results_NNS ._. 
Canadian_NNP Breast_NNP Cancer_NNP Research_NNP Alliance_NNP 4811-82_CD Introduction_NNP Low-vitamin_NNP D_NNP intakes_VBZ or_CC circulating_VBG levels_NNS have_VBP been_VBN associated_VBN with_IN increased_VBN breast_NN cancer_NN risk_NN in_IN several_JJ ecological_JJ -LRB-_-LRB- Garland_NNP et_FW al_FW ._. 
1990_CD ,_, 1999_CD ,_, Grant_NNP 2002_CD ,_, 2003_CD -RRB-_-RRB- ,_, case_NN 
1993_CD ,_, Rothman_NNP 
We_PRP ,_, like_IN others_NNS -LRB-_-LRB- Hayes_NNP et_FW al_FW ._. 
Associations_NNS of_IN Fok_NNP I_NNP and_CC Bsm_NNP I_PRP with_IN invasive_JJ breast_NN cancer_NN There_EX was_VBD no_DT statistically_RB significant_JJ deviation_NN from_IN the_DT expected_VBN Hardy_NNP 
Some_DT of_IN these_DT polymorphisms_NNS have_VBP been_VBN analyzed_VBN for_IN potential_JJ associations_NNS with_IN breast_NN cancer_NN ,_, including_VBG the_DT single_JJ nucleotide_NN polymorphisms_NNS -LRB-_-LRB- SNPs_NNS -RRB-_-RRB- restriction_NN enzyme_NN detecting_VBG SNP_NNP of_IN VDR_NNP -LRB-_-LRB- Fok_NNP I_NNP ;_: rs10735810_NNP and_CC Bsm_NNP I_NNP ;_: rs1544410_CD -RRB-_-RRB- ._. 
Being_VBG located_VBN at_IN each_DT end_NN of_IN the_DT gene_NN encoding_VBG VDR_NNP ,_, they_PRP are_VBP less_RBR likely_JJ to_TO be_VB in_IN linkage_NN disequilibrium_NN -LRB-_-LRB- LD_NNP -RRB-_-RRB- and_CC are_VBP therefore_RB good_JJ candidates_NNS for_IN independent_JJ effects_NNS on_IN invasive_JJ breast_NN cancer_NN risk_NN -LRB-_-LRB- reviewed_VBN in_IN Uitterlinden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- -RRB-_-RRB- ._. 
Studies_NNS of_IN VDR_NNP Fok_NNP I_NNP and_CC Bsm_NNP I_NNP polymorphisms_NNS have_VBP been_VBN conducted_VBN in_IN different_JJ populations_NNS with_IN mixed_JJ results_NNS ._. 
42_CD ;_: study_NN 2_CD ,_, B_NNP =_SYM 0_CD ._. 
39_CD and_CC Bsm_NNP I_PRP :_: study_NN 1_CD ,_, B_NNP =_SYM 0_CD ._. 
38_CD ;_: study_NN 2_CD ,_, f_SYM =_SYM 0_CD ._. 
Minor_NNP allele_JJ frequencies_NNS for_IN both_DT SNPs_NNS were_VBD similar_JJ in_IN both_DT studies_NNS -LRB-_-LRB- allele_JJ frequencies_NNS in_IN controls_NNS -_: Fok_NNP I_NNP :_: study_NN 1_CD ,_, f_SYM =_SYM 0_CD ._. 
39_CD -RRB-_-RRB- and_CC genotypes_VBZ frequencies_NNS in_IN these_DT samples_NNS from_IN French_JJ Canadian_JJ population_NN were_VBD similar_JJ to_TO other_JJ Caucasian_JJ populations_NNS -LRB-_-LRB- Uitterlinden_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
Fok_NNP I_PRP was_VBD associated_VBN with_IN an_DT increased_JJ relative_JJ risk_NN of_IN breast_NN cancer_NN in_IN the_DT two_CD studies_NNS reaching_VBG statistical_JJ significance_NN in_IN study_NN 2_CD -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- ._. 
The_DT Fok_NNP I_NNP polymorphism_NN is_VBZ located_VBN at_IN exon_NN 2_CD start_NN codon_NN of_IN the_DT VDR_NNP gene_NN ._. 
If_IN our_PRP$ observed_JJ associations_NNS are_VBP valid_JJ and_CC causal_JJ ,_, about_IN 13_CD and_CC 25_CD %_NN of_IN the_DT incidence_NN rate_NN of_IN breast_NN cancer_NN in_IN Ff_NN and_CC ff_NN carriers_NNS would_MD be_VB attributable_JJ to_TO their_PRP$ respective_JJ Fok_NNP I_NN genotypes_NNS ._. 
Individuals_NNS designated_VBD F_NN have_VBP VDR_NNP proteins_NNS missing_VBG three_CD amino_JJ acids_NNS -LRB-_-LRB- 424_CD amino_JJ acids_NNS -RRB-_-RRB- and_CC those_DT designated_VBN f_SYM have_VBP longer_JJR VDR_NNP proteins_NNS -LRB-_-LRB- 427_CD amino_JJ acids_NNS -RRB-_-RRB- that_WDT have_VBP been_VBN shown_VBN to_TO be_VB functionally_RB less_RBR efficient_JJ -LRB-_-LRB- reviewed_VBN in_IN Uitterlinden_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- -RRB-_-RRB- ._. 
Since_IN f_SYM allele_JJ results_NNS in_IN a_DT less_RBR efficient_JJ VDR_NNP ,_, the_DT increase_NN in_IN breast_NN cancer_NN incidence_NN associated_VBN with_IN f_SYM allele_FW could_MD possibly_RB be_VB overturned_VBN ,_, or_CC at_IN least_JJS reduced_VBN ,_, by_IN raising_VBG vitamin_JJ D_NNP levels_NNS ,_, for_IN instance_NN through_IN vitamin_JJ D_NNP supplementation_NN ._. 
Bsm_NNP I_PRP and_CC breast_NN cancer_NN Bsm_NNP I_NNP polymorphism_NN is_VBZ located_VBN in_IN intron_NN 8_CD of_IN the_DT VDR_NNP gene_NN and_CC is_VBZ unlikely_JJ to_TO affect_VB VDR_NNP function_NN ._. 
However_RB ,_, this_DT polymorphism_NN is_VBZ in_IN strong_JJ LD_NNP with_IN the_DT poly_NN -LRB-_-LRB- A_NN -RRB-_-RRB- microsatellite_NN located_VBN in_IN the_DT 3_CD 
Ahaplotype_JJ analysis_NN around_IN the_DT 3_CD 
1996_CD ,_, John_NNP et_NNP al_NNP ._. 
1996_CD ,_, Negri_NNP et_FW al_FW ._. 
1991_CD ,_, Knekt_FW et_FW al_FW ._. 
1991_CD ,_, Zaridze_FW et_FW al_FW ._. 
1990_CD ,_, 1999_CD ,_, Grant_NNP 2002_CD ,_, 2003_CD -RRB-_-RRB- ,_, case_NN 
2008_CD -RRB-_-RRB- although_IN not_RB all_DT -LRB-_-LRB- Graham_NNP et_NNP al_NNP ._. 
2002_CD ,_, Abbas_FW et_FW al_FW ._. 
1999_CD ,_, Shin_NNP et_FW al_FW ._. 
1996_CD ,_, John_NNP et_NNP al_NNP ._. 
1991_CD ,_, Simard_NNP et_FW al._FW ._. 
1991_CD ,_, Levi_NNP et_FW al_FW ._. 
2001_CD -RRB-_-RRB- ._. 
An_DT inverse_JJ relationship_NN between_IN vitamin_NN D\/calcium_NN intakes_NNS and_CC breast_NN density_NN has_VBZ also_RB been_VBN observed_VBN -LRB-_-LRB- Holmes_NNP et_NNP al_NNP ._. 
Population_NNP stratification_NN is_VBZ the_DT major_JJ source_NN of_IN confounding_VBG in_IN this_DT type_NN of_IN study_NN -LRB-_-LRB- Khoury_NNP et_FW al_FW ._. 
1993_CD ,_, Rothman_NNP 
The_DT variable-length_JJ poly_NN -LRB-_-LRB- A_NN -RRB-_-RRB- sequence_NN has_VBZ been_VBN associated_VBN with_IN breast_NN cancer_NN and_CC also_RB with_IN bone_NN mineral_NN density_NN and_CC height_NN ._. 
Eleven_CD studies_NNS assessed_VBD BsmI_JJ association_NN with_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Ruggiero_FW et_FW al._FW ._. 
1998_CD ,_, Ingles_FW et_FW al_FW ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
2001_CD ,_, Hou_FW et_FW al_FW ._. 
2002_CD ,_, Buyru_FW et_FW al_FW ._. 
2003_CD ,_, Guy_NNP et_NNP al_NNP ._. 
1991_CD ,_, Knekt_FW et_FW al_FW ._. 
1991_CD ,_, Zaridze_FW et_FW al_FW ._. 
1990_CD ,_, 1999_CD ,_, Grant_NNP 2002_CD ,_, 2003_CD -RRB-_-RRB- ,_, case_NN 
Population_NNP stratification_NN is_VBZ the_DT major_JJ source_NN of_IN confounding_VBG in_IN this_DT type_NN of_IN study_NN -LRB-_-LRB- Khoury_NNP et_FW al_FW ._. 
1993_CD ,_, Rothman_NNP 
2001_CD ,_, Berube_NNP et_FW al_FW ._. 
An_DT inverse_JJ relationship_NN between_IN vitamin_NN D\/calcium_NN intakes_NNS and_CC breast_NN density_NN has_VBZ also_RB been_VBN observed_VBN -LRB-_-LRB- Holmes_NNP et_NNP al_NNP ._. 
2004_CD ,_, 2005_CD ,_, Colangelo_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ,_, as_RB well_RB as_IN synchronized_VBN seasonal_JJ variations_NNS of_IN circulating_VBG 25-hydroxyvitamin_JJ D_NNP -LRB-_-LRB- 25_CD -LRB-_-LRB- OH_NNP -RRB-_-RRB- D_NNP -RRB-_-RRB- and_CC breast_NN density_NN -LRB-_-LRB- Brisson_NNP et_FW al_FW ._. 
Matching_VBG variables_NNS and_CC those_DT known_VBN to_TO be_VB breast_NN cancer_NN risk_NN factors_NNS were_VBD considered_VBN potential_JJ confounders_NNS and_CC were_VBD included_VBN in_IN the_DT models_NNS ._. 
No_DT attempt_NN to_TO reach_VB more_RBR parsimonious_JJ models_NNS were_VBD tried_VBN in_IN order_NN to_TO compare_VB our_PRP$ results_NNS with_IN the_DT recent_JJ and_CC largest_JJS study_NN done_VBN to_TO date_VB on_IN these_DT SNPs_NNS -LRB-_-LRB- Chen_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Effect_NN modification_NN -LRB-_-LRB- departure_NN from_IN odds-ratio_JJ multiplicativity_NN -RRB-_-RRB- was_VBD examined_VBN by_IN introducing_VBG an_DT interaction_NN term_NN between_IN the_DT SNP_NNP and_CC the_DT risk_NN factor_NN under_IN consideration_NN in_IN the_DT logistic_JJ regression_NN models_NNS with_IN both_DT factors_NNS as_IN main_JJ effect_NN ,_, and_CC tested_VBD as_RB above_JJ ._. 
2001_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
1999_CD ,_, Ingles_FW et_FW al_FW ._. 
FokI_NN and_CC breast_NN cancer_NN Seven_CD papers_NNS have_VBP analyzed_VBN the_DT association_NN of_IN Fok_NNP I_PRP with_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Curran_NNP et_FW al_FW ._. 
2003_CD ,_, 2004_CD ,_, Chen_FW et_FW al._FW ._. 
2005_CD ,_, McCullough_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ,_, three_CD of_IN which_WDT are_VBP apparently_RB emerging_VBG from_IN the_DT same_JJ UK_NNP Caucasian_NNP population_NN sample_NN -LRB-_-LRB- Bretherton-Watt_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- did_VBD not_RB observe_VB any_DT association_NN ._. 
2000_CD ,_, McCullough_NNP et_FW al_FW ._. 
1999_CD ,_, Ingles_FW et_FW al_FW ._. 
Three_CD other_JJ studies_NNS -LRB-_-LRB- Curran_NNP et_FW al_FW ._. 
In_IN the_DT Nurses_NNPS '_POS Health_NNP Study_NNP -LRB-_-LRB- Chen_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- conducted_VBN within_IN US_NNP population_NN ,_, the_DT ff_NN carriers_NNS showed_VBD a_DT statistically_RB significant_JJ increase_NN in_IN relative_JJ risk_NN of_IN breast_NN cancer_NN compared_VBN with_IN women_NNS with_IN the_DT FF_NNP genotype_NN -LRB-_-LRB- OR_NNP =_SYM 1_CD ._. 
2003_CD ,_, 2004_CD ,_, Hefler_NNP et_FW al_FW ._. 
2003_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2002_CD ,_, Buyru_FW et_FW al_FW ._. 
2001_CD ,_, Hou_FW et_FW al_FW ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
2004_CD ,_, Chen_FW et_FW al._FW ._. 
2005_CD ,_, Lowe_NNP et_NNP al_NNP ._. 
2005_CD ,_, McCullough_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
Only_RB two_CD studies_NNS reported_VBD a_DT significant_JJ increased_VBN risk_NN for_IN the_DT BB_NNP carriers_NNS and_CC they_PRP were_VBD respectively_RB from_IN a_DT Hispanic_JJ -LRB-_-LRB- Ingles_FW et_FW al_FW ._. 
2005_CD -RRB-_-RRB- reported_VBD significant_JJ increased_VBN risk_NN for_IN bb_NN carriers_NNS while_IN larger_JJR and_CC more_JJR recent_JJ ones_NNS -LRB-_-LRB- Hefler_NNP et_FW al_FW ._. 
2004_CD ,_, Chen_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- did_VBD not_RB confirm_VB previous_JJ associations_NNS ._. 
Although_IN our_PRP$ Bsm_NNP I_NN results_NNS from_IN both_DT studies_NNS are_VBP non-significant_JJ ,_, they_PRP are_VBP nevertheless_RB showing_VBG the_DT same_JJ pattern_NN ,_, perhaps_RB suggesting_VBG a_DT lack_NN of_IN statistical_JJ power_NN ._. 
Consequently_RB ,_, we_PRP re-evaluated_VBD the_DT associations_NNS of_IN Fok_NNP I_NNP and_CC Bsm_NNP I_NNP polymorphisms_NNS with_IN breast_NN cancer_NN risk_NN using_VBG two_CD independent_JJ case_NN 
Bsm_NNP I_NNP polymorphism_NN appears_VBZ to_TO bear_VB only_RB a_DT weak_JJ relationship_NN to_TO breast_NN cancer_NN risk_NN ,_, if_IN any_DT ,_, in_IN this_DT population_NN ._. 
FokI_NN and_CC breast_NN cancerSeven_JJ papers_NNS have_VBP analyzed_VBN the_DT association_NN of_IN FokI_NNP with_IN breast_NN cancer_NN risk_NN -LRB-_-LRB- Curran_NNP et_FW al._FW ._. 
1999_CD ,_, Ingles_FW et_FW al_FW ._. 
2000_CD ,_, Bretherton-Watt_NNP et_FW al_FW ._. 
2001_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2003_CD ,_, 2004_CD ,_, Chen_FW et_FW al_FW ._. 
2003_CD ,_, 2004_CD -RRB-_-RRB- and_CC are_VBP reporting_VBG non-significant_JJ but_CC generally_RB lower_JJR relative_JJ risk_NN of_IN breast_NN cancer_NN for_IN the_DT f_SYM allele_JJ carriers_NNS ._. 
Three_CD other_JJ studies_NNS -LRB-_-LRB- Curran_NNP et_FW al._FW ._. 
1999_CD ,_, Ingles_FW et_FW al_FW ._. 
2000_CD ,_, McCullough_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- did_VBD not_RB observe_VB any_DT association_NN ._. 
In_IN the_DT Nurses_NNPS '_POS Health_NNP Study_NNP -LRB-_-LRB- Chen_NNP et_FW al_FW ._. 
They_PRP also_RB suggest_VBP that_DT variability_NN in_IN observed_JJ associations_NNS between_IN VDR_NNP Fok_NNP I_NN and_CC breast_NN cancer_NN from_IN different_JJ studies_NNS may_MD partly_RB be_VB explained_VBN by_IN the_DT proportion_NN of_IN study_NN subjects_NNS with_IN a_DT family_NN history_NN of_IN breast_NN cancer_NN ._. 
Canadian_NNP Breast_NNP Cancer_NNP Research_NNP Alliance4811-82IntroductionLow-vitamin_NNP D_NNP intakes_VBZ or_CC circulating_VBG levels_NNS have_VBP been_VBN associated_VBN with_IN increased_VBN breast_NN cancer_NN risk_NN in_IN several_JJ ecological_JJ -LRB-_-LRB- Garland_NNP et_FW al._FW ._. 
1990_CD ,_, 1999_CD ,_, Grant_NNP 2002_CD ,_, 2003_CD -RRB-_-RRB- ,_, case_NN 
Materials_NNPS and_CC methods_NNS Study_NNP 1_CD This_DT case_NN 
The_DT VDR_NNP locus_NN was_VBD genotyped_VBN for_IN Bsm_NNP I_NNP and_CC Fok_NNP I_NNP polymorphisms_NNS after_IN PCR_NNP amplification_NN and_CC digestion_NN ._. 
Primer_NN sequences_NNS are_VBP available_JJ upon_IN request_NN and_CC PCR_NN conditions_NNS for_IN BsmI_NNP have_VBP already_RB been_VBN published_VBN -LRB-_-LRB- Giguere_NNP et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ._. 
The_DT absence_NN of_IN the_DT polymorphic_JJ site_NN -LRB-_-LRB- B_NNP -RRB-_-RRB- resulted_VBD in_IN an_DT 850_CD 
Canadian_NNP Breast_NNP Cancer_NNP Research_NNP Alliance_NNP 4811-82_CD Introduction_NNP Low-vitamin_NNP D_NNP intakes_VBZ or_CC circulating_VBG levels_NNS have_VBP been_VBN associated_VBN with_IN increased_VBN breast_NN cancer_NN risk_NN in_IN several_JJ ecological_JJ -LRB-_-LRB- Garland_NNP et_FW al_FW ._. 
1990_CD ,_, 1999_CD ,_, Grant_NNP 2002_CD ,_, 2003_CD -RRB-_-RRB- ,_, case_NN 
Canadian_NNP Breast_NNP Cancer_NNP Research_NNP Alliance_NNP 4811-82_CD Introduction_NNP Low-vitamin_NNP D_NNP intakes_VBZ or_CC circulating_VBG levels_NNS have_VBP been_VBN associated_VBN with_IN increased_VBN breast_NN cancer_NN risk_NN in_IN several_JJ ecological_JJ -LRB-_-LRB- Garland_NNP et_FW al_FW ._. 
1990_CD ,_, 1999_CD ,_, Grant_NNP 2002_CD ,_, 2003_CD -RRB-_-RRB- ,_, case_NN 
2002_CD ,_, Abbas_FW et_FW al_FW ._. 
1999_CD ,_, Shin_NNP et_FW al_FW ._. 
1996_CD ,_, John_NNP et_NNP al_NNP ._. 
1996_CD ,_, Negri_NNP et_FW al_FW ._. 
1991_CD ,_, Knekt_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- although_IN not_RB all_DT -LRB-_-LRB- Graham_NNP et_NNP al._NNP ._. 
1991_CD ,_, Simard_NNP et_FW al_FW ._. 
1991_CD ,_, Levi_NNP et_FW al_FW ._. 
2001_CD -RRB-_-RRB- ._. 
An_DT inverse_JJ relationship_NN between_IN vitamin_NN D\/calcium_NN intakes_NNS and_CC breast_NN density_NN has_VBZ also_RB been_VBN observed_VBN -LRB-_-LRB- Holmes_NNP et_NNP al_NNP ._. 
1991_CD ,_, Simard_NNP et_FW al_FW ._. 
2008_CD -RRB-_-RRB- although_IN not_RB all_DT -LRB-_-LRB- Graham_NNP et_NNP al_NNP ._. 
2002_CD ,_, Abbas_FW et_FW al_FW ._. 
1999_CD ,_, Shin_NNP et_FW al_FW ._. 
1991_CD ,_, Levi_NNP et_FW al._FW ._. 
2001_CD -RRB-_-RRB- ._. 
An_DT inverse_JJ relationship_NN between_IN vitamin_NN D\/calcium_NN intakes_NNS and_CC breast_NN density_NN has_VBZ also_RB been_VBN observed_VBN -LRB-_-LRB- Holmes_NNP et_NNP al_NNP ._. 
2007_CD -RRB-_-RRB- ._. 
2006_CD -RRB-_-RRB- ,_, as_RB well_RB as_IN synchronized_VBN seasonal_JJ variations_NNS of_IN circulating_VBG 25-hydroxyvitamin_JJ D_NNP -LRB-_-LRB- 25_CD -LRB-_-LRB- OH_NNP -RRB-_-RRB- D_NNP -RRB-_-RRB- and_CC breast_NN density_NN -LRB-_-LRB- Brisson_NNP et_FW al_FW ._. 
Arecent_NNP randomized_VBD controlled_JJ trial_NN involving_VBG vitamin_JJ D_NNP supplementation_NN sufficient_JJ to_TO raise_VB serum_NN 25_CD -LRB-_-LRB- OH_NNP -RRB-_-RRB- D_NNP 
Details_NNS from_IN this_DT cohort_NN studied_VBN for_IN genetic_JJ and_CC environmental_JJ risk_NN factors_NNS affecting_VBG bone_NN mineral_NN density_NN have_VBP already_RB been_VBN described_VBN elsewhere_RB -LRB-_-LRB- Blanchet_NNP et_FW al_FW ._. 
2003_CD ,_, Laflamme_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Atotal_NNP of_IN 622_CD cases_NNS and_CC 974_CD controls_NNS were_VBD genotyped_VBN in_IN the_DT same_JJ laboratory_NN as_IN in_IN study_NN 1_CD ._. 
1991_CD ,_, Zaridze_FW et_FW al_FW ._. 
1990_CD ,_, 1999_CD ,_, Grant_NNP 2002_CD ,_, 2003_CD -RRB-_-RRB- ,_, case_NN 
Since_IN we_PRP analyzed_VBD two_CD polymorphisms_NNS chosen_VBN on_IN the_DT basis_NN of_IN previous_JJ findings_NNS and_CC found_VBD the_DT same_JJ association_NN patterns_NNS in_IN two_CD independent_JJ studies_NNS ,_, we_PRP believe_VBP that_DT type_NN 1_CD errors_NNS are_VBP less_RBR likely_JJ to_TO explain_VB our_PRP$ findings_NNS ._. 
Population_NNP stratification_NN is_VBZ the_DT major_JJ source_NN of_IN confounding_VBG in_IN this_DT type_NN of_IN study_NN -LRB-_-LRB- Khoury_NNP et_FW al._FW ._. 
1993_CD ,_, Rothman_NNP 
This_DT type_NN of_IN misclassification_NN results_NNS from_IN the_DT fact_NN that_IN Bsm_NNP I_PRP marker_VBP ,_, being_VBG intronic_JJ ,_, needs_VBZ to_TO be_VB in_IN LD_NNP with_IN a_DT yet_RB unknown_JJ functional_JJ allele_NN in_IN order_NN to_TO explain_VB a_DT possible_JJ association_NN between_IN Bsm_NNP I_NNP polymorphism_NN and_CC breast_NN cancer_NN ._. 
As_IN LD_NNP between_IN the_DT BsmI_NNP marker_NN and_CC an_DT unknown_JJ functional_JJ allele_NN is_VBZ not_RB likely_JJ to_TO be_VB complete_JJ ,_, some_DT non-differential_JJ misclassification_NN can_MD occur_VB -LRB-_-LRB- Khoury_NNP et_FW al._FW ._. 
1993_CD -RRB-_-RRB- ._. 
Ahaplotype_JJ analysis_NN around_IN the_DT 3_CD 
1996_CD ,_, Negri_NNP et_FW al_FW ._. 
1991_CD ,_, Knekt_FW et_FW al_FW ._. 
1991_CD ,_, Zaridze_FW et_FW al_FW ._. 
1990_CD ,_, 1999_CD ,_, Grant_NNP 2002_CD ,_, 2003_CD -RRB-_-RRB- ,_, case_NN 
2004_CD ,_, Chen_FW et_FW al_FW ._. 
2003_CD ,_, 2004_CD ,_, Hefler_NNP et_FW al_FW ._. 
2003_CD ,_, Guy_NNP et_NNP al_NNP ._. 
2002_CD ,_, Buyru_FW et_FW al_FW ._. 
2001_CD ,_, Hou_FW et_FW al_FW ._. 
2005_CD ,_, Lowe_NNP et_NNP al._NNP ._. 
2005_CD ,_, McCullough_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
Only_RB two_CD studies_NNS reported_VBD a_DT significant_JJ increased_VBN risk_NN for_IN the_DT BB_NNP carriers_NNS and_CC they_PRP were_VBD respectively_RB from_IN a_DT Hispanic_JJ -LRB-_-LRB- Ingles_FW et_FW al_FW ._. 
2001_CD ,_, Guy_NNP et_NNP al_NNP ._. 
Some_DT earlier_JJR and_CC smaller_JJR studies_NNS -LRB-_-LRB- Bretherton-Watt_NNP et_FW al_FW ._. 
Studies_NNS among_IN Caucasian_JJ women_NNS are_VBP showing_VBG mixed_JJ results_NNS ._. 
2003_CD ,_, 2004_CD ,_, Lowe_NNP et_NNP al._NNP ._. 
2005_CD -RRB-_-RRB- reported_VBD significant_JJ increased_VBN risk_NN for_IN bb_NN carriers_NNS while_IN larger_JJR and_CC more_JJR recent_JJ ones_NNS -LRB-_-LRB- Hefler_NNP et_FW al_FW ._. 
Since_IN f_SYM allele_JJ results_NNS in_IN a_DT less_RBR efficient_JJ VDR_NNP ,_, the_DT increase_NN in_IN breast_NN cancer_NN incidence_NN associated_VBN with_IN f_SYM allele_FW could_MD possibly_RB be_VB overturned_VBN ,_, or_CC at_IN least_JJS reduced_VBN ,_, by_IN raising_VBG vitamin_JJ D_NNP levels_NNS ,_, for_IN instance_NN through_IN vitamin_JJ D_NNP supplementation_NN ._. 
Interaction_NN between_IN VDR_NNP FokI_NNP SNP_NNP and_CC vitamin_NNP D_NNP has_VBZ been_VBN recently_RB observed_VBN for_IN prostate_NN cancer_NN -LRB-_-LRB- Li_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
Carriers_NNS of_IN ff_FW genotype_FW with_IN less_JJR than_IN median_NN circulating_VBG vitamin_NNP D_NNP were_VBD at_IN higher_JJR risk_NN of_IN total_JJ and_CC aggressive_JJ cancers_NNS while_IN exposure_NN to_TO higher_JJR than_IN median_JJ vitamin_NN D_NNP was_VBD able_JJ to_TO completely_RB overcome_VB those_DT risks_NNS ._. 
Several_JJ recent_JJ studies_NNS with_IN transgenic_JJ mice_NNS with_IN inactivated_JJ VDR_NNP -LRB-_-LRB- VDR_NNP KO_NNP mice_NNS -RRB-_-RRB- suggest_VBP that_IN functional_JJ VDR_NNP tends_VBZ to_TO reduce_VB the_DT amount_NN of_IN breast_NN tissue_NN structures_NNS targeted_VBN in_IN breast_NN carcinogenesis_NN ._. 
It_PRP was_VBD shown_VBN that_IN VDR_NNP KO_NNP mice_NNS had_VBD heavier_JJR mammary_JJ glands_NNS ,_, increased_VBD branching_VBG ,_, greater_JJR ductal_JJ extension_NN and_CC higher_JJR number_NN of_IN undifferentiated_JJ terminal-end_JJ bud_NN structures_NNS during_IN puberty_NN compared_VBN with_IN the_DT wild-type_JJ mice_NNS -LRB-_-LRB- Zinser_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, knocking-out_JJ VDR_NNP induces_VBZ early_RB alveolar_JJ development_NN during_IN pregnancy_NN and_CC delays_VBZ apoptotic_JJ regression_NN during_IN involution_NN -LRB-_-LRB- Zinser_NNP 
2002_CD -RRB-_-RRB- ._. 
It_PRP was_VBD shown_VBN that_IN VDR_NNP KO_NNP mice_NNS had_VBD heavier_JJR mammary_JJ glands_NNS ,_, increased_VBD branching_VBG ,_, greater_JJR ductal_JJ extension_NN and_CC higher_JJR number_NN of_IN undifferentiated_JJ terminal-end_JJ bud_NN structures_NNS during_IN puberty_NN compared_VBN with_IN the_DT wild-type_JJ mice_NNS -LRB-_-LRB- Zinser_NNP et_FW al_FW ._. 
Moreover_RB ,_, knocking-out_JJ VDR_NNP induces_VBZ early_RB alveolar_JJ development_NN during_IN pregnancy_NN and_CC delays_VBZ apoptotic_JJ regression_NN during_IN involution_NN -LRB-_-LRB- Zinser_NNP 
These_DT effects_NNS of_IN vitamin_JJ D_NNP on_IN cells_NNS are_VBP thought_VBN to_TO be_VB mediated_VBN through_IN the_DT vitamin_JJ D_NNP receptor_NN -LRB-_-LRB- VDR_NNP -RRB-_-RRB- that_WDT belongs_VBZ to_TO the_DT steroid_NN receptor_NN superfamily_RB ._. 
The_DT VDR_NNP is_VBZ expressed_VBN in_IN different_JJ tissues_NNS including_VBG normal_JJ and_CC cancerous_JJ mammary_JJ epithelial_JJ cells_NNS -LRB-_-LRB- Wietzke_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Several_JJ recent_JJ studies_NNS with_IN transgenic_JJ mice_NNS with_IN inactivated_JJ VDR_NNP -LRB-_-LRB- VDR_NNP KO_NNP mice_NNS -RRB-_-RRB- suggest_VBP that_IN functional_JJ VDR_NNP tends_VBZ to_TO reduce_VB the_DT amount_NN of_IN breast_NN tissue_NN structures_NNS targeted_VBN in_IN breast_NN carcinogenesis_NN ._. 
2007_CD -RRB-_-RRB- ._. 
Arecent_NNP randomized_VBD controlled_JJ trial_NN involving_VBG vitamin_JJ D_NNP supplementation_NN sufficient_JJ to_TO raise_VB serum_NN 25_CD -LRB-_-LRB- OH_NNP -RRB-_-RRB- D_NNP 
Moreover_RB ,_, knocking-out_JJ VDR_NNP induces_VBZ early_RB alveolar_JJ development_NN during_IN pregnancy_NN and_CC delays_VBZ apoptotic_JJ regression_NN during_IN involution_NN -LRB-_-LRB- Zinser_NNP 
1990_CD ,_, 1999_CD ,_, Grant_NNP 2002_CD ,_, 2003_CD -RRB-_-RRB- ,_, case_NN 
2006_CD -RRB-_-RRB- ,_, and_CC laboratory_NN experiments_NNS have_VBP demonstrated_VBN that_IN nuclear_JJ factor_NN -_: 
matched_VBN sets_NNS with_IN CRP_NNP levels_NNS available_JJ for_IN the_DT case_NN and_CC at_IN least_JJS one_CD of_IN the_DT two_CD controls_NNS -RRB-_-RRB- ,_, IL6_NNP for_IN 291_CD ,_, and_CC IL1Ra_NNP for_IN 301_CD complete_JJ sets_NNS ._. 
Endogenous_NNP C-peptide_NNP and_CC sex-steroid_JJ hormone_NN measurements_NNS were_VBD performed_VBN on_IN a_DT substantial_JJ proportion_NN of_IN the_DT study_NN population_NN -LRB-_-LRB- 225_CD complete_JJ sets_NNS -RRB-_-RRB- at_IN the_DT International_NNP Agency_NNP for_IN Research_NNP on_IN Cancer_NNP ,_, using_VBG commercially_RB available_JJ immunoassays_NNS ,_, and_CC have_VBP been_VBN described_VBN in_IN details_NNS elsewhere_RB -LRB-_-LRB- Cust_FW et_FW al._FW ._. 
2007_CD ,_, Allen_NNP et_NNP al_NNP ._. 
2008_CD -RRB-_-RRB- ._. 
In_IN brief_NN ,_, serum_NN testosterone_NN ,_, DHEAS_NNP ,_, androstenedione_NN ,_, estradiol_NN -LRB-_-LRB- E_NNP 2_CD -RRB-_-RRB- ,_, and_CC estrone_NN -LRB-_-LRB- E_NNP 1_CD -RRB-_-RRB- were_VBD measured_VBN by_IN RIAs_NNP -LRB-_-LRB- Immunotech_NNP ,_, Marseille_NNP ,_, France_NNP and_CC DSL_NNP ,_, Webster_NNP ,_, TX_NNP ,_, USA_NNP -RRB-_-RRB- ,_, while_IN C-peptide_NN and_CC sex_NN hormone-binding_NN globulin_NN -LRB-_-LRB- SHBG_NNP -RRB-_-RRB- were_VBD measured_VBN by_IN IRMAs_NNP -LRB-_-LRB- Immunotech_NNP and_CC CIS-Bio_NNP ,_, Gif-sur-Yvette_NNP ,_, France_NNP -RRB-_-RRB- ._. 
2002_CD -RRB-_-RRB- ._. 
1999_CD ,_, Meier_NNP et_FW al_FW ._. 
1999_CD ,_, Yudkin_FW et_FW al_FW ._. 
1997_CD ,_, Visser_NNP et_FW al_FW ._. 
Excess_JJ body_NN weight_NN is_VBZ associated_VBN with_IN a_DT systemic_JJ low-grade_JJ inflammatory_JJ condition_NN -LRB-_-LRB- Das_NNP 2001_CD -RRB-_-RRB- ,_, characterized_VBN by_IN elevations_NNS in_IN circulating_VBG pro-inflammatory_JJ cytokines_NNS and_CC acute_JJ phase_NN proteins_NNS -LRB-_-LRB- Mohamed-Ali_FW et_FW al_FW ._. 
Chronic_JJ inflammation_NN promotes_VBZ angiogenesis_NNS ,_, sustains_VBZ cell_NN proliferation_NN ,_, and_CC increases_VBZ production_NN of_IN free_JJ radicals_NNS that_IN cause_NN DNA_NN damage_NN ,_, leading_VBG to_TO tumor_NN initiation_NN and_CC development_NN -LRB-_-LRB- Coussens_NNPS 
2002_CD -RRB-_-RRB- ._. 
2001_CD ,_, von_NNP Wolff_NNP et_FW al_FW ._. 
Within_IN the_DT uterus_NN ,_, IL6_NNP and_CC IL1_NNP are_VBP present_JJ throughout_IN the_DT menstrual_JJ cycle_NN ,_, with_IN a_DT peak_NN of_IN expression_NN during_IN the_DT proliferative_JJ phase_NN -LRB-_-LRB- Kelly_NNP et_NNP al_NNP ._. 
Cytokines_NNS have_VBP been_VBN shown_VBN to_TO enhance_VB the_DT growth_NN and_CC metastasis_NN of_IN various_JJ types_NNS of_IN tumors_NNS -LRB-_-LRB- Aggarwal_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ,_, and_CC alterations_NNS in_IN the_DT levels_NNS of_IN cytokine_NN production_NN have_VBP been_VBN reported_VBN in_IN several_JJ types_NNS of_IN cancer_NN ,_, including_VBG gynecologic_JJ cancers_NNS ._. 
2006_CD -RRB-_-RRB- ._. 
IL1_CD receptor_NN antagonist_NN -LRB-_-LRB- IL1Ra_NNP -RRB-_-RRB- is_VBZ secreted_VBN by_IN various_JJ types_NNS of_IN cells_NNS including_VBG immune_JJ cells_NNS ,_, epithelial_JJ cells_NNS ,_, and_CC adipocytes_NNS ,_, and_CC is_VBZ a_DT natural_JJ inhibitor_NN of_IN the_DT pro-inflammatory_JJ effect_NN of_IN IL1_CD 
Endogenous_NNP C-peptide_NNP and_CC sex-steroid_JJ hormone_NN measurements_NNS were_VBD performed_VBN on_IN a_DT substantial_JJ proportion_NN of_IN the_DT study_NN population_NN -LRB-_-LRB- 225_CD complete_JJ sets_NNS -RRB-_-RRB- at_IN the_DT International_NNP Agency_NNP for_IN Research_NNP on_IN Cancer_NNP ,_, using_VBG commercially_RB available_JJ immunoassays_NNS ,_, and_CC have_VBP been_VBN described_VBN in_IN details_NNS elsewhere_RB -LRB-_-LRB- Cust_FW et_FW al_FW ._. 
2007_CD ,_, Allen_NNP et_NNP al._NNP ._. 
2008_CD -RRB-_-RRB- ._. 
In_IN brief_NN ,_, serum_NN testosterone_NN ,_, DHEAS_NNP ,_, androstenedione_NN ,_, estradiol_NN -LRB-_-LRB- E_NNP 2_CD -RRB-_-RRB- ,_, and_CC estrone_NN -LRB-_-LRB- E_NNP 1_CD -RRB-_-RRB- were_VBD measured_VBN by_IN RIAs_NNP -LRB-_-LRB- Immunotech_NNP ,_, Marseille_NNP ,_, France_NNP and_CC DSL_NNP ,_, Webster_NNP ,_, TX_NNP ,_, USA_NNP -RRB-_-RRB- ,_, while_IN C-peptide_NN and_CC sex_NN hormone-binding_NN globulin_NN -LRB-_-LRB- SHBG_NNP -RRB-_-RRB- were_VBD measured_VBN by_IN IRMAs_NNP -LRB-_-LRB- Immunotech_NNP and_CC CIS-Bio_NNP ,_, Gif-sur-Yvette_NNP ,_, France_NNP -RRB-_-RRB- ._. 
1997_CD ,_, Punnonen_FW et_FW al_FW ._. 
For_IN example_NN ,_, increased_VBD IL6_CD concentrations_NNS have_VBP been_VBN reported_VBN in_IN patients_NNS with_IN endometrial_JJ carcinoma_NN -LRB-_-LRB- Chopra_FW et_FW al_FW ._. 
1998_CD ,_, Bellone_NNP et_FW al._FW ._. 
2005_CD ,_, Slater_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ,_, and_CC laboratory_NN experiments_NNS have_VBP demonstrated_VBN that_IN nuclear_JJ factor_NN -_: 
Indeed_RB ,_, the_DT stronger_JJR association_NN observed_VBD for_IN IL6_NNP among_IN cases_NNS diagnosed_VBN in_IN the_DT 2_CD years_NNS following_VBG blood_NN collection_NN suggests_VBZ the_DT presence_NN of_IN a_DT preclinical_JJ tumor_NN that_WDT can_MD release_VB IL6_NNP -LRB-_-LRB- Scambia_FW et_FW al_FW ._. 
1994_CD ,_, Bellone_NNP et_FW al._FW ._. 
2005_CD ,_, Slater_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- and_CC may_MD have_VB influenced_VBN circulating_VBG levels_NNS ._. 
However_RB ,_, this_DT was_VBD not_RB observed_JJ for_IN the_DT other_JJ two_CD markers_NNS ._. 
2004_CD -RRB-_-RRB- ._. 
2003_CD ,_, Hu_FW et_FW al_FW ._. 
2001_CD ,_, Spranger_NNP et_NNP al_NNP ._. 
2001_CD -RRB-_-RRB- ,_, and_CC with_IN the_DT development_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Pradhan_FW et_FW al_FW ._. 
Moreover_RB ,_, IL6_NNP enhances_VBZ the_DT hepatic_JJ production_NN of_IN the_DT suppressor_NN of_IN cytokine_NN signaling-3_JJ -LRB-_-LRB- a_DT protein_NN that_WDT is_VBZ known_VBN to_TO inhibit_VB the_DT insulin_NN signaling_VBG pathway_NN -RRB-_-RRB- -LRB-_-LRB- Lebrun_NNP 
2006_CD -RRB-_-RRB- ,_, and_CC alterations_NNS in_IN the_DT levels_NNS of_IN cytokine_NN production_NN have_VBP been_VBN reported_VBN in_IN several_JJ types_NNS of_IN cancer_NN ,_, including_VBG gynecologic_JJ cancers_NNS ._. 
For_IN example_NN ,_, increased_VBD IL6_CD concentrations_NNS have_VBP been_VBN reported_VBN in_IN patients_NNS with_IN endometrial_JJ carcinoma_NN -LRB-_-LRB- Chopra_FW et_FW al._FW ._. 
1997_CD ,_, Punnonen_FW et_FW al_FW ._. 
1998_CD ,_, Bellone_NNP et_FW al_FW ._. 
2005_CD ,_, Slater_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ,_, and_CC laboratory_NN experiments_NNS have_VBP demonstrated_VBN that_IN nuclear_JJ factor_NN -_: 
We_PRP provided_VBD epidemiological_JJ evidence_NN that_IN chronic_JJ inflammation_NN might_MD mediate_VB the_DT association_NN between_IN obesity_NN and_CC endometrial_NN cancer_NN and_CC that_IN endometrial_JJ carcinogenesis_NNS could_MD be_VB promoted_VBN by_IN an_DT inflammatory_JJ milieu_NN ._. 
Word_NNP Cancer_NNP Research_NNP Fund2007\/13IntroductionExcess_NNP body_NN weight_NN is_VBZ one_CD of_IN the_DT strongest_JJS risk_NN factors_NNS for_IN endometrial_JJ cancer_NN and_CC accounts_NNS for_IN about_IN 50_CD %_NN of_IN the_DT cases_NNS in_IN Europe_NNP and_CC in_IN the_DT USA_NNP -LRB-_-LRB- International_NNP Agency_NNP for_IN Research_NNP on_IN Cancer_NNP -LRB-_-LRB- IARC_NNP -RRB-_-RRB- 2002_CD ,_, Calle_NNP 
Word_NNP Cancer_NNP Research_NNP Fund_NNP 2007\/13_CD Introduction_NNP Excess_NNP body_NN weight_NN is_VBZ one_CD of_IN the_DT strongest_JJS risk_NN factors_NNS for_IN endometrial_JJ cancer_NN and_CC accounts_NNS for_IN about_IN 50_CD %_NN of_IN the_DT cases_NNS in_IN Europe_NNP and_CC in_IN the_DT USA_NNP -LRB-_-LRB- International_NNP Agency_NNP for_IN Research_NNP on_IN Cancer_NNP -LRB-_-LRB- IARC_NNP -RRB-_-RRB- 2002_CD ,_, Calle_NNP 
1995_CD ,_, Franks_NNP 1995_CD -RRB-_-RRB- ._. 
In_IN premenopausal_JJ women_NNS ,_, obesity_NN has_VBZ been_VBN associated_VBN with_IN the_DT development_NN of_IN polycystic_JJ ovary_JJ syndrome_NN ,_, a_DT disease_NN that_WDT affects_VBZ 4_CD 
This_DT hypothesis_NN is_VBZ also_RB supported_VBN by_IN the_DT fact_NN that_DT adjustment_NN for_IN inflammatory_JJ markers_NNS ,_, in_IN addition_NN to_TO E_NNP 1_CD ,_, further_RB attenuated_VBD the_DT risk_NN among_IN obese_JJ women_NNS ._. 
Furthermore_RB ,_, inflammatory_JJ markers_NNS have_VBP also_RB been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN the_DT development_NN of_IN insulin_NN resistance_NN ,_, hyperglycemia_NN ,_, and_CC type_NN 2_CD diabetes_NN -LRB-_-LRB- Greenberg_NNP 
Matching_VBG characteristics_NNS for_IN cases_NNS and_CC controls_NNS included_VBD study_NN recruitment_NN center_NN ,_, menopausal_JJ status_NN -LRB-_-LRB- premenopausal_JJ and_CC postmenopausal_JJ -RRB-_-RRB- ,_, age_NN -LRB-_-LRB- 
2002_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, inflammatory_JJ markers_NNS have_VBP also_RB been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN the_DT development_NN of_IN insulin_NN resistance_NN ,_, hyperglycemia_NN ,_, and_CC type_NN 2_CD diabetes_NN -LRB-_-LRB- Greenberg_NNP 
CRP_NNP binds_VBZ to_TO damaged_JJ cellular_JJ tissues_NNS and_CC components_NNS to_TO facilitate_VB phagocytosis_NN and_CC clearance_NN by_IN macrophages_NNS and_CC leukocytes_NNS -LRB-_-LRB- Pasche_NNP 
This_DT hypothesis_NN is_VBZ also_RB supported_VBN by_IN the_DT fact_NN that_DT adjustment_NN for_IN inflammatory_JJ markers_NNS ,_, in_IN addition_NN to_TO E_NNP 1_CD ,_, further_RB attenuated_VBD the_DT risk_NN among_IN obese_JJ women_NNS ._. 
Furthermore_RB ,_, inflammatory_JJ markers_NNS have_VBP also_RB been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN the_DT development_NN of_IN insulin_NN resistance_NN ,_, hyperglycemia_NN ,_, and_CC type_NN 2_CD diabetes_NN -LRB-_-LRB- Greenberg_NNP 
57_CD 
Moreover_RB ,_, recent_JJ studies_NNS implicated_VBD IL1Ra_NNP in_IN the_DT promotion_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Saltevo_FW et_FW al_FW ._. 
1998_CD -RRB-_-RRB- ._. 
2008_CD ,_, Herder_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ,_, another_DT well-known_JJ risk_NN factor_NN for_IN endometrial_JJ cancer_NN development_NN -LRB-_-LRB- Friberg_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
More_RBR recently_RB ,_, this_DT cytokine_NN has_VBZ also_RB been_VBN implicated_VBN in_IN the_DT development_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Saltevo_FW et_FW al_FW ._. 
2008_CD ,_, Herder_NNP et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
Its_PRP$ role_NN in_IN obesity-related_JJ inflammation_NN and_CC in_IN the_DT development_NN of_IN associated_JJ diseases_NNS is_VBZ not_RB yet_RB fully_RB understood_VBN ._. 
2001_CD ,_, Spranger_NNP et_NNP al_NNP ._. 
2001_CD -RRB-_-RRB- ,_, and_CC with_IN the_DT development_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Pradhan_FW et_FW al_FW ._. 
1999_CD ,_, Vozarova_FW et_FW al_FW ._. 
2003_CD ,_, Hu_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, IL6_NNP enhances_VBZ the_DT hepatic_JJ production_NN of_IN the_DT suppressor_NN of_IN cytokine_NN signaling-3_JJ -LRB-_-LRB- a_DT protein_NN that_WDT is_VBZ known_VBN to_TO inhibit_VB the_DT insulin_NN signaling_VBG pathway_NN -RRB-_-RRB- -LRB-_-LRB- Lebrun_NNP 
We_PRP provided_VBD epidemiological_JJ evidence_NN that_IN chronic_JJ inflammation_NN might_MD mediate_VB the_DT association_NN between_IN obesity_NN and_CC endometrial_NN cancer_NN and_CC that_IN endometrial_JJ carcinogenesis_NNS could_MD be_VB promoted_VBN by_IN an_DT inflammatory_JJ milieu_NN ._. 
Word_NNP Cancer_NNP Research_NNP Fund2007\/13IntroductionExcess_NNP body_NN weight_NN is_VBZ one_CD of_IN the_DT strongest_JJS risk_NN factors_NNS for_IN endometrial_JJ cancer_NN and_CC accounts_NNS for_IN about_IN 50_CD %_NN of_IN the_DT cases_NNS in_IN Europe_NNP and_CC in_IN the_DT USA_NNP -LRB-_-LRB- International_NNP Agency_NNP for_IN Research_NNP on_IN Cancer_NNP -LRB-_-LRB- IARC_NNP -RRB-_-RRB- 2002_CD ,_, Calle_NNP 
2004_CD -RRB-_-RRB- ._. 
2002_CD ,_, Pallares_NNPS et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ,_, and_CC laboratory_NN experiments_NNS have_VBP demonstrated_VBN that_IN nuclear_JJ factor_NN -_: 
2009_CD -RRB-_-RRB- ._. 
IL6_NNP is_VBZ also_RB the_DT main_JJ regulatory_JJ factor_NN of_IN hepatic_JJ production_NN of_IN CRP_NNP ,_, which_WDT also_RB decreases_VBZ insulin_NN signaling_VBG and_CC glucose_NN uptake_NN -LRB-_-LRB- Devaraj_NNP et_FW al_FW ._. 
IL1Ra_NNP is_VBZ another_DT cytokine_NN that_WDT is_VBZ released_VBN in_IN major_JJ amounts_NNS by_IN the_DT adipose_JJ tissue_NN -LRB-_-LRB- Juge-Aubry_NNP et_FW al._FW ._. 
2003_CD -RRB-_-RRB- and_CC is_VBZ elevated_VBN more_JJR than_IN sevenfold_RB in_IN obesity_NN -LRB-_-LRB- Meier_FW et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
More_RBR recently_RB ,_, this_DT cytokine_NN has_VBZ also_RB been_VBN implicated_VBN in_IN the_DT development_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Saltevo_FW et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
1999_CD ,_, Meier_NNP et_FW al_FW ._. 
However_RB ,_, it_PRP has_VBZ been_VBN hypothesized_VBN that_IN IL1Ra_NNP might_MD have_VB a_DT role_NN in_IN the_DT development_NN of_IN resistance_NN to_TO leptin_NN in_IN obese_JJ patients_NNS ,_, and_CC this_DT in_IN turn_NN may_MD further_RB sustain_VB obesity_NN -LRB-_-LRB- Luheshi_FW et_FW al_FW ._. 
IL1Ra_NNP could_MD also_RB contribute_VB to_TO an_DT increase_NN in_IN adiposity_NN by_IN inhibiting_VBG IL1_NNP 
1998_CD -RRB-_-RRB- ._. 
Nevertheless_RB ,_, induction_NN of_IN IL1Ra_JJ production_NN by_IN other_JJ cytokines_NNS and_CC acute_JJ phase_NN proteins_NNS indicates_VBZ a_DT possible_JJ role_NN of_IN this_DT cytokine_NN in_IN chronic_JJ inflammation_NN -LRB-_-LRB- Arend_FW et_FW al_FW ._. 
Moreover_RB ,_, recent_JJ studies_NNS implicated_VBD IL1Ra_NNP in_IN the_DT promotion_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Saltevo_FW et_FW al._FW ._. 
2008_CD ,_, Herder_NNP et_NNP al_NNP ._. 
2009_CD -RRB-_-RRB- ,_, another_DT well-known_JJ risk_NN factor_NN for_IN endometrial_JJ cancer_NN development_NN -LRB-_-LRB- Friberg_NNP et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
2003_CD -RRB-_-RRB- and_CC is_VBZ elevated_VBN more_JJR than_IN sevenfold_RB in_IN obesity_NN -LRB-_-LRB- Meier_FW et_FW al_FW ._. 
IL1Ra_NNP is_VBZ another_DT cytokine_NN that_WDT is_VBZ released_VBN in_IN major_JJ amounts_NNS by_IN the_DT adipose_JJ tissue_NN -LRB-_-LRB- Juge-Aubry_JJ et_FW al_FW ._. 
More_RBR recently_RB ,_, this_DT cytokine_NN has_VBZ also_RB been_VBN implicated_VBN in_IN the_DT development_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Saltevo_FW et_FW al._FW ._. 
2008_CD ,_, Herder_NNP et_NNP al_NNP ._. 
2009_CD -RRB-_-RRB- ._. 
Its_PRP$ role_NN in_IN obesity-related_JJ inflammation_NN and_CC in_IN the_DT development_NN of_IN associated_JJ diseases_NNS is_VBZ not_RB yet_RB fully_RB understood_VBN ._. 
This_DT design_NN reduces_VBZ the_DT possibility_NN of_IN 
In_IN the_DT present_JJ study_NN ,_, Norway_NNP was_VBD not_RB included_VBN because_IN blood_NN samples_NNS have_VBP been_VBN collected_VBN only_RB recently_RB ,_, and_CC very_RB few_JJ cases_NNS of_IN endometrial_JJ cancer_NN have_VBP been_VBN diagnosed_VBN after_IN blood_NN donation_NN ._. 
Study_NN population_NN and_CC baseline_NN data_NNS collection_NN have_VBP been_VBN previously_RB described_VBN in_IN details_NNS -LRB-_-LRB- Riboli_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
In_IN brief_NN ,_, questionnaires_NNS included_VBD data_NNS about_IN dietary_NN ,_, lifestyle_NN and_CC health_NN factors_NNS ,_, reproductive_JJ history_NN ,_, use_NN of_IN oral_JJ contraceptives_NNS -LRB-_-LRB- OCs_NNP -RRB-_-RRB- and_CC hormone_NN replacement_NN therapy_NN -LRB-_-LRB- HRT_NNP -RRB-_-RRB- ,_, history_NN of_IN any_DT disorders_NNS or_CC surgical_JJ operations_NNS ,_, tobacco_NN smoking_NN and_CC alcohol_NN consumption_NN ,_, occupational_JJ history_NN ,_, physical_JJ activity_NN ,_, and_CC education_NN level_NN ._. 
In_IN brief_NN ,_, questionnaires_NNS included_VBD data_NNS about_IN dietary_NN ,_, lifestyle_NN and_CC health_NN factors_NNS ,_, reproductive_JJ history_NN ,_, use_NN of_IN oral_JJ contraceptives_NNS -LRB-_-LRB- OCs_NNP -RRB-_-RRB- and_CC hormone_NN replacement_NN therapy_NN -LRB-_-LRB- HRT_NNP -RRB-_-RRB- ,_, history_NN of_IN any_DT disorders_NNS or_CC surgical_JJ operations_NNS ,_, tobacco_NN smoking_NN and_CC alcohol_NN consumption_NN ,_, occupational_JJ history_NN ,_, physical_JJ activity_NN ,_, and_CC education_NN level_NN ._. 
Collection_NN and_CC storage_NN of_IN blood_NN samplesIn_NNP France_NNP ,_, The_NNP Netherlands_NNP ,_, the_DT United_NNP Kingdom_NNP ,_, Germany_NNP ,_, Spain_NNP ,_, Italy_NNP ,_, and_CC Greece_NNP ,_, blood_NN samples_NNS were_VBD collected_VBN according_VBG to_TO a_DT standardized_JJ protocol_NN -LRB-_-LRB- Riboli_FW et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
From_IN each_DT subject_NN ,_, about_IN 30_CD 
Inflammatory_JJ processes_NNS also_RB play_VBP a_DT central_JJ role_NN in_IN the_DT regulation_NN of_IN endometrial_JJ mucosa_NN growth_NN and_CC shedding_VBG during_IN the_DT menstrual_JJ cycle_NN -LRB-_-LRB- Kelly_NNP et_NNP al_NNP ._. 
2001_CD -RRB-_-RRB- as_RB well_RB as_IN in_IN endometrial_JJ repair_NN following_VBG menstruation_NN -LRB-_-LRB- Salamonsen_NNP 2003_CD -RRB-_-RRB- ._. 
C-reactive_JJ protein_NN -LRB-_-LRB- CRP_NNP -RRB-_-RRB- is_VBZ an_DT acute_JJ phase_NN protein_NN produced_VBN by_IN the_DT liver_NN in_IN response_NN to_TO tissue_NN damage_NN and_CC inflammation_NN ._. 
The_DT association_NN between_IN adiposity_JJ measurements_NNS and_CC endometrial_JJ cancer_NN was_VBD also_RB substantially_RB attenuated_VBN after_IN adjustment_NN for_IN inflammatory_JJ markers_NNS ,_, even_RB when_WRB the_DT effect_NN of_IN C-peptide_NNP or_CC E_NNP 1_CD was_VBD already_RB taken_VBN into_IN account_NN ._. 
One_CD mechanism_NN for_IN the_DT inflammation-mediated_JJ association_NN between_IN obesity_NN and_CC endometrial_JJ cancer_NN could_MD be_VB the_DT modulation_NN of_IN aromatase_NN activity_NN by_IN cytokines_NNS within_IN the_DT adipose_JJ tissue_NN -LRB-_-LRB- Purohit_NNP 
Word_NNP Cancer_NNP Research_NNP Fund_NNP 2007\/13_CD Introduction_NNP Excess_NNP body_NN weight_NN is_VBZ one_CD of_IN the_DT strongest_JJS risk_NN factors_NNS for_IN endometrial_JJ cancer_NN and_CC accounts_NNS for_IN about_IN 50_CD %_NN of_IN the_DT cases_NNS in_IN Europe_NNP and_CC in_IN the_DT USA_NNP -LRB-_-LRB- International_NNP Agency_NNP for_IN Research_NNP on_IN Cancer_NNP -LRB-_-LRB- IARC_NNP -RRB-_-RRB- 2002_CD ,_, Calle_NNP 
1999_CD ,_, Vozarova_FW et_FW al_FW ._. 
Its_PRP$ concentration_NN correlates_VBZ with_IN measures_NNS of_IN obesity_NN and_CC insulin_NN resistance_NN -LRB-_-LRB- Yudkin_FW et_FW al_FW ._. 
2001_CD -RRB-_-RRB- ,_, and_CC with_IN the_DT development_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Pradhan_FW et_FW al._FW ._. 
2001_CD ,_, Spranger_NNP et_NNP al_NNP ._. 
2003_CD ,_, Hu_FW et_FW al_FW ._. 
2004_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, IL6_NNP enhances_VBZ the_DT hepatic_JJ production_NN of_IN the_DT suppressor_NN of_IN cytokine_NN signaling-3_JJ -LRB-_-LRB- a_DT protein_NN that_WDT is_VBZ known_VBN to_TO inhibit_VB the_DT insulin_NN signaling_VBG pathway_NN -RRB-_-RRB- -LRB-_-LRB- Lebrun_NNP 
For_IN example_NN ,_, increased_VBD IL6_CD concentrations_NNS have_VBP been_VBN reported_VBN in_IN patients_NNS with_IN endometrial_JJ carcinoma_NN -LRB-_-LRB- Chopra_FW et_FW al_FW ._. 
1997_CD ,_, Punnonen_FW et_FW al._FW ._. 
1998_CD ,_, Bellone_NNP et_FW al_FW ._. 
2005_CD ,_, Slater_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ,_, and_CC laboratory_NN experiments_NNS have_VBP demonstrated_VBN that_IN nuclear_JJ factor_NN -_: 
C-reactive_JJ protein_NN -LRB-_-LRB- CRP_NNP -RRB-_-RRB- is_VBZ an_DT acute_JJ phase_NN protein_NN produced_VBN by_IN the_DT liver_NN in_IN response_NN to_TO tissue_NN damage_NN and_CC inflammation_NN ._. 
CRP_NNP binds_VBZ to_TO damaged_JJ cellular_JJ tissues_NNS and_CC components_NNS to_TO facilitate_VB phagocytosis_NN and_CC clearance_NN by_IN macrophages_NNS and_CC leukocytes_NNS -LRB-_-LRB- Pasche_NNP 
The_DT major_JJ stimulus_NN of_IN CRP_NNP synthesis_NN is_VBZ interleukin_JJ 6_CD -LRB-_-LRB- IL6_NNP ;_: Goldman_NNP 
2002_CD ,_, Feve_NNP 
2005_CD -RRB-_-RRB- ._. 
More_RBR recently_RB ,_, it_PRP has_VBZ been_VBN proposed_VBN that_IN other_JJ adiposity-related_JJ factors_NNS such_JJ as_IN cytokines_NNS and_CC adipokines_NNS might_MD contribute_VB to_TO endometrial_JJ cancer_NN initiation_NN and_CC progression_NN and_CC to_TO the_DT obesity-related_JJ increase_NN in_IN risk_NN -LRB-_-LRB- Modugno_NNP et_FW al_FW ._. 
Excess_JJ body_NN weight_NN is_VBZ associated_VBN with_IN a_DT systemic_JJ low-grade_JJ inflammatory_JJ condition_NN -LRB-_-LRB- Das_NNP 2001_CD -RRB-_-RRB- ,_, characterized_VBN by_IN elevations_NNS in_IN circulating_VBG pro-inflammatory_JJ cytokines_NNS and_CC acute_JJ phase_NN proteins_NNS -LRB-_-LRB- Mohamed-Ali_FW et_FW al._FW ._. 
1997_CD ,_, Visser_NNP et_FW al_FW ._. 
1999_CD ,_, Yudkin_FW et_FW al_FW ._. 
1999_CD ,_, Meier_NNP et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
Chronic_JJ inflammation_NN promotes_VBZ angiogenesis_NNS ,_, sustains_VBZ cell_NN proliferation_NN ,_, and_CC increases_VBZ production_NN of_IN free_JJ radicals_NNS that_IN cause_NN DNA_NN damage_NN ,_, leading_VBG to_TO tumor_NN initiation_NN and_CC development_NN -LRB-_-LRB- Coussens_NNPS 
CRP_NNP and_CC IL6_NNP were_VBD measured_VBN by_IN using_VBG enzyme-linked_JJ immunoassays_NNS -LRB-_-LRB- R_NN 
7%_CD ,_, P_NNP =_SYM 0_CD ._. 
5vs_CD 16_CD ._. 
002_CD -RRB-_-RRB- ,_, and_CC more_RBR often_RB past_JJ HRT_NNP users_NNS -LRB-_-LRB- 29_CD ._. 
0%_CD ,_, P_NNP =_SYM 0_CD ._. 
8vs_CD 42_CD ._. 
002_CD -RRB-_-RRB- ,_, were_VBD less_RBR often_RB past_JJ OC_NNP users_NNS -LRB-_-LRB- 32_CD ._. 
0001_CD -RRB-_-RRB- as_IN reported_VBN previously_RB -LRB-_-LRB- Dossus_FW et_FW al._FW ._. 
2009_CD a_DT -RRB-_-RRB- ._. 
Differences_NNS in_IN cytokine_NN levels_NNS according_VBG to_TO baseline_JJ characteristics_NNS were_VBD evaluated_VBN among_IN controls_NNS after_IN adjusting_VBG for_IN age_NN at_IN blood_NN donation_NN ,_, laboratory_NN batch_NN ,_, and_CC BMI_NNP ._. 
IL6_NNP is_VBZ one_CD of_IN the_DT major_JJ cytokines_NNS released_VBN by_IN the_DT adipose_JJ tissue_NN -LRB-_-LRB- Orban_FW et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, inflammatory_JJ markers_NNS have_VBP also_RB been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN the_DT development_NN of_IN insulin_NN resistance_NN ,_, hyperglycemia_NN ,_, and_CC type_NN 2_CD diabetes_NN -LRB-_-LRB- Greenberg_NNP 
In_IN postmenopausal_JJ women_NNS ,_, excess_JJ weight_NN leads_NNS ,_, through_IN peripheral_JJ conversion_NN of_IN androgens_NNS ,_, to_TO increased_VBN circulating_VBG bioavailable_JJ estrogens_NNS which_WDT in_IN turn_NN ,_, when_WRB not_RB counterbalanced_VBN by_IN progesterone_NN ,_, increases_VBZ the_DT mitogenic_JJ activity_NN of_IN endometrial_JJ cells_NNS -LRB-_-LRB- Key_NNP 
In_IN premenopausal_JJ women_NNS ,_, obesity_NN has_VBZ been_VBN associated_VBN with_IN the_DT development_NN of_IN polycystic_JJ ovary_JJ syndrome_NN ,_, a_DT disease_NN that_WDT affects_VBZ 4_CD 
Moreover_RB ,_, IL6_NNP enhances_VBZ the_DT hepatic_JJ production_NN of_IN the_DT suppressor_NN of_IN cytokine_NN signaling-3_JJ -LRB-_-LRB- a_DT protein_NN that_WDT is_VBZ known_VBN to_TO inhibit_VB the_DT insulin_NN signaling_VBG pathway_NN -RRB-_-RRB- -LRB-_-LRB- Lebrun_NNP 
CRP_NNP binds_VBZ to_TO damaged_JJ cellular_JJ tissues_NNS and_CC components_NNS to_TO facilitate_VB phagocytosis_NN and_CC clearance_NN by_IN macrophages_NNS and_CC leukocytes_NNS -LRB-_-LRB- Pasche_NNP 
2008_CD ,_, Herder_NNP et_NNP al_NNP ._. 
Moreover_RB ,_, recent_JJ studies_NNS implicated_VBD IL1Ra_NNP in_IN the_DT promotion_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Saltevo_FW et_FW al_FW ._. 
2009_CD -RRB-_-RRB- ,_, another_DT well-known_JJ risk_NN factor_NN for_IN endometrial_JJ cancer_NN development_NN -LRB-_-LRB- Friberg_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
We_PRP conducted_VBD a_DT case_NN 
1999_CD ,_, Yudkin_FW et_FW al_FW ._. 
1997_CD ,_, Visser_NNP et_FW al_FW ._. 
Excess_JJ body_NN weight_NN is_VBZ associated_VBN with_IN a_DT systemic_JJ low-grade_JJ inflammatory_JJ condition_NN -LRB-_-LRB- Das_NNP 2001_CD -RRB-_-RRB- ,_, characterized_VBN by_IN elevations_NNS in_IN circulating_VBG pro-inflammatory_JJ cytokines_NNS and_CC acute_JJ phase_NN proteins_NNS -LRB-_-LRB- Mohamed-Ali_FW et_FW al_FW ._. 
1999_CD ,_, Meier_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
Chronic_JJ inflammation_NN promotes_VBZ angiogenesis_NNS ,_, sustains_VBZ cell_NN proliferation_NN ,_, and_CC increases_VBZ production_NN of_IN free_JJ radicals_NNS that_IN cause_NN DNA_NN damage_NN ,_, leading_VBG to_TO tumor_NN initiation_NN and_CC development_NN -LRB-_-LRB- Coussens_NNPS 
IL1Ra_NNP is_VBZ another_DT cytokine_NN that_WDT is_VBZ released_VBN in_IN major_JJ amounts_NNS by_IN the_DT adipose_JJ tissue_NN -LRB-_-LRB- Juge-Aubry_JJ et_FW al_FW ._. 
2003_CD -RRB-_-RRB- and_CC is_VBZ elevated_VBN more_JJR than_IN sevenfold_RB in_IN obesity_NN -LRB-_-LRB- Meier_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
More_RBR recently_RB ,_, this_DT cytokine_NN has_VBZ also_RB been_VBN implicated_VBN in_IN the_DT development_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Saltevo_FW et_FW al_FW ._. 
However_RB ,_, it_PRP has_VBZ been_VBN hypothesized_VBN that_IN IL1Ra_NNP might_MD have_VB a_DT role_NN in_IN the_DT development_NN of_IN resistance_NN to_TO leptin_NN in_IN obese_JJ patients_NNS ,_, and_CC this_DT in_IN turn_NN may_MD further_RB sustain_VB obesity_NN -LRB-_-LRB- Luheshi_FW et_FW al_FW ._. 
1999_CD ,_, Meier_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
IL1Ra_NNP could_MD also_RB contribute_VB to_TO an_DT increase_NN in_IN adiposity_NN by_IN inhibiting_VBG IL1_NNP 
Its_PRP$ role_NN in_IN obesity-related_JJ inflammation_NN and_CC in_IN the_DT development_NN of_IN associated_JJ diseases_NNS is_VBZ not_RB yet_RB fully_RB understood_VBN ._. 
However_RB ,_, it_PRP has_VBZ been_VBN hypothesized_VBN that_IN IL1Ra_NNP might_MD have_VB a_DT role_NN in_IN the_DT development_NN of_IN resistance_NN to_TO leptin_NN in_IN obese_JJ patients_NNS ,_, and_CC this_DT in_IN turn_NN may_MD further_RB sustain_VB obesity_NN -LRB-_-LRB- Luheshi_FW et_FW al._FW ._. 
1999_CD ,_, Meier_NNP et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
IL1Ra_NNP could_MD also_RB contribute_VB to_TO an_DT increase_NN in_IN adiposity_NN by_IN inhibiting_VBG IL1_NNP 
CRP_NNP binds_VBZ to_TO damaged_JJ cellular_JJ tissues_NNS and_CC components_NNS to_TO facilitate_VB phagocytosis_NN and_CC clearance_NN by_IN macrophages_NNS and_CC leukocytes_NNS -LRB-_-LRB- Pasche_NNP 
2004_CD -RRB-_-RRB- ._. 
2003_CD ,_, Hu_FW et_FW al_FW ._. 
2001_CD ,_, Spranger_NNP et_NNP al_NNP ._. 
2001_CD -RRB-_-RRB- ,_, and_CC with_IN the_DT development_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Pradhan_FW et_FW al_FW ._. 
Moreover_RB ,_, IL6_NNP enhances_VBZ the_DT hepatic_JJ production_NN of_IN the_DT suppressor_NN of_IN cytokine_NN signaling-3_JJ -LRB-_-LRB- a_DT protein_NN that_WDT is_VBZ known_VBN to_TO inhibit_VB the_DT insulin_NN signaling_VBG pathway_NN -RRB-_-RRB- -LRB-_-LRB- Lebrun_NNP 
Several_JJ biological_JJ mechanisms_NNS could_MD mediate_VB the_DT association_NN between_IN obesity_NN and_CC endometrial_JJ cancer_NN risk_NN ._. 
In_IN postmenopausal_JJ women_NNS ,_, excess_JJ weight_NN leads_NNS ,_, through_IN peripheral_JJ conversion_NN of_IN androgens_NNS ,_, to_TO increased_VBN circulating_VBG bioavailable_JJ estrogens_NNS which_WDT in_IN turn_NN ,_, when_WRB not_RB counterbalanced_VBN by_IN progesterone_NN ,_, increases_VBZ the_DT mitogenic_JJ activity_NN of_IN endometrial_JJ cells_NNS -LRB-_-LRB- Key_NNP 
Chronic_JJ inflammation_NN promotes_VBZ angiogenesis_NNS ,_, sustains_VBZ cell_NN proliferation_NN ,_, and_CC increases_VBZ production_NN of_IN free_JJ radicals_NNS that_IN cause_NN DNA_NN damage_NN ,_, leading_VBG to_TO tumor_NN initiation_NN and_CC development_NN -LRB-_-LRB- Coussens_NNPS 
It_PRP is_VBZ also_RB possible_JJ that_IN cytokines_NNS have_VBP a_DT direct_JJ effect_NN on_IN endometrial_JJ carcinogenesis_NNS ._. 
2003_CD -RRB-_-RRB- ._. 
IL1Ra_NNP could_MD also_RB contribute_VB to_TO an_DT increase_NN in_IN adiposity_NN by_IN inhibiting_VBG IL1_NNP 
2005_CD -RRB-_-RRB- ._. 
More_RBR recently_RB ,_, it_PRP has_VBZ been_VBN proposed_VBN that_IN other_JJ adiposity-related_JJ factors_NNS such_JJ as_IN cytokines_NNS and_CC adipokines_NNS might_MD contribute_VB to_TO endometrial_JJ cancer_NN initiation_NN and_CC progression_NN and_CC to_TO the_DT obesity-related_JJ increase_NN in_IN risk_NN -LRB-_-LRB- Modugno_NNP et_FW al_FW ._. 
Excess_JJ body_NN weight_NN is_VBZ associated_VBN with_IN a_DT systemic_JJ low-grade_JJ inflammatory_JJ condition_NN -LRB-_-LRB- Das_NNP 2001_CD -RRB-_-RRB- ,_, characterized_VBN by_IN elevations_NNS in_IN circulating_VBG pro-inflammatory_JJ cytokines_NNS and_CC acute_JJ phase_NN proteins_NNS -LRB-_-LRB- Mohamed-Ali_FW et_FW al._FW ._. 
1997_CD ,_, Visser_NNP et_FW al_FW ._. 
1999_CD ,_, Yudkin_FW et_FW al_FW ._. 
1999_CD ,_, Meier_NNP et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
Chronic_JJ inflammation_NN promotes_VBZ angiogenesis_NNS ,_, sustains_VBZ cell_NN proliferation_NN ,_, and_CC increases_VBZ production_NN of_IN free_JJ radicals_NNS that_IN cause_NN DNA_NN damage_NN ,_, leading_VBG to_TO tumor_NN initiation_NN and_CC development_NN -LRB-_-LRB- Coussens_NNPS 
After_IN menopause_NN ,_, when_WRB the_DT estrogen_NN production_NN from_IN the_DT ovary_NN has_VBZ ceased_VBN ,_, most_JJS of_IN the_DT circulating_VBG estrogens_NNS derive_VBP from_IN the_DT peripheral_JJ aromatase_NN conversion_NN of_IN androgens_NNS in_IN the_DT adipose_JJ tissue_NN ._. 
It_PRP has_VBZ been_VBN shown_VBN that_IN IL6_NNP can_MD stimulate_VB aromatase_NN activity_NN in_IN the_DT adipose_JJ tissue_NN -LRB-_-LRB- Zhao_NNP et_FW al._FW ._. 
1995_CD -RRB-_-RRB- and_CC therefore_RB enhance_VB the_DT estrogen_NN production_NN and_CC bioavailability_NN ._. 
This_DT hypothesis_NN is_VBZ also_RB supported_VBN by_IN the_DT fact_NN that_DT adjustment_NN for_IN inflammatory_JJ markers_NNS ,_, in_IN addition_NN to_TO E_NNP 1_CD ,_, further_RB attenuated_VBD the_DT risk_NN among_IN obese_JJ women_NNS ._. 
2002_CD -RRB-_-RRB- ._. 
Obesity-associated_JJ hyperinsulinemia_NN might_MD also_RB play_VB an_DT important_JJ role_NN in_IN endometrial_JJ carcinogenesis_NN ,_, in_IN both_DT pre_NN and_CC postmenopausal_JJ women_NNS ,_, either_CC directly_RB ,_, by_IN stimulating_VBG endometrial_JJ cell_NN proliferation_NN ,_, or_CC indirectly_RB ,_, through_IN the_DT sex_NN steroid_NN and_CC the_DT insulin-like_JJ growth_NN factor_NN 1_CD pathways_NNS -LRB-_-LRB- Kaaks_FW et_FW al_FW ._. 
More_RBR recently_RB ,_, it_PRP has_VBZ been_VBN proposed_VBN that_IN other_JJ adiposity-related_JJ factors_NNS such_JJ as_IN cytokines_NNS and_CC adipokines_NNS might_MD contribute_VB to_TO endometrial_JJ cancer_NN initiation_NN and_CC progression_NN and_CC to_TO the_DT obesity-related_JJ increase_NN in_IN risk_NN -LRB-_-LRB- Modugno_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Excess_JJ body_NN weight_NN is_VBZ associated_VBN with_IN a_DT systemic_JJ low-grade_JJ inflammatory_JJ condition_NN -LRB-_-LRB- Das_NNP 2001_CD -RRB-_-RRB- ,_, characterized_VBN by_IN elevations_NNS in_IN circulating_VBG pro-inflammatory_JJ cytokines_NNS and_CC acute_JJ phase_NN proteins_NNS -LRB-_-LRB- Mohamed-Ali_FW et_FW al_FW ._. 
Within_IN the_DT uterus_NN ,_, IL6_NNP and_CC IL1_NNP are_VBP present_JJ throughout_IN the_DT menstrual_JJ cycle_NN ,_, with_IN a_DT peak_NN of_IN expression_NN during_IN the_DT proliferative_JJ phase_NN -LRB-_-LRB- Kelly_NNP et_NNP al_NNP ._. 
2001_CD ,_, von_NNP Wolff_NNP et_FW al._FW ._. 
2002_CD -RRB-_-RRB- ._. 
Cytokines_NNS have_VBP been_VBN shown_VBN to_TO enhance_VB the_DT growth_NN and_CC metastasis_NN of_IN various_JJ types_NNS of_IN tumors_NNS -LRB-_-LRB- Aggarwal_NNP et_FW al_FW ._. 
Its_PRP$ concentration_NN correlates_VBZ with_IN measures_NNS of_IN obesity_NN and_CC insulin_NN resistance_NN -LRB-_-LRB- Yudkin_FW et_FW al_FW ._. 
2004_CD -RRB-_-RRB- ._. 
1999_CD ,_, Vozarova_FW et_FW al._FW ._. 
2001_CD -RRB-_-RRB- ,_, and_CC with_IN the_DT development_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Pradhan_FW et_FW al_FW ._. 
2001_CD ,_, Spranger_NNP et_NNP al_NNP ._. 
2003_CD ,_, Hu_FW et_FW al_FW ._. 
1997_CD ,_, Visser_NNP et_FW al_FW ._. 
Excess_JJ body_NN weight_NN is_VBZ associated_VBN with_IN a_DT systemic_JJ low-grade_JJ inflammatory_JJ condition_NN -LRB-_-LRB- Das_NNP 2001_CD -RRB-_-RRB- ,_, characterized_VBN by_IN elevations_NNS in_IN circulating_VBG pro-inflammatory_JJ cytokines_NNS and_CC acute_JJ phase_NN proteins_NNS -LRB-_-LRB- Mohamed-Ali_FW et_FW al_FW ._. 
1999_CD ,_, Yudkin_FW et_FW al._FW ._. 
1999_CD ,_, Meier_NNP et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
Chronic_JJ inflammation_NN promotes_VBZ angiogenesis_NNS ,_, sustains_VBZ cell_NN proliferation_NN ,_, and_CC increases_VBZ production_NN of_IN free_JJ radicals_NNS that_IN cause_NN DNA_NN damage_NN ,_, leading_VBG to_TO tumor_NN initiation_NN and_CC development_NN -LRB-_-LRB- Coussens_NNPS 
2004_CD -RRB-_-RRB- ._. 
1999_CD ,_, Fain_NNP et_FW al_FW ._. 
IL6_NNP is_VBZ one_CD of_IN the_DT major_JJ cytokines_NNS released_VBN by_IN the_DT adipose_JJ tissue_NN -LRB-_-LRB- Orban_FW et_FW al_FW ._. 
Its_PRP$ concentration_NN correlates_VBZ with_IN measures_NNS of_IN obesity_NN and_CC insulin_NN resistance_NN -LRB-_-LRB- Yudkin_FW et_FW al._FW ._. 
1999_CD ,_, Vozarova_FW et_FW al_FW ._. 
2001_CD -RRB-_-RRB- ,_, and_CC with_IN the_DT development_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Pradhan_FW et_FW al_FW ._. 
2001_CD ,_, Spranger_NNP et_NNP al_NNP ._. 
We_PRP provided_VBD epidemiological_JJ evidence_NN that_IN chronic_JJ inflammation_NN might_MD mediate_VB the_DT association_NN between_IN obesity_NN and_CC endometrial_NN cancer_NN and_CC that_IN endometrial_JJ carcinogenesis_NNS could_MD be_VB promoted_VBN by_IN an_DT inflammatory_JJ milieu_NN ._. 
Word_NNP Cancer_NNP Research_NNP Fund2007\/13IntroductionExcess_NNP body_NN weight_NN is_VBZ one_CD of_IN the_DT strongest_JJS risk_NN factors_NNS for_IN endometrial_JJ cancer_NN and_CC accounts_NNS for_IN about_IN 50_CD %_NN of_IN the_DT cases_NNS in_IN Europe_NNP and_CC in_IN the_DT USA_NNP -LRB-_-LRB- International_NNP Agency_NNP for_IN Research_NNP on_IN Cancer_NNP -LRB-_-LRB- IARC_NNP -RRB-_-RRB- 2002_CD ,_, Calle_NNP 
2001_CD -RRB-_-RRB- ,_, and_CC with_IN the_DT development_NN of_IN type_NN 2_CD diabetes_NN -LRB-_-LRB- Pradhan_FW et_FW al_FW ._. 
1999_CD ,_, Vozarova_FW et_FW al_FW ._. 
Its_PRP$ concentration_NN correlates_VBZ with_IN measures_NNS of_IN obesity_NN and_CC insulin_NN resistance_NN -LRB-_-LRB- Yudkin_FW et_FW al_FW ._. 
2001_CD ,_, Spranger_NNP et_FW al._FW ._. 
2003_CD ,_, Hu_FW et_FW al_FW ._. 
2004_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, IL6_NNP enhances_VBZ the_DT hepatic_JJ production_NN of_IN the_DT suppressor_NN of_IN cytokine_NN signaling-3_JJ -LRB-_-LRB- a_DT protein_NN that_WDT is_VBZ known_VBN to_TO inhibit_VB the_DT insulin_NN signaling_VBG pathway_NN -RRB-_-RRB- -LRB-_-LRB- Lebrun_NNP 
1998_CD ,_, Bellone_NNP et_FW al_FW ._. 
1997_CD ,_, Punnonen_FW et_FW al_FW ._. 
For_IN example_NN ,_, increased_VBD IL6_CD concentrations_NNS have_VBP been_VBN reported_VBN in_IN patients_NNS with_IN endometrial_JJ carcinoma_NN -LRB-_-LRB- Chopra_FW et_FW al_FW ._. 
2005_CD ,_, Slater_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ,_, and_CC laboratory_NN experiments_NNS have_VBP demonstrated_VBN that_IN nuclear_JJ factor_NN -_: 
1994_CD ,_, Bellone_NNP et_FW al_FW ._. 
Indeed_RB ,_, the_DT stronger_JJR association_NN observed_VBD for_IN IL6_NNP among_IN cases_NNS diagnosed_VBN in_IN the_DT 2_CD years_NNS following_VBG blood_NN collection_NN suggests_VBZ the_DT presence_NN of_IN a_DT preclinical_JJ tumor_NN that_WDT can_MD release_VB IL6_NNP -LRB-_-LRB- Scambia_FW et_FW al_FW ._. 
2005_CD ,_, Slater_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- and_CC may_MD have_VB influenced_VBN circulating_VBG levels_NNS ._. 
However_RB ,_, this_DT was_VBD not_RB observed_JJ for_IN the_DT other_JJ two_CD markers_NNS ._. 
Excess_JJ body_NN weight_NN is_VBZ associated_VBN with_IN a_DT systemic_JJ low-grade_JJ inflammatory_JJ condition_NN -LRB-_-LRB- Das_NNP 2001_CD -RRB-_-RRB- ,_, characterized_VBN by_IN elevations_NNS in_IN circulating_VBG pro-inflammatory_JJ cytokines_NNS and_CC acute_JJ phase_NN proteins_NNS -LRB-_-LRB- Mohamed-Ali_FW et_FW al_FW ._. 
1997_CD ,_, Visser_NNP et_FW al._FW ._. 
1999_CD ,_, Yudkin_FW et_FW al_FW ._. 
1999_CD ,_, Meier_NNP et_FW al_FW ._. 
2002_CD -RRB-_-RRB- ._. 
Chronic_JJ inflammation_NN promotes_VBZ angiogenesis_NNS ,_, sustains_VBZ cell_NN proliferation_NN ,_, and_CC increases_VBZ production_NN of_IN free_JJ radicals_NNS that_IN cause_NN DNA_NN damage_NN ,_, leading_VBG to_TO tumor_NN initiation_NN and_CC development_NN -LRB-_-LRB- Coussens_NNPS 
2005_CD ,_, Slater_NNP et_FW al_FW ._. 
1998_CD ,_, Bellone_NNP et_FW al_FW ._. 
1997_CD ,_, Punnonen_FW et_FW al_FW ._. 
For_IN example_NN ,_, increased_VBD IL6_CD concentrations_NNS have_VBP been_VBN reported_VBN in_IN patients_NNS with_IN endometrial_JJ carcinoma_NN -LRB-_-LRB- Chopra_FW et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ,_, and_CC laboratory_NN experiments_NNS have_VBP demonstrated_VBN that_IN nuclear_JJ factor_NN -_: 
2006_CD -RRB-_-RRB- ._. 
2005_CD -RRB-_-RRB- ,_, including_VBG the_DT prostate_NN -LRB-_-LRB- Leung_NNP et_FW al_FW ._. 
2005_CD ,_, Wong_NNP et_FW al_FW ._. 
2002_CD ,_, Poola_NNP 2003_CD ,_, Cammarata_NNP et_FW al_FW ._. 
The_DT functions_NNS of_IN these_DT isoforms_NNS are_VBP not_RB yet_RB clear_JJ ,_, but_CC they_PRP are_VBP known_VBN to_TO be_VB involved_VBN in_IN ER_NNP 
2004_CD ,_, Culig_NNP 
Although_IN androgen_JJ deprivation_NN therapies_NNS -LRB-_-LRB- ADTs_NNPS -RRB-_-RRB- remain_VBP as_IN the_DT mainstay_NN treatment_NN for_IN advanced_JJ PCas_NNS ,_, these_DT therapies_NNS eventually_RB fail_VBP ,_, in_IN part_NN ,_, due_JJ to_TO the_DT development_NN of_IN androgen_NN hypersensitivity_NN ,_, ligand-independent_JJ androgen_NN receptor_NN -LRB-_-LRB- AR_NNP -RRB-_-RRB- transactivation_NN ,_, and_CC AR_NNP gene_NN mutations_NNS and\/or_CC amplification_NN in_IN PCas_NNP -LRB-_-LRB- Scher_NNP et_FW al_FW ._. 
2004_CD ,_, Culig_NNP 
An_DT ER_NNP 
Nuclear_JJ and_CC cytoplasmic_JJ signals_NNS of_IN each_DT ER_NNP 
2001_CD ,_, Scobie_NNP et_FW al_FW ._. 
Both_DT isoforms_NNS have_VBP been_VBN found_VBN in_IN various_JJ tissues_NNS -LRB-_-LRB- Pedersen_NNP et_FW al_FW ._. 
The_DT utility_NN of_IN ER_NNP 
Mechanistic_JJ studies_NNS aimed_VBN at_IN elucidating_VBG the_DT biological_JJ roles_NNS of_IN ER_NNP 
2000_CD ,_, Dupont_NNP et_FW al_FW ._. 
However_RB ,_, other_JJ research_NN groups_NNS did_VBD not_RB observe_VB such_JJ phenotypes_NNS in_IN their_PRP$ ER_NN 
2008_CD -RRB-_-RRB- ._. 
2001_CD -RRB-_-RRB- ,_, arguing_VBG for_IN an_DT antiproliferative_JJ role_NN of_IN ER_NNP 
In_IN a_DT PCa_NNP cell_NN line_NN -LRB-_-LRB- PC3_NNP -RRB-_-RRB- ,_, ER_NNP 
2008_CD -RRB-_-RRB- ._. 
2000_CD ,_, Antal_NNP et_NNP al_NNP ._. 
2000_CD ,_, Dupont_NNP et_FW al_FW ._. 
However_RB ,_, other_JJ research_NN groups_NNS did_VBD not_RB observe_VB such_JJ phenotypes_NNS in_IN their_PRP$ ER_NN 
2007_CD -RRB-_-RRB- ._. 
2004_CD ,_, Zhang_NNP et_NNP al_NNP ._. 
The_DT dynamic_JJ change_NN in_IN ER_NNP 
After_IN construction_NN of_IN the_DT TMA_NNP blocks_NNS ,_, H_NNP 
The_DT dilution_NN ratio_NN for_IN the_DT primary_JJ antibodies_NNS used_VBN in_IN this_DT study_NN was_VBD maintained_VBN at_IN 1:1000_CD ._. 
2006_CD -RRB-_-RRB- ._. 
IHC_NNP analysesThe_NNP detection_NN of_IN ER_NNP 
Results_NNS Evaluation_NN of_IN ER_NNP 
In_IN benign_JJ prostate_NN glands_NNS ,_, ER_NNP 
Since_IN 84_CD %_NN of_IN the_DT patients_NNS -LRB-_-LRB- n_SYM =_SYM 121_CD -RRB-_-RRB- had_VBD intermediate-grade_JJ PCa_NNP -LRB-_-LRB- Gleason_NNP 5_CD 
The_DT action_NN of_IN estrogen_NN in_IN human_JJ normal_JJ and_CC malignant_JJ prostatic_JJ tissue_NN is_VBZ believed_VBN to_TO be_VB mediated_VBN partly_RB by_IN ER_NNP 
Western_JJ blot_NN analyses_NNS To_TO evaluate_VB the_DT specificity_NN of_IN our_PRP$ ER_NNP 
We_PRP recently_RB also_RB developed_VBD polyclonal_JJ monospecific_JJ antisera_NN to_TO ER_NNP 
ER_SYM 
We_PRP stably_RB infected_VBD LacZ_NNP ,_, ER_NNP 
2004_CD ,_, Skliris_FW et_FW al_FW ._. 
Data_NNS from_IN different_JJ research_NN groups_NNS conflict_NN -LRB-_-LRB- Speirs_FW et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
However_RB ,_, the_DT role_NN of_IN ER_NNP 
Unlike_IN breast_NN cancer_NN research_NN ,_, in_IN which_WDT the_DT discovery_NN of_IN these_DT molecules_NNS has_VBZ stimulated_VBN new_JJ research_NN directions_NNS -LRB-_-LRB- Speirs_NNP 
2005_CD ,_, Wong_NNP et_FW al_FW ._. 
2002_CD ,_, Poola_NNP 2003_CD ,_, Cammarata_NNP et_FW al_FW ._. 
2001_CD ,_, Scobie_NNP et_FW al_FW ._. 
Both_DT isoforms_NNS have_VBP been_VBN found_VBN in_IN various_JJ tissues_NNS -LRB-_-LRB- Pedersen_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ,_, including_VBG the_DT prostate_NN -LRB-_-LRB- Leung_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
The_DT functions_NNS of_IN these_DT isoforms_NNS are_VBP not_RB yet_RB clear_JJ ,_, but_CC they_PRP are_VBP known_VBN to_TO be_VB involved_VBN in_IN ER_NNP 
2003_CD ,_, Poola_FW et_FW al_FW ._. 
The_DT functions_NNS of_IN these_DT isoforms_NNS are_VBP not_RB yet_RB clear_JJ ,_, but_CC they_PRP are_VBP known_VBN to_TO be_VB involved_VBN in_IN ER_NNP 
2006_CD -RRB-_-RRB- ._. 
2005_CD -RRB-_-RRB- and_CC ER_NNP 
The_DT utility_NN of_IN ER_NNP 
2002_CD ,_, Poola_NNP 2003_CD ,_, Cammarata_NNP et_FW al_FW ._. 
2001_CD ,_, Scobie_NNP et_FW al_FW ._. 
Both_DT isoforms_NNS have_VBP been_VBN found_VBN in_IN various_JJ tissues_NNS -LRB-_-LRB- Pedersen_NNP et_FW al_FW ._. 
2005_CD ,_, Wong_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ,_, including_VBG the_DT prostate_NN -LRB-_-LRB- Leung_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
The_DT functions_NNS of_IN these_DT isoforms_NNS are_VBP not_RB yet_RB clear_JJ ,_, but_CC they_PRP are_VBP known_VBN to_TO be_VB involved_VBN in_IN ER_NNP 
The_DT dynamic_JJ change_NN in_IN ER_NNP 
We_PRP and_CC others_NNS have_VBP shown_VBN that_IN the_DT expression_NN of_IN ER_NNP 
2004_CD -RRB-_-RRB- ,_, but_CC reappears_VBZ in_IN the_DT lymph_JJ node_NN and_CC bone_NN metastases_NNS -LRB-_-LRB- Lai_NNP et_FW al_FW ._. 
2001_CD ,_, Zhu_NNP et_FW al_FW ._. 
We_PRP and_CC others_NNS have_VBP shown_VBN that_IN the_DT expression_NN of_IN ER_NNP 
2004_CD -RRB-_-RRB- ._. 
2004_CD ,_, Zhu_NNP et_FW al_FW ._. 
2004_CD -RRB-_-RRB- ,_, but_CC reappears_VBZ in_IN the_DT lymph_JJ node_NN and_CC bone_NN metastases_NNS -LRB-_-LRB- Lai_NNP et_FW al_FW ._. 
The_DT dynamic_JJ change_NN in_IN ER_NNP 
2002_CD ,_, Pais_FW et_FW al_FW ._. 
2001_CD ,_, Adams_NNP et_NNP al_NNP ._. 
An_DT ER_NNP 
These_DT findings_NNS may_MD aid_VB future_JJ clinical_JJ management_NN of_IN PCa_NNP ._. 
This_DT is_VBZ the_DT first_JJ study_NN to_TO uncover_VB a_DT metastasis-promoting_JJ role_NN of_IN ER_NNP 
This_DT phenomenon_NN could_MD be_VB due_JJ to_TO hormonal_JJ changes_NNS during_IN aging_NN ._. 
The_DT incidence_NN of_IN PCa_NNP rises_VBZ dramatically_RB in_IN men_NNS older_JJR than_IN 55_CD ._. 
Among_IN older_JJR men_NNS ,_, androgen_NN levels_NNS drop_VBP significantly_RB ,_, whereas_IN their_PRP$ estrogen_NN levels_NNS remain_VBP unchanged_JJ or_CC increased_VBN ,_, making_VBG the_DT estrogen_NN to_TO androgen_NN ratio_NN elevated_VBN in_IN the_DT aging_NN prostate_NN -LRB-_-LRB- Ho_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Epidemiological_JJ studies_NNS indicate_VBP a_DT correlation_NN between_IN PCa_NNP and_CC circulating_VBG estrogen_NN levels_NNS ,_, but_CC not_RB circulating_VBG testosterone_NN levels_NNS ,_, among_IN different_JJ ethnic\/racial_JJ groups_NNS with_IN diverse_JJ PCa_NNP incidence_NN -LRB-_-LRB- Rohrmann_NNP et_FW al_FW ._. 
Also_RB ,_, in_IN utero_NN exposure_NN to_TO higher_JJR levels_NNS of_IN maternal_JJ estrogen_NN in_IN African_NNP 
Taken_VBN together_RB ,_, these_DT findings_NNS established_VBD that_IN ER_NNP 
2001_CD -RRB-_-RRB- ._. 
1996_CD ,_, Leav_FW et_FW al_FW ._. 
The_DT action_NN of_IN estrogen_NN in_IN human_JJ normal_JJ and_CC malignant_JJ prostatic_JJ tissue_NN is_VBZ believed_VBN to_TO be_VB mediated_VBN partly_RB by_IN ER_NNP 
2001_CD -RRB-_-RRB- ._. 
These_DT findings_NNS suggest_VBP that_IN ER_NNP 
2010_CD -RRB-_-RRB- ._. 
2008_CD -RRB-_-RRB- and_CC impedes_VBZ epithelial_NN 
2006_CD -RRB-_-RRB- ._. 
Estrogen_NNP has_VBZ been_VBN shown_VBN to_TO be_VB involved_VBN in_IN normal_JJ and_CC malignant_JJ functions_NNS of_IN the_DT prostate_NN -LRB-_-LRB- Ho_NNP et_FW al_FW ._. 
Four_CD decades_NNS ago_RB ,_, the_DT oral_JJ estrogen_NN diethylstilbestrol_NN was_VBD the_DT treatment_NN of_IN choice_NN for_IN PCa_NNP -LRB-_-LRB- Huggins_NNP 
1996_CD -RRB-_-RRB- ,_, but_CC its_PRP$ function_NN remains_VBZ controversial_JJ ._. 
In_IN the_DT prostatic_JJ epithelium_NN ,_, ER_NNP 
ER_SYM 
Results_NNS from_IN this_DT study_NN serve_VBP as_IN the_DT first_JJ exploration_NN to_TO open_VB a_DT new_JJ line_NN of_IN investigation_NN ._. 
With_IN this_DT renewed_VBN interest_NN in_IN using_VBG estrogens_NNS as_IN single_JJ or_CC combination_NN therapy_NN for_IN PCa_NNP ,_, the_DT need_NN to_TO understand_VB how_WRB ERs_NNS affect_VBP PCa_NNP is_VBZ pressing_VBG ._. 
The_DT action_NN of_IN estrogen_NN in_IN human_JJ normal_JJ and_CC malignant_JJ prostatic_JJ tissue_NN is_VBZ believed_VBN to_TO be_VB mediated_VBN partly_RB by_IN ER_NNP 
2001_CD ,_, Zhu_NNP et_FW al_FW ._. 
We_PRP and_CC others_NNS have_VBP shown_VBN that_IN the_DT expression_NN of_IN ER_NNP 
Thus_RB ,_, limitations_NNS revolving_VBG around_IN ADTs_NNS have_VBP prompted_VBN exploration_NN of_IN other_JJ therapeutic_JJ options_NNS ._. 
2009_CD -RRB-_-RRB- ._. 
Transdermal_JJ estrogen_NN patches_NNS as_IN a_DT first-line_JJ therapy_NN in_IN patients_NNS with_IN locally_RB advanced_JJ or_CC metastatic_JJ PCa_NNP -LRB-_-LRB- Langley_NNP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- are_VBP now_RB in_IN phase_NN II_NNP trials_NNS ._. 
However_RB ,_, despite_IN significant_JJ research_NN efforts_NNS ,_, the_DT role_NN -LRB-_-LRB- s_PRP -RRB-_-RRB- of_IN estrogen_NN in_IN the_DT pathogenesis_NN of_IN PCa_NNP remains_VBZ poorly_RB understood_VBN ._. 
Estrogens_NNS are_VBP essential_JJ in_IN supporting_VBG the_DT normal_JJ functioning_NN of_IN the_DT prostate_NN ,_, and_CC yet_RB have_VBP long_RB been_VBN suspected_VBN as_IN a_DT risk_NN factor_NN for_IN PCa_NNP ._. 
Long-term_JJ exposure_NN to_TO elevated_JJ levels_NNS of_IN estrogen_NN against_IN a_DT normal_JJ androgen_NN background_NN induced_VBD a_DT high_JJ incidence_NN of_IN PCa_NNP in_IN rodents_NNS -LRB-_-LRB- Leav_FW et_FW al._FW ._. 
1988_CD ,_, Prins_NNPS et_FW al_FW ._. 
2007_CD ,_, Ricke_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ._. 
Also_RB ,_, in_IN utero_NN exposure_NN to_TO higher_JJR levels_NNS of_IN maternal_JJ estrogen_NN in_IN African_NNP 
2006_CD -RRB-_-RRB- ._. 
Among_IN older_JJR men_NNS ,_, androgen_NN levels_NNS drop_VBP significantly_RB ,_, whereas_IN their_PRP$ estrogen_NN levels_NNS remain_VBP unchanged_JJ or_CC increased_VBN ,_, making_VBG the_DT estrogen_NN to_TO androgen_NN ratio_NN elevated_VBN in_IN the_DT aging_NN prostate_NN -LRB-_-LRB- Ho_NNP et_FW al_FW ._. 
Epidemiological_JJ studies_NNS indicate_VBP a_DT correlation_NN between_IN PCa_NNP and_CC circulating_VBG estrogen_NN levels_NNS ,_, but_CC not_RB circulating_VBG testosterone_NN levels_NNS ,_, among_IN different_JJ ethnic\/racial_JJ groups_NNS with_IN diverse_JJ PCa_NNP incidence_NN -LRB-_-LRB- Rohrmann_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- ._. 
In_IN addition_NN ,_, estrogen_NN is_VBZ produced_VBN locally_RB by_IN aromatase_NN ,_, which_WDT converts_VBZ androgen_NN into_IN estrogen_NN in_IN the_DT prostate_NN -LRB-_-LRB- Stone_NNP et_NNP al_NNP ._. 
1970_CD ,_, Eisen_NNP et_FW al_FW ._. 
It_PRP was_VBD ultimately_RB abandoned_VBN because_RB of_IN its_PRP$ serious_JJ cardiovascular_JJ and_CC thromboembolic_JJ toxicity_NN -LRB-_-LRB- Hanash_FW et_FW al_FW ._. 
1975_CD -RRB-_-RRB- and_CC the_DT emergence_NN of_IN gonadotropin_NN agonists\/antagonists_NNS -LRB-_-LRB- Schally_FW et_FW al._FW ._. 
1983_CD -RRB-_-RRB- ._. 
However_RB ,_, other_JJ forms_NNS of_IN estrogen_NN ,_, including_VBG various_JJ ER_NNP selective_JJ modulators_NNS ,_, recently_RB have_VBP emerged_VBN as_IN effective_JJ and_CC economical_JJ therapies_NNS ,_, largely_RB because_IN of_IN clinical_JJ data_NNS showing_VBG minimal_JJ hepatic_JJ toxicity_NN of_IN these_DT agents_NNS if_IN they_PRP are_VBP administrated_VBN parentally_RB via_IN an_DT intramuscular_JJ or_CC transdermal_JJ route_NN -LRB-_-LRB- Ockrim_FW et_FW al_FW ._. 
1988_CD ,_, Prins_NNPS et_FW al_FW ._. 
Long-term_JJ exposure_NN to_TO elevated_JJ levels_NNS of_IN estrogen_NN against_IN a_DT normal_JJ androgen_NN background_NN induced_VBD a_DT high_JJ incidence_NN of_IN PCa_NNP in_IN rodents_NNS -LRB-_-LRB- Leav_FW et_FW al_FW ._. 
2007_CD ,_, Ricke_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ._. 
Also_RB ,_, in_IN utero_NN exposure_NN to_TO higher_JJR levels_NNS of_IN maternal_JJ estrogen_NN in_IN African_NNP 
Expression_NN of_IN the_DT transgenes_NNS was_VBD confirmed_VBN by_IN real-time_JJ PCR_NNP assays_NNS ._. 
PC3_CD cells_NNS stably_RB expressing_VBG LacZ_NNP ,_, ER_NNP 
1988_CD -RRB-_-RRB- ,_, a_DT thesis_NN supported_VBN by_IN animal_NN studies_NNS -LRB-_-LRB- Prins_NNP 1997_CD ,_, Ho_NNP et_FW al_FW ._. 
Also_RB ,_, in_IN utero_NN exposure_NN to_TO higher_JJR levels_NNS of_IN maternal_JJ estrogen_NN in_IN African_NNP 
Long-term_JJ exposure_NN to_TO elevated_JJ levels_NNS of_IN estrogen_NN against_IN a_DT normal_JJ androgen_NN background_NN induced_VBD a_DT high_JJ incidence_NN of_IN PCa_NNP in_IN rodents_NNS -LRB-_-LRB- Leav_FW et_FW al_FW ._. 
1988_CD ,_, Prins_NNPS et_FW al._FW ._. 
2007_CD ,_, Ricke_FW et_FW al_FW ._. 
2008_CD -RRB-_-RRB- ._. 
Also_RB ,_, in_IN utero_NN exposure_NN to_TO higher_JJR levels_NNS of_IN maternal_JJ estrogen_NN in_IN African_NNP 
2006_CD -RRB-_-RRB- and_CC the_DT lack_NN of_IN antibodies_NNS to_TO distinguish_VB them_PRP in_IN vitro_NN and_CC in_IN clinical_JJ specimens_NNS ._. 
2006_CD -RRB-_-RRB- ,_, in_IN part_NN because_IN of_IN insufficient_JJ understanding_NN of_IN ER_NNP 
Also_RB ,_, in_IN utero_NN exposure_NN to_TO higher_JJR levels_NNS of_IN maternal_JJ estrogen_NN in_IN African_NNP 
2001_CD ,_, Scobie_NNP et_FW al_FW ._. 
Both_DT isoforms_NNS have_VBP been_VBN found_VBN in_IN various_JJ tissues_NNS -LRB-_-LRB- Pedersen_NNP et_FW al_FW ._. 
The_DT utility_NN of_IN ER_NNP 
The_DT functions_NNS of_IN these_DT isoforms_NNS are_VBP not_RB yet_RB clear_JJ ,_, but_CC they_PRP are_VBP known_VBN to_TO be_VB involved_VBN in_IN ER_NNP 
It_PRP was_VBD ultimately_RB abandoned_VBN because_RB of_IN its_PRP$ serious_JJ cardiovascular_JJ and_CC thromboembolic_JJ toxicity_NN -LRB-_-LRB- Hanash_FW et_FW al_FW ._. 
1970_CD ,_, Eisen_NNP et_FW al._FW ._. 
1975_CD -RRB-_-RRB- and_CC the_DT emergence_NN of_IN gonadotropin_NN agonists\/antagonists_NNS -LRB-_-LRB- Schally_FW et_FW al_FW ._. 
1983_CD -RRB-_-RRB- ._. 
However_RB ,_, other_JJ forms_NNS of_IN estrogen_NN ,_, including_VBG various_JJ ER_NNP selective_JJ modulators_NNS ,_, recently_RB have_VBP emerged_VBN as_IN effective_JJ and_CC economical_JJ therapies_NNS ,_, largely_RB because_IN of_IN clinical_JJ data_NNS showing_VBG minimal_JJ hepatic_JJ toxicity_NN of_IN these_DT agents_NNS if_IN they_PRP are_VBP administrated_VBN parentally_RB via_IN an_DT intramuscular_JJ or_CC transdermal_JJ route_NN -LRB-_-LRB- Ockrim_FW et_FW al_FW ._. 
However_RB ,_, other_JJ research_NN groups_NNS did_VBD not_RB observe_VB such_JJ phenotypes_NNS in_IN their_PRP$ ER_NN 
In_IN addition_NN ,_, estrogen_NN is_VBZ produced_VBN locally_RB by_IN aromatase_NN ,_, which_WDT converts_VBZ androgen_NN into_IN estrogen_NN in_IN the_DT prostate_NN -LRB-_-LRB- Stone_NNP et_NNP al_NNP ._. 
1986_CD ,_, Matzkin_NNP 
The_DT roles_NNS of_IN ERs_NNS in_IN the_DT prostate_NN are_VBP not_RB fully_RB understood_VBN ._. 
2007_CD -RRB-_-RRB- ._. 
Upon_IN binding_JJ of_IN estradiol-17_NN 
Since_IN isoform-specific_JJ antibodies_NNS were_VBD unavailable_JJ until_IN very_RB recently_RB ,_, the_DT use_NN of_IN various_JJ antibodies_NNS directed_VBN against_IN different_JJ domains_NNS of_IN the_DT molecules_NNS might_MD have_VB generated_VBN immunohistochemistry_JJ -LRB-_-LRB- IHC_NNP -RRB-_-RRB- patterns_NNS that_WDT contradict_VBP each_DT other_JJ ._. 
No_DT functions_NNS for_IN ER_NNP 
In_IN this_DT TMA_NNP study_NN ,_, ER_NNP 
Materials_NNPS and_CC methods_NNS Patient_NN population_NN With_IN Institutional_NNP Review_NNP Board_NNP -LRB-_-LRB- IRB_NNP -RRB-_-RRB- approval_NN ,_, we_PRP included_VBD 144_CD patients_NNS with_IN PCa_NNP who_WP underwent_VBD radical_JJ prostatectomy_NN at_IN the_DT Massachusetts_NNP General_NNP Hospital_NNP -LRB-_-LRB- Boston_NNP ,_, MA_NNP ,_, USA_NNP -RRB-_-RRB- from_IN September_NNP 1993_CD to_TO March_NNP 1995_CD in_IN this_DT study_NN ._. 
All_DT hematoxyolin_NN 
Four_CD decades_NNS ago_RB ,_, the_DT oral_JJ estrogen_NN diethylstilbestrol_NN was_VBD the_DT treatment_NN of_IN choice_NN for_IN PCa_NNP -LRB-_-LRB- Huggins_NNP 
The_DT recently_RB discovered_VBN AR_NNP spliced_VBD variants_NNS in_IN PCa_NNP further_JJ raise_NN concerns_NNS on_IN the_DT efficacy_NN of_IN these_DT therapies_NNS -LRB-_-LRB- Dehm_FW et_FW al_FW ._. 
2008_CD ,_, Guo_FW et_FW al._FW ._. 
2009_CD -RRB-_-RRB- ._. 
Thus_RB ,_, limitations_NNS revolving_VBG around_IN ADTs_NNS have_VBP prompted_VBN exploration_NN of_IN other_JJ therapeutic_JJ options_NNS ._. 
2008_CD -RRB-_-RRB- ._. 
2007_CD ,_, Ricke_FW et_FW al_FW ._. 
1988_CD ,_, Prins_NNPS et_FW al_FW ._. 
Long-term_JJ exposure_NN to_TO elevated_JJ levels_NNS of_IN estrogen_NN against_IN a_DT normal_JJ androgen_NN background_NN induced_VBD a_DT high_JJ incidence_NN of_IN PCa_NNP in_IN rodents_NNS -LRB-_-LRB- Leav_FW et_FW al_FW ._. 
Also_RB ,_, in_IN utero_NN exposure_NN to_TO higher_JJR levels_NNS of_IN maternal_JJ estrogen_NN in_IN African_NNP 
Estrogen_NN receptors_NNS -LRB-_-LRB- ER_NNP -RRB-_-RRB- ,_, ER_NNP 
Apropos_NNS to_TO the_DT postulate_NN that_IN ER_NNP 
However_RB ,_, others_NNS have_VBP suggested_VBN that_IN ER_NNP 
1998_CD ,_, Weihua_FW et_FW al_FW ._. 
Hyperplasia_NNP and_CC dysplasia_NN have_VBP been_VBN found_VBN in_IN the_DT prostates_NNS of_IN adult_NN ER_NN 
The_DT functions_NNS of_IN each_DT isoform_NN in_IN the_DT normal_JJ prostate_NN epithelium_NN are_VBP unclear_JJ ._. 
Our_PRP$ IHC_NNP staining_NN revealed_VBD unique_JJ tissue_NN -_: \/_CD cell_NN type_NN -_: and_CC cellular_JJ compartment-specific_JJ distribution_NN for_IN each_DT isoform_NN in_IN the_DT normal_JJ and_CC malignant_JJ prostate_NN ._. 
Thus_RB ,_, in_IN this_DT study_NN ,_, ER_NNP 
The_DT continuing_VBG controversy_NN over_IN the_DT function_NN of_IN ER_NNP 
Therefore_RB ,_, the_DT confirmation_NN of_IN ER_NNP 
In_IN addition_NN ,_, estrogen_NN is_VBZ produced_VBN locally_RB by_IN aromatase_NN ,_, which_WDT converts_VBZ androgen_NN into_IN estrogen_NN in_IN the_DT prostate_NN -LRB-_-LRB- Stone_NNP et_NNP al_NNP ._. 
1986_CD ,_, Matzkin_NNP 
Thus_RB ,_, in_IN this_DT study_NN ,_, ER_NNP 
2001_CD ,_, Adams_NNP et_NNP al_NNP ._. 
An_DT ER_NNP 
Moreover_RB ,_, more_RBR active_JJ surveillance_NN and\/or_CC adjuvant_NN therapies_NNS ,_, such_JJ as_IN external_JJ beam_NN radiotherapy_NN and_CC ADTs_NNP -LRB-_-LRB- Michaelson_NNP et_FW al_FW ._. 
2008_CD ,_, Wirth_NNP et_FW al._FW ._. 
2008_CD -RRB-_-RRB- ,_, may_MD be_VB indicated_VBN for_IN the_DT subset_NN of_IN patients_NNS at_IN higher_JJR risk_NN for_IN metastases_NNS because_IN of_IN their_PRP$ positivity_NN for_IN ER_NNP 
Hyperplasia_NNP and_CC dysplasia_NN have_VBP been_VBN found_VBN in_IN the_DT prostates_NNS of_IN adult_NN ER_NN 
1983_CD -RRB-_-RRB- ._. 
1975_CD -RRB-_-RRB- and_CC the_DT emergence_NN of_IN gonadotropin_NN agonists\/antagonists_NNS -LRB-_-LRB- Schally_FW et_FW al_FW ._. 
1970_CD ,_, Eisen_NNP et_FW al_FW ._. 
However_RB ,_, other_JJ forms_NNS of_IN estrogen_NN ,_, including_VBG various_JJ ER_NNP selective_JJ modulators_NNS ,_, recently_RB have_VBP emerged_VBN as_IN effective_JJ and_CC economical_JJ therapies_NNS ,_, largely_RB because_IN of_IN clinical_JJ data_NNS showing_VBG minimal_JJ hepatic_JJ toxicity_NN of_IN these_DT agents_NNS if_IN they_PRP are_VBP administrated_VBN parentally_RB via_IN an_DT intramuscular_JJ or_CC transdermal_JJ route_NN -LRB-_-LRB- Ockrim_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
These_DT therapies_NNS also_RB have_VBP significant_JJ efficacy_NN in_IN protecting_VBG against_IN osteoporotic_JJ fracture_NN ,_, hot_JJ flashes_NNS ,_, asthenia_NN ,_, and_CC cognitive_JJ dysfunction_NN in_IN patients_NNS with_IN PCa_NNP -LRB-_-LRB- Ockrim_FW et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
However_RB ,_, other_JJ forms_NNS of_IN estrogen_NN ,_, including_VBG various_JJ ER_NNP selective_JJ modulators_NNS ,_, recently_RB have_VBP emerged_VBN as_IN effective_JJ and_CC economical_JJ therapies_NNS ,_, largely_RB because_IN of_IN clinical_JJ data_NNS showing_VBG minimal_JJ hepatic_JJ toxicity_NN of_IN these_DT agents_NNS if_IN they_PRP are_VBP administrated_VBN parentally_RB via_IN an_DT intramuscular_JJ or_CC transdermal_JJ route_NN -LRB-_-LRB- Ockrim_FW et_FW al_FW ._. 
These_DT therapies_NNS also_RB have_VBP significant_JJ efficacy_NN in_IN protecting_VBG against_IN osteoporotic_JJ fracture_NN ,_, hot_JJ flashes_NNS ,_, asthenia_NN ,_, and_CC cognitive_JJ dysfunction_NN in_IN patients_NNS with_IN PCa_NNP -LRB-_-LRB- Ockrim_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
With_IN this_DT renewed_VBN interest_NN in_IN using_VBG estrogens_NNS as_IN single_JJ or_CC combination_NN therapy_NN for_IN PCa_NNP ,_, the_DT need_NN to_TO understand_VB how_WRB ERs_NNS affect_VBP PCa_NNP is_VBZ pressing_VBG ._. 
2006_CD -RRB-_-RRB- ._. 
However_RB ,_, the_DT role_NN of_IN ER_NNP 
2006_CD -RRB-_-RRB- and_CC the_DT lack_NN of_IN antibodies_NNS to_TO distinguish_VB them_PRP in_IN vitro_NN and_CC in_IN clinical_JJ specimens_NNS ._. 
2006_CD -RRB-_-RRB- ,_, in_IN part_NN because_IN of_IN insufficient_JJ understanding_NN of_IN ER_NNP 
1986_CD ,_, Matzkin_NNP 
2007_CD -RRB-_-RRB- ._. 
Epidemiological_JJ studies_NNS indicate_VBP a_DT correlation_NN between_IN PCa_NNP and_CC circulating_VBG estrogen_NN levels_NNS ,_, but_CC not_RB circulating_VBG testosterone_NN levels_NNS ,_, among_IN different_JJ ethnic\/racial_JJ groups_NNS with_IN diverse_JJ PCa_NNP incidence_NN -LRB-_-LRB- Rohrmann_NNP et_FW al_FW ._. 
In_IN addition_NN ,_, estrogen_NN is_VBZ produced_VBN locally_RB by_IN aromatase_NN ,_, which_WDT converts_VBZ androgen_NN into_IN estrogen_NN in_IN the_DT prostate_NN -LRB-_-LRB- Stone_NNP et_NNP al._NNP ._. 
1986_CD ,_, Matzkin_NNP 
Both_DT isoforms_NNS have_VBP been_VBN found_VBN in_IN various_JJ tissues_NNS -LRB-_-LRB- Pedersen_NNP et_FW al_FW ._. 
The_DT utility_NN of_IN ER_NNP 
2009_CD -RRB-_-RRB- ._. 
NIH_NNP ES006096_NNP ,_, CA15776_NNP ,_, and_CC CA112532_NNP Bertucci_NNP Foundation_NNP of_IN Prostate_NNP Cancer_NNP Research_NNP US_NNP Army_NNP Prostate_NNP Cancer_NNP Program_NNP 81XWH-04-1-0165_NNP Introduction_NNP Prostate_NNP cancer_NN -LRB-_-LRB- PCa_NNP -RRB-_-RRB- is_VBZ the_DT most_RBS common_JJ cancer_NN and_CC the_DT second_JJ leading_JJ cause_NN of_IN death_NN among_IN American_JJ men_NNS -LRB-_-LRB- Jemal_NNP et_FW al_FW ._. 
Although_IN androgen_JJ deprivation_NN therapies_NNS -LRB-_-LRB- ADTs_NNPS -RRB-_-RRB- remain_VBP as_IN the_DT mainstay_NN treatment_NN for_IN advanced_JJ PCas_NNS ,_, these_DT therapies_NNS eventually_RB fail_VBP ,_, in_IN part_NN ,_, due_JJ to_TO the_DT development_NN of_IN androgen_NN hypersensitivity_NN ,_, ligand-independent_JJ androgen_NN receptor_NN -LRB-_-LRB- AR_NNP -RRB-_-RRB- transactivation_NN ,_, and_CC AR_NNP gene_NN mutations_NNS and\/or_CC amplification_NN in_IN PCas_NNP -LRB-_-LRB- Scher_NNP et_FW al._FW ._. 
2004_CD ,_, Culig_NNP 
Data_NNS from_IN different_JJ research_NN groups_NNS conflict_NN -LRB-_-LRB- Speirs_FW et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
However_RB ,_, the_DT role_NN of_IN ER_NNP 
2001_CD -RRB-_-RRB- ._. 
No_DT functions_NNS for_IN ER_NNP 
Statistical_NNP results_NNS of_IN TMA_NNP studies_NNS nER_NNP 
The_DT roles_NNS of_IN ER_NNP 
This_DT discrepancy_NN suggests_VBZ a_DT fundamental_JJ difference_NN in_IN the_DT role_NN played_VBN by_IN estrogens\/estrogen_NNS signaling_VBG in_IN the_DT pathogenesis_NN of_IN PCa_NNP versus_CC that_IN of_IN breast_NN cancer_NN ,_, which_WDT has_VBZ introduced_VBN an_DT intriguing_JJ question_NN regarding_VBG the_DT clinical_JJ management_NN of_IN these_DT cancers_NNS ._. 
We_PRP recognize_VBP that_IN our_PRP$ cohort_NN is_VBZ small_JJ -LRB-_-LRB- 144_CD patients_NNS -RRB-_-RRB- compared_VBN with_IN that_DT of_IN the_DT breast_NN cancer_NN study_NN -LRB-_-LRB- Shaaban_FW et_FW al._FW ._. 
2008_CD -RRB-_-RRB- and_CC thus_RB includes_VBZ relatively_RB few_JJ patients_NNS with_IN PF_NNP -LRB-_-LRB- n_SYM =_SYM 54_CD ;_: 
Cancer_NNP Research_NNP UK_NNP Introduction_NNP Neuroblastoma_NNP and_CC phaeochromocytoma_NN are_VBP the_DT commonest_JJS neural_JJ crest-derived_JJ tumors_NNS in_IN children_NNS and_CC adults_NNS respectively_RB ._. 
Most_JJS phaeochromocytomas_NNS are_VBP benign_JJ catecholamine-producing_JJ tumors_NNS arising_VBG within_IN the_DT adrenal_JJ medulla_NN ,_, but_CC may_MD be_VB extra-adrenal_JJ -LRB-_-LRB- when_WRB they_PRP may_MD be_VB designated_VBN as_IN paragangliomas_NNS -RRB-_-RRB- and\/or_CC approximately_RB malignant_JJ -LRB-_-LRB- Chrisoulidou_NNP et_FW al._FW ._. 
2007_CD ,_, Disick_NNP 
1996_CD ,_, Astuti_FW et_FW al_FW ._. 
1995_CD ,_, Hofstra_NNP et_FW al_FW ._. 
Inherited_VBN predisposition_NN to_TO phaeochromocytoma_NN may_MD be_VB associated_VBN with_IN mutations_NNS in_IN NF1_NNP ,_, RET_NNP ,_, SDHB_NNP ,_, SDHC_NNP ,_, SDHD_NNP or_CC VHL_NNP genes_NNS ,_, but_CC somatic_JJ mutations_NNS in_IN VHL_NNP ,_, RET_NNP ,_, NF1_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP rare_JJ in_IN sporadic_JJ phaeochromocytomas_NNS -LRB-_-LRB- Eng_FW et_FW al_FW ._. 
2001b_JJ ,_, c_NN ,_, 2003_CD -RRB-_-RRB- ._. 
Promoter_NN region_NN hypermethylation_NN and_CC transcriptional_JJ silencing_NN is_VBZ a_DT frequent_JJ cause_NN of_IN tumor_NN suppressor_NN gene_NN -LRB-_-LRB- TSG_NNP -RRB-_-RRB- inactivation_NN in_IN many_JJ human_JJ cancers_NNS ._. 
HOXA9_CD promoter_NN methylation_NN was_VBD identified_VBN previously_RB in_IN lung_NN cancer_NN -LRB-_-LRB- Rauch_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
2006_CD ,_, Piotrowski_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- and_CC in_IN neuroblastoma_NN -LRB-_-LRB- Alaminos_NNPS et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ,_, but_CC not_RB in_IN phaeochromocytoma_NN ._. 
Previously_RB ,_, we_PRP found_VBD significant_JJ differences_NNS in_IN the_DT frequency_NN of_IN HIC1_NNP and_CC CASP8_NNP methylation_NN between_IN VHL-associated_JJ and_CC sporadic_JJ phaeochromocytomas_NNS ,_, but_CC in_IN this_DT study_NN we_PRP did_VBD not_RB identify_VB any_DT further_RBR differentially_RB methylated_VBN genes_NNS ._. 
This_DT suggests_VBZ that_IN promoter_NN methylation_NN of_IN CTNNG_NNP does_VBZ not_RB play_VB a_DT large_JJ role_NN in_IN its_PRP$ regulation_NN of_IN expression_NN in_IN neural_JJ crest_NN tumors_NNS ._. 
SYK_NNP -LRB-_-LRB- spleen_FW tyrosine_FW kinase_FW -RRB-_-RRB- and_CC TMS1_NNP -LRB-_-LRB- also_RB known_VBN as_IN ASC_NNP ,_, apoptosis_VBZ speck-like_JJ protein_NN containing_VBG CARD_NNP -RRB-_-RRB- have_VBP been_VBN reported_VBN to_TO be_VB methylated_VBN in_IN 60_CD and_CC 80_CD %_NN of_IN neuroblastoma_NN cell_NN lines_NNS respectively_RB -LRB-_-LRB- Alaminos_NNPS et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ,_, our_PRP$ results_NNS suggest_VBP that_DT methylation_NN is_VBZ less_RBR frequent_JJ in_IN neuroblastoma_NN primary_NN tumors_NNS and_CC is_VBZ infrequent_JJ -LRB-_-LRB- 
Infrequent_JJ ,_, or_CC absent_JJ ,_, promoter_NN methylation_NN was_VBD found_VBN for_IN CTNNG_NNP -LRB-_-LRB- 
Based_VBN on_IN our_PRP$ previous_JJ studies_NNS ,_, we_PRP hypothesised_VBD that_IN the_DT identification_NN of_IN novel_NN genes_NNS exhibiting_VBG promoter_NN methylation_NN in_IN neuroblastoma_NN would_MD also_RB provide_VB plausible_JJ candidate_NN genes_NNS for_IN phaeochromocytoma_NN tumourigenesis_NN ._. 
In_IN order_NN to_TO expand_VB the_DT number_NN of_IN candidate_NN 
2003_CD ,_, Yang_NNP et_NNP al_NNP ._. 
2000_CD ,_, Sellar_FW et_FW al_FW ._. 
MSP_NNP was_VBD performed_VBN essentially_RB using_VBG previously_RB published_VBN primers_NNS and_CC conditions_NNS -LRB-_-LRB- Conway_NNP et_NNP al_NNP ._. 
2004_CD ,_, Alaminos_NNPS et_FW al._FW ._. 
2005_CD ,_, Breault_NNP et_FW al_FW ._. 
2005_CD ,_, Lind_FW et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
Expected_NNP PCR_NNP products_NNS are_VBP as_IN follows_VBZ :_: for_IN HSP47_NNP -LRB-_-LRB- a_DT -RRB-_-RRB- ,_, 134_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 135_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: HSP47_NNP -LRB-_-LRB- b_NN -RRB-_-RRB- ,_, 109_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 110_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: EMP3_NNP ,_, 252_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_CD 255_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: opioid_JJ binding_JJ protein_NN -LRB-_-LRB- OPCML_NNP -RRB-_-RRB- ,_, 135_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 135_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: CTNNG_NNP ,_, 95_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 85_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: SYK_NNP ,_, 242_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 140_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- ;_: TMS1_NNP ,_, 212_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_CD 209_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: Homeobox_NNP A9_NNP -LRB-_-LRB- HOXA9_NNP -RRB-_-RRB- ,_, 127_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_CD 139_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN -LRB-_-LRB- see_VB Supplementary_NNP Table_NNP 1_CD which_WDT can_MD be_VB viewed_VBN online_NN at_IN 
EMP3_CD is_VBZ a_DT peripheral_JJ myelin_NN protein_NN involved_VBN in_IN cell_NN proliferation_NN and_CC cell_NN 
2007_CD ,_, Disick_NNP 
http:\/\/www_NN ._. 
oncomine_NN ._. 
Thus_RB ,_, we_PRP used_VBD the_DT Oncomine_NNP -LRB-_-LRB- 
1996_CD ,_, Astuti_FW et_FW al_FW ._. 
1995_CD ,_, Hofstra_NNP et_FW al_FW ._. 
Inherited_VBN predisposition_NN to_TO phaeochromocytoma_NN may_MD be_VB associated_VBN with_IN mutations_NNS in_IN NF1_NNP ,_, RET_NNP ,_, SDHB_NNP ,_, SDHC_NNP ,_, SDHD_NNP or_CC VHL_NNP genes_NNS ,_, but_CC somatic_JJ mutations_NNS in_IN VHL_NNP ,_, RET_NNP ,_, NF1_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP rare_JJ in_IN sporadic_JJ phaeochromocytomas_NNS -LRB-_-LRB- Eng_FW et_FW al_FW ._. 
2001b_JJ ,_, c_NN ,_, 2003_CD -RRB-_-RRB- ._. 
Promoter_NN region_NN hypermethylation_NN and_CC transcriptional_JJ silencing_NN is_VBZ a_DT frequent_JJ cause_NN of_IN tumor_NN suppressor_NN gene_NN -LRB-_-LRB- TSG_NNP -RRB-_-RRB- inactivation_NN in_IN many_JJ human_JJ cancers_NNS ._. 
Previously_RB ,_, in_IN order_NN to_TO identify_VB candidate_NN epigenetically_RB inactivated_VBD TSGs_NNP in_IN phaeochromocytoma_NN ,_, we_PRP analyzed_VBD promoter_NN methylation_NN status_NN in_IN a_DT series_NN of_IN candidate_NN genes_NNS known_VBN to_TO undergo_VB epigenetic_JJ silencing_NN and_CC found_VBD similar_JJ patterns_NNS of_IN promoter_NN hypermethylation_NN in_IN neuroblastoma_NN and_CC phaeochromocytoma_NN ._. 
Thus_RB ,_, TSP1_NNP ,_, CASP8_NNP ,_, HIC1_NNP ,_, DcR1_NNP ,_, DcR2_NNP and_CC DR4_NNP and_CC RASSF1_NNP were_VBD methylated_VBN frequently_RB in_IN both_DT tumor_NN types_NNS -LRB-_-LRB- Astuti_FW et_FW al._FW ._. 
2001_CD c_NN ,_, Margetts_NNP et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN contrast_NN to_TO phaeochromocytoma_NN ,_, familial_JJ neuroblastoma_NN is_VBZ rare_JJ ._. 
Up_IN to_TO one-third_NN of_IN phaeochromocytomas_NNS occur_VBP in_IN genetically_RB susceptible_JJ individuals_NNS -LRB-_-LRB- Astuti_FW et_FW al_FW ._. 
2001a_JJ ,_, b_NN ,_, Neumann_NNP et_FW al._FW ._. 
2002_CD ,_, Gimenez-Roqueplo_NNP 2006_CD -RRB-_-RRB- ._. 
Inherited_VBN predisposition_NN to_TO phaeochromocytoma_NN may_MD be_VB associated_VBN with_IN mutations_NNS in_IN NF1_NNP ,_, RET_NNP ,_, SDHB_NNP ,_, SDHC_NNP ,_, SDHD_NNP or_CC VHL_NNP genes_NNS ,_, but_CC somatic_JJ mutations_NNS in_IN VHL_NNP ,_, RET_NNP ,_, NF1_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP rare_JJ in_IN sporadic_JJ phaeochromocytomas_NNS -LRB-_-LRB- Eng_FW et_FW al_FW ._. 
1995_CD ,_, Hofstra_NNP et_FW al_FW ._. 
Inherited_VBN predisposition_NN to_TO phaeochromocytoma_NN may_MD be_VB associated_VBN with_IN mutations_NNS in_IN NF1_NNP ,_, RET_NNP ,_, SDHB_NNP ,_, SDHC_NNP ,_, SDHD_NNP or_CC VHL_NNP genes_NNS ,_, but_CC somatic_JJ mutations_NNS in_IN VHL_NNP ,_, RET_NNP ,_, NF1_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP rare_JJ in_IN sporadic_JJ phaeochromocytomas_NNS -LRB-_-LRB- Eng_FW et_FW al_FW ._. 
1996_CD ,_, Astuti_FW et_FW al._FW ._. 
2001_CD b_NN ,_, c_NN ,_, 2003_CD -RRB-_-RRB- ._. 
Promoter_NN region_NN hypermethylation_NN and_CC transcriptional_JJ silencing_NN is_VBZ a_DT frequent_JJ cause_NN of_IN tumor_NN suppressor_NN gene_NN -LRB-_-LRB- TSG_NNP -RRB-_-RRB- inactivation_NN in_IN many_JJ human_JJ cancers_NNS ._. 
MSP_NNP was_VBD performed_VBN essentially_RB using_VBG previously_RB published_VBN primers_NNS and_CC conditions_NNS -LRB-_-LRB- Conway_NNP et_NNP al_NNP ._. 
org\/supplemental_JJ \/_NN for_IN primers_NNS and_CC PCR_NNP conditions_NNS -RRB-_-RRB- ._. 
2000_CD ,_, Sellar_FW et_FW al._FW ._. 
2003_CD ,_, Yang_NNP et_NNP al_NNP ._. 
2004_CD ,_, Alaminos_NNPS et_FW al_FW ._. 
2005_CD ,_, Breault_NNP et_FW al_FW ._. 
2005_CD ,_, Lind_FW et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
Previously_RB ,_, we_PRP found_VBD significant_JJ differences_NNS in_IN the_DT frequency_NN of_IN HIC1_NNP and_CC CASP8_NNP methylation_NN between_IN VHL-associated_JJ and_CC sporadic_JJ phaeochromocytomas_NNS ,_, but_CC in_IN this_DT study_NN we_PRP did_VBD not_RB identify_VB any_DT further_RBR differentially_RB methylated_VBN genes_NNS ._. 
OPCML_NNP -LRB-_-LRB- OPCML\/cell_NNP adhesion_NN molecule-like_NN -RRB-_-RRB- encodes_VBZ a_DT member_NN of_IN the_DT IgLON_NNP subfamily_NN in_IN the_DT immunoglobulin_NN protein_NN superfamily_RB and_CC was_VBD identified_VBN as_IN a_DT candidate_NN TSG_NNP following_VBG the_DT identification_NN of_IN extensive_JJ promoter_NN methylation_NN in_IN ovarian_NN cancer_NN -LRB-_-LRB- Sellar_FW et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
Ectopic_JJ expression_NN of_IN the_DT OPCML_NNP gene_NN product_NN suppressed_VBD cell_NN growth_NN in_IN vitro_NN and_CC tumor_NN growth_NN in_IN vivo_NN in_IN nude_JJ mice_NNS models_NNS ._. 
5and_JJ 11q25_NNS respectively_RB -RRB-_-RRB- and_CC chromosome_NN 11q_NNS allele_VBP loss_NN is_VBZ frequent_JJ in_IN both_DT tumor_NN types_NNS -LRB-_-LRB- Yokogoshi_FW et_FW al_FW ._. 
1990_CD ,_, Sun_NNP et_FW al._FW ._. 
2006_CD ,_, George_NNP et_NNP al_NNP ._. 
2007_CD -RRB-_-RRB- ._. 
HSP47_NNP encodes_VBZ a_DT collagen-specific_JJ molecular_JJ chaperone_NN and_CC is_VBZ essential_JJ for_IN the_DT production_NN and_CC maturation_NN of_IN collagens_NNS I_PRP and_CC IV_NNP -LRB-_-LRB- Sauk_FW et_FW al_FW ._. 
Both_DT heat-shock_JJ protein_NN 47_CD -LRB-_-LRB- HSP47_NNP -RRB-_-RRB- and_CC OPCML_NNP map_VBP to_TO 11q_VB -LRB-_-LRB- 11q13_JJ ._. 
Three_CD of_IN these_DT genes_NNS ,_, HSP47_NNP ,_, HOXA9_NNP and_CC OPCML_NNP were_VBD methylated_VBN in_IN 
2005_CD -RRB-_-RRB- ._. 
2003_CD ,_, Lodygin_FW et_FW al_FW ._. 
2002_CD ,_, Sato_FW et_FW al_FW ._. 
Such_JJ functional_JJ epigenomic_JJ screens_NNS have_VBP proven_VBN to_TO be_VB a_DT successful_JJ strategy_NN to_TO identify_VB epigenetically_RB inactivated_VBN TSGs_NNP in_IN a_DT number_NN of_IN different_JJ tumor_NN types_NNS including_VBG oesophageal_JJ ,_, pancreatic_JJ and_CC prostate_NN -LRB-_-LRB- Yamashita_NNP et_FW al_FW ._. 
In_IN addition_NN ,_, using_VBG this_DT strategy_NN in_IN RCC_NNP cell_NN lines_NNS ,_, we_PRP identified_VBD HAI-2_NNP \/_NNP SPINT2_NNP as_IN a_DT novel_NN epigenetically_RB inactivated_VBD RCC_NNP TSG_NNP -LRB-_-LRB- Morris_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Although_IN our_PRP$ selection_NN criteria_NNS for_IN investigating_VBG 
Up_IN to_TO one-third_NN of_IN phaeochromocytomas_NNS occur_VBP in_IN genetically_RB susceptible_JJ individuals_NNS -LRB-_-LRB- Astuti_FW et_FW al_FW ._. 
2001a_JJ ,_, b_NN ,_, Neumann_NNP et_FW al._FW ._. 
2002_CD ,_, Gimenez-Roqueplo_NNP 2006_CD -RRB-_-RRB- ._. 
Inherited_VBN predisposition_NN to_TO phaeochromocytoma_NN may_MD be_VB associated_VBN with_IN mutations_NNS in_IN NF1_NNP ,_, RET_NNP ,_, SDHB_NNP ,_, SDHC_NNP ,_, SDHD_NNP or_CC VHL_NNP genes_NNS ,_, but_CC somatic_JJ mutations_NNS in_IN VHL_NNP ,_, RET_NNP ,_, NF1_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP rare_JJ in_IN sporadic_JJ phaeochromocytomas_NNS -LRB-_-LRB- Eng_FW et_FW al_FW ._. 
g._VB Several_JJ Hox_NNP genes_NNS have_VBP been_VBN reported_VBN to_TO be_VB methylated_VBN in_IN human_JJ cancers_NNS ,_, e._JJ HOXA9_NNP promoter_NN region_NN methylation_NN was_VBD detected_VBN in_IN about_IN one-fifth_NN of_IN neuroblastoma_NN and_CC phaeochromocytomas_NNS ._. 
HOXB13_NNP and_CC HOXA5_NNP ,_, in_IN renal_JJ and_CC breast_NN cancer_NN respectively_RB -LRB-_-LRB- Okuda_FW et_FW al._FW ._. 
2006_CD ,_, Piotrowski_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
HOXA9_CD promoter_NN methylation_NN was_VBD identified_VBN previously_RB in_IN lung_NN cancer_NN -LRB-_-LRB- Rauch_NNP et_FW al_FW ._. 
HOXB13_NNP and_CC HOXA5_NNP ,_, in_IN renal_JJ and_CC breast_NN cancer_NN respectively_RB -LRB-_-LRB- Okuda_FW et_FW al_FW ._. 
g._VB Several_JJ Hox_NNP genes_NNS have_VBP been_VBN reported_VBN to_TO be_VB methylated_VBN in_IN human_JJ cancers_NNS ,_, e._NN 2006_CD ,_, Piotrowski_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
HOXA9_CD promoter_NN methylation_NN was_VBD identified_VBN previously_RB in_IN lung_NN cancer_NN -LRB-_-LRB- Rauch_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- and_CC in_IN neuroblastoma_NN -LRB-_-LRB- Alaminos_NNPS et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
2006_CD ,_, Piotrowski_NNP et_FW al_FW ._. 
HOXB13_NNP and_CC HOXA5_NNP ,_, in_IN renal_JJ and_CC breast_NN cancer_NN respectively_RB -LRB-_-LRB- Okuda_FW et_FW al_FW ._. 
HOXA9_CD promoter_NN methylation_NN was_VBD identified_VBN previously_RB in_IN lung_NN cancer_NN -LRB-_-LRB- Rauch_NNP et_FW al._FW ._. 
2007_CD -RRB-_-RRB- and_CC in_IN neuroblastoma_NN -LRB-_-LRB- Alaminos_NNPS et_FW al_FW ._. 
2004_CD -RRB-_-RRB- ,_, but_CC not_RB in_IN phaeochromocytoma_NN ._. 
Previously_RB ,_, we_PRP found_VBD significant_JJ differences_NNS in_IN the_DT frequency_NN of_IN HIC1_NNP and_CC CASP8_NNP methylation_NN between_IN VHL-associated_JJ and_CC sporadic_JJ phaeochromocytomas_NNS ,_, but_CC in_IN this_DT study_NN we_PRP did_VBD not_RB identify_VB any_DT further_RBR differentially_RB methylated_VBN genes_NNS ._. 
Promoter_NN methylation_NN associated_JJ silencing_NN of_IN OPCML_NNP has_VBZ also_RB been_VBN demonstrated_VBN in_IN hepatocellular_JJ carcinomas_NNS -LRB-_-LRB- Liu_NNP et_FW al_FW ._. 
2006_CD -RRB-_-RRB- and_CC gliomas_NNS and_CC other_JJ brain_NN tumors_NNS -LRB-_-LRB- including_VBG medulloblastomas_NNS -RRB-_-RRB- -LRB-_-LRB- Reed_NNP et_NNP al._NNP ._. 
2007_CD -RRB-_-RRB- ._. 
To_TO our_PRP$ knowledge_NN ,_, OPCML_NNP promoter_NN methylation_NN has_VBZ not_RB previously_RB been_VBN reported_VBN in_IN neuroblastoma_NN or_CC phaeochromocytoma_NN ._. 
Such_JJ functional_JJ epigenomic_JJ screens_NNS have_VBP proven_VBN to_TO be_VB a_DT successful_JJ strategy_NN to_TO identify_VB epigenetically_RB inactivated_VBN TSGs_NNP in_IN a_DT number_NN of_IN different_JJ tumor_NN types_NNS including_VBG oesophageal_JJ ,_, pancreatic_JJ and_CC prostate_NN -LRB-_-LRB- Yamashita_NNP et_FW al_FW ._. 
2002_CD ,_, Sato_FW et_FW al._FW ._. 
2003_CD ,_, Lodygin_FW et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN addition_NN ,_, using_VBG this_DT strategy_NN in_IN RCC_NNP cell_NN lines_NNS ,_, we_PRP identified_VBD HAI-2_NNP \/_NNP SPINT2_NNP as_IN a_DT novel_NN epigenetically_RB inactivated_VBD RCC_NNP TSG_NNP -LRB-_-LRB- Morris_NNP et_FW al_FW ._. 
2007_CD -RRB-_-RRB- ._. 
2006_CD ,_, George_NNP et_NNP al_NNP ._. 
1990_CD ,_, Sun_NNP et_FW al_FW ._. 
5and_JJ 11q25_NNS respectively_RB -RRB-_-RRB- and_CC chromosome_NN 11q_NNS allele_VBP loss_NN is_VBZ frequent_JJ in_IN both_DT tumor_NN types_NNS -LRB-_-LRB- Yokogoshi_FW et_FW al_FW ._. 
HSP47_NNP encodes_VBZ a_DT collagen-specific_JJ molecular_JJ chaperone_NN and_CC is_VBZ essential_JJ for_IN the_DT production_NN and_CC maturation_NN of_IN collagens_NNS I_PRP and_CC IV_NNP -LRB-_-LRB- Sauk_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Type_NNP I_NNP collagen_NN negatively_RB regulates_VBZ cell_NN proliferation_NN and_CC is_VBZ deficient_JJ in_IN aggressive_JJ neuroblastoma_NN tumors_NNS -LRB-_-LRB- Yang_NNP et_NNP al_NNP ._. 
2002_CD ,_, Gimenez-Roqueplo_NNP 2006_CD -RRB-_-RRB- ._. 
2001_CD a_DT ,_, b_NN ,_, Neumann_NNP et_FW al_FW ._. 
Up_IN to_TO one-third_NN of_IN phaeochromocytomas_NNS occur_VBP in_IN genetically_RB susceptible_JJ individuals_NNS -LRB-_-LRB- Astuti_FW et_FW al_FW ._. 
Inherited_VBN predisposition_NN to_TO phaeochromocytoma_NN may_MD be_VB associated_VBN with_IN mutations_NNS in_IN NF1_NNP ,_, RET_NNP ,_, SDHB_NNP ,_, SDHC_NNP ,_, SDHD_NNP or_CC VHL_NNP genes_NNS ,_, but_CC somatic_JJ mutations_NNS in_IN VHL_NNP ,_, RET_NNP ,_, NF1_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP rare_JJ in_IN sporadic_JJ phaeochromocytomas_NNS -LRB-_-LRB- Eng_FW et_FW al._FW ._. 
1995_CD ,_, Hofstra_NNP et_FW al_FW ._. 
1996_CD ,_, Astuti_FW et_FW al_FW ._. 
2001_CD b_NN ,_, c_NN ,_, 2003_CD -RRB-_-RRB- ._. 
Promoter_NN region_NN hypermethylation_NN and_CC transcriptional_JJ silencing_NN is_VBZ a_DT frequent_JJ cause_NN of_IN tumor_NN suppressor_NN gene_NN -LRB-_-LRB- TSG_NNP -RRB-_-RRB- inactivation_NN in_IN many_JJ human_JJ cancers_NNS ._. 
Most_JJS phaeochromocytomas_NNS are_VBP benign_JJ catecholamine-producing_JJ tumors_NNS arising_VBG within_IN the_DT adrenal_JJ medulla_NN ,_, but_CC may_MD be_VB extra-adrenal_JJ -LRB-_-LRB- when_WRB they_PRP may_MD be_VB designated_VBN as_IN paragangliomas_NNS -RRB-_-RRB- and\/or_CC approximately_RB malignant_JJ -LRB-_-LRB- Chrisoulidou_NNP et_FW al_FW ._. 
2007_CD ,_, Disick_NNP 
2001_CD a_DT ,_, b_NN ,_, Neumann_NNP et_FW al_FW ._. 
Up_IN to_TO one-third_NN of_IN phaeochromocytomas_NNS occur_VBP in_IN genetically_RB susceptible_JJ individuals_NNS -LRB-_-LRB- Astuti_FW et_FW al_FW ._. 
2002_CD ,_, Gimenez-Roqueplo_NNP 2006_CD -RRB-_-RRB- ._. 
Inherited_VBN predisposition_NN to_TO phaeochromocytoma_NN may_MD be_VB associated_VBN with_IN mutations_NNS in_IN NF1_NNP ,_, RET_NNP ,_, SDHB_NNP ,_, SDHC_NNP ,_, SDHD_NNP or_CC VHL_NNP genes_NNS ,_, but_CC somatic_JJ mutations_NNS in_IN VHL_NNP ,_, RET_NNP ,_, NF1_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP rare_JJ in_IN sporadic_JJ phaeochromocytomas_NNS -LRB-_-LRB- Eng_FW et_FW al_FW ._. 
1990_CD ,_, Sun_NNP et_FW al_FW ._. 
5and_JJ 11q25_NNS respectively_RB -RRB-_-RRB- and_CC chromosome_NN 11q_NNS allele_VBP loss_NN is_VBZ frequent_JJ in_IN both_DT tumor_NN types_NNS -LRB-_-LRB- Yokogoshi_FW et_FW al_FW ._. 
2006_CD ,_, George_NNP et_NNP al._NNP ._. 
2007_CD -RRB-_-RRB- ._. 
HSP47_NNP encodes_VBZ a_DT collagen-specific_JJ molecular_JJ chaperone_NN and_CC is_VBZ essential_JJ for_IN the_DT production_NN and_CC maturation_NN of_IN collagens_NNS I_PRP and_CC IV_NNP -LRB-_-LRB- Sauk_FW et_FW al_FW ._. 
Inherited_VBN predisposition_NN to_TO phaeochromocytoma_NN may_MD be_VB associated_VBN with_IN mutations_NNS in_IN NF1_NNP ,_, RET_NNP ,_, SDHB_NNP ,_, SDHC_NNP ,_, SDHD_NNP or_CC VHL_NNP genes_NNS ,_, but_CC somatic_JJ mutations_NNS in_IN VHL_NNP ,_, RET_NNP ,_, NF1_NNP ,_, SDHB_NNP and_CC SDHD_NNP are_VBP rare_JJ in_IN sporadic_JJ phaeochromocytomas_NNS -LRB-_-LRB- Eng_FW et_FW al_FW ._. 
1995_CD ,_, Hofstra_NNP et_FW al._FW ._. 
1996_CD ,_, Astuti_FW et_FW al_FW ._. 
2001_CD b_NN ,_, c_NN ,_, 2003_CD -RRB-_-RRB- ._. 
Promoter_NN region_NN hypermethylation_NN and_CC transcriptional_JJ silencing_NN is_VBZ a_DT frequent_JJ cause_NN of_IN tumor_NN suppressor_NN gene_NN -LRB-_-LRB- TSG_NNP -RRB-_-RRB- inactivation_NN in_IN many_JJ human_JJ cancers_NNS ._. 
Cell_NN lines_NNS The_DT ten_CD neuroblastoma_NN cell_NN lines_NNS used_VBN were_VBD SK-N-AS_NNP ,_, SK-N-F1_NNP ,_, SK-N-DZ_NNP ,_, SK-N-MC_NNP ,_, SK-N-BE_NNP ,_, SK-N-SH_NNP ,_, NMB_NNP and_CC LAN-5_NNP -LRB-_-LRB- American_NNP Type_NNP Culture_NNP Collection_NNP ,_, Manassas_NNP ,_, VA_NNP ,_, USA_NNP -RRB-_-RRB- ,_, KELLY_NNP and_CC CHP212_NNP ._. 
Sodium_NN bisulphate_NN modificationSodium_NN bisulphite_NN modification_NN was_VBD carried_VBN out_RP using_VBG an_DT adapted_VBN method_NN -LRB-_-LRB- Herman_NNP et_FW al._FW ._. 
1996_CD -RRB-_-RRB- ._. 
Genomic_NNP DNA_NNP -LRB-_-LRB- 0_CD ._. 
5_CD 
Ectopic_JJ expression_NN of_IN the_DT OPCML_NNP gene_NN product_NN suppressed_VBD cell_NN growth_NN in_IN vitro_NN and_CC tumor_NN growth_NN in_IN vivo_NN in_IN nude_JJ mice_NNS models_NNS ._. 
Promoter_NN methylation_NN associated_JJ silencing_NN of_IN OPCML_NNP has_VBZ also_RB been_VBN demonstrated_VBN in_IN hepatocellular_JJ carcinomas_NNS -LRB-_-LRB- Liu_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- and_CC gliomas_NNS and_CC other_JJ brain_NN tumors_NNS -LRB-_-LRB- including_VBG medulloblastomas_NNS -RRB-_-RRB- -LRB-_-LRB- Reed_NNP et_NNP al_NNP ._. 
2007_CD -RRB-_-RRB- ._. 
To_TO our_PRP$ knowledge_NN ,_, OPCML_NNP promoter_NN methylation_NN has_VBZ not_RB previously_RB been_VBN reported_VBN in_IN neuroblastoma_NN or_CC phaeochromocytoma_NN ._. 
2005_CD ,_, Breault_NNP et_FW al_FW ._. 
2004_CD ,_, Alaminos_NNPS et_FW al_FW ._. 
2003_CD ,_, Yang_NNP et_NNP al_NNP ._. 
2000_CD ,_, Sellar_FW et_FW al_FW ._. 
MSP_NNP was_VBD performed_VBN essentially_RB using_VBG previously_RB published_VBN primers_NNS and_CC conditions_NNS -LRB-_-LRB- Conway_NNP et_NNP al_NNP ._. 
2005_CD ,_, Lind_FW et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Expected_NNP PCR_NNP products_NNS are_VBP as_IN follows_VBZ :_: for_IN HSP47_NNP -LRB-_-LRB- a_DT -RRB-_-RRB- ,_, 134_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 135_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: HSP47_NNP -LRB-_-LRB- b_NN -RRB-_-RRB- ,_, 109_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 110_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: EMP3_NNP ,_, 252_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_CD 255_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: opioid_JJ binding_JJ protein_NN -LRB-_-LRB- OPCML_NNP -RRB-_-RRB- ,_, 135_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 135_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: CTNNG_NNP ,_, 95_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 85_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: SYK_NNP ,_, 242_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 140_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- ;_: TMS1_NNP ,_, 212_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_CD 209_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: Homeobox_NNP A9_NNP -LRB-_-LRB- HOXA9_NNP -RRB-_-RRB- ,_, 127_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_CD 139_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN -LRB-_-LRB- see_VB Supplementary_NNP Table_NNP 1_CD which_WDT can_MD be_VB viewed_VBN online_NN at_IN 
Thus_RB ,_, TSP1_NNP ,_, CASP8_NNP ,_, HIC1_NNP ,_, DcR1_NNP ,_, DcR2_NNP and_CC DR4_NNP and_CC RASSF1_NNP were_VBD methylated_VBN frequently_RB in_IN both_DT tumor_NN types_NNS -LRB-_-LRB- Astuti_FW et_FW al_FW ._. 
2001c_NNP ,_, Margetts_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN contrast_NN to_TO phaeochromocytoma_NN ,_, familial_JJ neuroblastoma_NN is_VBZ rare_JJ ._. 
However_RB ,_, the_DT genetic_JJ and_CC epigenetic_JJ events_NNS associated_VBN with_IN tumourigenesis_NNS in_IN sporadic_JJ neuroblastoma_NN are_VBP better_RBR defined_VBN than_IN in_IN phaeochromocytoma_NN and_CC molecular_JJ investigations_NNS of_IN phaeochromocytoma_NN tumourigenesis_NNS have_VBP been_VBN hampered_VBN by_IN the_DT absence_NN of_IN a_DT human_JJ phaeochromocytoma_NN cell_NN line_NN ._. 
No_DT association_NN was_VBD detected_VBN between_IN methylation_NN at_IN OPCML_NNP ,_, HOXA9_NNP or_CC HSP47_NNP in_IN individual_JJ tumors_NNS ._. 
TMS1_CD and_CC CTNNG_NNP displayed_VBD lower_JJR frequencies_NNS -LRB-_-LRB- 
2005_CD -RRB-_-RRB- ._. 
There_EX was_VBD also_RB no_DT association_NN between_IN methylation_NN at_IN OPCML_NNP or_CC HSP47_NNP and_CC methylation_NN as_IN CASP_NNP 8_CD or_CC HIC1_CD -LRB-_-LRB- Margetts_NNPS et_FW al_FW ._. 
To_TO analyze_VB whether_IN the_DT different_JJ subtypes_NNS of_IN neural_JJ crest_NN tumors_NNS showed_VBD different_JJ levels_NNS of_IN methylation_NN ,_, we_PRP combined_VBD data_NNS from_IN the_DT current_JJ study_NN with_IN additional_JJ data_NNS reported_VBN previously_RB for_IN FLIP_NNP ,_, TSP1_NNP ,_, DcR1_NNP ,_, DcR2_NNP ,_, DR4_NNP ,_, DR5_NNP ,_, CASP8_NNP and_CC HIC1_NNP -LRB-_-LRB- Margetts_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- and_CC estimated_VBD the_DT mean_JJ percentage_NN of_IN loci_NNS methylated_VBN in_IN each_DT tumor_NN sample_NN ._. 
There_EX were_VBD no_DT significant_JJ differences_NNS in_IN the_DT mean_JJ percentage_NN of_IN loci_NNS methylated_VBN among_IN neuroblastoma_NN -LRB-_-LRB- mean_JJ 34_CD ._. 
2002_CD ,_, Sato_FW et_FW al_FW ._. 
Such_JJ functional_JJ epigenomic_JJ screens_NNS have_VBP proven_VBN to_TO be_VB a_DT successful_JJ strategy_NN to_TO identify_VB epigenetically_RB inactivated_VBN TSGs_NNP in_IN a_DT number_NN of_IN different_JJ tumor_NN types_NNS including_VBG oesophageal_JJ ,_, pancreatic_JJ and_CC prostate_NN -LRB-_-LRB- Yamashita_NNP et_FW al_FW ._. 
2003_CD ,_, Lodygin_FW et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN addition_NN ,_, using_VBG this_DT strategy_NN in_IN RCC_NNP cell_NN lines_NNS ,_, we_PRP identified_VBD HAI-2_NNP \/_NNP SPINT2_NNP as_IN a_DT novel_NN epigenetically_RB inactivated_VBD RCC_NNP TSG_NNP -LRB-_-LRB- Morris_NNP et_FW al_FW ._. 
In_IN the_DT absence_NN of_IN a_DT human_JJ phaeochromocytoma_NN cell_NN line_NN ,_, we_PRP analyzed_VBD gene_NN expression_NN changes_NNS following_VBG treatment_NN with_IN a_DT demethylating_JJ agent_NN in_IN three_CD neuroblastoma_NN cell_NN lines_NNS ._. 
Such_JJ functional_JJ epigenomic_JJ screens_NNS have_VBP proven_VBN to_TO be_VB a_DT successful_JJ strategy_NN to_TO identify_VB epigenetically_RB inactivated_VBN TSGs_NNP in_IN a_DT number_NN of_IN different_JJ tumor_NN types_NNS including_VBG oesophageal_JJ ,_, pancreatic_JJ and_CC prostate_NN -LRB-_-LRB- Yamashita_NNP et_FW al._FW ._. 
2002_CD ,_, Sato_FW et_FW al_FW ._. 
2003_CD ,_, Lodygin_FW et_FW al_FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN addition_NN ,_, using_VBG this_DT strategy_NN in_IN RCC_NNP cell_NN lines_NNS ,_, we_PRP identified_VBD HAI-2_NNP \/_NNP SPINT2_NNP as_IN a_DT novel_NN epigenetically_RB inactivated_VBD RCC_NNP TSG_NNP -LRB-_-LRB- Morris_NNP et_FW al_FW ._. 
Thus_RB ,_, in_IN a_DT similar_JJ study_NN of_IN four_CD RCC_NNP cell_NN lines_NNS ,_, we_PRP identified_VBD SPINT2_NNP as_IN a_DT novel_NN epigenetically_RB inactivated_VBD renal_JJ TSG_NNP ._. 
However_RB ,_, analysis_NN of_IN a_DT further_JJ 60_CD genes_NNS that_WDT were_VBD differentially_RB expressed_VBN after_IN demethylation_NN revealed_VBD that_IN only_RB six_CD -LRB-_-LRB- four_CD of_IN which_WDT had_VBD been_VBN reported_VBN previously_RB -RRB-_-RRB- demonstrated_VBD primary_JJ tumour-specific_JJ promoter_NN methylation_NN -LRB-_-LRB- Morris_NNP et_NNP al._NNP ._. 
2008_CD -RRB-_-RRB- ._. 
Thus_RB ,_, this_DT approach_NN has_VBZ a_DT relatively_RB low_JJ specificity_NN for_IN identifying_VBG methylated_JJ TSGs_NNS ._. 
Analysis_NN of_IN a_DT larger_JJR number_NN of_IN genes_NNS might_MD have_VB led_VBN to_TO the_DT identification_NN of_IN novel_NN TSGs_NNS ,_, but_CC reducing_VBG the_DT stringency_NN of_IN the_DT selection_NN criteria_NNS would_MD also_RB probably_RB further_RBR lower_JJR specificity_NN ._. 
http:\/\/erc_JJ ._. 
MSP_NNP was_VBD performed_VBN essentially_RB using_VBG previously_RB published_VBN primers_NNS and_CC conditions_NNS -LRB-_-LRB- Conway_NNP et_NNP al._NNP ._. 
2000_CD ,_, Sellar_FW et_FW al_FW ._. 
2003_CD ,_, Yang_NNP et_NNP al_NNP ._. 
2004_CD ,_, Alaminos_NNPS et_FW al_FW ._. 
2005_CD ,_, Breault_NNP et_FW al_FW ._. 
2005_CD ,_, Lind_FW et_FW al_FW ._. 
2004_CD ,_, Alaminos_NNPS et_FW al_FW ._. 
2003_CD ,_, Yang_NNP et_NNP al_NNP ._. 
2000_CD ,_, Sellar_FW et_FW al_FW ._. 
MSP_NNP was_VBD performed_VBN essentially_RB using_VBG previously_RB published_VBN primers_NNS and_CC conditions_NNS -LRB-_-LRB- Conway_NNP et_NNP al_NNP ._. 
2005_CD ,_, Breault_NNP et_FW al._FW ._. 
2005_CD ,_, Lind_FW et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
Expected_NNP PCR_NNP products_NNS are_VBP as_IN follows_VBZ :_: for_IN HSP47_NNP -LRB-_-LRB- a_DT -RRB-_-RRB- ,_, 134_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 135_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: HSP47_NNP -LRB-_-LRB- b_NN -RRB-_-RRB- ,_, 109_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 110_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: EMP3_NNP ,_, 252_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_CD 255_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: opioid_JJ binding_JJ protein_NN -LRB-_-LRB- OPCML_NNP -RRB-_-RRB- ,_, 135_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 135_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: CTNNG_NNP ,_, 95_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 85_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: SYK_NNP ,_, 242_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 140_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- ;_: TMS1_NNP ,_, 212_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_CD 209_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: Homeobox_NNP A9_NNP -LRB-_-LRB- HOXA9_NNP -RRB-_-RRB- ,_, 127_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_CD 139_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN -LRB-_-LRB- see_VB Supplementary_NNP Table_NNP 1_CD which_WDT can_MD be_VB viewed_VBN online_NN at_IN 
g._NNP A_NNP more_RBR effective_JJ plan_NN of_IN investigation_NN might_MD be_VB to_TO combine_VB 
2004_CD -RRB-_-RRB- ,_, our_PRP$ results_NNS suggest_VBP that_DT methylation_NN is_VBZ less_RBR frequent_JJ in_IN neuroblastoma_NN primary_NN tumors_NNS and_CC is_VBZ infrequent_JJ -LRB-_-LRB- 
Three_CD genes_NNS -LRB-_-LRB- HSP47_NNP ,_, OPCML_NNP and_CC HOXA9_NNP -RRB-_-RRB- demonstrated_VBD frequent_JJ -LRB-_-LRB- 
2000_CD ,_, Sellar_FW et_FW al_FW ._. 
MSP_NNP was_VBD performed_VBN essentially_RB using_VBG previously_RB published_VBN primers_NNS and_CC conditions_NNS -LRB-_-LRB- Conway_NNP et_NNP al_NNP ._. 
2003_CD ,_, Yang_NNP et_NNP al._NNP ._. 
2004_CD ,_, Alaminos_NNPS et_FW al_FW ._. 
2005_CD ,_, Breault_NNP et_FW al_FW ._. 
2005_CD ,_, Lind_FW et_FW al_FW ._. 
2006_CD -RRB-_-RRB- ._. 
Expected_NNP PCR_NNP products_NNS are_VBP as_IN follows_VBZ :_: for_IN HSP47_NNP -LRB-_-LRB- a_DT -RRB-_-RRB- ,_, 134_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 135_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: HSP47_NNP -LRB-_-LRB- b_NN -RRB-_-RRB- ,_, 109_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 110_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: EMP3_NNP ,_, 252_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_CD 255_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: opioid_JJ binding_JJ protein_NN -LRB-_-LRB- OPCML_NNP -RRB-_-RRB- ,_, 135_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 135_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: CTNNG_NNP ,_, 95_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 85_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: SYK_NNP ,_, 242_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_IN 140_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- ;_: TMS1_NNP ,_, 212_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_CD 209_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN ;_: Homeobox_NNP A9_NNP -LRB-_-LRB- HOXA9_NNP -RRB-_-RRB- ,_, 127_CD -LRB-_-LRB- methylated_VBN -RRB-_-RRB- \/_CD 139_CD -LRB-_-LRB- unmethylated_JJ -RRB-_-RRB- bp_NN -LRB-_-LRB- see_VB Supplementary_NNP Table_NNP 1_CD which_WDT can_MD be_VB viewed_VBN online_NN at_IN 
2005_CD -RRB-_-RRB- ._. 
HSP47_NNP encodes_VBZ a_DT collagen-specific_JJ molecular_JJ chaperone_NN and_CC is_VBZ essential_JJ for_IN the_DT production_NN and_CC maturation_NN of_IN collagens_NNS I_PRP and_CC IV_NNP -LRB-_-LRB- Sauk_FW et_FW al_FW ._. 
Type_NNP I_NNP collagen_NN negatively_RB regulates_VBZ cell_NN proliferation_NN and_CC is_VBZ deficient_JJ in_IN aggressive_JJ neuroblastoma_NN tumors_NNS -LRB-_-LRB- Yang_NNP et_NNP al._NNP ._. 
2004_CD -RRB-_-RRB- ._. 
Previously_RB ,_, expression_NN of_IN HSP47_NNP was_VBD reported_VBN to_TO be_VB upregulated_VBN after_IN treatment_NN with_IN 5-aza-dC_NN in_IN the_DT neuroblastoma_NN cell_NN line_NN NB2-W-S_NN and_CC promoter_NN region_NN methylation_NN was_VBD detected_VBN in_IN neuroblastoma_NN cell_NN lines_NNS and_CC 4\/7_CD primary_JJ neuroblastoma_NN tumors_NNS analyzed_VBD -LRB-_-LRB- Yang_NNP et_NNP al_NNP ._. 
2004_CD -RRB-_-RRB- ._. 
Type_NNP I_NNP collagen_NN negatively_RB regulates_VBZ cell_NN proliferation_NN and_CC is_VBZ deficient_JJ in_IN aggressive_JJ neuroblastoma_NN tumors_NNS -LRB-_-LRB- Yang_NNP et_NNP al_NNP ._. 
Previously_RB ,_, expression_NN of_IN HSP47_NNP was_VBD reported_VBN to_TO be_VB upregulated_VBN after_IN treatment_NN with_IN 5-aza-dC_NN in_IN the_DT neuroblastoma_NN cell_NN line_NN NB2-W-S_NN and_CC promoter_NN region_NN methylation_NN was_VBD detected_VBN in_IN neuroblastoma_NN cell_NN lines_NNS and_CC 4\/7_CD primary_JJ neuroblastoma_NN tumors_NNS analyzed_VBD -LRB-_-LRB- Yang_NNP et_NNP al._NNP ._. 
2004_CD -RRB-_-RRB- ._. 
In_IN addition_NN ,_, expression_NN of_IN HSP47_NNP correlated_VBD with_IN that_DT of_IN collagen_NN I_PRP and_CC IV_NNP ._. 
We_PRP have_VBP confirmed_VBN and_CC extended_VBN the_DT analysis_NN of_IN HSP47_NNP promoter_NN methylation_NN in_IN neuroblastoma_NN and_CC demonstrated_VBD that_IN the_DT HSP47_NNP promoter_NN is_VBZ methylated_VBN in_IN 
For_IN example_NN ,_, only_RB the_DT subgroup_NN of_IN patients_NNS with_IN the_DT highest_JJS risk_NN of_IN dying_VBG ,_, reflected_VBN in_IN an_DT APACHE_NNP II_NNP score_NN of_IN more_JJR than_IN 24_CD points_NNS ,_, is_VBZ benefiting_VBG from_IN the_DT administration_NN of_IN activated_VBN protein_NN C_NNP -LRB-_-LRB- Drotrecogin_NNP alpha_NN -RRB-_-RRB- ._. 
The_DT APACHE_NNP II_NNP score_NN was_VBD originally_RB suggested_VBN not_RB to_TO be_VB used_VBN for_IN individual_JJ outcome_NN prediction_NN of_IN sepsis_NN patients_NNS -LRB-_-LRB- Wagner_NNP et_FW al._FW ._. 
1984_CD -RRB-_-RRB- ._. 
The_DT use_NN of_IN the_DT APACHE_NNP II_NNP score_NN for_IN individual_JJ treatment_NN decisions_NNS can_MD be_VB problematic_JJ because_IN of_IN the_DT difficulties_NNS of_IN determining_VBG the_DT score_NN clinically_RB -LRB-_-LRB- Abraham_NNP et_FW al._FW ._. 
2005_CD ,_, 2006_CD -RRB-_-RRB- ._. 
Conversely_RB ,_, ADM_NNP is_VBZ a_DT potent_JJ vasodilator_NN ,_, which_WDT assures_VBZ blood_NN supply_NN to_TO the_DT individual_JJ organ_NN and_CC has_VBZ been_VBN shown_VBN to_TO be_VB increased_VBN in_IN systemic_JJ infections_NNS -LRB-_-LRB- Christ-Crain_NNP et_FW al._FW ._. 
Both_DT peptides_NNS correlate_VBP with_IN mortality_NN and_CC ,_, thus_RB ,_, have_VBP been_VBN put_VBN forward_RB as_IN prognostic_JJ markers_NNS of_IN disease_NN severity_NN in_IN septic_JJ syndrome_NN -LRB-_-LRB- Ueda_FW et_FW al._FW ._. 
1999_CD ;_: Brauner_NNP et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ._. 
However_RB ,_, the_DT methodological_JJ reliability_NN of_IN plasma_NN ET-1_NNP and_CC ADM_NNP measurements_NNS is_VBZ challenging_JJ because_IN of_IN their_PRP$ rapid_JJ clearance_NN from_IN the_DT circulation_NN ,_, limiting_VBG their_PRP$ use_NN in_IN common_JJ practice_NN -LRB-_-LRB- Hinson_NNP et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ._. 
Brauner_NNP and_CC coworkers_NNS demonstrated_VBD an_DT association_NN of_IN ET1levels_NNS and_CC mortality_NN in_IN septic_JJ patients_NNS only_RB when_WRB measured_JJ 6h_NN after_IN admission_NN -LRB-_-LRB- Brauner_NNP et_FW al._FW ._. 
Similarly_RB ,_, ADM_NNP has_VBZ been_VBN suggested_VBN to_TO serve_VB as_IN an_DT outcome_NN predictor_NN in_IN patients_NNS with_IN SIRS_NNS and_CC sepsis_NNS -LRB-_-LRB- Ueda_FW et_FW al._FW ._. 
1999_CD ;_: Christ-Crain_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN our_PRP$ study_NN ,_, baseline_JJ MR-proADM_JJ levels_NNS but_CC not_RB ET-1_JJ levels_NNS were_VBD significantly_RB higher_JJR in_IN patients_NNS not_RB surviving_VBG their_PRP$ disease_NN as_IN compared_VBN to_TO those_DT who_WP did_VBD ._. 
2005_CD -RRB-_-RRB- ._. 
2004_CD ;_: Christ-Crain_NNP et_FW al._FW ._. 
2000_CD ;_: Landry_NNP et_NNP al._NNP ._. 
Endothelin-1_NNP -LRB-_-LRB- ET-1_NNP -RRB-_-RRB- and_CC adrenomedullin_JJ -LRB-_-LRB- ADM_NNP -RRB-_-RRB- ,_, two_CD endothelium-derived_JJ vasoactive_JJ peptides_NNS ,_, have_VBP attracted_VBN interest_NN as_IN physiological_JJ key_JJ mediators_NNS in_IN vascular_JJ tone_NN regulation_NN in_IN sepsis_NN and_CC cardiovascular_JJ disease_NN -LRB-_-LRB- Levin_NNP 1995_CD ;_: Hinson_NNP et_FW al._FW ._. 
ET-1_NNP ,_, a_DT 21_CD 
ADM_NNP contributes_VBZ to_TO the_DT extensive_JJ vasodilatation_NN and_CC hypotension_NN often_RB seen_VBN in_IN severe_JJ sepsis_NN and_CC especially_RB in_IN septic_JJ shock_NN -LRB-_-LRB- Hinson_NNP et_FW al._FW ._. 
2000_CD ;_: Struck_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
Conversely_RB ,_, with_IN its_PRP$ potent_JJ vasoconstrictor_NN properties_NNS ,_, the_DT vascular_JJ tissue-wide_JJ production_NN of_IN ET-1_NNP counteracts_VBZ this_DT vasodilatation_NN and_CC hypotension_NN and_CC therefore_RB assures_VBZ blood_NN pressure_NN homeostasis_NN and_CC blood_NN supply_NN to_TO the_DT individual_JJ organs_NNS -LRB-_-LRB- Kedzierski_NNP et_FW al._FW ._. 
2000_CD ;_: Eto_NNP 2001_CD -RRB-_-RRB- ._. 
The_DT measurement_NN of_IN mature_NNP ADM_NNP is_VBZ technically_RB challenging_JJ and_CC the_DT reliable_JJ measurement_NN almost_RB impossible_JJ ,_, because_IN it_PRP is_VBZ rapidly_RB cleared_VBN from_IN the_DT circulation_NN -LRB-_-LRB- Hinson_NNP et_FW al._FW ._. 
Recently_RB ,_, the_DT more_RBR stable_JJ mid-regional_JJ fragment_NN of_IN pro-adrenomedullin_NN -LRB-_-LRB- MR-proADM_NNP -RRB-_-RRB- comprising_VBG amino_JJ acids_NNS 45_CD to_TO 92_CD ,_, which_WDT directly_RB reflects_VBZ levels_NNS of_IN the_DT rapidly_RB degraded_JJ active_JJ peptide_NN ADM_NNP ,_, was_VBD identified_VBN in_IN the_DT plasma_NN of_IN patients_NNS with_IN septic_JJ shock_NN -LRB-_-LRB- Struck_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- and_CC a_DT technically_RB very_RB robust_JJ and_CC reliable_JJ assay_NN for_IN this_DT peptide_NN was_VBD subsequently_RB developed_VBN ._. 
We_PRP endorse_VBP further_JJ studies_NNS to_TO validate_VB our_PRP$ results_NNS and_CC to_TO prospectively_RB identify_VB patients_NNS in_IN whom_WP these_DT peptides_NNS could_MD possibly_RB improve_VB the_DT APACHE_NNP II_NNP score_NN ._. 
ET-1_NN originates_VBZ from_IN a_DT larger_JJR precursor_NN peptide_NN ,_, which_WDT is_VBZ first_RB proteolytically_RB processed_VBN to_TO big_JJ ET-1_NN and_CC further_RB excised_VBN by_IN the_DT action_NN of_IN endothelin-converting_JJ enzyme_NN -LRB-_-LRB- Rongen_NNP et_FW al._FW ._. 
1994_CD -RRB-_-RRB- ._. 
In_IN this_DT study_NN the_DT precursor_NN fragment_NN of_IN ET-1_NN was_VBD chosen_VBN to_TO monitor_VB ,_, because_IN pro-ET-1_JJ fragments_NNS can_MD be_VB detected_VBN for_IN hours_NNS after_IN its_PRP$ cleavage_NN in_IN the_DT circulation_NN ,_, in_IN contrast_NN to_TO ET-1_NNP ,_, which_WDT is_VBZ eliminated_VBN within_IN minutes_NNS and_CC therefore_RB escapes_VBZ detection_NN in_IN clinical_JJ routine_NN -LRB-_-LRB- Weitzberg_FW et_FW al._FW ._. 
2005_CD ;_: Parrillo_NNP 2005_CD -RRB-_-RRB- ._. 
The_DT use_NN of_IN the_DT APACHE_NNP II_NNP score_NN for_IN individual_JJ treatment_NN decisions_NNS can_MD be_VB problematic_JJ because_IN of_IN the_DT difficulties_NNS of_IN determining_VBG the_DT score_NN clinically_RB -LRB-_-LRB- Abraham_NNP et_FW al._FW ._. 
Calculating_VBG clinical_JJ scores_NNS is_VBZ time_NN consuming_NN ,_, sometimes_RB complex_JJ ,_, and_CC shows_VBZ a_DT high_JJ interobserver_NN variability_NN -LRB-_-LRB- Polderman_FW et_FW al._FW ._. 
2001_CD ;_: Booth_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
However_RB ,_, despite_IN its_PRP$ inherent_JJ limitations_NNS ,_, outcome_NN predictors_NNS are_VBP clearly_RB helpful_JJ in_IN identifying_VBG those_DT septic_JJ patients_NNS with_IN a_DT high_JJ risk_NN of_IN death_NN ,_, who_WP are_VBP more_RBR likely_JJ to_TO benefit_VB from_IN intervention_NN treatment_NN ._. 
Accumulating_VBG evidence_NN indicates_VBZ a_DT major_JJ role_NN for_IN different_JJ vasoactive_JJ substances_NNS causing_VBG dysregulation_NN of_IN the_DT endothelium_NN and_CC consecutive_JJ collapse_NN of_IN blood_NN pressure_NN and_CC microvascular_JJ homeostasis_NN -LRB-_-LRB- Grandel_FW et_FW al._FW ._. 
2003_CD ;_: Peters_NNP et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
The_DT two_CD endothelium-derived_JJ peptides_NNS ET-1_NNP and_CC ADM_NNP have_VBP been_VBN suggested_VBN as_IN two_CD pivotal_JJ mediators_NNS in_IN this_DT process_NN of_IN vascular_JJ tone_NN regulation_NN ._. 
The_DT use_NN of_IN the_DT APACHE_NNP II_NNP score_NN for_IN individual_JJ treatment_NN decisions_NNS can_MD be_VB problematic_JJ because_IN of_IN the_DT difficulties_NNS of_IN determining_VBG the_DT score_NN clinically_RB -LRB-_-LRB- Abraham_NNP et_FW al._FW ._. 
2005_CD ;_: Parrillo_NNP 2005_CD -RRB-_-RRB- ._. 
Calculating_VBG clinical_JJ scores_NNS is_VBZ time_NN consuming_NN ,_, sometimes_RB complex_JJ ,_, and_CC shows_VBZ a_DT high_JJ interobserver_NN variability_NN -LRB-_-LRB- Polderman_FW et_FW al._FW ._. 
Calculating_VBG clinical_JJ scores_NNS is_VBZ time_NN consuming_NN ,_, sometimes_RB complex_JJ ,_, and_CC shows_VBZ a_DT high_JJ interobserver_NN variability_NN -LRB-_-LRB- Polderman_FW et_FW al._FW ._. 
2001_CD ;_: Booth_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
However_RB ,_, despite_IN its_PRP$ inherent_JJ limitations_NNS ,_, outcome_NN predictors_NNS are_VBP clearly_RB helpful_JJ in_IN identifying_VBG those_DT septic_JJ patients_NNS with_IN a_DT high_JJ risk_NN of_IN death_NN ,_, who_WP are_VBP more_RBR likely_JJ to_TO benefit_VB from_IN intervention_NN treatment_NN ._. 
Both_DT peptides_NNS correlate_VBP with_IN mortality_NN and_CC ,_, thus_RB ,_, have_VBP been_VBN put_VBN forward_RB as_IN prognostic_JJ markers_NNS of_IN disease_NN severity_NN in_IN septic_JJ syndrome_NN -LRB-_-LRB- Ueda_FW et_FW al._FW ._. 
1999_CD ;_: Brauner_NNP et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ._. 
However_RB ,_, the_DT methodological_JJ reliability_NN of_IN plasma_NN ET-1_NNP and_CC ADM_NNP measurements_NNS is_VBZ challenging_JJ because_IN of_IN their_PRP$ rapid_JJ clearance_NN from_IN the_DT circulation_NN ,_, limiting_VBG their_PRP$ use_NN in_IN common_JJ practice_NN -LRB-_-LRB- Hinson_NNP et_FW al._FW ._. 
Accordingly_RB ,_, in_IN our_PRP$ study_NN both_DT precursor_NN peptides_NNS were_VBD markedly_RB increased_VBN in_IN different_JJ severities_NNS of_IN sepsis_NN and_CC both_DT substances_NNS correlated_VBN with_IN mean_JJ blood_NN pressure_NN ._. 
Brauner_NNP and_CC coworkers_NNS demonstrated_VBD an_DT association_NN of_IN ET1levels_NNS and_CC mortality_NN in_IN septic_JJ patients_NNS only_RB when_WRB measured_JJ 6h_NN after_IN admission_NN -LRB-_-LRB- Brauner_NNP et_FW al._FW ._. 
2000_CD -RRB-_-RRB- ._. 
Similarly_RB ,_, ADM_NNP has_VBZ been_VBN suggested_VBN to_TO serve_VB as_IN an_DT outcome_NN predictor_NN in_IN patients_NNS with_IN SIRS_NNS and_CC sepsis_NNS -LRB-_-LRB- Ueda_FW et_FW al._FW ._. 
2000_CD ;_: Landry_NNP et_NNP al._NNP ._. 
Endothelin-1_NNP -LRB-_-LRB- ET-1_NNP -RRB-_-RRB- and_CC adrenomedullin_JJ -LRB-_-LRB- ADM_NNP -RRB-_-RRB- ,_, two_CD endothelium-derived_JJ vasoactive_JJ peptides_NNS ,_, have_VBP attracted_VBN interest_NN as_IN physiological_JJ key_JJ mediators_NNS in_IN vascular_JJ tone_NN regulation_NN in_IN sepsis_NN and_CC cardiovascular_JJ disease_NN -LRB-_-LRB- Levin_NNP 1995_CD ;_: Hinson_NNP et_FW al._FW ._. 
2004_CD ;_: Christ-Crain_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
ET-1_NNP ,_, a_DT 21_CD 
2000_CD -RRB-_-RRB- ._. 
ET-1_NNP ,_, a_DT 21_CD 
Details_NNS of_IN the_DT characteristics_NNS of_IN the_DT study_NN population_NN ,_, study_NN design_NN ,_, the_DT diagnostic_JJ criteria_NNS ,_, and_CC the_DT levels_NNS of_IN different_JJ markers_NNS of_IN inflammation_NN and_CC infection_NN have_VBP been_VBN reported_VBN in_IN detail_NN -LRB-_-LRB- Muller_NNP et_FW al._FW ._. 
2000a_CD ,_, 2000b_CD ,_, 2001_CD ,_, 2002_CD ;_: Christ-Crain_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Briefly_RB ,_, over_IN a_DT 9-month_JJ period_NN ,_, 101_CD consecutive_JJ patients_NNS ,_, including_VBG neutropenic_JJ and_CC immunosuppressed_JJ patients_NNS ,_, admitted_VBN to_TO the_DT medical_JJ ICU_NNP were_VBD included_VBN ._. 
M._NNP H._NNP A._NN R._NNP Pro-endothelin-1_NNP fragments_NNS -LRB-_-LRB- CT-proET-1_JJ -RRB-_-RRB- and_CC mid-regional_JJ pro-adrenomedullin_NN -LRB-_-LRB- MR-proADM_NNP -RRB-_-RRB- were_VBD detected_VBN with_IN two_CD new_JJ sandwich_NN immunoassays_NNS -LRB-_-LRB- Sevacon_NNP LIA_NNP and_CC Sevadil_NNP LIA_NNP ,_, respectively_RB ;_: B._NNP S_NNP AG_NNP ,_, Hennigsdorf\/Berlin_NNP ,_, Germany_NNP -RRB-_-RRB- ,_, as_IN described_VBN in_IN detail_NN elsewhere_RB -LRB-_-LRB- Christ-Crain_NNP et_FW al._FW ._. 
2005_CD ;_: Morgenthaler_NNP et_FW al._FW ._. 
2005_CD ;_: Struck_NNP et_FW al._FW ._. 
2005_CD ;_: Papassotiriou_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Briefly_RB ,_, both_DT immunoassays_NNS employ_VBP two_CD polyclonal_JJ antibodies_NNS to_TO the_DT amino_JJ acids_NNS 168_CD 
SAG_NNP ,_, Hennigsdorf\/Berlin_NNP ,_, Germany_NNP -RRB-_-RRB- ,_, as_IN described_VBN in_IN detail_NN elsewhere_RB -LRB-_-LRB- Christ-Crain_NNP et_FW al._FW ._. 
M._NNP H._NNP A._NN 2005_CD ;_: Morgenthaler_NNP et_FW al._FW ._. 
2005_CD ;_: Struck_NNP et_FW al._FW ._. 
2005_CD ;_: Papassotiriou_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Briefly_RB ,_, both_DT immunoassays_NNS employ_VBP two_CD polyclonal_JJ antibodies_NNS to_TO the_DT amino_JJ acids_NNS 168_CD 
08_CD nmol\/L_NNP ,_, respectively_RB ._. 
4and_CD 0_CD ._. 
Briefly_RB ,_, both_DT immunoassays_NNS employ_VBP two_CD polyclonal_JJ antibodies_NNS to_TO the_DT amino_JJ acids_NNS 168_CD 
Similarly_RB ,_, ADM_NNP has_VBZ been_VBN suggested_VBN to_TO serve_VB as_IN an_DT outcome_NN predictor_NN in_IN patients_NNS with_IN SIRS_NNS and_CC sepsis_NNS -LRB-_-LRB- Ueda_FW et_FW al._FW ._. 
1999_CD ;_: Christ-Crain_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
In_IN our_PRP$ study_NN ,_, baseline_JJ MR-proADM_JJ levels_NNS but_CC not_RB ET-1_JJ levels_NNS were_VBD significantly_RB higher_JJR in_IN patients_NNS not_RB surviving_VBG their_PRP$ disease_NN as_IN compared_VBN to_TO those_DT who_WP did_VBD ._. 
Conversely_RB ,_, ADM_NNP is_VBZ a_DT potent_JJ vasodilator_NN ,_, which_WDT assures_VBZ blood_NN supply_NN to_TO the_DT individual_JJ organ_NN and_CC has_VBZ been_VBN shown_VBN to_TO be_VB increased_VBN in_IN systemic_JJ infections_NNS -LRB-_-LRB- Christ-Crain_NNP et_FW al._FW ._. 
2005_CD ,_, 2006_CD -RRB-_-RRB- ._. 
Both_DT peptides_NNS correlate_VBP with_IN mortality_NN and_CC ,_, thus_RB ,_, have_VBP been_VBN put_VBN forward_RB as_IN prognostic_JJ markers_NNS of_IN disease_NN severity_NN in_IN septic_JJ syndrome_NN -LRB-_-LRB- Ueda_FW et_FW al._FW ._. 
1984_CD -RRB-_-RRB- ._. 
The_DT APACHE_NNP II_NNP score_NN was_VBD originally_RB suggested_VBN not_RB to_TO be_VB used_VBN for_IN individual_JJ outcome_NN prediction_NN of_IN sepsis_NN patients_NNS -LRB-_-LRB- Wagner_NNP et_FW al._FW ._. 
The_DT use_NN of_IN the_DT APACHE_NNP II_NNP score_NN for_IN individual_JJ treatment_NN decisions_NNS can_MD be_VB problematic_JJ because_IN of_IN the_DT difficulties_NNS of_IN determining_VBG the_DT score_NN clinically_RB -LRB-_-LRB- Abraham_NNP et_FW al._FW ._. 
2005_CD ;_: Parrillo_NNP 2005_CD -RRB-_-RRB- ._. 
Calculating_VBG clinical_JJ scores_NNS is_VBZ time_NN consuming_NN ,_, sometimes_RB complex_JJ ,_, and_CC shows_VBZ a_DT high_JJ interobserver_NN variability_NN -LRB-_-LRB- Polderman_FW et_FW al._FW ._. 
The_DT study_NN protocol_NN had_VBD prior_JJ approval_NN by_IN the_DT hospital_NN institute_NN ethical_JJ review_NN board_NN ._. 
When_WRB feasible_JJ ,_, consent_NN was_VBD obtained_VBN prior_RB to_TO enrollment_NN in_IN conscious_JJ patients_NNS ;_: otherwise_RB ,_, the_DT consent_NN was_VBD obtained_VBN from_IN the_DT patients_NNS '_POS next_JJ of_IN kin_NN ._. 
Patients_NNS were_VBD classified_VBN at_IN the_DT time_NN of_IN blood_NN collection_NN into_IN sepsis_NN ,_, septic_JJ shock_NN and_CC Systemic_NNP Inflammatory_NNP Response_NNP Syndrome_NNP -LRB-_-LRB- SIRS_NNP -RRB-_-RRB- using_VBG international_JJ ,_, standardized_JJ criteria_NNS -LRB-_-LRB- Bone_FW et_FW al._FW ._. 
1992_CD -RRB-_-RRB- ._. 
In_IN case_NN of_IN uncertainty_NN of_IN infection_NN ,_, a_DT complete_JJ ,_, retrospective_JJ patient_JJ chart_NN review_NN including_VBG results_NNS of_IN microbiological_JJ cultures_NNS ,_, chest_NN radiographs_NNS ,_, and_CC ,_, when_WRB available_JJ ,_, postmortem_JJ examination_NN reports_NNS ,_, was_VBD performed_VBN by_IN an_DT infectious_JJ disease_NN specialist_NN ._. 
However_RB ,_, the_DT methodological_JJ reliability_NN of_IN plasma_NN ET-1_NNP and_CC ADM_NNP measurements_NNS is_VBZ challenging_JJ because_IN of_IN their_PRP$ rapid_JJ clearance_NN from_IN the_DT circulation_NN ,_, limiting_VBG their_PRP$ use_NN in_IN common_JJ practice_NN -LRB-_-LRB- Hinson_NNP et_FW al._FW ._. 
2000_CD ;_: Eto_NNP 2001_CD -RRB-_-RRB- ._. 
Therefore_RB ,_, new_JJ sandwich_NN assays_NNS have_VBP been_VBN introduced_VBN that_IN measure_NN the_DT more_RBR stable_JJ precursor_NN fragments_NNS CT-proET-1_NNP and_CC MR-proADM_NNP ._. 
The_DT measurement_NN of_IN mature_NNP ADM_NNP is_VBZ technically_RB challenging_JJ and_CC the_DT reliable_JJ measurement_NN almost_RB impossible_JJ ,_, because_IN it_PRP is_VBZ rapidly_RB cleared_VBN from_IN the_DT circulation_NN -LRB-_-LRB- Hinson_NNP et_FW al._FW ._. 
2000_CD ;_: Eto_NNP 2001_CD -RRB-_-RRB- ._. 
Recently_RB ,_, the_DT more_RBR stable_JJ mid-regional_JJ fragment_NN of_IN pro-adrenomedullin_NN -LRB-_-LRB- MR-proADM_NNP -RRB-_-RRB- comprising_VBG amino_JJ acids_NNS 45_CD to_TO 92_CD ,_, which_WDT directly_RB reflects_VBZ levels_NNS of_IN the_DT rapidly_RB degraded_JJ active_JJ peptide_NN ADM_NNP ,_, was_VBD identified_VBN in_IN the_DT plasma_NN of_IN patients_NNS with_IN septic_JJ shock_NN -LRB-_-LRB- Struck_FW et_FW al._FW ._. 
In_IN sepsis_NN ,_, microorganisms_NNS entering_VBG the_DT bloodstream_NN may_MD release_VB their_PRP$ toxins_NNS ,_, resulting_VBG in_IN a_DT host-derived_JJ mediator_NN response_NN activating_VBG an_DT inflammatory_JJ cascade_NN of_IN various_JJ peptides_NNS ._. 
Accumulating_VBG evidence_NN indicates_VBZ a_DT major_JJ role_NN for_IN different_JJ vasoactive_JJ substances_NNS causing_VBG dysregulation_NN of_IN the_DT endothelium_NN and_CC consecutive_JJ collapse_NN of_IN blood_NN pressure_NN and_CC microvascular_JJ homeostasis_NN -LRB-_-LRB- Grandel_FW et_FW al._FW ._. 
2003_CD ;_: Peters_NNP et_FW al._FW ._. 
2003_CD -RRB-_-RRB- ._. 
The_DT two_CD endothelium-derived_JJ peptides_NNS ET-1_NNP and_CC ADM_NNP have_VBP been_VBN suggested_VBN as_IN two_CD pivotal_JJ mediators_NNS in_IN this_DT process_NN of_IN vascular_JJ tone_NN regulation_NN ._. 
Details_NNS of_IN the_DT characteristics_NNS of_IN the_DT study_NN population_NN ,_, study_NN design_NN ,_, the_DT diagnostic_JJ criteria_NNS ,_, and_CC the_DT levels_NNS of_IN different_JJ markers_NNS of_IN inflammation_NN and_CC infection_NN have_VBP been_VBN reported_VBN in_IN detail_NN -LRB-_-LRB- Muller_NNP et_FW al._FW ._. 
2000a_CD ,_, 2000b_CD ,_, 2001_CD ,_, 2002_CD ;_: Christ-Crain_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Briefly_RB ,_, over_IN a_DT 9-month_JJ period_NN ,_, 101_CD consecutive_JJ patients_NNS ,_, including_VBG neutropenic_JJ and_CC immunosuppressed_JJ patients_NNS ,_, admitted_VBN to_TO the_DT medical_JJ ICU_NNP were_VBD included_VBN ._. 
Details_NNS of_IN the_DT characteristics_NNS of_IN the_DT study_NN population_NN ,_, study_NN design_NN ,_, the_DT diagnostic_JJ criteria_NNS ,_, and_CC the_DT levels_NNS of_IN different_JJ markers_NNS of_IN inflammation_NN and_CC infection_NN have_VBP been_VBN reported_VBN in_IN detail_NN -LRB-_-LRB- Muller_NNP et_FW al._FW ._. 
2000a_CD ,_, 2000b_CD ,_, 2001_CD ,_, 2002_CD ;_: Christ-Crain_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Briefly_RB ,_, over_IN a_DT 9-month_JJ period_NN ,_, 101_CD consecutive_JJ patients_NNS ,_, including_VBG neutropenic_JJ and_CC immunosuppressed_JJ patients_NNS ,_, admitted_VBN to_TO the_DT medical_JJ ICU_NNP were_VBD included_VBN ._. 
2005_CD ;_: Morgenthaler_NNP et_FW al._FW ._. 
SAG_NNP ,_, Hennigsdorf\/Berlin_NNP ,_, Germany_NNP -RRB-_-RRB- ,_, as_IN described_VBN in_IN detail_NN elsewhere_RB -LRB-_-LRB- Christ-Crain_NNP et_FW al._FW ._. 
2005_CD ;_: Struck_NNP et_FW al._FW ._. 
2005_CD ;_: Papassotiriou_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Briefly_RB ,_, both_DT immunoassays_NNS employ_VBP two_CD polyclonal_JJ antibodies_NNS to_TO the_DT amino_JJ acids_NNS 168_CD 
The_DT primary_JJ end_NN point_NN was_VBD the_DT assessment_NN of_IN the_DT prognostic_JJ value_NN of_IN endocrine_NN dysfunctions_NNS in_IN critically_RB ill_JJ patients_NNS -LRB-_-LRB- 
Endothelin-1_NNP -LRB-_-LRB- ET-1_NNP -RRB-_-RRB- and_CC adrenomedullin_JJ -LRB-_-LRB- ADM_NNP -RRB-_-RRB- ,_, two_CD endothelium-derived_JJ vasoactive_JJ peptides_NNS ,_, have_VBP attracted_VBN interest_NN as_IN physiological_JJ key_JJ mediators_NNS in_IN vascular_JJ tone_NN regulation_NN in_IN sepsis_NN and_CC cardiovascular_JJ disease_NN -LRB-_-LRB- Levin_NNP 1995_CD ;_: Hinson_NNP et_FW al._FW ._. 
2000_CD ;_: Landry_NNP et_NNP al._NNP ._. 
2004_CD ;_: Christ-Crain_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
ET-1_NNP ,_, a_DT 21_CD 
Endothelin-1_NNP Adrenomedullin_NNP Ratio_NNP ICU_NNP Sepsis_VBZ The_DT main_JJ cause_NN of_IN death_NN in_IN patients_NNS with_IN sepsis_NN is_VBZ multiple_JJ organ_NN failure_NN and_CC volume_NN refractory_JJ hypotension_NN ,_, which_WDT are_VBP frequently_RB complicated_VBN by_IN impaired_JJ tissue_NN perfusion_NN and_CC myocardial_JJ depression_NN ._. 
Endothelin-1_NNP -LRB-_-LRB- ET-1_NNP -RRB-_-RRB- and_CC adrenomedullin_JJ -LRB-_-LRB- ADM_NNP -RRB-_-RRB- ,_, two_CD endothelium-derived_JJ vasoactive_JJ peptides_NNS ,_, have_VBP attracted_VBN interest_NN as_IN physiological_JJ key_JJ mediators_NNS in_IN vascular_JJ tone_NN regulation_NN in_IN sepsis_NN and_CC cardiovascular_JJ disease_NN -LRB-_-LRB- Levin_NNP 1995_CD ;_: Hinson_NNP et_FW al._FW ._. 
2000_CD ;_: Landry_NNP et_NNP al._NNP ._. 
2004_CD ;_: Christ-Crain_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
ET-1_NNP ,_, a_DT 21_CD 
2005_CD -RRB-_-RRB- ._. 
2004_CD ;_: Christ-Crain_NNP et_FW al._FW ._. 
2000_CD ;_: Landry_NNP et_NNP al._NNP ._. 
Endothelin-1_NNP -LRB-_-LRB- ET-1_NNP -RRB-_-RRB- and_CC adrenomedullin_JJ -LRB-_-LRB- ADM_NNP -RRB-_-RRB- ,_, two_CD endothelium-derived_JJ vasoactive_JJ peptides_NNS ,_, have_VBP attracted_VBN interest_NN as_IN physiological_JJ key_JJ mediators_NNS in_IN vascular_JJ tone_NN regulation_NN in_IN sepsis_NN and_CC cardiovascular_JJ disease_NN -LRB-_-LRB- Levin_NNP 1995_CD ;_: Hinson_NNP et_FW al._FW ._. 
ET-1_NNP ,_, a_DT 21_CD 
Endothelin-1_NNP Adrenomedullin_NNP Ratio_NNP ICU_NNP Sepsis_VBZ The_DT main_JJ cause_NN of_IN death_NN in_IN patients_NNS with_IN sepsis_NN is_VBZ multiple_JJ organ_NN failure_NN and_CC volume_NN refractory_JJ hypotension_NN ,_, which_WDT are_VBP frequently_RB complicated_VBN by_IN impaired_JJ tissue_NN perfusion_NN and_CC myocardial_JJ depression_NN ._. 
Endothelin-1_NNP -LRB-_-LRB- ET-1_NNP -RRB-_-RRB- and_CC adrenomedullin_JJ -LRB-_-LRB- ADM_NNP -RRB-_-RRB- ,_, two_CD endothelium-derived_JJ vasoactive_JJ peptides_NNS ,_, have_VBP attracted_VBN interest_NN as_IN physiological_JJ key_JJ mediators_NNS in_IN vascular_JJ tone_NN regulation_NN in_IN sepsis_NN and_CC cardiovascular_JJ disease_NN -LRB-_-LRB- Levin_NNP 1995_CD ;_: Hinson_NNP et_FW al._FW ._. 
2000_CD ;_: Landry_NNP et_NNP al._NNP ._. 
2004_CD ;_: Christ-Crain_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
ET-1_NNP ,_, a_DT 21_CD 
2000_CD -RRB-_-RRB- ._. 
1999_CD ;_: Brauner_NNP et_FW al._FW ._. 
Both_DT peptides_NNS correlate_VBP with_IN mortality_NN and_CC ,_, thus_RB ,_, have_VBP been_VBN put_VBN forward_RB as_IN prognostic_JJ markers_NNS of_IN disease_NN severity_NN in_IN septic_JJ syndrome_NN -LRB-_-LRB- Ueda_FW et_FW al._FW ._. 
However_RB ,_, the_DT methodological_JJ reliability_NN of_IN plasma_NN ET-1_NNP and_CC ADM_NNP measurements_NNS is_VBZ challenging_JJ because_IN of_IN their_PRP$ rapid_JJ clearance_NN from_IN the_DT circulation_NN ,_, limiting_VBG their_PRP$ use_NN in_IN common_JJ practice_NN -LRB-_-LRB- Hinson_NNP et_FW al._FW ._. 
2000_CD ;_: Eto_NNP 2001_CD -RRB-_-RRB- ._. 
Therefore_RB ,_, new_JJ sandwich_NN assays_NNS have_VBP been_VBN introduced_VBN that_IN measure_NN the_DT more_RBR stable_JJ precursor_NN fragments_NNS CT-proET-1_NNP and_CC MR-proADM_NNP ._. 
The_DT two_CD endothelium-derived_JJ peptides_NNS ET-1_NNP and_CC ADM_NNP have_VBP been_VBN suggested_VBN as_IN two_CD pivotal_JJ mediators_NNS in_IN this_DT process_NN of_IN vascular_JJ tone_NN regulation_NN ._. 
ADM_NNP contributes_VBZ to_TO the_DT extensive_JJ vasodilatation_NN and_CC hypotension_NN often_RB seen_VBN in_IN severe_JJ sepsis_NN and_CC especially_RB in_IN septic_JJ shock_NN -LRB-_-LRB- Hinson_NNP et_FW al._FW ._. 
2000_CD ;_: Struck_NNP et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
Conversely_RB ,_, with_IN its_PRP$ potent_JJ vasoconstrictor_NN properties_NNS ,_, the_DT vascular_JJ tissue-wide_JJ production_NN of_IN ET-1_NNP counteracts_VBZ this_DT vasodilatation_NN and_CC hypotension_NN and_CC therefore_RB assures_VBZ blood_NN pressure_NN homeostasis_NN and_CC blood_NN supply_NN to_TO the_DT individual_JJ organs_NNS -LRB-_-LRB- Kedzierski_NNP et_FW al._FW ._. 
For_IN the_DT same_JJ reasons_NNS we_PRP measured_VBD MR-proADM_NNP instead_RB of_IN mature_NNP ADM._NNP Importantly_NNP ,_, CT-proET-1_JJ fragments_NNS are_VBP produced_VBN in_IN a_DT stoichiometrical_JJ ratio_NN to_TO ET-1_NN and_CC can_MD thus_RB be_VB used_VBN to_TO indirectly_RB assess_VB the_DT release_NN of_IN ET-1_NN in_IN physiological_JJ and_CC pathological_JJ conditions_NNS ._. 
The_DT measurement_NN of_IN mature_NNP ADM_NNP is_VBZ technically_RB challenging_JJ and_CC the_DT reliable_JJ measurement_NN almost_RB impossible_JJ ,_, because_IN it_PRP is_VBZ rapidly_RB cleared_VBN from_IN the_DT circulation_NN -LRB-_-LRB- Hinson_NNP et_FW al._FW ._. 
2000_CD ;_: Eto_NNP 2001_CD -RRB-_-RRB- ._. 
Recently_RB ,_, the_DT more_RBR stable_JJ mid-regional_JJ fragment_NN of_IN pro-adrenomedullin_NN -LRB-_-LRB- MR-proADM_NNP -RRB-_-RRB- comprising_VBG amino_JJ acids_NNS 45_CD to_TO 92_CD ,_, which_WDT directly_RB reflects_VBZ levels_NNS of_IN the_DT rapidly_RB degraded_JJ active_JJ peptide_NN ADM_NNP ,_, was_VBD identified_VBN in_IN the_DT plasma_NN of_IN patients_NNS with_IN septic_JJ shock_NN -LRB-_-LRB- Struck_FW et_FW al._FW ._. 
2004_CD -RRB-_-RRB- ._. 
2000_CD ;_: Struck_NNP et_FW al._FW ._. 
ADM_NNP contributes_VBZ to_TO the_DT extensive_JJ vasodilatation_NN and_CC hypotension_NN often_RB seen_VBN in_IN severe_JJ sepsis_NN and_CC especially_RB in_IN septic_JJ shock_NN -LRB-_-LRB- Hinson_NNP et_FW al._FW ._. 
Conversely_RB ,_, with_IN its_PRP$ potent_JJ vasoconstrictor_NN properties_NNS ,_, the_DT vascular_JJ tissue-wide_JJ production_NN of_IN ET-1_NNP counteracts_VBZ this_DT vasodilatation_NN and_CC hypotension_NN and_CC therefore_RB assures_VBZ blood_NN pressure_NN homeostasis_NN and_CC blood_NN supply_NN to_TO the_DT individual_JJ organs_NNS -LRB-_-LRB- Kedzierski_NNP et_FW al._FW ._. 
2001_CD -RRB-_-RRB- ._. 
Accordingly_RB ,_, in_IN our_PRP$ study_NN both_DT precursor_NN peptides_NNS were_VBD markedly_RB increased_VBN in_IN different_JJ severities_NNS of_IN sepsis_NN and_CC both_DT substances_NNS correlated_VBN with_IN mean_JJ blood_NN pressure_NN ._. 
Details_NNS of_IN the_DT characteristics_NNS of_IN the_DT study_NN population_NN ,_, study_NN design_NN ,_, the_DT diagnostic_JJ criteria_NNS ,_, and_CC the_DT levels_NNS of_IN different_JJ markers_NNS of_IN inflammation_NN and_CC infection_NN have_VBP been_VBN reported_VBN in_IN detail_NN -LRB-_-LRB- Muller_NNP et_FW al._FW ._. 
2000a_CD ,_, 2000b_CD ,_, 2001_CD ,_, 2002_CD ;_: Christ-Crain_NNP et_FW al._FW ._. 
2005_CD -RRB-_-RRB- ._. 
Briefly_RB ,_, over_IN a_DT 9-month_JJ period_NN ,_, 101_CD consecutive_JJ patients_NNS ,_, including_VBG neutropenic_JJ and_CC immunosuppressed_JJ patients_NNS ,_, admitted_VBN to_TO the_DT medical_JJ ICU_NNP were_VBD included_VBN ._. 
2005_CD ;_: Struck_NNP et_FW al._FW ._. 
2005_CD ;_: Morgenthaler_NNP et_FW al._FW ._. 
SAG_NNP ,_, Hennigsdorf\/Berlin_NNP ,_, Germany_NNP -RRB-_-RRB- ,_, as_IN described_VBN in_IN detail_NN elsewhere_RB -LRB-_-LRB- Christ-Crain_NNP et_FW al._FW ._. 
2005_CD ;_: Papassotiriou_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Briefly_RB ,_, both_DT immunoassays_NNS employ_VBP two_CD polyclonal_JJ antibodies_NNS to_TO the_DT amino_JJ acids_NNS 168_CD 
Values_NNS for_IN both_DT analytes_NNS followed_VBD a_DT Gaussian_JJ distribution_NN in_IN healthy_JJ individuals_NNS without_IN significant_JJ differences_NNS between_IN males_NNS and_CC females_NNS -LRB-_-LRB- Morgenthaler_NNP et_FW al._FW ._. 
2005_CD ;_: Papassotiriou_NNP et_FW al._FW ._. 
2006_CD -RRB-_-RRB- ._. 
Procalcitonin_NNP was_VBD measured_VBN using_VBG LUMITest_NNP PCT_NNP -LRB-_-LRB- B._NNP R._NNP A._NN H._NNP M._NNP S_NNP AG_NNP -RRB-_-RRB- with_IN a_DT functional_JJ assay_NN sensitivity_NN of_IN around_IN 0_CD ._. 
1994_CD -RRB-_-RRB- ._. 
ET-1_NN originates_VBZ from_IN a_DT larger_JJR precursor_NN peptide_NN ,_, which_WDT is_VBZ first_RB proteolytically_RB processed_VBN to_TO big_JJ ET-1_NN and_CC further_RB excised_VBN by_IN the_DT action_NN of_IN endothelin-converting_JJ enzyme_NN -LRB-_-LRB- Rongen_NNP et_FW al._FW ._. 
In_IN this_DT study_NN the_DT precursor_NN fragment_NN of_IN ET-1_NN was_VBD chosen_VBN to_TO monitor_VB ,_, because_IN pro-ET-1_JJ fragments_NNS can_MD be_VB detected_VBN for_IN hours_NNS after_IN its_PRP$ cleavage_NN in_IN the_DT circulation_NN ,_, in_IN contrast_NN to_TO ET-1_NNP ,_, which_WDT is_VBZ eliminated_VBN within_IN minutes_NNS and_CC therefore_RB escapes_VBZ detection_NN in_IN clinical_JJ routine_NN -LRB-_-LRB- Weitzberg_FW et_FW al._FW ._. 
1991_CD -RRB-_-RRB- ._. 
Importantly_RB ,_, CT-proET-1_JJ fragments_NNS are_VBP produced_VBN in_IN a_DT stoichiometrical_JJ ratio_NN to_TO ET-1_NN and_CC can_MD thus_RB be_VB used_VBN to_TO indirectly_RB assess_VB the_DT release_NN of_IN ET-1_NN in_IN physiological_JJ and_CC pathological_JJ conditions_NNS ._. 
2G_CD -RRB-_-RRB- from_IN the_DT oxidative_JJ pyrolysis_NN of_IN tobacco_NN ,_, which_WDT are_VBP surface-associated_JJ or_CC bulk_JJ polymeric_JJ ,_, carbon-centered_JJ radicals_NNS containing_VBG vicinal_JJ oxygen_NN ._. 
20,21_CD Figure_NN 4_CD shows_NNS the_DT relation_NN between_IN the_DT intensity_NN of_IN radicals_NNS and_CC the_DT percentage_NN of_IN elemental_JJ carbon_NN in_IN the_DT PM_NN from_IN wood_NN and_CC coal_NN combustion_NN ._. 
The_DT strong_JJ correlation_NN between_IN intensities_NNS of_IN free_JJ radical_JJ and_CC elemental_JJ carbon_NN -LRB-_-LRB- R_NNP =_SYM 0_CD ._. 
87_CD ,_, p_SYM 
2G_CD -RRB-_-RRB- from_IN the_DT oxidative_JJ pyrolysis_NN of_IN tobacco_NN ,_, which_WDT are_VBP surface-associated_JJ or_CC bulk_JJ polymeric_JJ ,_, carbon-centered_JJ radicals_NNS containing_VBG vicinal_JJ oxygen_NN ._. 
20,21_CD Figure_NN 4_CD shows_NNS the_DT relation_NN between_IN the_DT intensity_NN of_IN radicals_NNS and_CC the_DT percentage_NN of_IN elemental_JJ carbon_NN in_IN the_DT PM_NN from_IN wood_NN and_CC coal_NN combustion_NN ._. 
The_DT strong_JJ correlation_NN between_IN intensities_NNS of_IN free_JJ radical_JJ and_CC elemental_JJ carbon_NN -LRB-_-LRB- R_NNP =_SYM 0_CD ._. 
87_CD ,_, p_SYM 
0039_CD ,_, over_IN that_DT of_IN purely_RB carbon-centered_JJ radicals_NNS may_MD indicate_VB the_DT presence_NN of_IN the_DT vicinal_JJ oxygen_NN heteroatom_NN ._. 
While_IN oxygen-centered_JJ radicals_NNS are_VBP the_DT most_RBS studied_VBN and_CC are_VBP involved_VBN in_IN the_DT pathogenesis_NN of_IN many_JJ pulmonary_JJ diseases_NNS ,_, -LRB-_-LRB- 22_CD -RRB-_-RRB- carbon-centered_JJ free_JJ radicals_NNS may_MD be_VB also_RB reactive_JJ to_TO living_NN cells_NNS and_CC thus_RB important_JJ in_IN biology_NN ._. 
The_DT redox_NN and_CC biological_JJ activities_NNS of_IN these_DT carbon-centered_JJ radicals_NNS are_VBP worthy_JJ of_IN evaluation_NN ._. 
Figure_NN 4_CD Relation_NN between_IN the_DT radical_JJ intensities_NNS and_CC percentage_NN of_IN elemental_JJ carbon_NN in_IN the_DT PM_NNP emissions_NNS from_IN wood_NN and_CC coal_NN combustion_NN ._. 
The_DT contrast_NN here_RB may_MD reflect_VB the_DT effects_NNS of_IN different_JJ source_NN materials_NNS ,_, thermal_JJ treatment_NN procedures_NNS ,_, and_CC sample_NN storage_NN conditions_NNS ._. 
One_CD possible_JJ reason_NN for_IN the_DT decrease_NN of_IN radical_JJ intensities_NNS within_IN the_DT first_JJ two_CD months_NNS of_IN the_DT storage_NN time_NN is_VBZ the_DT 
-LRB-_-LRB- 13_CD -RRB-_-RRB- The_DT intensity_NN of_IN unpaired_JJ electron_JJ EPR_NNP signals_NNS in_IN charcoal_JJ produced_VBN today_NN is_VBZ comparable_JJ to_TO that_DT found_VBN in_IN the_DT pyramids_NNS in_IN Egypt_NNP ._. 
-LRB-_-LRB- 9_CD -RRB-_-RRB- Some_DT radicals_NNS found_VBN in_IN cigarette_NN tar_NN have_VBP an_DT essentially_RB infinite_JJ lifetime_NN ._. 
-LRB-_-LRB- 14_CD -RRB-_-RRB- Radicals_NNPS on_IN PM_NNP 2_CD ._. 
5collected_VBN from_IN urban_JJ air_NN are_VBP remarkably_RB persistent_JJ and_CC can_MD be_VB observed_VBN in_IN samples_NNS that_WDT had_VBD been_VBN stored_VBN for_IN several_JJ months_NNS ._. 
It_PRP has_VBZ been_VBN claimed_VBN that_IN free_JJ radicals_NNS are_VBP generated_VBN during_IN the_DT thermal_JJ breaking_NN down_IN of_IN the_DT carbon_NN 
Decay_NN of_IN thermally_RB generated_VBN free_JJ radicals_NNS in_IN nuts_NNS was_VBD studied_VBN by_IN Yordanov_NNP ._. 
It_PRP was_VBD likely_JJ that_IN an_DT even_RB sharper_JJR decrease_NN already_RB occurred_VBD before_IN the_DT first_JJ EPR_NNP measurement_NN at_IN day_NN 9_CD ._. 
-LRB-_-LRB- 8_CD -RRB-_-RRB- Free_JJ radical_JJ intensity_NN in_IN thermally_RB treated_VBN flakes_NNS of_IN almond_NN decreased_VBN over_IN time_NN :_: a_DT sharp_JJ decrease_NN by_IN 50_CD %_NN was_VBD observed_VBN in_IN the_DT first_JJ two_CD days_NNS and_CC remains_VBZ practically_RB unchanged_JJ over_IN a_DT period_NN of_IN 15_CD days_NNS ._. 
It_PRP took_VBD only_RB two_CD days_NNS for_IN the_DT radical_JJ intensity_NN to_TO stabilize_VB in_IN the_DT study_NN of_IN almond_JJ nuts_NNS ,_, while_IN in_IN the_DT present_JJ study_NN of_IN wood_NN and_CC coal_NN emissions_NNS it_PRP took_VBD two_CD months_NNS ._. 
The_DT redox_NN and_CC biology_NN activities_NNS of_IN these_DT carbon-centered_JJ radicals_NNS are_VBP worthy_JJ of_IN evaluation_NN ._. 
0039_CD ,_, over_IN that_DT of_IN purely_RB carbon-centered_JJ radicals_NNS may_MD indicate_VB the_DT presence_NN of_IN vicinal_JJ oxygen_NN heteroatom_NN ._. 
National_NNP Institutes_NNPS of_IN Health_NNP ,_, United_NNP Statesdocument-id-old-9ef8010096document-id-new-14ef-2008-010096IntroductionAlthough_NNP extensive_JJ epidemiological_JJ evidence_NN associates_NNS airborne_JJ particulate_NN matter_NN -LRB-_-LRB- PM_NNP -RRB-_-RRB- with_IN increases_NNS in_IN human_JJ mortality_NN ,1,2_CD the_DT mechanisms_NNS of_IN PM-related_JJ health_NN effects_NNS are_VBP still_RB incompletely_RB understood_VBN ._. 
One_CD mechanistic_JJ hypothesis_NN for_IN PM_NNP injury_NN is_VBZ the_DT ability_NN of_IN certain_JJ PM_NNP properties_NNS to_TO induce_VB oxidative_JJ stress_NN ,_, which_WDT refers_VBZ to_TO the_DT situation_NN of_IN a_DT serious_JJ imbalance_NN between_IN the_DT production_NN of_IN reactive_JJ oxygen_NN species_NNS -LRB-_-LRB- ROS_NNP -RRB-_-RRB- and_CC antioxidant_JJ defense_NN ._. 
Most_JJS previous_JJ studies_NNS on_IN PM-induced_JJ oxidative_JJ stress_NN have_VBP not_RB made_VBN the_DT difficult_JJ distinction_NN between_IN endogenous_JJ and_CC exogenous_JJ sources_NNS of_IN free_JJ radicals_NNS ,_, so_IN the_DT contribution_NN of_IN each_DT source_NN to_TO the_DT PM_NNP effect_NN is_VBZ unknown_JJ ._. 
-LRB-_-LRB- 3_CD -RRB-_-RRB- To_TO differentiate_VB the_DT contribution_NN of_IN each_DT source_NN to_TO the_DT PM_NNP effects_NNS ,_, we_PRP need_VBP to_TO first_RB measure_VB the_DT free_JJ radicals_NNS that_WDT already_RB exist_VBP on_IN the_DT particles_NNS before_RB inhaled_VBD ._. 
This_DT is_VBZ particularly_RB important_JJ for_IN combustion-generated_JJ carbonaceous_JJ particles_NNS ,_, which_WDT may_MD contain_VB not_RB only_JJ transition_NN metals_NNS and_CC polycyclic_JJ aromatic_JJ hydrocarbons_NNS -LRB-_-LRB- PAHs_NNS -RRB-_-RRB- that_WDT are_VBP responsible_JJ for_IN in_IN situ_NN production_NN of_IN free_JJ radicals_NNS in_IN the_DT lung_NN but_CC also_RB free_JJ radicals_NNS in_IN the_DT PM_NNP itself_PRP ._. 
The_DT redox_NN and_CC biology_NN activities_NNS of_IN these_DT carbon-centered_JJ radicals_NNS are_VBP worthy_JJ of_IN evaluation_NN ._. 
0039_CD ,_, over_IN that_DT of_IN purely_RB carbon-centered_JJ radicals_NNS may_MD indicate_VB the_DT presence_NN of_IN vicinal_JJ oxygen_NN heteroatom_NN ._. 
National_NNP Institutes_NNPS of_IN Health_NNP ,_, United_NNP Statesdocument-id-old-9ef8010096document-id-new-14ef-2008-010096IntroductionAlthough_NNP extensive_JJ epidemiological_JJ evidence_NN associates_NNS airborne_JJ particulate_NN matter_NN -LRB-_-LRB- PM_NNP -RRB-_-RRB- with_IN increases_NNS in_IN human_JJ mortality_NN ,1,2_CD the_DT mechanisms_NNS of_IN PM-related_JJ health_NN effects_NNS are_VBP still_RB incompletely_RB understood_VBN ._. 
One_CD mechanistic_JJ hypothesis_NN for_IN PM_NNP injury_NN is_VBZ the_DT ability_NN of_IN certain_JJ PM_NNP properties_NNS to_TO induce_VB oxidative_JJ stress_NN ,_, which_WDT refers_VBZ to_TO the_DT situation_NN of_IN a_DT serious_JJ imbalance_NN between_IN the_DT production_NN of_IN reactive_JJ oxygen_NN species_NNS -LRB-_-LRB- ROS_NNP -RRB-_-RRB- and_CC antioxidant_JJ defense_NN ._. 
Experimental_JJ Section_NNP Combustion_NNP Experiment_NNP and_CC Air_NNP SamplingThe_NNP experimental_JJ methods_NNS for_IN combustion_NN and_CC air_NN sampling_NN were_VBD reported_VBN elsewhere5_CD ,6_CD and_CC are_VBP only_RB summarized_VBN here_RB ._. 
Fifteen_CD types_NNS of_IN coal_NN -LRB-_-LRB- 12_CD bituminous_NNS and_CC 3_CD anthracite_NN -RRB-_-RRB- and_CC two_CD wood_NN samples_NNS -LRB-_-LRB- one_CD kindling_NN wood_NN Fatwood_NNP StarterStix_NNP and_CC another_DT oven-dried_JJ pine_VBP wood_NN sample_NN -RRB-_-RRB- were_VBD burned_VBN under_IN controlled_JJ conditions_NNS in_IN the_DT laboratory_NN to_TO measure_VB the_DT gaseous_JJ and_CC particulate_JJ emissions_NNS ._. 
The_DT coal_NN samples_NNS were_VBD taken_VBN from_IN Xuan_NNP Wei_NNP ,_, China_NNP ,_, where_WRB the_DT extremely_RB high_JJ indoor_JJ air_NN pollution_NN due_JJ to_TO bituminous_JJ coal_NN combustion_NN was_VBD linked_VBN to_TO the_DT highest_JJS women_NNS lung_NN cancer_NN rate_NN of_IN China_NNP ._. 
-LRB-_-LRB- 4_CD -RRB-_-RRB- We_PRP explored_VBD the_DT effects_NNS of_IN sample_NN storage_NN time_NN and_CC fuel_NN type_NN on_IN the_DT measurements_NNS of_IN free_JJ radicals_NNS in_IN PM_NNP emissions_NNS ._. 
Experimental_JJ Section_NNP Combustion_NNP Experiment_NN and_CC Air_NN Sampling_VBG The_DT experimental_JJ methods_NNS for_IN combustion_NN and_CC air_NN sampling_NN were_VBD reported_VBN elsewhere_RB 5_CD ,_, 6_CD and_CC are_VBP only_RB summarized_VBN here_RB ._. 
An_DT open_JJ fire_NN was_VBD assembled_VBN with_IN firebricks_NNS to_TO simulate_VB the_DT household_NN fire_NN pit_NN used_VBN in_IN Xuan_NNP Wei_NNP ,_, China_NNP ,_, where_WRB the_DT extremely_RB high_JJ indoor_JJ air_NN pollution_NN was_VBD linked_VBN to_TO the_DT highest_JJS female_JJ lung_NN cancer_NN rate_NN of_IN China_NNP ._. 
-LRB-_-LRB- 4_CD -RRB-_-RRB- The_DT combustion_NN experiment_NN involves_VBZ heating_NN 1_CD ._. 
5kg_CD of_IN water_NN from_IN ambient_JJ temperature_NN to_TO boiling_VBG ,_, kept_VBD simmering_VBG for_IN 10_CD min_NN ._. 
Air_NNP is_VBZ drawn_VBN from_IN the_DT exhaust_NN duct_NN through_IN 1\/4_CD in_IN ._. 
526_CD cm_NN 2_CD punch_NN aliquot_NN of_IN a_DT filter_NN stepwise_NN in_IN a_DT nonoxidizing_JJ helium_NN -LRB-_-LRB- He_PRP -RRB-_-RRB- atmosphere_NN to_TO measure_VB organic_JJ carbon_NN and_CC in_IN an_DT oxidizing_VBG atmosphere_NN of_IN 2_CD %_NN oxygen_NN in_IN a_DT balance_NN of_IN helium_NN to_TO measure_VB elemental_JJ carbon_NN ._. 
-LRB-_-LRB- 7_CD -RRB-_-RRB- Free_NNP Radical_NNP Analysis_NNP Electron_NNP paramagnetic_JJ resonance_NN -LRB-_-LRB- EPR_NNP -RRB-_-RRB- spectroscopy_NN analysis_NN was_VBD carried_VBN out_RP using_VBG the_DT standard_JJ continuous_JJ wave_NN method_NN in_IN which_WDT the_DT microwave_NN frequency_NN ,_, v_NN ,_, is_VBZ held_VBN constant_JJ and_CC the_DT magnetic_JJ field_NN strength_NN ,_, H_NNP ,_, is_VBZ swept_VBN ._. 
Experimental_JJ Section_NNP Combustion_NNP Experiment_NNP and_CC Air_NNP SamplingThe_NNP experimental_JJ methods_NNS for_IN combustion_NN and_CC air_NN sampling_NN were_VBD reported_VBN elsewhere5_CD ,6_CD and_CC are_VBP only_RB summarized_VBN here_RB ._. 
Fifteen_CD types_NNS of_IN coal_NN -LRB-_-LRB- 12_CD bituminous_NNS and_CC 3_CD anthracite_NN -RRB-_-RRB- and_CC two_CD wood_NN samples_NNS -LRB-_-LRB- one_CD kindling_NN wood_NN Fatwood_NNP StarterStix_NNP and_CC another_DT oven-dried_JJ pine_VBP wood_NN sample_NN -RRB-_-RRB- were_VBD burned_VBN under_IN controlled_JJ conditions_NNS in_IN the_DT laboratory_NN to_TO measure_VB the_DT gaseous_JJ and_CC particulate_JJ emissions_NNS ._. 
Over_IN 90_CD %_NN of_IN the_DT particulate_JJ mass_NN was_VBD attributed_VBN to_TO submicrometer_NN particles_NNS ._. 
Filter_NNP samples_NNS were_VBD stored_VBN in_IN 
These_DT radicals_NNS are_VBP inactive_JJ and_CC chemically_RB stable_JJ due_JJ to_TO the_DT delocalization_NN of_IN the_DT unpaired_JJ electron_NN over_IN many_JJ conjugated_JJ or_CC aromatic_JJ chemical_NN bonds_NNS ._. 
-LRB-_-LRB- 11_CD -RRB-_-RRB- The_DT lifetime_NN of_IN some_DT unpaired_JJ electrons_NNS ,_, strongly_RB delocalized_VBN over_IN the_DT condensed_JJ aromatic_JJ rings_NNS in_IN charcoal_NN or_CC coal_NN ,_, can_MD be_VB extremely_RB long_JJ ._. 
-LRB-_-LRB- 12_CD -RRB-_-RRB- Autopsy_NNP lung_NN tissue_NN from_IN coal_NN miners_NNS exhibited_VBD similar_JJ free_JJ radical_JJ activity_NN as_IN that_DT of_IN coal_NN dust_NN ._. 
The_DT contrast_NN here_RB may_MD reflect_VB the_DT effects_NNS of_IN different_JJ source_NN materials_NNS ,_, thermal_JJ treatment_NN procedures_NNS ,_, and_CC sample_NN storage_NN conditions_NNS ._. 
One_CD possible_JJ reason_NN for_IN the_DT decrease_NN of_IN radical_JJ intensities_NNS within_IN the_DT first_JJ two_CD months_NNS of_IN the_DT storage_NN time_NN is_VBZ the_DT 
Chemical_NNP Speciation_NNP of_IN Radicals_NNPS The_DT g_NN -_: factors_NNS of_IN EPR_NNP spectra_NN can_MD be_VB used_VBN to_TO assess_VB whether_IN a_DT radical_JJ is_VBZ carbon-centered_JJ or_CC oxygen-centered_JJ :_: whether_IN the_DT unpaired_JJ electron_NN is_VBZ located_VBN on_IN a_DT carbon_NN or_CC oxygen_NN atom_NN ._. 
10,19_CD Carbon-centered_JJ radicals_NNS with_IN an_DT adjacent_JJ oxygen_NN atom_NN have_VBP higher_JJR g-factors_NNS in_IN the_DT range_NN of_IN 2_CD ._. 
003_CD 
0G._CD 3_CD 
-LRB-_-LRB- 12_CD -RRB-_-RRB- Autopsy_NNP lung_NN tissue_NN from_IN coal_NN miners_NNS exhibited_VBD similar_JJ free_JJ radical_JJ activity_NN as_IN that_DT of_IN coal_NN dust_NN ._. 
-LRB-_-LRB- 13_CD -RRB-_-RRB- The_DT intensity_NN of_IN unpaired_JJ electron_JJ EPR_NNP signals_NNS in_IN charcoal_JJ produced_VBN today_NN is_VBZ comparable_JJ to_TO that_DT found_VBN in_IN the_DT pyramids_NNS in_IN Egypt_NNP ._. 
-LRB-_-LRB- 9_CD -RRB-_-RRB- Some_DT radicals_NNS found_VBN in_IN cigarette_NN tar_NN have_VBP an_DT essentially_RB infinite_JJ lifetime_NN ._. 
-LRB-_-LRB- 14_CD -RRB-_-RRB- Radicals_NNPS on_IN PM_NNP 2_CD ._. 
-LRB-_-LRB- 11_CD -RRB-_-RRB- The_DT lifetime_NN of_IN some_DT unpaired_JJ electrons_NNS ,_, strongly_RB delocalized_VBN over_IN the_DT condensed_JJ aromatic_JJ rings_NNS in_IN charcoal_NN or_CC coal_NN ,_, can_MD be_VB extremely_RB long_JJ ._. 
-LRB-_-LRB- 12_CD -RRB-_-RRB- Autopsy_NNP lung_NN tissue_NN from_IN coal_NN miners_NNS exhibited_VBD similar_JJ free_JJ radical_JJ activity_NN as_IN that_DT of_IN coal_NN dust_NN ._. 
-LRB-_-LRB- 13_CD -RRB-_-RRB- The_DT intensity_NN of_IN unpaired_JJ electron_JJ EPR_NNP signals_NNS in_IN charcoal_JJ produced_VBN today_NN is_VBZ comparable_JJ to_TO that_DT found_VBN in_IN the_DT pyramids_NNS in_IN Egypt_NNP ._. 
5collected_VBN from_IN urban_JJ air_NN are_VBP remarkably_RB persistent_JJ and_CC can_MD be_VB observed_VBN in_IN samples_NNS that_WDT had_VBD been_VBN stored_VBN for_IN several_JJ months_NNS ._. 
-LRB-_-LRB- 15_CD -RRB-_-RRB- Influence_NN of_IN Fuel_NN Type_NN on_IN Free_NNP Radical_NNP Measurement_NNP Radical_NNP intensities_NNS in_IN PM_NNP emissions_NNS tend_VBP to_TO decrease_VB with_IN respect_NN to_TO fuel_VB types_NNS from_IN Fatwood_NNP ,_, pine_VBP wood_NN ,_, and_CC bituminous_JJ coal_NN to_TO anthracite_NN -LRB-_-LRB- Figure_NN 2_CD -RRB-_-RRB- ._. 
5._CD 
5_CD 
-LRB-_-LRB- 9_CD -RRB-_-RRB- Some_DT radicals_NNS found_VBN in_IN cigarette_NN tar_NN have_VBP an_DT essentially_RB infinite_JJ lifetime_NN ._. 
-LRB-_-LRB- 13_CD -RRB-_-RRB- The_DT intensity_NN of_IN unpaired_JJ electron_JJ EPR_NNP signals_NNS in_IN charcoal_JJ produced_VBN today_NN is_VBZ comparable_JJ to_TO that_DT found_VBN in_IN the_DT pyramids_NNS in_IN Egypt_NNP ._. 
-LRB-_-LRB- 14_CD -RRB-_-RRB- Radicals_NNPS on_IN PM2_NNP ._. 
5collected_VBN from_IN urban_JJ air_NN are_VBP remarkably_RB persistent_JJ and_CC can_MD be_VB observed_VBN in_IN samples_NNS that_WDT had_VBD been_VBN stored_VBN for_IN several_JJ months_NNS ._. 
The_DT inverse_JJ relationship_NN observed_VBD here_RB for_IN the_DT PM_NNP emissions_NNS is_VBZ intriguing_JJ because_IN it_PRP is_VBZ just_RB opposite_JJ to_TO what_WP was_VBD reported_VBN for_IN the_DT source_NN fuels_NNS :_: coals_NNS show_VBP a_DT steady_JJ increase_NN in_IN radical_JJ densities_NNS with_IN increasing_VBG coalification_NN ._. 
-LRB-_-LRB- 17_CD -RRB-_-RRB- This_DT contrast_NN emphasizes_VBZ the_DT complexity_NN of_IN the_DT free_JJ radical_JJ creation_NN and_CC recombination_NN processes_NNS during_IN combustion_NN of_IN different_JJ fuels_NNS ._. 
Figure_NN 2_CD Effect_NN of_IN fuel_NN type_NN on_IN free_JJ radical_JJ measurements_NNS ._. 
Radical_NNP intensities_NNS in_IN PM_NNP emissions_NNS tend_VBP to_TO decrease_VB with_IN respect_NN to_TO fuel_VB types_NNS from_IN Fatwood_NNP ,_, pine_VBP wood_NN ,_, and_CC bituminous_JJ coal_NN to_TO anthracite_NN ._. 
58_CD 
Chemical_NNP Speciation_NNP of_IN Radicals_NNPS The_DT g_NN -_: factors_NNS of_IN EPR_NNP spectra_NN can_MD be_VB used_VBN to_TO assess_VB whether_IN a_DT radical_JJ is_VBZ carbon-centered_JJ or_CC oxygen-centered_JJ :_: whether_IN the_DT unpaired_JJ electron_NN is_VBZ located_VBN on_IN a_DT carbon_NN or_CC oxygen_NN atom_NN ._. 
10,19_CD Carbon-centered_JJ radicals_NNS with_IN an_DT adjacent_JJ oxygen_NN atom_NN have_VBP higher_JJR g-factors_NNS in_IN the_DT range_NN of_IN 2_CD ._. 
003_CD 
004_CD ._. 
004_CD ,_, while_IN oxygen-centered_JJ radicals_NNS have_VBP g_VBN -_: factors_NNS that_WDT are_VBP 
3_CD 
Exponential_JJ increases_NNS have_VBP been_VBN found_VBN in_IN human_JJ tissues_NNS since_IN the_DT 1970s_CD ,_, with_IN indications_NNS of_IN stagnation_NN in_IN European_JJ samples_NNS ,_, possibly_RB as_IN a_DT consequence_NN of_IN political_JJ regulation_NN 
Integration_NN of_IN available_JJ information_NN on_IN environmental_JJ and_CC human_JJ health_NN trends_NNS may_MD form_VB the_DT basis_NN for_IN a_DT screening_VBG level_NN indicator_NN system_NN that_WDT can_MD be_VB used_VBN to_TO design_VB a_DT biomonitoring_NN program_NN ._. 
Thus_RB ,_, Environmental_NNP Health_NNP Indicators_NNPS -LRB-_-LRB- EHI_NNP -RRB-_-RRB- identified_VBN scientifically_RB are_VBP tools_NNS that_WDT summarize_VBP the_DT relationship_NN between_IN the_DT environment_NN and_CC health_NN ,_, and_CC these_DT can_MD be_VB used_VBN for_IN regulatory_JJ actions_NNS to_TO manage_VB or_CC prevent_VB impacts_NNS on_IN environment_NN and_CC health_NN ._. 
The_DT proposal_NN for_IN a_DT coordinated_VBN action_NN involving_VBG existing_VBG infrastructures_NNS ,_, experts_NNS within_IN environment_NN and_CC health_NN monitoring_NN activities_NNS ,_, and_CC research_NN for_IN the_DT support_NN and_CC implementation_NN of_IN a_DT human_JJ biomonitoring_NN program_NN is_VBZ an_DT obvious_JJ continuation_NN of_IN the_DT activities_NNS and_CC cooperation_NN that_WDT have_VBP already_RB taken_VBN place_NN among_IN institutions_NNS in_IN Denmark_NNP ._. 
Integration_NN of_IN available_JJ information_NN on_IN environmental_JJ and_CC human_JJ health_NN trends_NNS may_MD form_VB the_DT basis_NN for_IN a_DT screening_VBG level_NN indicator_NN system_NN that_WDT can_MD be_VB used_VBN to_TO design_VB a_DT biomonitoring_NN program_NN ._. 
Thus_RB ,_, Environmental_NNP Health_NNP Indicators_NNPS -LRB-_-LRB- EHI_NNP -RRB-_-RRB- identified_VBN scientifically_RB are_VBP tools_NNS that_WDT summarize_VBP the_DT relationship_NN between_IN the_DT environment_NN and_CC health_NN ,_, and_CC these_DT can_MD be_VB used_VBN for_IN regulatory_JJ actions_NNS to_TO manage_VB or_CC prevent_VB impacts_NNS on_IN environment_NN and_CC health_NN ._. 
The_DT proposal_NN for_IN a_DT coordinated_VBN action_NN involving_VBG existing_VBG infrastructures_NNS ,_, experts_NNS within_IN environment_NN and_CC health_NN monitoring_NN activities_NNS ,_, and_CC research_NN for_IN the_DT support_NN and_CC implementation_NN of_IN a_DT human_JJ biomonitoring_NN program_NN is_VBZ an_DT obvious_JJ continuation_NN of_IN the_DT activities_NNS and_CC cooperation_NN that_WDT have_VBP already_RB taken_VBN place_NN among_IN institutions_NNS in_IN Denmark_NNP ._. 
The_DT European_NNP Environment_NNP and_CC Health_NNP Action_NNP Plan_NNP 2004_CD 
emission_NN data_NNS ,_, product_NN information_NN data_NNS ,_, epidemiological_JJ data_NNS ,_, air_NN and_CC drinking_NN water_NN quality_NN data_NNS combined_VBN with_IN available_JJ knowledge_NN on_IN possible_JJ human_JJ health_NN effects_NNS ._. 
As_IN such_JJ the_DT risk_NN scenario_NN analysis_NN is_VBZ aims_VBZ to_TO cover_VB all_DT aspects_NNS of_IN the_DT DPSEEA_NNP -LRB-_-LRB- Driving_VBG forces_NNS 
DPSEEA_NNP defines_VBZ driving_JJ forces_NNS -LRB-_-LRB- D_NNP -RRB-_-RRB- ,_, that_WDT lead_VBP to_TO pressures_NNS on_IN the_DT environment_NN -LRB-_-LRB- P_NNP -RRB-_-RRB- ,_, which_WDT in_IN turn_NN change_NN the_DT state_NN of_IN the_DT environment_NN -LRB-_-LRB- S_NNP -RRB-_-RRB- ,_, resulting_VBG in_IN human_JJ exposures_NNS -LRB-_-LRB- E_NNP -RRB-_-RRB- and_CC in_IN turn_NN health_NN effects_NNS -LRB-_-LRB- E_NNP -RRB-_-RRB- ._. 
Actions_NNS -LRB-_-LRB- A_NN -RRB-_-RRB- may_MD then_RB be_VB taken_VBN at_IN any_DT point_NN in_IN this_DT chain_NN to_TO mitigate_VB or_CC avoid_VB unwanted_JJ health_NN effects_NNS ._. 
The_DT structure_NN illustrated_VBD above_RB supports_VBZ the_DT development_NN of_IN information_NN systems_NNS as_RB well_RB as_IN the_DT compilation_NN of_IN adequate_JJ political_JJ measures_NNS ._. 
g._IN The_DT proposed_VBN framework_NN builds_VBZ on_IN the_DT principles_NNS and_CC experience_NN gained_VBN from_IN scientific_JJ work_NN at_IN national_JJ and_CC EU_NNP level_NN ,_, e._IN NoMiracle_NNP ,_, as_RB well_RB as_IN environment_NN and_CC human_JJ health_NN indicator_NN reporting_NN within_IN the_DT area_NN of_IN cumulative_JJ risk_NN from_IN exposure_NN ._. 
Figure_NNP 1_CD Framework_NNP for_IN a_DT national_JJ integrated_JJ environmental_JJ and_CC human_JJ health_NN surveillance_NN program_NN and_CC relations_NNS to_TO DPSEEA_NNP -LRB-_-LRB- Driving_VBG forces_NNS 
Integration_NN of_IN available_JJ information_NN on_IN environmental_JJ and_CC human_JJ health_NN trends_NNS may_MD form_VB the_DT basis_NN for_IN a_DT screening_VBG level_NN indicator_NN system_NN that_WDT can_MD be_VB used_VBN to_TO design_VB a_DT biomonitoring_NN program_NN ._. 
Thus_RB ,_, Environmental_NNP Health_NNP Indicators_NNPS -LRB-_-LRB- EHI_NNP -RRB-_-RRB- identified_VBN scientifically_RB are_VBP tools_NNS that_WDT summarize_VBP the_DT relationship_NN between_IN the_DT environment_NN and_CC health_NN ,_, and_CC these_DT can_MD be_VB used_VBN for_IN regulatory_JJ actions_NNS to_TO manage_VB or_CC prevent_VB impacts_NNS on_IN environment_NN and_CC health_NN ._. 
The_DT proposal_NN for_IN a_DT coordinated_VBN action_NN involving_VBG existing_VBG infrastructures_NNS ,_, experts_NNS within_IN environment_NN and_CC health_NN monitoring_NN activities_NNS ,_, and_CC research_NN for_IN the_DT support_NN and_CC implementation_NN of_IN a_DT human_JJ biomonitoring_NN program_NN is_VBZ an_DT obvious_JJ continuation_NN of_IN the_DT activities_NNS and_CC cooperation_NN that_WDT have_VBP already_RB taken_VBN place_NN among_IN institutions_NNS in_IN Denmark_NNP ._. 
Enhanced_JJ cooperation_NN between_IN ministries_NNS is_VBZ to_TO ensure_VB coordinated_VBN and_CC cohesive_JJ action_NN against_IN environmental_JJ factors_NNS that_WDT can_MD affect_VB health_NN ,_, and_CC in_IN particular_JJ within_IN areas_NNS of_IN common_JJ interest_NN are_VBP needed_VBN for_IN the_DT realisation_NN of_IN the_DT strategy_NN and_CC action_NN plan_NN ._. 
The_DT European_NNP Environment_NNP and_CC Health_NNP Action_NNP Plan_NNP 2004_CD 
Enhanced_JJ cooperation_NN between_IN ministries_NNS is_VBZ to_TO ensure_VB coordinated_VBN and_CC cohesive_JJ action_NN against_IN environmental_JJ factors_NNS that_WDT can_MD affect_VB health_NN ,_, and_CC in_IN particular_JJ within_IN areas_NNS of_IN common_JJ interest_NN are_VBP needed_VBN for_IN the_DT realisation_NN of_IN the_DT strategy_NN and_CC action_NN plan_NN ._. 
The_DT European_NNP Environment_NNP and_CC Health_NNP Action_NNP Plan_NNP 2004_CD 
g._IN The_DT proposed_VBN framework_NN builds_VBZ on_IN the_DT principles_NNS and_CC experience_NN gained_VBN from_IN scientific_JJ work_NN at_IN national_JJ and_CC EU_NNP level_NN ,_, e._IN NoMiracle_NNP ,_, as_RB well_RB as_IN environment_NN and_CC human_JJ health_NN indicator_NN reporting_NN within_IN the_DT area_NN of_IN cumulative_JJ risk_NN from_IN exposure_NN ._. 
Figure_NNP 1_CD Framework_NNP for_IN a_DT national_JJ integrated_JJ environmental_JJ and_CC human_JJ health_NN surveillance_NN program_NN and_CC relations_NNS to_TO DPSEEA_NNP -LRB-_-LRB- Driving_VBG forces_NNS 
The_DT scenario_NN descriptions_NNS deliver_VBP input_NN to_TO the_DT prioritization_NN of_IN the_DT exposure_NN modelling_NN of_IN high-risk_JJ chemicals_NNS with_IN respect_NN to_TO the_DT national_JJ and_CC European_JJ priority_NN diseases_NNS as_RB well_RB as_IN the_DT biomonitoring_NN and_CC monitoring_NN activities_NNS ._. 
The_DT modelling_NN of_IN outdoor_JJ exposure_NN is_VBZ already_RB included_VBN in_IN the_DT national_JJ monitoring_NN program_NN of_IN the_DT environment_NN ,_, whereas_IN the_DT indoor_JJ exposure_NN needs_VBZ to_TO be_VB monitored_VBN in_IN addition_NN to_TO internal_JJ exposure_NN ,_, i._FW e._FW biomarkers_NNS of_IN exposure_NN ._. 
This_DT could_MD be_VB formulated_VBN as_IN a_DT minimum_NN requirement_NN for_IN the_DT output_NN from_IN the_DT basic_JJ scenario_NN ,_, as_IN defined_VBN in_IN the_DT third_JJ recommendation_NN from_IN the_DT Implementation_NNP Group_NNP ._. 
research_NN studies_NNS on_IN biomarkers_NNS addressing_VBG childhood_NN cancer_NN and_CC endocrine_NN disruptors_NNS and_CC on_IN children_NNS 's_POS exposure_NN to_TO BFRs_NNS ,_, have_VBP been_VBN completed_VBN or_CC commenced_VBN ._. 
As_IN a_DT follow-up_NN on_IN the_DT Fourth_JJ Ministerial_NNP Conference_NNP on_IN Environment_NNP and_CC Health_NNP in_IN Budapest_NNP ,_, 23_CD 
The_DT ideas_NNS of_IN this_DT report_NN have_VBP been_VBN presented_VBN to_TO the_DT Danish_JJ Interministerial_NNP Group_NNP for_IN Environmental_NNP Factors_NNP and_CC Health_NNP ,_, which_WDT was_VBD established_VBN in_IN relation_NN to_TO the_DT National_NNP Environment_NNP and_CC Health_NNP Action_NNP Plan_NNP -LRB-_-LRB- NEHAP_NNP -RRB-_-RRB- ._. 
One_CD of_IN the_DT ideas_NNS of_IN the_DT report_NN are_VBP to_TO establish_VB a_DT systematic_JJ surveillance_NN and_CC risk_NN assessment_NN of_IN chemicals_NNS with_IN negative_JJ effects_NNS on_IN health_NN in_IN consumer_NN products_NNS ,_, food_NN and_CC tap_VB water_NN and_CC to_TO clarify_VB the_DT relation_NN between_IN environment_NN and_CC food_NN contaminants_NNS and_CC related_JJ health_NN effects_NNS on_IN male_JJ reproductive_JJ organs_NNS ._. 
Integration_NN of_IN available_JJ information_NN on_IN environmental_JJ and_CC human_JJ health_NN trends_NNS may_MD form_VB the_DT basis_NN for_IN a_DT screening_VBG level_NN indicator_NN system_NN that_WDT can_MD be_VB used_VBN to_TO design_VB a_DT biomonitoring_NN program_NN ._. 
and_CC AIPOLIFE_NNP 
;a_JJ national_JJ pilot_NN project_NN on_IN the_DT integration_NN of_IN environmental_JJ data_NNS bases_NNS and_CC population_NN health_NN registers_NNS has_VBZ been_VBN performed_VBN at_IN the_DT national_JJ level_NN ,_, in_IN Denmark_NNP ._. 
The_DT project_NN proposes_VBZ that_IN the_DT geographically_RB based_VBN health_NN database_NN of_IN the_DT National_NNP Board_NNP of_IN Health_NNP ,_, is_VBZ utilised_VBN as_IN the_DT basis_NN for_IN linkage_NN of_IN health_NN and_CC environmental_JJ registers_NNS 
Danish_JJ initiatives_NNS and_CC projects_NNS The_DT Danish_JJ Environmental_NNP Research_NNP Institute_NNP publishes_VBZ every_DT fourth_JJ year_NN a_DT state_NN of_IN the_DT environment_NN report_NN for_IN Denmark_NNP ,_, including_VBG a_DT chapter_NN on_IN environment_NN and_CC health_NN ,_, presenting_VBG status_NN and_CC development_NN in_IN knowledge_NN of_IN the_DT impact_NN of_IN environmental_JJ factor_NN on_IN human_JJ health_NN 
The_DT description_NN of_IN exposure_NN scenarios_NNS includes_VBZ identification_NN of_IN source_NN and_CC use_NN categories_NNS ,_, emissions_NNS and_CC exposures_NNS ._. 
Additional_JJ chemical-specific_JJ properties_NNS may_MD be_VB taken_VBN into_IN account_NN addressing_VBG critical_JJ exposure_NN routes_NNS ,_, as_IN has_VBZ for_IN example_NN been_VBN carried_VBN out_RP for_IN BRFs_NNP in_IN which_WDT case_NN unintentional_JJ ingestion_NN of_IN dust_NN is_VBZ suggested_VBN at_IN least_JJS of_IN similar_JJ importance_NN to_TO food_NN intake_NN ._. 
Likewise_RB ,_, existing_VBG fate_NN models_NNS may_MD be_VB part_NN of_IN the_DT exposure_NN description_NN of_IN a_DT given_VBN scenario_NN type_NN ._. 
External_NNP exposure_NN monitoring_NN is_VBZ included_VBN in_IN the_DT biomonitoring_VBG activities_NNS where_WRB these_DT data_NNS are_VBP needed_VBN to_TO quantify_VB the_DT internal\/external_JJ body_NN exposure_NN ratio_NN as_IN the_DT combined_JJ monitoring_NN high_JJ risk_NN exposure_NN route_NN concentrations_NNS ,_, and_CC biomonitoring_NN is_VBZ essential_JJ for_IN realistic_JJ human_JJ health_NN impact_NN assessment_NN ._. 
In_IN order_NN to_TO meet_VB the_DT goals_NNS of_IN the_DT EU_NNP Environment_NNP and_CC Health_NNP Strategy_NNP and_CC the_DT conditions_NNS formulated_VBN in_IN SCALE_NNP ,_, the_DT European_NNP Environment_NNP Agency_NNP recommends_VBZ that_IN :_: 
Alternatively_RB ,_, harmonization_NN may_MD relate_VB to_TO development_NN of_IN a_DT European_JJ framework_NN for_IN an_DT approach_NN to_TO select_VB biomarkers_NNS based_VBN on_IN existing_VBG structures_NNS and_CC knowledge_NN on_IN environmental_JJ quality_NN and_CC human_JJ health_NN ._. 
In_IN order_NN to_TO meet_VB the_DT goals_NNS of_IN the_DT EU_NNP Environment_NNP and_CC Health_NNP Strategy_NNP and_CC the_DT conditions_NNS formulated_VBN in_IN SCALE_NNP ,_, the_DT European_NNP Environment_NNP Agency_NNP recommends_VBZ that_IN :_: 
Alternatively_RB ,_, harmonization_NN may_MD relate_VB to_TO development_NN of_IN a_DT European_JJ framework_NN for_IN an_DT approach_NN to_TO select_VB biomarkers_NNS based_VBN on_IN existing_VBG structures_NNS and_CC knowledge_NN on_IN environmental_JJ quality_NN and_CC human_JJ health_NN ._. 
In_IN order_NN to_TO meet_VB the_DT goals_NNS of_IN the_DT EU_NNP Environment_NNP and_CC Health_NNP Strategy_NNP and_CC the_DT conditions_NNS formulated_VBN in_IN SCALE_NNP ,_, the_DT European_NNP Environment_NNP Agency_NNP recommends_VBZ that_IN :_: 
research_NN studies_NNS on_IN biomarkers_NNS addressing_VBG childhood_NN cancer_NN and_CC endocrine_NN disruptors_NNS and_CC on_IN children_NNS 's_POS exposure_NN to_TO BFRs_NNS ,_, have_VBP been_VBN completed_VBN or_CC commenced_VBN ._. 
As_IN a_DT follow-up_NN on_IN the_DT Fourth_JJ Ministerial_NNP Conference_NNP on_IN Environment_NNP and_CC Health_NNP in_IN Budapest_NNP ,_, 23_CD 
Integration_NN of_IN available_JJ information_NN on_IN environmental_JJ and_CC human_JJ health_NN trends_NNS may_MD form_VB the_DT basis_NN for_IN a_DT screening_VBG level_NN indicator_NN system_NN that_WDT can_MD be_VB used_VBN to_TO design_VB a_DT biomonitoring_NN program_NN ._. 
Thus_RB ,_, Environmental_NNP Health_NNP Indicators_NNPS -LRB-_-LRB- EHI_NNP -RRB-_-RRB- identified_VBN scientifically_RB are_VBP tools_NNS that_WDT summarize_VBP the_DT relationship_NN between_IN the_DT environment_NN and_CC health_NN ,_, and_CC these_DT can_MD be_VB used_VBN for_IN regulatory_JJ actions_NNS to_TO manage_VB or_CC prevent_VB impacts_NNS on_IN environment_NN and_CC health_NN ._. 
The_DT proposal_NN for_IN a_DT coordinated_VBN action_NN involving_VBG existing_VBG infrastructures_NNS ,_, experts_NNS within_IN environment_NN and_CC health_NN monitoring_NN activities_NNS ,_, and_CC research_NN for_IN the_DT support_NN and_CC implementation_NN of_IN a_DT human_JJ biomonitoring_NN program_NN is_VBZ an_DT obvious_JJ continuation_NN of_IN the_DT activities_NNS and_CC cooperation_NN that_WDT have_VBP already_RB taken_VBN place_NN among_IN institutions_NNS in_IN Denmark_NNP ._. 
Alternatively_RB ,_, harmonization_NN may_MD relate_VB to_TO development_NN of_IN a_DT European_JJ framework_NN for_IN an_DT approach_NN to_TO select_VB biomarkers_NNS based_VBN on_IN existing_VBG structures_NNS and_CC knowledge_NN on_IN environmental_JJ quality_NN and_CC human_JJ health_NN ._. 
In_IN order_NN to_TO meet_VB the_DT goals_NNS of_IN the_DT EU_NNP Environment_NNP and_CC Health_NNP Strategy_NNP and_CC the_DT conditions_NNS formulated_VBN in_IN SCALE_NNP ,_, the_DT European_NNP Environment_NNP Agency_NNP recommends_VBZ that_IN :_: 
Alternatively_RB ,_, harmonization_NN may_MD relate_VB to_TO development_NN of_IN a_DT European_JJ framework_NN for_IN an_DT approach_NN to_TO select_VB biomarkers_NNS based_VBN on_IN existing_VBG structures_NNS and_CC knowledge_NN on_IN environmental_JJ quality_NN and_CC human_JJ health_NN ._. 
In_IN order_NN to_TO meet_VB the_DT goals_NNS of_IN the_DT EU_NNP Environment_NNP and_CC Health_NNP Strategy_NNP and_CC the_DT conditions_NNS formulated_VBN in_IN SCALE_NNP ,_, the_DT European_NNP Environment_NNP Agency_NNP recommends_VBZ that_IN :_: 
Alternatively_RB ,_, harmonization_NN may_MD relate_VB to_TO development_NN of_IN a_DT European_JJ framework_NN for_IN an_DT approach_NN to_TO select_VB biomarkers_NNS based_VBN on_IN existing_VBG structures_NNS and_CC knowledge_NN on_IN environmental_JJ quality_NN and_CC human_JJ health_NN ._. 
In_IN order_NN to_TO meet_VB the_DT goals_NNS of_IN the_DT EU_NNP Environment_NNP and_CC Health_NNP Strategy_NNP and_CC the_DT conditions_NNS formulated_VBN in_IN SCALE_NNP ,_, the_DT European_NNP Environment_NNP Agency_NNP recommends_VBZ that_IN :_: 
Alternatively_RB ,_, harmonization_NN may_MD relate_VB to_TO development_NN of_IN a_DT European_JJ framework_NN for_IN an_DT approach_NN to_TO select_VB biomarkers_NNS based_VBN on_IN existing_VBG structures_NNS and_CC knowledge_NN on_IN environmental_JJ quality_NN and_CC human_JJ health_NN ._. 
In_IN order_NN to_TO meet_VB the_DT goals_NNS of_IN the_DT EU_NNP Environment_NNP and_CC Health_NNP Strategy_NNP and_CC the_DT conditions_NNS formulated_VBN in_IN SCALE_NNP ,_, the_DT European_NNP Environment_NNP Agency_NNP recommends_VBZ that_IN 
11_CD 
The_DT protection_NN level_NN must_MD take_VB account_NN of_IN especially_RB sensitive_JJ groups_NNS of_IN people_NNS 
Alternatively_RB ,_, harmonization_NN may_MD relate_VB to_TO development_NN of_IN a_DT European_JJ framework_NN for_IN an_DT approach_NN to_TO select_VB biomarkers_NNS based_VBN on_IN existing_VBG structures_NNS and_CC knowledge_NN on_IN environmental_JJ quality_NN and_CC human_JJ health_NN ._. 
In_IN order_NN to_TO meet_VB the_DT goals_NNS of_IN the_DT EU_NNP Environment_NNP and_CC Health_NNP Strategy_NNP and_CC the_DT conditions_NNS formulated_VBN in_IN SCALE_NNP ,_, the_DT European_NNP Environment_NNP Agency_NNP recommends_VBZ that_IN :_: 
The_DT protection_NN level_NN must_MD take_VB account_NN of_IN especially_RB sensitive_JJ groups_NNS of_IN people_NNS 
g._IN The_DT proposed_VBN framework_NN builds_VBZ on_IN the_DT principles_NNS and_CC experience_NN gained_VBN from_IN scientific_JJ work_NN at_IN national_JJ and_CC EU_NNP level_NN ,_, e._IN NoMiracle_NNP ,_, as_RB well_RB as_IN environment_NN and_CC human_JJ health_NN indicator_NN reporting_NN within_IN the_DT area_NN of_IN cumulative_JJ risk_NN from_IN exposure_NN ._. 
Figure_NNP 1_CD Framework_NNP for_IN a_DT national_JJ integrated_JJ environmental_JJ and_CC human_JJ health_NN surveillance_NN program_NN and_CC relations_NNS to_TO DPSEEA_NNP -LRB-_-LRB- Driving_VBG forces_NNS 
Alternatively_RB ,_, harmonization_NN may_MD relate_VB to_TO development_NN of_IN a_DT European_JJ framework_NN for_IN an_DT approach_NN to_TO select_VB biomarkers_NNS based_VBN on_IN existing_VBG structures_NNS and_CC knowledge_NN on_IN environmental_JJ quality_NN and_CC human_JJ health_NN ._. 
In_IN order_NN to_TO meet_VB the_DT goals_NNS of_IN the_DT EU_NNP Environment_NNP and_CC Health_NNP Strategy_NNP and_CC the_DT conditions_NNS formulated_VBN in_IN SCALE_NNP ,_, the_DT European_NNP Environment_NNP Agency_NNP recommends_VBZ that_IN :_: 
Alternatively_RB ,_, harmonization_NN may_MD relate_VB to_TO development_NN of_IN a_DT European_JJ framework_NN for_IN an_DT approach_NN to_TO select_VB biomarkers_NNS based_VBN on_IN existing_VBG structures_NNS and_CC knowledge_NN on_IN environmental_JJ quality_NN and_CC human_JJ health_NN ._. 
In_IN order_NN to_TO meet_VB the_DT goals_NNS of_IN the_DT EU_NNP Environment_NNP and_CC Health_NNP Strategy_NNP and_CC the_DT conditions_NNS formulated_VBN in_IN SCALE_NNP ,_, the_DT European_NNP Environment_NNP Agency_NNP recommends_VBZ that_IN :_: 
However_RB an_DT arctic_JJ program_NN for_IN HBM_NNP has_VBZ been_VBN in_IN force_NN for_IN decades_NNS and_CC from_IN the_DT preparations_NNS of_IN the_DT EU-pilot_NNP project_NN on_IN HBM_NNP increasing_VBG political_JJ interest_NN in_IN a_DT Danish_JJ program_NN has_VBZ developed_VBN ._. 
11_CD 
11_CD 
Denmark_NNP has_VBZ developed_VBN a_DT national_JJ strategy_NN for_IN sustainable_JJ development_NN for_IN which_WDT the_DT main_JJ goal_NN is_VBZ a_DT constant_JJ decrease_NN in_IN pollutant_NN levels_NNS in_IN products_NNS ,_, food_NN ,_, the_DT working_VBG environment_NN ,_, traffic_NN and_CC the_DT indoor_JJ environment_NN 
Harm_NN to_TO animals_NNS and_CC plants_NNS from_IN pollution_NN should_MD also_RB be_VB limited_VBN ._. 
Objective_NN 2_CD is_VBZ further_RB described_VBN in_IN the_DT section_NN on_IN the_DT cross-cutting_JJ issue_NN `_`` Environment_NNP and_CC health_NN '_'' which_WDT states_VBZ that_IN :_: `_`` Denmark_NNP should_MD be_VB a_DT country_NN where_WRB pollution_NN from_IN products_NNS ,_, food_NN ,_, working_VBG environment_NN ,_, traffic_NN and_CC physical_JJ indoor_JJ conditions_NNS affecting_VBG the_DT population_NN 's_POS quality_NN of_IN life_NN and_CC health_NN is_VBZ constantly_RB falling_VBG ._. 
The_DT protection_NN level_NN must_MD take_VB account_NN of_IN especially_RB sensitive_JJ groups_NNS of_IN people_NNS 
Its_PRP$ themes_NNS are_VBP :_: Scientific_NNP evidence_NN ,_, focus_NN on_IN Children_NNP ,_, raising_VBG of_IN Awareness_NN ,_, improving_VBG the_DT situation_NN by_IN use_NN of_IN Legal_JJ instruments_NNS and_CC allowing_VBG Evaluation_NN of_IN the_DT progress_NN made_VBD ._. 
In_IN the_DT same_JJ year_NN ,_, Denmark_NNP published_VBD a_DT background_NN report_NN 
Its_PRP$ themes_NNS are_VBP :_: Scientific_NNP evidence_NN ,_, focus_NN on_IN Children_NNP ,_, raising_VBG of_IN Awareness_NN ,_, improving_VBG the_DT situation_NN by_IN use_NN of_IN Legal_JJ instruments_NNS and_CC allowing_VBG Evaluation_NN of_IN the_DT progress_NN made_VBD ._. 
In_IN the_DT same_JJ year_NN ,_, Denmark_NNP published_VBD a_DT background_NN report_NN 
Enhancement_NN of_IN the_DT cooperation_NN at_IN administrative_JJ level_NN is_VBZ however_RB highlighted_VBN as_IN the_DT `_`` National_NNP Board_NNP of_IN Health_NNP has_VBZ primary_JJ responsibility_NN for_IN general_JJ health_NN monitoring_NN ,_, while_IN the_DT responsibilities_NNS of_IN other_JJ ministries_NNS are_VBP more_RBR linked_VBN to_TO preventive_JJ initiatives_NNS such_JJ as_IN setting_VBG limit_NN values_NNS and_CC detailed_JJ requirements_NNS for_IN the_DT different_JJ sources_NNS of_IN environmental_JJ factors_NNS '_POS ._. 
Enhanced_JJ cooperation_NN between_IN ministries_NNS is_VBZ to_TO ensure_VB coordinated_VBN and_CC cohesive_JJ action_NN against_IN environmental_JJ factors_NNS that_WDT can_MD affect_VB health_NN ,_, and_CC in_IN particular_JJ within_IN areas_NNS of_IN common_JJ interest_NN are_VBP needed_VBN for_IN the_DT realisation_NN of_IN the_DT strategy_NN and_CC action_NN plan_NN ._. 
The_DT European_NNP Environment_NNP and_CC Health_NNP Action_NNP Plan_NNP 2004_CD 
The_DT project_NN proposes_VBZ that_IN the_DT geographically_RB based_VBN health_NN database_NN of_IN the_DT National_NNP Board_NNP of_IN Health_NNP ,_, is_VBZ utilised_VBN as_IN the_DT basis_NN for_IN linkage_NN of_IN health_NN and_CC environmental_JJ registers_NNS 
Significant_JJ discrepancies_NNS arise_VBP when_WRB the_DT dose_NN range_NN is_VBZ restricted_VBN to_TO 0_CD 
It_PRP is_VBZ plausible_JJ that_IN such_JJ bias_NN would_MD be_VB reduced_VBN in_IN the_DT 0_CD 
If_IN datacells_NNS with_IN DS86_NNP dose_NN below_IN 5_CD mSv_NNP are_VBP excluded_VBN from_IN the_DT 0_CD 
The_DT response_NN might_MD be_VB clearer_JJR by_IN modelling_VBG the_DT effect_NN of_IN D_NNP \*_NN w_NN ,_, with_IN w_NN some_DT more_RBR general_JJ function_NN of_IN Time-Since-Exposure_NNP ._. 
Such_JJ models_NNS have_VBP been_VBN applied_VBN to_TO lung_NN cancer_NN mortality_NN in_IN uranium_NN miner_NN cohorts_NNS ._. 
If_IN the_DT linear_JJ model_NN were_VBD appropriate_JJ throughout_IN the_DT low_JJ dose_NN region_NN ,_, we_PRP might_MD expect_VB ERR_NNP 0_CD ._. 
025_CD ,_, 
The_DT response_NN might_MD be_VB clearer_JJR by_IN modelling_VBG the_DT effect_NN of_IN D_NNP \*_NN w_NN ,_, with_IN w_NN some_DT more_RBR general_JJ function_NN of_IN Time-Since-Exposure_NNP ._. 
Such_JJ models_NNS have_VBP been_VBN applied_VBN to_TO lung_NN cancer_NN mortality_NN in_IN uranium_NN miner_NN cohorts_NNS ._. 
If_IN the_DT linear_JJ model_NN were_VBD appropriate_JJ throughout_IN the_DT low_JJ dose_NN region_NN ,_, we_PRP might_MD expect_VB ERR_NNP 0_CD ._. 
025_CD ,_, 
Each_DT model_NN is_VBZ also_RB constrained_VBN by_IN 
Thus_RB latency_NN may_MD be_VB organ_NN and_CC gender_NN specific_NN ._. 
Latency_NN reflects_VBZ biochemical_JJ changes_NNS required_VBN after_IN initial_JJ radiation_NN if_IN mutant_JJ cells_NNS are_VBP to_TO progress_VB and_CC form_VB a_DT tumor_NN eventually_RB identified_VBN as_IN cause_NN of_IN death_NN ,_, and_CC historical_JJ changes_NNS in_IN environmental_JJ factors_NNS which_WDT interact_VBP with_IN radiation_NN for_IN a_DT particular_JJ cancer_NN ._. 
Rothman_NNP illustrates_VBZ how_WRB ignoring_VBG latency_NN may_MD mask_NN important_JJ effects_NNS ,_, whether_IN or_CC not_RB the_DT original_JJ exposure_NN was_VBD brief_JJ ._. 
Analysis_NN using_VBG the_DT lagged_VBN dose_NN D_NNP 
Cancer_NN of_IN the_DT uterus_NN refers_VBZ to_TO ICD9_CD 180_CD 
90_CD years_NNS f_SYM ERR_NNP 1_CD is_VBZ the_DT estimated_VBN Excess_NNP Relative_NNP Risk_NNP at_IN 10_CD mSv_NNP when_WRB the_DT two-phase_JJ model_NN with_IN latency_NN 
In_IN their_PRP$ study_NN of_IN gamma_NN radiation_NN and_CC mortality_NN in_IN the_DT Oak_NNP Ridge_NNP workforce_NN ,_, Frome_NNP et_FW al._FW ._. 
Ido_NNP not_RB know_VB whether_IN these_DT results_NNS and_CC the_DT optimal_JJ latencies_NNS are_VBP specific_JJ to_TO the_DT A-bomb_NNP cohort_NN ._. 
find_VB a_DT `_`` Low-dose_NN 
However_RB ,_, the_DT two-phase_JJ model_NN adapts_NNS and_CC simplifies_VBZ a_DT model_NN derived_VBN by_IN Brenner_NNP et_FW al._FW ._. 
Non-linear_JJ models_NNS are_VBP applied_VBN here_RB without_IN assuming_VBG any_DT cellular_JJ mechanism_NN ,_, and_CC their_PRP$ success_NN in_IN fitting_JJ the_DT cohort_NN data_NN does_VBZ not_RB prove_VB that_IN any_DT particular_JJ cell_NN mechanism_NN operated_VBD there_RB ._. 
to_TO explain_VB the_DT `_`` oncogenic_JJ transformation_NN frequency_NN '_'' of_IN cells_NNS exposed_VBN to_TO broad_JJ beam_NN irradiation_NN by_IN 
dat_NN shows_VBZ all_DT liver_NN cancers_NNS ._. 
Icould_NNP not_RB analyze_VB primary_JJ liver_NN cancer_NN because_IN the_DT data_NNS in_IN r12canc_CD ._. 
Persistent_JJ inflammation_NN including_VBG chronic_JJ liver_NN disease_NN has_VBZ been_VBN detected_VBN in_IN Japanese_JJ survivors_NNS 40_CD years_NNS after_IN the_DT bombing_NN and_CC correlated_VBN with_IN radiation_NN dose_NN ._. 
Conclusion_NN All_PDT the_DT models_NNS considered_VBN here_RB show_VBP unexpectedly_RB large_JJ and_CC significant_JJ results_NNS in_IN the_DT 0_CD 
Sharp_NNP et_NNP al._NNP ._. 
Non-linear_JJ dose_NN response_NN curves_NNS can_MD also_RB arise_VB from_IN a_DT hypersensitive_JJ population_NN subset_NN 
Induction_NN of_IN genomic_JJ instability_NN in_IN unirradiated_JJ bystander_NN cells_NNS has_VBZ been_VBN demonstrated_VBN for_IN neutron_NN irradiation_NN in_IN mice_NNS 
However_RB fission_NN neutrons_NNS ,_, like_IN 
2k._CD Thus_RB R_NNP ~_VBD 1_CD +_NN 6_CD ._. 
8._CD 
4_CD 
On_IN the_DT other_JJ hand_NN in_IN the_DT Life_NNP Span_NNP Study_NNP Report_NNP 12_CD -LRB-_-LRB- henceforth_NN LSS12_NNP -RRB-_-RRB- Pierce_NNP et_FW al._FW ._. 
The_DT ICRP_NNP risk_NN estimates_NNS are_VBP strongly_RB based_VBN on_IN analyses_NNS of_IN the_DT Japanese_JJ data_NNS for_IN the_DT full_JJ dose_NN range_NN assuming_VBG a_DT linear_JJ dose_NN response_NN ._. 
adopted_VBD a_DT linear_JJ ERR_NNP model_NN for_IN the_DT Japanese_JJ data_NNS but_CC found_VBD some_DT evidence_NN of_IN a_DT non-linear_JJ convex_NN dose-response_NN at_IN lower_JJR doses_NNS for_IN the_DT category_NN of_IN all-solid_JJ cancers_NNS combined_VBN ._. 
Around_IN one_CD third_NN of_IN the_DT data_NNS in_IN the_DT 1950_CD 
The_DT transient_JJ model_NN is_VBZ preferable_JJ here_RB ,_, for_IN simplicity_NN ._. 
The_DT models_NNS pass_VBP both_DT GoF_NNP tests_NNS ._. 
311_CD while_IN 
In_IN experiments_NNS at_IN cell_NN level_NN ,_, low_JJ dose_NN radiation_NN induces_VBZ significant_JJ and_CC non-linear_JJ effects_NNS on_IN micronuclei_NN ,_, chromosome_NN rearrangements_NNS and_CC instability_NN ,_, point_NN mutations_NNS ,_, and_CC changes_NNS in_IN cell_NN cycle_NN protein_NN levels_NNS ._. 
Studies_NNS reviewed_VBN by_IN Mothersill_NNP and_CC Seymour_NNP show_VBP low_JJ doses_NNS have_VBP large_JJ effects_NNS on_IN cells_NNS whose_WP$ nuclei_NNS ,_, or_CC even_RB the_DT affected_JJ cells_NNS themselves_PRP ,_, need_MD not_RB be_VB directly_RB traversed_VBN by_IN radiation_NN -LRB-_-LRB- bystander_NN effects_NNS -RRB-_-RRB- ._. 
Some_DT studies_NNS find_VBP responses_NNS rising_VBG rapidly_RB with_IN dose_NN and_CC then_RB reaching_VBG a_DT plateau_NN ._. 
Whilst_VB these_DT early_JJ non-linear_JJ cellular_JJ events_NNS may_MD be_VB critical_JJ for_IN tumor_NN formation_NN ,_, the_DT human_JJ body_NN 's_POS defences_NNS may_MD also_RB greatly_RB alter_VB the_DT initial_JJ dose_NN response_NN or_CC dilute_VB its_PRP$ significance_NN ,_, if_IN the_DT analyzed_VBN outcome_NN is_VBZ a_DT cancerous_JJ tumor_NN emerging_VBG decades_NNS later_RB and_CC eventually_RB identified_VBN as_IN cause_NN of_IN death_NN ._. 
Itest_JJ linearity_NN in_IN the_DT dose_NN response_NN by_IN modelling_VBG with_IN two_CD nested_JJ non-linear_JJ models_NNS ,_, each_DT of_IN which_WDT contains_VBZ the_DT linear_JJ model_NN ._. 
MethodsLife_NNP Span_NNP Study_NNP mortality_NN cohort_NN data_NNS -LRB-_-LRB- 1950_CD 
Induced_VBN radioactivity_NN appears_VBZ unlikely_JJ to_TO fully_RB explain_VB the_DT results_NNS ._. 
Separately_RB ,_, induced_JJ radioactivity_NN and_CC ``_`` black_JJ rain_NN ''_'' represent_VBP additional_JJ doses_NNS not_RB reported_VBN by_IN DS86_NNP or_CC DS02_NNP ._. 
According_VBG to_TO the_DT RERF_NNP website_NN 
Itest_JJ linearity_NN in_IN the_DT dose_NN response_NN by_IN modelling_VBG with_IN two_CD nested_JJ non-linear_JJ models_NNS ,_, each_DT of_IN which_WDT contains_VBZ the_DT linear_JJ model_NN ._. 
MethodsLife_NNP Span_NNP Study_NNP mortality_NN cohort_NN data_NNS -LRB-_-LRB- 1950_CD 
Non-linear_JJ models_NNS give_VBP a_DT much_RB better_JJR fit_NN and_CC are_VBP compatible_JJ with_IN a_DT bystander_NN effect_NN ._. 
Conclusion_NN The_DT standard_JJ linear_JJ model_NN applied_VBN to_TO the_DT full_JJ 1950_CD 
Non-linear_JJ models_NNS give_VBP a_DT much_RB better_JJR fit_NN and_CC are_VBP compatible_JJ with_IN a_DT bystander_NN effect_NN ._. 
Conclusion_NN The_DT standard_JJ linear_JJ model_NN applied_VBN to_TO the_DT full_JJ 1950_CD 
Background_NN Studies_NNS of_IN the_DT Japanese_NNP A-bomb_NNP survivors_NNS cohort_NN have_VBP been_VBN the_DT key_JJ source_NN of_IN radiation_NN risk_NN estimates_NNS used_VBN to_TO establish_VB environmental_JJ and_CC occupational_JJ protection_NN standards_NNS 
Cancer_NN of_IN the_DT uterus_NN refers_VBZ to_TO ICD9_CD 180_CD 
0km_CD from_IN the_DT hypocentre_NN ,_, the_DT estimates_NNS are_VBP about_IN 1\/10_CD and_CC 1\/100_CD of_IN the_DT value_NN at_IN the_DT hypocentre_NN ,_, respectively_RB ._. ''_'' 
The_DT issue_NN was_VBD examined_VBN in_IN detail_NN in_IN the_DT DS86_NNP Final_NNP Report_NNP Chapter_NNP 6_CD and_CC an_DT Appendix_NN to_TO this_DT Chapter_NN ._. 
The_DT cumulative_JJ dose_NN from_IN induced_JJ radioactivity_NN decreases_VBZ exponentially_RB with_IN distance_NN from_IN the_DT hypocentre_NN ._. 
The_DT corresponding_JJ doses_NNS at_IN the_DT hypocentres_NNS are_VBP believed_VBN to_TO be_VB only_RB about_RB 1\/10_CD of_IN these_DT values_NNS ._. 
4Gy_NNP in_IN Nagasaki_NNP ._. ''_'' 
According_VBG to_TO Chapter_NNP 6_CD of_IN the_DT DS86_NNP Final_NNP Report_NNP the_DT rainfall_NN was_VBD concentrated_VBN around_IN 3000_CD m_NN from_IN the_DT hypocentres_NNS in_IN both_DT cities_NNS ._. 
From_IN the_DT DS02_NNP dataset_NN ,_, the_DT maximum_NN distance_NN from_IN the_DT hypocentre_NN amongst_IN cells_NNS with_IN DS86_CD doses_NNS above_IN 5_CD mSv_NNP is_VBZ 2_CD ._. 
Cancer_NN of_IN the_DT uterus_NN refers_VBZ to_TO ICD9_CD 180_CD 
Adataset_NNP using_VBG DS02_NNP and_CC enabling_VBG comparison_NN with_IN DS86_NNP was_VBD released_VBN by_IN RERF_NNP last_JJ year_NN and_CC can_MD be_VB downloaded_VBN as_IN DS02can_NNP ._. 
dat_NN from_IN the_DT RERF_NNP website_NN ._. 
However_RB ,_, the_DT cancer_NN mortality_NN fields_NNS in_IN this_DT dataset_NN only_RB show_VBP deaths_NNS from_IN solid_JJ cancers_NNS -LRB-_-LRB- combined_VBN -RRB-_-RRB- ,_, liquid_JJ cancers_NNS ,_, and_CC leukemia_NN ._. 
Previous_JJ studies_NNS have_VBP reported_VBN that_IN NAHA_NNP represents_VBZ fungal_JJ biomass_NN both_DT in_IN the_DT growth_NN and_CC stationary_JJ phase_NN 
Methods_NNS Subjects_NNS The_DT clinic_NN of_IN respiratory_JJ diseases_NNS and_CC allergy_NN at_IN the_DT University_NNP medical_JJ center_NN ,_, Ljubljana_NNP ,_, Slovenia_NNP is_VBZ one_CD of_IN the_DT national_JJ centres_NNS for_IN patients_NNS with_IN sarcoidosis_NNS ._. 
For_IN the_DT diagnosis_NN the_DT ERS\/ATS_NNP criteria_NNS are_VBP used_VBN ,_, comprising_VBG a_DT bronchial_JJ lung_NN lavage_NN -LRB-_-LRB- BAL_NNP -RRB-_-RRB- and_CC one_CD or_CC more_JJR transbronchial_JJ biopsies_NNS ._. 
The_DT routine_NN at_IN the_DT clinic_NN is_VBZ to_TO make_VB once_RB bronchoscopy_JJ with_IN 5_CD to_TO 10_CD transbronchial_JJ biopsies_NNS and_CC BAL_NNP with_IN 200_CD mL_NN ._. 
Previous_JJ studies_NNS have_VBP reported_VBN that_IN NAHA_NNP represents_VBZ fungal_JJ biomass_NN both_DT in_IN the_DT growth_NN and_CC stationary_JJ phase_NN 
For_IN a_DT complete_JJ environmental_JJ assessment_NN ,_, measurements_NNS should_MD also_RB have_VB been_VBN made_VBN at_IN the_DT workplace_NN or_CC in_IN other_JJ environments_NNS where_WRB the_DT subject_NN spent_VBD considerable_JJ time_NN ._. 
On_IN the_DT other_JJ hand_NN experience_NN from_IN a_DT previous_JJ study_NN suggests_VBZ that_IN mould_JJ levels_NNS in_IN a_DT certain_JJ room_NN vary_VBP relatively_RB little_JJ within_IN a_DT year_NN ,_, particularly_RB in_IN buildings_NNS with_IN high_JJ levels_NNS of_IN moulds_NNS ._. 
Provided_VBN that_IN windows_NNS and_CC doors_NNS in_IN the_DT room_NN where_WRB measurements_NNS were_VBD made_VBN are_VBP closed_VBN prior_RB to_TO the_DT sampling_NN ,_, the_DT values_NNS reflect_VBP the_DT exposure_NN of_IN the_DT inhabitants_NNS ,_, irrespectively_RB of_IN outdoor_JJ conditions_NNS ._. 
Nutritional_NNP factors_NNS are_VBP an_DT example_NN of_IN another_DT important_JJ environmental_JJ influence_NN ._. 
Even_RB if_IN the_DT primary_JJ agent_NN studied_VBN here_RB was_VBD fungal_JJ cell_NN mass_NN ,_, it_PRP can_MD not_RB be_VB excluded_VBN that_IN agents_NNS such_JJ as_IN cooking_JJ fuels_NNS or_CC environmental_JJ tobacco_NN smoke_NN might_MD influence_VB the_DT exposure_NN outcome_NN and_CC hence_RB the_DT risk_NN of_IN disease_NN ._. 
Antioxidant_JJ status_NN has_VBZ also_RB been_VBN associated_VBN with_IN sarcoidosis_NNS although_IN it_PRP is_VBZ unclear_JJ if_IN it_PRP is_VBZ a_DT consequence_NN of_IN the_DT disease_NN ._. 
Conclusion_NN Measurements_NNS of_IN the_DT enzyme_NN NAHA_NNP as_IN a_DT marker_NN for_IN fungal_JJ biomass_NN demonstrated_VBD significantly_RB higher_JJR activities_NNS in_IN homes_NNS of_IN subjects_NNS with_IN sarcoidosis_NNS ,_, particularly_RB among_IN those_DT with_IN recurrent_JJ disease_NN ._. 
For_IN one_CD of_IN these_DT -_: 
In_IN a_DT case-control_JJ study_NN on_IN 706_CD newly_RB recruited_VBN cases_NNS of_IN sarcoidosis_NNS and_CC equal_JJ numbers_NNS of_IN age_NN -_: ,_, race_NN -_: ,_, and_CC gender_NN matched_VBD controls_NNS ,_, there_EX were_VBD positive_JJ associations_NNS between_IN sarcoidosis_NN and_CC agricultural_JJ employment_NN ,_, and_CC work_NN environments_NNS with_IN mould\/mildew_JJ exposure_NN 
It_PRP has_VBZ also_RB been_VBN reported_VBN that_IN sarcoidosis_NNS developed_VBN among_IN subjects_NNS in_IN a_DT group_NN of_IN persons_NNS working_VBG in_IN a_DT building_NN with_IN severe_JJ mould_NN problems_NNS 
It_PRP has_VBZ also_RB been_VBN reported_VBN that_IN sarcoidosis_NNS developed_VBN among_IN subjects_NNS in_IN a_DT group_NN of_IN persons_NNS working_VBG in_IN a_DT building_NN with_IN severe_JJ mould_NN problems_NNS 
This_DT possible_JJ relationship_NN does_VBZ not_RB necessarily_RB imply_VB infection_NN but_CC could_MD also_RB be_VB the_DT results_NNS of_IN an_DT immune_JJ reaction_NN to_TO one_CD or_CC several_JJ agents_NNS in_IN the_DT fungal_JJ cell_NN wall_NN ._. 
Apossible_JJ mechanism_NN could_MD be_VB the_DT development_NN of_IN a_DT late_JJ hypersensitivity_NN reaction_NN towards_IN some_DT agent_NN in_IN the_DT fungal_JJ cell_NN wall_NN such_JJ as_IN 
The_DT reason_NN why_WRB subjects_NNS with_IN a_DT history_NN of_IN disease_NN but_CC no_DT recurrence_NN had_VBD low_JJ values_NNS could_MD be_VB due_JJ to_TO cleaning_NN of_IN the_DT home_NN ,_, remediation_NN of_IN building_VBG related_JJ humidity_NN problems_NNS or_CC moving_VBG to_TO another_DT location_NN ,_, No_DT systematic_JJ evaluation_NN of_IN these_DT possibilities_NNS was_VBD made_VBN in_IN this_DT study_NN ,_, The_DT analysis_NN of_IN airborne_JJ samples_NNS comprised_VBD the_DT determination_NN of_IN NAHA_NNP as_IN a_DT measure_NN of_IN fungal_JJ biomass_NN ._. 
Measurements_NNS of_IN fungal_JJ cell_NN agents_NNS are_VBP more_RBR precise_JJ than_IN ocular_JJ inspection_NN to_TO detect_VB fungi_NNS 
The_DT results_NNS suggest_VBP that_IN remedial_JJ actions_NNS in_IN homes_NNS with_IN high_JJ levels_NNS of_IN fungi_NNS may_MD be_VB justified_VBN ._. 
Further_JJ environmental_JJ studies_NNS to_TO assess_VB the_DT importance_NN of_IN this_DT exposure_NN for_IN subjects_NNS with_IN sarcoidosis_NNS are_VBP warranted_VBN ._. 
BackgroundIt_NNP has_VBZ been_VBN suggested_VBN that_IN environmental_JJ agents_NNS ,_, particularly_RB microbes_NNS ,_, influence_VBP the_DT risk_NN to_TO develop_VB sarcoidosis_NNS ,_, Epidemiological_JJ studies_NNS have_VBP shown_VBN relationships_NNS between_IN sarcoidosis_NNS and_CC environments_NNS where_WRB mould_NN -LRB-_-LRB- fungi_NNS -RRB-_-RRB- would_MD be_VB present_JJ ._. 
Occupational_JJ risk_NN factors_NNS were_VBD evaluated_VBN among_IN 273_CD cases_NNS of_IN sarcoidosis_NNS and_CC 618_CD siblings_NNS without_IN the_DT disease_NN 
Background_NN It_PRP has_VBZ been_VBN suggested_VBN that_IN environmental_JJ agents_NNS ,_, particularly_RB microbes_NNS ,_, influence_VBP the_DT risk_NN to_TO develop_VB sarcoidosis_NNS ,_, Epidemiological_JJ studies_NNS have_VBP shown_VBN relationships_NNS between_IN sarcoidosis_NNS and_CC environments_NNS where_WRB mould_NN -LRB-_-LRB- fungi_NNS -RRB-_-RRB- would_MD be_VB present_JJ ._. 
Occupational_JJ risk_NN factors_NNS were_VBD evaluated_VBN among_IN 273_CD cases_NNS of_IN sarcoidosis_NNS and_CC 618_CD siblings_NNS without_IN the_DT disease_NN 
Specific_JJ risk_NN exposures_NNS that_WDT imply_VBP possible_JJ fungal_JJ exposures_NNS were_VBD vegetable_NN dusts_NNS ,_, and_CC indoor_JJ exposure_NN to_TO high_JJ humidity_NN ,_, water_NN damage_NN or_CC musty_JJ odours_NNS ._. 
In_IN a_DT case-control_JJ study_NN on_IN 706_CD newly_RB recruited_VBN cases_NNS of_IN sarcoidosis_NNS and_CC equal_JJ numbers_NNS of_IN age_NN -_: ,_, race_NN -_: ,_, and_CC gender_NN matched_VBD controls_NNS ,_, there_EX were_VBD positive_JJ associations_NNS between_IN sarcoidosis_NN and_CC agricultural_JJ employment_NN ,_, and_CC work_NN environments_NNS with_IN mould\/mildew_JJ exposure_NN 
Measurements_NNS of_IN fungal_JJ cell_NN agents_NNS are_VBP more_RBR precise_JJ than_IN ocular_JJ inspection_NN to_TO detect_VB fungi_NNS 
On_IN the_DT other_JJ hand_NN when_WRB the_DT fungi_NNS grow_VBP indoors_NNS such_JJ in_IN humid_JJ conditions_NNS ,_, there_EX is_VBZ no_DT reason_NN to_TO believe_VB that_IN other_JJ sources_NNS of_IN NAHA_NNP such_JJ as_IN pollen_NN or_CC mammalian_JJ cells_NNS would_MD also_RB multiply_VB ._. 
Aprevious_JJ study_NN has_VBZ demonstrated_VBN that_IN the_DT sensitivity_NN and_CC specificity_NN for_IN detection_NN of_IN buildings_NNS with_IN fungi_NNS are_VBP very_RB high_JJ and_CC the_DT possible_JJ confounding_JJ sources_NNS of_IN NAHA_NNP did_VBD not_RB play_VB an_DT important_JJ role_NN ._. 
Although_IN bacteria_NNS are_VBP generally_RB present_JJ in_IN environments_NNS with_IN fungal_JJ growth_NN ,_, their_PRP$ cell_NN wall_NN agents_NNS such_JJ as_IN endotoxin_FW elicit_FW other_JJ kinds_NNS of_IN immunological_JJ responses_NNS than_IN the_DT granulomatous_JJ inflammation_NN induced_VBN by_IN fungal_JJ components_NNS such_JJ as_IN 
Apossible_JJ mechanism_NN could_MD be_VB the_DT development_NN of_IN a_DT late_JJ hypersensitivity_NN reaction_NN towards_IN some_DT agent_NN in_IN the_DT fungal_JJ cell_NN wall_NN such_JJ as_IN 
There_EX are_VBP several_JJ fungal_JJ cell_NN components_NNS which_WDT may_MD influence_VB the_DT innate_JJ immune_JJ system_NN ._. 
This_DT suggests_VBZ that_IN ,_, if_IN fungi_NNS contribute_VBP to_TO the_DT development_NN of_IN sarcoidosis_NNS ,_, the_DT effect_NN would_MD be_VB mediated_VBN by_IN other_JJ mechanisms_NNS than_IN infection_NN ._. 
For_IN one_CD of_IN these_DT -_: 
At_IN low_JJ doses_NNS ,_, similar_JJ to_TO those_DT present_JJ in_IN the_DT environment_NN ,_, the_DT major_JJ initial_JJ effect_NN is_VBZ an_DT immune_JJ suppression_NN and_CC a_DT Th2_JJ deviated_VBN lymphocyte_NN response_NN which_WDT may_MD deviate_VB to_TO a_DT Th1_JJ driven_JJ response_NN with_IN repeated_JJ exposures_NNS ._. 
This_DT effect_NN would_MD be_VB present_JJ even_RB if_IN the_DT fungal_JJ cell_NN is_VBZ dead_JJ as_IN 
To_TO test_VB this_DT hypothesis_NN ,_, a_DT study_NN was_VBD undertaken_VBN with_IN the_DT aim_NN to_TO determine_VB airborne_JJ levels_NNS of_IN fungi_NNS in_IN homes_NNS of_IN subjects_NNS with_IN sarcoidosis_NNS and_CC those_DT without_IN pulmonary_JJ disease_NN ._. 
The_DT presence_NN of_IN fungal_JJ cells_NNS was_VBD determined_VBN by_IN analyzing_VBG the_DT air_NN samples_NNS for_IN the_DT enzyme_NN N-acetylhexosaminidase_NNP -LRB-_-LRB- NAHA_NNP -RRB-_-RRB- as_IN a_DT marker_NN of_IN fungal_JJ cell_NN biomass_NN ._. 
Methods_NNS Subjects_NNS The_DT clinic_NN of_IN respiratory_JJ diseases_NNS and_CC allergy_NN at_IN the_DT University_NNP medical_JJ center_NN ,_, Ljubljana_NNP ,_, Slovenia_NNP is_VBZ one_CD of_IN the_DT national_JJ centres_NNS for_IN patients_NNS with_IN sarcoidosis_NNS ._. 
Significant_JJ correlations_NNS between_IN NAHA_NNP and_CC total_JJ spore_NN counts_NNS were_VBD found_VBN in_IN air_NN samples_NNS and_CC in_IN dust_NN generated_VBN from_IN biomass_NN in_IN a_DT biofuel_NN plant_NN ._. 
Strong_JJ correlations_NNS were_VBD found_VBN between_IN fungal_JJ biomass_NN -LRB-_-LRB- gravimetric_JJ weight_NN -RRB-_-RRB- and_CC NAHA_NNP in_IN fungal_JJ species_NNS grown_VBN on_IN nutrient_NN agar_NN and_CC between_IN ergosterol_NNP and_CC NAHA_NNP activity_NN on_IN mould_JJ contaminated_VBN gypsum_NN boards_NNS 
Strong_JJ correlations_NNS were_VBD found_VBN between_IN fungal_JJ biomass_NN -LRB-_-LRB- gravimetric_JJ weight_NN -RRB-_-RRB- and_CC NAHA_NNP in_IN fungal_JJ species_NNS grown_VBN on_IN nutrient_NN agar_NN and_CC between_IN ergosterol_NNP and_CC NAHA_NNP activity_NN on_IN mould_JJ contaminated_VBN gypsum_NN boards_NNS 
Measurements_NNS of_IN fungal_JJ cell_NN agents_NNS are_VBP more_RBR precise_JJ than_IN ocular_JJ inspection_NN to_TO detect_VB fungi_NNS 
Overall_RB ,_, study_NN results_NNS showed_VBD an_DT excess_JJ risk_NN of_IN leukemia_NN ,_, but_CC not_RB of_IN other_JJ hematological_JJ malignancies_NNS ,_, in_IN children_NNS exposed_VBN to_TO magnetic_JJ fields_NNS generated_VBN from_IN power_NN lines_NNS ,_, and_CC this_DT finding_NN appears_VBZ in_IN line_NN with_IN most_JJS studies_NNS carried_VBD out_RP on_IN this_DT topic_NN 
In_IN this_DT way_NN EFC-400_NN is_VBZ able_JJ to_TO simulate_VB complex_JJ situations_NNS ,_, like_IN closing_NN ,_, crossing_VBG ,_, curved_JJ and_CC finite_JJ electric_JJ lines_NNS ._. 
Both_DT models_NNS have_VBP been_VBN validated_VBN in_IN a_DT survey_NN which_WDT confirmed_VBD that_IN both_DT models_NNS carefully_RB predicted_VBD the_DT magnetic_JJ field_NN distribution_NN detected_VBN through_IN on-site_JJ measurements_NNS around_IN a_DT high_JJ voltage_NN -LRB-_-LRB- 132_CD kilovolts_NNS -RRB-_-RRB- power_NN line_NN in_IN the_DT bordering_VBG Bologna_NNP province_NN ._. 
For_IN both_DT CAMPI_NNP and_CC EFC400_NNP models_NNS ,_, we_PRP considered_VBD the_DT characteristics_NNS and_CC the_DT disposition_NN of_IN conductors_NNS of_IN each_DT power_NN line_NN ,_, and_CC we_PRP used_VBD the_DT average_JJ current_JJ run_NN in_IN the_DT power_NN lines_NNS during_IN 2001_CD ,_, which_WDT is_VBZ the_DT earliest_JJS year_NN datum_NN made_VBD available_JJ by_IN the_DT regional_JJ environmental_JJ protection_NN agency_NN ,_, ARPA_NNP ,_, due_JJ to_TO mandatory_JJ reporting_NN of_IN currents_NNS by_IN the_DT electric_JJ companies_NNS in_IN compliance_NN with_IN the_DT Emilia-Romagna_NNP Region_NNP rule_NN `_`` Direttiva_NNP 197\/2001_CD '_'' ._. 
Another_DT limitation_NN of_IN the_DT study_NN is_VBZ the_DT use_NN of_IN calculated_JJ magnetic_JJ fields_NNS based_VBN on_IN power_NN lines_NNS configuration_NN and_CC not_RB on_IN direct_JJ measurements_NNS of_IN exposure_NN ._. 
However_RB ,_, previous_JJ studies_NNS have_VBP shown_VBN that_IN ,_, particularly_RB for_IN children_NNS ,_, this_DT methodology_NN tends_VBZ to_TO be_VB substantially_RB adequate_JJ in_IN reflecting_VBG actual_JJ exposure_NN to_TO power_NN lines-induced_JJ magnetic_JJ fields_NNS ,_, and_CC that_IN this_DT source_NN of_IN exposure_NN tends_VBZ to_TO exceed_VB the_DT contribution_NN of_IN other_JJ sources_NNS such_JJ as_IN home_NN appliances_NNS 
In_IN fact_NN ,_, all_DT children_NNS affected_VBN by_IN hematological_JJ malignancies_NNS are_VBP expected_VBN to_TO be_VB referred_VBN to_TO hospital_NN and_CC to_TO highly-specialized_JJ centers_NNS in_IN particular_JJ ,_, all_DT of_IN which_WDT are_VBP included_VBN in_IN the_DT AIEOP_NNP network_NN ._. 
Moreover_RB ,_, we_PRP verified_VBD the_DT completeness_NN of_IN this_DT registry_NN for_IN hematological_JJ cancers_NNS in_IN the_DT Reggio_NNP Emilia_NNP municipality_NN by_IN comparing_VBG its_PRP$ database_NN with_IN information_NN collected_VBN in_IN loco_NN from_IN several_JJ data_NNS sources_NNS -LRB-_-LRB- hospital_NN discharge_VB registry_NN ,_, drug_NN prescriptions_NNS ,_, family_NN doctors_NNS ,_, death_NN certificates_NNS -RRB-_-RRB- ._. 
All_DT but_CC one_CD case_NN was_VBD reported_VBN to_TO the_DT study_NN registry_NN ,_, which_WDT in_IN turn_NN was_VBD an_DT independent_JJ source_NN for_IN only_RB one_CD additional_JJ case_NN ._. 
It_PRP should_MD also_RB be_VB noted_VBN that_IN recent_JJ laboratory_NN studies_NNS have_VBP increased_VBN the_DT biological_JJ plausibility_NN of_IN adverse_JJ health_NN effects_NNS of_IN extremely_RB low_JJ frequency_NN magnetic_JJ fields_NNS 
Conclusions_NNS Though_IN the_DT number_NN of_IN exposed_JJ children_NNS in_IN this_DT study_NN was_VBD too_RB low_JJ to_TO allow_VB firm_JJ conclusions_NNS ,_, results_NNS were_VBD more_RBR suggestive_JJ of_IN an_DT excess_JJ risk_NN of_IN leukemia_NN among_IN exposed_JJ children_NNS than_IN of_IN a_DT null_JJ relation_NN ._. 
BackgroundSince_NN the_DT original_JJ observation_NN by_IN Wertheimer_NNP and_CC Leeper_NNP in_IN 1979_CD 
Overall_RB ,_, study_NN results_NNS showed_VBD an_DT excess_JJ risk_NN of_IN leukemia_NN ,_, but_CC not_RB of_IN other_JJ hematological_JJ malignancies_NNS ,_, in_IN children_NNS exposed_VBN to_TO magnetic_JJ fields_NNS generated_VBN from_IN power_NN lines_NNS ,_, and_CC this_DT finding_NN appears_VBZ in_IN line_NN with_IN most_JJS studies_NNS carried_VBD out_RP on_IN this_DT topic_NN 
Conclusions_NNS Though_IN the_DT number_NN of_IN exposed_JJ children_NNS in_IN this_DT study_NN was_VBD too_RB low_JJ to_TO allow_VB firm_JJ conclusions_NNS ,_, results_NNS were_VBD more_RBR suggestive_JJ of_IN an_DT excess_JJ risk_NN of_IN leukemia_NN among_IN exposed_JJ children_NNS than_IN of_IN a_DT null_JJ relation_NN ._. 
BackgroundSince_NN the_DT original_JJ observation_NN by_IN Wertheimer_NNP and_CC Leeper_NNP in_IN 1979_CD 
In_IN such_JJ investigations_NNS ,_, general_JJ population_NN residential_JJ distribution_NN might_MD have_VB substantially_RB changed_VBN over_IN time_NN with_IN reference_NN to_TO proximity_NN to_TO power_NN lines_NNS ,_, thus_RB biasing_VBG exposure_NN status_NN of_IN controls_NNS ._. 
Overall_RB ,_, study_NN results_NNS showed_VBD an_DT excess_JJ risk_NN of_IN leukemia_NN ,_, but_CC not_RB of_IN other_JJ hematological_JJ malignancies_NNS ,_, in_IN children_NNS exposed_VBN to_TO magnetic_JJ fields_NNS generated_VBN from_IN power_NN lines_NNS ,_, and_CC this_DT finding_NN appears_VBZ in_IN line_NN with_IN most_JJS studies_NNS carried_VBD out_RP on_IN this_DT topic_NN 
It_PRP should_MD also_RB be_VB noted_VBN that_IN recent_JJ laboratory_NN studies_NNS have_VBP increased_VBN the_DT biological_JJ plausibility_NN of_IN adverse_JJ health_NN effects_NNS of_IN extremely_RB low_JJ frequency_NN magnetic_JJ fields_NNS 
Background_NN Since_IN the_DT original_JJ observation_NN by_IN Wertheimer_NNP and_CC Leeper_NNP in_IN 1979_CD 
Another_DT limitation_NN of_IN the_DT study_NN is_VBZ the_DT use_NN of_IN calculated_JJ magnetic_JJ fields_NNS based_VBN on_IN power_NN lines_NNS configuration_NN and_CC not_RB on_IN direct_JJ measurements_NNS of_IN exposure_NN ._. 
However_RB ,_, previous_JJ studies_NNS have_VBP shown_VBN that_IN ,_, particularly_RB for_IN children_NNS ,_, this_DT methodology_NN tends_VBZ to_TO be_VB substantially_RB adequate_JJ in_IN reflecting_VBG actual_JJ exposure_NN to_TO power_NN lines-induced_JJ magnetic_JJ fields_NNS ,_, and_CC that_IN this_DT source_NN of_IN exposure_NN tends_VBZ to_TO exceed_VB the_DT contribution_NN of_IN other_JJ sources_NNS such_JJ as_IN home_NN appliances_NNS 
Conclusions_NNS Though_IN the_DT number_NN of_IN exposed_JJ children_NNS in_IN this_DT study_NN was_VBD too_RB low_JJ to_TO allow_VB firm_JJ conclusions_NNS ,_, results_NNS were_VBD more_RBR suggestive_JJ of_IN an_DT excess_JJ risk_NN of_IN leukemia_NN among_IN exposed_JJ children_NNS than_IN of_IN a_DT null_JJ relation_NN ._. 
BackgroundSince_NN the_DT original_JJ observation_NN by_IN Wertheimer_NNP and_CC Leeper_NNP in_IN 1979_CD 
Conclusions_NNS Though_IN the_DT number_NN of_IN exposed_JJ children_NNS in_IN this_DT study_NN was_VBD too_RB low_JJ to_TO allow_VB firm_JJ conclusions_NNS ,_, results_NNS were_VBD more_RBR suggestive_JJ of_IN an_DT excess_JJ risk_NN of_IN leukemia_NN among_IN exposed_JJ children_NNS than_IN of_IN a_DT null_JJ relation_NN ._. 
BackgroundSince_NN the_DT original_JJ observation_NN by_IN Wertheimer_NNP and_CC Leeper_NNP in_IN 1979_CD 
Conclusions_NNS Though_IN the_DT number_NN of_IN exposed_JJ children_NNS in_IN this_DT study_NN was_VBD too_RB low_JJ to_TO allow_VB firm_JJ conclusions_NNS ,_, results_NNS were_VBD more_RBR suggestive_JJ of_IN an_DT excess_JJ risk_NN of_IN leukemia_NN among_IN exposed_JJ children_NNS than_IN of_IN a_DT null_JJ relation_NN ._. 
BackgroundSince_NN the_DT original_JJ observation_NN by_IN Wertheimer_NNP and_CC Leeper_NNP in_IN 1979_CD 
Moreover_RB ,_, we_PRP could_MD acquire_VB all_DT study_NN data_NNS -LRB-_-LRB- residential_JJ histories_NNS and_CC socioeconomic_JJ information_NN -RRB-_-RRB- without_IN directly_RB contacting_VBG the_DT families_NNS ,_, thus_RB avoiding_VBG the_DT risk_NN of_IN recall_NN and_CC selection_NN bias_NN due_JJ to_TO refusal_NN to_TO participate_VB ,_, and_CC consequently_RB the_DT likelihood_NN of_IN generating_VBG inaccurate_JJ information_NN ._. 
We_PRP were_VBD also_RB able_JJ to_TO adjust_VB the_DT analysis_NN for_IN three_CD indicators_NNS of_IN socioeconomic_JJ status_NN including_VBG paternal_JJ income_NN ,_, thus_RB reducing_VBG the_DT risk_NN of_IN substantial_JJ confounding_NN ,_, though_IN no_DT obvious_JJ relation_NN between_IN socioeconomic_JJ status_NN and_CC leukemia_NN risk_NN appears_VBZ to_TO exist_VB ,_, and_CC in_IN the_DT present_JJ study_NN risk_NN estimates_NNS did_VBD not_RB substantially_RB change_VB after_IN adjusting_VBG for_IN these_DT indicators_NNS ._. 
Finally_RB ,_, we_PRP selected_VBD the_DT controls_NNS on_IN the_DT basis_NN of_IN the_DT historical_JJ databases_NNS of_IN municipal_JJ residents_NNS matched_VBN to_TO years_NNS of_IN diagnosis_NN of_IN cases_NNS ,_, different_JJ to_TO previous_JJ case-control_JJ studies_NNS where_WRB the_DT referents_NNS were_VBD sampled_VBN from_IN a_DT single_JJ ,_, recently_RB available_JJ directory_NN of_IN residents_NNS ,_, despite_IN the_DT long_JJ period_NN of_IN time_NN during_IN which_WDT disease_NN diagnoses_NNS occurred_VBD in_IN cases_NNS -LRB-_-LRB- even_RB in_IN the_DT order_NN of_IN 15-20_CD years_NNS -RRB-_-RRB- ._. 
In_IN fact_NN ,_, an_DT increased_VBN childhood_NN leukemia_NN risk_NN in_IN the_DT proximity_NN of_IN high_JJ voltage_NN power_NN lines_NNS was_VBD detected_VBN not_RB only_RB in_IN a_DT recent_JJ large_JJ case-control_JJ investigation_NN 
Background_NN Since_IN the_DT original_JJ observation_NN by_IN Wertheimer_NNP and_CC Leeper_NNP in_IN 1979_CD 
20-0_CD ._. 
94_CD %_NN ,_, higher_JJR than_IN the_DT available_JJ figures_NNS for_IN the_DT Italian_JJ population_NN of_IN 0_CD ._. 
4_CD 
In_IN such_JJ investigations_NNS ,_, general_JJ population_NN residential_JJ distribution_NN might_MD have_VB substantially_RB changed_VBN over_IN time_NN with_IN reference_NN to_TO proximity_NN to_TO power_NN lines_NNS ,_, thus_RB biasing_VBG exposure_NN status_NN of_IN controls_NNS ._. 
Overall_RB ,_, study_NN results_NNS showed_VBD an_DT excess_JJ risk_NN of_IN leukemia_NN ,_, but_CC not_RB of_IN other_JJ hematological_JJ malignancies_NNS ,_, in_IN children_NNS exposed_VBN to_TO magnetic_JJ fields_NNS generated_VBN from_IN power_NN lines_NNS ,_, and_CC this_DT finding_NN appears_VBZ in_IN line_NN with_IN most_JJS studies_NNS carried_VBD out_RP on_IN this_DT topic_NN 
It_PRP should_MD also_RB be_VB noted_VBN that_IN recent_JJ laboratory_NN studies_NNS have_VBP increased_VBN the_DT biological_JJ plausibility_NN of_IN adverse_JJ health_NN effects_NNS of_IN extremely_RB low_JJ frequency_NN magnetic_JJ fields_NNS 
Methods_NNP Study_NNP population_NN We_PRP attempted_VBD to_TO identify_VB all_DT cases_NNS of_IN hematological_JJ cancers_NNS newly-diagnosed_JJ during_IN the_DT 1986-2007_CD period_NN in_IN children_NNS while_IN residing_VBG in_IN the_DT two_CD northern_JJ Italy_NNP municipalities_NNS of_IN Modena_NNP e_SYM Reggio_NNP Emilia_NNP -LRB-_-LRB- around_IN 180,000_CD and_CC 160,000_CD inhabitants_NNS in_IN 2007_CD ,_, respectively_RB -RRB-_-RRB- ._. 
To_TO do_VB so_RB ,_, we_PRP used_VBD the_DT nation-wide_JJ hospital-based_JJ registry_NN of_IN childhood_NN malignancies_NNS managed_VBN by_IN the_DT Associazione_NNP Italiana_NNP Ematologia_NNP Oncologia_NNP Pediatrica_NNP -LRB-_-LRB- AIEOP_NNP -RRB-_-RRB- ._. 
The_DT AIEOP_NNP Registry_NNP ,_, operating_VBG since_IN 1985_CD and_CC based_VBN on_IN collaboration_NN with_IN 54_CD specialized_JJ hospital_NN centers_NNS in_IN Italy_NNP belonging_VBG to_TO this_DT network_NN ,_, has_VBZ to_TO date_NN registered_VBD 35,256_CD newly_RB diagnosed_VBN patients_NNS up_IN to_TO the_DT age_NN of_IN 14_CD ._. 
In_IN fact_NN ,_, an_DT increased_VBN childhood_NN leukemia_NN risk_NN in_IN the_DT proximity_NN of_IN high_JJ voltage_NN power_NN lines_NNS was_VBD detected_VBN not_RB only_RB in_IN a_DT recent_JJ large_JJ case-control_JJ investigation_NN 
However_RB ,_, previous_JJ studies_NNS have_VBP shown_VBN that_IN ,_, particularly_RB for_IN children_NNS ,_, this_DT methodology_NN tends_VBZ to_TO be_VB substantially_RB adequate_JJ in_IN reflecting_VBG actual_JJ exposure_NN to_TO power_NN lines-induced_JJ magnetic_JJ fields_NNS ,_, and_CC that_IN this_DT source_NN of_IN exposure_NN tends_VBZ to_TO exceed_VB the_DT contribution_NN of_IN other_JJ sources_NNS such_JJ as_IN home_NN appliances_NNS 
New_JJ techniques_NNS could_MD be_VB used_VBN in_IN addition_NN to_TO these_DT standard_JJ approaches_NNS to_TO identify_VB sources_NNS of_IN exposure_NN in_IN the_DT case_NN of_IN low_JJ B-Pb_NN ,_, particularly_RB as_IN environmental_JJ health_NN services_NNS in_IN some_DT European_JJ countries_NNS may_MD consider_VB B-Pb_JJ below_IN the_DT current_JJ limit_NN of_IN 100_CD 
Numerous_JJ studies_NNS have_VBP demonstrated_VBN the_DT usefulness_NN of_IN isotopic_JJ signatures_NNS for_IN identifying_VBG lead_JJ exposure_NN sources_NNS in_IN mining_NN regions_NNS and_CC in_IN homes_NNS 
In_IN addition_NN ,_, in_IN cases_NNS of_IN multi-source_JJ exposure_NN ,_, if_IN the_DT sources_NNS have_VBP different_JJ isotopic_JJ compositions_NNS ,_, the_DT blood_NN will_MD be_VB located_VBN ``_`` partway_NN ''_'' between_IN these_DT sources_NNS ,_, which_WDT may_MD be_VB considered_VBN as_IN incompatible_JJ ._. 
Furthermore_RB ,_, blood_NN lead_NN may_MD be_VB a_DT combination_NN of_IN external_JJ lead_NN and_CC lead_NN released_VBN from_IN bones_NNS ,_, in_IN which_WDT case_NN the_DT isotopic_JJ signature_NN of_IN sampled_VBN sources_NNS may_MD not_RB agree_VB owing_VBG to_TO the_DT presence_NN of_IN endogenous_JJ lead_NN sources_NNS ._. 
Finally_RB ,_, in_IN this_DT study_NN ,_, no_DT diet_NN samples_NNS were_VBD collected_VBN because_IN dietary_JJ inputs_NNS consisted_VBN of_IN many_JJ products_NNS for_IN which_WDT the_DT isotopic_JJ signature_NN is_VBZ a_DT mix_NN of_IN several_JJ signatures_NNS from_IN different_JJ lead_NN sources_NNS ._. 
This_DT study_NN used_VBD the_DT most_JJS discriminating_VBG LIRs_NNP for_IN the_DT French_JJ context_NN ,_, namely_RB 207_CD Pb_FW \/_FW 206_CD Pb_NNP and_CC 206_CD Pb_FW \/_FW 204_FW Pb_FW ._. 
However_RB ,_, it_PRP is_VBZ well_RB known_VBN that_IN using_VBG all_DT lead_JJ isotopes_NNS could_MD maximize_VB discrimination_NN of_IN sources_NNS ._. 
The_DT measurement_NN of_IN the_DT abundance_NN of_IN 204_CD Pb_NNP lead_NN ,_, which_WDT is_VBZ the_DT most_RBS difficult_JJ to_TO quantify_VB owing_NN to_TO its_PRP$ much_RB lower_JJR abundance_NN ,_, is_VBZ sometimes_RB omitted_VBN ._. 
Lead_JJ isotope_JJ ratios_NNS -LRB-_-LRB- LIR_NNP -RRB-_-RRB- could_MD be_VB a_DT useful_JJ means_NN of_IN identifying_VBG sources_NNS of_IN exposure_NN for_IN individual_JJ cases_NNS in_IN routine_JJ investigations_NNS 
This_DT national_JJ survey_NN estimated_VBD the_DT geometric_JJ mean_NN for_IN the_DT B-Pb_NN of_IN children_NNS in_IN France_NNP at_IN 15_CD 
Hospitals_NNS located_VBN in_IN areas_NNS with_IN a_DT higher_JJR risk_NN of_IN lead_NN exposure_NN in_IN housing_NN were_VBD intentionally_RB over-represented_VBN ;_: the_DT inclusion_NN and_CC survey_NN procedures_NNS are_VBP described_VBN by_IN Etchevers_NNPS et_FW al._FW ._. ._. 
The_DT sub-population_NN for_IN the_DT complete_JJ ,_, validated_VBN environmental_JJ investigation_NN included_VBD 484_CD children_NNS between_IN six_CD months_NNS and_CC six_CD years_NNS old_JJ ._. 
The_DT children_NNS included_VBD in_IN the_DT environmental_JJ investigation_NN coordinated_VBN by_IN CSTB_NNP were_VBD enrolled_VBN in_IN the_DT national_JJ study_NN conducted_VBN by_IN the_DT InVS_NNP ,_, whose_WP$ representativeness_NN is_VBZ discussed_VBN by_IN Etchevers_NNP et_FW al._FW ._. ._. 
Four_CD hundred_CD and_CC eighty_CD four_CD were_VBD included_VBN in_IN the_DT analysis_NN ._. 
When_WRB comparing_VBG the_DT group_NN who_WP declined_VBD participation_NN to_TO those_DT who_WP agreed_VBD ,_, on_IN the_DT basis_NN of_IN access_NN to_TO free_JJ health_NN insurance_NN in_IN France_NNP -LRB-_-LRB- CMU_NNP -RRB-_-RRB- -_: a_DT very_RB useful_JJ indicator_NN because_IN it_PRP is_VBZ a_DT risk_NN marker_NN for_IN lead_NN exposure_NN in_IN France_NNP 
Four_CD hundred_CD and_CC eighty_CD four_CD were_VBD included_VBN in_IN the_DT analysis_NN ._. ._. 
The_DT children_NNS included_VBD in_IN the_DT environmental_JJ investigation_NN coordinated_VBN by_IN CSTB_NNP were_VBD enrolled_VBN in_IN the_DT national_JJ study_NN conducted_VBN by_IN the_DT InVS_NNP ,_, whose_WP$ representativeness_NN is_VBZ discussed_VBN by_IN Etchevers_NNP et_FW al._FW ._. 
When_WRB comparing_VBG the_DT group_NN who_WP declined_VBD participation_NN to_TO those_DT who_WP agreed_VBD ,_, on_IN the_DT basis_NN of_IN access_NN to_TO free_JJ health_NN insurance_NN in_IN France_NNP -LRB-_-LRB- CMU_NNP -RRB-_-RRB- -_: a_DT very_RB useful_JJ indicator_NN because_IN it_PRP is_VBZ a_DT risk_NN marker_NN for_IN lead_NN exposure_NN in_IN France_NNP 
Routine_JJ identification_NN of_IN sources_NNS of_IN lead_NN exposure_NN in_IN France_NNP is_VBZ currently_RB based_VBN on_IN children_NNS 's_POS behavior_NN ,_, observation_NN of_IN their_PRP$ homes_NNS and_CC determination_NN of_IN lead_NN concentrations_NNS in_IN their_PRP$ environment_NN ,_, such_JJ as_IN paint_NN ,_, dust_NN ,_, soil_NN ,_, and_CC water_NN ._. 
New_JJ techniques_NNS could_MD be_VB used_VBN in_IN addition_NN to_TO these_DT standard_JJ approaches_NNS to_TO identify_VB sources_NNS of_IN exposure_NN in_IN the_DT case_NN of_IN low_JJ B-Pb_NN ,_, particularly_RB as_IN environmental_JJ health_NN services_NNS in_IN some_DT European_JJ countries_NNS may_MD consider_VB B-Pb_JJ below_IN the_DT current_JJ limit_NN of_IN 100_CD 
We_PRP calculated_VBD ,_, following_VBG the_DT method_NN described_VBN by_IN Glorennec_NNP et_FW al._FW ._. 
Isotopic_JJ analysis_NN of_IN an_DT environmental_JJ sample_NN is_VBZ relevant_JJ only_RB if_IN the_DT lead_JJ concentration_NN can_MD lead_VB to_TO B-Pb_JJ exceeding_VBG or_CC equal_JJ to_TO 25_CD 
This_DT would_MD not_RB be_VB the_DT case_NN in_IN an_DT individual_JJ study_NN for_IN a_DT public_JJ health_NN campaign_NN ._. 
Moreover_RB ,_, the_DT child_NN 's_POS history_NN ,_, personal_JJ practices_NNS and_CC details_NNS of_IN his\/her_JJ habits_NNS -LRB-_-LRB- including_VBG diet_NN -RRB-_-RRB- were_VBD not_RB considered_VBN ._. 
It_PRP is_VBZ noteworthy_JJ that_IN isotope_JJ analyses_NNS were_VBD shown_VBN to_TO be_VB more_RBR useful_JJ in_IN a_DT targeted_JJ area_NN in_IN France_NNP with_IN the_DT highest_JJS B-Pb_JJ and_CC more_RBR exhaustive_JJ environmental_JJ sampling_NN ._. 
Conclusions_NNS Current_JJ routine_NN -LRB-_-LRB- i._FW e._FW relatively_RB easy_JJ and_CC not_RB expensive_JJ to_TO implement_VB -RRB-_-RRB- identification_NN of_IN sources_NNS of_IN lead_NN exposure_NN is_VBZ based_VBN on_IN the_DT observation_NN of_IN child_NN behavior_NN and_CC determination_NN of_IN the_DT lead_JJ concentration_NN in_IN environmental_JJ samples_NNS ._. 
Children_NNS are_VBP more_RBR vulnerable_JJ because_IN of_IN their_PRP$ greater_JJR contact_NN with_IN their_PRP$ environment_NN -LRB-_-LRB- hand-mouth_JJ behavior_NN -RRB-_-RRB- ,_, their_PRP$ higher_JJR intake_NN rate_NN and_CC the_DT development_NN of_IN their_PRP$ neural_JJ system_NN ._. 
Recently_RB ,_, the_DT European_JJ food_NN safety_NN agency_NN -LRB-_-LRB- EFSA_NNP -RRB-_-RRB- established_VBD a_DT benchmark_JJ dose_NN :_: an_DT increase_NN of_IN 12_CD 
In_IN some_DT countries_NNS ,_, there_EX are_VBP many_JJ complex_JJ sources_NNS of_IN lead_NN exposure_NN -LRB-_-LRB- mining_NN activities_NNS ,_, pollution_NN from_IN leaded_VBN gasoline_NN remaining_VBG in_IN the_DT atmosphere_NN and_CC industrial_JJ emissions_NNS ,_, cosmetics_NNS ,_, etc_FW -RRB-_-RRB- ._. 
In_IN addition_NN ,_, lead-based_JJ paint_NN is_VBZ considered_VBN to_TO be_VB the_DT primary_JJ lead_NN source_NN for_IN children_NNS with_IN B-Pb_NN 
48_CD 
There_EX were_VBD fewer_JJR children_NNS with_IN relatively_RB high_JJ blood_NN lead_NN levels_NNS in_IN our_PRP$ sample_NN than_IN anticipated_VBN ._. 
The_DT B-Pb_NNP in_IN children_NNS six_CD months_NNS to_TO six_CD years_NNS have_VBP declined_VBN significantly_RB in_IN recent_JJ years_NNS and_CC the_DT number_NN of_IN children_NNS with_IN B-Pb_JJ greater_JJR than_IN 100_CD and_CC 50_CD 
9._CD 
Components_NNP of_IN the_DT sampling_NN design_NN -LRB-_-LRB- sampling_VBG weights_NNS ,_, stratification_NN and_CC stages_NNS -RRB-_-RRB- were_VBD taken_VBN into_IN account_NN with_IN the_DT ``_`` survey_NN ''_'' package_NN of_IN R_NN 
In_IN addition_NN ,_, in_IN cases_NNS of_IN multi-source_JJ exposure_NN ,_, if_IN the_DT sources_NNS have_VBP different_JJ isotopic_JJ compositions_NNS ,_, the_DT blood_NN will_MD be_VB located_VBN ``_`` partway_NN ''_'' between_IN these_DT sources_NNS ,_, which_WDT may_MD be_VB considered_VBN as_IN incompatible_JJ ._. 
Furthermore_RB ,_, blood_NN lead_NN may_MD be_VB a_DT combination_NN of_IN external_JJ lead_NN and_CC lead_NN released_VBN from_IN bones_NNS ,_, in_IN which_WDT case_NN the_DT isotopic_JJ signature_NN of_IN sampled_VBN sources_NNS may_MD not_RB agree_VB owing_VBG to_TO the_DT presence_NN of_IN endogenous_JJ lead_NN sources_NNS ._. 
Finally_RB ,_, in_IN this_DT study_NN ,_, no_DT diet_NN samples_NNS were_VBD collected_VBN because_IN dietary_JJ inputs_NNS consisted_VBN of_IN many_JJ products_NNS for_IN which_WDT the_DT isotopic_JJ signature_NN is_VBZ a_DT mix_NN of_IN several_JJ signatures_NNS from_IN different_JJ lead_NN sources_NNS ._. 
In_IN addition_NN ,_, in_IN cases_NNS of_IN multi-source_JJ exposure_NN ,_, if_IN the_DT sources_NNS have_VBP different_JJ isotopic_JJ compositions_NNS ,_, the_DT blood_NN will_MD be_VB located_VBN ``_`` partway_NN ''_'' between_IN these_DT sources_NNS ,_, which_WDT may_MD be_VB considered_VBN as_IN incompatible_JJ ._. 
Furthermore_RB ,_, blood_NN lead_NN may_MD be_VB a_DT combination_NN of_IN external_JJ lead_NN and_CC lead_NN released_VBN from_IN bones_NNS ,_, in_IN which_WDT case_NN the_DT isotopic_JJ signature_NN of_IN sampled_VBN sources_NNS may_MD not_RB agree_VB owing_VBG to_TO the_DT presence_NN of_IN endogenous_JJ lead_NN sources_NNS ._. 
Finally_RB ,_, in_IN this_DT study_NN ,_, no_DT diet_NN samples_NNS were_VBD collected_VBN because_IN dietary_JJ inputs_NNS consisted_VBN of_IN many_JJ products_NNS for_IN which_WDT the_DT isotopic_JJ signature_NN is_VBZ a_DT mix_NN of_IN several_JJ signatures_NNS from_IN different_JJ lead_NN sources_NNS ._. 
The_DT mass_NN bias_NN was_VBD corrected_VBN with_IN a_DT certified_JJ reference_NN material_NN -LRB-_-LRB- Common_JJ Lead_JJ Isotopic_NNP Standard_NNP ,_, SRM_NNP 981_CD ,_, NIST_NNP -RRB-_-RRB- using_VBG the_DT standard_JJ bracketing_NN technique_NN described_VBN in_IN 
Each_DT of_IN the_DT two_CD laboratories_NNS used_VBD its_PRP$ own_JJ method_NN for_IN determining_VBG mass_JJ correction_NN with_IN the_DT standard_JJ SRM_NNP 981_CD and_CC correction_NN of_IN blanks_NNS ._. 
The_DT results_NNS were_VBD comparable_JJ -LRB-_-LRB- details_NNS are_VBP provided_VBN in_IN additional_JJ file_NN 1_CD and_CC technical_JJ report_NN -RRB-_-RRB- ._. 
Relative_JJ standard_JJ deviations_NNS -LRB-_-LRB- RSD_NNP -RRB-_-RRB- of_IN LIR_NNP in_IN environmental_JJ samples_NNS were_VBD respectively_RB between_IN 0_CD ._. 
1%_CD and_CC 0_CD ._. 
It_PRP illustrates_VBZ the_DT variability_NN of_IN LIR_NNP between_IN sources_NNS from_IN this_DT home_NN ._. -RRB-_-RRB- 
from_IN a_DT child_NN 's_POS home_NN ..._: It_PRP is_VBZ defined_VBN as_IN :_: -LRB-_-LRB- 1_CD -RRB-_-RRB- D_NNP F_NN =_SYM V_NNP s_VBZ 
The_DT isotope_JJ ratios_NNS were_VBD determined_VBN using_VBG quadrupole_NN ICP-MS_NNP -LRB-_-LRB- Inductively_NNP Coupled_NNP Plasma_NNP -_: Mass_NNP Spectrometry_NNP -RRB-_-RRB- -LRB-_-LRB- Elan_NNP DRCe_NNP ,_, Perkin_NNP Elmer_NNP 
Interpretation_NN of_IN LIRs_NNP for_IN each_DT child_NN To_TO identify_VB sources_NNS of_IN lead_NN exposure_NN ,_, the_DT isotopic_JJ signature_NN of_IN the_DT child_NN 's_POS blood_NN was_VBD compared_VBN with_IN the_DT environmental_JJ samples_NNS collected_VBN in_IN the_DT home_NN ._. 
The_DT compatibility_NN between_IN blood_NN and_CC potential_JJ sources_NNS of_IN exposure_NN -LRB-_-LRB- with_IN lead_NN concentrations_NNS higher_JJR than_IN concentrations_NNS of_IN concern_NN -RRB-_-RRB- was_VBD assessed_VBN by_IN comparing_VBG the_DT isotope_JJ ratios_NNS of_IN the_DT four_CD lead_NN isotopes_NNS with_IN 95_CD %_NN confidence_NN intervals_NNS established_VBD using_VBG the_DT analytical_JJ uncertainty_NN -LRB-_-LRB- Ua_NNP =_SYM two_CD Standard_JJ Deviations_NNS of_IN measurement_NN of_IN a_DT triple_RB replicate_VB -RRB-_-RRB- to_TO determine_VB whether_IN there_EX was_VBD an_DT ``_`` overlap_VB ''_'' between_IN the_DT confidence_NN intervals_NNS of_IN the_DT LIRs_NNP of_IN the_DT blood_NN and_CC potential_JJ sources_NNS -LRB-_-LRB- see_VB Figure_NNP 1_CD -RRB-_-RRB- ._. 
Asource_NNP was_VBD considered_VBN compatible_JJ ,_, and_CC therefore_RB a_DT suspected_JJ source_NN ,_, when_WRB its_PRP$ LIR_NNP confidence_NN interval_NN overlapped_VBD the_DT blood_NN LIR_NNP confidence_NN interval_NN ._. 
It_PRP illustrates_VBZ the_DT variability_NN of_IN LIR_NNP between_IN sources_NNS from_IN this_DT home_NN ._. -RRB-_-RRB- 
from_IN a_DT child_NN 's_POS home_NN ..._: It_PRP is_VBZ defined_VBN as_IN :_: -LRB-_-LRB- 1_CD -RRB-_-RRB- D_NNP F_NN =_SYM V_NNP s_VBZ 
We_PRP calculated_VBD ,_, following_VBG the_DT method_NN described_VBN by_IN Glorennec_NNP et_FW al._FW ._. 
Isotopic_JJ analysis_NN of_IN an_DT environmental_JJ sample_NN is_VBZ relevant_JJ only_RB if_IN the_DT lead_JJ concentration_NN can_MD lead_VB to_TO B-Pb_JJ exceeding_VBG or_CC equal_JJ to_TO 25_CD 
The_DT concentrations_NNS in_IN leachable_JJ lead_NN -LRB-_-LRB- digestion_NN method_NN described_VBN by_IN Le_NNP Bot_NNP et_FW al._FW ._. 
Finally_RB ,_, where_WRB appropriate_JJ ,_, cosmetics_NNS -LRB-_-LRB- kohl_NN -RRB-_-RRB- or_CC traditional_JJ dishes_NNS known_VBN to_TO be_VB potential_JJ sources_NNS of_IN lead_NN were_VBD also_RB collected_VBN ._. -RRB-_-RRB- 
in_IN samples_NNS -LRB-_-LRB- excluding_VBG tap_VB water_NN for_IN which_WDT total_JJ lead_NN was_VBD measured_VBN -RRB-_-RRB- collected_VBN in_IN the_DT environment_NN of_IN children_NNS with_IN B-Pb_NN 
In_IN order_NN to_TO compare_VB to_TO US_NNP studies_NNS ,_, total_JJ digestion_NN of_IN the_DT same_JJ samples_NNS was_VBD also_RB performed_VBN using_VBG the_DT method_NN described_VBN by_IN Le_NNP Bot_NNP et_FW al._FW ._. ._. 
Comparison_NN of_IN results_NNS from_IN leachable_JJ and_CC total_JJ lead_NN would_MD be_VB useful_JJ if_IN French_JJ law_NN were_VBD to_TO change_VB by_IN prescribing_VBG total_JJ lead_NN analyses_NNS ._. 
In_IN each_DT home_NN ,_, up_IN to_TO five_CD rooms_NNS were_VBD selected_VBN using_VBG the_DT US-HUD_NNP protocol_NN in_IN the_DT following_JJ order_NN :_: child_NN 's_POS bedroom_NN ,_, living_VBG room_NN ,_, hall_NN ,_, kitchen_NN and_CC bedroom_NN of_IN the_DT brother\/sister_NN immediately_RB younger_JJR or_CC older_JJR ._. 
Finally_RB measurements_NNS were_VBD taken_VBN and_CC samples_NNS were_VBD collected_VBN :_: -_: One_PRP wiped_VBD dust_NN sample_NN of_IN the_DT floor_NN where_WRB the_DT child_NN played_VBD ,_, -_: X-ray_NN fluorescence_NN -LRB-_-LRB- XRF_NNP -RRB-_-RRB- measurements_NNS 
The_DT second_JJ step_NN was_VBD to_TO inspect_VB the_DT premises_NNS to_TO identify_VB the_DT presence_NN of_IN lead_NN in_IN the_DT walls_NNS ,_, floors_NNS ,_, etc._FW ._. 
In_IN each_DT home_NN ,_, up_IN to_TO five_CD rooms_NNS were_VBD selected_VBN using_VBG the_DT US-HUD_NNP protocol_NN in_IN the_DT following_JJ order_NN :_: child_NN 's_POS bedroom_NN ,_, living_VBG room_NN ,_, hall_NN ,_, kitchen_NN and_CC bedroom_NN of_IN the_DT brother\/sister_NN immediately_RB younger_JJR or_CC older_JJR ._. 
Finally_RB measurements_NNS were_VBD taken_VBN and_CC samples_NNS were_VBD collected_VBN :_: -_: One_PRP wiped_VBD dust_NN sample_NN of_IN the_DT floor_NN where_WRB the_DT child_NN played_VBD ,_, -_: X-ray_NN fluorescence_NN -LRB-_-LRB- XRF_NNP -RRB-_-RRB- measurements_NNS 
However_RB ,_, it_PRP is_VBZ more_RBR difficult_JJ to_TO assess_VB sources_NNS of_IN low_JJ B-Pb_NN within_IN a_DT restricted_JJ area_NN such_JJ as_IN the_DT child_NN 's_POS home_NN :_: this_DT approach_NN is_VBZ more_RBR likely_JJ to_TO be_VB successful_JJ when_WRB the_DT potential_JJ sources_NNS are_VBP few_JJ and_CC isotopically_RB distinct_JJ 
However_RB ,_, it_PRP is_VBZ more_RBR difficult_JJ to_TO assess_VB sources_NNS of_IN low_JJ B-Pb_NN within_IN a_DT restricted_JJ area_NN such_JJ as_IN the_DT child_NN 's_POS home_NN :_: this_DT approach_NN is_VBZ more_RBR likely_JJ to_TO be_VB successful_JJ when_WRB the_DT potential_JJ sources_NNS are_VBP few_JJ and_CC isotopically_RB distinct_JJ ._. 
In_IN addition_NN ,_, several_JJ studies_NNS showed_VBD that_IN use_NN of_IN LIR_NNP technique_NN could_MD be_VB indecisive_JJ for_IN B-Pb_NN below_IN 50_CD 
Lead_JJ isotope_JJ ratios_NNS -LRB-_-LRB- LIR_NNP -RRB-_-RRB- could_MD be_VB a_DT useful_JJ means_NN of_IN identifying_VBG sources_NNS of_IN exposure_NN for_IN individual_JJ cases_NNS in_IN routine_JJ investigations_NNS 
Despite_IN considerable_JJ reduction_NN of_IN the_DT amount_NN of_IN lead_NN in_IN the_DT environment_NN as_IN a_DT result_NN of_IN control_NN measures_NNS and_CC policies_NNS -LRB-_-LRB- in_IN particular_JJ ,_, ban_NN on_IN lead-based_JJ paints_NNS and_CC phase-out_NN of_IN leaded_VBN petrol_NN -RRB-_-RRB- ,_, environmental_JJ lead_NN exposure_NN remains_VBZ an_DT important_JJ public_JJ health_NN issue_NN ._. 
It_PRP is_VBZ well_RB established_VBN that_IN there_EX is_VBZ no_DT known_JJ safe_JJ exposure_NN to_TO lead_VB ._. 
Several_JJ studies_NNS have_VBP shown_VBN effects_NNS at_IN very_RB low_JJ doses_NNS ,_, even_RB below_IN the_DT established_JJ blood_NN lead_NN level_NN -LRB-_-LRB- B-Pb_JJ -RRB-_-RRB- limit_NN for_IN action_NN of_IN 100_CD 
Despite_IN considerable_JJ reduction_NN of_IN the_DT amount_NN of_IN lead_NN in_IN the_DT environment_NN as_IN a_DT result_NN of_IN control_NN measures_NNS and_CC policies_NNS -LRB-_-LRB- in_IN particular_JJ ,_, ban_NN on_IN lead-based_JJ paints_NNS and_CC phase-out_NN of_IN leaded_VBN petrol_NN -RRB-_-RRB- ,_, environmental_JJ lead_NN exposure_NN remains_VBZ an_DT important_JJ public_JJ health_NN issue_NN ._. 
It_PRP is_VBZ well_RB established_VBN that_IN there_EX is_VBZ no_DT known_JJ safe_JJ exposure_NN to_TO lead_VB ._. 
Several_JJ studies_NNS have_VBP shown_VBN effects_NNS at_IN very_RB low_JJ doses_NNS ,_, even_RB below_IN the_DT established_JJ blood_NN lead_NN level_NN -LRB-_-LRB- B-Pb_JJ -RRB-_-RRB- limit_NN for_IN action_NN of_IN 100_CD 
Several_JJ studies_NNS have_VBP shown_VBN effects_NNS at_IN very_RB low_JJ doses_NNS ,_, even_RB below_IN the_DT established_JJ blood_NN lead_NN level_NN -LRB-_-LRB- B-Pb_JJ -RRB-_-RRB- limit_NN for_IN action_NN of_IN 100_CD 
48_CD 
Background_NN Lead_JJ is_VBZ a_DT ubiquitous_JJ versatile_JJ heavy_JJ metal_NN ._. 
Conclusions_NNS In_IN France_NNP ,_, lead_NN isotope_NN ratios_NNS could_MD provide_VB valuable_JJ additional_JJ information_NN in_IN about_IN a_DT third_JJ of_IN routine_JJ environmental_JJ investigations_NNS ._. 
It_PRP has_VBZ been_VBN widely_RB used_VBN since_IN 3500_CD BC_SYM 
It_PRP has_VBZ been_VBN widely_RB used_VBN since_IN 3500_CD BC_SYM 
It_PRP is_VBZ the_DT most_RBS studied_VBN environmental_JJ pollutant_NN and_CC its_PRP$ adverse_JJ health_NN effects_NNS are_VBP well_RB documented_VBN 
Indicators_NNPS of_IN residential_JJ proximity_NN to_TO traffic_NN ,_, such_JJ as_IN distance_NN to_TO a_DT major_JJ road_NN and_CC traffic_NN intensity_NN around_IN a_DT location_NN ,_, are_VBP increasingly_RB being_VBG used_VBN as_IN proxies_NNS for_IN long-term_JJ exposure_NN to_TO traffic_NN pollutants_NNS ._. 
Epidemiological_JJ studies_NNS have_VBP linked_VBN these_DT indicators_NNS to_TO various_JJ health_NN outcomes_NNS ,_, such_JJ as_IN respiratory_JJ symptoms_NNS 
Indicators_NNPS of_IN residential_JJ proximity_NN to_TO traffic_NN ,_, such_JJ as_IN distance_NN to_TO a_DT major_JJ road_NN and_CC traffic_NN intensity_NN around_IN a_DT location_NN ,_, are_VBP increasingly_RB being_VBG used_VBN as_IN proxies_NNS for_IN long-term_JJ exposure_NN to_TO traffic_NN pollutants_NNS ._. 
Epidemiological_JJ studies_NNS have_VBP linked_VBN these_DT indicators_NNS to_TO various_JJ health_NN outcomes_NNS ,_, such_JJ as_IN respiratory_JJ symptoms_NNS 
Indicators_NNPS of_IN residential_JJ proximity_NN to_TO traffic_NN ,_, such_JJ as_IN distance_NN to_TO a_DT major_JJ road_NN and_CC traffic_NN intensity_NN around_IN a_DT location_NN ,_, are_VBP increasingly_RB being_VBG used_VBN as_IN proxies_NNS for_IN long-term_JJ exposure_NN to_TO traffic_NN pollutants_NNS ._. 
Epidemiological_JJ studies_NNS have_VBP linked_VBN these_DT indicators_NNS to_TO various_JJ health_NN outcomes_NNS ,_, such_JJ as_IN respiratory_JJ symptoms_NNS 
Indicators_NNPS of_IN residential_JJ proximity_NN to_TO traffic_NN ,_, such_JJ as_IN distance_NN to_TO a_DT major_JJ road_NN and_CC traffic_NN intensity_NN around_IN a_DT location_NN ,_, are_VBP increasingly_RB being_VBG used_VBN as_IN proxies_NNS for_IN long-term_JJ exposure_NN to_TO traffic_NN pollutants_NNS ._. 
Epidemiological_JJ studies_NNS have_VBP linked_VBN these_DT indicators_NNS to_TO various_JJ health_NN outcomes_NNS ,_, such_JJ as_IN respiratory_JJ symptoms_NNS 
5and_JJ PM_NNP 10_CD -RRB-_-RRB- 
5and_JJ PM_NNP 10_CD -RRB-_-RRB- 
This_DT spatial_JJ variation_NN in_IN air_NN pollutant_NN concentrations_NNS in_IN urban_JJ areas_NNS ,_, which_WDT can_MD be_VB largely_RB attributed_VBN to_TO traffic_NN emissions_NNS ,_, has_VBZ been_VBN documented_VBN for_IN several_JJ pollutants_NNS ,_, such_JJ as_IN nitrogen_NN dioxide_NN ,_, black_JJ smoke_NN ,_, elemental_JJ carbon_NN ,_, ultrafine_JJ particles_NNS ,_, and_CC particulate_JJ matter_NN -LRB-_-LRB- PM_NNP 2_CD ._. 
5and_JJ PM10_NNP -RRB-_-RRB- 
5and_JJ PM_NNP 10_CD -RRB-_-RRB- 
5and_JJ PM_NNP 10_CD -RRB-_-RRB- 
Indicators_NNPS of_IN residential_JJ proximity_NN to_TO traffic_NN ,_, such_JJ as_IN distance_NN to_TO a_DT major_JJ road_NN and_CC traffic_NN intensity_NN around_IN a_DT location_NN ,_, are_VBP increasingly_RB being_VBG used_VBN as_IN proxies_NNS for_IN long-term_JJ exposure_NN to_TO traffic_NN pollutants_NNS ._. 
Epidemiological_JJ studies_NNS have_VBP linked_VBN these_DT indicators_NNS to_TO various_JJ health_NN outcomes_NNS ,_, such_JJ as_IN respiratory_JJ symptoms_NNS 
In_IN addition_NN ,_, few_JJ studies_NNS explored_VBD the_DT effects_NNS of_IN these_DT indicators_NNS on_IN birth_NN and_CC pregnancy_NN outcomes_NNS ._. 
Associations_NNS of_IN proximity_NN to_TO traffic_NN with_IN birth_NN weight_NN 
In_IN addition_NN ,_, few_JJ studies_NNS explored_VBD the_DT effects_NNS of_IN these_DT indicators_NNS on_IN birth_NN and_CC pregnancy_NN outcomes_NNS ._. 
Associations_NNS of_IN proximity_NN to_TO traffic_NN with_IN birth_NN weight_NN 
Proximity_NN to_TO traffic_NN was_VBD defined_VBN by_IN means_NNS of_IN two_CD variables_NNS :_: distance-weighted_JJ traffic_NN density_NN -LRB-_-LRB- DWTD_NNP -RRB-_-RRB- and_CC distance_NN to_TO a_DT major_JJ road_NN ._. 
These_DT traffic_NN measures_NNS are_VBP used_VBN to_TO capture_VB the_DT spatial_JJ variation_NN within_IN a_DT city_NN ,_, and_CC have_VBP been_VBN applied_VBN previously_RB in_IN a_DT small_JJ number_NN of_IN register-based_JJ studies_NNS on_IN birth_NN outcomes_NNS ._. 
These_DT studies_NNS did_VBD not_RB show_VB conclusive_JJ evidence_NN ._. 
Two_CD studies_NNS ,_, both_DT conducted_VBN in_IN California_NNP ,_, used_VBD distance-weighted_JJ traffic_NN density_NN as_IN an_DT exposure_NN metric_NN ._. 
That_DT study_NN observed_VBD an_DT association_NN for_IN cumulative_JJ traffic_NN density_NN with_IN the_DT risk_NN for_IN SGA_NNP at_IN birth_NN ,_, but_CC not_RB with_IN birth_NN weight_NN and_CC preterm_NN birth_NN ._. 
Moreover_RB ,_, the_DT researchers_NNS also_RB reported_VBD evidence_NN for_IN effect_NN modification_NN by_IN socioeconomic_JJ status_NN ,_, with_IN stronger_JJR effects_NNS of_IN proximity_NN to_TO traffic_NN in_IN low_JJ educated_VBN women_NNS and_CC in_IN women_NNS living_VBG in_IN lower_JJR SES_NNP areas_NNS ._. 
Distance_NNP to_TO a_DT major_JJ road_NN or_CC highway_NN was_VBD examined_VBN previously_RB in_IN relation_NN to_TO birth_NN outcomes_NNS as_RB well_RB ._. 
Distance_NNP to_TO a_DT major_JJ road_NN or_CC highway_NN was_VBD examined_VBN previously_RB in_IN relation_NN to_TO birth_NN outcomes_NNS as_RB well_RB ._. 
The_DT Massachusetts_NNP study_NN observed_VBD associations_NNS between_IN distance_NN to_TO a_DT primary_JJ highway_NN and_CC birth_NN weight_NN ,_, but_CC not_RB with_IN the_DT risks_NNS of_IN preterm_NN birth_NN and_CC SGA_NNP at_IN birth_NN 
8_CD 
No_DT detailed_JJ information_NN was_VBD available_JJ about_IN time-activity_JJ patterns_NNS of_IN the_DT women_NNS ._. 
Exposure_NN levels_NNS were_VBD estimated_VBN at_IN the_DT home_NN address_NN ,_, whereas_IN pregnant_JJ women_NNS do_VBP not_RB spend_VB all_DT of_IN their_PRP$ time_NN at_IN home_NN ._. 
However_RB ,_, it_PRP has_VBZ been_VBN suggested_VBN that_IN outdoor_JJ levels_NNS of_IN traffic_NN components_NNS are_VBP well_RB correlated_VBN with_IN indoor_JJ levels_NNS 
No_DT detailed_JJ information_NN was_VBD available_JJ about_IN time-activity_JJ patterns_NNS of_IN the_DT women_NNS ._. 
Exposure_NN levels_NNS were_VBD estimated_VBN at_IN the_DT home_NN address_NN ,_, whereas_IN pregnant_JJ women_NNS do_VBP not_RB spend_VB all_DT of_IN their_PRP$ time_NN at_IN home_NN ._. 
However_RB ,_, it_PRP has_VBZ been_VBN suggested_VBN that_IN outdoor_JJ levels_NNS of_IN traffic_NN components_NNS are_VBP well_RB correlated_VBN with_IN indoor_JJ levels_NNS 
9mmol\/L_CD with_IN a_DT subsequent_JJ abnormal_JJ glucose_NN tolerance_NN test_NN ,_, in_IN women_NNS with_IN no_DT pre-existing_JJ diabetes_NN ._. 
Pregnancy-induced_JJ hypertension_NN was_VBD defined_VBN according_VBG to_TO criteria_NNS described_VBN by_IN the_DT International_NNP Society_NNP for_IN the_DT Study_NN of_IN Hypertension_NNP in_IN Pregnancy_NNP -LRB-_-LRB- ISSHP_NNP -RRB-_-RRB- :_: development_NN of_IN systolic_JJ blood_NN pressure_NN 
Pregnancy-induced_JJ hypertension_NN was_VBD defined_VBN according_VBG to_TO criteria_NNS described_VBN by_IN the_DT International_NNP Society_NNP for_IN the_DT Study_NN of_IN Hypertension_NNP in_IN Pregnancy_NNP -LRB-_-LRB- ISSHP_NNP -RRB-_-RRB- :_: development_NN of_IN systolic_JJ blood_NN pressure_NN 
97_CD ,_, p_SYM 
Maternal_JJ smoking_NN and_CC alcohol_NN consumption_NN habits_NNS were_VBD assessed_VBN on_IN the_DT basis_NN of_IN three_CD questionnaires_NNS -LRB-_-LRB- in_IN early_JJ ,_, mid_JJ -_: ,_, and_CC late_JJ pregnancy_NN -RRB-_-RRB- by_IN asking_VBG women_NNS whether_IN they_PRP smoked\/used_VBD alcohol_NN before_IN or_CC during_IN pregnancy_NN -LRB-_-LRB- no\/until_JJ pregnancy_NN was_VBD known\/yes_NNS -RRB-_-RRB- ._. 
Mothers_NNS who_WP reported_VBD in_IN the_DT first_JJ questionnaire_NN that_IN they_PRP did_VBD not_RB smoke_VB at_IN all_DT or_CC had_VBD smoked_VBN until_IN pregnancy_NN was_VBD known_VBN ,_, but_CC reported_VBD smoking_NN in_IN the_DT second_JJ or_CC third_JJ questionnaire_NN ,_, were_VBD reclassified_VBN into_IN the_DT continued_VBN smoking_NN category_NN ._. 
The_DT same_JJ approach_NN was_VBD followed_VBN for_IN maternal_JJ alcohol_NN consumption_NN habits_NNS ._. 
Population_NNP for_IN analysis_NN For_IN the_DT present_JJ analyses_NNS ,_, data_NNS on_IN all_DT prenatally_RB enrolled_VBN women_NNS were_VBD available_JJ -LRB-_-LRB- n_SYM =_SYM 8,880_CD -RRB-_-RRB- ._. 
To_TO our_PRP$ knowledge_NN ,_, no_DT previous_JJ studies_NNS have_VBP been_VBN conducted_VBN on_IN residential_JJ proximity_NN to_TO traffic_NN ,_, or_CC on_IN air_NN pollution_NN exposure_NN in_IN the_DT broader_JJR sense_NN ,_, and_CC pregnancy_NN complications_NNS ._. 
Recently_RB ,_, it_PRP has_VBZ been_VBN suggested_VBN that_IN studying_VBG these_DT outcomes_NNS may_MD provide_VB insights_NNS into_IN the_DT underlying_VBG mechanisms_NNS ._. 
In_IN the_DT present_JJ study_NN ,_, no_DT crude_JJ or_CC adjusted_JJ associations_NNS between_IN residential_JJ proximity_NN to_TO traffic_NN and_CC pregnancy_NN complications_NNS were_VBD observed_VBN ,_, although_IN we_PRP did_VBD observe_VB tendencies_NNS towards_IN elevated_JJ odds_NNS ratios_NNS in_IN the_DT highest_JJS exposure_NN groups_NNS ._. 
Methods_NNP Design_NNP The_DT present_JJ study_NN was_VBD embedded_VBN in_IN the_DT Generation_NNP R_NNP Study_NNP ,_, a_DT population-based_JJ prospective_JJ cohort_NN study_NN from_IN pregnancy_NN onwards_NNS ._. 
The_DT Generation_NNP R_NNP study_NN is_VBZ designed_VBN to_TO identify_VB early_RB environmental_JJ and_CC genetic_JJ determinants_NNS of_IN growth_NN ,_, development_NN and_CC health_NN and_CC has_VBZ been_VBN described_VBN previously_RB in_IN detail_NN ._. 
In_IN brief_NN ,_, the_DT cohort_NN includes_VBZ mothers_NNS and_CC children_NNS of_IN different_JJ ethnicities_NNS living_VBG in_IN Rotterdam_NNP ,_, the_DT Netherlands_NNP ._. 
In_IN total_JJ ,_, 8,880_CD pregnant_JJ women_NNS with_IN a_DT delivery_NN date_NN between_IN April_NNP 2002_CD and_CC January_NNP 2006_CD entered_VBD the_DT prenatal_JJ part_NN of_IN the_DT study_NN ._. 
The_DT majority_NN of_IN these_DT mothers_NNS -LRB-_-LRB- 75_CD %_NN -RRB-_-RRB- was_VBD enrolled_VBN in_IN early_JJ pregnancy_NN -LRB-_-LRB- gestational_JJ age_NN 
Parity_NN was_VBD classified_VBN into_IN two_CD categories_NNS :_: -LRB-_-LRB- 1_CD -RRB-_-RRB- nulliparous_JJ and_CC -LRB-_-LRB- 2_CD -RRB-_-RRB- multiparous_NNS ._. 
The_DT highest_JJS educational_JJ level_NN achieved_VBN by_IN mother_NN was_VBD used_VBN as_IN an_DT indicator_NN of_IN maternal_JJ socioeconomic_JJ status_NN -LRB-_-LRB- SES_NNP -RRB-_-RRB- and_CC was_VBD reclassified_VBN into_IN three_CD categories_NNS :_: -LRB-_-LRB- 1_CD -RRB-_-RRB- no_DT education_NN or_CC primary_JJ school_NN ,_, -LRB-_-LRB- 2_CD -RRB-_-RRB- secondary_JJ school_NN ,_, and_CC -LRB-_-LRB- 3_CD -RRB-_-RRB- higher_JJR education_NN ._. 
Ethnic_JJ background_NN of_IN the_DT woman_NN was_VBD assessed_VBN on_IN the_DT basis_NN of_IN country_NN of_IN birth_NN of_IN her_PRP and_CC her_PRP$ parents_NNS and_CC reclassified_VBD into_IN five_CD categories_NNS :_: -LRB-_-LRB- 1_CD -RRB-_-RRB- Dutch_NNP and_CC Caucasian_NNP ,_, -LRB-_-LRB- 2_CD -RRB-_-RRB- Turkish_JJ ,_, -LRB-_-LRB- 3_CD -RRB-_-RRB- Moroccan_NNP ,_, -LRB-_-LRB- 4_CD -RRB-_-RRB- Surinamese_JJ ,_, and_CC -LRB-_-LRB- 5_CD -RRB-_-RRB- other_JJ ._. 
Maternal_JJ anthropometrics_NNS were_VBD assessed_VBN at_IN time_NN of_IN enrolment_NN and_CC at_IN subsequent_JJ visits_NNS ._. 
Since_IN the_DT correlation_NN of_IN prepregnancy_NN weight_NN obtained_VBN by_IN questionnaire_NN and_CC weight_NN measured_VBN at_IN enrolment_NN was_VBD high_JJ -LRB-_-LRB- 0_CD ._. 
Population_NNP for_IN analysis_NN For_IN the_DT present_JJ analyses_NNS ,_, data_NNS on_IN all_DT prenatally_RB enrolled_VBN women_NNS were_VBD available_JJ -LRB-_-LRB- n_SYM =_SYM 8,880_CD -RRB-_-RRB- ._. 
We_PRP decided_VBD to_TO restrict_VB to_TO participants_NNS living_VBG in_IN the_DT Northern_JJ part_NN of_IN Rotterdam_NNP at_IN time_NN of_IN delivery_NN ,_, since_IN participants_NNS living_VBG in_IN the_DT Southern_JJ part_NN of_IN Rotterdam_NNP did_VBD not_RB participate_VB in_IN the_DT postnatal_JJ follow-up_JJ study_NN ._. 
This_DT yielded_VBD 7,506_CD women_NNS ._. 
We_PRP included_VBD all_DT live_JJ singleton_NN births_NNS -LRB-_-LRB- n_SYM =_SYM 7,431_CD -RRB-_-RRB- ;_: women_NNS who_WP gave_VBD birth_NN to_TO twins_NNS -LRB-_-LRB- n_SYM =_SYM 75_CD -RRB-_-RRB- were_VBD excluded_VBN ._. 
This_DT data_NN was_VBD used_VBN to_TO estimate_VB exposure_NN for_IN all_DT pregnancies_NNS between_IN 2002_CD and_CC 2006_CD ._. 
Annual_JJ average_JJ daily_JJ traffic_NN intensities_NNS for_IN the_DT year_NN 2004_CD were_VBD attached_VBN as_IN attributes_NNS to_TO the_DT road_NN segments_NNS for_IN a_DT dense_JJ network_NN of_IN roads_NNS ._. 
Based_VBN on_IN index_NN numbers_NNS for_IN traffic_NN intensity_NN in_IN the_DT years_NNS 2002-2006_CD ,_, it_PRP was_VBD concluded_VBN that_IN the_DT 2004_CD data_NNS could_MD reasonably_RB be_VB applied_VBN to_TO adjacent_JJ years_NNS ._. 
We_PRP geocoded_VBD the_DT mothers_NNS '_POS home_NN addresses_NNS at_IN time_NN of_IN delivery_NN using_VBG ArcGIS_NNP -LRB-_-LRB- v9_NN ,_, ESRI_NNP -RRB-_-RRB- ._. 
All_DT matches_NNS were_VBD made_VBN at_IN the_DT address_NN level_NN ._. 
In_IN addition_NN to_TO DWTD_NNP ,_, we_PRP identified_VBD the_DT nearest_JJS major_JJ road_NN -LRB-_-LRB- with_IN 
0SDS_CD birth_NN weight_NN -RRB-_-RRB- and_CC preterm_NN birth_NN -LRB-_-LRB- gestational_JJ age_NN 
Ideally_RB ,_, these_DT temporal_JJ variations_NNS would_MD be_VB taken_VBN into_IN account_NN in_IN the_DT exposure_NN assessment_NN ,_, next_JJ to_TO the_DT spatial_JJ variability_NN ._. 
This_DT has_VBZ been_VBN done_VBN by_IN a_DT few_JJ earlier_JJR pregnancy_NN studies_NNS ,_, some_DT of_IN them_PRP conducted_VBN in_IN Europe_NNP ,_, in_IN which_WDT air_NN pollution_NN concentrations_NNS were_VBD modeled_VBN and_CC subsequently_RB adjusted_VBN for_IN temporal_JJ variation_NN ._. 
Unfortunately_RB ,_, we_PRP were_VBD not_RB able_JJ to_TO take_VB into_IN account_NN temporal_JJ variations_NNS in_IN our_PRP$ air_NN pollution_NN exposure_NN assessment_NN ,_, but_CC we_PRP are_VBP planning_VBG to_TO do_VB this_DT for_IN future_JJ analyses_NNS ._. 
Unfortunately_RB ,_, we_PRP were_VBD not_RB able_JJ to_TO take_VB into_IN account_NN temporal_JJ variations_NNS in_IN our_PRP$ air_NN pollution_NN exposure_NN assessment_NN ,_, but_CC we_PRP are_VBP planning_VBG to_TO do_VB this_DT for_IN future_JJ analyses_NNS ._. 
Despite_IN these_DT limitations_NNS ,_, a_DT recent_JJ study_NN that_WDT assessed_VBD the_DT validity_NN of_IN traffic_NN variables_NNS showed_VBD that_IN measures_NNS of_IN -LRB-_-LRB- weighted_JJ -RRB-_-RRB- traffic_NN density_NN can_MD well_RB be_VB used_VBN as_IN predictors_NNS of_IN measured_JJ NO2_NNP ,_, and_CC are_VBP therefore_RB good_JJ proxies_NNS for_IN exposure_NN to_TO road_NN traffic_NN 
Ideally_RB ,_, these_DT temporal_JJ variations_NNS would_MD be_VB taken_VBN into_IN account_NN in_IN the_DT exposure_NN assessment_NN ,_, next_JJ to_TO the_DT spatial_JJ variability_NN ._. 
This_DT has_VBZ been_VBN done_VBN by_IN a_DT few_JJ earlier_JJR pregnancy_NN studies_NNS ,_, some_DT of_IN them_PRP conducted_VBN in_IN Europe_NNP ,_, in_IN which_WDT air_NN pollution_NN concentrations_NNS were_VBD modeled_VBN and_CC subsequently_RB adjusted_VBN for_IN temporal_JJ variation_NN ._. 
Unfortunately_RB ,_, we_PRP were_VBD not_RB able_JJ to_TO take_VB into_IN account_NN temporal_JJ variations_NNS in_IN our_PRP$ air_NN pollution_NN exposure_NN assessment_NN ,_, but_CC we_PRP are_VBP planning_VBG to_TO do_VB this_DT for_IN future_JJ analyses_NNS ._. 
No_DT detailed_JJ information_NN was_VBD available_JJ about_IN time-activity_JJ patterns_NNS of_IN the_DT women_NNS ._. 
Exposure_NN levels_NNS were_VBD estimated_VBN at_IN the_DT home_NN address_NN ,_, whereas_IN pregnant_JJ women_NNS do_VBP not_RB spend_VB all_DT of_IN their_PRP$ time_NN at_IN home_NN ._. 
However_RB ,_, it_PRP has_VBZ been_VBN suggested_VBN that_IN outdoor_JJ levels_NNS of_IN traffic_NN components_NNS are_VBP well_RB correlated_VBN with_IN indoor_JJ levels_NNS 
No_DT detailed_JJ information_NN was_VBD available_JJ about_IN time-activity_JJ patterns_NNS of_IN the_DT women_NNS ._. 
Exposure_NN levels_NNS were_VBD estimated_VBN at_IN the_DT home_NN address_NN ,_, whereas_IN pregnant_JJ women_NNS do_VBP not_RB spend_VB all_DT of_IN their_PRP$ time_NN at_IN home_NN ._. 
However_RB ,_, it_PRP has_VBZ been_VBN suggested_VBN that_IN outdoor_JJ levels_NNS of_IN traffic_NN components_NNS are_VBP well_RB correlated_VBN with_IN indoor_JJ levels_NNS 
Methods_NNP Design_NNP The_DT present_JJ study_NN was_VBD embedded_VBN in_IN the_DT Generation_NNP R_NNP Study_NNP ,_, a_DT population-based_JJ prospective_JJ cohort_NN study_NN from_IN pregnancy_NN onwards_NNS ._. 
The_DT Generation_NNP R_NNP study_NN is_VBZ designed_VBN to_TO identify_VB early_RB environmental_JJ and_CC genetic_JJ determinants_NNS of_IN growth_NN ,_, development_NN and_CC health_NN and_CC has_VBZ been_VBN described_VBN previously_RB in_IN detail_NN ._. 
In_IN brief_NN ,_, the_DT cohort_NN includes_VBZ mothers_NNS and_CC children_NNS of_IN different_JJ ethnicities_NNS living_VBG in_IN Rotterdam_NNP ,_, the_DT Netherlands_NNP ._. 
Data_NNS on_IN pregnancy_NN were_VBD collected_VBN on_IN the_DT basis_NN of_IN physical_JJ examinations_NNS ,_, fetal_JJ ultrasounds_NNS ,_, hospital_NN registrations_NNS and_CC questionnaires_NNS ._. 
Assessments_NNS were_VBD planned_VBN for_IN early_JJ pregnancy_NN ,_, mid-pregnancy_NN ,_, and_CC late_JJ pregnancy_NN ,_, but_CC the_DT individual_JJ time_NN schemes_NNS depended_VBD on_IN the_DT specific_JJ gestational_JJ age_NN at_IN enrolment_NN ._. 
The_DT study_NN protocol_NN was_VBD approved_VBN by_IN the_DT Medical_NNP Ethical_NNP Committee_NNP of_IN Erasmus_NNP Medical_NNP Centre_NNP ,_, Rotterdam_NNP ._. 
Aprospective_JJ pregnancy_NN cohort_NN study_NN with_IN detailed_JJ exposure_NN and_CC covariate_NN information_NN can_MD overcome_VB this_DT limitation_NN ._. 
Several_JJ potential_JJ biological_JJ mechanisms_NNS have_VBP been_VBN described_VBN through_IN which_WDT air_NN pollution_NN could_MD influence_VB pregnancy_NN outcomes_NNS ,_, such_JJ as_IN the_DT induction_NN of_IN inflammation_NN -LRB-_-LRB- placental_JJ ,_, pulmonary_JJ ,_, or_CC systemic_JJ -RRB-_-RRB- and_CC oxidative_JJ stress_NN 
This_DT may_MD have_VB reduced_VBN their_PRP$ ability_NN to_TO adjust_VB for_IN confounding_NN ,_, as_IN birth_NN records_NNS usually_RB include_VBP limited_JJ information_NN on_IN potential_JJ confounding_JJ factors_NNS 
Aprospective_JJ pregnancy_NN cohort_NN study_NN with_IN detailed_JJ exposure_NN and_CC covariate_NN information_NN can_MD overcome_VB this_DT limitation_NN ._. 
Several_JJ potential_JJ biological_JJ mechanisms_NNS have_VBP been_VBN described_VBN through_IN which_WDT air_NN pollution_NN could_MD influence_VB pregnancy_NN outcomes_NNS ,_, such_JJ as_IN the_DT induction_NN of_IN inflammation_NN -LRB-_-LRB- placental_JJ ,_, pulmonary_JJ ,_, or_CC systemic_JJ -RRB-_-RRB- and_CC oxidative_JJ stress_NN 
This_DT may_MD have_VB reduced_VBN their_PRP$ ability_NN to_TO adjust_VB for_IN confounding_NN ,_, as_IN birth_NN records_NNS usually_RB include_VBP limited_JJ information_NN on_IN potential_JJ confounding_JJ factors_NNS 
Previous_JJ studies_NNS generally_RB obtained_VBD information_NN on_IN birth_NN outcomes_NNS from_IN birth_NN certificates_NNS ._. 
Associations_NNS of_IN proximity_NN to_TO traffic_NN with_IN birth_NN weight_NN 
Ideally_RB ,_, these_DT temporal_JJ variations_NNS would_MD be_VB taken_VBN into_IN account_NN in_IN the_DT exposure_NN assessment_NN ,_, next_JJ to_TO the_DT spatial_JJ variability_NN ._. 
This_DT has_VBZ been_VBN done_VBN by_IN a_DT few_JJ earlier_JJR pregnancy_NN studies_NNS ,_, some_DT of_IN them_PRP conducted_VBN in_IN Europe_NNP ,_, in_IN which_WDT air_NN pollution_NN concentrations_NNS were_VBD modeled_VBN and_CC subsequently_RB adjusted_VBN for_IN temporal_JJ variation_NN ._. 
Unfortunately_RB ,_, we_PRP were_VBD not_RB able_JJ to_TO take_VB into_IN account_NN temporal_JJ variations_NNS in_IN our_PRP$ air_NN pollution_NN exposure_NN assessment_NN ,_, but_CC we_PRP are_VBP planning_VBG to_TO do_VB this_DT for_IN future_JJ analyses_NNS ._. 
In_IN addition_NN ,_, few_JJ studies_NNS explored_VBD the_DT effects_NNS of_IN these_DT indicators_NNS on_IN birth_NN and_CC pregnancy_NN outcomes_NNS ._. 
Associations_NNS of_IN proximity_NN to_TO traffic_NN with_IN birth_NN weight_NN 
In_IN addition_NN ,_, few_JJ studies_NNS explored_VBD the_DT effects_NNS of_IN these_DT indicators_NNS on_IN birth_NN and_CC pregnancy_NN outcomes_NNS ._. 
Associations_NNS of_IN proximity_NN to_TO traffic_NN with_IN birth_NN weight_NN 
Proximity_NN to_TO traffic_NN was_VBD defined_VBN by_IN means_NNS of_IN two_CD variables_NNS :_: distance-weighted_JJ traffic_NN density_NN -LRB-_-LRB- DWTD_NNP -RRB-_-RRB- and_CC distance_NN to_TO a_DT major_JJ road_NN ._. 
These_DT traffic_NN measures_NNS are_VBP used_VBN to_TO capture_VB the_DT spatial_JJ variation_NN within_IN a_DT city_NN ,_, and_CC have_VBP been_VBN applied_VBN previously_RB in_IN a_DT small_JJ number_NN of_IN register-based_JJ studies_NNS on_IN birth_NN outcomes_NNS ._. 
These_DT studies_NNS did_VBD not_RB show_VB conclusive_JJ evidence_NN ._. 
Two_CD 
-LRB-_-LRB- 2008_CD -RRB-_-RRB- observed_VBD an_DT increased_VBN risk_NN of_IN SGA_NNP at_IN birth_NN in_IN mothers_NNS living_VBG within_IN 50_CD m_NN from_IN an_DT expressway_NN or_CC highway_NN -LRB-_-LRB- with_IN a_DT mean_NN of_IN 
In_IN our_PRP$ study_NN ,_, maternal_JJ education_NN ,_, ethnicity_NN ,_, body_NN mass_NN index_NN ,_, parity_NN ,_, and_CC smoking_NN were_VBD the_DT main_JJ predictors_NNS in_IN most_JJS of_IN the_DT models_NNS with_IN birth_NN outcomes_NNS ,_, and_CC in_IN some_DT of_IN the_DT models_NNS with_IN pregnancy_NN complications_NNS ._. 
Earlier_JJR studies_NNS did_VBD not_RB have_VB information_NN on_IN all_DT of_IN these_DT covariates_NNS ._. 
As_IN a_DT result_NN ,_, they_PRP may_MD have_VB been_VBN more_RBR susceptible_JJ to_TO residual_JJ confounding_NN ,_, which_WDT could_MD have_VB affected_VBN some_DT of_IN the_DT observed_JJ associations_NNS ._. 
Ideally_RB ,_, these_DT temporal_JJ variations_NNS would_MD be_VB taken_VBN into_IN account_NN in_IN the_DT exposure_NN assessment_NN ,_, next_JJ to_TO the_DT spatial_JJ variability_NN ._. 
This_DT has_VBZ been_VBN done_VBN by_IN a_DT few_JJ earlier_JJR pregnancy_NN studies_NNS ,_, some_DT of_IN them_PRP conducted_VBN in_IN Europe_NNP ,_, in_IN which_WDT air_NN pollution_NN concentrations_NNS were_VBD modeled_VBN and_CC subsequently_RB adjusted_VBN for_IN temporal_JJ variation_NN ._. 
Unfortunately_RB ,_, we_PRP were_VBD not_RB able_JJ to_TO take_VB into_IN account_NN temporal_JJ variations_NNS in_IN our_PRP$ air_NN pollution_NN exposure_NN assessment_NN ,_, but_CC we_PRP are_VBP planning_VBG to_TO do_VB this_DT for_IN future_JJ analyses_NNS ._. 
Despite_IN these_DT limitations_NNS ,_, a_DT recent_JJ study_NN that_WDT assessed_VBD the_DT validity_NN of_IN traffic_NN variables_NNS showed_VBD that_IN measures_NNS of_IN -LRB-_-LRB- weighted_JJ -RRB-_-RRB- traffic_NN density_NN can_MD well_RB be_VB used_VBN as_IN predictors_NNS of_IN measured_VBN NO_RB 2_CD ,_, and_CC are_VBP therefore_RB good_JJ proxies_NNS for_IN exposure_NN to_TO road_NN traffic_NN 
In_IN addition_NN ,_, few_JJ studies_NNS explored_VBD the_DT effects_NNS of_IN these_DT indicators_NNS on_IN birth_NN and_CC pregnancy_NN outcomes_NNS ._. 
Associations_NNS of_IN proximity_NN to_TO traffic_NN with_IN birth_NN weight_NN 
The_DT first_JJ study_NN observed_VBD an_DT association_NN between_IN increased_VBN DWTD_NNP and_CC the_DT risk_NN of_IN preterm_NN birth_NN ,_, with_IN stronger_JJR effects_NNS in_IN women_NNS living_VBG in_IN lower_JJR SES_NNP areas_NNS 
The_DT Massachusetts_NNP study_NN observed_VBD associations_NNS between_IN distance_NN to_TO a_DT primary_JJ highway_NN and_CC birth_NN weight_NN ,_, but_CC not_RB with_IN the_DT risks_NNS of_IN preterm_NN birth_NN and_CC SGA_NNP at_IN birth_NN 
In_IN addition_NN ,_, few_JJ studies_NNS explored_VBD the_DT effects_NNS of_IN these_DT indicators_NNS on_IN birth_NN and_CC pregnancy_NN outcomes_NNS ._. 
Associations_NNS of_IN proximity_NN to_TO traffic_NN with_IN birth_NN weight_NN 
Various_JJ definitions_NNS of_IN DWTD_NNP are_VBP being_VBG used_VBN in_IN the_DT literature_NN ._. 
As_IN vehicles_NNS may_MD use_VB multiple_JJ segments_NNS in_IN the_DT buffer_NN ,_, the_DT DWTD_NNP values_NNS can_MD be_VB relatively_RB high_JJ -LRB-_-LRB- up_IN to_TO millions_NNS of_IN vehicles\/24_JJ h_JJ \*_NN m_NN -RRB-_-RRB- ._. 
We_PRP remark_VBP that_IN our_PRP$ method_NN to_TO define_VB DWTD_NNP is_VBZ derived_VBN from_IN the_DT method_NN used_VBN by_IN Wilhelm_NNP 
Two_CD studies_NNS ,_, both_DT conducted_VBN in_IN California_NNP ,_, used_VBD distance-weighted_JJ traffic_NN density_NN as_IN an_DT exposure_NN metric_NN ._. 
The_DT first_JJ study_NN observed_VBD an_DT association_NN between_IN increased_VBN DWTD_NNP and_CC the_DT risk_NN of_IN preterm_NN birth_NN ,_, with_IN stronger_JJR effects_NNS in_IN women_NNS living_VBG in_IN lower_JJR SES_NNP areas_NNS 
In_IN addition_NN ,_, few_JJ studies_NNS explored_VBD the_DT effects_NNS of_IN these_DT indicators_NNS on_IN birth_NN and_CC pregnancy_NN outcomes_NNS ._. 
Associations_NNS of_IN proximity_NN to_TO traffic_NN with_IN birth_NN weight_NN 
In_IN addition_NN ,_, few_JJ studies_NNS explored_VBD the_DT effects_NNS of_IN these_DT indicators_NNS on_IN birth_NN and_CC pregnancy_NN outcomes_NNS ._. 
Associations_NNS of_IN proximity_NN to_TO traffic_NN with_IN birth_NN weight_NN 
In_IN addition_NN ,_, few_JJ studies_NNS explored_VBD the_DT effects_NNS of_IN these_DT indicators_NNS on_IN birth_NN and_CC pregnancy_NN outcomes_NNS ._. 
Associations_NNS of_IN proximity_NN to_TO traffic_NN with_IN birth_NN weight_NN 
Also_RB ,_, no_DT significant_JJ associations_NNS were_VBD detected_VBN for_IN those_DT living_VBG within_IN 50_CD or_CC 150_CD m_NN from_IN a_DT road_NN with_IN a_DT mean_NN of_IN 15,000-18_CD ,000_CD vehicles\/day_NN ._. 
The_DT second_JJ study_NN reported_VBD that_DT proximity_NN to_TO a_DT highway_NN -LRB-_-LRB- with_IN a_DT minimum_JJ speed_NN of_IN 70_CD km\/hr_NN -RRB-_-RRB- was_VBD associated_VBN with_IN preterm_NN birth_NN ,_, but_CC not_RB with_IN SGA_NNP at_IN birth_NN 
In_IN our_PRP$ study_NN ,_, maternal_JJ education_NN ,_, ethnicity_NN ,_, body_NN mass_NN index_NN ,_, parity_NN ,_, and_CC smoking_NN were_VBD the_DT main_JJ predictors_NNS in_IN most_JJS of_IN the_DT models_NNS with_IN birth_NN outcomes_NNS ,_, and_CC in_IN some_DT of_IN the_DT models_NNS with_IN pregnancy_NN complications_NNS ._. 
Earlier_JJR studies_NNS did_VBD not_RB have_VB information_NN on_IN all_DT of_IN these_DT covariates_NNS ._. 
As_IN a_DT result_NN ,_, they_PRP may_MD have_VB been_VBN more_RBR susceptible_JJ to_TO residual_JJ confounding_NN ,_, which_WDT could_MD have_VB affected_VBN some_DT of_IN the_DT observed_JJ associations_NNS ._. 
Background_NN Exposure_NN to_TO air_NN pollution_NN has_VBZ been_VBN suggested_VBN to_TO adversely_RB affect_VB various_JJ birth_NN outcomes_NNS ._. 
As_IN reported_VBN in_IN a_DT number_NN of_IN reviews_NNS ,_, outcomes_NNS such_JJ as_IN low_JJ birth_NN weight_NN ,_, intrauterine_JJ growth_NN restriction_NN ,_, and_CC preterm_NN birth_NN have_VBP been_VBN associated_VBN with_IN ambient_JJ air_NN pollution_NN levels_NNS ,_, although_IN effects_NNS were_VBD not_RB always_RB consistent_JJ between_IN studies_NNS ._. 
In_IN large_JJ studies_NNS ,_, assessing_VBG individual_JJ exposure_NN to_TO air_NN pollution_NN is_VBZ often_RB rather_RB demanding_VBG for_IN participants_NNS and_CC requires_VBZ extensive_JJ resources_NNS ._. 
Therefore_RB ,_, other_JJ approaches_NNS have_VBP been_VBN used_VBN to_TO estimate_VB exposure_NN of_IN individuals_NNS ._. 
In_IN large_JJ studies_NNS ,_, assessing_VBG individual_JJ exposure_NN to_TO air_NN pollution_NN is_VBZ often_RB rather_RB demanding_VBG for_IN participants_NNS and_CC requires_VBZ extensive_JJ resources_NNS ._. 
Most_JJS studies_NNS have_VBP assessed_VBN exposure_NN to_TO air_NN pollution_NN using_VBG -LRB-_-LRB- an_DT often_RB limited_JJ number_NN of_IN -RRB-_-RRB- outdoor_JJ monitoring_NN stations_NNS ,_, either_CC by_IN using_VBG the_DT station_NN closest_JJS to_TO the_DT mother_NN 's_POS home_NN address_NN at_IN time_NN of_IN delivery_NN 
Therefore_RB ,_, other_JJ approaches_NNS have_VBP been_VBN used_VBN to_TO estimate_VB exposure_NN of_IN individuals_NNS ._. 
In_IN large_JJ studies_NNS ,_, assessing_VBG individual_JJ exposure_NN to_TO air_NN pollution_NN is_VBZ often_RB rather_RB demanding_VBG for_IN participants_NNS and_CC requires_VBZ extensive_JJ resources_NNS ._. 
Most_JJS studies_NNS have_VBP assessed_VBN exposure_NN to_TO air_NN pollution_NN using_VBG -LRB-_-LRB- an_DT often_RB limited_JJ number_NN of_IN -RRB-_-RRB- outdoor_JJ monitoring_NN stations_NNS ,_, either_CC by_IN using_VBG the_DT station_NN closest_JJS to_TO the_DT mother_NN 's_POS home_NN address_NN at_IN time_NN of_IN delivery_NN 
Therefore_RB ,_, other_JJ approaches_NNS have_VBP been_VBN used_VBN to_TO estimate_VB exposure_NN of_IN individuals_NNS ._. 
In_IN large_JJ studies_NNS ,_, assessing_VBG individual_JJ exposure_NN to_TO air_NN pollution_NN is_VBZ often_RB rather_RB demanding_VBG for_IN participants_NNS and_CC requires_VBZ extensive_JJ resources_NNS ._. 
Most_JJS studies_NNS have_VBP assessed_VBN exposure_NN to_TO air_NN pollution_NN using_VBG -LRB-_-LRB- an_DT often_RB limited_JJ number_NN of_IN -RRB-_-RRB- outdoor_JJ monitoring_NN stations_NNS ,_, either_CC by_IN using_VBG the_DT station_NN closest_JJS to_TO the_DT mother_NN 's_POS home_NN address_NN at_IN time_NN of_IN delivery_NN 
Aprospective_JJ pregnancy_NN cohort_NN study_NN with_IN detailed_JJ exposure_NN and_CC covariate_NN information_NN can_MD overcome_VB this_DT limitation_NN ._. 
Several_JJ potential_JJ biological_JJ mechanisms_NNS have_VBP been_VBN described_VBN through_IN which_WDT air_NN pollution_NN could_MD influence_VB pregnancy_NN outcomes_NNS ,_, such_JJ as_IN the_DT induction_NN of_IN inflammation_NN -LRB-_-LRB- placental_JJ ,_, pulmonary_JJ ,_, or_CC systemic_JJ -RRB-_-RRB- and_CC oxidative_JJ stress_NN 
Background_NN Exposure_NN to_TO air_NN pollution_NN has_VBZ been_VBN suggested_VBN to_TO adversely_RB affect_VB various_JJ birth_NN outcomes_NNS ._. 
As_IN reported_VBN in_IN a_DT number_NN of_IN reviews_NNS ,_, outcomes_NNS such_JJ as_IN low_JJ birth_NN weight_NN ,_, intrauterine_JJ growth_NN restriction_NN ,_, and_CC preterm_NN birth_NN have_VBP been_VBN associated_VBN with_IN ambient_JJ air_NN pollution_NN levels_NNS ,_, although_IN effects_NNS were_VBD not_RB always_RB consistent_JJ between_IN studies_NNS ._. 
In_IN large_JJ studies_NNS ,_, assessing_VBG individual_JJ exposure_NN to_TO air_NN pollution_NN is_VBZ often_RB rather_RB demanding_VBG for_IN participants_NNS and_CC requires_VBZ extensive_JJ resources_NNS ._. 
g._NN As_IN residential_JJ mobility_NN during_IN pregnancy_NN has_VBZ previously_RB been_VBN shown_VBN to_TO be_VB differential_JJ by_IN sociodemographic_JJ factors_NNS -LRB-_-LRB- e._JJ ,_, maternal_JJ age_NN ,_, household_NN income_NN ,_, parity_NN ,_, and_CC ethnicity_NN -RRB-_-RRB- ,_, it_PRP could_MD influence_VB the_DT results_NNS of_IN our_PRP$ study_NN ._. 
In_IN stratified_JJ analyses_NNS ,_, we_PRP observed_VBD that_IN results_NNS were_VBD not_RB different_JJ across_IN those_DT who_WP did\/did_VBP not_RB change_VB residence_NN in_IN the_DT period_NN between_IN seven_CD months_NNS before_IN conception_NN and_CC five_CD months_NNS of_IN pregnancy_NN ._. 
Therefore_RB ,_, other_JJ approaches_NNS have_VBP been_VBN used_VBN to_TO estimate_VB exposure_NN of_IN individuals_NNS ._. 
In_IN large_JJ studies_NNS ,_, assessing_VBG individual_JJ exposure_NN to_TO air_NN pollution_NN is_VBZ often_RB rather_RB demanding_VBG for_IN participants_NNS and_CC requires_VBZ extensive_JJ resources_NNS ._. 
Most_JJS studies_NNS have_VBP assessed_VBN exposure_NN to_TO air_NN pollution_NN using_VBG -LRB-_-LRB- an_DT often_RB limited_JJ number_NN of_IN -RRB-_-RRB- outdoor_JJ monitoring_NN stations_NNS ,_, either_CC by_IN using_VBG the_DT station_NN closest_JJS to_TO the_DT mother_NN 's_POS home_NN address_NN at_IN time_NN of_IN delivery_NN 
Most_JJS studies_NNS have_VBP assessed_VBN exposure_NN to_TO air_NN pollution_NN using_VBG -LRB-_-LRB- an_DT often_RB limited_JJ number_NN of_IN -RRB-_-RRB- outdoor_JJ monitoring_NN stations_NNS ,_, either_CC by_IN using_VBG the_DT station_NN closest_JJS to_TO the_DT mother_NN 's_POS home_NN address_NN at_IN time_NN of_IN delivery_NN 
Previous_JJ studies_NNS generally_RB obtained_VBD information_NN on_IN birth_NN outcomes_NNS from_IN birth_NN certificates_NNS ._. 
Associations_NNS of_IN proximity_NN to_TO traffic_NN with_IN birth_NN weight_NN 
This_DT spatial_JJ variation_NN in_IN air_NN pollutant_NN concentrations_NNS in_IN urban_JJ areas_NNS ,_, which_WDT can_MD be_VB largely_RB attributed_VBN to_TO traffic_NN emissions_NNS ,_, has_VBZ been_VBN documented_VBN for_IN several_JJ pollutants_NNS ,_, such_JJ as_IN nitrogen_NN dioxide_NN ,_, black_JJ smoke_NN ,_, elemental_JJ carbon_NN ,_, ultrafine_JJ particles_NNS ,_, and_CC particulate_JJ matter_NN -LRB-_-LRB- PM_NNP 2_CD ._. 
5and_JJ PM10_NNP -RRB-_-RRB- 
5and_JJ PM_NNP 10_CD -RRB-_-RRB- 
While_IN some_DT of_IN our_PRP$ results_NNS could_MD have_VB been_VBN due_JJ to_TO chance_NN ,_, it_PRP is_VBZ not_RB possible_JJ statistically_RB to_TO determine_VB which_WDT ones_NNS are_VBP just_RB random_JJ variations_NNS and_CC which_WDT represent_VBP true_JJ underlying_JJ associations_NNS ._. 
P-values_NNS are_VBP based_VBN on_IN the_DT assumption_NN of_IN the_DT universal_JJ null_JJ hypothesis_NN being_VBG correct_JJ ,_, whereas_IN a_DT priori_FW knowledge_NN motivated_VBD several_JJ of_IN the_DT hypotheses_NNS we_PRP examined_VBD ,_, specifically_RB those_DT related_VBN to_TO different_JJ congener_NN classes_NNS ;_: in_IN this_DT situation_NN ,_, multiple_JJ comparisons_NNS can_MD be_VB justifiable_JJ as_IN part_NN of_IN a_DT careful_JJ and_CC thorough_JJ evaluation_NN of_IN patterns_NNS of_IN associations_NNS ._. 
Notably_RB ,_, our_PRP$ significant_JJ results_NNS were_VBD not_RB sporadic_JJ ,_, as_IN would_MD be_VB expected_VBN if_IN they_PRP were_VBD chance_NN findings_NNS ,_, but_CC rather_RB showed_VBD a_DT pattern_NN whereby_WRB dioxin-like_JJ congeners_NNS showed_VBD the_DT strongest_JJS associations_NNS in_IN all_DT analyses_NNS :_: cord_NN or_CC maternal_JJ serum_NN ,_, MDI_NNP or_CC PDI_NNP ._. 
5to_CD 2_CD orders_NNS of_IN magnitude_NN greater_JJR than_IN that_DT observed_VBD for_IN 4-OH-CB-146_CD or_CC 4_CD '_'' -_: OH-CB-172_NN 
Thyroid_JJ hormones_NNS are_VBP critical_JJ to_TO neuronal_JJ proliferation_NN ,_, migration_NN ,_, synaptogenesis_NN ,_, and_CC brain_NN myelination_NN 
Achange_NNP in_IN a_DT few_JJ points_NNS on_IN the_DT Bayley_NNP scales_NNS may_MD seem_VB clinically_RB unimportant_JJ for_IN an_DT individual_JJ child_NN ._. 
However_RB ,_, beginning_VBG with_IN studies_NNS from_IN the_DT population_NN level_NN ,_, it_PRP can_MD be_VB predicted_VBN that_IN a_DT slight_JJ shift_NN in_IN the_DT mean_JJ performance_NN in_IN the_DT adverse_JJ direction_NN can_MD result_VB in_IN a_DT substantial_JJ increase_NN in_IN the_DT number_NN of_IN children_NNS who_WP are_VBP in_IN the_DT subnormal_JJ range_NN in_IN the_DT clinical_JJ setting_NN ._. 
Conclusion_NN Based_VBN on_IN the_DT results_NNS herein_VBP ,_, the_DT high_JJ levels_NNS of_IN mono-ortho_JJ PCBs_NNS ,_, and_CC the_DT literature_NN on_IN dioxin-like_JJ activity_NN in_IN relation_NN to_TO neurodevelopment_NN ,_, we_PRP conclude_VBP that_IN the_DT associations_NNS of_IN prenatal_JJ dioxin-like_JJ mono-ortho_NN PCBs_NNS ,_, in_IN either_DT maternal_JJ or_CC cord_NN serum_NN ,_, with_IN decreased_VBN performance_NN in_IN both_DT the_DT cognitive_NN and_CC motor_NN domains_NNS based_VBN on_IN BSID_NNP scores_NNS could_MD plausibly_RB be_VB causal_JJ ._. 
7for_NNP Svidnik_NNP ,_, n_VBP =_SYM 201_CD -RRB-_-RRB- ,_, but_CC lower_JJR than_IN the_DT mean_JJ scores_NNS of_IN 100_CD in_IN the_DT populations_NNS for_IN which_WDT they_PRP are_VBP standardized_JJ ._. 
Because_IN the_DT BSID_NNP has_VBZ not_RB been_VBN normed_VBN in_IN the_DT Slovak_NNP language_NN or_CC culture_NN ,_, some_DT cross-cultural_JJ or_CC language_NN differences_NNS might_MD have_VB played_VBN a_DT role_NN in_IN the_DT lower_JJR MDI_NNP scores_NNS in_IN our_PRP$ study_NN ._. 
Our_PRP$ research_NN objective_NN was_VBD to_TO examine_VB possible_JJ associations_NNS between_IN prenatal_JJ PCBs_NNS and_CC BSID_NNP scores_NNS within_IN this_DT study_NN cohort_NN ._. 
In_IN our_PRP$ analyses_NNS ,_, we_PRP included_VBD six_CD of_IN the_DT most_RBS abundant_JJ PCB_NNP congeners_NNS -LRB-_-LRB- PCB_NNP IUPAC_NNP #_# 118_CD ,_, #_# 138_CD ,_, #_# 153_CD ,_, #_# 156_CD ,_, #_# 170_CD ,_, and_CC #_# 180_CD -RRB-_-RRB- ._. 
For_IN the_DT values_NNS below_IN limits_NNS of_IN detection_NN -LRB-_-LRB- LOD_NNP -RRB-_-RRB- ,_, we_PRP imputed_JJ by_IN taking_VBG the_DT LOD_NNP value_NN divided_VBN by_IN the_DT square_JJ root_NN of_IN 2_CD for_IN congeners_NNS that_WDT had_VBD fewer_JJR than_IN 20_CD %_NN of_IN samples_NNS below_IN the_DT LOD_NNP and_CC the_DT LOD_NNP divided_VBN by_IN 2_CD if_IN 
The_DT TEQs_NNP for_IN intake_NN of_IN the_DT two_CD mono-ortho_JJ PCBs_NNS together_RB would_MD therefore_RB likely_RB be_VB larger_JJR than_IN what_WP we_PRP have_VBP calculated_VBN based_VBN on_IN circulating_VBG concentrations_NNS ._. 
Also_RB notable_JJ is_VBZ a_DT recent_JJ effort_NN to_TO develop_VB a_DT Neurotoxic_NNP Equivalence_NNP Scheme_NNP that_WDT would_MD take_VB into_IN account_NN multiple_JJ mechanisms_NNS 
Both_DT mono-ortho_JJ and_CC di-ortho_JJ substituted_VBN PCBs_NNS can_MD affect_VB nervous_JJ system_NN tissues_NNS ,_, but_CC these_DT effects_NNS are_VBP possibly_RB mediated_VBN by_IN different_JJ pathways_NNS 
We_PRP did_VBD not_RB find_VB significant_JJ associations_NNS of_IN neurodevelopmental_JJ scores_NNS with_IN anti-estrogenic_JJ PCBs_NNS -LRB-_-LRB- sum_NN of_IN #_# 138_CD ,_, 156_CD ,_, 170_CD and_CC 180_CD -RRB-_-RRB- ,_, but_CC did_VBD not_RB evaluate_VB possible_JJ roles_NNS of_IN PCB_NNP metabolites_NNS with_IN regard_NN to_TO estrogenic_JJ and\/or_CC anti-estrogenic_JJ activities_NNS in_IN this_DT paper_NN ._. 
As_IN mentioned_VBN above_IN ,_, in_IN our_PRP$ previous_JJ work_NN examining_VBG six_CD hydroxylated_JJ metabolites_NNS ,_, only_RB 4-OH-CB-107_NNP was_VBD significantly_RB associated_VBN with_IN decreased_VBN Bayley_NNP scores_NNS ._. 
Interestingly_RB ,_, an_DT in_IN vitro_NN study_NN that_WDT examined_VBD inhibition_NN of_IN an_DT estrogen_NN inactivator_NN by_IN OH-PCBs_NNS and_CC subsequent_JJ increases_NNS in_IN estrogen_NN levels_NNS at_IN the_DT target_NN tissue_NN ,_, reported_VBD 4-OH-CB-107_NNP to_TO be_VB one_CD of_IN strongest_JJS inhibitors_NNS of_IN the_DT human_JJ estrogen_NN sulfotransferase_NN -LRB-_-LRB- hEST_NNP -RRB-_-RRB- ,_, an_DT enzyme_NN that_WDT catalyzes_VBZ the_DT sulfation_NN and_CC inactivation_NN of_IN estrogens_NNS ._. 
Notably_RB ,_, our_PRP$ significant_JJ results_NNS were_VBD not_RB sporadic_JJ ,_, as_IN would_MD be_VB expected_VBN if_IN they_PRP were_VBD chance_NN findings_NNS ,_, but_CC rather_RB showed_VBD a_DT pattern_NN whereby_WRB dioxin-like_JJ congeners_NNS showed_VBD the_DT strongest_JJS associations_NNS in_IN all_DT analyses_NNS :_: cord_NN or_CC maternal_JJ serum_NN ,_, MDI_NNP or_CC PDI_NNP ._. 
Furthermore_RB ,_, the_DT pattern_NN is_VBZ upheld_VBN by_IN our_PRP$ analysis_NN of_IN hydroxy-metabolites_NNS of_IN PCBs_NNS :_: of_IN the_DT six_CD that_IN we_PRP evaluated_VBD ,_, the_DT only_JJ one_CD associated_VBN with_IN neurobehavioral_JJ deficits_NNS was_VBD 4-OH-PCB107_NNP ,_, the_DT metabolite_NN for_IN PCB_NNP #_# 118_CD and_CC another_DT mono-ortho_JJ congener_NN ._. 
Several_JJ strengths_NNS are_VBP worth_JJ emphasizing_VBG :_: the_DT large_JJ sample_NN size_NN ;_: direct_JJ exposure_NN assessments_NNS of_IN prenatal_JJ PCBs_NNS rather_RB than_IN using_VBG a_DT surrogate_NN such_JJ as_IN breast-milk_NN or_CC fish_NN consumption_NN during_IN pregnancy_NN ;_: good_JJ quality_NN control_NN of_IN laboratory_NN measurements_NNS ._. 
The_DT question_NN therefore_RB arises_VBZ :_: through_IN what_WDT mechanism_NN might_MD one_CD or_CC more_JJR of_IN these_DT compounds_NNS ,_, but_CC not_RB the_DT di-ortho_NN substituted_VBD congeners_NNS and_CC corresponding_JJ metabolites_NNS measured_VBN in_IN our_PRP$ cohort_NN ,_, act_NN ._. 
Mechanisms_NNPS hypothesized_VBD to_TO underlie_VB PCB_NNP neurotoxicity_NN have_VBP included_VBN thyroid_JJ disruption_NN 
Discussion_NN We_PRP observed_VBD higher_JJR concentrations_NNS of_IN two_CD mono-ortho_JJ PCBs_NNS in_IN maternal_JJ sera_NN to_TO be_VB associated_VBN with_IN decrements_NNS in_IN neurodevelopment_NN at_IN 16_CD months_NNS of_IN age_NN ._. 
Several_JJ lab-based_JJ studies_NNS reported_VBD alteration_NN of_IN dopamine_NN -LRB-_-LRB- DA_NNP -RRB-_-RRB- levels_NNS ,_, changes_NNS of_IN behavior_NN ,_, or_CC a_DT reduction_NN in_IN long-term_JJ potentiation_NN -LRB-_-LRB- LTP_NNP -RRB-_-RRB- ,_, regarded_VBN as_IN the_DT cellular_JJ and_CC molecular_JJ mechanisms_NNS that_WDT are_VBP linked_VBN to_TO some_DT forms_NNS of_IN learning_NN and_CC memory_NN ,_, by_IN coplanar_JJ dioxin-like_JJ PCBs_NNS such_JJ as_IN congener_NN #_# 77_CD or_CC #_# 126_CD 
The_DT question_NN therefore_RB arises_VBZ :_: through_IN what_WDT mechanism_NN might_MD one_CD or_CC more_JJR of_IN these_DT compounds_NNS ,_, but_CC not_RB the_DT di-ortho_NN substituted_VBD congeners_NNS and_CC corresponding_JJ metabolites_NNS measured_VBN in_IN our_PRP$ cohort_NN ,_, act_NN ._. 
Mechanisms_NNPS hypothesized_VBD to_TO underlie_VB PCB_NNP neurotoxicity_NN have_VBP included_VBN thyroid_JJ disruption_NN 
These_DT congener_JJ measurements_NNS would_MD be_VB expected_VBN to_TO largely_RB represent_VB noise_NN ._. 
However_RB ,_, estrogenic_JJ PCB_NNP levels_NNS -LRB-_-LRB- #_# 28_CD ,_, #_# 52_CD ,_, and_CC #_# 101_CD -RRB-_-RRB- were_VBD low_JJ ,_, with_IN values_NNS for_IN several_JJ congeners_NNS mostly_RB below_IN the_DT LOD_NNP -LRB-_-LRB- range_NN :_: 60-85_CD %_NN -RRB-_-RRB- and_CC hence_RB were_VBD not_RB assessed_VBN for_IN associations_NNS with_IN neurodevelopmental_JJ scores_NNS in_IN this_DT study_NN ._. 
Moreover_RB ,_, another_DT investigation_NN failed_VBD to_TO find_VB estrogenic_JJ activity_NN of_IN these_DT congeners_NNS 
Additionally_RB ,_, various_JJ epidemiological_JJ studies_NNS have_VBP found_VBN an_DT association_NN between_IN PCB_NNP exposure_NN and_CC decreased_VBD cognitive_JJ development_NN ._. 
The_DT most_RBS well-known_JJ mechanism_NN related_VBN to_TO adverse_JJ health_NN effects_NNS such_JJ as_IN immune_JJ suppression_NN ,_, hepatotoxicity_NN ,_, and_CC thymic_JJ atrophy_NN is_VBZ aryl_JJ hydrocarbon_NN -LRB-_-LRB- Ah_UH -RRB-_-RRB- receptor-mediated_JJ pathways_NNS for_IN dioxin_NN -_: like_IN PCBs_NNS 
Additionally_RB ,_, various_JJ epidemiological_JJ studies_NNS have_VBP found_VBN an_DT association_NN between_IN PCB_NNP exposure_NN and_CC decreased_VBD cognitive_JJ development_NN ._. 
The_DT most_RBS well-known_JJ mechanism_NN related_VBN to_TO adverse_JJ health_NN effects_NNS such_JJ as_IN immune_JJ suppression_NN ,_, hepatotoxicity_NN ,_, and_CC thymic_JJ atrophy_NN is_VBZ aryl_JJ hydrocarbon_NN -LRB-_-LRB- Ah_UH -RRB-_-RRB- receptor-mediated_JJ pathways_NNS for_IN dioxin_NN -_: like_IN PCBs_NNS 
5%_CD ,_, and_CC 40_CD ._. 
,cord_JJ concentrations_NNS of_IN PCB_NNP #_# 118_CD ,_, and_CC #_# 156_CD ,_, which_WDT had_VBD 41_CD ._. 
g._NN For_IN the_DT values_NNS below_IN limits_NNS of_IN detection_NN -LRB-_-LRB- LOD_NNP -RRB-_-RRB- ,_, we_PRP imputed_JJ by_IN taking_VBG the_DT LOD_NNP value_NN divided_VBN by_IN the_DT square_JJ root_NN of_IN 2_CD for_IN congeners_NNS that_WDT had_VBD fewer_JJR than_IN 20_CD %_NN of_IN samples_NNS below_IN the_DT LOD_NNP and_CC the_DT LOD_NNP divided_VBN by_IN 2_CD if_IN 
In_IN other_JJ words_NNS ,_, the_DT lower_JJR toxicity_NN was_VBD more_JJR than_IN compensated_VBN by_IN the_DT far_RB higher_JJR abundance_NN ,_, supporting_VBG relevance_NN of_IN dioxin-like_JJ activity_NN from_IN mono-ortho_JJ PCBs_NNS in_IN this_DT population_NN ._. 
Acautionary_JJ note_NN is_VBZ in_IN order_NN ,_, however_RB :_: TEFs_NNS are_VBP calculated_VBN based_VBN on_IN intake_NN and_CC are_VBP not_RB considered_VBN applicable_JJ to_TO circulating_VBG levels_NNS in_IN human_JJ tissues_NNS 
Acautionary_JJ note_NN is_VBZ in_IN order_NN ,_, however_RB :_: TEFs_NNS are_VBP calculated_VBN based_VBN on_IN intake_NN and_CC are_VBP not_RB considered_VBN applicable_JJ to_TO circulating_VBG levels_NNS in_IN human_JJ tissues_NNS 
Another_DT concern_NN about_IN the_DT calculation_NN of_IN dioxin-like_JJ potencies_NNS in_IN epidemiologic_JJ studies_NNS relates_VBZ to_TO the_DT difficulty_NN in_IN extrapolating_VBG from_IN rat_NN to_TO human_JJ ,_, given_VBN that_IN large_JJ differences_NNS in_IN AhR-mediated_JJ gene_NN expression_NN and_CC EROD_NNP activity_NN are_VBP observed_VBN even_RB comparing_VBG rats_NNS with_IN mice_NNS ._. 
Further_JJ concerns_NNS have_VBP focused_VBN on_IN the_DT presence_NN of_IN impurities_NNS in_IN test_NN samples_NNS ,_, specifically_RB 2,3,7,8-substituted_JJ polychlorinated_VBN dibenzo-dioxins_NNS -LRB-_-LRB- PCDDs_NNP -RRB-_-RRB- ,_, -_: furans_NNS -LRB-_-LRB- PCDFs_NNP -RRB-_-RRB- ,_, or_CC PCB_NNP 126_CD 
AMichigan_JJ study_NN in_IN a_DT fishing_NN community_NN 
However_RB ,_, other_JJ studies_NNS in_IN rats_NNS reported_VBD that_IN the_DT coplanar_NN dioxin-like_JJ PCB_NNP #_# 126_CD was_VBD not_RB associated_VBN with_IN deficits_NNS in_IN attention_NN and_CC behavioral_JJ performances_NNS ._. 
Regarding_VBG epidemiological_JJ studies_NNS ,_, although_IN the_DT birth_NN cohort_NN study_NN from_IN the_DT Netherlands_NNP found_VBD an_DT association_NN of_IN coplanar_NN and_CC mono-ortho_JJ dioxin-like_JJ PCBs_NNS -LRB-_-LRB- #_# 77_CD ,_, 126_CD ,_, 169_CD ,_, 105_CD ,_, 118_CD ,_, 156_CD -RRB-_-RRB- in_IN breast-milk_NN collected_VBD two_CD weeks_NNS after_IN delivery_NN with_IN suboptimality_NN at_IN birth_NN ,_, their_PRP$ findings_NNS were_VBD null_JJ at_IN 7_CD ,_, and_CC 18_CD months_NNS for_IN the_DT PDI_NNP and_CC MDI_NNP except_IN they_PRP found_VBD a_DT significant_JJ association_NN with_IN decreased_VBN PDI_NNP at_IN 3_CD months_NNS 
Although_IN there_EX is_VBZ growing_VBG evidence_NN from_IN in_IN vivo_NN and_CC in_IN vitro_NN studies_NNS to_TO support_VB the_DT hypothesis_NN of_IN adverse_JJ effects_NNS of_IN PCBs_NNS on_IN neurodevelopment_NN 
AMichigan_JJ study_NN in_IN a_DT fishing_NN community_NN 
Reports_NNS from_IN Germany_NNP indicated_VBD reduced_VBN MDI_NNP at_IN 7_CD ,_, 18_CD and_CC 30_CD months_NNS in_IN relation_NN to_TO prenatal_JJ PCBs_NNS -LRB-_-LRB- the_DT sum_NN of_IN PCB_NNP #_# 138_CD ,_, #_# 153_CD ,_, and_CC #_# 180_CD -RRB-_-RRB- ,_, although_IN the_DT 18-month_JJ scores_NNS were_VBD somewhat_RB less_RBR precise_JJ -LRB-_-LRB- p_VB =_SYM 0_CD ._. 
06_CD -RRB-_-RRB- as_IN compared_VBN with_IN the_DT other_JJ time_NN points_NNS ._. 
Our_PRP$ study_NN did_VBD n't_RB show_VB associations_NNS with_IN either_DT non-dioxin_NN like_IN PCBs_NNS or_CC the_DT sum_NN of_IN PCB_NNP #_# 138_CD ,_, #_# 153_CD ,_, and_CC #_# 180_CD even_RB though_IN the_DT concentration_NN of_IN the_DT sum_NN of_IN PCB_NNP #_# 138_CD ,_, #_# 153_CD ,_, and_CC #_# 180_CD was_VBD higher_JJR than_IN that_DT of_IN German_JJ study_NN -LRB-_-LRB- 1_CD ._. 
16_CD vs_NNS 0_CD ._. 
Our_PRP$ study_NN did_VBD n't_RB show_VB associations_NNS with_IN either_DT non-dioxin_NN like_IN PCBs_NNS or_CC the_DT sum_NN of_IN PCB_NNP #_# 138_CD ,_, #_# 153_CD ,_, and_CC #_# 180_CD even_RB though_IN the_DT concentration_NN of_IN the_DT sum_NN of_IN PCB_NNP #_# 138_CD ,_, #_# 153_CD ,_, and_CC #_# 180_CD was_VBD higher_JJR than_IN that_DT of_IN German_JJ study_NN -LRB-_-LRB- 1_CD ._. 
55_CD ng\/ml_NN -RRB-_-RRB- ._. 
It_PRP is_VBZ not_RB certain_JJ if_IN our_PRP$ inconsistent_JJ findings_NNS with_IN the_DT German_JJ study_NN were_VBD from_IN differences_NNS between_IN the_DT two_CD studies_NNS in_IN other_JJ nonquantitated_JJ PCBs_NNS or_CC in_IN other_JJ chemical_NN compounds_NNS that_WDT correlated_VBD with_IN the_DT measured_JJ non-dioxin_NN like_IN PCBs_NNS ,_, or_CC for_IN other_JJ methodologic_JJ reasons_NNS ._. 
Some_DT research_NN on_IN non-dioxin-like_JJ PCBs_NNS suggests_VBZ that_IN they_PRP tend_VBP to_TO show_VB more_JJR potency_NN for_IN neurotoxicity_NN than_IN dioxin-like_JJ PCBs_NNS through_IN various_JJ mechanisms_NNS :_: interference_NN with_IN protein_NN kinase_NN C_NNP -LRB-_-LRB- PKC_NNP -RRB-_-RRB- 
In_IN contrast_NN ,_, studies_NNS from_IN North_NNP Carolina_NNP 
In_IN contrast_NN ,_, studies_NNS from_IN North_NNP Carolina_NNP and_CC the_DT Netherlands_NNP -LRB-_-LRB- 14_CD 
Reports_NNS from_IN Germany_NNP indicated_VBD reduced_VBN MDI_NNP at_IN 7_CD ,_, 18_CD and_CC 30_CD months_NNS in_IN relation_NN to_TO prenatal_JJ PCBs_NNS -LRB-_-LRB- the_DT sum_NN of_IN PCB_NNP #_# 138_CD ,_, #_# 153_CD ,_, and_CC #_# 180_CD -RRB-_-RRB- ,_, although_IN the_DT 18-month_JJ scores_NNS were_VBD somewhat_RB less_RBR precise_JJ -LRB-_-LRB- p_VB =_SYM 0_CD ._. 
06_CD -RRB-_-RRB- as_IN compared_VBN with_IN the_DT other_JJ time_NN points_NNS ._. 
Our_PRP$ study_NN did_VBD n't_RB show_VB associations_NNS with_IN either_DT non-dioxin_NN like_IN PCBs_NNS or_CC the_DT sum_NN of_IN PCB_NNP #_# 138_CD ,_, #_# 153_CD ,_, and_CC #_# 180_CD even_RB though_IN the_DT concentration_NN of_IN the_DT sum_NN of_IN PCB_NNP #_# 138_CD ,_, #_# 153_CD ,_, and_CC #_# 180_CD was_VBD higher_JJR than_IN that_DT of_IN German_JJ study_NN -LRB-_-LRB- 1_CD ._. 
Some_DT research_NN on_IN non-dioxin-like_JJ PCBs_NNS suggests_VBZ that_IN they_PRP tend_VBP to_TO show_VB more_JJR potency_NN for_IN neurotoxicity_NN than_IN dioxin-like_JJ PCBs_NNS through_IN various_JJ mechanisms_NNS :_: interference_NN with_IN protein_NN kinase_NN C_NNP -LRB-_-LRB- PKC_NNP -RRB-_-RRB- 
Although_IN there_EX is_VBZ growing_VBG evidence_NN from_IN in_IN vivo_NN and_CC in_IN vitro_NN studies_NNS to_TO support_VB the_DT hypothesis_NN of_IN adverse_JJ effects_NNS of_IN PCBs_NNS on_IN neurodevelopment_NN 
In_IN contrast_NN ,_, studies_NNS from_IN North_NNP Carolina_NNP 
Also_RB notable_JJ is_VBZ a_DT recent_JJ effort_NN to_TO develop_VB a_DT Neurotoxic_NNP Equivalence_NNP Scheme_NNP that_WDT would_MD take_VB into_IN account_NN multiple_JJ mechanisms_NNS 
In_IN our_PRP$ analyses_NNS ,_, we_PRP included_VBD six_CD of_IN the_DT most_RBS abundant_JJ PCB_NNP congeners_NNS -LRB-_-LRB- PCB_NNP IUPAC_NNP #_# 118_CD ,_, #_# 138_CD ,_, #_# 153_CD ,_, #_# 156_CD ,_, #_# 170_CD ,_, and_CC #_# 180_CD -RRB-_-RRB- ._. 
For_IN the_DT values_NNS below_IN limits_NNS of_IN detection_NN -LRB-_-LRB- LOD_NNP -RRB-_-RRB- ,_, we_PRP imputed_JJ by_IN taking_VBG the_DT LOD_NNP value_NN divided_VBN by_IN the_DT square_JJ root_NN of_IN 2_CD for_IN congeners_NNS that_WDT had_VBD fewer_JJR than_IN 20_CD %_NN of_IN samples_NNS below_IN the_DT LOD_NNP and_CC the_DT LOD_NNP divided_VBN by_IN 2_CD if_IN 
The_DT most_RBS well-known_JJ mechanism_NN related_VBN to_TO adverse_JJ health_NN effects_NNS such_JJ as_IN immune_JJ suppression_NN ,_, hepatotoxicity_NN ,_, and_CC thymic_JJ atrophy_NN is_VBZ aryl_JJ hydrocarbon_NN -LRB-_-LRB- Ah_UH -RRB-_-RRB- receptor-mediated_JJ pathways_NNS for_IN dioxin_NN -_: like_IN PCBs_NNS 
Since_IN non-dioxin-like_JJ PCBs_NNS have_VBP shown_VBN low_JJ affinity_NN for_IN the_DT Ah_UH receptor_NN 
Compared_VBN to_TO our_PRP$ levels_NNS of_IN maternal_JJ PCBs_NNS ,_, median_JJ concentrations_NNS in_IN this_DT study_NN of_IN PCB_NNP #_# 118_CD ,_, #_# 156_CD ,_, #_# 170_CD ,_, and_CC #_# 180_CD were_VBD lower_JJR by_IN a_DT range_NN of_IN approximately_RB 2_CD to_TO 13_CD fold_VB ._. 
Some_DT research_NN on_IN non-dioxin-like_JJ PCBs_NNS suggests_VBZ that_IN they_PRP tend_VBP to_TO show_VB more_JJR potency_NN for_IN neurotoxicity_NN than_IN dioxin-like_JJ PCBs_NNS through_IN various_JJ mechanisms_NNS :_: interference_NN with_IN protein_NN kinase_NN C_NNP -LRB-_-LRB- PKC_NNP -RRB-_-RRB- 
Compared_VBN to_TO our_PRP$ levels_NNS of_IN maternal_JJ PCBs_NNS ,_, median_JJ concentrations_NNS in_IN this_DT study_NN of_IN PCB_NNP #_# 118_CD ,_, #_# 156_CD ,_, #_# 170_CD ,_, and_CC #_# 180_CD were_VBD lower_JJR by_IN a_DT range_NN of_IN approximately_RB 2_CD to_TO 13_CD fold_VB ._. 
Some_DT research_NN on_IN non-dioxin-like_JJ PCBs_NNS suggests_VBZ that_IN they_PRP tend_VBP to_TO show_VB more_JJR potency_NN for_IN neurotoxicity_NN than_IN dioxin-like_JJ PCBs_NNS through_IN various_JJ mechanisms_NNS :_: interference_NN with_IN protein_NN kinase_NN C_NNP -LRB-_-LRB- PKC_NNP -RRB-_-RRB- 
Some_DT research_NN on_IN non-dioxin-like_JJ PCBs_NNS suggests_VBZ that_IN they_PRP tend_VBP to_TO show_VB more_JJR potency_NN for_IN neurotoxicity_NN than_IN dioxin-like_JJ PCBs_NNS through_IN various_JJ mechanisms_NNS :_: interference_NN with_IN protein_NN kinase_NN C_NNP -LRB-_-LRB- PKC_NNP -RRB-_-RRB- 
Compared_VBN to_TO our_PRP$ levels_NNS of_IN maternal_JJ PCBs_NNS ,_, median_JJ concentrations_NNS in_IN this_DT study_NN of_IN PCB_NNP #_# 118_CD ,_, #_# 156_CD ,_, #_# 170_CD ,_, and_CC #_# 180_CD were_VBD lower_JJR by_IN a_DT range_NN of_IN approximately_RB 2_CD to_TO 13_CD fold_VB ._. 
Some_DT research_NN on_IN non-dioxin-like_JJ PCBs_NNS suggests_VBZ that_IN they_PRP tend_VBP to_TO show_VB more_JJR potency_NN for_IN neurotoxicity_NN than_IN dioxin-like_JJ PCBs_NNS through_IN various_JJ mechanisms_NNS :_: interference_NN with_IN protein_NN kinase_NN C_NNP -LRB-_-LRB- PKC_NNP -RRB-_-RRB- 
g._NN To_TO screen_VB for_IN confounders_NNS ,_, we_PRP did_VBD bivariate_JJ analyses_NNS regressing_VBG MDI_NNP scores_NNS ,_, PDI_NNP scores_NNS ,_, or_CC PCBs_NNS on_IN each_DT covariate_NN -LRB-_-LRB- e._JJ ,_, maternal_JJ age_NN ,_, education_NN ,_, smoking_NN and_CC alcohol_NN consumption_NN ,_, parity_NN ,_, ethnicity_NN ,_, gestational_JJ age_NN ,_, birth_NN weight_NN ,_, child_NN 's_POS sex_NN ,_, and_CC maternal_JJ illness_NN history_NN -RRB-_-RRB- ,_, and_CC examined_VBD these_DT variables_NNS in_IN a_DT directed_VBN acyclic_NN graph_NN ._. 
Then_RB multiple_JJ linear_JJ regression_NN models_NNS were_VBD developed_VBN with_IN a_DT broad_JJ inclusion_NN of_IN all_DT covariates_NNS showing_VBG an_DT association_NN with_IN the_DT PDI_NNP or_CC MDI_NNP of_IN p_NN 
3._CD 
Then_RB multiple_JJ linear_JJ regression_NN models_NNS were_VBD developed_VBN with_IN a_DT broad_JJ inclusion_NN of_IN all_DT covariates_NNS showing_VBG an_DT association_NN with_IN the_DT PDI_NNP or_CC MDI_NNP of_IN p_NN 
Because_IN of_IN the_DT lengthy_JJ half-lives_NNS of_IN PCBs_NNS ,_, any_DT measurement_NN in_IN serum_NN represents_VBZ an_DT accumulation_NN of_IN exposure_NN over_IN a_DT period_NN of_IN years_NNS ._. 
These_DT compounds_NNS circulate_VBP in_IN the_DT serum_NN lipids_NNS and_CC cross_VB the_DT placenta_NN ,_, albeit_IN less_RBR efficiently_RB than_IN their_PRP$ hydroxy-metabolites_NNS ;_: nonetheless_RB ,_, the_DT consistency_NN of_IN cord_NN :_: maternal_JJ ratios_NNS across_IN exposure_NN levels_NNS provides_VBZ the_DT rationale_NN for_IN use_NN of_IN maternal_JJ concentrations_NNS as_IN a_DT surrogate_NN for_IN fetal_JJ exposures_NNS ._. 
The_DT present_JJ study_NN investigated_VBD associations_NNS between_IN prenatal_JJ PCB_NNP exposures_NNS ,_, measured_VBN from_IN maternal_JJ and_CC cord_NN sera_NN ,_, characterized_VBN by_IN their_PRP$ chemical_NN structures_NNS and_CC hormonal_JJ activities_NNS ,_, and_CC neurodevelopment_NN measured_VBN by_IN BSID_NNP among_IN 16-month-old_JJ infants_NNS in_IN eastern_JJ Slovakia_NNP ._. 
2ml_JJ for_IN lipid_NN measurement_NN ,_, stored_VBN at_IN -18_CD 
The_DT limit_NN of_IN detection_NN for_IN each_DT analyte_NN was_VBD determined_VBN as_IN the_DT mean_NN of_IN background_NN noise_NN plus_CC three_CD standard_JJ deviations_NNS from_IN five_CD reagent_NN blank_NN samples_NNS ._. 
The_DT detailed_JJ methods_NNS for_IN analysis_NN have_VBP been_VBN described_VBN previously_RB ._. 
The_DT Department_NNP of_IN Toxic_NNP Organic_NNP Pollutants_NNPS at_IN the_DT SMU_NNP performed_VBD the_DT laboratory_NN analyses_NNS ._. 
This_DT accredited_JJ laboratory_NN has_VBZ annually_RB participated_VBN successfully_RB in_IN an_DT inter-laboratory_JJ comparison_NN program_NN organized_VBN by_IN the_DT German_NNP External_NNP Quality_NNP Assessment_NNP Scheme_NNP -LRB-_-LRB- G-EQUAS_NNP -RRB-_-RRB- for_IN Analysis_NNP in_IN Biological_NNP Materials_NNPS at_IN the_DT Friedrich-Alexander-University_NNP ,_, Erlagen-Nuremberg_NNP as_RB well_RB as_IN the_DT WHO-Coordinated_JJ Interlaboratory_NNP Quality_NNP Assessment_NNP of_IN Levels_NNPS of_IN PCBs_NNS ,_, PCDDs_NNS and_CC PCDFs_NNS in_IN Human_JJ Milk_NN and_CC Blood_NNP Plasma_NNP 
The_DT question_NN therefore_RB arises_VBZ :_: through_IN what_WDT mechanism_NN might_MD one_CD or_CC more_JJR of_IN these_DT compounds_NNS ,_, but_CC not_RB the_DT di-ortho_NN substituted_VBD congeners_NNS and_CC corresponding_JJ metabolites_NNS measured_VBN in_IN our_PRP$ cohort_NN ,_, act_NN ._. 
Mechanisms_NNPS hypothesized_VBD to_TO underlie_VB PCB_NNP neurotoxicity_NN have_VBP included_VBN thyroid_JJ disruption_NN 
Mechanisms_NNPS hypothesized_VBD to_TO underlie_VB PCB_NNP neurotoxicity_NN have_VBP included_VBN thyroid_JJ disruption_NN 
AMichigan_JJ study_NN in_IN a_DT fishing_NN community_NN 
AMichigan_JJ study_NN in_IN a_DT fishing_NN community_NN 
The_DT Department_NNP of_IN Toxic_NNP Organic_NNP Pollutants_NNPS at_IN the_DT SMU_NNP performed_VBD the_DT laboratory_NN analyses_NNS ._. 
The_DT detailed_JJ methods_NNS for_IN analysis_NN have_VBP been_VBN described_VBN previously_RB ._. 
This_DT accredited_JJ laboratory_NN has_VBZ annually_RB participated_VBN successfully_RB in_IN an_DT inter-laboratory_JJ comparison_NN program_NN organized_VBN by_IN the_DT German_NNP External_NNP Quality_NNP Assessment_NNP Scheme_NNP -LRB-_-LRB- G-EQUAS_NNP -RRB-_-RRB- for_IN Analysis_NNP in_IN Biological_NNP Materials_NNPS at_IN the_DT Friedrich-Alexander-University_NNP ,_, Erlagen-Nuremberg_NNP as_RB well_RB as_IN the_DT WHO-Coordinated_JJ Interlaboratory_NNP Quality_NNP Assessment_NNP of_IN Levels_NNPS of_IN PCBs_NNS ,_, PCDDs_NNS and_CC PCDFs_NNS in_IN Human_JJ Milk_NN and_CC Blood_NNP Plasma_NNP 
In_IN contrast_NN ,_, studies_NNS from_IN North_NNP Carolina_NNP 
In_IN contrast_NN ,_, studies_NNS from_IN North_NNP Carolina_NNP 
Estradiol_NNP protects_VBZ against_IN free_JJ radicals_NNS and_CC regulates_VBZ apoptosis_NN 
When_WRB bound_VBN to_TO estrogen_NN receptors_NNS ,_, the_DT complex_NN regulates_VBZ transcription_NN 
If_IN only_RB the_DT Bayley_NNP Scales_NNP of_IN Infant_NNP Development_NNP -LRB-_-LRB- BSID_NNP -RRB-_-RRB- assessment_NN is_VBZ considered_VBN ,_, findings_NNS across_IN studies_NNS are_VBP inconsistent_JJ ._. 
AMichigan_JJ study_NN in_IN a_DT fishing_NN community_NN 
If_IN only_RB the_DT Bayley_NNP Scales_NNP of_IN Infant_NNP Development_NNP -LRB-_-LRB- BSID_NNP -RRB-_-RRB- assessment_NN is_VBZ considered_VBN ,_, findings_NNS across_IN studies_NNS are_VBP inconsistent_JJ ._. 
AMichigan_JJ study_NN in_IN a_DT fishing_NN community_NN 
Several_JJ lab-based_JJ studies_NNS reported_VBD alteration_NN of_IN dopamine_NN -LRB-_-LRB- DA_NNP -RRB-_-RRB- levels_NNS ,_, changes_NNS of_IN behavior_NN ,_, or_CC a_DT reduction_NN in_IN long-term_JJ potentiation_NN -LRB-_-LRB- LTP_NNP -RRB-_-RRB- ,_, regarded_VBN as_IN the_DT cellular_JJ and_CC molecular_JJ mechanisms_NNS that_WDT are_VBP linked_VBN to_TO some_DT forms_NNS of_IN learning_NN and_CC memory_NN ,_, by_IN coplanar_JJ dioxin-like_JJ PCBs_NNS such_JJ as_IN congener_NN #_# 77_CD or_CC #_# 126_CD 
Thyroid_JJ hormones_NNS are_VBP critical_JJ to_TO neuronal_JJ proliferation_NN ,_, migration_NN ,_, synaptogenesis_NN ,_, and_CC brain_NN myelination_NN 
03_CD ,_, and_CC none_NN of_IN them_PRP were_VBD significant_JJ -RRB-_-RRB- ._. 
However_RB ,_, in_IN a_DT sub-sample_NN of_IN the_DT cohort_NN ,_, correlations_NNS between_IN these_DT heavy_JJ metals_NNS and_CC dioxin-like_JJ PCBs_NNS did_VBD n't_RB exist_VB -LRB-_-LRB- correlation_NN coefficients_NNS were_VBD either_DT negative_JJ or_CC less_JJR than_IN 0_CD ._. 
Although_IN fish_NN can_MD be_VB a_DT major_JJ source_NN of_IN methyl_NN mercury_NN ,_, in_IN other_JJ work_NN from_IN our_PRP$ Slovak_NNP birth_NN cohort_NN ,_, mothers_NNS '_POS fish_NN consumption_NN was_VBD very_RB low_JJ ,_, contributing_VBG a_DT negligible_JJ amount_NN of_IN fat_NN to_TO the_DT diet_NN ,_, and_CC hence_RB would_MD not_RB be_VB expected_VBN to_TO be_VB an_DT important_JJ source_NN of_IN PCBs_NNS ._. 
Multiple_JJ comparisons_NNS can_MD be_VB a_DT problem_NN in_IN the_DT study_NN because_IN we_PRP tested_VBD 36_CD various_JJ combinations_NNS of_IN PCBs_NNS and_CC outcomes_NNS ._. 
S._NNP ,_, in_IN U._NNP g._NN On_IN the_DT one_CD hand_NN ,_, dioxin-like_JJ activity_NN of_IN mono-ortho_JJ PCBs_NNS occurs_VBZ only_RB at_IN much_RB higher_JJR concentrations_NNS than_IN that_DT of_IN coplanar_JJ PCBs_NNS or_CC of_IN 2,3,7,8-TCDD_NNP ;_: on_IN the_DT other_JJ ,_, congeners_NNS #_# 118_CD and_CC #_# 156_CD are_VBP present_JJ ,_, in_IN virtually_RB every_DT human_JJ population_NN studied_VBD ,_, at_IN levels_NNS from_IN 4_CD to_TO 5_CD orders_NNS of_IN magnitude_NN greater_JJR than_IN 2,3,7,8-TCDD_NNP itself_PRP -LRB-_-LRB- e._JJ ,_, European_JJ ,_, and_CC Japanese_JJ studies_NNS -RRB-_-RRB- ._. 
Because_IN of_IN the_DT exceedingly_RB low_JJ levels_NNS of_IN the_DT coplanar_JJ PCBs_NNS ,_, furans_NNS ,_, 2,3,7,8-TCDD_JJ and_CC other_JJ dioxins_NNS and_CC the_DT high_JJ cost_NN to_TO quantitate_VB them_PRP ,_, we_PRP were_VBD unable_JJ to_TO measure_VB these_DT compounds_NNS in_IN cord_NN and_CC maternal_JJ sera_NN ._. 
S._NNP ,_, in_IN U._NNP g._NN On_IN the_DT one_CD hand_NN ,_, dioxin-like_JJ activity_NN of_IN mono-ortho_JJ PCBs_NNS occurs_VBZ only_RB at_IN much_RB higher_JJR concentrations_NNS than_IN that_DT of_IN coplanar_JJ PCBs_NNS or_CC of_IN 2,3,7,8-TCDD_NNP ;_: on_IN the_DT other_JJ ,_, congeners_NNS #_# 118_CD and_CC #_# 156_CD are_VBP present_JJ ,_, in_IN virtually_RB every_DT human_JJ population_NN studied_VBD ,_, at_IN levels_NNS from_IN 4_CD to_TO 5_CD orders_NNS of_IN magnitude_NN greater_JJR than_IN 2,3,7,8-TCDD_NNP itself_PRP -LRB-_-LRB- e._JJ ,_, European_JJ ,_, and_CC Japanese_JJ studies_NNS -RRB-_-RRB- ._. 
Because_IN of_IN the_DT exceedingly_RB low_JJ levels_NNS of_IN the_DT coplanar_JJ PCBs_NNS ,_, furans_NNS ,_, 2,3,7,8-TCDD_JJ and_CC other_JJ dioxins_NNS and_CC the_DT high_JJ cost_NN to_TO quantitate_VB them_PRP ,_, we_PRP were_VBD unable_JJ to_TO measure_VB these_DT compounds_NNS in_IN cord_NN and_CC maternal_JJ sera_NN ._. 
The_DT hEST_NNP activity_NN was_VBD 1_CD ._. 
Interestingly_RB ,_, an_DT in_IN vitro_NN study_NN that_WDT examined_VBD inhibition_NN of_IN an_DT estrogen_NN inactivator_NN by_IN OH-PCBs_NNS and_CC subsequent_JJ increases_NNS in_IN estrogen_NN levels_NNS at_IN the_DT target_NN tissue_NN ,_, reported_VBD 4-OH-CB-107_NNP to_TO be_VB one_CD of_IN strongest_JJS inhibitors_NNS of_IN the_DT human_JJ estrogen_NN sulfotransferase_NN -LRB-_-LRB- hEST_NNP -RRB-_-RRB- ,_, an_DT enzyme_NN that_WDT catalyzes_VBZ the_DT sulfation_NN and_CC inactivation_NN of_IN estrogens_NNS ._. 
5to_CD 2_CD orders_NNS of_IN magnitude_NN greater_JJR than_IN that_DT observed_VBD for_IN 4-OH-CB-146_CD or_CC 4_CD '_'' -_: OH-CB-172_NN 
09_CD -RRB-_-RRB- from_IN these_DT compounds_NNS measured_VBN in_IN cord_NN ,_, but_CC not_RB in_IN maternal_JJ samples_NNS -LRB-_-LRB- Table_NNP 3_CD -RRB-_-RRB- ._. 
195_CD ,_, p_VBP =_SYM 0_CD ._. 
In_IN contrast_NN to_TO some_DT other_JJ epidemiological_JJ or_CC lab-based_JJ studies_NNS ,_, we_PRP found_VBD the_DT evidence_NN was_VBD weaker_JJR for_IN a_DT relationship_NN between_IN neurodevelopment_NN and_CC prenatal_JJ exposures_NNS to_TO di-ortho-substituted_JJ PCBs_NNS ,_, although_IN a_DT suggestive_JJ association_NN was_VBD observed_VBN with_IN PDI_NNP -LRB-_-LRB- 
Thyroid_JJ hormones_NNS are_VBP critical_JJ to_TO neuronal_JJ proliferation_NN ,_, migration_NN ,_, synaptogenesis_NN ,_, and_CC brain_NN myelination_NN 
It_PRP has_VBZ long_RB been_VBN hypothesized_VBN that_IN one_CD mechanism_NN for_IN neurodevelopmental_JJ toxicity_NN of_IN PCBs_NNS is_VBZ through_IN disruption_NN of_IN thyroid_JJ hormones_NNS 
However_RB ,_, other_JJ studies_NNS in_IN rats_NNS reported_VBD that_IN the_DT coplanar_NN dioxin-like_JJ PCB_NNP #_# 126_CD was_VBD not_RB associated_VBN with_IN deficits_NNS in_IN attention_NN and_CC behavioral_JJ performances_NNS ._. 
Regarding_VBG epidemiological_JJ studies_NNS ,_, although_IN the_DT birth_NN cohort_NN study_NN from_IN the_DT Netherlands_NNP found_VBD an_DT association_NN of_IN coplanar_NN and_CC mono-ortho_JJ dioxin-like_JJ PCBs_NNS -LRB-_-LRB- #_# 77_CD ,_, 126_CD ,_, 169_CD ,_, 105_CD ,_, 118_CD ,_, 156_CD -RRB-_-RRB- in_IN breast-milk_NN collected_VBD two_CD weeks_NNS after_IN delivery_NN with_IN suboptimality_NN at_IN birth_NN ,_, their_PRP$ findings_NNS were_VBD null_JJ at_IN 7_CD ,_, and_CC 18_CD months_NNS for_IN the_DT PDI_NNP and_CC MDI_NNP except_IN they_PRP found_VBD a_DT significant_JJ association_NN with_IN decreased_VBN PDI_NNP at_IN 3_CD months_NNS 
5to_CD 2_CD orders_NNS of_IN magnitude_NN greater_JJR than_IN that_DT observed_VBD for_IN 4-OH-CB-146_CD or_CC 4_CD '_'' -_: OH-CB-172_NN 
Compared_VBN to_TO our_PRP$ levels_NNS of_IN maternal_JJ PCBs_NNS ,_, median_JJ concentrations_NNS in_IN this_DT study_NN of_IN PCB_NNP #_# 118_CD ,_, #_# 156_CD ,_, #_# 170_CD ,_, and_CC #_# 180_CD were_VBD lower_JJR by_IN a_DT range_NN of_IN approximately_RB 2_CD to_TO 13_CD fold_VB ._. 
Some_DT research_NN on_IN non-dioxin-like_JJ PCBs_NNS suggests_VBZ that_IN they_PRP tend_VBP to_TO show_VB more_JJR potency_NN for_IN neurotoxicity_NN than_IN dioxin-like_JJ PCBs_NNS through_IN various_JJ mechanisms_NNS :_: interference_NN with_IN protein_NN kinase_NN C_NNP -LRB-_-LRB- PKC_NNP -RRB-_-RRB- 
5to_CD 2_CD orders_NNS of_IN magnitude_NN greater_JJR than_IN that_DT observed_VBD for_IN 4-OH-CB-146_CD or_CC 4_CD '_'' -_: OH-CB-172_NN 
Moreover_RB ,_, another_DT investigation_NN failed_VBD to_TO find_VB estrogenic_JJ activity_NN of_IN these_DT congeners_NNS 
In_IN other_JJ words_NNS ,_, the_DT lower_JJR toxicity_NN was_VBD more_JJR than_IN compensated_VBN by_IN the_DT far_RB higher_JJR abundance_NN ,_, supporting_VBG relevance_NN of_IN dioxin-like_JJ activity_NN from_IN mono-ortho_JJ PCBs_NNS in_IN this_DT population_NN ._. 
Acautionary_JJ note_NN is_VBZ in_IN order_NN ,_, however_RB :_: TEFs_NNS are_VBP calculated_VBN based_VBN on_IN intake_NN and_CC are_VBP not_RB considered_VBN applicable_JJ to_TO circulating_VBG levels_NNS in_IN human_JJ tissues_NNS ._. 
The_DT WHO_WP 2005_CD report_NN 
Discussion_NN We_PRP observed_VBD higher_JJR concentrations_NNS of_IN two_CD mono-ortho_JJ PCBs_NNS in_IN maternal_JJ sera_NN to_TO be_VB associated_VBN with_IN decrements_NNS in_IN neurodevelopment_NN at_IN 16_CD months_NNS of_IN age_NN ._. 
Several_JJ lab-based_JJ studies_NNS reported_VBD alteration_NN of_IN dopamine_NN -LRB-_-LRB- DA_NNP -RRB-_-RRB- levels_NNS ,_, changes_NNS of_IN behavior_NN ,_, or_CC a_DT reduction_NN in_IN long-term_JJ potentiation_NN -LRB-_-LRB- LTP_NNP -RRB-_-RRB- ,_, regarded_VBN as_IN the_DT cellular_JJ and_CC molecular_JJ mechanisms_NNS that_WDT are_VBP linked_VBN to_TO some_DT forms_NNS of_IN learning_NN and_CC memory_NN ,_, by_IN coplanar_JJ dioxin-like_JJ PCBs_NNS such_JJ as_IN congener_NN #_# 77_CD or_CC #_# 126_CD 
The_DT WHO_WP 2005_CD report_NN 
It_PRP is_VBZ not_RB certain_JJ if_IN our_PRP$ inconsistent_JJ findings_NNS with_IN the_DT German_JJ study_NN were_VBD from_IN differences_NNS between_IN the_DT two_CD studies_NNS in_IN other_JJ nonquantitated_JJ PCBs_NNS or_CC in_IN other_JJ chemical_NN compounds_NNS that_WDT correlated_VBD with_IN the_DT measured_JJ non-dioxin_NN like_IN PCBs_NNS ,_, or_CC for_IN other_JJ methodologic_JJ reasons_NNS ._. 
Astudy_JJ with_IN 6-month-old_JJ children_NNS in_IN Japan_NNP reported_VBD no_DT statistically_RB significant_JJ association_NN between_IN prenatal_JJ non-dioxin_NN like_IN PCBs_NNS -LRB-_-LRB- #_# 170_CD ,_, #_# 180_CD -RRB-_-RRB- and_CC the_DT Bayley_NNP scores_NNS while_IN some_DT dioxin-like_JJ PCBs_NNS -LRB-_-LRB- #_# 118_CD ,_, #_# 126_CD ,_, #_# 157_CD ,_, and_CC #_# 189_CD -RRB-_-RRB- showed_VBD suggestive_JJ associations_NNS with_IN reduced_JJ PDI_NNP -LRB-_-LRB- p_SYM 
The_DT lipids_NNS were_VBD measured_VBN at_IN a_DT biochemical_JJ laboratory_NN accredited_VBN by_IN the_DT Slovak_NNP National_NNP Accreditation_NNP Service_NNP located_VBD at_IN the_DT Ministry_NNP of_IN Defense_NNP Military_NNP hospital_NN in_IN Bratislava_NNP ._. 
Neurodevelopmental_NNP assessmentThe_NNP BSID-II_NNP are_VBP age_NN standardized_JJ scales_NNS for_IN 1_CD -_: 42_CD months_NNS used_VBN widely_RB in_IN screening_NN in_IN clinical_JJ practice_NN and_CC for_IN research_NN studies_NNS of_IN factors_NNS influencing_VBG development_NN ._. 
Choosing_VBG a_DT specific_JJ neurodevelopment_NN assessment_NN tool_NN is_VBZ complicated_VBN ,_, in_IN particular_JJ ,_, for_IN non-English_JJ speaking_NN countries_NNS ._. 
g._NNP Categorization_NNP of_IN exposure_NN variables_NNS PCBs_NNS were_VBD categorized_VBN into_IN different_JJ groups_NNS by_IN their_PRP$ chemical_NN structures_NNS -LRB-_-LRB- e._JJ ,_, dioxin-like_JJ mono-ortho_JJ PCBs_NNS or_CC non-dioxin-like_JJ di-ortho_JJ PCBs_NNS -RRB-_-RRB- or_CC their_PRP$ estrogenic_JJ or_CC anti-estrogenic_JJ properties_NNS based_VBN on_IN the_DT published_JJ literature_NN ._. 
In_IN our_PRP$ analyses_NNS ,_, we_PRP included_VBD six_CD of_IN the_DT most_RBS abundant_JJ PCB_NNP congeners_NNS -LRB-_-LRB- PCB_NNP IUPAC_NNP #_# 118_CD ,_, #_# 138_CD ,_, #_# 153_CD ,_, #_# 156_CD ,_, #_# 170_CD ,_, and_CC #_# 180_CD -RRB-_-RRB- ._. 
Several_JJ lab-based_JJ studies_NNS reported_VBD alteration_NN of_IN dopamine_NN -LRB-_-LRB- DA_NNP -RRB-_-RRB- levels_NNS ,_, changes_NNS of_IN behavior_NN ,_, or_CC a_DT reduction_NN in_IN long-term_JJ potentiation_NN -LRB-_-LRB- LTP_NNP -RRB-_-RRB- ,_, regarded_VBN as_IN the_DT cellular_JJ and_CC molecular_JJ mechanisms_NNS that_WDT are_VBP linked_VBN to_TO some_DT forms_NNS of_IN learning_NN and_CC memory_NN ,_, by_IN coplanar_JJ dioxin-like_JJ PCBs_NNS such_JJ as_IN congener_NN #_# 77_CD or_CC #_# 126_CD 
In_IN addition_NN to_TO the_DT collection_NN of_IN socio-demographic_JJ and_CC lifestyle_NN factors_NNS ,_, the_DT Raven_NNP 's_POS Progressive_NNP Matrices_NNP ,_, a_DT non-verbal_JJ intelligence_NN test_NN ,_, was_VBD administered_VBN to_TO mothers_NNS after_IN delivery_NN ._. 
Additionally_RB ,_, the_DT Home_NNP Observation_NNP for_IN Measurement_NNP of_IN the_DT Environment_NNP -LRB-_-LRB- HOME_NNP -RRB-_-RRB- 
Covariate_NNP measures_VBZ Major_JJ data_NNS sources_NNS for_IN covariates_NNS for_IN this_DT analysis_NN were_VBD an_DT interview_NN with_IN the_DT mother_NN conducted_VBN by_IN trained_JJ staff_NN during_IN the_DT 5-day_JJ hospital_NN stay_NN after_IN delivery_NN ,_, and_CC the_DT newborn_JJ medical_JJ record_NN ._. 
In_IN addition_NN to_TO the_DT collection_NN of_IN socio-demographic_JJ and_CC lifestyle_NN factors_NNS ,_, the_DT Raven_NNP 's_POS Progressive_NNP Matrices_NNP ,_, a_DT non-verbal_JJ intelligence_NN test_NN ,_, was_VBD administered_VBN to_TO mothers_NNS after_IN delivery_NN ._. 
Additionally_RB ,_, the_DT Home_NNP Observation_NNP for_IN Measurement_NNP of_IN the_DT Environment_NNP -LRB-_-LRB- HOME_NNP -RRB-_-RRB- 
The_DT method_NN by_IN Takayama_NNP et_FW al._FW ._. 
Serum_NNP total_JJ cholesterol_NN -LRB-_-LRB- TC_NNP -RRB-_-RRB- and_CC triglyceride_NN -LRB-_-LRB- TG_NNP -RRB-_-RRB- were_VBD measured_VBN using_VBG a_DT DuPont_NNP aca_NNP III_NNP analyzer_NN and_CC cholesterol_NN oxidase_NN without_IN cholesterol_NN esterase_NN was_VBD used_VBN to_TO detect_VB free_JJ cholesterol_NN -LRB-_-LRB- FC_NNP -RRB-_-RRB- ._. 
was_VBD used_VBN to_TO determine_VB serum_NN choline-containing_NN phospholipids_NNS -LRB-_-LRB- PL_NNP -RRB-_-RRB- ._. 
Total_JJ serum_NN lipids_NNS were_VBD calculated_VBN from_IN the_DT formula_NN TL_NNP =_SYM 1_CD ._. 
677_CD \*_NN -LRB-_-LRB- TC-FC_NNP -RRB-_-RRB- +_NNP FC+TG+PL_NNP ._. 
The_DT lipids_NNS were_VBD measured_VBN at_IN a_DT biochemical_JJ laboratory_NN accredited_VBN by_IN the_DT Slovak_NNP National_NNP Accreditation_NNP Service_NNP located_VBD at_IN the_DT Ministry_NNP of_IN Defense_NNP Military_NNP hospital_NN in_IN Bratislava_NNP ._. 
g._NNP Categorization_NNP of_IN exposure_NN variables_NNS PCBs_NNS were_VBD categorized_VBN into_IN different_JJ groups_NNS by_IN their_PRP$ chemical_NN structures_NNS -LRB-_-LRB- e._JJ ,_, dioxin-like_JJ mono-ortho_JJ PCBs_NNS or_CC non-dioxin-like_JJ di-ortho_JJ PCBs_NNS -RRB-_-RRB- or_CC their_PRP$ estrogenic_JJ or_CC anti-estrogenic_JJ properties_NNS based_VBN on_IN the_DT published_JJ literature_NN ._. 
In_IN our_PRP$ analyses_NNS ,_, we_PRP included_VBD six_CD of_IN the_DT most_RBS abundant_JJ PCB_NNP congeners_NNS -LRB-_-LRB- PCB_NNP IUPAC_NNP #_# 118_CD ,_, #_# 138_CD ,_, #_# 153_CD ,_, #_# 156_CD ,_, #_# 170_CD ,_, and_CC #_# 180_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, another_DT investigation_NN failed_VBD to_TO find_VB estrogenic_JJ activity_NN of_IN these_DT congeners_NNS 
This_DT accredited_JJ laboratory_NN has_VBZ annually_RB participated_VBN successfully_RB in_IN an_DT inter-laboratory_JJ comparison_NN program_NN organized_VBN by_IN the_DT German_NNP External_NNP Quality_NNP Assessment_NNP Scheme_NNP -LRB-_-LRB- G-EQUAS_NNP -RRB-_-RRB- for_IN Analysis_NNP in_IN Biological_NNP Materials_NNPS at_IN the_DT Friedrich-Alexander-University_NNP ,_, Erlagen-Nuremberg_NNP as_RB well_RB as_IN the_DT WHO-Coordinated_JJ Interlaboratory_NNP Quality_NNP Assessment_NNP of_IN Levels_NNPS of_IN PCBs_NNS ,_, PCDDs_NNS and_CC PCDFs_NNS in_IN Human_JJ Milk_NN and_CC Blood_NNP Plasma_NNP ._. 
Lipids_NNP measurementTotal_NNP serum_NN lipids_NNS -LRB-_-LRB- TL_NNP -RRB-_-RRB- were_VBD estimated_VBN using_VBG enzymatic_JJ summation_NN method_NN 
2ml_JJ for_IN lipid_NN measurement_NN ,_, stored_VBN at_IN -18_CD 
The_DT limit_NN of_IN detection_NN for_IN each_DT analyte_NN was_VBD determined_VBN as_IN the_DT mean_NN of_IN background_NN noise_NN plus_CC three_CD standard_JJ deviations_NNS from_IN five_CD reagent_NN blank_NN samples_NNS ._. 
The_DT detailed_JJ methods_NNS for_IN analysis_NN have_VBP been_VBN described_VBN previously_RB 
Besides_IN playing_VBG a_DT major_JJ role_NN in_IN sex_NN differences_NNS ,_, including_VBG sexual_JJ dimorphic_JJ behaviors_NNS ,_, they_PRP modulate_VBP hypoxia-induced_JJ injury_NN of_IN neurons_NNS in_IN the_DT hippocampus_NN 
Gonadal_JJ hormones_NNS such_JJ as_IN estrogens_NNS can_MD alter_VB the_DT structure_NN and_CC function_NN of_IN the_DT hippocampus_NN ,_, which_WDT is_VBZ critical_JJ for_IN spatial_JJ and_CC declarative_JJ learning_NN and_CC memory_NN ,_, and_CC they_PRP modulate_VBP neural_JJ circuits_NNS by_IN interacting_VBG with_IN various_JJ neurotransmitters_NNS 
Gonadal_JJ hormones_NNS such_JJ as_IN estrogens_NNS can_MD alter_VB the_DT structure_NN and_CC function_NN of_IN the_DT hippocampus_NN ,_, which_WDT is_VBZ critical_JJ for_IN spatial_JJ and_CC declarative_JJ learning_NN and_CC memory_NN ,_, and_CC they_PRP modulate_VBP neural_JJ circuits_NNS by_IN interacting_VBG with_IN various_JJ neurotransmitters_NNS 
Alteration_NN of_IN sex-steroid_JJ hormone_NN homeostasis_NN by_IN PCBs_NNS has_VBZ been_VBN studied_VBN ,_, and_CC estrogen-like_JJ activity_NN of_IN PCBs_NNS was_VBD reported_VBN to_TO change_VB brain_NN dopamine_NN -LRB-_-LRB- DA_NNP -RRB-_-RRB- concentration_NN 
However_RB ,_, neurotoxicity_NN 
However_RB ,_, neurotoxicity_NN 
Compared_VBN to_TO our_PRP$ levels_NNS of_IN maternal_JJ PCBs_NNS ,_, median_JJ concentrations_NNS in_IN this_DT study_NN of_IN PCB_NNP #_# 118_CD ,_, #_# 156_CD ,_, #_# 170_CD ,_, and_CC #_# 180_CD were_VBD lower_JJR by_IN a_DT range_NN of_IN approximately_RB 2_CD to_TO 13_CD fold_VB ._. 
Some_DT research_NN on_IN non-dioxin-like_JJ PCBs_NNS suggests_VBZ that_IN they_PRP tend_VBP to_TO show_VB more_JJR potency_NN for_IN neurotoxicity_NN than_IN dioxin-like_JJ PCBs_NNS through_IN various_JJ mechanisms_NNS :_: interference_NN with_IN protein_NN kinase_NN C_NNP -LRB-_-LRB- PKC_NNP -RRB-_-RRB- 
Some_DT research_NN on_IN non-dioxin-like_JJ PCBs_NNS suggests_VBZ that_IN they_PRP tend_VBP to_TO show_VB more_JJR pot_NN 
However_RB ,_, neurotoxicity_NN 
Compared_VBN to_TO our_PRP$ levels_NNS of_IN maternal_JJ PCBs_NNS ,_, median_JJ concentrations_NNS in_IN this_DT study_NN of_IN PCB_NNP #_# 118_CD ,_, #_# 156_CD ,_, #_# 170_CD ,_, and_CC #_# 180_CD were_VBD lower_JJR by_IN a_DT range_NN of_IN approximately_RB 2_CD to_TO 13_CD fold_VB ._. 
Some_DT research_NN on_IN non-dioxin-like_JJ PCBs_NNS suggests_VBZ that_IN they_PRP tend_VBP to_TO show_VB more_JJR potency_NN for_IN neurotoxicity_NN than_IN dioxin-like_JJ PCBs_NNS through_IN various_JJ mechanisms_NNS :_: interference_NN with_IN protein_NN kinase_NN C_NNP -LRB-_-LRB- PKC_NNP -RRB-_-RRB- 
Since_IN non-dioxin-like_JJ PCBs_NNS have_VBP shown_VBN low_JJ affinity_NN for_IN the_DT Ah_UH receptor_NN 
g._NNP Categorization_NNP of_IN exposure_NN variables_NNS PCBs_NNS were_VBD categorized_VBN into_IN different_JJ groups_NNS by_IN their_PRP$ chemical_NN structures_NNS -LRB-_-LRB- e._JJ ,_, dioxin-like_JJ mono-ortho_JJ PCBs_NNS or_CC non-dioxin-like_JJ di-ortho_JJ PCBs_NNS -RRB-_-RRB- or_CC their_PRP$ estrogenic_JJ or_CC anti-estrogenic_JJ properties_NNS based_VBN on_IN the_DT published_JJ literature_NN ._. 
In_IN our_PRP$ analyses_NNS ,_, we_PRP included_VBD six_CD of_IN the_DT most_RBS abundant_JJ PCB_NNP congeners_NNS -LRB-_-LRB- PCB_NNP IUPAC_NNP #_# 118_CD ,_, #_# 138_CD ,_, #_# 153_CD ,_, #_# 156_CD ,_, #_# 170_CD ,_, and_CC #_# 180_CD -RRB-_-RRB- ._. 
Moreover_RB ,_, another_DT investigation_NN failed_VBD to_TO find_VB estrogenic_JJ activity_NN of_IN these_DT congeners_NNS 
Since_IN non-dioxin-like_JJ PCBs_NNS have_VBP shown_VBN low_JJ affinity_NN for_IN the_DT Ah_UH receptor_NN 
0%_CD ,_, respectively_RB ,_, below_IN the_DT LOD_NNP -RRB-_-RRB- The_DT two_CD mono-ortho_JJ dioxin-like_JJ PCBs_NNS we_PRP measured_VBD were_VBD #_# 118_CD and_CC #_# 156_CD 
Since_IN non-dioxin-like_JJ PCBs_NNS have_VBP shown_VBN low_JJ affinity_NN for_IN the_DT Ah_UH receptor_NN 
Thyroid_JJ hormones_NNS are_VBP critical_JJ to_TO neuronal_JJ proliferation_NN ,_, migration_NN ,_, synaptogenesis_NN ,_, and_CC brain_NN myelination_NN 
The_DT lack_NN of_IN a_DT similar_JJ effect_NN on_IN thyroid_JJ receptors_NNS from_IN PCB_NNP #_# 138_CD and_CC #_# 153_CD conforms_VBZ with_IN our_PRP$ results_NNS ,_, supporting_VBG plausibility_NN of_IN this_DT mechanism_NN for_IN 4-OH-CB107_NNP ,_, the_DT common_JJ metabolite_NN of_IN two_CD mono-ortho_JJ PCB_NNP #_# 105_CD and_CC #_# 118_CD ,_, in_IN impairment_NN of_IN neurodevelopment_NN ._. 
Disruption_NN of_IN thyroid_JJ hormones_NNS may_MD itself_PRP operate_VB via_IN altered_JJ cell_NN signaling_VBG and\/or_CC neurotransmitters_NNS ._. 
We_PRP did_VBD not_RB find_VB significant_JJ associations_NNS of_IN neurodevelopmental_JJ scores_NNS with_IN anti-estrogenic_JJ PCBs_NNS -LRB-_-LRB- sum_NN of_IN #_# 138_CD ,_, 156_CD ,_, 170_CD and_CC 180_CD -RRB-_-RRB- ,_, but_CC did_VBD not_RB evaluate_VB possible_JJ roles_NNS of_IN PCB_NNP metabolites_NNS with_IN regard_NN to_TO estrogenic_JJ and\/or_CC anti-estrogenic_JJ activities_NNS in_IN this_DT paper_NN ._. 
PCBs_NNS have_VBP been_VBN shown_VBN to_TO have_VB toxic_JJ effects_NNS on_IN various_JJ organs_NNS including_VBG tissues_NNS of_IN the_DT nervous_JJ ,_, reproductive_JJ ,_, and_CC immunologic_JJ systems_NNS 
Their_PRP$ production_NN and_CC use_NN were_VBD banned_VBN in_IN most_JJS industrialized_JJ countries_NNS in_IN the_DT late_JJ 1970s_NNS because_IN of_IN toxic_JJ effects_NNS in_IN wildlife_NN 
Improper_JJ disposal_NN has_VBZ been_VBN a_DT major_JJ source_NN of_IN environmental_JJ contamination_NN ._. 
Background_NN Polychlorinated_VBN biphenyls_NNS -LRB-_-LRB- PCBs_NNS -RRB-_-RRB- are_VBP ubiquitous_JJ environmental_JJ toxins_NNS ._. 
Their_PRP$ production_NN and_CC use_NN were_VBD banned_VBN in_IN most_JJS industrialized_JJ countries_NNS in_IN the_DT late_JJ 1970s_NNS because_IN of_IN toxic_JJ effects_NNS in_IN wildlife_NN 
Improper_JJ disposal_NN has_VBZ been_VBN a_DT major_JJ source_NN of_IN environmental_JJ contamination_NN ._. 
Background_NN Polychlorinated_VBN biphenyls_NNS -LRB-_-LRB- PCBs_NNS -RRB-_-RRB- are_VBP ubiquitous_JJ environmental_JJ toxins_NNS ._. 
Their_PRP$ production_NN and_CC use_NN were_VBD banned_VBN in_IN most_JJS industrialized_JJ countries_NNS in_IN the_DT late_JJ 1970s_NNS because_IN of_IN toxic_JJ effects_NNS in_IN wildlife_NN 
Their_PRP$ production_NN and_CC use_NN were_VBD banned_VBN in_IN most_JJS industrialized_JJ countries_NNS in_IN the_DT late_JJ 1970s_NNS because_IN of_IN toxic_JJ effects_NNS in_IN wildlife_NN 
However_RB ,_, other_JJ studies_NNS in_IN rats_NNS reported_VBD that_IN the_DT coplanar_NN dioxin-like_JJ PCB_NNP #_# 126_CD was_VBD not_RB associated_VBN with_IN deficits_NNS in_IN attention_NN and_CC behavioral_JJ performances_NNS ._. 
Regarding_VBG epidemiological_JJ studies_NNS ,_, although_IN the_DT birth_NN cohort_NN study_NN from_IN the_DT Netherlands_NNP found_VBD an_DT association_NN of_IN coplanar_NN and_CC mono-ortho_JJ dioxin-like_JJ PCBs_NNS -LRB-_-LRB- #_# 77_CD ,_, 126_CD ,_, 169_CD ,_, 105_CD ,_, 118_CD ,_, 156_CD -RRB-_-RRB- in_IN breast-milk_NN collected_VBD two_CD weeks_NNS after_IN delivery_NN with_IN suboptimality_NN at_IN birth_NN ,_, their_PRP$ findings_NNS were_VBD null_JJ at_IN 7_CD ,_, and_CC 18_CD months_NNS for_IN the_DT PDI_NNP and_CC MDI_NNP except_IN they_PRP found_VBD a_DT significant_JJ association_NN with_IN decreased_VBN PDI_NNP at_IN 3_CD months_NNS 
PCBs_NNS have_VBP been_VBN shown_VBN to_TO have_VB toxic_JJ effects_NNS on_IN various_JJ organs_NNS including_VBG tissues_NNS of_IN the_DT nervous_JJ ,_, reproductive_JJ ,_, and_CC immunologic_JJ systems_NNS 
5to_CD 2_CD orders_NNS of_IN magnitude_NN greater_JJR than_IN that_DT observed_VBD for_IN 4-OH-CB-146_CD or_CC 4_CD '_'' -_: OH-CB-172_NN 
In_IN a_DT similar_JJ way_NN ,_, high_JJ pressure_NN injections_NNS of_IN paint_NN 
Oil_NN based_VBN veterinary_JJ vaccines_NNS have_VBP previously_RB been_VBN reported_VBN to_TO cause_VB a_DT prolonged_JJ chronic_JJ granulomatous_JJ reaction_NN with_IN sterile_JJ abscess_NN formation_NN 
The_DT high_JJ pressure_NN injecting_VBG devices_NNS used_VBN in_IN industry_NN 
The_DT high_JJ pressure_NN injecting_VBG devices_NNS used_VBN in_IN industry_NN 
In_IN a_DT closed_JJ compartment_NN such_JJ as_IN the_DT flexor_JJ sheath_NN of_IN a_DT digit_NN injected_VBD oil_NN adjuvant_NN based_VBN vaccine_NN may_MD have_VB disastrous_JJ consequences_NNS ._. 
In_IN a_DT similar_JJ way_NN ,_, high_JJ pressure_NN injections_NNS of_IN paint_NN 
There_EX are_VBP no_DT clear_JJ guidelines_NNS available_JJ to_TO guide_VB practicing_NN clinicians_NNS in_IN deciding_VBG whether_IN to_TO explore_VB and_CC debride_VB such_PDT a_DT wound_NN ._. 
It_PRP has_VBZ been_VBN suggested_VBN that_IN injections_NNS of_IN a_DT small_JJ amount_NN of_IN vaccine_NN can_MD be_VB treated_VBN conservatively_RB ._. 
However_RB ,_, this_DT case_NN illustrates_VBZ the_DT seriousness_NN of_IN such_PDT an_DT injury_NN despite_IN early_JJ surgical_JJ treatment_NN ._. 
In_IN a_DT closed_JJ compartment_NN such_JJ as_IN the_DT flexor_JJ sheath_NN of_IN a_DT digit_NN injected_VBD oil_NN adjuvant_NN based_VBN vaccine_NN may_MD have_VB disastrous_JJ consequences_NNS ._. 
In_IN a_DT similar_JJ way_NN ,_, high_JJ pressure_NN injections_NNS of_IN paint_NN 
In_IN a_DT closed_JJ compartment_NN such_JJ as_IN the_DT flexor_JJ sheath_NN of_IN a_DT digit_NN injected_VBD oil_NN adjuvant_NN based_VBN vaccine_NN may_MD have_VB disastrous_JJ consequences_NNS ._. 
In_IN a_DT similar_JJ way_NN ,_, high_JJ pressure_NN injections_NNS of_IN paint_NN 
In_IN a_DT similar_JJ way_NN ,_, high_JJ pressure_NN injections_NNS of_IN paint_NN 
In_IN a_DT closed_JJ compartment_NN such_JJ as_IN the_DT flexor_JJ sheath_NN of_IN a_DT digit_NN injected_VBD oil_NN adjuvant_NN based_VBN vaccine_NN may_MD have_VB disastrous_JJ consequences_NNS ._. 
In_IN a_DT similar_JJ way_NN ,_, high_JJ pressure_NN injections_NNS of_IN paint_NN 
In_IN a_DT closed_JJ compartment_NN such_JJ as_IN the_DT flexor_JJ sheath_NN of_IN a_DT digit_NN injected_VBD oil_NN adjuvant_NN based_VBN vaccine_NN may_MD have_VB disastrous_JJ consequences_NNS ._. 
In_IN a_DT similar_JJ way_NN ,_, high_JJ pressure_NN injections_NNS of_IN paint_NN 
These_DT injuries_NNS are_VBP often_RB under-estimated_JJ and_CC delayed_JJ diagnosis_NN and_CC debridement_NN may_MD occur_VB ._. 
The_DT outcome_NN appears_VBZ to_TO be_VB related_VBN to_TO the_DT volume_NN injected_VBD ._. 
The_DT use_NN of_IN systemic_JJ steroids_NNS to_TO decrease_VB the_DT swelling_VBG is_VBZ controversial_JJ -LRB-_-LRB- as_IN it_PRP may_MD increase_VB the_DT risk_NN of_IN infection_NN -RRB-_-RRB- but_CC should_MD be_VB considered_VBN if_IN oedema_NN is_VBZ significant_JJ 
Oil_NN based_VBN veterinary_JJ vaccines_NNS have_VBP previously_RB been_VBN reported_VBN to_TO cause_VB a_DT prolonged_JJ chronic_JJ granulomatous_JJ reaction_NN with_IN sterile_JJ abscess_NN formation_NN 
Vaccination_NN is_VBZ carried_VBN out_RP by_IN a_DT 2_CD ml_JJ intramuscular_JJ injection_NN ._. 
It_PRP is_VBZ presented_VBN in_IN an_DT oil_NN based_VBN emulsion_NN adjuvant_NN to_TO boost_VB the_DT efficacy_NN and_CC duration_NN of_IN the_DT vaccine_NN ._. 
Asingle_JJ injection_NN is_VBZ given_VBN to_TO pregnant_JJ cows_NNS and_CC heifers_NNS 3_CD 
The_DT entire_JJ finger_NN -LRB-_-LRB- especially_RB the_DT finger_NN pulp_NN and_CC tendon_NN sheaths_NNS -RRB-_-RRB- is_VBZ at_IN risk_NN ._. 
The_DT oil-based_JJ nature_NN of_IN the_DT vaccine_NN means_VBZ that_IN it_PRP has_VBZ the_DT potential_NN to_TO cause_VB increased_VBN compartmental_JJ pressure_NN 
Injection_NN of_IN this_DT vaccine_NN into_IN a_DT closed_JJ compartment_NN such_JJ as_IN the_DT human_JJ finger_NN can_MD have_VB serious_JJ sequelae_NN ._. 
The_DT oil-based_JJ nature_NN of_IN the_DT vaccine_NN means_VBZ that_IN it_PRP has_VBZ the_DT potential_NN to_TO cause_VB increased_VBN compartmental_JJ pressure_NN ._. 
The_DT entire_JJ finger_NN -LRB-_-LRB- especially_RB the_DT finger_NN pulp_NN and_CC tendon_NN sheaths_NNS -RRB-_-RRB- is_VBZ at_IN risk_NN ._. 
The_DT information_NN leaflet_NN supplied_VBN with_IN the_DT vaccine_NN 
The_DT entire_JJ finger_NN -LRB-_-LRB- especially_RB the_DT finger_NN pulp_NN and_CC tendon_NN sheaths_NNS -RRB-_-RRB- is_VBZ at_IN risk_NN ._. 
The_DT oil-based_JJ nature_NN of_IN the_DT vaccine_NN means_VBZ that_IN it_PRP has_VBZ the_DT potential_NN to_TO cause_VB increased_VBN compartmental_JJ pressure_NN 
Asurvey_NNP of_IN veterinary_JJ surgeons_NNS reported_VBD the_DT rate_NN of_IN needlestick_NN injuries_NNS at_IN 5_CD ._. 
Discussion_NN Self_NN injection_NN with_IN veterinary_JJ vaccines_NNS is_VBZ an_DT occupational_JJ hazard_NN for_IN farmers_NNS and_CC veterinary_JJ surgeons_NNS ._. 
5\/100_CD vets_NNS per_IN year_NN or_CC 1_CD in_IN 1000_CD cases_NNS of_IN vaccine_NN given_VBN ._. 
The_DT hand_NN was_VBD the_DT site_NN of_IN injury_NN in_IN 17_CD %_NN of_IN cases_NNS ._. 
In_IN a_DT closed_JJ compartment_NN such_JJ as_IN the_DT flexor_JJ sheath_NN of_IN a_DT digit_NN injected_VBD oil_NN adjuvant_NN based_VBN vaccine_NN may_MD have_VB disastrous_JJ consequences_NNS ._. 
In_IN a_DT closed_JJ compartment_NN such_JJ as_IN the_DT flexor_JJ sheath_NN of_IN a_DT digit_NN injected_VBD oil_NN adjuvant_NN based_VBN vaccine_NN may_MD have_VB disastrous_JJ consequences_NNS ._. 
In_IN a_DT similar_JJ way_NN ,_, high_JJ pressure_NN injections_NNS of_IN paint_NN 
In_IN a_DT closed_JJ compartment_NN such_JJ as_IN the_DT flexor_JJ sheath_NN of_IN a_DT digit_NN injected_VBD oil_NN adjuvant_NN based_VBN vaccine_NN may_MD have_VB disastrous_JJ consequences_NNS ._. 
In_IN a_DT similar_JJ way_NN ,_, high_JJ pressure_NN injections_NNS of_IN paint_NN 
In_IN a_DT closed_JJ compartment_NN such_JJ as_IN the_DT flexor_JJ sheath_NN of_IN a_DT digit_NN injected_VBD oil_NN adjuvant_NN based_VBN vaccine_NN may_MD have_VB disastrous_JJ consequences_NNS ._. 
In_IN a_DT similar_JJ way_NN ,_, high_JJ pressure_NN injections_NNS of_IN paint_NN 
The_DT outcome_NN appears_VBZ to_TO be_VB related_VBN to_TO the_DT volume_NN injected_VBD ._. 
These_DT vaccinations_NNS are_VBP also_RB delivered_VBN at_IN hand_NN pressure_NN and_CC the_DT lack_NN of_IN a_DT high_JJ pressure_NN injecting_VBG system_NN does_VBZ not_RB negate_VB serious_JJ sequelae_NN of_IN these_DT injections_NNS ._. 
These_DT injuries_NNS are_VBP often_RB under-estimated_JJ and_CC delayed_JJ diagnosis_NN and_CC debridement_NN may_MD occur_VB ._. 
The_DT use_NN of_IN systemic_JJ steroids_NNS to_TO decrease_VB the_DT swelling_VBG is_VBZ con_NN 
These_DT injuries_NNS are_VBP not_RB to_TO be_VB underestimated_VBN ._. 
However_RB ,_, this_DT case_NN illustrates_VBZ the_DT seriousness_NN of_IN such_PDT an_DT injury_NN despite_IN early_JJ surgical_JJ treatment_NN ._. 
Early_JJ debridement_NN and_CC irrigation_NN of_IN the_DT injected_VBN area_NN with_IN decompression_NN is_VBZ likely_JJ to_TO give_VB the_DT best_JJS outcome_NN ._. 
Frequent_JJ review_NN is_VBZ necessary_JJ after_IN the_DT first_JJ procedure_NN because_IN repeat_NN operations_NNS may_MD be_VB required_VBN ._. 
Competing_VBG interests_NNS The_DT author_NN -LRB-_-LRB- s_PRP -RRB-_-RRB- declare_VBP that_IN they_PRP have_VBP no_DT competing_VBG interests_NNS ._. 
Griffin_NNP et_NNP al_NNP ,_, 1999_CD 
But_CC ,_, given_VBN the_DT fact_NN that_IN we_PRP may_MD not_RB have_VB all_DT information_NN on_IN all_DT possible_JJ risks_NNS ,_, some_DT chronic_JJ outcomes_NNS may_MD occur_VB at_IN concentrations_NNS lower_JJR than_IN those_DT at_IN which_WDT other_JJ recognized_VBN effects_NNS occur_VBP ._. 
For_IN example_NN ,_, by_IN analogy_NN ,_, there_EX is_VBZ experimental_JJ evidence_NN that_IN Chlorpyrifos_NNP exerts_VBZ neurodevelopmental_JJ impacts_NNS at_IN lower_JJR concentrations_NNS than_IN would_MD be_VB needed_VBN to_TO impact_VB on_IN cholinesterase_NN function_NN 
Edson_NNP et_NNP al_NNP ,_, 1967_CD 
Studies_NNS to_TO assess_VB dose-response_JJ relationships_NNS for_IN early_JJ markers_NNS of_IN toxicity_NN with_IN examples_NNS The_DT opposing_JJ viewpoints_NNS with_IN regard_NN to_TO studies_NNS undertaken_VBN for_IN the_DT purpose_NN of_IN determining_VBG a_DT NOAEL_NNP are_VBP highlighted_VBN in_IN an_DT exchange_NN of_IN correspondence_NN triggered_VBN by_IN Sass_NNP and_CC Needleman_NNP 
With_IN regard_NN to_TO the_DT power_NN issue_NN ,_, Chart_NNP et_NNP al_RB acknowledged_VBD the_DT relatively_RB small_JJ study_NN size_NN ,_, but_CC pointed_VBD to_TO an_DT overall_JJ database_NN of_IN hundreds_NNS of_IN animal_NN and_CC human_JJ studies_NNS with_IN dichlorvos_NNS ,_, arguing_VBG that_IN the_DT available_JJ health_NN data_NNS on_IN any_DT given_VBN substance_NN should_MD be_VB evaluated_VBN as_IN a_DT whole_NN in_IN risk_NN assessments_NNS ._. 
The_DT second_JJ study_NN criticised_VBN by_IN Sass_NNP and_CC Needleman_NNP 
Roy_NNP et_NNP al_NNP ,_, 2006_CD 
DuBois_NNP and_CC Mangun_NNP ,_, 1947_CD 
Although_IN such_JJ studies_NNS have_VBP been_VBN conducted_VBN for_IN many_JJ decades_NNS ,_, albeit_IN on_IN a_DT limited_VBN scale_NN ,_, the_DT controversy_NN around_IN their_PRP$ use_NN has_VBZ been_VBN prompted_VBN particularly_RB by_IN more_JJR recent_JJ debates_NNS on_IN the_DT use_NN of_IN data_NNS from_IN human_JJ volunteer_NN studies_NNS to_TO inform_VB regulatory_JJ risk_NN assessment_NN 
Introduction_NN In_IN recent_JJ years_NNS ,_, there_EX has_VBZ been_VBN considerable_JJ controversy_NN about_IN the_DT scientific_JJ value_NN and_CC ethical_JJ acceptability_NN of_IN studies_NNS involving_VBG experimental_JJ exposure_NN of_IN human_JJ volunteers_NNS to_TO low_JJ doses_NNS of_IN pesticides_NNS 
Although_IN such_JJ studies_NNS have_VBP been_VBN conducted_VBN for_IN many_JJ decades_NNS ,_, albeit_IN on_IN a_DT limited_VBN scale_NN ,_, the_DT controversy_NN around_IN their_PRP$ use_NN has_VBZ been_VBN prompted_VBN particularly_RB by_IN more_JJR recent_JJ debates_NNS on_IN the_DT use_NN of_IN data_NNS from_IN human_JJ volunteer_NN studies_NNS to_TO inform_VB regulatory_JJ risk_NN assessment_NN 
However_RB ,_, the_DT paper_NN also_RB highlights_VBZ ongoing_JJ unresolved_JJ differences_NNS of_IN opinion_NN inherent_JJ in_IN ethical_JJ analysis_NN of_IN contentious_JJ issues_NNS ,_, which_WDT we_PRP propose_VBP should_MD form_VB a_DT starting_JJ point_NN for_IN further_JJ debate_NN and_CC the_DT development_NN of_IN guidelines_NNS to_TO achieve_VB better_JJR resolution_NN of_IN this_DT matter_NN ._. 
IntroductionIn_JJ recent_JJ years_NNS ,_, there_EX has_VBZ been_VBN considerable_JJ controversy_NN about_IN the_DT scientific_JJ value_NN and_CC ethical_JJ acceptability_NN of_IN studies_NNS involving_VBG experimental_JJ exposure_NN of_IN human_JJ volunteers_NNS to_TO low_JJ doses_NNS of_IN pesticides_NNS 
Using_VBG experimental_JJ human_JJ data_NNS has_VBZ been_VBN argued_VBN to_TO reduce_VB uncertainty_NN in_IN the_DT risk_NN assessment_NN and_CC to_TO obviate_VB partially_RB the_DT requirement_NN to_TO use_VB uncertainty_NN factors_NNS ._. 
However_RB ,_, this_DT has_VBZ raised_VBN many_JJ ethical_JJ questions_NNS ,_, principally_RB because_IN of_IN possible_JJ risks_NNS to_TO the_DT participants_NNS from_IN the_DT experimental_JJ exposure_NN ,_, and_CC whether_IN the_DT reduced_VBN uncertainty_NN justifies_VBZ the_DT deliberate_JJ exposure_NN of_IN humans_NNS to_TO non-therapeutic_JJ agents_NNS 
This_DT resulted_VBD in_IN a_DT protracted_JJ and_CC intensely_RB polarized_VBN debate_NN ._. 
Anumber_NNP of_IN dosing_VBG studies_NNS with_IN volunteers_NNS were_VBD subsequently_RB submitted_VBN to_TO the_DT agency_NN with_IN the_DT intent_NN of_IN providing_VBG human_JJ data_NNS which_WDT would_MD not_RB require_VB application_NN of_IN the_DT normal_JJ inter-species_JJ uncertainty_NN factor_NN ._. 
Some_DT scientists_NNS and_CC activist_NN groups_NNS challenged_VBD the_DT ethical_JJ and_CC scientific_JJ validity_NN of_IN the_DT studies_NNS ,_, contending_VBG among_IN other_JJ things_NNS that_IN people_NNS should_MD not_RB be_VB put_VBN at_IN risk_NN for_IN the_DT purpose_NN of_IN reducing_VBG the_DT stringency_NN of_IN regulatory_JJ standards_NNS 
The_DT risk_NN of_IN toxicity_NN will_MD depend_VB upon_IN :_: a_DT -RRB-_-RRB- the_DT margin_NN between_IN the_DT experimental_JJ dose_NN of_IN the_DT pesticide_NN and_CC the_DT lowest_JJS dose_NN at_IN which_WDT adverse_JJ effects_NNS might_MD be_VB expected_VBN from_IN prior_JJ knowledge_NN ;_: and_CC b_NN -RRB-_-RRB- the_DT confidence_NN that_WDT can_MD be_VB placed_VBN in_IN this_DT prior_JJ knowledge_NN ._. 
Whilst_JJ study_NN design_NN aims_VBZ to_TO minimize_VB the_DT risk_NN of_IN toxicity_NN ,_, there_EX are_VBP concerns_NNS that_IN unexpected_JJ effects_NNS may_MD be_VB impossible_JJ to_TO predict_VB 
4-RRB-_CD The_DT group_NN also_RB differed_VBD with_IN regard_NN to_TO the_DT nature_NN of_IN benefits_NNS related_VBN to_TO data_NNS to_TO inform_VB more_RBR cost-effective_JJ regulation_NN ,_, or_CC reducing_VBG the_DT costs_NNS of_IN regulation_NN ._. 
One_CD view_NN held_VBD that_IN ,_, unless_IN they_PRP demonstrated_VBD a_DT need_NN for_IN protective_JJ measures_NNS which_WDT had_VBD earlier_RBR not_RB been_VBN known_VBN ,_, studies_NNS aimed_VBN at_IN providing_VBG more_RBR cost-effective_JJ regulation_NN ,_, or_CC simply_RB reducing_VBG the_DT cost_NN of_IN regulation_NN ,_, would_MD not_RB meet_VB the_DT criterion_NN for_IN benefit_NN and_CC therefore_RB could_MD not_RB be_VB justified_VBN in_IN relation_NN to_TO the_DT risks_NNS of_IN harm_NN from_IN which_WDT ethical_JJ codes_NNS seek_VBP to_TO protect_VB participants_NNS ,_, as_IN has_VBZ been_VBN argued_VBN elsewhere_RB ._. 
An_DT alternative_JJ view_NN in_IN the_DT workgroup_NN was_VBD that_IN such_JJ studies_NNS should_MD be_VB examined_VBN and_CC reviewed_VBN following_VBG the_DT principles_NNS of_IN balancing_VBG benefits_NNS and_CC risks_NNS ,_, the_DT ascertainment_NN of_IN an_DT informed_JJ consent_NN procedure_NN and_CC an_DT independent_JJ assessment_NN by_IN an_DT independent_JJ ethical_JJ review_NN board_NN or_CC its_PRP$ equivalent_NN ._. 
Introduction_NN In_IN recent_JJ years_NNS ,_, there_EX has_VBZ been_VBN considerable_JJ controversy_NN about_IN the_DT scientific_JJ value_NN and_CC ethical_JJ acceptability_NN of_IN studies_NNS involving_VBG experimental_JJ exposure_NN of_IN human_JJ volunteers_NNS to_TO low_JJ doses_NNS of_IN pesticides_NNS 
Some_DT scientists_NNS and_CC activist_NN groups_NNS challenged_VBD the_DT ethical_JJ and_CC scientific_JJ validity_NN of_IN the_DT studies_NNS ,_, contending_VBG among_IN other_JJ things_NNS that_IN people_NNS should_MD not_RB be_VB put_VBN at_IN risk_NN for_IN the_DT purpose_NN of_IN reducing_VBG the_DT stringency_NN of_IN regulatory_JJ standards_NNS 
While_IN it_PRP is_VBZ possible_JJ that_IN such_JJ effects_NNS may_MD be_VB judged_VBN irrelevant_JJ for_IN single_JJ dose_NN studies_NNS in_IN adults_NNS ,_, it_PRP is_VBZ nevertheless_RB important_JJ that_IN the_DT whole_JJ existing_VBG database_NN is_VBZ taken_VBN into_IN account_NN when_WRB making_VBG judgments_NNS on_IN the_DT risk_NN to_TO volunteers_NNS ,_, as_IN elaborated_VBD further_RBR below_IN ._. 
Resnik_NNP and_CC Porter_NNP -LRB-_-LRB- 2005_CD -RRB-_-RRB- deal_NN with_IN this_DT in_IN relation_NN to_TO carcinogens_NNS by_IN proposing_VBG that_IN pesticides_NNS that_WDT are_VBP possible_JJ carcinogens_NNS should_MD be_VB excluded_VBN from_IN any_DT experimental_JJ human_JJ volunteer_NN studies_NNS -LRB-_-LRB- although_IN this_DT begs_VBZ the_DT question_NN of_IN how_WRB a_DT ``_`` possible_JJ carcinogen_NN ''_'' should_MD be_VB defined_VBN -RRB-_-RRB- ._. 
They_PRP also_RB propose_VBP that_IN the_DT burden_NN of_IN proof_NN of_IN minimal_JJ risk_NN be_VB shifted_VBN onto_IN the_DT researcher_NN to_TO demonstrate_VB that_IN the_DT effects_NNS sought_VBN are_VBP not_RB serious_JJ and_CC are_VBP reversible_JJ and_CC suggest_VBP there_EX should_MD be_VB long-term_JJ follow_VB up_RP of_IN study_NN participants_NNS to_TO monitor_VB for_IN adverse_JJ outcomes_NNS ._. 
This_DT resulted_VBD in_IN a_DT protracted_JJ and_CC intensely_RB polarized_VBN debate_NN ._. 
Anumber_NNP of_IN dosing_VBG studies_NNS with_IN volunteers_NNS were_VBD subsequently_RB submitted_VBN to_TO the_DT agency_NN with_IN the_DT intent_NN of_IN providing_VBG human_JJ data_NNS which_WDT would_MD not_RB require_VB application_NN of_IN the_DT normal_JJ inter-species_JJ uncertainty_NN factor_NN ._. 
Some_DT scientists_NNS and_CC activist_NN groups_NNS challenged_VBD the_DT ethical_JJ and_CC scientific_JJ validity_NN of_IN the_DT studies_NNS ,_, contending_VBG among_IN other_JJ things_NNS that_IN people_NNS should_MD not_RB be_VB put_VBN at_IN risk_NN for_IN the_DT purpose_NN of_IN reducing_VBG the_DT stringency_NN of_IN regulatory_JJ standards_NNS 
The_DT risk_NN of_IN toxicity_NN will_MD depend_VB upon_IN :_: a_DT -RRB-_-RRB- the_DT margin_NN between_IN the_DT experimental_JJ dose_NN of_IN the_DT pesticide_NN and_CC the_DT lowest_JJS dose_NN at_IN which_WDT adverse_JJ effects_NNS might_MD be_VB expected_VBN from_IN prior_JJ knowledge_NN ;_: and_CC b_NN -RRB-_-RRB- the_DT confidence_NN that_WDT can_MD be_VB placed_VBN in_IN this_DT prior_JJ knowledge_NN ._. 
Whilst_JJ study_NN design_NN aims_VBZ to_TO minimize_VB the_DT risk_NN of_IN toxicity_NN ,_, there_EX are_VBP concerns_NNS that_IN unexpected_JJ effects_NNS may_MD be_VB impossible_JJ to_TO predict_VB ._. 
Informed_JJ consent_NN is_VBZ therefore_RB essential_JJ to_TO protect_VB the_DT autonomy_NN of_IN participants_NNS ,_, particularly_RB where_WRB overt_JJ or_CC covert_JJ pressures_NNS exist_VBP ,_, or_CC where_WRB scientific_JJ uncertainty_NN about_IN risk_NN requires_VBZ interpretation_NN for_IN a_DT prospective_JJ participant_NN whose_WP$ health_NN literacy_NN and_CC familiarity_NN with_IN scientific_JJ concepts_NNS is_VBZ low_JJ ._. 
Krieger_NNP et_NNP al_NNP ,_, 1993_CD 
Meaklim_NNP et_NNP al_NNP ,_, 2003_CD 
Verberk_NNP et_NNP al_NNP ,_, 1977_CD 
Verberk_NNP ,_, 1977_CD 
Moeller_NNP et_NNP al_NNP ,_, 1962_CD 
Moody_NNP et_NNP al_IN 1992_CD 
Yes_NNP No_NNP 2_CD ._. 
a._FW Bartels_FW et_FW al_FW ,_, 1998_CD 
Buchholz_NNP et_NNP al_NNP ,_, 1999_CD 
They_PRP argued_VBD that_IN the_DT conclusion_NN of_IN the_DT study_NN that_IN no_DT ``_`` treatment-related_JJ clinical_JJ symptoms_NNS ''_'' were_VBD present_JJ at_IN doses_NNS of_IN 0_CD ._. 
05_CD mg\/kg_NN or_CC less_RBR conflicted_JJ with_IN a_DT previously_RB reported_VBN Californian_NN food_NN poisoning_NN incident_NN 
They_PRP also_RB disputed_VBD the_DT NOEL_NNP of_IN 0_CD ._. 
In_IN response_NN ,_, Tobia_NNP et_FW al_FW -LRB-_-LRB- 2004_CD -RRB-_-RRB- argued_VBD that_IN almost_RB half_NN of_IN the_DT symptoms_NNS were_VBD in_IN the_DT placebo_NN group_NN ,_, others_NNS were_VBD temporally_RB unrelated_JJ ,_, or_CC were_VBD symptoms_NNS inconsistent_JJ with_IN cholinesterase_NN depression_NN ._. 
05_CD mg\/kg_NN ,_, arguing_VBG that_IN the_DT case_NN reports_NNS cited_VBN by_IN Goldman_NNP et_FW al_FW -LRB-_-LRB- 1990_CD -RRB-_-RRB- 
Guthrie_NNP et_NNP al_NNP ,_, 1976_CD 
Nineteen_CD of_IN the_DT evaluated_VBN studies_NNS collected_VBD information_NN that_WDT was_VBD not_RB obtainable_JJ in_IN other_JJ ways_NNS ,_, while_IN in_IN 7_CD cases_NNS the_DT need_NN for_IN the_DT study_NN was_VBD uncertain_JJ ._. 
It_PRP should_MD be_VB noted_VBN that_IN in_IN one_CD of_IN the_DT oldest_JJS studies_NNS evaluated_VBN ,_, the_DT experimental_JJ design_NN was_VBD such_JJ that_IN ``_`` severe_JJ poisonings_NNS ''_'' occurred_VBD in_IN two_CD of_IN the_DT studied_VBN subjects_NNS ,_, in_IN one_CD subject_NN on_IN two_CD occasions_NNS and_CC in_IN the_DT second_JJ subject_NN on_IN three_CD 
4,_CD point_NN 6_CD -RRB-_-RRB- ._. 
The_DT Regulation_NN firmly_RB states_VBZ that_IN ``_`` In_IN relation_NN to_TO human_JJ health_NN ,_, no_DT data_NNS collected_VBN on_IN humans_NNS shall_MD be_VB used_VBN to_TO lower_VB the_DT safety_NN margins_NNS resulting_VBG from_IN tests_NNS or_CC studies_NNS on_IN animals_NNS ''_'' -LRB-_-LRB- art_NN ._. 
Therefore_RB ,_, it_PRP appears_VBZ that_IN ,_, while_IN recognizing_VBG that_IN data_NNS on_IN the_DT effects_NNS of_IN human_JJ exposure_NN are_VBP valuable_JJ ,_, EU_JJ policy_NN has_VBZ taken_VBN the_DT view_NN that_IN their_PRP$ usefulness_NN is_VBZ to_TO confirm_VB the_DT validity_NN of_IN estimations_NNS made_VBD based_VBN on_IN extrapolation_NN from_IN the_DT full_JJ toxicological_JJ database_NN regarding_VBG target_NN organs_NNS ,_, dose-response_JJ relationships_NNS ,_, and_CC the_DT reversibility_NN of_IN toxic_JJ effects_NNS 
Therefore_RB ,_, it_PRP appears_VBZ that_IN ,_, while_IN recognizing_VBG that_IN data_NNS on_IN the_DT effects_NNS of_IN human_JJ exposure_NN are_VBP valuable_JJ ,_, EU_JJ policy_NN has_VBZ taken_VBN the_DT view_NN that_IN their_PRP$ usefulness_NN is_VBZ to_TO confirm_VB the_DT validity_NN of_IN estimations_NNS made_VBD based_VBN on_IN extrapolation_NN from_IN the_DT full_JJ toxicological_JJ database_NN regarding_VBG target_NN organs_NNS ,_, dose-response_JJ relationships_NNS ,_, and_CC the_DT reversibility_NN of_IN toxic_JJ effects_NNS 
e._VB No_DT such_JJ provision_NN has_VBZ been_VBN made_VBN for_IN the_DT reverse_JJ case_NN -LRB-_-LRB- i._NN Only_RB if_IN human_JJ study_NN data_NNS suggest_VBP that_IN humans_NNS are_VBP more_RBR sensitive_JJ -LRB-_-LRB- which_WDT would_MD imply_VB a_DT need_NN to_TO set_VB a_DT lower_JJR AOEL_NNP value_NN -RRB-_-RRB- would_MD these_DT data_NNS take_VBP precedence_NN over_IN animal_NN data_NNS ._. 
human_JJ data_NNS showing_VBG decreased_VBN sensitivity_NN ,_, allowing_VBG a_DT higher_JJR AOEL_NNP value_NN -RRB-_-RRB- ,_, a_DT position_NN criticized_VBN by_IN the_DT European_NNP Food_NNP Safety_NNP Authority_NNP 's_POS Panel_NNP on_IN Plant_NNP Protection_NNP products_NNS and_CC their_PRP$ Residues_NNS -LRB-_-LRB- PPR_NNP -RRB-_-RRB- ,_, who_WP have_VBP argued_VBN that_IN data_NNS from_IN human_JJ volunteer_NN studies_NNS should_MD be_VB used_VBN to_TO derive_VB reference_NN values_NNS ,_, if_IN the_DT studies_NNS were_VBD ethically_RB and_CC scientifically_RB valid_JJ ._. 
In_IN reaching_VBG this_DT view_NN ,_, the_DT PPR_NNP Panel_NNP noted_VBD limitations_NNS of_IN studies_NNS conducted_VBN in_IN humans_NNS including_VBG small_JJ sample_NN sizes_NNS ,_, lack_NN of_IN sex-specific_JJ data_NNS and_CC the_DT possibility_NN of_IN studying_VBG only_RB selected_VBN end-points_NNS ._. 
The_DT PPR_NNP Panel_NNP stressed_VBD that_IN human_JJ data_NNS should_MD be_VB used_VBN in_IN the_DT context_NN of_IN the_DT entire_JJ toxicological_JJ profile_NN of_IN the_DT PPP_NNP under_IN consideration_NN ._. 
`Review_NNP of_IN experimental_JJ studies_NNS involving_VBG human_JJ exposure_NN to_TO pesticidesStudies_NNS published_VBN in_IN peer-reviewed_JJ journalsThirty-seven_JJ -LRB-_-LRB- 37_CD -RRB-_-RRB- papers_NNS ,_, published_VBN in_IN peer_VB reviewed_VBN journals_NNS in_IN the_DT period_NN 1947_CD -_: 2006_CD that_WDT met_VBD the_DT inclusion_NN criteria_NNS ,_, were_VBD evaluated_VBN -LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- ._. 
The_DT compounds_NNS or_CC chemical_NN groups_NNS addressed_VBN were_VBD :_: organophosphate_JJ compounds_NNS -LRB-_-LRB- 18_CD papers_NNS -RRB-_-RRB- ,_, phenoxy_JJ herbicides_NNS -LRB-_-LRB- 4_CD papers_NNS -RRB-_-RRB- ,_, phenol_NN derivative_NN fungicides_NNS -LRB-_-LRB- 3_CD papers_NNS -RRB-_-RRB- ,_, pyrethrins_NNS or_CC pyrethroids_NNS and_CC piperonyl_NN butoxide_NN -LRB-_-LRB- 4_CD papers_NNS -RRB-_-RRB- ,_, atrazine_NN ,_, captan_NN ,_, diethylphenylacetamide_NN and_CC analogs_NNS ,_, lindane_NN and_CC warfarin_NN -LRB-_-LRB- one_CD paper_NN each_DT -RRB-_-RRB- ._. 
Table_NNP 1_CD A_DT profile_NN of_IN 37_CD human_JJ volunteer_NN studies_NNS in_IN the_DT peer-reviewed_JJ literature_NN Authors_NNP Study_NNP type_NN \*_NN Compound\/Chemical_NNP Group_NNP Route_NNP Statistical_NNP Power_NNP Details_NNP on_IN Ethics_NNP Committee_NNP Approval_NNP Higher_JJR Reference_NNP 1_CD ._. 
Bartels_NNP et_NNP al_NNP ,_, 1998_CD 
It_PRP has_VBZ always_RB been_VBN recognized_VBN that_IN ``_`` human_JJ data_NNS from_IN accidental_JJ or_CC deliberate_JJ poisonings_NNS ,_, biomarker_NN monitoring_NN studies_NNS ,_, epidemiology_NN studies_NNS ,_, volunteer_NN studies_NNS ,_, and_CC clinical_JJ trials_NNS on_IN the_DT same_JJ or_CC structurally_RB similar_JJ compounds_NNS can_MD provide_VB useful_JJ data_NNS to_TO help_VB establish_VB ''_'' reference_NN doses_NNS 
''_'' The_DT EPA_NNP position_NN is_VBZ therefore_RB not_RB to_TO exclude_VB human_JJ studies_NNS from_IN consideration_NN in_IN the_DT regulatory_JJ risk_NN assessment_NN process_NN ,_, but_CC to_TO set_VB conditions_NNS under_IN which_WDT such_JJ studies_NNS might_MD be_VB considered_VBN ._. 
The_DT Joint_NNP FAO\/WHO_NNP Meeting_VBG on_IN Pesticide_NNP Residues_NNP -LRB-_-LRB- JMPR_NNP -RRB-_-RRB- The_DT Joint_NNP FAO\/WHO_NNP Meeting_VBG on_IN Pesticide_NNP Residues_NNP -LRB-_-LRB- JMPR_NNP -RRB-_-RRB- has_VBZ several_JJ times_NNS addressed_VBD the_DT issue_NN of_IN studies_NNS in_IN human_JJ volunteers_NNS 
The_DT Joint_NNP FAO\/WHO_NNP Meeting_VBG on_IN Pesticide_NNP Residues_NNP -LRB-_-LRB- JMPR_NNP -RRB-_-RRB- The_DT Joint_NNP FAO\/WHO_NNP Meeting_VBG on_IN Pesticide_NNP Residues_NNP -LRB-_-LRB- JMPR_NNP -RRB-_-RRB- has_VBZ several_JJ times_NNS addressed_VBD the_DT issue_NN of_IN studies_NNS in_IN human_JJ volunteers_NNS 
In_IN addition_NN ,_, human_JJ data_NNS on_IN a_DT pesticide_NN ``_`` should_MD always_RB be_VB evaluated_VBN even_RB when_WRB they_PRP are_VBP not_RB used_VBN to_TO derive_VB ''_'' a_DT reference_NN value_NN 
During_IN its_PRP$ meetings_NNS the_DT JMPR_NNP pointed_VBD out_RP the_DT need_NN to_TO consider_VB both_DT ethical_JJ -LRB-_-LRB- particularly_RB the_DT relevant_JJ components_NNS of_IN the_DT Helsinki_NNP Declaration_NNP -RRB-_-RRB- and_CC scientific_JJ issues_NNS ,_, particularly_RB involving_VBG the_DT quality_NN and_CC integrity_NN of_IN the_DT data_NNS and_CC the_DT adequacy_NN of_IN the_DT documentation_NN of_IN methods_NNS -LRB-_-LRB- including_VBG statistics_NNS and_CC control_NN values_NNS -RRB-_-RRB- 
Only_RB after_IN the_DT relevant_JJ toxicological_JJ effects_NNS -LRB-_-LRB- end-points_NNS -RRB-_-RRB- have_VBP been_VBN identified_VBN ,_, could_MD a_DT study_NN in_IN human_JJ volunteers_NNS be_VB considered_VBN for_IN its_PRP$ scientific_JJ relevance_NN as_IN a_DT component_NN of_IN its_PRP$ ethical_JJ appropriateness_NN ._. 
The_DT scientific_JJ criteria_NNS included_VBD ,_, besides_IN those_DT generally_RB applicable_JJ to_TO studies_NNS in_IN animals_NNS :_: a_DT -RRB-_-RRB- group_NN size_NN in_IN relation_NN to_TO factors_NNS such_JJ as_IN inter-individual_JJ variation_NN in_IN response_NN and_CC the_DT level_NN of_IN change_NN considered_VBN not_RB to_TO be_VB adverse_JJ ,_, b_NN -RRB-_-RRB- reference_NN to_TO the_DT IPCS_NNP Guidance_NNP for_IN the_DT use_NN of_IN chemical-specific_JJ adjustment_NN factors_NNS of_IN a_DT minimum_JJ group_NN size_NN of_IN 56_CD or_CC smaller_JJR if_IN e._FW g._FW combining_VBG results_NNS from_IN two_CD or_CC more_JJR dose_NN levels_NNS or_CC applying_VBG an_DT increased_VBN uncertainty_NN factor_NN ;_: c_LS -RRB-_-RRB- the_DT fact_NN that_IN the_DT critical_JJ end-points_NNS identified_VBN in_IN animal_NN studies_NNS can_MD be_VB investigated_VBN appropriately_RB in_IN human_JJ studies_NNS ,_, d_LS -RRB-_-RRB- the_DT relevance_NN of_IN sex_NN differences_NNS in_IN toxicity_NN ._. 
4,_CD point_NN 6_CD -RRB-_-RRB- ._. 
The_DT Regulation_NN firmly_RB states_VBZ that_IN ``_`` In_IN relation_NN to_TO human_JJ health_NN ,_, no_DT data_NNS collected_VBN on_IN humans_NNS shall_MD be_VB used_VBN to_TO lower_VB the_DT safety_NN margins_NNS resulting_VBG from_IN tests_NNS or_CC studies_NNS on_IN animals_NNS ''_'' -LRB-_-LRB- art_NN ._. 
Therefore_RB ,_, it_PRP appears_VBZ that_IN ,_, while_IN recognizing_VBG that_IN data_NNS on_IN the_DT effects_NNS of_IN human_JJ exposure_NN are_VBP valuable_JJ ,_, EU_JJ policy_NN has_VBZ taken_VBN the_DT view_NN that_IN their_PRP$ usefulness_NN is_VBZ to_TO confirm_VB the_DT validity_NN of_IN estimations_NNS made_VBD based_VBN on_IN extrapolation_NN from_IN the_DT full_JJ toxicological_JJ database_NN regarding_VBG target_NN organs_NNS ,_, dose-response_JJ relationships_NNS ,_, and_CC the_DT reversibility_NN of_IN toxic_JJ effects_NNS 
The_DT two_CD studies_NNS contributing_VBG directly_RB to_TO setting_VBG reference_NN values_NNS included_VBD a_DT study_NN published_VBN in_IN 1977_CD involving_VBG 5_CD participants_NNS exposed_VBN to_TO 2_CD ._. 
4D_CD 
Sanderson_NNP and_CC Edson_NNP ,_, 1964_CD 
Ahuman_JJ volunteer_NN study_NN to_TO measure_VB excretion_NN of_IN the_DT acid_JJ metabolite_NN of_IN FB_NNP confirmed_VBD that_IN between_IN 80_CD %_NN and_CC 93_CD %_NN of_IN the_DT dose_NN was_VBD excreted_VBN in_IN urine_NN as_IN fluazifop_JJ acid_NN over_IN a_DT period_NN of_IN 6_CD days_NNS in_IN a_DT one-compartment_JJ model_NN 
Meuling_NNP et_NNP al_IN 2005_CD 
Nolan_NNP et_NNP al_NNP ,_, 1984a_CD 
The_DT two_CD studies_NNS contributing_VBG directly_RB to_TO setting_VBG reference_NN values_NNS included_VBD a_DT study_NN published_VBN in_IN 1977_CD involving_VBG 5_CD participants_NNS exposed_VBN to_TO 2_CD ._. 
4D_CD 
Rao_FW et_FW al_FW ,_, 1979_CD 
The_DT PPR_NNP Panel_NNP stressed_VBD that_IN human_JJ data_NNS should_MD be_VB used_VBN in_IN the_DT context_NN of_IN the_DT entire_JJ toxicological_JJ profile_NN of_IN the_DT PPP_NNP under_IN consideration_NN ._. 
`Review_NNP of_IN experimental_JJ studies_NNS involving_VBG human_JJ exposure_NN to_TO pesticidesStudies_NNS published_VBN in_IN peer-reviewed_JJ journalsThirty-seven_JJ -LRB-_-LRB- 37_CD -RRB-_-RRB- papers_NNS ,_, published_VBN in_IN peer_VB reviewed_VBN journals_NNS in_IN the_DT period_NN 1947_CD -_: 2006_CD that_WDT met_VBD the_DT inclusion_NN criteria_NNS 
Wester_NNP et_NNP al_NNP ,_, 1993_CD 
Not_RB provided_VBN No_NNP 11_CD ._. 
a._NNP Hayes_NNP et_FW al_FW ,_, 1964_CD 
Ramsey_NNP et_NNP al_IN 1992_CD 
Volunteers_NNS who_WP take_VBP part_NN in_IN experimental_JJ studies_NNS of_IN pesticides_NNS may_MD be_VB offered_VBN direct_JJ payment_NN or_CC a_DT benefit_NN in_IN kind_NN for_IN their_PRP$ participation_NN ._. 
Payments_NNS to_TO participants_NNS in_IN excess_NN of_IN their_PRP$ immediate_JJ direct_JJ costs_NNS -LRB-_-LRB- such_JJ as_IN travel_NN or_CC compensation_NN for_IN time_NN off_IN work_NN -RRB-_-RRB- may_MD be_VB viewed_VBN in_IN many_JJ domains_NNS as_IN undue_JJ inducements_NNS to_TO participate_VB ._. 
At_IN the_DT very_RB least_JJS ,_, planned_VBN compensation_NN to_TO research_NN subjects_NNS -LRB-_-LRB- monetary_JJ and_CC otherwise_RB ,_, e._FW g._FW social_JJ benefits_NNS ,_, medical_JJ examinations_NNS -RRB-_-RRB- must_MD be_VB openly_RB reported_VBN in_IN the_DT oversight_NN process_NN required_VBN for_IN ethical_JJ approval_NN ._. 
Further_RB ,_, in_IN none_NN of_IN the_DT studies_NNS reviewed_VBD ,_, in_IN either_CC the_DT peer-reviewed_JJ literature_NN or_CC the_DT JMPR_NNP database_NN ,_, was_VBD it_PRP evident_JJ that_IN the_DT human_JJ data_NNS contributed_VBD to_TO a_DT lower_JJR -LRB-_-LRB- more_RBR stringent_JJ -RRB-_-RRB- reference_NN value_NN than_IN that_DT based_VBN on_IN animal_NN data_NNS ;_: rather_RB ,_, the_DT converse_NN was_VBD true_JJ -_: human_JJ data_NNS ,_, if_IN they_PRP influenced_VBD a_DT reference_NN value_NN at_IN all_DT ,_, led_VBD to_TO a_DT relaxation_NN of_IN the_DT value_NN ._. 
Ethical_JJ AnalysisEthical_JJ analysis_NN requires_VBZ a_DT structured_JJ approach_NN to_TO identifying_VBG all_DT issues_NNS relevant_JJ to_TO judgments_NNS about_IN the_DT research_NN in_IN question_NN ,_, particularly_RB related_VBN to_TO the_DT expected_JJ and_CC unexpected_JJ consequences_NNS and_CC to_TO the_DT relative_JJ balance_NN of_IN burdens_NNS and_CC benefits_NNS from_IN participation_NN in_IN a_DT research_NN study_NN ._. 
Additionally_RB ,_, particular_JJ concerns_NNS regarding_VBG the_DT capability_NN of_IN research_NN participants_NNS ,_, who_WP are_VBP in_IN a_DT dependent_JJ position_NN in_IN relation_NN to_TO the_DT researcher_NN ,_, to_TO make_VB informed_JJ decisions_NNS regarding_VBG their_PRP$ participation_NN ,_, would_MD be_VB another_DT key_JJ issue_NN in_IN this_DT analysis_NN ._. 
7-RRB-_CD The_DT ethics_NNS of_IN using_VBG findings_NNS from_IN past_JJ studies_NNS involving_VBG experimental_JJ human_JJ exposure_NN to_TO pesticides_NNS should_MD be_VB considered_VBN on_IN a_DT case-by-case_JJ basis_NN ._. 
These_DT above_IN seven_CD points_NNS of_IN agreement_NN concur_NN with_IN ethical_JJ guidelines_NNS for_IN epidemiological_JJ studies_NNS published_VBN by_IN CIOMS_NNP in_IN 2009_CD ._. 
Points_NNS of_IN Disagreement_NNP Whilst_NNP agreement_NN within_IN the_DT authors_NNS was_VBD possible_JJ for_IN the_DT above_JJ recommendations_NNS ,_, areas_NNS of_IN dispute_NN that_WDT could_MD not_RB be_VB resolved_VBN included_VBD the_DT following_NN :_: 1_LS -RRB-_-RRB- Many_JJ criticisms_NNS of_IN studies_NNS entailing_VBG experimental_JJ exposure_NN of_IN human_JJ volunteers_NNS to_TO pesticides_NNS have_VBP focused_VBN on_IN their_PRP$ use_NN to_TO reduce_VB the_DT need_NN for_IN uncertainty_NN factors_NNS in_IN regulatory_JJ risk_NN assessments_NNS ._. 
Vessell_NNP et_NNP al_NNP ,_, 1975_CD A_NNP ,_, E_NNP ,_, O_NNP Warfarin_NNP -LRB-_-LRB- rodenticide_NN -RRB-_-RRB- Oral_NNP Acceptable_NNP Not_RB provided_VBD No_NNP 32_CD ._. 
Verberk_NNP ,_, 1977_CD 
Selim_NNP et_NNP al_NNP ,_, 1995_CD 
But_CC ,_, given_VBN the_DT fact_NN that_IN we_PRP may_MD not_RB have_VB all_DT information_NN on_IN all_DT possible_JJ risks_NNS ,_, some_DT chronic_JJ outcomes_NNS may_MD occur_VB at_IN concentrations_NNS lower_JJR than_IN those_DT at_IN which_WDT other_JJ recognized_VBN effects_NNS occur_VBP ._. 
For_IN example_NN ,_, by_IN analogy_NN ,_, there_EX is_VBZ experimental_JJ evidence_NN that_IN Chlorpyrifos_NNP exerts_VBZ neurodevelopmental_JJ impacts_NNS at_IN lower_JJR concentrations_NNS than_IN would_MD be_VB needed_VBN to_TO impact_VB on_IN cholinesterase_NN function_NN 
Dick_NNP et_NNP al_NNP ,_, 1997_CD 
Further_RB ,_, in_IN none_NN of_IN the_DT studies_NNS reviewed_VBD ,_, in_IN either_CC the_DT peer-reviewed_JJ literature_NN or_CC the_DT JMPR_NNP database_NN ,_, was_VBD it_PRP evident_JJ that_IN the_DT human_JJ data_NNS contributed_VBD to_TO a_DT lower_JJR -LRB-_-LRB- more_RBR stringent_JJ -RRB-_-RRB- reference_NN value_NN than_IN that_DT based_VBN on_IN animal_NN data_NNS ;_: rather_RB ,_, the_DT converse_NN was_VBD true_JJ -_: human_JJ data_NNS ,_, if_IN they_PRP influenced_VBD a_DT reference_NN value_NN at_IN all_DT ,_, led_VBD to_TO a_DT relaxation_NN of_IN the_DT value_NN ._. 
Ethical_JJ AnalysisEthical_JJ analysis_NN requires_VBZ a_DT structured_JJ approach_NN to_TO identifying_VBG all_DT issues_NNS relevant_JJ to_TO judgments_NNS about_IN the_DT research_NN in_IN question_NN ,_, particularly_RB related_VBN to_TO the_DT expected_JJ and_CC unexpected_JJ consequences_NNS and_CC to_TO the_DT relative_JJ balance_NN of_IN burdens_NNS and_CC benefits_NNS from_IN participation_NN in_IN a_DT research_NN study_NN ._. 
Additionally_RB ,_, particular_JJ concerns_NNS regarding_VBG the_DT capability_NN of_IN research_NN participants_NNS ,_, who_WP are_VBP in_IN a_DT dependent_JJ position_NN in_IN relation_NN to_TO the_DT researcher_NN ,_, to_TO make_VB informed_JJ decisions_NNS regarding_VBG their_PRP$ participation_NN ,_, would_MD be_VB another_DT key_JJ issue_NN in_IN this_DT analysis_NN ._. 
Timchalk_NNP et_NNP al_NNP ,_, 1998_CD 
Moody_NNP et_NNP al_NNP ,_, 1990_CD 
Williams_NNP et_NNP al_NNP ,_, 2004_CD 
Athird_JJ example_NN of_IN a_DT biomarker_NN study_NN is_VBZ one_CD involving_VBG fluazifop-butyl_JJ -LRB-_-LRB- FB_NNP -RRB-_-RRB- ,_, a_DT post-emergence_JJ herbicide_NN used_VBN to_TO control_VB grass_NN weeds_NNS in_IN a_DT large_JJ variety_NN of_IN broad-leaved_JJ crops_NNS ._. 
Ahuman_JJ volunteer_NN study_NN to_TO measure_VB excretion_NN of_IN the_DT acid_JJ metabolite_NN of_IN FB_NNP confirmed_VBD that_IN between_IN 80_CD %_NN and_CC 93_CD %_NN of_IN the_DT dose_NN was_VBD excreted_VBN in_IN urine_NN as_IN fluazifop_JJ acid_NN over_IN a_DT period_NN of_IN 6_CD days_NNS in_IN a_DT one-compartment_JJ model_NN ._. 
The_DT presence_NN of_IN an_DT accurate_JJ 
Yes_NNP No_NNP 12_CD ._. 
a._IN Kezic_NNP et_NNP ,_, 1996_CD 
But_CC ,_, given_VBN the_DT fact_NN that_IN we_PRP may_MD not_RB have_VB all_DT information_NN on_IN all_DT possible_JJ risks_NNS ,_, some_DT chronic_JJ outcomes_NNS may_MD occur_VB at_IN concentrations_NNS lower_JJR than_IN those_DT at_IN which_WDT other_JJ recognized_VBN effects_NNS occur_VBP ._. 
For_IN example_NN ,_, by_IN analogy_NN ,_, there_EX is_VBZ experimental_JJ evidence_NN that_IN Chlorpyrifos_NNP exerts_VBZ neurodevelopmental_JJ impacts_NNS at_IN lower_JJR concentrations_NNS than_IN would_MD be_VB needed_VBN to_TO impact_VB on_IN cholinesterase_NN function_NN 
Not_RB provided_VBN No_NNP 26_CD ._. 
a._FW Sauerhoff_FW et_FW al_FW ,_, 1977_CD 
Nolan_NNP et_FW al_FW ,_, 1984b_CD 
Ahuman_JJ volunteer_NN study_NN to_TO measure_VB excretion_NN of_IN the_DT acid_JJ metabolite_NN of_IN FB_NNP confirmed_VBD that_IN between_IN 80_CD %_NN and_CC 93_CD %_NN of_IN the_DT dose_NN was_VBD excreted_VBN in_IN urine_NN as_IN fluazifop_JJ acid_NN over_IN a_DT period_NN of_IN 6_CD days_NNS in_IN a_DT one-compartment_JJ model_NN 
1993_CD 
Woollen_NNP et_NNP al_NNP ,_, 1991_CD 
However_RB ,_, this_DT will_MD not_RB be_VB possible_JJ for_IN agents_NNS not_RB yet_RB approved_VBN for_IN distribution_NN ,_, or_CC where_WRB an_DT experimental_JJ study_NN is_VBZ expected_VBN to_TO generate_VB new_JJ information_NN that_WDT will_MD materially_RB enhance_VB the_DT risk_NN assessment_NN ._. 
Examples_NNS where_WRB ADME_NNP studies_NNS have_VBP contributed_VBN to_TO improving_VBG understanding_NN of_IN ,_, and_CC opportunities_NNS to_TO control_VB risks_NNS ,_, include_VBP the_DT following_NN :_: A_DT study_NN of_IN cypermethrin_NN metabolism_NN amongst_IN volunteers_NNS who_WP received_VBD a_DT single_JJ oral_JJ and_CC dermal_JJ dose_NN 
Yes_NNP No_NNP 4_CD ._. 
a._FW Cnubben_FW et_FW al_FW ,_, 2002_CD 
Wilks_FW et_FW al._FW ._. 
Wester_NNP et_NNP al_NNP ,_, 1994_CD 
Secondly_RB ,_, in_IN order_NN to_TO interpret_VB the_DT results_NNS of_IN biological_JJ monitoring_NN studies_NNS and_CC extrapolate_VB back_RB from_IN the_DT excretion_NN of_IN a_DT metabolite_NN to_TO exposure_NN to_TO the_DT parent_NN compound_NN ,_, detailed_JJ knowledge_NN about_IN the_DT human_JJ pharmacokinetics_NNS of_IN the_DT compound_NN is_VBZ required_VBN ._. 
The_DT best_JJS guide_NN to_TO interpretation_NN of_IN biological_JJ monitoring_NN studies_NNS is_VBZ therefore_RB a_DT controlled_JJ human_JJ volunteer_NN study_NN ,_, usually_RB with_IN a_DT single_JJ oral_JJ dose_NN of_IN the_DT compound_NN of_IN interest_NN ,_, although_IN it_PRP may_MD be_VB desirable_JJ to_TO study_VB more_JJR than_IN one_CD dose_NN level_NN ,_, and_CC ,_, where_WRB dermal_JJ or_CC inhalation_NN uptake_NN is_VBZ important_JJ ,_, more_JJR than_IN one_CD route_NN of_IN administration_NN ._. 
Improvements_NNP in_IN analytical_JJ methodology_NN enable_VB such_JJ studies_NNS to_TO be_VB carried_VBN out_RP with_IN very_RB low_JJ doses_NNS ,_, improving_VBG the_DT margins_NNS of_IN safety_NN for_IN volunteers_NNS ,_, particularly_RB when_WRB compared_VBN to_TO acute_JJ animal_NN studies_NNS ._. 
Examples_NNS where_WRB ADME_NNP studies_NNS have_VBP contributed_VBN to_TO improving_VBG understanding_NN of_IN ,_, and_CC opportunities_NNS to_TO control_VB risks_NNS ,_, include_VBP the_DT following_NN :_: A_DT study_NN of_IN cypermethrin_NN metabolism_NN amongst_IN volunteers_NNS who_WP received_VBD a_DT single_JJ oral_JJ and_CC dermal_JJ dose_NN 
Improved_JJ assessment_NN of_IN the_DT amount_NN absorbed_VBN across_IN the_DT skin_NN in_IN a_DT field_NN worker_NN exposure_NN study_NN 
Rider_NN et_FW al_FW ,_, 1975_CD 
Studies_NNS to_TO assess_VB human_JJ exposures_NNS when_WRB applying_VBG pesticides_NNS Of_IN the_DT studies_NNS identified_VBN from_IN the_DT peer-reviewed_JJ published_JJ literature_NN ,_, only_RB 4_CD were_VBD studies_NNS that_WDT evaluated_VBD exposures_NNS under_IN experimental_JJ conditions_NNS ,_, all_DT of_IN which_WDT examined_VBD dermal_JJ uptake_NN of_IN a_DT pesticide_NN ._. 
At_IN least_JJS one_CD study_NN was_VBD a_DT pilot_NN investigation_NN that_WDT was_VBD part_NN of_IN a_DT larger_JJR trial_NN to_TO examine_VB interactions_NNS between_IN various_JJ compounds_NNS used_VBN to_TO protect_VB armed_JJ forces_NNS against_IN disease_NN vectors_NNS and_CC chemical_NN warfare_NN agents_NNS ,_, and_CC was_VBD not_RB intended_VBN to_TO contribute_VB to_TO regulatory_JJ risk_NN assessment_NN ._. 
None_NN was_VBD deemed_VBN to_TO have_VB adequate_JJ power_NN and_CC none_NN had_VBD evidence_NN of_IN approval_NN by_IN an_DT independent_JJ ethics_NNS committee_NN ._. 
''_'' The_DT EPA_NNP position_NN is_VBZ therefore_RB not_RB to_TO exclude_VB human_JJ studies_NNS from_IN consideration_NN in_IN the_DT regulatory_JJ risk_NN assessment_NN process_NN ,_, but_CC to_TO set_VB conditions_NNS under_IN which_WDT such_JJ studies_NNS might_MD be_VB considered_VBN ._. 
The_DT Joint_NNP FAO\/WHO_NNP Meeting_VBG on_IN Pesticide_NNP Residues_NNP -LRB-_-LRB- JMPR_NNP -RRB-_-RRB- The_DT Joint_NNP FAO\/WHO_NNP Meeting_VBG on_IN Pesticide_NNP Residues_NNP -LRB-_-LRB- JMPR_NNP -RRB-_-RRB- has_VBZ several_JJ times_NNS addressed_VBD the_DT issue_NN of_IN studies_NNS in_IN human_JJ volunteers_NNS ._. 
It_PRP has_VBZ always_RB been_VBN 
While_IN recognizing_VBG that_IN the_DT use_NN of_IN data_NNS from_IN human_JJ volunteers_NNS in_IN chemical_NN risk_NN assessment_NN is_VBZ a_DT controversial_JJ issue_NN ,_, the_DT JMPR_NNP underlined_VBD that_IN ``_`` the_DT use_NN of_IN such_JJ data_NNS can_MD reduce_VB the_DT level_NN of_IN uncertainty_NN inherent_JJ in_IN extrapolating_VBG from_IN animal_NN models_NNS ''_'' ._. 
During_IN its_PRP$ meetings_NNS the_DT JMPR_NNP pointed_VBD out_RP the_DT need_NN to_TO consider_VB both_DT ethical_JJ -LRB-_-LRB- particularly_RB the_DT relevant_JJ components_NNS of_IN the_DT Helsinki_NNP Declaration_NNP -RRB-_-RRB- 
In_IN response_NN to_TO the_DT controversy_NN ,_, EPA_NNP commissioned_VBD the_DT National_NNP Academy_NNP of_IN Sciences_NNP to_TO advise_VB whether_IN and_CC under_IN what_WP circumstances_NNS the_DT Agency_NNP should_MD consider_VB and_CC accept_VB intentional_JJ human_JJ dosing_NN studies_NNS ._. 
The_DT National_NNP Research_NNP Council_NNP committee_NN recommended_VBD that_IN such_JJ studies_NNS should_MD be_VB conducted_VBN and_CC considered_VBN for_IN regulatory_JJ purposes_NNS only_RB if_IN all_DT of_IN a_DT set_NN of_IN specified_JJ conditions_NNS were_VBD met_VBN that_IN related_VBN to_TO both_DT scientific_JJ validity_NN and_CC ethical_JJ standards_NNS -LRB-_-LRB- see_VB appendix_NN below_IN -RRB-_-RRB- 
While_IN recognizing_VBG that_IN the_DT use_NN of_IN data_NNS from_IN human_JJ volunteers_NNS in_IN chemical_NN risk_NN assessment_NN is_VBZ a_DT controversial_JJ issue_NN ,_, the_DT JMPR_NNP underlined_VBD that_IN ``_`` the_DT use_NN of_IN such_JJ data_NNS can_MD reduce_VB the_DT level_NN of_IN uncertainty_NN inherent_JJ in_IN extrapolating_VBG from_IN animal_NN models_NNS ''_'' ._. 
During_IN its_PRP$ meetings_NNS the_DT JMPR_NNP pointed_VBD out_RP the_DT need_NN to_TO consider_VB both_DT ethical_JJ -LRB-_-LRB- particularly_RB the_DT relevant_JJ components_NNS of_IN the_DT Helsinki_NNP Declaration_NNP -RRB-_-RRB- 
combining_VBG results_NNS from_IN two_CD or_CC more_JJR dose_NN levels_NNS or_CC applying_VBG an_DT increased_VBN uncertainty_NN factor_NN ;_: c_LS -RRB-_-RRB- the_DT fact_NN that_IN the_DT critical_JJ end-points_NNS identified_VBN in_IN animal_NN studies_NNS can_MD be_VB investigated_VBN appropriately_RB in_IN human_JJ studies_NNS ,_, d_LS -RRB-_-RRB- the_DT relevance_NN of_IN sex_NN differences_NNS in_IN toxicity_NN ._. 
In_IN addition_NN the_DT JMPR_NNP indicated_VBD that_IN ``_`` studies_NNS that_WDT have_VBP not_RB been_VBN performed_VBN in_IN accordance_NN with_IN ethical_JJ principles_NNS but_CC are_VBP scientifically_RB valid_JJ should_MD be_VB used_VBN only_RB if_IN the_DT findings_NNS indicate_VBP that_IN acceptable_JJ human_JJ exposure_NN is_VBZ lower_JJR than_IN the_DT level_NN that_WDT would_MD be_VB determined_VBN without_IN the_DT use_NN of_IN such_PDT a_DT study_NN ''_'' ._. 
The_DT European_NNP Union_NNP -LRB-_-LRB- EU_NNP -RRB-_-RRB- In_IN Europe_NNP ,_, the_DT regulatory_JJ framework_NN concerning_VBG authorisation_NN and_CC use_NN of_IN pesticides_NNS has_VBZ been_VBN very_RB recently_RB changed_VBN with_IN the_DT approval_NN of_IN Regulation_NN 1007\/2009_CD of_IN 21_CD October_NNP 2009_CD that_WDT replaces_VBZ Council_NNP Directive_NNP 91\/414\/EEC_NNP of_IN 15_CD July_NNP 1991_CD on_IN the_DT placing_NN of_IN plant_NN protection_NN products_NNS -LRB-_-LRB- PPP_NNP -RRB-_-RRB- on_IN the_DT market_NN and_CC all_DT its_PRP$ subsequent_JJ amendments_NNS ._. 
Each_DT author_NN was_VBD primarily_RB responsible_JJ for_IN the_DT first_JJ draft_NN of_IN a_DT specific_JJ section_NN of_IN the_DT paper_NN and_CC each_DT author_NN contributed_VBD to_TO revisions_NNS of_IN subsequent_JJ drafts_NNS ._. 
AppendixNational_NNP Research_NNP Council_NNP recommendations_NNS regarding_VBG acceptance_NN of_IN data_NNS from_IN human_JJ volunteer_NN studies_NNS for_IN pesticide_NN registration_NN 
Some_DT scientists_NNS and_CC activist_NN groups_NNS challenged_VBD the_DT ethical_JJ and_CC scientific_JJ validity_NN of_IN the_DT studies_NNS ,_, contending_VBG among_IN other_JJ things_NNS that_IN people_NNS should_MD not_RB be_VB put_VBN at_IN risk_NN for_IN the_DT purpose_NN of_IN reducing_VBG the_DT stringency_NN of_IN regulatory_JJ standards_NNS 
05_CD mg\/kg_NN or_CC less_RBR conflicted_JJ with_IN a_DT previously_RB reported_VBN Californian_NN food_NN poisoning_NN incident_NN 
Some_DT scientists_NNS and_CC activist_NN groups_NNS challenged_VBD the_DT ethical_JJ and_CC scientific_JJ validity_NN of_IN the_DT studies_NNS ,_, contending_VBG among_IN other_JJ things_NNS that_IN people_NNS should_MD not_RB be_VB put_VBN at_IN risk_NN for_IN the_DT purpose_NN of_IN reducing_VBG the_DT stringency_NN of_IN regulatory_JJ standards_NNS 
We_PRP then_RB provide_VBP a_DT general_JJ ethical_JJ analysis_NN of_IN the_DT issues_NNS involved_VBN ,_, including_VBG problems_NNS that_WDT arise_VBP in_IN relation_NN to_TO use_NN of_IN data_NNS from_IN experimental_JJ studies_NNS conducted_VBN in_IN the_DT past_NN as_IN opposed_VBN to_TO those_DT that_WDT might_MD be_VB undertaken_VBN in_IN the_DT future_NN ._. 
Positions_NNS of_IN regulatory_JJ agencies_NNS on_IN the_DT use_NN of_IN data_NNS from_IN experimental_JJ human_JJ exposure_NN to_TO pesticidesThe_NNP United_NNP State_NNP Environmental_NNP Protection_NNP AgencyIn_NNP the_DT USA_NNP ,_, the_DT Food_NNP Quality_NNP Protection_NNP Act_NNP of_IN 1996_CD introduced_VBD the_DT concept_NN of_IN an_DT additional_JJ uncertainty_NN factor_NN of_IN up_IN to_TO 10_CD into_IN the_DT risk_NN assessment_NN process_NN for_IN pesticides_NNS ,_, to_TO account_VB for_IN possible_JJ increased_VBN sensitivity_NN of_IN infants_NNS and_CC children_NNS ._. 
Anumber_NNP of_IN dosing_VBG studies_NNS with_IN volunteers_NNS were_VBD subsequently_RB submitted_VBN to_TO the_DT agency_NN with_IN the_DT intent_NN of_IN providing_VBG human_JJ data_NNS which_WDT would_MD not_RB require_VB application_NN of_IN the_DT normal_JJ inter-species_JJ uncertainty_NN factor_NN ._. 
In_IN response_NN to_TO the_DT controversy_NN ,_, EPA_NNP commissioned_VBD the_DT National_NNP Academy_NNP of_IN Sciences_NNP to_TO advise_VB whether_IN and_CC under_IN what_WP circumstances_NNS the_DT Agency_NNP should_MD consider_VB and_CC accept_VB intentional_JJ human_JJ dosing_NN studies_NNS ._. 
The_DT National_NNP Research_NNP Council_NNP committee_NN recommended_VBD that_IN such_JJ studies_NNS should_MD be_VB conducted_VBN and_CC considered_VBN for_IN regulatory_JJ purposes_NNS only_RB if_IN all_DT of_IN a_DT set_NN of_IN specified_JJ conditions_NNS were_VBD met_VBN that_IN related_VBN to_TO both_DT scientific_JJ validity_NN and_CC ethical_JJ standards_NNS -LRB-_-LRB- see_VB appendix_NN below_IN -RRB-_-RRB- 
Thirdly_RB ,_, an_DT ethical_JJ analysis_NN was_VBD applied_VBN to_TO the_DT arguments_NNS identified_VBN from_IN the_DT literature_NN ._. 
Sampling_VBG for_IN this_DT analysis_NN was_VBD conducted_VBN with_IN the_DT intention_NN of_IN obtaining_VBG a_DT picture_NN of_IN the_DT range_NN of_IN the_DT types_NNS of_IN studies_NNS in_IN the_DT published_JJ literature_NN involving_VBG experimental_JJ exposure_NN of_IN humans_NNS to_TO pesticides_NNS to_TO inform_VB ethical_JJ analysis_NN rather_RB than_IN seeking_VBG representivity_NN of_IN the_DT population_NN of_IN such_JJ studies_NNS ._. 
In_IN approaching_VBG the_DT ethical_JJ analysis_NN ,_, cognizance_NN was_VBD taken_VBN of_IN the_DT numerous_JJ codes_NNS providing_VBG guidance_NN for_IN health_NN professionals_NNS in_IN relation_NN to_TO biomedical_JJ research_NN ,_, particularly_RB ,_, the_DT World_NNP Medical_NNP Association_NNP -LRB-_-LRB- WMA_NNP -RRB-_-RRB- Declaration_NNP of_IN Helsinki_NNP 
Even_RB if_IN the_DT study_NN in_IN question_NN was_VBD considered_VBN ethically_RB acceptable_JJ at_IN the_DT time_NN it_PRP was_VBD conducted_VBN ,_, an_DT ethical_JJ assessment_NN of_IN its_PRP$ current_JJ use_NN would_MD need_VB to_TO take_VB account_NN of_IN the_DT full_JJ spectrum_NN of_IN ethical_JJ issues_NNS ,_, including_VBG a_DT critical_JJ assessment_NN of_IN both_DT the_DT potential_JJ benefits_NNS and_CC any_DT adverse_JJ impacts_NNS on_IN human_JJ dignity_NN ._. 
Rather_RB than_IN applying_VBG a_DT general_JJ rule_NN ,_, such_JJ instances_NNS should_MD be_VB addressed_VBN on_IN a_DT case-by-case_JJ basisDiscussionThe_NNP Helsinki_NNP Declaration_NNP indicates_VBZ clearly_RB that_IN ''_'' ..._: in_IN medical_JJ research_NN on_IN human_JJ subjects_NNS ,_, considerations_NNS related_VBN to_TO the_DT well-being_NN of_IN the_DT human_JJ subject_NN should_MD take_VB precedence_NN over_IN the_DT interests_NNS of_IN science_NN and_CC society_NN ._. 
However_RB ,_, this_DT has_VBZ raised_VBN many_JJ ethical_JJ questions_NNS ,_, principally_RB because_IN of_IN possible_JJ risks_NNS to_TO the_DT participants_NNS from_IN the_DT experimental_JJ exposure_NN ,_, and_CC whether_IN the_DT reduced_VBN uncertainty_NN justifies_VBZ the_DT deliberate_JJ exposure_NN of_IN humans_NNS to_TO non-therapeutic_JJ agents_NNS 
Thirdly_RB ,_, an_DT ethical_JJ analysis_NN was_VBD applied_VBN to_TO the_DT arguments_NNS identified_VBN from_IN the_DT literature_NN ._. 
Sampling_VBG for_IN this_DT analysis_NN was_VBD conducted_VBN with_IN the_DT intention_NN of_IN obtaining_VBG a_DT picture_NN of_IN the_DT range_NN of_IN the_DT types_NNS of_IN studies_NNS in_IN the_DT published_JJ literature_NN involving_VBG experimental_JJ exposure_NN of_IN humans_NNS to_TO pesticides_NNS to_TO inform_VB ethical_JJ analysis_NN rather_RB than_IN seeking_VBG representivity_NN of_IN the_DT population_NN of_IN such_JJ studies_NNS ._. 
In_IN approaching_VBG the_DT ethical_JJ analysis_NN ,_, cognizance_NN was_VBD taken_VBN of_IN the_DT numerous_JJ codes_NNS providing_VBG guidance_NN for_IN health_NN professionals_NNS in_IN relation_NN to_TO biomedical_JJ research_NN ,_, particularly_RB ,_, the_DT World_NNP Medical_NNP Association_NNP -LRB-_-LRB- WMA_NNP -RRB-_-RRB- Declaration_NNP of_IN Helsinki_NNP 
However_RB ,_, this_DT has_VBZ raised_VBN many_JJ ethical_JJ questions_NNS ,_, principally_RB because_IN of_IN possible_JJ risks_NNS to_TO the_DT participants_NNS from_IN the_DT experimental_JJ exposure_NN ,_, and_CC whether_IN the_DT reduced_VBN uncertainty_NN justifies_VBZ the_DT deliberate_JJ exposure_NN of_IN humans_NNS to_TO non-therapeutic_JJ agents_NNS 
Thirdly_RB ,_, an_DT ethical_JJ analysis_NN was_VBD applied_VBN to_TO the_DT arguments_NNS identified_VBN from_IN the_DT literature_NN ._. 
Sampling_VBG for_IN this_DT analysis_NN was_VBD conducted_VBN with_IN the_DT intention_NN of_IN obtaining_VBG a_DT picture_NN of_IN the_DT range_NN of_IN the_DT types_NNS of_IN studies_NNS in_IN the_DT published_JJ literature_NN involving_VBG experimental_JJ exposure_NN of_IN humans_NNS to_TO pesticides_NNS to_TO inform_VB ethical_JJ analysis_NN rather_RB than_IN seeking_VBG representivity_NN of_IN the_DT population_NN of_IN such_JJ studies_NNS ._. 
In_IN approaching_VBG the_DT ethical_JJ analysis_NN ,_, cognizance_NN was_VBD taken_VBN of_IN the_DT numerous_JJ codes_NNS providing_VBG guidance_NN for_IN health_NN professionals_NNS in_IN relation_NN to_TO biomedical_JJ research_NN ,_, particularly_RB ,_, the_DT World_NNP Medical_NNP Association_NNP -LRB-_-LRB- WMA_NNP -RRB-_-RRB- Declaration_NNP of_IN Helsinki_NNP 
As_IN a_DT result_NN ,_, it_PRP was_VBD mistaken_JJ to_TO distinguish_VB between_IN industry_NN researchers_NNS and_CC academics_NNS who_WP erroneously_RB considered_VBN themselves_PRP to_TO be_VB independent_JJ ._. 
Acontrary_JJ view_NN argued_VBD that_IN epidemiologists_NNS and_CC occupational_JJ health_NN practitioners_NNS have_VBP well_RB recognized_VBN ethical_JJ obligations_NNS to_TO strive_VB for_IN full_JJ professional_JJ independence_NN in_IN research_NN ._. 
The_DT fact_NN that_IN there_EX are_VBP ,_, in_IN practice_NN ,_, threats_NNS to_TO researcher_NN independence_NN should_MD not_RB be_VB mistaken_VBN for_IN a_DT normative_JJ view_NN of_IN the_DT absence_NN of_IN independence_NN or_CC one_NN that_WDT renders_VBZ all_DT threats_NNS to_TO independence_NN as_IN equivalent_NN ._. 
Although_IN such_JJ studies_NNS have_VBP been_VBN conducted_VBN for_IN many_JJ decades_NNS ,_, albeit_IN on_IN a_DT limited_VBN scale_NN ,_, the_DT controversy_NN around_IN their_PRP$ use_NN has_VBZ been_VBN prompted_VBN particularly_RB by_IN more_JJR recent_JJ debates_NNS on_IN the_DT use_NN of_IN data_NNS from_IN human_JJ volunteer_NN studies_NNS to_TO inform_VB regulatory_JJ risk_NN assessment_NN 
Some_DT scientists_NNS and_CC activist_NN groups_NNS challenged_VBD the_DT ethical_JJ and_CC scientific_JJ validity_NN of_IN the_DT studies_NNS ,_, contending_VBG among_IN other_JJ things_NNS that_IN people_NNS should_MD not_RB be_VB put_VBN at_IN risk_NN for_IN the_DT purpose_NN of_IN reducing_VBG the_DT stringency_NN of_IN regulatory_JJ standards_NNS 
The_DT critique_NN further_RB pointed_VBD out_RP that_IN the_DT lack_NN of_IN power_NN in_IN the_DT study_NN would_MD invalidate_VB any_DT inferences_NNS for_IN or_CC against_IN a_DT NOAEL_NNP ._. 
In_IN response_NN ,_, Chart_NNP and_CC colleagues_NNS disputed_VBD the_DT biological_JJ significance_NN of_IN the_DT modest_JJ cholinesterase_NN decline_NN since_IN a_DT -RRB-_-RRB- no_DT clinical_JJ effects_NNS were_VBD seen_VBN and_CC b_NN -RRB-_-RRB- the_DT decline_NN was_VBD said_VBN to_TO provide_VB evidence_NN of_IN exposure_NN ,_, but_CC was_VBD too_RB small_JJ to_TO indicate_VB hazard_NN ._. 
With_IN regard_NN to_TO the_DT power_NN issue_NN ,_, Chart_NNP et_NNP al_RB acknowledged_VBD the_DT relatively_RB small_JJ study_NN size_NN ,_, but_CC pointed_VBD to_TO an_DT overall_JJ database_NN of_IN hundreds_NNS of_IN animal_NN and_CC human_JJ studies_NNS with_IN dichlorvos_NNS ,_, arguing_VBG that_IN the_DT available_JJ health_NN data_NNS on_IN any_DT given_VBN substance_NN should_MD be_VB evaluated_VBN as_IN a_DT whole_NN in_IN risk_NN assessments_NNS ._. 
Some_DT scientists_NNS and_CC activist_NN groups_NNS challenged_VBD the_DT ethical_JJ and_CC scientific_JJ validity_NN of_IN the_DT studies_NNS ,_, contending_VBG among_IN other_JJ things_NNS that_IN people_NNS should_MD not_RB be_VB put_VBN at_IN risk_NN for_IN the_DT purpose_NN of_IN reducing_VBG the_DT stringency_NN of_IN regulatory_JJ standards_NNS 
This_DT resulted_VBD in_IN a_DT protracted_JJ and_CC intensely_RB polarized_VBN debate_NN ._. 
Anumber_NNP of_IN dosing_VBG studies_NNS with_IN volunteers_NNS were_VBD subsequently_RB submitted_VBN to_TO the_DT agency_NN with_IN the_DT intent_NN of_IN providing_VBG human_JJ data_NNS which_WDT would_MD not_RB require_VB application_NN of_IN the_DT normal_JJ inter-species_JJ uncertainty_NN factor_NN ._. 
Some_DT scientists_NNS and_CC activist_NN groups_NNS challenged_VBD the_DT ethical_JJ and_CC scientific_JJ validity_NN of_IN the_DT studies_NNS ,_, contending_VBG among_IN other_JJ things_NNS that_IN people_NNS should_MD not_RB be_VB put_VBN at_IN risk_NN for_IN the_DT purpose_NN of_IN reducing_VBG the_DT stringency_NN of_IN regulatory_JJ standards_NNS 
The_DT risk_NN of_IN toxicity_NN will_MD depend_VB upon_IN :_: a_DT -RRB-_-RRB- the_DT margin_NN between_IN the_DT experimental_JJ dose_NN of_IN the_DT pesticide_NN and_CC the_DT lowest_JJS dose_NN at_IN which_WDT adverse_JJ effects_NNS might_MD be_VB expected_VBN from_IN prior_JJ knowledge_NN ;_: and_CC b_NN -RRB-_-RRB- the_DT confidence_NN that_WDT can_MD be_VB placed_VBN in_IN this_DT prior_JJ knowledge_NN ._. 
Whilst_JJ study_NN design_NN aims_VBZ to_TO minimize_VB the_DT risk_NN of_IN toxicity_NN ,_, there_EX are_VBP concerns_NNS that_IN unexpected_JJ effects_NNS may_MD be_VB impossible_JJ to_TO predict_VB ._. 
Informed_JJ consent_NN is_VBZ therefore_RB essential_JJ to_TO protect_VB the_DT autonomy_NN of_IN participants_NNS ,_, particularly_RB where_WRB overt_JJ or_CC covert_JJ pressures_NNS exist_VBP ,_, or_CC where_WRB scientific_JJ uncertainty_NN about_IN risk_NN requires_VBZ interpretation_NN for_IN a_DT prospective_JJ participant_NN whose_WP$ health_NN literacy_NN and_CC familiarity_NN with_IN scientific_JJ concepts_NNS is_VBZ low_JJ ._. 
However_RB ,_, the_DT paper_NN also_RB highlights_VBZ ongoing_JJ unresolved_JJ differences_NNS of_IN opinion_NN inherent_JJ in_IN ethical_JJ analysis_NN of_IN contentious_JJ issues_NNS ,_, which_WDT we_PRP propose_VBP should_MD form_VB a_DT starting_JJ point_NN for_IN further_JJ debate_NN and_CC the_DT development_NN of_IN guidelines_NNS to_TO achieve_VB better_JJR resolution_NN of_IN this_DT matter_NN ._. 
IntroductionIn_JJ recent_JJ years_NNS ,_, there_EX has_VBZ been_VBN considerable_JJ controversy_NN about_IN the_DT scientific_JJ value_NN and_CC ethical_JJ acceptability_NN of_IN studies_NNS involving_VBG experimental_JJ exposure_NN of_IN human_JJ volunteers_NNS to_TO low_JJ doses_NNS of_IN pesticides_NNS 
This_DT resulted_VBD in_IN a_DT protracted_JJ and_CC intensely_RB polarized_VBN debate_NN ._. 
Anumber_NNP of_IN dosing_VBG studies_NNS with_IN volunteers_NNS were_VBD subsequently_RB submitted_VBN to_TO the_DT agency_NN with_IN the_DT intent_NN of_IN providing_VBG human_JJ data_NNS which_WDT would_MD not_RB require_VB application_NN of_IN the_DT normal_JJ inter-species_JJ uncertainty_NN factor_NN ._. 
Some_DT scientists_NNS and_CC activist_NN groups_NNS challenged_VBD the_DT ethical_JJ and_CC scientific_JJ validity_NN of_IN the_DT studies_NNS ,_, contending_VBG among_IN other_JJ things_NNS that_IN people_NNS should_MD not_RB be_VB put_VBN at_IN risk_NN for_IN the_DT purpose_NN of_IN reducing_VBG the_DT stringency_NN of_IN regulatory_JJ standards_NNS 
It_PRP should_MD be_VB noted_VBN that_IN in_IN one_CD of_IN the_DT oldest_JJS studies_NNS evaluated_VBN ,_, the_DT experimental_JJ design_NN was_VBD such_JJ that_IN ``_`` severe_JJ poisonings_NNS ''_'' occurred_VBD in_IN two_CD of_IN the_DT studied_VBN subjects_NNS ,_, in_IN one_CD subject_NN on_IN two_CD occasions_NNS and_CC in_IN the_DT second_JJ subject_NN on_IN three_CD 
With_IN regard_NN to_TO the_DT power_NN issue_NN ,_, Chart_NNP et_NNP al_RB acknowledged_VBD the_DT relatively_RB small_JJ study_NN size_NN ,_, but_CC pointed_VBD to_TO an_DT overall_JJ database_NN of_IN hundreds_NNS of_IN animal_NN and_CC human_JJ studies_NNS with_IN dichlorvos_NNS ,_, arguing_VBG that_IN the_DT available_JJ health_NN data_NNS on_IN any_DT given_VBN substance_NN should_MD be_VB evaluated_VBN as_IN a_DT whole_NN in_IN risk_NN assessments_NNS ._. 
The_DT second_JJ study_NN criticised_VBN by_IN Sass_NNP and_CC Needleman_NNP 
Selim_NNP et_NNP al_NNP ,_, 1999_CD 
This_DT resulted_VBD in_IN a_DT protracted_JJ and_CC intensely_RB polarized_VBN debate_NN ._. 
Anumber_NNP of_IN dosing_VBG studies_NNS with_IN volunteers_NNS were_VBD subsequently_RB submitted_VBN to_TO the_DT agency_NN with_IN the_DT intent_NN of_IN providing_VBG human_JJ data_NNS which_WDT would_MD not_RB require_VB application_NN of_IN the_DT normal_JJ inter-species_JJ uncertainty_NN factor_NN ._. 
Some_DT scientists_NNS and_CC activist_NN groups_NNS challenged_VBD the_DT ethical_JJ and_CC scientific_JJ validity_NN of_IN the_DT studies_NNS ,_, contending_VBG among_IN other_JJ things_NNS that_IN people_NNS should_MD not_RB be_VB put_VBN at_IN risk_NN for_IN the_DT purpose_NN of_IN reducing_VBG the_DT stringency_NN of_IN regulatory_JJ standards_NNS 
Flannigan_NNP et_NNP al_NNP ,_, 1985_CD 
Furthermore_RB ,_, some_DT of_IN the_DT debates_NNS on_IN experimental_JJ human_JJ volunteer_NN studies_NNS suggest_VBP that_IN symptoms_NNS such_JJ as_IN headache_NN ,_, sweating_NN and_CC nausea_NN ,_, are_VBP ``_`` not_RB serious_JJ and_CC are_VBP reversible_JJ ''_'' so_RB would_MD constitute_VB minimal_JJ risk_NN ._. 
But_CC ,_, given_VBN ,_, for_IN example_NN ,_, a_DT view_NN that_IN neurobehavioural_JJ symptoms_NNS are_VBP part_NN of_IN a_DT spectrum_NN of_IN neurotoxicity_NN ,_, such_JJ symptoms_NNS may_MD ,_, however_RB ,_, also_RB be_VB markers_NNS of_IN more_RBR profound_JJ damage_NN to_TO the_DT CNS_NNP and_CC their_PRP$ prognostic_JJ significance_NN would_MD need_VB to_TO be_VB evaluated_VBN as_IN part_NN of_IN the_DT risk-benefit_JJ assessment_NN ._. 
Lastly_RB ,_, much_JJ unease_NN with_IN the_DT idea_NN of_IN permitting_VBG human_JJ experimental_JJ volunteer_NN studies_NNS rests_VBZ with_IN the_DT concern_NN that_IN this_DT will_MD be_VB a_DT slippery_JJ slope_NN ,_, which_WDT will_MD ,_, on_IN the_DT one_CD hand_NN ,_, encourage_VBP less_JJR than_IN ethical_JJ studies_NNS in_IN countries_NNS where_WRB there_EX are_VBP not_RB established_VBN oversight_NN structures_NNS ,_, and_CC ,_, on_IN the_DT other_JJ hand_NN ,_, justify_VB arguments_NNS for_IN very_RB low_JJ dosing_NN of_IN volunteers_NNS with_IN other_JJ well_RB recognized_VBN toxins_NNS and_CC toxicants_NNS such_JJ as_IN lead_NN if_IN improvements_NNS of_IN preventive_JJ action_NN or_CC health_NN protection_NN were_VBD envisaged_VBN ._. 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN ,_, which_WDT is_VBZ true_JJ for_IN the_DT overall_JJ Interphone_NNP data_NNS ,_, but_CC in_IN some_DT studies_NNS this_DT bias_NN alone_RB can_MD result_VB in_IN a_DT more_RBR significant_JJ reduction_NN in_IN OR_NNP assessment_NN :_: 
e._VB In_IN the_DT negative_JJ cohort_NN studies_NNS ,_, where_WRB exposure_NN is_VBZ based_VBN simply_RB on_IN the_DT fact_NN that_WDT subjects_VBZ work_NN for_IN an_DT industry_NN that_WDT produces_VBZ MPs_NNS or_CC are_VBP mobile_JJ telephony_NN company_NN subscribers_NNS -LRB-_-LRB- i._NN without_IN the_DT need_NN to_TO question_VB participants_NNS -RRB-_-RRB- ,_, and_CC where_WRB the_DT illness\/mortality_NN incidence_NN data_NNS estimate_NN is_VBZ based_VBN on_IN linkage_NN of_IN data_NNS from_IN people_NNS exposed_VBN with_IN data_NNS from_IN national_JJ tumor_NN registers_NNS ,_, there_EX is_VBZ an_DT overabundance_NN of_IN data_NNS showing_VBG a_DT reduced_JJ risk_NN of_IN those_DT exposed_VBN -_: in_IN all_DT subjects_NNS 
These_DT additional_JJ funds_NNS are_VBP not_RB specified_VBN in_IN the_DT Interphone_NNP protocol_NN 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
e._VB In_IN the_DT negative_JJ cohort_NN studies_NNS ,_, where_WRB exposure_NN is_VBZ based_VBN simply_RB on_IN the_DT fact_NN that_WDT subjects_VBZ work_NN for_IN an_DT industry_NN that_WDT produces_VBZ MPs_NNS or_CC are_VBP mobile_JJ telephony_NN company_NN subscribers_NNS -LRB-_-LRB- i._NN without_IN the_DT need_NN to_TO question_VB participants_NNS -RRB-_-RRB- ,_, and_CC where_WRB the_DT illness\/mortality_NN incidence_NN data_NNS estimate_NN is_VBZ based_VBN on_IN linkage_NN of_IN data_NNS from_IN people_NNS exposed_VBN with_IN data_NNS from_IN national_JJ tumor_NN registers_NNS ,_, there_EX is_VBZ an_DT overabundance_NN of_IN data_NNS showing_VBG a_DT reduced_JJ risk_NN of_IN those_DT exposed_VBN -_: in_IN all_DT subjects_NNS 
s-LRB-_NNS see_VBP additional_JJ file_NN 7_CD -RRB-_-RRB- ._. 
for_IN the_DT Interphone_NNP data_NNS ,_, and_CC an_DT equal_JJ split_NN of_IN values_NNS 
They_PRP may_MD ,_, however_RB ,_, be_VB informed_VBN ,_, together_RB with_IN representatives_NNS of_IN other_JJ concerned_JJ organizations_NNS such_JJ as_IN consumer_NN groups_NNS ,_, a_DT maximum_NN of_IN seven_CD days_NNS before_IN the_DT publication_NN of_IN the_DT results_NNS ,_, under_IN strict_JJ terms_NNS of_IN confidentiality_NN ''_'' ._. 
In_IN addition_NN to_TO the_DT above_JJ funds_NNS ,_, several_JJ authors_NNS participating_VBG in_IN the_DT Interphone_NNP study_NN received_VBD additional_JJ funding_NN from_IN their_PRP$ national_JJ MP_NNP companies_NNS 
These_DT additional_JJ funds_NNS are_VBP not_RB specified_VBN in_IN the_DT Interphone_NNP protocol_NN 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
Therefore_RB ,_, MP_NNP users_NNS willingly_RB elect_VBP to_TO participate_VB in_IN the_DT study_NN ,_, aware_JJ of_IN its_PRP$ goals_NNS ,_, while_IN non-users_NNS tend_VBP to_TO decline_VB ._. 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN ,_, which_WDT is_VBZ true_JJ for_IN the_DT overall_JJ Interphone_NNP data_NNS ,_, but_CC in_IN some_DT studies_NNS this_DT bias_NN alone_RB can_MD result_VB in_IN a_DT more_RBR significant_JJ reduction_NN in_IN OR_NNP assessment_NN :_: 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
-LRB-_-LRB- Figure_NNP 1B_NNP -RRB-_-RRB- :_: 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
And_CC indeed_RB ,_, even_RB some_DT Interphone_NNP authors_NNS have_VBP expressed_VBN disagreement_NN with_IN the_DT reassuring_JJ interpretation_NN of_IN the_DT Interphone_NNP results_NNS ,_, which_WDT essentially_RB indicates_VBZ a_DT lack_NN of_IN cause_NN for_IN alarm_NN 
s._NN In_IN addition_NN ,_, the_DT s._NN 10_CD -RRB-_-RRB- ._. 
25_CD to_TO 4_CD ._. 
16_CD ;_: 95_CD %_NN CI_NNP =_SYM +_CD 0_CD ._. 
in_IN the_DT age_NN group_NN 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
-LRB-_-LRB- Figure_NNP 1C_NNP ,_, see_VBP additional_JJ file_NN 6_CD -RRB-_-RRB- ._. 
s._RB ,_, while_IN the_DT Interphone_NNP data_NNS are_VBP largely_RB 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
They_PRP may_MD ,_, however_RB ,_, be_VB informed_VBN ,_, together_RB with_IN representatives_NNS of_IN other_JJ concerned_JJ organizations_NNS such_JJ as_IN consumer_NN groups_NNS ,_, a_DT maximum_NN of_IN seven_CD days_NNS before_IN the_DT publication_NN of_IN the_DT results_NNS ,_, under_IN strict_JJ terms_NNS of_IN confidentiality_NN ''_'' ._. 
In_IN addition_NN to_TO the_DT above_JJ funds_NNS ,_, several_JJ authors_NNS participating_VBG in_IN the_DT Interphone_NNP study_NN received_VBD additional_JJ funding_NN from_IN their_PRP$ national_JJ MP_NNP companies_NNS 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
Therefore_RB ,_, if_IN a_DT risk_NN exists_VBZ ,_, it_PRP is_VBZ ``_`` diluted_JJ ''_'' because_IN of_IN the_DT dominance_NN ,_, in_IN the_DT examined_VBN sample_NN ,_, of_IN subjects_NNS exposed_VBN too_RB little_JJ :_: the_DT average_JJ daily_JJ use_NN of_IN MPs_NNS in_IN subjects_NNS considered_VBN ``_`` exposed_VBN ''_'' by_IN Interphone_NNP is_VBZ just_RB 2-5_CD minutes_NNS per_IN day_NN ,_, very_RB scarcely_RB representative_JJ of_IN the_DT intensive_JJ use_NN made_VBN of_IN cellphones_NNS today_NN ;_: 
Therefore_RB ,_, MP_NNP users_NNS willingly_RB elect_VBP to_TO participate_VB in_IN the_DT study_NN ,_, aware_JJ of_IN its_PRP$ goals_NNS ,_, while_IN non-users_NNS tend_VBP to_TO decline_VB ._. 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN ,_, which_WDT is_VBZ true_JJ for_IN the_DT overall_JJ Interphone_NNP data_NNS ,_, but_CC in_IN some_DT studies_NNS this_DT bias_NN alone_RB can_MD result_VB in_IN a_DT more_RBR significant_JJ reduction_NN in_IN OR_NNP assessment_NN :_: 
Discarding_VBG the_DT idea_NN of_IN this_DT being_VBG due_JJ to_TO a_DT protective_JJ effect_NN from_IN head_NN tumor_NN risk_NN effected_VBN by_IN MP_NNP use_NN -LRB-_-LRB- not_RB supported_VBN by_IN experimental_JJ data_NNS -_: indeed_RB ,_, not_RB even_RB the_DT Interphone_NNP authors_NNS support_VBP it_PRP -RRB-_-RRB- ,_, the_DT only_JJ explanation_NN can_MD be_VB found_VBN from_IN a_DT strong_JJ reduction_NN in_IN the_DT assessment_NN of_IN risk_NN resulting_VBG from_IN the_DT methodological_JJ errors_NNS present_JJ in_IN the_DT Interphone_NNP protocol_NN ._. 
The_DT Interphone_NNP researchers_NNS themselves_PRP have_VBP published_VBN various_JJ studies_NNS on_IN the_DT methodological_JJ bias_NN and_CC flaws_NNS present_VBP in_IN their_PRP$ work_NN ._. 
Most_JJS of_IN the_DT errors_NNS are_VBP attributed_VBN to_TO the_DT fact_NN that_IN the_DT exposure_NN is_VBZ assessed_VBN on_IN the_DT basis_NN of_IN the_DT data_NNS self-reported_JJ by_IN participants_NNS in_IN the_DT case-control_JJ study_NN -LRB-_-LRB- ``_`` recall_NN errors_NNS ''_'' -RRB-_-RRB- :_: in_IN particular_JJ ,_, it_PRP has_VBZ been_VBN claimed_VBN that_IN the_DT increased_VBN risks_NNS reported_VBN in_IN some_DT studies_NNS -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- could_MD be_VB due_JJ to_TO cases_NNS blaming_VBG MPs_NNS as_IN the_DT cause_NN of_IN the_DT disease_NN ._. 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
Therefore_RB ,_, MP_NNP users_NNS willingly_RB elect_VBP to_TO participate_VB in_IN the_DT study_NN ,_, aware_JJ of_IN its_PRP$ goals_NNS ,_, while_IN non-users_NNS tend_VBP to_TO decline_VB ._. 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN ,_, which_WDT is_VBZ true_JJ for_IN the_DT overall_JJ Interphone_NNP data_NNS ,_, but_CC in_IN some_DT studies_NNS this_DT bias_NN alone_RB can_MD result_VB in_IN a_DT more_RBR significant_JJ reduction_NN in_IN OR_NNP assessment_NN :_: 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
On_IN this_DT basis_NN ,_, it_PRP is_VBZ small_JJ wonder_NN that_IN there_EX is_VBZ a_DT complete_JJ absence_NN of_IN increase_NN in_IN brain_NN or_CC acoustic_JJ tumor_NN risk_NN ;_: quite_RB the_DT contrary_NN :_: most_RBS OR_JJ values_NNS -LRB-_-LRB- 67-85_CD %_NN of_IN 122_CD total_JJ ORs_NNS 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
Therefore_RB ,_, MP_NNP users_NNS willingly_RB elect_VBP to_TO participate_VB in_IN the_DT study_NN ,_, aware_JJ of_IN its_PRP$ goals_NNS ,_, while_IN non-users_NNS tend_VBP to_TO decline_VB ._. 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN ,_, which_WDT is_VBZ true_JJ for_IN the_DT overall_JJ Interphone_NNP data_NNS ,_, but_CC in_IN some_DT studies_NNS this_DT bias_NN alone_RB can_MD result_VB in_IN a_DT more_RBR significant_JJ reduction_NN in_IN OR_NNP assessment_NN :_: 
the_DT low_JJ prevalence_NN of_IN long_JJ exposures_NNS or_CC latencies_NNS or_CC the_DT inadequate_JJ definition_NN of_IN cellphone_NN use_NN ._. 
g._VB In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
should_MD take_VB sponsorship_NN into_IN account_NN ''_'' ..._: According_VBG to_TO the_DT authors_NNS ``_`` this_DT study_NN indicates_VBZ that_IN the_DT interpretation_NN of_IN the_DT results_NNS from_IN existing_JJ and_CC future_JJ studies_NNS ._. 
Table_NNP 4Errors_NNP in_IN negative_JJ Interphone_NNP studies_NNS 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT case-control_JJ studies_NNS by_IN the_DT Hardell_NNP group_NN in_IN Sweden_NNP report_NN a_DT statistically_RB significant_JJ increase_NN of_IN at_IN least_JJS 100_CD %_NN in_IN risk_NN of_IN ipsilateral_JJ cerebral_JJ cancers_NNS -LRB-_-LRB- astrocytomas_NNS ,_, a_DT highly_RB invasive_JJ glioma_NN sub-type_NN -RRB-_-RRB- and_CC of_IN benign_JJ tumors_NNS of_IN the_DT acoustic_JJ nerve_NN -LRB-_-LRB- neuromas_NNS -RRB-_-RRB- among_IN MP_NNP users_NNS ,_, after_IN use_NN or_CC latency_NN period_NN 
Finally_RB ,_, the_DT increase_NN in_IN risk_NN of_IN cerebral_JJ astrocytomas_NNS and_CC acoustic_JJ neuromas_NNS ,_, in_IN particular_JJ ipsilateral_NN ,_, is_VBZ higher_JJR in_IN the_DT subgroup_NN that_WDT started_VBD using_VBG MPs_NNS at_IN an_DT age_NN 
Taking_VBG into_IN consideration_NN the_DT systematic_JJ underestimation_NN of_IN OR_NNP values_NNS in_IN the_DT Interphone_NNP studies_NNS ,_, this_DT is_VBZ a_DT clear_JJ indicator_NN of_IN probable_JJ carcinogenic_JJ risk_NN ._. 
The_DT meta-analysis_NN of_IN Ahlbom_NNP 
should_MD take_VB sponsorship_NN into_IN account_NN ''_'' ..._: According_VBG to_TO the_DT authors_NNS ``_`` this_DT study_NN indicates_VBZ that_IN the_DT interpretation_NN of_IN the_DT results_NNS from_IN existing_JJ and_CC future_JJ studies_NNS ._. 
Table_NNP 4Errors_NNP in_IN negative_JJ Interphone_NNP studies_NNS 
The_DT case-control_JJ studies_NNS by_IN the_DT Hardell_NNP group_NN in_IN Sweden_NNP report_NN a_DT statistically_RB significant_JJ increase_NN of_IN at_IN least_JJS 100_CD %_NN in_IN risk_NN of_IN ipsilateral_JJ cerebral_JJ cancers_NNS -LRB-_-LRB- astrocytomas_NNS ,_, a_DT highly_RB invasive_JJ glioma_NN sub-type_NN -RRB-_-RRB- and_CC of_IN benign_JJ tumors_NNS of_IN the_DT acoustic_JJ nerve_NN -LRB-_-LRB- neuromas_NNS -RRB-_-RRB- among_IN MP_NNP users_NNS ,_, after_IN use_NN or_CC latency_NN period_NN 
Finally_RB ,_, the_DT increase_NN in_IN risk_NN of_IN cerebral_JJ astrocytomas_NNS and_CC acoustic_JJ neuromas_NNS ,_, in_IN particular_JJ ipsilateral_NN ,_, is_VBZ higher_JJR in_IN the_DT subgroup_NN that_WDT started_VBD using_VBG MPs_NNS at_IN an_DT age_NN 
-LRB-_-LRB- Figure_NNP 1C_NNP ,_, see_VBP additional_JJ file_NN 6_CD -RRB-_-RRB- ._. 
s._RB ,_, while_IN the_DT Interphone_NNP data_NNS are_VBP largely_RB 
These_DT increases_NNS are_VBP smaller_JJR than_IN those_DT found_VBN by_IN Hardell_NNP in_IN the_DT pooled_VBN analyses_NNS of_IN his_PRP$ data_NNS alone_RB -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, being_VBG ``_`` diluted_JJ ''_'' with_IN the_DT Interphone_NNP data_NNS corresponding_JJ to_TO the_DT requirements_NNS indicated_VBD above_IN ._. 
Indeed_RB ,_, by_IN separating_VBG the_DT overall_JJ OR_NNP data_NNS of_IN these_DT meta-analyses_NNS according_VBG to_TO their_PRP$ source_NN ,_, only_RB Hardell_NNP 's_POS OR_NNP data_NNS are_VBP systematically_RB 
If_IN heterogeneity_NN was_VBD observed_VBN ,_, then_RB the_DT random-effect_NN model_NN was_VBD performed_VBN by_IN incorporating_VBG an_DT estimate_NN of_IN the_DT between-study_JJ heterogeneity_NN -LRB-_-LRB- DerSimonian_NNP and_CC Laid_NNP 
It_PRP should_MD be_VB stressed_VBN that_IN a_DT greater_JJR increase_NN in_IN ipsilateral_JJ tumors_NNS than_IN in_IN total_JJ tumors_NNS ,_, but_CC absence_NN of_IN increase_NN in_IN contralateral_JJ tumors_NNS ,_, is_VBZ precisely_RB what_WP would_MD be_VB expected_VBN in_IN the_DT case_NN of_IN MPs_NNS having_VBG oncogenic_JJ action_NN 
should_MD take_VB sponsorship_NN into_IN account_NN ''_'' ..._: According_VBG to_TO the_DT authors_NNS ``_`` this_DT study_NN indicates_VBZ that_IN the_DT interpretation_NN of_IN the_DT results_NNS from_IN existing_JJ and_CC future_JJ studies_NNS ._. 
Table_NNP 4Errors_NNP in_IN negative_JJ Interphone_NNP studies_NNS 
MPs_NNS were_VBD introduced_VBN onto_IN the_DT market_NN in_IN the_DT 1980s_CD ,_, and_CC widely_RB used_VBN for_IN the_DT following_JJ decade_NN in_IN the_DT USA_NNP ,_, the_DT Scandinavian_JJ countries_NNS and_CC Israel_NNP ._. 
Since_IN the_DT beginning_NN of_IN 1990s_CD MPs_NNS have_VBP become_VBN widespread_JJ in_IN many_JJ other_JJ countries_NNS too_RB ,_, with_IN the_DT consequence_NN that_IN there_EX has_VBZ been_VBN exposure_NN to_TO MP_NNP radiation_NN throughout_IN almost_RB the_DT entire_JJ world_NN for_IN at_IN least_JJS 20_CD years_NNS ._. 
Although_IN brain_NN and_CC cranial_JJ nerve_NN tumors_NNS may_MD have_VB very_RB long_JJ latency_NN times_NNS -LRB-_-LRB- up_IN to_TO 30_CD years_NNS or_CC more_JJR -RRB-_-RRB- ,_, it_PRP is_VBZ likely_JJ that_IN -_: as_IN found_VBN with_IN long-latency_NN tumors_NNS due_JJ to_TO ionizing_VBG radiations_NNS ,_, asbestos_NN or_CC smoking_NN -_: some_DT due_JJ to_TO MP_NNP will_MD be_VB diagnosed_VBN after_IN just_RB 10-15_CD year_NN 
Although_IN brain_NN and_CC cranial_JJ nerve_NN tumors_NNS may_MD have_VB very_RB long_JJ latency_NN times_NNS -LRB-_-LRB- up_IN to_TO 30_CD years_NNS or_CC more_JJR -RRB-_-RRB- ,_, it_PRP is_VBZ likely_JJ that_IN -_: as_IN found_VBN with_IN long-latency_NN tumors_NNS due_JJ to_TO ionizing_VBG radiations_NNS ,_, asbestos_NN or_CC smoking_NN -_: some_DT due_JJ to_TO MP_NNP will_MD be_VB diagnosed_VBN after_IN just_RB 10-15_CD years_NNS of_IN MP_NNP use_NN or_CC latency_NN ._. 
The_DT case-control_JJ studies_NNS by_IN the_DT Hardell_NNP group_NN in_IN Sweden_NNP report_NN a_DT statistically_RB significant_JJ increase_NN of_IN at_IN least_JJS 100_CD %_NN in_IN risk_NN of_IN ipsilateral_JJ cerebral_JJ cancers_NNS -LRB-_-LRB- astrocytomas_NNS ,_, a_DT highly_RB invasive_JJ glioma_NN sub-type_NN -RRB-_-RRB- and_CC of_IN benign_JJ tumors_NNS of_IN the_DT acoustic_JJ nerve_NN -LRB-_-LRB- neuromas_NNS -RRB-_-RRB- among_IN MP_NNP users_NNS ,_, after_IN use_NN or_CC latency_NN period_NN 
When_WRB the_DT general_JJ fixed_JJ effect_NN model_NN was_VBD applied_VBN to_TO each_DT study_NN estimate_NN ,_, a_DT weight_NN directly_RB proportional_JJ to_TO its_PRP$ precision_NN was_VBD given_VBN -LRB-_-LRB- inverse_JJ variance-weighted_JJ method_NN -RRB-_-RRB- 
2-16_CD ._. 
7;_CD 0_CD ._. 
9-LRB-_CD 1\/6_CD -RRB-_-RRB- :_: 1_CD ._. 
1-5_CD ._. 
7;_CD 0_CD ._. 
0_CD 
It_PRP should_MD be_VB stressed_VBN that_IN a_DT greater_JJR increase_NN in_IN ipsilateral_JJ tumors_NNS than_IN in_IN total_JJ tumors_NNS ,_, but_CC absence_NN of_IN increase_NN in_IN contralateral_JJ tumors_NNS ,_, is_VBZ precisely_RB what_WP would_MD be_VB expected_VBN in_IN the_DT case_NN of_IN MPs_NNS having_VBG oncogenic_JJ action_NN 
Therefore_RB ,_, if_IN a_DT risk_NN exists_VBZ ,_, it_PRP is_VBZ ``_`` diluted_JJ ''_'' because_IN of_IN the_DT dominance_NN ,_, in_IN the_DT examined_VBN sample_NN ,_, of_IN subjects_NNS exposed_VBN too_RB little_JJ :_: the_DT average_JJ daily_JJ use_NN of_IN MPs_NNS in_IN subjects_NNS considered_VBN ``_`` exposed_VBN ''_'' by_IN Interphone_NNP is_VBZ just_RB 2-5_CD minutes_NNS per_IN day_NN ,_, very_RB scarcely_RB representative_JJ of_IN the_DT intensive_JJ use_NN made_VBN of_IN cellphones_NNS today_NN ;_: 
Finally_RB ,_, an_DT editorial_NN by_IN Cardis_NNP ,_, former_JJ Interphone_NNP coordinator_NN ,_, and_CC by_IN Sadetzki_NNP -_: also_RB under_IN a_DT highly_RB significant_JJ title_NN ``_`` Indications_NNS of_IN possible_JJ brain-tumour_JJ risk_NN in_IN mobilie-phone_JJ studies_NNS :_: should_MD we_PRP be_VB concerned_VBN ._. ''_'' 
s._VB It_PRP must_MD be_VB noticed_VBN that_IN the_DT s._NN On_IN the_DT contrary_NN ,_, studies_NNS producing_VBG positive_JJ results_NNS -_: without_IN errors_NNS and_CC financial_JJ conditioning_NN -_: indicate_VBP a_DT cause\/effect_NN relationship_NN supported_VBN by_IN biological_JJ plausibility_NN ._. 
increase_NN in_IN malignant_JJ brain_NN tumor_NN risk_NN repeatedly_RB reported_VBN by_IN Hardell_NNP among_IN long-term_JJ MP_NNP users_NNS 
should_MD take_VB sponsorship_NN into_IN account_NN ''_'' ..._: According_VBG to_TO the_DT authors_NNS ``_`` this_DT study_NN indicates_VBZ that_IN the_DT interpretation_NN of_IN the_DT results_NNS from_IN existing_JJ and_CC future_JJ studies_NNS ._. 
Table_NNP 4Errors_NNP in_IN negative_JJ Interphone_NNP studies_NNS 
Finally_RB ,_, an_DT editorial_NN by_IN Cardis_NNP ,_, former_JJ Interphone_NNP coordinator_NN ,_, and_CC by_IN Sadetzki_NNP -_: also_RB under_IN a_DT highly_RB significant_JJ title_NN ``_`` Indications_NNS of_IN possible_JJ brain-tumour_JJ risk_NN in_IN mobilie-phone_JJ studies_NNS :_: should_MD we_PRP be_VB concerned_VBN ._. ''_'' 
MPs_NNS were_VBD introduced_VBN onto_IN the_DT market_NN in_IN the_DT 1980s_CD ,_, and_CC widely_RB used_VBN for_IN the_DT following_JJ decade_NN in_IN the_DT USA_NNP ,_, the_DT Scandinavian_JJ countries_NNS and_CC Israel_NNP ._. 
Since_IN the_DT beginning_NN of_IN 1990s_CD MPs_NNS have_VBP become_VBN widespread_JJ in_IN many_JJ other_JJ countries_NNS too_RB ,_, with_IN the_DT consequence_NN that_IN there_EX has_VBZ been_VBN exposure_NN to_TO MP_NNP radiation_NN throughout_IN almost_RB the_DT entire_JJ world_NN for_IN at_IN least_JJS 20_CD years_NNS ._. 
Although_IN brain_NN and_CC cranial_JJ nerve_NN tumors_NNS may_MD have_VB very_RB long_JJ latency_NN times_NNS -LRB-_-LRB- up_IN to_TO 30_CD years_NNS or_CC more_JJR -RRB-_-RRB- ,_, it_PRP is_VBZ likely_JJ that_IN -_: as_IN found_VBN with_IN long-latency_NN tumors_NNS due_JJ to_TO ionizing_VBG radiations_NNS ,_, asbestos_NN or_CC smoking_NN -_: some_DT due_JJ to_TO MP_NNP will_MD be_VB diagnosed_VBN after_IN just_RB 10-15_CD years_NNS of_IN MP_NNP use_NN or_CC latency_NN ._. 
Although_IN brain_NN and_CC cranial_JJ nerve_NN tumors_NNS may_MD have_VB very_RB long_JJ latency_NN times_NNS -LRB-_-LRB- up_IN to_TO 30_CD years_NNS or_CC more_JJR -RRB-_-RRB- ,_, it_PRP is_VBZ likely_JJ that_IN -_: as_IN found_VBN with_IN long-latency_NN tumors_NNS due_JJ to_TO ionizing_VBG radiations_NNS ,_, asbestos_NN or_CC smoking_NN -_: some_DT due_JJ to_TO MP_NNP will_MD be_VB diagnosed_VBN after_IN just_RB 10-15_CD years_NNS of_IN MP_NNP use_NN or_CC latency_NN ._. 
The_DT case-control_JJ studies_NNS by_IN the_DT Hardell_NNP group_NN in_IN Sweden_NNP report_NN a_DT statistically_RB significant_JJ increase_NN of_IN at_IN least_JJS 100_CD %_NN in_IN risk_NN of_IN ipsilateral_JJ cerebral_JJ cancers_NNS -LRB-_-LRB- astrocytomas_NNS ,_, a_DT highly_RB invasive_JJ glioma_NN sub-type_NN -RRB-_-RRB- and_CC of_IN benign_JJ tumors_NNS of_IN the_DT acoustic_JJ nerve_NN -LRB-_-LRB- neuromas_NNS -RRB-_-RRB- among_IN MP_NNP users_NNS ,_, after_IN use_NN or_CC latency_NN period_NN 
When_WRB the_DT general_JJ fixed_JJ effect_NN model_NN was_VBD applied_VBN to_TO each_DT study_NN estimate_NN ,_, a_DT weight_NN directly_RB proportional_JJ to_TO its_PRP$ precision_NN was_VBD given_VBN -LRB-_-LRB- inverse_JJ variance-weighted_JJ method_NN -RRB-_-RRB- 
3-2_CD ._. 
0;_CD 0_CD ._. 
0-LRB-_CD 4\/45_CD -RRB-_-RRB- :_: 1_CD ._. 
1-5_CD ._. 
6;_CD 0_CD ._. 
7-LRB-_CD 1\/18_CD -RRB-_-RRB- :_: 0_CD ._. 
7-5_CD ._. 
1;_CD 1_CD ._. 
8acoustic_JJ neuromas_NNS -LRB-_-LRB- 19\/84_CD -RRB-_-RRB- :_: 3_CD ._. 
9-2_CD ._. 
6;_CD 0_CD ._. 
9Idem_NNP ,_, but_CC also_RB as_IN a_DT function_NN of_IN head_NN tumor_NN laterality_NN -LRB-_-LRB- 
5-2_CD ._. 
1;_CD 0_CD ._. 
2-LRB-_CD 7\/20_CD -RRB-_-RRB- :_: 1_CD ._. 
3-7_CD ._. 
0;_CD 1_CD ._. 
2-LRB-_CD 11\/15_CD -RRB-_-RRB- :_: 3_CD ._. 
01-3_CD ._. 
8;_CD 1_CD ._. 
3_CD 
2-16_CD ._. 
7;_CD 0_CD ._. 
9-LRB-_CD 1\/6_CD -RRB-_-RRB- :_: 1_CD ._. 
1-5_CD ._. 
7;_CD 0_CD ._. 
0_CD 
It_PRP should_MD be_VB stressed_VBN that_IN a_DT greater_JJR increase_NN in_IN ipsilateral_JJ tumors_NNS than_IN in_IN total_JJ tumors_NNS ,_, but_CC absence_NN of_IN increase_NN in_IN contralateral_JJ tumors_NNS ,_, is_VBZ precisely_RB what_WP would_MD be_VB expected_VBN in_IN the_DT case_NN of_IN MPs_NNS having_VBG oncogenic_JJ action_NN 
risk_NN increase_NN is_VBZ found_VBN and_CC the_DT distribution_NN of_IN OR_NNP values_NNS is_VBZ shifted_VBN towards_IN values_NNS 
s._NN In_IN the_DT Hardell_NNP group_NN studies_VBZ a_DT dose\/response_JJ relationship_NN and_CC thus_RB the_DT existence_NN of_IN a_DT cause-effect_JJ relationship_NN are_VBP documented_VBN by_IN the_DT fact_NN that_IN :_: 
Therefore_RB ,_, if_IN a_DT risk_NN exists_VBZ ,_, it_PRP is_VBZ ``_`` diluted_JJ ''_'' because_IN of_IN the_DT dominance_NN ,_, in_IN the_DT examined_VBN sample_NN ,_, of_IN subjects_NNS exposed_VBN too_RB little_JJ :_: the_DT average_JJ daily_JJ use_NN of_IN MPs_NNS in_IN subjects_NNS considered_VBN ``_`` exposed_VBN ''_'' by_IN Interphone_NNP is_VBZ just_RB 2-5_CD minutes_NNS per_IN day_NN ,_, very_RB scarcely_RB representative_JJ of_IN the_DT intensive_JJ use_NN made_VBN of_IN cellphones_NNS today_NN ;_: 
s._VB It_PRP must_MD be_VB noticed_VBN that_IN the_DT s._NN On_IN the_DT contrary_NN ,_, studies_NNS producing_VBG positive_JJ results_NNS -_: without_IN errors_NNS and_CC financial_JJ conditioning_NN -_: indicate_VBP a_DT cause\/effect_NN relationship_NN supported_VBN by_IN biological_JJ plausibility_NN ._. 
increase_NN in_IN malignant_JJ brain_NN tumor_NN risk_NN repeatedly_RB reported_VBN by_IN Hardell_NNP among_IN long-term_JJ MP_NNP users_NNS 
should_MD take_VB sponsorship_NN into_IN account_NN ''_'' ..._: According_VBG to_TO the_DT authors_NNS ``_`` this_DT study_NN indicates_VBZ that_IN the_DT interpretation_NN of_IN the_DT results_NNS from_IN existing_JJ and_CC future_JJ studies_NNS ._. 
Table_NNP 4Errors_NNP in_IN negative_JJ Interphone_NNP studies_NNS 
The_DT meta-analysis_NN of_IN Ahlbom_NNP 
s-LRB-_NNS see_VBP additional_JJ file_NN 7_CD -RRB-_-RRB- ._. 
for_IN the_DT Interphone_NNP data_NNS ,_, and_CC an_DT equal_JJ split_NN of_IN values_NNS 
The_DT same_JJ pattern_NN is_VBZ shown_VBN by_IN Lahkola_NNP meta-analysis_NN 
Therefore_RB ,_, if_IN a_DT risk_NN exists_VBZ ,_, it_PRP is_VBZ ``_`` diluted_JJ ''_'' because_IN of_IN the_DT dominance_NN ,_, in_IN the_DT examined_VBN sample_NN ,_, of_IN subjects_NNS exposed_VBN too_RB little_JJ :_: the_DT average_JJ daily_JJ use_NN of_IN MPs_NNS in_IN subjects_NNS considered_VBN ``_`` exposed_VBN ''_'' by_IN Interphone_NNP is_VBZ just_RB 2-5_CD minutes_NNS per_IN day_NN ,_, very_RB scarcely_RB representative_JJ of_IN the_DT intensive_JJ use_NN made_VBN of_IN cellphones_NNS today_NN ;_: 
s-LRB-_NNS see_VBP additional_JJ file_NN 7_CD -RRB-_-RRB- ._. 
for_IN the_DT Interphone_NNP data_NNS ,_, and_CC an_DT equal_JJ split_NN of_IN values_NNS 
The_DT same_JJ pattern_NN is_VBZ shown_VBN by_IN Lahkola_NNP meta-analysis_NN 
It_PRP should_MD be_VB noticed_VBN that_IN many_JJ studies_NNS on_IN biological_JJ effects_NNS of_IN MP_NNP use_NN are_VBP negative_JJ ,_, but_CC for_IN the_DT major_JJ part_NN were_VBD conditioned_VBN having_VBG been_VBN funded_VBN by_IN the_DT cell-phone_NN industry_NN -LRB-_-LRB- see_VB Discussion_NNP -RRB-_-RRB- ._. 
MPs_NNS and_CC head_NN tumors_NNS :_: negative_JJ dataBetween_NNP 2000_CD and_CC 2002_CD three_CD case-control_JJ studies_NNS were_VBD published_VBN -_: two_CD were_VBD funded_VBN by_IN MP_NNP companies_NNS 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
Therefore_RB ,_, MP_NNP users_NNS willingly_RB elect_VBP to_TO participate_VB in_IN the_DT study_NN ,_, aware_JJ of_IN its_PRP$ goals_NNS ,_, while_IN non-users_NNS tend_VBP to_TO decline_VB ._. 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN ,_, which_WDT is_VBZ true_JJ for_IN the_DT overall_JJ Interphone_NNP data_NNS ,_, but_CC in_IN some_DT studies_NNS this_DT bias_NN alone_RB can_MD result_VB in_IN a_DT more_RBR significant_JJ reduction_NN in_IN OR_NNP assessment_NN :_: 
s-LRB-_NNS see_VBP additional_JJ file_NN 7_CD -RRB-_-RRB- ._. 
for_IN the_DT Interphone_NNP data_NNS ,_, and_CC an_DT equal_JJ split_NN of_IN values_NNS 
On_IN this_DT basis_NN ,_, it_PRP is_VBZ small_JJ wonder_NN that_IN there_EX is_VBZ a_DT complete_JJ absence_NN of_IN increase_NN in_IN brain_NN or_CC acoustic_JJ tumor_NN risk_NN ;_: quite_RB the_DT contrary_NN :_: most_RBS OR_JJ values_NNS -LRB-_-LRB- 67-85_CD %_NN of_IN 122_CD total_JJ ORs_NNS 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
Therefore_RB ,_, MP_NNP users_NNS willingly_RB elect_VBP to_TO participate_VB in_IN the_DT study_NN ,_, aware_JJ of_IN its_PRP$ goals_NNS ,_, while_IN non-users_NNS tend_VBP to_TO decline_VB ._. 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN ,_, which_WDT is_VBZ true_JJ for_IN the_DT overall_JJ Interphone_NNP data_NNS ,_, but_CC in_IN some_DT studies_NNS this_DT bias_NN alone_RB can_MD result_VB in_IN a_DT more_RBR significant_JJ reduction_NN in_IN OR_NNP assessment_NN :_: 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
-LRB-_-LRB- Figure_NNP 1B_NNP -RRB-_-RRB- :_: 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT above_JJ data_NNS seem_VBP to_TO indicate_VB that_IN ,_, starting_VBG from_IN 2000-2001_CD ,_, a_DT new_JJ factor_NN capable_JJ of_IN increasing_VBG the_DT risk_NN of_IN malignant_JJ head_NN tumors_NNS among_IN MP_NNP users_NNS began_VBD to_TO manifest_JJ its_PRP$ effect_NN ,_, which_WDT is_VBZ in_IN accordance_NN with_IN the_DT 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
s._JJ positive_JJ results_NNS were_VBD funded_VBN by_IN public_JJ bodies_NNS ,_, while_IN studies_NNS funded_VBN exclusively_RB by_IN industries_NNS were_VBD seven_CD fold_VBP less_RBR likely_JJ to_TO report_VB at_IN least_JJS one_CD such_JJ result_NN ,_, and_CC the_DT difference_NN between_IN the_DT two_CD sets_NNS of_IN data_NNS was_VBD highly_RB s._JJ ._. 
According_VBG to_TO the_DT authors_NNS ``_`` this_DT study_NN indicates_VBZ that_IN the_DT interpretation_NN of_IN the_DT results_NNS from_IN existing_JJ and_CC future_JJ studies_NNS ._. 
It_PRP should_MD be_VB noticed_VBN that_IN many_JJ studies_NNS on_IN biological_JJ effects_NNS of_IN MP_NNP use_NN are_VBP negative_JJ ,_, but_CC for_IN the_DT major_JJ part_NN were_VBD conditioned_VBN having_VBG been_VBN funded_VBN by_IN the_DT cell-phone_NN industry_NN -LRB-_-LRB- see_VB Discussion_NNP -RRB-_-RRB- ._. 
MPs_NNS and_CC head_NN tumors_NNS :_: negative_JJ dataBetween_NNP 2000_CD and_CC 2002_CD three_CD case-control_JJ studies_NNS were_VBD published_VBN -_: two_CD were_VBD funded_VBN by_IN MP_NNP companies_NNS 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
Therefore_RB ,_, MP_NNP users_NNS willingly_RB elect_VBP to_TO participate_VB in_IN the_DT study_NN ,_, aware_JJ of_IN its_PRP$ goals_NNS ,_, while_IN non-users_NNS tend_VBP to_TO decline_VB ._. 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN ,_, which_WDT is_VBZ true_JJ for_IN the_DT overall_JJ Interphone_NNP data_NNS ,_, but_CC in_IN some_DT studies_NNS this_DT bias_NN alone_RB can_MD result_VB in_IN a_DT more_RBR significant_JJ reduction_NN in_IN OR_NNP assessment_NN :_: 
the_DT low_JJ prevalence_NN of_IN long_JJ exposures_NNS or_CC latencies_NNS or_CC the_DT inadequate_JJ definition_NN of_IN cellphone_NN use_NN ._. 
g._VB In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
-LRB-_-LRB- Figure_NNP 1B_NNP -RRB-_-RRB- :_: 
Taking_VBG into_IN consideration_NN the_DT systematic_JJ underestimation_NN of_IN OR_NNP values_NNS in_IN the_DT Interphone_NNP studies_NNS ,_, this_DT is_VBZ a_DT clear_JJ indicator_NN of_IN probable_JJ carcinogenic_JJ risk_NN ._. 
The_DT meta-analysis_NN of_IN Ahlbom_NNP 
s-LRB-_NNS see_VBP additional_JJ file_NN 7_CD -RRB-_-RRB- ._. 
for_IN the_DT Interphone_NNP data_NNS ,_, and_CC an_DT equal_JJ split_NN of_IN values_NNS 
should_MD take_VB sponsorship_NN into_IN account_NN ''_'' ..._: According_VBG to_TO the_DT authors_NNS ``_`` this_DT study_NN indicates_VBZ that_IN the_DT interpretation_NN of_IN the_DT results_NNS from_IN existing_JJ and_CC future_JJ studies_NNS ._. 
Table_NNP 4Errors_NNP in_IN negative_JJ Interphone_NNP studies_NNS 
These_DT additional_JJ funds_NNS are_VBP not_RB specified_VBN in_IN the_DT Interphone_NNP protocol_NN 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
It_PRP should_MD be_VB noticed_VBN that_IN many_JJ studies_NNS on_IN biological_JJ effects_NNS of_IN MP_NNP use_NN are_VBP negative_JJ ,_, but_CC for_IN the_DT major_JJ part_NN were_VBD conditioned_VBN having_VBG been_VBN funded_VBN by_IN the_DT cell-phone_NN industry_NN -LRB-_-LRB- see_VB Discussion_NNP -RRB-_-RRB- ._. 
MPs_NNS and_CC head_NN tumors_NNS :_: negative_JJ dataBetween_NNP 2000_CD and_CC 2002_CD three_CD case-control_JJ studies_NNS were_VBD published_VBN -_: two_CD were_VBD funded_VBN by_IN MP_NNP companies_NNS 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
Therefore_RB ,_, MP_NNP users_NNS willingly_RB elect_VBP to_TO participate_VB in_IN the_DT study_NN ,_, aware_JJ of_IN its_PRP$ goals_NNS ,_, while_IN non-users_NNS tend_VBP to_TO decline_VB ._. 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN ,_, which_WDT is_VBZ true_JJ for_IN the_DT overall_JJ Interphone_NNP data_NNS ,_, but_CC in_IN some_DT studies_NNS this_DT bias_NN alone_RB can_MD result_VB in_IN a_DT more_RBR significant_JJ reduction_NN in_IN OR_NNP assessment_NN :_: 
Taking_VBG into_IN consideration_NN the_DT systematic_JJ underestimation_NN of_IN OR_NNP values_NNS in_IN the_DT Interphone_NNP studies_NNS ,_, this_DT is_VBZ a_DT clear_JJ indicator_NN of_IN probable_JJ carcinogenic_JJ risk_NN ._. 
The_DT meta-analysis_NN of_IN Ahlbom_NNP 
These_DT additional_JJ funds_NNS are_VBP not_RB specified_VBN in_IN the_DT Interphone_NNP protocol_NN 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
The_DT biological_JJ plausibility_NN of_IN the_DT oncogenic_JJ action_NN of_IN the_DT EM_NNP radiation_NN emitted_VBN by_IN the_DT MPs_NNP is_VBZ supported_VBN by_IN a_DT considerable_JJ amount_NN of_IN experimental_JJ data_NNS ._. 
This_DT radiation_NN ,_, in_IN fact_NN ,_, can_MD produce_VB a_DT variety_NN of_IN effects_NNS able_JJ to_TO cause_VB or_CC contribute_VB to_TO the_DT neoplastic_JJ cell_NN transformation_NN :_: 
Nevertheless_RB ,_, of_IN the_DT authors_NNS of_IN the_DT above_JJ negative_JJ studies_NNS ,_, 14_CD 
Nevertheless_RB ,_, of_IN the_DT authors_NNS of_IN the_DT above_JJ negative_JJ studies_NNS ,_, 14_CD 
Also_RB the_DT European_NNP Environment_NNP Agency_NNP 
The_DT above_JJ data_NNS seem_VBP to_TO indicate_VB that_IN ,_, starting_VBG from_IN 2000-2001_CD ,_, a_DT new_JJ factor_NN capable_JJ of_IN increasing_VBG the_DT risk_NN of_IN malignant_JJ head_NN tumors_NNS among_IN MP_NNP users_NNS began_VBD to_TO manifest_JJ its_PRP$ effect_NN ,_, which_WDT is_VBZ in_IN accordance_NN with_IN the_DT 
study_NN ,_, design_NN ,_, methods_NNS negative_NN studies_VBZ positive_JJ studies_NNS Mobile_NNP phone_NN use_NN inadequate_JJ :_: 2-5_CD min\/day_NN significant_JJ :_: 16-32_CD min\/day_NN Latency_NN time_NN 
The_DT above_JJ data_NNS seem_VBP to_TO indicate_VB that_IN ,_, starting_VBG from_IN 2000-2001_CD ,_, a_DT new_JJ factor_NN capable_JJ of_IN increasing_VBG the_DT risk_NN of_IN malignant_JJ head_NN tumors_NNS among_IN MP_NNP users_NNS began_VBD to_TO manifest_JJ its_PRP$ effect_NN ,_, which_WDT is_VBZ in_IN accordance_NN with_IN the_DT 
Nevertheless_RB ,_, of_IN the_DT authors_NNS of_IN the_DT above_JJ negative_JJ studies_NNS ,_, 14_CD 
The_DT authors_NNS make_VBP the_DT following_JJ conclusion_NN :_: ``_`` We_PRP feel_VBP the_DT need_NN to_TO mention_VB the_DT funding_NN sources_NNS for_IN each_DT research_NN group_NN because_IN it_PRP is_VBZ possible_JJ that_IN these_DT may_MD have_VB influenced_VBN the_DT respective_JJ study_NN designs_NNS and_CC results_NNS ''_'' ._. 
The_DT Hardell_NNP group_NN was_VBD supported_VBN only_RB by_IN grants_NNS from_IN Public_JJ Bodies_NNS ,_, whereas_IN the_DT Interphone-related_JJ studies_NNS by_IN the_DT Quality_NNP of_IN Life_NNP and_CC Management_NNP of_IN Living_VBG Resources_NNP program_NN of_IN the_DT European_NNP Union_NNP and_CC the_DT International_NNP Union_NNP Against_IN Cancer_NNP ;_: but_CC the_DT latest_JJS received_JJ funds_NNS for_IN those_DT studies_NNS from_IN the_DT Mobile_NNP Manufacturers_NNPS Forum_NNP and_CC the_DT Global_NNP System_NNP for_IN Mobile_NNP Communication_NNP Association_NNP 
The_DT Hardell_NNP group_NN was_VBD supported_VBN only_RB by_IN grants_NNS from_IN Public_JJ Bodies_NNS ,_, whereas_IN the_DT Interphone-related_JJ studies_NNS by_IN the_DT Quality_NNP of_IN Life_NNP and_CC Management_NNP of_IN Living_VBG Resources_NNP program_NN of_IN the_DT European_NNP Union_NNP and_CC the_DT International_NNP Union_NNP Against_IN Cancer_NNP ;_: but_CC the_DT latest_JJS received_JJ funds_NNS for_IN those_DT studies_NNS from_IN the_DT Mobile_NNP Manufacturers_NNPS Forum_NNP and_CC the_DT Global_NNP System_NNP for_IN Mobile_NNP Communication_NNP Association_NNP 
In_IN addition_NN to_TO the_DT above_JJ funds_NNS ,_, several_JJ authors_NNS participating_VBG in_IN the_DT Interphone_NNP study_NN received_VBD additional_JJ funding_NN from_IN their_PRP$ national_JJ MP_NNP companies_NNS 
Nevertheless_RB ,_, of_IN the_DT authors_NNS of_IN the_DT above_JJ negative_JJ studies_NNS ,_, 14_CD 
5-2_CD ._. 
1;_CD 0_CD ._. 
2-LRB-_CD 7\/20_CD -RRB-_-RRB- :_: 1_CD ._. 
3-7_CD ._. 
0;_CD 1_CD ._. 
2-LRB-_CD 11\/15_CD -RRB-_-RRB- :_: 3_CD ._. 
01-3_CD ._. 
8;_CD 1_CD ._. 
3_CD 
s._NN In_IN the_DT Hardell_NNP group_NN studies_VBZ a_DT dose\/response_JJ relationship_NN and_CC thus_RB the_DT existence_NN of_IN a_DT cause-effect_JJ relationship_NN are_VBP documented_VBN by_IN the_DT fact_NN that_IN :_: 
;_: 
The_DT above_JJ data_NNS seem_VBP to_TO indicate_VB that_IN ,_, starting_VBG from_IN 2000-2001_CD ,_, a_DT new_JJ factor_NN capable_JJ of_IN increasing_VBG the_DT risk_NN of_IN malignant_JJ head_NN tumors_NNS among_IN MP_NNP users_NNS began_VBD to_TO manifest_JJ its_PRP$ effect_NN ,_, which_WDT is_VBZ in_IN accordance_NN with_IN the_DT 
http:\/\/www_NN ._. 
sante-radiofrequences_NNS ._. 
A10-point_JJ list_NN of_IN simple_JJ personal_JJ actions_NNS designed_VBN to_TO substantially_RB reduce_VB the_DT exposure_NN to_TO cell-phone_JJ radiation_NN was_VBD produced_VBN by_IN Viennese_NNP Medical_NNP Officers_NNP in_IN 2006_CD ,_, adopted_VBN in_IN the_DT same_JJ year_NN by_IN the_DT French_NNP Agency_NNP on_IN Radiofrequencies_NNPS 
-LRB-_-LRB- Figure_NNP 1C_NNP ,_, see_VBP additional_JJ file_NN 6_CD -RRB-_-RRB- ._. 
s._RB ,_, while_IN the_DT Interphone_NNP data_NNS are_VBP largely_RB 
These_DT increases_NNS are_VBP smaller_JJR than_IN those_DT found_VBN by_IN Hardell_NNP in_IN the_DT pooled_VBN analyses_NNS of_IN his_PRP$ data_NNS alone_RB -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, being_VBG ``_`` diluted_JJ ''_'' with_IN the_DT Interphone_NNP data_NNS corresponding_JJ to_TO the_DT requirements_NNS indicated_VBD above_IN ._. 
Indeed_RB ,_, by_IN separating_VBG the_DT overall_JJ OR_NNP data_NNS of_IN these_DT meta-analyses_NNS according_VBG to_TO their_PRP$ source_NN ,_, only_RB Hardell_NNP 's_POS OR_NNP data_NNS are_VBP systematically_RB 
s._NN In_IN the_DT Hardell_NNP group_NN studies_VBZ a_DT dose\/response_JJ relationship_NN and_CC thus_RB the_DT existence_NN of_IN a_DT cause-effect_JJ relationship_NN are_VBP documented_VBN by_IN the_DT fact_NN that_IN :_: 
,and_IN the_DT probability_NN of_IN this_DT highly_RB asymmetrical_JJ distribution_NN of_IN OR_NNP values_NNS being_VBG due_JJ to_TO chance_NN is_VBZ almost_RB zero_CD -LRB-_-LRB- Figure_NNP 1A_NNP -RRB-_-RRB- ._. 
This_DT pattern_NN indicates_VBZ that_IN the_DT results_NNS are_VBP not_RB due_JJ to_TO errors_NNS or_CC conditioning_NN in_IN the_DT protocol_NN Hardell_NNP used_VBD ,_, since_IN in_IN other_JJ reports_NNS regarding_VBG other_JJ types_NNS of_IN tumor_NN -LRB-_-LRB- salivary_JJ glands_NNS 
risk_NN increase_NN is_VBZ found_VBN ,_, nor_CC is_VBZ there_RB any_DT clear_JJ prevalence_NN of_IN OR_NNP values_NNS 
It_PRP should_MD be_VB stressed_VBN that_IN a_DT greater_JJR increase_NN in_IN ipsilateral_JJ tumors_NNS than_IN in_IN total_JJ tumors_NNS ,_, but_CC absence_NN of_IN increase_NN in_IN contralateral_JJ tumors_NNS ,_, is_VBZ precisely_RB what_WP would_MD be_VB expected_VBN in_IN the_DT case_NN of_IN MPs_NNS having_VBG oncogenic_JJ action_NN 
Therefore_RB ,_, if_IN a_DT risk_NN exists_VBZ ,_, it_PRP is_VBZ ``_`` diluted_JJ ''_'' because_IN of_IN the_DT dominance_NN ,_, in_IN the_DT examined_VBN sample_NN ,_, of_IN subjects_NNS exposed_VBN too_RB little_JJ :_: the_DT average_JJ daily_JJ use_NN of_IN MPs_NNS in_IN subjects_NNS considered_VBN ``_`` exposed_VBN ''_'' by_IN Interphone_NNP is_VBZ just_RB 2-5_CD minutes_NNS per_IN day_NN ,_, very_RB scarcely_RB representative_JJ of_IN the_DT intensive_JJ use_NN made_VBN of_IN cellphones_NNS today_NN ;_: 
Finally_RB ,_, an_DT editorial_NN by_IN Cardis_NNP ,_, former_JJ Interphone_NNP coordinator_NN ,_, and_CC by_IN Sadetzki_NNP -_: also_RB under_IN a_DT highly_RB significant_JJ title_NN ``_`` Indications_NNS of_IN possible_JJ brain-tumour_JJ risk_NN in_IN mobilie-phone_JJ studies_NNS :_: should_MD we_PRP be_VB concerned_VBN ._. ''_'' 
should_MD take_VB sponsorship_NN into_IN account_NN ''_'' ..._: According_VBG to_TO the_DT authors_NNS ``_`` this_DT study_NN indicates_VBZ that_IN the_DT interpretation_NN of_IN the_DT results_NNS from_IN existing_JJ and_CC future_JJ studies_NNS ._. 
Table_NNP 4Errors_NNP in_IN negative_JJ Interphone_NNP studies_NNS 
,and_IN the_DT probability_NN of_IN this_DT highly_RB asymmetrical_JJ distribution_NN of_IN OR_NNP values_NNS being_VBG due_JJ to_TO chance_NN is_VBZ almost_RB zero_CD -LRB-_-LRB- Figure_NNP 1A_NNP -RRB-_-RRB- ._. 
This_DT pattern_NN indicates_VBZ that_IN the_DT results_NNS are_VBP not_RB due_JJ to_TO errors_NNS or_CC conditioning_NN in_IN the_DT protocol_NN Hardell_NNP used_VBD ,_, since_IN in_IN other_JJ reports_NNS regarding_VBG other_JJ types_NNS of_IN tumor_NN -LRB-_-LRB- salivary_JJ glands_NNS 
;_: 
These_DT additional_JJ funds_NNS are_VBP not_RB specified_VBN in_IN the_DT Interphone_NNP protocol_NN 
http:\/\/www_NN ._. 
sante-radiofrequences_NNS ._. 
A10-point_JJ list_NN of_IN simple_JJ personal_JJ actions_NNS designed_VBN to_TO substantially_RB reduce_VB the_DT exposure_NN to_TO cell-phone_JJ radiation_NN was_VBD produced_VBN by_IN Viennese_NNP Medical_NNP Officers_NNP in_IN 2006_CD ,_, adopted_VBN in_IN the_DT same_JJ year_NN by_IN the_DT French_NNP Agency_NNP on_IN Radiofrequencies_NNPS 
Discarding_VBG the_DT idea_NN of_IN this_DT being_VBG due_JJ to_TO a_DT protective_JJ effect_NN from_IN head_NN tumor_NN risk_NN effected_VBN by_IN MP_NNP use_NN -LRB-_-LRB- not_RB supported_VBN by_IN experimental_JJ data_NNS -_: indeed_RB ,_, not_RB even_RB the_DT Interphone_NNP authors_NNS support_VBP it_PRP -RRB-_-RRB- ,_, the_DT only_JJ explanation_NN can_MD be_VB found_VBN from_IN a_DT strong_JJ reduction_NN in_IN the_DT assessment_NN of_IN risk_NN resulting_VBG from_IN the_DT methodological_JJ errors_NNS present_JJ in_IN the_DT Interphone_NNP protocol_NN ._. 
The_DT Interphone_NNP researchers_NNS themselves_PRP have_VBP published_VBN various_JJ studies_NNS on_IN the_DT methodological_JJ bias_NN and_CC flaws_NNS present_VBP in_IN their_PRP$ work_NN ._. 
Most_JJS of_IN the_DT errors_NNS are_VBP attributed_VBN to_TO the_DT fact_NN that_IN the_DT exposure_NN is_VBZ assessed_VBN on_IN the_DT basis_NN of_IN the_DT data_NNS self-reported_JJ by_IN participants_NNS in_IN the_DT case-control_JJ study_NN -LRB-_-LRB- ``_`` recall_NN errors_NNS ''_'' -RRB-_-RRB- :_: in_IN particular_JJ ,_, it_PRP has_VBZ been_VBN claimed_VBN that_IN the_DT increased_VBN risks_NNS reported_VBN in_IN some_DT studies_NNS -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- could_MD be_VB due_JJ to_TO cases_NNS blaming_VBG MPs_NNS as_IN the_DT cause_NN of_IN the_DT disease_NN ._. 
They_PRP may_MD ,_, however_RB ,_, be_VB informed_VBN ,_, together_RB with_IN representatives_NNS of_IN other_JJ concerned_JJ organizations_NNS such_JJ as_IN consumer_NN groups_NNS ,_, a_DT maximum_NN of_IN seven_CD days_NNS before_IN the_DT publication_NN of_IN the_DT results_NNS ,_, under_IN strict_JJ terms_NNS of_IN confidentiality_NN ''_'' ._. 
In_IN addition_NN to_TO the_DT above_JJ funds_NNS ,_, several_JJ authors_NNS participating_VBG in_IN the_DT Interphone_NNP study_NN received_VBD additional_JJ funding_NN from_IN their_PRP$ national_JJ MP_NNP companies_NNS 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
Figure_NN 5_CD Meta-analyses_NNS on_IN data_NNS on_IN acoustic_JJ neuromas_NNS after_IN 
These_DT additional_JJ funds_NNS are_VBP not_RB specified_VBN in_IN the_DT Interphone_NNP protocol_NN 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN ,_, which_WDT is_VBZ true_JJ for_IN the_DT overall_JJ Interphone_NNP data_NNS ,_, but_CC in_IN some_DT studies_NNS this_DT bias_NN alone_RB can_MD result_VB in_IN a_DT more_RBR significant_JJ reduction_NN in_IN OR_NNP assessment_NN :_: 
e._VB In_IN the_DT negative_JJ cohort_NN studies_NNS ,_, where_WRB exposure_NN is_VBZ based_VBN simply_RB on_IN the_DT fact_NN that_WDT subjects_VBZ work_NN for_IN an_DT industry_NN that_WDT produces_VBZ MPs_NNS or_CC are_VBP mobile_JJ telephony_NN company_NN subscribers_NNS -LRB-_-LRB- i._NN without_IN the_DT need_NN to_TO question_VB participants_NNS -RRB-_-RRB- ,_, and_CC where_WRB the_DT illness\/mortality_NN incidence_NN data_NNS estimate_NN is_VBZ based_VBN on_IN linkage_NN of_IN data_NNS from_IN people_NNS exposed_VBN with_IN data_NNS from_IN national_JJ tumor_NN registers_NNS ,_, there_EX is_VBZ an_DT overabundance_NN of_IN data_NNS showing_VBG a_DT reduced_JJ risk_NN of_IN those_DT exposed_VBN -_: in_IN all_DT subjects_NNS 
e._VB In_IN the_DT negative_JJ cohort_NN studies_NNS ,_, where_WRB exposure_NN is_VBZ based_VBN simply_RB on_IN the_DT fact_NN that_WDT subjects_VBZ work_NN for_IN an_DT industry_NN that_WDT produces_VBZ MPs_NNS or_CC are_VBP mobile_JJ telephony_NN company_NN subscribers_NNS -LRB-_-LRB- i._NN without_IN the_DT need_NN to_TO question_VB participants_NNS -RRB-_-RRB- ,_, and_CC where_WRB the_DT illness\/mortality_NN incidence_NN data_NNS estimate_NN is_VBZ based_VBN on_IN linkage_NN of_IN data_NNS from_IN people_NNS exposed_VBN with_IN data_NNS from_IN national_JJ tumor_NN registers_NNS ,_, there_EX is_VBZ an_DT overabundance_NN of_IN data_NNS showing_VBG a_DT reduced_JJ risk_NN of_IN those_DT exposed_VBN -_: in_IN all_DT subjects_NNS 
They_PRP may_MD ,_, however_RB ,_, be_VB informed_VBN ,_, together_RB with_IN representatives_NNS of_IN other_JJ concerned_JJ organizations_NNS such_JJ as_IN consumer_NN groups_NNS ,_, a_DT maximum_NN of_IN seven_CD days_NNS before_IN the_DT publication_NN of_IN the_DT results_NNS ,_, under_IN strict_JJ terms_NNS of_IN confidentiality_NN ''_'' ._. 
In_IN addition_NN to_TO the_DT above_JJ funds_NNS ,_, several_JJ authors_NNS participating_VBG in_IN the_DT Interphone_NNP study_NN received_VBD additional_JJ funding_NN from_IN their_PRP$ national_JJ MP_NNP companies_NNS 
-LRB-_-LRB- Figure_NNP 1C_NNP ,_, see_VBP additional_JJ file_NN 6_CD -RRB-_-RRB- ._. 
s._RB ,_, while_IN the_DT Interphone_NNP data_NNS are_VBP largely_RB 
s._RB ,_, whereas_IN Interphone_NNP data_NNS include_VBP 50-70_CD %_NN of_IN OR_NNP 
-LRB-_-LRB- Figure_NNP 1C_NNP ,_, see_VBP additional_JJ file_NN 6_CD -RRB-_-RRB- ._. 
s._RB ,_, while_IN the_DT Interphone_NNP data_NNS are_VBP largely_RB 
These_DT increases_NNS are_VBP smaller_JJR than_IN those_DT found_VBN by_IN Hardell_NNP in_IN the_DT pooled_VBN analyses_NNS of_IN his_PRP$ data_NNS alone_RB -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, being_VBG ``_`` diluted_JJ ''_'' with_IN the_DT Interphone_NNP data_NNS corresponding_JJ to_TO the_DT requirements_NNS indicated_VBD above_IN ._. 
Indeed_RB ,_, by_IN separating_VBG the_DT overall_JJ OR_NNP data_NNS of_IN these_DT meta-analyses_NNS according_VBG to_TO their_PRP$ source_NN 
s._IN 44_CD -RRB-_-RRB- 95_CD %_NN s._FW 11-3_FW ._. 
96_CD -LRB-_-LRB- 1_CD ._. 
58_CD -RRB-_-RRB- ''_'' rural_JJ areas_NNS 32\/38_CD 1_CD ._. 
67-1_CD ._. 
02_CD -LRB-_-LRB- 0_CD ._. 
14_CD -RRB-_-RRB- 
should_MD take_VB sponsorship_NN into_IN account_NN ''_'' ..._: According_VBG to_TO the_DT authors_NNS ``_`` this_DT study_NN indicates_VBZ that_IN the_DT interpretation_NN of_IN the_DT results_NNS from_IN existing_JJ and_CC future_JJ studies_NNS ._. 
Table_NNP 4Errors_NNP in_IN negative_JJ Interphone_NNP studies_NNS 
6-7_CD ._. 
4;_CD 95_CD %_NN CI_NNP =_SYM 1_CD ._. 
1-RRB-_NNP ,_, increasing_VBG with_IN cumulative_JJ number_NN of_IN lifetime_NN hours_NNS of_IN cellular_JJ use_NN and_CC being_VBG highest_JJS in_IN the_DT 
should_MD take_VB sponsorship_NN into_IN account_NN ''_'' ..._: According_VBG to_TO the_DT authors_NNS ``_`` this_DT study_NN indicates_VBZ that_IN the_DT interpretation_NN of_IN the_DT results_NNS from_IN existing_JJ and_CC future_JJ studies_NNS ._. 
Table_NNP 4Errors_NNP in_IN negative_JJ Interphone_NNP studies_NNS 
Figure_NN 5_CD Meta-analyses_NNS on_IN data_NNS on_IN acoustic_JJ neuromas_NNS after_IN 
These_DT increases_NNS are_VBP smaller_JJR than_IN those_DT found_VBN by_IN Hardell_NNP in_IN the_DT pooled_VBN analyses_NNS of_IN his_PRP$ data_NNS alone_RB -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, being_VBG ``_`` diluted_JJ ''_'' with_IN the_DT Interphone_NNP data_NNS corresponding_JJ to_TO the_DT requirements_NNS indicated_VBD above_IN ._. 
Indeed_RB ,_, by_IN separating_VBG the_DT overall_JJ OR_NNP data_NNS of_IN these_DT meta-analyses_NNS according_VBG to_TO their_PRP$ source_NN ,_, only_RB Hardell_NNP 's_POS OR_NNP data_NNS are_VBP systematically_RB 
s-LRB-_NNS see_VBP additional_JJ file_NN 7_CD -RRB-_-RRB- ._. 
for_IN the_DT Interphone_NNP data_NNS ,_, and_CC an_DT equal_JJ split_NN of_IN values_NNS 
The_DT same_JJ pattern_NN is_VBZ shown_VBN by_IN Lahkola_NNP meta-analysis_NN 
The_DT reasons_NNS underlying_VBG the_DT discrepancy_NN between_IN Hardell_NNP 's_POS positive_JJ data_NNS and_CC the_DT negative_JJ Interphone_NNP findings_NNS are_VBP seen_VBN clearly_RB by_IN close_JJ examination_NN of_IN the_DT latest_JJS articles_NNS from_IN the_DT two_CD groups_NNS ._. 
Hardell_NNP carried_VBD out_RP a_DT new_JJ meta-analysis_NN ,_, which_WDT took_VBD into_IN account_NN the_DT Interphone_NNP data_NNS as_RB well_RB as_IN his_PRP$ own_JJ :_: while_IN the_DT data_NNS overall_RB do_VBP not_RB show_VB any_DT increase_NN in_IN head_NN tumor_NN risk_NN in_IN MP_NNP users_NNS ,_, limiting_VBG the_DT meta-analysis_NN to_TO just_RB ipsilateral_JJ tumors_NNS in_IN individuals_NNS with_IN 
should_MD take_VB sponsorship_NN into_IN account_NN ''_'' ..._: According_VBG to_TO the_DT authors_NNS ``_`` this_DT study_NN indicates_VBZ that_IN the_DT interpretation_NN of_IN the_DT results_NNS from_IN existing_JJ and_CC future_JJ studies_NNS ._. 
Table_NNP 4Errors_NNP in_IN negative_JJ Interphone_NNP studies_NNS 
-LRB-_-LRB- Figure_NNP 2B_NNP ,_, see_VBP additional_JJ file_NN 9_CD -RRB-_-RRB- ._. 
s._RB ,_, this_DT is_VBZ the_DT case_NN for_IN the_DT Interphone_NNP data_NNS only_RB when_WRB the_DT analysis_NN is_VBZ limited_VBN to_TO ipsilateral_JJ tumors_NNS in_IN individuals_NNS with_IN 
This_DT should_MD rule_VB out_RP the_DT possibility_NN of_IN the_DT increase_NN in_IN risk_NN of_IN head_NN tumors_NNS in_IN high_JJ MP_NNP users_NNS ,_, and_CC indeed_RB the_DT increase_NN in_IN gliomas_NNS ,_, acoustic_JJ neuromas_NN and_CC parotid_NN gland_NN tumors_NNS reported_VBN in_IN some_DT Interphone_NNP studies_NNS -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- ,_, being_VBG due_JJ to_TO methodological_JJ bias_NN and_CC confounding_JJ factors_NNS ._. 
The_DT conclusive_JJ report_NN from_IN Interphone_NNP 
Our_PRP$ analyses_NNS strongly_RB reduces_VBZ the_DT uncertainty_NN of_IN the_DT response_NN to_TO the_DT quoted_VBN question_NN :_: ``_`` better_RB not_RB ''_'' ._. 
And_CC indeed_RB ,_, even_RB some_DT Interphone_NNP authors_NNS have_VBP expressed_VBN disagreement_NN with_IN the_DT reassuring_JJ interpretation_NN of_IN the_DT Interphone_NNP results_NNS ,_, which_WDT essentially_RB indicates_VBZ a_DT lack_NN of_IN cause_NN for_IN alarm_NN 
should_MD take_VB sponsorship_NN into_IN account_NN ''_'' ..._: According_VBG to_TO the_DT authors_NNS ``_`` this_DT study_NN indicates_VBZ that_IN the_DT interpretation_NN of_IN the_DT results_NNS from_IN existing_JJ and_CC future_JJ studies_NNS ._. 
Table_NNP 4Errors_NNP in_IN negative_JJ Interphone_NNP studies_NNS 
This_DT should_MD rule_VB out_RP the_DT possibility_NN of_IN the_DT increase_NN in_IN risk_NN of_IN head_NN tumors_NNS in_IN high_JJ MP_NNP users_NNS ,_, and_CC indeed_RB the_DT increase_NN in_IN gliomas_NNS ,_, acoustic_JJ neuromas_NN and_CC parotid_NN gland_NN tumors_NNS reported_VBN in_IN some_DT Interphone_NNP studies_NNS -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- ,_, being_VBG due_JJ to_TO methodological_JJ bias_NN and_CC confounding_JJ factors_NNS ._. 
The_DT conclusive_JJ report_NN from_IN Interphone_NNP 
And_CC indeed_RB ,_, even_RB some_DT Interphone_NNP authors_NNS have_VBP expressed_VBN disagreement_NN with_IN the_DT reassuring_JJ interpretation_NN of_IN the_DT Interphone_NNP results_NNS ,_, which_WDT essentially_RB indicates_VBZ a_DT lack_NN of_IN cause_NN for_IN alarm_NN 
Finally_RB ,_, an_DT editorial_NN by_IN Cardis_NNP ,_, former_JJ Interphone_NNP coordinator_NN ,_, and_CC by_IN Sadetzki_NNP -_: also_RB under_IN a_DT highly_RB significant_JJ title_NN ``_`` Indications_NNS of_IN possible_JJ brain-tumour_JJ risk_NN in_IN mobilie-phone_JJ studies_NNS :_: should_MD we_PRP be_VB concerned_VBN ._. ''_'' 
The_DT authors_NNS conclude_VBP that_IN ``_`` the_DT overall_JJ balance_NN of_IN the_DT aboved-mentioned_JJ arguments_NNS suggests_VBZ the_DT existence_NN of_IN a_DT possible_JJ association_NN ''_'' between_IN MP_NNP exposure_NN and_CC increased_VBN head_NN tumor_NN risk_NN ._. 
DiscussionPrevious_JJ studies_NNS identified_VBD a_DT number_NN of_IN study_NN design_NN flaws_NNS and_CC bias_NN that_WDT give_VBP rise_NN to_TO underestimation_NN of_IN the_DT real_JJ risk_NN in_IN epidemiological_JJ studies_NNS ,_, particularly_RB in_IN those_DT funded_VBN by_IN industries_NNS ._. 
The_DT present_JJ paper_NN ,_, which_WDT concerns_VBZ one_CD of_IN the_DT most_RBS presently_RB controversial_JJ debate_NN -_: the_DT possible_JJ relationship_NN between_IN MP_NNP use_NN and_CC increased_VBN risk_NN of_IN head_NN tumors_NNS -_: shows_VBZ that_IN the_DT negative_JJ results_NNS produced_VBN by_IN studies_NNS funded_VBN by_IN the_DT cell-phone_NN companies_NNS are_VBP affected_VBN by_IN many_JJ biases_NNS and_CC flaws_NNS ,_, giving_VBG rise_NN to_TO a_DT systematic_JJ underestimate_NN of_IN the_DT risk_NN ._. 
The_DT authors_NNS conclude_VBP that_IN ``_`` the_DT overall_JJ balance_NN of_IN the_DT aboved-mentioned_JJ arguments_NNS suggests_VBZ the_DT existence_NN of_IN a_DT possible_JJ association_NN ''_'' between_IN MP_NNP exposure_NN and_CC increased_VBN head_NN tumor_NN risk_NN ._. 
DiscussionPrevious_JJ studies_NNS identified_VBD a_DT number_NN of_IN study_NN design_NN flaws_NNS and_CC bias_NN that_WDT give_VBP rise_NN to_TO underestimation_NN of_IN the_DT real_JJ risk_NN in_IN epidemiological_JJ studies_NNS ,_, particularly_RB in_IN those_DT funded_VBN by_IN industries_NNS ._. 
The_DT present_JJ paper_NN ,_, which_WDT concerns_VBZ one_CD of_IN the_DT most_RBS presently_RB controversial_JJ debate_NN -_: the_DT possible_JJ relationship_NN between_IN MP_NNP use_NN and_CC increased_VBN risk_NN of_IN head_NN tumors_NNS -_: shows_VBZ that_IN the_DT negative_JJ results_NNS produced_VBN by_IN studies_NNS funded_VBN by_IN the_DT cell-phone_NN companies_NNS are_VBP affected_VBN by_IN many_JJ biases_NNS and_CC flaws_NNS ,_, giving_VBG rise_NN to_TO a_DT systematic_JJ underestimate_NN of_IN the_DT risk_NN ._. 
s._VB It_PRP must_MD be_VB noticed_VBN that_IN the_DT s._NN On_IN the_DT contrary_NN ,_, studies_NNS producing_VBG positive_JJ results_NNS -_: without_IN errors_NNS and_CC financial_JJ conditioning_NN -_: indicate_VBP a_DT cause\/effect_NN relationship_NN supported_VBN by_IN biological_JJ plausibility_NN ._. 
increase_NN in_IN malignant_JJ brain_NN tumor_NN risk_NN repeatedly_RB reported_VBN by_IN Hardell_NNP among_IN long-term_JJ MP_NNP users_NNS 
The_DT above_JJ data_NNS seem_VBP to_TO indicate_VB that_IN ,_, starting_VBG from_IN 2000-2001_CD ,_, a_DT new_JJ factor_NN capable_JJ of_IN increasing_VBG the_DT risk_NN of_IN malignant_JJ head_NN tumors_NNS among_IN MP_NNP users_NNS began_VBD to_TO manifest_JJ its_PRP$ effect_NN ,_, which_WDT is_VBZ in_IN accordance_NN with_IN the_DT 
should_MD take_VB sponsorship_NN into_IN account_NN ''_'' ..._: According_VBG to_TO the_DT authors_NNS ``_`` this_DT study_NN indicates_VBZ that_IN the_DT interpretation_NN of_IN the_DT results_NNS from_IN existing_JJ and_CC future_JJ studies_NNS ._. 
Table_NNP 4Errors_NNP in_IN negative_JJ Interphone_NNP studies_NNS 
s._NN In_IN addition_NN ,_, the_DT s._NN 10_CD -RRB-_-RRB- ._. 
25_CD to_TO 4_CD ._. 
16_CD ;_: 95_CD %_NN CI_NNP =_SYM +_CD 0_CD ._. 
in_IN the_DT age_NN group_NN 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
Therefore_RB ,_, MP_NNP users_NNS willingly_RB elect_VBP to_TO participate_VB in_IN the_DT study_NN ,_, aware_JJ of_IN its_PRP$ goals_NNS ,_, while_IN non-users_NNS tend_VBP to_TO decline_VB ._. 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN ,_, which_WDT is_VBZ true_JJ for_IN the_DT overall_JJ Interphone_NNP data_NNS ,_, but_CC in_IN some_DT studies_NNS this_DT bias_NN alone_RB can_MD result_VB in_IN a_DT more_RBR significant_JJ reduction_NN in_IN OR_NNP assessment_NN :_: 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN o_NN 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
Therefore_RB ,_, MP_NNP users_NNS willingly_RB elect_VBP to_TO participate_VB in_IN the_DT study_NN ,_, aware_JJ of_IN its_PRP$ goals_NNS ,_, while_IN non-users_NNS tend_VBP to_TO decline_VB ._. 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN ,_, which_WDT is_VBZ true_JJ for_IN the_DT overall_JJ Interphone_NNP data_NNS ,_, but_CC in_IN some_DT studies_NNS this_DT bias_NN alone_RB can_MD result_VB in_IN a_DT more_RBR significant_JJ reduction_NN in_IN OR_NNP assessment_NN :_: 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
Discarding_VBG the_DT idea_NN of_IN this_DT being_VBG due_JJ to_TO a_DT protective_JJ effect_NN from_IN head_NN tumor_NN risk_NN effected_VBN by_IN MP_NNP use_NN -LRB-_-LRB- not_RB supported_VBN by_IN experimental_JJ data_NNS -_: indeed_RB ,_, not_RB even_RB the_DT Interphone_NNP authors_NNS support_VBP it_PRP -RRB-_-RRB- ,_, the_DT only_JJ explanation_NN can_MD be_VB found_VBN from_IN a_DT strong_JJ reduction_NN in_IN the_DT assessment_NN of_IN risk_NN resulting_VBG from_IN the_DT methodological_JJ errors_NNS present_JJ in_IN the_DT Interphone_NNP protocol_NN ._. 
The_DT Interphone_NNP researchers_NNS themselves_PRP have_VBP published_VBN various_JJ studies_NNS on_IN the_DT methodological_JJ bias_NN and_CC flaws_NNS present_VBP in_IN their_PRP$ work_NN ._. 
Most_JJS of_IN the_DT errors_NNS are_VBP attributed_VBN to_TO the_DT fact_NN that_IN the_DT exposure_NN is_VBZ assessed_VBN on_IN the_DT basis_NN of_IN the_DT data_NNS self-reported_JJ by_IN participants_NNS in_IN the_DT case-control_JJ study_NN -LRB-_-LRB- ``_`` recall_NN errors_NNS ''_'' -RRB-_-RRB- :_: in_IN particular_JJ ,_, it_PRP has_VBZ been_VBN claimed_VBN that_IN the_DT increased_VBN risks_NNS reported_VBN in_IN some_DT studies_NNS -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- could_MD be_VB due_JJ to_TO cases_NNS blaming_VBG MPs_NNS as_IN the_DT cause_NN of_IN the_DT disease_NN ._. 
They_PRP may_MD ,_, however_RB ,_, be_VB informed_VBN ,_, together_RB with_IN representatives_NNS of_IN other_JJ concerned_JJ organizations_NNS such_JJ as_IN consumer_NN groups_NNS ,_, a_DT maximum_NN of_IN seven_CD days_NNS before_IN the_DT publication_NN of_IN the_DT results_NNS ,_, under_IN strict_JJ terms_NNS of_IN confidentiality_NN ''_'' ._. 
In_IN addition_NN to_TO the_DT above_JJ funds_NNS ,_, several_JJ authors_NNS participating_VBG in_IN the_DT Interphone_NNP study_NN received_VBD additional_JJ funding_NN from_IN their_PRP$ national_JJ MP_NNP companies_NNS 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
They_PRP may_MD ,_, however_RB ,_, be_VB informed_VBN ,_, together_RB with_IN representatives_NNS of_IN other_JJ concerned_JJ organizations_NNS such_JJ as_IN consumer_NN groups_NNS ,_, a_DT maximum_NN of_IN seven_CD days_NNS before_IN the_DT publication_NN of_IN the_DT results_NNS ,_, under_IN strict_JJ terms_NNS of_IN confidentiality_NN ''_'' ._. 
In_IN addition_NN to_TO the_DT above_JJ funds_NNS ,_, several_JJ authors_NNS participating_VBG in_IN the_DT Interphone_NNP study_NN received_VBD additional_JJ funding_NN from_IN their_PRP$ national_JJ MP_NNP companies_NNS 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
-LRB-_-LRB- Figure_NNP 1C_NNP ,_, see_VBP additional_JJ file_NN 6_CD -RRB-_-RRB- ._. 
s._RB ,_, while_IN the_DT Interphone_NNP data_NNS are_VBP largely_RB 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
Therefore_RB ,_, MP_NNP users_NNS willingly_RB elect_VBP to_TO participate_VB in_IN the_DT study_NN ,_, aware_JJ of_IN its_PRP$ goals_NNS ,_, while_IN non-users_NNS tend_VBP to_TO decline_VB ._. 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
s-LRB-_NNS see_VBP additional_JJ file_NN 7_CD -RRB-_-RRB- ._. 
for_IN the_DT Interphone_NNP data_NNS ,_, and_CC an_DT equal_JJ split_NN of_IN values_NNS 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
-LRB-_-LRB- Figure_NNP 1C_NNP ,_, see_VBP additional_JJ file_NN 6_CD -RRB-_-RRB- ._. 
s._RB ,_, while_IN the_DT Interphone_NNP data_NNS are_VBP largely_RB 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
-LRB-_-LRB- Figure_NNP 1C_NNP ,_, see_VBP additional_JJ file_NN 6_CD -RRB-_-RRB- ._. 
s._RB ,_, while_IN the_DT Interphone_NNP data_NNS are_VBP largely_RB 
s-LRB-_NNS see_VBP additional_JJ file_NN 7_CD -RRB-_-RRB- ._. 
for_IN the_DT Interphone_NNP data_NNS ,_, and_CC an_DT equal_JJ split_NN of_IN values_NNS 
They_PRP may_MD ,_, however_RB ,_, be_VB informed_VBN ,_, together_RB with_IN representatives_NNS of_IN other_JJ concerned_JJ organizations_NNS such_JJ as_IN consumer_NN groups_NNS ,_, a_DT maximum_NN of_IN seven_CD days_NNS before_IN the_DT publication_NN of_IN the_DT results_NNS ,_, under_IN strict_JJ terms_NNS of_IN confidentiality_NN ''_'' ._. 
In_IN addition_NN to_TO the_DT above_JJ funds_NNS ,_, several_JJ authors_NNS participating_VBG in_IN the_DT Interphone_NNP study_NN received_VBD additional_JJ funding_NN from_IN their_PRP$ national_JJ MP_NNP companies_NNS 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
Therefore_RB ,_, MP_NNP users_NNS willingly_RB elect_VBP to_TO participate_VB in_IN the_DT study_NN ,_, aware_JJ of_IN its_PRP$ goals_NNS ,_, while_IN non-users_NNS tend_VBP to_TO decline_VB ._. 
This_DT ``_`` selection_NN bias_NN ''_'' is_VBZ recognized_VBN by_IN the_DT Interphone_NNP authors_NNS themselves_PRP ,_, but_CC in_IN their_PRP$ view_NN it_PRP does_VBZ not_RB cause_VB reduction_NN in_IN OR_NNP of_IN more_JJR than_IN 10_CD %_NN ,_, which_WDT is_VBZ true_JJ for_IN the_DT overall_JJ Interphone_NNP data_NNS ,_, but_CC in_IN some_DT studies_NNS this_DT bias_NN alone_RB can_MD result_VB in_IN a_DT more_RBR significant_JJ reduction_NN in_IN OR_NNP assessment_NN :_: 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
They_PRP may_MD ,_, however_RB ,_, be_VB informed_VBN ,_, together_RB with_IN representatives_NNS of_IN other_JJ concerned_JJ organizations_NNS such_JJ as_IN consumer_NN groups_NNS ,_, a_DT maximum_NN of_IN seven_CD days_NNS before_IN the_DT publication_NN of_IN the_DT results_NNS ,_, under_IN strict_JJ terms_NNS of_IN confidentiality_NN ''_'' ._. 
In_IN addition_NN to_TO the_DT above_JJ funds_NNS ,_, several_JJ authors_NNS participating_VBG in_IN the_DT Interphone_NNP study_NN received_VBD additional_JJ funding_NN from_IN their_PRP$ national_JJ MP_NNP companies_NNS 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
However_RB ,_, examination_NN of_IN all_PDT the_DT above_JJ ``_`` negative_JJ ''_'' studies_NNS shows_VBZ that_IN there_EX are_VBP bias_NN ,_, confounding_JJ factors_NNS ,_, and_CC errors_NNS in_IN the_DT methodological_JJ approach_NN and_CC the_DT data_NNS processing_NN and_CC presentation_NN ._. 
These_DT factors_NNS include_VBP -LRB-_-LRB- see_VB additional_JJ file_NN 3_CD -RRB-_-RRB- :_: 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
s._NN In_IN the_DT negative_JJ case-control_JJ studies_NNS the_DT combination_NN of_IN all_PDT the_DT above_JJ factors_NNS leads_VBZ to_TO strong_JJ underestimation_NN of_IN the_DT risk_NN ,_, and_CC together_RB act_VB such_JJ that_IN the_DT majority_NN of_IN OR_NNP values_NNS are_VBP 
-LRB-_-LRB- Figure_NNP 1B_NNP -RRB-_-RRB- :_: 
Furthermore_RB ,_, other_JJ negative_JJ studies_NNS quoted_VBN in_IN the_DT present_JJ article_NN have_VBP been_VBN supported_VBN by_IN the_DT mobile_JJ phone_NN industry_NN ,_, for_IN example_NN the_DT two_CD Muscat_NNP studies_NNS -LRB-_-LRB- Cellular_NNP Industry_NNP Telecommunications_NNP Association_NNP via_IN the_DT Wireless_NNP Technology_NNP Research_NNP -RRB-_-RRB- 
Of_IN potential_JJ concern_NN to_TO fetal_JJ and_CC infant_JJ health_NN endpoints_NNS is_VBZ the_DT presence_NN of_IN BPA_NNP in_IN follicular_JJ and_CC amniotic_JJ fluid_NN 
BPA_NNP has_VBZ been_VBN shown_VBN to_TO have_VB weak_JJ oestrogenic_JJ activity_NN and_CC potentially_RB impacts_VBZ thyroid_JJ function_NN 
al._RB ._. 
Supporting_VBG these_DT initial_JJ results_NNS ,_, Morck_NNP et_NNP ._. 
2ug\/mL_JJ -RRB-_-RRB- levels_NNS of_IN BPA_NNP ._. 
0002_CD to_TO 0_CD ._. 
Recently_RB ,_, it_PRP has_VBZ been_VBN shown_VBN that_IN human_JJ primary_JJ cytotrophoblast_NN cells_NNS undergo_VBP a_DT dose-dependent_JJ increase_NN in_IN TNF_NNP -_: 
Human_JJ studies_NNS have_VBP also_RB measured_VBN BPA_NNP in_IN a_DT variety_NN of_IN other_JJ human_JJ body_NN fluids_NNS and_CC some_DT tissues_NNS ._. 
Additionally_RB ,_, other_JJ studies_NNS in_IN the_DT Netherlands_NNP 
Of_IN potential_JJ concern_NN to_TO fetal_JJ and_CC infant_JJ health_NN endpoints_NNS is_VBZ the_DT presence_NN of_IN BPA_NNP in_IN follicular_JJ and_CC amniotic_JJ fluid_NN 
Human_JJ studies_NNS have_VBP also_RB measured_VBN BPA_NNP in_IN a_DT variety_NN of_IN other_JJ human_JJ body_NN fluids_NNS and_CC some_DT tissues_NNS ._. 
Additionally_RB ,_, other_JJ studies_NNS in_IN the_DT Netherlands_NNP 
Human_JJ studies_NNS have_VBP also_RB measured_VBN BPA_NNP in_IN a_DT variety_NN of_IN other_JJ human_JJ body_NN fluids_NNS and_CC some_DT tissues_NNS ._. 
Additionally_RB ,_, other_JJ studies_NNS in_IN the_DT Netherlands_NNP 
documented_VBN extensive_JJ exposure_NN to_TO the_DT general_JJ US_NNP population_NN in_IN a_DT subset_NN of_IN the_DT 2003-2004_CD National_NNP Health_NNP and_CC Nutrition_NNP Examination_NNP Survey_NNP -LRB-_-LRB- NHANES_NNP -RRB-_-RRB- ,_, where_WRB 93_CD %_NN of_IN the_DT 2,517_CD participants_NNS had_VBD detectable_JJ BPA_NNP in_IN their_PRP$ urine_NN 
documented_VBN extensive_JJ exposure_NN to_TO the_DT general_JJ US_NNP population_NN in_IN a_DT subset_NN of_IN the_DT 2003-2004_CD National_NNP Health_NNP and_CC Nutrition_NNP Examination_NNP Survey_NNP -LRB-_-LRB- NHANES_NNP -RRB-_-RRB- ,_, where_WRB 93_CD %_NN of_IN the_DT 2,517_CD participants_NNS had_VBD detectable_JJ BPA_NNP in_IN their_PRP$ urine_NN 
5_CD 
02_CD -_: 0_CD ._. 
Additionally_RB ,_, recent_JJ evidence_NN from_IN in_IN vitro_NN studies_NNS suggests_VBZ that_IN fetal_JJ exposure_NN to_TO BPA_NNP can_MD occur_VB through_IN placental_JJ exchange_NN and_CC that_IN BPA_NNP exposure_NN at_IN doses_NNS -LRB-_-LRB- 0_CD ._. 
1_CD 
Preterm_NN birth_NN is_VBZ likely_RB a_DT condition_NN with_IN multiple_JJ etiologies_NNS ._. 
As_RB far_RB as_IN we_PRP are_VBP aware_JJ ,_, this_DT is_VBZ the_DT first_JJ study_NN to_TO specifically_RB assess_VB the_DT relationship_NN between_IN BPA_NNP exposure_NN biomarker_NN concentrations_NNS during_IN pregnancy_NN and_CC preterm_NN birth_NN ._. 
BPA_NNP may_MD harm_VB fetal_JJ growth_NN and_CC promote_VB early_JJ parturition_NN through_IN various_JJ mechanisms_NNS ,_, as_IN it_PRP has_VBZ been_VBN shown_VBN to_TO disrupt_VB a_DT 
0002_CD to_TO 0_CD ._. 
Recently_RB ,_, it_PRP has_VBZ been_VBN shown_VBN that_IN human_JJ primary_JJ cytotrophoblast_NN cells_NNS undergo_VBP a_DT dose-dependent_JJ increase_NN in_IN TNF_NNP -_: 
1_CD 
Preterm_NN birth_NN is_VBZ likely_RB a_DT condition_NN with_IN multiple_JJ etiologies_NNS 
Preterm_NN birth_NN is_VBZ likely_RB a_DT condition_NN with_IN multiple_JJ etiologies_NNS 
Preterm_NN birth_NN is_VBZ likely_RB a_DT condition_NN with_IN multiple_JJ etiologies_NNS 
Preterm_NN birth_NN is_VBZ likely_RB a_DT condition_NN with_IN multiple_JJ etiologies_NNS 
Preterm_NN birth_NN is_VBZ likely_RB a_DT condition_NN with_IN multiple_JJ etiologies_NNS 
Preterm_NN birth_NN is_VBZ likely_RB a_DT condition_NN with_IN multiple_JJ etiologies_NNS 
Gestational_JJ length_NN was_VBD estimated_VBN by_IN date_NN of_IN maternally-recalled_JJ last_JJ menstrual_JJ period_NN which_WDT may_MD be_VB an_DT unreliable_JJ measure_NN ,_, varying_VBG as_RB much_RB as_IN 
Our_PRP$ study_NN has_VBZ several_JJ limitations_NNS including_VBG its_PRP$ small_JJ sample_NN size_NN ._. 
also_RB demonstrated_VBD that_IN similar_JJ levels_NNS of_IN BPA_NNP exposure_NN can_MD induce_VB cell_NN death_NN in_IN a_DT human_JJ choriocarcinoma_NN cell_NN line_NN and_CC increase_NN secretion_NN of_IN 
BPA_NNP may_MD harm_VB fetal_JJ growth_NN and_CC promote_VB early_JJ parturition_NN through_IN various_JJ mechanisms_NNS ,_, as_IN it_PRP has_VBZ been_VBN shown_VBN to_TO disrupt_VB a_DT variety_NN of_IN biologic_JJ functions_NNS including_VBG steroid_JJ hormone_NN synthesis_NN and_CC metabolism_NN 
Our_PRP$ study_NN has_VBZ several_JJ limitations_NNS including_VBG its_PRP$ small_JJ sample_NN size_NN ._. 
also_RB demonstrated_VBD that_IN similar_JJ levels_NNS of_IN BPA_NNP exposure_NN can_MD induce_VB cell_NN death_NN in_IN a_DT human_JJ choriocarcinoma_NN cell_NN line_NN and_CC increase_NN secretion_NN of_IN 
BPA_NNP may_MD harm_VB fetal_JJ growth_NN and_CC promote_VB early_JJ parturition_NN through_IN various_JJ mechanisms_NNS ,_, as_IN it_PRP has_VBZ been_VBN shown_VBN to_TO disrupt_VB a_DT variety_NN of_IN biologic_JJ functions_NNS including_VBG steroid_JJ hormone_NN synthesis_NN and_CC metabolism_NN 
Preterm_NN birth_NN is_VBZ likely_RB a_DT condition_NN with_IN multiple_JJ etiologies_NNS 
As_RB far_RB as_IN we_PRP are_VBP aware_JJ ,_, this_DT is_VBZ the_DT first_JJ study_NN to_TO specifically_RB assess_VB the_DT relationship_NN between_IN BPA_NNP exposure_NN biomarker_NN concentrations_NNS during_IN pregnancy_NN and_CC preterm_NN birth_NN ._. 
Preterm_NN birth_NN is_VBZ likely_RB a_DT condition_NN with_IN multiple_JJ etiologies_NNS 
However_RB ,_, unlike_IN the_DT present_JJ study_NN ,_, these_DT studies_NNS were_VBD not_RB designed_VBN to_TO assess_VB preterm_NN birth_NN in_IN relation_NN to_TO BPA_NNP exposure_NN ._. 
Other_JJ small-scale_JJ human_JJ studies_NNS of_IN BPA_NNP exposure_NN in_IN pregnancy_NN have_VBP reported_VBN increases_NNS in_IN the_DT risk_NN of_IN spontaneous_JJ abortion_NN 
However_RB ,_, unlike_IN the_DT present_JJ study_NN ,_, these_DT studies_NNS were_VBD not_RB designed_VBN to_TO assess_VB preterm_NN birth_NN in_IN relation_NN to_TO BPA_NNP exposure_NN ._. 
Other_JJ small-scale_JJ human_JJ studies_NNS of_IN BPA_NNP exposure_NN in_IN pregnancy_NN have_VBP reported_VBN increases_NNS in_IN the_DT risk_NN of_IN spontaneous_JJ abortion_NN 
However_RB ,_, unlike_IN the_DT present_JJ study_NN ,_, these_DT studies_NNS were_VBD not_RB designed_VBN to_TO assess_VB preterm_NN birth_NN in_IN relation_NN to_TO BPA_NNP exposure_NN ._. 
Other_JJ small-scale_JJ human_JJ studies_NNS of_IN BPA_NNP exposure_NN in_IN pregnancy_NN have_VBP reported_VBN increases_NNS in_IN the_DT risk_NN of_IN spontaneous_JJ abortion_NN 
0_CD 
In_IN these_DT models_NNS ,_, in_IN which_WDT we_PRP explored_VBD both_DT including_VBG and_CC then_RB excluding_VBG women_NNS who_WP delivered_VBD in_IN the_DT 37_CD th_NN week_NN in_IN the_DT control_NN group_NN ,_, there_EX were_VBD significantly_RB increased_VBN odds_NNS of_IN delivering_VBG prematurely_RB with_IN increasing_VBG specific_JJ gravity_NN adjusted_VBN third_JJ trimester_NN BPA_NNP concentrations_NNS -LRB-_-LRB- Table_NNP 4_CD -RRB-_-RRB- ._. 
Addition_NN of_IN third_JJ trimester_NN urinary_JJ phthalate_NN metabolites_NNS previously_RB shown_VBN to_TO be_VB related_VBN to_TO risk_NN of_IN prematurity_NN in_IN this_DT population_NN as_IN potential_JJ confounders_NNS did_VBD n't_RB appreciably_RB change_VB the_DT odds_NNS ratios_NNS in_IN our_PRP$ analysis_NN -LRB-_-LRB- data_NNS not_RB shown_VBN -RRB-_-RRB- ._. 
Table_NNP 3_NNP Unadjusted_NNP and_CC Adjusted_NNP Odd_NNP Ratios_NNP for_IN log_VB transformed_VBN third_JJ trimester_NN urinary_JJ bisphenol-A_JJ concentrations_NNS among_IN women_NNS who_WP delivered_VBD 
,Reno_NNP ,_, NV_NNP ,_, USA_NNP -RRB-_-RRB- and_CC Microplate_NNP Spectrophotometer_NNP -LRB-_-LRB- SpectraMax_NNP 340_CD ,_, Molecular_NNP Devices_NNP ,_, Sunnyvale_NNP ,_, CA_NNP ,_, USA_NNP -RRB-_-RRB- ._. 
Statistical_NNP AnalysisDescriptive_NNP statistics_NNS and_CC identification_NN of_IN outliers_NNS ,_, using_VBG the_DT generalized_JJ extreme_JJ studentized_JJ deviation_NN method_NN were_VBD performed_VBN ._. 
Exclusion_NN of_IN the_DT two_CD individuals_NNS identified_VBN as_IN outliers_NNS -LRB-_-LRB- who_WP give_VBP birth_NN to_TO very_RB early_JJ preterm_NN ,_, 
To_TO our_PRP$ knowledge_NN ,_, this_DT is_VBZ the_DT first_JJ report_NN on_IN the_DT biological_JJ monitoring_NN of_IN BPA_NNP in_IN Mexico_NNP ._. 
Asecondary_JJ aim_NN of_IN this_DT study_NN was_VBD to_TO determine_VB differences_NNS in_IN BPA_NNP concentrations_NNS between_IN women_NNS who_WP delivered_VBD less_JJR than_IN or_CC equal_JJ to_TO 37_CD weeks_NNS of_IN gestation_NN and_CC after_IN the_DT completion_NN of_IN 37_CD weeks_NNS of_IN gestation_NN ._. 
MethodsSample_NNP PopulationThe_NNP present_JJ study_NN was_VBD nested_VBN within_IN a_DT Mexican_JJ birth_NN cohort_NN study_NN in_IN which_WDT women_NNS were_VBD recruited_VBN during_IN prenatal_JJ visits_NNS at_IN one_CD of_IN four_CD clinics_NNS of_IN the_DT Mexican_NNP Institute_NNP of_IN Social_NNP Security_NNP in_IN Mexico_NNP City_NNP between_IN 2001_CD and_CC 2003_CD and_CC has_VBZ been_VBN described_VBN elsewhere_RB ._. 
The_DT research_NN protocol_NN was_VBD approved_VBN by_IN the_DT Ethics_NNP and_CC Research_NNP Committees_NNS of_IN all_DT participating_VBG institutions_NNS ._. 
In_IN animal_NN studies_NNS ,_, environmentally-relevant_JJ concentrations_NNS of_IN BPA_NNP have_VBP been_VBN associated_VBN with_IN low_JJ birth_NN weight_NN 
7_CD 
In_IN the_DT Children_NNP 's_POS Environmental_NNP Health_NNP study_NN ,_, Wolff_NNP et_FW al._FW ._. 
To_TO date_VB there_EX has_VBZ been_VBN limited_JJ human_JJ data_NNS on_IN preterm_NN birth_NN ,_, gestational_JJ length_NN ,_, and_CC prenatal_JJ BPA_NNP exposure_NN ._. 
found_VBD no_DT association_NN between_IN BPA_NNP exposure_NN during_IN the_DT third_JJ trimester_NN and_CC gestational_JJ length_NN among_IN 404_CD pregnant_JJ women_NNS in_IN New_NNP York_NNP City_NNP ._. 
In_IN addition_NN ,_, a_DT small_JJ scale_NN study_NN -LRB-_-LRB- N_NNP =_SYM 40_CD -RRB-_-RRB- in_IN Southeastern_NNP Michigan_NNP that_WDT measured_VBD BPA_NNP in_IN blood_NN of_IN women_NNS at_IN the_DT time_NN of_IN delivery_NN also_RB found_VBD no_DT difference_NN in_IN gestational_JJ length_NN between_IN women_NNS with_IN blood_NN BPA_NNP concentrations_NNS 
In_IN animal_NN studies_NNS ,_, environmentally-relevant_JJ concentrations_NNS of_IN BPA_NNP have_VBP been_VBN associated_VBN with_IN low_JJ birth_NN weight_NN 
found_VBD no_DT association_NN between_IN BPA_NNP exposure_NN during_IN the_DT third_JJ trimester_NN and_CC gestational_JJ length_NN among_IN 404_CD pregnant_JJ women_NNS in_IN New_NNP York_NNP City_NNP ._. 
In_IN addition_NN ,_, a_DT small_JJ scale_NN study_NN -LRB-_-LRB- N_NNP =_SYM 40_CD -RRB-_-RRB- in_IN Southeastern_NNP Michigan_NNP that_WDT measured_VBD BPA_NNP in_IN blood_NN of_IN women_NNS at_IN the_DT time_NN of_IN delivery_NN also_RB found_VBD no_DT difference_NN in_IN gestational_JJ length_NN between_IN women_NNS with_IN blood_NN BPA_NNP concentrations_NNS 
80-05-7_CD -RRB-_-RRB- is_VBZ produced_VBN in_IN high_JJ volume_NN worldwide_NN for_IN use_NN in_IN a_DT variety_NN of_IN industrial_JJ and_CC consumer_NN products_NNS ,_, such_JJ as_IN epoxy_NN resins_NNS used_VBN to_TO line_VB food_NN cans_NNS 
80-05-7_CD -RRB-_-RRB- is_VBZ produced_VBN in_IN high_JJ volume_NN worldwide_NN for_IN use_NN in_IN a_DT variety_NN of_IN industrial_JJ and_CC consumer_NN products_NNS ,_, such_JJ as_IN epoxy_NN resins_NNS used_VBN to_TO line_VB food_NN cans_NNS 
Calafat_NNP et_FW al._FW ._. 
Due_JJ to_TO this_DT wide_JJ spread_NN usage_NN ,_, the_DT primary_JJ exposure_NN route_NN in_IN humans_NNS is_VBZ thought_VBN to_TO occur_VB via_IN ingestion_NN of_IN food_NN or_CC water_NN ._. 
documented_VBN extensive_JJ exposure_NN to_TO the_DT general_JJ US_NNP population_NN in_IN a_DT subset_NN of_IN the_DT 2003-2004_CD National_NNP Health_NNP and_CC Nutrition_NNP Examination_NNP Survey_NNP -LRB-_-LRB- NHANES_NNP -RRB-_-RRB- ,_, where_WRB 93_CD %_NN of_IN the_DT 2,517_CD participants_NNS had_VBD detectable_JJ BPA_NNP in_IN their_PRP$ urine_NN 
4_CD 
documented_VBN extensive_JJ exposure_NN to_TO the_DT general_JJ US_NNP population_NN in_IN a_DT subset_NN of_IN the_DT 2003-2004_CD National_NNP Health_NNP and_CC Nutrition_NNP Examination_NNP Survey_NNP -LRB-_-LRB- NHANES_NNP -RRB-_-RRB- ,_, where_WRB 93_CD %_NN of_IN the_DT 2,517_CD participants_NNS had_VBD detectable_JJ BPA_NNP in_IN their_PRP$ urine_NN 
1_CD 
Background_NN Bisphenol_NNP A_NNP -LRB-_-LRB- BPA_NNP ,_, CAS_NNP no._NNP ._. 
This_DT study_NN also_RB provides_VBZ preliminary_JJ evidence_NN ,_, based_VBN on_IN a_DT single_JJ spot_NN urine_NN sample_NN collected_VBN during_IN the_DT third_JJ trimester_NN ,_, that_IN pregnant_JJ women_NNS who_WP delivered_VBD less_JJR than_IN or_CC equal_JJ to_TO 37_CD weeks_NNS of_IN gestation_NN and_CC prematurely_RB -LRB-_-LRB- 
Background_NN Bisphenol_NNP A_NNP -LRB-_-LRB- BPA_NNP ,_, CAS_NNP no._NNP ._. 
This_DT study_NN also_RB provides_VBZ preliminary_JJ evidence_NN ,_, based_VBN on_IN a_DT single_JJ spot_NN urine_NN sample_NN collected_VBN during_IN the_DT third_JJ trimester_NN ,_, that_IN pregnant_JJ women_NNS who_WP delivered_VBD less_JJR than_IN or_CC equal_JJ to_TO 37_CD weeks_NNS of_IN gestation_NN and_CC prematurely_RB -LRB-_-LRB- 
Background_NN Bisphenol_NNP A_NNP -LRB-_-LRB- BPA_NNP ,_, CAS_NNP no._NNP ._. 
This_DT study_NN also_RB provides_VBZ preliminary_JJ evidence_NN ,_, based_VBN on_IN a_DT single_JJ spot_NN urine_NN sample_NN collected_VBN during_IN the_DT third_JJ trimester_NN ,_, that_IN pregnant_JJ women_NNS who_WP delivered_VBD less_JJR than_IN or_CC equal_JJ to_TO 37_CD weeks_NNS of_IN gestation_NN and_CC prematurely_RB -LRB-_-LRB- 
documented_VBN extensive_JJ exposure_NN to_TO the_DT general_JJ US_NNP population_NN in_IN a_DT subset_NN of_IN the_DT 2003-2004_CD National_NNP Health_NNP and_CC Nutrition_NNP Examination_NNP Survey_NNP -LRB-_-LRB- NHANES_NNP -RRB-_-RRB- ,_, where_WRB 93_CD %_NN of_IN the_DT 2,517_CD participants_NNS had_VBD detectable_JJ BPA_NNP in_IN their_PRP$ urine_NN 
documented_VBN extensive_JJ exposure_NN to_TO the_DT general_JJ US_NNP population_NN in_IN a_DT subset_NN of_IN the_DT 2003-2004_CD National_NNP Health_NNP and_CC Nutrition_NNP Examination_NNP Survey_NNP -LRB-_-LRB- NHANES_NNP -RRB-_-RRB- ,_, where_WRB 93_CD %_NN of_IN the_DT 2,517_CD participants_NNS had_VBD detectable_JJ BPA_NNP in_IN their_PRP$ urine_NN 
These_DT variables_NNS were_VBD used_VBN to_TO calculate_VB the_DT mean_JJ apparent_JJ temperature_NN which_WDT is_VBZ defined_VBN as_IN an_DT individual_NN 's_POS perceived_VBN air_NN temperature_NN given_VBN the_DT humidity_NN ._. 
It_PRP is_VBZ calculated_VBN with_IN the_DT following_JJ formula_NN :_: In_IN our_PRP$ study_NN apparent_JJ temperature_NN is_VBZ used_VBN to_TO represent_VB the_DT effect_NN of_IN the_DT typical_JJ temperature_NN exposure_NN that_WDT is_VBZ commonly_RB experienced_VBN during_IN the_DT warmer_JJR months_NNS ._. 
Statistical_NNP Methods_NNS Similar_JJ to_TO Basu_NNP et_FW al._FW ._. 
In_IN our_PRP$ analyses_NNS we_PRP used_VBD the_DT same_JJ day_NN concentration_NN of_IN PM_NNP 10_CD and_CC O_NNP 3_CD -LRB-_-LRB- lag_NN 0_CD -RRB-_-RRB- ._. 
we_PRP investigated_VBD the_DT association_NN between_IN mean_JJ apparent_JJ temperature_NN and_CC daily_JJ mortality_NN using_VBG generalized_JJ additive_JJ models_NNS -LRB-_-LRB- GAM_NNP -RRB-_-RRB- ,_, with_IN a_DT quasi-Poisson_JJ link_NN function_NN ,_, in_IN the_DT warm_JJ period_NN -LRB-_-LRB- April_NNP to_TO September_NNP -RRB-_-RRB- ._. 
In_IN the_DT models_NNS we_PRP controlled_VBD for_IN time_NN trend_NN using_VBG natural_JJ cubic_JJ spline_NN smoothing_VBG function_NN ._. 
The_DT variable_JJ day_NN of_IN the_DT week_NN was_VBD included_VBN as_IN an_DT indicator_NN variable_JJ ._. 
3%_CD increase_NN in_IN all-cause_JJ mortality_NN per_IN 10_CD 
1million_CD people_NNS with_IN a_DT population_NN density_NN of_IN 898_CD inhabitants_NNS per_IN square_JJ kilometer_NN ;_: Oporto_NNP has_VBZ approximately_RB 1_CD ._. 
2million_CD people_NNS and_CC a_DT population_NN density_NN of_IN 540_CD per_IN square_JJ kilometer_NN ._. 
Health_NNP and_CC environment_NN data_NNS Mortality_NN data_NNS from_IN April_NNP to_TO September_NNP for_IN Lisbon_NNP -LRB-_-LRB- 2000-2004_CD -RRB-_-RRB- and_CC Oporto_NNP -LRB-_-LRB- 2000-2004_CD -RRB-_-RRB- were_VBD obtained_VBN from_IN the_DT National_NNP Institute_NNP of_IN Statistics_NNP ._. 
These_DT variables_NNS were_VBD used_VBN to_TO calculate_VB the_DT mean_JJ apparent_JJ temperature_NN which_WDT is_VBZ defined_VBN as_IN an_DT individual_NN 's_POS perceived_VBN air_NN temperature_NN given_VBN the_DT humidity_NN ._. 
It_PRP is_VBZ calculated_VBN with_IN the_DT following_JJ formula_NN :_: In_IN our_PRP$ study_NN apparent_JJ temperature_NN is_VBZ used_VBN to_TO represent_VB the_DT effect_NN of_IN the_DT typical_JJ temperature_NN exposure_NN that_WDT is_VBZ commonly_RB experienced_VBN during_IN the_DT warmer_JJR months_NNS ._. 
This_DT increase_NN in_IN mortality_NN is_VBZ likely_JJ to_TO be_VB related_VBN to_TO the_DT stress_NN placed_VBN on_IN the_DT respiratory_JJ and_CC circulatory_JJ systems_NNS to_TO increase_VB heat_NN loss_NN though_IN skin_NN surface_NN blood_NN circulation_NN 
5_CD 
5_CD 
Some_DT groups_NNS adopted_VBN for_IN a_DT time_NN series_NN approach_NN ,_, while_IN others_NNS focus_VBP on_IN extreme_JJ events_NNS such_JJ as_IN heat_NN waves_NNS and_CC cold_JJ spells_NNS using_VBG episode_NN analysis_NN ._. 
In_IN Europe_NNP ,_, populations_NNS living_VBG in_IN urban_JJ environments_NNS as_RB well_RB as_IN the_DT elderly_JJ have_VBP a_DT high_JJ risk_NN of_IN mortality_NN from_IN ambient_JJ heat_NN exposure_NN ._. 
If_IN future_JJ populations_NNS become_VBP more_RBR urbanized_JJ and_CC the_DT number_NN of_IN elderly_JJ continues_VBZ to_TO increase_VB ,_, the_DT issue_NN of_IN heat-related_JJ mortality_NN will_MD probably_RB become_VB more_RBR severe_JJ ._. 
Nevertheless_RB ,_, most_JJS of_IN these_DT studies_NNS yield_VBP results_NNS similar_JJ to_TO ours_PRP in_IN that_DT risks_NNS for_IN deaths_NNS from_IN cardiovascular_JJ and_CC respiratory_JJ diseases_NNS increase_NN with_IN increasing_VBG summer_NN ambient_JJ temperatures_NNS ._. 
Our_PRP$ finding_NN that_IN the_DT elderly_JJ are_VBP the_DT group_NN most_JJS at_IN risk_NN in_IN the_DT warmer_JJR periods_NNS is_VBZ also_RB consistent_JJ with_IN previous_JJ studies_NNS ._. 
In_IN our_PRP$ study_NN the_DT risk_NN of_IN death_NN for_IN people_NNS 
Observed_VBN climate_NN trends_NNS in_IN Portugal_NNP show_VBP that_IN between_IN 1970-2000_CD there_EX was_VBD an_DT increase_NN in_IN the_DT average_JJ temperature_NN at_IN a_DT rate_NN of_IN 0_CD ._. 
5_CD 
Our_PRP$ results_NNS are_VBP reported_VBN as_IN the_DT percent_NN change_NN in_IN mortality_NN per_IN 1_CD 
8a_CD Models_NNS adjusted_VBN for_IN time_NN trend_NN and_CC day_NN of_IN week_NN ._. 
7,_CD 1_CD ._. 
30_CD ._. 
0+_CD 8-hr_JJ average_JJ ozone_NN 1_CD ._. 
8,_CD 2_CD ._. 
40_CD ._. 
DiscussionFollowing_VBG the_DT 2003_CD heatwave_NN in_IN Europe_NNP ,_, various_JJ studies_NNS have_VBP assessed_VBN the_DT effects_NNS of_IN temperature_NN extremes_NNS in_IN various_JJ cities_NNS 
Acclimatization_NN and_CC individual_JJ susceptibility_NN should_MD also_RB be_VB investigated_VBN as_IN possible_JJ explanations_NNS for_IN the_DT differences_NNS between_IN the_DT cities_NNS ._. 
Finally_RB ,_, the_DT effect_NN of_IN access_NN to_TO prevention_NN and_CC to_TO emergency_NN care_NN between_IN cities_NNS is_VBZ also_RB an_DT area_NN warranting_VBG future_JJ research_NN ._. 
Conclusion_NN In_IN conclusion_NN ,_, our_PRP$ study_NN provides_VBZ evidence_NN of_IN increased_VBN mortality_NN due_JJ to_TO mean_VB apparent_JJ temperature_NN exposure_NN in_IN Portugal_NNP ,_, even_RB when_WRB adjusting_VBG for_IN air_NN pollution_NN ._. 
5_CD 
Nevertheless_RB ,_, most_JJS of_IN these_DT studies_NNS yield_VBP results_NNS similar_JJ to_TO ours_PRP in_IN that_DT risks_NNS for_IN deaths_NNS from_IN cardiovascular_JJ and_CC respiratory_JJ diseases_NNS increase_NN with_IN increasing_VBG summer_NN ambient_JJ temperatures_NNS ._. 
Our_PRP$ finding_NN that_IN the_DT elderly_JJ are_VBP the_DT group_NN most_JJS at_IN risk_NN in_IN the_DT warmer_JJR periods_NNS is_VBZ also_RB consistent_JJ with_IN previous_JJ studies_NNS ._. 
In_IN our_PRP$ study_NN the_DT risk_NN of_IN death_NN for_IN people_NNS 
Nevertheless_RB ,_, most_JJS of_IN these_DT studies_NNS yield_VBP results_NNS similar_JJ to_TO ours_PRP in_IN that_DT risks_NNS for_IN deaths_NNS from_IN cardiovascular_JJ and_CC respiratory_JJ diseases_NNS increase_NN with_IN increasing_VBG summer_NN ambient_JJ temperatures_NNS ._. 
Our_PRP$ finding_NN that_IN the_DT elderly_JJ are_VBP the_DT group_NN most_JJS at_IN risk_NN in_IN the_DT warmer_JJR periods_NNS is_VBZ also_RB consistent_JJ with_IN previous_JJ studies_NNS ._. 
In_IN our_PRP$ study_NN the_DT risk_NN of_IN death_NN for_IN people_NNS 
We_PRP found_VBD a_DT lower_JJR effect_NN when_WRB adjusting_VBG for_IN PM_NNP 10_CD in_IN Lisbon_NNP ,_, and_CC a_DT decrease_NN in_IN the_DT effect_NN with_IN PM_NNP 10_CD and_CC ozone_NN in_IN Oporto_NNP ._. 
Our_PRP$ results_NNS are_VBP consistent_JJ with_IN those_DT from_IN O'Neill_NNP and_CC colleagues_NNS 
From_IN a_DT public_JJ health_NN point_NN of_IN view_NN ,_, this_DT finding_NN is_VBZ important_JJ since_IN cardiovascular_JJ diseases_NNS are_VBP the_DT leading_VBG cause_NN of_IN death_NN for_IN both_DT men_NNS and_CC woman_NN in_IN Portugal_NNP ,_, accounting_VBG for_IN ~_CD 40_CD %_NN of_IN all_DT deaths_NNS during_IN the_DT study_NN period_NN ._. 
This_DT increase_NN in_IN mortality_NN is_VBZ likely_JJ to_TO be_VB related_VBN to_TO the_DT stress_NN placed_VBN on_IN the_DT respiratory_JJ and_CC circulatory_JJ systems_NNS to_TO increase_VB heat_NN loss_NN though_IN skin_NN surface_NN blood_NN circulation_NN 
Our_PRP$ results_NNS are_VBP consistent_JJ with_IN those_DT from_IN O'Neill_NNP and_CC colleagues_NNS 
It_PRP is_VBZ interesting_JJ to_TO note_VB that_IN this_DT result_NN is_VBZ in_IN agreement_NN with_IN observation_NN reported_VBN during_IN the_DT 2003_CD heatwave_NN were_VBD Lisbon_NNP was_VBD more_RBR vulnerable_JJ to_TO acute_JJ heatstress_NN 
It_PRP is_VBZ interesting_JJ to_TO note_VB that_IN this_DT result_NN is_VBZ in_IN agreement_NN with_IN observation_NN reported_VBN during_IN the_DT 2003_CD heatwave_NN were_VBD Lisbon_NNP was_VBD more_RBR vulnerable_JJ to_TO acute_JJ heatstress_NN 
It_PRP is_VBZ difficult_JJ to_TO directly_RB compare_VB our_PRP$ results_NNS with_IN other_JJ epidemiologic_JJ studies_NNS from_IN European_JJ cities_NNS because_IN of_IN the_DT various_JJ definitions_NNS used_VBN to_TO classify_VB temperature_NN exposure_NN and_CC the_DT different_JJ methodologies_NNS applied_VBD 
3-RRB-_CD ._. 
41_CD -RRB-_-RRB- was_VBD more_RBR vulnerable_JJ than_IN the_DT population_NN in_IN Oporto_NNP -LRB-_-LRB- OR_NNP of_IN 1_CD ._. 
Although_IN Lisbon_NNP was_VBD one_CD of_IN the_DT few_JJ cities_NNS in_IN Europe_NNP that_WDT had_VBD a_DT heatwave_NN early_RB warning_VBG system_NN already_RB in_IN place_NN and_CC alerts_VBZ were_VBD sent_VBN out_RP -LRB-_-LRB- via_IN the_DT media_NNS -RRB-_-RRB- to_TO warn_VB the_DT population_NN 
During_IN this_DT heatwave_NN period_NN ,_, in_IN Lisbon_NNP and_CC Oporto_NNP excess_JJ mortalities_NNS of_IN about_IN 400_CD and_CC 183_CD were_VBD reported_VBN respectively_RB ._. 
Although_IN Lisbon_NNP was_VBD one_CD of_IN the_DT few_JJ cities_NNS in_IN Europe_NNP that_WDT had_VBD a_DT heatwave_NN early_RB warning_VBG system_NN already_RB in_IN place_NN and_CC alerts_VBZ were_VBD sent_VBN out_RP -LRB-_-LRB- via_IN the_DT media_NNS -RRB-_-RRB- to_TO warn_VB the_DT population_NN 
Discussion_NN Following_VBG the_DT 2003_CD heatwave_NN in_IN Europe_NNP ,_, various_JJ studies_NNS have_VBP assessed_VBN the_DT effects_NNS of_IN temperature_NN extremes_NNS in_IN various_JJ cities_NNS 
41_CD -RRB-_-RRB- was_VBD more_RBR vulnerable_JJ than_IN the_DT population_NN in_IN Oporto_NNP -LRB-_-LRB- OR_NNP of_IN 1_CD ._. 
Although_IN Lisbon_NNP was_VBD one_CD of_IN the_DT few_JJ cities_NNS in_IN Europe_NNP that_WDT had_VBD a_DT heatwave_NN early_RB warning_VBG system_NN already_RB in_IN place_NN and_CC alerts_VBZ were_VBD sent_VBN out_RP -LRB-_-LRB- via_IN the_DT media_NNS -RRB-_-RRB- to_TO warn_VB the_DT population_NN ,_, the_DT final_JJ analyzes_NNS of_IN the_DT 2003_CD heatwave_NN health_NN effect_NN showed_VBD that_IN the_DT population_NN in_IN Lisbon_NNP -LRB-_-LRB- OR_NNP of_IN 1_CD ._. 
3-RRB-_NN 
Overall_RB ,_, the_DT population_NN in_IN Lisbon_NNP was_VBD more_RBR vulnerable_JJ than_IN the_DT population_NN in_IN Oporto_NNP ._. 
These_DT associations_NNS persist_VBP even_RB when_WRB controlling_VBG for_IN the_DT effects_NNS of_IN air_NN pollution_NN ._. 
It_PRP is_VBZ interesting_JJ to_TO note_VB that_IN this_DT result_NN is_VBZ in_IN agreement_NN with_IN observation_NN reported_VBN during_IN the_DT 2003_CD heatwave_NN were_VBD Lisbon_NNP was_VBD more_RBR vulnerable_JJ to_TO acute_JJ heatstress_NN 
8a_CD Models_NNS adjusted_VBN for_IN time_NN trend_NN and_CC day_NN of_IN week_NN ._. 
7,_CD 1_CD ._. 
30_CD ._. 
0+_CD 8-hr_JJ average_JJ ozone_NN 1_CD ._. 
8,_CD 2_CD ._. 
40_CD ._. 
DiscussionFollowing_VBG the_DT 2003_CD heatwave_NN in_IN Europe_NNP ,_, various_JJ studies_NNS have_VBP assessed_VBN the_DT effects_NNS of_IN temperature_NN extremes_NNS in_IN various_JJ cities_NNS 
Recent_JJ extreme_JJ weather_NN events_NNS ,_, such_JJ the_DT European_JJ heatwave_NN in_IN 2003_CD ,_, have_VBP attracted_VBN renewed_VBN interest_NN on_IN weather-related_JJ health_NN effects_NNS 
Since_IN climate_NN change_NN will_MD likely_RB increase_VB the_DT mean_JJ temperature_NN ,_, as_RB well_RB as_IN the_DT frequency_NN of_IN heat_NN events_NNS 
This_DT increase_NN in_IN mortality_NN is_VBZ likely_JJ to_TO be_VB related_VBN to_TO the_DT stress_NN placed_VBN on_IN the_DT respiratory_JJ and_CC circulatory_JJ systems_NNS to_TO increase_VB heat_NN loss_NN though_IN skin_NN surface_NN blood_NN circulation_NN 
6%_CD and_CC 1_CD ._. 
2%_CD ,_, 1_CD ._. 
Nevertheless_RB ,_, a_DT previous_JJ study_NN that_WDT analyzed_VBD the_DT effect_NN of_IN temperature_NN on_IN all-cause_JJ mortality_NN in_IN New_NNP Delhi_NNP ,_, Sao_NNP Paulo_NNP ,_, and_CC London_NNP found_VBD a_DT 2_CD ._. 
4%_CD increases_NNS per_IN degree_NN Celsius_NN above_IN 20_CD 
Additional_JJ research_NN is_VBZ needed_VBN to_TO allow_VB for_IN better_JJR assessment_NN of_IN vulnerability_NN within_IN populations_NNS in_IN Portugal_NNP in_IN order_NN to_TO develop_VB more_RBR effective_JJ heat-related_JJ morbidity_NN and_CC mortality_NN public_JJ health_NN programs_NNS ._. 
BackgroundClimate_JJ change_NN impacts_NNS on_IN human_JJ health_NN are_VBP a_DT global_JJ concern_NN 
Background_NN Climate_NN change_NN impacts_NNS on_IN human_JJ health_NN are_VBP a_DT global_JJ concern_NN 
8a_CD Models_NNS adjusted_VBN for_IN time_NN trend_NN and_CC day_NN of_IN week_NN ._. 
7,_CD 1_CD ._. 
30_CD ._. 
0+_CD 8-hr_JJ average_JJ ozone_NN 1_CD ._. 
8,_CD 2_CD ._. 
40_CD ._. 
DiscussionFollowing_VBG the_DT 2003_CD heatwave_NN in_IN Europe_NNP ,_, various_JJ studies_NNS have_VBP assessed_VBN the_DT effects_NNS of_IN temperature_NN extremes_NNS in_IN various_JJ cities_NNS 
Background_NN Climate_NN change_NN impacts_NNS on_IN human_JJ health_NN are_VBP a_DT global_JJ concern_NN 
8a_CD Models_NNS adjusted_VBN for_IN time_NN trend_NN and_CC day_NN of_IN week_NN ._. 
7,_CD 1_CD ._. 
30_CD ._. 
0+_CD 8-hr_JJ average_JJ ozone_NN 1_CD ._. 
8,_CD 2_CD ._. 
40_CD ._. 
DiscussionFollowing_VBG the_DT 2003_CD heatwave_NN in_IN Europe_NNP ,_, various_JJ studies_NNS have_VBP assessed_VBN the_DT effects_NNS of_IN temperature_NN extremes_NNS in_IN various_JJ cities_NNS 
This_DT increase_NN in_IN mortality_NN is_VBZ likely_JJ to_TO be_VB related_VBN to_TO the_DT stress_NN placed_VBN on_IN the_DT respiratory_JJ and_CC circulatory_JJ systems_NNS to_TO increase_VB heat_NN loss_NN though_IN skin_NN surface_NN blood_NN circulation_NN 
74_CD %_NN in_IN all-cause_JJ mortality_NN was_VBD found_VBN ._. 
5_CD 
It_PRP is_VBZ difficult_JJ to_TO directly_RB compare_VB our_PRP$ results_NNS with_IN other_JJ epidemiologic_JJ studies_NNS from_IN European_JJ cities_NNS because_IN of_IN the_DT various_JJ definitions_NNS used_VBN to_TO classify_VB temperature_NN exposure_NN and_CC the_DT different_JJ methodologies_NNS applied_VBD 
Nevertheless_RB ,_, most_JJS of_IN these_DT studies_NNS yield_VBP results_NNS similar_JJ to_TO ours_PRP in_IN that_DT risks_NNS for_IN deaths_NNS from_IN cardiovascular_JJ and_CC respiratory_JJ diseases_NNS increase_NN with_IN increasing_VBG summer_NN ambient_JJ temperatures_NNS ._. 
Our_PRP$ finding_NN that_IN the_DT elderly_JJ are_VBP the_DT group_NN most_JJS at_IN risk_NN in_IN the_DT warmer_JJR periods_NNS is_VBZ also_RB consistent_JJ with_IN previous_JJ studies_NNS ._. 
In_IN our_PRP$ study_NN the_DT risk_NN of_IN death_NN for_IN people_NNS 
Since_IN climate_NN change_NN will_MD likely_RB increase_VB the_DT mean_JJ temperature_NN ,_, as_RB well_RB as_IN the_DT frequency_NN of_IN heat_NN events_NNS 
It_PRP is_VBZ difficult_JJ to_TO directly_RB compare_VB our_PRP$ results_NNS with_IN other_JJ epidemiologic_JJ studies_NNS from_IN European_JJ cities_NNS because_IN of_IN the_DT various_JJ definitions_NNS used_VBN to_TO classify_VB temperature_NN exposure_NN and_CC the_DT different_JJ methodologies_NNS applied_VBD 
We_PRP searched_VBD for_IN impurities_NNS and_CC surface_NN silanol_NN structures_NNS with_IN the_DT aim_NN of_IN identifying_VBG any_DT relationship_NN to_TO differences_NNS in_IN known_JJ biological_JJ response_NN for_IN the_DT same_JJ powders_NNS ._. 
MethodsSamples_NNS chosen_VBN for_IN study_NN were_VBD Min-U-Sil_NNP 5_CD and_CC DQ12_CD ,_, both_DT already_RB well_RB characterised_VBN for_IN particle_NN size_NN ,_, surface_NN area_NN and_CC biological_JJ response_NN ._. 
No_DT pre-treatment_NN or_CC particle_NN size_NN separation_NN was_VBD performed_VBN on_IN these_DT samples_NNS therefore_RB all_DT results_NNS are_VBP indicative_JJ of_IN the_DT as-received_JJ samples_NNS ._. 
No_DT pre-treatment_NN or_CC particle_NN size_NN separation_NN was_VBD performed_VBN on_IN these_DT samples_NNS therefore_RB all_DT results_NNS are_VBP indicative_JJ of_IN the_DT as-received_JJ samples_NNS ._. 
DQ12_NNP is_VBZ regarded_VBN as_RB particularly_RB toxic_JJ and_CC the_DT spectra_NN for_IN this_DT sample_NN and_CC the_DT apparently_RB less_RBR toxic_JJ Min-U-Sil_NNP 5_CD are_VBP presented_VBN below_IN ._. 
X-Ray_JJ photoelectron_NN spectroscopy_NN -LRB-_-LRB- XPS_NNP -RRB-_-RRB- data_NNS were_VBD collected_VBN on_IN a_DT VG_NNP ESCALAB_NNP II_NNP instrument_NN with_IN un-monochromated_JJ Al_NNP K_NNP 
Discussion_NN The_DT work_NN of_IN Fubini_NNP et_FW al_FW 
An_DT inherent_JJ problem_NN with_IN this_DT type_NN of_IN detector_NN is_VBZ the_DT condensation_NN of_IN water_NN vapor_NN and_CC subsequent_JJ water_NN ice_NN formation_NN on_IN the_DT cold_JJ detector_NN window_NN as_IN a_DT function_NN of_IN time_NN ._. 
Indeed_RB 
Indeed_RB ,_, a_DT sample_NN of_IN Min-U-Sil_NNP 5_CD was_VBD made_VBN into_IN a_DT thick_JJ paste_NN with_IN deionised_JJ water_NN and_CC dried_VBN under_IN mild_JJ conditions_NNS -LRB-_-LRB- 24_CD hours_NNS at_IN 120_CD 
24_CD 
The_DT mineral_NN surface_NN is_VBZ implicated_VBN as_IN occlusion_NN of_IN the_DT surface_NN of_IN quartz_NN dusts_VBZ largely_RB eliminates_VBZ the_DT response_NN 
The_DT expected_JJ silanol_NN -LRB-_-LRB- hydrogen_NN bonded_VBD Si-O-H_NNP -RRB-_-RRB- band_NN at_IN ~_CD 900_CD cm_NN -1_CD is_VBZ absent_JJ ._. 
Asmall_JJ region_NN of_IN the_DT FTIR_NNP spectrum_NN of_IN the_DT DQ12_NNP quartz_NN sample_NN is_VBZ shown_VBN ._. 
DiscussionThe_JJ work_NN of_IN Fubini_NNP et_FW al_FW 
This_DT considerably_RB exceeds_VBZ what_WP might_MD be_VB expected_VBN for_IN surface_NN H_NNP 2_CD O_NNP or_CC OH_NNP species_NNS ._. 
Indeed_RB 
The_DT mineral_NN surface_NN is_VBZ implicated_VBN as_IN occlusion_NN of_IN the_DT surface_NN of_IN quartz_NN dusts_VBZ largely_RB eliminates_VBZ the_DT response_NN 
Pandurangi_FW et_FW al._FW ._. 
Due_JJ to_TO the_DT nature_NN of_IN the_DT toxicity_NN tests_NNS in_IN aqueous_JJ solution_NN ,_, the_DT presence_NN of_IN surface_NN silanols_NNS during_IN the_DT toxicity_NN tests_NNS certainly_RB can_MD not_RB be_VB ruled_VBN out_RB and_CC indeed_RB would_MD be_VB expected_VBN from_IN theoretical_JJ considerations_NNS ._. 
identified_VBN O-H_JJ bands_NNS in_IN FTIR_NN spectra_NN around_IN 3750_CD cm-1_JJ and_CC related_JJ these_DT to_TO their_PRP$ hemolysis_NN results_NNS suggesting_VBG that_IN the_DT correlation_NN was_VBD relevant_JJ to_TO the_DT cytotoxicity_NN of_IN respirable_JJ silica_NN particles_NNS ._. 
Our_PRP$ work_NN does_VBZ not_RB support_VB this_DT finding_NN given_VBN the_DT absence_NN in_IN our_PRP$ experiments_NNS of_IN the_DT corresponding_JJ O-H_NNP bands_NNS at_IN ~_CD 900_CD cm_NN -1_CD and_CC we_PRP suggest_VBP that_IN this_DT relationship_NN requires_VBZ further_JJ investigation_NN ._. 
No_DT evidence_NN of_IN widely-quoted_JJ surface_NN silanol_NN -LRB-_-LRB- SiOH_NNP -RRB-_-RRB- structures_NNS was_VBD found_VBN in_IN this_DT investigation_NN and_CC the_DT possibility_NN that_IN FTIR_NNP artefacts_NNS have_VBP been_VBN previously_RB misidentified_VBN as_IN silanol_JJ structures_NNS is_VBZ discussed_VBN ._. 
24_CD 
No_DT evidence_NN of_IN widely-quoted_JJ surface_NN silanol_NN -LRB-_-LRB- SiOH_NNP -RRB-_-RRB- structures_NNS was_VBD found_VBN in_IN this_DT investigation_NN and_CC the_DT possibility_NN that_IN FTIR_NNP artefacts_NNS have_VBP been_VBN previously_RB misidentified_VBN as_IN silanol_JJ structures_NNS is_VBZ discussed_VBN ._. 
24_CD 
24_CD 
We_PRP searched_VBD for_IN impurities_NNS and_CC surface_NN silanol_NN structures_NNS with_IN the_DT aim_NN of_IN identifying_VBG any_DT relationship_NN to_TO differences_NNS in_IN known_JJ biological_JJ response_NN for_IN the_DT same_JJ powders_NNS ._. 
MethodsSamples_NNS chosen_VBN for_IN study_NN were_VBD Min-U-Sil_NNP 5_CD and_CC DQ12_CD ,_, both_DT already_RB well_RB characterised_VBN for_IN particle_NN size_NN ,_, surface_NN area_NN and_CC biological_JJ response_NN ._. 
No_DT pre-treatment_NN or_CC particle_NN size_NN separation_NN was_VBD performed_VBN on_IN these_DT samples_NNS therefore_RB all_DT results_NNS are_VBP indicative_JJ of_IN the_DT as-received_JJ samples_NNS ._. 
No_DT pre-treatment_NN or_CC particle_NN size_NN separation_NN was_VBD performed_VBN on_IN these_DT samples_NNS therefore_RB all_DT results_NNS are_VBP indicative_JJ of_IN the_DT as-received_JJ samples_NNS ._. 
DQ12_NNP is_VBZ regarded_VBN as_RB particularly_RB toxic_JJ and_CC the_DT spectra_NN for_IN this_DT sample_NN and_CC the_DT apparently_RB less_RBR toxic_JJ Min-U-Sil_NNP 5_CD are_VBP presented_VBN below_IN ._. 
X-Ray_JJ photoelectron_NN spectroscopy_NN -LRB-_-LRB- XPS_NNP -RRB-_-RRB- data_NNS were_VBD collected_VBN on_IN a_DT VG_NNP ESCALAB_NNP II_NNP instrument_NN with_IN un-monochromated_JJ Al_NNP K_NNP 
Other_JJ studies_NNS have_VBP found_VBN associations_NNS between_IN NO_DT 2_CD ,_, cardiac_JJ autonomic_JJ dysfunction_NN and_CC increased_VBN blood_NN pressure_NN ,_, which_WDT are_VBP also_RB symptoms_NNS of_IN stress_NN and_CC can_MD lead_VB to_TO cardiovascular_JJ disease_NN 
Aprevious_JJ study_NN in_IN Sarnia_NNP found_VBD that_IN high_JJ annoyance_NN scores_NNS were_VBD significantly_RB related_VBN to_TO both_DT NO_RB 2_CD and_CC SO_RB 2_CD levels_NNS 
O'Neill_NNP et_FW al._FW ._. 
The_DT study_NN was_VBD also_RB limited_VBN by_IN lacking_VBG longitudinal_JJ measures_NNS of_IN health_NN and_CC SES_NNP as_IN the_DT study_NN used_VBD a_DT cross-sectional_JJ design_NN ._. 
suggest_VBP studies_NNS on_IN air_NN pollution_NN that_WDT include_VBP SES_NNP measures_NNS consider_VBP how_WRB they_PRP change_VBP through_IN the_DT course_NN of_IN life_NN ._. 
They_PRP also_RB propose_VBP that_DT exposure_NN assessment_NN include_VBP the_DT effect_NN of_IN daily_JJ movement_NN ,_, which_WDT our_PRP$ study_NN design_NN did_VBD not_RB permit_VB ._. 
Besides_IN the_DT apparent_JJ impact_NN of_IN access_NN to_TO regular_JJ care_NN on_IN community_NN satisfaction_NN ,_, our_PRP$ analysis_NN revealed_VBD that_IN the_DT a_FW priori_FW ,_, SES_NNP ,_, health_NN care_NN needs_NNS and_CC other_JJ health_NN related_VBN variables_NNS were_VBD significantly_RB associated_VBN with_IN GP_NNP access_NN ._. 
These_DT results_NNS confirm_VBP findings_NNS from_IN previous_JJ studies_NNS in_IN Canada_NNP and_CC abroad_RB 
Equitable_NNP access_NN to_TO health_NN care_NN can_MD not_RB be_VB meaningfully_RB discussed_VBN without_IN considering_VBG needs_NNS 
Furthermore_RB ,_, based_VBN on_IN the_DT important_JJ distinction_NN between_IN this_DT definition_NN of_IN access_NN versus_IN the_DT act_NN of_IN using_VBG or_CC receiving_VBG health_NN care_NN ,_, we_PRP measure_VBP utilization_NN of_IN primary_JJ health_NN care_NN ,_, or_CC general_JJ practitioner_NN -LRB-_-LRB- GP_NNP -RRB-_-RRB- use_NN ,_, by_IN a_DT positive_JJ response_NN to_TO the_DT question_NN ``_`` in_IN the_DT past_JJ two_CD weeks_NNS ,_, have_VBP you_PRP seen_VBN or_CC talked_VBN on_IN the_DT telephone_NN with_IN your_PRP$ family_NN doctor_NN about_IN your_PRP$ physical_NN ,_, emotional_JJ or_CC mental_JJ health_NN ._. ''_'' 
Similar_JJ questions_NNS have_VBP been_VBN used_VBN in_IN previous_JJ health_NN care_NN utilization_NN studies_NNS 
These_DT were_VBD dichotomous_JJ variables_NNS with_IN those_DT who_WP answered_VBD ``_`` no_DT ''_'' used_VBN as_IN the_DT reference_NN categories_NNS ._. 
Respondents_NNS were_VBD also_RB asked_VBN if_IN they_PRP believe_VBP the_DT odours_NNS from_IN the_DT chemical_NN plants_NNS were_VBD harmful_JJ to_TO their_PRP$ health_NN and_CC whether_IN they_PRP were_VBD aware_JJ of_IN Sarnia_NNP being_VBG classified_VBN as_IN an_DT AOC_NNP ._. 
Acategorical_JJ variable_NN constructed_VBN from_IN travel_NN and_CC wait_VB times_NNS for_IN health_NN care_NN provided_VBD a_DT measure_NN of_IN availability_NN and_CC those_DT who_WP responded_VBD with_IN ``_`` 20_CD minutes_NNS or_CC less_JJR ''_'' for_IN either_DT waiting_VBG or_CC traveling_VBG were_VBD used_VBN as_IN the_DT reference_NN category_NN ._. 
Respondents_NNS were_VBD also_RB asked_VBN to_TO rate_VB their_PRP$ level_NN of_IN satisfaction_NN with_IN Sarnia_NNP as_IN a_DT community_NN ._. 
The_DT variable_NN was_VBD dichotomized_VBN with_IN the_DT first_JJ two_CD responses_NNS of_IN the_DT following_JJ question_NN defined_VBN as_IN the_DT outcome_NN of_IN interest_NN -_: ``_`` In_IN general_JJ ,_, how_WRB satisfied_JJ are_VBP you_PRP with_IN your_PRP$ community_NN as_IN a_DT place_NN to_TO live_VB ._. 
Law_NNP et_NNP al._VBD 2_CD %_NN of_IN respondents_NNS indicated_VBD they_PRP had_VBD visited_VBN or_CC spoken_VBN with_IN a_DT GP_NNP during_IN the_DT two-week_JJ study_NN period_NN ._. 
found_VBN similar_JJ rates_NNS -LRB-_-LRB- 19_CD %_NN -RRB-_-RRB- of_IN utilization_NN using_VBG the_DT same_JJ question_NN in_IN Hamilton_NNP ,_, Ontario_NNP ,_, a_DT city_NN that_WDT is_VBZ also_RB associated_VBN with_IN heavy_JJ industrialization_NN ._. 
Independent_JJ samples_NNS t-tests_NNS showed_VBD that_IN respondents_NNS who_WP had_VBD consulted_VBN a_DT GP_NNP were_VBD on_IN average_NN exposed_VBN to_TO higher_JJR levels_NNS of_IN NO_DT 2_CD -LRB-_-LRB- t_NN =_SYM 3_CD ._. 
Previous_JJ studies_NNS have_VBP established_VBN relationships_NNS between_IN neighborhood_NN and_CC population_NN characteristics_NNS that_WDT amplify_VBP environmental_JJ health_NN impacts_NNS ,_, but_CC to_TO our_PRP$ knowledge_NN no_DT studies_NNS have_VBP examined_VBN the_DT relationship_NN between_IN health_NN care_NN and_CC air_NN quality_NN directly_RB ._. 
However_RB ,_, existing_VBG literature_NN indicates_VBZ that_IN people_NNS exposed_VBN to_TO higher_JJR levels_NNS of_IN air_NN pollution_NN are_VBP particularly_RB vulnerable_JJ to_TO the_DT effects_NNS of_IN inequitable_JJ access_NN to_TO primary_JJ health_NN care_NN 
-RRB-_-RRB- need_VBP to_TO be_VB examined_VBN in_IN order_NN to_TO understand_VB health_NN care_NN issues_NNS ._. 
,demographics_NNS ,_, SES_NNP ,_, mobility_NN ,_, ethnicity_NN ,_, pollution_NN ,_, etc._FW ._. 
Equitable_NNP access_NN to_TO health_NN care_NN can_MD not_RB be_VB meaningfully_RB discussed_VBN without_IN considering_VBG needs_NNS ._. 
Research_NN on_IN health_NN care_NN outcomes_NNS with_IN explicit_JJ reference_NN to_TO the_DT ph_NN 
Equitable_NNP access_NN to_TO health_NN care_NN can_MD not_RB be_VB meaningfully_RB discussed_VBN without_IN considering_VBG needs_NNS 
A._NNP S._NNP This_NNP `_`` double_JJ burden_NN of_IN deprivation_NN '_'' has_VBZ been_VBN identified_VBN in_IN studies_NNS conducted_VBN in_IN Worcester_NNP ,_, U._NNP ,_, and_CC Montreal_NNP ,_, Canada_NNP ._. 
We_PRP observed_VBD that_IN the_DT low_JJ income_NN only_RB predicted_VBD access_NN significantly_RB within_IN the_DT medium_NN and_CC high_JJ exposure_NN zones_NNS and_CC not_RB the_DT low_JJ exposure_NN area_NN ._. 
Birch_FW et_FW al._FW ._. 
Among_IN studies_NNS that_WDT did_VBD not_RB consider_VB temporality_NN ,_, but_CC rather_RB focused_VBN on_IN spatiality_NN ,_, efforts_NNS have_VBP included_VBN controlling_VBG for_IN health_NN service_NN environments_NNS as_IN different_JJ among_IN Public_NNP Health_NNP Units_NNS 
Gwynn_NNP and_CC Thurston_NNP 
This_DT stems_VBZ from_IN provider_NN inability_NN to_TO determine_VB the_DT needs_NNS of_IN those_DT who_WP do_VBP not_RB present_VB themselves_PRP as_IN patients_NNS ,_, which_WDT is_VBZ a_DT problem_NN reflected_VBN in_IN the_DT geography_NN of_IN health_NN care_NN literature_NN concerned_VBN with_IN the_DT spatial_JJ organization_NN of_IN health_NN services_NNS ._. 
Geographic_JJ analysis_NN of_IN health_NN care_NN draws_VBZ attention_NN to_TO the_DT complexity_NN of_IN population_NN needs_NNS in_IN health_NN service_NN access_NN and_CC utilization_NN ._. 
The_DT argument_NN is_VBZ that_IN the_DT relationships_NNS between_IN individual_JJ ,_, population_NN and_CC neighborhood_NN characteristics_NNS that_WDT determine_VBP need_NN in_IN a_DT particular_JJ context_NN -LRB-_-LRB- e._SYM 
However_RB ,_, SES_NNP inequities_NNS in_IN utilization_NN appeared_VBD attenuated_VBN after_IN initial_JJ contact_NN with_IN the_DT primary_JJ care_NN system_NN ._. 
Among_IN studies_NNS that_WDT did_VBD not_RB consider_VB temporality_NN ,_, but_CC rather_RB focused_VBN on_IN spatiality_NN ,_, efforts_NNS have_VBP included_VBN controlling_VBG for_IN health_NN service_NN environments_NNS as_IN different_JJ among_IN Public_NNP Health_NNP Units_NNS 
However_RB ,_, SES_NNP inequities_NNS in_IN utilization_NN appeared_VBD attenuated_VBN after_IN initial_JJ contact_NN with_IN the_DT primary_JJ care_NN system_NN ._. 
Among_IN studies_NNS that_WDT did_VBD not_RB consider_VB temporality_NN ,_, but_CC rather_RB focused_VBN on_IN spatiality_NN ,_, efforts_NNS have_VBP included_VBN controlling_VBG for_IN health_NN service_NN environments_NNS as_IN different_JJ among_IN Public_NNP Health_NNP Units_NNS 
Analysis_NNP Binary_NNP logistic_JJ regression_NN models_NNS for_IN the_DT dependant_JJ variables_NNS were_VBD built_VBN in_IN which_WDT each_DT consecutive_JJ ,_, conceptually_RB grouped_VBN ,_, block_NN of_IN variables_NNS were_VBD entered_VBN into_IN a_DT stepwise_JJ regression_NN algorithm_NN -LRB-_-LRB- SES_NNP ,_, health_NN and_CC behavior_NN ,_, community_NN context_NN ,_, and_CC pollution_NN health_NN effects_NNS -RRB-_-RRB- following_VBG forced_JJ entry_NN of_IN a_DT priori_FW variables_NNS ._. 
The_DT a_DT priori_FW variables_NNS were_VBD chosen_VBN because_IN of_IN their_PRP$ influence_NN as_IN demonstrated_VBN in_IN previous_JJ studies_NNS and_CC included_VBD age_NN ,_, sex_NN ,_, family_NN doctor_NN ,_, chronic_JJ disease_NN and_CC mental_JJ health_NN in_IN the_DT GP_NNP use_NN model_NN 
The_DT role_NN of_IN odour_NN annoyance_NN as_IN a_DT stressor_NN in_IN Sarnia_NNP is_VBZ consistent_JJ with_IN work_NN by_IN Shusterman_NNP et_FW al._FW ._. 
We_PRP also_RB found_VBD that_IN high_JJ exposure_NN ranked_VBD respondents_NNS were_VBD more_RBR likely_JJ than_IN low_JJ ranked_VBN respondents_NNS to_TO lack_VB GP_NNP access_NN if_IN renting_NN ,_, which_WDT provides_VBZ further_JJ support_NN for_IN low_JJ SES_NNP being_VBG a_DT barrier_NN to_TO health_NN care_NN ._. 
However_RB ,_, existing_VBG literature_NN indicates_VBZ that_IN people_NNS exposed_VBN to_TO higher_JJR levels_NNS of_IN air_NN pollution_NN are_VBP particularly_RB vulnerable_JJ to_TO the_DT effects_NNS of_IN inequitable_JJ access_NN to_TO primary_JJ health_NN care_NN 
Access_NN to_TO primary_JJ care_NN helps_VBZ prevent_VB illness_NN and_CC death_NN ,_, and_CC is_VBZ also_RB more_RBR highly_RB associated_VBN with_IN equitable_JJ distribution_NN of_IN health_NN in_IN populations_NNS than_IN specialty_NN care_NN 
This_DT could_MD be_VB because_IN of_IN gender_NN differences_NNS in_IN cognitive_JJ and_CC affective_JJ processes_NNS 
This_DT could_MD be_VB because_IN of_IN gender_NN differences_NNS in_IN cognitive_JJ and_CC affective_JJ processes_NNS 
Mental_NNP health_NN was_VBD measured_VBN using_VBG the_DT General_NNP Health_NNP Questionnaire_NNP -LRB-_-LRB- GHQ_NNP -_: 20_CD items_NNS -RRB-_-RRB- ._. 
Control_NN symptoms_NNS -LRB-_-LRB- backpain_JJ ,_, jointpain_JJ and_CC easy_JJ bruising_VBG -RRB-_-RRB- not_RB likely_RB related_VBN to_TO air_NN pollution_NN were_VBD also_RB included_VBN ._. 
Those_DT who_WP provided_VBD positive_JJ responses_NNS to_TO at_IN least_JJS four_CD of_IN the_DT questions_NNS were_VBD categorised_VBN as_RB emotionally_RB distressed_JJ 
Socioeconomic_JJ and_CC Demographic_JJ Characteristics_NNS Age_NNP was_VBD included_VBN as_IN a_DT categorical_JJ variable_NN with_IN the_DT intervals_NNS 18-24_CD ,_, 25-44_CD ,_, 45-64_CD ,_, and_CC 65_CD or_CC older_JJR ,_, while_IN males_NNS were_VBD used_VBN as_IN the_DT reference_NN category_NN for_IN the_DT influence_NN of_IN sex_NN ._. 
Income_NN below_IN the_DT Statistics_NNPS Canada_NNP Low_NNP Income_NNP Cut-Off_NNP 
Thompson_NNP et_FW al._FW ._. 
Therefore_RB ,_, we_PRP suggest_VBP that_IN NO_RB 2_CD ,_, BTEX_NNP and_CC SO_NNP 2_CD in_IN Chemical_NNP valley_NN increase_NN health_NN care_NN utilization_NN because_IN of_IN their_PRP$ effects_NNS on_IN respiratory_JJ and_CC cardiovascular_JJ diseases_NNS prominently_RB featured_VBN in_IN the_DT area_NN 
For_IN a_DT comprehensive_JJ review_NN of_IN LUR_NNP models_NNS for_IN exposure_NN assessment_NN in_IN epidemiologic_JJ studies_NNS see_VBP Hoek_NNP et_FW al._FW ._. ._. 
We_PRP controlled_VBD for_IN personal_JJ exposure_NN by_IN asking_VBG the_DT respondent_NN what_WDT number_NN of_IN outdoor_JJ -LRB-_-LRB- gases_NNS ,_, dusts_VBZ ,_, fumes_VBZ ,_, and_CC pesticides_NNS -RRB-_-RRB- or_CC indoor_JJ -LRB-_-LRB- pets_NNS ,_, carpets_NNS ,_, rugs_NNS and_CC fireplaces_NNS -RRB-_-RRB- irritants_NNS to_TO which_WDT they_PRP were_VBD regularly_RB exposed_VBN ._. 
Table_NNP 1_CD Explanatory_JJ variables_NNS in_IN final_JJ logistics_NNS model_NN Variable_NNP Type_NNP Coding_NNP Demographic_NNP Age_NNP of_IN respondent_NN Categorical_NNP 18-24_CD \*_NN vs_NNS 25-44_CD ,_, 45-64_CD ,_, 65_CD +_NN Gender_NNP Categorical_NNP Male_NNP \*_NN vs_VBZ Female_NNP Exposure_NNP Nitrogen_NNP dioxide_NN -LRB-_-LRB- NO_UH 2_CD -RRB-_-RRB- Continuous_NNP Sulphur_NNP dioxide_NN -LRB-_-LRB- SO_RB 2_CD -RRB-_-RRB- Continuous_NNP Benzene_NNP ,_, toluene_NN ,_, ethylbenzene_NN and_CC xylenes_NNS -LRB-_-LRB- BTEX_NNP -RRB-_-RRB- Continuous_NNP Gas_NNP ,_, dust_NN ,_, fumes_VBZ and_CC pesticides_NNS -LRB-_-LRB- outdoor_JJ exposure_NN -RRB-_-RRB- Continuous_JJ Pets_NNS ,_, carpets_NNS ,_, rugs_NNS and_CC fireplace_NN -LRB-_-LRB- indoor_JJ exposure_NN -RRB-_-RRB- Continuous_NNP Socioeconomic_NNP Marital_NNP status_NN Categorical_NNP Partner_NNP \*_NN vs_VBZ No_DT partner_NN High_JJ school_NN graduate_NN -LRB-_-LRB- education_NN -RRB-_-RRB- Categorical_NNP Yes_NNP \*_NN vs_VBZ No_NNP Below_NNP Low_NNP Income_NNP Cut_NNP Off_IN Categorical_NNP No_NNP \*_NN vs_VBZ yes_RB Employment_NNP status_NN Categorical_NNP Employed_NNP \*_NN ,_, Other_NNP ,_, Unemployed_NNP Children_NNP under_IN 18_CD -LRB-_-LRB- children_NNS -RRB-_-RRB- Categorical_JJ No_DT \*_NN vs_VBZ yes_RB Housing_NN tenure_NN Categorical_NNP Owned_NNP \*_NN vs_NNS rented_VBD Housing_NN condition_NN Categorical_NNP Sastisfactory_NNP \*_NN vs_NNS needs_VBZ repair_NN Health_NNP Behaviour_NNP Frequency_NN of_IN monthly_JJ alcohol_NN use_NN Continuous_JJ Regular_JJ smoker_NN Categorical_NNP No_NNP \*_NN vs_VBZ Yes_NNP Hours_NNS of_IN weekly_JJ exercise_NN Continuous_NNP Voluntary_NNP Medical_NNP Check-up_NNP Categorical_NNP No_NNP \*_NN vs_VBZ Yes_NNP Community_NNP 
The_DT results_NNS demonstrate_VBP that_IN there_EX are_VBP significant_JJ and_CC specific_JJ impacts_NNS of_IN different_JJ pollutants_NNS and_CC their_PRP$ spatial_JJ distributions_NNS on_IN primary_JJ care_NN access_NN and_CC utilization_NN ._. 
Aprevious_JJ study_NN in_IN Sarnia_NNP found_VBD that_IN high_JJ annoyance_NN scores_NNS were_VBD significantly_RB related_VBN to_TO both_DT NO2_CD and_CC SO2_CD levels_NNS 
General_JJ symptoms_NNS were_VBD defined_VBN as_IN those_DT likely_JJ to_TO be_VB caused_VBN by_IN stress-mediated_JJ mechanisms_NNS of_IN pollution_NN and_CC included_VBD chest_NN pains_NNS ,_, headaches_NNS ,_, dizzy_JJ spells_NNS ,_, sleep_NN problems_NNS ,_, stomach_NN aches_NNS ,_, diarrhea_NN and_CC loss_NN of_IN appetite_NN ._. 
Cardinal_NNP symptoms_NNS were_VBD defined_VBN as_IN those_DT likely_JJ to_TO be_VB the_DT result_NN of_IN irritant_JJ properties_NNS of_IN air_NN pollution_NN and_CC included_VBD coughs_NNS ,_, wheezing\/breathing_VBG problems_NNS ,_, nausea_NN ,_, sinus_NN congestion_NN ,_, colds_NNS ,_, skin_NN rashes_NNS ,_, eye_NN ,_, nose_NN or_CC throat_NN irritations_NNS ,_, earaches_NNS and_CC nosebleeds_NNS ._. 
Control_NN symptoms_NNS -LRB-_-LRB- backpain_NN ,_, 
Control_NN symptoms_NNS -LRB-_-LRB- backpain_JJ ,_, jointpain_JJ and_CC easy_JJ bruising_VBG -RRB-_-RRB- not_RB likely_RB related_VBN to_TO air_NN pollution_NN were_VBD also_RB included_VBN ._. 
Mental_NNP health_NN was_VBD measured_VBN using_VBG the_DT General_NNP Health_NNP Questionnaire_NNP -LRB-_-LRB- GHQ_NNP -_: 20_CD items_NNS -RRB-_-RRB- 
Therefore_RB we_PRP used_VBD these_DT questions_NNS to_TO evaluate_VB short-term_JJ effects_NNS of_IN air_NN pollution_NN on_IN health_NN care_NN utilization_NN and_CC equitable_JJ access_NN to_TO services_NNS ,_, and_CC furthermore_RB identify_VB the_DT inherent_JJ mediating_NN factors_NNS that_WDT contribute_VBP to_TO both_DT ._. 
Independent_NNP VariablesExposure_NNP AssessmentDuring_NNP administration_NN of_IN the_DT survey_NN several_JJ ambient_JJ air_NN pollutants_NNS including_VBG nitrogen_NN dioxide_NN -LRB-_-LRB- NO2_NNP -RRB-_-RRB- ,_, sulphur_NN dioxide_NN -LRB-_-LRB- SO2_CD -RRB-_-RRB- and_CC the_DT volatile_JJ organic_JJ compounds_NNS benzene_NN ,_, toluene_NN ,_, ethylbenzene_NN ,_, mp_NN -_: and_CC o-xylene_JJ -LRB-_-LRB- BTEX_NNP -RRB-_-RRB- were_VBD monitored_VBN at_IN 39_CD locations_NNS across_IN the_DT city_NN of_IN Sarnia_NNP for_IN 2_CD weeks_NNS in_IN October_NNP 2005_CD ._. 
Land_NN use_NN regression_NN -LRB-_-LRB- LUR_NNP -RRB-_-RRB- was_VBD utilized_VBN to_TO model_VB the_DT ambient_JJ NO_UH 2_CD ,_, SO_RB 2_CD and_CC total_JJ BTEX_NNP concentrations_NNS because_IN of_IN its_PRP$ potential_NN to_TO provide_VB spatial_JJ pollution_NN estimates_NNS in_IN small-areas_NNS without_IN the_DT data_NN requirements_NNS and_CC related_JJ expenses_NNS incurred_VBN in_IN other_JJ exposure_NN modelling_NN techniques_NNS ,_, such_JJ as_IN dispersion_NN 
Independent_NNP Variables_NNP Exposure_NNP Assessment_NNP During_IN administration_NN of_IN the_DT survey_NN several_JJ ambient_JJ air_NN pollutants_NNS including_VBG nitrogen_NN dioxide_NN -LRB-_-LRB- NO_UH 2_CD -RRB-_-RRB- ,_, sulphur_NN dioxide_NN -LRB-_-LRB- SO_RB 2_CD -RRB-_-RRB- and_CC the_DT volatile_JJ organic_JJ compounds_NNS benzene_NN ,_, toluene_NN ,_, ethylbenzene_NN ,_, mp_NN -_: and_CC o-xylene_JJ -LRB-_-LRB- BTEX_NNP -RRB-_-RRB- were_VBD monitored_VBN at_IN 39_CD locations_NNS across_IN the_DT city_NN of_IN Sarnia_NNP for_IN 2_CD weeks_NNS in_IN October_NNP 2005_CD ._. 
Land_NN use_NN regression_NN -LRB-_-LRB- LUR_NNP -RRB-_-RRB- was_VBD utilized_VBN to_TO model_VB the_DT ambient_JJ NO2_NNP ,_, SO2_NNP and_CC total_JJ BTEX_NNP concentrations_NNS because_IN of_IN its_PRP$ potential_NN to_TO provide_VB spatial_JJ pollution_NN estimates_NNS in_IN small-areas_NNS without_IN the_DT data_NN requirements_NNS and_CC related_JJ expenses_NNS incurred_VBN in_IN other_JJ exposure_NN modelling_NN techniques_NNS ,_, such_JJ as_IN dispersion_NN 
Independent_NNP Variables_NNP Exposure_NNP Assessment_NNP During_IN administration_NN of_IN the_DT survey_NN several_JJ ambient_JJ air_NN pollutants_NNS including_VBG nitrogen_NN dioxide_NN -LRB-_-LRB- NO_UH 2_CD -RRB-_-RRB- ,_, sulphur_NN dioxide_NN -LRB-_-LRB- SO_RB 2_CD -RRB-_-RRB- and_CC the_DT volatile_JJ organic_JJ compounds_NNS benzene_NN ,_, toluene_NN ,_, ethylbenzene_NN ,_, mp_NN -_: and_CC o-xylene_JJ -LRB-_-LRB- BTEX_NNP -RRB-_-RRB- were_VBD monitored_VBN at_IN 39_CD locations_NNS across_IN the_DT city_NN of_IN Sarnia_NNP for_IN 2_CD weeks_NNS in_IN October_NNP 2005_CD ._. 
Land_NN use_NN regression_NN -LRB-_-LRB- LUR_NNP -RRB-_-RRB- was_VBD utilized_VBN to_TO model_VB the_DT ambient_JJ NO2_NNP ,_, SO2_NNP and_CC total_JJ BTEX_NNP concentrations_NNS because_IN of_IN its_PRP$ potential_NN to_TO provide_VB spatial_JJ pollution_NN estimates_NNS in_IN small-areas_NNS without_IN the_DT data_NN requirements_NNS and_CC related_JJ expenses_NNS incurred_VBN in_IN other_JJ exposure_NN modelling_NN techniques_NNS ,_, such_JJ as_IN dispersion_NN 
Land_NN use_NN regression_NN -LRB-_-LRB- LUR_NNP -RRB-_-RRB- was_VBD utilized_VBN to_TO model_VB the_DT ambient_JJ NO_UH 2_CD ,_, SO_RB 2_CD and_CC total_JJ BTEX_NNP concentrations_NNS because_IN of_IN its_PRP$ potential_NN to_TO provide_VB spatial_JJ pollution_NN estimates_NNS in_IN small-areas_NNS without_IN the_DT data_NN requirements_NNS and_CC related_JJ expenses_NNS incurred_VBN in_IN other_JJ exposure_NN modelling_NN techniques_NNS ,_, such_JJ as_IN dispersion_NN 
Research_NN on_IN beliefs_NNS regarding_VBG toxicity_NN of_IN environmental_JJ pollution_NN suggests_VBZ that_IN ``_`` if_IN environments_NNS smell_VBP bad_JJ ,_, they_PRP 're_VBP probably_RB damaging_VBG to_TO health_NN ''_'' 
Consistent_JJ with_IN earlier_JJR studies_NNS 
Consequently_RB ,_, perceived_VBN personal_JJ susceptibility_NN and_CC severity_NN of_IN health_NN threats_NNS are_VBP modified_VBN by_IN psychosocial_JJ factors_NNS ,_, which_WDT thereafter_RB can_MD influence_VB compliance_NN with_IN medical_JJ recommendations_NNS and_CC perceived_VBN benefits_NNS of_IN preventive_JJ action_NN 
Astudy_NNP that_WDT looked_VBD at_IN access_NN to_TO family_NN physicians_NNS in_IN Southwestern_NNP Ontario_NNP found_VBD that_IN of_IN the_DT 9_CD ._. 
Our_PRP$ measure_NN of_IN access_NN did_VBD not_RB include_VB alternative_JJ sources_NNS of_IN care_NN such_JJ as_IN walk-in_JJ clinics_NNS ,_, Telehealth_NNP Ontario_NNP -LRB-_-LRB- free_JJ telephone_NN consultation_NN with_IN a_DT registered_JJ nurse_NN -RRB-_-RRB- and_CC nurse_NN practitioners_NNS ,_, and_CC these_DT providers_NNS arguably_RB represent_VBP important_JJ points_NNS of_IN access_NN for_IN certain_JJ deprived_VBN populations_NNS identified_VBN in_IN this_DT study_NN ._. 
1%_CD of_IN the_DT population_NN that_WDT did_VBD not_RB have_VB regular_JJ care_NN ,_, 55_CD %_NN used_VBD walk-in_JJ clinics_NNS and_CC 13_CD %_NN used_VBD emergency_NN rooms_NNS as_IN their_PRP$ source_NN of_IN care_NN ._. 
The_DT study_NN was_VBD also_RB limited_VBN by_IN lacking_VBG longitudinal_JJ measures_NNS of_IN health_NN and_CC SES_NNP as_IN the_DT study_NN used_VBD a_DT cross-sectional_JJ design_NN ._. 
g._NNP Our_NNP results_NNS suggest_VBP that_IN low_JJ SES_NNP and_CC stress_NN enhanced_VBN by_IN odour_NN annoyance_NN may_MD be_VB compounding_VBG health_NN care_NN demands_NNS ,_, possibly_RB due_JJ to_TO increased_VBN susceptibility_NN to_TO adverse_JJ pollution_NN impacts_NNS -LRB-_-LRB- e._NN ,_, compromised_VBN immune_JJ system_NN -RRB-_-RRB- ._. 
This_DT `_`` double_JJ burden_NN of_IN deprivation_NN '_'' has_VBZ been_VBN identified_VBN in_IN studies_NNS conducted_VBN in_IN Worcester_NNP ,_, U._NNP S._NNP A._NN 
Further_JJ research_NN is_VBZ required_VBN to_TO determine_VB the_DT apparent_JJ challenges_NNS of_IN delivering_VBG primary_JJ health_NN care_NN services_NNS to_TO these_DT areas_NNS and_CC their_PRP$ populations_NNS ._. 
Although_IN levels_NNS of_IN estimated_VBN exposure_NN for_IN respondents_NNS in_IN the_DT current_JJ study_NN were_VBD within_IN provincial_JJ guidelines_NNS ,_, our_PRP$ monitoring_NN methods_NNS were_VBD not_RB able_JJ to_TO capture_VB the_DT impact_NN of_IN individual_JJ release_NN events_NNS of_IN airborne_JJ toxins_NNS or_CC ``_`` bad_JJ air_NN days_NNS ''_'' ;_: they_PRP are_VBP not_RB uncommon_JJ and_CC are_VBP occasionally_RB accompanied_VBN by_IN warning_VBG sirens_NNS and_CC emergency_NN response_NN guides_NNS that_WDT demand_VBP individual_JJ coping_VBG mechanisms_NNS ._. 
We_PRP can_MD assume_VB that_IN residents_NNS at_IN risk_NN from_IN chronic_JJ exposure_NN are_VBP the_DT same_JJ residents_NNS at_IN most_JJS risk_NN from_IN these_DT events_NNS ._. 
The_DT pseudo_NN R_NN 2_CD values_NNS and_CC model_NN scores_NNS indicated_VBD that_IN the_DT GP_NNP access_NN models_NNS were_VBD in_IN general_JJ stronger_JJR than_IN for_IN GP_NNP use_NN ._. 
This_DT is_VBZ because_IN it_PRP is_VBZ much_RB more_RBR difficult_JJ to_TO capture_VB the_DT innumerable_JJ reasons_NNS for_IN visiting_VBG a_DT GP_NNP versus_IN the_DT population_NN characteristics_NNS associated_VBN with_IN health_NN care_NN access_NN ._. 
The_DT Hosmer-Lemeshow_NNP chi-square_NN statistics_NNS indicated_VBD that_IN the_DT goodness_NN of_IN fit_NN in_IN the_DT final_JJ mode_NN 
Aprevious_JJ study_NN in_IN Sarnia_NNP found_VBD that_IN high_JJ annoyance_NN scores_NNS were_VBD significantly_RB related_VBN to_TO both_DT NO_RB 2_CD and_CC SO_RB 2_CD levels_NNS 
Negative_JJ perceptions_NNS about_IN the_DT environmental_JJ health_NN of_IN one_NN 's_POS neighborhood_NN can_MD influence_VB health_NN outcomes_NNS along_IN with_IN predisposing_VBG determinants_NNS of_IN health_NN 
As_IN suggested_VBN by_IN Hosmer_NNP and_CC Lemeshow_NNP a_DT less_RBR stringent_JJ significance_NN level_NN of_IN 0_CD ._. 
The_DT variables_NNS that_WDT made_VBD a_DT significant_JJ contribution_NN to_TO the_DT model_NN at_IN the_DT entry_NN of_IN each_DT block_NN were_VBD retained_VBN and_CC included_VBN in_IN the_DT next_JJ block_NN ._. 
15_CD for_IN inclusion_NN was_VBD utilized_VBN to_TO ensure_VB variables_NNS with_IN coefficients_NNS different_JJ from_IN zero_CD were_VBD included_VBN ._. 
Based_VBN on_IN our_PRP$ study_NN objectives_NNS ,_, we_PRP examined_VBD if_IN burdens_NNS of_IN air_NN pollution_NN were_VBD borne_VBN by_IN residents_NNS of_IN Sarnia_NNP who_WP were_VBD also_RB at_IN a_DT disadvantage_NN with_IN respect_NN to_TO health_NN care_NN access_NN ._. 
A._NNP S._NNP This_NNP `_`` double_JJ burden_NN of_IN deprivation_NN '_'' has_VBZ been_VBN identified_VBN in_IN studies_NNS conducted_VBN in_IN Worcester_NNP ,_, U._NNP ,_, and_CC Montreal_NNP ,_, Canada_NNP ._. 
We_PRP observed_VBD that_IN the_DT low_JJ income_NN only_RB predicted_VBD access_NN significantly_RB within_IN the_DT medium_NN and_CC high_JJ exposure_NN zones_NNS and_CC not_RB the_DT low_JJ exposure_NN area_NN ._. 
This_DT is_VBZ consistent_JJ with_IN reports_NNS based_VBN on_IN the_DT 2005_CD Canadian_NNP Communities_NNP Health_NNP Survey_NNP data_NNS ,_, which_WDT found_VBD that_IN older_JJR people_NNS and_CC females_NNS used_VBD health_NN care_NN services_NNS more_RBR often_RB than_IN their_PRP$ young_JJ and_CC male_JJ counter_NN parts_NNS 
1_CD 
Power_NN transformations_NNS were_VBD applied_VBN to_TO several_JJ of_IN the_DT continuous_JJ variables_NNS for_IN the_DT regression_NN analysis_NN as_IN their_PRP$ distributions_NNS were_VBD skewed_VBN -LRB-_-LRB- Figure_NNP 2_CD -RRB-_-RRB- ._. 
To_TO evaluate_VB the_DT combined_JJ impact_NN of_IN pollutants_NNS each_DT respondent_NN was_VBD subsequently_RB ranked_VBN based_VBN on_IN estimated_VBN exposure_NN to_TO NO2_NNP and_CC SO2_NNP ,_, the_DT results_NNS of_IN which_WDT were_VBD in_IN turn_NN summed_VBD and_CC ranked_VBD to_TO assign_VB an_DT overall_JJ exposure_NN rank_NN to_TO individual_JJ respondents_NNS -LRB-_-LRB- 1-804_CD -RRB-_-RRB- ._. 
We_PRP split_VBD the_DT sample_NN into_IN tertiles_NNS of_IN low_JJ ,_, medium_JJ and_CC high_JJ rank_NN in_IN order_NN to_TO compare_VB the_DT determinants_NNS of_IN health_NN care_NN access_NN and_CC utilization_NN in_IN spatially_RB representable_JJ sub-samples_NNS -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ._. 
Analysis_NNP Binary_NNP logistic_JJ regression_NN models_NNS for_IN the_DT dependant_JJ variables_NNS were_VBD built_VBN in_IN which_WDT each_DT consecutive_JJ ,_, conceptually_RB grouped_VBN ,_, block_NN of_IN variables_NNS were_VBD entered_VBN into_IN a_DT stepwise_JJ regression_NN algorithm_NN -LRB-_-LRB- SES_NNP ,_, health_NN and_CC behavior_NN ,_, community_NN context_NN ,_, and_CC pollution_NN health_NN effects_NNS -RRB-_-RRB- following_VBG forced_JJ entry_NN of_IN a_DT priori_FW variables_NNS ._. 
The_DT a_DT priori_FW variables_NNS were_VBD chosen_VBN because_IN of_IN their_PRP$ influence_NN as_IN demonstrated_VBN in_IN previous_JJ studies_NNS and_CC included_VBD age_NN ,_, sex_NN ,_, family_NN doctor_NN ,_, chronic_JJ disease_NN and_CC mental_JJ health_NN in_IN the_DT GP_NNP use_NN model_NN and_CC income_NN ,_, age_NN ,_, sex_NN ,_, unmet_JJ health_NN care_NN needs_NNS in_IN past_JJ 12_CD months_NNS and_CC 
6%_CD in_IN 2005_CD and_CC 91_CD ._. 
7%_CD in_IN 2009_CD ,_, but_CC in_IN Ontario_NNP the_DT numbers_NNS were_VBD 91_CD ._. 
4%_CD in_IN 2005_CD to_TO 84_CD ._. 
In_IN Canada_NNP the_DT figure_NN changed_VBD from_IN 86_CD ._. 
0%_CD in_IN 2009_CD ._. 
Aproportion_NNP of_IN 23_CD ._. 
2%_CD of_IN respondents_NNS indicated_VBD they_PRP had_VBD visited_VBN or_CC spoken_VBN with_IN a_DT GP_NNP during_IN the_DT two-week_JJ study_NN period_NN ._. 
Analysis_NNP Binary_NNP logistic_JJ regression_NN models_NNS for_IN the_DT dependant_JJ variables_NNS were_VBD built_VBN in_IN which_WDT each_DT consecutive_JJ ,_, conceptually_RB grouped_VBN ,_, block_NN of_IN variables_NNS were_VBD entered_VBN into_IN a_DT stepwise_JJ regression_NN algorithm_NN -LRB-_-LRB- SES_NNP ,_, health_NN and_CC behavior_NN ,_, community_NN context_NN ,_, and_CC pollution_NN health_NN effects_NNS -RRB-_-RRB- following_VBG forced_JJ entry_NN of_IN a_DT priori_FW variables_NNS ._. 
The_DT a_DT priori_FW variables_NNS were_VBD chosen_VBN because_IN of_IN their_PRP$ influence_NN as_IN demonstrated_VBN in_IN previous_JJ studies_NNS and_CC included_VBD age_NN ,_, sex_NN ,_, family_NN doctor_NN ,_, chronic_JJ disease_NN and_CC mental_JJ health_NN in_IN the_DT GP_NNP use_NN model_NN 
The_DT sample_NN characteristics_NNS suggest_VBP that_IN the_DT sub-population_NN of_IN Sarnia_NNP without_IN a_DT family_NN physician_NN or_CC a_DT regular_JJ care_NN provider_NN is_VBZ disproportionately_RB composed_VBN of_IN younger_JJR males_NNS ._. 
This_DT is_VBZ consistent_JJ with_IN reports_NNS based_VBN on_IN the_DT 2005_CD Canadian_NNP Communities_NNP Health_NNP Survey_NNP data_NNS ,_, which_WDT found_VBD that_IN older_JJR people_NNS and_CC females_NNS used_VBD health_NN care_NN services_NNS more_RBR often_RB than_IN their_PRP$ young_JJ and_CC male_JJ counter_NN parts_NNS 
g._VB These_DT housing_NN variables_NNS were_VBD included_VBN in_IN the_DT analysis_NN to_TO control_VB for_IN their_PRP$ potential_JJ influence_NN on_IN health_NN and_CC as_IN an_DT additional_JJ SES_NNP measure_NN -LRB-_-LRB- e._FW ,_, -RRB-_-RRB- ._. 
Analysis_NNP Binary_NNP logistic_JJ regression_NN models_NNS for_IN the_DT dependant_JJ variables_NNS were_VBD built_VBN in_IN which_WDT each_DT consecutive_JJ ,_, conceptually_RB grouped_VBN ,_, block_NN of_IN variables_NNS were_VBD entered_VBN into_IN a_DT stepwise_JJ regression_NN algorithm_NN -LRB-_-LRB- SES_NNP ,_, health_NN and_CC behavior_NN ,_, community_NN context_NN ,_, and_CC pollution_NN health_NN effects_NNS -RRB-_-RRB- following_VBG forced_JJ entry_NN of_IN a_DT priori_FW variables_NNS ._. 
Therefore_RB we_PRP used_VBD these_DT questions_NNS to_TO evaluate_VB short-term_JJ effects_NNS of_IN air_NN pollution_NN on_IN health_NN care_NN utilization_NN and_CC equitable_JJ access_NN to_TO services_NNS ,_, and_CC furthermore_RB identify_VB the_DT inherent_JJ mediating_NN factors_NNS that_WDT contribute_VBP to_TO both_DT ._. 
Independent_NNP VariablesExposure_NNP AssessmentDuring_NNP administration_NN of_IN the_DT survey_NN several_JJ ambient_JJ air_NN pollutants_NNS including_VBG nitrogen_NN dioxide_NN -LRB-_-LRB- NO2_NNP -RRB-_-RRB- ,_, sulphur_NN dioxide_NN -LRB-_-LRB- SO2_CD -RRB-_-RRB- and_CC the_DT volatile_JJ organic_JJ compounds_NNS benzene_NN ,_, toluene_NN ,_, ethylbenzene_NN ,_, mp_NN -_: and_CC o-xylene_JJ -LRB-_-LRB- BTEX_NNP -RRB-_-RRB- were_VBD monitored_VBN at_IN 39_CD locations_NNS across_IN the_DT city_NN of_IN Sarnia_NNP for_IN 2_CD weeks_NNS in_IN October_NNP 2005_CD ._. 
Land_NN use_NN regression_NN -LRB-_-LRB- LUR_NNP -RRB-_-RRB- was_VBD utilized_VBN to_TO model_VB the_DT ambient_JJ NO_UH 2_CD ,_, SO_RB 2_CD and_CC total_JJ BTEX_NNP concentrations_NNS because_IN of_IN its_PRP$ potential_NN to_TO provide_VB spatial_JJ pollution_NN estimates_NNS in_IN small-areas_NNS without_IN the_DT data_NN requirements_NNS and_CC related_JJ expenses_NNS incurred_VBN in_IN other_JJ exposure_NN modelling_NN techniques_NNS ,_, such_JJ as_IN dispersion_NN 
''_'' Similar_JJ questions_NNS have_VBP been_VBN used_VBN in_IN previous_JJ health_NN care_NN utilization_NN studies_NNS 
Nonetheless_RB ,_, access_NN to_TO a_DT regular_JJ medical_JJ doctor_NN is_VBZ supposed_VBN to_TO be_VB equitable_JJ and_CC represents_VBZ a_DT particular_JJ aspect_NN of_IN quality_NN of_IN care_NN ,_, because_IN continuity_NN of_IN regular_JJ care_NN can_MD strongly_RB influence_VB health_NN care_NN satisfaction_NN and_CC use_NN of_IN health_NN care_NN services_NNS 
Hence_RB this_DT conceptualization_NN of_IN access_NN may_MD be_VB a_DT limited_VBN measure_NN of_IN the_DT potential_NN for_IN health_NN care_NN use_NN ._. 
Nonetheless_RB ,_, access_NN to_TO a_DT regular_JJ medical_JJ doctor_NN is_VBZ supposed_VBN to_TO be_VB equitable_JJ and_CC represents_VBZ a_DT particular_JJ aspect_NN of_IN quality_NN of_IN care_NN ,_, because_IN continuity_NN of_IN regular_JJ care_NN can_MD strongly_RB influence_VB health_NN care_NN satisfaction_NN and_CC use_NN of_IN health_NN care_NN services_NNS 
The_DT sample_NN represented_VBD approximately_RB 1_CD %_NN of_IN the_DT Sarnia_NNP population_NN ,_, yielding_VBG a_DT total_NN of_IN 804_CD respondents_NNS with_IN a_DT response_NN rate_NN of_IN 62_CD %_NN ._. 
This_DT sample_NN size_NN was_VBD determined_VBN to_TO be_VB sufficiently_RB large_JJ for_IN the_DT number_NN of_IN variables_NNS included_VBN in_IN the_DT analyses_NNS ._. 
The_DT study_NN was_VBD approved_VBN by_IN the_DT Social_NNP Sciences_NNP Research_NNP Ethics_NNP Board_NNP at_IN The_NNP University_NNP of_IN Western_NNP Ontario_NNP ._. 
Fung_NNP and_CC colleagues_NNS showed_VBD that_IN rates_NNS of_IN hospitalization_NN were_VBD significantly_RB higher_JJR in_IN Sarnia_NNP than_IN Windsor_NNP and_CC London_NNP ,_, two_CD nearby_JJ cities_NNS in_IN Southwestern_NNP Ontario_NNP ._. 
Furthermore_RB ,_, a_DT study_NN focused_VBN on_IN the_DT Aamjiwnaang_NNP First_NNP Nation_NNP 's_POS reserve_NN ,_, which_WDT is_VBZ surrounded_VBN by_IN Chemical_NNP Valley_NNP -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ,_, reported_VBD a_DT sex_NN ratio_NN of_IN 2:1_CD in_IN favor_NN of_IN females_NNS and_CC attributed_VBD this_DT anomaly_NN to_TO accumulative_JJ effects_NNS of_IN pollution_NN 
Fung_NNP and_CC colleagues_NNS showed_VBD that_IN rates_NNS of_IN hospitalization_NN were_VBD significantly_RB higher_JJR in_IN Sarnia_NNP than_IN Windsor_NNP and_CC London_NNP ,_, two_CD nearby_JJ cities_NNS in_IN Southwestern_NNP Ontario_NNP ._. 
Furthermore_RB ,_, a_DT study_NN focused_VBN on_IN the_DT Aamjiwnaang_NNP First_NNP Nation_NNP 's_POS reserve_NN ,_, which_WDT is_VBZ surrounded_VBN by_IN Chemical_NNP Valley_NNP -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ,_, reported_VBD a_DT sex_NN ratio_NN of_IN 2:1_CD in_IN favor_NN of_IN females_NNS and_CC attributed_VBD this_DT anomaly_NN to_TO accumulative_JJ effects_NNS of_IN pollution_NN 
Sarnia_NNP is_VBZ also_RB located_VBN within_IN the_DT government_NN designated_VBD St._NNP The_NNP Sarnia_NNP area_NN is_VBZ called_VBN `_`` Chemical_NNP Valley_NNP '_'' as_IN it_PRP is_VBZ home_NN to_TO more_JJR than_IN 40_CD per_IN cent_NN of_IN all_DT chemical_JJ processing_NN facilities_NNS in_IN Canada_NNP ._. 
Clair_NNP River_NNP Area_NNP Of_IN Concern_NN -LRB-_-LRB- AOC_NNP -RRB-_-RRB- ,_, which_WDT among_IN 16_CD other_JJ areas_NNS in_IN Canada_NNP was_VBD declared_VBN in_IN further_JJ need_NN of_IN health_NN investigations_NNS relating_VBG to_TO impacts_NNS of_IN environmental_JJ pollution_NN ._. 
The_DT region_NN is_VBZ also_RB subject_JJ to_TO significant_JJ outputs_NNS of_IN vehicular_JJ exhaust_NN due_JJ to_TO the_DT Canada-US_JJ international_JJ crossing_VBG at_IN Bluewater_NNP Bridge_NNP ,_, and_CC transnational_JJ air_NN and_CC water_NN pollution_NN from_IN Ohio_NNP ,_, Illinois_NNP and_CC Michigan_NNP ._. 
Local_JJ health_NN care_NN providers_NNS are_VBP faced_VBN with_IN resource_NN restraints_NNS that_WDT can_MD make_VB it_PRP difficult_JJ to_TO meet_VB federal_JJ objectives_NNS ,_, and_CC in_IN this_DT study_NN we_PRP seek_VBP to_TO further_RB understand_VB how_WRB the_DT distribution_NN of_IN air_NN pollution_NN is_VBZ associated_VBN with_IN consumption_NN of_IN health_NN care_NN in_IN Sarnia_NNP ,_, Chemical_NNP Valley_NNP ,_, Ontario_NNP 
Results_NNS Sample_NNP Characteristics_NNPS Table_NNP 2_CD shows_VBZ the_DT observed_JJ frequencies_NNS of_IN predictors_NNS within_IN the_DT dependant_JJ variable_JJ classes_NNS and_CC the_DT entire_JJ sample_NN ._. 
Comparing_VBG our_PRP$ sample_NN parameters_NNS to_TO census_NN data_NNS showed_VBD that_IN females_NNS were_VBD slightly_RB over-represented_VBN and_CC with_IN respect_NN to_TO age_VB the_DT sample_NN represented_VBD an_DT older_JJR population_NN than_IN in_IN Sarnia_NNP at_IN large_JJ ._. 
The_DT sample_NN characteristics_NNS suggest_VBP that_IN the_DT sub-population_NN of_IN Sarnia_NNP without_IN a_DT family_NN physician_NN or_CC a_DT regular_JJ care_NN provider_NN is_VBZ disproportionately_RB composed_VBN of_IN younger_JJR males_NNS ._. 
1_CD 
In_IN a_DT Canadian_JJ context_NN ,_, this_DT is_VBZ of_IN particular_JJ interest_NN since_IN the_DT Canada_NNP Health_NNP Act_NNP implicitly_RB assumes_VBZ that_IN care_NN is_VBZ available_JJ to_TO those_DT who_WP are_VBP in_IN need_NN ,_, but_CC individual_JJ providers_NNS have_VBP historically_RB been_VBN trusted_VBN to_TO allocate_VB resources_NNS according_VBG to_TO federal_JJ objectives_NNS 
The_DT Ontario_NNP Medical_NNP Association_NNP 
Increased_VBN likelihood_NN of_IN GP_NNP use_NN from_IN smoking_NN cigarettes_NNS was_VBD attenuated_VBN by_IN NO_RB 2_CD and_CC BTEX_NNP ,_, and_CC the_DT effect_NN became_VBD insignificant_JJ with_IN SO_NNP 2_CD in_IN the_DT model_NN ._. 
Therefore_RB ,_, we_PRP suggest_VBP that_IN NO2_NNP ,_, BTEX_NNP and_CC SO2_NNP in_IN Chemical_NNP valley_NN increase_NN health_NN care_NN utilization_NN because_IN of_IN their_PRP$ effects_NNS on_IN respiratory_JJ and_CC cardiovascular_JJ diseases_NNS prominently_RB featured_VBN in_IN the_DT area_NN 
Background_NN Research_NN based_VBN on_IN recent_JJ conceptualizations_NNS of_IN health_NN that_WDT recognize_VBP socioeconomic_JJ and_CC environmental_JJ determinants_NNS in_IN Canada_NNP shows_VBZ that_IN significant_JJ health_NN disparities_NNS continue_VBP to_TO persist_VB ,_, despite_IN a_DT health_NN care_NN system_NN based_VBN on_IN the_DT premise_NN of_IN universal_JJ and_CC equitable_JJ access_NN 
The_DT region_NN is_VBZ also_RB subject_JJ to_TO significant_JJ outputs_NNS of_IN vehicular_JJ exhaust_NN due_JJ to_TO the_DT Canada-US_JJ international_JJ crossing_VBG at_IN Bluewater_NNP Bridge_NNP ,_, and_CC transnational_JJ air_NN and_CC water_NN pollution_NN from_IN Ohio_NNP ,_, Illinois_NNP and_CC Michigan_NNP ._. 
The_DT Ontario_NNP Medical_NNP Association_NNP 
These_DT results_NNS confirm_VBP findings_NNS from_IN previous_JJ studies_NNS in_IN Canada_NNP and_CC abroad_RB 
Analyses_NNS of_IN primary_JJ health_NN care_NN outcomes_NNS under_IN the_DT assumption_NN of_IN universal_JJ access_NN have_VBP revealed_VBN that_DT access_NN and_CC utilization_NN depend_VBP on_IN a_DT host_NN of_IN individual_JJ ,_, social_JJ and_CC environmental_JJ factors_NNS ._. 
For_IN example_NN ,_, physician_NN use_NN is_VBZ determined_VBN by_IN both_DT individual_NN and_CC neighborhood_NN income_NN in_IN addition_NN to_TO educational_JJ attainment_NN 
Analyses_NNS of_IN primary_JJ health_NN care_NN outcomes_NNS under_IN the_DT assumption_NN of_IN universal_JJ access_NN have_VBP revealed_VBN that_DT access_NN and_CC utilization_NN depend_VBP on_IN a_DT host_NN of_IN individual_JJ ,_, social_JJ and_CC environmental_JJ factors_NNS ._. 
For_IN example_NN ,_, physician_NN use_NN is_VBZ determined_VBN by_IN both_DT individual_NN and_CC neighborhood_NN income_NN in_IN addition_NN to_TO educational_JJ attainment_NN 
Dunlop_NNP et_FW al._FW ._. 
For_IN example_NN ,_, physician_NN use_NN is_VBZ determined_VBN by_IN both_DT individual_NN and_CC neighborhood_NN income_NN in_IN addition_NN to_TO educational_JJ attainment_NN 
Levels_NNS of_IN exposure_NN to_TO pollution_NN appears_VBZ to_TO influence_VB utilization_NN of_IN health_NN care_NN services_NNS ,_, but_CC poor_JJ access_NN to_TO primary_JJ health_NN care_NN services_NNS additionally_RB burden_NN certain_JJ groups_NNS in_IN Sarnia_NNP ,_, Ontario_NNP ,_, Canada_NNP ._. 
BackgroundResearch_NN based_VBN on_IN recent_JJ conceptualizations_NNS of_IN health_NN that_WDT recognize_VBP socioeconomic_JJ and_CC environmental_JJ determinants_NNS in_IN Canada_NNP shows_VBZ that_IN significant_JJ health_NN disparities_NNS continue_VBP to_TO persist_VB ,_, despite_IN a_DT health_NN care_NN system_NN based_VBN on_IN the_DT premise_NN of_IN universal_JJ and_CC equitable_JJ access_NN 
Levels_NNS of_IN exposure_NN to_TO pollution_NN appears_VBZ to_TO influence_VB utilization_NN of_IN health_NN care_NN services_NNS ,_, but_CC poor_JJ access_NN to_TO primary_JJ health_NN care_NN services_NNS additionally_RB burden_NN certain_JJ groups_NNS in_IN Sarnia_NNP ,_, Ontario_NNP ,_, Canada_NNP ._. 
BackgroundResearch_NN based_VBN on_IN recent_JJ conceptualizations_NNS of_IN health_NN that_WDT recognize_VBP socioeconomic_JJ and_CC environmental_JJ determinants_NNS in_IN Canada_NNP shows_VBZ that_IN significant_JJ health_NN disparities_NNS continue_VBP to_TO persist_VB ,_, despite_IN a_DT health_NN care_NN system_NN based_VBN on_IN the_DT premise_NN of_IN universal_JJ and_CC equitable_JJ access_NN 
Background_NN Research_NN based_VBN on_IN recent_JJ conceptualizations_NNS of_IN health_NN that_WDT recognize_VBP socioeconomic_JJ and_CC environmental_JJ determinants_NNS in_IN Canada_NNP shows_VBZ that_IN significant_JJ health_NN disparities_NNS continue_VBP to_TO persist_VB ,_, despite_IN a_DT health_NN care_NN system_NN based_VBN on_IN the_DT premise_NN of_IN universal_JJ and_CC equitable_JJ access_NN 
found_VBD that_IN lower_JJR socioeconomic_JJ status_NN -LRB-_-LRB- SES_NNP -RRB-_-RRB- was_VBD associated_VBN with_IN increased_VBN use_NN of_IN primary_JJ care_NN and_CC lower_JJR rates_NNS of_IN specialist_NN service_NN utilization_NN ,_, whereas_IN health_NN needs_NNS as_IN measured_VBN by_IN perceived_VBN health_NN status_NN and_CC health_NN condition_NN predicted_VBD utilization_NN across_IN the_DT board_NN ._. 
Finkelstein_NNP 
Finkelstein_NNP 
The_DT costs_NNS ,_, the_DT benefits_NNS and_CC the_DT expected_VBN net_JJ benefit_NN were_VBD calculated_VBN for_IN each_DT simulation_NN according_VBG to_TO the_DT following_JJ formula_NN :_: The_DT results_NNS of_IN the_DT simulations_NNS were_VBD presented_VBN as_IN a_DT Cost-Benefit_NNP Acceptability_NNP curve_NN -LRB-_-LRB- CBAC_NNP -RRB-_-RRB- using_VBG standard_JJ methodologies_NNS ._. 
ACBAC_NNP shows_VBZ the_DT probability_NN that_IN a_DT reclaim_VBP policy_NN is_VBZ cost_NN beneficial_JJ for_IN a_DT range_NN of_IN clean-up_JJ intervention_NN costs_NNS by_IN plotting_VBG the_DT proportion_NN of_IN simulations_NNS for_IN which_WDT the_DT net_JJ benefit_NN of_IN the_DT remediation_NN policy_NN is_VBZ positive_JJ for_IN reclamation_NN costs_NNS ranging_VBG from_IN 
Probability_NN distributions_NNS were_VBD assigned_VBN to_TO important_JJ components_NNS of_IN the_DT analysis_NN 
000_CD 
g._NNP Importantly_NNP ,_, the_DT aim_NN of_IN cost-benefit_JJ analysis_NN is_VBZ not_RB to_TO assign_VB a_DT price_NN to_TO environmental-related_JJ health_NN outcomes_NNS -LRB-_-LRB- e._JJ cost_NN of_IN deaths_NNS -RRB-_-RRB- that_WDT have_VBP already_RB occurred_VBN but_CC to_TO estimate_VB ,_, in_IN monetary_JJ terms_NNS ,_, the_DT net_JJ benefits_NNS for_IN society_NN of_IN averting_VBG future_JJ pollution-related_JJ health_NN effects_NNS ._. 
To_TO date_NN ,_, there_EX is_VBZ a_DT paucity_NN of_IN studies_NNS evaluating_VBG the_DT net_JJ benefit_NN arising_VBG from_IN the_DT reduction_NN of_IN environmental_JJ health_NN hazards_NNS ._. 
To_TO date_NN ,_, there_EX is_VBZ a_DT paucity_NN of_IN studies_NNS evaluating_VBG the_DT net_JJ benefit_NN arising_VBG from_IN the_DT reduction_NN of_IN environmental_JJ health_NN hazards_NNS ._. 
The_DT majority_NN of_IN published_JJ cost-benefit_JJ analyses_NNS focus_VBP on_IN quantifying_VBG the_DT monetary_JJ health_NN benefit_NN ,_, and_CC in_IN particular_JJ the_DT reduction_NN in_IN respiratory_JJ ailments_NNS ,_, through_IN air_NN pollution_NN control_NN policies_NNS 
One_CD recent_JJ descriptive_JJ study_NN conducted_VBN in_IN Gela_NNP and_CC Priolo_NNP by_IN the_DT Dipartimento_NNP Osservatorio_NNP Epidemiologico_NNP -LRB-_-LRB- DOE_NNP -RRB-_-RRB- of_IN the_DT Sicilian_NNP Region_NNP showed_VBD excesses_NNS of_IN overall_JJ mortality_NN ,_, of_IN all_DT cancer_NN mortality_NN and_CC of_IN many_JJ cancer_NN and_CC non-cancer_JJ cases_NNS when_WRB compared_VBN with_IN regional_JJ and_CC local_JJ reference_NN levels_NNS 
Nevertheless_RB little_RB has_VBZ been_VBN done_VBN to_TO reduce_VB the_DT exposure_NN of_IN the_DT local_JJ population_NN to_TO pollution_NN ._. 
These_DT factors_NNS cause_VBP increasing_VBG concern_NN in_IN the_DT local_JJ communities_NNS 
Priolo_NNP and_CC Gela_NNP ,_, in_IN south-east_JJ Sicily_NNP ,_, provide_VBP extensively_RB documented_VBN cases_NNS of_IN toxic_JJ contaminated_VBN sites_NNS where_WRB ,_, due_JJ to_TO the_DT presence_NN of_IN large_JJ petrochemical_NN industrial_JJ plants_NNS and_CC to_TO widely_RB diffuse_VB environmental_JJ pollution_NN ,_, several_JJ negative_JJ health_NN effects_NNS have_VBP been_VBN observed_VBN ._. 
High_JJ levels_NNS of_IN many_JJ chemical_NN compounds_NNS have_VBP been_VBN detected_VBN in_IN soil_NN ,_, water_NN ,_, groundwater_NN ,_, air_NN sediments_NNS ,_, fish_NN and_CC shellfish_NN of_IN both_DT areas_NNS ._. 
One_CD recent_JJ descriptive_JJ study_NN conducted_VBN in_IN Gela_NNP and_CC Priolo_NNP by_IN the_DT Dipartimento_NNP Osservatorio_NNP Epidemiologico_NNP -LRB-_-LRB- DOE_NNP -RRB-_-RRB- of_IN the_DT 
The_DT analysis_NN of_IN pine-needles_NNS has_VBZ detected_VBN the_DT presence_NN of_IN heavy_JJ metals_NNS 
Marine_NNP sediments_NNS have_VBP been_VBN found_VBN to_TO be_VB polluted_JJ by_IN copper_NN ,_, arsenic_NN ,_, mercury_NN and_CC Polychlorinated_JJ biphenyls_NNS ,_, showing_VBG toxicity_NN in_IN ecotoxicological_JJ analysis_NN ;_: fish_NN and_CC benthic_JJ organisms_NNS are_VBP polluted_JJ by_IN heavy_JJ metals_NNS ._. 
The_DT two_CD rivers_NNS in_IN the_DT Gela_NNP plain_NN are_VBP polluted_JJ by_IN pesticides_NNS ,_, copper_NN ,_, and_CC zinc_NN 
4million_CD for_IN Gela_NNP ._. 
5million_NN for_IN Priolo_NNP and_CC 
In_IN Priolo_NNP ,_, on_IN the_DT other_JJ hand_NN ,_, a_DT pollution_NN control_NN policy_NN costing_VBG more_RBR than_IN 
Hydrocarbons_NNS ,_, organic_JJ compounds_NNS and_CC heavy_JJ metals_NNS pollution_NN have_VBP been_VBN detected_VBN ._. 
Groundwater_NNP is_VBZ subject_JJ to_TO depletion_NN ,_, withdrawal_NN ,_, and_CC salinisation_NN ._. 
The_DT analysis_NN of_IN pine-needles_NNS has_VBZ detected_VBN the_DT presence_NN of_IN heavy_JJ metals_NNS 
The_DT analysis_NN of_IN pine-needles_NNS has_VBZ detected_VBN the_DT presence_NN of_IN heavy_JJ metals_NNS 
There_EX is_VBZ also_RB evidence_NN of_IN ecological_JJ systems_NNS disturbance_NN and_CC food_NN chain_NN contamination_NN 
The_DT groundwater_NN inside_IN the_DT Gela_NNP remediation_NN site_NN contains_VBZ arsenic_NN ,_, benzene_NN ,_, 1,2_CD dicloroethane_NN ,_, vinyl_NN chloride_NN ,_, and_CC mercury_NN greatly_RB in_IN excess_NN of_IN legal_JJ limits_NNS 
There_EX are_VBP several_JJ abnormal_JJ data_NNS :_: toxic_JJ compounds_NNS in_IN the_DT air_NN -LRB-_-LRB- benzene_NN ,_, non-metanic_JJ hydrocarbons_NNS ,_, ozone_NN ,_, PM_NNP 10_CD ,_, VOC_NNP -RRB-_-RRB- ._. 
Again_RB the_DT analysis_NN of_IN pine-needles_NNS has_VBZ detected_VBN the_DT presence_NN of_IN heavy_JJ metals_NNS ._. 
Marine_NNP sediments_NNS have_VBP been_VBN found_VBN to_TO be_VB polluted_JJ by_IN copper_NN ,_, arsenic_NN ,_, mercury_NN and_CC Polychlorinated_JJ biphenyls_NNS ,_, showing_VBG toxicity_NN in_IN ecotoxicological_JJ analysis_NN ;_: fish_NN and_CC benthic_JJ organisms_NNS are_VBP polluted_JJ by_IN heavy_JJ metals_NNS ._. 
Marine_NNP sediments_NNS have_VBP been_VBN found_VBN to_TO be_VB polluted_JJ by_IN copper_NN ,_, arsenic_NN ,_, mercury_NN and_CC Polychlorinated_JJ biphenyls_NNS ,_, showing_VBG toxicity_NN in_IN ecotoxicological_JJ analysis_NN ;_: fish_NN and_CC benthic_JJ organisms_NNS are_VBP polluted_JJ by_IN heavy_JJ metals_NNS ._. 
The_DT two_CD rivers_NNS in_IN the_DT Gela_NNP plain_NN are_VBP polluted_JJ by_IN pesticides_NNS ,_, copper_NN ,_, and_CC zinc_NN 
For_IN instance_NN ,_, in_IN the_DT groundwater_NN of_IN Gela_NNP arsenic_NN concentrations_NNS reached_VBD the_DT value_NN of_IN 250_CD ._. 
Environmental_JJ data_NNS collected_VBN in_IN Gela_NNP and_CC Priolo_NNP reveal_VBP that_IN the_DT concentrations_NNS of_IN several_JJ harmful_JJ substances_NNS exceeded_VBD the_DT limits_NNS established_VBN by_IN the_DT law_NN ._. 
000_CD 
temporary_JJ versus_CC permanent_JJ -RRB-_-RRB- ._. 
g._NN income_NN and_CC education_NN -RRB-_-RRB- and_CC by_IN the_DT nature_NN of_IN the_DT clean-up_JJ interventions_NNS -LRB-_-LRB- e._NN In_IN 1993_CD ,_, President_NNP Bill_NNP Clinton_NNP 's_POS executive_NN order_NN 12866_CD established_VBD that_DT government_NN and_CC private_JJ parties_NNS should_MD be_VB fully_RB informed_VBN about_IN the_DT costs_NNS and_CC the_DT benefits_NNS of_IN regulatory_JJ options_NNS 
In_IN 1993_CD ,_, President_NNP Bill_NNP Clinton_NNP 's_POS executive_NN order_NN 12866_CD established_VBD that_DT government_NN and_CC private_JJ parties_NNS should_MD be_VB fully_RB informed_VBN about_IN the_DT costs_NNS and_CC the_DT benefits_NNS of_IN regulatory_JJ options_NNS 
To_TO date_NN ,_, there_EX is_VBZ a_DT paucity_NN of_IN studies_NNS evaluating_VBG the_DT net_JJ benefit_NN arising_VBG from_IN the_DT reduction_NN of_IN environmental_JJ health_NN hazards_NNS ._. 
The_DT majority_NN of_IN published_JJ cost-benefit_JJ analyses_NNS focus_VBP on_IN quantifying_VBG the_DT monetary_JJ health_NN benefit_NN ,_, and_CC in_IN particular_JJ the_DT reduction_NN in_IN respiratory_JJ ailments_NNS ,_, through_IN air_NN pollution_NN control_NN policies_NNS 
The_DT majority_NN of_IN published_JJ cost-benefit_JJ analyses_NNS focus_VBP on_IN quantifying_VBG the_DT monetary_JJ health_NN benefit_NN ,_, and_CC in_IN particular_JJ the_DT reduction_NN in_IN respiratory_JJ ailments_NNS ,_, through_IN air_NN pollution_NN control_NN policies_NNS 
g._NNP WTP_NNP to_TO avert_VB a_DT case_NN of_IN premature_JJ mortality_NN -RRB-_-RRB- ,_, Xa_NNP is_VBZ the_DT number_NN of_IN health_NN endpoints_NNS averted_VBN by_IN the_DT clean-up_JJ of_IN Gela_NNP and_CC Priolo_NNP industrial_JJ plants_NNS -LRB-_-LRB- e._JJ number_NN of_IN non-fatal_JJ cancers_NNS averted_VBN -RRB-_-RRB- ,_, t_NN is_VBZ the_DT number_NN of_IN years_NNS over_IN which_WDT the_DT benefits_NNS accrue_VBP ,_, and_CC d_SYM is_VBZ the_DT discount_NN rate_NN ._. 
There_EX is_VBZ uncertainty_NN regarding_VBG the_DT length_NN of_IN time_NN over_IN which_WDT a_DT clean-up_JJ intervention_NN will_MD display_VB its_PRP$ benefit_NN ._. 
There_EX is_VBZ currently_RB uncertainty_NN regarding_VBG the_DT type_NN of_IN clean-up_JJ technology_NN to_TO adopt_VB in_IN both_DT sites_NNS ._. 
Arecent_NNP US_NNP study_NN assumes_VBZ that_IN four_CD years_NNS after_IN clean-up_JJ it_PRP is_VBZ possible_JJ to_TO observe_VB a_DT 20-25_CD %_NN decline_NN in_IN the_DT number_NN of_IN congenital_JJ anomalies_NNS 
Nevertheless_RB ,_, the_DT damage_NN caused_VBD to_TO the_DT environment_NN and_CC the_DT impact_NN on_IN human_JJ health_NN by_IN industrial_JJ pollution_NN has_VBZ yet_RB to_TO be_VB fully_RB assessed_VBN sufficient_JJ to_TO address_VB the_DT complete_JJ continuum_NN of_IN public_JJ health_NN ,_, from_IN pollutants_NNS emission_NN to_TO human_JJ exposure_NN to_TO disease_NN 
g._NN For_IN example_NN ,_, if_IN the_DT cheapest_JJS technology_NN is_VBZ implemented_VBN ,_, e._VB The_DT permanence_NN of_IN clean-up_JJ depends_VBZ on_IN two_CD elements_NNS :_: the_DT intrinsic_JJ composition_NN of_IN the_DT contaminated_VBN site_NN and_CC the_DT type_NN of_IN remediation_NN technology_NN adopted_VBN ._. 
capping_VBG the_DT contaminated_VBN site_NN ,_, the_DT benefit_NN will_MD last_VB for_IN the_DT shelf-life_NN of_IN the_DT cap_NN ._. 
Another_DT important_JJ element_NN to_TO consider_VB is_VBZ how_WRB long_JJ it_PRP will_MD take_VB to_TO observe_VB a_DT decline_NN in_IN the_DT number_NN health_NN outcomes_NNS associated_VBN with_IN contaminated_VBN sites_NNS -LRB-_-LRB- also_RB referred_VBD as_IN cessation_NN lag_NN -RRB-_-RRB- ._. 
The_DT duration_NN of_IN the_DT cessation_NN lag_NN is_VBZ likely_JJ to_TO vary_VB by_IN type_NN of_IN health_NN outcome_NN -LRB-_-LRB- shorter_JJR for_IN mild_JJ adverse_JJ events_NNS such_JJ as_IN asthma_NN and_CC bronchitis_NN ,_, and_CC longer_RBR for_IN more_JJR severe_JJ events_NNS such_JJ as_IN cancer_NN -RRB-_-RRB- ._. 
Arecent_NNP US_NNP study_NN assumes_VBZ that_IN four_CD years_NNS after_IN clean-up_JJ it_PRP is_VBZ possible_JJ to_TO observe_VB a_DT 20-25_CD %_NN decline_NN in_IN the_DT number_NN of_IN congenital_JJ anomalies_NNS 
Although_IN this_DT model_NN is_VBZ generally_RB used_VBN in_IN economic_JJ evaluation_NN ,_, studies_NNS of_IN animal_NN and_CC human_JJ behaviors_NNS generally_RB show_VBP that_IN individual_JJ preferences_NNS are_VBP dynamically_RB inconsistent_JJ ._. 
Individuals_NNS tend_VBP to_TO display_VB higher_JJR discount_NN rates_NNS over_IN short_JJ time_NN horizons_NNS and_CC lower_JJR discount_NN rates_NNS over_IN long_JJ time_NN horizons_NNS 
the_DT cost_NN per_IN ton_NN of_IN emission_NN reduction_NN -RRB-_-RRB- which_WDT ,_, as_IN Kopp_NNP et_FW al._FW g._FW Frequently_RB the_DT estimated_VBN cost_NN of_IN a_DT regulatory_JJ intervention_NN is_VBZ only_RB the_DT abatement_NN expenditure_NN -LRB-_-LRB- e._FW suggest_VBP is_VBZ a_DT narrow_JJ measure_NN of_IN the_DT cost_NN of_IN regulatory_JJ compliance_NN ._. 
In_IN the_DT case_NN of_IN the_DT Italian_JJ Reclamation_NN Sites_NNS of_IN National_NNP Interest_NNP ,_, a_DT budget_NN is_VBZ established_VBN for_IN each_DT intervention_NN plan_NN and_CC approved_VBN by_IN the_DT Ministry_NNP of_IN the_DT Environment_NNP ._. 
Probabilistic_JJ sensitivity_NN analysis_NN To_TO further_RBR explore_VB uncertainty_NN a_DT probabilistic_JJ sensitivity_NN analysis_NN was_VBD performed_VBN ._. 
Probability_NN distributions_NNS were_VBD assigned_VBN to_TO important_JJ components_NNS of_IN the_DT analysis_NN 
4million_CD for_IN Gela_NNP ._. 
5million_NN for_IN Priolo_NNP and_CC 
The_DT cost_NN of_IN removing_VBG contamination_NN from_IN the_DT two_CD sites_NNS is_VBZ uncertain_JJ ._. 
Given_VBN the_DT potential_JJ health_NN benefits_NNS ,_, the_DT estimated_VBN monetary_JJ gain_NN of_IN an_DT effective_JJ pollution_NN control_NN policy_NN would_MD be_VB 
WTP_NNP estimates_NNS and_CC cessation_NN lags_VBZ were_VBD sampled_VBN from_IN a_DT gamma_NN distribution_NN while_IN normal_JJ distributions_NNS were_VBD adopted_VBN for_IN the_DT number_NN of_IN excess_JJ cases_NNS 
4million_CD for_IN Gela_NNP ._. 
5million_NN for_IN Priolo_NNP and_CC 
The_DT cost_NN of_IN removing_VBG contamination_NN from_IN the_DT two_CD sites_NNS is_VBZ uncertain_JJ ._. 
Given_VBN the_DT potential_JJ health_NN benefits_NNS ,_, the_DT estimated_VBN monetary_JJ gain_NN of_IN an_DT effective_JJ pollution_NN control_NN policy_NN would_MD be_VB 
._. 
The_DT upper_JJ value_NN used_VBN in_IN this_DT study_NN was_VBD estimated_VBN assuming_VBG that_IN the_DT population_NN living_VBG in_IN the_DT area_NN covered_VBN by_IN the_DT program_NN is_VBZ 1_CD million_CD ,_, while_IN the_DT intermediate_JJ estimate_NN is_VBZ the_DT baseline_JJ estimate_NN suggested_VBN by_IN Alberini_NNP et_FW al._FW ._. 
The_DT lower_JJR estimate_NN used_VBN ,_, 
It_PRP is_VBZ based_VBN upon_IN a_DT number_NN of_IN Contingent_NNP Valuation_NNP studies_NNS ._. 
The_DT lower_JJR estimate_NN used_VBN ,_, 
According_VBG to_TO Gravelle_NNP and_CC Smith_NNP 
To_TO estimate_VB the_DT impact_NN of_IN the_DT discount_NN rate_NN and_CC to_TO facilitate_VB the_DT comparison_NN of_IN the_DT study_NN findings_NNS with_IN other_JJ European_JJ studies_NNS ,_, analyses_NNS are_VBP presented_VBN using_VBG a_DT 7_CD %_NN discount_NN rate_NN ,_, as_IN estimated_VBN by_IN Alberini_NNP et_FW al._FW ._. 
cardiac_JJ versus_CC respiratory_JJ hospital_NN admission_NN -RRB-_-RRB- ._. 
g._NN Value_NN of_IN reductions_NNS in_IN risk_NN of_IN future_JJ negative_JJ health_NN outcomes_VBZ Individual_NNP WTP_NNP might_MD vary_VB according_VBG to_TO the_DT cause_NN of_IN the_DT hospital_NN admission_NN -LRB-_-LRB- e._NN As_IN Pearce_NNP 
As_IN Pearce_NNP 
Unfortunately_RB ,_, no_DT studies_NNS have_VBP been_VBN conducted_VBN to_TO estimate_VB the_DT WTP_NNP to_TO reduce_VB the_DT risk_NN of_IN a_DT hospital_NN admission_NN in_IN the_DT context_NN of_IN exposure_NN to_TO toxic_JJ pollutants_NNS ._. 
The_DT estimated_VBN WTP_NNP to_TO avoid_VB a_DT hospital_NN admission_NN comes_VBZ from_IN the_DT ExternE_NNP Project_NNP -LRB-_-LRB- 
The_DT estimated_VBN WTP_NNP to_TO avoid_VB a_DT hospital_NN admission_NN comes_VBZ from_IN the_DT ExternE_NNP Project_NNP -LRB-_-LRB- 
The_DT estimated_VBN WTP_NNP to_TO avoid_VB a_DT hospital_NN admission_NN comes_VBZ from_IN the_DT ExternE_NNP Project_NNP -LRB-_-LRB- 
Cost_NN of_IN reclaiming_VBG Gela_NNP and_CC Priolo_NNP It_PRP is_VBZ difficult_JJ to_TO establish_VB whether_IN a_DT remediation_NN strategy_NN will_MD attain_VB the_DT forecasted_VBN health_NN improvements_NNS within_IN the_DT planned_VBN budget_NN ._. 
The_DT costs_NNS of_IN long_JJ term_NN remediation_NN projects_NNS accumulate_VBP over_IN years_NNS and_CC effectiveness_NN is_VBZ only_RB observable_JJ after_IN a_DT long_JJ time_NN ._. 
Further_RB ,_, sometimes_RB it_PRP is_VBZ not_RB possible_JJ to_TO identify_VB all_PDT the_DT sources_NNS of_IN environmental_JJ externalities_NNS to_TO be_VB addressed_VBN by_IN the_DT intervention_NN -LRB-_-LRB- e._SYM 
Conclusions_NNS In_IN 1998_CD ,_, law_NN 426\/98_CD established_VBN Priolo_NNP and_CC Gela_NNP among_IN the_DT first_JJ 15_CD Italian_JJ sites_NNS included_VBN in_IN the_DT National_NNP Reclaim_NNP Program_NNP 
For_IN example_NN ,_, this_DT study_NN provides_VBZ only_RB a_DT partial_JJ estimate_NN of_IN the_DT overall_JJ benefit_NN obtainable_JJ with_IN the_DT clean-up_JJ of_IN the_DT two_CD contaminated_VBN sites_NNS in_IN Gela_NNP and_CC Priolo_NNP ._. 
Excess_JJ congenital_JJ malformations_NNS ,_, mainly_RB uro-genital_JJ anomalies_NNS and_CC particularly_RB hypospadias_NNS ,_, in_IN these_DT areas_NNS suggest_VBP a_DT plausible_JJ association_NN with_IN exposure_NN to_TO documented_VBN pollutants_NNS ._. 
However_RB ,_, because_IN there_EX are_VBP no_DT conclusive_JJ etiological_JJ studies_NNS ,_, or_CC studies_NNS estimating_VBG the_DT WTP_NNP to_TO avert_VB cases_NNS of_IN congenital_JJ malformation_NN these_DT potential_JJ benefits_NNS were_VBD not_RB included_VBN ._. 
For_IN example_NN ,_, this_DT study_NN provides_VBZ only_RB a_DT partial_JJ estimate_NN of_IN the_DT overall_JJ benefit_NN obtainable_JJ with_IN the_DT clean-up_JJ of_IN the_DT two_CD contaminated_VBN sites_NNS in_IN Gela_NNP and_CC Priolo_NNP ._. 
Excess_JJ congenital_JJ malformations_NNS ,_, mainly_RB uro-genital_JJ anomalies_NNS and_CC particularly_RB hypospadias_NNS ,_, in_IN these_DT areas_NNS suggest_VBP a_DT plausible_JJ association_NN with_IN exposure_NN to_TO documented_VBN pollutants_NNS ._. 
However_RB ,_, because_IN there_EX are_VBP no_DT conclusive_JJ etiological_JJ studies_NNS ,_, or_CC studies_NNS estimating_VBG the_DT WTP_NNP to_TO avert_VB cases_NNS of_IN congenital_JJ malformation_NN these_DT potential_JJ benefits_NNS were_VBD not_RB included_VBN ._. 
Although_IN this_DT model_NN is_VBZ generally_RB used_VBN in_IN economic_JJ evaluation_NN ,_, studies_NNS of_IN animal_NN and_CC human_JJ behaviors_NNS generally_RB show_VBP that_IN individual_JJ preferences_NNS are_VBP dynamically_RB inconsistent_JJ ._. 
Individuals_NNS tend_VBP to_TO display_VB higher_JJR discount_NN rates_NNS over_IN short_JJ time_NN horizons_NNS and_CC lower_JJR discount_NN rates_NNS over_IN long_JJ time_NN horizons_NNS 
In_IN the_DT present_JJ study_NN the_DT future_JJ health_NN benefits_NNS are_VBP discounted_VBN using_VBG a_DT constant_JJ 4_CD %_NN discount_NN rate_NN as_IN recommended_VBN by_IN the_DT European_NNP Commission_NNP 
lean-upIf_JJ the_DT NPB_NNP is_VBZ positive_JJ the_DT intervention_NN is_VBZ cost_VBN beneficial_JJ otherwise_RB the_DT clean-up_JJ option_NN is_VBZ not_RB deemed_VBN socially_RB worthwhile_JJ ._. 
NPB_NNP values_NNS can_MD be_VB also_RB use_VBP to_TO rank_VB the_DT clean-up_JJ of_IN different_JJ sites_NNS within_IN for_IN example_NN the_DT Superfund_NNP budget_NN and_CC to_TO prioritize_VB those_DT sites_NNS with_IN higher_JJR NPB_NNP values_NNS ._. 
Sensitivity_NN analysis_NN One-way_JJ sensitivity_NN analyses_VBZ Environmental_JJ health_NN benefits_NNS arising_VBG from_IN a_DT pollution_NN control_NN policy_NN are_VBP not_RB marketable_JJ goods_NNS and_CC as_IN a_DT consequence_NN their_PRP$ value_NN is_VBZ highly_RB uncertain_JJ ._. 
Despite_IN the_DT potential_JJ descriptive_JJ relevance_NN of_IN hyperbolic_JJ models_NNS they_PRP have_VBP rarely_RB been_VBN used_VBN normatively_RB in_IN the_DT evaluation_NN of_IN the_DT consequences_NNS of_IN environmental_JJ decisions_NNS and_CC the_DT discounted_JJ utility_NN model_NN remains_VBZ the_DT standard_NN 
While_IN there_EX is_VBZ a_DT broad_JJ consensus_NN that_IN future_JJ costs_NNS and_CC benefits_NNS should_MD be_VB discounted_VBN ,_, there_EX is_VBZ little_JJ agreement_NN on_IN both_DT the_DT discounting_NN model_NN and_CC the_DT discount_NN rate_NN to_TO use_VB ._. 
According_VBG to_TO the_DT discounted_JJ utility_NN model_NN -LRB-_-LRB- also_RB known_VBN as_IN the_DT constant_JJ rate_NN or_CC exponential_JJ model_NN -RRB-_-RRB- individuals_NNS '_POS intertemporal_JJ preferences_NNS are_VBP time_NN consistent_JJ 
Although_IN this_DT model_NN is_VBZ generally_RB used_VBN in_IN economic_JJ evaluation_NN ,_, studies_NNS of_IN animal_NN and_CC human_JJ behaviors_NNS generally_RB show_VBP that_IN individual_JJ preferences_NNS are_VBP dynamically_RB inconsistent_JJ ._. 
Individuals_NNS tend_VBP to_TO display_VB higher_JJR discount_NN rates_NNS over_IN short_JJ time_NN horizons_NNS and_CC lower_JJR discount_NN rates_NNS over_IN long_JJ time_NN horizons_NNS ._. 
Such_JJ a_DT relationship_NN conflicts_NNS with_IN the_DT discount_NN utility_NN model_NN 's_POS assumption_NN of_IN a_DT constant_JJ discount_NN rate_NN ,_, and_CC is_VBZ a_DT characteristic_NN of_IN hyperbolic_JJ models_NNS ._. 
100_CD years_NNS -RRB-_-RRB- ._. 
g._NNP Discounting_NNP plays_VBZ a_DT crucial_JJ role_NN in_IN determining_VBG the_DT future_JJ monetary_JJ benefits\/costs_NNS of_IN environmental_JJ health_NN interventions_NNS ,_, especially_RB for_IN long-lasting_JJ health_NN benefits_NNS -LRB-_-LRB- e._NN While_IN there_EX is_VBZ a_DT broad_JJ consensus_NN that_IN future_JJ costs_NNS and_CC benefits_NNS should_MD be_VB discounted_VBN ,_, there_EX is_VBZ little_JJ agreement_NN on_IN both_DT the_DT discounting_NN model_NN and_CC the_DT discount_NN rate_NN to_TO use_VB ._. 
According_VBG to_TO the_DT discounted_JJ utility_NN model_NN -LRB-_-LRB- also_RB known_VBN as_IN the_DT constant_JJ rate_NN or_CC exponential_JJ model_NN -RRB-_-RRB- individuals_NNS '_POS intertemporal_JJ preferences_NNS are_VBP time_NN consistent_JJ 
Such_JJ a_DT relationship_NN conflicts_NNS with_IN the_DT discount_NN utility_NN model_NN 's_POS assumption_NN of_IN a_DT constant_JJ discount_NN rate_NN ,_, and_CC is_VBZ a_DT characteristic_NN of_IN hyperbolic_JJ models_NNS ._. 
Despite_IN the_DT potential_JJ descriptive_JJ relevance_NN of_IN hyperbolic_JJ models_NNS they_PRP have_VBP rarely_RB been_VBN used_VBN normatively_RB in_IN the_DT evaluation_NN of_IN the_DT consequences_NNS of_IN environmental_JJ decisions_NNS and_CC the_DT discounted_JJ utility_NN model_NN remains_VBZ the_DT standard_NN 
g._NNP Contextual_NNP factors_NNS ,_, such_JJ as_IN individual_JJ characteristics_NNS ,_, nature_NN of_IN the_DT health_NN outcome_NN and_CC number_NN of_IN individuals_NNS affected_VBN by_IN the_DT clean-up_JJ policy_NN -LRB-_-LRB- e._JJ death_NN for_IN cancer_NN -RRB-_-RRB- have_VBP been_VBN found_VBN to_TO be_VB important_JJ determinants_NNS of_IN WTP_NNP ._. 
Finally_RB ,_, another_DT important_JJ issue_NN to_TO consider_VB in_IN the_DT evaluation_NN of_IN the_DT benefits_NNS of_IN a_DT clean-up_JJ policy_NN is_VBZ the_DT time_NN lag_NN -LRB-_-LRB- also_RB referred_VBD to_TO as_IN the_DT ``_`` cessation_NN lag_NN ''_'' -RRB-_-RRB- between_IN the_DT clean-up_JJ policy_NN and_CC the_DT onset_NN of_IN its_PRP$ related_JJ benefits_NNS ._. 
For_IN this_DT reason_NN ,_, in_IN the_DT present_JJ study_NN the_DT two_CD health_NN end-points_NNS ,_, cases_NNS of_IN cancer_NN and_CC non_NN cancer_NN hospital_NN admissions_NNS ,_, are_VBP considered_VBN separately_RB ._. 
Estimates_NNS of_IN the_DT value_NN of_IN a_DT statistical_JJ case_NN of_IN cancer_NN were_VBD retrieved_VBN from_IN a_DT conjoint_JJ choice_NN analysis_NN conducted_VBN among_IN 400_CD individuals_NNS who_WP live_VBP in_IN the_DT industrial_JJ complex_NN and_CC contaminated_VBN site_NN of_IN Marghera_NNP -LRB-_-LRB- Venice_NNP -RRB-_-RRB- 
The_DT lower_JJR estimate_NN ,_, 
g._NN income_NN and_CC education_NN -RRB-_-RRB- and_CC by_IN the_DT nature_NN of_IN the_DT clean-up_JJ interventions_NNS -LRB-_-LRB- e._FW g._FW Finally_RB ,_, although_IN results_NNS were_VBD presented_VBN separately_RB ,_, in_IN terms_NNS of_IN average_JJ ,_, high_JJ and_CC low_JJ estimates_NNS ,_, it_PRP was_VBD not_RB possible_JJ to_TO adjust_VB the_DT WTP_NNP values_NNS for_IN characteristics_NNS of_IN the_DT Gela_NNP and_CC Priolo_NNP populations_NNS -LRB-_-LRB- e._FW temporary_JJ versus_CC permanent_JJ -RRB-_-RRB- 
g._NNP Contextual_NNP factors_NNS ,_, such_JJ as_IN individual_JJ characteristics_NNS ,_, nature_NN of_IN the_DT health_NN outcome_NN and_CC number_NN of_IN individuals_NNS affected_VBN by_IN the_DT clean-up_JJ policy_NN -LRB-_-LRB- e._JJ death_NN for_IN cancer_NN -RRB-_-RRB- have_VBP been_VBN found_VBN to_TO be_VB important_JJ determinants_NNS of_IN WTP_NNP ._. 
Finally_RB ,_, another_DT important_JJ issue_NN to_TO consider_VB in_IN the_DT evaluation_NN of_IN the_DT benefits_NNS of_IN a_DT clean-up_JJ policy_NN is_VBZ the_DT time_NN lag_NN -LRB-_-LRB- also_RB referred_VBD to_TO as_IN the_DT ``_`` cessation_NN lag_NN ''_'' -RRB-_-RRB- between_IN the_DT clean-up_JJ policy_NN and_CC the_DT onset_NN of_IN its_PRP$ related_JJ benefits_NNS ._. 
The_DT baseline_NN and_CC the_DT upper_JJ values_NNS ,_, 
study_NN presents_VBZ several_JJ novel_NN elements_NNS ._. 
The_DT Alberini_NNP et_FW al._FW ._. 
Both_DT values_NNS reported_VBN have_VBP been_VBN inflated_VBN to_TO 2009_CD prices_NNS using_VBG the_DT Harmonised_JJ Index_NN of_IN Consumer_NN Prices_NNS 
The_DT upper_JJ value_NN used_VBN in_IN this_DT study_NN was_VBD estimated_VBN assuming_VBG that_IN the_DT population_NN living_VBG in_IN the_DT area_NN covered_VBN by_IN the_DT program_NN is_VBZ 1_CD million_CD ,_, while_IN the_DT intermediate_JJ estimate_NN is_VBZ the_DT baseline_JJ estimate_NN suggested_VBN by_IN Alberini_NNP et_FW al._FW ._. ._. 
The_DT lower_JJR estimate_NN used_VBN ,_, 
To_TO estimate_VB the_DT impact_NN of_IN the_DT discount_NN rate_NN and_CC to_TO facilitate_VB the_DT comparison_NN of_IN the_DT study_NN findings_NNS with_IN other_JJ European_JJ studies_NNS ,_, analyses_NNS are_VBP presented_VBN using_VBG a_DT 7_CD %_NN discount_NN rate_NN ,_, as_IN estimated_VBN by_IN Alberini_NNP et_FW al._FW ._. 
According_VBG to_TO Alberini_NNP et_FW al._FW ._. 
It_PRP is_VBZ unknown_JJ whether_IN or_CC not_RB the_DT clean-up_JJ interventions_NNS that_WDT have_VBP been_VBN planned_VBN in_IN Gela_NNP and_CC Priolo_NNP will_MD produce_VB a_DT permanent_JJ or_CC a_DT temporary_JJ reduction_NN in_IN pollutant_NN exposure_NN ._. 
different_JJ types_NNS of_IN remediation_NN policies_NNS would_MD lead_VB to_TO different_JJ degrees_NNS of_IN permanence_NN of_IN the_DT health_NN risk_NN reduction_NN ._. 
The_DT number_NN of_IN years_NNS over_IN which_WDT the_DT risk_NN reductions_NNS would_MD be_VB observed_VBN would_MD be_VB higher_JJR for_IN permanent_JJ remediation_NN compared_VBN to_TO temporary_JJ remediation_NN -LRB-_-LRB- contaminant_NN containment_NN interventions_NNS -RRB-_-RRB- ._. 
4million_CD of_IN reclaiming_VBG the_DT area_NN ,_, the_DT potential_JJ benefits_NNS are_VBP always_RB higher_JJR than_IN the_DT cost_NN in_IN Gela_NNP ,_, while_IN in_IN Priolo_NNP when_WRB benefits_NNS are_VBP discounted_VBN at_IN a_DT 7_CD %_NN discount_NN rate_NN ,_, as_IN suggested_VBN by_IN Alberini_NNP et_FW al._FW ._. 
the_DT pollution_NN control_NN interventions_NNS are_VBP not_RB cost_NN effective_JJ if_IN the_DT benefits_NNS arising_VBG from_IN the_DT remediation_NN only_RB last_JJ 10_CD years_NNS -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- ._. 
Table_NNP 3_CD Net_JJ benefits_NNS -LRB-_-LRB- million_CD 
g._NN income_NN and_CC education_NN -RRB-_-RRB- and_CC by_IN the_DT nature_NN of_IN the_DT clean-up_JJ interventions_NNS -LRB-_-LRB- e._FW g._FW Finally_RB ,_, although_IN results_NNS were_VBD presented_VBN separately_RB ,_, in_IN terms_NNS of_IN average_JJ ,_, high_JJ and_CC low_JJ estimates_NNS ,_, it_PRP was_VBD not_RB possible_JJ to_TO adjust_VB the_DT WTP_NNP values_NNS for_IN characteristics_NNS of_IN the_DT Gela_NNP and_CC Priolo_NNP populations_NNS -LRB-_-LRB- e._FW temporary_JJ versus_CC permanent_JJ -RRB-_-RRB- 
Economic_JJ evaluation_NN Monetary_NNP valuation_NN of_IN environmental_JJ health_NN benefits_NNS :_: methodologies_NNS and_CC issues_NNS Two_CD approaches_NNS are_VBP used_VBN to_TO assign_VB a_DT monetary_JJ value_NN to_TO the_DT adverse_JJ health_NN effects_NNS in_IN environmental_JJ cost-benefit_JJ assessment_NN ._. 
The_DT cost_NN of_IN illness_NN approach_NN usually_RB considers_VBZ the_DT direct_JJ medical_JJ cost_NN ,_, third_JJ party_NN costs_NNS and_CC productivity_NN losses_NNS ._. 
The_DT second_JJ and_CC more_RBR common_JJ approach_NN is_VBZ the_DT willingness_NN to_TO pay_VB -LRB-_-LRB- WTP_NNP -RRB-_-RRB- approach_NN ,_, which_WDT measures_VBZ how_WRB much_JJ individuals_NNS are_VBP willing_JJ to_TO pay_VB for_IN a_DT reduction_NN in_IN the_DT risk_NN of_IN a_DT given_VBN adverse_JJ event_NN -LRB-_-LRB- e._SYM 
g._IN The_DT second_JJ and_CC more_RBR common_JJ approach_NN is_VBZ the_DT willingness_NN to_TO pay_VB -LRB-_-LRB- WTP_NNP -RRB-_-RRB- approach_NN ,_, which_WDT measures_VBZ how_WRB much_JJ individuals_NNS are_VBP willing_JJ to_TO pay_VB for_IN a_DT reduction_NN in_IN the_DT risk_NN of_IN a_DT given_VBN adverse_JJ event_NN -LRB-_-LRB- e._JJ reduction_NN in_IN the_DT mortality_NN risk_NN -RRB-_-RRB- 
reduction_NN in_IN the_DT mortality_NN risk_NN -RRB-_-RRB- ._. 
g._IN The_DT second_JJ and_CC more_RBR common_JJ approach_NN is_VBZ the_DT willingness_NN to_TO pay_VB -LRB-_-LRB- WTP_NNP -RRB-_-RRB- approach_NN ,_, which_WDT measures_VBZ how_WRB much_JJ individuals_NNS are_VBP willing_JJ to_TO pay_VB for_IN a_DT reduction_NN in_IN the_DT risk_NN of_IN a_DT given_VBN adverse_JJ event_NN -LRB-_-LRB- e._NN Unlike_IN the_DT cost_NN of_IN illness_NN approach_NN ,_, WTP_NNP includes_VBZ the_DT evaluation_NN of_IN intangible_JJ costs_NNS associated_VBN with_IN adverse_JJ health_NN events_NNS ,_, for_IN example_NN ,_, pain_NN and_CC fear_NN ,_, and_CC account_NN for_IN individual_JJ preferences_NNS 
The_DT two_CD rivers_NNS in_IN the_DT Gela_NNP plain_NN are_VBP polluted_JJ by_IN pesticides_NNS ,_, copper_NN ,_, and_CC zinc_NN 
While_IN there_EX is_VBZ a_DT broad_JJ consensus_NN that_IN future_JJ costs_NNS and_CC benefits_NNS should_MD be_VB discounted_VBN ,_, there_EX is_VBZ little_JJ agreement_NN on_IN both_DT the_DT discounting_NN model_NN and_CC the_DT discount_NN rate_NN to_TO use_VB ._. 
According_VBG to_TO the_DT discounted_JJ utility_NN model_NN -LRB-_-LRB- also_RB known_VBN as_IN the_DT constant_JJ rate_NN or_CC exponential_JJ model_NN -RRB-_-RRB- individuals_NNS '_POS intertemporal_JJ preferences_NNS are_VBP time_NN consistent_JJ 
The_DT two_CD rivers_NNS in_IN the_DT Gela_NNP plain_NN are_VBP polluted_JJ by_IN pesticides_NNS ,_, copper_NN ,_, and_CC zinc_NN 
This_DT study_NN ,_, aims_VBZ to_TO quantify_VB the_DT long-term_JJ benefits_NNS resulting_VBG from_IN the_DT remediation_NN of_IN two_CD highly_RB polluted_JJ industrial_JJ sites_NNS :_: Gela_NNP and_CC Priolo_NNP ._. 
MethodsThe_JJ analytical_JJ framework_NN used_VBN to_TO estimate_VB the_DT monetary_JJ benefit_NN arising_VBG from_IN the_DT remediation_NN of_IN these_DT industrial_JJ sites_NNS is_VBZ the_DT Damage_NN Function_NNP Approach_NNP described_VBD in_IN Figure_NNP 1_CD ._. 
Figure_NNP 1_CD Damage_NN Function_NNP Approach_NNP ._. 
This_DT analytical_JJ framework_NN combines_VBZ both_DT epidemiological_JJ and_CC economic_JJ data_NNS to_TO quantify_VB how_WRB changes_NNS in_IN exposure_NN to_TO environmental_JJ hazards_NNS affect_VBP the_DT welfare_NN of_IN society_NN ._. 
The_DT majority_NN of_IN published_JJ cost-benefit_JJ analyses_NNS focus_VBP on_IN quantifying_VBG the_DT monetary_JJ health_NN benefit_NN ,_, and_CC in_IN particular_JJ the_DT reduction_NN in_IN respiratory_JJ ailments_NNS ,_, through_IN air_NN pollution_NN control_NN policies_NNS 
Background_NN It_PRP is_VBZ estimated_VBN that_IN approximately_RB one-quarter_NN of_IN the_DT global_JJ disease_NN burden_NN ,_, and_CC more_JJR than_IN one-third_NN of_IN the_DT burden_NN among_IN children_NNS ,_, is_VBZ due_JJ to_TO modifiable_JJ environmental_JJ factors_NNS 
g._NNP WTP_NNP is_VBZ preferred_VBN to_TO cost_NN of_IN illness_NN because_IN it_PRP takes_VBZ account_NN of_IN all_PDT the_DT costs_NNS associated_VBN with_IN a_DT given_VBN health_NN effect_NN -LRB-_-LRB- e._JJ suffering_NN ,_, loss_NN -RRB-_-RRB- and_CC thus_RB provide_VBP a_DT better_JJR estimate_NN of_IN the_DT potential_JJ benefits_NNS ._. 
Afurther_JJ strength_NN of_IN this_DT study_NN is_VBZ that_IN it_PRP allows_VBZ for_IN differences_NNS in_IN WTP_NNP for_IN different_JJ health_NN effects_NNS ._. 
However_RB ,_, because_IN there_EX are_VBP no_DT conclusive_JJ etiological_JJ studies_NNS ,_, or_CC studies_NNS estimating_VBG the_DT WTP_NNP to_TO avert_VB cases_NNS of_IN congenital_JJ malformation_NN these_DT potential_JJ benefits_NNS were_VBD not_RB included_VBN ._. 
Furthermore_RB ,_, the_DT analysis_NN excludes_VBZ the_DT potential_JJ benefits_NNS for_IN the_DT ecosystem_NN related_VBN to_TO increased_VBN agricultural_JJ and_CC fishing_NN productivity_NN and_CC also_RB the_DT increasing_VBG quality_NN of_IN environmental_JJ resources_NNS such_JJ as_IN rivers_NNS and_CC ground_NN waters_NNS and_CC the_DT sea_NN ._. 
Finally_RB ,_, although_IN results_NNS were_VBD presented_VBN separately_RB ,_, in_IN terms_NNS of_IN average_JJ ,_, high_JJ and_CC low_JJ estimates_NNS ,_, it_PRP was_VBD not_RB possible_JJ to_TO adjust_VB the_DT 
5million_CD in_IN Priolo_NNP ,_, implying_VBG that_IN further_JJ economic_JJ investments_NNS -_: even_RB considerable_JJ ones_NNS -_: could_MD still_RB prove_VB cost_NN beneficial_JJ ._. 
BackgroundIt_NNP is_VBZ estimated_VBN that_IN approximately_RB one-quarter_NN of_IN the_DT global_JJ disease_NN burden_NN ,_, and_CC more_JJR than_IN one-third_NN of_IN the_DT burden_NN among_IN children_NNS ,_, is_VBZ due_JJ to_TO modifiable_JJ environmental_JJ factors_NNS 
Although_IN these_DT data_NNS are_VBP currently_RB collected_VBN and_CC controlled_VBN through_IN standardized_JJ methods_NNS for_IN epidemiological_JJ and_CC public_JJ health_NN purposes_NNS some_DT limitations_NNS should_MD be_VB considered_VBN the_DT existing_VBG studies_NNS design_NN does_VBZ not_RB allow_VB to_TO assessing_VBG the_DT causal_JJ relationship_NN between_IN industrial_JJ pollution_NN exposure_NN and_CC health_NN ._. 
However_RB it_PRP should_MD be_VB noted_VBN that_IN the_DT proportions_NNS of_IN deaths_NNS and_CC non-fatal_JJ cancers_NNS attributed_VBN to_TO the_DT environment_NN are_VBP comparable_JJ to_TO those_DT suggested_VBN by_IN WHO_WP and_CC other_JJ authors_NNS 
5million_CD in_IN Priolo_NNP ,_, implying_VBG that_IN further_JJ economic_JJ investments_NNS -_: even_RB considerable_JJ ones_NNS -_: could_MD still_RB prove_VB cost_NN beneficial_JJ ._. 
BackgroundIt_NNP is_VBZ estimated_VBN that_IN approximately_RB one-quarter_NN of_IN the_DT global_JJ disease_NN burden_NN ,_, and_CC more_JJR than_IN one-third_NN of_IN the_DT burden_NN among_IN children_NNS ,_, is_VBZ due_JJ to_TO modifiable_JJ environmental_JJ factors_NNS 
Although_IN these_DT data_NNS are_VBP currently_RB collected_VBN and_CC controlled_VBN through_IN standardized_JJ methods_NNS for_IN epidemiological_JJ and_CC public_JJ health_NN purposes_NNS some_DT limitations_NNS should_MD be_VB considered_VBN the_DT existing_VBG studies_NNS design_NN does_VBZ not_RB allow_VB to_TO assessing_VBG the_DT causal_JJ relationship_NN between_IN industrial_JJ pollution_NN exposure_NN and_CC health_NN ._. 
However_RB it_PRP should_MD be_VB noted_VBN that_IN the_DT proportions_NNS of_IN deaths_NNS and_CC non-fatal_JJ cancers_NNS attributed_VBN to_TO the_DT environment_NN are_VBP comparable_JJ to_TO those_DT suggested_VBN by_IN WHO_WP and_CC other_JJ authors_NNS 
As_RB long_RB as_IN the_DT true_JJ benefits_NNS of_IN clean-up_JJ interventions_NNS are_VBP unknown_JJ it_PRP will_MD be_VB impossible_JJ to_TO allocate_VB efficiently_RB the_DT limited_JJ funds_NNS available_JJ ._. 
ConclusionsIn_NNP 1998_CD ,_, law_NN 426\/98_CD established_VBN Priolo_NNP and_CC Gela_NNP among_IN the_DT first_JJ 15_CD Italian_JJ sites_NNS included_VBN in_IN the_DT National_NNP Reclaim_NNP Program_NNP 
Background_NN It_PRP is_VBZ estimated_VBN that_IN approximately_RB one-quarter_NN of_IN the_DT global_JJ disease_NN burden_NN ,_, and_CC more_JJR than_IN one-third_NN of_IN the_DT burden_NN among_IN children_NNS ,_, is_VBZ due_JJ to_TO modifiable_JJ environmental_JJ factors_NNS 
Priolo_NNP and_CC Gela_NNP ,_, in_IN south-east_JJ Sicily_NNP ,_, provide_VBP extensively_RB documented_VBN cases_NNS of_IN toxic_JJ contaminated_VBN sites_NNS where_WRB ,_, due_JJ to_TO the_DT presence_NN of_IN large_JJ petrochemical_NN industrial_JJ plants_NNS and_CC to_TO widely_RB diffuse_VB environmental_JJ pollution_NN ,_, several_JJ negative_JJ health_NN effects_NNS have_VBP been_VBN observed_VBN ._. 
High_JJ levels_NNS of_IN many_JJ chemical_NN compounds_NNS have_VBP been_VBN detected_VBN in_IN soil_NN ,_, water_NN ,_, groundwater_NN ,_, air_NN sediments_NNS ,_, fish_NN and_CC shellfish_NN of_IN both_DT areas_NNS ._. 
One_CD recent_JJ descriptive_JJ study_NN conducted_VBN in_IN Gela_NNP and_CC Priolo_NNP by_IN the_DT Dipartimento_NNP Osservatorio_NNP Epidemiologico_NNP -LRB-_-LRB- DOE_NNP -RRB-_-RRB- of_IN the_DT Sicilian_NNP Region_NNP showed_VBD excesses_NNS of_IN overall_JJ mortality_NN ,_, of_IN all_DT cancer_NN mortality_NN and_CC of_IN many_JJ cancer_NN and_CC non-cancer_JJ cases_NNS when_WRB compared_VBN with_IN regional_JJ and_CC local_JJ reference_NN levels_NNS 
High_JJ levels_NNS of_IN many_JJ chemical_NN compounds_NNS have_VBP been_VBN detected_VBN in_IN soil_NN ,_, water_NN ,_, groundwater_NN ,_, air_NN sediments_NNS ,_, fish_NN and_CC shellfish_NN of_IN both_DT areas_NNS ._. 
One_CD recent_JJ descriptive_JJ study_NN conducted_VBN in_IN Gela_NNP a_DT 
Health_NNP outcomes_VBZ attributable_JJ to_TO exposure_NN to_TO industrial_JJ pollutants_NNS Since_IN the_DT early_JJ 1980s_NNS ,_, several_JJ epidemiological_JJ studies_NNS have_VBP been_VBN conducted_VBN in_IN Sicily_NNP to_TO investigate_VB the_DT health_NN status_NN of_IN the_DT populations_NNS living_VBG near_IN industrial_JJ sites_NNS ._. 
The_DT most_RBS recent_JJ epidemiological_JJ study_NN conducted_VBN by_IN the_DT DOE_NNP collected_VBD mortality_NN data_NNS -LRB-_-LRB- from_IN 1995_CD to_TO 2002_CD -RRB-_-RRB- and_CC hospital_NN discharges_NNS -LRB-_-LRB- from_IN 2001_CD to_TO 2006_CD -RRB-_-RRB- ,_, for_IN residents_NNS in_IN the_DT municipalities_NNS included_VBN in_IN the_DT high_JJ risk_NN areas_NNS 
individuals_NNS with_IN lung_NN cancer_NN -RRB-_-RRB- by_IN the_DT expected_VBN cases_NNS ._. 
g._NNP Standardised_NNP mortality\/hospitalisation_NN ratios_NNS -LRB-_-LRB- SMR_NNP ,_, SHR_NNP -RRB-_-RRB- were_VBD calculated_VBN by_IN dividing_VBG the_DT observed_JJ cases_NNS -LRB-_-LRB- e._NN Estimates_NNS were_VBD reported_VBN for_IN males_NNS and_CC females_NNS separately_RB and_CC adjusted_VBN by_IN age_NN and_CC socioeconomic_JJ deprivation_NN ._. 
The_DT potential_JJ health_NN benefits_NNS arising_VBG from_IN a_DT reduction_NN in_IN exposure_NN to_TO industrial_JJ pollutants_NNS are_VBP quantified_VBN for_IN both_DT Gela_NNP and_CC Priolo_NNP ,_, by_IN considering_VBG the_DT impact_NN on_IN total_JJ mortality_NN ,_, hospital_NN admissions_NNS for_IN cancer_NN and_CC non-cancer_JJ causes_NNS ._. 
Results_NNS The_DT health_NN outcomes_VBZ attributable_JJ annually_RB to_TO industrial_JJ pollution_NN exposure_NN in_IN Priolo_NNP and_CC Gela_NNP were_VBD estimated_VBN using_VBG data_NNS from_IN Cernigliaro_NNP et_FW al._FW ._. ._. 
As_IN shown_VBN in_IN Table_NNP 1_CD ,_, a_DT reduction_NN in_IN exposure_NN to_TO environmental_JJ pollution_NN in_IN Priolo_NNP would_MD avert_VB 8_CD -LRB-_-LRB- 2-11_CD -RRB-_-RRB- premature_JJ deaths_NNS ,_, 118_CD -LRB-_-LRB- 85-151_CD -RRB-_-RRB- -_: cancer_NN related_VBN hospital_NN admission_NN and_CC 692_CD -LRB-_-LRB- 587-780_CD -RRB-_-RRB- non_NN cancer_NN hospital_NN admissions_NNS each_DT year_NN ;_: while_IN in_IN Gela_NNP would_MD avert_VB 39_CD -LRB-_-LRB- 12-64_CD -RRB-_-RRB- premature_JJ deaths_NNS ,_, 163_CD -LRB-_-LRB- 134-192_CD -RRB-_-RRB- cancer_NN and_CC 2,010_CD -LRB-_-LRB- 1,912-2_CD ,095_CD -RRB-_-RRB- non_NN cancer_NN hospital_NN admissions_NNS each_DT year_NN ._. 
In_IN Priolo_NNP ,_, on_IN the_DT other_JJ hand_NN ,_, a_DT pollution_NN control_NN policy_NN costing_VBG more_RBR than_IN 
Although_IN these_DT data_NNS are_VBP currently_RB collected_VBN and_CC controlled_VBN through_IN standardized_JJ methods_NNS for_IN epidemiological_JJ and_CC public_JJ health_NN purposes_NNS some_DT limitations_NNS should_MD be_VB considered_VBN the_DT existing_VBG studies_NNS design_NN does_VBZ not_RB allow_VB to_TO assessing_VBG the_DT causal_JJ relationship_NN between_IN industrial_JJ pollution_NN exposure_NN and_CC health_NN ._. 
However_RB it_PRP should_MD be_VB noted_VBN that_IN the_DT proportions_NNS of_IN deaths_NNS and_CC non-fatal_JJ cancers_NNS attributed_VBN to_TO the_DT environment_NN are_VBP comparable_JJ to_TO those_DT suggested_VBN by_IN WHO_WP and_CC other_JJ authors_NNS 
Nevertheless_RB ,_, there_EX are_VBP several_JJ limitations_NNS to_TO the_DT study_NN ._. 
For_IN the_DT first_JJ time_NN ,_, in_IN the_DT context_NN of_IN environmental_JJ cost_NN benefit_NN analysis_NN ,_, this_DT work_NN used_VBD cost_NN benefit_NN acceptability_NN curves_NNS in_IN order_NN to_TO capture_VB the_DT uncertainty_NN around_IN the_DT estimated_JJ net_JJ benefit_NN and_CC to_TO show_VB the_DT probability_NN that_DT intervention_NN will_MD be_VB cost_VBN beneficial_JJ ,_, given_VBN a_DT range_NN of_IN clean-up_JJ policy_NN costs_NNS and_CC different_JJ degrees_NNS of_IN effectiveness_NN of_IN remedial_JJ interventions_NNS ._. 
It_PRP was_VBD assumed_VBN that_IN the_DT excess_JJ mortality_NN ,_, cancer_NN and_CC non_NN cancer_NN hospitalization_NN are_VBP attributable_JJ to_TO the_DT environmental_JJ pressures_NNS ,_, that_WDT represent_VBP the_DT main_JJ difference_NN between_IN the_DT study_NN areas_NNS and_CC the_DT reference_NN areas_NNS -LRB-_-LRB- not_RB only_RB the_DT whole_JJ Sicily_NNP region_NN but_CC also_RB a_DT limited_JJ number_NN of_IN neighbouring_JJ municipalities_NNS -RRB-_-RRB- ._. 
The_DT absence_NN of_IN studies_NNS with_IN an_DT analytical_JJ design_NN that_WDT would_MD provide_VB better_JJR evidence_NN of_IN the_DT causal_JJ relationship_NN between_IN environmental_JJ pressure_NN and_CC health_NN is_VBZ a_DT limitation_NN for_IN the_DT present_JJ analysis_NN ._. 
Also_RB ,_, since_IN 2000_CD ,_, lead_JJ concentrations_NNS in_IN the_DT air_NN have_VBP reached_VBN consistently_RB trimester_NN averages_NNS 
0_CD 
Soil_NN was_VBD the_DT major_JJ contaminated_VBN environmental_JJ media_NNS ,_, having_VBG concentrations_NNS above_IN 400_CD 
At_IN the_DT onset_NN of_IN the_DT study_NN -LRB-_-LRB- 0_CD time_NN -RRB-_-RRB- ,_, the_DT median_JJ value_NN of_IN B-Pb_JJ concentrations_NNS was_VBD slightly_RB higher_JJR than_IN 10_CD ._. 
0_CD 
When_WRB this_DT follow-up_JJ study_NN began_VBD in_IN 2001_CD ,_, the_DT median_NN of_IN B-Pb_JJ concentrations_NNS in_IN 6_CD year_NN old_JJ children_NNS was_VBD 10_CD ._. 
12_CD 
In_IN this_DT work_NN ,_, we_PRP also_RB studied_VBD the_DT concentrations_NNS of_IN hemoglobin_NN and_CC Zinc_NN protoporphyrin_NN as_IN biomarkers_NNS of_IN lead_NN effect_NN ._. 
Results_NNS showed_VBD that_IN at_IN the_DT beginning_NN of_IN the_DT study_NN ,_, when_WRB the_DT children_NNS had_VBD the_DT highest_JJS levels_NNS of_IN lead_NN exposure_NN ,_, they_PRP were_VBD more_JJR at_IN risk_NN for_IN anemia_NN ,_, which_WDT is_VBZ expressed_VBN as_IN low_JJ hemoglobin_NN levels_NNS -LRB-_-LRB- an_DT adverse_JJ effect_NN attributed_VBN to_TO lead_VB exposure_NN -RRB-_-RRB- ._. 
These_DT results_NNS confirm_VBP the_DT well_RB described_VBN effects_NNS of_IN lead_NN on_IN heme_NN metabolism_NN ._. 
Zinc_NN protoporphyrin_NN did_VBD not_RB show_VB significant_JJ changes_NNS during_IN the_DT study_NN ,_, possibly_RB due_JJ to_TO the_DT fact_NN that_IN most_JJS of_IN the_DT children_NNS had_VBD B-Pb_JJ levels_NNS under_IN the_DT threshold_NN for_IN increased_VBN Zinc-protoporphyrin_NN -LRB-_-LRB- 91_CD ._. 
Both_DT methods_NNS have_VBP been_VBN very_RB useful_JJ in_IN determining_VBG B-Pb_JJ levels_NNS but_CC there_EX are_VBP discrepancies_NNS when_WRB both_DT methods_NNS are_VBP applied_VBN ._. 
These_DT differences_NNS be_VB attributed_VBN to_TO the_DT fact_NN that_IN the_DT Lead_JJ Care_NN 
Ingestion_NN appeared_VBD to_TO be_VB the_DT main_JJ exposure_NN mechanism_NN for_IN lead_NN entry_NN to_TO the_DT organism_NN after_IN soil_NN and_CC dust_NN ._. 
Soil_NN was_VBD the_DT major_JJ contaminated_VBN environmental_JJ media_NNS ,_, having_VBG concentrations_NNS above_IN 400_CD 
Zinc_NN protoporphyrin_NN -LRB-_-LRB- ZPP_NNP -RRB-_-RRB- was_VBD tested_VBN in_IN whole_JJ blood_NN at_IN the_DT school_NN with_IN ZP_NNP Hematofluorometer_NNP -LRB-_-LRB- AVIV_NNP Biomedical_NNP -RRB-_-RRB- ._. 
Lead_JJ in_IN soil_NN determinationsParallel_NN to_TO this_DT study_NN ,_, other_JJ group_NN worked_VBD on_IN lead_NN in_IN soil_NN concentrations_NNS and_CC their_PRP$ impact_NN on_IN risk_NN assessment_NN of_IN adverse_JJ health_NN effects_NNS in_IN children_NNS ._. 
From_IN this_DT effort_NN ,_, we_PRP obtained_VBD the_DT lead_NN in_IN soil_NN concentrations_NNS in_IN the_DT neighboring_JJ areas_NNS of_IN all_PDT the_DT studied_VBN schools_NNS except_IN those_DT marked_VBN with_IN the_DT numbers_NNS 1_CD ,_, 8_CD and_CC 9_CD -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ._. 
Yet_RB one_CD other_JJ contributive_JJ explanation_NN is_VBZ that_IN 60_CD months_NNS of_IN environmental_JJ measures_NNS and_CC soil-dust_JJ cleaning_NN activities_NNS could_MD modify_VB the_DT geographical_JJ pattern_NN of_IN lead_NN in_IN soil_NN distribution_NN ,_, however_RB ,_, this_DT explanation_NN does_VBZ not_RB agree_VB with_IN the_DT general_JJ analyses_NNS of_IN lead_NN in_IN soil_NN results_NNS discovered_VBN by_IN Villalobos-Jauregui_NNP et_FW al._FW ._. 
,where_JJ soil_NN contamination_NN is_VBZ still_RB strongly_RB associated_VBN with_IN the_DT close_JJ proximity_NN to_TO the_DT smelter_NN complex_NN ._. 
The_DT decrease_NN in_IN the_DT exposure_NN biomarker_NN for_IN lead_NN -LRB-_-LRB- B-Pb_JJ -RRB-_-RRB- levels_NNS in_IN the_DT studied_VBN group_NN could_MD be_VB explained_VBN by_IN lower_JJR lead_NN exposure_NN due_JJ to_TO improvements_NNS in_IN environment_NN quality_NN ._. 
6%_CD of_IN children_NNS had_VBD B-Pb_JJ levels_NNS below_IN 20_CD ._. 
Zinc_NN protoporphyrin_NN did_VBD not_RB show_VB significant_JJ changes_NNS during_IN the_DT study_NN ,_, possibly_RB due_JJ to_TO the_DT fact_NN that_IN most_JJS of_IN the_DT children_NNS had_VBD B-Pb_JJ levels_NNS under_IN the_DT threshold_NN for_IN increased_VBN Zinc-protoporphyrin_NN -LRB-_-LRB- 91_CD ._. 
0_CD 
Aging_NNP can_MD also_RB decrease_VB lead_NN exposure_NN by_IN changes_NNS in_IN children_NNS 's_POS habits_NNS ,_, such_JJ as_IN the_DT normal_JJ abandon_VBP of_IN mouth_NN activities_NNS as_IN children_NNS age_NN 
It_PRP hosts_VBZ the_DT largest_JJS nonferrous_JJ metallurgical_JJ complex_NN in_IN Latin_NNP America_NNP ,_, which_WDT is_VBZ also_RB the_DT fourth_JJ largest_JJS in_IN the_DT world_NN ._. 
This_DT smelter_NN was_VBD built_VBN in_IN early_JJ 1900_CD and_CC processes_VBZ approximately_RB one_CD third_JJ of_IN the_DT lead_JJ ore_NN in_IN Latin_NNP America_NNP 
In_IN 2010_CD ,_, it_PRP produced_VBD 142,200_CD metric_JJ tons_NNS of_IN lead_NN ,_, 232,700_CD metric_JJ tons_NNS of_IN zinc_NN ,_, 103_CD ._. 
This_DT smelter_NN was_VBD built_VBN in_IN early_JJ 1900_CD and_CC processes_VBZ approximately_RB one_CD third_JJ of_IN the_DT lead_JJ ore_NN in_IN Latin_NNP America_NNP 
3million_CD ounces_NNS of_IN silver_NN and_CC 1,093_CD million_CD ounces_NNS of_IN gold_NN 
The_DT impact_NN of_IN the_DT smelter_NN complex_NN on_IN environmental_JJ health_NN has_VBZ been_VBN recorded_VBN since_IN 1977_CD 
Methods_NNS Subjects_NNS and_CC design_NN of_IN the_DT study_NN This_DT study_NN ,_, which_WDT began_VBD in_IN January_NNP 2001_CD ,_, consisted_VBN of_IN children_NNS living_VBG in_IN nine_CD neighborhoods_NNS in_IN Torreon_NNP ._. 
Children_NNS were_VBD recruited_VBN at_IN 6-8_CD years_NNS of_IN age_NN ,_, at_IN a_DT time_NN they_PRP start_VBP elementary_JJ school_NN ._. 
Children_NNP qualified_VBD for_IN the_DT follow-up_JJ study_NN if_IN they_PRP attended_VBD the_DT first_JJ grade_NN in_IN one_CD of_IN the_DT nine_CD public_JJ elementary_JJ schools_NNS located_VBN within_IN 3_CD ._. 
Yet_RB ,_, attention_NN to_TO environmental_JJ controls_NNS has_VBZ lagged_VBN behind_IN the_DT pace_NN of_IN industrialization_NN ._. 
Background_NN The_DT growth_NN of_IN industry_NN in_IN northern_JJ Mexico_NNP has_VBZ created_VBN the_DT potential_NN for_IN severe_JJ environmental_JJ problems_NNS ._. 
Industrial_JJ sites_NNS such_JJ as_IN ore_NN smelters_NNS are_VBP often_RB located_VBN in_IN residential_JJ areas_NNS ,_, where_WRB exposure_NN to_TO heavy_JJ metals_NNS through_IN inhalation_NN and_CC ingestion_NN of_IN contaminated_VBN soil_NN and_CC dust_NN is_VBZ possible_JJ 
Lead_JJ has_VBZ long_RB been_VBN established_VBN as_IN a_DT health_NN threat_NN to_TO people_NNS living_VBG in_IN communities_NNS surrounding_VBG ore_NN smelters_NNS and_CC refineries_NNS 
The_DT following_JJ bars_NNS represent_VBP lead_NN in_IN soil_NN concentrations_NNS during_IN the_DT time_NN the_DT study_NN was_VBD held_VBN ,_, from_IN 2002_CD to_TO 2006_CD ._. 
Superfund_NNP cleanup_NN goal_NN for_IN lead_NN is_VBZ of_IN 400_CD ppm_NN ._. 
Table_NNP 4_CD Linear_NNP regression_NN models_NNS of_IN logarithm_NN 10_CD Pb_NN in_IN blood_NN concentrations_NNS as_IN dependent_JJ variables_NNS of_IN logarithm_NN 10_CD Pb_NN in_IN soil_NN concentrations_NNS ,_, in_IN the_DT neighborhoods_NNS of_IN the_DT elementary_JJ schools_NNS were_VBD children_NNS lived_VBD at_IN 0_CD ,_, 6_CD ,_, 12_CD and_CC 60_CD months_NNS of_IN follow-up_JJ in_IN Torreon_NNP Coahuila_NNP ._. 
Discussion_NN This_DT report_NN shows_VBZ the_DT timeline_NN of_IN lead_NN exposure_NN in_IN children_NNS resulting_VBG in_IN lead_JJ environmental_JJ contamination_NN in_IN Torreon_NNP ,_, Coahuila_NNP ._. 
The_DT case_NN of_IN lead_NN poisoning_NN in_IN Torreon_NNP captured_VBD international_JJ attention_NN 
Industrial_JJ sites_NNS such_JJ as_IN ore_NN smelters_NNS are_VBP often_RB located_VBN in_IN residential_JJ areas_NNS ,_, where_WRB exposure_NN to_TO heavy_JJ metals_NNS through_IN inhalation_NN and_CC ingestion_NN of_IN contaminated_VBN soil_NN and_CC dust_NN is_VBZ possible_JJ 
In_IN 1999_CD ,_, the_DT Benin_NNP group_NN ,_, analyzed_VBD dust_NN samples_NNS obtained_VBN from_IN residential_JJ neighborhoods_NNS around_IN metallurgic_JJ industries_NNS in_IN Monterrey_NNP ,_, Chihuahua_NNP and_CC Torreon_NNP ,_, Mexico_NNP ._. 
Dust_NN concentrations_NNS of_IN all_DT heavy_JJ metals_NNS were_VBD significantly_RB higher_JJR around_IN the_DT active_JJ smelter_NN in_IN Torreon_NNP ,_, where_WRB more_JJR than_IN 90_CD %_NN of_IN samples_NNS exceeded_VBD Superfund_NNP cleanup_NN goals_NNS of_IN 400_CD 
Discussion_NN This_DT report_NN shows_VBZ the_DT timeline_NN of_IN lead_NN exposure_NN in_IN children_NNS resulting_VBG in_IN lead_JJ environmental_JJ contamination_NN in_IN Torreon_NNP ,_, Coahuila_NNP ._. 
The_DT case_NN of_IN lead_NN poisoning_NN in_IN Torreon_NNP captured_VBD international_JJ attention_NN 
The_DT case_NN of_IN lead_NN poisoning_NN in_IN Torreon_NNP captured_VBD international_JJ attention_NN 
Since_IN then_RB ,_, there_EX has_VBZ been_VBN a_DT general_JJ downward_JJ trend_NN to_TO 9_CD 
Early_RB ecological_JJ works_NNS from_IN 1982_CD ,_, also_RB reported_VBD high_JJ levels_NNS of_IN B-Pb_NNP in_IN children_NNS in_IN Torreon_NNP 
Soil_NN was_VBD the_DT major_JJ contaminated_VBN environmental_JJ media_NNS ,_, having_VBG concentrations_NNS above_IN 400_CD 
On_IN the_DT other_JJ hand_NN ,_, schools_NNS 1_CD and_CC 9_CD ,_, were_VBD located_VBN 3_CD km_NN far_RB away_RB from_IN the_DT smelter_NN ._. 
Schools_NNP 2_CD and_CC 6_CD were_VBD those_DT which_WDT presented_VBD higher_JJR B-Pb_JJ values_NNS at_IN 0_CD months_NNS ._. 
Schools_NNP 1_CD and_CC 9_CD had_VBD similar_JJ values_NNS to_TO those_DT found_VBN by_IN the_DT control_NN sites_NNS in_IN our_PRP$ previous_JJ work_NN ._. 
Table_NNP 3_NNP Timeline_NNP of_IN B-Pb_NNP ,_, Hb_NNP and_CC ZZP_NNP in_IN the_DT group_NN of_IN lead_JJ exposed_JJ children_NNS during_IN 60_CD months_NNS of_IN follow-up_JJ ._. 
The_DT correlations_NNS among_IN B-Pb_NNP were_VBD significantly_RB dependent_JJ of_IN Pb_NNP in_IN soil_NN at_IN 0_CD ,_, 6_CD ,_, and_CC 12_CD months_NNS of_IN follow-up_JJ but_CC the_DT relationship_NN was_VBD lost_VBN at_IN 60_CD months_NNS ,_, where_WRB B-Pb_NNP and_CC Pb_NNP concentrations_NNS in_IN soil_NN were_VBD markedly_RB lower_JJR than_IN previous_JJ times_NNS ._. 
Lead_JJ in_IN drinking_NN water_NN has_VBZ always_RB had_VBN very_RB low_JJ concentrations_NNS in_IN the_DT Lagunera_NNP region_NN ,_, with_IN values_NNS below_IN 5_CD 
The_DT case_NN of_IN lead_NN poisoning_NN in_IN Torreon_NNP captured_VBD international_JJ attention_NN 
Site_NN studies_NNS showed_VBD that_IN dust_NN and_CC soil_NN were_VBD the_DT main_JJ pathways_NNS to_TO human_JJ exposure_NN ,_, particularly_RB in_IN children_NNS 
Early_RB ecological_JJ works_NNS from_IN 1982_CD ,_, also_RB reported_VBD high_JJ levels_NNS of_IN B-Pb_NNP in_IN children_NNS in_IN Torreon_NNP 
As_IN reported_VBN by_IN Kranz_NNP et_FW al._FW ._. 
The_DT evolution_NN of_IN this_DT environmental_JJ case_NN in_IN Torreon_NNP Mexico_NNP is_VBZ similar_JJ to_TO that_DT reported_VBN for_IN Port_NNP Pirie_NNP in_IN South_NNP Australia_NNP ._. 
,in_IN 1984_CD children_NNS had_VBD B-Pb_JJ concentrations_NNS with_IN a_DT geometric_JJ mean_NN of_IN 20_CD 
For_IN B-Pb_JJ measurements_NNS ,_, samples_NNS were_VBD analyzed_VBN in_IN duplicate_VB using_VBG Atomic_NNP Absorption_NNP Spectrophotometry_NNP -LRB-_-LRB- Zeeman-Graphite_NNP Furnace-Analyst_NNP 800_CD ,_, Perkin_NNP Elmer_NNP Norwalk_NNP ,_, CT_NNP -RRB-_-RRB- ,_, according_VBG to_TO Miller_NNP et_FW al._FW ._. 
and_CC those_DT with_IN a_DT CV_NNP 
But_CC this_DT is_VBZ not_RB known_VBN ,_, and_CC the_DT response_NN may_MD be_VB approximately_RB linear_JJ over_IN a_DT wide_JJ dose_NN range_NN but_CC highly_RB non-linear_JJ at_IN lower_JJR doses_NNS ._. 
There_EX are_VBP many_JJ examples_NNS of_IN non-linear_JJ dose_NN response_NN in_IN radiation_NN cell_NN biology_NN ._. 
Thus_RB ,_, if_IN the_DT Japanese_JJ data_NNS is_VBZ used_VBN to_TO derive_VB risk_NN estimates_NNS for_IN doses_NNS such_JJ as_IN 10_CD mSv_NNP or_CC 1mSv_NNP which_WDT are_VBP directly_RB relevant_JJ to_TO occupational_JJ and_CC public_JJ exposure_NN ,_, it_PRP makes_VBZ sense_NN to_TO consider_VB the_DT 0_CD -_: 20_CD mSv_NNP data_NNS in_IN its_PRP$ own_JJ right_NN and_CC in_IN relation_NN to_TO wider_JJR dose_NN ranges_NNS ,_, rather_RB than_IN to_TO pool_VB the_DT data_NNS and_CC apply_VB linear_JJ extrapolation_NN ._. 
However_RB ,_, the_DT results_NNS may_MD also_RB indicate_VB that_IN low_JJ doses_NNS of_IN radiation_NN do_VBP impact_NN on_IN cancer_NN mortality_NN ,_, provided_VBD that_DT latency_NN is_VBZ included_VBN in_IN the_DT model_NN and_CC the_DT dose_NN response_NN is_VBZ not_RB constrained_VBN to_TO be_VB linear_JJ ._. 
In_IN radiation_NN cell_NN biology_NN ,_, non-linear_JJ dose_NN response_NN is_VBZ known_VBN for_IN the_DT bystander_NN effect_NN using_VBG a_DT variety_NN of_IN endpoints_NNS and_CC the_DT two-phase_JJ model_NN was_VBD proposed_VBN as_IN a_DT simplified_VBN form_NN of_IN a_DT model_NN for_IN the_DT bystander_NN effect_NN 
Possible_JJ sources_NNS of_IN error_NN in_IN the_DT Japanese_JJ data_NNS itself_PRP and_CC the_DT potential_NN for_IN confounding_VBG by_IN other_JJ covariates_NNS as_IN discussed_VBN in_IN 
But_CC this_DT is_VBZ not_RB known_VBN ,_, and_CC the_DT response_NN may_MD be_VB approximately_RB linear_JJ over_IN a_DT wide_JJ dose_NN range_NN but_CC highly_RB non-linear_JJ at_IN lower_JJR doses_NNS ._. 
There_EX are_VBP many_JJ examples_NNS of_IN non-linear_JJ dose_NN response_NN in_IN radiation_NN cell_NN biology_NN ._. 
Thus_RB ,_, if_IN the_DT Japanese_JJ data_NNS is_VBZ used_VBN to_TO derive_VB risk_NN estimates_NNS for_IN doses_NNS such_JJ as_IN 10_CD mSv_NNP or_CC 1mSv_NNP which_WDT are_VBP directly_RB relevant_JJ to_TO occupational_JJ and_CC public_JJ exposure_NN ,_, it_PRP makes_VBZ sense_NN to_TO consider_VB the_DT 0_CD -_: 20_CD mSv_NNP data_NNS in_IN its_PRP$ own_JJ right_NN and_CC in_IN relation_NN to_TO wider_JJR dose_NN ranges_NNS ,_, rather_RB than_IN to_TO pool_VB the_DT data_NNS and_CC apply_VB linear_JJ extrapolation_NN ._. 
For_IN model_NN I_PRP nested_VBD within_IN model_NN J_NNP ,_, LRT_NNP J-I_NNP ,_, 
LRT_NNP \*_NN is_VBZ then_RB tested_VBN against_IN gamma_NN distributions_NNS with_IN unknown_JJ shape_NN and_CC rate_NN parameters_NNS ._. 
by_IN the_DT Kolmogorov-Smirnov_NNP -LRB-_-LRB- one-sample_JJ -RRB-_-RRB- test_NN ._. 
A_DT 
In_IN the_DT two-phase_JJ model_NN when_WRB 
Since_IN 
In_IN this_DT paper_NN the_DT data_NN is_VBZ re-analysed_JJ with_IN other_JJ methods_NNS of_IN statistical_JJ inference_NN for_IN the_DT preferred_JJ non-linear_JJ model_NN ._. 
The_DT models_NNS use_VBP Poisson_NNP regression_NN to_TO analyze_VB the_DT grouped_VBN data_NNS in_IN the_DT 0_CD -_: 20_NNP mSv_NNP subcohort_NN of_IN the_DT 1950-1990_CD Life_NNP Span_NNP Study_NNP LSS12_NNP ._. 
The_DT models_NNS take_VBP the_DT form_NN 
Once_RB latency_NN is_VBZ fixed_VBN ,_, the_DT models_NNS depend_VBP smoothly_RB on_IN all_DT other_JJ parameters_NNS ._. 
Profile_NNP Likelihood_NNP Confidence_NNP Intervals_NNPS for_IN ERR_NNP were_VBD based_VBN in_IN on_IN the_DT Likelihood_NNP Ratio_NNP Test_NNP -LRB-_-LRB- LRT_NNP -RRB-_-RRB- for_IN comparisons_NNS between_IN nested_JJ models_NNS ._. 
If_IN Wilks_NNP Theorem_NNP 
-RRB-_-RRB- -RRB-_-RRB- where_WRB 
However_RB ,_, the_DT actual_JJ distribution_NN of_IN LRT_NNP can_MD be_VB estimated_VBN by_IN simulation_NN before_IN comparing_VBG two_CD competing_VBG models_NNS or_CC constructing_VBG confidence_NN intervals_NNS ._. 
Bootstrap_JJ methods_NNS can_MD also_RB be_VB used_VBN to_TO construct_VB confidence_NN intervals_NNS more_RBR directly_RB ._. 
In_IN response_NN to_TO questions_NNS raised_VBN during_IN peer_VB review_NN I_PRP also_RB consider_VBP whether_IN the_DT data_NN justifies_VBZ fitting_JJ the_DT two-phase_JJ model_NN ,_, investigate_VB uncertainties_NNS in_IN the_DT ``_`` optimal_JJ latency_NN ''_'' as_IN estimated_VBN from_IN the_DT data_NNS ,_, extend_VBP the_DT analysis_NN to_TO include_VB the_DT covariate_JJ ``_`` city_NN ''_'' ,_, and_CC compare_VB results_NNS from_IN the_DT 0_CD -_: 20_NNP mSv_NNP and_CC 5_CD -_: 500_CD mSv_NNP dose_NN ranges_NNS ._. 
However_RB ,_, the_DT actual_JJ distribution_NN of_IN LRT_NNP can_MD be_VB estimated_VBN by_IN simulation_NN before_IN comparing_VBG two_CD competing_VBG models_NNS or_CC constructing_VBG confidence_NN intervals_NNS ._. 
Bootstrap_JJ methods_NNS can_MD also_RB be_VB used_VBN to_TO construct_VB confidence_NN intervals_NNS more_RBR directly_RB ._. 
In_IN response_NN to_TO questions_NNS raised_VBN during_IN peer_VB review_NN I_PRP also_RB consider_VBP whether_IN the_DT data_NN justifies_VBZ fitting_JJ the_DT two-phase_JJ model_NN ,_, investigate_VB uncertainties_NNS in_IN the_DT ``_`` optimal_JJ latency_NN ''_'' as_IN estimated_VBN from_IN the_DT data_NNS ,_, extend_VBP the_DT analysis_NN to_TO include_VB the_DT covariate_JJ ``_`` city_NN ''_'' ,_, and_CC compare_VB results_NNS from_IN the_DT 0_CD -_: 20_NNP mSv_NNP and_CC 5_CD -_: 500_CD mSv_NNP dose_NN ranges_NNS ._. 
,and_VBD therefore_RB a_DT simulated_JJ value_NN of_IN ERR_NNP =_SYM ERR_NNP D_NNP ,_, 
95_CD percentile_NN interval_NN are_VBP the_DT 25_CD th_NN and_CC 975_CD th_JJ order_NN statistics_NNS of_IN ERR_NNP \*_NN ._. 
025_CD ,_, the_DT endpoints_NNS of_IN the_DT 0_CD ._. 
For_IN the_DT Bias-corrected_JJ accelerated_JJ -LRB-_-LRB- BCa_NNP -RRB-_-RRB- confidence_NN interval_NN -LRB-_-LRB- see_VB Chapter_NN 5_CD pp_NN ._. 
203-207_CD and_CC p._VB 249_CD -RRB-_-RRB- simulation_NN is_VBZ again_RB carried_VBN out_RP using_VBG 
For_IN various_JJ choices_NNS of_IN H_NNP 0_CD the_DT null_JJ distribution_NN of_IN assuming_VBG H0_NNP holds_VBZ is_VBZ sampled_VBN by_IN Monte_NNP Carlo_NNP simulation_NN -LRB-_-LRB- see_VB 
is_VBZ approximately_RB independent_JJ of_IN the_DT parameters_NNS used_VBN to_TO simulate_VB the_DT data_NNS ,_, provided_VBN that_IN H_NNP 0_CD holds_VBZ ._. 
In_IN the_DT terminology_NN of_IN -LRB-_-LRB- Chapter_NN 4_CD p._NN 139_CD -RRB-_-RRB- is_VBZ an_DT ``_`` approximate_JJ pivot_NN ''_'' even_RB though_IN Wilks_NNP Theorem_NNP fails_VBZ ._. 
,and_VBD therefore_RB a_DT simulated_JJ value_NN of_IN ERR_NNP =_SYM ERR_NNP D_NNP ,_, 
While_IN many_JJ people_NNS exposed_VBN at_IN Hiroshima_NNP and_CC Nagasaki_NNP received_VBD fairly_RB high_JJ doses_NNS ,_, the_DT recommended_VBN occupational_JJ and_CC environmental_JJ dose_NN limits_NNS aim_VBP to_TO control_VB the_DT risks_NNS from_IN much_RB lower_JJR doses_NNS ._. 
Typically_RB ,_, analyses_NNS of_IN the_DT full_JJ cohort_NN of_IN Japanese_JJ survivors_NNS ,_, whose_WP$ doses_NNS ranged_VBD from_IN 0_CD -_: 4000_CD mSv_NNP or_CC more_JJR ,_, are_VBP extrapolated_VBN downwards_NNS to_TO predict_VB the_DT risks_NNS from_IN doses_NNS below_IN 20_NNP mSv_NNP ._. 
However_RB ,_, even_RB if_IN a_DT particular_JJ model_NN gives_VBZ a_DT good_JJ overall_JJ account_NN of_IN the_DT full_JJ range_NN of_IN data_NNS ,_, fitting_JJ that_IN model_NN and_CC extrapolating_VBG the_DT results_NNS may_MD misrepresent_VB the_DT risks_NNS at_IN low_JJ doses_NNS where_WRB the_DT dose_NN response_NN may_MD be_VB quite_RB distinct_JJ ._. 
However_RB ,_, even_RB if_IN a_DT particular_JJ model_NN gives_VBZ a_DT good_JJ overall_JJ account_NN of_IN the_DT full_JJ range_NN of_IN data_NNS ,_, fitting_JJ that_IN model_NN and_CC extrapolating_VBG the_DT results_NNS may_MD misrepresent_VB the_DT risks_NNS at_IN low_JJ doses_NNS where_WRB the_DT dose_NN response_NN may_MD be_VB quite_RB distinct_JJ ._. 
My_PRP$ previous_JJ paper_NN considered_VBN the_DT cancer_NN mortality_NN data_NNS for_IN those_DT survivors_NNS whose_WP$ external_JJ -LRB-_-LRB- flash_NN -RRB-_-RRB- dose_NN from_IN the_DT A-bombs_NNS was_VBD below_IN 20_NNP mSv_NNP ,_, the_DT annual_JJ occupational_JJ dose_NN limit_NN recommended_VBN by_IN the_DT International_NNP Commission_NNP on_IN Radiological_NNP Protection_NNP -LRB-_-LRB- ICRP_NNP -RRB-_-RRB- ._. 
Iapplied_VBN several_JJ different_JJ models_NNS ,_, each_DT of_IN which_WDT used_VBD as_IN their_PRP$ exposure_NN variable_JJ the_DT radiation_NN dose_NN lagged_VBN by_IN an_DT unknown_JJ latency_NN ._. 
The_DT models_NNS take_VBP the_DT form_NN 
Computations_NNS use_VBP the_DT statistical_JJ freeware_NN R_NN 
75_CD p-y_NN ._. 
The_DT subcohort_NN comprises_VBZ 3011_CD data_NNS cells_NNS with_IN 1690391_CD ._. 
As_IN previously_RB source_NN data_NNS for_IN the_DT 1950-1990_CD mortality_NN cohort_NN LSS12_NNP was_VBD obtained_VBN from_IN RERF_NNP 
The_DT control_NN model_NN is_VBZ specified_VBN as_IN 
=82_CD ._. 
0076_CD ,_, =_SYM 120_CD ._. 
4586_CD ,_, 
may_MD differ_VB greatly_RB from_IN the_DT value_NN obtained_VBN by_IN fitting_JJ the_DT linear_JJ model_NN at_IN 
025_CD and_CC their_PRP$ bootstrap_JJ confidence_NN intervals_NNS by_IN the_DT BC_NNP a_DT -LRB-_-LRB- 5000_CD replications_NNS -RRB-_-RRB- and_CC percentile_NN -LRB-_-LRB- 1000_CD replications_NNS -RRB-_-RRB- methods_NNS ._. 
For_IN the_DT stomach_NN ,_, liver_NN ,_, and_CC lung_NN ,_, these_DT confirm_VBP the_DT point_NN estimates_NNS in_IN ._. 
Table_NNP 2_CD Latencies_NNPS ,_, LRT_NNP ,_, fitted_JJ parameters_NNS ,_, ERR_NNP and_CC bootstrap_JJ confidence_NN intervals_NNS for_IN the_DT two-phase_JJ model_NN Site_NN 
05_CD 
Regression_NN of_IN y_NN on_IN x_SYM is_VBZ significantly_RB positive_JJ over_IN portions_NNS of_IN data_NNS -LRB-_-LRB- black_JJ and_CC blue_JJ lines_NNS -RRB-_-RRB- but_CC lacks_VBZ significance_NN over_IN the_DT full_JJ range_NN -LRB-_-LRB- red_JJ line_NN -RRB-_-RRB- ._. 
As_IN discussed_VBN in_IN the_DT graphs_NNS of_IN ERR_NNP against_IN latency_NN show_VBP a_DT clear_JJ separation_NN into_IN positive_JJ and_CC negative_JJ regions_NNS ,_, as_IN is_VBZ also_RB apparent_JJ with_IN the_DT linear_JJ model_NN over_IN restricted_JJ dose_NN ranges_NNS for_IN the_DT liver_NN and_CC lung_NN ._. 
For_IN any_DT given_VBN model_NN ,_, the_DT ``_`` optimal_JJ latency_NN ''_'' 
The_DT next_JJ stage_NN of_IN analysis_NN concerns_NNS confidence_NN intervals_NNS for_IN ERR_NNP at_IN the_DT optimal_JJ latency_NN ._. 
The_DT point_NN estimates_NNS of_IN optimal_JJ latency_NN 
025_CD exclude_VBP 0_CD as_IN do_VB the_DT bootstrap_NN intervals_NNS ,_, which_WDT are_VBP tighter_JJR ._. 
For_IN these_DT 3_CD cancers_NNS ,_, all_PDT the_DT LRT-based_JJ intervals_NNS for_IN ERR_NNP 1_CD and_CC ERR_NNP 0_CD ._. 
This_DT validates_VBZ the_DT claim_NN in_IN that_DT ERR1_NNP is_VBZ significantly_RB elevated_VBN for_IN the_DT stomach_NN ,_, liver_NN ,_, and_CC lung_NN ._. 
All_DT five_CD cancers_NNS show_VBP significant_JJ non-linearity_NN of_IN the_DT dose_NN response_NN by_IN LRT_NNP comparison_NN of_IN the_DT two-phase_JJ and_CC linear_JJ models_NNS -LRB-_-LRB- Table_NNP 5_CD -RRB-_-RRB- ._. 
When_WRB the_DT uncertainty_NN in_IN the_DT optimal_JJ latency_NN is_VBZ determined_VBN by_IN simulation_NN at_IN 
The_DT higher_JJR dose_NN range_NN was_VBD chosen_VBN to_TO include_VB 10_CD mSv_NNP ,_, but_CC to_TO exclude_VB the_DT lowest_JJS dose_NN category_NN in_IN the_DT LSS12_NNP dataset_NN ._. 
Above_IN 5_CD mSv_NNP the_DT revised_VBN dosimetry_NN DS02_NNP generally_RB agrees_VBZ with_IN the_DT DS86_NNP dosimetry_NN used_VBD here_RB -LRB-_-LRB- and_CC in_IN -RRB-_-RRB- ._. 
Comparing_VBG these_DT ranges_NNS tests_NNS whether_IN the_DT results_NNS from_IN 0_CD -_: 20_NNP mSv_NNP simply_RB reflect_VBP some_DT anomaly_NN in_IN the_DT lowest_JJS dose_NN category_NN ._. 
Any_DT possible_JJ interaction_NN effects_NNS involving_VBG gender_NN would_MD disappear_VB with_IN the_DT all-male_JJ or_CC all-female_JJ data_NNS ._. 
As_IN mentioned_VBN in_IN the_DT use_NN of_IN log_VB mean_JJ attained_VBN age_NN was_VBD an_DT adequate_JJ alternative_NN to_TO the_DT full_JJ set_NN of_IN attained_VBN age_NN categories_NNS ,_, and_CC alternative_JJ controls_NNS affected_VBD the_DT estimates_NNS of_IN ERR_NNP by_IN no_DT more_JJR than_IN a_DT factor_NN of_IN 2_CD ._. 
The_DT results_NNS at_IN 0_CD ._. 
25_CD mSv_NNP -LRB-_-LRB- ERR_NNP 0_CD ._. 
025_CD -RRB-_-RRB- show_VBP that_IN the_DT risk_NN detected_VBD here_RB arises_VBZ at_IN extremely_RB low_JJ doses_NNS ._. 
In_IN radiation_NN cell_NN biology_NN ,_, non-linear_JJ dose_NN response_NN is_VBZ known_VBN for_IN the_DT bystander_NN effect_NN using_VBG a_DT variety_NN of_IN endpoints_NNS and_CC the_DT two-phase_JJ model_NN was_VBD proposed_VBN as_IN a_DT simplified_VBN form_NN of_IN a_DT model_NN for_IN the_DT bystander_NN effect_NN 
However_RB ,_, I_PRP hope_VBP it_PRP establishes_VBZ the_DT statistical_JJ validity_NN of_IN this_DT analysis_NN of_IN the_DT available_JJ public_JJ data_NNS for_IN the_DT 1950-1990_CD mortality_NN cohort_NN ._. 
ConclusionThis_NN reanalysis_NN validates_VBZ the_DT main_JJ conclusions_NNS of_IN ._. 
Bootstrap_JJ methods_NNS and_CC Monte_NNP Carlo_NNP simulation_NN of_IN LRT_NNP show_VBP that_IN Excess_NNP Relative_NNP Risk_NNP for_IN cancer_NN mortality_NN in_IN Japanese_JJ A-bomb_NN survivors_NNS exposed_VBN to_TO external_JJ radiation_NN doses_NNS below_IN 20_NNP mSv_NNP is_VBZ positive_JJ ,_, large_JJ ,_, and_CC significant_JJ for_IN various_JJ cancers_NNS ,_, as_IN detected_VBN by_IN models_NNS incorporating_VBG latency_NN ._. 
Thanks_NNS to_TO Duncan_NNP Thomas_NNP for_IN pointing_VBG out_RP the_DT uncertainty_NN in_IN optimal_JJ latency_NN ,_, and_CC for_IN other_JJ criticisms_NNS during_IN peer_VBP review_NN ._. 
Thanks_NNS to_TO Mark_NNP Little_NNP for_IN criticisms_NNS of_IN which_WDT provoked_VBD this_DT paper_NN ._. 
This_DT work_NN was_VBD not_RB funded_VBN ._. 
The_DT data_NNS described_VBN in_IN this_DT report_NN were_VBD obtained_VBN from_IN the_DT Radiation_NNP Effects_NNPS Research_NNP Foundation_NNP -LRB-_-LRB- RERF_NNP -RRB-_-RRB- via_IN the_DT Comprehensive_NNP Epidemiologic_NNP Data_NNP Resource_NNP ._. 
These_DT results_NNS occurred_VBD over_IN a_DT range_NN of_IN latencies_NNS ._. 
The_DT linear_JJ model_NN found_VBD large_JJ ,_, significant_JJ results_NNS for_IN the_DT liver_NN ,_, while_IN the_DT preferred_JJ non-linear_JJ model_NN found_VBD large_JJ ,_, significant_JJ results_NNS for_IN the_DT stomach_NN ,_, liver_NN ,_, and_CC lung_NN ._. 
The_DT statistical_JJ method_NN I_PRP used_VBD to_TO assess_VB the_DT significance_NN of_IN the_DT findings_NNS with_IN non-linear_JJ models_NNS was_VBD criticised_VBN by_IN Mark_NNP Little_NNP ._. 
In_IN this_DT paper_NN the_DT data_NN is_VBZ re-analysed_JJ with_IN other_JJ methods_NNS of_IN statistical_JJ inference_NN for_IN the_DT preferred_JJ non-linear_JJ model_NN ._. 
Here_RB the_DT null_JJ hypothesis_NN is_VBZ 
The_DT next_JJ stage_NN of_IN analysis_NN concerns_NNS confidence_NN intervals_NNS for_IN ERR_NNP at_IN the_DT optimal_JJ latency_NN ._. 
The_DT point_NN estimates_NNS of_IN optimal_JJ latency_NN 
,to_JJ form_NN a_DT sample_NN S_NNP ,_, a_DT new_JJ gamma_NN distribution_NN 
Further_JJ analysis_NN considers_VBZ variation_NN in_IN latency_NN ,_, the_DT impact_NN of_IN ``_`` city_NN ''_'' ,_, male_JJ and_CC female_JJ subcohorts_NNS ,_, and_CC the_DT 5_CD -_: 500_CD mSv_NNP dose_NN range_NN ._. 
Computations_NNS use_VBP the_DT statistical_JJ freeware_NN R_NN 
Possible_JJ sources_NNS of_IN error_NN in_IN the_DT Japanese_JJ data_NNS itself_PRP and_CC the_DT potential_NN for_IN confounding_VBG by_IN other_JJ covariates_NNS as_IN discussed_VBN in_IN 
In_IN the_DT two-phase_JJ model_NN when_WRB 
For_IN various_JJ choices_NNS of_IN H_NNP 0_CD the_DT null_JJ distribution_NN of_IN assuming_VBG H0_NNP holds_VBZ is_VBZ sampled_VBN by_IN Monte_NNP Carlo_NNP simulation_NN -LRB-_-LRB- see_VB 
Moreover_RB the_DT method_NN has_VBZ been_VBN validated_VBN in_IN subjects_NNS exposed_VBN to_TO asbestos_NN in_IN the_DT workplace_NN ._. 
Sputum_NN examination_NN was_VBD preferred_VBN to_TO the_DT bronchial_JJ alveolar_NN lavage_NN -LRB-_-LRB- BAL_NNP -RRB-_-RRB- technique_NN ,_, as_IN it_PRP is_VBZ non-invasive_JJ ._. 
MethodsSince_NNP the_DT sensitivity_NN of_IN sputum_NN examination_NN for_IN fibers_NNS and_CC ferruginous_JJ bodies_NNS as_IN a_DT marker_NN of_IN asbestos_NN exposure_NN is_VBZ low_JJ ,_, even_RB in_IN occupationally_RB exposed_VBN people_NNS 
An_DT ecological_JJ study_NN performed_VBD to_TO investigate_VB the_DT association_NN between_IN mortality_NN from_IN chronic_JJ obstructive_JJ pulmonary_JJ disease_NN -LRB-_-LRB- COPD_NNP -RRB-_-RRB- and_CC exposure_NN to_TO fluoro-edenite_JJ in_IN thirty-six_JJ municipalities_NNS located_VBN in_IN the_DT volcanic_JJ area_NN of_IN Mount_NNP Etna_NNP ,_, found_VBD a_DT significant_JJ association_NN between_IN COPD_NNP mortality_NN and_CC pleural_JJ neoplasm_NN mortality_NN among_IN women_NNS ,_, suggesting_VBG an_DT etiologic_JJ role_NN of_IN fluoro-edenite_NN in_IN nonmalignant_JJ respiratory_JJ diseases_NNS ._. 
Arecent_JJ study_NN confirmed_VBD the_DT increase_NN of_IN the_DT incidence_NN of_IN pleural_JJ mesothelioma_NN in_IN the_DT period_NN 1998_CD 
Methods_NNS Since_IN the_DT sensitivity_NN of_IN sputum_NN examination_NN for_IN fibers_NNS and_CC ferruginous_JJ bodies_NNS as_IN a_DT marker_NN of_IN asbestos_NN exposure_NN is_VBZ low_JJ ,_, even_RB in_IN occupationally_RB exposed_VBN people_NNS 
Arecent_JJ study_NN confirmed_VBD the_DT increase_NN of_IN the_DT incidence_NN of_IN pleural_JJ mesothelioma_NN in_IN the_DT period_NN 1998_CD 
In_IN order_NN to_TO investigate_VB fluoro-edenite_JJ respirability_NN and_CC persistence_NN ,_, a_DT study_NN was_VBD planned_VBN by_IN the_DT Department_NNP of_IN Occupational_NNP Medicine_NNP of_IN the_DT University_NNP of_IN Turin_NNP ,_, the_DT Italian_NNP National_NNP Institute_NNP of_IN Public_NNP Health_NNP ,_, the_DT Local_NNP Health_NNP District_NNP and_CC the_DT Biancavilla_NNP Hospital_NNP ._. 
Hypothesizing_VBG a_DT behavior_NN of_IN the_DT new_JJ fiber_NN analogous_JJ to_TO that_DT of_IN asbestos_NN and_CC other_JJ mineral_NN fibers_NNS in_IN the_DT environment_NN ,_, it_PRP was_VBD decided_VBN to_TO carry_VB out_RP the_DT determination_NN of_IN the_DT free_JJ fibers_NNS and_CC the_DT ferruginous_JJ bodies_NNS in_IN sputum_NN ._. 
To_TO verify_VB the_DT feasibility_NN of_IN using_VBG spontaneous_JJ sputum_NN as_IN an_DT exposure_NN indicator_NN for_IN these_DT fibers_NNS ,_, a_DT pilot_NN study_NN was_VBD performed_VBN ._. 
This_DT finding_NN may_MD be_VB due_JJ to_TO either_CC the_DT small_JJ number_NN of_IN subjects_NNS under_IN study_NN ,_, or_CC to_TO the_DT properties_NNS of_IN the_DT fiber_NN itself_PRP ,_, which_WDT might_MD not_RB be_VB capable_JJ of_IN inducing_VBG the_DT mechanism_NN of_IN ferruginous_JJ body_NN formation_NN ._. 
In_IN a_DT study_NN undertaken_VBN to_TO evaluate_VB the_DT usefulness_NN of_IN uncoated_JJ asbestos_NN fiber_NN in_IN sputum_NN to_TO distinguish_VB occupational_JJ exposed_JJ groups_NNS from_IN the_DT general_JJ population_NN ,_, uncoated_JJ fibers_NNS were_VBD found_VBN in_IN 10_CD out_IN of_IN 12_CD former_JJ amosite_JJ asbestos_NN workers_NNS and_CC in_IN only_RB one_CD out_IN of_IN 12_CD age-matched_JJ controls_NNS ._. 
Conclusion_NN The_DT observation_NN of_IN the_DT presence_NN of_IN fluoro-edenitic_JJ fibers_NNS in_IN the_DT sputum_NN of_IN 6_CD out_IN of_IN 12_CD COPD_NNP patients_NNS examined_VBD in_IN Biancavilla_NNP points_NNS to_TO a_DT relatively_RB important_JJ environmental_JJ exposure_NN ;_: in_IN this_DT frame_NN further_JJ action_NN aimed_VBN at_IN environmental_JJ reclamation_NN ,_, continuing_VBG exposure_NN assessment_NN ,_, and_CC evaluation_NN of_IN the_DT suggested_JJ relation_NN between_IN fluoro-edenitic_JJ fibers_NNS and_CC COPD_NNP are_VBP warranted_VBN ._. 
The_DT ferruginous_JJ bodies_NNS -LRB-_-LRB- fiber_NN \/_NN particle_NN coated_VBN with_IN both_DT protein_NN and_CC iron_NN -RRB-_-RRB- are_VBP considered_VBN to_TO be_VB the_DT result_NN of_IN a_DT protective_JJ mechanism_NN of_IN the_DT host_NN to_TO reduce_VB the_DT fiber_NN toxicity_NN ._. 
Only_RB a_DT fraction_NN of_IN fibers_NNS reaching_VBG the_DT alveoli_NN becomes_VBZ coated_JJ forming_VBG ferruginous_JJ bodies_NNS and_CC ,_, in_IN case_NN of_IN amphibole_JJ minerals_NNS ,_, fibers_NNS shorter_JJR than_IN 10_CD 
Amphibolic_JJ fibers_NNS were_VBD found_VBN in_IN the_DT quarry_NN and_CC identified_VBN as_IN fluoro-edenite_JJ ``_`` new_JJ end-member_NN of_IN the_DT edenite\/fluoro-edenite_JJ series_NN ''_'' and_CC recognized_VBD as_IN the_DT fluoro-edenite_JJ holotype_NN by_IN International_NNP Mineralogical_NNP Association_NNP 
Fluoro-edenite_NN was_VBD thus_RB considered_VBN to_TO be_VB the_DT causal_JJ agent_NN of_IN the_DT observed_JJ mesothelioma_NN cluster_NN 
Fluoro-edenite_NN was_VBD thus_RB considered_VBN to_TO be_VB the_DT causal_JJ agent_NN of_IN the_DT observed_JJ mesothelioma_NN cluster_NN 
Fluoro-edenitic_JJ fibers_NNS were_VBD found_VBN in_IN the_DT autopsy_NN samples_NNS of_IN lung_NN tissues_NNS of_IN an_DT 86-year-old_JJ woman_NN who_WP died_VBD of_IN mesothelioma_NN 
Arecent_JJ study_NN confirmed_VBD the_DT increase_NN of_IN the_DT incidence_NN of_IN pleural_JJ mesothelioma_NN in_IN the_DT period_NN 1998_CD 
Conclusion_NN The_DT occurrence_NN of_IN the_DT pleural_JJ mesothelioma_NN cases_NNS and_CC the_DT presence_NN of_IN fluoro-edenitic_JJ fibers_NNS in_IN spontaneous_JJ sputum_NN ,_, evidence_NN the_DT need_NN to_TO study_VB the_DT biological_JJ activity_NN of_IN fluoro-edenitic_JJ fibers_NNS and_CC the_DT implementation_NN of_IN epidemiological_JJ monitoring_NN systems_NNS ._. 
BackgroundAn_JJ excess_NN of_IN mortality_NN for_IN malignant_JJ neoplasms_NNS of_IN the_DT pleura_NN during_IN the_DT period_NN 1988_CD to_TO 1992_CD in_IN Biancavilla_NNP ,_, a_DT rural_JJ town_NN located_VBN on_IN the_DT southwest_JJ side_NN of_IN the_DT Etna_NNP volcano_NN 
Conclusion_NN The_DT occurrence_NN of_IN the_DT pleural_JJ mesothelioma_NN cases_NNS and_CC the_DT presence_NN of_IN fluoro-edenitic_JJ fibers_NNS in_IN spontaneous_JJ sputum_NN ,_, evidence_NN the_DT need_NN to_TO study_VB the_DT biological_JJ activity_NN of_IN fluoro-edenitic_JJ fibers_NNS and_CC the_DT implementation_NN of_IN epidemiological_JJ monitoring_NN systems_NNS ._. 
BackgroundAn_JJ excess_NN of_IN mortality_NN for_IN malignant_JJ neoplasms_NNS of_IN the_DT pleura_NN during_IN the_DT period_NN 1988_CD to_TO 1992_CD in_IN Biancavilla_NNP ,_, a_DT rural_JJ town_NN located_VBN on_IN the_DT southwest_JJ side_NN of_IN the_DT Etna_NNP volcano_NN 
Fluoro-edenite_NN was_VBD thus_RB considered_VBN to_TO be_VB the_DT causal_JJ agent_NN of_IN the_DT observed_JJ mesothelioma_NN cluster_NN 
In_IN the_DT light_NN of_IN the_DT absence_NN of_IN known_JJ sources_NNS of_IN asbestos_NN exposure_NN ,_, a_DT local_JJ stone_NN quarry_NN ,_, located_VBN near_IN the_DT inhabited_VBN area_NN ,_, used_VBN for_IN the_DT extraction_NN of_IN building_NN materials_NNS ,_, was_VBD investigated_VBN ._. 
Amphibolic_JJ fibers_NNS were_VBD found_VBN in_IN the_DT quarry_NN and_CC identified_VBN as_IN fluoro-edenite_JJ ``_`` new_JJ end-member_NN of_IN the_DT edenite\/fluoro-edenite_JJ series_NN ''_'' and_CC recognized_VBD as_IN the_DT fluoro-edenite_JJ holotype_NN by_IN International_NNP Mineralogical_NNP Association_NNP 
Sputum_NN examination_NN was_VBD preferred_VBN to_TO the_DT bronchial_JJ alveolar_NN lavage_NN -LRB-_-LRB- BAL_NNP -RRB-_-RRB- technique_NN ,_, as_IN it_PRP is_VBZ non-invasive_JJ ._. 
Moreover_RB the_DT method_NN has_VBZ been_VBN validated_VBN in_IN subjects_NNS exposed_VBN to_TO asbestos_NN in_IN the_DT workplace_NN 
Despite_IN the_DT small_JJ group_NN studied_VBD ,_, these_DT results_NNS prompt_VBP us_PRP to_TO continue_VB the_DT study_NN ,_, for_IN several_JJ considerations_NNS ._. 
The_DT presence_NN in_IN the_DT sputum_NN of_IN either_DT asbestos_NN or_CC other_JJ natural_JJ mineral_NN fibers_NNS confirms_VBZ recent_JJ and_CC past_JJ exposure_NN ,_, whereas_IN the_DT absence_NN of_IN ferruginous_JJ bodies_NNS can_MD not_RB rule_VB out_RP the_DT asbestos_NN exposure_NN ._. 
The_DT ferruginous_JJ bodies_NNS -LRB-_-LRB- fiber_NN \/_NN particle_NN coated_VBN with_IN both_DT protein_NN and_CC iron_NN -RRB-_-RRB- are_VBP considered_VBN to_TO be_VB the_DT result_NN of_IN a_DT protective_JJ mechanism_NN of_IN the_DT host_NN to_TO reduce_VB the_DT fiber_NN toxicity_NN ._. 
Therefore_RB ,_, it_PRP may_MD be_VB assumed_VBN that_IN the_DT exposure_NN to_TO fluoro-edenitic_JJ fibers_NNS was_VBD mainly_RB environmental_JJ ._. 
DiscussionNotwithstanding_VBG some_DT Authors_NNS showed_VBD that_IN aerosol-induced_JJ sputum_NN technique_NN was_VBD more_RBR effective_JJ for_IN detecting_VBG ferruginous_JJ bodies_NNS than_IN spontaneous_JJ sputum_NN specimens_NNS ,_, we_PRP decided_VBD to_TO test_VB the_DT latter_JJ one_CD method_NN because_IN it_PRP was_VBD more_RBR acceptable_JJ ,_, considering_VBG the_DT local_JJ social_JJ context_NN ._. 
Despite_IN the_DT small_JJ group_NN studied_VBD ,_, these_DT results_NNS prompt_VBP us_PRP to_TO continue_VB the_DT study_NN ,_, for_IN several_JJ considerations_NNS ._. 
Fluoro-edenitic_JJ fibers_NNS were_VBD found_VBN in_IN the_DT autopsy_NN samples_NNS of_IN lung_NN tissues_NNS of_IN an_DT 86-year-old_JJ woman_NN who_WP died_VBD of_IN mesothelioma_NN 
Studies_NNS on_IN the_DT effects_NNS fluoro-edenite_NN might_MD have_VB on_IN human_JJ health_NN were_VBD undertaken_VBN ._. 
The_DT termination_NN of_IN quarrying_VBG activity_NN and_CC the_DT asphalting_NN of_IN roads_NNS previously_RB paved_VBN with_IN local_JJ soil_NN materials_NNS were_VBD among_IN the_DT public_JJ health_NN recommendations_NNS adopted_VBN to_TO decrease_VB the_DT exposure_NN to_TO the_DT fluoro-edenite_NN ,_, and_CC were_VBD implemented_VBN in_IN 2003_CD ._. 
An_DT ecological_JJ study_NN performed_VBD to_TO investigate_VB the_DT association_NN between_IN mortality_NN from_IN chronic_JJ obstructive_JJ pulmonary_JJ disease_NN -LRB-_-LRB- COPD_NNP -RRB-_-RRB- and_CC exposure_NN to_TO fluoro-edenite_JJ in_IN thirty-six_JJ municipalities_NNS located_VBN in_IN the_DT volcanic_JJ area_NN of_IN Mount_NNP Etna_NNP ,_, found_VBD a_DT significant_JJ association_NN between_IN COPD_NNP mortality_NN and_CC pleural_JJ neoplasm_NN mortality_NN among_IN women_NNS ,_, suggesting_VBG an_DT etiologic_JJ role_NN of_IN fluoro-edenite_NN in_IN nonmalignant_JJ respiratory_JJ diseases_NNS ._. 
Arecent_JJ study_NN confirmed_VBD the_DT increase_NN of_IN the_DT incidence_NN of_IN pleural_JJ mesothelioma_NN in_IN the_DT period_NN 1998_CD 
Methods_NNS Since_IN the_DT sensitivity_NN of_IN sputum_NN examination_NN for_IN fibers_NNS and_CC ferruginous_JJ bodies_NNS as_IN a_DT marker_NN of_IN asbestos_NN exposure_NN is_VBZ low_JJ ,_, even_RB in_IN occupationally_RB exposed_VBN people_NNS ,_, the_DT criteria_NNS for_IN inclusion_NN in_IN the_DT study_NN were_VBD :_: 1_LS -RRB-_-RRB- subjects_NNS hospitalized_VBN for_IN exacerbation_NN of_IN COPD_NNP symptoms_NNS ,_, to_TO collect_VB the_DT highest_JJS possible_JJ quantity_NN of_IN sputum_NN ,_, 2_CD -RRB-_-RRB- age_NN 
In_IN order_NN to_TO investigate_VB fluoro-edenite_JJ respirability_NN and_CC persistence_NN ,_, a_DT study_NN was_VBD planned_VBN by_IN the_DT Department_NNP of_IN Occupational_NNP Medicine_NNP of_IN the_DT University_NNP of_IN Turin_NNP ,_, the_DT Italian_NNP National_NNP Institute_NNP of_IN Public_NNP Health_NNP ,_, the_DT Local_NNP Health_NNP District_NNP and_CC the_DT Biancavilla_NNP Hospital_NNP ._. 
Hypothesizing_VBG a_DT behavior_NN of_IN the_DT new_JJ fiber_NN analogous_JJ to_TO that_DT of_IN asbestos_NN and_CC other_JJ mineral_NN fibers_NNS in_IN the_DT environment_NN ,_, it_PRP was_VBD decided_VBN to_TO carry_VB out_RP the_DT determination_NN of_IN the_DT free_JJ fibers_NNS and_CC the_DT ferruginous_JJ bodies_NNS in_IN sputum_NN ._. 
To_TO verify_VB the_DT feasibility_NN of_IN using_VBG spontaneous_JJ sputum_NN as_IN an_DT exposure_NN indicator_NN for_IN these_DT fibers_NNS ,_, a_DT pilot_NN study_NN was_VBD performed_VBN ._. 
In_IN this_DT study_NN ,_, CASI_NNP and_CC AISA_NNP Eagle_NNP and_CC Hawk_NNP data_NNS were_VBD collected_VBN over_IN Esthwaite_NNP Water_NNP on_IN 26_CD April_NNP 2007_CD and_CC Loch_NNP Leven_NNP on_IN 13_CD April_NNP and_CC 22_CD August_NNP 2007_CD ._. 
CASI_NNP was_VBD operated_VBN in_IN Spatial_NNP Mode_NNP using_VBG the_DT band_NN configuration_NN detailed_VBN in_IN ._. 
AISA_NNP Eagle_NNP and_CC Hawk_NNP are_VBP tandem_NN hyperspectral_JJ instruments_NNS with_IN 244_CD and_CC 240_CD contiguous_JJ bands_NNS distributed_VBN across_IN the_DT 400-970_CD nm_NN and_CC 1000-2400_CD nm_NN ranges_NNS respectively_RB ._. 
However_RB ,_, this_DT approach_NN does_VBZ not_RB allow_VB the_DT biomass_NN of_IN cyanobacteria_NN to_TO be_VB determined_VBN independently_RB from_IN that_DT of_IN the_DT total_JJ phytoplankton_NN standing_NN crop_NN ._. 
It_PRP has_VBZ been_VBN recently_RB shown_VBN that_IN algorithms_NNS for_IN the_DT retrieval_NN of_IN the_DT cyanobacterial_JJ biomarker_NN pigment_NN C-PC_NN can_MD be_VB used_VBN to_TO determine_VB the_DT abundance_NN of_IN cyanobacteria_NN in_IN lakes_NNS 
459_CD -RRB-_-RRB- ._. 
945_CD respectively_RB -RRB-_-RRB- ,_, whereas_IN poor_JJ agreement_NN occurred_VBD between_IN soluble_JJ MC_NNP concentrations_NNS and_CC C-PC_NNP -LRB-_-LRB- r_SYM =_SYM 0_CD ._. 
The_DT results_NNS demonstrate_VBP that_IN remote_JJ sensing_VBG has_VBZ potential_JJ as_IN a_DT tool_NN for_IN monitoring_VBG blooms_NNS of_IN cyanobacteria_NN in_IN inland_RB water_NN bodies_NNS ,_, including_VBG those_DT containing_VBG particulate_NN MCs_NNS at_IN concentrations_NNS below_IN and_CC exceeding_VBG health_NN guidelines_NNS 
Model_NNP scenarios_NNS considered_VBD the_DT effects_NNS of_IN different_JJ temperature_NN ,_, nutrient-loading_JJ and_CC flushing_JJ regimes_NNS on_IN the_DT seasonal_JJ abundance_NN of_IN toxic_JJ cyanobacterial_JJ genera_NN ._. 
Further_JJ details_NNS of_IN the_DT PROTECH_NNP modelling_NN can_MD be_VB found_VBN in_IN ._. 
Early-warning_JJ monitoring_NN using_VBG airborne_JJ remote_JJ sensing_VBG The_DT retrieval_NN of_IN Chl_NNP a_DT concentrations_NNS from_IN remotely_RB sensed_VBN data_NNS has_VBZ been_VBN widely_RB used_VBN to_TO monitor_VB the_DT development_NN of_IN phytoplankton_NN blooms_NNS in_IN inland_RB ,_, coastal_JJ and_CC ocean_NN waters_NNS ._. 
It_PRP is_VBZ likely_JJ that_IN this_DT is_VBZ ,_, in_IN part_NN ,_, because_IN some_DT cyanobacterial_JJ species_NNS can_MD fix_VB atmospheric_JJ nitrogen_NN and_CC thus_RB continue_VBP to_TO grow_VB in_IN conditions_NNS that_WDT would_MD be_VB unfavourable_JJ to_TO other_JJ species_NNS ._. 
Water_NNP temperature_NN increases_NNS had_VBD little_JJ effect_NN and_CC the_DT lake_NN seemed_VBD to_TO be_VB heavily_RB controlled_VBN by_IN nutrient_NN resource_NN supply_NN 
The_DT response_NN of_IN Anabaena_NNP -LRB-_-LRB- chl_FW a_FW mg_FW m_FW -3_FW -RRB-_-RRB- to_TO changes_NNS in_IN nutrient_NN load_NN and_CC temperature_NN in_IN Loch_NNP Leven_NNP :_: -LRB-_-LRB- a_DT -RRB-_-RRB- nitrate_JJ and_CC SRP_NNP -LRB-_-LRB- b_NN -RRB-_-RRB- SRP_NNP ._. 
-LRB-_-LRB- Reproduced_VBN from_IN -RRB-_-RRB- ._. 
Figure_NNP 3_NNP Summer_NNP maximum_NN cyanobacterial_JJ abundance_NN in_IN Esthwaite_NNP Water_NNP ._. 
The_DT response_NN of_IN summer_NN maximum_NN percentage_NN cyanobacterial_JJ abundance_NN to_TO changing_VBG water_NN temperature_NN -LRB-_-LRB- 
However_RB ,_, this_DT approach_NN does_VBZ not_RB allow_VB the_DT biomass_NN of_IN cyanobacteria_NN to_TO be_VB determined_VBN independently_RB from_IN that_DT of_IN the_DT total_JJ phytoplankton_NN standing_NN crop_NN ._. 
It_PRP has_VBZ been_VBN recently_RB shown_VBN that_IN algorithms_NNS for_IN the_DT retrieval_NN of_IN the_DT cyanobacterial_JJ biomarker_NN pigment_NN C-PC_NN can_MD be_VB used_VBN to_TO determine_VB the_DT abundance_NN of_IN cyanobacteria_NN in_IN lakes_NNS 
The_DT dataset_NN was_VBD comprised_VBN of_IN 262_CD phytoplankton_NN samples_NNS drawn_VBN from_IN observations_NNS at_IN 134_CD lakes_NNS ._. 
However_RB ,_, in_IN this_DT study_NN ,_, a_DT statistical_JJ model_NN was_VBD developed_VBN to_TO specifically_RB predict_VB the_DT occurrence_NN of_IN toxic_JJ cyanobacteria_NN genera_NN in_IN UK_NNP lakes_NNS ._. 
General_JJ additive_JJ models_NNS for_IN predicting_VBG the_DT presence\/absence_NN of_IN toxic_JJ cyanobacteria_NN or_CC their_PRP$ abundance_NN -LRB-_-LRB- %_JJ relative_JJ abundance_NN or_CC biovolume_NN -RRB-_-RRB- were_VBD developed_VBN from_IN the_DT knowledge_NN of_IN widely-available_JJ lake_NN parameters_NNS -LRB-_-LRB- altitude_NN ,_, mean_NN depth_NN ,_, alkalinity_NN ,_, color_NN ,_, retention_NN time_NN and_CC TP_NNP concentration_NN -RRB-_-RRB- ._. 
The_DT process-based_JJ PROTECH_NNP model_NN was_VBD used_VBN to_TO examine_VB the_DT local-scale_JJ impacts_NNS of_IN climate_NN and_CC land-use_NN change_NN on_IN the_DT occurrence_NN of_IN potential_JJ toxin-producing_JJ cyanobacteria_NN in_IN two_CD water_NN bodies_NNS :_: Esthwaite_NNP Water_NNP and_CC Loch_NNP Leven_NNP -LRB-_-LRB- UK_NNP -RRB-_-RRB- ._. 
Model_NNP scenarios_NNS considered_VBD the_DT effects_NNS of_IN different_JJ temperature_NN ,_, nutrient-loading_JJ and_CC flushing_JJ regimes_NNS on_IN the_DT seasonal_JJ abundance_NN of_IN toxic_JJ cyanobacterial_JJ genera_NN ._. 
Further_JJ details_NNS of_IN the_DT PROTECH_NNP modelling_NN can_MD be_VB found_VBN in_IN ._. 
Early-warning_JJ monitoring_NN using_VBG airborne_JJ remote_JJ sensing_VBG The_DT retrieval_NN of_IN Chl_NNP a_DT concentrations_NNS from_IN remotely_RB sensed_VBN data_NNS has_VBZ been_VBN widely_RB used_VBN to_TO monitor_VB the_DT development_NN of_IN phytoplankton_NN blooms_NNS in_IN inland_RB ,_, coastal_JJ and_CC ocean_NN waters_NNS ._. 
In_IN contrast_NN ,_, the_DT modelling_NN of_IN Esthwaite_NNP Water_NNP showed_VBD that_IN cyanobacterial_JJ bloom_NN formation_NN was_VBD enhanced_VBN by_IN increasing_VBG temperature_NN and_CC decreasing_VBG flow_NN -LRB-_-LRB- flushing_NN -RRB-_-RRB- -LRB-_-LRB- Figure_NN 3_CD -RRB-_-RRB- ._. 
However_RB ,_, the_DT specifics_NNS of_IN this_DT response_NN were_VBD again_RB influenced_VBN by_IN nutrient_NN supply_NN and_CC nitrogen_NN availability_NN ._. 
Figure_NN 2_CD Mean_JJ annual_JJ Anabaena_NNP abundance_NN in_IN Loch_NNP Leven_NNP ._. 
The_DT response_NN of_IN Anabaena_NNP -LRB-_-LRB- chl_FW a_FW mg_FW m_FW -3_FW -RRB-_-RRB- to_TO changes_NNS in_IN nutrient_NN load_NN and_CC temperature_NN in_IN Loch_NNP Leven_NNP :_: -LRB-_-LRB- a_DT -RRB-_-RRB- nitrate_JJ and_CC SRP_NNP -LRB-_-LRB- b_NN -RRB-_-RRB- SRP_NNP ._. 
Figure_NNP 3_NNP Summer_NNP maximum_NN cyanobacterial_JJ abundance_NN in_IN Esthwaite_NNP Water_NNP ._. 
-LRB-_-LRB- Reproduced_VBN from_IN -RRB-_-RRB- ._. 
The_DT response_NN of_IN Anabaena_NNP -LRB-_-LRB- chl_FW a_FW mg_FW m_FW -3_FW -RRB-_-RRB- to_TO changes_NNS in_IN nutrient_NN load_NN and_CC temperature_NN in_IN Loch_NNP Leven_NNP :_: -LRB-_-LRB- a_DT -RRB-_-RRB- nitrate_JJ and_CC SRP_NNP -LRB-_-LRB- b_NN -RRB-_-RRB- SRP_NNP ._. 
The_DT response_NN of_IN summer_NN maximum_NN percentage_NN cyanobacterial_JJ abundance_NN to_TO changing_VBG water_NN temperature_NN -LRB-_-LRB- 
It_PRP has_VBZ been_VBN recently_RB shown_VBN that_IN algorithms_NNS for_IN the_DT retrieval_NN of_IN the_DT cyanobacterial_JJ biomarker_NN pigment_NN C-PC_NN can_MD be_VB used_VBN to_TO determine_VB the_DT abundance_NN of_IN cyanobacteria_NN in_IN lakes_NNS 
Cells_NNS counts_NNS were_VBD undertaken_VBN according_VBG to_TO standard_JJ procedures_NNS using_VBG an_DT inverted-microscope_NN ._. 
Microcystin_NNP detection_NN Cyanobacterial_NNP cell_NN counts_NNS and_CC microcystin_NN analyses_NNS were_VBD used_VBN to_TO evaluate_VB the_DT potential_JJ risks_NNS to_TO human_JJ health_NN in_IN Esthwaite_NNP Water_NNP and_CC Loch_NNP Leven_NNP ._. 
MC_NNP concentrations_NNS in_IN a_DT cyanobacterial_JJ cell-containing_NN particulate_NN fraction_NN and_CC as_IN dissolved_VBN toxins_NNS in_IN the_DT water_NN were_VBD determined_VBN by_IN PDA-HPLC_NN and_CC immunoassay_NN 
Notably_RB ,_, no_DT confirmatory_JJ identification_NN of_IN MC_NNP in_IN the_DT exposed_JJ potato_NN tissues_NNS was_VBD achieved_VBN using_VBG PDA-HPLC_NNP ._. 
Since_IN ELISAs_NNS do_VBP not_RB distinguish_VB between_IN authentic_JJ MC_NNP and_CC enzymically-converted_JJ MC-detoxication_NN products_NNS 
The_DT results_NNS demonstrate_VBP that_IN remote_JJ sensing_VBG has_VBZ potential_JJ as_IN a_DT tool_NN for_IN monitoring_VBG blooms_NNS of_IN cyanobacteria_NN in_IN inland_RB water_NN bodies_NNS ,_, including_VBG those_DT containing_VBG particulate_NN MCs_NNS at_IN concentrations_NNS below_IN and_CC exceeding_VBG health_NN guidelines_NNS 
These_DT include_VBP leaf_NN necrosis_NN 
Microcystin_JJ transfer_NN to_TO spray-irrigated_JJ crops_NNS Exposure_NN trials_NNS have_VBP been_VBN performed_VBN on_IN a_DT range_NN of_IN growing_VBG food_NN crop_NN plants_NNS and_CC sterile_JJ potato_NN shoots_VBZ using_VBG aqueous_JJ solutions_NNS of_IN MC_NNP ,_, including_VBG via_IN aerial_JJ spraying_VBG and_CC root_NN sprinkling_NN 
Microcystin_JJ transfer_NN to_TO spray-irrigated_JJ crops_NNS Exposure_NN trials_NNS have_VBP been_VBN performed_VBN on_IN a_DT range_NN of_IN growing_VBG food_NN crop_NN plants_NNS and_CC sterile_JJ potato_NN shoots_VBZ using_VBG aqueous_JJ solutions_NNS of_IN MC_NNP ,_, including_VBG via_IN aerial_JJ spraying_VBG and_CC root_NN sprinkling_NN 
These_DT include_VBP leaf_NN necrosis_NN 
The_DT results_NNS demonstrate_VBP that_IN remote_JJ sensing_VBG has_VBZ potential_JJ as_IN a_DT tool_NN for_IN monitoring_VBG blooms_NNS of_IN cyanobacteria_NN in_IN inland_RB water_NN bodies_NNS ,_, including_VBG those_DT containing_VBG particulate_NN MCs_NNS at_IN concentrations_NNS below_IN and_CC exceeding_VBG health_NN guidelines_NNS 
Microcystin_JJ transfer_NN to_TO spray-irrigated_JJ crops_NNS Exposure_NN trials_NNS have_VBP been_VBN performed_VBN on_IN a_DT range_NN of_IN growing_VBG food_NN crop_NN plants_NNS and_CC sterile_JJ potato_NN shoots_VBZ using_VBG aqueous_JJ solutions_NNS of_IN MC_NNP ,_, including_VBG via_IN aerial_JJ spraying_VBG and_CC root_NN sprinkling_NN 
Microcystin_JJ transfer_NN to_TO spray-irrigated_JJ crops_NNS Exposure_NN trials_NNS have_VBP been_VBN performed_VBN on_IN a_DT range_NN of_IN growing_VBG food_NN crop_NN plants_NNS and_CC sterile_JJ potato_NN shoots_VBZ using_VBG aqueous_JJ solutions_NNS of_IN MC_NNP ,_, including_VBG via_IN aerial_JJ spraying_VBG and_CC root_NN sprinkling_NN 
Samples_NNS of_IN roots_NNS ,_, tubers_NNS ,_, shoots_NNS and_CC leaves_NNS and_CC soil_NN were_VBD freeze-dried_JJ and_CC subsequently_RB toxin_NN concentrations_NNS were_VBD measured_VBN in_IN the_DT plant_NN tissues_NNS and_CC soil_NN using_VBG ELISA_NNP with_IN verification_NN by_IN PDA-HPLC_NNP ._. 
Risk_NN perception_NN and_CC CV_NN of_IN cyanobacterial_JJ health_NN risksNon-use_NN values_NNS are_VBP important_JJ components_NNS of_IN the_DT economic_JJ benefits_NNS of_IN water_NN quality_NN improvements_NNS 
Samples_NNS of_IN roots_NNS ,_, tubers_NNS ,_, shoots_NNS and_CC leaves_NNS and_CC soil_NN were_VBD freeze-dried_JJ and_CC subsequently_RB toxin_NN concentrations_NNS were_VBD measured_VBN in_IN the_DT plant_NN tissues_NNS and_CC soil_NN using_VBG ELISA_NNP with_IN verification_NN by_IN PDA-HPLC_NNP ._. 
Risk_NN perception_NN and_CC CV_NN of_IN cyanobacterial_JJ health_NN risksNon-use_NN values_NNS are_VBP important_JJ components_NNS of_IN the_DT economic_JJ benefits_NNS of_IN water_NN quality_NN improvements_NNS ._. 
Therefore_RB ,_, a_DT CV_NNP survey_NN including_VBG statements_NNS about_IN perceptions_NNS of_IN risk_NN of_IN local_JJ residents_NNS and_CC anglers_NNS in_IN four_CD small_JJ towns_NNS bordering_VBG Loch_NNP Leven_NNP was_VBD undertaken_VBN to_TO determine_VB their_PRP$ WTP_NNP for_IN reductions_NNS in_IN the_DT risks_NNS to_TO human_JJ health_NN posed_VBN by_IN blooms_NNS of_IN toxin-producing_JJ cyanobacteria_NN ._. 
MC_NNP concentrations_NNS in_IN a_DT cyanobacterial_JJ cell-containing_NN particulate_NN fraction_NN and_CC as_IN dissolved_VBN toxins_NNS in_IN the_DT water_NN were_VBD determined_VBN by_IN PDA-HPLC_NN and_CC immunoassay_NN 
Microcystins_NNS are_VBP among_IN the_DT most_RBS potent_JJ and_CC commonly_RB encountered_VBD ._. 
These_DT so-called_JJ cyanotoxins_NNS include_VBP neurotoxic_JJ ,_, hepatotoxic_JJ ,_, genotoxic_JJ ,_, inflammatory_JJ and_CC cytotoxic_JJ agents_NNS ._. 
These_DT toxins_NNS constitute_VBP one_CD of_IN the_DT highest_JJS risk_NN categories_NNS of_IN waterborne_JJ toxic_JJ biological_JJ substances_NNS ,_, as_IN shown_VBN by_IN :_: -LRB-_-LRB- i_FW -RRB-_-RRB- the_DT annual_JJ occurrence_NN of_IN toxic_JJ cyanobacterial_JJ populations_NNS in_IN water_NN bodies_NNS used_VBN for_IN drinking_NN ,_, recreation_NN ,_, stock-watering_NN ,_, fisheries_NNS and_CC crop_NN irrigation_NN ;_: -LRB-_-LRB- ii_FW -RRB-_-RRB- episodes_NNS of_IN illness_NN and_CC mortality_NN attributed_VBD solely_RB or_CC partly_RB to_TO cyanotoxins_NNS ;_: and_CC -LRB-_-LRB- iii_FW -RRB-_-RRB- the_DT identification_NN by_IN national_JJ and_CC international_JJ bodies_NNS of_IN a_DT need_NN for_IN improved_VBN risk_NN management_NN to_TO protect_VB water_NN resources_NNS ,_, water-based_JJ economies_NNS and_CC human_JJ health_NN 
These_DT toxins_NNS constitute_VBP one_CD of_IN the_DT highest_JJS risk_NN categories_NNS of_IN waterborne_JJ toxic_JJ biological_JJ substances_NNS ,_, as_IN shown_VBN by_IN :_: -LRB-_-LRB- i_FW -RRB-_-RRB- the_DT annual_JJ occurrence_NN of_IN toxic_JJ cyanobacterial_JJ populations_NNS in_IN water_NN bodies_NNS used_VBN for_IN drinking_NN ,_, recreation_NN ,_, stock-watering_NN ,_, fisheries_NNS and_CC crop_NN irrigation_NN ;_: -LRB-_-LRB- ii_FW -RRB-_-RRB- episodes_NNS of_IN illness_NN and_CC mortality_NN attributed_VBD solely_RB or_CC partly_RB to_TO cyanotoxins_NNS ;_: and_CC -LRB-_-LRB- iii_FW -RRB-_-RRB- the_DT identification_NN by_IN national_JJ and_CC international_JJ bodies_NNS of_IN a_DT need_NN for_IN improved_VBN risk_NN management_NN to_TO protect_VB water_NN resources_NNS ,_, water-based_JJ economies_NNS and_CC human_JJ health_NN 
The_DT results_NNS demonstrate_VBP that_IN -LRB-_-LRB- i_FW -RRB-_-RRB- cyanobacterial_JJ bloom_NN occurrence_NN can_MD be_VB predicted_VBN at_IN a_DT local_JJ -_: and_CC national-scale_JJ using_VBG process-based_JJ and_CC statistical_JJ models_NNS ;_: -LRB-_-LRB- ii_FW -RRB-_-RRB- cyanobacterial_JJ concentration_NN and_CC distribution_NN in_IN waterbodies_NNS can_MD be_VB monitored_VBN using_VBG remote_JJ sensing_VBG ,_, but_CC minimum_JJ detection_NN limits_NNS need_VBP to_TO be_VB evaluated_VBN ;_: -LRB-_-LRB- iii_FW -RRB-_-RRB- cyanotoxins_NNS may_MD be_VB transferred_VBN to_TO spray-irrigated_JJ root_NN crops_NNS ;_: and_CC -LRB-_-LRB- iv_NN -RRB-_-RRB- attitudes_NNS and_CC perceptions_NNS towards_IN risks_NNS influence_VBP the_DT public_NN 's_POS preferences_NNS and_CC willingness-to-pay_NN for_IN cyanobacterial_JJ health_NN risk_NN reductions_NNS in_IN recreational_JJ waters_NNS ._. 
24_CD 
These_DT so-called_JJ cyanotoxins_NNS include_VBP neurotoxic_JJ ,_, hepatotoxic_JJ ,_, genotoxic_JJ ,_, inflammatory_JJ and_CC cytotoxic_JJ agents_NNS ._. 
Microcystins_NNS are_VBP among_IN the_DT most_RBS potent_JJ and_CC commonly_RB encountered_VBD ._. 
These_DT toxins_NNS constitute_VBP one_CD of_IN the_DT highest_JJS risk_NN categories_NNS of_IN waterborne_JJ toxic_JJ biological_JJ substances_NNS ,_, as_IN shown_VBN by_IN :_: -LRB-_-LRB- i_FW -RRB-_-RRB- the_DT annual_JJ occurrence_NN of_IN toxic_JJ cyanobacterial_JJ populations_NNS in_IN water_NN bodies_NNS used_VBN for_IN drinking_NN ,_, recreation_NN ,_, stock-watering_NN ,_, fisheries_NNS and_CC crop_NN irrigation_NN ;_: -LRB-_-LRB- ii_FW -RRB-_-RRB- episodes_NNS of_IN illness_NN and_CC mortality_NN attributed_VBD solely_RB or_CC partly_RB to_TO cyanotoxins_NNS ;_: and_CC -LRB-_-LRB- iii_FW -RRB-_-RRB- the_DT identification_NN by_IN national_JJ and_CC international_JJ bodies_NNS of_IN a_DT need_NN for_IN improved_VBN risk_NN management_NN to_TO protect_VB water_NN resources_NNS ,_, water-based_JJ economies_NNS and_CC human_JJ health_NN 
The_DT results_NNS demonstrate_VBP that_IN -LRB-_-LRB- i_FW -RRB-_-RRB- cyanobacterial_JJ bloom_NN occurrence_NN can_MD be_VB predicted_VBN at_IN a_DT local_JJ -_: and_CC national-scale_JJ using_VBG process-based_JJ and_CC statistical_JJ models_NNS ;_: -LRB-_-LRB- ii_FW -RRB-_-RRB- cyanobacterial_JJ concentration_NN and_CC distribution_NN in_IN waterbodies_NNS can_MD be_VB monitored_VBN using_VBG remote_JJ sensing_VBG ,_, but_CC minimum_JJ detection_NN limits_NNS need_VBP to_TO be_VB evaluated_VBN ;_: -LRB-_-LRB- iii_FW -RRB-_-RRB- cyanotoxins_NNS may_MD be_VB transferred_VBN to_TO spray-irrigated_JJ root_NN crops_NNS ;_: and_CC -LRB-_-LRB- iv_NN -RRB-_-RRB- attitudes_NNS and_CC perceptions_NNS towards_IN risks_NNS influence_VBP the_DT public_NN 's_POS preferences_NNS and_CC willingness-to-pay_NN for_IN cyanobacterial_JJ health_NN risk_NN reductions_NNS in_IN recreational_JJ waters_NNS ._. 
24_CD 
Microcystins_NNS are_VBP among_IN the_DT most_RBS potent_JJ and_CC commonly_RB encountered_VBD ._. 
These_DT so-called_JJ cyanotoxins_NNS include_VBP neurotoxic_JJ ,_, hepatotoxic_JJ ,_, genotoxic_JJ ,_, inflammatory_JJ and_CC cytotoxic_JJ agents_NNS ._. 
These_DT toxins_NNS constitute_VBP one_CD of_IN the_DT highest_JJS risk_NN categories_NNS of_IN waterborne_JJ toxic_JJ biological_JJ substances_NNS ,_, as_IN shown_VBN by_IN :_: -LRB-_-LRB- i_FW -RRB-_-RRB- the_DT annual_JJ occurrence_NN of_IN toxic_JJ cyanobacterial_JJ populations_NNS in_IN water_NN bodies_NNS used_VBN for_IN drinking_NN ,_, recreation_NN ,_, stock-watering_NN ,_, fisheries_NNS and_CC crop_NN irrigation_NN ;_: -LRB-_-LRB- ii_FW -RRB-_-RRB- episodes_NNS of_IN illness_NN and_CC mortality_NN attributed_VBD solely_RB or_CC partly_RB to_TO cyanotoxins_NNS ;_: and_CC -LRB-_-LRB- iii_FW -RRB-_-RRB- the_DT identification_NN by_IN national_JJ and_CC international_JJ bodies_NNS of_IN a_DT need_NN for_IN improved_VBN risk_NN management_NN to_TO protect_VB water_NN resources_NNS ,_, water-based_JJ economies_NNS and_CC human_JJ health_NN 
459_CD -RRB-_-RRB- ._. 
945_CD respectively_RB -RRB-_-RRB- ,_, whereas_IN poor_JJ agreement_NN occurred_VBD between_IN soluble_JJ MC_NNP concentrations_NNS and_CC C-PC_NNP -LRB-_-LRB- r_SYM =_SYM 0_CD ._. 
The_DT results_NNS demonstrate_VBP that_IN remote_JJ sensing_VBG has_VBZ potential_JJ as_IN a_DT tool_NN for_IN monitoring_VBG blooms_NNS of_IN cyanobacteria_NN in_IN inland_RB water_NN bodies_NNS ,_, including_VBG those_DT containing_VBG particulate_NN MCs_NNS at_IN concentrations_NNS below_IN and_CC exceeding_VBG health_NN guidelines_NNS 
Methods_NNS National_JJ and_CC local-scale_JJ models_NNS for_IN cyanobacterial_JJ risk_NN assessment_NN Knowledge_NN of_IN which_WDT lakes_NNS are_VBP susceptible_JJ to_TO the_DT development_NN of_IN large_JJ populations_NNS of_IN potentially-toxic_JJ cyanobacteria_NN can_MD be_VB used_VBN to_TO inform_VB national-scale_JJ assessments_NNS of_IN risks_NNS to_TO public_JJ health_NN ._. 
Statistical_NNP approaches_NNS have_VBP been_VBN previously_RB used_VBN to_TO model_VB the_DT response_NN of_IN phytoplankton_NN communities_NNS to_TO nutrient_JJ enrichment_NN and_CC reduction_NN ._. 
However_RB ,_, in_IN this_DT study_NN ,_, a_DT statistical_JJ model_NN was_VBD developed_VBN to_TO specifically_RB predict_VB the_DT occurrence_NN of_IN toxic_JJ cyanobacteria_NN genera_NN in_IN UK_NNP lakes_NNS ._. 
Methods_NNS National_JJ and_CC local-scale_JJ models_NNS for_IN cyanobacterial_JJ risk_NN assessment_NN Knowledge_NN of_IN which_WDT lakes_NNS are_VBP susceptible_JJ to_TO the_DT development_NN of_IN large_JJ populations_NNS of_IN potentially-toxic_JJ cyanobacteria_NN can_MD be_VB used_VBN to_TO inform_VB national-scale_JJ assessments_NNS of_IN risks_NNS to_TO public_JJ health_NN ._. 
Statistical_NNP approaches_NNS have_VBP been_VBN previously_RB used_VBN to_TO model_VB the_DT response_NN of_IN phytoplankton_NN communities_NNS to_TO nutrient_JJ enrichment_NN and_CC reduction_NN ._. 
However_RB ,_, in_IN this_DT study_NN ,_, a_DT statistical_JJ model_NN was_VBD developed_VBN to_TO specifically_RB predict_VB the_DT occurrence_NN of_IN toxic_JJ cyanobacteria_NN genera_NN in_IN UK_NNP lakes_NNS ._. 
It_PRP may_MD be_VB suggested_VBN that_IN this_DT variable_NN indicates_VBZ greater_JJR distance_NN to_TO traffic_NN ,_, more_RBR green_JJ areas_NNS ,_, and_CC less_RBR urbanized_JJ residence_NN ,_, therefore_RB contributing_VBG to_TO less_JJR exposure_NN ._. 
The_DT geographic_JJ differences_NNS in_IN the_DT distribution_NN of_IN air_NN pollutants_NNS are_VBP related_VBN to_TO the_DT geographic_JJ distribution_NN of_IN wealth_NN and_CC socioeconomic_JJ status_NN ._. 
However_RB ,_, traffic_NN can_MD only_RB partly_RB explain_VB the_DT variability_NN in_IN exposures_NNS observed_VBN in_IN diverse_JJ neighborhoods_NNS ._. 
The_DT issue_NN stands_VBZ high_JJ in_IN the_DT public_JJ health_NN concerns_NNS due_JJ to_TO the_DT evidence_NN that_IN adverse_JJ health_NN in_IN early_JJ life_NN can_MD lead_VB to_TO later_JJ life_NN diseases_NNS of_IN childhood_NN and_CC adulthood_NN 
Socioeconomic_JJ status_NN is_VBZ a_DT determinant_NN of_IN health_NN in_IN populations_NNS 
These_DT results_NNS suggest_VBP that_DT race\/ethnicity_NN of_IN mother_NN is_VBZ a_DT strong_JJ confounder_NN in_IN this_DT study_NN ._. 
Including_VBG just_RB race\/ethnicity_NN in_IN exposure_NN model_NN reduced_VBD the_DT effect_NN on_IN birth_NN weight_NN of_IN cumulative_JJ traffic_NN density_NN by_IN 62_CD percent_NN ,_, distance_NN to_TO major_JJ roads_NNS by_IN 25_CD percent_NN ,_, and_CC that_IN of_IN land_NN use_NN as_IN open_JJ space_NN by_IN 47_CD percent_NN ._. 
Racial\/ethnic_JJ inequalities_NNS do_VBP predict_VB health_NN disparities_NNS ,_, and_CC such_JJ inequalities_NNS are_VBP a_DT representation_NN of_IN a_DT history_NN of_IN racial_JJ discrimination_NN ,_, economic_JJ deprivation_NN ,_, and_CC the_DT greater_JJR likelihood_NN of_IN adverse_JJ exposures_NNS throughout_IN life_NN 
The_DT issue_NN stands_VBZ high_JJ in_IN the_DT public_JJ health_NN concerns_NNS due_JJ to_TO the_DT evidence_NN that_IN adverse_JJ health_NN in_IN early_JJ life_NN can_MD lead_VB to_TO later_JJ life_NN diseases_NNS of_IN childhood_NN and_CC adulthood_NN 
The_DT issue_NN stands_VBZ high_JJ in_IN the_DT public_JJ health_NN concerns_NNS due_JJ to_TO the_DT evidence_NN that_IN adverse_JJ health_NN in_IN early_JJ life_NN can_MD lead_VB to_TO later_JJ life_NN diseases_NNS of_IN childhood_NN and_CC adulthood_NN 
Introduction_NN Adverse_JJ birth_NN outcomes_NNS such_JJ as_IN low_JJ birth_NN weight_NN and_CC its_PRP$ determinants_NNS ,_, preterm_NN births_NNS and_CC intrauterine_JJ growth_NN retardation_NN have_VBP been_VBN associated_VBN with_IN indicators_NNS of_IN socioeconomic_JJ status_NN and_CC physical_JJ environment_NN 
The_DT issue_NN stands_VBZ high_JJ in_IN the_DT public_JJ health_NN concerns_NNS due_JJ to_TO the_DT evidence_NN that_IN adverse_JJ health_NN in_IN early_JJ life_NN can_MD lead_VB to_TO later_JJ life_NN diseases_NNS of_IN childhood_NN and_CC adulthood_NN 
Socioeconomic_JJ status_NN is_VBZ a_DT determinant_NN of_IN health_NN in_IN populations_NNS 
It_PRP may_MD be_VB suggested_VBN that_IN this_DT variable_NN indicates_VBZ greater_JJR distance_NN to_TO traffic_NN ,_, more_RBR green_JJ areas_NNS ,_, and_CC less_RBR urbanized_JJ residence_NN ,_, therefore_RB contributing_VBG to_TO less_JJR exposure_NN ._. 
The_DT geographic_JJ differences_NNS in_IN the_DT distribution_NN of_IN air_NN pollutants_NNS are_VBP related_VBN to_TO the_DT geographic_JJ distribution_NN of_IN wealth_NN and_CC socioeconomic_JJ status_NN ._. 
However_RB ,_, traffic_NN can_MD only_RB partly_RB explain_VB the_DT variability_NN in_IN exposures_NNS observed_VBN in_IN diverse_JJ neighborhoods_NNS ._. 
It_PRP is_VBZ likely_JJ that_IN socioeconomic_JJ status_NN is_VBZ a_DT measure_NN of_IN access_NN to_TO health_NN care_NN ,_, empowerment_NN ,_, level_NN of_IN stress_NN and_CC violence_NN ,_, and_CC likelihood_NN of_IN exposure_NN to_TO environmental_JJ factors_NNS ,_, and_CC among_IN these_DT air_NN pollution_NN exposure_NN 
First_RB ,_, we_PRP used_VBD a_DT two-level_JJ hierarchical_JJ model_NN to_TO estimate_VB the_DT variability_NN in_IN birth_NN outcomes_NNS due_JJ to_TO individual_JJ and_CC contextual_JJ level_NN SEM_NNP and_CC indices_NNS of_IN physical_JJ environment_NN ._. 
Anumber_NNP of_IN epidemiologic_JJ studies_NNS from_IN the_DT US_NNP and_CC other_JJ countries_NNS have_VBP shown_VBN associations_NNS between_IN air_NN pollution_NN and_CC birth_NN weight_NN and_CC preterm_NN births_NNS ,_, in_IN particular_JJ with_IN carbon_NN monoxide_NN and_CC particulate_NN matter_NN ._. 
The_DT evidence_NN however_RB has_VBZ not_RB been_VBN fully_RB corroborated_VBN possibly_RB due_JJ to_TO inadequate_JJ control_NN for_IN individual_NN and_CC neighborhood_NN level_NN socioeconomic_JJ indicators_NNS ._. 
The_DT majority_NN of_IN the_DT studies_NNS that_WDT examined_VBD this_DT relationship_NN have_VBP not_RB taken_VBN into_IN account_NN variation_NN in_IN pollution_NN exposure_NN within_IN small_JJ localities_NNS ,_, which_WDT can_MD lead_VB to_TO exposure_NN misclassification_NN and_CC distortion_NN of_IN the_DT association_NN ._. 
Two_CD studies_NNS in_IN California_NNP ,_, US_NNP ,_, merely_RB averaged_VBD monitors_NNS within_IN few_JJ miles_NNS of_IN the_DT residence_NN of_IN the_DT child_NN ,_, for_IN example_NN 
We_PRP examined_VBD effect_NN modification_NN by_IN median_JJ household_NN income_NN and_CC maternal_JJ education_NN for_IN the_DT association_NN between_IN birth_NN weight_NN and_CC traffic_NN and_CC land_NN use_NN variables_NNS ._. 
We_PRP assessed_VBD precision_NN in_IN the_DT difference_NN of_IN effects_NNS by_IN calculating_VBG 95_CD percent_NN confidence_NN intervals_NNS around_IN that_DT difference_NN ._. 
Results_NNS Descriptive_JJ Analyses_NNPS We_PRP calculated_VBD mean_JJ birth_NN weight_NN and_CC the_DT percentages_NNS of_IN SGA_NNP ,_, preterm_NN births_NNS and_CC a_DT comparison_NN group_NN by_IN categories_NNS of_IN socio-demographic_JJ variables_NNS -LRB-_-LRB- table_NN 1_CD -RRB-_-RRB- ._. 
First_RB ,_, we_PRP used_VBD a_DT two-level_JJ hierarchical_JJ model_NN to_TO estimate_VB the_DT variability_NN in_IN birth_NN outcomes_NNS due_JJ to_TO individual_JJ and_CC contextual_JJ level_NN SEM_NNP and_CC indices_NNS of_IN physical_JJ environment_NN ._. 
Anumber_NNP of_IN epidemiologic_JJ studies_NNS from_IN the_DT US_NNP and_CC other_JJ countries_NNS have_VBP shown_VBN associations_NNS between_IN air_NN pollution_NN and_CC birth_NN weight_NN and_CC preterm_NN births_NNS ,_, in_IN particular_JJ with_IN carbon_NN monoxide_NN and_CC particulate_NN matter_NN ._. 
The_DT evidence_NN however_RB has_VBZ not_RB been_VBN fully_RB corroborated_VBN possibly_RB due_JJ to_TO inadequate_JJ control_NN for_IN individual_NN and_CC neighborhood_NN level_NN socioeconomic_JJ indicators_NNS ._. 
Smoking_NN during_IN pregnancy_NN is_VBZ associated_VBN with_IN adverse_JJ births_NNS ,_, and_CC it_PRP has_VBZ not_RB been_VBN controlled_VBN for_IN in_IN many_JJ previous_JJ studies_NNS ._. 
Because_IN smoking_NN varies_VBZ with_IN social_JJ class_NN in_IN the_DT United_NNP States_NNPS ,_, it_PRP may_MD represent_VB an_DT important_JJ confounder_NN ._. 
Information_NN on_IN smoking_NN was_VBD self-reported_JJ by_IN mother_NN on_IN birth_NN certificate_NN ,_, and_CC it_PRP reflects_VBZ the_DT number_NN of_IN cigarettes_NNS smoked_VBN per_IN day_NN during_IN and_CC pre-pregnancy_NN ._. 
Information_NN on_IN smoking_NN was_VBD self-reported_JJ by_IN mother_NN on_IN birth_NN certificate_NN ,_, and_CC it_PRP reflects_VBZ the_DT number_NN of_IN cigarettes_NNS smoked_VBN per_IN day_NN during_IN and_CC pre-pregnancy_NN ._. 
Statistical_NNP MethodsModeling_NNP for_IN gaussian_JJ dataFor_JJ continuous_JJ outcomes_NNS such_JJ as_IN birth_NN weight_NN ,_, linear_JJ mixed_JJ regression_NN models_NNS were_VBD carried_VBN out_IN ._. 
For_IN example_NN ,_, let_VB Y_FW ij_FW be_VB the_DT response_NN -LRB-_-LRB- birth_NN weight_NN -RRB-_-RRB- in_IN the_DT i_FW th_FW subject_NN in_IN census_NN tract_NN j_NN ,_, and_CC child_NN sex_NN i_FW ,_, maternal_JJ age_NN i_FW ,_, traffic_NN at_IN individual_JJ address_NN of_IN mother_NN i_FW ,_, individual-level_JJ socioeconomic_JJ measures_NNS -LRB-_-LRB- ILSEM_NNP -RRB-_-RRB- i_FW ,_, census_NN tract-level_JJ socioeconomic_JJ measures_NNS -LRB-_-LRB- TLSEM_NNP -RRB-_-RRB- j_NN denote_VBP the_DT set_NN of_IN covariates_NNS of_IN interest_NN ._. 
+e_JJ ij_NN Here_RB e_SYM ij_FW is_VBZ the_DT error_NN term_NN ,_, and_CC u_NN j_NN is_VBZ the_DT tract-specific_JJ random_JJ intercept_NN and_CC represents_VBZ the_DT variation_NN of_IN the_DT rate_NN in_IN the_DT groups_NNS due_JJ to_TO unmeasured_JJ factors_NNS ._. 
This_DT intercept_NN is_VBZ randomly_RB generated_VBN from_IN a_DT normal_JJ distribution_NN as_IN suggested_VBN by_IN Pickle_NNP ,_, modeled_VBN with_IN the_DT SAS_NNP procedure_NN MIXED_NNP -LRB-_-LRB- SAS_NNP Institute_NNP -RRB-_-RRB- ._. 
Modeling_NN for_IN binomial_JJ data_NNS Binomial_JJ data_NNS was_VBD modeled_VBN similarly_RB to_TO the_DT normal_JJ data_NNS ._. 
For_IN SGA_NNP and_CC preterm_NN births_NNS ,_, Y_FW ij_FW will_MD be_VB the_DT outcome_NN in_IN the_DT i_FW th_FW subject_NN in_IN the_DT j_FW th_FW census_NN tract_NN ,_, with_IN the_DT model_NN of_IN the_DT form_NN Logit_NNP -LRB-_-LRB- Pr_FW Y_FW ij_FW =_SYM 1_CD |_CD X_NNP -RRB-_-RRB- =_SYM u_FW j_FW +_FW 
+_SYM 
Because_IN measures_NNS of_IN concentrations_NNS of_IN air_NN pollutants_NNS at_IN individual_JJ addresses_NNS are_VBP unfeasible_JJ in_IN large_JJ studies_NNS of_IN births_NNS or_CC other_JJ outcomes_NNS ,_, either_CC modeled_VBD concentrations_NNS of_IN air_NN pollutants_NNS or_CC measures_NNS of_IN traffic_NN such_JJ as_IN traffic_NN density_NN or_CC distance_NN to_TO roadways_NNS have_VBP been_VBN used_VBN as_IN exposure_NN indices_NNS ._. 
One_CD concern_NN of_IN this_DT approach_NN is_VBZ that_DT variability_NN in_IN socioeconomic_JJ measures_NNS -LRB-_-LRB- SEM_NNP -RRB-_-RRB- can_MD predict_VB distribution_NN of_IN indices_NNS of_IN physical_JJ environment_NN 
The_DT evidence_NN however_RB has_VBZ not_RB been_VBN fully_RB corroborated_VBN possibly_RB due_JJ to_TO inadequate_JJ control_NN for_IN individual_NN and_CC neighborhood_NN level_NN socioeconomic_JJ indicators_NNS ._. 
Factors_NNS that_WDT account_VBP for_IN socioeconomic_JJ position_NN of_IN the_DT mother_NN have_VBP also_RB been_VBN associated_VBN with_IN birth_NN outcomes_NNS :_: racial\/ethnic_JJ background_NN ,_, education_NN ,_, and_CC area-based_JJ factors_NNS such_JJ as_IN income_NN and_CC level_NN of_IN poverty_NN ._. 
However_RB ,_, only_RB a_DT limited_JJ number_NN of_IN studies_NNS have_VBP examined_VBN the_DT influence_NN of_IN these_DT factors_NNS ,_, either_CC alone_RB or_CC in_IN combination_NN ,_, on_IN the_DT effects_NNS of_IN air_NN pollution_NN on_IN birth_NN outcomes_NNS ._. 
The_DT majority_NN of_IN the_DT studies_NNS that_WDT examined_VBD this_DT relationship_NN have_VBP not_RB taken_VBN into_IN account_NN variation_NN in_IN pollution_NN exposure_NN within_IN small_JJ localities_NNS ,_, which_WDT can_MD lead_VB to_TO exposure_NN misclassification_NN and_CC distortion_NN of_IN the_DT association_NN ._. 
Two_CD studies_NNS in_IN California_NNP ,_, US_NNP ,_, merely_RB averaged_VBD monitors_NNS within_IN few_JJ miles_NNS of_IN the_DT residence_NN of_IN the_DT child_NN ,_, for_IN example_NN 
Birth_NN addresses_NNS were_VBD then_RB assigned_VBN a_DT weighted_JJ average_NN of_IN the_DT estimates_NNS of_IN the_DT four_CD grid_NN points_NNS around_IN it_PRP ,_, using_VBG bilinear_JJ interpolation_NN ._. 
Distance_NNP to_TO roadwaysSpatial_JJ data_NNS on_IN major_JJ roadways_NNS were_VBD obtained_VBN through_IN the_DT US_NNP Census_NNP 2000_CD Topologically_NNP Integrated_NNP Geographic_NNP Encoding_NNP and_CC Referencing_NNP system_NN -LRB-_-LRB- TIGER_NNP -RRB-_-RRB- ._. 
Geocoded_JJ birth_NN addresses_NNS were_VBD joined_VBN to_TO these_DT data_NNS by_IN spatial_JJ location_NN ,_, using_VBG ArcGIS_NNP 9_CD ._. 
1._CD 
Using_VBG the_DT resulting_VBG database_NN we_PRP identified_VBD the_DT nearest_JJS primary_JJ highway_NN with_IN ``_`` limited_JJ access_NN ''_'' -LRB-_-LRB- these_DT roads_NNS can_MD only_RB be_VB accessed_VBN through_IN ramps_NNS ,_, have_VBP multiple_JJ lanes_NNS of_IN traffic_NN ,_, and_CC have_VBP no_DT direct_JJ intersection_NN with_IN other_JJ roads_NNS -RRB-_-RRB- to_TO the_DT birth_NN address_NN and_CC calculated_VBD the_DT distance_NN to_TO this_DT major_JJ road_NN ._. 
The_DT TIGER_NNP roads_NNS were_VBD chosen_VBN because_IN the_DT same_JJ database_NN source_NN was_VBD used_VBN for_IN geocoding_VBG the_DT birth_NN addresses_NNS ._. 
Land_NN use_NN for_IN recreation_NN and_CC conservation_NN -LRB-_-LRB- open_JJ space_NN -RRB-_-RRB- Protected_VBN and_CC recreational_JJ open_JJ space_NN was_VBD downloaded_VBN from_IN MassGIS_NNP ,_, Massachusetts_NNP Executive_NNP Office_NNP of_IN Environmental_NNP Affairs_NNP ._. 
The_DT subset_NN of_IN the_DT open_JJ space_NN designated_VBN for_IN recreation_NN ,_, conservation_NN ,_, water_NN supply_NN ,_, and_CC forestry_NN was_VBD intersected_VBN with_IN 2000_CD Census_NNP tract_NN boundaries_NNS -LRB-_-LRB- also_RB downloaded_VBN from_IN MassGIS_NNP -RRB-_-RRB- using_VBG ArcGIS_NNP 9_CD ._. 
We_PRP categorized_VBD education_NN as_IN :_: high_JJ school_NN or_CC less_JJR -LRB-_-LRB- 
Distance_NNP to_TO roadways_NNS has_VBZ been_VBN reported_VBN to_TO approximate_JJ somewhat_RB better_JJR personal_JJ exposure_NN levels_NNS of_IN air_NN pollutants_NNS than_IN ambient_JJ measurements_NNS ._. 
Studies_NNS have_VBP reported_VBN strong_JJ gradients_NNS of_IN pollutant_JJ concentrations_NNS and_CC particle_NN size_NN distribution_NN for_IN distances_NNS beyond_IN 100_CD meters_NNS from_IN the_DT roads_NNS ._. 
In_IN our_PRP$ study_NN we_PRP observed_VBD associations_NNS of_IN traffic_NN variables_NNS with_IN reduced_JJ birth_NN weight_NN ,_, suggestive_JJ evidence_NN with_IN SGA_NNP ,_, but_CC not_RB with_IN preterm_JJ births_NNS ._. 
Racial\/ethnic_JJ inequalities_NNS do_VBP predict_VB health_NN disparities_NNS ,_, and_CC such_JJ inequalities_NNS are_VBP a_DT representation_NN of_IN a_DT history_NN of_IN racial_JJ discrimination_NN ,_, economic_JJ deprivation_NN ,_, and_CC the_DT greater_JJR likelihood_NN of_IN adverse_JJ exposures_NNS throughout_IN life_NN 
These_DT results_NNS suggest_VBP that_DT race\/ethnicity_NN of_IN mother_NN is_VBZ a_DT strong_JJ confounder_NN in_IN this_DT study_NN ._. 
Including_VBG just_RB race\/ethnicity_NN in_IN exposure_NN model_NN reduced_VBD the_DT effect_NN on_IN birth_NN weight_NN of_IN cumulative_JJ traffic_NN density_NN by_IN 62_CD percent_NN ,_, distance_NN to_TO major_JJ roads_NNS by_IN 25_CD percent_NN ,_, and_CC that_IN of_IN land_NN use_NN as_IN open_JJ space_NN by_IN 47_CD percent_NN ._. 
Racial\/ethnic_JJ inequalities_NNS do_VBP predict_VB health_NN disparities_NNS ,_, and_CC such_JJ inequalities_NNS are_VBP a_DT representation_NN of_IN a_DT history_NN of_IN racial_JJ discrimination_NN ,_, economic_JJ deprivation_NN ,_, and_CC the_DT greater_JJR likelihood_NN of_IN adverse_JJ exposures_NNS throughout_IN life_NN 
The_DT evidence_NN however_RB has_VBZ not_RB been_VBN fully_RB corroborated_VBN possibly_RB due_JJ to_TO inadequate_JJ control_NN for_IN individual_NN and_CC neighborhood_NN level_NN socioeconomic_JJ indicators_NNS ._. 
Factors_NNS that_WDT account_VBP for_IN socioeconomic_JJ position_NN of_IN the_DT mother_NN have_VBP also_RB been_VBN associated_VBN with_IN birth_NN outcomes_NNS :_: racial\/ethnic_JJ background_NN ,_, education_NN ,_, and_CC area-based_JJ factors_NNS such_JJ as_IN income_NN and_CC level_NN of_IN poverty_NN ._. 
However_RB ,_, only_RB a_DT limited_JJ number_NN of_IN studies_NNS have_VBP examined_VBN the_DT influence_NN of_IN these_DT factors_NNS ,_, either_CC alone_RB or_CC in_IN combination_NN ,_, on_IN the_DT effects_NNS of_IN air_NN pollution_NN on_IN birth_NN outcomes_NNS ._. 
Arecent_JJ study_NN of_IN the_DT same_JJ population_NN examined_VBD confounding_JJ and_CC effect_NN modification_NN of_IN traffic_NN effect_NN estimates_NNS for_IN preterm_NN birth_NN by_IN both_DT individual_JJ and_CC contextual_JJ SEM_NNP variables_NNS in_IN two-level_JJ random_JJ effect_NN models_NNS 
Distance_NNP to_TO roadways_NNS has_VBZ been_VBN reported_VBN to_TO approximate_JJ somewhat_RB better_JJR personal_JJ exposure_NN levels_NNS of_IN air_NN pollutants_NNS than_IN ambient_JJ measurements_NNS ._. 
Studies_NNS have_VBP reported_VBN strong_JJ gradients_NNS of_IN pollutant_JJ concentrations_NNS and_CC particle_NN size_NN distribution_NN for_IN distances_NNS beyond_IN 100_CD meters_NNS from_IN the_DT roads_NNS ._. 
In_IN our_PRP$ study_NN we_PRP observed_VBD associations_NNS of_IN traffic_NN variables_NNS with_IN reduced_JJ birth_NN weight_NN ,_, suggestive_JJ evidence_NN with_IN SGA_NNP ,_, but_CC not_RB with_IN preterm_JJ births_NNS ._. 
First_RB ,_, we_PRP used_VBD a_DT two-level_JJ hierarchical_JJ model_NN to_TO estimate_VB the_DT variability_NN in_IN birth_NN outcomes_NNS due_JJ to_TO individual_JJ and_CC contextual_JJ level_NN SEM_NNP and_CC indices_NNS of_IN physical_JJ environment_NN ._. 
Anumber_NNP of_IN epidemiologic_JJ studies_NNS from_IN the_DT US_NNP and_CC other_JJ countries_NNS have_VBP shown_VBN associations_NNS between_IN air_NN pollution_NN and_CC birth_NN weight_NN and_CC preterm_NN births_NNS ,_, in_IN particular_JJ with_IN carbon_NN monoxide_NN and_CC particulate_NN matter_NN ._. 
The_DT evidence_NN however_RB has_VBZ not_RB been_VBN fully_RB corroborated_VBN possibly_RB due_JJ to_TO inadequate_JJ control_NN for_IN individual_NN and_CC neighborhood_NN level_NN socioeconomic_JJ indicators_NNS ._. 
The_DT evidence_NN however_RB has_VBZ not_RB been_VBN fully_RB corroborated_VBN possibly_RB due_JJ to_TO inadequate_JJ control_NN for_IN individual_NN and_CC neighborhood_NN level_NN socioeconomic_JJ indicators_NNS ._. 
Factors_NNS that_WDT account_VBP for_IN socioeconomic_JJ position_NN of_IN the_DT mother_NN have_VBP also_RB been_VBN associated_VBN with_IN birth_NN outcomes_NNS :_: racial\/ethnic_JJ background_NN ,_, education_NN ,_, and_CC area-based_JJ factors_NNS such_JJ as_IN income_NN and_CC level_NN of_IN poverty_NN ._. 
However_RB ,_, only_RB a_DT limited_JJ number_NN of_IN studies_NNS have_VBP examined_VBN the_DT influence_NN of_IN these_DT factors_NNS ,_, either_CC alone_RB or_CC in_IN combination_NN ,_, on_IN the_DT effects_NNS of_IN air_NN pollution_NN on_IN birth_NN outcomes_NNS ._. 
The_DT majority_NN of_IN the_DT studies_NNS that_WDT examined_VBD this_DT relationship_NN have_VBP not_RB taken_VBN into_IN account_NN variation_NN in_IN pollution_NN exposure_NN within_IN small_JJ localities_NNS ,_, which_WDT can_MD lead_VB to_TO exposure_NN misclassification_NN and_CC distortion_NN of_IN the_DT association_NN ._. 
Two_CD studies_NNS in_IN California_NNP ,_, US_NNP ,_, merely_RB averaged_VBD monitors_NNS within_IN few_JJ miles_NNS of_IN the_DT residence_NN of_IN the_DT child_NN ,_, for_IN example_NN 
In_IN Wilhelm_NNP and_CC Ritz_NNP 
Two_CD studies_NNS in_IN California_NNP ,_, US_NNP ,_, merely_RB averaged_VBD monitors_NNS within_IN few_JJ miles_NNS of_IN the_DT residence_NN of_IN the_DT child_NN ,_, for_IN example_NN 
Because_IN measures_NNS of_IN concentrations_NNS of_IN air_NN pollutants_NNS at_IN individual_JJ addresses_NNS are_VBP unfeasible_JJ in_IN large_JJ studies_NNS of_IN births_NNS or_CC other_JJ outcomes_NNS ,_, either_CC modeled_VBD concentrations_NNS of_IN air_NN pollutants_NNS or_CC measures_NNS of_IN traffic_NN such_JJ as_IN traffic_NN density_NN or_CC distance_NN to_TO roadways_NNS have_VBP been_VBN used_VBN as_IN exposure_NN indices_NNS ._. 
One_CD concern_NN of_IN this_DT approach_NN is_VBZ that_DT variability_NN in_IN socioeconomic_JJ measures_NNS -LRB-_-LRB- SEM_NNP -RRB-_-RRB- can_MD predict_VB distribution_NN of_IN indices_NNS of_IN physical_JJ environment_NN 
While_IN different_JJ sources_NNS of_IN air_NN pollution_NN have_VBP been_VBN associated_VBN with_IN increased_VBN risk_NN of_IN adverse_JJ health_NN ,_, it_PRP is_VBZ traffic_NN pollutants_NNS that_WDT show_VBP the_DT greater_JJR heterogeneity_NN in_IN concentration_NN within_IN urban_JJ areas_NNS 
Several_JJ studies_NNS from_IN California_NNP ,_, US_NNP ,_, have_VBP examined_VBN air_NN pollution_NN effects_NNS on_IN birth_NN weight_NN and_CC preterm_NN births_NNS controlling_VBG for_IN individual_JJ or_CC area-based_JJ SEM_NNP ,_, but_CC rarely_RB controlled_JJ for_IN both_DT or_CC examined_VBN interaction_NN 
Air_NN pollution_NN ,_, a_DT component_NN of_IN the_DT physical_JJ environment_NN ,_, has_VBZ also_RB been_VBN associated_VBN with_IN low_JJ birth_NN weight_NN and_CC preterm_NN births_NNS 
It_PRP is_VBZ likely_JJ that_IN socioeconomic_JJ status_NN is_VBZ a_DT measure_NN of_IN access_NN to_TO health_NN care_NN ,_, empowerment_NN ,_, level_NN of_IN stress_NN and_CC violence_NN ,_, and_CC likelihood_NN of_IN exposure_NN to_TO environmental_JJ factors_NNS ,_, and_CC among_IN these_DT air_NN pollution_NN exposure_NN 
First_RB ,_, we_PRP used_VBD a_DT two-level_JJ hierarchical_JJ model_NN to_TO estimate_VB the_DT variability_NN in_IN birth_NN outcomes_NNS due_JJ to_TO individual_JJ and_CC contextual_JJ level_NN SEM_NNP and_CC indices_NNS of_IN physical_JJ environment_NN ._. 
Anumber_NNP of_IN epidemiologic_JJ studies_NNS from_IN the_DT US_NNP and_CC other_JJ countries_NNS have_VBP shown_VBN associations_NNS between_IN air_NN pollution_NN and_CC birth_NN weight_NN and_CC preterm_NN births_NNS ,_, in_IN particular_JJ with_IN carbon_NN monoxide_NN and_CC particulate_NN matter_NN ._. 
The_DT evidence_NN however_RB has_VBZ not_RB been_VBN fully_RB corroborated_VBN possibly_RB due_JJ to_TO inadequate_JJ control_NN for_IN individual_NN and_CC neighborhood_NN level_NN socioeconomic_JJ indicators_NNS ._. 
However_RB ,_, only_RB a_DT limited_JJ number_NN of_IN studies_NNS have_VBP examined_VBN the_DT influence_NN of_IN these_DT factors_NNS ,_, either_CC alone_RB or_CC in_IN combination_NN ,_, on_IN the_DT effects_NNS of_IN air_NN pollution_NN on_IN birth_NN outcomes_NNS ._. 
Several_JJ studies_NNS from_IN California_NNP ,_, US_NNP ,_, have_VBP examined_VBN air_NN pollution_NN effects_NNS on_IN birth_NN weight_NN and_CC preterm_NN births_NNS controlling_VBG for_IN individual_JJ or_CC area-based_JJ SEM_NNP ,_, but_CC rarely_RB controlled_JJ for_IN both_DT or_CC examined_VBN interaction_NN 
It_PRP may_MD be_VB suggested_VBN that_IN this_DT variable_NN indicates_VBZ greater_JJR distance_NN to_TO traffic_NN ,_, more_RBR green_JJ areas_NNS ,_, and_CC less_RBR urbanized_JJ residence_NN ,_, therefore_RB contributing_VBG to_TO less_JJR exposure_NN ._. 
The_DT geographic_JJ differences_NNS in_IN the_DT distribution_NN of_IN air_NN pollutants_NNS are_VBP related_VBN to_TO the_DT geographic_JJ distribution_NN of_IN wealth_NN and_CC socioeconomic_JJ status_NN ._. 
However_RB ,_, traffic_NN can_MD only_RB partly_RB explain_VB the_DT variability_NN in_IN exposures_NNS observed_VBN in_IN diverse_JJ neighborhoods_NNS ._. 
First_RB ,_, we_PRP used_VBD a_DT two-level_JJ hierarchical_JJ model_NN to_TO estimate_VB the_DT variability_NN in_IN birth_NN outcomes_NNS due_JJ to_TO individual_JJ and_CC contextual_JJ level_NN SEM_NNP and_CC indices_NNS of_IN physical_JJ environment_NN ._. 
Anumber_NNP of_IN epidemiologic_JJ studies_NNS from_IN the_DT US_NNP and_CC other_JJ countries_NNS have_VBP shown_VBN associations_NNS between_IN air_NN pollution_NN and_CC birth_NN weight_NN and_CC preterm_NN births_NNS ,_, in_IN particular_JJ with_IN carbon_NN monoxide_NN and_CC particulate_NN matter_NN ._. 
The_DT evidence_NN however_RB has_VBZ not_RB been_VBN fully_RB corroborated_VBN possibly_RB due_JJ to_TO inadequate_JJ control_NN for_IN individual_NN and_CC neighborhood_NN level_NN socioeconomic_JJ indicators_NNS ._. 
First_RB ,_, we_PRP used_VBD a_DT two-level_JJ hierarchical_JJ model_NN to_TO estimate_VB the_DT variability_NN in_IN birth_NN outcomes_NNS due_JJ to_TO individual_JJ and_CC contextual_JJ level_NN SEM_NNP and_CC indices_NNS of_IN physical_JJ environment_NN ._. 
Anumber_NNP of_IN epidemiologic_JJ studies_NNS from_IN the_DT US_NNP and_CC other_JJ countries_NNS have_VBP shown_VBN associations_NNS between_IN air_NN pollution_NN and_CC birth_NN weight_NN and_CC preterm_NN births_NNS ,_, in_IN particular_JJ with_IN carbon_NN monoxide_NN and_CC particulate_NN matter_NN ._. 
The_DT evidence_NN however_RB has_VBZ not_RB been_VBN fully_RB corroborated_VBN possibly_RB due_JJ to_TO inadequate_JJ control_NN for_IN individual_NN and_CC neighborhood_NN level_NN socioeconomic_JJ indicators_NNS ._. 
However_RB ,_, only_RB a_DT limited_JJ number_NN of_IN studies_NNS have_VBP examined_VBN the_DT influence_NN of_IN these_DT factors_NNS ,_, either_CC alone_RB or_CC in_IN combination_NN ,_, on_IN the_DT effects_NNS of_IN air_NN pollution_NN on_IN birth_NN outcomes_NNS ._. 
Several_JJ studies_NNS from_IN California_NNP ,_, US_NNP ,_, have_VBP examined_VBN air_NN pollution_NN effects_NNS on_IN birth_NN weight_NN and_CC preterm_NN births_NNS controlling_VBG for_IN individual_JJ or_CC area-based_JJ SEM_NNP ,_, but_CC rarely_RB controlled_JJ for_IN both_DT or_CC examined_VBN interaction_NN 
The_DT evidence_NN however_RB has_VBZ not_RB been_VBN fully_RB corroborated_VBN possibly_RB due_JJ to_TO inadequate_JJ control_NN for_IN individual_NN and_CC neighborhood_NN level_NN socioeconomic_JJ indicators_NNS ._. 
Factors_NNS that_WDT account_VBP for_IN socioeconomic_JJ position_NN of_IN the_DT mother_NN have_VBP also_RB been_VBN associated_VBN with_IN birth_NN outcomes_NNS :_: racial\/ethnic_JJ background_NN ,_, education_NN ,_, and_CC area-based_JJ factors_NNS such_JJ as_IN income_NN and_CC level_NN of_IN poverty_NN ._. 
However_RB ,_, only_RB a_DT limited_JJ number_NN of_IN studies_NNS have_VBP examined_VBN the_DT influence_NN of_IN these_DT factors_NNS ,_, either_CC alone_RB or_CC in_IN combination_NN ,_, on_IN the_DT effects_NNS of_IN air_NN pollution_NN on_IN birth_NN outcomes_NNS ._. 
Introduction_NN Adverse_JJ birth_NN outcomes_NNS such_JJ as_IN low_JJ birth_NN weight_NN and_CC its_PRP$ determinants_NNS ,_, preterm_NN births_NNS and_CC intrauterine_JJ growth_NN retardation_NN have_VBP been_VBN associated_VBN with_IN indicators_NNS of_IN socioeconomic_JJ status_NN and_CC physical_JJ environment_NN 
Results_NNS revealed_VBD the_DT importance_NN of_IN controlling_VBG simultaneously_RB for_IN SEM_NNP and_CC environmental_JJ exposures_NNS as_IN the_DT way_NN to_TO better_RB understand_VB determinants_NNS of_IN health_NN ._. 
IntroductionAdverse_JJ birth_NN outcomes_NNS such_JJ as_IN low_JJ birth_NN weight_NN and_CC its_PRP$ determinants_NNS ,_, preterm_NN births_NNS and_CC intrauterine_JJ growth_NN retardation_NN have_VBP been_VBN associated_VBN with_IN indicators_NNS of_IN socioeconomic_JJ status_NN and_CC physical_JJ environment_NN 
However_RB ,_, only_RB a_DT limited_JJ number_NN of_IN studies_NNS have_VBP examined_VBN the_DT influence_NN of_IN these_DT factors_NNS ,_, either_CC alone_RB or_CC in_IN combination_NN ,_, on_IN the_DT effects_NNS of_IN air_NN pollution_NN on_IN birth_NN outcomes_NNS ._. 
Several_JJ studies_NNS from_IN California_NNP ,_, US_NNP ,_, have_VBP examined_VBN air_NN pollution_NN effects_NNS on_IN birth_NN weight_NN and_CC preterm_NN births_NNS controlling_VBG for_IN individual_JJ or_CC area-based_JJ SEM_NNP ,_, but_CC rarely_RB controlled_JJ for_IN both_DT or_CC examined_VBN interaction_NN 
The_DT majority_NN of_IN the_DT studies_NNS that_WDT examined_VBD this_DT relationship_NN have_VBP not_RB taken_VBN into_IN account_NN variation_NN in_IN pollution_NN exposure_NN within_IN small_JJ localities_NNS ,_, which_WDT can_MD lead_VB to_TO exposure_NN misclassification_NN and_CC distortion_NN of_IN the_DT association_NN ._. 
Two_CD studies_NNS in_IN California_NNP ,_, US_NNP ,_, merely_RB averaged_VBD monitors_NNS within_IN few_JJ miles_NNS of_IN the_DT residence_NN of_IN the_DT child_NN ,_, for_IN example_NN 
Results_NNS revealed_VBD the_DT importance_NN of_IN controlling_VBG simultaneously_RB for_IN SEM_NNP and_CC environmental_JJ exposures_NNS as_IN the_DT way_NN to_TO better_RB understand_VB determinants_NNS of_IN health_NN ._. 
IntroductionAdverse_JJ birth_NN outcomes_NNS such_JJ as_IN low_JJ birth_NN weight_NN and_CC its_PRP$ determinants_NNS ,_, preterm_NN births_NNS and_CC intrauterine_JJ growth_NN retardation_NN have_VBP been_VBN associated_VBN with_IN indicators_NNS of_IN socioeconomic_JJ status_NN and_CC physical_JJ environment_NN 
The_DT issue_NN stands_VBZ high_JJ in_IN the_DT public_JJ health_NN concerns_NNS due_JJ to_TO the_DT evidence_NN that_IN adverse_JJ health_NN in_IN early_JJ life_NN can_MD lead_VB to_TO later_JJ life_NN diseases_NNS of_IN childhood_NN and_CC adulthood_NN 
Nonetheless_RB ,_, whatever_WDT the_DT size_NN of_IN the_DT problem_NN ,_, ethical_JJ principles_NNS impose_VBP the_DT inclusion_NN in_IN any_DT cancer_NN control_NN program_NN of_IN actions_NNS to_TO prevent_VB occupational_JJ exposure_NN and_CC environmental_JJ contamination_NN with_IN carcinogens_NNS ._. 
As_IN a_DT first_JJ step_NN in_IN this_DT direction_NN both_DT rich_JJ and_CC poor_JJ countries_NNS should_MD be_VB encouraged_VBN to_TO sign_VB up_RP to_TO the_DT Rotterdam_NNP Convention_NNP whose_WP$ objectives_NNS are_VBP to_TO promote_VB shared_JJ responsibility_NN in_IN the_DT international_JJ trade_NN of_IN hazardous_JJ chemicals_NNS and_CC to_TO contribute_VB to_TO their_PRP$ sound_NN use_NN 
The_DT main_JJ objective_NN of_IN the_DT study_NN was_VBD to_TO prove_VB the_DT feasibility_NN of_IN such_JJ interventions_NNS and_CC quantify_VB the_DT efficacy_NN of_IN immunization_NN in_IN preventing_VBG chronic_JJ liver_NN diseases_NNS and_CC hepatocellular_NN cancer_NN in_IN an_DT African_JJ country_NN ._. 
Several_JJ more_JJR years_NNS of_IN observation_NN are_VBP needed_VBN to_TO measure_VB the_DT full_JJ impact_NN of_IN the_DT intervention_NN ;_: but_CC high_JJ coverage_NN and_CC reduced_JJ incidence_NN of_IN chronic_JJ hepatitis_NN have_VBP been_VBN achieved_VBN promising_JJ success_NN also_RB with_IN respect_NN to_TO the_DT malignant_JJ disease_NN ._. 
Sadly_RB ,_, immunization_NN coverage_NN remains_VBZ low_JJ in_IN the_DT regions_NNS that_WDT would_MD benefit_VB most_JJS from_IN this_DT public_JJ health_NN measure_NN -LRB-_-LRB- Figure_NN 2_CD -RRB-_-RRB- ._. 
Sadly_RB ,_, immunization_NN coverage_NN remains_VBZ low_JJ in_IN the_DT regions_NNS that_WDT would_MD benefit_VB most_JJS from_IN this_DT public_JJ health_NN measure_NN -LRB-_-LRB- Figure_NN 2_CD -RRB-_-RRB- ._. 
Figure_NNP 2Immunization_NNP coverage_NN among_IN 1-year-olds_NNS -LRB-_-LRB- WHO_WP -RRB-_-RRB- One_CD of_IN the_DT most_RBS celebrated_JJ successes_NNS of_IN cancer_NN research_NN is_VBZ the_DT recognition_NN that_IN virtually_RB all_DT cervix_NN cancers_NNS are_VBP caused_VBN by_IN certain_JJ types_NNS of_IN the_DT Human_NNP Papilloma_NNP Virus_NNP -LRB-_-LRB- HPV_NNP -RRB-_-RRB- with_IN types_NNS 16_CD and_CC 18_CD accounting_NN for_IN about_IN 80_CD %_NN of_IN the_DT burden_NN ._. 
The_DT finding_NN led_VBD to_TO the_DT development_NN and_CC testing_NN of_IN vaccines_NNS that_WDT are_VBP now_RB approved_VBN in_IN many_JJ countries_NNS ._. 
Prevention_NNP of_IN invasive_JJ cancer_NN by_IN early_JJ detection_NN and_CC timely_JJ treatment_NN will_MD remain_VB therefore_RB an_DT important_JJ component_NN of_IN cancer_NN control_NN policies_NNS ._. 
Compared_VBN with_IN classical_JJ cytology-based_JJ screening_NN ,_, the_DT HPV_NNP technology_NN offers_VBZ a_DT valid_JJ and_CC possibly_RB more_RBR cost-effective_JJ strategy_NN in_IN secondary_JJ prevention_NN of_IN cervix_NN cancer_NN in_IN low-resource_JJ settings_NNS ,_, because_IN the_DT sensitivity_NN and_CC specificity_NN of_IN available_JJ HPV_NNP tests_NNS in_IN exfoliated_JJ cells_NNS are_VBP much_RB more_RBR reproducible_JJ than_IN those_DT of_IN cytology_NN which_WDT strongly_RB depends_VBZ on_IN human_JJ expertise_NN and_CC skill_NN ._. 
In_IN fact_NN ,_, to_TO maintain_VB high_JJ quality_NN standards_NNS of_IN screening_NN by_IN cytology_NN in_IN developing_VBG countries_NNS has_VBZ proved_VBN difficult_JJ ,_, costly_JJ ,_, and_CC too_RB often_RB ineffective_JJ ._. 
Having_VBG this_DT principles_NNS in_IN mind_NN ,_, the_DT development_NN of_IN means_NNS to_TO provide_VB pain_NN relief_NN and_CC palliative_NN care_NN to_TO cancer_NN cases_NNS and_CC other_JJ terminally_RB ill_JJ patients_NNS is_VBZ a_DT much_JJ cost-effective_JJ option_NN -LRB-_-LRB- in_IN developing_VBG countries_NNS two_CD cases_NNS in_IN three_CD die_NN from_IN the_DT disease_NN -RRB-_-RRB- :_: to_TO reduce_VB the_DT suffering_NN is_VBZ a_DT benefit_NN that_IN all_DT human_JJ beings_NNS value_NN ,_, it_PRP does_VBZ not_RB require_VB sophisticated_JJ technology_NN ,_, and_CC it_PRP is_VBZ for_IN all_DT cases_NNS ._. 
Back_RB in_IN the_DT 1980s_CD ,_, having_VBG recognized_VBN that_DT lack_NN of_IN access_NN to_TO palliative_NN care_NN in_IN poor_JJ countries_NNS was_VBD a_DT major_JJ public_JJ health_NN problem_NN ,_, the_DT WHO_WP established_VBD the_DT Cancer_NNP Pain_NNP Programme_NNP 
Moreover_RB ,_, the_DT lack_NN of_IN comprehensive_JJ planning_NN of_IN health_NN systems_NNS has_VBZ led_VBN to_TO wider_JJR inequalities_NNS in_IN access_NN to_TO health_NN care_NN ._. 
Cancer_NN control_NN encompasses_VBZ a_DT package_NN of_IN diverse_JJ interventions_NNS aiming_VBG at_IN reducing_VBG morbidity_NN and_CC mortality_NN from_IN the_DT disease_NN ,_, with_IN wide_JJ variations_NNS in_IN costs_NNS and_CC potential_JJ impact_NN ._. 
Under_IN serious_JJ budgetary_JJ constrains_VBZ and_CC competition_NN with_IN the_DT demands_NNS of_IN other_JJ diseases_NNS ,_, cancer_NN control_NN programs_NNS need_VBP to_TO make_VB wise_JJ choices_NNS to_TO maximize_VB the_DT efficacy_NN of_IN their_PRP$ investments_NNS ._. 
Means_NNP to_TO monitor_VB the_DT occurrence_NN of_IN cancer_NN in_IN developing_VBG countries_NNS are_VBP still_RB very_RB limited_JJ ,_, therefore_RB planning_NN relies_VBZ largely_RB on_IN estimates_NNS ._. 
Based_VBN on_IN the_DT comprehensive_JJ GLOBOCAN2008_NNP dataset_NN ,_, in_IN developing_VBG countries_NNS as_IN a_DT whole_JJ cancers_NNS of_IN the_DT lung_NN ,_, stomach_NN ,_, breast_NN ,_, liver_NN ,_, colorectum_NN and_CC cervix_NN are_VBP the_DT most_RBS common_JJ sites_NNS in_IN this_DT order_NN ,_, each_DT is_VBZ at_IN least_JJS twice_RB more_RBR frequent_JJ than_IN the_DT majority_NN of_IN any_DT other_JJ cancer_NN type_NN -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ;_: they_PRP are_VBP a_DT mix_NN of_IN malignancies_NNS linked_VBN to_TO infections_NNS and_CC poverty_NN -LRB-_-LRB- stomach_NN ,_, liver_NN and_CC cervix_NN -RRB-_-RRB- and_CC westernization_NN of_IN life_NN styles_NNS -LRB-_-LRB- lung_NN ,_, breast_NN and_CC colorectum_NN -RRB-_-RRB- ._. 
The_DT Figure_NN 1_CD shows_NNS for_IN comparison_NN the_DT ranking_NN in_IN affluent_JJ regions_NNS where_WRB the_DT four_CD top_JJ sites_NNS are_VBP lung_NN ,_, breast_NN ,_, colorectum_NN and_CC prostate_NN ._. 
Figure_NNP 1_CD Cancer_NN incidence_NN 2008_CD ,_, males_NNS and_CC females_NNS ._. 
In_IN the_DT context_NN of_IN cancer_NN control_NN it_PRP is_VBZ particularly_RB important_JJ to_TO remark_VB that_IN in_IN both_DT high_JJ -_: -LRB-_-LRB- generally_RB rich_JJ -RRB-_-RRB- and_CC low-risk_JJ -LRB-_-LRB- generally_RB less_RBR wealthy_JJ -RRB-_-RRB- countries_NNS ,_, such_JJ common_JJ sites_NNS account_VBP for_IN only_JJ half_NN of_IN the_DT burden_NN ._. 
Estimated_JJ numbers_NNS of_IN new_JJ cases_NNS per_IN year_NN by_IN level_NN of_IN economical_JJ development_NN ._. 
Options_NNS for_IN prevention_NN Smoking_NN of_IN commercial_JJ cigarettes_NNS used_VBN to_TO be_VB uncommon_JJ in_IN developing_VBG countries_NNS where_WRB tobacco_NN smoking_NN is_VBZ a_DT recent_JJ aspect_NN of_IN Westernization_NN of_IN life_NN styles_NNS ._. 
Options_NNS for_IN prevention_NN Smoking_NN of_IN commercial_JJ cigarettes_NNS used_VBN to_TO be_VB uncommon_JJ in_IN developing_VBG countries_NNS where_WRB tobacco_NN smoking_NN is_VBZ a_DT recent_JJ aspect_NN of_IN Westernization_NN of_IN life_NN styles_NNS ._. 
While_IN interventions_NNS to_TO reduce_VB the_DT habit_NN in_IN rich_JJ countries_NNS is_VBZ now_RB showing_VBG positive_JJ results_NNS ,_, the_DT tobacco_NN industry_NN is_VBZ pursuing_VBG new_JJ markets_NNS in_IN the_DT developing_VBG world_NN ._. 
Of_IN all_DT possible_JJ interventions_NNS to_TO reduce_VB the_DT cancer_NN burden_NN ,_, comprehensive_JJ programs_NNS to_TO prevent_VB tobacco_NN smoking_NN are_VBP the_DT most_RBS cost-effective_JJ :_: the_DT impact_NN on_IN future_JJ chronic_JJ disease_NN burden_NN is_VBZ the_DT largest_JJS achievable_JJ by_IN preventing_VBG one_CD single_JJ factor_NN ,_, against_IN measures_NNS that_WDT are_VBP inexpensive_JJ to_TO governments_NNS such_JJ as_IN banning_VBG smoking_NN in_IN public_JJ places_NNS and_CC impose_VB high_JJ taxes_NNS on_IN the_DT product_NN ._. 
Options_NNS for_IN prevention_NN Smoking_NN of_IN commercial_JJ cigarettes_NNS used_VBN to_TO be_VB uncommon_JJ in_IN developing_VBG countries_NNS where_WRB tobacco_NN smoking_NN is_VBZ a_DT recent_JJ aspect_NN of_IN Westernization_NN of_IN life_NN styles_NNS ._. 
While_IN interventions_NNS to_TO reduce_VB the_DT habit_NN in_IN rich_JJ countries_NNS is_VBZ now_RB showing_VBG positive_JJ results_NNS ,_, the_DT tobacco_NN industry_NN is_VBZ pursuing_VBG new_JJ markets_NNS in_IN the_DT developing_VBG world_NN ._. 
Of_IN all_DT possible_JJ interventions_NNS to_TO reduce_VB the_DT cancer_NN burden_NN ,_, comprehensive_JJ programs_NNS to_TO prevent_VB tobacco_NN smoking_NN are_VBP the_DT most_RBS cost-effective_JJ :_: the_DT impact_NN on_IN future_JJ chronic_JJ disease_NN burden_NN is_VBZ the_DT largest_JJS achievable_JJ by_IN preventing_VBG one_CD single_JJ factor_NN ,_, against_IN measures_NNS that_WDT are_VBP inexpensive_JJ to_TO governments_NNS such_JJ as_IN banning_VBG smoking_NN in_IN public_JJ places_NNS and_CC impose_VB high_JJ taxes_NNS on_IN the_DT product_NN ._. 
Bodies_NNS subscribing_VBG to_TO the_DT Convention_NNP commit_VBP to_TO disseminate_VB information_NN on_IN the_DT characteristics_NNS and_CC hazards_NNS of_IN substances_NNS traded_VBN among_IN parties_NNS ._. 
Cancer_NNP careIn_NNP rich_JJ countries_NNS the_DT combination_NN of_IN early_JJ detection_NN and_CC new_JJ treatments_NNS that_WDT can_MD improve_VB disease_NN outcomes_NNS have_VBP contributed_VBN to_TO a_DT modest_JJ but_CC constant_JJ decline_NN in_IN cancer_NN mortality_NN rates_NNS that_WDT started_VBD in_IN the_DT 1980s_CD ._. 
The_DT main_JJ determinant_NN of_IN such_JJ success_NN is_VBZ not_RB the_DT availability_NN of_IN more_RBR effective_JJ curative_JJ drugs_NNS but_CC widespread_JJ access_NN to_TO health_NN care_NN through_IN comprehensive_JJ health_NN systems_NNS ._. 
In_IN fact_NN ,_, to_TO maintain_VB high_JJ quality_NN standards_NNS of_IN screening_NN by_IN cytology_NN in_IN developing_VBG countries_NNS has_VBZ proved_VBN difficult_JJ ,_, costly_JJ ,_, and_CC too_RB often_RB ineffective_JJ ._. 
In_IN a_DT large_JJ randomised_JJ trial_NN in_IN Kerala_NNP ,_, India_NNP ,_, Sankaranayan_NNP and_CC colleagues_NNS assessed_VBD the_DT efficacy_NN of_IN a_DT single_JJ examination_NN by_IN three_CD screening_NN modalities_NNS 
The_DT condition_NN for_IN any_DT intervention_NN to_TO be_VB successful_JJ and_CC cost-effective_JJ is_VBZ to_TO reach_VB high_JJ coverage_NN of_IN the_DT target_NN population_NN ;_: therefore_RB ,_, much_JJ attention_NN must_MD be_VB paid_VBN to_TO the_DT logistics_NNS of_IN how_WRB the_DT services_NNS are_VBP delivered_VBN in_IN order_NN to_TO ensure_VB access_NN and_CC high_JJ compliance_NN ._. 
Other_JJ preventive_JJ interventions_NNS that_WDT are_VBP the_DT object_NN of_IN much_JJ research_NN and_CC activities_NNS in_IN the_DT West_NNP focus_NN on_IN nutritional_JJ habits_NNS and_CC energy_NN balance_NN ,_, clearly_RB an_DT increasing_VBG problem_NN in_IN emerging_VBG economies_NNS as_IN shown_VBN by_IN rising_VBG rates_NNS of_IN diabetes_NN 
Twenty_CD years_NNS later_RB ,_, palliative_NN care_NN still_RB struggles_VBZ to_TO gain_VB priority_NN with_IN policy-makers_NNS ._. 
Back_RB in_IN the_DT 1980s_CD ,_, having_VBG recognized_VBN that_DT lack_NN of_IN access_NN to_TO palliative_NN care_NN in_IN poor_JJ countries_NNS was_VBD a_DT major_JJ public_JJ health_NN problem_NN ,_, the_DT WHO_WP established_VBD the_DT Cancer_NNP Pain_NNP Programme_NNP 
59_CD and_CC 0_CD ._. 
5measurements_NNS at_IN five_CD monitoring_NN sites_NNS in_IN the_DT UK_NNP -LRB-_-LRB- r_NN 2_CD of_IN between_IN 0_CD ._. 
5in_IN the_DT UK_NNP have_VBP found_VBN them_PRP to_TO be_VB strongly_RB associated_VBN :_: Harrison_NNP and_CC colleagues_NNS found_VBD strong_JJ correlations_NNS between_IN hourly_JJ PM_NNP 10_CD and_CC PM_NNP 2_CD ._. 
94_CD -RRB-_-RRB- ._. 
The_DT PM_NNP 2_CD ._. 
5\/_CD PM_NNP 10_CD ratio_NN varied_VBN from_IN 0_CD ._. 
63_CD to_TO 0_CD ._. 
73_CD ._. 
Moreover_RB ,_, some_DT of_IN the_DT most_RBS influential_JJ studies_NNS have_VBP found_VBN relationships_NNS between_IN cardiovascular_JJ mortality_NN and_CC PM_NNP 10_CD that_WDT are_VBP similar_JJ to_TO those_DT with_IN PM_NNP 2_CD ._. 
We_PRP estimated_VBD exposure_NN using_VBG comprehensive_JJ emission_NN inventories_NNS combined_VBN with_IN air_NN dispersion_NN models_NNS taking_VBG into_IN account_NN meteorological_JJ information_NN ._. 
The_DT emission_NN inventories_NNS were_VBD constructed_VBN using_VBG information_NN on_IN any_DT influence_NN on_IN air_NN pollution_NN levels_NNS likely_JJ to_TO have_VB a_DT measurable_JJ effect_NN -LRB-_-LRB- including_VBG population_NN density_NN ,_, emissions_NNS from_IN roads_NNS from_IN a_DT combination_NN of_IN traffic_NN activity_NN data_NNS ,_, type_NN of_IN vehicle_NN ,_, railways_NNS ,_, airports_NNS ,_, industry_NN and_CC domestic_JJ heating_NN -RRB-_-RRB- 
It_PRP was_VBD related_VBN to_TO known_VBN risk_NN factors_NNS as_IN we_PRP would_MD expect_VB ._. 
5_CD 
The_DT emission_NN inventories_NNS were_VBD constructed_VBN using_VBG information_NN on_IN any_DT influence_NN on_IN air_NN pollution_NN levels_NNS likely_JJ to_TO have_VB a_DT measurable_JJ effect_NN -LRB-_-LRB- including_VBG population_NN density_NN ,_, emissions_NNS from_IN roads_NNS from_IN a_DT combination_NN of_IN traffic_NN activity_NN data_NNS ,_, type_NN of_IN vehicle_NN ,_, railways_NNS ,_, airports_NNS ,_, industry_NN and_CC domestic_JJ heating_NN -RRB-_-RRB- 
For_IN people_NNS living_VBG very_RB close_RB to_TO main_JJ roads_NNS ,_, proximity_NN to_TO the_DT road_NN may_MD be_VB a_DT better_JJR determinant_NN of_IN exposure_NN than_IN modelled_JJ levels_NNS ._. 
People_NNS living_VBG less_JJR than_IN 50_CD metres_NNS from_IN a_DT main_JJ road_NN have_VBP an_DT increased_VBN prevalence_NN of_IN coronary_JJ artery_NN calcification_NN ,_, a_DT predictor_NN of_IN coronary_JJ events_NNS 
Many_JJ studies_NNS have_VBP shown_VBN short-term_JJ associations_NNS between_IN air_NN pollution_NN levels_NNS and_CC cardiovascular_JJ events_NNS up_IN to_TO a_DT few_JJ weeks_NNS later_RB 
5._CD 
6%_CD in_IN women_NNS per_IN 1_CD 
We_PRP used_VBD data_NNS on_IN adults_NNS participating_VBG in_IN 1994_CD ,_, 1998_CD and_CC 2003_CD ,_, years_NNS concentrating_VBG on_IN cardiovascular_JJ disease_NN and_CC its_PRP$ risk_NN factors_NNS ._. 
In_IN each_DT survey_NN year_NN ,_, adults_NNS were_VBD recruited_VBN using_VBG a_DT multistage_JJ sampling_NN strategy_NN designed_VBN to_TO generate_VB a_DT representative_JJ sample_NN of_IN the_DT English_JJ population_NN ._. 
Briefly_RB ,_, the_DT sampling_VBG units_NNS were_VBD single_JJ postcode_JJ sectors_NNS -LRB-_-LRB- each_DT containing_VBG around_IN 2500_CD addresses_NNS ;_: median_JJ area_NN about_IN 4_CD square_JJ kilometres_NNS -LRB-_-LRB- km_NN 2_CD -RRB-_-RRB- -RRB-_-RRB- ,_, except_IN where_WRB the_DT population_NN was_VBD very_RB sparse_JJ ,_, where_WRB they_PRP consisted_VBD of_IN two_CD or_CC more_JJR neighbouring_JJ sectors_NNS ._. 
We_PRP used_VBD data_NNS on_IN adults_NNS participating_VBG in_IN 1994_CD ,_, 1998_CD and_CC 2003_CD ,_, years_NNS concentrating_VBG on_IN cardiovascular_JJ disease_NN and_CC its_PRP$ risk_NN factors_NNS ._. 
In_IN each_DT survey_NN year_NN ,_, adults_NNS were_VBD recruited_VBN using_VBG a_DT multistage_JJ sampling_NN strategy_NN designed_VBN to_TO generate_VB a_DT representative_JJ sample_NN of_IN the_DT English_JJ population_NN ._. 
Briefly_RB ,_, the_DT sampling_VBG units_NNS were_VBD single_JJ postcode_JJ sectors_NNS -LRB-_-LRB- each_DT containing_VBG around_IN 2500_CD addresses_NNS ;_: median_JJ area_NN about_IN 4_CD square_JJ kilometres_NNS -LRB-_-LRB- km_NN 2_CD -RRB-_-RRB- -RRB-_-RRB- ,_, except_IN where_WRB the_DT population_NN was_VBD very_RB sparse_JJ ,_, where_WRB they_PRP consisted_VBD of_IN two_CD or_CC more_JJR neighbouring_JJ sectors_NNS ._. 
We_PRP considered_VBD people_NNS to_TO have_VB cardiovascular_JJ disease_NN if_IN they_PRP said_VBD that_IN they_PRP had_VBD had_VBN a_DT heart_NN attack_NN ,_, angina_NN or_CC stroke_NN that_WDT had_VBD been_VBN diagnosed_VBN by_IN a_DT doctor_NN ._. 
ExposuresWe_NNS have_VBP described_VBN methods_NNS for_IN assigning_VBG exposure_NN in_IN our_PRP$ previous_JJ publication_NN 
Acomparison_NNP of_IN modelled_JJ estimates_NNS with_IN independent_JJ data_NNS from_IN local_JJ authority_NN monitoring_NN sites_NNS showed_VBD good_JJ correlation_NN for_IN NO_DT 2_CD -LRB-_-LRB- r_NN 2_CD =_SYM 0_CD ._. 
85_CD -RRB-_-RRB- and_CC O3_NNP -LRB-_-LRB- r2_CD =_SYM 0_CD ._. 
81_CD 
32_CD 
We_PRP found_VBD strongly_RB positive_JJ associations_NNS between_IN particulate_JJ matter_NN and_CC cardiovascular_JJ disease_NN in_IN 2003_CD only_RB ,_, which_WDT highlights_VBZ the_DT importance_NN of_IN replicating_VBG findings_NNS in_IN more_JJR than_IN one_CD population_NN ._. 
BackgroundHigher_JJR outdoor_JJ particulate_NN concentration_NN is_VBZ associated_VBN with_IN increased_JJ cardiopulmonary_JJ deaths_NNS in_IN cohort_NN studies_NNS 
Moreover_RB ,_, some_DT of_IN the_DT most_RBS influential_JJ studies_NNS have_VBP found_VBN relationships_NNS between_IN cardiovascular_JJ mortality_NN and_CC PM_NNP 10_CD that_WDT are_VBP similar_JJ to_TO those_DT with_IN PM_NNP 2_CD ._. 
5_CD 
We_PRP found_VBD strongly_RB positive_JJ associations_NNS between_IN particulate_JJ matter_NN and_CC cardiovascular_JJ disease_NN in_IN 2003_CD only_RB ,_, which_WDT highlights_VBZ the_DT importance_NN of_IN replicating_VBG findings_NNS in_IN more_JJR than_IN one_CD population_NN ._. 
BackgroundHigher_JJR outdoor_JJ particulate_NN concentration_NN is_VBZ associated_VBN with_IN increased_JJ cardiopulmonary_JJ deaths_NNS in_IN cohort_NN studies_NNS 
Most_RBS commonly_RB ,_, researchers_NNS have_VBP used_VBN monitoring_VBG station_NN data_NNS to_TO assign_VB exposure_NN to_TO all_DT individuals_NNS living_VBG in_IN large_JJ areas_NNS ,_, which_WDT are_VBP likely_JJ to_TO reflect_VB individual_JJ exposure_NN poorly_RB ._. 
Other_JJ researchers_NNS have_VBP used_VBN population_NN density_NN 
Background_NN Higher_JJR outdoor_JJ particulate_NN concentration_NN is_VBZ associated_VBN with_IN increased_JJ cardiopulmonary_JJ deaths_NNS in_IN cohort_NN studies_NNS 
People_NNS living_VBG less_JJR than_IN 50_CD metres_NNS from_IN a_DT main_JJ road_NN have_VBP an_DT increased_VBN prevalence_NN of_IN coronary_JJ artery_NN calcification_NN ,_, a_DT predictor_NN of_IN coronary_JJ events_NNS 
The_DT UK_NNP Committee_NNP on_IN the_DT Medical_NNP Effects_NNPS of_IN Air_NNP Pollution_NNP has_VBZ estimated_VBN that_IN the_DT excess_JJ risk_NN of_IN cardiopulmonary_JJ death_NN associated_VBN with_IN a_DT 10_CD 
We_PRP assumed_VBD that_IN annual_JJ average_JJ pollutant_NN exposure_NN for_IN people_NNS living_VBG in_IN each_DT postcode_JJ sector_NN was_VBD that_IN of_IN the_DT 1_CD km_NN 2_CD where_WRB its_PRP$ centroid_NN was_VBD located_VBN ._. 
We_PRP estimated_VBD annual_JJ average_JJ background_NN exposure_NN to_TO PM10_NNP ,_, NO2_NNP ,_, SO2_NNP and_CC O3_NNP for_IN each_DT 1_CD km2_CD of_IN England_NNP using_VBG air_NN dispersion_NN models_NNS using_VBG meteorological_JJ parameters_NNS and_CC an_DT emission_NN inventory_NN ._. 
Additional_JJ file_NN 1_CD provides_VBZ further_JJ information_NN ._. 
Because_IN data_NNS collection_NN for_IN each_DT Health_NNP Survey_NNP is_VBZ carried_VBN out_RP over_IN the_DT whole_JJ year_NN and_CC part_NN of_IN the_DT following_JJ year_NN ,_, we_PRP averaged_VBD the_DT exposure_NN estimate_NN for_IN each_DT participant_NN for_IN each_DT pollutant_NN for_IN the_DT data_NNS collection_NN year_NN and_CC the_DT previous_JJ year_NN ,_, although_IN ,_, as_IN we_PRP did_VBD not_RB have_VB pollution_NN data_NNS for_IN 1993_CD ,_, for_IN 1994_CD we_PRP used_VBD annual_JJ averages_NNS for_IN 1994_CD only_RB ._. 
Our_PRP$ method_NN of_IN estimating_VBG individual_JJ exposure_NN to_TO outdoor_JJ air_NN pollutants_NNS may_MD be_VB more_RBR accurate_JJ because_IN it_PRP takes_VBZ account_NN many_JJ influences_NNS on_IN air_NN pollution_NN levels_NNS ._. 
We_PRP estimated_VBD exposure_NN using_VBG comprehensive_JJ emission_NN inventories_NNS combined_VBN with_IN air_NN dispersion_NN models_NNS taking_VBG into_IN account_NN meteorological_JJ information_NN ._. 
The_DT emission_NN inventories_NNS were_VBD constructed_VBN using_VBG information_NN on_IN any_DT influence_NN on_IN air_NN pollution_NN levels_NNS likely_JJ to_TO have_VB a_DT measurable_JJ effect_NN -LRB-_-LRB- including_VBG population_NN density_NN ,_, emissions_NNS from_IN roads_NNS from_IN a_DT combination_NN of_IN traffic_NN activity_NN data_NNS ,_, type_NN of_IN vehicle_NN ,_, railways_NNS ,_, airports_NNS ,_, industry_NN and_CC domestic_JJ heating_NN -RRB-_-RRB- 
Most_RBS commonly_RB ,_, researchers_NNS have_VBP used_VBN monitoring_VBG station_NN data_NNS to_TO assign_VB exposure_NN to_TO all_DT individuals_NNS living_VBG in_IN large_JJ areas_NNS ,_, which_WDT are_VBP likely_JJ to_TO reflect_VB individual_JJ exposure_NN poorly_RB ._. 
Other_JJ researchers_NNS have_VBP used_VBN population_NN density_NN 
This_DT highlights_VBZ the_DT importance_NN of_IN replicating_VBG findings_NNS in_IN more_JJR than_IN one_CD population_NN before_IN drawing_VBG firm_JJ conclusions_NNS ,_, and_CC the_DT pitfalls_NNS of_IN selective_JJ publication_NN ._. 
Publication_NN bias_NN has_VBZ been_VBN demonstrated_VBN in_IN studies_NNS of_IN short_JJ term_NN associations_NNS between_IN air_NN pollution_NN and_CC health_NN effects_NNS ._. 
The_DT UK_NNP Committee_NNP on_IN the_DT Medical_NNP Effects_NNPS of_IN Air_NNP Pollution_NNP has_VBZ estimated_VBN that_IN the_DT excess_JJ risk_NN of_IN cardiopulmonary_JJ death_NN associated_VBN with_IN a_DT 10_CD 
81_CD 
The_DT HVS3_NNP is_VBZ designed_VBN to_TO collect_VB particles_NNS 
Although_IN this_DT method_NN does_VBZ not_RB allow_VB for_IN the_DT estimation_NN of_IN chemical_NN loading_VBG ,_, it_PRP provides_VBZ a_DT simplified_VBN method_NN for_IN collecting_VBG dust_NN samples_NNS for_IN the_DT purpose_NN of_IN measuring_VBG pesticide_NN and_CC other_JJ chemical_NN concentrations_NNS ._. 
We_PRP previously_RB conducted_VBD a_DT small_JJ study_NN to_TO determine_VB whether_IN the_DT quality_NN of_IN the_DT chemical_NN concentration_NN data_NNS in_IN dust_NN samples_NNS collected_VBN from_IN used_JJ vacuum_NN cleaner_NN bags_NNS would_MD be_VB compromised_VBN by_IN variations_NNS in_IN peoples_NNS '_POS vacuuming_VBG equipment_NN and_CC practices_NNS and_CC by_IN the_DT repeated_JJ passage_NN of_IN air_NN through_IN the_DT dust_NN bag_NN during_IN multiple_JJ uses_NNS of_IN the_DT vacuum_NN ._. 
In_IN each_DT of_IN 15_CD homes_NNS ,_, we_PRP collected_VBD carpet_NN dust_NN samples_NNS using_VBG the_DT HVS3_NNP and_CC also_RB removed_VBD the_DT used_JJ bag_NN from_IN the_DT household_NN vacuum_NN ._. 
Carpets_NNS are_VBP repositories_NNS for_IN pesticides_NNS 
We_PRP used_VBD a_DT table_NN from_IN de_NNP Klerk_NNP et_FW al._FW ._. 
Finally_RB ,_, using_VBG the_DT analyte_JJ concentration_NN in_IN the_DT HVS3_NNP sample_NN as_IN the_DT Agold_NNP standard_NN ,_, @_IN we_PRP evaluated_VBD what_WDT effect_NN the_DT random_JJ measurement_NN error_NN introduced_VBN by_IN the_DT household_NN vacuum_NN sampling_NN method_NN would_MD have_VB on_IN the_DT estimate_NN of_IN relative_JJ risk_NN in_IN a_DT case-control_JJ study_NN ._. 
,in_NN which_WDT the_DT authors_NNS provide_VBP values_NNS for_IN observed_JJ relative_JJ risk_NN for_IN various_JJ combinations_NNS of_IN true_JJ relative_JJ risk_NN ,_, Pearson_NNP correlation_NN coefficient_NN ,_, and_CC anticipated_JJ method_NN of_IN calculating_VBG relative_JJ risk_NN ._. 
Four_CD methods_NNS for_IN calculating_VBG relative_JJ risk_NN are_VBP shown_VBN :_: logistic_JJ method_NN -LRB-_-LRB- odds_NNS ratio_NN per_IN unit_NN increment_NN in_IN a_DT logistic_JJ regression_NN model_NN -RRB-_-RRB- ,_, fixed_VBN value_NN method_NN -LRB-_-LRB- risk_NN of_IN some_DT fixed_VBN value_NN in_IN the_DT control_NN distribution_NN relative_JJ to_TO some_DT lower_JJR value_NN expressed_VBN in_IN terms_NNS of_IN the_DT variation_NN of_IN the_DT distribution_NN itself_PRP ,_, such_JJ as_IN the_DT risk_NN of_IN one_CD standard_JJ deviation_NN above_IN the_DT mean_NN relative_JJ to_TO the_DT mean_JJ value_NN -RRB-_-RRB- ,_, extreme_JJ quantile_JJ method_NN -LRB-_-LRB- risk_NN of_IN the_DT top_JJ quantile_JJ group_NN of_IN the_DT exposure_NN distribution_NN for_IN controls_NNS relative_JJ to_TO the_DT bottom_JJ quantile_JJ group_NN -RRB-_-RRB- ,_, and_CC median_JJ method_NN -LRB-_-LRB- risk_NN of_IN the_DT top_JJ half_NN of_IN the_DT exposure_NN distribution_NN among_IN controls_NNS relative_JJ to_TO the_DT bottom_JJ half_NN -RRB-_-RRB- ._. 
Background_NN Pesticides_NNS may_MD enter_VB the_DT home_NN from_IN indoor_JJ use_NN ,_, track-in_NN or_CC drift_NN from_IN outdoors_NNS ,_, or_CC take-home_JJ contamination_NN from_IN occupational_JJ use_NN 
Pesticides_NNS may_MD persist_VB for_IN long_JJ periods_NNS of_IN time_NN inside_IN the_DT home_NN ,_, where_WRB they_PRP are_VBP protected_VBN from_IN degradation_NN by_IN sunlight_NN ,_, rain_NN ,_, temperature_NN extremes_NNS ,_, and_CC most_RBS microbial_JJ action_NN 
Young_JJ children_NNS ,_, who_WP spend_VBP a_DT large_JJ proportion_NN of_IN time_NN on_IN the_DT floor_NN and_CC who_WP frequently_RB put_VBP hands_NNS and_CC objects_NNS in_IN their_PRP$ mouths_NNS ,_, are_VBP at_IN particularly_RB high_JJ risk_NN of_IN exposure_NN to_TO pesticides_NNS in_IN carpet_NN dust_NN ._. 
The_DT possible_JJ health_NN effects_NNS of_IN such_JJ exposures_NNS have_VBP been_VBN investigated_VBN in_IN epidemiologic_JJ studies_NNS using_VBG a_DT variety_NN of_IN exposure_NN assessment_NN techniques_NNS ,_, including_VBG use_NN of_IN a_DT specially-designed_JJ vacuum_NN cleaner_NN called_VBD the_DT high-volume_JJ surface_NN sampler_NN -LRB-_-LRB- HVS3_NNP ,_, Cascade_NNP Sampling_NNP Systems_NNP ,_, Bend_NNP ,_, Oregon_NNP -RRB-_-RRB- 
Pesticides_NNS may_MD persist_VB for_IN long_JJ periods_NNS of_IN time_NN inside_IN the_DT home_NN ,_, where_WRB they_PRP are_VBP protected_VBN from_IN degradation_NN by_IN sunlight_NN ,_, rain_NN ,_, temperature_NN extremes_NNS ,_, and_CC most_RBS microbial_JJ action_NN 
Several_JJ large_JJ epidemiology_NN and_CC exposure_NN studies_NNS have_VBP collected_VBN carpet_NN dust_NN samples_NNS for_IN analysis_NN for_IN pesticides_NNS and_CC other_JJ compounds_NNS ,_, including_VBG the_DT Long_NNP Island_NNP Breast_NNP Cancer_NNP Study_NNP 
Carpets_NNS are_VBP repositories_NNS for_IN pesticides_NNS 
Conclusion_NN The_DT household_NN vacuum_NN cleaner_NN method_NN appears_VBZ to_TO be_VB a_DT reasonable_JJ alternative_NN to_TO the_DT HVS3_NNP for_IN detecting_VBG ,_, ranking_NN ,_, and_CC quantifying_VBG the_DT concentrations_NNS of_IN pesticides_NNS and_CC other_JJ compounds_NNS in_IN carpet_NN dust_NN ._. 
BackgroundPesticides_NNS may_MD enter_VB the_DT home_NN from_IN indoor_JJ use_NN ,_, track-in_NN or_CC drift_NN from_IN outdoors_NNS ,_, or_CC take-home_JJ contamination_NN from_IN occupational_JJ use_NN 
Carpets_NNS are_VBP repositories_NNS for_IN pesticides_NNS 
Conclusion_NN The_DT household_NN vacuum_NN cleaner_NN method_NN appears_VBZ to_TO be_VB a_DT reasonable_JJ alternative_NN to_TO the_DT HVS3_NNP for_IN detecting_VBG ,_, ranking_NN ,_, and_CC quantifying_VBG the_DT concentrations_NNS of_IN pesticides_NNS and_CC other_JJ compounds_NNS in_IN carpet_NN dust_NN ._. 
BackgroundPesticides_NNS may_MD enter_VB the_DT home_NN from_IN indoor_JJ use_NN ,_, track-in_NN or_CC drift_NN from_IN outdoors_NNS ,_, or_CC take-home_JJ contamination_NN from_IN occupational_JJ use_NN 
The_DT HVS3_NNP is_VBZ designed_VBN to_TO collect_VB particles_NNS 
The_DT second_JJ study_NN was_VBD conducted_VBN in_IN Fresno_NNP County_NNP ,_, CA_NNP ._. 
Beginning_VBG in_IN 2001_CD ,_, interviewed_VBD cases_NNS and_CC controls_NNS under_IN 8_CD years_NNS old_JJ who_WP were_VBD living_VBG at_IN the_DT home_NN they_PRP occupied_VBD at_IN the_DT time_NN of_IN diagnosis_NN -LRB-_-LRB- or_CC a_DT similar_JJ reference_NN date_NN for_IN controls_NNS -RRB-_-RRB- were_VBD eligible_JJ for_IN a_DT second_JJ home_NN visit_NN in_IN which_WDT we_PRP collected_VBD detailed_JJ information_NN on_IN home_NN and_CC garden_NN pesticide_NN use_NN ,_, inventoried_VBD pesticides_NNS in_IN storage_NN ,_, and_CC collected_VBN carpet_NN dust_NN samples_NNS using_VBG the_DT HVS3_NNP and_CC from_IN household_NN vacuum_NN cleaners_NNS ._. 
It_PRP was_VBD designed_VBN to_TO examine_VB the_DT validity_NN of_IN agricultural_JJ metrics_NNS for_IN estimating_VBG exposure_NN to_TO pesticides_NNS in_IN residences_NNS located_VBN near_IN crops_NNS ._. 
Carpet_NN dust_NN samples_NNS were_VBD collected_VBN using_VBG both_DT methods_NNS ,_, and_CC interviewers_NNS obtained_VBD information_NN on_IN home_NN and_CC garden_NN pesticide_NN use_NN and_CC occupational_JJ pesticide_NN exposure_NN ._. 
Pesticides_NNS may_MD persist_VB for_IN long_JJ periods_NNS of_IN time_NN inside_IN the_DT home_NN ,_, where_WRB they_PRP are_VBP protected_VBN from_IN degradation_NN by_IN sunlight_NN ,_, rain_NN ,_, temperature_NN extremes_NNS ,_, and_CC most_RBS microbial_JJ action_NN 
Pesticides_NNS may_MD persist_VB for_IN long_JJ periods_NNS of_IN time_NN inside_IN the_DT home_NN ,_, where_WRB they_PRP are_VBP protected_VBN from_IN degradation_NN by_IN sunlight_NN ,_, rain_NN ,_, temperature_NN extremes_NNS ,_, and_CC most_RBS microbial_JJ action_NN 
Methods_NNP Study_NNP households_NNS We_PRP selected_VBD households_NNS from_IN two_CD ongoing_JJ studies_NNS ._. 
It_PRP also_RB addresses_VBZ two_CD limitations_NNS of_IN the_DT previous_JJ study_NN by_IN increasing_VBG the_DT sample_NN size_NN and_CC adding_VBG agricultural_JJ pesticides_NNS and_CC metals_NNS to_TO the_DT list_NN of_IN measured_JJ compounds_NNS ._. 
One_CD is_VBZ a_DT case-control_JJ study_NN of_IN childhood_NN leukemia_NN in_IN Northern_NNP California_NNP -LRB-_-LRB- the_DT Northern_NNP California_NNP Childhood_NNP Leukemia_NNP Study_NNP -RRB-_-RRB- ,_, which_WDT includes_VBZ 17_CD counties_NNS in_IN the_DT San_NNP Francisco_NNP Bay_NNP area_NN and_CC 18_CD counties_NNS in_IN the_DT Central_NNP Valley_NNP ,_, as_IN described_VBN previously_RB 
Young_JJ children_NNS ,_, who_WP spend_VBP a_DT large_JJ proportion_NN of_IN time_NN on_IN the_DT floor_NN and_CC who_WP frequently_RB put_VBP hands_NNS and_CC objects_NNS in_IN their_PRP$ mouths_NNS ,_, are_VBP at_IN particularly_RB high_JJ risk_NN of_IN exposure_NN to_TO pesticides_NNS in_IN carpet_NN dust_NN ._. 
The_DT possible_JJ health_NN effects_NNS of_IN such_JJ exposures_NNS have_VBP been_VBN investigated_VBN in_IN epidemiologic_JJ studies_NNS using_VBG a_DT variety_NN of_IN exposure_NN assessment_NN techniques_NNS ,_, including_VBG use_NN of_IN a_DT specially-designed_JJ vacuum_NN cleaner_NN called_VBD the_DT high-volume_JJ surface_NN sampler_NN -LRB-_-LRB- HVS3_NNP ,_, Cascade_NNP Sampling_NNP Systems_NNP ,_, Bend_NNP ,_, Oregon_NNP -RRB-_-RRB- 
Previous_JJ evidence_NN of_IN parasitic_JJ helminths_NNS acting_VBG as_IN vectors_NNS does_VBZ exist_VB ._. 
As_IN such_JJ ,_, helminths_NNS may_MD provide_VB an_DT additional_JJ method_NN of_IN pathogen_NN transmission_NN between_IN hosts_NNS and_CC may_MD confer_VB protection_NN from_IN the_DT environment_NN to_TO the_DT bacteria_NNS ,_, in_IN a_DT manner_NN similar_JJ to_TO observations_NNS upon_IN free-living_JJ non-parasitic_JJ helminths_NNS 
Despite_IN evidence_NN that_IN parasitic_JJ helminths_NNS can_MD harbor_VB pathogens_NNS and_CC that_IN these_DT can_MD lead_VB to_TO host_NN infection_NN there_EX is_VBZ a_DT paucity_NN of_IN studies_NNS that_WDT have_VBP investigated_VBN the_DT range_NN of_IN bacterial_JJ pathogens_NNS associated_VBN with_IN parasitic_JJ helminths_NNS ._. 
Considering_VBG how_WRB common_JJ helminth_NN infection_NN is_VBZ and_CC the_DT consequences_NNS for_IN host_NN health_NN of_IN helminth_NN vectoring_VBG there_EX is_VBZ a_DT clear_JJ need_NN for_IN further_JJ studies_NNS of_IN this_DT type_NN ._. 
We_PRP have_VBP shown_VBN a_DT range_NN of_IN animal_NN -LRB-_-LRB- and_CC human_JJ -RRB-_-RRB- pathogens_NNS are_VBP found_VBN internally_RB to_TO different_JJ parasitic_JJ helminth_NN species_NNS that_WDT were_VBD cultured_VBN from_IN host_NN feaces_NNS ,_, indicating_VBG that_IN they_PRP have_VBP the_DT potential_NN to_TO vector_NN bacteria_NNS to_TO their_PRP$ hosts_NNS ,_, or_CC to_TO perpetuate_VB bacteria_NNS in_IN the_DT environment_NN ._. 
Parasitic_JJ helminths_NNS are_VBP more_RBR intimately_RB associated_VBN with_IN bacterial_JJ pathogens_NNS than_IN the_DT non-parasitic_JJ helminths_NNS ._. 
For_IN example_NN ,_, they_PRP are_VBP often_RB found_VBN in_IN a_DT host_NN alongside_IN a_DT concomitant_JJ pathogen_NN infection_NN ._. 
Additionally_RB ,_, many_JJ parasitic_JJ helminth_NN species_NNS have_VBP a_DT free-living_JJ stage_NN in_IN the_DT environment_NN and_CC are_VBP in_IN direct_JJ contact_NN with_IN bacterial_JJ pathogens_NNS that_WDT are_VBP excreted_VBN from_IN infected_JJ hosts_NNS ._. 
Parasitic_JJ helminths_NNS are_VBP more_RBR intimately_RB associated_VBN with_IN bacterial_JJ pathogens_NNS than_IN the_DT non-parasitic_JJ helminths_NNS ._. 
For_IN example_NN ,_, they_PRP are_VBP often_RB found_VBN in_IN a_DT host_NN alongside_IN a_DT concomitant_JJ pathogen_NN infection_NN ._. 
Additionally_RB ,_, many_JJ parasitic_JJ helminth_NN species_NNS have_VBP a_DT free-living_JJ stage_NN in_IN the_DT environment_NN and_CC are_VBP in_IN direct_JJ contact_NN with_IN bacterial_JJ pathogens_NNS that_WDT are_VBP excreted_VBN from_IN infected_JJ hosts_NNS ._. 
Additionally_RB ,_, Mycobacterium_NN avium_NN has_VBZ been_VBN isolated_VBN from_IN helminths_NNS cultured_VBN from_IN fecal_JJ samples_NNS of_IN hosts_NNS that_WDT were_VBD simultaneously_RB co-infected_JJ with_IN both_DT helminths_NNS and_CC Mycobacterium_NN avium_NN 
Regardless_RB of_IN whether_IN the_DT bacterial_JJ isolates_VBZ were_VBD pathogens_NNS or_CC commensals_NNS it_PRP remains_VBZ that_IN bacteria_NNS can_MD survive_VB within_IN helminths_NNS ._. 
As_IN such_JJ ,_, helminths_NNS may_MD provide_VB an_DT additional_JJ method_NN of_IN pathogen_NN transmission_NN between_IN hosts_NNS and_CC may_MD confer_VB protection_NN from_IN the_DT environment_NN to_TO the_DT bacteria_NNS ,_, in_IN a_DT manner_NN similar_JJ to_TO observations_NNS upon_IN free-living_JJ non-parasitic_JJ helminths_NNS 
Parasitic_JJ helminths_NNS of_IN plants_NNS are_VBP well_RB known_VBN vectors_NNS of_IN a_DT range_NN of_IN plant_NN pathogens_NNS ,_, but_CC less_RBR studied_VBN are_VBP examples_NNS of_IN parasitic_JJ helminths_NNS of_IN vertebrates_NNS as_IN vectors_NNS of_IN pathogens_NNS -LRB-_-LRB- but_CC see_VBP for_IN a_DT review_NN -RRB-_-RRB- ._. 
The_DT discovery_NN of_IN plant_NN helminth_NN vectors_NNS has_VBZ prompted_VBN some_DT experimental_JJ work_NN with_IN helminths_NNS of_IN vertebrate_JJ hosts_NNS ,_, and_CC facultative_JJ vectoring_NN of_IN pathogens_NNS through_IN experimental_JJ infection_NN of_IN naive_JJ hosts_NNS with_IN pathogen-infected_JJ helminths_NNS was_VBD documented_VBN 
Whole_JJ homogenates_NNS were_VBD plated_VBN onto_IN blood_NN agar_NN plates_NNS and_CC the_DT colonies_NNS grown_VBN after_IN 24_CD h_NN incubation_NN at_IN 37_CD 
One_CD hypothesis_NN that_WDT is_VBZ under_IN investigation_NN is_VBZ that_IN free-living_JJ helminths_NNS ,_, ubiquitous_JJ and_CC numerous_JJ in_IN the_DT environment_NN alongside_IN pathogens_NNS may_MD be_VB a_DT vector_NN ,_, or_CC reservoir_NN ,_, of_IN bacterial_JJ pathogens_NNS ._. 
Evidence_NN supporting_VBG the_DT role_NN of_IN Caenorhabditis_NNP elegans_NNS ,_, a_DT common_JJ laboratory_NN model_NN system_NN ,_, and_CC other_JJ free-living_JJ helminths_NNS ,_, as_IN potential_JJ vectors_NNS of_IN pathogens_NNS include_VBP a_DT number_NN of_IN studies_NNS that_WDT have_VBP found_VBN bacteria_NNS to_TO survive_VB internally_RB to_TO the_DT helminth_NN and_CC to_TO have_VB increased_VBN survival_NN ,_, Figure_NNP 1_CD -RRB-_-RRB- ._. 
Additionally_RB ,_, ingestion_NN of_IN C._NNP elegans_NNS has_VBZ been_VBN shown_VBN to_TO cause_VB systemic_JJ infection_NN in_IN vertebrate_JJ hosts_NNS ,_, suggesting_VBG that_IN ,_, given_VBN sufficient_JJ numbers_NNS ,_, they_PRP can_MD be_VB vectors_NNS of_IN food-borne_JJ pathogens_NNS 
Additionally_RB ,_, ingestion_NN of_IN C._NNP Evidence_NN supporting_VBG the_DT role_NN of_IN Caenorhabditis_NNP elegans_NNS ,_, a_DT common_JJ laboratory_NN model_NN system_NN ,_, and_CC other_JJ free-living_JJ helminths_NNS ,_, as_IN potential_JJ vectors_NNS of_IN pathogens_NNS include_VBP a_DT number_NN of_IN studies_NNS that_WDT have_VBP found_VBN bacteria_NNS to_TO survive_VB internally_RB to_TO the_DT helminth_NN and_CC to_TO have_VB increased_VBN survival_NN ,_, Figure_NNP 1_CD -RRB-_-RRB- ._. 
elegans_NNS has_VBZ been_VBN shown_VBN to_TO cause_VB systemic_JJ infection_NN in_IN vertebrate_JJ hosts_NNS ,_, suggesting_VBG that_IN ,_, given_VBN sufficient_JJ numbers_NNS ,_, they_PRP can_MD be_VB vectors_NNS of_IN food-borne_JJ pathogens_NNS 
Regardless_RB of_IN whether_IN the_DT bacterial_JJ isolates_VBZ were_VBD pathogens_NNS or_CC commensals_NNS it_PRP remains_VBZ that_IN bacteria_NNS can_MD survive_VB within_IN helminths_NNS ._. 
As_IN such_JJ ,_, helminths_NNS may_MD provide_VB an_DT additional_JJ method_NN of_IN pathogen_NN transmission_NN between_IN hosts_NNS and_CC may_MD confer_VB protection_NN from_IN the_DT environment_NN to_TO the_DT bacteria_NNS ,_, in_IN a_DT manner_NN similar_JJ to_TO observations_NNS upon_IN free-living_JJ non-parasitic_JJ helminths_NNS 
During_IN this_DT development_NN period_NN the_DT helminths_NNS are_VBP associated_VBN with_IN bacteria_NNS in_IN the_DT environment_NN ._. 
Direct_JJ life_NN cycle_NN parasitic_NN helminths_NNS are_VBP excreted_VBN with_IN the_DT host_NN faeces_NNS as_IN eggs_NNS and_CC ,_, after_IN a_DT short_JJ period_NN of_IN approximately_RB a_DT few_JJ days_NNS ,_, develop_VB into_IN free-living_JJ larval_JJ helminths_NNS ready_JJ to_TO infect_VB a_DT susceptible_JJ host_NN ._. 
Given_VBN the_DT long_JJ evolutionary_JJ history_NN and_CC sympatric_JJ distribution_NN of_IN gastro-intestinal_JJ bacterial_JJ pathogens_NNS and_CC parasitic_JJ helminths_NNS both_DT inside_IN the_DT host_NN and_CC in_IN the_DT environment_NN it_PRP would_MD be_VB surprising_JJ if_IN helminths_NNS were_VBD not_RB associated_VBN with_IN pathogens_NNS ._. 
To_TO determine_VB whether_IN parasitic_JJ helminths_NNS act_VBP as_IN vectors_NNS for_IN bacterial_JJ pathogens_NNS in_IN human_JJ and_CC animal_JJ hosts_NNS ,_, the_DT first_JJ step_NN is_VBZ to_TO investigate_VB whether_IN parasitic_JJ helminths_NNS carry_VBP viable_JJ pathogenic_JJ bacteria_NNS ._. 
Further_JJ work_NN is_VBZ required_VBN to_TO assess_VB the_DT epidemiological_JJ impact_NN of_IN this_DT finding_NN ._. 
The_DT potential_NN for_IN helminths_NNS to_TO play_VB a_DT role_NN as_IN pathogen_NN vectors_NNS poses_VBZ a_DT potential_JJ livestock_NN and_CC human_JJ health_NN risk_NN ._. 
24_CD 
24_CD 
One_CD hypothesis_NN that_WDT is_VBZ under_IN investigation_NN is_VBZ that_IN free-living_JJ helminths_NNS ,_, ubiquitous_JJ and_CC numerous_JJ in_IN the_DT environment_NN alongside_IN pathogens_NNS may_MD be_VB a_DT vector_NN ,_, or_CC reservoir_NN ,_, of_IN bacterial_JJ pathogens_NNS ._. 
Evidence_NN supporting_VBG the_DT role_NN of_IN Caenorhabditis_NNP elegans_NNS ,_, a_DT common_JJ laboratory_NN model_NN system_NN ,_, and_CC other_JJ free-living_JJ helminths_NNS ,_, as_IN potential_JJ vectors_NNS of_IN pathogens_NNS include_VBP a_DT number_NN of_IN studies_NNS that_WDT have_VBP found_VBN bacteria_NNS to_TO survive_VB internally_RB to_TO the_DT helminth_NN and_CC to_TO have_VB increased_VBN survival_NN ,_, Figure_NNP 1_CD -RRB-_-RRB- ._. 
Additionally_RB ,_, ingestion_NN of_IN C._NNP elegans_NNS has_VBZ been_VBN shown_VBN to_TO cause_VB systemic_JJ infection_NN in_IN vertebrate_JJ hosts_NNS ,_, suggesting_VBG that_IN ,_, given_VBN sufficient_JJ numbers_NNS ,_, they_PRP can_MD be_VB vectors_NNS of_IN food-borne_JJ pathogens_NNS 
Discussion_NN and_CC conclusion_NN This_DT study_NN was_VBD a_DT qualitative_JJ survey_NN to_TO show_VB proof_NN of_IN principle_NN that_IN parasitic_JJ helminths_NNS may_MD act_VB as_IN vectors_NNS for_IN viable_JJ bacteria_NNS and_CC ,_, in_IN the_DT case_NN of_IN pathogens_NNS ,_, present_VBP a_DT reservoir_NN or_CC vector_NN for_IN the_DT transmission_NN of_IN pathogens_NNS between_IN hosts_NNS ._. 
The_DT bacteria_NNS isolated_VBD from_IN the_DT helminths_NNS included_VBD one_CD pathogen_NN of_IN both_DT cattle_NNS and_CC sheep_NN ,_, although_IN the_DT pathogenicity_NN to_TO livestock_NN of_IN most_JJS isolates_VBZ was_VBD unknown_JJ ._. 
Regardless_RB of_IN whether_IN the_DT bacterial_JJ isolates_VBZ were_VBD pathogens_NNS or_CC commensals_NNS it_PRP remains_VBZ that_IN bacteria_NNS can_MD survive_VB within_IN helminths_NNS ._. 
Additionally_RB ,_, Mycobacterium_NN avium_NN has_VBZ been_VBN isolated_VBN from_IN helminths_NNS cultured_VBN from_IN fecal_JJ samples_NNS of_IN hosts_NNS that_WDT were_VBD simultaneously_RB co-infected_JJ with_IN both_DT helminths_NNS and_CC Mycobacterium_NN avium_NN 
elegans_NNS and_CC can_MD be_VB clearly_RB seen_VBN in_IN the_DT intestine_NN ._. 
Bacteria_NNS were_VBD externally_RB removed_VBN from_IN the_DT C._NNP A_NNP fluorescent_JJ microscopy_NN image_NN of_IN the_DT free-living_JJ helminth_JJ Ceanorhabitis_NNP elegans_NNS that_WDT had_VBD fed_VBN ,_, for_IN 36_CD hours_NNS ,_, on_IN a_DT lawn_NN of_IN Salmonella_NNP Typhimurium_NNP that_WDT are_VBP expressing_VBG green_JJ fluorescent_JJ protein_NN -LRB-_-LRB- GFP_NNP -RRB-_-RRB- ,_, so_IN that_IN the_DT bacteria_NNS emitted_VBD phosphorescent_JJ light_NN ._. 
Numerous_JJ and_CC ubiquitous_JJ in_IN the_DT environment_NN ,_, alongside_IN the_DT non-parasitic_JJ helminths_NNS are_VBP the_DT parasitic_JJ helminths_NNS ,_, ranging_VBG in_IN density_NN from_IN 100_CD 's_POS to_TO 10,000_CD 's_POS per_IN kilogram_NN of_IN dry_JJ herbage_NN 
Numerous_JJ and_CC ubiquitous_JJ in_IN the_DT environment_NN ,_, alongside_IN the_DT non-parasitic_JJ helminths_NNS are_VBP the_DT parasitic_JJ helminths_NNS ,_, ranging_VBG in_IN density_NN from_IN 100_CD 's_POS to_TO 10,000_CD 's_POS per_IN kilogram_NN of_IN dry_JJ herbage_NN 
The_DT discovery_NN of_IN plant_NN helminth_NN vectors_NNS has_VBZ prompted_VBN some_DT experimental_JJ work_NN with_IN helminths_NNS of_IN vertebrate_JJ hosts_NNS ,_, and_CC facultative_JJ vectoring_NN of_IN pathogens_NNS through_IN experimental_JJ infection_NN of_IN naive_JJ hosts_NNS with_IN pathogen-infected_JJ helminths_NNS was_VBD documented_VBN 
Faeces_NNS were_VBD cultured_VBN at_IN 25_CD 
have_VBP shown_VBN overrepresentation_NN of_IN the_DT DQB1_NNP \*_NN 0503_CD allele_NN among_IN subjects_NNS with_IN TDI-induced_JJ asthma_NN ._. 
Tumor_NN necrosis_NN factor_NN alfa_NN -LRB-_-LRB- TNF_NNP -RRB-_-RRB- is_VBZ chronically_RB expressed_VBN in_IN TDI-induced_JJ asthma_NN 
have_VBP shown_VBN overrepresentation_NN of_IN the_DT DQB1_NNP \*_NN 0503_CD allele_NN among_IN subjects_NNS with_IN TDI-induced_JJ asthma_NN ._. 
Tumor_NN necrosis_NN factor_NN alfa_NN -LRB-_-LRB- TNF_NNP -RRB-_-RRB- is_VBZ chronically_RB expressed_VBN in_IN TDI-induced_JJ asthma_NN 
Proof_NN for_IN neutrophilic_JJ activation_NN in_IN occupational_JJ asthma_NN has_VBZ been_VBN reported_VBN ._. 
Aperoxidase-catalysed_JJ mechanism_NN ,_, possibly_RB through_IN myeloperoxidase_NN -LRB-_-LRB- MPO_NNP -RRB-_-RRB- in_IN neutrophiles_NNS ,_, to_TO activate_VB arylamines_NNS has_VBZ been_VBN suggested_VBN 
Mapp_FW et_FW al._FW ._. 
The_DT HLA_NNP class_NN II_NNP molecules_NNS are_VBP involved_VBN in_IN the_DT immune_JJ responses_NNS as_IN they_PRP bind_NN antigen-derived_JJ peptides_NNS and_CC present_VB them_PRP to_TO lymphocytes_NNS via_IN the_DT T-cell_JJ receptor_NN ._. 
have_VBP shown_VBN overrepresentation_NN of_IN the_DT DQB1_NNP \*_NN 0503_CD allele_NN among_IN subjects_NNS with_IN TDI-induced_JJ asthma_NN ._. 
Tumor_NN necrosis_NN factor_NN alfa_NN -LRB-_-LRB- TNF_NNP -RRB-_-RRB- is_VBZ chronically_RB expressed_VBN in_IN TDI-induced_JJ asthma_NN 
Mapp_FW et_FW al._FW ._. 
Compared_VBN to_TO the_DT \*_NN 0501_CD allele_NN ,_, the_DT \*_NN 0502_CD has_VBZ an_DT exchange_NN of_IN a_DT valine_NN to_TO a_DT serine_NN at_IN amino_JJ acid_JJ position_NN 57_CD in_IN the_DT beta_JJ chain_NN of_IN HLA_NNP class_NN II_NNP molecules_NNS ._. 
have_VBP found_VBN an_DT increased_VBN risk_NN of_IN asthma_NN for_IN \*_NN 0503_CD carriers_NNS -LRB-_-LRB- in_IN \*_NN 0503_CD ,_, valine_NN is_VBZ substituted_VBN with_IN aspartic_JJ acid_NN at_IN position_NN 57_CD -RRB-_-RRB- ,_, which_WDT we_PRP were_VBD unable_JJ to_TO analyze_VB ,_, due_JJ to_TO low_JJ number_NN of_IN study_NN subjects_NNS carrying_VBG this_DT allele_NN ._. 
In_IN contrast_NN to_TO Mapp_NNP ,_, we_PRP did_VBD not_RB find_VB a_DT protective_JJ effect_NN for_IN carriers_NNS of_IN DQB1_CD \*_NN 0501_CD 
have_VBP found_VBN an_DT increased_VBN risk_NN of_IN asthma_NN for_IN \*_NN 0503_CD carriers_NNS -LRB-_-LRB- in_IN \*_NN 0503_CD ,_, valine_NN is_VBZ substituted_VBN with_IN aspartic_JJ acid_NN at_IN position_NN 57_CD -RRB-_-RRB- ,_, which_WDT we_PRP were_VBD unable_JJ to_TO analyze_VB ,_, due_JJ to_TO low_JJ number_NN of_IN study_NN subjects_NNS carrying_VBG this_DT allele_NN ._. 
In_IN contrast_NN to_TO Mapp_NNP ,_, we_PRP did_VBD not_RB find_VB a_DT protective_JJ effect_NN for_IN carriers_NNS of_IN DQB1_CD \*_NN 0501_CD 
GSTs_NNS are_VBP not_RB involved_VBN in_IN TDI-related_JJ airway_NN obstruction_NN ._. 
e._IN One_CD possibility_NN is_VBZ that_IN these_DT symptoms_NNS are_VBP caused_VBN by_IN different_JJ mechanisms_NNS among_IN exposed_JJ and_CC non-exposed_JJ individuals_NNS ,_, i._NN Piiril_NN 
Aperoxidase-catalysed_JJ mechanism_NN ,_, possibly_RB through_IN myeloperoxidase_NN -LRB-_-LRB- MPO_NNP -RRB-_-RRB- in_IN neutrophiles_NNS ,_, to_TO activate_VB arylamines_NNS has_VBZ been_VBN suggested_VBN 
Proof_NN for_IN neutrophilic_JJ activation_NN in_IN occupational_JJ asthma_NN has_VBZ been_VBN reported_VBN ._. 
Aperoxidase-catalysed_JJ mechanism_NN ,_, possibly_RB through_IN myeloperoxidase_NN -LRB-_-LRB- MPO_NNP -RRB-_-RRB- in_IN neutrophiles_NNS ,_, to_TO activate_VB arylamines_NNS has_VBZ been_VBN suggested_VBN 
These_DT plants_NNS are_VBP described_VBN in_IN detail_NN in_IN Sennbro_NNP et_FW al._FW ._. 
Materials_NNPS and_CC methods_NNS Plants_NNS and_CC exposure_NN The_DT study_NN encompassed_VBD eleven_CD plants_NNS in_IN the_DT southern_JJ part_NN of_IN Sweden_NNP ._. 
The_DT non-exposed_JJ group_NN has_VBZ been_VBN described_VBN in_IN more_JJR detail_NN in_IN Sennbro_NNP et_FW al._FW ._. 
The_DT median_JJ age_NN in_IN the_DT exposed_JJ group_NN was_VBD 36_CD years_NNS -LRB-_-LRB- range_NN 18_CD 
82_CD -RRB-_-RRB- ;_: 2,6-TDA_NNP median_NN LOD_NNP nmol\/L_NNP 
The_DT -308_CD G\/A_NNP variant_NN has_VBZ been_VBN shown_VBN to_TO be_VB associated_VBN with_IN elevated_JJ plasma_NN TNF_NNP levels_NNS and_CC with_IN higher_JJR amounts_NNS of_IN TNF_NNP upon_IN stimulation_NN 
The_DT -863_CD C\/A_NNP variant_NN is_VBZ associated_VBN with_IN reduced_JJ circulating_VBG levels_NNS of_IN TNF_NNP 
No_DT such_JJ effects_NNS were_VBD observed_VBN for_IN benzo_NN -LRB-_-LRB- a_DT -RRB-_-RRB- pyrene_NN ._. 
The_DT difference_NN between_IN the_DT wild_JJ type_NN Ile_NNP and_CC the_DT Val_NNP variant_NN appears_VBZ to_TO depend_VB on_IN the_DT substrate_NN :_: when_WRB the_DT enzyme_NN contained_VBD Val_NNP ,_, ethoxyresorufin_NN exhibited_VBD a_DT mildly_RB elevated_JJ act_NN 
The_DT role_NN of_IN CYP1A1_NNP for_IN TDI-related_JJ effects_NNS of_IN the_DT eyes_NNS and_CC airways_NNS is_VBZ at_IN present_RB largely_RB unknown_JJ ._. 
There_EX are_VBP no_DT indications_NNS of_IN effect_NN of_IN the_DT Msp_NNP I_PRP variant_VBP alone_RB on_IN the_DT CYP1A1_NNP activity_NN 
However_RB ,_, the_DT role_NN of_IN CYP1A1_NNP for_IN TDI-asthma_NNP was_VBD unclear_JJ ,_, since_IN TDI_NNP seemed_VBD to_TO partly_RB inhibit_VB the_DT activity_NN of_IN CYP1A1_NNP ._. 
Elevated_JJ levels_NNS of_IN TNF_NNP are_VBP frequently_RB observed_VBN in_IN bronchoalveolar_JJ fluid_NN of_IN asthmatic_JJ subjects_NNS 
Elevated_JJ levels_NNS of_IN TNF_NNP are_VBP frequently_RB observed_VBN in_IN bronchoalveolar_JJ fluid_NN of_IN asthmatic_JJ subjects_NNS 
The_DT two_CD polymorphisms_NNS in_IN TNF_NNP -LRB-_-LRB- -308_CD G\/A_NNP and_CC -863_NNP C\/A_NNP -RRB-_-RRB- were_VBD analyzed_VBN with_IN matrix-assisted_JJ laser_NN desorption\/ionization_NN time-of-flight_NN -LRB-_-LRB- MALDI-TOF_NNP -RRB-_-RRB- mass_NN spectrometry_NN -LRB-_-LRB- Sequenom_NNP 
The_DT CYP1A1_NNP genotypes_NNS appeared_VBD to_TO modify_VB the_DT effect_NN of_IN TDI_NNP ._. 
Discussion_NN Gene-exposure_NN interaction_NN was_VBD observed_VBN for_IN symptoms_NNS of_IN the_DT eyes_NNS and_CC lower_JJR airways_NNS ,_, whereas_IN there_EX were_VBD no_DT strong_JJ indications_NNS of_IN interaction_NN for_IN nose_NN bleed_VB ._. 
Similar_JJ pattern_NN for_IN the_DT MspI_NNP -LRB-_-LRB- \*_SYM 2A_CD -RRB-_-RRB- variant_NN as_IN the_DT Val_NNP -LRB-_-LRB- \*_NN 2B_NN -RRB-_-RRB- variant_NN was_VBD found_VBN ,_, which_WDT probably_RB is_VBZ due_JJ to_TO linkage_NN between_IN these_DT two_CD polymorphisms_NNS ._. 
However_RB ,_, the_DT effect_NN was_VBD strongest_JJS for_IN \*_NN 2B_NN ,_, possibly_RB reflecting_VBG the_DT higher_JJR biological_JJ relevance_NN of_IN this_DT polymorphism_NN ._. 
The_DT difference_NN between_IN the_DT wild_JJ type_NN Ile_NNP and_CC the_DT Val_NNP variant_NN appears_VBZ to_TO depend_VB on_IN the_DT substrate_NN :_: when_WRB the_DT enzyme_NN contained_VBD Val_NNP ,_, ethoxyresorufin_NN exhibited_VBD a_DT mildly_RB elevated_JJ activity_NN ,_, and_CC estrogen_NN exhibited_VBD a_DT substantially_RB elevated_VBN activity_NN ._. 
No_DT such_JJ effects_NNS were_VBD observed_VBN for_IN benzo_NN -LRB-_-LRB- a_DT -RRB-_-RRB- pyrene_NN 
The_DT difference_NN between_IN the_DT wild_JJ type_NN Ile_NNP and_CC the_DT Val_NNP variant_NN appears_VBZ to_TO depend_VB on_IN the_DT substrate_NN :_: when_WRB the_DT enzyme_NN contained_VBD Val_NNP ,_, ethoxyresorufin_NN exhibited_VBD a_DT mildly_RB elevated_JJ activity_NN ,_, and_CC estrogen_NN exhibited_VBD a_DT substantially_RB elevated_VBN activity_NN ._. 
No_DT such_JJ effects_NNS were_VBD observed_VBN for_IN benzo_NN -LRB-_-LRB- a_DT -RRB-_-RRB- pyrene_NN 
Furthermore_RB ,_, in_IN contrast_NN to_TO Wikman_NNP ,_, we_PRP did_VBD not_RB select_VB asthma_NN cases_NNS but_CC rather_RB analyzed_VBD symptoms_NNS which_WDT may_MD be_VB early_JJ indicators_NNS of_IN asthma-related_JJ changes_NNS ._. 
The_DT -403_CD G\/A_NNP variant_NN of_IN CCL5_CD results_NNS in_IN a_DT new_JJ consensus_NN element_NN for_IN the_DT GATA_NNP transcription_NN factor_NN family_NN ,_, which_WDT suggests_VBZ a_DT role_NN in_IN the_DT regulation_NN of_IN gene_NN expression_NN ._. 
In_IN the_DT present_JJ study_NN ,_, the_DT CCL5_NNP genotype_NN appeared_VBD to_TO have_VB an_DT effect_NN on_IN the_DT risk_NN for_IN TDI-associated_JJ airway_NN symptoms_NNS such_JJ as_IN wheeze_NN etc._NN 
,since_IN both_DT Wikman_NNP 's_POS and_CC Piiril_NNP 
and_CC cough_NN with_IN mucus_NN :_: the_DT variant_JJ allele_NN was_VBD associated_VBN with_IN approximately_RB three_CD times_NNS higher_JJR risk_NN among_IN exposed_JJ ,_, suggesting_VBG a_DT CCL5-TDI_NNP interaction_NN ._. 
An_DT association_NN for_IN CCL5_NNP in_IN TDI-associated_JJ airway_NN symptoms_NNS is_VBZ also_RB suggested_VBN from_IN a_DT recent_JJ study_NN showing_VBG increased_VBN expression_NN of_IN CCL5_NNP in_IN vitro_NN in_IN bronchial_JJ epithelial_JJ cells_NNS when_WRB stimulated_VBN with_IN TDI_NNP ._. 
There_EX was_VBD also_RB evidence_NN for_IN association_NN of_IN HLA_NNP -_: DQB1_CD \*_NN 05_CD ,_, in_IN particular_JJ the_DT \*_NN 0502_CD allele_NN ,_, and_CC isocyanate-related_JJ symptoms_NNS of_IN the_DT lower_JJR airways_NNS ._. 
The_DT impact_NN of_IN TNF_NNP polymorphism_NN -LRB-_-LRB- -308_CD -RRB-_-RRB- on_IN TDI-asthma_NNP has_VBZ been_VBN analyzed_VBN in_IN a_DT recent_JJ study_NN by_IN Begh_NNP 
,since_IN both_DT Wikman_NNP 's_POS and_CC Piiril_NNP 
The_DT impact_NN of_IN TNF_NNP polymorphism_NN -LRB-_-LRB- -308_CD -RRB-_-RRB- on_IN TDI-asthma_NNP has_VBZ been_VBN analyzed_VBN in_IN a_DT recent_JJ study_NN by_IN Begh_NNP 
Thus_RB ,_, our_PRP$ results_NNS indicate_VBP that_IN genotypes_NNS associated_VBN with_IN low_JJ TNF_NNP circulating_VBG levels_NNS -LRB-_-LRB- -308_CD G_NNP and_CC -863_NNP A_NNP -RRB-_-RRB- may_MD be_VB linked_VBN to_TO symptoms_NNS in_IN the_DT TDI-exposed_JJ ._. 
The_DT impact_NN of_IN TNF_NNP polymorphism_NN -LRB-_-LRB- -308_CD -RRB-_-RRB- on_IN TDI-asthma_NNP has_VBZ been_VBN analyzed_VBN in_IN a_DT recent_JJ study_NN by_IN Begh_NNP 
For_IN the_DT MPO_NNP G-463A_NNP polymorphism_NN ,_, a_DT PCR\/RLFP_NNP method_NN with_IN Aci_NNP I_PRP was_VBD used_VBN ._. 
The_DT NAT2_NNP phenotype_NN was_VBD deduced_VBN from_IN the_DT genotype_NN and_CC subjects_NNS were_VBD classified_VBN as_IN slow_JJ -LRB-_-LRB- S_NNP =_SYM carriers_NNS of_IN two_CD mutations_NNS -RRB-_-RRB- ,_, intermediate_JJ -LRB-_-LRB- IM_NNP =_SYM carriers_NNS of_IN one_CD mutation_NN -RRB-_-RRB- or_CC rapid_JJ -LRB-_-LRB- R_NNP =_SYM carriers_NNS of_IN wild_JJ type_NN alleles_NNS only_RB -RRB-_-RRB- acetylators_NNS ._. 
The_DT SULT1A1_NNP ,_, Arg213His_NNP -LRB-_-LRB- R213H_NNP -RRB-_-RRB- was_VBD analyzed_VBN by_IN PCR\/RLFP_NNP using_VBG the_DT restriction_NN enzyme_NN Bsp143II_NNP to_TO distinguish_VB the_DT G_NNP and_CC A_NNP alleles_NNS according_VBG to_TO Engelke_NNP et_FW al_FW 
The_DT NAT2_NNP phenotype_NN was_VBD deduced_VBN from_IN the_DT genotype_NN and_CC subjects_NNS were_VBD classified_VBN as_IN slow_JJ -LRB-_-LRB- S_NNP =_SYM carriers_NNS of_IN two_CD mutations_NNS -RRB-_-RRB- ,_, intermediate_JJ -LRB-_-LRB- IM_NNP =_SYM carriers_NNS of_IN one_CD mutation_NN -RRB-_-RRB- or_CC rapid_JJ -LRB-_-LRB- R_NNP =_SYM carriers_NNS of_IN wild_JJ type_NN alleles_NNS only_RB -RRB-_-RRB- acetylators_NNS ._. 
For_IN the_DT MPO_NNP G-463A_NNP polymorphism_NN ,_, a_DT PCR\/RLFP_NNP method_NN with_IN AciI_NNP was_VBD used_VBN ._. 
The_DT SULT1A1_NNP ,_, Arg213His_NNP -LRB-_-LRB- R213H_NNP -RRB-_-RRB- was_VBD analyzed_VBN by_IN PCR\/RLFP_NNP using_VBG the_DT restriction_NN enzyme_NN Bsp143_NNP II_NNP to_TO distinguish_VB the_DT G_NNP and_CC A_NNP alleles_NNS according_VBG to_TO Engelke_NNP et_FW al_FW 
The_DT slow_JJ acetylator_NN alleles_VBZ NAT1_CD \*_NN 14_CD and_CC \*_SYM 15_CD were_VBD rare_JJ in_IN the_DT study_NN population_NN :_: there_EX were_VBD two_CD individuals_NNS carrying_VBG \*_NN 10_CD \*_NN 14_CD and_CC \*_SYM 10_CD \*_NN 15_CD and_CC four_CD individuals_NNS carrying_VBG \*_NN 4_CD \*_NN 14_CD and_CC all_DT were_VBD considered_VBN as_IN slow_JJ acetylators_NNS -LRB-_-LRB- S_NNP -RRB-_-RRB- ._. 
NAT2_CD polymorphisms_NNS -LRB-_-LRB- 341_CD T_SYM 
The_DT 3_CD bp_NN deletion_NN -LRB-_-LRB- intron_NN 6_CD -RRB-_-RRB- of_IN GSTM3_NNP was_VBD analyzed_VBN by_IN PCR\/RFLP_NNP using_VBG the_DT restriction_NN enzyme_NN Mnl_NNP I_PRP according_VBG to_TO Inskip_NNP et_FW al_FW ._. 
Five_CD different_JJ SNPs_NNS in_IN the_DT NAT1_NNP gene_NN ,_, 559_CD C_NNP 
When_WRB combining_VBG the_DT genotypes_NNS at_IN both_DT positions_NNS three_CD groups_NNS were_VBD formed_VBN ;_: A_DT :_: II+AA_NN at_IN position_NN 105_CD and_CC 114_CD ,_, respectively_RB ;_: B_NNP :_: IV+AA_NNP or_CC VV+AA_NNP ;_: and_CC C_NNP :_: IV+AV_NNP or_CC VV+AV_NNP ._. 
The_DT 3_CD bp_NN deletion_NN -LRB-_-LRB- intron_NN 6_CD -RRB-_-RRB- of_IN GSTM3_NNP was_VBD analyzed_VBN by_IN PCR\/RFLP_NNP using_VBG the_DT restriction_NN enzyme_NN MnlI_NNP according_VBG to_TO Inskip_NNP et_FW al_FW ._. 
Five_CD different_JJ SNPs_NNS in_IN the_DT NAT1_NNP gene_NN ,_, 559_CD C_NNP 
Genotyping_VBG for_IN the_DT GSTM1_NNP and_CC GSTT1_NNP null_NNP ,_, and_CC GSTP1_NNP I105V_NNP -LRB-_-LRB- A_NNP 
Moreover_RB ,_, all_DT 246_CD individuals_NNS approved_VBD analysis_NN of_IN metabolizing_VBG genes_NNS ,_, whereas_IN 239_CD individuals_NNS approved_VBD analysis_NN of_IN immune-related_JJ genes_NNS ._. 
Two_CD closely_RB linked_VBN single_JJ nucleotide_NN polymorphisms_NNS -LRB-_-LRB- SNPs_NNS -RRB-_-RRB- in_IN the_DT CYP1A1_NNP gene_NN were_VBD analyzed_VBN by_IN PCR_NNP ,_, as_RB previously_RB described_VBN ._. 
The_DT Msp_NNP I_NNP restriction_NN fragment_NN length_NN polymorphism_NN in_IN the_DT 3_CD `_`` end_NN of_IN CYP1A1_NNP -LRB-_-LRB- found_VBN on_IN the_DT CYP1A1_NNP \*_NN 2A_FW allele_FW -RRB-_-RRB- is_VBZ due_JJ to_TO a_DT C_NNP 
The_DT CYP1A1_NNP \*_NN 2B_NNP allele_NNP -LRB-_-LRB- A_NNP 
The_DT test_NN has_VBZ a_DT sensitivity_NN and_CC a_DT specificity_NN of_IN 95_CD %_NN -LRB-_-LRB- according_VBG to_TO the_DT company_NN supplying_VBG the_DT test_NN -RRB-_-RRB- ._. 
Exposure_NN assessment_NN methodsPersonal_NNP exposure_NN was_VBD monitored_VBN by_IN air_NN measurements_NNS and_CC by_IN analysis_NN of_IN biomarkers_NNS of_IN exposure_NN in_IN urine_NN and_CC plasma_NN ._. 
The_DT exposed_JJ subjects_NNS were_VBD exposed_VBN to_TO measurable_JJ concentrations_NNS of_IN airborne_JJ TDI_NNP -LRB-_-LRB- the_DT personal_JJ 8-hour_JJ time-weighted_JJ average_NN levels_NNS were_VBD for_IN 2,4_CD TDI_NNP :_: median_NN 0_CD ._. 
The_DT test_NN has_VBZ a_DT sensitivity_NN and_CC a_DT specificity_NN of_IN 95_CD %_NN -LRB-_-LRB- according_VBG to_TO the_DT company_NN supplying_VBG the_DT test_NN -RRB-_-RRB- ._. 
Exposure_NN assessment_NN methodsPersonal_NNP exposure_NN was_VBD monitored_VBN by_IN air_NN measurements_NNS and_CC by_IN analysis_NN of_IN biomarkers_NNS of_IN exposure_NN in_IN urine_NN and_CC plasma_NN ._. 
The_DT exposed_JJ subjects_NNS were_VBD exposed_VBN to_TO measurable_JJ concentrations_NNS of_IN airborne_JJ TDI_NNP -LRB-_-LRB- the_DT personal_JJ 8-hour_JJ time-weighted_JJ average_NN levels_NNS were_VBD for_IN 2,4_CD TDI_NNP :_: median_NN 0_CD ._. 
Blood_NNP was_VBD analyzed_VBN for_IN genotypes_NNS ,_, plasma_NN and_CC urine_NN for_IN biomarkers_NNS of_IN isocyanates_NNS ._. 
Venous_JJ blood_NN and_CC urinary_NN samples_NNS were_VBD collected_VBN at_IN work_NN and_CC stored_VBD at_IN -20_CD 
7-RRB-_NN ._. 
8_CD 
Isocyanates_NNS may_MD react_VB with_IN intracellular_JJ glutathione_NN ,_, either_CC directly_RB or_CC through_IN catalysis_NN by_IN the_DT glutathione_NN transferase_NN -LRB-_-LRB- GST_NNP -RRB-_-RRB- system_NN ._. 
In_IN the_DT group_NN of_IN GST_NNP enzymes_NNS that_WDT were_VBD analyzed_VBN ,_, GSTP1_NNP and_CC GSTM1_NNP were_VBD found_VBN to_TO be_VB the_DT most_RBS efficient_JJ catalysts_NNS of_IN glutathione_NN conjugation_NN of_IN several_JJ different_JJ isothiocyanates_NNS ._. 
Moreover_RB ,_, GSTs_NNS are_VBP involved_VBN in_IN the_DT protection_NN against_IN reactive_JJ oxygen_NN ,_, which_WDT is_VBZ a_DT key_JJ component_NN of_IN inflammation_NN ._. 
There_EX is_VBZ ample_JJ proof_NN that_IN aromatic_JJ and_CC heterocyclic_JJ amines_NNS are_VBP activated_VBN by_IN oxidation_NN of_IN the_DT primary_JJ amine_NN by_IN cytochrome_NN P450_CD enzymes_NNS to_TO aryl_JJ hydroxylamines_NNS ._. 
The_DT most_RBS important_JJ oxygenase_NN is_VBZ CYP1A2_CD ,_, but_CC also_RB CYP1A1_NNP and_CC CYP1B1_NNP can_MD activate_VB a_DT range_NN of_IN arylamines_NNS to_TO reactive_JJ intermediates_NNS ._. 
Another_DT frequent_JJ step_NN in_IN arylamine_NN metabolism_NN is_VBZ the_DT generation_NN of_IN acetoxy_NN esters_NNS by_IN N-acetyltransferases_NNS -LRB-_-LRB- NAT1_CD and_CC NAT2_CD -RRB-_-RRB- ._. 
Another_DT frequent_JJ step_NN in_IN arylamine_NN metabolism_NN is_VBZ the_DT generation_NN of_IN acetoxy_NN esters_NNS by_IN N-acetyltransferases_NNS -LRB-_-LRB- NAT1_CD and_CC NAT2_CD -RRB-_-RRB- ._. 
NAT1_CD is_VBZ more_RBR abundant_JJ in_IN the_DT lung_NN as_RB well_RB as_IN in_IN the_DT eye_NN ,_, but_CC low_JJ levels_NNS of_IN NAT2_NNP have_VBP also_RB been_VBN reported_VBN in_IN these_DT tissues_NNS ._. 
An_DT additional_JJ step_NN in_IN the_DT biotransformation_NN of_IN many_JJ aromatic_JJ amines_NNS is_VBZ sulfatation_NN by_IN cytosolic_JJ sulfotransferases_NNS -LRB-_-LRB- SULTs_NNS -RRB-_-RRB- ._. 
The_DT results_NNS suggest_VBP different_JJ mechanisms_NNS for_IN TDI_NNP -_: and_CC non-TDI-related_JJ symptoms_NNS of_IN the_DT eyes_NNS and_CC lower_JJR airways_NNS ._. 
BackgroundExposure_NN to_TO diisocyanates_NNS is_VBZ well_RB known_VBN to_TO cause_VB asthma_NN and_CC symptoms_NNS such_JJ as_IN cough_NN ,_, wheezing_VBG ,_, and_CC dyspnoea_NN 
Background_NN Exposure_NN to_TO diisocyanates_NNS is_VBZ well_RB known_VBN to_TO cause_VB asthma_NN and_CC symptoms_NNS such_JJ as_IN cough_NN ,_, wheezing_VBG ,_, and_CC dyspnoea_NN 
8_CD 
Health_NNP examinations_NNS The_DT health_NN examinations_NNS are_VBP described_VBN in_IN detail_NN in_IN Littorin_NNP et_FW al._FW ._. 
Written_VBN informed_JJ consent_NN was_VBD obtained_VBN from_IN all_DT subjects_NNS ._. 
In_IN the_DT present_JJ study_NN we_PRP have_VBP only_RB focused_VBN on_IN symptoms_NNS which_WDT were_VBD shown_VBN by_IN Littorin_NNP et_FW al._FW ._. 
069_CD ;_: and_CC nose_NN bleed_VBP p_SYM 
Another_DT frequent_JJ step_NN in_IN arylamine_NN metabolism_NN is_VBZ the_DT generation_NN of_IN acetoxy_NN esters_NNS by_IN N-acetyltransferases_NNS -LRB-_-LRB- NAT1_CD and_CC NAT2_CD -RRB-_-RRB- ._. 
NAT1_CD is_VBZ more_RBR abundant_JJ in_IN the_DT lung_NN as_RB well_RB as_IN in_IN the_DT eye_NN ,_, but_CC low_JJ levels_NNS of_IN NAT2_NNP have_VBP also_RB been_VBN reported_VBN in_IN these_DT tissues_NNS ._. 
An_DT additional_JJ step_NN in_IN the_DT biotransformation_NN of_IN many_JJ aromatic_JJ amines_NNS is_VBZ sulfatation_NN by_IN cytosolic_JJ sulfotransferases_NNS -LRB-_-LRB- SULTs_NNS -RRB-_-RRB- ._. 
An_DT additional_JJ step_NN in_IN the_DT biotransformation_NN of_IN many_JJ aromatic_JJ amines_NNS is_VBZ sulfatation_NN by_IN cytosolic_JJ sulfotransferases_NNS -LRB-_-LRB- SULTs_NNS -RRB-_-RRB- ._. 
Aperoxidase-catalysed_JJ mechanism_NN ,_, possibly_RB through_IN myeloperoxidase_NN -LRB-_-LRB- MPO_NNP -RRB-_-RRB- in_IN neutrophiles_NNS ,_, to_TO activate_VB arylamines_NNS has_VBZ been_VBN suggested_VBN 
While_IN there_EX have_VBP been_VBN multiple_JJ pesticides_NNS implicated_VBN in_IN breast_NN cancer_NN ,_, no_DT studies_NNS have_VBP been_VBN published_VBN related_VBN to_TO OTQ_NNP exposure_NN and_CC human_JJ cancer_NN incidence_NN 
However_RB ,_, potentially_RB carcinogenic_JJ exposures_NNS have_VBP already_RB occurred_VBN and_CC OTQ_NNP is_VBZ still_RB in_IN use_NN outside_IN of_IN the_DT US_NNP ,_, its_PRP$ mechanism_NN of_IN action_NN remains_VBZ of_IN interest_NN ._. 
In_IN addition_NN ,_, OTQ_NNP has_VBZ been_VBN shown_VBN to_TO have_VB an_DT inhibitory_JJ effect_NN on_IN cytochome_NN P450s_NNS ,_, enzymes_NNS known_VBN to_TO have_VB a_DT pivotal_JJ role_NN in_IN carcinogen_NN metabolism_NN ._. 
Although_IN early_JJ studies_NNS focused_VBN on_IN hepatic_JJ effects_NNS ,_, carcinogenic_JJ potential_NN may_MD occur_VB in_IN other_JJ tissues_NNS as_RB well_RB ._. 
Although_IN early_JJ studies_NNS focused_VBN on_IN hepatic_JJ effects_NNS ,_, carcinogenic_JJ potential_NN may_MD occur_VB in_IN other_JJ tissues_NNS as_RB well_RB ._. 
While_IN there_EX have_VBP been_VBN multiple_JJ pesticides_NNS implicated_VBN in_IN breast_NN cancer_NN ,_, no_DT studies_NNS have_VBP been_VBN published_VBN related_VBN to_TO OTQ_NNP exposure_NN and_CC human_JJ cancer_NN incidence_NN 
OTQ_NNP was_VBD shown_VBN to_TO be_VB a_DT carcinogen_NN and_CC hepatotoxin_NN in_IN laboratory_NN animals_NNS in_IN later_JJ studies_NNS 
However_RB ,_, potentially_RB carcinogenic_JJ exposures_NNS have_VBP already_RB occurred_VBN and_CC OTQ_NNP is_VBZ still_RB in_IN use_NN outside_IN of_IN the_DT US_NNP ,_, its_PRP$ mechanism_NN of_IN action_NN remains_VBZ of_IN interest_NN ._. 
In_IN addition_NN ,_, OTQ_NNP has_VBZ been_VBN shown_VBN to_TO have_VB an_DT inhibitory_JJ effect_NN on_IN cytochome_NN P450s_NNS ,_, enzymes_NNS known_VBN to_TO have_VB a_DT pivotal_JJ role_NN in_IN carcinogen_NN metabolism_NN ._. 
Although_IN early_JJ studies_NNS focused_VBN on_IN hepatic_JJ effects_NNS ,_, carcinogenic_JJ potential_NN may_MD occur_VB in_IN other_JJ tissues_NNS as_RB well_RB ._. 
While_IN there_EX have_VBP been_VBN multiple_JJ pesticides_NNS implicated_VBN in_IN breast_NN cancer_NN ,_, no_DT studies_NNS have_VBP been_VBN published_VBN related_VBN to_TO OTQ_NNP exposure_NN and_CC human_JJ cancer_NN incidence_NN 
Although_IN no_DT biological_JJ mechanism_NN for_IN the_DT role_NN of_IN this_DT variant_NN in_IN carcinogenesis_NN has_VBZ been_VBN defined_VBN ,_, several_JJ studies_NNS associating_VBG this_DT haplotype_NN with_IN various_JJ cancers_NNS support_VBP such_JJ role_NN ._. 
Analysis_NN of_IN genes_NNS altered_VBN in_IN just_RB those_DT strains_NNS expressing_VBG this_DT variant_NN ,_, including_VBG three_CD genes_NNS involved_VBN in_IN cell_NN cycle_NN control_NN :_: raf_NN oncogene_NN -LRB-_-LRB- X03484_NNP -RRB-_-RRB- ,_, cyclin_NN D1_NNP -LRB-_-LRB- Z29087_NNP -RRB-_-RRB- ,_, and_CC BTF2_NNP -LRB-_-LRB- U72649_NNP -RRB-_-RRB- may_MD further_RB support_VB an_DT association_NN between_IN OTQ_NNP exposure_NN ,_, p53_NN variant_NN status_NN and_CC carcinogenesis_NN 
Analysis_NN of_IN genes_NNS altered_VBN in_IN just_RB those_DT strains_NNS expressing_VBG this_DT variant_NN ,_, including_VBG three_CD genes_NNS involved_VBN in_IN cell_NN cycle_NN control_NN :_: raf_NN oncogene_NN -LRB-_-LRB- X03484_NNP -RRB-_-RRB- ,_, cyclin_NN D1_NNP -LRB-_-LRB- Z29087_NNP -RRB-_-RRB- ,_, and_CC BTF2_NNP -LRB-_-LRB- U72649_NNP -RRB-_-RRB- may_MD further_RB support_VB an_DT association_NN between_IN OTQ_NNP exposure_NN ,_, p53_NN variant_NN status_NN and_CC carcinogenesis_NN 
Two_CD of_IN the_DT four_CD cell_NN strains_NNS selected_VBN for_IN analysis_NN are_VBP heterozygote_JJ for_IN the_DT minor_JJ variant_JJ haplotype_NN of_IN p53_NN ,_, a_DT cell_NN cycle_NN control_NN gene_NN -LRB-_-LRB- cell_NN strains_NNS 3_CD and_CC 4_CD -RRB-_-RRB- ._. 
Although_IN no_DT biological_JJ mechanism_NN for_IN the_DT role_NN of_IN this_DT variant_NN in_IN carcinogenesis_NN has_VBZ been_VBN defined_VBN ,_, several_JJ studies_NNS associating_VBG this_DT haplotype_NN with_IN various_JJ cancers_NNS support_VBP such_JJ role_NN ._. 
Analysis_NN of_IN genes_NNS altered_VBN in_IN just_RB those_DT strains_NNS expressing_VBG this_DT variant_NN ,_, including_VBG three_CD genes_NNS involved_VBN in_IN cell_NN cycle_NN control_NN :_: raf_NN oncogene_NN -LRB-_-LRB- X03484_NNP -RRB-_-RRB- ,_, cyclin_NN D1_NNP -LRB-_-LRB- Z29087_NNP -RRB-_-RRB- ,_, and_CC BTF2_NNP -LRB-_-LRB- U72649_NNP -RRB-_-RRB- may_MD further_RB support_VB an_DT association_NN between_IN OTQ_NNP exposure_NN ,_, p53_NN variant_NN status_NN and_CC carcinogenesis_NN 
Although_IN no_DT biological_JJ mechanism_NN for_IN the_DT role_NN of_IN this_DT variant_NN in_IN carcinogenesis_NN has_VBZ been_VBN defined_VBN ,_, several_JJ studies_NNS associating_VBG this_DT haplotype_NN with_IN various_JJ cancers_NNS support_VBP such_JJ role_NN ._. 
Analysis_NN of_IN genes_NNS altered_VBN in_IN just_RB those_DT strains_NNS expressing_VBG this_DT variant_NN ,_, including_VBG three_CD genes_NNS involved_VBN in_IN cell_NN cycle_NN control_NN :_: raf_NN oncogene_NN -LRB-_-LRB- X03484_NNP -RRB-_-RRB- ,_, cyclin_NN D1_NNP -LRB-_-LRB- Z29087_NNP -RRB-_-RRB- ,_, and_CC BTF2_NNP -LRB-_-LRB- U72649_NNP -RRB-_-RRB- may_MD further_RB support_VB an_DT association_NN between_IN OTQ_NNP exposure_NN ,_, p53_NN variant_NN status_NN and_CC carcinogenesis_NN 
Two_CD of_IN the_DT four_CD cell_NN strains_NNS selected_VBN for_IN analysis_NN are_VBP heterozygote_JJ for_IN the_DT minor_JJ variant_JJ haplotype_NN of_IN p53_NN ,_, a_DT cell_NN cycle_NN control_NN gene_NN -LRB-_-LRB- cell_NN strains_NNS 3_CD and_CC 4_CD -RRB-_-RRB- ._. 
Although_IN no_DT biological_JJ mechanism_NN for_IN the_DT role_NN of_IN this_DT variant_NN in_IN carcinogenesis_NN has_VBZ been_VBN defined_VBN ,_, several_JJ studies_NNS associating_VBG this_DT haplotype_NN with_IN various_JJ cancers_NNS support_VBP such_JJ role_NN ._. 
Analysis_NN of_IN genes_NNS altered_VBN in_IN just_RB those_DT strains_NNS expressing_VBG this_DT variant_NN ,_, including_VBG three_CD genes_NNS involved_VBN in_IN cell_NN cycle_NN control_NN :_: raf_NN oncogene_NN -LRB-_-LRB- X03484_NNP -RRB-_-RRB- ,_, cyclin_NN D1_NNP -LRB-_-LRB- Z29087_NNP -RRB-_-RRB- ,_, and_CC BTF2_NNP -LRB-_-LRB- U72649_NNP -RRB-_-RRB- may_MD further_RB support_VB an_DT association_NN between_IN OTQ_NNP exposure_NN ,_, p53_NN variant_NN status_NN and_CC carcinogenesis_NN 
However_RB ,_, given_VBN that_IN this_DT haplotype_NN is_VBZ found_VBN only_RB in_IN a_DT limited_JJ portion_NN of_IN the_DT population_NN ,_, this_DT varied_JJ pattern_NN of_IN expression_NN in_IN key_JJ genes_NNS in_IN cell_NN cycle_NN control_NN may_MD highlight_VB a_DT specific_JJ at-risk_JJ population_NN ._. 
Searches_NNS for_IN similar_JJ natural_JJ compounds_NNS to_TO replace_VB these_DT potentially_RB disruptive_JJ chemicals_NNS can_MD also_RB use_VB gene_NN expression_NN profiles_NNS 
Analysis_NN of_IN genes_NNS altered_VBN in_IN just_RB those_DT strains_NNS expressing_VBG this_DT variant_NN ,_, including_VBG three_CD genes_NNS involved_VBN in_IN cell_NN cycle_NN control_NN :_: raf_NN oncogene_NN -LRB-_-LRB- X03484_NNP -RRB-_-RRB- ,_, cyclin_NN D1_NNP -LRB-_-LRB- Z29087_NNP -RRB-_-RRB- ,_, and_CC BTF2_NNP -LRB-_-LRB- U72649_NNP -RRB-_-RRB- may_MD further_RB support_VB an_DT association_NN between_IN OTQ_NNP exposure_NN ,_, p53_NN variant_NN status_NN and_CC carcinogenesis_NN 
The_DT results_NNS shown_VBN here_RB do_VBP not_RB suggest_VB a_DT direct_JJ role_NN of_IN OTQ_NNP in_IN carcinogenesis_NN ._. 
It_PRP is_VBZ possible_JJ that_IN the_DT main_JJ effect_NN of_IN OTQ_NNP exposure_NN is_VBZ not_RB on_IN the_DT direct_JJ alterations_NNS in_IN many_JJ genes_NNS ,_, but_CC on_IN alterations_NNS in_IN genes_NNS potentially_RB involved_VBN in_IN carcinogenesis_NN ,_, among_IN them_PRP the_DT examples_NNS of_IN CYP2A13_NNP and_CC dihydrodiol_JJ dehydrogenase_NN ._. 
They_PRP do_VBP ,_, however_RB ,_, suggest_VBP OTQ_NNP exposure_NN leads_VBZ to_TO an_DT increase_NN in_IN expression_NN of_IN genes_NNS that_WDT do_VBP play_VB a_DT direct_JJ role_NN in_IN carcinogen_NN ;_: metabolism_NN -LRB-_-LRB- for_IN example_NN ,_, exposure_NN to_TO carcinogens_NNS like_IN NNK_NNP and_CC benzo_JJ pyrene_NN along_IN with_IN exposure_NN to_TO OTQ_NNP may_MD lead_VB to_TO an_DT increased_VBN incidence_NN of_IN tobacco-related_JJ cancer_NN -RRB-_-RRB- 
Of_IN these_DT two_CD genes_NNS ,_, only_RB CYP2A13_CD seems_VBZ specific_JJ to_TO exposure_NN to_TO OTQ_NNP ._. 
Alterations_NNS of_IN genes_NNS like_IN this_DT may_MD suggest_VB an_DT indirect_JJ role_NN for_IN OTQ_NNP in_IN carcinogenesis_NN ._. 
DDH_NNP has_VBZ been_VBN found_VBN to_TO be_VB increased_VBN following_VBG exposure_NN to_TO various_JJ chemicals_NNS ,_, including_VBG malathion_NN ,_, di-n-butyl_JJ phthalate_NN ,_, and_CC benzo_FW pyrene_FW -LRB-_-LRB- Gwinn_NNP in_IN preparation_NN ,_, 2004_CD -RRB-_-RRB- 
Another_DT metabolic_JJ enzyme_NN affected_VBN by_IN OTQ_NNP exposure_NN is_VBZ dihydrodiol_JJ dehydrogenase_NN ._. 
Further_JJ analysis_NN by_IN RT-PCR_NNP showed_VBD that_IN this_DT p450_NN was_VBD increased_VBN at_IN later_JJ time_NN points_NNS -LRB-_-LRB- 12_CD h_NN and_CC 24_CD h_NN ,_, Table_NNP 2_CD -RRB-_-RRB- ._. 
Dihydrodiol_NNP dehydrogenase_NN is_VBZ known_VBN to_TO participate_VB in_IN activation_NN of_IN certain_JJ polycyclic_JJ aromatic_JJ hydrocarbons_NNS -LRB-_-LRB- PAHs_NNS -RRB-_-RRB- ,_, so_IN its_PRP$ increase_NN in_IN the_DT intermediate_JJ variant_NN after_IN OTQ_NNP exposure_NN may_MD result_VB in_IN an_DT increase_NN in_IN PAH_NNP activation_NN ._. 
Alterations_NNS of_IN genes_NNS like_IN this_DT may_MD suggest_VB an_DT indirect_JJ role_NN for_IN OTQ_NNP in_IN carcinogenesis_NN ._. 
Of_IN these_DT two_CD genes_NNS ,_, only_RB CYP2A13_CD seems_VBZ specific_JJ to_TO exposure_NN to_TO OTQ_NNP ._. 
Another_DT metabolic_JJ enzyme_NN affected_VBN by_IN OTQ_NNP exposure_NN is_VBZ dihydrodiol_JJ dehydrogenase_NN ._. 
Further_JJ analysis_NN by_IN RT-PCR_NNP showed_VBD that_IN this_DT p450_NN was_VBD increased_VBN at_IN later_JJ time_NN points_NNS -LRB-_-LRB- 12_CD h_NN and_CC 24_CD h_NN ,_, Table_NNP 2_CD -RRB-_-RRB- ._. 
Dihydrodiol_NNP dehydrogenase_NN is_VBZ known_VBN to_TO participate_VB in_IN activation_NN of_IN certain_JJ polycyclic_JJ aromatic_JJ hydrocarbons_NNS -LRB-_-LRB- PAHs_NNS -RRB-_-RRB- ,_, so_IN its_PRP$ increase_NN in_IN the_DT intermediate_JJ variant_NN after_IN OTQ_NNP exposure_NN may_MD result_VB in_IN an_DT increase_NN in_IN PAH_NNP activation_NN ._. 
Alterations_NNS of_IN genes_NNS like_IN this_DT may_MD suggest_VB an_DT indirect_JJ role_NN for_IN OTQ_NNP in_IN carcinogenesis_NN ._. 
Of_IN these_DT two_CD genes_NNS ,_, only_RB CYP2A13_CD seems_VBZ specific_JJ to_TO exposure_NN to_TO OTQ_NNP ._. 
The_DT results_NNS shown_VBN here_RB do_VBP not_RB suggest_VB a_DT direct_JJ role_NN of_IN OTQ_NNP in_IN carcinogenesis_NN ._. 
It_PRP is_VBZ possible_JJ that_IN the_DT main_JJ effect_NN of_IN OTQ_NNP exposure_NN is_VBZ not_RB on_IN the_DT direct_JJ alterations_NNS in_IN many_JJ genes_NNS ,_, but_CC on_IN alterations_NNS in_IN genes_NNS potentially_RB involved_VBN in_IN carcinogenesis_NN ,_, among_IN them_PRP the_DT examples_NNS of_IN CYP2A13_NNP and_CC dihydrodiol_JJ dehydrogenase_NN ._. 
They_PRP do_VBP ,_, however_RB ,_, suggest_VBP OTQ_NNP exposure_NN leads_VBZ to_TO an_DT increase_NN in_IN expression_NN of_IN genes_NNS that_WDT do_VBP play_VB a_DT direct_JJ role_NN in_IN carcinogen_NN ;_: metabolism_NN -LRB-_-LRB- for_IN example_NN ,_, exposure_NN to_TO carcinogens_NNS like_IN NNK_NNP and_CC benzo_JJ pyrene_NN along_IN with_IN exposure_NN to_TO OTQ_NNP may_MD lead_VB to_TO an_DT increased_VBN incidence_NN of_IN tobacco-related_JJ cancer_NN -RRB-_-RRB- 
Metabolism_NN genes_NNS that_WDT were_VBD altered_VBN after_IN OTQ_NNP exposure_NN ,_, like_IN cytochome_JJ P4502A13_NNP -LRB-_-LRB- CYP2A13_NNP -RRB-_-RRB- and_CC dihydrodiol_NN dehydrogenase_NN ,_, are_VBP involved_VBN in_IN xenobiotic_JJ metabolism_NN ._. 
It_PRP has_VBZ been_VBN suggested_VBN that_IN CYP2A13_NNP is_VBZ the_DT main_JJ metabolic_JJ activator_NN of_IN 4_CD -_: -LRB-_-LRB- methylnitrosamino_NN -RRB-_-RRB- -1_CD -_: -LRB-_-LRB- 3-pyridyl_JJ -RRB-_-RRB- -1_CD -_: butanone_NN -LRB-_-LRB- NNK_NNP -RRB-_-RRB- ,_, a_DT tobacco-specific_JJ nitrosamine_NN 
Anumber_NNP of_IN genes_NNS involved_VBN in_IN carcinogenesis_NNS were_VBD found_VBN altered_JJ after_IN exposure_NN to_TO OTQ_NNP ,_, both_DT induced_JJ and_CC down-regulated_JJ ._. 
For_IN example_NN ,_, prohibitin_NN expression_NN is_VBZ found_VBN to_TO be_VB up-regulated_JJ in_IN most_JJS cell_NN strains_NNS after_IN OTQ_NNP exposure_NN ,_, with_IN similar_JJ expression_NN patterns_NNS associated_VBN with_IN a_DT decrease_NN in_IN cancer_NN incidence_NN ._. 
Metabolism_NN genes_NNS that_WDT were_VBD altered_VBN after_IN OTQ_NNP exposure_NN ,_, like_IN cytochome_JJ P4502A13_NNP -LRB-_-LRB- CYP2A13_NNP -RRB-_-RRB- and_CC dihydrodiol_NN dehydrogenase_NN ,_, are_VBP involved_VBN in_IN xenobiotic_JJ metabolism_NN ._. 
From_IN the_DT full_JJ list_NN of_IN genes_NNS that_WDT fit_VBP these_DT criteria_NNS ,_, selected_VBN genes_NNS were_VBD chosen_VBN due_JJ to_TO their_PRP$ potential_JJ role_NN in_IN carcinogenesis_NN ,_, whether_IN by_IN cell_NN cycle_NN control_NN ,_, immune_JJ response_NN or_CC other_JJ specific_JJ functions_NNS ._. 
Functions_NNS were_VBD described_VBN as_IN annotated_JJ by_IN NetAffx_NNP ._. 
These_DT genes_NNS are_VBP listed_VBN in_IN Table_NNP 1_CD ._. 
Some_DT genes_NNS were_VBD selected_VBN based_VBN on_IN their_PRP$ possible_JJ role_NN in_IN disease_NN as_IN a_DT result_NN of_IN pesticide_NN exposure_NN ._. 
DNA_NNP microarray_NN DNA_NN microarray_NN analysis_NN found_VBD no_DT change_NN in_IN p53_NN ,_, despite_IN the_DT increase_NN in_IN p53_NN protein_NN levels_NNS observed_VBN by_IN immunofluorescence_NN ._. 
Studies_NNS of_IN benzo_NN 
Of_IN these_DT two_CD genes_NNS ,_, only_RB CYP2A13_CD seems_VBZ specific_JJ to_TO exposure_NN to_TO OTQ_NNP ._. 
Alterations_NNS of_IN genes_NNS like_IN this_DT may_MD suggest_VB an_DT indirect_JJ role_NN for_IN OTQ_NNP in_IN carcinogenesis_NN ._. 
DDH_NNP has_VBZ been_VBN found_VBN to_TO be_VB increased_VBN following_VBG exposure_NN to_TO various_JJ chemicals_NNS ,_, including_VBG malathion_NN ,_, di-n-butyl_JJ phthalate_NN ,_, and_CC benzo_FW pyrene_FW -LRB-_-LRB- Gwinn_NNP in_IN preparation_NN ,_, 2004_CD -RRB-_-RRB- 
Slides_NNS were_VBD washed_VBN in_IN triplicate_NN with_IN phosphate_NN buffered_VBN saline_NN -LRB-_-LRB- PBS_NNP -RRB-_-RRB- and_CC cover_NN slips_VBZ were_VBD added_VBN ._. 
The_DT next_JJ day_NN ,_, the_DT media_NNS was_VBD again_RB removed_VBN and_CC the_DT secondary_JJ antibody_NN -LRB-_-LRB- 1:1500_CD ,_, goat_NN anti-mouse_NN FITC_NNP ,_, Santa_NNP Cruz_NNP Biotech_NNP -RRB-_-RRB- was_VBD incubated_VBN for_IN one_CD hour_NN at_IN room_NN temperature_NN ._. 
Slides_NNS were_VBD dried_VBN for_IN one_CD hour_NN at_IN room_NN temperature_NN before_IN viewing_VBG ,_, using_VBG the_DT laser_NN scanning_VBG confocal_JJ microscope_NN BX50_NNP -LRB-_-LRB- Olympus_NNP -RRB-_-RRB- ,_, and_CC quantitative_JJ analysis_NN was_VBD performed_VBN ._. 
Relative_JJ p53_NN expression_NN was_VBD quantified_VBN between_IN different_JJ time_NN points_NNS and_CC strains_NNS by_IN determination_NN of_IN the_DT area_NN under_IN the_DT integrated_JJ intensity_NN curve_NN -LRB-_-LRB- Fluoview_NNP ,_, Olympus_NNP ,_, B_NNP 
Methods_NNP Cell_NNP culture_NN Primary_JJ normal_JJ human_JJ mammary_JJ epithelial_JJ cells_NNS -LRB-_-LRB- NHMECs_NNS -RRB-_-RRB- were_VBD derived_VBN from_IN tissues_NNS salvaged_VBN at_IN reduction_NN mammoplasty_NN obtained_VBN though_IN the_DT Cooperative_NNP Human_NNP Tissue_NNP Network_NNP -LRB-_-LRB- National_NNP Cancer_NNP Institute_NNP and_CC National_NNP Disease_NNP Research_NNP Interchange_NNP -RRB-_-RRB- ._. 
Development_NNP and_CC characterization_NN of_IN cell_NN strains_NNS was_VBD achieved_VBN using_VBG standard_JJ methods_NNS ._. 
Cells_NNS were_VBD grown_VBN in_IN MEGM_NNP media_NNS -LRB-_-LRB- Clonetics_NNP ,_, Cambrex_NNP ,_, Pittsburgh_NNP ,_, PA_NNP -RRB-_-RRB- at_IN 37_CD 
Arecent_JJ report_NN by_IN Shan_NNP etal_NNP ._. 
The_DT National_NNP Institute_NNP of_IN Environmental_NNP Health_NNP Systems_NNP -LRB-_-LRB- NIEHS_NNP -RRB-_-RRB- has_VBZ recently_RB funded_VBN a_DT consortium_NN to_TO expand_VB the_DT study_NN of_IN gene_NN expression_NN profile_NN signatures_NNS for_IN various_JJ chemicals_NNS ,_, with_IN the_DT long-term_JJ goal_NN to_TO use_VB these_DT analyses_NNS in_IN a_DT validated_VBN gene_NN expression_NN profile_NN signature_NN database_NN ._. 
2002_CD 
The_DT use_NN of_IN OTQ_NNP in_IN the_DT United_NNP States_NNPS was_VBD voluntarily_RB canceled_VBN in_IN 1999_CD with_IN stocks_NNS in_IN use_NN until_IN 2001_CD ,_, although_IN OTQ_NNP is_VBZ still_RB listed_VBN in_IN many_JJ different_JJ regions_NNS for_IN use_NN as_IN an_DT insecticide_NN 
The_DT use_NN of_IN OTQ_NNP in_IN the_DT United_NNP States_NNPS was_VBD voluntarily_RB canceled_VBN in_IN 1999_CD with_IN stocks_NNS in_IN use_NN until_IN 2001_CD ,_, although_IN OTQ_NNP is_VBZ still_RB listed_VBN in_IN many_JJ different_JJ regions_NNS for_IN use_NN as_IN an_DT insecticide_NN 
Scientifically_RB acceptable_JJ toxicity_NN studies_NNS of_IN OTQ_NNP are_VBP sparse_JJ ._. 
Further_RB ,_, OTQ_NNP is_VBZ still_RB in_IN use_NN today_NN in_IN other_JJ areas_NNS of_IN the_DT world_NN ,_, including_VBG Australia_NNP and_CC the_DT Caribbean_NNP 
Preliminary_JJ studies_NNS analyzed_VBD a_DT range_NN of_IN OTQ_NNP concentrations_NNS -LRB-_-LRB- 0_CD 
Early_RB in_IN vivo_NN studies_NNS in_IN rats_NNS found_VBD alterations_NNS of_IN a_DT variety_NN of_IN metabolic_JJ enzymes_NNS following_VBG OTQ_NNP exposures_NNS ,_, including_VBG alkaline_JJ phosphatase_NN 
Although_IN not_RB directly_RB analyzed_VBN ,_, the_DT results_NNS of_IN this_DT study_NN combined_VBN with_IN an_DT earlier_JJR study_NN suggest_VBP a_DT direct_JJ effect_NN of_IN OTQ_NNP on_IN succinate_NN dehydrogenase_NN ,_, or_CC other_JJ enzymes_NNS with_IN a_DT thiol_JJ group_NN ._. 
Further_JJ work_NN by_IN Carlson_NNP et_FW al_FW -LRB-_-LRB- 1970_CD -RRB-_-RRB- 
Preliminary_JJ studies_NNS analyzed_VBD a_DT range_NN of_IN OTQ_NNP concentrations_NNS -LRB-_-LRB- 0_CD 
OTQ_NNP is_VBZ a_DT member_NN of_IN the_DT quinoxaline_JJ class_NN of_IN pesticides_NNS ,_, which_WDT also_RB includes_VBZ chlorquinox_NN and_CC thioquinox_NN ._. 
Principal_NN agricultural_JJ use_NN of_IN OTQ_NNP was_VBD limited_VBN to_TO the_DT states_NNS of_IN California_NNP ,_, Washington_NNP ,_, Florida_NNP ,_, New_NNP York_NNP ,_, Pennsylvania_NNP ,_, Ohio_NNP and_CC Michigan_NNP 
Principal_NN agricultural_JJ use_NN of_IN OTQ_NNP was_VBD limited_VBN to_TO the_DT states_NNS of_IN California_NNP ,_, Washington_NNP ,_, Florida_NNP ,_, New_NNP York_NNP ,_, Pennsylvania_NNP ,_, Ohio_NNP and_CC Michigan_NNP 
Principal_NN agricultural_JJ use_NN of_IN OTQ_NNP was_VBD limited_VBN to_TO the_DT states_NNS of_IN California_NNP ,_, Washington_NNP ,_, Florida_NNP ,_, New_NNP York_NNP ,_, Pennsylvania_NNP ,_, Ohio_NNP and_CC Michigan_NNP 
Further_JJ work_NN by_IN Carlson_NNP et_FW al_FW -LRB-_-LRB- 1970_CD -RRB-_-RRB- 
However_RB ,_, potentially_RB carcinogenic_JJ exposures_NNS have_VBP already_RB occurred_VBN and_CC OTQ_NNP is_VBZ still_RB in_IN use_NN outside_IN of_IN the_DT US_NNP ,_, its_PRP$ mechanism_NN of_IN action_NN remains_VBZ of_IN interest_NN ._. 
In_IN addition_NN ,_, OTQ_NNP has_VBZ been_VBN shown_VBN to_TO have_VB an_DT inhibitory_JJ effect_NN on_IN cytochome_NN P450s_NNS ,_, enzymes_NNS known_VBN to_TO have_VB a_DT pivotal_JJ role_NN in_IN carcinogen_NN metabolism_NN ._. 
Although_IN early_JJ studies_NNS focused_VBN on_IN hepatic_JJ effects_NNS ,_, carcinogenic_JJ potential_NN may_MD occur_VB in_IN other_JJ tissues_NNS as_RB well_RB ._. 
Further_JJ studies_NNS looking_VBG mainly_RB at_IN hepatic_JJ enzyme_NN function_NN found_VBD that_IN OTQ_NNP exposure_NN inhibits_VBZ some_DT hepatic_JJ enzyme_NN functions_NNS 
Background_NN Growing_VBG evidence_NN of_IN the_DT adverse_JJ effect_NN of_IN air_NN pollution_NN on_IN human_JJ health_NN raises_VBZ the_DT question_NN as_IN to_TO what_WP extent_NN this_DT affects_VBZ the_DT foetus_NN and_CC the_DT newborn_JJ ,_, which_WDT are_VBP likely_JJ to_TO be_VB more_RBR vulnerable_JJ than_IN adults_NNS to_TO environmental_JJ toxicants_NNS ._. 
Recent_JJ epidemiological_JJ studies_NNS ,_, conducted_VBN in_IN various_JJ countries_NNS ,_, have_VBP reported_VBN relationships_NNS between_IN elevated_JJ levels_NNS of_IN air_NN pollutants_NNS -LRB-_-LRB- total_JJ suspended_JJ particles_NNS -LRB-_-LRB- TSP_NNP -RRB-_-RRB- ,_, sulfur_NN dioxide_NN -LRB-_-LRB- SO2_NNP -RRB-_-RRB- ,_, carbon_NN monoxide_NN -LRB-_-LRB- CO_NNP -RRB-_-RRB- ,_, nitrogen_NN dioxide_NN -LRB-_-LRB- NO2_NNP -RRB-_-RRB- ,_, polycyclic_JJ aromatic_JJ hydrocarbons_NNS -LRB-_-LRB- PAH_NNP -RRB-_-RRB- -RRB-_-RRB- and_CC birth_NN outcomes_NNS ,_, such_JJ as_IN low_JJ birth_NN weight_NN -LRB-_-LRB- LBW_NNP -RRB-_-RRB- ,_, pre-maturity_JJ ,_, intrauterine_JJ retardation_NN -LRB-_-LRB- IUGR_NNP -RRB-_-RRB- 
90_CD 
Recent_JJ epidemiological_JJ studies_NNS ,_, conducted_VBN in_IN various_JJ countries_NNS ,_, have_VBP reported_VBN relationships_NNS between_IN elevated_JJ levels_NNS of_IN air_NN pollutants_NNS -LRB-_-LRB- total_JJ suspended_JJ particles_NNS -LRB-_-LRB- TSP_NNP -RRB-_-RRB- ,_, sulfur_NN dioxide_NN -LRB-_-LRB- SO_RB 2_CD -RRB-_-RRB- ,_, carbon_NN monoxide_NN -LRB-_-LRB- CO_NNP -RRB-_-RRB- ,_, nitrogen_NN dioxide_NN -LRB-_-LRB- NO_UH 2_CD -RRB-_-RRB- ,_, polycyclic_JJ aromatic_JJ hydrocarbons_NNS -LRB-_-LRB- PAH_NNP -RRB-_-RRB- -RRB-_-RRB- and_CC birth_NN outcomes_NNS ,_, such_JJ as_IN low_JJ birth_NN weight_NN -LRB-_-LRB- LBW_NNP -RRB-_-RRB- ,_, pre-maturity_JJ ,_, intrauterine_JJ retardation_NN -LRB-_-LRB- IUGR_NNP -RRB-_-RRB- 
However_RB ,_, a_DT study_NN on_IN births_NNS in_IN Southern_NNP California_NNP found_VBD no_DT consistent_JJ effect_NN of_IN NO_DT 2_CD on_IN preterm_NN birth_NN in_IN regard_NN to_TO exposures_NNS during_IN any_DT of_IN pregnancy_NN trimesters_NNS ._. 
Recent_JJ epidemiological_JJ studies_NNS ,_, conducted_VBN in_IN various_JJ countries_NNS ,_, have_VBP reported_VBN relationships_NNS between_IN elevated_JJ levels_NNS of_IN air_NN pollutants_NNS -LRB-_-LRB- total_JJ suspended_JJ particles_NNS -LRB-_-LRB- TSP_NNP -RRB-_-RRB- ,_, sulfur_NN dioxide_NN -LRB-_-LRB- SO_RB 2_CD -RRB-_-RRB- ,_, carbon_NN monoxide_NN -LRB-_-LRB- CO_NNP -RRB-_-RRB- ,_, nitrogen_NN dioxide_NN -LRB-_-LRB- NO_UH 2_CD -RRB-_-RRB- ,_, polycyclic_JJ aromatic_JJ hydrocarbons_NNS -LRB-_-LRB- PAH_NNP -RRB-_-RRB- -RRB-_-RRB- and_CC birth_NN outcomes_NNS ,_, such_JJ as_IN low_JJ birth_NN weight_NN -LRB-_-LRB- LBW_NNP -RRB-_-RRB- ,_, pre-maturity_JJ ,_, intrauterine_JJ retardation_NN -LRB-_-LRB- IUGR_NNP -RRB-_-RRB- 
Nevertheless_RB ,_, factors_NNS expected_VBN to_TO contribute_VB to_TO differences_NNS between_IN area-wide_JJ and_CC individual_JJ exposures_NNS were_VBD most_RBS likely_JJ independent_NN of_IN exposure_NN assessment_NN ,_, with_IN a_DT resulting_VBG underestimation_NN of_IN the_DT effects_NNS of_IN air_NN pollution_NN ._. 
Evidence_NN has_VBZ been_VBN provided_VBN that_IN when_WRB area-wide_JJ measures_NNS of_IN exposure_NN to_TO air_NN pollution_NN were_VBD used_VBN as_IN proxies_NNS for_IN personal_JJ exposures_NNS ,_, then_RB estimates_NNS of_IN effects_NNS of_IN pollutant_NN effects_NNS were_VBD generally_RB smaller_JJR than_IN those_DT based_VBN on_IN exposure_NN levels_NNS determined_VBN by_IN personal_JJ sampling_NN 
Evidence_NN has_VBZ been_VBN provided_VBN that_IN when_WRB area-wide_JJ measures_NNS of_IN exposure_NN to_TO air_NN pollution_NN were_VBD used_VBN as_IN proxies_NNS for_IN personal_JJ exposures_NNS ,_, then_RB estimates_NNS of_IN effects_NNS of_IN pollutant_NN effects_NNS were_VBD generally_RB smaller_JJR than_IN those_DT based_VBN on_IN exposure_NN levels_NNS determined_VBN by_IN personal_JJ sampling_NN 
Evidence_NN has_VBZ been_VBN provided_VBN that_IN when_WRB area-wide_JJ measures_NNS of_IN exposure_NN to_TO air_NN pollution_NN were_VBD used_VBN as_IN proxies_NNS for_IN personal_JJ exposures_NNS ,_, then_RB estimates_NNS of_IN effects_NNS of_IN pollutant_NN effects_NNS were_VBD generally_RB smaller_JJR than_IN those_DT based_VBN on_IN exposure_NN levels_NNS determined_VBN by_IN personal_JJ sampling_NN 
It_PRP was_VBD suggested_VBN that_IN maternal_JJ exposure_NN to_TO NO_DT 2_CD can_MD increase_VB the_DT risk_NN of_IN pregnancy_NN complications_NNS through_IN stimulation_NN of_IN the_DT formation_NN of_IN cell-damaging_JJ lipid_NN peroxides_NNS and_CC from_IN decrease_NN in_IN maternal_JJ antioxidant_JJ reserves_NNS 
Although_IN there_EX is_VBZ an_DT opinion_NN that_IN adverse_JJ reproductive_JJ and_CC developmental_JJ effects_NNS related_VBN to_TO formaldehyde_NN are_VBP minimal_JJ 
Air_NN pollution_NN in_IN Kaunas_NNP ,_, as_RB well_RB as_IN in_IN the_DT whole_NN of_IN Lithuania_NNP ,_, has_VBZ actually_RB decreased_VBN during_IN its_PRP$ transformational_JJ period_NN of_IN economic_JJ decline_NN ._. 
During_IN the_DT last_JJ decade_NN ,_, the_DT concentration_NN of_IN SO2_NNP decreased_VBD to_TO almost_RB one-tenth_JJ ,_, NO2_NNP and_CC TSP_NNP decreased_VBD to_TO one-half_NN ,_, while_IN no_DT essential_JJ change_NN was_VBD noted_VBN for_IN formaldehyde_NN levels_NNS ._. 
The_DT major_JJ air_NN pollution_NN source_NN in_IN the_DT city_NN is_VBZ exhaust_NN emissions_NNS from_IN vehicles_NNS ,_, which_WDT account_VBP for_IN over_IN 70_CD %_NN of_IN the_DT total_JJ emissions_NNS ._. 
In_IN addition_NN ,_, we_PRP assessed_VBD the_DT effects_NNS of_IN average_JJ air_NN pollution_NN levels_NNS during_IN the_DT first_JJ ,_, second_JJ and_CC third_JJ trimester_NN of_IN gestation_NN ._. 
We_PRP then_RB examined_VBD the_DT distribution_NN of_IN several_JJ known_VBN risk_NN factors_NNS for_IN LBW_NNP and_CC preterm_JJ birth_NN across_IN different_JJ exposure_NN categories_NNS in_IN order_NN to_TO identify_VB potential_JJ confounders_NNS ._. 
Maternal_JJ age_NN was_VBD divided_VBN into_IN four_CD age_NN groups_NNS ,_, i._FW e._FW ,_, 
It_PRP was_VBD suggested_VBN that_IN maternal_JJ exposure_NN to_TO NO_DT 2_CD can_MD increase_VB the_DT risk_NN of_IN pregnancy_NN complications_NNS through_IN stimulation_NN of_IN the_DT formation_NN of_IN cell-damaging_JJ lipid_NN peroxides_NNS and_CC from_IN decrease_NN in_IN maternal_JJ antioxidant_JJ reserves_NNS 
It_PRP was_VBD suggested_VBN that_IN maternal_JJ exposure_NN to_TO NO_DT 2_CD can_MD increase_VB the_DT risk_NN of_IN pregnancy_NN complications_NNS through_IN stimulation_NN of_IN the_DT formation_NN of_IN cell-damaging_JJ lipid_NN peroxides_NNS and_CC from_IN decrease_NN in_IN maternal_JJ antioxidant_JJ reserves_NNS 
Increased_VBN lipid_JJ peroxidation_NN in_IN the_DT maternal_JJ and\/or_CC foetal_JJ compartment_NN has_VBZ been_VBN found_VBN in_IN preterm_NN birth_NN 
,proteins_NNS ,_, lipids_NNS -RRB-_-RRB- and_CC of_IN suppressing_VBG the_DT antioxidant_JJ protective_JJ systems_NNS of_IN organism_NN 
g._IN NO_DT 2_CD is_VBZ capable_JJ of_IN oxidising_VBG tissue_NN components_NNS -LRB-_-LRB- e._NN ,_, blood_NN viscosity_NN -RRB-_-RRB- 
g._VB Several_JJ potential_JJ mechanisms_NNS have_VBP been_VBN hypothesised_VBN ,_, including_VBG maternal_JJ susceptibility_NN to_TO infection_NN ,_, oxidative_JJ stress_NN ,_, hematological_JJ factors_NNS -LRB-_-LRB- e._NN ,_, blood_NN viscosity_NN -RRB-_-RRB- 
g._VB Several_JJ potential_JJ mechanisms_NNS have_VBP been_VBN hypothesised_VBN ,_, including_VBG maternal_JJ susceptibility_NN to_TO infection_NN ,_, oxidative_JJ stress_NN ,_, hematological_JJ factors_NNS -LRB-_-LRB- e._NN ,_, blood_NN viscosity_NN -RRB-_-RRB- 
g._VB Several_JJ potential_JJ mechanisms_NNS have_VBP been_VBN hypothesised_VBN ,_, including_VBG maternal_JJ susceptibility_NN to_TO infection_NN ,_, oxidative_JJ stress_NN ,_, hematological_JJ factors_NNS -LRB-_-LRB- e._NN ,_, blood_NN viscosity_NN -RRB-_-RRB- 
g._VB Several_JJ potential_JJ mechanisms_NNS have_VBP been_VBN hypothesised_VBN ,_, including_VBG maternal_JJ susceptibility_NN to_TO infection_NN ,_, oxidative_JJ stress_NN ,_, hematological_JJ factors_NNS -LRB-_-LRB- e._NN ,_, blood_NN viscosity_NN -RRB-_-RRB- 
The_DT biological_JJ mechanisms_NNS by_IN which_WDT air_NN pollutants_NNS may_MD interfere_VB with_IN the_DT processes_NNS of_IN prenatal_JJ development_NN are_VBP still_RB not_RB clear_JJ ._. 
Several_JJ potential_JJ mechanisms_NNS have_VBP been_VBN hypothesised_VBN ,_, including_VBG maternal_JJ susceptibility_NN to_TO infection_NN ,_, oxidative_JJ stress_NN ,_, hematological_JJ factors_NNS -LRB-_-LRB- e._FW g._FW ,_, blood_NN viscosity_NN -RRB-_-RRB- 
In_IN experimental_JJ studies_NNS it_PRP was_VBD found_VBN that_DT exposure_NN to_TO NO_DT 2_CD during_IN gestation_NN induced_VBD increased_VBN lipid_NN peroxidation_NN in_IN the_DT placenta_NN ,_, elevated_JJ postimplantation_NN embryonic_JJ lethality_NN ,_, and_CC disturbances_NNS of_IN postnatal_JJ development_NN 
21_CD per_IN 50_CD 
Conclusion_NNP Our_NNP findings_NNS suggest_VBP that_IN in_IN the_DT City_NN of_IN Kaunas_NNP there_EX might_MD be_VB a_DT relationship_NN between_IN maternal_JJ exposure_NN to_TO ambient_JJ formaldehyde_NN and_CC the_DT risk_NN of_IN LBW_NNP ,_, as_RB well_RB as_IN between_IN NO_DT 2_CD exposure_NN and_CC the_DT risk_NN of_IN preterm_NN birth_NN ._. 
BackgroundGrowing_VBG evidence_NN of_IN the_DT adverse_JJ effect_NN of_IN air_NN pollution_NN on_IN human_JJ health_NN raises_VBZ the_DT question_NN as_IN to_TO what_WP extent_NN this_DT affects_VBZ the_DT foetus_NN and_CC the_DT newborn_JJ ,_, which_WDT are_VBP likely_JJ to_TO be_VB more_RBR vulnerable_JJ than_IN adults_NNS to_TO environmental_JJ toxicants_NNS ._. 
Recent_JJ epidemiological_JJ studies_NNS ,_, conducted_VBN in_IN various_JJ countries_NNS ,_, have_VBP reported_VBN relationships_NNS between_IN elevated_JJ levels_NNS of_IN air_NN pollutants_NNS -LRB-_-LRB- total_JJ suspended_JJ particles_NNS -LRB-_-LRB- TSP_NNP -RRB-_-RRB- ,_, sulfur_NN dioxide_NN -LRB-_-LRB- SO_RB 2_CD -RRB-_-RRB- ,_, carbon_NN monoxide_NN -LRB-_-LRB- CO_NNP -RRB-_-RRB- ,_, nitrogen_NN dioxide_NN -LRB-_-LRB- NO_UH 2_CD -RRB-_-RRB- ,_, polycyclic_JJ aromatic_JJ hydrocarbons_NNS -LRB-_-LRB- PAH_NNP -RRB-_-RRB- -RRB-_-RRB- and_CC birth_NN outcomes_NNS ,_, such_JJ as_IN low_JJ birth_NN weight_NN -LRB-_-LRB- LBW_NNP -RRB-_-RRB- ,_, pre-maturity_JJ ,_, intrauterine_JJ retardation_NN -LRB-_-LRB- IUGR_NNP -RRB-_-RRB- 
Background_NN Growing_VBG evidence_NN of_IN the_DT adverse_JJ effect_NN of_IN air_NN pollution_NN on_IN human_JJ health_NN raises_VBZ the_DT question_NN as_IN to_TO what_WP extent_NN this_DT affects_VBZ the_DT foetus_NN and_CC the_DT newborn_JJ ,_, which_WDT are_VBP likely_JJ to_TO be_VB more_RBR vulnerable_JJ than_IN adults_NNS to_TO environmental_JJ toxicants_NNS ._. 
Recent_JJ epidemiological_JJ studies_NNS ,_, conducted_VBN in_IN various_JJ countries_NNS ,_, have_VBP reported_VBN relationships_NNS between_IN elevated_JJ levels_NNS of_IN air_NN pollutants_NNS -LRB-_-LRB- total_JJ suspended_JJ particles_NNS -LRB-_-LRB- TSP_NNP -RRB-_-RRB- ,_, sulfur_NN dioxide_NN -LRB-_-LRB- SO2_NNP -RRB-_-RRB- ,_, carbon_NN monoxide_NN -LRB-_-LRB- CO_NNP -RRB-_-RRB- ,_, nitrogen_NN dioxide_NN -LRB-_-LRB- NO2_NNP -RRB-_-RRB- ,_, polycyclic_JJ aromatic_JJ hydrocarbons_NNS -LRB-_-LRB- PAH_NNP -RRB-_-RRB- -RRB-_-RRB- and_CC birth_NN outcomes_NNS ,_, such_JJ as_IN low_JJ birth_NN weight_NN -LRB-_-LRB- LBW_NNP -RRB-_-RRB- ,_, pre-maturity_JJ ,_, intrauterine_JJ retardation_NN -LRB-_-LRB- IUGR_NNP -RRB-_-RRB- 
Results_NNS differed_VBD between_IN these_DT studies_NNS in_IN terms_NNS of_IN number_NN of_IN pollutants_NNS examined_VBD ,_, levels_NNS and_CC time_NN of_IN exposure_NN ,_, confounding_VBG factors_NNS that_WDT were_VBD present_JJ ,_, as_RB well_RB as_IN types_NNS of_IN pregnancy_NN outcomes_NNS ,_, and_CC magnitude_NN of_IN observed_JJ effects_NNS ._. 
Replication_NN of_IN findings_NNS in_IN different_JJ populations_NNS is_VBZ a_DT part_NN of_IN establishing_VBG a_DT convincing_NN relationship_NN between_IN air_NN pollution_NN and_CC pregnancy_NN outcomes_NNS ._. 
The_DT biological_JJ mechanisms_NNS by_IN which_WDT air_NN pollutants_NNS may_MD interfere_VB with_IN the_DT processes_NNS of_IN prenatal_JJ development_NN are_VBP still_RB not_RB clear_JJ ._. 
To_TO our_PRP$ knowledge_NN ,_, no_DT other_JJ epidemiological_JJ study_NN has_VBZ examined_VBN exposure_NN to_TO outdoor_JJ formaldehyde_NN as_IN a_DT risk_NN factor_NN for_IN adverse_JJ pregnancy_NN outcomes_NNS ._. 
Our_PRP$ results_NNS on_IN increased_VBN risk_NN for_IN preterm_NN delivery_NN in_IN relation_NN to_TO increasing_VBG levels_NNS of_IN NO2_NNP during_IN pregnancy_NN are_VBP consistent_JJ with_IN the_DT findings_NNS of_IN a_DT Czech_JJ study_NN ._. 
These_DT authors_NNS reported_VBD a_DT relation_NN between_IN maternal_JJ exposure_NN to_TO NO_DT x_SYM in_IN the_DT first_JJ trimester_NN and_CC a_DT slightly_RB increased_VBN risk_NN of_IN premature_JJ birth_NN -LRB-_-LRB- adjusted_VBN OR_NNP 1_CD ._. 
5_CD 
7%_CD a_DT HF_NNP :_: heart_NN failure_NN ;_: ICC_NNP :_: intraclass_JJ correlation_NN coefficient_NN ;_: CV_NNP WP_NNP :_: within-person_JJ coefficient_NN of_IN variation_NN ._. 
DiscussionAir_NNP Pollution_NNP and_CC Heart_NNP FailureStudies_NNP using_VBG administrative_JJ data_NNS have_VBP reported_VBN a_DT positive_JJ association_NN between_IN short-term_JJ increases_NNS in_IN ambient_JJ particles_NNS and_CC the_DT risk_NN of_IN hospitalization_NN for_IN HF_NNP ._. 
While_IN the_DT magnitude_NN of_IN the_DT effect_NN is_VBZ generally_RB small_JJ -LRB-_-LRB- on_IN the_DT order_NN of_IN 1_CD %_NN increase_NN in_IN risk_NN for_IN a_DT 10_CD 
Background_NN Ambient_JJ air_NN pollution_NN is_VBZ a_DT recognized_VBN risk_NN factor_NN for_IN cardiovascular_JJ morbidity_NN and_CC mortality_NN 
5_CD 
7%_CD a_DT HF_NNP :_: heart_NN failure_NN ;_: ICC_NNP :_: intraclass_JJ correlation_NN coefficient_NN ;_: CV_NNP WP_NNP :_: within-person_JJ coefficient_NN of_IN variation_NN ._. 
DiscussionAir_NNP Pollution_NNP and_CC Heart_NNP FailureStudies_NNP using_VBG administrative_JJ data_NNS have_VBP reported_VBN a_DT positive_JJ association_NN between_IN short-term_JJ increases_NNS in_IN ambient_JJ particles_NNS and_CC the_DT risk_NN of_IN hospitalization_NN for_IN HF_NNP ._. 
While_IN the_DT magnitude_NN of_IN the_DT effect_NN is_VBZ generally_RB small_JJ -LRB-_-LRB- on_IN the_DT order_NN of_IN 1_CD %_NN increase_NN in_IN risk_NN for_IN a_DT 10_CD 
5-RRB-_NNP ,_, respectively_RB -RRB-_-RRB- and_CC the_DT risk_NN of_IN hospitalization_NN for_IN congestive_JJ heart_NN failure_NN -LRB-_-LRB- HF_NNP -RRB-_-RRB- ._. 
5_CD 
recognized_VBN this_DT gap_NN in_IN the_DT literature_NN and_CC asked_VBD a_DT panel_NN of_IN 31_CD HF_NNP patients_NNS aged_VBD 
This_DT heterogeneity_NN is_VBZ captured_VBN in_IN the_DT large_JJ administrative_JJ studies_NNS which_WDT identify_VBP cases_NNS according_VBG to_TO discharge_VB diagnoses_NNS ,_, but_CC not_RB well_RB captured_VBN in_IN the_DT more_RBR selective_JJ studies_NNS of_IN Goldberg_NNP et_FW al._FW ._. 
B-type_JJ natriuretic_JJ peptide_NN -LRB-_-LRB- BNP_NNP -RRB-_-RRB- is_VBZ a_DT neurohormone_NN is_VBZ produced_VBN principally_RB by_IN the_DT ventricles_NNS of_IN the_DT heart_NN in_IN response_NN to_TO increasing_VBG wall_NN stress_NN ._. 
BNP_NNP has_VBZ beneficial_JJ vasodilatory_NN ,_, natriuretic_JJ ,_, and_CC neurohormonal_JJ actions_NNS which_WDT act_VBP to_TO reduce_VB this_DT wall_NN stress_NN 
Alternative_NNP ,_, more_RBR direct_JJ markers_NNS of_IN cardiac_JJ function_NN may_MD perform_VB better_RBR ._. 
To_TO put_VB this_DT effect_NN size_NN into_IN perspective_NN ,_, one_CD large_JJ clinical_JJ trial_NN found_VBD that_IN 4_CD months_NNS of_IN treatment_NN with_IN the_DT angiotensin_NN receptor_NN blocker_NN valsartan_NN reduced_VBD BNP_NNP levels_NNS by_IN approximately_RB 19_CD %_NN in_IN patients_NNS with_IN stable_JJ HF_NNP ._. 
For_IN example_NN ,_, novel_JJ Doppler_NNP echocardiographic_NN measures_NNS have_VBP been_VBN used_VBN in_IN the_DT context_NN of_IN pre-post_JJ studies_NNS to_TO demonstrate_VB that_DT cigarette_NN smoking_NN acut_NN 
Alternative_NNP ,_, more_RBR direct_JJ markers_NNS of_IN cardiac_JJ function_NN may_MD perform_VB better_RBR ._. 
To_TO put_VB this_DT effect_NN size_NN into_IN perspective_NN ,_, one_CD large_JJ clinical_JJ trial_NN found_VBD that_IN 4_CD months_NNS of_IN treatment_NN with_IN the_DT angiotensin_NN receptor_NN blocker_NN valsartan_NN reduced_VBD BNP_NNP levels_NNS by_IN approximately_RB 19_CD %_NN in_IN patients_NNS with_IN stable_JJ HF_NNP 
Only_RB the_DT study_NN by_IN Bruins_NNPS et_FW al._FW ._. 
Although_IN small_JJ in_IN size_NN ,_, prior_JJ studies_NNS have_VBP consistently_RB shown_VBN that_IN within-person_JJ hour-to-hour_JJ and_CC day-to-day_JJ variability_NN in_IN the_DT range_NN of_IN 15_CD 
There_EX has_VBZ been_VBN considerable_JJ interest_NN in_IN evaluating_VBG the_DT use_NN of_IN single_JJ measurements_NNS of_IN BNP_NNP and_CC NT-pro-BNP_NNP -LRB-_-LRB- an_DT inactive_JJ metabolite_NN of_IN pro-BNP_NNP -RRB-_-RRB- as_IN a_DT diagnostic_JJ aid_NN for_IN acute_JJ decompensated_JJ heart_NN failure_NN in_IN patients_NNS presenting_VBG to_TO the_DT emergency_NN department_NN with_IN acute_JJ dyspnea_NN ._. 
In_IN contrast_NN ,_, the_DT biologic_JJ variability_NN 
In_IN fact_NN ,_, based_VBN on_IN the_DT sample_NN size_NN formulas_NNS of_IN Fitzmaurice_NNP et_FW al._FW ._. 
In_IN the_DT context_NN of_IN environmental_JJ exposures_NNS ,_, these_DT results_NNS imply_VBP that_IN an_DT impracticably_RB large_JJ sample_NN size_NN would_MD be_VB required_VBN in_IN a_DT repeated-measures_JJ study_NN to_TO detect_VB the_DT typically_RB modest_JJ effects_NNS of_IN ambient_JJ air_NN pollutants_NNS that_IN one_PRP might_MD expect_VB to_TO see_VB at_IN the_DT level_NN of_IN an_DT individual_JJ subject_NN ._. 
and_CC assuming_VBG that_WDT log_VBP -LRB-_-LRB- BNP_NNP -RRB-_-RRB- is_VBZ modeled_VBN ,_, in_IN order_NN to_TO have_VB 80_CD %_NN power_NN to_TO detect_VB a_DT 5_CD ._. 
6%_CD increase_NN in_IN BNP_NNP associated_VBN with_IN an_DT interquartile_JJ range_NN increase_NN in_IN PM_NNP 2_CD ._. 
5-LRB-_IN the_DT largest_JJS point_NN estimate_NN for_IN PM_NNP 2_CD ._. 
5observed_VBN in_IN the_DT current_JJ study_NN -RRB-_-RRB- ,_, a_DT longitudinal_JJ study_NN with_IN 5_CD bi-weekly_JJ measures_NNS per_IN subject_NN would_MD require_VB approximately_RB 135_CD subjects_NNS ._. 
To_TO put_VB this_DT effect_NN size_NN into_IN perspective_NN ,_, one_CD large_JJ clinical_JJ trial_NN found_VBD that_IN 4_CD months_NNS of_IN treatment_NN with_IN the_DT angiotensin_NN receptor_NN blocker_NN valsartan_NN reduced_VBD BNP_NNP levels_NNS by_IN approximately_RB 19_CD %_NN in_IN patients_NNS with_IN stable_JJ HF_NNP ._. 
Alternative_NNP ,_, more_RBR direct_JJ markers_NNS of_IN cardiac_JJ function_NN may_MD perform_VB better_RBR ._. 
For_IN example_NN ,_, novel_JJ Doppler_NNP echocardiographic_NN measures_NNS have_VBP been_VBN used_VBN in_IN the_DT context_NN of_IN pre-post_JJ studies_NNS to_TO demonstrate_VB that_DT cigarette_NN smoking_NN acutely_RB impairs_VBZ ventricular_JJ relaxation_NN during_IN diastole_NN in_IN healthy_JJ 
There_EX has_VBZ been_VBN considerable_JJ interest_NN in_IN evaluating_VBG the_DT use_NN of_IN single_JJ measurements_NNS of_IN BNP_NNP and_CC NT-pro-BNP_NNP -LRB-_-LRB- an_DT inactive_JJ metabolite_NN of_IN pro-BNP_NNP -RRB-_-RRB- as_IN a_DT diagnostic_JJ aid_NN for_IN acute_JJ decompensated_JJ heart_NN failure_NN in_IN patients_NNS presenting_VBG to_TO the_DT emergency_NN department_NN with_IN acute_JJ dyspnea_NN ._. 
In_IN contrast_NN ,_, the_DT biologic_JJ variability_NN 
Although_IN much_JJ of_IN this_DT variability_NN was_VBD explained_VBN by_IN differences_NNS between_IN subjects_NNS ,_, there_EX remained_VBD substantial_JJ variability_NN in_IN BNP_NNP levels_NNS within_IN individuals_NNS ._. 
There_EX has_VBZ been_VBN considerable_JJ interest_NN in_IN evaluating_VBG the_DT use_NN of_IN single_JJ measurements_NNS of_IN BNP_NNP and_CC NT-pro-BNP_NNP -LRB-_-LRB- an_DT inactive_JJ metabolite_NN of_IN pro-BNP_NNP -RRB-_-RRB- as_IN a_DT diagnostic_JJ aid_NN for_IN acute_JJ decompensated_JJ heart_NN failure_NN in_IN patients_NNS presenting_VBG to_TO the_DT emergency_NN department_NN with_IN acute_JJ dyspnea_NN ._. 
In_IN contrast_NN ,_, the_DT biologic_JJ variability_NN 
To_TO address_VB this_DT problem_NN ,_, Symons_NNP et_FW al._FW ._. 
While_IN the_DT magnitude_NN of_IN the_DT effect_NN is_VBZ generally_RB small_JJ -LRB-_-LRB- on_IN the_DT order_NN of_IN 1_CD %_NN increase_NN in_IN risk_NN for_IN a_DT 10_CD 
5levels_NNS at_IN lags_VBZ of_IN 0_CD to_TO 3_CD days_NNS were_VBD considered_VBN in_IN separate_JJ models_NNS ._. 
PM_NN 2_CD ._. 
Indicator_NN variables_NNS for_IN calendar_NN month_NN of_IN blood_NN draw_NN ,_, measurement_NN occasion_NN ,_, treatment_NN assignment_NN ,_, and_CC measurement_NN occasion_NN by_IN treatment_NN assignment_NN interactions_NNS were_VBD also_RB included_VBN ._. 
To_TO assess_VB the_DT reproducibility_NN of_IN BNP_NNP and_CC log_VB -LRB-_-LRB- BNP_NNP -RRB-_-RRB- measurements_NNS over_IN the_DT 12_CD week_NN period_NN ,_, we_PRP calculated_VBD the_DT within-subject_JJ coefficient_NN of_IN variation_NN -LRB-_-LRB- CVWS_NNP -RRB-_-RRB- and_CC the_DT intraclass_JJ correlation_NN coefficient_NN -LRB-_-LRB- ICC_NNP -RRB-_-RRB- among_IN all_DT subjects_NNS ._. 
Variance_NN components_NNS were_VBD estimated_VBN from_IN a_DT mixed_JJ model_NN with_IN random_JJ subject_JJ intercepts_NNS and_CC a_DT fixed_JJ effect_NN for_IN treatment_NN assignment_NN ._. 
The_DT goal_NN of_IN this_DT study_NN was_VBD to_TO evaluate_VB the_DT association_NN between_IN short-term_JJ fluctuations_NNS in_IN ambient_JJ air_NN pollution_NN concentrations_NNS and_CC BNP_NNP levels_NNS in_IN a_DT panel_NN of_IN patients_NNS with_IN chronic_JJ stable_JJ HF_NNP ._. 
To_TO accomplish_VB this_DT ,_, we_PRP carried_VBD out_RP a_DT retrospective_JJ analysis_NN of_IN a_DT completed_VBN clinical_JJ trial_NN in_IN which_WDT 3_NNP repeated_VBD BNP_NNP measurements_NNS were_VBD made_VBN in_IN study_NN participants_NNS over_IN a_DT 3_CD month_NN period_NN 
To_TO accomplish_VB this_DT ,_, we_PRP carried_VBD out_RP a_DT retrospective_JJ analysis_NN of_IN a_DT completed_VBN clinical_JJ trial_NN in_IN which_WDT 3_NNP repeated_VBD BNP_NNP measurements_NNS were_VBD made_VBN in_IN study_NN participants_NNS over_IN a_DT 3_CD month_NN period_NN 
Patients_NNS currently_RB participating_VBG in_IN conventional_JJ cardiac_JJ rehabilitation_NN programs_NNS were_VBD excluded_VBN ._. 
The_DT intervention_NN consisted_VBD of_IN 1-hour_JJ group_NN tai_FW chi_FW classes_NNS held_VBD twice_RB weekly_JJ for_IN 12_CD weeks_NNS ._. 
Additional_JJ methodological_JJ details_NNS and_CC results_NNS have_VBP been_VBN previously_RB published_VBN ._. 
BNP_NNP was_VBD measured_VBN at_IN 0_CD ,_, 6_CD and_CC 12_CD weeks_NNS from_IN whole_JJ blood_NN collected_VBN in_IN ethylenediaminetetraacetic_JJ acid_NN using_VBG a_DT fluorescence_NN immunoassay_NN -LRB-_-LRB- Biosite_NNP Triage_NNP BNP_NNP Test_NNP ;_: San_NNP Diego_NNP ,_, California_NNP -RRB-_-RRB- ._. 
Among_IN patients_NNS undergoing_VBG treatment_NN for_IN acute_JJ decompensated_JJ HF_NNP ,_, BNP_NNP levels_NNS are_VBP positively_RB associated_VBN with_IN symptom_NN severity_NN and_CC key_JJ indices_NNS of_IN cardiac_JJ hemodynamics_NNS ,_, while_IN administration_NN of_IN human_JJ recombinant_JJ BNP_NNP -LRB-_-LRB- Nesiritide_NNP -RRB-_-RRB- improves_VBZ both_DT hemodynamics_NNS and_CC symptoms_NNS 
BNP_NNP has_VBZ beneficial_JJ vasodilatory_NN ,_, natriuretic_JJ ,_, and_CC neurohormonal_JJ actions_NNS which_WDT act_VBP to_TO reduce_VB this_DT wall_NN stress_NN 
BNP_NNP has_VBZ beneficial_JJ vasodilatory_NN ,_, natriuretic_JJ ,_, and_CC neurohormonal_JJ actions_NNS which_WDT act_VBP to_TO reduce_VB this_DT wall_NN stress_NN 
Although_IN much_JJ of_IN this_DT variability_NN was_VBD explained_VBN by_IN differences_NNS between_IN subjects_NNS ,_, there_EX remained_VBD substantial_JJ variability_NN in_IN BNP_NNP levels_NNS within_IN individuals_NNS ._. 
There_EX has_VBZ been_VBN considerable_JJ interest_NN in_IN evaluating_VBG the_DT use_NN of_IN single_JJ measurements_NNS of_IN BNP_NNP and_CC NT-pro-BNP_NNP -LRB-_-LRB- an_DT inactive_JJ metabolite_NN of_IN pro-BNP_NNP -RRB-_-RRB- as_IN a_DT diagnostic_JJ aid_NN for_IN acute_JJ decompensated_JJ heart_NN failure_NN in_IN patients_NNS presenting_VBG to_TO the_DT emergency_NN department_NN with_IN acute_JJ dyspnea_NN ._. 
In_IN contrast_NN ,_, the_DT biologic_JJ variability_NN 
BNP_NNP has_VBZ beneficial_JJ vasodilatory_NN ,_, natriuretic_JJ ,_, and_CC neurohormonal_JJ actions_NNS which_WDT act_VBP to_TO reduce_VB this_DT wall_NN stress_NN 
Background_NN Ambient_JJ air_NN pollution_NN is_VBZ a_DT recognized_VBN risk_NN factor_NN for_IN cardiovascular_JJ morbidity_NN and_CC mortality_NN 
Background_NN Ambient_JJ air_NN pollution_NN is_VBZ a_DT recognized_VBN risk_NN factor_NN for_IN cardiovascular_JJ morbidity_NN and_CC mortality_NN 
To_TO reduce_VB exposure_NN misclassification_NN ,_, we_PRP excluded_VBD from_IN analysis_NN 2_CD patients_NNS who_WP lived_VBD more_JJR than_IN 40_CD km_NN from_IN this_DT central_JJ monitor_NN ._. 
Additionally_RB ,_, we_PRP obtained_VBD hourly_JJ measures_NNS of_IN carbon_NN monoxide_NN -LRB-_-LRB- CO_NNP -RRB-_-RRB- ,_, nitrogen_NN dioxide_NN -LRB-_-LRB- NO2_NNP -RRB-_-RRB- ,_, sulfur_NN dioxide_NN -LRB-_-LRB- SO2_NNP -RRB-_-RRB- ,_, and_CC ozone_NN from_IN the_DT Massachusetts_NNP Department_NNP of_IN Environmental_NNP Protection_NNP and_CC calculated_JJ daily_JJ average_NN values_NNS as_IN previously_RB described_VBN ._. 
We_PRP obtained_VBD from_IN the_DT National_NNP Weather_NNP Service_NNP daily_JJ summaries_NNS of_IN meteorological_JJ data_NNS measured_VBN at_IN Logan_NNP International_NNP Airport_NNP ._. 
Background_NN Ambient_JJ air_NN pollution_NN is_VBZ a_DT recognized_VBN risk_NN factor_NN for_IN cardiovascular_JJ morbidity_NN and_CC mortality_NN 
To_TO reduce_VB exposure_NN misclassification_NN ,_, we_PRP excluded_VBD from_IN analysis_NN 2_CD patients_NNS who_WP lived_VBD more_JJR than_IN 40_CD km_NN from_IN this_DT central_JJ monitor_NN ._. 
Additionally_RB ,_, we_PRP obtained_VBD hourly_JJ measures_NNS of_IN carbon_NN monoxide_NN -LRB-_-LRB- CO_NNP -RRB-_-RRB- ,_, nitrogen_NN dioxide_NN -LRB-_-LRB- NO2_NNP -RRB-_-RRB- ,_, sulfur_NN dioxide_NN -LRB-_-LRB- SO2_NNP -RRB-_-RRB- ,_, and_CC ozone_NN from_IN the_DT Massachusetts_NNP Department_NNP of_IN Environmental_NNP Protection_NNP and_CC calculated_JJ daily_JJ average_NN values_NNS as_IN previously_RB described_VBN ._. 
We_PRP obtained_VBD from_IN the_DT National_NNP Weather_NNP Service_NNP daily_JJ summaries_NNS of_IN meteorological_JJ data_NNS measured_VBN at_IN Logan_NNP International_NNP Airport_NNP ._. 
The_DT magnitude_NN of_IN expected_VBN ambient_JJ air_NN pollution_NN health_NN effects_NNS appears_VBZ small_JJ in_IN relation_NN to_TO the_DT considerable_JJ within-person_NN variability_NN in_IN BNP_NNP levels_NNS in_IN this_DT population_NN ._. 
BackgroundAmbient_JJ air_NN pollution_NN is_VBZ a_DT recognized_VBN risk_NN factor_NN for_IN cardiovascular_JJ morbidity_NN and_CC mortality_NN 
Background_NN Ambient_JJ air_NN pollution_NN is_VBZ a_DT recognized_VBN risk_NN factor_NN for_IN cardiovascular_JJ morbidity_NN and_CC mortality_NN 
Background_NN Ambient_JJ air_NN pollution_NN is_VBZ a_DT recognized_VBN risk_NN factor_NN for_IN cardiovascular_JJ morbidity_NN and_CC mortality_NN 
Afew_JJ observations_NNS should_MD be_VB made_VBN here_RB regarding_VBG methods_NNS ._. 
The_DT risk_NN excess_NN is_VBZ also_RB evident_JJ in_IN females_NNS ,_, and_CC ,_, for_IN both_DT sexes_NNS taken_VBN together_RB ,_, for_IN cancers_NNS of_IN the_DT connective_NN and_CC other_JJ soft_JJ tissue_NN -LRB-_-LRB- ICD-IX_NNP 171_CD -RRB-_-RRB- ._. 
We_PRP believe_VBP that_IN cases_NNS have_VBP been_VBN correctly_RB and_CC completely_RB identified_VBN ,_, as_IN they_PRP are_VBP incident_NN cases_NNS taken_VBN from_IN a_DT permanent_JJ tumor_NN registry_NN -LRB-_-LRB- RTV_NNP -RRB-_-RRB- that_WDT has_VBZ been_VBN active_JJ for_IN many_JJ years_NNS and_CC whose_WP$ data_NNS have_VBP been_VBN published_VBN since_IN 1987_CD in_IN the_DT ``_`` Cancer_NNP Incidence_NNP in_IN Five_CD Continents_NNS ''_'' publications_NNS of_IN the_DT International_NNP Agency_NNP for_IN Research_NNP on_IN Cancer_NNP ,_, Lyon_NNP ._. 
By_IN consulting_VBG the_DT actual_JJ pathology_NN reports_NNS and_CC clinical_JJ records_NNS gathered_VBN by_IN the_DT RTV_NNP we_PRP were_VBD able_JJ to_TO identify_VB mixed_JJ forms_NNS -LRB-_-LRB- carcinosarcomas_NNS -RRB-_-RRB- ,_, sarcomas_VBZ with_IN ``_`` bone_NN ''_'' topography_NN ,_, ``_`` possible_JJ ''_'' diagnoses_NNS ,_, and_CC cases_NNS associated_VBN with_IN other_JJ known_VBN risk_NN factors_NNS ._. 
Afew_JJ observations_NNS should_MD be_VB made_VBN here_RB regarding_VBG methods_NNS ._. 
The_DT risk_NN excess_NN is_VBZ also_RB evident_JJ in_IN females_NNS ,_, and_CC ,_, for_IN both_DT sexes_NNS taken_VBN together_RB ,_, for_IN cancers_NNS of_IN the_DT connective_NN and_CC other_JJ soft_JJ tissue_NN -LRB-_-LRB- ICD-IX_NNP 171_CD -RRB-_-RRB- ._. 
We_PRP believe_VBP that_IN cases_NNS have_VBP been_VBN correctly_RB and_CC completely_RB identified_VBN ,_, as_IN they_PRP are_VBP incident_NN cases_NNS taken_VBN from_IN a_DT permanent_JJ tumor_NN registry_NN -LRB-_-LRB- RTV_NNP -RRB-_-RRB- that_WDT has_VBZ been_VBN active_JJ for_IN many_JJ years_NNS and_CC whose_WP$ data_NNS have_VBP been_VBN published_VBN since_IN 1987_CD in_IN the_DT ``_`` Cancer_NNP Incidence_NNP in_IN Five_CD Continents_NNS ''_'' publications_NNS of_IN the_DT International_NNP Agency_NNP for_IN Research_NNP on_IN Cancer_NNP ,_, Lyon_NNP ._. 
By_IN consulting_VBG the_DT actual_JJ pathology_NN reports_NNS and_CC clinical_JJ records_NNS gathered_VBN by_IN the_DT RTV_NNP we_PRP were_VBD able_JJ to_TO identify_VB mixed_JJ forms_NNS -LRB-_-LRB- carcinosarcomas_NNS -RRB-_-RRB- ,_, sarcomas_VBZ with_IN ``_`` bone_NN ''_'' topography_NN ,_, ``_`` possible_JJ ''_'' diagnoses_NNS ,_, and_CC cases_NNS associated_VBN with_IN other_JJ known_VBN risk_NN factors_NNS ._. 
Sarcoma_NN risks_NNS by_IN sex_NN and_CC by_IN ICD-IX_NNP code_NN were_VBD only_RB analyzed_VBN for_IN level_NN of_IN exposure_NN because_IN the_DT time-period_JJ variable_NN was_VBD not_RB significant_JJ ._. 
We_PRP used_VBD conditional_JJ logistic_JJ regression_NN to_TO calculate_VB Odds_NNS Ratio_NNP -LRB-_-LRB- OR_NNP -RRB-_-RRB- values_NNS and_CC 95_CD %_NN Confidence_NNP Interval_NNP ,_, and_CC the_DT Wald_NNP chi-square_JJ test_NN for_IN trend_NN ,_, using_VBG the_DT SAS_NNP Software_NNP 
Sarcoma_NN risks_NNS by_IN sex_NN and_CC by_IN ICD-IX_NNP code_NN were_VBD only_RB analyzed_VBN for_IN level_NN of_IN exposure_NN because_IN the_DT time-period_JJ variable_NN was_VBD not_RB significant_JJ ._. 
We_PRP used_VBD conditional_JJ logistic_JJ regression_NN to_TO calculate_VB Odds_NNS Ratio_NNP -LRB-_-LRB- OR_NNP -RRB-_-RRB- values_NNS and_CC 95_CD %_NN Confidence_NNP Interval_NNP ,_, and_CC the_DT Wald_NNP chi-square_JJ test_NN for_IN trend_NN ,_, using_VBG the_DT SAS_NNP Software_NNP 
Population_NNP on_IN analysis_NN Seventeen_CD controls_NNS out_IN of_IN 558_CD were_VBD lost_VBN because_IN the_DT Municipal_NNP Population_NNP Registers_NNP showed_VBD that_IN by_IN 1990_CD they_PRP were_VBD either_RB no_RB longer_JJR resident_NN or_CC had_VBD died_VBN ._. 
The_DT following_JJ subjects_NNS were_VBD also_RB excluded_VBN from_IN the_DT analysis_NN :_: -_: 3_CD childhood_NN cases_NNS ,_, born_VBN after_IN 1986_CD when_WRB the_DT exposure_NN studied_VBN had_VBD ceased_VBN and_CC their_PRP$ 9_CD matched_VBN controls_NNS ;_: -_: 2_CD cases_NNS ,_, correlated_VBN with_IN recognized_VBN risk_NN factors_NNS :_: one_CD radiation-induced_JJ case_NN and_CC one_CD associated_VBN with_IN von_NNP Recklinghausen_NNP 's_POS disease_NN and_CC their_PRP$ 6_CD matched_VBN controls_NNS ;_: -_: 9_CD cases_NNS of_IN subjects_NNS who_WP did_VBD not_RB continuously_RB reside_VB in_IN the_DT Province_NNP or_CC moved_VBD there_RB after_IN 1969_CD ;_: since_IN it_PRP was_VBD not_RB possible_JJ to_TO assign_VB a_DT level_NN of_IN exposure_NN to_TO addresses_NNS in_IN other_JJ provinces_NNS ,_, in_IN our_PRP$ study_NN we_PRP only_RB considered_VBN subjects_NNS who_WP were_VBD already_RB living_VBG in_IN the_DT area_NN under_IN study_NN in_IN 1969_CD or_CC resided_VBD there_RB from_IN birth_NN ._. 
We_PRP believe_VBP subjects_NNS could_MD not_RB be_VB exposed_VBN before_IN 1969_CD even_RB if_IN they_PRP resided_VBD elsewhere_RB because_IN Porto_NNP Marghera_NNP -LRB-_-LRB- Venice_NNP -RRB-_-RRB- was_VBD the_DT first_JJ industrial_JJ area_NN created_VBN in_IN Italy_NNP after_IN the_DT Second_NNP World_NNP War_NNP and_CC Veneto_NNP was_VBD also_RB the_DT place_NN were_VBD the_DT first_JJ incinerators_NNS for_IN urban_JJ and_CC hospital_NN waste_NN were_VBD built_VBN ;_: we_PRP also_RB excluded_VBD their_PRP$ 27_CD matched_VBN controls_NNS ;_: Moreover_RB ,_, among_IN controls_NNS we_PRP also_RB excluded_VBD the_DT following_NN :_: -_: 59_CD controls_NNS with_IN malignant_JJ tumors_NNS ,_, all_DT sites_NNS ,_, registered_VBN in_IN the_DT RTV_NNP database_NN ,_, because_IN dioxins_NNS are_VBP considered_VBN to_TO be_VB carcinogens_NNS for_IN all_DT types_NNS of_IN cancer_NN :_: only_JJ cases_NNS of_IN non_FW melanoma_FW skin_NN cancer_NN were_VBD accepted_VBN ;_: -_: 35_CD controls_NNS who_WP were_VBD not_RB continuously_RB resident_JJ in_IN the_DT Province_NNP or_CC had_VBD moved_VBN there_RB after_IN 1969_CD ._. 
44_CD 
30_CD -RRB-_-RRB- for_IN females_NNS ._. 
44_CD 
Comba_FW et_FW al._FW ._. 
Excess_JJ risk_NN for_IN non-Hodgkin_JJ lymphomas_NNS was_VBD only_RB present_JJ in_IN the_DT area_NN with_IN the_DT highest_JJS estimated_JJ concentrations_NNS of_IN dioxin_NN ._. 
reported_VBD a_DT significant_JJ increase_NN in_IN the_DT risk_NN of_IN sarcoma_NN associated_VBN with_IN living_NN within_IN a_DT two_CD kilometre_NN radius_NN of_IN an_DT incinerator_NN burning_VBG industrial_JJ waste_NN ._. 
The_DT cluster_NN is_VBZ remarkable_JJ for_IN the_DT net_JJ prevalence_NN of_IN women_NNS among_IN the_DT cases_NNS :_: given_VBN that_IN these_DT women_NNS would_MD not_RB have_VB been_VBN exposed_VBN to_TO risk_VB for_IN occupational_JJ reasons_NNS ,_, there_EX can_MD be_VB no_DT other_JJ explanation_NN apart_RB from_IN the_DT proximity_NN of_IN their_PRP$ home_NN to_TO the_DT incinerator_NN and_CC excess_JJ risk_NN does_VBZ not_RB extend_VB beyond_IN the_DT 2_CD kilometre_NN radius_NN ._. 
The_DT same_JJ authors_NNS also_RB conducted_VBD a_DT further_JJ study_NN in_IN order_NN to_TO validate_VB their_PRP$ method_NN ,_, using_VBG soil_NN samples_NNS ._. 
On_IN flat_JJ terrain_NN they_PRP discovered_VBD a_DT significant_JJ association_NN between_IN their_PRP$ estimated_VBN dioxin_NN concentrations_NNS and_CC the_DT log-transformed_JJ measured_JJ dioxin_NN soil_NN concentrations_NNS ,_, while_IN in_IN the_DT more_RBR topographically_RB complex_JJ areas_NNS their_PRP$ model_NN tended_VBD to_TO overestimate_VB concentrations_NNS ._. 
We_PRP used_VBD an_DT analogous_JJ dispersion_NN model_NN and_CC from_IN the_DT topographical_JJ point_NN of_IN view_NN the_DT entire_JJ Province_NNP is_VBZ completely_RB flat_JJ ,_, so_IN our_PRP$ estimates_NNS probably_RB do_VBP provide_VB a_DT good_JJ estimate_NN of_IN dioxin_NN exposure_NN ._. 
identified_VBN a_DT cluster_NN of_IN sarcomas_NNS and_CC non-Hodgkin_JJ lymphomas_NNS in_IN a_DT population_NN living_NN near_IN a_DT municipal_JJ waste_NN incinerator_NN ,_, with_IN high_JJ levels_NNS of_IN emissions_NNS ,_, at_IN Besan_NNP 
identified_VBN a_DT cluster_NN of_IN sarcomas_NNS and_CC non-Hodgkin_JJ lymphomas_NNS in_IN a_DT population_NN living_NN near_IN a_DT municipal_JJ waste_NN incinerator_NN ,_, with_IN high_JJ levels_NNS of_IN emissions_NNS ,_, at_IN Besan_NNP 
In_IN 2000_CD ,_, Viel_NNP et_FW al._FW ._. 
So_RB far_RB ,_, very_RB few_JJ studies_NNS have_VBP analyzed_VBN the_DT relationship_NN between_IN risk_NN of_IN sarcoma_NN and_CC emissions_NNS from_IN incinerators_NNS ._. 
identified_VBN a_DT cluster_NN of_IN sarcomas_NNS and_CC non-Hodgkin_JJ lymphomas_NNS in_IN a_DT population_NN living_NN near_IN a_DT municipal_JJ waste_NN incinerator_NN ,_, with_IN high_JJ levels_NNS of_IN emissions_NNS ,_, at_IN Besan_NNP 
Exposure_NN to_TO dioxin_NN has_VBZ been_VBN associated_VBN with_IN an_DT increased_VBN risk_NN of_IN sarcoma_NN 
Arecent_JJ review_NN of_IN the_DT literature_NN on_IN epidemiological_JJ studies_NNS concerning_VBG the_DT effect_NN on_IN health_NN of_IN exposure_NN to_TO emissions_NNS from_IN waste_NN incinerators_NNS showed_VBD that_IN a_DT significant_JJ association_NN between_IN exposure_NN and_CC cancer_NN was_VBD made_VBN in_IN two_CD thirds_NNS of_IN the_DT studies_NNS published_VBN by_IN 2003_CD 
Arecent_JJ review_NN of_IN the_DT literature_NN on_IN epidemiological_JJ studies_NNS concerning_VBG the_DT effect_NN on_IN health_NN of_IN exposure_NN to_TO emissions_NNS from_IN waste_NN incinerators_NNS showed_VBD that_IN a_DT significant_JJ association_NN between_IN exposure_NN and_CC cancer_NN was_VBD made_VBN in_IN two_CD thirds_NNS of_IN the_DT studies_NNS published_VBN by_IN 2003_CD 
Lastly_RB ,_, the_DT significant_JJ excess_NN of_IN risk_NN observed_VBN in_IN women_NNS was_VBD unlikely_JJ to_TO be_VB due_JJ to_TO occupational_JJ exposure_NN ,_, being_VBG instead_RB primarily_RB attributable_JJ to_TO environmental_JJ exposure_NN ,_, given_VBN that_IN women_NNS were_VBD less_RBR mobile_JJ in_IN the_DT past_NN and_CC would_MD have_VB rarely_RB been_VBN subject_JJ to_TO risk_NN of_IN occupational_JJ exposure_NN to_TO the_DT pollutants_NNS studied_VBD ._. 
Arecent_JJ review_NN of_IN the_DT literature_NN on_IN epidemiological_JJ studies_NNS concerning_VBG the_DT effect_NN on_IN health_NN of_IN exposure_NN to_TO emissions_NNS from_IN waste_NN incinerators_NNS showed_VBD that_IN a_DT significant_JJ association_NN between_IN exposure_NN and_CC cancer_NN was_VBD made_VBN in_IN two_CD thirds_NNS of_IN the_DT studies_NNS published_VBN by_IN 2003_CD 
We_PRP have_VBP no_DT information_NN about_IN social_JJ status_NN and_CC only_RB partial_JJ knowledge_NN regarding_VBG occupation_NN ,_, nevertheless_RB we_PRP consider_VBP it_PRP unlikely_JJ for_IN occupational_JJ exposure_NN to_TO have_VB had_VBN much_JJ influence_NN ,_, since_IN to_TO our_PRP$ knowledge_NN ,_, there_EX were_VBD no_DT industries_NNS in_IN the_DT area_NN at_IN the_DT time_NN where_WRB there_EX would_MD have_VB been_VBN risk_NN of_IN exposure_NN to_TO dioxins_NNS ._. 
As_IN regards_VBZ cases_NNS between_IN 35_CD 
The_DT three_CD LHUs_NNS cover_VBP a_DT relatively_RB small_JJ population_NN -LRB-_-LRB- 423,000_CD residents_NNS -RRB-_-RRB- and_CC there_EX is_VBZ no_DT reason_NN to_TO suppose_VB that_IN the_DT eating_JJ habits_NNS of_IN the_DT cases_NNS are_VBP very_RB much_RB different_JJ from_IN those_DT of_IN the_DT controls_NNS ,_, or_CC that_IN those_DT of_IN the_DT people_NNS living_VBG on_IN the_DT Riviera_NNP del_NNP Brenta_NNP -LRB-_-LRB- inland_RB -RRB-_-RRB- should_MD be_VB so_RB very_RB different_JJ from_IN those_DT of_IN the_DT Venetian_JJ lagoon_NN dwellers_NNS ._. 
Furthermore_RB ,_, a_DT recent_JJ study_NN carried_VBD out_RP by_IN the_DT Veneto_NNP region_NN to_TO monitor_VB the_DT level_NN of_IN dioxins_NNS and_CC PCBs_NNS in_IN foodstuffs_NNS -LRB-_-LRB- fish_NN ,_, meat_NN ,_, eggs_NNS ,_, milk_NN -RRB-_-RRB- suggested_VBD that_IN the_DT highest_JJS levels_NNS of_IN these_DT substances_NNS are_VBP found_VBN in_IN shellfish_NN ,_, which_WDT are_VBP probably_RB eaten_VBN more_RBR often_RB in_IN the_DT lagoon_NN area_NN ._. 
However_RB ,_, we_PRP have_VBP 
S._NNP The_NNP U._NNP ,_, the_DT new_JJ epidemiological_JJ and_CC toxicological_JJ evidence_NN reinforced_VBD the_DT IARC_NNP 's_POS assessment_NN and_CC indicated_VBD that_IN levels_NNS of_IN exposure_NN closer_RBR to_TO those_DT involving_VBG the_DT general_JJ population_NN can_MD be_VB carcinogenic_JJ ._. 
Environmental_NNP Protection_NNP Agency_NNP -LRB-_-LRB- EPA_NNP -RRB-_-RRB- ,_, which_WDT in_IN 1985_CD had_VBD classified_VBN TCDD_NNP as_IN a_DT ``_`` probable_JJ human_JJ carcinogen_NN ''_'' based_VBN on_IN the_DT data_NNS available_JJ at_IN the_DT time_NN ,_, concluded_VBD in_IN the_DT 2003_CD Reassessment_NN 
Environmental_NNP Protection_NNP Agency_NNP -LRB-_-LRB- EPA_NNP -RRB-_-RRB- ,_, which_WDT in_IN 1985_CD had_VBD classified_VBN TCDD_NNP as_IN a_DT ``_`` probable_JJ human_JJ carcinogen_NN ''_'' based_VBN on_IN the_DT data_NNS available_JJ at_IN the_DT time_NN ,_, concluded_VBD in_IN the_DT 2003_CD Reassessment_NN 
Information_NNP was_VBD gathered_VBN from_IN the_DT Population_NNP Registries_NNPS of_IN each_DT of_IN the_DT Municipalities_NNS where_WRB the_DT subject_NN had_VBD lived_VBN during_IN the_DT period_NN studied_VBD ._. 
Each_DT address_NN ,_, -LRB-_-LRB- total_JJ 1,823_CD -RRB-_-RRB- in_IN the_DT Province_NNP was_VBD then_RB geo-referenced_JJ ,_, using_VBG the_DT cartographic_JJ reference_NN system_NN for_IN Italy_NNP -LRB-_-LRB- Gauss_NNP Boaga_NNP Projection_NNP -RRB-_-RRB- ._. 
Only_RB five_CD addresses_NNS turned_VBD up_RP to_TO be_VB non-existent_JJ as_IN they_PRP are_VBP due_JJ to_TO identity_NN protection_NN measures_NNS ._. 
Exposure_NN data_NNS A_DT survey_NN of_IN the_DT incinerators_NNS and_CC industrial_JJ sources_NNS of_IN airborne_JJ dioxin_NN in_IN the_DT Province_NNP of_IN Venice_NNP was_VBD carried_VBN out_RP ._. 
This_DT kind_NN of_IN analysis_NN provided_VBD awareness_NN on_IN process_NN layout_NN and_CC changes_NNS spanning_VBG the_DT last_JJ 40_CD years_NNS and_CC also_RB led_VBD to_TO an_DT inquiry_NN into_IN the_DT characteristics_NNS of_IN pollutant_JJ treatment_NN systems_NNS ._. 
For_IN industrial_JJ sources_NNS of_IN PCDD\/PCDF_NNP emissions_NNS ,_, location_NN and_CC operational_JJ data_NNS needed_VBN to_TO calculate_VB emissions_NNS were_VBD taken_VBN from_IN the_DT administrative_JJ documentation_NN deposited_VBN in_IN the_DT offices_NNS of_IN the_DT Province_NNP of_IN Venice_NNP ,_, the_DT agency_NN in_IN charge_NN of_IN control_NN in_IN this_DT sector_NN ,_, and_CC from_IN the_DT proceedings_NNS of_IN an_DT important_JJ lawsuit_NN concerning_VBG the_DT pollution_NN caused_VBN by_IN the_DT petrochemical_NN plant_NN of_IN Porto_NNP Marghera_NNP -LRB-_-LRB- Venice_NNP -RRB-_-RRB- ._. 
With_IN regards_VBZ to_TO solid_JJ urban_JJ waste_NN ,_, data_NNS were_VBD taken_VBN from_IN the_DT administrative_JJ documentation_NN of_IN the_DT Province_NNP of_IN Venice_NNP and_CC also_RB from_IN technical_JJ surveys_NNS carried_VBD out_RP at_IN plant_NN sites_NNS ._. 
The_DT two_CD main_JJ routes_NNS through_IN which_WDT dioxins_NNS enter_VBP the_DT food_NN chain_NN and_CC human_JJ diet_NN are_VBP the_DT following_JJ :_: air-plants-animals_NNS and_CC water-sediments-fish_JJ ._. 
In_IN 1997_CD ,_, the_DT International_NNP Agency_NNP for_IN Research_NNP on_IN Cancer_NNP -LRB-_-LRB- IARC_NNP -RRB-_-RRB- classified_VBD TCDD_NNP as_IN a_DT Group_NNP I_NN carcinogen_NN on_IN the_DT basis_NN of_IN limited_JJ evidence_NN in_IN humans_NNS ,_, sufficient_JJ evidence_NN in_IN animals_NNS and_CC the_DT consideration_NN that_IN the_DT Ah_UH receptor_NN ,_, through_IN which_WDT dioxin_NN acts_NNS ,_, is_VBZ present_JJ in_IN both_DT humans_NNS and_CC animals_NNS ._. 
The_DT epidemiological_JJ evidence_NN in_IN humans_NNS was_VBD taken_VBN from_IN 4_CD cohort_NN studies_NNS carried_VBD out_RP on_IN subjects_NNS occupationally_RB exposed_VBN to_TO high_JJ levels_NNS of_IN dioxin_NN and_CC from_IN a_DT study_NN on_IN the_DT resident_JJ population_NN of_IN Seveso_NNP -LRB-_-LRB- Milan_NNP ,_, Italy_NNP -RRB-_-RRB- ._. 
This_DT evaluation_NN was_VBD strongly_RB criticised_VBN by_IN Cole_NNP et_FW al._FW ._. 
The_DT epidemiological_JJ evidence_NN in_IN humans_NNS was_VBD taken_VBN from_IN 4_CD cohort_NN studies_NNS carried_VBD out_RP on_IN subjects_NNS occupationally_RB exposed_VBN to_TO high_JJ levels_NNS of_IN dioxin_NN and_CC from_IN a_DT study_NN on_IN the_DT resident_JJ population_NN of_IN Seveso_NNP -LRB-_-LRB- Milan_NNP ,_, Italy_NNP -RRB-_-RRB- ._. 
On_IN the_DT contrary_NN ,_, according_VBG to_TO Steenland_NNP et_FW al._FW ._. 
The_DT quantity_NN of_IN waste_NN disposed_VBN was_VBD calculated_VBN on_IN the_DT basis_NN of_IN parameters_NNS provided_VBN in_IN the_DT documents_NNS of_IN the_DT Veneto_NNP Region_NNP :_: number_NN of_IN beds_NNS ;_: their_PRP$ level_NN of_IN occupation_NN ,_, amount_NN of_IN waste_NN per_IN patient_NN per_IN day_NN ,_, divided_VBN into_IN assimilable_JJ or_CC non_JJ assimilable_NN to_TO urban_JJ waste_NN ._. 
The_DT Industrial_NNP Source_NNP Complex_JJ Model_NNP in_IN Long_NNP Term_NNP mode_NN ,_, version_NN 3_CD -LRB-_-LRB- ISCLT3_NNP -RRB-_-RRB- model_NN ,_, developed_VBN by_IN the_DT US_NNP EPA_NNP ,_, was_VBD used_VBN to_TO assess_VB the_DT level_NN of_IN atmospheric_JJ dispersion_NN of_IN the_DT polluting_VBG substances_NNS ;_: the_DT model_NN takes_VBZ into_IN consideration_NN wind_NN speed_NN and_CC direction_NN and_CC the_DT degree_NN of_IN atmospheric_JJ stability_NN which_WDT causes_VBZ fog_NN to_TO form_VB ._. 
Aspecific_JJ value_NN for_IN exposure_NN was_VBD calculated_VBN for_IN each_DT point_NN -LRB-_-LRB- geo-referenced_JJ address_NN -RRB-_-RRB- ;_: the_DT value_NN for_IN each_DT address_NN in_IN a_DT given_VBN year_NN is_VBZ the_DT sum_NN of_IN the_DT values_NNS calculated_VBN for_IN the_DT plants_NNS that_WDT were_VBD active_JJ during_IN that_DT year_NN and_CC were_VBD located_VBN within_IN a_DT 50_CD kilometre_NN radius_NN ._. 
,by_IN the_DT number_NN of_IN days_NNS the_DT subject_NN lived_VBD at_IN that_DT specific_JJ address_NN ._. 
e._VB The_DT exposure_NN value_NN for_IN each_DT subject_NN is_VBZ the_DT average_NN of_IN the_DT values_NNS of_IN the_DT single_JJ addresses_NNS ,_, weighted_VBN by_IN time_NN ,_, i._VBP This_DT exposure_NN value_NN was_VBD expressed_VBN in_IN WHO_WP TEQ_NNP -LRB-_-LRB- PCDD\/PCDFs_NNP -RRB-_-RRB- ,_, using_VBG 1998_CD Toxic_NNP Equivalency_NNP Factors_NNP -LRB-_-LRB- TEF_NNP -RRB-_-RRB- values_NNS ._. 
Figure_NN 2_CD shows_VBZ a_DT graph_NN of_IN emission_NN levels_NNS over_IN time_NN ;_: the_DT value_NN of_IN each_DT year_NN was_VBD obtained_VBN by_IN adding_VBG the_DT emissions_NNS of_IN all_PDT the_DT plants_NNS active_JJ that_IN year_NN ._. 
All_DT of_IN the_DT results_NNS clearly_RB demonstrated_VBD that_IN arsenic_NN exposure_NN was_VBD associated_VBN with_IN liver_NN toxicity_NN ,_, as_IN indicated_VBN by_IN increased_VBN serum_NN liver_NN enzyme_NN activity_NN levels_NNS ._. 
The_DT results_NNS of_IN the_DT present_JJ study_NN were_VBD consistent_JJ with_IN the_DT results_NNS of_IN other_JJ studies_NNS of_IN toxic_JJ exposure_NN to_TO heavy_JJ metals_NNS such_JJ as_IN lead_NN ._. 
The_DT major_JJ strengths_NNS of_IN the_DT present_JJ study_NN were_VBD to_TO demonstrate_VB the_DT particular_JJ effects_NNS of_IN arsenic_NN on_IN serum_NN hepatic_JJ enzymes_NNS by_IN consideration_NN of_IN three_CD different_JJ exposure_NN metrics_NNS -LRB-_-LRB- water_NN ,_, hair_NN and_CC nail_NN arsenic_NN levels_NNS -RRB-_-RRB- ._. 
05_CD b_NN a_DT Statistically_RB significant_JJ 
The_DT general_JJ practitioner_NN involved_VBN in_IN this_DT study_NN carefully_RB determined_VBD whether_IN the_DT study_NN subjects_NNS were_VBD suffering_VBG from_IN jaundice_NN or_CC other_JJ types_NNS of_IN liver_NN disease_NN ;_: however_RB ,_, we_PRP did_VBD not_RB perform_VB laboratory_NN examinations_NNS for_IN additional_JJ confirmation_NN of_IN jaundice_NN or_CC other_JJ forms_NNS of_IN hepatitis_NN ._. 
Third_JJ ,_, it_PRP has_VBZ been_VBN reported_VBN that_IN nutritional_JJ status_NN can_MD influence_VB the_DT effects_NNS of_IN arsenic_NN on_IN health_NN ._. 
In_IN this_DT study_NN ,_, nutritional_JJ status_NN was_VBD not_RB taken_VBN into_IN account_NN as_IN a_DT covariate_NN ,_, as_IN the_DT study_NN subjects_NNS were_VBD selected_VBN from_IN the_DT same_JJ socioeconomic_JJ group_NN ,_, and_CC the_DT participants_NNS were_VBD similar_JJ to_TO each_DT other_JJ in_IN terms_NNS of_IN food_NN intake_NN -LRB-_-LRB- data_NNS not_RB shown_VBN -RRB-_-RRB- ._. 
Asignificant_JJ number_NN of_IN cases_NNS of_IN toxicity_NN have_VBP been_VBN reported_VBN in_IN different_JJ parts_NNS of_IN Bangladesh_NNP ,_, and_CC tens_NNS of_IN millions_NNS of_IN additional_JJ people_NNS are_VBP currently_RB at_IN risk_NN of_IN arsenic_NN toxicity_NN throughout_IN the_DT country_NN 
Bangladesh_NNP and_CC West_NNP Bengal_NNP of_IN India_NNP have_VBP already_RB experienced_VBN the_DT biggest_JJS catastrophe_NN in_IN the_DT world_NN due_JJ to_TO the_DT presence_NN of_IN the_DT excessive_JJ amounts_NNS of_IN arsenic_NN in_IN the_DT drinking_NN water_NN 
Bangladesh_NNP and_CC West_NNP Bengal_NNP of_IN India_NNP have_VBP already_RB experienced_VBN the_DT biggest_JJS catastrophe_NN in_IN the_DT world_NN due_JJ to_TO the_DT presence_NN of_IN the_DT excessive_JJ amounts_NNS of_IN arsenic_NN in_IN the_DT drinking_NN water_NN 
The_DT general_JJ practitioner_NN involved_VBN in_IN this_DT study_NN carefully_RB determined_VBD whether_IN the_DT study_NN subjects_NNS were_VBD suffering_VBG from_IN jaundice_NN or_CC other_JJ types_NNS of_IN liver_NN disease_NN ;_: however_RB ,_, we_PRP did_VBD not_RB perform_VB laboratory_NN examinations_NNS for_IN additional_JJ confirmation_NN of_IN jaundice_NN or_CC other_JJ forms_NNS of_IN hepatitis_NN ._. 
Third_JJ ,_, it_PRP has_VBZ been_VBN reported_VBN that_IN nutritional_JJ status_NN can_MD influence_VB the_DT effects_NNS of_IN arsenic_NN on_IN health_NN ._. 
In_IN this_DT study_NN ,_, nutritional_JJ status_NN was_VBD not_RB taken_VBN into_IN account_NN as_IN a_DT covariate_NN ,_, as_IN the_DT study_NN subjects_NNS were_VBD selected_VBN from_IN the_DT same_JJ socioeconomic_JJ group_NN ,_, and_CC the_DT participants_NNS were_VBD similar_JJ to_TO each_DT other_JJ in_IN terms_NNS of_IN food_NN intake_NN -LRB-_-LRB- data_NNS not_RB shown_VBN -RRB-_-RRB- ._. 
In_IN a_DT previous_JJ study_NN ,_, Guha_NNP Mazumder_NNP 
At_IN the_DT same_JJ time_NN ,_, Nabi_NNP and_CC colleagues_NNS 
Hepatic_JJ disorders_NNS appear_VBP to_TO be_VB one_CD of_IN the_DT major_JJ causes_NNS of_IN arsenic-related_JJ mortality_NN ._. 
1and_CD 50_CD 
The_DT general_JJ practitioner_NN involved_VBN in_IN this_DT study_NN carefully_RB determined_VBD whether_IN the_DT study_NN subjects_NNS were_VBD suffering_VBG from_IN jaundice_NN or_CC other_JJ types_NNS of_IN liver_NN disease_NN ;_: however_RB ,_, we_PRP did_VBD not_RB perform_VB laboratory_NN examinations_NNS for_IN additional_JJ confirmation_NN of_IN jaundice_NN or_CC other_JJ forms_NNS of_IN hepatitis_NN ._. 
Third_JJ ,_, it_PRP has_VBZ been_VBN reported_VBN that_IN nutritional_JJ status_NN can_MD influence_VB the_DT effects_NNS of_IN arsenic_NN on_IN health_NN ._. 
In_IN this_DT study_NN ,_, nutritional_JJ status_NN was_VBD not_RB taken_VBN into_IN account_NN as_IN a_DT covariate_NN ,_, as_IN the_DT study_NN subjects_NNS were_VBD selected_VBN from_IN the_DT same_JJ socioeconomic_JJ group_NN ,_, and_CC the_DT participants_NNS were_VBD similar_JJ to_TO each_DT other_JJ in_IN terms_NNS of_IN food_NN intake_NN -LRB-_-LRB- data_NNS not_RB shown_VBN -RRB-_-RRB- ._. 
All_DT of_IN the_DT results_NNS clearly_RB demonstrated_VBD that_IN arsenic_NN exposure_NN was_VBD associated_VBN with_IN liver_NN toxicity_NN ,_, as_IN indicated_VBN by_IN increased_VBN serum_NN liver_NN enzyme_NN activity_NN levels_NNS ._. 
The_DT results_NNS of_IN the_DT present_JJ study_NN were_VBD consistent_JJ with_IN the_DT results_NNS of_IN other_JJ studies_NNS of_IN toxic_JJ exposure_NN to_TO heavy_JJ metals_NNS such_JJ as_IN lead_NN ._. 
The_DT major_JJ strengths_NNS of_IN the_DT present_JJ study_NN were_VBD to_TO demonstrate_VB the_DT particular_JJ effects_NNS of_IN arsenic_NN on_IN serum_NN hepatic_JJ enzymes_NNS by_IN consideration_NN of_IN three_CD different_JJ exposure_NN metrics_NNS -LRB-_-LRB- water_NN ,_, hair_NN and_CC nail_NN arsenic_NN levels_NNS -RRB-_-RRB- ._. 
,clinical_JJ investigations_NNS that_WDT measure_VBP the_DT levels_NNS of_IN various_JJ biomarkers_NNS -LRB-_-LRB- proteins_NNS or_CC enzymes_NNS -RRB-_-RRB- in_IN the_DT blood_NN ._. 
These_DT proteins\/enzymes_NNS reflect_VBP different_JJ aspects_NNS of_IN a_DT normal_JJ functioning_NN liver_NN ._. 
For_IN example_NN ,_, ALT_NNP and_CC AST_NNP indicate_VBP hepatocellular_JJ integrity_NN ,_, and_CC ALP_NNP levels_NNS indicate_VBP whether_IN there_EX is_VBZ adequate_JJ formation_NN of_IN bile_NN and_CC albumin_NN for_IN protein_NN synthesis_NN ._. 
Liver_JJ function_NN testing_NN is_VBZ among_IN the_DT most_RBS commonly_RB used_JJ and_CC primary_JJ clinical_JJ investigation_NN for_IN the_DT assessment_NN of_IN liver_NN function_NN ._. 
Recently_RB ,_, we_PRP reported_VBD that_DT arsenic_NN exposure_NN is_VBZ associated_VBN with_IN plasma_NN cholinesterase_NN and_CC LDH_NNP activity_NN ._. 
Both_DT plasma_NN cholinesterase_NN and_CC LDH_NNP activities_NNS are_VBP associated_VBN with_IN multi-organ_JJ dysfunction_NN including_VBG liver_NN intoxication_NN ._. 
Confidentialities_NNS and_CC rights_NNS of_IN the_DT study_NN subjects_NNS were_VBD strictly_RB maintained_VBN in_IN accord_NN with_IN the_DT guidelines_NNS of_IN the_DT Bangladesh_NNP Medical_NNP Research_NNP Council_NNP ._. 
Arsenic-endemic_JJ areas_NNS for_IN this_DT study_NN were_VBD chosen_VBN as_IN described_VBN previously_RB ._. 
Residents_NNS from_IN arsenic-endemic_JJ areas_NNS included_VBD Marua_NNP in_IN the_DT Jessore_NNP District_NNP ;_: Dutpatila_NNP ,_, Vultie_NNP and_CC Kestopur_NNP in_IN the_DT Chuadanga_NNP District_NNP ;_: and_CC Bheramara_NNP in_IN the_DT Kushtia_NNP District_NNP of_IN the_DT northwest_RB region_NN of_IN Bangladesh_NNP were_VBD asked_VBN to_TO participate_VB in_IN this_DT study_NN ._. 
In_IN addition_NN ,_, a_DT ``_`` cumulative_JJ arsenic_NN index_NN ''_'' -LRB-_-LRB- CAI_NNP -RRB-_-RRB- 
Here_RB ,_, we_PRP found_VBD that_IN hair_NN and_CC nail_NN arsenic_NN levels_NNS were_VBD positively_RB correlated_VBN with_IN arsenic_NN levels_NNS in_IN drinking_NN water_NN -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ,_, and_CC these_DT correlations_NNS were_VBD statistically_RB significant_JJ ._. 
These_DT results_NNS are_VBP in_IN agreement_NN with_IN those_DT of_IN previous_JJ reports_NNS ,_, which_WDT suggests_VBZ that_IN arsenic_NN contents_NNS in_IN hair_NN and_CC nail_NN samples_NNS might_MD be_VB used_VBN as_IN effective_JJ biomarkers_NNS of_IN arsenic_NN exposure_NN ._. 
We_PRP found_VBD a_DT wide_JJ range_NN of_IN arsenic_NN concentrations_NNS in_IN the_DT drinking_NN water_NN of_IN the_DT study_NN subjects_NNS -LRB-_-LRB- 0_CD ._. 
11-546_CD 
Liver_JJ function_NN testing_NN is_VBZ among_IN the_DT most_RBS commonly_RB used_JJ and_CC primary_JJ clinical_JJ investigation_NN for_IN the_DT assessment_NN of_IN liver_NN function_NN ._. 
Recently_RB ,_, we_PRP reported_VBD that_DT arsenic_NN exposure_NN is_VBZ associated_VBN with_IN plasma_NN cholinesterase_NN and_CC LDH_NNP activity_NN ._. 
Both_DT plasma_NN cholinesterase_NN and_CC LDH_NNP activities_NNS are_VBP associated_VBN with_IN multi-organ_JJ dysfunction_NN including_VBG liver_NN intoxication_NN ._. 
05_CD b_NN a_DT Statistically_RB significant_JJ 
Both_DT plasma_NN cholinesterase_NN and_CC LDH_NNP activities_NNS are_VBP associated_VBN with_IN multi-organ_JJ dysfunction_NN including_VBG liver_NN intoxication_NN ._. 
In_IN a_DT previous_JJ study_NN ,_, Guha_NNP Mazumder_NNP 
Hepatic_JJ disorders_NNS appear_VBP to_TO be_VB one_CD of_IN the_DT major_JJ causes_NNS of_IN arsenic-related_JJ mortality_NN ._. 
1and_CD 50_CD 
The_DT general_JJ practitioner_NN involved_VBN in_IN this_DT study_NN carefully_RB determined_VBD whether_IN the_DT study_NN subjects_NNS were_VBD suffering_VBG from_IN jaundice_NN or_CC other_JJ types_NNS of_IN liver_NN disease_NN ;_: however_RB ,_, we_PRP did_VBD not_RB perform_VB laboratory_NN examinations_NNS for_IN additional_JJ confirmation_NN of_IN jaundice_NN or_CC other_JJ forms_NNS of_IN hepatitis_NN ._. 
Third_JJ ,_, it_PRP has_VBZ been_VBN reported_VBN that_IN nutritional_JJ status_NN can_MD influence_VB the_DT effects_NNS of_IN arsenic_NN on_IN health_NN ._. 
In_IN this_DT study_NN ,_, nutritional_JJ status_NN was_VBD not_RB taken_VBN into_IN account_NN as_IN a_DT covariate_NN ,_, as_IN the_DT study_NN subjects_NNS were_VBD selected_VBN from_IN the_DT same_JJ socioeconomic_JJ group_NN ,_, and_CC the_DT participants_NNS were_VBD similar_JJ to_TO each_DT other_JJ in_IN terms_NNS of_IN food_NN intake_NN -LRB-_-LRB- data_NNS not_RB shown_VBN -RRB-_-RRB- ._. 
The_DT major_JJ strengths_NNS of_IN the_DT present_JJ study_NN were_VBD to_TO demonstrate_VB the_DT particular_JJ effects_NNS of_IN arsenic_NN on_IN serum_NN hepatic_JJ enzymes_NNS by_IN consideration_NN of_IN three_CD different_JJ exposure_NN metrics_NNS -LRB-_-LRB- water_NN ,_, hair_NN and_CC nail_NN arsenic_NN levels_NNS -RRB-_-RRB- ._. 
There_EX are_VBP several_JJ factors_NNS ,_, including_VBG alcohol_NN intake_NN ,_, age_NN ,_, sex_NN ,_, BMI_NNP and_CC smoking_NN habit_NN that_WDT may_MD influence_VB hepatic_JJ enzyme_NN activity_NN ._. 
This_DT study_NN excluded_VBD the_DT probability_NN of_IN the_DT confounding_JJ effect_NN of_IN alcohol_NN consumption_NN on_IN serum_NN hepatic_NN enzymes_VBZ ,_, as_IN no_DT participants_NNS in_IN this_DT study_NN drank_NN alcohol_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, primarily_RB due_JJ to_TO the_DT social_JJ and_CC religious_JJ restrictions_NNS on_IN alcohol_NN intake_NN in_IN Bangladesh_NNP ._. 
Oxidative_NNP DNA_NNP damage_NN ,_, acquired_VBN tolerance_NN to_TO apoptosis_NN ,_, enhanced_JJ cell_NN proliferation_NN ,_, altered_JJ DNA_NN methylation_NN ,_, genomic_JJ instability_NN ,_, and_CC aberrant_JJ estrogen_NN signaling_VBG have_VBP been_VBN reported_VBN to_TO be_VB involved_VBN in_IN the_DT liver_NN toxicity_NN caused_VBN by_IN arsenic_NN 
,clinical_JJ investigations_NNS that_WDT measure_VBP the_DT levels_NNS of_IN various_JJ biomarkers_NNS -LRB-_-LRB- proteins_NNS or_CC enzymes_NNS -RRB-_-RRB- in_IN the_DT blood_NN ._. 
These_DT proteins\/enzymes_NNS reflect_VBP different_JJ aspects_NNS of_IN a_DT normal_JJ functioning_NN liver_NN ._. 
For_IN example_NN ,_, ALT_NNP and_CC AST_NNP indicate_VBP hepatocellular_JJ integrity_NN ,_, and_CC ALP_NNP levels_NNS indicate_VBP whether_IN there_EX is_VBZ adequate_JJ formation_NN of_IN bile_NN and_CC albumin_NN for_IN protein_NN synthesis_NN ._. 
Here_RB ,_, we_PRP found_VBD that_IN hair_NN and_CC nail_NN arsenic_NN levels_NNS were_VBD positively_RB correlated_VBN with_IN arsenic_NN levels_NNS in_IN drinking_NN water_NN -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ,_, and_CC these_DT correlations_NNS were_VBD statistically_RB significant_JJ ._. 
These_DT results_NNS are_VBP in_IN agreement_NN with_IN those_DT of_IN previous_JJ reports_NNS ,_, which_WDT suggests_VBZ that_IN arsenic_NN contents_NNS in_IN hair_NN and_CC nail_NN samples_NNS might_MD be_VB used_VBN as_IN effective_JJ biomarkers_NNS of_IN arsenic_NN exposure_NN ._. 
We_PRP found_VBD a_DT wide_JJ range_NN of_IN arsenic_NN concentrations_NNS in_IN the_DT drinking_NN water_NN of_IN the_DT study_NN subjects_NNS -LRB-_-LRB- 0_CD ._. 
11-546_CD 
In_IN addition_NN ,_, a_DT ``_`` cumulative_JJ arsenic_NN index_NN ''_'' -LRB-_-LRB- CAI_NNP -RRB-_-RRB- 
The_DT general_JJ practitioner_NN involved_VBN in_IN this_DT study_NN carefully_RB determined_VBD whether_IN the_DT study_NN subjects_NNS were_VBD suffering_VBG from_IN jaundice_NN or_CC other_JJ types_NNS of_IN liver_NN disease_NN ;_: however_RB ,_, we_PRP did_VBD not_RB perform_VB laboratory_NN examinations_NNS for_IN additional_JJ confirmation_NN of_IN jaundice_NN or_CC other_JJ forms_NNS of_IN hepatitis_NN ._. 
Third_JJ ,_, it_PRP has_VBZ been_VBN reported_VBN that_IN nutritional_JJ status_NN can_MD influence_VB the_DT effects_NNS of_IN arsenic_NN on_IN health_NN ._. 
In_IN this_DT study_NN ,_, nutritional_JJ status_NN was_VBD not_RB taken_VBN into_IN account_NN as_IN a_DT covariate_NN ,_, as_IN the_DT study_NN subjects_NNS were_VBD selected_VBN from_IN the_DT same_JJ socioeconomic_JJ group_NN ,_, and_CC the_DT participants_NNS were_VBD similar_JJ to_TO each_DT other_JJ in_IN terms_NNS of_IN food_NN intake_NN -LRB-_-LRB- data_NNS not_RB shown_VBN -RRB-_-RRB- ._. 
Nail_NN samples_NNS were_VBD collected_VBN from_IN each_DT study_NN subject_NN as_IN described_VBN previously_RB ._. 
Therefore_RB ,_, for_IN the_DT present_JJ study_NN ,_, we_PRP assessed_VBD hair_NN and_CC nail_NN arsenic_NN concentrations_NNS as_IN exposure_NN metrics_NNS ,_, together_RB with_IN our_PRP$ assessment_NN of_IN the_DT water_NN arsenic_NN concentrations_NNS ._. 
Hair_NN samples_NNS -LRB-_-LRB- length_NN ,_, approximately_RB 1_CD cm_NN -RRB-_-RRB- were_VBD collected_VBN from_IN a_DT region_NN of_IN the_DT head_NN close_RB to_TO the_DT scalp_NN behind_IN the_DT ear_NN by_IN using_VBG a_DT ceramic_JJ blade_NN cutter_NN ,_, and_CC the_DT samples_NNS were_VBD kept_VBN in_IN polypropylene_NN bottles_NNS 
Therefore_RB ,_, for_IN the_DT present_JJ study_NN ,_, we_PRP assessed_VBD hair_NN and_CC nail_NN arsenic_NN concentrations_NNS as_IN exposure_NN metrics_NNS ,_, together_RB with_IN our_PRP$ assessment_NN of_IN the_DT water_NN arsenic_NN concentrations_NNS ._. 
Nail_NN samples_NNS were_VBD collected_VBN from_IN each_DT study_NN subject_NN as_IN described_VBN previously_RB ._. 
Hair_NN samples_NNS -LRB-_-LRB- length_NN ,_, approximately_RB 1_CD cm_NN -RRB-_-RRB- were_VBD collected_VBN from_IN a_DT region_NN of_IN the_DT head_NN close_RB to_TO the_DT scalp_NN behind_IN the_DT ear_NN by_IN using_VBG a_DT ceramic_JJ blade_NN cutter_NN ,_, and_CC the_DT samples_NNS were_VBD kept_VBN in_IN polypropylene_NN bottles_NNS 
Here_RB ,_, we_PRP found_VBD that_IN hair_NN and_CC nail_NN arsenic_NN levels_NNS were_VBD positively_RB correlated_VBN with_IN arsenic_NN levels_NNS in_IN drinking_NN water_NN -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ,_, and_CC these_DT correlations_NNS were_VBD statistically_RB significant_JJ ._. 
These_DT results_NNS are_VBP in_IN agreement_NN with_IN those_DT of_IN previous_JJ reports_NNS ,_, which_WDT suggests_VBZ that_IN arsenic_NN contents_NNS in_IN hair_NN and_CC nail_NN samples_NNS might_MD be_VB used_VBN as_IN effective_JJ biomarkers_NNS of_IN arsenic_NN exposure_NN ._. 
We_PRP found_VBD a_DT wide_JJ range_NN of_IN arsenic_NN concentrations_NNS in_IN the_DT drinking_NN water_NN of_IN the_DT study_NN subjects_NNS -LRB-_-LRB- 0_CD ._. 
11-546_CD 
05_CD b_NN a_DT Statistically_RB significant_JJ 
Hair_NN samples_NNS -LRB-_-LRB- length_NN ,_, approximately_RB 1_CD cm_NN -RRB-_-RRB- were_VBD collected_VBN from_IN a_DT region_NN of_IN the_DT head_NN close_RB to_TO the_DT scalp_NN behind_IN the_DT ear_NN by_IN using_VBG a_DT ceramic_JJ blade_NN cutter_NN ,_, and_CC the_DT samples_NNS were_VBD kept_VBN in_IN polypropylene_NN bottles_NNS 
18_CD 
Assessment_NNP of_IN arsenic_NN exposure_NN Study_NN subjects_NNS identified_VBD the_DT tube_NN well_RB they_PRP used_VBD as_IN their_PRP$ primary_JJ source_NN of_IN drinking_NN water_NN ._. 
Water_NNP samples_NNS from_IN these_DT tube_NN wells_NNS were_VBD collected_VBN in_IN acid-washed_JJ containers_NNS after_IN the_DT well_NN was_VBD pumped_VBN for_IN five_CD minutes_NNS ,_, as_RB previously_RB described_VBN ._. 
The_DT total_JJ arsenic_NN concentration_NN in_IN the_DT water_NN samples_NNS was_VBD determined_VBN by_IN ICP-MS_NNP after_IN the_DT addition_NN of_IN a_DT solution_NN of_IN yttrium_NN -LRB-_-LRB- 10_CD ppb_NN in_IN 1_CD ._. 
1and_CD 50_CD 
In_IN addition_NN ,_, a_DT ``_`` cumulative_JJ arsenic_NN index_NN ''_'' -LRB-_-LRB- CAI_NNP -RRB-_-RRB- 
Here_RB ,_, we_PRP found_VBD that_IN hair_NN and_CC nail_NN arsenic_NN levels_NNS were_VBD positively_RB correlated_VBN with_IN arsenic_NN levels_NNS in_IN drinking_NN water_NN -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ,_, and_CC these_DT correlations_NNS were_VBD statistically_RB significant_JJ ._. 
These_DT results_NNS are_VBP in_IN agreement_NN with_IN those_DT of_IN previous_JJ reports_NNS ,_, which_WDT suggests_VBZ that_IN arsenic_NN contents_NNS in_IN hair_NN and_CC nail_NN samples_NNS might_MD be_VB used_VBN as_IN effective_JJ biomarkers_NNS of_IN arsenic_NN exposure_NN ._. 
We_PRP found_VBD a_DT wide_JJ range_NN of_IN arsenic_NN concentrations_NNS in_IN the_DT drinking_NN water_NN of_IN the_DT study_NN subjects_NNS -LRB-_-LRB- 0_CD ._. 
11-546_CD 
The_DT general_JJ practitioner_NN involved_VBN in_IN this_DT study_NN carefully_RB determined_VBD whether_IN the_DT study_NN subjects_NNS were_VBD suffering_VBG from_IN jaundice_NN or_CC other_JJ types_NNS of_IN liver_NN disease_NN ;_: however_RB ,_, we_PRP did_VBD not_RB perform_VB laboratory_NN examinations_NNS for_IN additional_JJ confirmation_NN of_IN jaundice_NN or_CC other_JJ forms_NNS of_IN hepatitis_NN ._. 
Third_JJ ,_, it_PRP has_VBZ been_VBN reported_VBN that_IN nutritional_JJ status_NN can_MD influence_VB the_DT effects_NNS of_IN arsenic_NN on_IN health_NN ._. 
In_IN this_DT study_NN ,_, nutritional_JJ status_NN was_VBD not_RB taken_VBN into_IN account_NN as_IN a_DT covariate_NN ,_, as_IN the_DT study_NN subjects_NNS were_VBD selected_VBN from_IN the_DT same_JJ socioeconomic_JJ group_NN ,_, and_CC the_DT participants_NNS were_VBD similar_JJ to_TO each_DT other_JJ in_IN terms_NNS of_IN food_NN intake_NN -LRB-_-LRB- data_NNS not_RB shown_VBN -RRB-_-RRB- ._. 
Oxidative_NNP DNA_NNP damage_NN ,_, acquired_VBN tolerance_NN to_TO apoptosis_NN ,_, enhanced_JJ cell_NN proliferation_NN ,_, altered_JJ DNA_NN methylation_NN ,_, genomic_JJ instability_NN ,_, and_CC aberrant_JJ estrogen_NN signaling_VBG have_VBP been_VBN reported_VBN to_TO be_VB involved_VBN in_IN the_DT liver_NN toxicity_NN caused_VBN by_IN arsenic_NN 
1and_CD 50_CD 
Generally_RB the_DT toxicity_NN of_IN arsenic_NN is_VBZ thought_VBN to_TO be_VB largely_RB the_DT result_NN of_IN its_PRP$ reaction_NN with_IN free_JJ sulfhydryl_NN groups_NNS of_IN enzymes_NNS and_CC proteins_NNS ,_, followed_VBN by_IN cross_NN linkage_NN 
Monomethylarsonic_JJ acid_NN is_VBZ relatively_RB more_RBR genotoxic_JJ than_IN the_DT dimethylarsinic_JJ acid_NN ._. 
The_DT methylation_NN of_IN arsenic_NN has_VBZ been_VBN demonstrated_VBN by_IN the_DT presence_NN of_IN monomethylarsonic_JJ acid_NN -LRB-_-LRB- MMA_NNP -RRB-_-RRB- and_CC dimethylarsinic_JJ acid_NN -LRB-_-LRB- DMA_NNP -RRB-_-RRB- in_IN the_DT urine_NN and_CC bile_NN 
Monomethylarsonic_JJ acid_NN is_VBZ relatively_RB more_RBR genotoxic_JJ than_IN the_DT dimethylarsinic_JJ acid_NN ._. 
The_DT methylation_NN of_IN arsenic_NN has_VBZ been_VBN demonstrated_VBN by_IN the_DT presence_NN of_IN monomethylarsonic_JJ acid_NN -LRB-_-LRB- MMA_NNP -RRB-_-RRB- and_CC dimethylarsinic_JJ acid_NN -LRB-_-LRB- DMA_NNP -RRB-_-RRB- in_IN the_DT urine_NN and_CC bile_NN 
The_DT methylation_NN of_IN arsenic_NN has_VBZ been_VBN demonstrated_VBN by_IN the_DT presence_NN of_IN monomethylarsonic_JJ acid_NN -LRB-_-LRB- MMA_NNP -RRB-_-RRB- and_CC dimethylarsinic_JJ acid_NN -LRB-_-LRB- DMA_NNP -RRB-_-RRB- in_IN the_DT urine_NN and_CC bile_NN 
The_DT major_JJ metabolic_JJ pathway_NN of_IN inorganic_JJ arsenic_NN in_IN humans_NNS is_VBZ its_PRP$ methylation_NN in_IN the_DT liver_NN ._. 
The_DT liver_NN is_VBZ the_DT primary_JJ target_NN organ_NN for_IN the_DT metabolism_NN of_IN arsenicals_NNS ._. 
The_DT methylation_NN of_IN arsenic_NN has_VBZ been_VBN demonstrated_VBN by_IN the_DT presence_NN of_IN monomethylarsonic_JJ acid_NN -LRB-_-LRB- MMA_NNP -RRB-_-RRB- and_CC dimethylarsinic_JJ acid_NN -LRB-_-LRB- DMA_NNP -RRB-_-RRB- in_IN the_DT urine_NN and_CC bile_NN 
The_DT major_JJ metabolic_JJ pathway_NN of_IN inorganic_JJ arsenic_NN in_IN humans_NNS is_VBZ its_PRP$ methylation_NN in_IN the_DT liver_NN ._. 
The_DT liver_NN is_VBZ the_DT primary_JJ target_NN organ_NN for_IN the_DT metabolism_NN of_IN arsenicals_NNS ._. 
The_DT methylation_NN of_IN arsenic_NN has_VBZ been_VBN demonstrated_VBN by_IN the_DT presence_NN of_IN monomethylarsonic_JJ acid_NN -LRB-_-LRB- MMA_NNP -RRB-_-RRB- and_CC dimethylarsinic_JJ acid_NN -LRB-_-LRB- DMA_NNP -RRB-_-RRB- in_IN the_DT urine_NN and_CC bile_NN ._. 
Monomethylarsonic_JJ acid_NN is_VBZ relatively_RB more_JJR genotoxic_NN 
Asignificant_JJ number_NN of_IN cases_NNS of_IN toxicity_NN have_VBP been_VBN reported_VBN in_IN different_JJ parts_NNS of_IN Bangladesh_NNP ,_, and_CC tens_NNS of_IN millions_NNS of_IN additional_JJ people_NNS are_VBP currently_RB at_IN risk_NN of_IN arsenic_NN toxicity_NN throughout_IN the_DT country_NN 
Elevated_JJ serum_NN hepatic_JJ enzyme_NN activities_NNS in_IN the_DT higher_JJR exposure_NN gradients_NNS provided_VBD new_JJ insights_NNS into_IN arsenic-induced_JJ liver_NN toxicity_NN that_WDT might_MD be_VB helpful_JJ for_IN the_DT early_JJ prognosis_NN of_IN arsenic-induced_JJ liver_NN diseases_NNS ._. 
BackgroundArsenic_NNP is_VBZ a_DT ubiquitous_JJ element_NN present_NN in_IN food_NN ,_, soil_NN ,_, water_NN and_CC air_NN ,_, and_CC it_PRP is_VBZ released_VBN into_IN the_DT environment_NN from_IN both_DT natural_JJ and_CC man-made_JJ sources_NNS ._. 
Arsenic_NN in_IN drinking_NN water_NN is_VBZ typically_RB inorganic_JJ ,_, and_CC can_MD be_VB present_JJ either_CC as_IN As_IN +3_CD -LRB-_-LRB- arsenite_NN -RRB-_-RRB- or_CC As_IN +5_CD -LRB-_-LRB- arsenate_NN -RRB-_-RRB- ._. 
Generally_RB the_DT toxicity_NN of_IN arsenic_NN is_VBZ thought_VBN to_TO be_VB largely_RB the_DT result_NN of_IN its_PRP$ reaction_NN with_IN free_JJ sulfhydryl_NN groups_NNS of_IN enzymes_NNS and_CC proteins_NNS ,_, followed_VBN by_IN cross_NN linkage_NN 
Arsenic_NN in_IN drinking_NN water_NN is_VBZ typically_RB inorganic_JJ ,_, and_CC can_MD be_VB present_JJ either_CC as_IN As_IN +3_CD -LRB-_-LRB- arsenite_NN -RRB-_-RRB- or_CC As_IN +5_CD -LRB-_-LRB- arsenate_NN -RRB-_-RRB- ._. 
In_IN Bangladesh_NNP ,_, arsenic_NN in_IN the_DT ground_NN water_NN is_VBZ primarily_RB in_IN the_DT As_IN +3_CD form_NN 
Arsenic_NN in_IN drinking_NN water_NN is_VBZ typically_RB inorganic_JJ ,_, and_CC can_MD be_VB present_JJ either_CC as_IN As_IN +3_CD -LRB-_-LRB- arsenite_NN -RRB-_-RRB- or_CC As_IN +5_CD -LRB-_-LRB- arsenate_NN -RRB-_-RRB- ._. 
In_IN Bangladesh_NNP ,_, arsenic_NN in_IN the_DT ground_NN water_NN is_VBZ primarily_RB in_IN the_DT As_IN +3_CD form_NN 
Arsenic_NN in_IN drinking_NN water_NN is_VBZ typically_RB inorganic_JJ ,_, and_CC can_MD be_VB present_JJ either_CC as_IN As_IN +3_CD -LRB-_-LRB- arsenite_NN -RRB-_-RRB- or_CC As_IN +5_CD -LRB-_-LRB- arsenate_NN -RRB-_-RRB- ._. 
In_IN Bangladesh_NNP ,_, arsenic_NN in_IN the_DT ground_NN water_NN is_VBZ primarily_RB in_IN the_DT As_IN +3_CD form_NN 
Arsenic_NN in_IN drinking_NN water_NN is_VBZ typically_RB inorganic_JJ ,_, and_CC can_MD be_VB present_JJ either_CC as_IN As_IN +3_CD -LRB-_-LRB- arsenite_NN -RRB-_-RRB- or_CC As_IN +5_CD -LRB-_-LRB- arsenate_NN -RRB-_-RRB- ._. 
In_IN Bangladesh_NNP ,_, arsenic_NN in_IN the_DT ground_NN water_NN is_VBZ primarily_RB in_IN the_DT As_IN +3_CD form_NN 
In_IN Bangladesh_NNP ,_, arsenic_NN in_IN the_DT ground_NN water_NN is_VBZ primarily_RB in_IN the_DT As_IN +3_CD form_NN 
Elevated_JJ serum_NN hepatic_JJ enzyme_NN activities_NNS in_IN the_DT higher_JJR exposure_NN gradients_NNS provided_VBD new_JJ insights_NNS into_IN arsenic-induced_JJ liver_NN toxicity_NN that_WDT might_MD be_VB helpful_JJ for_IN the_DT early_JJ prognosis_NN of_IN arsenic-induced_JJ liver_NN diseases_NNS ._. 
BackgroundArsenic_NNP is_VBZ a_DT ubiquitous_JJ element_NN present_NN in_IN food_NN ,_, soil_NN ,_, water_NN and_CC air_NN ,_, and_CC it_PRP is_VBZ released_VBN into_IN the_DT environment_NN from_IN both_DT natural_JJ and_CC man-made_JJ sources_NNS ._. 
Arsenic_NN in_IN drinking_NN water_NN is_VBZ typically_RB inorganic_JJ ,_, and_CC can_MD be_VB present_JJ either_CC as_IN As_IN +3_CD -LRB-_-LRB- arsenite_NN -RRB-_-RRB- or_CC As_IN +5_CD -LRB-_-LRB- arsenate_NN -RRB-_-RRB- ._. 
The_DT major_JJ strengths_NNS of_IN the_DT present_JJ study_NN were_VBD to_TO demonstrate_VB the_DT particular_JJ effects_NNS of_IN arsenic_NN on_IN serum_NN hepatic_JJ enzymes_NNS by_IN consideration_NN of_IN three_CD different_JJ exposure_NN metrics_NNS -LRB-_-LRB- water_NN ,_, hair_NN and_CC nail_NN arsenic_NN levels_NNS -RRB-_-RRB- ._. 
There_EX are_VBP several_JJ factors_NNS ,_, including_VBG alcohol_NN intake_NN ,_, age_NN ,_, sex_NN ,_, BMI_NNP and_CC smoking_NN habit_NN that_WDT may_MD influence_VB hepatic_JJ enzyme_NN activity_NN ._. 
This_DT study_NN excluded_VBD the_DT probability_NN of_IN the_DT confounding_JJ effect_NN of_IN alcohol_NN consumption_NN on_IN serum_NN hepatic_NN enzymes_VBZ ,_, as_IN no_DT participants_NNS in_IN this_DT study_NN drank_NN alcohol_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, primarily_RB due_JJ to_TO the_DT social_JJ and_CC religious_JJ restrictions_NNS on_IN alcohol_NN intake_NN in_IN Bangladesh_NNP ._. 
Arsenic_NN in_IN drinking_NN water_NN is_VBZ typically_RB inorganic_JJ ,_, and_CC can_MD be_VB present_JJ either_CC as_IN As_IN +3_CD -LRB-_-LRB- arsenite_NN -RRB-_-RRB- or_CC As_IN +5_CD -LRB-_-LRB- arsenate_NN -RRB-_-RRB- ._. 
In_IN Bangladesh_NNP ,_, arsenic_NN in_IN the_DT ground_NN water_NN is_VBZ primarily_RB in_IN the_DT As_IN +3_CD form_NN 
In_IN Bangladesh_NNP ,_, arsenic_NN in_IN the_DT ground_NN water_NN is_VBZ primarily_RB in_IN the_DT As_IN +3_CD form_NN 
The_DT ingestion_NN of_IN inorganic_JJ arsenic_NN is_VBZ a_DT significant_JJ public_JJ health_NN hazard_NN in_IN Bangladesh_NNP ._. 
The_DT main_JJ source_NN of_IN arsenic_NN poisoning_NN is_VBZ the_DT drinking_NN of_IN arsenic-contaminated_JJ ground_NN water_NN ._. 
Bangladesh_NNP and_CC West_NNP Bengal_NNP of_IN India_NNP have_VBP already_RB experienced_VBN the_DT biggest_JJS catastrophe_NN in_IN the_DT world_NN due_JJ to_TO the_DT presence_NN of_IN the_DT excessive_JJ amounts_NNS of_IN arsenic_NN in_IN the_DT drinking_NN water_NN 
The_DT test_NN continues_VBZ until_IN the_DT participant_NN reaches_VBZ a_DT target_NN heart_NN rate_NN ,_, unless_IN complications_NNS such_JJ as_IN chest_NN pain_NN or_CC an_DT exaggerated_JJ rise_NN in_IN blood_NN pressure_NN develop_VB ._. 
Each_DT participant_NN was_VBD monitored_VBN for_IN 10_CD 
Interpretation_NN and_CC extraction_NN of_IN heart_NN rate_NN variability_NN -LRB-_-LRB- HRV_NNP -RRB-_-RRB- parameters_NNS were_VBD performed_VBN automatically_RB by_IN using_VBG the_DT software_NN provided_VBN by_IN General_NNP Electric_NNP -LRB-_-LRB- MARS_NNP PC_NNP Ambulatory_NNP ECG_NNP Analysis_NNP System_NNP -RRB-_-RRB- ,_, and_CC then_RB reviewed_VBN by_IN a_DT cardiologist_NN to_TO determine_VB if_IN any_DT atypical_JJ electrical_JJ patterns_NNS ._. 
Areport_NNP of_IN the_DT heart_NN 's_POS activity_NN is_VBZ tabulated_JJ and_CC irregular_JJ heart_NN activity_NN is_VBZ correlated_VBN with_IN the_DT worker_NN 's_POS activity_NN at_IN the_DT time_NN ._. 
Lipid_NNP Profile_NNP Study_NNP Fasting_NNP lipid_JJ profile_NN was_VBD determined_VBN through_IN serum_NN samples_NNS obtained_VBN from_IN all_PDT the_DT participants_NNS using_VBG Dimension_NNP Expanded_NNP Auto-analyzer_NN where_WRB all_PDT the_DT subjects_NNS fasted_VBD for_IN a_DT period_NN of_IN 12_CD to_TO 14_CD hours_NNS before_IN the_DT test_NN ._. 
In_IN the_DT present_JJ study_NN ,_, there_EX were_VBD no_DT significant_JJ statistical_JJ differences_NNS between_IN the_DT two_CD study_NN groups_NNS in_IN regards_VBZ to_TO some_DT of_IN the_DT precipitating_VBG factors_NNS for_IN arrhythmias_NNS ,_, such_JJ as_IN age_NN and_CC serum_NN levels_NNS of_IN electrolytes_NNS ,_, which_WDT were_VBD within_IN the_DT normal_JJ range_NN for_IN the_DT two_CD study_NN groups_NNS ._. 
Also_RB ,_, none_NN of_IN the_DT workers_NNS in_IN the_DT study_NN group_NN had_VBD past_JJ medical_JJ histories_NNS suggesting_VBG the_DT presence_NN of_IN any_DT precipitating_VBG factors_NNS for_IN arrhythmia_NN or_CC occupational_JJ exposure_NN to_TO arrhythmogenic_JJ chemicals_NNS ,_, or_CC had_VBD family_NN history_NN of_IN arrhythmias_NNS ._. 
So_RB ,_, it_PRP could_MD be_VB concluded_VBN that_IN freon-exposed_JJ workers_NNS are_VBP at_IN increased_VBN risk_NN for_IN cardiac_JJ arrhythmias_NNS ._. 
The_DT mean_NN of_IN the_DT three_CD readings_NNS was_VBD recorded_VBN ._. 
Repeated_JJ measurements_NNS were_VBD obtained_VBN for_IN each_DT subject_NN for_IN arterial_JJ blood_NN pressure_NN ,_, which_WDT was_VBD taken_VBN three_CD times_NNS in_IN the_DT early_JJ morning_NN ,_, using_VBG a_DT stethoscope_NN and_CC a_DT mercury_NN sphygmomanometer_NN ._. 
Blood_NNP pressure_NN is_VBZ classified_VBN as_IN normal_JJ at_IN 
01129_CD ._. 
02586_CD and_CC for_IN serum_NN triglycerides_NNS in_IN mg\/dL_NNP to_TO mmol\/L_NNP is_VBZ 0_CD ._. 
The_DT conversion_NN factor_NN for_IN serum_NN cholesterol_NN ,_, LDL_NNP and_CC HDL_NNP in_IN mg\/dL_NNP to_TO mmol\/L_NNP is_VBZ 0_CD ._. 
Assessment_NNP of_IN Serum_NNP ElectrolytesSerum_NNP electrolytes_NNS were_VBD assessed_VBN to_TO exclude_VB their_PRP$ roles_NNS in_IN the_DT occurrence_NN of_IN arrhythmias_NNS ._. 
The_DT serum_NN samples_NNS were_VBD analyzed_VBN using_VBG Dimension_NNP Expanded_NNP Auto-analyzer_NNP to_TO determine_VB serum_NN sodium_NN -LRB-_-LRB- Na_FW +_FW -RRB-_-RRB- ,_, potassium_NN -LRB-_-LRB- k_NN +_NN -RRB-_-RRB- and_CC calcium_NN -LRB-_-LRB- Ca_MD +_RB +_VB -RRB-_-RRB- levels_NNS ._. 
Additionally_RB ,_, none_NN of_IN the_DT workers_NNS had_VBD previous_JJ jobs_NNS and\/or_CC secondary_JJ occupations_NNS exposing_VBG them_PRP to_TO different_JJ nephrotoxins_NNS ,_, nor_CC had_VBD family_NN history_NN of_IN nephropathy_NN associated_VBN with_IN hyperuricemia_NN and_CC gout_NN 
The_DT mean_NN of_IN the_DT three_CD readings_NNS was_VBD recorded_VBN ._. 
Repeated_JJ measurements_NNS were_VBD obtained_VBN for_IN each_DT subject_NN for_IN arterial_JJ blood_NN pressure_NN ,_, which_WDT was_VBD taken_VBN three_CD times_NNS in_IN the_DT early_JJ morning_NN ,_, using_VBG a_DT stethoscope_NN and_CC a_DT mercury_NN sphygmomanometer_NN ._. 
Blood_NNP pressure_NN is_VBZ classified_VBN as_IN normal_JJ at_IN 
Renal_JJ involvement_NN such_JJ as_IN the_DT characteristic_JJ loin_NN pain_NN ,_, hematuria_NN ,_, polyuria_NN ,_, oliguria_NN and_CC renal_JJ edema_NN ._. 
Clinical_JJ ExaminationAll_NNP workers_NNS were_VBD invited_VBN to_TO attend_VB a_DT clinical_JJ evaluation_NN and_CC then_RB subjected_VBN to_TO the_DT following_NN :_: -_: Body_NNP mass_JJ index_NN calculation_NN measuring_VBG the_DT height_NN in_IN meters_NNS and_CC weight_NN in_IN kilograms_NNS was_VBD implemented_VBN to_TO calculate_VB the_DT body_NN mass_NN index_NN -LRB-_-LRB- BMI_NNP -RRB-_-RRB- ;_: where_WRB the_DT formula_NN for_IN BMI_NNP is_VBZ weight_NN in_IN kilograms_NNS divided_VBN by_IN height_NN in_IN meters_NNS squared_VBD ._. 
This_DT was_VBD done_VBN to_TO exclude_VB renal_JJ impairment_NN ,_, proteinuria_NN and_CC cardiovascular_JJ diseases_NNS that_WDT can_MD result_VB from_IN obesity_NN ._. 
Sinus_NN rhythm_NN was_VBD considered_VBN at_IN the_DT range_NN of_IN 60_CD 
Moreover_RB ,_, overexposure_NN to_TO CFCs_NNP and_CC related_VBN halogenated_JJ hydrocarbons_NNS can_MD cause_VB arterial_JJ hypertension_NN ,_, myocardial_JJ infarction_NN and_CC temporary_JJ alteration_NN of_IN the_DT electrical_JJ activity_NN of_IN the_DT heart_NN -LRB-_-LRB- atrial_JJ and_CC ventricular_JJ cardiac_JJ arrhythmias_NNS -RRB-_-RRB- manifested_VBN with_IN palpitations_NNS ,_, irregular_JJ pulse_NN or_CC even_RB inadequate_JJ circulation_NN ._. 
Cardiac_JJ arrest_NN and_CC death_NN may_MD occur_VB from_IN gross_JJ overexposure_NN ._. 
Until_IN now_RB ,_, there_EX have_VBP been_VBN few_JJ isolated_JJ reports_NNS of_IN cardiotoxicity_NN and_CC nephrotoxicity_NN resulting_VBG from_IN occupational_JJ exposure_NN to_TO different_JJ fluorocarbons_NNS ._. 
Until_IN now_RB ,_, there_EX have_VBP been_VBN few_JJ isolated_JJ reports_NNS of_IN cardiotoxicity_NN and_CC nephrotoxicity_NN resulting_VBG from_IN occupational_JJ exposure_NN to_TO different_JJ fluorocarbons_NNS ._. 
Despite_IN the_DT life-threatening_JJ cardiotoxic_JJ consequences_NNS of_IN fluorinated_VBN hydrocarbon_NN exposure_NN ,_, the_DT documentation_NN of_IN toxic_JJ effects_NNS in_IN human_JJ subjects_NNS is_VBZ still_RB ambiguous_JJ ._. 
Thus_RB ,_, this_DT study_NN was_VBD conducted_VBN to_TO determine_VB the_DT occupational_JJ exposure_NN effects_NNS on_IN the_DT cardiovascular_JJ system_NN and_CC renal_JJ function_NN when_WRB exposed_VBN to_TO freon_NN ._. 
01129_CD ._. 
02586_CD and_CC for_IN serum_NN triglycerides_NNS in_IN mg\/dL_NNP to_TO mmol\/L_NNP is_VBZ 0_CD ._. 
The_DT conversion_NN factor_NN for_IN serum_NN cholesterol_NN ,_, LDL_NNP and_CC HDL_NNP in_IN mg\/dL_NNP to_TO mmol\/L_NNP is_VBZ 0_CD ._. 
Assessment_NNP of_IN Serum_NNP ElectrolytesSerum_NNP electrolytes_NNS were_VBD assessed_VBN to_TO exclude_VB their_PRP$ roles_NNS in_IN the_DT occurrence_NN of_IN arrhythmias_NNS 
Personal_JJ sampling_NN was_VBD conducted_VBN for_IN freon_NN 12_CD and_CC 22_CD using_VBG two_CD charcoal_JJ tubes_NNS in_IN a_DT series_NN as_IN first_JJ tube_NN 400\/200_CD mg_NN ,_, second_JJ tube_NN 100\/50_CD mg_NN sections_NNS and_CC both_DT 20\/40_CD mesh_NN ,_, which_WDT were_VBD manufactured_VBN by_IN Sigma-Aldrich\/Supelco_NNP ._. 
At_IN the_DT end_NN of_IN work_NN shift_NN ,_, charcoal_JJ adsorption_NN tubes_NNS were_VBD washed_VBN with_IN isopropyl_JJ alcohol_NN and_CC the_DT wash_NN was_VBD then_RB injected_VBN into_IN gas_NN chromatography\/mass_NN spectrometer_NN -LRB-_-LRB- GC\/MS_NNP -RRB-_-RRB- for_IN analysis_NN ._. 
Then_RB the_DT averages_NNS of_IN the_DT five_CD readings_NNS for_IN freon_NN 12_CD and_CC 22_CD were_VBD calculated_VBN and_CC compared_VBN to_TO the_DT threshold_NN limit_NN values_NNS of_IN the_DT American_NNP Conference_NNP of_IN Governmental_NNP Industrial_NNP Hygienists_NNP -LRB-_-LRB- ACGIH_NNP -RRB-_-RRB- -LRB-_-LRB- TLV-TWA_NNP -RRB-_-RRB- -LRB-_-LRB- threshold_NN limit_NN value_NN 
Dipsticks_NNS ,_, however_RB ,_, only_RB detect_VB albumin_NN in_IN a_DT concentration_NN around_IN 300_CD mg\/L_NNP ._. 
Normal_JJ urine_NN contains_VBZ albumin_NN in_IN a_DT concentration_NN of_IN less_JJR than_IN 20_CD mg\/L_NNP ._. 
An_DT increase_NN in_IN albumin_NN between_IN these_DT two_CD levels_NNS is_VBZ called_VBN microalbuminuria_NN ._. 
The_DT assessment_NN of_IN urinary_NN 
Another_DT theory_NN suggests_VBZ that_IN CFCs_NNS do_VBP n't_RB sensitize_VB the_DT myocardium_NN to_TO endogenous_JJ neurotransmitters_NNS ,_, but_CC have_VBP a_DT depressant_NN effect_NN on_IN the_DT sinus_NN atrio-ventricular_JJ and_CC ventricular_JJ conduction_NN systems_NNS ,_, allowing_VBG other_JJ ectopic_JJ foci_NNS to_TO produce_VB arrhythmias_NNS 
bronchodilator_NN and_CC nasal_JJ decongestant_NN ,_, may_MD have_VB increased_VBN susceptibility_NN to_TO the_DT toxicity_NN of_IN excessive_JJ exposure_NN 
On_IN this_DT rotation_NN ,_, the_DT only_JJ procedure_NN that_WDT could_MD have_VB possibly_RB caused_VBN palpitations_NNS was_VBD the_DT preparation_NN of_IN frozen_JJ sections_NNS in_IN which_WDT a_DT freon-22-based_JJ aerosol_NN was_VBD used_VBN to_TO decrease_VB work_NN time_NN 
Also_RB ,_, a_DT number_NN of_IN deaths_NNS have_VBP been_VBN reported_VBN among_IN persons_NNS ``_`` sniffing_VBG ''_'' freon_NN accidentally_RB and_CC intentionally_RB ._. 
In_IN addition_NN ,_, a_DT case_NN of_IN ventricular_JJ fibrillation_NN and_CC two_CD cases_NNS of_IN atrial_JJ fibrillation_NN were_VBD recorded_VBN after_IN exposure_NN to_TO a_DT fluorinated_VBN hydrocarbon_NN and_CC -LRB-_-LRB- CFC_NNP 113_CD -RRB-_-RRB- respectively_RB 
Also_RB ,_, a_DT number_NN of_IN deaths_NNS have_VBP been_VBN reported_VBN among_IN persons_NNS ``_`` sniffing_VBG ''_'' freon_NN accidentally_RB and_CC intentionally_RB ._. 
In_IN addition_NN ,_, a_DT case_NN of_IN ventricular_JJ fibrillation_NN and_CC two_CD cases_NNS of_IN atrial_JJ fibrillation_NN were_VBD recorded_VBN after_IN exposure_NN to_TO a_DT fluorinated_VBN hydrocarbon_NN and_CC -LRB-_-LRB- CFC_NNP 113_CD -RRB-_-RRB- respectively_RB 
In_IN addition_NN ,_, a_DT case_NN of_IN ventricular_JJ fibrillation_NN and_CC two_CD cases_NNS of_IN atrial_JJ fibrillation_NN were_VBD recorded_VBN after_IN exposure_NN to_TO a_DT fluorinated_VBN hydrocarbon_NN and_CC -LRB-_-LRB- CFC_NNP 113_CD -RRB-_-RRB- respectively_RB 
However_RB ,_, no_DT significant_JJ differences_NNS between_IN exposed_JJ and_CC unexposed_JJ periods_NNS ,_, and_CC no_DT consistent_JJ dose_NN effect_NN relations_NNS were_VBD observed_VBN ._. 
Thus_RB ,_, the_DT results_NNS did_VBD not_RB support_VB the_DT notion_NN that_IN fluorocarbons_NNS induce_VBP cardiac_JJ arrhythmia_NN in_IN occupationally_RB exposed_VBN refrigerator_NN repairmen_NNS ._. 
Moreover_RB ,_, the_DT absence_NN of_IN subject_JJ differences_NNS in_IN the_DT rate_NN of_IN ventricular_JJ and_CC supraventricular_JJ arrhythmias_NNS were_VBD recorded_VBN among_IN healthy_JJ workers_NNS cleaning_VBG rocket_NN and_CC ground_NN support_NN equipment_NN for_IN the_DT National_NNP Aeronautic_NNP and_CC Space_NNP Administration_NNP -LRB-_-LRB- NASA_NNP -RRB-_-RRB- programs_NNS and_CC exposed_VBN to_TO fluorocarbon_NN 113_CD ._. 
Moreover_RB ,_, the_DT absence_NN of_IN subject_JJ differences_NNS in_IN the_DT rate_NN of_IN ventricular_JJ and_CC supraventricular_JJ arrhythmias_NNS were_VBD recorded_VBN among_IN healthy_JJ workers_NNS cleaning_VBG rocket_NN and_CC ground_NN support_NN equipment_NN for_IN the_DT National_NNP Aeronautic_NNP and_CC Space_NNP Administration_NNP -LRB-_-LRB- NASA_NNP -RRB-_-RRB- programs_NNS and_CC exposed_VBN to_TO fluorocarbon_NN 113_CD ._. 
This_DT result_NN was_VBD attributed_VBN to_TO low_JJ level_NN of_IN FC113_CD exposures_NNS ,_, which_WDT was_VBD below_IN -LRB-_-LRB- OSHA_NNP -RRB-_-RRB- 8-hour_JJ -LRB-_-LRB- TWA_NNP -RRB-_-RRB- -LRB-_-LRB- PEL_NNP -RRB-_-RRB- and_CC -LRB-_-LRB- NIOSH_NNP -RRB-_-RRB- recommended_JJ exposure_NN limit_NN -LRB-_-LRB- REL_NNP -RRB-_-RRB- of_IN 1000_CD parts_NNS per_IN million_CD -LRB-_-LRB- ppm_NN -RRB-_-RRB- ,_, that_WDT did_VBD not_RB induce_VB cardiac_JJ arrhythmias_NNS or_CC subtle_JJ changes_NNS in_IN cardiac_JJ activity_NN 
These_DT results_NNS disagree_VBP with_IN the_DT findings_NNS of_IN other_JJ researchers_NNS ,_, who_WP revealed_VBD that_DT exposure_NN of_IN volunteers_NNS to_TO CFC-11_NN at_IN concentrations_NNS of_IN 250_CD ,_, 500_CD ,_, or_CC 1000_CD ppm_NN for_IN periods_NNS of_IN 1_CD min_NN to_TO 8_CD hr_NN ,_, did_VBD not_RB produce_VB any_DT untoward_JJ physiological_JJ effects_NNS ._. 
Exposure_NN for_IN 8_CD hr\/day_CD ,_, 5_CD days\/week_NN for_IN 2_CD to_TO 4_CD weeks_NNS to_TO CFC-11_NN at_IN a_DT concentration_NN of_IN 1000_CD ppm_NN showed_VBD only_RB minor_JJ decrement_NN in_IN several_JJ cognitive_JJ tests_NNS 
This_DT result_NN was_VBD attributed_VBN to_TO low_JJ level_NN of_IN FC113_CD exposures_NNS ,_, which_WDT was_VBD below_IN -LRB-_-LRB- OSHA_NNP -RRB-_-RRB- 8-hour_JJ -LRB-_-LRB- TWA_NNP -RRB-_-RRB- -LRB-_-LRB- PEL_NNP -RRB-_-RRB- and_CC -LRB-_-LRB- NIOSH_NNP -RRB-_-RRB- recommended_JJ exposure_NN limit_NN -LRB-_-LRB- REL_NNP -RRB-_-RRB- of_IN 1000_CD parts_NNS per_IN million_CD -LRB-_-LRB- ppm_NN -RRB-_-RRB- ,_, that_WDT did_VBD not_RB induce_VB cardiac_JJ arrhythmias_NNS or_CC subtle_JJ changes_NNS in_IN cardiac_JJ activity_NN 
In_IN one_CD study_NN ,_, all_DT pathology_NN residents_NNS in_IN a_DT Boston_NNP hospital_NN experienced_VBD palpitations_NNS that_WDT appeared_VBD to_TO be_VB associated_VBN with_IN the_DT addition_NN of_IN the_DT surgical_JJ pathology_NN rotation_NN to_TO their_PRP$ schedules_NNS ._. 
On_IN this_DT rotation_NN ,_, the_DT only_JJ procedure_NN that_WDT could_MD have_VB possibly_RB caused_VBN palpitations_NNS was_VBD the_DT preparation_NN of_IN frozen_JJ sections_NNS in_IN which_WDT a_DT freon-22-based_JJ aerosol_NN was_VBD used_VBN to_TO decrease_VB work_NN time_NN 
On_IN this_DT rotation_NN ,_, the_DT only_JJ procedure_NN that_WDT could_MD have_VB possibly_RB caused_VBN palpitations_NNS was_VBD the_DT preparation_NN of_IN frozen_JJ sections_NNS in_IN which_WDT a_DT freon-22-based_JJ aerosol_NN was_VBD used_VBN to_TO decrease_VB work_NN time_NN 
Exposure_NN for_IN 8_CD hr\/day_CD ,_, 5_CD days\/week_NN for_IN 2_CD to_TO 4_CD weeks_NNS to_TO CFC-11_NN at_IN a_DT concentration_NN of_IN 1000_CD ppm_NN showed_VBD only_RB minor_JJ decrement_NN in_IN several_JJ cognitive_JJ tests_NNS 
So_RB ,_, we_PRP suggested_VBD that_DT exposure_NN to_TO freon_NN may_MD be_VB an_DT important_JJ precipitating_NN factor_NN for_IN renal_JJ tubular_JJ damage_NN and_CC subsequently_RB renal_JJ impairment_NN ,_, which_WDT is_VBZ an_DT important_JJ cause_NN for_IN secondary_JJ arterial_JJ hypertension_NN 
In_IN the_DT present_JJ study_NN ,_, there_EX were_VBD no_DT statistically_RB significant_JJ differences_NNS between_IN the_DT two_CD study_NN groups_NNS regarding_VBG age_NN ,_, residence_NN ,_, type_NN of_IN domestic_JJ fuels_NNS ,_, excess_JJ salt_NN intake_NN ,_, obesity_NN ,_, cigarette_NN smoking_NN ,_, alcohol_NN consumption_NN ,_, past_JJ history_NN of_IN chronic_JJ systemic_JJ diseases_NNS ,_, certain_JJ infectious_JJ diseases_NNS ,_, complicated_JJ urinary_JJ tract_NN infection_NN ,_, obstructive_JJ uropathy_NN and_CC excess_JJ intake_NN of_IN nephrotoxic_JJ drugs_NNS ._. 
Additionally_RB ,_, none_NN of_IN the_DT workers_NNS had_VBD previous_JJ jobs_NNS and\/or_CC secondary_JJ occupations_NNS exposing_VBG them_PRP to_TO different_JJ nephrotoxins_NNS ,_, nor_CC had_VBD family_NN history_NN of_IN nephropathy_NN associated_VBN with_IN hyperuricemia_NN and_CC gout_NN 
In_IN the_DT present_JJ study_NN ,_, there_EX were_VBD no_DT statistically_RB significant_JJ differences_NNS between_IN the_DT two_CD study_NN groups_NNS regarding_VBG age_NN ,_, residence_NN ,_, type_NN of_IN domestic_JJ fuels_NNS ,_, excess_JJ salt_NN intake_NN ,_, obesity_NN ,_, cigarette_NN smoking_NN ,_, alcohol_NN consumption_NN ,_, past_JJ history_NN of_IN chronic_JJ systemic_JJ diseases_NNS ,_, certain_JJ infectious_JJ diseases_NNS ,_, complicated_JJ urinary_JJ tract_NN infection_NN ,_, obstructive_JJ uropathy_NN and_CC excess_JJ intake_NN of_IN nephrotoxic_JJ drugs_NNS ._. 
Additionally_RB ,_, none_NN of_IN the_DT workers_NNS had_VBD previous_JJ jobs_NNS and\/or_CC secondary_JJ occupations_NNS exposing_VBG them_PRP to_TO different_JJ nephrotoxins_NNS ,_, nor_CC had_VBD family_NN history_NN of_IN nephropathy_NN associated_VBN with_IN hyperuricemia_NN and_CC gout_NN 
However_RB ,_, these_DT studies_NNS do_VBP n't_RB negate_VB the_DT potential_JJ toxicity_NN of_IN these_DT substances_NNS in_IN situations_NNS where_WRB exposures_NNS are_VBP high_JJ ,_, such_JJ as_IN in_IN a_DT confined_VBN space_NN ,_, after_IN a_DT spill_NN or_CC in_IN individuals_NNS with_IN underlying_JJ heart_NN disease_NN ._. 
In_IN a_DT study_NN in_IN which_WDT ambulatory_JJ -LRB-_-LRB- ECG_NNP -RRB-_-RRB- were_VBD recorded_VBN for_IN 24_CD hours_NNS on_IN the_DT day_NN of_IN exposure_NN ,_, and_CC on_IN a_DT control_NN day_NN for_IN refrigerator_NN repairmen_NNS exposed_VBN to_TO FC_NNP 12_CD and_CC FC_NNP 22_CD ,_, and_CC on_IN any_DT work_NN day_NN for_IN a_DT control_NN group_NN ,_, no_DT clear_JJ connection_NN between_IN fluorocarbons_NNS and_CC cardiac_JJ arrhythmia_NN was_VBD found_VBN ,_, although_IN one_CD subject_NN had_VBD several_JJ ventricular_JJ ectopic_JJ beats_NNS ,_, which_WDT may_MD have_VB been_VBN with_IN the_DT result_NN of_IN exposure_NN 
In_IN the_DT present_JJ study_NN ,_, there_EX were_VBD no_DT significant_JJ statistical_JJ differences_NNS between_IN the_DT two_CD study_NN groups_NNS in_IN regards_VBZ to_TO some_DT of_IN the_DT precipitating_VBG factors_NNS for_IN arrhythmias_NNS ,_, such_JJ as_IN age_NN and_CC serum_NN levels_NNS of_IN electrolytes_NNS ,_, which_WDT were_VBD within_IN the_DT normal_JJ range_NN for_IN the_DT two_CD study_NN groups_NNS ._. 
Also_RB ,_, none_NN of_IN the_DT workers_NNS in_IN the_DT study_NN group_NN had_VBD past_JJ medical_JJ histories_NNS suggesting_VBG the_DT presence_NN of_IN any_DT precipitating_VBG factors_NNS for_IN arrhythmia_NN or_CC occupational_JJ exposure_NN to_TO arrhythmogenic_JJ chemicals_NNS ,_, or_CC had_VBD family_NN history_NN of_IN arrhythmias_NNS ._. 
So_RB ,_, it_PRP could_MD be_VB concluded_VBN that_IN freon-exposed_JJ workers_NNS are_VBP at_IN increased_VBN risk_NN for_IN cardiac_JJ arrhythmias_NNS ._. 
Contrary_JJ to_TO our_PRP$ findings_NNS ,_, many_JJ epidemiologic_JJ studies_NNS of_IN fluorocarbons_NNS exposure_NN have_VBP not_RB found_VBN a_DT significant_JJ increase_NN in_IN arrhythmia_NN frequencies_NNS under_IN normal_JJ working_NN conditions_NNS ._. 
However_RB ,_, these_DT studies_NNS do_VBP n't_RB negate_VB the_DT potential_JJ toxicity_NN of_IN these_DT substances_NNS in_IN situations_NNS where_WRB exposures_NNS are_VBP high_JJ ,_, such_JJ as_IN in_IN a_DT confined_VBN space_NN ,_, after_IN a_DT spill_NN or_CC in_IN individuals_NNS with_IN underlying_JJ heart_NN disease_NN ._. 
In_IN a_DT study_NN in_IN which_WDT ambulatory_JJ -LRB-_-LRB- ECG_NNP -RRB-_-RRB- were_VBD recorded_VBN for_IN 24_CD hours_NNS on_IN the_DT day_NN of_IN exposure_NN ,_, and_CC on_IN a_DT control_NN day_NN for_IN refrigerator_NN repairmen_NNS exposed_VBN to_TO FC_NNP 12_CD and_CC FC_NNP 22_CD ,_, and_CC on_IN any_DT work_NN day_NN for_IN a_DT control_NN group_NN ,_, no_DT clear_JJ connection_NN between_IN fluorocarbons_NNS and_CC cardiac_JJ arrhythmia_NN was_VBD found_VBN ,_, although_IN one_CD subject_NN had_VBD several_JJ ventricular_JJ ectopic_JJ beats_NNS ,_, which_WDT may_MD have_VB been_VBN with_IN the_DT result_NN of_IN exposure_NN 
In_IN addition_NN ,_, a_DT case_NN of_IN ventricular_JJ fibrillation_NN and_CC two_CD cases_NNS of_IN atrial_JJ fibrillation_NN were_VBD recorded_VBN after_IN exposure_NN to_TO a_DT fluorinated_VBN hydrocarbon_NN and_CC -LRB-_-LRB- CFC_NNP 113_CD -RRB-_-RRB- respectively_RB 
Our_PRP$ findings_NNS partially_RB agree_VBP with_IN previous_JJ study_NN results_NNS in_IN which_WDT serum_NN cholesterol_NN levels_NNS were_VBD slightly_RB higher_JJR and_CC triglyceride_NN levels_NNS were_VBD lower_JJR in_IN adult_NN male_NN rats_NNS exposed_VBN to_TO 50_CD ,_, 000_CD ppm_NN freon_NN 22_CD for_IN five_CD hours_NNS per_IN day_NN for_IN eight_CD weeks_NNS 
The_DT present_JJ study_NN revealed_VBD that_IN there_EX were_VBD no_DT significant_JJ statistical_JJ differences_NNS between_IN the_DT two_CD study_NN groups_NNS in_IN regards_VBZ to_TO lipid_VB profile_JJ markers_NNS ,_, except_IN total_JJ cholesterol_NN level_NN ,_, which_WDT was_VBD significantly_RB elevated_VBN in_IN the_DT exposed_JJ workers_NNS compared_VBN to_TO the_DT control_NN group_NN ._. 
Our_PRP$ findings_NNS partially_RB agree_VBP with_IN previous_JJ study_NN results_NNS in_IN which_WDT serum_NN cholesterol_NN levels_NNS were_VBD slightly_RB higher_JJR and_CC triglyceride_NN levels_NNS were_VBD lower_JJR in_IN adult_NN male_NN rats_NNS exposed_VBN to_TO 50_CD ,_, 000_CD ppm_NN freon_NN 22_CD for_IN five_CD hours_NNS per_IN day_NN for_IN eight_CD weeks_NNS 
Moreover_RB ,_, clinical_JJ pathologists_NNS exposed_VBN to_TO fluorocarbons_NNS during_IN the_DT preparation_NN of_IN frozen_JJ tissue_NN sections_NNS have_VBP been_VBN found_VBN to_TO develop_VB coronary_JJ heart_NN disease_NN to_TO an_DT increased_VBN degree_NN ._. 
This_DT discrepancy_NN of_IN the_DT results_NNS between_IN the_DT present_JJ study_NN and_CC the_DT other_JJ studies_NNS could_MD be_VB attributed_VBN to_TO exposure_NN of_IN workers_NNS to_TO different_JJ freon_NN levels_NNS and_CC types_NNS as_RB well_RB as_IN to_TO individual_JJ susceptibility_NN ,_, where_WRB individuals_NNS with_IN preexisting_JJ conditions_NNS of_IN the_DT cardiovascular_JJ system_NN and\/or_CC concurrent_JJ stress_NN -LRB-_-LRB- associated_VBN with_IN elevated_JJ levels_NNS of_IN catecholamines_NNS -RRB-_-RRB- may_MD have_VB increased_VBN susceptibility_NN to_TO the_DT toxicity_NN of_IN excessive_JJ freon_NN exposure_NN 
g._NN Individuals_NNS with_IN preexisting_VBG diseases\/conditions_NNS of_IN the_DT cardiovascular_JJ system_NN or_CC under_IN circumstances_NNS where_WRB an_DT abnormally_RB large_JJ amount_NN of_IN adrenaline_NN is_VBZ secreted_VBN endogenously_RB -LRB-_-LRB- such_JJ as_IN anger_NN ,_, fear_NN ,_, excitement_NN and_CC severe_JJ exertion_NN -RRB-_-RRB- or_CC exposed_VBN to_TO epinephrine_NN or_CC other_JJ sympathomimetic_JJ amines_NNS e._VBP bronchodilator_NN and_CC nasal_JJ decongestant_NN ,_, may_MD have_VB increased_VBN susceptibility_NN to_TO the_DT toxicity_NN of_IN excessive_JJ exposure_NN 
However_RB ,_, two_CD cases_NNS of_IN acute_JJ massive_JJ freon_NN exposure_NN preceded_VBD secondary_JJ arterial_JJ hypertension_NN and_CC a_DT fatal_JJ case_NN of_IN myocardial_JJ infarction_NN occurred_VBD in_IN an_DT elderly_JJ man_NN exposed_VBN to_TO decomposed_JJ freon-22_NN 
This_DT could_MD suggest_VB that_IN freon-exposed_JJ workers_NNS under_IN normal_JJ working_NN conditions_NNS are_VBP not_RB at_IN an_DT increased_VBN risk_NN for_IN arterial_JJ hypertension_NN or_CC coronary_JJ artery_NN disease_NN ._. 
However_RB ,_, two_CD cases_NNS of_IN acute_JJ massive_JJ freon_NN exposure_NN preceded_VBD secondary_JJ arterial_JJ hypertension_NN and_CC a_DT fatal_JJ case_NN of_IN myocardial_JJ infarction_NN occurred_VBD in_IN an_DT elderly_JJ man_NN exposed_VBN to_TO decomposed_JJ freon-22_NN 
Table_NNP 3_NNP Average_NNP concentration_NN of_IN freon_NN 12_CD and_CC 22_CD in_IN workshop_NN of_IN refrigeration_NN workers_NNS :_: Average_JJ concentration_NN of_IN freon_NN 12_CD and_CC 22_CD in_IN the_DT refrigeration_NN services_NNS workshop_VBP The_DT corresponding_JJ Threshold_NNP limit_NN value_NN -LRB-_-LRB- TLV_NNP -RRB-_-RRB- mg\/m_NN 3_CD Freon_NN 12_CD 5720_CD mg\/m_NN 3_CD 
Statistical_NNP Analysis_NNP The_DT collected_VBN data_NN was_VBD statistically_RB analyzed_VBN using_VBG Epi-Info_NNP software_NN version_NN 6_CD ._. 
1._CD 
Comparison_NN between_IN group_NN means_NNS was_VBD done_VBN using_VBG student_NN 's_POS t-test_JJS ;_: while_IN a_DT paired_VBN t_NN test_NN was_VBD used_VBN for_IN paired_VBN quantitative_JJ data_NNS and_CC Chi_NNP square_JJ test_NN for_IN qualitative_JJ data_NNS ._. 
Normal_JJ values_NNS for_IN urine_NN samples_NNS are_VBP in_IN the_DT range_NN of_IN 0_CD 
However_RB ,_, developing_VBG countries_NNS are_VBP in_IN the_DT early_JJ stages_NNS of_IN changing_VBG from_IN CFCs_NNS to_TO HFCs_NNS and_CC HCFCs_NNS ._. 
Since_IN the_DT 1990s_CD ,_, according_VBG to_TO the_DT Montreal_NNP Protocol_NNP on_IN Substances_NNS that_WDT Deplete_VBP the_DT Ozone_NN Layer_NN ,_, developed_JJ countries_NNS have_VBP replaced_VBN CFCs_NNS and_CC hydrochlorofluorocarbons_NNS -LRB-_-LRB- HCFCs_NNS -RRB-_-RRB- -LRB-_-LRB- hydrogenated_VBN chlorofluorocarbons_NNS -RRB-_-RRB- such_JJ as_IN dichlorodifluoromethane_NN -LRB-_-LRB- CFC-12_NN -RRB-_-RRB- -LRB-_-LRB- FC-12_NN -RRB-_-RRB- -LRB-_-LRB- Freon_NN 12_CD -RRB-_-RRB- ,_, and_CC chlorodifluoromethane_NN -LRB-_-LRB- HCFC-22_NN -RRB-_-RRB- -LRB-_-LRB- FC-22_NN -RRB-_-RRB- -LRB-_-LRB- Freon_NN 22_CD -RRB-_-RRB- respectively_RB ,_, which_WDT cause_VBP significant_JJ stratospheric_JJ ozone_NN depletion_NN and_CC global_JJ warming_NN ,_, and_CC replaced_VBD them_PRP with_IN hydrofluorocarbons_NNS -LRB-_-LRB- HFCs_NNP -RRB-_-RRB- -LRB-_-LRB- chlorine-free_JJ hydrogenated_VBN fluorocarbons_NNS -RRB-_-RRB- ,_, such_JJ as_IN HFC-32_NNP and_CC HFC-134_NNP ._. 
The_DT Montreal_NNP Protocol_NNP allows_VBZ continued_VBN production_NN and_CC importation_NN of_IN CFCs_NNS in_IN developing_VBG countries_NNS until_IN 2010_CD to_TO facilitate_VB their_PRP$ transition_NN to_TO the_DT newer_JJR CFC_NNP free_JJ technologies_NNS 
Accidental_JJ ingestion_NN can_MD cause_VB nausea_NN and_CC ulceration_NN of_IN the_DT stomach_NN ._. 
Inhalation_NN of_IN high_JJ concentrations_NNS of_IN CFC_NNP can_MD induce_VB airway_NN and_CC respiratory_NN problems_NNS ,_, in_IN addition_NN to_TO temporary_JJ nervous_JJ system_NN depression_NN with_IN anesthetic_JJ effects_NNS ._. 
Jaundice_NN and_CC mild_JJ elevations_NNS in_IN transaminases_NNS may_MD develop_VB after_IN inhalational_JJ exposure_NN or_CC ingestion_NN ._. 
Moreover_RB ,_, overexposure_NN to_TO CFCs_NNP and_CC related_VBN halogenated_JJ hydrocarbons_NNS can_MD cause_VB arterial_JJ hypertension_NN ,_, myocardial_JJ infarction_NN and_CC temporary_JJ alteration_NN of_IN the_DT electrical_JJ activity_NN of_IN the_DT heart_NN -LRB-_-LRB- atrial_JJ and_CC ventricular_JJ cardiac_JJ arrhythmias_NNS -RRB-_-RRB- manifested_VBN with_IN palpitations_NNS ,_, irregular_JJ pulse_NN or_CC even_RB inadequate_JJ circulation_NN ._. 
Moreover_RB ,_, clinical_JJ pathologists_NNS exposed_VBN to_TO fluorocarbons_NNS during_IN the_DT preparation_NN of_IN frozen_JJ tissue_NN sections_NNS have_VBP been_VBN found_VBN to_TO develop_VB coronary_JJ heart_NN disease_NN to_TO an_DT increased_VBN degree_NN ._. 
This_DT discrepancy_NN of_IN the_DT results_NNS between_IN the_DT present_JJ study_NN and_CC the_DT other_JJ studies_NNS could_MD be_VB attributed_VBN to_TO exposure_NN of_IN workers_NNS to_TO different_JJ freon_NN levels_NNS and_CC types_NNS as_RB well_RB as_IN to_TO individual_JJ susceptibility_NN ,_, where_WRB individuals_NNS with_IN preexisting_JJ conditions_NNS of_IN the_DT cardiovascular_JJ system_NN and\/or_CC concurrent_JJ stress_NN -LRB-_-LRB- associated_VBN with_IN elevated_JJ levels_NNS of_IN catecholamines_NNS -RRB-_-RRB- may_MD have_VB increased_VBN susceptibility_NN to_TO the_DT toxicity_NN of_IN excessive_JJ freon_NN exposure_NN 
g._NN Individuals_NNS with_IN preexisting_VBG diseases\/conditions_NNS of_IN the_DT cardiovascular_JJ system_NN or_CC under_IN circumstances_NNS where_WRB an_DT abnormally_RB large_JJ amount_NN of_IN adrenaline_NN is_VBZ secreted_VBN endogenously_RB -LRB-_-LRB- such_JJ as_IN anger_NN ,_, fear_NN ,_, excitement_NN and_CC severe_JJ exertion_NN -RRB-_-RRB- or_CC exposed_VBN to_TO epinephrine_NN or_CC other_JJ sympathomimetic_JJ amines_NNS e._VBP bronchodilator_NN and_CC nasal_JJ decongestant_NN ,_, may_MD have_VB increased_VBN susceptibility_NN to_TO the_DT toxicity_NN of_IN excessive_JJ exposure_NN 
Accidental_JJ ingestion_NN can_MD cause_VB nausea_NN and_CC ulceration_NN of_IN the_DT stomach_NN ._. 
Inhalation_NN of_IN high_JJ concentrations_NNS of_IN CFC_NNP can_MD induce_VB airway_NN and_CC respiratory_NN problems_NNS ,_, in_IN addition_NN to_TO temporary_JJ nervous_JJ system_NN depression_NN with_IN anesthetic_JJ effects_NNS ._. 
Jaundice_NN and_CC mild_JJ elevations_NNS in_IN transaminases_NNS may_MD develop_VB after_IN inhalational_JJ exposure_NN or_CC ingestion_NN ._. 
Moreover_RB ,_, overexposure_NN to_TO CFCs_NNP and_CC related_VBN halogenated_JJ hydrocarbons_NNS can_MD cause_VB arterial_JJ hypertension_NN ,_, myocardial_JJ infarction_NN and_CC temporary_JJ alteration_NN of_IN the_DT electrical_JJ activity_NN of_IN the_DT heart_NN -LRB-_-LRB- atrial_JJ and_CC ventricular_JJ cardiac_JJ arrhythmias_NNS -RRB-_-RRB- manifested_VBN with_IN palpitations_NNS ,_, irregular_JJ pulse_NN or_CC even_RB inadequate_JJ circulation_NN ._. 
Background_NN Fluorocarbons_NNS are_VBP a_DT group_NN of_IN synthetic_JJ halogen-substituted_JJ methane_NN and_CC ethane_NN derivatives_NNS containing_VBG atoms_NNS of_IN chlorine_NN and_CC fluorine_NN and_CC are_VBP commonly_RB known_VBN as_IN chlorofluorocarbons_NNS -LRB-_-LRB- CFCs_NNP -RRB-_-RRB- ._. 
They_PRP are_VBP generally_RB known_VBN by_IN commercial_JJ names_NNS such_JJ as_IN freon_NN ,_, arcton_NN and_CC frigen_NN ._. 
Since_IN the_DT 1930s_NNS ,_, when_WRB chlorofluorocarbons_NNS -LRB-_-LRB- CFCs_NNP -RRB-_-RRB- ,_, fully_RB halogenated_VBN or_CC non-hydrogenated_JJ fluorocarbons_NNS ,_, were_VBD developed_VBN ,_, they_PRP were_VBD considered_VBN to_TO be_VB nearly_RB perfect_JJ chemicals_NNS ._. 
Until_IN now_RB ,_, there_EX have_VBP been_VBN few_JJ isolated_JJ reports_NNS of_IN cardiotoxicity_NN and_CC nephrotoxicity_NN resulting_VBG from_IN occupational_JJ exposure_NN to_TO different_JJ fluorocarbons_NNS ._. 
Despite_IN the_DT life-threatening_JJ cardiotoxic_JJ consequences_NNS of_IN fluorinated_VBN hydrocarbon_NN exposure_NN ,_, the_DT documentation_NN of_IN toxic_JJ effects_NNS in_IN human_JJ subjects_NNS is_VBZ still_RB ambiguous_JJ ._. 
Thus_RB ,_, this_DT study_NN was_VBD conducted_VBN to_TO determine_VB the_DT occupational_JJ exposure_NN effects_NNS on_IN the_DT cardiovascular_JJ system_NN and_CC renal_JJ function_NN when_WRB exposed_VBN to_TO freon_NN ._. 
There_EX are_VBP several_JJ hypotheses_NNS on_IN the_DT mechanism_NN for_IN the_DT arrhythmogenic_JJ effect_NN of_IN hydrocarbons_NNS and_CC fluorocarbons_NNS including_VBG :_: the_DT effects_NNS on_IN the_DT central_JJ nervous_JJ system_NN ,_, respiratory_JJ reflexes_NNS ,_, changes_NNS in_IN potassium_NN levels_NNS ,_, or_CC either_CC the_DT adrenergic_JJ and\/or_CC cholinergic_JJ receptors_NNS ;_: the_DT direct_JJ effects_NNS on_IN the_DT cardiac_JJ conduction_NN system_NN ;_: or_CC the_DT sensitizing_NN of_IN the_DT heart_NN to_TO the_DT endogenous_JJ catecholamines_NNS 
Furthermore_RB ,_, the_DT arrhythmogenicity_NN of_IN freon_NN on_IN the_DT heart_NN conduction_NN system_NN is_VBZ enhanced_VBN synergistically_RB by_IN hypoxia_NN 
Since_IN the_DT 1930s_NNS ,_, when_WRB chlorofluorocarbons_NNS -LRB-_-LRB- CFCs_NNP -RRB-_-RRB- ,_, fully_RB halogenated_VBN or_CC non-hydrogenated_JJ fluorocarbons_NNS ,_, were_VBD developed_VBN ,_, they_PRP were_VBD considered_VBN to_TO be_VB nearly_RB perfect_JJ chemicals_NNS ._. 
They_PRP are_VBP stable_JJ ,_, nonflammable_JJ ,_, noncorrosive_JJ ,_, low_JJ in_IN toxicity_NN and_CC inexpensive_JJ to_TO produce_VB ._. 
In_IN 1974_CD ,_, scientists_NNS discovered_VBD that_IN CFCs_NNP have_VBP the_DT capability_NN of_IN depleting_VBG the_DT stratospheric_JJ ozone_NN layer_NN ._. 
Table_NNP 3_NNP illustrates_VBZ that_IN the_DT average_JJ concentrations_NNS of_IN freon_NN 12_CD and_CC 22_CD in_IN the_DT breathing_NN zone_NN of_IN refrigeration_NN workers_NNS were_VBD 5720_CD mg\/m_NN 3_CD and_CC 4310_CD mg\/m_NN 3_CD respectively_RB ,_, which_WDT exceed_VBP threshold_NN limit_NN values_NNS ,_, which_WDT are_VBP 4950_CD mg\/m_NN 3_CD and_CC 3540_CD mg\/m_NN 3_CD respectively_RB ._. 
Table_NNP 3Average_NNP concentration_NN of_IN freon_NN 12_CD and_CC 22_CD in_IN workshop_NN of_IN refrigeration_NN workers_NNS :_: Average_JJ concentration_NN of_IN freon_NN 12_CD and_CC 22in_CD the_DT refrigeration_NN services_NNS workshopThe_VBP corresponding_JJ Thresholdlimit_NNP value_NN -LRB-_-LRB- TLV_NNP -RRB-_-RRB- mg\/m3Freon_NNP 12_CD 5720_CD mg\/m3_NN 
In_IN 1974_CD ,_, scientists_NNS discovered_VBD that_IN CFCs_NNP have_VBP the_DT capability_NN of_IN depleting_VBG the_DT stratospheric_JJ ozone_NN layer_NN ._. 
Since_IN the_DT 1990s_CD ,_, according_VBG to_TO the_DT Montreal_NNP Protocol_NNP on_IN Substances_NNS that_WDT Deplete_VBP the_DT Ozone_NN Layer_NN ,_, developed_JJ countries_NNS have_VBP replaced_VBN CFCs_NNS and_CC hydrochlorofluorocarbons_NNS -LRB-_-LRB- HCFCs_NNS -RRB-_-RRB- -LRB-_-LRB- hydrogenated_VBN chlorofluorocarbons_NNS -RRB-_-RRB- such_JJ as_IN dichlorodifluoromethane_NN -LRB-_-LRB- CFC-12_NN -RRB-_-RRB- -LRB-_-LRB- FC-12_NN -RRB-_-RRB- -LRB-_-LRB- Freon_NN 12_CD -RRB-_-RRB- ,_, and_CC chlorodifluoromethane_NN -LRB-_-LRB- HCFC-22_NN -RRB-_-RRB- -LRB-_-LRB- FC-22_NN -RRB-_-RRB- -LRB-_-LRB- Freon_NN 22_CD -RRB-_-RRB- respectively_RB ,_, which_WDT cause_VBP significant_JJ stratospheric_JJ ozone_NN depletion_NN and_CC global_JJ warming_NN ,_, and_CC replaced_VBD them_PRP with_IN hydrofluorocarbons_NNS -LRB-_-LRB- HFCs_NNP -RRB-_-RRB- -LRB-_-LRB- chlorine-free_JJ hydrogenated_VBN fluorocarbons_NNS -RRB-_-RRB- ,_, such_JJ as_IN HFC-32_NNP and_CC HFC-134_NNP ._. 
However_RB ,_, developing_VBG countries_NNS are_VBP in_IN the_DT early_JJ stages_NNS of_IN changing_VBG from_IN CFCs_NNS to_TO HFCs_NNS and_CC HCFCs_NNS ._. 
The_DT Montreal_NNP Protocol_NNP allows_VBZ continued_VBN production_NN and_CC importation_NN of_IN CFCs_NNS in_IN developing_VBG countries_NNS until_IN 2010_CD to_TO facilitate_VB their_PRP$ transition_NN to_TO the_DT newer_JJR CFC_NNP free_JJ technologies_NNS 
Moreover_RB ,_, overexposure_NN to_TO CFCs_NNP and_CC related_VBN halogenated_JJ hydrocarbons_NNS can_MD cause_VB arterial_JJ hypertension_NN ,_, myocardial_JJ infarction_NN and_CC temporary_JJ alteration_NN of_IN the_DT electrical_JJ activity_NN of_IN the_DT heart_NN -LRB-_-LRB- atrial_JJ and_CC ventricular_JJ cardiac_JJ arrhythmias_NNS -RRB-_-RRB- manifested_VBN with_IN palpitations_NNS ,_, irregular_JJ pulse_NN or_CC even_RB inadequate_JJ circulation_NN ._. 
Cardiac_JJ arrest_NN and_CC death_NN may_MD occur_VB from_IN gross_JJ overexposure_NN ._. 
Until_IN now_RB ,_, there_EX have_VBP been_VBN few_JJ isolated_JJ reports_NNS of_IN cardiotoxicity_NN and_CC nephrotoxicity_NN resulting_VBG from_IN occupational_JJ exposure_NN to_TO different_JJ fluorocarbons_NNS ._. 
These_DT results_NNS agree_VBP with_IN Brogren_NNP et_FW al_FW 
This_DT could_MD suggest_VB that_IN freon-exposed_JJ workers_NNS under_IN normal_JJ working_NN conditions_NNS are_VBP not_RB at_IN an_DT increased_VBN risk_NN for_IN arterial_JJ hypertension_NN or_CC coronary_JJ artery_NN disease_NN ._. 
However_RB ,_, two_CD cases_NNS of_IN acute_JJ massive_JJ freon_NN exposure_NN preceded_VBD secondary_JJ arterial_JJ hypertension_NN and_CC a_DT fatal_JJ case_NN of_IN myocardial_JJ infarction_NN occurred_VBD in_IN an_DT elderly_JJ man_NN exposed_VBN to_TO decomposed_JJ freon-22_NN 
These_DT results_NNS agree_VBP with_IN Brogren_NNP et_FW al_FW 
The_DT high_JJ percentage_NN of_IN households_NNS reporting_VBG malaria_NN cases_NNS and_CC other_JJ fevers_NNS was_VBD probably_RB due_JJ to_TO poor_JJ utilization_NN of_IN preventive_JJ measures_NNS availed_VBD to_TO the_DT camp_NN occupants_NNS as_RB well_RB as_IN the_DT camp_NN living_NN situation_NN itself_PRP ._. 
One_CD can_MD argue_VB that_IN the_DT incidence_NN of_IN malaria_NN could_MD even_RB be_VB higher_JJR since_IN the_DT incubation_NN period_NN mostly_RB ranges_VBZ from_IN 7_CD days_NNS to_TO 4_CD weeks_NNS ._. 
Although_IN mosquito_NN nets_NNS had_VBD been_VBN provided_VBN to_TO children_NNS under_IN 5_CD and_CC pregnant_JJ mothers_NNS ,_, they_PRP were_VBD hardly_RB used_VBN ,_, largely_RB due_JJ to_TO lack_NN of_IN facilities_NNS to_TO hang_VB the_DT nets_NNS on_IN ._. 
This_DT situation_NN influenced_VBD people_NNS 's_POS sanitation_NN and_CC hygiene_NN behaviors_NNS ._. 
There_EX were_VBD inadequate_JJ hygiene_NN facilities_NNS ._. 
Outbreaks_NNS of_IN diarrheal_JJ diseases_NNS ,_, particularly_RB dysentery_NN and_CC cholera_NN ,_, are_VBP a_DT great_JJ concern_NN where_WRB a_DT population_NN is_VBZ living_VBG in_IN a_DT crowded_JJ environment_NN such_JJ as_IN a_DT camp_NN ,_, hence_RB provision_NN of_IN safe_JJ water_NN supply_NN is_VBZ one_CD of_IN the_DT rapid_JJ response_NN actions_NNS by_IN relief_NN agencies_NNS ._. 
Although_IN there_EX was_VBD evidence_NN that_IN efforts_NNS have_VBP been_VBN to_TO this_DT effect_NN ,_, our_PRP$ assessment_NN established_VBN that_IN safe_JJ water_NN was_VBD not_RB readily_RB accessible_JJ as_IN it_PRP was_VBD irregular_JJ ._. 
Moreover_RB ,_, we_PRP found_VBD traditional_JJ beliefs_NNS that_WDT prohibit_VBP latrine_NN sharing_NN among_IN certain_JJ groups_NNS of_IN people_NNS such_JJ as_IN in-laws_NNS or_CC other_JJ families_NNS ._. 
These_DT beliefs_NNS are_VBP not_RB only_RB unique_JJ to_TO Bududa_NNP ,_, but_CC similar_JJ taboos_NNS ,_, cultural_JJ and_CC customary_JJ beliefs_NNS deeply_RB affect_VBP sanitation_NN in_IN most_JJS parts_NNS of_IN rural_JJ Uganda_NNP ._. 
Such_JJ beliefs_NNS need_VBP to_TO be_VB corrected_VBN through_IN intensive_JJ mobilization_NN and_CC education_NN at_IN grassroot_JJ level_NN ._. 
This_DT often_RB leads_VBZ to_TO high_JJ morbidity_NN and_CC mortality_NN in_IN the_DT camps_NNS 
This_DT often_RB leads_VBZ to_TO high_JJ morbidity_NN and_CC mortality_NN in_IN the_DT camps_NNS 
The_DT excess_JJ morbidity_NN and_CC mortality_NN caused_VBN by_IN communicable_JJ diseases_NNS during_IN emergencies_NNS is_VBZ largely_RB avoidable_JJ ,_, when_WRB appropriate_JJ interventions_NNS are_VBP put_VBN in_IN place_NN ._. 
Experience_NN has_VBZ shown_VBN that_IN ,_, when_WRB these_DT interventions_NNS are_VBP implemented_VBN in_IN a_DT timely_JJ and_CC coordinated_VBN manner_NN ,_, deaths_NNS and_CC disease_NN are_VBP substantially_RB reduced_VBN 
Experience_NN has_VBZ shown_VBN that_IN ,_, when_WRB these_DT interventions_NNS are_VBP implemented_VBN in_IN a_DT timely_JJ and_CC coordinated_VBN manner_NN ,_, deaths_NNS and_CC disease_NN are_VBP substantially_RB reduced_VBN 
In_IN camp_NN situations_NNS ,_, diarrhoeal_JJ diseases_NNS account_VBP for_IN more_JJR than_IN 40_CD %_NN of_IN these_DT deaths_NNS in_IN the_DT acute_JJ phase_NN of_IN an_DT emergency_NN ,_, with_IN over_IN 80_CD %_NN of_IN these_DT deaths_NNS occurring_VBG in_IN children_NNS aged_VBD less_JJR than_IN two_CD years_NNS ._. 
Good_JJ planning_NN where_WRB public_JJ health_NN measures_NNS such_JJ as_IN appropriate_JJ camp_NN site_NN location_NN ,_, availability_NN of_IN clean_JJ water_NN ,_, good_JJ sanitation_NN and_CC personal_JJ hygiene_NN ,_, and_CC health_NN education_NN are_VBP critical_JJ in_IN controlling_VBG spread_NN of_IN diarrheal_JJ diseases_NNS ._. 
Immediately_RB following_VBG the_DT Bududa_NNP disaster_NN and_CC establishment_NN of_IN the_DT Buluchecke_NNP Internally_NNP Displaced_NNP Persons_NNP -LRB-_-LRB- IDP_NNP -RRB-_-RRB- camp_NN ,_, a_DT number_NN of_IN agencies_NNS ,_, such_JJ as_IN The_DT Uganda_NNP Red_NNP Cross_NNP Society_NNP ,_, UNICEF_NNP ,_, Ministry_NNP of_IN Health_NNP ,_, Bududa_NNP district_NN health_NN department_NN ,_, Oxfam_NNP ,_, Foundation_NNP for_IN Development_NNP of_IN Needy_NNP Communities_NNPS ,_, World_NNP Health_NNP Organization_NNP ,_, Ministry_NNP of_IN Water_NNP and_CC Environment_NNP ,_, Indian_NNP Association_NNP of_IN Uganda_NNP and_CC Uganda_NNP People_NNP 's_POS Defense_NNP Forces_NNP moved_VBD in_RP to_TO provide_VB emergency_NN interve_NN 
This_DT type_NN of_IN analysis_NN refers_VBZ to_TO a_DT process_NN where_WRB analysis_NN of_IN the_DT appearance_NN of_IN a_DT particular_JJ word_NN or_CC content_NN in_IN textual_JJ material_NN is_VBZ done_VBN ._. 
Description_NN of_IN the_DT visible_JJ ,_, obvious_JJ components_NNS of_IN text_NN and_CC what_WP the_DT text_NN says_VBZ in_IN the_DT transcripts_NNS is_VBZ taken_VBN into_IN account_NN ._. 
We_PRP read_VBP through_IN all_PDT the_DT transcripts_NNS several_JJ times_NNS while_IN making_VBG notes_NNS and_CC jotting_VBG in_IN the_DT transcript_NN ._. 
The_DT same_JJ river_NN was_VBD being_VBG used_VBN for_IN laundry_NN ,_, bathing_NN and_CC recreation_NN -LRB-_-LRB- swimming_NN -RRB-_-RRB- especially_RB for_IN the_DT children_NNS -LRB-_-LRB- Picture_NNP 1_CD -RRB-_-RRB- ._. 
Combined_VBN with_IN the_DT traditional_JJ beliefs_NNS that_IN `_`` un-boiled_JJ water_NN tastes_NNS better_RBR ''_'' ,_, this_DT could_MD lead_VB to_TO a_DT potentially_RB dangerous_JJ situation_NN that_WDT could_MD easily_RB lead_VB to_TO outbreaks_NNS of_IN diarrheal_JJ diseases_NNS ._. 
The_DT population_NN per_IN latrine_NN ratio_NN in_IN the_DT camp_NN was_VBD 217_CD people_NNS per_IN latrine_NN stance_NN ._. 
This_DT is_VBZ far_RB below_IN the_DT Minimum_NNP Sphere_NNP Standard_NNP which_WDT requires_VBZ a_DT maximum_NN of_IN 50_CD people_NNS per_IN latrine_NN in_IN areas_NNS where_WRB there_EX are_VBP no_DT latrines_NNS initially_RB -LRB-_-LRB- like_IN in_IN this_DT case_NN -RRB-_-RRB- and_CC decreasing_VBG to_TO 20_CD people_NNS per_IN latrine_NN stance_NN as_RB soon_RB as_IN possible_JJ 
Elgon_NN region_NN of_IN Bududa_NNP District_NNP in_IN Eastern_NNP Uganda_NNP experienced_VBD a_DT major_JJ landslide_NN of_IN unprecedented_JJ magnitude_NN in_IN the_DT history_NN Uganda_NNP ._. 
The_DT landslide_NN ,_, which_WDT was_VBD triggered_VBN by_IN heavy_JJ rains_NNS lasting_VBG over_IN three_CD months_NNS ,_, buried_VBD three_CD villages_NNS -LRB-_-LRB- Kubehwo_NNP ,_, Namakansa_NNP ,_, Nametsi_NNP -RRB-_-RRB- in_IN Bumayoka_NNP sub-county_NN ,_, killed_VBD over_RP about_IN 400_CD people_NNS and_CC left_VBD 5000_CD others_NNS displaced_VBD ._. 
The_DT displaced_VBN population_NN was_VBD temporarily_RB relocated_VBN to_TO a_DT camp_NN in_IN Bulucheke_NNP sub-county_JJ head_NN quarters_NNS ,_, 7_CD km_NN from_IN the_DT site_NN of_IN the_DT disaster_NN ._. 
Elgon_NNP before_RB ._. 
This_DT kind_NN of_IN destruction_NN both_DT to_TO human_JJ lives_NNS ,_, property_NN and_CC the_DT environment_NN had_VBD never_RB occurred_VBN on_IN Mt._NNP Human_NNP vulnerability_NN to_TO any_DT disaster_NN is_VBZ a_DT complex_JJ phenomenon_NN with_IN social_JJ ,_, economic_JJ ,_, health_NN ,_, and_CC cultural_JJ dimensions_NNS ._. 
Specifically_RB ,_, landslides_NNS usually_RB cause_VBP displacement_NN and_CC often_RB are_VBP accompanied_VBN by_IN hydro-meteorological_JJ events_NNS such_JJ as_IN floods_NNS ._. 
Displacement_NNP disrupts_VBZ public_JJ health_NN systems_NNS ,_, and_CC may_MD lead_VB to_TO inadequate_JJ safe_JJ water_NN and_CC poor_JJ sanitation_NN ._. 
This_DT often_RB leads_VBZ to_TO high_JJ morbidity_NN and_CC mortality_NN in_IN the_DT camps_NNS 
The_DT latrines_NNS were_VBD also_RB very_RB dirty_JJ ,_, littered_VBN with_IN feces_NNS ,_, smelly_JJ ,_, and_CC infested_JJ with_IN flies_VBZ ._. 
Such_JJ beliefs_NNS need_VBP to_TO be_VB corrected_VBN through_IN intensive_JJ mobilization_NN and_CC education_NN at_IN grassroot_JJ level_NN ._. 
These_DT factors_NNS obviously_RB impedes_VBZ use_NN and_CC de-motivates_JJ latrine_NN users_NNS ._. 
Absence_NN of_IN lighting_NN in_IN the_DT latrines_NNS further_RB compromised_VBD their_PRP$ use_NN ._. 
Light_NNP is_VBZ essential_JJ for_IN accurate_JJ aiming_VBG of_IN feces_NNS inside_IN the_DT pit_NN always_RB fear_NN of_IN stepping_VBG onto_IN feces_NNS ,_, and_CC reduces_VBZ fear_NN of_IN unknown_JJ dangers_NNS in_IN the_DT darkness_NN surrounding_VBG the_DT toilet_NN ._. 
This_DT type_NN of_IN analysis_NN refers_VBZ to_TO a_DT process_NN where_WRB analysis_NN of_IN the_DT appearance_NN of_IN a_DT particular_JJ word_NN or_CC content_NN in_IN textual_JJ material_NN is_VBZ done_VBN ._. 
Description_NN of_IN the_DT visible_JJ ,_, obvious_JJ components_NNS of_IN text_NN and_CC what_WP the_DT text_NN says_VBZ in_IN the_DT transcripts_NNS is_VBZ taken_VBN into_IN account_NN ._. 
We_PRP read_VBP through_IN all_PDT the_DT transcripts_NNS several_JJ times_NNS while_IN making_VBG notes_NNS and_CC jotting_VBG in_IN the_DT transcript_NN ._. 
All_DT data_NNS were_VBD logged_VBN into_IN a_DT matrix_NN and_CC frequency_NN of_IN responses_NNS made_VBN ._. 
We_PRP read_VBP through_IN all_PDT the_DT transcripts_NNS several_JJ times_NNS while_IN making_VBG notes_NNS and_CC jotting_VBG in_IN the_DT transcript_NN ._. 
Issues_NNS that_WDT commonly_RB appeared_VBD were_VBD therefore_RB closely_RB examined_VBN and_CC tracked_VBN in_IN the_DT transcripts_NNS as_IN stipulated_VBN by_IN Graneheim_NNP and_CC Lundman_NNP ,_, 2004_CD ._. 
Observation_NN data_NNS were_VBD triangulated_VBN with_IN KI_NNP and_CC FGD_NNP data_NNS ._. 
This_DT process_NN gave_VBD deep_JJ insight_NN of_IN the_DT situation_NN and_CC was_VBD useful_JJ in_IN validating_VBG and_CC interpreting_VBG the_DT results_NNS ._. 
This_DT situation_NN influenced_VBD people_NNS 's_POS sanitation_NN and_CC hygiene_NN behaviors_NNS ._. 
There_EX were_VBD inadequate_JJ hygiene_NN facilities_NNS ._. 
Outbreaks_NNS of_IN diarrheal_JJ diseases_NNS ,_, particularly_RB dysentery_NN and_CC cholera_NN ,_, are_VBP a_DT great_JJ concern_NN where_WRB a_DT population_NN is_VBZ living_VBG in_IN a_DT crowded_JJ environment_NN such_JJ as_IN a_DT camp_NN ,_, hence_RB provision_NN of_IN safe_JJ water_NN supply_NN is_VBZ one_CD of_IN the_DT rapid_JJ response_NN actions_NNS by_IN relief_NN agencies_NNS ._. 
Although_IN there_EX was_VBD evidence_NN that_IN efforts_NNS have_VBP been_VBN to_TO this_DT effect_NN ,_, our_PRP$ assessment_NN established_VBN that_IN safe_JJ water_NN was_VBD not_RB readily_RB accessible_JJ as_IN it_PRP was_VBD irregular_JJ ._. 
The_DT population_NN per_IN latrine_NN ratio_NN in_IN the_DT camp_NN was_VBD 217_CD people_NNS per_IN latrine_NN stance_NN ._. 
Combined_VBN with_IN the_DT traditional_JJ beliefs_NNS that_IN `_`` un-boiled_JJ water_NN tastes_NNS better_RBR ''_'' ,_, this_DT could_MD lead_VB to_TO a_DT potentially_RB dangerous_JJ situation_NN that_WDT could_MD easily_RB lead_VB to_TO outbreaks_NNS of_IN diarrheal_JJ diseases_NNS ._. 
This_DT is_VBZ far_RB below_IN the_DT Minimum_NNP Sphere_NNP Standard_NNP which_WDT requires_VBZ a_DT maximum_NN of_IN 50_CD people_NNS per_IN latrine_NN in_IN areas_NNS where_WRB there_EX are_VBP no_DT latrines_NNS initially_RB -LRB-_-LRB- like_IN in_IN this_DT case_NN -RRB-_-RRB- and_CC decreasing_VBG to_TO 20_CD people_NNS per_IN latrine_NN stance_NN as_RB soon_RB as_IN possible_JJ 
In_IN fact_NN ,_, breast_NN cancer_NN incidence_NN rates_NNS increase_VBP significantly_RB -LRB-_-LRB- 
2No_NNP Response_NNP 0_CD ._. 
8More_CD than_IN 30_CD years_NNS 25_CD ._. 
021_CD to_TO 30_CD years_NNS 18_CD ._. 
411_CD to_TO 20_CD years_NNS 22_CD ._. 
96_CD to_TO 10_CD years_NNS 20_CD ._. 
5Note_JJ :_: About_IN sixty-six_JJ percent_NN of_IN respondents_NNS lived_VBN at_IN the_DT current_JJ residence_NN for_IN more_JJR than_IN 10_CD years_NNS -LRB-_-LRB- Source_NN :_: -RRB-_-RRB- ._. 
We_PRP further_RB assumed_VBD that_IN the_DT dioxin_NN data_NNS from_IN 1995_CD to_TO 2003_CD represents_VBZ dioxin_NN levels_NNS in_IN the_DT preceding_JJ period_NN when_WRB causative_JJ exposure_NN may_MD have_VB occurred_VBN ._. 
Very_RB high_JJ levels_NNS of_IN dioxins_NNS are_VBP limited_VBN in_IN the_DT areas_NNS with_IN 10-year_JJ flood_NN frequency_NN ;_: -LRB-_-LRB- 2_CD -RRB-_-RRB- the_DT number_NN of_IN breast_NN cancer_NN cases_NNS increased_VBD from_IN 1985_CD to_TO 2002_CD among_IN females_NNS aged_VBN between_IN 45_CD and_CC 64_CD years_NNS and_CC they_PRP had_VBD the_DT highest_JJS risk_NN ;_: -LRB-_-LRB- 3_CD -RRB-_-RRB- rather_RB than_IN randomly_RB distributed_VBN in_IN the_DT study_NN area_NN ,_, ZIP_NNP codes_NNS where_WRB high_JJ breast_NN cancer_NN rates_NNS exist_VBP are_VBP clustered_VBN in_IN or_CC near_IN to_TO the_DT contaminated_VBN areas_NNS after_IN adjustment_NN for_IN age_NN ;_: and_CC -LRB-_-LRB- 4_CD -RRB-_-RRB- living_VBG on_IN or_CC close_RB to_TO the_DT contaminated_VBN areas_NNS is_VBZ spatially_RB associated_VBN with_IN the_DT increased_VBN incidences_NNS of_IN breast_NN cancer_NN ._. 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
In_IN fact_NN ,_, breast_NN cancer_NN incidence_NN rates_NNS increase_VBP significantly_RB -LRB-_-LRB- 
Third_NNP ,_, the_DT data_NNS sets_NNS lacked_VBD residential_JJ history_NN information_NN ._. 
Further_JJ analysis_NN should_MD include_VB characterization_NN of_IN environmental_JJ exposure_NN and_CC cancer_NN risk_NN at_IN the_DT individual_JJ level_NN ._. 
Breast_NN cancer_NN is_VBZ known_VBN to_TO have_VB long_JJ latencies_NNS 
Although_IN ZIP_NNP codes_NNS are_VBP arbitrary_JJ units_NNS of_IN analysis_NN in_IN terms_NNS of_IN contamination_NN and_CC potential_JJ health_NN outcomes_NNS ,_, it_PRP is_VBZ convenient_JJ for_IN public_JJ health_NN agencies_NNS to_TO register_VB patients_NNS at_IN this_DT level_NN so_RB as_IN to_TO protect_VB patient_JJ privacy_NN ._. 
In_IN addition_NN ,_, we_PRP did_VBD not_RB account_VB for_IN migration_NN because_IN of_IN low_JJ mobility_NN among_IN the_DT study_NN population_NN as_IN was_VBD reported_VBN in_IN several_JJ surveys_NNS 
People_NNS 's_POS exposure_NN pathways_NNS to_TO dioxins_NNS include_VBP inhalation_NN ,_, ingestion_NN ,_, and_CC dermal_JJ contact_NN ._. 
TCDD_NNP has_VBZ been_VBN classifie_NN 
Very_RB high_JJ levels_NNS of_IN dioxins_NNS are_VBP limited_VBN in_IN the_DT areas_NNS with_IN 10-year_JJ flood_NN frequency_NN ;_: -LRB-_-LRB- 2_CD -RRB-_-RRB- the_DT number_NN of_IN breast_NN cancer_NN cases_NNS increased_VBD from_IN 1985_CD to_TO 2002_CD among_IN females_NNS aged_VBN between_IN 45_CD and_CC 64_CD years_NNS and_CC they_PRP had_VBD the_DT highest_JJS risk_NN ;_: -LRB-_-LRB- 3_CD -RRB-_-RRB- rather_RB than_IN randomly_RB distributed_VBN in_IN the_DT study_NN area_NN ,_, ZIP_NNP codes_NNS where_WRB high_JJ breast_NN cancer_NN rates_NNS exist_VBP are_VBP clustered_VBN in_IN or_CC near_IN to_TO the_DT contaminated_VBN areas_NNS after_IN adjustment_NN for_IN age_NN ;_: and_CC -LRB-_-LRB- 4_CD -RRB-_-RRB- living_VBG on_IN or_CC close_RB to_TO the_DT contaminated_VBN areas_NNS is_VBZ spatially_RB associated_VBN with_IN the_DT increased_VBN incidences_NNS of_IN breast_NN cancer_NN ._. 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
TCDD_NNP has_VBZ been_VBN classified_VBN as_IN a_DT human_JJ carcinogen_NN 
Among_IN these_DT risk_NN factors_NNS ,_, exposure_NN to_TO carcinogens_NNS ,_, especially_RB endocrine_JJ disruption_NN chemicals_NNS ,_, is_VBZ a_DT higher-than-average_JJ risk_NN for_IN females_NNS to_TO develop_VB breast_NN cancer_NN 
For_IN example_NN ,_, two_CD human_JJ epidemiological_JJ studies_NNS 
Other_JJ studies_NNS also_RB reported_VBD increased_VBN breast_NN cancer_NN incidence_NN 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
People_NNS 's_POS exposure_NN pathways_NNS to_TO dioxins_NNS include_VBP inhalation_NN ,_, ingestion_NN ,_, and_CC dermal_JJ contact_NN 
Although_IN the_DT causal_JJ factors_NNS of_IN breast_NN cancer_NN are_VBP not_RB fully_RB known_VBN ,_, risks_NNS factors_NNS for_IN developing_VBG the_DT disease_NN include_VBP history_NN of_IN cancer_NN in_IN one_CD breast_NN ,_, family_NN history_NN of_IN breast_NN cancer_NN ,_, breast_NN implants_NNS ,_, history_NN of_IN benign_JJ breast_NN disease_NN ,_, and_CC exposure_NN to_TO endocrine_VB disruption_NN chemicals_NNS 
Other_JJ studies_NNS also_RB reported_VBD increased_VBN breast_NN cancer_NN incidence_NN 
Previous_JJ epidemiological_JJ studies_NNS have_VBP found_VBN increased_VBN breast_NN cancer_NN incidence_NN 
Although_IN the_DT causal_JJ factors_NNS of_IN breast_NN cancer_NN are_VBP not_RB fully_RB known_VBN ,_, risks_NNS factors_NNS for_IN developing_VBG the_DT disease_NN include_VBP history_NN of_IN cancer_NN in_IN one_CD breast_NN ,_, family_NN history_NN of_IN breast_NN cancer_NN ,_, breast_NN implants_NNS ,_, history_NN of_IN benign_JJ breast_NN disease_NN ,_, and_CC exposure_NN to_TO endocrine_VB disruption_NN chemicals_NNS 
Among_IN these_DT risk_NN factors_NNS ,_, exposure_NN to_TO carcinogens_NNS ,_, especially_RB endocrine_JJ disruption_NN chemicals_NNS ,_, is_VBZ a_DT higher-than-average_JJ risk_NN for_IN females_NNS to_TO develop_VB breast_NN cancer_NN 
8to_CD 11_CD ._. 
The_DT half-life_NN of_IN TCDD_NNP is_VBZ 5_CD ._. 
Dioxins_NNS are_VBP persistent_JJ in_IN the_DT environment_NN and_CC resistant_NN to_TO biodegradation_NN ._. 
3years_NNS in_IN human_JJ body_NN 
People_NNS 's_POS exposure_NN pathways_NNS to_TO dioxins_NNS include_VBP inhalation_NN ,_, ingestion_NN ,_, and_CC dermal_JJ contact_NN 
Michigan_JJ soil_NN generic_JJ residential_JJ direct_JJ contact_NN criterion_NN for_IN dioxins_NNS -LRB-_-LRB- RDCC_NNP -RRB-_-RRB- is_VBZ 90_CD ppt_NN TEQ_NNP ._. 
The_DT study_NN area_NN shows_VBZ sampling_NN locations_NNS and_CC corresponding_JJ dioxin_NN levels_NNS ,_, Tittabawassee_NNP River_NNP and_CC its_PRP$ floodplain_NN ,_, and_CC major_JJ cities_NNS ._. 
Dioxin_NNP refers_VBZ to_TO 210_CD congeners\/isomers_NNS of_IN structurally_RB and_CC chemically_RB related_JJ polychlorinated_VBN dibenzo-para-dioxins_NNS -LRB-_-LRB- PCDDs_NNP -RRB-_-RRB- and_CC polychlorinated_VBN dibenzofurans_NNS -LRB-_-LRB- PCDFs_NNP -RRB-_-RRB- ,_, and_CC the_DT 2,3,7,8-tetra-CDD_NNP -LRB-_-LRB- TCDD_NNP -RRB-_-RRB- is_VBZ considered_VBN the_DT most_RBS toxic_JJ dioxin_NN congener_NN in_IN this_DT group_NN ._. 
Aconcept_NNP of_IN toxic_JJ equivalency_NN factors_NNS -LRB-_-LRB- TEFs_NNP -RRB-_-RRB- is_VBZ used_VBN to_TO compare_VB the_DT relative_JJ toxicity_NN of_IN other_JJ dioxin_NN congeners_NNS with_IN that_DT of_IN TCDD_NNP 
Dioxin_NNP refers_VBZ to_TO 210_CD congeners\/isomers_NNS of_IN structurally_RB and_CC chemically_RB related_VBN polychlorinated_JJ dibenzo_NN -_: para_NN -_: dioxins_NNS -LRB-_-LRB- PCDDs_NNP -RRB-_-RRB- and_CC polychlorinated_VBN dibenzofurans_NNS -LRB-_-LRB- PCDFs_NNP -RRB-_-RRB- ,_, and_CC the_DT 2,3,7,8-tetra-CDD_NNP -LRB-_-LRB- TCDD_NNP -RRB-_-RRB- is_VBZ considered_VBN the_DT most_RBS toxic_JJ dioxin_NN congener_NN in_IN this_DT group_NN ._. 
Aconcept_NNP of_IN toxic_JJ equivalency_NN factors_NNS -LRB-_-LRB- TEFs_NNP -RRB-_-RRB- is_VBZ used_VBN to_TO compare_VB the_DT relative_JJ toxicity_NN of_IN other_JJ dioxin_NN congeners_NNS with_IN that_DT of_IN TCDD_NNP 
8to_CD 11_CD ._. 
The_DT half-life_NN of_IN TCDD_NNP is_VBZ 5_CD ._. 
Dioxins_NNS are_VBP persistent_JJ in_IN the_DT environment_NN and_CC resistant_NN to_TO biodegradation_NN ._. 
3years_NNS in_IN human_JJ body_NN 
We_PRP considered_VBD age_NN effect_NN ;_: however_RB ,_, we_PRP did_VBD not_RB adjust_VB for_IN other_JJ confounders_NNS ,_, such_JJ as_IN each_DT patient_NN 's_POS race_NN ,_, childbearing_VBG patterns_NNS ,_, socioeconomic_JJ status_NN ,_, exposure_NN to_TO other_JJ pollutants_NNS because_IN some_DT of_IN the_DT information_NN is_VBZ not_RB available_JJ to_TO the_DT public_NN ._. 
Yet_RB they_PRP are_VBP substantive_JJ factors_NNS in_IN the_DT development_NN of_IN breast_NN cancer_NN ._. 
In_IN a_DT separat_NN 
Previous_JJ studies_NNS show_VBP breast_NN cancer_NN risk_NN increases_NNS with_IN exposures_NNS to_TO high_JJ levels_NNS of_IN dioxins_NNS ._. 
For_IN example_NN ,_, two_CD human_JJ epidemiological_JJ studies_NNS 
Very_RB high_JJ levels_NNS of_IN dioxins_NNS are_VBP limited_VBN in_IN the_DT areas_NNS with_IN 10-year_JJ flood_NN frequency_NN ;_: -LRB-_-LRB- 2_CD -RRB-_-RRB- the_DT number_NN of_IN breast_NN cancer_NN cases_NNS increased_VBD from_IN 1985_CD to_TO 2002_CD among_IN females_NNS aged_VBN between_IN 45_CD and_CC 64_CD years_NNS and_CC they_PRP had_VBD the_DT highest_JJS risk_NN ;_: -LRB-_-LRB- 3_CD -RRB-_-RRB- rather_RB than_IN randomly_RB distributed_VBN in_IN the_DT study_NN area_NN ,_, ZIP_NNP codes_NNS where_WRB high_JJ breast_NN cancer_NN rates_NNS exist_VBP are_VBP clustered_VBN in_IN or_CC near_IN to_TO the_DT contaminated_VBN areas_NNS after_IN adjustment_NN for_IN age_NN ;_: and_CC -LRB-_-LRB- 4_CD -RRB-_-RRB- living_VBG on_IN or_CC close_RB to_TO the_DT contaminated_VBN areas_NNS is_VBZ spatially_RB associated_VBN with_IN the_DT increased_VBN incidences_NNS of_IN breast_NN cancer_NN ._. 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
TCDD_NNP has_VBZ been_VBN classified_VBN as_IN a_DT human_JJ carcinogen_NN 
Previous_JJ studies_NNS show_VBP breast_NN cancer_NN risk_NN increases_NNS with_IN exposures_NNS to_TO high_JJ levels_NNS of_IN dioxins_NNS ._. 
For_IN example_NN ,_, two_CD human_JJ epidemiological_JJ studies_NNS 
Very_RB high_JJ levels_NNS of_IN dioxins_NNS are_VBP limited_VBN in_IN the_DT areas_NNS with_IN 10-year_JJ flood_NN frequency_NN ;_: -LRB-_-LRB- 2_CD -RRB-_-RRB- the_DT number_NN of_IN breast_NN cancer_NN cases_NNS increased_VBD from_IN 1985_CD to_TO 2002_CD among_IN females_NNS aged_VBN between_IN 45_CD and_CC 64_CD years_NNS and_CC they_PRP had_VBD the_DT highest_JJS risk_NN ;_: -LRB-_-LRB- 3_CD -RRB-_-RRB- rather_RB than_IN randomly_RB distributed_VBN in_IN the_DT study_NN area_NN ,_, ZIP_NNP codes_NNS where_WRB high_JJ breast_NN cancer_NN rates_NNS exist_VBP are_VBP clustered_VBN in_IN or_CC near_IN to_TO the_DT contaminated_VBN areas_NNS after_IN adjustment_NN for_IN age_NN ;_: and_CC -LRB-_-LRB- 4_CD -RRB-_-RRB- living_VBG on_IN or_CC close_RB to_TO the_DT contaminated_VBN areas_NNS is_VBZ spatially_RB associated_VBN with_IN the_DT increased_VBN incidences_NNS of_IN breast_NN cancer_NN ._. 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
Previous_JJ epidemiological_JJ studies_NNS have_VBP found_VBN increased_VBN breast_NN cancer_NN incidence_NN 
These_DT techniques_NNS include_VBP Geographic_NNP Information_NNP System_NNP -LRB-_-LRB- GIS_NNP -RRB-_-RRB- mapping_NN ,_, descriptive_JJ statistics_NNS ,_, self-organizing_JJ map_NN algorithm_NN -LRB-_-LRB- SOM_NNP -RRB-_-RRB- 
For_IN example_NN ,_, SOM_NNP was_VBD employed_VBN to_TO evaluate_VB dioxin_NN patterns_NNS in_IN mother_NN milk_NN and_CC dietary_JJ habits_NNS from_IN various_JJ countries_NNS and_CC identify_VB contributing_VBG dietary_JJ factors_NNS in_IN different_JJ countries_NNS 
We_PRP used_VBD the_DT ZIP_NNP code_NN of_IN residence_NN at_IN diagnosis_NN as_IN an_DT indicator_NN of_IN exposure_NN and_CC did_VBD not_RB account_VB for_IN migration_NN between_IN ZIP_NNP codes_NNS and_CC cancer_NN latency_NN ._. 
This_DT is_VBZ a_DT typical_JJ assumption_NN in_IN other_JJ ecological_JJ studies_NNS 
Yet_CC epidemiological_JJ studies_NNS are_VBP vulnerable_JJ given_VBN insufficient_JJ sample_NN sizes_NNS 
In_IN fact_NN ,_, breast_NN cancer_NN incidence_NN rates_NNS increase_VBP significantly_RB -LRB-_-LRB- 
We_PRP considered_VBD age_NN effect_NN ;_: however_RB ,_, we_PRP did_VBD not_RB adjust_VB for_IN other_JJ confounders_NNS ,_, such_JJ as_IN each_DT patient_NN 's_POS race_NN ,_, childbearing_VBG patterns_NNS ,_, socioeconomic_JJ status_NN ,_, exposure_NN to_TO other_JJ pollutants_NNS because_IN some_DT of_IN the_DT information_NN is_VBZ not_RB available_JJ to_TO the_DT public_NN ._. 
Yet_RB they_PRP are_VBP substantive_JJ factors_NNS in_IN the_DT development_NN of_IN breast_NN cancer_NN 
Methods_NNP Study_NNP area_NN ,_, population_NN ,_, and_CC major_JJ river_NN systems_NNS The_DT study_NN area_NN -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- consists_VBZ of_IN Midland_NNP ,_, Saginaw_NNP ,_, and_CC Bay_NNP Counties_NNPS ._. 
It_PRP has_VBZ 38_CD ZIP_NNP codes_NNS with_IN a_DT population_NN of_IN over_IN 400,000_CD ._. 
Midland_NNP ,_, Saginaw_NNP ,_, and_CC Bay_NNP Cities_NNPS are_VBP three_CD densely_RB populated_JJ regions_NNS ._. 
The_DT study_NN area_NN has_VBZ several_JJ industries_NNS ,_, notably_RB the_DT Dow_NNP 's_POS Midland_NNP plant_NN ,_, making_VBG significant_JJ contributions_NNS to_TO economic_JJ growth_NN in_IN this_DT region_NN ._. 
Small_JJ population_NN problem_NN causes_VBZ an_DT area_NN with_IN a_DT small_JJ population_NN to_TO be_VB less_RBR reliable_JJ due_JJ to_TO the_DT higher_JJR variance_NN ._. 
This_DT is_VBZ prevalent_JJ in_IN rare_JJ disease_NN analysis_NN ,_, especially_RB in_IN cancer_NN studies_NNS when_WRB rates_NNS are_VBP used_VBN to_TO estimate_VB the_DT underlying_VBG risk_NN ._. 
The_DT findings_NNS in_IN this_DT study_NN are_VBP subject_JJ to_TO at_IN least_JJS four_CD limitations_NNS ._. 
First_RB ,_, the_DT sparsity_NN of_IN soil_NN dioxin_NN data_NNS and_CC scale_NN of_IN the_DT breast_NN cancer_NN incidence_NN data_NNS may_MD have_VB introduced_VBN uncertainties_NNS into_IN health_NN outcomes_NNS ._. 
Inspired_VBN by_IN the_DT challenge_NN and_CC the_DT growing_VBG concern_NN over_IN the_DT concurrent_JJ high_JJ breast_NN cancer_NN rates_NNS with_IN high_JJ levels_NNS of_IN dioxin_NN in_IN soils_NNS ,_, we_PRP employed_VBD a_DT variety_NN of_IN spatial_JJ and_CC statistical_JJ techniques_NNS to_TO evaluate_VB dioxin_NN levels_NNS in_IN soils_NNS and_CC analyzed_VBD whether_IN there_EX is_VBZ a_DT spatial_JJ association_NN with_IN the_DT incidence_NN of_IN breast_NN cancer_NN ._. 
These_DT techniques_NNS include_VBP Geographic_NNP Information_NNP System_NNP -LRB-_-LRB- GIS_NNP -RRB-_-RRB- mapping_NN ,_, descriptive_JJ statistics_NNS ,_, self-organizing_JJ map_NN algorithm_NN -LRB-_-LRB- SOM_NNP -RRB-_-RRB- 
census_NN count_NN for_IN the_DT two_CD periods_NNS 1990_CD and_CC 2000_CD ._. 
S._NNP For_IN these_DT models_NNS ,_, we_PRP assumed_VBD that_IN populations_NNS before_IN 1990_CD and_CC after_IN 2000_CD were_VBD the_DT same_JJ as_IN the_DT official_JJ U._NNP The_DT spatial_JJ techniques_NNS used_VBN to_TO detect_VB spatial_JJ clusters_NNS of_IN breast_NN cancer_NN incidence_NN include_VBP Kulldorff_NNP 's_POS spatial_NN and_CC space-time_NN scan_VB statistics_NNS 
Therefore_RB ,_, a_DT method_NN that_WDT can_MD ``_`` relax_VB ''_'' these_DT assumptions_NNS is_VBZ highly_RB desirable_JJ to_TO validate_VB the_DT results_NNS ._. 
Genetic_JJ algorithms_NNS for_IN spatial_JJ clustering_NN 
The_DT performance_NN evaluation_NN shows_VBZ that_IN the_DT methods_NNS are_VBP accurate_JJ and_CC reliable_JJ ._. 
2_CD 
These_DT techniques_NNS include_VBP Geographic_NNP Information_NNP System_NNP -LRB-_-LRB- GIS_NNP -RRB-_-RRB- mapping_NN ,_, descriptive_JJ statistics_NNS ,_, self-organizing_JJ map_NN algorithm_NN -LRB-_-LRB- SOM_NNP -RRB-_-RRB- 
For_IN example_NN ,_, SOM_NNP was_VBD employed_VBN to_TO evaluate_VB dioxin_NN patterns_NNS in_IN mother_NN milk_NN and_CC dietary_JJ habits_NNS from_IN various_JJ countries_NNS and_CC identify_VB contributing_VBG dietary_JJ factors_NNS in_IN different_JJ countries_NNS 
This_DT is_VBZ a_DT typical_JJ assumption_NN in_IN other_JJ ecological_JJ studies_NNS 
One_CD critique_NN remains_VBZ ,_, as_IN dioxin_NN in_IN 2000_CD could_MD not_RB have_VB caused_VBN cancers_NNS developed_VBD in_IN 1985_CD ._. 
Dioxin_NN samples_NNS were_VBD collected_VBN from_IN 1995_CD through_IN 2003_CD ,_, and_CC cancer_NN cases_NNS ranged_VBD from_IN 1985_CD through_IN 2002_CD ._. 
Jacquez_NNP and_CC Greiling_NNP 
Yet_CC epidemiological_JJ studies_NNS are_VBP vulnerable_JJ given_VBN insufficient_JJ sample_NN sizes_NNS 
Third_NNP ,_, the_DT data_NNS sets_NNS lacked_VBD residential_JJ history_NN information_NN ._. 
Further_JJ analysis_NN should_MD include_VB characterization_NN of_IN environmental_JJ exposure_NN and_CC cancer_NN risk_NN at_IN the_DT individual_JJ level_NN ._. 
Breast_NN cancer_NN is_VBZ known_VBN to_TO have_VB long_JJ latencies_NNS 
The_DT time_NN when_WRB the_DT patient_NN was_VBD diagnosed_VBN may_MD not_RB be_VB the_DT time_NN when_WRB causative_JJ exposures_NNS occurred_VBD ._. 
Breast_NN cancer_NN is_VBZ known_VBN to_TO have_VB long_JJ latencies_NNS 
GIS_NNP analysis_NN supported_VBN with_IN novel_JJ clustering_NN algorithms_NNS have_VBP become_VBN valuable_JJ tools_NNS in_IN environmental_JJ health_NN studies_NNS for_IN studying_VBG the_DT spatial_JJ distribution_NN of_IN environmental_JJ contaminants_NNS and_CC potential_JJ risks_NNS associated_VBN with_IN diseases_NNS 
We_PRP used_VBD the_DT ZIP_NNP code_NN of_IN residence_NN at_IN diagnosis_NN as_IN an_DT indicator_NN of_IN exposure_NN and_CC did_VBD not_RB account_VB for_IN migration_NN between_IN ZIP_NNP codes_NNS and_CC cancer_NN latency_NN ._. 
This_DT is_VBZ a_DT typical_JJ assumption_NN in_IN other_JJ ecological_JJ studies_NNS 
Yet_CC epidemiological_JJ studies_NNS are_VBP vulnerable_JJ given_VBN insufficient_JJ sample_NN sizes_NNS 
Breast_NN cancer_NN is_VBZ a_DT major_JJ burden_NN in_IN Midland_NNP ,_, Saginaw_NNP ,_, and_CC Bay_NNP Counties_NNPS ,_, Michigan_NNP ._. 
Dioxins_NNS act_VBP like_IN hormone_NN disruptors_NNS ,_, which_WDT may_MD explain_VB the_DT link_NN between_IN high_JJ body_NN burden_NN of_IN dioxins_NNS and_CC the_DT increased_VBN incidence_NN of_IN breast_NN cancer_NN ._. 
Existing_VBG data_NNS from_IN the_DT Michigan_NNP Department_NNP of_IN Community_NNP Health_NNP -LRB-_-LRB- MDCH_NNP -RRB-_-RRB- indicate_VBP that_IN breast_NN cancer_NN was_VBD one_CD of_IN the_DT highest_JJS cancer_NN burdens_NNS in_IN the_DT three_CD counties_NNS from_IN 1985_CD through_IN 2002_CD 
Existing_VBG data_NNS from_IN the_DT Michigan_NNP Department_NNP of_IN Community_NNP Health_NNP -LRB-_-LRB- MDCH_NNP -RRB-_-RRB- indicate_VBP that_IN breast_NN cancer_NN was_VBD one_CD of_IN the_DT highest_JJS cancer_NN burdens_NNS in_IN the_DT three_CD counties_NNS from_IN 1985_CD through_IN 2002_CD 
Inspired_VBN by_IN the_DT challenge_NN and_CC the_DT growing_VBG concern_NN over_IN the_DT concurrent_JJ high_JJ breast_NN cancer_NN rates_NNS with_IN high_JJ levels_NNS of_IN dioxin_NN in_IN soils_NNS ,_, we_PRP employed_VBD a_DT variety_NN of_IN spatial_JJ and_CC statistical_JJ techniques_NNS to_TO evaluate_VB dioxin_NN levels_NNS in_IN soils_NNS and_CC analyzed_VBD whether_IN there_EX is_VBZ a_DT spatial_JJ association_NN with_IN the_DT incidence_NN of_IN breast_NN cancer_NN ._. 
These_DT techniques_NNS include_VBP Geographic_NNP Information_NNP System_NNP -LRB-_-LRB- GIS_NNP -RRB-_-RRB- mapping_NN ,_, descriptive_JJ statistics_NNS ,_, self-organizing_JJ map_NN algorithm_NN -LRB-_-LRB- SOM_NNP -RRB-_-RRB- 
These_DT methods_NNS include_VBP -LRB-_-LRB- 1_CD -RRB-_-RRB- evaluation_NN of_IN soil_NN dioxin_NN contamination_NN by_IN using_VBG descriptive_JJ statistics_NNS and_CC the_DT SOM_NNP algorithm_NN ;_: -LRB-_-LRB- 2_CD -RRB-_-RRB- evaluation_NN of_IN the_DT association_NN between_IN breast_NN cancer_NN rates_NNS and_CC the_DT ZIP_NNP codes_NNS by_IN estimating_VBG the_DT odds_NNS ratio_NN and_CC their_PRP$ corresponding_JJ 95_CD %_NN confidence_NN intervals_NNS ;_: and_CC -LRB-_-LRB- 3_CD -RRB-_-RRB- cluster_NN detection_NN using_VBG Kulldorff_NNP 's_POS spatial_NN and_CC space-time_NN scan_VB statistics_NNS ,_, and_CC genetic_JJ algorithms_NNS for_IN spatial_JJ and_CC space-time_JJ clustering_NN ._. 
The_DT SOM_NNP is_VBZ an_DT unsupervised_JJ data_NN visualization_NN and_CC classification_NN technique_NN that_WDT reduces_VBZ high-dimensional_JJ data_NNS to_TO lower_VB ,_, usually_RB 1_CD or_CC 2_CD ,_, dimensions_NNS ._. 
Compared_VBN to_TO variance-covariance_JJ matrix_NN and_CC multi-dimensional_JJ scaling_NN ,_, the_DT SOM_NNP allows_VBZ one_CD to_TO visually_RB figure_VB out_RP the_DT number_NN of_IN clusters_NNS ,_, the_DT classification_NN of_IN different_JJ values_NNS of_IN each_DT variable_JJ ,_, and_CC relations_NNS between_IN variables_NNS ._. 
Inspired_VBN by_IN the_DT challenge_NN and_CC the_DT growing_VBG concern_NN over_IN the_DT concurrent_JJ high_JJ breast_NN cancer_NN rates_NNS with_IN high_JJ levels_NNS of_IN dioxin_NN in_IN soils_NNS ,_, we_PRP employed_VBD a_DT variety_NN of_IN spatial_JJ and_CC statistical_JJ techniques_NNS to_TO evaluate_VB dioxin_NN levels_NNS in_IN soils_NNS and_CC analyzed_VBD whether_IN there_EX is_VBZ a_DT spatial_JJ association_NN with_IN the_DT incidence_NN of_IN breast_NN cancer_NN ._. 
These_DT techniques_NNS include_VBP Geographic_NNP Information_NNP System_NNP -LRB-_-LRB- GIS_NNP -RRB-_-RRB- mapping_NN ,_, descriptive_JJ statistics_NNS ,_, self-organizing_JJ map_NN algorithm_NN -LRB-_-LRB- SOM_NNP -RRB-_-RRB- 
All_DT cases_NNS were_VBD matched_VBN with_IN respective_JJ female_JJ demographics_NNS and_CC their_PRP$ corresponding_JJ age_NN groups_NNS ._. 
2to_NNS join_VBP ZIP_NNP code_NN boundary_NN data_NNS with_IN breast_NN cancer_NN and_CC census_NN data_NNS ._. 
For_IN input_NN data_NNS to_TO the_DT space-time_NN scan_VB and_CC genetic_JJ algorithm_NN models_NNS ,_, we_PRP preprocessed_VBD data_NNS and_CC projected_JJ populations_NNS to_TO obtain_VB values_NNS between_IN 1990_CD and_CC 2000_CD using_VBG linear_JJ regression_NN ._. 
For_IN these_DT models_NNS ,_, we_PRP assumed_VBD that_IN populations_NNS before_IN 1990_CD and_CC after_IN 2000_CD were_VBD the_DT same_JJ as_IN the_DT official_JJ U._NNP 
census_NN count_NN for_IN the_DT two_CD periods_NNS 1990_CD and_CC 2000_CD ._. 
S._NNP For_IN these_DT models_NNS ,_, we_PRP assumed_VBD that_IN populations_NNS before_IN 1990_CD and_CC after_IN 2000_CD were_VBD the_DT same_JJ as_IN the_DT official_JJ U._NNP The_DT spatial_JJ techniques_NNS used_VBN to_TO detect_VB spatial_JJ clusters_NNS of_IN breast_NN cancer_NN incidence_NN include_VBP Kulldorff_NNP 's_POS spatial_NN and_CC space-time_NN scan_VB statistics_NNS 
Under_IN the_DT Poisson_NNP assumption_NN ,_, the_DT method_NN calculates_VBZ the_DT likelihood_NN function_NN for_IN all_DT windows_NNS ._. 
Because_IN the_DT number_NN of_IN events_NNS in_IN an_DT area_NN at_IN one_CD time_NN follows_VBZ Poisson_NNP distribution_NN ,_, the_DT expected_VBN number_NN of_IN events_NNS within_IN a_DT search_NN window_NN is_VBZ proportional_JJ to_TO at-risk_JJ background_NN population_NN size_NN when_WRB there_EX are_VBP no_DT covariates_NNS ._. 
The_DT one_NN with_IN the_DT maximum_NN likelihood_NN represents_VBZ the_DT most_RBS likely_JJ cluster_NN ,_, and_CC this_DT cluster_NN is_VBZ least_JJS likely_JJ to_TO have_VB occurred_VBN by_IN chance_NN 
Inspired_VBN by_IN the_DT challenge_NN and_CC the_DT growing_VBG concern_NN over_IN the_DT concurrent_JJ high_JJ breast_NN cancer_NN rates_NNS with_IN high_JJ levels_NNS of_IN dioxin_NN in_IN soils_NNS ,_, we_PRP employed_VBD a_DT variety_NN of_IN spatial_JJ and_CC statistical_JJ techniques_NNS to_TO evaluate_VB dioxin_NN levels_NNS in_IN soils_NNS and_CC analyzed_VBD whether_IN there_EX is_VBZ a_DT spatial_JJ association_NN with_IN the_DT incidence_NN of_IN breast_NN cancer_NN ._. 
These_DT techniques_NNS include_VBP Geographic_NNP Information_NNP System_NNP -LRB-_-LRB- GIS_NNP -RRB-_-RRB- mapping_NN ,_, descriptive_JJ statistics_NNS ,_, self-organizing_JJ map_NN algorithm_NN -LRB-_-LRB- SOM_NNP -RRB-_-RRB- 
All_DT cases_NNS were_VBD matched_VBN with_IN respective_JJ female_JJ demographics_NNS and_CC their_PRP$ corresponding_JJ age_NN groups_NNS ._. 
2to_NNS join_VBP ZIP_NNP code_NN boundary_NN data_NNS with_IN breast_NN cancer_NN and_CC census_NN data_NNS ._. 
For_IN input_NN data_NNS to_TO the_DT space-time_NN scan_VB and_CC genetic_JJ algorithm_NN models_NNS ,_, we_PRP preprocessed_VBD data_NNS and_CC projected_JJ populations_NNS to_TO obtain_VB values_NNS between_IN 1990_CD and_CC 2000_CD using_VBG linear_JJ regression_NN ._. 
For_IN these_DT models_NNS ,_, we_PRP assumed_VBD that_IN populations_NNS before_IN 1990_CD and_CC after_IN 2000_CD were_VBD the_DT same_JJ as_IN the_DT official_JJ U._NNP 
census_NN count_NN for_IN the_DT two_CD periods_NNS 1990_CD and_CC 2000_CD ._. 
S._NNP For_IN these_DT models_NNS ,_, we_PRP assumed_VBD that_IN populations_NNS before_IN 1990_CD and_CC after_IN 2000_CD were_VBD the_DT same_JJ as_IN the_DT official_JJ U._NNP The_DT spatial_JJ techniques_NNS used_VBN to_TO detect_VB spatial_JJ clusters_NNS of_IN breast_NN cancer_NN incidence_NN include_VBP Kulldorff_NNP 's_POS spatial_NN and_CC space-time_NN scan_VB statistics_NNS 
Therefore_RB ,_, a_DT method_NN that_WDT can_MD ``_`` relax_VB ''_'' these_DT assumptions_NNS is_VBZ highly_RB desirable_JJ to_TO validate_VB the_DT results_NNS ._. 
Genetic_JJ algorithms_NNS for_IN spatial_JJ clustering_NN 
The_DT performance_NN evaluation_NN shows_VBZ that_IN the_DT methods_NNS are_VBP accurate_JJ and_CC reliable_JJ ._. 
2_CD 
We_PRP considered_VBD age_NN effect_NN ;_: however_RB ,_, we_PRP did_VBD not_RB adjust_VB for_IN other_JJ confounders_NNS ,_, such_JJ as_IN each_DT patient_NN 's_POS race_NN ,_, childbearing_VBG patterns_NNS ,_, socioeconomic_JJ status_NN ,_, exposure_NN to_TO other_JJ pollutants_NNS because_IN some_DT of_IN the_DT information_NN is_VBZ not_RB available_JJ to_TO the_DT public_NN ._. 
Yet_RB they_PRP are_VBP substantive_JJ factors_NNS in_IN the_DT development_NN of_IN breast_NN cancer_NN 
We_PRP used_VBD the_DT ZIP_NNP code_NN of_IN residence_NN at_IN diagnosis_NN as_IN an_DT indicator_NN of_IN exposure_NN and_CC did_VBD not_RB account_VB for_IN migration_NN between_IN ZIP_NNP codes_NNS and_CC cancer_NN latency_NN ._. 
This_DT is_VBZ a_DT typical_JJ assumption_NN in_IN other_JJ ecological_JJ studies_NNS 
Very_RB high_JJ levels_NNS of_IN dioxins_NNS are_VBP limited_VBN in_IN the_DT areas_NNS with_IN 10-year_JJ flood_NN frequency_NN ;_: -LRB-_-LRB- 2_CD -RRB-_-RRB- the_DT number_NN of_IN breast_NN cancer_NN cases_NNS increased_VBD from_IN 1985_CD to_TO 2002_CD among_IN females_NNS aged_VBN between_IN 45_CD and_CC 64_CD years_NNS and_CC they_PRP had_VBD the_DT highest_JJS risk_NN ;_: -LRB-_-LRB- 3_CD -RRB-_-RRB- rather_RB than_IN randomly_RB distributed_VBN in_IN the_DT study_NN area_NN ,_, ZIP_NNP codes_NNS where_WRB high_JJ breast_NN cancer_NN rates_NNS exist_VBP are_VBP clustered_VBN in_IN or_CC near_IN to_TO the_DT contaminated_VBN areas_NNS after_IN adjustment_NN for_IN age_NN ;_: and_CC -LRB-_-LRB- 4_CD -RRB-_-RRB- living_VBG on_IN or_CC close_RB to_TO the_DT contaminated_VBN areas_NNS is_VBZ spatially_RB associated_VBN with_IN the_DT increased_VBN incidences_NNS of_IN breast_NN cancer_NN ._. 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
The_DT one_NN with_IN the_DT maximum_NN likelihood_NN represents_VBZ the_DT most_RBS likely_JJ cluster_NN ,_, and_CC this_DT cluster_NN is_VBZ least_JJS likely_JJ to_TO have_VB occurred_VBN by_IN chance_NN 
We_PRP implemented_VBD the_DT two_CD clustering_VBG algorithms_NNS based_VBN on_IN the_DT genetic_JJ algorithm_NN toolbox_NN 1_CD ._. 
Similar_JJ to_TO SatScan_NNP ,_, the_DT genetic_JJ algorithms_NNS can_MD adjust_VB for_IN covariate_NN by_IN comparing_VBG the_DT observed_JJ number_NN of_IN case_NN patients_NNS in_IN a_DT category_NN with_IN the_DT corresponding_JJ underlying_JJ at-risk_JJ background_NN population_NN ._. 
2_CD 
Genetic_JJ algorithms_NNS are_VBP randomized_VBN search_NN techniques_NNS simulating_VBG the_DT principle_NN of_IN survival_NN of_IN the_DT fittest_JJS ._. 
They_PRP are_VBP effective_JJ in_IN cluster_NN detection_NN by_IN producing_VBG near-optimal_JJ solutions_NNS to_TO search_VB problems_NNS ._. 
Each_DT genetic_JJ algorithm_NN consists_VBZ of_IN an_DT initialization_NN step_NN ,_, a_DT pre-specified_JJ number_NN of_IN iterative_JJ generations_NNS ,_, and_CC three_CD genetic_JJ operators_NNS -LRB-_-LRB- namely_RB ,_, reproduction_NN ,_, crossover_NN ,_, and_CC mutation_NN -RRB-_-RRB- ._. 
1-LRB-_NNP The_NNP MathWorks_NNP ,_, Inc_NNP ,_, Natrick_NNP ,_, Massachusetts_NNP -RRB-_-RRB- ._. 
We_PRP implemented_VBD the_DT SOM_NNP model_NN using_VBG SOM_NNP Toolbox_NNP 
We_PRP used_VBD the_DT ZIP_NNP code_NN of_IN residence_NN at_IN diagnosis_NN as_IN an_DT indicator_NN of_IN exposure_NN and_CC did_VBD not_RB account_VB for_IN migration_NN between_IN ZIP_NNP codes_NNS and_CC cancer_NN latency_NN ._. 
This_DT is_VBZ a_DT typical_JJ assumption_NN in_IN other_JJ ecological_JJ studies_NNS 
This_DT is_VBZ a_DT typical_JJ assumption_NN in_IN other_JJ ecological_JJ studies_NNS 
By_IN reading_VBG several_JJ component_NN planes_NNS and_CC their_PRP$ color_NN legends_NNS together_RB ,_, it_PRP is_VBZ easy_JJ to_TO examine_VB the_DT correlations_NNS between_IN different_JJ attributes_NNS ._. 
See_NNP reference_NN 
See_NNP reference_NN 
Methods_NNP Study_NNP area_NN ,_, population_NN ,_, and_CC major_JJ river_NN systems_NNS The_DT study_NN area_NN -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- consists_VBZ of_IN Midland_NNP ,_, Saginaw_NNP ,_, and_CC Bay_NNP Counties_NNPS ._. 
It_PRP has_VBZ 38_CD ZIP_NNP codes_NNS with_IN a_DT population_NN of_IN over_IN 400,000_CD ._. 
Midland_NNP ,_, Saginaw_NNP ,_, and_CC Bay_NNP Cities_NNPS are_VBP three_CD densely_RB populated_JJ regions_NNS ._. 
The_DT study_NN area_NN has_VBZ several_JJ industries_NNS ,_, notably_RB the_DT Dow_NNP 's_POS Midland_NNP plant_NN ,_, making_VBG significant_JJ contributions_NNS to_TO economic_JJ growth_NN in_IN this_DT region_NN ._. 
Other_JJ studies_NNS also_RB reported_VBD increased_VBN breast_NN cancer_NN incidence_NN 
Very_RB high_JJ levels_NNS of_IN dioxins_NNS are_VBP limited_VBN in_IN the_DT areas_NNS with_IN 10-year_JJ flood_NN frequency_NN ;_: -LRB-_-LRB- 2_CD -RRB-_-RRB- the_DT number_NN of_IN breast_NN cancer_NN cases_NNS increased_VBD from_IN 1985_CD to_TO 2002_CD among_IN females_NNS aged_VBN between_IN 45_CD and_CC 64_CD years_NNS and_CC they_PRP had_VBD the_DT highest_JJS risk_NN ;_: -LRB-_-LRB- 3_CD -RRB-_-RRB- rather_RB than_IN randomly_RB distributed_VBN in_IN the_DT study_NN area_NN ,_, ZIP_NNP codes_NNS where_WRB high_JJ breast_NN cancer_NN rates_NNS exist_VBP are_VBP clustered_VBN in_IN or_CC near_IN to_TO the_DT contaminated_VBN areas_NNS after_IN adjustment_NN for_IN age_NN ;_: and_CC -LRB-_-LRB- 4_CD -RRB-_-RRB- living_VBG on_IN or_CC close_RB to_TO the_DT contaminated_VBN areas_NNS is_VBZ spatially_RB associated_VBN with_IN the_DT increased_VBN incidences_NNS of_IN breast_NN cancer_NN ._. 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
Among_IN these_DT risk_NN factors_NNS ,_, exposure_NN to_TO carcinogens_NNS ,_, especially_RB endocrine_JJ disruption_NN chemicals_NNS ,_, is_VBZ a_DT higher-than-average_JJ risk_NN for_IN females_NNS to_TO develop_VB breast_NN cancer_NN 
For_IN example_NN ,_, two_CD human_JJ epidemiological_JJ studies_NNS 
Among_IN these_DT risk_NN factors_NNS ,_, exposure_NN to_TO carcinogens_NNS ,_, especially_RB endocrine_JJ disruption_NN chemicals_NNS ,_, is_VBZ a_DT higher-than-average_JJ risk_NN for_IN females_NNS to_TO develop_VB breast_NN cancer_NN 
1billion_NN is_VBZ spent_VBN on_IN treatment_NN of_IN breast_NN cancer_NN in_IN the_DT United_NNP States_NNPS 
Third_NNP ,_, the_DT data_NNS sets_NNS lacked_VBD residential_JJ history_NN information_NN ._. 
Further_JJ analysis_NN should_MD include_VB characterization_NN of_IN environmental_JJ exposure_NN and_CC cancer_NN risk_NN at_IN the_DT individual_JJ level_NN ._. 
Breast_NN cancer_NN is_VBZ known_VBN to_TO have_VB long_JJ latencies_NNS 
Each_DT year_NN about_IN $_$ 8_CD ._. 
3per_CD 100,000_CD females_NNS ._. 
In_IN 2005_CD ,_, the_DT annual_JJ incidence_NN rate_NN was_VBD 124_CD ._. 
1-RRB-_NN 
4-RRB-_NNP ,_, and_CC a_DT noticeable_JJ decline_NN from_IN 2001_CD to_TO 2005_CD -LRB-_-LRB- APC_NNP =_SYM -3_CD ._. 
7from_CD 1980_CD to_TO 1987_CD ,_, a_DT slight_JJ increase_NN from_IN 1987_CD to_TO 2001_CD -LRB-_-LRB- APC_NNP =_SYM 0_CD ._. 
1-RRB-_NN 
In_IN 2005_CD ,_, the_DT annual_JJ incidence_NN rate_NN was_VBD 124_CD ._. 
1-RRB-_CD ._. 
4-RRB-_NNP ,_, and_CC a_DT noticeable_JJ decline_NN from_IN 2001_CD to_TO 2005_CD -LRB-_-LRB- APC_NNP =_SYM -3_CD ._. 
3per_CD 100,000_CD females_NNS 
43_CD ,_, which_WDT is_VBZ slightly_RB higher_JJR than_IN the_DT national_JJ trend_NN -LRB-_-LRB- 0_CD ._. 
Results_NNS From_IN 1985_CD to_TO 2002_CD ,_, there_EX was_VBD an_DT increasing_VBG trend_NN in_IN the_DT number_NN of_IN breast_NN cancer_NN cases_NNS in_IN females_NNS between_IN 45_CD and_CC 64_CD years_NNS old_JJ in_IN Midland_NNP ,_, Saginaw_NNP ,_, and_CC Bay_NNP Counties_NNP -LRB-_-LRB- Figure_NNP 2_CD -RRB-_-RRB- with_IN an_DT APC_NNP of_IN 0_CD ._. 
4-RRB-_CD during_IN the_DT approximately_RB same_JJ period_NN ._. 
These_DT females_NNS are_VBP apparently_RB overrepresented_VBN and_CC have_VBP the_DT highest_JJS risk_NN in_IN all_DT age_NN groups_NNS ._. 
Cases_NNS among_IN females_NNS aged_VBN over_IN 65_CD years_NNS remained_VBD relatively_RB stable_JJ during_IN the_DT study_NN period_NN ,_, while_IN females_NNS aged_VBN between_IN 15_CD and_CC 44_CD had_VBD the_DT lowest_JJS risk_NN ._. 
Breast_NN cancer_NN refers_VBZ to_TO cancerous_JJ tumors_NNS consisting_VBG of_IN uncontrolled_JJ growth_NN and_CC spread_NN of_IN abnormal_JJ cells_NNS formed_VBN in_IN breast_NN tissues_NNS ,_, usually_RB ducts_NNS and_CC lobules_NNS 
Studies_NNS have_VBP shown_VBN an_DT apparent_JJ increase_NN in_IN the_DT incidence_NN of_IN breast_NN cancer_NN 
1billion_NN is_VBZ spent_VBN on_IN treatment_NN of_IN breast_NN cancer_NN in_IN the_DT United_NNP States_NNPS 
In_IN fact_NN ,_, breast_NN cancer_NN incidence_NN rates_NNS increase_VBP significantly_RB -LRB-_-LRB- 
We_PRP considered_VBD age_NN effect_NN ;_: however_RB ,_, we_PRP did_VBD not_RB adjust_VB for_IN other_JJ confounders_NNS ,_, such_JJ as_IN each_DT patient_NN 's_POS race_NN ,_, childbearing_VBG patterns_NNS ,_, socioeconomic_JJ status_NN ,_, exposure_NN to_TO other_JJ pollutants_NNS because_IN some_DT of_IN the_DT information_NN is_VBZ not_RB available_JJ to_TO the_DT public_NN ._. 
Yet_RB they_PRP are_VBP substantive_JJ factors_NNS in_IN the_DT development_NN of_IN breast_NN cancer_NN 
TCDD_NNP has_VBZ been_VBN classified_VBN as_IN a_DT human_JJ carcinogen_NN 
Among_IN these_DT risk_NN factors_NNS ,_, exposure_NN to_TO carcinogens_NNS ,_, especially_RB endocrine_JJ disruption_NN chemicals_NNS ,_, is_VBZ a_DT higher-than-average_JJ risk_NN for_IN females_NNS to_TO develop_VB breast_NN cancer_NN 
For_IN example_NN ,_, two_CD human_JJ epidemiological_JJ studies_NNS 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
TCDD_NNP has_VBZ been_VBN classified_VBN as_IN a_DT human_JJ carcinogen_NN 
For_IN example_NN ,_, two_CD human_JJ epidemiological_JJ studies_NNS 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
We_PRP used_VBD ZIP_NNP code_NN 48883_CD ,_, an_DT area_NN located_VBN upstream_RB of_IN the_DT river_NN -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- as_IN the_DT reference_NN for_IN comparison_NN ._. 
Given_VBN that_IN the_DT levels_NNS of_IN dioxins_NNS in_IN this_DT area_NN are_VBP close_RB to_TO background_NN levels_NNS across_IN Michigan_NNP as_IN reported_VBN by_IN previous_JJ studies_NNS ,_, the_DT population_NN was_VBD assumed_VBN to_TO be_VB unexposed_JJ to_TO dioxin_VB ._. 
The_DT female_JJ populations_NNS in_IN this_DT ZIP_NNP code_NN in_IN both_DT 1990_CD and_CC 2000_CD are_VBP close_JJ to_TO the_DT average_JJ female_JJ population_NN per_IN ZIP_NN code_NN in_IN the_DT study_NN area_NN ._. 
The_DT moderation_NN of_IN the_DT facilities_NNS -LRB-_-LRB- 99_CD ._. 
Although_IN this_DT assumption_NN is_VBZ not_RB ideal_JJ ,_, it_PRP is_VBZ reasonable_JJ because_IN occurrence_NN of_IN elevated_JJ concentrations_NNS of_IN PCDD\/Fs_NNS in_IN sediments_NNS at_IN depths_NNS below_IN 60_CD ''_'' in_IN the_DT river_NN indicates_VBZ that_IN the_DT contamination_NN is_VBZ occurring_VBG historically_RB 
Very_RB high_JJ levels_NNS of_IN dioxins_NNS are_VBP limited_VBN in_IN the_DT areas_NNS with_IN 10-year_JJ flood_NN frequency_NN ;_: -LRB-_-LRB- 2_CD -RRB-_-RRB- the_DT number_NN of_IN breast_NN cancer_NN cases_NNS increased_VBD from_IN 1985_CD to_TO 2002_CD among_IN females_NNS aged_VBN between_IN 45_CD and_CC 64_CD years_NNS and_CC they_PRP had_VBD the_DT highest_JJS risk_NN ;_: -LRB-_-LRB- 3_CD -RRB-_-RRB- rather_RB than_IN randomly_RB distributed_VBN in_IN the_DT study_NN area_NN ,_, ZIP_NNP codes_NNS where_WRB high_JJ breast_NN cancer_NN rates_NNS exist_VBP are_VBP clustered_VBN in_IN or_CC near_IN to_TO the_DT contaminated_VBN areas_NNS after_IN adjustment_NN for_IN age_NN ;_: and_CC -LRB-_-LRB- 4_CD -RRB-_-RRB- living_VBG on_IN or_CC close_RB to_TO the_DT contaminated_VBN areas_NNS is_VBZ spatially_RB associated_VBN with_IN the_DT increased_VBN incidences_NNS of_IN breast_NN cancer_NN ._. 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
The_DT dioxin_NN data_NNS had_VBD significant_JJ number_NN of_IN outliers_NNS with_IN extremely_RB high_JJ TEQ_NNP values_NNS even_RB after_RB log_VB transformation_NN of_IN the_DT data_NNS ,_, thus_RB remaining_VBG outliers_NNS and_CC nonhomogeneous_JJ variations_NNS between_IN groups_NNS made_VBD classical_JJ statistical_JJ methods_NNS less_RBR reliable_JJ ._. 
Our_PRP$ approach_NN complements_VBZ Goovaerts_NNP 's_POS recently_RB modified_VBD geostatistical_JJ method_NN that_WDT was_VBD used_VBN to_TO analyze_VB soil_NN dioxin_NN distribution_NN in_IN the_DT vicinity_NN of_IN an_DT incinerator_NN in_IN Midland_NNP ._. 
Preliminary_JJ statistical_JJ analysis_NN suggests_VBZ that_IN there_EX is_VBZ a_DT strong_JJ association_NN between_IN elevated_JJ levels_NNS of_IN breast_NN cancer_NN incidence_NN and_CC aging_NN ,_, particularly_RB among_IN females_NNS residing_VBG in_IN the_DT city_NN of_IN Midland_NNP or_CC near_IN areas_NNS contaminated_VBN with_IN high_JJ dioxins_NNS levels_NNS ._. 
Findings_NNS can_MD be_VB used_VBN for_IN heightened_JJ surveillance_NN and_CC education_NN ,_, as_RB well_RB as_IN formulating_VBG new_JJ study_NN hypotheses_NNS for_IN further_JJ research_NN ._. 
BackgroundPrevious_JJ studies_NNS have_VBP reported_VBN higher_JJR than_IN normal_JJ levels_NNS of_IN dioxins_NNS in_IN some_DT locations_NNS in_IN the_DT city_NN of_IN Midland_NNP and_CC Tittabawassee_NNP River_NNP floodplain_NN in_IN Michigan_NNP -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ;_: while_IN dioxin_NN concentration_NN in_IN soils_NNS upstream_RB of_IN the_DT river_NN is_VBZ similar_JJ to_TO background_NN levels_NNS across_IN Michigan_NNP ._. 
The_DT most_RBS probable_JJ historic_JJ source_NN of_IN dioxins_NNS in_IN the_DT river_NN is_VBZ located_VBN in_IN the_DT city_NN of_IN Midland_NNP from_IN industrial_JJ processes_NNS in_IN the_DT Dow_NNP Chemical_NNP Company_NNP 's_POS -LRB-_-LRB- Dow_NNP -RRB-_-RRB- Midland_NNP plant_NN 
Background_NN Previous_JJ studies_NNS have_VBP reported_VBN higher_JJR than_IN normal_JJ levels_NNS of_IN dioxins_NNS in_IN some_DT locations_NNS in_IN the_DT city_NN of_IN Midland_NNP and_CC Tittabawassee_NNP River_NNP floodplain_NN in_IN Michigan_NNP -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ;_: while_IN dioxin_NN concentration_NN in_IN soils_NNS upstream_RB of_IN the_DT river_NN is_VBZ similar_JJ to_TO background_NN levels_NNS across_IN Michigan_NNP ._. 
The_DT most_RBS probable_JJ historic_JJ source_NN of_IN dioxins_NNS in_IN the_DT river_NN is_VBZ located_VBN in_IN the_DT city_NN of_IN Midland_NNP from_IN industrial_JJ processes_NNS in_IN the_DT Dow_NNP Chemical_NNP Company_NNP 's_POS -LRB-_-LRB- Dow_NNP -RRB-_-RRB- Midland_NNP plant_NN 
Background_NN Previous_JJ studies_NNS have_VBP reported_VBN higher_JJR than_IN normal_JJ levels_NNS of_IN dioxins_NNS in_IN some_DT locations_NNS in_IN the_DT city_NN of_IN Midland_NNP and_CC Tittabawassee_NNP River_NNP floodplain_NN in_IN Michigan_NNP -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ;_: while_IN dioxin_NN concentration_NN in_IN soils_NNS upstream_RB of_IN the_DT river_NN is_VBZ similar_JJ to_TO background_NN levels_NNS across_IN Michigan_NNP ._. 
The_DT most_RBS probable_JJ historic_JJ source_NN of_IN dioxins_NNS in_IN the_DT river_NN is_VBZ located_VBN in_IN the_DT city_NN of_IN Midland_NNP from_IN industrial_JJ processes_NNS in_IN the_DT Dow_NNP Chemical_NNP Company_NNP 's_POS -LRB-_-LRB- Dow_NNP -RRB-_-RRB- Midland_NNP plant_NN 
Taking_VBG into_IN account_NN dioxins_NNS '_POS long_JJ half-lives_NNS and_CC resistance_NN to_TO biodegradation_NN ,_, we_PRP assumed_VBD dioxin_NN data_NNS from_IN 1995_CD to_TO 2003_CD adequately_RB represent_VBP dioxin_NN levels_NNS in_IN soils_NNS prior_RB to_TO 1995_CD ._. 
Although_IN this_DT assumption_NN is_VBZ not_RB ideal_JJ ,_, it_PRP is_VBZ reasonable_JJ because_IN occurrence_NN of_IN elevated_JJ concentrations_NNS of_IN PCDD\/Fs_NNS in_IN sediments_NNS at_IN depths_NNS below_IN 60_CD ''_'' in_IN the_DT river_NN indicates_VBZ that_IN the_DT contamination_NN is_VBZ occurring_VBG historically_RB 
The_DT levels_NNS of_IN dioxins_NNS in_IN samples_NNS within_IN or_CC beyond_IN 500-year_JJ floodplain_NN were_VBD below_IN 90_CD ppt_NN TEQ_NNP ._. 
Along_IN the_DT Tittabawassee_NNP River_NNP ,_, samples_NNS within_IN the_DT 100-year_JJ floodplain_NN range_NN up_IN to_TO 6450_CD ppt_NN TEQ_NNP ._. 
Three_CD samples_NNS collected_VBN by_IN USACE_NNP along_IN the_DT Saginaw_NNP River_NNP exceeded_VBD 90_CD ppt_NN TEQ_NNP ,_, which_WDT is_VBZ consistent_JJ with_IN a_DT previous_JJ study_NN ._. 
In_IN temporal_JJ extent_NN ,_, the_DT box_NN plots_NNS of_IN dioxins_NNS plotted_VBD using_VBG original_JJ values_NNS -LRB-_-LRB- Figure_NNP 3a_CD -RRB-_-RRB- and_CC natural_JJ logarithm_NN transformation_NN -LRB-_-LRB- Figure_NNP 3b_CD -RRB-_-RRB- provide_VBP insighful_JJ variations_NNS of_IN dioxin_NN contamination_NN during_IN the_DT study_NN period_NN ._. 
Air_NN deposition_NN from_IN historical_JJ operations_NNS at_IN the_DT Dow_NNP and_CC soil_NN relocation_NN activities_NNS may_MD explain_VB the_DT presence_NN of_IN very_RB high_JJ levels_NNS of_IN dioxins_NNS in_IN Midland_NNP 
The_DT interpretation_NN of_IN clusters_NNS in_IN Bay_NNP city_NN -LRB-_-LRB- Figures_NNS 5_CD and_CC 6_CD -RRB-_-RRB- takes_VBZ caution_NN ._. 
This_DT is_VBZ a_DT common_JJ shortcoming_NN of_IN the_DT clustering_VBG algorithms_NNS in_IN use_NN as_IN they_PRP rely_VBP on_IN minimum_JJ population_NN size_NN to_TO detect_VB high_JJ rates_NNS ._. 
Although_IN these_DT clusters_NNS are_VBP far_RB away_RB from_IN Midland_NNP and_CC the_DT Tittabawassee_NNP River_NNP ,_, in_IN one_CD recent_JJ study_NN it_PRP was_VBD reported_VBN that_DT sediment_NN and_CC floodplain_NN soils_NNS of_IN the_DT Saginaw_NNP River_NNP ,_, where_WRB these_DT clusters_NNS are_VBP ,_, are_VBP considerably_RB contaminated_VBN with_IN high_JJ levels_NNS of_IN dioxins_NNS similar_JJ to_TO the_DT ones_NNS in_IN the_DT Tittabawassee_NNP River_NNP with_IN respect_NN to_TO their_PRP$ profiles_NNS ._. 
Thus_RB dioxin_NN contamination_NN may_MD be_VB playing_VBG a_DT role_NN in_IN the_DT increase_NN in_IN breast_NN cancer_NN incidence_NN within_IN these_DT clusters_NNS ,_, though_IN other_JJ factors_NNS can_MD not_RB be_VB ruled_VBN out_RP ._. 
Findings_NNS can_MD be_VB used_VBN for_IN heightened_JJ surveillance_NN and_CC education_NN ,_, as_RB well_RB as_IN formulating_VBG new_JJ study_NN hypotheses_NNS for_IN further_JJ research_NN ._. 
BackgroundPrevious_JJ studies_NNS have_VBP reported_VBN higher_JJR than_IN normal_JJ levels_NNS of_IN dioxins_NNS in_IN some_DT locations_NNS in_IN the_DT city_NN of_IN Midland_NNP and_CC Tittabawassee_NNP River_NNP floodplain_NN in_IN Michigan_NNP -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ;_: while_IN dioxin_NN concentration_NN in_IN soils_NNS upstream_RB of_IN the_DT river_NN is_VBZ similar_JJ to_TO background_NN levels_NNS across_IN Michigan_NNP ._. 
The_DT most_RBS probable_JJ historic_JJ source_NN of_IN dioxins_NNS in_IN the_DT river_NN is_VBZ located_VBN in_IN the_DT city_NN of_IN Midland_NNP from_IN industrial_JJ processes_NNS in_IN the_DT Dow_NNP Chemical_NNP Company_NNP 's_POS -LRB-_-LRB- Dow_NNP -RRB-_-RRB- Midland_NNP plant_NN 
The_DT most_RBS probable_JJ historic_JJ source_NN of_IN dioxins_NNS in_IN the_DT river_NN is_VBZ located_VBN in_IN the_DT city_NN of_IN Midland_NNP from_IN industrial_JJ processes_NNS in_IN the_DT Dow_NNP Chemical_NNP Company_NNP 's_POS -LRB-_-LRB- Dow_NNP -RRB-_-RRB- Midland_NNP plant_NN 
Given_VBN the_DT evidence_NN from_IN human_JJ epidemiological_JJ studies_NNS and_CC animal_NN studies_NNS ,_, high_JJ incidence_NN rates_NNS of_IN breast_NN cancer_NN support_NN the_DT hypothesis_NN that_IN dioxin_NN contamination_NN in_IN soils_NNS may_MD contribute_VB significantly_RB to_TO the_DT etiology_NN and_CC exacerbation_NN of_IN the_DT development_NN of_IN breast_NN cancer_NN in_IN this_DT region_NN ._. 
Despite_IN a_DT variety_NN of_IN studies_NNS investigating_VBG the_DT soil_NN dioxin_NN contamination_NN in_IN this_DT area_NN ,_, the_DT resulting_VBG health_NN effects_NNS in_IN the_DT local_JJ communities_NNS are_VBP largely_RB unknown_JJ ._. 
In_IN particular_JJ ,_, the_DT spatial_JJ relation_NN between_IN soil_NN dioxin_NN contamination_NN and_CC risks_NNS of_IN breast_NN cancer_NN development_NN is_VBZ still_RB unclear_JJ ._. 
We_PRP used_VBD ZIP_NNP code_NN 48883_CD ,_, an_DT area_NN located_VBN upstream_RB of_IN the_DT river_NN -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- as_IN the_DT reference_NN for_IN comparison_NN ._. 
Given_VBN that_IN the_DT levels_NNS of_IN dioxins_NNS in_IN this_DT area_NN are_VBP close_RB to_TO background_NN levels_NNS across_IN Michigan_NNP as_IN reported_VBN by_IN previous_JJ studies_NNS ,_, the_DT population_NN was_VBD assumed_VBN to_TO be_VB unexposed_JJ to_TO dioxin_VB ._. 
The_DT female_JJ populations_NNS in_IN this_DT ZIP_NNP code_NN in_IN both_DT 1990_CD and_CC 2000_CD are_VBP close_JJ to_TO the_DT average_JJ female_JJ population_NN per_IN ZIP_NN code_NN in_IN the_DT study_NN area_NN ._. 
The_DT moderation_NN of_IN the_DT facilities_NNS -LRB-_-LRB- 99_CD ._. 
Although_IN this_DT assumption_NN is_VBZ not_RB ideal_JJ ,_, it_PRP is_VBZ reasonable_JJ because_IN occurrence_NN of_IN elevated_JJ concentrations_NNS of_IN PCDD\/Fs_NNS in_IN sediments_NNS at_IN depths_NNS below_IN 60_CD ''_'' in_IN the_DT river_NN indicates_VBZ that_IN the_DT contamination_NN is_VBZ occurring_VBG historically_RB 
Very_RB high_JJ levels_NNS of_IN dioxins_NNS are_VBP limited_VBN in_IN the_DT areas_NNS with_IN 10-year_JJ flood_NN frequency_NN ;_: -LRB-_-LRB- 2_CD -RRB-_-RRB- the_DT number_NN of_IN breast_NN cancer_NN cases_NNS increased_VBD from_IN 1985_CD to_TO 2002_CD among_IN females_NNS aged_VBN between_IN 45_CD and_CC 64_CD years_NNS and_CC they_PRP had_VBD the_DT highest_JJS risk_NN ;_: -LRB-_-LRB- 3_CD -RRB-_-RRB- rather_RB than_IN randomly_RB distributed_VBN in_IN the_DT study_NN area_NN ,_, ZIP_NNP codes_NNS where_WRB high_JJ breast_NN cancer_NN rates_NNS exist_VBP are_VBP clustered_VBN in_IN or_CC near_IN to_TO the_DT contaminated_VBN areas_NNS after_IN adjustment_NN for_IN age_NN ;_: and_CC -LRB-_-LRB- 4_CD -RRB-_-RRB- living_VBG on_IN or_CC close_RB to_TO the_DT contaminated_VBN areas_NNS is_VBZ spatially_RB associated_VBN with_IN the_DT increased_VBN incidences_NNS of_IN breast_NN cancer_NN ._. 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
Background_NN Previous_JJ studies_NNS have_VBP reported_VBN higher_JJR than_IN normal_JJ levels_NNS of_IN dioxins_NNS in_IN some_DT locations_NNS in_IN the_DT city_NN of_IN Midland_NNP and_CC Tittabawassee_NNP River_NNP floodplain_NN in_IN Michigan_NNP -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ;_: while_IN dioxin_NN concentration_NN in_IN soils_NNS upstream_RB of_IN the_DT river_NN is_VBZ similar_JJ to_TO background_NN levels_NNS across_IN Michigan_NNP ._. 
The_DT most_RBS probable_JJ historic_JJ source_NN of_IN dioxins_NNS in_IN the_DT river_NN is_VBZ located_VBN in_IN the_DT city_NN of_IN Midland_NNP from_IN industrial_JJ processes_NNS in_IN the_DT Dow_NNP Chemical_NNP Company_NNP 's_POS -LRB-_-LRB- Dow_NNP -RRB-_-RRB- Midland_NNP plant_NN 
Background_NN Previous_JJ studies_NNS have_VBP reported_VBN higher_JJR than_IN normal_JJ levels_NNS of_IN dioxins_NNS in_IN some_DT locations_NNS in_IN the_DT city_NN of_IN Midland_NNP and_CC Tittabawassee_NNP River_NNP floodplain_NN in_IN Michigan_NNP -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- ;_: while_IN dioxin_NN concentration_NN in_IN soils_NNS upstream_RB of_IN the_DT river_NN is_VBZ similar_JJ to_TO background_NN levels_NNS across_IN Michigan_NNP ._. 
The_DT most_RBS probable_JJ historic_JJ source_NN of_IN dioxins_NNS in_IN the_DT river_NN is_VBZ located_VBN in_IN the_DT city_NN of_IN Midland_NNP from_IN industrial_JJ processes_NNS in_IN the_DT Dow_NNP Chemical_NNP Company_NNP 's_POS -LRB-_-LRB- Dow_NNP -RRB-_-RRB- Midland_NNP plant_NN 
The_DT most_RBS probable_JJ historic_JJ source_NN of_IN dioxins_NNS in_IN the_DT river_NN is_VBZ located_VBN in_IN the_DT city_NN of_IN Midland_NNP from_IN industrial_JJ processes_NNS in_IN the_DT Dow_NNP Chemical_NNP Company_NNP 's_POS -LRB-_-LRB- Dow_NNP -RRB-_-RRB- Midland_NNP plant_NN 
3years_NNS in_IN human_JJ body_NN 
We_PRP used_VBD ZIP_NNP code_NN 48883_CD ,_, an_DT area_NN located_VBN upstream_RB of_IN the_DT river_NN -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- as_IN the_DT reference_NN for_IN comparison_NN ._. 
Given_VBN that_IN the_DT levels_NNS of_IN dioxins_NNS in_IN this_DT area_NN are_VBP close_RB to_TO background_NN levels_NNS across_IN Michigan_NNP as_IN reported_VBN by_IN previous_JJ studies_NNS ,_, the_DT population_NN was_VBD assumed_VBN to_TO be_VB unexposed_JJ to_TO dioxin_VB ._. 
The_DT female_JJ populations_NNS in_IN this_DT ZIP_NNP code_NN in_IN both_DT 1990_CD and_CC 2000_CD are_VBP close_JJ to_TO the_DT average_JJ female_JJ population_NN per_IN ZIP_NN code_NN in_IN the_DT study_NN area_NN ._. 
Jacquez_NNP and_CC Greiling_NNP 
Taking_VBG into_IN account_NN dioxins_NNS '_POS long_JJ half-lives_NNS and_CC resistance_NN to_TO biodegradation_NN ,_, we_PRP assumed_VBD dioxin_NN data_NNS from_IN 1995_CD to_TO 2003_CD adequately_RB represent_VBP dioxin_NN levels_NNS in_IN soils_NNS prior_RB to_TO 1995_CD ._. 
Although_IN this_DT assumption_NN is_VBZ not_RB ideal_JJ ,_, it_PRP is_VBZ reasonable_JJ because_IN occurrence_NN of_IN elevated_JJ concentrations_NNS of_IN PCDD\/Fs_NNS in_IN sediments_NNS at_IN depths_NNS below_IN 60_CD ''_'' in_IN the_DT river_NN indicates_VBZ that_IN the_DT contamination_NN is_VBZ occurring_VBG historically_RB 
The_DT moderation_NN of_IN the_DT facilities_NNS -LRB-_-LRB- 99_CD ._. 
Although_IN this_DT assumption_NN is_VBZ not_RB ideal_JJ ,_, it_PRP is_VBZ reasonable_JJ because_IN occurrence_NN of_IN elevated_JJ concentrations_NNS of_IN PCDD\/Fs_NNS in_IN sediments_NNS at_IN depths_NNS below_IN 60_CD ''_'' in_IN the_DT river_NN indicates_VBZ that_IN the_DT contamination_NN is_VBZ occurring_VBG historically_RB 
The_DT moderation_NN of_IN the_DT facilities_NNS -LRB-_-LRB- 99_CD ._. 
Although_IN this_DT assumption_NN is_VBZ not_RB ideal_JJ ,_, it_PRP is_VBZ reasonable_JJ because_IN occurrence_NN of_IN elevated_JJ concentrations_NNS of_IN PCDD\/Fs_NNS in_IN sediments_NNS at_IN depths_NNS below_IN 60_CD ''_'' in_IN the_DT river_NN indicates_VBZ that_IN the_DT contamination_NN is_VBZ occurring_VBG historically_RB 
Very_RB high_JJ levels_NNS of_IN dioxins_NNS are_VBP limited_VBN in_IN the_DT areas_NNS with_IN 10-year_JJ flood_NN frequency_NN ;_: -LRB-_-LRB- 2_CD -RRB-_-RRB- the_DT number_NN of_IN breast_NN cancer_NN cases_NNS increased_VBD from_IN 1985_CD to_TO 2002_CD among_IN females_NNS aged_VBN between_IN 45_CD and_CC 64_CD years_NNS and_CC they_PRP had_VBD the_DT highest_JJS risk_NN ;_: -LRB-_-LRB- 3_CD -RRB-_-RRB- rather_RB than_IN randomly_RB distributed_VBN in_IN the_DT study_NN area_NN ,_, ZIP_NNP codes_NNS where_WRB high_JJ breast_NN cancer_NN rates_NNS exist_VBP are_VBP clustered_VBN in_IN or_CC near_IN to_TO the_DT contaminated_VBN areas_NNS after_IN adjustment_NN for_IN age_NN ;_: and_CC -LRB-_-LRB- 4_CD -RRB-_-RRB- living_VBG on_IN or_CC close_RB to_TO the_DT contaminated_VBN areas_NNS is_VBZ spatially_RB associated_VBN with_IN the_DT increased_VBN incidences_NNS of_IN breast_NN cancer_NN ._. 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
The_DT most_RBS important_JJ insight_NN was_VBD that_IN contaminated_VBN areas_NNS were_VBD predominantly_RB the_DT city_NN of_IN Midland_NNP and_CC the_DT Tittabawassee_NNP River_NNP 100-year_JJ floodplain_NN ._. 
Air_NN deposition_NN from_IN historical_JJ operations_NNS at_IN the_DT Dow_NNP and_CC soil_NN relocation_NN activities_NNS may_MD explain_VB the_DT presence_NN of_IN very_RB high_JJ levels_NNS of_IN dioxins_NNS in_IN Midland_NNP 
The_DT dioxin_NN data_NNS had_VBD significant_JJ number_NN of_IN outliers_NNS with_IN extremely_RB high_JJ TEQ_NNP values_NNS even_RB after_RB log_VB transformation_NN of_IN the_DT data_NNS ,_, thus_RB remaining_VBG outliers_NNS and_CC nonhomogeneous_JJ variations_NNS between_IN groups_NNS made_VBD classical_JJ statistical_JJ methods_NNS less_RBR reliable_JJ ._. 
Our_PRP$ approach_NN complements_VBZ Goovaerts_NNP 's_POS recently_RB modified_VBD geostatistical_JJ method_NN that_WDT was_VBD used_VBN to_TO analyze_VB soil_NN dioxin_NN distribution_NN in_IN the_DT vicinity_NN of_IN an_DT incinerator_NN in_IN Midland_NNP ._. 
Preliminary_JJ statistical_JJ analysis_NN suggests_VBZ that_IN there_EX is_VBZ a_DT strong_JJ association_NN between_IN elevated_JJ levels_NNS of_IN breast_NN cancer_NN incidence_NN and_CC aging_NN ,_, particularly_RB among_IN females_NNS residing_VBG in_IN the_DT city_NN of_IN Midland_NNP or_CC near_IN areas_NNS contaminated_VBN with_IN high_JJ dioxins_NNS levels_NNS ._. 
Findings_NNS from_IN the_DT Dioxin_NNP Exposure_NNP Study_NNP 
Yet_RB they_PRP are_VBP substantive_JJ factors_NNS in_IN the_DT development_NN of_IN breast_NN cancer_NN 
Although_IN the_DT association_NN between_IN increased_VBN incidence_NN of_IN breast_NN cancer_NN and_CC living_NN on_IN or_CC close_RB to_TO dioxin_NN contamination_NN areas_NNS was_VBD found_VBN in_IN our_PRP$ study_NN ,_, the_DT question_NN of_IN whether_IN exposure_NN to_TO dioxin_VB in_IN soil_NN has_VBZ caused_VBN or_CC is_VBZ causing_VBG breast_NN cancer_NN in_IN this_DT region_NN is_VBZ obviously_RB complex_JJ and_CC likely_JJ to_TO be_VB answered_VBN only_RB through_IN various_JJ comprehensive_JJ approaches_NNS and_CC by_IN controlling_VBG for_IN other_JJ confounders_NNS ._. 
For_IN example_NN ,_, in_IN a_DT separate_JJ report_NN we_PRP compiled_VBD more_JJR than_IN 325_CD chemicals_NNS that_WDT are_VBP released_VBN into_IN the_DT environment_NN besides_IN dioxins_NNS ._. 
It_PRP is_VBZ possible_JJ that_IN these_DT chemicals_NNS contribute_VBP to_TO the_DT high_JJ rates_NNS of_IN breast_NN cancer_NN as_RB well_RB ._. 
Conclusion_NN In_IN summary_NN ,_, this_DT study_NN finds_VBZ that_IN there_EX are_VBP elevated_JJ levels_NNS of_IN dioxin_NN contamination_NN in_IN the_DT city_NN of_IN Midland_NNP and_CC Tittabawassee_NNP River_NNP 100-year_JJ floodplain_NN ._. 
Floods_NNS then_RB swept_VBD and_CC redeposited_VBD sediments_NNS and_CC soils_NNS within_IN the_DT floodplain_NN ._. 
As_IN by-products_NNS in_IN chlorine-based_JJ chemical_NN processes_NNS ,_, dioxins_NNS were_VBD released_VBN into_IN the_DT air_NN and_CC water_NN decades_NNS ago_RB and_CC accumulated_VBN in_IN the_DT sediments_NNS and_CC soils_NNS in_IN and_CC near_IN the_DT Tittabawassee_NNP River_NNP 
3years_NNS in_IN human_JJ body_NN 
Given_VBN the_DT evidence_NN from_IN human_JJ epidemiological_JJ studies_NNS and_CC animal_NN studies_NNS ,_, high_JJ incidence_NN rates_NNS of_IN breast_NN cancer_NN support_NN the_DT hypothesis_NN that_IN dioxin_NN contamination_NN in_IN soils_NNS may_MD contribute_VB significantly_RB to_TO the_DT etiology_NN and_CC exacerbation_NN of_IN the_DT development_NN of_IN breast_NN cancer_NN in_IN this_DT region_NN ._. 
Despite_IN a_DT variety_NN of_IN studies_NNS investigating_VBG the_DT soil_NN dioxi_NN 
We_PRP used_VBD ZIP_NNP code_NN 48883_CD ,_, an_DT area_NN located_VBN upstream_RB of_IN the_DT river_NN -LRB-_-LRB- Figure_NNP 1_CD -RRB-_-RRB- as_IN the_DT reference_NN for_IN comparison_NN ._. 
Given_VBN that_IN the_DT levels_NNS of_IN dioxins_NNS in_IN this_DT area_NN are_VBP close_RB to_TO background_NN levels_NNS across_IN Michigan_NNP as_IN reported_VBN by_IN previous_JJ studies_NNS ,_, the_DT population_NN was_VBD assumed_VBN to_TO be_VB unexposed_JJ to_TO dioxin_VB ._. 
The_DT female_JJ populations_NNS in_IN this_DT ZIP_NNP code_NN in_IN both_DT 1990_CD and_CC 2000_CD are_VBP close_JJ to_TO the_DT average_JJ female_JJ population_NN per_IN ZIP_NN code_NN in_IN the_DT study_NN area_NN ._. 
Although_IN ZIP_NNP codes_NNS are_VBP arbitrary_JJ units_NNS of_IN analysis_NN in_IN terms_NNS of_IN contamination_NN and_CC potential_JJ health_NN outcomes_NNS ,_, it_PRP is_VBZ convenient_JJ for_IN public_JJ health_NN agencies_NNS to_TO register_VB patients_NNS at_IN this_DT level_NN so_RB as_IN to_TO protect_VB patient_JJ privacy_NN ._. 
In_IN addition_NN ,_, we_PRP did_VBD not_RB account_VB for_IN migration_NN because_IN of_IN low_JJ mobility_NN among_IN the_DT study_NN population_NN as_IN was_VBD reported_VBN in_IN several_JJ surveys_NNS 
Very_RB high_JJ levels_NNS of_IN dioxins_NNS are_VBP limited_VBN in_IN the_DT areas_NNS with_IN 10-year_JJ flood_NN frequency_NN ;_: -LRB-_-LRB- 2_CD -RRB-_-RRB- the_DT number_NN of_IN breast_NN cancer_NN cases_NNS increased_VBD from_IN 1985_CD to_TO 2002_CD among_IN females_NNS aged_VBN between_IN 45_CD and_CC 64_CD years_NNS and_CC they_PRP had_VBD the_DT highest_JJS risk_NN ;_: -LRB-_-LRB- 3_CD -RRB-_-RRB- rather_RB than_IN randomly_RB distributed_VBN in_IN the_DT study_NN area_NN ,_, ZIP_NNP codes_NNS where_WRB high_JJ breast_NN cancer_NN rates_NNS exist_VBP are_VBP clustered_VBN in_IN or_CC near_IN to_TO the_DT contaminated_VBN areas_NNS after_IN adjustment_NN for_IN age_NN ;_: and_CC -LRB-_-LRB- 4_CD -RRB-_-RRB- living_VBG on_IN or_CC close_RB to_TO the_DT contaminated_VBN areas_NNS is_VBZ spatially_RB associated_VBN with_IN the_DT increased_VBN incidences_NNS of_IN breast_NN cancer_NN ._. 
Findings_NNS in_IN this_DT study_NN are_VBP consistent_JJ with_IN findings_NNS from_IN previous_JJ studies_NNS 
Air_NN deposition_NN from_IN historical_JJ operations_NNS at_IN the_DT Dow_NNP and_CC soil_NN relocation_NN activities_NNS may_MD explain_VB the_DT presence_NN of_IN very_RB high_JJ levels_NNS of_IN dioxins_NNS in_IN Midland_NNP 
Residents_NNS living_VBG in_IN or_CC near_IN to_TO these_DT contaminated_VBN areas_NNS are_VBP more_RBR likely_JJ to_TO visit_VB these_DT areas_NNS ;_: therefore_RB ,_, they_PRP are_VBP more_RBR likely_JJ to_TO have_VB been_VBN exposed_VBN to_TO dioxins_NNS than_IN residents_NNS living_VBG far_RB away_RB ._. 
Findings_NNS from_IN the_DT Dioxin_NNP Exposure_NNP Study_NNP 
g._VB Other_JJ pathways_NNS may_MD also_RB expose_VB local_JJ residents_NNS to_TO high_JJ risks_NNS ,_, e._VB Long-term_JJ exposure_NN due_JJ to_TO air_NN deposition_NN of_IN high_JJ concentrations_NNS of_IN dioxins_NNS from_IN inefficient_JJ incinerators_NNS in_IN Midland_NNP presents_VBZ a_DT significant_JJ health_NN hazard_NN to_TO local_JJ residents_NNS 
,direct_JJ soil_NN and_CC household_NN dust_NN contact_NN ,_, using_VBG contaminated_VBN sediments_NNS infill_VBP material_NN in_IN housing_NN projects_NNS ,_, eating_VBG fish_NN and_CC game_NN from_IN the_DT contaminated_VBN area_NN ,_, doing_VBG water-related_JJ activities_NNS in_IN the_DT contaminated_VBN area_NN ,_, and_CC working_VBG at_IN the_DT Dow_NNP 
Michigan_JJ soil_NN generic_JJ residential_JJ direct_JJ contact_NN criterion_NN for_IN dioxins_NNS -LRB-_-LRB- RDCC_NNP -RRB-_-RRB- is_VBZ 90_CD ppt_NN TEQ_NNP ._. 
The_DT study_NN area_NN shows_VBZ sampling_NN locations_NNS and_CC corresponding_JJ dioxin_NN levels_NNS ,_, Tittabawassee_NNP River_NNP and_CC its_PRP$ floodplain_NN ,_, and_CC major_JJ cities_NNS ._. 
Dioxin_NNP refers_VBZ to_TO 210_CD congeners\/isomers_NNS of_IN structurally_RB and_CC chemically_RB related_JJ polychlorinated_VBN dibenzo-para-dioxins_NNS -LRB-_-LRB- PCDDs_NNP -RRB-_-RRB- and_CC polychlorinated_VBN dibenzofurans_NNS -LRB-_-LRB- PCDFs_NNP -RRB-_-RRB- ,_, and_CC the_DT 2,3,7,8-tetra-CDD_NNP -LRB-_-LRB- TCDD_NNP -RRB-_-RRB- is_VBZ considered_VBN the_DT most_RBS toxic_JJ dioxin_NN congener_NN in_IN this_DT group_NN ._. 
Aconcept_NNP of_IN toxic_JJ equivalency_NN factors_NNS -LRB-_-LRB- TEFs_NNP -RRB-_-RRB- is_VBZ used_VBN to_TO compare_VB the_DT relative_JJ toxicity_NN of_IN other_JJ dioxin_NN congeners_NNS with_IN that_DT of_IN TCDD_NNP 
However_RB ,_, no_DT significant_JJ association_NN was_VBD found_VBN between_IN levels_NNS of_IN this_DT pollutant_NN and_CC the_DT analyzed_VBN causes_NNS of_IN death_NN in_IN either_DT city_NN ,_, although_IN estimates_NNS were_VBD mainly_RB positive_JJ and_CC of_IN higher_JJR magnitude_NN on_IN death_NN caused_VBN by_IN respiratory_JJ diseases_NNS ._. 
It_PRP is_VBZ generally_RB accepted_VBN that_IN one_CD source_NN of_IN uncertainty_NN in_IN time_NN series_NN analysis_NN is_VBZ the_DT exposure_NN measurement_NN error_NN that_WDT potentially_RB leads_VBZ to_TO the_DT loss_NN of_IN statistical_JJ power_NN and_CC the_DT underestimation_NN of_IN the_DT association_NN ._. 
We_PRP must_MD point_VB out_RP that_IN due_JJ to_TO the_DT mild_JJ climate_NN of_IN the_DT Canary_NNP archipelago_NN ,_, and_CC particularly_RB in_IN these_DT two_CD seaside_JJ cities_NNS ,_, ventilation_NN inside_IN the_DT home_NN is_VBZ natural_JJ ,_, with_IN hardly_RB any_DT use_NN of_IN air-conditioning_NN systems_NNS ._. 
Overall_RB ,_, the_DT risk_NN estimates_NNS present_VBP a_DT higher_JJR magnitude_NN when_WRB associated_VBN with_IN specific_JJ mortality_NN outcomes_NNS ,_, including_VBG those_DT due_JJ to_TO heart_NN disease_NN and_CC especially_RB with_IN those_DT caused_VBN by_IN respiratory_JJ diseases_NNS ._. 
This_DT is_VBZ in_IN good_JJ agreement_NN with_IN the_DT psychopathological_JJ mechanisms_NNS described_VBN for_IN these_DT events_NNS 
The_DT unconstrained_JJ distributed_VBN lag_NN model_NN showed_VBD a_DT greater_JJR total_JJ effect_NN than_IN the_DT average_JJ lag01_JJ and_CC concurrent_JJ day_NN -LRB-_-LRB- lag_NN 0_CD -RRB-_-RRB- models_NNS ,_, especially_RB in_IN PM_NNP estimates_NNS ._. 
These_DT results_NNS are_VBP all_DT in_IN good_JJ agreement_NN with_IN diverse_JJ findings_NNS from_IN time_NN series_NN analysis_NN studies_NNS 
To_TO assess_VB whether_IN there_EX was_VBD confounding_VBG by_IN other_JJ pollutants_NNS in_IN the_DT estimates_NNS ,_, two-pollutant_JJ models_NNS were_VBD calculated_VBN ,_, simultaneously_RB including_VBG all_PDT the_DT possible_JJ pairs_NNS of_IN pollutants_NNS and_CC subsequently_RB examining_VBG the_DT variations_NNS in_IN the_DT coefficients_NNS of_IN the_DT one_CD pollutant_NN models_NNS after_IN each_DT of_IN the_DT other_JJ pollutants_NNS had_VBD been_VBN included_VBN ._. 
To_TO investigate_VB the_DT cumulative_JJ associations_NNS between_IN air_NN pollutants_NNS and_CC daily_JJ mortality_NN counts_VBZ up_IN to_TO 5_CD days_NNS after_IN exposure_NN ,_, unconstrained_JJ distributed_VBN lag_NN models_NNS were_VBD used_VBN ._. 
From_IN these_DT we_PRP obtained_VBD cumulative_JJ estimates_NNS as_IN the_DT sum_NN of_IN the_DT estimated_VBN coefficients_NNS for_IN any_DT given_VBN lag_NN -LRB-_-LRB- lags_VBZ 0_CD to_TO 5_CD -RRB-_-RRB- ._. 
To_TO assess_VB whether_IN there_EX was_VBD confounding_VBG by_IN other_JJ pollutants_NNS in_IN the_DT estimates_NNS ,_, two-pollutant_JJ models_NNS were_VBD calculated_VBN ,_, simultaneously_RB including_VBG all_PDT the_DT possible_JJ pairs_NNS of_IN pollutants_NNS and_CC subsequently_RB examining_VBG the_DT variations_NNS in_IN the_DT coefficients_NNS of_IN the_DT one_CD pollutant_NN models_NNS after_IN each_DT of_IN the_DT other_JJ pollutants_NNS had_VBD been_VBN included_VBN ._. 
To_TO investigate_VB the_DT cumulative_JJ associations_NNS between_IN air_NN pollutants_NNS and_CC daily_JJ mortality_NN counts_VBZ up_IN to_TO 5_CD days_NNS after_IN exposure_NN ,_, unconstrained_JJ distributed_VBN lag_NN models_NNS were_VBD used_VBN ._. 
From_IN these_DT we_PRP obtained_VBD cumulative_JJ estimates_NNS as_IN the_DT sum_NN of_IN the_DT estimated_VBN coefficients_NNS for_IN any_DT given_VBN lag_NN -LRB-_-LRB- lags_VBZ 0_CD to_TO 5_CD -RRB-_-RRB- ._. 
Yaxis_NNP :_: percent_NN of_IN mortality_NN risk_NN increase_NN ._. 
Xaxis_NNP :_: each_DT of_IN the_DT analyzed_VBN lags_VBZ ._. 
LPGC_NNP :_: Las_NNP Palmas_NNP de_IN Gran_NNP Canaria_NNP city_NN ;_: SCTF_NNP :_: Santa_NNP Cruz_NNP de_IN Tenerife_NNP city_NN ._. 
Due_JJ to_TO O3_VB transboundary_JJ transport_NN ,_, the_DT highest_JJS levels_NNS of_IN ozone_NN are_VBP usually_RB observed_VBN from_IN February_NNP to_TO May_NNP in_IN L\/P_NNP de_IN Gran_NNP Canaria_NNP and_CC between_IN March_NNP and_CC May_NNP in_IN S\/C_NNP de_IN Tenerife_NNP ._. 
Consequently_RB we_PRP examined_VBD the_DT effect_NN of_IN ozone_NN for_IN the_DT entire_JJ annual_JJ period_NN and_CC as_RB well_RB as_IN for_IN the_DT period_NN restricted_VBN to_TO the_DT aforementioned_JJ months_NNS in_IN each_DT city_NN -LRB-_-LRB- basically_RB during_IN springtime_NN -RRB-_-RRB- ._. 
Yaxis_NNP :_: percent_NN of_IN mortality_NN risk_NN increase_NN ._. 
Xaxis_NNP :_: each_DT of_IN the_DT analyzed_VBN lags_VBZ ._. 
LPGC_NNP :_: Las_NNP Palmas_NNP de_IN Gran_NNP Canaria_NNP city_NN ;_: SCTF_NNP :_: Santa_NNP Cruz_NNP de_IN Tenerife_NNP city_NN ._. 
Due_JJ to_TO O3_VB transboundary_JJ transport_NN ,_, the_DT highest_JJS levels_NNS of_IN ozone_NN are_VBP usually_RB observed_VBN from_IN February_NNP to_TO May_NNP in_IN L\/P_NNP de_IN Gran_NNP Canaria_NNP and_CC between_IN March_NNP and_CC May_NNP in_IN S\/C_NNP de_IN Tenerife_NNP ._. 
Consequently_RB we_PRP examined_VBD the_DT effect_NN of_IN ozone_NN for_IN the_DT entire_JJ annual_JJ period_NN and_CC as_RB well_RB as_IN for_IN the_DT period_NN restricted_VBN to_TO the_DT aforementioned_JJ months_NNS in_IN each_DT city_NN -LRB-_-LRB- basically_RB during_IN springtime_NN -RRB-_-RRB- ._. 
5in_VB both_DT cities_NNS -LRB-_-LRB- correlation_NN coefficient_NN ,_, r_NN =_SYM 0_CD ._. 
PM_NNP 10_CD was_VBD very_RB strongly_RB correlated_VBN with_IN PM_NNP 2_CD ._. 
2_CD 
Exposure_NN on_IN the_DT current_JJ day_NN and_CC lags_VBZ up_IN to_TO 5_CD days_NNS were_VBD also_RB examined_VBN ._. 
We_PRP assumed_VBD linearity_NN when_WRB the_DT effective_JJ df_NN values_NNS were_VBD close_RB to_TO 1_CD ._. 
Given_VBN that_IN a_DT 2-day_JJ moving_JJ average_NN of_IN air_NN pollutants_NNS has_VBZ been_VBN described_VBN as_IN fitting_JJ better_RBR than_IN any_DT single_JJ day_NN 's_POS results_NNS ,_, a_DT model_NN with_IN concurrent_JJ and_CC previous_JJ day_NN average_NN -LRB-_-LRB- lag01_CD -RRB-_-RRB- was_VBD fitted_VBN ._. 
To_TO account_VB for_IN serial_JJ correlation_NN in_IN the_DT residuals_NNS ,_, we_PRP added_VBD autoregressive_JJ terms_NNS into_IN the_DT model_NN as_IN appropriate_JJ 
Given_VBN that_IN a_DT 2-day_JJ moving_JJ average_NN of_IN air_NN pollutants_NNS has_VBZ been_VBN described_VBN as_IN fitting_JJ better_RBR than_IN any_DT single_JJ day_NN 's_POS results_NNS 
Overall_RB ,_, the_DT risk_NN estimates_NNS present_VBP a_DT higher_JJR magnitude_NN when_WRB associated_VBN with_IN specific_JJ mortality_NN outcomes_NNS ,_, including_VBG those_DT due_JJ to_TO heart_NN disease_NN and_CC especially_RB with_IN those_DT caused_VBN by_IN respiratory_JJ diseases_NNS ._. 
This_DT is_VBZ in_IN good_JJ agreement_NN with_IN the_DT psychopathological_JJ mechanisms_NNS described_VBN for_IN these_DT events_NNS 
Zmirou_NNP 
In_IN contrast_NN ,_, we_PRP obtained_VBD a_DT linear_JJ association_NN in_IN S\/C_NNP de_IN Tenerife_NNP ,_, which_WDT has_VBZ a_DT lower_JJR daily_JJ average_NN of_IN deaths_NNS ,_, and_CC more_RBR precise_JJ confidence_NN intervals_NNS in_IN respiratory_JJ mortality_NN estimates_NNS ._. 
If_IN we_PRP compare_VBP the_DT results_NNS of_IN both_DT cities_NNS with_IN different_JJ European_JJ meta-analyses_NNS ,_, these_DT estimates_NNS are_VBP consistent_JJ with_IN the_DT direction_NN of_IN the_DT association_NN 
If_IN we_PRP compare_VBP the_DT results_NNS of_IN both_DT cities_NNS with_IN different_JJ European_JJ meta-analyses_NNS ,_, these_DT estimates_NNS are_VBP consistent_JJ with_IN the_DT direction_NN of_IN the_DT association_NN 
If_IN we_PRP compare_VBP the_DT results_NNS of_IN both_DT cities_NNS with_IN different_JJ European_JJ meta-analyses_NNS ,_, these_DT estimates_NNS are_VBP consistent_JJ with_IN the_DT direction_NN of_IN the_DT association_NN 
We_PRP confirmed_VBD these_DT results_NNS using_VBG average_JJ concurrent_JJ and_CC previous_JJ day_NN -LRB-_-LRB- lag_NN 01_CD -RRB-_-RRB- data_NNS ,_, as_RB well_RB as_IN under_IN the_DT DLM_NNP ._. 
Studies_NNS reporting_VBG the_DT association_NN between_IN O3_NNP and_CC mortality_NN have_VBP found_VBN no_DT evidence_NN of_IN a_DT confounding_JJ effect_NN due_JJ to_TO other_JJ pollutants_NNS 
Zmirou_NNP 
We_PRP confirmed_VBD these_DT results_NNS using_VBG average_JJ concurrent_JJ and_CC previous_JJ day_NN -LRB-_-LRB- lag_NN 01_CD -RRB-_-RRB- data_NNS ,_, as_RB well_RB as_IN under_IN the_DT DLM_NNP ._. 
Studies_NNS reporting_VBG the_DT association_NN between_IN O3_NNP and_CC mortality_NN have_VBP found_VBN no_DT evidence_NN of_IN a_DT confounding_JJ effect_NN due_JJ to_TO other_JJ pollutants_NNS 
The_DT unconstrained_JJ distributed_VBN lag_NN model_NN showed_VBD a_DT greater_JJR total_JJ effect_NN than_IN the_DT average_JJ lag01_JJ and_CC concurrent_JJ day_NN -LRB-_-LRB- lag_NN 0_CD -RRB-_-RRB- models_NNS ,_, especially_RB in_IN PM_NNP estimates_NNS ._. 
These_DT results_NNS are_VBP all_DT in_IN good_JJ agreement_NN with_IN diverse_JJ findings_NNS from_IN time_NN series_NN analysis_NN studies_NNS 
The_DT unconstrained_JJ distributed_VBN lag_NN model_NN showed_VBD a_DT greater_JJR total_JJ effect_NN than_IN the_DT average_JJ lag01_JJ and_CC concurrent_JJ day_NN -LRB-_-LRB- lag_NN 0_CD -RRB-_-RRB- models_NNS ,_, especially_RB in_IN PM_NNP estimates_NNS ._. 
These_DT results_NNS are_VBP all_DT in_IN good_JJ agreement_NN with_IN diverse_JJ findings_NNS from_IN time_NN series_NN analysis_NN studies_NNS 
In_IN contrast_NN ,_, we_PRP obtained_VBD a_DT linear_JJ association_NN in_IN S\/C_NNP de_IN Tenerife_NNP ,_, which_WDT has_VBZ a_DT lower_JJR daily_JJ average_NN of_IN deaths_NNS ,_, and_CC more_RBR precise_JJ confidence_NN intervals_NNS in_IN respiratory_JJ mortality_NN estimates_NNS ._. 
If_IN we_PRP compare_VBP the_DT results_NNS of_IN both_DT cities_NNS with_IN different_JJ European_JJ meta-analyses_NNS ,_, these_DT estimates_NNS are_VBP consistent_JJ with_IN the_DT direction_NN of_IN the_DT association_NN 
In_IN contrast_NN ,_, we_PRP obtained_VBD a_DT linear_JJ association_NN in_IN S\/C_NNP de_IN Tenerife_NNP ,_, which_WDT has_VBZ a_DT lower_JJR daily_JJ average_NN of_IN deaths_NNS ,_, and_CC more_RBR precise_JJ confidence_NN intervals_NNS in_IN respiratory_JJ mortality_NN estimates_NNS ._. 
If_IN we_PRP compare_VBP the_DT results_NNS of_IN both_DT cities_NNS with_IN different_JJ European_JJ meta-analyses_NNS ,_, these_DT estimates_NNS are_VBP consistent_JJ with_IN the_DT direction_NN of_IN the_DT association_NN 
We_PRP confirmed_VBD these_DT results_NNS using_VBG average_JJ concurrent_JJ and_CC previous_JJ day_NN -LRB-_-LRB- lag_NN 01_CD -RRB-_-RRB- data_NNS ,_, as_RB well_RB as_IN under_IN the_DT DLM_NNP ._. 
Studies_NNS reporting_VBG the_DT association_NN between_IN O3_NNP and_CC mortality_NN have_VBP found_VBN no_DT evidence_NN of_IN a_DT confounding_JJ effect_NN due_JJ to_TO other_JJ pollutants_NNS 
All_DT of_IN this_DT is_VBZ in_IN good_JJ agreement_NN with_IN our_PRP$ results_NNS ._. 
Studies_NNS reporting_VBG the_DT association_NN between_IN O_NNP 3_CD and_CC mortality_NN have_VBP found_VBN no_DT evidence_NN of_IN a_DT confounding_JJ effect_NN due_JJ to_TO other_JJ pollutants_NNS 
We_PRP confirmed_VBD these_DT results_NNS using_VBG average_JJ concurrent_JJ and_CC previous_JJ day_NN -LRB-_-LRB- lag_NN 01_CD -RRB-_-RRB- data_NNS ,_, as_RB well_RB as_IN under_IN the_DT DLM_NNP ._. 
Studies_NNS reporting_VBG the_DT association_NN between_IN O3_NNP and_CC mortality_NN have_VBP found_VBN no_DT evidence_NN of_IN a_DT confounding_JJ effect_NN due_JJ to_TO other_JJ pollutants_NNS 
However_RB ,_, no_DT significant_JJ association_NN was_VBD found_VBN between_IN levels_NNS of_IN this_DT pollutant_NN and_CC the_DT analyzed_VBN causes_NNS of_IN death_NN in_IN either_DT city_NN ,_, although_IN estimates_NNS were_VBD mainly_RB positive_JJ and_CC of_IN higher_JJR magnitude_NN on_IN death_NN caused_VBN by_IN respiratory_JJ diseases_NNS ._. 
It_PRP is_VBZ generally_RB accepted_VBN that_IN one_CD source_NN of_IN uncertainty_NN in_IN time_NN series_NN analysis_NN is_VBZ the_DT exposure_NN measurement_NN error_NN that_WDT potentially_RB leads_VBZ to_TO the_DT loss_NN of_IN statistical_JJ power_NN and_CC the_DT underestimation_NN of_IN the_DT association_NN ._. 
We_PRP must_MD point_VB out_RP that_IN due_JJ to_TO the_DT mild_JJ climate_NN of_IN the_DT Canary_NNP archipelago_NN ,_, and_CC particularly_RB in_IN these_DT two_CD seaside_JJ cities_NNS ,_, ventilation_NN inside_IN the_DT home_NN is_VBZ natural_JJ ,_, with_IN hardly_RB any_DT use_NN of_IN air-conditioning_NN systems_NNS ._. 
All_DT of_IN this_DT is_VBZ in_IN good_JJ agreement_NN with_IN our_PRP$ results_NNS ._. 
Studies_NNS reporting_VBG the_DT association_NN between_IN O_NNP 3_CD and_CC mortality_NN have_VBP found_VBN no_DT evidence_NN of_IN a_DT confounding_JJ effect_NN due_JJ to_TO other_JJ pollutants_NNS 
We_PRP confirmed_VBD these_DT results_NNS using_VBG average_JJ concurrent_JJ and_CC previous_JJ day_NN -LRB-_-LRB- lag_NN 01_CD -RRB-_-RRB- data_NNS ,_, as_RB well_RB as_IN under_IN the_DT DLM_NNP ._. 
Studies_NNS reporting_VBG the_DT association_NN between_IN O3_NNP and_CC mortality_NN have_VBP found_VBN no_DT evidence_NN of_IN a_DT confounding_JJ effect_NN due_JJ to_TO other_JJ pollutants_NNS 
We_PRP found_VBD evidence_NN that_IN an_DT increase_NN of_IN 10_CD 
The_DT unconstrained_JJ distributed_VBN lag_NN model_NN showed_VBD a_DT greater_JJR total_JJ effect_NN than_IN the_DT average_JJ lag01_JJ and_CC concurrent_JJ day_NN -LRB-_-LRB- lag_NN 0_CD -RRB-_-RRB- models_NNS ,_, especially_RB in_IN PM_NNP estimates_NNS ._. 
These_DT results_NNS are_VBP all_DT in_IN good_JJ agreement_NN with_IN diverse_JJ findings_NNS from_IN time_NN series_NN analysis_NN studies_NNS 
The_DT unconstrained_JJ distributed_VBN lag_NN model_NN showed_VBD a_DT greater_JJR total_JJ effect_NN than_IN the_DT average_JJ lag01_JJ and_CC concurrent_JJ day_NN -LRB-_-LRB- lag_NN 0_CD -RRB-_-RRB- models_NNS ,_, especially_RB in_IN PM_NNP estimates_NNS ._. 
These_DT results_NNS are_VBP all_DT in_IN good_JJ agreement_NN with_IN diverse_JJ findings_NNS from_IN time_NN series_NN analysis_NN studies_NNS 
The_DT association_NN between_IN particulate_JJ matter_NN and_CC mortality_NN has_VBZ been_VBN studied_VBN extensively_RB in_IN European_NNP ,_, North_NNP American_NNP ,_, and_CC Asian_JJ cities_NNS 
The_DT association_NN between_IN particulate_JJ matter_NN and_CC mortality_NN has_VBZ been_VBN studied_VBN extensively_RB in_IN European_NNP ,_, North_NNP American_NNP ,_, and_CC Asian_JJ cities_NNS 
This_DT is_VBZ in_IN good_JJ agreement_NN with_IN the_DT psychopathological_JJ mechanisms_NNS described_VBN for_IN these_DT events_NNS 
This_DT is_VBZ in_IN good_JJ agreement_NN with_IN the_DT psychopathological_JJ mechanisms_NNS described_VBN for_IN these_DT events_NNS 
The_DT island_NN factor_NN of_IN the_DT cities_NNS of_IN Las_NNP Palmas_NNP de_IN Gran_NNP Canaria_NNP -LRB-_-LRB- L\/P_NNP de_IN Gran_NNP Canaria_NNP -RRB-_-RRB- and_CC Santa_NNP Cruz_NNP de_IN Tenerife_NNP -LRB-_-LRB- S\/C_NNP de_IN Tenerife_NNP -RRB-_-RRB- ,_, in_IN addition_NN to_TO the_DT meteorology_NN that_WDT characterizes_VBZ the_DT Canary_NNP Islands_NNP as_IN a_DT whole_NN ,_, create_VB a_DT particular_JJ setting_NN that_WDT influences_VBZ the_DT air_NN quality_NN in_IN both_DT cities_NNS ._. 
The_DT predominance_NN of_IN trade_NN winds_NNS ,_, which_WDT blow_VBP almost_RB constantly_RB from_IN May_NNP to_TO October_NNP ,_, facilitates_VBZ the_DT dispersion_NN of_IN primary_JJ pollutants_NNS in_IN this_DT urban_JJ environment_NN ,_, whereas_IN their_PRP$ proximity_NN to_TO Africa_NNP favors_VBZ the_DT arrival_NN of_IN natural_JJ particulate_JJ matter_NN to_TO the_DT islands_NNS ._. 
The_DT special_JJ environmental_JJ and_CC climatic_JJ features_NNS ,_, including_VBG mild_JJ temperatures_NNS ,_, limited_JJ temperature_NN fluctuation_NN ,_, irregular_JJ and_CC scarce_JJ rainfall_NN ,_, trade_NN winds_NNS ,_, and_CC seasonality_NN of_IN African_JJ air_NN mass_NN intrusions_NNS ,_, offer_VBP a_DT opportunity_NN to_TO analyze_VB the_DT relation_NN between_IN air_NN pollutants_NNS and_CC their_PRP$ short-term_JJ health_NN effects_NNS in_IN the_DT two_CD Canary_NNP capitals_NNS ._. 
Because_IN dust_NN events_NNS also_RB have_VBP an_DT impact_NN on_IN PM_NNP 2_CD ._. 
4%_CD in_IN S\/C_NNP de_IN Tenerife_NNP -RRB-_-RRB- were_VBD excluded_VBN from_IN this_DT analysis_NN ._. 
5levels_NNS ,_, those_DT days_NNS with_IN average_JJ PM2_NNP ._. 
5levels_NNS over_IN 75_CD 
The_DT association_NN between_IN particulate_JJ matter_NN and_CC mortality_NN has_VBZ been_VBN studied_VBN extensively_RB in_IN European_NNP ,_, North_NNP American_NNP ,_, and_CC Asian_JJ cities_NNS 
05_CD -RRB-_-RRB- ._. 
The_DT presence_NN of_IN the_DT remaining_VBG variables_NNS was_VBD tested_VBN by_IN means_NNS of_IN the_DT likelihood_NN ratio_NN test_NN -LRB-_-LRB- p_SYM 
05_CD -RRB-_-RRB- ._. 
The_DT presence_NN of_IN the_DT remaining_VBG variables_NNS was_VBD tested_VBN by_IN means_NNS of_IN the_DT likelihood_NN ratio_NN test_NN -LRB-_-LRB- p_SYM 
Following_VBG this_DT procedure_NN ,_, in_IN L\/P_NNP de_IN Gran_NNP Canaria_NNP the_DT effective_JJ df_NN s_VBZ for_IN the_DT time_NN trend_NN for_IN total_JJ mortality_NN and_CC mortality_NN from_IN heart_NN and_CC respiratory_JJ diseases_NNS were_VBD 9_CD ,_, 8_CD ,_, and_CC 12_CD ,_, respectively_RB ,_, while_IN 5_CD resulted_VBD for_IN all_DT three_CD mortality_NN outcomes_NNS in_IN S\/C_NNP de_IN Tenerife_NNP ._. 
The_DT smoothing_VBG parameter_NN for_IN the_DT remaining_VBG smoothers_NNS was_VBD chosen_VBN automatically_RB by_IN means_NNS of_IN generalized_JJ cross-validation_NN ._. 
For_IN each_DT pollutant_NN ,_, mortality_NN outcome_NN ,_, and_CC city_NN ,_, the_DT exposure_NN on_IN the_DT current_JJ day_NN -LRB-_-LRB- lag_NN 0_CD -RRB-_-RRB- was_VBD introduced_VBN into_IN the_DT basal_JJ model_NN as_IN a_DT smoothing_VBG term_NN ._. 
05_CD -RRB-_-RRB- ._. 
The_DT presence_NN of_IN the_DT remaining_VBG variables_NNS was_VBD tested_VBN by_IN means_NNS of_IN the_DT likelihood_NN ratio_NN test_NN -LRB-_-LRB- p_SYM 
Risk_NN coefficients_NNS were_VBD higher_JJR for_IN respiratory_JJ and_CC cardiovascular_JJ mortality_NN ,_, showing_VBG a_DT delayed_JJ effect_NN over_IN several_JJ days_NNS ._. 
BackgroundSince_NNP the_DT 1990s_CD ,_, a_DT number_NN of_IN studies_NNS have_VBP shown_VBN that_IN daily_JJ pollution_NN variations_NNS in_IN urban_JJ ambient_JJ air_NN are_VBP associated_VBN with_IN an_DT increase_NN in_IN mortality_NN even_RB when_WRB the_DT fluctuations_NNS are_VBP below_IN international_JJ standards_NNS 
Risk_NN coefficients_NNS were_VBD higher_JJR for_IN respiratory_JJ and_CC cardiovascular_JJ mortality_NN ,_, showing_VBG a_DT delayed_JJ effect_NN over_IN several_JJ days_NNS ._. 
BackgroundSince_NNP the_DT 1990s_CD ,_, a_DT number_NN of_IN studies_NNS have_VBP shown_VBN that_IN daily_JJ pollution_NN variations_NNS in_IN urban_JJ ambient_JJ air_NN are_VBP associated_VBN with_IN an_DT increase_NN in_IN mortality_NN even_RB when_WRB the_DT fluctuations_NNS are_VBP below_IN international_JJ standards_NNS 
Background_NN Since_IN the_DT 1990s_CD ,_, a_DT number_NN of_IN studies_NNS have_VBP shown_VBN that_IN daily_JJ pollution_NN variations_NNS in_IN urban_JJ ambient_JJ air_NN are_VBP associated_VBN with_IN an_DT increase_NN in_IN mortality_NN even_RB when_WRB the_DT fluctuations_NNS are_VBP below_IN international_JJ standards_NNS 
Penalized_VBN regression_NN splines_NNS ,_, implemented_VBN by_IN Wood_NNP in_IN R_NNP 
Exposure_NN on_IN the_DT current_JJ day_NN and_CC lags_VBZ up_IN to_TO 5_CD days_NNS were_VBD also_RB examined_VBN ._. 
We_PRP assumed_VBD linearity_NN when_WRB the_DT effective_JJ df_NN values_NNS were_VBD close_RB to_TO 1_CD ._. 
Given_VBN that_IN a_DT 2-day_JJ moving_JJ average_NN of_IN air_NN pollutants_NNS has_VBZ been_VBN described_VBN as_IN fitting_JJ better_RBR than_IN any_DT single_JJ day_NN 's_POS results_NNS ,_, a_DT model_NN with_IN concurrent_JJ and_CC previous_JJ day_NN average_NN -LRB-_-LRB- lag01_CD -RRB-_-RRB- was_VBD fitted_VBN ._. 
To_TO account_VB for_IN serial_JJ correlation_NN in_IN the_DT residuals_NNS ,_, we_PRP added_VBD autoregressive_JJ terms_NNS into_IN the_DT model_NN as_IN appropriate_JJ 
If_IN we_PRP compare_VBP the_DT results_NNS of_IN both_DT cities_NNS with_IN different_JJ European_JJ meta-analyses_NNS ,_, these_DT estimates_NNS are_VBP consistent_JJ with_IN the_DT direction_NN of_IN the_DT association_NN 
Under_IN a_DT public_JJ health_NN point_NN of_IN view_NN a_DT clear_JJ understanding_NN of_IN factors_NNS affecting_VBG heat_NN wave_NN related_VBN mortality_NN is_VBZ important_JJ to_TO properly_RB target_VB prevention_NN programs_NNS ._. 
Moreover_RB after_IN the_DT 2003_CD heat_NN wave_NN in_IN Europe_NNP the_DT introduction_NN of_IN prevention_NN programs_NNS may_MD have_VB modified_VBN the_DT determinants_NNS of_IN the_DT population_NN 's_POS susceptibility_NN to_TO high_JJ temperature_NN 
Moreover_RB after_IN the_DT 2003_CD heat_NN wave_NN in_IN Europe_NNP the_DT introduction_NN of_IN prevention_NN programs_NNS may_MD have_VB modified_VBN the_DT determinants_NNS of_IN the_DT population_NN 's_POS susceptibility_NN to_TO high_JJ temperature_NN 
Tappmax_NNP was_VBD defined_VBN as_IN the_DT maximum_NN daily_JJ value_NN of_IN apparent_JJ temperatures_NNS ._. 
Exposure_NN The_DT exposure_NN of_IN interest_NN was_VBD a_DT heat_NN wave_NN episode_NN ,_, defined_VBD using_VBG maximum_JJ apparent_JJ temperature_NN -LRB-_-LRB- Tappmax_NNP -RRB-_-RRB- ,_, an_DT index_NN of_IN discomfort_NN based_VBN on_IN air_NN and_CC dew_NN point_NN temperatures_NNS ._. 
Aheat_NNP wave_NN episode_NN was_VBD defined_VBN when_WRB Tappmax_NNP rises_VBZ above_IN the_DT monthly_JJ threshold_NN ,_, defined_VBN by_IN the_DT Heat_NNP Health_NNP Watch_NNP Warning_NNP System_NNP -LRB-_-LRB- HHWWS_NNP -RRB-_-RRB- 
Heart_NNP failure_NN and_CC heart_NN conduction_NN disorders_NNS were_VBD not_RB currently_RB identified_VBN as_IN risk_NN modifiers_NNS as_IN they_PRP had_VBD been_VBN previously_RB 
Until_IN now_RB ,_, most_JJS of_IN the_DT evidence_NN regarding_VBG factors_NNS that_WDT modify_VBP the_DT health_NN effects_NNS of_IN heat_NN waves_NNS derives_VBZ from_IN case-control_JJ studies_NNS 
Under_IN a_DT public_JJ health_NN point_NN of_IN view_NN a_DT clear_JJ understanding_NN of_IN factors_NNS affecting_VBG heat_NN wave_NN related_VBN mortality_NN is_VBZ important_JJ to_TO properly_RB target_VB prevention_NN programs_NNS ._. 
Moreover_RB after_IN the_DT 2003_CD heat_NN wave_NN in_IN Europe_NNP the_DT introduction_NN of_IN prevention_NN programs_NNS may_MD have_VB modified_VBN the_DT determinants_NNS of_IN the_DT population_NN 's_POS susceptibility_NN to_TO high_JJ temperature_NN 
Asmall_NNP area-based_JJ -LRB-_-LRB- census_NN tract_NN -RRB-_-RRB- socio-economic_JJ status_NN indicator_NN using_VBG 2001_CD census_NN data_NNS was_VBD also_RB used_VBN ._. 
Health_NNP StatusWe_NNP selected_VBD a_DT list_NN of_IN 13_CD groups_NNS of_IN diagnoses_NNS ,_, known_VBN to_TO be_VB associated_VBN with_IN an_DT increased_VBN mortality_NN risk_NN from_IN high_JJ temperatures_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- 
This_DT has_VBZ enabled_VBN us_PRP to_TO identify_VB a_DT series_NN of_IN health_NN conditions_NNS that_WDT modify_VBP the_DT heat-mortality_NN relationship_NN on_IN an_DT additive_JJ scale_NN but_CC not_RB on_IN a_DT multiplicative_JJ scale_NN ._. 
The_DT higher_JJR relative_JJ risk_NN of_IN mortality_NN during_IN heat_NN waves_NNS in_IN subjects_NNS with_IN previous_JJ hospitalizations_NNS for_IN a_DT chronic_JJ respiratory_JJ illness_NN is_VBZ supported_VBN by_IN previous_JJ case-only_JJ ,_, case-crossover_JJ and_CC time-series_JJ studies_NNS 
Such_JJ mechanism_NN offers_VBZ an_DT explanation_NN of_IN the_DT higher_JJR rates_NNS of_IN hospitalization_NN for_IN respiratory_JJ causes_NNS observed_VBN by_IN a_DT European_JJ multicity_NN study_NN 
The_DT higher_JJR risk_NN of_IN dying_VBG among_IN people_NNS with_IN psychiatric_JJ disorders_NNS is_VBZ supported_VBN by_IN previous_JJ studies_NNS 
It_PRP should_MD be_VB noted_VBN that_IN our_PRP$ indicator_NN of_IN socio-economic_JJ status_NN is_VBZ derived_VBN from_IN a_DT census_NN tract_NN level_NN study_NN 
The_DT comparison_NN of_IN our_PRP$ results_NNS with_IN previous_JJ studies_NNS on_IN risk_NN factors_NNS for_IN heat_NN related_VBN mortality_NN in_IN the_DT 65_CD +_NN age_NN group_NN in_IN Rome_NNP before_IN 2003_CD 
Under_IN a_DT public_JJ health_NN point_NN of_IN view_NN a_DT clear_JJ understanding_NN of_IN these_DT factors_NNS is_VBZ important_JJ to_TO ensure_VB the_DT effectiveness_NN of_IN prevention_NN programs_NNS ._. 
Until_IN now_RB ,_, most_JJS of_IN the_DT evidence_NN regarding_VBG factors_NNS that_WDT modify_VBP the_DT health_NN effects_NNS of_IN heat_NN waves_NNS derives_VBZ from_IN case-control_JJ studies_NNS 
Under_IN a_DT public_JJ health_NN point_NN of_IN view_NN a_DT clear_JJ understanding_NN of_IN these_DT factors_NNS is_VBZ important_JJ to_TO ensure_VB the_DT effectiveness_NN of_IN prevention_NN programs_NNS ._. 
Until_IN now_RB ,_, most_JJS of_IN the_DT evidence_NN regarding_VBG factors_NNS that_WDT modify_VBP the_DT health_NN effects_NNS of_IN heat_NN waves_NNS derives_VBZ from_IN case-control_JJ studies_NNS 
This_DT has_VBZ enabled_VBN us_PRP to_TO identify_VB a_DT series_NN of_IN health_NN conditions_NNS that_WDT modify_VBP the_DT heat-mortality_NN relationship_NN on_IN an_DT additive_JJ scale_NN but_CC not_RB on_IN a_DT multiplicative_JJ scale_NN ._. 
The_DT higher_JJR relative_JJ risk_NN of_IN mortality_NN during_IN heat_NN waves_NNS in_IN subjects_NNS with_IN previous_JJ hospitalizations_NNS for_IN a_DT chronic_JJ respiratory_JJ illness_NN is_VBZ supported_VBN by_IN previous_JJ case-only_JJ ,_, case-crossover_JJ and_CC time-series_JJ studies_NNS 
http:\/\/www_NN ._. 
ccm-network_NN ._. 
In_IN Italy_NNP the_DT National_NNP Department_NNP of_IN Civil_NNP Protection_NNP and_CC the_DT Ministry_NNP of_IN Health_NNP implemented_VBD a_DT national_JJ heat_NN prevention_NN program_NN ,_, and_CC national_JJ guidelines_NNS for_IN the_DT prevention_NN of_IN heat_NN health_NN effects_NNS have_VBP been_VBN defined_VBN ,_, targeted_VBN to_TO high_JJ risk_NN subgroups_NNS 
Heart_NNP failure_NN and_CC heart_NN conduction_NN disorders_NNS were_VBD not_RB currently_RB identified_VBN as_IN risk_NN modifiers_NNS as_IN they_PRP had_VBD been_VBN previously_RB 
Information_NN on_IN resident_NN 's_POS age_NN ,_, gender_NN ,_, and_CC marital_JJ status_NN was_VBD extracted_VBN from_IN the_DT Population_NNP Registry_NNP of_IN the_DT Roma_NNP Municipal_NNP Office_NNP ._. 
Asmall_NNP area-based_JJ -LRB-_-LRB- census_NN tract_NN -RRB-_-RRB- socio-economic_JJ status_NN indicator_NN using_VBG 2001_CD census_NN data_NNS was_VBD also_RB used_VBN ._. 
Health_NNP Status_NNP We_PRP selected_VBD a_DT list_NN of_IN 13_CD groups_NNS of_IN diagnoses_NNS ,_, known_VBN to_TO be_VB associated_VBN with_IN an_DT increased_VBN mortality_NN risk_NN from_IN high_JJ temperatures_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- 
As_IN reported_VBN by_IN previous_JJ studies_NNS 
Such_JJ mechanism_NN offers_VBZ an_DT explanation_NN of_IN the_DT higher_JJR rates_NNS of_IN hospitalization_NN for_IN respiratory_JJ causes_NNS observed_VBN by_IN a_DT European_JJ multicity_NN study_NN 
In_IN this_DT as_IN in_IN other_JJ studies_NNS 
outpatient_NN care_NN ,_, pharmaceutical_JJ care_NN -RRB-_-RRB- could_MD have_VB provided_VBN a_DT more_RBR accurate_JJ measure_NN of_IN the_DT prevalence_NN of_IN the_DT disease_NN in_IN our_PRP$ population_NN ._. 
Furthermore_RB ,_, it_PRP should_MD be_VB noted_VBN that_IN the_DT use_NN of_IN hospital_NN admissions_NNS could_MD provide_VB a_DT biased_VBN picture_NN of_IN morbidity_NN since_IN it_PRP reflects_VBZ not_RB only_JJ morbidity_NN levels_NNS but_CC also_RB provider-specific_JJ factors_NNS and_CC the_DT availability_NN of_IN primary_JJ care_NN and_CC out-patient_JJ services_NNS ._. 
In_IN this_DT study_NN ,_, we_PRP used_VBD ``_`` population-averaged_JJ ''_'' temperatures_NNS collected_VBN at_IN 
In_IN patients_NNS with_IN COPD_NNP an_DT exposure_NN to_TO extreme_JJ heat_NN might_MD induce_VB hyperventilation_NN leading_VBG to_TO dyspnea_NN and_CC to_TO mechanical_JJ and_CC cardiovascular_JJ effects_NNS 
The_DT higher_JJR relative_JJ risk_NN of_IN mortality_NN during_IN heat_NN waves_NNS in_IN subjects_NNS with_IN previous_JJ hospitalizations_NNS for_IN a_DT chronic_JJ respiratory_JJ illness_NN is_VBZ supported_VBN by_IN previous_JJ case-only_JJ ,_, case-crossover_JJ and_CC time-series_JJ studies_NNS 
The_DT higher_JJR relative_JJ risk_NN of_IN mortality_NN during_IN heat_NN waves_NNS in_IN subjects_NNS with_IN previous_JJ hospitalizations_NNS for_IN a_DT chronic_JJ respiratory_JJ illness_NN is_VBZ supported_VBN by_IN previous_JJ case-only_JJ ,_, case-crossover_JJ and_CC time-series_JJ studies_NNS 
This_DT has_VBZ enabled_VBN us_PRP to_TO identify_VB a_DT series_NN of_IN health_NN conditions_NNS that_WDT modify_VBP the_DT heat-mortality_NN relationship_NN on_IN an_DT additive_JJ scale_NN but_CC not_RB on_IN a_DT multiplicative_JJ scale_NN ._. 
The_DT higher_JJR relative_JJ risk_NN of_IN mortality_NN during_IN heat_NN waves_NNS in_IN subjects_NNS with_IN previous_JJ hospitalizations_NNS for_IN a_DT chronic_JJ respiratory_JJ illness_NN is_VBZ supported_VBN by_IN previous_JJ case-only_JJ ,_, case-crossover_JJ and_CC time-series_JJ studies_NNS 
This_DT has_VBZ enabled_VBN us_PRP to_TO identify_VB a_DT series_NN of_IN health_NN conditions_NNS that_WDT modify_VBP the_DT heat-mortality_NN relationship_NN on_IN an_DT additive_JJ scale_NN but_CC not_RB on_IN a_DT multiplicative_JJ scale_NN ._. 
The_DT higher_JJR relative_JJ risk_NN of_IN mortality_NN during_IN heat_NN waves_NNS in_IN subjects_NNS with_IN previous_JJ hospitalizations_NNS for_IN a_DT chronic_JJ respiratory_JJ illness_NN is_VBZ supported_VBN by_IN previous_JJ case-only_JJ ,_, case-crossover_JJ and_CC time-series_JJ studies_NNS ._. 
In_IN patients_NNS with_IN COPD_NNP an_DT exposure_NN to_TO extreme_JJ heat_NN might_MD induce_VB hyperventilation_NN leading_VBG to_TO dysp_VB 
Acomparison_NNP between_IN RDs_NNP relative_JJ to_TO different_JJ modalities_NNS of_IN the_DT same_JJ variable_NN was_VBD performed_VBN to_TO evaluate_VB a_DT possible_JJ effect_NN modification_NN on_IN an_DT additive_JJ scale_NN ._. 
The_DT analysis_NN was_VBD performed_VBN using_VBG SAS_NNP ._. 
Results_NNS We_PRP enrolled_VBD a_DT total_NN of_IN 651,195_CD subjects_NNS over_IN the_DT three-year_JJ period_NN ,_, 574,192_CD of_IN which_WDT were_VBD included_VBN in_IN the_DT first_JJ year_NN ._. 
Daily_JJ weather_NN data_NNS from_IN Ciampino_NNP airport_NN station_NN were_VBD obtained_VBN from_IN the_DT Italian_NNP Air_NNP Force_NNP Meteorological_NNP Service_NNP ,_, during_IN summer_NN -LRB-_-LRB- 1_CD st_NN of_IN May_NNP until_IN the_DT 15_CD th_NN of_IN September_NNP -RRB-_-RRB- ._. 
OutcomeVital_JJ status_NN was_VBD determined_VBN each_DT year_NN ,_, for_IN each_DT subject_NN through_IN a_DT record_NN linkage_NN with_IN the_DT Regional_NNP Registry_NNP of_IN Causes_NNPS of_IN Death_NNP -LRB-_-LRB- Regional_NNP Mortality_NNP Register_NNP -RRB-_-RRB- 
258_CD For_IN each_DT subject_NN ,_, the_DT number_NN of_IN Hospitalization_NNP Diagnosed_NNP Disease_NNP -LRB-_-LRB- HDD_NNP -RRB-_-RRB- over_IN the_DT previous_JJ two_CD years_NNS for_IN any_DT cause_NN ,_, other_JJ than_IN those_DT specified_VBN on_IN our_PRP$ list_NN ,_, was_VBD also_RB considered_VBN as_IN an_DT indicator_NN of_IN general_JJ health_NN status_NN ._. 
ExposureThe_JJ exposure_NN of_IN interest_NN was_VBD a_DT heat_NN wave_NN episode_NN ,_, defined_VBD using_VBG maximum_JJ apparent_JJ temperature_NN -LRB-_-LRB- Tappmax_NNP -RRB-_-RRB- ,_, an_DT index_NN of_IN discomfort_NN based_VBN on_IN air_NN and_CC dew_NN point_NN temperatures_NNS ._. 
Tappmax_NNP was_VBD defined_VBN as_IN the_DT maximum_NN daily_JJ value_NN of_IN apparent_JJ temperatures_NNS ._. 
Aheat_NNP wave_NN episode_NN was_VBD defined_VBN when_WRB Tappmax_NNP rises_VBZ above_IN the_DT monthly_JJ threshold_NN ,_, defined_VBN by_IN the_DT Heat_NNP Health_NNP Watch_NNP Warning_NNP System_NNP -LRB-_-LRB- HHWWS_NNP -RRB-_-RRB- 
Health_NNP Status_NNP We_PRP selected_VBD a_DT list_NN of_IN 13_CD groups_NNS of_IN diagnoses_NNS ,_, known_VBN to_TO be_VB associated_VBN with_IN an_DT increased_VBN mortality_NN risk_NN from_IN high_JJ temperatures_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
Information_NN about_IN the_DT prevalence_NN of_IN past_JJ hospitalizations_NNS for_IN each_DT of_IN these_DT conditions_NNS in_IN the_DT study_NN population_NN was_VBD extracted_VBN by_IN linking_VBG the_DT regional_JJ hospital_NN discharge_VB files_NNS -LRB-_-LRB- Regional_NNP Hospital_NNP Information_NNP System_NNP -RRB-_-RRB- -LRB-_-LRB- HIS_PRP$ -RRB-_-RRB- 
Asmall_NNP area-based_JJ -LRB-_-LRB- census_NN tract_NN -RRB-_-RRB- socio-economic_JJ status_NN indicator_NN using_VBG 2001_CD census_NN data_NNS was_VBD also_RB used_VBN ._. 
Health_NNP StatusWe_NNP selected_VBD a_DT list_NN of_IN 13_CD groups_NNS of_IN diagnoses_NNS ,_, known_VBN to_TO be_VB associated_VBN with_IN an_DT increased_VBN mortality_NN risk_NN from_IN high_JJ temperatures_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- 
The_DT higher_JJR risk_NN of_IN dying_VBG among_IN people_NNS with_IN psychiatric_JJ disorders_NNS is_VBZ supported_VBN by_IN previous_JJ studies_NNS 
Several_JJ countries_NNS throughout_IN Europe_NNP have_VBP put_VBN into_IN place_NN a_DT series_NN of_IN preventive_JJ measures_NNS ,_, but_CC only_RB few_JJ are_VBP specifically_RB targeted_VBN to_TO high-risk_JJ individuals_NNS 
Several_JJ countries_NNS throughout_IN Europe_NNP have_VBP put_VBN into_IN place_NN a_DT series_NN of_IN preventive_JJ measures_NNS ,_, but_CC only_RB few_JJ are_VBP specifically_RB targeted_VBN to_TO high-risk_JJ individuals_NNS 
Several_JJ countries_NNS throughout_IN Europe_NNP have_VBP put_VBN into_IN place_NN a_DT series_NN of_IN preventive_JJ measures_NNS ,_, but_CC only_RB few_JJ are_VBP specifically_RB targeted_VBN to_TO high-risk_JJ individuals_NNS 
Under_IN a_DT public_JJ health_NN point_NN of_IN view_NN a_DT clear_JJ understanding_NN of_IN these_DT factors_NNS is_VBZ important_JJ to_TO ensure_VB the_DT effectiveness_NN of_IN prevention_NN programs_NNS ._. 
Until_IN now_RB ,_, most_JJS of_IN the_DT evidence_NN regarding_VBG factors_NNS that_WDT modify_VBP the_DT health_NN effects_NNS of_IN heat_NN waves_NNS derives_VBZ from_IN case-control_JJ studies_NNS 
Asmall_NNP area-based_JJ -LRB-_-LRB- census_NN tract_NN -RRB-_-RRB- socio-economic_JJ status_NN indicator_NN using_VBG 2001_CD census_NN data_NNS was_VBD also_RB used_VBN ._. 
Health_NNP StatusWe_NNP selected_VBD a_DT list_NN of_IN 13_CD groups_NNS of_IN diagnoses_NNS ,_, known_VBN to_TO be_VB associated_VBN with_IN an_DT increased_VBN mortality_NN risk_NN from_IN high_JJ temperatures_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- 
We_PRP calculated_VBD the_DT relative_JJ risks_NNS -LRB-_-LRB- RR_NNP -RRB-_-RRB- of_IN dying_VBG on_IN heat_NN wave_NN and_CC non_NN heat_NN wave_NN days_NNS for_IN each_DT of_IN the_DT modalities_NNS of_IN the_DT covariates_NNS and_CC the_DT REM_NNP -LRB-_-LRB- Relative_JJ Effect_NN Modification_NN -RRB-_-RRB- index_NN ._. 
REM_NNP index_NN was_VBD the_DT ratio_NN of_IN the_DT relative_JJ risks_NNS of_IN dying_VBG during_IN a_DT heat_NN wave_NN for_IN each_DT of_IN the_DT covariates_NNS considered_VBN ,_, comparing_VBG each_DT category_NN to_TO the_DT reference_NN one_CD ._. 
Asignificant_NNP REM_NNP index_NN -LRB-_-LRB- p-value_JJ lesser_JJR than_IN 0_CD ._. 
20_CD -RRB-_-RRB- means_VBZ that_IN the_DT specific_JJ covariate_JJ acts_NNS as_IN an_DT effect_NN modifier_NN of_IN the_DT heat-mortality_NN relationship_NN ._. 
The_DT higher_JJR risk_NN of_IN dying_VBG among_IN people_NNS with_IN psychiatric_JJ disorders_NNS is_VBZ supported_VBN by_IN previous_JJ studies_NNS 
On_IN the_DT other_JJ hand_NN ,_, it_PRP has_VBZ been_VBN suggested_VBN that_IN the_DT lower_JJR risk_NN of_IN dying_VBG during_IN heat_NN waves_NNS for_IN pre-hospitalized_JJ people_NNS should_MD be_VB interpreted_VBN more_RBR as_IN an_DT additive_NN than_IN a_DT multiplicative_JJ effect_NN ,_, since_IN the_DT absolute_JJ risk_NN of_IN dying_VBG among_IN those_DT who_WP had_VBD an_DT hospitalization_NN during_IN the_DT previous_JJ two_CD years_NNS is_VBZ presumably_RB higher_JJR than_IN in_IN the_DT not_RB hospitalized_VBN group_NN 
It_PRP should_MD be_VB noted_VBN that_IN our_PRP$ indicator_NN of_IN socio-economic_JJ status_NN is_VBZ derived_VBN from_IN a_DT census_NN tract_NN level_NN study_NN 
The_DT comparison_NN of_IN our_PRP$ results_NNS with_IN previous_JJ studies_NNS on_IN risk_NN factors_NNS for_IN heat_NN related_VBN mortality_NN in_IN the_DT 65_CD +_NN age_NN group_NN in_IN Rome_NNP before_IN 2003_CD 
Several_JJ countries_NNS throughout_IN Europe_NNP have_VBP put_VBN into_IN place_NN a_DT series_NN of_IN preventive_JJ measures_NNS ,_, but_CC only_RB few_JJ are_VBP specifically_RB targeted_VBN to_TO high-risk_JJ individuals_NNS 
Several_JJ countries_NNS throughout_IN Europe_NNP have_VBP put_VBN into_IN place_NN a_DT series_NN of_IN preventive_JJ measures_NNS ,_, but_CC only_RB few_JJ are_VBP specifically_RB targeted_VBN to_TO high-risk_JJ individuals_NNS 
Under_IN a_DT public_JJ health_NN point_NN of_IN view_NN a_DT clear_JJ understanding_NN of_IN these_DT factors_NNS is_VBZ important_JJ to_TO ensure_VB the_DT effectiveness_NN of_IN prevention_NN programs_NNS ._. 
Until_IN now_RB ,_, most_JJS of_IN the_DT evidence_NN regarding_VBG factors_NNS that_WDT modify_VBP the_DT health_NN effects_NNS of_IN heat_NN waves_NNS derives_VBZ from_IN case-control_JJ studies_NNS 
For_IN some_DT specific_JJ health_NN conditions_NNS ,_, such_JJ as_IN cancer_NN or_CC other_JJ severe_JJ chronic_NN illnesses_NNS ,_, this_DT lower_JJR mortality_NN risk_NN could_MD be_VB due_JJ to_TO the_DT fact_NN that_IN these_DT patients_NNS received_VBD greater_JJR medical_JJ attention_NN ._. 
On_IN the_DT other_JJ hand_NN ,_, it_PRP has_VBZ been_VBN suggested_VBN that_IN the_DT lower_JJR risk_NN of_IN dying_VBG during_IN heat_NN waves_NNS for_IN pre-hospitalized_JJ people_NNS should_MD be_VB interpreted_VBN more_RBR as_IN an_DT additive_NN than_IN a_DT multiplicative_JJ effect_NN ,_, since_IN the_DT absolute_JJ risk_NN of_IN dying_VBG among_IN those_DT who_WP had_VBD an_DT hospitalization_NN during_IN the_DT previous_JJ two_CD years_NNS is_VBZ presumably_RB higher_JJR than_IN in_IN the_DT not_RB hospitalized_VBN group_NN 
Several_JJ countries_NNS throughout_IN Europe_NNP have_VBP put_VBN into_IN place_NN a_DT series_NN of_IN preventive_JJ measures_NNS ,_, but_CC only_RB few_JJ are_VBP specifically_RB targeted_VBN to_TO high-risk_JJ individuals_NNS 
Asmall_NNP area-based_JJ -LRB-_-LRB- census_NN tract_NN -RRB-_-RRB- socio-economic_JJ status_NN indicator_NN using_VBG 2001_CD census_NN data_NNS was_VBD also_RB used_VBN ._. 
Health_NNP StatusWe_NNP selected_VBD a_DT list_NN of_IN 13_CD groups_NNS of_IN diagnoses_NNS ,_, known_VBN to_TO be_VB associated_VBN with_IN an_DT increased_VBN mortality_NN risk_NN from_IN high_JJ temperatures_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- 
Epidemiological_JJ research_NN and_CC public_JJ health_NN efforts_NNS have_VBP been_VBN focused_VBN to_TO better_RB understand_VB the_DT health_NN impact_NN of_IN heat_NN and_CC of_IN the_DT individual_JJ factors_NNS that_WDT confer_VBP susceptibility_NN to_TO heat_NN stress_NN ._. 
Several_JJ countries_NNS throughout_IN Europe_NNP have_VBP put_VBN into_IN place_NN a_DT series_NN of_IN preventive_JJ measures_NNS ,_, but_CC only_RB few_JJ are_VBP specifically_RB targeted_VBN to_TO high-risk_JJ individuals_NNS 
Several_JJ countries_NNS throughout_IN Europe_NNP have_VBP put_VBN into_IN place_NN a_DT series_NN of_IN preventive_JJ measures_NNS ,_, but_CC only_RB few_JJ are_VBP specifically_RB targeted_VBN to_TO high-risk_JJ individuals_NNS 
Several_JJ countries_NNS throughout_IN Europe_NNP have_VBP put_VBN into_IN place_NN a_DT series_NN of_IN preventive_JJ measures_NNS ,_, but_CC only_RB few_JJ are_VBP specifically_RB targeted_VBN to_TO high-risk_JJ individuals_NNS 
Several_JJ countries_NNS throughout_IN Europe_NNP have_VBP put_VBN into_IN place_NN a_DT series_NN of_IN preventive_JJ measures_NNS ,_, but_CC only_RB few_JJ are_VBP specifically_RB targeted_VBN to_TO high-risk_JJ individuals_NNS 
Asmall_NNP area-based_JJ -LRB-_-LRB- census_NN tract_NN -RRB-_-RRB- socio-economic_JJ status_NN indicator_NN using_VBG 2001_CD census_NN data_NNS was_VBD also_RB used_VBN ._. 
Health_NNP StatusWe_NNP selected_VBD a_DT list_NN of_IN 13_CD groups_NNS of_IN diagnoses_NNS ,_, known_VBN to_TO be_VB associated_VBN with_IN an_DT increased_VBN mortality_NN risk_NN from_IN high_JJ temperatures_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- 
Such_JJ mechanism_NN offers_VBZ an_DT explanation_NN of_IN the_DT higher_JJR rates_NNS of_IN hospitalization_NN for_IN respiratory_JJ causes_NNS observed_VBN by_IN a_DT European_JJ multicity_NN study_NN 
Such_JJ mechanism_NN offers_VBZ an_DT explanation_NN of_IN the_DT higher_JJR rates_NNS of_IN hospitalization_NN for_IN respiratory_JJ causes_NNS observed_VBN by_IN a_DT European_JJ multicity_NN study_NN 
Several_JJ countries_NNS throughout_IN Europe_NNP have_VBP put_VBN into_IN place_NN a_DT series_NN of_IN preventive_JJ measures_NNS ,_, but_CC only_RB few_JJ are_VBP specifically_RB targeted_VBN to_TO high-risk_JJ individuals_NNS 
Under_IN a_DT public_JJ health_NN point_NN of_IN view_NN a_DT clear_JJ understanding_NN of_IN these_DT factors_NNS is_VBZ important_JJ to_TO ensure_VB the_DT effectiveness_NN of_IN prevention_NN programs_NNS ._. 
Until_IN now_RB ,_, most_JJS of_IN the_DT evidence_NN regarding_VBG factors_NNS that_WDT modify_VBP the_DT health_NN effects_NNS of_IN heat_NN waves_NNS derives_VBZ from_IN case-control_JJ studies_NNS 
If_IN surrogate_JJ exposure_NN ,_, like_IN proximity_NN to_TO releases_NNS ,_, is_VBZ related_VBN to_TO a_DT rare_JJ disease_NN ,_, like_IN childhood_NN cancer_NN ,_, then_RB investigation_NN should_MD focus_VB on_IN the_DT higher_JJR risk_NN locations_NNS ._. 
Infectious_JJ causes_NNS of_IN childhood_NN cancer_NN have_VBP been_VBN proposed_VBN and_CC population_NN characteristics_NNS of_IN stability_NN or_CC mixing_NN have_VBP been_VBN proposed_VBN and_CC evaluated_VBN ._. 
An_DT Ohio_NNP study_NN examined_VBD the_DT geographic_JJ distribution_NN of_IN childhood_NN leukemias_NNS relative_JJ to_TO population_NN density_NN ,_, population_NN growth_NN ,_, and_CC rural\/urban_JJ locale_NN ._. 
The_DT study_NN found_VBD higher_JJR rates_NNS for_IN acute_JJ lymphocytic_JJ leukemia_NN among_IN the_DT counties_NNS with_IN most_JJS rapid_JJ population_NN growth_NN and_CC the_DT most_RBS urbanized_JJ counties_NNS had_VBD reduced_VBN risk_NN for_IN acute_JJ myeloid_JJ leukemia_NN ._. 
The_DT authors_NNS reasoned_VBD that_IN the_DT findings_NNS supported_VBD population_NN mixing_NN as_IN a_DT cause_NN of_IN some_DT childhood_NN cancers_NNS ._. 
Mixing_VBG at_IN the_DT population_NN level_NN must_MD have_VB risks_NNS that_WDT can_MD be_VB estimated_VBN and_CC communicated_VBN at_IN the_DT individual_JJ level_NN ._. 
County-years_NNS that_WDT showed_VBD population_NN growth_NN of_IN more_JJR than_IN one_CD percent_NN from_IN the_DT previous_JJ year_NN were_VBD classified_VBN as_IN rapid_JJ growth_NN ._. 
The_DT definition_NN was_VBD chosen_VBN to_TO be_VB comparable_JJ to_TO a_DT recent_JJ study_NN that_WDT evaluated_VBD a_DT similar_JJ growth_NN rate_NN ._. 
Disease_NNP Modeling_NNP The_DT hierarchical_JJ modeling_NN approach_NN followed_VBD a_DT general_JJ framework_NN ._. 
The_DT observed_JJ counts_NNS Y_VBP kij_NN of_IN childhood_NN cancer_NN histotype_NN k_NN in_IN county_NN i_FW and_CC year_NN j_NN were_VBD assumed_VBN to_TO follow_VB independent_JJ Poisson_NNP distributions_NNS conditional_JJ on_IN an_DT unknown_JJ mean_JJ E_NN kij_FW exp_FW -LRB-_-LRB- u_FW kij_FW -RRB-_-RRB- Y_FW kij_FW |_FW u_FW kij_FW ~_FW Poisson_NNP -LRB-_-LRB- E_NNP kij_FW exp_FW -LRB-_-LRB- u_FW kij_FW -RRB-_-RRB- -RRB-_-RRB- The_DT expected_VBN count_NN for_IN histotype_JJ k_NN in_IN county_NN i_FW ,_, and_CC year_NN j_NN -LRB-_-LRB- E_NN kij_NN -RRB-_-RRB- was_VBD obtained_VBN by_IN internal_JJ standardization_NN from_IN the_DT given_VBN dataset_NN such_JJ that_IN the_DT sum_NN of_IN observed_JJ cases_NNS for_IN each_DT histotype_NN was_VBD exactly_RB equal_JJ to_TO the_DT sum_NN of_IN expected_VBN cases_NNS for_IN each_DT histotype_JJ accounting_NN for_IN race_NN ._. 
The_DT purpose_NN of_IN the_DT current_JJ study_NN was_VBD to_TO evaluate_VB the_DT use_NN of_IN population_NN characteristics_NNS for_IN focusing_VBG further_JJ study_NN ._. 
One_CD study_NN found_VBD excess_JJ risk_NN when_WRB population_NN growth_NN was_VBD greater_JJR than_IN 10_CD %_NN in_IN an_DT eleven-year_JJ period_NN ,_, thus_RB our_PRP$ risk_NN definition_NN of_IN 1_CD %_NN per_IN year_NN ._. 
The_DT population_NN mixing_NN theory_NN does_VBZ not_RB parse_VB the_DT risk_NN for_IN those_DT moving_VBG into_IN a_DT region_NN from_IN those_DT already_RB residing_VBG in_IN the_DT region_NN and_CC thus_RB has_VBZ only_RB a_DT population-based_JJ inference_NN ._. 
For_IN example_NN ,_, childhood_NN cancers_NNS and_CC leukemias_NNS in_IN Great_NNP Britain_NNP exhibited_VBD geographical_JJ clustering_NN of_IN birth_NN places_NNS close_RB to_TO environmental_JJ hazards_NNS that_WDT included_VBD large_JJ scale_NN combustion_NN processes_NNS ,_, processes_NNS using_VBG volatile_JJ organic_JJ compounds_NNS and_CC waste_NN incineration_NN 
Automobile_NNP exhaust_NN is_VBZ an_DT area-source_JJ HAP_NNP that_WDT has_VBZ received_VBN considerable_JJ scrutiny_NN as_IN a_DT potential_JJ cause_NN of_IN childhood_NN cancer_NN ._. 
The_DT studies_NNS have_VBP shown_VBN conflicting_JJ results_NNS and_CC a_DT critical_JJ review_NN concluded_VBD that_IN the_DT weight_NN of_IN the_DT epidemiological_JJ evidence_NN indicates_VBZ no_DT increased_VBN risk_NN for_IN childhood_NN cancer_NN associated_VBN with_IN exposure_NN to_TO traffic-related_JJ residential_JJ air_NN pollution_NN ._. 
If_IN surrogate_JJ exposure_NN ,_, like_IN proximity_NN to_TO releases_NNS ,_, is_VBZ related_VBN to_TO a_DT rare_JJ disease_NN ,_, like_IN childhood_NN cancer_NN ,_, then_RB investigation_NN should_MD focus_VB on_IN the_DT higher_JJR risk_NN locations_NNS ._. 
Hazardous_JJ air_NN pollutants_NNS -LRB-_-LRB- HAP_NNP -RRB-_-RRB- have_VBP been_VBN linked_VBN to_TO increased_VBN cancer_NN risks_NNS for_IN individuals_NNS living_VBG in_IN close_JJ proximity_NN to_TO major_JJ point_NN source_NN HAP-releases_NNS ._. 
For_IN example_NN ,_, childhood_NN cancers_NNS and_CC leukemias_NNS in_IN Great_NNP Britain_NNP exhibited_VBD geographical_JJ clustering_NN of_IN birth_NN places_NNS close_RB to_TO environmental_JJ hazards_NNS that_WDT included_VBD large_JJ scale_NN combustion_NN processes_NNS ,_, processes_NNS using_VBG volatile_JJ organic_JJ compounds_NNS and_CC waste_NN incineration_NN 
Some_DT studies_NNS whose_WP$ objectives_NNS were_VBD to_TO evaluate_VB pesticide_NN exposure_NN used_VBD cropping_VBG intensity_NN as_IN an_DT exposure_NN surrogate_NN and_CC implicated_VBN farm_NN or_CC rural_JJ living_NN as_IN a_DT positive_JJ risk_NN factor_NN 
The_DT current_JJ study_NN supports_VBZ further_JJ studies_NNS on_IN germ_JJ cell_NN tumors_NNS and_CC other_JJ gliomas_NNS in_IN areas_NNS with_IN intensive_JJ cropping_VBG ._. 
Several_JJ studies_NNS have_VBP linked_VBN georeferenced_JJ disease_NN counts_NNS and_CC cropping_VBG patterns_NNS as_IN a_DT surrogate_NN for_IN pesticide_NN exposure_NN ._. 
These_DT studies_NNS varied_VBD widely_RB on_IN how_WRB cropping_VBG patterns_NNS were_VBD defined_VBN as_IN exposure_NN and_CC how_WRB the_DT childhood_NN cancers_NNS ,_, as_IN a_DT group_NN of_IN outcomes_NNS ,_, were_VBD pooled_VBN or_CC parsed_VBN ._. 
Hazardous_JJ air_NN pollutants_NNS -LRB-_-LRB- HAP_NNP -RRB-_-RRB- have_VBP been_VBN linked_VBN to_TO increased_VBN cancer_NN risks_NNS for_IN individuals_NNS living_VBG in_IN close_JJ proximity_NN to_TO major_JJ point_NN source_NN HAP-releases_NNS ._. 
For_IN example_NN ,_, childhood_NN cancers_NNS and_CC leukemias_NNS in_IN Great_NNP Britain_NNP exhibited_VBD geographical_JJ clustering_NN of_IN birth_NN places_NNS close_RB to_TO environmental_JJ hazards_NNS that_WDT included_VBD large_JJ scale_NN combustion_NN processes_NNS ,_, processes_NNS using_VBG volatile_JJ organic_JJ compounds_NNS and_CC waste_NN incineration_NN 
-RRB-_-RRB- ._. 
Cancer_NN diagnoses_NNS were_VBD grouped_VBN into_IN 19_CD groups_NNS based_VBN on_IN the_DT most_RBS recent_JJ International_NNP Classification_NNP of_IN Childhood_NNP Cancers_NNP -LRB-_-LRB- ICCC-3_NNP -RRB-_-RRB- ._. 
Some_DT pooling_VBG of_IN very_RB rare_JJ cancer_NN types_NNS was_VBD performed_VBN as_IN follows_VBZ :_: childhood_NN cancer_NN subgroups_NNS Ic_NNP ,_, Id_NN and_CC Ie_NN were_VBD pooled_VBN and_CC assigned_VBN the_DT name_NN ``_`` other_JJ leukemias_NNS ''_'' ;_: subgroups_NNS IIb_NNP ,_, IIc_NNP ,_, IId_NNP and_CC IIe_NNP were_VBD pooled_VBN into_IN a_DT single_JJ group_NN and_CC were_VBD labeled_VBN ``_`` non-Hodgkin_JJ lymphoma_NN ''_'' ;_: and_CC subtypes_NNS IIIe_VBP ,_, and_CC IIIf_NNP were_VBD pooled_VBN into_IN a_DT group_NN called_VBN ``_`` other_JJ CNS_NNP tumors_NNS ._. 
The_DT spatial_JJ model_NN also_RB adjusted_VBN risks_NNS for_IN spatial_JJ associations_NNS and_CC histotype_JJ correlations_NNS for_IN the_DT potential_JJ MCAR_NNP relationships_NNS that_WDT were_VBD estimated_VBN fully_RB conditional_JJ upon_IN all_DT factors_NNS in_IN the_DT Disease_NNP Model_NNP ,_, described_VBD previously_RB ._. 
The_DT parameterization_NN used_VBN for_IN spatial_JJ modeling_NN was_VBD the_DT posterior_JJ probability_NN that_IN the_DT SMR_NNP estimate_NN was_VBD greater_JJR than_IN one_CD ._. 
This_DT parameter_NN is_VBZ affected_VBN by_IN both_DT the_DT magnitude_NN and_CC the_DT precision_NN of_IN the_DT SMR_NNP and_CC was_VBD chosen_VBN to_TO facilitate_VB the_DT objective_NN of_IN focusing_VBG further_JJ research_NN on_IN high-risk_JJ location_NN and_CC histotype_JJ combinations_NNS ._. 
Low_NNP socioeconomic_JJ status_NN increases_VBZ risk_NN for_IN Hodgkin_NNP lymphoma_NN 
The_DT risks_NNS seen_VBN for_IN these_DT two_CD cancers_NNS in_IN rapidly_RB growing_VBG counties_NNS should_MD receive_VB more_JJR study_NN ._. 
Both_DT Hodgkin_NNP lymphoma_NN and_CC osteosarcoma_NN are_VBP considered_VBN to_TO be_VB more_RBR common_JJ in_IN teenagers_NNS and_CC the_DT current_JJ study_NN did_VBD not_RB include_VB any_DT incident_NN cases_NNS among_IN teenagers_NNS ._. 
Infectious_JJ causes_NNS and_CC population_NN mixing_NN have_VBP been_VBN proposed_VBN as_IN causes_NNS of_IN childhood_NN cancer_NN 
It_PRP has_VBZ been_VBN reasoned_VBN that_IN more_RBR definitive_JJ prospective_JJ studies_NNS should_MD utilize_VB biomarkers_NNS to_TO study_VB the_DT risks_NNS of_IN prenatal_JJ exposures_NNS 
Incriminating_VBG areal-source_JJ HAP_NNP concentrations_NNS in_IN childhood_NN cancer_NN has_VBZ been_VBN and_CC will_MD continue_VB to_TO be_VB difficult_JJ ._. 
It_PRP has_VBZ been_VBN reasoned_VBN that_IN more_RBR definitive_JJ prospective_JJ studies_NNS should_MD utilize_VB biomarkers_NNS to_TO study_VB the_DT risks_NNS of_IN prenatal_JJ exposures_NNS 
It_PRP has_VBZ been_VBN reasoned_VBN that_IN more_RBR definitive_JJ prospective_JJ studies_NNS should_MD utilize_VB biomarkers_NNS to_TO study_VB the_DT risks_NNS of_IN prenatal_JJ exposures_NNS 
The_DT current_JJ study_NN supports_VBZ the_DT investigation_NN of_IN Hodgkin_NNP lymphoma_NN and_CC malignant_JJ bone_NN tumors_NNS in_IN areas_NNS of_IN rapid_JJ population_NN growth_NN ._. 
Hodgkin_NNP lymphoma_NN is_VBZ thought_VBN to_TO be_VB partly_RB attributable_JJ to_TO Epstein-Barr_NNP virus_NN but_CC also_RB has_VBZ genetic_JJ and_CC environmental_JJ factors_NNS 
The_DT current_JJ study_NN supports_VBZ the_DT investigation_NN of_IN Hodgkin_NNP lymphoma_NN and_CC malignant_JJ bone_NN tumors_NNS in_IN areas_NNS of_IN rapid_JJ population_NN growth_NN ._. 
Hodgkin_NNP lymphoma_NN is_VBZ thought_VBN to_TO be_VB partly_RB attributable_JJ to_TO Epstein-Barr_NNP virus_NN but_CC also_RB has_VBZ genetic_JJ and_CC environmental_JJ factors_NNS 
Incriminating_VBG areal-source_JJ HAP_NNP concentrations_NNS in_IN childhood_NN cancer_NN has_VBZ been_VBN and_CC will_MD continue_VB to_TO be_VB difficult_JJ ._. 
It_PRP has_VBZ been_VBN reasoned_VBN that_IN more_RBR definitive_JJ prospective_JJ studies_NNS should_MD utilize_VB biomarkers_NNS to_TO study_VB the_DT risks_NNS of_IN prenatal_JJ exposures_NNS 
When_WRB individual_JJ cancer_NN types_NNS are_VBP evaluated_VBN across_IN studies_NNS ,_, the_DT cumulative_JJ evidence_NN seems_VBZ to_TO support_VB the_DT null_NN ._. 
Leukemia_NNP may_MD be_VB the_DT exception_NN ,_, with_IN some_DT indication_NN of_IN increased_VBN risk_NN among_IN multiple_JJ studies_NNS of_IN air_NN pollution_NN ._. 
For_IN cancer_NN types_NNS other_JJ than_IN hepatic_JJ cancer_NN ,_, the_DT current_JJ study_NN provides_VBZ SMR_NNP estimates_NNS that_WDT center_VBP on_IN no_DT risk_NN and_CC have_VBP narrow_JJ confidence_NN bounds_NNS ,_, providing_VBG inductive_JJ support_NN for_IN the_DT frequentist_JJ null_JJ results_NNS ._. 
98_CD -RRB-_-RRB- for_IN county-years_NNS with_IN greater_JJR than_IN 100_CD tonnes_NNS of_IN HAP_NNP releases_NNS ._. 
95_CD ,_, 3_CD ._. 
87_CD -LRB-_-LRB- 0_CD ._. 
The_DT SMR_NNP for_IN hepatic_JJ tumors_NNS was_VBD 1_CD ._. 
Studies_NNS evaluating_VBG air_NN pollution_NN as_IN a_DT cause_NN of_IN childhood_NN cancer_NN have_VBP been_VBN inconsistent_JJ among_IN a_DT variety_NN of_IN cancer_NN types_NNS 
Studies_NNS evaluating_VBG air_NN pollution_NN as_IN a_DT cause_NN of_IN childhood_NN cancer_NN have_VBP been_VBN inconsistent_JJ among_IN a_DT variety_NN of_IN cancer_NN types_NNS 
The_DT current_JJ study_NN supports_VBZ further_JJ studies_NNS on_IN germ_JJ cell_NN tumors_NNS and_CC other_JJ gliomas_NNS in_IN areas_NNS with_IN intensive_JJ cropping_VBG ._. 
Several_JJ studies_NNS have_VBP linked_VBN georeferenced_JJ disease_NN counts_NNS and_CC cropping_VBG patterns_NNS as_IN a_DT surrogate_NN for_IN pesticide_NN exposure_NN ._. 
These_DT studies_NNS varied_VBD widely_RB on_IN how_WRB cropping_VBG patterns_NNS were_VBD defined_VBN as_IN exposure_NN and_CC how_WRB the_DT childhood_NN cancers_NNS ,_, as_IN a_DT group_NN of_IN outcomes_NNS ,_, were_VBD pooled_VBN or_CC parsed_VBN ._. 
All_DT non-zero_JJ correlations_NNS contribute_VBP to_TO increased_VBN precision_NN ._. 
In_IN the_DT posterior_NN distribution_NN ,_, correlations_NNS among_IN histotype_JJ pairs_NNS were_VBD small_JJ but_CC ranged_VBD from_IN moderately_RB negative_JJ to_TO moderately_RB positive_JJ correlations_NNS ._. 
The_DT correlations_NNS were_VBD estimated_VBN fully_RB conditionally_RB on_IN the_DT geographic_JJ factors_NNS and_CC were_VBD much_RB smaller_JJR than_IN in_IN a_DT previous_JJ study_NN that_WDT did_VBD not_RB identify_VB attributes_NNS of_IN specific_JJ locations_NNS ._. 
As_IN cancer_NN risk_NN modeling_NN proceeds_NNS with_IN geographic_JJ risk_NN factors_NNS more_RBR precisely_RB defined_VBN ,_, the_DT correlation_NN among_IN histotypes_NNS will_MD eventually_RB become_VB attributable_JJ to_TO specific_JJ geographic_JJ factors_NNS ._. 
More_RBR specific_JJ causal_JJ studies_NNS should_MD involve_VB geographic_JJ risk_NN modeling_NN with_IN a_DT more_RBR precise_JJ geographic_JJ scale_NN ._. 
The_DT current_JJ study_NN had_VBD available_JJ geocoordinates_NNS for_IN individual_JJ births_NNS so_IN it_PRP was_VBD theoretically_RB possible_JJ to_TO plot_VB a_DT continuous_JJ risk_NN surface_NN with_IN a_DT Bayesian_JJ geo-statistical_JJ approach_NN 
More_RBR specific_JJ causal_JJ studies_NNS should_MD involve_VB geographic_JJ risk_NN modeling_NN with_IN a_DT more_RBR precise_JJ geographic_JJ scale_NN ._. 
The_DT current_JJ study_NN had_VBD available_JJ geocoordinates_NNS for_IN individual_JJ births_NNS so_IN it_PRP was_VBD theoretically_RB possible_JJ to_TO plot_VB a_DT continuous_JJ risk_NN surface_NN with_IN a_DT Bayesian_JJ geo-statistical_JJ approach_NN 
The_DT precision_NN for_IN geographic_JJ risk_NN estimates_NNS has_VBZ been_VBN especially_RB problematic_JJ in_IN the_DT study_NN of_IN childhood_NN cancer_NN ._. 
It_PRP has_VBZ been_VBN proposed_VBN that_IN broader_JJR geographic_JJ regions_NNS could_MD increase_VB the_DT precision_NN of_IN areal_JJ risk_NN estimates_NNS for_IN rare_JJ diseases_NNS ._. 
However_RB ,_, aggregating_VBG of_IN areal_JJ units_NNS will_MD reduce_VB the_DT resolution_NN of_IN the_DT GIS_NNP risk_NN layer_NN and_CC will_MD alter_VB the_DT relationship_NN with_IN a_DT GIS_NNP exposure_NN layer_NN ._. 
Acute_JJ lymphocytic_JJ leukemia_NN has_VBZ a_DT peak_NN in_IN infancy_NN that_WDT is_VBZ prominent_JJ among_IN white_JJ children_NNS but_CC less_RBR evident_JJ among_IN black_JJ children_NNS ._. 
There_EX are_VBP also_RB histotypes_NNS with_IN peaks_NNS in_IN infancy_NN and_CC another_DT peak_NN later_RB in_IN childhood_NN ,_, including_VBG ``_`` other_JJ ''_'' leukemias_NNS and_CC germ_JJ cell_NN tumors_NNS ,_, trophoblastic_JJ tumors_NNS and_CC neoplasms_NNS of_IN gonads_NNS ._. 
Cancers_NNS with_IN known_JJ incidence_NN peaks_NNS in_IN infancy_NN showed_VBD temporal_JJ trends_NNS with_IN relatively_RB slow_JJ decrease_NN in_IN incidence_NN for_IN birth_NN years_NNS 1990_CD to_TO 2002_CD ._. 
Cancers_NNS with_IN known_JJ incidence_NN peaks_NNS in_IN infancy_NN showed_VBD temporal_JJ trends_NNS with_IN relatively_RB slow_JJ decrease_NN in_IN incidence_NN for_IN birth_NN years_NNS 1990_CD to_TO 2002_CD ._. 
In_IN contrast_NN ,_, the_DT observed_JJ risk_NN for_IN cancers_NNS with_IN incidence_NN peaks_NNS in_IN teenage_JJ years_NNS ,_, Hodgkin_NNP lymphoma_NN and_CC malignant_JJ bone_NN tumors_NNS 
Hodgkin_NNP lymphoma_NN is_VBZ thought_VBN to_TO be_VB partly_RB attributable_JJ to_TO Epstein-Barr_NNP virus_NN but_CC also_RB has_VBZ genetic_JJ and_CC environmental_JJ factors_NNS 
43_CD 
Thus_RB ,_, the_DT risk_NN estimate_NN would_MD apply_VB to_TO an_DT individual_NN considering_VBG alternative_JJ living_NN locations_NNS ._. 
One_CD of_IN the_DT potential_JJ advantages_NNS for_IN performing_VBG the_DT risk_NN estimation_NN in_IN a_DT Bayesian_JJ approach_NN is_VBZ that_IN the_DT inference_NN is_VBZ based_VBN on_IN parameter_NN or_CC risk_NN certainty_NN and_CC the_DT risk_NN can_MD apply_VB to_TO the_DT lower_JJR organizational_JJ unit_NN ,_, such_JJ as_IN individuals_NNS ,_, in_IN a_DT hierarchal_JJ Bayes_NNP approach_NN 
Pesticide_NN exposure_NN has_VBZ long_RB been_VBN implicated_VBN as_IN a_DT cause_NN of_IN childhood_NN cancer_NN and_CC has_VBZ been_VBN the_DT focus_NN of_IN multiple_JJ studies_NNS ,_, however_RB ,_, an_DT unambiguous_JJ mechanistic_JJ cause-and-effect_NN relationship_NN has_VBZ not_RB been_VBN demonstrated_VBN 
Some_DT studies_NNS whose_WP$ objectives_NNS were_VBD to_TO evaluate_VB pesticide_NN exposure_NN used_VBD cropping_VBG intensity_NN as_IN an_DT exposure_NN surrogate_NN and_CC implicated_VBN farm_NN or_CC rural_JJ living_NN as_IN a_DT positive_JJ risk_NN factor_NN 
The_DT current_JJ study_NN supports_VBZ further_JJ studies_NNS on_IN germ_JJ cell_NN tumors_NNS and_CC other_JJ gliomas_NNS in_IN areas_NNS with_IN intensive_JJ cropping_VBG ._. 
Several_JJ studies_NNS have_VBP linked_VBN georeferenced_JJ disease_NN counts_NNS and_CC cropping_VBG patterns_NNS as_IN a_DT surrogate_NN for_IN pesticide_NN exposure_NN ._. 
These_DT studies_NNS varied_VBD widely_RB on_IN how_WRB cropping_VBG patterns_NNS were_VBD defined_VBN as_IN exposure_NN and_CC how_WRB the_DT childhood_NN cancers_NNS ,_, as_IN a_DT group_NN of_IN outcomes_NNS ,_, were_VBD pooled_VBN or_CC parsed_VBN ._. 
It_PRP would_MD be_VB helpful_JJ to_TO optimize_VB future_JJ studies_NNS to_TO incorporate_VB knowledge_NN of_IN high-risk_JJ locations_NNS or_CC geographic_JJ risk_NN patterns_NNS ._. 
Bayesian_JJ methods_NNS have_VBP begun_VBN to_TO predominate_VB disease_NN mapping_NN applications_NNS 
This_DT emergence_NN has_VBZ been_VBN largely_RB attributed_VBN to_TO advances_NNS in_IN computer_NN hardware_NN that_WDT have_VBP enabled_VBN Markov_NNP Chain_NNP Monte_NNP Carlo_NNP implementations_NNS of_IN relatively_RB complex_JJ Bayesian_JJ models_NNS 
Bayesian_JJ methods_NNS have_VBP begun_VBN to_TO predominate_VB disease_NN mapping_NN applications_NNS 
Bayesian_JJ methods_NNS have_VBP begun_VBN to_TO predominate_VB disease_NN mapping_NN applications_NNS 
The_DT MCMC_NNP implementation_NN was_VBD performed_VBN by_IN use_NN of_IN WinBUGS_NNP version_NN 1_CD ._. 
All_DT modeling_NN All_DT models_NNS employed_VBD Bayesian_JJ inference_NN ,_, with_IN vague_JJ or_CC flexible_JJ prior_JJ beliefs_NNS and_CC an_DT MCMC_NNP implementation_NN ._. 
43_CD 
found_VBD that_IN the_DT mothers_NNS of_IN cases_NNS had_VBD higher_JJR levels_NNS of_IN free_JJ and_CC albumin-bound_JJ estradiol_NN during_IN pregnancy_NN as_IN compared_VBN with_IN controls_NNS ,_, but_CC there_EX was_VBD no_DT difference_NN in_IN total_JJ estradiol_NN concentration_NN 
Asimilar_JJ study_NN found_VBD higher_JJR levels_NNS of_IN total_JJ estradiol_NN in_IN the_DT mothers_NNS of_IN cases_NNS overall_JJ but_CC did_VBD not_RB find_VB a_DT difference_NN for_IN levels_NNS during_IN the_DT first_JJ trimester_NN of_IN pregnancy_NN 
It_PRP has_VBZ been_VBN hypothesized_VBN that_IN exogenous_JJ female_JJ sex_NN hormones_NNS ,_, acting_VBG transplacentally_RB ,_, might_MD interfere_VB with_IN the_DT action_NN of_IN mullerian_JJ inhibiting_NN factor_NN 
In_IN a_DT case-control_JJ study_NN of_IN boys_NNS with_IN cryptorchidism_NN ,_, Bernstein_NNP et_NNP al._NNP ._. 
The_DT second_JJ stage_NN ,_, inguinal-scrotal_JJ descent_NN ,_, is_VBZ induced_VBN by_IN androgens_NNS and_CC usually_RB occurs_VBZ during_IN weeks_NNS 26-35_CD ._. 
found_VBD that_IN the_DT mothers_NNS of_IN cases_NNS had_VBD higher_JJR levels_NNS of_IN free_JJ and_CC albumin-bound_JJ estradiol_NN during_IN pregnancy_NN as_IN compared_VBN with_IN controls_NNS ,_, but_CC there_EX was_VBD no_DT difference_NN in_IN total_JJ estradiol_NN concentration_NN 
Because_IN nearly_RB all_DT women_NNS who_WP receive_VBP a_DT cumulative_JJ dose_NN of_IN 5_CD grams_NNS or_CC greater_JJR had_VBD begun_VBN taking_VBG DES_NNP before_IN the_DT 11_CD th_JJ week_NN of_IN gestation_NN ,_, it_PRP was_VBD not_RB possible_JJ to_TO determine_VB definitively_RB which_WDT of_IN these_DT factors_NNS was_VBD more_RBR important_JJ ._. 
Studies_NNS of_IN rats_NNS 
The_DT occurrence_NN of_IN epididymal_JJ cysts_NNS may_MD be_VB due_JJ to_TO the_DT persistence_NN of_IN mullerian_JJ remnants_NNS ._. 
Studies_NNS of_IN rats_NNS 
They_PRP were_VBD also_RB asked_VBN if_IN they_PRP had_VBD ever_RB been_VBN diagnosed_VBN with_IN infection_NN or_CC inflammation_NN of_IN the_DT prostate_NN ,_, urethra_NN ,_, testicle_NN ,_, or_CC epididymal_JJ tube_NN ._. 
Data_NNP analysisWe_NNP used_VBD Cox_NNP regression_NN with_IN constant_JJ time_NN at_IN risk_NN to_TO estimate_VB risk_NN ratios_NNS -LRB-_-LRB- RRs_NNP -RRB-_-RRB- and_CC 95_CD percent_NN confidence_NN -LRB-_-LRB- CI_NNP -RRB-_-RRB- intervals_NNS for_IN the_DT association_NN of_IN DES_NNP exposure_NN with_IN urogenital_JJ outcomes_NNS ._. 
All_DT analyses_NNS were_VBD adjusted_VBN for_IN year_NN of_IN birth_NN and_CC cohort_NN ._. 
SAS_NNP statistical_JJ software_NN -LRB-_-LRB- version_NN 9_CD ._. 
1-RRB-_NNP was_VBD used_VBN for_IN all_DT analyses_NNS ._. 
Because_IN nearly_RB all_DT women_NNS who_WP receive_VBP a_DT cumulative_JJ dose_NN of_IN 5_CD grams_NNS or_CC greater_JJR had_VBD begun_VBN taking_VBG DES_NNP before_IN the_DT 11_CD th_JJ week_NN of_IN gestation_NN ,_, it_PRP was_VBD not_RB possible_JJ to_TO determine_VB definitively_RB which_WDT of_IN these_DT factors_NNS was_VBD more_RBR important_JJ ._. 
Studies_NNS of_IN rats_NNS 
Interestingly_RB ,_, timing_NN of_IN in_IN utero_NN exposure_NN to_TO DES_NNP has_VBZ also_RB been_VBN shown_VBN to_TO be_VB a_DT predictive_JJ factor_NN for_IN structural_JJ anomalies_NNS of_IN the_DT lower_JJR genital_JJ tract_NN in_IN exposed_JJ daughters_NNS ._. 
In_IN a_DT study_NN of_IN structural_JJ anomalies_NNS of_IN the_DT cervix_NN and_CC vagina_NN in_IN DES-exposed_JJ daughters_NNS ,_, investigators_NNS found_VBD a_DT higher_JJR prevalence_NN of_IN anomalies_NNS -LRB-_-LRB- 44_CD percent_NN -RRB-_-RRB- in_IN women_NNS who_WP were_VBD prenatally_RB exposed_VBN to_TO DES_NNP before_IN the_DT 15th_JJ week_NN of_IN gestation_NN ,_, compared_VBN to_TO prevalences_NNS of_IN 22_CD percent_NN for_IN weeks_NNS 15-22_CD and_CC 5_CD percent_NN for_IN weeks_NNS 23_CD and_CC greater_JJR ._. 
The_DT chief_JJ limitation_NN of_IN our_PRP$ study_NN is_VBZ reliance_NN on_IN self-reports_NNS for_IN all_DT outcomes_NNS ._. 
It_PRP is_VBZ certainly_RB possible_JJ that_IN urogenital_JJ abnormalities_NNS may_MD be_VB more_RBR likely_JJ to_TO come_VB to_TO diagnosis_NN among_IN DES-exposed_JJ men_NNS ,_, and_CC that_IN DES-exposed_JJ men_NNS may_MD be_VB more_RBR likely_JJ than_IN unexposed_JJ men_NNS to_TO remember_VB and_CC report_VB such_JJ abnormalities_NNS or_CC inflammation_NN ._. 
Conclusion_NN The_DT present_JJ results_NNS indicate_VBP that_IN DES_NNP exposed_JJ sons_NNS have_VBP a_DT higher_JJR occurrence_NN of_IN cryptorchidism_NN and_CC epididymal_JJ cysts_NNS than_IN unexposed_JJ sons_NNS ,_, and_CC that_IN the_DT increased_VBN risk_NN is_VBZ related_VBN to_TO timing_NN and_CC dose_NN ._. 
Fortunately_RB ,_, it_PRP has_VBZ already_RB been_VBN shown_VBN that_IN prenatal_JJ DES_NNP exposure_NN in_IN men_NNS does_VBZ not_RB materially_RB affect_VB fertility_NN ,_, even_RB in_IN men_NNS with_IN urogenital_JJ anomalies_NNS ._. 
From_IN a_DT public_JJ health_NN viewpoint_NN ,_, the_DT importance_NN of_IN these_DT findings_NNS lies_VBZ in_IN their_PRP$ applicability_NN to_TO the_DT question_NN of_IN whether_IN environmental_JJ factors_NNS acting_VBG as_IN endocrine_NN disruptors_NNS may_MD have_VB a_DT detrimental_JJ effect_NN on_IN the_DT male_JJ reproductive_JJ system_NN ._. 
Under_IN this_DT hypothesis_NN ,_, the_DT increased_VBN prevalence_NN of_IN cryptorchidism_NN and_CC related_JJ conditions_NNS may_MD be_VB related_VBN to_TO increased_VBN estrogen_NN exposure_NN in_IN utero_NN ._. 
In_IN animal_NN studies_NNS ,_, exogenous_JJ estrogens_NNS have_VBP been_VBN shown_VBN to_TO cause_VB disorders_NNS of_IN genital_JJ development_NN ._. 
Our_PRP$ confirmation_NN of_IN an_DT increased_VBN risk_NN of_IN these_DT conditions_NNS in_IN men_NNS prenatally_RB exposed_VBN to_TO high_JJ doses_NNS of_IN DES_NNP lends_VBZ credence_NN to_TO this_DT hypothesis_NN ._. 
From_IN a_DT public_JJ health_NN viewpoint_NN ,_, the_DT importance_NN of_IN these_DT findings_NNS lies_VBZ in_IN their_PRP$ applicability_NN to_TO the_DT question_NN of_IN whether_IN environmental_JJ factors_NNS acting_VBG as_IN endocrine_NN disruptors_NNS may_MD have_VB a_DT detrimental_JJ effect_NN on_IN the_DT male_JJ reproductive_JJ system_NN ._. 
The_DT prevalence_NN of_IN cryptorchidism_NN appears_VBZ to_TO have_VB increased_VBN in_IN recent_JJ years_NNS and_CC it_PRP has_VBZ been_VBN hypothesized_VBN that_IN it_PRP is_VBZ caused_VBN by_IN a_DT combination_NN of_IN genetic_JJ and_CC environmental_JJ factors_NNS ,_, including_VBG endocrine_NN disrupting_VBG chemicals_NNS ._. 
Under_IN this_DT hypothesis_NN ,_, the_DT increased_VBN prevalence_NN of_IN cryptorchidism_NN and_CC related_JJ conditions_NNS may_MD be_VB related_VBN to_TO increased_VBN estrogen_NN exposure_NN in_IN utero_NN ._. 
From_IN a_DT public_JJ health_NN viewpoint_NN ,_, the_DT importance_NN of_IN these_DT findings_NNS lies_VBZ in_IN their_PRP$ applicability_NN to_TO the_DT question_NN of_IN whether_IN environmental_JJ factors_NNS acting_VBG as_IN endocrine_NN disruptors_NNS may_MD have_VB a_DT detrimental_JJ effect_NN on_IN the_DT male_JJ reproductive_JJ system_NN ._. 
The_DT prevalence_NN of_IN cryptorchidism_NN appears_VBZ to_TO have_VB increased_VBN in_IN recent_JJ years_NNS and_CC it_PRP has_VBZ been_VBN hypothesized_VBN that_IN it_PRP is_VBZ caused_VBN by_IN a_DT combination_NN of_IN genetic_JJ and_CC environmental_JJ factors_NNS ,_, including_VBG endocrine_NN disrupting_VBG chemicals_NNS ._. 
Under_IN this_DT hypothesis_NN ,_, the_DT increased_VBN prevalence_NN of_IN cryptorchidism_NN and_CC related_JJ conditions_NNS may_MD be_VB related_VBN to_TO increased_VBN estrogen_NN exposure_NN in_IN utero_NN ._. 
Conclusion_NN The_DT present_JJ results_NNS indicate_VBP that_IN DES_NNP exposed_JJ sons_NNS have_VBP a_DT higher_JJR occurrence_NN of_IN cryptorchidism_NN and_CC epididymal_JJ cysts_NNS than_IN unexposed_JJ sons_NNS ,_, and_CC that_IN the_DT increased_VBN risk_NN is_VBZ related_VBN to_TO timing_NN and_CC dose_NN ._. 
Fortunately_RB ,_, it_PRP has_VBZ already_RB been_VBN shown_VBN that_IN prenatal_JJ DES_NNP exposure_NN in_IN men_NNS does_VBZ not_RB materially_RB affect_VB fertility_NN ,_, even_RB in_IN men_NNS with_IN urogenital_JJ anomalies_NNS ._. 
From_IN a_DT public_JJ health_NN viewpoint_NN ,_, the_DT importance_NN of_IN these_DT findings_NNS lies_VBZ in_IN their_PRP$ applicability_NN to_TO the_DT question_NN of_IN whether_IN environmental_JJ factors_NNS acting_VBG as_IN endocrine_NN disruptors_NNS may_MD have_VB a_DT detrimental_JJ effect_NN on_IN the_DT male_JJ reproductive_JJ system_NN ._. 
DES_NNP is_VBZ a_DT more_RBR potent_JJ estrogen_NN than_IN estradiol_NN and_CC may_MD have_VB other_JJ chemical_JJ effects_NNS as_RB well_RB ._. 
Athird_NNP study_NN also_RB found_VBD no_DT differences_NNS between_IN cases_NNS and_CC controls_NNS in_IN mother_NN 's_POS total_JJ estradiol_NN in_IN the_DT first_JJ trimester_NN of_IN pregnancy_NN 
Whether_IN there_EX are_VBP similar_JJ effects_NNS in_IN the_DT exposed_JJ sons_NNS is_VBZ still_RB unclear_JJ and_CC only_RB a_DT few_JJ studies_NNS have_VBP appreciable_JJ numbers_NNS ._. 
Two_CD studies_NNS found_VBD a_DT higher_JJR prevalence_NN of_IN genital_JJ tract_NN abnormalities_NNS among_IN exposed_JJ men_NNS 
An_DT examination_NN study_NN of_IN 308_CD DES-exposed_JJ and_CC 307_CD unexposed_JJ sons_NNS of_IN women_NNS who_WP participated_VBD in_IN the_DT University_NNP of_IN Chicago_NNP randomized_VBN trial_NN indicated_VBD a_DT higher_JJR prevalence_NN of_IN epididymal_JJ cysts_NNS and_CC of_IN hypoplastic_JJ testes_NNS in_IN exposed_JJ relative_JJ to_TO unexposed_JJ men_NNS 
Conclusion_NN The_DT present_JJ results_NNS indicate_VBP that_IN DES_NNP exposed_JJ sons_NNS have_VBP a_DT higher_JJR occurrence_NN of_IN cryptorchidism_NN and_CC epididymal_JJ cysts_NNS than_IN unexposed_JJ sons_NNS ,_, and_CC that_IN the_DT increased_VBN risk_NN is_VBZ related_VBN to_TO timing_NN and_CC dose_NN ._. 
Fortunately_RB ,_, it_PRP has_VBZ already_RB been_VBN shown_VBN that_IN prenatal_JJ DES_NNP exposure_NN in_IN men_NNS does_VBZ not_RB materially_RB affect_VB fertility_NN ,_, even_RB in_IN men_NNS with_IN urogenital_JJ anomalies_NNS 
Two_CD studies_NNS found_VBD a_DT higher_JJR prevalence_NN of_IN genital_JJ tract_NN abnormalities_NNS among_IN exposed_JJ men_NNS 
8\*_CD Risk_NNP ratios_NNS adjusted_VBN for_IN year_NN of_IN birth_NN and_CC cohort_NN ._. 
7-5_CD ._. 
21_CD ._. 
8_CD 
This_DT study_NN found_VBD the_DT observed_JJ associations_NNS to_TO be_VB stronger_JJR among_IN men_NNS whose_WP$ mothers_NNS DES_NNP treatment_NN had_VBD started_VBN less_JJR than_IN 11_CD weeks_NNS after_IN their_PRP$ last_JJ menstrual_JJ period_NN as_IN compared_VBN with_IN men_NNS whose_WP$ mothers_NNS had_VBD begun_VBN taking_VBG DES_NNP later_RB in_IN the_DT pregnancy_NN ._. 
Subsequent_JJ to_TO the_DT examination_NN study_NN from_IN the_DT Chicago_NNP cohort_NN ,_, a_DT separate_JJ examination_NN study_NN was_VBD carried_VBN out_RP in_IN 265_CD exposed_JJ and_CC 274_CD unexposed_JJ men_NNS who_WP had_VBD been_VBN delivered_VBN at_IN the_DT Mayo_NNP Clinic_NNP between_IN 1939_CD and_CC 1962_CD ._. 
Contrary_JJ to_TO findings_NNS from_IN the_DT University_NNP of_IN Chicago_NNP study_NN ,_, the_DT Mayo_NNP Clinic_NNP study_NN reported_VBD no_DT association_NN between_IN prenatal_JJ DES_NNP exposure_NN and_CC epididymal_JJ cyst_NN or_CC anomalies_NNS of_IN the_DT testes_NNS -LRB-_-LRB- including_VBG cryptorchidism_NN -RRB-_-RRB- 
Subsequent_JJ to_TO the_DT examination_NN study_NN from_IN the_DT Chicago_NNP cohort_NN ,_, a_DT separate_JJ examination_NN study_NN was_VBD carried_VBN out_RP in_IN 265_CD exposed_JJ and_CC 274_CD unexposed_JJ men_NNS who_WP had_VBD been_VBN delivered_VBN at_IN the_DT Mayo_NNP Clinic_NNP between_IN 1939_CD and_CC 1962_CD ._. 
Contrary_JJ to_TO findings_NNS from_IN the_DT University_NNP of_IN Chicago_NNP study_NN ,_, the_DT Mayo_NNP Clinic_NNP study_NN reported_VBD no_DT association_NN between_IN prenatal_JJ DES_NNP exposure_NN and_CC epididymal_JJ cyst_NN or_CC anomalies_NNS of_IN the_DT testes_NNS -LRB-_-LRB- including_VBG cryptorchidism_NN -RRB-_-RRB- 
The_DT weaker_JJR association_NN observed_VBN in_IN the_DT Mayo_NNP Clinic_NNP cohort_NN in_IN the_DT present_JJ study_NN and_CC the_DT conflicting_JJ results_NNS from_IN earlier_JJR studies_NNS can_MD be_VB explained_VBN by_IN differences_NNS in_IN timing_NN and_CC cumulative_JJ dose_NN of_IN DES_NNP ._. 
Women_NNS treated_VBN at_IN the_DT Mayo_NNP Clinic_NNP typically_RB took_VBD DES_NNP for_IN a_DT few_JJ weeks_NNS to_TO a_DT few_JJ months_NNS and_CC their_PRP$ median_JJ cumulative_JJ dose_NN was_VBD 720_CD mg_NN 
One_CD comprised_VBD the_DT sons_NNS of_IN women_NNS who_WP participated_VBD in_IN a_DT randomized_JJ trial_NN of_IN DES_NNP at_IN the_DT University_NNP of_IN Chicago_NNP in_IN the_DT early_JJ 1950s_CD ._. 
In_IN the_DT 1970s_NNS ,_, the_DT current_JJ addresses_NNS of_IN these_DT young_JJ men_NNS were_VBD determined_VBN ,_, after_IN which_WDT they_PRP were_VBD followed_VBN periodically_RB with_IN examinations_NNS and_CC questionnaires_NNS ._. 
Asecond_JJ group_NN included_VBD the_DT sons_NNS of_IN women_NNS who_WP had_VBD been_VBN treated_VBN in_IN a_DT private_JJ infertility_NN practice_NN near_IN Boston_NNP between_IN 1943_CD and_CC 1975_CD ;_: they_PRP have_VBP been_VBN followed_VBN by_IN questionnaire_NN since_IN 1975_CD ._. 
Women_NNS treated_VBN at_IN the_DT Mayo_NNP Clinic_NNP typically_RB took_VBD DES_NNP for_IN a_DT few_JJ weeks_NNS to_TO a_DT few_JJ months_NNS and_CC their_PRP$ median_JJ cumulative_JJ dose_NN was_VBD 720_CD mg_NN 
The_DT findings_NNS support_VBP the_DT hypothesis_NNS that_WDT endocrine_VBP disrupting_VBG chemicals_NNS may_MD be_VB a_DT cause_NN of_IN the_DT increased_VBN prevalence_NN of_IN cryptorchidism_NN that_WDT has_VBZ been_VBN seen_VBN in_IN recent_JJ years_NNS ._. 
BackgroundDiethylstilbestrol_NNP -LRB-_-LRB- DES_NNP -RRB-_-RRB- ,_, a_DT synthetic_JJ estrogen_NN that_WDT was_VBD widely_RB prescribed_VBN to_TO pregnant_JJ women_NNS during_IN the_DT 1940s_CD to_TO 1970s_CD ,_, has_VBZ been_VBN associated_VBN with_IN an_DT increased_VBN prevalence_NN of_IN abnormalities_NNS of_IN the_DT reproductive_JJ tract_NN in_IN women_NNS who_WP were_VBD exposed_VBN in_IN utero_NN ._. 
Whether_IN there_EX are_VBP similar_JJ effects_NNS in_IN the_DT exposed_JJ sons_NNS is_VBZ still_RB unclear_JJ and_CC only_RB a_DT few_JJ studies_NNS have_VBP appreciable_JJ numbers_NNS ._. 
Whether_IN there_EX are_VBP similar_JJ effects_NNS in_IN the_DT exposed_JJ sons_NNS is_VBZ still_RB unclear_JJ and_CC only_RB a_DT few_JJ studies_NNS have_VBP appreciable_JJ numbers_NNS ._. 
Two_CD studies_NNS found_VBD a_DT higher_JJR prevalence_NN of_IN genital_JJ tract_NN abnormalities_NNS among_IN exposed_JJ men_NNS 
Asecond_JJ group_NN included_VBD the_DT sons_NNS of_IN women_NNS who_WP had_VBD been_VBN treated_VBN in_IN a_DT private_JJ infertility_NN practice_NN near_IN Boston_NNP between_IN 1943_CD and_CC 1975_CD ;_: they_PRP have_VBP been_VBN followed_VBN by_IN questionnaire_NN since_IN 1975_CD ._. 
The_DT third_JJ group_NN included_VBD men_NNS whose_WP$ mothers_NNS were_VBD identified_VBN as_IN DES-exposed_JJ or_CC unexposed_JJ by_IN systematic_JJ review_NN of_IN prenatal_JJ records_NNS at_IN the_DT Mayo_NNP Clinic_NNP for_IN the_DT period_NN from_IN 1939_CD to_TO 1962_CD ;_: questionnaire_NN follow-up_JJ of_IN this_DT group_NN began_VBD in_IN 1982_CD ._. 
The_DT study_NN protocol_NN for_IN the_DT present_JJ collaborative_JJ study_NN has_VBZ been_VBN approved_VBN by_IN institutional_JJ review_NN boards_NNS of_IN all_DT participating_VBG institutions_NNS and_CC the_DT National_NNP Cancer_NNP Institute_NNP ._. 
Aprevious_JJ investigation_NN of_IN participants_NNS in_IN the_DT Mayo_NNP Clinic_NNP study_NN reported_VBD null_JJ findings_NNS regarding_VBG a_DT possible_JJ association_NN of_IN prenatal_JJ DES_NNP exposure_NN with_IN risk_NN of_IN epididymal_JJ cyst_NN ,_, cryptorchidism_NN ,_, or_CC other_JJ urogenital_JJ abnormalities_NNS 
Timing_NN of_IN first_JJ exposure_NN to_TO DES_NNP was_VBD available_JJ for_IN 90_CD percent_NN of_IN exposed_JJ men_NNS ._. 
Five_CD grams_NNS was_VBD used_VBN as_IN a_DT cutpoint_NN for_IN ``_`` high_JJ ''_'' versus_CC ``_`` low_JJ ''_'' dose_NN because_IN the_DT distribution_NN of_IN cumulative_JJ dose_NN was_VBD bimodal_JJ ,_, with_IN peaks_NNS at_IN around_IN 2_CD and_CC 12_CD grams_NNS ._. 
Acut-point_NN of_IN 11_CD weeks_NNS gestational_JJ age_NN was_VBD used_VBN because_IN the_DT male_JJ genitalia_NNS are_VBP most_RBS susceptible_JJ to_TO teratogens_NNS in_IN this_DT early_JJ period_NN -LRB-_-LRB- the_DT first_JJ nine_CD weeks_NNS of_IN gestation_NN -RRB-_-RRB- ._. 
The_DT 1994_CD ,_, 1997_CD ,_, and_CC 2001_CD questionnaires_NNS included_VBD questions_NNS on_IN demographic_JJ and_CC lifestyle_NN factors_NNS ,_, reproductive_JJ history_NN ,_, and_CC medical_JJ history_NN ._. 
Fatalities_NNS due_JJ to_TO methylene_NN chloride_NN vapor_NN inhalation_NN in_IN furniture_NN stripping_VBG operations_NNS have_VBP been_VBN reported_VBN ._. 
OSHA_NNP 's_POS 1997_CD methylene_NN chloride_NN standard_NN is_VBZ strict_JJ and_CC comprehensive_JJ ;_: it_PRP lowered_VBD the_DT 8-hour_JJ time_NN weighted_JJ average_NN Permissible_NNP Exposure_NNP Limit_NNP for_IN the_DT chemical_NN from_IN 1736_CD mg\/m3_CD to_TO 87_CD mg\/m3_CD -LRB-_-LRB- 500_CD ppm_NN to_TO 25_CD ppm_NN -RRB-_-RRB- and_CC required_VBN exposure_NN monitoring_NN ,_, worker_NN training_NN ,_, engineering_NN controls_NNS ,_, designation_NN of_IN restricted_JJ areas_NNS ,_, spill_NN and_CC leak_NN prevention_NN and_CC medical_JJ surveillance_NN ._. 
OSHA_NNP demonstrated_VBD that_IN the_DT proposed_VBN standard_NN was_VBD technically_RB and_CC economically_RB feasible_JJ with_IN standard_JJ engineering_NN controls_NNS and_CC asserted_VBD that_IN companies_NNS could_MD comply_VB with_IN the_DT new_JJ standard_NN without_IN eliminating_VBG methylene_NN chloride_NN from_IN industrial_JJ operations_NNS ._. 
Afew_NNP substitutes_NNS for_IN methylene_NN chloride_NN are_VBP briefly_RB described_VBN in_IN the_DT compliance_NN guides_NNS that_WDT accompany_VBP the_DT standard_NN ,_, but_CC these_DT guides_NNS focus_VBP on_IN local_JJ exhaust_NN ventilation_NN and_CC work_NN practices_NNS as_IN the_DT best_JJS ways_NNS to_TO lower_JJR exposure_NN ._. 
Environmental_NNP Protection_NNP Agency_NNP ,_, and_CC the_DT International_NNP Agency_NNP for_IN Research_NNP on_IN Cancer_NNP ._. 
S._NNP Methylene_NNP chloride_NN has_VBZ been_VBN characterized_VBN as_IN a_DT potential_JJ occupational_JJ carcinogen_NN by_IN OSHA_NNP ,_, U._NNP Occupational_NNP exposure_NN to_TO methylene_NN chloride_NN can_MD occur_VB during_IN its_PRP$ production_NN and_CC use_NN as_IN a_DT paint_NN stripper_NN ,_, cleaner_NN ,_, degreaser_NN ,_, adhesive_NN thinner_JJR ,_, process_NN solvent_JJ and_CC as_IN an_DT aerosol_JJ carrier_NN ._. 
With_IN an_DT odor_NN threshold_NN of_IN around_IN 868_CD mg\/m_NN 3_CD -LRB-_-LRB- 250_CD parts_NNS per_IN million_CD or_CC ppm_NN -RRB-_-RRB- ,_, methylene_NN chloride_NN has_VBZ poor_JJ warning_NN properties_NNS and_CC ,_, due_JJ to_TO its_PRP$ volatility_NN ,_, concentrations_NNS may_MD rapidly_RB approach_VB high_JJ levels_NNS in_IN poorly_RB ventilated_VBN areas_NNS 
OSHA_NNP 's_POS Preamble_NN to_TO the_DT methylene_NN chloride_NN standard_NN noted_VBD that_IN engineering_NN controls_NNS ,_, such_JJ as_IN local_JJ exhaust_NN ventilation_NN were_VBD likely_JJ to_TO be_VB infeasible_JJ to_TO control_VB methylene_NN chloride_NN exposure_NN below_IN the_DT Permissible_NNP Exposure_NNP Limit_NNP in_IN vessel_NN cleaning_NN ._. 
The_DT Preamble_NN states_VBZ that_IN respiratory_JJ protection_NN equipment_NN has_VBZ been_VBN used_VBN in_IN the_DT past_NN in_IN vessel_NN cleaning_NN and_CC it_PRP expected_VBD that_IN it_PRP would_MD be_VB relied_VBN upon_IN under_IN this_DT standard_NN ._. 
Process_NN and_CC Source_NN Reduction_NN In_IN the_DT usual_JJ cleaning_NN process_NN ,_, workers_NNS first_RB used_VBD hot_JJ and_CC cold_JJ water_NN under_IN pressure_NN to_TO clean_VB the_DT outside_NN and_CC inside_NN of_IN the_DT tank_NN or_CC tote_VB ._. 
Occupational_JJ exposure_NN to_TO methylene_NN chloride_NN can_MD occur_VB during_IN its_PRP$ production_NN and_CC use_NN as_IN a_DT paint_NN stripper_NN ,_, cleaner_NN ,_, degreaser_NN ,_, adhesive_NN thinner_JJR ,_, process_NN solvent_JJ and_CC as_IN an_DT aerosol_JJ carrier_NN ._. 
With_IN an_DT odor_NN threshold_NN of_IN around_IN 868_CD mg\/m3_CD -LRB-_-LRB- 250_CD parts_NNS per_IN million_CD or_CC ppm_NN -RRB-_-RRB- ,_, methylene_NN chloride_NN has_VBZ poor_JJ warning_NN properties_NNS and_CC ,_, due_JJ to_TO its_PRP$ volatility_NN ,_, concentrations_NNS may_MD rapidly_RB approach_VB high_JJ levels_NNS in_IN poorly_RB ventilated_VBN areas_NNS 
Environmental_NNP Protection_NNP Agency_NNP ,_, and_CC the_DT International_NNP Agency_NNP for_IN Research_NNP on_IN Cancer_NNP ._. 
S._NNP Methylene_NNP chloride_NN has_VBZ been_VBN characterized_VBN as_IN a_DT potential_JJ occupational_JJ carcinogen_NN by_IN OSHA_NNP ,_, U._NNP Occupational_NNP exposure_NN to_TO methylene_NN chloride_NN can_MD occur_VB during_IN its_PRP$ production_NN and_CC use_NN as_IN a_DT paint_NN stripper_NN ,_, cleaner_NN ,_, degreaser_NN ,_, adhesive_NN thinner_JJR ,_, process_NN solvent_JJ and_CC as_IN an_DT aerosol_JJ carrier_NN ._. 
With_IN an_DT odor_NN threshold_NN of_IN around_IN 868_CD mg\/m_NN 3_CD -LRB-_-LRB- 250_CD parts_NNS per_IN million_CD or_CC ppm_NN -RRB-_-RRB- ,_, methylene_NN chloride_NN has_VBZ poor_JJ warning_NN properties_NNS and_CC ,_, due_JJ to_TO its_PRP$ volatility_NN ,_, concentrations_NNS may_MD rapidly_RB approach_VB high_JJ levels_NNS in_IN poorly_RB ventilated_VBN areas_NNS 
,increased_JJ ventilation_NN and_CC production_NN enclosure_NN -RRB-_-RRB- ,_, rather_RB than_IN on_IN new_JJ technology_NN ranging_VBG from_IN sophisticated_JJ emissions_NNS control_VBP devices_NNS to_TO technologies_NNS capable_JJ of_IN supporting_VBG basic_JJ shifts_NNS in_IN production_NN processes_NNS ,_, including_VBG process_NN redesigns_NNS ,_, product_NN reformulations_NNS ,_, and_CC material_NN substitution_NN ._. 
Evidence_NN for_IN the_DT report_NN 's_POS conclusions_NNS included_VBD industry_NN responses_NNS to_TO the_DT cotton_NN dust_NN standard_NN ,_, with_IN which_WDT industry_NN complied_VBN by_IN modernizing_VBG equipment_NN and_CC processes_NNS at_IN a_DT substantially_RB reduced_VBN cost_NN -LRB-_-LRB- compared_VBN to_TO those_DT projected_VBN for_IN traditional_JJ control_NN approaches_NNS -RRB-_-RRB- and_CC with_IN tremendous_JJ production_NN benefits_NNS ,_, and_CC the_DT formaldehyde_NN standard_NN ,_, where_WRB industry_NN complied_VBD not_RB by_IN utilizing_VBG the_DT OSHA-recommended_JJ ventilation_NN and_CC enclosure_NN strategy_NN but_CC with_IN a_DT source_NN reduction_NN strategy_NN -LRB-_-LRB- low-formaldehyde_JJ resins_NNS -RRB-_-RRB- that_WDT had_VBD been_VBN available_JJ at_IN the_DT time_NN of_IN the_DT rulemaking_NN ._. 
In_IN 1997_CD OSHA_NNP promulgated_VBD a_DT new_JJ comprehensive_JJ methylene_NN chloride_NN standard_NN ._. 
In_IN 1997_CD OSHA_NNP promulgated_VBD a_DT new_JJ comprehensive_JJ methylene_NN chloride_NN standard_NN ._. 
Evidence_NN for_IN the_DT report_NN 's_POS conclusions_NNS included_VBD industry_NN responses_NNS to_TO the_DT cotton_NN dust_NN standard_NN ,_, with_IN which_WDT industry_NN complied_VBN by_IN modernizing_VBG equipment_NN and_CC processes_NNS at_IN a_DT substantially_RB reduced_VBN cost_NN -LRB-_-LRB- compared_VBN to_TO those_DT projected_VBN for_IN traditional_JJ control_NN approaches_NNS -RRB-_-RRB- and_CC with_IN tremendous_JJ production_NN benefits_NNS ,_, and_CC the_DT formaldehyde_NN standard_NN ,_, where_WRB industry_NN complied_VBD not_RB by_IN utilizing_VBG the_DT OSHA-recommended_JJ ventilation_NN and_CC enclosure_NN strategy_NN but_CC with_IN a_DT source_NN reduction_NN strategy_NN -LRB-_-LRB- low-formaldehyde_JJ resins_NNS -RRB-_-RRB- that_WDT had_VBD been_VBN available_JJ at_IN the_DT time_NN of_IN the_DT rulemaking_NN ._. 
.._NN 
It_PRP is_VBZ not_RB OSHA_NNP 's_POS intention_NN to_TO force_VB industries_NNS to_TO abandon_VB methylene_NN chloride_NN ._. 
''_'' 
Additionally_RB ,_, the_DT investigators_NNS believe_VBP that_IN the_DT experience_NN of_IN these_DT companies_NNS largely_RB comports_VBZ with_IN the_DT experience_NN of_IN other_JJ companies_NNS in_IN Massachusetts_NNP who_WP had_VBD used_VBN methylene_NN chloride_NN based_VBN upon_IN an_DT investigation_NN of_IN more_JJR than_IN twenty_CD such_JJ companies_NNS ._. 
ConclusionsThese_NN cases_NNS suggest_VBP that_IN source_NN reduction_NN strategies_NNS can_MD be_VB a_DT feasible_JJ and_CC effective_JJ approach_NN to_TO compliance_NN with_IN workplace_NN and_CC environmental_JJ standards_NNS and_CC reduction_NN of_IN worker_NN health_NN hazards_NNS ._. 
In_IN its_PRP$ methylene_NN chloride_NN standard_NN ,_, OSHA_NNP had_VBD concluded_VBN that_IN engineering_NN controls_NNS were_VBD not_RB feasible_JJ for_IN vessel_NN cleaning_NN and_CC this_DT industry_NN would_MD rely_VB on_IN supplied-air_JJ respirators_NNS for_IN exposure_NN control_NN ._. 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
-RRB-_-RRB- It_PRP is_VBZ an_DT eye_NN and_CC skin_NN irritant_NN ,_, has_VBZ a_DT noxious_JJ odor_NN and_CC it_PRP has_VBZ been_VBN found_VBN to_TO cause_VB fetal_JJ death_NN and_CC fetal_JJ abnormalities_NNS in_IN rat_NN studies_NNS ._. 
15_CD ,_, 1998_CD -RRB-_-RRB- ._. 
-LRB-_-LRB- See_NNP Table_NNP 1_CD -RRB-_-RRB- Indeed_RB ,_, it_PRP is_VBZ one_CD leading_VBG expert_NN 's_POS opinion_NN that_IN effective_JJ substitute_NN chemistries_NNS and_CC technologies_NNS exist_VBP for_IN virtually_RB every_DT current_JJ application_NN of_IN methylene_NN chloride_NN in_IN industry_NN -LRB-_-LRB- Personal_JJ communication_NN ,_, K_NNP Wolf_NNP :_: Oct._NNP ._. 
Table_NNP 1Source_NNP Reduction_NNP Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP ChlorideIndustrial_NNP ActivitySource_NNP Reduction_NNP StrategyPaint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
Air_NNP Force_NNP has_VBZ determined_VBN that_IN it_PRP is_VBZ not_RB a_DT potential_JJ substitute_NN for_IN methylene_NN chloride_NN because_IN of_IN both_DT potential_JJ worker_NN health_NN and_CC performance_NN concerns_NNS ._. -RRB-_-RRB- 
It_PRP is_VBZ an_DT eye_NN and_CC skin_NN irritant_NN ,_, has_VBZ a_DT noxious_JJ odor_NN and_CC it_PRP has_VBZ been_VBN found_VBN to_TO cause_VB fetal_JJ death_NN and_CC fetal_JJ abnormalities_NNS in_IN rat_NN studies_NNS ._. 
The_DT American_NNP Industrial_NNP Hygiene_NNP Association_NNP has_VBZ established_VBN a_DT Workplace_NNP Environmental_NNP Exposure_NNP Level_NNP of_IN 10_CD mg\/m_NN 3_CD ,_, 8-hour_CD ,_, TWA_NNP for_IN polyethylene_NN glycol_NN ._. 
The_DT very_RB low_JJ vapor_NN pressure_NN of_IN dibasic_JJ esters_NNS and_CC polyethylene_NN glycol_NN would_MD mitigate_VB against_IN inhalation_NN ._. 
The_DT costs_NNS of_IN hazardous_JJ waste_NN disposal_NN ,_, raw_JJ material_NN ,_, and_CC compliance_NN related_JJ activities_NNS ,_, were_VBD a_DT major_JJ motivation_NN for_IN the_DT elimination_NN of_IN methylene_NN chloride_NN ._. 
''_'' Additionally_RB ,_, case_NN studies_NNS are_VBP especially_RB useful_JJ when_WRB context_NN is_VBZ key_JJ to_TO understanding_VBG a_DT particular_JJ phenomenon_NN and_CC we_PRP deem_VBP it_PRP useful_JJ to_TO understand_VB that_DT phenomenon_NN 
In_IN Case_NNP Study_NNP Research_NNP :_: Design_NNP and_CC Methods_NNP ,_, Yin_NNP notes_VBZ that_IN case_NN studies_NNS ``_`` are_VBP the_DT preferred_JJ strategy_NN when_WRB `_`` how_WRB '_'' or_CC `_`` why_WRB '_'' questions_NNS are_VBP being_VBG posed_VBN ,_, when_WRB the_DT investigator_NN has_VBZ little_JJ control_NN over_IN events_NNS ,_, and_CC when_WRB the_DT focus_NN is_VBZ on_IN a_DT contemporary_JJ phenomenon_NN within_IN some_DT real-life_JJ context_NN ._. ''_'' 
Additionally_RB ,_, case_NN studies_NNS are_VBP especially_RB useful_JJ when_WRB context_NN is_VBZ key_JJ to_TO understanding_VBG a_DT particular_JJ phenomenon_NN and_CC we_PRP deem_VBP it_PRP useful_JJ to_TO understand_VB that_DT phenomenon_NN 
The_DT bulk_NN of_IN the_DT qualitative_JJ data_NN was_VBD collected_VBN in_IN in-depth_JJ interviews_NNS with_IN key_JJ informants_NNS where_WRB the_DT investigator_NN used_VBD a_DT semi-structured_JJ ,_, open-ended_JJ interview_NN guide_NN for_IN all_DT four_CD companies_NNS ._. 
These_DT interviews_NNS were_VBD designed_VBN to_TO capture_VB informants_NNS '_POS perspectives_NNS on_IN the_DT motivations_NNS ,_, processes_NNS ,_, and_CC impacts_NNS related_VBN to_TO their_PRP$ source_NN reduction_NN experience_NN ._. 
Each_DT interview_NN was_VBD followed_VBN by_IN a_DT guided_VBN tour_NN of_IN the_DT industrial_JJ process_NN that_WDT had_VBD used_VBN methylene_NN chloride_NN ._. 
The_DT selection_NN of_IN these_DT study_NN subjects_NNS was_VBD the_DT result_NN of_IN a_DT sampling_NN approach_NN that_WDT sought_VBD information-rich_JJ cases_NNS available_JJ for_IN in-depth_JJ study_NN in_IN four_CD diverse_JJ industrial_JJ settings_NNS ._. 
Four_CD companies_NNS ,_, large_JJ and_CC small_JJ ,_, in_IN four_CD different_JJ industrial_JJ sectors_NNS were_VBD enrolled_VBN as_IN cases_NNS ._. 
The_DT potential_JJ cases_NNS were_VBD initially_RB selected_VBN from_IN the_DT 37_CD companies_NNS that_WDT had_VBD reported_VBN their_PRP$ 1997_CD use_NN of_IN methylene_NN chloride_NN under_IN the_DT Massachusetts_NNP Toxics_NNP Use_NNP Reduction_NNP Act_NNP because_IN they_PRP used_VBD more_JJR than_IN 4545_CD kg_NN -LRB-_-LRB- 10000_CD lbs_NNS -RRB-_-RRB- of_IN the_DT chemical_NN in_IN that_DT year_NN ._. 
Data_NNP source_NN triangulation_NN ,_, or_CC the_DT use_NN of_IN multiple_JJ data_NNS sources_NNS to_TO provide_VB more_JJR than_IN one_CD perspective_NN on_IN the_DT phenomenon_NN under_IN investigation_NN ,_, was_VBD used_VBN to_TO enhance_VB the_DT depth_NN of_IN information_NN about_IN each_DT case_NN and_CC internal_JJ validity_NN ._. 
For_IN example_NN ,_, for_IN two_CD cases_NNS we_PRP were_VBD able_JJ to_TO access_VB the_DT documentation_NN provided_VBN to_TO the_DT Toxic_NNP Use_NNP Reduction_NNP Institute_NNP as_IN part_NN of_IN the_DT companies_NNS '_POS participation_NN in_IN the_DT Institute_NNP 's_POS Demonstration_NNP Site_NNP program_NN and_CC compare_VB the_DT reporting_NN of_IN process_NN and_CC motivational_JJ factors_NNS between_IN the_DT program_NN documentation_NN and_CC that_IN provided_VBN to_TO us_PRP in_IN interviews_NNS ._. 
The_DT bulk_NN of_IN the_DT qualitative_JJ data_NN was_VBD collected_VBN in_IN in-depth_JJ interviews_NNS with_IN key_JJ informants_NNS where_WRB the_DT investigator_NN used_VBD a_DT semi-structured_JJ ,_, open-ended_JJ interview_NN guide_NN for_IN all_DT four_CD companies_NNS ._. 
The_DT standard_NN for_IN vapor_NN degreasers_NNS specifically_RB recommends_VBZ against_IN local_JJ exhaust_NN ventilation_NN because_IN of_IN its_PRP$ potential_JJ role_NN in_IN generating_VBG emissions_NNS to_TO the_DT environment_NN ._. 
Thus_RB ,_, OSHA_NNP 's_POS primary_JJ recommendation_NN for_IN exposure_NN control_NN contradicted_VBD the_DT goals_NNS of_IN environmental_JJ protection_NN by_IN potentially_RB increasing_VBG emissions_NNS of_IN methylene_NN chloride_NN to_TO the_DT environment_NN ._. 
Additionally_RB ,_, for_IN many_JJ processes_NNS ,_, off-the-shelf_JJ technologies_NNS and_CC chemistries_NNS were_VBD available_JJ to_TO take_VB methylene_NN chloride_NN 's_POS place_NN ._. 
Clean_NNP Air_NNP Act_NNP ._. 
S._NNP Methylene_NNP chloride_NN is_VBZ regulated_VBN as_IN a_DT Hazardous_NNP Air_NNP Pollutant_NNP under_IN the_DT U._NNP 
Pollution_NNP Prevention_NNP Act_NNP of_IN 1990_CD and_CC the_DT 1989_CD Massachusetts_NNP Toxics_NNP Use_NNP Reduction_NNP Act_NNP have_VBP helped_VBN to_TO ``_`` mainstream_JJ ''_'' source_NN reduction_NN in_IN industrial_JJ production_NN practices_NNS in_IN the_DT United_NNP States_NNPS ._. 
Source_NN reduction_NN activities_NNS motivated_VBN by_IN environmental_JJ protection_NN goals_NNS have_VBP had_VBN a_DT significant_JJ impact_NN on_IN the_DT work_NN environment_NN ._. 
Many_JJ of_IN the_DT technological_JJ breakthroughs_NNS that_WDT have_VBP occurred_VBN in_IN chemistry_NN ,_, process_NN engineering_NN ,_, and_CC industrial_JJ equipment_NN in_IN response_NN to_TO demand_NN for_IN reducing_VBG the_DT environmental_JJ impact_NN of_IN production_NN have_VBP had_VBN the_DT added_VBN benefit_NN of_IN reducing_VBG workers_NNS '_POS hazardous_JJ chemical_NN exposure_NN ._. 
Many_JJ of_IN the_DT technological_JJ breakthroughs_NNS that_WDT have_VBP occurred_VBN in_IN chemistry_NN ,_, process_NN engineering_NN ,_, and_CC industrial_JJ equipment_NN in_IN response_NN to_TO demand_NN for_IN reducing_VBG the_DT environmental_JJ impact_NN of_IN production_NN have_VBP had_VBN the_DT added_VBN benefit_NN of_IN reducing_VBG workers_NNS '_POS hazardous_JJ chemical_NN exposure_NN ._. 
But_CC while_IN most_JJS industrial_JJ hygienists_NNS would_MD state_VB their_PRP$ philosophical_JJ commitment_NN to_TO ``_`` prevention_NN at_IN the_DT source_NN ,_, ''_'' source_NN reduction_NN strategies_NNS are_VBP not_RB common_JJ in_IN industrial_JJ hygiene_NN practice_NN ._. 
Indeed_RB ,_, early_JJ industrial_JJ hygienists_NNS maintained_VBD that_IN source_NN reduction_NN was_VBD not_RB a_DT practical_JJ approach_NN ,_, nor_CC even_RB theoretically_RB superior_JJ to_TO local_JJ exhaust_NN ventilation_NN ,_, from_IN a_DT prevention_NN standpoint_NN ._. 
Indeed_RB ,_, early_JJ industrial_JJ hygienists_NNS maintained_VBD that_IN source_NN reduction_NN was_VBD not_RB a_DT practical_JJ approach_NN ,_, nor_CC even_RB theoretically_RB superior_JJ to_TO local_JJ exhaust_NN ventilation_NN ,_, from_IN a_DT prevention_NN standpoint_NN ._. 
This_DT latter_JJ view_NN has_VBZ been_VBN supported_VBN by_IN an_DT assumption_NN that_IN control_NN strategies_NNS that_WDT require_VBP changes_NNS to_TO industrial_JJ processes_NNS or_CC products_NNS are_VBP inherently_RB ``_`` infeasible_JJ ._. ''_'' 
Thus_RB ,_, ``_`` add-on_JJ ''_'' controls_NNS 
''_'' Thus_RB ,_, ``_`` add-on_JJ ''_'' controls_NNS 
Table_NNP 1_CD Source_NN Reduction_NN Strategies_NNS for_IN Principal_NN Uses_VBZ of_IN Methylene_NNP Chloride_NNP Industrial_NNP Activity_NNP Source_NNP Reduction_NNP Strategy_NNP Paint_NNP stripping_VBG -LRB-_-LRB- Aircraft_NNP ,_, Ship_NNP ,_, Metal_NNP -RRB-_-RRB- Benzyl_NNP alcohol-based_JJ stripper_NN 
Source_NN reduction_NN ,_, also_RB called_VBN pollution_NN prevention_NN ,_, includes_VBZ chemical_NN substitution_NN ,_, process_NN modification_NN ,_, and_CC substitute_NN technologies_NNS that_WDT intervene_VBP in_IN the_DT industrial_JJ process_NN itself_PRP to_TO eliminate_VB or_CC reduce_VB hazards_NNS ._. 
In_IN the_DT environmental_JJ protection_NN field_NN ,_, awareness_NN of_IN pollution_NN ``_`` media-shifting_JJ ,_, ''_'' e._FW g._FW protecting_VBG the_DT air_NN by_IN filtering_VBG contaminants_NNS through_IN a_DT filter_NN that_WDT then_RB becomes_VBZ or_CC collects_VBZ hazardous_JJ waste_NN ,_, has_VBZ given_VBN rise_NN to_TO support_NN for_IN pollution_NN prevention_NN in_IN place_NN of_IN ``_`` end-of-pipe_JJ ''_'' controls_NNS ._. 
Danish_JJ law_NN has_VBZ since_IN 1982_CD prohibiting_VBG the_DT use_NN of_IN hazardous_JJ chemicals_NNS if_IN safer_JJR substitutes_NNS are_VBP available_JJ ._. 
The_DT U._NNP S._NNP Pollution_NNP Prevention_NNP Act_NNP of_IN 1990_CD and_CC the_DT 1989_CD Massachusetts_NNP Toxics_NNP Use_NNP Reduction_NNP Act_NNP have_VBP helped_VBN to_TO ``_`` mainstream_JJ ''_'' source_NN reduction_NN in_IN industrial_JJ production_NN practices_NNS in_IN the_DT United_NNP States_NNPS ._. 
Pollution_NNP Prevention_NNP Act_NNP of_IN 1990_CD and_CC the_DT 1989_CD Massachusetts_NNP Toxics_NNP Use_NNP Reduction_NNP Act_NNP have_VBP helped_VBN to_TO ``_`` mainstream_JJ ''_'' source_NN reduction_NN in_IN industrial_JJ production_NN practices_NNS in_IN the_DT United_NNP States_NNPS ._. 
Source_NN reduction_NN activities_NNS motivated_VBN by_IN environmental_JJ protection_NN goals_NNS have_VBP had_VBN a_DT significant_JJ impact_NN on_IN the_DT work_NN environment_NN ._. 
Many_JJ of_IN the_DT technological_JJ breakthroughs_NNS that_WDT have_VBP occurred_VBN in_IN chemistry_NN ,_, process_NN engineering_NN ,_, and_CC industrial_JJ equipment_NN in_IN response_NN to_TO demand_NN for_IN reducing_VBG the_DT environmental_JJ impact_NN of_IN production_NN have_VBP had_VBN the_DT added_VBN benefit_NN of_IN reducing_VBG workers_NNS '_POS hazardous_JJ chemical_NN exposure_NN ._. 
''_'' Thus_RB ,_, ``_`` add-on_JJ ''_'' controls_NNS 
In_IN 2009_CD ,_, the_DT California_NNP Environmental_NNP Protection_NNP Agency_NNP proposed_VBD a_DT public_JJ health_NN goal_NN level_NN of_IN 0_CD ._. 
However_RB ,_, as_IN of_IN yet_RB ,_, there_EX are_VBP no_DT limits_NNS set_VBN by_IN any_DT international_JJ body_NN for_IN Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- ._. 
06_CD 
This_DT evidence_NN contributed_VBD to_TO the_DT proposal_NN of_IN the_DT California_NNP Environmental_NNP Protection_NNP Agency_NNP to_TO set_VB a_DT public_JJ health_NN goal_NN -LRB-_-LRB- 0_CD ._. 
06_CD 
Since_IN 2007_CD ,_, three_CD independent_JJ sets_NNS of_IN hexavalent_NN chromium_NN measurements_NNS are_VBP available_JJ for_IN the_DT Oinofita_NNP area_NN ._. 
These_DT include_VBP :_: a_DT -RRB-_-RRB- a_DT study_NN of_IN the_DT Institute_NNP of_IN Geology_NNP and_CC Mineral_NNP Exploration_NNP -LRB-_-LRB- IGME_NNP -RRB-_-RRB- during_IN the_DT period_NN November_NNP 2007_CD to_TO February_NNP 2008_CD ,_, which_WDT detected_VBD 35_CD samples_NNS -LRB-_-LRB- out_IN of_IN 87_CD -RRB-_-RRB- taken_VBN from_IN different_JJ wells_NNS in_IN the_DT same_JJ area_NN to_TO have_VB levels_NNS above_IN 10_CD 
\*\*_SYM Statistically_RB significant_JJ at_IN 5_CD %_NN level_NN ._. 
598_CD Notes_NNS :_: \*_NN Statistically_RB significant_JJ at_IN 10_CD %_NN level_NN ._. 
20_CD ._. 
Types_NNS of_IN cancer_NN are_VBP classified_VBN according_VBG to_TO the_DT Hellenic_NNP Statistical_NNP Authority_NNP ._. 
Tests_NNS for_IN linear_JJ trend_NN performed_VBN after_IN grouping_VBG the_DT period_NN specific_JJ SMRs_NNS into_IN 3_CD time_NN intervals_NNS ,_, i._NN 
These_DT data_NNS were_VBD re-analyzed_VBN and_CC re-evaluated_VBN by_IN other_JJ investigators_NNS 
Due_JJ to_TO the_DT proximity_NN to_TO Attica_NNP ,_, the_DT number_NN of_IN industries_NNS in_IN the_DT Oinofita_NNP region_NN increased_VBD precipitously_RB after_IN 1984_CD ,_, when_WRB a_DT new_JJ law_NN imposed_VBD restrictions_NNS on_IN the_DT establishment_NN of_IN various_JJ industries_NNS within_IN Attica_NNP ._. 
According_VBG to_TO the_DT Technical_NNP Chamber_NNP of_IN Greece_NNP ,_, in_IN 2009_CD ,_, there_EX were_VBD about_IN 700_CD industries_NNS operating_VBG in_IN the_DT Oinofita_NNP area_NN ,_, of_IN which_WDT 500_CD generated_VBD liquid_JJ industrial_JJ waste_NN ._. 
Initial_JJ concerns_NNS were_VBD raised_VBN after_IN Oinofita_NNP area_NN citizens_NNS complained_VBD about_IN the_DT discoloration_NN and_CC turbidity_NN of_IN their_PRP$ drinking_NN water_NN ._. 
Elevated_JJ mortality_NN rates_NNS for_IN total_JJ cancer_NN ,_, lung_NN cancer_NN ,_, and_CC stomach_NN cancer_NN were_VBD noted_VBN ._. 
One_CD of_IN the_DT most_RBS cited_VBN and_CC controversial_JJ studies_NNS analyzing_VBG the_DT effects_NNS of_IN oral_JJ exposure_NN to_TO Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- on_IN population_NN cancer_NN mortality_NN rates_NNS was_VBD conducted_VBN near_IN a_DT chromium_NN smelting_NN plant_NN in_IN the_DT Liaoning_NNP Province_NNP ,_, China_NNP 
Elevated_JJ mortality_NN rates_NNS for_IN total_JJ cancer_NN ,_, lung_NN cancer_NN ,_, and_CC stomach_NN cancer_NN were_VBD noted_VBN ._. 
One_CD of_IN the_DT most_RBS cited_VBN and_CC controversial_JJ studies_NNS analyzing_VBG the_DT effects_NNS of_IN oral_JJ exposure_NN to_TO Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- on_IN population_NN cancer_NN mortality_NN rates_NNS was_VBD conducted_VBN near_IN a_DT chromium_NN smelting_NN plant_NN in_IN the_DT Liaoning_NNP Province_NNP ,_, China_NNP 
Elevated_JJ mortality_NN rates_NNS for_IN total_JJ cancer_NN ,_, lung_NN cancer_NN ,_, and_CC stomach_NN cancer_NN were_VBD noted_VBN ._. 
One_CD of_IN the_DT most_RBS cited_VBN and_CC controversial_JJ studies_NNS analyzing_VBG the_DT effects_NNS of_IN oral_JJ exposure_NN to_TO Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- on_IN population_NN cancer_NN mortality_NN rates_NNS was_VBD conducted_VBN near_IN a_DT chromium_NN smelting_NN plant_NN in_IN the_DT Liaoning_NNP Province_NNP ,_, China_NNP 
Elevated_JJ mortality_NN rates_NNS for_IN total_JJ cancer_NN ,_, lung_NN cancer_NN ,_, and_CC stomach_NN cancer_NN were_VBD noted_VBN ._. 
One_CD of_IN the_DT most_RBS cited_VBN and_CC controversial_JJ studies_NNS analyzing_VBG the_DT effects_NNS of_IN oral_JJ exposure_NN to_TO Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- on_IN population_NN cancer_NN mortality_NN rates_NNS was_VBD conducted_VBN near_IN a_DT chromium_NN smelting_NN plant_NN in_IN the_DT Liaoning_NNP Province_NNP ,_, China_NNP 
Discussion_NN There_EX is_VBZ considerable_JJ debate_NN on_IN the_DT potential_JJ health_NN effects_NNS of_IN oral_JJ exposure_NN to_TO Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- ._. 
Based_VBN on_IN available_JJ evidence_NN 
Further_RB ,_, our_PRP$ results_NNS suggest_VBP possibly_RB higher_JJR risk_NN of_IN other_JJ epithelial_JJ and_CC gastrointestinal_JJ cancers_NNS ._. 
These_DT findings_NNS are_VBP consistent_JJ with_IN previous_JJ epidemiological_JJ and_CC animal_JJ studies_NNS indicating_VBG carcinogenesis_NNS after_IN consumption_NN of_IN drinking_NN water_NN contaminated_VBN with_IN Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- ._. 
Our_PRP$ study_NN ,_, similar_JJ to_TO previous_JJ epidemiologic_JJ studies_NNS ,_, was_VBD based_VBN on_IN an_DT ecologic_JJ comparison_NN ._. 
Thus_RB ,_, exposure_NN is_VBZ expressed_VBN as_IN residing_VBG in_IN the_DT area_NN assuming_VBG that_IN all_DT residents_NNS consumed_VBD water_NN provided_VBN by_IN the_DT municipality_NN ._. 
Since_IN 2007_CD ,_, three_CD independent_JJ sets_NNS of_IN hexavalent_NN chromium_NN measurements_NNS are_VBP available_JJ for_IN the_DT Oinofita_NNP area_NN ._. 
These_DT include_VBP :_: a_DT -RRB-_-RRB- a_DT study_NN of_IN the_DT Institute_NNP of_IN Geology_NNP and_CC Mineral_NNP Exploration_NNP -LRB-_-LRB- IGME_NNP -RRB-_-RRB- during_IN the_DT period_NN November_NNP 2007_CD to_TO February_NNP 2008_CD ,_, which_WDT detected_VBD 35_CD samples_NNS -LRB-_-LRB- out_IN of_IN 87_CD -RRB-_-RRB- taken_VBN from_IN different_JJ wells_NNS in_IN the_DT same_JJ area_NN to_TO have_VB levels_NNS above_IN 10_CD 
The_DT expected_JJ deaths_NNS were_VBD obtained_VBN by_IN multiplying_VBG the_DT corresponding_JJ person_NN years_NNS with_IN the_DT age-gender-year_JJ and_CC cause_VB specific_JJ mortality_NN rate_NN of_IN the_DT Voiotia_NNP prefecture_NN population_NN ._. 
In_IN the_DT analysis_NN ,_, we_PRP reduced_VBD the_DT four-digit_JJ ICD-9_NN code_NN to_TO a_DT three-digit_JJ level_NN classification_NN system_NN similar_JJ to_TO what_WP is_VBZ used_VBN by_IN the_DT Hellenic_NNP Statistical_NNP Authority_NNP 
Discussion_NN There_EX is_VBZ considerable_JJ debate_NN on_IN the_DT potential_JJ health_NN effects_NNS of_IN oral_JJ exposure_NN to_TO Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- ._. 
Based_VBN on_IN available_JJ evidence_NN 
e._VB These_DT figures_NNS -LRB-_-LRB- i._FW 0_CD Total_JJ deaths_NNS 17_CD 16_CD 18_CD 20_CD 19_CD 25_CD 13_CD 14_CD 25_CD 17_CD 23_CD 207_CD Cancer_NNP deaths_NNS 2_CD 5_CD 0_CD 4_CD 3_CD 6_CD 2_CD 3_CD 6_CD 4_CD 7_CD 42_CD A_DT total_NN of_IN 474_CD deaths_NNS were_VBD observed_VBN ,_, of_IN which_WDT 118_CD were_VBD cancer_NN related_VBN -LRB-_-LRB- Table_NNP 3_CD -RRB-_-RRB- ._. 
one_CD in_IN four_CD deaths_NNS being_VBG cancer_NN related_VBN -RRB-_-RRB- are_VBP in_IN accordance_NN to_TO the_DT general_JJ Greek_JJ ,_, EU15_NNP and_CC EU27_NNP averages_NNS 
We_PRP calculated_VBD 95_CD %_NN confidence_NN intervals_NNS and_CC p-values_NNS for_IN the_DT SMRs_NNS on_IN the_DT basis_NN of_IN the_DT exact_JJ Poisson_NNP method_NN ._. 
Tests_NNS of_IN linear_JJ trend_NN were_VBD performed_VBN -LRB-_-LRB- under_IN the_DT Chi-square_JJ distribution_NN -RRB-_-RRB- 
We_PRP used_VBD SPSS_NNP 17_CD and_CC confirmed_VBD results_NNS using_VBG Stata_NNP 10_CD ._. 
In_IN the_DT analysis_NN ,_, we_PRP reduced_VBD the_DT four-digit_JJ ICD-9_NN code_NN to_TO a_DT three-digit_JJ level_NN classification_NN system_NN similar_JJ to_TO what_WP is_VBZ used_VBN by_IN the_DT Hellenic_NNP Statistical_NNP Authority_NNP 
We_PRP used_VBD SPSS_NNP 17_CD and_CC confirmed_VBD results_NNS using_VBG Stata_NNP 10_CD ._. 
In_IN the_DT analysis_NN ,_, we_PRP reduced_VBD the_DT four-digit_JJ ICD-9_NN code_NN to_TO a_DT three-digit_JJ level_NN classification_NN system_NN similar_JJ to_TO what_WP is_VBZ used_VBN by_IN the_DT Hellenic_NNP Statistical_NNP Authority_NNP 
5-LRB-_NNP mg\/kg\/day_NNP -RRB-_-RRB- -1_CD ._. 
In_IN a_DT recent_JJ article_NN using_VBG data_NNS from_IN the_DT National_NNP Toxicology_NNP Program_NNP -LRB-_-LRB- NTP_NNP -RRB-_-RRB- of_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ,_, hexavalent_NN chromium_NN was_VBD identified_VBN as_IN `_`` likely_JJ to_TO be_VB a_DT carcinogen_NN to_TO humans_NNS '_POS with_IN an_DT estimate_NN of_IN the_DT cancer_NN potency_NN to_TO humans_NNS equal_JJ to_TO 0_CD ._. 
At_IN the_DT cellular_JJ level_NN ,_, Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- is_VBZ a_DT highly_RB active_JJ carcinogen_NN 
2_CD 
At_IN the_DT cellular_JJ level_NN ,_, Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- is_VBZ a_DT highly_RB active_JJ carcinogen_NN ._. 
5-LRB-_NNP mg\/kg\/day_NNP -RRB-_-RRB- -1_CD 
Akey_NNP issue_NN is_VBZ whether_IN Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- ingested_VBD through_IN the_DT oral_JJ route_NN ,_, converts_VBZ to_TO trivalent_VB Chromium_NNP Cr_NNP -LRB-_-LRB- III_NNP -RRB-_-RRB- -LRB-_-LRB- which_WDT does_VBZ not_RB cross_VB the_DT cell_NN membrane_NN that_WDT easily_RB -RRB-_-RRB- before_IN entering_VBG a_DT living_NN cell_NN 
Given_VBN the_DT absence_NN of_IN adequate_JJ evidence_NN ,_, the_DT California_NNP Congressional_NNP Delegation_NNP ,_, California_NNP Environmental_NNP Protection_NNP Agency_NNP ,_, and_CC California_NNP Department_NNP of_IN Health_NNP Services_NNPS nominated_VBD Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- for_IN toxicity_NN and_CC carcinogenicity_NN testing_NN to_TO the_DT National_NNP Toxicology_NNP Program_NNP -LRB-_-LRB- NTP_NNP -RRB-_-RRB- ._. 
The_DT NTP_NNP results_NNS published_VBD recently_RB report_NN that_IN rats_NNS and_CC mice_NNS exposed_VBN to_TO drinking_NN water_NN with_IN Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- developed_VBD oral_JJ cavity_NN neoplasms_NNS ,_, small_JJ intestine_NN neoplasms_NNS and_CC hyperplasia_NN ,_, and_CC displayed_VBD a_DT significant_JJ increase_NN in_IN histiocytic_JJ cell_NN infiltration_NN in_IN the_DT duodenum_NN ,_, jejunum_NN ,_, and_CC liver_NN as_RB well_RB as_IN in_IN mesenteric_JJ and_CC pancreatic_JJ lymph_NN nodes_NNS ._. 
This_DT evidence_NN contributed_VBD to_TO the_DT proposal_NN of_IN the_DT California_NNP Environmental_NNP Protection_NNP Agency_NNP to_TO set_VB a_DT public_JJ health_NN goal_NN -LRB-_-LRB- 0_CD ._. 
Further_RB ,_, our_PRP$ results_NNS suggest_VBP possibly_RB higher_JJR risk_NN of_IN other_JJ epithelial_JJ and_CC gastrointestinal_JJ cancers_NNS ._. 
These_DT findings_NNS are_VBP consistent_JJ with_IN previous_JJ epidemiological_JJ and_CC animal_JJ studies_NNS indicating_VBG carcinogenesis_NNS after_IN consumption_NN of_IN drinking_NN water_NN contaminated_VBN with_IN Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- ._. 
Our_PRP$ study_NN ,_, similar_JJ to_TO previous_JJ epidemiologic_JJ studies_NNS ,_, was_VBD based_VBN on_IN an_DT ecologic_JJ comparison_NN ._. 
Thus_RB ,_, exposure_NN is_VBZ expressed_VBN as_IN residing_VBG in_IN the_DT area_NN assuming_VBG that_IN all_DT residents_NNS consumed_VBD water_NN provided_VBN by_IN the_DT municipality_NN ._. 
Arecent_JJ study_NN revealed_VBD that_IN rats_NNS and_CC mice_NNS exposed_VBN to_TO Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- -_: contaminated_VBN drinking_NN water_NN developed_VBD gastrointestinal_JJ abnormalities_NNS ,_, including_VBG oral_JJ and_CC intestinal_JJ tumors_NNS ._. 
An_DT earlier_JJR study_NN 
Discussion_NN There_EX is_VBZ considerable_JJ debate_NN on_IN the_DT potential_JJ health_NN effects_NNS of_IN oral_JJ exposure_NN to_TO Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- ._. 
Based_VBN on_IN available_JJ evidence_NN 
Further_JJ studies_NNS are_VBP needed_VBN to_TO determine_VB whether_IN this_DT association_NN is_VBZ causal_JJ ,_, and_CC to_TO establish_VB preventive_JJ guidelines_NNS and_CC public_JJ health_NN recommendations_NNS ._. 
BackgroundHexavalent_JJ chromium_NN Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- is_VBZ recognized_VBN by_IN the_DT World_NNP Health_NNP Organization_NNP -LRB-_-LRB- WHO_WP -RRB-_-RRB- as_IN a_DT human_JJ carcinogen_NN through_IN inhalation_NN ,_, but_CC there_EX is_VBZ significant_JJ debate_NN on_IN the_DT carcinogenicity_NN of_IN hexavalent_NN chromium_NN when_WRB it_PRP is_VBZ orally_RB ingested_VBN ._. 
In_IN a_DT recent_JJ article_NN using_VBG data_NNS from_IN the_DT National_NNP Toxicology_NNP Program_NNP -LRB-_-LRB- NTP_NNP -RRB-_-RRB- of_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ,_, hexavalent_NN chromium_NN was_VBD identified_VBN as_IN `_`` likely_JJ to_TO be_VB a_DT carcinogen_NN to_TO humans_NNS '_POS with_IN an_DT estimate_NN of_IN the_DT cancer_NN potency_NN to_TO humans_NNS equal_JJ to_TO 0_CD ._. 
In_IN a_DT recent_JJ article_NN using_VBG data_NNS from_IN the_DT National_NNP Toxicology_NNP Program_NNP -LRB-_-LRB- NTP_NNP -RRB-_-RRB- of_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ,_, hexavalent_NN chromium_NN was_VBD identified_VBN as_IN `_`` likely_JJ to_TO be_VB a_DT carcinogen_NN to_TO humans_NNS '_POS with_IN an_DT estimate_NN of_IN the_DT cancer_NN potency_NN to_TO humans_NNS equal_JJ to_TO 0_CD ._. 
5-LRB-_NNP mg\/kg\/day_NNP -RRB-_-RRB- -1_CD ._. 
At_IN the_DT cellular_JJ level_NN ,_, Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- is_VBZ a_DT highly_RB active_JJ carcinogen_NN 
5-LRB-_NNP mg\/kg\/day_NNP -RRB-_-RRB- -1_CD ._. 
In_IN a_DT recent_JJ article_NN using_VBG data_NNS from_IN the_DT National_NNP Toxicology_NNP Program_NNP -LRB-_-LRB- NTP_NNP -RRB-_-RRB- of_IN the_DT National_NNP Institutes_NNPS of_IN Health_NNP ,_, hexavalent_NN chromium_NN was_VBD identified_VBN as_IN `_`` likely_JJ to_TO be_VB a_DT carcinogen_NN to_TO humans_NNS '_POS with_IN an_DT estimate_NN of_IN the_DT cancer_NN potency_NN to_TO humans_NNS equal_JJ to_TO 0_CD ._. 
At_IN the_DT cellular_JJ level_NN ,_, Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- is_VBZ a_DT highly_RB active_JJ carcinogen_NN 
Arecent_JJ study_NN revealed_VBD that_IN rats_NNS and_CC mice_NNS exposed_VBN to_TO Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- -_: contaminated_VBN drinking_NN water_NN developed_VBD gastrointestinal_JJ abnormalities_NNS ,_, including_VBG oral_JJ and_CC intestinal_JJ tumors_NNS ._. 
An_DT earlier_JJR study_NN 
Because_IN areas_NNS characterized_VBN by_IN high_JJ Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- concentrations_NNS in_IN drinking_NN water_NN are_VBP relatively_RB uncommon_JJ ,_, human_JJ epidemiologic_JJ studies_NNS are_VBP scant_JJ ._. 
One_CD of_IN the_DT most_RBS cited_VBN and_CC controversial_JJ studies_NNS analyzing_VBG the_DT effects_NNS of_IN oral_JJ exposure_NN to_TO Cr_NNP -LRB-_-LRB- VI_NNP -RRB-_-RRB- on_IN population_NN cancer_NN mortality_NN rates_NNS was_VBD conducted_VBN near_IN a_DT chromium_NN smelting_NN plant_NN in_IN the_DT Liaoning_NNP Province_NNP ,_, China_NNP 
In_IN the_DT cases_NNS presented_VBD ,_, dermatitis_NNS appeared_VBD a_DT few_JJ days_NNS after_IN the_DT oil_NN was_VBD introduced_VBN at_IN the_DT workplace_NN and_CC it_PRP is_VBZ likely_JJ that_IN sensitization_NN occurred_VBD from_IN only_JJ few_JJ exposures_NNS ._. 
Occupational_JJ sensitization_NN to_TO epoxy_VB resin_NN and_CC other_JJ potent_JJ allergens_NNS from_IN a_DT single_JJ exposure_NN has_VBZ been_VBN described_VBN ._. 
In_IN the_DT safety_NN data_NNS sheet_NN of_IN the_DT oil_NN no_DT risk_NN phrases_NNS were_VBD listed_VBN ,_, and_CC it_PRP was_VBD stated_VBN that_DT sensitization_NN from_IN the_DT product_NN was_VBD not_RB known_VBN ._. 
In_IN the_DT late_JJ 1990s_NNS an_DT epidemic_NN of_IN allergic_JJ contact_NN dermatitis_NNS from_IN epoxy_NN resins_NNS in_IN Leica_NNP Microscopy_NNP immersion_NN oil_NN occurred_VBD ._. 
At_IN least_JJS 24_CD cases_NNS have_VBP been_VBN reported_VBN in_IN Europe_NNP and_CC in_IN some_DT of_IN these_DT cases_NNS a_DT cycloaliphatic_JJ epoxy_NN resin_NN was_VBD shown_VBN to_TO be_VB one_CD of_IN the_DT allergens_NNS ,_, but_CC probably_RB not_RB the_DT primary_JJ sensitizer_NN in_IN most_JJS cases_NNS 
It_PRP may_MD be_VB that_DT sensitization_NN from_IN some_DT additives_NNS in_IN oils_NNS occurs_VBZ more_RBR frequently_RB than_IN indicated_VBN by_IN the_DT number_NN of_IN published_JJ cases_NNS ,_, because_IN the_DT allergenic_JJ component_NN often_RB remains_VBZ undetected_JJ ._. 
Scerri_NNP reported_VBD 12_CD cases_NNS of_IN allergic_JJ contact_NN dermatitis_NNS with_IN positive_JJ reactions_NNS to_TO the_DT chlorinated_JJ paraffin_NN component_NN of_IN a_DT neat_JJ cutting_NN oil_NN ._. 
They_PRP did_VBD not_RB find_VB the_DT sensitizer_NN ,_, which_WDT they_PRP believed_VBD to_TO be_VB a_DT stabilizer_NN ,_, due_JJ to_TO insufficient_JJ cooperation_NN from_IN a_DT manufacturer_NN ._. 
At_IN least_JJS 24_CD cases_NNS have_VBP been_VBN reported_VBN in_IN Europe_NNP and_CC in_IN some_DT of_IN these_DT cases_NNS a_DT cycloaliphatic_JJ epoxy_NN resin_NN was_VBD shown_VBN to_TO be_VB one_CD of_IN the_DT allergens_NNS ,_, but_CC probably_RB not_RB the_DT primary_JJ sensitizer_NN in_IN most_JJS cases_NNS 
Our_PRP$ two_CD case-patients_NNS ,_, however_RB ,_, showed_VBD either_CC no_DT reaction_NN or_CC a_DT doubtful_JJ reaction_NN to_TO the_DT standard_JJ DGEBA_NNP epoxy_NN ._. 
It_PRP has_VBZ been_VBN reported_VBN in_IN several_JJ cases_NNS that_IN the_DT standard_JJ series_NN often_RB does_VBZ not_RB uncover_VB an_DT allergy_NN to_TO a_DT non-DGEBA_JJ epoxy_NN ._. 
It_PRP is_VBZ important_JJ to_TO supplement_VB the_DT standard_JJ patch_NN test_NN with_IN the_DT relevant_JJ epoxy_NN resins_NNS to_TO which_WDT the_DT patient_NN has_VBZ been_VBN exposed_VBN ._. 
English_NNP reported_VBD in_IN 1986_CD five_CD cases_NNS of_IN allergic_JJ contact_NN dermatitis_NN also_RB from_IN the_DT cycloaliphatic_JJ epoxy_NN resin_NN ,_, 1,2-cyclohexanedicarboxylic_JJ acid_NN ,_, bis_VBZ -LRB-_-LRB- oxiranylmethyl_NN -RRB-_-RRB- ester_NN in_IN a_DT cutting_NN oil_NN 
English_NNP reported_VBD in_IN 1986_CD five_CD cases_NNS of_IN allergic_JJ contact_NN dermatitis_NN also_RB from_IN the_DT cycloaliphatic_JJ epoxy_NN resin_NN ,_, 1,2-cyclohexanedicarboxylic_JJ acid_NN ,_, bis_VBZ -LRB-_-LRB- oxiranylmethyl_NN -RRB-_-RRB- ester_NN in_IN a_DT cutting_NN oil_NN 
In_IN the_DT late_JJ 1990s_NNS an_DT epidemic_NN of_IN allergic_JJ contact_NN dermatitis_NNS from_IN epoxy_NN resins_NNS in_IN Leica_NNP Microscopy_NNP immersion_NN oil_NN occurred_VBD ._. 
At_IN least_JJS 24_CD cases_NNS have_VBP been_VBN reported_VBN in_IN Europe_NNP and_CC in_IN some_DT of_IN these_DT cases_NNS a_DT cycloaliphatic_JJ epoxy_NN resin_NN was_VBD shown_VBN to_TO be_VB one_CD of_IN the_DT allergens_NNS ,_, but_CC probably_RB not_RB the_DT primary_JJ sensitizer_NN in_IN most_JJS cases_NNS 
Atotal_NNP of_IN 6_CD patients_NNS reacted_VBD to_TO phenyl_VB glycidyl_JJ ether_NN in_IN the_DT testing_NN of_IN the_DT 57_CD patients_NNS mentioned_VBN above_IN ._. 
This_DT possibly_RB indicates_VBZ cross-reactivity_NN between_IN the_DT cycloaliphatic_JJ epoxy_NN resin_NN and_CC the_DT reactive_JJ diluent_NN ._. 
In_IN the_DT cases_NNS presented_VBD ,_, dermatitis_NNS appeared_VBD a_DT few_JJ days_NNS after_IN the_DT oil_NN was_VBD introduced_VBN at_IN the_DT workplace_NN and_CC it_PRP is_VBZ likely_JJ that_IN sensitization_NN occurred_VBD from_IN only_JJ few_JJ exposures_NNS ._. 
At_IN least_JJS 24_CD cases_NNS have_VBP been_VBN reported_VBN in_IN Europe_NNP and_CC in_IN some_DT of_IN these_DT cases_NNS a_DT cycloaliphatic_JJ epoxy_NN resin_NN was_VBD shown_VBN to_TO be_VB one_CD of_IN the_DT allergens_NNS ,_, but_CC probably_RB not_RB the_DT primary_JJ sensitizer_NN in_IN most_JJS cases_NNS 
Visual_JJ reading_NN was_VBD carried_VBN out_RP on_IN day_NN 2_CD or_CC day_NN 3_CD -LRB-_-LRB- D2_CD or_CC D3_CD -RRB-_-RRB- and_CC on_IN day_NN 7_CD -LRB-_-LRB- D7_NNP -RRB-_-RRB- ._. 
The_DT patches_NNS were_VBD placed_VBN on_IN normal_JJ skin_NN on_IN the_DT back_NN and_CC removed_VBD after_IN 2_CD days_NNS ._. 
Reactions_NNS were_VBD scored_VBN according_VBG to_TO the_DT International_NNP Contact_NN Dermatitis_NNP Research_NNP Group_NNP guidelines_NNS -LRB-_-LRB- table_NN 1_CD -RRB-_-RRB- ._. 
Table_NNP 1_CD Reading_VBG of_IN patch_NN test_NN reactions_NNS according_VBG to_TO International_NNP Contact_NN Dermatitis_NNP Research_NNP Group_NNP guidelines_NNS Score_NN Patch_NNP test_NN reaction_NN Criteria_NNP -_: Negative_JJ No_NNP reaction_NN +_NN ._. 
Discussion_NN More_JJR than_IN 90_CD %_NN of_IN manufactured_JJ epoxy_NN resins_NNS are_VBP based_VBN on_IN the_DT diglycidylether_NN of_IN bisphenol_NN A_NNP -LRB-_-LRB- DGEBA_NNP -RRB-_-RRB- -LRB-_-LRB- fig_NN ._. 
1-RRB-_NNP ,_, while_IN the_DT remaining_VBG 10_CD %_NN non-DGEBA_JJ epoxy_NN resins_NNS are_VBP based_VBN on_IN the_DT diglycidyl_JJ ethers_NNS of_IN bisphenol_NN F_NN ,_, cycloaliphatic_JJ compounds_NNS ,_, or_CC other_JJ more_RBR complex_JJ systems_NNS ._. 
Epoxy_NN resins_NNS are_VBP organic_JJ chemicals_NNS that_WDT contain_VBP more_JJR than_IN one_CD epoxy_NN group_NN ._. 
The_DT most_RBS common_JJ epoxy_NN compound_NN is_VBZ made_VBN from_IN reacting_VBG bisphenol_NN A_NN with_IN epichlorohydrin_NN creating_VBG low-molecular_JJ weight_NN polymers_NNS ._. 
There_EX are_VBP only_RB few_JJ reports_NNS of_IN sensitization_NN from_IN cycloaliphatic_JJ epoxy_NN resins_NNS in_IN oils_NNS ._. 
25_CD %_NN ._. 
The_DT epoxy_NN resin_NN was_VBD present_JJ in_IN the_DT oil_NN at_IN a_DT concentration_NN of_IN 0_CD ._. 
English_NNP reported_VBD in_IN 1986_CD five_CD cases_NNS of_IN allergic_JJ contact_NN dermatitis_NN also_RB from_IN the_DT cycloaliphatic_JJ epoxy_NN resin_NN ,_, 1,2-cyclohexanedicarboxylic_JJ acid_NN ,_, bis_VBZ -LRB-_-LRB- oxiranylmethyl_NN -RRB-_-RRB- ester_NN in_IN a_DT cutting_NN oil_NN 
Our_PRP$ two_CD case-patients_NNS ,_, however_RB ,_, showed_VBD either_CC no_DT reaction_NN or_CC a_DT doubtful_JJ reaction_NN to_TO the_DT standard_JJ DGEBA_NNP epoxy_NN ._. 
It_PRP has_VBZ been_VBN reported_VBN in_IN several_JJ cases_NNS that_IN the_DT standard_JJ series_NN often_RB does_VBZ not_RB uncover_VB an_DT allergy_NN to_TO a_DT non-DGEBA_JJ epoxy_NN ._. 
It_PRP is_VBZ important_JJ to_TO supplement_VB the_DT standard_JJ patch_NN test_NN with_IN the_DT relevant_JJ epoxy_NN resins_NNS to_TO which_WDT the_DT patient_NN has_VBZ been_VBN exposed_VBN ._. 
The_DT distribution_NN system-wide_JJ average_NN of_IN THM_NNP and_CC HAA_NNP data_NNS is_VBZ used_VBN for_IN exposure_NN assessment_NN in_IN most_JJS epidemiological_JJ studies_NNS 
,without_NN considering_VBG the_DT presence_NN of_IN an_DT intermediary_JJ water_NN infrastructure_NN -RRB-_-RRB- ._. 
e._NNP Method_NNP E_NNP :_: CBP_NNP data_NNS from_IN the_DT closest_JJS sampling_NN site_NN to_TO the_DT subject_NN 's_POS residence_NN were_VBD assigned_VBN directly_RB to_TO the_DT subjects_NNS -LRB-_-LRB- i._VB This_DT approach_NN has_VBZ also_RB been_VBN applied_VBN to_TO assign_VB CBP_NNP data_NNS to_TO the_DT subjects_NNS in_IN several_JJ epidemiological_JJ studies_NNS ._. 
Method_NN F_NN :_: The_DT average_NN of_IN CBP_NNP data_NNS from_IN all_DT sampling_VBG sites_NNS located_VBN in_IN the_DT distribution_NN system_NN was_VBD calculated_VBN and_CC assigned_VBN to_TO the_DT subjects_NNS ._. 
As_IN a_DT result_NN ,_, alternative_JJ data_NNS are_VBP used_VBN in_IN epidemiological_JJ investigations_NNS on_IN population_NN exposure_NN assessment_NN ._. 
In_IN fact_NN ,_, the_DT majority_NN of_IN these_DT studies_NNS use_VBP data_NNS available_JJ through_IN regulatory_JJ compliance_NN on_IN CBPs_NNS in_IN drinking_NN water_NN for_IN which_WDT THMs_NNP and_CC HAAs_NNP -LRB-_-LRB- the_DT latter_NN only_RB in_IN United_NNP States_NNP -LRB-_-LRB- US_NNP -RRB-_-RRB- -RRB-_-RRB- are_VBP routinely_RB measured_VBN 
Usually_RB ,_, in_IN epidemiological_JJ studies_NNS ,_, the_DT relationship_NN between_IN adverse_JJ health_NN outcomes_NNS and_CC CBPs_NNS in_IN drinking_NN water_NN is_VBZ evaluated_VBN using_VBG categorical_JJ exposure_NN variables_NNS ._. 
The_DT categories_NNS of_IN CBP_NNP exposure_NN are_VBP generally_RB based_VBN on_IN CBP_NNP levels_NNS measured_VBN in_IN the_DT area_NN under_IN study_NN and_CC more_RBR precisely_RB on_IN CBP_NNP level_NN percentiles_NNS ._. 
As_IN a_DT result_NN ,_, for_IN each_DT of_IN the_DT six_CD methods_NNS under_IN study_NN ,_, the_DT subjects_NNS were_VBD classified_VBN in_IN TTHM_NNP and_CC HAA9_NNP exposure_NN categories_NNS according_VBG to_TO the_DT estimation_NN of_IN CBP_NNP levels_NNS in_IN their_PRP$ residence_NN drinking_NN water_NN obtained_VBN from_IN the_DT specific_JJ method_NN ._. 
Usually_RB ,_, in_IN epidemiological_JJ studies_NNS ,_, the_DT relationship_NN between_IN adverse_JJ health_NN outcomes_NNS and_CC CBPs_NNS in_IN drinking_NN water_NN is_VBZ evaluated_VBN using_VBG categorical_JJ exposure_NN variables_NNS ._. 
The_DT categories_NNS of_IN CBP_NNP exposure_NN are_VBP generally_RB based_VBN on_IN CBP_NNP levels_NNS measured_VBN in_IN the_DT area_NN under_IN study_NN and_CC more_RBR precisely_RB on_IN CBP_NNP level_NN percentiles_NNS ._. 
As_IN a_DT result_NN ,_, for_IN each_DT of_IN the_DT six_CD methods_NNS under_IN study_NN ,_, the_DT subjects_NNS were_VBD classified_VBN in_IN TTHM_NNP and_CC HAA9_NNP exposure_NN categories_NNS according_VBG to_TO the_DT estimation_NN of_IN CBP_NNP levels_NNS in_IN their_PRP$ residence_NN drinking_NN water_NN obtained_VBN from_IN the_DT specific_JJ method_NN ._. 
However_RB ,_, in_IN the_DT case_NN where_WRB more_JJR than_IN one_CD location_NN in_IN the_DT subject_NN 's_POS distribution_NN system_NN is_VBZ sampled_VBN ,_, different_JJ approaches_NNS are_VBP applied_VBN to_TO estimate_VB THM_NNP and_CC HAA_NNP levels_NNS in_IN the_DT subject_NN 's_POS residential_JJ tap_VBP water_NN ._. 
The_DT distribution_NN system-wide_JJ average_NN of_IN THM_NNP and_CC HAA_NNP data_NNS is_VBZ used_VBN for_IN exposure_NN assessment_NN in_IN most_JJS epidemiological_JJ studies_NNS 
Method_NN F_NN :_: The_DT average_NN of_IN CBP_NNP data_NNS from_IN all_DT sampling_VBG sites_NNS located_VBN in_IN the_DT distribution_NN system_NN was_VBD calculated_VBN and_CC assigned_VBN to_TO the_DT subjects_NNS ._. 
This_DT method_NN represents_VBZ the_DT usual_JJ spatial_JJ approach_NN applied_VBN to_TO assign_VB available_JJ CBP_NNP data_NNS to_TO the_DT subjects_NNS in_IN epidemiological_JJ studies_NNS ._. 
In_IN these_DT methods_NNS applied_VBD at_IN the_DT two_CD geographical_JJ scales_NNS ,_, the_DT road_NN distance_NN from_IN the_DT subject_NN 's_POS residence_NN to_TO a_DT specific_JJ sampling_NN site_NN was_VBD used_VBN as_IN an_DT indicator_NN of_IN proximity_NN -LRB-_-LRB- not_RB used_VBN in_IN the_DT methods_NNS D_NNP and_CC F_NN -RRB-_-RRB- ._. 
Different_JJ methods_NNS to_TO assign_VB available_JJ data_NNS to_TO subjects_NNS are_VBP also_RB applied_JJ ,_, such_JJ as_IN the_DT use_NN of_IN the_DT distribution_NN and_CC statistical_JJ variance_NN of_IN THM_NNP and_CC HAA_NNP levels_NNS in_IN distribution_NN systems_NNS 
However_RB ,_, in_IN the_DT case_NN where_WRB more_JJR than_IN one_CD location_NN in_IN the_DT subject_NN 's_POS distribution_NN system_NN is_VBZ sampled_VBN ,_, different_JJ approaches_NNS are_VBP applied_VBN to_TO estimate_VB THM_NNP and_CC HAA_NNP levels_NNS in_IN the_DT subject_NN 's_POS residential_JJ tap_VBP water_NN ._. 
The_DT distribution_NN system-wide_JJ average_NN of_IN THM_NNP and_CC HAA_NNP data_NNS is_VBZ used_VBN for_IN exposure_NN assessment_NN in_IN most_JJS epidemiological_JJ studies_NNS 
However_RB ,_, this_DT type_NN of_IN information_NN is_VBZ rarely_RB available_JJ ._. 
The_DT more_RBR accurate_JJ approach_NN is_VBZ based_VBN on_IN the_DT assignment_NN to_TO the_DT subjects_NNS of_IN data_NNS from_IN the_DT sampling_VBG location_NN in_IN the_DT distribution_NN system_NN with_IN hydraulic_JJ characteristics_NNS similar_JJ to_TO the_DT target_NN location_NN 
Method_NN F_NN :_: The_DT average_NN of_IN CBP_NNP data_NNS from_IN all_DT sampling_VBG sites_NNS located_VBN in_IN the_DT distribution_NN system_NN was_VBD calculated_VBN and_CC assigned_VBN to_TO the_DT subjects_NNS ._. 
This_DT method_NN represents_VBZ the_DT usual_JJ spatial_JJ approach_NN applied_VBN to_TO assign_VB available_JJ CBP_NNP data_NNS to_TO the_DT subjects_NNS in_IN epidemiological_JJ studies_NNS ._. 
In_IN these_DT methods_NNS applied_VBD at_IN the_DT two_CD geographical_JJ scales_NNS ,_, the_DT road_NN distance_NN from_IN the_DT subject_NN 's_POS residence_NN to_TO a_DT specific_JJ sampling_NN site_NN was_VBD used_VBN as_IN an_DT indicator_NN of_IN proximity_NN -LRB-_-LRB- not_RB used_VBN in_IN the_DT methods_NNS D_NNP and_CC F_NN -RRB-_-RRB- ._. 
Different_JJ methods_NNS to_TO assign_VB available_JJ data_NNS to_TO subjects_NNS are_VBP also_RB applied_JJ ,_, such_JJ as_IN the_DT use_NN of_IN the_DT distribution_NN and_CC statistical_JJ variance_NN of_IN THM_NNP and_CC HAA_NNP levels_NNS in_IN distribution_NN systems_NNS 
However_RB ,_, in_IN the_DT case_NN where_WRB more_JJR than_IN one_CD location_NN in_IN the_DT subject_NN 's_POS distribution_NN system_NN is_VBZ sampled_VBN ,_, different_JJ approaches_NNS are_VBP applied_VBN to_TO estimate_VB THM_NNP and_CC HAA_NNP levels_NNS in_IN the_DT subject_NN 's_POS residential_JJ tap_VBP water_NN ._. 
The_DT distribution_NN system-wide_JJ average_NN of_IN THM_NNP and_CC HAA_NNP data_NNS is_VBZ used_VBN for_IN exposure_NN assessment_NN in_IN most_JJS epidemiological_JJ studies_NNS 
Method_NN F_NN :_: The_DT average_NN of_IN CBP_NNP data_NNS from_IN all_DT sampling_VBG sites_NNS located_VBN in_IN the_DT distribution_NN system_NN was_VBD calculated_VBN and_CC assigned_VBN to_TO the_DT subjects_NNS ._. 
This_DT method_NN represents_VBZ the_DT usual_JJ spatial_JJ approach_NN applied_VBN to_TO assign_VB available_JJ CBP_NNP data_NNS to_TO the_DT subjects_NNS in_IN epidemiological_JJ studies_NNS ._. 
In_IN these_DT methods_NNS applied_VBD at_IN the_DT two_CD geographical_JJ scales_NNS ,_, the_DT road_NN distance_NN from_IN the_DT subject_NN 's_POS residence_NN to_TO a_DT specific_JJ sampling_NN site_NN was_VBD used_VBN as_IN an_DT indicator_NN of_IN proximity_NN -LRB-_-LRB- not_RB used_VBN in_IN the_DT methods_NNS D_NNP and_CC F_NN -RRB-_-RRB- ._. 
In_IN fact_NN ,_, the_DT majority_NN of_IN these_DT studies_NNS use_VBP data_NNS available_JJ through_IN regulatory_JJ compliance_NN on_IN CBPs_NNS in_IN drinking_NN water_NN for_IN which_WDT THMs_NNP and_CC HAAs_NNP -LRB-_-LRB- the_DT latter_NN only_RB in_IN United_NNP States_NNP -LRB-_-LRB- US_NNP -RRB-_-RRB- -RRB-_-RRB- are_VBP routinely_RB measured_VBN 
In_IN fact_NN ,_, the_DT highest_JJS average_JJ TTHM_NNP levels_NNS were_VBD found_VBN for_IN the_DT LE_NNP ,_, AR_NNP and_CC DE_NNP systems_NNS ._. 
As_IN shown_VBN in_IN this_DT table_NN ,_, average_JJ CBP_NNP levels_NNS during_IN the_DT entire_JJ study_NN period_NN differed_VBD from_IN one_CD distribution_NN system_NN to_TO another_DT ._. 
The_DT regulatory_JJ standard_NN for_IN TTHMs_NNP is_VBZ 80_CD 
g._NN Since_IN the_DT mechanisms_NNS of_IN toxic_JJ action_NN differ_VBP from_IN one_CD compound_NN of_IN the_DT same_JJ CBP_NNP class_NN to_TO another_DT -LRB-_-LRB- e._JJ ,_, individual_JJ THMs_NNS or_CC HAAs_NNS -RRB-_-RRB- ,_, the_DT effect_NN of_IN individual_JJ CBPs_NNS should_MD be_VB investigated_VBN 
e._NN Given_VBD the_DT ordered_VBN nature_NN of_IN outcomes_NNS -LRB-_-LRB- i._IN The_DT Kappa_NNP coefficient_NN represents_VBZ the_DT agreement_NN between_IN two_CD methods_NNS ._. 
,exposure_NN categories_NNS -RRB-_-RRB- ,_, weighted_JJ kappa_NN coefficients_NNS -LRB-_-LRB- 
81_CD 
,studies_NNS on_IN adverse_JJ reproductive_JJ outcomes_NNS -RRB-_-RRB- ._. 
g._VB This_DT temporal_JJ aspect_NN should_MD be_VB considered_VBN in_IN the_DT assessment_NN of_IN the_DT CBP_NNP levels_NNS in_IN the_DT subject_NN 's_POS drinking_NN water_NN ,_, particularly_RB in_IN the_DT case_NN where_WRB short-term_JJ exposure_NN periods_NNS are_VBP studied_VBN -LRB-_-LRB- e._JJ THMs_NNS and_CC HAAs_NNS are_VBP not_RB always_RB correlated_VBN with_IN other_JJ CBP_NNP compounds_NNS ._. 
As_IN a_DT result_NN ,_, the_DT relevance_NN of_IN their_PRP$ use_NN as_IN markers_NNS of_IN CBP_NNP exposure_NN could_MD be_VB questioned_VBN ._. 
In_IN future_JJ studies_NNS ,_, the_DT assessment_NN of_IN population_NN exposure_NN to_TO CBPs_NNS in_IN drinking_NN water_NN assessment_NN should_MD include_VB the_DT measurement_NN of_IN other_JJ CBPs_NNS -LRB-_-LRB- e._SYM 
,individual_JJ THMs_NNS or_CC HAAs_NNS -RRB-_-RRB- ,_, the_DT effect_NN of_IN individual_JJ CBPs_NNS should_MD be_VB investigated_VBN 
g._NN Since_IN the_DT mechanisms_NNS of_IN toxic_JJ action_NN differ_VBP from_IN one_CD compound_NN of_IN the_DT same_JJ CBP_NNP class_NN to_TO another_DT -LRB-_-LRB- e._JJ ,_, individual_JJ THMs_NNS or_CC HAAs_NNS -RRB-_-RRB- ,_, the_DT effect_NN of_IN individual_JJ CBPs_NNS should_MD be_VB investigated_VBN 
,individual_JJ THMs_NNS or_CC HAAs_NNS -RRB-_-RRB- ,_, the_DT effect_NN of_IN individual_JJ CBPs_NNS should_MD be_VB investigated_VBN 
Kappa_NNP statistics_NNS were_VBD estimated_VBN to_TO compare_VB the_DT classification_NN of_IN the_DT subjects_NNS in_IN TTHM_NNP and_CC HAA9_NNP exposure_NN categories_NNS obtained_VBN from_IN the_DT six_CD methods_NNS ._. 
The_DT Kappa_NNP coefficient_NN represents_VBZ the_DT agreement_NN between_IN two_CD methods_NNS ._. 
Given_VBN the_DT ordered_VBN nature_NN of_IN outcomes_NNS -LRB-_-LRB- i._FW e._FW ,_, exposure_NN categories_NNS -RRB-_-RRB- ,_, weighted_JJ kappa_NN coefficients_NNS -LRB-_-LRB- 
Kappa_NNP statistics_NNS were_VBD estimated_VBN to_TO compare_VB the_DT classification_NN of_IN the_DT subjects_NNS in_IN TTHM_NNP and_CC HAA9_NNP exposure_NN categories_NNS obtained_VBN from_IN the_DT six_CD methods_NNS ._. 
The_DT Kappa_NNP coefficient_NN represents_VBZ the_DT agreement_NN between_IN two_CD methods_NNS ._. 
Given_VBN the_DT ordered_VBN nature_NN of_IN outcomes_NNS -LRB-_-LRB- i._FW e._FW ,_, exposure_NN categories_NNS -RRB-_-RRB- ,_, weighted_JJ kappa_NN coefficients_NNS -LRB-_-LRB- 
For_IN each_DT method_NN ,_, the_DT estimation_NN of_IN CBP_NNP levels_NNS in_IN the_DT subject_NN 's_POS tap_VBP water_NN through_IN the_DT assignment_NN of_IN available_JJ CBP_NNP data_NNS in_IN this_DT study_NN was_VBD performed_VBN using_VBG SAS_NNP Version_NNP 9_CD ._. 
2._CD 
Data_NNP analysis_NN In_IN order_NN to_TO compare_VB CBP_NNP levels_NNS between_IN years_NNS ,_, sub-systems_NNS and_CC systems_NNS ,_, several_JJ statistical_JJ tests_NNS were_VBD carried_VBN out_IN ._. 
HAA9_NNP refers_VBZ to_TO the_DT sum_NN of_IN these_DT nine_CD compounds_NNS ._. 
The_DT nine_CD individual_JJ HAAs_NNS were_VBD also_RB analyzed_VBN :_: monochloroacetic_JJ -LRB-_-LRB- MCAA_NNP -RRB-_-RRB- ,_, dichloroacetic_JJ -LRB-_-LRB- DCAA_NNP -RRB-_-RRB- ,_, trichloroacetic_JJ -LRB-_-LRB- TCAA_NNP -RRB-_-RRB- ,_, monobromoacetic_JJ -LRB-_-LRB- MBAA_NNP -RRB-_-RRB- and_CC dibromoacetic_JJ -LRB-_-LRB- DBAA_NNP -RRB-_-RRB- ,_, tribromoacetic_JJ -LRB-_-LRB- TBAA_NNP -RRB-_-RRB- ,_, bromochloroacetic_JJ -LRB-_-LRB- BCAA_NNP -RRB-_-RRB- ,_, dibromochloroacetic_JJ -LRB-_-LRB- DBCAA_NNP -RRB-_-RRB- ,_, bromodichloroacetic_JJ -LRB-_-LRB- BDCAA_NNP -RRB-_-RRB- acids_NNS ._. 
The_DT sampling_NN and_CC analytical_JJ procedures_NNS applied_VBN to_TO characterize_VB the_DT THM_NNP and_CC HAA_NNP levels_NNS are_VBP described_VBN in_IN a_DT previous_JJ study_NN 
e._VB The_DT spatial_JJ variability_NN of_IN THMs_NNS and_CC HAAs_NNS within_IN distribution_NN systems_NNS can_MD be_VB influenced_VBN by_IN temporal_JJ variations_NNS -LRB-_-LRB- i._NN ,_, seasons_NNS ,_, months_NNS -RRB-_-RRB- of_IN water_NN quality_NN ._. 
In_IN order_NN to_TO minimize_VB the_DT temporal_JJ impact_NN of_IN the_DT occurrence_NN of_IN THMs_NNS and_CC HAAs_NNS on_IN the_DT subject_NN 's_POS exposure_NN assessment_NN obtained_VBN from_IN the_DT different_JJ spatial_JJ approaches_NNS ,_, multiple_JJ exposure_NN periods_NNS were_VBD investigated_VBN for_IN each_DT subject_NN ._. 
However_RB ,_, this_DT type_NN of_IN information_NN is_VBZ rarely_RB available_JJ ._. 
The_DT more_RBR accurate_JJ approach_NN is_VBZ based_VBN on_IN the_DT assignment_NN to_TO the_DT subjects_NNS of_IN data_NNS from_IN the_DT sampling_VBG location_NN in_IN the_DT distribution_NN system_NN with_IN hydraulic_JJ characteristics_NNS similar_JJ to_TO the_DT target_NN location_NN 
Other_JJ studies_NNS consider_VBP THM_NNP and_CC HAA_NNP data_NNS from_IN the_DT closest_JJS sampling_NN location_NN within_IN the_DT distribution_NN system_NN to_TO the_DT subject_NN 's_POS residence_NN as_IN representative_NN of_IN the_DT subject_NN 's_POS exposure_NN 
The_DT sampling_NN and_CC analytical_JJ procedures_NNS applied_VBN to_TO characterize_VB the_DT THM_NNP and_CC HAA_NNP levels_NNS are_VBP described_VBN in_IN a_DT previous_JJ study_NN 
The_DT distribution_NN system-wide_JJ average_NN of_IN THM_NNP and_CC HAA_NNP data_NNS is_VBZ used_VBN for_IN exposure_NN assessment_NN in_IN most_JJS epidemiological_JJ studies_NNS 
Other_JJ studies_NNS consider_VBP THM_NNP and_CC HAA_NNP data_NNS from_IN the_DT closest_JJS sampling_NN location_NN within_IN the_DT distribution_NN system_NN to_TO the_DT subject_NN 's_POS residence_NN as_IN representative_NN of_IN the_DT subject_NN 's_POS exposure_NN 
However_RB ,_, this_DT type_NN of_IN information_NN is_VBZ rarely_RB available_JJ ._. 
The_DT more_RBR accurate_JJ approach_NN is_VBZ based_VBN on_IN the_DT assignment_NN to_TO the_DT subjects_NNS of_IN data_NNS from_IN the_DT sampling_VBG location_NN in_IN the_DT distribution_NN system_NN with_IN hydraulic_JJ characteristics_NNS similar_JJ to_TO the_DT target_NN location_NN 
The_DT sampling_NN and_CC analytical_JJ procedures_NNS applied_VBN to_TO characterize_VB the_DT THM_NNP and_CC HAA_NNP levels_NNS are_VBP described_VBN in_IN a_DT previous_JJ study_NN 
,without_NN considering_VBG the_DT presence_NN of_IN an_DT intermediary_JJ water_NN infrastructure_NN -RRB-_-RRB- ._. 
e._NNP Method_NNP E_NNP :_: CBP_NNP data_NNS from_IN the_DT closest_JJS sampling_NN site_NN to_TO the_DT subject_NN 's_POS residence_NN were_VBD assigned_VBN directly_RB to_TO the_DT subjects_NNS -LRB-_-LRB- i._VB This_DT approach_NN has_VBZ also_RB been_VBN applied_VBN to_TO assign_VB CBP_NNP data_NNS to_TO the_DT subjects_NNS in_IN several_JJ epidemiological_JJ studies_NNS ._. 
Method_NN F_NN :_: The_DT average_NN of_IN CBP_NNP data_NNS from_IN all_DT sampling_VBG sites_NNS located_VBN in_IN the_DT distribution_NN system_NN was_VBD calculated_VBN and_CC assigned_VBN to_TO the_DT subjects_NNS ._. 
In_IN these_DT methods_NNS applied_VBD at_IN the_DT two_CD geographical_JJ scales_NNS ,_, the_DT road_NN distance_NN from_IN the_DT subject_NN 's_POS residence_NN to_TO a_DT specific_JJ sampling_NN site_NN was_VBD used_VBN as_IN an_DT indicator_NN of_IN proximity_NN -LRB-_-LRB- not_RB used_VBN in_IN the_DT methods_NNS D_NNP and_CC F_NN -RRB-_-RRB- ._. 
However_RB ,_, the_DT systematic_JJ correlation_NN between_IN the_DT distance_NN to_TO a_DT sampling_NN site_NN and_CC the_DT CBP_NNP levels_NNS was_VBD not_RB demonstrated_VBN ._. 
Since_IN this_DT type_NN of_IN proximity_NN indicator_NN was_VBD available_JJ -LRB-_-LRB- contrary_JJ to_TO the_DT precise_JJ water_NN residence_NN time_NN in_IN the_DT pipes_NNS -RRB-_-RRB- ,_, it_PRP was_VBD used_VBN in_IN the_DT CBP_NNP level_NN assessment_NN methods_NNS presented_VBD herein_RB ._. 
However_RB ,_, in_IN the_DT case_NN where_WRB more_JJR than_IN one_CD location_NN in_IN the_DT subject_NN 's_POS distribution_NN system_NN is_VBZ sampled_VBN ,_, different_JJ approaches_NNS are_VBP applied_VBN to_TO estimate_VB THM_NNP and_CC HAA_NNP levels_NNS in_IN the_DT subject_NN 's_POS residential_JJ tap_VBP water_NN ._. 
The_DT distribution_NN system-wide_JJ average_NN of_IN THM_NNP and_CC HAA_NNP data_NNS is_VBZ used_VBN for_IN exposure_NN assessment_NN in_IN most_JJS epidemiological_JJ studies_NNS 
Usually_RB ,_, in_IN epidemiological_JJ studies_NNS ,_, the_DT relationship_NN between_IN adverse_JJ health_NN outcomes_NNS and_CC CBPs_NNS in_IN drinking_NN water_NN is_VBZ evaluated_VBN using_VBG categorical_JJ exposure_NN variables_NNS ._. 
The_DT categories_NNS of_IN CBP_NNP exposure_NN are_VBP generally_RB based_VBN on_IN CBP_NNP levels_NNS measured_VBN in_IN the_DT area_NN under_IN study_NN and_CC more_RBR precisely_RB on_IN CBP_NNP level_NN percentiles_NNS ._. 
As_IN a_DT result_NN ,_, for_IN each_DT of_IN the_DT six_CD methods_NNS under_IN study_NN ,_, the_DT subjects_NNS were_VBD classified_VBN in_IN TTHM_NNP and_CC HAA9_NNP exposure_NN categories_NNS according_VBG to_TO the_DT estimation_NN of_IN CBP_NNP levels_NNS in_IN their_PRP$ residence_NN drinking_NN water_NN obtained_VBN from_IN the_DT specific_JJ method_NN ._. 
In_IN fact_NN ,_, the_DT majority_NN of_IN these_DT studies_NNS use_VBP data_NNS available_JJ through_IN regulatory_JJ compliance_NN on_IN CBPs_NNS in_IN drinking_NN water_NN for_IN which_WDT THMs_NNP and_CC HAAs_NNP -LRB-_-LRB- the_DT latter_NN only_RB in_IN United_NNP States_NNP -LRB-_-LRB- US_NNP -RRB-_-RRB- -RRB-_-RRB- are_VBP routinely_RB measured_VBN 
In_IN fact_NN ,_, the_DT highest_JJS average_JJ TTHM_NNP levels_NNS were_VBD found_VBN for_IN the_DT LE_NNP ,_, AR_NNP and_CC DE_NNP systems_NNS ._. 
As_IN shown_VBN in_IN this_DT table_NN ,_, average_JJ CBP_NNP levels_NNS during_IN the_DT entire_JJ study_NN period_NN differed_VBD from_IN one_CD distribution_NN system_NN to_TO another_DT ._. 
The_DT regulatory_JJ standard_NN for_IN TTHMs_NNP is_VBZ 80_CD 
Asimilar_JJ pattern_NN was_VBD observed_VBN for_IN HAA9_NNP with_IN levels_NNS below_IN those_DT measured_VBN for_IN TTHM_NNP ,_, except_IN for_IN the_DT AR_NNP ,_, DE_NNP and_CC QC_NNP systems_NNS -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- ._. 
Levels_NNS above_IN the_DT US_NNP standard_NN for_IN HAA5_NNP -LRB-_-LRB- which_WDT is_VBZ the_DT sum_NN of_IN MCAA_NNP ,_, DCAA_NNP ,_, TCAA_NNP ,_, MBAA_NNP and_CC DBAA_NNP -RRB-_-RRB- of_IN 60_CD 
g._NN Background_NN In_IN recent_JJ decades_NNS ,_, various_JJ epidemiological_JJ studies_NNS have_VBP been_VBN conducted_VBN to_TO determine_VB the_DT relationship_NN between_IN chlorination_NN by-products_NNS -LRB-_-LRB- CBPs_NNS -RRB-_-RRB- and_CC different_JJ health_NN outcomes_NNS -LRB-_-LRB- e._NN ,_, cancers_NNS and_CC reproductive_JJ outcomes_NNS -RRB-_-RRB- ._. 
Since_IN trihalomethanes_NNS -LRB-_-LRB- THMs_NNS -RRB-_-RRB- and_CC haloacetic_JJ acids_NNS -LRB-_-LRB- HAAs_NNP -RRB-_-RRB- are_VBP the_DT most_RBS prevalent_JJ and_CC documented_VBD CBP_NNP compounds_NNS in_IN drinking_NN water_NN ,_, they_PRP are_VBP generally_RB considered_VBN as_IN indicators_NNS of_IN CBP_NNP exposure_NN in_IN epidemiological_JJ investigations_NNS ._. 
Since_IN trihalomethanes_NNS -LRB-_-LRB- THMs_NNS -RRB-_-RRB- and_CC haloacetic_JJ acids_NNS -LRB-_-LRB- HAAs_NNP -RRB-_-RRB- are_VBP the_DT most_RBS prevalent_JJ and_CC documented_VBD CBP_NNP compounds_NNS in_IN drinking_NN water_NN ,_, they_PRP are_VBP generally_RB considered_VBN as_IN indicators_NNS of_IN CBP_NNP exposure_NN in_IN epidemiological_JJ investigations_NNS ._. 
In_IN epidemiological_JJ studies_NNS focusing_VBG on_IN THMs_NNS and_CC HAAs_NNS in_IN drinking_NN water_NN and_CC human_JJ health_NN outcomes_NNS ,_, exposure_NN misclassification_NN can_MD occur_VB through_IN the_DT assessment_NN of_IN population_NN exposure_NN to_TO these_DT compounds_NNS and_CC especially_RB in_IN the_DT estimation_NN of_IN their_PRP$ levels_NNS in_IN residential_JJ tap_VBP water_NN 
Since_IN trihalomethanes_NNS -LRB-_-LRB- THMs_NNS -RRB-_-RRB- and_CC haloacetic_JJ acids_NNS -LRB-_-LRB- HAAs_NNP -RRB-_-RRB- are_VBP the_DT most_RBS prevalent_JJ and_CC documented_VBD CBP_NNP compounds_NNS in_IN drinking_NN water_NN ,_, they_PRP are_VBP generally_RB considered_VBN as_IN indicators_NNS of_IN CBP_NNP exposure_NN in_IN epidemiological_JJ investigations_NNS ._. 
In_IN epidemiological_JJ studies_NNS focusing_VBG on_IN THMs_NNS and_CC HAAs_NNS in_IN drinking_NN water_NN and_CC human_JJ health_NN outcomes_NNS ,_, exposure_NN misclassification_NN can_MD occur_VB through_IN the_DT assessment_NN of_IN population_NN exposure_NN to_TO these_DT compounds_NNS and_CC especially_RB in_IN the_DT estimation_NN of_IN their_PRP$ levels_NNS in_IN residential_JJ tap_VBP water_NN 
g._VB As_IN a_DT result_NN ,_, data_NNS used_VBD to_TO assess_VB the_DT THM_NNP and_CC HAA_NNP levels_NNS in_IN the_DT subject_NN 's_POS tap_VBP water_NN from_IN a_DT sampling_NN location_NN in_IN the_DT subject_NN 's_POS distribution_NN system_NN are_VBP not_RB necessarily_RB representative_JJ of_IN the_DT subject_NN 's_POS residential_JJ water_NN quality_NN -LRB-_-LRB- e._FW ,_, with_IN different_JJ hydraulic_JJ characteristics_NNS and_CC not_RB being_VBG supplied_VBN by_IN the_DT same_JJ direct_JJ water_NN infrastructure_NN -RRB-_-RRB- ._. 
The_DT main_JJ objective_NN of_IN this_DT paper_NN is_VBZ to_TO investigate_VB and_CC compare_VB different_JJ spatially-based_JJ approaches_NNS to_TO assign_VB available_JJ THM_NNP and_CC HAA_NNP concentration_NN data_NNS to_TO subjects_NNS involved_VBN in_IN epidemiological_JJ studies_NNS ._. 
g._NN Background_NN In_IN recent_JJ decades_NNS ,_, various_JJ epidemiological_JJ studies_NNS have_VBP been_VBN conducted_VBN to_TO determine_VB the_DT relationship_NN between_IN chlorination_NN by-products_NNS -LRB-_-LRB- CBPs_NNS -RRB-_-RRB- and_CC different_JJ health_NN outcomes_NNS -LRB-_-LRB- e._NN ,_, cancers_NNS and_CC reproductive_JJ outcomes_NNS -RRB-_-RRB- ._. 
Since_IN trihalomethanes_NNS -LRB-_-LRB- THMs_NNS -RRB-_-RRB- and_CC haloacetic_JJ acids_NNS -LRB-_-LRB- HAAs_NNP -RRB-_-RRB- are_VBP the_DT most_RBS prevalent_JJ and_CC documented_VBD CBP_NNP compounds_NNS in_IN drinking_NN water_NN ,_, they_PRP are_VBP generally_RB considered_VBN as_IN indicators_NNS of_IN CBP_NNP exposure_NN in_IN epidemiological_JJ investigations_NNS ._. 
g._NN In_IN future_JJ studies_NNS ,_, the_DT assessment_NN of_IN population_NN exposure_NN to_TO CBPs_NNS in_IN drinking_NN water_NN assessment_NN should_MD include_VB the_DT measurement_NN of_IN other_JJ CBPs_NNS -LRB-_-LRB- e._FW ,_, haloacetonitriles_NNS ,_, haloketones_NNS -RRB-_-RRB- ._. 
Since_IN the_DT mechanisms_NNS of_IN toxic_JJ action_NN differ_VBP from_IN one_CD compound_NN of_IN the_DT same_JJ CBP_NNP class_NN to_TO another_DT -LRB-_-LRB- e._NN 
In_IN epidemiological_JJ studies_NNS focusing_VBG on_IN THMs_NNS and_CC HAAs_NNS in_IN drinking_NN water_NN and_CC human_JJ health_NN outcomes_NNS ,_, exposure_NN misclassification_NN can_MD occur_VB through_IN the_DT assessment_NN of_IN population_NN exposure_NN to_TO these_DT compounds_NNS and_CC especially_RB in_IN the_DT estimation_NN of_IN their_PRP$ levels_NNS in_IN residential_JJ tap_VBP water_NN 
As_IN a_DT result_NN ,_, alternative_JJ data_NNS are_VBP used_VBN in_IN epidemiological_JJ investigations_NNS on_IN population_NN exposure_NN assessment_NN ._. 
In_IN fact_NN ,_, the_DT majority_NN of_IN these_DT studies_NNS use_VBP data_NNS available_JJ through_IN regulatory_JJ compliance_NN on_IN CBPs_NNS in_IN drinking_NN water_NN for_IN which_WDT THMs_NNP and_CC HAAs_NNP -LRB-_-LRB- the_DT latter_NN only_RB in_IN United_NNP States_NNP -LRB-_-LRB- US_NNP -RRB-_-RRB- -RRB-_-RRB- are_VBP routinely_RB measured_VBN 
However_RB ,_, in_IN the_DT case_NN where_WRB more_JJR than_IN one_CD location_NN in_IN the_DT subject_NN 's_POS distribution_NN system_NN is_VBZ sampled_VBN ,_, different_JJ approaches_NNS are_VBP applied_VBN to_TO estimate_VB THM_NNP and_CC HAA_NNP levels_NNS in_IN the_DT subject_NN 's_POS residential_JJ tap_VBP water_NN ._. 
The_DT distribution_NN system-wide_JJ average_NN of_IN THM_NNP and_CC HAA_NNP data_NNS is_VBZ used_VBN for_IN exposure_NN assessment_NN in_IN most_JJS epidemiological_JJ studies_NNS 
Method_NN F_NN :_: The_DT average_NN of_IN CBP_NNP data_NNS from_IN all_DT sampling_VBG sites_NNS located_VBN in_IN the_DT distribution_NN system_NN was_VBD calculated_VBN and_CC assigned_VBN to_TO the_DT subjects_NNS ._. 
This_DT method_NN represents_VBZ the_DT usual_JJ spatial_JJ approach_NN applied_VBN to_TO assign_VB available_JJ CBP_NNP data_NNS to_TO the_DT subjects_NNS in_IN epidemiological_JJ studies_NNS ._. 
In_IN these_DT methods_NNS applied_VBD at_IN the_DT two_CD geographical_JJ scales_NNS ,_, the_DT road_NN distance_NN from_IN the_DT subject_NN 's_POS residence_NN to_TO a_DT specific_JJ sampling_NN site_NN was_VBD used_VBN as_IN an_DT indicator_NN of_IN proximity_NN -LRB-_-LRB- not_RB used_VBN in_IN the_DT methods_NNS D_NNP and_CC F_NN -RRB-_-RRB- ._. 
S._NNP Samples_NNP representing_VBG U._NNP Results_NNS Description_NN of_IN Studies_NNS The_DT 21_CD quantitative_JJ articles_NNS included_VBN in_IN this_DT review_NN included_VBD randomized_VBN controlled_JJ trials_NNS ,_, as_RB well_RB as_IN cohort_NN studies_NNS and_CC interrupted_JJ time_NN series_NN ,_, but_CC the_DT majority_NN were_VBD one-time_JJ surveys_NNS or_CC interviews_NNS ._. 
adult_NN men_NNS and_CC women_NNS were_VBD most_RBS common_JJ ;_: however_RB four_CD studies_NNS were_VBD conducted_VBN in_IN the_DT Netherlands_NNP 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
The_DT only_JJ study_NN to_TO actually_RB test_VB a_DT theory_NN -LRB-_-LRB- Social_NNP Cognitive_NNP Theory_NNP -RRB-_-RRB- was_VBD Major_JJ 
One_CD study_NN compared_VBD print_NN information_NN versus_IN in-person\/verbal_JJ communication_NN 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP StrategiesThe_NNP risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
Mailed_VBN information_NN :_: Letter_NN and_CC card_NN The_DT Seveso_NNP Directive_NNP is_VBZ a_DT broad_JJ European_JJ initiative_NN that_WDT requires_VBZ -LRB-_-LRB- among_IN other_JJ things_NNS -RRB-_-RRB- the_DT public_NN who_WP are_VBP most_RBS likely_JJ to_TO be_VB affected_VBN by_IN an_DT industrial_JJ accident_NN be_VB informed_VBN of_IN their_PRP$ risks_NNS and_CC the_DT best_JJS way_NN to_TO act_VB in_IN the_DT event_NN of_IN an_DT accident_NN ._. 
In_IN response_NN to_TO the_DT directive_NN ,_, a_DT Dutch_JJ research_NN group_NN conducted_VBD a_DT controlled_JJ clinical_JJ trial_NN to_TO help_VB identify_VB what_WP information_NN formats_NNS would_MD be_VB best_RB for_IN target_NN populations_NNS ._. 
The_DT primary_JJ information_NN was_VBD contained_VBN in_IN a_DT letter_NN signed_VBN by_IN the_DT mayor_NN and_CC the_DT director_NN of_IN the_DT plant_NN ,_, as_RB well_RB as_IN a_DT card_NN with_IN instructions_NNS on_IN the_DT correct_JJ behavior_NN in_IN case_NN of_IN an_DT emergency_NN ._. 
S._NNP Samples_NNP representing_VBG U._NNP Results_NNS Description_NN of_IN Studies_NNS The_DT 21_CD quantitative_JJ articles_NNS included_VBN in_IN this_DT review_NN included_VBD randomized_VBN controlled_JJ trials_NNS ,_, as_RB well_RB as_IN cohort_NN studies_NNS and_CC interrupted_JJ time_NN series_NN ,_, but_CC the_DT majority_NN were_VBD one-time_JJ surveys_NNS or_CC interviews_NNS ._. 
adult_NN men_NNS and_CC women_NNS were_VBD most_RBS common_JJ ;_: however_RB four_CD studies_NNS were_VBD conducted_VBN in_IN the_DT Netherlands_NNP 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
The_DT only_JJ study_NN to_TO actually_RB test_VB a_DT theory_NN -LRB-_-LRB- Social_NNP Cognitive_NNP Theory_NNP -RRB-_-RRB- was_VBD Major_JJ 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP StrategiesThe_NNP risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
Following_VBG the_DT intervention_NN ,_, there_EX was_VBD a_DT reduction_NN in_IN percentage_NN of_IN the_DT test_NN group_NN who_WP indicated_VBD they_PRP did_VBD not_RB know_VB what_WP to_TO do_VB to_TO shelter_NN -LRB-_-LRB- from_IN 46_CD %_NN to_TO 20_CD %_NN -RRB-_-RRB- ,_, but_CC no_DT statistically_RB significant_JJ -LRB-_-LRB- p_NN values_NNS not_RB reported_VBD -RRB-_-RRB- change_NN in_IN the_DT proportion_NN of_IN control_NN group_NN 1_CD who_WP indicated_VBD they_PRP did_VBD not_RB know_VB what_WP to_TO do_VB ._. 
The_DT second_JJ study_NN ,_, Predy_NNP ,_, Carney_NNP ,_, and_CC Edwards_NNP used_VBD a_DT one-time_JJ survey_NN design_NN to_TO determine_VB the_DT effectiveness_NN of_IN a_DT recorded_VBN information_NN line_NN in_IN communicating_VBG health_NN risk_NN during_IN the_DT emergence_NN of_IN a_DT new_JJ disease_NN ,_, hantavirus_VBZ pulmonary_JJ syndrome_NN -LRB-_-LRB- HPS_NNP -RRB-_-RRB- ,_, and_CC to_TO study_VB the_DT accuracy_NN of_IN recall_NN of_IN information_NN about_IN the_DT virus_NN among_IN the_DT general_JJ public_NN ._. 
The_DT sample_NN -LRB-_-LRB- N_NNP =_SYM 740_CD -RRB-_-RRB- was_VBD randomly_RB selected_VBN through_IN telephone_NN numbers_NNS in_IN Edmonton_NNP ,_, Canada_NNP ._. 
Two_CD percent_NN of_IN the_DT people_NNS received_VBD their_PRP$ information_NN from_IN the_DT recorded_VBN line_NN ,_, and_CC more_JJR people_NNS remembered_VBD receiving_VBG their_PRP$ information_NN through_IN the_DT news_NN media_NNS ,_, particularly_RB television_NN -LRB-_-LRB- 74_CD %_NN -RRB-_-RRB- and_CC newspaper_NN -LRB-_-LRB- 57_CD %_NN -RRB-_-RRB- ._. 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
Methods_NNS of_IN Risk_NNP Communication_NNP Print_NNP information_NN 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP StrategiesThe_NNP risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
The_DT authors_NNS indicated_VBD that_IN the_DT media_NNS got_VBD much_JJ of_IN their_PRP$ information_NN from_IN the_DT information_NN line_NN ,_, although_IN there_EX were_VBD no_DT data_NNS to_TO support_VB this_DT claim_NN ._. 
Contact_NN with_IN ExpertsTerpstra_NNP ,_, Lindell_NNP ,_, and_CC Gutteling_NNP evaluated_VBD the_DT effects_NNS of_IN a_DT flood_NN risk_NN communication_NN program_NN in_IN the_DT Netherlands_NNP ._. 
The_DT pre\/post-test_JJ quasi-experimental_JJ study_NN design_NN measured_VBD the_DT effect_NN of_IN direct_JJ personal_JJ experience_NN and_CC vicarious_JJ experience_NN to_TO risk_VB communication_NN on_IN changes_NNS in_IN individuals_NNS '_POS beliefs_NNS and_CC attitudes_NNS toward_IN flood_NN risk_NN ._. 
MW_NNP W_NNP W_NNP W_NNP N\/A_NNP W_NNP Rich_NNP 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
The_DT only_JJ study_NN to_TO actually_RB test_VB a_DT theory_NN -LRB-_-LRB- Social_NNP Cognitive_NNP Theory_NNP -RRB-_-RRB- was_VBD Major_JJ 
The_DT outcome_NN measured_VBD most_RBS often_RB in_IN the_DT articles_NNS was_VBD change_NN in_IN knowledge_NN 
Most_JJS studies_NNS were_VBD one-time_JJ interviews_NNS and_CC surveys_NNS which_WDT ,_, in_IN general_JJ ,_, used_JJ questionnaires_NNS that_WDT had_VBD been_VBN developed_VBN specifically_RB for_IN that_DT one_CD study_NN and_CC had_VBD not_RB been_VBN tested_VBN for_IN reliability_NN or_CC validity_NN ._. 
In_IN only_RB one_CD study_NN was_VBD a_DT valid_JJ and_CC reliable_JJ data_NNS collection_NN tool_NN used_VBD ._. 
The_DT data_NN collection_NN methods_NNS were_VBD often_RB self-response_JJ -LRB-_-LRB- paper\/pencil_NN -RRB-_-RRB- and_CC there_EX was_VBD a_DT strong_JJ possibility_NN of_IN recall_NN bias_NN ._. 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP StrategiesThe_NNP risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
The_DT post-campaign_JJ level_NN of_IN knowledge_NN of_IN asbestos-associated_JJ illness_NN risks_NNS increased_VBD from_IN 58_CD %_NN pre-campaign_JJ to_TO 67_CD %_NN -LRB-_-LRB- level_NN of_IN statistical_JJ significance_NN not_RB reported_VBD -RRB-_-RRB- ._. 
Staats_NNP ,_, Wit_NNP ,_, and_CC Midden_NNP used_VBD a_DT pre\/post-test_JJ design_NN to_TO evaluate_VB the_DT effect_NN of_IN a_DT mass_NN media_NNS campaign_NN for_IN communicating_VBG the_DT risk_NN of_IN greenhouse_NN gas_NN ._. 
The_DT study_NN was_VBD conducted_VBN in_IN the_DT Netherlands_NNP ._. 
Arepresentative_JJ sample_NN of_IN the_DT Dutch_JJ population_NN with_IN respect_NN to_TO age_NN and_CC sex_NN -LRB-_-LRB- N_NNP =_SYM 965_CD -RRB-_-RRB- were_VBD given_VBN pre-test_JJ questionnaires_NNS ._. 
The_DT three_CD qualitative_JJ articles_NNS were_VBD assessed_VBN using_VBG the_DT Letts_NNPS et_FW al._FW ._. 
Levels_NNS of_IN statistical_JJ significance_NN were_VBD also_RB often_RB not_RB reported_VBN ._. 
tool_NN ._. 
This_DT tool_NN does_VBZ not_RB provide_VB an_DT overall_JJ score_NN for_IN methodological_JJ quality_NN ;_: however_RB ,_, the_DT component_NN scores_NNS lead_VBP the_DT reviewers_NNS to_TO determine_VB the_DT three_CD qualitative_JJ papers_NNS were_VBD methodologically_RB weak_JJ ._. 
WW_NNP W_NNP W_NNP W_NNP N\/A_NNP w_NNP Connelly_NNP 
S._NNP Samples_NNP representing_VBG U._NNP Results_NNS Description_NN of_IN Studies_NNS The_DT 21_CD quantitative_JJ articles_NNS included_VBN in_IN this_DT review_NN included_VBD randomized_VBN controlled_JJ trials_NNS ,_, as_RB well_RB as_IN cohort_NN studies_NNS and_CC interrupted_JJ time_NN series_NN ,_, but_CC the_DT majority_NN were_VBD one-time_JJ surveys_NNS or_CC interviews_NNS ._. 
adult_NN men_NNS and_CC women_NNS were_VBD most_RBS common_JJ ;_: however_RB four_CD studies_NNS were_VBD conducted_VBN in_IN the_DT Netherlands_NNP 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
Theory_NNP was_VBD explicitly_RB used_VBN in_IN only_RB three_CD of_IN the_DT included_JJ studies_NNS ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- ,_, natural_JJ disasters_NNS -LRB-_-LRB- floods_NNS ;_: hurricanes_NNS ;_: earthquakes_NNS -RRB-_-RRB- 
The_DT only_JJ study_NN to_TO actually_RB test_VB a_DT theory_NN -LRB-_-LRB- Social_NNP Cognitive_NNP Theory_NNP -RRB-_-RRB- was_VBD Major_JJ 
One_CD study_NN compared_VBD print_NN information_NN versus_IN in-person\/verbal_JJ communication_NN 
Alimited_JJ number_NN of_IN articles_NNS measured_VBN additional_JJ outcomes_NNS such_JJ as_IN judgement_NN and_CC acceptance_NN of_IN risk_NN communication_NN 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP StrategiesThe_NNP risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
001_CD -RRB-_-RRB- ._. 
Those_DT who_WP heard_VBD the_DT lesson_NN provided_VBD the_DT correct_JJ answers_NNS more_RBR often_RB than_IN did_VBD those_DT who_WP read_VBP the_DT same_JJ information_NN in_IN the_DT brochure_NN for_IN 18_CD of_IN the_DT 20_CD questions_NNS asked_VBD -LRB-_-LRB- p_SYM 
The_DT tool_NN is_VBZ based_VBN on_IN guidelines_NNS set_VBN out_RP by_IN Mulrow_NNP ,_, Cook_NNP and_CC Davidoff_NNP 
and_CC includes_VBZ six_CD criteria_NNS -LRB-_-LRB- selection_NN and_CC allocation_NN bias_NN ,_, blinding_VBG ,_, confounders_NNS ,_, data_NNS collection_NN methods_NNS ,_, and_CC withdrawls_NNS and_CC dropouts_NNS -RRB-_-RRB- ._. 
The_DT tool_NN has_VBZ been_VBN reviewed_VBN by_IN experts_NNS in_IN the_DT field_NN 
MW_NNP W_NNP W_NNP W_NNP N\/A_NNP W_NNP Freimuth_NNP 
S._NNP Samples_NNP representing_VBG U._NNP Results_NNS Description_NN of_IN Studies_NNS The_DT 21_CD quantitative_JJ articles_NNS included_VBN in_IN this_DT review_NN included_VBD randomized_VBN controlled_JJ trials_NNS ,_, as_RB well_RB as_IN cohort_NN studies_NNS and_CC interrupted_JJ time_NN series_NN ,_, but_CC the_DT majority_NN were_VBD one-time_JJ surveys_NNS or_CC interviews_NNS ._. 
adult_NN men_NNS and_CC women_NNS were_VBD most_RBS common_JJ ;_: however_RB four_CD studies_NNS were_VBD conducted_VBN in_IN the_DT Netherlands_NNP 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
Alimited_JJ number_NN of_IN articles_NNS measured_VBN additional_JJ outcomes_NNS such_JJ as_IN judgement_NN and_CC acceptance_NN of_IN risk_NN communication_NN 
Factors_NNS that_WDT can_MD impact_VB communication_NN uptake_NN Six_CD quantitative_JJ and_CC three_CD qualitative_JJ articles_NNS included_VBN in_IN this_DT review_NN examined_VBD factors_NNS that_IN impact_NN risk_NN communication_NN uptake_NN ._. 
These_DT can_MD be_VB grouped_VBN into_IN the_DT following_JJ categories_NNS of_IN factors_NNS :_: personal_JJ risk_NN perception_NN 
The_DT direct_JJ effects_NNS of_IN the_DT negative_JJ threat_NN appeals_NNS on_IN respondents_NNS -LRB-_-LRB- which_WDT were_VBD significant_JJ at_IN the_DT time_NN the_DT communication_NN was_VBD read_VBN -RRB-_-RRB- diminished_VBN in_IN intensity_NN when_WRB an_DT increase_NN in_IN preparedness_NN behavior_NN was_VBD measured_VBN ._. 
Natter_NNP and_CC Berry_NNP 's_POS randomized_JJ controlled_JJ trial_NN compared_VBD the_DT relative_JJ and_CC absolute_JJ forms_NNS of_IN presenting_VBG risk_NN information_NN about_IN influenza_NN and_CC the_DT need_NN for_IN vaccination_NN ._. 
They_PRP investigated_VBD whether_IN differences_NNS in_IN people_NNS 's_POS estimates_NNS and_CC evaluation_NN of_IN risk_NN information_NN change_NN when_WRB they_PRP are_VBP presented_VBN with_IN baseline_JJ data_NNS ._. 
Blanchard_NNP et_FW al._FW ._. 
Table_NNP 2_CD Quality_NNP assessment_NN results_NNS for_IN qualitative_JJ relevant_JJ studies_NNS -LRB-_-LRB- n_SYM =_SYM 3_CD -RRB-_-RRB- S_NNP TUDY_NNP Eisenman_NNP et_FW al._FW ._. 
Each_DT of_IN the_DT three_CD qualitative_JJ articles_NNS used_VBD descriptive_JJ designs_NNS ._. 
Total_JJ sample_NN size_NN ranged_VBD from_IN 80_CD to_TO 3,546_CD ._. 
Two_CD 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
All_DT of_IN the_DT studies_NNS provided_VBD a_DT review_NN of_IN relevant_JJ background_NN literature_NN and_CC a_DT justification_NN of_IN need_NN for_IN the_DT study_NN ._. 
One_CD of_IN the_DT studies_NNS used_VBD a_DT grounded_VBN theory_NN study_NN design_NN 
All_DT of_IN the_DT studies_NNS provided_VBD a_DT general_JJ discussion_NN about_IN the_DT characteristics_NNS of_IN participants_NNS ._. 
Interview_NN and_CC focus_NN group_NN results_NNS were_VBD coded_VBN and_CC grouped_VBN under_IN themes_NNS and_CC sub-themes_NNS to_TO structure_VB a_DT narrative_NN and_CC discussion_NN of_IN findings_NNS ._. 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP Strategies_NNS The_DT risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
Factors_NNS that_WDT can_MD impact_VB communication_NN uptake_NN Six_CD quantitative_JJ and_CC three_CD qualitative_JJ articles_NNS included_VBN in_IN this_DT review_NN examined_VBD factors_NNS that_IN impact_NN risk_NN communication_NN uptake_NN ._. 
These_DT can_MD be_VB grouped_VBN into_IN the_DT following_JJ categories_NNS of_IN factors_NNS :_: personal_JJ risk_NN perception_NN 
S._NNP ,_, in_IN a_DT qualitative_JJ study_NN ,_, determined_VBD that_IN the_DT main_JJ source_NN for_IN information_NN about_IN the_DT anthrax_NN threat_NN was_VBD the_DT general_JJ media_NNS such_JJ as_IN television_NN and_CC newspapers_NNS ,_, as_RB well_RB as_IN communication_NN from_IN the_DT U._NNP Centers_NNPS for_IN Disease_NNP Control_NNP -LRB-_-LRB- CDC_NNP -RRB-_-RRB- ._. 
Some_DT postal_JJ workers_NNS said_VBD that_DT information_NN was_VBD communicated_VBN by_IN the_DT United_NNP States_NNPS Postal_NNP Service_NNP management_NN team_NN ._. 
Blanchard_NNP et_FW al._FW ._. 
The_DT media_NNS also_RB provided_VBD supports_NNS to_TO people_NNS that_WDT were_VBD isolated_VBN from_IN society_NN for_IN various_JJ reasons_NNS ._. 
examined_VBN risk_NN communication_NN strategies_NNS related_VBN to_TO bioterrorism_NN in_IN the_DT case_NN of_IN the_DT anthrax_NN threat_NN in_IN Washington_NNP ,_, DC_NNP among_IN postal_JJ -LRB-_-LRB- N_NNP =_SYM 36_CD -RRB-_-RRB- and_CC senate_NN workers_NNS -LRB-_-LRB- N_NNP =_SYM 7_CD -RRB-_-RRB- ._. 
Using_VBG focus_NN groups_NNS ,_, the_DT study_NN determined_VBD that_IN many_JJ postal_JJ workers_NNS did_VBD not_RB trust_VB the_DT higher_JJR authorities_NNS from_IN which_WDT risk_NN communication_NN information_NN was_VBD disseminated_VBN ._. 
Effective_JJ risk_NN communication_NN is_VBZ challenging_JJ ;_: no_DT single_JJ approach_NN works_VBZ for_IN all_DT populations_NNS or_CC for_IN all_DT environmental_JJ risk_NN situations_NNS ._. 
Given_VBN the_DT powerful_JJ influence_NN of_IN mass_NN media_NNS on_IN risk_NN perception_NN ,_, it_PRP is_VBZ noteworthy_JJ that_IN the_DT quantitative_JJ articles_NNS suggest_VBP that_IN a_DT multi-media_JJ approach_NN is_VBZ more_RBR effective_JJ than_IN any_DT single_JJ media_NNS approach_NN ._. 
For_IN example_NN ,_, a_DT public_JJ service_NN advertisement_NN campaign_NN that_WDT includes_VBZ ads_NNS on_IN radio_NN ,_, television_NN ,_, Internet_NN and_CC print_NN media_NNS is_VBZ more_RBR effective_JJ than_IN a_DT public_JJ service_NN announcement_NN campaign_NN that_WDT targets_VBZ a_DT single_JJ media_NNS source_NN ._. 
There_EX is_VBZ some_DT evidence_NN that_IN people_NNS who_WP have_VBP experience_NN with_IN natural_JJ disasters_NNS but_CC have_VBP not_RB experienced_VBN damage_NN to_TO their_PRP$ own_JJ property_NN or_CC injury_NN continue_VBP to_TO believe_VB that_IN they_PRP are_VBP also_RB protected_VBN against_IN possible_JJ danger_NN from_IN impending_JJ disasters_NNS ._. 
The_DT important_JJ role_NN that_IN trust_NN plays_NNS in_IN risk_NN communication_NN uptake_NN identified_VBN within_IN conceptual_JJ literature_NN is_VBZ also_RB supported_VBN by_IN the_DT results_NNS of_IN this_DT review_NN ._. 
People_NNS pay_VBP more_JJR attention_NN to_TO information_NN delivered_VBN by_IN credible_JJ sources_NNS ._. 
As_IN a_DT trusted_VBN and_CC important_JJ source_NN of_IN risk_NN information_NN ,_, people_NNS often_RB turn_VBP to_TO the_DT media_NNS ahead_RB of_IN other_JJ sources_NNS ,_, including_VBG public_JJ officials_NNS ._. 
MW_NNP W_NNP W_NNP W_NNP N\/A_NNP W_NNP Freimuth_NNP 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
Theory_NNP was_VBD explicitly_RB used_VBN in_IN only_RB three_CD of_IN the_DT included_JJ studies_NNS ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- ,_, natural_JJ disasters_NNS -LRB-_-LRB- floods_NNS ;_: hurricanes_NNS ;_: earthquakes_NNS -RRB-_-RRB- 
The_DT outcome_NN measured_VBD most_RBS often_RB in_IN the_DT articles_NNS was_VBD change_NN in_IN knowledge_NN 
Factors_NNS that_WDT can_MD impact_VB communication_NN uptake_NN Six_CD quantitative_JJ and_CC three_CD qualitative_JJ articles_NNS included_VBN in_IN this_DT review_NN examined_VBD factors_NNS that_IN impact_NN risk_NN communication_NN uptake_NN ._. 
These_DT can_MD be_VB grouped_VBN into_IN the_DT following_JJ categories_NNS of_IN factors_NNS :_: personal_JJ risk_NN perception_NN 
05_CD -RRB-_-RRB- than_IN were_VBD respondents_NNS in_IN Baton_NNP Rouge_NNP or_CC Mississippi\/Alabama_NNP ._. 
Houston_NNP respondents_NNS were_VBD statistically_RB significantly_RB more_RBR likely_JJ not_RB to_TO evacuate_VB -LRB-_-LRB- p_SYM 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
The_DT only_JJ study_NN to_TO actually_RB test_VB a_DT theory_NN -LRB-_-LRB- Social_NNP Cognitive_NNP Theory_NNP -RRB-_-RRB- was_VBD Major_JJ 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP StrategiesThe_NNP risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
For_IN instance_NN ,_, at_IN Phase_NN 2_CD only_RB 2_CD %_NN of_IN the_DT respondents_NNS recalled_VBD TRI_NNP without_IN prompting_VBG when_WRB asked_VBN to_TO name_VB the_DT government_NN program_NN that_WDT gathers_VBZ and_CC publicly_RB reports_VBZ information_NN about_IN industry_NN 's_POS releases_NNS of_IN chemicals_NNS into_IN the_DT environment_NN -LRB-_-LRB- level_NN of_IN statistical_JJ significance_NN not_RB reported_VBD -RRB-_-RRB- ._. 
Automated_NNP phone_NN messageA_NNP controlled_VBD clinical_JJ trial_NN was_VBD used_VBN by_IN Rich_NNP and_CC Conn_NNP to_TO explore_VB the_DT use_NN of_IN a_DT computerized_JJ system_NN to_TO alert_VB the_DT public_NN of_IN hazards_NNS ._. 
The_DT auto_NN 
WW_NNP W_NNP W_NNP W_NNP N\/A_NNP w_NNP Connelly_NNP 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
One_CD study_NN compared_VBD print_NN information_NN versus_IN in-person\/verbal_JJ communication_NN 
The_DT outcome_NN measured_VBD most_RBS often_RB in_IN the_DT articles_NNS was_VBD change_NN in_IN knowledge_NN 
Alimited_JJ number_NN of_IN articles_NNS measured_VBN additional_JJ outcomes_NNS such_JJ as_IN judgement_NN and_CC acceptance_NN of_IN risk_NN communication_NN 
0001_CD -RRB-_-RRB- ._. 
The_DT campaign_NN effect_NN on_IN voluntary_JJ behavior_NN change_NN was_VBD evident_JJ only_RB in_IN terms_NNS of_IN the_DT separate_JJ disposal_NN of_IN small_JJ chemical_NN waste_NN -LRB-_-LRB- p_SYM 
Educational_NNP program_NN A_DT one-time_JJ survey_NN studied_VBD the_DT impact_NN of_IN an_DT educational_JJ program_NN delivered_VBN through_IN printed_VBN new_JJ releases_NNS ,_, newsletter_NN articles_NNS ,_, newspaper_NN and_CC radio_NN PSA_NNP ,_, video_NN news_NN release_NN ,_, prewritten_JJ letters_NNS to_TO the_DT editor_NN and_CC brochures_NNS ,_, in_IN English_NNP and_CC Spanish_NNP ,_, on_IN increased_VBN awareness_NN of_IN West_NNP Nile_NNP Virus_NNP ._. 
Fox_NNP ,_, Averett_NNP ,_, Hansen_NNP ,_, and_CC Neuberger_NNP ,_, administered_VBD a_DT survey_NN to_TO individuals_NNS in_IN Kansas_NNP -LRB-_-LRB- N_NNP =_SYM 516_CD -RRB-_-RRB- in_IN urban_JJ and_CC rural_JJ households_NNS with_IN listed_JJ telephone_NN numbers_NNS 
One_CD of_IN the_DT five_CD other_JJ booklets_NNS was_VBD randomly_RB assigned_VBN to_TO everyone_NN else_RB in_IN the_DT study_NN ._. 
The_DT experiment_NN was_VBD structured_VBN so_RB that_IN one_CD half_NN of_IN those_DT with_IN a_DT radon_NN reading_NN below_IN 1_CD picocuries_NNS of_IN radon_NN per_IN litre_NN -LRB-_-LRB- pCi\/1_NNP -RRB-_-RRB- received_VBD a_DT fact_NN sheet_NN outlining_VBG radon_NN ._. 
Those_DT with_IN a_DT reading_NN above_IN 1_CD -LRB-_-LRB- pCi\/1_NNP -RRB-_-RRB- also_RB received_VBD the_DT Environmental_NNP Protection_NNP Agency_NNP -LRB-_-LRB- EPA_NNP -RRB-_-RRB- publication_NN ,_, A_NNP Citizen_NNP 's_POS Guide_NNP to_TO Radon_NNP 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
The_DT outcome_NN measured_VBD most_RBS often_RB in_IN the_DT articles_NNS was_VBD change_NN in_IN knowledge_NN 
Alimited_JJ number_NN of_IN articles_NNS measured_VBN additional_JJ outcomes_NNS such_JJ as_IN judgement_NN and_CC acceptance_NN of_IN risk_NN communication_NN 
Factors_NNS that_WDT can_MD impact_VB communication_NN uptake_NN Six_CD quantitative_JJ and_CC three_CD qualitative_JJ articles_NNS included_VBN in_IN this_DT review_NN examined_VBD factors_NNS that_IN impact_NN risk_NN communication_NN uptake_NN ._. 
These_DT can_MD be_VB grouped_VBN into_IN the_DT following_JJ categories_NNS of_IN factors_NNS :_: personal_JJ risk_NN perception_NN 
Personal_NNP Risk_NNP Perception_NNP Blendon_NNP et_FW al._FW ._. 
These_DT can_MD be_VB grouped_VBN into_IN the_DT following_JJ categories_NNS of_IN factors_NNS :_: personal_JJ risk_NN perception_NN 
SM_NNP W_NNP W_NNP W_NNP W_NNP W_NNP Burger_NNP 
Alimited_JJ number_NN of_IN articles_NNS measured_VBN additional_JJ outcomes_NNS such_JJ as_IN judgement_NN and_CC acceptance_NN of_IN risk_NN communication_NN 
Factors_NNS that_WDT can_MD impact_VB communication_NN uptake_NN Six_CD quantitative_JJ and_CC three_CD qualitative_JJ articles_NNS included_VBN in_IN this_DT review_NN examined_VBD factors_NNS that_IN impact_NN risk_NN communication_NN uptake_NN ._. 
These_DT can_MD be_VB grouped_VBN into_IN the_DT following_JJ categories_NNS of_IN factors_NNS :_: personal_JJ risk_NN perception_NN 
Sources_NNS of_IN Information_NNP Burnside_NNP et_FW al._FW ,_, being_VBG male_NN or_CC a_DT member_NN of_IN a_DT non-white_JJ ethic_JJ group_NN -RRB-_-RRB- ._. 
g._NN Study_NN findings_NNS also_RB indicated_VBD that_IN perceived_VBN risk_NN had_VBD a_DT direct_JJ and_CC positive_JJ impact_NN on_IN response_NN to_TO warnings_NNS with_IN protective_JJ actions_NNS ;_: warning_VBG information_NN quality_NN and_CC quantity_NN or_CC reinforcement_NN had_VBD a_DT direct_JJ positive_JJ effect_NN on_IN response_NN ;_: pre-event_JJ hazard_NN salience_NN enhanced_JJ warning_NN response_NN both_DT directly_RB and_CC indirectly_RB ;_: and_CC ,_, selected_VBN demographics_NNS could_MD negatively_RB constrain_VB both_DT perception_NN of_IN risk_NN and_CC warning_NN response_NN -LRB-_-LRB- e._NN considered_VBD a_DT hypothetical_JJ evacuation_NN order_NN to_TO residents_NNS in_IN Greater_NNP New_NNP Orleans_NNP -LRB-_-LRB- N_NNP =_SYM 1207_CD -RRB-_-RRB- ._. 
This_DT study_NN used_VBD a_DT one-time_JJ survey_NN design_NN ._. 
Respondents_NNS were_VBD asked_VBN :_: if_IN public_JJ officials_NNS recommended_VBD an_DT evacuation_NN because_IN of_IN the_DT threat_NN of_IN a_DT hurricane_NN this_DT year_NN ,_, what_WP would_MD you_PRP most_RBS likely_RB do_VBP :_: definitely_RB evacuate_VB ,_, probably_RB evacuate_VB ,_, probably_RB not_RB evacuate_VB or_CC definitely_RB not_RB evacuate_VB ._. 
MW_NNP W_NNP W_NNP W_NNP N\/A_NNP W_NNP Freimuth_NNP 
Protection_NNP Motivation_NNP Theory_NNP provided_VBD a_DT conceptual_JJ framework_NN in_IN the_DT study_NN by_IN Mulilis_NNP and_CC Lippa_NNP 
Alimited_JJ number_NN of_IN articles_NNS measured_VBN additional_JJ outcomes_NNS such_JJ as_IN judgement_NN and_CC acceptance_NN of_IN risk_NN communication_NN 
Finally_RB ,_, Situational_NNP Communication_NNP Theory_NNP explores_VBZ the_DT relationship_NN between_IN public_JJ opinion_NN and_CC communication_NN within_IN the_DT context_NN of_IN small_JJ ,_, active_JJ group_NN of_IN people_NNS -LRB-_-LRB- called_VBN ``_`` publics_NNS ''_'' -RRB-_-RRB- that_WDT develop_VBP around_IN a_DT specific_JJ issue_NN ._. 
Major_NNP tested_VBD Situation_NNP Communication_NNP Theory_NNP using_VBG an_DT interrupted_JJ time_NN series_NN design_NN in_IN the_DT context_NN of_IN disaster_NN communication_NN ,_, specifically_RB an_DT earthquake_NN prediction_NN for_IN the_DT New_NNP Madrid_NNP fault_NN region_NN ._. 
The_DT sample_NN -LRB-_-LRB- N_NNP =_SYM 998_CD -RRB-_-RRB- was_VBD adults_NNS living_VBG in_IN Missouri_NNP or_CC Illinois_NNP ._. 
Aseries_NNS of_IN interview_NN questions_NNS were_VBD used_VBN to_TO determine_VB the_DT level_NN of_IN involvement_NN for_IN the_DT respondent_NN in_IN a_DT disaster_NN situation_NN according_VBG to_TO the_DT four_CD types_NNS of_IN publics_NNS based_VBN on_IN situational_JJ theory_NN :_: problem_NN recognition_NN ,_, constrained_VBN recognition_NN ,_, fatalistics_NNS or_CC routines_NNS ._. 
MW_NNP W_NNP W_NNP W_NNP N\/A_NNP W_NNP Freimuth_NNP 
The_DT only_JJ study_NN to_TO actually_RB test_VB a_DT theory_NN -LRB-_-LRB- Social_NNP Cognitive_NNP Theory_NNP -RRB-_-RRB- was_VBD Major_JJ 
The_DT outcome_NN measured_VBD most_RBS often_RB in_IN the_DT articles_NNS was_VBD change_NN in_IN knowledge_NN 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP StrategiesThe_NNP risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
Factors_NNS that_WDT can_MD impact_VB communication_NN uptake_NN Six_CD quantitative_JJ and_CC three_CD qualitative_JJ articles_NNS included_VBN in_IN this_DT review_NN examined_VBD factors_NNS that_IN impact_NN risk_NN communication_NN uptake_NN ._. 
These_DT can_MD be_VB grouped_VBN into_IN the_DT following_JJ categories_NNS of_IN factors_NNS :_: personal_JJ risk_NN perception_NN 
e._VB Previous_JJ Experience_NN with_IN Risk_NNP Mileti_NNP and_CC O'Brien_NNP used_VBD a_DT one-time_JJ survey_NN to_TO explore_VB public_JJ response_NN to_TO risk_VB information_NN that_WDT was_VBD issued_VBN in_IN the_DT context_NN of_IN an_DT on-going_JJ emergency_NN -LRB-_-LRB- i._NN ,_, earthquake_NN aftershocks_NNS -RRB-_-RRB- ._. 
Two_CD populations_NNS were_VBD studied_VBN ,_, San_NNP Francisco_NNP -LRB-_-LRB- N_NNP =_SYM 734_CD -RRB-_-RRB- ,_, which_WDT had_VBD a_DT high_JJ media_NNS exposure_NN ,_, and_CC Santa_NNP Cruz_NNP County_NNP -LRB-_-LRB- N_NNP =_SYM 918_CD -RRB-_-RRB- ,_, where_WRB there_EX had_VBD been_VBN substantially_RB greater_JJR damage_NN but_CC lower_JJR media_NNS coverage_NN ._. 
There_EX is_VBZ some_DT evidence_NN that_IN people_NNS who_WP have_VBP experience_NN with_IN natural_JJ disasters_NNS but_CC have_VBP not_RB experienced_VBN damage_NN to_TO their_PRP$ own_JJ property_NN or_CC injury_NN continue_VBP to_TO believe_VB that_IN they_PRP are_VBP also_RB protected_VBN against_IN possible_JJ danger_NN from_IN impending_JJ disasters_NNS ._. 
The_DT important_JJ role_NN that_IN trust_NN plays_NNS in_IN risk_NN communication_NN uptake_NN identified_VBN within_IN conceptual_JJ literature_NN is_VBZ also_RB supported_VBN by_IN the_DT results_NNS of_IN this_DT review_NN ._. 
People_NNS pay_VBP more_JJR attention_NN to_TO information_NN delivered_VBN by_IN credible_JJ sources_NNS ._. 
As_IN a_DT trusted_VBN and_CC important_JJ source_NN of_IN risk_NN information_NN ,_, people_NNS often_RB turn_VBP to_TO the_DT media_NNS ahead_RB of_IN other_JJ sources_NNS ,_, including_VBG public_JJ officials_NNS ._. 
In_IN addition_NN to_TO being_VBG tailored_VBN to_TO the_DT specific_JJ needs_NNS of_IN the_DT targeted_JJ population_NN ,_, trust_NN in_IN communication_NN can_MD be_VB enhanced_VBN when_WRB it_PRP is_VBZ presented_VBN to_TO all_PDT the_DT affected_JJ people_NNS in_IN a_DT timely_JJ manner_NN ,_, consistent_JJ ,_, easy_JJ to_TO understand_VB ,_, and_CC comes_VBZ from_IN a_DT trusted_VBN source_NN ._. 
Recommendations_NNS for_IN risk_NN communication_NN plans_NNS in_IN public_JJ health_NN have_VBP previously_RB been_VBN published_VBN and_CC receive_VB empirical_JJ support_NN in_IN the_DT following_JJ summary_NN of_IN recommendations_NNS to_TO maximize_VB effectiveness_NN of_IN risk_NN communications_NNS as_IN a_DT result_NN of_IN this_DT review_NN :_: 
MW_NNP W_NNP W_NNP W_NNP N\/A_NNP W_NNP Freimuth_NNP 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
The_DT only_JJ study_NN to_TO actually_RB test_VB a_DT theory_NN -LRB-_-LRB- Social_NNP Cognitive_NNP Theory_NNP -RRB-_-RRB- was_VBD Major_JJ 
One_CD study_NN compared_VBD print_NN information_NN versus_IN in-person\/verbal_JJ communication_NN 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP StrategiesThe_NNP risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
Additional_JJ desirable_JJ information_NN thought_VBN to_TO be_VB important_JJ included_VBD how_WRB to_TO get_VB additional_JJ copies_NNS of_IN fact_NN sheets_NNS ,_, more_JJR information_NN on_IN the_DT levels_NNS of_IN contamination_NN in_IN fish_NN and_CC information_NN on_IN risk_NN levels_NNS and_CC ecological_JJ pathways_NNS ._. 
Arandomized_VBN controlled_JJ trial_NN -LRB-_-LRB- social_JJ experiment_NN -RRB-_-RRB- was_VBD conducted_VBN by_IN Johnson_NNP ,_, Fisher_NNP ,_, Smith_NNP ,_, and_CC Desvouges_NNP to_TO test_VB the_DT sensitivity_NN of_IN people_NNS 's_POS responses_NNS to_TO alternative_JJ presentations_NNS of_IN the_DT same_JJ information_NN on_IN radon_NN risk_NN ._. 
The_DT intervention_NN placed_VBD radon_NN detection_NN monitors_VBZ in_IN 2300_CD homes_NNS ,_, shared_VBD readings_NNS from_IN the_DT monitors_NNS and_CC provided_VBD printed_VBN materials_NNS that_WDT outlined_VBD the_DT meaning_NN of_IN the_DT reading_NN and_CC what_WP should_MD be_VB done_VBN ._. 
The_DT only_JJ study_NN to_TO actually_RB test_VB a_DT theory_NN -LRB-_-LRB- Social_NNP Cognitive_NNP Theory_NNP -RRB-_-RRB- was_VBD Major_JJ 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP StrategiesThe_NNP risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
WW_NNP W_NNP W_NNP W_NNP N\/A_NNP w_NNP Connelly_NNP 
Media_NNP Approaches_NNP Mass_NNP media_NNS An_DT interrupted_JJ time_NN series_NN evaluated_VBD a_DT campaign_NN to_TO increase_VB awareness_NN of_IN and_CC information_NN about_IN the_DT nature_NN ,_, extent_NN and_CC seriousness_NN of_IN asbestos_NN exposure_NN ._. 
The_DT aim_NN of_IN the_DT study_NN conducted_VBN by_IN Friemuth_NNP and_CC Van_NNP Nevel_NNP was_VBD to_TO deliver_VB information_NN to_TO a_DT target_NN group_NN of_IN manual_JJ labourers_NNS over_IN the_DT age_NN of_IN 50_CD who_WP could_MD not_RB be_VB individually_RB identified_VBN ._. 
Public_JJ service_NN announcements_NNS were_VBD created_VBN to_TO be_VB disseminated_VBN via_IN media_NNS ,_, including_VBG radio_NN and_CC television_NN ._. 
Table_NNP 1_CD Quality_NNP assessment_NN results_NNS for_IN relevant_JJ quantitative_JJ studies_NNS -LRB-_-LRB- n_SYM =_SYM 21_CD -RRB-_-RRB- Author_NN \/_NN Date_NNP Selection_NNP Bias_NNP Study_NNP Design_NNP Confounders_NNP Blinding_NNP Data_NNP Collection_NNP Methods_NNP Withdrawal_NNP \/_NNP Dropouts_NNPS G_NNP LOBAL_NNP R_NNP ATING_NNP Angulo_NNP et_FW al._FW ._. 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
The_DT only_JJ study_NN to_TO actually_RB test_VB a_DT theory_NN -LRB-_-LRB- Social_NNP Cognitive_NNP Theory_NNP -RRB-_-RRB- was_VBD Major_JJ 
One_CD study_NN compared_VBD print_NN information_NN versus_IN in-person\/verbal_JJ communication_NN 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP StrategiesThe_NNP risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitati_NNS 
S._NNP Web-based_JJ Atlas_NN examined_VBD the_DT effectiveness_NN and_CC use_NN of_IN the_DT web-based_JJ U._NNP Many_JJ of_IN the_DT people_NNS who_WP reported_VBD that_IN they_PRP heard_VBD the_DT boil_NN water_NN order_NN did_VBD not_RB appreciate_VB the_DT severity_NN of_IN the_DT situation_NN ;_: the_DT initial_JJ boil_NN water_NN order_NN did_VBD not_RB give_VB reasons_NNS for_IN its_PRP$ issuance_NN and_CC did_VBD not_RB mention_VB associated_JJ illness_NN ._. 
Toxic_NNP Release_NNP Inventory_NNP -LRB-_-LRB- TRI_NNP -RRB-_-RRB- ,_, an_DT internationally_RB recognized_VBN environmental_JJ information_NN program_NN that_WDT provides_VBZ industrial_JJ chemical_NN release_NN and_CC transfer_NN data_NNS ._. 
The_DT data_NN was_VBD gathered_VBN in_IN a_DT three-phase_JJ survey_NN design_NN ._. 
Participants_NNS -LRB-_-LRB- N_NNP =_SYM 1292_CD -RRB-_-RRB- were_VBD recruited_VBN from_IN two_CD counties_NNS ._. 
SM_NNP W_NNP W_NNP W_NNP W_NNP W_NNP Burger_NNP 
The_DT included_JJ studies_NNS were_VBD of_IN various_JJ types_NNS of_IN risks_NNS ._. 
,with_JJ one_NN conducted_VBN in_IN Puerto_NNP Rico_NNP 
The_DT only_JJ study_NN to_TO actually_RB test_VB a_DT theory_NN -LRB-_-LRB- Social_NNP Cognitive_NNP Theory_NNP -RRB-_-RRB- was_VBD Major_JJ 
Alimited_JJ number_NN of_IN articles_NNS measured_VBN additional_JJ outcomes_NNS such_JJ as_IN judgement_NN and_CC acceptance_NN of_IN risk_NN communication_NN 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP StrategiesThe_NNP risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
No_DT significant_JJ differences_NNS were_VBD found_VBN in_IN any_DT of_IN the_DT measured_JJ variables_NNS when_WRB comparing_VBG those_DT who_WP received_VBD a_DT brochure_NN with_IN or_CC without_IN explicit_JJ conclusions_NNS ._. 
Fact_NNP sheetsA_NNP one-time_JJ post-test_JJ design_NN explored_VBD four_CD presentation_NN formats_NNS for_IN fact_NN sheets_NNS about_IN fish_NN 
Fact_NN sheets_NNS A_DT one-time_JJ post-test_JJ design_NN explored_VBD four_CD presentation_NN formats_NNS for_IN fact_NN sheets_NNS about_IN fish_NN 
WW_NNP W_NNP W_NNP W_NNP N\/A_NNP W_NNP Bord_NNP 
The_DT outcome_NN measured_VBD most_RBS often_RB in_IN the_DT articles_NNS was_VBD change_NN in_IN knowledge_NN 
Alimited_JJ number_NN of_IN articles_NNS measured_VBN additional_JJ outcomes_NNS such_JJ as_IN judgement_NN and_CC acceptance_NN of_IN risk_NN communication_NN 
S._NNP Burger_NNP and_CC Waishwell_NNP used_VBD a_DT one-time_JJ survey_NN in_IN the_DT U._NNP Seventy-nine_JJ percent_NN of_IN all_DT respondents_NNS indicated_VBD that_IN the_DT cajoling_VBG tone_NN best_RB suited_VBD their_PRP$ information_NN needs_NNS compared_VBN with_IN the_DT commanding_JJ tone_NN -LRB-_-LRB- level_NN of_IN statistical_JJ significance_NN not_RB reported_VBD -RRB-_-RRB- ._. 
to_TO gain_VB insight_NN into_IN whether_IN fact_NN sheets_NNS advising_VBG the_DT risk_NN of_IN eating_VBG contaminated_VBN fish_NN were_VBD read_VBN and_CC the_DT main_JJ messages_NNS understood_VBN ._. 
Participants_NNS were_VBD given_VBN a_DT fact_NN sheet_NN and_CC interviewed_VBD to_TO determine_VB their_PRP$ knowledge_NN ,_, the_DT major_JJ message_NN ,_, to_TO whom_WP the_DT fact_NN sheet_NN should_MD be_VB distributed_VBN and_CC suggestions_NNS for_IN ways_NNS to_TO deliver_VB the_DT message_NN to_TO fishers_NNS specifically_RB ,_, as_RB well_RB as_IN to_TO all_DT others_NNS who_WP might_MD eat_VB the_DT fish_NN ._. 
WW_NNP W_NNP W_NNP W_NNP N\/A_NNP W_NNP Bord_NNP 
Methods_NNS of_IN Risk_NNP Communication_NNP Print_NNP information_NN 
One_CD study_NN compared_VBD print_NN information_NN versus_IN in-person\/verbal_JJ communication_NN 
Burger_NNP et_NNP al._NN ._. 
Trust_NNP was_VBD related_VBN to_TO industry_NN in_IN general_JJ ,_, the_DT food_NN irradiation_NN business_NN specifically_RB ,_, government_NN regulatory_JJ industries_NNS and_CC the_DT science_NN that_WDT says_VBZ food_NN irradiation_NN is_VBZ safe_JJ ._. 
's_POS controlled_JJ clinical_JJ trial_NN examined_VBD the_DT efficacy_NN of_IN two_CD different_JJ formats_NNS for_IN communicating_VBG the_DT risks_NNS of_IN eating_VBG contaminated_VBN fish_NN :_: a_DT brochure_NN and_CC a_DT classroom_NN presentation_NN ._. 
The_DT sample_NN included_VBD pregnant_JJ women_NNS and_CC other_JJ women_NNS of_IN childbearing_VBG age_NN -LRB-_-LRB- N_NNP =_SYM 96_CD -RRB-_-RRB- in_IN the_DT Newark_NNP Bay_NNP area_NN of_IN New_NNP Jersey_NNP ._. 
The_DT only_JJ study_NN to_TO actually_RB test_VB a_DT theory_NN -LRB-_-LRB- Social_NNP Cognitive_NNP Theory_NNP -RRB-_-RRB- was_VBD Major_JJ 
One_CD study_NN compared_VBD print_NN information_NN versus_IN in-person\/verbal_JJ communication_NN 
Behaviour_NNP was_VBD also_RB a_DT commonly_RB measured_VBN outcome_NN with_IN both_DT hypothetical_JJ 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP StrategiesThe_NNP risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
S._NNP Print_NNP Information_NNP Brochures_NNP Bord_NNP and_CC O'Connor_NNP ,_, a_DT U._NNP None_NN of_IN the_DT included_JJ qualitative_JJ articles_NNS measured_VBD the_DT effectiveness_NN of_IN communication_NN strategies_NNS ._. 
controlled_JJ clinical_JJ trial_NN ,_, explored_VBD the_DT use_NN of_IN different_JJ structured_JJ formats_NNS to_TO communicate_VB information_NN about_IN food_NN irradiation_NN ._. 
Women_NNP -LRB-_-LRB- N_NNP =_SYM 195_CD -RRB-_-RRB- were_VBD presented_VBN with_IN one_CD of_IN eight_CD documents_NNS that_WDT explained_VBD and_CC diagrammed_VBD the_DT food_NN irradiation_NN process_NN ._. 
Table_NNP 1_CD Quality_NNP assessment_NN results_NNS for_IN relevant_JJ quantitative_JJ studies_NNS -LRB-_-LRB- n_SYM =_SYM 21_CD -RRB-_-RRB- Author_NN \/_NN Date_NNP Selection_NNP Bias_NNP Study_NNP Design_NNP Confounders_NNP Blinding_NNP Data_NNP Collection_NNP Methods_NNP Withdrawal_NNP \/_NNP Dropouts_NNPS G_NNP LOBAL_NNP R_NNP ATING_NNP Angulo_NNP et_FW al._FW ._. 
The_DT included_JJ studies_NNS were_VBD of_IN various_JJ types_NNS of_IN risks_NNS ._. 
,with_JJ one_NN conducted_VBN in_IN Puerto_NNP Rico_NNP 
The_DT only_JJ study_NN to_TO actually_RB test_VB a_DT theory_NN -LRB-_-LRB- Social_NNP Cognitive_NNP Theory_NNP -RRB-_-RRB- was_VBD Major_JJ 
The_DT outcome_NN measured_VBD most_RBS often_RB in_IN the_DT articles_NNS was_VBD change_NN in_IN knowledge_NN 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP StrategiesThe_NNP risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
Asmall_JJ percentage_NN of_IN respondents_NNS cited_VBD health_NN professionals_NNS -LRB-_-LRB- 8_CD %_NN -RRB-_-RRB- as_IN sources_NNS of_IN information_NN -LRB-_-LRB- level_NN of_IN statistical_JJ significances_NNS not_RB reported_VBD -RRB-_-RRB- ._. 
RadioA_NNP post-test_JJ survey_NN explored_VBD the_DT effectiveness_NN of_IN a_DT boil_NN water_NN order_NN that_WDT was_VBD delivered_VBN via_IN radio_NN to_TO residents_NNS in_IN a_DT community_NN with_IN a_DT Salmonella_NNP typhimurium_NN outbreak_NN ._. 
Angulo_FW et_FW al._FW ._. 
selected_VBN a_DT random_JJ sample_NN -LRB-_-LRB- N_NNP =_SYM 120_CD households_NNS with_IN 329_CD members_NNS -RRB-_-RRB- from_IN 548_CD households_NNS on_IN the_DT municipal_JJ tax_NN roster_NN 
Angulo_FW et_FW al._FW ._. 
Radio_NNP A_NNP post-test_JJ survey_NN explored_VBD the_DT effectiveness_NN of_IN a_DT boil_NN water_NN order_NN that_WDT was_VBD delivered_VBN via_IN radio_NN to_TO residents_NNS in_IN a_DT community_NN with_IN a_DT Salmonella_NNP typhimurium_NN outbreak_NN ._. 
selected_VBN a_DT random_JJ sample_NN -LRB-_-LRB- N_NNP =_SYM 120_CD households_NNS with_IN 329_CD members_NNS -RRB-_-RRB- from_IN 548_CD households_NNS on_IN the_DT municipal_JJ tax_NN roster_NN 
Blanchard_NNP et_FW al._FW ._. 
Table_NNP 2_CD Quality_NNP assessment_NN results_NNS for_IN qualitative_JJ relevant_JJ studies_NNS -LRB-_-LRB- n_SYM =_SYM 3_CD -RRB-_-RRB- S_NNP TUDY_NNP Eisenman_NNP et_FW al._FW ._. 
S._NNP Two_CD 
Alimited_JJ number_NN of_IN articles_NNS measured_VBN additional_JJ outcomes_NNS such_JJ as_IN judgement_NN and_CC acceptance_NN of_IN risk_NN communication_NN 
All_DT of_IN the_DT studies_NNS provided_VBD a_DT review_NN of_IN relevant_JJ background_NN literature_NN and_CC a_DT justification_NN of_IN need_NN for_IN the_DT study_NN ._. 
One_CD of_IN the_DT studies_NNS used_VBD a_DT grounded_VBN theory_NN study_NN design_NN 
Factors_NNS that_WDT can_MD impact_VB communication_NN uptake_NN Six_CD quantitative_JJ and_CC three_CD qualitative_JJ articles_NNS included_VBN in_IN this_DT review_NN examined_VBD factors_NNS that_IN impact_NN risk_NN communication_NN uptake_NN ._. 
These_DT can_MD be_VB grouped_VBN into_IN the_DT following_JJ categories_NNS of_IN factors_NNS :_: personal_JJ risk_NN perception_NN 
There_EX was_VBD no_DT discussion_NN of_IN the_DT factors_NNS that_WDT influenced_VBD the_DT participants_NNS '_POS decisions_NNS in_IN terms_NNS of_IN their_PRP$ timing_NN when_WRB evacuating_VBG the_DT area_NN ._. 
Perez-Lugo_NNP sought_VBD to_TO determine_VB the_DT role_NN of_IN the_DT media_NNS in_IN a_DT community_NN 's_POS coping_VBG strategy_NN in_IN the_DT face_NN of_IN natural_JJ disasters_NNS ._. 
Participants_NNS -LRB-_-LRB- N_NNP =_SYM 37_CD -RRB-_-RRB- were_VBD residents_NNS living_VBG in_IN areas_NNS of_IN Puerto_NNP Rico_NNP that_WDT were_VBD recently_RB affected_VBN by_IN Hurricane_NNP Georges_NNP ._. 
The_DT availability_NN or_CC lack_NN of_IN information_NN regarding_VBG Hurricane_NNP Katrina_NNP ,_, for_IN example_NN ,_, played_VBD a_DT clear_JJ role_NN in_IN determining_VBG how_WRB people_NNS chose_VBD to_TO react_VB to_TO the_DT disaster_NN 
Additionally_RB ,_, effective_JJ risk_NN communication_NN can_MD impact_VB the_DT public_NN 's_POS perception_NN of_IN and_CC trust_NN in_IN public_JJ health_NN authorities_NNS at_IN the_DT regional_JJ ,_, national_JJ and_CC international_JJ level_NN 
Effective_JJ communication_NN is_VBZ part_NN of_IN the_DT risk_NN analysis_NN process_NN and_CC is_VBZ necessary_JJ for_IN management_NN of_IN information_NN and_CC opinion_NN related_VBN to_TO real_JJ and_CC perceived_VBN hazards_NNS 
Systematic_JJ information_NN delivery_NN to_TO the_DT public_NN is_VBZ important_JJ for_IN ensuring_VBG clear_JJ communication_NN ,_, enhancing_VBG understanding_NN of_IN risk_NN and_CC increasing_VBG transparency_NN of_IN risk-analysis_NNS for_IN decision_NN making_NN ._. 
Effective_JJ information_NN dissemination_NN approaches_NNS are_VBP also_RB important_JJ for_IN eliciting_VBG desired_VBN outcomes_NNS ,_, whether_IN increased_VBN awareness_NN or_CC attitudinal_JJ or_CC behavioural_JJ change_NN 
Background_NN The_DT Effective_NNP Public_NNP Health_NNP Practice_NNP Project_NNP -LRB-_-LRB- EPHPP_NNP -RRB-_-RRB- prepared_VBN this_DT review_NN for_IN the_DT National_NNP Collaborating_NNP Centre_NNP for_IN Methods_NNP and_CC Tools_NNP -LRB-_-LRB- NCCMT_NNP -RRB-_-RRB- as_IN part_NN of_IN their_PRP$ joint_JJ ``_`` Small_NNP Drinking_NNP Water_NNP Project_NNP ''_'' of_IN the_DT National_NNP Collaborating_NNP Centres_NNP for_IN Public_NNP Health_NNP ._. 
The_DT topic_NN for_IN the_DT review_NN was_VBD informed_VBN by_IN the_DT National_NNP Collaborating_NNP Centre_NNP for_IN Environmental_NNP Health_NNP 's_POS ``_`` Needs_NNS ,_, Gaps_NNS ,_, and_CC Opportunities_NNPS Assessment_NNP ''_'' report_NN ,_, which_WDT initially_RB identified_VBD methods_NNS and_CC techniques_NNS for_IN communication_NN regarding_VBG boil_NN water_NN advisories_NNS as_IN a_DT highly_RB important_JJ topic_NN for_IN practitioners_NNS ._. 
However_RB ,_, the_DT preliminary_JJ search_NN revealed_VBD very_RB few_JJ studies_NNS involving_VBG boiled_JJ water_NN advisories_NNS ,_, so_IN the_DT search_NN was_VBD broadened_VBN to_TO include_VB communication_NN of_IN environmental_JJ health_NN risks_NNS ._. 
Effective_JJ information_NN dissemination_NN approaches_NNS are_VBP also_RB important_JJ for_IN eliciting_VBG desired_VBN outcomes_NNS ,_, whether_IN increased_VBN awareness_NN or_CC attitudinal_JJ or_CC behavioural_JJ change_NN 
Background_NN The_DT Effective_NNP Public_NNP Health_NNP Practice_NNP Project_NNP -LRB-_-LRB- EPHPP_NNP -RRB-_-RRB- prepared_VBN this_DT review_NN for_IN the_DT National_NNP Collaborating_NNP Centre_NNP for_IN Methods_NNP and_CC Tools_NNP -LRB-_-LRB- NCCMT_NNP -RRB-_-RRB- as_IN part_NN of_IN their_PRP$ joint_JJ ``_`` Small_NNP Drinking_NNP Water_NNP Project_NNP ''_'' of_IN the_DT National_NNP Collaborating_NNP Centres_NNP for_IN Public_NNP Health_NNP ._. 
The_DT topic_NN for_IN the_DT review_NN was_VBD informed_VBN by_IN the_DT National_NNP Collaborating_NNP Centre_NNP for_IN Environmental_NNP Health_NNP 's_POS ``_`` Needs_NNS ,_, Gaps_NNS ,_, and_CC Opportunities_NNPS Assessment_NNP ''_'' report_NN ,_, which_WDT initially_RB identified_VBD methods_NNS and_CC techniques_NNS for_IN communication_NN regarding_VBG boil_NN water_NN advisories_NNS as_IN a_DT highly_RB important_JJ topic_NN for_IN practitioners_NNS ._. 
However_RB ,_, the_DT preliminary_JJ search_NN revealed_VBD very_RB few_JJ studies_NNS involving_VBG boiled_JJ water_NN advisories_NNS ,_, so_IN the_DT search_NN was_VBD broadened_VBN to_TO include_VB communication_NN of_IN environmental_JJ health_NN risks_NNS ._. 
Effective_JJ information_NN dissemination_NN approaches_NNS are_VBP also_RB important_JJ for_IN eliciting_VBG desired_VBN outcomes_NNS ,_, whether_IN increased_VBN awareness_NN or_CC attitudinal_JJ or_CC behavioural_JJ change_NN 
This_DT information_NN may_MD include_VB the_DT nature_NN of_IN the_DT risk_NN and_CC potential_JJ benefits_NNS ,_, uncertainties_NNS ,_, rationale_NN for_IN action_NN and_CC strategies_NNS for_IN managing_VBG risk_NN ._. 
Risk_NN communication_NN strategies_NNS may_MD vary_VB across_IN emergency_NN and_CC non-emergency_NN situations_NNS ,_, and_CC may_MD require_VB local_JJ ,_, regional_JJ ,_, national_JJ or_CC international_JJ responses_NNS ._. 
The_DT objective_NN of_IN this_DT systematic_JJ review_NN is_VBZ to_TO identify_VB the_DT effectiveness_NN of_IN communication_NN strategies_NNS for_IN environmental_JJ health_NN risk_NN ,_, and_CC factors_NNS that_WDT impact_VBP communication_NN uptake_NN ._. 
Over_IN the_DT past_JJ several_JJ years_NNS ,_, global_JJ populations_NNS have_VBP endured_VBN many_JJ environmental_JJ health_NN threats_NNS ,_, ranging_VBG from_IN natural_JJ disasters_NNS and_CC bioterrorism_NN to_TO viral_JJ outbreaks_NNS ;_: communication_NN about_IN these_DT threats_NNS has_VBZ played_VBN a_DT vital_JJ role_NN on_IN affected_JJ populations_NNS ._. 
The_DT availability_NN or_CC lack_NN of_IN information_NN regarding_VBG Hurricane_NNP Katrina_NNP ,_, for_IN example_NN ,_, played_VBD a_DT clear_JJ role_NN in_IN determining_VBG how_WRB people_NNS chose_VBD to_TO react_VB to_TO the_DT disaster_NN 
Table_NNP 2_CD Quality_NNP assessment_NN results_NNS for_IN qualitative_JJ relevant_JJ studies_NNS -LRB-_-LRB- n_SYM =_SYM 3_CD -RRB-_-RRB- S_NNP TUDY_NNP Eisenman_NNP et_FW al._FW ._. 
Each_DT of_IN the_DT three_CD qualitative_JJ articles_NNS used_VBD descriptive_JJ designs_NNS ._. 
Total_JJ sample_NN size_NN ranged_VBD from_IN 80_CD to_TO 3,546_CD ._. 
Two_CD 
Anumber_NNP of_IN articles_NNS considered_VBN those_DT associated_VBN with_IN food_NN consumption_NN such_JJ fish_NN ,_, salmonella_NN ,_, and_CC food_NN irradiation_NN ._. 
Others_NNS included_VBD environmental_JJ risks_NNS -LRB-_-LRB- asbestos_NN ;_: toxins_NNS ;_: radon_NN gas_NN ;_: chemical_JJ spills_NNS ;_: hazardous_JJ technology_NN -RRB-_-RRB- 
All_DT of_IN the_DT studies_NNS provided_VBD a_DT review_NN of_IN relevant_JJ background_NN literature_NN and_CC a_DT justification_NN of_IN need_NN for_IN the_DT study_NN ._. 
One_CD of_IN the_DT studies_NNS used_VBD a_DT grounded_VBN theory_NN study_NN design_NN 
All_DT of_IN the_DT studies_NNS provided_VBD a_DT general_JJ discussion_NN about_IN the_DT characteristics_NNS of_IN participants_NNS ._. 
Interview_NN and_CC focus_NN group_NN results_NNS were_VBD coded_VBN and_CC grouped_VBN under_IN themes_NNS and_CC sub-themes_NNS to_TO structure_VB a_DT narrative_NN and_CC discussion_NN of_IN findings_NNS ._. 
In_IN terms_NNS of_IN overall_JJ rigor_NN ,_, two_CD articles_NNS met_VBD the_DT four_CD components_NNS of_IN trustworthiness_NN -LRB-_-LRB- credibility_NN ,_, transferability_NN ,_, dependability_NN and_CC confirmability_NN -RRB-_-RRB- ._. 
Effectiveness_NN of_IN Risk_NNP Communication_NNP Strategies_NNS The_DT risk_NN communication_NN strategies_NNS evaluated_VBN in_IN the_DT included_JJ quantitative_JJ articles_NNS fall_VBP into_IN three_CD broad_JJ categories_NNS :_: print_NN information_NN 
Factors_NNS that_WDT can_MD impact_VB communication_NN uptake_NN Six_CD quantitative_JJ and_CC three_CD qualitative_JJ articles_NNS included_VBN in_IN this_DT review_NN examined_VBD factors_NNS that_IN impact_NN risk_NN communication_NN uptake_NN ._. 
These_DT can_MD be_VB grouped_VBN into_IN the_DT following_JJ categories_NNS of_IN factors_NNS :_: personal_JJ risk_NN perception_NN 
Eisenman_NNP et_FW al._FW ._. 
Trust_NNP in_IN Sources_NNS of_IN Information_NNP All_NNP three_CD qualitative_JJ articles_NNS considered_VBN how_WRB trust_NN in_IN sources_NNS of_IN information_NN can_MD affect_VB risk_NN communication_NN ._. 
examined_VBN factors_NNS affecting_VBG evacuation_NN decisions_NNS among_IN people_NNS affected_VBN by_IN Hurricane_NNP Katrina_NNP ._. 
The_DT study_NN focused_VBD on_IN evacuation_NN orders_NNS and_CC issues_NNS of_IN trust_NN related_VBN to_TO these_DT orders_NNS ._. 
Semi-structured_JJ interviews_NNS were_VBD conducted_VBN with_IN participants_NNS living_VBG in_IN areas_NNS affected_VBN by_IN Hurricane_NNP Katrina_NNP who_WP received_VBD evacuation_NN orders_NNS related_VBN to_TO the_DT hurricane_NN ._. 
Figure_NNP 1_CD Flow_NNP Diagram_NNP Assessment_NNP of_IN Risk_NNP of_IN Bias_NNP in_IN Included_VBN Studies_NNS The_DT 24_CD articles_NNS that_WDT passed_VBD full_JJ text_NN screening_NN were_VBD assessed_VBN for_IN methodological_JJ quality_NN by_IN two_CD independent_JJ reviewers_NNS ._. 
Quantitative_JJ and_CC mixed-method_JJ studies_NNS were_VBD assessed_VBN using_VBG a_DT tool_NN that_WDT was_VBD developed_VBN and_CC tested_VBN for_IN primary_JJ studies_NNS in_IN public_JJ health_NN -LRB-_-LRB- see_VB Additional_JJ file_NN 4_CD -RRB-_-RRB- ._. 
The_DT tool_NN is_VBZ based_VBN on_IN guidelines_NNS set_VBN out_RP by_IN Mulrow_NNP ,_, Cook_NNP and_CC Davidoff_NNP 
Quantitative_JJ and_CC mixed-method_JJ studies_NNS were_VBD assessed_VBN using_VBG a_DT tool_NN that_WDT was_VBD developed_VBN and_CC tested_VBN for_IN primary_JJ studies_NNS in_IN public_JJ health_NN -LRB-_-LRB- see_VB Additional_JJ file_NN 4_CD -RRB-_-RRB- ._. 
The_DT tool_NN is_VBZ based_VBN on_IN guidelines_NNS set_VBN out_RP by_IN Mulrow_NNP ,_, Cook_NNP and_CC Davidoff_NNP 
Factors_NNS that_WDT can_MD impact_VB communication_NN uptake_NN Six_CD quantitative_JJ and_CC three_CD qualitative_JJ articles_NNS included_VBN in_IN this_DT review_NN examined_VBD factors_NNS that_IN impact_NN risk_NN communication_NN uptake_NN ._. 
These_DT can_MD be_VB grouped_VBN into_IN the_DT following_JJ categories_NNS of_IN factors_NNS :_: personal_JJ risk_NN perception_NN 
e._VB It_PRP is_VBZ uncertain_JJ whether_IN such_JJ differential_JJ effects_NNS carry_VBP biological_JJ plausibility_NN ,_, i._JJ Other_JJ studies_NNS ,_, however_RB ,_, have_VBP found_VBN little_JJ evidence_NN of_IN differential_JJ effects_NNS by_IN season_NN 
Effect_NN modification_NN by_IN season_NN Seasonal_JJ differential_JJ effects_NNS of_IN changes_NNS in_IN levels_NNS of_IN air_NN pollution_NN on_IN the_DT risk_NN of_IN hospitalization_NN have_VBP been_VBN previously_RB reported_VBN ,_, particularly_RB with_IN respects_NNS to_TO stronger_JJR effects_NNS of_IN PM_NNP on_IN respiratory_JJ health_NN during_IN the_DT warm_JJ season_NN such_JJ as_IN those_DT observed_VBN here_RB 
either_CC confirm_VB ,_, invalidate_VB or_CC propose_VB additional_JJ days_NNS -RRB-_-RRB- with_IN the_DT main_JJ aim_NN of_IN categorizing_VBG days_NNS into_IN confirmed_VBN events_NNS ,_, where_WRB the_DT criteria_NNS were_VBD in_IN agreement_NN with_IN the_DT meteorological_JJ observation_NN and_CC suspected_JJ events_NNS ,_, where_WRB all_DT criteria_NNS suggest_VBP an_DT event_NN that_WDT might_MD have_VB been_VBN overlooked_VBN or_CC coded_VBN otherwise_RB by_IN the_DT observer_NN ._. 
Possible_JJ markers_NNS of_IN dust_NN storm_NN events_NNS used_VBN in_IN the_DT past_NN ,_, such_JJ as_IN low_JJ carbon_NN monoxide_NN levels_NNS 
Possible_JJ markers_NNS of_IN dust_NN storm_NN events_NNS used_VBN in_IN the_DT past_NN ,_, such_JJ as_IN low_JJ carbon_NN monoxide_NN levels_NNS 
either_CC confirm_VB ,_, invalidate_VB or_CC propose_VB additional_JJ days_NNS -RRB-_-RRB- with_IN the_DT main_JJ aim_NN of_IN categorizing_VBG days_NNS into_IN confirmed_VBN events_NNS ,_, where_WRB the_DT criteria_NNS were_VBD in_IN agreement_NN with_IN the_DT meteorological_JJ observation_NN and_CC suspected_JJ events_NNS ,_, where_WRB all_DT criteria_NNS suggest_VBP an_DT event_NN that_WDT might_MD have_VB been_VBN overlooked_VBN or_CC coded_VBN otherwise_RB by_IN the_DT observer_NN ._. 
Possible_JJ markers_NNS of_IN dust_NN storm_NN events_NNS used_VBN in_IN the_DT past_NN ,_, such_JJ as_IN low_JJ carbon_NN monoxide_NN levels_NNS 
either_CC confirm_VB ,_, invalidate_VB or_CC propose_VB additional_JJ days_NNS -RRB-_-RRB- with_IN the_DT main_JJ aim_NN of_IN categorizing_VBG days_NNS into_IN confirmed_VBN events_NNS ,_, where_WRB the_DT criteria_NNS were_VBD in_IN agreement_NN with_IN the_DT meteorological_JJ observation_NN and_CC suspected_JJ events_NNS ,_, where_WRB all_DT criteria_NNS suggest_VBP an_DT event_NN that_WDT might_MD have_VB been_VBN overlooked_VBN or_CC coded_VBN otherwise_RB by_IN the_DT observer_NN ._. 
Possible_JJ markers_NNS of_IN dust_NN storm_NN events_NNS used_VBN in_IN the_DT past_NN ,_, such_JJ as_IN low_JJ carbon_NN monoxide_NN levels_NNS 
There_EX is_VBZ some_DT modest_JJ evidence_NN from_IN Taiwan_NNP and_CC Korea_NNP of_IN adverse_JJ effects_NNS of_IN wind-blown_JJ dust_NN from_IN the_DT Mongolia\/China_NNP desert_NN on_IN both_DT cardiovascular_JJ and_CC respiratory_JJ health_NN ,_, some_DT times_NNS lasting_VBG for_IN up_RB 3_CD days_NNS after_IN the_DT event_NN 
either_CC confirm_VB ,_, invalidate_VB or_CC propose_VB additional_JJ days_NNS -RRB-_-RRB- with_IN the_DT main_JJ aim_NN of_IN categorizing_VBG days_NNS into_IN confirmed_VBN events_NNS ,_, where_WRB the_DT criteria_NNS were_VBD in_IN agreement_NN with_IN the_DT meteorological_JJ observation_NN and_CC suspected_JJ events_NNS ,_, where_WRB all_DT criteria_NNS suggest_VBP an_DT event_NN that_WDT might_MD have_VB been_VBN overlooked_VBN or_CC coded_VBN otherwise_RB by_IN the_DT observer_NN ._. 
Possible_JJ markers_NNS of_IN dust_NN storm_NN events_NNS used_VBN in_IN the_DT past_NN ,_, such_JJ as_IN low_JJ carbon_NN monoxide_NN levels_NNS 
g._NN With_IN the_DT major_JJ exception_NN of_IN the_DT APHEA_NNP project_NN ,_, a_DT multi-centre_JJ European_JJ study_NN with_IN a_DT common_JJ protocol_NN 
No_DT positive_JJ effects_NNS were_VBD observed_VBN with_IN levels_NNS of_IN PM_NNP 10_CD the_DT 2_CD previous_JJ days_NNS ._. 
The_DT extent_NN to_TO which_WDT this_DT atypical_JJ weekly_JJ pattern_NN has_VBZ produced_VBN a_DT discrepancy_NN between_IN actual_JJ need_NN and_CC admission_NN and_CC ,_, thus_RB ,_, contributed_VBD to_TO the_DT lack_NN of_IN any_DT strong_JJ association_NN with_IN overall_JJ respiratory_JJ admissions_NNS is_VBZ not_RB known_VBN ._. 
While_IN lagged_VBN or_CC cumulative_JJ effects_NNS have_VBP commonly_RB been_VBN observed_VBN between_IN levels_NNS of_IN PM_NNP and_CC mortality_NN in_IN several_JJ studies_NNS 
While_IN large_JJ cities_NNS in_IN the_DT Eastern_NNP Mediterranean_NNP ,_, such_JJ as_IN Athens_NNP ,_, Tel_NNP Aviv_NNP and_CC Istanbul_NNP were_VBD considered_VBN in_IN APHEA_NNP ,_, associations_NNS have_VBP not_RB been_VBN investigated_VBN in_IN smaller_JJR size_NN cities_NNS where_WRB socio-economic_JJ factors_NNS -LRB-_-LRB- such_JJ as_IN driving_JJ patterns_NNS ,_, time_NN spent_VBD outdoors_NNS and_CC access_NN to_TO health_NN care_NN -RRB-_-RRB- as_RB well_RB as_IN climatic_JJ conditions_NNS might_MD vary_VB considerably_RB ._. 
Aparticular_JJ feature_NN of_IN the_DT Eastern_NNP Mediterranean_NNP is_VBZ episodes_NNS of_IN re-suspended_JJ wind_NN blown_VBN dust_NN from_IN desert_NN regions_NNS ,_, raising_VBG particle_NN concentrations_NNS a_DT few_JJ times_NNS a_DT year_NN considerably_RB above_IN European_JJ guidelines_NNS ._. 
It_PRP is_VBZ not_RB entirely_RB clear_JJ whether_IN high_JJ levels_NNS of_IN particulate_JJ matter_NN from_IN such_JJ natural_JJ phenomena_NNS pose_VBP the_DT same_JJ risks_NNS on_IN cardiovascular_JJ and_CC respiratory_JJ health_NN as_IN particles_NNS from_IN anthropogenic_JJ sources_NNS ._. 
Background_NN In_IN the_DT last_JJ 20_CD years_NNS ,_, evidence_NN on_IN adverse_JJ health_NN effects_NNS 
Surprisingly_RB ,_, other_JJ than_IN the_DT warm_JJ season_NN ,_, no_DT overall_JJ effect_NN was_VBD observed_VBN with_IN respiratory_JJ admissions_NNS ._. 
While_IN several_JJ studies_NNS have_VBP shown_VBN associations_NNS between_IN levels_NNS of_IN PM_NNP and_CC respiratory_JJ mortality_NN 
g._NN With_IN the_DT major_JJ exception_NN of_IN the_DT APHEA_NNP project_NN ,_, a_DT multi-centre_JJ European_JJ study_NN with_IN a_DT common_JJ protocol_NN 
Unlike_IN the_DT mineral_NN and_CC chemical_NN composition_NN as_RB well_RB as_IN transport_NN patterns_NNS of_IN Saharan_JJ dust_NN ,_, the_DT possible_JJ health_NN effects_NNS of_IN these_DT natural_JJ events_NNS have_VBP not_RB been_VBN extensively_RB studied_VBN ._. 
There_EX is_VBZ some_DT modest_JJ evidence_NN from_IN Taiwan_NNP and_CC Korea_NNP of_IN adverse_JJ effects_NNS of_IN wind-blown_JJ dust_NN from_IN the_DT Mongolia\/China_NNP desert_NN on_IN both_DT cardiovascular_JJ and_CC respiratory_JJ health_NN ,_, some_DT times_NNS lasting_VBG for_IN up_RB 3_CD days_NNS after_IN the_DT event_NN ;_: reported_VBN associations_NNS were_VBD ,_, however_RB ,_, not_RB always_RB statistically_RB significant_JJ ._. 
In_IN contrast_NN ,_, a_DT study_NN of_IN 17_CD episodes_NNS with_IN a_DT high_JJ concentration_NN of_IN coarse_JJ -LRB-_-LRB- crustal-derived_JJ -RRB-_-RRB- but_CC not_RB fine_JJ particles_NNS during_IN a_DT six-year_JJ period_NN in_IN Spokane_NNP ,_, Washington_NNP ,_, revealed_VBD no_DT evidence_NN of_IN an_DT increased_VBN risk_NN of_IN death_NN on_IN dust_NN days_NNS 
Possible_JJ markers_NNS of_IN dust_NN storm_NN events_NNS used_VBN in_IN the_DT past_NN ,_, such_JJ as_IN low_JJ carbon_NN monoxide_NN levels_NNS 
Of_IN course_NN ,_, the_DT possibility_NN of_IN air-borne_JJ dust_NN containing_VBG particles_NNS of_IN anthropogenic_JJ sources_NNS can_MD not_RB be_VB excluded_VBN since_IN mega-cities_NNS ,_, such_JJ as_IN Cairo_NNP ,_, are_VBP commonly_RB on_IN the_DT path_NN of_IN these_DT events_NNS ._. 
Alternatively_RB ,_, some_DT support_NN for_IN the_DT adverse_JJ effects_NNS of_IN particles_NNS due_JJ to_TO natural_JJ sources_NNS observed_VBD here_RB comes_VBZ from_IN a_DT recent_JJ study_NN of_IN the_DT biological_JJ content_NN in_IN dust_NN transferred_VBN to_TO Haifa_NNP ,_, Israel_NNP during_IN similar_JJ events_NNS in_IN 2004_CD 
In_IN contrast_NN ,_, a_DT study_NN of_IN 17_CD episodes_NNS with_IN a_DT high_JJ concentration_NN of_IN coarse_JJ -LRB-_-LRB- crustal-derived_JJ -RRB-_-RRB- but_CC not_RB fine_JJ particles_NNS during_IN a_DT six-year_JJ period_NN in_IN Spokane_NNP ,_, Washington_NNP ,_, revealed_VBD no_DT evidence_NN of_IN an_DT increased_VBN risk_NN of_IN death_NN on_IN dust_NN days_NNS 
Similarly_RB ,_, an_DT investigation_NN into_IN an_DT unusual_JJ event_NN of_IN transported_VBN dust_NN over_IN the_DT Atlantic_NNP to_TO Greater_NNP Vancouver_NNP ,_, Canada_NNP ,_, has_VBZ shown_VBN no_DT effect_NN on_IN hospital_NN admissions_NNS 
Perhaps_RB ,_, even_RB more_RBR so_RB in_IN the_DT case_NN of_IN Cypriot_NNP cities_NNS where_WRB ,_, with_IN no_DT referral_NN system_NN ,_, direct_JJ access_NN to_TO specialist_NN health_NN care_NN may_MD be_VB considerably_RB easier_JJR than_IN in_IN larger_JJR European_NNP or_CC US_NNP cities_NNS ._. 
Anumber_NNP of_IN person-based_JJ studies_NNS have_VBP now_RB used_VBN average_JJ levels_NNS of_IN air_NN pollutants_NNS the_DT 24_CD hours_NNS preceding_VBG an_DT event_NN -LRB-_-LRB- rather_RB than_IN same_JJ calendar_NN day_NN which_WDT would_MD include_VB hours_NNS after_IN as_RB well_RB as_IN before_IN the_DT event_NN -RRB-_-RRB- and_CC ,_, at_IN least_JJS amongst_IN susceptible_JJ populations_NNS ,_, have_VBP shown_VBN effects_NNS in_IN as_RB little_JJ as_IN 6_CD hours_NNS prior_RB to_TO an_DT arrhythmia_NN and_CC even_RB 2_CD hours_NNS prior_RB to_TO a_DT myocardial_JJ infarction_NN ._. 
In_IN contrast_NN to_TO the_DT same-day_JJ association_NN with_IN levels_NNS of_IN PM_NNP ,_, only_RB effects_NNS of_IN lagged_VBN exposure_NN to_TO ozone_NN were_VBD observed_VBN ._. 
Nonetheless_RB ,_, in_IN a_DT recent_JJ cross-sectional_JJ study_NN in_IN Korea_NNP ,_, it_PRP was_VBD reported_VBN that_IN measures_NNS of_IN blood_NN pressure_NN ,_, a_DT risk_NN factor_NN for_IN cardiovascular_JJ disease_NN ,_, were_VBD significantly_RB associated_VBN with_IN PM_NNP 10_CD levels_NNS only_RB in_IN the_DT warm_JJ season_NN while_IN the_DT reverse_NN was_VBD true_JJ for_IN O_NNP 3_CD ,_, with_IN associations_NNS only_RB during_IN the_DT cold_JJ season_NN 
No_DT positive_JJ effects_NNS were_VBD observed_VBN with_IN levels_NNS of_IN PM_NNP 10_CD the_DT 2_CD previous_JJ days_NNS ._. 
The_DT extent_NN to_TO which_WDT this_DT atypical_JJ weekly_JJ pattern_NN has_VBZ produced_VBN a_DT discrepancy_NN between_IN actual_JJ need_NN and_CC admission_NN and_CC ,_, thus_RB ,_, contributed_VBD to_TO the_DT lack_NN of_IN any_DT strong_JJ association_NN with_IN overall_JJ respiratory_JJ admissions_NNS is_VBZ not_RB known_VBN ._. 
While_IN lagged_VBN or_CC cumulative_JJ effects_NNS have_VBP commonly_RB been_VBN observed_VBN between_IN levels_NNS of_IN PM_NNP and_CC mortality_NN in_IN several_JJ studies_NNS 
No_DT positive_JJ effects_NNS were_VBD observed_VBN with_IN levels_NNS of_IN PM_NNP 10_CD the_DT 2_CD previous_JJ days_NNS ._. 
The_DT extent_NN to_TO which_WDT this_DT atypical_JJ weekly_JJ pattern_NN has_VBZ produced_VBN a_DT discrepancy_NN between_IN actual_JJ need_NN and_CC admission_NN and_CC ,_, thus_RB ,_, contributed_VBD to_TO the_DT lack_NN of_IN any_DT strong_JJ association_NN with_IN overall_JJ respiratory_JJ admissions_NNS is_VBZ not_RB known_VBN ._. 
While_IN lagged_VBN or_CC cumulative_JJ effects_NNS have_VBP commonly_RB been_VBN observed_VBN between_IN levels_NNS of_IN PM_NNP and_CC mortality_NN in_IN several_JJ studies_NNS 
Perhaps_RB ,_, even_RB more_RBR so_RB in_IN the_DT case_NN of_IN Cypriot_NNP cities_NNS where_WRB ,_, with_IN no_DT referral_NN system_NN ,_, direct_JJ access_NN to_TO specialist_NN health_NN care_NN may_MD be_VB considerably_RB easier_JJR than_IN in_IN larger_JJR European_NNP or_CC US_NNP cities_NNS ._. 
Anumber_NNP of_IN person-based_JJ studies_NNS have_VBP now_RB used_VBN average_JJ levels_NNS of_IN air_NN pollutants_NNS the_DT 24_CD hours_NNS preceding_VBG an_DT event_NN -LRB-_-LRB- rather_RB than_IN same_JJ calendar_NN day_NN which_WDT would_MD include_VB hours_NNS after_IN as_RB well_RB as_IN before_IN the_DT event_NN -RRB-_-RRB- and_CC ,_, at_IN least_JJS amongst_IN susceptible_JJ populations_NNS ,_, have_VBP shown_VBN effects_NNS in_IN as_RB little_JJ as_IN 6_CD hours_NNS prior_RB to_TO an_DT arrhythmia_NN and_CC even_RB 2_CD hours_NNS prior_RB to_TO a_DT myocardial_JJ infarction_NN ._. 
In_IN contrast_NN to_TO the_DT same-day_JJ association_NN with_IN levels_NNS of_IN PM_NNP ,_, only_RB effects_NNS of_IN lagged_VBN exposure_NN to_TO ozone_NN were_VBD observed_VBN ._. 
However_RB ,_, some_DT similar_JJ patterns_NNS have_VBP been_VBN observed_VBN elsewhere_RB ,_, particularly_RB amongst_IN the_DT elderly_JJ 
4%_CD 
Surprisingly_RB ,_, other_JJ than_IN the_DT warm_JJ season_NN ,_, no_DT overall_JJ effect_NN was_VBD observed_VBN with_IN respiratory_JJ admissions_NNS ._. 
While_IN several_JJ studies_NNS have_VBP shown_VBN associations_NNS between_IN levels_NNS of_IN PM_NNP and_CC respiratory_JJ mortality_NN 
Surprisingly_RB ,_, other_JJ than_IN the_DT warm_JJ season_NN ,_, no_DT overall_JJ effect_NN was_VBD observed_VBN with_IN respiratory_JJ admissions_NNS ._. 
While_IN several_JJ studies_NNS have_VBP shown_VBN associations_NNS between_IN levels_NNS of_IN PM_NNP and_CC respiratory_JJ mortality_NN 
In_IN general_JJ ,_, neither_CC the_DT fact_NN that_IN stronger_JJR associations_NNS with_IN lagged_VBN rather_RB than_IN concurrent_JJ exposure_NN nor_CC that_IN stronger_JJR effects_NNS for_IN cardiovascular_JJ than_IN respiratory_JJ admissions_NNS were_VBD observed_VBN seem_VBP inconsistent_JJ with_IN previous_JJ findings_NNS 
Surprisingly_RB ,_, other_JJ than_IN the_DT warm_JJ season_NN ,_, no_DT overall_JJ effect_NN was_VBD observed_VBN with_IN respiratory_JJ admissions_NNS ._. 
While_IN several_JJ studies_NNS have_VBP shown_VBN associations_NNS between_IN levels_NNS of_IN PM_NNP and_CC respiratory_JJ mortality_NN 
Unlike_IN the_DT mineral_NN and_CC chemical_NN composition_NN as_RB well_RB as_IN transport_NN patterns_NNS of_IN Saharan_JJ dust_NN ,_, the_DT possible_JJ health_NN effects_NNS of_IN these_DT natural_JJ events_NNS have_VBP not_RB been_VBN extensively_RB studied_VBN ._. 
There_EX is_VBZ some_DT modest_JJ evidence_NN from_IN Taiwan_NNP and_CC Korea_NNP of_IN adverse_JJ effects_NNS of_IN wind-blown_JJ dust_NN from_IN the_DT Mongolia\/China_NNP desert_NN on_IN both_DT cardiovascular_JJ and_CC respiratory_JJ health_NN ,_, some_DT times_NNS lasting_VBG for_IN up_RB 3_CD days_NNS after_IN the_DT event_NN ;_: reported_VBN associations_NNS were_VBD ,_, however_RB ,_, not_RB always_RB statistically_RB significant_JJ ._. 
In_IN contrast_NN ,_, a_DT study_NN of_IN 17_CD episodes_NNS with_IN a_DT high_JJ concentration_NN of_IN coarse_JJ -LRB-_-LRB- crustal-derived_JJ -RRB-_-RRB- but_CC not_RB fine_JJ particles_NNS during_IN a_DT six-year_JJ period_NN in_IN Spokane_NNP ,_, Washington_NNP ,_, revealed_VBD no_DT evidence_NN of_IN an_DT increased_VBN risk_NN of_IN death_NN on_IN dust_NN days_NNS 
Alternatively_RB ,_, some_DT support_NN for_IN the_DT adverse_JJ effects_NNS of_IN particles_NNS due_JJ to_TO natural_JJ sources_NNS observed_VBD here_RB comes_VBZ from_IN a_DT recent_JJ study_NN of_IN the_DT biological_JJ content_NN in_IN dust_NN transferred_VBN to_TO Haifa_NNP ,_, Israel_NNP during_IN similar_JJ events_NNS in_IN 2004_CD 
Nonetheless_RB ,_, in_IN a_DT recent_JJ cross-sectional_JJ study_NN in_IN Korea_NNP ,_, it_PRP was_VBD reported_VBN that_IN measures_NNS of_IN blood_NN pressure_NN ,_, a_DT risk_NN factor_NN for_IN cardiovascular_JJ disease_NN ,_, were_VBD significantly_RB associated_VBN with_IN PM_NNP 10_CD levels_NNS only_RB in_IN the_DT warm_JJ season_NN while_IN the_DT reverse_NN was_VBD true_JJ for_IN O_NNP 3_CD ,_, with_IN associations_NNS only_RB during_IN the_DT cold_JJ season_NN 
Effect_NN modification_NN by_IN season_NN Seasonal_JJ differential_JJ effects_NNS of_IN changes_NNS in_IN levels_NNS of_IN air_NN pollution_NN on_IN the_DT risk_NN of_IN hospitalization_NN have_VBP been_VBN previously_RB reported_VBN ,_, particularly_RB with_IN respects_NNS to_TO stronger_JJR effects_NNS of_IN PM_NNP on_IN respiratory_JJ health_NN during_IN the_DT warm_JJ season_NN such_JJ as_IN those_DT observed_VBN here_RB 
Similarly_RB ,_, an_DT investigation_NN into_IN an_DT unusual_JJ event_NN of_IN transported_VBN dust_NN over_IN the_DT Atlantic_NNP to_TO Greater_NNP Vancouver_NNP ,_, Canada_NNP ,_, has_VBZ shown_VBN no_DT effect_NN on_IN hospital_NN admissions_NNS 
Asimilar_JJ pattern_NN of_IN negative_JJ same-day_JJ associations_NNS ,_, albeit_IN much_RB weaker_JJR ,_, was_VBD observed_VBN with_IN levels_NNS of_IN ozone_NN as_IN recorded_VBN at_IN the_DT rural_JJ station_NN ,_, not_RB influenced_VBN by_IN local_JJ pollution_NN ._. 
Finally_RB ,_, while_IN ,_, there_EX have_VBP generally_RB been_VBN some_DT inconsistent_JJ findings_NNS for_IN the_DT association_NN between_IN cardiovascular_JJ morbidity_NN and_CC levels_NNS of_IN ozone_NN ,_, with_IN some_DT reporting_NN positive_NN 
Finally_RB ,_, while_IN ,_, there_EX have_VBP generally_RB been_VBN some_DT inconsistent_JJ findings_NNS for_IN the_DT association_NN between_IN cardiovascular_JJ morbidity_NN and_CC levels_NNS of_IN ozone_NN ,_, with_IN some_DT reporting_NN positive_NN 
In_IN general_JJ ,_, neither_CC the_DT fact_NN that_IN stronger_JJR associations_NNS with_IN lagged_VBN rather_RB than_IN concurrent_JJ exposure_NN nor_CC that_IN stronger_JJR effects_NNS for_IN cardiovascular_JJ than_IN respiratory_JJ admissions_NNS were_VBD observed_VBN seem_VBP inconsistent_JJ with_IN previous_JJ findings_NNS 
Nonetheless_RB ,_, in_IN a_DT recent_JJ cross-sectional_JJ study_NN in_IN Korea_NNP ,_, it_PRP was_VBD reported_VBN that_IN measures_NNS of_IN blood_NN pressure_NN ,_, a_DT risk_NN factor_NN for_IN cardiovascular_JJ disease_NN ,_, were_VBD significantly_RB associated_VBN with_IN PM_NNP 10_CD levels_NNS only_RB in_IN the_DT warm_JJ season_NN while_IN the_DT reverse_NN was_VBD true_JJ for_IN O_NNP 3_CD ,_, with_IN associations_NNS only_RB during_IN the_DT cold_JJ season_NN 
Finally_RB ,_, while_IN ,_, there_EX have_VBP generally_RB been_VBN some_DT inconsistent_JJ findings_NNS for_IN the_DT association_NN between_IN cardiovascular_JJ morbidity_NN and_CC levels_NNS of_IN ozone_NN ,_, with_IN some_DT reporting_NN positive_NN 
Asimilar_JJ pattern_NN of_IN negative_JJ same-day_JJ associations_NNS ,_, albeit_IN much_RB weaker_JJR ,_, was_VBD observed_VBN with_IN levels_NNS of_IN ozone_NN as_IN recorded_VBN at_IN the_DT rural_JJ station_NN ,_, not_RB influenced_VBN by_IN local_JJ pollution_NN ._. 
Finally_RB ,_, while_IN ,_, there_EX have_VBP generally_RB been_VBN some_DT inconsistent_JJ findings_NNS for_IN the_DT association_NN between_IN cardiovascular_JJ morbidity_NN and_CC levels_NNS of_IN ozone_NN ,_, with_IN some_DT reporting_NN positive_NN 
In_IN general_JJ ,_, neither_CC the_DT fact_NN that_IN stronger_JJR associations_NNS with_IN lagged_VBN rather_RB than_IN concurrent_JJ exposure_NN nor_CC that_IN stronger_JJR effects_NNS for_IN cardiovascular_JJ than_IN respiratory_JJ admissions_NNS were_VBD observed_VBN seem_VBP inconsistent_JJ with_IN previous_JJ findings_NNS 
Asimilar_JJ pattern_NN of_IN negative_JJ same-day_JJ associations_NNS ,_, albeit_IN much_RB weaker_JJR ,_, was_VBD observed_VBN with_IN levels_NNS of_IN ozone_NN as_IN recorded_VBN at_IN the_DT rural_JJ station_NN ,_, not_RB influenced_VBN by_IN local_JJ pollution_NN ._. 
Finally_RB ,_, while_IN ,_, there_EX have_VBP generally_RB been_VBN some_DT inconsistent_JJ findings_NNS for_IN the_DT association_NN between_IN cardiovascular_JJ morbidity_NN and_CC levels_NNS of_IN ozone_NN ,_, with_IN some_DT reporting_NN positive_NN 
In_IN contrast_NN to_TO the_DT same-day_JJ association_NN with_IN levels_NNS of_IN PM_NNP ,_, only_RB effects_NNS of_IN lagged_VBN exposure_NN to_TO ozone_NN were_VBD observed_VBN ._. 
Negative_JJ associations_NNS with_IN same-day_JJ levels_NNS of_IN ozone_NN have_VBP previously_RB been_VBN observed_VBN in_IN several_JJ of_IN the_DT 23_CD APHEA_NNP cities_NNS ,_, an_DT effect_NN which_WDT persisted_VBD even_RB in_IN the_DT summer_NN period_NN in_IN at_IN least_JJS 4_CD of_IN the_DT cities_NNS ,_, namely_RB Rome_NNP ,_, Paris_NNP ,_, Tel_NNP Aviv_NNP and_CC Valencia_NNP ._. 
While_IN explanations_NNS for_IN this_DT are_VBP not_RB clear_JJ ,_, it_PRP is_VBZ thought_VBN to_TO be_VB a_DT product_NN of_IN the_DT relationship_NN between_IN ozone_NN -LRB-_-LRB- a_DT secondary_JJ pollutant_NN produced_VBN by_IN photochemical_JJ reactions_NNS -RRB-_-RRB- and_CC traffic-related_JJ primary_JJ pollutants_NNS such_JJ as_IN nitrogen_NN oxides_NNS -LRB-_-LRB- NO_UH -RRB-_-RRB- and_CC volatile_JJ organic_JJ compounds_NNS -LRB-_-LRB- VOC_NNP -RRB-_-RRB- which_WDT can_MD reduce_VB ozone_NN concentrations_NNS at_IN least_JJS at_IN the_DT local_JJ scale_NN ._. 
Here_RB ,_, other_JJ than_IN some_DT weak_JJ evidence_NN of_IN strongest_JJS effects_NNS on_IN cardio-respiratory_JJ morbidity_NN on_IN the_DT warmest_JJS days_NNS -LRB-_-LRB- 
4%_CD 
While_IN a_DT statistically_RB significant_JJ association_NN was_VBD observed_VBN only_RB for_IN overall_JJ admissions_NNS ,_, in_IN all_DT cases_NNS ,_, effects_NNS were_VBD at_IN least_JJS comparable_JJ in_IN magnitude_NN to_TO those_DT seen_VBN on_IN non-storm_JJ days_NNS with_IN the_DT highest_JJS levels_NNS of_IN PM_NNP 10_CD ,_, particularly_RB for_IN cardiovascular_JJ causes_NNS ._. 
LimitationsSeveral_JJ studies_NNS have_VBP shown_VBN that_IN the_DT effect_NN of_IN air_NN pollution_NN on_IN hospitalization_NN is_VBZ stronger_JJR for_IN certain_JJ cardio-respiratory_JJ conditions_NNS 
While_IN a_DT statistically_RB significant_JJ association_NN was_VBD observed_VBN only_RB for_IN overall_JJ admissions_NNS ,_, in_IN all_DT cases_NNS ,_, effects_NNS were_VBD at_IN least_JJS comparable_JJ in_IN magnitude_NN to_TO those_DT seen_VBN on_IN non-storm_JJ days_NNS with_IN the_DT highest_JJS levels_NNS of_IN PM_NNP 10_CD ,_, particularly_RB for_IN cardiovascular_JJ causes_NNS ._. 
LimitationsSeveral_JJ studies_NNS have_VBP shown_VBN that_IN the_DT effect_NN of_IN air_NN pollution_NN on_IN hospitalization_NN is_VBZ stronger_JJR for_IN certain_JJ cardio-respiratory_JJ conditions_NNS 
While_IN a_DT statistically_RB significant_JJ association_NN was_VBD observed_VBN only_RB for_IN overall_JJ admissions_NNS ,_, in_IN all_DT cases_NNS ,_, effects_NNS were_VBD at_IN least_JJS comparable_JJ in_IN magnitude_NN to_TO those_DT seen_VBN on_IN non-storm_JJ days_NNS with_IN the_DT highest_JJS levels_NNS of_IN PM_NNP 10_CD ,_, particularly_RB for_IN cardiovascular_JJ causes_NNS ._. 
LimitationsSeveral_JJ studies_NNS have_VBP shown_VBN that_IN the_DT effect_NN of_IN air_NN pollution_NN on_IN hospitalization_NN is_VBZ stronger_JJR for_IN certain_JJ cardio-respiratory_JJ conditions_NNS 
Figure_NN 4_CD shows_NNS 4-day_JJ backwards_RB trajectories_NNS ending_VBG in_IN Cyprus_NNP on_IN the_DT day\/time_NN of_IN the_DT four_CD suspected_JJ dust_NN storm_NN events_NNS identifying_VBG the_DT Sahara_NNP desert_NN or_CC the_DT Arabian_NNP Peninsula_NNP as_IN a_DT likely_JJ source_NN ._. 
Similar_JJ southerly_JJ -LRB-_-LRB- mainly_RB in_IN the_DT spring_NN -RRB-_-RRB- or_CC easterly_JJ -LRB-_-LRB- mainly_RB in_IN the_DT autumn_NN -RRB-_-RRB- wind_NN trajectories_NNS ,_, generally_RB consistent_JJ with_IN previously_RB described_VBN transport_NN patterns_NNS ,_, were_VBD observed_VBN on_IN all_DT other_JJ days_NNS ._. 
Figure_NN 3_CD Typical_JJ levels_NNS of_IN PM_NNP 10_CD concentrations_NNS during_IN a_DT dust_NN storm_NN ._. 
Hourly_JJ levels_NNS of_IN PM_NNP 10_CD concentrations_NNS as_IN recorded_VBN at_IN Nicosia_NNP Central_NNP and_CC Ayia_NNP Marina_NNP stations_NNS during_IN A_NNP -RRB-_-RRB- a_DT suspected_JJ dust_NN storm_NN ,_, not_RB confirmed_VBN by_IN Meteorological_NNP Services_NNP records_NNS ,_, between_IN 4_CD 
The_DT effect_NN of_IN dust_NN storms_NNS Long-range_JJ transport_NN of_IN Saharan_JJ dust_NN across_IN the_DT Mediterranean_NNP into_IN southern_JJ Europe_NNP 
Same-day_JJ and_CC lagged_VBN exposure_NN -LRB-_-LRB- up_IN to_TO 2_CD previous_JJ days_NNS -RRB-_-RRB- were_VBD considered_VBN ._. 
The_DT effect_NN of_IN ozone_NN was_VBD assessed_VBN before_IN and_CC after_IN controlling_VBG for_IN the_DT effect_NN of_IN PM_NNP 10_CD ._. 
Due_JJ to_TO lack_NN of_IN statistical_JJ power_NN ,_, distributed_VBN lag_NN models_NNS were_VBD not_RB considered_VBN ._. 
Similarly_RB ,_, due_JJ to_TO the_DT small_JJ number_NN of_IN daily_JJ cause-specific_JJ admissions_NNS ,_, analyses_NNS were_VBD only_RB stratified_VBN by_IN gender_NN -LRB-_-LRB- all_DT ages_NNS combined_VBN -RRB-_-RRB- or_CC age_NN -LRB-_-LRB- i._SYM 
Minimising_VBG the_DT absolute_JJ value_NN of_IN the_DT sum_NN of_IN the_DT partial_JJ autocorrelation_NN function_NN was_VBD used_VBN to_TO assess_VB the_DT appropriateness_NN of_IN the_DT degree_NN of_IN smoothing_NN ._. 
To_TO avoid_VB oversmoothing_NN and_CC ,_, thus_RB ,_, eliminating_VBG patterns_NNS due_JJ to_TO the_DT exposure_NN under_IN study_NN ,_, windows_NNS below_IN 2_CD months_NNS were_VBD generally_RB not_RB considered_VBN ._. 
The_DT weather_NN variables_NNS as_RB well_RB as_IN the_DT appropriate_JJ lags_VBZ for_IN these_DT to_TO include_VB in_IN the_DT models_NNS were_VBD then_RB chosen_VBN by_IN minimizing_VBG the_DT Unbiased_JJ Risk_NNP Estimator_NNP -LRB-_-LRB- UBRE_NNP -RRB-_-RRB- and\/or_CC the_DT Akaike_NNP 's_POS Information_NNP Criterion_NNP -LRB-_-LRB- AIC_NNP -RRB-_-RRB- ._. 
asynergistic_JJ effect_NN of_IN air_NN pollution_NN and_CC temperature_NN amplifying_VBG people_NNS 's_POS response_NN to_TO lower_JJR levels_NNS of_IN air_NN pollutants_NNS than_IN normally_RB ,_, or_CC it_PRP simply_RB ,_, reflects_VBZ an_DT increased_VBN proportion_NN of_IN time_NN spent_VBN outdoors_NNS ,_, and_CC thus_RB higher_JJR exposure_NN ,_, on_IN warm_JJ days_NNS 
Possible_JJ markers_NNS of_IN dust_NN storm_NN events_NNS used_VBN in_IN the_DT past_NN ,_, such_JJ as_IN low_JJ carbon_NN monoxide_NN levels_NNS 
While_IN inference_NN from_IN these_DT associations_NNS is_VBZ limited_VBN due_JJ to_TO the_DT small_JJ number_NN of_IN dust_NN storm_NN days_NNS in_IN the_DT study_NN period_NN ,_, it_PRP would_MD appear_VB imperative_JJ to_TO issue_VB health_NN warnings_NNS for_IN these_DT natural_JJ events_NNS ,_, particularly_RB directed_VBN towards_IN vulnerable_JJ population_NN groups_NNS ._. 
BackgroundIn_IN the_DT last_JJ 20_CD years_NNS ,_, evidence_NN on_IN adverse_JJ health_NN effects_NNS 
While_IN inference_NN from_IN these_DT associations_NNS is_VBZ limited_VBN due_JJ to_TO the_DT small_JJ number_NN of_IN dust_NN storm_NN days_NNS in_IN the_DT study_NN period_NN ,_, it_PRP would_MD appear_VB imperative_JJ to_TO issue_VB health_NN warnings_NNS for_IN these_DT natural_JJ events_NNS ,_, particularly_RB directed_VBN towards_IN vulnerable_JJ population_NN groups_NNS ._. 
BackgroundIn_IN the_DT last_JJ 20_CD years_NNS ,_, evidence_NN on_IN adverse_JJ health_NN effects_NNS 
While_IN inference_NN from_IN these_DT associations_NNS is_VBZ limited_VBN due_JJ to_TO the_DT small_JJ number_NN of_IN dust_NN storm_NN days_NNS in_IN the_DT study_NN period_NN ,_, it_PRP would_MD appear_VB imperative_JJ to_TO issue_VB health_NN warnings_NNS for_IN these_DT natural_JJ events_NNS ,_, particularly_RB directed_VBN towards_IN vulnerable_JJ population_NN groups_NNS ._. 
BackgroundIn_IN the_DT last_JJ 20_CD years_NNS ,_, evidence_NN on_IN adverse_JJ health_NN effects_NNS 
Surprisingly_RB ,_, other_JJ than_IN the_DT warm_JJ season_NN ,_, no_DT overall_JJ effect_NN was_VBD observed_VBN with_IN respiratory_JJ admissions_NNS ._. 
While_IN several_JJ studies_NNS have_VBP shown_VBN associations_NNS between_IN levels_NNS of_IN PM_NNP and_CC respiratory_JJ mortality_NN 
Background_NN In_IN the_DT last_JJ 20_CD years_NNS ,_, evidence_NN on_IN adverse_JJ health_NN effects_NNS 
While_IN inference_NN from_IN these_DT associations_NNS is_VBZ limited_VBN due_JJ to_TO the_DT small_JJ number_NN of_IN dust_NN storm_NN days_NNS in_IN the_DT study_NN period_NN ,_, it_PRP would_MD appear_VB imperative_JJ to_TO issue_VB health_NN warnings_NNS for_IN these_DT natural_JJ events_NNS ,_, particularly_RB directed_VBN towards_IN vulnerable_JJ population_NN groups_NNS ._. 
BackgroundIn_IN the_DT last_JJ 20_CD years_NNS ,_, evidence_NN on_IN adverse_JJ health_NN effects_NNS 
While_IN inference_NN from_IN these_DT associations_NNS is_VBZ limited_VBN due_JJ to_TO the_DT small_JJ number_NN of_IN dust_NN storm_NN days_NNS in_IN the_DT study_NN period_NN ,_, it_PRP would_MD appear_VB imperative_JJ to_TO issue_VB health_NN warnings_NNS for_IN these_DT natural_JJ events_NNS ,_, particularly_RB directed_VBN towards_IN vulnerable_JJ population_NN groups_NNS ._. 
BackgroundIn_IN the_DT last_JJ 20_CD years_NNS ,_, evidence_NN on_IN adverse_JJ health_NN effects_NNS 
While_IN inference_NN from_IN these_DT associations_NNS is_VBZ limited_VBN due_JJ to_TO the_DT small_JJ number_NN of_IN dust_NN storm_NN days_NNS in_IN the_DT study_NN period_NN ,_, it_PRP would_MD appear_VB imperative_JJ to_TO issue_VB health_NN warnings_NNS for_IN these_DT natural_JJ events_NNS ,_, particularly_RB directed_VBN towards_IN vulnerable_JJ population_NN groups_NNS ._. 
BackgroundIn_IN the_DT last_JJ 20_CD years_NNS ,_, evidence_NN on_IN adverse_JJ health_NN effects_NNS 
Background_NN In_IN the_DT last_JJ 20_CD years_NNS ,_, evidence_NN on_IN adverse_JJ health_NN effects_NNS 
In_IN the_DT light_NN of_IN evidence_NN of_IN ozone_NN effects_NNS on_IN mortality_NN restricted_VBN to_TO the_DT warm_JJ season_NN across_IN 23_CD APHEA_NNP cities_NNS ,_, the_DT stronger_JJR association_NN between_IN cardiovascular_JJ admissions_NNS and_CC ozone_NN during_IN the_DT colder_JJR season_NN observed_VBD here_RB appears_VBZ surprising_JJ 
Forward_RB and_CC reverse_VB primers_NNS -LRB-_-LRB- Sigma_NNP ,_, St._NNP 0_CD C_NNP for_IN 1:00_CD minute_NN for_IN annealing\/extension_NN for_IN 40_CD cycles_NNS ,_, followed_VBN by_IN a_DT dissociation_NN step_NN ._. 
Louis_NNP ,_, MO_NNP USA_NNP -RRB-_-RRB- were_VBD either_RB designed_VBN by_IN Primer_NNP 3_CD or_CC selected_VBN for_IN each_DT gene_NN to_TO maximize_VB specificity_NN and_CC efficiency_NN in_IN the_DT reaction_NN :_: CYP19_CD -LRB-_-LRB- 249_CD base_NN pairs_NNS -LRB-_-LRB- BP_NNP -RRB-_-RRB- -RRB-_-RRB- -LRB-_-LRB- forward_RB -RRB-_-RRB- 5_CD '_'' -_: ATACCAGGTCCTGGCTACTG-3_NNP '_POS and_CC CYP19_NNP -LRB-_-LRB- reverse_NN -RRB-_-RRB- 5_CD '_'' -_: TCTCATGCATACCGATGCACTG-3_NN '_'' 
Consistent_JJ with_IN differences_NNS by_IN degree_NN of_IN hypoxia_NN ,_, we_PRP also_RB saw_VBD a_DT non-significant_JJ trend_NN towards_IN higher_JJR expression_NN of_IN the_DT hypoxia-related_JJ transcript_NN PPAR_NN 
We_PRP observed_VBD significant_JJ decreases_VBZ over_IN 25_CD minutes_NNS in_IN the_DT expression_NN of_IN both_DT transcripts_NNS -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- ._. 
We_PRP observed_VBD a_DT trend_NN towards_IN higher_JJR PPAR_NN 
18S_CD was_VBD later_RB chosen_VBN as_IN the_DT consensus_NN housekeeping_NN gene_NN based_VBN on_IN the_DT more_RBR recent_JJ placenta_NN literature_NN ._. 
Total_NNP RNA_NNP -LRB-_-LRB- 
Adjustment_NNP for_IN an_DT appropriate_JJ internal_JJ control_NN should_MD in_IN theory_NN minimize_VBP variability_NN due_JJ to_TO differences_NNS in_IN the_DT quality_NN and_CC quantity_NN of_IN the_DT RNA_NNP that_WDT went_VBD into_IN the_DT RT_NNP reaction_NN ._. 
Several_JJ possible_JJ internal_JJ controls_NNS have_VBP been_VBN proposed_VBN for_IN qPCR_NNP including_VBG total_JJ RNA_NNP ,_, ribosomal_JJ RNAs_NNS ,_, and_CC one_CD or_CC more_JJR reference_NN messenger_NN RNAs_NNS ._. 
Reference_NNP mRNAs_NNP are_VBP the_DT most_RBS common_JJ approach_NN ._. 
Some_DT of_IN the_DT criteria_NNS are_VBP that_IN they_PRP be_VB constitutively_RB expressed_VBN in_IN the_DT cell_NN type_NN of_IN interest_NN ,_, in_IN the_DT tissue_NN of_IN interest_NN and_CC not_RB be_VB affected_VBN by_IN the_DT exposure_NN of_IN interest_NN or_CC experimental_JJ conditions_NNS ._. 
We_PRP found_VBD that_IN total_JJ RNA_NNP did_VBD better_RBR than_IN CYC_NNP in_IN controlling_VBG for_IN within-placenta_JJ variation_NN ._. 
Total_NNP RNA_NNP is_VBZ thought_VBN to_TO vary_VB minimally_RB by_IN cell_NN and_CC therefore_RB be_VB more_RBR stable_JJ within_IN a_DT tissue_NN type_NN ,_, to_TO be_VB less_RBR variable_JJ by_IN method_NN of_IN homogenization_NN ,_, more_RBR uniformly_RB measured_VBN across_IN studies_NNS ,_, and_CC possibly_RB a_DT more_RBR accurate_JJ measure_NN of_IN the_DT quality_NN of_IN the_DT tissue_NN at_IN the_DT time_NN of_IN sampling_NN 
It_PRP supplants_VBZ the_DT ovary_NN in_IN the_DT production_NN ,_, metabolism_NN and_CC regulation_NN of_IN steroid_NN and_CC other_JJ hormones_NNS necessary_JJ for_IN pregnancy_NN maintenance_NN and_CC fetal_JJ development_NN 
The_DT placenta_NN ,_, through_IN autocrine_NN and_CC paracrine_NN signaling_VBG ,_, helps_VBZ to_TO maintain_VB uterine_JJ quiescence_NN until_IN late_JJ pregnancy_NN when_WRB a_DT tightly_RB regulated_JJ signaling_VBG cascade_NN between_IN the_DT placenta_NN ,_, the_DT fetus_NN ,_, and_CC the_DT uterus_NN is_VBZ initiated_VBN to_TO stimulate_VB uterine_JJ contractions_NNS 
Existing_VBG ,_, previously-validated_JJ methods_NNS for_IN identifying_VBG toxic_JJ or_CC pathologic_JJ responses_NNS in_IN the_DT human_JJ placenta_NN include_VBP measuring_VBG the_DT residues_NNS of_IN the_DT compound_NN of_IN interest_NN in_IN placental_JJ tissues_NNS 
We_PRP chose_VBD to_TO study_VB the_DT placenta_NN as_IN a_DT potential_JJ target_NN of_IN phthalate_JJ toxicity_NN during_IN pregnancy_NN ._. 
Urinary_JJ phthalate_NN metabolites_NNS can_MD be_VB characterized_VBN as_IN low_JJ dose_NN chronic_NN exposures_NNS in_IN 
The_DT placenta_NN is_VBZ a_DT transient_JJ endocrine_NN organ_NN which_WDT assumes_VBZ a_DT wide_JJ range_NN of_IN functions_NNS to_TO facilitate_VB maternal-fetal_JJ interactions_NNS 
CYP19_CD codes_NNS for_IN the_DT enzyme_NN aromatase_NN that_WDT is_VBZ responsible_JJ for_IN the_DT conversion_NN of_IN androstenedione_NN to_TO estradiol_NN in_IN the_DT placenta_NN ._. 
Estradiol_NNP is_VBZ essential_JJ for_IN fetal_JJ development_NN and_CC parturition_NN signaling_VBG 
Phthalates_NNS have_VBP been_VBN shown_VBN to_TO be_VB reproductive_JJ and_CC developmental_JJ toxicants_NNS in_IN animal_NN models_NNS with_IN some_DT preliminary_JJ evidence_NN of_IN effects_NNS in_IN humans_NNS ._. 
Urinary_JJ phthalate_NN metabolites_NNS can_MD be_VB characterized_VBN as_IN low_JJ dose_NN chronic_NN exposures_NNS in_IN 
In_IN the_DT present_JJ study_NN ,_, we_PRP explored_VBD the_DT utility_NN of_IN placental_JJ gene_NN expression_NN measured_VBN by_IN real-time_JJ quantitative_JJ polymerase_NN chain_NN reaction_NN -LRB-_-LRB- qPCR_NNP -RRB-_-RRB- as_IN a_DT novel_NN biomarker_NN for_IN use_NN in_IN environmental_JJ epidemiology_NN ,_, including_VBG in_IN our_PRP$ research_NN on_IN prenatal_JJ exposures_NNS to_TO common_JJ endocrine_NN disrupting_VBG chemicals_NNS called_VBN phthalates_NNS ._. 
Phthalates_NNS have_VBP been_VBN shown_VBN to_TO be_VB reproductive_JJ and_CC developmental_JJ toxicants_NNS in_IN animal_NN models_NNS with_IN some_DT preliminary_JJ evidence_NN of_IN effects_NNS in_IN humans_NNS ._. 
Urinary_JJ phthalate_NN metabolites_NNS can_MD be_VB characterized_VBN as_IN low_JJ dose_NN chronic_NN exposures_NNS in_IN 
Phthalates_NNS have_VBP been_VBN shown_VBN to_TO be_VB reproductive_JJ and_CC developmental_JJ toxicants_NNS in_IN animal_NN models_NNS with_IN some_DT preliminary_JJ evidence_NN of_IN effects_NNS in_IN humans_NNS ._. 
Urinary_JJ phthalate_NN metabolites_NNS can_MD be_VB characterized_VBN as_IN low_JJ dose_NN chronic_NN exposures_NNS in_IN 
Each_DT standard_JJ curve_NN included_VBD 2_CD non-template_JJ controls_NNS and_CC 8_CD serial_JJ dilutions_NNS covering_VBG the_DT range_NN of_IN 1000_CD molecules_NNS \/_SYM 
The_DT maternal_JJ side_NN of_IN the_DT placenta_NN or_CC basal_NN plate_NN emanates_VBZ from_IN the_DT uterine_NN wall_NN and_CC consists_VBZ of_IN trophoblastic_JJ and_CC endometrium-derived_JJ cells_NNS ._. 
The_DT fetal_JJ component_NN or_CC the_DT placental_JJ villous_NN is_VBZ composed_VBN of_IN a_DT mixture_NN of_IN cell_NN types_NNS including_VBG trophoblasts_NNS ,_, the_DT trophoblastic_JJ basement_NN membrane_NN ,_, stroma_NN -LRB-_-LRB- mesenchymal_JJ cells_NNS ,_, macrophages_NNS ,_, fibroblasts_NNS ,_, and_CC matrix_NN components_NNS -RRB-_-RRB- and_CC fetal_JJ vessels_NNS ._. 
In_IN the_DT application_NN of_IN biomarkers_NNS of_IN transcription_NN ,_, it_PRP is_VBZ of_IN critical_JJ importance_NN to_TO identify_VB tissue_NN type_NN and_CC cell_NN type_NN of_IN interest_NN and_CC design_NN methods_NNS to_TO maximize_VB the_DT presence_NN of_IN these_DT cells_NNS in_IN any_DT given_VBN biopsy_NN ._. 
We_PRP were_VBD interested_JJ in_IN targeting_VBG villous_JJ tissue_NN and_CC specifically_RB gene_NN targets_NNS expressed_VBN in_IN the_DT syncytiotrophoblast_NN ._. 
Existing_VBG ,_, previously-validated_JJ methods_NNS for_IN identifying_VBG toxic_JJ or_CC pathologic_JJ responses_NNS in_IN the_DT human_JJ placenta_NN include_VBP measuring_VBG the_DT residues_NNS of_IN the_DT compound_NN of_IN interest_NN in_IN placental_JJ tissues_NNS 
However_RB ,_, because_IN the_DT tissue_NN collection_NN was_VBD IRB-exempt_JJ we_PRP were_VBD not_RB able_JJ to_TO collect_VB information_NN on_IN specific_JJ gestational_JJ age_NN which_WDT has_VBZ been_VBN shown_VBN to_TO be_VB associated_VBN with_IN placental_JJ gene_NN expression_NN 
Adjustment_NNP for_IN an_DT appropriate_JJ internal_JJ control_NN should_MD in_IN theory_NN minimize_VBP variability_NN due_JJ to_TO differences_NNS in_IN the_DT quality_NN and_CC quantity_NN of_IN the_DT RNA_NNP that_WDT went_VBD into_IN the_DT RT_NNP reaction_NN ._. 
Several_JJ possible_JJ internal_JJ controls_NNS have_VBP been_VBN proposed_VBN for_IN qPCR_NNP including_VBG total_JJ RNA_NNP ,_, ribosomal_JJ RNAs_NNS ,_, and_CC one_CD or_CC more_JJR reference_NN messenger_NN RNAs_NNS ._. 
Reference_NNP mRNAs_NNP are_VBP the_DT most_RBS common_JJ approach_NN ._. 
Some_DT of_IN the_DT criteria_NNS are_VBP that_IN they_PRP be_VB constitutively_RB expressed_VBN in_IN the_DT cell_NN type_NN of_IN interest_NN ,_, in_IN the_DT tissue_NN of_IN interest_NN and_CC not_RB be_VB affected_VBN by_IN the_DT exposure_NN of_IN interest_NN or_CC experimental_JJ conditions_NNS ._. 
18S_NNP appears_VBZ to_TO be_VB the_DT most_RBS commonly_RB used_VBN reference_NN gene_NN in_IN placental_JJ studies_NNS of_IN gene_NN expression_NN ._. 
Additional_JJ reference_NN genes_NNS -LRB-_-LRB- SDHA_NNP ,_, TBP_NNP and_CC YWHAZ_NNP -RRB-_-RRB- have_VBP recently_RB been_VBN proposed_VBN for_IN placenta_NN studies_NNS that_WDT are_VBP expressed_VBN are_VBP lower_JJR levels_NNS than_IN 18S_CD and_CC should_MD be_VB considered_VBN in_IN future_JJ studies_NNS 
The_DT internal_JJ control_NN should_MD not_RB share_VB regulatory_JJ factors_NNS with_IN the_DT gene_NN of_IN interest_NN ._. 
Some_DT of_IN the_DT criteria_NNS are_VBP that_IN they_PRP be_VB constitutively_RB expressed_VBN in_IN the_DT cell_NN type_NN of_IN interest_NN ,_, in_IN the_DT tissue_NN of_IN interest_NN and_CC not_RB be_VB affected_VBN by_IN the_DT exposure_NN of_IN interest_NN or_CC experimental_JJ conditions_NNS ._. 
It_PRP should_MD have_VB low_JJ intra-individual_JJ variation_NN and_CC should_MD be_VB expressed_VBN at_IN roughly_RB the_DT same_JJ order_NN of_IN magnitude_NN as_IN the_DT target_NN gene_NN ._. 
Unlike_IN Pidoux_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- who_WP showed_VBD that_DT cyclophilin_NN was_VBD a_DT suitable_JJ housekeeping_NN gene_NN in_IN studies_NNS of_IN PPAR_NNP 
Previous_JJ reports_NNS have_VBP shown_VBN that_IN PPAR_NNP 
We_PRP found_VBD that_IN total_JJ RNA_NNP did_VBD better_RBR than_IN CYC_NNP in_IN controlling_VBG for_IN within-placenta_JJ variation_NN ._. 
Total_NNP RNA_NNP is_VBZ thought_VBN to_TO vary_VB minimally_RB by_IN cell_NN and_CC therefore_RB be_VB more_RBR stable_JJ within_IN a_DT tissue_NN type_NN ,_, to_TO be_VB less_RBR variable_JJ by_IN method_NN of_IN homogenization_NN ,_, more_RBR uniformly_RB measured_VBN across_IN studies_NNS ,_, and_CC possibly_RB a_DT more_RBR accurate_JJ measure_NN of_IN the_DT quality_NN of_IN the_DT tissue_NN at_IN the_DT time_NN of_IN sampling_NN 
To_TO our_PRP$ knowledge_NN ,_, there_EX are_VBP no_DT published_JJ placenta_NN studies_NNS that_WDT have_VBP used_VBN total_JJ RNA_NNP as_IN an_DT internal_JJ control_NN ._. 
Ribosomal_JJ RNAs_NNS such_JJ as_IN 18S_NNP have_VBP been_VBN recommended_VBN as_IN reference_NN genes_NNS in_IN that_IN they_PRP are_VBP generated_VBN by_IN a_DT polymerase_NN distinct_JJ from_IN those_DT that_WDT generate_VBP mRNA_NNP ,_, they_PRP are_VBP less_RBR likely_JJ to_TO vary_VB by_IN conditions_NNS that_WDT affect_VBP the_DT expression_NN of_IN mRNA_NNP ,_, and_CC they_PRP have_VBP been_VBN shown_VBN to_TO be_VB more_RBR reliable_JJ than_IN other_JJ housekeeping_NN genes_NNS in_IN a_DT variety_NN of_IN tissues_NNS 
Forward_RB and_CC reverse_VB primers_NNS -LRB-_-LRB- Sigma_NNP ,_, St._NNP 0_CD C_NNP for_IN 1:00_CD minute_NN for_IN annealing\/extension_NN for_IN 40_CD cycles_NNS ,_, followed_VBN by_IN a_DT dissociation_NN step_NN ._. 
Louis_NNP ,_, MO_NNP USA_NNP -RRB-_-RRB- were_VBD either_RB designed_VBN by_IN Primer_NNP 3_CD or_CC selected_VBN for_IN each_DT gene_NN to_TO maximize_VB specificity_NN and_CC efficiency_NN in_IN the_DT reaction_NN :_: CYP19_CD -LRB-_-LRB- 249_CD base_NN pairs_NNS -LRB-_-LRB- BP_NNP -RRB-_-RRB- -RRB-_-RRB- -LRB-_-LRB- forward_RB -RRB-_-RRB- 5_CD '_'' -_: ATACCAGGTCCTGGCTACTG-3_NNP '_POS and_CC CYP19_NNP -LRB-_-LRB- reverse_NN -RRB-_-RRB- 5_CD '_'' -_: TCTCATGCATACCGATGCACTG-3_NN '_'' 
Estradiol_NNP is_VBZ essential_JJ for_IN fetal_JJ development_NN and_CC parturition_NN signaling_VBG 
CYP19_NNP may_MD also_RB be_VB important_JJ in_IN the_DT metabolism_NN of_IN xenobiotic_JJ compounds_NNS 
PPAR_NN 
PPAR_NN 
CYC_NNP was_VBD chosen_VBN based_VBN on_IN a_DT previous_JJ study_NN that_WDT evaluated_VBD 3_CD housekeeping_NN genes_NNS for_IN use_NN in_IN human_JJ placental_JJ tissue_NN analysis_NN and_CC found_VBD no_DT difference_NN between_IN them_PRP 
Ribosomal_JJ RNAs_NNS such_JJ as_IN 18S_NNP have_VBP been_VBN recommended_VBN as_IN reference_NN genes_NNS in_IN that_IN they_PRP are_VBP generated_VBN by_IN a_DT polymerase_NN distinct_JJ from_IN those_DT that_WDT generate_VBP mRNA_NNP ,_, they_PRP are_VBP less_RBR likely_JJ to_TO vary_VB by_IN conditions_NNS that_WDT affect_VBP the_DT expression_NN of_IN mRNA_NNP ,_, and_CC they_PRP have_VBP been_VBN shown_VBN to_TO be_VB more_RBR reliable_JJ than_IN other_JJ housekeeping_NN genes_NNS in_IN a_DT variety_NN of_IN tissues_NNS 
18_CD -RRB-_-RRB- p_VBP =_SYM 0_CD ._. 
20_CD -LRB-_-LRB- 0_CD ._. 
77_CD 0_CD ._. 
15_CD -RRB-_-RRB- p_VBP =_SYM 0_CD ._. 
04_CD -LRB-_-LRB- 0_CD ._. 
outer_JJ 0_CD ._. 
002_CD Regional_NNP differences_NNS 
Messenger_NNP RNA_NNP was_VBD chosen_VBN given_VBN the_DT feasibility_NN in_IN measuring_VBG it_PRP in_IN a_DT large_JJ number_NN of_IN placentas_NNS and_CC its_PRP$ clear_JJ physiologic_JJ relevance_NN ._. 
qPCR_NNP was_VBD chosen_VBN over_IN global_JJ gene_NN expression_NN microarrays_NNS ,_, another_DT commonly_RB used_VBN method_NN in_IN studies_NNS using_VBG human_JJ placental_JJ tissue_NN ,_, for_IN two_CD reasons_NNS ._. 
We_PRP had_VBD identified_VBN our_PRP$ gene_NN targets_NNS based_VBN on_IN apriori_JJ evidence_NN from_IN the_DT toxicologic_JJ literature_NN ._. 
Secondly_RB ,_, qPCR_NNP was_VBD more_RBR cost-effective_JJ given_VBN that_IN our_PRP$ ultimate_JJ goal_NN was_VBD to_TO analyze_VB a_DT large_JJ enough_JJ number_NN of_IN samples_NNS -LRB-_-LRB- N_NNP 
CYC_NNP was_VBD chosen_VBN based_VBN on_IN a_DT previous_JJ study_NN that_WDT evaluated_VBD 3_CD housekeeping_NN genes_NNS for_IN use_NN in_IN human_JJ placental_JJ tissue_NN analysis_NN and_CC found_VBD no_DT difference_NN between_IN them_PRP 
Ribosomal_JJ RNAs_NNS such_JJ as_IN 18S_NNP have_VBP been_VBN recommended_VBN as_IN reference_NN genes_NNS in_IN that_IN they_PRP are_VBP generated_VBN by_IN a_DT polymerase_NN distinct_JJ from_IN those_DT that_WDT generate_VBP mRNA_NNP ,_, they_PRP are_VBP less_RBR likely_JJ to_TO vary_VB by_IN conditions_NNS that_WDT affect_VBP the_DT expression_NN of_IN mRNA_NNP ,_, and_CC they_PRP have_VBP been_VBN shown_VBN to_TO be_VB more_RBR reliable_JJ than_IN other_JJ housekeeping_NN genes_NNS in_IN a_DT variety_NN of_IN tissues_NNS 
All_DT of_IN the_DT placentas_NNS in_IN this_DT study_NN were_VBD full-term_JJ ._. 
Likewise_RB ,_, we_PRP recommend_VBP evaluating_VBG the_DT impact_NN of_IN the_DT time_NN elapsed_VBN from_IN delivery_NN to_TO collection_NN on_IN expression_NN values_NNS of_IN specific_JJ transcripts_NNS ._. 
However_RB ,_, because_IN the_DT tissue_NN collection_NN was_VBD IRB-exempt_JJ we_PRP were_VBD not_RB able_JJ to_TO collect_VB information_NN on_IN specific_JJ gestational_JJ age_NN which_WDT has_VBZ been_VBN shown_VBN to_TO be_VB associated_VBN with_IN placental_JJ gene_NN expression_NN 
Estradiol_NNP is_VBZ essential_JJ for_IN fetal_JJ development_NN and_CC parturition_NN signaling_VBG 
There_EX was_VBD no_DT overlap_VBP in_IN the_DT 95_CD %_NN confidence_NN intervals_NNS for_IN these_DT three_CD correlation_NN coefficients_NNS ,_, suggesting_VBG that_IN there_EX are_VBP significant_JJ differences_NNS in_IN the_DT point_NN estimate_NN depending_VBG on_IN which_WDT internal_JJ control_NN is_VBZ used_VBN ._. 
PPAR_NN 
We_PRP also_RB saw_VBD that_IN CYC_NNP mRNA_NNP was_VBD correlated_VBN with_IN PPAR_NNP 
18S_NNP appears_VBZ to_TO be_VB the_DT most_RBS commonly_RB used_VBN reference_NN gene_NN in_IN placental_JJ studies_NNS of_IN gene_NN expression_NN ._. 
Additional_JJ reference_NN genes_NNS -LRB-_-LRB- SDHA_NNP ,_, TBP_NNP and_CC YWHAZ_NNP -RRB-_-RRB- have_VBP recently_RB been_VBN proposed_VBN for_IN placenta_NN studies_NNS that_WDT are_VBP expressed_VBN are_VBP lower_JJR levels_NNS than_IN 18S_CD and_CC should_MD be_VB considered_VBN in_IN future_JJ studies_NNS 
Forward_RB and_CC reverse_VB primers_NNS -LRB-_-LRB- Sigma_NNP ,_, St._NNP 0_CD C_NNP for_IN 1:00_CD minute_NN for_IN annealing\/extension_NN for_IN 40_CD cycles_NNS ,_, followed_VBN by_IN a_DT dissociation_NN step_NN ._. 
Louis_NNP ,_, MO_NNP USA_NNP -RRB-_-RRB- were_VBD either_RB designed_VBN by_IN Primer_NNP 3_CD or_CC selected_VBN for_IN each_DT gene_NN to_TO maximize_VB specificity_NN and_CC efficiency_NN in_IN the_DT reaction_NN :_: CYP19_CD -LRB-_-LRB- 249_CD base_NN pairs_NNS -LRB-_-LRB- BP_NNP -RRB-_-RRB- -RRB-_-RRB- -LRB-_-LRB- forward_RB -RRB-_-RRB- 5_CD '_'' -_: ATACCAGGTCCTGGCTACTG-3_NNP '_POS and_CC CYP19_NNP -LRB-_-LRB- reverse_NN -RRB-_-RRB- 5_CD '_'' -_: TCTCATGCATACCGATGCACTG-3_NN '_'' 
We_PRP also_RB saw_VBD that_IN CYC_NNP mRNA_NNP was_VBD correlated_VBN with_IN PPAR_NNP 
However_RB ,_, because_IN the_DT tissue_NN collection_NN was_VBD IRB-exempt_JJ we_PRP were_VBD not_RB able_JJ to_TO collect_VB information_NN on_IN specific_JJ gestational_JJ age_NN which_WDT has_VBZ been_VBN shown_VBN to_TO be_VB associated_VBN with_IN placental_JJ gene_NN expression_NN 
CYC_NNP was_VBD chosen_VBN based_VBN on_IN a_DT previous_JJ study_NN that_WDT evaluated_VBD 3_CD housekeeping_NN genes_NNS for_IN use_NN in_IN human_JJ placental_JJ tissue_NN analysis_NN and_CC found_VBD no_DT difference_NN between_IN them_PRP 
Ribosomal_JJ RNAs_NNS such_JJ as_IN 18S_NNP have_VBP been_VBN recommended_VBN as_IN reference_NN genes_NNS in_IN that_IN they_PRP are_VBP generated_VBN by_IN a_DT polymerase_NN distinct_JJ from_IN those_DT that_WDT generate_VBP mRNA_NNP ,_, they_PRP are_VBP less_RBR likely_JJ to_TO vary_VB by_IN conditions_NNS that_WDT affect_VBP the_DT expression_NN of_IN mRNA_NNP ,_, and_CC they_PRP have_VBP been_VBN shown_VBN to_TO be_VB more_RBR reliable_JJ than_IN other_JJ housekeeping_NN genes_NNS in_IN a_DT variety_NN of_IN tissues_NNS 
Forward_RB and_CC reverse_VB primers_NNS -LRB-_-LRB- Sigma_NNP ,_, St._NNP 0_CD C_NNP for_IN 1:00_CD minute_NN for_IN annealing\/extension_NN for_IN 40_CD cycles_NNS ,_, followed_VBN by_IN a_DT dissociation_NN step_NN ._. 
Louis_NNP ,_, MO_NNP USA_NNP -RRB-_-RRB- were_VBD either_RB designed_VBN by_IN Primer_NNP 3_CD or_CC selected_VBN for_IN each_DT gene_NN to_TO maximize_VB specificity_NN and_CC efficiency_NN in_IN the_DT reaction_NN :_: CYP19_CD -LRB-_-LRB- 249_CD base_NN pairs_NNS -LRB-_-LRB- BP_NNP -RRB-_-RRB- -RRB-_-RRB- -LRB-_-LRB- forward_RB -RRB-_-RRB- 5_CD '_'' -_: ATACCAGGTCCTGGCTACTG-3_NNP '_POS and_CC CYP19_NNP -LRB-_-LRB- reverse_NN -RRB-_-RRB- 5_CD '_'' -_: TCTCATGCATACCGATGCACTG-3_NN '_'' 
It_PRP showed_VBD extremely_RB high_JJ within-placenta_JJ variability_NN that_IN we_PRP speculate_VBP is_VBZ related_VBN to_TO its_PRP$ role_NN in_IN hypoxia_NN therefore_RB obviating_VBG its_PRP$ use_NN as_IN a_DT housekeeping_NN gene_NN ._. 
Reports_NNS of_IN CYC_NNP expression_NN in_IN other_JJ tissues_NNS showed_VBD that_IN it_PRP was_VBD upregulated_VBN in_IN response_NN to_TO hypoxia_NN which_WDT would_MD make_VB it_PRP inappropriate_JJ for_IN use_NN in_IN placental_JJ studies_NNS where_WRB hypoxia_NN might_MD be_VB in_IN the_DT causal_JJ pathway_NN between_IN exposure_NN and_CC disease_NN ._. 
We_PRP also_RB saw_VBD that_IN CYC_NNP mRNA_NNP was_VBD correlated_VBN with_IN PPAR_NNP 
However_RB ,_, because_IN the_DT tissue_NN collection_NN was_VBD IRB-exempt_JJ we_PRP were_VBD not_RB able_JJ to_TO collect_VB information_NN on_IN specific_JJ gestational_JJ age_NN which_WDT has_VBZ been_VBN shown_VBN to_TO be_VB associated_VBN with_IN placental_JJ gene_NN expression_NN 
Specificity_NN of_IN the_DT PCR_NNP product_NN was_VBD evaluated_VBN using_VBG the_DT melting_VBG curve_NN generated_VBN at_IN the_DT end_NN of_IN amplification_NN and_CC by_IN running_VBG a_DT 2_CD %_NN agarose_JJ gel_NN to_TO visualize_VB the_DT PCR_NNP product_NN ._. 
Absolute_JJ quantitation_NN of_IN mRNA_NNP concentration_NN in_IN the_DT original_JJ sample_NN was_VBD achieved_VBN using_VBG a_DT standard_JJ curve_NN generated_VBN for_IN each_DT batch_NN ._. 
Each_DT standard_JJ curve_NN included_VBD 2_CD non-template_JJ controls_NNS and_CC 8_CD serial_JJ dilutions_NNS covering_VBG the_DT range_NN of_IN 1000_CD molecules_NNS \/_SYM 
e._VB In_IN a_DT setting_NN ,_, i._VBP A_DT common_JJ practice_NN in_IN clinical_JJ and_CC basic_JJ research_NN settings_NNS is_VBZ to_TO restrict_VB to_TO C-section_NN placentas_NNS due_JJ to_TO tighter_JJR control_NN over_IN the_DT time_NN of_IN sampling_VBG relative_JJ to_TO the_DT birth_NN of_IN the_DT baby_NN ._. 
prenatal_JJ phthalate_NN exposure_NN ,_, where_WRB the_DT exposure_NN of_IN interest_NN may_MD have_VB a_DT putative_JJ effect_NN on_IN parturition_NN signalling_NN ,_, this_DT type_NN of_IN exclusion_NN may_MD introduce_VB bias_NN and_CC possibly_RB preclude_VB the_DT detection_NN of_IN associations_NNS of_IN interest_NN ._. 
For_IN this_DT reason_NN ,_, we_PRP propose_VBP sampling_VBG placentas_NNS of_IN all_DT delivery_NN methods_NNS and_CC routinely_RB recording_VBG detailed_JJ information_NN on_IN the_DT method_NN and_CC conditions_NNS of_IN labor_NN and_CC delivery_NN to_TO be_VB used_VBN in_IN the_DT data_NNS analysis_NN ._. 
Cyclophilin_NNP -LRB-_-LRB- CYC_NNP -RRB-_-RRB- and_CC 18S_CD ribosomal_JJ RNA_NNP -LRB-_-LRB- 18S_NNP -RRB-_-RRB- were_VBD included_VBN as_IN housekeeping_NN genes_NNS to_TO serve_VB as_IN internal_JJ controls_NNS for_IN quantity_NN and_CC quality_NN of_IN cDNA_NNP going_VBG into_IN the_DT RT_NNP reaction_NN ._. 
CYC_NNP was_VBD chosen_VBN based_VBN on_IN a_DT previous_JJ study_NN that_WDT evaluated_VBD 3_CD housekeeping_NN genes_NNS for_IN use_NN in_IN human_JJ placental_JJ tissue_NN analysis_NN and_CC found_VBD no_DT difference_NN between_IN them_PRP 
18_CD -RRB-_-RRB- p_VBP =_SYM 0_CD ._. 
20_CD -LRB-_-LRB- 0_CD ._. 
77_CD 0_CD ._. 
15_CD -RRB-_-RRB- p_VBP =_SYM 0_CD ._. 
04_CD -LRB-_-LRB- 0_CD ._. 
outer_JJ 0_CD ._. 
002_CD Regional_NNP differences_NNS 
Within_IN the_DT chorionic_JJ villi_NN ,_, PPAR_NNP 
PPAR_NN 
CYC_NNP was_VBD chosen_VBN based_VBN on_IN a_DT previous_JJ study_NN that_WDT evaluated_VBD 3_CD housekeeping_NN genes_NNS for_IN use_NN in_IN human_JJ placental_JJ tissue_NN analysis_NN and_CC found_VBD no_DT difference_NN between_IN them_PRP 
18_CD -RRB-_-RRB- p_VBP =_SYM 0_CD ._. 
20_CD -LRB-_-LRB- 0_CD ._. 
77_CD 0_CD ._. 
15_CD -RRB-_-RRB- p_VBP =_SYM 0_CD ._. 
04_CD -LRB-_-LRB- 0_CD ._. 
outer_JJ 0_CD ._. 
002_CD Regional_NNP differences_NNS 
Wyatt_NNP et_NNP al._VBD 26_CD Tissue_NN heterogeneity_NN as_RB well_RB as_IN differences_NNS in_IN perfusion_NN and_CC the_DT degree_NN of_IN hypoxia_NN are_VBP major_JJ sources_NNS of_IN within-placenta_JJ variability_NN ._. 
did_VBD a_DT detailed_JJ analysis_NN of_IN concordance_NN between_IN histologic_JJ parameters_NNS and_CC gene_NN expression_NN using_VBG 6_CD placentas_NNS sampled_VBN at_IN 9_CD sites_NNS including_VBG the_DT chorionic_JJ -LRB-_-LRB- fetal_JJ side_NN -RRB-_-RRB- and_CC basal_JJ -LRB-_-LRB- maternal_JJ side_NN -RRB-_-RRB- plates_NNS and_CC the_DT inner_JJ -LRB-_-LRB- medial_JJ -RRB-_-RRB- and_CC outer_JJ -LRB-_-LRB- lateral_JJ -RRB-_-RRB- regions_NNS on_IN both_DT sides_NNS 
Ribosomal_JJ RNAs_NNS such_JJ as_IN 18S_NNP have_VBP been_VBN recommended_VBN as_IN reference_NN genes_NNS in_IN that_IN they_PRP are_VBP generated_VBN by_IN a_DT polymerase_NN distinct_JJ from_IN those_DT that_WDT generate_VBP mRNA_NNP ,_, they_PRP are_VBP less_RBR likely_JJ to_TO vary_VB by_IN conditions_NNS that_WDT affect_VBP the_DT expression_NN of_IN mRNA_NNP ,_, and_CC they_PRP have_VBP been_VBN shown_VBN to_TO be_VB more_RBR reliable_JJ than_IN other_JJ housekeeping_NN genes_NNS in_IN a_DT variety_NN of_IN tissues_NNS 
However_RB ,_, because_IN the_DT tissue_NN collection_NN was_VBD IRB-exempt_JJ we_PRP were_VBD not_RB able_JJ to_TO collect_VB information_NN on_IN specific_JJ gestational_JJ age_NN which_WDT has_VBZ been_VBN shown_VBN to_TO be_VB associated_VBN with_IN placental_JJ gene_NN expression_NN 
We_PRP observed_VBD significant_JJ decreases_VBZ over_IN 25_CD minutes_NNS in_IN the_DT expression_NN of_IN both_DT transcripts_NNS -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- ._. 
We_PRP observed_VBD a_DT trend_NN towards_IN higher_JJR PPAR_NN 
Within_IN the_DT chorionic_JJ villi_NN ,_, PPAR_NNP 
Messenger_NNP RNA_NNP was_VBD chosen_VBN given_VBN the_DT feasibility_NN in_IN measuring_VBG it_PRP in_IN a_DT large_JJ number_NN of_IN placentas_NNS and_CC its_PRP$ clear_JJ physiologic_JJ relevance_NN ._. 
qPCR_NNP was_VBD chosen_VBN over_IN global_JJ gene_NN expression_NN microarrays_NNS ,_, another_DT commonly_RB used_VBN method_NN in_IN studies_NNS using_VBG human_JJ placental_JJ tissue_NN ,_, for_IN two_CD reasons_NNS ._. 
We_PRP had_VBD identified_VBN our_PRP$ gene_NN targets_NNS based_VBN on_IN apriori_JJ evidence_NN from_IN the_DT toxicologic_JJ literature_NN ._. 
Secondly_RB ,_, qPCR_NNP was_VBD more_RBR cost-effective_JJ given_VBN that_IN our_PRP$ ultimate_JJ goal_NN was_VBD to_TO analyze_VB a_DT large_JJ enough_JJ number_NN of_IN samples_NNS -LRB-_-LRB- N_NNP 
We_PRP were_VBD interested_JJ in_IN targeting_VBG villous_JJ tissue_NN and_CC specifically_RB gene_NN targets_NNS expressed_VBN in_IN the_DT syncytiotrophoblast_NN ._. 
Existing_VBG ,_, previously-validated_JJ methods_NNS for_IN identifying_VBG toxic_JJ or_CC pathologic_JJ responses_NNS in_IN the_DT human_JJ placenta_NN include_VBP measuring_VBG the_DT residues_NNS of_IN the_DT compound_NN of_IN interest_NN in_IN placental_JJ tissues_NNS 
We_PRP were_VBD interested_JJ in_IN targeting_VBG villous_JJ tissue_NN and_CC specifically_RB gene_NN targets_NNS expressed_VBN in_IN the_DT syncytiotrophoblast_NN ._. 
Existing_VBG ,_, previously-validated_JJ methods_NNS for_IN identifying_VBG toxic_JJ or_CC pathologic_JJ responses_NNS in_IN the_DT human_JJ placenta_NN include_VBP measuring_VBG the_DT residues_NNS of_IN the_DT compound_NN of_IN interest_NN in_IN placental_JJ tissues_NNS 
We_PRP were_VBD interested_JJ in_IN targeting_VBG villous_JJ tissue_NN and_CC specifically_RB gene_NN targets_NNS expressed_VBN in_IN the_DT syncytiotrophoblast_NN ._. 
Existing_VBG ,_, previously-validated_JJ methods_NNS for_IN identifying_VBG toxic_JJ or_CC pathologic_JJ responses_NNS in_IN the_DT human_JJ placenta_NN include_VBP measuring_VBG the_DT residues_NNS of_IN the_DT compound_NN of_IN interest_NN in_IN placental_JJ tissues_NNS 
18S_CD was_VBD later_RB chosen_VBN as_IN the_DT consensus_NN housekeeping_NN gene_NN based_VBN on_IN the_DT more_RBR recent_JJ placenta_NN literature_NN ._. 
Total_NNP RNA_NNP -LRB-_-LRB- 
Adjustment_NNP for_IN an_DT appropriate_JJ internal_JJ control_NN should_MD in_IN theory_NN minimize_VBP variability_NN due_JJ to_TO differences_NNS in_IN the_DT quality_NN and_CC quantity_NN of_IN the_DT RNA_NNP that_WDT went_VBD into_IN the_DT RT_NNP reaction_NN ._. 
Several_JJ possible_JJ internal_JJ controls_NNS have_VBP been_VBN proposed_VBN for_IN qPCR_NNP including_VBG total_JJ RNA_NNP ,_, ribosomal_JJ RNAs_NNS ,_, and_CC one_CD or_CC more_JJR reference_NN messenger_NN RNAs_NNS ._. 
Reference_NNP mRNAs_NNP are_VBP the_DT most_RBS common_JJ approach_NN ._. 
Some_DT of_IN the_DT criteria_NNS are_VBP that_IN they_PRP be_VB constitutively_RB expressed_VBN in_IN the_DT cell_NN type_NN of_IN interest_NN ,_, in_IN the_DT tissue_NN of_IN interest_NN and_CC not_RB be_VB affected_VBN by_IN the_DT exposure_NN of_IN interest_NN or_CC experimental_JJ conditions_NNS ._. 
The_DT internal_JJ control_NN should_MD not_RB share_VB regulatory_JJ factors_NNS with_IN the_DT gene_NN of_IN interest_NN ._. 
Some_DT of_IN the_DT criteria_NNS are_VBP that_IN they_PRP be_VB constitutively_RB expressed_VBN in_IN the_DT cell_NN type_NN of_IN interest_NN ,_, in_IN the_DT tissue_NN of_IN interest_NN and_CC not_RB be_VB affected_VBN by_IN the_DT exposure_NN of_IN interest_NN or_CC experimental_JJ conditions_NNS ._. 
It_PRP should_MD have_VB low_JJ intra-individual_JJ variation_NN and_CC should_MD be_VB expressed_VBN at_IN roughly_RB the_DT same_JJ order_NN of_IN magnitude_NN as_IN the_DT target_NN gene_NN ._. 
Unlike_IN Pidoux_NNP et_FW al._FW ._. 
-LRB-_-LRB- 2004_CD -RRB-_-RRB- who_WP showed_VBD that_DT cyclophilin_NN was_VBD a_DT suitable_JJ housekeeping_NN gene_NN in_IN studies_NNS of_IN PPAR_NNP 
Previous_JJ reports_NNS have_VBP shown_VBN that_IN PPAR_NNP 
We_PRP found_VBD that_IN total_JJ RNA_NNP did_VBD better_RBR than_IN CYC_NNP in_IN controlling_VBG for_IN within-placenta_JJ variation_NN ._. 
Total_NNP RNA_NNP is_VBZ thought_VBN to_TO vary_VB minimally_RB by_IN cell_NN and_CC therefore_RB be_VB more_RBR stable_JJ within_IN a_DT tissue_NN type_NN ,_, to_TO be_VB less_RBR variable_JJ by_IN method_NN of_IN homogenization_NN ,_, more_RBR uniformly_RB measured_VBN across_IN studies_NNS ,_, and_CC possibly_RB a_DT more_RBR accurate_JJ measure_NN of_IN the_DT quality_NN of_IN the_DT tissue_NN at_IN the_DT time_NN of_IN sampling_NN 
We_PRP were_VBD interested_JJ in_IN targeting_VBG villous_JJ tissue_NN and_CC specifically_RB gene_NN targets_NNS expressed_VBN in_IN the_DT syncytiotrophoblast_NN ._. 
Existing_VBG ,_, previously-validated_JJ methods_NNS for_IN identifying_VBG toxic_JJ or_CC pathologic_JJ responses_NNS in_IN the_DT human_JJ placenta_NN include_VBP measuring_VBG the_DT residues_NNS of_IN the_DT compound_NN of_IN interest_NN in_IN placental_JJ tissues_NNS 
We_PRP were_VBD interested_JJ in_IN targeting_VBG villous_JJ tissue_NN and_CC specifically_RB gene_NN targets_NNS expressed_VBN in_IN the_DT syncytiotrophoblast_NN ._. 
Existing_VBG ,_, previously-validated_JJ methods_NNS for_IN identifying_VBG toxic_JJ or_CC pathologic_JJ responses_NNS in_IN the_DT human_JJ placenta_NN include_VBP measuring_VBG the_DT residues_NNS of_IN the_DT compound_NN of_IN interest_NN in_IN placental_JJ tissues_NNS 
As_IN an_DT endocrine_NN organ_NN ,_, which_WDT plays_VBZ a_DT critical_JJ role_NN in_IN all_DT aspects_NNS of_IN pregnancy_NN maintenance_NN and_CC fetal_JJ development_NN ,_, the_DT placenta_NN can_MD provide_VB insight_NN into_IN mechanisms_NNS by_IN which_WDT specific_JJ exposures_NNS and_CC risk_NN factors_NNS are_VBP associated_VBN with_IN outcomes_NNS measured_VBN at_IN delivery_NN ._. 
Outcomes_NNS which_WDT are_VBP placentally-mediated_JJ include_VBP the_DT timing_NN of_IN labor_NN 
As_IN an_DT endocrine_NN organ_NN ,_, which_WDT plays_VBZ a_DT critical_JJ role_NN in_IN all_DT aspects_NNS of_IN pregnancy_NN maintenance_NN and_CC fetal_JJ development_NN ,_, the_DT placenta_NN can_MD provide_VB insight_NN into_IN mechanisms_NNS by_IN which_WDT specific_JJ exposures_NNS and_CC risk_NN factors_NNS are_VBP associated_VBN with_IN outcomes_NNS measured_VBN at_IN delivery_NN ._. 
Outcomes_NNS which_WDT are_VBP placentally-mediated_JJ include_VBP the_DT timing_NN of_IN labor_NN 
As_IN an_DT endocrine_NN organ_NN ,_, which_WDT plays_VBZ a_DT critical_JJ role_NN in_IN all_DT aspects_NNS of_IN pregnancy_NN maintenance_NN and_CC fetal_JJ development_NN ,_, the_DT placenta_NN can_MD provide_VB insight_NN into_IN mechanisms_NNS by_IN which_WDT specific_JJ exposures_NNS and_CC risk_NN factors_NNS are_VBP associated_VBN with_IN outcomes_NNS measured_VBN at_IN delivery_NN ._. 
Outcomes_NNS which_WDT are_VBP placentally-mediated_JJ include_VBP the_DT timing_NN of_IN labor_NN 
As_IN an_DT endocrine_NN organ_NN ,_, which_WDT plays_VBZ a_DT critical_JJ role_NN in_IN all_DT aspects_NNS of_IN pregnancy_NN maintenance_NN and_CC fetal_JJ development_NN ,_, the_DT placenta_NN can_MD provide_VB insight_NN into_IN mechanisms_NNS by_IN which_WDT specific_JJ exposures_NNS and_CC risk_NN factors_NNS are_VBP associated_VBN with_IN outcomes_NNS measured_VBN at_IN delivery_NN ._. 
Outcomes_NNS which_WDT are_VBP placentally-mediated_JJ include_VBP the_DT timing_NN of_IN labor_NN 
As_IN an_DT endocrine_NN organ_NN ,_, which_WDT plays_VBZ a_DT critical_JJ role_NN in_IN all_DT aspects_NNS of_IN pregnancy_NN maintenance_NN and_CC fetal_JJ development_NN ,_, the_DT placenta_NN can_MD provide_VB insight_NN into_IN mechanisms_NNS by_IN which_WDT specific_JJ exposures_NNS and_CC risk_NN factors_NNS are_VBP associated_VBN with_IN outcomes_NNS measured_VBN at_IN delivery_NN ._. 
Outcomes_NNS which_WDT are_VBP placentally-mediated_JJ include_VBP the_DT timing_NN of_IN labor_NN 
As_IN an_DT endocrine_NN organ_NN ,_, which_WDT plays_VBZ a_DT critical_JJ role_NN in_IN all_DT aspects_NNS of_IN pregnancy_NN maintenance_NN and_CC fetal_JJ development_NN ,_, the_DT placenta_NN can_MD provide_VB insight_NN into_IN mechanisms_NNS by_IN which_WDT specific_JJ exposures_NNS and_CC risk_NN factors_NNS are_VBP associated_VBN with_IN outcomes_NNS measured_VBN at_IN delivery_NN ._. 
Outcomes_NNS which_WDT are_VBP placentally-mediated_JJ include_VBP the_DT timing_NN of_IN labor_NN 
As_IN an_DT endocrine_NN organ_NN ,_, which_WDT plays_VBZ a_DT critical_JJ role_NN in_IN all_DT aspects_NNS of_IN pregnancy_NN maintenance_NN and_CC fetal_JJ development_NN ,_, the_DT placenta_NN can_MD provide_VB insight_NN into_IN mechanisms_NNS by_IN which_WDT specific_JJ exposures_NNS and_CC risk_NN factors_NNS are_VBP associated_VBN with_IN outcomes_NNS measured_VBN at_IN delivery_NN ._. 
Outcomes_NNS which_WDT are_VBP placentally-mediated_JJ include_VBP the_DT timing_NN of_IN labor_NN 
As_IN an_DT endocrine_NN organ_NN ,_, which_WDT plays_VBZ a_DT critical_JJ role_NN in_IN all_DT aspects_NNS of_IN pregnancy_NN maintenance_NN and_CC fetal_JJ development_NN ,_, the_DT placenta_NN can_MD provide_VB insight_NN into_IN mechanisms_NNS by_IN which_WDT specific_JJ exposures_NNS and_CC risk_NN factors_NNS are_VBP associated_VBN with_IN outcomes_NNS measured_VBN at_IN delivery_NN ._. 
Outcomes_NNS which_WDT are_VBP placentally-mediated_JJ include_VBP the_DT timing_NN of_IN labor_NN 
In_IN the_DT present_JJ study_NN ,_, we_PRP explored_VBD the_DT utility_NN of_IN placental_JJ gene_NN expression_NN measured_VBN by_IN real-time_JJ quantitative_JJ polymerase_NN chain_NN reaction_NN -LRB-_-LRB- qPCR_NNP -RRB-_-RRB- as_IN a_DT novel_NN biomarker_NN for_IN use_NN in_IN environmental_JJ epidemiology_NN ,_, including_VBG in_IN our_PRP$ research_NN on_IN prenatal_JJ exposures_NNS to_TO common_JJ endocrine_NN disrupting_VBG chemicals_NNS called_VBN phthalates_NNS ._. 
Phthalates_NNS have_VBP been_VBN shown_VBN to_TO be_VB reproductive_JJ and_CC developmental_JJ toxicants_NNS in_IN animal_NN models_NNS with_IN some_DT preliminary_JJ evidence_NN of_IN effects_NNS in_IN humans_NNS 
They_PRP include_VBP technologies_NNS to_TO recycle_VB and_CC reduce_VB presence_NN of_IN lead_NN in_IN batteries_NNS and_CC in_IN glass_NN ,_, abatement_NN of_IN diffuse_NN emissions_NNS through_IN increase_NN in_IN the_DT efficiency_NN of_IN recycling_NN ,_, capture_NN and_CC treatment_NN of_IN the_DT contaminated_VBN discharges_NNS ._. 
Investment_NN costs_NNS were_VBD weighted_VBN per_IN factory_NN volumes_NNS based_VBN on_IN data_NNS from_IN a_DT National_NNP Institute_NNP for_IN Industrial_NNP Environment_NNP and_CC Risks_NNS -_: -LRB-_-LRB- INERIS_NNP -RRB-_-RRB- ._. 
These_DT were_VBD annual_JJ costs_NNS ._. 
Costs_NNS to_TO eliminate_VB water_NN lead_NN pipes_NNS These_DT costs_NNS ,_, denoted_VBN C_NNP water_NN ,_, were_VBD estimated_VBN following_VBG the_DT High_NNP Council_NNP of_IN Hygiene_NNP -LRB-_-LRB- CSHPF_NNP -RRB-_-RRB- and_CC the_DT French_NNP Food_NNP Safety_NNP Agency_NNP -LRB-_-LRB- AFSSA_NNP -RRB-_-RRB- recommendations_NNS for_IN removing_VBG all_DT lead_JJ pipes_NNS used_VBN in_IN public_JJ water_NN supply_NN and_CC in_IN household_NN plumbing_NN ,_, in_IN order_NN to_TO reach_VB a_DT lead_JJ concentration_NN of_IN 
6per_CD 100,000_CD being_VBG much_RB greater_JJR than_IN the_DT French_JJ rate_NN crime_NN ,_, 1_CD ._. 
All_DT costs_NNS were_VBD adjusted_VBN by_IN the_DT ratio_NN of_IN US_NNP and_CC French_JJ crime_NN rates_NNS -LRB-_-LRB- the_DT US_NNP rate_NN crime_NN of_IN 5_CD ._. 
7per_CD 100,000_CD ,_, in_IN 2005_CD -RRB-_-RRB- ._. 
In_IN this_DT case_NN ,_, -LRB-_-LRB- 5_CD -RRB-_-RRB- where_WRB B_NNP crime_NN are_VBP the_DT cost_NN estimates_NNS for_IN B-Pb_NN 
The_DT overall_JJ return_NN of_IN investments_NNS is_VBZ important_JJ and_CC must_MD be_VB taken_VBN into_IN account_NN by_IN the_DT policy_NN makers_NNS ._. 
They_PRP are_VBP in_IN line_NN with_IN several_JJ US_NNP findings_NNS that_WDT illustrate_VBP how_WRB reduction_NN of_IN childhood_NN lead_NN exposure_NN has_VBZ a_DT high_JJ social_JJ benefit_NN ,_, in_IN particular_JJ the_DT studies_NNS from_IN Schwartz_NNP 
Between_IN 1976_CD and_CC 1999_CD ,_, Grosse_NNP et_FW al._FW ._. 
They_PRP are_VBP in_IN line_NN with_IN several_JJ US_NNP findings_NNS that_WDT illustrate_VBP how_WRB reduction_NN of_IN childhood_NN lead_NN exposure_NN has_VBZ a_DT high_JJ social_JJ benefit_NN ,_, in_IN particular_JJ the_DT studies_NNS from_IN Schwartz_NNP 
6per_CD 100,000_CD being_VBG much_RB greater_JJR than_IN the_DT French_JJ rate_NN crime_NN ,_, 1_CD ._. 
All_DT costs_NNS were_VBD adjusted_VBN by_IN the_DT ratio_NN of_IN US_NNP and_CC French_JJ crime_NN rates_NNS -LRB-_-LRB- the_DT US_NNP rate_NN crime_NN of_IN 5_CD ._. 
7per_CD 100,000_CD ,_, in_IN 2005_CD -RRB-_-RRB- ._. 
In_IN this_DT case_NN ,_, -LRB-_-LRB- 5_CD -RRB-_-RRB- where_WRB B_NNP crime_NN are_VBP the_DT cost_NN estimates_NNS for_IN B-Pb_NN 
Several_JJ economic_JJ studies_NNS ,_, mainly_RB in_IN the_DT US_NNP ,_, have_VBP estimated_VBN the_DT costs_NNS and_CC risks_NNS associated_VBN with_IN infantile_JJ lead_NN poisoning_NN and_CC lead_NN toxicity_NN ,_, in_IN some_DT cases_NNS weighing_VBG them_PRP against_IN the_DT costs_NNS associated_VBN with_IN lead-based_JJ paint_NN control_NN and_CC other_JJ efforts_NNS ._. 
These_DT studies_NNS have_VBP also_RB calculated_VBN the_DT potential_NN increased_VBD financial_JJ earnings_NNS that_WDT would_MD result_VB if_IN the_DT level_NN of_IN lead_NN in_IN children_NNS 's_POS blood_NN were_VBD to_TO be_VB reduced_VBN 
We_PRP therefore_RB applied_VBD these_DT IQ_NNP losses_NNS to_TO the_DT selected_JJ 1-6_CD years_NNS children_NNS ._. 
Although_IN the_DT IQ_NNP and_CC the_DT B-Pb_JJ assessments_NNS were_VBD usually_RB made_VBN at_IN 7_CD years_NNS ,_, similar_JJ associations_NNS were_VBD found_VBN for_IN lead_NN concentrations_NNS at_IN younger_JJR ages_NNS ,_, but_CC they_PRP are_VBP considered_VBN less_RBR stable_JJ 
The_DT Medical_NNP Educational_NNP Institutes_NNP -LRB-_-LRB- IME_NNP -RRB-_-RRB- educates_VBZ children_NNS with_IN intellectual_JJ deficiency_NN symptoms_NNS while_IN the_DT Educational_NNP and_CC Therapeutic_NNP Institutes_NNP -LRB-_-LRB- ITEP_NNP -RRB-_-RRB- do_VBP so_RB for_IN behavioral_JJ problems_NNS ._. 
According_VBG to_TO Schwartz_NNP ,_, 20_CD %_NN of_IN children_NNS with_IN B-Pb_NN 
The_DT overall_JJ return_NN of_IN investments_NNS is_VBZ important_JJ and_CC must_MD be_VB taken_VBN into_IN account_NN by_IN the_DT policy_NN makers_NNS ._. 
They_PRP are_VBP in_IN line_NN with_IN several_JJ US_NNP findings_NNS that_WDT illustrate_VBP how_WRB reduction_NN of_IN childhood_NN lead_NN exposure_NN has_VBZ a_DT high_JJ social_JJ benefit_NN ,_, in_IN particular_JJ the_DT studies_NNS from_IN Schwartz_NNP 
Several_JJ economic_JJ studies_NNS ,_, mainly_RB in_IN the_DT US_NNP ,_, have_VBP estimated_VBN the_DT costs_NNS and_CC risks_NNS associated_VBN with_IN infantile_JJ lead_NN poisoning_NN and_CC lead_NN toxicity_NN ,_, in_IN some_DT cases_NNS weighing_VBG them_PRP against_IN the_DT costs_NNS associated_VBN with_IN lead-based_JJ paint_NN control_NN and_CC other_JJ efforts_NNS ._. 
These_DT studies_NNS have_VBP also_RB calculated_VBN the_DT potential_NN increased_VBD financial_JJ earnings_NNS that_WDT would_MD result_VB if_IN the_DT level_NN of_IN lead_NN in_IN children_NNS 's_POS blood_NN were_VBD to_TO be_VB reduced_VBN 
We_PRP therefore_RB applied_VBD these_DT IQ_NNP losses_NNS to_TO the_DT selected_JJ 1-6_CD years_NNS children_NNS ._. 
Although_IN the_DT IQ_NNP and_CC the_DT B-Pb_JJ assessments_NNS were_VBD usually_RB made_VBN at_IN 7_CD years_NNS ,_, similar_JJ associations_NNS were_VBD found_VBN for_IN lead_NN concentrations_NNS at_IN younger_JJR ages_NNS ,_, but_CC they_PRP are_VBP considered_VBN less_RBR stable_JJ 
The_DT overall_JJ return_NN of_IN investments_NNS is_VBZ important_JJ and_CC must_MD be_VB taken_VBN into_IN account_NN by_IN the_DT policy_NN makers_NNS ._. 
They_PRP are_VBP in_IN line_NN with_IN several_JJ US_NNP findings_NNS that_WDT illustrate_VBP how_WRB reduction_NN of_IN childhood_NN lead_NN exposure_NN has_VBZ a_DT high_JJ social_JJ benefit_NN ,_, in_IN particular_JJ the_DT studies_NNS from_IN Schwartz_NNP 
The_DT B-Pb_JJ concentration_NN intervention_NN value_NN in_IN the_DT US_NNP and_CC France_NNP is_VBZ 100_CD 
At_IN lower_JJR values_NNS lead_VBP toxicity_NN may_MD still_RB cause_VB damage_NN to_TO nervous_JJ system_NN functions_NNS ,_, including_VBG decreased_VBN nerve_NN conduction_NN velocity_NN and_CC cognitive_JJ deficits_NNS 
Assessment_NNP of_IN IQ_NNP decrements_VBZ Environmental_JJ lead_NN exposure_NN in_IN children_NNS may_MD cause_VB cognitive_JJ impairment_NN among_IN children_NNS 
IQ_NNP and_CC lost_VBD lifetime_NN earnings_NNS due_JJ to_TO lead_VB poisoning_NN The_DT lifetime_NN costs_NNS associated_VBN with_IN lower_JJR earning_NN potential_NN caused_VBN by_IN lead_NN toxicity_NN is_VBZ based_VBN on_IN a_DT linear_JJ relationship_NN between_IN the_DT loss_NN of_IN IQ_NNP due_JJ to_TO lead_JJ and_CC expected_JJ lifetime_NN earnings_NNS ._. 
From_IN the_DT studies_NNS by_IN Lanphear_NNP and_CC colleagues_NNS 
9-RRB-_CD per_IN 100_CD 
3Based_VBN on_IN a_DT EFSA_NNP conclusions_NNS 
At_IN the_DT individual_JJ level_NN ,_, this_DT drop_NN may_MD seem_VB small_JJ and_CC inconsequential_JJ ,_, but_CC at_IN the_DT population_NN level_NN ,_, small_JJ effects_NNS in_IN many_JJ individuals_NNS are_VBP likely_JJ to_TO have_VB an_DT impact_NN on_IN the_DT overall_JJ societal_JJ benefits_NNS 
This_DT exposure_NN level_NN was_VBD similar_JJ to_TO other_JJ Western_JJ European_JJ countries_NNS ._. 
approximately_RB 85,000_CD children_NNS -RRB-_-RRB- ;_: the_DT geometric_JJ mean_JJ blood-lead_JJ concentration_NN was_VBD 37_CD 
e._IN 11_CD %_NN -LRB-_-LRB- i._NN 6_CD -RRB-_-RRB- among_IN children_NNS aged_VBN 1-6_CD years_NNS ,_, and_CC the_DT prevalence_NN of_IN B-Pb_JJ concentrations_NNS 
Lastly_RB ,_, we_PRP compare_VBP the_DT main_JJ findings_NNS of_IN this_DT study_NN and_CC discuss_VB the_DT role_NN of_IN CBA_NNP in_IN a_DT societal_JJ perspective_NN of_IN public_JJ policy_NN development_NN ._. 
MethodsPopulation_NNP studied_VBD and_CC sources_NNS of_IN lead_NN exposureWe_NN based_VBN our_PRP$ estimations_NNS on_IN the_DT InVS_NNP study_NN ._. 
The_DT geometric_JJ mean_NN of_IN children_NNS 's_POS B-Pb_JJ concentrations_NNS in_IN France_NNP was_VBD found_VBN to_TO be_VB 15_VBN ._. 
1_CD 
We_PRP used_VBD the_DT same_JJ target_NN population_NN consisting_VBG of_IN 4_CD ._. 
6-LRB-_CD log-normal_JJ distribution_NN -RRB-_-RRB- ._. 
1_CD 
Estimates_NNS were_VBD made_VBN based_VBN on_IN the_DT entire_JJ cohort_NN in_IN order_NN to_TO highlight_VB the_DT global_JJ economic_JJ impact_NN on_IN the_DT most_RBS sensitive_JJ segment_NN of_IN the_DT population_NN to_TO lead_VB exposure_NN ._. 
Derived_VBN from_IN this_DT estimate_NN ,_, the_DT size_NN of_IN the_DT population_NN experiencing_VBG lead_NN poisoning_NN -LRB-_-LRB- at_IN B-Pb_NN 
''_'' approach_NN ;_: the_DT first_JJ value_NN is_VBZ close_JJ to_TO the_DT geometric_JJ mean_NN of_IN B-Pb_NN among_IN French_JJ children_NNS -LRB-_-LRB- 15_CD ._. 
Given_VBN that_IN no_DT threshold_NN for_IN lead_NN toxicity_NN has_VBZ been_VBN established_VBN ,_, we_PRP conducted_VBD a_DT sensitivity_NN analysis_NN assuming_VBG that_DT loss_NN of_IN IQ_NNP in_IN the_DT study_NN population_NN starts_VBZ at_IN values_NNS exceeding_VBG 15_CD 
51_CD point_NN per_IN 10_CD 
The_DT B-Pb_JJ concentration_NN intervention_NN value_NN in_IN the_DT US_NNP and_CC France_NNP is_VBZ 100_CD 
Overall_JJ ,_, lead_JJ poisoning_NN is_VBZ still_RB a_DT serious_JJ hazard_NN for_IN children_NNS and_CC causes_VBZ significant_JJ neurologic_JJ damage_NN linked_VBN to_TO cognitive_JJ and_CC behavioral_JJ impairment_NN 
approximately_RB 85,000_CD children_NNS -RRB-_-RRB- ;_: the_DT geometric_JJ mean_JJ blood-lead_JJ concentration_NN was_VBD 37_CD 
The_DT intellectual_JJ decrement_NN may_MD be_VB expressed_VBN in_IN terms_NNS of_IN a_DT loss_NN of_IN IQ_NNP points_NNS for_IN every_DT 
At_IN the_DT individual_JJ level_NN ,_, this_DT drop_NN may_MD seem_VB small_JJ and_CC inconsequential_JJ ,_, but_CC at_IN the_DT population_NN level_NN ,_, small_JJ effects_NNS in_IN many_JJ individuals_NNS are_VBP likely_JJ to_TO have_VB an_DT impact_NN on_IN the_DT overall_JJ societal_JJ benefits_NNS 
3Based_VBN on_IN a_DT EFSA_NNP conclusions_NNS 
Although_IN a_DT longer_JJR investment_NN plan_NN could_MD have_VB been_VBN chosen_VBN ,_, we_PRP calculated_VBD the_DT annual_JJ costs_NNS for_IN an_DT investment_NN plan_NN over_IN 5_CD years_NNS to_TO cover_VB the_DT expenses_NNS ._. 
We_PRP used_VBD ANAH_NNP estimates_NNS and_CC French_NNP or_CC US_NNP data_NNS ,_, according_VBG to_TO which_WDT were_VBD available_JJ ._. 
Results_NNS Annual_JJ Benefits_NNP Direct_NNP health_NN care_NN costs_NNS were_VBD estimated_VBN in_IN accordance_NN with_IN equation_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC were_VBD found_VBN to_TO be_VB 
,d_FW =_SYM Mc_NNP Laine_NNP and_CC colleagues_NNS ._. 
c=_IN The_DT National_NNP Agency_NNP of_IN the_DT housing_NN environment_NN -LRB-_-LRB- ANAH_NNP -RRB-_-RRB- ,_, 2010_CD ._. 
,2006_CD ,_, 
In_IN France_NNP ,_, studies_NNS are_VBP mostly_RB epidemiological_JJ ,_, focusing_VBG on_IN targeted_JJ screening_NN and_CC lead_NN exposure_NN ._. 
These_DT studies_NNS have_VBP also_RB calculated_VBN the_DT potential_NN increased_VBD financial_JJ earnings_NNS that_WDT would_MD result_VB if_IN the_DT level_NN of_IN lead_NN in_IN children_NNS 's_POS blood_NN were_VBD to_TO be_VB reduced_VBN 
Lead_JJ exposure_NN provokes_VBZ other_JJ health_NN impacts_NNS besides_IN cognitive_JJ disorders_NNS which_WDT were_VBD not_RB assessed_VBN in_IN this_DT paper_NN ,_, such_JJ as_IN cardiovascular_JJ diseases_NNS and_CC cancer_NN that_WDT lead_VBP to_TO premature_JJ mortality_NN ._. 
This_DT would_MD yield_VB higher_JJR social_JJ costs_NNS than_IN IQ_NNP decrement_NN alone_RB ._. 
We_PRP disregarded_VBD for_IN instance_NN ,_, drug_NN costs_NNS and_CC medical_JJ intervention_NN costs_NNS such_JJ as_IN intravenous_JJ chelation_NN ._. 
5to_CD 1_CD ._. 
The_DT somewhat_RB uncertain_JJ data_NNS on_IN crime_NN costs_NNS suggest_VBP that_IN the_DT economic_JJ impact_NN is_VBZ comparatively_RB low_JJ ,_, but_CC the_DT costs_NNS of_IN crime_NN and_CC rape_NN were_VBD probably_RB underestimated_VBN ,_, because_IN they_PRP did_VBD not_RB include_VB the_DT value_NN of_IN statistical_JJ life_NN ,_, which_WDT may_MD be_VB greater_JJR than_IN that_DT of_IN accidents_NNS -LRB-_-LRB- between_IN 
We_PRP could_MD not_RB make_VB a_DT complete_JJ CBA_NNP because_IN of_IN lack_NN of_IN available_JJ data_NNS on_IN the_DT abatement_NN costs_NNS ,_, we_PRP had_VBD a_DT very_RB small_JJ part_NN of_IN the_DT industrial_JJ costs_NNS ._. 
Official_JJ data_NNS from_IN the_DT ministry_NN of_IN Environment_NNP show_VBP that_IN the_DT major_JJ industrial_JJ sources_NNS of_IN lead_NN in_IN France_NNP are_VBP the_DT metals_NNS and_CC non_JJ metallic_JJ minerals_NNS sectors_NNS 
showed_VBD that_IN ,_, even_RB at_IN low_JJ levels_NNS of_IN lead_NN exposure_NN ,_, the_DT need_NN for_IN special_JJ education_NN increases_NNS with_IN the_DT exposure_NN level_NN ._. 
Another_DT reference_NN also_RB showed_VBD for_IN children_NNS with_IN B-Pb_NN 
8%_CD and_CC 20_CD ._. 
The_DT French_JJ national_JJ data_NNS show_VBP that_IN 79_CD ._. 
ed_VBN 
Costs_NNS to_TO eliminate_VB water_NN lead_NN pipes_NNS These_DT costs_NNS ,_, denoted_VBN C_NNP water_NN ,_, were_VBD estimated_VBN following_VBG the_DT High_NNP Council_NNP of_IN Hygiene_NNP -LRB-_-LRB- CSHPF_NNP -RRB-_-RRB- and_CC the_DT French_NNP Food_NNP Safety_NNP Agency_NNP -LRB-_-LRB- AFSSA_NNP -RRB-_-RRB- recommendations_NNS for_IN removing_VBG all_DT lead_JJ pipes_NNS used_VBN in_IN public_JJ water_NN supply_NN and_CC in_IN household_NN plumbing_NN ,_, in_IN order_NN to_TO reach_VB a_DT lead_JJ concentration_NN of_IN 
9-RRB-_CD per_IN 100_CD 
Landrigan_NNP et_FW al._FW ._. 
The_DT estimate_NN cost_NN was_VBD valued_VBN from_IN $_$ 110_CD to_TO $_$ 319_CD billion_CD -LRB-_-LRB- US_NNP -RRB-_-RRB- for_IN the_DT cohort_NN each_DT year_NN ,_, comparing_VBG it_PRP as_IN if_IN the_DT blood_NN lead_NN concentration_NN were_VBD that_DT same_JJ as_IN in_IN 1975_CD ._. 
estimated_VBN the_DT total_JJ annual_JJ costs_NNS of_IN childhood_NN lead_NN poisoning_NN to_TO be_VB $_$ 199743_CD billion_CD in_IN each_DT birth_NN cohort_NN exposed_VBN to_TO lead_VB in_IN the_DT US_NNP ._. 
Their_PRP$ methodological_JJ approach_NN was_VBD based_VBN on_IN the_DT contribution_NN of_IN environmental_JJ pollutants_NNS by_IN using_VBG an_DT Environmentally_NNP Attributable_NNP Fraction_NNP -LRB-_-LRB- EAF_NNP -RRB-_-RRB- model_NN ,_, which_WDT was_VBD estimated_VBN at_IN 100_CD %_NN for_IN lead_NN poisoning_NN ._. 
We_PRP therefore_RB applied_VBD these_DT IQ_NNP losses_NNS to_TO the_DT selected_JJ 1-6_CD years_NNS children_NNS ._. 
Although_IN the_DT IQ_NNP and_CC the_DT B-Pb_JJ assessments_NNS were_VBD usually_RB made_VBN at_IN 7_CD years_NNS ,_, similar_JJ associations_NNS were_VBD found_VBN for_IN lead_NN concentrations_NNS at_IN younger_JJR ages_NNS ,_, but_CC they_PRP are_VBP considered_VBN less_RBR stable_JJ 
According_VBG to_TO Schwartz_NNP ,_, 20_CD %_NN of_IN children_NNS with_IN B-Pb_NN 
The_DT estimated_VBN average_JJ annual_JJ cost_NN per_IN child_NN was_VBD 
Violent_JJ behavior_NN leading_VBG to_TO juvenile_JJ delinquency_NN The_DT Nevin_NNP 's_POS study_NN recent_JJ evidence_NN of_IN a_DT link_NN between_IN prenatal_JJ and_CC early-childhood_JJ lead_NN exposure_NN and_CC increased_VBN risk_NN of_IN criminal_JJ behavior_NN later_RB in_IN life_NN illustrated_VBD that_WDT showed_VBD a_DT strong_JJ association_NN between_IN preschool_JJ B-Pb_JJ and_CC subsequent_JJ crime_NN rate_NN trends_NNS over_IN several_JJ decades_NNS in_IN vari_NN 
We_PRP first_RB obtained_VBD the_DT total_JJ number_NN of_IN violent\/aggressive_JJ specific_JJ crimes_NNS committed_VBN in_IN 2008_CD from_IN the_DT French_JJ national_JJ observatory_NN of_IN Delinquency_NN 
129_CD 30,645_CD 0_CD ._. 
33_CD 0_CD ._. 
8Murder_NN 1_CD ._. 
4171_CD 27,990_CD 4_CD ._. 
50_CD ._. 
3Rape_JJ 15_CD ._. 
42,206_CD 20,058_CD 44_CD ._. 
85_CD ._. 
3Aggravated_JJ assaults_NNS 172_CD ._. 
9a_NN :_: calculated_JJ using_VBG data_NNS from_IN the_DT National_NNP Observatory_NNP of_IN the_DT delinquency_NN ,_, 2009_CD b_NN :_: -LRB-_-LRB- Nevin_NNP ,_, 2006_CD -RRB-_-RRB- by_IN using_VBG French_JJ rate_NN crime_NN 
Lyngbye_NNP and_CC al._NNP ._. 
when_WRB B-Pb_NNP exceeds_VBZ 100_CD 
For_IN our_PRP$ estimations_NNS ,_, we_PRP used_VBD the_DT purchasing_VBG parity_NN power_NN -LRB-_-LRB- GDPppp_NNP $_$ -_: 
Annual_JJ benefit_NN estimation_NN Health_NNP benefits_NNS :_: costs_NNS of_IN avoiding_VBG lead_NN poisoning_NN Based_VBN on_IN the_DT InVS_NNP data_NNS B-Pb_JJ distribution_NN -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ,_, we_PRP estimated_VBD direct_JJ costs_NNS B_NNP med_VBD from_IN the_DT component_NN costs_VBZ B_NNP screening15-24_NNP ,_, B_NNP screening24-100_NN and_CC B_NN treatment_NN 
In_IN this_DT case_NN ,_, the_DT screening_VBG cost_NN per_IN child_NN was_VBD estimated_VBN from_IN 
Unit_NN cost_NN estimate_NN of_IN outpatient_NN chelation_NN treatment_NN ,_, without_IN medication_NN ,_, was_VBD 
Muennig_NNP et_FW al._FW ._. 
Therefore_RB ,_, a_DT specific_JJ calculation_NN induced_VBN by_IN lead-based_JJ paint_NN was_VBD not_RB performed_VBN in_IN this_DT study_NN ._. 
,whereas_NNS ,_, provided_VBN information_NN on_IN the_DT benefits_NNS that_WDT might_MD be_VB realized_VBN if_IN all_DT children_NNS in_IN the_DT United_NNP States_NNPS had_VBD a_DT blood_NN lead_NN level_NN of_IN less_JJR than_IN 10_CD 
5to_CD 1_CD ._. 
The_DT somewhat_RB uncertain_JJ data_NNS on_IN crime_NN costs_NNS suggest_VBP that_IN the_DT economic_JJ impact_NN is_VBZ comparatively_RB low_JJ ,_, but_CC the_DT costs_NNS of_IN crime_NN and_CC rape_NN were_VBD probably_RB underestimated_VBN ,_, because_IN they_PRP did_VBD not_RB include_VB the_DT value_NN of_IN statistical_JJ life_NN ,_, which_WDT may_MD be_VB greater_JJR than_IN that_DT of_IN accidents_NNS -LRB-_-LRB- between_IN 
So_RB far_RB ,_, clean-up_JJ costs_NNS of_IN industrial_JJ lead-contaminated_JJ sites_NNS can_MD not_RB be_VB evaluated_VBN in_IN France_NNP ._. 
We_PRP had_VBD also_RB quite_RB imprecise_JJ cost_NN estimates_NNS for_IN substitution_NN of_IN lead_NN pipes_NNS ,_, whose_WP$ yearly_JJ estimates_NNS are_VBP certainly_RB exaggerated_JJ ._. 
Partial_JJ data_NNS stem_VBP from_IN the_DT experience_NN of_IN the_DT highly_RB polluted_JJ MetalEurop_NNP site_NN remediated_VBN by_IN SITA-Suez_NNP Environment_NNP ,_, which_WDT amounted_VBD to_TO 
Various_JJ uncertainties_NNS exist_VBP in_IN our_PRP$ calculations_NNS :_: benefits_NNS linked_VBN to_TO the_DT dose-response_JJ function_NN ,_, and_CC monetary_JJ valuation_NN of_IN the_DT abatement_NN costs_NNS linked_VBN to_TO houses_NNS remediation_NN ,_, which_WDT yield_VBP uncertainties_NNS in_IN the_DT partial_JJ cost_NN benefit_NN estimates_NNS ._. 
According_VBG to_TO Rabl_NNP and_CC colleagues_NNS ,_, there_EX is_VBZ a_DT factor_NN two_CD uncertainty_NN ,_, both_DT in_IN the_DT dose-response_JJ function_NN and_CC in_IN the_DT monetary_JJ valuation_NN ._. 
Should_MD the_DT scientific_JJ literature_NN show_VBP some_DT day_NN evidence_NN of_IN lower_JJR toxicity_NN level_NN values_NNS than_IN the_DT one_NN we_PRP used_VBD in_IN this_DT sensitivity_NN analysis_NN ,_, the_DT health_NN cost_NN figures_NNS would_MD be_VB substantially_RB increased_VBN ._. 
Although_IN a_DT longer_JJR investment_NN plan_NN could_MD have_VB been_VBN chosen_VBN ,_, we_PRP calculated_VBD the_DT annual_JJ costs_NNS for_IN an_DT investment_NN plan_NN over_IN 5_CD years_NNS to_TO cover_VB the_DT expenses_NNS ._. 
We_PRP used_VBD ANAH_NNP estimates_NNS and_CC French_NNP or_CC US_NNP data_NNS ,_, according_VBG to_TO which_WDT were_VBD available_JJ ._. 
Results_NNS Annual_JJ Benefits_NNP Direct_NNP health_NN care_NN costs_NNS were_VBD estimated_VBN in_IN accordance_NN with_IN equation_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC were_VBD found_VBN to_TO be_VB 
b=_NNP LERES_NNP ,_, 2009_CD 
Various_JJ uncertainties_NNS exist_VBP in_IN our_PRP$ calculations_NNS :_: benefits_NNS linked_VBN to_TO the_DT dose-response_JJ function_NN ,_, and_CC monetary_JJ valuation_NN of_IN the_DT abatement_NN costs_NNS linked_VBN to_TO houses_NNS remediation_NN ,_, which_WDT yield_VBP uncertainties_NNS in_IN the_DT partial_JJ cost_NN benefit_NN estimates_NNS ._. 
According_VBG to_TO Rabl_NNP and_CC colleagues_NNS ,_, there_EX is_VBZ a_DT factor_NN two_CD uncertainty_NN ,_, both_DT in_IN the_DT dose-response_JJ function_NN and_CC in_IN the_DT monetary_JJ valuation_NN ._. 
Should_MD the_DT scientific_JJ literature_NN show_VBP some_DT day_NN evidence_NN of_IN lower_JJR toxicity_NN level_NN values_NNS than_IN the_DT one_NN we_PRP used_VBD in_IN this_DT sensitivity_NN analysis_NN ,_, the_DT health_NN cost_NN figures_NNS would_MD be_VB substantially_RB increased_VBN ._. 
We_PRP next_RB calculated_VBD -LRB-_-LRB- B_NNP crime_NN -RRB-_-RRB- the_DT costs_NNS directly_RB associated_VBN with_IN each_DT sort_NN of_IN crime_NN and_CC the_DT total_JJ cost_NN of_IN lead-linked_JJ crimes_NNS ._. 
We_PRP used_VBD French_JJ data_NNS when_WRB available_JJ ,_, and_CC otherwise_RB US_NNP data_NNS in_IN the_DT absence_NN of_IN French_JJ data_NNS for_IN direct_JJ costs_NNS of_IN victims_NNS and_CC overhead_JJ costs_NNS of_IN justice_NN and_CC incarceration_NN and_CC for_IN lost_VBN earnings_NNS for_IN both_DT criminals_NNS and_CC victims_NNS ,_, as_RB well_RB ._. 
All_DT costs_NNS were_VBD adjusted_VBN by_IN the_DT ratio_NN of_IN US_NNP and_CC French_JJ crime_NN rates_NNS -LRB-_-LRB- the_DT US_NNP rate_NN crime_NN of_IN 5_CD ._. 
6per_CD 100,000_CD being_VBG much_RB greater_JJR than_IN the_DT French_JJ rate_NN crime_NN ,_, 1_CD ._. 
129_CD 30,645_CD 0_CD ._. 
33_CD 0_CD ._. 
8Murder_NN 1_CD ._. 
4171_CD 27,990_CD 4_CD ._. 
50_CD ._. 
3Rape_JJ 15_CD ._. 
42,206_CD 20,058_CD 44_CD ._. 
85_CD ._. 
3Aggravated_JJ assaults_NNS 172_CD ._. 
9a_NN :_: calculated_JJ using_VBG data_NNS from_IN the_DT National_NNP Observatory_NNP of_IN the_DT delinquency_NN ,_, 2009_CD b_NN :_: -LRB-_-LRB- Nevin_NNP ,_, 2006_CD -RRB-_-RRB- by_IN using_VBG French_JJ rate_NN crime_NN 
The_DT judge_NN called_VBD for_IN 
Official_JJ data_NNS from_IN the_DT ministry_NN of_IN Environment_NNP show_VBP that_IN the_DT major_JJ industrial_JJ sources_NNS of_IN lead_NN in_IN France_NNP are_VBP the_DT metals_NNS and_CC non_JJ metallic_JJ minerals_NNS sectors_NNS 
The_DT relationship_NN was_VBD characterized_VBN by_IN best-fit_NN lags_VBZ consistent_JJ with_IN neurobehavioral_JJ damage_NN in_IN the_DT first_JJ year_NN of_IN life_NN and_CC the_DT know_VBP peak_JJ age_NN of_IN offending_VBG for_IN index_NN crime_NN ,_, burglary_NN ,_, and_CC violent_JJ crime_NN 
5a_CD =_SYM Argeron_NNP ,_, 1995_CD ,_, actualized_VBN in_IN 2008_CD by_IN INVS_NNP ._. 
3342_CD ._. 
1245_CD ._. 
Table_NNP 5_CD Costs_NNS to_TO decontaminate_VB French_JJ houses_NNS with_IN lead-based_JJ paint_NN -LRB-_-LRB- 
The_DT introduction_NN of_IN unleaded_JJ petrol_NN has_VBZ greatly_RB decreased_VBN emissions_NNS of_IN lead_NN in_IN the_DT atmosphere_NN in_IN France_NNP and_CC globally_RB ._. 
-LRB-_-LRB- Paris_NNP ambient_JJ air_NN concentrations_NNS decreased_VBN by_IN 97_CD %_NN between_IN 1991_CD and_CC 2005_CD -RRB-_-RRB- 
4%_CD -RRB-_-RRB- ._. 
7%_CD -RRB-_-RRB- ,_, and_CC murder_NN -LRB-_-LRB- 5_CD ._. 
1%_CD -RRB-_-RRB- ,_, rape_NN -LRB-_-LRB- 2_CD ._. 
7%_CD -RRB-_-RRB- ,_, aggravated_VBN assaults_NNS -LRB-_-LRB- 3_CD ._. 
4%_CD -RRB-_-RRB- ,_, robberies_NNS -LRB-_-LRB- 0_CD ._. 
These_DT include_VBP burglaries_NNS -LRB-_-LRB- 2_CD ._. 
The_DT total_JJ lead-linked_JJ crimes_NNS were_VBD computed_VBN on_IN the_DT basis_NN of_IN the_DT French_JJ population_NN aged_VBN 13-60_CD years_NNS liable_JJ to_TO commit_VB a_DT violent_JJ act_NN ._. 
We_PRP next_RB calculated_VBD -LRB-_-LRB- B_NNP crime_NN -RRB-_-RRB- the_DT costs_NNS directly_RB associated_VBN with_IN each_DT sort_NN of_IN crime_NN and_CC the_DT total_JJ cost_NN of_IN lead-linked_JJ crimes_NNS ._. 
We_PRP therefore_RB estimated_VBD the_DT costs_NNS linked_VBN to_TO lead-associated_JJ crime_NN on_IN the_DT basis_NN of_IN Gould_NNP 's_POS approach_NN 
129_CD 30,645_CD 0_CD ._. 
33_CD 0_CD ._. 
8Murder_NN 1_CD ._. 
4171_CD 27,990_CD 4_CD ._. 
50_CD ._. 
3Rape_JJ 15_CD ._. 
42,206_CD 20,058_CD 44_CD ._. 
85_CD ._. 
3Aggravated_JJ assaults_NNS 172_CD ._. 
9a_NN :_: calculated_JJ using_VBG data_NNS from_IN the_DT National_NNP Observatory_NNP of_IN the_DT delinquency_NN ,_, 2009_CD b_NN :_: -LRB-_-LRB- Nevin_NNP ,_, 2006_CD -RRB-_-RRB- by_IN using_VBG French_JJ rate_NN crime_NN 
The_DT relationship_NN was_VBD characterized_VBN by_IN best-fit_NN lags_VBZ consistent_JJ with_IN neurobehavioral_JJ damage_NN in_IN the_DT first_JJ year_NN of_IN life_NN and_CC the_DT know_VBP peak_JJ age_NN of_IN offending_VBG for_IN index_NN crime_NN ,_, burglary_NN ,_, and_CC violent_JJ crime_NN 
We_PRP next_RB calculated_VBD -LRB-_-LRB- B_NNP crime_NN -RRB-_-RRB- the_DT costs_NNS directly_RB associated_VBN with_IN each_DT sort_NN of_IN crime_NN and_CC the_DT total_JJ cost_NN of_IN lead-linked_JJ crimes_NNS ._. 
We_PRP used_VBD French_JJ data_NNS when_WRB available_JJ ,_, and_CC otherwise_RB US_NNP data_NNS in_IN the_DT absence_NN of_IN French_JJ data_NNS for_IN direct_JJ costs_NNS of_IN victims_NNS and_CC overhead_JJ costs_NNS of_IN justice_NN and_CC incarceration_NN and_CC for_IN lost_VBN earnings_NNS for_IN both_DT criminals_NNS and_CC victims_NNS ,_, as_RB well_RB ._. 
All_DT costs_NNS were_VBD adjusted_VBN by_IN the_DT ratio_NN of_IN US_NNP and_CC French_JJ crime_NN rates_NNS -LRB-_-LRB- the_DT US_NNP rate_NN crime_NN of_IN 5_CD ._. 
6per_CD 100,000_CD being_VBG much_RB greater_JJR than_IN the_DT French_JJ rate_NN crime_NN ,_, 1_CD ._. 
8million_NN per_IN year_NN ,_, as_IN shown_VBN in_IN Table_NNP 3_CD ,_, this_DT accounted_VBD for_IN 0_CD ._. 
In_IN France_NNP ,_, the_DT total_NN estimated_VBD cost_NN of_IN lead-linked_JJ crimes_NNS -LRB-_-LRB- B_NN crime_NN 
129_CD 30,645_CD 0_CD ._. 
33_CD 0_CD ._. 
8Murder_NN 1_CD ._. 
4171_CD 27,990_CD 4_CD ._. 
50_CD ._. 
3Rape_JJ 15_CD ._. 
42,206_CD 20,058_CD 44_CD ._. 
85_CD ._. 
3Aggravated_JJ assaults_NNS 172_CD ._. 
9a_NN :_: calculated_JJ using_VBG data_NNS from_IN the_DT National_NNP Observatory_NNP of_IN the_DT delinquency_NN ,_, 2009_CD b_NN :_: -LRB-_-LRB- Nevin_NNP ,_, 2006_CD -RRB-_-RRB- by_IN using_VBG French_JJ rate_NN crime_NN 
Violent_JJ behavior_NN leading_VBG to_TO juvenile_JJ delinquency_NN The_DT Nevin_NNP 's_POS study_NN 
1%_CD children_NNS with_IN cognitive_JJ and_CC behavioral_JJ deficiencies_NNS are_VBP in_IN IME_NNP and_CC ITEP_NNP ,_, respectively_RB ._. 
8%_CD and_CC 20_CD ._. 
The_DT estimated_VBN average_JJ annual_JJ cost_NN per_IN child_NN was_VBD 
For_IN our_PRP$ estimations_NNS ,_, we_PRP used_VBD the_DT purchasing_VBG parity_NN power_NN -LRB-_-LRB- GDPppp_NNP $_$ -_: 
An_DT alternative_JJ way_NN of_IN expressing_VBG this_DT is_VBZ to_TO say_VB that_IN its_PRP$ net_JJ benefit_NN -LRB-_-LRB- B-C_NNP -RRB-_-RRB- is_VBZ positive_JJ or_CC that_IN its_PRP$ B\/C_NNP ratio_NN is_VBZ greater_JJR than_IN 1_CD ._. 
The_DT preferred_JJ option_NN will_MD be_VB the_DT one_NN which_WDT maximizes_VBZ this_DT net_JJ benefit_NN ,_, and_CC consequently_RB the_DT new_JJ CBA-based_JJ health_NN strategy_NN will_MD provide_VB a_DT net_JJ benefit_NN to_TO society_NN ._. 
For_IN this_DT study_NN ,_, we_PRP based_VBD our_PRP$ estimation_NN on_IN the_DT yearly_JJ economic_JJ impact_NN of_IN reduction_NN of_IN lead_NN exposure_NN for_IN each_DT birth_NN cohort_NN -LRB-_-LRB- children_NNS born_VBN within_IN one_CD calendar_NN year_NN -RRB-_-RRB- and_CC compared_VBN these_DT social_JJ benefits_NNS to_TO investments_NNS needed_VBN to_TO reduce_VB exposure_NN and_CC control_NN risk_NN factors_NNS ._. 
An_DT alternative_JJ way_NN of_IN expressing_VBG this_DT is_VBZ to_TO say_VB that_IN its_PRP$ net_JJ benefit_NN -LRB-_-LRB- B-C_NNP -RRB-_-RRB- is_VBZ positive_JJ or_CC that_IN its_PRP$ B\/C_NNP ratio_NN is_VBZ greater_JJR than_IN 1_CD ._. 
The_DT preferred_JJ option_NN will_MD be_VB the_DT one_NN which_WDT maximizes_VBZ this_DT net_JJ benefit_NN ,_, and_CC consequently_RB the_DT new_JJ CBA-based_JJ health_NN strategy_NN will_MD provide_VB a_DT net_JJ benefit_NN to_TO society_NN ._. 
For_IN this_DT study_NN ,_, we_PRP based_VBD our_PRP$ estimation_NN on_IN the_DT yearly_JJ economic_JJ impact_NN of_IN reduction_NN of_IN lead_NN exposure_NN for_IN each_DT birth_NN cohort_NN -LRB-_-LRB- children_NNS born_VBN within_IN one_CD calendar_NN year_NN -RRB-_-RRB- and_CC compared_VBN these_DT social_JJ benefits_NNS to_TO investments_NNS needed_VBN to_TO reduce_VB exposure_NN and_CC control_NN risk_NN factors_NNS ._. 
For_IN our_PRP$ estimations_NNS ,_, we_PRP used_VBD the_DT purchasing_VBG parity_NN power_NN -LRB-_-LRB- GDPppp_NNP $_$ -_: 
However_RB ,_, as_IN concluded_VBN by_IN the_DT European_NNP Food_NNP Authority_NNP Safety_NNP -LRB-_-LRB- EFSA_NNP -RRB-_-RRB- :_: ``_`` no_DT threshold_NN for_IN these_DT effects_NNS has_VBZ been_VBN identified_VBN ,_, and_CC the_DT evidence_NN suggests_VBZ that_IN the_DT response_NN at_IN B-Pb_JJ concentrations_NNS below_IN 100_CD 
Our_PRP$ results_NNS emphasize_VB the_DT substantial_JJ monetary_JJ advantages_NNS obtained_VBN from_IN preventing_VBG losses_NNS of_IN a_DT few_JJ IQ_NNP points_NNS because_IN of_IN lead_JJ exposures_NNS among_IN children_NNS ._. 
While_IN 1-point_JJ change_NN in_IN Full_NNP Scale_NNP IQ_NNP score_NN is_VBZ within_IN the_DT standard_JJ error_NN of_IN an_DT individual_NN 's_POS single_JJ measurement_NN ,_, it_PRP may_MD be_VB highly_RB significant_JJ on_IN a_DT population_NN basis_NN ._. 
Conclusions_NNS The_DT primary_JJ economic_JJ benefits_NNS of_IN policies_NNS focused_VBN on_IN lead_NN exposure_NN abatement_NN are_VBP the_DT further_JJ reduction_NN of_IN low_JJ blood_NN lead_NN levels_NNS ._. 
However_RB ,_, as_IN concluded_VBN by_IN the_DT European_NNP Food_NNP Authority_NNP Safety_NNP -LRB-_-LRB- EFSA_NNP -RRB-_-RRB- :_: ``_`` no_DT threshold_NN for_IN these_DT effects_NNS has_VBZ been_VBN identified_VBN ,_, and_CC the_DT evidence_NN suggests_VBZ that_IN the_DT response_NN at_IN B-Pb_JJ concentrations_NNS below_IN 100_CD 
IQ_NNP and_CC lost_VBD lifetime_NN earnings_NNS due_JJ to_TO lead_VB poisoning_NN The_DT lifetime_NN costs_NNS associated_VBN with_IN lower_JJR earning_NN potential_NN caused_VBN by_IN lead_NN toxicity_NN is_VBZ based_VBN on_IN a_DT linear_JJ relationship_NN between_IN the_DT loss_NN of_IN IQ_NNP due_JJ to_TO lead_JJ and_CC expected_JJ lifetime_NN earnings_NNS ._. 
From_IN the_DT studies_NNS by_IN Lanphear_NNP and_CC colleagues_NNS 
922_CD ._. 
3TOTAL_CD 4,696,182_CD 3,107,009_CD 53_CD ._. 
60_CD ._. 
9-RRB-_CD 5,333_CD 36,265_CD 0_CD ._. 
9+1_CD ._. 
8-LRB-_CD 1_CD +3_CD ._. 
2B-Pb_NN 
Based_VBN on_IN these_DT same_JJ data_NNS ,_, all_DT regions_NNS included_VBD ,_, we_PRP thus_RB considered_VBD that_IN contaminated_VBN soils_NNS and_CC dust_NN or_CC ingested_JJ flakes_NNS from_IN degraded_JJ paint_NN in_IN old_JJ homes_NNS 
Derived_VBN from_IN this_DT estimate_NN ,_, the_DT size_NN of_IN the_DT population_NN experiencing_VBG lead_NN poisoning_NN -LRB-_-LRB- at_IN B-Pb_NN 
Total_JJ lead-based_JJ paint_NN decontamination_NN costs_NNS to_TO remediate_VB French_JJ houses_NNS These_DT costs_NNS ,_, denoted_VBN C_NNP paint_NN ,_, were_VBD calculated_VBN on_IN the_DT basis_NN of_IN InVS_NNS 
In_IN France_NNP ,_, studies_NNS are_VBP mostly_RB epidemiological_JJ ,_, focusing_VBG on_IN targeted_JJ screening_NN and_CC lead_NN exposure_NN ._. 
These_DT studies_NNS have_VBP also_RB calculated_VBN the_DT potential_NN increased_VBD financial_JJ earnings_NNS that_WDT would_MD result_VB if_IN the_DT level_NN of_IN lead_NN in_IN children_NNS 's_POS blood_NN were_VBD to_TO be_VB reduced_VBN 
In_IN France_NNP ,_, studies_NNS are_VBP mostly_RB epidemiological_JJ ,_, focusing_VBG on_IN targeted_JJ screening_NN and_CC lead_NN exposure_NN ._. 
These_DT studies_NNS have_VBP also_RB calculated_VBN the_DT potential_NN increased_VBD financial_JJ earnings_NNS that_WDT would_MD result_VB if_IN the_DT level_NN of_IN lead_NN in_IN children_NNS 's_POS blood_NN were_VBD to_TO be_VB reduced_VBN 
The_DT relative_JJ importance_NN of_IN different_JJ sources_NNS depends_VBZ on_IN the_DT blood_NN lead_NN range_NN ._. 
In_IN France_NNP ,_, lead_NN has_VBZ multiple_JJ anthropogenic_JJ sources_NNS and_CC is_VBZ now_RB mainly_RB present_JJ in_IN its_PRP$ inorganic_JJ form_NN in_IN the_DT environment_NN 
Now_RB ,_, 99_CD %_NN of_IN children_NNS from_IN one_CD to_TO six_CD years_NNS old_JJ have_VBP B-Pb_JJ concentrations_NNS 
Total_JJ lead-based_JJ paint_NN decontamination_NN costs_NNS to_TO remediate_VB French_JJ houses_NNS These_DT costs_NNS ,_, denoted_VBN C_NNP paint_NN ,_, were_VBD calculated_VBN on_IN the_DT basis_NN of_IN InVS_NNS 
Other_JJ incidental_JJ sources_NNS of_IN lead_NN exposure_NN include_VBP consumer_NN products_NNS ,_, notably_RB toys_NNS ,_, and_CC hobbies_NNS or_CC occupations_NNS involving_VBG lead_NN 
Other_JJ incidental_JJ sources_NNS of_IN lead_NN exposure_NN include_VBP consumer_NN products_NNS ,_, notably_RB toys_NNS ,_, and_CC hobbies_NNS or_CC occupations_NNS involving_VBG lead_NN 
Children_NNS under_IN six_CD years_NNS of_IN age_NN have_VBP the_DT highest_JJS exposure_NN to_TO lead_VB because_IN of_IN several_JJ factors_NNS such_JJ as_IN greater_JJR hand_NN dust_NN contamination_NN ,_, frequent_JJ hand-to-mouth_JJ transfer_NN and_CC higher_JJR absorption_NN rates_NNS than_IN adults_NNS ._. 
Also_RB ,_, lead_NN can_MD pass_VB through_IN the_DT placenta_NN so_IN that_IN the_DT child_NN is_VBZ born_VBN with_IN lead_NN from_IN the_DT mother_NN 's_POS cumulated_JJ body_NN burden_NN 
Prudent_JJ public_JJ policies_NNS would_MD help_VB avoiding_VBG future_JJ medical_JJ interventions_NNS ,_, limit_VBP the_DT need_NN for_IN special_JJ education_NN and_CC increase_VB future_JJ productivity_NN ,_, and_CC hence_RB lifetime_NN income_NN for_IN children_NNS exposed_VBN to_TO lead_VB ._. 
BackgroundLead_NNP is_VBZ a_DT well_RB known_VBN toxic_JJ metal_NN ,_, and_CC current_JJ exposures_NNS in_IN children_NNS constitute_VBP a_DT reason_NN for_IN concern_NN 
The_DT relative_JJ importance_NN of_IN different_JJ sources_NNS depends_VBZ on_IN the_DT blood_NN lead_NN range_NN ._. 
In_IN France_NNP ,_, lead_NN has_VBZ multiple_JJ anthropogenic_JJ sources_NNS and_CC is_VBZ now_RB mainly_RB present_JJ in_IN its_PRP$ inorganic_JJ form_NN in_IN the_DT environment_NN 
Also_RB ,_, lead_NN can_MD pass_VB through_IN the_DT placenta_NN so_IN that_IN the_DT child_NN is_VBZ born_VBN with_IN lead_NN from_IN the_DT mother_NN 's_POS cumulated_JJ body_NN burden_NN 
The_DT B-Pb_JJ concentration_NN intervention_NN value_NN in_IN the_DT US_NNP and_CC France_NNP is_VBZ 100_CD 
Thus_RB far_RB ,_, there_EX are_VBP few_JJ studies_NNS so_RB far_RB examining_VBG exposures_NNS below_IN 24_CD 
922_CD ._. 
3TOTAL_CD 4,696,182_CD 3,107,009_CD 53_CD ._. 
60_CD ._. 
9-RRB-_CD 5,333_CD 36,265_CD 0_CD ._. 
9+1_CD ._. 
8-LRB-_CD 1_CD +3_CD ._. 
2B-Pb_NN 
Discussion_NN The_DT aim_NN of_IN this_DT paper_NN was_VBD to_TO provide_VB an_DT economic_JJ evaluation_NN of_IN the_DT health_NN impacts_NNS of_IN children_NNS with_IN lead_NN exposure_NN in_IN France_NNP ._. 
Based_VBN on_IN the_DT assumption_NN of_IN the_DT EFSA_NNP report_NN ,_, that_IN there_EX is_VBZ no_DT threshold_NN of_IN lead_NN exposure_NN ,_, our_PRP$ study_NN provides_VBZ a_DT range_NN of_IN annual_JJ benefits_NNS and_CC partial_JJ costs_NNS estimated_VBN in_IN order_NN to_TO highlight_VB the_DT economic_JJ impact_NN for_IN society_NN of_IN lead_NN exposure_NN reduction_NN policies_NNS below_IN the_DT conventional_JJ B-Pb_JJ screening_NN value_NN of_IN 100_CD 
The_DT French_JJ 2004_CD national_JJ environmental_JJ health_NN action_NN plan_NN has_VBZ also_RB contributed_VBN to_TO the_DT steady_JJ decrease_NN in_IN exposure_NN of_IN the_DT general_JJ population_NN and_CC of_IN its_PRP$ most_RBS vulnerable_JJ young_JJ segment_NN over_IN the_DT last_JJ years_NNS in_IN France_NNP ._. 
EFSA_NNP recommends_VBZ that_IN ``_`` work_NN should_MD continue_VB to_TO reduce_VB exposure_NN to_TO lead_VB ,_, from_IN both_DT dietary_JJ and_CC non-dietary_JJ sources_NNS ''_'' ._. 
The_DT major_JJ prevention_NN campaigns_NNS aim_VBP to_TO reduce_VB lead_NN exposure_NN to_TO the_DT lowest_JJS possible_JJ level_NN in_IN order_NN to_TO protect_VB children_NNS and_CC childbearing_VBG age_NN women_NNS ._. 
Background_NN Lead_JJ is_VBZ a_DT well_RB known_VBN toxic_JJ metal_NN ,_, and_CC current_JJ exposures_NNS in_IN children_NNS constitute_VBP a_DT reason_NN for_IN concern_NN 
e._VB The_DT first_JJ national_JJ study_NN carried_VBD out_RP in_IN France_NNP in_IN 1999_CD by_IN the_DT National_NNP Institute_NNP of_IN Health_NNP and_CC Medical_NNP Research_NNP -LRB-_-LRB- INSERM_NNP -RRB-_-RRB- showed_VBD that_IN 2_CD %_NN of_IN French_JJ children_NNS aged_VBD one_CD to_TO six_CD years_NNS of_IN age_NN had_VBD B-Pb_JJ concentrations_NNS 
We_PRP estimated_VBD total_JJ lead-based_JJ paint_NN decontamination_NN costs_NNS ,_, partial_JJ costs_NNS of_IN industrial_JJ emission_NN abatement_NN and_CC lead_NN pipe_NN removal_NN costs_NNS ._. 
Total_JJ lead-based_JJ paint_NN decontamination_NN costs_NNS to_TO remediate_VB French_JJ housesThese_NN costs_NNS ,_, denoted_VBN Cpaint_NNP ,_, were_VBD calculated_VBN on_IN the_DT basis_NN of_IN InVS_NNS 
Background_NN Lead_JJ is_VBZ a_DT well_RB known_VBN toxic_JJ metal_NN ,_, and_CC current_JJ exposures_NNS in_IN children_NNS constitute_VBP a_DT reason_NN for_IN concern_NN 
Degradation_NN of_IN old_JJ lead-based_JJ paint_NN results_NNS in_IN the_DT contamination_NN of_IN indoor_JJ dust_NN that_WDT can_MD be_VB inhaled_VBN or_CC ingested_VBN ,_, thus_RB adding_VBG to_TO the_DT sources_NNS already_RB mentioned_VBN ._. 
Other_JJ incidental_JJ sources_NNS of_IN lead_NN exposure_NN include_VBP consumer_NN products_NNS ,_, notably_RB toys_NNS ,_, and_CC hobbies_NNS or_CC occupations_NNS involving_VBG lead_NN 
After_IN the_DT ban_NN of_IN leaded_VBN petrol_NN ,_, air_NN concentrations_NNS have_VBP decreased_VBN substantially_RB and_CC are_VBP now_RB due_JJ almost_RB entirely_RB to_TO industrial_JJ emissions_NNS 
We_PRP calculated_VBD B_NNP screening15-24_NNP ,_, B_NNP screening24-100_NN and_CC B_NN treatment_NN 
The_DT direct_JJ health_NN cost_NN estimates_NNS for_IN B-Pb_NN 
We_PRP estimated_VBD total_JJ lead-based_JJ paint_NN decontamination_NN costs_NNS ,_, partial_JJ costs_NNS of_IN industrial_JJ emission_NN abatement_NN and_CC lead_NN pipe_NN removal_NN costs_NNS ._. 
Total_JJ lead-based_JJ paint_NN decontamination_NN costs_NNS to_TO remediate_VB French_JJ housesThese_NN costs_NNS ,_, denoted_VBN Cpaint_NNP ,_, were_VBD calculated_VBN on_IN the_DT basis_NN of_IN InVS_NNS 
Although_IN a_DT longer_JJR investment_NN plan_NN could_MD have_VB been_VBN chosen_VBN ,_, we_PRP calculated_VBD the_DT annual_JJ costs_NNS for_IN an_DT investment_NN plan_NN over_IN 5_CD years_NNS to_TO cover_VB the_DT expenses_NNS ._. 
We_PRP used_VBD ANAH_NNP estimates_NNS and_CC French_NNP or_CC US_NNP data_NNS ,_, according_VBG to_TO which_WDT were_VBD available_JJ ._. 
Results_NNS Annual_JJ Benefits_NNP Direct_NNP health_NN care_NN costs_NNS were_VBD estimated_VBN in_IN accordance_NN with_IN equation_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC were_VBD found_VBN to_TO be_VB 
3342_CD ._. 
1245_CD ._. 
Table_NNP 5_CD Costs_NNS to_TO decontaminate_VB French_JJ houses_NNS with_IN lead-based_JJ paint_NN -LRB-_-LRB- 
-LRB-_-LRB- Paris_NNP ambient_JJ air_NN concentrations_NNS decreased_VBN by_IN 97_CD %_NN between_IN 1991_CD and_CC 2005_CD -RRB-_-RRB- 
Also_RB ,_, lead_NN can_MD pass_VB through_IN the_DT placenta_NN so_IN that_IN the_DT child_NN is_VBZ born_VBN with_IN lead_NN from_IN the_DT mother_NN 's_POS cumulated_JJ body_NN burden_NN 
Several_JJ economic_JJ studies_NNS ,_, mainly_RB in_IN the_DT US_NNP ,_, have_VBP estimated_VBN the_DT costs_NNS and_CC risks_NNS associated_VBN with_IN infantile_JJ lead_NN poisoning_NN and_CC lead_NN toxicity_NN ,_, in_IN some_DT cases_NNS weighing_VBG them_PRP against_IN the_DT costs_NNS associated_VBN with_IN lead-based_JJ paint_NN control_NN and_CC other_JJ efforts_NNS ._. 
These_DT studies_NNS have_VBP also_RB calculated_VBN the_DT potential_NN increased_VBD financial_JJ earnings_NNS that_WDT would_MD result_VB if_IN the_DT level_NN of_IN lead_NN in_IN children_NNS 's_POS blood_NN were_VBD to_TO be_VB reduced_VBN 
There_EX have_VBP been_VBN few_JJ economic_JJ assessments_NNS of_IN lead_NN 's_POS impact_NN on_IN the_DT children_NNS 's_POS health_NN ,_, with_IN the_DT exception_NN of_IN the_DT studies_NNS by_IN Chanel_NNP 
3Based_VBN on_IN a_DT EFSA_NNP conclusions_NNS 
Several_JJ other_JJ studies_NNS support_VBP the_DT link_NN between_IN preschool_JJ lead_NN exposure_NN and_CC aggressive_JJ or_CC delinquent_JJ adolescent_JJ behavior_NN and_CC subsequent_JJ criminal_JJ violence_NN 
S._NNP The_NNP most_RBS recent_JJ major_JJ U._NNP Recent_JJ studies_NNS calculated_VBD the_DT economic_JJ impact_NN of_IN childhood_NN poisoning_NN below100_NN 
Overall_JJ ,_, lead_JJ poisoning_NN is_VBZ still_RB a_DT serious_JJ hazard_NN for_IN children_NNS and_CC causes_VBZ significant_JJ neurologic_JJ damage_NN linked_VBN to_TO cognitive_JJ and_CC behavioral_JJ impairment_NN 
This_DT topic_NN has_VBZ been_VBN gaining_VBG ever_RB greater_JJR attention_NN from_IN researchers_NNS and_CC law-makers_NNS ._. 
Maintaining_VBG data_NNS confidentiality_NN is_VBZ a_DT current_JJ public_JJ concern_NN raised_VBD ,_, possibly_RB unduly_RB ,_, by_IN increased_VBN use_NN of_IN computerized_JJ databases_NNS ._. 
In_IN spite_NN of_IN this_DT ,_, there_EX is_VBZ still_RB a_DT lack_NN of_IN regulation_NN on_IN specific_JJ aspects_NNS in_IN many_JJ countries_NNS ,_, including_VBG Portugal_NNP ,_, as_IN can_MD be_VB seen_VBN from_IN the_DT tables_NNS on_IN data_NNS protection_NN ,_, presented_VBN in_IN the_DT document_NN ``_`` Ethics_NNS and_CC data_NNS protection_NN in_IN a_DT number_NN of_IN European_JJ countries_NNS ''_'' 
The_DT afore-mentioned_JJ Convention_NNP also_RB defines_VBZ that_DT research_NN may_MD only_RB be_VB carried_VBN out_RP on_IN a_DT person_NN who_WP does_VBZ not_RB have_VB the_DT capacity_NN to_TO consent_VB if_IN ``_`` the_DT results_NNS of_IN the_DT research_NN have_VBP the_DT potential_NN to_TO produce_VB real_JJ and_CC direct_JJ benefit_NN to_TO his_PRP$ or_CC her_PRP$ health_NN ''_'' unless_IN ``_`` the_DT research_NN has_VBZ the_DT aim_NN of_IN contributing_VBG ,_, through_IN significant_JJ improvement_NN in_IN the_DT scientific_JJ understanding_NN of_IN the_DT individual_NN 's_POS condition_NN ,_, disease_NN or_CC disorder_NN ,_, to_TO the_DT ultimate_JJ attainment_NN of_IN results_NNS capable_JJ of_IN conferring_VBG benefit_NN to_TO the_DT person_NN concerned_VBN or_CC to_TO other_JJ persons_NNS in_IN the_DT same_JJ age_NN category_NN or_CC afflicted_VBN with_IN the_DT same_JJ disease_NN or_CC disorder_NN or_CC having_VBG the_DT same_JJ condition_NN ''_'' 
As_IN such_JJ ,_, it_PRP is_VBZ the_DT authors_NNS '_POS best_JJS interpretation_NN that_DT surveillance_NN should_MD be_VB guided_VBN by_IN this_DT legislation_NN in_IN addition_NN to_TO pondering_VBG input_NN from_IN the_DT relevant_JJ health_NN ethics_NNS committees_NNS and_CC other_JJ bodies_NNS ._. 
BeneficenceThe_JJ principle_NN of_IN doing_VBG good_JJ 
Other_JJ ethics_NNS issues_NNS related_VBN to_TO recruitment_NN and_CC sample_NN collection_NN The_DT lack_NN of_IN any_DT immediate_JJ benefit_NN for_IN the_DT participant_NN ,_, while_IN not_RB in_IN itself_PRP a_DT deterrent_NN ,_, does_VBZ not_RB on_IN the_DT other_JJ hand_NN constitute_VBP an_DT incentive_NN to_TO voluntary_JJ participation_NN ._. 
Added_VBN to_TO the_DT fact_NN that_IN individuals_NNS should_MD not_RB be_VB pressured_VBN to_TO participate_VB in_IN a_DT study_NN 
The_DT study_NN is_VBZ therefore_RB financed_VBN by_IN entities_NNS that_WDT have_VBP obvious_JJ vested_JJ interests_NNS in_IN the_DT outcome_NN of_IN the_DT study_NN ._. 
Ethically_RB ,_, transparency_NN is_VBZ key_JJ ,_, requiring_VBG full_JJ disclosure_NN of_IN the_DT conflict_NN of_IN interest_NN 
However_RB ,_, as_IN all_DT projects_NNS store_VBP sensitive_JJ data_NNS on_IN health_NN ,_, participants_NNS '_POS names_NNS are_VBP coded_VBN prior_RB to_TO data_NN processing_NN and_CC analysis_NN and_CC database_NN access_NN is_VBZ protected_VBN by_IN user_NN passwords_NNS ,_, conforming_VBG to_TO legislation_NN on_IN information_NN storage_NN 
Appraisals_NNS from_IN health_NN ethics_NNS committees_NNS are_VBP not_RB legally_RB binding_JJ 
Donation_NN of_IN umbilical_JJ cord_NN blood_NN for_IN sampling_NN in_IN ProVEpA_NNP provides_VBZ useful_JJ estimates_NNS of_IN maternal_JJ pollutant_NN load_NN and_CC of_IN foetal_JJ exposure_NN ,_, but_CC decreases_VBZ in_IN adhesion_NN rates_NNS forced_VBD the_DT practice_NN to_TO be_VB dropped_VBN in_IN Lisbon_NNP ,_, although_IN still_RB ongoing_JJ in_IN Madeira_NNP ._. 
Acontributing_VBG factor_NN is_VBZ thought_VBN to_TO be_VB the_DT increase_NN in_IN the_DT number_NN of_IN parents_NNS cryo-preserving_VBG umbilical_JJ cord_NN stem_NN cells_NNS in_IN private_JJ bio-banks_NNS for_IN future_JJ health-care_NN options_NNS for_IN their_PRP$ child_NN ,_, an_DT interesting_JJ ethical_JJ issue_NN itself_PRP ._. 
The_DT non-targeted_JJ recruitment_NN strategy_NN of_IN VAEDA_NNP ,_, where_WRB potential_JJ participants_NNS contact_VBP a_DT toll-free_JJ call_NN center_NN of_IN their_PRP$ own_JJ initiative_NN ,_, enables_VBZ records_NNS of_IN contacts_NNS made_VBN and_CC subsequent_JJ participation_NN to_TO be_VB kept_VBN ,_, with_IN a_DT current_JJ recruitment_NN rate_NN of_IN 44_CD %_NN ._. 
Communicating_VBG or_CC not_RB the_DT dioxin_NN or_CC heavy_JJ metal_NN load_NN in_IN human_JJ milk_NN -LRB-_-LRB- ProVEpA_NNP and_CC human_JJ milk_NN survey_NN -RRB-_-RRB- is_VBZ a_DT sensitive_JJ issue_NN which_WDT must_MD be_VB approached_VBN particularly_RB carefully_RB ._. 
The_DT benefits_NNS of_IN breast-feeding_NN are_VBP so_RB significant_JJ that_IN the_DT WHO_WP has_VBZ advised_VBN that_IN they_PRP outweigh_VBP any_DT risks_NNS resulting_VBG from_IN exposure_NN of_IN the_DT nursing_NN child_NN to_TO raised_VBN pollutant_NN levels_NNS in_IN milk_NN ._. 
This_DT must_MD be_VB unambiguously_RB communicated_VBN to_TO mothers_NNS when_WRB informing_VBG them_PRP of_IN their_PRP$ raised_VBN pollutant_NN load_NN so_IN that_IN their_PRP$ concerns_NNS for_IN the_DT health_NN of_IN their_PRP$ infant_NN do_VBP not_RB lead_VB them_PRP to_TO stop_VB breast-feeding_NN ._. 
Results_NNS and_CC discussion_NN Autonomy_NNP Autonomy_NNP is_VBZ one_CD of_IN the_DT basic_JJ ethical_JJ principles_NNS governing_VBG all_DT research_NN involving_VBG human_JJ subjects_NNS ._. 
It_PRP upholds_VBZ the_DT subjects_NNS '_POS right_NN to_TO be_VB fully_RB informed_VBN and_CC free_JJ to_TO decide_VB whether_IN they_PRP wish_VBP to_TO participate_VB 
As_IN such_JJ ,_, it_PRP is_VBZ the_DT authors_NNS '_POS best_JJS interpretation_NN that_DT surveillance_NN should_MD be_VB guided_VBN by_IN this_DT legislation_NN in_IN addition_NN to_TO pondering_VBG input_NN from_IN the_DT relevant_JJ health_NN ethics_NNS committees_NNS and_CC other_JJ bodies_NNS ._. 
BeneficenceThe_JJ principle_NN of_IN doing_VBG good_JJ 
Informed_JJ consent_NN forms_NNS explicitly_RB state_VBP that_IN samples_NNS will_MD only_RB be_VB kept_VBN until_IN analysis_NN and_CC no_DT use_NN beyond_IN that_DT initially_RB predicted_VBN and_CC informed_VBN to_TO the_DT donor_NN will_MD be_VB made_VBN ._. 
Data_NNP protectionData_NNP protection_NN is_VBZ another_DT topic_NN where_WRB public_JJ interests_NNS are_VBP put_VBN above_IN the_DT rights_NNS of_IN the_DT individuals_NNS ,_, namely_RB the_DT right_NN to_TO privacy_NN ._. 
Maintaining_VBG data_NNS confidentiality_NN is_VBZ a_DT current_JJ public_JJ concern_NN raised_VBD ,_, possibly_RB unduly_RB ,_, by_IN increased_VBN use_NN of_IN computerized_JJ databases_NNS ._. 
It_PRP upholds_VBZ the_DT subjects_NNS '_POS right_NN to_TO be_VB fully_RB informed_VBN and_CC free_JJ to_TO decide_VB whether_IN they_PRP wish_VBP to_TO participate_VB 
Appraisals_NNS from_IN health_NN ethics_NNS committees_NNS are_VBP not_RB legally_RB binding_JJ 
Increasingly_RB ,_, in_IN research_NN involving_VBG children_NNS ,_, the_DT assent_NN of_IN the_DT child_NN is_VBZ required_VBN ,_, in_IN addition_NN to_TO the_DT informed_JJ consent_NN of_IN one_CD or_CC both_DT parents\/guardians_NNS ._. 
This_DT involves_VBZ a_DT child_NN 's_POS affirmative_JJ agreement_NN to_TO participate_VB in_IN the_DT research_NN and_CC not_RB mere_JJ failure_NN to_TO object_VB 
This_DT involves_VBZ a_DT child_NN 's_POS affirmative_JJ agreement_NN to_TO participate_VB in_IN the_DT research_NN and_CC not_RB mere_JJ failure_NN to_TO object_VB 
Appraisals_NNS from_IN health_NN ethics_NNS committees_NNS are_VBP not_RB legally_RB binding_JJ 
The_DT study_NN is_VBZ therefore_RB financed_VBN by_IN entities_NNS that_WDT have_VBP obvious_JJ vested_JJ interests_NNS in_IN the_DT outcome_NN of_IN the_DT study_NN ._. 
Ethically_RB ,_, transparency_NN is_VBZ key_JJ ,_, requiring_VBG full_JJ disclosure_NN of_IN the_DT conflict_NN of_IN interest_NN 
11_CD 
11_CD 
As_IN such_JJ ,_, it_PRP is_VBZ the_DT authors_NNS '_POS best_JJS interpretation_NN that_DT surveillance_NN should_MD be_VB guided_VBN by_IN this_DT legislation_NN in_IN addition_NN to_TO pondering_VBG input_NN from_IN the_DT relevant_JJ health_NN ethics_NNS committees_NNS and_CC other_JJ bodies_NNS ._. 
BeneficenceThe_JJ principle_NN of_IN doing_VBG good_JJ 
Dissemination_NN has_VBZ comprised_VBN TV_NN reports_NNS and_CC interviews_NNS ,_, articles_NNS in_IN newspapers_NNS and_CC magazines_NNS ,_, raising_VBG awareness_NN among_IN primary_JJ health_NN care_NN workers_NNS and_CC the_DT distribution_NN of_IN flyers_NNS and_CC posters_NNS in_IN primary_JJ health-care_NN centres_NNS ,_, maternities_NNS ,_, pharmacies_NNS ,_, shops_NNS and_CC hairdressers_NNS ._. 
Following_VBG a_DT World_NNP Health_NNP Organization_NNP -LRB-_-LRB- WHO_WP -RRB-_-RRB- protocol_NN ,_, another_DT study_NN monitors_VBZ twelve_CD persistent_JJ organic_JJ pollutants_NNS in_IN human_JJ milk_NN and_CC geographically_RB representative_JJ sampling_NN is_VBZ being_VBG achieved_VBN through_IN local_JJ recruitments_NNS by_IN family_NN health_NN doctors_NNS in_IN primary_JJ health-care_NN centres_NNS ._. 
The_DT authors_NNS '_POS most_RBS recent_JJ study_NN is_VBZ FEXHE-BIO_JJ ,_, determining_VBG foetal_JJ exposure_NN to_TO lead_NN and_CC correlation_NN with_IN environmental_JJ indicators_NNS including_VBG lead_NN in_IN moss_NN and_CC topsoil_NN ._. 
This_DT topic_NN has_VBZ been_VBN gaining_VBG ever_RB greater_JJR attention_NN from_IN researchers_NNS and_CC law-makers_NNS ._. 
Maintaining_VBG data_NNS confidentiality_NN is_VBZ a_DT current_JJ public_JJ concern_NN raised_VBD ,_, possibly_RB unduly_RB ,_, by_IN increased_VBN use_NN of_IN computerized_JJ databases_NNS ._. 
In_IN spite_NN of_IN this_DT ,_, there_EX is_VBZ still_RB a_DT lack_NN of_IN regulation_NN on_IN specific_JJ aspects_NNS in_IN many_JJ countries_NNS ,_, including_VBG Portugal_NNP ,_, as_IN can_MD be_VB seen_VBN from_IN the_DT tables_NNS on_IN data_NNS protection_NN ,_, presented_VBN in_IN the_DT document_NN ``_`` Ethics_NNS and_CC data_NNS protection_NN in_IN a_DT number_NN of_IN European_JJ countries_NNS ''_'' 
The_DT guarantee_NN of_IN the_DT confidentiality_NN of_IN this_DT data_NNS under_IN any_DT circumstances_NNS is_VBZ a_DT fundamental_JJ part_NN of_IN initial_JJ information_NN practices_NNS ._. 
Ethics_NNS committeesAlthough_VBP no_DT official_JJ opinions_NNS from_IN national_JJ ethics_NNS bodies_NNS have_VBP been_VBN stated_VBN in_IN regard_NN to_TO human_JJ biomonitoring_NN ,_, all_DT Portuguese_JJ public_JJ health_NN institutions_NNS have_VBP an_DT ethics_NNS committee_NN to_TO which_WDT research_NN and_CC surveillance_NN projects_NNS using_VBG a_DT HBM_NNP approach_NN have_VBP to_TO be_VB submitted_VBN prior_RB to_TO their_PRP$ commencement_NN ,_, as_IN any_DT project_NN involving_VBG data_NNS and_CC sample_NN collection_NN ._. 
All_DT study_NN protocols_NNS mentioned_VBN were_VBD approved_VBN by_IN the_DT University_NNP of_IN Lisbon_NNP ,_, Faculty_NNP of_IN Medicine_NNP Ethics_NNPS Committee_NNP ._. 
As_IN the_DT most_RBS conspicuous_JJ ethical_JJ issue_NN ,_, the_DT presence_NN of_IN conflicts_NNS of_IN interest_NN has_VBZ been_VBN successfully_RB handled_VBN ._. 
Raising_NNP the_DT profile_NN of_IN human_JJ biomonitoring_NN 
This_DT involves_VBZ a_DT child_NN 's_POS affirmative_JJ agreement_NN to_TO participate_VB in_IN the_DT research_NN and_CC not_RB mere_JJ failure_NN to_TO object_VB 
Appraisals_NNS from_IN health_NN ethics_NNS committees_NNS are_VBP not_RB legally_RB binding_JJ but_CC it_PRP is_VBZ accepted_JJ practice_NN to_TO conform_VB to_TO the_DT recommendations_NNS made_VBN ._. 
Current_JJ le_FW 
This_DT involves_VBZ a_DT child_NN 's_POS affirmative_JJ agreement_NN to_TO participate_VB in_IN the_DT research_NN and_CC not_RB mere_JJ failure_NN to_TO object_VB 
This_DT results_NNS from_IN a_DT decision_NN implicitly_RB prioritizing_VBG the_DT protection_NN of_IN a_DT vulnerable_JJ group_NN over_IN their_PRP$ right_NN to_TO self-determination_NN ._. 
The_DT afore-mentioned_JJ Convention_NNP also_RB defines_VBZ that_DT research_NN may_MD only_RB be_VB carried_VBN out_RP on_IN a_DT person_NN who_WP does_VBZ not_RB have_VB the_DT capacity_NN to_TO consent_VB if_IN ``_`` the_DT results_NNS of_IN the_DT research_NN have_VBP the_DT potential_NN to_TO produce_VB real_JJ and_CC direct_JJ benefit_NN to_TO his_PRP$ or_CC her_PRP$ health_NN ''_'' unless_IN ``_`` the_DT research_NN has_VBZ the_DT aim_NN of_IN contributing_VBG ,_, through_IN significant_JJ improvement_NN in_IN the_DT scientific_JJ understanding_NN of_IN the_DT individual_NN 's_POS condition_NN ,_, disease_NN or_CC disorder_NN ,_, to_TO the_DT ultimate_JJ attainment_NN of_IN results_NNS capable_JJ of_IN conferring_VBG benefit_NN to_TO the_DT person_NN concerned_VBN or_CC to_TO other_JJ persons_NNS in_IN the_DT same_JJ age_NN category_NN or_CC afflicted_VBN with_IN the_DT same_JJ disease_NN or_CC disorder_NN or_CC having_VBG the_DT same_JJ condition_NN ''_'' 
In_IN the_DT context_NN of_IN children_NNS 's_POS participation_NN ,_, requesting_VBG altruistic_JJ actions_NNS from_IN an_DT individual_NN who_WP can_MD not_RB provide_VB true_JJ informed_JJ consent_NN is_VBZ ethically_RB debatable_JJ however_RB ,_, notwithstanding_IN the_DT nobility_NN of_IN the_DT principle_NN of_IN protecting_VBG the_DT vulnerable_JJ ._. 
In_IN legislative_JJ terms_NNS ,_, the_DT situation_NN is_VBZ equally_RB contradictory_JJ ,_, with_IN the_DT European_NNP Convention_NNP on_IN Human_JJ Rights_NNS stating_VBG that_IN ``_`` the_DT interests_NNS and_CC welfare_NN of_IN the_DT human_JJ being_NN shall_MD prevail_VB over_IN the_DT sole_JJ interest_NN of_IN society_NN or_CC science_NN ''_'' ,_, yet_RB foreseeing_VBG restrictions_NNS to_TO this_DT ``_`` in_IN the_DT interest_NN of_IN public_JJ safety_NN ,_, for_IN the_DT prevention_NN of_IN crime_NN ,_, for_IN the_DT protection_NN of_IN public_JJ health_NN or_CC for_IN the_DT protection_NN of_IN the_DT rights_NNS and_CC freedoms_NNS of_IN others_NNS ''_'' ._. 
The_DT authors_NNS '_POS current_JJ research_NN includes_VBZ attempts_NNS to_TO correlate_VB hair_NN and_CC blood_NN heavy_JJ metal_NN levels_NNS in_IN children_NNS ,_, to_TO determine_VB if_IN the_DT less_RBR invasive_JJ technique_NN with_IN hair_NN samples_NNS could_MD replace_VB the_DT need_NN for_IN blood_NN sampling_NN ._. 
Added_VBN to_TO the_DT fact_NN that_IN individuals_NNS should_MD not_RB be_VB pressured_VBN to_TO participate_VB in_IN a_DT study_NN 
Consequences_NNS and_CC risks_NNS are_VBP not_RB generally_RB specified_VBN as_IN they_PRP are_VBP only_RB relevant_JJ in_IN the_DT case_NN of_IN blood_NN sampling_NN ,_, and_CC in_IN this_DT case_NN -LRB-_-LRB- with_IN the_DT exception_NN of_IN VAEDA_NNP -RRB-_-RRB- the_DT participants_NNS are_VBP drawing_VBG blood_NN irrespectively_RB so_RB possible_JJ negative_JJ consequences_NNS are_VBP not_RB linked_VBN to_TO ,_, and_CC as_IN such_JJ do_VBP not_RB constitute_VB a_DT deterrent_NN from_IN ,_, participation_NN ._. 
Assent_NN is_VBZ not_RB obtained_VBN from_IN children_NNS as_IN a_DT rule_NN due_JJ to_TO their_PRP$ age_NN -LRB-_-LRB- one_CD to_TO six_CD years_NNS -RRB-_-RRB- 
The_DT `_`` right_NN to_TO know_VB '_'' concerning_VBG an_DT individual_NN 's_POS health_NN information_NN has_VBZ lately_RB been_VBN supplemented_VBN by_IN the_DT `_`` right_RB not_RB to_TO know_VB '_'' ,_, of_IN particular_JJ interest_NN when_WRB the_DT health_NN effects_NNS of_IN a_DT substance_NN are_VBP not_RB know_VB ,_, or_CC if_IN known_VBN ,_, reduction_NN options_NNS are_VBP not_RB clear_JJ ._. 
Both_DT these_DT rights_NNS are_VBP protected_VBN by_IN European_NNP Convention_NNP 
Appraisals_NNS from_IN health_NN ethics_NNS committees_NNS are_VBP not_RB legally_RB binding_JJ 
In_IN addition_NN ,_, projects_NNS where_WRB recruitment_NN involved_VBN collaborations_NNS with_IN other_JJ health_NN institutes_NN were_VBD also_RB approved_VBN by_IN their_PRP$ respective_JJ ethics_NNS committees_NNS ,_, as_IN was_VBD the_DT case_NN of_IN Dr_NNP Alfredo_NNP da_NNP Costa_NNP Maternity_NNP where_WRB pregnant_JJ women_NNS are_VBP recruited_VBN in_IN Lisbon_NNP and_CC Dona_NNP Estef_NNP 
Appraisals_NNS from_IN health_NN ethics_NNS committees_NNS are_VBP not_RB legally_RB binding_JJ 
Both_DT these_DT rights_NNS are_VBP protected_VBN by_IN European_NNP Convention_NNP 
In_IN order_NN to_TO be_VB able_JJ to_TO communicate_VB individual_JJ results_NNS ,_, and_CC to_TO guarantee_VB access_NN to_TO participants_NNS for_IN follow-up_JJ sampling_NN in_IN VAEDA_NNP and_CC in_IN the_DT human_JJ milk_NN survey_NN ,_, volunteers_NNS '_POS identities_NNS can_MD not_RB be_VB irreversibly_RB anonymized_VBN ._. 
However_RB ,_, as_IN all_DT projects_NNS store_VBP sensitive_JJ data_NNS on_IN health_NN ,_, participants_NNS '_POS names_NNS are_VBP coded_VBN prior_RB to_TO data_NN processing_NN and_CC analysis_NN and_CC database_NN access_NN is_VBZ protected_VBN by_IN user_NN passwords_NNS ,_, conforming_VBG to_TO legislation_NN on_IN information_NN storage_NN 
Appraisals_NNS from_IN health_NN ethics_NNS committees_NNS are_VBP not_RB legally_RB binding_JJ 
Potential_JJ misinterpretation_NN of_IN the_DT concept_NN of_IN biobanking_VBG in_IN regard_NN to_TO sample_NN storage_NN for_IN the_DT relatively_RB short_JJ period_NN between_IN collection_NN and_CC analysis_NN means_VBZ sample_NN storage_NN practices_NNS within_IN the_DT projects_NNS underway_NN probably_RB ought_MD to_TO be_VB re-evaluated_VBN according_VBG to_TO Article_NNP 19_CD of_IN Law_NNP no._NNP ._. 
12\/2005_CD ,_, dated_VBN January_NNP 26th_JJ ._. 
As_IN the_DT most_RBS conspicuous_JJ ethical_JJ issue_NN ,_, the_DT presence_NN of_IN conflicts_NNS of_IN interest_NN has_VBZ been_VBN successfully_RB handled_VBN ._. 
Several_JJ constituents_NNS of_IN hair_NN care_NN products_NNS are_VBP airway_JJ irritants_NNS and_CC may_MD induce_VB respiratory_JJ conditions_NNS ,_, including_VBG impairment_NN of_IN the_DT pulmonary_JJ function_NN and_CC chronic_NN bronchitis_NN 
1times_NNS higher_JJR than_IN those_DT found_VBN in_IN the_DT small_JJ and_CC large_JJ salons_NNS they_PRP studied_VBD 
Several_JJ constituents_NNS of_IN hair_NN care_NN products_NNS are_VBP airway_JJ irritants_NNS and_CC may_MD induce_VB respiratory_JJ conditions_NNS ,_, including_VBG impairment_NN of_IN the_DT pulmonary_JJ function_NN and_CC chronic_NN bronchitis_NN 
Hairdressers_NNS are_VBP exposed_VBN to_TO a_DT variety_NN of_IN chemical_NN agents_NNS as_IN a_DT result_NN of_IN usage_NN of_IN several_JJ hair_NN cosmetic_NN products_NNS such_JJ as_IN hair_NN dyes_NNS ,_, permanent_JJ wave_NN solutions_NNS and_CC bleaches_NNS ._. 
Several_JJ constituents_NNS of_IN hair_NN care_NN products_NNS are_VBP airway_JJ irritants_NNS and_CC may_MD induce_VB respiratory_JJ conditions_NNS ,_, including_VBG impairment_NN of_IN the_DT pulmonary_JJ function_NN and_CC chronic_NN bronchitis_NNS ._. 
Hairdressing_NN is_VBZ described_VBN as_IN an_DT occupation_NN at_IN risk_NN of_IN ast_NN 
Several_JJ constituents_NNS of_IN hair_NN care_NN products_NNS are_VBP airway_JJ irritants_NNS and_CC may_MD induce_VB respiratory_JJ conditions_NNS ,_, including_VBG impairment_NN of_IN the_DT pulmonary_JJ function_NN and_CC chronic_NN bronchitis_NN 
Several_JJ constituents_NNS of_IN hair_NN care_NN products_NNS are_VBP airway_JJ irritants_NNS and_CC may_MD induce_VB respiratory_JJ conditions_NNS ,_, including_VBG impairment_NN of_IN the_DT pulmonary_JJ function_NN and_CC chronic_NN bronchitis_NN 
1times_NNS higher_JJR than_IN those_DT found_VBN in_IN the_DT small_JJ and_CC large_JJ salons_NNS they_PRP studied_VBD 
Several_JJ constituents_NNS of_IN hair_NN care_NN products_NNS are_VBP airway_JJ irritants_NNS and_CC may_MD induce_VB respiratory_JJ conditions_NNS ,_, including_VBG impairment_NN of_IN the_DT pulmonary_JJ function_NN and_CC chronic_NN bronchitis_NN 
1times_NNS higher_JJR than_IN those_DT found_VBN in_IN the_DT small_JJ and_CC large_JJ salons_NNS they_PRP studied_VBD 
Although_IN the_DT 2_CD minutes_NNS spot_NN exposure_NN measurements_NNS found_VBN by_IN Van_NNP der_NNP Wal_NNP are_VBP very_RB high_JJ compared_VBN to_TO our_PRP$ values_NNS ,_, their_PRP$ ambient_JJ air_NN measurements_NNS are_VBP similar_JJ to_TO ours_PRP ._. 
It_PRP should_MD be_VB noted_VBN that_IN all_PDT these_DT results_NNS were_VBD below_IN the_DT French_NNP and_CC Belgium_NNP TLVs_NNP for_IN ammonia_NN -LRB-_-LRB- 7_CD and_CC 14_CD mg\/m3_CD ,_, respectively_RB -RRB-_-RRB- 
5and_CD 1_CD ._. 
French_NNP and_CC Belgium_NNP TLVs_NNP ,_, NIOSH_NNP REL_NNP TWA_NNP ,_, OSHA_NNP PEL_NNP TWA_NNP for_IN H_NNP 2_CD O_NNP 2_CD are_VBP 1_CD ._. 
4times_NNS greater_JJR than_IN our_PRP$ maximum_NN value_NN in_IN technical_JJ areas_NNS ,_, during_IN the_DT winter_NN period_NN measurements_NNS 
To_TO our_PRP$ knowledge_NN ,_, there_EX is_VBZ no_DT TLV_NNP for_IN persulfates_NNS as_IN a_DT whole_NN ;_: a_DT persulfate_JJ ammonium_NN TLV_NNP of_IN 0_CD ._. 
It_PRP should_MD be_VB noted_VBN ,_, however_RB ,_, that_IN the_DT former_JJ stem_NN from_IN short_JJ periods_NNS measurements_NNS ,_, focused_VBN in_IN particular_JJ when_WRB mixtures_NNS of_IN hairdressing_NN products_NNS were_VBD made_VBN ,_, while_IN our_PRP$ data_NNS correspond_VBP to_TO shift_VB averages_NNS over_IN all_DT daily_JJ activities_NNS ._. 
1mg\/m3_NNP has_VBZ been_VBN set_VBN by_IN the_DT US_NNP ACGIH_NNP and_CC in_IN Belgium_NNP ._. 
Conclusion_NN Ventilation_NN is_VBZ not_RB frequent_JJ in_IN the_DT study_NN hairdressing_NN salons_NNS ._. 
Manipulation_NN of_IN bleaching_NN products_NNS ,_, among_IN other_JJ chemical_JJ substances_NNS used_VBN in_IN the_DT hairdressing_NN process_NN ,_, yields_NNS exposure_NN to_TO airways_NNS irritants_NNS ._. 
Hair_NN coloring_NN is_VBZ the_DT task_NN most_RBS often_RB practiced_VBN among_IN the_DT chemical_NN services_NNS ,_, more_JJR than_IN permanente_NN waving_VBG and_CC hair_NN bleaching_NN ._. 
According_VBG to_TO Kersemaekers_NNP ,_, however_RB ,_, hairdressers_NNS tend_VBP to_TO overestimate_VB their_PRP$ work_NN load_NN ;_: also_RB ,_, they_PRP do_VBP not_RB know_VB accurately_RB the_DT type_NN of_IN ventilation_NN in_IN their_PRP$ facility_NN ._. 
While_IN the_DT observed_JJ greater_JJR personal_JJ exposure_NN values_NNS ,_, as_IN opposed_VBN to_TO H_NNP 2_CD O_NNP 2_CD and_CC NH_NNP 3_CD workplace_JJ concentrations_NNS ,_, were_VBD expected_VBN ,_, in_IN accord_NN with_IN the_DT `_`` personal_JJ cloud_NN '_'' concept_NN ,_, we_PRP found_VBD opposite_JJ results_NNS for_IN H_NNP 2_CD S_NNP 2_CD O_NNP 8_CD ._. 
For_IN the_DT American_NNP Society_NNP of_IN Heating_NN Refrigerating_VBG and_CC Air_NNP Conditioning_NNP Engineers_NNP ,_, ventilation_NN rates_NNS in_IN beauty_NN salons_NNS should_MD ensure_VB values_NNS of_IN 20_CD cubic_JJ feet\/minute\/person_NN ,_, and_CC 7_CD ._. 
5cfm\/person_JJ for_IN barber_NN shops_NNS -LRB-_-LRB- minimum_JJ ventilation_NN rates_NNS breathing_VBG zone_NN -RRB-_-RRB- ._. 
Our_PRP$ results_NNS for_IN personal_JJ exposures_NNS to_TO ammonia_VB show_NN maximum_NN values_VBZ similar_JJ to_TO those_DT described_VBN by_IN Hollund_NNP et_NNP al_NNP for_IN dyeing_VBG and_CC waving_VBG -LRB-_-LRB- 4_CD ._. 
Although_IN the_DT 2_CD minutes_NNS spot_NN exposure_NN measurements_NNS found_VBN by_IN Van_NNP der_NNP Wal_NNP are_VBP very_RB high_JJ compared_VBN to_TO our_PRP$ values_NNS ,_, their_PRP$ ambient_JJ air_NN measurements_NNS are_VBP similar_JJ to_TO ours_PRP ._. 
It_PRP should_MD be_VB noted_VBN that_IN all_PDT these_DT results_NNS were_VBD below_IN the_DT French_NNP and_CC Belgium_NNP TLVs_NNP for_IN ammonia_NN -LRB-_-LRB- 7_CD and_CC 14_CD mg\/m3_CD ,_, respectively_RB -RRB-_-RRB- 
5and_CD 1_CD ._. 
French_NNP and_CC Belgium_NNP TLVs_NNP ,_, NIOSH_NNP REL_NNP TWA_NNP ,_, OSHA_NNP PEL_NNP TWA_NNP for_IN H_NNP 2_CD O_NNP 2_CD are_VBP 1_CD ._. 
4times_NNS greater_JJR than_IN our_PRP$ maximum_NN value_NN in_IN technical_JJ areas_NNS ,_, during_IN the_DT winter_NN period_NN measurements_NNS 
Although_IN the_DT 2_CD minutes_NNS spot_NN exposure_NN measurements_NNS found_VBN by_IN Van_NNP der_NNP Wal_NNP are_VBP very_RB high_JJ compared_VBN to_TO our_PRP$ values_NNS ,_, their_PRP$ ambient_JJ air_NN measurements_NNS are_VBP similar_JJ to_TO ours_PRP ._. 
It_PRP should_MD be_VB noted_VBN that_IN all_PDT these_DT results_NNS were_VBD below_IN the_DT French_NNP and_CC Belgium_NNP TLVs_NNP for_IN ammonia_NN -LRB-_-LRB- 7_CD and_CC 14_CD mg\/m3_CD ,_, respectively_RB -RRB-_-RRB- 
To_TO our_PRP$ knowledge_NN ,_, there_EX is_VBZ no_DT TLV_NNP for_IN persulfates_NNS as_IN a_DT whole_NN ;_: a_DT persulfate_JJ ammonium_NN TLV_NNP of_IN 0_CD ._. 
It_PRP should_MD be_VB noted_VBN ,_, however_RB ,_, that_IN the_DT former_JJ stem_NN from_IN short_JJ periods_NNS measurements_NNS ,_, focused_VBN in_IN particular_JJ when_WRB mixtures_NNS of_IN hairdressing_NN products_NNS were_VBD made_VBN ,_, while_IN our_PRP$ data_NNS correspond_VBP to_TO shift_VB averages_NNS over_IN all_DT daily_JJ activities_NNS ._. 
1mg\/m3_NNP has_VBZ been_VBN set_VBN by_IN the_DT US_NNP ACGIH_NNP and_CC in_IN Belgium_NNP ._. 
Conclusion_NN Ventilation_NN is_VBZ not_RB frequent_JJ in_IN the_DT study_NN hairdressing_NN salons_NNS ._. 
Manipulation_NN of_IN bleaching_NN products_NNS ,_, among_IN other_JJ chemical_JJ substances_NNS used_VBN in_IN the_DT hairdressing_NN process_NN ,_, yields_NNS exposure_NN to_TO airways_NNS irritants_NNS ._. 
-Chemical_JJ analyses_NNS methods_NNS For_IN analyses_NNS of_IN hydrogen_NN peroxide_NN ,_, quartz_NN fiber_NN filters_NNS were_VBD impregnated_VBN with_IN 210_CD 
Also_RB ,_, the_DT maximum_NN concentrations_NNS measured_VBN in_IN the_DT hairdressing_NN laboratory_NN were_VBD 2_CD ._. 
6times_NNS higher_JJR than_IN ours_PRP in_IN customer_NN salons_NNS ._. 
4times_NNS greater_JJR than_IN our_PRP$ maximum_NN value_NN in_IN technical_JJ areas_NNS ,_, during_IN the_DT winter_NN period_NN measurements_NNS 
These_DT results_NNS are_VBP worrisome_JJ since_IN persulfate_JJ salts_NNS are_VBP important_JJ asthma_NN causal_JJ agents_NNS 
7milliMole_NNP of_IN sodium_NN carbonate_NN ,_, 0_CD ._. 
The_DT analyses_NNS used_VBD ionchromatography_NN ,_, Dionex_NNP ,_, model_NN DX_NNP 600_CD ,_, Dionex_NNP CS12_NNP column_NN with_IN ,_, as_IN eluents_NNS :_: carbonate\/bicarbonate_NN -LRB-_-LRB- 2_CD ._. 
3milliMole_CD of_IN sodium_NN bicarbonate_NN -RRB-_-RRB- at_IN a_DT flow_NN of_IN 1_CD ml\/min_NN ._. 
Detection_NN limits_NNS were_VBD 0_CD ._. 
006_CD mg\/m_NN 3_CD ,_, 0_CD ._. 
0005_CD mg\/m_NN 3_CD and_CC 0_CD ._. 
003_CD mg\/m_NN 3_CD for_IN H_NNP 2_CD O_NNP 2_CD ,_, H_NNP 2_CD S_NNP 2_CD O_NNP 8_CD and_CC NH_NNP 3_CD respectively_RB ._. 
First_JJ ,_, occupational_JJ health_NN is_VBZ not_RB regarded_VBN as_IN of_IN serious_JJ concern_NN in_IN this_DT population_NN of_IN teenagers_NNS ._. 
Discussion_NN Although_IN a_DT larger_JJR sample_NN for_IN the_DT exposure_NN study_NN population_NN was_VBD expected_VBN ,_, achieving_VBG this_DT objective_NN was_VBD difficult_JJ for_IN many_JJ reasons_NNS ._. 
Appreciation_NN of_IN respiratory_JJ diseases_NNS prevention_NN was_VBD low_JJ among_IN apprentices_NNS ,_, an_DT observation_NN also_RB made_VBN by_IN Wong_NNP et_FW al_FW among_IN hairdressing_NN students_NNS 
In_IN order_NN to_TO minimize_VB recall_NN bias_NN ,_, individual_JJ tasks_NNS we_PRP explored_VBD for_IN a_DT typical_JJ weekday_NN ,_, to_TO be_VB chosen_VBN within_IN the_DT ongoing_JJ week_NN ;_: it_PRP was_VBD frequently_RB the_DT previous_JJ work_NN day_NN ._. 
We_PRP did_VBD not_RB attempt_VB to_TO study_VB the_DT busiest_JJS day_NN ,_, as_IN Labreche_NNP et_FW al_FW did_VBD ;_: however_RB ,_, the_DT number_NN of_IN tasks_NNS that_WDT are_VBP accomplished_VBN in_IN our_PRP$ study_NN is_VBZ in_IN the_DT same_JJ order_NN as_IN those_DT they_PRP reported_VBD ._. 
Hair_NN coloring_NN is_VBZ the_DT task_NN most_RBS often_RB practiced_VBN among_IN the_DT chemical_NN services_NNS ,_, more_JJR than_IN permanente_NN waving_VBG and_CC hair_NN bleaching_NN ._. 
All_DT samplers_NNS -LRB-_-LRB- environmental_JJ and_CC personal_JJ exposure_NN -RRB-_-RRB- were_VBD stopped_VBN during_IN the_DT lunch_NN break_NN in_IN case_NN it_PRP took_VBD place_NN out_IN of_IN the_DT salon_NN ._. 
-Chemical_JJ analyses_NNS methodsFor_NNP analyses_NNS of_IN hydrogen_NN peroxide_NN ,_, quartz_NN fiber_NN filters_NNS were_VBD impregnated_VBN with_IN 210_CD 
-Air_JJ sampling_NN Personal_JJ exposure_NN measurements_NNS were_VBD done_VBN during_IN a_DT complete_JJ 5_CD to_TO 8_CD hours_NNS work_NN shift_NN ,_, the_DT apprentices_NNS carrying_VBG the_DT sampler_NN installed_VBN in_IN a_DT rucksack_NN ;_: sampling_VBG heads_NNS were_VBD near_IN the_DT breathing_NN zone_NN ._. 
The_DT Harvard_NNP Chempass_NNP sampler_NN was_VBD used_VBN during_IN the_DT first_JJ year_NN measurements_NNS -LRB-_-LRB- winter_NN and_CC summer_NN 2004_CD ;_: 8_CD measurements_NNS -RRB-_-RRB- ,_, when_WRB only_RB two_CD compounds_NNS were_VBD measured_VBN -LRB-_-LRB- persulfate_NN and_CC ammonia_NN -RRB-_-RRB- ,_, a_DT portable_JJ pump_NN BGI_NNP -LRB-_-LRB- model_NN 400_CD -RRB-_-RRB- providing_VBG an_DT air_NN flow_NN of_IN 1_CD ._. 
8l\/min_CD in_IN each_DT head_NN ._. 
For_IN practical_JJ reasons_NNS -LRB-_-LRB- weight_NN of_IN the_DT BGI_NNP pump_NN -RRB-_-RRB- ,_, Gillian_NNP pumps_NNS were_VBD used_VBN the_DT second_JJ year_NN -LRB-_-LRB- winter_NN and_CC summer_NN 2005_CD -RRB-_-RRB- ,_, with_IN a_DT 1_CD l\/min_NN airflow_NN for_IN the_DT three_CD compounds_NNS ._. 
Among_IN the_DT variety_NN of_IN chemicals_NNS used_VBN in_IN the_DT hairdressing_NN process_NN ,_, three_CD compounds_NNS were_VBD chosen_VBN after_IN review_NN of_IN the_DT literature_NN :_: ammonia_NN -LRB-_-LRB- NH_NNP 3_CD -RRB-_-RRB- ,_, hydrogen_NN peroxide_NN -LRB-_-LRB- H_NNP 2_CD O_NNP 2_CD -RRB-_-RRB- and_CC persulfates_NNS -LRB-_-LRB- H_NNP 2_CD S_NNP 2_CD 0_CD 8_CD -RRB-_-RRB- ._. 
Hair_NN dyeing_NN formulations_NNS belong_VBP to_TO three_CD categories_NNS used_VBN for_IN temporary_JJ ,_, semi-permanent_JJ and_CC permanent_JJ hair_NN coloring_NN ._. 
Colours_NNS of_IN temporary_JJ dyes_NNS are_VBP readily_RB removable_JJ with_IN a_DT single_JJ shampoo_NN ._. 
The_DT coloring_VBG effects_NNS of_IN the_DT semi-permanent_JJ dyes_NNS gradually_RB fade_VBP over_IN a_DT period_NN of_IN 4_CD to_TO 6_CD weeks_NNS ,_, following_VBG the_DT levels_NNS of_IN hydrogen_NN peroxide_NN ,_, ammonia_NN and_CC artificial_JJ color_NN molecules_NNS that_WDT have_VBP been_VBN applied_VBN ._. 
Permanent_JJ hair_NN dyes_NNS ,_, also_RB called_VBD oxidative_JJ hair_NN dyes_NNS ,_, contain_VBP adjusting_VBG agents_NNS such_JJ ammonia_NN and_CC a_DT stabilised_JJ solution_NN of_IN hydrogen_NN peroxide_NN ._. 
Oxidative_JJ hair_NN dyes_NNS are_VBP resistant_JJ to_TO fading_JJ by_IN shampooing_VBG ._. 
Hair_NN bleaches_NNS contain_VBP ammonium_NN ,_, sodium_NN and_CC potassium_NN persulfates_NNS ._. 
The_DT active_JJ ingredients_NNS are_VBP persulfates_NNS which_WDT are_VBP mixed_JJ with_IN an_DT oxidant_NN -LRB-_-LRB- hydrogen_NN peroxide_NN -RRB-_-RRB- just_RB before_IN usage_NN ._. 
They_PRP contain_VBP salts_NNS of_IN thioglycolic_JJ acid_NN and_CC hydrogen_NN peroxide_NN ._. 
Permanent_JJ waving_VBG chemicals_NNS are_VBP of_IN two_CD types_NNS :_: alkaline_JJ or_CC slightly_RB acidic_JJ water_NN solutions_NNS ._. 
Like_IN for_IN hair_NN bleaching_NN ,_, ammonia_NN is_VBZ added_VBN to_TO enhance_VB hair_NN penetration_NN ._. 
As_IN a_DT result_NN ,_, ammonia_NN and_CC hydrogen_NN peroxide_NN are_VBP ingredients_NNS of_IN permanent_JJ waves_NNS ,_, hair_NN dyes_NNS and_CC hair_NN bleaching_NN ._. 
The_DT study_NN by_IN Leino_NNP et_FW al_FW aimed_VBN at_IN measuring_VBG peak_NN concentrations_NNS during_IN the_DT process_NN of_IN dyeing_NN ,_, permanenting_NN and_CC bleaching_NN ;_: it_PRP shows_VBZ values_NNS 1_CD ._. 
3times_NNS smaller_JJR than_IN our_PRP$ maximum_JJ personal_JJ exposure_NN measurements_NNS 
6and_CD 21_CD ._. 
Our_PRP$ average_JJ workplace_NN concentrations_NNS are_VBP also_RB respectively_RB 6_CD ._. 
8times_NNS greater_JJR than_IN the_DT peak_NN values_NNS found_VBN by_IN Leino_NNP et_FW al_FW during_IN mixing_VBG of_IN bleaching_NN powder_NN ._. 
1times_NNS higher_JJR than_IN those_DT found_VBN in_IN the_DT small_JJ and_CC large_JJ salons_NNS they_PRP studied_VBD 
1times_NNS higher_JJR than_IN those_DT found_VBN in_IN the_DT small_JJ and_CC large_JJ salons_NNS they_PRP studied_VBD 
7%_CD among_IN 116_CD apprentices_NNS 
The_DT prevalence_NN of_IN occupational_JJ asthma_NN was_VBD 1_CD ._. 
Variability_NN of_IN the_DT peak_JJ expiratory_JJ flow_NN was_VBD assessed_VBN in_IN Florence_NNP ,_, Italy_NNP ,_, across_IN 10_CD days_NNS and_CC was_VBD associated_VBN with_IN job_NN tasks_NNS ,_, with_IN influences_NNS of_IN gender_NN and_CC smoking_NN habits_NNS 
Health_NNP studies_NNS among_IN apprentices_NNS are_VBP sparse_JJ ,_, however_RB ._. 
Hairdressing_VBG apprentices_NNS experience_NN exposure_NN to_TO the_DT same_JJ substances_NNS during_IN their_PRP$ training_NN activities_NNS ._. 
Variability_NN of_IN the_DT peak_JJ expiratory_JJ flow_NN was_VBD assessed_VBN in_IN Florence_NNP ,_, Italy_NNP ,_, across_IN 10_CD days_NNS and_CC was_VBD associated_VBN with_IN job_NN tasks_NNS ,_, with_IN influences_NNS of_IN gender_NN and_CC smoking_NN habits_NNS 
Exposure_NN studies_NNS in_IN hairdressing_NN salons_NNS are_VBP few_JJ ._. 
Hairdressing_NN is_VBZ described_VBN as_IN an_DT occupation_NN at_IN risk_NN of_IN asthma_NN 
CO_IN 2_CD concentrations_NNS and_CC levels_NNS for_IN ammonia_NN and_CC ethanol_NN were_VBD found_VBN high_RB in_IN absence_NN of_IN mechanical_JJ ventilation_NN 
Among_IN the_DT variety_NN of_IN chemicals_NNS used_VBN in_IN the_DT hairdressing_NN process_NN ,_, three_CD compounds_NNS were_VBD chosen_VBN after_IN review_NN of_IN the_DT literature_NN :_: ammonia_NN -LRB-_-LRB- NH_NNP 3_CD -RRB-_-RRB- ,_, hydrogen_NN peroxide_NN -LRB-_-LRB- H_NNP 2_CD O_NNP 2_CD -RRB-_-RRB- and_CC persulfates_NNS -LRB-_-LRB- H_NNP 2_CD S_NNP 2_CD 0_CD 8_CD -RRB-_-RRB- ._. 
Hair_NN dyeing_NN formulations_NNS belong_VBP to_TO three_CD categories_NNS used_VBN for_IN temporary_JJ ,_, semi-permanent_JJ and_CC permanent_JJ hair_NN coloring_NN ._. 
Colours_NNS of_IN temporary_JJ dyes_NNS are_VBP readily_RB removable_JJ with_IN a_DT single_JJ shampoo_NN ._. 
The_DT coloring_VBG effects_NNS of_IN the_DT semi-permanent_JJ dyes_NNS gradually_RB fade_VBP over_IN a_DT period_NN of_IN 4_CD to_TO 6_CD weeks_NNS ,_, following_VBG the_DT levels_NNS of_IN hydrogen_NN peroxide_NN ,_, ammonia_NN and_CC artificial_JJ color_NN molecules_NNS that_WDT have_VBP been_VBN applied_VBN ._. 
Permanent_JJ hair_NN dyes_NNS ,_, also_RB called_VBD oxidative_JJ hair_NN dyes_NNS ,_, contain_VBP adjusting_VBG agents_NNS such_JJ ammonia_NN and_CC a_DT stabilised_JJ solution_NN of_IN hydrogen_NN peroxide_NN ._. 
Oxidative_JJ hair_NN dyes_NNS are_VBP resistant_JJ to_TO fading_JJ by_IN shampooing_VBG ._. 
Hair_NN bleaches_NNS contain_VBP ammonium_NN ,_, sodium_NN and_CC potassium_NN persulfates_NNS ._. 
The_DT active_JJ ingredients_NNS are_VBP persulfates_NNS which_WDT are_VBP mixed_JJ with_IN an_DT oxidant_NN -LRB-_-LRB- hydrogen_NN peroxide_NN -RRB-_-RRB- just_RB before_IN usage_NN ._. 
They_PRP contain_VBP salts_NNS of_IN thioglycolic_JJ acid_NN and_CC hydrogen_NN peroxide_NN ._. 
Permanent_JJ waving_VBG chemicals_NNS are_VBP of_IN two_CD types_NNS :_: alkaline_JJ or_CC slightly_RB acidic_JJ water_NN solutions_NNS ._. 
Like_IN for_IN hair_NN bleaching_NN ,_, ammonia_NN is_VBZ added_VBN to_TO enhance_VB hair_NN penetration_NN ._. 
As_IN a_DT result_NN ,_, ammonia_NN and_CC hydrogen_NN peroxide_NN are_VBP ingredients_NNS of_IN permanent_JJ waves_NNS ,_, hair_NN dyes_NNS and_CC hair_NN bleaching_NN ._. 
In_IN the_DT study_NN by_IN Hollund_NNP et_FW al_FW ._. 
Other_JJ differences_NNS across_IN studies_NNS may_MD be_VB due_JJ to_TO exposure_NN sampling_VBG designs_NNS and_CC stem_NN from_IN the_DT fact_NN that_IN working_VBG conditions_NNS may_MD vary_VB across_IN study_NN locations_NNS ._. 
,for_JJ example_NN ,_, measurements_NNS were_VBD done_VBN during_IN the_DT phase_NN of_IN preparation_NN of_IN the_DT technique_NN ,_, with_IN a_DT view_NN to_TO assess_VB peak_NN concentrations_NNS ,_, also_RB taking_VBG into_IN account_NN certain_JJ parameters_NNS of_IN ventilation_NN ._. 
We_PRP found_VBD that_IN more_JJR than_IN half_NN of_IN technical_JJ areas_NNS did_VBD not_RB have_VB ventilation_NN systems_NNS nor_CC did_VBD they_PRP open_JJ outside_NN -LRB-_-LRB- through_IN a_DT door_NN or_CC a_DT window_NN -RRB-_-RRB- ._. 
5mg\/m_CD 3_CD during_IN our_PRP$ `_`` cold_JJ period_NN '_'' -RRB-_-RRB- but_CC Hollund_NNP et_NNP al_NNP found_VBD levels_NNS up_IN to_TO 10_CD mg\/m_NN 3_CD during_IN bleaching_NN ,_, in_IN absence_NN of_IN exhaust_NN ventilation_NN ._. 
Also_RB ,_, while_IN average_JJ exposure_NN values_NNS were_VBD greater_JJR than_IN in_IN our_PRP$ study_NN ,_, workplace_JJ ambient_JJ concentrations_NNS in_IN both_DT studies_NNS are_VBP close_JJ ._. 
The_DT study_NN by_IN Leino_NNP et_FW al_FW aimed_VBN at_IN measuring_VBG peak_NN concentrations_NNS during_IN the_DT process_NN of_IN dyeing_NN ,_, permanenting_NN and_CC bleaching_NN ;_: it_PRP shows_VBZ values_NNS 1_CD ._. 
Ethanol_NN was_VBD used_VBN to_TO categorize_VB hairdressing_NN workplace_NN concentrations_NNS according_VBG to_TO ventilation_NN levels_NNS and_CC intensity_NN of_IN technical_JJ services_NNS 
3times_NNS smaller_JJR than_IN our_PRP$ maximum_JJ personal_JJ exposure_NN measurements_NNS 
14_CD 
4mg\/m_CD 3_CD ,_, during_IN 2_CD minutes_NNS spot_NN exposure_NN measurements_NNS -RRB-_-RRB- ._. 
14_CD 
A1992_CD study_NN showed_VBD that_IN workplace_JJ concentrations_NNS of_IN phenylenediamine_NN were_VBD below_IN the_DT ACGIH_NNP TLV-TWA_NNP 
Exposure_NN studies_NNS in_IN hairdressing_NN salons_NNS are_VBP few_JJ ._. 
Hairdressing_NN is_VBZ described_VBN as_IN an_DT occupation_NN at_IN risk_NN of_IN asthma_NN 
Given_VBN the_DT variety_NN of_IN chemical_NN substances_NNS that_WDT are_VBP used_VBN ,_, some_DT authors_NNS have_VBP measured_VBN tracer_NN agents_NNS such_JJ as_IN hydrogen_NN peroxide_NN ,_, ammonia_NN ,_, volatile_JJ organic_JJ compounds_NNS -LRB-_-LRB- toluene_NN ,_, ethanol_NN ,_, isopropanol_NN ,_, ether_NN ,_, diaminotoluene_NN ,_, phenylenediamine_NN -RRB-_-RRB- and_CC carbon_NN dioxide_NN 
Onset_NN of_IN symptoms_NNS occurs_VBZ after_IN repeated_JJ exposure_NN to_TO chemicals_NNS and_CC allergens_NNS in_IN the_DT work_NN environment_NN 
Several_JJ constituents_NNS of_IN hair_NN care_NN products_NNS are_VBP airway_JJ irritants_NNS and_CC may_MD induce_VB respiratory_JJ conditions_NNS ,_, including_VBG impairment_NN of_IN the_DT pulmonary_JJ function_NN and_CC chronic_NN bronchitis_NN 
Hairdressers_NNS are_VBP exposed_VBN to_TO a_DT variety_NN of_IN chemical_NN agents_NNS as_IN a_DT result_NN of_IN usage_NN of_IN several_JJ hair_NN cosmetic_NN products_NNS such_JJ as_IN hair_NN dyes_NNS ,_, permanent_JJ wave_NN solutions_NNS and_CC bleaches_NNS ._. 
Several_JJ constituents_NNS of_IN hair_NN care_NN products_NNS are_VBP airway_JJ irritants_NNS and_CC may_MD induce_VB respiratory_JJ conditions_NNS ,_, including_VBG impairment_NN of_IN the_DT pulmonary_JJ function_NN and_CC chronic_NN bronchitis_NN 
Background_NNP Occupational_NNP asthma_NN is_VBZ caused_VBN by_IN sensitisation_NN to_TO an_DT agent_NN inhaled_VBN in_IN the_DT workplace_NN ._. 
As_IN a_DT consequence_NN ,_, young_JJ apprentices_NNS and_CC senior_JJ hairdressers_NNS experience_VBP substantial_JJ exposure_NN to_TO known_VBN airways_NNS irritants_NNS ._. 
Onset_NN of_IN symptoms_NNS occurs_VBZ after_IN repeated_JJ exposure_NN to_TO chemicals_NNS and_CC allergens_NNS in_IN the_DT work_NN environment_NN 
Background_NNP Occupational_NNP asthma_NN is_VBZ caused_VBN by_IN sensitisation_NN to_TO an_DT agent_NN inhaled_VBN in_IN the_DT workplace_NN ._. 
As_IN a_DT consequence_NN ,_, young_JJ apprentices_NNS and_CC senior_JJ hairdressers_NNS experience_VBP substantial_JJ exposure_NN to_TO known_VBN airways_NNS irritants_NNS ._. 
Onset_NN of_IN symptoms_NNS occurs_VBZ after_IN repeated_JJ exposure_NN to_TO chemicals_NNS and_CC allergens_NNS in_IN the_DT work_NN environment_NN 
Onset_NN of_IN symptoms_NNS occurs_VBZ after_IN repeated_JJ exposure_NN to_TO chemicals_NNS and_CC allergens_NNS in_IN the_DT work_NN environment_NN 
Hairdressers_NNS are_VBP exposed_VBN to_TO a_DT variety_NN of_IN chemical_NN agents_NNS as_IN a_DT result_NN of_IN usage_NN of_IN several_JJ hair_NN cosmetic_NN products_NNS such_JJ as_IN hair_NN dyes_NNS ,_, permanent_JJ wave_NN solutions_NNS and_CC bleaches_NNS ._. 
Several_JJ constituents_NNS of_IN hair_NN care_NN products_NNS are_VBP airway_JJ irritants_NNS and_CC may_MD induce_VB respiratory_JJ conditions_NNS ,_, including_VBG impairment_NN of_IN the_DT pulmonary_JJ function_NN and_CC chronic_NN bronchitis_NN 
Several_JJ constituents_NNS of_IN hair_NN care_NN products_NNS are_VBP airway_JJ irritants_NNS and_CC may_MD induce_VB respiratory_JJ conditions_NNS ,_, including_VBG impairment_NN of_IN the_DT pulmonary_JJ function_NN and_CC chronic_NN bronchitis_NN 
1times_NNS higher_JJR than_IN those_DT found_VBN in_IN the_DT small_JJ and_CC large_JJ salons_NNS they_PRP studied_VBD 
The_DT phytoestrogens_NNS ,_, genistein_NN and_CC daidzein_NN ,_, are_VBP also_RB of_IN interest_NN ._. 
Asubsequent_JJ small_JJ ,_, case_NN control_NN study_NN of_IN patients_NNS in_IN New_NNP York_NNP found_VBD no_DT relationship_NN between_IN serum_JJ DDE_NNP levels_NNS and_CC premature_JJ delivery_NN ._. 
These_DT chemicals_NNS have_VBP inherent_JJ estrogenic_JJ activity_NN on_IN the_DT Er_NN 
These_DT chemicals_NNS have_VBP inherent_JJ estrogenic_JJ activity_NN on_IN the_DT Er_NN 
S._NNP A_NNP large_JJ ,_, retrospective_NN ,_, U._NNP DDT_NNP and_CC PCBs_NNS have_VBP also_RB been_VBN of_IN interest_NN in_IN the_DT pathogenesis_NN of_IN premature_JJ labor_NN and_CC have_VBP shown_VBN to_TO increase_VB myometrial_JJ contractility_NN in-vitro_NN 
One_CD obvious_JJ explanation_NN for_IN our_PRP$ results_NNS is_VBZ that_DT ,_, as_IN DDE_NNP is_VBZ no_RB longer_RBR in_IN widespread_JJ use_NN in_IN North_NNP America_NNP ._. 
Therefore_RB ,_, our_PRP$ subjects_NNS are_VBP not_RB exposed_VBN to_TO the_DT same_JJ levels_NNS of_IN this_DT toxicant_NN as_IN women_NNS delivering_VBG in_IN the_DT 1960_CD 's_POS who_WP had_VBD been_VBN the_DT subject_NN of_IN previous_JJ studies_NNS ._. 
In_IN our_PRP$ study_NN ,_, the_DT median_JJ DDE_NNP concentrations_NNS were_VBD lower_JJR :_: 0_CD ._. 
43_CD ng\/ml_JJ range_NN 0_CD ._. 
16_CD ,_, 2_CD ._. 
98_CD in_IN cases_NNS compared_VBN to_TO controls_NNS 0_CD ._. 
al._RB ._. 
However_RB ,_, the_DT levels_NNS we_PRP observed_VBD were_VBD substantially_RB lower_JJR than_IN those_DT reported_VBN by_IN Longnecker_NNP et_NNP ._. 
,where_VB the_DT majority_NN of_IN normal_JJ and_CC preterm_JJ birth_NN subjects_NNS had_VBD concentrations_NNS well_RB above_IN 15_CD ug\/l_NN 
Therefore_RB ,_, our_PRP$ results_NNS can_MD not_RB be_VB generalized_VBN to_TO regions_NNS where_WRB subjects_NNS can_MD be_VB anticipated_VBN as_IN having_VBG higher_JJR levels_NNS of_IN DDE_NNP ._. 
Furthermore_RB ,_, our_PRP$ study_NN ,_, unlike_IN Longnecker_NNP et_FW al_FW ,_, included_VBD only_JJ women_NNS with_IN spontaneous_JJ premature_JJ delivery_NN rather_RB than_IN all_DT premature_JJ births_NNS of_IN which_WDT one_CD third_JJ follow_VBP induced_JJ labor_NN ._. 
Indeed_RB ,_, Longnecker_NNP 's_POS study_NN ,_, also_RB ,_, identified_VBD that_IN having_VBG a_DT small_JJ for_IN gestational_JJ age_NN -LRB-_-LRB- SGA_NNP -RRB-_-RRB- fetus_NN was_VBD associated_VBN with_IN DDE_NNP levels_NNS ,_, even_RB with_IN the_DT preterm_NN cases_NNS removed_VBD ._. 
However_RB ,_, the_DT serum_NN samples_NNS were_VBD from_IN women_NNS delivering_VBG in_IN the_DT 1960_CD 's_POS when_WRB DDT_NNP use_NN was_VBD much_RB more_RBR prevalent_JJ ._. 
Asubsequent_JJ small_JJ ,_, case_NN control_NN study_NN of_IN patients_NNS in_IN New_NNP York_NNP found_VBD no_DT relationship_NN between_IN serum_JJ DDE_NNP levels_NNS and_CC premature_JJ delivery_NN ._. 
The_DT phytoestrogens_NNS ,_, genistein_NN and_CC daidzein_NN ,_, are_VBP also_RB of_IN interest_NN ._. 
These_DT chemicals_NNS have_VBP inherent_JJ estrogenic_JJ activity_NN on_IN the_DT Er_NN 
Discussion_NNP Our_NNP study_NN did_VBD not_RB demonstrate_VB an_DT association_NN between_IN spontaneous_JJ premature_JJ labor_NN and_CC serum_NN DDE_NN levels_NNS ._. 
Our_PRP$ results_NNS ,_, considered_VBN with_IN the_DT results_NNS of_IN another_DT case_NN control_NN study_NN on_IN a_DT contemporary_JJ population_NN ,_, would_MD suggest_VB that_IN DDE_NNP exposure_NN is_VBZ not_RB currently_RB a_DT risk_NN factor_NN for_IN prematurity_NN ._. 
One_CD obvious_JJ explanation_NN for_IN our_PRP$ results_NNS is_VBZ that_DT ,_, as_IN DDE_NNP is_VBZ no_RB longer_RBR in_IN widespread_JJ use_NN in_IN North_NNP America_NNP ._. 
Still_RB ,_, a_DT post-hoc_JJ power_NN calculation_NN suggests_VBZ that_IN we_PRP had_VBD 100_CD %_NN power_NN to_TO detect_VB a_DT 50_CD %_NN increase_NN in_IN DDE_NNP levels_NNS in_IN cases_NNS compared_VBN to_TO controls_NNS ._. 
Our_PRP$ results_NNS were_VBD also_RB similar_JJ to_TO those_DT of_IN the_DT other_JJ contemporary_JJ case_NN control_NN study_NN in_IN which_WDT the_DT median_JJ DDE_NNP levels_NNS were_VBD 1_CD ._. 
3ng\/ml_JJ range_NN 0_CD ._. 
5,_CD 17_CD ._. 
9in_JJ cases_NNS and_CC 1_CD ._. 
35_CD range_NN ng\/ml_NN 0_CD ._. 
6,_CD 4_CD ._. 
0in_CD controls_NNS ._. 
However_RB ,_, the_DT levels_NNS we_PRP observed_VBD were_VBD substantially_RB lower_JJR than_IN those_DT reported_VBN by_IN Longnecker_NNP et_NNP ._. 
Furthermore_RB ,_, the_DT oral_JJ administration_NN of_IN phytoestrogens_NNS have_VBP been_VBN reported_VBN to_TO reverse_VB the_DT anti-estrogenic_JJ actions_NNS of_IN clomiphene_NN citrate_NN on_IN the_DT endometrial_JJ lining_NN 
Phytoestrogens_NNS have_VBP also_RB been_VBN associated_VBN with_IN regulation_NN of_IN the_DT HOX_NNP genes_NNS that_WDT are_VBP particularly_RB of_IN interest_NN in_IN pregnancy_NN 
Furthermore_RB ,_, the_DT oral_JJ administration_NN of_IN phytoestrogens_NNS have_VBP been_VBN reported_VBN to_TO reverse_VB the_DT anti-estrogenic_JJ actions_NNS of_IN clomiphene_NN citrate_NN on_IN the_DT endometrial_JJ lining_NN ._. 
DDT_NNP and_CC PCBs_NNS have_VBP also_RB been_VBN of_IN interest_NN in_IN the_DT pathogenesis_NN of_IN premature_JJ l_NN 
Previous_JJ work_NN at_IN our_PRP$ center_NN had_VBD documented_VBN significant_JJ levels_NNS of_IN the_DT DDT_NNP metabolite_NN DDE_NNP in_IN maternal_JJ serum_NN in_IN a_DT cross_JJ sectional_JJ survey_NN 
We_PRP had_VBD deuterated_VBN internal_JJ standards_NNS for_IN daidzein_NN and_CC genistein_NN and_CC internal_JJ standards_NNS for_IN DDE_NNP in_IN which_WDT the_DT recovery_NN was_VBD close_RB to_TO 100_CD %_NN ._. 
The_DT sample_NN size_NN was_VBD based_VBN on_IN a_DT cross_JJ sectional_JJ survey_NN of_IN women_NNS in_IN the_DT second_JJ trimester_NN of_IN pregnancy_NN ._. 
In_IN that_DT study_NN ,_, the_DT mean_JJ serum_NN concentration_NN of_IN daidzein_NN was_VBD 4_CD ._. 
75_CD ng\/ml_NN ,_, with_IN a_DT standard_JJ error_NN of_IN 3_CD ._. 
Methods_NNS Cases_NNS were_VBD defined_VBN as_IN primiparous_JJ women_NNS having_VBG a_DT premature_JJ delivery_NN at_IN greater_JJR than_IN 23_CD weeks_NNS and_CC less_JJR than_IN 35_CD weeks_NNS gestation_NN following_VBG spontaneous_JJ labor_NN ._. 
The_DT gestational_JJ age_NN of_IN 
While_IN we_PRP accept_VBP this_DT potential_JJ criticism_NN ,_, we_PRP point_VBP out_RP that_IN not_RB only_RB were_VBD the_DT differences_NNS we_PRP observed_VBD not_RB statistically_RB significant_JJ but_CC that_IN our_PRP$ point_NN estimates_NNS were_VBD also_RB very_RB close_JJ to_TO the_DT null_JJ value_NN ._. 
However_RB ,_, it_PRP is_VBZ still_RB possible_JJ that_IN the_DT effect_NN of_IN these_DT phytoestrogens_NNS may_MD be_VB mediated_VBN by_IN complex_JJ interactions_NNS with_IN other_JJ estrogenic_JJ compounds_NNS ,_, as_IN has_VBZ been_VBN indicated_VBN in_IN studies_NNS using_VBG the_DT rat_NN uterotrophic_JJ assay_NN ._. 
As_IN our_PRP$ study_NN was_VBD only_RB able_JJ to_TO examine_VB the_DT possible_JJ additive_JJ effects_NNS of_IN DDE_NNP and_CC genistein_NN and_CC daidzein_NN we_PRP can_MD not_RB rule_VB out_RP the_DT possible_JJ interactions_NNS with_IN other_JJ agents_NNS ._. 
It_PRP would_MD be_VB difficult_JJ and_CC expensive_JJ to_TO have_VB performed_VBN serial_JJ measurements_NNS and_CC ,_, as_IN it_PRP is_VBZ difficult_JJ to_TO predict_VB the_DT onset_NN of_IN premature_JJ labor_NN ,_, even_RB a_DT prospective_JJ study_NN would_MD have_VB similar_JJ limitations_NNS ._. 
Genistein_NN and_CC diadzein_NN levels_NNS appear_VBP to_TO peak_VB approximately_RB 6_CD hours_NNS after_IN intake_NN and_CC their_PRP$ half_NN lives_NNS are_VBP approximately_RB 6_CD and_CC 8_CD hours_NNS respectively_RB ._. 
Inevitably_RB ,_, the_DT subject_NN 's_POS levels_NNS will_MD vary_VB depending_VBG on_IN their_PRP$ peak_NN level_NN and_CC time_NN from_IN their_PRP$ last_JJ ingestion_NN of_IN phytoestrogens_NNS ._. 
Furthermore_RB ,_, our_PRP$ study_NN is_VBZ the_DT only_RB one_CD we_PRP know_VBP of_IN that_DT has_VBZ restricted_VBN enrollment_NN to_TO primiparous_JJ subjects_NNS ._. 
As_IN prematurity_NN is_VBZ associated_VBN with_IN primiparity_NN and_CC previous_JJ pregnancy_NN and_CC breastfeeding_NN decreases_VBZ the_DT total_JJ body_NN DDE_NNP load_NN this_DT could_MD have_VB been_VBN an_DT unrecognized_JJ confounder_NN in_IN previous_JJ studies_NNS ._. 
Although_IN our_PRP$ previous_JJ work_NN had_VBD suggested_VBN that_IN the_DT placenta_NN and_CC uterus_NN are_VBP being_VBG exposed_VBN to_TO significant_JJ levels_NNS of_IN the_DT phytoestrogens_NNS daidzein_NN and_CC genistein_NN ,_, their_PRP$ levels_NNS were_VBD not_RB associated_VBN with_IN spontaneous_JJ premature_JJ delivery_NN ._. 
,where_VB the_DT majority_NN of_IN normal_JJ and_CC preterm_JJ birth_NN subjects_NNS had_VBD concentrations_NNS well_RB above_IN 15_CD ug\/l_NN 
Furthermore_RB ,_, our_PRP$ study_NN is_VBZ the_DT only_RB one_CD we_PRP know_VBP of_IN that_DT has_VBZ restricted_VBN enrollment_NN to_TO primiparous_JJ subjects_NNS ._. 
As_IN prematurity_NN is_VBZ associated_VBN with_IN primiparity_NN and_CC previous_JJ pregnancy_NN and_CC breastfeeding_NN decreases_VBZ the_DT total_JJ body_NN DDE_NNP load_NN this_DT could_MD have_VB been_VBN an_DT unrecognized_JJ confounder_NN in_IN previous_JJ studies_NNS ._. 
Although_IN our_PRP$ previous_JJ work_NN had_VBD suggested_VBN that_IN the_DT placenta_NN and_CC uterus_NN are_VBP being_VBG exposed_VBN to_TO significant_JJ levels_NNS of_IN the_DT phytoestrogens_NNS daidzein_NN and_CC genistein_NN ,_, their_PRP$ levels_NNS were_VBD not_RB associated_VBN with_IN spontaneous_JJ premature_JJ delivery_NN ._. 
After_IN recruiting_VBG a_DT case_NN ,_, the_DT next_JJ 10_CD women_NNS who_WP delivered_VBD a_DT term_NN infant_NN ,_, and_CC were_VBD within_IN 5_CD years_NNS of_IN age_NN of_IN the_DT case_NN subject_NN ,_, were_VBD approached_VBN until_IN two_CD controls_NNS were_VBD recruited_VBN ._. 
Only_RB primigravid_JJ subjects_NNS were_VBD included_VBN in_IN the_DT study_NN in_IN order_NN to_TO avoid_VB the_DT confounding_JJ problems_NNS that_WDT occur_VBP in_IN organochlorine_JJ exposure_NN from_IN the_DT substantial_JJ reduction_NN in_IN total_JJ body_NN burden_NN through_IN previous_JJ parturition_NN and_CC breast_NN feeding_NN ._. 
Women_NNS with_IN a_DT stillbirth_NN or_CC a_DT fetus_NN with_IN known_JJ congenital_JJ anomalies_NNS were_VBD not_RB included_VBN ._. 
Based_VBN on_IN our_PRP$ preliminary_JJ data_NNS ,_, we_PRP intended_VBD to_TO recruit_VB 26_CD cases_NNS and_CC 52_CD control_NN subjects_NNS ._. 
After_IN recruiting_VBG a_DT case_NN ,_, the_DT next_JJ 10_CD women_NNS who_WP delivered_VBD a_DT term_NN infant_NN ,_, and_CC were_VBD within_IN 5_CD years_NNS of_IN age_NN of_IN the_DT case_NN subject_NN ,_, were_VBD approached_VBN until_IN two_CD controls_NNS were_VBD recruited_VBN ._. 
Only_RB primigravid_JJ subjects_NNS were_VBD included_VBN in_IN the_DT study_NN in_IN order_NN to_TO avoid_VB the_DT confounding_JJ problems_NNS that_WDT occur_VBP in_IN organochlorine_JJ exposure_NN from_IN the_DT substantial_JJ reduction_NN in_IN total_JJ body_NN burden_NN through_IN previous_JJ parturition_NN and_CC breast_NN feeding_NN ._. 
Women_NNS with_IN a_DT stillbirth_NN or_CC a_DT fetus_NN with_IN known_JJ congenital_JJ anomalies_NNS were_VBD not_RB included_VBN ._. 
Based_VBN on_IN our_PRP$ preliminary_JJ data_NNS ,_, we_PRP intended_VBD to_TO recruit_VB 26_CD cases_NNS and_CC 52_CD control_NN subjects_NNS ._. 
Methods_NNS Cases_NNS were_VBD defined_VBN as_IN primiparous_JJ women_NNS having_VBG a_DT premature_JJ delivery_NN at_IN greater_JJR than_IN 23_CD weeks_NNS and_CC less_JJR than_IN 35_CD weeks_NNS gestation_NN following_VBG spontaneous_JJ labor_NN ._. 
The_DT gestational_JJ age_NN of_IN 
Therefore_RB ,_, endocrine_NN disruptors_NNS ,_, especially_RB those_DT that_WDT have_VBP estrogen_VBN like_IN effects_NNS ,_, may_MD have_VB a_DT role_NN in_IN preterm_NN labor_NN ._. 
The_DT phytoestrogens_NNS are_VBP of_IN increasing_VBG interest_NN owing_NN to_TO their_PRP$ estrogenic_JJ properties_NNS and_CC ubiquitous_JJ exposure_NN from_IN a_DT variety_NN of_IN foods_NNS and_CC the_DT ability_NN of_IN individuals_NNS to_TO alter_VB the_DT exposure_NN through_IN soy_NN supplementation_NN 
These_DT chemicals_NNS have_VBP been_VBN shown_VBN to_TO exert_VB estrogenicity_NN through_IN binding_JJ to_TO the_DT ErB_NNP receptor_NN ._. 
The_DT phytoestrogens_NNS are_VBP of_IN increasing_VBG interest_NN owing_NN to_TO their_PRP$ estrogenic_JJ properties_NNS and_CC ubiquitous_JJ exposure_NN from_IN a_DT variety_NN of_IN foods_NNS and_CC the_DT ability_NN of_IN individuals_NNS to_TO alter_VB the_DT exposure_NN through_IN soy_NN supplementation_NN 
These_DT chemicals_NNS have_VBP been_VBN shown_VBN to_TO exert_VB estrogenicity_NN through_IN binding_JJ to_TO the_DT ErB_NNP receptor_NN ._. 
The_DT phytoestrogens_NNS are_VBP of_IN increasing_VBG interest_NN owing_NN to_TO their_PRP$ estrogenic_JJ properties_NNS and_CC ubiquitous_JJ exposure_NN from_IN a_DT variety_NN of_IN foods_NNS and_CC the_DT ability_NN of_IN individuals_NNS to_TO alter_VB the_DT exposure_NN through_IN soy_NN supplementation_NN 
With_IN regard_NN to_TO pregnancy_NN ,_, genistein_NN and_CC daidzein_NN have_VBP been_VBN isolated_VBN in_IN amniotic_JJ fluid_NN with_IN evidence_NN of_IN transfer_NN from_IN the_DT mother_NN to_TO the_DT fetus_NN 
The_DT inability_NN to_TO identify_VB an_DT effect_NN may_MD be_VB related_VBN to_TO the_DT comparatively_RB low_JJ concentrations_NNS of_IN DDE_NNP in_IN our_PRP$ population_NN and_CC the_DT rapid_JJ and_CC variable_JJ reduction_NN of_IN phytoestrogens_NNS from_IN women_NNS in_IN labor_NN ._. 
BackgroundPremature_JJ delivery_NN occurs_VBZ after_IN spontaneous_JJ labor_NN in_IN approximately_RB 6_CD %_NN of_IN pregnancies_NNS -LRB-_-LRB- 
The_DT inability_NN to_TO identify_VB an_DT effect_NN may_MD be_VB related_VBN to_TO the_DT comparatively_RB low_JJ concentrations_NNS of_IN DDE_NNP in_IN our_PRP$ population_NN and_CC the_DT rapid_JJ and_CC variable_JJ reduction_NN of_IN phytoestrogens_NNS from_IN women_NNS in_IN labor_NN ._. 
BackgroundPremature_JJ delivery_NN occurs_VBZ after_IN spontaneous_JJ labor_NN in_IN approximately_RB 6_CD %_NN of_IN pregnancies_NNS -LRB-_-LRB- 
Progesterone_NNP is_VBZ widely_RB regarded_VBN as_IN promoting_VBG uterine_JJ quiescence_NN ._. 
The_DT pathophysiology_NN of_IN preterm_NN labor_NN is_VBZ not_RB entirely_RB clear_JJ but_CC reproductive_JJ hormones_NNS ,_, such_JJ as_IN progesterone_NN and_CC estrogen_NN appear_VBP to_TO have_VB a_DT role_NN ._. 
Estrogen_NNP ,_, on_IN the_DT other_JJ hand_NN ,_, may_MD promote_VB myometrial_JJ activation_NN with_IN increased_VBN receptivity_NN to_TO uterotonic_JJ agents_NNS by_IN up_RB regulating_VBG membrane_NN receptors_NNS and_CC gap_NN junctions_NNS ._. 
Therefore_RB ,_, endocrine_NN disruptors_NNS ,_, especially_RB those_DT that_WDT have_VBP estrogen_VBN like_IN effects_NNS ,_, may_MD have_VB a_DT role_NN in_IN preterm_NN labor_NN ._. 
With_IN regard_NN to_TO pregnancy_NN ,_, genistein_NN and_CC daidzein_NN have_VBP been_VBN isolated_VBN in_IN amniotic_JJ fluid_NN with_IN evidence_NN of_IN transfer_NN from_IN the_DT mother_NN to_TO the_DT fetus_NN 
With_IN regard_NN to_TO pregnancy_NN ,_, genistein_NN and_CC daidzein_NN have_VBP been_VBN isolated_VBN in_IN amniotic_JJ fluid_NN with_IN evidence_NN of_IN transfer_NN from_IN the_DT mother_NN to_TO the_DT fetus_NN 
Increased_VBN risk_NN of_IN colon_NN cancer_NN due_JJ to_TO exceedance_NN of_IN the_DT nitrate_JJ standard_NN in_IN drinking_NN water_NN We_PRP derive_VBP the_DT increased_VBN colon_NN cancer_NN risk_NN from_IN DeRoos_FW et_FW al._FW ._. 
,a_JJ case-control_JJ study_NN on_IN nitrate_NN in_IN public_JJ water_NN supplies_NNS in_IN Iowa_NNP ._. 
This_DT study_NN did_VBD not_RB find_VB an_DT association_NN between_IN colon_NN cancer_NN and_CC nitrate_NN for_IN the_DT total_JJ population_NN ,_, but_CC did_VBD find_VB such_JJ associations_NNS for_IN specific_JJ subgroups_NNS ._. 
2mg\/L_JJ ._. 
5mg\/L_JJ in_IN drinking_NN water_NN as_IN compared_VBN to_TO a_DT reference_NN group_NN below_IN 2_CD ._. 
4%_CD of_IN total_JJ incidence_NN -RRB-_-RRB- using_VBG the_DT assumption_NN based_VBN on_IN DeRoos_NNP et_FW al._FW ._. 
Morbidity_NN ,_, mortality_NN and_CC health_NN loss_NN due_JJ to_TO nitrate_VB induced_JJ colon_NN cancer_NN In_IN Table_NNP 2_CD we_PRP estimate_VBP the_DT number_NN of_IN additional_JJ colon_NN cancer_NN cases_NNS for_IN the_DT 11_CD member_NN states_NNS -LRB-_-LRB- excluding_VBG Greece_NNP because_IN no_DT cancer_NN registration_NN data_NNS were_VBD available_JJ -RRB-_-RRB- at_IN 4800_CD per_IN year_NN -LRB-_-LRB- 3_CD ._. 
that_IN for_IN individuals_NNS with_IN above_JJ median_JJ meat_NN consumption_NN ,_, exposure_NN to_TO drinking_NN water_NN with_IN 
In_IN view_NN of_IN the_DT uncertainty_NN about_IN the_DT health_NN impact_NN itself_PRP ,_, the_DT lower_JJR limit_NN of_IN the_DT health_NN cost_NN is_VBZ zero_CD ,_, and_CC in_IN line_NN with_IN the_DT lower_JJR limit_NN of_IN the_DT 95_CD %_NN confidence_NN interval_NN of_IN the_DT risk_NN increase_NN inferred_VBD from_IN DeRoos_FW et_FW al._FW ._. ._. 
Using_VBG the_DT subgroup_NN with_IN above_JJ median_JJ meat_NN consumption_NN to_TO quantify_VB the_DT risk_NN increase_NN of_IN colon_NN cancer_NN ,_, could_MD be_VB regarded_VBN as_IN a_DT worst_JJS case_NN approach_NN ._. 
In_IN an_DT ecologic_JJ study_NN ,_, Gulis_NNP et_NNP al._IN 5_CD mg\/L_NNP NO_UH 3_CD -RRB-_-RRB- ._. 
For_IN the_DT purpose_NN of_IN this_DT assessment_NN we_PRP assumed_VBD a_DT doubling_NN of_IN colon_NN cancer_NN incidence_NN for_IN above_JJ median_NN meat_NN consumers_NNS exposed_VBN to_TO a_DT NO_RB 3_CD -_: N_NNP concentration_NN exceeding_VBG 5_CD mg\/L_NNP -LRB-_-LRB- 22_CD ._. 
These_DT results_NNS are_VBP similar_JJ to_TO those_DT of_IN DeRoos_NNS 
Gulis_FW et_FW al._FW 2_CD mg\/L_NNP ,_, but_CC did_VBD find_VB nearly_RB a_DT doubling_NN of_IN the_DT relative_JJ risk_NN of_IN mortality_NN for_IN stomach_NN cancer_NN ._. 
state_NN that_IN these_DT different_JJ results_NNS may_MD be_VB caused_VBN by_IN using_VBG mortality_NN data_NNS ,_, which_WDT are_VBP a_DT function_NN of_IN both_DT incidence_NN and_CC changes_NNS in_IN survival_NN -LRB-_-LRB- e._FW g._FW because_IN of_IN developments_NNS in_IN medical_JJ diagnosis_NN and_CC treatment_NN -RRB-_-RRB- ._. 
The_DT studies_NNS by_IN Gulis_NNP et_FW al._FW ._. 
and_CC Morales-Suarez-Varela_NNP et_FW al._FW 
Present_JJ incidence_NN and_CC prevalence_NN of_IN colon_NN cancer_NN in_IN Europe_NNP Data_NNP were_VBD taken_VBN from_IN IARC_NNP 
http:\/\/www_NN ._. 
ikcnet_NN ._. 
Loss_NN of_IN healthy_JJ life_NN years_NNS and_CC life_NN years_NNS from_IN premature_JJ death_NN for_IN colon_NN cancer_NN We_PRP inferred_VBD loss_NN of_IN healthy_JJ life_NN years_NNS and_CC life_NN years_NNS due_JJ to_TO premature_JJ death_NN using_VBG data_NNS on_IN colon_NN cancer_NN incidence_NN and_CC mortality_NN per_IN five_CD year_NN age_NN class_NN between_IN 1989_CD and_CC 2006_CD provided_VBN by_IN the_DT Dutch_NNP Cancer_NNP Registry_NNP -LRB-_-LRB- 
Figure_NN 2_CD Increase_VB of_IN colon_NN cancer_NN incidence_NN by_IN drinking_NN water_NN nitrate_NN in_IN Iowa_NNP ._. 
did_VBD not_RB consider_VB dietary_JJ or_CC medical_JJ risk_NN factors_NNS ._. 
Increase_VB of_IN incidence_NN of_IN colon_NN cancer_NN -LRB-_-LRB- and_CC 95_CD %_NN confidence_NN intervals_NNS -RRB-_-RRB- in_IN Iowa_NNP public_JJ water_NN supply_NN ,_, for_IN subgroups_NNS with_IN above_IN and_CC below_IN median_JJ dietary_JJ and_CC medical_JJ risk_NN factors_NNS ,_, and_CC with_IN 1-10_CD years_NNS of_IN exposure_NN and_CC more_JJR than_IN 10_CD years_NNS of_IN exposure_NN to_TO NO3-concentrations_NNS in_IN drinking_NN water_NN exceeding_VBG 25_CD mg\/L_NNP NO3_NNP ,_, relative_JJ to_TO the_DT subgroup_NN with_IN no_DT exposure_NN -LRB-_-LRB- after_IN -RRB-_-RRB- ._. 
Relationship_NN between_IN nitrogen_NN leaching_NN and_CC nitrate_NN in_IN groundwater_NN First_JJ ,_, we_PRP investigated_VBD potential_JJ associations_NNS between_IN observed_JJ nitrate_JJ concentrations_NNS in_IN shallow_JJ aquifers_NNS and_CC estimates_NNS of_IN the_DT nitrogen_NN leaching_VBG from_IN agricultural_JJ land_NN ._. 
Present_JJ incidence_NN and_CC prevalence_NN of_IN colon_NN cancer_NN in_IN Europe_NNP Data_NNP were_VBD taken_VBN from_IN IARC_NNP 
Incidence_NN -LRB-_-LRB- World_NNP standard_NN age-adjusted_JJ -RRB-_-RRB- of_IN colon_NN cancer_NN in_IN 1992_CD in_IN Europe_NNP was_VBD 17_CD cases_NNS per_IN year_NN -LRB-_-LRB- per_IN 100,000_CD -RRB-_-RRB- ,_, prevalence_NN was_VBD 176_CD cases_NNS -LRB-_-LRB- per_IN 100,000_CD -RRB-_-RRB- ,_, making_VBG colon_NN cancer_NN one_CD of_IN the_DT most_RBS frequent_JJ cancer_NN sites_NNS ._. 
Boyle_NNP and_CC Ferlay_NNP 
Even_RB though_IN most_JJS nitrates_NNS in_IN drinking_NN water_NN come_VBN from_IN fertilizer_NN ,_, a_DT full_JJ analysis_NN would_MD have_VB to_TO consider_VB more_JJR than_IN just_RB the_DT passage_NN from_IN fertilizer_NN to_TO drinking_NN water_NN ._. 
Since_IN part_NN of_IN the_DT fertilizer_NN nitrogen_NN also_RB ends_VBZ up_RP as_IN emission_NN of_IN N2O_NNP ,_, NO2_NNP and_CC NH3_NNP to_TO the_DT atmosphere_NN ,_, the_DT damage_NN costs_NNS of_IN the_DT latter_NN would_MD have_VB to_TO be_VB included_VBN in_IN the_DT search_NN for_IN optimal_JJ nitrate_JJ abatement_NN -_: a_DT point_NN we_PRP take_VBP up_RP again_RB in_IN the_DT discussion_NN ._. 
Methods_NNS For_IN our_PRP$ assessment_NN we_PRP assume_VBP a_DT link_NN with_IN colon_NN cancer_NN as_IN working_VBG hypothesis_NNS to_TO provide_VB a_DT tentative_JJ assessment_NN of_IN health_NN loss_NN and_CC social_JJ cost_NN of_IN nitrate_NN in_IN drinking_NN water_NN in_IN the_DT European_NNP Union_NNP ._. 
3-RRB-_NN Inferred_VBN from_IN nine_CD data_NNS sets_NNS of_IN field_NN trials_NNS across_IN Europe_NNP ._. 
2-RRB-_NNP Range_NNP refers_VBZ to_TO range_NN of_IN values_NNS for_IN EU_NNP member_NN states_NNS ._. 
Since_IN part_NN of_IN the_DT fertilizer_NN or_CC manure_NN nitrogen_NN ends_VBZ up_RP as_IN emission_NN of_IN N2O_NNP ,_, NO2_NNP and_CC NH3_NNP to_TO the_DT atmosphere_NN 
The_DT health_NN impacts_NNS for_IN airborne_JJ NH_NNP 3_CD -_: compounds_NNS are_VBP very_RB uncertain_JJ and_CC unit_NN costs_NNS could_MD be_VB much_RB smaller_JJR ._. 
Using_VBG typical_JJ emission_NN factors_NNS for_IN NOx-N_NN from_IN fertilizer_NN -LRB-_-LRB- 0_CD ._. 
2-0_CD ._. 
6%_CD -RRB-_-RRB- and_CC NH_NNP 3_NNP -_: N_NNP -LRB-_-LRB- 1-3_CD %_NN for_IN Calcium_NN Ammonium_NN Nitrate_NNP which_WDT is_VBZ the_DT most_RBS common_JJ chemical_NN fertilizer_NN in_IN the_DT EU_NNP -RRB-_-RRB- mean_JJ damage_NN costs_NNS were_VBD derived_VBN for_IN the_DT EU_NNP per_IN kg_JJ applied_JJ fertilizer_NN N_NNP -LRB-_-LRB- Table_NNP 4_CD -RRB-_-RRB- ._. 
Schematic_JJ representation_NN of_IN a_DT method_NN to_TO assess_VB incidence_NN and_CC social_JJ cost_NN of_IN colon_NN cancer_NN induced_VBN by_IN drinking_NN water_NN nitrate_NN in_IN the_DT EU_NNP -LRB-_-LRB- rectangles_NNS for_IN external_JJ data_NNS ;_: rounded_VBD rectangles_NNS for_IN assessment_NN results_NNS -RRB-_-RRB- ._. 
Present_JJ incidence_NN and_CC prevalence_NN of_IN colon_NN cancer_NN in_IN EuropeData_NNP were_VBD taken_VBN from_IN IARC_NNP 
Cancer_NN registration_NN data_NNS refer_VBP to_TO the_DT mid-1990_NN 's_POS ._. 
This_DT effect_NN is_VBZ not_RB fully_RB compensated_VBN by_IN improved_VBN diagnosis_NN and_CC medical_JJ treatment_NN ._. 
In_IN many_JJ countries_NNS in_IN the_DT EU_NNP ,_, colon_NN cancer_NN incidence_NN increases_NNS with_IN time_NN because_IN populations_NNS are_VBP ageing_JJ and_CC incidence_NN increases_NNS with_IN age_NN ._. 
Incidence_NN of_IN colon_NN cancer_NN varies_VBZ considerably_RB over_IN Europe_NNP with_IN low_JJ values_NNS in_IN Finland_NNP ,_, Poland_NNP and_CC Baltic_NNP states_NNS -LRB-_-LRB- 10-13_CD new_JJ cases_NNS per_IN 100,000_CD per_IN year_NN -RRB-_-RRB- and_CC high_JJ values_NNS in_IN Germany_NNP ,_, Czech_JJ Republic_NNP ,_, UK_NNP and_CC Italy_NNP -LRB-_-LRB- 23-24_CD new_JJ cases_NNS per_IN 100,000_CD per_IN year_NN -RRB-_-RRB- ._. 
Loss_NN of_IN healthy_JJ life_NN years_NNS and_CC life_NN years_NNS from_IN premature_JJ death_NN for_IN colon_NN cancer_NN We_PRP inferred_VBD loss_NN of_IN healthy_JJ life_NN years_NNS and_CC life_NN years_NNS due_JJ to_TO premature_JJ death_NN using_VBG data_NNS on_IN colon_NN cancer_NN incidence_NN and_CC mortality_NN per_IN five_CD year_NN age_NN class_NN between_IN 1989_CD and_CC 2006_CD provided_VBN by_IN the_DT Dutch_NNP Cancer_NNP Registry_NNP -LRB-_-LRB- 
loss_NN of_IN healthy_JJ life_NN years_NNS for_IN all_DT patients_NNS ,_, including_VBG those_DT that_WDT are_VBP cured_VBN ,_, was_VBD calculated_VBN as_IN the_DT ratio_NN of_IN prevalence_NN over_IN incidence_NN ._. 
Using_VBG prevalence_NN data_NNS of_IN IARC_NNP ,_, we_PRP found_VBD a_DT YLD_NNP of_IN 4_CD ._. 
9for_IN the_DT Netherlands_NNP ,_, and_CC we_PRP assume_VBP that_DT value_NN for_IN the_DT other_JJ countries_NNS as_RB well_RB ._. 
Increased_VBN risk_NN of_IN colon_NN cancer_NN due_JJ to_TO exceedance_NN of_IN the_DT nitrate_JJ standard_NN in_IN drinking_NN water_NN We_PRP derive_VBP the_DT increased_VBN colon_NN cancer_NN risk_NN from_IN DeRoos_FW et_FW al._FW 
In_IN response_NN to_TO L'hirondel_NNP et_FW al._FW ''_'' ._. 
,that_NNP :_: ``_`` However_RB ,_, these_DT were_VBD mostly_RB studies_NNS with_IN a_DT weak_JJ study_NN design_NN and_CC limited_JJ strength_NN of_IN evidence_NN ;_: other_JJ case-control_JJ studies_NNS and_CC cohort_NN studies_NNS -LRB-_-LRB- which_WDT provide_VBP stronger_JJR evidence_NN -RRB-_-RRB- find_VBP no_DT increased_VBN risk_NN with_IN increasing_VBG nitrate_JJ intake_NN after_IN multivariate_JJ adjustment_NN ._. 
In_IN response_NN to_TO L'hirondel_NNP et_FW al._FW ''_'' ._. 
,that_NNP :_: ``_`` However_RB ,_, these_DT were_VBD mostly_RB studies_NNS with_IN a_DT weak_JJ study_NN design_NN and_CC limited_JJ strength_NN of_IN evidence_NN ;_: other_JJ case-control_JJ studies_NNS and_CC cohort_NN studies_NNS -LRB-_-LRB- which_WDT provide_VBP stronger_JJR evidence_NN -RRB-_-RRB- find_VBP no_DT increased_VBN risk_NN with_IN increasing_VBG nitrate_JJ intake_NN after_IN multivariate_JJ adjustment_NN ._. 
In_IN an_DT ecologic_JJ study_NN in_IN the_DT province_NN of_IN Valencia_NNP in_IN Spain_NNP ,_, Morales-Suarez-Varela_NNP et_FW al._FW ._. 
For_IN this_DT purpose_NN we_PRP combined_VBD monitoring_VBG data_NNS reported_VBN by_IN Zwart_NNP et_FW al._FW ._. 
Relationship_NN between_IN nitrogen_NN leaching_NN and_CC nitrate_NN in_IN groundwater_NN First_JJ ,_, we_PRP investigated_VBD potential_JJ associations_NNS between_IN observed_JJ nitrate_JJ concentrations_NNS in_IN shallow_JJ aquifers_NNS and_CC estimates_NNS of_IN the_DT nitrogen_NN leaching_VBG from_IN agricultural_JJ land_NN ._. 
Since_IN part_NN of_IN the_DT fertilizer_NN or_CC manure_NN nitrogen_NN ends_VBZ up_RP as_IN emission_NN of_IN N_NNP 2_CD O_NNP ,_, NO_RB 2_CD and_CC NH_NNP 3_CD to_TO the_DT atmosphere_NN 
Since_IN part_NN of_IN the_DT fertilizer_NN or_CC manure_NN nitrogen_NN ends_VBZ up_RP as_IN emission_NN of_IN N_NNP 2_CD O_NNP ,_, NO_RB 2_CD and_CC NH_NNP 3_CD to_TO the_DT atmosphere_NN 
Illustrative_JJ annual_JJ cost_NN values_NNS are_VBP 0_CD ._. 
Data_NNS on_IN costs_NNS of_IN these_DT measures_NNS are_VBP scarce_JJ but_CC the_DT costs_NNS are_VBP expected_VBN to_TO decrease_VB with_IN increasing_VBG scale_NN of_IN the_DT drinking_NN water_NN production_NN ._. 
5euro\/capita\/yr_JJ for_IN water_NN treatment_NN and_CC mixing_VBG for_IN the_DT UK_NNP and_CC the_DT Netherlands_NNPS where_WRB large_JJ aquifers_NNS are_VBP available_JJ 
Illustrative_JJ annual_JJ cost_NN values_NNS are_VBP 0_CD ._. 
Data_NNS on_IN costs_NNS of_IN these_DT measures_NNS are_VBP scarce_JJ but_CC the_DT costs_NNS are_VBP expected_VBN to_TO decrease_VB with_IN increasing_VBG scale_NN of_IN the_DT drinking_NN water_NN production_NN ._. 
5euro\/capita\/yr_JJ for_IN water_NN treatment_NN and_CC mixing_VBG for_IN the_DT UK_NNP and_CC the_DT Netherlands_NNPS where_WRB large_JJ aquifers_NNS are_VBP available_JJ 
g._NNP Agricultural_NNP production_NN clearly_RB benefits_VBZ from_IN additional_JJ nitrogen_NN input_NN ,_, but_CC there_EX is_VBZ an_DT optimum_JJ and_CC for_IN some_DT crops_NNS -LRB-_-LRB- e._JJ cereals_NNS -RRB-_-RRB- the_DT yield_NN diminishes_VBZ when_WRB the_DT nitrogen_NN input_NN is_VBZ further_RB increased_VBN -LRB-_-LRB- see_VB for_IN example_NN Lord_NNP and_CC Mitchell_NNP -RRB-_-RRB- ._. 
Although_IN unit_NN cost_NN analysis_NN for_IN agricultural_JJ production_NN is_VBZ complex_JJ and_CC beyond_IN the_DT scope_NN of_IN this_DT paper_NN ,_, we_PRP give_VBP one_CD example_NN of_IN a_DT possible_JJ outcome_NN for_IN winter_NN wheat_NN ,_, which_WDT is_VBZ the_DT most_RBS important_JJ food_NN crop_NN in_IN the_DT EU_NNP -LRB-_-LRB- Table_NNP 4_CD -RRB-_-RRB- ._. 
Since_IN part_NN of_IN the_DT fertilizer_NN or_CC manure_NN nitrogen_NN ends_VBZ up_RP as_IN emission_NN of_IN N_NNP 2_CD O_NNP ,_, NO_RB 2_CD and_CC NH_NNP 3_CD to_TO the_DT atmosphere_NN 
Needless_JJ to_TO say_VB ,_, the_DT uncertainties_NNS of_IN the_DT monetary_JJ valuation_NN are_VBP large_JJ ._. 
3VOLY_CD =_SYM 12,000_CD euro\/YLD_NNP ._. 
64_CD ,_, and_CC thus_RB we_PRP value_VBP each_DT year_NN lived_VBD with_IN colon_NN cancer_NN as_IN 0_CD ._. 
In_IN particular_JJ we_PRP note_VBP that_IN often_RB an_DT alternative_JJ approach_NN is_VBZ used_VBN for_IN the_DT monetary_JJ valuation_NN of_IN fatal_JJ cancers_NNS ,_, based_VBN on_IN the_DT value_NN of_IN a_DT prevented_VBN fatality_NN -LRB-_-LRB- also_RB known_VBN under_IN the_DT unfortunate_JJ name_NN ``_`` value_NN of_IN statistical_JJ life_NN ''_'' -RRB-_-RRB- for_IN which_WDT the_DT DG_NNP Environment_NNP of_IN the_DT European_NNP Commission_NNP assumes_VBZ approximately_RB one_CD million_CD euro_NN ;_: some_DT economists_NNS even_RB add_VBP a_DT cancer_NN premium_NN of_IN about_IN 50_CD to_TO 100_CD %_NN to_TO that_DT because_IN of_IN the_DT dreaded_JJ nature_NN of_IN this_DT disease_NN ._. 
The_DT result_NN is_VBZ a_DT cost_NN in_IN the_DT range_NN of_IN 1_CD to_TO 2_CD million_CD euro_NN per_IN fatal_JJ cancer_NN ._. 
There_EX is_VBZ no_DT consensus_NN on_IN which_WDT approach_NN is_VBZ best_JJS ,_, and_CC the_DT valuation_NN of_IN fatal_JJ cancers_NNS could_MD be_VB an_DT order_NN of_IN magnitude_NN higher_JJR than_IN what_WP we_PRP obtain_VBP by_IN using_VBG YLL_NNP ._. 
On_IN the_DT other_JJ hand_NN colon_NN cancer_NN is_VBZ just_RB one_CD of_IN over_IN ten_CD possible_JJ cancers_NNS for_IN which_WDT positive_JJ ,_, but_CC also_RB negative_JJ ,_, associations_NNS with_IN nitrate_NN have_VBP been_VBN published_VBN ._. 
Afurther_JJ illustration_NN of_IN the_DT complexity_NN of_IN the_DT relation_NN between_IN nitrogen_NN in_IN drinking_NN water_NN and_CC human_JJ health_NN is_VBZ the_DT production_NN of_IN the_DT potent_JJ carcinogen_NN N-nitrosodimethylamine_NNP -LRB-_-LRB- NDMA_NNP -RRB-_-RRB- caused_VBN by_IN interaction_NN of_IN disinfection_NN treatment_NN of_IN drinking_NN water_NN sources_NNS and_CC environmental_JJ concentrations_NNS and_CC mixtures_NNS of_IN unknown_JJ nitrosamine_NN precursors_NNS 
Illustrative_JJ annual_JJ cost_NN values_NNS are_VBP 0_CD ._. 
Data_NNS on_IN costs_NNS of_IN these_DT measures_NNS are_VBP scarce_JJ but_CC the_DT costs_NNS are_VBP expected_VBN to_TO decrease_VB with_IN increasing_VBG scale_NN of_IN the_DT drinking_NN water_NN production_NN ._. 
5euro\/capita\/yr_JJ for_IN water_NN treatment_NN and_CC mixing_VBG for_IN the_DT UK_NNP and_CC the_DT Netherlands_NNPS where_WRB large_JJ aquifers_NNS are_VBP available_JJ 
Illustrative_JJ annual_JJ cost_NN values_NNS are_VBP 0_CD ._. 
Data_NNS on_IN costs_NNS of_IN these_DT measures_NNS are_VBP scarce_JJ but_CC the_DT costs_NNS are_VBP expected_VBN to_TO decrease_VB with_IN increasing_VBG scale_NN of_IN the_DT drinking_NN water_NN production_NN ._. 
5euro\/capita\/yr_JJ for_IN water_NN treatment_NN and_CC mixing_VBG for_IN the_DT UK_NNP and_CC the_DT Netherlands_NNPS where_WRB large_JJ aquifers_NNS are_VBP available_JJ ,_, 3_NNP euro\/capita\/yr_NNP for_IN Austria_NNP and_CC Germany_NNP when_WRB also_RB extraction_NN 
In_IN EU27_NNP ,_, the_DT consumption_NN of_IN bottled_JJ drinking_NN water_NN ,_, that_WDT is_VBZ very_RB low_JJ in_IN nitrate_NN ,_, increased_VBD from_IN around_IN 12_CD %_NN of_IN total_JJ intake_NN in_IN 2001_CD to_TO 15_CD %_NN in_IN 2007_CD and_CC consideration_NN would_MD slightly_RB lower_JJR exposure_NN estimates_NNS ._. 
In_IN fact_NN total_JJ beverage_NN consumption_NN is_VBZ relevant_JJ ;_: fruit_NN juices_NNS can_MD be_VB high_JJ in_IN nitrate_NN and_CC beers_NNS high_RB in_IN nitrosamines_NNS ._. 
The_DT assumption_NN that_IN percentage_NN of_IN drinking_NN water_NN samples_NNS from_IN large_JJ public_JJ facilities_NNS not_RB complying_VBG with_IN standards_NNS for_IN nitrate_NN -LRB-_-LRB- 50_CD mg\/L_NNP -RRB-_-RRB- or_CC nitrite_JJ -LRB-_-LRB- 0_CD ._. 
Considering_VBG non-compliance_NN in_IN surface_NN water_NN based_VBN public_JJ drinking_NN water_NN increases_VBZ health_NN cost_NN by_IN about_RB 15_CD %_NN ._. 
Although_IN about_RB 40_CD %_NN of_IN EU_NNP surface_NN waters_NNS exceed_VBP 25_CD mg\/L_NNP NO3_NNP ,_, we_PRP assume_VBP that_IN private_JJ use_NN of_IN surface_NN water_NN for_IN drinking_NN water_NN is_VBZ negligible_JJ compared_VBN to_TO groundwater_NN ._. 
Not_RB considering_VBG consumption_NN of_IN bottled_JJ water_NN ._. 
In_IN EU27_NNP ,_, the_DT consumption_NN of_IN bottled_JJ drinking_NN water_NN ,_, that_WDT is_VBZ very_RB low_JJ in_IN nitrate_NN ,_, increased_VBD from_IN around_IN 12_CD %_NN of_IN total_JJ intake_NN in_IN 2001_CD to_TO 15_CD %_NN in_IN 2007_CD and_CC consideration_NN would_MD slightly_RB lower_JJR exposure_NN estimates_NNS ._. 
7euro\/kg_CD of_IN N_NNP -RRB-_-RRB- is_VBZ much_RB lower_JJR than_IN for_IN NO_DT x_SYM and_CC NH_NNP 3_CD ,_, health_NN damage_NN values_NNS expressed_VBN per_IN kg_NN of_IN added_JJ fertilizer-N_NNP are_VBP comparable_JJ because_IN of_IN the_DT relatively_RB high_JJ emission_NN factor_NN for_IN nitrate_NN ._. 
Consideration_NN of_IN the_DT health_NN cost_NN of_IN nitrate_JJ leaching_NN from_IN fertilizer_NN and_CC manure_NN in_IN agriculture_NN ,_, is_VBZ therefore_RB a_DT relevant_JJ N-related_JJ externality_NN that_WDT needs_VBZ to_TO be_VB considered_VBN when_WRB defining_VBG the_DT socially_RB optimal_JJ input_NN level_NN of_IN nitrogen_NN in_IN agriculture_NN ,_, in_IN addition_NN to_TO externalities_NNS related_VBN to_TO impacts_NNS of_IN nitrogen_NN use_NN on_IN ecosystems_NNS and_CC greenhouse_NN gas_NN emissions_NNS ._. 
This_DT will_MD be_VB further_RB explored_VBN in_IN a_DT forthcoming_JJ paper_NN ._. 
Conclusions_NNP Health_NNP loss_NN due_JJ to_TO nitrate_VB in_IN drinking_NN water_NN is_VBZ an_DT issue_NN under_IN debate_NN both_DT in_IN the_DT scientific_JJ and_CC policy_NN arena_NN ._. 
2for_JJ colon_NN cancer_NN during_IN the_DT period_NN of_IN diagnosis\/treatment\/waiting_VBG ._. 
Mathers_NNPS et_FW al._FW ._. 
Such_JJ differences_NNS do_VBP not_RB matter_VB in_IN view_NN of_IN the_DT uncertainties_NNS ,_, and_CC we_PRP set_VBD the_DT monetary_JJ value_NN of_IN a_DT DALY_NNP or_CC QALY_NNP equal_JJ to_TO 1_CD VOLY_CD =_SYM 40,000_CD euro\/YLL_NNP ._. 
For_IN the_DT value_NN of_IN a_DT life_NN year_NN -LRB-_-LRB- VOLY_NNP -RRB-_-RRB- we_PRP take_VBP 40,000_CD euro\/YLL_NNP ,_, as_IN determined_VBN by_IN a_DT large_JJ contingent_JJ valuation_NN study_NN in_IN nine_CD EU_NNP countries_NNS by_IN Desaigues_NNP et_NNP al._NNP ._. 
For_IN the_DT value_NN of_IN a_DT life_NN year_NN -LRB-_-LRB- VOLY_NNP -RRB-_-RRB- we_PRP take_VBP 40,000_CD euro\/YLL_NNP ,_, as_IN determined_VBN by_IN a_DT large_JJ contingent_JJ valuation_NN study_NN in_IN nine_CD EU_NNP countries_NNS by_IN Desaigues_NNP et_NNP al._NNP ._. 
Since_IN part_NN of_IN the_DT fertilizer_NN or_CC manure_NN nitrogen_NN ends_VBZ up_RP as_IN emission_NN of_IN N_NNP 2_CD O_NNP ,_, NO_RB 2_CD and_CC NH_NNP 3_CD to_TO the_DT atmosphere_NN 
It_PRP may_MD be_VB expected_VBN that_DT exposure_NN in_IN eastern_JJ European_JJ countries_NNS is_VBZ higher_JJR than_IN in_IN northern_JJ and_CC western_JJ Europe_NNP in_IN view_NN of_IN a_DT lower_JJR access_NN of_IN the_DT rural_JJ population_NN to_TO improved_VBN drinking_NN water_NN supply_NN -LRB-_-LRB- 10-70_CD %_NN -RRB-_-RRB- and_CC lower_JJR implementation_NN levels_NNS of_IN environmental_JJ policies_NNS ._. 
In_IN the_DT Netherlands_NNP ,_, nitrate_JJ concentrations_NNS in_IN drinking_NN water_NN exceeding_VBG 25_CD mg\/L_NNP NO3_NNP in_IN 2001_CD were_VBD reported_VBN 
Non-compliance_NN between_IN 2000_CD and_CC 2004_CD in_IN 14_CD reporting_NN member_NN states_NNS was_VBD somewhat_RB lower_JJR ,_, but_CC in_IN the_DT same_JJ range_NN ,_, with_IN a_DT highest_JJS level_NN of_IN non-compliance_NN to_TO nitrite_VB of_IN 11_CD %_NN in_IN Denmark_NNP 
5%_CD of_IN the_DT water_NN samples_NNS for_IN large_JJ supplies_NNS in_IN 12_CD reporting_VBG EU_NNP member_NN states_NNS ._. 
5mg\/L_IN NO_DT 2_CD -RRB-_-RRB- between_IN 1995_CD and_CC 2000_CD occurred_VBD in_IN 0_CD and_CC 4_CD ._. 
Non-compliance_NN between_IN 2000_CD and_CC 2004_CD in_IN 14_CD reporting_NN member_NN states_NNS was_VBD somewhat_RB lower_JJR ,_, but_CC in_IN the_DT same_JJ range_NN ,_, with_IN a_DT highest_JJS level_NN of_IN non-compliance_NN to_TO nitrite_VB of_IN 11_CD %_NN in_IN Denmark_NNP 
1Drinking_JJ water_NN supply_NN ,_, nitrogen_NN loading_VBG ,_, nitrate_JJ leaching_NN and_CC exposure_NN to_TO drinking_NN water_NN exceeding_VBG 25_CD mg\/L_NNP NO_UH 3_CD in_IN the_DT period_NN 1995-2000_CD in_IN 12_CD EU_NNP member_NN states_NNS selected_VBN for_IN availability_NN of_IN data_NNS on_IN drinking_NN water_NN infrastructure_NN and_CC quality_NN ._. 
Non-compliance_NN with_IN EU_NNP legal_JJ limits_NNS in_IN the_DT EU_NNP drinking_NN water_NN directive_NN for_IN either_DT nitrate_JJ -LRB-_-LRB- 50_CD mg\/L_NNP NO3_NNP -RRB-_-RRB- or_CC nitrite_JJ -LRB-_-LRB- 0_CD ._. 
5mg\/L_IN NO_DT 2_CD -RRB-_-RRB- between_IN 1995_CD and_CC 2000_CD occurred_VBD in_IN 0_CD and_CC 4_CD ._. 
5%_CD of_IN the_DT water_NN samples_NNS for_IN large_JJ supplies_NNS in_IN 12_CD reporting_VBG EU_NNP member_NN states_NNS 
Important_JJ variables_NNS are_VBP the_DT percentage_NN of_IN the_DT population_NN connected_VBN to_TO public_JJ supply_NN ,_, the_DT presence_NN of_IN drinking_NN water_NN treatment_NN in_IN public_JJ supplies_NNS and_CC the_DT relative_JJ use_NN of_IN surface_NN water_NN and_CC groundwater_NN ._. 
These_DT parameters_NNS vary_VBP considerably_RB across_IN the_DT EU_NNP ;_: for_IN 12_CD member_NN states_NNS ,_, selected_VBN for_IN data_NNS availability_NN ,_, connection_NN to_TO large_JJ public_JJ supplies_NNS -LRB-_-LRB- serving_VBG more_JJR than_IN 5000_CD customers_NNS or_CC delivering_VBG more_JJR than_IN on_IN million_CD liters_NNS per_IN day_NN -RRB-_-RRB- ranged_VBD from_IN 36_CD to_TO 100_CD %_NN and_CC use_NN of_IN groundwater_NN for_IN public_JJ supply_NN from_IN 25_CD to_TO 99_CD %_NN -LRB-_-LRB- Table_NNP 1_CD ;_: -RRB-_-RRB- ._. 
Exposure_NN to_TO drinkin_VB 
5mg\/L_IN NO_DT 2_CD -RRB-_-RRB- between_IN 1995_CD and_CC 2000_CD occurred_VBD in_IN 0_CD and_CC 4_CD ._. 
Non-compliance_NN with_IN EU_NNP legal_JJ limits_NNS in_IN the_DT EU_NNP drinking_NN water_NN directive_NN for_IN either_DT nitrate_JJ -LRB-_-LRB- 50_CD mg\/L_NNP NO_UH 3_CD -RRB-_-RRB- or_CC nitrite_JJ -LRB-_-LRB- 0_CD ._. 
5%_CD of_IN the_DT water_NN samples_NNS for_IN large_JJ supplies_NNS in_IN 12_CD reporting_VBG EU_NNP member_NN states_NNS 
g._VB It_PRP should_MD be_VB pointed_VBN out_RP that_IN monitoring_VBG procedures_NNS in_IN different_JJ EU_NNP member_NN states_NNS may_MD vary_VB considerably_RB ,_, e._VB with_IN respect_NN to_TO depth_NN and_CC frequency_NN and_CC density_NN of_IN sampling_NN ._. 
The_DT median_JJ depth_NN for_IN monitoring_NN of_IN implementation_NN of_IN the_DT EU_NNP Nitrates_NNP Directive_NNP is_VBZ between_IN 10_CD and_CC 20_CD m_NN -LRB-_-LRB- based_VBN on_IN 22,000_CD samples_NNS for_IN 18_CD EU_NNP member_NN states_NNS taken_VBN between_IN 2004_CD and_CC 2007_CD ;_: data_NNS come_VBP from_IN Member_NNP State_NNP reporting_NN to_TO the_DT European_NNP Commission_NNP as_IN referred_VBN to_TO in_IN art_NN ._. 
This_DT is_VBZ somewhat_RB surprising_JJ as_IN both_DT in_IN the_DT EU_NNP and_CC in_IN the_DT US_NNP policies_NNS and_CC measures_NNS to_TO remove_VB or_CC prevent_VB nitrate_NN in_IN drinking_NN water_NN and_CC groundwater_NN have_VBP been_VBN in_IN place_NN for_IN several_JJ decades_NNS mainly_RB for_IN reasons_NNS of_IN preventive_JJ health_NN care_NN ._. 
Based_VBN on_IN theoretical_JJ economic_JJ considerations_NNS ,_, Hanley_NNP in_IN 1990_CD 
For_IN Austria_NNP and_CC Germany_NNP -LRB-_-LRB- 3_CD and_CC 5_CD euro\/capita\/yr_NN respectively_RB -RRB-_-RRB- there_EX are_VBP also_RB potential_JJ welfare_NN gains_NNS even_RB for_IN installation_NN of_IN shallow_JJ ,_, less_RBR expensive_JJ types_NNS of_IN private_JJ wells_NNS ._. 
Hanley_NNP concluded_VBD for_IN East_NNP Anglia_NNP in_IN the_DT UK_NNP that_IN in_IN 1989_CD the_DT willingness_NN of_IN households_NNS to_TO pay_VB -LRB-_-LRB- WTP_NNP -RRB-_-RRB- for_IN drinking_NN water_NN not_RB exceeding_VBG the_DT EU_NNP nitrate_JJ standard_NN was_VBD larger_JJR than_IN the_DT actual_JJ costs_NNS of_IN the_DT required_JJ treatment_NN ._. 
Our_PRP$ results_NNS support_VBP Hanley_NNP 's_POS conclusion_NN ,_, however_RB ,_, it_PRP is_VBZ doubtful_JJ whether_IN these_DT potential_JJ gains_NNS would_MD motivate_VB public_JJ authorities_NNS or_CC individuals_NNS to_TO invest_VB in_IN nitrate_JJ treatment_NN or_CC drinking_NN water_NN infrastructure_NN ,_, as_IN the_DT costs_NNS may_MD appear_VB more_RBR tangible_JJ than_IN the_DT potential_JJ health_NN gains_NNS ._. 
Based_VBN on_IN theoretical_JJ economic_JJ considerations_NNS ,_, Hanley_NNP in_IN 1990_CD 
There_EX is_VBZ consensus_NN that_IN the_DT role_NN of_IN nitrate_JJ exposure_NN in_IN causing_VBG methemoglobinaemia_NN is_VBZ minor_JJ 
Moreover_RB ,_, health_NN effects_NNS may_MD also_RB results_NNS from_IN other_JJ drinking_NN water_NN pollutants_NNS -LRB-_-LRB- pathogens_NNS ,_, pesticides_NNS ,_, trace_VBP metals_NNS -RRB-_-RRB- ._. 
Therefore_RB ,_, it_PRP is_VBZ not_RB surprising_JJ that_IN epidemiological_JJ studies_NNS into_IN the_DT relation_NN between_IN nitrate_NN in_IN drinking_NN water_NN and_CC cancers_NNS -LRB-_-LRB- or_CC other_JJ health_NN effects_NNS -RRB-_-RRB- often_RB provide_VBP weak_JJ associations_NNS ,_, both_DT positive_JJ and_CC negative_JJ 
Ward_NNP et_NNP al._NNP ._. 
Therefore_RB ,_, it_PRP is_VBZ not_RB surprising_JJ that_IN epidemiological_JJ studies_NNS into_IN the_DT relation_NN between_IN nitrate_NN in_IN drinking_NN water_NN and_CC cancers_NNS -LRB-_-LRB- or_CC other_JJ health_NN effects_NNS -RRB-_-RRB- often_RB provide_VBP weak_JJ associations_NNS ,_, both_DT positive_JJ and_CC negative_JJ 
Ward_NNP et_NNP al._NNP ._. 
Methods_NNS For_IN our_PRP$ assessment_NN we_PRP assume_VBP a_DT link_NN with_IN colon_NN cancer_NN as_IN working_VBG hypothesis_NNS to_TO provide_VB a_DT tentative_JJ assessment_NN of_IN health_NN loss_NN and_CC social_JJ cost_NN of_IN nitrate_NN in_IN drinking_NN water_NN in_IN the_DT European_NNP Union_NNP ._. 
indicate_VBP that_DT colon_NN cancer_NN is_VBZ the_DT impact_NN for_IN which_WDT there_EX seems_VBZ to_TO be_VB more_RBR epidemiological_JJ evidence_NN than_IN for_IN other_JJ types_NNS of_IN cancer_NN ._. 
In_IN order_NN to_TO match_VB the_DT year_NN of_IN cancer_NN registration_NN data_NNS and_CC monitoring_NN data_NNS for_IN nitrogen_NN emissions_NNS and_CC nitrate_NN in_IN groundwater_NN and_CC drinking_NN water_NN ,_, we_PRP used_VBD data_NNS for_IN the_DT period_NN 1995-2000_CD ._. 
Using_VBG the_DT subgroup_NN with_IN above_JJ median_JJ meat_NN consumption_NN to_TO quantify_VB the_DT risk_NN increase_NN of_IN colon_NN cancer_NN ,_, could_MD be_VB regarded_VBN as_IN a_DT worst_JJS case_NN approach_NN ._. 
On_IN the_DT other_JJ hand_NN colon_NN cancer_NN is_VBZ just_RB one_CD of_IN over_IN ten_CD possible_JJ cancers_NNS for_IN which_WDT positive_JJ ,_, but_CC also_RB negative_JJ ,_, associations_NNS with_IN nitrate_NN have_VBP been_VBN published_VBN ._. 
Afurther_JJ illustration_NN of_IN the_DT complexity_NN of_IN the_DT relation_NN between_IN nitrogen_NN in_IN drinking_NN water_NN and_CC human_JJ health_NN is_VBZ the_DT production_NN of_IN the_DT potent_JJ carcinogen_NN N-nitrosodimethylamine_NNP -LRB-_-LRB- NDMA_NNP -RRB-_-RRB- caused_VBN by_IN interaction_NN of_IN disinfection_NN treatment_NN of_IN drinking_NN water_NN sources_NNS and_CC environmental_JJ concentrations_NNS 
Adverse_JJ health_NN effects_NNS related_VBN to_TO nitrate_VB or_CC nitrite_VB eventually_RB ,_, irrespective_RB of_IN its_PRP$ source_NN ,_, are_VBP caused_VBN by_IN carcinogenesis_NNS from_IN chronic_JJ exposure_NN to_TO N-nitroso-compounds_NNS ._. 
However_RB ,_, nitrate_JJ intake_NN via_IN drinking_NN water_NN is_VBZ about_RB four_CD times_NNS 
''_'' ._. 
However_RB ,_, nitrate_JJ intake_NN via_IN drinking_NN water_NN is_VBZ about_RB four_CD times_NNS 
Therefore_RB ,_, Galloway_NNP et_FW al._FW ._. 
On_IN the_DT other_JJ hand_NN nitrogen_NN is_VBZ a_DT key_JJ input_NN for_IN food_NN production_NN and_CC deficient_JJ in_IN many_JJ parts_NNS of_IN the_DT developing_VBG world_NN ._. 
conclude_VB that_IN ``_`` Optimizing_VBG the_DT need_NN for_IN a_DT key_JJ human_JJ resource_NN while_IN minimizing_VBG its_PRP$ negative_JJ consequences_NNS requires_VBZ an_DT integrated_JJ interdisciplinary_JJ approach_NN and_CC the_DT development_NN of_IN strategies_NNS to_TO decrease_VB nitrogen-containing_JJ waste_NN ._. ''_'' ._. 
In_IN fact_NN the_DT question_NN is_VBZ whether_IN the_DT N-cycle_NN can_MD be_VB changed_VBN in_IN such_PDT a_DT way_NN that_IN a_DT welfare_NN improvement_NN is_VBZ achieved_VBN ,_, implying_VBG that_IN the_DT economic_JJ benefits_NNS for_IN society_NN -LRB-_-LRB- the_DT social_JJ benefits_NNS -RRB-_-RRB- from_IN improvement_NN of_IN human_JJ health_NN ,_, ecosystems_NNS and_CC climate_NN should_MD exceed_VB the_DT social_JJ costs_NNS of_IN mitigation_NN and_CC their_PRP$ effect_NN on_IN prices_NNS of_IN food_NN or_CC energy_NN ._. 
However_RB ,_, CBA_NNP for_IN integrated_VBN nitrogen_NN policies_NNS is_VBZ very_RB complex_JJ in_IN view_NN of_IN the_DT many_JJ possible_JJ sources_NNS ,_, effects_NNS and_CC measures_NNS for_IN nitrogen_NN ._. 
Health_NNP impacts_NNS from_IN nitrate_NN in_IN drinking_NN waterThe_NN existence_NN of_IN adverse_JJ health_NN impacts_NNS of_IN nitrate_NN via_IN drinking_NN water_NN has_VBZ been_VBN debated_VBN ._. 
There_EX are_VBP no_DT assessments_NNS available_JJ of_IN social_JJ costs_NNS of_IN health_NN impacts_NNS from_IN emission_NN of_IN nitrate_NN to_TO drinking_NN water_NN ._. 
However_RB ,_, CBA_NNP for_IN integrated_VBN nitrogen_NN policies_NNS is_VBZ very_RB complex_JJ in_IN view_NN of_IN the_DT many_JJ possible_JJ sources_NNS ,_, effects_NNS and_CC measures_NNS for_IN nitrogen_NN ._. 
Health_NNP impacts_NNS from_IN nitrate_NN in_IN drinking_NN waterThe_NN existence_NN of_IN adverse_JJ health_NN impacts_NNS of_IN nitrate_NN via_IN drinking_NN water_NN has_VBZ been_VBN debated_VBN ._. 
There_EX are_VBP no_DT assessments_NNS available_JJ of_IN social_JJ costs_NNS of_IN health_NN impacts_NNS from_IN emission_NN of_IN nitrate_NN to_TO drinking_NN water_NN ._. 
However_RB ,_, nitrate_JJ intake_NN via_IN drinking_NN water_NN is_VBZ about_RB four_CD times_NNS 
Nitrate_JJ intake_NN also_RB leads_VBZ to_TO increased_VBN physiological_JJ levels_NNS of_IN nitric_JJ oxide_NN which_WDT play_VBP a_DT beneficial_JJ role_NN in_IN the_DT vascular_JJ endothelial_JJ function_NN and_CC the_DT defense_NN against_IN infections_NNS ._. 
Nitric_JJ oxide_NN and_CC NO-synthase_NN are_VBP also_RB known_VBN to_TO be_VB involved_VBN in_IN cancer-related_JJ events_NNS -LRB-_-LRB- angiogenesis_NN ,_, apoptosis_NN ,_, cell_NN cycle_NN ,_, invasion_NN ,_, and_CC metastasis_NNS -RRB-_-RRB- and_CC are_VBP linked_VBN to_TO increased_VBN oxidative_JJ stress_NN and_CC DNA_NN damage_NN 
Encouraging_VBG children_NNS from_IN an_DT early_JJ age_NN to_TO eat_VB fresh_JJ fruit_NN and_CC vegetables_NNS has_VBZ been_VBN shown_VBN to_TO establish_VB healthy_JJ choices_NNS and_CC improve_VB their_PRP$ long-term_JJ health_NN 
This_DT is_VBZ likely_JJ to_TO be_VB further_RB enhanced_VBN by_IN active_JJ engagement_NN of_IN both_DT children_NNS and_CC adults_NNS in_IN GYO_NNP providing_VBG outdoor_JJ exercise_NN ,_, and_CC psychologically-enriching_JJ interaction_NN with_IN greenspace_NN ,_, together_RB with_IN the_DT nutritional_JJ rewards_NNS of_IN greater_JJR access_NN to_TO some_DT of_IN the_DT key_JJ components_NNS of_IN the_DT life-extending_NN `_`` Mediterranean_NNP diet_NN '_'' 
Furthermore_RB ,_, CLEA_NNP places_VBZ considerable_JJ emphasis_NN on_IN soil_NN ingestion_NN 
In_IN the_DT UK_NNP ,_, there_EX has_VBZ been_VBN a_DT 34_CD %_NN decrease_NN in_IN vegetable_NN consumption_NN in_IN the_DT past_JJ 50_CD years_NNS ,_, one_CD in_IN five_CD children_NNS eat_VBP virtually_RB no_DT fresh_JJ fruit_NN or_CC vegetables_NNS and_CC 60_CD %_NN eat_VBP no_DT leafy_JJ vegetables_NNS ._. 
Nutritional_NNP deficiencies_NNS of_IN iron_NN and_CC folic_JJ acid_NN -LRB-_-LRB- both_DT rich_JJ in_IN leafy_JJ vegetables_NNS -RRB-_-RRB- ,_, Vitamin_NNP D_NNP -LRB-_-LRB- synthesised_VBN in_IN skin_NN from_IN absorption_NN of_IN sunlight_NN -RRB-_-RRB- and_CC Vitamin_NNP C_NNP -LRB-_-LRB- rich_JJ in_IN most_JJS fruit_NN and_CC vegetables_NNS -RRB-_-RRB- are_VBP implicated_VBN in_IN poor_JJ health_NN 
Nutritional_NNP deficiencies_NNS of_IN iron_NN and_CC folic_JJ acid_NN -LRB-_-LRB- both_DT rich_JJ in_IN leafy_JJ vegetables_NNS -RRB-_-RRB- ,_, Vitamin_NNP D_NNP -LRB-_-LRB- synthesised_VBN in_IN skin_NN from_IN absorption_NN of_IN sunlight_NN -RRB-_-RRB- and_CC Vitamin_NNP C_NNP -LRB-_-LRB- rich_JJ in_IN most_JJS fruit_NN and_CC vegetables_NNS -RRB-_-RRB- are_VBP implicated_VBN in_IN poor_JJ health_NN 
The_DT time_NN spent_VBD watching_VBG television_NN ,_, videos_NNS ,_, and_CC playing_VBG computer_NN games_NNS has_VBZ more_RBR than_IN doubled_VBD compared_VBN to_TO the_DT time_NN spent_VBD watching_VBG television_NN in_IN the_DT 1960s_NNS ,_, and_CC these_DT sedentary_JJ amusements_NNS contribute_VBP to_TO inactive_JJ lifestyles_NNS and_CC increasing_VBG childhood_NN obesity_NN 
However_RB ,_, these_DT gains_NNS in_IN environmental_JJ quality_NN have_VBP been_VBN overshadowed_VBN by_IN the_DT rapidly_RB escalating_VBG public_JJ health_NN crisis_NN of_IN obesity_NN linked_VBN to_TO poor_JJ diet_NN and_CC lack_NN of_IN exercise_NN ._. 
The_DT lethal_JJ combination_NN of_IN `_`` gluttony_NN and_CC sloth_NN '_'' 
The_DT lethal_JJ combination_NN of_IN `_`` gluttony_NN and_CC sloth_NN '_'' 
In_IN low-income_JJ and_CC materially_RB deprived_VBN populations_NNS in_IN the_DT UK_NNP ,_, it_PRP has_VBZ been_VBN estimated_VBN that_IN 25_CD %_NN of_IN men_NNS and_CC 16_CD %_NN of_IN women_NNS have_VBP vitamin_VBN C_NNP deficiency_NN 
In_IN the_DT UK_NNP ,_, there_EX has_VBZ been_VBN a_DT 34_CD %_NN decrease_NN in_IN vegetable_NN consumption_NN in_IN the_DT past_JJ 50_CD years_NNS ,_, one_CD in_IN five_CD children_NNS eat_VBP virtually_RB no_DT fresh_JJ fruit_NN or_CC vegetables_NNS and_CC 60_CD %_NN eat_VBP no_DT leafy_JJ vegetables_NNS ._. 
Nutritional_NNP deficiencies_NNS of_IN iron_NN and_CC folic_JJ acid_NN -LRB-_-LRB- both_DT rich_JJ in_IN leafy_JJ vegetables_NNS -RRB-_-RRB- ,_, Vitamin_NNP D_NNP -LRB-_-LRB- synthesised_VBN in_IN skin_NN from_IN absorption_NN of_IN sunlight_NN -RRB-_-RRB- and_CC Vitamin_NNP C_NNP -LRB-_-LRB- rich_JJ in_IN most_JJS fruit_NN and_CC vegetables_NNS -RRB-_-RRB- are_VBP implicated_VBN in_IN poor_JJ health_NN 
Nutritional_NNP deficiencies_NNS of_IN iron_NN and_CC folic_JJ acid_NN -LRB-_-LRB- both_DT rich_JJ in_IN leafy_JJ vegetables_NNS -RRB-_-RRB- ,_, Vitamin_NNP D_NNP -LRB-_-LRB- synthesised_VBN in_IN skin_NN from_IN absorption_NN of_IN sunlight_NN -RRB-_-RRB- and_CC Vitamin_NNP C_NNP -LRB-_-LRB- rich_JJ in_IN most_JJS fruit_NN and_CC vegetables_NNS -RRB-_-RRB- are_VBP implicated_VBN in_IN poor_JJ health_NN 
In_IN recent_JJ decades_NNS significant_JJ environmental_JJ and_CC societal_JJ changes_NNS appear_VBP to_TO have_VB shifted_VBN the_DT balance_NN of_IN benefits_NNS and_CC risks_NNS in_IN GYO_NNP towards_IN the_DT benefits_NNS ._. 
The_DT general_JJ population_NN exposures_NNS to_TO the_DT heavy_JJ metals_NNS ,_, polyaromatic_JJ hydrocarbons_NNS and_CC dioxin_NN pollutants_NNS that_WDT are_VBP considered_VBN the_DT greatest_JJS risks_NNS to_TO health_NN have_VBP fallen_VBN in_IN the_DT UK_NNP since_IN the_DT 1980s_CD ,_, and_CC this_DT has_VBZ been_VBN reflected_VBN in_IN a_DT 20-fold_JJ reduction_NN in_IN lead_NN 
However_RB ,_, these_DT gains_NNS in_IN environmental_JJ quality_NN have_VBP been_VBN overshadowed_VBN by_IN the_DT rapidly_RB escalating_VBG public_JJ health_NN crisis_NN of_IN obesity_NN linked_VBN to_TO poor_JJ diet_NN and_CC lack_NN of_IN exercise_NN ._. 
The_DT lethal_JJ combination_NN of_IN `_`` gluttony_NN and_CC sloth_NN '_'' 
However_RB ,_, these_DT gains_NNS in_IN environmental_JJ quality_NN have_VBP been_VBN overshadowed_VBN by_IN the_DT rapidly_RB escalating_VBG public_JJ health_NN crisis_NN of_IN obesity_NN linked_VBN to_TO poor_JJ diet_NN and_CC lack_NN of_IN exercise_NN ._. 
The_DT lethal_JJ combination_NN of_IN `_`` gluttony_NN and_CC sloth_NN '_'' 
Children_NNP today_NN only_RB spend_VBP half_PDT the_DT amount_NN of_IN time_NN outdoors_NNS compared_VBN to_TO 20_CD years_NNS ago_IN 
The_DT major_JJ pathways_NNS of_IN exposure_NN to_TO toxins_NNS through_IN GYO_NNP are_VBP by_IN ingestion_NN of_IN contaminated_VBN soil_NN adhering_VBG to_TO crops_NNS or_CC through_IN eating_JJ produce_NN that_WDT has_VBZ absorbed_VBN toxins_NNS from_IN the_DT soil_NN 
The_DT major_JJ pathways_NNS of_IN exposure_NN to_TO toxins_NNS through_IN GYO_NNP are_VBP by_IN ingestion_NN of_IN contaminated_VBN soil_NN adhering_VBG to_TO crops_NNS or_CC through_IN eating_JJ produce_NN that_WDT has_VBZ absorbed_VBN toxins_NNS from_IN the_DT soil_NN 
Exposure_NN to_TO lead_NN is_VBZ the_DT most_RBS important_JJ risk_NN factor_NN in_IN typical_JJ urban_JJ areas_NNS 
These_DT findings_NNS accord_VBP with_IN those_DT of_IN an_DT earlier_JJR and_CC larger_JJR study_NN of_IN 94_CD allotments_NNS and_CC vegetable_NN gardens_NNS in_IN nine_CD English_JJ towns_NNS and_CC cities_NNS which_WDT found_VBD that_IN although_IN the_DT geometric_JJ mean_JJ soil_NN lead_NN concentration_NN was_VBD five_CD times_NNS higher_JJR than_IN in_IN typical_JJ agricultural_JJ soils_NNS ,_, less_JJR than_IN 1_CD %_NN of_IN 80_CD samples_NNS each_DT of_IN lettuce_NN ,_, spinach_NN ,_, broccoli_NN ,_, cabbage_NN ,_, carrot_NN and_CC parsnip_NN exceeded_VBD the_DT old_JJ statutory_JJ limit_NN of_IN 1_CD mg_NN of_IN lead_NN kg_FW -1_FW fresh_JJ weight_NN 
These_DT findings_NNS accord_VBP with_IN those_DT of_IN an_DT earlier_JJR and_CC larger_JJR study_NN of_IN 94_CD allotments_NNS and_CC vegetable_NN gardens_NNS in_IN nine_CD English_JJ towns_NNS and_CC cities_NNS which_WDT found_VBD that_IN although_IN the_DT geometric_JJ mean_JJ soil_NN lead_NN concentration_NN was_VBD five_CD times_NNS higher_JJR than_IN in_IN typical_JJ agricultural_JJ soils_NNS ,_, less_JJR than_IN 1_CD %_NN of_IN 80_CD samples_NNS each_DT of_IN lettuce_NN ,_, spinach_NN ,_, broccoli_NN ,_, cabbage_NN ,_, carrot_NN and_CC parsnip_NN exceeded_VBD the_DT old_JJ statutory_JJ limit_NN of_IN 1_CD mg_NN of_IN lead_NN kg_FW -1_FW fresh_JJ weight_NN 
02_CD -_: 0_CD ._. 
33_CD 
02_CD -_: 0_CD ._. 
33_CD 
This_DT can_MD be_VB built_VBN onto_IN existing_VBG risk_NN assessment_NN tools_NNS such_JJ as_IN CLEA_NNP through_IN the_DT development_NN of_IN predictions_NNS of_IN the_DT consequences_NNS of_IN modelled_JJ pollutant_NN exposures_NNS to_TO health_NN ,_, together_RB with_IN parallel_JJ assessment_NN of_IN health_NN benefits_NNS ._. 
One_CD approach_NN that_WDT allows_VBZ this_DT kind_NN of_IN overall_JJ synthesis_NN of_IN risks_NNS is_VBZ the_DT disability_NN adjusted_VBN life_NN years_NNS -LRB-_-LRB- DALY_NNP -RRB-_-RRB- assessment_NN which_WDT expresses_VBZ the_DT number_NN of_IN life-years_NNS lost_VBD due_JJ to_TO morbidity_NN and_CC mortality_NN ._. 
Refining_NN a_DT DALY_NNP like_IN approach_NN to_TO a_DT GYO_NNP context_NN would_MD enable_VB negative_JJ effects_NNS of_IN exposure_NN to_TO pollutants_NNS to_TO be_VB directly_RB compared_VBN to_TO health-promoting_JJ benefits_NNS of_IN GYO_NNP ,_, and_CC overall_JJ risks_NNS calculated_VBN ._. 
Based_VBN on_IN a_DT worst-case_JJ scenario_NN risk_NN assessment_NN ,_, the_DT site_NN was_VBD closed_VBN down_RB -_: the_DT local_JJ authority_NN approving_VBG remediation_NN but_CC `_`` the_DT cost_NN being_VBG prohibitive_JJ '_'' 
005-0_CD ._. 
010_CD -LRB-_-LRB- M_NNP -RRB-_-RRB- NR_NNP NR_NNP NR_NNP NR_NNP NR_NNP 
005-0_CD ._. 
010_CD -LRB-_-LRB- M_NNP -RRB-_-RRB- NR_NNP NR_NNP NR_NNP NR_NNP NR_NNP 
35_CD 4_CD 5_CD 
05_CD -_: 0_CD ._. 
013_CD -LRB-_-LRB- M_NNP -RRB-_-RRB- 
National_JJ surveys_NNS of_IN lead_NN concentrations_NNS in_IN agricultural_JJ and_CC urban_JJ soils_NNS show_VBP that_IN the_DT latter_JJ are_VBP typically_RB more_RBR contaminated_VBN -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- ._. 
In_IN a_DT UK-wide_JJ risk_NN assessment_NN ,_, the_DT Food_NNP Standards_NNP Agency_NNP analyzed_VBD crops_NNS from_IN 6_CD urban_JJ allotment_NN plots_NNS which_WDT have_VBP typical_JJ urban_JJ soil_NN metal_NN concentrations_NNS ,_, and_CC concluded_VBD that_IN GYO_NNP posed_VBD no_DT significant_JJ risks_NNS 
In_IN a_DT UK-wide_JJ risk_NN assessment_NN ,_, the_DT Food_NNP Standards_NNP Agency_NNP analyzed_VBD crops_NNS from_IN 6_CD urban_JJ allotment_NN plots_NNS which_WDT have_VBP typical_JJ urban_JJ soil_NN metal_NN concentrations_NNS ,_, and_CC concluded_VBD that_IN GYO_NNP posed_VBD no_DT significant_JJ risks_NNS 
Risk_NN assessment_NN modelling_NN of_IN GYO_NNP for_IN the_DT West_NNP Midlands_NNP Conurbation_NNP in_IN the_DT UK_NNP 
Cultivating_VBG and_CC eating_VBG `_`` home-grown_JJ '_'' foods_NNS holds_VBZ both_DT risks_NNS and_CC benefits_NNS ._. 
24_CD 
In_IN view_NN of_IN all_PDT these_DT potential_JJ benefits_NNS ,_, how_WRB great_JJ are_VBP the_DT risks_NNS from_IN environmental_JJ pollutants_NNS in_IN GYO_NNP in_IN urban_JJ environments_NNS ._. 
The_DT major_JJ pathways_NNS of_IN exposure_NN to_TO toxins_NNS through_IN GYO_NNP are_VBP by_IN ingestion_NN of_IN contaminated_VBN soil_NN adhering_VBG to_TO crops_NNS or_CC through_IN eating_JJ produce_NN that_WDT has_VBZ absorbed_VBN toxins_NNS from_IN the_DT soil_NN 
The_DT current_JJ method_NN of_IN risk_NN assessment_NN ,_, CLEA_NNP ,_, is_VBZ based_VBN on_IN measuring_VBG the_DT concentrations_NNS of_IN contaminants_NNS in_IN soils_NNS ,_, although_IN lead_NN ,_, arsenic_NN and_CC polyaromatic_JJ hydrocarbons_NNS are_VBP not_RB readily_RB absorbed_VBN by_IN food_NN crops_NNS and_CC their_PRP$ crop_NN uptake_NN is_VBZ not_RB reliably_RB predicted_VBD from_IN soil_NN analysis_NN -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- ._. 
Furthermore_RB ,_, CLEA_NNP places_VBZ considerable_JJ emphasis_NN on_IN soil_NN ingestion_NN 
GYO_NNP -_: an_DT antidote_NN to_TO sloth_NN and_CC obesity_NN ._. 
As_IN a_DT consequence_NN ,_, expensive_JJ soil_NN remediation_NN treatments_NNS or_CC site_NN closures_NNS can_MD occur_VB where_WRB the_DT risks_NNS to_TO public_JJ health_NN from_IN pollutants_NNS are_VBP negligible_JJ and_CC the_DT benefits_NNS to_TO health_NN may_MD be_VB much_RB greater_JJR than_IN these_DT risks_NNS ._. 
There_EX is_VBZ compelling_JJ evidence_NN of_IN major_JJ health_NN benefits_NNS of_IN fruit_NN and_CC vegetable_NN consumption_NN 
GYO_NNP -_: an_DT antidote_NN to_TO sloth_NN and_CC obesity_NN ._. 
As_IN a_DT consequence_NN ,_, expensive_JJ soil_NN remediation_NN treatments_NNS or_CC site_NN closures_NNS can_MD occur_VB where_WRB the_DT risks_NNS to_TO public_JJ health_NN from_IN pollutants_NNS are_VBP negligible_JJ and_CC the_DT benefits_NNS to_TO health_NN may_MD be_VB much_RB greater_JJR than_IN these_DT risks_NNS ._. 
There_EX is_VBZ compelling_JJ evidence_NN of_IN major_JJ health_NN benefits_NNS of_IN fruit_NN and_CC vegetable_NN consumption_NN 
There_EX is_VBZ compelling_JJ evidence_NN of_IN major_JJ health_NN benefits_NNS of_IN fruit_NN and_CC vegetable_NN consumption_NN 
This_DT highlights_VBZ a_DT more_RBR general_JJ need_NN for_IN a_DT new_JJ generation_NN of_IN risk_NN assessment_NN tools_NNS that_WDT also_RB predict_VBP overall_JJ consequences_NNS for_IN health_NN to_TO more_RBR effectively_RB guide_VB risk_NN management_NN in_IN our_PRP$ increasingly_RB risk-averse_JJ culture_NN ._. 
24_CD 
This_DT highlights_VBZ a_DT more_RBR general_JJ need_NN for_IN a_DT new_JJ generation_NN of_IN risk_NN assessment_NN tools_NNS that_WDT also_RB predict_VBP overall_JJ consequences_NNS for_IN health_NN to_TO more_RBR effectively_RB guide_VB risk_NN management_NN in_IN our_PRP$ increasingly_RB risk-averse_JJ culture_NN ._. 
24_CD 
Exposure_NN to_TO lead_NN is_VBZ the_DT most_RBS important_JJ risk_NN factor_NN in_IN typical_JJ urban_JJ areas_NNS 
001_CD -_: 0_CD ._. 
026_CD -LRB-_-LRB- M_NNP -RRB-_-RRB- 
001_CD -_: 0_CD ._. 
026_CD -LRB-_-LRB- M_NNP -RRB-_-RRB- 
Risk_NN assessment_NN modelling_NN of_IN GYO_NNP for_IN the_DT West_NNP Midlands_NNP Conurbation_NNP in_IN the_DT UK_NNP 
These_DT studies_NNS provide_VBP further_JJ reassurance_NN that_IN even_RB at_IN sites_NNS classed_VBN as_RB badly_RB contaminated_VBN the_DT risks_NNS can_MD be_VB low_JJ ._. 
The_DT first_JJ case_NN ,_, in_IN Newcastle_NNP ,_, involved_VBD a_DT site_NN with_IN 200_CD plots_NNS in_IN which_WDT major_JJ and_CC widespread_JJ soil_NN contamination_NN by_IN lead_NN and_CC arsenic_NN together_RB with_IN local_JJ enrichment_NN with_IN polychlorinated_JJ dibenzo-dioxins_NNS and_CC furans_NNS were_VBD reported_VBN ._. 
Despite_IN the_DT soil_NN contaminants_NNS considerably_RB exceeding_VBG guideline_NN values_NNS requiring_VBG intervention_NN ,_, minimal_JJ lead_NN -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- ,_, arsenic_NN and_CC dioxin_NN contamination_NN was_VBD found_VBN in_IN vegetables_NNS and_CC eggs_NNS produced_VBN from_IN the_DT site_NN ,_, and_CC it_PRP was_VBD concluded_VBN that_IN eating_VBG this_DT produce_NN would_MD create_VB no_DT significant_JJ risk_NN of_IN harm_NN ._. 
The_DT major_JJ pathways_NNS of_IN exposure_NN to_TO toxins_NNS through_IN GYO_NNP are_VBP by_IN ingestion_NN of_IN contaminated_VBN soil_NN adhering_VBG to_TO crops_NNS or_CC through_IN eating_JJ produce_NN that_WDT has_VBZ absorbed_VBN toxins_NNS from_IN the_DT soil_NN 
The_DT major_JJ pathways_NNS of_IN exposure_NN to_TO toxins_NNS through_IN GYO_NNP are_VBP by_IN ingestion_NN of_IN contaminated_VBN soil_NN adhering_VBG to_TO crops_NNS or_CC through_IN eating_JJ produce_NN that_WDT has_VBZ absorbed_VBN toxins_NNS from_IN the_DT soil_NN 
Exposure_NN to_TO lead_NN is_VBZ the_DT most_RBS important_JJ risk_NN factor_NN in_IN typical_JJ urban_JJ areas_NNS 
05_CD -_: 0_CD ._. 
013_CD -LRB-_-LRB- M_NNP -RRB-_-RRB- 
28_CD NR_NNP NR_NNP NR_VBD 120_CD 24_CD 24_CD 24_CD 
This_DT highlights_VBZ a_DT more_RBR general_JJ need_NN for_IN a_DT new_JJ generation_NN of_IN risk_NN assessment_NN tools_NNS that_WDT also_RB predict_VBP overall_JJ consequences_NNS for_IN health_NN to_TO more_RBR effectively_RB guide_VB risk_NN management_NN in_IN our_PRP$ increasingly_RB risk-averse_JJ culture_NN ._. 
24_CD 
The_DT general_JJ population_NN exposures_NNS to_TO the_DT heavy_JJ metals_NNS ,_, polyaromatic_JJ hydrocarbons_NNS and_CC dioxin_NN pollutants_NNS that_WDT are_VBP considered_VBN the_DT greatest_JJS risks_NNS to_TO health_NN have_VBP fallen_VBN in_IN the_DT UK_NNP since_IN the_DT 1980s_CD ,_, and_CC this_DT has_VBZ been_VBN reflected_VBN in_IN a_DT 20-fold_JJ reduction_NN in_IN lead_NN 
87-5_CD ._. 
58_CD 0_CD ._. 
18_CD -_: 3_CD ._. 
82_CD -LRB-_-LRB- M_NNP -RRB-_-RRB- 0_CD ._. 
83_CD -LRB-_-LRB- M_NNP -RRB-_-RRB- 2_CD ._. 
13_CD 11_CD Contaminated_VBN allotment_NN soils_NNS -LRB-_-LRB- Case_NNP study_NN 2_CD -RRB-_-RRB- London_NNP ,_, location_NN undisclosed_JJ 1050_CD -LRB-_-LRB- GM_NNP -RRB-_-RRB- 513-2910_CD 11_CD Cabbage_NNP Carrots_NNP ,_, parsnip_NN ,_, beetroot_NN ,_, potatoes_NNS 1_CD ._. 
3545_CD 
87-5_CD ._. 
58_CD 0_CD ._. 
18_CD -_: 3_CD ._. 
82_CD -LRB-_-LRB- M_NNP -RRB-_-RRB- 0_CD ._. 
83_CD -LRB-_-LRB- M_NNP -RRB-_-RRB- 2_CD ._. 
13_CD 11_CD Contaminated_VBN allotment_NN soils_NNS -LRB-_-LRB- Case_NNP study_NN 2_CD -RRB-_-RRB- London_NNP ,_, location_NN undisclosed_JJ 1050_CD -LRB-_-LRB- GM_NNP -RRB-_-RRB- 513-2910_CD 11_CD Cabbage_NNP Carrots_NNP ,_, parsnip_NN ,_, beetroot_NN ,_, potatoes_NNS 1_CD ._. 
3545_CD 
Risk_NN assessment_NN modelling_NN of_IN GYO_NNP for_IN the_DT West_NNP Midlands_NNP Conurbation_NNP in_IN the_DT UK_NNP 
Nonetheless_RB ,_, because_IN of_IN the_DT nature_NN and_CC extent_NN of_IN the_DT soil_NN contamination_NN and_CC the_DT apparent_JJ risk_NN suggested_VBN by_IN the_DT CLEA_NNP model_NN ,_, the_DT site_NN underwent_VBD expensive_JJ remediation_NN treatment_NN involving_VBG excavating_VBG and_CC replacing_VBG the_DT topsoil_NN ._. 
The_DT second_JJ case_NN ,_, in_IN London_NNP ,_, involved_VBD a_DT site_NN of_IN 7_CD allotment_NN plots_NNS with_IN serious_JJ lead_NN contamination_NN ._. 
Samples_NNS of_IN cabbages_NNS and_CC lettuce_NN ,_, and_CC root_NN crops_NNS -LRB-_-LRB- carrot_NN ,_, parsnip_NN ,_, beetroot_NN and_CC potato_NN -RRB-_-RRB- revealed_VBD lead_JJ concentrations_NNS in_IN most_JJS samples_NNS exceeding_VBG the_DT new_JJ statutory_JJ limit_NN set_VBN for_IN commercial_JJ food_NN -LRB-_-LRB- Table_NNP 2_CD -RRB-_-RRB- ._. 
Analysis_NN of_IN blood-lead_JJ concentrations_NNS of_IN a_DT very_RB small_JJ sample_NN of_IN allotment_NN holders_NNS with_IN contaminated_VBN plots_NNS revealed_VBD them_PRP to_TO be_VB in_IN the_DT normal_JJ range_NN ._. 
Based_VBN on_IN a_DT worst-case_JJ scenario_NN risk_NN assessment_NN ,_, the_DT site_NN was_VBD closed_VBN down_RB -_: the_DT local_JJ authority_NN approving_VBG remediation_NN but_CC `_`` the_DT cost_NN being_VBG prohibitive_JJ '_'' 
There_EX is_VBZ compelling_JJ evidence_NN of_IN major_JJ health_NN benefits_NNS of_IN fruit_NN and_CC vegetable_NN consumption_NN 
In_IN recent_JJ decades_NNS significant_JJ environmental_JJ and_CC societal_JJ changes_NNS appear_VBP to_TO have_VB shifted_VBN the_DT balance_NN of_IN benefits_NNS and_CC risks_NNS in_IN GYO_NNP towards_IN the_DT benefits_NNS ._. 
The_DT general_JJ population_NN exposures_NNS to_TO the_DT heavy_JJ metals_NNS ,_, polyaromatic_JJ hydrocarbons_NNS and_CC dioxin_NN pollutants_NNS that_WDT are_VBP considered_VBN the_DT greatest_JJS risks_NNS to_TO health_NN have_VBP fallen_VBN in_IN the_DT UK_NNP since_IN the_DT 1980s_CD ,_, and_CC this_DT has_VBZ been_VBN reflected_VBN in_IN a_DT 20-fold_JJ reduction_NN in_IN lead_NN 
05_CD -_: 0_CD ._. 
013_CD -LRB-_-LRB- M_NNP -RRB-_-RRB- 
05_CD -_: 0_CD ._. 
013_CD -LRB-_-LRB- M_NNP -RRB-_-RRB- 
05_CD -_: 0_CD ._. 
013_CD -LRB-_-LRB- M_NNP -RRB-_-RRB- 
The_DT immune_JJ reaction_NN in_IN humans_NNS to_TO mercury_NN exposure_NN is_VBZ varied_VBN ._. 
Animal_NNP studies_NNS show_VBP that_IN low_JJ doses_NNS of_IN mercury_NN damages_NNS T_VBP cells_NNS ,_, leads_VBZ to_TO immune_JJ system_NN dysfunction_NN and_CC induces_VBZ autoimmunity_NN 
The_DT immune_JJ reaction_NN in_IN humans_NNS to_TO mercury_NN exposure_NN is_VBZ varied_VBN ._. 
Animal_NNP studies_NNS show_VBP that_IN low_JJ doses_NNS of_IN mercury_NN damages_NNS T_VBP cells_NNS ,_, leads_VBZ to_TO immune_JJ system_NN dysfunction_NN and_CC induces_VBZ autoimmunity_NN 
Setting_VBG and_CC study_NN populations_NNS Exposed_NNP Population_NNP 
Hobbs_NNP was_VBD founded_VBN in_IN 1907_CD as_IN an_DT agricultural_JJ and_CC ranching_JJ community_NN and_CC became_VBD prominent_JJ after_IN the_DT discovery_NN of_IN oil_NN in_IN 1928_CD ._. 
Hobbs_NNP is_VBZ known_VBN as_IN the_DT oil_NN capital_NN of_IN New_NNP Mexico_NNP ._. 
Numerous_JJ oil_NN and_CC gas_NN wells_NNS are_VBP scattered_VBN throughout_IN the_DT area_NN and_CC this_DT industry_NN is_VBZ the_DT principal_JJ source_NN of_IN employment_NN in_IN Hobbs_NNP ._. 
Research_NNP indicates_VBZ that_IN a_DT combination_NN of_IN genetic_JJ and_CC environmental_JJ factors_NNS can_MD trigger_VB the_DT development_NN of_IN SLE_NNP ,_, however_RB there_EX is_VBZ a_DT need_NN for_IN additional_JJ research_NN to_TO identify_VB and_CC characterize_VB the_DT specific_JJ exposures_NNS that_WDT contribute_VBP to_TO the_DT incidence_NN and_CC aggravation_NN of_IN SLE_NNP 
Case_NN definition_NN We_PRP defined_VBD a_DT case_NN of_IN SLE_NNP as_IN an_DT individual_NN who_WP had_VBD received_VBN a_DT physician_NN 's_POS diagnosis_NN ._. 
We_PRP confirmed_VBD the_DT diagnosis_NN with_IN medical_JJ records_NNS to_TO confirm_VB that_IN the_DT diagnosis_NN had_VBD been_VBN reached_VBN in_IN accordance_NN with_IN American_NNP Rheumatology_NNP Association_NNP 's_POS ``_`` Eleven_CD Criteria_NNP of_IN Lupus_NNP ''_'' ._. 
We_PRP excluded_VBD cases_NNS that_WDT were_VBD diagnosed_VBN within_IN 6_CD months_NNS of_IN moving_VBG to_TO the_DT neighborhood_NN or_CC cases_NNS that_WDT were_VBD diagnosed_VBN more_JJR than_IN 5_CD years_NNS after_IN moving_VBG away_RB ._. 
In_IN certain_JJ strains_NNS of_IN mice_NNS ._. 
Pristane_NNP injected_VBD into_IN a_DT rat_NN also_RB induces_VBZ arthritis_NNS 
Pristane_NNP is_VBZ a_DT likely_JJ candidate_NN to_TO be_VB an_DT environmental_JJ trigger_NN for_IN SLE_NNP in_IN susceptible_JJ sub-populations_NNS ._. 
The_DT authors_NNS wrote_VBD in_IN their_PRP$ paper_NN ``_`` Finally_RB ,_, it_PRP may_MD be_VB worth_JJ noting_VBG that_DT pristane_NN is_VBZ found_VBN in_IN mineral_NN oil_NN ,_, shark_NN oil_NN ,_, and_CC many_JJ foods_NNS ,_, raising_VBG the_DT possibility_NN that_IN environmental_JJ exposure_NN to_TO pristane_NN could_MD be_VB involved_VBN in_IN the_DT pathogenesis_NN of_IN some_DT cases_NNS of_IN human_JJ SLE_NNP ''_'' 
In_IN certain_JJ strains_NNS of_IN mice_NNS ._. 
Pristane_NNP injected_VBD into_IN a_DT rat_NN also_RB induces_VBZ arthritis_NNS 
pristane_NN exposure_NN is_VBZ known_VBN to_TO induce_VB autoimmunity_NN and_CC systemic_JJ lupus_NN erythematosus_NN 
3,10_CD ._. 
6;_CD 95_CD %_NN CI_NNP =_SYM 1_CD ._. 
There_EX have_VBP been_VBN case_NN reports_NNS linking_VBG mercury_NN to_TO autoimmune_JJ disease_NN in_IN humans_NNS and_CC a_DT recent_JJ epidemiologic_JJ study_NN of_IN occupational_JJ risk_NN factors_NNS for_IN SLE_NNP identified_VBD mercury_NN as_IN a_DT potential_JJ causal_JJ agent_NN -LRB-_-LRB- OR_NNP =_SYM 3_CD ._. 
0-RRB-_NN ._. 
We_PRP investigated_VBD an_DT apparent_JJ cluster_NN of_IN SLE_NNP cases_NNS in_IN a_DT community_NN in_IN Hobbs_NNP ,_, New_NNP Mexico_NNP ._. 
This_DT investigation_NN was_VBD initiated_VBN by_IN residents_NNS of_IN a_DT six_CD square_JJ block_NN area_NN who_WP noted_VBD an_DT excess_NN of_IN SLE_NNP cases_NNS in_IN their_PRP$ neighborhood_NN ._. 
None_NN of_IN our_PRP$ subjects_NNS had_VBD been_VBN dental_JJ workers_NNS ._. 
4-RRB-_NN ._. 
2,_CD 23_CD ._. 
1;_CD 95_CD %_NN CI_NNP =_SYM 2_CD ._. 
0-RRB-_CD and_CC reported_VBD a_DT significantly_RB increased_VBN prevalence_NN of_IN SLE_NNP among_IN dental_JJ workers_NNS -LRB-_-LRB- OR_NNP =_SYM 7_CD ._. 
Mercury_NNP 's_POS presence_NN can_MD be_VB explained_VBN in_IN this_DT community_NN by_IN mercury_NN presence_NN in_IN crude_JJ oil_NN and_CC its_PRP$ use_NN in_IN instruments_NNS found_VBN in_IN oil_NN fields_NNS 
Questionnaire_NN responses_NNS are_VBP machine-readable_JJ ,_, scanned_VBN on-site_JJ and_CC verified_VBN before_IN subjects_NNS leave_VBP ._. 
One_CD unlikely_JJ symptom_NN question_NN is_VBZ designed_VBN to_TO test_VB for_IN the_DT veracity_NN of_IN the_DT responses_NNS provided_VBD ._. 
This_DT basic_JJ questionnaire_NN has_VBZ been_VBN used_VBN in_IN prior_JJ studies_NNS of_IN exposed_JJ and_CC unexposed_JJ groups_NNS ._. 
Case_NN definition_NN We_PRP defined_VBD a_DT case_NN of_IN SLE_NNP as_IN an_DT individual_NN who_WP had_VBD received_VBN a_DT physician_NN 's_POS diagnosis_NN ._. 
We_PRP excluded_VBD cases_NNS that_WDT were_VBD diagnosed_VBN within_IN 6_CD months_NNS of_IN moving_VBG to_TO the_DT neighborhood_NN or_CC cases_NNS that_WDT were_VBD diagnosed_VBN more_JJR than_IN 5_CD years_NNS after_IN moving_VBG away_RB ._. 
This_DT criteria_NNS for_IN diagnosis_NN is_VBZ consistent_JJ with_IN previously_RB published_VBN studies_NNS ._. 
Exposure_NN assessment_NN House_NNP dust_NN We_PRP collected_VBD house_NN dust_NN samples_NNS from_IN residents_NNS who_WP permitted_VBD access_NN to_TO their_PRP$ homes_NNS ._. 
Conclusion_NN Despite_IN some_DT possible_JJ limitations_NNS ,_, the_DT findings_NNS in_IN this_DT study_NN are_VBP compelling_JJ ._. 
Most_JJS people_NNS who_WP were_VBD ever_RB diagnosed_VBN with_IN this_DT disease_NN would_MD never_RB forget_VB it_PRP ._. 
The_DT hypothesis_NN that_IN environmental_JJ toxins_NNS may_MD induce_VB lupus_NN is_VBZ consistent_JJ with_IN the_DT known_VBN ability_NN of_IN certain_JJ medications_NNS to_TO cause_VB SLE_NNP 
The_DT authors_NNS wrote_VBD in_IN their_PRP$ paper_NN ``_`` Finally_RB ,_, it_PRP may_MD be_VB worth_JJ noting_VBG that_DT pristane_NN is_VBZ found_VBN in_IN mineral_NN oil_NN ,_, shark_NN oil_NN ,_, and_CC many_JJ foods_NNS ,_, raising_VBG the_DT possibility_NN that_IN environmental_JJ exposure_NN to_TO pristane_NN could_MD be_VB involved_VBN in_IN the_DT pathogenesis_NN of_IN some_DT cases_NNS of_IN human_JJ SLE_NNP ''_'' 
In_IN certain_JJ strains_NNS of_IN mice_NNS ._. 
Pristane_NNP injected_VBD into_IN a_DT rat_NN also_RB induces_VBZ arthritis_NNS 
The_DT authors_NNS wrote_VBD in_IN their_PRP$ paper_NN ``_`` Finally_RB ,_, it_PRP may_MD be_VB worth_JJ noting_VBG that_DT pristane_NN is_VBZ found_VBN in_IN mineral_NN oil_NN ,_, shark_NN oil_NN ,_, and_CC many_JJ foods_NNS ,_, raising_VBG the_DT possibility_NN that_IN environmental_JJ exposure_NN to_TO pristane_NN could_MD be_VB involved_VBN in_IN the_DT pathogenesis_NN of_IN some_DT cases_NNS of_IN human_JJ SLE_NNP ''_'' 
The_DT authors_NNS wrote_VBD in_IN their_PRP$ paper_NN ``_`` Finally_RB ,_, it_PRP may_MD be_VB worth_JJ noting_VBG that_DT pristane_NN is_VBZ found_VBN in_IN mineral_NN oil_NN ,_, shark_NN oil_NN ,_, and_CC many_JJ foods_NNS ,_, raising_VBG the_DT possibility_NN that_IN environmental_JJ exposure_NN to_TO pristane_NN could_MD be_VB involved_VBN in_IN the_DT pathogenesis_NN of_IN some_DT cases_NNS of_IN human_JJ SLE_NNP ''_'' 
While_IN it_PRP is_VBZ claimed_VBN that_IN litigants_NNS exaggerate_VBP their_PRP$ symptoms_NNS we_PRP know_VBP of_IN no_DT evidence_NN that_IN this_DT is_VBZ true_JJ ,_, particularly_RB when_WRB examining_VBG averaged_VBD group_NN responses_NNS ._. 
Astudy_JJ by_IN the_DT Agency_NNP for_IN Toxic_NNP Substance_NNP and_CC Disease_NNP Registry_NNP -LRB-_-LRB- ATSDR_NNP -RRB-_-RRB- revealed_VBD no_DT evidence_NN of_IN ``_`` litigation_NN bias_NN ''_'' among_IN subjects_NNS being_VBG followed_VBN for_IN health_NN effects_NNS from_IN trichloroethylene_NN in_IN their_PRP$ drinking_NN water_NN with_IN no_DT statistically_RB significant_JJ difference_NN in_IN the_DT validity_NN of_IN the_DT survey_NN responses_NNS from_IN litigant_NN versus_IN non-litigant_JJ populations_NNS ._. 
These_DT authors_NNS write_VBP ,_, ``_`` Litigants_NNS are_VBP no_RB more_RBR likely_JJ than_IN non-litigant_JJ -LRB-_-LRB- s_PRP -RRB-_-RRB- to_TO provide_VB inaccurate_JJ or_CC exaggerated_JJ responses_NNS ._. 
On_IN the_DT other_JJ hand_NN there_EX can_MD be_VB immune_JJ suppression_NN with_IN decreases_VBZ in_IN immune_JJ defenses_NNS such_JJ as_IN macrophage_NN function_NN 
The_DT occurrence_NN of_IN autoimmunity_NN in_IN animal_NN studies_NNS depends_VBZ on_IN the_DT dose_NN ,_, chemical_NN form_NN or_CC strain_NN of_IN animal_NN ._. 
Animal_NNP studies_NNS show_VBP that_IN low_JJ doses_NNS of_IN mercury_NN damages_NNS T_VBP cells_NNS ,_, leads_VBZ to_TO immune_JJ system_NN dysfunction_NN and_CC induces_VBZ autoimmunity_NN 
None_NN of_IN our_PRP$ subjects_NNS had_VBD been_VBN dental_JJ workers_NNS ._. 
4-RRB-_NN ._. 
2,_CD 23_CD ._. 
1;_CD 95_CD %_NN CI_NNP =_SYM 2_CD ._. 
0-RRB-_CD and_CC reported_VBD a_DT significantly_RB increased_VBN prevalence_NN of_IN SLE_NNP among_IN dental_JJ workers_NNS -LRB-_-LRB- OR_NNP =_SYM 7_CD ._. 
Mercury_NNP 's_POS presence_NN can_MD be_VB explained_VBN in_IN this_DT community_NN by_IN mercury_NN presence_NN in_IN crude_JJ oil_NN and_CC its_PRP$ use_NN in_IN instruments_NNS found_VBN in_IN oil_NN fields_NNS 
The_DT immune_JJ reaction_NN in_IN humans_NNS to_TO mercury_NN exposure_NN is_VBZ varied_VBN ._. 
Animal_NNP studies_NNS show_VBP that_IN low_JJ doses_NNS of_IN mercury_NN damages_NNS T_VBP cells_NNS ,_, leads_VBZ to_TO immune_JJ system_NN dysfunction_NN and_CC induces_VBZ autoimmunity_NN 
Humans_NNS have_VBP increased_VBN activity_NN of_IN the_DT immune_JJ system_NN leading_VBG to_TO autoimmunity_NN 
Studies_NNS have_VBP implicated_VBN residents_NNS living_VBG near_IN industrial_JJ emissions_NNS or_CC environmental_JJ contamination_NN to_TO increased_VBN prevalence_NN of_IN SLE_NNP 
In_IN 1976_CD ,_, Cancro_NNP and_CC Potter_NNP injected_VBD mineral_NN oil_NN or_CC the_DT pure_JJ alkane_NN pristane_NN into_IN mice_NNS 
Inorganic_JJ mercury_NN salt_NN poisoning_NN which_WDT was_VBD once_RB a_DT common_JJ cause_NN of_IN renal_JJ failure_NN is_VBZ now_RB less_RBR common_JJ 
Recent_JJ research_NN has_VBZ been_VBN done_VBN on_IN the_DT adverse_JJ effects_NNS of_IN mercury_NN on_IN various_JJ components_NNS of_IN the_DT immune_JJ system_NN 
Recent_JJ research_NN has_VBZ been_VBN done_VBN on_IN the_DT adverse_JJ effects_NNS of_IN mercury_NN on_IN various_JJ components_NNS of_IN the_DT immune_JJ system_NN 
Cancro_NNP and_CC Potter_NNP reported_VBD that_IN in_IN as_RB little_JJ as_IN three_CD days_NNS plasmacytosis_NN was_VBD evident_JJ 
The_DT authors_NNS wrote_VBD in_IN their_PRP$ paper_NN ``_`` Finally_RB ,_, it_PRP may_MD be_VB worth_JJ noting_VBG that_DT pristane_NN is_VBZ found_VBN in_IN mineral_NN oil_NN ,_, shark_NN oil_NN ,_, and_CC many_JJ foods_NNS ,_, raising_VBG the_DT possibility_NN that_IN environmental_JJ exposure_NN to_TO pristane_NN could_MD be_VB involved_VBN in_IN the_DT pathogenesis_NN of_IN some_DT cases_NNS of_IN human_JJ SLE_NNP ''_'' 
There_EX exists_VBZ a_DT plausible_JJ biological_JJ basis_NN for_IN such_JJ an_DT association_NN 
The_DT hypothesis_NN that_IN environmental_JJ toxins_NNS may_MD induce_VB lupus_NN is_VBZ consistent_JJ with_IN the_DT known_VBN ability_NN of_IN certain_JJ medications_NNS to_TO cause_VB SLE_NNP 
There_EX exists_VBZ a_DT plausible_JJ biological_JJ basis_NN for_IN such_JJ an_DT association_NN 
There_EX exists_VBZ a_DT plausible_JJ biological_JJ basis_NN for_IN such_JJ an_DT association_NN 
Cancro_NNP and_CC Potter_NNP reported_VBD that_IN in_IN as_RB little_JJ as_IN three_CD days_NNS plasmacytosis_NN was_VBD evident_JJ 
Satoh_NNP in_IN 2000_CD reported_VBD that_DT pristane_NN was_VBD able_JJ to_TO induce_VB lupus_NN in_IN virtually_RB any_DT strain_NN of_IN mouse_NN regardless_RB of_IN its_PRP$ genetic_JJ background_NN 
In_IN certain_JJ strains_NNS of_IN mice_NNS ._. 
Pristane_NNP injected_VBD into_IN a_DT rat_NN also_RB induces_VBZ arthritis_NNS 
The_DT occurrence_NN of_IN autoimmunity_NN in_IN animal_NN studies_NNS depends_VBZ on_IN the_DT dose_NN ,_, chemical_NN form_NN or_CC strain_NN of_IN animal_NN ._. 
Animal_NNP studies_NNS show_VBP that_IN low_JJ doses_NNS of_IN mercury_NN damages_NNS T_VBP cells_NNS ,_, leads_VBZ to_TO immune_JJ system_NN dysfunction_NN and_CC induces_VBZ autoimmunity_NN 
Conclusion_NN Despite_IN some_DT possible_JJ limitations_NNS ,_, the_DT findings_NNS in_IN this_DT study_NN are_VBP compelling_JJ ._. 
Most_JJS people_NNS who_WP were_VBD ever_RB diagnosed_VBN with_IN this_DT disease_NN would_MD never_RB forget_VB it_PRP ._. 
The_DT hypothesis_NN that_IN environmental_JJ toxins_NNS may_MD induce_VB lupus_NN is_VBZ consistent_JJ with_IN the_DT known_VBN ability_NN of_IN certain_JJ medications_NNS to_TO cause_VB SLE_NNP 
On_IN the_DT other_JJ hand_NN there_EX can_MD be_VB immune_JJ suppression_NN with_IN decreases_VBZ in_IN immune_JJ defenses_NNS such_JJ as_IN macrophage_NN function_NN 
Inorganic_JJ mercury_NN salt_NN poisoning_NN which_WDT was_VBD once_RB a_DT common_JJ cause_NN of_IN renal_JJ failure_NN is_VBZ now_RB less_RBR common_JJ 
Exposure_NN to_TO mercury_NN can_MD depress_VB or_CC stimulate_VB the_DT immune_JJ system_NN 
Mercury_NNP is_VBZ one_CD of_IN the_DT few_JJ chemicals_NNS that_WDT are_VBP conclusively_RB known_VBN to_TO cause_VB adverse_JJ immune_JJ system_NN disruption_NN in_IN animals_NNS and_CC humans_NNS ._. 
Exposure_NN to_TO mercury_NN can_MD depress_VB or_CC stimulate_VB the_DT immune_JJ system_NN 
Recent_JJ research_NN has_VBZ been_VBN done_VBN on_IN the_DT adverse_JJ effects_NNS of_IN mercury_NN on_IN various_JJ components_NNS of_IN the_DT immune_JJ system_NN 
8cases\/100_CD ,000_CD ._. 
6to_CD 50_CD ._. 
The_DT literature_NN reports_VBZ a_DT prevalence_NN for_IN SLE_NNP that_WDT varies_VBZ from_IN 14_CD ._. 
Controlled_VBN for_IN age_NN ,_, gender_NN ,_, race\/ethnicity_NN ,_, education_NN and_CC smoking_NN history_NN Discussion_NN We_PRP not_RB only_RB observed_VBD a_DT significantly_RB increased_VBN prevalence_NN of_IN SLE_NNP but_CC also_RB an_DT increase_NN of_IN cardiovascular_JJ ,_, neurological_JJ and_CC respiratory_JJ problems_NNS in_IN this_DT subdivision_NN of_IN Hobbs_NNP ,_, New_NNP Mexico_NNP ._. 
The_DT highest_JJS rates_NNS are_VBP seen_VBN in_IN African_NNP Americans_NNPS ._. 
If_IN all_PDT the_DT cases_NNS reported_VBN here_RB in_IN this_DT one_CD neighborhood_NN were_VBD the_DT only_JJ cases_NNS in_IN the_DT entire_JJ town_NN of_IN Hobbs_NNP ,_, we_PRP would_MD have_VB a_DT SLE_NNP prevalence_NN of_IN 45_CD cases\/100_CD ,000_CD -LRB-_-LRB- 13_CD cases\/28_CD ,657_CD -RRB-_-RRB- ._. 
8cases\/100_CD ,000_CD ._. 
6to_CD 50_CD ._. 
The_DT literature_NN reports_VBZ a_DT prevalence_NN for_IN SLE_NNP that_WDT varies_VBZ from_IN 14_CD ._. 
Controlled_VBN for_IN age_NN ,_, gender_NN ,_, race\/ethnicity_NN ,_, education_NN and_CC smoking_NN history_NN Discussion_NN We_PRP not_RB only_RB observed_VBD a_DT significantly_RB increased_VBN prevalence_NN of_IN SLE_NNP but_CC also_RB an_DT increase_NN of_IN cardiovascular_JJ ,_, neurological_JJ and_CC respiratory_JJ problems_NNS in_IN this_DT subdivision_NN of_IN Hobbs_NNP ,_, New_NNP Mexico_NNP ._. 
The_DT highest_JJS rates_NNS are_VBP seen_VBN in_IN African_NNP Americans_NNPS ._. 
If_IN all_PDT the_DT cases_NNS reported_VBN here_RB in_IN this_DT one_CD neighborhood_NN were_VBD the_DT only_JJ cases_NNS in_IN the_DT entire_JJ town_NN of_IN Hobbs_NNP ,_, we_PRP would_MD have_VB a_DT SLE_NNP prevalence_NN of_IN 45_CD cases\/100_CD ,000_CD -LRB-_-LRB- 13_CD cases\/28_CD ,657_CD -RRB-_-RRB- ._. 
However_RB ,_, women_NNS are_VBP more_RBR likely_JJ to_TO have_VB SLE_NNP and_CC women_NNS of_IN color_NN are_VBP more_RBR likely_JJ to_TO have_VB SLE_NNP compared_VBN to_TO white_JJ women_NNS 
8cases\/100_CD ,000_CD ._. 
6to_CD 50_CD ._. 
The_DT literature_NN reports_VBZ a_DT prevalence_NN for_IN SLE_NNP that_WDT varies_VBZ from_IN 14_CD ._. 
Controlled_VBN for_IN age_NN ,_, gender_NN ,_, race\/ethnicity_NN ,_, education_NN and_CC smoking_NN history_NN Discussion_NN We_PRP not_RB only_RB observed_VBD a_DT significantly_RB increased_VBN prevalence_NN of_IN SLE_NNP but_CC also_RB an_DT increase_NN of_IN cardiovascular_JJ ,_, neurological_JJ and_CC respiratory_JJ problems_NNS in_IN this_DT subdivision_NN of_IN Hobbs_NNP ,_, New_NNP Mexico_NNP ._. 
The_DT highest_JJS rates_NNS are_VBP seen_VBN in_IN African_NNP Americans_NNPS ._. 
If_IN all_PDT the_DT cases_NNS reported_VBN here_RB in_IN this_DT one_CD neighborhood_NN were_VBD the_DT only_JJ cases_NNS in_IN the_DT entire_JJ town_NN of_IN Hobbs_NNP ,_, we_PRP would_MD have_VB a_DT SLE_NNP prevalence_NN of_IN 45_CD cases\/100_CD ,000_CD -LRB-_-LRB- 13_CD cases\/28_CD ,657_CD -RRB-_-RRB- ._. 
Migration_NN studies_NNS suggest_VBP that_IN environmental_JJ factors_NNS play_VBP a_DT role_NN in_IN the_DT development_NN of_IN SLE_NNP 
We_PRP excluded_VBD cases_NNS that_WDT were_VBD diagnosed_VBN within_IN 6_CD months_NNS of_IN moving_VBG to_TO the_DT neighborhood_NN or_CC cases_NNS that_WDT were_VBD diagnosed_VBN more_JJR than_IN 5_CD years_NNS after_IN moving_VBG away_RB ._. 
This_DT criteria_NNS for_IN diagnosis_NN is_VBZ consistent_JJ with_IN previously_RB published_VBN studies_NNS ._. 
Exposure_NN assessment_NN House_NNP dust_NN We_PRP collected_VBD house_NN dust_NN samples_NNS from_IN residents_NNS who_WP permitted_VBD access_NN to_TO their_PRP$ homes_NNS ._. 
Mercury_NNP 's_POS presence_NN can_MD be_VB explained_VBN in_IN this_DT community_NN by_IN mercury_NN presence_NN in_IN crude_JJ oil_NN and_CC its_PRP$ use_NN in_IN instruments_NNS found_VBN in_IN oil_NN fields_NNS 
Migration_NN studies_NNS suggest_VBP that_IN environmental_JJ factors_NNS play_VBP a_DT role_NN in_IN the_DT development_NN of_IN SLE_NNP 
Mercury_NNP 's_POS presence_NN can_MD be_VB explained_VBN in_IN this_DT community_NN by_IN mercury_NN presence_NN in_IN crude_JJ oil_NN and_CC its_PRP$ use_NN in_IN instruments_NNS found_VBN in_IN oil_NN fields_NNS 
Residents_NNS living_VBG near_IN industrial_JJ emissions_NNS or_CC environmental_JJ contamination_NN have_VBP been_VBN shown_VBN to_TO have_VB an_DT increase_NN prevalence_NN of_IN SLE_NNP 
3,10_CD ._. 
6;_CD 95_CD %_NN CI_NNP =_SYM 1_CD ._. 
There_EX have_VBP been_VBN case_NN reports_NNS linking_VBG mercury_NN to_TO autoimmune_JJ disease_NN in_IN humans_NNS and_CC a_DT recent_JJ epidemiologic_JJ study_NN of_IN occupational_JJ risk_NN factors_NNS for_IN SLE_NNP identified_VBD mercury_NN as_IN a_DT potential_JJ causal_JJ agent_NN -LRB-_-LRB- OR_NNP =_SYM 3_CD ._. 
0-RRB-_NN ._. 
We_PRP investigated_VBD an_DT apparent_JJ cluster_NN of_IN SLE_NNP cases_NNS in_IN a_DT community_NN in_IN Hobbs_NNP ,_, New_NNP Mexico_NNP ._. 
This_DT investigation_NN was_VBD initiated_VBN by_IN residents_NNS of_IN a_DT six_CD square_JJ block_NN area_NN who_WP noted_VBD an_DT excess_NN of_IN SLE_NNP cases_NNS in_IN their_PRP$ neighborhood_NN ._. 
6;_CD 95_CD %_NN CI_NNP =_SYM 1_CD ._. 
There_EX have_VBP been_VBN case_NN reports_NNS linking_VBG mercury_NN to_TO autoimmune_JJ disease_NN in_IN humans_NNS and_CC a_DT recent_JJ epidemiologic_JJ study_NN of_IN occupational_JJ risk_NN factors_NNS for_IN SLE_NNP identified_VBD mercury_NN as_IN a_DT potential_JJ causal_JJ agent_NN -LRB-_-LRB- OR_NNP =_SYM 3_CD ._. 
3,10_CD -RRB-_-RRB- ._. 
Cooper_NNP 's_POS epidemiologic_JJ study_NN of_IN human_JJ exposure_NN to_TO mercury_NN reveals_VBZ increased_VBN rates_NNS of_IN immunologic_JJ disease_NN ._. 
2,_CD 23_CD ._. 
1;_CD 95_CD %_NN CI_NNP =_SYM 2_CD ._. 
0-RRB-_CD and_CC reported_VBD a_DT significantly_RB increased_VBN prevalence_NN of_IN SLE_NNP among_IN dental_JJ workers_NNS -LRB-_-LRB- OR_NNP =_SYM 7_CD ._. 
4-RRB-_NN 
Lupus_NNP can_MD affect_VB many_JJ parts_NNS of_IN the_DT body_NN ,_, including_VBG the_DT joints_NNS ,_, skin_NN ,_, kidneys_NNS ,_, heart_NN ,_, lungs_NNS ,_, blood_NN vessels_NNS ,_, and_CC brain_NN ._. 
It_PRP is_VBZ a_DT chronic_NN ,_, complex_NN ,_, and_CC potentially_RB fatal_JJ multi-system_JJ inflammatory_JJ disorder_NN that_WDT can_MD be_VB difficult_JJ to_TO diagnose_VB 
Lupus_NNP can_MD affect_VB many_JJ parts_NNS of_IN the_DT body_NN ,_, including_VBG the_DT joints_NNS ,_, skin_NN ,_, kidneys_NNS ,_, heart_NN ,_, lungs_NNS ,_, blood_NN vessels_NNS ,_, and_CC brain_NN ._. 
It_PRP is_VBZ a_DT chronic_NN ,_, complex_NN ,_, and_CC potentially_RB fatal_JJ multi-system_JJ inflammatory_JJ disorder_NN that_WDT can_MD be_VB difficult_JJ to_TO diagnose_VB 
No_DT single_JJ laboratory_NN test_NN confirms_VBZ a_DT diagnosis_NN of_IN SLE_NNP ._. 
It_PRP is_VBZ a_DT chronic_NN ,_, complex_NN ,_, and_CC potentially_RB fatal_JJ multi-system_JJ inflammatory_JJ disorder_NN that_WDT can_MD be_VB difficult_JJ to_TO diagnose_VB ._. 
Many_JJ physicians_NNS use_VBP the_DT American_NNP College_NNP of_IN Rheumatology_NNP 's_POS ``_`` Eleven_CD Criteria_NNP of_IN Lupus_NNP ''_'' to_TO aid_VB in_IN the_DT diagnosis_NN where_WRB the_DT appearance_NN of_IN four_CD of_IN the_DT ``_`` Eleven_CD Criteria_NNP of_IN Lupus_NNP ''_'' qualifies_VBZ as_IN 
SLE_NNP can_MD occur_VB at_IN any_DT age_NN and_CC in_IN either_DT sex_NN ._. 
Figure_NNP 1_CD American_NNP College_NNP of_IN Rheumatology_NNP 
Residents_NNS living_VBG near_IN industrial_JJ emissions_NNS or_CC environmental_JJ contamination_NN have_VBP been_VBN shown_VBN to_TO have_VB an_DT increase_NN prevalence_NN of_IN SLE_NNP 
On_IN the_DT other_JJ hand_NN there_EX can_MD be_VB immune_JJ suppression_NN with_IN decreases_VBZ in_IN immune_JJ defenses_NNS such_JJ as_IN macrophage_NN function_NN 
Research_NNP indicates_VBZ that_IN a_DT combination_NN of_IN genetic_JJ and_CC environmental_JJ factors_NNS can_MD trigger_VB the_DT development_NN of_IN SLE_NNP ,_, however_RB there_EX is_VBZ a_DT need_NN for_IN additional_JJ research_NN to_TO identify_VB and_CC characterize_VB the_DT specific_JJ exposures_NNS that_WDT contribute_VBP to_TO the_DT incidence_NN and_CC aggravation_NN of_IN SLE_NNP 
Recent_JJ research_NN has_VBZ been_VBN done_VBN on_IN the_DT adverse_JJ effects_NNS of_IN mercury_NN on_IN various_JJ components_NNS of_IN the_DT immune_JJ system_NN 
The_DT occurrence_NN of_IN autoimmunity_NN in_IN animal_NN studies_NNS depends_VBZ on_IN the_DT dose_NN ,_, chemical_NN form_NN or_CC strain_NN of_IN animal_NN ._. 
Animal_NNP studies_NNS show_VBP that_IN low_JJ doses_NNS of_IN mercury_NN damages_NNS T_VBP cells_NNS ,_, leads_VBZ to_TO immune_JJ system_NN dysfunction_NN and_CC induces_VBZ autoimmunity_NN 
6;_CD 95_CD %_NN CI_NNP =_SYM 1_CD ._. 
There_EX have_VBP been_VBN case_NN reports_NNS linking_VBG mercury_NN to_TO autoimmune_JJ disease_NN in_IN humans_NNS and_CC a_DT recent_JJ epidemiologic_JJ study_NN of_IN occupational_JJ risk_NN factors_NNS for_IN SLE_NNP identified_VBD mercury_NN as_IN a_DT potential_JJ causal_JJ agent_NN -LRB-_-LRB- OR_NNP =_SYM 3_CD ._. 
3,10_CD -RRB-_-RRB- ._. 
Cooper_NNP 's_POS epidemiologic_JJ study_NN of_IN human_JJ exposure_NN to_TO mercury_NN reveals_VBZ increased_VBN rates_NNS of_IN immunologic_JJ disease_NN ._. 
Sensitization_NN is_VBZ assessed_VBN by_IN objective_JJ measurements_NNS and_CC misclassification_NN is_VBZ therefore_RB a_DT minor_JJ problem_NN ._. 
Sensitization_NN to_TO inhalant_NN allergens_NNS predominates_VBZ after_IN infancy_NN 
Sensitization_NN is_VBZ assessed_VBN by_IN objective_JJ measurements_NNS and_CC misclassification_NN is_VBZ therefore_RB a_DT minor_JJ problem_NN ._. 
Sensitization_NN to_TO inhalant_NN allergens_NNS predominates_VBZ after_IN infancy_NN 
The_DT development_NN of_IN the_DT lungs_NNS is_VBZ not_RB finished_VBN until_IN adulthood_NN ._. 
Atenfold_JJ rise_NN in_IN the_DT number_NN of_IN alveoli_NNS occurs_VBZ during_IN the_DT first_JJ four_CD years_NNS of_IN life_NN ._. 
The_DT ratio_NN of_IN lung_NN surface_NN area_NN to_TO body_NN weight_NN is_VBZ much_RB larger_JJR in_IN ch_NN 
Lower_NNP respiratory_JJ illness_NN and_CC wheezing_VBG symptoms_NNS are_VBP frequent_JJ in_IN early_JJ childhood_NN but_CC very_RB few_JJ of_IN these_DT children_NNS develop_VBP asthma_NN ._. 
Moreover_RB ,_, childhood_NN asthma_NN is_VBZ not_RB a_DT homogeneous_JJ disorder_NN and_CC different_JJ phenotypes_NNS of_IN wheeze_NN and_CC asthma_NN have_VBP been_VBN identified_VBN based_VBN on_IN prognosis_NN ,_, atopic_JJ status_NN and_CC lung_NN function_NN ._. 
Sensitization_NN is_VBZ assessed_VBN by_IN objective_JJ measurements_NNS and_CC misclassification_NN is_VBZ therefore_RB a_DT minor_JJ problem_NN ._. 
It_PRP has_VBZ been_VBN argued_VBN that_IN children_NNS are_VBP more_RBR susceptible_JJ to_TO adverse_JJ effects_NNS from_IN traffic_NN exhaust_NN 
Atenfold_JJ rise_NN in_IN the_DT number_NN of_IN alveoli_NNS occurs_VBZ during_IN the_DT first_JJ four_CD years_NNS of_IN life_NN ._. 
The_DT newborn_JJ child_NN has_VBZ an_DT immature_JJ immune_JJ system_NN and_CC the_DT respiratory_JJ epithelium_NN in_IN the_DT developing_VBG lung_NN has_VBZ an_DT increased_VBN permeability_NN ._. 
The_DT development_NN of_IN the_DT lungs_NNS is_VBZ not_RB finished_VBN until_IN adulthood_NN 
Combined_JJ exposure_NN to_TO diesel_JJ exhaust_NN particles_NNS and_CC antigen_NN could_MD switch_VB the_DT immune_JJ response_NN towards_IN IgE_NNP 
Changes_NNS in_IN the_DT methylation_NN affect_VB the_DT differentiation_NN of_IN the_DT T_NNP helper_NN cells_NNS and_CC thereby_RB possibly_RB also_RB the_DT risk_NN of_IN allergic_JJ sensitization_NN and_CC asthma_NN ._. 
It_PRP has_VBZ been_VBN argued_VBN that_IN children_NNS are_VBP more_RBR susceptible_JJ to_TO adverse_JJ effects_NNS from_IN traffic_NN exhaust_NN 
Sensitization_NN to_TO inhalant_NN allergens_NNS predominates_VBZ after_IN infancy_NN 
Rather_RB substantial_JJ evidence_NN suggested_VBD that_IN the_DT inflammatory_JJ processes_NNS associated_VBN with_IN exposure_NN to_TO traffic_NN related_VBN pollutants_NNS contributed_VBD to_TO an_DT increased_VBN risk_NN of_IN non-allergic_JJ respiratory_JJ symptoms_NNS ._. 
Antioxidants_NNS and_CC possibly_RB surfactant_JJ components_NNS could_MD be_VB important_JJ determinants_NNS of_IN individual_JJ susceptibility_NN 
However_RB ,_, it_PRP was_VBD less_RBR clear_JJ whether_IN exposure_NN to_TO traffic_NN exhaust_NN may_MD induce_VB allergic_JJ sensitization_NN ._. 
Antioxidants_NNS and_CC possibly_RB surfactant_JJ components_NNS could_MD be_VB important_JJ determinants_NNS of_IN individual_JJ susceptibility_NN 
Nevertheless_RB ,_, the_DT consistency_NN in_IN the_DT results_NNS indicates_VBZ that_IN traffic_NN exhaust_NN contributes_VBZ to_TO the_DT development_NN of_IN respiratory_JJ symptoms_NNS in_IN healthy_JJ children_NNS ._. 
This_DT is_VBZ supported_VBN by_IN recent_JJ genetic_JJ association_NN studies_NNS strongly_RB suggesting_VBG that_DT variability_NN in_IN the_DT susceptibility_NN to_TO air_NN pollutants_NNS is_VBZ influenced_VBN by_IN polymorphism_NN in_IN genes_NNS involved_VBN in_IN airway_NN inflammation_NN and_CC oxidative_JJ stress_NN 
Such_JJ findings_NNS strongly_RB indicate_VBP that_IN traffic-related_JJ effects_NNS on_IN sensitization_NN could_MD be_VB restricted_VBN to_TO individuals_NNS with_IN a_DT specific_JJ genetic_JJ polymorphism_NN ._. 
Harmful_JJ effects_NNS of_IN environmental_JJ factors_NNS are_VBP diluted_JJ and_CC difficult_JJ to_TO detect_VB in_IN a_DT large_JJ population_NN where_WRB only_RB some_DT individuals_NNS are_VBP genetically_RB susceptible_JJ ._. 
Conclusion_NN The_DT findings_NNS from_IN recent_JJ cohort_NN studies_NNS indicate_VBP that_IN traffic_NN exhaust_NN contributes_VBZ to_TO the_DT development_NN of_IN respiratory_JJ illness_NN in_IN childhood_NN ._. 
Nevertheless_RB ,_, the_DT consistency_NN in_IN the_DT results_NNS indicates_VBZ that_IN traffic_NN exhaust_NN contributes_VBZ to_TO the_DT development_NN of_IN respiratory_JJ symptoms_NNS in_IN healthy_JJ children_NNS ._. 
This_DT is_VBZ supported_VBN by_IN recent_JJ genetic_JJ association_NN studies_NNS strongly_RB suggesting_VBG that_DT variability_NN in_IN the_DT susceptibility_NN to_TO air_NN pollutants_NNS is_VBZ influenced_VBN by_IN polymorphism_NN in_IN genes_NNS involved_VBN in_IN airway_NN inflammation_NN and_CC oxidative_JJ stress_NN 
The_DT birth_NN cohorts_NNS from_IN Germany_NNP -LRB-_-LRB- Munich_NNP -RRB-_-RRB- ,_, the_DT Netherlands_NNP and_CC Sweden_NNP -LRB-_-LRB- Stockholm_NNP -RRB-_-RRB- participated_VBD in_IN TRAPCA_NNP ,_, an_DT international_JJ collaboration_NN on_IN the_DT impact_NN of_IN Traffic_NNP Related_NNP Air_NNP Pollution_NNP on_IN Childhood_NNP Asthma_NNP 
Infants_NNS who_WP resided_VBD less_JJR than_IN 50_CD m_NN from_IN stop-and-go_JJ traffic_NN had_VBD a_DT threefold_RB increased_VBN risk_NN of_IN wheeze_NN without_IN cold_NN compared_VBN with_IN those_DT children_NNS who_WP were_VBD unexposed_JJ ._. 
In_IN the_DT next_JJ paper_NN ,_, the_DT individual_JJ exposure_NN assessment_NN also_RB included_VBD levels_NNS of_IN ECAT_NNP -LRB-_-LRB- elemental_JJ carbon_NN attributable_JJ to_TO traffic_NN sources_NNS -RRB-_-RRB- 
The_DT association_NN between_IN traffic-related_JJ air_NN pollutants_NNS and_CC respiratory_JJ health_NN during_IN infancy_NN was_VBD assessed_VBN in_IN three_CD birth_NN cohorts_NNS ._. 
In_IN two_CD of_IN the_DT large_JJ European_JJ birth_NN cohorts_NNS ,_, exposure_NN to_TO traffic_NN exhaust_NN was_VBD related_VBN to_TO slightly_RB increased_VBN odds_NNS ratios_NNS for_IN coughing_VBG symptoms_NNS 
Aslightly_RB increased_VBN risk_NN was_VBD also_RB observed_VBN for_IN doctor-diagnosed_JJ asthma_NN ,_, although_IN significant_JJ only_RB for_IN children_NNS with_IN a_DT diagnosis_NN of_IN asthma_NN during_IN first_JJ year_NN of_IN life_NN ._. 
The_DT next_JJ report_NN from_IN the_DT PIAMA_NNP study_NN assessed_VBD the_DT outcome_NN at_IN four_CD years_NNS of_IN age_NN and_CC data_NNS were_VBD collected_VBN from_IN 3,538_CD children_NNS ._. 
The_DT individual_JJ annual_JJ average_NN of_IN exposure_NN to_TO air_NN pollutants_NNS calculated_VBN from_IN the_DT address_NN at_IN birth_NN was_VBD related_VBN to_TO prevalence_NN and_CC cumulative_JJ incidence_NN of_IN reported_VBN symptoms_NNS ._. 
Wheezing_VBG is_VBZ not_RB specific_JJ for_IN asthma_NN and_CC many_JJ of_IN the_DT wheezers_NNS are_VBP symptom-free_JJ when_WRB they_PRP start_VBP at_IN school_NN 
There_EX were_VBD some_DT inconsistencies_NNS ,_, however_RB ._. 
The_DT findings_NNS were_VBD fairly_RB similar_JJ ._. 
Collaborative_JJ centres_NNS in_IN the_DT TRAPCA_NNP study_NN assessed_VBD potential_JJ effects_NNS of_IN traffic_NN exhaust_NN also_RB at_IN four_CD 
Long-term_JJ exposure_NN to_TO outdoor_JJ air_NN pollutants_NNS had_VBD no_DT association_NN with_IN sensitization_NN in_IN ten-year-old_JJ schoolchildren_NNS in_IN Norway_NNP 
Wheeze_VB and_CC cough_VB induced_VBN by_IN respiratory_JJ infections_NNS are_VBP common_JJ in_IN early_JJ childhood_NN ._. 
In_IN two_CD of_IN the_DT large_JJ European_JJ birth_NN cohorts_NNS ,_, exposure_NN to_TO traffic_NN exhaust_NN was_VBD related_VBN to_TO slightly_RB increased_VBN odds_NNS ratios_NNS for_IN coughing_VBG symptoms_NNS 
Control_NNP of_IN confounding_VBG was_VBD limited_VBN also_RB in_IN this_DT study_NN due_JJ to_TO the_DT fairly_RB small_JJ sample_NN size_NN ._. 
However_RB ,_, reporting_VBG of_IN symptoms_NNS could_MD be_VB more_RBR likely_JJ in_IN children_NNS exposed_VBN to_TO violence_NN ._. 
Asthma_NN is_VBZ a_DT heterogeneous_JJ disease_NN and_CC there_EX are_VBP several_JJ phenotypes_NNS of_IN childhood_NN wheezing_VBG 
The_DT birth_NN cohorts_NNS from_IN Germany_NNP -LRB-_-LRB- Munich_NNP -RRB-_-RRB- ,_, the_DT Netherlands_NNP and_CC Sweden_NNP -LRB-_-LRB- Stockholm_NNP -RRB-_-RRB- participated_VBD in_IN TRAPCA_NNP ,_, an_DT international_JJ collaboration_NN on_IN the_DT impact_NN of_IN Traffic_NNP Related_NNP Air_NNP Pollution_NNP on_IN Childhood_NNP Asthma_NNP 
6to_CD 298_CD -RRB-_-RRB- ._. 
0-LRB-_CD 95_CD %_NN CI_NNP 1_CD ._. 
Thus_RB ,_, exposure_NN to_TO NO_DT x_SYM was_VBD associated_VBN with_IN an_DT increased_VBN risk_NN of_IN sensitization_NN mainly_RB in_IN children_NNS ,_, who_WP combined_VBD the_DT TNF-308_NN with_IN the_DT GSTP1_NNP 105Val_NNP allele_NN ,_, adjusted_VBN OR_NNP 22_CD ._. 
NorwayIn_NNP all_DT ,_, 2,244_CD schoolchildren_NNS from_IN Oslo_NNP were_VBD skin_NN prick_NN tested_VBN at_IN 9_CD 
This_DT association_NN was_VBD no_RB longer_RB significant_JJ after_IN adjustment_NN for_IN socioeconomic_JJ indicators_NNS suggesting_VBG that_IN the_DT association_NN was_VBD caused_VBN by_IN confounding_VBG ._. 
Similarly_RB ,_, sensitization_NN to_TO cat_NN was_VBD associated_VBN with_IN lifetime_NN exposure_NN to_TO traffic_NN pollutants_NNS but_CC only_RB in_IN the_DT non-cohort_JJ population_NN ._. 
The_DT United_NNP States_NNPS Two_CD studies_NNS were_VBD based_VBN on_IN children_NNS participating_VBG in_IN the_DT Southern_NNP California_NNP Children_NNP 's_POS Health_NNP Study_NNP -LRB-_-LRB- CHS_NNP -RRB-_-RRB- ._. 
Some_DT studies_NNS seem_VBP to_TO have_VB a_DT very_RB high_JJ spatial_JJ resolution_NN in_IN exposure_NN data_NNS ,_, but_CC it_PRP is_VBZ difficult_JJ to_TO compare_VB these_DT different_JJ approaches_NNS ._. 
However_RB ,_, internal_JJ validations_NNS show_VBP for_IN example_NN that_IN the_DT dispersion_NN model_NN in_IN the_DT Norwegian_JJ study_NN 
Potential_JJ effects_NNS of_IN traffic_NN exhaust_NN on_IN the_DT development_NN of_IN allergic_JJ sensitization_NN were_VBD only_RB assessed_VBN in_IN the_DT four_CD European_JJ birth_NN cohorts_NNS ._. 
Long-term_JJ exposure_NN to_TO outdoor_JJ air_NN pollutants_NNS had_VBD no_DT association_NN with_IN sensitization_NN in_IN ten-year-old_JJ schoolchildren_NNS in_IN Norway_NNP 
The_DT birth_NN cohorts_NNS from_IN Germany_NNP -LRB-_-LRB- Munich_NNP -RRB-_-RRB- ,_, the_DT Netherlands_NNP and_CC Sweden_NNP -LRB-_-LRB- Stockholm_NNP -RRB-_-RRB- participated_VBD in_IN TRAPCA_NNP ,_, an_DT international_JJ collaboration_NN on_IN the_DT impact_NN of_IN Traffic_NNP Related_NNP Air_NNP Pollution_NNP on_IN Childhood_NNP Asthma_NNP 
5,_CD soot_NN and_CC NO_RB 2_CD was_VBD assessed_VBN from_IN regression_NN models_NNS very_RB similar_JJ to_TO the_DT model_NN used_VBN in_IN Munich_NNP 
The_DT association_NN between_IN traffic-related_JJ air_NN pollutants_NNS and_CC respiratory_JJ health_NN during_IN infancy_NN was_VBD assessed_VBN in_IN three_CD birth_NN cohorts_NNS ._. 
In_IN two_CD of_IN the_DT large_JJ European_JJ birth_NN cohorts_NNS ,_, exposure_NN to_TO traffic_NN exhaust_NN was_VBD related_VBN to_TO slightly_RB increased_VBN odds_NNS ratios_NNS for_IN coughing_VBG symptoms_NNS 
An_DT increasing_VBG level_NN of_IN ECAT_NNP was_VBD associated_VBN with_IN an_DT increasing_VBG risk_NN of_IN wheeze_NN ._. 
In_IN the_DT next_JJ paper_NN ,_, the_DT individual_JJ exposure_NN assessment_NN also_RB included_VBD levels_NNS of_IN ECAT_NNP -LRB-_-LRB- elemental_JJ carbon_NN attributable_JJ to_TO traffic_NN sources_NNS -RRB-_-RRB- 
In_IN the_DT cohort_NN study_NN from_IN East_NNP Boston_NNP ,_, the_DT children_NNS were_VBD followed_VBN annually_RB from_IN birth_NN up_IN to_TO 18_CD years_NNS ._. 
Long-term_JJ exposure_NN to_TO traffic_NN exhaust_NN and_CC exposure_NN to_TO violence_NN appeared_VBD to_TO have_VB synergistic_JJ effects_NNS on_IN the_DT risk_NN of_IN asthma_NN ._. 
However_RB ,_, reporting_VBG of_IN symptoms_NNS could_MD be_VB more_RBR likely_JJ in_IN children_NNS exposed_VBN to_TO violence_NN ._. 
Control_NNP of_IN confounding_VBG was_VBD limited_VBN also_RB in_IN this_DT study_NN due_JJ to_TO the_DT fairly_RB small_JJ sample_NN size_NN ._. 
g._NNP Adjustment_NNP for_IN relevant_JJ covariates_NNS ,_, e._VB Potential_JJ effects_NNS of_IN traffic_NN related_VBN air_NN pollutants_NNS on_IN different_JJ wheezing_VBG phenotypes_NNS were_VBD only_RB assessed_VBN in_IN one_CD of_IN the_DT birth_NN cohorts_NNS 
Confounders_NNS may_MD contribute_VB to_TO a_DT lower_JJR incidence_NN of_IN asthma_NN in_IN rural_JJ areas_NNS Germany_NNP Three_NNP papers_NNS originated_VBD from_IN the_DT GINI_NNP -LRB-_-LRB- German_NNP Infant_NNP Intervention_NN Programme_NNP -RRB-_-RRB- and_CC LISA_NNP -LRB-_-LRB- Influences_NNPS of_IN Lifestyle_NNP Related_NNP Factors_NNP on_IN the_DT Immune_NNP System_NNP and_CC Development_NNP of_IN Allergies_NNPS in_IN Children_NNP -RRB-_-RRB- birth_NN cohorts_NNS in_IN Munich_NNP as_IN a_DT part_NN of_IN the_DT TRAPCA_NNP project_NN ._. 
The_DT paper_NN by_IN Gehring_NNP et_NNP al_NNP was_VBD based_VBN on_IN 1,756_CD children_NNS living_VBG in_IN Munich_NNP City_NNP ._. 
Levels_NNS of_IN NO_DT 2_CD and_CC PM_NNP 2_CD ._. 
5at_JJ home_NN were_VBD estimated_VBN from_IN regression_NN models_NNS ._. 
Annual_JJ mean_JJ values_NNS of_IN the_DT pollutants_NNS were_VBD related_VBN to_TO questionnaire-reported_JJ symptoms_NNS at_IN one_CD and_CC two_CD years_NNS of_IN age_NN ._. 
Individual_JJ exposure_NN to_TO PM_NNP 2_CD ._. 
The_DT birth_NN cohort_NN initially_RB comprised_VBD 4,146_CD children_NNS from_IN various_JJ communities_NNS in_IN different_JJ parts_NNS of_IN the_DT Netherlands_NNP ._. 
5,_CD soot_NN and_CC NO2_NNP was_VBD assessed_VBN from_IN regression_NN models_NNS very_RB similar_JJ to_TO the_DT model_NN used_VBN in_IN Munich_NNP 
The_DT association_NN between_IN traffic-related_JJ air_NN pollutants_NNS and_CC respiratory_JJ health_NN during_IN infancy_NN was_VBD assessed_VBN in_IN three_CD birth_NN cohorts_NNS ._. 
In_IN two_CD of_IN the_DT large_JJ European_JJ birth_NN cohorts_NNS ,_, exposure_NN to_TO traffic_NN exhaust_NN was_VBD related_VBN to_TO slightly_RB increased_VBN odds_NNS ratios_NNS for_IN coughing_VBG symptoms_NNS 
Such_JJ findings_NNS strongly_RB indicate_VBP that_IN traffic-related_JJ effects_NNS on_IN sensitization_NN could_MD be_VB restricted_VBN to_TO individuals_NNS with_IN a_DT specific_JJ genetic_JJ polymorphism_NN ._. 
Harmful_JJ effects_NNS of_IN environmental_JJ factors_NNS are_VBP diluted_JJ and_CC difficult_JJ to_TO detect_VB in_IN a_DT large_JJ population_NN where_WRB only_RB some_DT individuals_NNS are_VBP genetically_RB susceptible_JJ ._. 
Conclusion_NN The_DT findings_NNS from_IN recent_JJ cohort_NN studies_NNS indicate_VBP that_IN traffic_NN exhaust_NN contributes_VBZ to_TO the_DT development_NN of_IN respiratory_JJ illness_NN in_IN childhood_NN ._. 
Microsomal_JJ epoxide_NN hydrolase_NN -LRB-_-LRB- EPHX1_NNP -RRB-_-RRB- plays_VBZ a_DT role_NN in_IN the_DT detoxification_NN of_IN polyaromatic_JJ hydrocarbons_NNS -LRB-_-LRB- PAHs_NNPS -RRB-_-RRB- ._. 
EPHX1_CD and_CC GSTP1_CD variants_NNS affect_VBP the_DT risk_NN of_IN asthma_NN in_IN children_NNS exposed_VBN to_TO traffic_NN exhaust_NN ._. 
Transforming_VBG growth_NN factor_NN -LRB-_-LRB- TGF_NNP -RRB-_-RRB- -_: 
Transforming_VBG growth_NN factor_NN -LRB-_-LRB- TGF_NNP -RRB-_-RRB- -_: 
Astrong_JJ exposure-response_JJ association_NN was_VBD demonstrated_VBN in_IN Germany_NNP and_CC the_DT Netherlands_NNPS but_CC not_RB in_IN Sweden_NNP ,_, where_WRB a_DT significant_JJ difference_NN in_IN sensitization_NN was_VBD presented_VBN only_RB for_IN the_DT fifth_NN to_TO ninety-fifth_JJ percentile_NN difference_NN in_IN air_NN pollution_NN exposure_NN within_IN the_DT cohort_NN ._. 
Traffic_NN related_VBN pollutants_NNS may_MD induce_VB the_DT release_NN of_IN allergenic_JJ granules_NNS from_IN grass_NN pollen_NN 
Astrong_JJ exposure-response_JJ association_NN was_VBD demonstrated_VBN in_IN Germany_NNP and_CC the_DT Netherlands_NNPS but_CC not_RB in_IN Sweden_NNP ,_, where_WRB a_DT significant_JJ difference_NN in_IN sensitization_NN was_VBD presented_VBN only_RB for_IN the_DT fifth_NN to_TO ninety-fifth_JJ percentile_NN difference_NN in_IN air_NN pollution_NN exposure_NN within_IN the_DT cohort_NN ._. 
Traffic_NN related_VBN pollutants_NNS may_MD induce_VB the_DT release_NN of_IN allergenic_JJ granules_NNS from_IN grass_NN pollen_NN 
Glutathione-S-transferase_NNP is_VBZ a_DT catalyst_NN of_IN the_DT conjugation_NN of_IN reduced_VBN glutathione_NN and_CC an_DT important_JJ component_NN in_IN the_DT protection_NN against_IN reactive_JJ oxygen_NN species_NNS ._. 
An_DT interaction_NN has_VBZ been_VBN demonstrated_VBN between_IN glutathione-S-transferase_NNP P1_NNP -LRB-_-LRB- GSTP1_NNP -RRB-_-RRB- gene_NN polymorphism_NN and_CC outdoor_JJ air_NN pollution_NN on_IN asthma_NN among_IN schoolchildren_NNS in_IN Taiwan_NNP 
In_IN the_DT Netherlands_NNP ,_, however_RB ,_, traffic_NN exhaust_NN was_VBD associated_VBN with_IN sensitization_NN only_RB to_TO food_NN allergen_NN ._. 
There_EX is_VBZ some_DT evidence_NN from_IN experimental_JJ studies_NNS in_IN mice_NNS that_IN exposure_NN to_TO diesel_JJ exhaust_NN could_MD counteract_VB the_DT development_NN of_IN oral_JJ tolerance_NN against_IN food_NN allergens_NNS ._. 
In_IN the_DT Norwegian_JJ study_NN ,_, sensitization_NN to_TO single_JJ allergens_NNS in_IN subpopulations_NNS suggested_VBD that_IN confounding_VBG and_CC selection_NN bias_NN could_MD influence_VB the_DT outcome_NN ._. 
Type_NN and_CC timing_NN of_IN exposures_NNS regulate_VBP the_DT expression_NN of_IN the_DT genes_NNS 
This_DT is_VBZ supported_VBN by_IN recent_JJ genetic_JJ association_NN studies_NNS strongly_RB suggesting_VBG that_DT variability_NN in_IN the_DT susceptibility_NN to_TO air_NN pollutants_NNS is_VBZ influenced_VBN by_IN polymorphism_NN in_IN genes_NNS involved_VBN in_IN airway_NN inflammation_NN and_CC oxidative_JJ stress_NN 
The_DT odds_NNS ratios_NNS for_IN sensitization_NN were_VBD slightly_RB reduced_VBN after_IN sensitivity_NN analysis_NN comprising_VBG only_JJ children_NNS who_WP had_VBD not_RB moved_VBN since_IN birth_NN ._. 
SwedenRespiratory_JJ health_NN and_CC allergic_JJ sensitization_NN were_VBD assessed_VBN at_IN four_CD years_NNS of_IN age_NN amongst_IN 3,515_CD children_NNS of_IN a_DT Swedish_JJ birth_NN cohort_NN -LRB-_-LRB- BAMSE_NNP -RRB-_-RRB- in_IN Stockholm_NNP within_IN the_DT TRAPCA_NNP study_NN ._. 
Individual_JJ exposure_NN to_TO traffic_NN pollutants_NNS was_VBD based_VBN on_IN an_DT atmospheric_JJ dispersion_NN model_NN with_IN high_JJ resolution_NN ._. 
Some_DT studies_NNS seem_VBP to_TO have_VB a_DT very_RB high_JJ spatial_JJ resolution_NN in_IN exposure_NN data_NNS ,_, but_CC it_PRP is_VBZ difficult_JJ to_TO compare_VB these_DT different_JJ approaches_NNS ._. 
However_RB ,_, internal_JJ validations_NNS show_VBP for_IN example_NN that_IN the_DT dispersion_NN model_NN in_IN the_DT Norwegian_JJ study_NN 
Wheezing_VBG is_VBZ not_RB specific_JJ for_IN asthma_NN and_CC many_JJ of_IN the_DT wheezers_NNS are_VBP symptom-free_JJ when_WRB they_PRP start_VBP at_IN school_NN 
In_IN Munich_NNP ,_, exposure_NN to_TO pollutants_NNS and_CC distance_NN to_TO main_JJ road_NN were_VBD associated_VBN with_IN doctor-diagnosed_JJ asthma_NN or_CC asthmatic_JJ bronchitis_NNS whereas_IN the_DT association_NN between_IN traffic_NN exposure_NN and_CC reported_VBD wheeze_NN was_VBD less_RBR consistent_JJ 
Asthma_NN is_VBZ a_DT heterogeneous_JJ disease_NN and_CC there_EX are_VBP several_JJ phenotypes_NNS of_IN childhood_NN wheezing_VBG 
Long-term_JJ exposure_NN to_TO outdoor_JJ air_NN pollutants_NNS had_VBD no_DT association_NN with_IN sensitization_NN in_IN ten-year-old_JJ schoolchildren_NNS in_IN Norway_NNP 
The_DT birth_NN cohorts_NNS from_IN Germany_NNP -LRB-_-LRB- Munich_NNP -RRB-_-RRB- ,_, the_DT Netherlands_NNP and_CC Sweden_NNP -LRB-_-LRB- Stockholm_NNP -RRB-_-RRB- participated_VBD in_IN TRAPCA_NNP ,_, an_DT international_JJ collaboration_NN on_IN the_DT impact_NN of_IN Traffic_NNP Related_NNP Air_NNP Pollution_NNP on_IN Childhood_NNP Asthma_NNP 
The_DT odds_NNS ratios_NNS for_IN sensitization_NN were_VBD slightly_RB reduced_VBN after_IN sensitivity_NN analysis_NN comprising_VBG only_JJ children_NNS who_WP had_VBD not_RB moved_VBN since_IN birth_NN ._. 
SwedenRespiratory_JJ health_NN and_CC allergic_JJ sensitization_NN were_VBD assessed_VBN at_IN four_CD years_NNS of_IN age_NN amongst_IN 3,515_CD children_NNS of_IN a_DT Swedish_JJ birth_NN cohort_NN -LRB-_-LRB- BAMSE_NNP -RRB-_-RRB- in_IN Stockholm_NNP within_IN the_DT TRAPCA_NNP study_NN ._. 
Individual_JJ exposure_NN to_TO traffic_NN pollutants_NNS was_VBD based_VBN on_IN an_DT atmospheric_JJ dispersion_NN model_NN with_IN high_JJ resolution_NN ._. 
53_CD -RRB-_-RRB- ,_, respectively_RB ._. 
10_CD to_TO 2_CD ._. 
67_CD -LRB-_-LRB- 1_CD ._. 
29_CD -RRB-_-RRB- and_CC 1_CD ._. 
23_CD to_TO 4_CD ._. 
30_CD -LRB-_-LRB- 95_CD %_NN CI_NNP 1_CD ._. 
Adjusted_NNP OR_NNP were_VBD 2_CD ._. 
Sensitization_NN to_TO pollen_NN was_VBD significantly_RB associated_VBN with_IN traffic-PM_NN 10_CD and_CC traffic-NO_NNP x_SYM ._. 
Another_DT paper_NN evaluated_VBD whether_IN potential_JJ effects_NNS of_IN traffic-related_JJ pollutants_NNS on_IN doctor-diagnosed_JJ asthma_NN ,_, wheezing_VBG symptoms_NNS and_CC sensitization_NN were_VBD modified_VBN by_IN polymorphism_NN in_IN genes_NNS encoding_VBG glutathione_NN S-transferase_NNP P1_NNP -LRB-_-LRB- GSTP1_NNP -RRB-_-RRB- and_CC tumor_NN necrosis_NN factor_NN -LRB-_-LRB- TNF_NNP -RRB-_-RRB- ._. 
The_DT study_NN had_VBD a_DT case-cohort_JJ design_NN of_IN in_IN all_DT 1,084_CD children_NNS comprising_VBG a_DT random_JJ sample_NN of_IN 709_CD children_NNS from_IN the_DT cohort_NN at_IN four_CD years_NNS -LRB-_-LRB- 542_CD non-wheezers_NNS and_CC 167_CD wheezers_NNS -RRB-_-RRB- and_CC in_IN addition_NN ,_, all_DT remaining_VBG children_NNS with_IN wheezing_VBG at_IN four_CD years_NNS ._. 
Some_DT studies_NNS seem_VBP to_TO have_VB a_DT very_RB high_JJ spatial_JJ resolution_NN in_IN exposure_NN data_NNS ,_, but_CC it_PRP is_VBZ difficult_JJ to_TO compare_VB these_DT different_JJ approaches_NNS ._. 
However_RB ,_, internal_JJ validations_NNS show_VBP for_IN example_NN that_IN the_DT dispersion_NN model_NN in_IN the_DT Norwegian_JJ study_NN 
In_IN Munich_NNP ,_, exposure_NN to_TO pollutants_NNS and_CC distance_NN to_TO main_JJ road_NN were_VBD associated_VBN with_IN doctor-diagnosed_JJ asthma_NN or_CC asthmatic_JJ bronchitis_NNS whereas_IN the_DT association_NN between_IN traffic_NN exposure_NN and_CC reported_VBD wheeze_NN was_VBD less_RBR consistent_JJ 
Asthma_NN is_VBZ a_DT heterogeneous_JJ disease_NN and_CC there_EX are_VBP several_JJ phenotypes_NNS of_IN childhood_NN wheezing_VBG 
The_DT birth_NN cohorts_NNS from_IN Germany_NNP -LRB-_-LRB- Munich_NNP -RRB-_-RRB- ,_, the_DT Netherlands_NNP and_CC Sweden_NNP -LRB-_-LRB- Stockholm_NNP -RRB-_-RRB- participated_VBD in_IN TRAPCA_NNP ,_, an_DT international_JJ collaboration_NN on_IN the_DT impact_NN of_IN Traffic_NNP Related_NNP Air_NNP Pollution_NNP on_IN Childhood_NNP Asthma_NNP 
The_DT birth_NN cohorts_NNS from_IN Germany_NNP -LRB-_-LRB- Munich_NNP -RRB-_-RRB- ,_, the_DT Netherlands_NNP and_CC Sweden_NNP -LRB-_-LRB- Stockholm_NNP -RRB-_-RRB- participated_VBD in_IN TRAPCA_NNP ,_, an_DT international_JJ collaboration_NN on_IN the_DT impact_NN of_IN Traffic_NNP Related_NNP Air_NNP Pollution_NNP on_IN Childhood_NNP Asthma_NNP 
Very_RB few_JJ children_NNS were_VBD reported_VBN to_TO have_VB doctor-diagnosed_JJ asthma_NN ._. 
51_CD -RRB-_-RRB- ,_, respectively_RB ._. 
00_CD to_TO 1_CD ._. 
23_CD -LRB-_-LRB- 95_CD %_NN CI_NNP 1_CD ._. 
The_DT third_JJ paper_NN evaluated_VBD the_DT outcome_NN of_IN long-term_JJ exposure_NN to_TO traffic-related_JJ air_NN pollutants_NNS at_IN six_CD years_NNS and_CC encompassed_VBD the_DT Munich_NNP metropolitan_JJ area_NN ,_, in_IN all_DT 3,066_CD children_NNS ._. 
The_DT individual_JJ exposure_NN modelling_NN was_VBD based_VBN on_IN the_DT home_NN addresses_NNS at_IN birth_NN ,_, two_CD or_CC three_CD years_NNS and_CC at_IN six_CD years_NNS ._. 
Wheezing_VBG is_VBZ not_RB specific_JJ for_IN asthma_NN and_CC many_JJ of_IN the_DT wheezers_NNS are_VBP symptom-free_JJ when_WRB they_PRP start_VBP at_IN school_NN 
In_IN the_DT Dutch_JJ cohort_NN ,_, exposure_NN to_TO traffic_NN related_VBN pollutants_NNS was_VBD associated_VBN with_IN an_DT increased_VBN risk_NN of_IN doctor-diagnosed_JJ asthma_NN and_CC wheeze_NN 
Long-term_JJ exposure_NN to_TO outdoor_JJ air_NN pollutants_NNS had_VBD no_DT association_NN with_IN sensitization_NN in_IN ten-year-old_JJ schoolchildren_NNS in_IN Norway_NNP 
The_DT birth_NN cohorts_NNS from_IN Germany_NNP -LRB-_-LRB- Munich_NNP -RRB-_-RRB- ,_, the_DT Netherlands_NNP and_CC Sweden_NNP -LRB-_-LRB- Stockholm_NNP -RRB-_-RRB- participated_VBD in_IN TRAPCA_NNP ,_, an_DT international_JJ collaboration_NN on_IN the_DT impact_NN of_IN Traffic_NNP Related_NNP Air_NNP Pollution_NNP on_IN Childhood_NNP Asthma_NNP 
The_DT birth_NN cohorts_NNS from_IN Germany_NNP -LRB-_-LRB- Munich_NNP -RRB-_-RRB- ,_, the_DT Netherlands_NNP and_CC Sweden_NNP -LRB-_-LRB- Stockholm_NNP -RRB-_-RRB- participated_VBD in_IN TRAPCA_NNP ,_, an_DT international_JJ collaboration_NN on_IN the_DT impact_NN of_IN Traffic_NNP Related_NNP Air_NNP Pollution_NNP on_IN Childhood_NNP Asthma_NNP 
The_DT associations_NNS were_VBD attenuated_VBN at_IN two_CD years_NNS ._. 
Dry_NNP cough_NN at_IN night_NN and_CC cough_NN without_IN infection_NN were_VBD associated_VBN with_IN slightly_RB increased_VBN odds_NNS ratios_NNS at_IN one_CD year_NN but_CC the_DT associations_NNS were_VBD significant_JJ only_RB in_IN boys_NNS ._. 
The_DT next_JJ paper_NN from_IN Munich_NNP also_RB evaluated_VBD the_DT effects_NNS of_IN air_NN pollutants_NNS at_IN one_CD and_CC two_CD years_NNS but_CC the_DT study_NN population_NN was_VBD doubled_VBN since_IN the_DT analyses_NNS comprised_VBD all_DT recruited_VBN children_NNS in_IN the_DT Munich_NNP metropolitan_JJ area_NN -LRB-_-LRB- city_NN and_CC surroundings_NNS -RRB-_-RRB- ._. 
The_DT individual_JJ exposure_NN assessment_NN was_VBD further_RB improved_VBN and_CC included_VBN buffer_NN zone_NN variables_NNS ._. 
In_IN contrast_NN to_TO the_DT previous_JJ paper_NN ,_, the_DT associations_NNS tended_VBD to_TO be_VB stronger_JJR in_IN girls_NNS ._. 
The_DT association_NN between_IN traffic-related_JJ air_NN pollutants_NNS and_CC respiratory_JJ health_NN during_IN infancy_NN was_VBD assessed_VBN in_IN three_CD birth_NN cohorts_NNS ._. 
In_IN two_CD of_IN the_DT large_JJ European_JJ birth_NN cohorts_NNS ,_, exposure_NN to_TO traffic_NN exhaust_NN was_VBD related_VBN to_TO slightly_RB increased_VBN odds_NNS ratios_NNS for_IN coughing_VBG symptoms_NNS 
The_DT birth_NN cohorts_NNS from_IN Germany_NNP -LRB-_-LRB- Munich_NNP -RRB-_-RRB- ,_, the_DT Netherlands_NNP and_CC Sweden_NNP -LRB-_-LRB- Stockholm_NNP -RRB-_-RRB- participated_VBD in_IN TRAPCA_NNP ,_, an_DT international_JJ collaboration_NN on_IN the_DT impact_NN of_IN Traffic_NNP Related_NNP Air_NNP Pollution_NNP on_IN Childhood_NNP Asthma_NNP 
However_RB ,_, the_DT protective_JJ effect_NN of_IN a_DT high_JJ lung_NN function_NN was_VBD attenuated_VBN in_IN children_NNS living_VBG in_IN communities_NNS with_IN a_DT high_JJ level_NN of_IN pollutants_NNS ._. 
Jerrett_NNP et_NNP al_RB assessed_VBD onset_NN of_IN asthma_NN in_IN a_DT sample_NN of_IN 217_CD children_NNS from_IN 11_CD communities_NNS in_IN southern_JJ California_NNP with_IN an_DT equal_JJ number_NN of_IN children_NNS from_IN two_CD strata_NNS in_IN each_DT community_NN -LRB-_-LRB- above_IN or_CC below_IN the_DT median_JJ traffic_NN exposure_NN -RRB-_-RRB- ._. 
At_IN the_DT entry_NN of_IN the_DT study_NN ,_, residential_JJ exposure_NN levels_NNS of_IN NO_DT 2_CD were_VBD monitored_VBN outside_IN the_DT homes_NNS during_IN two_CD weeks_NNS in_IN the_DT summer_NN and_CC two_CD weeks_NNS during_IN the_DT winter_NN season_NN ._. 
The_DT birth_NN cohorts_NNS from_IN Germany_NNP -LRB-_-LRB- Munich_NNP -RRB-_-RRB- ,_, the_DT Netherlands_NNP and_CC Sweden_NNP -LRB-_-LRB- Stockholm_NNP -RRB-_-RRB- participated_VBD in_IN TRAPCA_NNP ,_, an_DT international_JJ collaboration_NN on_IN the_DT impact_NN of_IN Traffic_NNP Related_NNP Air_NNP Pollution_NNP on_IN Childhood_NNP Asthma_NNP 
Doctor-diagnosed_JJ asthma_NN was_VBD associated_VBN with_IN high_JJ levels_NNS of_IN NO_DT 2_CD at_IN the_DT time_NN for_IN the_DT diagnosis_NN but_CC only_RB in_IN children_NNS with_IN exposure_NN to_TO violence_NN above_IN median_NN ._. 
JapanThe_JJ first_JJ paper_NN comprised_VBD 3,049_CD schoolchildren_NNS from_IN eight_CD different_JJ urban_JJ and_CC rural_JJ communities_NNS ._. 
Respiratory_JJ symptoms_NNS were_VBD evaluated_VBN annually_RB from_IN the_DT first_JJ through_IN the_DT sixth_JJ grades_NNS ._. 
Exposure_NN to_TO NO_DT 2_CD and_CC PM_NNP 10_CD were_VBD only_RB assessed_VBN at_IN community_NN level_NN from_IN monitoring_VBG stations_NNS usually_RB less_JJR than_IN 1_CD ._. 
Five_CD studies_NNS assessed_VBD the_DT outcome_NN in_IN schoolchildren_NN ._. 
Inconsistencies_NNS in_IN wheezing_VBG and_CC doctor_NN diagnosed_VBD asthma_NN between_IN countries_NNS could_MD possibly_RB be_VB related_VBN to_TO discrepancies_NNS in_IN the_DT interpretation_NN of_IN the_DT term_NN ``_`` wheeze_NN ''_'' and_CC variability_NN in_IN diagnostic_JJ routines_NNS and_CC labeling_VBG of_IN symptoms_NNS ._. 
In_IN the_DT two_CD Japanese_JJ cohorts_NNS ,_, urban_JJ schoolchildren_NNS exposed_VBN to_TO traffic_NN related_VBN pollutants_NNS and\/or_CC living_VBG close_RB to_TO main_JJ road_NN had_VBD an_DT increased_VBN prevalence_NN of_IN asthma_NN in_IN comparison_NN with_IN rural_JJ children_NNS ._. 
It_PRP could_MD not_RB be_VB excluded_VBN ,_, however_RB ,_, that_IN a_DT low_JJ prevalence_NN of_IN asthma_NN was_VBD attributed_VBN to_TO protective_JJ factors_NNS related_VBN to_TO rural_JJ living_NN ._. 
g._NNP Adjustment_NNP for_IN relevant_JJ covariates_NNS ,_, e._VB Potential_JJ effects_NNS of_IN traffic_NN related_VBN air_NN pollutants_NNS on_IN different_JJ wheezing_VBG phenotypes_NNS were_VBD only_RB assessed_VBN in_IN one_CD of_IN the_DT birth_NN cohorts_NNS 
Incidence_NN of_IN asthma_NN was_VBD associated_VBN with_IN increasing_VBG levels_NNS of_IN NO_DT 2_CD ._. 
4km_CD from_IN the_DT study_NN schools_NNS ._. 
Exposure_NN to_TO NO_DT 2_CD and_CC PM_NNP 10_CD were_VBD only_RB assessed_VBN at_IN community_NN level_NN from_IN monitoring_VBG stations_NNS usually_RB less_JJR than_IN 1_CD ._. 
In_IN the_DT second_JJ paper_NN ,_, 2,506_CD schoolchildren_NNS from_IN urban_JJ and_CC rural_JJ communities_NNS were_VBD followed_VBN for_IN four_CD years_NNS ._. 
Exposure_NN assessment_NN also_RB included_VBD the_DT distance_NN between_IN residential_JJ site_NN and_CC the_DT closest_JJS main_JJ road_NN ._. 
Five_CD studies_NNS assessed_VBD the_DT outcome_NN in_IN schoolchildren_NN ._. 
Inconsistencies_NNS in_IN wheezing_VBG and_CC doctor_NN diagnosed_VBD asthma_NN between_IN countries_NNS could_MD possibly_RB be_VB related_VBN to_TO discrepancies_NNS in_IN the_DT interpretation_NN of_IN the_DT term_NN ``_`` wheeze_NN ''_'' and_CC variability_NN in_IN diagnostic_JJ routines_NNS and_CC labeling_VBG of_IN symptoms_NNS ._. 
In_IN the_DT two_CD Japanese_JJ cohorts_NNS ,_, urban_JJ schoolchildren_NNS exposed_VBN to_TO traffic_NN related_VBN pollutants_NNS and\/or_CC living_VBG close_RB to_TO main_JJ road_NN had_VBD an_DT increased_VBN prevalence_NN of_IN asthma_NN in_IN comparison_NN with_IN rural_JJ children_NNS ._. 
It_PRP could_MD not_RB be_VB excluded_VBN ,_, however_RB ,_, that_IN a_DT low_JJ prevalence_NN of_IN asthma_NN was_VBD attributed_VBN to_TO protective_JJ factors_NNS related_VBN to_TO rural_JJ living_NN ._. 
g._NNP Adjustment_NNP for_IN relevant_JJ covariates_NNS ,_, e._VB Potential_JJ effects_NNS of_IN traffic_NN related_VBN air_NN pollutants_NNS on_IN different_JJ wheezing_VBG phenotypes_NNS were_VBD only_RB assessed_VBN in_IN one_CD of_IN the_DT birth_NN cohorts_NNS 
The_DT birth_NN cohorts_NNS from_IN Germany_NNP -LRB-_-LRB- Munich_NNP -RRB-_-RRB- ,_, the_DT Netherlands_NNP and_CC Sweden_NNP -LRB-_-LRB- Stockholm_NNP -RRB-_-RRB- participated_VBD in_IN TRAPCA_NNP ,_, an_DT international_JJ collaboration_NN on_IN the_DT impact_NN of_IN Traffic_NNP Related_NNP Air_NNP Pollution_NNP on_IN Childhood_NNP Asthma_NNP 
The_DT United_NNP States_NNPS Two_CD studies_NNS were_VBD based_VBN on_IN children_NNS participating_VBG in_IN the_DT Southern_NNP California_NNP Children_NNP 's_POS Health_NNP Study_NNP -LRB-_-LRB- CHS_NNP -RRB-_-RRB- ._. 
Islam_NNP et_FW al_FW has_VBZ prospectively_RB evaluated_VBN the_DT incidence_NN of_IN asthma_NN in_IN 2,057_CD schoolchildren_NN over_IN a_DT period_NN of_IN eight_CD years_NNS in_IN twelve_CD communities_NNS ._. 
Exposure_NN to_TO traffic_NN related_JJ air_NN pollutants_NNS was_VBD only_RB assessed_VBN at_IN area_NN level_NN and_CC classified_VBD as_RB high_JJ or_CC low_JJ ._. 
Lung_NN function_NN and_CC exposure_NN to_TO ambient_JJ air_NN pollutants_NNS appeared_VBD to_TO have_VB interactive_JJ effects_NNS on_IN the_DT development_NN of_IN asthma_NN in_IN one_CD of_IN the_DT studies_NNS ._. 
Exposure_NN assessment_NN was_VBD less_RBR sophisticated_JJ when_WRB compared_VBN with_IN the_DT European_JJ studies_NNS and_CC levels_NNS of_IN pollutants_NNS were_VBD only_RB defined_VBN as_IN high_JJ or_CC low_JJ ._. 
Residential_NNP exposure_NN to_TO NO_DT 2_CD was_VBD assessed_VBN in_IN the_DT other_JJ study_NN from_IN California_NNP but_CC this_DT study_NN had_VBD limitations_NNS due_JJ to_TO the_DT study_NN size_NN and_CC included_VBD only_RB 26_CD new_JJ cases_NNS of_IN asthma_NN over_IN a_DT period_NN of_IN eight_CD years_NNS ._. 
Most_JJS of_IN these_DT papers_NNS are_VBP too_RB recent_JJ to_TO have_VB influenced_VBN the_DT WHO_WP review_NN ._. 
The_DT following_JJ search_NN terms_NNS have_VBP been_VBN used_VBN in_IN PubMed_NNP and_CC Medline_NNP :_: Traffic_NN ,_, air_NN pollution_NN ,_, diesel_NN particulate_NN ,_, asthma_NN ,_, sensitization_NN ,_, cohort_NN ,_, child_NN Results_NNS We_PRP have_VBP evaluated_VBN 15_CD papers_NNS based_VBN on_IN 10_CD different_JJ cohort_NN studies_NNS from_IN Germany_NNP ,_, the_DT Netherlands_NNP ,_, Sweden_NNP ,_, Norway_NNP ,_, the_DT US_NNP and_CC Japan_NNP ,_, in_IN all_DT six_CD birth_NN cohorts_NNS and_CC four_CD prospective_JJ studies_NNS where_WRB the_DT children_NNS were_VBD enrolled_VBN at_IN or_CC after_IN entry_NN at_IN school_NN ._. 
The_DT birth_NN cohorts_NNS from_IN Germany_NNP -LRB-_-LRB- Munich_NNP -RRB-_-RRB- ,_, the_DT Netherlands_NNP and_CC Sweden_NNP -LRB-_-LRB- Stockholm_NNP -RRB-_-RRB- participated_VBD in_IN TRAPCA_NNP ,_, an_DT international_JJ collaboration_NN on_IN the_DT impact_NN of_IN Traffic_NNP Related_NNP Air_NNP Pollution_NNP on_IN Childhood_NNP Asthma_NNP 
Rather_RB substantial_JJ evidence_NN suggested_VBD that_IN the_DT inflammatory_JJ processes_NNS associated_VBN with_IN exposure_NN to_TO traffic_NN related_VBN pollutants_NNS contributed_VBD to_TO an_DT increased_VBN risk_NN of_IN non-allergic_JJ respiratory_JJ symptoms_NNS ._. 
Antioxidants_NNS and_CC possibly_RB surfactant_JJ components_NNS could_MD be_VB important_JJ determinants_NNS of_IN individual_JJ susceptibility_NN 
However_RB ,_, it_PRP was_VBD less_RBR clear_JJ whether_IN exposure_NN to_TO traffic_NN exhaust_NN may_MD induce_VB allergic_JJ sensitization_NN ._. 
Antioxidants_NNS and_CC possibly_RB surfactant_JJ components_NNS could_MD be_VB important_JJ determinants_NNS of_IN individual_JJ susceptibility_NN 
g._NNP Short-term_NNP exposure_NN to_TO air_NN pollutants_NNS has_VBZ been_VBN associated_VBN with_IN e._NN Background_NN There_EX is_VBZ a_DT strong_JJ body_NN of_IN evidence_NN that_IN traffic-related_JJ air_NN pollutants_NNS aggravate_VBP asthmatic_JJ symptoms_NNS ._. 
peak_NN flow_NN values_NNS 
g._NNP Short-term_NNP exposure_NN to_TO air_NN pollutants_NNS has_VBZ been_VBN associated_VBN with_IN e._NN Background_NN There_EX is_VBZ a_DT strong_JJ body_NN of_IN evidence_NN that_IN traffic-related_JJ air_NN pollutants_NNS aggravate_VBP asthmatic_JJ symptoms_NNS ._. 
peak_NN flow_NN values_NNS 
However_RB ,_, exposure_NN to_TO traffic_NN exhaust_NN may_MD also_RB induce_VB onset_NN of_IN asthma_NN and_CC asthma-like_JJ symptoms_NNS in_IN healthy_JJ individuals_NNS ._. 
Oxidative_JJ stress_NN has_VBZ been_VBN suggested_VBN as_IN the_DT major_JJ ,_, underlying_JJ mechanism_NN behind_IN many_JJ of_IN the_DT toxic_JJ reactions_NNS induced_VBN by_IN air_NN pollutants_NNS 
Oxidative_JJ stress_NN has_VBZ been_VBN suggested_VBN as_IN the_DT major_JJ ,_, underlying_JJ mechanism_NN behind_IN many_JJ of_IN the_DT toxic_JJ reactions_NNS induced_VBN by_IN air_NN pollutants_NNS 
g._NNP Short-term_NNP exposure_NN to_TO air_NN pollutants_NNS has_VBZ been_VBN associated_VBN with_IN e._NN Background_NN There_EX is_VBZ a_DT strong_JJ body_NN of_IN evidence_NN that_IN traffic-related_JJ air_NN pollutants_NNS aggravate_VBP asthmatic_JJ symptoms_NNS ._. 
peak_NN flow_NN values_NNS 
g._NNP Short-term_NNP exposure_NN to_TO air_NN pollutants_NNS has_VBZ been_VBN associated_VBN with_IN e._NN Background_NN There_EX is_VBZ a_DT strong_JJ body_NN of_IN evidence_NN that_IN traffic-related_JJ air_NN pollutants_NNS aggravate_VBP asthmatic_JJ symptoms_NNS ._. 
peak_NN flow_NN values_NNS 
g._NNP Short-term_NNP exposure_NN to_TO air_NN pollutants_NNS has_VBZ been_VBN associated_VBN with_IN e._NN Background_NN There_EX is_VBZ a_DT strong_JJ body_NN of_IN evidence_NN that_IN traffic-related_JJ air_NN pollutants_NNS aggravate_VBP asthmatic_JJ symptoms_NNS ._. 
peak_NN flow_NN values_NNS 
There_EX is_VBZ increasing_VBG evidence_NN mainly_RB from_IN experimental_JJ studies_NNS that_IN exposure_NN to_TO diesel_JJ exhaust_NN particles_NNS also_RB has_VBZ immunologic_JJ effects_NNS influencing_VBG the_DT development_NN of_IN allergic_JJ sensitization_NN ._. 
Several_JJ animal_NN and_CC human_NN in_IN vivo_NN and_CC in_IN vitro_NN studies_NNS strongly_RB suggest_VBP that_IN diesel_JJ exhaust_NN particles_NNS act_VBP as_IN adjuvants_NNS and_CC augment_VB the_DT allergic_JJ reaction_NN 
Several_JJ animal_NN and_CC human_NN in_IN vivo_NN and_CC in_IN vitro_NN studies_NNS strongly_RB suggest_VBP that_IN diesel_JJ exhaust_NN particles_NNS act_VBP as_IN adjuvants_NNS and_CC augment_VB the_DT allergic_JJ reaction_NN 
The_DT birth_NN cohorts_NNS from_IN Germany_NNP -LRB-_-LRB- Munich_NNP -RRB-_-RRB- ,_, the_DT Netherlands_NNP and_CC Sweden_NNP -LRB-_-LRB- Stockholm_NNP -RRB-_-RRB- participated_VBD in_IN TRAPCA_NNP ,_, an_DT international_JJ collaboration_NN on_IN the_DT impact_NN of_IN Traffic_NNP Related_NNP Air_NNP Pollution_NNP on_IN Childhood_NNP Asthma_NNP 
Two_CD papers_NNS have_VBP assessed_VBN development_NN of_IN symptoms_NNS during_IN the_DT first_JJ year_NN of_IN life_NN among_IN 633_CD children_NNS with_IN at_IN least_JJS one_CD atopic_JJ parent_NN in_IN an_DT ongoing_JJ birth_NN cohort_NN study_NN ,_, the_DT Cincinnati_NNP Childhood_NNP Allergy_NNP and_CC Air_NNP Pollution_NNP Study_NNP -LRB-_-LRB- CCAAPS_NNP -RRB-_-RRB- ._. 
In_IN the_DT first_JJ paper_NN ,_, individual_JJ exposure_NN to_TO traffic_NN was_VBD assessed_VBN using_VBG a_DT GIS_NNP model_NN and_CC a_DT traffic_NN exposure_NN classification_NN scheme_NN ._. 
Infants_NNS who_WP resided_VBD less_JJR than_IN 50_CD m_NN from_IN stop-and-go_JJ traffic_NN had_VBD a_DT threefold_RB increased_VBN risk_NN of_IN wheeze_NN without_IN cold_NN compared_VBN with_IN those_DT children_NNS who_WP were_VBD unexposed_JJ ._. 
The_DT association_NN between_IN traffic-related_JJ air_NN pollutants_NNS and_CC respiratory_JJ health_NN during_IN infancy_NN was_VBD assessed_VBN in_IN three_CD birth_NN cohorts_NNS ._. 
In_IN two_CD of_IN the_DT large_JJ European_JJ birth_NN cohorts_NNS ,_, exposure_NN to_TO traffic_NN exhaust_NN was_VBD related_VBN to_TO slightly_RB increased_VBN odds_NNS ratios_NNS for_IN coughing_VBG symptoms_NNS 
Our_PRP$ results_NNS suggest_VBP that_IN there_EX could_MD be_VB a_DT difference_NN of_IN nearly_RB a_DT factor_NN seven_CD in_IN creatinine-adjusted_JJ concentrations_NNS of_IN a_DT metabolite_NN measured_VBN in_IN two_CD different_JJ urine_NN samples_NNS taken_VBD the_DT same_JJ day_NN from_IN a_DT same_JJ individual_NN solely_RB due_JJ to_TO the_DT intra-individual_JJ intra-day_JJ variation_NN in_IN creatinine_NN excretion_NN rate_NN ._. 
Inter-individual_JJ variability_NN in_IN the_DT urinary_JJ output_NN and_CC creatinine_NN excretion_NN rate_NN has_VBZ also_RB been_VBN extensively_RB studied_VBN ;_: factors_NNS influencing_VBG these_DT variations_NNS include_VBP age_NN ,_, gender_NN ,_, ethnicity_NN ,_, fat-free_JJ mass_NN and_CC height_NN ,_, ambient_JJ temperature_NN ,_, physical_JJ activity_NN 
However_RB ,_, it_PRP is_VBZ often_RB deemed_VBN difficult_JJ to_TO achieve_VB in_IN some_DT cases_NNS due_JJ the_DT risk_NN of_IN incomplete_JJ samples_NNS ,_, insufficient_JJ adherence_NN to_TO the_DT protocol_NN and_CC potential_JJ attrition_NN among_IN the_DT participants_NNS ._. 
Therefore_RB ,_, urinary_JJ metabolite_NN levels_NNS of_IN these_DT pesticides_NNS are_VBP usually_RB reported_VBN in_IN volume-weighted_JJ concentrations_NNS -LRB-_-LRB- 
However_RB ,_, it_PRP is_VBZ often_RB deemed_VBN difficult_JJ to_TO achieve_VB in_IN some_DT cases_NNS due_JJ the_DT risk_NN of_IN incomplete_JJ samples_NNS ,_, insufficient_JJ adherence_NN to_TO the_DT protocol_NN and_CC potential_JJ attrition_NN among_IN the_DT participants_NNS ._. 
Therefore_RB ,_, urinary_JJ metabolite_NN levels_NNS of_IN these_DT pesticides_NNS are_VBP usually_RB reported_VBN in_IN volume-weighted_JJ concentrations_NNS -LRB-_-LRB- 
In_IN the_DT specific_JJ case_NN of_IN non-persistent_JJ pesticides_NNS ,_, namely_RB pyrethroids_NNS and_CC organophosphates_NNS -LRB-_-LRB- OPs_NNP -RRB-_-RRB- ,_, the_DT determination_NN of_IN amounts_NNS of_IN a_DT biomarker_NN in_IN 24-h_JJ urine_NN collections_NNS is_VBZ generally_RB considered_VBN the_DT ``_`` benchmark_JJ ''_'' unit_NN of_IN expression_NN of_IN biomonitoring_VBG results_NNS ._. 
Some_DT authors_NNS have_VBP successfully_RB measured_VBN cumulative_JJ daily_JJ amounts_NNS or_CC hourly_JJ excretion_NN rates_NNS of_IN pyrethroids_NNS -LRB-_-LRB- 
and_CC by_IN Mage_FW et_FW al._FW ._. 
Estimation_NN of_IN daily_RB absorbed_VBN dose_NN from_IN metabolite_JJ creatinine-adjusted_JJ concentrations_NNS in_IN nighttime_JJ collections_NNS For_IN dose_NN reconstruction_NN from_IN creatinine-adjusted_JJ concentrations_NNS -LRB-_-LRB- DDCAC_NNP p_NN -RRB-_-RRB- ,_, the_DT approaches_NNS published_VBN by_IN Fenske_NNP et_FW al._FW ._. 
Gorse_NNP ,_, personal_JJ communication_NN -RRB-_-RRB- ._. 
Permethrin_NNP was_VBD chosen_VBN since_IN it_PRP appears_VBZ as_IN one_CD of_IN the_DT main_JJ pyrethroids_NNS to_TO which_WDT the_DT general_JJ population_NN is_VBZ chronically_RB exposed_VBN 
With_IN a_DT more_RBR refined_JJ approach_NN published_VBN by_IN Mage_FW et_FW al._FW 7_CD times_NNS ,_, the_DT values_NNS obtained_VBN from_IN cumulative_JJ amounts_NNS ._. 
for_IN dose_NN reconstruction_NN based_VBN on_IN creatinine-adjusted_JJ concentrations_NNS that_WDT takes_VBZ into_IN account_NN the_DT height_NN of_IN the_DT subjects_NNS in_IN addition_NN to_TO their_PRP$ weight_NN and_CC age_NN ,_, the_DT estimates_NNS of_IN absorbed_VBN dose_NN were_VBD slightly_RB closer_JJR to_TO the_DT values_NNS calculated_VBN from_IN cumulative_JJ amounts_NNS of_IN biomarker_NN -LRB-_-LRB- Table_NNP 7_CD -RRB-_-RRB- ,_, ranging_VBG from_IN -63_CD %_NN to_TO +93_CD %_NN of_IN the_DT actual_JJ amounts_NNS in_IN the_DT case_NN of_IN adults_NNS and_CC from_IN -61_CD %_NN to_TO +187_CD %_NN in_IN the_DT case_NN of_IN children_NNS ._. 
Effect_NN of_IN inter-individual_JJ variability_NN in_IN the_DT urinary_JJ flow_NN rate_NN and_CC creatinine_NN excretion_NN rate_NN on_IN the_DT comparison_NN of_IN biomarker_NN values_NNS between_IN two_CD populations_NNS Table_NNP 8_CD shows_VBZ the_DT effect_NN of_IN the_DT units_NNS of_IN measurements_NNS -LRB-_-LRB- volume-weighted_JJ or_CC creatinine_JJ adjusted_JJ concentrations_NNS -RRB-_-RRB- on_IN results_NNS of_IN the_DT comparison_NN of_IN pyrethroid_NN biomarker_NN levels_NNS between_IN two_CD populations_NNS -LRB-_-LRB- urban_JJ versus_CC rural_JJ -RRB-_-RRB- ._. 
In_IN 2007_CD ,_, Mage_FW et_FW al._FW ._. 
Results_NNS of_IN our_PRP$ study_NN show_VBP that_DT variability_NN in_IN creatinine_NN excretion_NN and_CC urinary_JJ output_NN will_MD directly_RB influence_VB the_DT estimates_NNS of_IN reconstructed_JJ absorbed_VBN dose_NN of_IN pyrethroids_NNS in_IN an_DT individual_NN conducted_VBN on_IN the_DT basis_NN of_IN the_DT volume-weighted_JJ or_CC creatinine-adjusted_JJ concentrations_NNS of_IN biomarkers_NNS ._. 
proposed_VBN a_DT formula_NN to_TO predict_VB daily_JJ creatinine_NN excretion_NN to_TO estimate_VB pesticide_NN daily_RB absorbed_VBD doses_NNS from_IN creatinine-adjusted_JJ concentrations_NNS of_IN metabolites_NNS in_IN spot_NN urine_NN samples_NNS while_IN accounting_VBG for_IN inter-individual_JJ differences_NNS in_IN age_NN ,_, gender_NN ,_, height_NN and_CC weight_NN ._. 
Although_IN this_DT latter_JJ approach_NN yields_NNS results_NNS closer_RBR to_TO the_DT cumulative_JJ amounts_NNS directly_RB measured_VBN in_IN urine_NN than_IN the_DT approach_NN used_VBN by_IN Fenske_NNP et_FW al._FW 
Our_PRP$ results_NNS suggest_VBP that_IN there_EX could_MD be_VB a_DT difference_NN of_IN nearly_RB a_DT factor_NN seven_CD in_IN creatinine-adjusted_JJ concentrations_NNS of_IN a_DT metabolite_NN measured_VBN in_IN two_CD different_JJ urine_NN samples_NNS taken_VBD the_DT same_JJ day_NN from_IN a_DT same_JJ individual_NN solely_RB due_JJ to_TO the_DT intra-individual_JJ intra-day_JJ variation_NN in_IN creatinine_NN excretion_NN rate_NN ._. 
Inter-individual_JJ variability_NN in_IN the_DT urinary_JJ output_NN and_CC creatinine_NN excretion_NN rate_NN has_VBZ also_RB been_VBN extensively_RB studied_VBN ;_: factors_NNS influencing_VBG these_DT variations_NNS include_VBP age_NN ,_, gender_NN ,_, ethnicity_NN ,_, fat-free_JJ mass_NN and_CC height_NN ,_, ambient_JJ temperature_NN ,_, physical_JJ activity_NN 
._. 
,diabetes_NNS ,_, lupus_NN -RRB-_-RRB- ,_, menstrual_JJ cycle_NN ,_, etc._FW g._FW Volume-weighted_JJ concentrations_NNS are_VBP influenced_VBN by_IN urine_NN dilution_NN ,_, which_WDT has_VBZ been_VBN documented_VBN to_TO be_VB subject_JJ to_TO important_JJ intra_NN -_: and_CC inter-individual_JJ variations_NNS due_JJ to_TO the_DT variability_NN in_IN intrinsic_JJ and_CC extrinsic_JJ factors_NNS :_: liquid_JJ intake_NN ,_, perspiration_NN ,_, humidity_NN level_NN ,_, circadian_JJ changes_NNS ,_, glomerular_JJ filtration_NN rate_NN ,_, age_NN ,_, disease_NN -LRB-_-LRB- e._FW To_TO account_VB for_IN the_DT variations_NNS in_IN urine_NN volume_NN ,_, numerous_JJ researchers_NNS re_VBP 
._. 
fold_VB -RRB-_-RRB- during_IN the_DT course_NN of_IN a_DT day_NN in_IN adults_NNS ,_, the_DT latter_JJ being_VBG larger_JJR than_IN the_DT day-to-day_JJ variations_NNS reported_VBN by_IN Garde_NNP et_FW al._FW ._. 
Those_DT variations_NNS are_VBP likely_JJ the_DT consequence_NN of_IN fluid_JJ intake_NN for_IN the_DT former_JJ and_CC dietary_JJ protein_NN intake_NN 
To_TO account_VB for_IN the_DT variations_NNS in_IN urine_NN volume_NN ,_, numerous_JJ researchers_NNS rely_VBP on_IN creatinine_NN standardization_NN although_IN creatinine_NN levels_NNS have_VBP also_RB been_VBN reported_VBN to_TO be_VB subject_JJ to_TO intra_NN -_: and_CC inter-individual_JJ variations_NNS linked_VBN to_TO :_: physical_JJ activity_NN ,_, circadian_JJ changes_NNS ,_, age_NN ,_, gender_NN ,_, ethnicity_NN ,_, body_NN size_NN ,_, lean-body_JJ mass_NN and_CC protein_NN intake_NN 
Estimation_NN of_IN daily_RB absorbed_VBN dose_NN from_IN metabolite_JJ volume-weighted_JJ concentrations_NNS in_IN nighttime_JJ collections_NNS For_IN dose_NN reconstruction_NN from_IN volume-weighted_JJ concentrations_NNS -LRB-_-LRB- DDVWC_NNP p_NN -RRB-_-RRB- ,_, the_DT approach_NN published_VBN by_IN Fenske_NNP et_FW al._FW ._. 
was_VBD followed_VBN -LRB-_-LRB- equation_NN 3_CD -RRB-_-RRB- ._. 
Daily_JJ exposure_NN to_TO permethrin_NN was_VBD determined_VBN from_IN the_DT volume-weighted_JJ concentrations_NNS -LRB-_-LRB- 
Estimation_NN of_IN daily_RB absorbed_VBN dose_NN from_IN metabolite_JJ creatinine-adjusted_JJ concentrations_NNS in_IN nighttime_JJ collections_NNS For_IN dose_NN reconstruction_NN from_IN creatinine-adjusted_JJ concentrations_NNS -LRB-_-LRB- DDCAC_NNP p_NN -RRB-_-RRB- ,_, the_DT approaches_NNS published_VBN by_IN Fenske_NNP et_FW al._FW ._. 
The_DT estimated_VBN absorbed_VBD daily_JJ dose_NN of_IN permethrin_NN reconstructed_VBN from_IN volume-weighted_JJ concentrations_NNS -LRB-_-LRB- as_IN proposed_VBN by_IN Fenske_NNP et_FW al._FW ._. -RRB-_-RRB- 
-LRB-_-LRB- Table_NNP 5_CD -RRB-_-RRB- or_CC creatinine-adjusted_JJ concentrations_NNS -LRB-_-LRB- as_IN proposed_VBN by_IN Fenske_NNP et_FW al._FW ._. 
-RRB-_-RRB- -LRB-_-LRB- Table_NNP 5_CD -RRB-_-RRB- or_CC creatinine-adjusted_JJ concentrations_NNS -LRB-_-LRB- as_IN proposed_VBN by_IN Fenske_NNP et_FW al._FW ._. 
The_DT estimated_VBN absorbed_VBD daily_JJ dose_NN of_IN permethrin_NN reconstructed_VBN from_IN volume-weighted_JJ concentrations_NNS -LRB-_-LRB- as_IN proposed_VBN by_IN Fenske_NNP et_FW al._FW ._. 
52_CD a_DT Calculated_VBN according_VBG to_TO the_DT method_NN of_IN Fenske_NNP et_FW al._FW 00980_CD 0_CD ._. 
0188_CD 0_CD ._. 
63_CD Highest_JJS f_SYM 0_CD ._. 
0115_CD 0_CD ._. 
0183_CD 0_CD ._. 
bAbsorbed_JJ dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT lowest_JJS urinary_JJ flow_NN ratecAbsorbed_VBD dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT urinary_JJ flow_NN rate_NN closest_JJS to_TO the_DT 5th_JJ percentile_NN valuedAbsorbed_VBD dose_NN estimates_NNS for_IN the_DT participants_NNS with_IN the_DT median_JJ urinary_JJ flow_NN rateeAbsorbed_VBD dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT urinary_JJ flow_NN rate_NN closest_JJS to_TO the_DT 95th_JJ percentile_NN valuefAbsorbed_VBD dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT highest_JJS urinary_JJ flow_NN rateTable_JJ 6Absorbed_JJ permethrin_NN dose_NN estimated_VBN from_IN creatinine-adjusted_JJ concentrations_NNS -LRB-_-LRB- C1_CD -RRB-_-RRB- and_CC amounts_NNS -LRB-_-LRB- A_NN -RRB-_-RRB- of_IN DCCAPermethrin_NNP absorbed_VBD doseRelative_JJ creatinine_NN excretion_NN rate_NN -LRB-_-LRB- A_NN -RRB-_-RRB- Estimated_VBN from_IN cumulative_JJ amounts_NNS -LRB-_-LRB- 
42_CD a_DT Calculated_VBN according_VBG to_TO the_DT method_NN of_IN Fenske_NNP et_FW al._FW 00786_CD 0_CD ._. 
0188_CD 0_CD ._. 
65_CD Highest_JJS f_SYM 0_CD ._. 
0153_CD 0_CD ._. 
0237_CD 0_CD ._. 
bAbsorbed_JJ dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT lowest_JJS creatinine_NN excretion_NN ratecAbsorbed_VBD dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT creatinine_NN excretion_NN rate_NN closest_JJS to_TO the_DT 5th_JJ percentile_NN valuedAbsorbed_VBD dose_NN estimates_NNS for_IN the_DT participants_NNS with_IN the_DT median_JJ creatinine_NN excretion_NN rateeAbsorbed_VBD dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT creatinine_NN excretion_NN rate_NN closest_JJS to_TO the_DT 95th_JJ percentile_NN valuefAbsorbed_VBD dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT highest_JJS creatinine_NN excretion_NN rateTable_NNP 7Absorbed_NNP permethrin_NN dose_NN estimated_VBN from_IN creatinine-adjusted_JJ concentrations_NNS -LRB-_-LRB- C2_CD -RRB-_-RRB- and_CC amounts_NNS -LRB-_-LRB- A_NN -RRB-_-RRB- of_IN DCCAPermethrin_NNP absorbed_VBD doseRelative_JJ creatinine_NN excretion_NN rate_NN -LRB-_-LRB- A_NN -RRB-_-RRB- Estimated_VBN from_IN cumulative_JJ amounts_NNS -LRB-_-LRB- 
Although_IN this_DT latter_JJ approach_NN yields_NNS results_NNS closer_RBR to_TO the_DT cumulative_JJ amounts_NNS directly_RB measured_VBN in_IN urine_NN than_IN the_DT approach_NN used_VBN by_IN Fenske_NNP et_FW al._FW ._. 
,it_NN is_VBZ nonetheless_RB not_RB very_RB precise_JJ for_IN individuals_NNS with_IN marginal_JJ creatinine_NN excretions_NNS -LRB-_-LRB- high_JJ or_CC low_JJ -RRB-_-RRB- ,_, or_CC atypical_JJ creatinine_NN excretion_NN -LRB-_-LRB- i._FW e._FW urinary_JJ creatinine_NN excretion_NN not_RB well_RB predicted_VBN by_IN the_DT formula_NN -RRB-_-RRB- ,_, as_IN observed_VBN in_IN our_PRP$ study_NN ._. 
In_IN fact_NN ,_, errors_NNS in_IN dose_NN estimates_NNS based_VBN on_IN creatinine-adjusted_JJ or_CC volume-weighted_JJ concentrations_NNS can_MD reach_VB 500_CD %_NN or_CC more_JJR in_IN some_DT cases_NNS ._. 
,diabetes_NNS ,_, lupus_NN -RRB-_-RRB- ,_, menstrual_JJ cycle_NN ,_, etc._FW g._FW Volume-weighted_JJ concentrations_NNS are_VBP influenced_VBN by_IN urine_NN dilution_NN ,_, which_WDT has_VBZ been_VBN documented_VBN to_TO be_VB subject_JJ to_TO important_JJ intra_NN -_: and_CC inter-individual_JJ variations_NNS due_JJ to_TO the_DT variability_NN in_IN intrinsic_JJ and_CC extrinsic_JJ factors_NNS :_: liquid_JJ intake_NN ,_, perspiration_NN ,_, humidity_NN level_NN ,_, circadian_JJ changes_NNS ,_, glomerular_JJ filtration_NN rate_NN ,_, age_NN ,_, disease_NN -LRB-_-LRB- e._SYM 
._. 
,diabetes_NNS ,_, lupus_NN -RRB-_-RRB- ,_, menstrual_JJ cycle_NN ,_, etc._FW g._FW Volume-weighted_JJ concentrations_NNS are_VBP influenced_VBN by_IN urine_NN dilution_NN ,_, which_WDT has_VBZ been_VBN documented_VBN to_TO be_VB subject_JJ to_TO important_JJ intra_NN -_: and_CC inter-individual_JJ variations_NNS due_JJ to_TO the_DT variability_NN in_IN intrinsic_JJ and_CC extrinsic_JJ factors_NNS :_: liquid_JJ intake_NN ,_, perspiration_NN ,_, humidity_NN level_NN ,_, circadian_JJ changes_NNS ,_, glomerular_JJ filtration_NN rate_NN ,_, age_NN ,_, disease_NN -LRB-_-LRB- e._FW To_TO account_VB for_IN the_DT variations_NNS in_IN urine_NN volume_NN ,_, numerous_JJ researchers_NNS rely_VBP on_IN creatinine_NN standardization_NN although_IN creatinine_NN levels_NNS have_VBP also_RB been_VBN reported_VBN to_TO be_VB subject_JJ to_TO intra_NN -_: and_CC inter-individual_JJ variations_NNS linked_VBN to_TO :_: physical_JJ activity_NN ,_, circadian_JJ changes_NNS ,_, age_NN ,_, gender_NN ,_, ethnicity_NN ,_, body_NN size_NN ,_, lean-body_JJ mass_NN and_CC protein_NN intake_NN 
Our_PRP$ results_NNS suggest_VBP that_IN there_EX could_MD be_VB a_DT difference_NN of_IN nearly_RB a_DT factor_NN seven_CD in_IN creatinine-adjusted_JJ concentrations_NNS of_IN a_DT metabolite_NN measured_VBN in_IN two_CD different_JJ urine_NN samples_NNS taken_VBD the_DT same_JJ day_NN from_IN a_DT same_JJ individual_NN solely_RB due_JJ to_TO the_DT intra-individual_JJ intra-day_JJ variation_NN in_IN creatinine_NN excretion_NN rate_NN ._. 
Inter-individual_JJ variability_NN in_IN the_DT urinary_JJ output_NN and_CC creatinine_NN excretion_NN rate_NN has_VBZ also_RB been_VBN extensively_RB studied_VBN ;_: factors_NNS influencing_VBG these_DT variations_NNS include_VBP age_NN ,_, gender_NN ,_, ethnicity_NN ,_, fat-free_JJ mass_NN and_CC height_NN ,_, ambient_JJ temperature_NN ,_, physical_JJ activity_NN 
Barr_NNP et_NNP al._NNP ._. 
In_IN another_DT context_NN ,_, if_IN one_CD would_MD compare_VB concentrations_NNS of_IN a_DT pyrethroid_NN metabolite_NN in_IN an_DT Asian_JJ population_NN to_TO those_DT of_IN North-Americans_NNP on_IN the_DT basis_NN of_IN creatinine-adjusted_JJ values_NNS ,_, significant_JJ differences_NNS could_MD emerge_VB due_JJ to_TO variations_NNS in_IN creatinine_NN excretion_NN rate_NN as_IN a_DT result_NN of_IN differences_NNS in_IN muscular_JJ mass_NN between_IN the_DT two_CD populations_NNS -LRB-_-LRB- higher_JJR stature_NN of_IN North-Americans_NNS compared_VBN to_TO Asians_NNPS -RRB-_-RRB- ._. 
described_VBN in_IN details_NNS the_DT factors_NNS influencing_VBG inter-individual_JJ creatinine_NN variability_NN in_IN the_DT US_NNP population_NN and_CC analyzed_VBD the_DT influence_NN of_IN different_JJ factors_NNS ,_, including_VBG ethnicity_NN ,_, gender_NN and_CC age_NN ,_, with_IN a_DT multiple_JJ linear_JJ regression_NN model_NN ._. 
They_PRP then_RB stratified_VBD creatinine_NN concentrations_NNS in_IN their_PRP$ population_NN -LRB-_-LRB- n_SYM =_SYM 22_CD 245_CD ,_, NHANES_NNP -RRB-_-RRB- according_VBG to_TO these_DT factors_NNS ,_, thus_RB providing_VBG reference_NN values_NNS for_IN different_JJ subgroups_NNS of_IN the_DT US_NNP population_NN ._. 
The_DT application_NN of_IN the_DT regression_NN model_NN elaborated_VBD by_IN Barr_NNP et_FW al._FW ._. 
They_PRP then_RB stratified_VBD creatinine_NN concentrations_NNS in_IN their_PRP$ population_NN -LRB-_-LRB- n_SYM =_SYM 22_CD 245_CD ,_, NHANES_NNP -RRB-_-RRB- according_VBG to_TO these_DT factors_NNS ,_, thus_RB providing_VBG reference_NN values_NNS for_IN different_JJ subgroups_NNS of_IN the_DT US_NNP population_NN ._. 
in_IN such_PDT a_DT context_NN might_MD not_RB be_VB adequate_JJ since_IN the_DT coefficients_NNS were_VBD derived_VBN for_IN people_NNS of_IN different_JJ races_NNS ,_, but_CC living_VBG more_JJR or_CC less_JJR in_IN the_DT same_JJ environment_NN ._. 
Therefore_RB ,_, to_TO verify_VB adequately_RB that_IN there_EX is_VBZ no_DT bias_NN in_IN the_DT results_NNS of_IN comparisons_NNS of_IN exposure_NN levels_NNS assessed_VBN on_IN the_DT basis_NN of_IN volume-weighted_JJ or_CC creatinine-adjusted_JJ concentrations_NNS between_IN populations_NNS from_IN different_JJ countries_NNS ,_, one_CD also_RB needs_VBZ to_TO verify_VB if_IN there_EX is_VBZ a_DT significant_JJ difference_NN in_IN the_DT urinary_JJ flow_NN rate_NN or_CC in_IN the_DT creatinine_NN excretion_NN rate_NN ,_, which_WDT requires_VBZ timed_VBN collections_NNS ._. 
Those_DT variations_NNS are_VBP likely_JJ the_DT consequence_NN of_IN fluid_JJ intake_NN for_IN the_DT former_JJ and_CC dietary_JJ protein_NN intake_NN 
Adult_NN participants_NNS gave_VBD their_PRP$ informed_JJ consent_NN and_CC children_NNS gave_VBD their_PRP$ assent_NN in_IN addition_NN to_TO the_DT parents_NNS consent_NN ._. 
Study_NNP 1_CD consisted_VBD in_IN the_DT biomonitoring_NN of_IN OP_NNP exposure_NN in_IN a_DT group_NN of_IN horticultural_JJ greenhouse_NN workers_NNS with_IN low_JJ physical_JJ workload_NN -LRB-_-LRB- n_VB =_SYM 15_CD -RRB-_-RRB- ._. 
The_DT workers_NNS collected_VBD all_DT their_PRP$ urine_NN during_IN a_DT 24-h_JJ period_NN ;_: they_PRP provided_VBD each_DT void_NN in_IN a_DT separate_JJ bottle_NN and_CC recorded_VBD the_DT time_NN of_IN each_DT micturition_NN ._. 
The_DT creatinine_NN concentration_NN was_VBD assessed_VBN with_IN a_DT DRI_NNP creatinine_NN kit_NN from_IN Diagnostix_NNP Ltd_NNP -LRB-_-LRB- Mississauga_NNP ,_, Canada_NNP -RRB-_-RRB- ._. 
The_DT other_JJ analytical_JJ methods_NNS followed_VBN are_VBP described_VBN in_IN details_NNS elsewhere_RB ._. 
Data_NNP analysis_NN Assessment_NNP of_IN the_DT variability_NN in_IN the_DT urinary_JJ flow_NN rate_NN and_CC creatinine_NN excretion_NN rate_NN Metabolite_NN conc_NN 
Using_VBG the_DT method_NN of_IN Fenske_NNP et_FW al._FW ._. 
were_VBD followed_VBN -LRB-_-LRB- equation_NN 4_CD -RRB-_-RRB- ._. 
Gorse_NNP ,_, personal_JJ communication_NN -RRB-_-RRB- ._. 
Permethrin_NNP was_VBD chosen_VBN since_IN it_PRP appears_VBZ as_IN one_CD of_IN the_DT main_JJ pyrethroids_NNS to_TO which_WDT the_DT general_JJ population_NN is_VBZ chronically_RB exposed_VBN 
was_VBD followed_VBN -LRB-_-LRB- equation_NN 3_CD -RRB-_-RRB- ._. 
Estimation_NN of_IN daily_RB absorbed_VBN dose_NN from_IN metabolite_JJ volume-weighted_JJ concentrations_NNS in_IN nighttime_JJ collections_NNS For_IN dose_NN reconstruction_NN from_IN volume-weighted_JJ concentrations_NNS -LRB-_-LRB- DDVWC_NNP p_NN -RRB-_-RRB- ,_, the_DT approach_NN published_VBN by_IN Fenske_NNP et_FW al._FW ._. 
Daily_JJ exposure_NN to_TO permethrin_NN was_VBD determined_VBN from_IN the_DT volume-weighted_JJ concentrations_NNS -LRB-_-LRB- 
Gorse_NNP ,_, personal_JJ communication_NN -RRB-_-RRB- ._. 
Permethrin_NNP was_VBD chosen_VBN since_IN it_PRP appears_VBZ as_IN one_CD of_IN the_DT main_JJ pyrethroids_NNS to_TO which_WDT the_DT general_JJ population_NN is_VBZ chronically_RB exposed_VBN 
This_DT led_VBD to_TO identify_VB the_DT most_RBS suitable_JJ units_NNS of_IN expression_NN of_IN biomonitoring_VBG data_NNS and_CC straightforward_JJ strategies_NNS for_IN data_NNS collection_NN in_IN the_DT case_NN of_IN non-persistent_JJ pesticides_NNS such_JJ as_IN pyrethroids_NNS ._. 
Intra-individual_JJ day-to-day_JJ variations_NNS in_IN daily_JJ creatinine_NN excretion_NN -LRB-_-LRB- g\/day_NN -RRB-_-RRB- have_VBP been_VBN well_RB documented_VBN but_CC ,_, to_TO our_PRP$ knowledge_NN ,_, this_DT is_VBZ the_DT first_JJ report_NN of_IN between-void_JJ variability_NN in_IN creatinine_NN excretion_NN rate_NN and_CC urinary_JJ flow_NN rate_NN during_IN the_DT course_NN of_IN a_DT day_NN ._. 
In_IN an_DT assessment_NN of_IN intra-individual_JJ day-to-day_JJ variations_NNS in_IN creatinine_NN excretion_NN rate_NN in_IN 24-h_JJ urine_NN collections_NNS based_VBN on_IN several_JJ studies_NNS ,_, Garde_FW et_FW al._FW 
This_DT led_VBD to_TO identify_VB the_DT most_RBS suitable_JJ units_NNS of_IN expression_NN of_IN biomonitoring_VBG data_NNS and_CC straightforward_JJ strategies_NNS for_IN data_NNS collection_NN in_IN the_DT case_NN of_IN non-persistent_JJ pesticides_NNS such_JJ as_IN pyrethroids_NNS ._. 
Intra-individual_JJ day-to-day_JJ variations_NNS in_IN daily_JJ creatinine_NN excretion_NN -LRB-_-LRB- g\/day_NN -RRB-_-RRB- have_VBP been_VBN well_RB documented_VBN but_CC ,_, to_TO our_PRP$ knowledge_NN ,_, this_DT is_VBZ the_DT first_JJ report_NN of_IN between-void_JJ variability_NN in_IN creatinine_NN excretion_NN rate_NN and_CC urinary_JJ flow_NN rate_NN during_IN the_DT course_NN of_IN a_DT day_NN ._. 
In_IN an_DT assessment_NN of_IN intra-individual_JJ day-to-day_JJ variations_NNS in_IN creatinine_NN excretion_NN rate_NN in_IN 24-h_JJ urine_NN collections_NNS based_VBN on_IN several_JJ studies_NNS ,_, Garde_FW et_FW al._FW 
As_IN for_IN volume-weighted_JJ concentrations_NNS ,_, they_PRP are_VBP converted_VBN to_TO 24-h_JJ excretions_NNS using_VBG age_NN -_: and_CC gender-specific_JJ default_NN daily_JJ urine_NN volumes_NNS ._. 
Pyrethroids_NNS are_VBP compounds_NNS with_IN relatively_RB short_JJ half-lives_NNS and_CC a_DT large_JJ fraction_NN ,_, as_RB much_JJ as_IN 78_CD %_NN ,_, of_IN an_DT oral_JJ dose_NN in_IN volunteers_NNS is_VBZ excreted_VBN as_IN metabolites_NNS in_IN urine_NN within_IN 24_CD hours_NNS post-exposure_NN 
To_TO account_VB for_IN the_DT variations_NNS in_IN urine_NN volume_NN ,_, numerous_JJ researchers_NNS rely_VBP on_IN creatinine_NN standardization_NN although_IN creatinine_NN levels_NNS have_VBP also_RB been_VBN reported_VBN to_TO be_VB subject_JJ to_TO intra_NN -_: and_CC inter-individual_JJ variations_NNS linked_VBN to_TO :_: physical_JJ activity_NN ,_, circadian_JJ changes_NNS ,_, age_NN ,_, gender_NN ,_, ethnicity_NN ,_, body_NN size_NN ,_, lean-body_JJ mass_NN and_CC protein_NN intake_NN 
._. 
,diabetes_NNS ,_, lupus_NN -RRB-_-RRB- ,_, menstrual_JJ cycle_NN ,_, etc._FW g._FW Volume-weighted_JJ concentrations_NNS are_VBP influenced_VBN by_IN urine_NN dilution_NN ,_, which_WDT has_VBZ been_VBN documented_VBN to_TO be_VB subject_JJ to_TO important_JJ intra_NN -_: and_CC inter-individual_JJ variations_NNS due_JJ to_TO the_DT variability_NN in_IN intrinsic_JJ and_CC extrinsic_JJ factors_NNS :_: liquid_JJ intake_NN ,_, perspiration_NN ,_, humidity_NN level_NN ,_, circadian_JJ changes_NNS ,_, glomerular_JJ filtration_NN rate_NN ,_, age_NN ,_, disease_NN -LRB-_-LRB- e._FW To_TO account_VB for_IN the_DT variations_NNS in_IN urine_NN volume_NN ,_, numerous_JJ researchers_NNS rely_VBP on_IN creatinine_NN standardization_NN although_IN creatinine_NN levels_NNS have_VBP also_RB been_VBN reported_VBN to_TO be_VB subject_JJ to_TO intra_NN -_: and_CC inter-individual_JJ variations_NNS linked_VBN to_TO :_: physical_JJ activity_NN ,_, circadian_JJ changes_NNS ,_, age_NN ,_, gender_NN ,_, ethnicity_NN ,_, body_NN size_NN ,_, lean-body_JJ mass_NN and_CC protein_NN intake_NN 
Pyrethroids_NNS are_VBP compounds_NNS with_IN relatively_RB short_JJ half-lives_NNS and_CC a_DT large_JJ fraction_NN ,_, as_RB much_JJ as_IN 78_CD %_NN ,_, of_IN an_DT oral_JJ dose_NN in_IN volunteers_NNS is_VBZ excreted_VBN as_IN metabolites_NNS in_IN urine_NN within_IN 24_CD hours_NNS post-exposure_NN 
84_CD a_DT Calculated_VBN according_VBG to_TO the_DT method_NN of_IN Mage_FW et_FW al._FW 0158_CD 0_CD ._. 
0188_CD 0_CD ._. 
74_CD Highest_JJS f_SYM 0_CD ._. 
0176_CD 0_CD ._. 
0237_CD 0_CD ._. 
bAbsorbed_JJ dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT lowest_JJS creatinine_NN excretion_NN ratecAbsorbed_VBD dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT creatinine_NN excretion_NN rate_NN closest_JJS to_TO the_DT 5th_JJ percentile_NN valuedAbsorbed_VBD dose_NN estimates_NNS for_IN the_DT participants_NNS with_IN the_DT median_JJ creatinine_NN excretion_NN rateeAbsorbed_VBD dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT creatinine_NN excretion_NN rate_NN closest_JJS to_TO the_DT 95th_JJ percentile_NN valuefAbsorbed_VBD dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT highest_JJS creatinine_NN excretion_NN rategThis_NNP individual_NN was_VBD obese_JJ -LRB-_-LRB- BMI_NNP 
0-RRB-_NN and_CC ,_, in_IN this_DT specific_JJ case_NN ,_, Mage_FW et_FW al._FW ._. 
bAbsorbed_JJ dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT lowest_JJS creatinine_NN excretion_NN rate_NN c_NN Absorbed_VBD dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT creatinine_NN excretion_NN rate_NN closest_JJS to_TO the_DT 5th_JJ percentile_NN value_NN d_SYM Absorbed_VBN dose_NN estimates_NNS for_IN the_DT participants_NNS with_IN the_DT median_JJ creatinine_NN excretion_NN rate_NN e_SYM Absorbed_VBN dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT creatinine_NN excretion_NN rate_NN closest_JJS to_TO the_DT 95th_JJ percentile_NN value_NN f_SYM Absorbed_VBN dose_NN estimates_NNS for_IN the_DT participant_NN with_IN the_DT highest_JJS creatinine_NN excretion_NN rate_NN g_VBD This_DT individual_NN was_VBD obese_JJ -LRB-_-LRB- BMI_NNP 
,diabetes_NNS ,_, lupus_NN -RRB-_-RRB- ,_, menstrual_JJ cycle_NN ,_, etc._FW g._FW Volume-weighted_JJ concentrations_NNS are_VBP influenced_VBN by_IN urine_NN dilution_NN ,_, which_WDT has_VBZ been_VBN documented_VBN to_TO be_VB subject_JJ to_TO important_JJ intra_NN -_: and_CC inter-individual_JJ variations_NNS due_JJ to_TO the_DT variability_NN in_IN intrinsic_JJ and_CC extrinsic_JJ factors_NNS :_: liquid_JJ intake_NN ,_, perspiration_NN ,_, humidity_NN level_NN ,_, circadian_JJ changes_NNS ,_, glomerular_JJ filtration_NN rate_NN ,_, age_NN ,_, disease_NN -LRB-_-LRB- e._SYM 
Such_JJ units_NNS are_VBP generally_RB used_VBN when_WRB participants_NNS provide_VBP one_CD or_CC more_JJR spot_NN samples_NNS ._. 
Therefore_RB ,_, urinary_JJ metabolite_NN levels_NNS of_IN these_DT pesticides_NNS are_VBP usually_RB reported_VBN in_IN volume-weighted_JJ concentrations_NNS -LRB-_-LRB- 
The_DT influence_NN of_IN the_DT toxicokinetics_NNS of_IN non-persistent_JJ pesticides_NNS on_IN the_DT choice_NN of_IN a_DT sampling_NN time_NN frame_NN was_VBD more_RBR thoroughly_RB discussed_VBN in_IN Barr_NNP et_FW al._FW ._. ._. 
However_RB ,_, the_DT influence_NN of_IN the_DT variability_NN in_IN creatinine_NN excretion_NN rate_NN and_CC urinary_JJ flow_NN rate_NN on_IN estimated_JJ absorbed_VBN doses_NNS reconstructed_VBN from_IN creatinine-adjusted_JJ concentrations_NNS or_CC volume-weighted_JJ concentrations_NNS has_VBZ not_RB been_VBN systematically_RB assessed_VBN in_IN the_DT case_NN of_IN the_DT non-persistent_JJ pyrethroid_NN pesticides_NNS ._. 
Such_JJ units_NNS are_VBP generally_RB used_VBN when_WRB participants_NNS provide_VBP one_CD or_CC more_JJR spot_NN samples_NNS ._. 
Therefore_RB ,_, urinary_JJ metabolite_NN levels_NNS of_IN these_DT pesticides_NNS are_VBP usually_RB reported_VBN in_IN volume-weighted_JJ concentrations_NNS -LRB-_-LRB- 
However_RB ,_, it_PRP is_VBZ often_RB deemed_VBN difficult_JJ to_TO achieve_VB in_IN some_DT cases_NNS due_JJ the_DT risk_NN of_IN incomplete_JJ samples_NNS ,_, insufficient_JJ adherence_NN to_TO the_DT protocol_NN and_CC potential_JJ attrition_NN among_IN the_DT participants_NNS ._. 
Therefore_RB ,_, urinary_JJ metabolite_NN levels_NNS of_IN these_DT pesticides_NNS are_VBP usually_RB reported_VBN in_IN volume-weighted_JJ concentrations_NNS -LRB-_-LRB- 
._. 
fold_VB -RRB-_-RRB- during_IN the_DT course_NN of_IN a_DT day_NN in_IN adults_NNS ,_, the_DT latter_JJ being_VBG larger_JJR than_IN the_DT day-to-day_JJ variations_NNS reported_VBN by_IN Garde_NNP et_FW al._FW ._. 
Those_DT variations_NNS are_VBP likely_JJ the_DT consequence_NN of_IN fluid_JJ intake_NN for_IN the_DT former_JJ and_CC dietary_JJ protein_NN intake_NN 
In_IN an_DT assessment_NN of_IN intra-individual_JJ day-to-day_JJ variations_NNS in_IN creatinine_NN excretion_NN rate_NN in_IN 24-h_JJ urine_NN collections_NNS based_VBN on_IN several_JJ studies_NNS ,_, Garde_FW et_FW al._FW ._. 
reported_VBD a_DT coefficient_NN of_IN variation_NN of_IN 9_CD 
fold_VB -RRB-_-RRB- during_IN the_DT course_NN of_IN a_DT day_NN in_IN adults_NNS ,_, the_DT latter_JJ being_VBG larger_JJR than_IN the_DT day-to-day_JJ variations_NNS reported_VBN by_IN Garde_NNP et_FW al._FW ._. 
Garde_FW et_FW al._FW ._. 
Inter-individual_JJ variability_NN in_IN the_DT urinary_JJ output_NN and_CC creatinine_NN excretion_NN rate_NN has_VBZ also_RB been_VBN extensively_RB studied_VBN ;_: factors_NNS influencing_VBG these_DT variations_NNS include_VBP age_NN ,_, gender_NN ,_, ethnicity_NN ,_, fat-free_JJ mass_NN and_CC height_NN ,_, ambient_JJ temperature_NN ,_, physical_JJ activity_NN 
However_RB ,_, it_PRP is_VBZ often_RB deemed_VBN difficult_JJ to_TO achieve_VB in_IN some_DT cases_NNS due_JJ the_DT risk_NN of_IN incomplete_JJ samples_NNS ,_, insufficient_JJ adherence_NN to_TO the_DT protocol_NN and_CC potential_JJ attrition_NN among_IN the_DT participants_NNS ._. 
Therefore_RB ,_, urinary_JJ metabolite_NN levels_NNS of_IN these_DT pesticides_NNS are_VBP usually_RB reported_VBN in_IN volume-weighted_JJ concentrations_NNS -LRB-_-LRB- 
However_RB ,_, it_PRP is_VBZ often_RB deemed_VBN difficult_JJ to_TO achieve_VB in_IN some_DT cases_NNS due_JJ the_DT risk_NN of_IN incomplete_JJ samples_NNS ,_, insufficient_JJ adherence_NN to_TO the_DT protocol_NN and_CC potential_JJ attrition_NN among_IN the_DT participants_NNS ._. 
Therefore_RB ,_, urinary_JJ metabolite_NN levels_NNS of_IN these_DT pesticides_NNS are_VBP usually_RB reported_VBN in_IN volume-weighted_JJ concentrations_NNS -LRB-_-LRB- 
In_IN the_DT specific_JJ case_NN of_IN non-persistent_JJ pesticides_NNS ,_, namely_RB pyrethroids_NNS and_CC organophosphates_NNS -LRB-_-LRB- OPs_NNP -RRB-_-RRB- ,_, the_DT determination_NN of_IN amounts_NNS of_IN a_DT biomarker_NN in_IN 24-h_JJ urine_NN collections_NNS is_VBZ generally_RB considered_VBN the_DT ``_`` benchmark_JJ ''_'' unit_NN of_IN expression_NN of_IN biomonitoring_VBG results_NNS ._. 
Some_DT authors_NNS have_VBP successfully_RB measured_VBN cumulative_JJ daily_JJ amounts_NNS or_CC hourly_JJ excretion_NN rates_NNS of_IN pyrethroids_NNS -LRB-_-LRB- 
Characteristics_NNS of_IN the_DT participants_NNS are_VBP shown_VBN in_IN Table_NNP 1_CD ._. 
The_DT workers_NNS collected_VBD all_DT their_PRP$ urine_NN during_IN a_DT 24-h_JJ period_NN ;_: they_PRP provided_VBD each_DT void_NN in_IN a_DT separate_JJ bottle_NN and_CC recorded_VBD the_DT time_NN of_IN each_DT micturition_NN ._. 
Table_NNP 1Characteristics_NNP of_IN the_DT subjects_NNS in_IN study_NN 1SubjectGenderWeight_NNP -LRB-_-LRB- kg_NN -RRB-_-RRB- Subject_NNP 1Male75Subject_NNP 2Male64Subject_NNP 3Female57Subject_NNP 4Female48Subject_NNP 5Female43Subject_NNP 6Female55Subject_NNP 7Female50Subject_NNP 8Male77Subject_NNP 9Female64Subject10Female56Subject_NNP 11Female50Subject_NNP 12Female68Subject_NNP 13Male73Subject_NNP 14Female55Subject_NNP 15Female57Study_NNP 2_CD was_VBD conducted_VBN in_IN the_DT adult_NN and_CC infantile_JJ general_JJ population_NN of_IN a_DT large_JJ urban_JJ and_CC suburban_JJ area_NN ,_, the_DT Montreal_NNP Island_NNP ,_, Quebec_NNP ,_, Canada_NNP ._. 
Adults_NNS -LRB-_-LRB- n_SYM =_SYM 74_CD -RRB-_-RRB- collected_VBN all_DT their_PRP$ urine_NN during_IN a_DT period_NN of_IN 24_CD h_NN ,_, in_IN two_CD separate_JJ bottles_NNS ._. 
The_DT first_JJ bottle_NN contained_VBD the_DT urines_NNS voided_VBD between_IN 6_CD pm_NN until_IN the_DT next_JJ morning_NN including_VBG first_JJ urine_NN void_NN on_IN rising_VBG ._. 
The_DT creatinine_NN concentration_NN was_VBD assessed_VBN with_IN a_DT DRI_NNP creatinine_NN kit_NN from_IN Diagnostix_NNP Ltd_NNP -LRB-_-LRB- Mississauga_NNP ,_, Canada_NNP -RRB-_-RRB- ._. 
The_DT other_JJ analytical_JJ methods_NNS followed_VBN are_VBP described_VBN in_IN details_NNS elsewhere_RB ._. 
Data_NNP analysis_NN Assessment_NNP of_IN the_DT variability_NN in_IN the_DT urinary_JJ flow_NN rate_NN and_CC creatinine_NN excretion_NN rate_NN Metabolite_NNP concentrations_NNS -LRB-_-LRB- 
-LRB-_-LRB- 1_CD -RRB-_-RRB- MHER_NNP =_SYM -LRB-_-LRB- 
Children_NNP -LRB-_-LRB- n_SYM =_SYM 74_CD -RRB-_-RRB- only_RB carried_VBD out_RP the_DT overnight_JJ collection_NN from_IN 6_CD pm_NN until_IN the_DT next_JJ morning_NN including_VBG first_JJ morning_NN void_NN -LRB-_-LRB- equivalent_JJ to_TO the_DT first_JJ bottle_NN in_IN adults_NNS -RRB-_-RRB- ._. 
Study_NNP 3_NNP was_VBD conducted_VBN in_IN the_DT adult_NN and_CC infantile_JJ general_JJ population_NN of_IN the_DT large_JJ rural_JJ and_CC agricultural_JJ area_NN of_IN the_DT Mont_NNP 
The_DT creatinine_NN concentration_NN was_VBD assessed_VBN with_IN a_DT DRI_NNP creatinine_NN kit_NN from_IN Diagnostix_NNP Ltd_NNP -LRB-_-LRB- Mississauga_NNP ,_, Canada_NNP -RRB-_-RRB- ._. 
The_DT other_JJ analytical_JJ methods_NNS followed_VBN are_VBP described_VBN in_IN details_NNS elsewhere_RB ._. 
Data_NNP analysis_NN Assessment_NNP of_IN the_DT variability_NN in_IN the_DT urinary_JJ flow_NN rate_NN and_CC creatinine_NN excretion_NN rate_NN Metabolite_NNP concentrations_NNS -LRB-_-LRB- 
In_IN the_DT specific_JJ case_NN of_IN non-persistent_JJ pesticides_NNS ,_, namely_RB pyrethroids_NNS and_CC organophosphates_NNS -LRB-_-LRB- OPs_NNP -RRB-_-RRB- ,_, the_DT determination_NN of_IN amounts_NNS of_IN a_DT biomarker_NN in_IN 24-h_JJ urine_NN collections_NNS is_VBZ generally_RB considered_VBN the_DT ``_`` benchmark_JJ ''_'' unit_NN of_IN expression_NN of_IN biomonitoring_VBG results_NNS ._. 
Some_DT authors_NNS have_VBP successfully_RB measured_VBN cumulative_JJ daily_JJ amounts_NNS or_CC hourly_JJ excretion_NN rates_NNS of_IN pyrethroids_NNS -LRB-_-LRB- 
All_PDT those_DT units_NNS can_MD be_VB corrected_VBN for_IN the_DT body_NN weight_NN of_IN the_DT participants_NNS ._. 
Biomarker_NN results_NNS can_MD therefore_RB be_VB expressed_VBN in_IN terms_NNS of_IN volume-weighted_JJ concentrations_NNS -LRB-_-LRB- 
All_PDT those_DT units_NNS can_MD be_VB corrected_VBN for_IN the_DT body_NN weight_NN of_IN the_DT participants_NNS ._. 
Biomarker_NN results_NNS can_MD therefore_RB be_VB expressed_VBN in_IN terms_NNS of_IN volume-weighted_JJ concentrations_NNS -LRB-_-LRB- 
In_IN the_DT specific_JJ case_NN of_IN non-persistent_JJ pesticides_NNS ,_, namely_RB pyrethroids_NNS and_CC organophosphates_NNS -LRB-_-LRB- OPs_NNP -RRB-_-RRB- ,_, the_DT determination_NN of_IN amounts_NNS of_IN a_DT biomarker_NN in_IN 24-h_JJ urine_NN collections_NNS is_VBZ generally_RB considered_VBN the_DT ``_`` benchmark_JJ ''_'' unit_NN of_IN expression_NN of_IN biomonitoring_VBG results_NNS ._. 
Some_DT authors_NNS have_VBP successfully_RB measured_VBN cumulative_JJ daily_JJ amounts_NNS or_CC hourly_JJ excretion_NN rates_NNS of_IN pyrethroids_NNS -LRB-_-LRB- 
In_IN the_DT specific_JJ case_NN of_IN non-persistent_JJ pesticides_NNS ,_, namely_RB pyrethroids_NNS and_CC organophosphates_NNS -LRB-_-LRB- OPs_NNP -RRB-_-RRB- ,_, the_DT determination_NN of_IN amounts_NNS of_IN a_DT biomarker_NN in_IN 24-h_JJ urine_NN collections_NNS is_VBZ generally_RB considered_VBN the_DT ``_`` benchmark_JJ ''_'' unit_NN of_IN expression_NN of_IN biomonitoring_VBG results_NNS ._. 
Some_DT authors_NNS have_VBP successfully_RB measured_VBN cumulative_JJ daily_JJ amounts_NNS or_CC hourly_JJ excretion_NN rates_NNS of_IN pyrethroids_NNS -LRB-_-LRB- 
Adult_NN participants_NNS gave_VBD their_PRP$ informed_JJ consent_NN and_CC children_NNS gave_VBD their_PRP$ assent_NN in_IN addition_NN to_TO the_DT parents_NNS consent_NN ._. 
Study_NNP 1_CD consisted_VBD in_IN the_DT biomonitoring_NN of_IN OP_NNP exposure_NN in_IN a_DT group_NN of_IN horticultural_JJ greenhouse_NN workers_NNS with_IN low_JJ physical_JJ workload_NN -LRB-_-LRB- n_VB =_SYM 15_CD -RRB-_-RRB- ._. 
The_DT workers_NNS collected_VBD all_DT their_PRP$ urine_NN during_IN a_DT 24-h_JJ period_NN ;_: they_PRP provided_VBD each_DT void_NN in_IN a_DT separate_JJ bottle_NN and_CC recorded_VBD the_DT time_NN of_IN each_DT micturition_NN ._. 
The_DT creatinine_NN concentration_NN was_VBD assessed_VBN with_IN a_DT DRI_NNP creatinine_NN kit_NN from_IN Diagnostix_NNP Ltd_NNP -LRB-_-LRB- Mississauga_NNP ,_, Canada_NNP -RRB-_-RRB- ._. 
The_DT other_JJ analytical_JJ methods_NNS followed_VBN are_VBP described_VBN in_IN details_NNS elsewhere_RB ._. 
Data_NNP analysis_NN Assessment_NNP of_IN the_DT variability_NN in_IN the_DT urinary_JJ flow_NN rate_NN and_CC creatinine_NN excretion_NN rate_NN Metabolite_NNP concentrations_NNS -LRB-_-LRB- 
The_DT role_NN of_IN genotype_NN may_MD also_RB be_VB important_JJ ._. 
In_IN contrast_NN ,_, the_DT gold_NN miners_NNS were_VBD likely_JJ to_TO have_VB relatively_RB variable_JJ exposures_NNS to_TO inorganic_JJ mercury_NN ,_, with_IN episodes_NNS of_IN very_RB high_JJ inhalation_NN exposure_NN 
We_PRP have_VBP also_RB reported_VBN that_DT exposure_NN of_IN mice_NNS to_TO low_JJ levels_NNS of_IN mercury_NN both_DT decreases_VBZ host_NN resistance_NN to_TO murine_VB malaria_NN -LRB-_-LRB- Plasmodium_NNP yoelii_FW -RRB-_-RRB- and_CC impairs_VBZ acquisition_NN of_IN immunity_NN to_TO murine_VB malaria_NN in_IN the_DT Nussenzweig_NNP model_NN 
We_PRP have_VBP also_RB reported_VBN that_DT exposure_NN of_IN mice_NNS to_TO low_JJ levels_NNS of_IN mercury_NN both_DT decreases_VBZ host_NN resistance_NN to_TO murine_VB malaria_NN -LRB-_-LRB- Plasmodium_NNP yoelii_FW -RRB-_-RRB- and_CC impairs_VBZ acquisition_NN of_IN immunity_NN to_TO murine_VB malaria_NN in_IN the_DT Nussenzweig_NNP model_NN 
In_IN a_DT study_NN of_IN chloralkali_JJ workers_NNS ,_, circulating_VBG anti-laminin_JJ antibodies_NNS were_VBD found_VBN in_IN some_DT workers_NNS as_RB well_RB as_IN autoantibodies_NNS against_IN glomerular_JJ basement_NN membrane_NN and_CC circulating_VBG immune_JJ complexes_NNS ,_, but_CC no_DT significant_JJ increases_NNS in_IN antinuclear_JJ autoantibodies_NNS -LRB-_-LRB- ANA_NNP -RRB-_-RRB- were_VBD found_VBN 
No_DT studies_NNS of_IN immune_JJ parameters_NNS have_VBP been_VBN conducted_VBN in_IN the_DT large_JJ longitudinal_JJ studies_NNS of_IN children_NNS exposed_VBN to_TO methylmercury_NN via_IN fish_NN consumption_NN in_IN the_DT Seychelles_NNP or_CC in_IN the_DT Faeroe_NNP Islands_NNP ._. 
In_IN a_DT cross-sectional_JJ study_NN of_IN a_DT maritime_JJ population_NN of_IN children_NNS with_IN exposure_NN to_TO polychlorinated_JJ biphenyls_NNS and_CC methylmercury_NN via_IN seafood_NN consumption_NN ,_, numbers_NNS of_IN na_TO 
At_IN relatively_RB high_JJ levels_NNS of_IN occupational_JJ exposure_NN ,_, changes_NNS in_IN immunoglobulins_NNS have_VBP been_VBN reported_VBN ,_, but_CC not_RB consistently_RB 
In_IN a_DT study_NN of_IN chloralkali_JJ workers_NNS ,_, circulating_VBG anti-laminin_JJ antibodies_NNS were_VBD found_VBN in_IN some_DT workers_NNS as_RB well_RB as_IN autoantibodies_NNS against_IN glomerular_JJ basement_NN membrane_NN and_CC circulating_VBG immune_JJ complexes_NNS ,_, but_CC no_DT significant_JJ increases_NNS in_IN antinuclear_JJ autoantibodies_NNS -LRB-_-LRB- ANA_NNP -RRB-_-RRB- were_VBD found_VBN 
Nephropathy_NNP described_VBD in_IN workers_NNS with_IN either_DT acute_JJ or_CC chronic_JJ exposures_NNS to_TO Hg_VB 0_CD vapor_NN may_MD involve_VB deposition_NN of_IN autoantibodies_NNS to_TO basement_NN membrane_NN proteins_NNS in_IN the_DT glomerulus_NN ._. 
In_IN a_DT study_NN of_IN chloralkali_JJ workers_NNS ,_, circulating_VBG anti-laminin_JJ antibodies_NNS were_VBD found_VBN in_IN some_DT workers_NNS as_RB well_RB as_IN autoantibodies_NNS against_IN glomerular_JJ basement_NN membrane_NN and_CC circulating_VBG immune_JJ complexes_NNS ,_, but_CC no_DT significant_JJ increases_NNS in_IN antinuclear_JJ autoantibod_NN 
Discussion_NN In_IN this_DT paper_NN we_PRP report_VBP the_DT first_JJ data_NNS on_IN specific_JJ biomarkers_NNS of_IN autoimmune_JJ dysfunction_NN in_IN persons_NNS exposed_VBN to_TO inorganic_JJ mercury_NN or_CC methylmercury_NN ._. 
One_CD earlier_JJR study_NN reported_VBD elevations_NNS in_IN anti-laminin_JJ autoantibodies_NNS in_IN workers_NNS exposed_VBN to_TO mercury_NN 
Afew_NNP studies_NNS have_VBP examined_VBN relationships_NNS between_IN mercury_NN exposures_NNS and_CC adverse_JJ immunological_JJ reactions_NNS ,_, particularly_RB in_IN connection_NN with_IN mercury_NN amalgam_NN ,_, but_CC these_DT are_VBP controversial_JJ 
Mercury_NNP may_MD reset_VB immunologic_JJ responses_NNS to_TO malaria_NN ,_, to_TO increase_VB expression_NN of_IN autoantibodies_NNS through_IN its_PRP$ documented_VBN effects_NNS to_TO up_RB regulate_VB Th2_NNP mediated_VBD immune_JJ responses_NNS 
Finally_RB ,_, we_PRP may_MD speculate_VB as_IN to_TO why_WRB we_PRP have_VBP been_VBN able_JJ to_TO observe_VB associations_NNS between_IN mercury_NN exposures_NNS and_CC these_DT biomarkers_NNS of_IN autoimmune_JJ dysfunction_NN in_IN these_DT populations_NNS ,_, while_IN most_RBS clinical_JJ or_CC epidemiological_JJ studies_NNS of_IN mercury_NN and_CC immunotoxicity_NN have_VBP been_VBN negative_JJ or_CC only_RB weakly_RB positive_JJ ._. 
In_IN these_DT other_JJ studies_NNS ,_, the_DT cohorts_NNS were_VBD relatively_RB small_JJ -LRB-_-LRB- between_IN 44_CD 
Inhaled_VBN Hg_NN 0_CD vapor_NN easily_RB crosses_VBZ the_DT pulmonary_JJ alveolar_JJ membranes_NNS to_TO enter_VB the_DT circulatory_NN system_NN ,_, where_WRB it_PRP is_VBZ primarily_RB bound_VBN to_TO red_JJ blood_NN cells_NNS ,_, and_CC is_VBZ rapidly_RB distributed_VBN to_TO the_DT central_JJ nervous_JJ system_NN ,_, and_CC the_DT kidneys_NNS 
Mercury_NNP absorbed_VBD through_IN skin_NN contact_NN is_VBZ oxidized_VBN in_IN the_DT liver_NN to_TO Hg_VB 2_CD +_CD by_IN glutathione_NN 
Afew_NNP studies_NNS have_VBP examined_VBN relationships_NNS between_IN mercury_NN exposures_NNS and_CC adverse_JJ immunological_JJ reactions_NNS ,_, particularly_RB in_IN connection_NN with_IN mercury_NN amalgam_NN ,_, but_CC these_DT are_VBP controversial_JJ 
Mercury_NNP may_MD reset_VB immunologic_JJ responses_NNS to_TO malaria_NN ,_, to_TO increase_VB expression_NN of_IN autoantibodies_NNS through_IN its_PRP$ documented_VBN effects_NNS to_TO up_RB regulate_VB Th2_NNP mediated_VBD immune_JJ responses_NNS 
Finally_RB ,_, we_PRP may_MD speculate_VB as_IN to_TO why_WRB we_PRP have_VBP been_VBN able_JJ to_TO observe_VB associations_NNS between_IN mercury_NN exposures_NNS and_CC these_DT biomarkers_NNS of_IN autoimmune_JJ dysfunction_NN in_IN these_DT populations_NNS ,_, while_IN most_RBS clinical_JJ or_CC epidemiological_JJ studies_NNS of_IN mercury_NN and_CC immunotoxicity_NN have_VBP been_VBN negative_JJ or_CC only_RB weakly_RB positive_JJ ._. 
In_IN these_DT other_JJ studies_NNS ,_, the_DT cohorts_NNS were_VBD relatively_RB small_JJ -LRB-_-LRB- between_IN 44_CD 
The_DT goal_NN of_IN this_DT study_NN was_VBD to_TO test_VB the_DT hypothesis_NN that_IN exposures_NNS to_TO methylmercury_NN and\/or_CC inorganic_JJ mercury_NN may_MD have_VB effects_NNS on_IN specific_JJ markers_NNS of_IN mercury-induced_JJ autoimmunity_NN ,_, that_DT is_VBZ ,_, ANA_NNP and_CC antinucleolar_JJ -LRB-_-LRB- ANoA_NNP -RRB-_-RRB- autoantibodies_NNS ,_, and_CC in_IN a_DT subset_NN of_IN subjects_NNS anti-fibrillarin_JJ -LRB-_-LRB- AFA_NNP -RRB-_-RRB- autoantibodies_NNS ._. 
ANoA_JJ autoantibodies_NNS ,_, a_DT marker_NN found_VBN in_IN some_DT human_JJ autoimmune_JJ diseases_NNS 
The_DT goal_NN of_IN this_DT study_NN was_VBD to_TO test_VB the_DT hypothesis_NN that_IN exposures_NNS to_TO methylmercury_NN and\/or_CC inorganic_JJ mercury_NN may_MD have_VB effects_NNS on_IN specific_JJ markers_NNS of_IN mercury-induced_JJ autoimmunity_NN ,_, that_DT is_VBZ ,_, ANA_NNP and_CC antinucleolar_JJ -LRB-_-LRB- ANoA_NNP -RRB-_-RRB- autoantibodies_NNS ,_, and_CC in_IN a_DT subset_NN of_IN subjects_NNS anti-fibrillarin_JJ -LRB-_-LRB- AFA_NNP -RRB-_-RRB- autoantibodies_NNS ._. 
ANoA_JJ autoantibodies_NNS ,_, a_DT marker_NN found_VBN in_IN some_DT human_JJ autoimmune_JJ diseases_NNS 
However_RB ,_, as_IN shown_VBN in_IN Figure_NN 3_CD ,_, there_EX appear_VBP to_TO be_VB many_JJ unidentified_JJ nuclear_JJ antigens_NNS observed_VBN in_IN serum_NN samples_NNS from_IN this_DT population_NN ,_, which_WDT were_VBD not_RB observed_VBN in_IN either_CC the_DT SC_NNP serum_NN ,_, or_CC in_IN studies_NNS of_IN US_NNP control_NN subjects_NNS -LRB-_-LRB- data_NNS not_RB shown_VBN -RRB-_-RRB- ._. 
It_PRP would_MD be_VB very_RB pertinent_JJ to_TO analyze_VB sera_NN from_IN all_PDT these_DT three_CD populations_NNS ,_, using_VBG a_DT range_NN of_IN other_JJ nuclear_JJ antigens_NNS known_VBN to_TO be_VB targeted_VBN in_IN autoimmune_JJ diseases_NNS 
The_DT median_JJ hair_NN mercury_NN concentration_NN of_IN 5_CD ._. 
The_DT distribution_NN of_IN hair_NN mercury_NN is_VBZ shown_VBN in_IN Figure_NNP 1A_NNP ;_: the_DT majority_NN of_IN the_DT persons_NNS had_VBD hair_NN mercury_NN levels_NNS below_IN 8_CD 
Persons_NNS from_IN Tabatinga_NNP ,_, with_IN the_DT lowest_JJS range_NN of_IN mercury_NN exposures_NNS ,_, had_VBD lower_JJR prevalence_NN of_IN detectable_JJ ANA_NNP or_CC ANoA_NNP ,_, and_CC in_IN those_DT few_JJ persons_NNS with_IN detectable_JJ autoantibodies_NNS ,_, the_DT concentrations_NNS were_VBD low_JJ ._. 
Nonetheless_RB ,_, Tabatinga_NNP subjects_NNS had_VBD significantly_RB elevated_VBN mercury_NN levels_NNS ,_, as_IN compared_VBN to_TO North_NNP America_NNP populations_NNS 
Most_JJS measurements_NNS -LRB-_-LRB- 90_CD %_NN -RRB-_-RRB- were_VBD not_RB detectable_JJ even_RB at_IN the_DT lowest_JJS -LRB-_-LRB- 1:10_CD -RRB-_-RRB- dilution_NN ._. 
The_DT prevalence_NN of_IN detectable_JJ ANA_NNP and_CC ANoA_NNP in_IN the_DT Tabatinga_NNP samples_NNS was_VBD very_RB low_JJ -LRB-_-LRB- Table_NNP 3_CD ;_: Figure_NN 2_CD -RRB-_-RRB- ._. 
These_DT data_NNS are_VBP similar_JJ to_TO those_DT recently_RB reported_VBN for_IN a_DT referent_JJ population_NN in_IN Sao_NNP Paulo_NNP ._. 
In_IN the_DT few_JJ subjects_NNS with_IN ANA_NNP or_CC ANoA_NNP detectable_JJ at_IN 
We_PRP examined_VBD the_DT serum_NN ANA_NNP and_CC ANoA_NNP results_NNS at_IN both_DT 1:10_CD and_CC 1:40_CD dilutions_NNS ._. 
It_PRP would_MD be_VB very_RB pertinent_JJ to_TO analyze_VB sera_NN from_IN all_PDT these_DT three_CD populations_NNS ,_, using_VBG a_DT range_NN of_IN other_JJ nuclear_JJ antigens_NNS known_VBN to_TO be_VB targeted_VBN in_IN autoimmune_JJ diseases_NNS 
However_RB ,_, the_DT purpose_NN of_IN this_DT study_NN was_VBD not_RB to_TO detect_VB persons_NNS with_IN latent_NN autoimmune_JJ disease_NN ,_, but_CC rather_RB to_TO use_VB these_DT antibody_NN measurements_NNS as_IN biomarkers_NNS to_TO test_VB the_DT hypothesis_NN that_IN mercury_NN exposures_NNS might_MD induce_VB autoimmune_JJ dysfunction_NN ._. 
Arecent_JJ publication_NN on_IN the_DT prevalence_NN of_IN ANA_NNP in_IN serum_NN of_IN normal_JJ blood_NN donors_NNS in_IN Brazil_NNP found_VBD no_DT age-related_JJ differences_NNS in_IN prevalence_NN of_IN detectable_JJ ANA_NNP among_IN adults_NNS ,_, and_CC that_IN very_RB few_JJ subjects_NNS had_VBD detectable_JJ ANA_NNP at_IN dilutions_NNS 
In_IN rodents_NNS ,_, genotype_NN clearly_RB plays_VBZ an_DT important_JJ role_NN in_IN both_DT modulating_VBG the_DT immune_JJ response_NN to_TO inorganic_JJ mercury_NN as_RB well_RB as_IN toxicokinetics_NNS ._. 
In_IN susceptible_JJ mice_NNS ,_, induction_NN of_IN genetically_RB restrictive_JJ ANoA_NN by_IN mercury_NN are_VBP linked_VBN to_TO mouse_NN MHC_NNP -LRB-_-LRB- H-2_NNP -RRB-_-RRB- haplotype_NN s_VBZ and_CC q_SYM 
In_IN addition_NN ,_, mercury_NN toxicokinetics_NNS differ_VBP among_IN inbred_JJ mouse_NN strains_NNS ._. 
Non-MHC_JJ genes_NNS decide_VBP the_DT strength_NN of_IN ANoA_JJ response_NN in_IN susceptible_JJ mice_NNS exposed_VBN to_TO mercury_NN 
For_IN persons_NNS in_IN Tabatinga_NNP and_CC Jacareacanga_NNP with_IN chronic_JJ exposure_NN via_IN fish_NN consumption_NN ,_, hair_NN mercury_NN -LRB-_-LRB- 
For_IN persons_NNS with_IN occupational_JJ exposures_NNS to_TO inorganic_JJ mercury_NN ,_, in_IN Rio-Rato_NNP ,_, urine_NN mercury_NN was_VBD used_VBN as_IN the_DT biomarker_NN -LRB-_-LRB- 
Detection_NNP of_IN ANA\/ANoA_NNP The_DT serum_NN samples_NNS were_VBD stored_VBN at_IN -80_CD 
Data_NNP analyses_VBZ The_DT concentration_NN of_IN serum_NN autoantibodies_NNS is_VBZ expressed_VBN in_IN terms_NNS of_IN the_DT dilution_NN factor_NN at_IN which_WDT fluorescence_NN could_MD still_RB be_VB detected_VBN ._. 
Detection_NN of_IN autoantibodies_NNS at_IN a_DT serum_NN dilution_NN of_IN 
Detection_NN of_IN autoantibodies_NNS at_IN a_DT serum_NN dilution_NN of_IN 
However_RB ,_, as_IN shown_VBN in_IN Figure_NN 3_CD ,_, there_EX appear_VBP to_TO be_VB many_JJ unidentified_JJ nuclear_JJ antigens_NNS observed_VBN in_IN serum_NN samples_NNS from_IN this_DT population_NN ,_, which_WDT were_VBD not_RB observed_VBN in_IN either_CC the_DT SC_NNP serum_NN ,_, or_CC in_IN studies_NNS of_IN US_NNP control_NN subjects_NNS -LRB-_-LRB- data_NNS not_RB shown_VBN -RRB-_-RRB- ._. 
It_PRP would_MD be_VB very_RB pertinent_JJ to_TO analyze_VB sera_NN from_IN all_PDT these_DT three_CD populations_NNS ,_, using_VBG a_DT range_NN of_IN other_JJ nuclear_JJ antigens_NNS known_VBN to_TO be_VB targeted_VBN in_IN autoimmune_JJ diseases_NNS 
Tan_NNP et_NNP al._NNP ._. 
Interpretation_NN must_MD be_VB cautious_JJ ._. 
The_DT results_NNS in_IN Jacareacanga_NNP and_CC Rio-Rato_NNP subjects_NNS are_VBP clearly_RB different_JJ from_IN studies_NNS of_IN healthy_JJ individuals_NNS in_IN the_DT US_NNP and_CC Brazil_NNP 
This_DT site_NN is_VBZ in_IN the_DT lower_JJR Tapaj_NNP 
The_DT 140_CD subjects_NNS consisted_VBN of_IN 54_CD %_NN women_NNS and_CC had_VBD a_DT mean_JJ age_NN of_IN 25_CD years_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
Jacareacanga_NNP Jacareacanga_NNP is_VBZ a_DT riverine_JJ settlement_NN of_IN approximately_RB 500_CD persons_NNS ,_, located_VBN on_IN the_DT mid-Tapaj_NN 
No_DT reports_NNS of_IN exposure_NN to_TO other_JJ risk_NN factors_NNS ,_, such_JJ as_IN infectious_JJ diseases_NNS ,_, were_VBD reported_VBN ._. 
In_IN these_DT other_JJ studies_NNS ,_, the_DT cohorts_NNS were_VBD relatively_RB small_JJ -LRB-_-LRB- between_IN 44_CD 
At_IN Jacareacanga_NNP ,_, a_DT riverine_JJ community_NN on_IN the_DT Tapaj_NNP 
Because_IN of_IN this_DT ,_, we_PRP used_VBD exposure_NN history_NN to_TO characterize_VB mercury_NN exposures_NNS in_IN this_DT population_NN ._. 
Ahigh_JJ degree_NN of_IN variability_NN in_IN urine_NN mercury_NN levels_NNS among_IN gold_NN miners_NNS has_VBZ been_VBN reported_VBN by_IN others_NNS 
Study_NN design_NN The_DT overall_JJ design_NN of_IN the_DT mercury_NN surveillance_NN studies_NNS conducted_VBN by_IN Dr_NNP Santos_NNP is_VBZ a_DT community_NN based_VBN ,_, cross_JJ sectional_JJ survey_NN of_IN Brazilian_JJ populations_NNS in_IN Amazonia_NNP ,_, focused_VBD on_IN the_DT states_NNS of_IN Par_NN 
All_DT smears_NNS were_VBD read_VBN by_IN trained_JJ technicians_NNS ._. 
Malaria_NN was_VBD assessed_VBN by_IN questionnaire_NN to_TO determine_VB past_JJ history_NN of_IN malaria_NN -LRB-_-LRB- self_NN reported_VBD -RRB-_-RRB- ,_, as_RB well_RB as_IN by_IN thick_JJ smears_NNS taken_VBN to_TO determine_VB prevalent_JJ malaria_NN ._. 
Data_NNS on_IN past_JJ malaria_NN were_VBD stratified_VBN using_VBG Baird_NNP as_IN reference_NN ,_, in_IN which_WDT he_PRP determined_VBD the_DT minimum_JJ number_NN -LRB-_-LRB- 4_CD -RRB-_-RRB- of_IN prior_JJ malaria_NN infections_NNS associated_VBN with_IN acquisition_NN of_IN functional_JJ immunity_NN -LRB-_-LRB- i._FW e._FW ,_, no_DT disease_NN and\/or_CC parasitemia_NN after_IN biting_VBG -RRB-_-RRB- ._. 
The_DT study_NN was_VBD approved_VBN by_IN the_DT institutional_JJ review_NN board_NN of_IN the_DT IEC_NNP and_CC FUNASA_NNP ._. 
We_PRP have_VBP reported_VBN a_DT suggested_JJ correlation_NN between_IN mercury_NN exposures_NNS and_CC number_NN of_IN past_JJ malaria_NN infections_NNS among_IN gold_JJ miners_NNS in_IN another_DT gold_NN mine_NN settlement_NN ,_, in_IN Brazil_NNP ,_, at_IN Piranha_NNP ._. 
We_PRP have_VBP also_RB reported_VBN that_DT exposure_NN of_IN mice_NNS to_TO low_JJ levels_NNS of_IN mercury_NN both_DT decreases_VBZ host_NN resistance_NN to_TO murine_VB malaria_NN -LRB-_-LRB- Plasmodium_NNP yoelii_FW -RRB-_-RRB- and_CC impairs_VBZ acquisition_NN of_IN immunity_NN to_TO murine_VB malaria_NN in_IN the_DT Nussenzweig_NNP model_NN 
No_DT reports_NNS of_IN exposure_NN to_TO other_JJ risk_NN factors_NNS ,_, such_JJ as_IN infectious_JJ diseases_NNS ,_, were_VBD reported_VBN ._. 
In_IN these_DT other_JJ studies_NNS ,_, the_DT cohorts_NNS were_VBD relatively_RB small_JJ -LRB-_-LRB- between_IN 44_CD 
Persons_NNS from_IN Tabatinga_NNP ,_, with_IN the_DT lowest_JJS range_NN of_IN mercury_NN exposures_NNS ,_, had_VBD lower_JJR prevalence_NN of_IN detectable_JJ ANA_NNP or_CC ANoA_NNP ,_, and_CC in_IN those_DT few_JJ persons_NNS with_IN detectable_JJ autoantibodies_NNS ,_, the_DT concentrations_NNS were_VBD low_JJ ._. 
Nonetheless_RB ,_, Tabatinga_NNP subjects_NNS had_VBD significantly_RB elevated_VBN mercury_NN levels_NNS ,_, as_IN compared_VBN to_TO North_NNP America_NNP populations_NNS 
In_IN Jacareacanga_NNP ,_, there_EX was_VBD a_DT positive_JJ relationship_NN between_IN malaria_NN -LRB-_-LRB- any_DT past_NN reported_VBD cases_NNS -RRB-_-RRB- and_CC likelihood_NN of_IN elevated_JJ ANoA_NNP ._. 
We_PRP examined_VBD these_DT potential_JJ biological_JJ interactions_NNS among_IN mercury_NN ,_, malaria_NN ,_, and_CC autoimmune_JJ biomarkers_NNS further_RBR ,_, because_IN of_IN studies_NNS demonstrating_VBG that_IN repeated_VBN malaria_NN infections_NNS are_VBP associated_VBN with_IN increased_VBN levels_NNS of_IN autoantibodies_NNS ,_, including_VBG ANA_NNP ,_, presumably_RB due_JJ to_TO cytotoxic_JJ damage_NN and_CC exposure_NN of_IN intracellular_JJ epitopes_NNS 
In_IN Jacareacanga_NNP ,_, there_EX was_VBD a_DT positive_JJ relationship_NN between_IN malaria_NN -LRB-_-LRB- any_DT past_NN reported_VBD cases_NNS -RRB-_-RRB- and_CC likelihood_NN of_IN elevated_JJ ANoA_NNP ._. 
We_PRP examined_VBD these_DT potential_JJ biological_JJ interactions_NNS among_IN mercury_NN ,_, malaria_NN ,_, and_CC autoimmune_JJ biomarkers_NNS further_RBR ,_, because_IN of_IN studies_NNS demonstrating_VBG that_IN repeated_VBN malaria_NN infections_NNS are_VBP associated_VBN with_IN increased_VBN levels_NNS of_IN autoantibodies_NNS ,_, including_VBG ANA_NNP ,_, presumably_RB due_JJ to_TO cytotoxic_JJ damage_NN and_CC exposure_NN of_IN intracellular_JJ epitopes_NNS 
One_CD earlier_JJR study_NN reported_VBD elevations_NNS in_IN anti-laminin_JJ autoantibodies_NNS in_IN workers_NNS exposed_VBN to_TO mercury_NN 
We_PRP examined_VBD these_DT potential_JJ biological_JJ interactions_NNS among_IN mercury_NN ,_, malaria_NN ,_, and_CC autoimmune_JJ biomarkers_NNS further_RBR ,_, because_IN of_IN studies_NNS demonstrating_VBG that_IN repeated_VBN malaria_NN infections_NNS are_VBP associated_VBN with_IN increased_VBN levels_NNS of_IN autoantibodies_NNS ,_, including_VBG ANA_NNP ,_, presumably_RB due_JJ to_TO cytotoxic_JJ damage_NN and_CC exposure_NN of_IN intracellular_JJ epitopes_NNS 
This_DT may_MD have_VB been_VBN due_JJ to_TO the_DT timing_NN of_IN our_PRP$ visit_NN ,_, during_IN the_DT dry_JJ season_NN ,_, when_WRB gold_JJ amalgamation_NN activities_NNS were_VBD reduced_VBN ._. 
Ahigh_JJ degree_NN of_IN variability_NN in_IN urine_NN mercury_NN levels_NNS among_IN gold_NN miners_NNS has_VBZ been_VBN reported_VBN by_IN others_NNS 
In_IN our_PRP$ study_NN ,_, some_DT of_IN the_DT exposures_NNS were_VBD chronic_JJ in_IN nature_NN and_CC included_VBD exposures_NNS to_TO methylmercury_NN -LRB-_-LRB- certainly_RB for_IN fish_NN consumption_NN in_IN Amazonian_JJ populations_NNS ,_, where_WRB fish_NN form_NN the_DT major_JJ portion_NN of_IN the_DT protein_NN consumed_VBN -RRB-_-RRB- 
Educational_NNP and_CC socioeconomic_JJ variables_NNS were_VBD low_JJ ._. 
Approximately_RB 2\/3_CD of_IN the_DT population_NN was_VBD male_JJ with_IN a_DT mean_JJ age_NN of_IN 30_CD years_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
Urine_NN mercury_NN levels_NNS -LRB-_-LRB- 4_CD 
Urine_NN mercury_NN levels_NNS -LRB-_-LRB- 4_CD 
We_PRP could_MD not_RB test_VB this_DT hypothesis_NN in_IN the_DT Rio-Rato_NNP group_NN ,_, since_IN almost_RB all_DT subjects_NNS had_VBD prevalent_JJ malaria_NN and_CC extensive_JJ histories_NNS of_IN past_JJ infection_NN ._. 
We_PRP have_VBP reported_VBN a_DT suggested_JJ correlation_NN between_IN mercury_NN exposures_NNS and_CC number_NN of_IN past_JJ malaria_NN infections_NNS among_IN gold_JJ miners_NNS in_IN another_DT gold_NN mine_NN settlement_NN ,_, in_IN Brazil_NNP ,_, at_IN Piranha_NNP ._. 
We_PRP have_VBP also_RB reported_VBN that_DT exposure_NN of_IN mice_NNS to_TO low_JJ levels_NNS of_IN mercury_NN both_DT decreases_VBZ host_NN resistance_NN to_TO murine_VB malaria_NN -LRB-_-LRB- Plasmodium_NNP yoelii_FW -RRB-_-RRB- and_CC impairs_VBZ acquisition_NN of_IN immunity_NN to_TO murine_VB malaria_NN in_IN the_DT Nussenzweig_NNP model_NN 
This_DT site_NN is_VBZ in_IN the_DT lower_JJR Tapaj_NNP 
Study_NN design_NN The_DT overall_JJ design_NN of_IN the_DT mercury_NN surveillance_NN studies_NNS conducted_VBN by_IN Dr_NNP Santos_NNP is_VBZ a_DT community_NN based_VBN ,_, cross_JJ sectional_JJ survey_NN of_IN Brazilian_JJ populations_NNS in_IN Amazonia_NNP ,_, focused_VBD on_IN the_DT states_NNS of_IN Par_NN 
The_DT 140_CD subjects_NNS consisted_VBN of_IN 54_CD %_NN women_NNS and_CC had_VBD a_DT mean_JJ age_NN of_IN 25_CD years_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
Jacareacanga_NNP Jacareacanga_NNP is_VBZ a_DT riverine_JJ settlement_NN of_IN approximately_RB 500_CD persons_NNS ,_, located_VBN on_IN the_DT mid-Tapaj_NN 
At_IN Rio-Rato_NNP ,_, a_DT garimpo_NN or_CC gold_NN mine_NN site_NN ,_, most_JJS of_IN the_DT population_NN was_VBD directly_RB involved_VBN in_IN gold_NN extraction_NN and_CC refining_NN ,_, resulting_VBG in_IN relatively_RB high_JJ but_CC often_RB episodic_JJ exposures_NNS to_TO inorganic_JJ mercury_NN ,_, similar_JJ to_TO those_DT described_VBN by_IN us_PRP and_CC others_NNS ._. 
This_DT site_NN is_VBZ in_IN the_DT lower_JJR Tapaj_NNP 
Because_IN of_IN this_DT ,_, we_PRP used_VBD exposure_NN history_NN to_TO characterize_VB mercury_NN exposures_NNS in_IN this_DT population_NN ._. 
Ahigh_JJ degree_NN of_IN variability_NN in_IN urine_NN mercury_NN levels_NNS among_IN gold_NN miners_NNS has_VBZ been_VBN reported_VBN by_IN others_NNS 
The_DT gold_NN miners_NNS are_VBP directly_RB exposed_VBN to_TO inorganic_JJ mercury_NN and_CC residents_NNS of_IN downstream_JJ communities_NNS are_VBP exposed_VBN to_TO methylmercury_NN via_IN consumption_NN of_IN fish_NN ._. 
Extensive_JJ work_NN has_VBZ been_VBN done_VBN on_IN many_JJ of_IN these_DT populations_NNS ,_, documenting_VBG a_DT range_NN of_IN exposures_NNS among_IN miners_NNS and_CC fish_NN consumers_NNS 
The_DT gold_NN miners_NNS are_VBP directly_RB exposed_VBN to_TO inorganic_JJ mercury_NN and_CC residents_NNS of_IN downstream_JJ communities_NNS are_VBP exposed_VBN to_TO methylmercury_NN via_IN consumption_NN of_IN fish_NN ._. 
Extensive_JJ work_NN has_VBZ been_VBN done_VBN on_IN many_JJ of_IN these_DT populations_NNS ,_, documenting_VBG a_DT range_NN of_IN exposures_NNS among_IN miners_NNS and_CC fish_NN consumers_NNS 
The_DT communities_NNS in_IN our_PRP$ study_NN were_VBD chosen_VBN from_IN this_DT surveillance_NN database_NN on_IN the_DT basis_NN of_IN differences_NNS in_IN exposures_NNS to_TO mercury_NN and_CC other_JJ risk_NN factors_NNS in_IN Par_NN 
Educational_NNP and_CC socioeconomic_JJ variables_NNS were_VBD low_JJ ._. 
Approximately_RB 2\/3_CD of_IN the_DT population_NN was_VBD male_JJ with_IN a_DT mean_JJ age_NN of_IN 30_CD years_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
Urine_NN mercury_NN levels_NNS -LRB-_-LRB- 4_CD 
This_DT may_MD have_VB been_VBN due_JJ to_TO the_DT timing_NN of_IN our_PRP$ visit_NN ,_, during_IN the_DT dry_JJ season_NN ,_, when_WRB gold_JJ amalgamation_NN activities_NNS were_VBD reduced_VBN ._. 
Ahigh_JJ degree_NN of_IN variability_NN in_IN urine_NN mercury_NN levels_NNS among_IN gold_NN miners_NNS has_VBZ been_VBN reported_VBN by_IN others_NNS 
In_IN our_PRP$ study_NN ,_, some_DT of_IN the_DT exposures_NNS were_VBD chronic_JJ in_IN nature_NN and_CC included_VBD exposures_NNS to_TO methylmercury_NN -LRB-_-LRB- certainly_RB for_IN fish_NN consumption_NN in_IN Amazonian_JJ populations_NNS ,_, where_WRB fish_NN form_NN the_DT major_JJ portion_NN of_IN the_DT protein_NN consumed_VBN -RRB-_-RRB- 
We_PRP were_VBD able_JJ to_TO conduct_VB this_DT study_NN in_IN collaboration_NN with_IN an_DT ongoing_JJ epidemiological_JJ surveillance_NN of_IN mercury_NN exposures_NNS in_IN Amazonian_NNP Brazil_NNP ,_, where_WRB populations_NNS are_VBP exposed_VBN to_TO both_DT inorganic_JJ and_CC organic_JJ mercury_NN associated_VBN with_IN gold_JJ mining_NN activities_NNS 
The_DT communities_NNS in_IN our_PRP$ study_NN were_VBD chosen_VBN from_IN this_DT surveillance_NN database_NN on_IN the_DT basis_NN of_IN differences_NNS in_IN exposures_NNS to_TO mercury_NN and_CC other_JJ risk_NN factors_NNS in_IN Par_NN 
Educational_NNP and_CC socioeconomic_JJ variables_NNS were_VBD low_JJ ._. 
Approximately_RB 2\/3_CD of_IN the_DT population_NN was_VBD male_JJ with_IN a_DT mean_JJ age_NN of_IN 30_CD years_NNS -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
Urine_NN mercury_NN levels_NNS -LRB-_-LRB- 4_CD 
In_IN our_PRP$ study_NN ,_, some_DT of_IN the_DT exposures_NNS were_VBD chronic_JJ in_IN nature_NN and_CC included_VBD exposures_NNS to_TO methylmercury_NN -LRB-_-LRB- certainly_RB for_IN fish_NN consumption_NN in_IN Amazonian_JJ populations_NNS ,_, where_WRB fish_NN form_NN the_DT major_JJ portion_NN of_IN the_DT protein_NN consumed_VBN -RRB-_-RRB- 
However_RB ,_, the_DT sample_NN size_NN was_VBD small_JJ and_CC levels_NNS of_IN mercury_NN were_VBD low_JJ in_IN all_DT subjects_NNS ._. 
Arecent_JJ case-control_JJ study_NN reported_VBD that_IN severely_RB affected_JJ scleroderma_NN patients_NNS with_IN AFA_NNP were_VBD more_RBR likely_JJ to_TO have_VB higher_JJR levels_NNS of_IN mercury_NN in_IN urine_NN ,_, as_IN compared_VBN either_RB to_TO less_RBR severely_RB affected_VBN cases_NNS without_IN AFA_NNP ,_, or_CC controls_NNS ,_, suggesting_VBG an_DT etiologic_JJ role_NN for_IN mercury_NN in_IN this_DT autoimmune_JJ disease_NN 
The_DT gold_NN miners_NNS are_VBP directly_RB exposed_VBN to_TO inorganic_JJ mercury_NN and_CC residents_NNS of_IN downstream_JJ communities_NNS are_VBP exposed_VBN to_TO methylmercury_NN via_IN consumption_NN of_IN fish_NN ._. 
Extensive_JJ work_NN has_VBZ been_VBN done_VBN on_IN many_JJ of_IN these_DT populations_NNS ,_, documenting_VBG a_DT range_NN of_IN exposures_NNS among_IN miners_NNS and_CC fish_NN consumers_NNS 
This_DT site_NN is_VBZ in_IN the_DT lower_JJR Tapaj_NNP 
There_EX is_VBZ little_JJ autochthonous_JJ malaria_NN in_IN this_DT town_NN but_CC many_JJ people_NNS have_VBP histories_NNS of_IN malaria_NN because_IN of_IN contact_NN with_IN the_DT nearby_JJ region_NN ._. 
Finally_RB ,_, at_IN the_DT village_NN of_IN Tabatinga_NNP ,_, located_VBN on_IN the_DT lower_JJR Amazon_NNP River_NNP east_JJ of_IN the_DT Tapaj_NNP 
However_RB ,_, the_DT sample_NN size_NN was_VBD small_JJ and_CC levels_NNS of_IN mercury_NN were_VBD low_JJ in_IN all_DT subjects_NNS ._. 
Arecent_JJ case-control_JJ study_NN reported_VBD that_IN severely_RB affected_JJ scleroderma_NN patients_NNS with_IN AFA_NNP were_VBD more_RBR likely_JJ to_TO have_VB higher_JJR levels_NNS of_IN mercury_NN in_IN urine_NN ,_, as_IN compared_VBN either_RB to_TO less_RBR severely_RB affected_VBN cases_NNS without_IN AFA_NNP ,_, or_CC controls_NNS ,_, suggesting_VBG an_DT etiologic_JJ role_NN for_IN mercury_NN in_IN this_DT autoimmune_JJ disease_NN 
We_PRP were_VBD able_JJ to_TO conduct_VB this_DT study_NN in_IN collaboration_NN with_IN an_DT ongoing_JJ epidemiological_JJ surveillance_NN of_IN mercury_NN exposures_NNS in_IN Amazonian_NNP Brazil_NNP ,_, where_WRB populations_NNS are_VBP exposed_VBN to_TO both_DT inorganic_JJ and_CC organic_JJ mercury_NN associated_VBN with_IN gold_JJ mining_NN activities_NNS ._. 
In_IN Amazonian_NNP Brazil_NNP ,_, as_IN in_IN many_JJ other_JJ regions_NNS of_IN the_DT world_NN ,_, elemental_JJ mercury_NN is_VBZ used_VBN in_IN liquid_JJ form_NN for_IN amalgamation_NN of_IN go_NN 
Mercury-induced_JJ ANoA_NN in_IN mice_NNS reacts_VBZ with_IN a_DT conserved_VBN epitope_NN of_IN fibrillarin_NN 
More_RBR recently_RB ,_, Pollard_NNP et_FW al._FW ._. 
ANoA_JJ autoantibodies_NNS ,_, a_DT marker_NN found_VBN in_IN some_DT human_JJ autoimmune_JJ diseases_NNS 
have_VBP proposed_VBN that_IN ANoA_NNP antibodies_NNS targeting_VBG the_DT nucleolar_JJ 34-KDa_JJ protein_NN fibrillarin_NN may_MD be_VB specific_JJ biomarkers_NNS of_IN mercury-induced_JJ immunotoxicity_NN 
It_PRP is_VBZ possible_JJ that_IN exposure_NN to_TO inorganic_JJ mercury_NN may_MD be_VB more_JJR ``_`` autoimmunogenic_JJ ''_'' than_IN exposure_NN to_TO methylmercury_NN ,_, as_IN shown_VBN in_IN mice_NNS models_NNS 
More_RBR recently_RB ,_, Pollard_NNP et_FW al._FW ._. 
ANoA_JJ autoantibodies_NNS ,_, a_DT marker_NN found_VBN in_IN some_DT human_JJ autoimmune_JJ diseases_NNS 
have_VBP proposed_VBN that_IN ANoA_NNP antibodies_NNS targeting_VBG the_DT nucleolar_JJ 34-KDa_JJ protein_NN fibrillarin_NN may_MD be_VB specific_JJ biomarkers_NNS of_IN mercury-induced_JJ immunotoxicity_NN 
Randomly_RB selected_VBN slides_NNS were_VBD re-checked_VBN by_IN an_DT experienced_JJ immunologist_NN -LRB-_-LRB- CLB_NNP -RRB-_-RRB- ._. 
The_DT slides_NNS were_VBD stored_VBN in_IN the_DT dark_NN at_IN 4_CD 
It_PRP is_VBZ possible_JJ that_IN exposure_NN to_TO inorganic_JJ mercury_NN may_MD be_VB more_JJR ``_`` autoimmunogenic_JJ ''_'' than_IN exposure_NN to_TO methylmercury_NN ,_, as_IN shown_VBN in_IN mice_NNS models_NNS 
Awareness_NN of_IN the_DT effects_NNS of_IN mercury_NN on_IN the_DT immune_JJ system_NN has_VBZ increased_VBN in_IN the_DT last_JJ decade_NN 
In_IN rodent_NN models_NNS exposure_NN to_TO inorganic_JJ and_CC organic_JJ mercury_NN has_VBZ a_DT range_NN of_IN immunotoxic_JJ effects_NNS ,_, functionally_RB associated_VBN with_IN decreased_VBN cell-mediated_JJ immunity_NN and_CC the_DT induction_NN of_IN autoimmunity_NN 
One_CD earlier_JJR study_NN reported_VBD elevations_NNS in_IN anti-laminin_JJ autoantibodies_NNS in_IN workers_NNS exposed_VBN to_TO mercury_NN 
The_DT role_NN of_IN genotype_NN may_MD also_RB be_VB important_JJ ._. 
In_IN contrast_NN ,_, the_DT gold_NN miners_NNS were_VBD likely_JJ to_TO have_VB relatively_RB variable_JJ exposures_NNS to_TO inorganic_JJ mercury_NN ,_, with_IN episodes_NNS of_IN very_RB high_JJ inhalation_NN exposure_NN 
These_DT effects_NNS vary_VBP with_IN strain_NN 
One_CD earlier_JJR study_NN reported_VBD elevations_NNS in_IN anti-laminin_JJ autoantibodies_NNS in_IN workers_NNS exposed_VBN to_TO mercury_NN 
Detectable_JJ levels_NNS of_IN ANA_NNP and\/or_CC ANoA_NNP were_VBD prevalent_JJ and_CC detectable_JJ at_IN high_JJ concentrations_NNS -LRB-_-LRB- 1:320_CD -RRB-_-RRB- ._. 
It_PRP is_VBZ possible_JJ that_IN exposure_NN to_TO inorganic_JJ mercury_NN may_MD be_VB more_JJR ``_`` autoimmunogenic_JJ ''_'' than_IN exposure_NN to_TO methylmercury_NN ,_, as_IN shown_VBN in_IN mice_NNS models_NNS 
In_IN susceptible_JJ mice_NNS ,_, induction_NN of_IN genetically_RB restrictive_JJ ANoA_NN by_IN mercury_NN are_VBP linked_VBN to_TO mouse_NN MHC_NNP -LRB-_-LRB- H-2_NNP -RRB-_-RRB- haplotype_NN s_VBZ and_CC q_SYM 
In_IN rodent_NN models_NNS exposure_NN to_TO inorganic_JJ and_CC organic_JJ mercury_NN has_VBZ a_DT range_NN of_IN immunotoxic_JJ effects_NNS ,_, functionally_RB associated_VBN with_IN decreased_VBN cell-mediated_JJ immunity_NN and_CC the_DT induction_NN of_IN autoimmunity_NN 
The_DT role_NN of_IN genotype_NN may_MD also_RB be_VB important_JJ ._. 
In_IN contrast_NN ,_, the_DT gold_NN miners_NNS were_VBD likely_JJ to_TO have_VB relatively_RB variable_JJ exposures_NNS to_TO inorganic_JJ mercury_NN ,_, with_IN episodes_NNS of_IN very_RB high_JJ inhalation_NN exposure_NN 
In_IN rodents_NNS ,_, genotype_NN clearly_RB plays_VBZ an_DT important_JJ role_NN in_IN both_DT modulating_VBG the_DT immune_JJ response_NN to_TO inorganic_JJ mercury_NN as_RB well_RB as_IN toxicokinetics_NNS ._. 
In_IN susceptible_JJ mice_NNS ,_, induction_NN of_IN genetically_RB restrictive_JJ ANoA_NN by_IN mercury_NN are_VBP linked_VBN to_TO mouse_NN MHC_NNP -LRB-_-LRB- H-2_NNP -RRB-_-RRB- haplotype_NN s_VBZ and_CC q_SYM 
In_IN susceptible_JJ mice_NNS ,_, induction_NN of_IN genetically_RB restrictive_JJ ANoA_NN by_IN mercury_NN are_VBP linked_VBN to_TO mouse_NN MHC_NNP -LRB-_-LRB- H-2_NNP -RRB-_-RRB- haplotype_NN s_VBZ and_CC q_SYM 
Conclusions_NNS This_DT is_VBZ the_DT first_JJ study_NN to_TO report_VB immunologic_JJ changes_NNS ,_, indicative_JJ of_IN autoimmune_JJ dysfunction_NN in_IN persons_NNS exposed_VBN to_TO mercury_NN ,_, which_WDT may_MD also_RB reflect_VB interactions_NNS with_IN infectious_JJ disease_NN and_CC other_JJ factors_NNS ._. 
BackgroundMercury_NNP has_VBZ been_VBN recognized_VBN as_IN a_DT significant_JJ environmental_JJ and_CC public_JJ health_NN problem_NN for_IN more_JJR than_IN 40_CD years_NNS ,_, primarily_RB for_IN its_PRP$ effects_NNS on_IN the_DT developing_VBG nervous_JJ system_NN ,_, as_IN expressed_VBN in_IN tragic_JJ episodes_NNS of_IN human_JJ poisoning_NN in_IN Japan_NNP and_CC Iraq_NNP 
Ethylmercury_NNP -LRB-_-LRB- C_NNP 2_CD H_NNP 5_CD Hg_FW +_FW -RRB-_-RRB- ,_, the_DT active_JJ compound_NN in_IN thimerosal_NN and_CC other_JJ medical_JJ compounds_NNS ,_, induces_VBZ in_IN a_DT dose-dependent_JJ pattern_NN all_PDT the_DT features_NNS of_IN systemic_JJ autoimmunity_NN that_WDT have_VBP been_VBN described_VBN after_IN exposure_NN to_TO mercuric_JJ chloride_NN -LRB-_-LRB- HgCl_NNP 2_CD -RRB-_-RRB- ._. 
Mercury_NNP can_MD enter_VB the_DT body_NN through_IN inhalation_NN ,_, as_IN elemental_JJ mercury_NN -LRB-_-LRB- Hg0_NNP -RRB-_-RRB- ,_, through_IN dermal_NN or_CC eye_NN contact_NN ,_, as_IN ethylmercury_NN ,_, and_CC by_IN absorption_NN through_IN the_DT gastrointestinal_JJ track_NN ,_, primarily_RB as_IN methylmercury_NN -LRB-_-LRB- CH3Hg_JJ +_NN -RRB-_-RRB- through_IN ingestion_NN of_IN contaminated_VBN fish_NN 
Mercury_NNP absorbed_VBD through_IN skin_NN contact_NN is_VBZ oxidized_VBN in_IN the_DT liver_NN to_TO Hg_VB 2_CD +_CD by_IN glutathione_NN 
In_IN the_DT literature_NN ,_, no_DT cases_NNS of_IN frank_JJ autoimmune_JJ disease_NN have_VBP been_VBN reported_VBN in_IN persons_NNS exposed_VBN to_TO mercury_NN ,_, occupationally_RB or_CC environmentally_RB 
In_IN a_DT study_NN of_IN chloralkali_JJ workers_NNS ,_, circulating_VBG anti-laminin_JJ antibodies_NNS were_VBD found_VBN in_IN some_DT workers_NNS as_RB well_RB as_IN autoantibodies_NNS against_IN glomerular_JJ basement_NN membrane_NN and_CC circulating_VBG immune_JJ complexes_NNS ,_, but_CC no_DT significant_JJ increases_NNS in_IN antinuclear_JJ autoantibodies_NNS -LRB-_-LRB- ANA_NNP -RRB-_-RRB- were_VBD found_VBN 
The_DT gold_NN miners_NNS are_VBP directly_RB exposed_VBN to_TO inorganic_JJ mercury_NN and_CC residents_NNS of_IN downstream_JJ communities_NNS are_VBP exposed_VBN to_TO methylmercury_NN via_IN consumption_NN of_IN fish_NN ._. 
Extensive_JJ work_NN has_VBZ been_VBN done_VBN on_IN many_JJ of_IN these_DT populations_NNS ,_, documenting_VBG a_DT range_NN of_IN exposures_NNS among_IN miners_NNS and_CC fish_NN consumers_NNS 
There_EX is_VBZ little_JJ autochthonous_JJ malaria_NN in_IN this_DT town_NN but_CC many_JJ people_NNS have_VBP histories_NNS of_IN malaria_NN because_IN of_IN contact_NN with_IN the_DT nearby_JJ region_NN ._. 
Finally_RB ,_, at_IN the_DT village_NN of_IN Tabatinga_NNP ,_, located_VBN on_IN the_DT lower_JJR Amazon_NNP River_NNP east_JJ of_IN the_DT Tapaj_NNP 
Second_JJ ,_, mercury_NN concentrations_NNS were_VBD measured_VBN in_IN biologic_JJ compartments_NNS ._. 
First_RB ,_, information_NN was_VBD gathered_VBN by_IN questionnaire_NN on_IN occupational_JJ history_NN -LRB-_-LRB- contact_NN with_IN and_CC use_NN of_IN mercury_NN in_IN gold_NN mining_NN -RRB-_-RRB- ,_, and\/or_CC fish_NN consumption_NN -LRB-_-LRB- by_IN weekly_JJ frequency_NN and_CC predominant_JJ types_NNS of_IN fish_NN consumed_VBN -RRB-_-RRB- ._. 
For_IN persons_NNS in_IN Tabatinga_NNP and_CC Jacareacanga_NNP with_IN chronic_JJ exposure_NN via_IN fish_NN consumption_NN ,_, hair_NN mercury_NN -LRB-_-LRB- 
For_IN persons_NNS with_IN occupational_JJ exposures_NNS to_TO inorganic_JJ mercury_NN ,_, in_IN Rio-Rato_NNP ,_, urine_NN mercury_NN was_VBD used_VBN as_IN the_DT biomarker_NN -LRB-_-LRB- 
The_DT distribution_NN of_IN hair_NN mercury_NN is_VBZ shown_VBN in_IN Figure_NNP 1B_NNP ._. 
No_DT persons_NNS reported_VBD current_JJ employment_NN in_IN gold_NN mining_NN or_CC refining_NN ,_, but_CC some_DT persons_NNS reported_VBD a_DT history_NN of_IN such_JJ activities_NNS ._. 
Median_JJ hair_NN mercury_NN levels_NNS were_VBD 8_CD 
Persons_NNS from_IN Tabatinga_NNP ,_, with_IN the_DT lowest_JJS range_NN of_IN mercury_NN exposures_NNS ,_, had_VBD lower_JJR prevalence_NN of_IN detectable_JJ ANA_NNP or_CC ANoA_NNP ,_, and_CC in_IN those_DT few_JJ persons_NNS with_IN detectable_JJ autoantibodies_NNS ,_, the_DT concentrations_NNS were_VBD low_JJ ._. 
Nonetheless_RB ,_, Tabatinga_NNP subjects_NNS had_VBD significantly_RB elevated_VBN mercury_NN levels_NNS ,_, as_IN compared_VBN to_TO North_NNP America_NNP populations_NNS 
Background_NNP Mercury_NNP has_VBZ been_VBN recognized_VBN as_IN a_DT significant_JJ environmental_JJ and_CC public_JJ health_NN problem_NN for_IN more_JJR than_IN 40_CD years_NNS ,_, primarily_RB for_IN its_PRP$ effects_NNS on_IN the_DT developing_VBG nervous_JJ system_NN ,_, as_IN expressed_VBN in_IN tragic_JJ episodes_NNS of_IN human_JJ poisoning_NN in_IN Japan_NNP and_CC Iraq_NNP 
Background_NNP Mercury_NNP has_VBZ been_VBN recognized_VBN as_IN a_DT significant_JJ environmental_JJ and_CC public_JJ health_NN problem_NN for_IN more_JJR than_IN 40_CD years_NNS ,_, primarily_RB for_IN its_PRP$ effects_NNS on_IN the_DT developing_VBG nervous_JJ system_NN ,_, as_IN expressed_VBN in_IN tragic_JJ episodes_NNS of_IN human_JJ poisoning_NN in_IN Japan_NNP and_CC Iraq_NNP 
After_IN entering_VBG the_DT blood_NN stream_NN ,_, mercury_NN is_VBZ distributed_VBN to_TO all_DT tissues_NNS ,_, including_VBG the_DT brain_NN ,_, kidney_NN ,_, lungs_NNS ,_, hair_NN ,_, nails_NNS ,_, liver_NN ,_, fetus_NN ,_, milk_NN ,_, etc_FW 
Afew_NNP studies_NNS have_VBP examined_VBN relationships_NNS between_IN mercury_NN exposures_NNS and_CC adverse_JJ immunological_JJ reactions_NNS ,_, particularly_RB in_IN connection_NN with_IN mercury_NN amalgam_NN ,_, but_CC these_DT are_VBP controversial_JJ 
At_IN relatively_RB high_JJ levels_NNS of_IN occupational_JJ exposure_NN ,_, changes_NNS in_IN immunoglobulins_NNS have_VBP been_VBN reported_VBN ,_, but_CC not_RB consistently_RB 
Both_DT inorganic_JJ and_CC organic_JJ forms_NNS of_IN mercury_NN are_VBP immunotoxic_JJ ,_, although_IN they_PRP differ_VBP quantitatively_RB and_CC qualitatively_RB in_IN their_PRP$ effects_NNS on_IN the_DT immune_JJ system_NN ;_: methylmercury_NN may_MD require_VB metabolism_NN into_IN inorganic_JJ species_NNS to_TO induce_VB immunotoxic_JJ effects_NNS ,_, such_JJ that_IN the_DT effects_NNS of_IN methylmercury_NN are_VBP delayed_VBN and_CC reduced_VBN in_IN appearance_NN ._. 
Ethylmercury_NNP -LRB-_-LRB- C2H5Hg_FW +_FW -RRB-_-RRB- ,_, the_DT active_JJ compound_NN in_IN thimerosal_NN and_CC other_JJ medical_JJ compounds_NNS ,_, induces_VBZ in_IN a_DT dose-dependent_JJ pattern_NN all_PDT the_DT features_NNS of_IN systemic_JJ autoimmunity_NN that_WDT have_VBP been_VBN described_VBN after_IN exposure_NN to_TO mercuric_JJ chloride_NN -LRB-_-LRB- HgCl2_NNP -RRB-_-RRB- 
Mercury_NNP can_MD enter_VB the_DT body_NN through_IN inhalation_NN ,_, as_IN elemental_JJ mercury_NN -LRB-_-LRB- Hg_NN 0_CD -RRB-_-RRB- ,_, through_IN dermal_NN or_CC eye_NN contact_NN ,_, as_IN ethylmercury_NN ,_, and_CC by_IN absorption_NN through_IN the_DT gastrointestinal_JJ track_NN ,_, primarily_RB as_IN methylmercury_NN -LRB-_-LRB- CH_NNP 3_NNP Hg_NNP +_VBD -RRB-_-RRB- through_IN ingestion_NN of_IN contaminated_VBN fish_NN 
Cooking_NN and_CC heating_NN are_VBP the_DT main_JJ household_NN activities_NNS that_WDT lead_VBP to_TO the_DT excess_NN NO_RB 2_CD concentration_NN due_JJ to_TO solid_JJ biomass_NN fuel_NN use_NN in_IN general_JJ ,_, and_CC in_IN the_DT highland_JJ areas_NNS in_IN particular_JJ ._. 
In_IN other_JJ studies_NNS ,_, given_VBN the_DT range_NN of_IN the_DT purpose_NN of_IN biomass_NN fuel_NN use_NN ,_, cooking_NN has_VBZ been_VBN implicated_VBN as_IN the_DT main_JJ factor_NN for_IN the_DT greater_JJR proportion_NN of_IN exposure_NN to_TO IAP_NNP in_IN developing_VBG countries_NNS 
It_PRP is_VBZ evident_JJ from_IN the_DT data_NNS that_IN home_NN heating_NN in_IN the_DT highlands_NNS might_MD have_VB caused_VBN an_DT additional_JJ fuel_NN use_NN burden_NN ,_, which_WDT possibly_RB contributed_VBD to_TO the_DT increased_VBN concentration_NN of_IN indoor_JJ NO_UH 2_CD compared_VBN to_TO the_DT relatively_RB low_JJ fuel_NN use_NN burden_NN required_VBN for_IN repelling_VBG insects_NNS in_IN the_DT lowlands_NNS ._. 
The_DT extreme_JJ temperature_NN difference_NN 
Kerosene_NNP is_VBZ less_RBR affordable_JJ for_IN rural_JJ residents_NNS to_TO use_VB it_PRP for_IN cooking_NN purposes_NNS compared_VBN to_TO residents_NNS of_IN urban_JJ areas_NNS such_JJ as_IN Addis_NNP Ababa_NNP 
Aparticulate_JJ matter_NN -LRB-_-LRB- PM_NNP -RRB-_-RRB- of_IN various_JJ aerodynamic_JJ sizes_NNS is_VBZ also_RB used_VBN to_TO measure_VB the_DT level_NN of_IN IAP_NNP ._. 
The_DT use_NN of_IN gas_NN stoves_NNS and_CC heaters_NNS were_VBD often_RB accompanied_VBN with_IN exceeding_VBG the_DT current_JJ World_NNP Health_NNP organization_NN -LRB-_-LRB- WHO_WP -RRB-_-RRB- Air_NNP Quality_NNP Guideline_NNP -LRB-_-LRB- AQG_NNP -RRB-_-RRB- of_IN 21_CD ppb_NN for_IN 8_CD hours_NNS ._. 
The_DT mean_JJ concentration_NN of_IN respirable_JJ suspended_VBN particles_NNS -LRB-_-LRB- RSP_NNP -RRB-_-RRB- in_IN homes_NNS that_WDT use_VBP biomass_NN fuels_NNS had_VBD variation_NN depending_VBG on_IN the_DT type_NN of_IN kitchen_NN and_CC fuel_NN used_VBN :_: 500-2000_CD 
Studies_NNS have_VBP shown_VBN that_IN proxy_JJ factors_NNS related_VBN to_TO socio-economic_JJ status_NN like_IN income_NN education_NN ,_, and_CC use_NN of_IN biomass_NN fuel_NN to_TO be_VB highly_RB associated_VBN with_IN the_DT level_NN of_IN IAP_NNP 
Studies_NNS have_VBP shown_VBN that_IN proxy_JJ factors_NNS related_VBN to_TO socio-economic_JJ status_NN like_IN income_NN education_NN ,_, and_CC use_NN of_IN biomass_NN fuel_NN to_TO be_VB highly_RB associated_VBN with_IN the_DT level_NN of_IN IAP_NNP 
The_DT health_NN risk_NN of_IN direct_JJ exposure_NN to_TO biomass_NN combustion_NN is_VBZ evident_JJ in_IN part_NN due_JJ to_TO cooking_JJ practices_NNS in_IN poorly_RB ventilated_VBN and_CC crowded_VBN single_JJ roomed_VBD houses_NNS in_IN developing_VBG countries_NNS 
The_DT mean_JJ concentration_NN of_IN respirable_JJ suspended_VBN particles_NNS -LRB-_-LRB- RSP_NNP -RRB-_-RRB- in_IN homes_NNS that_WDT use_VBP biomass_NN fuels_NNS had_VBD variation_NN depending_VBG on_IN the_DT type_NN of_IN kitchen_NN and_CC fuel_NN used_VBN :_: 500-2000_CD 
Kerosene_NNP is_VBZ less_RBR affordable_JJ for_IN rural_JJ residents_NNS to_TO use_VB it_PRP for_IN cooking_NN purposes_NNS compared_VBN to_TO residents_NNS of_IN urban_JJ areas_NNS such_JJ as_IN Addis_NNP Ababa_NNP 
The_DT health_NN risk_NN of_IN direct_JJ exposure_NN to_TO biomass_NN combustion_NN is_VBZ evident_JJ in_IN part_NN due_JJ to_TO cooking_JJ practices_NNS in_IN poorly_RB ventilated_VBN and_CC crowded_VBN single_JJ roomed_VBD houses_NNS in_IN developing_VBG countries_NNS 
Studies_NNS have_VBP shown_VBN that_IN proxy_JJ factors_NNS related_VBN to_TO socio-economic_JJ status_NN like_IN income_NN education_NN ,_, and_CC use_NN of_IN biomass_NN fuel_NN to_TO be_VB highly_RB associated_VBN with_IN the_DT level_NN of_IN IAP_NNP 
Kerosene_NNP is_VBZ less_RBR affordable_JJ for_IN rural_JJ residents_NNS to_TO use_VB it_PRP for_IN cooking_NN purposes_NNS compared_VBN to_TO residents_NNS of_IN urban_JJ areas_NNS such_JJ as_IN Addis_NNP Ababa_NNP 
Such_JJ rooms_NNS do_VBP not_RB have_VB functional_JJ ventilation_NN outlets_NNS 
Kerosene_NNP is_VBZ less_RBR affordable_JJ for_IN rural_JJ residents_NNS to_TO use_VB it_PRP for_IN cooking_NN purposes_NNS compared_VBN to_TO residents_NNS of_IN urban_JJ areas_NNS such_JJ as_IN Addis_NNP Ababa_NNP 
Therefore_RB ,_, the_DT magnitude_NN of_IN health_NN risk_NN due_JJ to_TO biomass_NN combustion_NN can_MD reach_VB as_RB much_JJ as_IN 2-3_CD times_NNS greater_JJR than_IN the_DT risk_NN among_IN clean_JJ fuel_NN users_NNS 
5exceeded_VBN by_IN a_DT factor_NN of_IN 2_CD to_TO 40_CD times_NNS of_IN the_DT standards_NNS set_VBN by_IN US_NNP Environmental_NNP Protection_NNP Agency_NNP ,_, -LRB-_-LRB- US-EPA_NNP -RRB-_-RRB- for_IN 24-hr_JJ and_CC annual_JJ standards_NNS and_CC by_IN a_DT factor_NN of_IN 10_CD to_TO 80_CD times_NNS of_IN the_DT present_JJ WHO_WP 8_CD hr_NN of_IN air_NN quality_NN guideline_NN -LRB-_-LRB- AQG_NNP -RRB-_-RRB- 
5exceeded_VBN by_IN a_DT factor_NN of_IN 2_CD to_TO 40_CD times_NNS of_IN the_DT standards_NNS set_VBN by_IN US_NNP Environmental_NNP Protection_NNP Agency_NNP ,_, -LRB-_-LRB- US-EPA_NNP -RRB-_-RRB- for_IN 24-hr_JJ and_CC annual_JJ standards_NNS and_CC by_IN a_DT factor_NN of_IN 10_CD to_TO 80_CD times_NNS of_IN the_DT present_JJ WHO_WP 8_CD hr_NN of_IN air_NN quality_NN guideline_NN -LRB-_-LRB- AQG_NNP -RRB-_-RRB- 
Biomass_NN fuel_NN in_IN the_DT form_NN of_IN firewood_NN ,_, agricultural_JJ residues_NNS and_CC animal_NN dung_NN is_VBZ the_DT primary_JJ source_NN of_IN household_NN energy_NN in_IN Ethiopia_NNP 
Cooking_NN takes_VBZ place_NN in_IN the_DT same_JJ room_NN using_VBG traditional_JJ unvented_JJ stoves_NNS ._. 
The_DT majority_NN of_IN rural_JJ homes_NNS have_VBP only_RB 1_CD room_NN serving_VBG all_DT types_NNS of_IN household_NN activities_NNS 
Aparticulate_JJ matter_NN -LRB-_-LRB- PM_NNP -RRB-_-RRB- of_IN various_JJ aerodynamic_JJ sizes_NNS is_VBZ also_RB used_VBN to_TO measure_VB the_DT level_NN of_IN IAP_NNP ._. 
The_DT use_NN of_IN gas_NN stoves_NNS and_CC heaters_NNS were_VBD often_RB accompanied_VBN with_IN exceeding_VBG the_DT current_JJ World_NNP Health_NNP organization_NN -LRB-_-LRB- WHO_WP -RRB-_-RRB- Air_NNP Quality_NNP Guideline_NNP -LRB-_-LRB- AQG_NNP -RRB-_-RRB- of_IN 21_CD ppb_NN for_IN 8_CD hours_NNS ._. 
The_DT mean_JJ concentration_NN of_IN respirable_JJ suspended_VBN particles_NNS -LRB-_-LRB- RSP_NNP -RRB-_-RRB- in_IN homes_NNS that_WDT use_VBP biomass_NN fuels_NNS had_VBD variation_NN depending_VBG on_IN the_DT type_NN of_IN kitchen_NN and_CC fuel_NN used_VBN :_: 500-2000_CD 
In_IN Ghana_NNP and_CC Nicaragua_NNP ,_, the_DT average_JJ concentrations_NNS of_IN PM_NNP 2_CD ._. 
Smith_NNP showed_VBD that_IN the_DT concentration_NN of_IN PM_NNP 10_CD commonly_RB varied_VBN between_IN 200-5000_CD 
In_IN Ghana_NNP and_CC Nicaragua_NNP ,_, the_DT average_JJ concentrations_NNS of_IN PM_NNP 2_CD ._. 
Smith_NNP showed_VBD that_IN the_DT concentration_NN of_IN PM_NNP 10_CD commonly_RB varied_VBN between_IN 200-5000_CD 
The_DT above_JJ cited_VBD aerial_JJ concentrations_NNS related_VBN to_TO RSP_NNP ,_, PM_NNP 10_CD and_CC PM_NNP 2_CD ._. 
These_DT studies_NNS indicated_VBD that_IN the_DT type_NN of_IN kitchen_NN -LRB-_-LRB- whether_IN inside_NN or_CC outside_NN -RRB-_-RRB- ,_, the_DT type_NN of_IN stove_NN -LRB-_-LRB- traditional_JJ or_CC improved_VBN -RRB-_-RRB- ,_, ventilation_NN condition_NN ,_, place_NN of_IN measurement_NN -LRB-_-LRB- kitchen_NN or_CC sleeping_VBG room_NN -RRB-_-RRB- ,_, and_CC type_NN of_IN biomass_NN fuel_NN -LRB-_-LRB- wood_NN ,_, dung_NN ,_, or_CC residues_NNS -RRB-_-RRB- were_VBD major_JJ factors_NNS affecting_VBG the_DT concentrations_NNS of_IN indoor_JJ air_NN pollutants_NNS ._. 
5exceeded_VBN by_IN a_DT factor_NN of_IN 2_CD to_TO 40_CD times_NNS of_IN the_DT standards_NNS set_VBN by_IN US_NNP Environmental_NNP Protection_NNP Agency_NNP ,_, -LRB-_-LRB- US-EPA_NNP -RRB-_-RRB- for_IN 24-hr_JJ and_CC annual_JJ standards_NNS and_CC by_IN a_DT factor_NN of_IN 10_CD to_TO 80_CD times_NNS of_IN the_DT present_JJ WHO_WP 8_CD hr_NN of_IN air_NN quality_NN guideline_NN -LRB-_-LRB- AQG_NNP -RRB-_-RRB- 
Ecology_NNP ,_, season_NN ,_, type_NN of_IN biomass_NN fuel_NN ,_, the_DT purpose_NN and_CC time_NN of_IN having_VBG fire_NN events_NNS ,_, and_CC the_DT frequency_NN of_IN cooked_VBN food_NN items_NNS were_VBD all_DT found_VBN to_TO affect_VB the_DT level_NN of_IN indoor_JJ air_NN in_IN a_DT bivariate_JJ analysis_NN ,_, while_IN this_DT association_NN was_VBD consistent_JJ in_IN a_DT linear_JJ mixed_JJ model_NN except_IN for_IN the_DT type_NN of_IN biomass_NN fuel_NN for_IN wood_NN ._. 
In_IN western_JJ countries_NNS ,_, the_DT type_NN of_IN fuel_NN -LRB-_-LRB- gas_NN or_CC electricity_NN -RRB-_-RRB- ,_, occupancy_NN density_NN ,_, the_DT number_NN of_IN cooked_VBN meals_NNS ,_, frequency_NN of_IN cooking_NN ,_, season_NN and_CC income_NN were_VBD found_VBN to_TO significantly_RB impact_VB indoor_JJ NO2_NNP concentrations_NNS ._. 
Those_DT studies_NNS have_VBP indicated_VBN the_DT presence_NN of_IN strong_JJ link_NN among_IN factors_NNS responsible_JJ for_IN the_DT increased_VBN level_NN of_IN indoor_JJ NO_UH 2_CD both_DT in_IN the_DT developed_JJ and_CC developing_JJ countries_NNS ._. 
While_IN biomass_NN fuel_NN sources_NNS are_VBP relatively_RB cheap_JJ and_CC easily_RB available_JJ locally_RB ,_, fuels_NNS of_IN fossil_JJ origin_NN such_JJ as_IN kerosene_NN was_VBD only_RB used_VBN to_TO light_VB local_JJ lamps_NNS for_IN the_DT interior_NN of_IN housing_NN units_NNS at_IN night_NN ._. 
Kerosene_NNP is_VBZ less_RBR affordable_JJ for_IN rural_JJ residents_NNS to_TO use_VB it_PRP for_IN cooking_NN purposes_NNS compared_VBN to_TO residents_NNS of_IN urban_JJ areas_NNS such_JJ as_IN Addis_NNP Ababa_NNP 
Low_NNP temperature_NN in_IN early_JJ mornings_NNS and_CC nights_NNS is_VBZ common_JJ in_IN the_DT highlands_NNS of_IN Ethiopia_NNP ._. 
The_DT extreme_JJ temperature_NN difference_NN 
Adigital_JJ watch_NN was_VBD used_VBN to_TO record_VB the_DT time_NN ._. 
A24_CD hours_NNS indoor_JJ air_NN sampling_NN was_VBD done_VBN by_IN trained_JJ local_JJ enumerators_NNS at_IN about_IN 3_CD months_NNS interval_JJ to_TO collect_VB data_NNS on_IN the_DT date_NN ,_, start_NN and_CC finishing_JJ time_NN -LRB-_-LRB- hh_NN :_: mm_NN -RRB-_-RRB- of_IN each_DT sample_NN ._. 
NO2_CD concentration_NN was_VBD measured_VBN using_VBG Willems_NNP Badge_NNP that_WDT was_VBD developed_VBN at_IN the_DT University_NNP of_IN Wageningen_NNP in_IN the_DT Netherlands_NNP ._. 
The_DT polyethylene_NN passive_NN sampler_NN consists_VBZ of_IN a_DT small_JJ cylindrical_JJ cup_NN equipped_VBN with_IN 2_CD rings_NNS ,_, chemically_RB impregnated_VBN fibreglass_NNS placed_VBN at_IN the_DT bottom_NN of_IN the_DT cup_NN and_CC Teflon_NNP to_TO serve_VB as_IN a_DT wind_NN barrier_NN ._. 
The_DT high_JJ level_NN of_IN NO_DT 2_CD in_IN the_DT highland_JJ areas_NNS can_MD also_RB be_VB explained_VBN by_IN high_JJ proportion_NN of_IN wood_NN fuel_NN use_NN ._. 
Wood_NNP is_VBZ at_IN least_JJS better_JJR than_IN crop_NN residues_NNS and_CC animal_NN dung_NN in_IN the_DT energy_NN ladder_NN and_CC provides_VBZ relatively_RB better_JJR energy_NN efficiency_NN ._. 
When_WRB wood_NN is_VBZ used_VBN ,_, it_PRP oxidizes_VBZ relatively_RB more_RBR indoor_JJ air_NN nitrogen_NN because_IN of_IN the_DT relatively_RB high_JJ combustion_NN temperature_NN than_IN others_NNS ._. 
Adigital_JJ watch_NN was_VBD used_VBN to_TO record_VB the_DT time_NN ._. 
A24_CD hours_NNS indoor_JJ air_NN sampling_NN was_VBD done_VBN by_IN trained_JJ local_JJ enumerators_NNS at_IN about_IN 3_CD months_NNS interval_JJ to_TO collect_VB data_NNS on_IN the_DT date_NN ,_, start_NN and_CC finishing_JJ time_NN -LRB-_-LRB- hh_NN :_: mm_NN -RRB-_-RRB- of_IN each_DT sample_NN ._. 
NO2_CD concentration_NN was_VBD measured_VBN using_VBG Willems_NNP Badge_NNP that_WDT was_VBD developed_VBN at_IN the_DT University_NNP of_IN Wageningen_NNP in_IN the_DT Netherlands_NNP ._. 
The_DT polyethylene_NN passive_NN sampler_NN consists_VBZ of_IN a_DT small_JJ cylindrical_JJ cup_NN equipped_VBN with_IN 2_CD rings_NNS ,_, chemically_RB impregnated_VBN fibreglass_NNS placed_VBN at_IN the_DT bottom_NN of_IN the_DT cup_NN and_CC Teflon_NNP to_TO serve_VB as_IN a_DT wind_NN barrier_NN ._. 
Astandard_JJ curve_NN NO_RB 2_CD solution_NN was_VBD developed_VBN to_TO calculate_VB the_DT NO_UH 2_CD concentrations_NNS using_VBG the_DT following_JJ equation_NN :_: where_WRB :_: `_`` C_NNP '_'' is_VBZ indoor_JJ air_NN concentration_NN of_IN NO2_NNP in_IN micrograms_NNS per_IN cubic_JJ meter_NN ,_, `_`` mass_NN '_'' is_VBZ mass_NN of_IN NO2_CD on_IN the_DT glass_NN fiber_NN used_VBN for_IN air_NN sampling_NN after_IN subtracting_VBG mass_NN of_IN NO2_NNP of_IN the_DT blank_JJ glass_NN fiber_NN ,_, `_`` expmin_NN '_'' is_VBZ indoor_JJ air_NN sampling_VBG duration_NN in_IN minutes_NNS ,_, and_CC '_POS 40_CD '_'' is_VBZ a_DT constant_JJ of_IN air_NN sampling_NN rate_NN for_IN the_DT diffusive_JJ sampler_NN ,_, 40_CD mlmn-1_JJ ._. 
The_DT laboratory_NN data_NN quality_NN was_VBD maintained_VBN using_VBG various_JJ methods_NNS ._. 
Laboratory_NN technicians_NNS were_VBD properly_RB trained_VBN and_CC supervised_VBN on_IN each_DT day_NN of_IN laboratory_NN analysis_NN ._. 
The_DT present_JJ study_NN was_VBD undertaken_VBN with_IN an_DT effort_NN to_TO further_RB explore_VB other_JJ factors_NNS associated_VBN with_IN indoor_JJ air_NN pollution_NN in_IN the_DT rural_JJ Ethiopia_NN ._. 
Given_VBN the_DT high_JJ level_NN of_IN exposure_NN to_TO IAP_NNP in_IN poorly_RB ventilated_VBN housing_NN units_NNS ,_, increased_VBN morbidity_NN and_CC mortality_NN due_JJ to_TO acute_JJ respiratory_JJ infection_NN -LRB-_-LRB- ARI_NNP -RRB-_-RRB- in_IN the_DT general_JJ population_NN ,_, especially_RB among_IN children_NNS under-five_JJ years_NNS old_JJ ,_, are_VBP expected_VBN ._. 
Therefore_RB ,_, this_DT study_NN will_MD have_VB great_JJ operational_JJ relevance_NN in_IN achieving_VBG the_DT Millennium_NNP Development_NNP Goal_NNP 7_CD -LRB-_-LRB- MDG_NNP 7_CD ,_, target_NN 9_CD ,_, indicators_NNS 27_CD 
Low_NNP temperature_NN in_IN early_JJ mornings_NNS and_CC nights_NNS is_VBZ common_JJ in_IN the_DT highlands_NNS of_IN Ethiopia_NNP ._. 
The_DT extreme_JJ temperature_NN difference_NN 
Nearly_RB all_DT households_NNS in_IN the_DT study_NN area_NN used_VBD biomass_NN fuel_NN in_IN the_DT form_NN of_IN firewood_NN ,_, crop_NN residues_NNS ,_, and_CC animal_JJ dung_NN among_IN which_WDT the_DT first_JJ two_CD predominated_VBN ._. 
The_DT population_NN in_IN the_DT study_NN area_NN is_VBZ known_VBN for_IN using_VBG wood_NN most_JJS of_IN the_DT time_NN throughout_IN the_DT year_NN ,_, crop_NN residues_NNS such_JJ as_IN stocks_NNS of_IN maize_NN and_CC barley_NN during_IN harvest_NN times_NNS ,_, and_CC animal_NN dung_NN during_IN summer_NN ._. 
While_IN biomass_NN fuel_NN sources_NNS are_VBP relatively_RB cheap_JJ and_CC easily_RB available_JJ locally_RB ,_, fuels_NNS of_IN fossil_JJ origin_NN such_JJ as_IN kerosene_NN was_VBD only_RB used_VBN to_TO light_VB local_JJ lamps_NNS for_IN the_DT interior_NN of_IN housing_NN units_NNS at_IN night_NN ._. 
However_RB ,_, the_DT results_NNS of_IN these_DT studies_NNS could_MD not_RB be_VB generalized_VBN to_TO a_DT larger_JJR population_NN due_JJ to_TO their_PRP$ methodological_JJ limitations_NNS ._. 
Arecent_JJ study_NN conducted_VBN by_IN the_DT authors_NNS revealed_VBD increased_VBN indoor_JJ NO2_NNP concentration_NN levels_NNS ._. 
It_PRP also_RB has_VBZ shown_VBN that_DT ecology_NN and_CC season_NN were_VBD factors_NNS that_WDT affect_VBP NO_RB 2_CD concentrations_NNS ._. 
The_DT present_JJ study_NN was_VBD undertaken_VBN with_IN an_DT effort_NN to_TO further_RB explore_VB other_JJ factors_NNS associated_VBN with_IN indoor_JJ air_NN pollution_NN in_IN the_DT rural_JJ Ethiopia_NN ._. 
The_DT inter-laboratory_JJ variation_NN was_VBD controlled_VBN by_IN comparing_VBG the_DT variations_NNS of_IN NO_DT 2_CD concentrations_NNS of_IN duplicate_VBP samples_NNS and_CC exposed_JJ samples_NNS that_WDT were_VBD taken_VBN at_IN different_JJ conditions_NNS ._. 
Detailed_JJ description_NN of_IN the_DT study_NN area_NN ,_, sampling_VBG procedures_NNS ,_, air_NN sample_NN location_NN ,_, and_CC the_DT analytical_JJ method_NN is_VBZ available_JJ elsewhere_RB ._. 
Assessment_NNP of_IN determinants_NNS of_IN indoor_JJ nitrogen_NN dioxide_NN A_DT structured_JJ questionnaire_NN was_VBD administered_VBN at_IN household_NN level_NN immediately_RB after_IN the_DT completion_NN of_IN the_DT air_NN sampling_NN to_TO collect_VB fuel_NN use_NN related_VBN data_NNS and_CC events_NNS that_WDT occurred_VBD at_IN the_DT time_NN of_IN NO_DT 2_CD sampling_NN ._. 
Type_NN of_IN household_NN fuel_NN ,_, purpose_NN of_IN having_VBG fire_NN ,_, type_NN of_IN cooked_VBN food_NN and_CC its_PRP$ timing_NN were_VBD main_JJ variables_NNS collected_VBN during_IN data_NNS collection_NN ._. 
Ecological_NNP and_CC seasonal_JJ factors_NNS were_VBD also_RB considered_VBN due_JJ to_TO their_PRP$ importance_NN to_TO affect_VB indoor_JJ NO2_NNP ._. 
The_DT physical_JJ dimensions_NNS -LRB-_-LRB- radius_NN ,_, axis_NN ,_, and_CC wall_NN height_NN -RRB-_-RRB- ,_, the_DT presence_NN of_IN window_NN and_CC separate_JJ kitchen_NN in_IN the_DT study_NN homes_NNS were_VBD extracted_VBN from_IN the_DT 1999_CD census_NN data_NNS of_IN the_DT study_NN setting_NN ._. 
Descriptive_JJ statistics_NNS ,_, tables_NNS and_CC inferential_JJ statistics_NNS were_VBD mainly_RB used_VBN to_TO present_VB the_DT findings_NNS ._. 
Further_JJ detailed_JJ management_NN and_CC data_NN quality_NN control_NN are_VBP presented_VBN elsewhere_RB ._. 
Results_NNS Characteristics_NNS of_IN fuel_NN use_NN The_DT study_NN was_VBD conducted_VBN for_IN 2_CD years_NNS period_NN involving_VBG 17215_CD indoor_JJ air_NN samples_NNS in_IN 3300_CD households_NNS with_IN no_DT refusal_NN of_IN participation_NN ._. 
Such_JJ rooms_NNS do_VBP not_RB have_VB functional_JJ ventilation_NN outlets_NNS 
Aparticulate_JJ matter_NN -LRB-_-LRB- PM_NNP -RRB-_-RRB- of_IN various_JJ aerodynamic_JJ sizes_NNS is_VBZ also_RB used_VBN to_TO measure_VB the_DT level_NN of_IN IAP_NNP ._. 
The_DT use_NN of_IN gas_NN stoves_NNS and_CC heaters_NNS were_VBD often_RB accompanied_VBN with_IN exceeding_VBG the_DT current_JJ World_NNP Health_NNP organization_NN -LRB-_-LRB- WHO_WP -RRB-_-RRB- Air_NNP Quality_NNP Guideline_NNP -LRB-_-LRB- AQG_NNP -RRB-_-RRB- of_IN 21_CD ppb_NN for_IN 8_CD hours_NNS ._. 
The_DT mean_JJ concentration_NN of_IN respirable_JJ suspended_VBN particles_NNS -LRB-_-LRB- RSP_NNP -RRB-_-RRB- in_IN homes_NNS that_WDT use_VBP biomass_NN fuels_NNS had_VBD variation_NN depending_VBG on_IN the_DT type_NN of_IN kitchen_NN and_CC fuel_NN used_VBN :_: 500-2000_CD 
Aparticulate_JJ matter_NN -LRB-_-LRB- PM_NNP -RRB-_-RRB- of_IN various_JJ aerodynamic_JJ sizes_NNS is_VBZ also_RB used_VBN to_TO measure_VB the_DT level_NN of_IN IAP_NNP ._. 
The_DT use_NN of_IN gas_NN stoves_NNS and_CC heaters_NNS were_VBD often_RB accompanied_VBN with_IN exceeding_VBG the_DT current_JJ World_NNP Health_NNP organization_NN -LRB-_-LRB- WHO_WP -RRB-_-RRB- Air_NNP Quality_NNP Guideline_NNP -LRB-_-LRB- AQG_NNP -RRB-_-RRB- of_IN 21_CD ppb_NN for_IN 8_CD hours_NNS ._. 
The_DT mean_JJ concentration_NN of_IN respirable_JJ suspended_VBN particles_NNS -LRB-_-LRB- RSP_NNP -RRB-_-RRB- in_IN homes_NNS that_WDT use_VBP biomass_NN fuels_NNS had_VBD variation_NN depending_VBG on_IN the_DT type_NN of_IN kitchen_NN and_CC fuel_NN used_VBN :_: 500-2000_CD 
Kerosene_NNP is_VBZ less_RBR affordable_JJ for_IN rural_JJ residents_NNS to_TO use_VB it_PRP for_IN cooking_NN purposes_NNS compared_VBN to_TO residents_NNS of_IN urban_JJ areas_NNS such_JJ as_IN Addis_NNP Ababa_NNP 
In_IN addition_NN ,_, these_DT studies_NNS consistently_RB demonstrated_VBD that_IN the_DT type_NN of_IN fuel_NN ,_, purpose_NN of_IN fuel_NN use_NN ,_, and_CC location_NN of_IN indoor_JJ activities_NNS are_VBP associated_VBN with_IN increased_VBN NO_RB 2_CD ._. 
The_DT use_NN of_IN gas_NN stoves_NNS and_CC heaters_NNS were_VBD often_RB accompanied_VBN with_IN exceeding_VBG the_DT current_JJ World_NNP Health_NNP organization_NN -LRB-_-LRB- WHO_WP -RRB-_-RRB- Air_NNP Quality_NNP Guideline_NNP -LRB-_-LRB- AQG_NNP -RRB-_-RRB- of_IN 21_CD ppb_NN for_IN 8_CD hours_NNS ._. 
Aparticulate_JJ matter_NN -LRB-_-LRB- PM_NNP -RRB-_-RRB- of_IN various_JJ aerodynamic_JJ sizes_NNS is_VBZ also_RB used_VBN to_TO measure_VB the_DT level_NN of_IN IAP_NNP ._. 
The_DT mean_JJ concentration_NN of_IN respi_NNS 
The_DT above_JJ cited_VBD aerial_JJ concentrations_NNS related_VBN to_TO RSP_NNP ,_, PM_NNP 10_CD and_CC PM_NNP 2_CD ._. 
These_DT studies_NNS indicated_VBD that_IN the_DT type_NN of_IN kitchen_NN -LRB-_-LRB- whether_IN inside_NN or_CC outside_NN -RRB-_-RRB- ,_, the_DT type_NN of_IN stove_NN -LRB-_-LRB- traditional_JJ or_CC improved_VBN -RRB-_-RRB- ,_, ventilation_NN condition_NN ,_, place_NN of_IN measurement_NN -LRB-_-LRB- kitchen_NN or_CC sleeping_VBG room_NN -RRB-_-RRB- ,_, and_CC type_NN of_IN biomass_NN fuel_NN -LRB-_-LRB- wood_NN ,_, dung_NN ,_, or_CC residues_NNS -RRB-_-RRB- were_VBD major_JJ factors_NNS affecting_VBG the_DT concentrations_NNS of_IN indoor_JJ air_NN pollutants_NNS ._. 
5exceeded_VBN by_IN a_DT factor_NN of_IN 2_CD to_TO 40_CD times_NNS of_IN the_DT standards_NNS set_VBN by_IN US_NNP Environmental_NNP Protection_NNP Agency_NNP ,_, -LRB-_-LRB- US-EPA_NNP -RRB-_-RRB- for_IN 24-hr_JJ and_CC annual_JJ standards_NNS and_CC by_IN a_DT factor_NN of_IN 10_CD to_TO 80_CD times_NNS of_IN the_DT present_JJ WHO_WP 8_CD hr_NN of_IN air_NN quality_NN guideline_NN -LRB-_-LRB- AQG_NNP -RRB-_-RRB- 
Such_JJ rooms_NNS do_VBP not_RB have_VB functional_JJ ventilation_NN outlets_NNS 
In_IN low_JJ income_NN homes_NNS of_IN USA_NNP ,_, mean_JJ concentrations_NNS of_IN NO_DT 2_CD were_VBD found_VBN to_TO be_VB 43_CD ppb_NN and_CC 36_CD ppb_NN in_IN kitchens_NNS and_CC living_NN rooms_NNS ,_, respectively_RB 
Ecology_NNP ,_, season_NN ,_, type_NN of_IN biomass_NN fuel_NN ,_, the_DT purpose_NN and_CC time_NN of_IN having_VBG fire_NN events_NNS ,_, and_CC the_DT frequency_NN of_IN cooked_VBN food_NN items_NNS were_VBD all_DT found_VBN to_TO affect_VB the_DT level_NN of_IN indoor_JJ air_NN in_IN a_DT bivariate_JJ analysis_NN ,_, while_IN this_DT association_NN was_VBD consistent_JJ in_IN a_DT linear_JJ mixed_JJ model_NN except_IN for_IN the_DT type_NN of_IN biomass_NN fuel_NN for_IN wood_NN ._. 
In_IN western_JJ countries_NNS ,_, the_DT type_NN of_IN fuel_NN -LRB-_-LRB- gas_NN or_CC electricity_NN -RRB-_-RRB- ,_, occupancy_NN density_NN ,_, the_DT number_NN of_IN cooked_VBN meals_NNS ,_, frequency_NN of_IN cooking_NN ,_, season_NN and_CC income_NN were_VBD found_VBN to_TO significantly_RB impact_VB indoor_JJ NO2_NNP concentrations_NNS ._. 
Those_DT studies_NNS have_VBP indicated_VBN the_DT presence_NN of_IN strong_JJ link_NN among_IN factors_NNS responsible_JJ for_IN the_DT increased_VBN level_NN of_IN indoor_JJ NO_UH 2_CD both_DT in_IN the_DT developed_JJ and_CC developing_JJ countries_NNS ._. 
8ppb_CD -RRB-_-RRB- in_IN Umea_NNP -LRB-_-LRB- Sweden_NNP -RRB-_-RRB- ._. 
8in_NNP Barcelona_NNP -LRB-_-LRB- Spain_NNP -RRB-_-RRB- 
8ppb_CD -RRB-_-RRB- in_IN Umea_NNP -LRB-_-LRB- Sweden_NNP -RRB-_-RRB- ._. 
8in_NNP Barcelona_NNP -LRB-_-LRB- Spain_NNP -RRB-_-RRB- 
Ecology_NNP ,_, season_NN ,_, type_NN of_IN biomass_NN fuel_NN ,_, the_DT purpose_NN and_CC time_NN of_IN having_VBG fire_NN events_NNS ,_, and_CC the_DT frequency_NN of_IN cooked_VBN food_NN items_NNS were_VBD all_DT found_VBN to_TO affect_VB the_DT level_NN of_IN indoor_JJ air_NN in_IN a_DT bivariate_JJ analysis_NN ,_, while_IN this_DT association_NN was_VBD consistent_JJ in_IN a_DT linear_JJ mixed_JJ model_NN except_IN for_IN the_DT type_NN of_IN biomass_NN fuel_NN for_IN wood_NN ._. 
In_IN western_JJ countries_NNS ,_, the_DT type_NN of_IN fuel_NN -LRB-_-LRB- gas_NN or_CC electricity_NN -RRB-_-RRB- ,_, occupancy_NN density_NN ,_, the_DT number_NN of_IN cooked_VBN meals_NNS ,_, frequency_NN of_IN cooking_NN ,_, season_NN and_CC income_NN were_VBD found_VBN to_TO significantly_RB impact_VB indoor_JJ NO2_NNP concentrations_NNS ._. 
Those_DT studies_NNS have_VBP indicated_VBN the_DT presence_NN of_IN strong_JJ link_NN among_IN factors_NNS responsible_JJ for_IN the_DT increased_VBN level_NN of_IN indoor_JJ NO_UH 2_CD both_DT in_IN the_DT developed_JJ and_CC developing_JJ countries_NNS ._. 
8in_NNP Barcelona_NNP -LRB-_-LRB- Spain_NNP -RRB-_-RRB- and_CC 11_CD 
1ppb_CD in_IN Minorca_NNP -LRB-_-LRB- Spain_NNP -RRB-_-RRB- ,_, 23_CD ._. 
8ppb_CD in_IN Ashford_NNP -LRB-_-LRB- United_NNP Kingdom_NNP -RRB-_-RRB- ,_, 6_CD ._. 
Median_JJ NO_DT 2_CD concentrations_NNS in_IN living_NN rooms_NNS were_VBD 5_CD ._. 
8in_NNP Barcelona_NNP -LRB-_-LRB- Spain_NNP -RRB-_-RRB- and_CC 11_CD 
Data_NNS on_IN the_DT measurement_NN of_IN indoor_JJ NO_UH 2_CD is_VBZ limited_VBN in_IN developed_JJ countries_NNS ._. 
Despite_IN the_DT prevailing_VBG knowledge_NN that_DT exposure_NN to_TO biomass_VB combustion_NN products_NNS is_VBZ high_JJ 
Data_NNS on_IN the_DT measurement_NN of_IN indoor_JJ NO_UH 2_CD is_VBZ limited_VBN in_IN developed_JJ countries_NNS ._. 
Despite_IN the_DT prevailing_VBG knowledge_NN that_DT exposure_NN to_TO biomass_VB combustion_NN products_NNS is_VBZ high_JJ 
Data_NNS on_IN the_DT measurement_NN of_IN indoor_JJ NO_UH 2_CD is_VBZ limited_VBN in_IN developed_JJ countries_NNS ._. 
Despite_IN the_DT prevailing_VBG knowledge_NN that_DT exposure_NN to_TO biomass_VB combustion_NN products_NNS is_VBZ high_JJ 
Ecology_NNP ,_, season_NN ,_, type_NN of_IN biomass_NN fuel_NN ,_, the_DT purpose_NN and_CC time_NN of_IN having_VBG fire_NN events_NNS ,_, and_CC the_DT frequency_NN of_IN cooked_VBN food_NN items_NNS were_VBD all_DT found_VBN to_TO affect_VB the_DT level_NN of_IN indoor_JJ air_NN in_IN a_DT bivariate_JJ analysis_NN ,_, while_IN this_DT association_NN was_VBD consistent_JJ in_IN a_DT linear_JJ mixed_JJ model_NN except_IN for_IN the_DT type_NN of_IN biomass_NN fuel_NN for_IN wood_NN ._. 
In_IN western_JJ countries_NNS ,_, the_DT type_NN of_IN fuel_NN -LRB-_-LRB- gas_NN or_CC electricity_NN -RRB-_-RRB- ,_, occupancy_NN density_NN ,_, the_DT number_NN of_IN cooked_VBN meals_NNS ,_, frequency_NN of_IN cooking_NN ,_, season_NN and_CC income_NN were_VBD found_VBN to_TO significantly_RB impact_VB indoor_JJ NO2_NNP concentrations_NNS ._. 
Those_DT studies_NNS have_VBP indicated_VBN the_DT presence_NN of_IN strong_JJ link_NN among_IN factors_NNS responsible_JJ for_IN the_DT increased_VBN level_NN of_IN indoor_JJ NO_UH 2_CD both_DT in_IN the_DT developed_JJ and_CC developing_JJ countries_NNS ._. 
This_DT proportion_NN is_VBZ tantamount_JJ to_TO about_IN half_DT million_CD premature_JJ deaths_NNS annually_RB 
The_DT health_NN risk_NN of_IN direct_JJ exposure_NN to_TO biomass_NN combustion_NN is_VBZ evident_JJ in_IN part_NN due_JJ to_TO cooking_JJ practices_NNS in_IN poorly_RB ventilated_VBN and_CC crowded_VBN single_JJ roomed_VBD houses_NNS in_IN developing_VBG countries_NNS 
Studies_NNS have_VBP shown_VBN that_IN proxy_JJ factors_NNS related_VBN to_TO socio-economic_JJ status_NN like_IN income_NN education_NN ,_, and_CC use_NN of_IN biomass_NN fuel_NN to_TO be_VB highly_RB associated_VBN with_IN the_DT level_NN of_IN IAP_NNP 
In_IN Bangladesh_NNP ,_, the_DT average_JJ concentration_NN of_IN particulate_JJ matter_NN -LRB-_-LRB- PM_NNP -RRB-_-RRB- of_IN aerodynamic_JJ diameter_NN of_IN 10_CD microns_NNS -LRB-_-LRB- PM_NNP 10_CD -RRB-_-RRB- in_IN kitchens_NNS that_WDT use_VBP biomass_NN fuels_NNS ranged_VBD between_IN 237_CD and_CC 291_CD 
Cooking_NN and_CC heating_NN are_VBP the_DT main_JJ household_NN activities_NNS that_WDT lead_VBP to_TO the_DT excess_NN NO_RB 2_CD concentration_NN due_JJ to_TO solid_JJ biomass_NN fuel_NN use_NN in_IN general_JJ ,_, and_CC in_IN the_DT highland_JJ areas_NNS in_IN particular_JJ ._. 
In_IN other_JJ studies_NNS ,_, given_VBN the_DT range_NN of_IN the_DT purpose_NN of_IN biomass_NN fuel_NN use_NN ,_, cooking_NN has_VBZ been_VBN implicated_VBN as_IN the_DT main_JJ factor_NN for_IN the_DT greater_JJR proportion_NN of_IN exposure_NN to_TO IAP_NNP in_IN developing_VBG countries_NNS 
In_IN other_JJ studies_NNS ,_, given_VBN the_DT range_NN of_IN the_DT purpose_NN of_IN biomass_NN fuel_NN use_NN ,_, cooking_NN has_VBZ been_VBN implicated_VBN as_IN the_DT main_JJ factor_NN for_IN the_DT greater_JJR proportion_NN of_IN exposure_NN to_TO IAP_NNP in_IN developing_VBG countries_NNS 
Biomass_NN fuel_NN emits_VBZ about_IN 50_CD times_NNS more_JJR pollution_NN during_IN cooking_NN compared_VBN to_TO cleaner_JJR fuels_NNS 
Biomass_NN fuel_NN ,_, also_RB designated_VBN as_IN unprocessed_JJ or_CC dirty_JJ solid_JJ biofuel_NN ,_, mainly_RB includes_VBZ firewood_NN ,_, animal_NN dung_NN ,_, agricultural_JJ residues_NNS and_CC plant_NN leaves_NNS ._. 
Indoor_JJ air_NN pollution_NN is_VBZ considered_VBN as_IN one_CD of_IN the_DT risk_NN factors_NNS causing_VBG high_JJ burden_NN of_IN diseases_NNS and_CC of_IN premature_JJ deaths_NNS in_IN developing_VBG countries_NNS 
Indoor_JJ air_NN pollution_NN is_VBZ considered_VBN as_IN one_CD of_IN the_DT risk_NN factors_NNS causing_VBG high_JJ burden_NN of_IN diseases_NNS and_CC of_IN premature_JJ deaths_NNS in_IN developing_VBG countries_NNS 
1%_CD of_IN the_DT total_JJ national_JJ burden_NN of_IN disease_NN ,_, which_WDT is_VBZ considered_VBN as_IN a_DT major_JJ public_JJ health_NN concern_NN ._. 
2-6_CD ._. 
This_DT proportion_NN is_VBZ tantamount_JJ to_TO about_IN half_DT million_CD premature_JJ deaths_NNS annually_RB 
The_DT health_NN risk_NN of_IN direct_JJ exposure_NN to_TO biomass_NN combustion_NN is_VBZ evident_JJ in_IN part_NN due_JJ to_TO cooking_JJ practices_NNS in_IN poorly_RB ventilated_VBN and_CC crowded_VBN single_JJ roomed_VBD houses_NNS in_IN developing_VBG countries_NNS 
In_IN other_JJ studies_NNS ,_, given_VBN the_DT range_NN of_IN the_DT purpose_NN of_IN biomass_NN fuel_NN use_NN ,_, cooking_NN has_VBZ been_VBN implicated_VBN as_IN the_DT main_JJ factor_NN for_IN the_DT greater_JJR proportion_NN of_IN exposure_NN to_TO IAP_NNP in_IN developing_VBG countries_NNS 
Background_NN Biomass_NN fuel_NN is_VBZ the_DT primary_JJ source_NN of_IN household_NN energy_NN in_IN developing_VBG countries_NNS ._. 
Improved_VBN kitchen_NN conditions_NNS and_CC ventilation_NN are_VBP highly_RB recommended_VBN ._. 
Fifty_CD two_CD percent_NN of_IN the_DT global_JJ population_NN and_CC more_JJR than_IN 90_CD %_NN of_IN rural_JJ homes_NNS in_IN developing_VBG countries_NNS use_VBP solid_JJ biomass_NN fuels_NNS for_IN cooking_NN ,_, heating_NN ,_, and_CC lighting_NN purposes_NNS ._. 
Biomass_NN fuel_NN ,_, also_RB designated_VBN as_IN unprocessed_JJ or_CC dirty_JJ solid_JJ biofuel_NN ,_, mainly_RB includes_VBZ firewood_NN ,_, animal_NN dung_NN ,_, agricultural_JJ residues_NNS and_CC plant_NN leaves_NNS ._. 
Kerosene_NNP is_VBZ less_RBR affordable_JJ for_IN rural_JJ residents_NNS to_TO use_VB it_PRP for_IN cooking_NN purposes_NNS compared_VBN to_TO residents_NNS of_IN urban_JJ areas_NNS such_JJ as_IN Addis_NNP Ababa_NNP 
Biomass_NN fuel_NN ,_, also_RB designated_VBN as_IN unprocessed_JJ or_CC dirty_JJ solid_JJ biofuel_NN ,_, mainly_RB includes_VBZ firewood_NN ,_, animal_NN dung_NN ,_, agricultural_JJ residues_NNS and_CC plant_NN leaves_NNS ._. 
Indoor_JJ air_NN pollution_NN is_VBZ considered_VBN as_IN one_CD of_IN the_DT risk_NN factors_NNS causing_VBG high_JJ burden_NN of_IN diseases_NNS and_CC of_IN premature_JJ deaths_NNS in_IN developing_VBG countries_NNS 
Cooking_NN takes_VBZ place_NN in_IN the_DT same_JJ room_NN using_VBG traditional_JJ unvented_JJ stoves_NNS ._. 
The_DT majority_NN of_IN rural_JJ homes_NNS have_VBP only_RB 1_CD room_NN serving_VBG all_DT types_NNS of_IN household_NN activities_NNS 
The_DT present_JJ study_NN was_VBD undertaken_VBN with_IN an_DT effort_NN to_TO further_RB explore_VB other_JJ factors_NNS associated_VBN with_IN indoor_JJ air_NN pollution_NN in_IN the_DT rural_JJ Ethiopia_NN ._. 
Given_VBN the_DT high_JJ level_NN of_IN exposure_NN to_TO IAP_NNP in_IN poorly_RB ventilated_VBN housing_NN units_NNS ,_, increased_VBN morbidity_NN and_CC mortality_NN due_JJ to_TO acute_JJ respiratory_JJ infection_NN -LRB-_-LRB- ARI_NNP -RRB-_-RRB- in_IN the_DT general_JJ population_NN ,_, especially_RB among_IN children_NNS under-five_JJ years_NNS old_JJ ,_, are_VBP expected_VBN ._. 
Therefore_RB ,_, this_DT study_NN will_MD have_VB great_JJ operational_JJ relevance_NN in_IN achieving_VBG the_DT Millennium_NNP Development_NNP Goal_NNP 7_CD -LRB-_-LRB- MDG_NNP 7_CD ,_, target_NN 9_CD ,_, indicators_NNS 27_CD 
This_DT proportion_NN is_VBZ tantamount_JJ to_TO about_IN half_DT million_CD premature_JJ deaths_NNS annually_RB 
This_DT proportion_NN is_VBZ tantamount_JJ to_TO about_IN half_DT million_CD premature_JJ deaths_NNS annually_RB 
Studies_NNS have_VBP shown_VBN that_IN proxy_JJ factors_NNS related_VBN to_TO socio-economic_JJ status_NN like_IN income_NN education_NN ,_, and_CC use_NN of_IN biomass_NN fuel_NN to_TO be_VB highly_RB associated_VBN with_IN the_DT level_NN of_IN IAP_NNP 
Biomass_NN fuel_NN emits_VBZ about_IN 50_CD times_NNS more_JJR pollution_NN during_IN cooking_NN compared_VBN to_TO cleaner_JJR fuels_NNS 
Concerning_VBG CAT_NNP gene_NN ,_, the_DT deviation_NN from_IN Hardy_NNP Weinberg_NNP Equilibrium_NNP in_IN favor_NN of_IN homozygosis_NN was_VBD not_RB observed_JJ in_IN these_DT studies_NNS ._. 
However_RB ,_, another_DT study_NN that_IN our_PRP$ group_NN carried_VBD out_RP with_IN athletes_NNS suggested_VBD greater_JJR efficiency_NN in_IN oxygen_NN transport_NN for_IN individuals_NNS carrying_VBG variant_JJ T_NNP allele_NN ,_, because_IN they_PRP presented_VBD significantly_RB higher_JJR mean_JJ cell_NN hemoglobin_NN -LRB-_-LRB- MCH_NNP -RRB-_-RRB- values_NNS in_IN comparison_NN with_IN other_JJ CAT_NNP genotypes_NNS ._. 
Nevertheless_RB ,_, from_IN our_PRP$ current_JJ results_NNS with_IN comet_NN assay_NN ,_, any_DT selective_JJ advantage_NN that_WDT may_MD exist_VB is_VBZ not_RB directly_RB related_VBN to_TO protection_NN against_IN DNA_NNP damage_NN ,_, given_VBN that_IN for_IN this_DT parameter_NN there_EX are_VBP no_DT significant_JJ differences_NNS between_IN MnSOD_NNP and_CC CAT_NNP genotypes_NNS ._. 
Given_VBN that_IN the_DT Federal_NNP District_NNP was_VBD formed_VBN by_IN a_DT wide-ranging_JJ mixture_NN of_IN migrants_NNS from_IN all_DT regions_NNS of_IN Brazil_NNP its_PRP$ population_NN tends_VBZ to_TO reflect_VB the_DT constitution_NN of_IN the_DT Brazilian_JJ population_NN bet_NN 
The_DT Brazilian_JJ population_NN as_IN a_DT whole_NN is_VBZ very_RB mixed_JJ and_CC heterogeneous_JJ ,_, primarily_RB as_IN a_DT result_NN of_IN five_CD centuries_NNS of_IN interethnic_JJ crosses_NNS between_IN Europeans_NNPS ,_, Africans_NNPS and_CC Amerindians_NNPS 
It_PRP is_VBZ also_RB used_VBN to_TO investigate_VB DNA_NN damage_NN and_CC repair_NN in_IN different_JJ cell_NN types_NNS in_IN response_NN to_TO a_DT range_NN of_IN DNA-damaging_JJ agents_NNS ,_, as_RB well_RB as_IN monitoring_VBG the_DT effects_NNS of_IN dietary_JJ antioxidants_NNS 
Examples_NNS include_VBP the_DT glutathione_NN transferase_NN -LRB-_-LRB- GST_NNP -RRB-_-RRB- null_JJ alleles_NNS and_CC many_JJ single_JJ nucleotide_NN polymorphisms_NNS -LRB-_-LRB- SNPs_NNS -RRB-_-RRB- such_JJ as_IN the_DT Val9Ala_NNP in_IN the_DT mitochondrial_JJ targeting_VBG sequence_NN of_IN the_DT MnSOD_NNP gene_NN -LRB-_-LRB- NCBI_NNP ,_, refSNP_NNP ID_NNP :_: rs1799725_CD -RRB-_-RRB- ,_, -21_CD A\/T_NNP in_IN the_DT promoter_NN region_NN of_IN the_DT CAT_NNP gene_NN -LRB-_-LRB- NCBI_NNP ,_, refSNP_NNP ID_NNP :_: rs7943316_CD -RRB-_-RRB- and_CC Pro198Leu_NNP of_IN the_DT GPx-1_JJ gene_NN -LRB-_-LRB- NCBI_NNP ,_, refSNP_NNP ID_NNP :_: rs1050450_CD -RRB-_-RRB- ._. 
Most_JJS of_IN these_DT genetic_JJ variants_NNS have_VBP been_VBN reported_VBN to_TO result_VB in_IN changes_NNS in_IN enzyme_NN levels_NNS or_CC activities_NNS ,_, which_WDT can_MD lead_VB to_TO reduction_NN in_IN protection_NN against_IN oxidative_JJ stress_NN ._. 
In_IN addition_NN ,_, it_PRP has_VBZ been_VBN demonstrated_VBN that_IN the_DT ability_NN of_IN serum_NN glycoprotein_NN haptoglobin_NN -LRB-_-LRB- Hp_NNP -RRB-_-RRB- to_TO bind_NN free_JJ hemoglobin_NN -LRB-_-LRB- Hb_NNP -RRB-_-RRB- in_IN the_DT plasma_NN and_CC block_NN Hb-induced_JJ oxidative_JJ damage_NN is_VBZ phenotype_JJ dependent_JJ 
It_PRP is_VBZ also_RB used_VBN to_TO investigate_VB DNA_NN damage_NN and_CC repair_NN in_IN different_JJ cell_NN types_NNS in_IN response_NN to_TO a_DT range_NN of_IN DNA-damaging_JJ agents_NNS ,_, as_RB well_RB as_IN monitoring_VBG the_DT effects_NNS of_IN dietary_JJ antioxidants_NNS 
In_IN such_JJ circumstances_NNS ,_, ROS_NNP may_MD interact_VB with_IN cellular_JJ biomolecules_NNS ,_, such_JJ as_IN DNA_NNP ,_, leading_VBG to_TO modification_NN and_CC potentially_RB serious_JJ consequences_NNS for_IN the_DT cell_NN 
It_PRP is_VBZ a_DT valuable_JJ tool_NN for_IN population_NN monitoring_NN ,_, for_IN example_NN in_IN assessing_VBG the_DT role_NN of_IN oxidative_JJ stress_NN in_IN human_JJ disease_NN ,_, mechanisms_NNS of_IN mutagenesis_NNS ,_, genotoxicology_JJ and_CC ecological_JJ monitoring_NN ._. 
It_PRP is_VBZ also_RB used_VBN to_TO investigate_VB DNA_NN damage_NN and_CC repair_NN in_IN different_JJ cell_NN types_NNS in_IN response_NN to_TO a_DT range_NN of_IN DNA-damaging_JJ agents_NNS ,_, as_RB well_RB as_IN monitoring_VBG the_DT effects_NNS of_IN dietary_JJ antioxidants_NNS 
In_IN the_DT same_JJ way_NN ,_, the_DT frequencies_NNS of_IN variants_NNS ,_, such_JJ as_IN the_DT Ala_NNP allele_NN of_IN MnSOD_NNP gene_NN ,_, T_NN allele_NN of_IN CAT_NNP gene_NN and_CC Leu_NNP allele_NN of_IN GPx-1_JJ gene_NN vary_VBP between_IN ethnic_JJ groups_NNS 
Examples_NNS include_VBP the_DT glutathione_NN transferase_NN -LRB-_-LRB- GST_NNP -RRB-_-RRB- null_JJ alleles_NNS and_CC many_JJ single_JJ nucleotide_NN polymorphisms_NNS -LRB-_-LRB- SNPs_NNS -RRB-_-RRB- such_JJ as_IN the_DT Val9Ala_NNP in_IN the_DT mitochondrial_JJ targeting_VBG sequence_NN of_IN the_DT MnSOD_NNP gene_NN -LRB-_-LRB- NCBI_NNP ,_, refSNP_NNP ID_NNP :_: rs1799725_CD -RRB-_-RRB- ,_, -21_CD A\/T_NNP in_IN the_DT promoter_NN region_NN of_IN the_DT CAT_NNP gene_NN -LRB-_-LRB- NCBI_NNP ,_, refSNP_NNP ID_NNP :_: rs7943316_CD -RRB-_-RRB- and_CC Pro198Leu_NNP of_IN the_DT GPx-1_JJ gene_NN -LRB-_-LRB- NCBI_NNP ,_, refSNP_NNP ID_NNP :_: rs1050450_CD -RRB-_-RRB- ._. 
Most_JJS of_IN these_DT genetic_JJ variants_NNS have_VBP been_VBN reported_VBN to_TO result_VB in_IN changes_NNS in_IN enzyme_NN levels_NNS or_CC activities_NNS ,_, which_WDT can_MD lead_VB to_TO reduction_NN in_IN protection_NN against_IN oxidative_JJ stress_NN ._. 
In_IN addition_NN ,_, it_PRP has_VBZ been_VBN demonstrated_VBN that_IN the_DT ability_NN of_IN serum_NN glycoprotein_NN haptoglobin_NN -LRB-_-LRB- Hp_NNP -RRB-_-RRB- to_TO bind_NN free_JJ hemoglobin_NN -LRB-_-LRB- Hb_NNP -RRB-_-RRB- in_IN the_DT plasma_NN and_CC block_NN Hb-induced_JJ oxidative_JJ damage_NN is_VBZ phenotype_JJ dependent_JJ 
In_IN the_DT same_JJ way_NN ,_, the_DT frequencies_NNS of_IN variants_NNS ,_, such_JJ as_IN the_DT Ala_NNP allele_NN of_IN MnSOD_NNP gene_NN ,_, T_NN allele_NN of_IN CAT_NNP gene_NN and_CC Leu_NNP allele_NN of_IN GPx-1_JJ gene_NN vary_VBP between_IN ethnic_JJ groups_NNS 
This_DT is_VBZ because_IN it_PRP was_VBD the_DT only_JJ genotype_NN where_WRB the_DT two_CD H_NNP 2_CD O_NNP 2_CD treated_VBN groups_NNS were_VBD not_RB significantly_RB more_RBR damaged_JJ than_IN the_DT controls_NNS ._. 
Two_CD previous_JJ studies_NNS by_IN our_PRP$ group_NN corroborate_VB this_DT suggestion_NN 
Two_CD previous_JJ studies_NNS by_IN our_PRP$ group_NN corroborate_VB this_DT suggestion_NN 
In_IN the_DT second_JJ study_NN ,_, carried_VBD out_RP with_IN runners_NNS ,_, one_CD of_IN the_DT main_JJ factors_NNS that_WDT contributed_VBD to_TO deviation_NN of_IN the_DT Hp_NNP locus_NN from_IN HWE_NNP was_VBD the_DT higher_JJR frequencies_NNS of_IN Hp1F-1F_NN than_IN the_DT expected_VBN 
The_DT choices_NNS of_IN 250_CD 
The_DT reaction_NN of_IN H_NNP 2_CD O_NNP 2_CD with_IN transition_NN metals_NNS imposes_VBZ an_DT oxidative_JJ stress_NN condition_NN on_IN cells_NNS ._. 
Hydrogen_NN peroxide_NN -LRB-_-LRB- H_NNP 2_CD O_NNP 2_CD -RRB-_-RRB- is_VBZ an_DT important_JJ reactive_JJ oxygen_NN species_NNS -LRB-_-LRB- ROS_NNP -RRB-_-RRB- that_WDT arises_VBZ either_CC during_IN the_DT aerobic_JJ respiration_NN process_NN or_CC as_IN a_DT by-product_NN of_IN water_NN radiolysis_NNS after_IN exposure_NN to_TO ionizing_VBG radiation_NN 
In_IN this_DT context_NN ,_, our_PRP$ results_NNS indicated_VBD that_IN ,_, under_IN higher_JJR hydrogen_NN peroxide_NN concentrations_NNS ,_, the_DT protective_JJ effect_NN of_IN Hp_NNP \*_SYM 1_CD alleles_NNS can_MD depend_VB on_IN the_DT interaction_NN with_IN GSTM1T1_CD genotypes_NNS ._. 
Additionally_RB ,_, synthesis_NN of_IN the_DT antioxidant_JJ enzymes_NNS is_VBZ part_NN of_IN the_DT adaptive_JJ response_NN triggered_VBN by_IN the_DT stress_NN posed_VBN by_IN ROS_NNP 
This_DT in_IN turn_NN can_MD result_VB in_IN damage_NN to_TO cell_NN components_NNS such_JJ as_IN proteins_NNS ,_, lipids_NNS and_CC principally_RB to_TO DNA_NNP ,_, leading_VBG to_TO mutagenesis_NNS and_CC cell_NN death_NN 
In_IN this_DT context_NN ,_, our_PRP$ results_NNS indicate_VBP that_IN oxidative_JJ stress_NN ,_, such_JJ as_IN that_DT simulated_JJ by_IN treatment_NN with_IN H_NNP 2_CD O_NNP 2_CD at_IN 250_CD 
In_IN this_DT context_NN ,_, our_PRP$ results_NNS indicate_VBP that_IN oxidative_JJ stress_NN ,_, such_JJ as_IN that_DT simulated_JJ by_IN treatment_NN with_IN H_NNP 2_CD O_NNP 2_CD at_IN 250_CD 
This_DT is_VBZ in_IN accordance_NN with_IN the_DT literature_NN ,_, since_IN aging_NN is_VBZ an_DT inevitable_JJ biological_JJ process_NN and_CC characterized_VBN by_IN a_DT general_JJ decline_NN in_IN physiological_JJ function_NN 
,1992_CD ,_, using_VBG DMSO_NNP -LRB-_-LRB- dimethyl_JJ sulfoxide_NN -RRB-_-RRB- as_IN recommended_VBN by_IN Odawara_NNP et_FW al._FW ._. 
DNA_NN fragments_NNS containing_VBG I\/D_NNP polymorphism_NN in_IN intron_NN 16_CD of_IN the_DT ACE_NNP gene_NN were_VBD amplified_VBN by_IN PCR_NNP as_RB previously_RB described_VBN by_IN Rigat_NNP et_NNP al._NNP ,_, 1997_CD 
The_DT glutathione_NN S-transferase_NNP -LRB-_-LRB- GST_NNP -RRB-_-RRB- GSTM1_NNP and_CC GSTT1_NNP fragments_NNS were_VBD amplified_VBN simultaneously_RB as_IN proposed_VBN by_IN Chen_NNP et_FW al._FW ,_, 1996_CD ,_, using_VBG 
Besides_IN the_DT influences_NNS of_IN gene_NN polymorphisms_NNS ,_, the_DT influences_NNS of_IN sex_NN -LRB-_-LRB- 55_CD men_NNS and_CC 80_CD women_NNS -RRB-_-RRB- ,_, use_NN of_IN tobacco_NN and_CC age_NN groups_NNS were_VBD also_RB treated_VBN statistically_RB ._. 
The_DT stratification_NN of_IN subjects_NNS according_VBG to_TO age_NN was_VBD done_VBN according_VBG to_TO their_PRP$ inclusion_NN in_IN one_CD of_IN the_DT following_JJ groups_NNS :_: adolescents_NNS -LRB-_-LRB- 15-19_CD year-olds_NNS -RRB-_-RRB- ,_, young_JJ adults_NNS -LRB-_-LRB- 20-40_CD year-olds_NNS -RRB-_-RRB- and_CC middle-aged_JJ adults_NNS -LRB-_-LRB- 41-56_CD year-olds_NNS -RRB-_-RRB- ,_, following_VBG the_DT age_NN criteria_NNS for_IN reference_NN values_NNS of_IN biochemical_JJ parameters_NNS ;_: for_IN clinical_JJ purposes_NNS some_DT reference_NN values_NNS are_VBP different_JJ for_IN ages_NNS up_IN to_TO 19_CD years_NNS old_JJ ._. 
The_DT continuous_JJ variables_NNS were_VBD tested_VBN for_IN normal_JJ distribution_NN with_IN Shapiro-Wilk_NNP ._. 
Differences_NNS between_IN sexes_NNS and_CC between_IN non-smokers_NNS and_CC smokers_NNS were_VBD evaluated_VBN by_IN the_DT Mann-Whitney_NNP U_NNP test_NN ,_, while_IN possible_JJ differences_NNS between_IN the_DT groups_NNS analyzed_VBN were_VBD investigated_VBN through_IN Kruskal-Wallis_NNP test_NN ,_, given_VBN that_IN the_DT data_NNS presented_VBD heterogeneous_JJ variability_NN ._. 
Discussion_NN The_DT relatively_RB high_JJ concentrations_NNS of_IN hydrogen_NN peroxide_NN used_VBN in_IN the_DT present_JJ study_NN were_VBD to_TO provide_VB oxidative_JJ stress_NN ,_, since_IN this_DT was_VBD a_DT secondary_JJ aim_NN of_IN this_DT study_NN ._. 
The_DT choices_NNS of_IN 250_CD 
This_DT is_VBZ because_IN it_PRP was_VBD the_DT only_JJ genotype_NN where_WRB the_DT two_CD H_NNP 2_CD O_NNP 2_CD treated_VBN groups_NNS were_VBD not_RB significantly_RB more_RBR damaged_JJ than_IN the_DT controls_NNS ._. 
Two_CD previous_JJ studies_NNS by_IN our_PRP$ group_NN corroborate_VB this_DT suggestion_NN 
The_DT first_JJ study_NN ,_, run_VBN with_IN a_DT young_JJ population_NN group_NN of_IN Brasilia_NNP ,_, indicated_VBD that_IN among_IN Hp_NNP \*_SYM 1_CD alleles_NNS ,_, Hp_NNP \*_NN 1F_NNP was_VBD the_DT most_RBS protective_JJ ,_, besides_IN showing_NN that_WDT homozygous_VBZ Hp_NNP 1F-1F_NNP incurred_VBD less_JJR DNA_NN damage_NN than_IN other_JJ genotypes_NNS 
Given_VBN that_IN the_DT Federal_NNP District_NNP was_VBD formed_VBN by_IN a_DT wide-ranging_JJ mixture_NN of_IN migrants_NNS from_IN all_DT regions_NNS of_IN Brazil_NNP its_PRP$ population_NN tends_VBZ to_TO reflect_VB the_DT constitution_NN of_IN the_DT Brazilian_JJ population_NN better_RBR than_IN those_DT of_IN other_JJ Brazilian_JJ regions_NNS ._. 
In_IN this_DT context_NN ,_, our_PRP$ results_NNS suggest_VBP a_DT possible_JJ adaptive_JJ advantage_NN for_IN MnSOD_NNP heterozygosis_NNPS ;_: further_RBR ,_, they_PRP are_VBP in_IN accordance_NN with_IN other_JJ results_NNS obtained_VBN by_IN our_PRP$ group_NN with_IN other_JJ population_NN groups_NNS of_IN Bras_NNS 
Thus_RB ,_, studies_NNS mapping_VBG their_PRP$ distribution_NN can_MD be_VB important_JJ to_TO gain_VB a_DT better_JJR understanding_NN of_IN their_PRP$ biological_JJ significance_NN ._. 
The_DT Brazilian_JJ population_NN as_IN a_DT whole_NN is_VBZ very_RB mixed_JJ and_CC heterogeneous_JJ ,_, primarily_RB as_IN a_DT result_NN of_IN five_CD centuries_NNS of_IN interethnic_JJ crosses_NNS between_IN Europeans_NNPS ,_, Africans_NNPS and_CC Amerindians_NNPS 
In_IN this_DT context_NN ,_, our_PRP$ results_NNS suggest_VBP a_DT possible_JJ adaptive_JJ advantage_NN for_IN MnSOD_NNP heterozygosis_NNPS ;_: further_RBR ,_, they_PRP are_VBP in_IN accordance_NN with_IN other_JJ results_NNS obtained_VBN by_IN our_PRP$ group_NN with_IN other_JJ population_NN groups_NNS of_IN Bras_NNS 
In_IN this_DT context_NN ,_, our_PRP$ results_NNS suggest_VBP a_DT possible_JJ adaptive_JJ advantage_NN for_IN MnSOD_NNP heterozygosis_NNPS ;_: further_RBR ,_, they_PRP are_VBP in_IN accordance_NN with_IN other_JJ results_NNS obtained_VBN by_IN our_PRP$ group_NN with_IN other_JJ population_NN groups_NNS of_IN Bras_NNS 
Polymorphisms_NNS in_IN the_DT GPx-1_JJ gene_NN -LRB-_-LRB- locus_FW 3p21_FW ._. 
9-RRB-_NN catalyses_VBZ the_DT reduction_NN of_IN hydrogen_NN peroxide_NN to_TO water_NN in_IN the_DT erythrocytes_NNS ,_, using_VBG glutathione_NN as_IN a_DT reducing_VBG substrate_NN ._. 
3,_CD OMIM_NNP ,_, +138320_CD -RRB-_-RRB- have_VBP been_VBN related_VBN to_TO enhanced_JJ risk_NN of_IN cancer_NN 
One_CD of_IN the_DT potential_JJ answers_NNS is_VBZ related_VBN to_TO the_DT composition_NN of_IN polymorphisms_NNS in_IN different_JJ study_NN populations_NNS 
Thus_RB ,_, at_IN this_DT hydrogen_NN peroxide_NN concentration_NN ,_, results_NNS also_RB indicate_VBP that_IN the_DT interaction_NN between_IN GPx-1_NNP and_CC ACE_NNP genotypes_NNS can_MD be_VB more_RBR significant_JJ for_IN phenotype_NN manifestation_NN than_IN for_IN GPX-1_JJ polymorphism_NN only_RB ._. 
It_PRP has_VBZ been_VBN reported_VBN that_IN ACE_NNP DD_NNP polymorphism_NN is_VBZ a_DT potent_JJ risk_NN factor_NN for_IN myocardial_JJ infarction_NN 
It_PRP has_VBZ been_VBN reported_VBN that_IN ACE_NNP DD_NNP polymorphism_NN is_VBZ a_DT potent_JJ risk_NN factor_NN for_IN myocardial_JJ infarction_NN 
However_RB ,_, different_JJ populations_NNS apparently_RB responded_VBD differently_RB with_IN regard_NN to_TO the_DT appearance_NN and_CC overall_JJ impact_NN of_IN the_DT ACE_NNP polymorphism_NN on_IN myocardial_JJ infarction_NN ._. 
One_CD of_IN the_DT potential_JJ answers_NNS is_VBZ related_VBN to_TO the_DT composition_NN of_IN polymorphisms_NNS in_IN different_JJ study_NN populations_NNS 
Polymorphisms_NNS in_IN the_DT GPx-1_JJ gene_NN -LRB-_-LRB- locus_FW 3p21_FW ._. 
9-RRB-_NN catalyses_VBZ the_DT reduction_NN of_IN hydrogen_NN peroxide_NN to_TO water_NN in_IN the_DT erythrocytes_NNS ,_, using_VBG glutathione_NN as_IN a_DT reducing_VBG substrate_NN ._. 
3,_CD OMIM_NNP ,_, +138320_CD -RRB-_-RRB- have_VBP been_VBN related_VBN to_TO enhanced_JJ risk_NN of_IN cancer_NN 
In_IN the_DT same_JJ way_NN ,_, the_DT frequencies_NNS of_IN variants_NNS ,_, such_JJ as_IN the_DT Ala_NNP allele_NN of_IN MnSOD_NNP gene_NN ,_, T_NN allele_NN of_IN CAT_NNP gene_NN and_CC Leu_NNP allele_NN of_IN GPx-1_JJ gene_NN vary_VBP between_IN ethnic_JJ groups_NNS 
Polymorphisms_NNS in_IN the_DT GPx-1_JJ gene_NN -LRB-_-LRB- locus_FW 3p21_FW ._. 
9-RRB-_NN catalyses_VBZ the_DT reduction_NN of_IN hydrogen_NN peroxide_NN to_TO water_NN in_IN the_DT erythrocytes_NNS ,_, using_VBG glutathione_NN as_IN a_DT reducing_VBG substrate_NN ._. 
3,_CD OMIM_NNP ,_, +138320_CD -RRB-_-RRB- have_VBP been_VBN related_VBN to_TO enhanced_JJ risk_NN of_IN cancer_NN 
1._CD 
11_CD ._. 
Glutathione_NN peroxidase_NN 1_CD -LRB-_-LRB- GPx-1_NNP ,_, EC_NNP 1_CD ._. 
Additionally_RB ,_, synthesis_NN of_IN the_DT antioxidant_JJ enzymes_NNS is_VBZ part_NN of_IN the_DT adaptive_JJ response_NN triggered_VBN by_IN the_DT stress_NN posed_VBN by_IN ROS_NNP ._. 
9-RRB-_NN catalyses_VBZ the_DT reduction_NN of_IN hydrogen_NN peroxide_NN to_TO water_NN in_IN the_DT erythrocytes_NNS ,_, using_VBG glutathione_NN as_IN a_DT reducing_VBG substrate_NN 
DNA_NN fragments_NNS containing_VBG I\/D_NNP polymorphism_NN in_IN intron_NN 16_CD of_IN the_DT ACE_NNP gene_NN were_VBD amplified_VBN by_IN PCR_NNP as_RB previously_RB described_VBN by_IN Rigat_NNP et_FW al._FW ,_, 1992_CD ,_, using_VBG DMSO_NNP -LRB-_-LRB- dimethyl_JJ sulfoxide_NN -RRB-_-RRB- as_IN recommended_VBN by_IN Odawara_NNP et_FW al._FW ,_, 1997_CD 
,2001_CD 
1._CD 
11_CD ._. 
Glutathione_NN peroxidase_NN 1_CD -LRB-_-LRB- GPx-1_NNP ,_, EC_NNP 1_CD ._. 
Additionally_RB ,_, synthesis_NN of_IN the_DT antioxidant_JJ enzymes_NNS is_VBZ part_NN of_IN the_DT adaptive_JJ response_NN triggered_VBN by_IN the_DT stress_NN posed_VBN by_IN ROS_NNP ._. 
9-RRB-_NN catalyses_VBZ the_DT reduction_NN of_IN hydrogen_NN peroxide_NN to_TO water_NN in_IN the_DT erythrocytes_NNS ,_, using_VBG glutathione_NN as_IN a_DT reducing_VBG substrate_NN 
Polymorphisms_NNS in_IN the_DT GPx-1_JJ gene_NN -LRB-_-LRB- locus_FW 3p21_FW ._. 
9-RRB-_NN catalyses_VBZ the_DT reduction_NN of_IN hydrogen_NN peroxide_NN to_TO water_NN in_IN the_DT erythrocytes_NNS ,_, using_VBG glutathione_NN as_IN a_DT reducing_VBG substrate_NN ._. 
3,_CD OMIM_NNP ,_, +138320_CD -RRB-_-RRB- have_VBP been_VBN related_VBN to_TO enhanced_JJ risk_NN of_IN cancer_NN 
One_CD of_IN the_DT potential_JJ answers_NNS is_VBZ related_VBN to_TO the_DT composition_NN of_IN polymorphisms_NNS in_IN different_JJ study_NN populations_NNS 
,2001_CD 
One_CD of_IN the_DT potential_JJ answers_NNS is_VBZ related_VBN to_TO the_DT composition_NN of_IN polymorphisms_NNS in_IN different_JJ study_NN populations_NNS 
,1998_CD ,_, while_IN Mn-SOD_NNP ,_, CAT_NNP and_CC GPx-1_NNP genotypes_NNS were_VBD determined_VBN by_IN polymerase_NN chain_NN reaction_NN -LRB-_-LRB- PCR_NNP -RRB-_-RRB- -_: based_VBN restriction_NN fragment_NN length_NN polymorphism_NN -LRB-_-LRB- RFLP_NNP -RRB-_-RRB- assays_NNS performed_VBN as_IN described_VBN respectively_RB by_IN Mitrunen_NNP et_NNP al._NNP ,_, 2001_CD 
Hp_NN genotypes_NNS were_VBD determined_VBN by_IN allele-specific_JJ polymerase_NN chain_NN reaction_NN -LRB-_-LRB- PCR_NNP -RRB-_-RRB- as_IN described_VBN by_IN Yano_NNP et_FW al._FW ,_, 1998_CD ,_, while_IN Mn-SOD_NNP ,_, CAT_NNP and_CC GPx-1_NNP genotypes_NNS were_VBD determined_VBN by_IN polymerase_NN chain_NN reaction_NN -LRB-_-LRB- PCR_NNP -RRB-_-RRB- -_: based_VBN restriction_NN fragment_NN length_NN polymorphism_NN -LRB-_-LRB- RFLP_NNP -RRB-_-RRB- assays_NNS performed_VBN as_IN described_VBN respectively_RB by_IN Mitrunen_NNP et_NNP al._NNP ,_, 2001_CD 
,1995_CD 
Single-cell-gel_NN electrophoresis_VBZ The_DT comet_NN assay_NN -LRB-_-LRB- alkali_JJ method_NN -RRB-_-RRB- was_VBD performed_VBN according_VBG to_TO the_DT method_NN developed_VBN by_IN Singh_NNP et_FW al._FW ,_, 1988_CD ,_, with_IN a_DT few_JJ modifications_NNS ._. 
Briefly_RB ,_, 20_CD 
Hp_NN polymorphism_NN has_VBZ been_VBN associated_VBN with_IN the_DT prevalence_NN and_CC clinical_JJ evolution_NN of_IN many_JJ inflammatory_JJ diseases_NNS ,_, including_VBG infections_NNS ,_, atherosclerosis_NN and_CC autoimmune_JJ disorders_NNS 
It_PRP has_VBZ been_VBN reported_VBN that_IN ACE_NNP DD_NNP polymorphism_NN is_VBZ a_DT potent_JJ risk_NN factor_NN for_IN myocardial_JJ infarction_NN 
It_PRP has_VBZ been_VBN reported_VBN that_IN ACE_NNP DD_NNP polymorphism_NN is_VBZ a_DT potent_JJ risk_NN factor_NN for_IN myocardial_JJ infarction_NN 
In_IN addition_NN ,_, it_PRP has_VBZ been_VBN demonstrated_VBN that_IN the_DT ability_NN of_IN serum_NN glycoprotein_NN haptoglobin_NN -LRB-_-LRB- Hp_NNP -RRB-_-RRB- to_TO bind_NN free_JJ hemoglobin_NN -LRB-_-LRB- Hb_NNP -RRB-_-RRB- in_IN the_DT plasma_NN and_CC block_NN Hb-induced_JJ oxidative_JJ damage_NN is_VBZ phenotype_JJ dependent_JJ 
In_IN addition_NN ,_, it_PRP has_VBZ been_VBN demonstrated_VBN that_IN the_DT ability_NN of_IN serum_NN glycoprotein_NN haptoglobin_NN -LRB-_-LRB- Hp_NNP -RRB-_-RRB- to_TO bind_NN free_JJ hemoglobin_NN -LRB-_-LRB- Hb_NNP -RRB-_-RRB- in_IN the_DT plasma_NN and_CC block_NN Hb-induced_JJ oxidative_JJ damage_NN is_VBZ phenotype_JJ dependent_JJ 
Moreover_RB ,_, the_DT excessive_JJ production_NN of_IN ROS_NNP and_CC the_DT consequent_JJ imbalance_NN between_IN their_PRP$ concentrations_NNS and_CC the_DT antioxidant_JJ defense_NN may_MD be_VB related_VBN to_TO the_DT aging_NN process_NN 
Most_JJS of_IN these_DT genetic_JJ variants_NNS have_VBP been_VBN reported_VBN to_TO result_VB in_IN changes_NNS in_IN enzyme_NN levels_NNS or_CC activities_NNS ,_, which_WDT can_MD lead_VB to_TO reduction_NN in_IN protection_NN against_IN oxidative_JJ stress_NN ._. 
In_IN addition_NN ,_, it_PRP has_VBZ been_VBN demonstrated_VBN that_IN the_DT ability_NN of_IN serum_NN glycoprotein_NN haptoglobin_NN -LRB-_-LRB- Hp_NNP -RRB-_-RRB- to_TO bind_NN free_JJ hemoglobin_NN -LRB-_-LRB- Hb_NNP -RRB-_-RRB- in_IN the_DT plasma_NN and_CC block_NN Hb-induced_JJ oxidative_JJ damage_NN is_VBZ phenotype_JJ dependent_JJ 
In_IN addition_NN ,_, it_PRP has_VBZ been_VBN demonstrated_VBN that_IN the_DT ability_NN of_IN serum_NN glycoprotein_NN haptoglobin_NN -LRB-_-LRB- Hp_NNP -RRB-_-RRB- to_TO bind_NN free_JJ hemoglobin_NN -LRB-_-LRB- Hb_NNP -RRB-_-RRB- in_IN the_DT plasma_NN and_CC block_NN Hb-induced_JJ oxidative_JJ damage_NN is_VBZ phenotype_JJ dependent_JJ 
Moreover_RB ,_, the_DT excessive_JJ production_NN of_IN ROS_NNP and_CC the_DT consequent_JJ imbalance_NN between_IN their_PRP$ concentrations_NNS and_CC the_DT antioxidant_JJ defense_NN may_MD be_VB related_VBN to_TO the_DT aging_NN process_NN 
Background_NN Normal_JJ cellular_JJ metabolism_NN is_VBZ well_RB established_VBN as_IN the_DT source_NN of_IN endogenous_JJ reactive_JJ oxygen_NN species_NNS -LRB-_-LRB- ROS_NNP -RRB-_-RRB- ,_, mainly_RB as_IN a_DT result_NN of_IN normal_JJ oxidative_JJ metabolism_NN in_IN the_DT mitochondria_NN 
One_CD hundred_CD comets_NNS on_IN each_DT slide_NN were_VBD scored_VBN visually_RB by_IN a_DT trained_JJ professional_NN as_IN belonging_VBG to_TO one_CD of_IN the_DT five_CD classes_NNS proposed_VBN by_IN Collins_NNP et_NNP al._NNP ,_, 1995_CD 
Background_NN Normal_JJ cellular_JJ metabolism_NN is_VBZ well_RB established_VBN as_IN the_DT source_NN of_IN endogenous_JJ reactive_JJ oxygen_NN species_NNS -LRB-_-LRB- ROS_NNP -RRB-_-RRB- ,_, mainly_RB as_IN a_DT result_NN of_IN normal_JJ oxidative_JJ metabolism_NN in_IN the_DT mitochondria_NN 
In_IN such_JJ circumstances_NNS ,_, ROS_NNP may_MD interact_VB with_IN cellular_JJ biomolecules_NNS ,_, such_JJ as_IN DNA_NNP ,_, leading_VBG to_TO modification_NN and_CC potentially_RB serious_JJ consequences_NNS for_IN the_DT cell_NN 
In_IN this_DT context_NN ,_, the_DT comet_NN assay_NN could_MD be_VB used_VBN to_TO evaluate_VB this_DT damage_NN ,_, because_IN it_PRP is_VBZ widely_RB accepted_VBN as_IN a_DT standard_JJ method_NN for_IN assessing_VBG DNA_NNP damage_NN type_NN in_IN individual_JJ cells_NNS 
It_PRP is_VBZ a_DT valuable_JJ tool_NN for_IN population_NN monitoring_NN ,_, for_IN example_NN in_IN assessing_VBG the_DT role_NN of_IN oxidative_JJ stress_NN in_IN human_JJ disease_NN ,_, mechanisms_NNS of_IN mutagenesis_NNS ,_, genotoxicology_JJ and_CC ecological_JJ monitoring_NN ._. 
It_PRP is_VBZ also_RB used_VBN to_TO investigate_VB DNA_NN damage_NN and_CC repair_NN in_IN different_JJ cell_NN types_NNS in_IN response_NN to_TO a_DT range_NN of_IN DNA-damaging_JJ agents_NNS ,_, as_RB well_RB as_IN monitoring_VBG the_DT effects_NNS of_IN dietary_JJ antioxidants_NNS 
Under_IN normal_JJ circumstances_NNS ,_, ROS_NNP are_VBP neutralized_VBN by_IN an_DT elaborate_JJ antioxidant_JJ defense_NN system_NN consisting_VBG of_IN enzymes_NNS such_JJ as_IN catalase_NN -LRB-_-LRB- CAT_NNP -RRB-_-RRB- ,_, superoxide_NN dismutase_NN -LRB-_-LRB- SOD_NNP -RRB-_-RRB- ,_, glutathione_NN peroxidase_NN -LRB-_-LRB- GPx_NNP -RRB-_-RRB- and_CC numerous_JJ non-enzymatic_JJ antioxidants_NNS 
,._NN 
Under_IN normal_JJ circumstances_NNS ,_, ROS_NNP are_VBP neutralized_VBN by_IN an_DT elaborate_JJ antioxidant_JJ defense_NN system_NN consisting_VBG of_IN enzymes_NNS such_JJ as_IN catalase_NN -LRB-_-LRB- CAT_NNP -RRB-_-RRB- ,_, superoxide_NN dismutase_NN -LRB-_-LRB- SOD_NNP -RRB-_-RRB- ,_, glutathione_NN peroxidase_NN -LRB-_-LRB- GPx_NNP -RRB-_-RRB- and_CC numerous_JJ non-enzymatic_JJ antioxidants_NNS 
Conclusions_NNS The_DT GPx-1_JJ polymorphism_NN and_CC the_DT interactions_NNS between_IN GPX-1_NNP \/_NNP ACE_NNP and_CC Hp\/GSTM1T1_NNP can_MD be_VB determining_VBG factors_NNS for_IN DNA_NN oxidation_NN provoked_VBN by_IN hydrogen_NN peroxide_NN ,_, and_CC thus_RB for_IN higher_JJR susceptibility_NN to_TO or_CC protection_NN against_IN oxidative_JJ stress_NN suffered_VBN by_IN healthy_JJ individuals_NNS ._. 
BackgroundNormal_JJ cellular_JJ metabolism_NN is_VBZ well_RB established_VBN as_IN the_DT source_NN of_IN endogenous_JJ reactive_JJ oxygen_NN species_NNS -LRB-_-LRB- ROS_NNP -RRB-_-RRB- ,_, mainly_RB as_IN a_DT result_NN of_IN normal_JJ oxidative_JJ metabolism_NN in_IN the_DT mitochondria_NN 
Because_IN the_DT byproducts_NNS of_IN oxidative_JJ phosphorylation_NN reactions_NNS can_MD diffuse_VB from_IN mitochondria_NNS ,_, reach_VBP the_DT nuclear_JJ DNA_NN and_CC induce_VB damage_NN 
The_DT reaction_NN of_IN H_NNP 2_CD O_NNP 2_CD with_IN transition_NN metals_NNS imposes_VBZ an_DT oxidative_JJ stress_NN condition_NN on_IN cells_NNS ._. 
Hydrogen_NN peroxide_NN -LRB-_-LRB- H_NNP 2_CD O_NNP 2_CD -RRB-_-RRB- is_VBZ an_DT important_JJ reactive_JJ oxygen_NN species_NNS -LRB-_-LRB- ROS_NNP -RRB-_-RRB- that_WDT arises_VBZ either_CC during_IN the_DT aerobic_JJ respiration_NN process_NN or_CC as_IN a_DT by-product_NN of_IN water_NN radiolysis_NNS after_IN exposure_NN to_TO ionizing_VBG radiation_NN 
Conclusions_NNS The_DT GPx-1_JJ polymorphism_NN and_CC the_DT interactions_NNS between_IN GPX-1_NNP \/_NNP ACE_NNP and_CC Hp\/GSTM1T1_NNP can_MD be_VB determining_VBG factors_NNS for_IN DNA_NN oxidation_NN provoked_VBN by_IN hydrogen_NN peroxide_NN ,_, and_CC thus_RB for_IN higher_JJR susceptibility_NN to_TO or_CC protection_NN against_IN oxidative_JJ stress_NN suffered_VBN by_IN healthy_JJ individuals_NNS ._. 
BackgroundNormal_JJ cellular_JJ metabolism_NN is_VBZ well_RB established_VBN as_IN the_DT source_NN of_IN endogenous_JJ reactive_JJ oxygen_NN species_NNS -LRB-_-LRB- ROS_NNP -RRB-_-RRB- ,_, mainly_RB as_IN a_DT result_NN of_IN normal_JJ oxidative_JJ metabolism_NN in_IN the_DT mitochondria_NN 
Background_NN Normal_JJ cellular_JJ metabolism_NN is_VBZ well_RB established_VBN as_IN the_DT source_NN of_IN endogenous_JJ reactive_JJ oxygen_NN species_NNS -LRB-_-LRB- ROS_NNP -RRB-_-RRB- ,_, mainly_RB as_IN a_DT result_NN of_IN normal_JJ oxidative_JJ metabolism_NN in_IN the_DT mitochondria_NN 
Although_IN a_DT certain_JJ level_NN of_IN damage_NN can_MD not_RB be_VB avoided_VBN ,_, oxidative_JJ stress_NN can_MD occur_VB when_WRB the_DT balance_NN is_VBZ upset_JJ ,_, either_CC by_IN an_DT excessive_JJ production_NN of_IN ROS_NNP ,_, by_IN deficient_JJ antioxidant_JJ defenses_NNS ,_, or_CC by_IN a_DT combination_NN of_IN both_DT 
In_IN such_JJ circumstances_NNS ,_, ROS_NNP may_MD interact_VB with_IN cellular_JJ biomolecules_NNS ,_, such_JJ as_IN DNA_NNP ,_, leading_VBG to_TO modification_NN and_CC potentially_RB serious_JJ consequences_NNS for_IN the_DT cell_NN 
It_PRP is_VBZ a_DT valuable_JJ tool_NN for_IN population_NN monitoring_NN ,_, for_IN example_NN in_IN assessing_VBG the_DT role_NN of_IN oxidative_JJ stress_NN in_IN human_JJ disease_NN ,_, mechanisms_NNS of_IN mutagenesis_NNS ,_, genotoxicology_JJ and_CC ecological_JJ monitoring_NN ._. 
It_PRP is_VBZ also_RB used_VBN to_TO investigate_VB DNA_NN damage_NN and_CC repair_NN in_IN different_JJ cell_NN types_NNS in_IN response_NN to_TO a_DT range_NN of_IN DNA-damaging_JJ agents_NNS ,_, as_RB well_RB as_IN monitoring_VBG the_DT effects_NNS of_IN dietary_JJ antioxidants_NNS 
7nm_CD -RRB-_-RRB- ._. 
T-Hg_NN was_VBD analyzed_VBN in_IN full_JJ blood_NN from_IN 22_CD harbor_NN seals_NNS by_IN cold_JJ vapor_NN atomic_JJ absorption_NN spectrometry_NN on_IN a_DT Perkin-Elmer_NNP Coleman_NNP Mas-50_NNP Mercury_NNP Analyser_NNP -LRB-_-LRB- wavelength_NN 253_CD ._. 
The_DT freeze-dried_JJ samples_NNS were_VBD subjected_VBN to_TO microwave-assisted_JJ digestion_NN with_IN nitric_JJ acid_NN and_CC H2O2_NNP ,_, as_IN described_VBN previously_RB for_IN blood_NN and_CC other_JJ tissues_NNS ._. 
Quality_JJ control_NN measurements_NNS for_IN T-Hg_NNP included_VBD replicate_VB analysis_NN resulting_VBG in_IN coefficients_NNS of_IN variation_NN 
Primer_NN sequences_NNS for_IN the_DT amplification_NN of_IN GAPDH_NNP and_CC TGF_NNP -_: 
Primer_NN sequences_NNS for_IN the_DT amplification_NN of_IN GAPDH_NNP and_CC TGF_NNP -_: 
Exposure_NN of_IN T-Cells_NNS to_TO MeHg_NNP chloride_NN has_VBZ been_VBN found_VBN to_TO cause_VB a_DT decrease_NN in_IN the_DT overall_JJ size_NN of_IN mitochondria_NNS and_CC changes_NNS in_IN the_DT structure_NN of_IN the_DT cristae_NN ,_, leading_VBG finally_RB to_TO apoptosis_NN ._. 
ml_FW -1_FW ._. 
PHA_NNP was_VBD diluted_VBN in_IN culture_NN medium_NN at_IN an_DT optimal_JJ concentration_NN of_IN 1_CD 
After_IN DNase-treatment_NNP -LRB-_-LRB- DNA_NNP -_: free_JJ 
Protein_NN preparation_NN After_IN 72_CD h_NN of_IN MeHg_NNP exposure_NN -LRB-_-LRB- 1_CD 
Buffy_JJ coats_NNS from_IN healthy_JJ 30_CD 
MeHg_NNP has_VBZ a_DT high_JJ bioavailability_NN ;_: it_PRP bioaccumulates_NNS and_CC biomagnifies_NNS at_IN all_DT trophic_JJ levels_NNS in_IN the_DT food_NN web_NN and_CC has_VBZ severe_JJ toxicological_JJ effects_NNS 
1to_CD 10_CD 
8_CD 
Methylation_NN of_IN inorganic_JJ Hg_NN is_VBZ a_DT key_JJ processes_NNS in_IN marine_JJ food_NN webs_NNS affected_VBN by_IN several_JJ variables_NNS including_VBG temperature_NN 
The_DT high_JJ relevance_NN of_IN tiemannite_JJ precipitation_NN in_IN marine_JJ mammals_NNS -LRB-_-LRB- compared_VBN to_TO other_JJ mammals_NNS and_CC birds_NNS -RRB-_-RRB- is_VBZ likely_JJ to_TO be_VB related_VBN to_TO a_DT combination_NN of_IN factors_NNS ,_, namely_RB ,_, elevated_JJ MeHg_NNP exposure_NN ,_, due_JJ to_TO fish_NN eating_NN habits_NNS ,_, and_CC the_DT inability_NN to_TO excrete_VB MeHg_NNP through_IN gills_NNS ,_, feathers_NNS or_CC fur_NN 
However_RB ,_, the_DT demethylation_NN process_NN is_VBZ not_RB ``_`` instantaneous_JJ ''_'' and_CC before_IN reaching_VBG these_DT long-term_JJ accumulation_NN organs_NNS ,_, Hg_NNP is_VBZ assimilated_VBN from_IN fish_NN ,_, and_CC is_VBZ transferred_VBN and_CC transported_VBN via_IN the_DT blood_NN stream_NN ,_, mainly_RB in_IN its_PRP$ methylated_JJ form_NN ._. 
Ahigh_JJ percentage_NN of_IN blood_NN Hg_NN concentration_NN is_VBZ in_IN a_DT methylated_JJ form_NN -LRB-_-LRB- up_IN to_TO 90_CD %_NN -RRB-_-RRB- ,_, especially_RB in_IN human_JJ and_CC marine_JJ mammal_JJ populations_NNS relying_VBG on_IN fish_NN 
1to_CD 10_CD 
Buffy_JJ coats_NNS from_IN healthy_JJ 30_CD 
MeHg_NNP has_VBZ a_DT high_JJ bioavailability_NN ;_: it_PRP bioaccumulates_NNS and_CC biomagnifies_NNS at_IN all_DT trophic_JJ levels_NNS in_IN the_DT food_NN web_NN and_CC has_VBZ severe_JJ toxicological_JJ effects_NNS 
However_RB ,_, despite_IN these_DT regulations_NNS ,_, a_DT decrease_NN in_IN levels_NNS of_IN mercury_NN in_IN the_DT biota_NN ,_, including_VBG marine_JJ mammals_NNS ,_, is_VBZ not_RB obvious_JJ 
However_RB ,_, despite_IN these_DT regulations_NNS ,_, a_DT decrease_NN in_IN levels_NNS of_IN mercury_NN in_IN the_DT biota_NN ,_, including_VBG marine_JJ mammals_NNS ,_, is_VBZ not_RB obvious_JJ 
Methylation_NN of_IN inorganic_JJ Hg_NN is_VBZ a_DT key_JJ processes_NNS in_IN marine_JJ food_NN webs_NNS affected_VBN by_IN several_JJ variables_NNS including_VBG temperature_NN 
The_DT high_JJ relevance_NN of_IN tiemannite_JJ precipitation_NN in_IN marine_JJ mammals_NNS -LRB-_-LRB- compared_VBN to_TO other_JJ mammals_NNS and_CC birds_NNS -RRB-_-RRB- is_VBZ likely_JJ to_TO be_VB related_VBN to_TO a_DT combination_NN of_IN factors_NNS ,_, namely_RB ,_, elevated_JJ MeHg_NNP exposure_NN ,_, due_JJ to_TO fish_NN eating_NN habits_NNS ,_, and_CC the_DT inability_NN to_TO excrete_VB MeHg_NNP through_IN gills_NNS ,_, feathers_NNS or_CC fur_NN 
However_RB ,_, the_DT demethylation_NN process_NN is_VBZ not_RB ``_`` instantaneous_JJ ''_'' and_CC before_IN reaching_VBG these_DT long-term_JJ accumulation_NN organs_NNS ,_, Hg_NNP is_VBZ assimilated_VBN from_IN fish_NN ,_, and_CC is_VBZ transferred_VBN and_CC transported_VBN via_IN the_DT blood_NN stream_NN ,_, mainly_RB in_IN its_PRP$ methylated_JJ form_NN ._. 
Ahigh_JJ percentage_NN of_IN blood_NN Hg_NN concentration_NN is_VBZ in_IN a_DT methylated_JJ form_NN -LRB-_-LRB- up_IN to_TO 90_CD %_NN -RRB-_-RRB- ,_, especially_RB in_IN human_JJ and_CC marine_JJ mammal_JJ populations_NNS relying_VBG on_IN fish_NN 
ml_FW -1_FW ._. 
PHA_NNP was_VBD diluted_VBN in_IN culture_NN medium_NN at_IN an_DT optimal_JJ concentration_NN of_IN 1_CD 
Fish_NN represent_VBP the_DT major_JJ MeHg_NNP source_NN for_IN human_JJ and_CC marine_JJ mammal_JJ populations_NNS 
Similarly_RB ,_, Devos_FW et_FW al._FW ._. 
IL-4_NN is_VBZ known_VBN to_TO induce_VB the_DT differentiation_NN of_IN naive_JJ helper_NN T_NN cells_NNS -LRB-_-LRB- Th0_JJ cells_NNS -RRB-_-RRB- into_IN Th2_JJ cells_NNS ._. 
found_VBN that_IN inorganic_JJ mercury_NN -LRB-_-LRB- HgCl2_NNP -RRB-_-RRB- and_CC MeHg_NNP was_VBD capable_JJ of_IN increasing_VBG IL-4_NN production_NN in_IN Con_NN A-stimulated_JJ human_JJ PBMC_NN in_IN vitro_NN 
found_VBN that_IN inorganic_JJ mercury_NN -LRB-_-LRB- HgCl_NNP 2_CD -RRB-_-RRB- and_CC MeHg_NNP was_VBD capable_JJ of_IN increasing_VBG IL-4_NN production_NN in_IN Con_NN A-stimulated_JJ human_JJ PBMC_NN in_IN vitro_NN 
1_CD 
These_DT preliminary_JJ in_IN vitro_NN results_NNS suggest_VBP that_IN MeHg_NNP could_MD induce_VB a_DT differentiation_NN of_IN na_TO 
The_DT observed_JJ correlation_NN reflects_VBZ daily_JJ Hg_NNP intake_NN and_CC thus_RB ,_, the_DT amount_NN of_IN fish_NN ingested_VBD ,_, which_WDT differs_VBZ according_VBG the_DT body_NN mass_NN of_IN animals_NNS ._. 
Adult_NN harbor_NN seals_NNS eat_VBP 5_CD %_NN to_TO 6_CD %_NN of_IN their_PRP$ body_NN weight_NN per_IN day_NN ,_, up_IN to_TO 7_CD kg_NN for_IN big_JJ individuals_NNS ._. 
T-Hg_JJ levels_NNS measured_VBN in_IN the_DT blood_NN of_IN harbor_NN seals_NNS caught_VBN in_IN the_DT North_NNP Sea_NNP are_VBP higher_JJR than_IN those_DT previously_RB described_VBN in_IN North_NNP Atlantic_NNP or_CC in_IN Arctic_NNP regions_NNS -LRB-_-LRB- Table_NNP 3_CD -RRB-_-RRB- 
Whether_IN this_DT phenomenon_NN has_VBZ clinical_JJ relevance_NN in_IN marine_JJ mammal_JJ populations_NNS remains_VBZ to_TO be_VB determined_VBN ._. 
Study_NNP of_IN the_DT proteomeProteomics_NNS facilitates_VBZ the_DT identification_NN of_IN new_JJ biomarkers_NNS of_IN chemical_NN exposure_NN and_CC studies_NNS of_IN mechanisms_NNS by_IN which_WDT protein_NN modification_NN contribute_VBP to_TO the_DT adverse_JJ effects_NNS of_IN environmental_JJ exposure_NN 
Study_NNP of_IN the_DT proteome_NN Proteomics_NNP facilitates_VBZ the_DT identification_NN of_IN new_JJ biomarkers_NNS of_IN chemical_NN exposure_NN and_CC studies_NNS of_IN mechanisms_NNS by_IN which_WDT protein_NN modification_NN contribute_VBP to_TO the_DT adverse_JJ effects_NNS of_IN environmental_JJ exposure_NN 
Study_NNP of_IN the_DT proteome_NN Proteomics_NNP facilitates_VBZ the_DT identification_NN of_IN new_JJ biomarkers_NNS of_IN chemical_NN exposure_NN and_CC studies_NNS of_IN mechanisms_NNS by_IN which_WDT protein_NN modification_NN contribute_VBP to_TO the_DT adverse_JJ effects_NNS of_IN environmental_JJ exposure_NN 
Interest_NN in_IN the_DT harbor_NN seal_NN has_VBZ stemmed_VBN partly_RB from_IN earlier_JJR captive_JJ studies_NNS on_IN the_DT reproductive_JJ toxicity_NN of_IN environmental_JJ contaminants_NNS using_VBG this_DT species_NNS ,_, but_CC more_RBR importantly_RB this_DT interest_NN has_VBZ occurred_VBN as_IN a_DT consequence_NN of_IN recurrent_JJ phocine_JJ distemper_NN virus_NN -LRB-_-LRB- PDV_NNP -RRB-_-RRB- epizootics_NNS 
These_DT preliminary_JJ in_IN vitro_NN results_NNS suggest_VBP that_IN MeHg_NNP could_MD induce_VB a_DT differentiation_NN of_IN na_TO 
PBMCs_NNS were_VBD incubated_VBN without_IN mitogen_NN or_CC in_IN the_DT presence_NN of_IN phytohemaglutinin_NN -LRB-_-LRB- PHA_NNP ,_, 5_CD 
ml_FW -1_FW ._. 
PHA_NNP was_VBD diluted_VBN in_IN culture_NN medium_NN at_IN an_DT optimal_JJ concentration_NN of_IN 1_CD 
Primers_NNS for_IN the_DT detection_NN of_IN IL-2_NN and_CC IL-4_NN were_VBD selected_VBN from_IN conserved_VBN nucleotide_NN sequences_NNS of_IN gray_JJ seals_NNS -LRB-_-LRB- Halichoerus_FW grypus_FW -RRB-_-RRB- and_CC dogs_NNS -LRB-_-LRB- Canis_NNP familiaris_NNS -RRB-_-RRB- respectively_RB -LRB-_-LRB- GenBank_NNP accession_NN numbers_NNS AF072871_NNP ,_, AF187322_NNP ,_, AF104245_NNP -RRB-_-RRB- ._. 
Primer_NN sequences_NNS for_IN the_DT amplification_NN of_IN GAPDH_NNP and_CC TGF_NNP -_: 
The_DT seals_NNS were_VBD physically_RB restrained_VBN ._. 
Methods_NNP Blood_NNP sampling_NN Blood_NNP was_VBD sampled_VBN from_IN 33_CD harbor_NN seals_NNS caught_VBN along_IN the_DT German_JJ coast_NN or_CC kept_VBD in_IN captivity_NN -LRB-_-LRB- Seal_NNP Station_NNP ,_, Friedrichskoog_NNP ,_, Germany_NNP -RRB-_-RRB- between_IN 1997_CD and_CC 2006_CD -LRB-_-LRB- Table_NNP 1_CD -RRB-_-RRB- ._. 
Health_NNP status_NN was_VBD determined_VBN by_IN physical_JJ examination_NN ,_, using_VBG routine_JJ hematological_JJ analysis_NN -LRB-_-LRB- blood_NN counts_NNS -RRB-_-RRB- and_CC serum_NN chemistry_NN -LRB-_-LRB- detailed_JJ protocol_NN described_VBD previously_RB -RRB-_-RRB- ._. 
